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LYMPHATIC FILARIASIS RESIDUAL TRANSMISSION 
HOTSPOTS IN AMERICAN SAMOA
Patricia M. Graves1, Colleen Lau2, Maureen Roineau1, Stephanie 
Ryan1, Athena Andreosso1, Sarah Sheridan3, Saipale Fuimano4, 
Joseph Tufa4
1James Cook University, Cairns, Qld, Australia, 2Australia National 
University, Canberra, ACT, Australia, 3University of Queensland, Brisbane, 
Qld, Australia, 4Department of Health, Pago Pago, American Samoa
To achieve elimination of lymphatic filariasis, American Samoa carried out 
7 rounds of mass drug administration from 2000 to 2006 and passed 
Transmission Assessment Surveys (TAS) in 6-7 yr-old children in 2011 
and 2015, although 1 or 2 ICT-positive children were found on each 
occasion in the same school. Serology studies using Og4C3, Wb123 and 
Bm14 in 807 adults in 2010 identified higher antigen prevalence in two 
spatial clusters, one of which included the school attended by ICT-positive 
children in both TAS. Prevalence was higher in men and those residing in 
American Samoa for <5 yrs. To follow up these findings, a targeted study 
in 2014 tested three groups of individuals: 124 residents aged 3-70 yrs 
in the two putative ‘hotspots’; 337 children aged 7-13 yrs in the school 
where ICT-positives had been identified in TAS; and 650 adult workers 
(residing across the island) attending a pre-employment clinic or working 
in the tuna cannery. Overall prevalence (N=898 to 1,111 depending 
on the test) was 2.1% (95% CI 1.3-3.1%) for ICT and Og4C3, 5.7% 
(4.2-7.3%) for Wb123, and 10.2% (8.5-12.2%) for Bm14. The study 
confirmed elevated prevalence of ICT and Og4C3 (both 8.1%) antigen as 
well as Wb123 (9.8%) and Bm14 (23.6%) antibody in all ages in the two 
suspected hotspots. Bm14 antibody prevalence was higher in males than 
females in all groups (32.1% vs 17.1% in hotspot villages (p=0.05); 19.9% 
vs 7.0% in adult workers (p<0.001); and 3.3% vs 0.6% in children aged 
7-13 yrs (p=0.06)). All ICT positive persons were treated and had slides 
taken. Microfilariae (Mf) with density from 8 to 3267/ml were observed on 
4 of 20 slides examined, with all Mf positive persons residing in hotspots. 
Thus age, gender and residence in a hotspot village were the predominant 
risk factors for being positive for diagnostic markers of LF. This study has 
confirmed the suspected hotspots previously identified in 2010 from a 
spatially representative adult sample as sites of continuing transmission 
and potential sources of resurgence. The results further support the 
potential use of spatial epidemiological methods for identifying residual 
foci of infection in the endgame phase of LF elimination programs.
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EXCESS MORTALITY ASSOCIATED WITH HIGH LOA LOA 
MICROFILAREMIA IN THE EAST REGION OF CAMEROON: A 
RETROSPECTIVE COHORT STUDY
Cédric B. Chesnais1, Innocent Takougang2, Marius Paguele3, 
Michel Boussinesq1, Sébastien D. Pion1
1Institut de Recherche pour le Développement, Montpellier, France, 
2Department of Public Health, Faculty of Medicine and Biomedical 
Sciences, University of Yaounde I, Yaoundé, Cameroon, 3Regional 
Delegation of Health, Ministry of Public Health, Bertoua, Cameroon
Loiasis affects more than 10 million people, most in Central Africa. 
Besides its classical signs (“eye worm” and “Calabar swelling”), it 
has also been reported as a cause of renal and cardiac complications. 
However, the burden of loiasis has never been assessed and it is still 
considered a benign condition. To assess whether loiasis bears any excess 
mortality, we conducted a retrospective cohort study in the East Region of 
Cameroon. In 2001, 3,627 individuals living in 28 villages were included 
in a survey during which thick blood smears (50 µL) were analyzed for 
Loa loa microfilarial (mf) density. In 2016, these villages (where no mass 
ivermectin treatment has ever been organized) were visited again to assess 
whether the subjects examined 15 years before were still alive. The vital 
status could be determined for 3,301 individuals (91%). Data analyses 
included (a) an analysis at the community level between the age- and 
sex-standardized prevalence of (hyper)-microfilaremia in 2001 and the 
standardized mortality rates (SMR); (b) an assessment, using multivariate 
accelerated failure model, of the excess mortality relative to the initial 
mf density (4 classes: 0, 1-8,000, 8,000-30,000 and >30,000 mf/mL); (c) 
the calculation of the population-attributable fraction of mortality due to 
presence (vs. absence) of a Loa microfilaremia. At community level, the 
SMRs increased by 5.5% when the proportion of subjects with >30,000 
mf/ml increased by 1% (P=0.040). A similar trend was observed when the 
threshold was 8,000 mf/ml (2.9%/1%; P=0.068). People aged >25 years 
with more than 30,000 mf/mL in 2001 died significantly earlier than those 
with lower mf densities (Time Ratio=0.67, 95% CI: 0.48-0.95, P=0.024). 
Lastly, 14.5% (95% CI: 6.5-21.8) of all-cause mortality was attributable 
to the presence of Loa mf. In conclusion, high Loa microfilaremia was 
associated with increased mortality in the study site. There is a need to 
validate our observations in other Loa areas, as they are likely to have 
implications on the status of loiasis in terms of public health, and the 
implementation of onchocerciasis and lymphatic filariasis elimination 
programs in Central Africa.
3
PROGRESS TOWARDS ONCHOCERCIASIS ELIMINATION IN 
THE PARTICIPATING COUNTRIES OF THE AFRICAN PROGRAM 
FOR ONCHOCERCIASIS CONTROL: EPIDEMIOLOGICAL 
EVALUATION RESULTS
Afework H. Tekle1, Honorat G. Zouré1, Mounkaila Noma1, Michel 
Boussinesq2, Luc E. Coffeng3, Wilma A. Stolk3, Jan H. Remme4
1African Programme for Onchocerciasis Control, Ouagadougou, Burkina 
Faso, 2Institut de Recherche pour le Développement (IRD), Montpellier, 
France, 3Erasmus MC, Rotterdam, Netherlands, 4Consultant, Ornex, France
The African Programme for Onchocerciasis Control (APOC) was created 
in 1995 in order to control onchocerciasis as a public health problem by 
implementing sustainable Community Directed Treatment with Ivermectin 
(CDTI). When research showed that mass treatment can lead to complete 
elimination of the infection in Africa, APOC shifted its target to elimination 
of infection and interruption of transmission. Epidemiological evaluations 
have been undertaken from 2008 to 2014 in evaluation areas with ≥6 
years of effective treatment. We analyzed these unique data, to assess 
progress towards elimination. Epidemiological evaluations were done per 
area, in two phases. First, parasitological surveys were done in about 10 
selected high risk communities per area with high pre-control endemicity 
level. By comparing observed prevalence levels to expected trends (as 
predicted by the established ONCHOSIM model, developed at Erasmus 
MC Rotterdam, and extensively used for policy support in onchocerciasis 
control in Africa), using Bayesian methods and Monte Carlo simulation, 
we classified the progress towards elimination as “faster than predicted”, 
“on track”, or “delayed”. Second, in areas close to elimination, additional 
parasitological surveys were done in more communities to assess whether 
mass ivermectin treatment can safely be stopped. Initial parasitological 
surveys covered 54 areas, 639 villages and 127,665 people out of 53 
million total population. The decline in prevalence was faster than 
predicted in 23 areas, on track in another 23 and delayed in 8 areas. 
Additional surveys were done in 22 areas and 13 of these met the 
epidemiological criteria for stopping treatment. Overall, 32 areas (25.4 
million people) had reached or were close to elimination, 18 areas (17.4 
million) were on track but required more years treatment, and in 8 areas 
(10.4 million) progress was unsatisfactory. Great progress has been made 
by APOC in realizing elimination beyond its prime goal. Elimination is 
reached or close for millions of people. Extra effort is needed in areas with 
unsatisfactory progress.
2astmh.org
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DETECTING INFECTION HOTSPOTS: MODELING THE 
SURVEILLANCE CHALLENGE FOR ELIMINATION OF 
LYMPHATIC FILARIASIS AND OTHER DISEASES
Julie Harris, Ryan Wiegand
Centers for Disease Control and Prevention, Atlanta, GA, United States
Confirming elimination of lymphatic filariasis (LF) is a challenge due 
to its existence in small endemic foci (microfoci; µf). The capacity of 
post-treatment surveillance (PTS) to detect µf is unclear. We used 
microsimulation modeling to assess the ability of different types of PTS 
to detect LF µf in a background of low prevalence. Five µf of radius 1, 2, 
or 3 km with infection marker prevalence (intensity) of 3, 6, or 10 times 
background were placed in each simulation, run in R Version 3.2. Tests 
included microfilaremia, immunochromatographic test (ICT), and Wb123 
ELISA. We set population size (360,000) and area (60 x 60 km) and based 
demographics on literature; background ICT prevalence in 6-7 year olds 
was 1.0%. Adults≥18 years, women 15-40 (‘WCBA’) years, 6-7 year 
olds, or children≤5 years were sampled. Cluster (CS) or simple random 
sampling (SRS) was conducted, with follow-up testing of nearest 20, 100, 
or 500 persons to each positive. A threshold count of positive persons in 
follow-up testing indicated a suspected µf. Suspected and true µf were 
compared for predictive value positive (PVP). Each parameter set was 
referred to as a protocol. Protocols were scored by efficiency, defined as 
the most µf identified and fewest persons tested. Of 3402 protocols, 384 
(11.3%) identified all 5 µf (PVP 3.4-100.0%) testing 0.73-35.6% of the 
population. All used SRS; 378 (98.4%) only identified all 5 µf if they were 
2-3 km diameter or intense infection (6x or 10x). 374 (97.4%) required 
ICT or Wb123 and 281 (73.0%) required sampling adults or WCBA. The 
most efficient CS protocol identified 2/5 µf. After limiting to 1-km radius 
µf with 3x intensity (n=378), 8 protocols identified all 5 µf; all used SRS 
and ICT but required testing 31.2-33.3% of the population. Nine protocols 
identified 4 µf, all using SRS and ICT with adults or WCBA and testing 
3.5-9.7% of the population. Of those using CS (42.2%), only 14 (8.6%) 
identified any µf (1 of 5). Of the protocols using microfilaremia tests, only 
6 (3.7%) identified any µf (1 of 5). In this model, SRS, ICT and sampling 
of adults maximized µf detection efficiency. The model provides many PTS 
protocols that can be selected for optimal outcomes.
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USE OF AN ADULT TRANSMISSION ASSESSMENT SURVEY 
TO ASSESS PERSISTENCE OF LYMPHATIC FILARIASIS AT THE 
EVALUATION UNIT LEVEL IN GALLE, SRI LANKA
Sandhya D. Samarasekera1, Ramakrishna U. Rao2, Kumara C. 
Nagodavithana1, Manjula W. Punchihewa3, Gary J. Weil2
1Ministry of Health and Nutrition, Anti-Filariasis Campaign, Colombo, 
Sri Lanka, 2Washington University School of Medicine, St. Louis, MO, 
United States, 3Ministry of Health and Nutrition, Regional Anti-Filariasis 
Campaign, Galle, Sri Lanka
Sri Lanka’s Anti Filariasis Campaign (AFC) conducted 5 annual rounds of 
mass drug administration (MDA) with DEC plus albendazole in all endemic 
regions in the country between 2002-2006. Post-MDA surveillance has 
consistently documented microfilaremia (Mf) rates <1% in all sentinel 
and spot check sites, and all implementation units easily satisfied WHO 
transmission assessment survey (school-based TAS) targets in 2013. 
However, alternate surveillance methods documented persistence of 
LF in some areas. For example, molecular xenomonitoring (MX) surveys 
showed alarmingly high rates of filarial DNA in mosquitoes in the coastal 
Galle evaluation unit (EU) in southern Sri Lanka. The purpose of this study 
was to explore the utility and feasibility of AdultTAS for detecting low 
level persistence of W. bancrofti infection at the EU level using coastal 
Galle (population 0.7 million) as a positive control study site. We used 
Survey Sample Builder to randomly select two samples of 30 evaluation 
areas (EAs, mean population per EA 3,000), and approximately 1,800 
adults were tested for filarial antigenemia with the Alere Filariasis Test 
Strip (FTS) in each of EA samples. Thirty of these EAs had previously been 
assessed for persistent LF by MX. The FTS rate for the entire study sample 
(N=3,612) was 1.8% (CI 1.4-2.2), and rates for the two sets of 30 EAs 
were 1.5% (CI 1.0-2.2) and 2.0% (CI 1.4-2.7), respectively. Thus the two 
EA samples provided similar results for the EU with upper CI values that 
exceeded the 2% target. FTS rates by EA were highly variable (range 
0-11%) and exceeded 5% in 6 EAs. FTS rates in adults and filarial DNA 
rate in mosquitoes for 30 EAs tested by both methods were significantly 
correlated (r = 0.43; P=0.02). This study has shown that AdultTAS is 
more sensitive than school-based TAS and more convenient than MX 
for detecting persistent LF following MDA. Results from AdultTAS may 
be useful for identifying hot spot areas that require mop-up activities. 
AdultTAS is feasible for use by national LF elimination programs at 
the EU level, and it should also be more useful than school-based TAS 
for remapping “non-endemic” areas that were not included in MDA 
programs.
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IMPACT OF LONG LASTING INSECTICIDE TREATED BEDNETS 
ON LYMPHATIC FILARIASIS PREVALENCE IN PAPUA NEW 
GUINEA
Daniel J. Tisch1, Yao-Chieh Cheng1, Samson Satofan2, Naomi 
Vincent2, Lisa Reimer3, Christopher King1, Peter Siba4, James W. 
Kazura1, Peter A. Zimmerman1
1Case Western Reserve University, Cleveland, OH, United States, 2Papua 
New Guinea Institute of Medical Research, Maprik, Papua New Guinea, 
3Liverpool School of Tropical Medicine, Liverpool, United Kingdom, 4Papua 
New Guinea Institute of Medical Research, Goroka, Papua New Guinea
Vector control efforts against malaria may accelerate lymphatic filariasis 
(LF) elimination in coendemic areas with anopheline LF transmission such 
as Papua New Guinea. Long lasting insecticide treated bednets (LLIN) 
were distributed nationwide in Papua New Guinea in 2009. Mathematical 
models have predicted that LLIN could be sufficient to end transmission 
in some of these study communities based on the previously described 
decrease in anopheline mosquito density and LF vectorial transmission 
potential, as reported previously. Here, we evaluate the impact on human 
markers of LF infection 5 years after LLIN distribution in the absence 
of mass drug administration (MDA) in communities previously shown 
to have different LF transmission levels. 1,262 Night-time finger prick 
blood samples were collected January-May, 2015. These samples were 
assessed for microfilaria (MF), ICT antigen card test, and BM14 antibody 
test. Current bednet usage was self-reported to be >80%. The moderate 
transmission communities had zero MF positive individuals and only one 
ICT-positive individual among children under 10 years of age (living most 
of their lives post-LLIN). Although age adjusted prevalence had decreased 
from 5.0% to 2.4% (p<0.001) during this time, older age groups were 
observed with mf prevalence up to 14.6%. Nearby higher transmission 
study communities (between 2 and 15km away) maintained similar 
infection profiles to pre-LLIN with mf prevalence ranging from 3.8% in 
the children <10 years to 21.9% in the older age groups and ICT card 
positivity of 53.7%. Furthermore, 29% of MF-negative individuals in the 
study were antibody positive, including 46 of 529 (8.7%) MF-negative 
children under 10 years of age (considered the sentinel population for 
exposure). These results indicate that adults remain a reservoir for MF in 
these communities and antibody assays indicate continued LF transmission, 
even after the distribution of LLIN. These results indicate that LLIN 
are insufficient to interrupt transmission in this area and MDA will be 
necessary to achieve elimination endpoints.
3astmh.org
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IMPACT OF ANNUAL AND SEMIANNUAL MASS DRUG 
ADMINISTRATION IN AREAS CO-ENDEMIC FOR BRUGIA 
TIMORI AND WUCHERERIA BANCROFTI IN EAST NUSA 
TENGGARA, INDONESIA
Taniawati Supali1, Yenny Djuardi1, Roospita Maylasari1, Difa 
Stefanie1, Elisa Iskandar1, Gary J. Weil2, Peter Uwe Fischer2
1Department of Parasitology, University of Indonesia, Jakarta, Indonesia, 
2Washington University School of Medicine, St. Louis, MO, United States
Lymphatic filariasis is targeted for global elimination by the year 2020. 
Key strategy is the annual mass drug administration (MDA) with single 
dose of DEC combined with albendazole for at least five years. In order 
to shorten the duration of MDA, more rounds may be needed to achieve 
similar outcome. Here we compared the impact of annual and semiannual 
MDA on the prevalence of Brugia timori and Wuchereria bancrofti in 
Sikka District in Flores Island. Two villages (Paga, B. timori only and 
Lewomada, co-endemic) were assigned annual MDA with single dose of 
DEC/albendazole, while the third village (Pruda, co-endemic) was assigned 
semiannual MDA. Blood samples were collected from individuals aged 5 
years and older before and 1, 2, and 3 years after the first treatment. The 
overall compliance with MDA was ranging from 67-90%. Microfilaremia 
(mf) was determined by microscopic examination of thick night blood 
smears for all years. Detection of filarial-specific IgG4 (Brugia Rapid, 
BR, for B. timori) or filarial antigen (ICT cart test for W. bancrofti) were 
performed at baseline and after three years post initial treatment. The mf 
prevalence in Pruda village decreased after 5 semiannual treatments from 
14.2% to 1.3%, while in other two villages the mf prevalence decreased 
after 3 annual treatments from 3.9 and 5% to 0 and 0.3%, respectively. 
The ICT positivity rate in Pruda and Lewomada decreased from 22.9 and 
6.5% to 7 and 0.8%, while the BR positivity rate in Pruda, Lewomada 
and Paga decreased even stronger from 28.9, 31.7 and 12.5% to 3.6, 
4.1 and 1.8%. Mf prevalence and BR as well as ICT positivity rates show 
similar levels of reduction in both MDA regimens, but Pruda started out 
at much higher levels. We conclude that in our setting 3 annual rounds of 
MDA are sufficient to reduce mf rates to less than 1% in the population, 
but semiannual MDA is helpful for higher prevalence settings to reach the 
same degree of reduction.
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EL NIÑO AND THE SHIFTING GEOGRAPHY OF CHOLERA IN 
AFRICA
Sean M. Moore, Andrew S. Azman, Heather McKay, Justin 
Lessler
Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United 
States
In the wake of the 2015-2016 El Niño event, there has been an explosion 
of cholera cases in East Africa, including the largest outbreak since the last 
strong El Niño (1997-1998) in Tanzania. El Niño conditions are associated 
with increased rainfall in East Africa and decreased rainfall in Southern 
Africa, West Africa, and parts of the Sahel. Because of the key role of 
water supplies in cholera transmission, a relationship between El Niño 
events and cholera incidence is highly plausible, and previous research 
has shown a link between El Niño patterns and cholera in Bangladesh. 
However, there is little systematic evidence for this link in Africa. Using 
high-resolution mapping techniques, we find that El Niño profoundly 
changed the annual geographic distribution of cholera in Africa from 
2000-2014, shifting the burden to continental East Africa, where almost 
50,000 additional cases occur during El Niño years. Cholera incidence 
during El Niño years was higher in regions of East Africa with increased 
rainfall, but incidence was also higher in some areas with decreased 
rainfall suggesting a complex relationship between rainfall and cholera 
incidence. Here we show clear evidence for a shift in the distribution of 
cholera incidence throughout Africa in El Niño and non-El Niño years, 
likely mediated by El Niño’s impact on local climatic factors. Knowledge 
of this relationship between cholera and climate patterns coupled with El 
Niño forecasting could be used to notify countries in Africa when they are 
likely to see a major shift in their cholera risk. Effective case management 
enormously decreases mortality in cholera outbreaks and new control tools 
(e.g., oral cholera vaccines) may be able to prevent outbreaks altogether. 
Therefore the ability to step up preparedness and surveillance when local 
risk is high can have a major impact on saving lives and lowering the 
disease burden.
9
SURVEILLANCE FOR CHOLERA MORTALITY DURING AN 
URBAN EPIDEMIC—DAR ES SALAAM, TANZANIA, 2016
Lindsey S. McCrickard1, Amani Elibariki Massay2, Rupa Narra1, 
Janneth Mghamba3, Ahmed Abade Mohamed4, Rogath Saika 
Kishimba2, Loveness John Urio4, Neema Rusibayamila3, Grace 
Magembe5, Muhammad Bakari3, James J. Gibson6, Robert E. 
Quick1
1Centers for Disease Control and Prevention, Atlanta, GA, United 
States, 2Tanzania Field Epidemiology and Laboratory Training Program 
and Ministry of Health, Community Development, Gender, Elderly and 
Children, Dar es Salaam, United Republic of Tanzania, 3Ministry of Health, 
Community Development, Gender, Elderly and Children, Dar es Salaam, 
United Republic of Tanzania, 4Tanzania Field Epidemiology and Laboratory 
Training Program, Dar es Salaam, United Republic of Tanzania, 5DSM 
Regional Secretariat, Dar es Salaam, United Republic of Tanzania, 6Centers 
for Disease Control and Prevention, Dar es Salaam, United Republic of 
Tanzania
Cholera can cause profuse watery diarrhea, severe dehydration, and 
death within hours. Effective treatment with oral rehydration salts (ORS) 
and intravenous fluids (IVF) can lower the case fatality rate from >30% to 
<1%. In August 2015, a cholera epidemic occurred in Tanzania, and by 
27 October 3,773 cases and 36 deaths were reported in Dar es Salaam. 
Because of rumors of additional deaths in the community, we conducted 
a mortality investigation. We defined a suspected cholera death as death 
from acute watery diarrhea in a person ≥2 years old in Dar es Salaam after 
15 August 2015. We obtained information about health facility deaths 
from cholera treatment centers and referral hospitals, and community 
deaths from municipal burial permits. We interviewed family members 
about decedents’ demographic characteristics, timing and location of 
death, care-seeking behavior, and treatment. We identified 96 cholera 
deaths in 2015; 56 (58%) were not captured by surveillance. We were 
unable to interview family members of 40 (42%) of 96 decedents; 35 
(85%) could not be found, 3 (8%) had moved, and one entire family of 
2 (5%) died. Family interviews revealed that 56 decedents ranged in age 
from 2 - 80 years (median 23 years); 32 (57%) were male; 35 (63%) had 
primary school education or less; and 45 (80%) died within 24 hours of 
symptom onset. Of 56 decedents, 33 (59%) died in the community or en 
route to care, 22 (39%) in a health facility, and 1 (2%) in an unknown 
location. Ten percent of decedents reportedly took ORS at home after 
becoming ill, and 31% waited >6 hours to seek care. Of 43 decedents 
who sought care at a health facility, 15 (35%) received neither ORS nor 
IVF. Of 33 community decedents, 24 (72%) had sought care at a health 
facility and were discharged before death. Most cholera deaths were not 
captured by surveillance. ORS use at home was inadequate, care-seeking 
was often delayed, and most community decedents were discharged 
from a health facility before death. For many decedents treated in health 
facilities, rehydration therapy was inadequate. To address these problems, 
case management trainings were held and cholera messages disseminated 
to the population.
4astmh.org
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THE PLASMA AND MUCOSAL ANTIBODY RESPONSE TO THE 
COMPLETE VIBRIO CHOLERAE O1 PROTEIN IMMUNOME 
AND O-SPECIFIC POLYSACCHARIDE IN ADULTS WITH INABA 
OR OGAWA CHOLERA IN BANGLADESH
Richelle C. Charles1, Rie Nakajima2, Li Liang2, Amanda Berger1, 
Daniel T. Leung3, Meagan Kelly1, Peng Xu4, Pavol Kovac4, Fahima 
Chowdhury5, Ashraful I. Khan5, Stephen B. Calderwood1, Taufiqur 
Rahman Bhuiyan5, Jason B. Harris1, Philip L. Felgner2, Firdausi 
Qadri5, Edward T. Ryan1
1Massachusetts General Hospital, Boston, MA, United States, 2University 
of California Irvine, Irvine, CA, United States, 3University of Utah School of 
Medicine, Salt Lake City, UT, United States, 4National Institutes of Health, 
Bethesda, MD, United States, 5International Centre of Diarrhoeal Disease 
Research, Bangladesh, Dhaka, Bangladesh
Cholera is a severe dehydrating illness of humans caused by Vibrio 
cholerae O1 serotype Inaba or Ogawa. Characterization of immunogenic 
V. cholerae antigens could lead to a better understanding of protective 
immunity in human cholera infection. Using microarrays, we immuno-
probed > 3500 V. cholerae antigens with plasma and antibody-in-
lymphocyte supernatant (ALS) collected from 7 adult Bangladeshi cholera 
patients infected with V. cholerae O1 (4 Ogawa; 3 Inaba). Antibodies in 
ALS peak within a week of infection, and reflect transiently circulating 
activated lymphocytes migrating to lamina propria; as such, antibodies in 
day 7 ALS are surrogate markers for humoral responses in intestinal tissue. 
Overall, we identified 151 V. cholerae O1 immunoreactive antigens (61 in 
plasma and 103 in ALS). We rank ordered immunoreactivity, and identified 
16 antigens with significantly higher immunoreactivity at convalescence 
(day 7 and day 30) compared to acute phase plasma (day 2), and 18 
antigens with higher immunoreactivity in ALS of cholera patients collected 
at day 7 compared to age, gender, and ABO-matched healthy Bangladeshi 
controls. A number of the identified antigens have previously been 
demonstrated to be immunogenic and associated with virulence (e.g. V. 
cholerae O-specific polysaccharide (OSP); cholera toxin A and B subunits 
(CtxA, CtxB); toxin co-regulated pilus A (TcpA); and V. cholerae cytolysin, 
VCC/HlyA). Additional identified antigens included sialidase (NanH), a 
virulence factor required for mucosal colonization; and flagellin proteins 
FlaC and FlaD, involved in motility. Thus far we have confirmed plasma 
immunoreactivity to sialidase and FlaC via standard ELISA, and are in the 
process of confirming immunoreactivity of these and other identified 
antigens using ALS. This study is the first profiling of the mucosal and 
systemic antibody responses to the complete V. cholerae O1 protein 
immunome and O-specific polysaccharide. Our analysis has identified novel 
antigens that may be involved in host-pathogen interactions, and the 
results may aid in the development of an improved cholera vaccine.
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THE EARLY B CELL RESPONSE TO THE VIBRIO CHOLERAE 
O1 ANTIGEN IS CHARACTERIZED BY A HIGH DEGREE OF 
CLONALITY, SOMATIC HYPERMUTATION AND RECALL OF 
PRIOR ANTIGEN EXPOSURE
Jason B. Harris1, Robert Kauffman2, Taufiqur Bhuiyan3, Leslie 
Mayo-Smith1, Rasheduzzaman Rashu3, Rie Nakajima4, Fahima 
Chowdhury3, Ashraful Kahn3, Regina LaRocque1, Richelle Charles1, 
Stephen Calderwood1, Edward Ryan1, Phillip Felgner4, Firduasi 
Qadri3, Jens Wrammert2
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Vibrio cholerae is non-invasive, induces long lasting protective immunity, 
and is an example of a highly effective human mucosal immune response. 
Plasmablasts, or early activated antibody secreting cells, which are found 
briefly in the circulation after cholera are strongly predictive of subsequent 
duodenal responses, suggesting that these cells provide a transient 
window into immunologic memory at the mucosal surface. In this study, 
we investigated early B cell responses to cholera using a single-cell, 
single-antibody analysis of the immunoglobulin repertoire, specificity, and 
functional characteristics of cholera induced plasmablasts. Analyzing an 
array B-cell receptor sequences and a panel of 140 monoclonal antibodies 
generated from these sequences, we found that cholera induces a 
plasmablast response marked by high levels of somatic hypermutation 
and clonality, and that the majority of B cell expansions following cholera 
produce antibodies that target the immunodominant antigens of V. 
cholerae: CT and LPS. In addition, V. cholerae sialidase was a novel major 
target of the early B cell response following cholera. We found that 
effective cholera toxin neutralizing responses targeted both the A and B 
subunits, and were likely impacted by prior exposure to Enterotoxigenic E. 
coli in the study population. Most notably, V. cholerae O1 LPS responses 
uniformly target the O-specific polysaccharide, but varied widely in 
serotype specificity and functional characteristics. Unexpectedly, we found 
that antibodies which bind preferentially to the previously circulating V. 
cholerae O1 Inaba serotype were characterized by high levels of somatic 
hypermutation and but additional mutations provided the ability to adapt 
to the Ogawa serotype. These findings suggest the existence of bona 
fide immunologic memory against a canonical T-cell independent antigen 
and provide an underlying mechanism for the long term immunity seen 
following cholera.
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IMMUNE RESPONSE TO ORAL CHOLERA VACCINE 
(SHANCHOL) IN INTERNALLY DISPLACED PERSONS IN SOUTH 
SUDAN
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5World Health Organization, Geneva, Switzerland, 6Department of 
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MD, United States, 8Epicenter, Paris, France, 9Division of Infectious 
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Large scale outbreaks of cholera outside of historically endemic regions 
have renewed interest in new cholera control toolkits, including oral 
cholera vaccines (OCV). Extensive evidence supports the use of OCV 
in South Asia where the disease is endemic, but there is a dearth of 
efficacy studies outside of historically endemic regions where differential 
demographics, health status and co-circulation of other pathogens 
could influence vaccine response. We conducted an immunogenicity 
study during a 2015 pre-emptive OCV campaign in internally displaced 
persons (IDPs) in South Sudan. We report the immunological responses to 
Shanchol in a subset of volunteers (n=205), the impact of age, one versus 
two OCV doses and baseline titers on vaccine response. Consistent with 
recent circulation of cholera, high baseline titers (>80) were observed 
in 21% of the study participants. Amongst those without evidence of 
recent exposure to cholera (baseline vibriocidal titers ≤80), 90% of young 
children, 73% of older children and 72% of adults seroconverted (≥4 fold 
changes in vibriocidal titers) after the 1st OCV dose against serotype Inaba; 
with similar percentages of individuals seroconverting after 2nd dose; 
responses against serotype Ogawa were similar. Immunological endpoints 
(vibriocidal titers, isotype antibody levels) did not differ between the 3 age 
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groups post vaccination suggesting the beneficial effects of Shanchol in 
all. Adults and older children had baseline titers >80 more frequently than 
younger children (consistent with higher probability of previous cholera 
exposure), which was inversely associated with seroconversion. For all age 
groups, responses did not differ significantly between one or two doses 
of vaccine. Immunological priming (high baseline titer) is reflective of 
the increasing endemicity of Vibrio cholerae in South Sudan. Our results 
indicate Shanchol is immunogenic in a cohort of internally displaced 
individuals in South Sudan, and that a single dose alone may be sufficient 
to achieve a similar immunological response as the currently licensed two-
dose regimen.
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Oral cholera vaccines (OCV) represent a new effective tool to fight 
cholera and are licensed as two-dose regimens with 2-4 weeks between 
doses. Evidence from immunologic studies and secondary analyses from 
epidemiologic studies suggests that a single-dose of OCV may provide 
significant protection against cholera. A one-dose regimen, if effective, 
would be cheaper and easier to use in outbreaks to rapidly protect large 
at-risk populations. During a cholera outbreak starting in May 2015 in 
Juba, South Sudan, the Ministry of Health, Médecins Sans Frontières 
and partners engaged in the first field deployment of a single-dose of 
OCV (Shanchol®) to enhance their outbreak response. We conducted a 
case-cohort study to estimate the short-term effectiveness of one-dose 
of Shanchol, enrolling suspected cholera cases from 9-August-2015 
through 29-September-2015 and an 898-person cohort. Suspected 
cholera was confirmed through multiple diagnostic tests including PCR 
and culture. Unadjusted and adjusted vaccine effectiveness were estimated 
with proportional-hazards regression models. We enrolled 87 suspected 
cases into the study from cholera treatment centers throughout Juba 
with 34 classified as cholera positive, 52 as cholera negative and 1 with 
indeterminate results. None of the 858 cohort members who completed a 
follow-up visit developed clinical cholera during follow-up. The unadjusted 
single-dose effectiveness was 80·2% (95% CI 61·5,100·0) and after 
adjusting for potential confounders, 87·3% (95% CI 70·2,100·0). One 
dose of Shanchol was effective in preventing medically-attended cholera in 
this study. These results support the use of single-dose strategy in response 
to outbreaks.
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ORAL CHOLERA VACCINE STUDIES IN HIGH CHOLERA 
ENDEMIC SETTINGS IN BANGLADESH
Firdausi Qadri
International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, 
Bangladesh
Bangladesh bears the highest burden of endemic cholera with an 
estimated 450,000 cholera cases and over 4,500 deaths annually. From 
2011 to 2016 large scale vaccination studies have being conducted 
with the oral cholera vaccine (OCV) ShancholTM in high risk urban 
areas in Bangladesh. The objective these studies is to assess the 
feasibility of delivery and vaccination strategies utilizing the existing 
national immunization facilities. To study effectiveness, thermal stability, 
optimal dosage, host factors including immune responses and interval 
of vaccination needed for making the OCV program successful in 
Bangladesh. Vaccination with a 2 dose of Shanchol through the routine 
public health care system in urban settings of Bangladesh is feasible, 
acceptable and impactful with over 50% protection evident in all age 
groups and sustained for 2 years. In the rural settings the program was 
successful and 92% of the 1st dose recipients received 2nd dose of OCV. 
A Phase III protective efficacy study carried out in urban slums of Dhaka 
city among 205,600 participants and efficacy measured one year and 
above. Overall results from these studies have shown that OCV is safe and 
satisfactory immune response is elicited after intake of vaccine stored in 
the cold or at elevated temperatures of storage. This latter observation 
makes the cold chain not obligatory for vaccine delivery in large campaigns 
such as in epidemics and outbreaks. The vaccine could be delivered to 
people in high risk densely populated settings in over 500,000 people in 
children and adults with support of the EPI. However, to better understand 
the optimal strategy for vaccination the population to immunize against 
cholera; surveillance for cholera is ongoing in 22 sites in Bangladesh to 
gauge the prevalence of the disease. In summary to implement OCV 
uptake in national immunization programs factors such as the target age 
group to vaccinate, feasibility of program, cost-effectiveness as well as the 
availability of enough cholera vaccine doses as funding to meet the large 
demand for a successful and sustainable OCV program in the country.
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EVIDENCE TO OPTIMIZE THE DESIGN OF SCHOOL-BASED 
INTERVENTIONS AGAINST MALARIA
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In Malawi, the prevalence of Plasmodium infection is highest in school-
age children, making this age group an attractive target for interventions 
to decrease the burden of malaria. However, prior trials of school-based 
malaria control interventions have had mixed results. Two potential reasons 
for intervention failures are insensitive diagnostics used in screen-and-
treat efforts, and/or frequent reinfection following the intervention. We 
conducted school-based cohort studies to further evaluate the dynamics of 
Plasmodium infection in this age group and to help improve intervention 
efficacy. Students were randomly selected and enrolled in observational, 
school-based, cohort studies in the rainy (N=405) and dry (N=381) seasons 
of 2015 in Malawi. All students were followed at 1, 2, and 6 weeks after 
baseline, using surveys of malaria symptoms and bed net use, microscopic 
examination of blood smears, and PCR testing of dried blood spots. At 
baseline, students with positive rapid diagnostic tests (RDTs) were treated 
with artemether-lumefantrine. Thirty-eight percent of participants were 
RDT-positive and treated at baseline and an additional 11% had PCR-
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based infection that was below the limit of detection (LOD) of RDTs 
(Negative predictive value 81%, CI: 77-85%). Among students who 
were RDT positive and treated at baseline during the rainy season, 35% 
were RDT-positive, and 44% were PCR-positive at week 6. Among RDT-
negative, PCR-positive students who were not treated at baseline, 75% 
had infection detected at least one more time during the 6-week follow 
up. Nearly one quarter were PCR-positive at each of the four visits. More 
detailed longitudinal analysis and dry season results will also be presented. 
RDTs frequently do not detect low-density Plasmodium infections. 
However, the high rate of reinfection following treatment in school-age 
children highlights the need to tailor the timing of treatment intervals to 
the prophylactic period of the drug and the epidemiologic context.
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Despite school-age children harbouring a large proportion of malaria 
parasites in the community, evidence suggests they are the age-group least 
likely to be taken for treatment at a health facility, or to sleep under a bed 
net. Evidence also indicates malaria is an important cause of morbidity 
in school children and a potentially significant contributor to school 
absenteeism. Primary schools present a pragmatic opportunity to address 
this disease burden and improve access to malaria diagnosis and treatment 
in this age group. A cluster randomized controlled trial was conducted in 
58 primary schools in Zomba District. In 29 randomly selected schools, 2-4 
teachers were selected to diagnose and treat uncomplicated malaria using 
rapid diagnostic tests (RDTs) and artemisinin-based combination therapy 
(ACT) as part of a basic first aid kit (Learner Treatment Kit or LTK). School 
attendance of children in Standards 2, 4 and 6 in was monitored using 
daily teacher-recorded registers and unannounced attendance ‘spotchecks’ 
by the study team. Prevalence of malaria parasitaemia, anaemia and 
educational performance was assessed at the end of the study. Between 
December 2013 to March 2015, 92 trained teachers in 29 primary schools 
provided 32,193 unique consultations to school children seeking care. 
During the peak transmission season significantly more children sought 
care; fulfilled diagnostic criteria for testing by RDT; and were found 
malaria positive. Despite a significantly greater proportion of consultations 
provided to female children between 6 and 14 years old, no difference 
was observed in the type of symptom reported. No significant difference 
was observed in the proportion of child-days recorded as absent in teacher 
registers (unadjusted OR=0.90 (0.59-1.36), p=0.614) or of children absent 
during ‘spotchecks’ throughout the intervention. There was no significant 
difference in prevalence of malaria parasitaemia, anaemia or education 
scores between the groups at the end of the intervention. In spite of this 
apparent lack of impact this programme of school-based malaria case 
management was a highly utilised and acceptable source of care.
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Reliable monitoring and evaluation platforms to measure the impact of 
malaria control interventions are important for programs. We implemented 
enhanced malaria surveillance at 10 health facilities in western Kenya to 
monitor the impact of discontinuing indoor residual spraying (IRS). One 
health facility in 10 sub-counties was purposefully selected for enhanced 
surveillance for 1 week per month from August 2012 to April 2015. We 
collected clinical data and malaria rapid diagnostic test (RDT) results for all 
persons in outpatient clinics with a documented temperature of ≥37.5°C 
or history of fever. We compared the change over time in facility-specific 
malaria test positivity rates in relation to historical IRS implementation. 
During 155 enhanced-surveillance days over 33 months, 84,365 persons 
presented to facilities; 65.1% fit criteria for suspect malaria, of whom 
45.1% were RDT positive. Older children ages 5-14 years (66.4%) were 
more likely to have confirmed malaria than children ages <5 years (49.1%; 
OR=1.35; 95% CI: 1.25-1.45; p<0.0001). Males of all ages (48.4%) were 
more likely to have confirmed malaria than females (42.6%; OR=1.14; 
95% CI: 1.11-1.17, p-value <0.0001), which was most pronounced in 
males aged ≥15 years. The test positivity rate was significantly lower 
(31.5%) in IRS sub-counties in the first 9-months after spraying compared 
to the following 9 months (42.7%) after discontinuing IRS (OR=0.74, 
CI: 0.62-0.88, p=0.0008). Over the surveillance period, there was no 
difference in malaria positivity rate trends between facilities in historical IRS 
areas (i.e., with 1-5 years of spraying) and those without IRS. Monitoring 
the effects of a dynamic vector-control strategy was facilitated by 
enhanced malaria surveillance at a few facilities. Males and older children 
were most likely to have confirmed malaria perhaps because of prevention 
efforts focused on pregnant women and young children. Although 
reductions in malaria positivity rates were not detected as a long-term 
effect of IRS, the results highlight the importance of complementary 
vector-control activities as priorities and strategies shift.
18
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Seasonal malaria chemoprevention (SMC) is a simple and effective strategy 
recently recommended by WHO for malaria control in children between 
3 to 59 months living in Sahelian countries with seasonal transmission 
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like Mali. SMC entails administration of curative doses of sulfadoxine 
-pyrimathamine and Amodiquine at monthly intervals during the high 
transmission season. SMC efficacy in Mali, Senegal and Burkina Faso 
was demonstrated with three treatment courses, and there are no data 
to support additional benefit provided by a 4th treatment course ass 
suggested in the WHO recommendation. Considering the logistics of an 
additional treatment course, we sought to determine the benefit of 4 
versus 3 courses of treatment. Children aged 3-59 months in 17 villages 
in two health sub-districts in Oulelessebougou were randomized to 
receive either 3 or 4 SMC rounds during the transmission season, starting 
in August 2015 using the door-to-door delivery method. Incidence rate 
of clinical malaria over the transmission season (August to December) 
measured by passive surveillance was compared between the arms. 
Overall, 3578 children were enrolled and followed during the 2015 
transmission season. The incidence rate of clinical malaria was 0.26 
episodes/child/season in children who received 3 courses of SMC and 
0.20 episodes/child/season in those who received the 4th SMC treatment 
course, corresponding to a reduction of 25% in incidence of clinial malaria 
in chidren who received the 4th SMC treatment course (incidence rate 
ratio (IRR) = 0.75 , 95% Confidence Intervals (CI) 0.63-0.90, p = 0.002). 
After adjustment for age and gender, using negative binomial regression, 
the reduction remained unchanged (IRR = 0.75, 95% CI 0.63, p = 0.001). 
A fourth treatment course of SMC during the malaria transmission season 
provided additional protection against malaria clinical episodes.
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SUBPATENT MALARIA INFECTION IS NOT ASSOCIATED 
WITH POOR BIRTH OUTCOMES IN KENYAN WOMEN 
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Malaria in pregnancy has significant adverse consequences. However, the 
impact of subpatent infections on pregnancy outcomes remains unclear. 
We assessed the impact of subpatent infections in a longitudinal cohort 
of women enrolled in a study evaluating the efficacy of intermittent 
screening and treatment in pregnancy with dihydroartemisinin-piperaquine 
(ISTp-DP), and intermittent preventive treatment in pregnancy (IPTp) 
with DP compared to IPTp-sulfadoxine-pyrimethamine (SP). HIV-negative 
women were enrolled at 12-32 weeks gestation. At each visit, samples 
were collected for malaria detection by microscopy and polymerase chain 
reaction (PCR), and by RDT for women in the ISTp-DP arm. Logistic and 
linear regression were used to assess the cumulative effect of patent 
and subpatent infections (compared to no infection) on birthweight 
(BW), low birth weight (LBW, <2500 gm), maternal haemoglobin (Hb) 
at delivery, and maternal anemia (Hb<11 g/dL), adjusted for relevant 
covariates. Among 1523 singleton pregnancies, 54% were paucigravid 
women (G1/2) and 46% multigravid women (G3+); 33% had malaria 
by PCR at enrolment. Neither patent nor subpatent parasitemia was 
associated with LBW (adjusted odds ratio (aOR) and 95% CI for patent: 
1.2, 0.45-3.33; subpatent: 0.3, 0.03-1.87, or mean BW (adjusted mean 
difference (MD) and 95% CI for patent: -101g, -213 to 11; subpatent: 
86g, -21- 192). Both patent and subpatent parasitemia were associated 
with reduced mean maternal Hb, though this was significant only for 
patent (MD, 95% CI for patent: -0.50g/dL, -0.87- -0.13; subpatent: -0.15, 
-0.50, 0.20). Subpatent parasitemia was associated with an increased risk 
of maternal anemia among G1/2 (aOR 2.9, 1.5-5.8) but not G3+ (aOR 
0.75, 0.34-1.66); patent parasitemia was not significantly associated with 
anemia in either G1/2 or G3+ (aOR 1.61, 0.83-3.12 and 1.48, 0.62-3.57, 
respectively). In the context of routine screening (ISTp-DP) or IPTp in a 
high malaria transmission setting in western Kenya, we found no evidence 
that patent or subpatent parasitemia were associated with LBW or mean 
birthweight, despite associations with maternal anemia and Hb.
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SUCCESS OF MASS DRUG ADMINISTRATION FOR MALARIA: 
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The Gambia has achieved great reductions in malaria morbidity but 
complete elimination still presents a challenge. Mass drug administration 
(MDA) has been proposed for eradication of malaria in low- and 
moderate-transmission settings but no MDA programme has been 
successful in sub-Saharan Africa. This social science study aimed to 
determine the consequences of the assumption that rural villages are static 
entities and exclusion of mobile people from MDA on malaria transmission 
in villages. The study was nested into a cohort study in twelve villages 
in The Gambia, which implemented two MDA campaigns. In sequential 
mixed-methods study design a quantitative survey in four villages 
complemented findings from qualitative research. Active case-finding 
identified individuals not enrolled in the cohort but present in the village 
at the time of study. 1384 people from four villages were enrolled in the 
cohort at baseline. In December 2015, 112 individuals who stayed in the 
villages but were not included in the MDA cohort were interviewed and 
screened for parasiteamia. The main reasons for not being included in the 
cohort study were mobility (travelled or moved); not meeting the study’s 
eligibility criteria; withdrawal or lack of awareness. Among surveyed 
individuals 9.8% were parasitemic and 74.1% were not adequately 
protected by bed net. Males (OR=1.14, P<0.05) had increased odds of 
malaria parasitemia and sleeping under long-lasting insecticide-treated 
net (LLIN) was protective from malaria (OR=0.7, P=0.007). The findings 
confirm the importance of human mobility for malaria elimination in two 
ways. Mobile people might constitute a reservoir of malaria infection that 
is missed but in addition the people not involved in the cohort study used 
little protective measures and were thus at increased risk of infection. 
The use of census lists to identify the beneficiaries could mitigate success 
of MDA interventions. To achieve sustainable reduction of malaria, MDA 
interventions have to take into consideration the fluidity of villages and 
expand their eligibility criteria to include targeting people who are mobile 
and may not be documented as residents.
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The Zambian National Malaria Elimination Program has embarked on 
a national strategy of malaria elimination because of recent successes 
and challenges in sustaining malaria control efforts. As part of this 
strategy, community-based treatment approaches, combined with 
vector control, are being tested in a large scale trial with the intent of 
possibly interrupting malaria transmission and reducing the burden of 
malaria in southern Zambia. The trial compared three arms: 1) Standard 
of Care including high vector control coverage with LLIN and IRS using 
Actellic®, roll-out of community case management for malaria and 
efforts to improve the quality of diagnostics and treatment, 2) Mass Drug 
Administration (MDA) using dihydroartemisinin-piperaqunie (DHAp) 
and 3) Focal Mass Drug Administration (fMDA) with DHAp. Cost was 
measured at the health facility catchment level to estimate the costs and 
cost-effectiveness of the MDA and fMDA strategies. Results differed by 
outcome (infections averted vs. clinical cases averted) and transmission 
strata (high vs. low), but in all cases MDA showed superior cost-
effectiveness to fMDA. Cost-effectiveness acceptability curves produced in 
probabilistic sensitivity analysis indicated that both MDA and fMDA would 
be highly likely (>80%) to be considered cost-effective interventions (≤3x 
GDP per capita per disability adjusted life year (DALY) averted by WHO 
standards when infections averted were used as a basis for modelling 
DALY outcomes, but that neither intervention was considered highly cost-
effective in these settings (<1x GDP per capita per DALY averted).
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DISCOVERY AND DEVELOPMENT OF A MULTISTAGE 
ANTIMALARIAL WITH NEW MECHANISM OF ACTION USING 
NEXT GENERATION SYNTHESIS
Eamon Comer1, Nobutaka Kato1, Micah Maetani1, Tomoyo Sakata 
Kato2, Amanda K. Lukens2, Marshall Morningstar1, Elizabeth A. 
Winzeler3, Christina A. Scherer1, Dyann F. Wirth2, Stuart Schreiber1
1Broad Institute, Cambridge, MA, United States, 2Harvard T.H. Chan School 
of Public Health, Boston, MA, United States, 3University of California San 
Diego, La Jolla, CA, United States
Despite increased efforts in the last decade, the antimalarial drug 
discovery and development pipeline still lacks compounds with non-
erythrocyte stage activity or with novel mechanism of action (nMOA). 
Antimalarial leads have thus far been derived mainly from two sources 
- natural products and synthetic ‘drug-like’ compounds. At the Broad 
Institute, we created a diverse collection of synthetic compounds 
having three-dimensional features reminiscent of natural products and 
underrepresented in typical screening collections (Diversity Oriented 
Synthesis compound collection). A novel series, the bicyclic azetidine, 
was found with robust in vivo efficacy in erythrocytic, hepatic and 
sexual stages. The compound series inhibits phenylalanine t-RNA 
synthetase activity, a novel molecular target, with a low propensity 
to induce resistance and shows efficacy with a single dose efficacy in 
both Plasmodium berghei and NSG P. falciparum models. Extensive 
pharmacokinetic and preclinical safety data supports the progression of 
this novel antimalarial agent towards pre-IND development.
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TARGETING RESISTANCE: EXPLOITING EVOLUTION IN DRUG 
DISCOVERY
Tomoyo Sakata-Kato1, Leila S. Ross1, Maria Jose Lafuente-
Monasterio2, Francisco-Javier Gamo2, Dyann F. Wirth1, Amanda K. 
Lukens3
1Harvard T. H. Chan School of Public Health, Boston, MA, United States, 
2GlaxoSmithKline, Tres Cantos, Spain, 3The Broad Institute, Cambridge, 
MA, United States
Significant strides have been made in the past decade to control malaria, 
however these fragile gains are in danger of being lost due to the rise and 
spread of ACT resistance. New strategies are needed to combat resistance 
and extend the lifespan of antimalarial chemotherapies. As evidenced 
by the emergence of ACT failure, traditional approaches of ad hoc drug 
combinations are not sufficient. Here we explore a new paradigm for 
protecting the efficacy of antimalarial therapies by identifying partner 
drugs that decrease the selective advantage of drug resistant cells from 
emerging. We propose suppressing resistance with a population biology 
trap: by identifying situations where resistance to one compound confers 
hypersensitivity to another, we can design combination therapies that not 
only kill the parasite, but also guide its evolution away from resistance. We 
applied this concept, termed “targeting resistance,” to the malaria enzyme 
dihydroorotate dehydrogenase (PfDHODH). We have demonstrated that 
resistance mutations quickly arise from in vitro parasite selection with 
single PfDHODH inhibitors. Characterization of these resistant parasites 
showed that resistance to one PfDHODH inhibitor rendered them 
hypersensitive to other structural classes. To further develop this concept, 
we performed a high-throughput screen to identify inhibitors selective for 
mutant PfDHODH. As part of a Tres Cantos Open Lab Foundation project, 
we screened select GSK libraries and identified 25 mutant-selective and 
74 wild-type-selective compounds. Of particular interest are an additional 
28 compounds that were equally potent against both the wild-type and 
mutant enzymes. These molecules were then validated in cellular assays 
and prioritized candidates identified, representing promising starting 
points for further development. Furthermore, pairing wild-type and 
mutant-selective PfDHODH inhibitors largely suppressed the emergence of 
resistant parasites in in vitro experiments. We believe that this approach is 
widely applicable to other antimalarial targets and represents a new drug 
development strategy for a variety of diseases.
24
A NEW BENZOXABOROLE WITH AN APPARENT NOVEL 
MECHANISM OF ACTION AGAINST PLASMODIUM 
FALCIPARUM
Kirthana Mysore Vasudevarao Sindhe1, Ebere Sonoiki1, 
Denghui Guo1, Jiri Gut1, Jenny Legac1, Yen Tran2, Yong-Kang 
Zhang2, Pamela Berry2, Vic Ciaravino2, Francisco-Javier Gamo3, 
Laura Sanz3, Eric E. Easom2, Joseph L. DeRisi1, Jacob J. Plattner2, 
Yvonne R. Freund2, Philip J. Rosenthal1
1University of California San Francisco, San Francisco, CA, United 
States, 2Anacor Pharmaceuticals, Inc., Palo Alto, CA, United States, 
3GlaxoSmithKline, Inc., Tres Cantos, Spain
New antimalarial drugs are needed. We have synthesized several 
oxaboroles with nanomolar activity against cultured malaria parasites 
and excellent efficacy in murine malaria models. AN13762 is a current 
lead candidate. It was active against multiple laboratory strains (IC50 for 
Dd2: 50 nM, W2: 30 nM, 3D7: 41nM, 7G8: 70 nM, and VS1: 73 nM) 
and fresh field isolates of Plasmodium falciparum (mean IC50 91nM). 
Pharmacokinetic assessment showed that AN13762 was ~100% orally 
bioavailable with t1/2 5-10 h in mouse, rat, and dog. AN13762 had 
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potent activity in murine models, with ED90 6.3 mg/kg against P. berghei 
and 0.85 mg/kg against P. falciparum-infected mice, with in vivo rates 
of clearance similar to those for artesunate. No genetic toxicology safety 
concerns for AN13762 were identified in Ames assays or in vivo rat 
micronucleus studies. Cytotoxicity was not seen at concentrations up 
to 100 µM in human cell lines. Treatment of cultured P. falciparum with 
AN13762 for 8 h intervals across the erythrocytic life cycle demonstrated 
maximal activity against rings and trophozoites, and parasites did not 
develop beyond this stage. To gain further insight into mechanisms of 
action we selected P. falciparum with decreased sensitivity to AN13762 
by culturing Dd2-strain parasites in step-wise increasing concentrations 
or a single high concentration of AN13762. Parasites selected rapidly for 
resistance, with IC50 values of 400-2500 nM after selection. AN13762-
resistant parasites were analyzed by whole genome sequencing. 
Compared with sensitive parental parasites, resistant parasites consistently 
had SNPs in genes predicted to encode a microtubule and actin binding 
protein (PFC0960c), lysophospholipase (PF07_0040), SUMO-activating 
enzyme subunit 2 (PFL1790w), and a protein of unknown function 
(PF14_0594). In summary, the benzoxaborole AN13762 represents a 
promising new class of antimalarial compounds, for which the mechanism 
of resistance appears to be complex.
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NOVEL CLINICAL STUDY AND PHARMACOMETRIC 
MODELLING TO FIND THE MINIMUM INHIBITORY 
CONCENTRATION (MIC) OF A NEW ANTIMALARIAL
Joel Tarning1, Tran Tinh Hien2, Nicholas J. White1, Nguyen 
Thanh Thuy Nhien3, Nhu Thi Hoa3, Phung Duc Thuan3, Nguyen 
Thanh Tong3, Huynh Thi Thuy Van3, Francois Nosten4, Baldur 
Magnusson5, Jay Prakash Jain6, Micha Levi7, Kamal Hamed7
1Mahidol Oxford Tropical Medicine Research Unit, Bangkok, Thailand, 
2Centre for Tropical Medicine and Global Health, Nuffield Department of 
Clinical Medicine, University of Oxford, Oxford, United Kingdom, 3Oxford 
University Clinical Research Unit – Hospital for Tropical Diseases, Ho Chi 
Minh City, Vietnam, 4Mahidol-Oxford Tropical Medicine Research Unit, 
Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand, 
5Novartis Pharma AG, Basel, Switzerland, 6Novartis Healthcare Pvt. Ltd., 
Hyderabad, India, 7Novartis Pharmaceuticals Corporation, East Hanover, 
NJ, United States
Determination of the MIC of antimalarial drugs in the clinical setting may 
provide a better alternative to empirical approaches to effective dose 
finding. This was an open-label, dose-ranging (de-escalation), phase 
IIa study in Vietnamese adults (n=25) with uncomplicated Plasmodium 
falciparum malaria to estimate prospectively the in-vivo MIC of cipargamin. 
Patients were treated sequentially with single cipargamin doses (30, 
20, 10, or 15 mg). Population PK/PD modelling of plasma cipargamin 
concentrations, serial parasite densities assessed by microscopy and 
real-time quantitative PCR were used for estimating the in-vivo MIC. PK 
properties of cipargamin were described by a flexible transit-absorption 
model followed by a one-compartment disposition model, resulting in a 
high predictive performance. Individual PK estimates were then imputed 
into the PK/PD model to assess the cipargamin-dependent parasite 
killing effect. As no parasite growth data were available before drug 
administration, the parasite multiplication rates were fixed to 10-fold 
multiplication/parasite life-cycle (48 hours) based on malariatherapy and 
volunteer data. Initial implementation of the PK/PD model assumed a 
homogenous parasite population and drug-dependent killing of parasites 
(EMAX model). Population and individual parasite clearance curves showed 
a biphasic pattern of parasitaemia decline, suggesting the presence of 
dormant (non-sensitive) parasite population. The fraction of sensitive/
dormant parasites and the activation of dormant parasites were estimated. 
Higher doses and plasma cipargamin concentrations were associated with 
significantly faster maximum parasite killing. A total of 23 patients were 
characterized accurately as either cured, having had early treatment failure 
or recrudescent infection using the final model. Median (range) MIC was 
estimated at 0.126 (0.0375-0.803) ng/mL occurring at median (range) 
time of 7.45 (5.29-11.4) days. The developed PK/PD model demonstrated 
an informative approach for determining the in-vivo MIC, providing a 
rational framework for dose finding in antimalarial drug development.
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ASSESSING THE SPEED OF CLEARANCE OF PLASMODIUM 
VIVAX FROM THE BLOOD FOLLOWING TREATMENT WITH A 
LICENSED AND EXPERIMENTAL ANTIMALARIALS
James S. McCarthy1, Louise Marquart1, John Woodford1, Paul 
Griffin2, Joerg Moehrle3
1QIMR Berghofer Medical Research Institute, Herston, Australia, 2Q-Pharm, 
Herston, Australia, 3Medicines for Malaria, Geneva, Switzerland
The rate of clearance of malaria parasites from the blood of patients 
is a key determinant of treatment success. For example, in falciparum 
malaria the rate of clearance in early infection is inversely associated with 
mortality. Although it is considered that drug response in Plasmodium 
vivax infection is generally faster, there is a paucity of information, both 
because in vitro culture is not possible and because clinical trials have been 
fewer. To investigate the relative activity of four antimalarials against P. 
vivax we undertook clinical trials entailing induced blood stage infection 
with P. vivax. Artemether/lumefantrine (A/L) and chloroquine (CQ) were 
administered at the approved doses, while artefenomel (OZ439) and 
DSM265 are scheduled to be administered as a single dose of 200mg and 
400mg, respectively. Subjects were treated at symptom onset, and rate 
of clearance of asexual parasitemia measured by qPCR. Parasite clearance 
half life (PCt1/2) and parasite reduction ratio (PRR) were derived from 
the slope of the parasite clearance curve. Data from 10 subjects treated 
with A/L indicate a PCt1/2 of 1.6 hrs (95%CI: 1.5-1.7) and a Log10PRR 
of 9.1 (95%CI: 8.4-9.7). Data from 8 subjects treated with CQ indicate a 
PCt1/2 of 5.0 hrs (95%CI: 4.7-5.4) and a Log10PRR of 2.9 (95%CI: 2.7-
3.1). Similar data from the OZ439 and DSM265 cohorts will be available 
for presentation. Deriving these key pharmacodynamics variables of 
antimalarials against P. vivax will be of major assistance in selecting optimal 
drugs, combinations, doses and regimens so that optimal systems are 
developed for treatment of this widely prevalent and important pathogen.
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FOSMIDOMYCIN-PIPERAQUINE AS NON-ARTEMISININ-
BASED COMBINATION THERAPY FOR ACUTE 
UNCOMPLICATED PLASMODIUM FALCIPARUM MALARIA
Ghyslain Mombo-Ngoma1, Jonathan Remppis1, Moritz Sievers1, 
Rella Zoleko Manego1, Lilian Endamne1, Bertrand Lell1, David 
Hutchinson2, Peter G. Kremsner1
1Centre de Recherches Medicales de Lambaréné (CERMEL), Lambaréné, 
Gabon, 2Jomaa Pharma GmbH, Hamburg, Germany
The combination of fosmidomycin and piperaquine, with the attributes 
of rapid blood schizonticidal activity and prolonged post-treatment 
prophylaxis, is being developed to meet the challenge of emerging 
artemisinin resistance. As a potent inhibitor of 1-Deoxy-D-xylulose 
5-phosphate (DOXP) reductoisomerase, fosmidomycin possesses a unique 
mode of action through blockade of the non-mevalonate pathway of 
isoprenoid biosynthesis. In contrast, piperaquine is thought to bind to 
heme, inhibiting its detoxification within the malaria parasite. It is further 
postulated that the toxic build-up of heme increases the membrane 
permeability of red cells favouring the influx of fosmidomycin. The efficacy, 
tolerance and safety of the combination for the treatment of acute 
uncomplicated Plasmodium falciparum mono-infection are being evaluated 
in a proof of concept study in Gabon. A total of 100 symptomatic patients 
including 10 adults aged >14 years, 40 older children aged 5 to 14 years, 
and 50 younger children aged one to five years with initial parasite counts 
between 1,000 and 150,000/µL have been treated with fosmidomycin, 
in twice daily doses of 30mg/kg, and piperaquine, in a once daily dose of 
16mg/kg, orally for three days and followed-up for 63 days. The primary 
efficacy endpoint is the per protocol PCR-corrected Day 28 cure rate. 
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Preliminary results at all ages show the combination is highly effective with 
an excellent tolerance and there are no safety concerns. The full results 
will be presented at the ASTMH meeting in November 2016. Meanwhile, 
proposals are being drawn up for dose optimisation studies aimed at 
achieving a therapeutic regimen of once daily dosing administered over 
three days.
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MALARIA, MALNUTRITION, AND ADVERSE BIRTH 
OUTCOMES AMONG PREGNANT WOMEN: A POOLED 
ANALYSIS
Jordan Cates1, Holger W. Unger2, Valerie Briand3, Nadine Fievet3, 
Innocent Valea4, Halidou Tinto4, Umberto d’Alessandro5, Sarah 
H. Landis6, Seth Adu-Afarwuah7, Kathryn G. Dewey8, Feiko Ter 
Kuile9, Meghna Desai10, Stephanie Dellicour9, Peter Ouma11, 
Julie Gutman10, Martina Oneko11, Laurence Slutsker10, Dianne J. 
Terlouw12, Simon Kariuki11, John Ayisi11, Mwayi Madanitsa13, Linda 
Kalilani-Phiri13, Per Ashorn14, Kenneth Maleta13, Ivo Mueller15, 
Danielle Stanisic16, Christentze Schmiegelow17, John Lusingu17, 
Anna Maria van Eijk9, Melissa Bauserman1, Linda Adair1, Steve 
Cole1, Steven Meshnick1, Daniel Westreich1, Stephen Rogerson18
1University of North Carolina-Chapel Hill, Chapel Hill, NC, United States, 
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5Medical Research Council Unit, Serrekunda, Gambia, 6GlaxoSmithKline, 
Uxbridge, United Kingdom, 7University of Ghana, Accra, Ghana, 
8University of California, Davis, CA, United States, 9Liverpool School of 
Tropical Medicine, Liverpool, United Kingdom, 10Center for Global Health, 
Centers for Disease Control and Prevention, Atlanta, GA, United States, 
11Kenya Medical Research Institute (KEMRI)/Centre for Global Health 
Research, Kisumu, Kenya, 12Malawi-Liverpool-Wellcome Trust Clinical 
Research Programme Liverpool School of Tropical Medicine, Liverpool, 
United Kingdom, 13University of Malawi, Blantyre, Malawi, 14University of 
Tampere and Tampere University Hospital, Tampere, Finland, 15Walter and 
Eliza Hall Institute, Parkville, Australia, 16Griffith University, Gold Coast, 
Australia, 17University of Copenhagen, Copenhagen, Denmark, 18The 
University of Melbourne, Parkville, Australia
Malnutrition and malaria infection commonly co-exist, afflicting pregnant 
women in resource-poor settings. Prior small studies have indicated that 
the effect of malaria on low birthweight (LBW; <2500g) may depend 
upon maternal nutritional status. We investigated the interaction between 
malaria infection during pregnancy and maternal nutrition with regards to 
the risk of LBW using data from 14,635 singleton, live birth pregnancies 
from women who participated in 13 pregnancy studies conducted in 
malaria endemic countries across Africa and Asia from 1996-2015. Study-
specific effect estimates and measures of interaction were calculated 
using linear and log-binomial regression models, adjusted for confounders 
(maternal age, gravidity, area of residence, HIV infection, anemia) using 
inverse probability of treatment weights, and pooled across studies 
using a restricted maximum likelihood random effect model. Nine of the 
thirteen studies assessed malaria (microscopy or RDT) and mid-upper-arm 
circumference (MUAC) at enrollment. Across these 9 studies, 75% of 
women were well-nourished (MUAC≥23 cm) and malaria-uninfected at 
enrollment, 10% were well-nourished but malaria infected, 12% were 
malnourished and not malaria infected, and 2% were both malnourished 
and malaria infected. Compared to women who were well-nourished and 
uninfected, the pooled risk ratios for LBW were: malaria alone, 1.18 (95% 
confidence interval [CI]: 0.93, 1.48); malnutrition alone, 1.55 (95% CI: 
1.29, 1.85); and malaria and malnutrition together, 1.75 (95% CI: 0.90, 
3.37). The pooled interaction contrast was -0.03 (95% CI: -0.11, 0.06; 
p=0.57), with minimal statistical heterogeneity across studies (=0.0014, 
Cochran Q=11.63 [p=0.11]). While MUAC<23cm was associated with an 
increased risk of LBW, malaria infection at enrollment was not as strongly 
associated and there does not appear to be synergism between these 
two factors. Additional analyses to be presented will consider: mean birth 
weight; preterm birth; malaria infection at delivery; malnutrition defined 
by BMI; meta-regression for subgroup effects; selection bias by excluding 
pregnancy loss.
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ASSESSING ULTRASONOGRAPHY AS A DIAGNOSTIC TOOL 
FOR PORCINE CYSTICERCOSIS
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and Sciences University, Portland, OR, United States, 4Center for Global 
Health, Universidad Peruana Cayetano Heredia, Tumbes, Peru, 5School of 
Veterinary Medicine, Universidad Nacional Mayor de San Marcos, Lima, 
Peru, 6School of Public Health, Oregon Health and Sciences University 
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Peruana Cayetano Heredia, Lima, Peru
Neurocysticercosis caused by the pork tapeworm, Taenia solium, causes 
30% of epilepsy in poor rural communities of the developing world. Use 
of the ring strategy is a promising control intervention targeting treatment 
of humans and pigs living near heavily infected pigs. Tongue examination 
for T. solium cysts provides a crude means of identifying heavily 
infected pigs. However, as prevalence decreases over time in treatment 
communities, higher sensitivity methods are needed to achieve full 
treatment coverage. This study evaluates ultrasonography as an alternative 
method to detect pigs infected with varying burdens of T. solium cysts. We 
collected blood samples and purchased 158 seropositive pigs living in eight 
villages of Piura, a province of northern Peru where T. solium is endemic. 
Tongue examination and ultrasonography of the limbs were performed 
in these animals, followed by fine dissection necropsy to determine cyst 
burden. We used necropsy as a gold standard and compared the sensitivity 
and specificity of ultrasonography with tongue examination for their 
ability to detect heavy infection (≥ 100 viable cysts) in pigs. Compared to 
tongue examination, ultrasonography was more sensitive (92% vs. 83%) 
but less specific (90% vs. 97%) detecting pigs with heavy cyst burdens, 
although these differences were not statistically significant. The improved 
sensitivity of ultrasound resulted in the detection of one additional 
heavily infected pig compared to tongue examination, but also resulted 
in more false positives (14 vs. 3) due to poor specificity. Ultrasonography 
was highly sensitive in detecting pigs with heavy cyst burdens and may 
allow for better treatment coverage in endemic areas compared to 
tongue examination. In its current form, however, the high rate of false 
positives results in a substantial number of unnecessary treatments, and 
must be improved before ultrasound can replace tongue examination as 
the preferred screening tool for pigs in ring strategy interventions. With 
improvements in training and technology, the use of ultrasound could 
potentially benefit local elimination strategies where previous efforts have 
stalled.
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VASCULAR LEAKAGE IN THE BRAIN IN PORCINE 
NEUROCYSTICERCOSIS IS ASSOCIATED WITH ANGIOGENESIS
Carla Cangalaya1, Miguel Angel Orrego1, Javier Mamani1, Renzo 
Gutierrez-Loli1, Carlota Roca1, Armando E Gonzalez2, HH García3, 
Cristina Guerra-Giraldez1, Siddartha Mahanty4, Theodore Nash4, 
For the Cysticercosis Working Group in Peru
1Universidad Peruana Cayetano Heredia, Lima, Peru, 2Universidad Nacional 
Mayor de San Marcos, Lima, Peru, 3Unidad de Cisticercosis, Instituto 
Nacional de Ciencias Neurológicas, Lima, Peru, 4National Institute of 
Allergy and Infectious Diseases, National Institutes of Health, Bethesda, 
MD, United States
Anthelmintic therapy for neurocysticercosis, brain infection by Taenia 
solium cysts (larvae), frequently exacerbates neurological symptoms. 
We have used naturally infected pigs and Evans Blue (EB) to show 
that the acute post treatment immune response is associated with 
increased vascular permeability of the blood-brain barrier (BBB). Here 
we studied potential mechanisms for this increase. We used 11 infected 
pigs, 3 controls (T0) and 8 treated with a single dose of Praziquantel, 
euthanized 2 and 5 days later (T2 and T5). EB was injected 2h before 
sacrifice; biopsies of brain tissue around cysts (capsules) were analyzed 
using immunohistochemistry (IHC) and real time quantitative PCR for 
selected markers.EB-stained (blue), “leaky” capsules from all groups had 
more newly formed vessels (strong IHC reaction for cadherin, vascular 
endothelial growth factor (VEGF) and von Willebrand factor (vW)) than 
clear (“non-leaky”) capsules and also had higher expression of VEGF, 
vWf, transforming growth factor beta and ephrine genes, as evidence of 
angiogenesis. Immature new vessels, with incomplete basal lamina and 
weak cellular junctions, demonstrated perivascular lymphocytic cuffing, 
with clear recruitment of immune cells, consistent with high permeability. 
These effects were significantly more intense in T5 compared to T2 and 
T0. The “leaky”, highly vascularized capsules also showed increased 
astroglyosis (extreme IHC reaction for glial fibrillar acidic protein, GFAP) 
and the deposition of beta-amyloid peptide compared to clear capsules. A 
decrease in transcripts for GFAP and the amyloid precursor protein (APP) 
on T5 versus T2 and T0 suggested downregulation of these markers and a 
possible restabilization of the BBB. This is consistent with early remodeling 
by matrix metalloproteinases (MMP)-2 and MMP-9, suggested by their 
high gene expression on blue capsules at T5.We conclude that the increase 
of vascular permeability as a result of treatment-induced inflammation 
happens mainly around newly formed vessels; we also suggest the 
existence of a restabilization process of the BBB that follows the rapid post 
treatment disruption.
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PRECURSOR PROTEIN GENE (APP) ARE INDUCED 
BY ANTHELMINTIC TREATMENT IN PORCINE 
NEUROCYSTICERCOSIS
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y Moleculares, Facultad de Ciencias y Filosofía, Universidad Peruana 
Cayetano Heredia, Lima, Peru
Neurocysticercosis (NCC), hyperendemic in Peru, is the brain infection 
with the larval stage (cyst) of Taenia solium; a main frequent clinical 
manifestation are seizures. This disease has been well documented 
clinically, but the complex host-parasite interaction and the resulting 
inflammation, a main factor of the severity of the symptoms, are not 
completely understood. Among many inflammatory markers, amyloid-
beta peptides (Aβ) have been associated with neuropathological 
processes including glial activation, synaptic dysfunction and neuronal 
apoptosis. However, the role of Aβ in the neuropathology of NCC has 
not been explored yet the effect of anthelmintics on this molecule is 
unknown. We used brain sections of eight pigs naturally infected with 
Taenia solium cysts. Five animals received a single dose of 100 mg/kg 
praziquantel (PZQ), which is demonstrated to trigger inflammation, and 
three untreated pigs served as controls (T0). Three pigs were sacrificed 
after two days of treatment (T2) and two after five days (T5). Two hours 
before sacrifice, all animals were sedated and injected with Evans Blue to 
delineate increased permeability of the blood-brain barrier (BBB), shown 
to correlate with inflammation. Eighty-two cyst capsules (23 from T0, 36 
from T2 and 23 from T5) were examined to evaluate the presence of Aβ 
in host tissue by immunohistochemistry (IHC). The relative expression of 
the amyloid precursor protein gene (app) was analyzed by quantitative 
real time PCR in 20 capsules (7 from T0, 7 from T2 and 6 from T5). We 
found that PZQ induced both the presence of Aβ and app expression, this 
was more evident when the BBB had been affected. IHC results showed 
similar values for T2 and T5, both being significantly higher that T0, but 
app expression was clearly higher for T2 than T0 and T5, indicating post-
transcriptional regulation. Besides, we observed less Aβ in degenerated 
cysts, which suggests the possibility of a regeneration process that follows 
the acute inflammatory phase. Together, these findings suggest that Aβ 
is a component of the acute inflammatory response in NCC and that its 
expression is regulated at some point of the cyst degeneration.
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TAENIA SOLIUM CYSTICERCOSIS SEROCONVERSION AND 
SEROREVERSION CUMULATIVE INCIDENCE IN A LARGE-
SCALE COMMUNITY TRIAL IN BURKINA FASO
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Cysticercosis is a debilitating yet neglected disease caused by Taenia 
solium, a zoonosis transmitted between humans and pigs. Knowledge 
on the disease transmission patterns is crucial to develop effective control 
strategies. Our objective was to estimate the seroconversion (SC) and 
seroreversion (SR) cumulative incidence as well as related risk factors in 
a large scale community randomized controlled trial in Burkina Faso. The 
study was conducted in all pig-raising departments of the provinces of 
Nayala, Boulkiemdé and Sanguié. Two villages per department meeting 
eligibility criteria were randomly selected and clustered sampling based 
on pig raising was used to select 80 concessions per village. In each 
concession, one household was randomly selected from which one eligible 
individual was randomly chosen. Sixty people were asked to consent 
to provide three blood samples over the course of three years in each 
village. Socio-demographic factors, pork cooking and eating practices 
and pig management practices were assessed through questionnaires. 
The presence of excretory secretory circulating antigens (Ag) of T. solium 
metacestodes was measured in sera using the B158/B60 enzyme-linked 
immunosorbent assay (ELISA). Sera were collected at baseline and 18 
months follow-up from 2211 consenting individuals. The SC and SR 
cumulative incidences were 3.3% (95% confidence interval (CI) 2.6-
4.2) and 35.8% (95% CI 24.7-48.5), respectively. Univariable analyses 
indicated higher SC in Boulkiemdé vs. Sanguié (4.0 vs. 2.2%, cumulative 
incidence ratio (CIR) = 1.8, 95% CI 1.0-3.3). While SC tended to be higher 
among individuals older than 40 years versus those of 6-17 years (4.3 
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vs. 2.5%, CIR = 1.7, 95% CI 1.0-3.1), SR was much lower in the older 
group (18.9 vs. 80.0%, RR = 0.2, 95% CI 0.1-0.5). Lastly, SC was higher 
in individuals eating pork at the village market compared to those never 
eating pork (4.7 vs. 2.0%, RR = 2.4, 95% CI 1.1-5.2). This is the largest 
cohort study of cysticercosis SC and SR ever conducted in West Africa. 
Multivariable and hierarchical analyses will be conducted to explore the 
impact of village-level and other individual level factors.
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USE OF DIFFERENTIALLY EXPRESSED MONOCYTE GENES TO 
DISTINGUISH BETWEEN NEUROCYSTICERCOSIS-ASSOCIATED 
EPILEPSY AND IDIOPATHIC EPILEPSY
Vasuvedan Prabhakaran1, Govindan Ramajayam1, Josephine J. 
Babu1, Anna Oommen2, Douglas A. Drevets3, Anderson Michael3, 
Vedantam Rajshekhar1, Hélène Carabin3
1Christian Medical College, Vellore, India, 2Gudalur Adivasi Hospital, 
Gudalur, India, 3University of Oklahoma Health Sciences Center, Oklahoma 
City, OK, United States
Neurocysticercosis (NCC) is a parasitic infection of the brain that accounts 
for 34% of active epilepsy cases in Vellore district, India. New diagnostic 
methods are needed due to the high cost of brain imaging and because 
antibody detection misses 34% of NCC patients.. We conducted a cross-
sectional study of patients aged 18 to 51 years seeking care at the Dept. 
of Neurological Sciences, Christian Medical College and Hospital, Vellore 
between Jan. 2013 and Oct. 2014. Subjects were categorized as patients 
diagnosed with NCC-associated epilepsy with at least one seizure in the 
past 7 months (Group 1, n=76); recovered NCC (RNCC) patients without 
seizures and brain lesions for at least two years (Group 2, n=10); patients 
with epilepsy with at least one seizure in the past 7 months without any 
structural brain lesion on imaging (Group 3, n=29); patients who had 
a normal brain CT scan or MRI, no epilepsy or head trauma (Group 4, 
n=17). Groups 3 and 4 were negative for antigens or antibodies to T 
solium larvae in serum. Group 1 was sub-divided into those with Solitary 
Cysticercus Granuloma (SCG, n=29), single calcified cysts (SCC, n=20) 
and multiple cysts (MNCC, n=27). We used mRNA arrays of CD14+ blood 
monocytes from 6, 6 and 4 patients in Groups 1, 3 and 4, respectively, 
to identify differentially expressed genes linked to inflammation, host 
defenses or central nervous system processes. We identified 15 genes 
including GTPase’s (4), and genes linked to immune regulation (4) 
enzymes with role in signaling (3), neurogenesis (1), and other immune 
function (3). Expression of these genes was measured by qPCR in all 
participants and fold-change in NCC cases (Groups 1-3)/Control (Group 
4) was calculated. Highest expression levels were observed in patients 
with NCC-associated epilepsy, followed by RNCC and finally by those with 
idiopathic epilepsy. Expression levels of 7 of 15 genes differed among NCC 
patients with different types of brain lesions with expression decreasing 
as lesions became calcified. In contrast, one gene (RAP1A), increased as 
lesions calcified. This study suggests measuring expression of key blood 
monocytes genes may be useful to diagnose and stage NCC.
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VENTRICULAR NEUROCYSTICERCOSIS IN THE UNITED 
STATES: TREATMENT, COMPLICATIONS AND OUTCOME IN A 
TERTIARY REFERRAL CENTER
Theodore E. Nash, JeanAnne M. Ware, Siddhartha Mahanty
National Institutes of Health, Bethesda, MD, United States
Ventricular involvement in neurocysticercosis (NCC) has distinct clinical 
presentations, complications and treatments. Here we review the clinical 
course of 21 patients with one or more ventricular cysts referred to the 
National Institutes of Health (NIH) over 31 years. 21 patients with one or 
more ventricular cysts had a median age of 29.6 yr. (range 22.4-52.6), 
52.4% male and the median follow up was 3.1 yr. (range 0.12-27.7). 
Most of the patients presented with a single cyst (19/21, 90.5%); two 
patients had 2 and 3 cysts, respectively. The 4th ventricle was involved 
alone in 12/21(57.1%) persons but a single cyst occupied more than one 
ventricle, migrated or there were multiple cysts in 16/24 (66.7%). Most 
of the patients presented with one or more additional manifestations 
of NCC, 5/21 (23.8%) with viable/degenerating parenchymal cysts, 
9/21 (42.9%) with parenchymal calcification(s), and 8/21 (38.1%) with 
subarachnoid cysts. Only 4 had a single 4th ventricular cyst without any 
other accompanying types of NCC. Most of the symptoms were due to 
acute or chronic hydrocephalus (76.1%) including headache, vomiting, 
nausea, syncope, confusion, dizziness, coma, and vision disturbance, in 
decreasing order. A majority of patients were initially treated with cyst 
removal and/or shunt placement before referral to NIH. Patients with 
non-resectable cysts were treated medically. A number of complications 
were noted, mostly related to surgery prior to referral and to residual 
long-lasting symptoms.Of the 6 persons with only ventricular cysts and/or 
calcifications, 4 had sufficient follow-up and serial evaluations to assess if 
resolution occurred. Negative or decreasing cestode antigen levels in the 
CSF predicted resolution after cyst removal without the need for cysticidal 
treatment. Low WBCs counts in the CSF mostly corroborated the cestode 
antigen findings but, in one case, interpretation was complicated by the 
use of corticosteroids and presence of an infected shunt. Careful follow up 
of patients with surgically removed ventricular cysts, allows determination 
of the need for treatment.
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RISK FACTORS FOR SEIZURE RECURRENCE AFTER 
SUCCESSFUL ANTIPARASITIC TREATMENT IN PARENCHYMAL 
NEUROCYSTICERCOSIS
Kevin R. Duque1, Javier A. Bustos1, Isidro Gonzales1, Herbert 
Saavedra2, Javier Pretell3, Hector H. Garcia1, for the Cysticercosis 
Working Group in Peru
1Center of Global Health - Tumbes, Universidad Peruana Cayetano Heredia, 
Lima, Peru, 2Cysticercosis Unit, National Institute of Neurological Science, 
Lima, Peru, 3Hospital Nacional Alberto Sabogal, Essalud, Callao, Peru
Neurocysticercosis (NCC), caused by the larval stage of the pork tapeworm 
Taenia solium, is a major risk factor for seizures worldwide. In this 
retrospective cohort analysis based on two randomized clinical trials in 
which patients had a systematic post treatment follow up of 18 months, 
patients in whom all viable cysts resolved after antiparasitic treatment were 
identified to assess risk factors for seizure recurrence from 6 to 18 months 
after treatment onset. Out of 188 patients, 85 (45.2%) had complete 
resolution of viable cysts demonstrated on follow up MRI at 6 months. 
Eight (9.4%) of these patients had at least one seizure between 6 and 18 
months after treatment. A seizure in the initial month after the onset of 
antiparasitic treatment (present in 30 cases) was associated with seizure 
relapse between months 6 and 18 (6/30, 20% versus 2/55, 4%, relative 
risk 5.6, 95% confidence interval 1.2-25.6, p=0.02). Similarly, a seizure in 
the initial two months or in the initial 6 months after treatment onset were 
associated with further seizure episodes in the same period (2-months: 
7/33, 21.2% versus 1/52, 1.9%, relative risk 11.0, 95% confidence 
interval 1.4-85.6, p=0.003; 6 months: 8/36, 22.2% versus 0/49, 0%, risk 
reduction 0.22, 95% confidence interval 0.09-0.36, p<0.001). The risk 
of seizure relapse was also significantly higher in patients with a history 
of previous courses of antiparasitic treatment (RR 6.7, 95% confidence 
interval 1.6-29.3, p=0.03), but no significant differences in risk of seizure 
relapse were found in regards to their length of seizure history, number of 
seizure episodes in the 12 months before antiparasitic treatment, number 
of cysticercotic lesions, presence of calcifications, proportion of lesions 
with inflammation at baseline, or length of antiepileptic drug treatment. 
Our results show that early post-treatment seizures will be associated with 
further seizure relapse in a subgroup of NCC patients. Enhanced seizure 
control in the first months should be considered to reduce this risk.
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FUNCTIONAL ANALYSIS OF DIVERGENT GPCR-LIKE 
PROTEINS DURING PLASMODIUM CHABAUDI BLOOD-STAGE 
DEVELOPMENT
Rachel Milne, Gabriella Lindergard, Wiebke Nahrendorf, Philip 
Spence, Joanne Thompson
Immunology and Infection Research, Edinburgh, United Kingdom
Whilst malaria infection results in a complex range of responses and 
disease in the host, the parasite must respond in turn to changing 
host conditions to optimise its infectivity and transmission capacity. 
The components of parasite signaling pathways, therefore, have great 
potential as anti-malarial therapeutic targets. Signaling pathways operating 
through G-Protein Coupled Receptors (GPCR) are the best-established 
class of therapeutic targets and, although almost nothing is known about 
the identities of Plasmodium-encoded components of GPCR signalling 
pathways, chemical library screens and experimental approaches suggest 
that they operate during Plasmodium blood-stage development. We have 
therefore investigated the function of two Plasmodium proteins that are 
members of ancient and divergent GPCR families using the rodent in vivo 
malaria model, P. chabaudi. Gene deletion and mutation has revealed that 
Plasmodium GPCR-like genes play a role in parasite egress and invasion 
and in host-parasite interactions necessary for the establishment of both 
acute and chronic infection. The function of GPCR-like family members 
in regulating the signalling pathways involved in these processes will be 
discussed.
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A NOVEL POPULATION OF TCRαβ-EXPRESSING 
CD11BHIGHCD14+F4/80+ MACROPHAGES IS INDUCED BY 
PLASMODIUM BERGHEI ANKA MURINE MALARIA
Miranda Oakley, Joanna Chorazeczewski, Victoria Majam, 
Bhavna Chawla, Maya Aleshnick, Kazuyo Takeda, Adovi Akue, 
Mark KuKuruga, Sanjai Kumar
FDA, Silver Spring, MD, United States
Macrophages are equipped with a wide array of invariant receptors that 
facilitate their phagocytic function and the regulation of inflammation. 
In malaria, macrophages mediate both immune protective (parasite 
clearance) and pathogenic (cerebral malaria and severe malaria anemia) 
processes. Using the virulent asexual stage of the Plasmodium berghei 
ANKA (Pb-A) parasite which causes experimental cerebral malaria in 
C57BL/6 mice and severe anemia in Balb/c mice, we have identified a 
novel population of CD11bhighCD14+F4/80+ macrophages that express 
TCRαβ during malaria infection. This population expands rapidly during 
a Pb-A infection and preferentially sequesters in the brain during ECM. 
Proliferation of malaria specific TCRαβ-expressing macrophages requires 
a threshold level of parasite burden and optimal expression of TCRαβ on 
CD11bhigh cells requires coexpression of CD14 and F4/80. Furthermore, in 
depth flow cytometric analysis demonstrates that these unique TCRαβ-
expressing macrophages are CD3-CD4-CD8- and the Vβ TCR repertoire 
of macrophages is distinctly different from conventional T cells during 
Pb-A infection. Identification of this unusual macrophage population 
that uses combinatorial TCRαβ expands our knowledge of macrophage 
biology during malaria and adds another layer of complexity to malaria 
immunology while providing new considerations in vaccine and drug 
design.
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PLASMODIUM FALCIPARUM PHISTC PROTEINS ARE 
REQUIRED FOR ANTIGEN DELIVERY TO THE INFECTED 
ERYTHROCYTE SURFACE
Deepali B. Ravel, Pierre-Yves Mantel, Kathleen W. Dantzler, 
William C. Beyer, Nicolas M. Brancucci, Manoj T. Duraisingh, 
Matthias Marti
Harvard School of Public Health, Boston, MA, United States
Plasmodium falciparum extensively remodels its host cell to mediate 
nutrient exchange and avoid immune and splenic pressure during blood 
stage infection. This remodeling includes changes to the adhesive and 
biophysical characteristics of infected cells and is mediated by exported 
parasite proteins. Here, we investigate the role of Plasmodium PHISTc 
proteins in erythrocyte remodeling. PHISTc proteins are exported and 
contain a helical core domain shared by all PHIST paralogs. They are 
conserved across primate malarias, and several are expressed in both 
asexual and sexual blood stages, suggesting conserved function in host 
pathogen interactions. While several proteins from the PHISTb sub-
class have a role in cellular rigidity or cytoskeletal architecture, little is 
known about the function of PHISTc proteins. To investigate the role of 
PHISTc proteins in asexual and sexual stage remodeling, we knocked 
out 9 of the 16 P. falciparum paralogs in the reference line 3D7 and in a 
second line, CS2. Flow cytometry showed that 6 of the 9 PHISTc knock 
outs have decreased asexual surface reactivity to serum from malaria 
patients, suggesting that they are required for efficient surface antigen 
trafficking. Of these 6 PHISTc knockouts with decreased surface antigen 
display, 2 showed a complete absence of the VAR2CSA PfEMP1 variant 
at the erythrocyte surface by flow cytometry and immunofluorescence 
microscopy while 2 others showed normal VAR2CSA display. These 
data suggest differential specificity for surface antigen delivery between 
PHISTc proteins. Finally, microsphere filtration showed that none of 
the 9 PHISTc knock outs affects cellular rigidity of asexual stages, and 
immunofluorescence microscopy showed that PHISTc disruption also does 
not affect trafficking of knob or Maurer’s clefts markers. Altogether our 
observations suggest that PHISTc proteins, in contrast to PHISTb proteins, 
play a specialized role in antigen delivery to the host cell surface without 
drastically altering cellular architecture. We hypothesize that each PHISTc 
protein may differentially contribute to the trafficking of specific antigen 
families or PfEMP1 variants.
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EXPLORING THE ROLE OF PLASMODIUM VIVAX DUFFY 
BINDING PROTEIN 1 IN INVASION OF DUFFY-NULL AFRICANS
Karthigayan Gunalan1, Eugenia Lo2, Jessica B. Hostetler3, 
Delenasaw Yewhalaw4, Jianbing Mu3, Daniel E. Neafsey5, Guiyun 
Yan2, Louis H. Miller1
1National Institute of Health, Rockville, MD, United States, 2Program 
in Public Health, College of Health Sciences, University of California, 
Irvine, CA, United States, 3National Institutes of Health, Rockville, 
MD, United States, 4Department of Medical Laboratory Sciences and 
Pathology, College of Health Sciences, Jimma University, Jimma, Ethiopia, 
5Broad Institute of Massachusetts Institute of Technology and Harvard, 
Cambridge, MA, United States
The ability of the malaria parasite Plasmodium vivax to invade red 
blood cells (RBCs) is dependent on the expression of the Duffy blood 
group antigen on RBCs. Consequently, Africans who are null for the 
Duffy antigen are not susceptible to P. vivax infections. Recently, P. vivax 
infections in Duffy-null Africans have been documented, raising the 
possibility that P. vivax, a virulent infection in other parts of the world, may 
expand malarial disease in Africa. In our study, we have identified two 
Duffy-null Ethiopians infected with P. vivax. For invasion, P. vivax binds the 
Duffy blood group antigen through its Duffy binding ligand 1 (PvDBP1). 
Previously several mutations were observed in PvDBP1 from Madagascar, 
India, and Brazil and we identified unique mutations in PvDBP1 in Duffy-
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null Ethiopians by sequencing. We aimed at understanding whether the 
mutations in PvDBP1 results in binding to another receptor on Duffy-
null RBCs. We determined PvDBP1 from these parasites failed to bind 
Duffy-null RBCs, but bound strongly to Duffy-positive RBCs, indicating 
that mutations in DBP1 did not account for the ability of P. vivax to 
infect Duffy-null Africans. Interestingly, by real-time quantitative PCR 
we identified three and eight copies of PvDBP1 in the two Duffy-null 
Ethiopians suggesting that it may be selected to bind low copy number 
of Duffy blood group antigen if expressed on Duffy null RBCs or another 
new receptor on the RBCs by increasing its gene expression. Moreover, Sal 
I P. vivax invades Squirrel monkeys despite the failure of PvDBP1 binding 
to squirrel RBCs. It is surprising to know that despite the high similarity 
between the Duffy blood group antigens from Squirrel, Aotus monkeys 
and humans, Sal I PvDBP1 does not bind Squirrel monkey erythrocytes. 
Furthermore, we determined P. vivax DBP1 from India and Brazil bound 
squirrel monkey RBCs as strongly as Aotus RBCs. Therefore, Sal I P. vivax 
infects Squirrel monkeys in the absence of PvDBP1 binding to Squirrel 
monkey RBCs. We conclude that P. vivax Sal I and perhaps P. vivax in 
Duffy null patients may have adapted to use new ligand-receptor pairs for 
invasion.
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GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY 
PREVALENCE: GENETIC VARIANTS AND THEIR INFLUENCE 
ON HEMOLYTIC EFFECT IN MALARIA ENDEMIC AREAS OF 
COLOMBIA
Sonia M. Herrera1, Iván Dario Ocampo1, Maria Isabel Arce1, 
Alberto Alzate1, Judith Recht2, Julio Padilla3, Pablo Chaparro4, 
Myriam Arévalo Herrera5
1Caucaseco Scientific Research Center/Centro Latino Americano de 
Investigación en Malaria (CLAIM), Cali, Colombia, 2Caucaseco Scientific 
Research Center, Cali, Colombia, 3Instituto Nacional de Salud, Bogotá, 
Colombia, 4Ministerio de Salud y Protección Social, Bogotá, Colombia, 
5Caucaseco Scientific Research Center/Universidad del Valle, Cali, Colombia
Glucose 6-phosphate dehydrogenase (G6PD) is an enzyme involved 
in prevention of cellular oxidative damage, particularly protecting 
erythrocytes from hemolysis. An estimated 400 million people present 
variable degrees of inherited G6PD deficiency (G6PDd) which puts them 
at risk for developing hemolysis triggered by several risk factors including 
certain foods and multiple drugs including Primaquine (PQ). Intensification 
of malaria control programs worldwide are recommending a more 
extensive use of PQ and related drugs in populations with different levels 
of G6PDd prevalence. The aim of this study is to assess the prevalence 
of G6PDd in representative malaria endemic areas of Colombia and the 
influence of PQ administration on the induction of hemolysis. A total of 
426 volunteers from Buenaventura, Tumaco, Tierralta and Quibdó were 
evaluated for G6PD enzymatic activity by using a quantitative G6PD test 
and a subset of samples were analyzed by PCR-RFLP to determine the 
frequency of the three most common G6PD genotypic variants: A-, A+ 
and Mediterranean. Preliminary results indicate a high frequency of G6PD 
A- genotype, followed by A+ genotype. A total of 28 individuals (6.56%) 
displayed either severe or intermediate G6PDd. The highest prevalence 
(3.51%) was found in Buenaventura, whereas G6PDd prevalence was 
lower (<1%) in Tierralta and Quibdó. G6PD A alleles were the most 
frequent (15.23%) particularly in Buenaventura and Tumaco. In order 
to determine the hemolytic effect of PQ administration for treatment of 
P.vivax infections, in a second phase, individuals attending the malaria 
control program are being studied. Blood samples from P.vivax malaria 
patients are being collected over a period of three weeks after initiation of 
PQ treatment and are being analyzed to assess hematologic parameters 
such as hemoglobin, hematocrit, and bilirubin as well as G6PD phenotype 
and genotype. Final results of these studies will be presented. Assessment 
of G6PDd prevalence in malaria endemic areas is crucial in view of possible 
mass drug administration (MDA) for malaria elimination in these regions.
41
ACUTE KIDNEY INJURY IS COMMON IN UGANDAN 
CHILDREN WITH SEVERE MALARIA, AND STRONGLY 
ASSOCIATED WITH SEQUESTERED PARASITE BIOMASS AND 
MORTALITY
Andrea L. Conroy1, Robert O. Opoka2, Paul Bangirana2, Chandy 
C. John1
1Indiana University School of Medicine, Indianapolis, IN, United States, 
2Makerere University College of Health Sciences, Kampala, Uganda
Acute kidney injury (AKI) is a common complication in severe malaria that 
portends adverse clinical outcomes. A major challenge in assessing AKI 
relates to defining baseline kidney function. A number of approaches 
have been evaluated in pediatric cohorts, but none have been validated in 
African children. This study was performed at Mulago Hospital, Kampala, 
Uganda. Children with cerebral malaria (CM), severe malaria anemia 
(SMA), or community children (CC) were enrolled if they were between 
18 months and 12 years of age. In this study we validate an approach to 
estimate baseline renal function in children assuming a normal glomerular 
filtration rate (GFR) of 120mL/min/1.73m2 to back-calculate creatinine 
(Cr) using the Schwartz equation. We compared the estimated baseline Cr 
(eCr) values to a population-derived normal curve of Cr for height using 
CC (n=169). The eCr calculated a GFR of 120mL/min/1.73m2 correlated 
very well with values derived from the reference population (R2=0.997, 
p<0.0001). AKI was defined using the Kidney Disease: Improving Global 
Outcomes (KDIGO) classification where a 1.5x increase in baseline Cr 
constituted AKI. Rates of AKI classification using the two approaches 
were identical with 39.5% of children with CM (n=99/257), and 21.0% 
of children with SMA (n=46/219) meeting a definition of AKI. AKI was 
associated with the sequestered parasite biomass in children with CM 
and SMA, p<0.0001 and p=0.005 respectively. In children with CM, AKI 
was associated with increased odds of in-hospital and all-cause 24-month 
mortality (odds ratio, 95% confidence interval: in-hospital mortality, 1.59, 
1.04-2.45, p=0.009; 24 month mortality, 1.69, 1.09-2.61, p=0.003). This 
study validates a GFR of 120mL/min/1.73m2 as an appropriate estimate of 
baseline renal function in Ugandan children. AKI was strongly associated 
with sequestered, but not circulating, parasite biomass in children with 
both SMA and CM. In children with CM, AKI was also strongly associated 
with increased short- and long-term mortality. Interventions that decrease 
sequestration should be studied for their potential to reduce AKI and 
mortality in children with CM.
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PFHRP2 PERSISTENCE IN “ONCE INFECTED RBC” ENABLES 
A RAPID PREDICTION OF POST-ARTESUNATE DELAYED 
HEMOLYSIS
Papa Alioune Ndour1, Sébastien Larréché2, Oussama Mouri3, 
Nicolas Argy4, Camille Roussel1, Stéphane Jauréguiberry3, Claire 
Perillaud5, Dominique Langui6, Sylvestre Biligui3, Nathalie Chartrel3, 
Audrey Mérens2, Arjen Dondorp7, Sandrine Houzé4, Frédéric Gay5, 
Serge Bonnefoy8, Marc Thellier3, Charlie Woodrow9, Pierre Buffet1, 
French Artesunate working group
1National Institute of Blood Transfusion/Inserm U1134 - Paris 5 University, 
Paris, France, 2UF Bactériologie – Parasitologie – Mycologie, Hôpital 
d’instruction des armées Bégin, Paris, France, 3APHP Pitiè-Salpêtrière 
- Centre National du Paludisme Pitiè-Salpêtrière, Paris, France, 4APHP 
Bichat - Centre National du Paludisme Bichat, Paris, France, 5APHP 
Pitiè-Salpêtrière, Paris, France, 6University Paris 6, Paris, France, 7MORU 
- Université d’oxford, Bangkok, Thailand, 8Institut Pasteur de Paris, Paris, 
France, 9MORU - Université d’oxford, Paris, Thailand
Artesunate rapidly cures patients with severe malaria but frequently 
induces anemic episodes called Post-Artesunate Delayed Hemolysis 
(PADH) for which a simple predictive method is urgently needed. The 
concentration of “once-infected” red blood cells - appearing when 
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artesunate-exposed parasites are expelled from their host RBC by pitting 
- is predictive of subsequent PADH. In 103 French travellers patients, we 
observed that Plasmodium falciparum Histidine-Rich Protein 2 (HRP2) 
persists in the whole blood (not plasma) of artesunate-treated patients 
at significantly higher levels than quinine-treated patients (p=0.035). This 
HRP2 persistence was also observed in 70 Bengladesh patients. Using 
an optimized membrane permeation method, HRP2 was observed by 
immunofluorescence, Western blot and electron microscopy to persist in 
once-infected red cells from artesunate-treated patients. HRP2 deposition 
followed a membrane-bound pattern similar to that of Ring-Erythrocyte 
Surface Antigen (RESA), the conventional marker of these cells. Based on 
these observations, we developed a semi-quantitative titration method 
using a widely available HRP2-based RDT. Positivity of this RDT using a 
1:500 dilution of whole blood collected after parasite clearance (2-4 days 
after start of treatment) predicted subsequent PADH with 93% sensitivity 
and 74% specificity. These results immediately open the way to the 
adaptation and adoption of existing HRP2-based malaria RDTs for cheap, 
bed-side prediction of PADH several days before it occurs.
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EVALUATE MOSQUITO NETS FASTER AND CHEAPER: 
RESULTS FOR PUBLIC HEALTH INTEREST
Sanjiarizaha Randriamaherijaona1, Thomas Kesteman1, Emilie 
Pothin2, Mickael Green3, Ray Beach3, Sebastien Boyer1
1Institut Pasteur de Madagascar, Antananarivo, Madagascar, 2Swiss 
Tropical and Public Health Institute, Basel, Switzerland, 3Malaria Branch, 
Division of Parasitic Diseases and Malaria, Center for Global Health, U.S. 
Centers for Disease Control and Prevention, Atlanta, GA, United States
The World Health Organization (WHO) promotes the use of long-lasting 
insecticidal nets (LLINs) to prevent malaria and also advises national 
programs to evaluate insecticidal activity on nets. To measure insecticidal 
activity, the WHO guidance mentions the use of a cone test, which needs 
100 female mosquitoes per tested net. However, it requires a major and 
steady effort to produce thousands of insecticide-susceptible female 
mosquitoes, involving also expensive materials. The aim of the present 
study is to improve LLIN bio-efficacy testing by reducing cost and efforts 
while guaranteeing the accuracy of results. We evaluated two alternative 
methods to fulfill this objective: reducing the number of mosquitoes and 
evaluating a mosquito-free method. First, we compared the use of one, 
two, three or four cones (i.e. 25, 50, 75 or 100 mosquitoes) on each 
piece of LLIN with its Bayesian probability to be a valid LLIN. The result 
showed that using two cones has a limited impact on accuracy (93%) as 
compared with actual standard of four cones (94%). In a series of several 
LLINs, the average error in the measured proportion of valid LLINs was 
<1%. This result shows that it is possible to halve the time of lab processes 
without loss of accuracy for Public Health recommendations. Second, we 
evaluated a Colorimetric Field Test (CFT), a chemical method to measure 
surface levels of insecticide on LLINs. From three brand of LLINs collected 
in Madagascar, cut off values corresponding to the threshold value of 
80% mortality with bio-assay test were determined at 0.35 µg, 0.60 
µg and 0.07 µg per sample to consider a LLIN as ‘good net’. The results 
showed 92% sensitivity and 100% specificity, demonstrating that CFT is 
an excellent tool for assessing the residual activity of the insecticide. By 
adopting one of these methods, one could save much time and money 
to make a faster and cheaper decision for malaria control programs. A 
decision that could save human lives!
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INTERROGATING MOSQUITO-PATHOGEN COMMUNITIES 
USING HIGH-THROUGHPUT MICROFLUIDICS
Felix J. Hol, Haripriya Mukundarajan, Manu Prakash
Stanford University, Stanford, CA, United States
Eliminating mosquito-borne diseases requires intimate knowledge of the 
ecology of vectors. Such knowledge can for instance be used to design 
effective vector control strategies, or to understand the eco-evolutionary 
processes that drive range expansions of vectors and pathogens. Current 
techniques in vector ecology, such as human landing catches or chemically 
baited traps, are very labor intensive and therefore severely limited in 
throughput. These limitations prevent the detailed interrogation of 
mosquito-pathogen communities in the field. We demonstrate a low-cost 
automated screening tool that enables dissection-free, high-throughput 
molecular analysis of individual vectors and their pathogens. We exploit 
the  fact that mosquitoes transmit pathogens by expectorating saliva to 
autonomously collect saliva droplets resulting from single mosquito bites. 
Multiple cues (e.g. temperature, odorants, texture) are integrated on a 
microfabricated substrate mimicking human skin, the substrate is designed 
to maximize its attractiveness to mosquitoes and induce them to bite, 
thereby depositing saliva. We present behavioral data extracted  from 
laboratory experiments that allow us to quantitatively assess the 
interaction of mosquitoes with the device. The use of high-throughput 
microfluidics  enables us to perform small volume biochemical analyses 
on a huge number of pico-to-nanoliter saliva samples in parallel, greatly 
reducing reagent cost and processing time. We implement multiplexed 
microfluidic assays that enable the simultaneous characterization of the 
biting mosquito’s genetic make-up and its pathogens. This platform 
provides us with a means of high-throughput, high-resolution sampling of 
individual insects in field and laboratory settings. Large scale application 
of this tool in public health surveillance may provide early warnings for 
epidemics, detect the emergence of drug resistance, and track the spread 
of emerging infectious diseases.
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A PROMISING NEW MODE OF ACTION CHEMISTRY INDOOR 
RESIDUAL SPRAY PRODUCT TO CONTROL RESISTANT 
MOSQUITOES
John Lucas1, John Invest1, Takao Ishiwatari2, Yoshihiro 
Takebayashi2, Kazunori Ohashi2, Edi Constant3, Mouhamadou 
Chouaïbou3, Benjamin Koudu3, David Malone4, Pie Muller5
1Sumitomo Chemical Company Ltd, London, United Kingdom, 2Sumitomo 
Chemical Company Ltd, Tokyo, Japan, 3Centre Suisse de Recherches 
Scientifiques, Abidjan, Côte D’Ivoire, 4Innovative Vector Control 
Consortium, Liverpool, United Kingdom, 5Swiss Tropical and Public Health 
Institute and University of Basel, Basel, Switzerland
Widespread insecticide resistance of Anopheline mosquitoes to pyrethroids 
has dramatically reduced their effectiveness and as a consequence their 
use in indoor residual spray (IRS) programs has declined dramatically. 
Currently there are only three other mode of action insecticides 
recommended by the World Health Organization that are currently in use 
as IRS adulticides: carbamates, organophosphates and organochlorines, 
all of which also have cases of resistance reported. A new mode of action 
IRS chemistry is therefore urgently needed to control resistant populations 
and also to help prolong the life of existing IRS chemistry by rotating 
applications over time between different classes. SumiShield™ 50 WG is 
an indoor residual spray product based on the neonicitinoid insecticide 
clothianidin that has previously not been used in vector control. Initial 
laboratory studies have shown excellent residual activity of this water 
dispersible granule (WG) formulation on typical indoor surfaces such as 
mud, wood and cement. Experimental hut and semi field studies have 
also been conducted that confirm these initial findings and have shown 
residual activity of over 6 months against both susceptible and resistant 
strains. These findings are discussed in detail. This clothianidin based 
IRS product is currently undergoing evaluation by the World Health 
Pesticide Evaluation Scheme (WHOPES) in both experimental huts and 
also in village scale trials. Introducing an alternative mode of action 
chemistry to the marketplace will allow use of IRS products to be rotated 
and thus help facilitate the implementation of the WHO Global Plan for 
Insecticide Resistance Management (GPRIM). When used alongside other 
interventions such as bed nets and other modes of action IRS products 
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SumiShield 50 WG will be a valuable tool to help control both susceptible 
and resistant mosquitoes and bring us closer to the goal of eliminating and 
ultimately eradicating malaria.
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SHAZAM FOR MOSQUITOES : CROWDSOURCING VECTOR 
SURVEILLANCE BY USING MOBILE PHONES AS ACOUSTIC 
SENSORS
Haripriya Mukundarajan, Felix J. Hol, Erica A. Castillo, Cooper 
Newby, Manu Prakash
Stanford University, Stanford, CA, United States
One of the most ubiquitous, powerful and easily accessible data collection 
tools that we possess today is the mobile phone. Here we show that 
mobile phones can be harnessed to identify insects around us through 
acoustic measurements. We demonstrate that a variety of mobile phones, 
from recent smart phones to the feature-phone models of the 1990s, can 
be used to record sufficiently sensitive signals for the acoustic identification 
of individual insects. Through signal processing analyses, we create an 
“acoustic fingerprint” for disease vectors such as mosquitoes, which can 
be used to infer its species and physiological characteristics like sex and 
blood-feeding status. We outline a citizen science initiative to create an 
open database of acoustic signatures, with insect recordings from all 
over the world being processed for crowd-sourced, real time surveillance 
of vector ecology. This technique makes it possible to collect vector 
surveillance data at extremely high spatio-temporal resolutions, which can 
help plan disease control strategies, monitor invasive species and gauge 
infection risks for vector-borne diseases.
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AUTOCIDAL MOSQUITO CONTROL: ALLOWING 
MOSQUITOES TO HELP US WITH OUR WORK
Stephen L. Dobson1, Corey Brelsfoard2, James Mains2
1University of Kentucky, Lexington, KY, United States, 2MosquitoMate, Inc., 
Lexington, KY, United States
The ongoing problem of mosquito borne disease provides an impetus 
to develop additional methods for the control of invasive mosquito 
species and against the globalization of mosquito-vectored pathogens. 
In addition to the development of new active ingredients, there is need 
also to develop additional methods for delivering pesticides. Autocidal 
methods rely on the use of mosquitoes to ‘self-deliver’ pesticides and may 
provide a useful compliment to traditional application methods. Here, 
the results of recent field trials will be presented. The trials are based on 
the release of male mosquitoes that have been either 1) infected with a 
naturally-occurring bacterium “Wolbachia” to cause sterility in a targeted 
population or 2) dusted with pyriproxyfen, which is a powerful inhibitor 
of immature mosquito development. The Wolbachia method is non-GMO 
and categorized by the EPA as a microbial biopesticide. The Wolbachia 
method is species specific and has been developed for multiple mosquito 
species, including Aedes albopictus, Ae. aegypti and Anopheles stephensi. 
The pyriproxyfen dusting approach can be used alone, or combined 
with classical Sterile Insect Technique, Wolbachia and GMO approaches, 
to increase the overall impact of the introduced male mosquitoes. The 
different approaches will be discussed and contrasted, and their relevance 
to different mosquito control contexts, including areal delivery, will be 
discussed. The results of recent field trials will be summarized.
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TRANSGENIC INSECT KILLING FUNGUS BETTER KILLS 
INSECTICIDE-RESISTANT, MALARIA-VECTOR MOSQUITOES
Etienne M. Bilgo1, Brian Richard Lovett2, Raymond St.Leger2, 
Roch K. Dabiré1, Antoine Sanon3, Abdoulaye Diabaté1
1IRSS/Centre Muraz, Bobo Dioulasso, Burkina Faso, 2University of 
Maryland College Park, College Park, MD, United States, 3Université de 
Ouagadougou, Ouagadougou, Burkina Faso
The continued success of malaria control efforts requires the development, 
study and implementation of new technologies. Here we present a 
significant advancement in the development of insect killing fungi as a 
means of mosquito biocontrol. We have combined the natural abilities 
of Metarhizium spp. fungi and the field of arthropod-derived toxins 
to engineer a highly specific and potent pathogen of mosquitoes. Our 
studies show significant improvements in the rate of mosquito mortality 
due to the transgene in both insecticide-susceptible and wild-caught, 
insecticide-resistant populations. We further discovered the enhanced 
ability of the transgenic fungus to decrease a critical aspect of mosquito 
behavior for the spread of malaria (blood feeding behavior). In only 5 
days, the transgenic fungus not only decreases disease transmission in 
mosquitoes faster than the wild-type fungus, but it decreases blood 
feeding to a greater degree. This research characterizes our transgenic 
entomopathogen as an effective and rapid mosquito control technology, 
which can be readily applied to mitigate risks involved with existing 
insecticide-based control methods.
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COMPARING THE EFFICACY OF INSECTICIDE MIXTURE AND 
COMBINATION STRATEGIES FOR IMPROVED CONTROL 
AND MANAGEMENT OF PYRETHROID RESISTANT MALARIA 
VECTORS IN SOUTHERN BENIN, WEST AFRICA
Corine Ngufor1, Jessica Critchley1, Raphael N’Guessan1, Martin 
Akogbeto2, Mark Rowland1
1London School of Hygiene & Tropical Medicine, London, United Kingdom, 
2Centre de Recherche Entomologique de Cotonou, Cotonou, Benin
The Global Plan for Insecticide Resistance Management (GPIRM) 
recommends the use of a combination/mixture of unrelated insecticides 
against insecticide resistant malaria vectors for improving control and 
managing resistance. This concept can be applied by using insecticide 
mixtures on mosquito bed nets, co-formulated insecticide mixtures for 
indoor residual spraying (IRS) or deploying non-pyrethroid IRS together 
with pyrethroid bed nets. The uptake of these strategies at national levels 
has been slow due to lack of effective new mixture/combination tools and 
insufficient evidence on efficacy to guide decision making. Mixtures on 
bed nets or IRS being single interventions could be cost effective and more 
desirable than the combined intervention approach if comparable levels 
of impact can be demonstrated in terms of their ability to improve vector 
control and manage resistance. The current study compared the efficacy 
of a newly developed chlorfenapyr (a pyrolle) and alphacypermethrin (a 
pyrethroid) mixture long-lasting bed net (Interceptor G2) to an IRS mixture 
of chlorfenapyr and alphacypermethrin and a combined chlorfenapyr 
IRS and alphacyperthrin long-lasting net (Interceptor 1) intervention 
in experimental huts against wild pyrethroid resistant malaria vectors 
in Cove, Benin. Mortality rates were very low with alphacypermethrin 
IRS alone (5%) and Interceptor 1 alone (24%) owing to high levels of 
pyrethroid resistance in the vector population. Mortality with the mixture 
IRS (42%) was unexpectedly lower than IRS with chlorfenapyr alone 
(51%) (P<0.005). The mixture net (Interceptor G2) and the combined 
IRS and bed net approach provided the highest mortality rates and 
these were similar between both treatments (75% vs. 69% respectively, 
P>0.05). Blood feeding rates were also significantly reduced with these 
treatments compared to the control and the mixture IRS (P>0.05). The 
results demonstrate that Interceptor G2 could be a more cost-effective and 
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reliable strategy for improving the control of pyrethroid resistant malaria 
vectors and managing resistance compared to the combined intervention 
approach and the mixture IRS.
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LYMPHATIC FILARIASIS ELIMINATION IN AMERICAN SAMOA: 
EVALUATION OF MOLECULAR XENOMONITORING AS A 
SURVEILLANCE TOOL IN THE ENDGAME
Colleen L. Lau1, Kimberly Y. Won2, Patrick J. Lammie2, Patricia M. 
Graves3
1Research School of Population Health, Australian National University, 
Canberra, Australia, 2Division of Parasitic Diseases and Malaria, Centers 
for Disease Control and Prevention, Atlanta, GA, United States, 3WHO 
Collaborating Centre for Lymphatic Filariasis, Soil-Transmitted Helminths 
and Other Neglected Tropical Diseases, James Cook University, Cairns, 
Australia
The Global Programme to Eliminate Lymphatic Filariasis (GPELF) has 
made significant progress toward interrupting transmission of lymphatic 
filariasis (LF) through mass drug administration (MDA). Operational 
challenges in defining endpoints of elimination programs have been 
identified, including the need to determine appropriate post-MDA 
surveillance strategies. As humans are the only reservoirs of LF parasites, 
one such strategy is molecular xenomonitoring (MX), the detection of 
filarial DNA in mosquitoes using molecular methods (PCR), to provide 
an indirect indicator of infected persons nearby. MX could potentially 
be used to evaluate program success, provide support for decisions to 
stop MDA, and conduct post-MDA surveillance. American Samoa has 
successfully completed MDA and passed WHO recommended Transmission 
Assessment Surveys in 2011 and 2015, but recent studies using spatial 
analysis of antigen and antibody prevalence in adults (aged ≥18 years) and 
entomological surveys showed evidence of possible ongoing transmission. 
This study evaluated MX as a surveillance tool in American Samoa by 
linking village-level results of the recent human and mosquito studies. 
Of 32 villages, seropositive persons for Og4C3 antigen were identified in 
11 (34.4%), Wb123 antibody in 18 (56.3%) and Bm14 antibody in 27 
(84.4%) of villages. Village-level seroprevalence ranged from 0%-33%, 
0%-67% and 0%-100% for Og4C3, Wb123 and Bm14 respectively. PCR-
positive Aedes polynesiensis mosquitoes were found in 15 (47%) villages, 
and their presence was associated with a significantly higher probability 
of seropositive persons for Og4C3 (67% vs 6%) and Wb123 (87% vs 
29%), but not Bm14. In villages with seropositive persons for Og4C3 
and Wb123, PCR-positive A. polynesiensis were found in 91% and 72% 
respectively. In villages without Og4C3-positive persons, PCR-positive A. 
polynesiensis were absent in 94%. Our study provides promising evidence 
to support the potential usefulness of MX in post-MDA surveillance in an 
Aedes transmission area in the Pacific Island setting, and to predict sub-
national areas where LF transmission may be continuing.
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FILARIASES IN GABON: EMPIRIC ASSESSMENTS REDEFINE 
DISTRIBUTION AND TREATMENT STRATEGIES FOR 
ONCHOCERCIASIS AND LOIASIS
Julienne Atsame1, Kira A. Barbre2, Kristen Renneker2, Maria P. 
Rebollo2, Honorat Zoure3
1Ministry of Health Gabon, Libreville, Gabon, 2The Task Force for Global 
Health, Decatur, GA, United States, 3Regional Office for Africa, World 
Health Organization, Brazzaville, Republic of the Congo
Previous surveys for Rapid Epidemiological Mapping of Onchocerciasis 
(REMO) in Gabon predicted very low prevalence of onchocerciasis (0 – 
5%) across the country, whereas Rapid Assessment for Loiasis (RAPLOA) 
predicted more than 40% prevalence in the entire country. Ivermectin was 
never given in Gabon due to the low onchocerciasis prevalence and the 
considerable risk of serious adverse events (SAE) to ivermectin in highly-
prevalent Loa loa endemic areas where individuals with Loa loa infections 
with intensities of >30,000 mf/ml may reside. Due to the new global 
target to eliminate onchocerciasis, there is an urgent need to determine 
which treatment intervention is required to eliminate the disease from 
Gabon. Therefore, in 2014-2015, 7,108 individuals in 93 communities 
in 34 districts were tested for onchocerciasis by skin snip and/or Ov16, 
and 10,214 individuals in 176 communities in 43 districts were tested by 
blood smear to detect L. loa microfilaremia. Prevalence of onchocerciasis 
was found to be much higher in some communities than predicted by 
REMO; 9% of districts were hyper-endemic (at least one community > 
60% infected) and 12% of districts were meso-endemic (at least one 
community 40 - 60% infected). In contrast, L. loa prevalence was lower 
than predicted by RAPLOA; 82% of individuals tested were negative, and 
in one district the maximum prevalence found in any community was 0% 
despite a RAPLOA prediction of >40%. Of 93 communities tested for 
onchocerciasis, 67 communities (72%) were endemic (any positive results 
from skin snip or Ov16). All 67 communities had some L. loa prevalence 
(ranging from 2% to 51%), but, importantly, 31 communities (46%) had 
no individuals with high intensity (30,000 mf/mL+) infection. Our results 
have shown that it is possible to find areas with very little L. loa infection 
and high onchocerciasis burden where treatment with ivermectin could be 
appropriate. They also emphasize the importance of empiric assessments 
to refine our understanding of the distribution of these two diseases in 
Central Africa and guide treatment interventions to achieve onchocerciasis 
elimination.
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HIGH PREVALENCE OF EPILEPSY IN ONCHOCERCIASIS 
ENDEMIC REGIONS IN THE DEMOCRATIC REPUBLIC OF THE 
CONGO (DRC)
Robert Colebunders1, Floribert Tepage2, Michel Mandro3, 
Kenneth Pfarr4, Jean Marie Kashama5, Bethanie Levick6, Deogratias 
Rossy3, Alliance Tagoto7, Anne Laudisoit1
1University of Antwerp, Antwerp, Belgium, 2Programme National de lutte 
contre l’onchocercose, Kisangani, Democratic Republic of the Congo, 
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4University Hospital Bonn, Bonn, Germany, 5Université de Kinshasa, 
Kinshasa, Democratic Republic of the Congo, 6University of Liverpool, 
Liverpool, United Kingdom, 7Ministry of Health, Kisangani, Democratic 
Republic of the Congo
Between 2014 and 2016, we conducted epilepsy prevalence surveys in 
61 villages in onchocerciasis endemic areas in the DRC. A case control 
study was performed in Titule (Bas-Uélé), Salambongo (Tshopo) and Draju 
(Ituri). Cases were patients with active convulsive epilepsy and controls 
were age matched persons without epilepsy randomly selected from 
the same village. A high prevalence of epilepsy was observed in villages 
located closely to Simulidae (blackfly) infested rivers: 2.3-6.4% in Bas-
Uélé, 1.5-6.0% in Tshopo, and 3.0-5.6% in Ituri. Epilepsy cases showed 
a marked spatial pattern with clustering of cases occurring within and 
between adjacent households. Individual risk for epilepsy was found to 
be associated with living close to the river. Peak onset of epilepsy was 
around the age of 14-15. Nodding syndrome was not observed but 
adolescents with epilepsy and with severe stunting and without secondary 
external signs of sexual development were observed in several villages. 
Phenobarbital was the anti-epileptic drug most frequently used but rarely 
continuously. In villages where Ivermectin was distributed for at least 10 
years, no difference in the presence of Onchocerca volvulus (OV) DNA in 
the skin was observed between cases and controls. On the other hand 
in Draju, where Ivermectin was never distributed, OV microfilaria were 
observed in skin snips of 55.9% (33/59) of epilepsy cases compared 
to 29% (20/69) of controls (p = 0.002); mean density of microfilaria 
(Mf) in skin snips of cases was 33.6 parasites/mg skin compared to 3.8 
parasites/mg skin in controls (p = 0.002); and 45.8 % (27/59) of cases had 
OV16 antibodies compared to 26.1% (18/69) of controls (p = 0.002). A 
quantitative real-time PCR assay showed that the amount of Wolbachia 
ftsZ gene (bacterial OV endosymbiont) in skin snips was significantly 
higher in cases than in controls (p < 0.01). In conclusion, the prevalence of 
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epilepsy in villages in onchocerciasis endemic areas in the DRC was 2-10 
times higher than in non-onchocerciasis endemic regions in Africa. Our 
study confirms that OV infestation is associated with epilepsy.
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SIMULATING THE EFFECT OF EVALUATION UNIT SIZE 
IN DETERMINING ELIGIBILITY TO STOP MASS DRUG 
ADMINISTRATION FOR LYMPHATIC FILARIASIS IN HAITI
Natalya Kostandova1, Luccene Desir2, Abdel Direny3, Alaine 
Knipes4, Jean Frantz Lemoine5, Franck Monestime6, Fayette Carl 
Renand6, Michael S. Deming4, Amy Kirby1, Katherine Gass7
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Croix, Leogane, Haiti, 3ENVISION Project, RTI International, Washington, 
DC, United States, 4Centers for Disease Control and Prevention, Atlanta, 
GA, United States, 5Ministry of Public Health and Population, Port-au-
Prince, Haiti, 6IMA World Health, Port-au-Prince, Haiti, 7NTD Support 
Center, Task Force for Global Health, Decatur, GA, United States
The Transmission Assessment Survey (TAS) was designed as a decision-
making tool for program managers to determine when transmission 
of lymphatic filariasis (LF) is presumed to have reached a level low 
enough that it cannot be sustained even in the absence of mass drug 
administration (MDA). The geographic area over which a TAS is applied 
is referred to as an evaluation unit (EU). EUs may comprise one or 
multiple program implementation units (IUs) and should have no more 
than 2 million people. In 2015, TAS was conducted in 14 EUs in Haiti, 
many comprising a single IU. Of these 14 TAS, two failed and one had 
a borderline result (i.e., the number of positive results was equal to 
the critical threshold). Simulations were used to understand what the 
programmatic conclusions would have been had Haiti chosen to form 
larger EUs. Eight “combination-EUs” were formed through various 
groupings of existing adjacent EUs. Several simulation approaches 
to replicate TAS were carried out in these combination-EUs, using 
bootstrapping to simulate the expected data. Each approach was 
replicated 1000 times, with the number of “passing” and “failing” TAS 
results recorded. The simulations showed that when the combination-
EU was comprised of discordant EUs - at least one “passing” and one 
“failing” - the combination-EU would pass the TAS 71% - 100% of the 
time, with exception of one combination-EU, where the TAS failure rate 
of the combination-EU was never more than 83%. Combining IUs to form 
large EUs is common practice, as it can result in considerable cost savings 
and detailed prevalence data to better inform such decisions is often 
lacking. Our results demonstrate the high potential for misclassification 
when the prevalence of LF in the combined IUs differs. Of particular 
concern is the risk of “passing” larger EUs that include focal areas where 
prevalence is high enough to be potentially self-sustaining. Our results 
reaffirm the approach that Haiti took in forming smaller EUs, based on 
historical knowledge, and suggests that in areas where such information 
is lacking greater detail, perhaps gathered through additional spot check 
sites, may be useful to inform EU creation.
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PREVALENCE OF OV16 ANTIBODIES AMONG SCHOOL-AGE 
CHILDREN AFTER TWENTY YEARS OF MASS TREATMENT 
WITH IVERMECTIN IN TOGO
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Potchoziou Karabou1, Koffi S. Sognikin1, Rachel N. Bronzan7
1Ministère de la santé, Lomé, Togo, 2Université de Lomé, Lomé, Togo, 
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The Onchocerciasis Control Program of Togo (OCP) is in the process of 
shifting its focus from control to elimination of onchocerciasis. Thirty-
two of Togo’s 40 districts are endemic for onchocerciasis and have been 
receiving annual treatment with ivermectin in villages with population 
≤2000 for more than 20 years, and the 15 northern most districts receive 
two rounds of treatment per year. Yearly epidemiological surveillance 
focuses on approximately 300 villages where onchocerciasis remains 
prevalent according to skin snip surveys. In preparation for the move 
to elimination, Togo’s Ministry of Health conducted a survey to obtain 
preliminary data on the distribution of antibodies to the Ov16 protein 
of Onchocerca volvulus in school-age children outside of the areas 
of ongoing surveillance. The survey was integrated with an impact 
assessment for other neglected tropical diseases (NTD). In 2015, in each 
of 1126 schools serving as NTD sentinel sites, a convenience sample of 8 
school-going children aged 6 to 9 years had finger-stick blood drawn for 
the Ov16 rapid test. Altogether, 9007 children were tested by Ov16 rapid 
test and 60 (0.7%) children tested positive. A map of the locations of the 
60 children with positive results shows that most were from areas where 
onchocerciasis is believed to be low, and one child was from a district that 
was categorized as non-endemic according to baseline mapping and has 
never received mass treatment with ivermectin. The OCP is conducting 
follow-up visits for all 60 children to document residency and travel 
history, to repeat the Ov16 rapid test, and to conduct skin snip testing 
with treatment if indicated. While there are challenges and limitations 
associated with use of the Ov16 rapid test for onchocerciasis, this 
survey provides important information for Togo’s OCP in moving toward 
onchocerciasis elimination in Togo.
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TOWARDS ELIMINATION OF LYMPHATIC FILARIASIS IN MALI 
BY 2020
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In Mali all 63 health districts (HD) were endemic for lymphatic filariasis 
(LF) and an initial mapping with ICT cards in 2004 revealed a national 
prevalence of 7.1% (from 1% in the north to 18.6% in the south). 
The country committed to the goal of eliminating LF as a public health 
problem by 2020. The implementation of mass drug administration 
(MDA) with albendazole and ivermectin began in areas co endemic with 
onchocerciasis in southern Mali in 2005, and scaled up to other endemic 
areas in northern Mali, reaching 100% geographical coverage in 2009. 
Since 2008, Mali has benefited from the support from Helen Keller 
International with funding from the USAID’s NTD Control Program and 
ENVISION Project, managed by RTI International. According to World 
Health Organization guidelines, LF transmission assessment surveys (TAS) 
were conducted in districts which had had at least 5 effective rounds of 
MDA. The Survey Sample Builder (SSB) was used to determine sample sizes 
and the selection of clusters. Evaluation units (EU) were approved by the 
RPRG before the implementation of the surveys. By 2016, transmission 
assessment surveys have been conducted in 31 health districts (11 EUs) 
across Mali. The 31 districts surveyed included all 10 districts in the 
Koulikoro region, all 6 communes in the district of Bamako, 9 out of 
10 districts in Sikasso region, and 6 out of 8 districts in Segou region. A 
community based cluster sampling (in 9 EUs) and school-based cluster 
sampling (2 EUs) strategy was used depending on school enrollment rates. 
All 11 EU surveyed passed the TAS with the number of positive cases being 
below the critical cut-off values determined by the SSB (18 or 20 positive 
cases). Currently, 49% (31/63) of the originally LF endemic districts have 
reached the criteria to stop MDA and evaluations are in preparation for the 
13 other districts in the center and south Mali and should be completed 
by June 2016. Insecurity in the north has caused some MDA rounds 
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to be cancelled and made it impossible to carry out evaluations. If the 
security situation improves, Mali will be on course to achieve national LF 
elimination objectives by 2020.
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EMPLOYING THE NEW OV16 RAPID DIAGNOSTIC TEST (RDT) 
TO EVALUATE ONCHOCERCIASIS IN AFRICA
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Elimination of onchocerciasis in Africa is targeted to be achieved by 
2025. Over the next decade, thousands of people will need to be 
tested to identify where treatment interventions are needed, when 
transmission interruption has been achieved, and for surveillance to 
verify that elimination has been attained. Nodule palpation and skin-
snip assessment of microfiladermia have been the traditional diagnostic 
tools, but a principal limitation of both is their lack of sensitivity in low 
prevalence settings. Because the Ov16 ELISA test has already been proven 
a useful tool in the Americas and a few settings in Africa to assess the 
interruption of transmission of onchocerciasis, World Health Organization 
(WHO) guidelines now recommend Ov16 serology as a diagnostic tool 
for onchocerciasis elimination programs. A new, point-of-care rapid 
diagnostic test (RDT) which detects antibodies to the parasite antigen 
Ov16 has recently been developed by PATH and its partners. While benefits 
of the RDT include requiring no cold chain, its ease of use, and being 
relatively low-cost, this test still requires evaluation at scale before it can be 
recommended for routine programmatic use. Therefore, in a multi-country 
study to compare skin snip tests with the new Ov16 RDT, a total of 31,633 
people were tested in 3 post-treatment settings (in Mali, Malawi, Guinea 
Bissau) and in 3 settings where treatment for onchocerciasis has never 
been given (in Gabon, Nigeria, the Democratic Republic of the Congo). In 
the post-treatment settings, the prevalence of onchocerciasis as diagnosed 
by a positive Ov16 RDT was 3.18% (95% CI: 2.74-3.62) but 0.00% when 
diagnosed by skin snip. In the treatment-naïve settings, the prevalence via 
Ov16 RDT was 3.30% (95% CI: 3.11-3.55) and by skin snip was 1.00% 
(95% CI: 0.90-1.10). The Ov16 RDT was found to have a higher sensitivity 
compared with the skin snip diagnostic for all age groups in both the 
pre- and post-treatment settings. It is likely that as similar experience 
accumulates in other studies, the Ov16 RDT will become the standard 
diagnostic tool in the future for monitoring all programs aiming to achieve 
elimination of onchocerciasis in Africa.
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Over the past several decades dengue has become hyper-endemic in all 
tropical and sub-tropical regions of the world. Current estimates report 
nearly 100 million symptomatic and 300 million asymptomatic dengue 
infections annually. Dengue can range from an asymptomatic or mildly 
symptomatic illness to one that results in bleeding diatheses, plasma 
leakage, and vascular collapse. The recently licensed dengue vaccine 
Dengvaxia™, was found to be significantly less efficacious in persons 
who were sero-naive to dengue at the time of vaccination and regulatory 
authorities, including the WHO SAGE committee, have recommended that 
it be administered only to children 9 years or older living in highly dengue 
endemic regions. Previously, we demonstrated that the live attenuated 
tetravalent dengue vaccine (LATV) TV003 elicited complete protection 
against DENV-2 challenge using our controlled dengue human infection 
model (DHIM). As a first assessment of the protective efficacy of our 
second LATV dengue vaccine candidate TV005 in sero-naïve subjects, we 
conducted a randomized, placebo-controlled, double-blind trial utilizing 
this same DHIM. Forty-eight flavivirus-naïve subjects were enrolled. On 
Study Day 0, 24 subjects received TV005 and 24 subjects received a 
placebo. Six months later, 43 subjects returned and received 1,000 PFU 
of the DEN2∆30 challenge virus (22 TV005 recipients and 21 controls). 
The DEN2 challenge virus is a different genotype than that included in the 
vaccine. All 21 controls had detectable viremia following challenge and all 
developed rash. None of the TV005 recipients had detectable DENV-2 in 
the blood following challenge and none developed rash. The LATV TV005 
induced complete protection against the both viremia rash. In addition, 
70% of TV005 recipients demonstrated sterilizing immunity to challenge 
as evidenced by lack of detectable virus in the blood and a < 4-fold rise in 
serum neutralizing antibody to DEN2. These data demonstrate that TV005 
induces strong protection in subjects who are flavivirus-naïve at the time of 
vaccination.
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HUMAN CD4+ T CELL RESPONSES INDUCED BY A LIVE 
ATTENUATED TETRAVALENT DENGUE VACCINE PARALLEL 
THOSE INDUCED BY NATURAL INFECTION, IN MAGNITUDE, 
HLA RESTRICTION AND FINE ANTIGEN SPECIFICITY
Daniela Weiskopf1, Michael A. Angelo1, Alba Grifoni1, John 
Sidney1, Sinu Paul1, Bjoern Peters1, Aruna D. de Silva2, Aravinda M. 
de Silva3, Sean A. Diehl4, Beth Kirkpatrick4, Stephen Whitehead5, 
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Four dengue virus (DENV) serotypes are responsible for a growing number 
of infections, making DENV the most frequent mosquito-transmitted 
viral disease in humans, and creating a unique challenge for vaccine 
development. While considerable debate exists regarding which immune 
mechanisms may confer protection, a hallmark of live attenuated vaccines 
(LAV) is their ability to induce both humoral and cellular immune memory. 
We previously demonstrated that DENV-specific CD8+ T cell responses 
elicited by live attenuated DENV vaccines resemble those elicited by natural 
infection. CD4+ T cells are also a key component of cellular immunity, and 
contribute to host protection directly through cytokine production, and 
indirectly by providing help for CD8+ and antibody responses. Here, we 
characterize for the first time CD4+ T cell responses after live attenuated 
dengue vaccination and compare them to responses observed in natural 
infection with dengue virus. PBMCs from study participants receiving 
the tetravalent live attenuated DENV vaccine (TV-003), developed by the 
U.S. National Institutes of Health were screened in IFNγ ELISPOT assays 
with pools of HLA matched, predicted class II binding peptides covering 
the entire DENV proteome. CD4+ T cell responses were detected with 
magnitude and breadth similar to natural dengue infection. In natural 
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infection and vaccines alike, DENV specific CD4+ T cells are focused 
dominantly focused on the capsid, NS3 and NS5 antigens, while the 
envelope protein is a minor target for CD4+ DENV specific T cells.
59
A PHASE I CLINICAL TRIAL EVALUATING THE IMPACT 
OF TETRAVALENT RECOMBINANT SUBUNIT DENGUE 
VACCINE BOOST ADMINISTERED TO SUBJECTS WHO HAVE 
PREVIOUSLY BEEN VACCINATED WITH A LIVE-ATTENUATED 
TETRAVALENT DENGUE VACCINE
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With the increasing global burden of dengue, there remains an urgent 
need for dengue vaccines. The V180 vaccine candidate consists of four 
truncated, soluble, dengue envelope glycoproteins (DEN-80E). The vaccine 
has been shown to induce robust virus-neutralizing antibody responses 
when formulated with ISCOMATRIX™ adjuvant and administered to 
flavivirus-naïve volunteers in a Phase I clinical trial (NCT01477580). V180 
was also tested in a Phase I clinical trial (NCT02450838) where subjects 
who had previously received the live-attenuated tetravalent vaccine (LATV) 
developed by the National Institute of Allergy and Infectious Diseases 
(NIAID) were administered a V180 booster dose. The study was designed 
to assess whether a recombinant subunit vaccine is able to boost the 
trivalent or tetravalent responses induced by the LATV vaccine, which 
have proven difficult to boost with an additional dose of the LATV itself. 
The study was a randomized, placebo-controlled, double-blind study of 
safety and immunogenicity of the V180 vaccine. Twenty subjects who 
had previously received one or two doses of LATV were randomized and 
received a single dose of V180 non-adjuvanted (N=8), V180 adjuvanted 
with Alhydrogel™ (N=8), or placebo (N=4). Vaccine safety (solicited and 
unsolicited adverse events) was assessed using a Vaccination Report Card 
for 28 days following vaccination. Serious adverse events were captured 
from the time of informed consent through the final study visit at 6 
months postvaccination. Immunogenicity was assessed using a plaque 
reduction neutralization test at Day 0, Day 14, Day 28, and Month 6 
relative to vaccination. The results of the study demonstrate that the 
vaccine is generally well tolerated and immunogenic in these dengue-
experienced volunteers.
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TETRAVALENT DENGUE HETEROLOGOUS PRIME-BOOST 
VACCINATION - SAFETY, HUMORAL, AND CELL-MEDIATED 
IMMUNITY AT 1 AND 6 MONTHS
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Heterologous prime boost approaches have been explored as vaccination 
strategies in a number of infectious diseases. We studied whether 
sequential administration of live and inactivated tetravalent dengue 
vaccine candidates could improve safety and immunogenicity performance 
metrics. Tetravalent dengue virus live-attenuated vaccine (LAV) and 
tetravalent dengue virus purified inactivated vaccine (PIV) have been 
evaluated previously using homologous two-dose strategies. This phase 
1, randomized, open-label, primary vaccination study conducted in non-
dengue endemic region (Maryland, USA). Eighty subjects were enrolled 
into 4 heterologous prime-boost vaccination treatment groups (N=20): 
Group 1 = LAV (day 0), PIV (1 month); Group 2 = PIV (day 0), LAV (1 
month); Group 3 = LAV (day 0), PIV (6 month); Group 4 = PIV (day 0), 
LAV (6 month). Subjects were followed for 6 months after vaccination. 
Safety (primary end point), microneutralization (MN50) antibody titers, 
RNAemia, and cell-medicated immunity (CMI) were assessed. At one 
month after the second vaccination, there were no related severe adverse 
events (SAEs), no related medically attended adverse events (AEs), and no 
grade 3 related local AEs. Grade 3 related systemic AEs occurred in small 
numbers (N=11), with the majority in Group 4. LAV associated rash was 
observed in 8 subjects. Post LAV dengue RNAemia was detected in 18%, 
26%, 20%, and 61% of the subjects in groups 1, 2, 3, and 4 respectively. 
At one month, PIV priming followed by LAV boost generated superior 
MN50 antibody titers and broader seroconversion rates with no clear 
difference between Groups 2 and 4. One month CMI was assessed by an 
IFN-γ ELISpot assay and overlapping peptide pools from all four serotypes. 
PIV priming appeared to result in the highest magnitude of response and 
the most balanced median IFN-γ spot counts. These results suggest a PIV 
prime, LAV boost strategy against dengue has further developmental 
potential despite manufacturing challenges. All follow up study visits were 
completed in March 2016. Safety, MN50, RNAemia, and CMI at 6 months 
post boost dose will also be presented.
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TAKEDA’S TETRAVALENT DENGUE VACCINE (TDV) 
CANDIDATE PROGRESSES TO PHASE III: SAFETY AND 
IMMUNOGENICITY OF TDV
Derek Wallace1, Vianney Tricou1, Dan Stinchcomb2, Kwasi Amfo1, 
Astrid Borkowski3
1Takeda Vaccines Pte Ltd, Singapore, Singapore, 2Takeda Vaccines Inc., 
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Takeda’s live attenuated tetravalent dengue vaccine candidate (TDV) 
contains a molecularly characterized dengue serotype 2 virus (TDV-2) 
and three recombinant viruses expressing the pre-membrane (prM) and 
envelope (E) structural genes for serotypes 1, 3, and 4 in the attenuated 
TDV-2 backbone. On the path to phase III, Takeda has investigated 
different formulations, routes of administration, dosage schedules and 
vaccine presentations, through four phase I and four phase II studies 
involving more than 3800 participants (adults and children in endemic 
and non-endemic countries). The TDV clinical program has followed 
the WHO guideline for dengue vaccine development. The safety and 
immunogenicity profile of TDV supports continued clinical development. 
Key data from the development program will be presented and their 
implications for decisions affecting the schedule and formulation will be 
discussed.
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A considerable fraction of dengue virus (DENV) infections is thought to 
result in either no detectable symptoms (asymptomatic) or symptoms 
that are sufficiently mild that they go undetected by surveillance 
systems (clinically inapparent). The unknown contribution of undetected 
infections to the transmission of DENV and other emerging mosquito-
borne viruses, like Zika virus, raises questions about the effectiveness of 
reactive practices for detecting and responding to outbreaks. Despite 
estimates that 293 million people experience either asymptomatic or 
clinically inapparent infection each year, it has been assumed that these 
individuals contribute little to onward transmission. Recently, however, 
blood-feeding experiments with Aedes aegypti showed that people with 
asymptomatic DENV infections are capable of infecting mosquitoes. We 
combined those findings with models of within-host DENV dynamics and 
human demographic projections to: (1) quantify the net infectiousness of 
individuals that experience either asymptomatic or symptomatic (either 
clinically inapparent or clinically apparent) infections, and (2) quantify 
the contributions of asymptomatic and symptomatic infections to DENV 
force of infection, which depends not just on their infectiousness but 
also on their numerical prominence in a population. Our calculations 
indicate that individuals with asymptomatic infections have a lower net 
infectiousness than symptomatic infections, yet they are still capable of 
making appreciable contributions to DENV transmission. We estimate 
that approximately two-thirds of infections could result from individuals 
with undetected infections. Among infections that result from clinically 
apparent infected individuals, more than half could result from mosquitoes 
biting during the pre-symptomatic phase of the infection. Our findings 
emphasize the need to reorient current practices for responding to 
outbreaks of dengue and Zika viruses, to pre-emptive interventions that 
take account of the role of undetected infections in DENV transmission 
dynamics.
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PREDICTORS FOR SEVERE DENGUE: RESULTS FROM A 
PROSPECTIVE MULTI-CENTRE STUDY IN EIGHT COUNTRIES 
ACROSS ASIA AND LATIN AMERICA
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The clinical spectrum of symptomatic dengue is broad, ranging from 
mild febrile illness to severe disease with potentially life-threatening 
complications such as bleeding, organ impairment, and plasma leakage 
that may result in hypovolemic shock. Without an effective therapy patient 
outcomes depend primarily on appropriate triage and judicious use of 
intravenous fluids. However although the revised 2009 WHO guidelines 
indicate a number of warning signs to identify potentially severe cases 
early, the evidence base to support these recommendations is presently 
limited. A prospective multi-centre observational study recruiting out-
patients aged ≥ 5 yrs with symptoms consistent with possible dengue 
within 72 hrs of fever onset is in progress in 8 countries across Asia and 
Latin America, aiming to enrol around 3000 participants with confirmed 
dengue by June 2016. A broad range of clinical and laboratory features 
are assessed daily during the acute illness, and at follow-up 1 week later. 
We aim to identify clinical and/or simple laboratory predictors of severe 
dengue, in particular to explore the value of repeated measurements 
during the febrile phase. Severe outcomes are defined according to the 
need for hospitalisation or intravenous fluid administration, as well as by 
the WHO 2009 guidelines. After assessing heterogeneity of outcomes 
across countries, we will investigate the predictive value of a range of 
candidate predictors in classical prognostic models depending on baseline 
covariates only, and also explore dynamic prognostic models which 
take into account longitudinal data. Despite heterogeneity in clinical 
management between sites, preliminary findings in 2254 patients with 
laboratory-confirmed dengue from 5 countries suggest certain parameters, 
eg haematological indices such as the platelet count, to be of interest. 
A detailed description of the disease spectrum and risk factors identified 
among ~3000 dengue cases will be presented, representing the most 
comprehensive dataset available to date. We anticipate these results will 
have substantial impact on future triage and management policies in 
dengue endemic countries.
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ACT PARTNER DRUG EROSION—EVIDENCE OF PPQ 
RESISTANT PARASITES FROM CAMBODIA
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of Allergy and Infectious Diseases, National Institutes of Health, Rockville, 
MD, United States
With the emergence and spread of artemisinin (ART) resistance, more 
pressure is put on the partner drugs (e.g., piperaquine) used in ART 
combination therapies (ACTs). Recent data from Western Cambodia 
indicate that ART and piperaquine (PPQ) resistance has emerged in this 
region, leading to declining frontline ACT efficacy. To assess whether 
ART-resistant parasites also show resistance to PPQ, we obtained 157 
cryopreserved isolates from Pursat and Pailin, Western Cambodia that 
were collected by the Tracking Resistance to Artemisinin Collaboration 
(TRAC). We culture-adapted 68 parasites and focused on parasites with 
slow clearance rates in patients and high % survival values in the ring-
stage survival assay (RSA) in vitro – two ART-resistance phenotypes. We 
first exposed parasites to a single high PPQ dose (2 µM) for 72 hours 
and found that some parasites were able to recover. We then profiled 
23 isolates by standard EC50 assays. A PPQ-resistant subset of these 
isolates showed a bimodal response to PPQ with increased survival 
under higher drug pressure, while their primary EC50 values were 
comparable to sensitive isolates (5 nM). This bimodal response was not 
due to the presence of mixed parasite populations within the isolate, as 
daughter clones retained the phenotype. Exposure of parasites to PPQ at 
consecutive 12-hour intervals throughout the lifecycle showed that later 
stages (schizonts) are less susceptible than earlier stage parasites. Use of 
available whole-genome sequencing data and independent interrogation 
of these PPQ-resistant isolates did not identify any of the previously-
reported markers of PPQ resistance. These results confirm the existence of 
PPQ-resistant parasites in Cambodia. Ongoing studies aim to identify the 
underlying mechanism of PPQ resistance.
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Artemisinin (ART) combination therapies (ACTs) are recommended 
worldwide for the treatment of Plasmodium falciparum malaria. 
Dihydroartemisinin-piperaquine (DHA-PPQ) was adopted as the frontline 
ACT in Cambodia in 2008, and was safe, tolerable, and 96-98% 
efficacious. However, the rapid spread of ART resistance, defined as a 
parasite clearance half-life >5 h following treatment, exposes a larger 
biomass of parasites to the unprotected partner drug – due to the short 
(~1 h) elimination half-life of the ART derivative, and long elimination 
half-life of the partner drug. We postulated that parasites in areas with 
ART resistance would readily develop partner drug resistance, resulting 
in decreased ACT efficacy. Among patients treated with DHA-PPQ in 
western, northern, and eastern Cambodia (in Pursat, Preah Vihear, and 
Ratanakiri provinces) in 2012-2013, 46%, 16% and 2% of patients 
experienced recrudescent infections, respectively, over 63 days of follow-
up. Recrudescent parasites had higher prevalence of K13 mutations 
(molecular markers of ART resistance), higher PPQ 50% inhibitory 
concentrations (IC50s), and higher prevalence of Exo-E415G (a molecular 
marker of PPQ resistance). They also showed lower mefloquine (MQ) IC50s 
and did not have >1 pfmdr1 gene (a molecular marker of MQ resistance). 
We thus hypothesized that these parasites could be effectively treated 
with artesunate-MQ (AS-MQ) – the former frontline ACT in Cambodia. In 
2014-2015, while DHA-PPQ was still the frontline ACT in Cambodia, we 
measured the efficacy of AS-MQ in 144, 60, and 92 patients in Pursat, 
Preah Vihear, and Ratanakiri provinces, respectively. In Pursat, Preah Vihear, 
and Ratanakiri the prevalence of parasites with K13 mutations increased 
(77, 34, and 11% to 94, 93, and 18%) and similarly the prevalence of 
Exo-E415G increased (74, 20, and 3% to 76, 88, and 17%) from 2012-
2013 to 2014-2015. Meanwhile, the prevalence of >1 pfmdr1 gene 
decreased (8, 14, and 2% to 0, 0, and 0%). Only 1/296 patients presented 
with a recrudescent infection over 42 days of follow-up, indicating that 
AS-MQ effectively treats DHA-PPQ-resistant malaria.
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Resistance to artemisinin derivatives is associated with delayed parasite 
clearance. In Mali, five years after ACTs were recommended as the 
first-line treatment for uncomplicated malaria, a prospective artesunate 
monotherapy efficacy study observed no delayed parasite clearance 
time. In the context of regular monitoring of artemisinin resistance we 
repeated the above studies in two sites of Mali. From October 2015 to 
March 2016, we conducted a prospective study to evaluate the efficacy 
of artesunate monotherapy in subjects aged 6 months and longer in 
Bougoula-Hameau and Faladje. Patients with uncomplicated malaria 
were treated with artesunate for 7 days and followed for 28 days. 
Parasitaemia was evaluated every 8 hours until three consecutive slides 
were negatives. MSP2, Ca1 and TA99 polymorphisms was assessed by 
PCR to distinguish new infections from recrudescent infections. PCT and 
parasite clearance half-life were calculated using the online WWARN 
parasite clearance estimator software (PCE).Results were compared with 
the studies conducted in Bougoula-Hameau in 2011.We included 100 
patients in Bougoula-Hameau and 120 others in Faladje. Adequate Clinical 
and parasitological response (ACPR) was 92.0% and 79.2% in Bougoula-
Hameau and Faladje, respectively. After molecular correction cACPRs 
was 100% at both sites. By 24 hours after treatment initiation, 28% of 
participants had cleared parasitemia in Bougoula-Hameau, compared with 
2.5% in Faladje (P<0.0001). The median parasite clearance time was 32 
hours in Bougoula-Hameau (similar to the Bougoula-Hameau 2011 results) 
but 40 hours in Faladje (P<0.001). The parasite clearance half-life was 2.0 
hours (1.66 to 2.23) in Bougoula-Hameau and 2.8 hours (2.39 to 2.99) in 
Faladje (p < 0.001). Only two participants still had parasites at 48 hours in 
Faladje and no participant in Bougoula-Hameau. Artesunate monotherapy 
remains effective on P. falciparum in Mali but there are significant 
differences in the level of susceptibility of parasites from different settings 
of the country.
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In the Sahel, malaria and malnutrition frequently overlap. Severe acute 
malnutrition (SAM) affects almost all organs and has been associated 
with a loss of intestinal villosities reducing intestinal absorption of 
medicines. However, very limited information is available on the 
pharmacokinetic properties of antimalarial drugs in children with SAM. 
We assessed artemether-lumefantrine (AL) clinical efficacy in children 
with SAM compared to those without SAM, with respect to lumefantrine 
concentration in their blood. Children under 5 with uncomplicated P. 
falciparum malaria were enrolled between November 2013 and January 
2015 in Mali and Niger, one third with uncomplicated SAM and two 
thirds without SAM. The three-day twice daily AL treatment was directly 
observed and children were followed for 42 days, with PCR-corrected 
adequate clinical and parasitological response (ACPR) at day 28 as the 
primary outcome. Lumefantrine capillary blood concentrations were 
assessed in a subset of participants at different time points including 
systematic measurement on day 7. A total of 399 children were enrolled. 
Children with SAM were younger than their non-SAM counterparts (mean 
17 versus 28 months, P<0.0001). PCR-corrected ACPR at day 28 was 
100% (95% CI: 96.8%-100%) in SAM versus 98.8% (96.4%-99.7%) in 
non-SAM, P=0.236. In the age stratified analyses, SAM was associated 
with a greater risk of reinfection by day 28 in children older than the 
median of 21 months (hazard ratio=2.25 [1.12-4.48], P=0.022) and day 7 
lumefantrine concentrations were significantly lower in SAM (median 251 
versus 365 ng/ml in non-SAM, P=0.049). This study shows comparable 
clinical efficacy of standard doses of AL in children with and without SAM, 
but a higher risk of reinfection in older children suffering of SAM probably 
associated with poorer exposure to ACTs, as documented by a lower 
lumefantrine concentration on day 7. Sub-therapeutic concentration of a 
drug does not necessarily translate into lower efficacy but could contribute 
to selecting resistant parasites at population level. Further studies of dose 
optimization of AL in SAM children are urgently needed.
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Malaria chemotherapy relies heavily on the use of artemisinin-based 
combination therapies (ACTs), which pair a fast-acting, short half-life 
artemisinin derivative with a longer half-life partner drug. The current 
arsenal of partner drugs include lumefantrine, mefloquine, amodiaquine 
and piperaquine. The recent emergence of resistance to artemisinin 
has placed increased pressure on these partner drugs, with piperaquine 
failures increasingly documented in in western Cambodia. Epidemiological 
studies have suggested that Plasmodium falciparum susceptibility to 
many of these agents can be modulated by mutations at positions 86 
or 184 in the digestive vacuole-resident transporter protein PfMDR1. To 
characterize the role of these PfMDR1 mutations, we employed zinc-
finger nuclease-mediated genome editing to modify pfmdr1 in genetic 
strains harboring Asian/African or South American alleles of the related 
transporter PfCRT. Our data show a significant role for PfMDR1 N86Y 
in increasing P. falciparum susceptibility to lumefantrine, mefloquine 
and dihydroartemisinin. This polymorphism also decreased parasite 
susceptibility to chloroquine and amodiaquine. We also observed a 
modest, strain-dependent reduction in susceptibility to piperaquine 
with the PfMDR1 N86/184F haplotype. We also mapped these PfMDR1 
variants, as well as copy number changes, globally using 2,500 African and 
Southeast Asian genomes recently released by the MalariaGEN consortium. 
These data, combined with findings from our pfmdr1-modifed lines, help 
inform region-specific drug use policies by predicting changes in parasite 
susceptibility to current ACTs.
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UNSUPERVISED PRIMAQUINE FOR PLASMODIUM VIVAX 
RADICAL CURE LACKS EFFECTIVENESS IN SOUTHERN PAPUA
Nicholas M. Douglas1, Jeanne Rini Poespoprodjo2, Rian Patriani3, 
Michael Malloy4, Enny Kenangalem5, Paulus Sugiarto6, Julie A. 
Simpson4, Yati Soenarto7, Nicholas M. Anstey1, Ric N. Price1
1Menzies School of Health Research, Darwin, Australia, 2University Gadjah 
Mada, Yogyakarta, Indonesia, 3University of Gadjah Mada, Yogyakarta, 
Indonesia, 4University of Melbourne, Melbourne, Australia, 5Papuan Health 
and Community Development Foundation, Timika, Indonesia, 6Rumah 
Sakit Mitra Masyarakat, Timika, Indonesia, 7University Gadjah Mada, 
Yogyakarta, Indonesia
Primaquine is the only licensed drug for eradicating Plasmodium vivax 
hypnozoites and therefore preventing relapses. It is efficacious when 
prescribed in clinical trials but its effectiveness in real-world settings is 
unknown. Using individualised hospital surveillance data from southern 
Papua, Indonesia, we conducted a retrospective cohort study to 
determine the effectiveness of unsupervised primaquine in combination 
with dihydroartemisinin-piperaquine for preventing representation to 
hospital with vivax malaria. Between April 2004 and December 2013 
there were 62,492 episodes of vivax malaria available for analysis. The 
risk of representation with vivax malaria within one year was 34·4% 
(95% Confidence Interval (95% CI) 33·8-35·0%) after initial vivax 
monoinfection. Prescription of any dose of primaquine was associated 
with an Adjusted Hazard Ratio (AHR) for representation with vivax 
malaria of 0·89 (95% CI 0·85-0·93, p<0.001). Limiting the comparison 
to high dose (≥5mg/kg total dose) versus no primaquine in the period 
during and 6 months either side of a large, unplanned primaquine stock 
outage attenuated substantially this difference (AHR 0·95, 95% CI 0·88-
1·02, p=0·15). Unsupervised primaquine for P. vivax malaria, prescribed 
according to international guidelines, had minimal impact on the risk of 
clinical recurrence within one year. New strategies for effective radical cure 
are needed urgently.
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ESTIMATING THE RISK OF PLASMODIUM VIVAX RELAPSES IN 
AFGHANISTAN
Ghulam R. Awab1, Mallika Imwong2, Germana Bancone2, 
Nicholas P. Day2, Nicholas J. White2, Charles J. Woodrow2
1Nangarhar Medical Faculty, Nangarhar University, Afghanistan, 2Mahidol-
Oxford Tropical Medicine Research Unit, Bangkok, Thailand
Plasmodium vivax is responsible for more than 90% of laboratory-
confirmed malaria cases in Afghanistan and continues to cause 
considerable morbidity in several areas of the country. Control of vivax 
malaria requires radical cure with primaquine to prevent relapse from 
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hypnozoite forms, although the proportion of cases with liver forms has 
not been determined. In Nangarhar and Kunar provinces, Afghanistan, 
between 2009 and 2014, we undertook an open, randomised controlled 
trial in patients with vivax malaria, comparing chloroquine plus primaquine 
(0.25mg/kg/day for 14 days) with chloroquine treatment alone. In patients 
randomised to the primaquine arm, G6PD deficiency was excluded by 
the fluorescent spot test prior to treatment. Patients were followed-up 
for one year; at recurrence, treatment was as at baseline. Preliminary 
analyses indicate that 588 patients were enrolled (295 chloroquine, 293 
chloroquine plus primaquine) with 84.9% completing follow-up or having 
a P. vivax recurrence by 12 months. During the first 6 months, 45 / 263 
(17.1%) patients in the chloroquine group had P. vivax recurrence, while 
only 7 / 262 (2.7%) had recurrence in tbe chloroquine plus primaquine 
group (p<0.0001). In the 6-12 month period, 40 / 205 (19.5%) patients 
in the chloroquine group had P. vivax recurrence, while 30 / 242 (14.0%) 
had recurrence in the chloroquine plus primaquine group (p = 0.127). 
This large randomised study shows clearly that there is a signicant store of 
hypnozoites in patients presenting with P. vivax in Afghanistan, and that 
unsupervised primaquine reduces relapse in the first 6 months by at least 
5-fold. G6PD testing will be needed for primaquine deployment at scale. 
Further analyses will be presented in the meeting.
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IMPACT OF NEW COMBINATION LLINS ON ENTOMOLOGICAL 
MEASURES OF MALARIA TRANSMISSION IN MALI
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Long-lasting insecticidal nets (LLIN) are a key component to malaria control 
in sub-Saharan Africa, but widespread pyrethroid resistance may threaten 
their effectiveness. Combination LLIN containing pyrethroid insecticides 
plus piperonyl butoxide (PBO) are a possible mitigation strategy, but field 
evaluations are needed to determine if performance against resistant 
vectors is superior to standard LLIN. In this study, 16 Malian villages in 
areas where pyrethroid resistance had previously been documented 
were randomized to receive one of four types of PBO-containing or 
traditional LLIN (permethrin+PBO, deltamethrin+PBO, permethrin only, or 
deltamethrin only). Indoor resting mosquitoes were collected in all villages 
bimonthly over two years (2014-2015) using pyrethrum spray catch and 
Prokopack aspirator. The primary outcome measure was the sporozoite 
rate (proportion of An. gambiae s.l. mosquitoes positive for P. falciparum 
sporozoites); a secondary outcome was indoor resting vector density. 
Bottle bioassays containing permethrin or delamethrin plus PBO resulted 
in significantly greater mortality than assays containing only permethrin 
or deltamethrin ; however, none of the PBO-containing assays restored 
full insecticide susceptibility (mortality >97%). During high malaria 
transmission seasons (June, August, October) in both years, sporozoite 
rates were not significantly different between the permethrin+PBO and 
permethrin only net arms: 5.1% (95% CI: 4.0, 6.2) versus 5.5% (95% 
CI: 4.2, 6.7) (p=0.67). Sporozoite rates were significantly lower in the 
deltamethrin+PBO arm compared to the deltamethrin only arm: 1.9% 
(95% CI: 1.2, 2.7) versus 3.7% (95% CI: 2.6, 4.8) (p=0.01). Over the 
2014-15 rainy season morning indoor resting collections yielded a mean of 
five and three An. gambiae s.l. per house/night for the deltamethrin+PBO 
and deltamethrin only net arms, respectively. Overall, there was some 
evidence that deltamethrin+PBO LLIN were more effective in reducing 
sporozoite rates in pyrethroid resistant An. gambiae s.l.; however, 
deltamethrin+PBO nets did not reduce vector density compared to 
deltamethrin only LLIN.
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IMPACT OF COMBINING INDOOR RESIDUAL SPRAYING 
AND LONG-LASTING INSECTICIDAL NETS ON ANOPHELES 
ARABIENSIS IN ETHIOPIA: PRELIMINARY FINDINGS OF A 
RANDOMIZED CONTROLLED TRIAL
Oljira Kenea1, Meshesha Balkew1, Habte Tekie1, Teshome Gebre-
Michael1, Wakgari Deressa1, Eskindir Loha2, Hans J. Overgaard3, 
Bernt Lindtjorn4
1Addis Ababa University, Addis Ababa, Ethiopia, 2Hawassa University, 
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4University of Bergen, Bergen, Norway
The current malaria vector control interventions, indoor residual 
spraying (IRS) and long-lasting insecticidal nets (LLINs) have been used in 
combination in sub-Saharan Africa with inconclusive evidence that the 
combined intervention is more effective than either IRS or LLINs alone. In 
Ethiopia, both interventions target Anopheles arabiensis, the sole primary 
malaria vector. This study compared the impact of combining IRS and 
LLINs with either intervention alone in south-central Ethiopia. Villages were 
randomly allocated to four study arms: IRS + LLIN, IRS, LLIN, and control. 
LLINs (PermaNet 2.0) were provided free of charge. IRS with propoxur was 
applied before the main malaria transmission season in 2014 and 2015. 
Adult mosquitoes were collected in randomly selected villages in each arm 
using CDC light trap catch (LTC) set close to a sleeping person, pyrethrum 
spray catch (PSC), and artificial pit shelter (PIT), for measuring host-seeking 
density (HSD), indoor resting density (IRD), and outdoor resting density 
(ORD). Human landing catch (HLC) was performed in selected villages to 
monitor An. arabiensis biting behaviors. Mean densities were compared 
using incidence rate ratio (IRR) calculated by negative binomial regression. 
A total of 1786 female anophelines of four species was collected of which 
An. arabiensis (n=574) was highest in the control arm (51.4%) followed 
by LLIN (31.5%), IRS (9.2%), and IRS+LLIN (7.9%). The mean HSD of An. 
arabiensis in the IRS+LLIN arm was similar to either the IRS arm (0.03 vs. 
0.03/ house/LTC/night) or the LLIN arm (0.03 vs. 0.10/house/LTC/night, 
p=0.07) and so was the difference in IRD and ORD between the IRS and 
LLIN compared to the IRS arm. However, both IRD and ORD were higher 
in LLIN compared to IRS+LLIN (p < 0.001 for indoors). In all study arms, 
An. arabiensis was actively biting indoors and outdoors throughout the 
night with an early night biting peak before the local people retire to bed. 
IRS+LLIN compared to IRS had equal powerful impact on resting density of 
An. arabiensis, but LLIN had the least impact.
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IMPLEMENTATION OF A NON-PYRETHROID INSECTICIDE-
TREATED DURABLE WALL LINING FOR MALARIA CONTROL 
UNDER OPERATIONAL CONDITIONS IN RURAL TANZANIA
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1National Institute for Medical Research, Amani Medical Research 
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Despite considerable reductions in malaria achieved by scaling-up long-
lasting insecticidal nets (LLINs) and indoor residual spraying, maintaining 
community protection is challenging. An insecticide treated wall lining 
(ITWL) has been developed that can be attached to inner house walls 
and releases a mixture of two non-pyrethroid insecticides over 3-4 
years. The operational success of ITWL will be determined not only by 
its demonstrable efficacy (being evaluated in a 44-cluster randomized 
trial in Muheza, Tanzania) but also its feasibility, household acceptability 
and durability under field conditions. To install the ITWL, we recruited 
110 teams comprising two local installers and one team leader. Cluster 
supervisors each supervised 5 teams. Over 6 months in 2015-16, these 
teams installed ITWL in 5666 rural households (67.7% of all enrolled 
houses). Completion rate by village varied dramatically (range 42.5%-
95.8%). Principal reasons for household refusals included rumors and 
skepticism, concerns about wall damage, and fear of changing house 
appearance. Concurrent political elections, higher socio-economic status 
and skin and eye irritation among 5% of installation workers also lowered 
initial intervention uptake in some villages. Determining an appropriate 
scheme for paying installers given differences in house size, providing 
adequate protective equipment, and reimbursement were a serious 
challenge. Furthermore, approximately 8% of homeowners consented 
to installation in only some of eligible rooms, which has potential 
epidemiological implications. Cross-sectional durability surveys conducted 
3 months after installation indicated that ITWLs were no longer installed 
properly in 33.3% of surveyed rooms, principally due to failed installation 
fixings (71.8%) and that 91.0% of ITWLs had developed holes from 
general wear and tear (44.3%) or during actual installation (23.6%). 
Lessons learned included the need for better communication among 
supervisors, installers and households, prompt payment of installers, and 
better protective equipment. Such insights can facilitate future scale up.
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EXPERIMENTAL HUT EVALUATION OF A NEW NON-
PYRETHROID INSECTICIDE-TREATED DURABLE WALL LINERS 
FOR CONTROL OF PYRETHROID RESISTANT ANOPHELES 
GAMBIAE AND AN. FUNESTUS SENSU STRICTO IN MUHEZA, 
TANZANIA
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A new insecticide-treated durable wall liner (ITWL) has been developed 
which mimics the effect of IRS but is designed to last for 3-4 years. 
Meant to be used in combination with LLILN, it is made of high-density 
polypropylene treated with two slow-release non-pyrethroid insecticides. 
A 9 week experimental hut trial was conducted in Muheza, Tanzania 
between May-July 2015 in an area with pyrethroid-resistant Anopheles 
gambiae and An. funestus s.s. to compare the efficacy of several 
interventions: including the new ITWL + WHOPES recommended LLIN, 
ITWL alone, LLIN alone, and pyrethroid wall liner alone. Ceilings were 
not covered with ITWL. Performance was measured primarily in terms 
of insecticide-induced mortality. ITWL produced mortality 40-50% of 
An. funestus s.s. and An. gambiae. Against An. funestus s.s. ITWL alone 
produced 47% mortality, which was not significantly different to that of 
LLIN alone (29%, P=0.306) or ITWL + LLIN (35%, P=0.385). Although 
the numbers of An. gambiae were lower, results were similar, with ITWL 
producing 43% mortality compared with 26% for LLIN. The ceilings 
provided an untreated refuge for resting mosquitoes. Partial covering of 
the eaves with DL (1 versus 4 eaves open) had no impact on numbers of 
either species entering the huts. LLIN provided added personal protection 
against An. funestus s.s over ITWL alone (24% blood-fed for ITWL + LLIN 
compared with 69% for ITWL only, 1 eave (P=0.001) and 56% (P=0.001) 
ITWL only, 4 eaves. Cone bioassays of ITWL material after the hut trial 
produced 98% mortality using pyrethroid-susceptible An. gambiae kisumu 
from the insectary, while F1 offspring of field-collected An. gambiae 
showed lower mortality (80%). Comparison of cone and cylinder bioassays 
suggested some irritancy from the ITWL. The effect of high community-
level coverage of ITWL on epidemiological and entomological parameters 
of malaria transmission is currently being evaluated in Muheza, Tanzania.
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THE AVECNET TRIAL TO ASSESS WHETHER ADDITION OF 
PYRIPROXYFEN, AN INSECT JUVENILE HORMONE MIMIC, 
TO LONG-LASTING INSECTICIDAL MOSQUITO NETS 
PROVIDES ADDITIONAL PROTECTION AGAINST CLINICAL 
MALARIA OVER CURRENT BEST PRACTICE IN AN AREA WITH 
PYRETHROID-RESISTANT VECTORS IN RURAL BURKINA 
FASO: A CLUSTER-RANDOMIZED CONTROLLED TRIAL USING 
A STEP-WEDGE DESIGN
Alfred B. Tiono1, Margaret Pinder2, N’Fale Sagnon1, Moussa 
Guelbeogo1, Brian Faragher3, Alphonse Ouedraogo1, Daouda 
Ouattara1, Tom Smith4, Sodiomon Sirima1, Steve Lindsay2
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Recent reductions in malaria in sub-Saharan Africa have been associated 
with increased coverage with long-lasting insecticidal nets (LLINs). 
Pyrethroids are currently the only insecticide class used for treating nets, 
and the rapid increase in resistance to pyrethroids in vector mosquitoes 
may jeopardize future vector control. We assessed whether nets containing 
a novel combination of permethrin, a pyrethroid, and pyriproxyfen, an 
insect juvenile hormone mimic, (PPF-LLIN) provide incremental protection 
against malaria over current best practice of LLINs and prompt treatment 
in an area with pyrethroid-resistant vectors. In this two-armed step-wedge, 
cluster-randomized, controlled efficacy trial in Burkina Faso, we used a 
computerized algorithm to allocated PPF-LLINs randomly to 5 clusters and 
LLINs to 35 clusters at the start of the trial. One month later, and each 
subsequent month during the malaria transmission seasons, LLINs were 
exchanged for PPF-LLIN by groups of 5 clusters, so that 3 months before 
the end of the 2 year trial all participants had received a PPF-LLIN. A cohort 
of ~2000 children aged 6 months to 5 years was enrolled by random 
sampling proportionate to cluster size, and surveyed at the start of the 
2014 transmission season and followed in 2014 and 2015 by passive case 
detection for clinical malaria. Exposure to malaria parasites was assessed 
by collection of mosquitoes indoors using CDC light traps. The primary 
endpoints were clinical malaria incidence measured by passive case 
detection and entomological inoculation rate from Anopheles gambiae 
sensu lato mosquitoes. Generalised Linear Mixed Models will be used to 
carry out a likelihood ratio test of this primary effectiveness estimate (with 
alpha=0.05), using Poisson errors, and person-time-at risk as an offset 
variable. Microscopists reading the slides were blinded. The results from 
this trial will be presented at the meeting.
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ODOR-BAITED TRAPS AS A NOVEL TOOL FOR MALARIA 
CONTROL - THE SOLARMAL TRIAL
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Medical Centre, Nijmegen, Netherlands
Recent progress in malaria control promises that elimination is feasible 
but to achieve this aim, current tools need to be complemented by novel 
strategies to combat insecticide and drug resistance. We explored the 
impact of solar powered, odor-baited mosquito traps on malaria incidence 
and prevalence on Rusinga Island, Kenya; a location where malaria is 
endemic and LLINs and drug treatment were already widely available 
to the population of 25,000. Anopheles funestus and An. gambiae s.l. 
were the main vectors. A system containing a mosquito trap, solar panel, 
battery, mobile phone charging port and LED lights was termed a SMoTS 
(solar-powered mosquito trapping system). A novel stepped wedge cluster-
randomized control design was used to implement the roll-out of the 
SMoTS across the island, from zero to complete coverage over 24 months. 
Three times per year a health and demographic surveillance (HDSS) was 
conducted covering the entire population while malaria prevalence was 
measured in a randomly selected 10% of the population. Mosquitoes 
were monitored over successive six-weekly intervals in 80 randomly 
selected houses per round. A contemporaneous comparison of clinical 
malaria incidence was insufficiently powerful to measure an intervention 
effect due to the unexpectedly low number of clinical cases recorded. 
Malaria prevalence was significantly lower in intervened compared with 
non-intervened clusters (29.8% reduction, 95% CI: 20.9 - 38%) and 
mosquito densities were similarly reduced in intervened clusters, with 
highest effect on An. funestus (69.2% reduction, 95% CI: 29.1 - 87.4%). 
It is concluded that the odor-baited traps led to significant reductions in 
malaria transmission, an effect comparable in size to the impact of LLINs. 
Sociological investigations showed that the provision of electric light 
contributed to the high degree of compliance and approval of the SMoTS 
technology, whereby the population undertook the maintenance of the 
traps. Mass trapping of mosquitoes should be considered a viable tool for 
future malaria interventions.
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ANOPHELES DIRUS EFFICIENTLY TRANSMITS MIXED SPECIES 
AND MULTIPLE CLONE MALARIA INFECTIONS IN CAMBODIA
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Mixed species and multiple clone infections occur commonly in human 
malaria. It remains unknown whether species and clonal diversity are 
maintained during transmission in spite of a bottleneck in parasite 
numbers during Plasmodial transmission to the mosquito. In a study of 
12 Cambodians with mixed infections whose blood was membrane fed 
to reared Anopheles dirus mosquitoes, we answered a twofold question. 
We assessed, first, the relative transmissibility of Plasmodium falciparum 
(Pf) and P. vivax (Pv) and second, preservation/loss of Pv/Pf genotypes 
from patient blood to mosquitoes by deep sequencing at targeted loci. 
DNA from 30 membrane-fed mosquitoes per patient were subject to 
real-time species-specific PCR. We found that Pv was transmitted more 
frequently (7/12) than Pf (2/12) from mixed species infections prior 
to dihydroartemisinin-piperaquine treatment. Pf was the only species 
transmitted post-treatment. While few mosquitoes caught in the wild 
have demonstrated mixed infection, we found that 21% (46/222) of 
mosquitoes fed on mixed patient blood carried both species. All doubly 
infected mosquitoes had fed upon blood from patients with concomitant 
microscopic Pf/Pv gametocytemia. We compared diversity of Pf ama1 and 
Pvmsp1 haplotypes in patient blood to those at the parasite oocyst and 
sporozoite stages. Clone diversity (multiplicity of infection roughly 2.6 in 
both mono and mixed patients) was transmitted to mosquitoes intact, 
often even on an individual-mosquito basis. In 6/7 patients, all pvmsp1 
clones present within infected patients were also found in both the 
oocyst and sporozoite stages within the mosquito. Assessed individually, 
mosquitoes often carried multiple clones, with multiplicity of infection 
similar to that in the blood. Pf infections were mostly monoclonal, but 
findings were similar. In conclusion we see transmissibility of both Pv 
and Pf simultaneously from mixed infection patients and the absence 
of a transmission bottleneck in terms of genetic diversity. The observed 
transmission efficiency of Pv has important implications for malaria control 
and models of transmission.
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MESOAMERICAN NEPHROPATHY (MEN) IN NICARAGUA: 
ACUTE INTERSTITIAL NEPHRITIS OF INFECTIOUS ORIGIN?
Rebecca Susann B. Fischer, Sreedhar Mandayam, Denis 
Chavarria, Melissa N. Garcia, Rodion Gorchakov, Kristy O. Murray
Baylor College of Medicine, Houston, TX, United States
Mesoamerican nephropathy (MeN), a kidney disease of unknown origin, 
is an unrelenting epidemic, primarily in pacific coastal areas of Central 
America, resulting in over 20,000 deaths. MeN primarily affects young 
agricultural workers who lack traditional risk factors for kidney disease, 
and sugarcane workers in Nicaragua are disproportionately affected. 
MeN’s etiology is a mystery, and no case definition of acute onset has 
been established. Our goal was to describe the acute clinical scenario of 
early suspect MeN cases. We conducted a prospective case investigation 
at a large sugar estate in Nicaragua. Physicians identified patients in the 
emergency room with decreased kidney function and completed case 
reports with clinical data and medical history. From Feb 2015-Feb 2016, 
255 cases of acute MeN cases were identified, mostly male (90%) and 
young (median age 29yrs), and glomerular filtration rates (eGFR) were 
low (mean 48±15 ml/min/1.73m2). The highest incidence was in June 
(16% of cases). Frequent symptoms were fever (55%), nausea/vomiting 
(65%), back pain (58%), headache (47%), and muscle debility (45%). 
Leukocytosis (75%), with neutrophilia (85%), was characteristic. Almost 
all had WBC (98%), epithelial cells (94%) and erythrocytes (82%) in urine. 
Few had history of hypertension (n=8) or diabetes (n=4). Based on this 
data, we defined an acute case of MeN as: a patient with unexplained 
impaired kidney function and leukocyturia and 2 or more of the following: 
(1)nausea/vomiting, (2)back pain, (3)headache, (4)muscle weakness, (5)
fever, or (6)leukocytosis or neutrophilia. Our data suggests acute MeN 
involves systemic inflammation and may reflect acute interstitial nephritis, 
which can progress to chronic tubulointerstitial nephritis and CKD. Renal 
biopsy results will confirm diagnosis. We establish an evidence-based case 
definition of acute MeN to be used to identify new cases in Nicaragua and 
throughout the region, allowing targeted diagnostics to determine the 
etiology of MeN.
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SEVERE AND HIGHLY FATAL OUTBREAK OF 
HISTOPLASMOSIS AMONG TUNNEL WORKERS — 
DOMINICAN REPUBLIC, 2015
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Histoplasmosis is typically a self-limited illness in immunocompetent 
persons and can be acquired through inhalation of fungal spores from 
disturbed bat guano. In September 2015, Dominican Republic (DR) 
health authorities received reports of several tunnel workers hospitalized 
with a febrile illness suggestive of histoplasmosis. Outbreaks of 
histoplasmosis have never been reported in the DR. We investigated to 
confirm etiology and identify factors associated with severe infection. A 
case was defined as fever and ≥2 symptoms (headache, constitutional, 
cough, or respiratory difficulty) in a person who worked in the tunnels 
during July 30–September 2, 2015. We interviewed workers, reviewed 
medical charts, and tested serum and urine for Histoplasma antigen at 
the Centers for Disease Control and Prevention (CDC). Thirty-five workers 
used shovels and wheelbarrows to remove large amounts of bat guano 
from enclosed, unventilated tunnels without respiratory protection. Thirty 
(86%) workers had illnesses meeting the case definition, 28 (80%) were 
hospitalized, 9 (26%) required intensive care unit (ICU) admission, 6 
(17%) were intubated, and 3 (9%) died. All were men and none were 
immunocompromised; median age was 30 (range: 18–62) years. The 
most common symptoms were fever (83%), cough (77%), and headache 
(70%). Median time from symptom onset to antifungal treatment was 6.5 
days. All intubated patients developed ventilator-associated pneumonia. 
Eighteen (53%) serum and 13 (42%) urine specimens tested positive 
for Histoplasma antigen. The high case-fatality rate (10-fold higher than 
typically reported) likely resulted from exposure to a high inoculum of 
Histoplasma in the setting of inadequate respiratory protection, delays in 
treatment, and high rates of nosocomial infection. Clinicians in the DR 
should be familiar with the presentation of histoplasmosis to allow for 
timely recognition and appropriate treatment. The risk of histoplasmosis 
should be considered in creation and implementation of occupational 
health and environmental safety standards in the DR.
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PERFORMANCE CHARACTERISTICS OF THE WHATMAN FTA 
ELUTE CARD AND TAQMAN ARRAY CARD PCR ASSAY AS AN 
ALTERNATIVE METHOD OF STORAGE OF FECAL SAMPLES 
AND ENTEROPATHOGEN DETECTION AS PART OF THE 
TRAVELERS’ DIARRHEA TREATMENT TRIAL
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Hutley6, Patrick Connor6, Stephen Becker2, Eric Houpt2, David 
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Polymerase Chain Reaction (PCR) assays are increasingly used for pathogen 
detection in travelers’ diarrhea (TD), but their use is limited in field 
settings due to on-site processing and storage requirements for fecal 
specimens. The Whatman FTA® Elute Card (FTA card) is an appealing 
alternative for stool collection, due to its ability to store nucleic acid for 
prolonged periods at room temperature. We evaluated the performance 
characteristics of the TaqMan Array Card, a quantitative, singleplex 
PCR (TaqMan PCR), when performed on diarrheal smears on FTA cards, 
compared to frozen stool samples. Subjects enrolled in a treatment trial 
for acute watery diarrhea provided a stool sample prior to treatment, a 
portion of which was smeared onto a FTA card. FTA cards and frozen stool 
samples were tested at a central lab, using the TaqMan PCR assay with a 
broad range of enteropathogen targets. A cycle threshold of 35 was used 
as the cut-off for positive detection. 153 paired FTA stool cards and frozen 
stool samples were stored for a median of 23 months (IQR 13-25) before 
testing. High detection rates were observed for frozen stool (79% [95% 
CI:73-86%]) and FTA cards (72% [95% CI:65-79%]). The most common 
pathogens detected in frozen stool were enterotoxigenic Escherichia coli 
(ETEC) (36%), enteroaggregative E coli (EAEC) (36%), enteropathogenic 
E coli (EPEC) (31%), Norovirus (14%), and Shigella/enteroinvasive E coli 
(7%). Co-pathogens were detected in 33% of samples, the most common 
being EAEC and EPEC. Sensitivity and specificity of the TaqMan PCR on 
FTA cards compared to frozen stool for common enteropathogens was 
as follows: ETEC (89% [95% CI:78-96%]; 99% [95% CI:94-99%]); 
EAEC(76% [95% CI:62-86%]; 93%[95% CI:86-97%]); EPEC: (75% 
[95% CI:60-86%]; 93% [95% CI:86-96%]). No significant decline in 
performance characteristics was noted with prolonged duration of FTA 
stool cards. FTA stool cards are a useful alternative to standard collection 
and storage methods in the field setting, allowing sample storage for 
several months at room temperature, and exhibiting good performance 
characteristics when tested with the TaqMan PCR.
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RESULTS FROM THE TRIAL EVALUATING AMBULATORY 
THERAPY OF TRAVELERS’ DIARRHEA (TREAT TD) STUDY: 
A RANDOMIZED CONTROLLED TRIAL COMPARING THREE 
SINGLE DOSE ANTIBIOTIC REGIMENS WITH LOPERAMIDE
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Brett Swierczewski4, Emma J. Hutley2, Brook A. Danboise5, 
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A recommended treatment for non-inflammatory travelers’ diarrhea 
(TD) is the combination of an antibiotic, usually a fluoroquinolone or 
azithromycin, and loperamide. However, adverse events, post-dose nausea 
with high dose azithromycin, effectiveness of single dose versus multi-dose 
regimens, limited effectiveness data in Africa, and emerging antibiotic 
resistance to front line agents, remain a concern impacting evidence-based 
recommendations. A randomized, double-blind trial was conducted at four 
sites in Afghanistan, Djibouti, Kenya and Honduras between September 
2012 and July 2015. US and UK adults with acute non-inflammatory 
diarrhea were randomized and received single dose azithromycin (500 mg; 
106 persons), levofloxacin (500 mg; 111 persons), and rifaximin (1650 
mg, 107 persons) plus loperamide (labelled dosing). Volunteers maintained 
a symptom diary and were evaluated 1, 3, and 7 days after therapy. 
The primary efficacy outcome, clinical cure at 24 hours, was evaluated 
in a non-inferiority trial design (delta, -0.15) with both rifaximin and 
azithromycin compared to a levofloxacin standard. Time to last unformed 
stool (TLUS) was a secondary efficacy outcome in addition to safety and 
tolerability. Clinical cure at 24 hours occurred in 80.2% of the levofloxacin 
arm, compared to 78.3% and 74.8% in the azithromycin and rifaximin 
arms, respectively. Compared to levofloxacin, azithromycin was not inferior 
(p=0.0105). Non-inferiority could not be shown with rifaximin (p=0.033). 
At 48 and 72 hours, efficacy among regimens was equivalent. Median 
TLUS among all three arms was no different (azithromycin: 4.0 hours; 
levofloxacin: 5.6 hours; rifaximin: 5.6 hours). Treatment failures were 
uncommon (3.8%, 4.5% and 1.9% in the azithromycin, levofloxacin and 
rifaximin arms, respectively) (p=0.6). There were no differences between 
treatment groups with respect to post-dose nausea (overall 3.1%, 
p=0.44), vomiting (overall 1.2%, p=0.7) or other adverse events. Single-
dose azithromycin (500 mg), levofloxacin (500 mg) and rifaximin (1650 
mg) with loperamide were comparable for treatment of watery diarrhea.
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EFFICACY AND SAFETY OF A SINGLE-DOSE MEBENDAZOLE 
500 MG CHEWABLE TABLET IN THE TREATMENT OF ASCARIS 
LUMBRICOIDES AND TRICHURIS TRICHIURA INFECTION 
IN PEDIATRIC PATIENTS: A DOUBLE-BLIND, RANDOMIZED, 
PLACEBO-CONTROLLED, PHASE 3 STUDY
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A double-blind, multi-center study was conducted to evaluate efficacy 
and safety of a single dose of a new chewable, rapidly-disintegrating, 
mebendazole (MBZ) 500 mg tablet for the treatment of Ascaris 
lumbricoides and Trichuris trichiura in pediatric patients (1−16 years). 
The study had a screening phase (3 days), double-blind treatment phase 
(DBP, 19 days) and an open-label follow-up (OLP, 7 days). A total of 
295 patients, excreting eggs of A. lumbricoides and/or T. trichiura, were 
randomized (1:1) (age: mean [SD] =7.8 [3.18] years) and received MBZ or 
placebo on day 1 in the DBP. All patients were administered MBZ on day 
19 (the start of OLP) post repeat stool microscopy analysis. At baseline, 
167 patients were infected with A. lumbricoides, 243 with T. trichiura 
and 115 were infected with both. Cure rates (primary efficacy endpoint, 
end of DBP) were significantly higher in MBZ group vs. placebo group 
for A. lumbricoides (% [95% CI], 83.7% [74.2%; 90.8%] vs. 11.1% 
[5.2%; 20.1%], p<0.001) and T. trichiura (33.9% [25.6%; 42.9%] vs. 
7.6% [3.5%; 13.9%], p<0.001). Egg reduction rates (secondary efficacy 
endpoint) were also significantly higher in the MBZ group vs. placebo for 
A. lumbricoides (97.9% vs. 19.2%; p<0.001) and T. trichiura (59.7% vs. 
10.5%; p<0.001). There were no deaths or serious treatment-emergent 
adverse events (TEAEs). Comparable rates and low incidence of TEAEs 
were reported in the DBP between MBZ (9/144 [6.3%]) and placebo 
(8/140 [5.7%]) with none of the individual TEAEs being reported in >2 
patients in either group. Abdominal pain (n=1), abdominal distension 
(n=2), and rash (n=1) were the only TEAEs considered possibly related to 
MBZ treatment. During OLP, the total TEAEs incidence was 2.5% with 
diarrhea (n=2), abdominal pain (n=1), and vomiting (n=1) considered 
possibly related to MBZ. All TEAEs resolved spontaneously. In conclusion, 
a single 500 mg chewable tablet of MBZ was found to have an adequate 
safety profile and was more efficacious than placebo in the treatment of 
A. lumbricoides and T. trichiura in pediatric patients. This new formulation 
will enable treatment of young children who have difficulty swallowing a 
tablet.
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ILLNESS AMONG MIGRANTS TO CANADA: SURVEILLANCE 
REPORT FROM CANTRAVNET SURVEILLANCE DATA, 2015
Andrea K. Boggild1, Jennifer Geduld2, Michael Libman3, Cedric 
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1University of Toronto, Toronto, ON, Canada, 2Public Health Agency 
of Canada, Ottawa, ON, Canada, 3McGill University, Montreal, QC, 
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Columbia, Vancouver, BC, Canada, 6Université de Montréal, Montreal, 
QC, Canada, 7University of Calgary, Calgary, AB, Canada, 8Winnipeg 
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Due to ongoing political instability and conflict in many parts of the 
world, migrants are increasingly seeking asylum and refuge in Canada. 
We examined demographic and travel correlates of illnesses among 
migrants to Canada to establish a detailed epidemiologic framework of 
this population for Canadian practitioners. Data on ill returned Canadian 
travellers presenting to a CanTravNet site between January 1, 2015 and 
December 31, 2015 were analyzed. During the study period, 2415 ill 
travellers and migrants presented to a CanTravNet site, and of those, 
519 (21.5%) travelled for the purpose of migration. Sub-Saharan Africa 
(n=160, 30.8%), southeast Asia (n=84, 16.2%), and south central Asia 
(n=75, 14.5%) were the most common source regions for migrants, while 
the top specific source countries, of 98 represented, were the Philippines 
(n=45, 8.7%), China (n=36, 6.9%), and Vietnam (n=31, 6.0%). 
Compared to non-migrant travellers, migrants were more likely to have 
a pre-existing immunocompromising medical condition (p<0.0001) and 
to require inpatient management of their illness (p<0.0001). Diagnoses 
such as TB (n=263, 50.7%), viral hepatitis (n=80, 15.4%), nationally 
notifiable diseases (n=380, 73.2%), and HIV (n=11, 2.1%) were greatly 
over-represented in the migrant population compared to non-migrant 
travellers (p<0.0001). Among cases of TB in the migrant population, 
82% (n=216) were latent, and 18% (n=47) were active. Compared 
to non-migrant travellers, migrants were more likely to present with a 
serious, communicable infectious disease, potentially complicated by an 
underlying immunosuppressing condition. These differences highlight the 
divergent health care needs in the migrant population, and underscore the 
importance of surveillance programs to understand their burden of illness.
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MATERNAL PARASITIC INFECTIONS ALTER INFANT 
ANTIBODY RESPONSE TO PNEUMOCOCCAL IMMUNIZATION
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Vaccine-preventable diseases remain a significant cause of early childhood 
mortality in developing countries, despite concerted efforts to improve 
vaccine coverage. One reason for this discrepancy may be the impact of 
prenatal exposure to parasitic antigens on the infant’s developing immune 
system. Our goal in this study was to investigate the effect of maternal 
parasitic infections on the infant immune response to early childhood 
vaccines. 580 pregnant Kenyan mothers were enrolled in the study and 
tested at prenatal visits for malaria, soil transmitted helminths, Giardia 
lamblia, Strongyloides stercoralis and Schistosoma haematobium infection. 
The infants received the 10-valent Streptococcus pneumonia conjugate 
vaccine (PCV), Haemophilus influenzae type B (Hib) and Diphtheria toxoid 
(DT) vaccines at 6, 10, and 14 weeks of age. Serum was collected from 
cord blood, 10 and 14-weeks, 6 months, and every 6 months following 
through the second year of life. A multiplex fluorescent bead assay 
determined IgG concentrations to HiB, DT, and the ten PCV serotypes: 
1, 4, 5, 6B, 7F, 9V, 14, 18C, 19F and 23F. Total parasitic infection 
incidence among mothers in the study is high, with 373 of 580 (64.2%) 
participants having at least one parasitic infection during pregnancy and 
75 participants (13%) with 2 or more infections. The most common 
infections were hookworm (19.7%), Plasmodium falciparum (16.2%), 
S. haematobium (11%), and Trichuris trichiura (10.5%). In preliminary 
analysis using a mixed linear model comparing infection status to log 
(antibody concentration), we are able to see a 37% higher concentration 
of PCV 9V antibody in children born to mothers with infections (p=0.016) 
compared to uninfected mother/child pairs. S. haematobium infection 
was associated with significantly higher concentrations in 4 PCV antigens: 
1 (3.9 fold higher, p=0.0006), 7 (2.3 fold higher, p=0.004), 9V (2.3 fold 
higher, p=0.002), and 18C (6.8 fold higher, p<0.0001). More testing is 
ongoing with this study, including more samples from later time-points, 
which will provide a more detailed analysis of the dynamics of first and 
second year responses to vaccine antigens.
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POPULATION GENOMICS OF WUCHERERIA BANCROFTI 
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Lymphatic filariasis (LF) is a major threat to human health in the tropics, 
leading to the disfiguring and debilitating conditions hydroceles and 
elephantiasis. There are approximately 1.2 billion people living in LF 
endemic countries where 120 million people currently suffer from the 
disease. The parasites that cause LF are separated into two genera, Brugia 
and Wuchereria, with W. bancrofti (Wb) responsible for ~90% of LF 
cases. Until recently, Wb has been neglected in genomic studies due to 
complications in sample collection and preparation, such as lack of adult 
stage samples. Our previous work has shown it is possible to concentrate 
Wb microfilaria from an infected blood sample and produce high quality 
genomic sequence. Here we expand upon our previous studies in Papua 
New Guinea to include three more endemic areas of Wb infectivity: Mali, 
Kenya, and Haiti. We utilize a new method of whole-genome amplification 
to generate whole-genome sequence data from archived DNA, blood, 
and PBMC samples containing microfilaria of Wb. Using this method, we 
have generated whole-genome data for 42 single microfilaria isolates from 
Haiti (9), Mali (11), Kenya (10), and PNG (12). We report on thousands of 
unique single nucleotide polymorphisms (SNPs) and identify genes that are 
highly variable among localities. We utilize discovered SNPs to: i) elucidate 
the historical context of admixture between endemic areas, retracing the 
possible routes of Wb migration, ii) root the gene trees of Wb to identify 
the species origin, and iii) reconstruct the historical demography by whole-
genome coalescent models. Our results provide a new context for studying 
Wb biology and may implicate biological complexities that will hinder 
elimination. Our methods advance the study of Wb genomics by allowing 
the sequencing of archived Wb samples. This new data source, when 
paired with WGS from recent times and epidemiological data, provides a 
post-hoc method of hypothesis generation. These hypotheses can then be 
used to predict how different regions infected with Wb may respond to 
ongoing elimination pressure.
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POST-GENOMIC EMPIRIC IMMUNOMIC ANALYSES IDENTIFY 
NOVEL BIOMARKERS FOR ACTIVE ONCHOCERCA VOLVULUS 
INFECTION
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Onchocerciasis is a neglected tropical disease that has been targeted for 
control and elimination through mass drug administration of ivermectin. 
Currently, surveillance tools have relied on xenomonitoring and Ov16-
based IgG4 antibody tests, the latter having sensitivities ranging from 
70-80% across most endemic countries. As program goals have shifted 
from disease control to elimination of Onchocerca volvulus (Ov), additional 
tools may be needed that can be used in both surveillance and in the 
certification of elimination of onchocerciasis. Empiric analyses of the stage-
specific Ov transcriptomes resulted in the identification of 398 proteins 
that favor exposure and propensity for eliciting antibody responses. These 
proteins were expressed, gridded on protein arrays and screened for 
isotype-specific (IgG1, IgG3, IgG4, IgE) responses using 52 individual sera 
from Ov-infected and appropriate control individuals. Multivariate analyses 
of isotype reactivity level and infection status resulted in the identification 
of 15 ‘Ov-specific’ proteins that had significantly higher IgG4 responses 
(p < 0.0001, ANOVA) in infected individuals compared to control sera. 
The top 5 candidate proteins (OVOC10469, OVOC3261, OVOC10602, 
OVOC5127 and OVOC11950) were each expressed in mammalian 
cells as fusion proteins and tested in a luciferase immunoprecipitation 
system that allowed for the rapid identification of O. volvulus - (but not 
related filarial parasite-) specific targets of IgG4 reactivity. Among these 
5 potential biomarkers 3 showed sensitivities ranging between 80-90%, 
with specificities that approached 100% when tested with a large panel 
(n=400) of well-characterized sera. When coupled to the IgG4 responses 
to Ov16, the IgG4 responses to any one of these 3 biomarkers achieved 
close to 100% sensitivity with no apparent loss of the 100% specificity 
seen individually. Additional optimization is being performed to configure 
the next generation of point of care immunoassays. These data provide 
an important and practical example of how “immunomic” analyses in the 
post-genomic era can rapidly provide solutions to very practical problems.
87
NOVEL BIOMARKERS FOR THE IMMUNE-BASED 
QUANTIFICATION OF LOA LOA MICROFILARIAE AND THE 
DIAGNOSIS OF LOIASIS
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Some individuals infected with high levels of Loa loa (Ll) microfilariae (mf) 
are known to experience fatal post-ivermectin severe adverse events that 
have led to the interruption of ivermectin-based mass drug administration 
programs in some regions of Central and West Africa. Thus, tools that 
can accurately identify “at risk” individuals (with high Ll mf loads) at the 
point of contact (POC) are of critical need. To identify potential biomarkers 
that could be used as the basis of immunologically-based POC assays, 
we first conducted transcriptomic analysis of the Ll mf and used these 
data to provide a framework for identifying proteins (through LC-MS/MS 
analysis) present in the secretory/excretory (E/S) products of Ll mf from in 
vitro cultures. In addition, proteomic analyses of individual plasma (n= 10) 
and urine (n=6) of Ll-infected individuals compared to uninfected controls 
were also performed. Of the 12,200 transcripts expressed by Ll mf, 1,166 
proteins were found in the Ll mf E/S products. Some of the mf E/S proteins 
were specifically detected in the urine (n=205) or the plasma (n=25) of 
Ll-infected individuals. Through a bioinformatics-filtering pipeline, we 
identified 28 potential Ll mf-specific biomarkers. Among these 28, 2 
mf-specific antigens (LOAG_14221 and LOAG_15846) were detected 
in plasma of Ll-infected patients with little to no reactivity to sera from 
patients infected with W. bancrofti or O. volvulus. Interestingly, levels of 
LOAG_14221 in mf-positive Ll infected patients were positively correlated 
to measured mf densities in the corresponding blood (r = 0.6 and P = 
0.0007), and LOAG_14221-based assay showed a sensitivity of 76% and 
a specificity of 78% compared to gold-standard microscopy. Thus, we are 
in the process of creating additional reagents to configure a quantitative 
POC rapid immunoassay for LOAG_14221 antigen in plasma and urine as 
a surrogate for Ll mf quantification using standard techniques.
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ALLERGIC SENSITIZATION UNDERLIES HYPER-REACTIVE 
ANTIGEN-SPECIFIC CD4+ T-CELL RESPONSES IN COINCIDENT 
FILARIAL INFECTION
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Among the various hypotheses put forward to explain the modulatory 
influence of helminth infection on allergic effector responses in humans, 
the IL-10 induced suppression of Th2-associated responses has been the 
leading candidate. To explore this helminth/allergy interaction more fully, 
parasite- and allergen--specific T cell responses CD4+ T cell responses 
in 12 subjects with filarial infections and coincident allergic sensitization 
(Fil+A+) were compared these to the responses to 3 appropriate control 
groups [Fil-A- (n=13), Fil-A+ (n=12), Fil+A- (n=11)]. The most important 
findings revealed that FIL+A+ had marked (p<0001 for all cytokines) 
increases in parasite antigen-driven Th2 (IL-4, IL-5, IL-13), Th9 (IL-9) and 
the regulatory (IL-10) cytokines when compared with Fil+A-. Moreover, 
using multiparameter flow cytometry, filarial parasite antigen induced a 
marked increase in not only the frequency of CD4+ T cells producing IL-4, 
IL-5, IL-2 and TNF-α in Fil+A+ when compared to Fil+A- patients but also 
in the frequencies of polyfunctional Th2-like (CD4+IL-4+IL-5+ and CD4+IL-
2+IL-4+IL-5+TNF-α+) cells. The Th2-associated responses seen in the 
Fil+A+ group was correlated with serum IgE levels (p<0.01, r=0.5165 for 
IL-4; p<0.001, r=0.5544 for IL-5; and, p<0.001, r=0.4901 for IL-13), levels 
of circulating eosinophils (p<0.0116, r=0.5656) and their degranulation/
activation products [major basic protein (p<0.001, r=0.7353) and, 
eosinophil derived neurotoxin (p<0.01, r=0.7059)]. CD4+ responses to 
allergen were not different (to a large extent) among the groups. Taken 
together, our data suggest that filarial infection drives an augmented 
parasite antigen-specific T cell response characterized by a Th2-dominated 
immune response that largely is pro-allergenic. This response, while 
possibly able to limit parasite burden, may be responsible for the induction 
of parasite-associated (but pro-allergic) pathology.
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SCHISTOSOMA MANSONI INFECTION IMPAIRS 
REPRODUCTION IN MICE
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Schistosomiasis is a neglected tropical disease, endemic in 76 countries, 
that afflicts more than 240 million people. The impact of schistosomiasis 
on infertility may be underestimated according to recent literature. Extracts 
of Schistosoma haematobium include estrogen-like metabolites termed 
catechol-estrogens that down regulate estrogen receptors alpha and beta 
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in estrogen responsive cells. In addition, schistosome derived catechol-
estrogens induce genotoxicity that result in estrogen-DNA adducts 
and cause hormonal imbalance. We now hypothesize the induction of 
infertility in individuals infected with S. mansoni also through an hormonal 
imbalance. The aim of this study was to study infertility in mice infected 
with S. mansoni. Female mice infected with S. mansoni and noninfected 
female controls, male mice infected with S. mansoni and noninfected male 
controls were mated during 8 months. Gestational length and, number 
of pupps were studied. Animals were euthanized and their ovaries, uterus 
and testes were examined histopathologically. Infected females had 
shorted gestational length than controls. Births of infected females were 
not synchronous as in controls. The number of pupps was decreased in 
infected females in comparison to controls. Ovaries, uterus and testes 
of infected mice showed definite structural damage. No ova, worms or 
specific granulomata were detected in infected mice in organs other than 
liver and spleen. To our knowledge this is the first study addressing S. 
mansoni infection associated infertility. It is concluded that schistosomiasis 
has an important metabolic effect leading to reproduction disorder in 
infected animals. These results together with histopathological findings 
with absence of egg in all examined ovaries, uterus and testicular sections 
emphasize the possible role of hormonal imbalance in the pathogenesis 
of such lesions. The changes observed could be due to catechol-estrogens 
associated with schistosomiasis.
90
THE EFFECTS OF PRAZIQUANTEL ON THE TEMPORAL 
INTERACTION BETWEEN THE HELMINTH PARASITE 
SCHISTOSOMA MANSONI AND ITS MURINE HOST
Melissa C. Sanchez1, Amalia Sanchez Parra1, Christain von 
Cabanlong1, Pauline M. Cupit2, Charles Cunningham1
1Center for Evolutionary and Theoretical Immunology, Dept. of Biology, 
University of New Mexico, Albuquerque, NM, United States, 2Skaggs 
School of Pharmacy and Pharmaceutical Sciences, University of California, 
San Diego, CA, United States
After penetrating the skin of its mammalian host, Schistosoma mansoni 
schistosomula migrate via the bloodstream to the liver and mesenteric 
veins where males and females mature and pair to produce fertile eggs. 
While many of these eggs are excreted in the feces, a number become 
lodged in the liver where they drive granuloma formation that causes 
much of the pathology associated with the disease. Praziquantel (PZQ) 
is the only drug available for treatment of schistosomiasis. Although the 
drug kills sexually mature worms it is unable to cure infection because 
it is ineffective against sexually immature juvenile worms 2-4 weeks 
after infection. The molecular basis of juvenile resistance to PZQ remains 
unknown and here we investigate the potential role of ATP Binding 
Cassette (ABC) transporter genes in the differential response of adult and 
juvenile S. mansoni to PZQ treatment. Expression data for 16 S. mansoni 
genes including 9 ABC transporters over the treatment period will be 
shown. Our data suggests there is significant differential expression of 
transporters between S. mansoni adult versus juvenile in response to 
PZQ. In addition, we have employed next generation RNA sequencing 
technology (Illumina) together with the Lumenogix data analysis platform 
to examine the differential expression of mouse hepatic genes during S. 
mansoni infection. S. mansoni infected mice were treated with a lethal 
dose of PZQ over 4 consecutive days beginning on either day 25 (juvenile 
S. mansoni) or day 32 (adult S. mansoni) post infection. Infected liver 
tissue was excised and total RNA extracted. The differential expression of 
immune, fibrotic, and inflammatory genes and pathways will be reported 
and correlated with egg deposition and granuloma formation in the 
murine liver.
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DENGUE VIRUS: THE CIRCULATION OF FOUR SEROTYPES 
IN AN ENDEMIC REGION, DURING NINE SEASONS: 
SINGULARITIES ON EPIDEMIC DYNAMICS AND GENETIC 
DIVERSITY
Danila Vedovello1, Leila Sabrina Ullmman2, Joice M. Biselli-
Périco3, Tatiana E. Colombo4, Tauyne M. Pinheiro4, Roberta V. 
Bronzoni5, Adriano Mondini6, Ana carolina B. Terzian4, João P. 
Araújo Jr2, Francisco Chiavanotti-Neto7, Mauro M. Teixeira8, 
Nikos Vasilakis9, Betânia P. Drumond8, Paula Rahal3, Maurício L. 
Nogueira4
1UFABC, São Bernardo do Campo, Brazil, 2UNESP, Botucatu, Brazil, 3UNESP, 
São José do Rio Preto, Brazil, 4FAMERP, São José do Rio Preto, Brazil, 
5UFMT, Sinop, Brazil, 6UNESP, Araraquara, Brazil, 7FSP/USP, São Paulo, 
Brazil, 8UFMG, Belo Horizonte, Brazil, 9University of Texas Medical Branch, 
Galveston, TX, United States
Dengue virus (DENV) is a Flavivirus of great importance in public health, 
especially in tropical regions that present favorable environment for 
mosquito vector development. This study presents a molecular surveillance 
of dengue occurred in São José do Rio Preto, São Paulo State, Brazil, 
during nine epidemiological seasons (August 2005 to July 2014). Patients 
with typical symptoms of dengue who were attended in the public 
health system had blood samples collected for DENV detection. A total of 
1,774 samples were DENV positive. They were identified 511 (27.80%) 
DENV1, 202 (11.38%) DENV2, 494 (27.84%) DENV3 and 567 (32.96%) 
DENV4. DENV serotypes circulation can be described as it follows: DENV1 
was mainly detected from 2009 to 2012; DENV2 was detected from 
2008 to 2012; DENV3 was identified in 2006 but no longer detected 
after 2007 and finally, DENV4 was detected 2011 onwards. The four 
dengue serotypes have been detected, representing a hyperendemicity 
scenario. Phylogenetic reconstructions of 4 serotypes were conducts from 
81 complete genome 74 complete sequences of the envelope gene (E 
Protein). The genotypes circulating were: DENV1 genotype V, DENV2 
Asian/American genotype, DENV3 genotype III and DENV4 genotype II. 
DENV1 strains are from two different lineages, with specific amino acids 
for each lineage and two dates of introduction: 2008 up to 2014 (MRCA 
estimated to 2006) and 2010 up to 2012 (MRCA estimated to have 
existed in 2008). Two subgroups of DENV2 were founded, with specific 
amino acids changes for one: First group that include 2008 strains (MRCA 
dating probably in 2004) and other group with strains from 2006, 2011 up 
to 2014 (MRCA dating probably in 2006. DENV 3 and DENV4 showed one 
lineage each one and the serotypes circulating are the same as described 
previously, on Brazil. The co-circulation of multiple serotypes resulted in 
competition, and genetic diversity. Dengue surveillance is important to 
understand the mechanisms of introduction and extinction of strains and 
replacement of serotypes, genotypes or lineages.
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EVALUATION OF THE HEALTH-RELATED QUALITY OF LIFE 
OF CHILDREN WITH DENGUE AND MALARIA IN WESTERN 
KENYA
Elizabeth Liu1, David Vu1, Derek Boothroyd1, Bryson Ndenga2, 
Winnie Onyango2, Victoria Okuta2, A. Desiree LaBeaud1
1Stanford University School of Medicine, Stanford, CA, United States, 
2Kenya Medical Research Institute, Kisumu City, Kenya
Malaria and dengue are leading causes of mortality and morbidity in 
sub-Saharan Africa. Although acute disease symptoms can be clinically 
recognized, the effects on daily living associated with disease due to either 
or both infections are still unclear, especially in a pediatric population 
where disease burden is the greatest. The goal of this study was to 
investigate the effect of dengue virus (DENV) and/or malaria infection 
on health-related quality of life (HrQoL) in children in Western Kenya. 
We used the Pediatric Quality of Life Inventory (PedsQL), a modular 
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instrument, to assess health-related quality of life (HrQoL) among children, 
aged 2-18 (n = 171), who presented with fever to one of two health 
centers in Western Kenya. The PedsQL questionnaires were administered 
to subjects and their parents in their native Luo language. Blood samples 
from child with acute febrile illness were assayed for malaria parasitemia 
by light microscopy or by rapid diagnostic testing cards, and for DENV 
viremia by RT-PCR. Cases of DENV infection were also identified based on 
anti-DENV IgG seroconversion by ELISA between blood samples obtained 
at time of presentation and at one month follow up. The mean PedsQL 
score for all febrile children was 87.3 (95% CI 85.6 to 89.1) at the time of 
presentation. By the one month follow up visit, the mean score increased 
to 94.9 (95% CI 93.5 to 96.4, p<0.001 by paired T-test). The increases by 
the convalescent visit were also observed for groups of children who had 
malaria (mean score 88.5 to 96.1, p<0.001) or who had febrile illness that 
was neither malaria nor DENV (mean score 87.7 to 96.3, p<0.001). For 
children who were infected with DENV, or who had concurrent infection 
with both DENV and malaria, the increase in scores was less pronounced; 
the mean score increased from 84.7 to 91.1 (p=0.3) and 83.6 to 90.7 
(p=0.07) for children with DENV mono-infection or DENV/malaria co-
infection, respectively. Data are continuing to be collected as part of our 
ongoing study. However slower recovery in the PedsQL scores of DENV-
infected children may indicate that consequences of DENV infection may 
have longer-lasting effects than previously believed.
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MOLECULAR CHARACTERIZATION OF TWO MAJOR DENGUE 
OUTBREAKS IN COSTA RICA
Claudio Soto-Garita1, Teresita Somogyi2, Vicente-Santos 
Amanda3, Eugenia Corrales-Aguilar1
1Virology-CIET (Research Center for Tropical Diseases), Faculty of 
Microbiology, University of Costa Rica, San José, Costa Rica, 2Molecular 
Diagnostics Unit, Hospital Mexico, Caja Costarricense del Seguro Social, 
San José, Costa Rica, 3Conservation Genetics, School of Biology, University 
of Costa Rica, San José, Costa Rica
Dengue virus (Flavivirus; Flaviviridae) is a re-emerging arthropod-borne 
virus with worldwide circulation transmitted mainly by Aedes aegypti 
and Ae. albopictus mosquitoes. Since the first detection of its main 
transmitting vector in 1992 and the invasion of DENV-1 in 1993, Costa 
Rica has faced dengue outbreaks yearly. In 2007 and 2013 Costa Rica 
experienced two of the largest outbreaks in terms of total and severe 
cases. In order to provide genetic information about the etiologic agents 
producing these outbreaks we conducted phylogenetic analysis of 
viruses isolated from human samples. A total of 23 DENV-1 and DENV-
2 sequences were characterized. These analyses signaled that DENV-1 
genotype V and DENV-2 American/Asian genotype were circulating in 
those outbreaks. Our results suggest that the 2007 and 2013 outbreak 
viral strains of DENV-1 and DENV-2 originated from nearby countries and 
underwent in situ microevolution.
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ARTHROPOD EXOSOMES AS NOVEL TRANSMISSION 
BLOCKING STRATEGIES FOR VECTOR-BORNE PATHOGENS
Hameeda Sultana
Old Dominion University, Norfolk, VA, United States
Molecular determinants and mechanisms of arthropod-borne flavivirus 
transmission to the vertebrate host are poorly understood. The 
transmission strategies used by flaviviruses to exit arthropods and 
infect human host were envisioned as best approaches to develop 
transmission-blocking vaccines against molecules or determinants that 
facilitate pathogen transmission. Research in my laboratory has shown 
that both tick and mosquito-borne flaviviruses uses exosomes, the small 
membranous extracellular vesicles for transmission from arthropods to 
human host. Our studies have revealed that arthropod derived exosomes 
are important means of communication and transmission between the 
vector and the vertebrate host. We have found that Langat virus (LGTV), 
a flavivirus member closely related to tick-borne encephalitis virus and 
mosquito-borne dengue viruses are transmitted from vector to the 
vertebrate host through exosomes. The exosomes containing LGTV and 
dengue viruses were viable, secured and highly virulent in all tests such 
as re-infection kinetics, trans-migration, inhibitor studies and viral plaque 
formation assays suggesting exosomes as favorable modes of transmission. 
Both matured virions and replicative forms of arthropod-borne flaviviruses 
were found to be using exosomes for transmission. Our data also showed 
that arthropod derived exosomes facilitated infection of human cells that 
eventually produced exosomes loaded with flaviviruses. Our current efforts 
are focused on understanding the molecular mechanisms/associated 
signaling cascades and virus conformations in exosomes derived from 
arthropods and arthropod cells. Overall, our studies would suggest the 
arthropod derived exosomes as novel transmission blocking strategies for 
treating flavivirus infections.
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PLASMODIUM FALCIPARUM CO-INFECTION MODULATES 
DENGUE DISEASE SEVERITY
David M. Vu1, Kelsey Ripp2, Noah Mutai3, Bryson A. Ndenga3, 
Claire Heath1, A. Desiree LaBeaud1
1Stanford University School of Medicine, Stanford, CA, United States, 
2Warren Alpert Medical School of Brown University, Providence, RI, United 
States, 3Centre for Global Health Research, Kenya Medical Research 
Institute, Kisumu, Kenya
Severe dengue virus (DENV) disease is an important cause of childhood 
mortality worldwide. Due to lack of surveillance, the burden of DENV 
infection in Sub-Saharan Africa is unknown, but likely underestimated. 
Further, since the DENV mosquito vector shares a geographic distribution 
with that of the Plasmodium falciparum (Pf) vector, concurrent infection 
with both pathogens can occur. Although DENV/malaria co-infection is 
increasingly recognized in other parts of the world, reports of DENV/Pf 
co-infection are sparse in Africa due to under-recognition of DENV disease. 
Consequently, little is known about the disease manifestations of DENV/
Pf co-infection, particularly in children, who are known to bear a larger 
burden of both diseases. The purpose of the present study is to bridge 
gaps in our understanding of DENV/Pf co-infection disease. As part of 
our ongoing study on arboviral infection in Kenyan children, we enrolled 
children who presented with fever of unclear etiology to one of four 
centers located in Kisumu County in western Kenya, and Kwale County 
on the Kenyan coast. To date, 579 blood samples from febrile children 
(mean age 4.3-years) have been tested for both DENV RNA by RT-PCR and 
malaria by light microscopy. 333 (58%) were positive for Pf. 73 (13%) 
samples were positive for DENV. 33 (49%) of the DENV-positive samples 
also were positive for Pf. Children with DENV/Pf co-infection or Pf mono-
infection were older than DENV mono-infected children (mean age 5.1 
and 4.8 years vs. 3.4 years, respectively, p=0.008). DENV/Pf co-infected 
and Pf mono-infected children also had higher fevers at presentation 
than did DENV mono-infected children (mean temperatures of 39.0 
and 38.8 vs. 38.5 degrees C, respectively, p<0.01). Compared with Pf 
mono-infected children, body aches, joint tenderness, and splenomegaly 
were observed more frequently in DENV mono-infected children, but less 
frequently in DENV/Pf co-infected children. These preliminary findings 
suggest that concurrent infection with Pf may exert a modulatory effect 
on clinical DENV disease. Further investigation of DENV/Pf co-infection will 
yield insights important for clinical care.
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LOWER T CELL APOPTOSIS IN THE SECOND INFECTION WITH 
HETERO-SEROTYPE DENV
Jintao Li, Wang Yang, Hongxia Guo, Nan Ye, Tiantian Yu
Tropical Medicine Institute, Chongqing, China
The available evidence suggests that dengue virus-specific T lymphocytes 
and cytokine storm play a pivotal role in the immunopathogenesis of 
plasma leakage. Investigations are underway to identify the immune 
profiles associated with increased or decreased risk for severe disease. 
In this study, CD14+ cells from the peripheral blood mononuclear cells 
(PBMCs) of patients who recovered from DENV-1 infection were infected 
with DENV-1 or DENV-2 and co-cultured with memory T cells. We found 
that secondary infection with DENV-2 suppresses the cell reproductive 
capacity but forms more cell clones and more functional cells to produce 
more proinflammatory factors (IFN-γ, TNF-α, IL-6, IL-8, IL-12 and IL-17) 
and less regulatory cytokines (IL-10, TGF-β) which results in higher viral 
replication compared to secondary infection with DENV-1. Memory 
dengue virus-specific T cells which are induced in a primary dengue virus 
infection are reactivated by the heterologous serotype of dengue virus and 
antigen-presenting cells (APCs) during a secondary infection. Dramatically, 
less apoptosis and more continuous activation of T cells in secondary 
infection with hetero-serotype DENV were observed. This discovery 
which has not been reported previously may be the reasonable and vital 
interpretation for the cytokine storm and severe symptoms observed in 
secondary infection with DENV. In summary, secondary infection with 
hetero-serotype DENV elicits the relatively pathological immune response 
while secondary infection with homologous-serotype DENV induces the 
relatively protective immune response by activation-induced cell death 
(AICD) of T cells.
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PREDISPOSING SECOND IN ADULT DENGUE PATIENTS
Ananda D. Wijewickrama1, Sunethra Gunasena2, Gaveshika 
Abeyrathna1, Chalaka D. Chandima1, Damayanthi Idampitiya1
1National Institute of Infectious Diseases, Angoda, Sri Lanka, 2Medical 
Research Institute, Colombo, Sri Lanka
Dengue, a major public health problem in the world, is now endemic 
in more than 100 countries. It is estimated to have 390 million Dengue 
infections with 96 million cases worldwide. Mortality rate can be high 
ranging from 0.1% to 5%. Bleeding is a common complication in Dengue 
which can even lead to death if not detected and treated early. Therefore, 
identifying predictors of bleeding would be very valuable as such 
patients could be closely monitored to detect and treat bleeding early. A 
prospective Case Control Study was conducted to determine the incidence 
of bleeding, type of bleeding and possible predictors of bleeding. All 
patients admitted to Dengue Management Unit at the National Institute 
of Infectious Diseases, Colombo, Sri Lanka for a period of four months 
from 1st of July 2014 were included in the study. Dengue infection was 
confirmed by NS1 antigen or Dengue Specific IgM antibodies. These 
patients were followed up to see the development of bleeding, possible 
effects of bleeding and the need of blood transfusion.There were 1000 
patients with confirmed Dengue infection with 546 males and 454 
females. Age ranged from 12 to 86 years. (mean 31 yrs.) 56.2% (n=562) 
had DF; 43.8% (n= 438) had DHF. 332(33.2%) had some degree of 
bleeding; major bleeding in 17.0%, minor bleeding in 15.9%; 67.1% 
had no bleeding at all, other than petechial bleeding. 81(8.1%) needed 
therapeutic blood transfusions. Major bleeding was significantly more 
common (p<0.05) in those who had severe vomiting, postural dizziness, 
abdominal pain and hepatic tenderness and those who had NSAIDS. 
Females had more bleeding than men (p<0.05). Obese patients had a 
higher risk of having bleeding (p<0.05), but not overweight patients(BMI 
23-27). Patients with platelet counts less than 50,000 per cmm were at a 
higher risk of having bleeding as well as DHF patients. This study identifies 
predictors which would put Dengue patients at high risk of bleeding. This 
will enable clinicians to monitor such patients carefully to detect and to 
treat bleeding promptly thereby reducing morbidity and mortality.
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PREVALENCE OF DENGUE AND CHIKUNGUNYA VIRUS 
INFECTIONS IN NORTHEASTERN TANZANIA: A CROSS 
SECTIONAL STUDY AMONG PARTICIPANTS PRESENTING 
WITH MALARIA-LIKE SYMPTOMS
Debora C. Kajeguka1, Reginald A. A. Kavishe1, Robert D. Kaaya1, 
Jaffu O. Chilongola1, Michael Alifrangis2, Franklin W. Mosha1, 
Karin L. Schiøler2
1Kilimanjaro Christian Medical University College, Moshi, United Republic 
of Tanzania, 2University Of Copenhagen, Copenhagen, Denmark
Abstract In spite of increasing reports of dengue and chikungunya activity 
in Tanzania, limited research has been done to document the general 
epidemiology of dengue and chikungunya in the country. This study aimed 
at determining the sero-prevalence and prevalence of acute infections 
of dengue and chikungunya virus among participants presenting with 
malaria-like symptoms in three communities with distinct ecologies of 
north-eastern Tanzania. Cross sectional studies were conducted among 
1100 participants (aged 2-70 years) presenting with malaria-like symptoms 
at health facilities at Bondo dispensary (Bondo, Tanga), Hai hospital (Hai, 
Kilimanjaro) and TPC hospital (Lower Moshi). Participants who were 
malaria negative using rapid diagnostic tests (mRDT) were screened for 
sero-positivity towards dengue and chikungunya Immunoglobulin G and 
M using ELISA-based kits. Participants with specific symptoms defined 
as probable dengue and/or chikungunya by WHO were further screened 
for acute dengue and chikungunya infections by PCR. Out of a total of 
1100 participants recruited, 91.2% (n=1003) were malaria negative by 
mRDT. Out of these, few of the participants (<5%) were dengue IgM or 
IgG positive. A total of 381 participants had fever out of which 7.9% 
(30/381) met the defined criteria for probable dengue, though none (0%) 
was confirmed to be acute cases. Chikungunya IgM positives among 
febrile participants were 12.9% (49/381) while IgG positives were at 3.7% 
(14/381). A total of 69.0% (263/381) participants met the defined criteria 
for probable chikungunya and 4.2% (11/263) were confirmed by PCR 
to be acute chikungunya cases. Further analyses revealed that headache 
and joint pain were significantly associated with chikungunya IgM 
seropositivity. In north-eastern Tanzania, mainly chikungunya virus appears 
to be actively circulating in the population. Continuous surveillance is 
needed to determine the contribution of viral infections of fever cases. A 
possible establishment of arboviral vector preventive control measures and 
better diagnosis of pathogens to avoid over-treatment of other diseases 
should be considered.
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NATURAL ANTIBODY RESPONSES TO THE CAPSID PROTEIN 
OF DENGUE
Mahesha N. Sigera Nadugala1, Chandima Jeewandara2, Neelika 
Malavige2, Prasad H. Premaratne1, Charitha L. Goonasekara1
1Faculty of Medicine,General Sir John Kotelawala Defence University, 
Ratmalana, Sri Lanka; Institute for Combinatorial Advanced Research and 
Education, General Sir John Kotelawala Defence University, Ratmalana, Sri 
Lanka, 2Centre for Dengue Research, University of Sri Jayawardanapura., 
Gangodawila, Sri Lanka
The capsid (C) protein is a structural protein of the dengue virus (DENV) 
that encloses its genetic material. Few previous studies reported antibody 
responses to DENV C protein during natural infection. To further 
understand this, we studied natural antibody responses against C protein 
of all four DENV serotypes. Antibody responses of sera obtained from 
dengue seropositive healthy volunteers (DENV1 n=8: DENV2 n=8: DENV3 
n=5 and DENV4 n=8) from Sri Lanka, were screened against an array of 
14 peptides, representing the entire C protein sequence of DENV2, using 
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ELISA assay. The peptides are of 15- to 18-amino acids (aa) in length, 
with 10 aa overlaps. Three peptides P1 (2-18 aa), P11 (79-95 aa) and P12 
(86-101 aa) showed positive responses (cut-off = mean OD of 8 negative 
controls + 3 standard deviation) to sera from individuals infected with all 
four DENV serotypes. For P11 and P12, 100% of sera from each serotype 
were positive, whereas for P1, 100% sera from DENV1, 3 & 4 and 86% 
sera from DENV2 were positive. These peptides are located on N and C 
terminal regions (1-40 and 70-100 respectively) which are characterized 
to be highly hydrophilic, surface accessible and flexible regions. According 
to IEDB conservancy analysis, the overall conservancy % values across 
the four serotypes of the three positive peptides: P1, P11 and P12, are 
44%, 64% and 58% respectively. Two peptides P6 (39-56 aa) and P10 
(71-89 aa) were positive only against the sera of individuals who had 
been infected with DENV2 and DENV4 (100% positive). Remaining nine 
peptides P2 (8-25 aa), P3 (16-32 aa), P4 (23-40 aa), P5 (40-48 aa), P7 (47-
63 aa), P8 (54-71 aa), P9 (62-79 aa), P13 (93-110 aa) and P14 (100-114 
aa) did not show significant positive antibody responses. Out of those: P5, 
P7 and P8 are located in a hydrophobic region and therefore not likely to 
be potentially antigenic. These results further provide evidences for DENV 
C protein being immunogenic in natural infections.
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COCULTURE OF ENDOTHELIAL CELLS AND MONOCYTES AS 
A POTENTIAL MODEL TO STUDY DENGUE PATHOGENESIS 
AND SCREEN COMPOUNDS WITH THERAPEUTIC POTENTIAL
Francielle T. Cardozo, Camila M. Romano, Ester C. Sabino
University of Sao Paulo, Sao Paulo, Brazil
Plasma leakage is one of the main signs of complication of dengue virus 
(DENV) infections and it is related to the disease severity. The lack of 
animal models representing satisfactorily the pathophysiology of dengue 
fever in humans has been limiting the advances in understanding the 
disease mechanisms as well as the development of drugs and vaccines for 
dengue management. Many studies have been shown that monocytes 
are one of the main cells responsible for immune response to DENV, 
producing mediators that interact with endothelia increasing vascular 
leakage in humans. Therefore, the aim of this work was to stablish a 
model for assessing the in vitro vascular permeability using endothelial 
cells co-cultured with monocytes infected by DENV. Monocytes (THP-1 
cells) were infected with DENV-2 strain ACS 46, at MOI of 0.1 and 1, 
and put in contact with endothelial cells (HUVEC) monolayers through 
apical or basolateral side of transwell inserts. As controls, monocultures 
of HUVECs were infected likewise. UV inactivated virus and supernatant 
of mock infections were also tested. The endothelial barrier function was 
evaluated by measuring the Transendothelial electrical resistance (TEER). 
Data were compared by one-way ANOVA/Tukey’s test with p<0.05. 
Results show that the coculture system, infected at MOI of 0.1 , presented 
significant lower TEER values in comparison to the infected monocultures 
of endothelial cells, as well as the cocultures infected with UV inactivated 
virus or supernatant of mock infections, after 24 h of basolateral contact. 
No differences were observed at the same conditions with apical contact. 
At MOI of 1, we found no difference between mono- or cocultures. These 
results indicate that the infected coculture more efficiently interfered with 
the endothelial barrier function in vitro at low MOI (0.1), being a potential 
mimicry model of plasma leakage triggered by dengue infections. The 
proposed system will allow us to screen of compounds with therapeutic 
potential and study the interference of different immunomediators on 
vascular permeability in order to better understand the pathogenic factors 
associated with severe outcomes.
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EFFICACY OF RUPATADINE IN THE TREATMENT OF ACUTE 
DENGUE INFECTION
Gathsaurie Neelika Malavige1, Ananda Wijewickrama2, Samitha 
Fernando1, Praveen Madushanka1, Chameera Punchihewa1, 
Anushka Ginneliya1, Supun Samarasekara1, Shiran Paranavitana1, 
Damayanthi Idampitiya2, Chandanie Wanigatunga1, Harsha 
Dissanayaka1, Shamini Prathapan1, Chandima Jeewandara1, Laksiri 
Gomes1, Graham Ogg3
1University of Sri Jayawardenapura, Nugegoda, Sri Lanka, 2Infectious 
Diseases Hospital, Colombo, Sri Lanka, 3University of Oxford, Oxford, 
United Kingdom
Our previous studies showed that platelet activating factor (PAF) 
was a potent mediator of vascular leak. Therefore, we proceeded to 
investigate the efficacy of rupatadine which is a PAF receptor blocker in 
patients with acute dengue infection. We conducted a phase II, open 
label, randomized placebo controlled trial to determine the safety of 
rupatadine in patients with acute dengue, the efficacy of rupatadine 
in preventing or reducing vascular leak and to determine its efficacy in 
reducing complications associated with acute dengue. The study was 
carried out in 3 arms: rupatadine 40mg daily, rupatadine 10mg daily and 
the placebo. The patients were examined and laboratory parameters 
were measured at least twice a day to detect any complications and fluid 
leakage. Daily ultrasound scans were done from the day of admission to 
determine the presence and the quantity of fluid leakage. 138 patients 
were recruited on day 4.8 of illness (SD±0.55) with 44 receiving 40mg 
daily rupatadine, 44 receiving 10mg daily rupatadine and 44 receiving 
placebo. Both rupatadine 10mg and 40mg were found to be safe and did 
not cause any increase in adverse effects when compared to the placebo. 
The proportion of individuals who developed either pleural effusions or 
ascites (22.7%), were similar in all 3 arms. None of the patients given 
rupatadine 40mg developed bleeding manifestations, while 2 (4.5%) 
in the 10mg and 5 (11.4%) in the placebo arms developed significant 
bleeding manifestations. None of the patients in the rupatadine 40mg arm 
developed organ dysfunction, while 1 (2.3%) patient in 10mg arm and 
3 patients (6.8%), in the placebo arm developed liver dysfunction. Those 
given rupatadine 40mg daily had less reduction in the platelet counts 
and less elevation of liver transaminases when compared to the 10mg 
rupatadine and the placebo arm. Rupatadine appears to be safe in patients 
with acute dengue infection. Although rupatadine did not reduce the 
proportion of individuals who develop fluid leakage when given on day 
4-5 of illness, it appears to reduce complications associated with dengue. 
However, it will be important to confirm these findings in larger studies.
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COMPARISON BETWEEN DENGUE AND CHIKUNGUNYA BY 
CBC AT THE HOSPITAL OF THE NO. 2 POLICE OF THE CITY OF 
GUAYAQUIL PERIOD 2015
Diego A. Vasquez
Universidad Católica de Santiago de Guayquil, Guayaquil, Ecuador
Introduction Dengue and chikungunya are similar in their classical forms 
of clinical presentation, especially present as febrile syndrome and in areas 
where both viruses can circulate simultaneously confused clinically and 
even coexist in the same patient, also transmitted by the same vector. It is 
important to reach a differential diagnosis in patients with febrile illness 
as dengue carries a worse prognosis. Objectives This study aims to define 
and compare the clinical and laboratory associated with each condition 
in a hospital population who came to the hospital for febrile syndrome 
Police features N.2 Methodology  A retrospective cross-sectional study. 150 
patients were compared to positive 150 Chikungunya IgM positive patients 
Dengue IgM. Laboratory variables were extracted through medical records 
of patients and laboratory records Health Center, then compared by 
measuring association adjusted odds ratio obtained by logistic regression. 
Software used STATA version 14.1 for Mac. results The parameters of 
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the blood count which most were associated with Chikungunya were 
leukopenia with an OR 3.5 CI (1.63-7.47) p = <0.000, OR 7.14 IC low 
Hemoglobin (1.71-29.85) p = <0.000. however not decreased hematocrit 
IC OR 0.58 (0.27-1.23) p = 0.15 and OR 1.05 plaquetopenia IC (0.41-
2.65) p = 0.9 In the case of Dengue low hematocrit OR 1.71 CI (0.8-3.63) 
p = 0.15, OR 0.13 low hemoglobin IC (from 0.03 to 0.58) p = 0.016, OR 
0.94 plaquetopenia IC (0.37-2.38) p = 0.9, leucopenia OR IC 0.28 (0.13 
to 0.61) p = <0.000. In the distribution by age was evident that CHIKV 
only present in the 80 years Dengue change in the most affected range 
was 20-40 years but was not significant p = 0.38 GPT transaminase 
CHIKV presents an OR 0.26 IC (0.05-1.22) p = 0.06, OR 3.84 Dengue the 
IC (0.81-18.05) in the case of GOT in CHIKV OR 0.47 IC (0.10-2.20) p 
Dengue = 0.33 and OR 2.10 IC (0.45-9.79) p = 0.23 Discussion We found 
a clear distribution of laboratory values  that associate low hemoglobin 
disorders and leukopenia with Chikungunya, the platelet count and 
hematocrit was indistinct between the two diseases. T.
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A CLINICAL GRADING AND DECISION SUPPORT SYSTEM 
FOR DENGUE VIRAL INFECTION AND ACCOMPANYING 
COMORBIDITIES USING SYNDROMIC SURVEILLANCE IN THE 
HOSPITAL SETTING
Thomas C. Tsai1, Marie Y. Wu1, Jui-Hung Kao2, Shu-Chuan Hsu3, 
Chih-Hen Chung3, Chia-Chi Ku4, Chwan-Chuen King5
1National Taiwan University College of Medicine, Taipei City, Taiwan, 
2National Taiwan University Hospital, Taipei City, Taiwan, 3Kuo General 
Hospital, Tainan City, Taiwan, 4National Taiwan University College of 
Medicine, Institute of Immunology, Taipei City, Taiwan, 5National Taiwan 
University College of Public Health, Institute of Epidemiology and 
Preventive Medicine, Taipei City, Taiwan
Dengue fever has increased its geographical spread across non-endemic 
areas. Therefore, timely surveillance and clinical decision-making before, 
during, and after outbreaks of dengue are highly important to controlling 
epidemics. While dengue has not been endemic to Taiwan, outbreaks have 
occurred annually in southern Taiwan for the vast majority of the past two 
decades. Therefore, Taiwan’s health authorities have employed a system of 
both passive surveillance and serological surveillance for the detection of 
dengue. However, as detection of early cases may prove to be challenging 
using current methods, a more sophisticated form of is preferable for the 
early detection of cases of dengue, especially as Taiwan’s case population 
is one of the oldest in the world and complicated with multiple co-
morbidities such as diabetes and cardiovascular, renal, and liver disease. 
Extending previous studies from this group, this study attempts to establish 
a clinical grading and decision support system based around a concept of 
syndromic surveillance, drawing from a hospital database of confirmed 
cases of dengue in southern Taiwan and its complete set of electronic 
health record information to determine the significance and contribution 
of accompanying co-morbidities on the clinical presentations of dengue 
infections. The resultant data provide helpful insight into the formulation 
of clinical guidelines for early detection and management of dengue 
infection, particularly for severe, complicated cases in adults. Syndromic 
surveillance in an area non-endemic for dengue such as Taiwan may also 
prove applicable for other non-endemic nations also under the threat of 
dengue fever outbreaks.
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INVESTIGATING DENGUE VIRUS INFECTION AS A CAUSE OF 
FEVER IN KENYAN CHILDREN
Ana L. Eyherabide
Sanatorio de Niños, Rosario, Santa Fe, Argentina
Dengue virus (DENV) is endemic in more than 100 countries around the 
world and causes 400 million infections yearly. 16% of DENV disease is 
predicted to occur in Africa, but due to lack of surveillance, the burden 
of DENV in the Africa remains uncertain. The objective of this study is 
to describe the incidence of DENV infection in febrile children in coastal 
and western Kenya. We are enrolling children presenting with acute 
fever to any of 4 health centers located in Chulaimbo and Obama 
Children’s Hospital in western Kenya, and Msambweni and Ukunda on 
the Kenyan coastal region. To investigate whether DENV causes febrile 
illness in Kenyan children, clinical data and blood samples are collected 
at presentation and at one month follow up and tested for DENV IgG by 
ELISA. Out of 180 paired serum samples tested to date, 1 (0.6%, 95% 
CI 0.01 to 3.1%) male subject aged 2 years old seroconverted from 
Chulaimbo. Based on preliminary results the incidence of DENV infection 
is 56 per 10,000 cases of febrile illness in Kenyan children.Further ongoing 
testing of 1000 paired samples will measure the true incidence of DENV 
infection in this region. These data will be helpful to clinicians since 
dengue symptoms are non-specific and lack of awareness leads to missed 
opportunities for community education and vector control and prevention. 
Without further investigation, our knowledge of the real impact of DENV 
in the region is severely limited.
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A HUMANIZED MOUSE MODEL FOR STUDYING HUMAN 
IMMUNOLOGY AND PATHOGENESIS OF DENGUE VIRUS 
INFECTION
Peifang Sun, Lauren Geary, Nishith Nagabhushana, Zhaodong 
Liang, Shuenn-Jue Wu, Joel Sklar, Nimfa Teneza-Mora, Maya 
Williams, Sofia Casares, Brian Morrison
Naval Medical Research Center, USN, Silver Spring, MD, United States
The limitation in our current understanding of dengue disease 
pathogenesis may be attributed to the lack of an ideal animal model. 
To address this, we have utilized a mouse strain, DRAGA, that is 
immunocompromised and transgenically expresses Human Lymphocyte 
Antigen (HLA) molecules. We hypothesize that these mice are capable 
of sustaining dengue virus (DENV) infection and will generate a human 
immune response to DENV. We conducted experiments to determine 
if DRAGA mice can support DENV replication, sustain DENV infection, 
develop clinical signs of disease, and produce a humoral and cellular 
immune response to DENV. Mice were injected subcutaneously in the 
right flank with 1x106 pfu of DENV-1 Western Pacific 74, and monitored 
for several weeks for clinical signs (clinical score, temperature, weight 
loss). Blood was sampled at various time points for viremia determination 
by a CDC DENV-1 RT-PCR assay. Measurements of anti-dengue antibody 
titers (IgM and IgG) in serum samples were done at various time points 
using two-fold serial dilutions of sera in an in-house ELISA. Cell mediated 
immune responses in spleens of humanized mice was measured by IFN-γ 
ELISPOT assay at the time of euthanasia, and organs were harvested for 
detection of virus. Mice demonstrated relevant clinical symptoms. Clinical 
scores (including rashes, hunching posture, lack of movement) increased 
for all five mice resulting in all five mice being euthanized before day 80. 
Kaplan-Meir results indicate a difference in outcome for infected mice 
compared to controls (P=0.0011, Log-Rank Test). Viremia was detected 
in all mice. At the time of euthanasia one mouse demonstrated a strong 
cellular immune response to DENV non-structural 1 glycoprotein by 
ELISPOT following stimulation by peptide pools (P=0.0013, Unpaired t 
test). No other cellular immune response was observed. This mouse also 
demonstrated an IgM humoral immune response. This model has the 
potential to represent a powerful small animal model for the preclinical 
testing of experimental vaccines and become a critical capability for 
advancing candidate dengue vaccines to human trials.
36
astmh.org
106
EVALUATING INTERNET-BASED COMMUNICABLE DISEASE 
BIOSURVEILLANCE METHODS FOR VECTOR BORNE 
DISEASES: A SYSTEMATIC REVIEW AND META-ANALYSIS
Simon Pollett, Peter Bacchetti, Henry F. Chambers, George W. 
Rutherford
University of California, San Francisco, San Francisco, CA, United States
Internet-based vector-borne disease (VBD) surveillance methods using ‘big 
data’ sources such as Google and Twitter have recently been developed. 
These methods may offer complementary real-time VBD surveillance, 
but appraisal of their performance and validity is essential for their 
improvement and possible implementation. We performed a systematic 
review and meta-analysis to assess the performance of VBD internet-based 
surveillance methods and the quality of evidence supporting them. We 
included studies that predicted population-level VBD activity with search-
engine, social media and other forms of internet data and that were 
validated against a reference source of public health data. We searched 
MEDLINE, EMBASE and Web of Science databases in addition to reviewing 
bibliographies. Study quality was assessed using a framework covering 
documentation, analysis reproducibility and external validation. Studies 
measuring performance by correlation between internet-predicted and 
reported VBD trends underwent meta-analysis, weighted by effective 
sample size. Subanalyses were performed to explore heterogeneity. 
Of 2476 non-duplicate studies, 14 met eligibility criteria, of which 11 
examined dengue, and the remainder malaria, leishmaniasis, Lyme disease 
or other arboviruses. Two completely satisfied quality criteria across 
all domains and six underwent external validation. Ten were included 
in the meta-analysis, yielding a summary correlation r = 0.69 (95% CI 
0.67 - 0.70) with large heterogeneity between subgroups of pathogens, 
internet data type and disease endemicity. Internet-based VBD prediction 
performed best for malaria (r = 0.92) and dengue (r = 0.73); and with data 
derived from Wikipedia (r = 0.89) and Twitter (r = 0.70). Internet-based 
surveillance is overall moderately accurate for detecting trends in VBD 
yet may perform better for certain pathogens, internet-data sources and 
disease burdens. Variable study quality warrants further rigorous study in 
this field.
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COMPLEMENTARY USE OF CRYO-ELECTRON MICROSCOPY 
AND MASS SPECTROMETRY TO ASSESS THE MATURITY OF 
SANOFI PASTEUR DENGUE VACCINE VIRUSES
Mathieu Trauchessec1, Pierre Bonnafous2, Olivier Lambert3, Yves 
Berard4, Fabienne Barrière4, Céline Huillet4, Devika Sirohi5, Richard 
Kuhn5, Bruno Guy4, Frederic Ronzon4, Catherine Manin4
1Commissariat à l’énergie atomique, Grenoble, France, 2University of 
Bordeaux ARNA, Pessac, France, 3University of Bordeaux CBMN, Pessac, 
France, 4Sanofi Pasteur, Marcy l’étoile, France, 5Purdue University, West 
Lafayette, IN, United States
The Sanofi Pasteur dengue vaccine demonstrated significant efficacy in 
phase III studies and is now licensed in several countries. The vaccine is 
composed of four recombinant, live, attenuated viruses based on a yellow 
fever 17D vaccine backbone, each expressing the pre-membrane (prM) 
and envelope (E) genes of one of the four dengue virus serotypes. Dengue 
is a flavivirus, which are small, enveloped, icosahedral, positive-single 
strand RNA viruses. The glycoprotein shell consists in 180 copies each of 
an envelope (E) and membrane proteins (prM/M, prM being M precursor). 
In immature particles, 60 trimeric spikes extend from the particle surface, 
each of them consisting of 3 prM:E heterodimers, conferring the “spiky” 
morphology to the virion as observed by cryo-electron microscopy. 
Maturation process occurs during transport through the Trans-Golgi 
where E undergoes conformational changes triggered by low pH, after 
which prM is eventually cleaved by furin, a host protease. The final 
mature particle presents 90 E homodimers on its surface and usually 
presents a “smooth” morphology, while it may also present a “bumpy” 
structure depending on the temperature and serotype. Maturity plays a 
critical role in dengue virus infectivity but it remains unclear if it is linked 
to some extent to immunogenicity and eventually protection triggered 
by vaccine viruses. To first address this question at the protein level, we 
have developed a mass spectrometry based method (LC-MS) to quantify 
specifically prM, pr and M proteins and estimate the mean maturity of 
the 4 vaccine viruses that were part of clinical phase III studies. Virus 
maturity was also analyzed by cryo-electron microscopy at the particle 
level. Percentage of spiky (immature), smooth/bumpy (mature) and mixed 
(partially mature) viral particles were determined. Results from these two 
orthogonal methods were in good agreement and showed a significant 
maturity for all batches and serotypes used in Phase III studies. In this 
regard, it does not appear that differences in serotype-specific efficacy 
observed in these trials could be linked to differences in maturity for the 
corresponding serotypes.
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A STATISTICAL APPROACH TO ESTIMATE DENGUE VIRUS 
INFECTION HISTORIES, INCLUDING BROADER CRITERIA FOR 
INAPPARENT INFECTIONS
Leah C. Katzelnick1, Angel Balmaseda2, Eva Harris1
1Division of Infectious Diseases and Vaccinology, School of Public Health, 
University of California, Berkeley, Berkeley, CA, United States, 2Laboratorio 
Nacional de Virología, Centro Nacional de Diagóstico y Referencia, Ministry 
of Health, Managua, Nicaragua
The four dengue viruses (DENV1-4) cause 100 million symptomatic dengue 
cases and an estimated 300 million inapparent infections each year. We 
explored current assumptions used to identify inapparent infections and 
describe a statistical approach to create probabilistic infection histories for 
children in the Nicaraguan Pediatric Dengue Cohort Study (PDCS), ongoing 
since 2004. Inapparent infections were identified by a ≥4-fold increase 
in antibody titers as measured with the Inhibition ELISA (IE) between 
annual samples. Controlling for year, we found that the proportion 
of children with symptomatic or inapparent infections decreased with 
higher pre-infection IE titers. Further, there was a significant inverse 
relationship between pre-infection IE titer and the magnitude of IE titer 
increases the following year. These observations suggest that children 
with high pre-infection IE titers may control infection without observable 
disease or large increases in IE titer, making them an important group 
for studying protection. We also observed that the number of boosts 
(≥2-fold increases in IE titer) correlated with epidemic cycles: the largest 
proportion of children had boosts before or after the year with the highest 
DENV incidence, with the lowest proportion of boosts observed in years of 
transition in epidemic dominance of one DENV type to another. Consistent 
with this observation, children with symptomatic infections were more 
likely to have an increase in IE titer the next year if that year had high 
incidence of symptomatic dengue, even if the dominant circulating DENV 
type matched their previous infecting type. Based on these observations, 
we are estimating probabilistic infection histories for all children in the 
PDCS with a Bayesian approach that accounts for infections that cause <4-
fold IE titer increases as well homologous reinfection. From this model, we 
estimate the infection probability per child per year and repeatedly sample 
the cohort with these probabilities to create DENV infection histories. We 
then use these infection histories to test for determinants of protection 
against symptomatic dengue and severe disease.
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SUSCEPTIBILITY OF NEOTROPICAL PRIMARY BAT CELL LINES 
TO DENGUE INFECTION
Andrés Moreira-Soto, Claudio Soto-Garita, Eugenia Corrales-
Aguilar
Virology-CIET University of Costa Rica, San Pedro, Costa Rica
Dengue Virus is the most widespread arboviral disease that affects 
humans worldwide. Bats have been identified as carriers of emerging viral 
zoonoses and proposed as possible Dengue reservoirs, since viral RNA/NS1 
and/or antiviral antibodies have been detected. Yet, Dengue experimental 
inoculation of Artibeus bat species failed to show dengue replication. 
Also, a putative organ for virus replication in bats is still not identified. 
Therefore for testing in vitro susceptibility of bat cells for dengue infection, 
we established primary bat embryonic cells from diverse organs of three 
different bat species (Artibeus jamaicensis, Molossus sinaloae, and 
Desmodus rotundus). We observe a serotype-, organ-, and bat species- 
specific dengue susceptibility of infection, though virus replication in 
all cases is limited. Only Molossus-derived fibroblasts, kidney, liver, and 
intestine cells sustained poor dengue serotype 1 replication, though at 
96 hpi replication is controlled by bat-specific mediators. Dengue does 
not replicate efficiently in cell lines derived from the other bat species. 
Therefore, Artibeus and Desmodus bats may unlikely serve as dengue 
reservoirs. Nevertheless, to elucidate if Molossus bats play a role in dengue 
replication, ecological or in vivo experiments must be performed, however 
with an appropriate dengue serotype.
110
EFFECTS OF COMMUNITY STRUCTURES AND 
ENVIRONMENTAL HETEROGENEITIES ON THE SPREAD AND 
PERSISTENCE OF DENGUE
Warren S. Tennant, Mario Recker
University of Exeter, Penryn, United Kingdom
Dengue, a multi-strain vector-borne tropical disease, presents a substantial 
and increasing burden on global public health. The interactions between 
the virus, its mosquito vectors and the human host are complex and 
only partially understood. Immune competition between dengue’s 
four antigenically related serotypes (DENV1-4) together with the 
dependencies of vector ecologies on environmental attributes, such 
as temperature, rainfall, and host density, introduce strong spatio-
temporal heterogeneities, resulting in irregular epidemic outbreaks 
and asynchronous oscillations in serotype prevalence. Local and global 
human movement have been implicated as important drivers of dengue 
epidemiology across space and time and further create the conditions 
for the geographic expansion of dengue into new habitats. However, the 
effects of demographic and ecological structures on dengue epidemiology 
have not yet been explored in detail. To this end, we constructed a 
stochastic individual-based transmission model that explicitly includes 
spatio-temporal heterogeneities in host and vector population sizes and 
further incorporates complex community structures and connectivities 
between sub-populations. The model’s more realistic meta-population 
formulation allows for the exploration of the effects of environmental 
heterogeneities on dengue incidence, in addition to the identification of 
critical community size and connectivity necessary for the emergence and 
spread of dengue virus. Our results will thus help to better understand the 
spatio-temporal epidemiology of dengue and assess the risks of further 
geographic expansion.
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DEVELOPMENT OF ANTIBODY-DEPENDENT CELLULAR 
CYTOTOXICITY ASSAYS FOR DENGUE VIRUS
Nishith Nagabhushana1, Jeffrey Currier2, Zhaodong Liang1, 
Jessica Roman1, Maya Williams1, Peifang Sun1, Brian J. Morrison1
1Naval Medical Research Center, Silver Spring, MD, United States, 2Walter 
Reed Army Institute of Research, Silver Spring, MD, United States
Dengue virus (DENV) infection affects US military personnel deployed 
to endemic areas. DENV infection leads to a number of host immune 
responses, one of which is antibody-dependent cell-mediated cytotoxicity 
(ADCC). The aim of this study is to develop and standardize assays to 
assess serum ADCC activity. We first examined the percentage of antigen 
opsonization and level of natural killer (NK) cell degranulation using CEM-
NKR-DC-SIGN cells as targets and normal human PBMCs as effectors. 
CEM-NKR-DC-SIGN cells were infected with DENV for 3 and 24-hours. 
The infected cells were treated with a dengue immune and a control 
naïve serum at five-fold dilutions and then with a secondary antibody, 
PE-labelled goat anti-human IgG Fc. The opsonization assessment 
indicated similar levels of DENV Ag expression on the surface of target 
cells at both 3- and 24-hours. The degranulation experiment was done 
by co-incubating the effectors and the opsonized targets for 2 hours and 
consequently staining the cultures with an antibody cocktail (APC-CD56, 
PerCP-CD3, FITC-CD107a, and PE-CD16). The expression of CD107a 
on CD3-CD56+ suggested a significant increase in degranulation of NK 
cells against target cells infected for 24-hours but not 3 hours for all four 
serotypes. This could be due to possible increase in expression of different 
viral antigens on the cell surface at 24-hour. Additionally, cells infected 
by DENV for 24 hours may express certain stress factors and certain NK 
cell activation ligands which could potentially increase functional activity 
of NK cells. ADCC is a mechanism that leads to lysis of infected cells; 
therefore it is important for viremia control during an infection. Hence we 
are working towards developing a non-radioactive lysis assay and further 
standardizing these assays for future application for clinical research and 
vaccine development.
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SEROCONVERSION TO DENGUE AND CHIKUNGUNYA IN 
IMMUNOLOGICALLY NAÏVE ADULTS IN ST. KITTS
Inaki Deza-Cruz1, Aileen Mill2, Steven Rushton2, Patrick Kelly1
1Ross University, Basseterre, Saint Kitts and Nevis, 2Newcastle University, 
Newcastle-upon-Tyne, United Kingdom
Ross University School of Veterinary Medicine (RUSVM) is located on St. 
Kitts and Nevis, a popular tourist destination in the Lesser Antilles in the 
Caribbean. Dengue and chikungunya are endemic on St Kitts and students 
attending RUSVM for their 2 ½ years of study principally come from areas 
where these diseases are not present. Studying the rates of exposure of 
the students to the viruses and the risk factors involved would provide 
valuable epidemiological data for students and tourists visiting areas where 
dengue and chikungunya are endemic. The aim of the prospective study 
is to determine the survival time and risk factors in naïve adults visiting 
an endemic area. Student volunteers attending RUSVM at one of the 
three intakes between September 2014 and May 2015 were recruited for 
the study. Whole blood was collected from consenting volunteers when 
they enrolled in the study and every 4 months subsequently. Plasma was 
separated and tested with a DENV IgM and IgG antibody capture ELISA 
developed at the Centers for Disease Control and Anti-Chikungunya Virus 
ELISA IgM test and Anti-Chikungunya Virus ELISA IgG test - (Euroimmun, 
Lübeck, Germany). Plaque reduction neutralization (PRNT) following 
standard methods is also being performed to confirm the dengue serology 
results. A total of 161 of the 218 volunteers were sampled within 4 weeks 
of arrival to the island with 76 (47%) already showing IgG antibodies to 
dengue virus at titers of 2 or higher. Of these, 27 reported they had not 
previously visited any dengue endemic areas which would indicate that 
seroconversion may have occurred very shortly after arrival on St Kitts. In 
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the subsequent testing of the students we found 21 (10%) seroconverted 
against dengue virus with an average time to seroconversion of 24 weeks. 
The rate of seroconversion between sampling periods was 1.35 per 10 
individuals. One student (1%) seroconverted against chikungunya within 
2 weeks of arrival while another 4 (2%) seroconverted subsequently with 
an average time to seroconversion of 25 weeks. None of the seropositive 
students reported classical signs of dengue or chikungunya. (The 
confirmatory PRNT results for dengue are pending).
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FLUORESCENTLY LABELED FLAVIVIRUSES TO TRACK 
ANTIGEN-SPECIFIC B CELLS
Anuja Mathew1, Marcia Woda1, Heather Friberg2, Jeffrey Currier2, 
Sharone Green3, Anon Srikiatkhachorn3, Louis Macareo4, Richard 
Jarman2, Alan Rothman1
1University of Rhode Island, Providence, RI, United States, 2Walter Reed 
Army Institute of Research, Silver Spring, MD, United States, 3University 
of Massachusetts, Worcester, MA, United States, 4Armed Forces Research 
Institute of Medical Sciences, Bangkok, Thailand
We recently developed alexa fluor labeled dengue viruses (AF DENV) to 
evaluate frequencies of antigen-specific memory B cells in the peripheral 
blood of immune individuals. We used two serotypes of AF DENV together 
on PBMC from children in Thailand undergoing acute primary or secondary 
DENV-1 infections to determine whether patterns emerged on antigen-
specific B cells that reflected their exposure or clinical diagnosis. Brightly 
labeled AF DENV serotype specific and cross-reactive B cells were identified 
in PBMC from all subjects. Frequencies of AF-DENV+ class switched 
memory B cells (IgD-CD27+ CD19+ cells) reached up to 8% during acute 
infection and early convalescence. In a number of subjects, AF DENV 
labeled B cells expressed high levels of CD27 and CD38 during acute 
infection, characteristic of plasmablasts, and transitioned into memory B 
cells (CD38-CD27+) at the early convalescent time point. Our analysis of 
total B cells and AF DENV+ B cells revealed higher activation of memory B 
cells early during acute secondary infection suggesting reactivation from 
a previous dengue infection. AF DENV are useful reagents to identify 
differences in the phenotype of subsets of antigen-specific and cross-
reactive B cells during and after natural dengue infection and vaccination.
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A CASE OF DENGUE ENCEPHALITIS CAUSED BY DENV-4
Deborah Ng, Sapna P. Sadarangani
Tan Tock Seng Hospital, Singapore, Singapore
We describe a case of dengue encephalitis in a primary dengue infection 
caused by DENV-4. A 62 year old Chinese woman, previously well, 
presented with a four-day history of fever, headache, postural giddiness, 
vomiting and exertional dyspnoea. She had not travelled out of Singapore. 
Clinical evaluation on admission (day 4 of illness) revealed temperature 
of 38.2oC, blood pressure 140/80 mmHg, pulse rate 92/min, physical 
examination was otherwise unremarkable. Total white cell count was 
1.9 x 109/L (neutrophils 1.2 x109/L), haemoglobin 13 g/dL, haematocrit 
39.5%, platelet count 106 x 109/L, ALT 218 u/L and AST 155u/L. Renal 
function was normal. Dengue NS1 antigen was positive, dengue IgM 
and IgG were negative. Chest radiograph was normal. She developed 
confusion and expressive aphasia on day 6 of illness. Neurological exam 
was unremarkable with no focal deficit. Blood cultures were negative and 
there was no pyuria. Cerebrospinal fluid (CSF) analysis revealed a cell count 
of 62 cells/uL (97% lymphocytes), red cell count 9 cells/uL, protein 2.33 g/L 
and glucose 3.5 mmol/L (serum glucose 5.9 mmol/L). CSF bacterial culture, 
antibody (measles, mumps), and polymerase chain reaction (PCR) for CMV, 
HSV, VZV, Toxoplasma, Enterovirus were negative. Magnetic resonance 
imaging of the brain was normal. CSF dengue PCR was negative but 
IgM and IgG were positive. Serum dengue PCR was positive for DENV-4. 
She was treated with intravenous acyclovir till PCR results were available, 
and made a complete recovery at day 11 of illness. The proposed case 
definition for dengue encephalitis includes (1) fever, (2) acute cerebral 
involvement, (3) positive dengue IgM or PCR on serum and/or CSF, and 
(4) exclusion of other causes of viral encephalitis, encephalopathy as 
demonstrated in our patient. Prior case series of dengue encephalitis have 
been associated most commonly with DENV-2, DENV-3 and occasionally 
with DENV-1. ,3 Although DENV-4 has been reported to potentially cause 
encephalitis, those cases were fatal with multi-organ involvement and 
dengue haemorrhagic fever , . This is the first known case of DENV-4 
encephalitis with complete recovery.
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PROFILING ANTIBODY RESPONSES TO DENGUE NS1 IN 
VACCINE STUDIES AND NATURAL HUMAN INFECTIONS 
USING PEPTIDE MICROARRAYS
P. Robert Beatty1, Tomer Hertz2, Zachary MacMillen2, Sarah 
Killingbeck1, Eva Harris1
1Division of Infectious Diseases and Vaccinology, School of Public Health, 
University of California Berkeley, Berkeley, CA, United States, 2Vaccine 
and Infectious Disease Division, Fred Hutchinson Cancer Research Center, 
Seattle, WA, United States
A major challenge in dengue vaccine development is that cross-
reactive anti-dengue virus (DENV) antibodies can be protective or 
potentially enhance disease via antibody-dependent enhancement. 
DENV nonstructural protein 1 (NS1) has long been considered a vaccine 
candidate, and we have shown that NS1 from all 4 DENV serotypes 
protects against challenge in a mouse model of lethal vascular leak 
syndrome. Conversely, we found that DENV NS1 by itself triggers 
vascular leak in vivo and in vitro and increases disease severity during 
infection. Here, we evaluated survival to challenge in the lethal DENV 
vascular leak model in mice immunized with NS1 combined with alum, 
Monophosphoryl Lipid A (MPLA) + AddaVax, or Sigma adjuvant system 
(SAS) + CpG DNA. We characterized antibody responses to NS1 using 
a microarray with 20-mer peptides (overlapping by 15 amino acids [aa]) 
from prM, E, and NS1 of DENV-1, -2 and -3. We compared these antibody 
profiles to those of mice immunized with ovalbumin (OVA) plus adjuvant 
and mice infected with a sublethal dose of DENV2. Mice immunized 
with OVA or NS1+alum were not protected, whereas immunization with 
NS1+MPLA/Addavax or NS1+SAS/CpG or prior infection with DENV2 
resulted in 100% survival but exhibited distinct antibody responses to NS1 
peptides. We identified two DENV-2 NS1 peptides (D345 and D347) that 
were recognized strongly by NS1+MPLA/Addavax-immunized mice and 
DENV-infected mice; analogous peptides in DENV-1 and -3 were similarly 
recognized. In addition, immunization with NS1+MPLA/AddaVax induced 
antibodies specific NS1 epitopes that were not observed following DENV2 
infection (e.g, D356). In parallel, we found that human sera from natural 
DENV infections reacted to the same D345 and D347 peptides but did not 
react to D356. We mapped these epitopes onto the NS1 crystal structure 
and found that D345 and D347 mapped to aa 101-130 in a surface-
exposed flexible loop in the wing domain. D356 (aa 156-174) is in the 
putative membrane-binding “greasy-finger” region of NS1. These data 
identify antibody responses to NS1 vaccination that target specific epitopes 
and may help prevent NS1-mediated pathogenesis.
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POLYCLONAL ANTIBODY RESPONSES TO SEROTYPE-SPECIFIC 
NEUTRALIZING EPITOPES IN NATURAL DENGUE VIRUS 
INFECTIONS
Daniela V. Andrade1, Douglas G. Widman2, Aravinda M. de 
Silva3, Ralph S. Baric2, Eva Harris1
1Division of Infectious Diseases and Vaccinology, School of Public Health, 
University of California Berkeley, Berkeley, CA, United States, 2Department 
of Epidemiology, University of North Carolina School of Public Health, 
Chapel Hill, NC, United States, 3Department of Microbiology and 
Immunology, School of Medicine, University of North Carolina, Chapel Hill, 
NC, United States
The development of an effective and safe dengue vaccine relies on 
identification of neutralizing epitopes from all four dengue virus (DENV) 
serotypes. Strongly neutralizing DENV serotype-specific human monoclonal 
antibodies (hmAbs) target quaternary epitopes spanning multiple E protein 
monomers and are only preserved in intact virions. Among hmAbs with 
these properties is 5J7, which is a DENV3 serotype-specific hmAb. Given 
the potential role of the 5J7 epitope as a determinant of the DENV3 type-
specific neutralizing response, we previously created a partial functional 
transfer of the DENV3 5J7 epitope into a DENV4 background. The 
recombinant virus, rDENV4/3, is neutralized by human DENV3-immune 
sera, indicating the functionality of this epitope. Here, our study aims to 
explore the recognition of the hmAb 5J7 epitope in the epidemiological 
context of an endemic setting. Specifically, we are assessing the proportion 
of 5J7 epitope-specific neutralizing antibodies following primary DENV3 
infection and determining the kinetics and magnitude of the response 
over time. We first analyzed primary DENV3 sera from 24 individuals 
enrolled in a longitudinal dengue hospital-based study in Nicaragua, which 
allowed us to track the proportion of the DENV3 type-specific neutralizing 
response attributable to the 5J7 epitope at two time-points post-infection 
(3 and 18 months). The neutralizing titers (NT50) to the rDENV4/3 virus 
and its parental viruses (DENV3 and DENV4) were obtained via a flow 
cytometry-based neutralization assay using human U937-DC-SIGN cells. 
We also measured the cross-reactive DENV4-directed antibody responses 
that recognize the rDENV4/3 virus at 3 and 18 months post-infection. 
Further studies will evaluate how the DENV3 type-specific neutralization 
tracks with the 5J7 epitope using samples from our Nicaraguan cohort 
study over multiple years and following second and third DENV infections. 
Overall, this project contributes to increased understanding of the antibody 
response in natural DENV infections and has direct implication for design 
and evaluation of dengue vaccine candidates.
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Dengue fever (DF) is the most important arbovirus infection in the world. 
Our busy hospital emergency room (ER) located in an endemic DF region 
in Brazil has been facing large DF outbreaks every year. In 2016, a new 
virus (Zika) was introduced to our region. We described how we dealt with 
both epidemics in the setting of not having Zika serology and reserving 
Zika RT- PCR for pregnant women (PW). The patient care flow was based 
upon in the Lean Methodology that has a focus in process improvement 
with the identification and elimination of everything that does not add 
value. We followed the Brazilian Health Ministry Guidelines for dengue 
care; the focus was prompt detection of alarm signs, vigorous endovenous 
hydration for high hematocrit and low platelet count, oral hydration for 
every patient at the ER and daily or every other day returns based upon the 
patient risk to develop severe DF. We established a flow for PW presenting 
with a rash and/or suspected DF (SDF); they would have daily returns, 
samples would be sent to Zika RT- PCR testing and dengue testing, and 
after disease resolution, they would be followed at a high-risk pregnancy 
clinic (HRPC). From January 1 to April 10, 2016, the total # of SDF patients 
was 29, 841, 43% of the total # of ER patients (69,777); the peak of SDF 
patients was seen on February (12,668). Only 101 patients (0.34%) of 
SDF were admitted to the hospital; there was one death of a woman with 
adrenal insufficiency. Eight hundred thirty seven NS1 tests were done, with 
120 (14%) positive. One hundred twenty six PW presented to the ER with 
rash and/or SDF; six were NS1positive, 23 with DF IgM; 22 (17% of total) 
had Zika RT-PCR results released by the State Reference Laboratory for Zika 
(13 positive and 9 negative). There were two spontaneous abortions in 
both groups; 91 women (72%) are still seen at the HRPC with no report of 
microcephaly so far. DF disrupts ER routines in our region; it is possible that 
many SDF patients had in fact Zika but because tests were not available 
except for PW, all were treated as SDF. Health services in our region need 
to be prepared to endure dengue and Zika epidemics in the next years.
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Dengue is a major public health problem in Venezuela. Timely health 
centre (HC) attendance is crucial in reducing mortality and severity of 
dengue. The health care system in Venezuela comprises a public and 
a private sector. The public system includes the traditional primary/
secondary (Ambulatorios), and tertiary level HCs (Hospitals) and is 
usually free of charge. To improve limited access to care for the poorer, a 
parallel public health care system (“Mission Barrio Adentro”) was set up 
in 2003. We assessed the intended HC attendance in the case of fever 
and suspected dengue in an urban area of high dengue transmission. 
Between September 2013 and February 2014 a crosssectional household 
survey was performed in Maracay, Venezuela. Intended HC attendance 
and the perceived barriers in the case of fever and dengue of adults and 
parents/guardians of children were assessed. Data was collected through 
structured questionnaires from 105 individuals. We show that people 
would visit several different HCs if needed, and that the health preferences 
differed throughout the community. The most frequent first choice of 
health centre was an Ambulatorio, in the case of fever (n=82; 78.8%) 
and dengue (n=84; 80.8%). Several economic, ethnic, logistic, and quality 
aspects influenced the preference to access the HCs. Individuals preferred 
to first attend traditional HCs as they trusted the care given at these 
institutions, but a barrier was the lack of treatment supplies. Although the 
lack of supplies was mentioned to a lesser extent in the case of the parallel 
HCs, people reported not to trust the medical staff, nor the diagnosis and 
treatment given in these HCs. Furthermore, the private care, which was 
considered best, was mainly accessible for those with a health insurance. 
A higher education (fever/dengue: p=0.001/p=0.001) and a nonmanual 
occupation (fever/dengue: p=0.007/p=0.016) were associated with more 
intended private HC attendance. Access to care in Venezuela is currently a 
complex situation where individuals need to juggle between the different 
available public and private HCs in order to obtain proper/timely care and 
medical supplies.
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As of March 2016, the prospective multicentre IDAMS study has enrolled 
7178 out-patients aged ≥ 5 years in 8 countries across Latin America and 
Asia. Participants with non-specific febrile illness are enrolled within 72 
hours of fever onset and followed daily with a common protocol, a key 
objective being to identify simple clinical and/or laboratory parameters 
that distinguish between dengue and other febrile illness (OFI) thus 
leading to an evidence-based case definition. Laboratory diagnosis 
relies on an algorithm including PCR, NS1, and IgM seroconversion, 
all performed following strict protocols. We will analyse clinical and 
laboratory parameters at enrolment as predictors for confirmed dengue by 
multivariable logistic regression and flexible classification algorithms. The 
full analysis will be carried out stratified by age group, day of illness and 
country/ continent, and subsequently pooled if appropriate. To improve 
model prediction we will also include changes between enrolment and 
the following day, thus basing the assessment on two time points. Data is 
currently available on 5078 Asian participants originating from Vietnam, 
Malaysia, Cambodia, Bangladesh and Indonesia, with data from Latin 
America (Brazil, Venezuela, and El Salvador) due to be added after the 
study closes in June 2016. In the preliminary pooled analysis, adjusting 
for age group and day of illness at enrolment, the presence of skin rash 
and skin flush, anorexia, dizziness, diarrhoea and conjunctival injection 
at enrolment was associated with a diagnosis of dengue. The strongest 
association was found for skin bleeding and low platelet count at 
enrolment. The presence of sore throat, cough, and rhinitis was associated 
with OFI. However, more than 20% of patients with these symptoms 
had laboratory confirmed dengue, highlighting the role of dengue in the 
differential diagnosis when upper respiratory tract symptoms are present. 
The findings of the full analysis will be presented and are expected to 
have an important impact on diagnostic algorithms for dengue in settings 
where confirmatory laboratory testing is not possible.
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Antibody-dependent enhancement of infection (ADE) is postulated as one 
factor contributing to dengue severe disease such as dengue haemorrhagic 
fever and dengue shock syndrome (DHF/DSS). Pre-existing antibody against 
heterotypic dengue serotypes binds to the virus but does not neutralize it. 
Thereby, enhancing DENV infection of Fcγ receptor bearing cells increasing 
the number of viral infected cells and the amount of virus produced. DENV 
has routinely showed cross-reactivity in serological assays with Zika virus 
(ZIKV) and co-infections of DENV and ZIKV have been reported. Here we 
report the effect of pre-existing DENV antibody on the ability of three 
different strains of ZIKV (African and Asian genotypes) to infect THP-1 
monocytes cell line. The mean amino acid sequences homology between 
DENV and ZIKV showed 42.9%, 42.5% and 57.0% identical for capsid, 
prM and E regions, respectively. The growth of ZIKV in the presence 
of pre-existing DENV antibody was higher than that in the absence of 
DENV antibody. Immune mediators involved virus infection were also 
investigated. ADE-induced ZIKV infection had higher production of IL-12, a 
pro-inflammatory cytokines than in the absence of DENV antibody. Down-
regulation sensors including RIG-I and MDA-5 are waiting to be elucidated. 
As DENV vaccines have been licensed in endemic areas of both DENV and 
ZIKV, an understanding of the pre-existing DENV antibody effect on other 
flavivirus is necessary.
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SEROLOGICAL DIAGNOSIS OF ZIKV INFECTION
Kanittha Sirikajornpan1, Butsaya Thaisomboonsuk1, Ananda 
Nisalak1, Chonticha Klungthong1, Taweewun Hunsawong1, 
Rawiwan Imerbsin1, In-Kyu Yoon2, Damon W. Ellison1, Alden L. 
Weg1, Louis R. Macareo1
1Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand, 
2Dengue Vaccine Initiative (DVI), International Vaccine (IVI), Seoul, Republic 
of Korea
Laboratory diagnosis of acute Zika virus (ZIKV) infection during the febrile 
phase of illness currently depends on detection of the virus by RT-PCR. 
A specific IgM serological assay for ZIKV has yet to be developed. Here 
we describe the development of a specific anti-ZIKA IgM ELISA for the 
diagnosis of acute ZIKV infections. To develop a specific anti-ZIKA IgM 
antibody to use as a positive control for the assay, the ATCC strain of ZIKV 
was subcutaneously injected into a Rhesus monkey at a dose of 5x106 
PFU. Blood was collected from the monkey daily from 0 to 12 days after 
infection and on days 15 and 30. Viremia was determined by RT-PCR and 
IgM/IgG antibody kinetics was determined by EIA form blood collections. 
The data show ZIKV was detected by PCR on days 1, 2, and 3 with the 
highest peak occurring on day 2. ZIKA specific IgM was detected starting 
on day 6 and continued through day 30 with a peak from days 10 to 15. 
To determine the specificity of the assay we tested known positive cases 
of DENV, JEV and ZIKV to establish the amount of cross-reactivity from 
previous infections. The following samples were used to test the specificity 
of the ZIKA ELISA: 9 cases of primary DENV, 10 cases of secondary DENV 
infection, 10 cases of JEV infection, 3 cases of ZIKV infection and 7 cases 
of negative specimens. The cut off value for the anti-ZIKV IgM/IgG EIA was 
set at ≥40 EIA units. The results showed that primary DENV infection and 
samples testing negative for other flaviviruses tested negative for anti-ZIKA 
IgM. However, 1 out of 10 secondary DENV infections and 2 of 10 JEV 
infections tested positive for ZIKV IgM most likely due to cross-reactive 
antibodies. These data indicate that detection of acute ZIKV infections in 
patients previously exposed to flavivirus could produce false positive results 
under certain conditions but should be useful in detecting ZIKV in patients 
with primary flavivirus infections.
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Arthropod-borne viruses (arboviruses) are known to cause significant 
public health problems throughout the world. Indonesia has been affected 
by the arboviral diseases such as dengue for decades with frequent 
epidemic cycles. In 2015, dengue cases increased significantly in Jambi 
municipality in Sumatra with the number doubled from previous year. To 
understand the dynamic of the disease, we conducted dengue molecular 
study in Jambi. Sera were collected from dengue-suspected patients 
and dengue diagnosis was performed using NS1, IgG/IgM, and RT-PCR 
detection. Of 210 dengue-suspected patients, 107 were confirmed dengue 
based on NS1 and RT-PCR. All four dengue virus (DENV) serotypes were 
detected with DENV-1 as the predominant serotype (66%). To determine 
the disease etiology of the 103 dengue-negative cases, we screened 
the samples using RT-PCR for other viruses which include flavivirus and 
alphavirus families. Among them, we detected eight cases were infected 
by Chikungunya viruses (CHIKV) and one by Zika virus (ZIKV). All viruses 
were successfully isolated and propagated in tissue culture. The clinical 
manifestations of the Chikungunya and Zika patients were mild and 
mimicking dengue symptoms. To determine the genotypes the viruses, we 
sequenced the Envelope, E1, and NS5 genes of DENV, CHIKV, and ZIKV, 
respectively. Phylogenetic analyses revealed the DENV-1 viruses belonged 
to Genotype I, DENV-2 was of Cosmopolitan genotype, DENV-3 as 
Genotype I, and DENV-4 belonged to Genotype II. The CHIKV isolates were 
grouped as Asian genotype, while the ZIKV was classified as Asian lineage. 
Our finding demonstrates the co-circulation of multiple arboviruses during 
dengue outbreak in Indonesia. This co-circulation will likely to contribute 
to a large neglected disease burden and causes misdiagnosis and 
underreporting of these diseases. It is essential that systematic surveillance 
be implemented to evaluate and monitor the distribution these arboviruses 
infections and its potential public health problems in Indonesia.
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Dengue and Zika viruses involve common vectors - Aedes (Ae.) aegypti 
and Ae. albopictus - both widespread in Taiwan. While the epidemics 
of dengue in Kaohsiung and Tainan in 2015 have been the largest and 
most severe, one imported Zika case from Thailand was detected in 
January 2016, indicating that future public health threat of Zika virus 
can’t be ignored. Epidemiology of dengue in Taiwan involves three types: 
(1) sporadic cases in Taipei where only Ae. albopictus are present, (2) an 
epidemic type in Tainan with a lower ratio of Ae. aegypti /Ae. albopictus, 
and (3) DENV-endemicity in Kaohsiung with higher ratio of Ae. aegypti/
Ae. albopictus. The specific aims of this study were: (1) to compare 
epidemiology of dengue in Taipei, Tainan, and Kaohsiung, (2) to investigate 
the impact of daily meteorological factors on mosquito populations and 
dengue cases, and (3) to address recommendations for prevention and 
control measures. Among 43,784 total laboratory-confirmed dengue 
cases in 2015, 43,419 were indigenous cases (99.16%). Most of them 
were in Tainan (22,777 cases, 52.4%) [predominantly dengue serotype 
2 virus (DENV-2)] and Kaohsiung (19,784 cases, 45.6%) [predominantly 
DENV-1 in the beginning but subsequently turning to DENV-2]. Taipei had 
128 confirmed cases, in which 70 were indigenous DENV-2 cases (0.2% 
of total in Taiwan), with 21 cases from Kaohsiung, and 46 cases from 
Tainan. About one month after typhoon Soudelor hit, dengue cases of 
DENV-2 peaked in Tainan, while Kaohsiung still had mostly DENV-1 cases. 
Interestingly, after the 3-month window period of cross-protection of 
different serotypes, DENV-2 cases started to climb and peaked about one 
month after typhoon Dujuan. Taipei, however, with Ae. albopictus only, 
was least impacted by the typhoon. In conclusion, Ae. aegypti plays the 
most crucial role in dengue transmission, so reducing the population of 
Ae. aegypti is the key element in preventing dengue and Zika infections. 
The lessons from dengue epidemics in southern Taiwan in 2015 provide an 
important future direction for the elimination of Ae. aegypti.
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ZIKA VIRUS INFECTION
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Zika virus (ZIKV) is a mosquito-borne flavivirus first isolated in Uganda, 
in 1947. Since then, sporadic cases of human ZIKV infections were 
reported in Africa and Asia, but the first ZIKV outbreaks occurred in the 
last decade, in the Pacific Ocean region. Late in 2014, large outbreaks of 
acute exanthematous illness (AEI) were reported from various Northeast 
states of Brazil, and, in April 2015, ZIKV was identified as the etiologic 
agent. ZIKV diagnosis is challenging, because serological methods is not 
specific as a consequence of IgM cross reactivity between Flaviviruses. 
Currently, molecular techniques, such as conventional or real time reverse 
transcriptase–polymerase-chain-reaction (qRT-PCR), are the most used 
methods to diagnosis ZIKV. ZIKV RNA is usually detected by RT-PCR in 
serum samples, but use of alternative samples has already been described. 
ZIKV RNA has been found in saliva in concomitance with either blood or 
urine. There are also a few studies describing viral RNA amplified only 
from saliva. The objective of this study was to investigate the potential 
use of saliva samples as an alternative for diagnosis of ZIKV infection. In 
June 2015, nine patients assisted in an emergency health unit of Salvador, 
Brazil due to an AEI suggestive of ZIKV had both saliva and serum 
samples collected after two to five days of symptoms onset. Samples 
were subjected to RNA extraction using the QIAamp Viral RNA Mini Kit 
(QIAGEN) and ZIKV qRT-PCR described by Lanciotti et al (2008) using the 
QuantiTect Probe RT-PCR Kit (QIAGEN). Zika RNA was detected in four of 
nine samples of saliva (Ct values < 38.5). All serum samples were negative. 
Our findings coincide with that of prior studies and suggest that qRT-
PCR performed in saliva samples may have greater sensitivity compared 
to serum. In addition, obtaining saliva is easier than serum, particularly 
in newborns or in remote places where medical facilities are lacking. 
Further studies with larger number of specimens are needed to confirm 
our findings, but given the current evidence we suggest that in situations 
where a blood sample cannot be collected, the use of saliva should be 
considered.
42
astmh.org
125
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Zika virus, first described in central Africa in the late 1940s, has attracted 
considerable attention in recent months. Over more than six decades, 
researchers have carefully described its arthropod-mosquito vector, its 
pathogenicity, and its structure. During the past year, however, numerous 
studies have suggested the possibility of non-arthropod transmission 
via sexual intercourse. Indeed, health authorities have cautioned 
women in high-risk areas to avoid pregnancy because of the risk of 
fetal microcephaly. Sexual transmission of Zika virus, of course, is quite 
plausible. Clearly, a number of viral pathogens, most notably HIV, can be 
transmitted via sexual intercourse. This study will analyze what is—and has 
been—known about sexual transmission of Zika virus. It will also examine 
ongoing public efforts to prevent its transmission.
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Zika virus (ZIKV) has disseminated throughout Latin America and is a 
major public health concern due to an association with adverse pregnancy 
outcomes such as miscarriage and microcephaly as well as an increased 
incidence of Guillain-Barré syndrome. Many of the urgent needs (including 
diagnostics, surveillance, vaccine development, and pathogenesis 
studies) in responding to this epidemic hinge on a clear and detailed 
understanding of the human antibody (Ab) response to ZIKV. It is well 
known that humans produce flavivirus cross-reactive Ab following natural 
infection and that these responses can confound interpretation of serology 
during a secondary flavivirus infection - a highly relevant phenomenon 
in Latin America where dengue (DENV) seroprevalence can exceed 90%. 
Serodiagnosis is particularly essential in the ZIKV epidemic as the window 
for diagnosis by molecular methods is narrow and the majority of new 
infections are asymptomatic. To address these issues and develop critical 
tools for study of humoral immunity to ZIKV, we recruited travelers 
reporting potential exposure to arbovirus infection and tested serum 
samples for reactivity to DENV and ZIKV. Depending on an individual’s 
travel history and country of origin, we find a variety of patters. Some sera 
samples bind and neutralize a single virus; others demonstrate broad cross-
reactivity. Several primary ZIKV infections were identified in those reporting 
an acute febrile illness during or after travel to Brazil or Colombia in 2015. 
This well-characterized set of sera serve as a standard of comparison for 
novel serodiagnostics that we are developing and deploying to ZIKV-
endemic regions. Human monoclonal Ab derived from memory B cells 
of participants with primary ZIKV infection will be used to map binding 
determinants of ZIKV-specific and flavivirus cross-reactive Ab and define 
epitopes targeted by neutralizing Ab.
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In mid-2015, reports of Guillain-Barré syndrome (GBS) increased in 
certain regions of Brazil. These reports coincided with the introduction 
and rapid spread of Zika virus in Brazil, and geographic areas with the 
highest reports of Zika-like illness and GBS overlapped. The Brazil Ministry 
of Health and CDC performed an investigation to identify risk factors 
and potential infectious pathogens associated with GBS. We conducted 
a case-control investigation in the Salvador metropolitan area, Brazil. 
We defined GBS cases according to the Brighton Collaboration criteria. 
Two controls matched by age group were randomly selected from the 
same neighborhoods as the cases using modified WHO cluster survey 
methodology. We conducted in-person interviews to obtain risk factor 
and exposure (environmental, food/water) histories in the 2-month period 
prior to GBS-case onset. Of 77 suspected GBS case-patients, 50 (65%) 
met Brighton case definition criteria. The incidence of GBS during April-
July 2015 was approximately 12-times higher than expected. Among 41 
enrolled GBS case-patients and 85 controls, there were no differences 
in demographic or exposure data. A higher proportion of GBS cases 
compared to controls reported an antecedent illness (88% versus 21%, 
P<.01), with rash and conjunctivitis being reported by 71% and 56% 
of GBS case-patients, respectively, versus 39% and 22% of the controls 
(P<.01). Arboviral testing is underway for serum samples collected from 
all cases and controls. Our investigation identified increased incidence 
of GBS case-patients occurring in tight geo-temporal clustering in the 
Salvador area during mid-2015. Many GBS case-patients reported an 
exanthematous illness during a time of recognized Zika transmission in 
Salvador, suggesting a possible association between GBS and Zika virus 
infection. Further surveillance for GBS, additional case control studies, and 
refined Zika virus laboratory diagnostics are needed to substantiate this 
possible association.
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Kévin Jean1, Neil M. Ferguson1, Maria D. Van Kerkhove2, Sergio 
Yactayo3, William Perea3, Joseph Biey4, Messeret E. Shibeshi5, Tini 
Garske1
1Imperial College, London, United Kingdom, 2Center for Global 
Health, Pasteur Institute, Paris, France, 3World Health Organization, 
Geneva, Switzerland, 4AFRO West Africa Inter-country Support Team, 
Ouagadougou, Burkina Faso, 5AFRO Eastern and Southern Africa Inter-
country Support Team, Harare, Zimbabwe
Yellow Fever (YF) is a mosquito-borne flavivirus infection, its major burden 
is concentrated in sub-Saharan Africa. Two transmission cycles co-exist: a 
sylvatic cycle in non-human primates causing zoonotic spill-over infections 
in humans and an urban cycle perpetuated in human populations, with 
intermediate transmission among both humans and non-human primates 
also playing a role. The relative contribution of these cycles to the human 
burden of YF is not well understood. After a period of re-emergence, 
implementation of large mass vaccination campaigns started in 2006 
in the most affected West African countries. Mathematical modelling is 
currently used to inform these vaccination activities. However, vaccine 
impact estimates differ depending on assumptions about transmission 
cycles. In urban transmission, herd immunity effects increase the impact 
of vaccination compared to the sylvatic cycle. To address this issue, we 
constructed two alternative versions of a model estimating YF burden, 
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assuming either 100% zoonotic or 100% inter-human transmission. 
Both models were fitted to reported outbreaks from 1984-2013 using 
environmental and demographic variables across the endemic zone 
of Africa, and were calibrated with serological survey data. Over the 
1984-2013 period, both models estimated a very similar cumulative YF 
burden across Africa. However temporal trends in the burden differed 
between both models. Notably, the inter-human model estimated a 
lower burden than the zoonotic model for the period corresponding to 
recent vaccination activities (2006-2013). Over this period, vaccination 
was estimated to have prevented 4.5x105 (95% CI: 1.5x105 - 10.4x105) 
deaths according to the zoonotic and 21x105 (95% CI: 8x105 - 45x105) 
according to the inter-human model. This corresponds to an estimated 2.2 
(95% CI: 0.7 - 5.0) and 10.0 (95% CI: 4.0 - 22) deaths averted per 1,000 
vaccine doses, respectively. Integrating herd immunity into the model thus 
strongly influences vaccine impact estimates. Further efforts to assess the 
relative contribution of both transmission cycles are needed.
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FULL GENOME SEQUENCING OF ZIKA VIRUSES USING A 
TARGETED AMPLIFICATION APPROACH
Mariana Leguia, Vidal Felices, Armando Torre, Carolina Guevara, 
Gilda Troncos, Victoria Espejo, Christopher Mores
U.S. Naval Medical Research Unit-6 (Peru), Washington, DC, United States
The recent outbreak of Zika virus highlights the importance of having 
access to sensitive molecular tools for diagnosis and identification 
of circulating viral strains. Next-generation sequencing, and shotgun 
sequencing in particular, are powerful tools that can be used to generate 
complete viral genomes even in the absence of any a priori knowledge 
about the virus of interest. As such, shotgun sequencing is usually one of 
the first tools utilized to generate complete viral genomes from clinical 
samples. Unfortunately, viruses in clinical samples can be present in small 
amounts, and as such, these “low viral load” samples are often plagued 
by high signal-to-noise ratios that prevent the generation of complete 
viral genomes. One way around this issue is to culture the virus in order to 
increase viral load. However, passaging viruses through laboratory cell lines 
can have the unintended consequence of introducing mutations that are 
not observed in the wild. Here, we report a set of 22 Zika-specific primers 
that can be used to generate overlapping amplicons by PCR to cover the 
entire Zika genome even in samples with low viral load. Given that PCR 
amplification efficiency is directly related to template concentration and 
to amplicon size, samples where Zika is present in low abundance can 
be fully covered by as many as 11 overlapping segments (of about 1 KB 
each), whereas samples with high Zika abundance can be fully covered by 
as few as 5 (of about 2.5 KB each). An added advantage of this targeted 
amplification approach is that although the overlapping amplicons can 
be used as starting material for next-generation sequencing libraries, 
sequencing can also be completed using Sanger methods. As such, this 
approach may be useful for epidemiological surveillance in low resource 
settings that may not have access to the latest next-generation sequencing 
technologies.
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ZIKA VIRUS PERSISTENCE IN BODY FLUIDS AMONG 
PATIENTS WITH ZIKA VIRUS INFECTION IN PUERTO RICO
Gabriela Paz-Bailey1, Janice Perez-Padilla1, Matthew Lozier1, 
Jorge Munoz-Jordan1, Brad Biggerstaff1, Olga Lorenzi1, Carlos 
Garcia-Gubern2, Steve Waterman1, Luisa Alvarado2, Tyler Sharp1
1Centers for Disease Control and Prevention, Atlanta, GA, United States, 
2Ponce Health Sciences University, San Juan, Puerto Rico
Little is known about the presence or duration of Zika virus (ZIKV) in 
body fluids other than blood. Understanding the presence and duration 
of ZIKV detection in urine and saliva may facilitate diagnostic testing. 
Information about ZIKV in semen and vaginal secretions is urgently needed 
to inform prevention messages to prevent sexual transmission. Moreover, 
the relationship between development of anti-ZIKV antibodies and the 
presence and duration of ZIKV in body fluids other than blood has not 
been described. To investigate the persistence of ZIKV in body fluids and 
its relation to immune response, we are conducting a prospective cohort 
study of patients with laboratory-confirmed ZIKV infection. Patients with 
rash, fever, arthralgia, or conjunctivitis that present to an out-patient clinic 
or hospital emergency department in Ponce, Puerto Rico will be offered 
participation in the study. For those that consent, demographic and clinical 
characteristics will be collected in addition to blood, nasopharyngeal, and 
urine specimens. Patients in which ZIKV nucleic acid is detected by RT-
PCR in any specimen will be invited for follow-up, in which blood, saliva, 
and urine specimens will be collected; among participants 21 years and 
older, semen or vaginal secretions will also be collected. All specimens will 
be tested for the presence of ZIKV nucleic acid by RT-PCR, and positive 
specimens will be further tested for virus isolation to evaluate the presence 
of infectious virus. Each body fluid will be collected on a weekly basis for 
4 weeks and biweekly thereafter until two consecutive negative RT-PCR 
results are obtained from all specimens. Irrespective of RNA detection, 
body fluids will also be collected for RT-PCR at 2, 4, 6 and 9 months 
to investigate intermittent shedding. All blood specimens will also be 
tested by anti-ZIKV IgM and IgG ELISA. Results will be used to update 
relevant counseling messages and recommendations from the CDC. At 
the conference we will present preliminary results regarding the antibody 
response and RNA persistence in body fluids. Only results for body fluids 
for which sufficient sample size and follow-up will be presented.
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EPIDEMIOLOGIC INVESTIGATIONS OF GUILLAIN-BARRÉ 
SYNDROME INCLUDING CASE-CONTROL INVESTIGATION 
TO DEFINE ASSOCIATION WITH ZIKA VIRUS INFECTION — 
PUERTO RICO, 2016
Emilio Dirlikov1, Chelsea Major1, Marrielle Mayshack1, Jorge 
Salinas2, Cesar Virgen3, Daniel M. Pastula4, Jim Sejvar2, Tyler 
Sharp1, Brenda Rivera-García5
1Centers for Disease Control and Prevention, San Juan, PR, United 
States, 2Centers for Disease Control and Prevention, Atlanta, GA, United 
States, 3University of California San Diego, San Diego, CA, United 
States, 4University of Colorado, Denver, CO, United States, 5Puerto Rico 
Department of Health, San Juan, PR, United States
Guillain-Barré syndrome (GBS) is a post-infection autoimmune disorder 
characterized by motor weakness, sensory abnormalities, and/or 
autonomic dysfunction due to peripheral nerve damage. In February 
2016, Puerto Rico Department of Health (PRDH) reported its first case 
of GBS with evidence of Zika virus (ZIKV) infection. Given reported 
increased GBS incidence in ZIKV-affected regions, PRDH aimed to calculate 
GBS incidence, implement a GBS surveillance system, and investigate 
the association between GBS and ZIKV infection. Medical records at 8 
hospitals for patients admitted with suspicion of GBS during 2012-2015 
were evaluated using Brighton Collaboration criteria for GBS diagnostic 
certainty. Of 140 patient records reviewed, 61 (44%) met the confirmed 
case definition (Brighton levels 1-3). By applying the proportion of 
confirmed cases to 2013 Puerto Rico medical insurance claim data, 
2013 incidence was estimated at 1.6 cases per 100,000 population. For 
GBS surveillance, neurologists and hospital infection control staff report 
suspected cases using a case report form and submit specimens for ZIKV 
diagnostic testing by reverse transcription-polymerase chain reaction 
(RT-PCR) and anti-ZIKV immunoglobulin M (IgM) antibodies by enzyme-
linked immunosorbent assay (ELISA). During January 1-April 11, 2016, 
14 suspected GBS cases were reported, of which 6 (43%) had anti-ZIKV 
IgM antibodies in serum. Of these, median age was 42 years (range = 
32-68) and 3 (50%) were male. All 6 patients were residents of ZIKV-
affected municipalities in eastern Puerto Rico. A prospective case-control 
investigation is underway whereby cases are matched to two controls by 
age and location of residence. Data on behaviors, exposures, and recent 
illnesses are collected; RT-PCR and IgM ELISA is conducted on blood 
specimens, and RT-PCR on urine and saliva specimens. Results of the case-
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control investigation are pending. The 2013 GBS incidence provides a 
baseline to assess trends in GBS cases reported to PRDH during ongoing 
ZIKV transmission. The case-control study will prospectively recruit cases to 
better define the association between GBS and ZIKV infection.
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CHARACTERIZATION OF ZIKA VIRUS INFECTIONS AND THE 
POTENTIAL EFFECT OF PRIOR DENGUE VIRUS EXPOSURE IN 
CHILDREN IN MANAGUA, NICARAGUA
Lionel Gresh1, Sergio Ojeda1, Nery Sanchez1, Guillermina Kuan2, 
Andrea Nuñez3, Aubree Gordon4, Angel Balmaseda3, Eva Harris5
1Sustainable Sciences Institute, Managua, Nicaragua, 2Health Center 
Sócrates Flores Vivas, Ministry of Health, Managua, Nicaragua, 
3Laboratorio Nacional de Virología, Centro Nacional de Diagóstico y 
Referencia, Ministry of Health, Managua, Nicaragua, 4Department of 
Epidemiology, School of Public Health, University of Michigan, Ann Arbor, 
MI, United States, 5Division of Infectious Diseases and Vaccinology, School 
of Public Health, University of California Berkeley, Berkeley, CA, United 
States
The first evidence of Zika virus (ZIKV) emergence in the Americas was 
documented in Northeast Brazil in May 2015. Since then, 35 countries 
and territories in the Americas have reported autochthonous transmission 
of ZIKV. In Nicaragua, the first case was reported in January 2016, and by 
April 2016, 130 cases had been identified by the national surveillance of 
the Ministry of Health. We are currently analyzing the epidemiology and 
clinical presentation of Zika in a prospective, community-based pediatric 
cohort study of dengue and chikungunya in Managua, Nicaragua. This 
study, ongoing since 2004, follows ~3,500 children aged 2-14 in a 
low- to middle-income area of Managua. Suspected Zika, chikungunya, 
and/or dengue cases and cases with undifferentiated fever are screened 
for ZIKV infection. Blood, saliva and urine samples are collected from 
suspected cases during the acute phase and at convalescence. Screening 
is conducted by real-time RT-PCR using the CDC protocol and a triplex 
ZIKV-CHIKV-DENV (ZCD) assay developed at Stanford University and 
validated in Nicaragua. From January to April 2016 (the dry season is 
March-May), 8 Zika cases were identified in the cohort (5 female and 3 
male). Median age at presentation was 11 years (range: 7-14). One case 
required hospitalization. Six participants were DENV-naïve and two had 
had a previous DENV infection. As ZIKV transmission increases in the 
next rainy season, we will describe the natural history of ZIKV infection 
in our study populations and detection of ZIKV in blood, saliva and urine. 
In particular, clinical follow-up will continue after the acute phase, and 
participants requiring hospitalization and/or neurological examination will 
be transferred to our study hospital. We will also study potential immune 
enhancement between DENV and ZIKV infections. In our cohort, we will 
be able to compare ZIKV infection outcomes in participants with no, 
one or >2 previous DENV infections. Finally, as current serological assays 
cannot easily differentiate DENV and ZIKV, in particular if the patient has 
had a previous flavivirus infection or vaccination, we are developing and 
assessing new serological methods.
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THE SEASONAL INFLUENCE OF CLIMATE AND 
ENVIRONMENT ON YELLOW FEVER TRANSMISSION ACROSS 
AFRICA
Arran Hamlet1, Kévin Jean1, Neil Ferguson1, Maria Van Kerkhove2, 
Sergio Yactayo3, William Perea3, Joseph Biey4, Amadou Sall5, Tini 
Garske1
1MRC Centre for Outbreak Analysis and Modelling, Imperial College, 
London, United Kingdom, 2Centre for Global Health, Institut Pasteur, Paris, 
France, 3World Health Organization, Geneva, Switzerland, 4WHO-AFRO, 
Ouagodougou, Burkina Faso, 5Institut Pasteur, Dakar, Senegal
Yellow fever (YF) is a vector-borne, viral haemorrhagic fever endemic to 
Africa and Latin America with 90% of the burden occurring in Africa, 
transmitted primarily by Aedes spp, with Ae. aegypti the main vector 
for urban YF. Mosquito life cycle and viral replication in the mosquito 
heavily depend on climate indicators, particularly temperature and 
rainfall. We aimed to assess whether seasonal variations in climatic 
factors are associated with the seasonality of YF reports. We constructed 
a temperature suitability index for YF transmission, capturing the 
temperature dependence of mosquito life cycle and viral replication 
within the mosquito. We then fitted a series of generalised linear 
models to a dataset of YF reports across Africa, taking into account 
location and seasonality of occurrence for seasonal models and using 
the temperature suitability index, rainfall and the Enhanced Vegetation 
Index (EVI) as covariates alongside further demographic indicators. 
Model fit was assessed by the Area Under the Curve (AUC), and models 
were ranked by Akaike’s Information Criterion. The seasonal interaction 
between temperature suitability and rainfall explained the seasonal and 
geographical patterns of YF occurrence well (AUC = 0.84), although 
models also including EVI performed significantly better (AUC = 0.88, p < 
0.001). Despite the lower performance of the interaction of temperature 
suitability and rainfall compared to the EVI as a predictor of YF reports, the 
former offers a mechanistic explanation for the spatio-temporal variability 
and therefore enhances our understanding of the factors influencing YF 
transmission intensity. The description of seasonality in the transmission 
of YF opens up the possibility for the development of “early-warning” 
systems for outbreaks, which could facilitate the allocation of resources 
and guide vector-control programmes particularly if the insights gained 
here are combined with seasonal weather forecast data.
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ZIKA VIRUS: KNOWLEDGE GAPS AND VACCINE RESEARCH 
AND DEVELOPMENT CHALLENGES
Nicholas Jackson1, Valerie Lecouturier2, Konstantin Pugachev3, 
Nicolas Burdin2, Harry Kleanthous3, Kent Kester4, Fernando 
Noriega4, Jim Tartaglia4, Jon Heinrichs4
1Sanofi Pasteur, Lyon, France, 2Sanofi Pasteur, Marcy-l’Étoile, France, 
3Sanofi Pasteur, Cambridge, MA, United States, 4Sanofi Pasteur, 
Swiftwater, PA, United States
The recent emergence of Zika virus as a cause of severe disease has 
mobilized public health agencies, as well as commercial organizations, 
to embark on efforts to develop new approaches for combating 
this infection. Zika, a mosquito-borne flavivirus, has only recently 
been associated with severe disease in humans, including a variety 
of neurological complications that include microcephaly, congenital 
cerebral embryopathy and Guillain-Barré syndrome associated with an 
unprecedented spread of the virus. These links prompted the World Health 
Organization to list Zika as a “Public Health Emergency of International 
Concern” and the US CDC has now declared that Zika is a cause of 
microcephaly and other severe fetal brain defects. As exemplified during 
the recent Ebola outbreak, international and regional collaborations will be 
required to advance our understanding of Zika and to accelerate vaccine 
research and development. Potentially significant challenges for vaccine 
R&D have been identified, including; unknown incidence rates for clinical 
complications; while neutralizing antibodies will likely mediate protection, 
the level required is not yet known; the complexities of symptomatic and 
asymptomatic infection leading to clinical trials needing to demonstrate 
efficacy against disease/viremia and possibly fetal transmission for 
registration, and the development of diagnostic assays that avoid cross-
reactivity with other flaviviruses. Sanofi Pasteur has initiated vaccine 
research and development activities to rapidly proceed through preclinical 
assessment into clinical evaluation. Assay optimization, animal model 
development and process improvements, as well as further disease 
understanding through potential surveillance of subjects participating in 
the follow up of the dengue efficacy study in Latin America, constitute the 
current focus of our work. Sanofi Pasteur’s experience in licensed flavivirus 
vaccines will be leveraged against Zika vaccine development. Available 
results and progress will be presented.
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CO-INFECTION STUDIES BETWEEN WEST NILE VIRUS AND 
CULEX FLAVIVIRUS DETERMINE AN INHIBITORY EFFECT ON 
WEST NILE VIRUS INFECTION
Silvina Goenaga, Delia A. Enria, Silvana C. Levis
Instituto Nacional de Enfermedades Virales Humanas “Dr. Julio I. 
Maiztegui”, Pergamino, Argentina
Vector-borne diseases remain a major public health concern as new 
diseases are emerging and previously controlled diseases are now 
resurging. West Nile virus (WNV) is a mosquito-transmitted flavivirus. Since 
its introduction in North America in 1999, it was spread rapidly to Central 
and South America. In Argentina, WNV was isolated in 2006; however, 
evidence of circulation by neutralizing antibodies in birds was detected 
by 2004. Still, human cases are scarce; interactions between vector, 
virus, and environment could be playing a role to explain it.The high 
rate of prevalence of Culex flavivirus (CxFV), an insect-specific flavivirus, 
detected in Argentina in previous studies, determined the importance to 
develop co-infection studies with WNV. For that purpose, in vitro studies 
were conducted in order to assess the potential of CxFV for blocking 
WNV infection. Co-infection assays using WNV and CxFV with different 
multiplicity of infection (MOI) in C6/36 cells from Aedes albopictus, were 
performed during 7 days. WNV titers were analyzed by plaque titration 
on 12-well plates of Vero cells.Results indicated that concurrent infection 
with CxFV resulted in a significant reduction in virus production of WNV. 
An inhibition of 100 fold reduction for WNV in presence of CxFV was 
detected. Reduction was statistically significant at 1 days post infection 
(dpi) and at 7 dpi using MOI of 0.1 for both viruses. Interesting, when MOI 
of CxFV was 10 or 100 times higher than MOI of WNV, reduction was 
statistically significant for every dpi. These results are in concordance with 
previous studies from other authors; co-infection resulted in suppression 
at higher total MOI, as a result of competition since the degree of 
resource depletion increases with MOI. This highlights that CxFV could be 
interfering in transmission of other flaviviruses of medical importance such 
as WNV. These results could explain, in part, the low level of transmission 
of WNV in Argentina. However, it will be necessary in vivo assays in order 
to evaluate this hypothesis. The results that are presented remark the 
potential interaction between flaviviruses.
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WEST NILE VIRUS INFECTION IN HUMAN AND MOUSE 
CORNEA TISSUE
Bradley Blitvich1, Tian Wang2, Vandana Saxena2, Shemin Zeng3, 
Karen M. Harmon1, Matthew D. Raymond1, Kenneth M. Goins3, 
Cynthia Reed4, Robert F. Mullins3, Mark A. Greiner3
1Iowa State University, Ames, IA, United States, 2The University of Texas 
Medical Branch, Galveston, TX, United States, 3The University of Iowa, 
Iowa City, IA, United States, 4Iowa Lions Eye Bank, Coralville, IA, United 
States
The purpose of this study was to determine the in vitro and ex vivo 
susceptibility of human corneal cells to West Nile virus (WNV) infection 
and evaluate the ability of the virus to disseminate to the corneas of 
infected mice. Human corneal epithelial cells were challenged with WNV, 
incubated for 1 to 6 days, and tested for evidence of WNV infection. Viral 
RNA and antigen were detected at every time point and the virus reached 
a peak titer of 2.5 x 107 plaque-forming units per milliliter (pfu/ml) at 3 
days post-inoculation (PI). Corneas procured from donors were incubated 
in culture dishes containing WNV for 1 to 5 days and tested for evidence 
of WNV. Viral RNA and antigen were detected and the virus reached a 
mean peak titer of 4.9 x 104 pfu/ml at 5 days PI. Mice were inoculated 
intraperitoneally with WNV, and their eyes harvested at 2, 5, and 8 days 
PI and tested for evidence of WNV. Viral RNA was detected in anterior 
segment tissues in 4 of 9 systemically infected mice as early as 2 days PI. 
We conclude that human corneal cells support WNV replication in vitro 
and ex vivo, and WNV may disseminate into the corneas of experimentally 
infected mice. These findings indicate that corneal transmission cannot 
be ruled out as a novel mode of human-to-human WNV transmission and 
additional experiments should be conducted to assess this risk further.
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INTEGRATING SATELLITE REMOTE SENSING AND MOSQUITO 
SURVEILLANCE TO PREDICT HUMAN ARBOVIRAL DISEASE
Justin K. Davis, Geoffrey Vincent, Mike Hildreth, Mike Wimberly
South Dakota State University, Brookings, SD, United States
Mosquito-borne diseases present both novel and persistent challenges to 
public health, and predicting human risk is a perpetual, difficult exercise in 
integrating various streams of data. While remotely sensed environmental 
data (e.g. temperature and moisture) are readily available and are relevant 
to mosquito ecology, they do not directly capture other essential factors 
such as the immunity status of reservoir hosts. Mosquito surveillance data 
(e.g. infection status) are better measures of these hidden aspects of the 
disease transmission cycle, but are less accessible and more difficult to 
incorporate into operational forecasts of human disease. We present a 
flexible framework for predicting a mosquito-borne disease in humans, 
combining large volumes of meteorological data and sparse measurements 
of mosquito infection status. The approach was applied to reported 
human West Nile virus (WNV) infections in South Dakota, USA, 2004-
2016. Data from NASA’s North American Land Data Assimilation System 
(NLDAS) characterized temperature, precipitation, etc. on a daily basis. 
Early-season mosquito infection status data, measured in relatively few 
of the state’s counties, were used to estimate influences not perceptible 
remotely. A statistical model of human WNV based on a parsimonious 
set of covariates achieved excellent discriminatory and predictive power, 
and yielded a straightforward description of human risk. Namely, long-
term, interannual trends in human disease were explained by early-season 
mosquito infection status, and short-term variations by temperature. 
Early-season predictions for 2015 and 2016 are compared to observations. 
Scenarios for 2017, conditioned on predictive climate models, are 
discussed.
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WEST NILE VIRUS SUSCEPTIBILITY OF AMERICAN SINGER 
CANARIES: A LABORATORY MODEL OF A HIGHLY 
SUSCEPTIBLE AVIAN SPECIES
Erik K. Hofmeister, Melissa Lund, Valerie Shearn Bochsler
USGS NWHC, Madison, WI, United States
In North America, West Nile virus (WNV) was first detected in 1999 
in the New York area, and has since spread across the continental 
U.S., southern Canada, Mexico, Central America, and South America. 
Significant mortality, caused by WNV, was recognized in corvids (ravens, 
crows, magpies, and jays), and population declines have been recorded 
in corvids, as well as other avian species. Experimental challenge of 
birds with WNV has demonstrated susceptibility ranging from low - no 
mortality following challenge and WNV viremia unlikely to infect feeding 
mosquitoes - to high -frequent mortality and viremia very likely to infect 
feeding mosquitoes. Using wild-caught birds the extreme of this range 
might be observed with doves and corvids, with house sparrows filling 
the mid-range of susceptibility. Using wild-caught birds to examine 
species susceptibility to WNV has several disadvantages including difficulty 
of capture, presence of potential co-infections, such as avian malaria, 
and the potential for stress hormone release due to confinement at a 
research facility. We examined the susceptibility of mature American 
singer canaries (Serinus canaria) for WNV and found the species to be 
highly susceptible to the virus. Birds were inoculated with 105, 102, and 
101 plaque forming units of WNV and mortality was observed in all birds 
by 5 days post inoculation. Viremia was quantitated by referring RT-PCR 
Ct scores to a standard curve and was comparable to the level of viremia 
that developed in American crows (Corvus brachyrhynchos) experimentally 
infected with WNV. Using a plaque assay, WNV was quantitated in tissues 
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obtained from diseased birds that were euthanized and was similar to 
viral load reported in WNV challenged American crows. Histopathology 
revealed lesions in a variety of tissues with liver, spleen, and kidney most 
severely affected. Immunohistochemistry (IHC) staining was pronounced in 
spleen and kidney sections. Brain and heart tissue were unremarkable on 
histopathology, and IHC stained sections were negative. American singer 
canaries provide a useful laboratory model to study the effects of WNV on 
birds highly susceptible to the virus.
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POLYMORPHISMS AT THE NS3-249 LOCI ARE ASSOCIATED 
WITH ALTERED VECTOR COMPETENCE OF CULEX PIPIENS 
FOR LINEAGE 2 WEST NILE VIRUSES
Hannah E. Romo1, Michael Anishchenko2, Anna Papa3, Gregory 
D. Ebel1, Aaron C. Brault1
1Colorado State University, Fort Collins, CO, United States, 2Division of 
Vector-borne Diseases, Centers for Disease Control and Prevention, Fort 
Collins, CO, United States, 3Department of Microbiology, Medical School, 
Aristotle University of Thessaloniki, Thessaloniki, Greece
Lineage 2 (L2) West Nile viruses (WNV) have undergone recent geographic 
expansions, resulting in outbreaks in eastern and southern Europe. Most 
notably, L2 WNV outbreaks have occurred annually in Greece since 2010. 
Genetic analysis of mosquito pool isolates made annually from Greece 
since 2010 have demonstrated the presence of a conserved L2 genetic 
variant containing a proline at NS3-249. This same genetic mutation 
has previously been associated with increased viremia and mortality in 
American crows (Corvus brachyrhynchos) infected with lineage 1 WNV 
strains. In order to evaluate if NS3-249 polymorphisms can alter L2 vector 
competence phenotypes, three parental L2 isolates (with NS3-249H) were 
compared to a Greek isolate from 2010 (NS10; NS3-249P) in Culex pipiens 
and Cx. quinquefasciatus mosquitoes. A lower infection rate was observed 
for Cx. pipiens orally exposed to NS10 compared to the three parental 
L2 isolates (NS3-249H); however, a similar lower infection rate for NS10 
wasn’t observed in Cx. quinquefasciatus mosquitoes. NS10 also exhibited 
reduced dissemination and transmission rates compared to SA89, a 
South African L2 (NS3-249H). To assess whether the NS3-249 loci is a 
determinant of vector competence in Cx. pipiens, vector competence of 
SA89, NS10 and corresponding mutants generated containing reciprocal 
substitutions at the NS3-249 loci (His vs Pro) was assessed. A higher 
infection rate was observed with the NS10-His mutant compared to 
wild type NS10. No differences in rates of dissemination or transmission 
were observed. Reciprocally, no difference in infection rate was observed 
for the SA88-Pro mutant relative to WT SA89; however, dissemination 
and transmission were lower. Increased avian replication could offset 
the negative impact of the NS10 Pro mutation observed on mosquito 
infectivity. In contrast, a loss in dissemination and transmission efficiency 
observed for the SA89-Pro mutant likely precluded maintenance of this 
mutant. As such, these data indicate the potential role mosquitoes play 
in restricting the emergence potential of high avian fitness variant due to 
reciprocal fitness effect in mosquito vectors.
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EVALUATION OF DIFFERENT VIRAL ENRICHMENT METHODS 
FOR WEST NILE VIRUS RNA EXTRACTION IN BRAIN
Dhani Prakoso1, Thomas B. Waltzek1, Jun J. Liu1, Nanny 
Wenzlow1, Gretchen H. Delcambre2, Anthony F. Barbet1, Maureen 
T. Long1
1University of Florida, Gainesville, FL, United States, 2Colorado State 
University, Fort Collins, CO, United States
Physical virus enrichment is thought to increase sensitivity and enhance 
detection of viral diversity, but these techniques are limited using brain 
tissue. Physical virus enrichment is especially useful for deep sequencing 
investigations. The hypotheses that elimination of host brain RNA will 
enhance sensitivity of viral detection and render undetectable virus 
available to sequence was investigated. Specifically, since West Nile virus 
(WNV) causes grave clinical signs in the face of low to undetectable 
virus, the aim of this research was to develop repeatable methods for 
detecting and generating WNV sequences from archived brain tissues 
of horses in which virus was either not detected or in limited quantity. 
Different WNV viral RNA extraction methods and host RNA separation 
methods were investigated by conducting artificial inoculation of WNV 
into horse brain. Twenty-one horse brains were collected and small pieces 
of brain from each were inoculated with WNV NY99 strain (low passage 
to maintain diversity) and each of them underwent eight different RNA 
extraction protocols. The protocols utilized low-speed centrifugation, 
syringe filtration, and nuclease treatment with combinations of these. The 
WNV viral RNA was analyzed using real-time PCR targeting WNV Envelope 
(e) protein and equine G3PDH. Deep sequencing was also performed 
using Illumina® platform. Real-time PCR results showed that the more 
enrichment applied to a sample, the less viral and host RNA was obtained. 
Data obtained for sequencing showed that more enrichment treatments 
resulted in more reads. Although calculation of single nucleotide 
polymorphism and diversity is necessary for full analysis, these results 
demonstrate that additional steps utilized for extraction of brain do not 
enhance detection of WNV. Methods for phylogenetic and phylodynamic 
studies in RNA viruses need to be tissue specific.
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DEVELOPMENT OF A LIVE ATTENUATED WEST NILE VIRUS 
VACCINE
Heather Kenney, NL Teterina, G. Liu, Alexander Pletnev
National Institutes of Health, Bethesda, MD, United States
West Nile Virus (WNV) is an emerging human neurotropic pathogen 
that targets the central nervous system (CNS). Recent work has shown 
that inserting a single copy of a target for brain-expressed microRNAs 
(miRNAs) in the 3’ noncoding region (3’NCR) of the flavivirus genome 
abolished virus neurovirulence in the mature mouse CNS. Furthermore, 
studies showed that introducing mir-124a target sequence into a flavivirus 
genome completely abolished neuroinvasivness in immunodeficient mice. 
Here, we developed a chimeric WNV / Dengue 4 virus vaccine candidate 
containing mir-124a targets in the junction of E-NS1 genes and in 3’ non-
coding region. miRNA targeted WNV / Dengue 4 was attenuated in 3-day 
old Swiss mice infected IC and did not cause neurologic disease in type 
I interferon receptor deficient mice infected intraperitoneally with10^4 
PFU. To determine if miRNA targeted WNV /DEN4 is immunogenic and 
protects against challenge with wild type WNV, we inoculated C3H mice 
intraperitoneally with 10^5 PFU. Virus induced a high level of serum 
WNV-specific neutralizing antibodies in each immunized animal 28 days 
following inoculation. Moreover, 100% of immunized mice survived the 
lethal WNV challenge. We conclude that our developed virus has potential 
to be used as a live attenuated vaccine candidate against WNV disease.
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CLINICAL FEATURES OF ADMITTED CHILDREN WITH 
LABORATORY-CONFIRMED EBOLA VIRUS INFECTION DURING 
THE 2014-2015 EBOLA OUTBREAK IN GUINEA
Mahamoud S. Cherif, Mamadou Pathe Diallo, Dienaba Kasse, 
Sekou Dittin Camara, Facely Camara, Moumie Barry, Saliou Bella 
Diallo
Universite Gamal Abdel Nasser of Conakry, Conakry, Guinea
Background:Ebola outbreak in 2014 in West Africa is the largest in 
history and children are the most vulnerable. In this study, we aimed 
to understand the clinical characteristics of admitted children with 
confirmed Ebola virus infection. Methods: We have analyzed the data 
from 30447suspected or probable cases were admitted in ETC in Guinea. 
Among them 3062 were EVD confirmed between January 2014 and May 
2015. Results:9155 were children less than 16 years and 518 of them 
were confirmed for EVD in Guinea. We observed that the main symptoms 
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were fever (92%), fatigue (85.7%)and anorexia (75.3%). The lethality rate 
were 82.9% and 55.8% for less 5 and 6-16 age groups respectively. age 
les than 5 and hospitalization less than 7 days were associated with death. 
Conclusion: We observed that the risk of getting the Ebola disease was 
significantly lower in children under 5 years. In contrast, the fatality rate 
was a higher rate in the same group (82.9 %).
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HEPATITIS E SEROPREVALENCE AMONG BLOOD DONORS IN 
RWANDA
Fred Mugabo1, Walker Timothy1, Theogene Twagirumugabe1, 
Swaibu Gatare2, Fredrick Kateera2
1University of Rwanda, Huye, Rwanda, 2Rwanda Biomedical Center, Kigali, 
Rwanda
Hepatitis E Virus is mainly transmitted by the fecal-oral route but other 
routes have been reported. It usually causes self limited disease but 
can cause fulminant hepatitis in pregnant women. The prevalence of 
hepatitis E viral infection among Rwandan adults has not been reported 
previously. We aimed to determine the seroprevalence of Hepatitis E 
Virus among adult Rwandans, its relationship with pork consumption 
and other risk factors. A cross-sectional survey was conducted between 
November and December, 2014 on 309 blood donors in Rwanda. A 
subsequent nested case-control study assessed exposures in seropositive 
cases and seronegative controls. Hepatitis E Virus testing was performed 
by detection of anti- Hepatitis E Virus IgG antibodies. Demographic data 
and information about risk factors for Hepatitis E Virus infection were 
recorded. The average age was 30.6 years with a male to female ratio of 
4:1. 54% were farmers .The overall Hepatitis E Virus seroprevalence was 
13.3%. Rates of anti- Hepatitis E Virus positivity were lower in the Eastern 
Province and Kigali city than the Southern Province (p=0.01 and p=0.003, 
respectively). An association was found between pork consumption and 
Hepatitis E Virus seropositivity (p=0.04).The rate of pork consumption 
positively correlated with the rate of anti-HEV seropositivity (p=0.01).
The analysis did not show an association between Hepatitis E Virus 
seropositivity and the source of drinking water, status of drinking water 
, exposure to animals or exposure activity. Therefore Hepatitis E Virus 
seroprevalence among blood donors in Rwanda is high. Anti- Hepatitis E 
Virus IgG seropositivity is likely associated with pork consumption and may 
be more prevalent in some regions of Rwanda.
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SINU VIRUS, A NOVEL ORTHOMYXOVIRUS RELATED TO 
MEMBERS OF THE THOGOTOVIRUS GENUS, ISOLATED FROM 
MOSQUITOES IN COLOMBIA
María Angélica Contreras Gutierrez1, Marcio Roberto Nunes2, 
Hilda Guzman3, Sandra I. Uribe4, Richard O. Hoyos5, Juan Carlos 
Gallego Gomez6, Sandro Patroca da Silva2, Jedson Ferreira 
Cardoso2, Vsevolov Popov3, Nikos Vasilakis3, Robert B. Tesh3
1Programa de Estudio y Control de Enfermedades Tropicales (PECET), 
Universidad de Antioquia. Grupo de Investigación en Sistemática 
Molecular (GSM), Universidad Nacional de Colombia, Medellín, Colombia, 
2Center for Technological Innovation, Evandro Chagas Institute, Ministry 
of Health, Ananindeua, Pará, Brazil, 3Department of Pathology, University 
of Texas Medical Branch, Galveston, TX, United States, 4Grupo de 
Investigación en Sistemática Molecular (GSM), Escuela de Biociencias, 
Universidad Nacional de Colombia., Medellín, Colombia, 5Grupo de 
Investigación en Enfermedades Tropicales y Resistencia Bacteriana. 
Universidad del Sinú, Monteria, Colombia, 6Molecular and Translational 
Medicine Group, Medical Research Institute, Faculty of Medicina, 
Universidad de Antioquia, Medellín, Colombia
During the past decade, many novel insect-specific viruses have been 
isolated from characterized in mosquitoes and phlebotomine sandflies. 
These insect-specific viruses are widely distributed geographically 
and represent a number of different virus taxa, including Togaviridae, 
Flaviviridae, Bunyaviridae, Rhabdoviridae, Mesoniviridae, Reoviridae 
and Birnaviridae. Here we report a novel insect-specific orthomyxovirus, 
designated CoB 38d, isolated in C6/36 cells from mosquitoes collected 
northwestern Colombia. Genome sequencing of CoB38d revealed the 
presence of a hexa-segmented RNA virus (Segments 1 to 6). Genetic 
analysis of each RNA segment demonstrated the presence of six distinct 
ORFs encoding for the following genes: PBS (Segment 1), PB1, (Segment 
2), PA subunit (Segment 3), envelope glycoprotein gene (Segment 4), 
Nucleoprotein (Segment 5), and Membrane gene (Segment 6). Multiple 
sequence alignment, using all RNA segments of CoB 38d, revealed low 
nucleotide and amino acid identity (<50%) with all other members of 
the Orthomyxoviridae family. Phylogenetic analysis using the polymerase 
subunit 1 (PB1) amino acid sequences showed that the isolate is most 
closely related to members of the Thogotovirus genus. Based on the 
geographic origin of the isolate and phylogenetic analyses, we propose the 
name of Sinu virus (SINUV) and show that it is a new member of the family 
Orthomyxoviridae, and possibly a new genus within the family.
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PREDICTING THE GEOGRAPHIC SPREAD OF THE 2014-2016 
WEST AFRICA EBOLA VIRUS DISEASE OUTBREAK
Moritz U. Kraemer1, Nick Golding2, Donal Bisanzio1, Samir 
Bhatt1, David M. Pigott1, Nuno R. Faria1, Oliver G. Pybus1, David L. 
Smith1, Andrew J. Tatem3, Simon I. Hay1, Robert C. Reiner, Jr.4
1University of Oxford, Oxford, United Kingdom, 2University of 
Melbourne; University of Oxford, Oxford, United Kingdom, 3University 
of Southampton, Southampton, United Kingdom, 4Indiana University, 
Indiana, IN, United States
Between 2013 and 2016 West Africa experienced the most geographically 
extensive outbreak of Ebola virus disease (EVD) recorded to date. It 
affected all districts in Sierra Leone and Liberia and most of Guinea, 
resulting in more than 11,301 deaths among 28,603 reported cases. The 
outbreak spread from its origin in Meliandou, Guinea by movements of 
infected individuals across the region. Understanding how human mobility 
influenced the transmission dynamics of this epidemic is important in 
planning responses to future outbreaks. Using empirical data on human 
mobility, we model the effect of human movement on the geographic 
diffusion of the outbreak, as well as on the dynamics of the growth 
and decline phases of the epidemic within and between each country’s 
districts, to identify areas that were the main exporters and importers 
of disease transmission. We identify considerable spatio-temporal 
heterogeneity in transmission that is driven by human mobility both locally 
and between regions. We show that by incorporating a range of different 
human mobility models we improve predictions of both spatial spread 
and the prediction of the epidemic’s trajectory. These results provide a 
robust approach to predicting the geographic spread of future outbreaks. 
Such models are crucial information for surveillance and control strategies 
both in preparation for, and in response to, future contagious disease 
outbreaks.
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SEVEN YEARS OF INFLUENZA SURVEILLANCE IN 
PRAMONGKUTKLAO HOSPITAL, THAILAND FROM 2009 TO 
2015
Duangrat Mongkolsirichaikul1, Chuanpis Ajariyakajorn1, 
Kittinun Hussem1, Butsaya Thaisomboonsuk1, Chonthicha 
Klangthong1, Sriluck Simasathien2, Veerachai Watanaveeradej2, 
Ananda Nisalak1, Stefan Fernandez3, In-Kyu Yoon4, Damon Ellison1, 
Alden Weg1, Louis Macareo1
1Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand, 
2Phamongkutklao hospital, Bangkok, Thailand, 3Pharmaceutical Systems 
Project Management Office, Fort Detrick, MD, United States, 4International 
Vaccine Institute (IVI), Seoul, Republic of Korea
Influenza poses a constant threat to military forces around the world due 
to close living quarters and other environmental factors. The Virology 
department, AFRIMS conducted flu surveillance at Pramongkutklao 
Hospital, Thailand in order to assess this threat. Patients who presented 
with ILI were considered for enrollment. Two respiratory specimens were 
collected from each consented patient, a nasal swab for performing rapid 
testing and throat swab for RT-PCR testing / virus isolation. From 2009 
to 2015, a total of 6263 patients with ILI were enrolled. A total of 4526 
patients were negative and 1736 patients were found to be positive 
for Flu by rapid testing. Through RT-PCR testing, 2045 (32.6%) of the 
specimens were found to be positive for Flu. Of the positives, 1309 (64%) 
tested positive for Flu A (H1, H3) while 735 (36%) tested positive for Flu 
B viruses. Of Flu A subtypes, A/H1N1pdm contributed 577 (28.2%) of 
all Flu A positives while A/H3 accounted for 732 (35.8%). A subset of 
RT-PCR positive specimens were tested by virus isolation and sub-typed 
by HAI. From 2045 specimens cultured 779 (38%) yielded virus and 139 
(6.8%) specimens were positive for A/H1N1pdm, 223 (11%) specimens 
were positive for A/H3, 216 (10.5%) specimens were positive for B/
Victoria Lineage and 174 (8.5%) were positive for B/Yamagata Lineage. 
There are 26 (1.3%) Flu A specimens that could not be subtyped. All HAI 
sub-typing results correlate with RT-PCR results. For the entire surveillance 
period, specimens positive for A/H1N1pdm peaked in 2010, accounting 
for 307 (15%) of the specimens evaluated. Specimens positive for A/H3 
were most commonly found in 2015, 222 (10.8%) and those positive for 
Flu B were very common in 2010 and 2014, accounting for (9.8% and 
9.3%) of evaluated specimens, respectively. It was found that some of 
patients testing positive for influenza by RT-PCR in each year had received 
the seasonal Flu vaccine (within the last year). The vaccine efficacy was 
between 70% and 86%, except in 2014, where the level of protection 
was 28%. Most of the patients who received Flu vaccination one year 
prior to 2014 acquired Flu B, with incidence as high as 44.5%.
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PERSISTENCE OF IMMUNE RESPONSE IN EBOLA ZAIRE 
SURVIVORS FORTY YEARS AFTER INFECTION
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Okitolonda4, Muyembe Jj Tamfum1, Anne W. Rimoin2
1National Institute for Biomedical Research, Kinshasa, Democratic Republic 
of the Congo, 2University of California Los Angeles Fielding School of 
Public Health, Los Angeles, CA, United States, 3Ministry of Public Health, 
Kinshasa, Democratic Republic of the Congo, 4Kinshasa School of Public 
Health, Kinshasa, Democratic Republic of the Congo
Ebola virus (EBOV) is a zoonotic filovirus that can produce highly lethal 
disease in humans. Presentation is non-specific, characterized by vomiting, 
diarrhea, fever and bleeding. The first reported outbreak of Ebola Zaire 
(ZEBOV) occurred in 1976 in the northwestern part of the Democratic 
Republic of Congo in the Yambuku village (DRC, former Zaire). While there 
is no licensed EBOV targeted vaccine or treatment, there is a growing body 
of evidence that offers hope for finding ways to pharmacologically mimic 
or boost the natural resistance some individuals have to EBOV. To better 
understand long-term humoral immunity following EBOV infection, we 
obtained blood from 12 remaining survivors from the Yambuku outbreak 
to determine if antibodies to ZEBOV were retained 40 years post initial 
infection. Serum samples from survivors were screened and analyzed 
using Human Anti-Zaire Ebola Virus Glycoprotein (GP) IgG ELISA Assay 
kits (Alpha diagnostic International, Inc) in Kinshasa, DRC. Manufacturer 
procedures were followed for all incubation and washing steps. Cutoffs 
were calculated using the provided calibrator 1 and subtracting the 
background optical density (OD). OD values at 450nm (OD450) were 
recorded. Results demonstrate that samples obtained 40 years post 
infection contain virus specific antibodies. We identified 5 positive subjects 
(OD ≥ Cal 2.5OD), 5 weak positives subject (≥Cal 1.0 OD and <Cal 2.5 OD) 
and two negative subject (<Cal 1 OD). These results provide insight into 
the duration of humoral immune response against ZEBOV and open the 
door to in depth characterization of the immune mechanism against EBOV 
as well as further studies are needed to provide more details on long term 
sequelae of the Ebola virus disease.
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ASSESSMENT OF MISEQ NEXT GENERATION SEQUENCING 
PROCEDURE FOR VIRAL PATHOGEN DETECTION IN 
SOUTHEAST ASIA
Piyawan Chinnawirotpisan, Angkana Huang, Chonticha 
Klungthong, Wudtichai Manasatienkij, Louis R. Macareo, Damon 
W. Ellison, Stefan Fernandez, Wiriya Rutvisuttinunt
U.S. Army Medical Directorate-Armed Forces Research Institute of Medical 
Sciences, Bangkok, Thailand
Southeast Asian (SEA) countries have recently reported an increase in the 
detection and spread of emerging diseases. Currently, Next Generation 
Sequencing (NGS) is becoming an important tool for detection and 
analysis of emerging diseases. NGS is a reliable and accurate method of 
detection for emerging viral pathogens and provides critical information 
during outbreaks and routine disease surveillance. The Department of 
Virology, AFRIMS, has developed standard operating procedures and 
viral panels for performing NGS to assess the ability of laboratories to 
achieve reliable, accurate and rapid turnaround times for the detection 
of viral pathogens. The viral panels consist of the following commonly 
found viral pathogens circulating in Southeast Asia: Zika virus (ZIKV), 
dengue viruses (DENV) serotype 1-4, influenza A/pdmH1N and A/H3N2, 
and influenza B Victoria and Yamagata. Laboratories were trained to 
follow the SOPs and given the viral panel to perform NGS sequencing and 
pathogen identification. The laboratories were unaware of the viruses 
included in the panel before performing sequencing and analysis. A total 
of four different laboratories from three different countries including 
Thailand (2 laboratories), Cambodia, and Philippines were trained and 
given viral panels for sequencing. The panels were tested by 21 laboratory 
personnel from the different laboratories using the MiSeq® (Illumina) 
sequencing platform. All 21 laboratory personnel correctly identified 
the viral pathogens represented in the panel. Suggesting results from 
different locations and personnel are highly reproducible after laboratory 
technicians are trained to follow NGS sequencing SOP.
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ACCEPTANCE OF THE EBOLA VIRUS VACCINE BY THE 
COMMUNITY IN GUINEA
Sylla Thiam1, Soriba Camara2, Liz Pavlovich3, Alexandre 
Delamou4, Kabinet Kourouma2, Aboubakiry Koulibaly1, 
Mouhamadou Maodo Sow1, Bara Ndiaye1, Robert Kelty3, Josephat 
Nyagero5
1Amref Health Africa, Dakar, Senegal, 2Amref Health Africa, Conakry, 
Guinea, 3Amref Health Africa, New York, NY, United States, 4Centre de 
Formation et de Recherche de Maferinyah, Forecariah, Guinea, 5Amref 
Health Africa, Nairobi, Kenya
The rVSV-ZEBOV vaccine was tested as Prevention means to Ebola virus 
through a vaccine trial led by the WHO in the region of Lower Guinea 
between April and July, 2015. The preliminary results of this vaccine 
trial showed that the rVSV-ZEBOV vaccine was safe and effective in the 
prevention of the Ebola virus disease ten days after its administration. With 
the prospect of moving to scale up for a large part of the population, a 
study on acceptability of the vacccine was conducted to identify possible 
challenges. Interviews were conducted on the basis of a standard 
questionnaire administered to 209 people in Coyah, Forécariah, Kindia 
and Dubreka. Quantitative datas were entered in the Epidata version 
3.1 software and then exported to the software Stata 13 (Stata Corp., 
Texas, USA) for analysis. Descriptive statistics and chi square test at 95% 
confidence interval were used to measure the association of selected 
variables in the study. Nearly 78% of the people interviewed agreed to 
be vaccinated and 73% of those interviewed were willing to encourage 
their close ones and relatives to take this vaccine. Nevertheless, 22% of 
the survey participants expressed doubts or had mixed feelings about the 
vaccine. The main concerns raised in the qualitative interviews conducted 
focused on the quality of the vaccine, the side effects of the vaccine, fear 
of being contaminated by Ebola during vaccination exercise and lack of 
adequate information. Knowledge of the existence of the new vaccine was 
higher in areas where the community was involved in response activities 
(Coyah and Forecariah) than in the areas where the community was not 
involved (Dubreka and Kindia). Similarly the willingness to be vaccinated 
(p= 0.003) or encourage relatives to do the same were higher in the 
prefectures of Forécariah and Coyah compared to the Prefectures Dubreka 
and Kindia (p = 0.011).The results of this study show that there is need 
for public information on the new Ebola vaccine, especially in prefectures 
where acceptance is low, by involving local authorities, community leaders 
and community-based organisations to conduct outreach sensitization 
outreaches.
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COMPARISON OF CULTURE, SINGLE AND MULTIPLEX REAL-
TIME PCR FOR DETECTION OF SABIN POLIOVIRUS SHEDDING 
IN RECENTLY VACCINATED INDIAN CHILDREN
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1Christian Medical College, Vellore, Vellore, India, 2Institute of Infection 
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3Imperial College London, London, United Kingdom
Poliovirus identification in clinical and environmental samples is a crucial 
component of the global polio eradication program led by the World 
Health Organization (WHO). Although culture is considered the gold 
standard for poliovirus detection from stool samples, real-time polymerase 
chain reaction (PCR) has emerged as a faster and more sensitive 
alternative. In this study, we evaluated the performance of culture in the 
L20B cell line and two real-time PCR assays (for single poliovirus types and 
a one step multiplex real-time PCR) in the detection of Sabin poliovirus 
from stool samples of recently vaccinated Indian children. A random set 
of 80 stool samples from infants vaccinated with trivalent OPV (tOPV) at 
6 weeks of age was selected for the study. The samples were collected as 
part of a clinical trial (CTRI/2012/05/002677) evaluating supplementation 
with zinc and/or probiotics to enhance the immune response of oral 
rotavirus vaccine and tOPV in Indian infants which was conducted at 
Vellore, India, between July 2012, and February 2013. Of the 80 stool 
samples tested, 55 (68.75%) were positive by culture. In contrast, 61 
(76.25%) and 60 (75%) samples were positive for poliovirus by the 
single and one step multiplex real-time PCR assays respectively. If culture 
in L20B cell line is considered the gold standard for poliovirus detection, 
the sensitivity of singleplex and multiplex real-time PCR were 94.5% and 
92.7% respectively, while the specificity was 64% for both the PCR assays. 
If the PCR methods are considered the gold standard for detection, the 
sensitivity of culture was 85% and the specificity varied from 84.2% to 
80%. The quantity of virus as estimated by Ct values differed between 
culture positive and negative samples. Culture positive samples had 
significantly lower Ct values than samples that were negative in culture, 
(p<0.05), except for Sabin 3 detection by multiplex real-time PCR where 
the difference did not reach statistical significance. To conclude, the two 
real-time PCR assays for detection of single or multiple Sabin polioviruses 
in stool samples from vaccinated children were more sensitive than culture.
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THE PREVALENCE OF HUMAN PAPILLOMAVIRUS (HPV) 
GENOTYPES AMONG WOMEN WHO PRESENTED FOR 
ROUTINE PAP SMEAR TEST IN THE UNITED ARAB EMIRATES
Maryam Y. AlAli1, Nishi Singh2, Muhammad Zaman1
1Sharjah Women’s College, Sharjah, United Arab Emirates, 2Dubai 
Women’s College, Dubai, United Arab Emirates
Cervical cancer is the second most common cancer that affects women 
worldwide. Some genotypes of human papillomaviruses cause genital 
infection and can lead to cervical cancer. Therefore, the aim of this study 
was to determine the prevalence of HPV genotypes among women who 
presented themselves for a routine Pap smear test in the United Arab 
Emirates. A total of one hundred three (n=103) samples were collected 
between April-October 2011 and January-October 2012. Pap smear 
method was used to detect the abnormal cytology results of HPV. Then, 
initial test which is Digene hc2 was used to detect high/low risk HPV and 
DNA was extracted from these samples .After that, PCR was used to 
amplify the desired gene of HPV and the specific genotypes of HPVs were 
identified by an automated sequencing. One patient was excluded from 
the study because of incomplete data and a total of 102 were used for 
the final analysis. Based on the collected data, 39 (38.2%) samples out 
of 102 samples were positive for HPV DNA and 63 (61.8%) samples had 
negative results for HPV DNA. Meanwhile twenty seven (26.5%) samples 
were detected positive for HPV with PCR as well as Pap smear method. 
However, twenty (42.6%) samples were identifies positive for HPV with 
Pap smear method; were negative for HPV DNA by PCR. Among 102 
samples; HPV types were identified as following; 4.9% samples with HPV-
16, 3.9% samples with HPV-6 and 3.9% samples with HPV-53. The result 
illustrated that the most prevalent high risk HPV type among women in 
the United Arab Emirates was HPV-16. In conclusion, the high prevalence 
of carcinogenic HPV in our study, screening the normal population of 
women in the United Arab Emirates is recommended by both Pap smear 
and HPV DNA tests to avoid any false positive or negative results. The 
genotyping is essential for the decisions by the national government to 
support vaccination initiatives.
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INFLUENZA, DENGUE, CHIKUNGUNYA AND MULTI-DRUG 
RESISTANT BACTERIA SURVEILLANCE IN A PHILIPPINE 
TERTIARY HOSPITAL
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Alera1, Kathyleen Nogrado1, Ma. Nila Lopez2, Domingo Chua Jr.3, 
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1Virology Department, U.S. Army Medical Directorate-Armed Forces 
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Service School, Manila, Philippines, 3Dept of Research and Training, V Luna 
General Hospital, Philippines, 4Enterics Department, U.S. Army Medical 
Directorate-Armed Forces Research Institute of Medical Sciences, Bangkok, 
Thailand
USAMD-AFRIMS has collaborated with the V Luna General Hospital 
since 2008 in emerging and re-emerging disease surveillance including 
antimicrobial resistance. Influenza and dengue virus was identified by 
real-time and conventional Polymerase Chain Reaction (PCR) respectively. 
Bacterial identification and antibiotic susceptibility testing was conducted 
using the Microscan Walkaway 40 Plus System. Mycobacterium 
tuberculosis was identified using the GeneXpert (Cepheid). From Feb 
2008 - Mar 2016, 950/2,896 (33%) of collected respiratory specimens 
were positive for influenza: 307 FluA/H3; 325 Flu A/pdmH1; 289 Flu B; 11 
Flu A/H1. 224/552 (44%) specimens collected from Nov 2012 - Feb 2016 
were positive for dengue virus with the following serotypes detected: 
69 DENV-1, 71 DENV-2, 61 DENV-3 and 41 DENV-4. 11/112 (10%) of 
clinically diagnosed dengue cases were confirmed to be chikungunya 
after PCR testing for both dengue virus and chikungunya virus. From 
Aug 2013 - Dec 2015, 28.3% (45/159) of Klebsiella spp. isolates and 
2.7% (4/146) of Escherichia coli isolates were identified as imipenem 
resistant. 39.5% (30/76) of Acinetobacter spp. and 19.5% (30/154) of 
Pseudomonas aeruginosa isolates were resistant to all antibiotics in the 
Microscan negative breakpoint combo 30 and 34 panels. 70.4% (95/135) 
of Staphylococcus aureus isolates were methicillin resistant. 22% (18/81) 
sputum samples collected from Mar 2015 - Feb 2016 were identified as 
Mycobacterium tuberculosis and 22% (4/18) of the M. tuberculosis isolates 
were rifampicin resistant. This paper describes a research collaboration 
focusing on monitoring for emerging & re-emerging diseases in a tertiary 
military hospital setting. This information is crucial to define disease 
burden as well as to strengthen disease surveillance to better characterize 
and improve early detection and containment strategies.
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Ebola virus disease (EVD) is caused by a zoonotic filovirus infection that 
can be highly lethal in humans. Since 1976, a total of seven confirmed 
EVD outbreaks have occurred in the Democratic Republic of Congo (DRC). 
Health care workers (HCW) are at particularly high risk of EVD infection 
given the high titers of virus in bodily fluids and lack of compliance with 
precautions to prevent exposure either due to lack of knowledge, training 
or equipment. Therefore, we conducted a serosurvey among HCWs 
attending a workshop in the Tshuapa district’s capital, Boende, DRC. Field 
collection occurred in September 2015. Interviews and blood specimens 
were collected from all consenting individuals. Serum samples from 
70 HCWs based in12 health zones in Tshuapa were screened for Ebola 
virus zaire (ZEBOV) GP Ig detection using Human Anti-Zaire Ebola Virus 
Glycoprotein (GP) IgG ELISA Assay kits (Alpha diagnostic International, 
Inc.) in Kinshasa, DRC. Among the 70 health care workers, 43% (n=30) 
were seropositive for ZEBOV GP IgG, 49% (n=40) were seronegative, 
and 21% (n=17) were indeterminate. Among those seropositive, 68% 
(n=34) had participated in 1 or more EVD outbreaks of which 41% (n=14) 
had used Personal Protective Equipment (PPE). Among all HCWs, only 
10% (n=6) suspected that they had become infected with EVD, however 
none were confirmed through testing. Our findings suggest that some 
Tshuapa HCW’s may be highly exposed to EBOV. While our estimate of 
seroprevalence is higher than other studies, this may be explained by HCW 
participation in the 2014 Boende outbreak or by asymptomatic exposure 
in an endemic region. Regardless, increased biosafety training is needed to 
prevent transmission in HCWs.
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SUSCEPTIBILITY OF BAT CELL LINES R06E AND R05T DERIVED 
FROM THE EGYPTIAN FRUIT BAT TO PATHOGENIC HUMAN 
VIRUSES
Briana Benton, Jessica M. Shifflett, Sujatha Rashid
American Type Culture Collection, BEI, Manassas, VA, United States
Recent surveys have found that bats harbor viruses from at least 24 
viral families and are suspected reservoirs for many emerging human 
pathogenic viruses. While the variety of viruses identified in bats is 
staggering, many have been detected only by serology or molecular 
techniques, with the isolation of virus particles being a challenge in 
existing cell lines. Dr. Ingo Jordan’s group at ProBioGen, Germany 
developed the R06E and R05T primary cell lines as potential tools for the 
propagation of bat viruses. These cultures are adenovirus E1 immortalized 
cell lines derived from Rousettus aegyptiacus fruit bat fetal cells. Both cell 
lines have been verified by BEI Resources to be of R. aegyptiacus origin 
through cytochrome c oxidase subunit 1 (CO1) barcoding. Select viruses 
from BEI Resources were passaged in R06E and R05T to evaluate infectivity 
and the initial host cell line used for the propagation of the stock virus 
was run as a control for optimal growth. The tissue culture infectious dose 
(TCID50) was determined for each passage and cytopathic effect was 
documented. The first two viruses tested were the Sindbis (Togaviridae) 
and Tacaribe (Arenaviridae) viruses, which are known to be found in bats. 
Both bat cell lines demonstrated cytopathic effects comparable to those 
observed in Vero E6 control cell line. Susceptibility to a particular virus 
was observed in cells that did not exhibit a significant decrease in viral 
titer after three passages. Testing is underway for cell line susceptibility to 
additional virus families, including Coronaviridae (Middle East respiratory 
syndrome virus) and Flaviviridae (Zika virus). The verified pure culture R06E 
and R05T bat cell lines support the growth of zoonotic viruses detected 
in both humans and bats, and can be used to study crossover between 
human and bat pathogens. Future studies are required to demonstrate 
whether these cells support the isolation and propagation of bat viruses 
that are currently detected by molecular methods only. These cell lines 
should support further research in bat immunology and virus-host 
interactions and are available through NIAID’s BEI Resources.
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ETIOLOGY OF ACUTE FEBRILE ILLNESSES AMONG 
PREGNANT WOMEN FROM THE SENTINEL ENHANCED 
DENGUE SURVEILLANCE SYSTEM (SEDSS) IN PUERTO RICO
Francisco Colon-Rivera1, Doris Andújar-Perez1, Nicole Pérez-
Rodríguez1, Janice Pérez-Padilla2, Juan Orengo1, Jésus Cruz-
Correa1, Joaquín Laboy1, Luisa Alvarado1
1Saint Luke’s Episcopal Hospital, Ponce, PR, United States, 2Dengue 
Branch, Division of Vector-Borne Diseases, Centers for Disease Control and 
Prevention, San Juan, PR, United States
Acute febrile illnesses (AFI), characterized by undifferentiated fever, 
present a risk for pregnant women due the level of suppression of the 
immunological system during pregnancy. Fever during pregnancy has been 
consistently associated with congenital anomalies, including neural tube 
defects, craniofacial malformations, and cardiac anomalies, with 1.5-3 fold 
increased risk after febrile illness in the first trimester. There is no published 
evidence that describes the etiology of AFI during pregnancy in Puerto 
Rico, an island with endemic transmission of arboviruses such as dengue 
(DENV), chikungunya (CHIKV) and Zika (ZIKV) viruses. Our study aims to 
describe the infectious agents and outcomes of AFI during pregnancy by 
trimester of participants from the Sentinel Enhanced Dengue Surveillance 
System (SEDSS), a facility-based epidemiologic platform established in 
southern PR. Pregnant women with fever of <7 days were enrolled from 
May 7, 2012 to May 6, 2015. Clinical data was collected and specimens 
were obtained and tested by RT-PCR and immunodiagnostic methods 
as appropriate for DENV-1-4, CHIKV, Leptospira species, enteroviruses, 
influenza A/B viruses, and other respiratory viruses. A total of 152 
pregnant women were enrolled in SEDSS, half (46%) of which were 
aged 20-24 years. A pathogen was identified in 93 (61%) cases: 56 
(37%) had CHIKV, 23 (15%) influenza A/B virus, 6 (4%) DENV, 5 (3%) 
other respiratory virus, 2 (1%) enterovirus and 1 (1%) co-infected. When 
analyzing by trimester of pregnancy, one (1.1%) DENV and 2 (2.2%) 
CHIKV cases were found during the first trimester; 3 (3.2%) DENV and 25 
(26.9%) CHIKV during the second; and 2 (2.2%) dengue and 26 (28%) 
CHIKV during the third. All DENV cases were diagnosed between 2012 
(n=4) and 2013 (n=2) and all CHIKV cases between 2014 (n=53) and 
2015 (n=3). In conclusion, the surveillance system was able to identify 
pathogens associated to AFI during pregnancy. The most recent CHIKV 
outbreak contributed the majority of the cases presenting in pregnant 
women. Of interest are the outcomes of the mother and newborns, for 
which analysis is currently being done and will be presented.
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LEISHMANIA INFECTION IN SANDFLIES IN A CUTANEOUS 
LEISHMANIASIS FOCUS IN GHANA
Mba-Tihssommah Mosore1, Andy Asafu-adjaye1, Naiki 
Puplampu2, Seth Addo1, Paul A. Bates3, Michael D. Wilson1, Daniel 
A. Boakye1
1Noguchi Memorial Institute For Medical Research, Accra, Ghana, 2U.S. 
Naval Medical Research Unit - 3, Ghana Detachment, Accra, Ghana, 
3School of Health and Medicine, Division of Biomedical and Life Science, 
Lancaster University, Lancaster, United Kingdom
The distribution and Leishmania infection in sandflies was examined 
in the endemic cutaneous leishmaniasis (CL) communities of the Volta 
region, Ghana. CL was first report in 1999 by the Ghana Health Service 
in the Ho, Hohoe and kpando municipality. Since the first outbreak of 
the disease, there have be increasing reports of the disease in various 
villages in the Volta Region of Ghana. In this study, to identify natural 
infection by Leishmania sp. in insect vectors of CL, entomological survey 
was performed in three endemic communities (Dodome Awiasu, Dodome 
dogblome and Lume atsyame) in the Volta region. From October 2012 
to February 2013, a total of 4219 female sandflies were captured with 
CDC light traps and dissected for morphological identification. It was 
observed the 20(0.5%) female sandflies were identified from the genus 
Phlebotomus and 4199 (99.5%) from the Sergentomyia. To determine 
leismania infection in female sandlies, DNA was extracted from pools of 
sandfly species ranging from 1 to 25 dissected females. In considering the 
pools of individual sandfly species, Leishmania sp. infection of 0.0384% 
was detected in a pool of 7 (5.7%) S. africana female sandflies out of 122 
pools using PCR. This is the first report of natural infection by Leishmania 
sp. in S. africana in Ghana. This observation that S. africana are naturally 
infected by Leishmania sp., suggest that the sandfly species might play a 
role in the transmission of cutaneous leishmaniasis within the Volta Region 
of Ghana.
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MEGALOPYGE OPERCULARIS: THE STING THAT KEEPS ON 
STINGING, 1798-2016
David Adams1, Femi T2, Sarah Jillson2, Tatiana Eversley2
1Mercer University School of Medicine, Savannah, GA, United States, 
2Armstrong State University, Savannah, GA, United States
Megalopyge opercularis (Order: Lepidoptera) is known commonly by 
a number of monikers, most notably the “wooly asp” and the “puss 
caterpillar.” First described by the pioneering English lepidopterist, James 
Edward Smith in 1798, the Megalopyge opercularis quickly gained a 
reputation for its painful “urticating sting.” In the more than two centuries 
that have passed since Smith first described the Megalopyge opercularis, 
a steady flow of studies has made it one of the most widely studied of 
the “urticating lepidoptera.” This presentation will examine reports on 
Megalopyge opercularis since the late 18th century. Particular attention 
will be paid to their place within the historical development of medical 
entomology.
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ECTOPARASITE INFESTATION OF A HOSPITAL DUE TO 
NESTING CLIFF SWALLOWS
Norman L. Beatty1, Stephen A. Klotz1, Sean P. Elliott2
1Division of Infectious Diseases, Department of Medicine, University of 
Arizona College of Medicine Tucson, Banner University Medical Center 
Tucson, Tucson, AZ, United States, 2Professor and Associate Chair, 
Department of Pediatrics Director, Pediatric Residency Program Medical 
Director, Infection Prevention Banner University Medicine Division, Tucson, 
AZ, United States
The Cliff Swallow (Petrochelidon pyrrhonota) is a migratory passerine that 
constructs conical mud nests in colonies during the summer throughout 
North America. A large colony of swallows was established in the 
window eaves of a hospital. In July of 2015 the Infection Prevention 
Committee was informed of unusual “bugs” found in patient rooms. 
Two avian ectoparasites were identified, Argas cooleyi (argasid tick) and 
Oeciacus vicarius (swallow bug). Initial surveillance revealed ectoparasites 
in twenty-two locations (hallways, entrance points, and patient rooms) 
correlating with the presence of swallow nesting sites. Eradication of 
the ectoparasites was executed over a six-month period which included 
insecticide application and re-caulking of window sills throughout the 
structure. However, the swallows were not disturbed during their nesting 
period as required by the Migratory Bird Act and by late November of 
2015 the birds had migrated. Removal of the abandoned nests (n=267) 
soon followed. Installation of bird netting in locations of prior and/or 
potential nesting sites completed the project. Since the discovery of this 
infestation, bimonthly surveillance took place to assess the ectoparasite 
burden. Decreasing numbers were recorded with each month and by 
the end of December 2015 no more ectoparasites were discovered. 
Argasid ticks are known to opportunistically feed on humans in the right 
circumstances. The collected ticks (n=237) were tested for the presence 
of human blood by an immunohistochemical test specific for human 
glycophorin A (surface protein on red blood cells). The results indicated 
that human blood was present in some of the collected ticks. The nesting 
of Cliff Swallows on man-made structures, including medical facilities, may 
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facilitate an accompanying ectoparasite infestation as demonstrated in 
this case. Argasid ticks are known vectors worldwide in the transmission 
of arboviruses and bacterial (Borrelia and Rickettsia species) pathogens 
that can infect both animal and human hosts. This unusual ectoparasite 
infestation involved two arthropods whose domiciles needed to be 
removed in order to eradicate them.
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FIRST DETECTION OF LEISHMANIA TROPICA IN NATURALLY 
INFECTED PHLEBOTOMUS PAPATASI (DIPTERA: 
PSYCHODIDAE) IN NORTH SINAI, EGYPT
Noha W. Ibrahim1, Christopher M. Hinnerichs2, Rania M. Kaldas1, 
Joseph W. Diclaro II1
1U.S. Naval Medical Research Unit - 3, Cairo, Egypt, 2U.S. Force Preventive 
Medicine, MFO, Sinai, Egypt
Cutaneous Leishmaniasis (CL) is endemic in the Middle East and prevalent 
in the Sinai Peninsula, Egypt. Cutaneous Leishmaniasis is caused by 
Leishmania major or L. tropica. Leishmania major is transmitted by a bite 
of female Phlebotomus papatasi (P. papatasi), the principal sand fly vector 
throughout the Mediterranean basin, Middle East, Central Asia, and East 
Africa. Leishmania tropica occurs widely in Israel, Jordan Valley, and the 
Negev Desert. Personnel participating in the peace keeping in the Sinai-
based Multinational Force and Observers (MFO) camps, are at risk to sand 
fly bites. Herein we describe surveillance of Leishmania disease vectors in 
the Sinai. Vector surveillance was conducted at multiple MFO remote sites 
using the Centers for Disease Control and Prevention (CDC) light traps. 
Species identification was done based on the morphological characters. 
Leishmania species was detected by amplification of the small-subunit 
ribosomal RNA (ssu rRNA) gene. Phlebotomus papatasi (Scopoli) comprised 
999 (97%) of 1,030 collected sand flies. Out of 354 tested P. papatasi 
females, 106 (29.9%) of 354 were positive for Leishmania ssu rRNA 
gene by Real-time PCR. Restriction fragment length polymorphism (RFLP) 
typing of the internal transcribed region (ITS1) of ssu rRNA amplicons from 
positive samples confirmed L. tropica and L. major fingerprints. Twenty of 
106 (19%) females captured were infected with L. tropica, while 86 (81%) 
females were infected with L. major. This study reports the first detection 
of L. tropica in P. papatasi from Sinai, Egypt. The abundance of infected 
and non-gravid P. papatasi suggests a vectorial capacity of this species to 
transmit L. tropica. This work emphasizes the value of systematic survey of 
Leishmania reservoir hosts and vectors.
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DEVELOPMENT OF A MULTIPLEX REAL-TIME PCR ASSAY 
FOR IDENTIFICATION OF PHLEBOTOMUS SAND FLY SPECIES 
INVOLVED IN LEISHMANIA TRANSMISSION
Nermeen T. Fahmy, Jeffrey T. Villinski
U.S. Naval Medical Research Unit - 3, Cairo, Egypt
Phlebotomine sand flies (Diptera, Psychodidae, Phlebotominae) are 
the principal vectors of Leishmania parasites. Phlebotomine vectors 
are significant threats to public health in areas such as North Africa, 
the Mediterranean basin and the Middle East. Of 800 sand fly species 
published, 10% are competent vectors of Leishmaniasis. Identification of 
sand flies in Leishmania-endemic areas is paramount. Morphological sand 
fly identification, a process reliant on discernment of delicate features, 
is time consuming and requires taxonomic expertise. Molecular-based 
identification methods provide an alternative approach to morphological 
identification; however few studies have developed PCR techniques to 
discriminate between specific sand fly species. Here we describe the 
development of a multiplex TaqMan real-time PCR assay for the detection 
of three Leishmania vector species (Phlebotomus papatasi, Ph. sergenti, 
and Ph. alexandri) in a single reaction. DNA was extracted from individual 
Phlebotomus sandfly species that have been maintained in continuous 
laboratory colonies. We design three species-specific primers and TaqMan 
probes targeting a consensus region of 18S ribosomal DNA gene using 
sequences retrieved from the GenBank in addition to other in-house 
sequences generated from individual Phlebotomus specimens (target 
species) and Sergentomyia specimens (non-target species). To evaluate the 
sensitivity of the assay serial dilutions of the three target species in mixed-
pools were prepared at ratios ranging from 1:10 to 1:50. Mixed-pools 
of target to non-target species were used to determine the specificity 
of the assay. This TaqMan multiplex real-time PCR method identified Ph. 
papatasi, Ph. sergenti, and Ph. alexandri effectively, and demonstrates a 
higher sensitivity up to a dilution of 1:20. Mixed pools of target and non-
target species showed the assay to be 100% specific. The present study 
provides a quick and reliable one-step multiplex assay for the identification 
of Leishmania vectors in field-caught sand flies where pools of vector and 
non-vector species share the same ecological niche.
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IMMUNE MODULATING MOLECULES OF SARCOPTES SCABIEI
Marjorie Morgan, S. Dean Rider, Jr., Larry G. Arlian
Wright State University, Dayton, OH, United States
The ectoparasitic mite Sarcoptes scabiei uses a variety of mechanisms to 
evade its host allowing a parasitic colony to become established. One of 
these strategies involves modulation of the innate and adaptive immune 
responses in the host skin. Having previously sequenced the scabies 
mite genome and characterized > 200 of the proteins produced by this 
mite, we are now seeking to identify the molecules that this mite uses 
to immunomodulate the function of fibroblasts and endothelial cells of 
the microvasculature of the host dermis. Several proteins were selected 
for study and their genes were chemically synthesized and cloned into 
appropriate vectors for expression in Escherichia coli. Fusion proteins 
were purified and used to challenge normal human dermal fibroblasts 
(NHDF) and microvascular endothelial cells (HMVEC). Two of these clones 
stimulated the secretion of IL-6, IL-8, and GCSF by NHDF and of IL-6 and 
GM-CSF by HMVEC in a dose dependent manner. These responses are 
similar to the cellular responses to whole scabies mite extract suggesting 
that these molecules may be among those used by the mite to protect 
itself from the host. Neither protein bound antibody from the serum of any 
scabies infested hosts tested suggesting that they are able to evade the 
host’s adaptive immune system as well.
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CONCEALED ANTIGENS AS VACCINE TARGETS FOR 
CONTROLLING TRIATOMINES, VECTORS OF CHAGAS 
DISEASE
Alice C. Sutcliffe1, Rick L. Tarleton2, Ellen M. Dotson1, Donald E. 
Champagne2
1Centers for Disease Control and Prevention, Atlanta, GA, United States, 
2University of Georgia, Athens, GA, United States
Controlling triatomine (Hemiptera:Reduviidae) bugs is an important 
aspect of managing the spread of Trypanosoma cruzi, the causative 
agent of Chagas disease, for which no vaccine is currently available. 
Triatomine control methods depend on insecticide use and environmental 
management. Insecticide resistance and the ecology of some triatomine 
species, that tend to persistently re-invade domestic and peridomestic 
structures following the application of these control methods, may require 
additional control approaches. The development of a triatomine vaccine to 
target the insect vector would provide an additional prevention and control 
method. Vaccination of animal hosts with triatomine antigens would cause 
the hosts’ immune system to produce antibodies that would be ingested 
in a blood meal. Many proteins within the triatomine salivary glands and 
midgut are critical to the acquisition and digestion of obligatory blood 
meals. Thus, inhibiting one or more of these proteins using ingested 
antibodies could interrupt important biological processes required for 
triatomine survival. To this end, the selection, recombinant expression and 
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vaccine evaluation of twelve Rhodnius prolixus (Hemiptera:Reduviidae) 
midgut protein targets are discussed as well as the concept of “exposed” 
and “concealed” antigens.
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OVIPOSITION ATTRACTANTS OF PHLEBOTOMUS PAPATASI - 
PRELIMINARY RESULTS
Gideon Wasserberg1, Bahjat Fadi Marayati2, Loganathan 
Ponnusamy3, Charles Apperson3, Madhavi Kakumanu3, Eduardo 
Hatano3, Coby Schal3
1University of North Carolina at Greensboro, Greensboro, NC, United 
States, 2Wake-Forest University, Winston Salem, NC, United States, 3North 
Carolina State University, Raleigh, NC, United States
Phlebotomine sand flies transmit protozoan parasites (Leishmania spp.), 
bacterial (Bartonella bacilliformis), and viral pathogens. An alternative 
approach to the traditional delivery of an insecticide to the vector is to 
bring the vector to the insecticide using an attractant. In the context 
of controlling vector-borne disease, oviposition-site attractants are 
expected to be highly effective because they target gravid females that 
are responsible for transmission of the pathogen and amplifying vector 
populations. Decomposing organic matter is the main food source for sand 
fly larvae. We therefore hypothesize that gravid sand flies are differentially 
attracted in a dose-dependent manner to a blend of fecal- and microbially-
derived chemical cues associated with the decomposition of fecal 
material, as well as to signals from eggs and larvae which indicate suitable 
oviposition sites. Our overall goal is to develop and optimize an attractive 
blend of semiochemicals that would function as a lure for oviposition-site 
seeking sand fly females using Phlebotomus papatasi (vector of old-world 
cutaneous leishmaniasis) as a model system. We will apply an integrated 
interdisciplinary approach including behavioral, electrophysiological, and 
microbiological studies to address the following specific aims: (1) Identify 
the most attractive and oviposition stimulating conspecific stages, rearing 
medium, and saprophytic microbes; (2) Isolate and identify oviposition 
attractants and stimulants from the most attractive conspecific stage, 
rearing medium, and microbial isolates; and (3) Develop an optimal 
blend of oviposition attractants and stimulants and evaluate it at the 
micro- and meso-scales. This proposed study introduces several novel and 
innovative approaches including: (1) Application of an integrated approach 
including behavioral, electrophysiological, analytical and microbiological 
investigations; (2) Study a neglected aspect of oviposition - the role of 
saprophytic fungi as indicators of suitable oviposition sites; (3) Evaluate the 
effectiveness of the optimized blends at the scale of meters using a wind-
tunnel.
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RNASEQ OF WILD CAUGHT SAND FLY PHLEBOTOMUS 
CHINENSIS FROM SICHUAN, CHINA
Yuhao Lan1, Huiyin Chen2, Yan Wang2, Kali Li2, Wanqin Yu1, Yajun 
Ma2, Jiannong Xu1
1New Mexico State University, Las Cruces, NM, United States, 2Second 
Military Medical University, Shanghai, China
Sandfly Phlebotomus chinensis is responsible for the transmission of 
visceral leishmaniasis in China. In this study we conducted RNA-seq for 
head and body of both male and female sandflies to determine the 
transcriptional differences between females and males, head and body. 
Wild caught sandfly specimens were collected in an endemic region in 
Sichuan, China. cDNA libraries of male heads and male bodies, female 
heads and female bodies were prepared for RNAseq using Illumina paired-
end sequencing technology. Approximately 128 million clean reads were 
assembled into 32,628 unigenes with an average length of 1,235 bp, an 
N50 of 2,551 bp, and an average GC content of 47.88%. All unigenes 
have good hits against Nr, 26,601 (46%) have Swiss-Prot hits, 5,244 
(19.15%) have KEGG annotation. Furthermore, a total of 256,890 SNPs 
were identified. Transcriptomic comparisons between head vs. body as 
well as males vs. females revealed ~5,000 unigenes that were deferentially 
expressed between these samples. Our RNAseq data provide a 
comprehensive transcriptomic resource for Ph. chinensis, and will facilitate 
further studies on genetic and genomics. The genome of Ph. chinensis has 
been sequenced. Efforts are now underway to assemble and annotate the 
genome.
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TOXICITY OF PLANT EXTRACTS AND PYRETHROIDS TO 
CATTLE TICK, BOOPHILUS SPECIES (IXODIDA : IXODIDAE)
Edith N. Nwankwo1, Patricia N. Okorie2, Bright C. Agwara1, 
Confidence U. Ogbonna3, Peter C. Okeke4, Nnaemeka J. 
Okonkwo1
1Nnamdi Azikiwe University, Awka, Nigeria, 2Institute for Advance Medical 
Research and Training College of Medicine, University of Ibadan, Ibadan, 
Nigeria, 3Department of Biology, Federal University of Ndufu Alike Ikwo, 
Abakiliki, Nigeria, 4African Regional Postgraduate Programme in Insect 
Science, University of Ghana, Legon, Ghana
Ticks transmit protozoan, bacterial, rickettsial and viral pathogens to 
both human and animals worldwide leading to enormous economic 
losses to the livestock industry. However, the indiscriminate use of 
synthetic acaricides for tick control has contributed to the development 
of resistance in tick population. There is an urgent need to search for 
effective and safe alternative means of control. A laboratory evaluation 
was therefore carried out to determine the toxicity of aqueous extracts 
of two plants (Azadirachta indica and Annona muricata leaf) and two 
synthetic pyretheroids (deltamethrin and lambda-cyhalothrin) to tick 
species of cattle (Boophilus species). Wild adult ticks collected from cattles 
around Amansea, Awka, Anambra state, Nigeria were exposed to the 
acaricides using adult immersion test. Five concentrations of the plant 
extracts (500, 250, 125, 62.5 and 31.2µL/mL) and synthetic pyrethroids 
(50, 25, 12.5, 6.25 and 3.12µg/mL) were used to immerse 10 active adult 
Boophilus ticks. Each concentration was done in duplicate and replicated 
thrice and a control was included. Mortality post exposure was monitored 
and recorded at 24, 48, 72 and 96 hours and data was analysed using 
log-probit regression analysis. Results showed that dose-related mortality 
responses were observed at different time intervals. Mortalities of 100% 
and 76.7% respectively was recorded for A. indica and A. muricata 
at 50% concentration while exposure to deltamethrin and lambda-
cyhalothrin resulted in 86.7% and 76.6% mortality respectively at 50µg/
mL concentration. LD50 values for adult Boophilus ticks were 5.36% and 
14.40% for A. indica and A. muricata while that of deltamethrin and 
lambda-cyhalothrin were 6.00µg/ml and 2.25µg/ml respectively. The LT50 
values were 63.66 and 119 hours for A. indica and A. muricata and 66.69 
and 76.13 hours for deltamethrin and lambda-cyhalothrin respectively. The 
study suggests that botanical extracts could serve as a good alternative to 
synthetic acaricides.
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A BANDIT MODEL TO OPTIMIZE ENTOMOLOGICAL SURVEYS
Sarah K. Nutman1, Alexander Gutfraind2, Erica Billig1, Ricardo 
Castillo-Neyra3, Michael Z. Levy1, Zoonotic Disease Research Group 
in Arequipa, Peru
1University of Pennsylvania, Philadelphia, PA, United States, 2University of 
Illinois Chicago, Chicago, IL, United States, 3Universidad Peruana Cayetano 
Heredia, Arequipa, Peru
Although vector-control campaigns have prevented considerable 
morbidity and mortality from vector-borne diseases, there is increasingly 
a need to find strategies that accurately and efficiently identify foci of 
transmission based on limited information. Currently, control strategies 
rely on systematic screening for infestations and require time- and 
resource-intensive surveillance, while less resource-intensive reactive 
control strategies are often inadequate to detect the emergence or re-
emergence of disease vectors. We propose and test a novel spatial search 
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strategy. Our strategy uses a multi-armed bandit algorithm to select 
among a number of proposed search areas each day based on results 
from previous days, and ultimately localizes searches to the most heavily 
infested areas. As an online optimization strategy, it obviates the need 
for preliminary surveys and responds to changing conditions experienced 
by the field teams. Furthermore, as a bandit strategy, the algorithm is 
designed to optimally balance between exploiting high-prevalence areas 
and exploring unknown areas that may have a high infestation burden. 
We investigate the properties of this strategy using simulation studies and 
apply it to retrospective data from several recent vector-control campaigns 
in Arequipa, Peru.
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VECTOR CONTROL USING LONG-LASTING INSECTICIDAL 
NETS AGAINST VISCERAL LEISHMANIASIS IN BANGLADESH
Chizu Sanjoba1, Yusuf Ozbel2, Bunpei Tojo3, Eisei Noiri3, 
Yoshitsugu Matsumoto1
1The University of Tokyo, Tokyo, Japan, 2Ege University of Faculty of 
Medicine, Izmir, Turkey, 3The University of Tokyo Hospital, Tokyo, Japan
Vector control takes on a role as important part in controlling the diseases 
transmitted by arthropods such as leishmaniasis. Visceral leishmaniasis (VL) 
is one of the major public health problem in Bangladesh, but the most 
appropriate vector control measures is still a matter of debate. Here, the 
efficacy of permethrin treated long-lasting insecticidal nets (LLINs), Olyset® 
and Olyset® Plus against field collected sand flies was evaluated in a VL 
endemic area in Bangladesh. Sand fly bioassays were conducted according 
to the WHO-approved cone test methodology with modification. A 
major species of tested sand flies (91.28%) was Phlebotomus argentipes. 
Sand flies were introduced into a plastic cone attached with a piece of 
Olyset® or Olyset® Plus for 3 min and mortality and knock down rate were 
continuously recorded until 24 hrs after the exposure. Approximately 20-
25 sand flies were used in each set, and the tests were repeated 4 times. 
The mortality of sand flies recorded on 24 hrs was 100% in Olyset® Plus 
group while that mortality of sand flies in Olyset® group was 83.63% 
(corrected mortality = (% test mortality − % control mortality) / (100 − 
% control mortality) × 100). The knowledge, attitude and practice of 
people live in endemic area about VL are also essential in order to propose 
successful vector control strategies. Therefore, questionnaire-based survey 
was also demonstrated to know whether the vector control using LLINs 
is sustainable application for the people lived in endemic are or not. 
The questionnaire was consists of three sections, socio-demographic 
characteristics, knowledge of VL and history of VL, and perceptions of VL 
vector control. Based on the analysis of 1393 households, the knowledge, 
attitude and practice of people live in endemic area about VL were 
relatively low. Though utilization of LLINs is promising, its ownership is 
noticeably low. Vector control using permethrin treated LLINs can be one 
of a potential tool for reducing the morbidity rate of VL in endemic area 
in Bangladesh. This works was supported by Science and Technology 
Research Partnership for Sustainable Development.
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EXPERIMENTAL SUSCEPTIBILITY OF LUTZOMYIA 
LONGIPALPIS TO DIFFERENT SPECIES OF LEISHMANIA
Ana Clara M. Pires, Paulo F. Pimenta, Nagila F. Secundino
FIOCRUZ-MG, Belo Horizonte, Brazil
In order to better understand the epidemiology of leishmaniasis and 
the parasite transmission it is important to develop studies on the 
Leishmania-vector interaction. The knowledge of the process of the sand 
fly-parasite interaction can contribute for new control strategies of a 
disease that until now has no effective vaccine a and limited range of 
drugs for the treatment. In nature, some sandfly species show remarkable 
specificity to transmit an exclusive Leishmania species (non-permissive 
vector) while others can be vectors of more than one parasite species 
(permissive vector). However, in in the laboratory some sandfly like 
Lutzomyia longipalpis, exclusive vector of L. chagasi infantum, can be 
experimentally infected by different parasite species. Here, we analyzed 
in details the development of four Leishmania species: Leishmania major, 
L. amazonensis, L. braziliensis and L. chagasi in the Lu. longipalpis, a 
New World sandfly. Experimental infections were conducted using three 
parasite doses (4x107, 2x107 and 1x107) achei que fossem 4 doses mixed 
with mouse blood. Our data demonstrated that Lu. longipalpis is capable 
of sustaining infection by L. infantum chagasi, L. amazonensis and L. 
major, but not by L. braziliensis, which only developed infection when the 
vector ingested a high dose of parasites and even so, with low parasitic 
density. We also showed that infection rates of the Lu. longipalpis are 
correlated with the amount of ingested parasites. This study characterizes 
important aspect of the Lu. longipalpis vector competence.
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PRELIMINARY CHARACTERIZATION OF POTENTIAL SAND 
FLY VECTORS IN LEISHMANIASIS AND BARTONELLOSIS 
ENDEMIC AREAS IN THE PERU-ECUADOR BORDER
Victor Zorrilla1, Liz Espada1, Marisa Lozano1, Victor Ocaña2, Mario 
Troyes2, Craig Stoops1, Gissella Vasquez1
1U.S. Naval Medical Research Unit - 6, Callao, Peru, 2Peruvian Ministry of 
Health, Lima, Peru
Leishmaniasis and bartonellosis are known to be endemic in the Peru-
Ecuador border, yet information about the sand fly vector species 
incriminated in transmission of both diseases is lacking. A major 
bartonellosis outbreak was reported in the Peruvian side of this region in 
2013-2014 with 622 cases reported in Piura department and 159 cases 
in Cajamarca province. Concurrently, 417 and 85 leishmaniasis cases 
were reported in Piura and Cajamarca, respectively. The goal of this study 
was to characterize the sand fly fauna and potential bartonellosis and 
leishmaniasis vectors in sites with the highest prevalence of both diseases 
in this region: Lalaquiz (Piura; 1027 m.a.s.l) and Namballe (Cajamarca; 
1197 m.a.s.l). Sand flies were collected in July 2015 and January 2016 
using standard CDC light traps, CDC blue LED traps, CDC UV traps and 
Mosquito Magnet trap. A total of 464 adult Lutzomyia sand flies were 
captured; 22 from Lalaquiz (5%) and 442 from Namballe (95%). Standard 
CDC light trap and Mosquito Magnet trap collected the highest proportion 
of sand flies in Lalaquiz (45%) and Namballe (59%). The most abundant 
sand fly species collected from Lalaquiz were Lu. castanea (23%) and 
Lu. shannoni (23%); other species included Lu. ayacuchensis, Lu. gomezi 
and members of the Verrucarum and Micropygomyia Groups. Lutzomyia 
maranonensis (38%), Lu. robusta (35%), and Lu. castanea (27%) were 
recorded in Namballe. Differences in sand fly species composition between 
sites may be related to ecological factors. Our preliminary results suggest 
that different species could play a role in leishmaniasis and bartonellosis 
transmission at study sites. In Lalaquiz, Lu. ayacuchensis and Lu. gomezi 
are potential vectors of both diseases, while in Namballe, the potential 
vectors are Lu. maranonensis and Lu. robusta. Future studies will include 
assessing Leishmania and Bartonella infection rates to further characterize 
potential regional vectors of both diseases and contribute entomological 
risk information for military and civilian populations in the Peru-Ecuador 
border.
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NUTRITIONAL STATUS, FREQUENCY OF HUMAN BLOOD 
MEALS, AND TRYPANOSOMA CRUZI INFECTION OF 
TRIATOMA DIMIDIATA IN YUCATAN, MEXICO
Silvia Pérez Carrillo, Joel Moo Millan, Eric Dumonteil, Etienne 
Waleckx
Universidad Nacional Autonoma de Yucatan, Mérida, Mexico
In Yucatan, the causative agent of Chagas disease, Trypanosoma cruzi, is 
transmitted by the hematophagous bug Triatoma dimidiata. In order to 
evaluate human/vector/parasite contact, and clarify the parasite cycles of 
transmission in the region, we are currently assessing by PCR the presence 
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of vertebrate and human blood meals, and the presence of the parasite 
in T. dimidiata specimens collected in sylvatic and domestic/peridomestic 
ecotopes in 3 rural communities of Yucatan. At this time, 222 bugs (100 
males, 113 females, and nine 5th instar nymphs) have been tested for 
infection with T. cruzi. Of them, 33% were infected; infection prevalence 
did not differ significantly between males (33%, 33/100) and females 
(35%, 39/113) (χ2=0.05, p=0.8); 22% of nymphs (2/9) were found 
infected. Infection rate of sylvatic bugs (45%, 34/75) was significantly 
higher than infection rate of (peri)domestic bugs (27%, 40/147) (χ2=7.4, 
p=0.007). This may be due to different blood feeding sources between 
sylvatic and (peri)domestic bugs. Vertebrate blood meals were detected 
in 45/62 (73%) bugs tested. Of the 45 detected blood meals, 10 (22%) 
were human blood meals. All human blood meals were detected in (peri)
domestic bugs. Thirty percent of human-fed bugs were infected with 
T. cruzi, confirming the risk of parasite transmission to human. Cloning 
and sequencing is now been used to identify the different vertebrate 
blood meal sources, and possible associations between T. cruzi infection 
and the different vertebrates. At this time, Homo sapiens (human), Canis 
lupus familiaris (dog), and Zenaida macroura (Mourning dove) have been 
identified. This work will help us to better understand the feeding behavior 
of T. dimidiata and to accurately describe the parasite transmission cycles 
occurring in Yucatan, Mexico.
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THE LUTZOMYIA LONGIPALPIS MICROBIOTA ASSOCIATED 
WITH INFECTION BY LEISHMANIA INFANTUM CHAGASI
Luciana C. Pinto, Ana Clara M. Pires, Luiz M. Villegas, Thais B. 
Campolina, Alessandra A. Orfano, Paulo F. Pimenta, Nagila F. 
Secundino
René Rachou Research Centre- FIOCRUZ, Belo Horizonte, Minas Gerais, 
Brazil., Belo Horizonte, Brazil
Lutzomyia longipalpis is the main vector of Leishmania chagasi, which is a 
protozoan transmitted by sandfly bite. During blood feeding on infected 
vertebrates, sandflies can ingest the parasites. In the midgut, the parasites 
interact with the native microbiota. This interaction may contribute to the 
metabolism of the insect providing resistance against natural enemies and 
parasites and also, affects the immune and reproduction. The microbiota 
diversity in sandflies is well known but their role on parasite infection 
is still not clear. Our aim was to identify the microbiota role associated 
with Leishmania infection in the sandfly L. longipalpis. The microbiota 
diversity was determined by metagenomic method using next generation 
sequencing (NGS) of the 4 sandfly experimental groups: sugar-fed, blood 
-fed, infected-blood fed and gravid. We used the multivariate method 
NMDS to analyze the results. It was observed that the two groups of 
sandflies that were fed on blood separated from the other two other 
groups. This observation was firstly based on the abundance of bacterial 
family profiles. However, the Multivariate Analysis using PCA showed 
the similar profile. Throughout these analysis, it was possible exclusively 
identify in the blood-fed sandflies the bacteria family Xanthomonadaceae. 
Distinctly, in the infected-blood fed sandflies, it was identify the 
following families: Enterobacteriaceae, Enterococcaceae, Bacteroidaceae, 
Coxiellaceae, Flameovirgaceae, Deferribacteraceae, Glycomycetaceae. Our 
results demonstrated that the bacterial community in blood-fed differs 
from infected blood-fed L. longipalpis. In vivo studies are necessary in 
order to show how bacteria interfere in the growth of the parasite.
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A REVERSE TRANSCRIPTASE PCR ASSAY FOR THE 
IDENTIFICATION OF DIROFILARIA IMMITIS INFECTIVE (L3) 
LARVAE IN MOSQUITOES
Simone J. Thompson, Eric W. Chambers
Valdosta State University, Valdosta, GA, United States
Dirofilariasis, a mosquito-transmitted disease, is caused by parasitic 
nematode worms from the genus Dirofilaria. Dirofilaria immitis is 
principally associated with infections of domestic canines and felines 
but it is also capable of infecting a wide-range of mammalian species 
including humans. Current molecular assays for detecting D. immitis 
DNA in mosquitoes by PCR are unable to differentiate between infected 
mosquitoes that contain any stage of parasite DNA and infective 
mosquitoes that harbor third-stage larvae (L3), the larval stage capable 
of establishing infections in canines and other mammals. D. immitis has 
the potential to be a major public health concern due to its distribution in 
tropical, subtropical, and temperate regions around the world. However 
cases of human dirofilariasis are likely under reported due to a dearth of 
knowledge concerning the epidemiology and risk factors associated with 
this disease. The ability to identify mosquitoes that are both competent 
vectors of D. immitis and could infect humans (based upon known 
host feeding preferences), could play an important role in estimating 
transmission risks to humans. We have developed a detection assay for D. 
immitis in a model system using the mosquito, Aedes aegypti, based on 
a conventional RT-PCR assay that detects an L3-activated gene transcript. 
Potential L3 genes were identified using bioinformatics tools and were 
screened by RT-PCR using D. immitis stage-specific mRNA libraries as 
templates. Candidate genes were screened for stage-specific expression 
using RNA isolated from both D. immitis infected and uninfected 
mosquitoes. This L3 specific gene combined with a D. immitis specific 
control gene, expressed in all vector-stage filarial larvae, can be utilized to 
accurately identify mosquito species capable of transmitting this zoonotic 
disease.
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ARE THE POPULATIONS OF TRIATOMA INFESTANS FROM 
SANTIAGO DEL ESTERO, ARGENTINA, RESISTANT TO 
PYRETHROIDS
Andrea Gómez-Bravo1, Claudia Vassena2, Raúl A. Alzogaray2, 
Eduardo Zerba2, Marcelo C. Abril1
1Fundación Mundo Sano, Buenos Aires, Argentina, 2Centro de 
Investigaciones de Plagas e Insecticidas (CIPEIN), Villa Martelli, Argentina
Under the vector surveillance and control program for Triatoma infestans 
that Mundo Sano has in place since 2002 in the urban and surrounding 
rural areas of Añatuya (Santiago del Estero Province), monitoring of 
insecticide resistance was implemented in 2014. The objective was to 
evaluate the susceptibility of T. infestans samples from this area to the 
pyrethroid deltamethrin, active ingredient found in the most widely used 
formulations for triatomine control. Bioassays were performed following 
the World Health Organization protocol for the evaluation of insecticidal 
effect on triatomines. First instar nymphs obtained in the laboratory from 
adult insects collected in the field (F1 generation) were used. Mortality was 
evaluated 24 hours after topical application of the discriminant dose (2 
ng/insect). The CIPEIN and La Pista (resistant to deltamethrin) strains were 
used as negative and positive controls, respectively. Possible resistance 
was considered when survival was observed in at least one insect in two 
of every three independent assays. Percent mortality for the different 
collection sites were: El Desvio 90%; Barrio Sportivo, 75%; Miel de Palo, 
70%; Lote 47, 38%. These results suggest that some of the populations 
evaluated present early-stage resistance to deltamethrin. New assays will 
be conducted in order to quantify this phenomenon with greater precision.
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ANOPHELES COUSTANI, AN IGNORED SUPER VECTOR OF 
ARBOVIRUS AND PLASMODIUM
Thiery Nirina Jean Jose Nepomichene, Faranantenaina 
Raharimalala, Sébastien Boyer
Institut Pasteur of Madagascar, Antananarivo, Madagascar
Human malaria cases increased in Madagascar despite the use of indoor 
residual spraying and long lasting insecticide-treated bed nets. Vectors 
diversity and abundance over the year explained the persistence of 
malaria. Amongst 7 Anopheles malaria vectors including An. funestus and 
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An. gambiae s.s., An. coustani attracted the attention. During the past few 
years and in different seasons, An. coustani was regularly found positive 
with Plasmodium sp. in different ecotypes.. It was quite surprising to find 
this mosquito species naturally infected either by P. falciparum or P. vivax, 
and sometimes also with a co-infection P. falciparum / P. vivax. Moreover, 
during the Rift Valley Fever (RVF) outbreaks occurred in Madagascar in 
2008 and 2009, An. coustani was also detected positive with other two 
species, Culex antennatus and An. squamosus/cydippis. This study aims to 
highlight the exact role played by An. coustani facing the Plasmodium and 
RVF virus transmission. To achieve this objective, experimental infections 
were developed in a high malaria prevalence area. In parallel, study on 
vector competence of An. coustani and Cx. antennatus to RVF virus was 
carried out in laboratory. We suspect that An. coustani played, and still 
playing an important role in malaria transmission whereas 14.1% of An. 
coustani and 7.23% of Cx. antennatus were able to transmit RVF virus in 
laboratory. The role of An. coustani in transmission of human Plasmodium 
and RVF virus was highlighted in field and in laboratory. These findings 
coupled with its tendency to bite on animal with an opportunistic to 
human confirmed its medical and veterinary importance. Otherwise, this 
species was found involved in transmission of Wuchereria bancrofti and 
West Nile virus in Madagascar and in transmission of Zika virus in Africa. 
Thus, specific attention of the biology study of this species must be carried 
out in order to control it and to determine its role during inter epidemic 
period.
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SCREENING THE MIDGUT BACTERIAL COMPOSITION OF 
TWO COLOMBIAN FIELD-COLLECTED MALARIA VECTORS 
FOR BIOCONTROL STRATEGIES
Priscila Bascunan1, Yadira Galeano-Castañeda1, Estefani 
Piedrahita1, Paula A. Urrea1, Juan David Sánchez-Rodrigez1, David 
Serre2, Margarita M. Correa1
1Group of Molecular Microbiology, University of Antioquia, Medellin, 
Colombia, 2Genomic Medicine Institute, Cleveland Clinic, Cleveland, OH, 
United States
Malaria constitutes a relevant problem of public health in Latin America 
with more than 300,000 cases confirmed every year in Brazil, Venezuela 
and Colombia. Although the number of deaths has decreased worldwide, 
the dramatic increase in insecticide-resistant Anopheles populations has 
led to search for alternative strategies to diminish or eliminate malaria 
vector populations. Recent studies have shown that some bacteria 
present in the mosquito microbiota have important negative effects on 
the sexual stages of the parasite within the mosquito midgut, as well 
as in vector survival. However, little is known about the microbiota of 
Latin American anopheline mosquitoes and its significance for parasite 
inhibition. Therefore, the purpose of this study is to characterize the 
midgut microbiota composition of two main Latin American malaria 
vectors, Anopheles darlingi and An. nuneztovari, collected in two malaria-
endemic regions of Colombia. Metadata generated for adult mosquitoes, 
larvae and breeding sites by Illumina sequencing is currently under 
analysis. In addition, preliminary data resulting from culture-dependent 
methods shows interesting differences in the diversity profiles in the 
bacterial community of female adult mosquitoes of the two localities and 
species. A combined analysis of both culture-dependent methods and 
high throughput sequencing will help to reveal a detailed composition of 
the midgut microbiota of these two main vectors and elucidate potential 
candidates for future vector biocontrol strategies.
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DISTRIBUTION AND HABITAT CHARACTERIZATION OF 
ANOPHELES LARVAE IN FOUR COMMUNITIES IN THE PERI-
IQUITOS REGION OF AMAZONIAN PERU
Marlon P. Saavedra1, Marta Moreno2, Sara A. Bickersmith3, 
Carlos Tong1, Joseph M. Vinetz2, Jan E. Conn4
1Laboratorio ICEMR-Amazonia, Laboratorios de Investigación y Desarrollo, 
Facultad de Ciencias y Filosofia, Universidad Peruana Cayetano Heredia, 
Lima, Iquitos, Peru, 2Division of Infectious Diseases, Department of 
Medicine, University of California San Diego, La Jolla, CA, United States, 
3Wadsworth Center, New York State Department of Health., Albany, 
NY, United States, 4School of Public Health, Department of Biomedical 
Sciences, SUNY Albany, Albany, NY, United States
Malaria control focused on drug treatment and insecticide-impregnated 
nets, or insecticide residual spraying, is increasingly compromised by 
insecticide resistance in many endemic regions. One consequence is 
renewed interest in the reduction of adult vector populations by targeting 
aquatic immature stages. Aquatic stages determine abundance, dynamics 
and fitness of mosquito adults, directly affecting malaria transmission. To 
evaluate the characterization and distribution of anopheline breeding sites, 
collections are being carried out in two riverine sites, Lupuna and Santa 
Emilia, and two highway sites, Triunfo and Nuevo Horizonte during the 
rainy season (Jan-Feb; April-May) and the dry season (Aug-Sept). Sampling 
of breeding sites is conducted using a standard dipping technique within 
a 1 km radius of the center of each village. Quantification includes 
relative abundance of larvae and Larval Index (LI) (larval density). Breeding 
sites will be sampled and analyzed for: concentration of nitrates and 
nitrites, alkalinity, pH, temperature, conductivity, salinity, turbidity, water 
movement, algae, density of surrounding vegetation, relative shade, 
and emergent light and canopy coverage. In Jan-Feb, 2016, of 32 
sampled breeding sites, Anopheles larvae were detected in 5. Positive 
breeding site types were fishpond, stream margin, pond and swamp. 
Of 255 Anopheles larvae collected, An. darlingi represented 37% (96 
larvae). In Lupuna 2 breeding site types were identified: stream margin 
(larvae=45) and swamp (larvae=65); in Santa Emilia, only pond was 
positive (larvae=71). In Nuevo Horizonte, larvae were found exclusively 
in fishponds (larvae=51); in Triunfo only pond was positive (larvae=51). 
Mean quantitative characteristics of the positive breeding sites were: pH 
= 5.5, conductivity = 29.9 ppm, salinity =4.1%, and turbidity = 20 JTU. 
Collected larval stages were: I = 32, II = 66, III = 92, IV = 59, and 6 pupae. 
Descriptive characteristics were partial shade, moderate water movement, 
and moderate submerged and emergent aquatic vegetation. These 
characteristics can determine presence of Anopheles larvae in the habitats.
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CHARACTERIZATION OF LARVAL HABITATS OF AEDES 
AEGYPTI IN KENYA
Harun N. Ngugi1, Francis Mutuku2, Bryson Ndenga3, Peter 
Siema4, Henry Maleka4, Lucy Irungu5, Dunstan Mukoko6, John 
Vulule3, Uriel Kitron7, A. Desiree LaBeaud8
1University of Nairobi/Chuka University, Nairobi/Chuka, Kenya, 2Technical 
University of Mombasa, Mombasa, Kenya, 3Kenya Medical Research 
Institute, Kisumu, Kenya, 4Vector Borne Disease Unit, Msambweni, Kenya, 
5University of Nairobi, Nairobi, Kenya, 6Vector Borne Disease Unit, Nairobi, 
Kenya, 7Emory University, Atlanta, GA, United States, 8Stanford University, 
Stanford, CA, United States
Aedes aegypti, the principal vector for dengue and other emerging 
arboviruses, breeds preferentially in various man-made and natural 
container habitats. In the absence of vaccine, vector control is the primary 
means to reduce the incidence of dengue. Effective vector control 
depends on a good understanding of larval and adult vector ecology of 
which little is known in Kenya. Twenty sentinel houses in each of four 
study sites (in western and coastal Kenya) were assessed for immature 
mosquito incidence once a month for a period of 20 months (May 2014 
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to December 2015). All water-holding containers in and around the 
households were inspected monthly for immature Ae. aegypti mosquitoes. 
A total of 19,249 containers were inspected from Chulaimbo (6929) 
and Kisumu (6927) in the west, and from Msambweni (2689), and 
Ukunda (2704) on the coast. Of these, only 5.8%, 5.3%, 5%, and 6.6%, 
respectively, were positive for Ae. aegypti immatures. In all four sites, 
significantly more positive containers were located outdoors than indoors 
(χ2= 712.4, DF=1, P<0.001). A total of 12,547 Ae. aegypti immatures 
were collected from these containers, which comprised 13 container 
types. More than 40% were from buckets, tires, and water-tanks, which 
produced 49% (1,245/2,530) of the pupae in the western and coastal 
study sites combined. Tanks, buckets, drums, and flowerpots were the key 
indoor containers, producing > 80% (92/108) of the pupae. Key outdoor 
containers in the coast were tires, tanks, buckets, and basins which 
accounted for 57% (1,316/1,965) of pupae, while pots and tires were the 
only key containers in the western region producing 71% (329/457) of 
pupae. Coast region produced significantly more Ae. aegypti immatures 
than the western region (Kruskal-Wallis, χ2 = 179.8, DF=1, P< 0.0001). 
These results indicate that Ae. aegypti breeding habitats are abundant 
outdoors and are diverse both in the coast and western regions of 
Kenya. However, only a few containers are responsible for majority of the 
production. Targeting source reduction efforts towards these productive 
containers may be a cost-effective way to reduce dengue transmission in 
these regions.
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XENOMONITORING OF WUCHERERIA BANCROFTII 
INFECTION BEFORE AND AFTER MASS DRUG 
ADMINISTRATION IN DREKIKIER, PAPUA NEW GUINEA
Naomi J. Vincent1, Brooke Mancuso2, Yao-Chieh Cheng2, Muker 
Sakur1, Yule E’ele1, Lemen Kilepak1, Cyrille Czeher1, Lisa Reimer3, 
Peter Siba4, Daniel Tisch2
1Papua New Guinea Institute of Medical Research, Madang, Papua New 
Guinea, 2Case Western Reserve University, Cleveland, OH, United States, 
3Liverpool School of Tropical Medicine, Liverpool, United Kingdom, 4Papua 
New Guinea Institute of Medical Research, Goroka, Papua New Guinea
Xenomonitoring using entomological techniques is useful for measuring 
filarial infection in human populations indirectly through mosquito 
collections. Since the introduction of mass drug administration (MDA) and 
vector control programs, microfilaria prevalence in human populations 
is decreasing to thresholds where transmission may no longer be 
sustainable. The human landing catch is the standard used in calculating 
transmission indices where large numbers of mosquitoes can be collected 
to estimate disease prevalence and monitor transmission of Wuchereria 
bancrofti filarial worms in post-MDA programs. In this study, we monitor 
bancroftian infection in mosquitoes pre- and post-MDA using 2014 
and 2015 collections from East Sepik, Papua New Guinea. Monitoring 
was conducted in three representative villages of high and moderate 
transmission zones within the Drekikier District. In the two representative 
villages of high transmission, 293 samples were collected in 2014, and 448 
samples were collected in 2015. In the representative village of moderate 
transmission, 43 samples were collected in 2014, and 61 samples were 
collected in 2015. The samples were collected using human landing catch 
conducted from 6pm to 6am each night for six nights before and after one 
round of MDA. Results show 1.5 times more infection in the moderate 
transmission zone than in the high transmission zone pre-MDA but 0.6 
times lower in post-MDA. This could be explained by a roughly 7-fold 
higher man biting rate in the high transmission zone compared to the 
moderate transmission zone (24.4±3.6 vs. 3.6±1.5 in 2014 and 74.7±14.8 
vs. 10.2±2.9 in 2015). Sample DNA was extracted, run using conventional 
PCR and viewed through gel electrophoresis to find the mosquito infection 
rates. The mosquito infection rates of W. bancrofti decreased in both high 
(10.8%±0.21% to 2.6%±0.07%, p<0.0001) and moderate (16.3%±1.7% 
to 1.6%±0.4%, p=0.0082) transmission zones. Xenomonitoring of 
mosquito collections done before and after one round of MDA correspond 
with decreases in human infection by light microscopy (28.8% to 9.0%, 
p< 0.0001) in one representative village after one round of MDA.
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ASSESSING THE SPATIAL HETEROGENEITY OF MALARIA 
VECTORS IN THE CONTEXT OF INCREASING VECTOR 
CONTROL INTERVENTIONS
Robert S. McCann1, Monicah M. Mburu1, Daniela Schluter2, 
Michael G. Chipeta2, Peter J. Diggle2, Dianne J. Terlouw3, Henk van 
den Berg1, Kamija Phiri4, Michèle van Vugt5, Willem Takken1
1Wageningen University and Research, Wageningen, Netherlands, 
2Lancaster University, Lancaster, United Kingdom, 3Liverpool School of 
Tropical Medicine, Liverpool, United Kingdom, 4College of Medicine, 
Blantyre, Malawi, 5University of Amsterdam, Amsterdam, Netherlands
Environmental variation across a landscape naturally contributes to spatial 
heterogeneity in malaria risk, yet the coverage of malaria interventions is 
increasing dramatically across many endemic regions. Novel geostatistical 
methods to investigate the spatio-temporal heterogeneity of malaria are 
increasingly available in open-source software. Investigating the spatio-
temporal heterogeneity of malaria vectors is critical for understanding 
how transmission patterns change in the context of increasing 
intervention coverage. In this study we investigated the spatio-temporal 
heterogeneity of host-seeking adult mosquitoes in a region of southern 
Malawi where malaria interventions are being intensively scaled-up. We 
used geostatistical methods to efficiently sample houses for mosquitoes 
at a sub-district level. Host-seeking mosquitoes were collected using 
Suna traps on a continuous, rolling basis for one year. We used model-
based geostatistics to account for spatial correlation in assessing the 
determinants of mosquito distribution, and to map spatial variation 
in the abundance of mosquitoes. Preliminary findings suggest clear 
spatial patterns in mosquito abundance. The results provide a basis for 
determining the spatio-temporal heterogeneity of malaria in the context of 
a community-based, vector-control intervention trial.
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BITING BEHAVIOR OF ANOPHELES ALBIMANUS IN 
ARTIBONITE, GRAND’ANSE AND NORD-EST, HAITI
Daniel E. Impoinvil1, Yvan St.Jean2, Joseph Frederick2, Michelle 
Chang1, Jean Frantz Lemoine2, Ellen M. Dotson1
1Centers for Disease Control and Prevention, Atlanta, GA, United States, 
2Programme National de Contrôle de la Malaria, Port-au-Prince, Haiti
Hispaniola is the only island in the Caribbean where malaria transmission 
still occurs, with Haiti having a higher number of malaria cases than 
the Dominican Republic (DR).  While both Haiti and DR are committed 
to eliminating malaria by 2020, no studies on mosquito behavior have 
been conducted on the island since 1988.  We conducted studies to 
determine human exposure to Anopheles albimanus bites indoors and 
outdoors during the night in three different regions in Haiti: Artibonite, 
Grand’Anse and Nord-Est. Mosquitoes were collected by all-night human 
landing catches to determine man-biting rates and the timing of bites. A. 
albimanus showed preference to bite more often outdoors than indoors 
in all three sites: the outdoor-to-indoor biting ratio (O/I) was 1.10 (95% 
CI: 1.03 – 1.18) in Artibonite, 1.72 (95% CI: 1.59 – 1.87) in Grand’Anse 
and 1.88 (95% CI: 1.13 – 3.92) in Nord-Est.  However, when weighting 
the biting rate against the time people reported being in bed, there was 
a higher exposure of mosquito bites to people indoors than outdoors in 
Artibonite (weighted O/I =  0.11; 95% CI: 0.11 – 0.13) and Grand’Anse 
(weighted O/I = 0.51; 95% CI: 0.41 – 0.61) but not Nord-Est (weighted O/I 
= 1.36; 95% CI: 0.57 – 3.40).  These results suggest that indoor mosquito 
control methods such as indoor residual spraying or insecticide treated 
bednets may be effective in preventing malaria transmission in some areas 
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of Haiti where most people are indoors during the early evening. However, 
outdoor vector approaches may still be required to support malaria 
elimination efforts in Haiti.
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CHARACTERIZING TEMPERATURE IN LOCAL MALARIA 
TRANSMISSION ENVIRONMENTS
Sunita Swain1, Jacqui Montgomery1, Mohhamed A. Haque2, 
Matthew B. Thomas1
1Pennsylvania State University, State College, PA, United States, 2National 
Institute of Malaria Research, New Delhi, India
The key mosquito and parasite life history traits that combine to determine 
malaria transmission intensity are all affected by temperature. To 
understand transmission ecology, therefore, it is important to determine 
the range of microclimatic temperatures experienced by malaria vectors 
in the field. This study was conducted in 6 rural villages of Sundargarh 
District in Odisha, India. Within these villages, data loggers were used 
to record microclimates in multiple locations and structures. These 
microclimate data were then used to drive a malaria parasite development 
model to compare predictions of parasite extrinsic incubation period (EIP) 
under local conditions (we use EIP here as an illustrative trait to explore 
the biological consequences of variation in local microclimate). Mean 
temperatures and temperature variation differed between resting sites 
within the transmission environments. Mean temperatures were around 
2°C higher inside asbestos roofed houses than in outdoor vegetation, 
with tiled houses and cattle sheds intermediate to these extremes. Diurnal 
temperature variation was much greater outdoors compared with variation 
measured within domestic dwellings. Exploring the effects of temperatures 
on malaria parasite development rate revealed negligible differences 
between mircohabitats during the warmest times of the year (i.e. EIPs 
of around 10 days irrespective of environment). However, under cooler 
times the predicted EIPs varied substantially, being 10 or 20 days longer in 
vegetation, tiled houses or cattle sheds, than asbestos houses. Moreover, 
for large parts of the year, the EIPs predicted for the specific microhabitats 
differed to those predicted using weather station data. The current study 
reveals that microclimates can vary substantially between habitats within 
local transmission environments. Small differences in microclimate can 
potentially lead to large differences in life history traits. Measuring the 
range of conditions available to mosquitoes within local transmission 
settings should provide a more robust characterization of transmission 
ecology than remote weather station data.
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MEASURING SPECIES - AND REGION-SPECIFIC MARKERS OF 
MOSQUITO BITES BY SMALL PEPTIDE ARRAYS
Andrew Pike1, Jason A. Bailey1, John C. Tan2, Jigar J. Patel2, 
Matthew B. Laurens1, Drissa Coulibaly3, Amadou Niangaly3, 
Mahamadou A. Thera3, Ogobara K. Doumbo3, Tracking Resistance 
to Artemisinin Collaboration, Mark A. Travassos1, Andrea A. 
Berry1, Christopher V. Plowe1
1Institute for Global Health, Division of Malaria Research, University of 
Maryland School of Medicine, Baltimore, MD, United States, 2Roche 
NimbleGen Inc., Madison, WI, United States, 3University of Sciences, 
Techniques and Technologies of Bamako, Bamako, Mali
Knowledge about human exposure to mosquitoes can help target 
interventions to those at greatest risk of malaria and other vector-
borne diseases. Mosquito trapping estimates local vector populations, 
but implementation of large scale collection programs is difficult, and 
mosquito presence alone does not indicate who is being bitten. Measuring 
antibody responses to mosquito salivary antigens is a potential strategy 
to estimate exposure to specific vectors, locations and risk groups. Two 
Anopheles salivary antigens, SG6 and cE5, have been shown to elicit a 
humoral immune response in humans that can be measured by ELISA 
to indicate recent exposure to mosquito bites. However, due to the 
conservation of these genes, ELISAs have limited ability to discriminate 
between exposures to different vector species. We developed a small 
linear peptide array to measure antibody responses to individual epitopes 
along the full length of six mosquito salivary proteins each from six 
Anopheles species. The arrays were probed with sera from West African 
children and adults, Southeast Asian adults with acute falciparum malaria, 
and North American adults, allowing us to observe differences in the 
antibody binding profiles of people to antigens from geographically 
separated mosquito species. Southeast Asian adults reacted most strongly 
to peptides from Southeast Asian mosquitoes and West African sera 
reacted most to peptides from African mosquitoes, while North American 
adults had the lowest seroreactivity to all six Anopheles species. From 
these data, we identified a set of peptides that can differentiate between 
the sera of people bitten by mosquitoes from different regions. The set 
of mosquito proteins on the array can expand to include more salivary 
proteins and mosquito species, allowing us to build a panel of peptides to 
measure human exposure to diverse vectors of a variety of mosquito-borne 
diseases. These peptides could potentially be used to develop a point-of-
care test to estimate human exposure to mosquitoes allowing for better 
targeting of vector-borne disease interventions.
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ENVIRONMENTAL FACTORS INFLUENCING ANOPHELES 
DARLINGI POPULATION DYNAMICS AND MALARIA 
TRANSMISSION IN ZUNGAROCOCHA, LORETO, PERU
Fanny Castro-Llanos1, Nicole L. Achee2, John P. Grieco2, Lila V. 
Hidalgo3, Giannina V. Arias3, Carmen Flores-Mendoza1, Victor 
López-Sifuentes1, Craig A. Stoops1, Gissella M. Vásquez1
1U.S. Naval Medical Research Unit - 6, Callao 2, Peru, 2University of Notre 
Dame, Notre Dame, IN, United States, 3Peruvian Ministry of Health, Loreto, 
Peru
A sustained increase in the number of malaria cases has been observed 
in Peru since 2012 with the majority of cases reported in Loreto, northern 
Amazon, where Anopheles darlingi is the dominant malaria vector. 
Examining An. darlingi population densities, age structure, and natural 
Plasmodium infection rates in this malaria endemic region is essential 
for malaria transmission risk assessment. Moreover, the impact of 
environmental factors on An. darlingi abundance and malaria transmission 
could further contribute to understand malaria transmission patterns. This 
study aimed to estimate An. darlingi seasonal abundance, age structure, 
and Plasmodium infection rates; and correlate with local environmental 
parameters and malaria cases reported by the Ministry of Health in 
Zungarococha, a malaria-endemic community in Loreto. An. darlingi 
densities were estimated by protected Human Landing Catch performed 
outside local homes from 1800h to 0600h for a 3-day period each month 
from June 2014-March 2016. A subset of An. darlingi females (30%) was 
dissected to determine parity status and remaining specimens were stored 
for Plasmodium spp. detection. Local temperature, humidity and rainfall 
were simultaneously recorded. A total 15,904 An. darlingi females were 
captured; 5,123 were dissected. An. darlingi densities ranged from 0.5 to 
164 mosquitoes landing per person per hour, with the highest densities 
(>100) recorded in June 2014 (111), January-March 2015 (123-127), July 
2015 (117) and January 2016 (164). Parous was the predominant ovarian 
stage in mosquitoes dissected (>60%) during density peaks. The number 
of malaria cases reported monthly ranged from 62-285, with highest 
numbers (>150 cases) in June-July 2014 (175-214), July-September 2015 
(152-157), and Feb-March 2016 (157-285), a few weeks after mosquito 
population density peaks and heavy rainfall. An. darlingi densities shows 
a positive association with rainfall events. Results are discussed in terms 
of the impact of environmental factors on vector population and malaria 
transmission dynamics, and will help guiding vector control strategies in 
the region.
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ASSOCIATION OF AUTOCIDAL GRAVID OVITRAPS WITH 
REDUCED RATES OF CHIKUNGUNYA VIRUS INFECTION IN 
PUERTO RICO
Tyler M. Sharp1, Olga Lorenzi1, Veronica Acevedo1, Chelsea 
Major1, Brad J. Biggerstaff2, Janice Perez-Padilla1, Jorge Munoz-
Jordan1, Stephen Waterman1, Roberto Barrera1
1Centers for Disease Control and Prevention, San Juan, PR, United States, 
2Centers for Disease Control and Prevention, Fort Collins, CO, United 
States
There are currently no effective and sustainable interventions to prevent 
infections with viruses transmitted by Aedes mosquitoes. Since 2012, 
four communities in Puerto Rico have been participating in a field trial of 
a recently developed autocidal gravid ovitrap (AGO). After 3 AGO traps 
were placed in >85% of homes in two intervention communities, adult 
Ae. aegypti mosquito populations were reduced by ~80% compared to 
two non-intervention communities. The introduction of chikungunya virus 
(CHIKV) to Puerto Rico in May 2014 provided an opportunity to determine 
if AGO traps were associated with CHIKV infection rates in humans and 
mosquitos in these communities. To estimate the seroprevalance of CHIKV 
infection in intervention and non-intervention communities, 377 houses 
were randomly selected. Participating household members provided a 
blood specimen and completed a questionnaire on demographics, recent 
illnesses, and mosquito avoidance practices. Serum specimens were 
tested by IgG ELISA to detect historic CHIKV infection. During November 
2015 and February 2016, a total of 233 (62%) households from the four 
communities agreed to participate. Mean age of participants (53 years) 
was greater than that of all eligible residents (49 years). Mean age of 
participants from intervention communities was not significantly different 
from those from non-intervention communities. Among 152 and 175 
participants from non-intervention and intervention communities, historic 
CHIKV infection was detected in 69 (45%) and 40 (23%) participants, 
respectively. The observed two-fold difference in the prevalence of CHIKV 
infection in intervention compared to non-intervention communities may 
be associated with the lower measured mosquito densities in communities 
where AGO traps are present. Additional analyses are being performed 
to adjust anti-CHIKV antibody prevalence with respect to sampling 
design, community differences, and participation rates. These findings 
may implicate AGO traps as an effective and sustainable community 
intervention to prevent infections transmitted by Ae. aegypti mosquitos.
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BACTERIAL COMPOSITION OF LARVAL BREEDING SITES OF 
AFRICAN AEDES AEGYPTI AND ITS EFFECT ON VECTORIAL 
CAPACITY
Laura B. Dickson1, Davy Jiolle1, Guillaume Minard2, Isabelle 
Moltini-Conclois1, Diego Ayala3, Christophe Paupy4, Claire Valiente 
Moro2, Louis Lambrechts1
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Institut Pasteur, URA CNRS 3012, Paris, France, 2Ecologie Microbienne, 
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3CIRMF, BP 769, Franceville, Gabon, 4UMR MIVEGEC IRD 224 CNRS 5290 
UM1 UM2, Montpellier, France
Like other animals, insects establish symbiotic associations with microbial 
communities that shape their individual phenotype and fitness. In 
particular, the native gut bacteria of insect vectors can modulate 
their immunity and susceptibility to human pathogens. Compared to 
vertebrates, insects have more labile gut bacterial associations that 
are under strong influence of the environment. Thus, habitat-related 
differences in bacterial communities could mediate an environmental 
influence on vector-borne pathogen transmission. We investigated 
whether differences in the bacterial communities of larval breeding sites 
may drive variation in vectorial capacity of the mosquito Aedes aegypti, 
a major vector of dengue, Zika, and chikungunya viruses. In Sub-Saharan 
Africa, Ae. aegypti larvae develop both in domestic habitats such as 
human-associated containers and in sylvatic habitats such as rock pools or 
tree holes. Comparison of natural sylvatic and domestic breeding sites in 
Gabon by metataxogenomics revealed contrasted bacterial communities 
in the water and, to a lesser extent, in the midgut of adult Ae. aegypti 
emerging from these breeding sites. To test whether exposure to different 
bacteria during larval development may differentially affect adult vectorial 
capacity, we created gnotobiotic larvae using a selection of four bacterial 
isolates from the natural breeding sites in Gabon. Mono-association 
with Enterobacter, Salmonella, Arthrobacter, or Rhizobium bacterial 
isolates during larval development resulted in significant differences in 
pupation rate. In addition, larvae exposed to the Arthrobacter isolate 
had larger bacterial loads in adult midguts pre and post blood meal, 
showed decreased antibacterial activity in adult hemolymph, and were 
less susceptible to dengue virus infection. No differences in adult lifespan 
were detected between the different gnotobiotic treatments. Together, 
our results provide the proof of principle that habitat-related differences in 
larval exposure to bacteria can drive variation in adult mosquito immunity 
and vectorial capacity.
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THE IMPORTANCE OF HUMAN POPULATION 
CHARACTERISTICS IN MODELING MOSQUITO VECTORS: A 
COMPARATIVE ANALYSIS OF MODEL COMPONENTS
Julie Obenauer Motley, Andrew Joyner, Megan Quinn
East Tennessee State University, Johnson City, TN, United States
The current Zika virus epidemic in the Western hemisphere is 
representative of the confluence of global climate change and infectious 
disease expansion, and vector modeling represents a pertinent and 
timely method to analyze the environment associated with Zika-carrying 
mosquitoes. Among many mosquito species distribution models, there are 
varying opinions on which variables are most predictive and, consequently, 
should be included in modeling efforts. While climate variables (e.g., 
mean temperature, mean precipitation) are routinely included, some 
argue that human population dynamics, in the form of population density 
and socioeconomic status, should also be included. This project aimed 
to test the importance of including human population characteristics 
by modelling the Zika virus vector Aedes aegypti in the Southeastern 
United States with climate variables, population density, and poverty 
characteristics. A. aegypti occurrences, global climate data, and population 
characteristics were obtained from publicly available sources and sampled 
at a resolution of 2.5 arc-minutes. Data pre and post-processing was 
completed in ArcMap 10.3 and models were created in Maxent v.3.3.3k. 
Four models were developed for this project: a climate-only model, a 
climate and population density model, a climate and poverty model, 
and a combined model with climate, population density, and poverty. 
Models were evaluated by comparing test and training area under the 
curve metrics, omission and commission errors, and variable jackknifing 
results. The climate-only model performed poorly compared to models 
with human population characteristics. The combined model was the best 
fit, though the model with climate and population density had a lower 
commission rate (21.0% and 20.6%, respectively). Jackknife results for 
the full model showed that population density was the most significant 
contributor to the model. This research indicates that more consideration 
should be given to human population characteristics when modelling 
mosquito habitats.
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URBAN MICROCLIMATE AND DENGUE VECTOR 
COMPETENCE OF THE INVASIVE ASIAN TIGER MOSQUITO, 
AEDES ALBOPICTUS
Michelle V. Evans, Courtney C. Murdock
University of Georgia, Athens, GA, United States
Vector-borne diseases have increased in urban environments in recent 
decades. Incidence of vector-borne disease is often unevenly distributed 
across urban landscapes, which are themselves comprised of a diversity 
of landscape features that can modify thermal microclimates. Because 
mosquitoes are small ectotherms, their growth, survival, and reproduction 
are all sensitive to fine-scale variation in microclimate. Additionally, 
microclimate during the larval stage can affect life history traits of adults, 
a phenomenon known as carry-over effects. The majority of studies 
assume temperature to be the most important factor driving carry-over 
effects, enabling research to be done in the lab. However, laboratory 
research is unable to fully incorporate realistic field microclimate conditions 
experienced by mosquito vectors. To further explore the effect of larval 
microclimate on Ae. albopictus vector competence, we conducted a semi-
field experiment examining vector competence across urban, suburban, 
and rural sites in Athens, GA. Aedes albopictus larvae were reared in 
the field across the three treatments, and offered a DENV-2 infectious 
bloodmeal post-eclosure, to measure the effect of microclimate on 
dengue infection, dissemination, and transmission. Information on vector 
competence was then incorporated with mosquito life history, potential 
larval habitat density, and adult abundance data collected from the same 
sites, to better characterize risk of dengue through vectorial capacity 
across the urban gradient.
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A TRADE-OFF BETWEEN DRY SEASON SURVIVAL LONGEVITY 
AND HIGH WET SEASON NET REPRODUCTION EXPLAINS THE 
PERSISTENCE OF ANOPHELES MOSQUITOES
Gesham Magombedze, Azra Ghani
Imperial College, London, United Kingdom
Plasmodium falciparum malaria remains a leading cause of death in 
tropical regions of the world. Despite efforts to drive transmission down, 
rebound epidemics associated with the persistence of malaria vectors have 
remained a major impediment to local elimination. One area that remains 
poorly understood is how Anopheles populations survive long dry seasons 
to re-emerge following the onset of the rains. We developed mathematical 
models to explore the impact of different mosquito survival strategies on 
the dynamics of the vector population. We show that mosquitoes have 
different lifestyles between the wet season and the dry season. Their 
ability to persist is attributed by their propensity to exploit the wet season 
(fast and high reproductive output), but then mitigate the effects of the 
dry season (longevity and aestivation). We demonstrate that aestivation 
is a population rescue strategy that makes ecological vector population 
extinction difficult, while wet season high reproductive output buffers 
the population against dry season potential extinction. We show that 
both longevity/aestivation and high wet reproduction allow persistence of 
the mosquitoes, and can reproduce patterns observed in field data from 
the Sahel region. Our results demonstrate the importance of practical 
ecological methods to control vectors in the dry and wet seasons if malaria 
transmission is to be interrupted.
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DENGUE FEVER AND AEDES AEGYPTI RISK IN THE 
GALAPAGOS ISLANDS, ECUADOR
Fernando Ortega1, Ryan Nightingale2, David Basantes3, Mercy 
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(ABG), Puerto Ayora, Galapagos, Ecuador, 6Center for Global Health and 
Translational Science, SUNY Upstate Medical University, Syracuse, NY, 
United States
Dengue fever, chikungunya and zika virus, transmitted by the Aedes 
aegypti mosquito, are emerging infectious diseases in the Galapagos 
Islands of Ecuador. In 2014 we conducted a pilot study on two islands 
(Puerto Ayora (PA) on San Cristobal and Puerto Baquerizo (PB) on Santa 
Cruz) to assess Ae. aegypti abundance, key larval habitats and household 
risk factors for dengue infection. We surveyed 100 households (50 
per island) in high-risk areas. Adult Ae. aegypti were collected inside 
and outside the home using prokopack aspirators, larval indices were 
determined through container surveys, and heads of households were 
interviewed to determine demographics, housing conditions, and 
knowledge, attitudes and practices regarding dengue. Multimodel 
selection methods were used to identify best-fit logistic regression models 
to explain the presence of Ae. aegypti and self-reported prior dengue 
infections. We found that 24.3% of PB and 14% of PA participants self-
reported a prior dengue infection. The best-fit model to explain prior 
infection indicated higher risk for people who frequently traveled between 
the islands, households that experienced interruptions in the piped 
water supply, and heads of households with salary above the minimum 
wage. Adult Ae. aegypti were collected from 14% of PB and 4% of PA 
houses; other adult mosquitoes collected included Culex quinquefasciatus 
and Ae. taeniorhynchus. Significantly more PB homes than PA homes 
had containers with Ae. aegypti juveniles (p = 0.012; PB House Index 
= 20, Breteau Index = 26; PA House Index = 6, Breteau Index = 6). 
The characteristics of the predominant Ae. aegypti larval habitat were 
55-gallon water storage drums, located outdoors, uncovered, shaded, 
and filled with tap-water. The best-fit model to explain the presence of 
Ae. aegypti indicated higher risk in households that used tanks for water 
storage and in households that perceived that dengue prevention was 
difficult. These findings provide the region’s public health sector with 
key information for conducting dengue and zika control campaigns, and 
highlight the importance of local socio-ecological studies to understand 
dengue risk.
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DYNAMICS OF INGESTED ENTEROBACTER SP. IN THE GUT OF 
MOSQUITOES THROUGHOUT LIFE CYCLE
Jinjin Jiang, Crisandra Diaz, Wanqin Yu, Dong Pei, Jiannong Xu
New Mexico State University, Las Cruces, NM, United States
There is a symbiotic relationship between the mosquito and its gut 
microbial residents. Taxa in genus Enterobaacter are commonly present in 
the gut of various mosquitoes. But few data were available regarding the 
dynamics of bacteria from being ingested to being egested. In this study 
the strain Ag1 of Enterobacter sp. was tagged with green fluorescent 
protein (GFP), and its dynamics were tracked in the gut of both Anopheles 
gambiae and An. stephensi. GFP tagged bacteria were provided to 
mosquitoes in the sugar meals for two days. Introduced bacteria were 
visualized by imaging individual gut under a fluorescent microscope. 
The bacterial intensity was estimated by average number of fluorescent 
colonies per gut. In the sugar fed guts, the prevalence of bacteria 
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decreased over time from 100% to 37% in An. gambiae on day 6 post 
ingestion and 30% in An. stephensi on day 6 post ingestion. At this time 
point, mosquitoes were given a blood meal, which brought prevalence 
back to ~70%. The decline of bacteria in the gut is correlated with the 
presence of GFP-bacteria in the feces, indicating that the bacteria were 
discharged through defecation. Enterobacter was favored in the blood fed 
guts, and proliferated well for two days, then starting being egested with 
digested wastes in feces. The data indicate that the bacteria are able to 
reside in the gut but the length of stay varies individually. Moreover, when 
gravid mosquitoes laid eggs in water, Enterobacter cells in feces entered 
into aquatic habitat. GFP bacteria were detected in the culture of larval 
gut homogenates of larvae and emerged adults. Evidently, Enterobacter 
transstadially passed through metamorphosis from larvae to adults. 
Mosquito associated bacteria can cycle from generation to generation 
through fecal-oral route.
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DRIED BLOODSPOTS FROM PAIRED HUMAN AND 
ENGORGED MOSQUITOES TO DEMONSTRATE THE 
FEASIBILITY OF XENOSURVEILLANCE IN WEST AFRICA
Joseph R. Fauver1, James Weger-Lucarelli1, Nathan D. Grubaugh1, 
Benjamin J. Krajachich1, Lawrence S. Fakoli III2, Fatorma K. Bolay2, 
Joseph W. Diclaro III3, Douglas D. Brackney4, Mark D. Stenglein1, 
Brian D. Foy1, Gregory D. Ebel1
1Colorado State University, Fort Collins, CO, United States, 2Liberian 
Institute for Biomedical Research, Charlsville, Liberia, 3United States Navy 
Medical Research Unit No. 3, Cairo, Egypt, 4Connecticut Agricultural 
Experiment Station, New Haven, CT, United States
Xenosurveillance is a novel technique that utilizes mosquito bloodmeals 
to noninvasively survey human populations for infectious diseases. 
The technique takes advantage of the host-seeking and blood-feeding 
behavior of Anopheles gambiae mosquitoes. Two villages in Northern 
Liberia were enrolled in to our study, and human dried bloodspots 
were collected during the initial enrollment period. The villages were 
subsequently sampled for indoor resting engorged mosquitoes on a 
rotating schedule for the following two weeks. Bloodfed mosquitoes 
collected from inside homes had their midgut contents expelled onto FTA 
cards for further testing. RNA from both human and mosquito samples 
were eluted, extracted, pooled, and subjected to Next Generation 
Sequencing. Bioinformatic analysis revealed the presence of GB virus C 
in both human and mosquito samples collected in the same home. A 
total of 15 and 28 reads aligned to West African strain of GB virus C, 
respectively. This resulted in a combined coverage of 40% of the genome. 
These matched results indicate that our technique can reliably detect 
genetic signatures of human viruses in mosquito bloodmeals. This study 
demonstrates the feasibility of Xenosurveillance in a field setting.
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ADVANCING ARBOVIRUS SURVEILLANCE BY ASSESSING 
THE EFFICIENCY OF VECTOR AND DISEASE MONITORING 
PROGRAMS
Geoffrey Vincent, Justin Davis, Michael C. Wimberly, Michael B. 
Hildreth
South Dakota State University, Brookings, SD, United States
Mosquito surveillance is a necessary component of public health for 
assessing human health risks for a plethora of transmittable diseases. 
Vector presence, abundance, and infection rates are needed to effectively 
manage efforts in mosquito control operations. Over the past few years, 
mosquito surveillance and control have become increasingly important as 
endemic diseases resurface, as happened West Nile virus (WNV) in 2012 
in the United States, and new diseases emerge, as is currently occurring 
with Zika virus. However, mosquito collection and testing to monitor these 
diseases can become financially burdensome, especially in developing 
countries and sparsely population regions. Using WNV surveillance data 
from South Dakota, our study looks to determine whether the current level 
of mosquito and arbovirus surveillance can be reduced while maintaining a 
similar capacity to predict risk to humans. Mosquitoes were captured and 
tested for WNV in 27 counties for varying numbers of years from 2003 
to 2015. The minimum infection rate was calculated for every county in 
every reported week, and the maximum MIR (MMIR) for every county-year 
combination was estimated in those county-years. Analysis of variance was 
used to determine if any significant differences could be detected among 
the MMIR for county-year combinations. Our model suggests that there 
are some persistent differences in MMIR between counties (p = 0.01245). 
A Tukey multiple comparison test showed only two counties to have a 
significant difference in their mean MMIR. However, MMIR correlated 
well with human cases, and was an effective predictor of total yearly risk. 
In a set of regressions, we considered whether any county could serve 
as a proxy for other counties or the state as a whole. We found that no 
individual county’s MMIR was more informative than statewide MMIR. The 
results suggest that maintaining broader spatial coverage across the state 
is likely preferable to oversampling individual counties.
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COMPARATIVE SUSCEPTIBILITY BETWEEN FIVE AEDES 
AEGYPTI POPULATIONS TO FOUR DENGUE VIRUS 
SEROTYPES
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Norris3, Nagila Secundino4, Paulo Pimenta4
1Fundação de Medicina Tropical Dr. Heitor Vieira Dourado, Manaus 
- Amazonas, Brazil, 2Fundação de Medicina Tropical Dr. Heitor Vieira 
Dourado, Manaus - Amazonas, Brazil, 3John Hopkins Bloomberg School 
of Public Health, Baltimore, MD, United States, 4Centro de Pesquisas Rene 
Rachou FIOCRUZ-MG, Belo Horizonte MG, Brazil
Dengue is the most important arboviral-infection affecting humans and in 
the America, its main vector is Aedes aegypti. There are multiple factors 
that are key to the successful spread and maintenance of the dengue 
virus cycle in nature: vertebrate host biology, circulating viral strain, 
vector susceptibility towards the virus. The last one, vector competence, 
may vary according their geographic distribution, even within the same 
city. Therefore our aim is assessing the existence of vector competence 
differences between five Ae. aegypti populations collected throughout 
the city of Manaus considering four dengue virus serotypes. Ae. aegypti 
eggs from five locations within the city of Manaus, Amazonas, Brazil were 
collected and reared under laboratory conditions (temperature 26°C and 
a relative humidity of 80%). Individuals from each mosquito population 
were then challenged simultaneously to the tested serotypes by membrane 
feeding assay. Fourteen days post infection, the mosquitoes were dissected 
separating the head from the body. Viral RNA extraction was performed 
with the QIAamp Viral RNA Mini Kit, whereas the detection and 
quantification of viral RNA were performed with the Power SYBR Green Kit 
Step-1. We then calculated the infection rate (IR) and dissemination rates 
(DIR), as well as the vector competence(VC) for each population. To date, 
our analyses showed significant differences regarding DENV-1 IR than 
have variation 25 to 100% and DIR range of 50 to 95%, as well in VC 
with a range of 12,5 to 95% between the five Ae. aegypti populations. 
Despite the high rates of infection, there was no significant difference 
with DENV-2 in all populations with IR varying from 90-100%, DIR 100% 
and VC varying from 90 to 100%. The results also showed DENV-4 with 
the similarity among populations, with IR ranging from 85 to 100%, DIR 
varying from 80 to 100% and VC with a range of 70 to 94.7%. This study 
we will be able us to further understand the vector- virus interaction and 
the dynamics of dengue transmission in a local urban context.
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HUMAN EHRLICHIOSIS AND ANAPLASMOSIS IN 
NORTHEASTERN THAILAND
Wilawan Thipmontree1, Chien-Chung Chao2, Yupin 
Suputtamongkol3, Zhiwen Zhang2, Tatyana Belinskaya2, Wei-Mei 
Ching2
1Maharat Nakhon Ratchasima Hospital, Nakhon Ratchasima, Thailand, 
2Naval Medical Research Center, Bethesda, MD, United States, 3Mahidol 
University, Bangkok, Thailand
Human Monocytic Ehrlichiosis (HME) and human granulocytic 
anaplasmosis (HGA) are emerging, tick-borne rickettsial diseases. In 
Thailand, the first HME cases were first reported in 1997.A prospective 
etiologic study of patients with acute undifferentiated fever (AUF) was 
conducted in Maharat Nakhon Ratchasima hospital, northeastern Thailand. 
Serological tests for Ehrlichia chaffeensis and Anaplasma phagocytophilium 
IgM and IgG antibodies using commercial immunofluorescence antibody 
assay were performed in 70 AUF patients who tested negative for scrub 
typhus, murine typhus, spotted fever group, Q fever, leptospirosis, dengue, 
malaria, and bloodstream infection. The result showed seroprevalence 
(IgG) of E. chaffeensis and A. phagocytophilium in 37.1% (26/70) and 
21.4% (15/70) patients, respectively. Eleven (15.7%) patients were 
IgG positive for both E. chaffeensis and A. phagocytophilium antigens. 
Additionally, 5 (7.1%) cases had positive E. chaffeensis IgM antibody 
titer at 1:64. Three confirmed HME cases were diagnosed based on 
clinical compatible illness and single serum of E. chaffeensis IgG titer ≥ 
1:256. Most of them had common clinical (fever, myalgia, headache) 
and laboratory findings (elevated liver enzyme, thrombocytopenia). 
Complications developed in two patients: septic shock and acute 
renal failure. Two patients, one of which had acute renal failure, 
received ceftriaxone and doxycycline and both of them fully recovered. 
Another patient with septic shock received intravenous ceftriaxone and 
chloramphenicol and subsequently died. In conclusions, HME and HGA 
should be included in the differential diagnosis of Thai AUF patients and 
prompt doxycycline treatment is likely to improve outcome.
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DISTRIBUTION AND MOLECULAR CHARACTERISTICS OF 
RICKETTSIAE FOUND IN TICKS ACROSS CENTRAL MONGOLIA
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Mongolia, 5National Center for Zoonotic Diseases, Ulaanbaatar, Mongolia, 
6Duke University, Department of Medicine, Division of Infectious Disease, 
Durham, NC, United States
Little is known regarding tickborne diseases in Mongolia. A total of 1,497 
adult unfed ticks; 261 Ixodes persulcatus, 795 Dermacentor nuttalli, and 
441 Hyalomma asiaticum, were collected from the environment and 
off livestock returning from pasture, across a vertical stretch of Central 
Mongolia spanning from China to Russia (Selenge, Tov, & Dornogovi 
aimags). Ticks were then separated into genus specific pools (n=299), by 
sample location, containing ~5 ticks each. After extraction of DNA and 
RNA, nested polymerase chain reaction (PCR), reverse transcription-PCR 
(RT-PCR), and quantitative real-time RT-PCR (qRT-PCR) were conducted to 
detect rickettsia bacteria and tickborne encephalitis virus (TBEV). Assays 
yielded pool detection rates of 92.5% (49/53) and 1.9% (1/53) of I. 
persulcatus pools testing positive for Candidatus Rickettsia tarasevichiae 
and TBEV respectively, while Rickettsia raoultii was found in 72.8% 
(115/158) of D. nuttalli pools. Both R. tarasevichiae and R. raoultii are 
recognized as emerging tickborne diseases, with this being one of the first 
reports of R. tarasevichiae in Mongolia. Given that R. tarasevichiae shares 
the same vector (I. persulcatus) as TBEV, and may present with severe 
atypical spotted fever group (SFG) rickettsia-like symptoms, Mongolian 
physicians treating suspected cases of TBEV should include R. tarasevichiae 
infection in their differential diagnosis and consider prescribing 
antimicrobial therapy.
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SEROPREVALENCE OF RICKETTSIA AND ANAPLASMA 
EXPOSURE IN HUMANS AND LIVESTOCK ACROSS A 
CENTRAL STRETCH OF MONGOLIA
Michael E. von Fricken1, Lkhagvatseren Sukhbaatar2, Boldbaatar 
Bazartseren2, Baigalmaa Bekhochir3, Pagbajab Nymadawa4, 
Benjamin D. Anderson5, Paul M. Lantos5, Gregory C. Gray5
1George Mason University, Dept. of Global and Community Health, 
Fairfax, VA, United States, 2Institute of Veterinary Medicine, Ulaanbaatar, 
Mongolia, 3National Center for Zoontic Diseases, Ulaanbaatar, Mongolia, 
4Mongolian Academy of Medicial Sciences, Ulaanbaatar, Mongolia, 5Duke 
Medicine, Division of Infectious Diseases, Durham, NC, United States
Tickborne diseases (TBD) are suspected to be a major cause of illness in 
Mongolia, although the extent of which remains unknown. Therefore, 
to better understand the burden of TBD in Mongolia, serosurveillance 
focusing on anaplasma and rickettsial infections was carried out through 
an international collaboration between US and Mongolian researchers 
from September 2014 to October 2015. Samples were collected from 
388 nomadic herders, 867 goats, 871 sheep, 367 cattle, and 216 horses, 
across three provinces (Selenge, Tov, Dornogovi). Serum samples diluted 
1:50 in sterile 1X PBS were placed on IFA slides coated with R. rickettsii 
and A. phagocytophilum, and examined using a fluorescent microscope. 
The overall seroprevalence of anaplasma and rickettsia in human samples 
was 136/365 (37.3%) and 73/374 (19.5%), respectively. Anaplasma and 
rickettsia seroprevalence rates in livestock were 1,120/2,370 (47.3%) 
and 478/2342 (20.4%). Such high rates of exposure might possibly be 
attributed to the increased risk of tick bites associated with a nomadic 
lifestyle, where both herder and livestock spend most of the day traveling 
from pasture to pasture. Significant differences in detection rates by 
sample species and region were observed for both pathogens of interest, 
indicating a higher prevalence of exposure of TBD in the central and 
northern provinces of Tov and Selenge, compared to that of the Gobi 
region of Dornogovi. These findings lay a framework for much needed 
future tickborne disease research in Mongolia, while providing valuable 
information to veterinarians, clinicians, and policy makers currently 
involved in ongoing TBD control efforts.
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RAPID DIAGNOSIS OF ANAPLASMA PHAGOCYTOPHILUM 
WITH P44 DIPSTICK ASSAY
Yun Sang Cho, Hyun-Ji Seo, Mi-Sun Yoo, Woo Ram Bae, Hee-Soo 
Lee, Seung-Won Kang, Na Ra Kim
Animal and Plant Quarantine Agency, Gimcheon, Republic of Korea
Anaplasma phagocytophilum is tick-borne bacterial zoonosis, infects 
into and destroys host blood cells. Human patients show influenza-like 
symptoms with fever, headache, myalgia, and malaise. Human granulocytic 
anaplasmosis (HGA) is 3rd most common tick-borne infections in US 
behind Lyme disease and Rocky Mountain spotted fever. Commercial IFA 
kit has been used for diagnosis of canine or horse Anaplasmosis, but other 
animal reservoirs, such as cattle, deer, goats, have not been developed 
until now. Dipstick for detection of A. phagocytophilum antibody will 
be useful for early control of A. phagocytophilum because of on-site 
applicability. Therefore, dipstick kit for reservoir animals is urgently needed 
for early diagnosis of animal anaplasmosis. Recombinant surface protein 
p44 of A. phagocytophilum was produced by E. coli expression system 
and the immunological specificity was confirmed by Western blotting with 
positive control serum. Three types of dipstick kit for A. phagocytophilum 
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antibody detection were designed and compared with their reactivity, 
which were sandwich, indirect I using anti-bovine IgG, and indirect II using 
protein A. And then the reactivity of test line was also read by gold reader. 
Recombinant p44 protein was expressed from E. coli, and used as dipstick 
antigen. The protein size was 44 kDa and the specificity was confirmed by 
Western blotting. Indirect I and II could differentiate positive and negative 
serum, and the discriminatory power of indirect II was superior to those 
of other types. Dipstick kit for A. phagocytophilum will be useful for early 
detection of A. phagocytophilum infection at on-site farm and helpful for 
early control of zoonotic anaplasmosis at animal level.
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RAPID DIAGNOSIS OF EHRLICHIA CHAFFEENSIS WITH P120 
DIPSTICK ASSAY
Yun Sang Cho, Hyun-Ji Seo, Mi-Sun Yoo, Woo Ram Bae, Hee-Soo 
Lee, Seung-Won Kang, Na Ra Kim
Animal and Plant Quarantine Agency, Gimcheon, Republic of Korea
Ehrlichia chaffeensis is tick-borne bacterial zoonosis, infects into and 
destroys host blood cells. Human patients show influenza-like symptoms 
with fever, headache, myalgia, and malaise. Human monocytic ehrlichiosis 
(HME) is 4th most common tick-borne infections in US behind Lyme 
disease, Rocky Mountain spotted fever, and HME. Commercial IFA kit 
has been used for diagnosis of human or canine Ehrlichiosis, but those 
for other animal reservoirs, such as deer, goats, and cattle, has not been 
developed until now. Antibody detection dipstick kit to E. chaffeensis 
infection will be useful for early control of E. chaffeensis by early detection 
at on-site farm. Therefore, dipstick kit for reservoir animas is urgently 
needed for early diagnosis of animal ehrlichiosis. Recombinant surface 
protein p120 of E. chaffeensis was produced by E. coli expression system 
and the immunological specificity was confirmed by Western blotting with 
positive control serum. Concentration of gold particle and dilution factor 
of serum were determined by Dot assay with recombinant p120 protein 
and positive control serum. Recombinant p120 protein was expressed from 
E. coli and used for dipstick antigen. The protein size was 43 kDa and the 
specificity was confirmed by Western blotting. Optimal concentration of 
gold particle in Dot assay was OD7 and that of serum dilution 2X dilution. 
Deer positive serum showed clear band on test line, and there was no 
reaction band to deer negative serum. Dipstick kit for E. chaffeensis will 
be useful for early detection of E. chaffeensis infection in on-site farm and 
helpful for early control of zoonotic ehrlichiosis at animal level.
199
UTILIZE ALL FOR HEALTH. AN OBSERVATIONAL STUDY
Faheem Ahmed Khanzada
Gulf Medical University, Karachi, Pakistan
Human is the only attribute to blush good innermost emotions healthy 
norm of daily living activities. Human mutual cooperation, share events, 
happiness and benefiting the human as a whole less tendencies toward 
disease, deaths. Happiness more choices, more demand and increasing 
supply goods decreasing diseases, deaths, disparities among human. 
Health contribution is susceptible to sustainable variable environment. 
The total gross world product (GWP) is approximately US$107.5 trillion 
reflect purchasing power parity the per capita GWP was approximately 
US$16,100 in 2014. An in-depth review was performed to emerging 
idea on the role of the global health investors in health service utility. 
The articles and other documentation were then summarized to assess 
what is known about the investor’s sector’s role in global health as well 
as gaps in the literature. In conclusion, society health contribution system 
reduces the health care cost serve the wellbeing of humanity the final key 
to health for all. The health utility is a total multidisciplinary and multi-
sectoral approach is emerging, leading to sustainable global health. It is 
suggested to promote and practice global health collaboration education, 
promotion activities among sectors to raising the health status of societies 
to accepting globalization and prosperous future societies.
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USING AN INNOVATIVE TELEHEALTH MODEL TO SUPPORT 
PROVIDERS IN GEOGRAPHICALLY DISPERSED AREAS WHO 
DELIVER CARE TO HIV-POSITIVE PREGNANT WOMEN
Tara Ness1, Mary F. Annese2, Natalia Martinez-Paz2, Kenton T. 
Unruh2, David H. Spach2, Brian R. Wood2
1University of Washington, Seattle, WA, United States, 2University of 
Washington, Frontier AETC, Seattle, WA, United States
Human Immunodeficiency Virus (HIV) remains a global pandemic, with 
mother-to-child transmission (MTCT) persisting in many areas due to 
inadequate access to early diagnosis and prenatal care. These barriers to 
HIV management are most pronounced in rural areas where resources are 
often limited, both in the United States and abroad. As many rural primary 
care providers do not receive a high volume of HIV patients, they often 
face challenges in maintaining familiarity with current HIV guidelines, 
including those related to MTCT. Frontier AETC ECHO is an innovative 
telehealth program that offers longitudinal teaching and mentorship as 
well as remote consultation to community HIV practitioners with the goal 
of strengthening capacity of the HIV workforce, supporting high-quality 
HIV care, and disseminating best practices in HIV medicine. This virtual 
peer-to-peer support network connects community HIV providers and a 
multidisciplinary team of specialists at the University of Washington across 
vast distances and employs real-time, case-based discussion and lectures 
to educate and support providers in low-resource and rural settings. Here, 
our goal is to assess the impact of the Frontier AETC ECHO program 
on provider management of HIV in pregnancy through two means: 1) 
reviewing cases of HIV in pregnancy presented by community practitioners 
to the ECHO network, and 2) a survey of community providers who 
regularly participate in ECHO. The survey assessed providers’ knowledge, 
comfort level, and local resources for managing HIV in pregnancy. 
More than half of participants responded. All patient cases had the 
successful outcome of prevention of MTCT of HIV. Patient and provider-
based outcomes support that ECHO is an efficient tool for supporting 
management of HIV in pregnancy, with providers reporting increased 
knowledge as a result of both presenting and observing cases on ECHO 
and many providers reporting they would be refer their patient to another 
provider if ECHO support were not available. These results demonstrate 
the potential of this unique model for application to other prevalent 
healthcare issues in rural and low-resource settings.
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COMMUNITY-BASED SCREENING FOR CARDIOVASCULAR 
RISK USING A NOVEL MOBILE HEALTH (MHEALTH) 
TECHNOLOGY IN RURAL KENYA
Benard O. Ochieng1, James Aw2, Jennifer Mannik2, Julius 
Chesire3, Michael Hawkes4
1Kenya Medical Research Institute, Kisumu, Kenya, 2Medcan Clinic, 
Toronto, ON, Canada, 3Field-Marsham Medical Clinic, Kenya Fluorspar 
Company, Kimwarer, Kenya, 4University of Alberta, Edmonton, AB, Canada
An increasing burden of non-communicable diseases, including 
cardiovascular disease (CVD), in low- and middle-income countries 
demands innovative approaches. In remote, resource-constrained settings, 
models of laboratory-based, physician-supervised management are not 
sustainable. Community health workers (CHWs) can provide primary 
health care, yet many lack necessary background, training and skills. 
Communication technology, such as mobile health (mHealth) has the 
potential to augment CHW capacity. We hypothesized that mHealth could 
be used to identify individuals at high CVD risk in remote communities 
with poor access to health clinics who would benefit from education and 
pharmacologic interventions. We designed and implemented a novel 
mHealth tool based on principles and data from the WHO Package of 
Essential Noncommunicable Disease Interventions for Primary Health Care. 
Our “two-way” mobile phone application collects and centrally stores SMS 
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text message data entered by a CHW on a subject’s age, gender, smoking, 
diabetes, and systolic blood pressure, and returns as SMS text message the 
category of 10-year CVD risk: “green” <10%; “yellow” 10 to 140mmHg. 
The prevalence of hypertension was similar in men and women (22/97 
[23%] men vs 26/126 [20%] women, p=0.74). Only 2/223 (0.9%) of 
subjects reported a history of diabetes. The estimated 10-year risk of CVD 
event was <10% (“green”) in 218/223 (98%) and 10-20% (“yellow”) 
in 5/223 (2.2%). All subjects received immediate feedback on their risk 
profile, counseling on cessation of tobacco use, healthy diet and exercise, 
and referral to the a nearby clinic for follow-up for patients with elevated 
CVD risk. Acceptability of the mHealth application, and of CHW CVD risk 
screening by subjects was excellent. We have developed an mHealth tool 
that can be used by CHWs to screen for CVD risk factors, demonstrating 
proof-of-concept in rural Kenya.
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DOMESTIC IMPLEMENTATION OF THE INTERNATIONAL 
HEALTH REGULATIONS: BRINGING THE WORLD OF HEALTH 
SECURITY HOME
Cody R. Thornton
Department of Health and Human Services, Washington, DC, United 
States
Domestic Implementation of the International Health Regulations: Bringing 
the World of Global Health Security Home The IHR is an agreement 
between all WHO Member States, 196 countries, to strengthen public 
health preparedness and response capacities globally. Under the IHR 
member states are required to establish core capacities to detect, assess, 
report and respond to public health emergencies. These core capacities 
allow for the assessment and notification of public health emergencies 
with potential international impact to World Health Organization (WHO) 
through the international network of IHR NFPs. In the United States, 
the Division of International Health Security (DIHS) in the Office of the 
Assistant Secretary for Preparedness and Response (ASPR) coordinates, and 
is a critical component of, the three-part U.S. NFP. In this role, DIHS advises 
the federal government on international IHR policies, develops domestic 
polices and processes to address IHR obligations, coordinates IHR-related 
communications and technical exchanges with international partners and 
domestic stakeholders, and leads efforts on bilateral policy and capacity-
building exchanges with foreign NFPs. State, local, tribal, and territorial 
(SLTT) public health professionals play an integral role in the fulfillment 
of U.S. obligations under the IHR Specifically, the US NFP works closely 
with federal departments and agencies who support SLTT reporting and 
response networks (e.g., CDC, FDA, DOI, USDA) to ensure communication 
of IHR-relevant events to WHO and international partners. Additionally, 
the US NFP uses SLTT self-assessments associated with the federal Public 
Health Emergency Preparedness cooperative agreement and the Hospital 
Preparedness Program to inform annual assessments of domestic IHR 
capacities and reporting to WHO. Attendees of this Learning Session 
will have the opportunity to discuss management of the US NFP, better 
understand the policies and processes central to the U.S. NFP, and consider 
how capacities at the state and local level support U.S. IHR obligations 
and, as a result, reinforce domestic and international health security.
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IMPLEMENTATION OF INTEGRATED POINT-OF-CARE TESTING 
FOR HIV SYPHILIS MALARIA AND ANAEMIA (IPOC) IN 
ANTENATAL CLINICS IN WESTERN KENYA
Nicole Yan1, Meghna Desai2, George Aol3, Godfrey M. Bigogo3, 
Miriam Taegtmeyer1, Ivor Langley1, Kayla Laserson2, Penelope A. 
Phillipes-Howard1, Feiko O. Ter Kuile1
1Liverpool School of Tropical Medicine, Liverpool, United Kingdom, 
2Centers for Disease Control and Prevention, Atlanta, GA, United States, 
3Kenya Medical Research Institute, Kisumu, Kenya
Prevalence of HIV, syphilis, malaria, and anemia is high among pregnant 
women in western Kenya; testing for these is currently part of the 
country’s antenatal recommendations. However, implementation of the full 
antenatal testing profile is limited because not all tests are done in smaller 
facilities, requiring women to be referred to distant labs. We conducted an 
implementation study to introduce point-of-care testing for HIV, syphilis, 
malaria and anemia (iPOC) in small rural health facilities in western Kenya. 
Seven small facilities without screening tests were purposively selected 
to introduce iPOC in December 2014. Antenatal nurses received a week 
of training. All 4 point-of-care tests were provided. For 8 months, 588 
exit interviews were done to assess testing uptake and quality of care. 
Comparison of ANC register data before and after iPOC was done to 
assess uptake increase. On-site observations of testing for quality control 
were done at 3, 6, 9 and 14 months. To determine the perception of the 
ANC experience with iPOC, 12 focus group discussions were held among 
women who had attended ANC recently. In-depth interviews on iPOC 
delivery were also done with program stakeholders and 16 iPOC nurses. 
Overall implementation success was assessed using 5 indicators: program 
acceptability, adoption, appropriateness, feasibility and fidelity. We 
assessed the impact of iPOC on operations using discrete event simulation 
(DES) modelling to compare system outputs with and without iPOC. 
Over a 4-week period in August 2015, clients attending MCH services at 
these facilities were observed and their process times taken to construct 
flow pathways and parameters to input into the model using WITNESS 
software. DES model outputs will include time to complete testing, waiting 
times, duration of activities, staff and resource impacts, disease diagnosed, 
process bottlenecks, and cost impacts in clinics with and without iPOC 
intervention. This study will give insight into the implementation of iPOC 
from the client, provider and health system perspective for future program 
delivery. The study will be completed in August 2016 and results will be 
presented.
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CROWDSOURCE REPORTING OF INFECTIOUS DISEASES 
DURING A DISASTER: A NOVEL TECHNOLOGY APPROACH
Saviniano Perez
University of Arizona College of Medicine-Phoenix, Phoenix, AZ, United 
States
Crowdsourcing of patient text data related to infectious diseases such as 
viral respiratory is a viable option for reporting of cases in the event of 
a natural disaster such as floods and hurricanes. The challenge during a 
natural is that access to the Internet is limited and traditional websites 
for logging infectious reports may not be operational. The data gathered 
from this process will be kept confidential and used as planning data 
and tracking cases for healthcare provider resources in a community. A 
personal cloud server is a solution to host a data collection system that 
will crowd source infectious disease data for a community such as gender, 
age of patient, patient history and medications, etc. Community citizens, 
public employees, healthcare providers can input data to the wireless 
personal cloud infrastructure via a smartphone or a laptop. These personal 
cloud servers can be co-located in storm-protected buildings with a back-
up power source and be connected to a wireless wide area network 
(WAN). Even in the absence of general Internet connectivity, a user just 
has to be in the range proximity of the wireless WAN and be able to 
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upload their text data to the personal cloud server. After regular Internet 
is restored to the community, an administrator can download the text 
data from the personal cloud server to a larger database for cartographic 
and statistical analysis. The outcome of this project is to identify the user 
and technical requirements and human interface & security challenges for 
connecting several connecting personal cloud servers to a larger cloud-
based database and creating a strategy for implementing, testing and 
evaluating this process in a real-world natural or man-made disaster. In 
onclusion, local healthcare administrators will find this system a viable 
alternative to reporting of infectious diseases during a natural disaster. 
The continuous reporting of infectious diseases at ground zero level is 
important for planning, monitoring and tracking of these cases. This novel 
approach allows for the uninterrupted collection of infectious disease text 
data for later analysis.
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EBOLA VIRUS DISEASE PREPAREDNESS AND RESPONSE 
STRATEGIES IN ETHIOPIA AND LESSONS LEARNED FROM 
WEST AFRICAN COUNTRIES
Netsanet H. Dadi1, Mesfin T. Manyazewal2
1Menelik II Referral Hospital, Addis Ababa, Ethiopia, 2Ethiopian Public 
Health Institute (EPHI), Addis Ababa, Ethiopia
Ebola Virus Disease Preparedness And Response Strategies In Ethiopia 
Lessons Learned From West African Countries Ebola virus disease has 
claimed more than 11,000 lives during the current epidemic in West Africa 
making it the deadliest outbreak since Ebola was discovered in 1976.On 8 
August the World Health Organization declared Ebola outbreak as a public 
health emergency of global Concern. The Ebola outbreak in West Africa 
is unprecedented in terms of its geographical scope. It began in Guinea in 
early 2014 and quickly spread to the neighboring countries. Inadequate 
health infrastructure and overall fragile health system has fueled rapid 
spread of the outbreak in West Africa. The severity of the outbreak is 
exacerbated by lack of understanding about the disease by communities 
and lack of experience among health-care workers .Lack of adequate 
treatment facilities, rumor, fear and stigma has in turn led families to keep 
sick patients at home, risking further spread of the virus. Resistance to 
proposed response measures as well as traditional burial practices further 
aggravated high transmission of the outbreak with devastating economic 
and livelihood implications. Ethiopia by the virtue of its geographic 
position and being political capital of Africa and being a major transport 
hub in the east Africa region is very prone to the deadly virus due to 
importation from Ebola riddled countries. Hence it has swiftly enhanced 
its domestic preparedness to respond in a predictable manner in the event 
of Ebola outbreak .It has employed state of the art screening measures at 
main entry ports and has also been engaged in fighting the outbreak at 
its source by sending medical teams to Ebola-stricken nations. This paper 
reviews the current Ebola preparedness and response strategies in Ethiopia, 
challenges and crucial lessons learned from West African countries and 
map out the strategies that are in place for improvement preventing future 
outbreaks.
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ASSESSMENT ON COMMUNITY BASED HEALTH INSURANCE 
IMPLEMENTATION IN RURAL ETHIOPIA
Abayengo Awel Ababulgu
Ethiopian Economic Association/Ethiopian Economic, Addis Ababa, 
Ethiopia
Ethiopia is among developing country with more than 90 million 
populations. The country is highly depending on external development 
partner to fiancé the health need of this huge population.Since 
the presence of donors’ resource is unpredictable, inadequate and 
unsustainable, the health sector is doing its best to bring sustainable 
domestic financing through implementing health care financing 
reforms (HFR). Community based health insurance (CBHI) is one of 
the reforms under implementation at piolet level in rural part of the 
country. This research is aimed to assess the implementation of CBHI 
and understand dropout, enrollment, re-enrollment, regional disparities 
and service uptake to inform the scale up strategy of the program. Both 
quantitative and qualitative methodology used to generate evidences. 
Around 1600 household surveyed in the piolet and control districts. 
Four rounds of survey data from same households, with same survey 
instrument and at the same season applied to understand the trends 
of key CBHI implementation indicators aforementioned above with 
econometrics model. It is found that the uptake of the scheme has been 
41% of the target households in 2012 and this has increased to 58% 
in 2015. Membership renewal is more than 80% of the initially enrolled 
households. The Ethiopian scheme enrollment and retention rates are 
impressive as compared to the experiences of other African countries. In 
terms of uptake, there are substantial differences across the pilot regions. 
It is found that Amhara is the best preforming region with coverage rate 
of 68% while Tigray is the lowest one with 49% uptake rate. Variations 
in the extent of ownership and commitment from local administration 
bodies to concerted mobilization effort during the defined renewal time 
frame, waiting time, renewal timing, and allocation of targeted subsidies 
for indigent groups contributed to the differences in the coverage of the 
scheme across the pilot regions. Drop out decision does not significantly 
relate with socioeconomic status.
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WEAK COLD CHAIN CAPACITY CAN COMPROMISE IPV 
INTRODUCTION IN SUB-SAHARAN AFRICA: A CASE STUDY 
FROM CAMEROON
Yauba Saidu
Expanded Program on Immunization, Yaounde, Cameroon
In 1988, the World Health Assembly resolved to eradicate poliomyelitis by 
the year 2000. Since then, tremendous strides have been made towards 
this goal and the incidence of polio has fallen by more than 99%. As part 
of the endgame strategy, the World Health Organization recommended 
countries to introduced at least one dose of inactivated polio vaccine 
(IPV) by 2015 into their routine immunization schedules. However, there 
is emerging evidence that weaknesses in cold chain systems can hamper 
successful introduction and roll out of IPV in low income countries. In 
Cameroon, for instance, over half of country’s stock was damaged prior 
to IPV launch. In this paper, we explored the reasons that led to this loss 
and the potential implications. We collected data from central, regional, 
district and health facility levels on IPV stock status, functional status of 
cold chain equipment, temperature monitoring practices and IPV coverage 
rates. Following the decision to introduce IPV, Cameroon imported a total 
of 840,000 doses of IPV. Nearly 500.000 of these doses were damaged at 
a central level. An additional 18,000 doses were damaged in one region. 
The primary causes for this loss were dysfunctional cold chain equipments, 
limited staff training and weak temperature control practices amongst 
others. The estimated financial loss was US$452,000. This loss, alongside 
challenges in importing additional doses because of limited global 
production capacity, resulted into prolonged stock out in many health 
facilities, which turn affected national coverage rates. With limited global 
IPV production capacity, weak cold chain systems can affect the availability 
and adequacy of IPV for routine immunization. This, in turn, may affect IPV 
coverage rates and may ultimately compromise polio eradication efforts.
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COMMUNITY HEALTH VOLUNTEERS’ USE OF MOBILE 
PHONES TO REPORT MASS DRUG ADMINISTRATION (MDA) 
DATA
Baaba da-Costa Vroom, Richmond Aryeetey, Richard Boateng, 
Francis Anto, John Gyapong
University of Ghana, Legon, Accra, Ghana
There is growing evidence of the potential of mobile phones to support 
public health programmes. Community health volunteers (CHV) who 
play a major role in mass drug administration (MDA) for Neglected 
Tropical Diseases Control Programmes (NTDP) are being considered as 
potential aides in improving data reporting from the community level. 
Little is known about technology adoption for MDA reporting by the 
CHVs working with NTD programmes. This study sought to determine 
CHVs willingness to use mobile phones to report MDA data and factors 
associated with their intention to use. This was a mixed methods study 
with data collected during two consecutive annual LF MDAs in two 
districts in Ghana. A structured questionnaire was used to collect data 
on socio-demographic characteristics, mobile phone use experience and 
readiness to adopt mobile phones for MDA data reporting. Readiness was 
measured using the Unified Theory of Acceptance and Use of Technology 
model. CHVs were trained to submit summarised MDA reports by SMS 
in the first year in both districts and USSD in year two in one district. 
Overall mobile phone ownership was 99% while 33% had text messaging 
experience. About 31% (χ2=2.67, p<0.05) submitted their MDA report 
using the mobile phone. The model explained very little about the CHVs 
behavioural intention (R2= 0.17). Willingness to submit text was high 
however actual submission was low. Factors associated with the low 
response were the CHVs perception of effort needed to send the text, 
social influence, poor network quality and texting experience. Factors such 
as age and gender did not have significant effect on their intention to use 
and actual use. General enthusiasm for MDAs should be reignited among 
CHVs. National policies on network quality improvement will provide 
enabling environment for implementation of such technology.
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COST-EFFECTIVENESS OF DENGUE VACCINATION IN FIVE 
SOUTHEAST ASIAN COUNTRIES
Wu Zeng1, Yara A. Halasa1, Laurent Coudeville2, Nicolas Baurin2, 
Donald S. Shepard1
1Brandeis University, Waltham, MA, United States, 2Sanofi Pasteur, Lyon, 
France
In 2015, the first dengue vaccine was licensed in several endemic 
countries, initiating a valuable new control tool. Decisions about its 
use in public programs depend on anticipated health benefits, costs, 
and cost-effectiveness. To inform policy discussions in Asia, we used 
a transmission model calibrated with data collected during vaccine 
efficacy Phase III trials. Costs of vaccine administration, procurement, and 
dengue treatment were based on publications and reports. Each vaccine 
dose was projected to cost $2 for vaccine delivery plus $20 for vaccine 
procurement. Our base case assumed that a 3-dose vaccination program 
would be offered to all 9 year-old children each year, plus a 4-cohort 
initial catch up (10-13 year-olds), phased over 3 years and achieving 80% 
coverage. Our base case expressed costs in 2013 US dollars from a health 
system perspective, conducted 100 simulations with a 30-year horizon 
to account for variability in dengue transmission and uncertainty on 
vaccine efficacy, measured health impacts in disability-adjusted life years 
(DALYs), and assessed cost effectiveness as $/DALY averted. Our base case 
results indicated that vaccination would save from $0.11 (Vietnam) to 
$1.72 (Malaysia) in annual per capita dengue treatment costs and would 
reduce dengue-related DALYs by 26% (Thailand) to 32% (Malaysia). Cost 
effectiveness ratios, expressed as multiples of each country’s per capita 
gross domestic product (GDP), were: Indonesia (0.17), Malaysia (-0.13), 
Philippines (0.56), Thailand (0.20), and Vietnam (3.57). In Malaysia, the 
vaccine is cost saving. Using WHO benchmarks of 1 and 3 times per capita 
GDP, the vaccine is highly cost-effective in Indonesia, Philippines, and 
Thailand (being below the most stringent benchmark), but is not cost-
effective in Vietnam from a health system perspective. Cost effectiveness 
results were similar for other vaccination programs (0 to 8 catch-up 
cohorts) and coverage rates (50% to 80%). The consideration of a societal 
perspective, increasing dengue incidence, dengue’s adverse impacts on 
tourism, and rising real incomes and health care costs further favor the 
case for vaccination.
210
COMMUNITY PERCEPTIONS OF HYPERTENSION IN LOW-
RESOURCE SETTINGS IN THE DOMINICAN REPUBLIC
Tanishq Suryavanshi1, Shicheng Jin1, Shirley (Xue) Jiang1, 
Salmi Noor1, Raiya Suleman1, Henry Lin2, Lawrence Loh3, Jazmin 
Marlinga4
1McMaster University, Hamilton, ON, Canada, 2Children’s Hospital of 
Philadelphia, Philadelphia, PA, United States, 3Dalla Lana School of Public 
Health, Toronto, ON, Canada, 4University of Calgary, Calgary, AB, Canada
The bateys (sugar cane towns) of La Romana, Dominican Republic are 
home to a large number of Haitian migrant workers. Due to their poor 
living conditions and barriers to accessing care, the health status of batey 
residents is severely compromised. Although efforts have been made to 
improve the health outcomes of batey residents, the discontinuity and 
lack of culturally appropriate care significantly reduces the effectiveness of 
these efforts. This study describes the perceptions of hypertension (HTN) 
among batey residents, to aid in developing a protocol that improves 
quality of care provided in the bateys. The goal of this study was to assess 
participants knowledge of HTN and HTN care. Data was collected using 
surveys administered verbally (N=81) using an interpreter fluent in Creole 
and Spanish. Of those surveyed, 54 were female and 27 were male, with 
59 participants aged 40 or older. Results showed that batey residents had 
learned about HTN from various sources including local clinics, hospitals, 
foreign medical teams and other batey residents. Headache (n=18), 
dizziness (n=15), shortness of breath (n=10), and weakness (n=7) were 
commonly reported symptoms of HTN. Additionally, most respondents 
were aware of the nearest clinic, with a majority (n=62) accessing clinics 
by taxi. Finally, batey residents viewed financial cost (n=24), a lack of 
clinicians in the bateys (n=20), and underdeveloped transportation (n=10) 
as the most significant barriers to accessing HTN care. Our findings reveal 
that males are underserved by existing models of HTN care, as many work 
during the day when mobile clinics visit the batey. Results also suggest 
that an optimized protocol should focus on bringing care closer to the 
bateys to increase access. Finally, there is a need for coordinated education 
and treatment programs between the different care providers in batey 
communities to ensure sustainable and continuous care. Overall, these 
results shed insight on how chronic disease protocols can be successfully 
implemented in low-resource settings to improve health outcomes.
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PEACE AND POST-CONFLICT HEALTH: NEONATAL AND 
MATERNAL MORTALITY AFTER CIVIL WARS WITH DIFFERENT 
ENDS
Riley G. Jones1, Fawzia Gibson-Fall1, Rachel C. Jones2, Karoline 
Skogo1
1King’s College London, London, United Kingdom, 2University of 
Edinburgh, Edinburgh, United Kingdom
The outbreak of “peace” after civil war is characterized by deeply 
entrenched grievances, mistrust, and insecurity. Violence often persists 
at high levels as the beneficiaries of resilient war economies shift 
to alternative means of maintaining profit and power. Institutional 
violence disproportionately affects different segments of society as the 
quality of peace may be dictated by a conquering victor who may seek 
retribution or well-armed warlords invited to the negotiating table whose 
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interests may only be the legitimization of territorial and economic gains 
achieved through battle. This study tests the assumption that diplomatic 
negotiations at the end of war protect the health and interests of 
vulnerable, non-combatant populations such as women and children. We 
examined neonatal and maternal health in societies after civil war whereby 
neonatal mortality rates and maternal mortality ratios are compared 
between three peace types: a peace imposed by the victor, a negotiated 
peace between capable warring parties, and no peace/continued war. 
The Uppsala Conflict Data Program Armed Conflict Dataset was queried 
with UNDP neonatal mortality rates (NMR) and maternal mortality ratios 
(MMR) for five years after conflict termination in Africa, South Asia, and 
South America between 1990 and 2013. Health data were annualized 
to net change year-on-year relative to health at the point of peace 
declaration. Health outcomes by peace type were compared by Mann-
Whitney U-tests at α=0.05 with 95% confidence intervals. We found that 
NMR fell by 1.8 and 1.9 deaths per 1,000 births in VP and NP, respectively, 
with no statistical differences observed; we found that MMR fell by 35.5 
and 55.6 deaths per 100,000 births in VP and NP, respectively, with no 
statistical difference observed. Although a statistical difference could not 
be appreciated at five years, concerning trends in MMR between different 
peace outcomes were observed and suggest a difference in the quality of 
peace for women.
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MANAGEMENT OF DENGUE HOSPITALIZATIONS IN BRAZIL 
DURING AND OUTSIDE EPIDEMIC PERIODS: INSIGHTS FROM 
DATA MINING
Nicolas Baurin1, David Morley2, Leon Ochiai1, Mariana Guergova-
Kuras2, Mohammad Afshar2, Laurent Coudeville1
1SanofiPasteur, Lyon, France, 2Ariana Pharmaceuticals, Paris, France
Brazil reported 1.5 million dengue cases in 2015, more than any 
other country. Most of the Brazilian population rely exclusively on the 
publicly funded health care system SUS (Sistema Unico de Saude). All 
hospitalizations paid for by SUS are registered in a publicly available 
database (SIH/SUS). We used the information included in this database 
to assess the implication of the epidemic nature of dengue on the 
management of dengue hospitalisations during and outside epidemic 
periods. Over 2008-2015, the SIH/SUS database describes 92 million 
admissions in 15,002 departments of 4,293 hospitals, of which 354k are 
admissions associated to a dengue diagnostic. For the analysis, hospital 
departments were classified as “High Dengue Activity” (HDA) departments 
or “Low Dengue Activity” (LDA) departments using the following criteria 
for HDA departments: at least 200 dengue admissions over 2009-2015 
and a maximum dengue patient load (daily bed count) exceeding 20% 
of the estimated bed capacity of the department. Over 2009-2015, 43% 
of admissions occurred in 274 HDA departments, while the remaining 
57% dengue cases were managed in 4,070 LDA departments. The 
maximum level of dengue patient load in the 274 HDA departments was 
notably high, at 43% on average and up to 62%. The overall patient load 
indicated that these HDA departments operate near or even sometimes 
beyond their maximum capacity during dengue epidemic periods. The 
systematic analysis of admissions to HDA departments using data mining 
tools also led to the identification of subgroups showing an excess of 
mortality during dengue epidemic periods. These subgroups are associated 
to dengue-related diseases and case management characteristics. We 
also observed a larger proportion of cases managed in LDA departments 
during dengue epidemic periods. Finally, we observed a higher dengue 
case fatality rate in LDA departments than in HDA departments (0.9% 
and 0.4% respectively; OR=2.1 (1.9-2.3)).This analysis highlights the 
consequences of the seasonal aspect of dengue on the management of 
dengue hospitalization in Brazil and some implications for dengue-related 
mortality.
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BALANCING RISK AND COSTS IN CONTROLLING THE 
INTERNATIONAL SPREAD OF INFECTIOUS DISEASE 
OUTBREAKS WITH ACTIVE MONITORING
Nicholas G. Reich1, Justin Lessler2
1University of Massachusetts, Amherst, MA, United States, 2Johns Hopkins 
Bloomberg School of Public Health, Baltimore, MD, United States
The 2014-2015 west African Ebola outbreak was an unprecedented global 
public health emergency that underscored the ease with which pathogens 
can spread in today’s interconnected world. To improve rapid identification 
and evaluation of individuals at risk for Ebola, some countries actively 
monitored of individuals who were returning from Ebola-affected regions. 
A common policy was to have individuals under active monitoring make 
daily contact with local health authorities each day for 21 days after their 
last potential exposure. Active monitoring has shown promise as a tool in 
preventing and responding to outbreaks of pathogens that pose a grave 
threat to public health. It may also play an important role in containing 
outbreaks of emerging pathogens that could rapidly spread throughout a 
population. We developed a framework for evaluating the risks and costs 
associated with active monitoring using. As a case study, we analyzed 
new data on the cost of the Ebola response in New York City and existing 
data on the incubation periods of Ebola, MERS-CoV, and smallpox. Our 
analysis provides empirical evidence that could inform the design and 
implementation of future active monitoring programs. For example, to 
tolerate the level of absolute risk implied by Ebola active monitoring 
programs, our model would suggest that for both MERS-CoV or Smallpox, 
a duration of active monitoring could be set at less than 2 times the 
median incubation period for each disease. Furthermore, for low-risk and 
high-risk individuals, our model provides estimates of how long individuals 
should be monitored to minimize the expected cost of the monitoring 
program. This model could be used to help guide future assessments and 
data collection on active monitoring programs. It also provides a pathway 
for data to inform the design of active monitoring programs for the next 
global epidemic.
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UNDERSTANDING RESEARCH ACTIVITY IN THE HEALTH 
SECTOR OF UZBEKISTAN: IMPLICATIONS FOR HEALTH 
RESEARCH CAPACITY STRENGTHENING
Min J. Cho1, Mohir Ahmedov2, Saravanan Subramanian1, Shuhrat 
Abdujalilovoch3
1Center for Development Research, Bonn, Germany, 2Consultant, Tashkent, 
Uzbekistan, 3Tashkent Medical Academy, Tashkent, Uzbekistan
Health research capacity building between high income countries and low 
income countries is being recognized as an important field in achieving 
health equity. Evaluating the research capacity is considered to be one 
of the key principles in achieving good practices in research capacity 
building. This study sheds light on the current research capacity in health 
sector of Uzbekistan. Bibliometric analysis was applied to examine the 
publications trends in health research to map the Uzbekistan research 
production along with the key research topics. A search strategy was 
built to retrieve journal articles from the Web of Science (WOS) and 
PubMed Medline from 1991-2015. A total of 430 articles were identified 
and 321 articles were analyzed after exclusion criteria were applied. The 
number of articles trended upward with accentuated growth during 2000 
to 2010 of 180 articles, six times than the earlier decade (1991-2000). 
62.7% of the articles were related to communicable diseases, newborn, 
maternal, and nutritional causes and 26.8% of the articles reported on 
non-communicable diseases while only 9.5% of articles reported research 
on health systems. In total, 60.4% of papers involved international 
collaborations with institutions in USA(26.8%), Japan(13.4%), and Russia 
(10.3%) followed by multilateral organizations such as WHO and MSF. 
Uzbek authors in international collaborations published in high impact 
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factor journals (average of 2.46) while studies reporting of only Uzbek 
authors published in low impact factor journals (average of 0.205). 
Health research output in Uzbekistan has increased since independence 
but Uzbek authors face difficulty in making their research visible in 
international community without international collaboration.
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RESIDENT-DRIVEN TELEDERMATOLOGY IN HAITI: A 
SYMBIOTIC PARTNERSHIP IN DERMATOLOGIC EDUCATION 
AND HEALTH
Jennifer Abrahams
University of Miami, Miami, FL, United States
It is important for residents to pursue relevant exposures during training 
for their intended career niche. I created a resident-driven teledermatology 
program in Haiti with the dual-goal of providing care to patients lacking 
access while broadening resident exposure in a tropical underserved 
population. 59% of Haitians live on less than $2 a day with a life 
expectancy of 63 years. Up to 20% of outpatients in the tropics have a 
skin complaint. Infrastructure and health services are limited in Haiti, but 
internet access and cellular service is present throughout the country- 
making teledermatology a more practical approach to see patients. The 
foundation for this program was built upon multiple medical aid trips to 
Haiti working alongside local Haitian Dermatologists. The partnerships 
developed with local practitioners helped to create the foundation for this 
program through patient evaluation, referrals, follow up, and treatment. 
A donated used cameraphone held by a local nurse offers a portable 
method to take clinical images which can be emailed at any time (“store 
and forward telemedicine”)- ideal in an area with sporadic internet 
connectivity. A patient questionnaire provides relevant information without 
the time & cost of a physician visit. Recommendations are made within 
48 hours by volunteer residents, overseen by attending physicians, and 
conveyed to local health providers. Donations cover the costs of labs, 
biopsies, or medications for patients who cannot afford them. Referrals are 
provided to those requiring additional care in-person. From mycetomas to 
varicella and an increased rate of genodermatoses (due to founder effect 
in an island population), the educational value for residents is vast. Dengue 
and Chikungunya viruses appeared in the Caribbean a full year before 
cases appeared in Florida and as we anticipate the spread of Zika virus our 
residents have already become clinically familiar through Haiti. Establishing 
a telemedicine program is an inexpensive, reproducible and feasible 
endeavor for residents seeking niche experience in the field of global 
medicine while providing healthcare to those most in need.
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AN INNOVATIVE TRAVEL MEDICINE APPROACH USING 
MHEALTH TECHNOLOGY TO DESCRIBE HEALTH RISKS TO 
TRAVELERS
Andrea Farnham, Milo Puhan, Christoph Hatz
Epidemiology, Biostatistics, and Prevention Institute, Zürich, Switzerland
Emerging mHealth technology shows great potential in more accurately 
and completely documenting travel itineraries and modeling health and 
disease risk patterns of travelers, including accidents/injuries, infectious 
and other non-communicable disease outcomes. Our study aims to 
address several major shortcomings in travel health research by using 
a smartphone application to collect detailed information on health 
behaviors, symptoms and accidents, and environmental risk factors during 
travel. In partnership with the Swiss Federal Institute of Technology (ETH) 
Wearable Computing Lab, the Epidemiology, Biostatistics, and Prevention 
Institute at the University of Zürich have developed a novel data collection 
instrument and analysis concept: a smartphone application that collects 
data on 1) travelers’ exact itinerary and environmental conditions using 
passive GPS localization, and 2) a daily-self report questionnaire on health 
risk behavior, accidents, and symptoms while traveling. A prospective 
cohort of 107 travelers planning travel to Thailand between January 
and June 2015 was recruited from the travel clinics of Zurich and Basel 
in Switzerland. Of the 101 recruited travelers that went to Thailand, 75 
(74.3%) answered at least 1 questionnaire during travel, 10 (9.9%) had 
technical difficulties, and 16 (15.8%) dropped out or were lost to follow-
up. Travelers filled out a median of 12.0 surveys during their trip (range: 
1-30), corresponding to a median completion rate of 85.0% days of 
travel. Questionnaire completion rates were best for shorter trips, with a 
survey completed on average 94.8% of days for trips less than 10 days. 
Non-infectious disease health outcomes were common, with 22.7% of 
travelers experiencing an accident, 49.3% mental distress, and 14.7% an 
animal bite. Use of a smartphone application to collect health information 
is technically feasible and acceptable among the traveler population, 
minimizes recall bias, and greatly increases the quality and quantity of 
data collected during travel. MHealth technology shows great potential for 
innovation in the field of travel medicine.
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ASSOCIATION BETWEEN IMPROVED HOUSING 
CHARACTERISTICS AND MALARIA PREVALENCE IN CHILDREN 
UNDER FIVE
Cameron Taylor, Lia Florey
ICF International, Rockville, MD, United States
In the past decade, malaria vector control strategies in sub-Saharan Africa 
have focused on the use of insecticide-treated nets (ITNs) and indoor 
residual spraying (IRS) in combatting malaria. House construction using 
modern, impermeable materials also improves vector control. Past studies 
have examined the association between household characteristics and 
malaria through meta-analysis or localized surveys; however, there has 
been few studies using nationally-representative population-based surveys. 
This study examined 24 Demographic Health Surveys (DHS) and Malaria 
Indicator Surveys (MIS) with data on malaria parasitemia status in children 
under five and household characteristics such as type of flooring, wall, and 
roofing materials. Logistic regression was used to assess whether improved 
flooring, wall, and roofing types were protective against malaria after 
controlling for ITN use, IRS spraying in the past 12 months, household 
wealth status, age of child, sex, and malaria endemicity in survey specific 
analyses as well as meta-analysis. Results of the country-specific analyses 
showed a significant protective effect of an improved roof on malaria 
infection in children in 10 of the 24 surveys included (from Benin, Burundi, 
Cameroon, Mali, Malawi, Nigeria, Senegal, Tanzania and Uganda). Results 
of the meta-analysis show a protective effect of improved roof (metal, 
wood, ceramic tiles, cement, and shingles) on malaria infection in children 
under five (OR=0.82; 95% CI: 0.74-0.92). Marginally significant protective 
effects of improved walls (baked bricks or cement blocks) and improved 
floor (not earth, sand or dung) on malaria infection in children under five 
was also found (OR = 0.91; 95% CI: 0.82-1.00) and (OR=0.95; 95% CI: 
0.86-1.04, respectively). Results corroborate findings from other studies 
that show housing as an important risk factor for malaria. Findings suggest 
that investments in improved housing may contribute to sustainable 
development goals by conferring protection against malaria as well as 
other socio-economic benefits.
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THE IMPROVING MALARIA CARE (IMC) PROJECT’S 
CONTRIBUTION TO FOLLOW UP A PILOT TO USE RAPID 
DIAGNOSTIC TESTS (RDTS) AT THE COMMUNITY LEVEL IN 
BURKINA FASO
Ousmane Badolo1, Stanislas P. Nebie1, Moumouni Bonkoungou1, 
Mathurin Dodo1, Rachel Waxman2, Danielle Burke2, William 
Brieger3
1Jhpiego, Ouagadougou, Burkina Faso, 2Jhpiego, Baltimore, MD, United 
States, 3Johns Hopkins School of Public Health, Baltimore, MD, United 
States
Early and correct case management of malaria in health facilities and at 
the community level is among the priorities of Burkina Faso’s National 
Malaria Control Program (NMCP). In line with this initiative, the NMCP 
piloted use of Rapid Diagnostic Tests (RDTs) by Community Health Workers 
(CHWs) to confirm malaria cases in the three health districts of Kaya, 
Saponé and Nouna between 2013 and 2015. With PMI support, follow-up 
visits were organized to document best practices, as well as challenges, on 
RDT use by CHWs that could serve as lessons learned for scale-up. During 
follow-up visits, malaria commodities management (supply, storage and 
use) at the community level was examined, use of RDTs was assessed, 
and implementation at the community level was discussed with all actors 
at regional, district, health facilities, and community levels. The team 
examined the monitoring/supervision processes at all levels, used a check 
list on malaria commodities management, and employed a questionnaire 
for each type of actor. Both qualitative and quantitative data have been 
collected. A total of 108 persons were contacted including 32 CHWs, 42 
community leaders and 34 health care providers and managers. Findings 
revealed frequent stock-outs of RDTs and artemisinin-based combination 
therapies, non-payment of stipends to CHWs (a demotivator) and 
insufficient supervision of CHW by health teams. From the community 
perspective, 66% of community leaders were satisfied with their CHW’s 
work (diagnosis and treatment of uncomplicated malaria and referral of 
severe cases to health facilities). However, 46% of community leaders 
complained of frequent stock-outs and unanimously agreed on the 
importance of regular payment of premiums to CHW. Follow up of the 
pilot was valuable in obtaining community, CHW and health worker 
perspectives for improving the program. While the community finds the 
program acceptable, its sustainability will require that solutions be found 
for stock-outs, non-payment, and insufficient supervision before scale up 
takes place.
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AVAILABILITY OF ORS, ZINC, AND AMOXICILLIN AMONGST 
PUBLIC FRONTLINE WORKERS IN UTTAR PRADESH, INDIA: A 
KEY DETERMINANT TO REDUCING UNDER FIVE MORTALITY 
DUE TO CHILDHOOD DIARRHEA AND PNEUMONIA
Ashutosh Mishra1, Niranjan Saggurti2, Punit Kumar Mishra1, 
Lorine Pelly3, Margaret Baker4, Animesh Rai1, Suneeta Krishnan1
1Research Triangle Institute Global India Private Limited, New Delhi, 
India, 2Bill & Melinda Gates Foundation, New Delhi, India, 3University 
of Manitoba, Manitoba, MB, Canada, 4Research Triangle Institute 
International, Washington, WA, United States
In India, diarrhea and pneumonia contribute to around 12% and 23% 
of all under five deaths. Under the National Rural Health Mission, 
Government of India’s flagship initiative to provide quality health care to 
rural population, accredited social health activists (ASHAs), the community-
based workers, have been key players for the provision of health services 
in Indian villages. ASHAs have received a number of trainings in the past 
to strengthen their skills in the management of childhood illnesses. Despite 
the trainings and widespread presence of ASHAs, the decline in the 
mortality rates due to childhood diarrhea and pneumonia has been slow. 
473 ASHAs sampled as per a predetermined randomization protocol were 
interviewed face-to-face from six districts of Uttar Pradesh to understand 
their treatment recommendation practices and proportion of diarrhea 
and pneumonia cases seen by them. Additionally, a medicine audit was 
undertaken to check the availability of ORS, zinc, and amoxicillin. On 
average, ASHAs assessed less than one case of diarrhea and pneumonia 
in the last 7 days. 72% recommended both ORS and zinc, 16% ORS 
alone, and 0.2% zinc alone, and none recommended amoxicillin. Of 
those ASHAs that did not recommend ORS and zinc, non-availability was 
mentioned as the main reason for non-recommendation. During the 
medicine audit, 43% and 17% had a stock of ORS and zinc respectively, 
and none had amoxicillin. Significantly low number of diarrhea and 
pneumonia cases seen by ASHAs means that there is little opportunity 
for them to consolidate and refine their skills. Also, a high proportion of 
ASHAs recommended ORS and zinc for diarrhea, but did not have ORS or 
zinc in their drug kits. Lack of amoxicillin in their drug kits was a significant 
factor in not recommending amoxicillin for pneumonia. The success of 
government rural health programs is dependent on ASHAs and their ability 
to cater to the health needs of the rural population. Ensuring adequate 
stocks of ORS, zinc, and amoxicillin with ASHAs is crucial to accelerating 
the decline in diarrhea and pneumonia mortality rates.
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COMPREHENSION OF SURGICAL INFORMED CONSENT IN 
HAITI
Justine S. Broecker1, Caitlin Sutton2, Linda Demma3, Grant C. 
Lynde3
1Emory University School of Medicine, Atlanta, GA, United States, 
2Stanford University Department of Anesthesiology, Palo Alto, CA, United 
States, 3Emory University Department of Anesthesiology, Atlanta, GA, 
United States
Informed consent has long been considered an essential requirement of 
surgical care in the United States. However, little is known about the use 
of informed consent on international surgical trips. Since 2008, a multi-
disciplinary team from Emory University has partnered with Hospital St. 
Therese in Hinche, Haiti to provide surgical care. An informed consent tool 
has been developed and evaluated by the Emory team to prepare patients 
for surgery. All patients at Hospital St. Therese scheduled for surgery by the 
Emory team (n=52) received a dual video and written informed consent 
both translated into Creole describing the procedures, risk and benefits 
of both surgery and anesthesia. Procedures performed were primarily 
inguinal herniorraphy and open prostatectomy. Following the informed 
consent, patients completed a survey translated into Creole evaluating 
their understanding of and satisfaction with the procedures using a 
tablet app both before (n=48) and after surgery(n=47). Prior to surgery, 
91% of patients were able to correctly identify their surgical procedure. 
The majority of patients were able to identify the most common risks 
of surgery including pain (85%), bleeding (80%) and infection (70%). 
98% of patients were satisfied with the informed consent process and 
91% of patients would have their operation again at discharge. Our 
survey revealed that our ability to obtain informed consent was limited by 
language barriers despite the use of translators (61%) and poor literacy 
(54%). We plan to refine our informed consent process to better address 
these challenges in the future. The results of our survey demonstrate that 
an informed consent tool can aid in preparing patients for surgery but that 
communication barriers inherent to the setting of international surgical 
trips should be considered in the development of successful informed 
consent tools.
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LONG-LEAD EL NIÑO FORECAST INFORMATION TO SUPPORT 
PUBLIC HEALTH DECISION MAKING: APPLICATION TO 
DENGUE EPIDEMICS IN ECUADOR
Desislava Petrova1, Rachel Lowe1, Anna Stewart-Ibarra2, Joan 
Ballester1, Siem Jan Koopman3, Xavier Rodo1
1Catalan Institute for Climate Science (IC3), Barcelona, Spain, 2SUNY 
Upstate Medical University, Syracuse, NY, United States, 3Vrije Universiteit 
Amsterdam, Amsterdam, Netherlands
El Niño Southern Oscillation (ENSO) is a high-impact climatic phenomenon 
causing substantial changes in the weather worldwide. It leads to floods or 
droughts in certain regions of the globe, damaging agriculture and marine 
ecosystems, and increasing the risk of infectious disease epidemics such as 
dengue epidemics in some tropical countries. Therefore, ENSO forecasts 
could help authorities to plan in advance of imminent disasters, to mitigate 
the risk, and to protect vulnerable communities. A structural time series 
model, which uses a state space approach and explanatory variables 
relevant to the El Niño (EN) evolution, has been developed and tested to 
predict sea surface temperature (SST) in the equatorial Pacific Ocean (in 
the Niño 3.4 region). The model configuration is specifically tailored to 
forecast EN at long lead times of 24 months or more, going well beyond 
the traditional ¨spring barrier¨ of ENSO prediction. The forecasting scheme 
provides information about the amplitude of the events, their duration, 
and the peak time of the SST. This information could be used to support 
decision making, especially in tropical and subtropical countries, which 
are directly and severely affected by the anomalous temperature and 
precipitation rates that occur during and after El Niño events. Certain 
diseases are particularly sensitive to climate extremes. For example, a 
previous study found that the timing and magnitude of dengue outbreaks 
in El Oro province in Ecuador were associated with El Niño events. In 
this study, long-lead forecasts of equatorial Pacific SST (i.e. the Niño 3.4 
index) are used within a dengue prediction model, to assess the extent 
to which dengue epidemics can be predicted well in advance. The ENSO 
forecasting model could have helped to predict the dengue epidemic 
that occurred in the region in 2010 as early as 30 months ahead. Thus, 
long-lead ENSO forecasts could be incorporated into dengue prediction 
models, to enhance the development of a dengue warning system for 
Ecuador and other tropical and subtropical countries sensitive to the ENSO 
phenomenon.
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DUAL PERSPECTIVES ON STIGMA: REPORTS OF 
EXPERIENCED AND ENACTED STIGMA BY THOSE AFFECTED 
AND UNAFFECTED BY PODOCONIOSIS
Desta A. Alembo1, Abebayehu Tora2, Getnet Tadele1, David 
Farrell3, Gail Davey4, Colleen McBride5
1Addis Ababa University College of Social Science, Addis Ababa, Ethiopia, 
2Wolaita Sodo University, Department of Sociology, Sodo, Ethiopia, 3People 
Designs Inc., Durham, NC, United States, 4Brighton and Sussex Medical 
School, Brighton, United Kingdom, 5Behavioral Sciences and Health 
Education, Emory University, Atlanta, GA, United States
Disease-related stigma is a public health concern steadily gaining global 
attention. Evidence consistently shows that an individual’s attribution of 
disease cause can prompt or justify interpersonal stigma. However, few 
studies have explored causal beliefs about inherited disease and their 
influence on stigmatizing behaviours in low and middle income countries 
(LMICs). The study was conducted in 2013, in six communities in Wolaita 
zone, southern Ethiopia. A total of 1800 respondents (600 affected and 
1200 unaffected parents of an index child aged between 3 and 6 years) 
took part in the study. Two versions of the enumerator-administered 
survey were created, with measures assessed in parallel on “experienced” 
stigma for the affected and “enacted” stigma for unaffected household 
respondents. Mean levels of reported enacted stigma were slightly lower 
(2.0, SD 0.7) than experienced stigma reported by affected respondents 
(2.2,SD 1.1). Males consistently reported significantly lower levels of 
experienced and enacted stigma than females, p<0.0001. Beliefs that 
podoconiosis was hereditary were significantly and positively associated 
with reported levels of experienced stigma among affected respondents 
and enacted stigma for unaffected respondents (p<0.001). There was no 
association between levels of stigma experienced by affected households 
with corresponding levels of enacted stigma reported by the neighbouring 
unaffected households. In conclusion, if stigma reduction interventions are 
to be successful, culturally-tailored, gender inclusive and innovative health 
education programs are required, directed at the general community as 
well as at patients.
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DOES HAVING HEALTH INSURANCE RELATE TO MEDICATION 
USE FOR HYPERTENSION IN THE DOMINICAN REPUBLIC?
Sophie Hu, Jazmin Marlinga, John D. McLennan
University of Calgary, Calgary, AB, Canada
Hypertension, a major contributing factor to mortality worldwide, can 
be reduced by the use of antihypertensive medications. Studies within 
high-income countries have found that having health insurance increases 
the odds of use of medication among those with hypertension. However, 
there has been little examination of influence of health insurance on 
hypertension management in low and middle-income countries (LMIC) 
where hypertension affects a larger number of people. This study 
examined one LMIC, the Dominican Republic (DR), which has high rates of 
hypertension and a population incompletely covered by health insurance. 
This study investigated the relationship between having health insurance 
and recent use of medication among those diagnosed with hypertension 
using data from the 2013 Demographic and Health Survey (DHS) for the 
DR. Among survey participants who had been told by a health professional 
that they had hypertension, 42.3% of men and 42.7% of women 
reported taking antihypertensive medication in the two weeks preceding 
the survey. On bivariate analysis, women, but not men, were more likely 
to report having taken medication if they had health insurance. Within 
a multivariate model, having health insurance significantly increased the 
odds of medication use. Being a women and older age also increased the 
odds of medication use in the model. A sex by health insurance coverage 
interaction term was not significant. The wealth indicator demonstrated 
a more complex relationship with those in households classified in the 
poorest quintiles having higher medication use than those in the poorer 
quintile; this despite lower insurance coverage for the poorest. Perhaps 
non-insurance based targeted intervention efforts for the poorest may 
have extended coverage. This study is limited secondary to the truncated 
age range for women (15-49 years) available from the DHS. Future 
research should investigate types and quality of care provided for persons 
with hypertension for a fuller age range, with consideration of both health 
insurance coverage and wealth strata.
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LOW COST, IMAGING BASED DEVICE FOR PERFORMING A 
WHITE BLOOD CELL COUNT AND 3-PART DIFFERENTIAL AT 
THE POINT OF CARE
Catherine E. Majors, Michal Pawlowski, Tomasz Tkaczyk, 
Rebecca Richards-Kortum
Rice University, Houston, TX, United States
The white blood cell (WBC) count and differential is an important 
laboratory diagnostic test. However, current methods for performing a 
WBC count and differential have high associated costs and infrastructure 
requirements and are therefore not available in low resource settings. 
There is a particular need for affordable tools to rapidly measure the 
WBC count and differential at the point of care in such settings. To meet 
this need, we have developed a portable device and low cost disposable 
cartridge that can be used at the point of care to perform a WBC count 
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and 3-part differential using 10 uL of blood obtained from a finger prick. 
The device is battery powered, can be deployed at the bedside, and 
produces results in under 5 minutes. The cartridge contains a microfluidic 
channel in which acridine orange is pre-dried. Blood from a finger stick is 
drawn into the channel via capillarity and WBCs are fluorescently stained 
with acridine orange, staining nuclei green and granules red without any 
sample processing. An all plastic fluorescence microscope is housed within 
the device, and a series of three images is captured and automatically 
analyzed to report the WBC count and the percentages of granulocytes, 
monocytes, and lymphocytes to the user. This is achieved by a novel 
image analysis program that identifies the WBCs in each field of view and 
classifies them into the WBC subtypes based on the red and green pixel 
intensity within each cell. The device has been recently tested with finger 
prick samples from 91 oncology patients at Lyndon B. Johnson Hospital in 
Houston, TX with WBC counts ranging from 2.7x103 to 30.4x103 WBCs/
uL. Preliminary analysis of the results shows a strong linear correlation 
between the number of WBCs in the image field of view and the WBC 
count (R-squared 0.96). Further, the differential data also correlates 
strongly with the true values with an overall R-squared value of 0.92. We 
estimate at production scale the device can be developed for under $800 
and the cartridge for less than $0.25, increasing access to this important 
diagnostic measurement to settings that currently cannot determine a 
patient’s WBC count and differential.
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ADAPTING AND ENHANCING MALARIA INFORMATION 
SYSTEMS IN COUNTRIES ENTERING PRE-ELIMINATION
Jui A. Shah1, Michael Paula2, Yazoume Ye2
1MEASURE Evaluation, ICF International, Washington, DC, United States, 
2MEASURE Evaluation, ICF International, Rockville, MD, United States
There has been substantial progress in addressing sub-Saharan Africa’s 
malaria burden. As countries reduce transmission and move from malaria 
control to pre-elimination, strong health management and information 
systems (HMIS) become critical to provide routine data to monitor 
progress, identify rebounds, and tailor new approaches for residual 
foci transmission. To ensure HMIS in sub-Saharan Africa are prepared 
to perform these roles in countries with the potential to move to pre-
elimination, MEASURE Evaluation conducted a study to systematically 
measure the functionality of HMIS and to identify supporting factors. 
The study comprised a systematic literature review of HMIS performance 
assessments with a special focus on malaria. From an initial 1,581 peer-
reviewed articles on HMIS in Africa, information was extracted and 
synthesized from a final 25 along the following subthemes: indicators of 
data quality, elements of well-functioning HMIS, supportive context for 
HMIS, and comprehensive measures of HMIS performance. The literature 
review revealed no uniform approach for assessing and improving the 
performance of HMIS and little guidance on how to adapt and enhance 
HMIS to keep them functional for countries at various points on the 
malaria control-to-elimination continuum. HMIS strengthening approaches 
generally focused on human capacity and participation, data quality 
and completeness, and a country-led enabling environment for policy 
and planning. The results of this desk review will be supplemented with 
in-country work to develop country case studies and a toolbox to help 
countries entering pre-elimination learn from the experiences of countries 
further along the continuum to adapt and strengthen routine data 
capture.
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THE PRIORITY REVIEW VOUCHER AS A MEANS OF 
ADDRESSING GLOBAL HEALTH PRIORITIES
Mark Sullivan1, Curt LaBelle2, Errol Malta1, Patty Fegan1, Victoria 
Ryg-Cornejo1, David Ridley3
1Medicines Development for Global Health, Melbourne, Australia, 2Global 
Health Investment Fund, New York, NY, United States, 3Fuqua School of 
Business, Duke University, Durham, NC, United States
Neglected tropical diseases (NTDs) remain important sources of morbidity, 
mortality and disadvantage in low and middle-income countries, and yet 
the development and registration of new treatments for these diseases is 
rare. Funding to support the research and development of new medicines 
for these diseases is directly correlated with their low potential for return 
on investment, and remains insufficient to consistently meet regulatory 
standards. To drive this drug development, in 2007 the United States 
Congress created the priority review voucher (PRV) to reward sponsors 
who successfully register medicines to treat specified NTDs. The PRV is 
saleable to any company wishing to gain priority review of their new 
treatment, regardless of indication, creating a market that has yielded up 
to US$350 million per PRV. Although three new NTD treatments have been 
approved under the scheme, concerns have been expressed that sponsors 
benefitting from PRV sale are not bound to ensure treatment access 
and that the program does little to drive new NTD drug development. 
Medicines Development for Global Health (MDGH), a non-profit 
biotechnology company, partnered with the Global Health Investment 
Fund (GHIF), a U.S.-based social impact investment fund, to develop and 
register moxidectin for the treatment of onchocerciasis. MDGH is the first 
company to attract venture capital investment for a new treatment for a 
NTD on the basis of the PRV program. With limited commercial return, 
the investment in moxidectin would have been previously inconceivable, 
particularly as the registered treatment option for onchocerciasis 
(ivermectin) is donated. GHIF and MDGH, both with constitutionally 
enshrined global health objectives, have entered into a legally binding 
commitment to use PRV funds to support equitable and sustainable access 
to moxidectin for onchocerciasis, as well as support further development 
of moxidectin for other NTDs. In conclusion, this is the first example of a 
program utilizing the PRV scheme to support NTD drug development and 
access, directly addressing the majority of concerns raised about the use of 
PRV scheme to achieve global health impact.
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EVALUATING LONG-LASTING INSECTICIDAL NET 
EFFECTIVENESS OVER TIME USING SENTINEL SURVEILLANCE 
NETWORK: EVIDENCE FROM MADAGASCAR
Florian Girond1, Yoann Madec2, Thomas Kesteman1, 
Milijaona Randrianarivelojosia1, Rindra Randremanana1, Lea 
Randriamampionona1, Judith Hedje3, Annett Cotte3, Christophe 
Rogier1, Patrice Piola1
1Institut Pasteur de Madagascar, Antananarivo, Madagascar, 2Institut 
Pasteur, Paris, France, 3Centers for Disease Control and Prevention, 
Atlanta, GA, United States
The reduction of global malaria burden over the past 15 years can be 
attributed to an unprecedented scale-up of malaria control interventions, 
particularly through mass distribution campaigns (MDCs) of long-lasting 
insecticidal nets (LLIN). Three LLIN MDCs were implemented in Madagascar 
at the end of 2009, 2012 and 2015 (coverage ranges from 80% to 
94%). While malaria decline in Madagascar suggests the impact of MCIs, 
instances of malaria outbreaks between LLIN MDCs (in the absence of 
routine continuous distribution channels) suggest that diminished LLIN 
coverage may exist or net effectiveness may decline faster than expected. 
We conducted a study based on sentinel surveillance at 17 sites to assess 
the relationship between the effectiveness of LLIN MDCs over time and 
malaria outbreaks identified in Madagascar from 2009 to 2015. The 
association was evaluated using Generalized Linear regression Model 
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(GLM) and survival analysis. An alert was defined as weekly malaria cases 
exceeding the 90th percentile value for the three previous consecutive 
weeks. The percentile value is not seasonally-dependent and calculated 
over the whole chronological series of a site. GLM analysis showed that 
compared to the first year after a LLIN MDC, the probability of a malaria 
risk alert at surveillance sites increased dramatically during the second 
year (OR 37.9, 95% C.I 15.9-123.7) and further increased during the third 
year (OR 54.2, 95% C.I. 22.6-177.5). The survival analysis showed that 
each year that followed an LLIN MDC was alert free. Within two years 
after LLIN MDC, 51.4% (18/35) of sites were affected by an outbreak, and 
77% (27/35) after 2 years. Data from Malagasy sentinel surveillance were 
valuable in assessing the effectiveness of LLIN mass campaigns. We provide 
evidence that LLIN MDC prevent malaria outbreaks although over time the 
frequency of outbreak alerts increased. Approaches for continuous LLIN 
distributions to maintain high coverage between MDCs are likely necessary 
to accelerate malaria control in Madagascar. Further studies are needed to 
investigate other causes responsible for the increase in malaria alerts over 
time after LLIN MDCs.
228
A FRAMEWORK FOR THE SYSTEMATIC EVALUATION OF 
SEVERE DISEASE SURVEILLANCE SYSTEMS: BANGLADESH AS 
A CASE STUDY
Birgit Nikolay1, Henrik Salje2, Katharine Sturm-Ramirez3, Eduardo 
Azziz-Baumgartner3, Nusrat Homaira4, Makhdum Ahmed5, 
A. Danielle Iuliano3, Repon C. Paul4, Mahmudur Rahman6, M. 
Jahangir Hossain7, Steven P. Luby8, Simon Cauchemez1, Emily S. 
Gurley9
1Institut Pasteur, Paris, France, 2Johns Hopkins Bloomberg School of 
Public Health, Baltimore, MD, United States, 3Centers for Disease Control 
and Prevention, Atlanta, GA, United States, 4University of New South 
Wales, Sydney, Australia, 5University of Texas Health Science Center, 
Houston, TX, United States, 6Institute of Epidemiology, Disease Control 
& Research, Dhaka, Bangladesh, 7Medical Research Council Unit, Banjul, 
Gambia, 8Stanford University, Stanford, CA, United States, 9Icddr,b, Dhaka, 
Bangladesh
The International Health Regulations (IHR) outline the core requirements 
to ensure the timely detection of public health threats of international 
concern. Assessing the sensitivity and representativeness of surveillance 
systems to detect these threats is crucial to quantify the capacity to detect 
outbreaks and to interpret case statistics. We propose a framework for 
the systematic evaluation of severe disease surveillance systems and apply 
it to assess severe neurological and respiratory diseases surveillance in 
Bangladesh at tertiary care hospitals. During 2009- 2013, all cases of 
severe neurological and respiratory diseases were identified in surveillance 
hospital catchment areas outside of the capital city using key informant 
and house-to-house surveys. We ascertained where cases had sought 
care. We then estimated the probability of the surveillance system 
detecting case-clusters of varying size by distance from hospitals using a 
statistical algorithm and compared characteristics of cases identified in 
the community to the subset that sought care at surveillance hospitals. 
An estimated 25% of severe neurological and 16% of severe respiratory 
cases residing at 10km from the surveillance hospital sought care at those 
facilities. Outbreak detection probabilities decreased with distance from 
the hospital such that a cluster of severe respiratory disease occurring 
30km from the hospital would be detected 90% of the time only if 
it included >30 cases. Characteristics of cases from surveillance were 
largely representative of all cases, however, <5 year-old children and 
lowest socioeconomic neurological cases and severe respiratory cases 
aged ≥60 were underrepresented (absolute difference 19%, 13%, 16%, 
respectively). Our study identified weaknesses of this system in detecting 
small-to-medium sized outbreaks at >30km distance from surveillance 
sites, likely because of limited access to healthcare in rural areas. These 
findings highlight difficulties that low and middle income countries may 
have in meeting IHR requirements, despite considerable investment in 
hospital-based surveillance platforms.
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KNOWLEDGE, ATTITUDES AND PRACTICES (KAP) 
ASSESSMENT OF MALARIA INTERVENTIONS IN ZAMBIA
Desmond T. Jumbam1, Jennifer S. Stevenson2, John P. Grieco3, 
Lacey Ahern3, Busiku Hamainza4, Chadwick H. Sikaala4, Pascalina 
Chanda-Kapata5, Japhet Matoba6, Nicole L. Achee3
1University of Notre Dame, Notre Dame, IN, United States, 2Johns Hopkins 
Malaria Research Institute, Johns Hopkins Bloomberg School of Public 
Health, Baltimore, MD, United States, 3University of Notre Dame, Notre 
Dame, IN, United States, 4National Malaria Control Centre, Ministry of 
Health, Lusaka, Zambia, 5Ministry of Health, Lusaka, Zambia, 6Macha 
Research Trust, Choma, Zambia
Despite the rapid upscale of malaria control interventions, such as long-
lasting insecticidal nets and indoor residual spraying, malaria remains 
a major source of morbidity and mortality in Zambia. A comprehensive 
understanding of community knowledge, attitudes and practices (KAP) 
is a crucial component for enhancing the uptake and use of current and 
novel malaria control interventions for sustained disease prevention. 
The overall objective of this study was to assess malaria-related KAP, as 
well as entomological factors associated with the use and acceptability 
of malaria vector control interventions in a select cohort of caregivers 
(n=75) within Luangwa and Nyimba districts, eastern Zambia. Specific 
aims focused on assessing acceptance and/or use of currently deployed 
malaria interventions in relation to: 1) socio-demographic factors 
(education, age and occupation); 2) knowledge of malaria disease 
and function of available interventions; 3) cultural attitudes regarding 
perceptions of disease risk, the barriers to and benefits of intervention 
use; 4) cultural practices (outdoor sleeping and cooking); and 5) indoor 
densities of mosquitoes in study households. Similar data were generated 
and analyzed for assessing potential acceptance and use of a novel 
intervention currently being evaluated for malaria control, specifically a 
spatial repellent. Methodologies included the use of questionnaires and 
in-depth interviews as well as mosquito collections using CDC light traps. 
Findings from this study are anticipated to benefit the Zambian Ministry 
of Health’s malaria education and vector control campaigns in these study 
sites.
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SITUATIONAL ANALYSIS OF MENTAL HEALTH ON 
EBOLA VIRUS DISEASE (EVD) AFFECTED COUNTRIES’ 
VULNERABILITY USING THE PRESSURE AND RELEASE MODEL
Elizabeth L. Glaser, Rebecca Sliwoski
Brandeis University, Waltham, MA, United States
Prior to the 2013 West Africa Ebola outbreak, there were high rates of 
Post-Traumatic Stress Disorder (PTSD), intimate partner violence, and 
poor psychosocial adjustment in Liberia, Sierra Leone, and Guinea as an 
aftermath of two decades of civil war and political instability. Yet a low 
level of economic development contributed to poor access to health 
care and a high unmet need for treatment, particularly for PTSD. We 
adapted Blaikie’s Pressure and Release (PAR) Model for disasters to apply 
it to a situational analysis of mental health factors that contributed to 
the initially poor Ebola Virus Disease (EVD) response in West Africa. 
The PAR Model assesses the contribution of political, economic, and 
environmental vulnerabilities as root causes for socio-economic pressures 
that create unsafe conditions. We posited that systemic vulnerabilities 
in the three countries contributed to the epidemic: A traumatized 
population evidenced distrust for existing institutions, yielding low levels 
of cooperation with public health authorities early in the outbreak, 
resulting in a delayed response to EVD. As it is highly likely that the EVD 
outbreak has increased trauma and economic losses in a population 
already burdened with high rates of mental illness, there has never 
been a more crucial time to address mental health needs in West Africa 
to reduce societal vulnerability and decrease maladaptive responses to 
hazards inherent in the environment. Community based services focusing 
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on building psycho-social and economic resilience can rebuild trust and 
lessen poverty, supporting healthy individual and societal adaption to 
change. The PAR model provides an effective tool for situational analysis 
by highlighting vulnerabilities and suggesting interventions to mitigate or 
prevent future health-related or natural disasters.
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HIGH PREVALENCE OF DUFFY-NEGATIVITY AMONG 
INDIVIDUALS INFECTED WITH PLASMODIUM VIVAX AND P. 
OVALE IN NORTHWEST ETHIOPIA
Sisay Getie Belay1, Mitaly Srivastava2, Gebeyaw Getnet1, Abebe 
Alemu1, Aline Lamien Meda2, Hans-Peter Fuehrer3, Harald Noedl2
1University of Gondar, Gondar, Ethiopia, 2Institute of Specific Prophylaxis 
and Tropical Medicine, Medical University of Vienna, Vienna, Austria, 
3Institute of Parasitology, University of Veterinary Medicine, Vienna, Austria
The Duffy blood group antigen (Fy) is expressed on the surface of red 
blood cells and encoded by the Duffy Antigen Receptor for Chemokines 
(DARC) gene. Until very recently it was considered to be essential as a 
portal of entry of the Plasmodium vivax parasite into human red blood 
cells. Recent data suggest that this theory may no longer hold true and 
that in some parts of the world, P. vivax infects and causes disease in 
Duffy-negative individuals. Ethiopia reports one of the highest P. vivax 
malaria burdens in the world and the role the Duffy blood group is 
playing remains poorly understood. A total of 122 randomly selected 
samples from P. vivax-positive individuals originating from a region of high 
malaria endemicity and host genetic diversity in northwestern Ethiopia 
were successfully genotyped at the -33rd (promoter region SNP) and 
the 125th (A/B SNP) nucleotide positions. Another 47 samples from P. 
vivax-negative individuals from the same region as well as 15 samples 
from Asian individuals were tested as controls. Eleven out of 122 (9.0%) 
P. vivax malaria patients tested Duffy-negative (FY*BES/*BES). The allele 
frequencies were 18.8, 34.8, 0, and 46.3% for FY*A, FY*B, FY*AES, and 
FY*BES, respectively. The majority of the test samples (91/122; 74.6%) 
were heterozygous in the promoter region with the most common 
(58/122; 47.5%) genotype being FY*B/*BES. With almost 50% (23/47) 
the proportion of Duffy-negative individuals was significantly (OR=9.67; 
P<0.001) higher among P. vivax-negative controls from the same region. 
Interestingly among a small subgroup (N=10) of P. ovale-positive controls 
the proportion of Duffy-negative individuals was 70%. Although the 
FY*BES/*BES genotype seems to confer a certain level of protection 
against P. vivax malaria in Ethiopia, this protection seems to be far from 
universal. The fact that the population of northern Ethiopia is genetically 
highly heterogeneous may allow for the circulation of P. vivax parasites 
in host populations that otherwise may not be able to sustain long term 
transmission of P. vivax.
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EXPRESSION OF PLASMODIUM FALCIPARUM GENES 
INVOLVED IN ERYTHROCYTE INVASION, IMMUNE 
RESPONSES AND CLINICAL OUTCOMES
Aida Valmaseda1, Alfons Jiménez1, Betuel Sigaúque2, Pau 
Cisteró1, Pedro Aide2, Pedro L. Alonso1, Quique Bassat1, Ruth 
Aguilar1, Alfredo Mayor1
1ISGlobal, Barcelona, Spain, 2Centro de Investigçao em Saúde de Manhiça, 
Manhiça, Mozambique
Red blood cell (RBC) invasion is a key step in the Plasmodium falciparum’s 
life cycle and many vaccine candidates are proteins involved in this process. 
However, redundancy in protein function leads to different pathways 
used to invade and therefore, to a high diversity in ligand expression, 
highlighting the need of studying gene expression profiles in field isolates. 
We hypothesize that differences in gene expression are associated with 
immune responses to the proteins expressed or with the clinical outcomes 
of the infection (severe (SM) / uncomplicated (UM) malaria). Therefore, we 
sought to study the expression of genes involved in the invasion process 
in clinical isolates from infected individuals in Mozambique (adults with 
UM n=50; children with UM n= 25 or SM n=25). Transcript levels of P. 
falciparum genes pfrh1, pfrh2a, pfrh2b, pfrh4, pfrh5, eba175, eba140, 
aarp, ptramp, p41, cyrpa and ama1 were determined using quantitative 
Polymerase-Chain Reaction (qPCR) and IgG/IgM levels against the resulting 
proteins were measured by Luminex. Preliminary results show a negative 
correlation between antibodies to some proteins participating in one 
invasion pathway (SA dependent or independent) and expression of genes 
involved in the other: IgG to EBA175 PfF2 and pfrh2a expression; IgG to 
PfRh22030 and eba140 expression; IgG to PfRh240 and eba140 expression; 
IgM to EBA175 III-V and pfrh4 expression; IgM to EBA175 PfF2 and pfrh4 
expression. Also, we report a negative correlation between ptramp, 
eba140, pfrh2b, pfrh4, pfrh5 and age, while p41 expression is higher 
in older individuals. When accounted for “immune pressure” we found 
aarp expression at higher levels with higher immune pressure, whereas 
pfrh2a and pfrh4 expression was lower. We also found that p41 negatively 
correlated with pfrh5 (rho -0,49; p<0,0001) and positively correlated with 
IgG against PfRh5. Data analysis is still ongoing. The greatest impact of this 
work will be on vaccine development: the effectivity of a vaccine designed 
to target RBC invasion could depend on the expression of candidate 
genes, which could be influenced by immunity against the ligands, as we 
suggest in this study.
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A LAP-LIKE PROCESS AS A NOVEL IMMUNE MECHANISM 
DOWNSTREAM OF IFN-γ IN THE CONTROL OF THE HUMAN 
MALARIA PLASMODIUM VIVAX LIVER STAGE
Rachasak Boonhok1, Nattawan Rachaphaew2, Apisak 
Duangmanee2, Pornpimol Chobson2, Sittiporn Pattaradilokrat3, 
Pongsak Utaisincharoen4, Jetsumon Prachumsri2, Marisa Ponpuak4
1Department of Microbiology, Faculty of Science, and Mahidol Vivax 
Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, 
Thailand, 2Mahidol Vivax Research Unit, Faculty of Tropical Medicine, 
Mahidol University, Bangkok, Thailand, 3Department of Biology, Faculty 
of Science, Chulalongkorn University, Bangkok, Thailand, 4Depatment of 
Microbiology, Faculty of Science, Mahidol University, Bangkok, Thailand
Interferon-gamma (IFN-γ) is a main regulator of immune functions and has 
been previously shown to induce Plasmodium liver stage elimination both 
in in vitro and in vivo. However, the molecular mechanism responsible for 
the restriction of Plasmodium liver stage downstream of IFN-γ remains 
uncertain. Recently autophagy, a newly described immune defense 
mechanism, was identified as a downstream pathway in response to IFN-γ 
in the control of intracellular infections. We, therefore, hypothesized 
that the killing of liver stage malaria parasites by IFN-γ may be through 
autophagy induction. Our results showed that while IFN-γ treatment of 
human hepatocytes activates autophagy, IFN-γ-mediated P. vivax liver stage 
restriction only requires downstream autophagy-related proteins Beclin 1, 
PI3K, and ATG5 but not the upstream autophagy-initiating protein ULK1. 
In addition, an enhanced recruitment of LC3 onto the parasitophorous 
vacuole membrane (PVM) and an increased colocalization of lysosomal 
vesicles with P. vivax compartments were observed in response to IFN-γ. 
Altogether, these data indicated that IFN-γ mediates the control of P. vivax 
liver stage by inducing a noncanonical autophagy pathway resembling 
that of LAP in which LC3 is directly decorated onto the PVM and mediates 
the fusion of P. vivax compartments with lysosomes resulting in the killing 
of the pathogens. Understanding hepatocyte response to IFN-γ during 
Plasmodium infection and the roles of autophagy-related proteins may 
provide an alternative strategy urgently needed for the elimination of this 
human malaria.
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ASSOCIATION OF HOST GENETIC POLYMORPHISMS WITH 
PROTECTION AGAINST SEVERE MALARIA IN UGANDAN 
CHILDREN
Andrew Walakira1, Arthur Mpimbaza1, Elizabeth Namirembe1, 
Victoria Namazzi1, Moses Kiggundu1, Sam L. Nsobya1, Philip J. 
Rosenthal2
1Infectious Diseases Research Collaboration, Kampala, Uganda, 2University 
of California San Francisco, San Francisco, CA, United States
Human genetic polymorphisms are associated with risk of severe malaria. 
We compared the prevalence of selected host polymorphisms in children 
aged 4 months to 10 years enrolled in a case-control study in Jinja District, 
Uganda. Healthy controls (HC) and children with uncomplicated malaria 
(UM) were matched by date and location with children with severe 
malaria (SM) diagnosed based on standard WHO criteria; 305 children 
were enrolled in each group. Malaria was diagnosed based on fever 
and a positive Giemsa-stained smear. Genes of interest were amplified 
from purified DNA, polymorphisms identified by standard methods, and 
prevalences compared by Fisher’s exact test. We present preliminary results 
for the first 100 cases and controls. For two studied alleles, the prevalence 
of WT was significantly greater in children with SM compared to UM 
(α-thalassemia 3.7kb deletion 60% in SM vs. 42% in UM, p = 0.0193; 
CD36 T188G 84% in SM vs. 38% in UM, p<0.0001) or compared toHC 
(α-thalassemia 60% in SM vs. 43% in HC, p = 0.0290; CD36 T188G 
84% in SM vs. 55% in UM, p<0.0001). Non-significant trends toward a 
greater prevalence of WT with SM were also seen for sickle hemoglobin 
(β-globin E6V 92% in SM vs. 86% in UM, p=0.25 and vs. 87% in HC, 
p=0.36) and ICAM1K29M (61% in SM vs. 55% in UM, p=0.46 and vs. 
48% in HC, p=0.063), but not the G6PD A- genotype (80% in SM vs. 
79% in UM, p=1.0 and vs. 83% in HC, p=0.58) or CD36 T1264G (85% 
in SM vs. 82% in UM, p=0.70 and vs. 82% in HC, p=0.70). Our results 
suggest associationsin Ugandan childrenbetween some previously studied 
polymorphisms and protection against severe malaria, and in particular 
suggest a marked protective effect of the CD36 T188G genotype. 
Analysis of our full study population and consideration of different clinical 
presentations of SM are underway.
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THE IMPACT OF PRENATAL MALARIA EXPOSURE ON THE 
VULNERABILITY OF OFFSPRING TO NEUROPSYCHIATRIC 
DISORDERS
Andrea Weckman1, Vanessa Tran2, Kevin C. Kain2
1University of Toronto, Toronto, ON, Canada, 2University Health Network, 
Toronto, ON, Canada
Each year ~125 million pregnant women are at risk for malaria infection. 
Malaria in pregnancy (MiP) has a profound impact on mother-child health, 
including delivery of low birth weight (LBW) infants. Even in the absence of 
LBW, epidemiological studies have shown a connection between maternal 
infections during pregnancy and increased susceptibility of offspring 
to neuropsychiatric disorders later in life. Moreover, immune activation 
in pregnancy has been shown to prime the offspring to psychological 
trauma, showing a synergistic effect with stress-induced neuropsychiatric 
disorders. Mental illness represents the leading cause of DALYs globally 
and exerts a huge burden in malaria-endemic areas, but the impact of 
malaria exposure in utero on long-term vulnerability to psychiatric diseases 
has not been reported. We hypothesize that prenatal exposure to MiP will 
increase the risk of neuropsychiatric disorders in offspring. We used the 
established mouse model of MiP with Plasmodium berghei ANKA (PbA). 
Uninfected offspring of dams infected with an inoculum of PbA that 
does not induce a birth phenotype, were subjected to stressors or control 
handling at peripubertal age. Adult behavioural outcomes were assessed 
using standardized neuropsychiatric tests, including prepulse inhibition, 
open field, and amphetamine hypersensitivity. MRI, neurochemistry and 
levels of neuroinflammation were monitored to define correlates of 
susceptibility. Recent work by our lab showed that interrupting pathways 
of complement activation (i.e. C5a) and dysregulated angiogenesis (i.e. 
decreased Ang-1) improved fetal outcome in the MiP mouse model. We 
will therefore compare the neuropsychiatric outcomes in α-C5a/rAng-1 
treated and untreated offspring as putative interventions. This concept 
represents a paradigm shift in our current understanding of the risk factors 
for neuropsychiatric disorders and identifies PM as a potential modifiable 
risk factor. This has important implications for the cause and prevention 
of what are believed to be “non-communicable” diseases, and may shift 
global health priorities from costly rehabilitation to prevention.
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EARLY AND LATE PLASMODIUM FALCIPARUM 
GAMETOCYTES-SPECIFIC EXPRESSION FOLLOWING 
TREATMENT WITH CHLOROQUINE AND SULPHADOXINE/
PYREMITHAMINE
Amal Gadalla, Hamza Babiker
Sultan Qaboos University, Muscat, Oman
Elevation of sexual stages of Plasmodium falciparum following 
anti-malarial treatment has been attributed to either induction of 
gametocytogenesis, or release of sequestrated gametocytes in deep 
tissues. Attempts to address this question have been impaired by the 
unavailability of markers to specifically detect and quantify expression of 
early stages gametocyte (I-III) in peripheral blood. We have established 
and validated RT-qPCR assays to detect and quantify genes specifically 
expressed in early gametocytes and used them alongside a known 
mature gametocyte-specific marker (pfs25) to monitor gametocytogensis 
following treatment of P. falciparum infections with CQ or SP. The density 
of early and mature gametocytes and its ratio to total parasite density 
pre-treatment (D0) were compared to that seen post-treatment on D7, 
D14 and D21 among patients treated with different drug regimens 
(CQ or SP) and among different parasitological responses (sensitive and 
resistant [RI and RIII]). Prevalence and density of early gametocytes as well 
as early gametocyte parasite ratio (EGPR) decreased following treatment 
(D7), paralleled to parasite density, among all treatment groups and 
parasitological responses. However, EGPR increased significantly on D14 
irrespective of the treatment regimen or parasitological response, which 
suggests an enhanced gametocytogenesis. Density but not prevalence of 
mature gametocytes increased on D7 and D14 post-treatment, regardless 
of drug treatment regimen or parasitological response, suggesting release 
of sequestrated gametocytes that were not affected by treatment on 
D0. This study demonstrated evidences for increasing commitment to 
gametocytogenesis following anti-malarial therapy as well as possible 
release of sequestrated gametocytes.
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COMBATING ANEMIA WITH IRON SUPPLEMENTATION MAY 
INEVITABLY CAUSE A TRANSIENT INCREASE IN MALARIA 
RISK
Morgan M. Goheen1, Rita Wegmuller2, Amat Bah2, Bakary 
Darboe2, Ebrima Danso2, Andrew M. Prentice3, Carla Cerami1
1University of North Carolina Chapel Hill School of Medicine, Chapel Hill, 
NC, United States, 2MRC International Nutrition Group, Keneba, Gambia, 
3London School of Hygiene & Tropical Medicine, London, United Kingdom
Epidemiological studies suggest iron deficiency protects against malaria 
and administering iron to iron-deficient individuals may increase malaria 
risk. This has generated much debate in the public health field about 
how to best distribute iron supplements to anemic populations in malaria 
endemic areas. Our previous laboratory work demonstrated decreased 
Plasmodium falciparum growth in iron deficient red blood cells (RBCs) 
and increased infection susceptibility in young RBCs and reticulocytes in 
vitro. Here, our objective was to comprehensively evaluate P. falciparum 
75
astmh.org
pathogenesis in iron deficient children and pregnant women before, 
during, and after iron supplementation. We also sought to evaluate 
the hypothesis that malaria risk increases as erythropoiesis increases in 
response to iron supplementation. To do so, we investigated P. falciparum 
in vitro growth characteristics in RBCs from Gambians participating in 
iron supplementation trials. RBCs were collected from 135 children (ages 
6-24 months; hemoglobin levels < 11 g/dL) and 165 pregnant women 
(2nd and 3rd trimester) before, during, and upon completion of 12 weeks 
of iron supplementation (12 mg or 60 mg daily, respectively). Using flow 
cytometry-based assays, we separately examined effects of iron deficiency 
and iron supplementation on overall parasite growth and merozoite RBC 
invasion. Our results demonstrate P. falciparum erythrocytic stage growth 
in vitro is low at baseline and increases during supplementation using 
RBCs from both the children and pregnant women. Additionally, we show 
parasite invasion is reduced in iron deficient RBCs from Gambian children 
and increases during iron supplementation. The elevated growth rates 
parallel increases in circulating reticulocytes and RBC mean corpuscular 
hemoglobin concentration, the kinetics of which correlate with increased 
erythropoiesis. We conclude malaria growth in vitro corresponds 
with elevated erythropoiesis, an inevitable consequence of iron 
supplementation. Our findings imply iron supplementation in malarious 
regions should be accompanied by effective preventative measures against 
falciparum malaria.
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CD155, THE POLIOVIRUS RECEPTOR, NEGATIVELY 
REGULATES IMMUNE PROTECTION TO PLASMODIUM YOELII 
17XNL MURINE MALARIA
Joanna Chorazeczewski1, Maya Aleshnick2, Victoria Majam2, 
Sanjai Kumar2, Miranda S. Oakley1
1Division of Bacterial, Parasitic, and Allergenic Products, Center for 
Biologics Evaluation and Research, Food and Drug Administration, 
Silver Spring, MD, United States, 2Division of Emerging and Transfusion 
Transmitted Diseases, Center for Biologics Evaluation and Research, Food 
and Drug Administration, Silver Spring, Maryland, Silver Spring, MD, 
United States
CD155, the cell entry receptor for poliovirus, is a member of a large family 
of immunoglobulin-like molecules called nectins and nectin-like proteins. 
Recently, CD155 has been ascribed several important immunological 
functions. For example, CD155 expression on target cells is essential 
for natural killer and CD8+ T cell mediated lysis of certain tumor cells. 
In addition, CD155 promotes Th1 development from naïve CD4+ T cells 
and can significantly alter the humoral immune response to invading 
pathogens. We measured the effect of CD155 on the immune response 
and pathogenesis following infection with a highly virulent and avirulent 
malaria in mice deficient for the CD155 gene. In the Plasmodium berghei 
ANKA murine model of experimental cerebral malaria (ECM), there was 
no significant difference in susceptibility to ECM or parasitemia between 
CD155-deficient mice and wild type (WT) controls. In contrast, loss of 
CD155 resulted in a 2.8 fold decrease in peak parasite burden on day 
10 post-infection in the P. yoelii 17XNL, self-resolving and non-lethal 
malaria, suggesting that CD155 hinders the immune clearance of P. yoelii 
17XNL. Since CD155 can serve as a ligand for the CD96, CD226, and 
TIGIT receptors, functional studies are currently underway to determine 
which interaction is responsible for CD155 mediated regulation of P. yoelii 
17XNL parasite burden. In addition, key differences in immune cell subsets 
measured by in depth flow cytometric analysis and the cytokine and 
antibody profiles determined by ELISA between WT and CD155 knockout 
mice over the course of a P. yoelii 17XNL infection will be presented.
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PLASMODIUM FALCIPARUM PARASITES THAT INFECT 
RETINOPATHY POSITIVE AND NEGATIVE CEREBRAL MALARIA 
CHILDREN HAVE SIMILAR TRANSCRIPT ABUNDANCE OF VAR 
GENES ASSOCIATED WITH SEVERE MALARIA
Estela Shabani1, Robert O. Opoka2, Benjamin Hanisch3, Buyun 
Tang4, Paul Bangirana2, Thomas Lavstsen5, Chandy C. John4
1University of Minnesota and Indiana University, Indianapolis, IN, United 
States, 2Makerere University, Kampala, Uganda, 3Children’s National 
Medical Center, Washington, DC, United States, 4Indiana University, 
Indianapolis, IN, United States, 5University of Copenhagen, Copenhagen, 
Denmark
An accurate diagnosis of cerebral malaria (CM) is important for 
understanding the pathogenesis of CM. Malarial retinopathy, which is seen 
in some (retinopathy-positive, RP) children but not others (retinopathy-
negative, RN) with clinical CM (coma with P. falciparum on blood smear) 
has been associated with parasite sequestration in the brain and is 
considered a strong indicator of “true” CM. However, it is unclear whether 
RN CM is a severe non-malarial illness with incidental parasitemia or a 
less severe form of RP CM. P.falciparum erythrocyte membrane protein-1 
(PfEMP-1) is an important virulence factor in severe malaria and expression 
of group A var genes and more specifically domain cassette (DC) 8 and 
DC13 PfEMP-1 have been associated with severe malaria. Characterizing 
var gene expression in both RN and RP CM children could help elucidate 
the role of P.falciparum in RN CM pathogenesis. In the present study 
we performed RT-quantitative PCR using degenerate primers amplifying 
var genes encoding for 13 different PfEMP-1 domains. Testing was 
performed on RNA isolated from whole blood of Ugandan children with 
RP CM (N=39), RN CM (N=35), severe malarial anemia (SMA, N=39) and 
asymptomatic children (AC, N=12). Transcript abundance of var genes 
encoding for DC8, DC13 and other group A domains (CIDRα1.7) was 
higher in children with severe malaria than in asymptomatically infected 
community children (P<0.007 for all). The prevalence of DC8 and DC13 
high transcribers was similar between RP and RN CM children (74.4% 
vs. 68.5 %, P=0.58 for DC8 and 53.8% vs. 37.1%, P=0.15 for DC13). 
RN children had lower median transcript abundance for DC13 (median 
arbitrary units Tu 4.16, interquartile range (IQR) 1-11.12) than children 
with RP CM (median Tu 8.08, IQR 2.43-20.31, P=0.04) but similar to SMA 
(median Tu 1.11, IQR 1-10.51, P=0.43) and higher than asymptomatically 
infected children (median Tu 1, IQR 1-1, P=0.0009). In our cohort, the 
parasites infecting RN CM children have similar transcript abundance for 
var subtypes associated with binding and severe disease as compared 
to RP CM, suggesting an important role for P.falciparum binding in the 
pathogenesis of RN CM.
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CONTINUOUS DETERMINATION OF BLOOD GLUCOSE 
IN ADMITTED CHILDREN WITH MALARIA IN A RURAL 
MOZAMBICAN HOSPITAL
Lola Madrid1, Rosauro Varo1, Antonio Sitoe2, Miguel Lanaspa1, 
Helio Mucavele2, Quique Bassat1
1ISGlobal, Barcelona Ctr. Int. Health Res. (CRESIB), Hospital Clínic - 
Universitat de Barcelona, Barc, Barcelona, Spain, 2Centro de Investigação 
em Saúde de Manhiça (CISM), Maputo, Mozambique
Hypoglycaemia is a frequent complication among admitted children, 
particularly in malaria-endemic areas. We aimed to estimate the incidence 
of hypoglycaemia throughout the hospitalization in children with malaria. 
A simple pilot study to monitor continuously glycaemia in children aged 
0 to 10 years, admitted with malaria in a rural hospital was carried 
out in Southern Mozambique. Continuous glucose monitors (CGMs) 
were inserted in subcutaneous tissue of the abdominal area, producing 
glycaemia readings every 5 minutes. Glucose was continuously monitored 
during a mean of 48 hours, in 74 children. All of them were admitted 
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with malaria (22 severe, 52 uncomplicated). Five children (6.8%) had 
hypoglycemia (<3.0mmol/l) on admission as detected by routine capillary 
determination. Analyzing the data collected by the CGMs, we detected 
hypoglycemia episodes (<3.0mmol/l) in 11/74 (14.9%) children, of which, 
8 (10.8%) could be classified as severe (≤2.5mmol)%). No differences in 
age, sex, malnutrition status and duration of hospital stay were found 
among hypoglycemic and normoglycemic children. Anemia was more 
common in hypoglycemic children. Only one death happened (1/74, 
1.4%) among a normoglycaemic child. Hypoglycaemia beyond admission 
in children with malaria appears to be much more frequent than what 
had been previously described. The clinical relevance of these episodes of 
hypoglycemia in medium or long term remains unclear.
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ASSESSING THE PROTECTIVE ROLE OF NEUREGULIN 1 (NRG-
1) AGAINST HEME-INDUCED TROPHOBLAST APOPTOSIS 
AND FUSION DAMAGE
Mingli Liu, Hassana Salifu, Jonathan Stiles
Morehouse School of Medicine, Atlanta, GA, United States
Syncytial trophoblasts (ST) Fusion and conversion from the mononucleated 
to the syncytial state are mandatory for successful pregnancy. In placental 
malaria, Plasmodium falciparum infected erythrocytes (IE) bind to 
trophoblasts resulting in inflammation and pathology associated with poor 
pregnancy outcomes. The interaction between ST and IE is reminiscent 
of the interaction that occurs in the brain leading to cerebral malaria. 
However, the role of free heme in the maintenance of the integrity of 
the placental barrier and the effects of free heme on pregnancy outcome 
are unclear. Recent studies have demonstrated the cyto-protective role 
of Neuregulin 1 (NRG-1) in brain vascular endothelial and neuroglia cells 
during cerebral malaria pathogenesis. We hypothesized that apoptosis 
and fusion of trophoblast-derived choriocarcinoma cell line (BeWo) will 
be attenuated by NRG-1In the present study we determined the effect 
and molecular mechanisms of heme on the syncytial fusion triggered by 
forskolin using the BeWo cell line. Results of this study demonstrated 
that 1). Heme induces BeWo cells apoptosis which is attenuated in the 
presence of NRG-1 2). Heme induces apoptosis of BeWo cells through 
activation of STAT3/caspase-3/PARP and P73 signaling pathways. 3). 
BeWo cell fusion is reduced in the presence of heme, 4).Heme reduces 
mRNA expressions of cell-fusion related genes when forskolin induces 
syncytialisation, 5). Heme inhibits differentiation and fusion of BeWo cells 
through activation of STAT3 signaling pathways. 6)NRG-1 against heme-
induced trophoblast apoptosis and fusion damage. In conclusion, we 
identified a nove mechanism responsible for the inhibition of trophoblast 
fusion by heme. In the absence of forskolin, heme induced apoptosis in 
BeWo cells via activation of STST3/caspase-3/APARP; while in the presence 
of forskolin, pSTAT3 was induced by heme to inhibit cell fusion. Our 
studies indicated that heme-induced pathways may be attenuated by 
NRG-1 and therefore could be potential drug targets in the prevention of 
heme-associted trophoblast cell apoptosis and fusion damage.
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PREVALENCE OF PFCRT, MOLECULAR MARKER OF 
RESISTANCE OF PLASMODIUM FALCIPARUM ISOLATED 
FROM PATIENTS WITH UNCOMPLICATED MALARIA IN 
DAKAR
Ndeye A. Gaye, Babacar Faye, Magatte Ndiaye, Jean L. Ndiaye, 
Doudou Sow, Khadim Sylla, Oumar Gaye
University Cheikh Anta Diop, Dakar, Senegal
The malaria remains the major parasitic disease affecting for Human. 
Nearly 40 % of the world population lives in an area at risk of infection. In 
Senegal a new strategy called Seasonal Malaria Chemoprevention (SMC) 
is currently implemented in four districts in the center and the south of 
the country. However, the protective efficacy of these strategies depends 
heavily on the current level of resistance to Sulfadoxine-Pyrimethamine (SP) 
and its spread among populations of Plasmodium falciparum. Resistance 
of P. falciparum to this molecule is well established in East Africa and 
continues to spread westward. It is shown further that Amodiaquine 
(AQ) associated with SP in the SMC had the same action as Chloroquine 
(CQ) and malaria strains resistant to CQ became resistant to AQ. It is in 
this context that our work objective was to provide information on the 
impact of control strategies against malaria on molecular markers of 
resistance, this for a good orientation of policy making malaria burden 
and thereby strengthen malaria control programs. The specific objective 
was to re-evaluate the prevalence of mutations associated with resistance 
of P. falciparum to CQ after the abandonment of this molecule in the 
treatment of uncomplicated malaria in Senegal. Blood samples on filter 
paper were made in patients with uncomplicated malaria and treated 
with ACTs as ASAQ, Duo-Cotexcin and Coartem in two health districts 
in Dakar. We have identified mutations in the pfcrt gene by PCR- RFLP. 
Result In this study, men were more represented than women, 63% and 
37% respectively. Pfcrt mutation gene is more pronounced among women 
within all treatment groups. Also our study showed return susceptible 
strains to Chloroquine (75% of wild strains), molecular analysis showed 
that among the 160 patients analyzed 25 % of patients had a mutation 
located on the pfcrt gene. In conclusion, this study showed a relatively 
high prevalence compared to WHO standards which provides for a 
maximum transfer of 10%. This is a sign of resistance to antimalarial 
P. falciparum face hence the need to implement the ACT resistance 
surveillance studies.
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A NOVEL CLASS OF METABOLIC REGULATORS MEDIATE 
FOSMIDOMYCIN SENSITIVITY AND RESISTANCE IN MALARIA 
PARASITES
Ann M. Guggisberg, Aakash Y. Gandhi, Audrey R. Odom
Washington University in St. Louis, St. Louis, MO, United States
Drug resistance remains a significant challenge in malaria control. 
Isoprenoid synthesis via the methylerythritol phosphate (MEP) pathway 
is essential for parasite survival and is a proven antimalarial drug 
target. The phosphonic acid antibiotic fosmidomycin (FSM) is a well-
characterized inhibitor of this pathway and is currently in Phase II 
clinical trials. In a forward selection for FSM resistance, we identify 
a loss-of-function mutation in PfHAD2, a member of the haloacid 
dehalogenase-like hydrolase (HAD) superfamily, as the resistance-
causing mutation. Enzymatic characterization of PfHAD2 shows that it 
is a purine monophosphatase. Using metabolic profiling, we show that 
loss of PfHAD2 results in increased levels of MEP pathway metabolites, 
allowing the parasites to overcome pathway inhibition by FSM. PfHAD2 
mutants also have a growth defect, allowing for selection of suppressors 
of PfHAD2-mediated resistance. We identify hypomorphic mutations 
in the glycolytic enzyme phosphofructokinase (PfPFK9) that suppress 
HAD2-mediated resistance. This points to PfHAD2 as a novel regulator of 
essential central carbon metabolism, and dysregulation of this metabolism 
mediates drug sensitivity. Our work represents a novel use of forward 
genetics in Plasmodium falciparum to better understand drug resistance, 
metabolism, and the function of this previously undescribed protein 
class. PfHAD2, PfPFK9, and other regulators of essential metabolism may 
function as future targets for antimalarials.
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PREVALENCE OF MOLECULAR MARKERS OF PLASMODIUM 
FALCIPARUM RESISTANCE TO SULPHADOXINE/
PYRIMETHAMINE IN CHILDREN WITH SICKLE CELL ANAEMIA 
AGED 6 TO 59 MONTHS IN BENIN CITY
Izehiuwa G. Enato1, Ayebo E. Sadoh1, Michael O. Ibadin1, 
Magdalene E. Odunvbun1, Iriagbonse Osaigbovo1, Polycarp G. 
Ekpe2, Mary C. Oguike3, Colin Sutherland3
1University of Benin Teaching Hospital, Benin, Nigeria, 2University of Benin, 
Benin, Nigeria, 3London School of Hygiene & Tropical Medicine, London, 
United Kingdom
Sulphadoxine/Pyrimethamine (SP) for Seasonal Malaria Chemoprevention 
(SMC) or Intermittent Preventive Therapy (IPT) has been shown to be 
efficacious and effective in preventing malarial induced morbidities 
and deaths in infants and young children including those with sickle 
cell anaemia (SCA). However, mutations in Plasmodium falciparum 
dihydrofolate reductase (pfdhfr) and dihydropteroate synthase (pfdhps) 
genes, resulting in SP resistance pose a threat to its efficacy. Little is known 
about the prevalence of these mutations in malaria parasites infecting 
children with SCA, who are usually on proguanil as chemoprophylaxis 
(which has been found to be ineffective). To determine the pattern 
and prevalence of pfdhps and pfdhfr mutations in children with SCA 
infected with P.falciparum, we enrolled 146 (71 children with SCA and 
75 children without SCA) children. Genomic DNA was extracted from 
one hundred and forty six filter paper bloodspots and point mutations at 
codons 431, 436, 437, 540, 581 and 613 of the pfdhps gene and codons 
16, 51, 59, 108, and 164 of the pfdhfr gene were evaluated by nested 
Polymerase chain reaction amplification followed by direct sequencing. In 
children with SCA, the prevalence of pfdhps S436A, A581G and A613S 
mutations were 40(56.0%), 31(44.0%), and 30(42.0%) respectively; while 
children without SCA had a statistically significantly higher prevalence: 
54(72.0%), 52(69.3%), and 53(70.7%) respectively (p=0.048 for A436S, 
p=0.002 for A581G, p=0.001 for A613S). The pfdhps K540E mutation 
and pfdhps double mutant haplotype (A437G+K540E), which confer 
significant resistance to SP were not found in this study. The prevalence 
of the emerging pfdhps mutant haplotype VAGKGS was significantly 
higher in the non-SCA group (p<0.001). The prevalence of pfdhfr triple 
mutant haplotype: N51I+C59R+108N was similar in both study groups. 
The deployment of SP for malaria chemoprevention in infants and 
young children with SCA can be explored in Nigeria as an alternative to 
proguanil. Parasites with mutations on the pfdhps gene are more likely to 
be found in children without SCA than in those with SCA.
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SELECTIVE SWEEPS AND GENETIC LINEAGES OF 
PLASMODIUM FALCIPARUM MULTI-DRUG RESISTANCE 
(PFMDR1) GENE IN KENYA
Peninah M. Muiruri, Dennis W. Juma, Mathew Brown, Edwin 
Kamau
U.S. Army Medical Research Unit-Kenya, Kisumu, Kenya
Artemether-lumefantrine (AL) has been the first-line treatment for 
uncomplicated falciparum malaria in Kenya since 2006. However, there 
are concerns that resistance to current drugs might emerge as has 
been reported along the Thailand-Cambodia border. Single nucleotide 
polymorphisms (SNPs) in critical alleles of Pfmdr1 gene has been associated 
with resistance to Artemisinin and its partner drugs. AL selects for K76 in 
Pfcrt and N86, 184F and D1246 in Pfmdr1 genes in recurring parasites 
compared to the baseline infections. Microsatellite analysis of loci flanking 
genes associated with antimalarial drug resistance has been used in 
defining the geographic origins, dissemination of resistant parasites 
and identifying regions in the genome that have been under selection. 
This study investigated evidence of selection in Pfmdr1 genotypes 
selected for by AL in treatment of malaria infections in Kenya and their 
genetic lineages. Parasites (n=252) from different regions in Kenya were 
assayed for SNPs at codons 86, 184 and 1246 and typed for 7 neutral 
microsatellites (NMS) and 13 microsatellites loci flanking (±99 kb) Pfmdr1 
in Plasmodium falciparum infections. Full data sets of pure SNP genotypic 
data were obtained in 132 of the samples. Overall, the prevalence of 
N86 and D1246 was highest at 86.4% and 93.9% respectively. Single 
mutant NFD was the most prevalent haplotype at 44.7%, whereas the 
least prevalent were double mutants YFD and NFY both at 0.8%. The 
mean Expected heterozygosity (He) for NMS was 0.908 vs. 0.535 for the 
8 closest MS indicating selection. Parasites carrying mutant alleles had 
reduced He compared to the NMS and wild type. Analysis of parasite 
genetic lineages showed that mutant parasites genotypes came from 
multiple genetic backgrounds. Data show a generally high prevalence 
of NFD and NYD, difference in genetic diversity between sites and little 
reduction of He in NYD and NFD from NMS. The reduction of He in YYD 
is however significant (P=0.0001). Data indicates parasites are evolving 
differently in response to AL drug pressure in the different regions 
suggesting the rate at which AL tolerance will develop in different regions 
of Kenya might vary.
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IN VITRO CHEMO-SENSITIVITY OF PLASMODIUM 
FALCIPARUM ISOLATES ON DAY 0 PRIOR TO TREATMENT 
DURING PHASE IIIB/IV CLINICAL STUDY IN BOBO 
DIOULASSO (BURKINA FASO)
Aminata Fofana
IRSS, Bobo-Dioulasso, Burkina Faso
Artemisinin-based combination therapy (ACT) is used to treat all cases 
of uncomplicated malaria in Burkina Faso. In this study, 50% inhibitory 
concentration to determine the cut-off values for in vitro reduced 
susceptibility of Chloroquine (CQ), Dihydroartemisinin (DHA), Pyronaridine 
(PYD) and Piperaquine (PIP) for Plasmodium falciparum isolates from 
a phase IIIb/IV comparative 3-arm clinical study to assess the safety 
and efficacy of repeated administration of pyronaridine-artesunate, 
dihydroartemisinin-piperaquine or artemether-lumefantrine or artesunate-
amodiaquine over a two-year period in children and adult patients with 
acute uncomplicated Plasmodium sp. malaria. In vitro susceptibility on day 
0 prior treatments was assessed by the standard WWARN protocol. Each 
isolate was tested in triplicate by using pre-coated microplates with serial 
dilutions of CQ, DHA, PYD and PIP. The results were analysed on HNnonlin 
software and expressed as the 50% inhibitory concentration (IC50) or 
geometric mean IC50 (GMIC50). CQ IC50 values ranged from 25 to 
464.89 nM, with a geometric mean of 63.34 nM. DHA IC50 values ranged 
from 0.33 to 12 nM, with a geometric mean of 1.16 nM. PYD IC50 values 
ranged from 1,250 to 25, 35 nM, with a geometric mean of 57.21 nM. 
PIP IC50 values ranged from 5 to 230.5 nM, with a geometric mean of 
13.16 nM. In conclusion, around 70-90 % isolates were sensitive to CQ 
and DHA, but only 57% for PIP. Pyronaridine showed susceptibility of 14% 
on isolates tested. The risk of emerging resistance to ACT in West Africa 
makes necessary to continue monitor the susceptibilities of parasites to 
antimalarial drugs, particularly those used in combination with artemisinin 
derivatives.
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ROLE OF ANTIMALARIAL DRUG CONCENTRATION IN DE 
NOVO SELECTION OF DRUG TOLERANT PLASMODIUM 
FALCIPARUM PARASITE STRAINS IN VITRO
Agnes C. Cheruiyot, Edwin Kamau, Matthew Brown, Hosea 
Akala
U.S. Army Medical Research Directorate-Kenya, Kisumu, Kenya
Malaria is one of the most devastating infectious diseases, with the 
emergence of antimalarial drug resistance being of great concern. 
Availability of effective antimalarial drugs is quickly dwindling due to 
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different causes. Several factors have been attributed to drug resistance. 
However inadequate antimalarial drug concentration in blood plasma 
has been identified as a major cause. When exposed to a drug, sensitive 
parasites die while tolerant parasites survive leading to subsequent 
transmission. Genetic identity of these strains could give an answer to 
occurrences of treatment failure.This study seeks to establish how different 
antimalarial concentration can contribute in selection of drug tolerant 
parasite strains in vitro. It will utilize Plasmodium falciparum samples 
from an ongoing ethically approved clinical trial in holoendemic sites. 
Each admission sample (day 0) will be exposed to 70 nanomolar (nM) 
and 700nM dihydroartemisinin (DHA) for 6hrs and compared with the 
parasites in drug-free (DMSO) wells. The 700nM DHA is the optimum 
clinical relevant concentration while 70nM DHA is 10 fold lower sufficient 
to produce a change in malaria treatment. The DHA-exposed sample 
will be washed 3 times and re-cultured for 66 hours. Aliquot of 200 µL 
will be obtained from each of 28 samples recruited at 24 and 72 hour in 
culture respectively. Extraction of genomic deoxyribonucleic acid (gDNA) 
will be done using Qiagen kit. To determine selection after 24hrs and 72 
hrs in culture respectively, fragment analysis will be run on 12 loci using 
capillary electrophoresis. Single nucleotide polymorphisms (SNPs) of Pfcrt 
and Pfmdr1 and will be determined using MassArray platform and Sanger 
sequencing. Categorical data for respective SNPs will be analyzed using 
Kruskal-Wallis test. Heterozygosity (He) and genetic differentiation at the 
2 time points and concentration will obtain using GenAlex software. He 
values obtained will be used to determine selection. The findings from 
this study may reveal useful genetic information associated with tolerant 
Plasmodium strains that likely to become precursors for drug resistance.
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PHYSIOLOGICALLY RELEVANT EXPOSURE TO SYNTHETIC 
OZONIDE ANTIMALARIALS KILLS K13 WILDTYPE AND 
MUTANT PLASMODIUM FALCIPARUM MORE EFFECTIVELY 
THAN DIHYDROARTEMISININ
Tuo Yang1, Stanley C. Xie1, Pengxing Cao2, Carlo Giannangelo3, 
James McCaw4, Darren J. Creek3, Susan A. Charman3, Nectarios 
Klonis1, Leann Tilley1
1Department of Biochemistry and Molecular Biology, Bio21 Molecular 
Science and Biotechnology Institute, The University of Melbourne, 
Melbourne, Australia, 2School of Mathematics and Statistics, The 
University of Melbourne, Melbourne, Australia, 3Monash Institute of 
Pharmaceutical Sciences, Faculty of Pharmacy and Pharmaceutical 
Sciences, Melbourne, Australia, 4School of Mathematics and Statistics, 
The University of Melbourne; Centre for Epidemiology and Biostatistics, 
Melbourne School of Population and Global Health, The University 
of Melbourne; Murdoch Childrens Research Institute, Royal Childrens 
Hospital, Melbourne, Australia
Fully synthetic endoperoxide antimalarials, namely OZ277 (RBx11160, 
arterolane) and OZ439 (artefenomel), have been approved for marketing 
or are currently in clinical development. We undertook an analysis of 
the kinetics of the in vitro responses of Plasmodium falciparum to the 
new ozonide antimalarials, using a K13 mutant (artemisinin resistant) 
isolate from a region in Cambodia and a genetically matched (artemisinin 
sensitive) K13 revertant. We used a pulsed exposure assay format to 
interrogate the time-dependence of the response. Because the ozonides 
have different physicochemical properties to the artemisinins, assay 
optimization was required to ensure that the drugs are completely 
removed following the pulsed exposure. Like the artemisinins, ozonide 
activity requires active hemoglobin degradation. Short pulses of the 
ozonides were less effective that dihydroartemisinin; however when early 
ring stage parasites are exposed to drugs for time periods relevant to their 
in vivo exposure, the ozonide antimalarials are markedly more effective.
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HISTORICAL AND CURRENT PATTERN OF ANTIMALARIAL 
DRUGS USE IN THE EPIDEMIC PRONE AREAS OF WESTERN 
KENYA
Anthony D. Kapesa1, Goufa Zhou2, Eliningaya J. Kweka3, 
Erasmus Kamugisha4, Harrysone Atieli5, Andrew Githeko1, Guiyun 
Yan2
1Kenya Institute of Medical Research (KEMRI), Kisumu, Kenya, 2Program 
in Public Health, College of Health Sciences, University of California Irvine, 
Irvine, CA, United States, 3Division of Livestock and Human Disease Vector 
Control, Tropical Pesticides Research Institute, Arusha, United Republic 
of Tanzania, 4School of Medicine, Catholic University of Health and Allied 
Sciences, Mwanza, Mwanza, United Republic of Tanzania, 5School of 
Public Health, Maseno University, Kisumu, Kenya
Management of malaria by artemisinin based combination therapy 
(ACTs) averts the disease sequel and limits infection propagation. This 
study aimed at examining the historical and current clinical prescription 
pattern, household use and availability of antimalarial drugs in Western 
Kenya. Multiple community and hospital based cross-sectional studies in 
three sites were done on types of antimalarial used and those prescribed 
respectively during ACTs drug policy implementation. Random selection 
of participants and review outpatient hospital registers together with the 
assessment of antimalarial drug availability in registered drug outlets were 
done. The hospital ACT prescription compliance was effectively done 
(100% (4042/4042) by 2015 but the adoption of the new drug policy had 
some rise and fall. Back in 2007 the prescription was 60% (6,363/10306) 
compliant before it dropped to 54.2% (712/1313) in 2010. The 
monotherapy antimalarial drugs use in households had been subsequently 
decreasing to 5.7% (86/1500) in 2015. Majority of users (90.5% (76/84) 
were from epidemic prone areas [χ2=27.54; df =2; p<0.001] and 
most were above 14 years of age (70/84 (83.3%) [χ2= 56.08; df=2; 
p<0.001]. In 2015 survey, majority (76.7% (227/296) of the under five 
years obtained their antimalarial drugs from Government hospitals while 
nearly half (42.5% (281/661) of the above 14 years of age obtained 
theirs from community drug outlets [χ2= 126.13; df =4; p<0.001]. The 
surveyed community drug outlets in 2015 found with high availability 
of both ACTs (100% (59/59) and 81.4% (48/59) of sulphadoxine-
pyremethamine monotherapy. Compliance to ACTs drug prescription in 
Kenyan Government health facilities had been staggering along the course 
but currently effective. Similarly, the trend of household ACTs use had 
been improving with some rise and falls but the observed magnitude of 
monotherapies use might be even higher as their availability in community 
drug outlets still high. Continued monitoring of AMD use both in health 
facilities as well as in the community along with reinforcement of the 
endorsed efficacious drug use is highly recommended.
250
PREVALENCE OF CHLOROQUINE AND ANTIFOLATE DRUG 
RESISTANCE MUTATIONS IN PLASMODIUM FALCIPARUM 
FIELD ISOLATES FROM TWO AREAS IN GHANA
James Abugri1, Felix Ansah1, Nicholas Amoako1, Lucas Amenga-
Etego2, David J. Conway3, Gordon A. Awandare1
1West African Centre for Cell Biology of Infectious Pathogens, University 
of Ghana, Accra, Ghana, 2Navrongo Health Research Centre, Navrongo, 
Ghana, 3Pathogen Molecular Biology Department, London School of 
Hygiene & Tropical Medicine, London, United Kingdom
As a result of widespread drug resistance to chloroquine and the 
antifolates among Plasmodium falciparum parasites, artesunate 
combination therapies (ACTs) were introduced as first line drugs in Ghana 
in 2005. However, the establishment of ACT resistance in South East Asia 
is an ominous sign, since this region is notorious for the emergence of 
antimalarial drug resistance, with possible spread to the African region. 
To investigate the prevalence of chloroquine and antifolate drug resistant 
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parasites in Ghana, we tested for P. falciparum drug resistance gene 
mutations using Polymerase Chain Reaction Restriction Fragment Length 
Polymorphism (PCR-RFLP). P. falciparum isolates were collected from 
203 children aged 2-14 years from two areas in Ghana with different 
transmission patterns, Navrongo and Kintampo, during the peak seasons 
in 2012-2013. The proportions of isolates with the pfcrt T76 mutation 
were 13.7% and 11.9% in Kintampo and Navrongo respectively. The 
overall prevalence rate of T76 mutation was 8.9% in the 2012-2013 
period, which is significantly reduced when compared to data from the 
World Wide Antimalarial Resistance Network (WWARN) showing 76-
100% rate from 2000-2005. For pfmdr1, the Y86 polymorphism was 
10.4% and 17.5% in Kintampo and Navrongo respectively, with the 
overall prevalence in the combined population being 12.8% as against 
51-75% in 2007-2008 as captured in the WWARN database. However, 
drug resistance mediating gene polymorphisms in pfdhfr (N108, 88.4%, 
I51, 80.6%; R59, 82.5%) and pfdhps (G437, 88.2%, E540, 1.2%) were 
comparable to data from 2000-2005 on pfdhfr (N108, 51-75%, I51, 
51-75%; R59, 76-100%) and pfdhps (G437, 76-100%; E540, 1-25%) 
polymorphisms. The reduction in the pfcrt T76 genotype in the Ghanaian 
population is attributable to the re-expansion of the wildtype genotype 
K76 as result of the proscription of chloroquine as a first line antimalarial 
drug in 2004. However, the use of antifolates for intermittent preventive 
treatment of malaria in pregnancy and for seasonal malaria chemotherapy 
in infancy may explain the persistence of antifolate drug resistant gene 
polymorphisms at higher frequencies.
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CHANGES IN DRUG RESISTANCE-MEDIATING PLASMODIUM 
FALCIPARUM POLYMORPHISMS IN UGANDA OVER TIME
Stephen Tukwasibwe
IDRC, Kampala, Uganda
Antimalarial drug resistance, mediated in part by known Plasmodium 
falciparum genetic polymorphisms, is of great concern. Chloroquine plus 
sulfadoxine-pyrimethamine (SP) was replaced by artemether/lumefantrine 
(AL) as the national treatment regimen, beginning in 2006. SP remains 
the standard-of-care to prevent malaria in pregnant women. We 
hypothesized that altered selective pressure for drug resistance would lead 
to changes in resistance polymorphisms in Ugandan parasites. We used 
ligase detection reaction-fluorescent microsphere assays to analyze 1486 
samples from cross-sectional surveys of subjects in 2012, 2013, and 2015 
in Tororo, Jinja, and Kanungu districts for polymorphisms in the putative 
drug transporters pfcrt and pfmdr1 that impact on response to AL and 
other drugs, and polymorphisms in the folate genes pfdhfr and pfdhps 
associated with resistance to SP. The prevalence of pure WT sequences 
was markedly greater than seen in Uganda previously, and increased from 
2012 to 2015 for pfcrt K76T (3.0% to 28.6%), pfmdr1 N86Y (33.9% to 
84.5%), and pfmdr1 D1246Y (45.6% to 74.4%); combined WT/mixed 
genotypes increased in a similar manner. For antifolates, the prevalence 
of 5 mutations (pfdhfr N51I, C59R, S108N; pfdhps A437G, K540E) that 
have been common since initial studies over a decade ago remained high 
(generally >90% mixed/mutant). Of concern, two additional mutations 
that predict a greater level of resistance to SP appear to be emerging in 
Uganda, with the prevalence of mixed/mutant pfdhfr I164L increasing 
from 7.3% to 11.3% and of pfdhps A581G from 29% to 35% in 
Kanungu, and mixed/mutant pfdhps A581G also seen commonly in Jinja 
(21.0%) and Tororo (14.1%) in 2015. Our results demonstrate significant 
changes in the prevalence of transporter polymorphisms with increasing 
use of AL to treat malaria, persistent prevalence of 5 common antifolate 
mutations despite decreased use of SP to treat malaria, and the presence 
of additional antifolate mutations that predict high level resistance. 
Continued surveillance for drug resistance markers is an important priority.
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MUTATION ANALYSIS OF K13 GENE, PFMDR1 AND PFCRT  ∫G 
V IN PLASMODIUM FALCIPARUM ISOLATES COLLECTED 
FROM WESTERN KENYA
Lorna J. Chebon, Zaydah deLaurent, Luiser Ingasia, Hosea Akala, 
Ben Andagalu, Edwin Kamau, Matthew Brown
U.S. Army Medical Research Directorate-Kenya/Walter Reed Project, 
Kisumu, Kenya
In Southeast Asia (SEA), mutations in K13 gene have been shown to be 
artemisinin resistance key determinant. Single Nucleotide Polymorphisms 
(SNPs) within the K13-propeller domain confer significantly higher ring-
stage survival of the parasite in vitro and delayed parasite clearance in 
vivo, as reported previously. Although AL remains highly efficacious in 
Africa including Kenya, it is also associated with selection of SNPs in 
Plasmodium falciparum chloroquine resistance transporter gene (pfcrt) 
and P. falciparum multidrug resistance gene 1 (pfmdr1) in re-infections. 
The genotype associated with re-infection is K76 in pfcrt and N86, 184F 
and D1246 (NFD) in pfmdr1; K+NFD haplotype. In Africa however, data 
suggests K+NFD haplotype is selected for by AL, though no evidence 
linking this to artemisinin resistance. This study aims to investigate 
genetic markers for any polymorphisms found in western Kenya parasites 
associated with changes seen in clinical phenotype. K13 full gene was 
sequenced using previously published and designed primers. For Pfmdr1 
gene, regions covering SNP 86, 184 and 1246 were amplified while for 
Pfcrt we amplified regions flanking the 72-76 haplotype region. Ring stage 
assay was performed and survival rates calculated. Pfmdr1 gene showed 
95.7% wild, 58% mutant and 81.5% wild at codons 86, 184 and 1246 
respectively. For haplotypes, K+NFD had highest frequency of 48.7%. 
K13 Full gene analysis showed 61 (84.7%) had non-synonymous SNPs 
in >5 locations out of which K189T dominated with highest frequency 
of (20.2%). Other SNPs include: Y493I (1.2%), A578S (1.9%) reported 
elsewhere while E433K (6), D464N (6), F483L (5) are uniquely found 
in western Kenya parasites (yet to be validated). Also, no variations in 
the number of a microsatellite repeat (ATA) corresponding to amino 
acid positions 137-142 of K13 was observed. No direct correlation seen 
between the mutations and the survival rates >10. It is evident that 
genetic determinant for higher survival rates to ACTs in African parasites 
is different compared to SEA parasites. K13 mutations described here 
including K189T are not linked to artemisinin resistance, as reported 
previously.
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HEPATOMEGALY IN ACUTE FALCIPARUM MALARIA IN 
NIGERIAN CHILDREN: BEFORE, DURING AND AFTER 
ARTEMISININ-BASED COMBINATION TREATMENTS
Kazeem Akano1, Adejumoke I. Ayede1, Elsie O. Adewoye1, 
Godwin Ntadom2, Bayo Fatunmbi3, Folasade Ibironke4, Akintunde 
Sowunmi1
1University of Ibadan, Ibadan, Nigeria, 2National Malaria Elimination 
Programme, Federal Ministry of Health, Abuja, Nigeria, 3World Health 
Organization, Regional Office for the Western Pacific, Phnom Penh, 
Cambodia, 4University College Hospital, Ibadan, Nigeria
Hepatomegaly or splenomegaly is common in childhood acute falciparum 
malaria but there is little evaluation of the risk factors, temporal changes 
and the disposition kinetics of the malaria-associated hepatomegaly 
following artemisinin-based combination treatments (ACTs). Liver and 
spleen enlargement below costal margin was detected by abdominal 
palpation and percussion and the liver size measured over a 6-week 
period. Changes in liver size was characterized using the rate of decrease 
or increase in size. Kinetics of the disposition of liver enlargement 
was evaluated using a non-compartment model. At presentation, 
hepatomegaly was significantly more common than splenomegaly in 
acutely malarious children (224 versus 129 of 786 children, P < 0.0001). 
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In a multivariate analysis, an age <5 years (adjusted odd ratio [AOR] = 
3.1, 95%CI 2.2-4.6, P < 0.0001), duration of illness >2 days (AOR = 1.5, 
95%CI 1.1-2.2, P = 0.02), core temperature >39oC (AOR = 1.5, 95%CI 
1.0-2.2, P = 0.03) and haematocrit <30% (AOR = 2.1, 95%CI 1.2-3.6, P 
= 0.01) were independent predictors of hepatomegaly or splenomegaly 
at presentation. The commonest temporal change following ACTs was 
ultra-rapid complete regression of hepatomegaly in over 93% of the 
children. Overall, mean hepatomegaly regression time (HRT) was 2.9 days 
(95%CI 1.9 – 3.8) and it was similar in artesunate-amodiaquine- and 
artemether-lumefantrine-treated children. Declines in hepatomegaly 
were monoexponential with overall estimated half-time (t½hep) of 0.2 day 
(95%CI 0.2-0.3). HRT correlated significantly with t½hep (P < 0.0001). 
Bland-Altman analysis of 9.5 and 10 multiples of t½hep and HRT showed 
narrow limit of agreement with insignificant bias (P ≥ 0.06) suggesting 
both can be used interchangeably in the same patients. Young, febrile 
and anaemic malarious children with duration of illness >2 days, are at 
significant risk of hepatomegaly or splenomegaly at presentation. In acute 
childhood falciparum malaria, regression of hepatomegaly is rapid and is a 
first-order process following ACTs.
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GROWTH ADVANTAGE OF WILD-TYPE OVER DRUG 
RESISTANT PLASMODIUM FALCIPARUM GENOTYPES 
AMONG ASYMPTOMATIC CARRIERS IN ABSENCE OF 
THERAPY
Amal A.H. Gadalla1, Thomas Churcher2, Elkhansaa Nassir3, Abdel-
Muhsin A. Abdel-Muhsin4, Hamza A. Babiker1
1Sultan Qaboos University, Al-khod, Oman, 2Department of Infectious 
Disease Epidemiology, Imperial College London, London, United Kingdom, 
3Ahfad University, Oumdurman, Sudan, 4Tropical Medicine Research 
Institute, Khartoum, Sudan
A large set of data, field and animal models, demonstrated a compromised 
fitness of drug-resistant malaria parasites in absence of chemotherapy. 
Here we extended the above observations, and quantitatively monitored 
drug resistant and sensitive parasite genotypes, within asymptomatic 
Plasmodium falciparum carriers, in absence of therapy, and determine their 
relative growth and ability to produce gametocytes. We test the prediction 
that drug resistant genotypes in absence of therapy are constrained 
by competition with co-infecting wild-type clones to maintaining low 
gametocyte production. We recruited 123 patients, in a seasonal malaria 
setting, where transmission occurs over a short period, and the rest of the 
year remains transmission-free. The patients were initially treated, and then 
monitored monthly throughout the long dry season. Relative abundance 
(RA) of wild- versus mutant genotypes of pfcrt and pfmdr-1 was 
determined using qPCR. Parasite and gametocyte densities were quantified 
by qPCR of 18s rRNA and RT-qPCR of pfs25 and pfs230, respectively. 
The densities of the mutant genotype of pfcrt and pfmdr-1 were high at 
enrolment and post treatment, however it decreased steadily over the dry 
season. The RA of wild-type of both genes increased substantially over 
the long dry and transmission-free period (pfcrt, p=0.009738; pfmdr-1, 
p=0.006867). Gametocytes density negatively correlated with the RA of 
wild-type pfcrt-CVMNK (p = 0.03044) but not with the wild-type pfmdr-1 
86N (p= 0.06512). We provide the first direct evidence for within host 
growth advantage of wild-type strains of P. falciparum, in a therapy-free 
environment among asymptomatic carriers. Thus, in areas of seasonal 
transmission, the dry season can play an important role in harnessing 
susceptible parasites.
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ACTIVE MONITORING OF PHARMACOVIGILANCE AT 
COMMUNITY LEVEL DURING THE SEASONAL MALARIA 
CHEMOPREVENTION CAMPAIGN IN THE HEALTH DISTRICT 
KOLDA SENEGAL, 2015
Ibrahima Diallo1, Mamadou Lamine Diouf1, Jean Louis Ndiaye2, 
Medoune Ndiop1, Alioune Badara Gueye1, Mady BA1
1Senegal National Malaria Control Program, Dakar Fann, Senegal, 2Senegal 
University Cheikh Anta Diop Dakar, Dakar, Senegal
The scaling up of seasonal malaria chemoprevention campaign (SMC) 
began in Senegal in 2013 in four health districts with an extension in 
2014 to cover four regions and over 600 000 children aged 3 months to 
10 years. It is made in the form of local distribution campaigns / free mass 
administration of drugs Sulfadoxine-pyrimethamine (SP) + Amodiaquine 
(AQ) by a door to door strategy relying on the community network. The 
regions of Kedougou, Tambacounda, Kolda and Sedhiou meet the WHO 
criteria for eligibility. While the drugs used in SMC are generally considered 
safe and effective, they can cause adverse events that may be minor, 
moderate, or in very rare cases, severe. Spontaneous reporting is essential 
but not sufficient to assess any adverse effects related to the use of a 
drug. Its need to develop a community-based active pharmacovigilance 
through a cohort followed for SMC. The overall objective was to assess 
the ability of a strategy to strengthen the pharmacovigilance system and 
improve the reporting rate of adverse events in the context of SMC. The 
study took place in the health district of Kolda in southern Senegal during 
the season 2015 SMC for a total of three rounds (August, September and 
October) for 10,000 children benefiting SMC in three health posts district. 
In the same district, three other health posts targeting the same number 
of children were selected as controls. The side effects filings were received 
by the NMCP and processed by the pharmacovigilance center. In total 829 
adverse events were reported for 743 consultations. More than half of 
the symptoms reported (591) were gastrointestinal disorders (71%). Other 
common symptoms are fever (24%). Accountability side effects made by 
the pharmacovigilance center and approved by the technical committee 
of experts shows 48% possible and probable for 28%.These results show 
a clear improvement compared to routine pharmacovigilance system 
implemented in other health districts. All results must be sent to Uppsala 
center UMC / WHO by vigiflow.
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HOT AND STICKY: THE EFFECT OF TROPICAL CONDITIONS 
ON THE STABILITY OF ARTEMISININ-BASED COMBINATIONS 
THERAPIES
Harparkash Kaur, Zoe Hall, Elizabeth Louise Allan, Donelly 
Andrew van Schalkwyk, Albert van Wyk
London School of Hygiene & Tropical Medicine, London, United Kingdom
Poor-quality medicines, including falsified, substandard and degraded 
drugs, pose serious health concerns in malaria endemic countries as they 
contribute to the rise in drug resistance, can kill patients, and increase the 
public’s mistrust of health systems. Substandard drugs are defined as those 
that contain either less or more than the acceptable dose (compliance 
with pharmacopeia tolerance limits) of stated active pharmaceutical 
ingredients (SAPIs) resulting from poor manufacturing practices, while 
degraded drugs are good quality formulations that have degraded on 
storage in the presence of heat, light and humidity. Guidelines are lacking 
distinguishing between substandard and degraded drugs in terms of 
markers of degradation. ‘Forced degradation’ was carried out on three 
common artemisinin-based combination therapy (ACT) brands and 
analytical methodology was developed to facilitate the classification of 
degraded drugs. This methodology was applied to ACTs purchased in 
Enugu, Nigeria that had been classified to be substandard (206 samples) 
and 18% of these were found to contain degradation products. We 
previously conducted a large-scale ‘natural ageing’ study (2,880 samples 
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of Coartem® and Winthrop®) to evaluate the long-term stability of ACTs 
in tropical climates, on-site in Ghana and in a stability chamber in London. 
Samples were aged in the presence and absence of light and removed 
from each site at regular intervals to measure loss of SAPIs over time as 
well as detect products of degradation. Loss of SAPIs in these naturally 
aged samples was 0 to 7% over 3 years (~12 months beyond expiry) with 
low levels of degradation products detected. ACTs that were found to be 
stable in tropical climates for periods up to and beyond their expiry dates 
were from WHO prequalified manufacturers, while those found to contain 
degradation products were from non-WHO prequalified manufacturers. 
Hence, presence of insufficient SAPIs, together with detection of 
degradation products, can be used to classify drugs as degraded.
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READMISSION TO HOSPITAL FOR WORSENED ANAEMIA IN 
MOZAMBICAN CHILDREN TREATED WITH INTRAVENOUS 
ARTESUNATE
Rosauro Varo1, Lola Madrid1, Antonio Sitóe2, Helio Mucavele2, 
Salesio Macuacua2, Sozinho Acacio2, Pedro Aide2, Quique Bassat2
1Barcelona Institute for Global Health, Barcelona, Spain, 2Centro de 
Investigação em Saúde de Manhiça (CISM), Manhiça, Mozambique
Readmission to hospital for worsened anaemia in Mozambican children 
treated with intravenous artesunate Parenteral artesunate is recommended 
as first-line therapy for severe malaria. While its efficacy is firmly 
established, data on safety are still incomplete and scarce among African 
children. We aim to assess and compare delayed (newly incident or 
worsening) anaemia rates in the first 30 days after parenteral treatment 
with Quinine or artesunate, after its introduction as first line policy. We 
also aim to identify risk factors associated to delayed anemia following 
artesunate iv treatment. We conduct a retrospective analysis for the period 
2001-2015 using the outpatient and inpatient morbidity databases, and 
linking them with the demographic surveillance system ongoing in the 
Manhiça district, in Southern Mozambique. Recurrent hospital admissions 
or outpatient visits after a documented parenteral treatment for malaria 
will be analysed to determine whether the use of parenteral artesunate 
is associated with an increased risk of anaemia. Comparison of trends of 
this phenomenon (before and after the year when the switch from quinine 
to artesunate in first line policy occurred), in addition to the evaluation of 
other potential confounding factors, will allow an inference of the possible 
attribution to artesunate. We will present the results of this analysis, 
reviewing over 50,000 admissions during the study period.
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IMPROVING UPTAKE OF IPTP IN UGANDA THROUGH TEXT 
MESSAGING HEALTH WORKERS
Christian Rassi1, Georgia Gore-Langton1, Kirstie Graham1, Badru 
Gidudu2, Patrobas Mufubenga2, Michelle Li1, Rebecca King3, Sam 
Gudoi Siduda2
1Malaria Consortium, London, United Kingdom, 2Malaria Consortium, 
Kampala, Uganda, 3University of Leeds, Leeds, United Kingdom
Malaria in pregnancy poses a risk to mother and child. The World Health 
Organization recommends intermittent preventive treatment in pregnancy 
(IPTp) for the prevention and control of malaria in pregnancy, typically 
provided through the focused antenatal care (ANC) package. Coverage 
of at least two doses of IPTp remains low in most countries implementing 
IPTp, despite generally high ANC attendance. Qualitative formative 
research conducted in 2013/14 concluded that supply-side issues are likely 
to account for the majority of missed opportunities for the provision of 
IPTp in Uganda. In particular, health workers’ knowledge of IPTp guidelines 
was poor. To address this barrier, a pilot intervention was implemented in 
West Nile in 2015. This involved provision of classroom-based malaria in 
pregnancy training to selected health workers in two districts (n=24 per 
district). In one district only, all health workers involved in ANC provision 
(n=49) subsequently received 25 text messages reinforcing the training 
content. The study used a mixed-methods design to determine the 
impact of text messaging: i) a multiple choice knowledge questionnaire 
administered immediately after training (n=90) and six months after 
training (n=89), ii) calculation of IPTp coverage in participating health 
facilities (n=16) over six months pre- and post-training and iii) four focus 
group discussions with health workers and three in-depth interviews 
with district officials. Health workers who had received text messages 
in addition to training demonstrated better knowledge of malaria in 
pregnancy six months post-training compared to health workers receiving 
training only. IPTp coverage was also higher in facilities where health 
workers received text messages. Complementing classroom-based malaria 
in pregnancy training with text messages has the potential to improve 
health worker knowledge of and adherence to guidelines. Text messaging 
is inexpensive, well-received by health workers and does not disrupt 
service provision. This approach has potential applications to health worker 
training on other topics.
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EFFICACY OF THREE ARTEMISININ-BASED COMBINATION 
THERAPIES IN ANGOLAN CHILDREN WITH PLASMODIUM 
FALCIPARUM INFECTION, 2015
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Development, Luanda, Angola, 7U.S. President’s Malaria Initiative, 
Division of Parasitic Diseases and Malaria, Centers for Disease Control 
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Geneva, Switzerland
Antimalarial resistance monitoring in Angola has recently garnered 
increased attention. Therapeutic efficacy studies (TES) from 2011-2013 in 
Luanda and from 2013 in Zaire Province showed efficacy of artemether-
lumefantrine (AL) approaching the 90% threshold identified by the World 
Health Organization for artemisinin-based combination therapies (ACTs). 
In addition, a controversial case of malaria unresponsive to artemisinins 
was reported in a patient infected in Lunda Sul Province in 2013. In 
January-June 2015, investigators monitored the clinical and parasitological 
response of children with uncomplicated Plasmodium falciparum infection 
treated with one of three ACTs: AL, artesunate-amodiaquine (ASAQ), or 
dihydroartemisinin-piperaquine (DP). The study comprised two treatment 
arms in each of three provinces: Benguela (AL and ASAQ), Zaire (AL 
and DP), and Lunda Sul (ASAQ and DP). Participants were followed for 
28 (ASAQ and AL) and 42 (DP) days. Samples from treatment failures 
were analyzed for molecular markers of resistance for artemisinin (K13) 
and lumefantrine (pfmdr1). A total of 475 children reached a study 
endpoint. Fifty-five treatment failures were observed: 4 early treatment 
failures, 41 reinfections, and 10 recrudescences. Excluding reinfections, 
the microsatellite-corrected efficacy at day 28 was 96.3% (95% CI: 91-
100) for the AL arm in Benguela, 99.9% (95-100) for ASAQ in Benguela, 
88.1% (81-95) for the AL arm in Zaire, and 100% for ASAQ in Lunda Sul. 
For DP, the corrected efficacy at day 42 was 98.8% (96-100) in Zaire and 
100% in Lunda Sul. All treatment failures were wildtype for K13, but all 
AL treatment failures had pfmdr1 haplotypes associated with decreased 
lumefantrine susceptibility. The results suggest a parasite population 
sensitive to artemisinin derivatives in these three provinces. No evidence 
was found to corroborate the specific allegation of artemisinin resistance 
in Lunda Sul. The continued low efficacy of AL in Zaire might be due 
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to decreased susceptibility to lumefantrine, and further monitoring, 
particularly including measurement of lumefantrine blood levels during 
TES, is recommended.
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ACCELERATING THE DISCOVERY OF TRANSMISSION-
BLOCKING DRUGS: HT SCREENING WITH A NOVEL 
PLASMODIUM FALCIPARUM FUNCTIONAL GAMETOCYTE 
ASSAY
Celia Miguel-Blanco1, Irene Molina1, Ana I. Bardera1, Beatriz Diaz1, 
Laura de las Heras1, Carolina Gonzalez1, Gonzalo Colmenarejo1, 
Sonia Lozano1, Andrea Ruecker2, Michael Delves2, Sara Marques2, 
David Calvo1, Juliana Sanchez1, Janneth Rodrigues1, Jake Baum2, 
Robert Sinden2, Esperanza Herreros1
1GlaxoSmithKline, Tres Cantos, Spain, 2Imperial College, London, United 
Kingdom
The last decade has witnessed unprecedented progress in reducing the 
incidence of Plasmodium falciparum malaria, especially in Africa where 
the burden of disease is greatest. Nevertheless, in order to achieve 
the ultimate goal of eradicating malaria, more effective tools will be 
required. These include efficacious vaccines and innovative antimalarial 
drugs with novel mechanisms of action displaying not only efficacy 
against resistant parasites but also transmission blocking potential. P. 
falciparum mature gametocytes are the parasite forms responsible for 
malaria transmission, thus our objective was the discovery of drugs with 
a novel mechanism of action, active against these stages, either by killing 
or functionally preventing their maturation to mosquito stages. For this 
purpose, we have developed a phenotypic HTS assay, which assesses 
the functionality and viability of P. falciparum stage V gametocytes by 
measuring the formation of female gametes. In this work, we present the 
screening of GSK compound collections. Over 400 hits were identified 
after a primary screening at 2µM and a subset of approximately 100 
compounds representative of new chemical diversity were prioritized for 
further profiling. A selection of hits was assessed ex vivo in the standard 
membrane feeding assay and demonstrated complete transmission 
blockage. This new set of compounds may serve as starting points for 
future drug discovery programs as well as tool compounds for identifying 
new modes of action involved in malaria transmission.
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NEW ANTIMALARIAL FAMILY “RESISTANT TO RESISTANCE” 
DEVELOPMENT
Laura M. Sanz, Isabel Castellote, Cristina de Cozar, Benigno 
Crespo, Maria Jesus Almela, Virginia Franco, Maria Gracia Gomez, 
Noemi Bahamontes, Sara Prats, Maria Jose Lafuente, Sara Viera, 
John Haselden, Francisco Javier Gamo
GlaxoSmithKline, Tres Cantos (Madrid), Spain
Malaria continues to be a major global disease still causing impermissible 
number of deaths. The effectiveness of current antimalarial therapy is 
under continuous threat through the spread of resistance. Consequently, 
there is an urgent need to replace those drugs compromised by resistance, 
as well as identifying potential novel therapies that offer significant 
advantages over the current standard of care. As result of the whole 
cell phenotypic screen conducted by GSK to identify TCAMS set of 
compounds, a number of lead optimization programs were initiated. 
One of them, pyrazine family, was progressed because the chemical 
novelty displaying exciting opportunities as antimalarial. The program 
led to the identification of balanced molecules with appealing biological 
profile. Pyrazine molecules demonstrated relevant activities against intra-
erythrocytic asexual Plasmodium stages including multiple MDR laboratory 
adapted strains and clinical isolates. Pyrazines displayed a desirable rapid 
in vitro killing profile. This activity is accompanied by an oral efficacy 
characterized by a rapid parasite clearance in the P. falciparum mouse 
model. This rapid antimalarial activity is expected to maximize efficacy, 
achieving fast clinical resolution, and minimizing the in-patient window 
of opportunity for resistant parasite selection and dissemination. Notably, 
the series displayed an extremely low propensity to select resistance in 
vitro. The biological profile that the series offers seems to be associated to 
an unique mode of action not related to any of the known mechanisms 
tested, hence offering differentiation against all other antimalarials. 
The development of differentiated MoA antimalarials is of paramount 
importance to be able to develop de novo combination treatments, 
thereby ultimately avoiding the emergence of resistance. The overall 
properties of pyrazines constitutes a promising profile justifying further 
development and makes these assets suitable partners for any future 
combination treatment.
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IN VIVO STUDIES OF FITNESS OF DRUG RESISTANT 
PLASMODIUM FALCIPARUM DHFR MUTANTS USING 
PLASMODIUM BERGHEI TRANSGENIC PARASITES
Mofolusho O. Falade1, Sumalee Kamchonwongpaisan2, 
Yongyuth Yuthavong2, Chairat Uthaipibull2
1Cellular Parasitology Programme, Department of Zoology, University of 
Ibadan, Ibadan, Nigeria, 2National Center for Genetic Engineering and 
Biotechnology (BIOTEC) National Science and Technology Development 
Agency (NSTDA), Thanon Phahonyothin, Tambon Khlong Neung, Amphoe 
Khlong Luang, Pathum Thani, Thailand
Drug resistance has hindered control efforts for malaria, where mutations 
to the target dihydrofolate reductase (DHFR) enzyme are responsible for 
resistance to pyrimethamine. Nonetheless, antifolates are key components 
of ACT’s and used for intermittent preventive treatment in pregnancy. 
Understanding parasite fitness evolution is important for transmission. 
There is a lack of information about the cost of drug resistance mutations 
on parasite fitness, or the ability of resistant parasites to compete with 
sensitive strains and persist in the field. We studied how DHFR mutations 
under drug pressure influences survival of resistant alleles. We conducted 
competition experiments between Plasmodium berghei parasites in which 
endogenous dhfr was modified by gene replacement, with P. falciparum 
single (108 {1M}), double (59 and 108 {2M}) and triple (59, 108 and 164 
{3M}) mutants. For each parasite line created, GFP and cherry RFP were 
used as reporters to aid parasite enumeration via flow cytometric analysis. 
All single infection and competition experiments were initiated with 
1x106 parasites. Infections were followed up, with the treated groups 
administered 10-mg/kg pyrimethamine for 3 days, after which, parasitemia 
was assessed via counting of fluorescent parasites by a flow cytometer. 
In all experiments (both treated and non treated groups), single infection 
parasites grew better in mixed infections (competition). For all mutant lines 
in competition experiments, higher resistant parasites grew better in mixed 
infections when competing against lesser resistant mutants. 2M mutants 
grew better in single infections with drugs than without drugs. In all 
competition experiments 3M mutants grew better with or without drugs 
than other mutants. These findings support a model of parasite release 
and facilitation, whereby under drug pressure highly resistant parasites do 
better than less resistant parasites. Recognizing the costs of fitness will aid 
the development of optimal guidelines for the treatment and prevention 
of malaria.
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EVALUATION OF THE PERFORMANCE OF SD BIOLINE 
MALARIA AG PF/PV AND CARESTART™ MALARIA PF/PV 
COMBO TESTS FOR THE DIAGNOSIS OF MALARIA IN TWO 
MALARIOUS AREAS IN CENTRAL ETHIOPIA
Abeba G. Reda
EPHI, Addis Ababa, Ethiopia
Early and accurate diagnosis of malaria followed by prompt treatment 
reduces morbidity and mortality in endemic regions. Presumptive 
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treatment of malaria is widely practiced where microscopy or rapid 
diagnostic tests are not readily available. Introduction of rapid diagnostic 
tests (RDTs) for the treatment of malaria in many low-resource settings 
need evaluation of their performance. This study evaluated the 
performance of two RDTs in two health centers from November-December, 
2014 in Adam and Amaya. Oromia, Ethiopia. This study was undertaken 
to evaluate the diagnostic performance of SD BIOLINE malaria Ag Pf/Pv 
and CareStart™ malaria Pf/Pv Combo test relative to microscopy for the 
diagnosis of P. falciparum and P. vivax malaria in Ethiopia. In this cross-
sectional study, patients who had malaria symptoms and visited two health 
facilities in Oromia Region were recruited. Thin and thick blood smears 
were prepared from finger prick and stained by 10% Giemsa. Microscopic 
examination was done under 100x magnifications for Plasmodium species 
identification and determination of parasitaemia. The two RDTs were 
performed as per the manufacturers instructionsA total of 547 febrile 
patients were diagnosed, of which 127 were microscopy positive for Pf 
(n=38) and Pv (n=85). The sensitivity, specificity, positive and negative 
predictive value of SD BIOLINE malaria Ag Pf/Pv test were 92.1%, 99.1%, 
95.9% and 98.2%, respectively; and for CareStart™ malaria Pf/Pv Combo 
tests were 94.5%, 99.6%, 98.4% and 99.6%, respectively. In conclusion, 
the diagnostic performance of SD BIOLINE malaria Ag Pf/Pv test and 
CareStart™ malaria Pf/Pv Combo test were very good with respect to 
malaria microscopy.
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THE EFFECTS OF MALARIA SPECIES-SPECIFIC TREATMENT 
POLICY ON CASE MANAGEMENT AND DYNAMICS OF 
RESISTANCE MARKERS IN ETHIOPIA
Lemu G. Woyessa, Abraham Aseffa, Berhanu Erko
Aklilu Lemma Institute of Pathobiology, Addis Ababa University, Addis 
Ababa, Ethiopia
In Ethiopia, Plasmodium falciparum and P. vivax are co-endemic and 
virtually responsible for 60 and 40% of all malaria cases, respectively. 
Artemether-lumefantrine and CQ are first-line treatments for 
uncomplicated P. falciparum and P. vivax infections, respectively. The 
change from one drug to another, following the emergence of drug 
resistance, would alter the dynamics of sensitive and resistant parasite 
haplotype. Accurate diagnosis is, therefore, crucial for appropriate 
prescription of the correct drugs. A total of 1,094 patients were screened 
for malaria using microscopy and RDTs. Sets of microscopy and RDT-
positive and negative samples were tested for confirmation using PCR. 
Anti-malarial drugs were prescribed for 9.3 and 20.0% microscopy- and 
RDT-based parasite negative patients, respectively, as confirmed by PCR. 
PCR detected the presence of P. falciparum DNA in 19.2% of microscopy- 
and RDT-negative samples. Of microscopy-positive P. vivax infections, 
63.2% were proved vivax malaria by PCR. Of microscopy-positive P. 
falciparum infections, 71.4% were proved falciparum malaria by PCR. Of 
RDT-positive P. falciparum infections, PCR proved in 62.7% of them. Of 
RDT-positive P. vivax infections, 77.3% were proved vivax malaria by PCR. 
All parasites were carrying the pfcrt K76T mutant variants. The prevalence 
of parasites with the wildtype codon pmdr1 Y86N was 76.7%. Microscopy 
and RDT were insufficient at low density parasitaemia and hence 
misdiagnosis was significant. The use of molecular methods appropriate 
at field setting would help avoid over-prescription and under-diagnosis of 
malaria infections. While the presence of the mutant variant of pfcrt in the 
Ethiopian samples can be explained by continued use of chloroquine in 
Ethiopia for treatment of P. vivax, the selection of wild type pfmdr1 could 
be a consequence of using ACT for treatment of P. falciparum.
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PARASITOLOGIC CORRELATES OF PLASMODIUM OVALE 
WALLIKERI AND PLASMODIUM OVALE CURTISI INFECTION
Melissa Phuong1, Rachel Lau2, Filip Ralevski2, Andrea K. Boggild3
1McMaster University, Hamilton, ON, Canada, 2Public Health Ontario 
Laboratories, Toronto, ON, Canada, 3University of Toronto, Toronto, ON, 
Canada
Plasmodium ovale is one species of human malaria that is prevalent in 
West Africa and can be challenging to diagnose due to clinically mild 
disease and low parasite burden. Consequently, conventional diagnostic 
tools, such as microscopy of blood films and rapid antigen-based 
diagnostic tests, have limited performance in detecting P. ovale infection. 
Furthermore, two genetically distinct sub-species of P. ovale exist: P. 
ovale curtisi (Poc) and P. ovale wallikeri (Pow). At present, it is unknown 
if the sub-species causing infection may affect clinical presentation 
or performance of malaria diagnostic tests. Therefore, we sought to 
investigate if parasite burden, morphological features, and pan-aldolase 
antigen-positivity differ between Poc and Pow. 49 P. ovale-positive, whole-
blood specimens were identified from our malaria biobank, and DNA 
was extracted. Parasitemia and pan-aldolase antigen-positivity that were 
reported upon initial processing were obtained for analysis. Real-time PCR 
(qPCR) assays were conducted to confirm microscopy species identification, 
and quantify 18S rRNA gene copy number. Endpoint PCR of target regions 
and Sanger sequencing were conducted, and sub-species was determined 
by analyzing the 18S rRNA sequence. We compared reported parasitemia, 
parasite morphology, pan-aldolase antigen-positivity, and 18S gene copy 
number between the two sub-species. We identified 22 Poc and 27 Pow. 
There were no statistically significant differences between the two sub-
species by parasitemia, 18S rRNA gene copy number, or pan-aldolase 
antigen-positivity. When comparing morphological features, we noted that 
all 8 P. ovale parasites without Schuffner’s stippling were Pow while all Poc 
parasites had this feature (p=0.02). Poc and Pow do not differ significantly 
by parasite burden, although a lack of discernible Schuffner’s stippling may 
be a feature specific to Pow. This is a novel finding, considering that the 
sub-species have been previously distinguished by their genotype alone.
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FALSE-NEGATIVE MALARIA RAPID DIAGNOSTIC TESTS IN 
RWANDA: IMPACT OF PLASMODIUM FALCIPARUM ISOLATES 
LACKING HRP2 AND IMPROVED MALARIA CONTROL
Christina T. Kozycki1, Noella Umulisa2, Stephen Rulisa3, Corine 
Karema2, Emil I. Mwikarago4, Jean Pierre Habimana4, Donald J. 
Krogstad1
1Tulane University, New Orleans, LA, United States, 2Malaria and Other 
Parasitic Diseases Division, Rwanda Biomedical Centre, Ministry of Health, 
Kigali, Rwanda, 3University of Rwanda, Faculty of Medicine, Kigali, 
Rwanda, 4National Reference Laboratory, Rwanda Biomedical Centre, 
Ministry of Health, Kigali, Rwanda
Rapid Diagnostic Tests (RDTs) have become the focal point of the global 
approach to malaria control and are often used to determine whether 
persons with fever, chills or other symptoms of malaria are treated 
with antimalarials. Because false-negative RDTs can delay or prevent 
the effective treatment of this potentially fatal disease, it is essential to 
examine the factors that affect RDT performance. Recently, Plasmodium 
falciparum isolates lacking the hrp2 gene have been identified as a 
cause of false-negative RDTs. However, despite the importance of this 
issue, there is a paucity of data on the frequency of these isolates. This 
study examined RDT sensitivity at sites with varying intensities of malaria 
transmission in Rwanda and used PCR to determine whether hrp2 
deletions were responsible for false-negative HRP2-based RDT results. 
Between April 2014 and April 2015, the study enrolled 9,219 symptomatic 
patients from 3 health centers in Rwanda and compared RDT results to 
microscopy for Plasmodium species as the gold standard. The overall slide 
positivity rates (SPR) were 53% at Rukara, 35% at Kibirizi and 10% at 
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Busogo. RDT sensitivity varied by month and site and was highest (94% 
[95% CI 92-95%.]) at Rukara, the site with the highest SPR. At Kibirizi, a 
site targeted by pre-elimination activities during this study, RDT sensitivity 
declined from 88% to 67% as the monthly SPR fell from 46% to 3%. 
For samples that were positive by microscopy but negative by RDT, PCR 
was performed to test for Plasmodium DNA and confirm the presence or 
absence of the hrp2 gene. PCR analysis identified a total of 34 infections 
that were positive by PCR for P. falciparum but negative by RDT and PCR 
for hrp2 (consistent with deletion of the hrp2 gene). To the authors’ 
knowledge, this is the first report of circulating P. falciparum isolates 
lacking hrp2 in East Africa. However, this is not the first time that a decline 
in RDT sensitivity occurred following a decline in malaria transmission. 
Further investigation is warranted to assess the factors driving the decline 
in RDT sensitivity as malaria control improves.
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SNP-LAMP POINT OF CARE TEST FOR THE DETECTION OF 
ARTEMISININ-RESISTANCE IN THE FIELD
Abu Naser Mohon, Dylan Ravindran Pillai
University of Calgary, Calgary, AB, Canada
Cases of artemisinin resistant malaria are rapidly increasing in South-East 
Asia. Even in some part of Cambodia, the proportion of the slow clearing 
parasites is now above 75%. Several mutations in the K13 propeller 
gene have been associated with 91.8% of slow-clearing parasites. Of 
these drug resistant mutations, C580Y and R539T constituted 85% of 
the resistant population in Cambodia. Recently,the C580Y mutation was 
also reported from Guyana, a South American country but not Africa. 
Monitoring resistance in the field site is important for the treatment and 
surveillance of resistant clones. Current methods to evaluate artemisinin 
resistance such as in vitro culture methods and DNA sequencing are time-
consuming, reagent intensive, expensive and not applicable to the field 
setting. Point of care detection of K13 mutations will allow for correct 
antimalarial treatment choices as well as enhance surveillance. Loop 
mediated amplification (LAMP) has proven to be field adaptable in our 
hands. We now modify LAMP to detect the C580Y and R539T SNP. SNP-
LAMP is based on the differential binding of amplification primers. Our 
strategy was to validate SNP-LAMP on bona fide resistant clones from 
Cambodia. Input template DNA and enzyme concentrations were varied 
to optimize amplificationof the mutant strain while not amplifying the 
wild type. Preliminary data is presented on the K13 SNP-LAMP assay for 
control strains, clinical isolates, and non- falciparum controls including 
Plasmodium vivax, P. ovale and P. malariae. Our data suggest the mutant 
K13 propeller gene can be specifically amplified within a range of 1000-
10000 parasites/µL.Specificity is lost if parasitaemia goes over 10000/µL. 
Dilution of the high copy number sample can maintain the accuracy of the 
diagnosis. Further work is going on improve the minimum and maximum 
limit of detection by altering different sequences of loop primers.
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ASSESSMENT OF LOOP MEDIATED ISOTHERMAL DNA 
AMPLIFICATION (LAMP) METHOD FOR ASYMPTOMATIC 
MALARIA SCREENING IN THE PERUVIAN AMAZON SETTINGS
Anthony Gave1, Paulo Manrique1, Freddy Alava1, Daniel 
Sanchez1, Roy Tenorio1, Elisa Serra2, Anna Rosanas2, Iveth 
Gonzalez3, Xavier Ding4, Dionicia Gamboa1
1Universidad Peruana Cayetano Heredia, Lima, Peru, 2Institute of Tropical 
Medicine, Antwerp, Belgium, 3Caucaseco Scientific Research Cente, Cali, 
Colombia, 4FIND Diagnosis, Geneva, Switzerland
In the Peruvian Amazon, asymptomatic malaria infections, with low 
parasite density, are common and has impact on maintaining malaria 
transmission. Within this context, molecular diagnostic tests would be 
more efficient than microscopy or RDTs to identify these cases; however, 
it requires well trained users and special equipment. LAMP is expected 
to be a point-of-care method that could be applied in rural communities 
with basic facilities and also an alternative for population screening aiming 
malaria elimination. In this work, we assessed the performance of LAMP 
to detect asymptomatic malaria infections compared with microscopy and 
validated by three different PCR protocols: nested PCR (nPCR), qPCR base 
on mitochondrial genome (qPCR-Pgmt) and qPCR base on 18S rRNA gene 
(qPCR-18S). 1173 subjects from eight communities along Alto Nanay river 
were screened by LAMP and microscopy and all asymptomatic individuals 
above 3 years old were enrolled. 58 (4.9%) were positive by microscopy 
and 259 (22.1%) were positive by LAMP (34 Plasmodium falciparum 
and 225 no-falciparum). All LAMP positive samples, 30% of negative 
samples and 7 positive controls with different parasitaemia were tested to 
evaluate LAMP sensitivity and specificity. Stratified analysis by parasitaemia 
level between LAMP and PCR showed a sensitivity of 100%, 94.8% and 
93.1% against nPCR, qPCR-Pgmt and qPCR-18S, respectively, when 
parasitaemia was higher than 1 parasite/µL. However, with parasitaemias 
bellow 1 parasite/µL, LAMP sensitivity decrease to 77.8%, 86.6% and 
69.9% against nPCR, qPCR-Pgmt and qPCR-18S, respectively. Our results 
suggest that LAMP is a good alternative for a point of care diagnostic and 
population screening, but its performance decays with samples with very 
low parasitaemia. To move towards malaria elimination in settings with 
very low transmission, LAMP performance should be improved, and the 
development of new tests capable of identifying very low parasite densities 
is required.
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VALIDATION OF DRUG SELLERS’ MALARIA RAPID 
DIAGNOSTIC TESTS (MRDTS) RESULT RECORD AND FIELD 
MALARIA RDT PERFORMANCE AGAINST PCR ANALYSIS OF 
DUPLICATE BLOOD SAMPLES FROM UNDER-FIVE CHILDREN 
IN SOUTHWESTERN UGANDA
Freddy E. Kitutu
Makerere University, Kampala, Uganda
Currently, the WHO recommends that every case of suspected malaria 
be confirmed by a diagnostic test. Use of malaria Rapid Diagnostic Tests 
(mRDTs) has been emphasized in communities and private drug outlets 
where more than 50% of fever case management occurs in malaria 
endemic LMICs. Due to limitations in mRDT sensitivity for efficient 
detection of low-density parasitemia or sub-microscopic infections, 
nucleic acid amplification techniques (NAATs) have been encouraged for 
epidemiological research and surveys to map sub-microscopic malaria 
infections in low-transmission settings such as South Western Uganda. 
Operator error, transport and storage conditions can also cause false 
negatives. On this basis, we are comparing test results from mRDT done 
by drug sellers in field conditions on under-five children in South Western 
Uganda against PCR test. A duplicate blood sample is picked using 
Whatman FTE card for additional test comparisons. Methods Duplicate 
samples from under-five children are collected using CareStartTM HRP2 
Pf RDT cassettes and WhatmanTM 3MM filter paper at drug shops 
participating in the on-going AXEX study in cross-sectional study design. 
A total of 203 samples have been collected and analysis is ongoing at 
the Molecular Biology Lab at Makerere University. Proficiency testing on 
the PCR method was done. The method includes extracting Plasmodium 
DNA from blood spot collected on Whatman FTE card and mRDT cassette 
using Chelex method and Qiagen Blood DNA kit following manufacturer’s 
instructions. The quantity and quality of the extracted DNA is assessed 
using a Nano Spectrophotometer and QIAexcel automated capillary 
electrophoresis. Results Results to be presented will include field mRDT 
performance when test is done by drug seller against PCR analysis. 
Sensitivity, specificity, positive and negative predictive values will be 
reported. Agreement between the two tests will also be calculated and 
evaluated using the kappa statistic. In conclusion, this study will provide 
additional empirical information on who to deploy mRDT alongside NAATs 
in screening and surveillance of malaria during country elimination efforts.
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HEALTH WORKER AND POLICY MAKER PERSPECTIVES ON 
USE OF INTRAMUSCULAR ARTESUNATE FOR TREATMENT OF 
SEVERE MALARIA AT HEALTH POSTS IN ETHIOPIA
Takele K. Desie1, Zelalem Kebede1, Dawit Getachew1, Tessema 
Awano2, Agonafer Tekalegne1, Esey Batisso2, Wasihun Edossa3, 
Emebet Mekonnen4, James Tibenderana5, Ebenezer Sheshi Baba6, 
Constance Shumba6, Joaniter Nankabirwa6, Prudence Hamade5
1Malaria Consortium, Addis Ababa, Ethiopia, 2Malaria Consortium, 
Hawassa, Ethiopia, 3ORHB, Addis Ababa, Ethiopia, 4SNNP RHB, Hawassa, 
Ethiopia, 5Malaria Consortium, London, United Kingdom, 6Malaria 
Consortium, Kampala, Uganda
World Health Organization (WHO) recommends intravenous (IV) and 
intramuscular (IM) artesunate (AS) for management of severe malaria. 
The current national malaria treatment guidelines do not provide for use 
of IM AS at health posts (manned by health extension workers (HEWs)). 
Although WHO recommends use of pre-referral intrarectal artesunate, 
there are no WHO prequalified suppliers of intrarectal artesunate, and 
its use is limited to children under 6 years of age. We assessed the 
perspectives of health workers, and policy makers on the use of IM AS as 
a pre-referral and definitive treatment for severe malaria at health post 
level in Ethiopia. A qualitative exploratory study that employed in-depth 
interviews with 101 health workers from 60 health facilities, the Federal 
Ministry of Health, and development partners. All respondents were either 
health workers involved in the treatment of malaria, or in formulation 
of malaria policy. An interview guide was used. Data transcripts were 
translated into English, uploaded into Atlas.ti7 software, and coded. 
Thematic content analysis was employed. Key findings from this study are: 
(1) Provision of IM AS as pre-referral and definitive treatment for severe 
malaria at health posts could be lifesaving; (2) With adequate training, and 
provision of facilities including beds, health posts can provide definitive 
treatment for severe malaria using IM AS where referral is delayed or not 
possible; (3) Health workers at health centers and hospitals frequently use 
the IV route because it allows for co-administration of other drugs, but 
they find the IM route easier and propose it for HEWs; (4) The reasons 
commonly cited against the management of severe malaria using IM AS 
at community level were: Lack of capacity to manage complications and 
fear of irrational drug use; (5) use of IM AS at health post level will require 
evidence on safety and feasibility before policy shift. IM AS could be used 
at health posts to provide life-saving pre-referral, or definitive treatment 
when referral is delayed or not possible. Evidence on safety and feasibility 
of its use by HEWs is needed before policy change.
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EVOLUTION AND SPREAD OF “STEALTH” PFHRP2 DELETIONS 
IN PLASMODIUM FALCIPARUM IN THE DEMOCRATIC 
REPUBLIC OF THE CONGO
Jonathan B. Parr1, Robert Verity2, Stephanie Doctor1, Kelly 
Carey-Ewend1, Breanna Turman1, Mark Janko1, Corinna Keeler1, 
Amy Whitesell1, Kashamuka Mwandagalirwa1, Azra Ghani2, Joris 
Likwela3, Antoinette Tshefu4, Michael Emch1, Jonathan Juliano1, 
Steven Meshnick1
1University of North Carolina, Chapel Hill, NC, United States, 2Imperial 
College London, London, United Kingdom, 3Programme National de la 
Lutte contre le Paludisme, Kinshasa, Democratic Republic of the Congo, 
4University of Kinshasa School of Public Health, Kinshasa, Democratic 
Republic of the Congo
Deletions of the Plasmodium falciparum hrp2 (pfhrp2) gene cause false-
negative rapid diagnostic test (RDT) results and have been sporadically 
reported but never investigated systematically on a national population 
level. RDTs are a cornerstone of modern malaria control efforts; 
understanding the evolution of pfhrp2 deletions is essential for ensuring 
their continued effectiveness. Using a nationally representative cross-
sectional study of 7,137 children in the Democratic Republic of Congo, we 
investigated whether P. falciparum parasites with false-negative RDT results 
harbored deletions of pfhrp2. We employed polymerase chain reaction 
assays to identify pfhrp2-deleted parasites among those with false-
negative RDTs and to examine microsatellite regions flanking the pfhrp2 
gene for population genetic analyses. We found that 4.3% (n = 117) 
of all P. falciparum infections country-wide were due to pfhrp2-deleted 
mutants, representing 14.9% of 783 parasites with false-negative RDT 
results. Bayesian spatial analyses identified two geographical clusters with 
significantly higher proportions of parasites harboring pfhrp2 deletions. 
Population genetic analysis of these clusters revealed significant genetic 
differentiation between wild-type and pfhrp2-deleted parasite populations 
(GST = 0.021, p ≤ 0.00001). In conclusion, Pfhrp2-deleted P. falciparum 
is a common cause of false-negative RDTs in the DRC. Use of RDTs as 
indicators for treatment may be exerting evolutionary pressure favoring the 
spread of “stealth” parasites, resistant to detection by currently used RDTs. 
To our knowledge, this is the first report of an outbreak of a pathogen 
that has mutated to elude detection by a diagnostic test.
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INTRODUCTION OF COMPETENCY BASED SELECTION 
CRITERIA FOR WHO EXTERNAL COMPETENCY ASSESSMENT 
FOR MALARIA MICROSCOPY
Nicole Whitehurst, Matt Worges, Emanuel Yamo, Luis 
Benavente, Sean Fennell
MCDI, Silver Spring, MD, United States
In 2015 MalariaCare introduced a new selection criterion to the WHO 
External Competency Assessment for Malaria Microscopists (ECAMM) to 
determine the best-qualified candidates among those who met course 
entry requirements. We describe a competency-based modification to 
existing ECAMM course entry requirements that can be used to identify 
the best-qualified candidates for participation in WHO ECAMM courses. 
Pools of candidates were screened using existing WHO ECAMM course 
entry requirements. A second selection criterion was added based on 
satisfactory performance from a five-day pre-ECAMM refresher training 
course. Of the 119 participants included in the final WHO ECAMM data 
set, 103 (86.6%) were assessed prior to 2015 and did not participate in a 
pre-ECAMM course; however, 16 (13.4%) microscopists assessed in 2015 
participated in a pre-ECAMM course and were selected for advancement 
to WHO ECAMM courses based on attainment of prescribed competency 
levels. Post-test pass rates for WHO ECAMM course components among 
microscopists not participating in pre-ECAMM courses were 82.5% for 
parasite detection (mean score = 89.8%), 26.2% for species identification 
(mean score = 62.5%), and 43.7% for parasite quantitation (mean score = 
34.8%). Among participants who were subjected to the revised selection 
criteria, post-test pass rates for all 3 WHO ECAMM course components 
were 100.0%. Mean post-test scores within this participant pool were 
97.6% (parasite detection), 90.2% (species ID), and 60.8% (parasite 
quant).Participants attending WHO ECAMM courses before 2015 were 
3.7 times less likely to attain WHO certification, whereas all participants 
from the 2015 participant pool attained WHO certification based on their 
accreditation levels. WHO ECAMM course outcome (certification vs. non-
certification) was not independent of participant selection criteria type, c2 
(1, N=119) = 35.87, p<0.0001. To identify the best qualified participants, 
our results suggest that course administrators may consider a second 
competency-based selection criterion based on satisfactory completion of 
a five-day pre-ECAMM refresher-training course.
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METHODS FOR IMPROVED NUCLEIC ACID-BASED 
DETECTION OF INTRAERYTHROCYTIC PLASMODIUM AND 
BABESIA PARASITES
Bryan Grabias1, Jean Clement1, Edward Essuman1, Isabella 
Quakyi2, Peter Krause3, Sanjai Kumar1
1FDA, Silver Spring, MD, United States, 2School of Public Health University 
of Ghana, Legon, Ghana, 3Yale School of Public Health and Yale School of 
Medicine, New Haven, CT, United States
We have developed a novel nanoparticle-based sandwich hybridization 
assay (SHA) for the detection of Plasmodium falciparum (Pf) and Babesia 
microti (Bm) parasites without the need for amplification of target 
sequences in genomic DNA. A uniquely identifiable “barcoded” magnetic 
microbead and biotinylated silica nanoparticle are conjugated to either 
Pf or Bm specific 30-mer oligonucleotides corresponding to sequences 
of the 18S ribosomal gene. Parasite burden can then be quantified and 
analyzed upon the binding of an Avidin-PE fluorophore to the target 
capture complexes via a Bio-Plex 200 instrument. Probit analysis of 1 
mL of parasite-spiked human blood revealed 95% detection thresholds 
of 62 and 122 p/mL for the Pf and Bm 18S bead sets, respectively. To 
further enhance assay sensitivity, we evaluated additional probe sets 
specific to novel high abundant targets for each pathogen (Pf EMP1 
and Bm BMN) which dramatically improved detection of both parasites 
4-30 fold. Utilizing these high copy probe sets against clinical blood 
samples has demonstrated 90-100% sensitivity. We also report on 
the development of PCR-based nucleic acid tests utilizing these same 
biomarkers for Pf and Bm parasites, detecting as few as 1 parasite/mL with 
a broad dynamic linear range allowing quantitation of parasite densities 
above 100 p/mL. Extensive data obtained during assay validation will be 
presented to highlight protocol-specific variables such as blood volume, 
reaction volume, and test sample volume that affect the sensitivity of 
both methods. For example, the performance of 18S target probes are 
dramatically improved when genomic DNA extracts are prepared from 
larger volumes of blood. Cumulatively, these data establish both the 
sandwich hybridization and PCR assays as sensitive pathogen detection 
platforms for diagnosis of chronically infected blood donors and provide 
useful insights on the development of general blood-based detection 
methods.
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COSTS AND AFFORDABILITY OF LAMP FOR MOLECULAR 
DIAGNOSIS OF MALARIA IN RESOURCE LIMITED, ENDEMIC 
SETTINGS
Hojoon Sohn1, Lekha Puri2, Eunice S. Santos3, Jennifer S. 
Luchavez3, Ivan Condori-Millan4, Ivan Condori-Lizarraga4, Angel 
Rosas-Aguirre5, Dionicia Gamboa6, Xavier Ding7, Iveth J. González7
1Research Institute of the McGill University Health Centre, Montreal, 
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Canada, 3Research Institute for Tropical Medicine - Department of Health, 
Muntinlupa City, Philippines, 4Facultad de Salud Pública y Administración, 
Universidad Peruana Cayetano Heredia, Lima, Peru, 5Instituto de Medicina 
Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, 
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de Ciencias y Filosofia, Universidad Peruana Cayetano Heredia, Lima, Peru, 
7FIND, Geneva, Switzerland
Loopamp Malaria Pan/Pf Detection Kit (Eiken Chemical), based on the 
loop-mediated isothermal amplification of DNA (LAMP), is a simplified 
molecular method that offers PCR-equivalent diagnostic accuracy for the 
detection of low-density malaria parasitaemia and its speciation. Given 
its applicability in resource restricted field settings of malaria endemic 
areas, LAMP has considerable potential in shaping post-2015 strategies 
for global malaria control and elimination. We evaluated economic 
cost and affordability (in 2015 US$) of implementing LAMP as part of 
routine malaria control programs in two countries (Peru and Philippines) 
and compared it with that of smear microscopy and conventional PCR 
techniques. Per test costs were assessed based on a time and motion 
study that examined both direct and indirect resource inputs at various 
workload levels. Costs of LAMP implementation were calculated based 
on the laboratory workload and network data available in Peru. Per test 
cost of LAMP Pan or Pf followed an inverse exponential pattern against 
the workload levels with the cost stabilizing when at least 8 samples were 
processed per batch ($11-14). At highest workload levels (60 smears/88 
PCR samples per batch), smear and PCR were $1.5 and $13 per test, but 
could cost as high as $7.5 (1 sample/batch) and $70 (4 PCR samples/
batch). Implementing LAMP at 179 eligible laboratories (at least 1 to 5 
samples per day) in Iquitos region in Peru, required $4.7 million per year 
for the first three years of implementation. Restricting implementation 
to 36 high workload laboratories (at least 12 samples per day), costs can 
be reduced to $2.1 million (contingency fund for malaria control in Peru 
for 2015 was $2.3 million). Though cost of LAMP can be competitive 
(vs. PCR), it will require considerable financial resources to achieve 
adequate coverage to meaningfully reduce time delays in malaria care. 
Likewise, cost-effectiveness or budget impact analysis evaluating various 
implementation strategies and their effects must be assessed to better 
guide policy decisions on future utility of LAMP for malaria control in high 
endemic, resource limited settings.
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FACTORS INFLUENCING THE USE OF MRDTS AMONG 
PRIVATE HEALTH PROVIDERS AND CONSUMERS AT THE 
KENYAN COAST
Nancy Njoki1, Anne Musuva1, Stephen Poyer2
1Population Services Kenya, Nairobi, Kenya, 2Population Services 
International, Nairobi, Kenya
In 2010, the Government of Kenya adopted the WHO test, treat and 
track policy which saw the introduction of malaria RDT testing in the 
public sector but limited support for the private sector. Fever seeking 
statistics indicate that 27% of people seek treatment in the private sector 
where availability of RDTs remains low at less than 20%. PS Kenya is 
implementing a fever case management project seeking to create a private 
sector market for increased access to and use of quality assured mRDTs. 
A qualitative study using In-Depth Interviews was conducted targeting 
private providers and patients in Kilifi, Mombasa and Kwale Counties. 
The study reached a total of 40 respondents i.e. 24 outlet personnel and 
16 adult patients. Providers were trained and had 2 to 23 years’ work 
experience. Patient interviews were conducted in private locations near 
but not affiliated with the health facilities. Interviews had no personal 
identifiers and were digitally recorded after obtaining interviewees’ 
consent. All transcripts were analyzed and coded. Results showed that 
most providers reported using RDTs after training. They reported increased 
number of clients, ability to conduct out-of-office testing, reduction 
in workload /operation cost and patient preference and satisfaction. 
Concerns and challenges were 1) the lancets used were blunt and painful 
when pricking 2) inadequate buffer solution to conduct the test and 3) 
invalid results. Adoption of mRDTs depended on 1) trusted sources of the 
RDTs and type of brand 2) Purchase price for RDTs and costs to end-users. 
Overall, patients reported improved quality of care due to diagnosis before 
treatment and they liked seeing and interpreting results. In conclusion,Key 
factors that influence the use of the mRDT kit include ease of use of the 
kit, reliability of the test, reduction in provider work load and patient 
preference. Barriers include blunt lancets and inadequate amount of 
buffer- mRDT supply reliability, provider training and cost of mRDT to 
end user must also be addressed to ensure expansion of mRDT use in the 
private sector in emerging markets.
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EARLY POST-TREATMENT LEVEL OF HRP2 PREDICTS 
RECRUDESCENCE IN PLASMODIUM FALCIPARUM INFECTION
Mateusz Plucinski1, Rafael Dimbu2, Filomeno Fortes2, Eric S. 
Halsey1, John W. Barnwell3, Eric Rogier3
1U.S. President’s Malaria Initiative, Division of Parasitic Diseases and 
Malaria, Centers for Disease Control and Prevention, Atlanta, GA, United 
States, 2National Malaria Control Program, Luanda, Angola, 3Malaria 
Branch, Division of Parasitic Diseases and Malaria, Centers for Disease 
Control and Prevention, Atlanta, GA, United States
Recrudescent infections following incomplete clearance of parasites are 
routinely reported for all classes of antimalarials. Traditionally, monitoring 
of response to antimalarial treatment has relied on serial blood microscopy. 
However, due to the limit of detection of microscopy, treatment 
failures are typically detected late, when the recrudescing infection has 
already reached a parasitemia high enough to cause symptoms. Stored 
longitudinal samples from 301 children enrolled in two therapeutic efficacy 
studies from 2013 and 2015 in Angola were analyzed, representing 243 
participants with adequate clinical and parasitological response (ACPR), 39 
with reinfection, and 19 with recrudescence. An ultra-sensitive bead-based 
Luminex immunoassay platform was used to quantify the concentration of 
the P. falciparum HRP2 protein in samples from follow up, ranging from 28 
to 42 days. The HRP2 concentration on each day was normalized by the 
participant’s HRP2 concentration on day 0, the first day of treatment. The 
concentration of HRP2 in participants with ACPR decayed exponentially 
after day 0, with a consistent decay rate of 6.5% (95% CI: 6.3-6.7) per 
day over the course of follow-up. Participants that ultimately suffered 
reinfections cleared HRP2 at an indistinguishable rate of 7.1% (6.4-7.8) 
per day prior to reinfection. In contrast, HRP2 concentration in participants 
that ultimately recrudesced behaved differently, increasing on average 
by 25% from day 0 to day 3, and was higher than in participants with 
ACPR or reinfections at all time points. The HRP2 concentration at day 
3 was predictive of treatment outcome, with an area under the receiver 
operating characteristic curve of 0.86 (0.73-0.99). The remarkably 
consistent HRP2 decay rate in participants with ACPR and reinfections 
implies a common underlying biological clearance mechanism in the 
human body. Individuals that will ultimately fail treatment do not exhibit 
this same pattern of clearance, even in the absence of other indications of 
inadequate response to treatment. This raises the potential of using HRP2 
concentration, particularly at day 3, to predict response to treatment.
277
RELIABILITY OF RAPID DIAGNOSTIC TESTS TO ASSESS 
MALARIA TRENDS IN MADAGASCAR THROUGH A SENTINEL 
FEVER SURVEILLANCE NETWORK
Laurence Randrianasolo1, Elisabeth Ravaoarisoa1, Charles 
Ramarokoto1, Léa Randriamampionona2, Clémence 
Rakotoarivony2, Judith Hedje3, Patrice Piola1, Milijaona 
Randrianarivelojosia1
1Institut Pasteur de Madagascar, Antananarivo, Madagascar, 2Ministry of 
Health Madagascar, Antananarivo, Madagascar, 3U.S. President’s Malaria 
Initiative, Antananarivo, Madagascar
A sentinel fever surveillance network has been operational since 2007 
in Madagascar. In all 34 sentinel sites, all febrile patients are tested with 
malaria rapid diagnostic tests (RDTs) for pan-LDH and pfHRP2, and data are 
monitored for diagnostically-confirmed malaria trends. Quality assurance 
of on-site RDT results are managed by the Institut Pasteur de Madagascar 
(IPM). Special attention is given to storage conditions and compliance 
with the manufacturer’s instructions for RDTs. Results of RDTs stored at 
facilities are compared with results from the same RDT batch stored in 
ambient temperature <25°C and humidity <80% at IPM and also with 
microscopy. From January 2013 to December 2015, 33/34 sentinel fever 
surveillance sites were visited regularly throughout the country. There were 
no RDTs storage errors and no expired RDTs in stock at any sentinel sites. 
Most technicians (61/75, 81.3%) properly used RDTs in accordance with 
the manufacturer’s instructions. The results of 1,638 febrile patients were 
used for quality assurance (3 invalid tests). Results of on-site RDTs and 
those stored at IPM were 99.8% concordant. Comparison with microscopy 
resulted in sensitivity of 92.5%, specificity of 97.1%, positive predictive 
value of 86.0%, and negative predictive value of 98.5% (n=1,635). 
These results indicate the reliability of malaria RDTs results from the fever 
sentinel sites. Thus, data collected at fever sentinel sites can be used by 
the National Malaria Control Program to better understand temporal and 
spatial trends in malaria transmission across Madagascar.
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COMPARISON BETWEEN A NOVEL COMMERCIAL ASSAY 
BASED ON LOOP MEDIATED ISOTHERMAL AMPLIFICATION 
(LAMP) AND PCR-NESTED ASSAY FOR MOLECULAR 
DIAGNOSIS OF PLASMODIUM PARASITES
Michela Menegon1, Mariangela L’Episcopia1, Daniela Boccolini1, 
Maria Grazia Paglia2, Luigi Gradoni1, Carlo Severini1
1Istituto Superiore di Sanità, Rome, Italy, 2Lazzaro Spallanzani National 
Institute for Infectious Diseases, Rome, Italy
Currently, approximately 2 billion people still live in areas at risk for 
malaria, with disease morbidity surpassing 200 million cases and about 
500,000 deaths per year. Standard methods for malaria diagnosis 
include microscopic examination of blood films and rapid diagnostic tests 
(RDTs). Conventional and real-time PCR techniques are more reliable 
than either microscopy and RDTs in identifying Plasmodium species 
accurately, however, these molecular methods are technically challenging 
and resource intensive making them generally restricted to reference 
laboratories. Recently, Illumigene®, a panel of simplified assays based on 
LAMP technology (Loop Mediated Isothermal Amplification), has been 
developed for the diagnosis of major public health impact infections. In 
2016, two assays have been set up also for malaria diagnosis (Illumigene® 
Malaria and Illumigene® Malaria PLUS, Meridian Bioscience Inc, Cincinnati, 
OH, USA), in collaboration with the US CDC and the University Cheikh 
Anta Diop (Dakar, Senegal). These assays are commercially available as 
CE IVD. In clinical studies, they have proven to be extremely sensitive, 
detecting up to ½ parasite genome per sample. The objective of this study 
was to evaluate both “Malaria” and “Malaria PLUS” assays for malaria 
diagnosis in 50 patients from retrospective Italian imported malaria cases, 
infected with Plasmodium falciparum, P. vivax, P. malariae and the two 
subspecies P.ovale wallikeri and P. ovale curtisi. These new Illumigene® 
LAMP-based assays were able to detect all Plasmodium species (including 
P. ovale subspecies) at genus level, and no discrepancies were found 
between these assays and our in-house nested-PCR. Product from the 
assay sample preparation could be also used for Plasmodium speciation by 
conventional PCR approach. The hands on for these new assays showed to 
be extremely simple, rapid (results in less than one hour) and thus suitable 
for all microbiology and hematology laboratories. All these characteristics 
open up new opportunities for exploiting new molecular tools for malaria 
diagnosis in endemic and non-endemic countries.
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COVERAGE AND IMPACT OF THE WHO-FIND MALARIA 
RAPID DIAGNOSTIC TESTS (RDT) EVALUATION PROGRAM: 
SHAPING THE GLOBAL MALARIA RDT MARKET
Sandra Incardona1, Elisa Serra Casas2, Nora Champouillon1, 
Christian Nsanzabana1, Jane A. Cunningham3, Iveth J. Gonzalez1
1FIND, Geneva, Switzerland, 2Independent consultant, FIND, Geneva, 
Switzerland, 3WHO GMP, Geneva, Switzerland
Rapid diagnostic tests for malaria (RDTs) play a critical role in malaria 
case management, with quality being a key factor for good adherence 
to test results. The WHO-FIND Malaria RDT Evaluation Programme now 
functions since 2007, comprising a pre-purchase performance evaluation 
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(Product Testing, PT) and a pre-distribution quality control of lots (Lot 
Testing, LT). A small-scale survey in 2011 showed that the market-share of 
good performing RDTs has increased since then, however large-scale and 
recent data were not available. More generally, the current knowledge 
on the global malaria RDT market is still limited and mostly based on 
general trends, with little information about procurement practices. In 
order to better document the global RDT market, and to evaluate the 
current impact of the PT- and LT Programmes, a large-scale survey has 
been conducted, gathering RDT sales and procurement data from 2011 
to 2014 from a total of 32 manufacturers, 12 procurers and 68 national 
malaria control programmes (NMCPs). The RDT sales results highlight 
a concentration of the market around 3 manufacturers (86% of 2014 
sales), and a confirmed market shift towards RDTs complying with WHO 
procurement criteria (from 83% in 2011 to 93% in 2014). Procurement 
data showed that 74% of the NMCPs procure only ‘complying’ RDT 
products, however there is a frequent overlap of different products and 
even product types (e.g. Pf-only and Pf-pan) in the same year and country 
(60% and 46% of countries, respectively). Importantly, the proportion 
of ‘non-complying’ or ‘not-evaluated’ products was found to be higher 
in the private health care sector than in the public sector (32% vs. 5%), 
and even increasing over time (from 22% in 2011 to 39% in 2014). An 
estimated 70% of the RDTs market is covered by the LT programme. The 
opinion about the PT- and LT Programmes has been positive overall, and 
the quality of RDTs was rated as one of the most important procurement 
criteria. In summary, this survey provides in-depth information on RDT sales 
and procurement dynamics, including the largely unknown private sector, 
and demonstrates how the WHO-FIND Programme contributes to shaping 
the RDT market.
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ANTIPLASMODIAL ACTIVITIES OF CHLOROQUINE AND 
ARTEMISININ IN COMBINATION WITH VERBASCOSIDE, A 
PHENYLETHANOID GLYCOSIDE FROM STACHYTARPHETA 
CAYENNENSIS
Ifeoma C. Ezenyi1, Peter A. Akah2, Charles O. Okoli2
1Department of Pharmacology and Toxicology, National Institute for 
Pharmaceutical Research and Development, Abuja, Nigeria, 2Department 
of Pharmacology and Toxicology, University of Nigeria, Enugu, Nigeria
Verbascoside (VB), a phenylethanoid glycoside has been shown to possess 
strong antioxidant and immune-stimulant effects. The present study 
was designed to evaluate the antiplasmodial effect of VB purified from 
Stachytarpheta cayennensis leaves and its combination with artemether 
(Art) and chloroquine (CQ) in established Plasmodium berghei berghei 
infection in mice. VB was obtained by successive column separation of 
a methanol extract of S. cayennensis leaves; identity and purity of the 
compound were established by nuclear magnetic resonance spectroscopy 
(proton, carbon), high performance liquid chromatography and differential 
scanning calorimetric thermal analysis. In antiplasmodial tests, mice were 
inoculated on day 0 with chloroquine - sensitive P. berghei berghei NK65 
infected blood. On day 3, mice were grouped (n=5) and respective groups 
treated for five days with VB, combinations of VB and CQ, combinations 
of VB and Art, CQ alone, or Art alone; at a dose range of 1-25 mg/kg 
of body weight. During treatment, thin films of tail vein blood of the 
mice were prepared daily and assessed for parasitaemia. After treatment, 
survival time was also monitored for all the experimental groups. The 
results showed that VB alone possessed significant (P<0.001) intrinsic 
antiplasmodial activity and exhibited synergism in combination with CQ, 
as increasing doses of VB significantly (P<0.05, 0.01, 0.001) boosted 
parasite clearance and prolonged survival time compared to CQ alone. 
Co-administered VB and Art produced significant (P<0.001), rapid 
and sustained parasite clearance within the first 4 days of treatment 
compared to Art alone, but survival time was highest in the group that 
received Art alone and was reduced with increasing doses of VB given in 
combination with Art. VB also produced a rapid onset action as observed 
in its ability to elicit rapid parasite clearance when administered alone 
or with the low doses of CQ or Art administered as monotherapy. Thus 
verbascoside warrants further investigation as possible combination agent 
in antimalarial regimens for uncomplicated malaria.
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FLAVONE DERIVATIVES: A PROMISING NEW CLASS OF 
DRUGS ACTIVE AGAINST MULTI-RESISTANT FALCIPARUM 
MALARIA PARASITES
Flore Nardella1, Silvia Stiebing2, Valérie Collot2, Patrick Wagner1, 
Marcel Kaiser3, Benoit Witkowski4, Didier Menard4, Martine 
Schmitt1, Ermanno Candolfi5, Catherine Vonthron-Sénécheau1
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en Normandie, Université de Caen Basse-Normandie, Caen, France, 
3Swiss Tropical and Public Health Institute, Basel, Switzerland, 4Unité 
d’Epidémiologie Moléculaire du Paludisme, Institut Pasteur du Cambodge, 
Phnom Penh, Cambodia, 5Institut de Parasitologie et de Pathologie 
Tropicale de Strasbourg, University of Strasbourg, Strasbourg, France
 Plasmodium falciparum malaria is the deadliest parasitic disease with 
438.000 deaths in 2013. The emergence and the increasing proportion 
of P. falciparum parasites resistant to artemisinin derivatives, the most 
potent antimalarials, is a major concern in Southeast Asia. Fast acting 
drugs, with unaltered activity versus the current multi-drug resistant 
strains are urgently needed to replace artemisinins. Previously, traditional 
remedies such as Cinchona bark or Artemisia aerial parts led to the 
discovery of the most potent antimalarials, bearing out that Nature is still 
an incredible source of original compounds. Following this approach, we 
are developing new synthetic antimalarial agents based on the structure of 
an active natural product. We isolated a biflavonoid from Campnosperma 
panamense (IC50 = 480 nM in vitro on P. falciparum K1 multi-resistant 
strain), and developed novel simplified synthetic analogs (MR series) with 
improved pharmacological and pharmacokinetic profiles. One of these 
compounds, MR70, is strongly effective on P. falciparum early blood 
stage in less than 6 hours. Moreover, MR70 and its analog MR87, exhibit 
a partial in vivo antimalarial activity, reducing parasitemia by 35% and 
70% respectively on day 4 in a murine model (P. berghei ANKA, 100 mg/
kg for 4 days). The investigations of structure-activity relationship are 
still ongoing to further improve these results. As MR70 acts specifically 
on early ring stage, which has been associated to artemisinin resistance, 
we have assessed the in vitro susceptibility of Cambodian artemisinin-
resistant isolates to MR70 and found no cross-resistance between MR70 
and artemisinins. These findings make flavone derivatives a promising 
new class of antimalarials. Further investigation is needed to optimize 
MR70 activity and assess its efficacy against strains resistant to partner 
drugs, usually combined with artemisinin derivatives, like piperaquine, 
mefloquine, lumefantrine and amodiaquine.
282
DISCOVERY OF NEW HERB EXTRACTS TO TREAT MALARIA
Hye Soo Yun, Ui-Han Son, Yeonchul Hong, Dong-Il Chung, 
Youn-Kyoung Goo
Department of Parasitology and Tropical Medicine, Daegu, Republic of 
Korea
Malaria caused by Plasmodium spp. is found worldwide in tropical and 
subtropical areas. It is estimated that about 3.2 billion people - almost 
half of the world’s population - are at risk of malaria. Especially, P. 
falciparum can cause severe malaria because it multiples rapidly in the 
blood, and can thus cause severe blood loss (anemia), cerebral malaria, 
and death. Currently, there are several drugs, chloroquine, atovaquone-
proguanil, artemether-lumefantrine, mefloquine, etc. to treat malaria. 
However, an appearance of drug resistance malaria parasite is getting 
the greatest challenges facing malaria control today. To overcome this 
matter, a development of novel malaria drug is necessitated. Therefore, 
we evaluated antimalarial effect of 10 herb extracts used to treat febrile 
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patients in South Korea. Among the herb extracts, 50 µg/ml of two 
extracts obtained from mushrooms inhibited P. falciparum growth in 
vitro culture. In addition, lipoxygenase fraction of the extracts especially 
inhibited P. falciparum growth in vitro culture. Moreover, the lipoxygenase 
from the extracts inhibited chloroquine-resistant and atovaquone-resistant 
P. falciparum. Further study about the target molecule of the lipoxygenase 
fraction will be needed.
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MODULATION OF THE ANG/TIE2 AXIS REDUCES 
PATHOLOGICAL VASCULAR LEAK AND ACUTE LUNG INJURY 
IN A MURINE MODEL OF SEVERE MALARIA (SM)
Kevin R. Barker1, Sarah J. Higgins1, Andrea L. Conroy1, Ziyue Lu2, 
Kevin G. Peters3, Kevin C. Kain1
1University Health Network/The University of Toronto, Toronto, ON, 
Canada, 2University Health Network, Toronto, ON, Canada, 3Aerpio 
Therapeutics, Cincinnati, OH, United States
Malaria -induced acute lung injury (MA-ALI) carries a high fatality rate 
despite the use of potent antimalarial therapies and optimal supportive 
care. Therapies targeting the underlying pathophysiology of MA-ALI may 
be required to further improve clinical outcome. The angiopoietin-tyrosine 
kinase 2 (Ang-Tie2) signalling pathway is a key regulator of vascular 
integrity and recent evidence implicates Ang-Tie2 axis disruption in ALI 
development in ICU settings. We hypothesise that the Tie2 receptor 
ligand Ang-1, Tie2 and its activation are required to prevent MA-ALI, and 
that pharmacological approaches using pro-Ang-1, and Tie2 activation 
strategies will reduce or prevent MA-ALI. Respiratory distress (RD) occurs 
in ¬16% of SM and results in 39% of deaths , and is associated with 
Ang-Tie2 axis dysregulation in children and susceptibility in mice . Genetic 
models of Tie2+/- and Ang-1-/- mice will be infected with PbA-infected 
erythrocytes. We will determine MA-ALI markers of vascular leak (i.e. 
Evans Blue assay, IgM), histology and physiological dysfunction (i.e. O2 
saturation) in the lungs and endothelial activation markers in lung tissue/
plasma. We will administer pro-Ang-1, Tie2 treatment strategies alone or 
in combination at parasitaemia onset and compare MA-ALI markers with 
littermate controls. Pilot studies indicate that genetic disruption of Ang-1 
results in decreased survival (p=0.0091), and increased pulmonary vascular 
leak as determined by Evans Blue dye assay (p<0.05) and pulmonary fluid 
accumulation (p<0.05). Tie2 activation using AKB9785, a phosphatase 
inhibitor that selectively inhibits VE-PTP, reduces IgM accumulation in the 
lung and vascular leak (p<0.05). We will report mechanistic studies of 
ALI in our genetic models and intervention studies using both pro-Ang-1 
and other Tie2 activating strategies. Pilot results indicate that Ang-1 is 
necessary for the prevention of MA-ALI. Increased Tie2 activation shows 
evidence of reduced pathological leak and improved survival. These 
findings support targeting the Tie2 pathway with pro-Ang-1 and Tie2 
strategies as adjunctive therapy for MA-ALI.
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PHARMACOKINETICS AND PROPHYLACTIC EFFICACY 
OF EMULSION OF DECOQUINATE FOLLOWING SINGLE 
INTRAMUSCULAR INJECTION IN MICE
Hsiuling Lin, Lisa H. Xie, Caridha Diana, Zeng Qiang, Jing Zhang, 
Ping Zhang, Chau Vuong, Brittney Potter, Jason Sousa, Sean 
Marcsisin, Charles Bane, Qigui Li
Walter Reed Army Institute of Research, Silver Spring, MD, United States
Prophylactic efficacy and pharmacokinetics (PK) were examined following 
single intramuscular (IM) depot formulation of decoquinate (DQ) emulsion 
injected into mice infected with P. berghei sporozoites. DQ nano-emulsion 
in 50% oily vehicle to retard drug release is suitable for long-term malaria 
prophylaxis. PK studies in normal animals and antimalarial efficacy in liver-
stage malaria mice were conducted at various IM-DQ emulsion doses for 2, 
3, or 4 weeks prior to infection with Plasmodium berghei sporozoites. The 
liver stage efficacy evaluation was monitored by using an in vivo imaging 
system (IVIS). Full causal prophylaxis was shown in mice with a single IM 
dose of large particle of nano-emulsion DQ (0.44 µm) at 120 mg/kg for 
4 weeks and with small particle (0.18 µm) at 120 mg/kg lasted 2 weeks 
prior to inoculation. The 120 mg/kg IM emulsion dose was shown to be 
the minimal prophylactic dose required to provide full causal prophylaxis 
of malaria sufficient for a period of 2-4 weeks. A significant increase in 
the elimination half-life of the large particle DQ emulsion (632.15 hrs.) 
was achieved compared to that of the small particle DQ (494.47 hrs.). 
Similarly, the AUC of the large particle DQ nano-emulsion in plasma was 
observed to be 8,795 ng·h/ml, which is double the AUC observed for the 
small particle DQ emulsion (4,288 ng·h/ml) at the same single 120 mg/kg 
dose administered to both animal groups. Body clearance results indicated 
that the CL/F in the animals treated with nanoparticle DQ was 14.46 L/
hr/kg, which is twice as fast as the clearance observed in animals treated 
with the microparticle DQ formulation (27.99 L/hr/kg). PK/PD evaluations 
have demonstrated the minimal inhibitory concentration (MIC) of DQ to 
provide full causal prophylaxis in mice infected with P. berghei sporozoites 
is 5.12 ng/mL. The large particle of DQ emulsion provided a longer and 
more constant DQ release in the plasma, which resulted in a 1.8 fold 
longer drug exposure time above MIC. The prophylactic effect of the large 
particle emulsion observed in mice was shown to be 2 times longer than 
the small particle of DQ nano-emulsion.
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ANTIMALARIAL POTENTIAL OF KOLAVIRON, A BIFLAVONOID 
FRACTION, FROM GARCINIA KOLA SEEDS, AGAINST 
PLASMODIUM BERGHEI INFECTION IN SWISS ALBINO MICE
Oluwatosin Adaramoye
University of Ibadan, Ibadan, Nigeria
To investigate the antimalarial potential of kolaviron (KV), a biflavonoid 
fraction from Garcinia kola seeds, against Plasmodium berghei infection 
in Swiss albino mice. The study consists of seven groups of ten mice 
each. Groups I, II and III were normal mice that received corn oil, KV1 
and chloroquine (CQ), respectively. Groups IV, V, VI and VII were infected 
mice that received corn oil, CQ, KV1 and KV2, respectively. CQ, KV1 
and KV2 were given at 10-, 100- and 200-mg/kg daily, respectively for 
three consecutive days. Results indicate that administration of KV1 and 
KV2 significantly (P<0.05) suppressed P. berghei-infection in the mice by 
85% and 90%, respectively while CQ produced 87% suppression relative 
to untreated infected group after the fifth day of treatment. Also, KV2 
significantly (P<0.05) increased the mean survival time of the infected 
mice by 175%. The biflavonoid prevented a drastic reduction in PCV 
from day 4 of treatment, indicating its efficacy in ameliorating anaemia. 
Significant (P<0.05) oxidative stress assessed by the elevation of serum and 
hepatic malondialdehyde were observed in untreated P. berghei-infected 
mice. Specifically, serum and hepatic malondialdehyde levels increased by 
93% and 78%, respectively in the untreated infected mice. Furthermore, 
antioxidant indices, viz; superoxide dismutase, catalase, glutathione-s-
transferase, gluathione peroxidase and reduced gluathione decreased 
significantly (P<0.05) in the tissues of untreated P. berghei-infected mice. 
KV significantly (P<0.05) ameliorated the P. berghei-induced decrease 
in antioxidant status of the infected mice. Overall, the study shows that 
kolaviron at doses of 100 and 200 mg/kg elicits potent antimalarial activity 
in P. berghei-infected mice.
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EVALUATION OF ANTIMALARIAL ACTIVITY OF 
CYCLOPENTANONE AND CYCLOHEXANONE ANALOGUES OF 
CURCUMIN IN PLASMODIUM BERGHEI INFECTED MICE
Catherine Olufunke Falade1, Anne Adenike Adesanya-Adams1, 
Oyindamola Abiodun1, Olusegun George Ademowo1, Kulkarni 
Amol2, Nekhai Sergei2, Evaristus Awele Nwulia2
1University of Ibadan, Ibadan, Nigeria, 2Translational Neuroscience 
Laboratory, Howard University College of Medicine, Washington, DC, 
United States
Malaria is one of the world’s most common and serious tropical diseases. 
Resistance of Plasmodium to available antimalarial agents has necessitated 
the need to develop new antimalarial drugs which would be efficacious 
against drug resistant strains of malaria parasites. The in vivo antimalarial 
activity of cyclopentanone (CP) and cyclohexanone (CH) analogues of 
curcumin as potential antimalarial agents was evaluated using Plasmodium 
berghei mouse model. Female Swiss albino mice (n=55) were infected with 
standard inoculum (1x107) of chloroquine resistant strain of Plasmodium 
berghei (ANKA) intravenously. Infected animals were randomly distributed 
into eleven groups of five animals each. Once daily dose of chloroquine 
(10 mg/kg), twice daily graded doses (50, 100, 200 and 400 mg/kg) of 
each of the curcumin analogues and artemether/lumefantrine (4 mg/
kg artemether) were administered to the infected animals while the 
control animals (infected but not treated) received polyethylene glycol 
(PEG, 100%), the vehicle for drug delivery twice daily for three days. All 
treatments were orally administered for three days starting from 24 hours 
post infection. Thin blood smears were prepared from tail snips of the 
mice daily between days 4 and 7 and subsequently on days 9, 12, 14 
and 21, and parasite count was estimated by microscopic examination 
of Giemsa-stained thin smears. The result of this study showed that 
there was no significant difference in the antimalarial activity of both 
analogues of curcumin (p>0.05) on day four. However, the cyclopentanone 
analogue of curcumin at a dose of 200mg/kg demonstrated a recordable 
suppressive antimalarial activity (75% suppression). Cyclopentanone and 
cyclohexanone analogues of curcumin appeared to have weak suppressive 
antimalarial activity. Further research into the pharmacological properties 
of these analogues is recommended.
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TARGET-BASED DRUG DISCOVERY IN MALARIA: A NEW WAY 
TO IMPLEMENT AN OLD STRATEGY
Elena Fernández Álvaro1, Anke Harupa2, Alexis Kaushansky2, 
Maria Penzo3, Maria Penzo3, David Baker3, Esperanza Herreros1, 
Lluis Ballell-Pages1
1GlaxoSmithKline, Tres Cantos, Madrid, Spain, 2Center for Infectious 
Disease Research, Seattle, WA, United States, 3London School of Hygiene 
& Tropical Medicine, London, United Kingdom
Compared to phenotypic screening, target-based drug discovery allows for 
a more directed medicinal chemistry optimization and a better prediction 
of the safety risks. Despite these advantages, the target-screening 
strategy has clearly lagged behind phenotypic screening approaches in 
malaria drug discovery. This is probably because of two hurdles: the often 
found disconnect between enzymatic and whole cell activity and the 
lack of robustly validated targets in Plasmodium. Recent advances in our 
capacity to identify validated drug targets in Plasmodium might provide 
a way to increase the success rate of target-based approaches in the 
near future. The Tres Cantos Open Lab Foundation (TCOLF) has recently 
pursued this approach in cases where a high level of genetic and small 
molecule validation has been achieved. Among others, current TCOLF-
funded projects are working on identification of compounds that inhibit 
plasmodial N-myristoyl transferase (NMT) and cGMP dependent protein 
kinase (PKG). Projects are implemented in collaboration with GSK and 
academic experts, aiming to combine the in depth biology knowledge 
with the possibility to find the best starting points for medicinal chemistry 
optimization within GSK diverse small molecule compound libraries. 
We will present progress to date in the quest to identify target-based 
antimalarials.
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PRE-CLINICAL ASSESSMENT OF DRUG-DRUG INTERACTIONS 
BETWEEN PRIMAQUINE AND BLOOD STAGE ANTI-MALARIAL 
AGENTS
Xiannu Jin1, Corttney Potter1, Thu-lan Luong1, Brittney Potter1, 
Gregory Reichard1, Babu Tekwani2, Larry Walker2, Mara Kreishman-
Deitrick1, Mark Hickman1, Robert Paris1, Sean R. Marcsisin1
1Walter Reed Army Institute of Research, Silver Spring, MD, United States, 
2University of Mississippi, Oxford, MS, United States
The liver stage anti-malarial activity of primaquine and other 
8-aminoqinoline molecules are directly dependent upon bio-activation 
through Cytochrome (CYP) 2D6 metabolism. Primaquine metabolism 
through the CYP 2D6 pathway makes the drug prone to CYP 2D6 
mediated drug-drug interactions with concurrent medications that are CYP 
2D6 substrates/inhibitors. Primaquine therapy is typically accompanied 
by administration of blood stage anti-malarial agents that clear the 
blood stages of the parasite and resolve the clinical symptoms of malaria. 
Concurrent primaquine-blood stage anti-malarial therapies have the 
potential to interact through CYP 2D6 and alter pharmacokinetics anti-
malarial activity. We sought to investigate these interactions using an 
in vitro primaquine metabolism assay and recombinant CYP 2D6. In 
this study, commercially available blood stage anti-malarial agents were 
evaluated for the potential to interact with primaquine. The inhibitory 
potential of the blood stage anti-malarials for CYP 2D6-mediated 
primaquine metabolism were assessed in vitro. The blood stage anti-
malarial agents tested displayed a range of inhibitory activities on CYP 
2D6-mediated metabolism of primaquine in vitro (IC50 ranges 2-523 
µM). Quinine was the most potent inhibitor (IC50 ~ 2.98 µM) of CYP 2D6 
mediated primaquine metabolism. Artesunate and the artemisinin class 
were the least potent (IC50s > 200 µM). The in vitro inhibitory data was 
then used to predict in vivo interactions using the AUCin/AUC prediction 
method. The results indicate that primaquine interacts with several blood 
stage anti-malarial agents through CYP 2D6. The clinical implications 
of these interactions are currently unknown and warrant further 
investigation.
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THE COMBINED IMPACT OF TRANSMISSION-BLOCKING 
INTERVENTIONS AND PRE-ERYTHROCYTIC VACCINES FOR 
MALARIA ELIMINATION
Ellie Sherrard-Smith1, Thomas S. Churcher1, Leanna M. Upton1, 
Katarzyna A. Sala1, Sara E. Zakutansky1, Azra C. Ghani1, Andrew 
M. Blagborough1, Michael Betancourt2
1Imperial College London, London, United Kingdom, 2Warwick University, 
Warwick, United Kingdom
Transmission-blocking interventions (TBIs) aim to eliminate malaria by 
interrupting transmission of the parasite between hosts and mosquito 
vectors. Accurate methods to assess TBI efficacy are key to ensure that 
the best candidate TBI drugs or vaccines progress to clinical trials. This 
is particularly vital for novel population assays (PA) where efficacy is 
measured over successive transmission cycles. We present a method for 
estimating TBI efficacy from PA data by fitting a hierarchical Bayesian 
model to multiple life stages of the parasite. This enables both host-to-
vector and vector-to-host transmission to be density-dependent processes 
whilst accounting for stochastic fluctuations driven by superinfection and 
small sample sizes. This improves the precision of intervention efficacy 
estimates and demonstrates that TBI impact is not sufficiently captured by 
changes in prevalence alone because TBIs also suppress parasite density 
in secondarily infected hosts. Partially effective TBIs require multiple 
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generations before substantial reductions in prevalence are observed whilst 
immediately suppressing parasite density. This has valuable implications for 
assessing the performance of TBI candidates in field and clinical trials.
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NOVEL ELQ-300 PRODRUGS FOR ENHANCED DELIVERY AND 
SINGLE-DOSE CURE OF MALARIA
Lisa Frueh1, Sovitj Pou2, Yuexin Li2, Aaron Nilsen1, Isaac Forquer2, 
Jane X. Kelly2, Martin Smilkstein1, Rolf Winter2, Rozalia Dodean2, 
Michael W. Mather3, Akhil B. Vaidya3, Suresh Potharaju4, Gita 
Shankar4, Michael Riscoe1
1Oregon Health & Science University, Portland, OR, United States, 
2Portland Veterans Affairs Medical Center, Portland, OR, United States, 
3Drexel University School of Medicine, Philadelphia, PA, United States, 4SRI 
International, Menlo Park, CA, United States
In the effort toward global malaria eradication, the discovery of a 
single-dose cure would facilitate ease of drug distribution and limit 
propagation of drug resistance, two issues that burden the current state 
of malaria treatment. One class of Plasmodium cytochrome bc1-inhibitory 
compounds, the endochin-like-quinolones (ELQs), are extremely effective 
against the parasite and have been shown to deliver single dose cures. 
Specifically, ELQ-300 is a pre-clinical drug candidate that is effective 
against all life cycle stages of P. falciparum and against blood stage 
parasites at low nanomolar concentrations. ELQ-300 is curative with three 
sequential low doses in treatment of patent malaria infection in murine 
models, but its low aqueous solubility and high degree of crystallinity 
prevent the higher bloodstream concentrations necessary to achieve a 
single dose cure. To accelerate the clinical development of ELQ-300 we 
have employed a prodrug approach, attaching a variety of bioreversible 
groups to ELQ-300 to increase bloodstream drug exposure. We have 
synthesized over 30 prodrugs of ELQ-300, many with a significantly lower 
degree of crystallinity than ELQ-300, aiding in solubility while retaining 
antiplasmodial activity. We will present a number of the most effective 
prodrugs that show excellent antiplasmodial activity in vitro and are 
curative with a single low dose in vivo. In addition to full antiplasmodial 
and pharmacokinetic profiles, we will present optimal formulations 
of spray-dried dispersions that improve aqueous solubility and oral 
bioavailability of these highly effective prodrugs.
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 PLASMODIUM FALCIPARUM CYCLIC AMINE RESISTANCE 
LOCUS, PFCARL: A RESISTANCE MECHANISM FOR TWO 
DISTINCT COMPOUND CLASSES
Pamela A. Magistrado1, Victoria C. Corey2, Amanda K. Lukens1, 
Greg LaMonte2, Erika Sasaki2, Melanie Wree2, Elizabeth Winzeler2, 
Dyann F. Wirth1
1Harvard T.H. Chan School of Public Health, Boston, MA, United States, 
2School of Medicine, University of California San Diego, San Diego, CA, 
United States
The emergence and spread of drug resistance to current antimalarial 
therapies remains a pressing concern, escalating the need for compounds 
that demonstrate novel modes of action and prevent the development 
of drug-resistance. As part of the Malaria Drug Target Identification 
Project efforts, we have adopted a chemogenomic approach to identify 
the targets of the most prominent compounds from chemically diverse 
libraries. Study compounds were selected based on availability, purity, 
potency in a multi-drug resistant isolate, and lack of known mechanism of 
action towards the mitochondrion or folate biosynthesis. Here we present 
studies of a drug-like compound from the Malaria Box, MMV007564, a 
novel antimalarial benzimidazolyl piperidine chemotype. To identify the 
genetic determinant of MMV007564 resistance, parasites were cultured 
in the presence of the compound to generate resistant lines. Whole 
genome sequencing revealed distinct mutations in the gene named 
Plasmodium falciparum cyclic amine resistance locus (pfcarl), encoding a 
conserved protein of unknown function. Mutations in pfcarl are strongly 
associated with resistance to a structurally unrelated class of compounds, 
the imidazolopiperazines, including KAF156, currently in clinical trials. Our 
data demonstrate that pfcarl mutations confer resistance to two distinct 
compound classes - benzimidazolyl piperidines and imidazolopiperazines. 
However, MMV007564 and the imidazolopiperazines – KAF156 and 
GNF179 – have different timing of action in the asexual blood stage and 
different potencies against the liver and sexual blood stages. Our results 
demonstrate that mutations in PfCARL mediate resistance to multiple 
chemical classes and might represent a common parasite drug-resistance 
pathway. Further characterization of PfCARL as a common drug-resistance 
pathway is underway.
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LEAD CANDIDATE SELECTION OF BROAD-SPECTRUM 
ANTIMALARIAL ACRIDONES
Jane X. Kelly1, Yuexin Li1, Rosie Dodean1, Christina Nolan2, Qigui 
Li2, Sean Marcsisin2, Raul Olmeda2, Thulan Long2, Heather Gaona2, 
Diana Caridha2, Lisa Xie2, Norma Roncal2, Brittney Potter2, Isaac 
Forquer1, Rolf Winter1, Dave Hinrichs1, Stephanie Huezo3, Roland 
Cooper3, Mike Riscoe1, Mara Kreishman-Deitrick2
1Portland Veterans Affairs Medical Center, Portland, OR, United States, 
2Walter Reed Army Institute of Research, Silver Spring, MD, United States, 
3Dominican University of California, San Rafael, CA, United States
We have previously reported the discovery of a novel antimalarial acridone 
chemotype that displays efficacy against sporozoite-induced Plasmodium 
infection in addition to efficacy against blood stage parasites. We have 
been successful in producing extremely potent new lead candidates with 
pico molar IC50 values against MDR resistant parasites, as well as full 
protection of liver stage infection at comparable dosage with primaquine. 
Details of the design, chemistry, structure-activity relationships (SAR), 
safety, metabolic studies, and mechanism of action will be presented.
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GLUCOSE-6-PHOSPHATE DEHYDROGENASE (G6PD) 
DEFICIENCY PHENOTYPE AND GENOTYPE DISTRIBUTION IN 
POINT-OF-CARE SETTINGS IN VHEMBE DISTRICT, LIMPOPO 
PROVINCE, SOUTH AFRICA
Shehu S. Awandu1, Jaishree Raman2, John Frean2, Philip Kruger3, 
Taneshka Kruger1, Jandeli Niemand1, Braam Louw1, Lyn- Marie 
Birkholtz1
1University of Pretoria, Centre for Sustainable Malaria Control, 
Pretoria, South Africa, 2National Institute for Communicable Diseases, 
Johannesburg, South Africa, 3National Malaria Control Programme, 
Tzaneen, Limpopo, South Africa
South Africa is targeting malaria elimination by the year 2018. To 
facilitate transmission reduction, primaquine may be used as an 
additional chemotherapy to clear gametocytes, the transmissible stage 
of Plasmodium. Unfortunately, individuals with glucose-6-phosphate 
dehydrogenase deficiency (G6PDd) risk acute haemolytic anaemia if 
exposed to oxidant drugs, including primaquine particularly at high doses. 
A total of 248 subjects attending 6 primary health care facilities in Vhembe 
district, Limpopo province, South Africa were phenotyped for G6PDd using 
a commercial G6PDd test kit. Additionally G6PDd genotypes of the most 
common African forms G6PD A (A376G) and G6PD A- (G202A, A542T, 
G680T and T968C) were determined by polymerase chain reaction and 
restriction length fragment polymorphisms. There was 13.03% (33/248) 
G6PDd prevalence in Vhembe district as measured by the commercial 
testing kit. Of all males 18.2% (10/55) were G6PDd according to the 
commercial test, while females had a lower prevalence of 11.9% (23/193), 
Odds ratio 0.6088 (95% confidence interval 0.270 -1.371). The A376G/
G202A genotype prevalence was 3.22% (6/248; 2.42% [N=6] male 
hemizygous and 0.80% [N=2] female homozygous). Heterozygous 
females were 12.90% (32/248) of participants. The A542T, G680T or 
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T968C variants were not detected in this locality. The sensitivity [95 % 
confidence interval (95 % CI)] and specificity of the commercial test kit 
to correctly identify G6PDd A- G202A deficiency were 90.38 % (95 % 
CI 85.54–94.03%) and 32.50% (95 % CI 18.57–49.13 %) respectively 
compared to genotyping. The agreement in test results was fair, Kappa 
value 0.246 (95% CI 0.090-0.413). There are low levels of G6PDd A376G/
G202A mutations in the study locality. However, the poor specificity 
and agreement of the comercial G6PDd testing kit in comparison to 
the genotyping results call for development of additional robust field 
deployable point-of-care G6PDd test kits.
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SOCIETAL AND ENVIRONMENT CONTEXT OF PARENTS 
ACTING AS PREDICTORS OF SEVERE MALARIA IN CHILDREN 
UNDER 5 YEARS OF AGE ADMITTED IN KOUDOUGOU 
REGIONAL HOSPITAL, BURKINA FASO: A CROSS SECTIONAL 
STUDY
Amadou Zoungrana1, Ziemle Clement Meda2, Zoungrana 
Yacouba3
1International Committee of the Red Cross, Gao, Mali, 2National Institute 
of Health Sciences, University of Bobo Dioulasso, Burkina Faso, Bobo 
Dioulasso, Burkina Faso, 3Minitère de la santé, Ouagadougou, Burkina 
Faso
Burkina Faso has a high incidence and death rate of severe malaria, 
especially for children under five years of age. Although the malaria 
elimination program is a cornerstone and high-priority public health 
project. Rating and understanding the various factors that contribute to 
the severity of malaria is useful in designing and conducting an effective 
strategy. In this study, factors associated with complicated malaria in 
Burkinabe children were investigated in semi urban city’s hospital, Burkina 
Faso. Between Jun and September 2012, a cross-sectional study was 
used to test 510 children under 5 years of age (mean age: 32.23 months) 
admitted with suspected malaria. Each child was screened using two 
types of methods (test of diagnosis rapid and blood smear) to identify 
whether ill child had severe malaria focused on the criteria established by 
the World Health Organization. When a child was diagnosed with malaria, 
the relatives were interviewed by a trained nurse using a structured 
questionnaire to assess predicting determinants. A logistic regression using 
SPSS software version 17.0 was used to identify theses determinants of 
severe malaria and associated deaths. Of the 510 children having malaria, 
203 (39.8%) had severe malaria. Most of the patients having severe 
malaria 86.2 % lived in rural areas. The main parental factors associated 
with severe malaria were delayed treatment [OR= 4.53, 95% CI = 1.76-
11.65], low socioeconomic status [OR = 9.69, 95% CI (4.12-22.78)], a 
large household [OR = 2.28, 95% CI (1.50-3.47)], housewife [R = 16.39, 
95% CI (2.18-122.9)], farmer [R = 19.39, 95% CI (4.61-81.44)]. The 
finding gathered from this study is one of the challenging and resources 
limited settings for emphasizing malaria elimination in children which 
remains a serious public health concern.Nevertheless understanding 
societal and environment contexts as possible predictors are still an 
important step towards the control of the disease. Improved health 
promotion, and encouragement to seek early care are urgently needed.
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IVERMAL: EFFICACY AND SAFETY OF HIGH-DOSE 
IVERMECTIN FOR REDUCING MALARIA TRANSMISSION - A 
DOSE FINDING STUDY
Menno R. Smit1, Eric Ochomo2, Ghaith Aljayyoussi1, Titus 
Kwambai2, Bernard Abong’o2, Nabie Bayoh3, John Gimnig3, Aaron 
Samuels3, Meghna Desai3, Penelope Phillips-Howard1, Simon 
Kariuki2, Duolao Wang1, Steve Ward1, Feiko ter Kuile1
1Liverpool School of Tropical Medicine, Liverpool, United Kingdom, 2Kenya 
Medical Research Institute, Kisumu, Kenya, 3Centers for Disease Control 
and Prevention, Atlanta, GA, United States
Innovative approaches are needed to complement existing tools 
for malaria elimination. Ivermectin is a broad spectrum antiparasitic 
endectocide widely used for onchocerciasis and lymphatic filariasis control 
at doses of 150-200 mcg/kg. Ivermectin also has potent mosquitocidal 
properties, shortening the lifespan of mosquitoes that feed on individuals 
recently treated with ivermectin. However, the effect with the 150-200 
mcg/kg dose is short-lived (6-11 days). Modelling suggests higher doses 
that prolong the mosquitocidal effects are needed for ivermectin to 
provide a significant contribution to malaria elimination. Ivermectin has 
a wide therapeutic margin, and previous studies have shown doses of 
2,000 mcg/kg (i.e. 10x the FDA approved dose) are well tolerated and 
safe; the highest used for onchocerciasis is single-dose 800 mcg/kg. We 
are conducting a double-blind placebo-controlled, parallel-group, 3-arm, 
dose finding trial to determine the efficacy, tolerance and safety of 3-day 
courses of ivermectin 0, 300, 600 mcg/kg/day, when given in combination 
with standard 3-day course of dihydroartemisinin-piperaquine. We 
performed Monte Carlo simulations based on pharmacokinetic modelling 
to determine the dosing regimens to be tested. In our models, a dose 
of 600 mcg/kg/day for 3 days achieved similar median (5-95 percentiles) 
Cmax concentrations of ivermectin as single-dose 800 mcg/kg: 111 ng/
mL (83-161) vs 108 (75-164), while increasing the median time above the 
MIC from 1.9 days (1.0-5.7) to 6.8 (3.8-13.4) days. The 300 mcg/kg dose 
was chosen at 50% to allow for a dose response. The clinical trial outcome 
of daily mosquito survival up to 28 days is assessed in laboratory-reared 
Anopheles gambiae s.s. populations fed on patients’ blood taken at days 
0, 2 (Cmax), 7 (primary outcome), 10, 14, 21, and 28 after the start of 
treatment. Safety outcomes include QT-prolongation and mydriasis. The 
sample size is 141 participants (47 per arm). Sub-studies include: (1) rich 
pharmacokinetics and (2) direct skin vs membrane feeding. The trial is 
ongoing in 6 facilities in western Kenya and will be completed in August 
2016. Results will be presented.
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SPATIAL AND TEMPORAL VARIATIONS OF MALARIA RISK 
BETWEEN 2013 AND 2015 IN ZANZIBAR: A PRE-ELIMINATION 
SETTING
Humphrey Raphael Mkali1, Abdul-wahid Al-mafazy2, Mike 
McKay3, Abdullah Suleiman Ali2, Lynn R. Paxton4, Naomi R. 
Kaspar5, George R. Greer5, Wahida Shiraz Hassan2, Mohamed Ali2, 
Jeremiah Ngondi1
1RTI International, Dar Es Salaam, United Republic of Tanzania, 2Zanzibar 
Malaria Elimination Programme, Zanzibar, United Republic of Tanzania, 
3RTI International, Nairobi, Kenya, 4U.S. President’s Malaria Initiative, 
US Centers for Disease Control and Prevention, Dar Es Salaam, United 
Republic of Tanzania, 5U.S. President’s Malaria Initiative, United States 
Agency for International Development, Dar Es Salaam, United Republic of 
Tanzania
The monitoring and evaluation of local transmission epidemiology to 
characterize malaria risk is essential for strategic planning of malaria 
elimination programs. Geographical Information System mapping 
techniques are a major set of tools for this approach to assess local time, 
spatial distribution and clustering of malaria cases in Zanzibar. In 2012, 
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the Malaria Case Notification system was developed to support individual 
case reporting. Each District Malaria Surveillance Officer (DMSO) was 
equipped with a tablet computer running a mobile application called 
Coconut Surveillance. Once a DMSO is alerted of a new case, he or 
she is guided through an active case response protocol by Coconut 
Surveillance. Additional case data are entered into the tablet at the 
facility and household. Each household member is tested and new cases 
are treated immediately. Coconut Surveillance uses the Geographical 
Positioning System (GPS) capability of the tablet to record the location of 
the household. Officials use near real-time maps and reports to quickly 
identify hot-spots and transmission patterns. Mapping of cases was done 
using Quantum-GISTM software version 2.12.0 and cluster analysis was 
performed using Bernoulli spatial scan statistic through the SaTScan® 
software. All 10 districts had malaria although incidence was lower in 
Pemba than Unguja. Unguja had an annual incidence increased from 6.3 
per 1000 population in 2013 to 14.8 per 1000 population in 2015, of 
which 60% of cases in Unguja occurred between weeks 18 and 30 of 
each year. Among 9,352 cases identified during the surveillance, which 
were matched to 32,355 controls, we identified significant spatial clusters 
of malaria cases localized in Urban and West districts in Unguja, Wete and 
Micheweni districts in Pemba. Our results confirm the existence of a spatial 
heterogeneity and the seasonality of malaria transmission in Zanzibar, 
providing evidence for implementation of targeted interventions.
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IMPLICATION OF FLUCTUATING COMMODITY AVAILABILITY 
ON SUSTENANCE OF GAINS OF POPULATION BASED 
INTERVENTIONS
Osita S. Okonkwo1, Chibuzo Ed Oguoma1, Edward Ndibuagu2
1Support to National Malaria Program (SuNMaP), Enugu, Nigeria, 2Enugu 
State University Teaching Hospital, Parklane, Enugu, Nigeria
Preventing malaria in pregnancy remains a daunting challenge in ensuring 
healthy mothers and newborns in malaria endemic communities. This 
study examines the effect of fluctuating antimalarial commodity support 
for the administration of intermittent preventive therapy for malaria 
in pregnancy (IPTp) using sulphadoxine pyrimethamine (SP), on the 
sustenance of gains of improved antenatal clinic visits and consequent 
reduction in the incidences of malaria among pregnant women accessing 
care in public health facilities across Enugu State, Nigeria. This study 
assessed clinical records of antenatal visits, administration of sulphadoxine 
pyrimethamine (SP), and confirmed cases of malaria among pregnant 
women during the high transmission period, across 255 health facilities. 
Trend analyses of percentage uptake of IPTp, were compared with and 
pattern of antenatal visits, and reported incidence of malaria over the 
study period. Findings: Using the first year as a baseline, observed 42% 
cumulative increase in antenatal visits in the second year appears to 
correspond significantly with the introduction of IPTp with an over 300% 
increase in uptake, and over 3% reduction in incidence of malaria in 
pregnancy (7.5% to 4.2%). With reduction in availability, IPTp uptake 
dropped in the third year to 5.6%, a proportionate reduction in antenatal 
visit of 6%, and malaria in pregnancy reduction was 1.6% (4.2% to 
2.6%). As the availability dropped further in year 4 (-31.3%), the antenatal 
visits and malaria in pregnancy recorded relative marginal increases at 
14.7% and 2.9% respectively. Further percentage reductions in antenatal 
visit at 22.4%, marginal increase in malaria in pregnancy incidence of 
4.8% recorded in year 5 corresponds to the percentage reductions in 
IPTp uptake 23.6% occasioned by non-availability of commodities. In 
conclusion, it is imperative that interventions of which commodity supply is 
a critical component, has the tendency to impact positively on uptake and 
invariably produce and sustain desired results if emphasis is on ensuring 
unhindered commodity availability and improved access.
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HUMAN POLYMORPHISM ASSESSMENT AGAINST THE 
SAFETY AND EFFICACY USAGE OF PRIMAQUINE
Yi Wan Quah1, Andreea Waltmann1, Cristian Koepfli1, Ventis 
Vahi2, Andrew Darcy3, Freda Pitakaka3, Maxine Whittaker4, 
James Kazura5, Daniel J. Tisch5, Alyssa Barry1, Aaron Jex1, Celine 
Barnadas1, Ivo Mueller1
1Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, 
Australia, 2National Health Training and Research Institute, Ministry of 
Health, Honiara, Solomon Islands, 3National Health Training & Research 
Institute, Ministry of Health, Honiara, Solomon Islands, 4College of 
Public Health, Medical and Veterinary Sciences, James Cook University, 
Townsville, Queensland, Australia, 5Case Western Reserve University, 
Cleveland, OH, United States
In all malaria-endemic countries outside sub-Saharan Africa, Plasmodium 
vivax infections are becoming the major challenge for control programs. 
The relapsing nature of P. vivax makes elimination difficult without radical 
treatment with 8-aminoquinoline drugs such as primaquine or tafenoquine 
against the long-lasting liver stage, hypnozoites. The safety and efficacy 
of 8-aminoquinoline drugs are however crucially dependent on each 
individual’s glucose-6-phosphate dehydrogenase (G6PD) and cytochrome 
P450 2D6 (CYP2D6) genotype, respectively. Assessment of the impact 
of G6PD and CYP2D6 genotypes on the usage of 8-aminoquinoline 
drugs is hence important for designing optimal treatment schedules 
and drug-based public health inventions. A sensitive next-generation 
sequencing-based method to genetically characterise G6PD and CYP2D6 
was established. This assay is suitable for large-scale screening strategy to 
evaluate the risk of primaquine therapy in different populations. Validation 
of assay performance will be conducted in a cohort of children (6 months 
to 12 years old) from Solomon Islands (2013-2014), which were tested 
for point-of-care RDT G6PD deficiency and treated with primaquine 
if clinical vivax malaria were observed. The ability to rapidly assess the 
genetic background for safe and efficient usage of primaquine in a given 
population has important implications for the planning of potential mass 
drug administration intervention programs. This study thus provides 
guidance for a better informed P. vivax elimination strategy.
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CHARACTERIZATION OF POPULATIONS CROSSING FORMAL 
AND INFORMAL BORDERS ON THE CAMBODIA-LAOS 
BORDER, INCLUDING IDENTIFICATION OF MALARIA 
INFECTION AND ARTEMISININ RESISTANCE INFECTION
Sao Sarady Ay
Malaria Consortium, Phnom Penh, Cambodia
Recent evidence identified malaria prevalence among cross-borders to be 
as high as 11.5% in Cambodia-Laos border. As information is available 
for international border post which is not available at along the porous 
borders. The aim of this study is to estimate the potential contribution 
of crosser border to the spread of malaria and artemisinin resistance. A 
cross sectional study is being conducted at 7 informal and 1 international 
Cambodia-Laos border posts, in Stung Treng province. A total of 4500 
individuals are expected to be tested between April 2015 and February 
2016: sample collection started in September 2015. Participants are 
diagnosed malaria by using RDT and RT-PCR analysis. A structured 
questionnaire is capturing: demographic characteristics, history of travel, 
occupation. All crossers borders are eligible to participate and a written 
consent is required. Positive cases by RDT treat at the spot. Double entry 
questionnaire in EpiData 3.1 and PCR data is entered in Ms Excel database 
and then merged by unique identifiers in to STATA 12. A descriptive 
analysis of the primary data was conducted: demographic characteristics, 
RDT and RT-PCR results disaggregated by species. RT-PCR positive cases 
were also disaggregated and classified according to their fever status. A 
total of 291 samples were tested; 66.3% were male and the majority had 
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between 15-40 years old (63.2%); agricultural work was main occupation 
68.7% but in Srei Champa Post, 20% of tested were security personnel. 
RT-PCR results: 16.2% of tested were deemed positive: informal border 
posts registered higher malaria prevalence than international border 
post (19.8% and 17.1% vs 11.4%). Among the positive, 87.2% were 
Cambodian and 12.8% Laos. RDT results indicated 2.7% were positive: 
international border post was also higher than informal posts (5.7% 
vs 0.9% and 2.3%). RT-PCR results: 65.1% of positive cases were 
asymptomatic: 16.3% were P.f, 69.8% P.v, and 13.9% P.f/P.v. Despite 
sample size limitations, differences in malaria prevalence among different 
types of border seem to exist.
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AN ASSESSMENT OF NATIONAL MALARIA SURVEILLANCE 
SYSTEMS FOR MALARIA ELIMINATION IN THE ASIA PACIFIC
Chris Erwin G. Mercado, Nattwut Ekapirat, Arjen M. Dondorp, 
Richard J. Maude
Mahidol-Oxford Tropical Medicine Research Unit (MORU), Bangkok, 
Thailand
Heads of Government from Asia and the Pacific have committed to a 
malaria-free region by 2030. The Asia Pacific Leaders Malaria Alliance 
(APLMA) recognises that for malaria elimination to succeed, it is essential 
to have an accurate picture of malaria incidence over time and space. 
Having a closer look at each country’s disease reporting system is a crucial 
component of this endeavour. It helps to recognise gaps in surveillance 
and develop evidence to support health system strengthening. This study 
describes the sources of malaria incidence data collected by national 
malaria control programmes (NMCPs) in 22 countries in the Asia Pacific 
targeting elimination. From April 2015, a short survey was sent to each 
NMCP. It collected country-specific information on existing sources of 
malaria incidence data, the system for collecting and collating these 
data and the role of the private sector in malaria treatment. Follow-up 
with key persons was done to ensure quality of survey responses, which 
were then stored in a secure database. Summary tables and thematic 
maps were generated to facilitate effective communication of findings to 
policymakers. Twenty-one countries completed the survey. Most of the 
malaria incidence data collected by NMCPs originate from government 
facilities, while many do not collect comprehensive malaria incidence data 
from mobile and migrant populations, the private sector or the military. 
All data from village health workers was included by 9/19 countries and 
some by 4/19. Other sources of data included police, plantations and 
other government ministries. Malaria is treated in private health facilities 
in 17/18 countries, while antimalarials are available in pharmacies in 
15/18 and shops in 6/18. Countries should be supported to improve the 
completeness of malaria surveillance data collected from existing sources. 
In addition, a regional effort is warranted to include additional sources of 
malaria case data in the national surveillance database for each country, 
in particular from village health workers, mobile and migrant populations, 
the private sector, non-governmental organisations and the military.
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DECREASED ENDEMIC MALARIA IN SURINAME: MOVING 
TOWARDS ELIMINATION
Edward Van Eer1, Gustavo Bretas2, Hélène Hiwat3
1Medical Mission Primary Health Care, Paramaribo, Suriname, 2Public 
Health Advisor, Rio de Janeiro, Brazil, 3Ministry of Health Malaria Program, 
Paramaribo, Suriname
Suriname has moved from being the country with the highest annual 
parasite index in the Americas to one on the threshold of elimination. 
The progress toward elimination in the stable populations of Suriname 
between 2000 and 2015 is reviewed. Data were obtained from the 
Medical Mission and the Ministry of Health Malaria Program case-reporting 
systems, and analyzed with a focus on disease burden and differentiation 
of the disease geographically, by malaria species, age, ethnicity and 
trophocite and gametocyte infection rates. Between 2000 and 2015 there 
were 57.811 locally acquired cases of malaria in the stable populations 
of Suriname. A significant reduction in authochthonous malaria cases 
was observed from 2006 to 2015. The number of imported malaria cases 
is higher than the number of locally acquired cases since 2014, with 
a total of 10 imported cases vs 5 authochthonous cases in 2015. The 
overall decline in malaria case incidence can be attributed to active case 
detection in high risk areas, free distribution of impregnated bed nets in all 
transmission areas, public awareness campaigns and improved accessibility 
of diagnosis and treatment. The results from Suriname show how the local 
availability of good quality diagnosis and treatment are essential for the 
success of a malaria control program.
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RAPID REPORTING AND A SPATIAL DECISION SUPPORT 
SYSTEM TO STRENGTHEN MALARIA ELIMINATION 
INTERVENTIONS AND RESEARCH IN ZAMBEZI REGION, 
NAMIBIA
Oliver Medzihradsky1, Kathryn Roberts1, Gerard Kelly2, Davis 
Mumbengegwi3, Jennifer Smith1, Hugh Sturrock1, Adam Bennett1, 
Petrina Uusiku4, Immo Kleinschmidt5, Mwalenga Nghipumbwa4, 
Bradley Didier6, Roland Gosling1, Michelle Hsiang7
1University of California San Francisco, San Francisco, CA, United States, 
2The Australian National University, Canberra, Australia, 3University of 
Namibia, Windhoek, Namibia, 4National Vector-borne Diseases Control 
Programme, Windhoek, Namibia, 5London School of Hygiene & Tropical 
Medicine, London, United Kingdom, 6Clinton Health Access Initiative, 
Windhoek, Namibia, 7University of Texas Southwestern, Dallas, TX, United 
States
As countries transition from control to elimination, surveillance systems 
must shift from periodic and aggregated case reporting to real-time 
reporting on individually geo-located cases. In Zambezi region Namibia, 
completed case forms often remained at health facilities (HFs), with 
delayed entry into databases that would permit finer scale analyses. 
To address these challenges a national rapid reporting system was 
piloted in western Zambezi (pop.~35381) and linked to a geographical 
reconnaissance (GR) of 8026 households conducted 2014-15. The GR 
mapped and collected baseline data on households and included a QR 
code affixed to each doorframe and resident’s health passport. The 
rapid reporting system involves HF entry of minimum essential data on 
confirmed cases via tablet, sent by 3G network to a secure cloud database. 
A spatial decision support system (SDSS) was developed, incorporating a 
geographical information system (GIS)-based framework, a surveillance 
database, graphical maps, and expert knowledge. The SDSS includes GR 
data, retrospective 2012-14 incidence data from HF registries (including 
3152 rapid diagnostic test-confirmed cases from 2013-15), and ongoing 
incidence data collected (2015-) by rapid reporting system. The SDSS 
enables users to plot cases to the household level within 24 hours of 
case detection, track progress by household during community-level 
investigations, and generate transmission risk maps. Challenges have 
included ensuring patients carry health passports and building capacity for 
nurses to complete the rapid report despite heavy workload. The Zambezi 
region SDSS has 3 roles: (i) to support Ministry of Health and Social 
Services (MoHSS) targeting of human and financial resources towards 
most at-risk areas; (ii) to support the implementation of a randomized 
controlled study exploring innovative case response strategies; and (iii) to 
coordinate the region’s MoHSS and research activities. This represents one 
of the first reports of an SDSS being used to help a country move towards 
elimination, support research, and contribute to making that research 
more accessible and acceptable to local actors.
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DOCUMENTATION AND REACTIVE DETECTION OF MALARIA 
CASES IN A ZONE OF PRE-ELIMINATION FROM JULY TO 
SEPTEMBER 2015
Moustapha Cisse, Medoune Ndiop, Ibrahima Diallo, Mamadou 
Lamine Diouf, Alioune Badara Gueye, Mady Ba
National Malaria Control Programm, Dakar, Senegal
The ongoing decrease of the cases of malaria in Senegal has led the 
National Malaria Control Program (NMCP) to set a target of pre-
elimination in the low transmission north and acceleration of control in 
the higher transmission south. In the north, malaria cases are investigated 
and reactive active case detection is conducted. Implementation started 
in 2011 in one northern district, and in 2015, the NMCP decided to 
progressively extend investigations in a northern region, adding three 
additional districts of the same region (St-Louis). Following extensive 
informational meetings and consultations with administrative, health and 
local authorities, health district personnel and community stakeholders 
were trained. Of the 580 cases diagnosed, 20% (115) were traveling 
through, and had no local address and 88% (508/580) were investigated. 
Of these, 59% of cases had traveled outside the district during in the 
previous 15 days. Among the 580 diagnosed cases, the 80% (465/580) 
who had addresses in the district were eligible for reactive active case 
detection within 7 days, with 82% (380) of these conducted within the 
correct time frame. Active case detection carried out in the household of 
the index case revealed 1.3% (57/4,466) test positivity, and in high risk 
members of five households around the index case, 0.6% (13/2,279) 
test positivity. Of the 70 additional cases detected through active case 
detection, 63 were in the household of the index case. The investigation 
of the cases of malaria in areas of pre elimination initiated by the NMCP 
and the responsibility of the district health management teams gave very 
satisfactory results. The NMCP plans to extend the strategy to other low 
transmission districts, integrating lessons learned to improve results and 
ensure success, namely involvement of all administrative and community 
actors, overseeing close and regular at the beginning and throughout the 
intervention, good coordination between the district teams and hospitals, 
and the need to consider focusing the investigation only at the household 
of the index case.
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COLLABORATIVE EFFORTS TO IMPROVE PREVENTION OF 
MALARIA IN PREGNANCY IN BURKINA FASO THROUGH USE 
OF IPTP-SP
Mathurin Dodo, Stanislas Paul Nebie, Ousmane Badolo, Thierry 
Ouedraogo
Jhpiego, Ouagadougou, Burkina Faso
Malaria remains the first cause of consultation (47%), hospitalization 
(62%) and death (31%) in health facilities in Burkina Faso (2014 Statistical 
Yearbook). Pregnant women are among the most vulnerable to malaria. 
Intermittent preventive treatment in pregnancy (IPTp) is a priority 
intervention in the Burkina Faso 2011-2015 National Malaria Strategic 
Plan. In 2012, IPTp2 was low across the country at 53%. The President’s 
Malaria Initiative (PMI) supported the National Malaria Control Program 
(NMCP) in implementing the national malaria control strategic plans. IPTp 
was promoted through 3 strategies: advocacy and policy updates, capacity 
building, and behavior change communication. Malaria prevention and 
management guidelines and job aids updated stressed IPTp in line with 
WHO recommendations. 185 trainers were trained who in turn organized 
one-day briefings for over 1,300 healthcare providers from 1081 health 
facilities (61.3% of health facilities nationally) on the revised guidelines, 
which were distributed along with job aids. Health information system 
tools now reflect new IPTp guidance, and 190 district and regional level 
data managers were trained in their use. 208 community health workers 
were trained in sensitization and community mobilization around early 
ANC attendance. Over 3000 radio and TV spots were aired on 28 stations 
on the importance of IPTp. In 21 project districts in 2013, IPTp2 and IPTp3 
coverage rates based on ANC registration were 54% and 0%. Following 
the interventions, rates in these districts increased to 72% (IPTp2) and 
23% (IPTp3) in 2014 compared to 63% and 8% in the other 42 districts. 
These efforts have resulted in improvements in IPTp service delivery and 
reporting, Based on successes, training and guideline dissemination 
continued in 2015 across the country so that all health facilities received 
copies of the new guidelines and 82% of districts received training.
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FINDING THE LAST FEW CASES: MOST EXPOSED 
INDIVIDUALS LESS LIKELY TO PARTICIPATE IN MALARIA 
SCREENING IN A PRE-ELIMINATION SETTING IN VIETNAM
Melanie Bannister-Tyrrell1, Nguyen Xuan Xa2, Vu Khac Anh 
Dung2, Tran Thanh Duong2, Nguyen Thi Hong Ngoc2, Eduard 
Rovira-Vallbona1, Annette Erhart3, Anna Rosanas-Urgell1, Koen 
Peeters Grietens1
1Institute of Tropical Medicine, Antwerpen, Belgium, 2National Institute 
of Malariology, Parasitology and Entomology, Hanoi, Vietnam, 3Medical 
Research Council, Fajara, Gambia
In a one-year cohort study comprising five malariometric screening 
surveys (n=456) in a remote, forested and recently endemic region of 
Central Vietnam, only 6 asymptomatic malaria infections (3 Plasmodium 
falciparum and 3 P. vivax) were identified, leading to speculation that 
local transmission may be fading out to elimination. However, people 
who spend overnights in forest fields, the most significant local risk factor 
for malaria, may be less likely to participate in screening due to regular 
absences from the villages where the surveys were conducted, leading 
to challenges in the identification of the remaining infection reservoir. 
Ancillary to the cohort study, an exploratory mixed methods study, 
comprising ethnographic fieldwork and a cross-sectional survey (n=160) 
was conducted to assess variation in malaria exposure-related behaviours 
and participation in screening. Full participation in all five screening 
surveys (40%) was not associated with spending overnights at forest fields 
(n=72), but individuals spending periods of one week to more than one 
month at their fields (n=16) were significantly less likely to participate 
in all screenings (12.5%). There was no difference in bed net availability 
by duration of stay, though 57% of bed nets at the fields had tears. In 
addition, people staying for longer durations at the fields were less likely 
to consistently sleep under a bed net, stayed in larger family groups, with 
fewer bed nets per person, and were twice as likely to have new unused 
LLINs stored in the village home, which suggests bed nets in use were 
older. Finally, those staying for longer durations at their fields had lower 
malaria knowledge. In conclusion, this study identified a sub-population 
with multiple malaria risk factors including extended stays in forest fields, 
lower effective bed net use, and lower malaria knowledge, but who are 
less likely to participate in screening surveys, which challenges elimination 
efforts. Mixed methods studies can improve the robustness of findings 
from small samples and highlight small populations in which the last few 
malaria cases are more likely to occur.
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IMPROVING IVERMECTIN´S EFFICACY AS A VECTOR 
CONTROL TOOL: REDUCING ITS METABOLISM AND 
EXCRETION TO PROLONG THE MOSQUITO-KILLING 
WINDOW
Carlos J. Chaccour1, Sandra Castejon2, Gloria Abizanda3, Ángel 
Irigoyen4, Azucena Aldaz2, Felix Hammann5, José Luis Del Pozo2
1Instituto de Salud Tropical Universidad de Navarra, Pamplona, Spain, 
2Clínica Universidad de Navarra, Pamplona, Spain, 3Centro de Investigación 
Médica Aplicada, Pamplona, Spain, 4Drug Developing Unit Universidad de 
Navarra, Pamplona, Spain, 5University Hospital Basel, Basel, Switzerland
The potential use of ivermectin mass drug administration to kill 
mosquitoes and reduce malaria transmission is gaining momentum. This 
endectocide has the potential to target mosquitoes feeding during the 
temporal and spatial gaps left by core vector control tools (insecticide 
treated nets and indoor residual spraying) and reduce residual malaria 
transmission, possibly easing the path to elimination. With a plasma half-
life of 12-18 hours, however, either multiple daily doses or slow-release 
formulations are required to sustain effective mosquitocidal plasma 
concentrations. An additional alternative is the pharmacological inhibition 
of the metabolism and excretion of the drug. This strategy forms the basis 
of several drug combinations used effectively and safely in oncology and 
HIV treatment. Ivermectin is a substrate of both the CYP 450 (CYP) 3A4 
and the P-glycoprotein (P-gp). We conducted an animal model experiment 
showing the effect of ketoconazole, a CYP3A4/P-gp inhibitor, in the oral 
pharmacokinetics (PK) of ivermectin. Six adult hybrid minipigs (37-60 kg) 
received a single oral dose of 800 mcg/kg of ivermectin. Blood samples for 
plasma-HPLC drug quantification were taken hourly for the first 8 hours 
and then at regular intervals for two weeks. The main PK parameters were 
calculated including the area under the curve (AUC) and the time above 6 
ng/ml (a concentration known to kill 50% of biting Anopheles gambiae). 
The experiment was repeated after a wash-out period of one month, the 
animals were randomized to receive premedication with ketoconazole or 
nothing as a control before ivermectin. In animals pre-treated with the 
CYP3A4/P-gp inhibitor ketoconazole, we saw a statistically significant 
6-fold increase in the time above mosquito-killing concentration and 
a significant increase in the AUC (1750 vs 464 ng/ml·hr). No sign of 
neurological toxicity was seen. Modifying the metabolism and excretion 
of ivermectin by means of CYP3A4/P-gp inhibitors appears to be an 
alternative strategy for prolonging its mosquito-killing effect and possibly 
increase its efficacy in reducing malaria transmission.
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CONTROL AND PRE-ELIMINATION OF MALARIA IN THE 
YUNNAN PROVINCE OF CHINA FROM 1983 TO 2013
Yaming Yang, Xu, Xiao-dong Sun, Hui Liu, Xiao-tao Zhao, Chun 
W Ben-fu Li, Heng-lin Yang, Hong-ning Zhou, Jian-wei
Yunan Institute of Parasitic Diseases, Puer, China
Yunnan faces an increasing risk of imported malaria cases from border 
countries, which Myanmar, Laos and Vietnam. With imported malaria 
thus becoming a major challenge in the context of malaria elimination in 
the province. The aim of this study is to understand the past and present 
malaria situation, and the challenges involved in its control, in Yunnan 
Province. A retrospective study of the past 30 years’ of surveillance 
data and relevant sources on malaria in Yunnan was conducted. Data 
on malaria cases from 1983 to 2013 were collected from the China 
Information System for Disease Control and Prevention, as well as from 
case investigation reports.Results: From 1983 to 2013, a total of 375,602 
malaria cases were reported in Yunnan Province; among these 739 
resulted in death. Of the total number of malaria cases, 72.7% were 
infected with Plasmodium vivax, 21.2% with P. falciparum, 0.02% with 
P. malariae, 1.4% were mixed infection cases, and 4.7% were untyped 
cases. Out of the total number of reported cases, 207,956 were reported 
from the 25 border counties, accounting for 55.4% of the total malaria 
cases, and 44.6% (167,646) were reported from the mainland counties 
(the other 104 counties) of the province. The annual malaria incidence rate 
decreased from 64.8 per 100,000 in 1983 to 0.9 per 100, 000 in 2013. 
Among the 25 border counties, the malaria incidence rate decreased from 
179.8 per 100,000 in 1983 to 4.5 per 100,000 in 2013, and the mainland 
counties malaria incidence rate decreased from 45.4 per 100,000 in 
1983 to 0.3 per 100,000 in 2013. In 1983, malaria was prevalent in 
the northwest of Yunnan, Zhaotong city (northeast of Yunnan), and 
Yuanjiang-Honghe River Valley and border areas, while it was prevalent in 
the western and southern border areas of Yunnan in 2013. The population 
segment at high risk of contracting malaria consists of young male farmers 
and migrant workers. Conclusion: From 1983 to 2013, malaria control has 
been effective in Yunnan Province. Malaria has almost been eliminated in 
the mainland areas, and future control interventions should focus on the 
border areas.
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EFFECTIVENESS OF MALARIACONNECT FOR REAL-TIME CASE 
NOTIFICATION TO STRENGTHEN SURVEILLANCE IN SOUTH 
AFRICA
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4National Institute of Communicable Diseases, Johannesburg, South 
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South Africa is targeting malaria elimination by 2018. Strengthening the 
surveillance system is key to the country achieving its elimination goal. 
South Africa’s historical paper-based notification system led to reporting 
delays before data was entered into the national malaria information 
system (MIS). To enable real-time case notification, South Africa developed 
MalariaConnect, an Unstructured Supplementary Service Data (USSD) 
tool for health care workers to notify malaria cases immediately from any 
mobile phone. MalariaConnect was deployed in November 2015 across 
297 public health care facilities. These facilities are located in South Africa’s 
five endemic districts (Ehlanzeni, Mopani, Umkhanyakude, Uthungulu, 
and Vhembe) and had previously reported at least 1 malaria case from 
2012-2014. MalariaConnect notifications were compared against the 
paper-based data to assess consistency of reporting, and timeliness 
through a paired t-test. User acceptability has been assessed using an 
unstructured interviewer-administered questionnaire. From November 
2015 through March 2016 there were 1234 cases reported through the 
paper-based system from facilities enrolled on the MalariaConnect project. 
On average, cases were notified through MalariaConnect within 1 day of 
patient diagnosis, compared to 5.1 days in the paper-based system (95% 
Confidence Interval 4.09-5.17: p 0.001). Of these, 70% (n=865/1234) 
were reported through MalariaConnect. Of the 108 healthcare 
workers that were interviewed and had used MalariaConnect, 96% 
(n=104/108) were willing to continue using the system. MalariaConnect 
has significantly improved timeliness of case reporting in South Africa 
and achieved high user acceptability. In 2016 South Africa will focus 
on increasing reporting rates through continued follow up visits and by 
strengthening systems for data-driven response.
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MALARIA ELIMINATION BY REACTIVE CASE DETECTION: 
CHALLENGES AND OPPORTUNITIES
Jaline Gerardin1, Caitlin Bever1, Milen Nikolov1, Busiku 
Hamainza2, John Miller3, Philip Eckhoff1, Edward Wenger1
1Institute for Disease Modeling, Seattle, WA, United States, 2National 
Malaria Control Centre, Lusaka, Zambia, 3PATH-MACEPA, Lusaka, Zambia
As several regions with historically substantial vectorial capacity approach 
eliminating malaria, there is a need to understand which features of a 
malaria surveillance and response system are most crucial for achieving 
local elimination and stemming resurgence. To investigate how local 
hotspots and spatial biases in surveillance quality interact to sustain local 
transmission, an individual-based model of malaria transmission, including 
vector life cycle dynamics and within-host immunity, was adapted to 
explicitly simulate transmission at the spatially-connected household level. 
A community of a few hundred households in Gwembe District, Southern 
Province, Zambia, where elimination operations are currently underway, 
was used as a model system. Vector bionomics, treatment-seeking, bednet 
usage, and mass drug campaign schedules and coverages were modeled 
according to household-level survey data from the area. Simulations 
predict that case management rate is the strongest determinant of success 
of reactive approaches, and high coverage and magnitude of response 
cannot completely compensate when a portion of symptomatic infections 
are left untreated. Rather than devoting resources to coordinating 
extensive reactive campaigns, we propose that a more effective strategy 
would be to improve access to treatment through strategic placement 
of village health workers and active community engagement on the 
importance of promptly treating cases.
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RWANDA TOWARDS MALARIA PRE-ELIMINATION: ACTIVE 
CASE INVESTIGATION IN A LOW ENDEMIC DISTRICT
Noella Umulisa1, Angelique Mugirente1, Veneranda Umubyeyi1, 
Beata Mukarugwiro1, Stephen Mutwiwa1, Jean Pierre Habimana2, 
Corrine Karema2
1Maternal and Child Survival Program/Jhpiego Rwanda, Kigali, Rwanda, 
2Malaria and Other Parasitic Diseases Division/Rwanda Biomedical Center, 
Kigali, Rwanda
Rwanda has seen an increase in malaria cases recently with an increase 
from 514,173 cases in 2012 to 1,957,402 cases in 2015. This change 
can be attributed to an increase in temperature, rainfall, and resistance 
to insecticides. Despite this setback, Rwanda is aiming to reach the 
pre-elimination phase by 2018. In January 2015, 11 health facilities in 
Rubavu, a low endemic district, started implementing reactive active case 
detection after training 55 health care providers and 11 lab technicians on 
the topic. This strategy involves screening and treating individuals living 
in close proximity to passively detected cases, also known as index cases. 
Index cases can be used to identify population groups that are sources 
of infection. From January 2015 to December 2015, 16,434 cases of 
Malaria were detected and treated at 11 health facilities in Rubavu District. 
Among these cases, 2,917(17.8%) index cases were investigated and 
4,943 individuals (between 1 and 2 contacts for each index case) living 
in proximity of index cases were tested using rapid diagnostic tests by 
health care providers. Of these, 508 (10.3%) tested positive for malaria 
and were treated according to national guidelines. This data shows that 
the number of investigated cases is still lower than the national guidelines 
of screening 5 individuals residing between 100 to 500 meters of every 
confirmed case. This low rate could be due to the increase of malaria cases 
in Rwanda which has placed a burden on health care providers and health 
facilities in areas like Rubavu which used to be low endemic malaria areas. 
Additionally, data gathered through supervision activities has indicated a 
need for additional training on screening investigations in order to adhere 
to national guidelines and conduct the investigations more efficiently. 
Active case investigation could be improved by training and involving 
more health care providers such as community health workers who could 
reduce the burden on health center staff. The additional support for case 
investigation activities and improved training can help to achieve higher 
coverage of individuals located near index cases.
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THE UTILITY OF MALARIA RAPID DIAGNOSTIC TESTS AS 
A TOOL IN ENHANCED SURVEILLANCE FOR MALARIA 
ELIMINATION IN VANUATU
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As part of efforts to eliminate malaria, Vanuatu has piloted the 
implementation of enhanced malaria surveillance and response strategies 
since 2011. This involves passive case detection (PCD) in health facilities, 
proactive case detection (Pro-ACD) and reactive case detection (Re-ACD) 
in communities using malaria rapid diagnostic tests (RDTs). While RDTs 
improve case management, their utility for detection of malaria infections 
in ACDs in this setting is unclear. We evaluated the utility of malaria RDTs 
as diagnostic tools in PCD, in five rounds of Pro-ACDs and five rounds of 
Re-ACDs conducted in Tafea and Torba Provinces, Vanuatu between 2011 
and 2014. In PCD conducted in Tafea Province in 2013, a RDT-positive rate 
of 0.21% (2/939) and a PCR-positive rate of 0.44% (2/453) was observed 
in fever patients, demonstrating less than 1% of suspected malaria cases 
in this province were due to malaria. In Pro-ACDs conducted in Tafea and 
Torba Provinces, RDT-positive rates in 2013 and 2014 were 0.14% (3/2145) 
and 0% (0/2823), respectively, while the corresponding PCR-positive 
rates were 0.72% (9/1242) and 0.79% (9/1141). PCR identified villages 
in both provinces appearing to be transmission foci with a small number 
of low-density infections, mainly P. falciparum infections. In five rounds of 
Re-ACD, RDTs did not identify any additional infections while PCR detected 
only one among 173 subjects screened. These results demonstrate that 
both Tafea and Torba Provinces in Vanuatu has achieved very low malaria 
prevalence. In these low-transmission areas, conducting Pro-ACD and Re-
ACDs using RDTs appears not cost-effective and may have limited impact 
on interrupting malaria transmission due to the small number of infections 
identified by RDTs and considerable operational resources invested. More 
sensitive, field deployable and affordable diagnostic tools will improve 
malaria surveillance in malaria elimination settings.
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BACK TO THE FUTURE: REVISITING THE ROLE OF 
CHLOROQUINE FOR MALARIA ELIMINATION IN 
MOZAMBIQUE
Beatriz Galatas
Centro de Investigação em Saúde de Manhiça (CISM), Manhiça, 
Mozambique
Chloroquine (CQ) was used for many decades as the mainstay of 
antimalarial treatment, but was progressively abandoned due to increasing 
parasite resistance throughout the majority of malaria-endemic areas, 
particularly in Sub-Saharan Africa. Recent evidence from Malawi suggest 
that CQ sensitivity may be returning in places where discontinuation has 
reduced the drug pressure to the parasite populations. While this does not 
support the reintroduction of CQ as first line therapy, it suggests that, if 
proven sensitive in a given area, it could play a prophylactic role in malaria 
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elimination strategies when used in combination with other drugs or tools. 
Additionally, due to its high safety profile, CQ could also be considered an 
alternative for prophylaxis in first-term pregnancies and young infants.
A randomized, single-blind, placebo-controlled trial in asymptomatic 
Mozambican adults was conducted in the district of Manhiça, Southern 
Mozambique. Participants were followed up at days 0, 1, 2, 3, 7, 14, 
21 and 28. The primary study endpoint was the rate of adequate and 
parasitological response (ACPR) to therapy on day 28 (PCR-corrected). 
Blood-slides and filter papers were collected at every study visit to measure 
parasite density and differentiate recrudescenses from new infections. 
A total of 52 and 27 participants were included in the CQ and Placebo 
group respectively. Mean parasite density at study entry was 517p/µL and 
there were 7 lost-to-follow-up participants in each arm. A PCR-corrected 
ACPR was 89% (95%CI 80%-98%) in the CQ arm and 36% (95%CI 
17%-59%) among those in the placebo group (p< 0.001). In conclusion, 
this exploratory study suggests the return of CQ sensitivity in the South 
of Mozambique, implying its potential role as a prophylactic drug to be 
used in malaria elimination efforts such as mass drug administration, in 
combination with other effective anti-malarials. To further explore this 
question in Mozambique, additional studies will be performed on adults 
with clinical malaria and special populations.
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HETEROGENEITY OF PLASMODIUM FALCIPARUM MALARIA 
CASES IN MATABELELAND SOUTH: ANALYSIS OF CASES 
REPORTING TRAVEL HISTORY IN THE EARLY STAGES OF AN 
ELIMINATION PROGRAM
Joseph Mberikunashe1, Abel Brian Maponga2, Heather 
Chamberlain3, Victor Alegana3, Andrew J. Tatem3, Deepa Pindolia4, 
Jehan Ahmed4, Katelyn Woolheater4, Charlotte Dolenz4, Arnaud 
Le Menach4, Abaden Svisva4, Jason Owen4, Munashe Madinga4, 
Brighton Gambinga4
1Zimbabwe National Malaria Control Programme, Harare, Zimbabwe, 
2Ministry of Health and Child Care, Beitbridge, Zimbabwe, 3WorldPop, 
Geography and Environment, University of Southampton, Southampton, 
United Kingdom, 4Clinton Health Access Initiative, Boston, MA, United 
States
As malaria prevalence decreases, imported malaria cases pose a challenge 
to malaria programs due to their potential to instigate local transmission. 
Travel history of RDT-confirmed cases, available through routine passive 
surveillance, was used to estimate potential for malaria importation in 
Zimbabwe’s Matabeleland South province, where an elimination agenda 
was launched in 2013. Individual travel history records from 1,190 cases 
reported between September 2014 and June 2015 were analysed to 
quantify the number of cases travelling within Matabeleland South, to 
other parts of Zimbabwe and outside Zimbabwe. Reported travel locations 
of cases were geo-located. 185 (15.5%) of cases were reported to have 
travelled outside their home in the past 4 weeks, of which 99 (53.5%) 
were domestic travellers and 86 (46.5%) were international travellers. 
Beitbridge (63%) and Gwanda (21%) reported greatest proportion of 
cases that travelled. 44.3% of cases with travel outside Matabeleland 
South were identified in low transmission risk settings (<1 case per 1,000) 
and 20% were in high and medium transmission risk areas (>10 cases per 
1,000) of the province. Environmental Health Practitioners classified 80 
(6.7%) of all 1,190 confirmed cases as imported (transmission occurred 
outside Matabeleland South), 11 (0.9%) as intraported (transmission 
occurred outside case’s home district but within Matabeleland South), 
and 744 (62.5%) as local (transmission occurred in home district of case). 
As locations reported in travel history data were described by coarse 
spatial resolutions, accurate classification was a challenge. Characteristics 
such as age, gender, and occupation will be explored to determine 
the demographic differences between travellers and non-travellers. 
Improvements in data collection, validation of travel history and its link to 
infections (including clustering of local cases) are needed for successful 
national and regional elimination of malaria.
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QUANTIFYING MALARIA-ATTRIBUTABLE FEVER IN AFRICA, 
AND THE DIFFERENCE IN TREATMENT-SEEKING RATES 
FOR MALARIA-COINCIDENT FEVERS AND NON-MALARIAL 
FEBRILE ILLNESS
Ursula Dalrymple, Ewan Cameron, Daniel J. Weiss, Samir Bhatt, 
Katherine E. Battle, Donal Bisanzio, Peter W. Gething
University of Oxford, Oxford, United Kingdom
Malaria is typically assumed to be the causal parasite of febrile illness 
in Africa. While it is increasingly common for individuals to receive a 
diagnostic test for malaria before receiving treatment, it remains possible 
that the individual could have a co-infection with another disease that is 
in reality the underlying cause of their fever. Using paired observations of 
two-week fever history and Plasmodium falciparum malaria positivity from 
household survey datasets, we use model-based geostatistics to estimate 
prevalence of malaria-attributable fever, malaria-coincident fever, and 
non-malarial febrile illness across Africa. We show that febrile illness that 
is directly attributable to malaria accounts for a decreasing proportion 
of malaria-coincident febrile illness with increasing malaria prevalence, 
and that non-malarial febrile illness is widespread across the continent. 
Additionally, using household survey data on treatment-seeking rates for 
febrile illness, we show the difference in treatment-seeking rates between 
individuals with a malaria-coincident fever and non-malaria fevers. We 
show that if a substantial number of symptomatic malaria infections are 
not seeking care for their symptoms in low-transmission areas, then small-
scale outbreaks may remain undetected, causing a problem for malaria 
elimination.
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SPATIAL DISTRIBUTION OF MALARIA CASES AND 
VECTORS IN A HYPO-ENDEMIC AREA OF WESTERN KENYA 
HIGHLANDS
Ebenezer K. Aidoo1, Yaw A. Afrane2, Bernard W. Lawson3, 
Harrysone Atieli4, Guofa Zhou5, Andrew K. Githeko1, Guiyun Yan5
1Climate and Human Health Research Unit, Kenya Medical Research 
Institute, Kisumu, Kenya, 2Department of Medical Microbiology, College 
of Health Sciences, University of Ghana, Korle - Bu, Ghana, 3Department 
of Theoretical and Applied Biology, College of Science, Kwame Nkrumah 
University of Science and Technology, Kumasi, Ghana, 4School of Public 
Health, Maseno University, Maseno, Kenya, 5University of California, Irvine, 
CA, United States
Malaria transmission in hypo endemic areas of Western Kenya highlands 
have been significantly reduced by extensive use of insecticide treated 
bed nets. However, residual transmission continues to maintain the 
disease in the community. Ecological studies suggest that there are 
foci of transmission. This study was undertaken to determine whether 
the distribution of malaria cases is random or clustered. Forty four 
microscopically confirmed index malaria cases from a local hospital were 
identified and homesteads of these patients geo-referenced. Household 
members in the index case population were screened for malaria. Houses 
located at a distance of 500 - 1000 m radius from the index case houses 
were identified and blood samples obtained for malaria diagnoses. This 
group served as the control. Mosquitoes were collected in the index case 
houses and control houses using pyrethrum spray catches. The number 
of malaria cases and vector density was compared between index case 
households and control population. In the index case household, the 
prevalence of malaria cases was 8 % compared to 4 % in the control 
houses. In the index case houses, vector density was 0.11 for Anopheles 
gambiae and 0.38 for An. funestus. In contrast, vector density in the 
control houses was 0.04 for An. gambiae and 0.27 for An. funestus .The 
malaria prevalence in the index case household was 2 fold greater than 
the control household. The indoor house density for Anopheles gambiae 
and Anopheles funestus were respectively 2.8 and 1.4 fold, greater in the 
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index houses compared to the control. Differences in the indoor density 
of the mosquitoes species were significant (P = 0.04). The data indicates 
higher transmission and malaria prevalence in the index case houses 
compared to the control, hence an indication of non-random vector and 
case distribution. Analysis of spatial distribution will be undertaken to 
show relationship between malaria cases and potential breeding habitats.
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SEVERE FLOODING AND MALARIA TRANSMISSION: 
IMPLICATIONS FOR DISEASE CONTROL IN AN ERA OF 
GLOBAL CLIMATE CHANGE
Ross M. Boyce1, Raquel Reyes1, Michael Matte2, Moses Ntaro2, 
Edgar Mulogo2, Joshua P. Metlay3, Lawrence Band1, Mark Siedner3
1University of North Carolina at Chapel Hill, Chapel Hill, NC, United 
States, 2Mbarara University of Science and Technology, Mbarara, Uganda, 
3Massachusetts General Hospital, Boston, MA, United States
There are several mechanisms by which global climate change may 
impact malaria transmission, including those that relate to changes in the 
frequency of extreme weather events including heat, drought, and floods. 
We sought to assess how the increased frequency of extreme precipitation 
events associated with global climate change will impact malaria 
transmission in highland areas of East Africa. We used a differences-in-
differences, quasi-experimental design to examine spatial variability in 
the incidence rate of laboratory-confirmed malaria cases and malaria-
related hospitalizations comparing villages at (1) high vs. low elevations, 
(2) with and without rivers, and (3) upstream vs. downstream before and 
after severe flooding that occurred May 1, 2013 in the Kasese District 
of Western Uganda. Findings: During the study period 7,596 diagnostic 
test were performed and 1,285 patients were admitted with a diagnosis 
of malaria. We observed that extreme flooding resulted in an increase of 
approximately 30% in the risk of an individual having a positive malaria 
diagnostic test in the post-flood period in villages bordering a flood-
affected river compared with villages further from a river with a larger 
relative impact on upstream vs. downstream villages (adjusted RR 1.91 vs. 
1.33). In conclusion, extreme precipitation such as the flooding described 
here may pose significant challenges to malaria control and elimination 
programs, and will demand timely and sustained responses to prevent and 
mitigate deleterious impacts on human health.
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MALARIA IN THE FIRST TRIMESTER OF PREGNANCY: 
INCIDENCE AND ASSOCIATED RISK FACTORS IN BENIN, SUB-
SAHARAN AFRICA
Manfred M. Accrombessi1, Emmanuel Yovo2, Gilles Cottrell3, 
Nadine Fievet3, Achille Massougbodji2, Michel Cot3, Valérie Briand3
1Institut de Recherche pour le Développement, Cotonou, Benin, 2Centre 
d’Etude et de Recherche sur le Paludisme Associé à la Grossesse et à 
l’Enfance, Cotonou, Benin, 3Institut de Recherche pour le Développement, 
Paris, France
In Africa, preventive drug strategies against malaria in pregnancy are 
recommended from the 2nd trimester and bed nets are rarely used in early 
pregnancy. Therefore, women remain insufficiently, or not, protected 
during the first trimester, when malaria may be particularly deleterious 
for the mother and the child. The incidence of and risk factors associated 
with malaria in the first trimester have been poorly explored so far. A 
subsample of 200 pregnant women recruited before conception, were 
followed up monthly until delivery. Malaria was detected during the 1st, 
2nd and 3rd month of pregnancy. A multivariate mixed model was used 
to assess factors associated with malaria during the first trimester. The 
cumulative incidence of malaria during the first trimester of pregnancy was 
17.8% (11.2% during the first month). Early gestational age (≤ 6 weeks’ 
gestation) (aOR: 2.69 [1.35-5.37]) and living in a lakeside area (aOR: 0.17 
[0.04-0.85]) were the main factors significantly associated with malaria 
in the first trimester. In conclusion, malaria was highly incident during 
the first trimester of pregnancy, particularly during the first month and in 
women living far from the lake. The consequences of these infections for 
the mother and her child need to be assessed.
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FIRST PILOT PROJECT FOR ACTIVE SURVEILLANCE OF 
ASYMPTOMATIC MALARIA CASES IN HISTORICALLY 
ENDEMIC REGIONS IN PARAGUAY BY TWO METHODS 
MICROSCOPY AND MULTIPLEX SEMINESTED PCR
Florencia Del Puerto
Instituto de Investigaciones en Ciencias de las Salud, Universidad Nacional 
de Asunción, San Lorenzo, Paraguay
In 2014, Paraguay was placed among the 16 countries that reported zero 
indigenous cases of Malaria. The implementation of active surveillance 
to detect potential asymptomatic cases in historically endemic regions in 
Paraguay is needed considering the indigenous parasite is Plasmodium 
vivax that contrary to P. falciparum, can remain latent as hypnozoites in the 
host. In the present study we applied the microscopy and the molecular 
diagnosis to search for sub-patent parasitemias in asymptomatic cases. 
Adults from a total of 15 localities from three departments, Alto Paraná, 
Caaguazú and Canindeyú were selected, based on the records of the 
SENEPA considered as the last localities that reported at least one case in 
the period of 2007-2011. The sample size obtained for 95% confidence 
was 361 but 332 samples were collected and analyzed up to now and 
informed consent of each of them was obtained. Thick smears were 
analyzed by microscopy. DNA samples were extracted from blood drop 
dried on filter paper and analyzed by the Seminested Multiplex PCR using 
the primers that amplify the 18 S rDNA for the four species that cause 
Malaria ( P. falciparum, P. ovale, P. malariae and P. vivax). Human 18S rDNA 
was amplified as internal control. Sensitive essays allowed to detect until 
0,01 ng of genomic P. falciparum DNA. From the 332 samples, 11.4% 
were from the department of Canindeyú, 30.1% from Alto Parana and 
58,4% from Caaguazú. The distribution per locality was: 11,4% from Pira 
Vera, 10.5% from Maracamoa, 7.8% from Nueva Esperanza, 11.7% from 
Mision Verbo Divino, 2.4% from San Juan, 1.8% from Mbarigui Indígena, 
17.2% from Mil Palo, 0.9% from Nueva Brasilia, 4.2% from Nueva 
Esperanza, 11.1% from Nueva Toledo, 1.8 from Ñu Jhovy, 3.6% from 
Pindo´i, 2.4% from Santa Clara, 7.5% from Santa Teresa and 5.4 from Yby 
Moroti. Fifty seven percent were female and 43% were male. We could 
not detect any sub-patent parasitemia that can reveal the presence of 
asymptomatic cases. The results obtained in this study are very promising 
for our country, at this stage where all the efforts are done towards the 
eradication of the Malaria.
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MALARIA IN AN INTERNALLY DISPLACED PERSONS CAMP IN 
THE DEMOCRATIC REPUBLIC OF CONGO
Hannah M. Brooks1, Makelele Katsuva Jean Paul2, Kasereka 
Masumbuko Claude3, Michael Hawkes4
1School of Public Health, University of Alberta, Edmonton, AB, Canada, 
2Médecins Sans Frontières, Goma, Democratic Republic of the Congo, 
3Université Catholique du Graben, Butembo, Democratic Republic of the 
Congo, 4Department of Pediatrics, University of Alberta, Edmonton, AB, 
Canada
Malaria remains a leading cause of death in children under 5. Malaria 
prevention and treatment efforts in the Democratic Republic of the 
Congo (DRC) are hindered by armed conflict, which has resulted in the 
displacement of approximately 2.7 million individuals. This study aimed 
to describe malaria cases treated at a health centre serving an internally 
displaced persons (IDP) camp in DRC. The study took place in Luchebere 
IDP camp in the DRC which housed 2,580 individuals (318 children <5) at 
the time of the study in 2014. The camp consisted of two waves of IDPs: 
(1) ~1,400 individuals from Masisi and Walikale in Sept 2013; and (2) 
~1,500 individuals from Northwest Masisi in Jan-Feb 2014. Febrile patients 
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presenting to the only health clinic in the area, which provides free 
medical services to IDPs, were tested for malaria using a rapid diagnostic 
test (Paracheck®). Demographic and clinical data were abstracted from 
clinic records. Uncomplicated malaria cases were treated with artemisinin-
based combination therapy, according to WHO recommendations, and 
severe malaria with intravenous quinine. Between January and July 2014, 
751 patients presenting to the clinic with fever were tested for malaria. 
323/751 (43%) tested positive, including 169/279 (61%) children <5. The 
incidence of malaria requiring treatment in the IDP camp was estimated to 
be at least 210 per 1,000 at risk per year overall and 910 per 1,000 at risk 
per year in children under 5 (>3-fold higher than the WHO Africa region). 
Of the participants with malaria, 292/323 (91%) had uncomplicated 
disease and 28/323 (8.8%) had severe malaria. There were 4 deaths, 2 in 
children <5. 452/751 (60%) of patients had a bednet in their shelter and 
of these, 259/452 (59%) reported using the bednet. Malaria accounted 
for a higher proportion of febrile illness among patients from the second 
wave of IDPs who had lived in the camp for <6 months (72% vs 12%, 
p<0.0001), and among those who reported that they did not use a bednet 
(62% vs 8.9%, p<0.0001). The findings suggest that control measures 
targeting this high risk population may reduce the burden of malaria, 
particularly children under 5 and recent arrivals to the IDP camp.
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PREVALENCE OF SUBMICROSCOPIC MALARIA IN 
PREGNANCY IN COLOMBIA
Kenneth Gavina1, Eliana Arango2, Amanda Maestre2, Stephanie 
Yanow1
1University of Alberta, Edmonton, AB, Canada, 2Universidad de Antioquia, 
Medellín, Colombia
For countries progressing towards malaria elimination, highly sensitive 
diagnostic methods are required to target reservoirs of transmission. 
Currently, microscopy is the gold standard for malaria diagnosis however, 
more sensitive tests are needed to identify low-density submicroscopic 
infections. Pregnant women are an important risk group as they may 
harbour submicroscopic infections which could impact clinical outcomes 
for the mother and fetus. Here, a reverse transcription real-time PCR (RT-
qPCR) was developed for detection of the 18S rRNA gene for Plasmodium 
falciparum and P. vivax. The assay was validated with 42 blood samples 
and demonstrated a specificity and sensitivity of 100% when compared 
to qPCR. To investigate the prevalence of submicroscopic malaria in 
pregnancy, a cohort of 200 women from Colombia were recruited and 
followed longitudinally via antenatal visits until delivery. Of the 38 women 
followed up so far, 19 were positive for submicroscopic malaria during 
pregnancy. 228 samples were screened by RT-qPCR, of which 27 samples 
tested positive. 22%, 59%, and 19% of the infections were caused by 
P. falciparum, P. vivax, or mixed, respectively. Additionally, samples from 
asymptomatic subjects and from febrile patients were collected from 
Colombia and tested via microscopy and RT-qPCR to investigate the 
frequency of submicroscopic malaria outside of pregnancy. Of the 84 
asymptomatic samples screened by RT-qPCR, 6 and 10 were positive for 
P. falciparum and P. vivax, respectively. Further, of the 322 febrile samples 
screened by RT-qPCR, 36 and 66 were positive for P. falciparum and P. 
vivax, respectively. These results reveal a high frequency of submicroscopic 
malaria in this region. We report that 50% of pregnant women followed 
up in this study were positive for a submicroscopic infection at some point 
during pregnancy. 15% of the asymptomatic population and 27% of 
the febrile population were also positive for submicroscopic malaria. We 
propose that the use of more sensitive tests and active surveillance during 
pregnancy will become a necessity for the end goal of malaria elimination 
in this part of Latin America.
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CORRELATION BETWEEN MALARIA INFECTION DURING 
PREGNANCY AND ADVERSE BIRTH OUTCOMES IN VARIED 
MALARIA TRANSMISSION SETTINGS IN UGANDA AND 
BURKINA FASO RESPECTIVELY
John Ategeka1, Daniel Kyabayinze1, Miriam Nakalembe2, Heidi 
Hopkins1
1Foundation For Innovative New Diagnostics (FIND), Kampala, Uganda, 
2Makerere University College of Health Sciences, Kampala, Uganda
Preterm delivery and low birth weight are the leading causes of neonatal 
mortality and morbidity in children below the age of five years. The 
mechanisms under which malaria leads to low birth weight, still birth 
and preterm labor are poorly understood. Using data from a prospective 
cohort in which; 990 pregnant women were enrolled, 853 (85.2%) 
followed through delivery and resulting in 838 live births, we assessed the 
association between malaria infection during pregnancy and adverse birth 
outcome that included low birth weight, still birth, abortions and preterm 
delivery in two African clinical settings (Uganda, hyperendemic, and 
Burkina Faso, seasonal transmission). Women were categorised according 
to their malaria infection history during the study: Baseline, high parasite 
group and low parasite group. A total of 338 (40.8%) were in the baseline 
group, 310 (37.4%) were in the high-level infection group, 120 (14.5%) 
were in the low-level infection group, and 60 (7.2%) had occult or early 
infections. Overall there were 230 adverse birth outcomes across the two 
study sites; this represented 27.0% of all births: Uganda (83) and Burkina 
Faso (147). Premature births represented 74% of adverse outcomes. The 
proportion of preterm births was highest in low parasite group (0.215) in 
Burkina Faso and (0.296) in Uganda. Infection group was not found to 
be a significant predictor of an adverse outcome (P>0.05) using logistic 
regression. Although proportion of infants weighing <2.5kg was highest in 
the occult infection group (0.169), the proportion of infants with low birth 
weight was not significantly associated with infection group (P=0.257) 
even after adjusting for potential confounders (age, gravidity, country and 
weeks of amenorrhea at delivery); infection group did not significantly 
influence the odds of having a low birth weight infant (P=0.603). In the 
cohort of women enrolled in this study, malaria infection during pregnancy 
was not statistically associated with adverse birth outcomes.
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MAPPING CLIMATIC, GEOGRAPHIC AND SOCIO-ECONOMIC 
DETERMINANTS OF MALARIA IN MALAWI FOR MALARIA 
RISK ASSESSMENT
James Chirombo1, Rachel Lowe2, Dianne J. Terlouw3, Pietro 
Ceccato4, Madeleine C. Thomson4, Peter J. Diggle5, Jonathan M. 
Read5
1Lancaster University Medical School/Malawi Liverpool Wellcome Trust 
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del Clima (IC3), Barcelona, Spain, 3Malawi Liverpool Wellcome Trust Clinical 
Research Programme/Liverpool School of Tropical Medicine, Blantyre, 
Malawi, 4International Research Institute for Climate and Society, New 
York, NY, United States, 5Lancaster University Medical School, Lancaster, 
United Kingdom
The 2016-2030 WHO global technical strategy for malaria aims to 
reduce malaria case incidence by 90% in 2030. Achieving this will not 
only depend on new interventions but require optimal use of novel 
technologies and methods. More accurate profiling of geographical 
variation in malaria over time, aimed at identifying transmission hotspots, 
will enable more targeted control. Modelling interactions between 
various potential drivers and their effect on malaria risk can also lead to a 
better understanding of transmission dynamics. Modern spatio-temporal 
statistical models and Bayesian predictive inference are particularly well 
suited to mapping health outcomes in low resource settings for (at least) 
three reasons. Firstly, they enable more precise prediction in data-sparse 
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regions by exploiting spatio-temporal dependence in the health outcome 
of interest in addition to associations with spatio-temporally dense 
environmental covariates. Secondly, they can simultaneously capture 
spatial variation at large and small scales. Finally, they deliver honest 
assessments of predictive uncertainty. We use spatio-temporal statistical 
models to investigate the contribution of climatic, environmental and 
socio-economic factors to district-level variation in malaria risk in Malawi. 
Outcome data (malaria cases) are taken from an age stratified health 
management information system data covering all 28 districts in Malawi 
between July 2004 and December 2015 while socio-economic data are 
obtained from national surveys. Remotely sensed climate data averaged 
over the districts are used to capture the impact of climatic variations on 
transmission. We first assessed covariate effects in a non-spatial model to 
identify the most important significant drivers of malaria, which we then 
used to build a spatio-temporal model and generate Bayesian predictive 
maps of spatial variation in disease risk. These predictive maps serve two 
purposes: to highlight areas of unusually high and low risk that could 
inform sub-district surveillance and control strategies; and to target 
augmented sampling designs on areas where current predictions are 
imprecise.
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RURAL-URBAN DIFFERENCES IN THE UTILIZATION OF 
MALARIA PREVENTIVE AND TREATMENT SERVICES BY 
WOMEN OF REPRODUCTIVE AGE GROUP IN NIGERIA
Tolu M. Arowolo1, Sam T. Awolola2, Olufemi O. Ajumobi3
1London School of Hygiene & Tropical Medicine, London, United Kingdom, 
2Nigeria Institute of Medical Research, Lagos, Nigeria, 3National Malaria 
Elimination Programme, Abuja, Nigeria
Nigeria witnessed a dramatic improvement in the provision of universal 
access to malaria prevention, diagnosis and treatment tools. The objective 
of this analysis is to describe rural urban differences in the utilization 
of malaria preventive and treatment services in Nigeria by women of 
reproductive age group to inform malaria control programming and 
planning. A cross sectional survey involving 6,344 women aged 15-
49 years selected through multi staged cluster sampling procedure. 
Descriptive analysis was done to obtain weighted prevalence and 
proportions of women background characteristics and selected outcome 
variables. Univariate and multivariate logistic regression analyses were then 
conducted to obtain crude and adjusted odds ratios for the hypothesized 
association. Statistical testing was done using the adjusted Wald test. 
An estimated 30% of the women reported the use of net the night 
before the survey. 30% of them claimed their children had experienced 
fever in the preceding 2 weeks before the survey but only 14% had a 
malaria confirmatory test for their children. An estimated 65% percent 
of the women who sought treatment for their children used the private 
sector. Rural women have about twice the odds of using a net than their 
urban counterparts (2.12(1.47; 3.06), p<0.001). The odds of using nets 
decrease with any form of formal education, with increasing wealth 
index and among older women. Further multivariate analysis showed 
that younger, rural women are more likely to use net OR (1.77(1.12; 
2.80) p=0.013) while the inverse relationship between level of education 
and net use persisted. There is no evidence of an association between 
place of residence and malaria diagnostic testing. Utilization of net is 
generally low with more tendencies to use net among rural, un-educated 
and lower socio economic status. Treatment of malaria based on clinical 
suspicion is widely prevalent and majority of the women patronize the 
private sector. Recommendations were made for public health strategies to 
encourage use of nets; improve infrastructures for malaria diagnosis and 
strengthening of the health system.
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DESIGN OF A CLUSTER SURVEY STUDY TO DESCRIBE THE 
EPIDEMIOLOGY OF MALARIA GAMETOCYTE CARRIAGE 
AND TRANSMISSION DYNAMICS IN A HOLOENDEMIC 
TRANSMISSION SETTING IN KISUMU COUNTY, WESTERN 
KENYA
Ben Andagalu1, Irene A. Omollo1, Irene A. Onyango1, Shirley 
Onyango1, Peter Sifuna1, Benjamin Opot1, David Abuom1, Hoseah 
M. Akala1, Matthew Brown2, Derek Monthei2, Jessica Cowden2
1Kenya Medical Research Institute/United States Army Medical Research 
Directorate – Kenya (The Walter Reed Project), Kisumu, Kenya, 2United 
States Army Medical Research Directorate – Kenya, Kisumu, Kenya
To better target malaria control interventions, more information is needed 
about the human, mosquito and environmental factors that affect who 
is carrying gametocytes and who among these carriers is transmitting 
malaria. While human and parasite factors, including the intensity and 
duration of gametocytemia, affect infectiousness at the individual level, 
entomological factors such as mosquito exposure dictate the transmission 
potential of each individual and the infectious reservoir as a whole. 
Most malaria transmission studies have not measured these factors 
simultaneously and longitudinally. Here, we describe the design of a 
pilot cluster design survey study that is simultaneously and longitudinally 
assessing human, parasite and entomologic factors that influence malaria 
transmission in Kisumu, Kenya. The study area is a 369km2 region located 
on the northeastern shores of Lake Victoria that has been mapped using 
Global Positioning System (GPS) technology and divided into clusters that 
measure 1km by 1km. Thirty clusters were randomly selected, ensuring 
at least a 1 km buffer zone around a selected cluster and that each 
selected cluster had at least 4 households with each household having 
at least 1 person in all of the following age categories: above 25 years, 
below 5 years and between 6 and 25 years. Field workers with GPS 
devices were sent to the homesteads to obtain consent from the heads 
of the households. The clusters cover 18% of the total study area. Each 
cluster is visited weekly and each homestead monthly to collect resting 
mosquitoes as well as epidemiological data and blood samples from the 
study participants. Testing for the presence of asexual and sexual stages by 
microscopy and molecular methods is performed on the samples collected 
from the study participants. Female mosquitoes are dissected and tested 
for the presence of Plasmodium sp. An analysis of blood meal is done 
for fed female mosquitoes. Individuals identified to harbor gametocytes 
undergo mosquito feeding assays; a subset of adults undergo both direct 
and membrane feeding assays for direct assay comparison. Preliminary 
findings will be presented.
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INCREASE IN MALARIA AWARENESS AND REDUCTION 
IN MALARIA PREVALENCE IN ENDEMIC DISTRICTS OF 
BANGLADESH: EVIDENCE FROM FOLLOW UP MALARIA 
PREVALENCE SURVEY 2013
Mohammad Shafiul Alam1, Mohammad Moktadir Kabir2, 
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Ferdous2, Wasif Ali Khan1, Dinesh Mondal1, Jahirul Karim3, A K M 
Shasuzzaman4, Be-Nazir Ahmed5, Md. Akramul Islam2, Rashidul 
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1International Centre for Diarrhoeal Disease Research, Bangladesh, 
Dhaka, Bangladesh, 2BRAC, Dhaka, Bangladesh, 3National Malaria Control 
Programme, DGHS, Dhaka, Bangladesh, 4DGHS, Dhaka, Bangladesh, 
5NIPSOM, Dhaka, Bangladesh
Malaria is endemic in 13 districts of Bangladesh. A baseline malaria 
prevalence survey across the endemic districts of Bangladesh in 2007 was 
conducted by our group, when the point prevalence was reported around 
39.7 per 1,000 population. Followed by the two rounds of Global Fund 
to Fight AIDS, Tuberculosis and Malaria (GFATM) funded intervention by 
102
astmh.org
National Malaria Control Programme and BRAC led NGO consortium we 
had conducted a follow up survey during August to November 2013 in 
70 upazilas (sub districts) of 13 malaria endemic districts of Bangladesh 
to measure the reduction following GFATM interventions.. We used a 
multi-stage cluster sampling technique to collect 9750 blood samples from 
same number of households. We used “FalciVax” rapid diagnostic tests 
(RDT) to diagnose malaria from blood from randomly selected individual 
from a household and the test result was recorded. The same RDT was 
used during the baseline survey. As in the baseline survey, the household 
head or available eldest person was interviewed using a pre-coded 
structured questionnaire to collect data on the knowledge and awareness 
to malaria of the household. Based on weighted calculation, overall 
malaria prevalence was found 1.4 per 1,000 population. The proportion 
of Plasmodium falciparum mono infection was 78% while P. vivax and 
mixed infection of these two species were 11% in both cases which was 
90.2% for P. falciparum mono infection 5.3% and 4.5% for P. vivax and 
mixed infection during 2007. Bandarban was the highest malaria prevalent 
district (6.7 per 1,000 population) in the follow up survey. Knowledge 
on malaria sign and symptoms and mode of transmission were found 
better in follow up survey (97.3%) than the baseline survey (34.0%). 
Use of insecticide treated bed nets for prevention of malaria was found 
high (90.2%) at the respondents level during follow up survey. Overall, 
people in Chittagong hill tracts areas had slightly better knowledge than 
those in other areas. In a nutshell, a reduced point prevalence of malaria 
and increased level of knowledge were reported in the follow up malaria 
prevalence survey in Bangladesh.
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SEASONAL CHANGES IN THE ANTIBODY RESPONSES 
AGAINST PLASMODIUM FALCIPARUM ANTIGENS ON 
ISLANDS IN LAKE VICTORIA, KENYA
Zulkarnain Md Idris1, Chim W. Chan1, James Kongere2, Tom 
Hall3, Chris Drakeley3, Akira Kaneko1
1Karolinska Institutet, Island Malaria Group, Department of Microbiology, 
Tumor and Cell Biology (MTC), Stockholm, Sweden, 2Nagasaki University 
Nairobi Research Station, NUITM-KEMRI Project, Nairobi, Kenya, 
3Department of Immunology and Infection, London School of Hygiene & 
Tropical Medicine, London, United Kingdom
Anti-malaria antibody responses can help characterize heterogeneous 
in malaria transmission. In the present study antibody responses to 
Plasmodium falciparum AMA-1, MSP-119 and CSP were measured to 
assess the transmission intensity in meso-endemic settings in Lake Victoria. 
Two cross-sectional surveys were conducted in dry and wet seasons in 
2012 comprised of five settings: Ungoye (mainland), Mfangano (large 
island) and small islands (Takawiri, Kibuogi, Ngodhe). Individuals provide 
a finger-blood sample to assess malaria infection by rapid diagnostic test 
(RDT). Exposure to malaria antibodies were detected by ELISA using eluted 
dried blood form filter paper. Of 5044 participants, RDT tests were done 
in 4852 (96.2%) and 4112 (81.5%) were tested for serology. The overall 
seroprevalence was 64.0% for AMA-1, 39.5% for MSP-119, and 12.9% 
for CSP. Within settings, seroprevalences for merozoite antigens were 
higher in Ungoye and Mfangano than in small islands, showed different 
patterns between seasons and consistently high in the wet season for CSP 
(p<0.01). The overall seroprevalence and antibody titers generally increase 
with age group (p<0.001). Seroconversion rates (SCR) demonstrated 
different patterns between seasons where AMA-1 seroconversion rates 
constantly high and similar in Ungoye, decreased in Mfangano and 
Takawiri but increased in Kibuogi and Ngodhe from dry to wet seasons. 
Increasing age was strongly associated with increased odd of seropositivity 
in all settings. We observed heterogeneity of parasite prevalence and 
serological indices acroos study sites and temporal changes in the force 
of infection islands in Lake Victoria. These data suggest that AMA-1 sero-
epidemiological analysis may have a role in assessing short-term changes in 
exposure especially in high or seasonal transmission settings and appeared 
to best reflect transmission intensity.
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IMPACT OF ANTIMALARIAL INTERVENTIONS ON MALARIA 
MORBIDLY AND MORTALITY IN HOSPITALS FROM 2001-
2015, SENEGAL
Medoune Ndiop, Alioune Badara Gueye, Ibrahima Diallo, 
Moustapha Cisse, Mamadou Lamine Diouf
National Malaria Control Programm, Dakar, Senegal
The Senegal National Malaria Control Program and partners accelerated 
malaria control in the last decade, with nationwide roll-out of artemisinin-
based combination therapy (ACT) starting in 2006, and rapid diagnostic 
tests (RDTs) starting in October 2007. Since 2003, insecticide-treated 
nets (ITNs) have been distributed through health facilities to pregnant 
women and children under five years, and since 2008, mass campaigns 
of ITN distribution have targeted children under five years, with universal 
coverage starting in 2010, and 2014. Since 2007, indoor residual spraying 
has been implemented in seven districts. We assessed the trends of malaria 
cases, hospitalizations and deaths at 35 hospitals and in all 76 districts 
during the period of the scale-up of malaria control interventions. Data 
collected from all hospitals and districts from 2001-2015 were used to 
assess the impact of accelerated malaria control. Numbers of outpatient 
and inpatient cases and deaths were compared between the 2001-2007 
period and the accelerated - intervention period of 2008-2015. From 2001 
to 2007, the proportion of suspect cases confirmed increased slightly from 
2.2% to 4.0%. With the introduction of RDTs, this increased to 99.3% in 
2015, with a mean test positivity rate of 42% during the 15 year period. 
The proportion of all consultations due to malaria decreased from 39.7% 
in 2001 to 26.9% in 2007 (pre-RDT). After the introduction of RDTs and 
change in definition from clinical to laboratory-confirmed, the proportion 
of all consultations due to malaria decreased from 9.1% in 2008 to 5.0% 
in 2015. The proportion of patients hospitalized for malaria accounted for 
11.5% of all hospitalizations in 2001, and decreased to 7.5% in 2015. 
From 2001 to 2007, the proportion of hospitalized deaths attributable 
to malaria decreased from 24.5% in 2001 to 8.1% in 2007. From 2008 
to 2015, the proportion of hospitalized deaths attributable to malaria 
decreased from 7.1% to 3.5%. We conclude that malaria morbidity and 
mortality has decreased substantially during the scale up of malaria control 
interventions.
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ASSOCIATION BETWEEN HOUSE QUALITY AND MALARIA 
INFECTION IN SUB-SAHARAN AFRICA: A MULTI-COUNTRY 
ANALYSIS
Lucy S. Tusting1, Christian Bottomley2, Harry Gibson1, Immo 
Kleinschmidt2, Andrew Tatem3, Steve W. Lindsay4, Peter W. 
Gething1
1University of Oxford, Oxford, United Kingdom, 2London School of 
Hygiene & Tropical Medicine, London, United Kingdom, 3University of 
Southampton, Southampton, United Kingdom, 4Durham University, 
Durham, United Kingdom
Improvements to housing may contribute to malaria control and 
elimination by reducing house entry by malaria vectors and thus exposure 
to biting. We tested the hypothesis that malaria infection risk is lower 
in modern, improved housing compared to traditional housing in sub-
Saharan Africa (SSA). All Demographic and Heath Surveys (DHS) and 
Malaria Indicator Surveys (MIS) that measured malaria infection by rapid 
diagnostic test or microscopy in SSA were analysed. Houses built using 
non-rudimentary wall, roof and floor materials were classified as modern 
and all other houses were classified as traditional. Conditional logistic 
regression was used to determine the association between house quality 
and prevalence of malaria infection in children aged 0-5 years, adjusting 
for age, gender, intervention coverage, household wealth and geographic 
cluster. We will present the association between house quality and the 
odds of malaria infection in children and discuss the potential of improved 
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housing as an intervention against malaria in a range of transmission 
settings across SSA. Improved housing may be an important strategy to 
prevent the re-introduction of malaria in areas where malaria has been 
eliminated.
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NOVEL APPLICATION OF A SPATIAL ANALYSIS METHOD 
IDENTIFYING FINE-SCALE SPATIAL CLUSTERING OF MALARIA 
DISEASE AND MOSQUITO VECTORS AMONG MATCHED 
CASES AND CONTROLS IN BLANTYRE, MALAWI
Lindsay Townes1, Atupele Kapito-Tembo2, Don P. Mathanga2, 
Karl B. Seydel3, Andrew Bauleni2, Clarissa Valim4, Terrie E. Taylor3, 
Mark L. Wilson1
1University of Michigan, Ann Arbor, MI, United States, 2Malaria Alert 
Centre, Blantyre, Malawi, 3Michigan State University, East Lansing, MI, 
United States, 4Harvard University, Cambridge, MA, United States
Matching cases and controls in epidemiological studies usually produces 
greater statistical power in analyses, but precludes direct analysis of 
matched variables on the outcome. We analyzed clinical cases of malaria in 
under-five year olds in Blantyre Malawi (n=187) with age-, and residence- 
matched controls (n=286) who were Plasmodium-negative from the same 
clinic. To explore spatial patterns of household environmental risks among 
malaria cases and vectors, we used nonhomogeneous Poisson point 
process (NPPP), an analytic method employed in landscape ecology, which 
treats the cases as a ‘presence-only’ data set and omits controls from 
analysis, to determine environmental variables associated with malaria case 
or anopheline-positive households. Using this method, non-random spatial 
distributions of case (p<0.01) and anopheline-positive households (p<0.01) 
were detected. In a ‘pseudo-absence’ logistic regression model informed 
by NPPP results, environmental variables associated with both malaria 
case- and anopheline-positive households included natural roofs (p<0.01), 
unfinished walls (p=0.02), open eaves (p=0.02), and proximity to open 
water (p=0.02). NPPP is a method that can expand the use of matched 
case-control data that has been matched on location, although there is a 
cost in power related to diminished sample size. These results demonstrate 
that there are environmental factors associated with increased risk of 
malaria in urban and peri-urban Blantyre.
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SCALING-UP AND USING ROUTINE MALARIA SURVEILLANCE 
DATA TO IDENTIFY MALARIA HOTSPOTS AND TARGET 
MALARIA CONTROL INTERVENTIONS DURING AND AFTER 
THE EBOLA EPIDEMIC IN GUINEA
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1Guinea National Malaria Control Program, Conakry, Guinea, 2U.S. 
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and Malaria, Centers for Disease Control and Prevention, Atlanta, GA, 
United States, 3U.S. Agency for International Development StopPalu 
Project, RTI International, Conakry, Guinea, 4U.S. Agency for International 
Development Systems for Improved Access to Pharmaceuticals and 
Services Project, Management Sciences for Health, Conakry, Guinea, 
5U.S. President’s Malaria Initiative, United States Agency for International 
Development, Conakry, Guinea
Malaria is the principal cause of morbidity and mortality in Guinea; its 
burden was exacerbated by the recent Ebola outbreak. Due to historical 
limitations in the routine health management information system, the 
Guinea National Malaria Control Program (NMCP) developed a monthly 
reporting system for malaria epidemiologic and commodity data prior to 
the outbreak. With the expansion of access to rapid diagnostic tests for 
malaria, the reporting system has facilitated accurate tracking of malaria 
burden through widespread diagnostic confirmation of cases. The scale-
up of this system also coincided with the Ebola outbreak and the related 
interruptions in health care service delivery in Ebola-affected areas. The 
malaria reporting system is based on standardized forms completed 
at health facilities. Data are entered into the electronic system at the 
district level and analyzed by the NMCP. The NMCP issues a monthly 
malaria bulletin that is disseminated nationally and regionally. The bulletin 
reports malaria incidence, testing and treatment rates, and commodity 
stock levels for Guinea’s 38 health districts. Each bulletin also highlights 
the 10 health facilities reporting the highest incidence of malaria cases. 
Completeness of data entered at the district level increased from 66% 
for the first issue in November 2014, to 82% by March 2015, to 97% in 
January 2016. As data completeness improved, the bulletin allowed the 
NMCP to identify a high malaria transmission hotspot in Boffa district, 
where annualized malaria incidence in certain areas was as high as 425 
cases per 1,000 population. Follow-up investigations based on surveillance 
data allowed NMCP and district health officers to target behavior change 
communications to hotspot areas. Despite staffing and logistics challenges 
related to the Ebola outbreak, the NMCP was able to successfully scale up 
a new malaria-specific reporting system. This system allowed the NMCP 
to improve data reporting from remote areas and to begin using routine 
surveillance data to identify malaria hotspots and target interventions.
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AN OUTBREAK OF AUTOCHTHONOUS MALARIA IN THE 
ATLANTIC FOREST, STATE OF RIO DE JANEIRO, BRAZIL
Anielle Pina-Costa, André M. Siqueira, Césare Bianco Junior, 
Carolina Romero Cardoso Machado, Otília Helena Rosa Lupi, 
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Sidnei Silva, Maria de Fátima Ferreira-da-Cruz, Cláudio Tadeu 
Daniel-Ribeiro, Patrícia Brasil
FIOCRUZ, Rio de Janeiro, Brazil
In the state of Rio de Janeiro (RJ) malaria transmission was considered 
eliminated in 1968 but since 1993 some sporadic autochthonous cases 
with history of having visited native locations of the Atlantic Forest (AF) 
are been described with no identifiable source of infection. From 2006 
to 2014, 51 autochthonous malaria cases were reported, an average of 
5.6 cases/year. We describe an outbreak of autochthonous malaria that 
occurred in 2015 in the AF of RJ state diagnosed in Fiocruz. A FOUR-fold 
increase over the average of autochthonous malaria cases from RJ, with 25 
individuals without history of travelling outside the State being diagnosed 
with malaria infection. Most male (23/25) aged 7-59 years (median 41y), 
with clinical presentation characterized by sudden onset of fever, chills, 
headache, and myalgia. The time from onset of symptoms and diagnosis 
varied from 3 to 21 days (median 13 days). The fever pattern was daily 
progressing to a tertian pattern after a median of 10 days. Microscopic 
examination (thick blood smear) showed low parasitaemia (48 p/mm3 
to 1200 p/mm3) with unusual morphological forms of Plasmodium 
vivax. All cases were positive for P. vivax by PCR, and this is currently 
been investigated by genomic sequencing. No patient presented clinical 
or laboratory complications and all were treated with chloroquine and 
primaquine, as recommended by Brazilian guidelines. Most (22/25) were 
inhabitants of RJ capital city, who visited AF areas for leisure or work-
related activities in vegetation-dense areas (median 8 days). The median 
time between probable exposure and onset of symptoms was 24.5 days 
(range: 17 to 41). No individual had visited well-established malaria 
endemic areas or had any other risk factor for infection. The presumed 
areas where the infections occurred are widespread throughout the AF 
with mountainous topography and very dense native vegetation coverage, 
a natural habitat for malaria vectors Anopheles (Kerteszia), and with 
circulation of non human primates. This indicates that the transmission can 
occur, and may reflect the existence of a zoonotic transmission cycle.
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BREAKDOWN IN MALARIA CONTROL IN VENEZUELA - 440% 
INCREASE IN MALARIA CASES
Leopoldo Villegas, Maria-Mercedes Villegas, Maria Guevara
ASOCIS, Tumeremo, Bolivar, Bolivarian Republic of Venezuela
Venezuela’s health care system is in deep crisis at all levels. Patients in 
urban and rural areas do not have access to essential drugs and prevention 
activities have been severely affected. The country is experiencing a 
breakdown in malaria control and national health authorities stopped 
reporting malaria epidemiological information in November 2015. The 
routine weekly malaria reporting system started in the 1960s and plays 
a key role in the identification of malaria epidemics and it is a useful tool 
for decision-making at the national malaria program. The objective of 
this study was to describe the changes in the total number of confirmed 
malaria cases (officially reported) between 2000-2015 and compared 
them with the adjusted malaria estimations for the same period. 
Malaria morbidity data was updated incorporating information from 
the Venezuelan health system including annual national epidemiological 
bulletin, the world malaria report 2015, and data on relapses, 
recrudescences, under reporting and self-treatment rates. Between 2000-
2015, Venezuela officially reported 794,531 cases of malaria contrasting 
with the estimated 1,172,285 malaria cases for the same period. 
Compared to the baseline in 2000, in 2015 Venezuela had a 350% and 
440% increased of reported and estimated malaria cases respectively. This 
represent approximately 25% of the malaria cases in the Americas. 80% 
of Venezuelan’s malaria morbidity is concentrated in Sifontes Municipality, 
Bolivar State a complex operating environment with high mobilization, 
crime rates, illegal mining and lack of security. Malaria interventions are 
limited in the country: there is not mass/routine distribution of bednets, 
stock out of antimalarials are common, no malaria rapid test are routinely 
used and logistical/administrative limitations impedes the implementation 
of the activities. It is unjustifiable that in a country that has a trillion dollars 
from oil revenues in the last decade has derailed its health’s investment to 
protect its population from malaria. There is a need to act now to prevent 
further spread of this malaria epidemic in Venezuela and neighboring 
countries.
333
EFFECTS OF SEASONALITY AND HOST FACTORS ON 
LONGITUDINAL PLASMODIUM FALCIPARUM GAMETOCYTE 
PREVALENCE IN KENIEROBA, MALI
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In order to build upon recent gains in global malaria control and 
elimination efforts, it is necessary to enhance our current understanding 
of the spatiotemporal dynamics of parasite carriage and the human risk 
factors affecting them in areas with varying transmission patterns and 
intensities. To achieve this objective, sensitive molecular diagnostic tools 
have been recently developed and applied in epidemiological surveys 
of both Plasmodium falciparum blood-stage parasites and sexual-stage 
gametocytes in endemic areas. However, many of these studies are cross-
sectional by design and fail to effectively address the longitudinal dynamics 
of gametocytes that are critical for transmission. In Kenieroba, Mali, 
where malaria transmission follows a seasonal pattern, we conducted a 
one-year longitudinal cohort study and used molecular methods to assess 
the dynamics of both total parasite and gametocyte prevalence among 
village residents. From June 2013 to May 2014, we followed a cohort 
of 500 individuals aged 1-65 years that represented the age structure 
of the village population, and measured both P. falciparum parasitemia 
(PCR) and gametocyte prevalence (stage-specific RT-PCR) in peripheral 
blood every two weeks. Approximately 80% of P. falciparum DNA-positive 
individuals were found to be gametocyte-positive, regardless of the time 
of year. In addition to asexual parasite prevalence, host age (peak at 9-16 
years) and gender (higher in males) were also significantly associated 
with longitudinal gametocyte prevalence. Among P. falciparum-positive 
individuals, longitudinal gametocyte prevalence over the one-year period 
was found to be consistently high (median range: 72-82%) among 
children aged 16 years or less, and then declined with increasing age. 
Other host factors (i.e., G6PD genotype, ABO blood type, and sickle-cell 
trait) showed no significant association with longitudinal gametocyte 
prevalence. Our findings show that asexual parasite prevalence, and host 
age and gender are important determinants of longitudinal gametocyte 
prevalence in a seasonal, high-transmission area of Mali.
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THE EFFECT OF HOLES IN LONG-LASTING INSECTICIDAL NETS 
ON MALARIA: A CASE-CONTROL STUDY IN MALAWI, 2013
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Long-lasting insecticidal nets (LLINs) are a cornerstone of malaria 
prevention. Holes develop in LLINs over time, which compromise their 
physical integrity; however, the effect of holes on the risk of malaria 
infection is not well known. After a mass LLIN distribution in southern 
Malawi in 2012 that led to >95% LLIN coverage among children, we 
conducted one of the first in-depth studies to assess the relationship 
between LLIN holes and malaria. From March–September 2013, we 
enrolled febrile children ages 6–59 months who consistently slept under 
LLINs (every night for two weeks before illness onset) in a case-control 
study at a clinic. Cases were positive for Plasmodium by microscopy, 
and controls were negative. Digital photographs of participants’ LLINs 
were taken and analyzed using image processing software to measure 
holes. Total hole area was divided into quartiles and the World Health 
Organization’s (WHO) proportionate Hole Index (pHI) cut-offs: <79 cm2 
(good), 80–789 cm2 (damaged), and >790 cm2 (too torn). We compared 
hole characteristics between case and control LLINs using non-parametric 
and logistic regression analyses. Of 248 LLINs analyzed, 97 (39%) were 
from cases. Overall, 86% of LLINs had at least one hole. The median 
number of holes per net was 9 for case and control LLINs (p=.82). Hole 
location was divided into roof, upper halves, and lower halves. For both 
case and control LLINs, the median number of holes in the roof was 0 
and in the upper halves was 2. The median number of holes in the lower 
halves of LLINs was 6 for cases and 7 for controls (p=.63). Median total 
hole area was 10 cm2 for controls and 8 cm2 for cases (p=.10). Multivariate 
modeling showed no association between pHI or total hole area quartiles 
and malaria, controlling for child age, caregiver education, socioeconomic 
status, windows, closed versus open housing eaves, and iron versus 
thatched roof. LLINs in this study were in relatively good condition one 
year after an LLIN campaign, which may be why holes were not associated 
with increased odds of malaria. Future studies should examine associations 
between LLIN holes and malaria risk in other populations and with more 
damaged nets.
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INTER-PROVINCIAL DIFFERENCES IN MALARIA CASE 
MANAGEMENT PRACTICES IN ANGOLA: A CROSS-
SECTIONAL HEALTH FACILITY SURVEY
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Malaria accounts for the largest portion of healthcare demand in Angola. 
A pillar of malaria control in Angola is the appropriate management of 
malaria illness, including testing of suspect cases with rapid diagnostic 
tests (RDTs) and treatment of confirmed cases with artemisinin-based 
combination therapies (ACTs). Periodic systematic evaluations of malaria 
case management are recommended to measure health facility (HF) 
readiness and adherence to national case management guidelines. 
Cross-sectional HF surveys were performed in low-transmission Huambo 
and high-transmission Uíge Provinces in early 2016. In each province, 
45 HFs were randomly selected from among all public HFs. Survey 
teams performed inventories of malaria commodities and conducted 
exit interviews and re-examinations, including RDT testing, of a random 
selection of all patients completing outpatient consultations. Key HF 
readiness and case management indicators were calculated adjusting for 
the cluster sampling design. Availability of RDTs on the day of the survey 
was 71% (54-83) in Huambo and 85% (67-94) in Uíge. At least one 
formulation of an ACT was available in 83% (66-92) of HFs in Huambo 
and 79% (61-90) of HFs in Uíge. A total of 590 patients in Huambo and 
634 in Uíge were re-examined. Among re-examined patients in Huambo, 
8.9% (95% CI: 5-15) were true malaria cases, compared to 32% (26-
39) in Uíge. Testing rates of suspect malaria cases in Huambo were 31% 
(23-39) versus 70% (55-82) in Uíge. Overall, 28% (13-50) of patients 
with uncomplicated malaria, as determined during the re-examination, 
were appropriately treated with an ACT with the correct dose in Huambo, 
compared to 62% (44-77) in Uíge. The results reveal important differences 
between provinces. Despite similar availability of RDTs and ACTs, testing 
and treatment rates were significantly lower in Huambo compared to Uíge. 
A majority of true malaria cases seeking care in HFs in Huambo were not 
appropriately treated with antimalarials, highlighting the importance of 
continued training and supervision of healthcare workers in malaria case 
management, particularly in areas with decreased malaria transmission.
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Malaria control strategies have focused on children under the age of 5 
years and pregnant women. However, more studies in West Africa showed 
that clinical malaria attacks also occur in adults living in areas of high 
endemicity. The present study was undertaken to investigate the clinical 
malaria incidence in adults living in malaria endemic area. A total of 120 
and 200 volunteers aged from 18 years to 50 years old were enrolled 
respectively in malaria vaccine study of Pfs25-EPA/Alhydrogel® and of 
combined Pfs230D1M-EPA/Alhydrogel® and Pfs25-EPA/Alhydrogel® in 
Bancoumana, Mali. Clinical malaria data were collected from May 2013 
to December 2014 and from May 2015 to December 2015 respectively 
in study cohort of Pfs25-EPA/Alhydrogel® and of combined Pfs230D1M-
EPA/Alhydrogel® and Pfs25-EPA/Alhydrogel®. Malaria smear and or rapid 
diagnostic test (RDT) was performed in case of clinical symptoms to 
confirm clinical malaria before the treatment initiation. In 2013, from July 
to December, the incidence rate of clinical malaria during that transmission 
season period was 0.96 (101/110) episode of malaria per person per 
season. In 2014, during the same malaria transmission season period, 
the incidence rate of clinical malaria was 0.87 episode of malaria per 
person per season (94/107), during that year, the overall incidence rate of 
clinical malaria was 0.99 (106/107) episode per person per year. In 2015, 
from July to December, the incidence rate of clinical malaria during that 
transmission season period was 0.91 (174/191) episode of malaria per 
person per season. During that year, the overall incidence rate of clinical 
malaria was 0.96 (185/191) episode per person per year. The incidence 
of malaria continues to be high and seasonal in Bancoumana in adults 
population. This malaria burden in adult population needs to be taken into 
account in malaria control strategies.
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GENETIC POLYMORPHISM OF MEROZOITE SURFACE 
PROTEIN2 (MSP2) IN PLASMODIUM FALCIPARUM ISOLATES 
FROM PAWE DISTRICT, NORTHWEST ETHIOPIA
Hussein M. Ali, Moges Kassa, Ashenafi Assefa, Mekonnen 
Taddesse, Amha Kebede
Ethiopia Public Health Institute, Addis Ababa, Ethiopia
In malaria-endemic regions, Plasmodium falciparum infection is 
characterized by extensive genetic diversity. Describing this diversity 
provides important information about the local malaria situation. This 
study was conducted to evaluate the extent of genetic diversity of P. 
falciparum in Pawe, in the northwest Ethiopia. A total of 92 isolates from 
patients with uncomplicated P. falciparum attending Pawe Health Centre 
was collected from September to December, 2013.Genomic DNA was 
extracted using Chelex® method and anlysed by length polymorphism 
following gel electrophoresis of DNA products from nested-PCR of msp2 
(block 3) targeting allelic families of FC27 and 3D7/IC. There were 22 
different MSP2 alleles, 11 corresponding to the3D7/ IC/ and 11 to the 
FC27 allelic family. However, isolates of the 3D7/IC allelic family showed 
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higher frequency (87%) compared to FC27 (85%). The overall multiplicity 
of infection was 2.8 (CI 95% 2.55-3.03), seventy-six percent of isolates 
contained multiple infections. The heterozygosity index was 0.75 for msp2 
.There was no statically significant difference in the multiplicity of infection 
by either age or parasite density. In conclusion, this study showed that the 
genetic diversity in P. falciparum isolates from northwest Ethiopia was high 
and mainly of multiple infections.
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ROLE OF ALPHA-THALASSEMIA AND GLUCOSE-
6-PHOSPHATE DEHYDROGENASE DEFICIENCY IN 
PLASMODIUM FALCIPARUM TRANSMISSION FROM HUMAN 
TO MOSQUITO
Yao A. Franck1, Yerbanga R. Serge1, Mangano Valentina2, 
Avellino Pamela2, Santolamazza Federica2, Bancone Germana3, 
Cohuet Anna4, Ouédraogo Jean Bosco1, David Modiano2
1IRSS/DRO, Bobo Dioulasso, Burkina Faso, 2SAPIENZA, Roma, Italy, 3Shoklo 
Malaria Research Unit, Mae Sot, Thailand, 4IRD, Bobo Dioulasso, Burkina 
Faso
Large evidence is available showing that human genetic variation affects 
susceptibility to infectious diseases, but it is unknown whether it also 
affects the host efficiency to transmit pathogens. We have previously 
shown that haemoglobin S and C, known to protect from clinical 
Plasmodium falciparum malaria, increase the transmission of the parasite 
from the human host to the mosquito vector. In this study we evaluated 
the role of 3.7 alpha deletional thalassemia and glucose-6-phosphate 
dehydrogenase deficiency, in the ability to infect mosquitoes.To assess 
the impact of these genetic factors on the ability to infect mosquitoes, 
we conducted Standard Membrane Feeding Assays on blood samples 
from 69 children aged 3-15 years from the village of Soumousso, Burkina 
Faso with known alpha thalassemia and G6PDA- genotypes. A total of 
15515 Anopheles were dissected on day seven after membrane feeding 
and oocysts were detected by microscopy in mosquito guts.We found 
that alpha thalassemia increases both the prevalence and density of P. 
falciparum infection in mosquitoes while G6PDA- increases the prevalence 
but not the density of infection.These results confirm that human genetics 
variation affects P. falciparum transmission from human to mosquitoes.
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GENETIC DIVERSITY AND COMPLEXITY OF PLASMODIUM 
FALCIPARUM ISOLATES IN NORTH-CENTRAL NIGERIA
Emmanuel T. Idowu1, Muyiwa K. Oyebola1, Joshua A. Idakwo1, 
Yetunde A. Olukosi2, Olubunmi A. Otubanjo1, Taiwo S. Awolola2
1University of Lagos, Lagos, Nigeria, 2Nigerian Institute of Medical 
Research, Lagos, Nigeria
Malaria is a parasitic disease of significant public health importance in 
Nigeria. Population-specific investigation of the genetic diversity of the 
parasites is important for effective vaccinological and chemotherapeutic 
intervention. This study determine the genetic diversity of Plasmodium 
falciparum isolates using two antigenic markers in individuals attending 
health facilities in Idah and Ibaji Local Government Areas of Kogi State, 
North-Central, Nigeria. DNA was extracted from finger-prick blood samples 
collected from P. falciparum positive individuals, followed by polymerase 
chain reaction genotyping which targeted the MSP-1 and MSP-2 allelic 
families. All the three families of MSP-1 (K1, MAD20 and RO33) and two 
of MSP-2 (FC27 and 3D7) were observed among the isolates. Prevalence 
of (MSP-1) K1, MAD20 and RO33 were 70%, 20% and 40% respectively 
for Idah while prevalence of 40%, 10% and 20% was recorded for MSP-
1 (K1, MAD20 and RO33) respectively. Analysis of MSP-2 allelic families 
revealed prevalence of FC27 family was 40% in Idah and 30% in Ibaji 
while 3D7 had a prevalence of 20% in both Idah and Ibaji. The frequency 
of FC27 genotypes was higher than 3D7 in both populations. Multiplicity 
of Infections (MoI) for MSP-1 was higher in Ibaji (1.30) than Idah (1.05) 
while MoI with MSP-2 families was lower in Ibaji (2.00) than Idah (2.13). 
There was no significant difference between the MoI values in Idah and 
Ibaji (P > 0.05). The expected heterozygosity (HE) value was 0.56 for MSP-
1 and 0.84 for MSP-2 showing higher diversity in MSP-2. The findings 
showed a high genetic diversity of P. falciparum in the study populations 
providing population-specific genetic information on the malaria parasites 
circulating in North-Central Nigeria.
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INFLUENCE OF GENETIC AND EPIGENETIC VARIATIONS ON 
MALARIA SUSCEPTIBILITY
Himanshu Gupta, Abdul Vahab Saadi, Kapaettu Satyamoorthy
School of Life Sciences, Manipal University, Manipal, India
Erythrocyte phase of Plasmodium falciparum malaria infection results 
from complex membrane sorting and signaling. Proteins in the 
erythrocyte membrane lipid rafts regulate membrane sorting and 
signaling processes in erythrocytes, and hence some of these proteins 
(Gαs and ß2AR) and their interacting proteins (ADORA2A and GRK5) 
were expected to influence pathogen entry to erythrocytes. It is also 
known that entry of malaria parasite in patients induces the synthesis 
of inflammatory cytokines such as TNF-α, IL-1, IL-6 and IL-10. Altered 
gene expression of cytokines regulated by mutations or epigenetic 
mechanisms, and cytokines by themselves inducing epigenetic changes 
may influence malaria pathogenesis. Epigenetic modifications of drug 
transporters like P-glycoprotein may also influence the chemotherapy for 
malaria. We hypothesize, that genetic and epigenetic variants in GNAS, 
ADRB2, ADORA2A, GRK5 and ABCB1 genes may influence the malaria 
susceptibility. To test the hypothesis, a case - control study of individuals 
affected by P. falciparum malaria versus healthy controls, was performed. 
Genetic and/or epigenetic variations of the genes were analyzed after 
PCR-RFLP and direct DNA sequencing. Western blotting was used to 
access the levels of ABCB1 protein. Genetic association was observed at 
allele, genotype and haplotypes of SNPs in the genes, and significant DNA 
methylation differences among cases and controls. Our study provides 
evidence for the proposed role of studied genes mediated mechanisms in 
the etiology of malaria susceptibility.
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K13 POLYMORPHISMS IN PLASMODIUM FALCIPARUM FROM 
LOW AND HIGH TRANSMISSION AREAS IN KENYA
Zaydah de Laurent1, Lorna J. Chebon1, Luiser Ingasia1, Hosea 
Akala1, Ben Andagalu1, Isabella Oyier2, Edwin Kamau3, Matthew 
Brown1
1Global Emerging Infections Surveillance (GEIS) Program, United States 
Army Medical Research Directorate-Kenya, Kisumu, Kenya, 2KEMRI - 
Wellcome Trust Research Programme, Kilifi, Kenya, 3Walter Reed Army 
Institute of Research, Silver Spring, MD, United States
The development of artemisinin resistance in Southeast Asia (SEA) threaten 
malaria control globally. The recent genetic marker Kelch 13 propeller 
has proven useful in identifying resistance but only in SEA. Sub-Saharan 
African (SSA) countries show mutations in this marker but none of the 
haplotypes are those reported in SEA. Further, none of the observed 
mutations in SSA exhibit delayed parasite clearance, defined as longer 
than 3 days following treatment with artemisinin. On the Kenya’s coast, 
a study showed a decelerated responsiveness to ACTs but it was not clear 
whether it was due to declining immunity or changes in parasite sensitivity. 
With this realization it is important for SSA countries to identify single 
nucleotide polymorphisms (SNPs) that would best describe resistance 
in this part of the world. A total of 380 Plasmodium falciparum clinical 
isolates, collected before 2003 and after the introduction of artemisinin 
combination therapy, were screened for Kelch 13 propeller mutations. 
These were collected from regions with different malaria transmission 
intensities in Kenya which include Kisumu, Kombewa, Marigat, Kericho, 
Kisii and Malindi. Twenty six pre-ACT isolates screened showed mutation 
at position 493 (7.7%) and 539 (7.7%). Mutations in both these positions 
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have been reported in SEA and have shown delayed parasite clearance 3 
days post treatment. Mutation at position A578S accounted for 3.8% of 
the mutations. This mutation has been reported in Bangladesh and SSA 
and is said to alter protein interactions although not reported to have any 
delayed parasite clearance following treatment with ACTs. Unique SNPs 
were also found with D464N accounting for 15% of the mutations. There 
is an urgent need for continued identification of ACT resistance markers 
for SSA parasites, in part to ease traditional laborious surveillance efforts 
and to aid in prompt action in the event of identified ACT resistance.
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GAMETOCYTE CARRIAGE IN A LOW MALARIA 
TRANSMISSION AREA OF GHANA
Eunice Owusu-Yeboa
Noguchi Memorial Institute for Medical Research (NMIMR), Accra, Ghana
Gametocytes (the sexual stage parasites of Plasmodium falciparum) play 
a major role in malaria transmission in different endemic settings and 
their identification is important for transmission-blocking interventions. 
Asymptomatic individuals in malaria endemic areas tend to harbor 
both microscopic and submicroscopic gametocytes of P. falciparum 
which can infect mosquitoes and contribute to malaria transmission. 
Knowledge of the population at risk of harboring gametocytes is 
important in determining the infectious reservoir for transmission-blocking 
interventions. This cross-sectional study therefore aimed to determine the 
prevalence of Plasmodium falciparum gametocytaemia among a cohort 
of children and its association with the transmission pattern in a low 
malaria transmission area of Ghana. A total of 181children within age 
groups 2-5, 6-10 and 11-15 years took part in this study. Finger prick and 
venous blood samples were taken from the children and screened for the 
prevalence of Plasmodium falciparum parasites by microscopy, Nested PCR 
targeting Plasmodium DNA and Real-Time PCR targeting both 18SrRNA 
gene and transcripts using the gametocyte marker pfs25. Data collected 
were analyzed using R regression and GraphPad Prism 5. Out of 181 
children, 3.9% (7/181) had microscopically confirmed asexual parasites, 
with no gametocytes found (0/180). Asexual parasite prevalence was 
4.4% (2/48), 2.5% (2/80) and 5.8% (3/53) for 2-5, 6-10 and 11-15 years 
respectively. nPCR gave an overall parasite prevalence of 7.2% (13/181) 
with prevalences of 1.1% (2/181), 2.2% (4/181) and 3.9% (7/181) for 
ages 2-5, 6-10 and 11-15 years respectively. qPCR showed 6 out of 13 
nPCR positive samples had gametocytes with one sample missing. Within 
the age groups, individuals carrying gametocytes were 1, 3 and 3 for ages 
2-5, 6-10 and 11-15 years respectively. The study has therefore determined 
the presence of submicroscopic gametocytaemia in the cohort and this is 
likely to contribute to malaria transmission in the study area.
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GENETIC DIVERSITY AND NATURAL SELECTION AT DOMAIN 
I OF PLASMODIUM FALCIPARUM APICAL MEMBRANE 
ANTIGEN 1 NIGERIAN ISOLATES: RELATIONSHIP WITH T-CELL 
RESPONSES OF MALARIA PATIENTS FROM LAGOS NIGERIA
Olusola Ajibaye1, Akinniyi A. Osuntoki2, Albert O. Ebuehi2, 
Bamidele A. Iwalokun1, Yetunde A. Olukosi1, Kolapo M. Oyebola1, 
Kathleen N. Egbuna1, Kazumi Narose3, Kita Kiyoshi4, Hikoshika 
Kenji3, Emmanuel O. Balogun4
1Nigerian Institute of Medical Research, Lagos, Nigeria, 2University of 
Lagos, Lagos, Nigeria, 3Department of Infection and Host Defense, 
Graduate School of Medicine, Chiba University, Chiba, Japan, 4Department 
of Biomedical Chemistry, Graduate School of Medicine, The University of 
Tokyo, Bunkyo-ku, Tokyo, Japan
The Plasmodium falciparum apical membrane antigen I (AMA1) is a 
leading malaria vaccine candidate antigen. Population genetic analyses 
of vaccine candidate antigens provide insights into the status and natural 
dynamics of diversity and evolution in these antigens. T-cell responses 
mediate immunity against malaria. This study describes the extent of 
genetic polymorphisms and selection at the hyper-variable domain 
I of AMA1 among Plasmodium falciparum isolates circulating in the 
Nigerian population and the consequence on T-cell responses of malaria 
patients. The Domain I of AMA1 gene was amplified in a nested-PCR and 
sequenced in both directions from 195 P.falciparum isolates collected from 
microscopically confirmed P.falciparum dry blood spots of patients from 
the three senatorial districts in Lagos, Nigeria. Pro-inflammatory cytokines 
were determined by capture ELISA. A total of 74 AMA1 haplotypes 
were observed among 195 isolates sequenced. Forty-eight of these 74 
haplotypes are new and here reported for the first time. The nucleotide 
diversity (π) was in the order Ajeromi > Ijede > Lekki while the number of 
haplotypes (H) was highest in Ajeromi with relatively higher transmission. 
Analysis of the inter-population genetic differentiation showed moderate 
gene flow and genetic differentiation (Fst range = 0.007-0.037) between 
two populations. Analysis of the non-synonymous and synonymous 
mutations, Tajima’s D and recombination rates showed evidence of 
positive selection in the AMA1 antigen with high rates of recombination 
events while Phylogenetic analysis showed no population-wise clustering. 
The relationship between genetic diversity in AMA1 and innate immune 
responses revealed no statistically significant association. In Nigeria, 
PfAMA1 is under positive natural selection with 48 new haplotypes 
reported. Genetic diversity level and selection were highest in Ajeromi, the 
gene flow among these populations were moderate. T-cell components 
of immunity against malaria are independent of genetic polymorphisms 
in AMA1. Data reported here will update information needed for the 
development of effective malaria vaccine.
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GENETIC STRUCTURE OF PLASMODIUM FALCIPARUM 
ISOLATES IN PRE-ARTEMISININ THERAPY ERA OF INDIA
Prashant K. Mallick1, Om Prakash Singh1, Neena Valecha1, Ruchi 
Singh2
1National Institute of Malaria Research, New Delhi, India, 2National 
Institute of Pathology, New Delhi, India
Population studies conducted on Plasmodium falciparum have revealed 
its success to perpetuate high genetic diversity and this diversity has 
hampered all attempts to control malaria. Limited information is available 
about genetic sub-structuring in Indian falciparum populations. We want 
to evaluate the genetic diversity and population structure prevailed in 
high and low falciparum prevalent malaria endemic areas, and to predict 
the geographic origin of Indian falciparum malaria before artemisinin 
regimen. In this study, samples were collected from six study sites from 
both low and high falciparum prevalent areas across India. The samples 
were collected in year 2002-2006, when artemisinin was not introduced as 
antimalarial treatment in India. Twelve polymorphic microsatellite markers 
were used to understand the genetic structures of falciparum populations. 
All the parasite populations were analyzed for genetic diversity, linkage 
disequilibrium and genetic structure. The measures of genetic diversity 
revealed all microsatellite loci to be polymorphic and the number of 
alleles per locus varied from 4 to 14. The mean expected heterozygosity 
(He) were from 0.376 ± 0.036 and 0.864 ± 0.039, revealing a moderate 
to high level of genetic diversity at these loci. Evaluation of geographic 
population structure within and among populations using F-statistic and 
STRUCTURE analysis revealed genetically distinct groups in accordance 
with transmission intensity of different geography. Results of this study will 
provide an insight towards the population structure of falciparum prevailed 
before artemisinin regimen in India and also provide a basis to study how 
artemisinin could affect the population structure in Indian falciparum 
population.
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DOES A SINGLE PERIPHERAL BLOOD SAMPLE FROM A 
MALARIA-INFECTED INDIVIDUAL CAPTURE ALL PARASITE 
GENOTYPES PRESENT IN AN INFECTION?
Tamika J. Sisya1, Stanley Khoswe1, Rachel Banda1, Andrew 
Mtande1, Mirriam Phiri1, Ruth Daiman1, Standwell Nkhoma2
1Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, 
Malawi, 2Malawi-Liverpool-Wellcome Trust Clinical Research Programme, 
Blantyre, Malawi and Liverpool School of Tropical Medicine, Liverpool, UK, 
Blantyre, Malawi
There is contradicting data about whether or not a single peripheral blood 
sample accurately captures all parasite genotypes present in a malaria 
infection. Previous studies have demonstrated a rapid turnover of parasite 
genotypes during the course of an asymptomatic infection with some 
genotypes appearing while others disappearing from the peripheral blood. 
This rapid turnover of genotypes suggests that a peripheral blood sample 
taken at a single time-point contains only a subset of parasite genotypes 
present in the entire malaria infection. Parasite genotypes not detected in 
the peripheral blood are thought sequester in deep tissues precluding their 
detection in the peripheral blood. However, recent studies have shown 
that parasites sequestered in deep tissues are genetically identical to those 
circulating in the peripheral blood. This suggests that a single peripheral 
blood sample effectively captures all the parasite diversity present in the 
infection. These discrepant findings may have resulted from the poor 
resolution of msp1/2 genotyping methods used to determine the genetic 
composition of infections. To resolve problems associated with msp1/2 
measures of infection complexity, we have employed a more-sensitive and 
less ambiguous 24-SNP Taqman assay to obtain the DNA fingerprint of 
malaria parasites sampled from adults with asymptomatic malaria over the 
course of seven consecutive days. We have used this approach to examine 
whether or not the within-host parasite genetic diversity in asymptomatic 
individuals remains constant or changes over seven consecutive days. 
Results from the first set of asymptomatic infections will be presented and 
discussed at the meeting.
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COMPARISON OF TWO GENOTYPING METHODS FOR 
DISTINGUISHING RECRUDESCENCE FROM RE-INFECTION IN 
ANTIMALARIAL DRUG EFFICACY/EFFECTIVENESS TRIALS
Trancizeo R. Lipenga1, Joseph R. Fulakeza2, Rachel L. Banda1, 
Anja D. Terlouw3, Standwell C. Nkhoma3, Eva Maria Hodel4
1Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, 
Malawi, 2University of Malawi, College of Medicine, Blantyre, Malawi, 
3Malawi-Liverpool-Wellcome Trust Clinical Research Programme/Liverpool 
School of Tropical Medicine, Blantyre/Liverpool, Malawi, 4Liverpool School 
of Tropical Medicine, Liverpool, United Kingdom
In areas of intense malaria transmission, individuals treated for malaria 
may encounter new episodes of malaria parasitaemia during the period of 
follow-up. Without comparing the genetic identity of pre-treatment and 
post-treatment parasites, it is difficult to resolve whether the recurrence 
is as a result of treatment failure (recrudescence) or a new infection. 
Genotyping of the merozoite surface proteins 1 and 2 (msp 1 and 2) is the 
current gold standard for genotyping infections to correct drug efficacy/
effectiveness data. However interpretation of msp1 and msp2 data is 
often ambiguous and subjective. Therefore, new and better methods 
for distinguishing recrudescence from re-infection are urgently needed.
We compared the performance of the msp1 and msp2 genotyping with 
a high sensitivity and high resolution 24 single nucleotide polymorphism 
(SNP) Taqman assay in a cluster-randomized effectiveness trial in an area of 
high malaria transmission in Malawi. Filter paper samples were collected 
on day 0 and day 42 of follow-up from children with malaria aged 4-11 
(n=106) treated with either artemether-lumefantrine or dihydroartemisinin-
piperaquine. Parasite DNA was extracted from pre-treatment (day 0) and 
post-treatment (day 42) and genotyped using msp1 and msp2 genotyping 
method and 24-SNP Taqman assay as previously described.The agreement 
between the two methods was 86%. Discordant results were often due 
to false positive msp1/2 results. We found a high rate of re-infection with 
33% of new episodes of parasitemia detected on day 42 of follow up. 
Rate of treatment failure based on SNP barcoding of day 0 and d42 filter 
paper blood samples was 3%. A full comparison of the two genotyping 
methods for distinguishing re-infections and treatment failure will be 
presented during the meeting.
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MICROSATELLITE ANALYSIS REVEALS DIFFERENT 
TRANSMISSION PATTERNS IN THE PERUVIAN AMAZON
Paulo C. Manrique Valverde1, Oscar Nolasco Cardenas1, Henry 
Herrera Milla1, Jhonatan Jesus Alarcon Baldeon1, Mitchel Guzman 
Guzman1, Roberson Ramirez Saavedra1, Elmer Alejandro Llanos-
Cuentas1, Joseph Vinetz2, Dionicia Gamboa Vilela1
1Malaria Laboratory, Instituto de Medicina Tropical Alexander von 
Humboldt, Universidad Peruana Cayetano Heredia, Lima, Peru, 2Division of 
Infectious Diseases, Department of Medicine, University of California San 
Diego, La Jolla, CA, United States
Population genetics studies provides critical information about where and 
when the infection took place, so imported cases as result of migration 
can be separated from endogenous cases that indicate the efficacy of the 
control programs. To address the hypothesis that endogenous transmission 
is the main mechanism that maintain malaria in rural communities in 
Peruvian Amazon, 1031 Plasmodium vivax positive samples were identified 
from a population-based cohort by PCR performed every three months 
from March 2013 to March 2014 in two communities: Cahuide (CAH), 
community with high mobility by road; and Lupuna (LUP), riverine and 
isolated community. 390 samples were chosen for microsatellite (MS) 
genotyping with 9 previously reported MS and 7 new MS. High genetic 
diversity was observed among communities (He 0.622 ± 0.045) but it 
was low (0.38 ± 0.043 ) in LUP in December 2013. Higher proportion of 
polyclonal infections was found in CAH (19%-36%) in comparison to LUP 
(5%-24%). AMOVA analysis showed that most of the variance occurs 
within population (58%) and among communities (37%), suggesting 
strong population structure within and between communities. Genetic 
differentiation was high between communities, but low between months 
in each community (Pairwise FST 0.039), except for LUP in March 2013 
which showed moderate differentiation with respect to other months 
in LUP (0.25), but low differentiation in comparison to CAH (0.09). 
Analysis of population structure revealed the presence of 4 clusters or 
subpopulation within these communities (Cluster A, B1, B2 and C).Cluster 
A was mainly present in March and June 2013 in CAH and only in March 
2013 in LUP. Cluster C was predominantly along the follow-up in LUP, 
except in March 2013. Neighbor joining and burst analysis showed a 
clonal expansion of these two clusters. Regarding clusters B1 and B2, 
they are polyphyletic groups that did not maintain fixed over time. In 
conclusion, results are consistent with an outbreak in Cahuide caused by 
a clonal expansion of cluster A. In contrast, Lupuna showed endogenous 
stationary transmission pattern caused by Cluster C that prevails along the 
seasons.
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POPULATION GENETICS OF PLASMODIUM VIVAX IN 
MICROSCOPIC AND SUB-MICROSCOPIC INFECTIONS IN 
RIVERINE AND ROAD COMMUNITIES
Henry Herrera Milla1, Paulo Manrique1, Oscar Nolasco1, 
Roberson Ramirez1, Mitchel Guzman1, Alejandro Llanos1, Joseph 
Vinetz2, Dionicia Gamboa1
1Universidad Peruana Cayetano Heredia, Lima, Peru, 2University of 
California San Diego, San Diego, CA, United States
Plasmodium vivax population diversity has been reported along time in 
different settings in the Peruvian Amazon. The aim of this study was 
to explore the genetic diversity and parasite population structure of 
P. vivax parasites from microscopic and submicroscopic infections in 
two communities: Cahuide (Km 56 at Iquitos-Nauta road) and Lupuna 
(accessible only by river), in Loreto. 473 P. vivax positive samples were 
selected from a cohort of 1031 P. vivax positive samples based on DNA 
quantity that will allow Microsatellite (MS) analysis. These samples were 
collected from March 2013 to March 2014 (168 samples from Cahuide 
and 305 samples from Lupuna) by monthly active case detection surveys. 
All samples were confirmed as positive to P. vivax by microscopy and/
or PCR, DNA was quantified by qPCR. Only 437 samples were used for 
genotyping using 16 microsatellites. Genotyping was performed and 
subsequently analyzed by capillary electrophoresis using an ABI PRISM 
3100 avant genetic analyzer. Based on microscopy and/or PCR, from the 
total number of samples, 177 (35%) were classified as submicroscopic 
and 296 (65%) as microscopic. From genotyped samples, 339 (77%) 
were classified as monoclonal infections and 98 (29%) were polyclonal 
infections. Around 361 had an almost-complete allele profile (75% or 
higher). Our results showed an average genetic diversity (He) of 0.565 
for Cahuide and 0.52 for Lupuna, meaning high genetic variability for 
both communities. A total of 51 haplotypes were found, 21 haplotypes 
were present in Cahuide and 30 in Lupuna. 2 haplotypes with the 
highest frequencies where found one in each community. In Cahuide, 
“haplotype-20” is present only during March and June 2013 in 23 
samples; whereas in Lupuna “haplotype-42” is present along year 2013. 
Interestingly 4 population clusters were found in both communities with 
no differentiation between microscopic and submicroscopic infections. 
This data suggests that there is no genetic differences between parasites 
from microscopic and submicroscopic infections and are stable along time. 
Population structure of P. vivax might be explained by other factors rather 
than type of infection.
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VALIDATING A SNP-BASED BARCODING TOOL FOR 
PLASMODIUM VIVAX IN PAPUA NEW GUINEA
Lincoln Timinao1, Rachel F. Daniels2, Sarah K. Volkman2, Alyssa 
Barry3, Peter M. Siba4, Leanne J. Robinson1, Ingrid Felger5
1Papua New Guinea Institute of Medical Research, Madang, Papua New 
Guinea, 2Havard T.H. Chan School of Public Health, Boston, MA, United 
States, 3Walter and Eliza Hall Institute of Medical Research, Melbourne, 
Australia, 4Papua New Guinea Institute of Medical Research, Goroka, 
Papua New Guinea, 5Swiss Tropical and Public Health Institute, Basel, 
Switzerland
Plasmodium vivax is one of the four species of Plasmodium that cause 
malaria in Papua New Guinea (PNG) and is the dominant species in some 
areas of PNG. Efforts to reduce and eventually eliminate malaria in PNG 
will require a combination of different strategies and tools to effectively 
monitor the parasite. We have validated a field deployable SNP-based 
barcoding tool for genotyping P. vivax parasites in PNG. We selected P. 
vivax field samples with infections containing single parasite clones for 
validating this new tool. The selection of single clone infections was based 
on genotyping length polymorphic molecular markers, Pvmsp1F3 and 
microsatellite MS16. We then performed High Resolution Melting (HRM) 
analysis on amplicons from established polymerase chain reaction assays. 
Genotyping was performed on 24 SNPs, which were previously identified 
amongst a global panel of isolates. These SNPs are spread across all 14 
chromosomes of P. vivax and are located on putatively neutral sites. Eight 
of the 24 SNPs had a minor allele frequency of ≥0.15 across three different 
geographic areas of PNG. These were identified as suitable candidates 
for genotyping P. vivax parasites in PNG. A complete 8-SNP-haplotype 
was obtained for 42 (44%) of the 96 samples tested. Amongst these 
there were 33 unique haplotypes identified. The discriminatory power of 
SNP-based barcoding will be compared with that of the fragment length 
polymorphic markers which are currently being used to genotype P. vivax 
in PNG. SNP-based barcoding is a field based tool that can be adapted to 
platforms that perform HRM and with further validation may be useful for 
studying P. vivax population genetics in PNG.
350
LONGITUDINAL POOLED DEEP SEQUENCING OF 
PLASMODIUM VIVAX KELCH PROPELLER DOMAIN IN 
CAMBODIA REVEALS A LACK OF DIRECTIONAL SELECTION
Nicholas F. Brazeau1, Christian M. Parobek1, Nicholas J. 
Hathaway2, Jessica T. Lin3, Chanthap Lon4, David L. Saunders4, 
Jonathan J. Juliano3
1University of North Carolina School of Medicine, Chapel Hill, NC, United 
States, 2University of Massachusetts Medical School, Worcester, MA, 
United States, 3Division of Infectious Diseases, University of North Carolina 
School of Medicine, Chapel Hill, NC, United States, 4Armed Forces 
Research Institute of Medical Sciences, Bangkok, Thailand
The emergence of artemisinin resistance among Plasmodium falciparum 
in the Greater Mekong region threatens malaria treatment and control 
interventions. Mutations in K13 (PF3D7_1343700) provide potential 
molecular markers of artemisinin resistance in P. falciparum. The aim of 
this study was to survey the sympatric species, P. vivax, in Cambodia, 
for mutations in the orthologous gene (K12, PVX_083080) that might 
similarly confer artemisinin resistance. 359 clinical isolates collected in 
western and northern Cambodia from 2009-2013 were organized into 
eleven pools by province and year. The propeller domain of PVX_083080, 
2139 bp in length, was amplified using PCR. Amplification products 
were submitted to the Ion Torrent Personal Genome Machine®. Single 
nucleotide polymorphisms (SNPs) were identified using a C++ module 
and a pileup approach with filters for mapping quality, base quality, read 
length, and strand bias. In total, 3,898,057 reads from P. vivax pools and 
1,005,303 reads from sequencing controls were obtained and analyzed 
for SNPs. Control sequences demonstrated no false-positive SNPs at the 
quality cut-offs used. In addition, simulations validated the C++ module 
for SNP detection to 0.5% frequency within each pool. Among the eleven 
pools, we found 23 SNPs across twelve codons in the kelch propeller 
region. Twelve of the SNPs produced nonsynonymous mutations, none of 
which were maintained year-to-year. Two synonymous mutations persisted 
over multiple time-points. Five mutations were shared between parasite 
populations, of which, one mutation (V552I) has been previously reported 
in northeastern Cambodia. However, none of our detected SNPs produced 
orthologous artemisinin-resistance conferring P. vivax mutations and did 
not persist within the populations, which suggests a lack of directional 
selection on the K12 propeller region attributable to artemisinin drug 
pressures. Next-generation sequencing described several SNPs that were 
not described previously by traditional surveillance techniques, providing a 
timely way to conduct in-depth molecular surveillance for early artemisinin 
resistance detection.
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EVOLUTION OF SOLUBLE HLA-G LEVELS DURING 
PREGNANCY AND INFANCY IN A BENINESE POPULATION 
EXPOSED TO MALARIA INFECTION
Tania Carenne d’Almeida1, Ibrahim Abiodoun Sadissou2, Gilles 
Cottrell3, Rachida Tahar1, Philippe Moreau4, Benoit Favier4, Kabirou 
Moutairou5, Eduardo Antonio Donadi2, Achille Massougbodji6, 
Nathalie Rouas-freiss4, David Courtin3, André Garcia3
1UMR216 MERIT “Mère et enfant face aux infections tropicales”, Institut 
de Recherche pour le Développement, Paris, France, 2Division of Clinical 
Immunology, School of Medicine of Ribeirão Preto, University of São 
Paulo, Ribeirao Preto, Brazil, 3UMR216 MERIT “Mère et enfant face aux 
infections tropicales”, Institut de Recherche pour le Développement, 
Paris, France, 4UMR Commissariat à l’Energie Atomique et aux Energies 
Alternatives (CEA), Université Paris Diderot - Paris 7, IMETI Service de 
Recherches en Hémato-Immunologie, Paris, France, 5Université d’Abomey-
Calavi, Cotonou, Benin, 6Centre d’Etude et de Recherche sur le Paludisme 
Associé à la Grossesse et à l’Enfance (CERPAGE), Cotonou, Benin
Human Leucocyte Antigen-G is a non-classical HLA class I molecule 
firstly described on the surface of extravillous cytotrophoblast cells at 
foeto-maternal interface. HLA-G binds its inhibitory receptors present 
on the surface of immune cells (monocytes, NK, T,B and dendritic cells) 
modulating host’s immune response.These immunosuppressive properties 
of HLA-G are crucial and benefic during pregnancy where HLA-G plays 
a crucial role in maternal-fetal tolerance. There are known associations 
between high levels of circulating soluble HLA-G (sHLA-G) and either 
parasite or viral infections (HIV,cytomegalovirus)and it has been suggested 
that the induction of sHLA-G expression could be a mechanism via which 
infectious agents subvert host immune defence. To explore more precisely 
interactions between soluble HLA-G and malaria,latent class analysis 
was used to test whether distinct sub-populations of children, each with 
distinctive soluble HLA-G evolutions may suggest the existence of groups 
presenting variable malaria susceptibility. This study was conducted in 
Benin from 2010 to 2013 and 165 children were followed from birth 
to12 months and soluble HLA-G was quantified by Elisa method.Three 
groups of children were identified: one with consistently low levels of 
soluble HLA-G during follow-up, a second with very high levels and a last 
intermediate group. In all groups, low birth weight, malaria infection and 
high exposure to malaria transmission were associated with high level of 
soluble HLA-G.Placental malaria was not. Presence of soluble HLA-G in 
cord blood increased the probability of belonging to the highest trajectory. 
These results, together with previous ones,confirm the importante role of 
HLA-G in the individual susceptibility to malaria. Assaying soluble HLA-G 
at birth could be a good indicator of newborns more fragile and at risk of 
infections during childhood.
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MEMORY T CELLS METABOLISM DURING CHRONIC 
MALARIA INFECTION
Samad A. Ibitokou, Michael Opata, Brian E. Dillon, Robin 
Stephens
University of Texas Medical Branch, Galveston, TX, United States
Malaria infection kills up to 0.85 million people each year. The first 
generation of vaccine does not generate long-lived protection. We have 
shown, in Plasmodium chabaudi infection that CD4 effector memory T 
cells generated protect from parasitemia and pathology. However, the 
mechanisms underlying development and maintenance of this long-
lived protective memory T cells (Tmem) are not well understood. Recent 
findings have highlighted the importance of cellular metabolism in Tmem 
generation. Specifically, fatty acid oxidation (FAO) has been associated 
with CD8 Tmem development in acute infection. Substrates for FAO in 
CD8 Tmem are generated through the fatty acid synthesis (FAS) pathway. 
However, it’s not clear whether FAS pathway controls Tmem differentiation 
or survival. Using transcriptomic analysis, we found upregulation of FAS 
genes in Tmem compared to effector (Teff) in malaria-specific CD4 T cells. 
Interestingly, blockade of FAS pathway in vivo using TOFA (Acc1-specific), 
impairs Tmem development. To determine when FAS is required for Tmem 
differentiation, P. chabaudi- infected mice were treated with TOFA at the 
priming or contraction phase of the immune response. Preventing fatty 
acid synthesis during priming inhibits memory formation and reduces 
parasitemia. Using stable isotope tracer, memory T cells show high 
phospholipids synthesis. Together these data suggest that an early shift to 
FAS is important for CD4 Tmem differentiation and may prove crucial to 
development of malaria vaccine.
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IL-15 COMPLEX-STIMULATED NK CELLS PROTECT MICE 
FROM CEREBRAL MALARIA
Kristina S. Burrack, Sara E. Hamilton, Stephen C. Jameson
University of Minnesota, Minneapolis, MN, United States
To date, no effective adjunctive therapies exist for severe malaria. 
Plasmodium falciparum is the main cause of severe malaria in humans 
and accounts for about 600,000 deaths per year, mainly in children 
in sub-Saharan Africa. Cerebral malaria (CM) is one of the most lethal 
complications of severe malaria. Infection of susceptible mouse strains 
such as C57BL/6 with Plasmodium berghei ANKA (PbA) induces a fatal 
neurological syndrome from 6-10 days post-infection (dpi). We found that 
prophylactic or therapeutic treatment of C57BL/6 mice with interleukin 
(IL)-15 complexes (IL-15C; IL-15 bound to an IL-15Rα-Fc fusion protein) 
prevented the development of PbA-induced CM. IL-15C treatment 
stimulates Natural Killer (NK) and CD8 T cells. Interestingly, adoptive 
transfer of IL-15C-stimulated NK cells, not CD8 T cells, prevented CM. 
Similar complexes formed with IL-2 (IL-2C; IL-2 bound to the anti-IL-2 
S4B6 antibody) also causes robust expansion and activation of NK cells, 
but NK cells from mice treated with IL-2C failed to protect against CM. 
Comparative RNAseq analysis of IL-15C and IL-2C-treated NK cells 
identified novel gene expression patterns, demonstrating previously 
unappreciated differences between these cytokine complex signaling 
cascades in NK cells. Interestingly, IL-15C treatment resulted in reduced 
CD8 T cell activation in the brain at 6 dpi and reduced blood brain barrier 
breakdown, suggesting that IL-15C-stimulated NK cells limit the CD8 
T cell-mediated pathology in CM. Indeed, a large subset of NK cells in 
the spleen, blood, and brain of IL-15C-treated, but not IL-2C-treated, 
mice produced the immunoregulatory cytokine IL-10 on day 3 pi. These 
data indicate that NK cells - which are typically involved in promoting 
inflammatory responses - can restrain damaging immune responses. 
A mechanistic understanding of CM pathogenesis and the process of 
cytokine complex perturbation will provide an important foundation for 
the identification of new therapeutic targets and aid in the development 
of adjunctive therapies for treating severe malaria.
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THE ROLE OF INFLAMMATION AND MICROVASCULAR 
DAMAGE/REPAIR IN THE PATHOGENESIS OF CEREBRAL 
MALARIA
Amma A. Larbi1, Daniel Oduro1, Linnie M. Golightly2, Thomas 
Addison1, Dorotheah Obiri1, Margaret Frimpong3, Ben A. Gyan1
1Noguchi Memorial Institute for Medical Research, Accra, Ghana, 2Weill 
Cornell Medical School, Department of Infectious Diseases, New York, NY, 
United States, 3Kwame Nkrumah University of Science and Technology, 
Kumasi, Ghana
Cerebral Malaria (CM), a severe form of malaria, caused by Plasmodium 
falciparum remains a major cause of morbidity and mortality. Currently, 
there is no available test to predict potential CM patients, as well as 
mortality or recovery from the syndrome. The disease results from a 
combination of vascular and inflammatory immune system dysfunction. 
Triggering receptor expressed on myeloid cells 1 (TREM-1) has been shown 
to potentiate inflammatory response. A recent preliminary study has 
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shown that there is an increase in soluble TREM-1 production in CM as 
compared to uncomplicated malaria (UM). Another study in our lab has 
shown that there is lower levels of endothelial progenitor cells (EPC) in 
CM children as compared to UM and Healthy controls (HC). Based on this 
result, it could be suggested that there could be an association between 
inflammation and microvascular damage/repair in the pathogenesis of 
cerebral malaria. To study this hypothesis, children between the ages 
of 2-12 years who are either CM, UM or HC have been recruited into 
the study. Samples were taken at three or four time points i.e. Day 
0, (Recovery-for only CM), Day 7 and Day14. TREM-1 data and EPC 
data would be correlated to give a better insight into cerebral malaria 
pathogenesis. Findings from this study could be employed in the diagnosis 
of CM.
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CLINICAL DEVELOPMENT OF A VAR2CSA-BASED PLACENTAL 
MALARIA VACCINE PLACMALVAC: QUANTIFYING VACCINE 
ANTIGEN-SPECIFIC MEMORY B & T CELL ACTIVITY IN 
BENINESE PRIMIGRAVIDAE
Komi Gbedande1, Nadine Fievet2, Sem Ezinmegnon1, Firmine 
Viwami1, Saadou Issifou1, Yannelle Dossou1, Jean-Philippe 
Chippaux2, Kabirou Moutaïrou3, Achille Massougbodji1, Nicaise 
Tuikue Ndam2, Ali Salanti4, Benjamin Mordmüller5, Philippe 
Deloron2, Adrian J. F. Luty2
1Centre d’Etude et de Recherche sur le Paludisme Associé à la Grossesse 
et à l’Enfance (CERPAGE), Faculté des Sciences de la Santé, Université 
d’Abomey-Calavi, Cotonou, Benin, 2Institut de Recherche pour le 
Développement, MERIT UMR D216 Mère et enfant face aux infections 
tropicales, Paris, France, 3Département de Biochimie et de Biologie 
Cellulaire, Faculté des Sciences et Techniques, Université d’Abomey-
Calavi, Cotonou, Benin, 4Department of International Health, Institute 
of International Health, Immunology and Microbiology, University of 
Copenhagen, Copenhagen, Denmark, 5Institut für Tropmedezin, Tübingen, 
Germany
Pregnancy associated malaria (PAM) is a major public health problem 
associated with poor pregnancy outcomes that commonly include 
maternal anemia and fetal growth alterations, whilst neonatal and infant 
health can also be affected. A malaria vaccine that targets the pre-
erythrocytic stages of the parasite will not prevent the consequences of 
PAM. The identification of the parasite antigen VAR2CSA that is implicated 
in the pathophysiology of PAM has led to the development of a candidate 
vaccine by an EU-funded consortium (PlacMalVac project: German, Danish, 
French and Beninese Partners). The vaccine is currently under Phase I trial 
in Germany and Benin. As part of the PlacMalVac project, we quantified B 
and T cell memory responses to the VAR2CSA sub-unit vaccine candidate 
in a cohort of pregnant primigravid Beninese who were followed up 
throughout pregnancy. Clinical and parasitological data were collected 
every month from 37 primigravid women recruited at the beginning of 
their pregnancies and followed through to delivery. Mononuclear cells 
from peripheral blood collected on 4 occasions (first and fifth month of 
pregnancy, at delivery and 6 months post-delivery) were isolated and 
cryopreserved under liquid nitrogen. The concentrations of the cytokines 
IL-5, IL-6, IL-10, IL-13, IFN-γ and TNF-α produced in response to the 
vaccine antigen, to PPD and to PHA were quantified in supernatants of 
stimulated cells using cytometric bead array. The frequencies of vaccine 
antigen-specific antibody-secreting memory B cells were evaluated in the 
same cell samples using standard ELISPOT assays. Preliminary analysis 
shows that the profile of vaccine-specific B cell populations increased as 
a function of women’s Plasmodium falciparum infection histories, whilst 
tetanus toxoid-specific B cell frequencies increased following tetanus 
vaccine boosts administered according to national guidelines. Multivariate 
analyses are under way to illustrate in detail the effects of P. falciparum 
infections during first pregnancies on the establishment of cellular 
immunological responses to the vaccine antigen.
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THE INFLUENCE OF INHIBITORY MOLECULES ON TREG CELLS 
DURING PLASMODIUM VIVAX MALARIA
Pedro A. Costa1, Maria Marta Figueiredo1, Ana Paula Marino1, 
Suelen Queiroz Diniz1, Mauro Shugiro Tada2, Dhelio Batista 
Pereira2, Ricardo Tostes Gazzinelli1, Lis Ribeiro Antonelli1
1Fiocruz/Centro de Pesquisas René Rachou, Belo Horizonte, Brazil, 2Centro 
de Pesquisas em Medicina Tropical de Rondônia, Porto Velho, Brazil
Malaria is still considered a major helath problem worldwide, and the 
Plasmodium vivax is the most spread causative agent, with 80% of 
incidence in Brazil. The balance between pro- and anti-inflammatory 
responses is essential to limit immune response-mediated pathology and 
regulatory T cells (Treg) probably play an important role in this process. 
Recently our group demonstrated that the expression of inhibitory 
receptors on T cells regulates cytokines production by P. vivax-specific 
cells. The expression of one of these inhibitory receptors, the programmed 
death- 1 (PD-1), negatively regulates Treg function in patients chronically 
infected with HCV. Since the function of P. vivax-specific T cells is impaired 
due to inhibitory receptors expression, our goal is to assess the expression 
of these receptors on Treg upon malaria infection and to evaluate their 
function. Our hypothesis is that the increased expression of inhibitory 
receptors on Treg during P. vivax infection, affects the functions of these 
cells in regulating inflammatory responses. Peripheral blood mononuclear 
cells were collected from P. vivax–infected patients and from the same 
individuals after treatment, in Porto Velho-RO. Leukocytes were analyzed 
by flow cytometry. Our data show that P. vivax infection triggers an 
increase in the frequency of Treg cells and in the frequency of cytotoxic T 
lymphocyte attenuator (CTLA-4) and PD-1 expressing Treg. The expression 
of CTLA-4 and PD-1 on Treg was correlated with the bilirubins serum 
levels. Importantly, PD-1+ Treg express lower levels of Forkhead Box 3 
(FoxP3) than PD-1- Treg when analyzed ex vivo or after culture. Moreover, 
PD-1+ Treg become able to produce IFN-γ. All together, our results indicate 
that malaria infection triggers the expression of PD-1 and decreases the 
expression of FoxP3 in Treg, phenomenum that could affect its regulatory 
functions.
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ANTIBODIES TO PLASMODIUM FALCIPARUM APICAL 
MEMBRANE ANTIGEN-1 AND CIRCUMSPOROZOITE 
PROTEIN ARE ASSOCIATED WITH PROTECTION FROM 
HOSPITALIZATION AFTER SEVERE MALARIA DISEASE
Benson O. Juma
Makerere University College of Health Sciences, Kampala, Uganda
Severe malaria is a leading cause of morbidity and mortality in children. 
We hypothesize malaria-specific antibodies are markers of exposure and 
immunity; higher antibody levels will protect children against subsequent 
hospital sick visits and admission. A prospective cohort study was 
conducted at Mulago Hospital in Kampala, Uganda. Children between 
18 months and 12 years with severe malaria were enrolled: cerebral 
malaria (CM, n=221), severe malarial anemia (SMA, n=198); and age-
matched community controls (CC, n=170) and followed for one year. At 
enrollment, serum samples were collected and assessed for IgG antibody 
levels to apical membrane antigen-1 (AMA-1), circumsporozoite protein 
(CSP), glutamate rich protein (GLURP) and merozoite surface proteins-1 
(MSP-1) using a multiplex assay. Children with SMA were the youngest, 
33.5 months 41.0 months (CM), and 46.3 months (CC). Children with CM 
and SMA had significantly higher antibody levels for all antigens. Children 
with CM had higher antibody levels against malaria-specific antigens 
than children with SMA or CC, p<0.05 for all comparisons. The rate of 
returning sick visits for clinical malaria in the year following enrollment 
was 19.5% (n=43) for children with CM, 23.2% (n=46) for children with 
SMA, and 15.3% n=26 for CC. Higher antibody levels to AMA-1 were 
associated with protection from clinical malaria in CM and CC, (odds ratio 
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(OR), 95% confidence interval (CI): CM, 0.97(0.95, 1.00), p=0.05; CC, 
0.97(0.95, 1.00), p=0.05). Following adjustment for age, the antibody 
levels against AMA-1, CSP and MSP-1were not protective against clinical 
malaria for all comparisons, (OR) 95% (CI) 0.99, (0.92, 1.06), P=0.71; 
1.04, (0.98, 1.00), p, 0.17; 0.94, (0.88, 1.00), P=0.06), respectively. 
Despite having higher exposure to malaria, children with severe malaria 
were not protected from clinical malaria in the year following admission. 
These data suggest that acquisition of IgG antibodies against the antigens 
we measured may not be sufficient to protect against clinical malaria. 
Further studies are needed to look at IgG subclass responses in this cohort.
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ANTIBODY DEPENDENT CELLULAR INHIBITION IS 
ASSOCIATED WITH PROTECTION AGAINST FEBRILE 
MALARIA IN A LONGITUDINAL COHORT STUDY INVOLVING 
GHANAIAN CHILDREN
Regis W. Tiendrebeogo
Center for Medical Parasitology, Copenhagen, Denmark
The antibody dependent respiratory burst and opsonic phagocytosis 
assays have been associated with protection against malaria; however, 
other mechanisms may also be involved. The antibody dependent 
cellular inhibition (ADCI) assay is yet to be correlated with protection 
in longitudinal cohort studies (LCS). We investigated the relationship 
between ADCI activity of immunoglobulin G prior to malaria season 
and risk of malaria in a LCS involving 98 Ghanaian children. Purified 
IgG was tested in ADCI assay and in schizont extract Enzyme-Linked 
Immunosorbent Assay. Antibody-dependent cellular inhibition activity 
increases with age and high ADCI (75% SGI) activity was significantly 
associated with protection against malaria. The importance of IgG3 in 
the ADCI mechanism was also substantiated. In conclusion, findings 
here suggest a potential usefulness of the ADCI assay as a correlate of 
protection to guide malaria vaccine studies.
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THE PRESENCE, PERSISTENCE AND FUNCTIONAL PROPERTIES 
OF DUFFY BINDING PROTEIN II ANTIBODIES ARE 
INFLUENCED BY HLA CLASS II ALLELIC VARIATIONS
Flora S. Kano1, Flavia A. Souza-Silva1, Leticia M. Torres1, Barbara 
A. Lima1, Taís N. Sousa1, Jéssica R. Alves1, Roberto S. Rocha1, Cor 
J. Fontes2, Bruno A. Sanchez3, John H. Adams4, Cristiana F. Brito1, 
Ana Maria Sell5, Luzia H. Carvalho1
1Centro de Pesquisas Rene Rachou / Oswaldo Cruz Foundation, Belo 
Horizonte, Brazil, 2Federal University of Mato Grosso, Cuiabá, Brazil, 
3Federal University of Mato Grosso, Sinop, Brazil, 4University of South of 
Florida, Tampa, FL, United States, 5State University of Maringá, Maringa, 
Brazil
Plasmodium vivax infects human reticulocytes through the interaction 
between the Duffy binding protein (region II, DBPII) and its cognate 
receptor on reticulocytes, the Duffy antigen/receptor for chemokines 
(DARC). A high proportion of individuals naturally exposed to P.vivax fails 
to develop antibodies that inhibit the DBPII-DARC interaction, and genetic 
factors that modulate humoral immune response are poorly characterized. 
Here, we investigate if DBPII responsiveness could be HLA class II-linked. 
A community-based open cohort study was carried-out in a community 
of the Brazilian Amazon region, in which 336 non-related volunteers 
were genotyped for HLA class II (DRB1, DQA1 and DQB1 loci), and their 
DBPII immune responses were followed-up (baseline, 6 and 12 months) 
by conventional serology (DBPII-IgG antibodies) and functional assays 
(DBPII-Binding Inhibition Antibodies, BIAbs). In silico analyzes evaluated the 
relative binding affinities of DBPII peptides for class II molecules associated 
with distinct immune outcomes. After 12-month follow-up, the results 
demonstrated an increased susceptibility of DRB1*13:01 carries to develop 
and sustain their DBPII-IgG antibody response, and strengthen as persistent 
non-responder individuals harboring the haplotype DRB1*14:02-
DQA1*05:03-DQB1*03:01. The HLA class II polymorphisms also 
influenced the functional proprieties of DBPII antibodies, with three alleles 
(DRB1*07:01 DQA1*02:01 DQB1*02:02) that comprise a single haplotype 
linked with the presence and persistence of the BIAbs response. Finally, 
quantitative prediction of DBPII-HLA class II binding affinity demonstrated 
that the nonresponse to DBPII was not due to failure of immune epitopes 
to bind HLA class II molecules. In conclusion, the current study confirms 
the heritability of DBPII antibody response, with genetic variation on 
HLA class II influencing in both the development and persistence of IgG 
antibody responses. Further studies on knowledge of the binding affinities 
of DBPII peptides for class II molecules linked with antibody responses 
might be useful for vaccine development.
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UNCOMPLICATED MALARIA CHILDREN AND ADULTS WITH 
IN MALARIA HYPERENDEMIC AREA OF BURKINA FASO 
TREATMENT AND ANTIBODIES PRODUCTION
Fatimata Thiombiano
Centre National de Recherche et de Formation sur le paludisme, 
Ouagadougou, Burkina Faso
Artemisinin-based Combination Therapies (ACTs) are the first line drug 
for the treatment of uncomplicated malaria in most endemic countries. 
They quickly clear the parasitaemia and reduce fever. In animal model, it 
has been found that artemisinin derivatives have an immunosuppressive 
effect. In the present study we assessed the effect of ACT on malaria 
antigens specific antibodies in population living in malaria hyperendemic 
area and repeatedly having uncomplicated malaria.In 2013, patients 
presenting with uncomplicated malaria were recruited and allocated 
to receive ACTs and follow up to 2 years. Antibodies titer against three 
P.falciparum blood stage antigens (MSP3, GLURP R0, GLURP R2) were 
measured by ELISA before and twenty eight days after treatment and 
during subsequent uncomplicated malaria episodes.In total 478 volunteers 
were recruited for antibody measurement. Antibody levels were always 
high Twenty eight days after the initiation of the treatment for all tested 
antigens but not significative. IgG titer measurement for MSP3 antigen 
show a trend between D0 and D28 with respectively 7.52 [1.5 13.6] AU 
and 7.85[2.5 13.1] AU. Subsequent malaria episodes also appear to have 
a boosting effect on antibody responses.Concomitant parasitaemia initiate 
and boost immunological responses in population naturally exposed to 
malaria and Artemisinin-based Combination Therapies seem not to have 
immunosuppressive effect.
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CELLULAR IMMUNE RESPONSES FOLLOWING CONTROLLED 
HUMAN MALARIA INFECTIONS BY DIRECT VENOUS 
INOCULATION OF CRYOPRESERVED PLASMODIUM 
FALCIPARUM SPOROZOITES IN MALARIA-NAÏVE, MALARIA-
IMMUNIZED AND SEMI-IMMUNE AFRICAN INDIVIDUALS
Gloria P. Gomez-Perez1, Matthew B. McCall2, Gemma 
Moncunill3, Sanne E. de Jong4, Pilar Requena3, Joseph J. Campo5, 
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4Department of Parasitology, Leiden University Medical Center, Leiden, 
Netherlands, 5Antigen Discovery, Inc., Irvine, CA, United States, 6Sanaria 
Inc., Rockville, MD, United States, 7Centre de Recherches Médicales de 
Lambaréné, Gabon; Institut für Tropenmedizin, Universität Tübingen, 
Tübingen, Germany, 8Centre de Recherches Médicales de Lambaréné, 
Gabon; Department of Parasitology, Leiden University Medical Center, 
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Gabon; Department of Parasitology, Leiden University Medical Center, 
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Controlled human malaria infection (CHMI) trials represent an important 
tool to test vaccine and drug efficacy against Plasmodium falciparum 
malaria, as well as to study the immune response of the human host under 
controlled conditions. We studied B and T cell responses in volunteers 
with three different malaria-immunology backgrounds from CHMI trials 
performed in Europe and Africa. All volunteers received a direct venous 
inoculation (DVI) of 3,200 cryopreserved P. falciparum sporozoites (PfSPZ, 
Sanaria® PfSPZ Challenge), with cellular studies performed at baseline 
(prior to challenge), and at different time points following challenge. 
Trials: 1. Malaria-naïve individuals: Barcelona, Spain; 2. Malaria-immunized 
individuals: Tübingen, Germany, volunteers were challenged 10 weeks 
after being immunized with PfSPZ Challenge by DVI or placebo both under 
chloroquine treatment (Sanaria® PfSPZ-CVac); 3. Lambaréné, Gabon, 
semi-immune Gabonese volunteers, including both sickle cell trait (AS) 
and no sickle cell trait (AA) individuals. The study included volunteers who 
developed patent parasitemia and also those who remained protected 
following challenge. B cell phenotyping was performed in all samples 
ex vivo by flow cytometry (FACS) with a panel of 11 markers aimed at 
analysing different B cells subsets including classical, atypical and marginal 
zone-like memory B cells. T cellular studies were performed after in vitro 
stimulation with NF54 P. falciparum infected red blood cells (all samples) 
and PfSPZ (only a subset of samples), with a cellular panel of 11 markers 
aimed at analysing T regulatory cells, γδT cells, cytotoxicity markers 
(CD107a) and cytokine production (IL-1, IL-10, INFγ). These studies provide 
relevant information on/about the immune response at B and T cell level in 
individuals with different malaria-exposure and immunology backgrounds 
that can/may/should guide the study of correlates of protection in malaria-
vaccine trials involving naïve and semi-immune subjects.
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HIGH TOTAL IGG LEVELS AND IGG1 SUBCLASS AGAINST 
MSP10 PROTEIN ARE ASSOCIATED TO PROTECTION IN 
ASYMPTOMATIC SERA FROM PLASMODIUM FALCIPARUM 
INFECTED PATIENTS FROM THE PERUVIAN AMAZON REGION
Katherine Garro1, Katherine Torres1, Gabriel Carrasco1, Dionicia 
Gamboa1, Joseph Vinetz2
1Peruvian University Cayetano Heredia, Lima, Peru, 2University of California 
San Diego, San Diego, CA, United States
A previous study conducted by our group demonstrated that recombinant 
protein MSP10 was highly reactive in sera from symptomatic and 
asymptomatic patients infected with Plasmodium falciparum from a low 
transmission setting in the Peruvian Amazon region. The aim of this study 
was to evaluated the humoral response in sera from 122 symptomatic 
(Sym), 21 asymptomatic (Asym) patients infected with P. falciparum and 
20 controls negative (Ctr) against recombinant MSP10 (rMSP10) and to 
compare total IgG and subclass profiles (IgG1, IgG2 and IgG3) in naturally 
exposed individuals living in this region by ELISA. Total IgG responses, 
calculated as optical density (OD), were significantly higher in Asym vs. 
Sym and both groups had a higher OD levels compared to Ctrl. Likewise, 
IgG1 subclass showed a significant difference between the 3 groups with 
higher OD mean level in Asym followed by Sym. IgG2 showed significant 
differences between Asym vs. Control and Sym vs. Control. Nevertheless, 
IgG3 only had basal levels and a significant difference between Asym vs. 
Ctrl and showed the lowest OD levels. No negative correlation was found 
between parasitemia and humoral response in any of the groups.The 
results here demonstrated that rMSP10 was able to induce a differential 
response in IgG1 levels between Sym and Asym being higher in the last 
group showing association to clinical protection against this antigen. It 
was also found that total IgG levels were high in both Asym and Sym 
patients in comparison to Ctrl confirming our previous results. Interestingly, 
this preliminary study shows rMSP10 as a potential antigen for the 
identification of asymptomatic individuals which are known to represent 
an infectious reservoir in malaria endemic areas. Definitely a larger sample 
number would be needed to ascertain this.
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IS TIMING OF IN UTERO EXPOSURE KEY IN PREVENTING 
FETAL PRIMING?
Ronald Ottichilo1, Ruth Nyakundi2, Francis Mutuku3, Desiree 
LaBeaud4, Charles King5, Indu Malhotra5
1Vector Borne and Neglected Diseases Unit (Ministry of Health Kenya), 
Msambweni, Kenya, 2Institute of Primate Research Kenya, Nairobi, Kenya, 
3Technical University of Mombasa, Mombasa, Kenya, 4Stanford School 
of Medicine, Stanford, CA, United States, 5Center for Global Health and 
Diseases, Case Western Reserve University, Cleaveland, OH, United States
In malaria endemic regions, pregnant women are at increased risk for 
malaria. Prenatal exposure to malaria parasites or their soluble antigens 
modifies subsequent immune responses and susceptibility to malaria 
infection. Timing of in utero exposure may be the key in whether immune 
imprinting occurs. In this study we examined whether the timing of 
exposure and early detection and treatment of malaria in mothers can 
prevent or limit fetal priming and the resultant phenotypes. 300 pregnant 
Kenyan women were enrolled in the study. Mothers received malaria 
prophylaxis during the antenatal care (ANC) visits and were treated if 
found positive for malaria during pregnancy. Malaria was diagnosed 
by blood smear and PCR. We examined T cell immunity to Plasmodium 
falciparum merozoite surface protein-1 (MSP1-42) and the peptides to 
MSP1-42 in cord blood lymphocytes (CBL) and assayed for lymphocyte 
proliferation and used Bioplex to detect IL-2, IFN-γ, IL-13, IL-5, IL-10 and 
TNF-α. Newborns were categorized as: i) malaria +ve at ANC visits and 
delivery (n=21) ii) malaria +ve at ANC visits and -ve at delivery (n=195) iii) 
malaria -ve at ANC visits and delivery (n=84). Preliminary analysis was done 
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using one way ANOVA with Dunnetts multiple comparisons to compare 
the 3 groups. Data, though not statistically significant, shows a reduced 
proliferation to malaria-antigens in offspring of women positive for malaria 
at delivery as compared to the malaria negative. Th2 response and IL-10 
was greater in offspring of mothers with malaria at ANC and delivery 
(mean IL-13 273.9 pg/ml vs 2.86 pg/ml; IL-5 20.56 pg/ml vs 3.09 pg/ml 
and IL-10 27.5 pg/ml vs 1.03 pg/ml); though data was not statistically 
significant. These preliminary results show a high cellular immune response 
to malarial Ags in CBL isolated from neonates whose mothers were 
exposed to malaria later in pregnancy as compared to those exposed early 
into pregnancy. Further testing and analysis is ongoing to determine the 
implications of early detection and treatment of antenatal malaria on 
neonates’ immunity to malaria.
364
PHAGOCYTIC FUNCTION OF MONOCYTE SUBSETS DURING 
ACUTE UNCOMPLICATED MALARIA IN KENYAN CHILDREN
Katherine R. Dobbs1, Paula Embury1, John Vulule2, Peter Sumba 
Odada2, James W. Kazura1, Arlene E. Dent1
1Case Western Reserve University, Cleveland, OH, United States, 2Kenya 
Medical Research Institute, Kisumu, Kenya
Monocytes play an important role in innate and adaptive immunity to 
malaria. Human blood monocytes are classified into 3 subsets according to 
levels of CD14 and CD16 expression (classical CD14hiCD16-, intermediate 
CD14hiCD16+, and nonclassical CD14loCD16+). The functional roles of the 
subsets during malaria infection are still being described. Cryopreserved 
peripheral blood mononuclear cells (PBMC) were obtained from 9 children 
in western Kenya at presentation with acute uncomplicated malaria 
and 6 weeks following treatment. Phagocytic activity was determined 
using assays in which CFSE-labeled Pf-infected erythrocytes (IE) were 
opsonized with heat-inactivated plasma (pooled Kenyan adult (KA) plasma 
as a positive control, or malaria-naïve North American (NAM) plasma 
as a negative control). After incubation of IE with PBMC, the cells were 
stained with fluorescently-labeled anti-CD14 and anti-CD16 antibodies 
and subjected to flow cytometry. The percentage of monocytes within 
a population that had phagocytosed IE was calculated according the 
the CFSE signal. Opsonic phagocytic activity of classical monocytes and 
all monocyte subsets combined was decreased during acute malaria 
compared to 6 week recovery (classical subset median values 20.8% vs. 
28.9%, p < 0.01; all monocytes 25.5% vs. 43.8%, p < 0.01). Phagocytic 
activity of the monocyte subsets in the presence of NAM-opsonized IE 
did not differ between acute and recovery. Intermediate and nonclassical 
monocytes displayed greater phagocytic activity compared to classical 
monocytes in the presence of NAM-opsonized IE (9.2% and 7.3% vs. 
4.5%, respectively, p values < 0.01) as well as KA-opsonized IE (52.4% 
and 62.6% vs. 27.8%, respectively, p values < 0.01). These data indicate 
that opsonic phagocytic function of monocytes is decreased during acute 
malaria compared to 6 weeks following treatment. Compared to the 
classical subset, intermediate and nonclassical monocytes were more 
efficient at phagocytosing IE.
365
CD68 REGULATES PARASITE DENSITY OF PLASMODIUM 
YOELII 17XNL MURINE MALARIA
Maya Aleshnick1, Joanna Chorazeczewski2, Victoria Majam1, 
Sanjai Kumar1, Miranda Oakley2
1Division of Emerging and Transfusion Transmitted Diseases, Center for 
Biologics Evaluation and Research, Food and Drug Administration, Silver 
Spring, MD, United States, 2Division of Bacterial, Parasitic and Allergenic 
Products, Center for Biologics Evaluation and Research, Food and Drug 
Administration, Silver Spring, MD, United States
CD68 is a highly glycosylated transmembrane protein found on 
macrophages and other immune cells. Although CD68 is a well-known 
marker for macrophages, its function is poorly understood. Recently, this 
molecule has been identified as a candidate receptor for Plasmodium 
sporozoite invasion of Kupffer cells– the specialized macrophages that line 
the sinusoids in the liver. In this study, we measured the effect of CD68 
on the erythrocytic stage of Plasmodium murine malarias using mice 
deficient for the CD68 gene. Loss of CD68 had no effect on susceptibility 
to experimental cerebral malaria or on parasite burden during lethal 
Plasmodium berghei ANKA infection. However, absence of CD68 resulted 
in a two-fold increase in parasite density at peak parasitemia (day 10 
post-infection) during non-lethal P. yoelii 17XNL (Py 17XNL) infection. To 
better understand the immune mechanism of CD68-mediated control 
of Py 17XNL parasitemia, we compared the major immune cell subsets 
by flow cytometry and measured serum cytokine and antibody levels 
in wildtype verses mice lacking the CD68 gene over the course of Py 
17XNL infection. Significant differences were observed in the number of 
macrophages, natural killer cells, and B cells expanded in the spleen. In 
addition, production of the IL-12p70, IL-10, MCP1, MIP1β, G-CSF, and 
RANTES cytokines were significantly altered in the absence of CD68. Lastly, 
there was a dramatic difference in the quantity of IgG in the serum of WT 
verses CD68 knockout mice, suggesting that CD68 may alter the B cell 
response during Py 17XNL malaria. Studies are underway to determine the 
role of CD68 in the differentiation of macrophages into the M1 and M2 
subsets, and to dissect the mechanism of CD68-mediated regulation of B 
cell immunity by in vivo depletion experiments. The results of these studies 
will be useful in discerning the function of CD68 and in understanding the 
requirements for immune protection to malaria.
366
TACI CONTRIBUTES TO PLASMODIUM YOELII HOST 
RESISTANCE BY CONTROLLING THE KINETICS OF TFH AND 
GC FORMATION AND ANTIBODY DEVELOPMENT
Marcela Parra, Thomas Schmidt, Jiyeon Yang, Steven Derrick, 
Amy Yang, Xia Liu, Shafiuddin Siddiqui, Mustafa Akkoyunlu
FDA, Silver Spring, MD, United States
The transmembrane activator and calcium-modulator and cyclophilin 
ligand receptor (TACI) is involved in B-cell survival, antibody isotype 
switching and plasma cell generation. TACI expression is severely impaired 
in murine and human newborns as compared to adults. We challenged 
TACI knock-out (KO) mice with P. yoelii (Py) NL in order to evaluate the role 
of TACI in response to malaria infection. We found that the parasitemia 
levels were significantly elevated in TACI KO-mice (61.8% at day 18) 
compared to C57BL-6 WT-mice (11.1% at day 11), and that parasite 
clearance was substantially delayed in the TACI KO (27 days) mice relative 
to WT controls (18 days). We also determined that TACI KO-mice have 
a delay in anti-Py NL IgG-antibody production when compared with the 
WT-mice. Since the interaction of T follicular helper (Tfh) cells with antigen 
specific B cells in the germinal center (GC) is essential for the generation 
of antibody responses against T cell-dependent antigens, we measured 
the formation of Tfh and GC in the spleens of Py NL infected mice. 
Interestingly, we determined that while Tfh cell numbers were elevated 
on day 10 in both the strains, WT mice Tfh cell numbers sharply declined 
by day 15 as the number of Tfh cells in TACI KO-mice remained high. 
Coinciding with parasite clearance kinetics, TACI KO Tfh cells declined to 
baseline values on day 25. Similar to the Tfh cells, GC B cells remained 
high in TACI KO-mice after their decline on day 15 in WT mice. Finally, we 
detected elevated serum levels of the TACI ligand B cell-activating factor 
belonging to the TNF family (BAFF) in infected TACI KO mice as compared 
to the WT mice. Conclusion: Susceptibility of TACI deficient mice to Py NL 
infection appears to be based on altered Tfh and GC kinetics, which in 
turn results in delayed antibody development.
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IMMUNOLOGICAL EFFECT OF SEASONAL MALARIA 
CHEMOPREVENTION (SMC) WITH SULFADOXINE- 
PYRIMETHAMINE (SP) AND AMODIAQUINE (AQ) IN 
CHILDREN UNDER 10 YEARS IN THE SOUTHEASTERN PART 
OF SENEGAL
Khadime Sylla, Roger Clement Tine, Doudou Sow, Magatte 
Ndiaye, Jean Louis Ndiaye, Daouda Ndiaye, Oumar Gaye, Babacar 
Faye
University Cheikh Anta Diop, Dakar, Dakar, Senegal
In developing countries, malaria is still a major public health problem and 
children are the most affected individuals. In order to strengthen malaria 
control, Seasonal Malaria Chemoprevention (SMC) has been developed. 
This strategy is very effective in preventing malaria clinical episodes but its 
effect on children’s immunity is not well documented. This study aimed to 
assess the immunological effects of SMC among children under 10 years 
living in the southern part of Senegal (Velingara). The study was nested in 
a cluster randomized trial assessing the impact of SMC with a single dose 
of Sulphadoxine-Pyrimethamine (SP) and 3 doses of Amodiaquine (AQ). 
Two cross-sectional surveys were carried out at baseline (October 2010) 
and a year after intervention (September 2011). Thick and thin blood 
smears were used to assess malaria prevalence. Blood was collected on 
filter paper for serological measurement by ELISA to measure IgG anti-
MSP1_42 and anti-AMA1. Logistic regression analysis was performed 
to assess factors associated with the production of antibodies. A total 
number of 1611 children under 10 were included (866 children in 2010 
and 745 children in 2011). Malaria prevalence was 10.39% in 2010 
and 5.03% in 2011. The seroprevalence of anti-MSP1_42 anti-AMA1 
antibodies was higher in 2010 compared to 2011 providing a significant 
reduction of IgG production at 11.4 AU (95%CI [8.3-14.4]) for MSP1_42 
and 7.2 AU (95%CI [4.5-9.9]) for AMA1. Seroprevalence increased with 
age and Plasmodium falciparum carriage while it decreased according to 
the area and the study period. In conclusion, SMC is an effective strategy 
for malaria prevention in children under 10 years. The strategy can as 
well induce a decrease of IgG anti-AMA1 and anti-MSP1_42 which are 
associated with the protectiion against malaria. Consequently this strategy 
needs to be renewed each year in areas where malaria is highly seasonal 
to avoid a resurgence of malaria, while promoting the use of other 
antimalarial interventions.
368
MALARIA INTERVENTION SCALE-UP IN AFRICA: STATISTICAL 
EFFECTIVENESS PREDICTIONS FOR HEALTH PROGRAM 
PLANNING TOOLS, BASED ON DYNAMIC TRANSMISSION 
MODELLING
Guy Mahiané1, Eline L. Korenromp2, Carel Pretorius1, Thomas 
Smith3, Olivier Briët3
1Avenir Health, Glastonbury, CT, United States, 2Avenir Health, Geneva, 
Switzerland, 3Swiss Tropical and Public Health Institute, Basel, Switzerland
Malaria prevention and treatment needs to expand, and national strategies 
and budget allocations be evidence-based. We statistically summarized 
dynamically simulated relations between intervention coverage scale-
up and impact, to inform a malaria module in the Spectrum program 
planning tool. The dynamic transmission model OpenMalaria was used 
to simulate health impacts of insecticide-treated net usage (ITNs), indoor 
residual spraying (IRS), management of uncomplicated malaria cases (CM) 
and seasonal malaria chemoprophylaxis (SMC) over a 10-year horizon, for 
a range of African settings with stable endemic falciparum malaria. ITN 
effectiveness was parameterized by fitting to estimates from Cochrane 
review of ITN trials. Generalized linear regression models (GLMs) were 
used to summarize impact patterns in the simulations. GLMs explained 
94-97% of variation in simulated post-intervention parasite prevalence 
(three age groups, three 3-year horizons); 86-97% for case incidence and 
74-95% for malaria mortality, which was most stochastic. For a given 
effective population coverages, CM and ITNs were predicted to avert 
most infections, cases and deaths, with lower impacts for IRS. Impact of 
SMC was limited to young children reached. Proportional impacts were 
similar across ages, larger at lower endemicity, and (except for SMC) 
largest in low-endemic settings with low seasonality. Vector control and 
CM, by reducing endemicity and immunity, entailed a partial rebound in 
malaria mortality among over 5 year olds from around 7 years after scale-
up in low-endemic settings. SMC did not reduce endemicity, but slightly 
shifted malaria to older ages by reducing immunity in children reached. 
Incremental health impacts for single-intervention scale-up started to 
diminish noticeably above 40% coverage, while in high-endemic settings 
CM and ITNs acted synergistically by lowering endemicity. Statistical 
models can emulate epidemiological dynamics and inform strategic 
planning and target setting for malaria control.
369
UNDERSTANDING THE MECHANISM OF PLASMODIUM 
VIVAX HYPNOZOITES REACTIVATION
Adeshina I. Adekunle, Mykola Pinkevych, Deborah Cromer, 
Miles P. Davenport
Infection Analytics, Kirby Institute, UNSW, Kensington, Australia
Plasmodium vivax hypnozoites serve as the major source of maintaining P. 
vivax transmission in endemic countries. Controlling this parasite requires 
a thorough understanding of the factors determining the timing of P. 
vivax hypnozoite reactivation, which is not completely understood. In 
this study, we analyze previously published data from infected patients 
who were treated for blood stage infection and subsequently followed-
up until detection of P. vivax blood stage parasites. We develop a 
mathematical model of the frequency of hypnozoite reactivation from 
the liver, and apply this to published treatment-to-infection studies to 
investigate the frequency of hypnozoite reactivation over time. We first 
investigate whether the timing hypnoziote reactivation is constant with 
time or whether there is evidence that reactivation is induced by previous 
infection, and subsequently slows with time. We fitted our model to the 
dynamics of P. vivax reactivation of military personnel returning from 
endemic region, and found that reactivation dynamics were consistent 
with being induced by previous episodes of infection, and then the 
reactivation rate slowing over time with a half-life of around 60 days 
(CI: 45- 89). We also analysed time-to-P. vivax infection in patients 
under continual exposure in an endemic area of PNG, and found that 
although the initial rate of infection was highest in patients infected 
with P. falciparum at baseline, follow by those infected with P vivax and 
those uninfected at baseline, there was evidence for slowing of P. vivax 
reactivation rate with time. Mathematical modeling of the reactivation of 
P. vivax hypnozoites after anti-malarial treatment provides insights into the 
timing of reactivation, and has important implications for understanding 
treatment trials and planning eradication strategies.
370
USING CELL PHONE DATA TO IMPROVE MALARIA 
TARGETING AND MITIGATE THE NEGATIVE EXTERNALITY OF 
INTERNAL POPULATION MOVEMENT
Sveta P. Milusheva1, Nick W. Ruktanonchai2, Victor A. Alegana2, 
Andrew J. Tatem2
1Brown University, Providence, RI, United States, 2University of 
Southampton, Southampton, United Kingdom
The effect of population movement on malaria prevalence has been 
studied through small case control studies or using modeled parasite 
prevalence maps linked to human movement data. Yet, case control 
studies only cover a small geographic area and are not representative of 
a whole region or country, and using parasite prevalence becomes more 
difficult in areas that are at a pre-elimination stage. In those areas of low 
transmission, population movement is critical because most new cases 
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are imported from abroad or other parts of the country, and contribute to 
secondary cases. This study utilizes a unique dataset of cell phone usage 
for 9 million people in Senegal to measure population movement, and 
combines it with monthly malaria case data available at the health post 
level for the North of the country. This type of analysis, linking detailed 
movement data from cell phone records to case data on malaria makes it 
possible to study the effect of population movement in low transmission 
settings. In addition, movement is broken down into residents returning 
after travel away from home and visitors coming in from outside areas, 
in order to better understand which travelers are at the highest risk for 
spreading the disease. An important effect of population movement on 
malaria cases is found, especially for the very low malaria transmission 
districts that receive many travelers. The majority of the effect comes 
from residents travelling and returning, with each expected infected case 
coming into an area in the north leading to 2.5 new cases of malaria 
in that area, and very little impact from visitors. In addition, simulations 
demonstrate which are the districts in Senegal that are the leading 
exporters of the disease to low malaria areas of the country, and how 
targeting these districts could lead to larger decreases in prevalence. This 
paper also contributes to the research field of malaria more generally, 
demonstrating how as areas approach elimination, environmental factors 
like rainfall decrease in importance and human factors, such as travel, play 
a more prominent role in driving transmission.
371
CLUSTER-LEVEL DETERMINANTS OF REACTIVE CASE 
DETECTION PERFORMANCE IN MALARIA ENDEMIC 
SETTINGS: A MONTE-CARLO SIMULATION AND MODEL 
EMULATION STUDY
Logan H. Stuck1, Adam Bennett2, Rudy Yukich3, Busiku 
Hamainza4, Kafula Silumbe5, Rick Steketee5, John M. Miller5, 
Timothy P. Finn1, Thomas P. Eisele1, Joshua Yukich1
1Tulane School of Public Health and Tropical Medicine, New Orleans, LA, 
United States, 2University of California San Francisco, San Francisco, CA, 
United States, 3Sensorstar Inc., Ellicott City, MD, United States, 4National 
Malaria Control Centre, Ministry of Health, Lusaka, Zambia, 5PATH Malaria 
Control and Evaluation Partnership in Africa (MACEPA), Lusaka, Zambia
In recent years, many countries and regions within countries have achieved 
unprecedentedly low levels of malaria and are now looking towards 
elimination. Paradoxically, many current surveillance systems face the 
challenge of identifying and responding to increasingly rare and often 
hidden infections. Health officials within these settings are exploring novel 
approaches to malaria surveillance, such as reactive case detection (RCD), 
to combat this challenge. Little research has been done to evaluate if such 
an approach improves the sensitivity of malaria surveillance systems. The 
aim of this study was to develop a model emulator which predicted the 
cluster-level sensitivity of RCD, given a set of cluster-level attributes. RCD 
sensitivity, defined as the proportion of the malaria reservoir detected, 
was simulated within clusters of geo-coded census data from southern 
Zambia using a previously described monte-carlo algorithm. Eight rounds 
of parasite census data were used to maximize variability in the cluster-
level attributes, consequently increasing the performance of the model 
emulator. Cluster-level attributes such as prevalence, treatment-seeking 
behavior, population density, rainfall, forestation, and others were taken 
both from the Zambia data and from remote sensing data sources. 
Program modifiable attributes, such as CHW coverage, were also included 
in the model emulation. The model emulator was formed by regressing 
monte-carlo-simulated RCD sensitivity on a function of the cluster-level 
attributes, including complex interactions between them. Preliminary 
results suggest that local treatment-seeking behavior and prevalence 
will be major determinants of RCD sensitivity. The results of this study 
supplement the limited empirical research on malaria RCD and provide 
new information for decision making around RCD implementation.
372
WITHIN-HOST DYNAMICS AND SPREAD OF DRUG 
RESISTANCE IN PLASMODIUM FALCIPARUM MALARIA
Mary Bushman, Jaap de Roode, Rustom Antia
Emory University, Atlanta, GA, United States
In the malaria parasite Plasmodium falciparum, drug resistance emerges 
more readily in low-transmission areas than in high-transmission settings. 
One possible explanation for this phenomenon is that within-host 
dynamics of P. falciparum infections make it harder for drug-resistant 
parasites to spread in high—transmission settings. With intense 
transmission, multi-strain infections are common; therefore, a drug-
resistant mutant will likely have to compete against several drug-sensitive 
strains in any host it infects, reducing its chances of survival and onward 
transmission. To examine the effects of within-host competition on the 
emergence of resistance, we constructed a nested mathematical model 
which describes the within-host dynamics of individual infections as well 
as the dynamics of transmission in the host population. We used the 
model to examine the effect of transmission intensity on the evolutionary 
emergence of drug resistance; we also investigated how the impact of 
transmission intensity depended on host immunity and antimalarial drug 
use.
373
IS THE USE OF HRP2-DETECTING RAPID DIAGNOSTIC TESTS 
SUFFICIENT TO SELECT FOR HRP2-NEGATIVE PLASMODIUM 
FALCIPARUM PARASITES?
Michelle Gatton1, Qin Cheng2, Jane Cunningham3
1Queensland University of Technology, Brisbane, Australia, 2Australian 
Army Malaria Institute, Brisbane, Australia, 3World Health Organization, 
Geneva, Switzerland
Successful control and elimination of malaria relies on rapid and accurate 
diagnosis of clinical cases and surveillance. The use of malaria rapid 
diagnostic tests (RDTs) has significantly expanded over the past decade 
with the majority of tests detecting histidine-rich protein 2 (HRP2), 
expressed only by Plasmodium falciparum (Pf). However, HRP2-negative 
parasites have been reported in several regions, most notably the South 
America Amazon, but more recently countries such as India, Myanmar, 
Ghana, Mali and Senegal. A high prevalence of HRP2-negative parasites 
can undermine the utility of HRP2-detecting RDTs. While the selection 
forces on these parasites are unclear it has been hypothesized that the 
use of HRP2-detecting RDTs could be the primary mechanism for selection 
of HRP2-negative parasites. In this study we test this hypothesis using 
an individual-based mathematical simulation model of P. falciparum 
transmission. The purpose was to determine whether diagnosis using 
HRP2-detecting RDTs alone provides a sufficient selective force to allow 
newly introduced HRP2-negative parasites to become established within 
a community, and the probability of this occurring. Results indicate that 
the probability of successful introduction of HRP2-negative parasites 
is influenced by transmission intensity, half-life of the ACT companion 
drug and type of RDT used for diagnosis (HRP2 only vs HRP2/pan-pLDH 
combination test). In certain circumstances there is also a considerable lag 
between introduction and clinical evidence of HRP2-negative parasites. 
Since wide-spread emergence of HRP2-negative parasites has the 
potential to impact on timely and accurate diagnosis of malaria, improved 
understanding of the factors facilitating the establishment of non-HRP2 
expressing parasites allows for targeted surveillance and monitoring, and 
subsequently the adaptation of case management strategies in regions 
with or susceptible to HRP2-negative parasites.
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 PLASMODIUM VIVAX AND P. FALCIPARUM INFECTION 
DYNAMICS IN CO-ENDEMIC SETTINGS: RELAPSES, 
RECRUDESCENCES, RE-INFECTIONS AND THE ROLE OF CO-
INFECTION
Michael White1, Stephan Karl2, Azra Ghani1, Ingrid Felger3, Wang 
Nguitragool4, Leanne Robinson5, Ivo Mueller2
1Imperial College London, London, United Kingdom, 2Walter and Eliza Hall 
Institute of Medical Research, Melbourne, Australia, 3Swiss Tropical and 
Public Health Institute, Basel, Switzerland, 4Mahidol University, Bangkok, 
Thailand, 5Papua New Guinea Institute of Medical Research, Madang, 
Papua New Guinea
Plasmodium vivax infected populations are often co-endemic with P. 
falciparum malaria, with co-infection frequently observed in individuals. P. 
vivax infection dynamics are qualitatively different from P. falciparum due 
to liver-stage infection with hypnozoites which activate to cause relapses. 
Intensely sampled longitudinal data on genotyped malaria infections is 
assembled from cohorts spanning the P. vivax and P. falciparum endemic 
world, including Papua New Guinea, Solomon Islands, Thailand and Brazil. 
Individual and population-level infection dynamics are analysed using a 
mathematical model with statistical inference implemented in a Bayesian 
framework. Examples are presented where P. vivax recurrences are 
probabilistically classified into relapses, recrudescences and re-infections, 
depending on primaquine treatment, transmission intensity, and genotype 
detectability. P. vivax infections have shorter durations than P. falciparum 
infections, with the duration of both decreasing in higher transmission 
settings. We also present multi-site analyses of the association between 
P. falciparum induced fevers and P. vivax relapses, and of the impact of 
co-infection on the duration of blood-stage infections. The combination 
of longitudinal data, genotyping of samples and statistical analysis 
presented here allows for probabilistic identification of P. vivax relapses and 
estimation of their contribution to onwards transmission.
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OPTIMIZING THE GLOBAL ALLOCATION OF MALARIA FUNDS
Peter Winskill1, Patrick G. Walker1, Jamie T. Griffin2, Azra C. 
Ghani1
1Imperial College London, London, United Kingdom, 2Queen Mary 
University of London, London, United Kingdom
The burden of Plasmodium falciparum malaria remains high and efforts at 
control are resource-constrained. Optimal allocation of both internal and 
global financing is therefore paramount. In light of this, and coinciding 
with the Global Fund’s fifth replenishment call we undertook work to 
inform the allocation and spending of domestic, bi-lateral and multi-lateral 
funding for malaria control. We used a well-established mathematical 
model of malaria to describe the cost and impact of varying coverage 
levels for 4 key interventions (LLINs, IRS, SMC and treatment) across a wide 
range of epidemiological strata. We used these simulations to estimate 
the impact of intervention packages on malaria transmission in Global 
Fund supported countries. We optimised, at the first administrative unit, 
the spending of domestic financing within country and the distribution 
and spending of external and Global Fund financing across countries to 
maximise the number of cases or deaths averted. Targeting interventions 
can potentially lead to improved impact, with substantial benefits from 
countries optimising internally. We demonstrate the trade-off between 
maximising burden reductions and targeting countries for elimination. 
The optimal allocation is driven by four key factors: baseline transmission 
intensity, population at risk, current transmission and domestic financing 
capability.
376
DEVELOPMENT OF A NEW SOFTWARE TOOL AND ANALYSIS 
METHOD TO IMPROVE DETERMINATION OF GLUCOSE-6-
PHOSPHATE-DEHYDROGENASE (G6PD) STATUS
Michael Kalnoky1, Maria Kahn1, Sampa Pal1, Nicole LaRue1, 
Brandon Leader1, Germana Bancone2, Francois Nosten2, Gonzalo 
Domingo1
1PATH, Seattle, WA, United States, 2Shoklo Malaria Research Unit, Mae 
Sot, Thailand
For the radical cure of Plasmodium vivax infection, safe administration of 
8-aminoquinoline drugs is critical, but these drugs can be administered 
only after the determination of G6PD status. Cytochemical staining allows 
for the determination of G6PD activity in an individual red blood cell. It 
is possible to estimate the relative proportions of G6PD-deficient cells 
to those with normal G6PD activity. This research describes a software 
tool to standardize the analysis of flow cytometry in screening for G6PD-
heterozygous females. Its primary function is to provide standardized 
ratios of “normal” to “G6PD-deficient” cells in an individual blood 
sample. The goal is to determine zygosity of individuals spanning the 
G6PD polymorphisms found in African and Southeast Asian populations 
referenced to DNA sequencing methods. Methods: A reference 
quantitative assay and cytofluorometry method were used to determine 
G6PD status. A software tool for standardization and interpretation of 
cytochemical staining for G6PD status has been developed. Criteria for 
calling zygosity in females was determined using DNA sequencing as 
the reference assay. The tool was validated with 472 females and males 
spanning the G6PD polymorphisms found in African and Southeast Asian 
populations referenced to DNA sequencing methods. Validation of the 
analysis tool showed 100% sensitivity and 100% specificity for both 
normal and G6PD-deficient males when referenced to DNA sequencing. 
For females with varying levels of G6PD activity, the specificity and 
sensitivity were 91% and 98% respectively for homozygous deficient, 
97% and 91% for heterozygous, and 91% and 100% for homozygous 
normal. In onclusion, a methodology for standardizing the analysis of 
cytofluorometry in screening for G6PD-heterozygous females has been 
developed and packaged into a free, open-source software tool that is 
available online. The software tool is able to correctly call zygosity with a 
high level of sensitivity and specificity, even across polymorphisms found 
in Southeast Asian and African populations, making it a useful tool in the 
identification of G6PD-heterozygous females.
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SPATIAL MODELING AND HETEROGENEOUS ANALYSIS OF 
THE EFFICACY OF LONG-LASTING MICROBIAL LARVICIDING 
ON MALARIA OUTDOOR TRANSMISSION IN WESTERN 
KENYA HIGHLANDS
Ming-Chieh Lee1, Yaw Afrane2, Guiyun Yan1
1Univ. of California Irvine, Irvine, CA, United States, 2University of Ghana, 
Accra, Ghana
The rising insecticide resistance and increase in outdoor transmission have 
greatly hampered the effectiveness of currently available first line malaria 
prevention tools such as long lasting insecticidal nets (LLIN) and indoor 
residual spray methods. Among the alternative intervention methods are 
being developed and tested in the field, microbial larvicides represent 
a promising supplemental intervention tool that may tackle outdoor 
transmission and pyrethroid insecticide resistance. Long-lasting microbial 
larvicides (LLML) are particularly attractive because reduce the number of 
reapplications and thus costs associated with insecticide application, and 
subsequently they may be potentially more cost-effective. To determine 
the efficacy of LLML in reducing malaria transmission and optimal field 
application strategies, the Epidemiological Modeling (EMOD) model for 
Malaria Transmission developed by Institute for Disease Modeling (IDM) 
was employed to simulate sites with different malaria prevalence and 
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landscape scenarios through its Computation Modeling Platform Services. 
Three sites in western Kenya highland and lowland with well characterized 
vector ecology and malaria prevalence were simulated using the multi-
node spatial model with vector migration method of EMOD. The results 
show that the beneficial killing efficacy of nets might gradually be reduced 
due to increased insecticide resistance and outdoor transmission in the 
absence of other supplemental interventions. The potential reduction of 
population infected rate after LLML application can reach up to 24%. 
Re-treatment of aquatic habitats every 4 months would lead to consistent 
reduction in malaria transmission. In summary, the modeling analyses 
suggest that LLML has the potential to provide significant added benefits 
to LLIN for malaria control in a range of sites with different transmission 
intensities and landscape characteristics.
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USING A BAYESIAN GEOSTATISTICAL MODEL TO 
UNDERSTAND LOCAL-SCALE HETEROGENEITY IN MALARIA 
RISK: THE EXAMPLE OF BUNKPURUGU-YUNYOO DISTRICT IN 
NORTHERN GHANA
Punam Amratia1, Justin Millar1, Paul Psychas1, Benjamin Abuaku2, 
Collins Ahorlu2, Kwadwo Koram2, Samuel Oppong3, Denis Valle1
1University of Florida, Gainesville, FL, United States, 2Noguchi Memorial 
Institute for Medical Research, University of Ghana, Accra, Ghana, 
3National Malaria Control Program, Accra, Ghana
Bayesian methods have been used to generate country-level and global 
maps of malaria risk on a large geographical scale. However, these maps 
may lack the ability to identify smaller scale heterogeneity and may not 
be ideal for operational malaria activities. The aim of this study is to apply 
Bayesian geostatistical models to high-resolution malaria data in order to 
construct a predictive model of local-scale spatial heterogeneity. We used 
existing malaria parasitemia survey data from a 30x40km study area in 
the Bunkpurugu-Yunyoo district of northern Ghana, consisting of 10,366 
children from 438 geo-coded communities sampled between November 
2010 and November 2013 bi-annually. A Bayesian hierarchical model using 
a Gibbs sampler and Metropolis Hasting algorithm estimated parameter 
values for geostatistical predictions and accounted for spatial dependency 
at individual and community level. To permit generalizability of the model 
to other districts, we selected only remote-sensed variables, including 
environmental factors - such as elevation, temperature, rainfall - and 
GIS-derived demographic factors such as distance to health facility, urban 
centres, roads and water bodies. Overall, malaria prevalence in the district 
varied between 19% and 90%, showing a north-east to south-west 
gradient of predicted risk with the highest prevalence rates found at lower 
elevations. Model selection revealed elevation and distance to urban centre 
to be important covariates. The general distribution is heavily weighted 
between the two modest urban centres, showing lower risk in urban 
centres compared to rural areas, with some indication that a threshold 
distance-to-urban-centre exists for malaria risk. Model predictions revealed 
high variability in malaria prevalence in areas previously assumed to be 
homogenous, indicating important shortcomings of country level spatial 
modelling from a programmatic perspective. Our modelling approach 
could potentially be applied to infer fine-scale malaria risk in other areas of 
northern Ghana and beyond, using readily available remote-sensed data.
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GEOGRAPHIC TARGETING OF MALARIA INTERVENTIONS 
IN MYANMAR USING A DYNAMIC ECONOMIC 
EPIDEMIOLOGICAL MODEL
Tom Drake1, Shwe Sin Kyaw1, Wynn Zaw1, Myat Phone Kyaw2, 
Frank Smithuis3, Nicholas Day1, Lisa White1, Yoel Lubell1
1Mahidol Oxford Tropical Medicine Research Unit, Bangkok, Thailand, 
2Department of Medical Research, Ministry of Health, Yangon, Myanmar, 
3Medical Action Myanmar, Yangon, Myanmar
Two interventions receive the majority of malaria control funding in 
Myanmar i) insecticide treated bed nets and ii) early diagnosis and 
treatment through malaria community health workers. While malaria 
funding has increased markedly in recent years, universal coverage of 
both interventions is not currently affordable nor likely to be financially 
sustainable. This study focuses on 52 priority townships and aims to 
provide practical recommendations for targeted geographic allocation of 
these interventions such that impact on malaria is maximised from the 
investment. Malaria surveillance in Myanmar is undergoing substantial 
improvement but does not currently capture detailed incidence data 
from non-governmental organizations. A data repository was established 
to collect and process historical incidence data from governmental and 
non-governmental sources. This information was used within a dynamic 
economic epidemiological model to estimate intervention costs and effects 
in terms of Disability Adjusted Life Years averted within each township. 
Township specific intervention recommendations given a fixed total budget 
are obtained via a resource allocation algorithm. Scenario analysis was 
employed to illustrate alternative allocation results under variations of 
certain model or parameter assumptions, such as cost sharing with other 
disease funds. Finally, uncertainty analysis presents the consistency of 
intervention allocation result separately for each townships, given the total 
prior parameter uncertainty. Final results will be completed prior to the 
conference.
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SIMULATING WITHIN-VECTOR GENERATION OF MALARIA 
PARASITE DIVERSITY
Lauren M. Childs1, Olivia Prosper2
1Harvard T.H. Chan School of Public Health, Boston, MA, United States, 
2University of Kentucky, Lexington, KY, United States
Plasmodium falciparum, the most virulent malaria parasite causing disease 
in humans, undergoes asexual reproduction within the human host, 
and sexual reproduction within the vector host, Anopheles mosquitoes. 
Consequently, the mosquito stage of the parasite life cycle provides 
an opportunity to create novel parasite genotypes in superinfected 
mosquitoes, a likely contributor to the observed high degree of parasite 
diversity in both high and low transmission settings. This diversity has 
important implications for disease transmission and malaria control, 
however the mechanisms driving this diversity within the vector remain 
under investigation. To understand the role that vector biology plays in 
modulating the generation of parasite diversity, we developed a two-stage 
model framework that estimates the genetic diversity across a population 
of mosquitoes as a consequence of different bottlenecks and expansion 
events occurring during the vector-stage of the parasite life cycle. In the 
first stage of this framework, we developed the first stochastic model of 
within-vector P. falciparum parasite dynamics and simulate the dynamics 
of two competing parasite genotypes, emulating superinfection. Coupled 
to this model of parasite dynamics is the second stage of our framework: 
a model of sequence diversity generation through recombination between 
genotypes within a mosquito. Our model framework demonstrates that 
bottlenecks from the ookinete to oocyst stage decrease diversity from the 
initial gametocyte population in a mosquito’s blood meal, and increases 
with the development of sporozoites. Furthermore, the bottlenecks in the 
transition from the human host to a mosquito population results in a pool 
of parasites that has increased in diversity at the population level.
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REMOTELY SENSED ENVIRONMENTAL CONDITIONS AND 
MALARIA MORTALITY IN THREE MALARIA ENDEMIC 
REGIONS IN WESTERN KENYA
Maquins O. Sewe1, Clas Ahlm2, Joacim Rocklöv2
1Kenya Medical Research Institute/Centers for Disease Control and 
Prevention, Kisumu, Kenya, 2Umeå University, Umeå, Sweden
Malaria is an important cause of morbidity and mortality in endemic 
countries. The malaria mosquito vectors depend on environmental 
conditions, such as temperature and rainfall, for reproduction and survival. 
To investigate the potential for weather driven early warning systems to 
prevent disease occurrence, the disease relationship to weather conditions 
needs to be carefully investigated. Where meteorological observations are 
scarce, satellite derived products provide new opportunities to study the 
disease patterns depending on remotely sensed variables. In this study, 
we explored the lagged association of Normalized Difference Vegetation 
Index (NVDI), day Land Surface Temperature (LST) and precipitation on 
malaria mortality in three areas in Western Kenya. The lagged effect of 
each environmental variable on weekly malaria mortality was modeled 
using a Distributed Lag Non Linear Modeling approach. For each variable 
we constructed a natural spline basis with 3 degrees of freedom for both 
the lag dimension and the variable. Lag periods up to 12 weeks were 
considered. The effect of day LST varied between the areas with longer 
lags. In all three areas, malaria mortality was associated with precipitation. 
The risk increased with increasing weekly total precipitation above 20 
mm and peaking at 80 mm. The NDVI threshold for increased mortality 
risk was between 0.3 and 0.4 at shorter lags. This study identified lag 
patterns and association of remote-sensing environmental factors and 
malaria mortality in three malaria endemic areas in Western Kenya. Our 
results show that rainfall has the most consistent predictive pattern to 
malaria transmission in the study area. Results highlight the potential for 
developing locally based early warning forecasts that could reduce the 
disease burden by enabling timely control actions.
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EFFECT OF IMMEDIATE VS. DELAYED IRON THERAPY ON 
NEUROCOGNITIVE OUTCOMES IN CHILDREN WITH SEVERE 
MALARIA
Ssemata S. Andrew
Makerere University, Kampala, Uganda
Malaria and iron deficiency are associated with neuropsychological deficits, 
but iron supplementation given concurrently with antimalarial treatment 
per the standard of care may not be well absorbed due to malaria-
induced inflammation. We compared neuropsychological functioning 
after 6 and 12-months between children with cerebral malaria (CM) or 
severe malarial anemia (SMA) who received ferrous sulphate on admission 
concurrently with antimalarial treatment (immediate group) or four weeks 
after admission (delayed group). We hypothesized that children with 
delayed iron treatment would have better iron uptake, therefore better 
neurocognitive outcomes at 12-months follow-up. We recruited 239 
Ugandan children aged 18 months - 4.9 years for 12 months: 79 with 
CM, 77 with SMA, and 83 healthy community children (CC). All CM, 
SMA and 35 CC were iron-deficient (zinc protoporphyrin (ZPP)≥80 mmol/
mol heme) and randomly assigned to start a 3-month course of ferrous 
sulphate immediately or after four weeks. Children were assessed for 
overall cognitive ability, attention, and associative memory 1 week and 6 
and 12 months after admission. Administration of iron immediately vs. 
delayed did not lead to significantly different neurocognitive outcomes in 
cognitive ability, attention or associative memory in children with CM or 
SMA at 12-months follow-up. However, a mixed effects model analysis 
that included outcomes at all three time points showed that children with 
CM in the immediate treatment group exhibited better attention scores 
than the delayed group. Regardless of treatment arm, CM had significantly 
worse cognitive ability and associative memory scores, and SMA had 
significantly worse cognitive ability scores compared to CCs at 12-months. 
Delay of iron may not result in improved long-term neurocognitive 
outcomes in children with severe malaria as compared to immediate iron 
treatment. In children with CM, it was associated with worsened long-
term attention. Administration of iron therapy with either timing may not 
prevent worsened neurocognitive outcomes in children with severe malaria 
when compared to community children in the area.
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IMPROVING REPORTING OF WEEKLY MALARIA DATA 
THROUGH THE ELECTRONIC INTEGRATED DISEASES 
SURVEILLANCE AND RESPONSE (E-IDSR) IN TEN REGIONS OF 
TANZANIA
Ritha Willilo1, Osia Mwaipape1, Franky Chacky2, Renata 
Mandike2, Elibariki Mwakapeje3, Lynn Paxton4, Naomi Kaspar5, 
George Greer5, Anold Mutafungwa1, Jeremiah Ngondi1
1RTI International, Dar es salaam, United Republic of Tanzania, 2National 
Malaria Control Program, Dar es salaam, United Republic of Tanzania, 
3Ministry of Health and Social Welfare, Dar es salaam, United Republic 
of Tanzania, 4U.S. President’s Malaria Initiative, U.S. Centers for Disease 
Control and Prevention, Dar es salaam, United Republic of Tanzania, 
5President’s Malaria Initiative, United States Agency for International 
Development, Dar es salaam, United Republic of Tanzania
To ensure that malaria epidemics are detected and addressed within 
two weeks of onset, the Tanzania National Malaria Control Program 
monitors malaria cases reported weekly via the electronic Integrated 
Disease Surveillance and Response System (e-IDSR). Implementation of 
the e-IDSR started with 67 health facilities (HF) in November 2013 and 
progressively scaled-up to reach 2,967 HFs by January, 2016, covering a 
total of 10 out of 25 regions. This study reports trends in reporting rate, 
gaps, and the ongoing initiative to improve low reporting rates. At the HF 
a health worker compiles data for each epidemiological week (Monday to 
Sunday) and submits the previous week’s data via mobile phone by dialing 
number *152* 05#. Reports are submitted every Monday by 3:30pm, 
later submission is considered late reporting. Malaria data reported are 
number tested with RDT/microscope, positive and clinical malaria case. The 
submitted report goes directly into the DHIS2 information management 
system and can be accessed by officials at district, regional, and national 
levels. Overall, in 2013 the reporting rate was 49%, 63.3% in 2014, 
and 38.3% in 2015. Reports received on time (by Monday 3:30 pm) 
were 35.6% in 2013, 36.4% in 2014 and 10.8% in 2015. There was 
considerable variation in reporting rate between districts. In 2015, only 
3(5%) out of 60 districts had reporting rates which met the national target 
of 80% (range 80%-84%). 13(22%) out of 60 districts had a reporting 
rate ranging from 50%-74%. Overall malaria data reported in 2013 
showed that a total of 54,985 people tested of which 15, 654 (28%) had 
malaria, in 2014 and 2015 a total of 1,211,789(87%) and 2, 458,807 
(89%) people were tested of which 474,556(39%) and 817,494(33%) 
tested positive for malaria respectively. Complete and timely reporting of 
malaria cases is crucial to prevent and mitigate malaria outbreaks. The 
e-IDSR reporting rate remains far below target and has faltered after three 
years. To improve reporting a series of 3 day workshops incorporating 
practices and lesson learned from the best performing districts is being 
conducted and attended by regional and district authorities in all 10 
regions.
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“I FEEL SO BAD BUT HAVE NOTHING TO DO.” A 
QUALITATIVE STUDY OF UGANDAN CAREGIVERS’ 
EXPERIENCES OF PARENTING WITH CHILDREN WITH SEVERE 
MALARIA AND SUBSEQUENT REPEATED EPISODES OF 
UNCOMPLICATED MALARIA
Ann J. Nakitende
Makerere University, Kampala, Uganda
Severe malaria (SM) and repeated malaria attacks (RMA) are major public 
health concern. In the endemic regions, children experience 2-5 malaria 
attacks annually. The experience of caregivers with children having 
repeated malaria attacks has not been documented. The purpose of this 
study was to explore caregivers’ experiences in parenting of a child with a 
history of severe malaria followed by repeated episodes of uncomplicated 
malaria. This was a qualitative study that used phenomenological 
approaches. Twenty five caregivers of children previously exposed to 
severe malaria and who had experienced repeated subsequent episodes 
of uncomplicated malaria were purposively selected. Data was collected 
using in-depth interviews conducted in Luganda, a native dialect. 
Interviews were audio recorded, transcribed and translated into English 
language. Data was manually analyzed using content analysis. The main 
themes and subthemes exploring caregivers’ experiences of parenting 
a child with a history of severe malaria and repeated malaria episodes 
were generated. From the interviews, the 4 main themes were identified. 
These included; societal burden where children are left with community 
members when their caregivers have to inevitably work; disagreements in 
seeking healthcare from traditional, spiritual or modern medicine among 
caregivers, family and the community; family life disruptions involving 
breakdown of relationships and inadequate male-spouses involvement in 
the child care; and a sense of helplessness in management of a child with 
severe malaria and repeated malaria episodes. Severe malaria and repeated 
malaria episodes affect not only the children who have these illnesses but 
also their caregivers’ parenting experiences. There is need for caregiver-
parenting sessions towards the management of children who have had 
severe malaria and repeated subsequent episodes of malaria.
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PREVALENCE OF SEVERE VIVAX MALARIA: A SYSTEMATIC 
REVIEW AND META-ANALYSIS SINCE 1900
Bilal Ahmad Rahimi1, Nicholas J. White2, Arjen M. Dondorp2, 
Ammarin Thakkinstian3, Chukiat Sirivichayakul3, Watcharee 
Chokejindachai3
1Kandahar University, Kandahar, Afghanistan, 2Oxford University, Oxford, 
United Kingdom, 3Mahidol University, Bangkok, Thailand
Malaria caused by Plasmodium vivax was long considered to have a low 
mortality, but recent reports suggest that severe and complicated vivax 
malaria may be more common than previously thought. The primary 
objective of this systematic review and meta-analysis was to describe 
the reported clinical characteristics and the geographical variation in 
prevalence of reported severe vivax malaria and its change over time 
derived from English-language articles published since 1900. Medline 
and Scopus databases were searched for original papers on severe vivax 
malaria. A total of 77 studies with reported severe vivax malaria and 
63 studies with no reported severe vivax malaria (totaling 46,411 and 
6,753 vivax malaria patients, respectively) were included. The 77 studies 
with reported severe vivax malaria were mainly from India (n = 33), USA 
(n = 8), Indonesia (n = 6), and Pakistan (n = 6). Among the 77 studies 
reporting severe vivax malaria, severe thrombocytopenia (<50,000/
mm3) was the most common “severe” manifestation (888/45,775 with 
pooled prevalence of 8.6%). The case fatality was 0.3% (353/46,411). In 
conclusion, P. vivax can cause severe and even fatal disease. More detailed 
epidemiological studies are needed which dissociate causation from 
association to refine the definition and estimate the prevalence of severe 
vivax malaria.
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COMPARISON OF METHEMOGLOBIN LEVEL BETWEEN 
CHILDREN AND ADULT AFTER TREATMENT WITH 
PRIMAQUINE
Ayodhia Pitaloka Pasaribu
University of Sumatera Utara, Medan, Indonesia
Primaquine prevents relapse and sterilizes infectious sexual plasmodia, 
but confusion surrounds its use. It is able to convert hemoglobin to 
methemoglobin, producing cyanosis. Limited data support the influence 
of primaquine on level of methemoglobin in children. A prospective 
study part of a clinical trial was done in an endemic area of malaria, 
North Sumatera, Indonesia. Patients diagnosed with Plasmodium vivax 
were given ACTs and low dose primaquine for 14 days. Methemoglobin 
level was measured on day 0, 7 and 14. A descriptive analysis and un-
paired ttest were carried out. Among 3168 patients that were screened, 
331 (10.45%) was enrolled. We found 65.86% children and 34.14% 
adult. Mean level of Methemoglobin in children on day 0 was 1.75% 
compared to 1.53% in adult, p=0.03. On day 14, Mean methemoglobin 
level in children was 5.46% and adult 4.76%, p=0.03. 12/218 (5.5%) 
of children had methemoglobin level > 10% compared to adult (5.3%) 
6/113. The highest methemoglobin level (19.6%) was found in a child 
on day 14, fortunately without any symptoms. An increase level of 
methemoglobin found in malaria patients in North Sumatera, Indonesia 
after receiving treatment of primaquine. Children were more prone to 
methemoglobinemia compared to adult.
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HEALTH SYSTEM STRENGTHENING
Elizabeth Oele
Ministry of Health, Kisumu, Kenya
Kisumu is one of the top 15 counties with poor maternal and neonatal 
health indicators. Malaria in pregnancy (MIP) is one of the conditions 
associated with poor pregnancy outcomes including maternal anaemia, 
miscarriages, low birth weight and neonatal deaths. However, the uptake 
of the effective interventions like intermittent preventive treatment of 
malaria in pregnancy using sulfadoxine pyrimethamine (IPTp-SP) has 
remained belowthe national targets at 50% for 2 or more doses and 
33% for 3 or more doses in areas providing IPTp.To enable the country 
move towards achieving the national targets,ministry of health has 
developed simplified guidelines on how to prevent and treat malaria in 
pregnancy and how to create demand for health services by communities. 
To build the capacity of Muhoroni subcounty to scale up the effective 
MIP interventions a) health care workers (HCWs) in public, faith-based 
organizations, community-based organizations and private sector 
providing antenatal care services (ANC) services were trained on provision 
of the interventions b) community health volunteers (CHVs)were trained 
on MIP messaging at community levelto sensitize pregnant women and 
create demand for health services. A total of 264 out of 312 (84.6 %) 
HCWs in 30 out of 32 (93.8 %) facilities providing ANC were trained. 
A total of 318 out 340 (93.5 %) targeted CHVs in all 34 community 
units were trained on sensitization of pregnant women on importance 
of adhering to scheduled ANC visits. To reduce the poor maternal and 
neonatal health indicators associated with effects of malaria in pregnancy, 
it is important to scale up the coverage rates of MIP interventions to the 
set national targets. The subcounty in an effort to increase coverage 
towards the national targets built the capacity of HCWs on prevention and 
treatment of malaria in pregnancy and CHVs on sensitization of pregnant 
women to attend scheduled ANC visits.
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REDUCTIONS IN MALARIA IN PREGNANCY AND ADVERSE 
BIRTH OUTCOMES FOLLOWING INDOOR RESIDUAL 
SPRAYING OF INSECTICIDE IN UGANDA
Mary K. Muhindo
Infectious Diseases Research Collaboration, Tororo, Uganda
Indoor residual spraying of insecticide (IRS) is a key intervention for 
reducing the burden of malaria in Africa. However, data on the impact of 
IRS on malaria in pregnancy and birth outcomes is limited. We conducted 
an observational study nested within a trial of intermittent preventive 
therapy during pregnancy in Tororo, Uganda. Women were enrolled at 12-
20 weeks of gestation between June-Oct 2014, provided with insecticide 
treated bednets, and followed through delivery. From Dec 2014-Feb 2015, 
carbamate-containing IRS was implemented in Tororo district for the first 
time. Exact spray dates were collected for each household. The exposure 
of interest was the proportion of time during a woman’s pregnancy under 
protection of IRS. Of 289 women followed, 134 had no IRS protection 
during pregnancy, 90 had >0-20% IRS protection, and 65 had >20-43% 
protection. During pregnancy, malaria incidence (0.49 vs 0.10 episodes 
ppy, P=0.02) and parasite prevalence (20.0% vs 8.9%, P<0.001) were 
both significantly lower after IRS. At the time of delivery, the prevalence 
of placental parasitemia was significantly higher in women with no IRS 
protection (16.8%) compared to women with 0-20% (1.1%, P=0.001) 
or >20-43% IRS protection (1.6%, P=0.006). Compared to women 
with no IRS protection, those with >20-43% IRS protection had a lower 
risk of LBW (20.9% vs 3.1%, P=0.002), preterm birth (17.2% vs 1.5%, 
P=0.006), and fetal/neonatal deaths (7.5% vs 0%, P=0.03). In cocnlusion, 
in this setting, IRS was temporally associated with lower malaria parasite 
prevalence during pregnancy and at delivery, and improved birth 
outcomes.
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HIGH-THROUGHPUT METABOLOMICS TO IDENTIFY 
BIOMARKERS OF RELAPSES IN PLASMODIUM VIVAX-
INFECTED PATIENTS
Cristiana F. Brito1, Sophia Banton2, Karan Uppal2, Dean Jones2, 
Mary Galinski2
1Institute René Rachou/Fiocruz, Belo Horizonte, Brazil, 2Emory University, 
Atlanta, GA, United States
 Plasmodium vivax is the most widely distributed cause of human malaria 
worldwide, and presently more than 40% of the global population is at 
risk of infection with this parasite. P. vivax develops latent stages in the 
liver, where the hypnozoites can generate new acute malaria episode 
months or years after the initial infection. Recently, systems biology and 
mathematical modeling studies have highlighted the role of relapses in 
P. vivax infection in geographical areas where the parasite is transmitted. 
Therefore, the new agenda of malaria eradication includes controlling 
relapses in P. vivax infected patients. Although this is an important 
challenge towards eradication, a differential diagnosis for relapse in 
patients is currently unavailable. Thus, the aim of this study was to identify 
human metabolites that are differentially expressed in relapse compared 
to the primary infection in the same individuals. To reach this goal, high 
throughput untargeted metabolomics was performed on serum samples 
from individuals with clinical cases of initial infection and relapses. More 
than 2,800 metabolites features were detected using this platform, and 
86 metabolites showed significant differences between the two groups 
(primary x relapse). Significant metabolites included inosine and taurine, 
and the former increased in relapses and the latter decreased in relapses. 
These metabolites can serve as potential biomarkers of relapse in P. vivax 
infection, and confirmation of their identities will determine their full 
potential.
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NEW EFFORTS AIMED AT REPLACING ARTEMISININS FOR 
MALARIA TREATMENT: IDENTIFICATION OF NOVEL, DRUG-
LIKE AND FAST-ACTING COMPOUNDS WITH TRANSMISSION 
BLOCKING POTENTIAL FROM WITH PHENOTYPIC SCREENING
María J. Chaparro
GlaxoSmithKline, Tres Cantos, Spain
Malaria is a mosquito-borne protozoal infection caused by parasites of 
the genus Plasmodium. Despite efforts to eradicate malaria in the past 
century, the disease remains a major global health problem. Nowdays, 
according to the 2014 World Health Organization (WHO) global malaria 
report, 3.3 billion people are at risk of being infected with malaria. From 
the 198 million cases reported in 2013 the disease led to ca. 500,000 
deaths.[1] Plasmodium has been able to adapt to the different treatments 
developed by humans along history. Part of it as a consequence of its 
complicated life-cycle which involves resistance to the current first line 
treatments Artemisins Combination Therapies (ACT) is also arising. The 
wide knowledge of the illness and the awareness of governments/health 
systems/funding agencies, makes the current time a unique opportunity 
to change the course of this disease and achieve eradication. GSK efforts 
are focused on identifying quality novel chemotypes suitable for oral 
administration and activity versus strains resistant to current antimalarials 
in the clinic. Ideally that new molecule should present activity versus the 
parasite forms involve in the transmission of the disease. [2,3] Therefore, 
we are seeking the next generation of antimalarials. In this communication 
we will discuss our latest advances in the field. References [1] World 
Health Organization. World malaria Report 2014; WHO Press: Geneva, 
Switzerland, 2014. http://www.who.int/malaria/ publications/world_ 
malaria_report_2014/report/en/ (accessed August, 4, 2015). [2] F. J. Gamo, 
et. al., Nature 2010, 465, 305-312.; [3] J. Lelièvre et al, PLoS ONE 2012, 
7(4), e35019 The human biological samples were sourced ethically and 
their research use was in accord with the terms of the informed consents. 
All animal studies were ethically reviewed and carried out in accordance 
with European Directive 86/609/EEC and the GSK Policy on the Care, 
Welfare and Treatment of Animals.
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TRENDS IN U.S. PRESIDENT’S MALARIA INITIATIVE-FUNDED 
INDOOR RESIDUAL SPRAY COVERAGE AND INSECTICIDE 
CHOICE IN SUB-SAHARAN AFRICA (2008-2015): URGENT 
NEED FOR AFFORDABLE, LONG-LASTING INSECTICIDES
Richard Martin Oxborough
Richard Oxborough Consultancy, London, United Kingdom
The changing pattern of US President’s Malaria Initiative-funded IRS 
in sub-Saharan Africa between 2008-2015 was studied. IRS coverage 
in sub-Saharan Africa increased from <2% of the at-risk population 
in 2005, to 11% or 78 million people in 2010, mainly as a result of 
increased funding from PMI. The scaling up of IRS in sub-Saharan Africa 
has been successful in several epidemiological settings. However, the 
spread and intensification of pyrethroid resistance in malaria vectors led 
many control programmes to spray alternative insecticides. Between 
2009-2013, pyrethroid spraying decreased from 87% (13/15) of PMI-
funded countries conducting IRS to 44% (7/16), while bendiocarb use 
increased from 7% (1/15) to 56% (9/16). Long-lasting pirimiphos-methyl 
CS received WHOPES recommendation in 2013 and was scheduled to be 
sprayed in 85% (11/13) of PMI-funded countries conducting IRS in 2015. 
The gradual replacement of relatively inexpensive pyrethroids firstly with 
bendiocarb (carbamate) and subsequently with pirimiphos methyl CS 
(organophosphate) has contributed to downscaling of most PMI-funded 
IRS programmes. Overall, there was a 53% decrease in the number of 
structures sprayed between years of peak coverage and 2015, down from 
9.04 million to 4.26 million structures. Sizeable reductions in the number 
of structures sprayed were reported in Madagascar (56%, 576,320 
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to 254,986), Senegal (64%, 306,916 to 111,201), Tanzania (68%, 
1,224,095 to 389,714) and Zambia (63%, 1,300,000 to 482,077), while 
in Angola, Liberia and Malawi PMI-funded spraying was suspended. The 
most commonly cited reason was increased cost of pesticides, as vector 
resistance necessitated switching from pyrethroids to organophosphates. 
There are worrying preliminary reports of malaria resurgence following IRS 
withdrawal in parts of Benin, Tanzania and Uganda. At present, there are 
several countries reliant on organophosphates and carbamates for IRS and 
increasing resistance is a serious threat that could result in IRS no longer 
being viable. A portfolio of new cost-effective insecticides with different 
modes of action is urgently needed.
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SENTINEL-SITE SURVEILLANCE FOR MALARIA MORTALITY 
AND ITS POTENTIAL FOR EBOLA VIRUS DISEASE OUTBREAK 
DETECTION IN GUÉCKÉDOU, GUINEA
Amanda Tiffany1, Faya Pascal Moundekeno2, Alexis Traore3, 
Melat Haile4, Esther Sterk5, Timothé Guilavogui6, Micaela Serafini5, 
Blaise Genton7, Rebecca Grais8
1Epicentre, Geneva, Switzerland, 2Medecins Sans Frontieres, Guéckédou, 
Guinea, 3Prefectoral Health Directorate, Guéckédou, Guinea, 4Medecins 
Sans Frontieres, Conakry, Guinea, 5Medecins Sans Frontieres, Geneva, 
Switzerland, 6National Malaria Control Program, Conakry, Guinea, 7Swiss 
Tropical and Public Health Institute, Basel, Switzerland, 8Epicentre, Paris, 
France
Community-based surveillance systems are used to document program 
impact on mortality from diseases such as malaria. They could also act as 
surveillance systems for outbreak detection. We conducted a retrospective 
analysis of data from a prospective malaria mortality surveillance system in 
Guéckédou, Guinea through which data was reported monthly from July 
2011-July 2014. In 46 sentinel sites, 40 with a malaria control program 
(program) and 6 without (comparison), cause of death as reported by 
the deceased’s family was recorded by key informants. Deaths were 
classified as due to malaria or another cause. Suspect Ebola virus disease 
(EVD) deaths were those reported as due to symptoms compatible with 
the EVD case definition. Deaths were aggregated by area and analyzed 
by 6 month surveillance period (1-6) corresponding to the dry (January-
June) and rainy (July-December)seasons. Logistic regression models were 
used to investigate temporal trends in malaria-attributable mortality and 
suspect EVD mortality. From July 2011-June 2014 approximately 45,000 
individuals were monitored by the surveillance system, 1,242 deaths were 
reported. The majority (55.2%, n=686) were reported as due to malaria. 
Proportional mortality attributable to malaria decreased from 66.8% 
to 40.3% (p<0.001) in the program area and from 65.8% to 59.2% 
(p=0.782) in the comparison area. 75.2% (n=934) of all deaths occurred 
at home, 17.8% (n=221) occurred in a health facility. In total, 68 deaths 
[range 6-17, by period] were classified as EVD suspect and increased over 
time (p=0.021). Seventeen suspect EVD deaths were reported during 
period 6, January-June 2014, when EVD was detected; these included the 
first two (11.7%, 2/17) laboratory confirmed EVD deaths in the region. 
Community surveillance can be used to document program impact on 
mortality and complement health facility surveillance particularly in areas 
where the majority of deaths occur in the community. Such systems could 
also be used for outbreak detection. Had community surveillance for 
outbreak detection been in place, the EVD outbreak in Guéckédou might 
have been identified earlier.
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BUILDING CAPACITY TO ACCELERATE IPTP UPTAKE 
THROUGH THE ADOPTION OF 2012 WHO IPTP GUIDANCE IN 
MALAWI
John K. Munthali
Jhpiego Corporation, Lilongwe, Malawi
Malawi adopted the World Health Organization’s updated guidance on 
intermittent preventive treatment in pregnancy (IPTp) in 2013. Support 
from the US President’s Malaria Initiative through USAID funded health 
projects, enabled collaboration between the National Malaria Control 
Program (NMCP) and the Reproductive Health Directorate (RHD) of the 
Ministry of Health, to build capacity from national to district to frontline 
health facility levels to implement the updated IPTp policy. These partners 
updated IPTp policy in the National Malaria Treatment Guidelines, and 
developed appropriate training manuals. All 5708 health workers from 
the 304 facilities in the 15 project districts were trained on the IPTp policy 
and guidelines. Post-training test scores of health staff increased over 
pre-test by an average of 40 percentage points. The community action 
cycle approach engages community volunteers and local community 
based organizations to identify and solve local problems and was used 
to encourage pregnant women to attend antenatal care (ANC) and 
receive IPTp and long lasting insecticide-treated nets. Health information 
system data from the 15 Districts were used to compare ANC and IPTp 
coverage for 2012 and 2015 fiscal years (Oct.-Sept.). ANC registration in 
the project area rose from 113,683 to 394,116. IPTp1 as a proportion of 
ANC registration rose from 52% to 87%, and IPTp2 increased from 17% 
to 62%. While IPTp3 doses were recorded in the ANC registers, reporting 
forms in 2015 still did not include space to enter this IPTp3. Observations 
at clinics showed IPTp3 and 4 were provided. Malawi’s experience shows 
that collaboration between NMCP and RHD as well as between clinics 
and communities not only disseminated knowledge of the new policy, but 
resulted in increased uptake of services and protection of pregnant women 
from malaria.
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ACCURATE MALARIA MICROSCOPY: IS IT THE READER 
OR QUALITY OF PREPARED SMEARS? A QUANTITATIVE 
COMPARISON OF FALSE POSITIVES/NEGATIVES VS SMEAR 
QUALITY IN TANZANIAN MILITARY HEALTH FACILITIES
Eyako K. Wurapa
Walter Reed Army Institute of Research, Silver Spring, MD, United States
Quality malaria microscopy remains the gold standard for malaria 
diagnosis. For the past 5 year WRAIR/TPDF has implemented innovative 
strategies to increase access to quality malaria case management through 
monitoring and improving quality of malaria microscopy. The accuracy and 
reliability of results are critically dependent on the quality of the blood film 
preparation, the staining procedure and the microscopist’s expertise in 
reading the smears. Studies have demonstrated poor malaria microscopy 
performance in Africa, including Tanzania. Walter Reed and Tanzania 
Peoples Defence Forces (TPDF) have established a Quality Monitoring and 
Improvement Program. The key objective is to perform crosschecking 
of malaria slides prepared and examined in current and future research 
sites. All testing sites are provided with high quality equipment, reagents 
and supplies to perform malaria microscopy. All blood films prepared for 
routine testing are stored and a monthly QC sample is crosschecked by 
the Walter Reed Malaria Program. The QC samples are selected in situ 
from the laboratory register on a quarterly basis. 10 negative and all 
positive slides for each month are selected using a random representative 
sampling protocol. The quality of blood films are quantitatively assessed 
macroscopically for blood film preparation quality and microscopically 
for staining quality and reading accuracy. The quantitative assessment of 
preparation, staining and reading shows correlation between the quality 
of the smear and accuracy of the results reported. In this study we will 
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present the data on the trend of false positive rates as compared to 
increase or decrease on the total quality index of preparation and staining 
of blood smears over the past 12 months.
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A CROSS-SECTIONAL SURVEY OF KNOWLEDGE AND 
PERCEPTIONS RELATED TO PREVENTION AND TREATMENT 
OF MALARIA IN PREGNANCY AMONG HEALTH CARE 
PROVIDERS AT HEALTH FACILITIES IN TANZANIA
R. Matthew Chico1, Joyce Wamoyi2, Myles-Jay Linton3, Catherine 
Bunga2, Nnko Soori2, John Changalucha2, Daniel Chandramohan1, 
Antonieta Medina-Lara3
1London School of Hygiene & Tropical Medicine, London, United Kingdom, 
2National Institute for Medical Research, Mwanza, United Republic of 
Tanzania, 3University of Exeter, Exeter, United Kingdom
A cross-sectional survey was conducted among 131 health-care providers 
in rural Tanzania to examine the knowledge and availability of malaria 
preventive and curative treatment for pregnant women recommended 
by the World Health Organization and contained in Tanzanian national 
guidelines. Perceptions of harm attributable to malaria infection and, 
separately, to malaria treatment were recorded, as well as malaria-
specific training received in the last three years. Thirty-nine percent of 
providers correctly stated that malaria during the first trimester should 
be prevented by sleeping under insecticide treated nets only. In contrast, 
80% of providers correctly reported that malaria is to be prevented 
using insecticide treated nets and intermittent preventive treatment of 
malaria with sulfadoxine-pyrimethamine during the second and third 
trimesters. Knowledge of appropriate first-trimester case management 
was correctly reported by 50% of providers, increasing to 60% when 
providers were asked to describe curative care for pregnant women in 
their second and third trimesters. Approximately 30% of the providers 
stated having received malaria training in the last three years. Untreated 
malaria infection was viewed as extremely harmful by over 93% of 
providers to pregnant women and their unborn babies in any trimester. 
Malaria treatment was considered harmful to pregnant women in the first 
trimester and unborn babies in the second and third trimesters by 44% 
and 45% of providers, respectively. Only 48%, 44% and 69% of providers 
reported having sulfadoxine-pyrimethamine, quinine, and artemisinin-
combination treatment available at the health facility, respectively, for 
preventive and curative care. These results suggest that the scale up of 
interventions to reduce the burden of malaria in pregnancy will, in part, 
require substantial improvements in supply chain management as well as 
pre-service training and in-service retraining of health-care providers in 
appropriate preventive and curative care with an emphasis on the safety of 
treatments by trimester.
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DEVELOPMENT OF PLASMODIUM FALCIPARUM 
EXFLAGELLATION ASSAY
Kazutoyo Miura1, Binging Deng1, Luwen Zhou1, Tomoko Ishino2, 
Takafumi Tsuboi3, Carole A. Long1
1Laboratory of Malaria and Vector Research/National Institute of Allergy 
and Infectious Diseases/National Institutes of Health, Rockville, MD, United 
States, 2Div. Mol. Parasitol., Proteo-Science Center, Esime Univ., Toon, 
Japan, 3Div. Malaria Res., Proteo-Science Center, Ehime Univ., Matsuyama, 
Japan
The standard membrane-feeding assay (SMFA) is considered a gold 
standard functional assay for transmission-blocking vaccine (TBV) 
development against Plasmodium falciparum malaria. However, it has 
been shown that SMFA reproducibility is poor when % inhibition of 
oocysts is low. In addition, the assay needs an insectary which can provide 
Anopheles mosquitoes and fulfill all regulatory requirements to maintain 
infectious mosquitoes. Therefore, we evaluated an exflagellation assay 
(EXA) for assessment of functional activity of transmission-blocking 
antibodies. Since EXA does not involve parasite development process in 
mosquitoes, it is possible that EXA could show better precision than SMFA. 
Two monoclonal antibodies (mAbs), 1B3 (anti-Pfs230) and IIC5B10 (anti-
Pfs48/45), both of which have shown strong functional activities in SMFA, 
were utilized for the assay development. We first optimized the protocol 
of EXA, e.g., ratio of test antibody and gametocyte culture, incubation 
time. In the optimized EXA, clear enhancement of inhibition was observed 
in the presence of complement for both mAbs, while IIC5B10 mAb does 
not require complement to work in SMFA. We confirmed the specificity 
of inhibition using 4B7 mAb, which recognizes Pfs25, one of the post-
fertilization TBV candidates. Both 1B3 and IIC5B10 mAbs showed dose-
dependent inhibition in the EXA, and the inter-assay precision of IIC5B10 
mAb was much better in EXA than in SMFA. The results indicate that 
EXA could be one option to evaluate functional activity of transmission-
blocking antibodies which target pre-fertilization antigens.
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SAFETY AND IMMUNOGENICITY OF WITH NOVEL MALARIA 
VACCINE CANDIDATE, R21 ADJUVANTED WITH MATRIX M1
Navin Venkatraman1, Saranya Sridhar1, Georgina Bowyer1, Philip 
Angell-Manning1, Jonathan Powlson1, Carly Bliss1, Greg Glenn2, 
Ian Poulton1, Sarah Moyle1, Eleanor Berrie1, Nicola Green1, Ekta 
Mukhopadhyay1, Alison Lawrie1, Rachel Roberts1, David J. Lewis3, 
Katie Ewer1, Adrian V. Hill1
1University of Oxford, Oxford, United Kingdom, 2Novavax, Gaithersburg, 
MD, United States, 3NIHR/Wellcome Trust Imperial Clinical Research Facility, 
London, United Kingdom
Falciparum malaria remains one of the leading infectious causes of 
morbidity and mortality worldwide. Development of a durable efficacious 
vaccine is a priority, and there remains an urgent need to improve efficacy 
to achieve the World Health Organisation goal of a deployable vaccine 
with at least 75% durable efficacy against clinical malaria by 2030. R21 
has been developed at the Jenner Institute, University of Oxford. This is an 
improved RTS,S construct, an antigen derived from the pre-erythrocytic 
circumsporozoite protein, which is an abundant coat protein involved 
in sporozoite development and hepatocyte invasion. R21 comprises 
recombinant particles expressing the central repeat and the C-terminus of 
the circumsporozoite protein (CSP) fused to HBsAg, but without the excess 
of unfused HBsAg protein found in RTS,S. It was GMP manufactured 
in Pichia pastoris at the Clinical Biomanufacturing Facility at Oxford 
University. We undertook a Phase I, open-label clinical trial to assess the 
safety and immunogenicity of R21 administered alone (Group 2; n=4) 
and with the novel saponin-based adjuvant, Matrix M1 (Group 1 and 3; 
n=10 per group). Safety was assessed by active and passive collection 
of local and systemic adverse events. The immunoassay of most interest 
was the antibody response to NANP because this correlates with vaccine 
efficacy after RTS,S/AS01 administration, and induction of antibody levels 
comparable to or greater than RTS,S/AS01 would suggest likely vaccine 
efficacy. Preliminary analysis shows that the vaccine is safe and well 
tolerated with the majority of adverse events being mild in nature and 
short-lived. Initial assessment of antibody responses indicate antibody 
levels elicited at least as high as reported for RTS,S/AS01 in previous 
studies. This trial was the first administration of R21 in humans and safety 
and immunogenicity profiles observed support further testing in Phase IIa 
studies using a controlled human malaria infection model.
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PHASE I VACCINE TRIAL FOR EBA-175 RII INDUCES HIGH 
LEVELS OF BINDING INHIBITORY ANTIBODIES THAT TARGET 
KEY FUNCTIONAL EPITOPES
Vashti Irani1, Annie Mo2, Ivo Mueller3, Peter Siba4, Paul 
Ramsland5, Jack Richards1, James Beeson1
1Burnet Institute, Melbourne, Australia, 2National Institute of Allergy and 
Infectious Diseases, National Institutes of Health, Bethesda, MD, United 
States, 3Walter and Eliza Hall Institute, Parkville, Melbourne, Australia, 
4Papua New Guinea Institute of Medical Research, Goroka, Papua New 
Guinea, 5School of Science, RMIT University, Melbourne, Australia
Naturally acquired antibody responses against blood-stage parasites are 
associated with protective immunity. Erythrocyte Binding Antigen-175 
(EBA-175) is a leading vaccine candidate of Plasmodium falciparum that 
plays a key role in merozoite invasion by binding to glycophorin A on 
the erythrocyte surface. We have previously shown that antibodies to 
EBA-175 are associated with protection and can inhibit EBA-175 binding 
to glycophorin A. This binding is mediated through Duffy-binding like 
(DBL) domains in Region II of the protein. EBA175 Region II was recently 
assessed in a dose escalation Phase I trial adjuvanted with Alum and 
individuals (n=71) were shown to develop high titres of IgG but relatively 
low growth inhibitory responses. Our study aimed to further assess the 
properties and functional activity of these vaccine-induced antibodies 
and relate the magnitude of these responses with antibodies acquired 
following natural infection in a cohort of children from Papua New Guinea 
(n=206). There were no statistically significant differences in total IgG 
levels between the vaccine-induced and naturally acquired responses 
(p=0.883). However, vaccine-induced responses were significantly 
lower compared to naturally-induced responses for IgG1 (p=0.003) and 
IgG3 (p<0.001); both key subclasses associated with protection from 
symptomatic disease in naturally immune populations. Vaccine induced 
antibodies were able to inhibit EBA-175 binding, especially for the 20µg 
per dose or greater. Furthermore, the vaccine was able to elicit antibodies 
that targeted epitopes shared with the functional monoclonals, R217 and 
R218. Importantly, there was a high correlation between binding inhibitory 
activity and antibodies to the R217 epitope (0.8860; p<0.0001). This 
study demonstrates that a recombinant EBA-175 vaccine can induce high 
level binding inhibitory antibodies that target key epitopes on EBA-175 
Region II however the differences in subclass responses requires further 
optimisation. The exploration of adjuvants is required to ensure that 
the vaccine-induced immunity is optimised further and exceeds natural 
immunity.
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PROTEOMIC ANTIBODY PROFILING OF U.S. AND AFRICAN 
VOLUNTEERS IN MULTIPLE CLINICAL TRIALS OF PFSPZ 
VACCINE
Joseph J. Campo1, Sumana Chakravarty2, Jozelyn Pablo1, Andy 
Teng1, Adam Shandling1, Tim Le1, Cassidy Walker1, Minglin Li3, 
Natasha KC3, Neville Kisalu4, Barbara Flynn4, Azza Idris4, Ogobara 
Doumbo5, Mahamadou S. Sissoko5, Sara Healy6, Patrick Duffy6, 
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Claudia Daubenberger8, Judith E. Epstein9, Robert A. Seder4, Philip 
L. Felgner10, Xiaowu Liang1, Stephen Hoffman2
1Antigen Discovery, Inc., Irvine, CA, United States, 2Sanaria, Inc., Rockville, 
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MD, United States, 5Malaria Research and Training Center, Mali-NIAID 
ICER, University of Science, Techniques and Technologies of Bamako, 
Bamako, Mali, 6Laboratory of Malaria Immunology and Vaccinology, 
National Institute of Allergy and Infectious Diseases, National Institutes of 
Health, Rockville, MD, United States, 7Ifakara Health Institute, Bagamoyo 
Research and Training Centre, Bagamoyo, United Republic of Tanzania, 
8Department of Medical Parasitology and Infection Biology, Swiss Tropical 
and Public Health Institute; University of Basel, Basel, Switzerland, 9Naval 
Medical Research Center Malaria Department, Silver Spring, MD, United 
States, 10Antigen Discovery, Inc.; Currently: Department of Medicine, 
University of California Irvine, Irvine, CA, United States
A vaccine against malaria would benefit the millions affected worldwide 
and accelerate efforts to eliminate malaria. Immunization with PfSPZ 
Vaccine, a metabolically active, non-replicating malaria sporozoite vaccine, 
induced high-level protective efficacy against Plasmodium falciparum (Pf) 
malaria infection in multiple clinical trials. An antibody assay that predicted 
protection would facilitate vaccine development and deployment. To 
identify the target proteins for such an assay, we developed whole Pf 
proteome microarrays representing 4,805 unique genes, or approximately 
91% of the Pf proteome, to screen sera from volunteers in clinical trials of 
PfSPZ Vaccine who underwent controlled human malaria infection (CHMI) 
or followed for risk of malaria. Sera have been assessed for proteomic 
antibody profiles in three clinical trials of U.S. volunteers and clinical trials 
of African volunteers from Mali and Tanzania. We have detected over 
1,500 responses to Pf proteins in PfSPZ Vaccine recipients. Over 50 Pf 
proteins have been identified with an immunogenic profile and association 
with sterile protection after CHMI. A combination of 6 proteins (PfCSP, 
PfMSP5, PfGSK3, PfLRR9, PfDOC2 and PF3D7_1030200) that predicted 
protection was identified in one clinical trial with 32 U.S. volunteers, which 
had a cross-validated AUC of 0.89 and sensitivity and specificity of 92% 
and 89%, respectively. This signature of protection has been confirmed 
in an independent clinical trial. These 6 Pf proteins were selected for 
further development as companion assays to PfSPZ Vaccine for travelers 
and potential components of subunit malaria vaccines. Unique antibody 
profiles were observed between trials of PfSPZ Vaccine in U.S. and African 
volunteers. A signature of protection is being investigated for African 
PfSPZ Vaccine recipients for development of a companion assay to predict 
when subjects will be protected during malaria elimination.
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A HIGHLY INFECTIOUS PLASMODIUM YOELII PARASITE, 
BEARING PLASMODIUM CIRCUMSPOROZOITE PROTEIN
Min Zhang1, Izumi Kaneko2, Tiffany Tsao3, Robert Mitchell4, 
Elizabeth H. Nardin4, Shiroh Iwanaga2, Masao Yuda2, Moriya Tsuji3
1HIV and Malaria Vaccine Program, Aaron Diamond AIDS Research Center 
and Department of Pathology, New York University School of Medicine, 
New York, NY, United States, 2Department of Medical Zoology, Mie 
University Graduate School of Medicine, Tsu, Japan, 3HIV and Malaria 
Vaccine Program, Aaron Diamond AIDS Research Center, New York, NY, 
United States, 4Division of Parasitology, Department of Microbiology, New 
York University School of Medicine, New York, NY, United States
Plasmodium circumsporozoite protein (CSP) is a major surface antigen 
present in the sporozoite (Spz) stage of a malaria parasite. RTS,S 
vaccine, the most clinically advanced malaria vaccine, consists of a large 
portion of Plasmodium falciparum CSP (PfCSP). A highly infectious, 
recombinant rodent malaria, Plasmodium yoelii parasite bearing a full-
length PfCSP (PfCSP/Py) was generated by double cross-over homologous 
recombination. This PfCSP/Py parasite produced up to 30,000 Spz in 
mosquito salivary glands, which is equal or even higher than the number 
of Spz produced by wild-type P. yoelii parasites. Five bites of PfCSP/Py-
infected mosquitoes could induce blood infection in BALB/c mice. Our new 
transgenic parasite that expresses a full-length PfCSP may become a useful 
tool for researchers to investigate immunity against PfCSP in a mouse 
model.
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VECTORED PFCSP VACCINES BASED ON BACULOVIRUS 
DUAL EXPRESSION SYSTEM AND ADHU5 INDUCE STRONG 
PROTECTIVE EFFICACY AGAINST TRANSGENIC PLASMODIUM 
BERGHEI
Mitsuhiro Iyori1, Andrew M. Blagborough2, Sota Ogata1, 
Hidesato Nishiura1, Miako Sakaguchi3, Masanori Mizutani1, 
Takahiko Tamura1, Kento Genshi1, Satoshi Shimada1, Daisuke S. 
Yamamoto1, Hiroyuki Matsuoka1, Shigeto Yoshida1
1Kanazawa University, Kanazawa, Japan, 2Imperial College London, 
London, United Kingdom, 3Nagasaki University, Nagasaki, Japan
The baculovirus-vectored vaccine based on the “baculovirus dual 
expression system (BDES)” has been exploited as a novel vaccine platform 
for malaria. The gene encoding the human decay-accelerating factor was 
incorporated into the BDES malaria vaccine expressing the Plasmodium 
falciparum circumsporozoite protein (PfCSP). The newly developed BDES 
vaccine “BDES-sPfCSP2-Spider” resulted in complement resistance both 
in vitro and in vivo. To improve the vaccine efficacy, baculovirus expressing 
mouse interleukin-12 (mIL-12) and the adenoviral vaccine expressing PfCSP 
“AdHu5-sPfCSP2” were generated. Large-scale immunization studies 
were conducted in mice, and the protective efficacy was examined by 
using biting of mosquitoes infected with transgenic P. berghei sporozoites 
expressing PfCSP. After the priming immunization with AdHu5-sPfCSP2, 
booster immunization with BDES-sPfCSP2-Spider together with the mIL-12 
vector conferred strong protective efficacy as compared to the controls 
(29 mice out of 44 were protected; 65%), following the high level of 
anti-PfCSP IgG titer. Thus, we propose that the prime-boost regimen 
using adenovirus and BDES offer great potential as a new malaria vaccine 
platform.
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MALARIA TRANSMISSION-BLOCKING VACCINE ANTIGEN 
DISCOVERY USING NATURALLY ACQUIRED FUNCTIONAL 
ANTIBODY
Munir H. Buhaya1, Sujith K. Joseph2, Shaji Daniel1, Issaka Sagara3, 
Sara Healy1, Olga Muratova1, Lynn Lambert1, Mahamadoun H. 
Assadou3, Agnes Guindo3, Joan Aebig1, Ogobara K. Doumbo3, 
Yimin Wu4, Patrick E. Duffy1
1National Institutes of Health, Rockville, MD, United States, 2Baylor College 
of Medicine, Houston, TX, United States, 3Malaria Research and Training 
Center, Bamako, Mali, 4PATH Malaria Vaccine Initiative, Seattle, WA, 
United States
Transmission-blocking vaccines (TBV) target the Plasmodium falciparum 
parasite’s sexual stages to interrupt its life cycle and would be useful for 
elimination efforts. We previously identified human sera from Malian 
adults whose purified IgG conveyed high transmission-blocking activity 
(TBA) by standard membrane feeding assay (SMFA) against laboratory 
cultured gametocytes fed to A. stephensi mosquitoes. Here, we describe 
the results from an iterative subtractive screening of a gametocyte stage 
cDNA phage display library using naturally acquired IgG with versus 
without TBA. A set of novel TBV candidate antigens was identified 
including 3 proteins with hits in four independent differential screens. 
The top 9 candidates are being evaluated in an animal model using DNA 
immunization via gold particle bombardment, and the top 3 mentioned 
above using protein immunization as well. Briefly, synthetic genes 
were cloned into pCI-SF mammalian expression vector and pET-24b(+) 
for E. coli protein expression, respectively. Mammalian cell transient 
transfection was used to assess expression from pCI-SF clone’s prior to 
animal immunizations. Independently, cobalt affinity column was used for 
protein purification from pET-24b(+) bacterial expression. Protein and DNA 
immunogens are being used to immunize small animals, and functional 
immune responses evaluated by SMFA will be reported.
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ASSOCIATION OF SPECIFIC VAR2CSA HAPLOTYPES 
WITH WORSENED BIRTH OUTCOMES IN WOMEN WITH 
PLASMODIUM FALCIPARUM PLACENTAL MALARIA IN 
MALAWI AND BENIN
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Linda Kalilani-Phiri4, Victor Mwapasa4, Achille Massougbodji5, 
Nadine Fievet6, Jeffery A. Bailey2, Feiko O. ter Kuile3, Philippe 
Deloron6, Jonathan J. Juliano1, Steve M. Taylor7, Stephanie M. 
Engel1, Nicaise T. Ndam6, Steven R. Meshnick1
1University of North Carolina at Chapel Hill, Chapel Hill, NC, United States, 
2University of Massachusetts, Worcester, MA, United States, 3Liverpool 
School of Tropical Medicine, Liverpool, United Kingdom, 4University of 
Malawi, Blantyre, Malawi, 5Université d’Abomey-Calavi, Cotonou, Benin, 
6Institut de Recherche pour le Développement, UMR216-MERIT, Paris, 
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Pregnancy associated malaria (PAM) causes adverse pregnancy and birth 
outcomes including low birth weight (LBW) and small for gestational age 
(SGA). Placental accumulation of Plasmodium falciparum is mediated 
by VAR2CSA. This protein’s ID1-DBL2x region is considered a minimal 
binding epitope and is a promising vaccine candidate against PAM. We 
hypothesized that variation in the ID1-DBL2x region would be associated 
with differential prevalence of poor birth outcomes. Using two clinical 
cohorts of women with placental malaria at delivery, we deep-sequenced 
the 1.6kb ID1-DBL2x region in 101 placental samples in Malawi and Benin 
to characterize genetic diversity and identify pathogenic clades. In Malawi, 
we identified two genetic clades which resembled the sequences of the 
current vaccine candidate antigens, 3D7 & FCR3. In Benin, along with 
3D7-like and FCR3-like clades, three other unique clades were detected. 
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We estimated the association of specific clades with birth weight, LBW, 
and SGA, controlling for confounders using inverse probability weights. 
In our study population, the mean (SD) infant birth weight in Malawi 
was 2677g (540g) and 2840g (380g) in Benin. Prevalence of LBW was 
19.6% (n=11) in Malawi and 13.3% (n=6) in Benin; prevalence of SGA 
was 16.1% (n=9) in Malawi and 24.4% (n=11) in Benin. In phylogenetic 
analyses, the variants present in the placentae of women delivering LBW 
or SGA infants clustered more readily in the 3D7-like clade in Malawi but 
were more evenly distributed in Benin. Compared to women infected 
with FCR3-like only variants, women infected with 3D7-like only variants 
delivered infants with lower birth weight (-267.99g; 95% CI: -466.43g 
- -69.55g) and higher odds of LBW (OR: 8.19; 95% CI: 1.65 - 40.57) 
and SGA (OR: 3.65; 95% CI: 1.00 - 13.38). These associations were 
attenuated in Benin, but were overall supported by country-level analyses. 
The results from our study provide evidence that 3D7-like genetic variants 
of VAR2CSA in parasites infecting the placenta are associated with worse 
birth outcomes including LBW and SGA. This supports the development 
of polyvalent vaccines that target multiple clades of VAR2CSA to combat 
PAM.
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EFFICACY OF PFSPZ VACCINE AGAINST HETEROLOGOUS 
MALARIA CHALLENGE IN MALARIA-NAÏVE ADULTS
Kirsten E. Lyke, The VRC 314 Study Team
Division of Malaria Research, University of Maryland, Baltimore, MD, 
United States
Sterile protection lasting 14 months against Plasmodium falciparum (Pf) 
malaria has been achieved in humans after intravenous (IV) injection 
of a non-replicating, cryopreserved Pf sporozoite (SPZ) vaccine (PfSPZ 
Vaccine). Further development is focused on identification of a dose-
sparing immunization regimen that induces durable protection against 
heterologous Pf strains. We conducted an open-label trial of PfSPZ 
Vaccine, composed of attenuated, aseptic, purified cryopreserved PfSPZ, 
at a dose of 9.0 x105 PfSPZ administered IV 3 times at 8-week intervals 
to 15 healthy, malaria-naïve adults. Vaccinated and non-vaccinated 
control volunteers underwent controlled human malaria infection (CHMI) 
by exposure to mosquitoes carrying infectious PfSPZ of homologous 
3D7 and heterologous 7G8 Pf strains at 19 and 33 weeks, respectively, 
after final immunization. Antibody and cellular immune responses were 
assessed. PfSPZ Vaccine was well tolerated. After CHMI with homologous 
PfSPZ at 19 weeks, 9/14 volunteers (64%) remained without parasitemia 
compared to 0/6 controls (P=0.012, Fisher’s exact test, one-sided). Six non-
parasitemic volunteers underwent repeat CHMI with heterologous PfSPZ 
at 33 weeks, and 5/6 vaccinees remained without parasitemia compared 
to 0/6 controls (P=0.0076). Pf-specific antibody, CD8, CD4, and γδ T 
cell responses were detected in all vaccinees. A 3-dose regimen of PfSPZ 
Vaccine conferred sterile protection for at least 33 weeks against CHMI 
with heterologous Pf and induced broad-based PfSPZ-specific immune 
responses. Ongoing studies using higher doses are evaluating protective 
efficacy in travelers, military personnel, and infants and adults living in 
endemic areas.
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IMMUNIZATION BY MOSQUITO BITE WITH RADIATION 
ATTENUATED SPOROZOITES (IMRAS): A PHASE 1 CLINICAL 
TRIAL
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Jun Huang2, Maria Belmonte2, Arnel Belmonte2, Esteban Abot2, 
Alexandra Singer1, Cindy Tamminga1, James Moon3, Michele 
Spring3, Patrick Twomey3, Megan Dowler3, Lindsey Garver3, Silas 
Davidson3, Martha Sedegah1, Thomas Richie1, Eileen Villasante1, 
Judith Epstein1
1Naval Medical Research Center, Silver Spring, MD, United States, 2Henry 
M. Jackson Foundation, Bethesda, MD, United States, 3Walter Reed Army 
Institute of Research, Silver Spring, MD, United States
Human clinical trials have demonstrated that immunization with radiation-
attenuated Plasmodium falciparum sporozoites (PfRAS) by mosquito bite 
is an excellent model for malaria vaccine development conferring the 
highest levels of sterile protection. In the study Immunization by mosquito 
bite with radiation-attenuated P. falciparum sporozoites, or IMRAS, we 
have applied a systems biology approach to this model to improve current 
understanding of immune mechanisms of protection by comparing 
sterilely protected with non-protected study subjects. The clinical study 
was designed such that approximately 50% of immunized human subjects 
would be protected against homologous controlled human malaria 
infection (CHMI) to facilitate the analysis of biomarkers and correlates 
of protection. Earlier studies suggested that immunization with a total 
of 960 bites from mosquitoes infected with PfRAS would yield 50% 
protective efficacy. The study was conducted with two sequential cohorts, 
each consisting of twelve true-immunized and four mock-immunized 
human subjects. Subjects in both cohorts underwent five immunization 
sessions every four weeks receiving approximately 200 infectious bites 
per immunization session. Immunization procedures were well-tolerated, 
and there were no vaccine-related serious adverse events. All twelve 
infectivity controls (six per cohort) became parasitemic and none of the 
mock-immunized subjects were protected. Surprisingly, despite the similar 
number of total infectious bites in each cohort, the percentage of subjects 
protected in the two cohorts was quite different. Six of the 11 (55%) 
true-immunized subjects in the first cohort were sterilely protected against 
parasitemia after primary challenge at 23-25 days post-last immunization. 
In the second cohort, 9 of 10 (90%) true-immunized subjects were 
protected after primary challenge. We will present a detailed analysis of 
all factors which may have impacted the discordant levels of protective 
efficacy in the two cohorts; such data may provide key information for the 
development of a highly protective malaria vaccine.
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TOLERABILITY, SAFETY AND EFFICACY (ADULTS) OF 
ESCALATING DOSES OF PFSPZ VACCINE ADMINISTERED BY 
DIRECT VENOUS INOCULATION TO TANZANIAN INFANTS, 
CHILDREN, ADOLESCENTS AND ADULTS
Said A. Jongo1, Thomas L. Richie2, Claudia A. Daubenberger3, 
Preston Church2, Peter F. Billingsley2, Munira Qassim1, Kamaka 
Kassimu1, B. Kim Sim2, Florence A. Milando1, Ally Mtoro1, Tobias 
Schindler1, Anneth Tumbo1, Thabit Athuman1, Ummi Abdul1, 
Ramla Rashid1, Maximillian Mpina1, Bakary Mwalim1, Sumana 
Chakravarty2, Eric James2, Yonas Abebe2, Anita Manoj2, Salim 
Abdulla1, Stephen Hoffman2, Marcel Tanner3, Seif Shekalaghe1
1Ifakara Health Institute, Bagamoyo, United Republic of Tanzania, 2Sanaria 
Inc., Rockville, MD, United States, 3Swiss Tropical and Public Health 
Institute, Ifakara Health Institute, Basel, Switzerland
PfSPZ Vaccine administered by direct venous inoculation (DVI) has been 
shown to be extremely well tolerated and safe and induce durable, sterile 
protection against homologous and heterologous Plasmodium falciparum 
(Pf) parasites in controlled human malaria infection (CHMI)(U.S. and 
Tanzania) and field (Mali) studies in doses up to 2.7x105 Pf sporozoites 
(SPZ). However, while good, the protective efficacy has not yet been 
shown to achieve our target of at least 80% sterile protection for at least 
6 months, and PfSPZ Vaccine has not yet been studied in adolescents, 
children, or infants. All current data indicate that increasing the numbers 
of PfSPZ per dose will increase protective efficacy. To address both 
deficiencies, we are conducting a double blind, normal saline placebo-
controlled trial at the Bagamoyo Clinical Trials Unit of the Ifakara Health 
Institute in Tanzania. The trial is aimed at determining if 3 doses of up 
to 9.0x105 PfSPZ (young children and infants) and 1.8x106 PfSPZ (adults, 
adolescents, older children) are well tolerated, safe and immunogenic 
and protect adults against CHMI. 93 female and male subjects were 
enrolled in an approximately 2:1 ratio (vaccinee to control) in the five age 
groups including 18 volunteers in each of the adult, 11-17, 6-10, and 1-5 
year age groups, and 21 in the 6-11 months group, plus an additional 6 
adults to serve as infectivity controls for CHMI. Two of the three planned 
doses have been administered to adults, adolescents, and older children 
and 50% of the younger children and infants. The study is still blinded. 
However, there have been no serious adverse events, nor any indication of 
differences in adverse events among the age groups, or of a safety signal. 
Adults will undergo CHMI by DVI of PfSPZ Challenge (aseptic, purified, 
infectious PfSPZ) in May and June 2016, and the study will be completed 
in September 2016. The complete un-blinded results of tolerability, safety, 
immunogenicity, and protective efficacy will be presented, as will plans 
for the next Tanzanian study designed to support licensure for the mass 
vaccine administration indication.
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CLINICAL MANIFESTATIONS OF PLASMODIUM FALCIPARUM 
INFECTION IN TANZANIAN ADULTS AFTER CONTROLLED 
HUMAN MALARIA INFECTION BY INJECTION OF PFSPZ 
CHALLENGE
Seif Shekalaghe
Ifakara Health Institute, BRTC, Bagamoyo, United Republic of Tanzania
The clinical manifestations of Plasmodium falciparum (Pf) malaria in 
volunteers in the United States and Europe after controlled human malaria 
infection (CHMI) by exposure to mosquitoes carrying Pf sporozoites 
(SPZ) and by injection of aseptic, purified, cryopreserved, infectious 
Pf sporozoites (SPZ), a product called Sanaria® PfSPZ Challenge, have 
been well described. We conducted the first CHMI study in Africans 
using intradermal injection of PfSPZ Challenge; 21 subjects developed 
malaria. Since then we have conducted three different CHMIs by direct 
venous inoculation (DVI) of PfSPZ Challenge; 56 subjects developed 
malaria. In May and June 2016 we will conduct two more CHMIs by DVI of 
PfSPZ Challenge in 26 subjects. In general with the same dose of PfSPZ 
Challenge the pre-patent periods are longer and the clinical manifestations 
less in previously exposed Tanzanians as compared to subjects in the 
U.S. and Europe with no previous exposure to malaria. We will present 
a detailed analysis of the parasitological findings and the clinical 
manifestations in the Tanzanian subjects, and contrast them with those 
reported for non-immune subjects. These data will provide a foundation 
for groups in Africa to design, justify, and execute CHMIs to assess the 
effects of antimalarial drugs and vaccines, naturally acquired immunity, 
and genetic background on malaria.
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CHEMOPROPHYLAXIS VACCINATION (CVAC) WITH 
SANARIA® PFSPZ CHALLENGE AND PYRIMETHAMINE: PHASE 
1 TRIAL TO DETERMINE SAFETY AND PROTECTIVE EFFICACY 
AFTER EXPOSURE TO ONLY PLASMODIUM FALCIPARUM 
LIVER STAGES
Agnes Mwakingwe1, Sara A. Healy1, Jacquelyn Lane1, Aarti 
Kolluri1, Erin Gabriel2, Irfan Zaidi1, Junhui Duan1, Jen CC 
Hume1, Charles Anderson1, Kelly Ding1, Tooba Murshedkar3, 
Adam J. Ruben3, Sumana Chakravarty3, Anita Manoj3, Anusha 
Gunasekera3, B. Kim Lee Sim3, Peter F. Billingsley3, Eric R. James3, 
Thomas L. Richie3, Stephen L. Hoffman3, Patrick E. Duffy1
1National Institutes of Health/DIR/National Institute of Allergy and 
Infectious Diseases/Laboratory of Malaria Immunology and Vaccinology, 
Rockville, MD, United States, 2National Institutes of Health/DIR/BRB, 
Rockville, MD, United States, 3Sanaria, Inc., Rockville, MD, United States
Direct venous inoculation (DVI) of aseptic, purified, infectious Plasmodium 
falciparum (Pf) sporozoites (SPZ) (Sanaria® PfSPZ Challenge) under 
chloroquine (CQ) prophylaxis (Sanaria® PfSPZ-CVac approach) protected 
100% (9/9) of malaria naive vaccinees against homologous controlled 
human malaria infection (CHMI), 9 weeks after the third and last dose. 
CVac-CQ exposes vaccinees to both liver and blood stage antigens, 
thus the contribution of each parasite stage to immunity is unclear. We 
are investigating the safety and protective efficacy of CVac using CQ 
and pyrimethamine chemoprophylaxis (liver stage only exposure) versus 
CVac-CQ. Upon determination in a pilot study with 2 subjects that 
pyrimethamine dosing at days 2 and 3 post PfSPZ Challenge inoculation 
was sufficient, the main study enrolled 12 subjects to receive CVac using 
CQ and pyrimethamine and 6 subjects to receive CVac using CQ only. 
Subjects completed 3 rounds of PfSPZ-CVac at 4 weeks intervals. Thus 
far, PfSPZ-CVac has been well tolerated with the majority of adverse 
events (AEs) being transient Grade 1 AEs, with one serious AE reported. 
No subjects developed parasitemia, detected by thick blood smear, or 
clinical malaria. Subpatent parasitemia detected by polymerase chain 
reaction (PCR), was seen on days 7 and 8 post PfSPZ Challenge inoculation 
in during CVac-CQ, but not in any subject receiving CVac with CQ and 
pyrimethamine. All eligible vaccinated subjects and 5 subjects in an 
infectivity control group will undergo CHMI with 3,200 PfSPZ Challenge in 
June 2016.  Unblinded tolerability, safety, immunogenicity, and protective 
efficacy results will be presented. This is the first trial to evaluate whether 
exposure limited to live replicating liver stage parasites in humans results in 
the development of immunity against homologous CHMI.
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DEVELOPMENT OF A PFSPZ VACCINE REGIMEN TO PROTECT 
MILITARY PERSONNEL AGAINST PLASMODIUM FALCIPARUM 
INFECTION
Alexandra L. Singer, Judith E. Epstein, for the International 
PfSPZ Consortium
Naval Medical Research Center, Silver Spring, MD, United States
Plasmodium falciparum (Pf) sporozoites (SPZ) are the only immunogens 
ever shown to induce >90%, sterile protective immunity against malaria. 
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Sanaria® PfSPZ Vaccine, an aseptic, purified, cryopreserved radiation 
attenuated Pf sporozoite (SPZ) malaria vaccine administered by direct 
venous inoculation has been shown to be safe, well-tolerated, easy to 
administer, immunogenic and highly protective. In order to be utilized as a 
vaccine to protect deployed military personnel, the vaccine must have an 
efficacy of >80% against infection with heterologous strains of Pf for at 
least 6 months. A series of clinical trials conducted by the Naval Medical 
Research Center, Walter Reed Army Institute of Research and other 
members of the International PfSPZ Consortium have demonstrated a 
distinct dose response for protection induced by PfSPZ Vaccine. Gradually 
increasing the total amount of vaccine (administered in as few as 3 
immunizations) has generated increasing levels of protection and anti-
PfCSP antibody titers. After reaching >90% protective efficacy against 
short-term homologous controlled human malaria infection (CHMI) at 3 
weeks post final dose, we set the next benchmarks to include protection 
against 1) long-term homologous CHMI (6 months post final dose), 2) 
short-term heterologous CHMI, 3) long-term heterologous CHMI and 
finally, 4) protection against P. vivax. In our most recently completed clinical 
trial, we had unprecedented success in reaching the first and second of 
these benchmarks. We expect to meet the third benchmark (protection 
against long-term heterologous CHMI) with one of the regimens being 
assessed in our newly initiated clinical trial. These include a 3 dose regimen 
with up to 4 times as many PfSPZ per dose (1.8x10^6) as in our previous 
study and a regimen with the highest dose given in humans thus far 
(2.7x10^6), followed by two doses of 9x10^5. We will present a detailed 
analysis of the dose response to PfSPZ Vaccine, preliminary results from our 
ongoing trial, plans to assess protection against P. vivax CHMI and plans 
for Phase 3 testing to support submission for FDA licensure.
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SAFETY, TOLERABILITY AND EFFICACY OF DOSE 
ESCALATING DIRECT VENOUS INOCULATION WITH 
RADIATION ATTENUATED PLASMODIUM FALCIPARUM 
NF54 SPOROZOITES (PFSPZ VACCINE) IN HEALTHY MALIAN 
ADULTS
Mahamadou S. Sissoko1, Sara A. Healy2, Abdoulaye Katile1, 
Irfan Zaidi2, Erin Gabriel3, Bourama Kamate1, Yacouba Samake1, 
Kourane Sissoko1, Amagana Dolo1, Karamoko Niare1, Amadou 
Niangaly1, Merepen A. Guindo1, Fanta Koita1, Yonas Abebe4, 
Eric R. James4, Anita Manoj4, Anusha Gunasekera4, B. Kim Lee 
Sim4, Peter F. Billingsley4, Thomas L. Richie4, Stephen L. Hoffman4, 
Patrick E. Duffy2, Ogobara Doumbo1
1Malaria Research and Training Center, Mali-NIAID ICER, University of 
Science, Techniques and Technologies of Bamako, Bamako, Mali, 2National 
Institutes of Health/DIR/National Institute of Allergy and Infectious 
Diseases/Laboratory of Malaria Immunology and Vaccinology, Rockville, 
MD, United States, 3National Institutes of Health/DIR/BRB, Rockville, MD, 
United States, 4Sanaria, Inc., Rockville, MD, United States
A double blind, randomized Phase 1/2 clinical trial is being conducted 
in Mali, West Africa to assess the safety, immunogenicity and protective 
efficacy of increased doses of Sanaria® PfSPZ Vaccine administered via 
direct venous inoculation (DVI) against natural malaria exposure and 
controlled human malaria infection (CHMI) in healthy 18-50 year old 
adults. The initial dose escalation pilot study (part A) started in January 
2016. Five volunteers received 1 dose of PfSPZ Vaccine (4.5x105 PfSPZ) 
and five volunteers received 1 dose of PfSPZ Vaccine (9.0x105 PfSPZ) in a 
staggered manner. Following no identified safety concerns, 30 additional 
volunteers have received three doses of PfSPZ Vaccine (18.0x105 PfSPZ) 
at eight week intervals in the dry season.  These 30 subjects will also 
undergo further evaluation, including examination of protective efficacy 
against homologous CHMI via PfSPZ Challenge in May/June 2016. Fifteen 
additional subjects will be enrolled as infectivity controls during CHMI.  
The targeted dose (18.0x105 PfSPZ Vaccine), having been shown to be 
safe and tolerable, is now being administered to a larger main cohort in 
a double blind, randomized, placebo controlled trial (part B) to examine 
the protective efficacy of the vaccine against naturally occurring infection. 
During the malaria transmission season (August-December), volunteers 
will be examined and blood smears obtained every 2 weeks for 20 weeks 
in total, with the primary efficacy endpoint being observation of a positive 
blood smear following receipt of third vaccination. Safety, tolerability, 
immunogenicity, and protective efficacy from the pilot phase (part A) and 
safety and tolerability from the main phase (part B) will be presented.
411
ANTIBODY PROFILING BY PROTEIN MICROARRAY OF 
HUMAN VOLUNTEERS PROTECTED BY IMMUNIZATION 
WITH RADIATION-ATTENUATED PLASMODIUM VIVAX 
SPOROZOITES
Emmanuel Y. Dotsey1, Maria Isabel Arce-Plata2, Aarti Jain1, 
Andres Vallejo2, Angelica Castellanos2, Myriam Arévalo-Herrera2, 
Philip L. Felgner1, Huw Davies1, Socrates Herrera2
1University of California Irvine, Irvine, CA, United States, 2Caucaseco 
Scientific Research Center (CSRC), Cali, Colombia, 3School of Health, 
Universidad del Valle, Cali, Colombia
A randomized, single-blinded clinical trial was conducted with Duffy 
positive (Fy+; Pv susceptible) individuals (n=21) assigned to either radiation 
attenuated sporozoites (RAS) or control groups; 14 received bites from 
irradiated (150 ± 10 cGy) Pv-infected Anopheles mosquitoes (RAS) 
and 7 from non-irradiated non-infected mosquitoes (control). Fy- (Pv 
refractory) volunteers (n=7) were immunized with non-irradiated Pv-
infected mosquitoes. Eight weeks after the last immunization, 19 Fy+ and 
Fy- volunteers received a controlled human malaria infection (CHMI) with 
non-irradiated Pv–infected mosquitoes. Nineteen volunteers completed 7 
immunizations (12 RAS, 2 Ctl and 5 Fy-) and received a CHMI. Five of 12 
(42%) RAS volunteers were protected compared with 0/2 controls. None 
of the Fy- volunteers developed infection by the 7th immunization or 
after CHMI. To test whether protection might also be associated with IgG 
profiles, serum samples from day (0), after each immunization dose and 60 
days post-CHMI were probed on a custom protein microarray displaying 
500 P. vivax sero-reactive antigens. We observed that, while Fy- volunteers 
respond vigorously to non-irradiated vaccine, the RAS vaccine appeared 
to be only weakly antigenic in Fy+ volunteers (despite being protective 
in 5/12 RAS volunteers). Nevertheless, we observed significant changes 
in antibody profiles between protected and unprotected RAS volunteers 
post-CHMI, consistent with similar studies in P. falciparum vaccinees. We 
conclude that, protection from P vivax challenge can be achieved with 
relatively low doses of RAS vaccine.
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CHANGING THE PARADIGM OF VACCINE DEVELOPMENT: 
TURNING THE TARGET PRODUCT PROFILE (TPP) ON ITS HEAD
Thomas L. Richie, on behalf of the International PfSPZ 
Consortium
Sanaria Inc., Rockville, MD, United States
Vaccines are lacking for many complex pathogens such as parasites and 
fungi, may be only partially protective, or may not be approved for key 
populations like children and pregnant women. There is an exigent need 
to enhance the efficiency of vaccine development, to generate new and 
better products, and to protect vulnerable populations. The International 
PfSPZ Consortium is developing a vaccine against a “refractory” pathogen 
- the malaria parasite - on an efficient and accelerated time line, with 
plans to submit a Biologics License Application in 2018 for a sporozoite-
based vaccine providing > 80% sterile protection against malaria infection 
for > 6 months. The principles we have followed may be of value to the 
field. 1) We have avoided a detailed target product profile (TTP), even 
though this is often considered the first step in development. We believe 
TTPs force thinking “inside the box” and suppress innovation. Rather, we 
have ignored conventional restrictions such as adherence to traditional 
manufacturing methods, storage conditions, and routes of administration, 
contending that vaccines have just 3 required attributes (our universal TPP): 
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safety, tolerability and efficacy. 2) We selected a vaccine platform based 
on established proof-of-concept for high-level protection in humans. 
While a prototype vaccine may stray from other practical norms, high-level 
protection trumps everything else as the cornerstone of success. 3) The 
logistics of vaccine manufacturing, storage, delivery and administration 
have been addressed head-on as bioengineering and clinical challenges 
that need to be overcome. 4) Optimizing the immunization regimen 
has required classic vaccinology studies to adjust dose size, number 
and interval, and to select the best route of administration. 5) Speed 
of development has been enhanced by flexible trial design, receptivity 
to new approaches, intense transparent collaboration, immediate data 
communication, and frequent consultation with regulatory authorities, all 
driving toward licensure. These concepts will be discussed with the goal of 
promulgating a new, highly effective paradigm for vaccine development.
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DETERMINANTS OF INSECTICIDE TREATED NET USE AMONG 
UNDER-FIVE CHILDREN IN NIGERIA
Temitope O. Ojo1, Tosin E. Orhorhamreru2, Adewumi B. Tijani2, 
Olufemi Ajumobi2
1Obafemi Awolowo University Teaching Hospitals Complex, Ile Ife, Nigeria, 
2National Malaria Elimination Program, Nigeria, Abuja, Nigeria
The use of Insecticide-treated nets (ITN) is the most cost effective malaria 
preventive measure. However, malaria remains a big killer of children 
in Nigeria accounting for about 30% of the under-fives (U5) deaths. 
Despite massive distribution campaigns nationwide, ITN use among (U5s) 
is low. This study assessed factors influencing ITN use among U5s across 
households in Nigeria.We analyzed the 2013 Nigerian Demographic and 
Health Survey dataset with specific focus on ITN use in children. A total 
of 17,664 U5s who slept in households with at least one ITN the night 
prior to the survey were studied. We conducted binary logistic regression 
analysis to identify factors influencing ITN use by U5s in (1) households 
that have at least one ITN and (2) households with at least one ITN for 
every two people (universal coverage). Data analysis was conducted using 
STATA (version 14.0) and results were considered significant at p < 0.05.
In households with ITN ownership, only 28.5% of U5s slept under the ITN 
the night before the survey. Significantly, children less than three years old, 
those who reside in urban areas, those from other regions of the country 
except the North East had higher odds of using ITN the night before the 
survey. Also, children from households with less than 7 members and 
those from the second and third wealth quintiles had significantly higher 
odds of using ITN. On the second regression model among households 
with universal coverage, U5s who reside in urban areas, those from other 
regions of the country except the North East and those from the second 
and third wealth quintiles still had significantly higher odds of sleeping 
under ITN the night before the survey.Our findings have programmatic 
implications for malaria control among U5s in Nigeria. Alongside sustained 
ITN distribution to improve ITN coverage, health promotion/education 
efforts targeting parents/guardians on the relevance of ITN use in malaria 
prevention among U5s should be emphasized. Interventions to improve 
ITN use should be intensified among rural dwellers, larger households, and 
residents of North-Eastern Nigeria.
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TRANS STAGE DYNAMICS OF MIDGUT MICROBIOTA OF 
ANOPHELES ALBIMANUS FROM THE PACIFIC COAST OF 
COLOMBIA
Yadira Galeano-Castañeda1, Priscila Bascuñan-Garcia1, Paula A. 
Urrea1, Stefani Piedrahita1, Julian Rodriguez-Zabala1, David Serre2, 
Margarita M. Correa1
1Universidad de Antioquia-Escuela de Microbiología, Microbiología 
Molecular Group, Medellín, Colombia, 2Genomic Medicine Institute. Lerner 
Research Institute, Cleveland, OH, United States
Colombia is the second country in Latin America in number of malaria 
cases reported, with an average in the last decades of over 100,000 cases 
per year, but underreporting is presumed. Some bacteria of the Anopheles 
mosquitoes gut microbiota seem to be involved in blocking development 
of the Plasmodium parasites and are being studied as alternative 
paratransgensis approach. Little is known about the autochthonous 
microbiota of the Latin-American anopheline mosquitoes; therefore, in this 
study, the midgut microbiota of fourth-instar larvae and adults of the main 
Colombian malaria vector An. albimanus was characterized. The midgut 
microbiota of specimens collected in the locality of the Colombian Pacific 
Coast was analyzed by both, culture-dependent and Mi-Seq Illumina high-
throughput technology. Higher bacterial species richness was detected 
in immature stages while various bacterial species were detected in both 
stages, larval and adult females. Gram positive bacteria predominated in 
larvae and similar number of Gram positive and Gram negative bacteria 
were detected in adults. Current metagenomics analysis will complement 
the information on the bacterial community composition and their 
dynamics within the different stages of this important Anopheles vector 
species. This knowledge provides the basis for the design of new and 
effective vector interventions to control malaria transmission.
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FACTORS ASSOCIATED WITH OWNERSHIP OF INSECTICIDE 
TREATED NETS IN HOUSEHOLDS IN UGANDA
Ruth N. Kigozi1, Adoke Yeka2
1Infectious Diseases Research Collaboration, Kampala, Uganda, 2Makerere 
University, Kampala, Uganda
Malaria is still a global public health challenge and in Uganda, it accounts 
for 40% of hospital outpatient visits, 20% of hospital admissions, and 
14% of hospital deaths. Use of Insecticide treated nets (ITNs) is effective 
for malaria prevention and control in households. Universal coverage 
of ITNs (defined as one ITN for two people regardless of age or gender) 
is recommended for all households to achieve impact. Mass ITNs 
distribution campaigns remain a cornerstone in efforts to achieve universal 
coverage. As such, Uganda recently conducted a mass ITN distribution 
campaign, distributing over 33 million nets country wide. We examine 
factors associated with universal ownership of ITNs among households 
in Uganda to guide programmatic planning. We analyzed the Uganda 
Malaria Indicator Survey data collected in 2013/14. Factors associated with 
universal ownership of ITNs in households were examined using logistic 
regression. Independent variables assessed included area of residence, 
age and sex of household head, household socio-economic class, number 
of rooms in the household, and whether the household had odd or even 
number household size. Households in the lowest socio-economic class 
(OR = 0.641, p = 0.00) were less likely to have universal ownership of ITNs 
compared to those in the highest socio-economic class. Households with 
household size as an odd number (OR = 0.600, p = 0.00) were also less 
likely to have universal ownership of ITNs. Allocation strategies for future 
mass ITN distribution campaigns need to incorporate households in low 
socio-economic classes as a first step. More consideration should also be 
accorded to households with odd number household size.
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LABORATORY AND SEMI-FIELD EVALUATION OF A LONG-
LASTING MICROBIAL LARVICIDE FOR MALARIA VECTOR 
CONTROL
Samuel C. Kahindi1, Yahya A. Derua1, Guofa Zhou2, Simon 
Muriu3, Joseph Mwangangi4, Harrysone Atieli5, Andrew Githeko1, 
Guiyun Yan2
1Kenya Medical Research Institute, Kisumu, Kenya, 2University of 
California, Irvine, CA, United States, 3Pwani University, Kilifi, Kenya, 4Kenya 
Medical Research Institute, Kilifi, Kenya, 5Maseno University, Kisumu, 
Kenya
Bio-larvicides can target both insecticide resistant and outdoor biting 
mosquitoes however, currently available formulations have a short 
duration of efficacy and the need for frequent applications hence more 
costs involved. The study was designed to evaluate the efficacy and 
duration of activity of a new slow release briquet formulation of Bacillus 
thuringiensis israelenis (Bti) and Bacillus sphaericus (Bs) under laboratory 
and semi-field conditions. One and Two larvicide briquets were dissolved 
in separate plastic tanks to make two different Bti/Bs solutions while a 
non-Bti/Bs briquet was dissolved in another plastic container to make 
the control solution. After 24 hours, 2 liters of each solution and twenty 
2nd - 3rd instar of field collected Anopheles larvae were added to a 
set up of 10 small plastic basins and placed in the insectary. The same 
was done for the semi-field experiment and left in the open outside the 
insectary. The surviving larvae and pupae in each plastic basin in both 
treatment and control set-ups were counted daily. The experiment was 
repeated on day 3, 7, 2 weeks and thereafter monthly. Results in the lab 
show both larvicide solutions gave high larval mortality of about 90% 
for the 5 months period with no larval pupation observed during the first 
two months. About 5%, 8% and 11% of the larvae pupated within 3, 
4 and 5 months respectively for the one briquet larvicide. For the two 
briquet solution, about 2.5%, 4.5% and 7.5% of the larvae pupated 
within 3, 4 and 5 months respectively. More than 75% larval pupation 
was observed in all the 5 months in the control set up. In the semi-field, 
both the larvicide solutions gave high larval mortality for 3 months and 
there was no larval pupation observed in the two larvicide solutions during 
the first two months. In the control set up larval pupation was more 
than 80% for all the 4 months. This study showed that this new Bti/Bs 
briquet formulation is effective in killing larval mosquitoes for more than 4 
months.
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DEVELOPMENT AND EVALUATION OF A NOVEL PIPE 
TRAP FOR OUTDOOR HOST-SEEKING MALARIA VECTOR 
SURVEILLANCE IN WESTERN KENYA
Teshome Degefa1, Delenasaw Yewhalaw2, Goufa Zhou3, Tesfaye 
Kassa2, Harrysone Atieli4, Andrew Githeko1, Guiyun Yan3
1Kenya Medical Research Institute, Kisumu, Kenya, 2Jimma University, 
Jimma, Ethiopia, 3University of California Irvine, Irvine, CA, United States, 
4Maseno University, Kisumu, Kenya
Monitoring outdoor biting malaria vectors is essential to monitor residual 
malaria transmission and evaluate the likely success of vector control 
measures. Human landing catch (HLC) has been considered standard 
method for monitoring host-seeking vectors. However, its use is facing 
increasing ethical concern. CDC light trap has been used as an alternative, 
but it does not provide a direct estimate of human biting rate. In this 
study, we evaluated a novel pipe trap for surveillance of outdoor host-
seeking malaria vectors. The pipe trap was made of pipe that pumps 
human odor from sleeping room to outdoor station and CDC light trap 
which was connected to the outer end of the pipe. Fan was fitted in to the 
pipe to enhance outflow of the odor. The sampling efficiency of the pipe 
trap was compared with outdoor CDC light trap (LT-outdoor) in cross-over 
experimental design in lowland (Ahero) and highland (Iguhu) settings of 
western Kenya from November 2015 to February 2016. A total of sixty 
trap-nights were done for each trap per site. Overall, 2,924 Anopheles 
mosquitoes were collected by pipe trap and LT-outdoor. Of these An. 
arabiensis, An. funestus, An. gambiae, An. pharoensis and An. coustani 
accounted for 18.4%, 6.2%, 0.3%, 39.8%, and 35.3%, respectively. In 
Ahero, pipe trap yielded significantly (Mann-Whitney p = 0.003) higher 
numbers of An. arabiensis (mean = 5.53, 95% CI: 3.61-7.45) than LT-
outdoor (mean = 2.48, 95% CI: 1.36-3.60). Similarly, the pipe trap caught 
significantly (p = 0.002) higher numbers of An. funestus (mean = 1.65, 
95% CI: 1.15-2.15) than LT-outdoor (mean = 0.78, 95% CI: 0.43-1.13). 
The mean numbers of other species collected did not vary significantly 
between the two traps. In the highland, mean numbers of An. gambiae 
and An. funestus was 0.1 and 0.15 in the pipe trap, and 0.05 and 0.1 in 
the LT-outdoor, respectively. Both traps collected mostly unfed mosquitoes, 
with higher proportion recorded in the pipe trap. The pipe trap attracted 
higher numbers of human seeking malaria vectors, suggesting its potential 
to replace HLC. Validation of the pipe trap for collecting outdoor human 
biting mosquitoes will be done by comparing against Malaise trap.
418
ESTIMATING BEDNET DEMAND IN TANZANIA USING A 
DISCRETE CHOICE EXPERIMENT
Chris Gingrich, Hannah Koenker
Johns Hopkins University, Baltimore, MD, United States
During the last 10 years, widespread evidence confirms that insecticide-
treated bednets (ITNs) are an effective tool for decreasing malaria 
incidence. While this evidence has supported mass distribution of free ITNs 
in various sub-Saharan African countries, no current information exists 
regarding private household demand for ITNs. This study estimates private 
demand for bednets in Tanzania using an experimental approach, namely 
a non-hypothetical Discrete Choice Experiment (DCE). The results should 
prove useful to policymakers, donors, and bednet manufacturers as they 
explore the extent that upper and middle income households might share 
the cost of ITN distribution and identify preferences among potential users 
for various bednet attributes (texture, shape and size). Tanzania provides a 
suitable locale to explore these questions because the government recently 
implemented several nationwide distribution campaigns. The study gauges 
the impact of these campaigns on private demand. Moreover, the DCE 
provides an improved estimate of demand elasticity and willingness-to-
pay for specific attributes, including the pre-treated insecticide. Existing 
estimates of bednet demand in Tanzania were conducted prior to the 
introduction of pre-treated long lasting nets (LLINs) and before the mass 
distribution campaigns. Consequently, the bednet market has experienced 
potentially significant demand and supply side shocks. The DCE method 
involves displaying two different nets to each participant and assigning 
prices to the nets. Participants then choose the net they would prefer 
to buy, or neither one. The DCE replicates a market environment since 
participants receive a small stipend, with the cost of the chosen net 
deducted from the stipend. DCEs are routinely used for market studies 
in high-income countries but this study marks their debut application to 
bednets. Data collection will occur during May 2016, with 800 participants 
spread across two rural and two urban locations.
419
KNOWLEDGE, ACCEPTANCE AND WILLINGNESS TO PAY 
FOR INDOOR RESIDUAL SPRAY IN RURAL AND URBAN 
COMMUNITIES IN NIGER STATE, NIGERIA
Olatunde Olotu1, Oladipupo Ipadeola2
1Malaria Consortium, Aweil, South Sudan, 2Univerisity of Ilorin, Ilorin, 
Nigeria
Malaria is the leading cause of U5 mortality (20%) and responsible 
for 11% maternal mortality in Nigeria. The Nigeria National Malaria 
Elimination Programme (NMEP) adopted In-door Residual Spray (IRS) 
in 2007 as one of her key strategies for reducing malaria burden in 
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the country. A quantitative study was conducted among households 
in Niger state to assess the knowledge, acceptance, and willingness to 
pay for IRS by households to inform nationwide IRS implementation. 
Respondents were selected through a multistage sampling technique. 
Data were collected by trained research assistants using semi-structured 
questionnaire, administered to 400 consenting households across six 
communities in two local government areas. Ethical approval for the study 
was granted by the Niger State Ministry of Health. Association between 
Willingness to pay and socio-demographic characteristics such as age, 
sex, education, religion and socio economic status was explored using 
the Chi Square Test. Result showed that only 8.4% of the respondents 
have ever heard of IRS therefore information on IRS was provided to all 
households that had never heard of it before the study. Although about 
70% of the households were using LLIN to prevent malaria, 88.4% were 
willing to have their houses sprayed while 71% where willing to pay 
for IRS. Majority of the respondents were willing to pay at most N1000 
(about $5) per spray while about 1.2% wanted IRS provided at no cost. 
Place of residence (urban, rural), status of respondent (whether household 
head or not), ownership of dwelling place and level of education were 
observed to be significantly associated with willingness to pay for IRS. 
The study revealed low knowledge of IRS in households in Niger state 
but a high level of acceptance and willingness to pay once the benefits 
of IRS have been provided to respondents. To facilitate acceptance of 
IRS, implementers should obtain consent from head of households and 
sensitization on the importance of IRS should be carried out. Findings from 
this study will guide implementation of state-wide implementation of IRS 
in Niger state.
420
EVALUATION OF THE IMPACT OF IMPLEMENTATION OF 
SEASONAL MALARIA CHEMOPREVENTION ON MORBIDITY 
AND MORTALITY IN YOUNG CHILDREN: A QUALITATIVE 
STUDY IN NORTHERN GHANA
Nana Akosua Ansah1, Keziah Malm2, Samuel Tamti Chatio1, 
Patrick Ansah1, Samuel Tampuulo1, Dennis Awuni1, Abraham R. 
Oduro1
1Navrongo Health Research Centre, Navrongo, Ghana, 2National Malaria 
Control Programme, Accra, Ghana
Seasonal Malaria Chemoprevention (SMC) intervention was introduced 
in the Upper West Region of Ghana in July 2015. This was by the 
recommendation of WHO as an additional tool which has been shown to 
be effective, safe and feasible in preventing malaria among children under 
five years in areas with high seasonal malaria transmission. Community 
involvement is critical in controlling malaria. This may determine the 
effectiveness of the intervention. A study was undertaken to assess the 
community acceptability of this intervention in addition to other malaria 
control measures in reducing the burden of malaria among children under 
five years in the Upper West Region of Ghana. Fifty interviews and eight 
focus group discussions were conducted in the Lawra district where SMC 
intervention was introduced for the first time. Participants consisted of 
parents and guardians of children who received the intervention and 
community health workers and health volunteers. The intervention was 
generally acceptable to the local population who opined that it had led 
to a reduction in the prevalence of malaria in the district compared to 
previous years. An overwhelming majority of the respondents said the 
drug was very good because it prevented malaria in children who took 
it.Drug adherence was very good and there was no serious adverse event 
associated with drug intake. The various adverse events that occurred did 
not result in interruption of the treatment course. Community members 
and other stakeholders believe that the SMC intervention played a role 
in reducing the burden of malaria in the study area and wish that the 
program would continue so that their children would continue to benefit. 
Some participants called for the intervention to be introduced into the EPI 
and made compulsory for all children under five years. Acceptability of 
the intervention was very high among parents and other stakeholders in 
the study area. They however wanted to be counselled on the potential 
side effects and their management. Community acceptability of SMC is 
very high and can contribute to control malaria in areas where malaria 
transmission is seasonal.
421
THE IMPACT OF INDOOR RESIDUAL SPRAYING ON THE 
DENSITY AND PARITY RATE OF ANOPHELES GAMBIAE S.L. IN 
OROMIA REGION - ETHIOPIA
Alemayehu G. Tesfaye
Abt Associates Inc. AIRS Project, Addis Ababa, Ethiopia
Entomological monitoring is an integral part of the US President’s Malaria 
Initiative’s (PMI’s) vector control efforts. Data on key entomological 
indicators is regularly collected and used to guide vector control programs 
and track their impact. A non-randomized, interrupted controlled time 
series design was used to assess the impact of IRS on vector density and 
parity rate in Ethiopia. Pre-spray data was collected from one control 
and two intervention districts in monthly intervals from March to August 
2015, while post-spray data was collected monthly from September to 
November 2015 from the same sites. Pyrethrum spray and human landing 
catch mosquito sampling methods were used to determine indoor resting 
density and parity rate, respectively. Before spray, the mean indoor resting 
density of the main vector, Anopheles gambiae s.l., was 4.1 (n=496 
mosquitoes) and 1.03 (n=124) per house per day in the intervention and 
control sites, respectively. Post spray, the mean vector density dropped to 
0.49 (n=59) in the intervention and to 0.73 (n=88) in the control districts. 
The decline in vector density was four-fold in the intervention sites as 
opposed to only a 30% decline in the control site. The reduction was 
statistically significant in the intervention (p=0.025) but not in the control 
(p=0.738) site. The difference noted between the two treatments might 
be due to the impact of IRS.At the same time, data on parity rate for An. 
gambiae s.l. was collected pre- and post-spray from the intervention and 
control sites. Before the spray campaign, the parity rate was 79.75% 
(n=553) in the intervention and 96.94% (n=193) in the control sites. After 
spraying, the parity rate dropped to 54.57% (n=405) in the intervention 
sites but increased to 100% (n=148) in the control site. The decline and 
increase in parity rate observed after spray as compared to before spray in 
the intervention and control sites, respectively, were statistically significant. 
(p<0.001). The change detected in parity rate might partially or totally 
be attributed to the impact of IRS. Further study is needed to understand 
if the reduction in density and parity rate has led to reduced malaria 
transmission.
422
STRATIFICATION OF INDOOR RESIDUAL SPRAYING (IRS) IN 
BIOKO ISLAND: METHODOLOGY AND IMPACT
Dianna B. Hergott1, Christopher Schwabe1, Guillermo Garcia2, 
Wonder Philip Phiri2, Megan Perry1, Jose Luis Segura2, Immo 
Kleinschmidt3, Jackie Cook3
1Medical Care Development International, Silver Spring, MD, United States, 
2Medical Care Development International, Malabo, Equatorial Guinea, 
3London School of Hygiene & Tropical Medicine, London, United Kingdom
The Bioko Island Malaria Control Project (BIMCP) uses a GIS-based 
Campaign Information Management System (CIMS) that uniquely 
identifies each household based on geographical location. 2014 spray 
data revealed Island wide coverage of just 57% with high refusal rates, 
well below the WHO recommended coverage for effectiveness. Due 
to this, as well as budget constraints that did not support long term-
sustainability of Island-wide IRS, the BIMCP stratified households and 
communities targeting spraying at the most vulnerable populations only, 
relying on LLINs in other areas. To stratify households by vulnerability, 
we utilized community-level parasite prevalence and risk of importation 
derived from the 2014 MIS, quality of housing and 2014 IRS coverage 
from the CIMS. As the 2014 MIS sampling frame was based on sentinel 
sites, MIS values for prevalence and importation in communities not 
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included in the MIS sample were imputed. Based on this information, 
a risk score (R) and a risk-acceptability score (Ra) were derived for each 
community. Communities with the highest R and Ra values were selected 
for IRS- targeting, given the available budget, 30% of all households. 
Spray coverage in targeted communities was high, with an overall 
coverage of 80%. As such, in 2016, the BIMCP re-ran the stratification 
but removed previous IRS coverage as a criteria utilizing only prevalence, 
importation and housing quality - our measures of vulnerability. In 
addition, the 2015 MIS sampling frame was all communities in the Island 
with 20 households or more, eliminating the need to impute data. MIS 
data from 2014, 2015, and 2016 will be analyzed in communities that 
were stratified for IRS and in those that were not, to determine if the 
stratification of IRS and replacement of LLINs as the main control strategy 
in all communities resulted in a differential change in prevalence of 
infection across communities. An initial analysis of 2014 and 2015 data 
revealed prevalence of infection decreased both in communities stratified 
for IRS and those where LLINs alone were deployed, indicating that the 
withdrawal of IRS from less vulnerable communities did not lead to 
adverse consequences.
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COST-EFFECTIVENESS OF MALARIA CONTROL MEASURES: A 
CLUSTER-RANDOMIZED CONTROL TRIAL OF IRS AND ITNS IN 
MOZAMBIQUE
Molly L. Robertson1, Abuchahama Saifodine2, Baltazar 
Candrinho3, Christen Fornadel4, Tom McLean5, Lourdes Loch6, 
Cara A. Carty1, Joseph Wagman1, Francisco Saute7
1PATH, Washington, DC, United States, 2U.S. President’s Malaria Initiative, 
U.S. Agency for International Development, Maputo, Mozambique, 
3National Malaria Control Program, Maputo, Mozambique, 4U.S. 
President’s Malaria Initiative, Malaria Branch, Division of Parasitic Diseases 
and Malaria, U.S. Centers for Disease Control and Prevention, Arlington, 
VA, United States, 5IVCC, Liverpool, United Kingdom, 6PMI AIRS Project, 
Abt Associates, Maputo, Mozambique, 7Centro de Investigacoes em Saude 
de Manhica, Maputo, Mozambique
Malaria endemic countries face challenging decisions regarding choice 
and financing of interventions to prevent malaria. To maintain the 
gains in malaria control and move toward elimination, malaria endemic 
countries need information on the cost effectiveness of interventions 
and combinations of interventions. Vector control programs, through 
insecticide treated nets (ITN) and indoor residual spraying (IRS), are 
a critical component of national malaria strategies. Yet, widespread 
insecticide resistance - particularly to pyrethroids, is a serious threat 
to program effectiveness. Additionally, important questions remain 
regarding the benefits and costs of IRS in the context of expanding 
ITN coverage. In order to inform national vector control strategies, this 
study will compare the cost-effectiveness of different interventions in 
a malaria endemic region of Mozambique by determining the cost per 
case averted of ITNs alone, as compared to ITNs plus IRS. Clusters will be 
randomized in mid-2016 to receive either IRS with the organophosphate, 
Actellic CS (intervention), within a context of high coverage of pyrethroid 
impregnated ITNs or ITN coverage only (control). Data collection is from 
2016 to 2018 with baseline data available by October 2016. Changes 
in malaria incidence from strengthened health facility data, community 
parasite prevalence and net use from community surveys, entomological 
inoculation rates and resistance levels from entomological surveillance, and 
intervention costs will provide evidence on the impact of the intervention. 
Routine case burden data, cost data, cross-sectional prevalence surveys 
and entomological monitoring will be triangulated to determine overall 
and incremental impact and cost-effectiveness of IRS plus ITNs compared 
with ITNs alone. These findings will be critical to support informed-
decision making to control and eliminate malaria by malaria programs in 
Mozambique and other high-burden countries.
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DETERMINING THE PREVALENCE AND GEOGRAPHIC 
DISTRIBUTION OF MIXED FUNCTION OXIDASES IN 
ANOPHELES GAMBIAE S.L. WITH PYRETHROID RESISTANCE 
IN RELATION TO SITE SELECTION FOR A TRIAL OF 
COMBINATION LLINS IN MALI
Moussa Cisse1, Dereje Dengela2, Richard Oxborough2, Bradford 
Lucas2, Abdourhamane Dicko3, Jules Mihigo4, Aboubacar Sadou5, 
Kristen George6, Christien Fornadel6, Laura Norris6, Allison 
Belemvire6, Suzanne Powell7, Raymond F. Beach8
1U.S. Agency for International Development AIRS Project, Abt Associates, 
Bamako, Mali, 2U.S. Agency for International Development AIRS Project, 
Abt Associates, Bethesda, MD, United States, 3Programme National 
de Lutte contre le Paludisme, Bamako, Mali, 4U.S. President’s Malaria 
Initiative, U.S. Centers for Disease Control and Prevention, Bamako, 
Mali, 5U.S. President’s Malaria Initiative, U.S. Agency for International 
Development, Bamako, Mali, 6U.S. President’s Malaria Initiative, U.S. 
Agency for International Development, Washington, DC, United States, 
7U.S. President’s Malaria Initiative, U.S. Centers for Disease Control and 
Prevention, Atlanta, GA, United States, 8Entomology Branch, U.S. Centers 
for Disease Control and Prevention, Atlanta, GA, United States
The only long-lasting insecticidal nets (LLINs) currently under consideration 
for use in areas of pyrethroid resistance are LLINs treated with pyrethroids 
plus piperonyl-butoxide (PBO), a synergist that inhibits the activity of 
mixed function oxidases (MFOs) in resistant mosquitoes. This study sought 
to document the prevalence of MFO mechanisms in pyrethroid-resistant 
An. gambiae s.l. mosquitoes in different geographic areas of Mali. This 
information was used to identify sites for an intervention trial involving 
PBO-containing LLINs. Anopheles gambiae s.l. larvae were sampled in 
12 sites in central and southern Mali from August-December 2015. 
Local vector populations were screened with the CDC bottle bioassay 
tests for permethrin and deltamethrin resistance. Bottle bioassays with 
PBO as a synergist were used to determine the association between 
reduced survival and elevated levels of MFOs. Taxonomic identification of 
species as well as presence of the L1014F and L1014S kdr (knock down 
resistance) mutations were determined by polymerase chain reaction. 
Based on WHO’s 2013 resistance classification guidelines (mortality rate 
< 90%), evidence of high-frequency pyrethroid resistance was observed 
in all 12 test sites. Mortality increased (P97%). This suggests evidence 
of MFO-based metabolic resistance mechanisms involved in pyrethroid 
resistance. High variability was observed in resistance and the effect 
of PBO on mortality among sites. L1014F kdr allelic frequencies were 
>60% in Anopheles coluzzii, >40% in An. gambiae s.s. L1014S kdr allelic 
frequencies were <15% in An. coluzzii, <10% in An. gambiae s.s. This 
study demonstrated high variability of MFO mechanisms in wild-caught 
mosquitoes with pyrethroid resistance in central and southern Mali. Even 
though use of PBO did not restore full susceptibility, several sites were 
identified as potentially suitable for further evaluation of combination 
LLINs with PBO.
425
WHY NO NETS? AN IN-DEPTH INVESTIGATION INTO THE 
DECREASE IN NET ACCESS ON BIOKO ISLAND AFTER BED-
NET DISTRIBUTION
Thomas C. Stabler1, Dianna Hergott1, Guillermo Garcia1, Aveika 
Akum1, Chris Schwabe1, Immo Kleinschmidt2
1Medical Care Development International, Silver Spring, MD, United States, 
2London School of Hygiene & Tropical Medicine, London, United Kingdom
From December 2014 to June 2015, the Bioko Island Malaria Control 
Project (BIMCP) conducted a mass-top up LLIN distribution campaign on 
Bioko Island, Equatorial Guinea. Despite good reported coverage (88% 
of households received at least 1 LLIN), results from the BIMCP’s 2015 
Malaria Indicator Survey (MIS) reported low levels of net ownership (69%) 
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and low net access (32%) approximately 7 months following distribution. 
While the distribution campaign ensured that one net was distributed per 
sleeping area, achieving an average of one net per 2 residents in 88% of 
households, a better understanding of the reasons behind the reduction of 
nets is needed to allow BIMCP to implement strategies against a decrease 
in net access in future campaigns. An initial analysis of MIS questions 
regarding net ownership indicated that a high proportion of households 
reported a dislike of the net (16.2%), while other households reported 
giving them to relatives on the mainland (12.7%). A mixed quantitative 
and qualitative study will be performed to determine the reasons behind 
the reduction in bed net access. A random sample of 150 households 
on Bioko Island will be selected from BIMCP’s Campaign Information 
Management System (CIMS) and MIS databases. These databases use 
a GIS-based household mapping system, used to easily locate and track 
every household location to be sampled. A semi-structured interview will 
be employed to determine participant household’s current net access 
relative to the number of nets distributed during the campaign and the 
number of nets reported in the subsequent MIS, what happened to the 
nets that were lost and the reasons why, current net usage by household 
member type (e.g. under-5’s, pregnant women, etc.), their knowledge and 
attitudes acquired from the distribution teams and/or other media about 
LLINs, and their perceptions about the distribution process. The analysis 
will seek to discern what the primary reasons are for the unexpected 
decrease in net access. Findings will inform the BIMCP on how to reduce 
the LLIN loss rates, in planning for the upcoming 2017 LLIN distribution 
and for future continuous distribution.
426
DETERMINANTS OF BED NET USE CONDITIONAL ON ACCESS 
IN POPULATION SURVEYS IN GHANA
Olivier J. Briet1, Samuel Oppong2
1Swiss Tropical and Public Health Institute, Basel, Switzerland, 2National 
Malaria Control Programme, Accra, Ghana
Out of 23 African countries surveyed with a Demographic and Health 
Survey (DHS) in the 2012-2015 period, Ghana ranks 21st in net use 
conditional on access (NUCA) (with 57.5%), and only Namibia and Nigeria 
have a larger proportion of people not using nets despite having access to 
a space under one. In literature, self-reported reasons for not using nets 
include discomfort (due to heat), disruption of sleeping arrangements, and 
low mosquito density. We explored if ‘geographical region’, ‘residence’ 
(urban or rural), ‘wealth quintile’, ‘spraying of the dwelling with residual 
insecticides’ (IRS), the ‘humidex’ in the month of survey, ‘connection to 
electricity’, the ‘mean age’ of the nets in the household, the ‘nets : people 
ratio’ in the household and the ‘respondent heard a message on the use 
of nets’ could explain NUCA with beta-binomial regression models that 
corrected for spatially correlated random effects in the Ghana 2014 DHS. 
Similarly, this was done with these variables (except the not collected 
one on messaging) for the Ghana 2011 Multiple Indicator Cluster Survey 
(MICS), with as additional variables ‘ethnicity’, ‘religion’ and an estimate 
of ‘vector density in the month of survey’. In the DHS, ‘wealth quintile’, 
‘electricity’, ‘residence’, ‘messaging’, ‘humidex’ and ‘IRS’ (in order of 
decreasing importance) individually improved model fit, as assessed by the 
deviance information criterion (DIC), compared to a null model without 
covariates, and also all these variables combined in one model improved 
the DIC over simpler models. In the MICS, the variables ‘region’, ‘net age’, 
and ‘IRS’ improved the fit when individually added to the null model. 
‘Net age’ improved the fit when included into a model with ‘region’ as 
covariate. Differences in results between 2011 and 2014 are possibly due 
to the 2011 MICS being held in the midst of a mass distribution campaign, 
with 4 regions (partly) completed and 6 not yet begun. Surprisingly, the 
‘nets : people ratio’ (the higher the ratio, the less need for sharing nets 
and possibly disrupting sleeping arrangements) did not explain NUCA and 
the humidex (a measure of comfort due to heat) only did so in the 2014 
DHS.
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JOINT DISTRIBUTION OF ACUTE RESPIRATORY INFECTION, 
DIARRHEA AND STUNTING AMONG CHILDREN UNDER THE 
AGE OF FIVE YEARS IN SOMALIA
Damaris K. Kinyoki1, Samuel Manda2, Grainne Moloney3, Elijah 
Odundo4, James Berkley5, Abdisalan Noor1, Ngianga-Bakwin 
Kandala6
1KEMRI-Wellcome Trust Research Programme, Nairobi, Kenya, 2Biostatistics 
Research Unit, South African Medical Research Council, Pretoria, South 
Africa, Nairobi, Kenya, 3Nutrition Section, United Nations Children’s 
Fund (UNICEF), Kenya Country Office, Nairobi, Kenya, 4Food Security 
and Nutrition Analysis Unit (FSNAU) - Somalia, United Nations Food 
and Agricultural Organization, Nairobi, Kenya, 5KEMRI-Wellcome Trust 
Research Programme, Kilifi, Kenya, 6Northumbria University, Department 
of Mathematics and Information sciences, Nairobi, Kenya
The aim of this study was to assess the spatial co-occurrence of acute 
respiratory infections (ARI), diarrhoea and stunting among children the 
age of five years in Somalia. Data were obtained from routine bi-annually 
nutritional surveys conducted by the Food and Agriculture Organization 
(FAO) from 2007 - 2010. A Bayesian hierarchical shared component 
model was fitted to the spatial components of the three health conditions 
concurrently. Risk maps of the common spatial effects at 1 x 1 km 
resolution were derived. The empirical correlations of the proportion were 
0.37, 0.63 and 0.66 for ARI and stunting; diarrhoea and stunting and ARI 
and diarrhoea respectively. Spatially, the posterior residual effects ranged 
from 0.04 to 18, 0.19 to 5.39 and 0.07 to 8.16 for shared component 
between ARI and stunting; diarrhoea and stunting; and ARI and diarrhoea 
respectively. This analysis shows clear spatial shared component between 
ARI, diarrhoea and stunting in Somalia with the southern part of the 
country experiencing a higher than usual rate of these conditions. 
Intervention aimed at reducing the rates of these three health conditions 
should focus on the common risk factors particularly in the South in 
Somalia.
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SHANCHOL, THE ORAL CHOLERA VACCINE IS SAFE 
AND IMMUNOGENIC WHEN STORED AT ELEVATED 
TEMPERATURES IN BANGLADESHI PARTICIPANTS
Amit Saha, Arifuzzaman Khan, Taufiqur Rahman Bhuiyan, John 
D. Clemens, Firdausi Qadri
International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, 
Bangladesh
Immunization against cholera is recognized as a major intervention for 
control of the disease, however the requirement for a cold chain has 
limited its use in resource poor settings.The aim was to determine the 
safety and immunogenicity of Shanchol after stored at temperature upto 
42°C. The study conducted in adult participants in Dhaka, Bangladesh. 
The vaccine kept under standard (Group A; 2-8°C) and at three elevated 
temperatures (Group B; 25°C, Group C; 37°C, Group D; 42°C) for 14 
days. Vibriocidal and LPS antibody responses were determined at baseline 
and 7 days after each dose. 580 participants; 145 in each group (A=2-8 °C 
; B=25 °C; C=37 °C and D= 42°C ) were vaccinated. Only 17 mild adverse 
events, which did not differ between groups. Increases of vibriocidal 
responses observed at day 7 and 21 (P<0.001) compared to day 0 in all 
groups. Over four-fold increases to V. cholerae O1 Ogawa were observed 
at day 7 and/or day 21 after vaccination in at all groups, with responder 
rates of; 76%, 80% , 69% and 74% in Groups A, B, C, and D (p=0.240). 
Significant vibriocidal antibodies to V. cholerae O1 Inaba and O139, and 
LPS- Ogawa and Inaba antibody responses also observed after each dose 
(p<0.001); with comparable seroconversion rates between Group A and 
Groups B, C, and D. Interpretation: This is the first report of the testing 
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the temperature stability of Shanchol in people. Shanchol is safe and 
immunogenic in endemic settings even when kept outside the cold chain. 
Further study should conduct to assess the impact in younger age group.
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HOST AND ENVIRONMENTAL CORRELATES OF MULTI-DRUG 
RESISTANCE IN KENYAN CHILDREN WITH ACUTE BACTERIAL 
DIARRHEA
Rebecca Brander1, Judd Walson1, Grace John-Stewart1, Jackline 
Naulikha2, Janet Ndonye3, Nancy Kipkemo3, Doreen Rwigi2, Benson 
Singa2, Patricia Pavlinac1
1University of Washington, Seattle, WA, United States, 2Kenya Medical 
Research Institute, Nairobi, Kenya, 3Walter Reed Army Institute of 
Research, United States Army Medical Research Unit, Kericho, Kenya
Bacterial diarrhea results in significant morbidity and mortality in children 
in sub-Saharan Africa. Antibiotic treatment may be important in this 
population but is limited by concerns about antibiotic resistance. Stool/
rectal swab samples of children aged 6 mos - 15 yrs presenting with 
acute diarrhea in western Kenya were cultured for bacterial pathogens. 
HIV uninfected children with identified Shigella or Salmonella species, 
or enteropathogenic [EPEC], enterotoxigenic [ETEC], enteroaggregative 
[EAEC], or enteroinvasive Escherichia coli [EIEC] were included in 
this substudy. Resistance to ampicillin, ceftriaxone, ciprofloxacin, 
cotrimoxazole, and tetracycline was determined using MicroScan 
Walkaway40 Plus. To evaluate correlates of multi-drug resistance 
(MDR [resistance to ≥ 3 classes of antibiotics]), we used multivariable 
log-binomial regression to estimate prevalence ratios (PRs) and 95% 
confidence intervals (CIs). Of 336 children in the analysis, median age was 
19 mos (interquartile range: 10-39 mos), 38% used unimproved sanitation 
facilities and 10% were HIV-exposed. Resistance to cotrimoxazole (96%) 
was most common among all pathogens, followed by ampicillin (81%) 
and tetracycline (77%). Phenotypic MDR was identified in 11% of 
children; and in 38% of Shigella, 40% of Salmonella, 76% of EPEC, 54% 
of ETEC, 78% of EAEC, and 77% of EIEC isolates. Children 6-24 mos were 
more likely to have MDR infections identified than those 24-59 mos (aPR 
= 1.56 [95% CI: 1.25, 1.92]). Children whose caregivers used a shared pit 
latrine or who openly defecated were more likely to have MDR (aPR = 1.71 
[95% CI: 1.02, 2.86]) than those with flush or unshared toilets. Duration 
of exclusive breastfeeding, malnutrition, maternal HIV, water source, and 
hand washing were not associated with MDR infections in this study. 
Young age and unimproved sanitation may be associated with MDR as a 
result of greater exposure to fecal contamination. Community antibiotic 
use may select for resistant enteric bacteria in settings with poor sanitation 
by eliminating susceptible bacteria before excretion and increasing inter-
species transfer of resistant plasmids.
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GENOTYPIC IDENTIFICATION OF AMPC β-LACTAMASES 
PRODUCTION IN DIARRHOEAGENIC E.COLI FROM CHILDREN 
UNDER FIVE AND MOLECULAR DOCKING OF THEIR 
PROTEINS
Taru Singh
UCMS and GTBH, New Delhi, India
AmpC beta-lactamases are bacterial enzymes that hydrolyse 3rd 
generation extended spectrum cephalosporins and cephamycins 
engendering resistance to these categories of antibiotic. AmpC 
β-lactamase expression can increase in the nosocomial pathogens, 
triggered by exposure to antibiotics and β-lactamase inhibitors with the 
β-lactam function. Therefore, AmpC β-lactamase is an important target 
for developing novel effective antibacterial therapies. The objective of 
this study was to evaluate the Real Time PCR as a rapid diagnostic tool 
for simultaneous detection of AmpC beta-lactamase producing E.coli 
and in silico determination of docking sites of AmpC proteins.During 
one year period from July 2012 to July 2013, 120 stool samples were 
collected, including 80 diarrheagenic E.coli and 40 controls from children 
in University College of Medical Sciences and Guru Teg Bahadur Hospital, 
East Delhi. E.coli was diagnosed for AmpC beta lactamase production 
using conventional phenotypic tests. DNA extraction was done, and 
extracted DNA was used as a template for Real Time PCR. Bioinformatics 
tools were used for molecular docking. Real time PCR detected target 
genes of AmpC beta lactamase in 18.75% and 22.5% in cases and 
controls respectively. Chi square test and Fisher’s exact test were used to 
determine statistical significance of data. Real time PCR assay will save 
time and help investigators to explore the role of multidrug resistant E. 
coli. Active binding sites will be useful in synthesis of new drugs. Modeling 
and docking studies may provide useful insights for developing new 
antibiotic drugs to minimize multidrug resistance.
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CAMPYLOBACTER SPECIES, CAPSULE TYPES AND VIRULENCE 
FACTORS CIRCULATING AMONG CHILDREN IN EGYPT
Rebecca J. Sainato1, Atef ElGendy2, Frederic Poly3, Janelle 
Kuroiwa3, Patricia Guerry3, Mark S. Riddle3, Chad Porter3
1Department of Pediatrics, Walter Reed National Military Medical Center, 
Rockville, MD, United States, 2Naval Medical Research Unit - 3, Cairo, 
Egypt, 3Enteric Diseases Department, Naval Medical Research Center, Silver 
Spring, MD, United States
Campylobacter is one of the most frequently isolated bacterial pathogens 
in children with diarrhea. There are 47 recognized Penner serotypes of 
Campylobacter jejuni, represented by 35 capsule types. The capsule serves 
as a target for vaccine development. Campylobacter can also harbor the 
type-6 secretion system (T6SS), which is a known virulence factor among 
Gram negative pathogens. Data are lacking on the distribution of C. jejuni 
capsule types in most developing countries. The prevalence of the T6SS 
within Campylobacter species and capsule types has not previously been 
reported. The US Naval Medical Research Unit #3, based in Cairo, Egypt 
conducted three prospective diarrheal studies in Abu Homos, Egypt from 
1995-2000. In total, 531 Campylobacter spp. isolates were obtained 
from 397 children. Each isolate was re-grown and DNA was extracted 
for speciation, capsule typing and hcp gene presence, a marker for T6SS. 
Of the isolates, only 522 and 501 were respectively available for capsule 
and T6SS analysis; 60.9% (318) were C. jejuni, 37.9% (198) were C. coli 
and 1.1% (6) were unable to be speciated. Capsule types were identified 
in 88.4% (281) of the C. jejuni isolates; HS-2 and HS-3 were the most 
prevalent (both 11.9%). The hcp gene was found in 57.5% (172) of C. 
jejuni isolates compared to 19.4% (38) of C. coli isolates (p<0.001) and 
83.3% (5) of the unspeciated isolates (p<0.578). The presence of the 
hcp gene among C. jejuni capsule types varied significantly (0-100%). 
This study provides epidemiological data regarding the distribution of 
circulating C. jejuni capsule types. Within this cohort, eight capsule types 
together accounted for 72% of C. jejuni infections. The heterogeneity 
of C. jejuni serotypes is higher than previously reported, although prior 
studies of serotype distribution within Africa are limited and have not 
focused on pediatric infections. Our data suggests that the T6SS is more 
commonly found among C. jejuni isolates compared to C. coli. We also 
highlight significant gaps that persist. Further studies are needed to 
determine whether specific capsule types or presence of the T6SS are 
associated with more severe clinical illness.
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ENTEROPATHOGENS DISTRIBUTION AND BURDEN WITHIN 
ORAL CHOLERA VACCINE RECIPIENTS IN SOUTH SUDAN
Peter Hale1, Malika Bouhenia2, Briannee A. Couturier3, Anita 
S. Iyer1, John Rumunu4, Stephen Martin5, Abdinasir Abubakar2, 
David Sack6, Francisco J. Luquero7, Marc R. Couturier3, Andrew S. 
Azman6, Daniel T. Leung1
1University of Utah, Salt Lake City, UT, United States, 2World Health 
Organization, Juba, South Sudan, 3ARUP Laboratories, Salt Lake City, UT, 
United States, 4Republic of South Sudan Ministry of Health, Juba, South 
Sudan, 5World Health Organization, Geneva, Switzerland, 6Johns Hopkins 
University, Baltimore, MD, United States, 7Epicentre, Paris, France
The efficacy of oral cholera vaccine (OCV) is poorer in younger children 
than adults and there is great heterogeneity in immunogenicity within and 
between different sub-populations. Multiple oral vaccines have shown 
decreased efficacy in the setting of concurrent enteric infections. The 
objective of this study was to explore the distribution of enteropathogens 
within stool of recipients of OCV and the relationship between pathogen 
carriage and immunogenicity. As part of a mass vaccination campaign 
in an internally displaced person’s camp in South Sudan, we obtained 
paired stool and serum samples from a subset of recipients who received 
2 doses of the OCV Shanchol 14 days apart. We used the vibriocidal 
assay to determine titers just before the first dose (day 0) then 14 and 28 
days after. We extracted nucleic acid from stool samples and performed 
multiplex real-time PCR on 18 bacterial, viral and protozoal targets. Stool 
from a total of 89 subjects were examined, 13 (15%) of which reported 
diarrhea the week prior to vaccination. Overall, 39 of 89 (44%) subjects 
had at least one pathogen identified in stool, with 19 (21%) having two 
or more identified. Among those aged 1-5 years (young children, n=8), 
6-17 years (older children, n=26) and 18-60 years (adults, n=55), we 
found stools to be positive for at least one pathogen in 50%, 50%, and 
38% of subjects, respectively. The most commonly identified pathogens 
were Shigella spp. (13% of subjects), D fragilis (12%), norovirus (12%), 
and STEC (9%). 32 of 46 (70%) subjects with vibriocidal data available 
seroconverted. We did not find any significant differences in the presence 
of co-infection, type of co-infection or extent of pathogen burden 
between those who did and did not seroconvert. We demonstrate that 
a large proportion of OCV recipients in an internally displaced person 
camp in South Sudan had asymptomatic carriage of enteropathogens. 
While these preliminary analyses suggest that these co-infections may not 
be associated with immune responses to OCV, we are in the process of 
completing analysis of additional pathogens, including helminthic targets, 
and final data will be available by time of presentation.
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EFFECT OF HELICOBACTER PYLORI INFECTION ON GROWTH 
TRAJECTORIES IN YOUNG ETHIOPIAN CHILDREN: A 
LONGITUDINAL STUDY 
Bineyam Taye
Colgate University, Hamilton, NY, United States
Helicobacter pylori infection has been associated with early childhood 
growth impairment in high and middle-income countries; however, few 
studies have examined this relationship within low-income countries or 
used a longitudinal design. We examined the possible effects of H. pylori 
infection on growth trajectories in a cohort of young Ethiopian children. 
In 2011/12, 856 children (85.1% of the 1006 original singletons in a 
population-based birth cohort) were followed up at age six-and-a-half. 
An interviewer-led questionnaire administered to mothers provided 
information on demographic and lifestyle variables. Height and weight 
were measured twice, and the average of the two measurements was 
used. Exposure to H. pylori infection was assessed using a rapid H. pylori 
stool antigen test. The independent associations of positive H. pylori 
infection status (measured at ages 3 and 6.5 years) with baseline height 
and weight (age 3) and height and weight growth trajectory (from age 3 
to 6.5 years) were modeled using Hierarchical Linear Models. At baseline 
(age 3), children’s mean height was 85.7 cm and their mean weight was 
11.9 kg. They gained height at a mean rate of 8.7 cm/year, and weight 
at a mean rate of 1.76 kg/year. H. pylori infection was associated with 
lower baseline measurements and linear height trajectory (β=-0.74cm, 
and -0.79cm/year, respectively), after controlling for demographics and 
markers of socio-economic status. However, the positive coefficient was 
associated with quadratic growth in height among H. pylori infected 
children (β=0.28, 95% CI, 0.07 to 0.49, p<0.01), and indicated increase in 
height trajectory as the child increased in age. In conclusion, our findings 
add to the growing body of evidence supporting that H. pylori infection is 
inversely associated with childhood growth trajectory, after controlling for 
a range of factors associated with reduced growth and H. pylori status.
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ANTIMICROBIAL RESISTANCE PATTERNS AMONG 
INTERMEDIATE - TO LONG-TERM TRAVELERS TO CUSCO, 
PERU, WITH DIARRHEA
Sarah-Blythe Ballard1, Mary Carol Jennings2, Hannah E. 
Steinberg2, Drake H. Tilley1, Rina Meza1, Miguel Villanueva3, 
Fernando Maldonado Costa4, Martha Lopez5, C. Giannina Luna1, 
Maria E. Silva1, Ryan C. Maves6, Andres W. Lescano1, Miguel M. 
Cabada5, Mark P. Simons1
1U.S. Naval Medical Research Unit - 6, Lima, Peru, 2Johns Hopkins 
Bloomberg School of Public Health, Baltimore, MD, United States, 
3Hospital Universitario de la Princesa, Madrid, Spain, 4Royal Tropical 
Institute, Amsterdam, Netherlands, 5University of Texas Medical Branch, 
Galveston, TX, United States, 6Naval Medical Center San Diego, San Diego, 
CA, United States
In order to characterize antimicrobial resistance among travelers with 
diarrhea in Cusco, Peru, we prospectively collected stool from students 
older than 18 years of age presenting consecutively to the Amanta Spanish 
School’s physician with diarrhea between June 2003 and July 2010. We 
performed antibiotic susceptibility testing using the disk diffusion method 
according to the Clinical and Laboratory Standards Institute guidelines 
(CLSI, 2011). Reduced susceptibility to ampicillin and first-generation 
cephalosporins was common among all isolates, except Shigella 
sonnei. Non-Campylobacter isolates were nearly uniformly susceptible 
to ceftriaxone. Campylobacter coli and C. jejuni isolates had reduced 
susceptibility to erythromycin and both quinolones, naldixic acid and 
ciprofloxacin, whereas susceptibility to azithromycin was 100% for both 
species and susceptibility to sulfamethoxazole-trimethoprim 100% and 
94%, respectively, for both species. For the E. coli enteropathogens, ETEC 
was the most common isolate and was highly susceptible to amoxicillin-
clavulanic acid (89%), ceftriaxone (100%), azithromycin (79%), and 
ciprofloxacin (93%), but showed greatly reduced susceptibility to cefazolin 
(64%), erythromycin (4%), sulfamethoxazole-trimethoprim (61%), and 
tetracycline (61%). Susceptibility trends for EAEC were similar to ETEC. Of 
the Shigella sp., S. sonnei strains were more common than S. flexneri and 
notable differences in susceptibility between the two species were found. 
Shigella sonnei was more susceptible to ampicillin (100%), cefazolin 
(100%), and sulfamethoxazole-trimethoprim (100%) than S. flexneri, but 
less susceptible to azithromycin (56%). Ciprofloxacin, tetracycline, and 
ceftriaxone susceptibility was 100% for both S. sonnei and S. flexneri. 
These results suggest that azithromycin is the most appropriate empiric 
treatment for travelers’ diarrhea in this region, as it will effectively treat 
ETEC, Shigella, and fluoroquinolone-resistant Campylobacter-associated 
diarrhea, whereas ciprofloxacin would only effectively treat ETEC and 
Shigella.
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LETHALITY OF FIRST CONTACT DYSENTERY EPIDEMICS ON 
PACIFIC ISLANDS
G. Dennis Shanks
Army Malaria Institute, Enoggera, Australia
Infectious diseases de-populated many isolated Pacific islands when they 
were first exposed to global pathogen circulation from the 18th century. 
Although the mortality was great, the lack of medical observers makes 
determination of what happened during these historical epidemics 
largely speculative. Bacillary dysentery caused by Shigella is the most 
likely infection causing some of the most lethal island epidemics. The 
fragmentary historical record is reviewed in order to gain insight into the 
possible causes of the extreme lethality that was observed during first 
contact epidemics in the Pacific. Subacute dysentery occurred following 
first contact measles epidemics but not in subsequent smaller measles 
outbreaks. Immune aspects of the early dysentery epidemics and post-
measles infection resulting in subacute inflammatory enteric disease 
suggest that epidemiologic isolation was the major lethality risk factor on 
Pacific islands in the 19th century. Other possible risk factors include HLA 
homogeneity from a founder effect and pathogen-induced derangement 
of immune tolerance to gut flora. If this analysis is correct, then Pacific 
Islands are currently at no greater risk of emerging disease epidemics than 
other developing countries despite their dark history.
436
PLASMA AND MEMORY B CELL RESPONSES TARGETING 
O-SPECIFIC POLYSACCHARIDE (OSP) ARE ASSOCIATED WITH 
PROTECTION AGAINST VIBRIO CHOLERAE O1 INFECTION 
AMONG HOUSEHOLD CONTACTS OF CHOLERA PATIENTS IN 
BANGLADESH
Amena Aktar1, M. Arifur Rahman1, Sadia Afrin1, Aklima Akter1, 
Taher Uddin1, Md. Israk Nur Sami1, Tahirah Yasmin1, Pinki Dash1, 
Rownok Jahan1, Fahima Chowdhury1, Ashraful I. Khan1, Daniel 
T. Leung2, Regina C. LaRocque2, Richelle C. Charles2, Tafiqur R. 
Bhuiyan1, Anjali Mandlik2, Meagan Kelly2, Pavol Kováč3, Peng Xu3, 
Stephen B. Calderwood2, Jason B. Harris2, Firdausi Qadri1, Edward 
T. Ryan2
1International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, 
Bangladesh, 2Massachusetts General Hospital, Boston, MA, United 
States, 3National Institute of Diabetes and Digestive and Kidney Diseases, 
Bethesda, MD, United States
Vibrio cholerae is a noninvasive intestinal pathogen, and the cause 
of cholera, a severe dehydrating illness in humans. The mediators 
of protection against cholera are currently unknown. However, we 
have previously shown that IgG memory B cell responses targeting 
lipopolysaccharide (LPS) of V. cholerae O1 correlate with protection 
against V. cholerae O1 infection among household contacts of cholera 
patients. Protection against cholera is serogroup specific, and serogroup 
specificity is defined by the O-specific polysaccharide (OSP) component of 
LPS. Therefore, we prospectively followed household contacts of cholera 
patients to determine whether OSP-specific immune responses present at 
the time of enrollment are associated with protection against V. cholerae 
infection over a 30 day period. Two hundred forty two household contacts 
of 150 index patients with cholera were enrolled. The presence of OSP-
specific IgG memory B cell responses in peripheral blood on study entry 
was associated with a decrease in the risk of infection in household 
contacts (43% reduction; p = 0.048). No protection was associated 
with cholera toxin B subunit (CtxB)-specific memory B cell responses. In 
addition, the presence of OSP-specific plasma IgA, IgM, and IgG antibody 
responses on study entry was also associated with protection among 
household contacts. These results suggest that immune responses that 
target OSP, both in plasma and memory responses, may be important in 
mediating protection against infection with V. cholerae O1.
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ROTAVIRUS VACCINE TAKES SEASONAL SIGNATURE OF 
CHILDHOOD DIARRHEA BACK TO PRE-SANITATION ERA IN 
BRAZIL (AND THAT IS A GOOD THING!)
Julia M. Baker1, Wladimir J. Alonso2
1Emory University, Rollins School of Public Health, Atlanta, GA, United 
States, 2National Institutes of Health, Fogarty International Center, 
Bethesda, MD, United States
Diarrhea mortality and morbidity have not only declined substantially 
in developing nations, but also switched from a summer-bacterial to a 
predominantly winter-viral seasonal pattern. However, little is known 
about the effect of the rotavirus vaccine introduction on seasonal 
patterns of diarrheal disease. Here we examined the long-term evolution 
of diarrheal morbidity and mortality risks across age and geography in 
Brazil, including the effect of rotavirus immunization (introduced in 2006) 
and other development indicators. Nationwide mortality (1979 - 2013) 
and hospitalization (1998 - 2013) data were obtained from the Brazilian 
Ministry of Health. Secular trends and seasonality were inspected for each 
Brazilian state and age group using the software Epipoi. For most states, 
the primary peak in mortality risk among children under 5 years occurred 
from December to April (summer/early autumn) from 1979 - 1988, then 
switched to the period between June and October (winter) by 2000 - 2005 
(just prior to the 2006 implementation of the rotavirus vaccine for children 
under 1), and next shifted back to summer/early autumn by 2007 - 2013. 
A similar pattern was observed for hospitalizations. In contrast, the risk 
of diarrhea-related death among older children (5 to 19 years) and adults 
(≥ 20 years) did not have a well-defined seasonality or spatial pattern 
until 2007, when a trend towards summer/autumn peaks of mortality 
was observable. Hospitalizations for these age groups tended to peak 
in summer/early autumn throughout the period. Rotavirus vaccination 
policies were not only associated with a change in the risk of death, but 
also with a shift in the timing of peaks in risk in children under 5 years, 
which is reminiscent of the summer-diarrhea period. Additionally, young 
children were shown to have distinct annual disease patterns compared to 
other age groups, suggesting a different etiology of disease.
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REACTIVE VACCINATION IN NSANJE, MALAWI USING AN 
ORAL CHOLERA VACCINE
Hyejin Seo, Malawi Ministry of Health, World Health 
Organization, Geneva, John Snow Inc., Nsanje District Health 
Office
International Vaccine Institute, Seoul, Republic of Korea
Malawi experiences regular cholera outbreaks, particularly in the 
southernmost district of Nsanje (population: 292,083 people) where 
Lake Malawi drains, causing frequent inundations. Flooding occurred in 
January 2015 and the President of the Republic of Malawi declared a state 
of disaster. One month later the first cholera case was reported, marking 
the beginning of an outbreak, during which Nsanje was one of the most 
heavily affected districts. At that time, the International Vaccine Institute 
(IVI) had planned to conduct a preemptive oral cholera vaccination (OCV) 
campaign in Nsanje in collaboration with the Malawi Ministry of Health 
(MOH), targeting 50,000 people with a two-dose regimen of Shancol® 
(Shanta Biotechnics, Hyderabad, India). As the outbreak began to spread, 
the Malawian MOH addressed the International Coordinating Group (ICG) 
and requested additional cholera vaccine doses from the WHO emergency 
OCV global stockpile to equip a public health response. IVI-procured 
vaccines were repurposed for this activity. A multi-organizational task 
force was put in place to plan and deliver cholera vaccination. 160,482 
people including 70,000 internally displaced people were targeted for 
vaccination; overall 156,592 (97.6%) received the first dose, of which 
108,440 (67.6%) received both scheduled doses. Here we report on the 
experiences in planning the activities, the outcome and lessons learnt 
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of the vaccination campaign as well as a comparison of this outbreak 
response to other reactive oral cholera vaccine (OCV) campaigns in sub-
Saharan Africa conducted to date.
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HUMAN IMMUNE RESPONSES AGAINST ENTEROTOXIGENIC 
ESCHERICHIA COLI (ETEC) YGHJ MUCINASE, A PROMISING 
NEW ETEC VACCINE ANTIGEN
Kurt Hanevik, Halvor Sommerfelt, Hans Steinsland
University of Bergen, Bergen, Norway
The human enterotoxigenic Escherichia coli (ETEC) vaccine development 
effort has mainly been focused on inducing protective immunity by 
immunization with the ETEC colonization factor (CF) and heat-labile 
toxin antigens. But the main contributors to childhood ETEC diarrhea 
are heat-stable toxin-producing ETEC strains, of which about one third 
lack any known CFs. Identifying additional broad-coverage ETEC vaccine 
antigens is therefore important. YghJ, a chromosomally encoded mucinase 
common to most E. coli, and present in close to 100% of all ETEC, is a 
promising alternative. YghJ helps ETEC reach the small intestinal cell wall 
by breaking down the protective mucus barrier, and ETEC seem to secrete 
substantially more YghJ than other E. coli. We aim to describe immune 
responses to YghJ in human volunteers who have been experimentally 
infected with wild-type ETEC strains. Saliva, serum and intestinal lavage 
were obtained from adult human volunteers before (d0) and 10 days after 
(d10) experimental infection with wild-type strains TW10598 (O6:H16, 
CS2, CS3, CS21, STh, LT; 30 volunteers) and TW10722 (O11 5:H5, CS5, 
CS6, STh; 9 volunteers). T-cell responses were measured by flow cytometry 
gating for activated CD4 T cells expressing CD25 and CD134 after 2 days 
culture with YghJ. Antibody responses were measured by immunoassays 
where beads had been coated with purified recombinant YghJ. In 
preliminary analyses we found serum IgA antibody responses towards 
YghJ increasing significantly from d0 to d10; mean fluorescence 2625 
to 14187, p=0.043, while IgG responses did not increase significantly. T 
cell responses increased significantly from 0.73 to 1.37 percent activated 
YghJ-specific CD4 T cells out of all CD4 T cells, p=0.008. In general there 
was higher background to YghJ than to more distinct ETEC proteins like 
the CS5 colonization factor, suggesting previous exposures to this protein. 
We have found that human volunteers experimentally infected with ETEC 
induce an anti-YghJ IgA antibody response, as well as T-cell responses. 
Further investigation into YghJ responses in saliva and intestinal lavage 
fluids are ongoing and results will be presented.
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OBSERVATIONS ON THE NATURAL HISTORY OF CYSTIC 
ECHINOCOCCOSIS IN UNTREATED AND ALBENDAZOLE-
TREATED PATIENTS
Nadia Solomon1, Eberhard Zeyhle2, Malika Kachani3, Calum N. 
Macpherson1
1Windward Islands Research and Education Foundation (WINDREF) and St. 
George’s University, True Blue, Grenada, 2African Medical and Research 
Foundation (Amref Health Africa), Nairobi, Kenya, 3Western University of 
Health Sciences, Pomona, CA, United States
The natural history of cystic echinococcosis (CE), a complex, neglected, and 
arcane zoonotic disease with a global distribution, is still being elucidated. 
This study examined the natural history and albendazole-induced changes 
of CE, and whether the standardized WHO ultrasound (US) classification 
reflects these changes. Patient data were collected during mass US 
screening surveys in endemic regions amongst transhumant populations, 
the Turkana of Kenya, and the Berber of the Mid-Atlas Mountain region of 
Morocco. Cysts were categorized using the WHO US classification (CL, and 
CE1 to CE5). Patient records occurring prior to the receipt of treatment, 
and after the administration of albendazole, were selected. 852 paired 
before/after observations of 360 cysts (10 CL, 140 CE1, 7 CE2A, 14 CE2B, 
5 CE3A, 144 CE3B, 38 CE4, 2 CE5) from 257 patients (241 Turkana, 16 
Berber) who went untreated for up to 9789 days (mean 600 days, median 
215 days) were analyzed using a McNemar-Bowker χ2 test for symmetry, 
which achieved significance (p < .0005). Next expected observations 
of cyst type exhibited no instances of regression to earlier types, only 
progression. A McNemar-Bowker χ2 test of 1414 paired before/after 
observations of 288 cysts (93 CE1, 6 CE2A, 6 CE2B, 5 CE3A, 158 CE3B, 
19 CE4, 1 CE5) from 157 Turkana patients treated with albendazole 
also achieved significance (p < .0005). Regression from the CE4 to CE3B 
type occurred in a small percentage (2.05%) of these observations. The 
significant finding of asymmetry for the McNemar-Bowker test and the 
absence of instances of cyst regression for the natural history group re-
affirms that the standardized WHO US classification is reflective of the 
natural history of CE, and more reflective of the natural history of CE than 
earlier classifications. Similarly, the significant McNemar-Bowker test for 
the albendazole-treated group demonstrates that the WHO classification 
also reflects the albendazole-induced changes in cysts. The regression of 
CE4 to CE3B in a few of the albendazole-treated cysts may reflect the 
stability of the CE3B cyst type.
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G1 STRAIN OF ECHINOCOCCUS GRANULOSUS IN SUDANESE 
PATIENTS: A THREATENING ALARM
Rihab A. Omer1, Mohamed Sir Alkhatim2, Ibrahim Elhag3, 
Abdelmonem Elhag3, Denis Debbi4, Marion Wasserman4, Thomas 
Romig4, Peter Kern5, Suzan Alhakeem6
1Central Veterinary Research Laboratories, Khartoum, Sudan, 2National 
University Research Institute (NURI), Khartoum, Sudan, 3Faculty of Health, 
University of Gezira, Wad Medani, Sudan, 4Institute of Parasitology, 
University of Hohenheim, Stuttgart, Germany, 5Faculty of Medicine, 
University of Ulm, Ulm, Germany, 6ibn Sinaa Teaching Hospital, Khartoum, 
Sudan
Cystic echinococcosis is a zoonosis caused by the cestodes Echinococcus 
spp. Its life cycle involves dogs and other canids as definitive hosts for the 
intestinal tapeworm, as well as domestic and wild ungulates including 
human as intermediate hosts for the tissue -invading metacestode (larval) 
stage. It was previously suggested that few data are available on the 
frequency of CE in humans in Sudan compared with published data on 
animal cystic echinococcosis. Few recent reports mentioned a prevalence 
of about 0.33% in central Sudan and sporadic cases in different areas in 
the Sudan. Recently, cystic echinococcosis is having an increased attention 
in Sudan as it is now more frequent having patients suffering from either 
respiratory or abdominal symptoms found to be associated with the 
presence of cyst or cysts in a vital organ associated with either of these 
systems. This emerging situation necessities studying the factors which 
have an impact on the increasing frequency of such an important disease 
in a country like Sudan suffering from tribal un restless and poverty. One 
of these factors was thought to be that 100% of cyst material obtained 
from human were genetically identified as Echinococcus canadensis G6. 
The infectivity of this taxon for humans was in doubt for many years, and 
even today the number of confirmed human cases is small and scattered 
all over the world and that was considered as the main reason of having 
a rather rare disease in Sudan despite all epidemiological conditions for 
autochthonous transmission of CE. From the other hand, E. granulosus 
G1 which is highly prevalent in regions known to be endemic for the 
disease was thought to be extremely rare in most of Sudan, as there was 
only one record from a dog in the central part of the country. However 
characterization of genetic materials recently obtained from human 
patients showed that this strain is present in human. A situation alarming 
the need of further studies to investigate to what extent is it present, 
population at risk and preventive measure. Hence this study represents the 
first study confirming the presence of G1 in patients in Sudan, knocking 
an alarm and discussing a preventive policy.
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CDNA LIBRARY FROM TAENIA SOLIUM RACEMOSE 
CYST: A NOVEL TOOL FOR TRANSCRIPTOMICS IN 
NEUROCYSTICERCOSIS
Jaeson S. Calla-Choque1, Miguel A. Orrego1, Pamela L. Pacheco-
Rivera1, Javier A. Bustos2, Hector H. Garcia1, Siddhartha Mahanty3, 
Theodore Nash3, Cristina Guerra-Giraldez1, Cysticercosis Working 
Group in Peru
1Cayetano Heredia University, Lima, Peru, 2Instituto Nacional de Ciencias 
Neurológicas Santo Toribio de Mogrovejo, Lima, Peru, 3National Institutes 
of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, 
MD, United States
Human neurocysticercosis (NCC), caused by the larval stage or cysts of 
the flatworm Taenia solium, is the most frequent parasitic disease of 
the brain in humans and is endemic in many developing countries. The 
murine model of NCC using T. crassiceps has advanced our understanding 
of immunopathology. However most molecular mechanisms involved 
in the host-pathogen interaction remain unknown. The best studied 
form of NCC is parenchymal disease in which cysts are lodged in the 
parenchymal tissue. Cysts that develop in subarachnoid spaces can grow 
into very large multivesicular structures commonly named “racemose 
cysts”, which appear to differ in many characteristics from parenchymal 
cysts, with an aggressive course of infection that is difficult to treat, and 
has a high mortality rate. Investigation of T. solium at the molecular level 
is limited to detection and identification; a characterization of genes 
involved in regulation of growth, proliferation, and virulence has not been 
undertaken to date. The identification of the genes involved in survival and 
proliferation of racemose parasites would advance our understanding of 
this aberrant and malignant form of the disease. To this end, we isolated 
total RNA from a human T. solium racemose cyst, obtained at surgery, 
synthesized cDNA, generated double strand cDNA (ds cDNA) by long 
distance PCR, purified the ds cDNA using CHROMA SPIN columns, and 
cloned it into pSMART2IFD (In-Fusion, Clontech). Electrocompetent E. 
coli TG1 cells were transformed with these plasmids and a cDNA library 
was generated successfully. This library, the first generated from a T. 
solium racemose cyst, will allow systematic studies of the development 
and biology of the parasite and will aid in the search for novel targets for 
diagnostic and anthelmintic drugs. Our immediate aim is amplification 
and sequencing of full-length cDNA fragments by long distance PCR for 
cloning and identification of genes with significant roles in proliferation 
and cyst growth, and to determine their role in the development of 
the racemose parasite. This cDNA library promises to serve as a tool for 
detailed studies of the biology of T. solium.
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RISK FACTORS FOR REFRACTORY EPILEPSY DEVELOPMENT 
IN NEUROCYSTICERCOSIS
Jesica A. Herrick1, Anjali Garg1, Javier Bustos2, Hector H. Garcia2, 
Jeffrey A. Loeb1, Cysticercosis Working Group in Peru
1University of Illinois at Chicago, Chicago, IL, United States, 2Instituto 
Nacional de Ciencias Neurologicas and Universidad Peruana Cayetano 
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Epilepsy is a major public health problem linked to increased mortality. 
The helminth infection Neurocysticercosis (NCC) is the number one cause 
of adult epilepsy worldwide; 70-80% of people with NCC experience 
seizures that can develop into treatment-refractory epilepsy (TRE). Early 
intervention before recurrent seizures establish abnormal electrical circuits 
in the brain could impact disease progression, but in order to do so 
predictors of TRE in NCC patients need to be identified. To identify such 
predictors, we conducted a retrospective review of 39 randomly selected 
subjects from a large clinical trial of patients with NCC and seizures. These 
subjects presented a mean of 14.9 months following their first seizure 
(SD, 64.3 months), most commonly had partial seizures (29/39 subjects, 
74%), and had a mean of 3.3 viable or degenerating lesions due to NCC 
(range 1-21, SD 6.6). Eleven subjects went on to develop TRE (defined 
as seizures > 2 months after treatment for NCC despite anticonvulsant 
therapy) and 28 did not. We examined a number of clinical factors in these 
patients in order to identify variables associated with TRE. The primary risk 
factor identified was a strong and sustained inflammatory response to the 
parasite. This was demonstrated by a significantly increased number of 
bands seen on the initial NCC western blot in subjects who developed TRE 
(GM 5.8 bands) compared to those who did not (GM 3.8 bands, p<.05). 
As further evidence that ongoing brain inflammation is associated with 
epilepsy risk there was an increased (though not statistically significant) 
percentage of subjects with continued edema on follow-up imaging 6-12 
months following treatment in those with TRE (2/6, 33%) compared to 
those without (2/18, 11%, p=.6); the total volume of edema at follow-
up was also increased in those who developed epilepsy (22.7 cm3) 
compared to those who did not (1.8 cm3, p=.2). These findings provide a 
compelling rationale for further exploring signs and symptoms of ongoing 
inflammation as predictors of epilepsy development in NCC patients; this 
knowledge could aid in the development of targeted antiepileptogenic 
treatments.
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Taenia hydatigena is a non-zoonotic tapeworm transmitted between dogs, 
and ruminants or pigs. While T. hydatigena does not cause clinical signs 
in pigs, its presence impacts the validity of serological tests used for the 
diagnosis of current porcine T. solium infection through cross-reactions. 
Estimating T. hydatigena prevalence is crucial to validly interpreting 
T. solium serological results. The only five studies published in Africa, 
including 888 pigs, reported prevalences from 1.4 to 6.6%. We performed 
a cross-sectional study in Koudougou, Burkina Faso, to estimate the 
prevalence of T. hydatigena in slaughtered pigs. Pigs came from nearby 
villages practicing traditional breeding with free roaming. Over 35 days, 
452 pigs were carefully inspected post-mortem for the presence of 
abdominal T. hydatigena cysticerci including the liver. In addition, meat 
inspectors routinely inspected the carcasses for T. solium cysticerci and 
blood samples were taken for B158/B60 Ag-ELISA examination. Cysticerci 
were stored in ethanol for molecular analysis by PCR-RFLP. T. hydatigena 
cysticerci were found in liver, abdomen and both in 27, 12 and one pigs, 
respectively. Meat inspectors found seven carcasses infected with T. solium 
cysticerci; molecular analysis confirmed six of these, one was identified as 
T. hydatigena. Seven cysts found in the liver were molecularly identified 
as T. solium. Overall, 41 carcasses (9.1%) were found infected with T. 
hydatigena and 14 (3.1%) with T. solium; two pigs were infected with 
both Taenia spp. 219 pigs (48.5%) were positive to the Ag-ELISA of which 
23/41 (56%) and 9/14 (64%) were of pigs with T. hydatigena and T. 
solium cysts, respectively. The relatively high prevalence of T. hydatigena in 
this study suggests that estimates of current T. solium infection prevalence 
should be adjusted for the presence of T. hydatigena. Adjustment values 
can be estimated through post-mortem examination. T. solium prevalence 
derived from meat inspection is invalid as routine meat inspection has 
a low sensitivity, and pigs with tongue cysts are mostly diverted to the 
unofficial slaughter circuit.
139
astmh.org
445
EFFICACY OF A SINGLE-DOSE OF OXFENDAZOLE AT THREE 
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Oxfendazole (OFZ) is the drug of choice against porcine cysticercosis. 
This drug is commercialized as a broad-spectrum antiparasitic for farm 
animals. However, its high cost limits its use by many health programs 
in low-income countries, so local formulations of OFZ could be an 
alternative for its implementation This study evaluated the efficacy of 
three different formulations of OFZ against porcine cysticercosis in a 
randomized controlled trial. Twenty-eight pigs naturally infected pigs with 
Taenia solium cysts were distributed in the following treatments: OFZ in 
a commercial formulation (Synanthic 9.06% Fort Dodge®, Mexico), OFZ 
in two experimental formulations (22.5% and 10.9%) and an untreated 
group. Experimental formulations were prepared in the Laboratory of 
Pharmacology at the National University of San Marcos University in Lima, 
Peru using OFZ p.a (Spectrum Laboratory Products Inc, Gardena, CA). OFZ 
was given to pigs at a single oral dose of 30 mg/kg under experimental 
conditions. Necropsies were performed at day 60 post-treatment and 
the carcasses were examined for the presence of cysts in muscle samples 
and brains. OFZ efficacy against cysts in muscle was 100% for the three 
treatment groups (viable cysts were not observed) compared to the 
untreated group (p<0.001). OFZ efficacy in brain was variable and non-
statistical differences in the proportion of pigs with viable cysts in brains 
among treatments were observed. Although some differences in the 
plasmatic maximum concentration and the time to peak concentration 
in plasma after oral administration of OFZ at 30mg/kg in pigs were 
reported previously using the same formulations, we found no differences 
in the efficacy among the tested OFZ formulations. Since pigs are is a 
vital component in the transmission chain of T. solium, a cost-effective 
treatment in endemic areas should greatly help to eliminate the source 
of infection in humans. From a practical point of view, our results provide 
evidence that local formulation of OFZ at high concentrations (thus 
requiring lower volumes to be given to pigs) can be cheaper and efficient 
alternatives for use in the control of T. solium/cysticercosis.
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Neurocysticercosis (NCC) causes substantial neurologic morbidity in 
endemic regions around the world. Ring strategy for control involves 
focusing treatment resources for taeniasis and porcine cysticercosis within 
clusters (rings) of households surrounding a heavily-infected pig. This 
strategy is based on the assumption that risk of parasite transmission is 
greatest within the rings. At the end of a community trial of ring strategy 
in northern Peru, we offered neurologic screening to all participants 
who resided within an identified ring. Our objective was to describe the 
prevalence of NCC and epilepsy in these rings. We offered screening to 
576 ring residents by applying a 9 question seizure survey. Our study 
physician evaluated positive respondents to confirm the diagnosis using 
International League Against Epilepsy criteria. Those with confirmed 
epilepsy were offered a non-contrast CT of the head. We also tested 
sera using EITB LLGP to detect anti-cysticercus antibodies and ELISA B60/
B158 to detect cysticercosis antigens. Those with strongly positive ELISA 
(ODR>=3) were offered a non-contrast MRI of the brain. 527 people 
completed seizure screening and 114 (21.6%) were positive. The physician 
evaluated 108, of which 35 had confirmed seizures and 16 had epilepsy 
(lifetime prevalence 30 per 1000). 12 with epilepsy accepted CT scan 
and 5 (41.7%) had parenchymal calcifications. None had viable cysts. Of 
the 514 that provided a blood sample, 241 (46.9%) were seropositive 
by EITB, 39 (7.6%) were positive by ELISA, and 12 (2.9%) were strongly 
positive by ELISA. 11 accepted MRI and 8 (72.3%) had NCC, including 5 
with subarachnoid cysts, 5 with parenchymal vesicular cysts and 2 with 
parenchymal granulomas. Epilepsy and NCC are common among ring 
residents although it is unclear whether the risk is greater than in the 
general population as no controls were evaluated in this study. The high 
positive predictive value of ELISA in this population suggests a potential 
role for antigen screening of blood or urine to allow early detection and 
intervention of people with NCC, particularly those with subarachnoid 
cysts, the most malignant presentation.
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DECREASED ACADEMIC PERFORMANCE ASSOCIATED WITH 
BRAIN INFECTION IN SCHOOL AGED CHILDREN, SOUTHWEST 
CHINA
John J. Openshaw1, Alexis Medina1, Stephen A. Felt1, Tiaoying 
Li2, Zhou Huan3, Scott Rozelle1, Stephen P. Luby1
1Stanford University, Stanford, CA, United States, 2Sichuan Centers for 
Disease Control and Prevention, Chengdu, Sichuan, China, 3West China 
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Neurocysticercosis (NCC) is caused by larval forms of the pig tapeworm, 
Taenia solium, invading the brain and has been shown to cause cognitive 
deficits in adults. We characterized T. solium exposure as well as NCC 
burden and resulting cognitive deficits in school-aged children living in 
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southwest China. We surveyed 3,038 students aged 10- 15 years in poor 
areas of southwest China, characterizing exposure history, collecting blood 
for T. solium serologic testing by ELISA, and administering a standardized 
math test. We characterized children as probable NCC cases if they had 
positive serologic testing and reported serious neurologic symptoms 
(seizures or recurrent headaches or weakness). We randomly selected 
a subset of students representing all possible combinations of serologic 
results and presence or absence of neurologic symptoms for in- depth 
testing that included brain MRIs and additional cognitive testing. 6% of 
children (175/2867) had positive serologies demonstrating exposure to T. 
solium, with some counties having prevalences higher than 15%. 15% 
(459/2953) of children reported consumption of undercooked pork in the 
month prior to the survey and 25% (761/3027) reported seeing encysted 
parasites in their meat in the past year. 14% (408/2781) reported being 
treated with a deworming medication within the past year. Children 
reported seizures (93 cases, 3%), severe headaches (>6 headaches per 
month, 241 cases, 8%), and recurrent extremity weakness (>6 episodes 
per month, 59 cases, 2%). 2% of children (65/2867) met criteria as 
probable NCC cases. Children classified as probable NCC cases had 
significantly lower math scores compared to their uninfected classmates 
(average score difference of 0.65 standard deviations, p=0.02). MRI scans 
on a subset of students revealed evidence of T. solium brain involvement in 
9% (6/63). Our results suggest that T. solium infection and NCC are wide 
spread in school-aged children in southwest China. Children with NCC 
underperform academically and this may contribute to a cycle of poverty. 
Our results suggest the need for T. solium eradication efforts to decrease 
disease burden in school-aged children.
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Taeniasis is an important parasitic infection as the immediate cause of 
neurocysticercosis (NCC). Mass drug administration with niclosamide 
(NSM) is one strategy to control the disease. NSM is reported to be 90-
95% efficacious against taeniasis and is considered safe for use in endemic 
regions given that it is minimally absorbed and therefore poses no risk 
to individuals with NCC. However, there is little published information 
regarding treatment efficacy and adverse events of NSM when used in 
endemic community settings. We evaluated the efficacy and adverse 
events of NSM during a large-scale cysticercosis elimination demonstration 
program in Tumbes, Peru, in which we offered three rounds of mass 
treatment with oral NSM, at 4 month intervals, to 79,191 rural residents 
older than 2 years of age. We collected post-treatment stools after the 
first round of NSM to diagnose taeniasis using coproantigen ELISA, and 
collected an additional stool sample at 30 days for those with taeniasis to 
evaluate treatment efficacy. We visited all participants in their homes to 
collect information about adverse treatment events. At total of 158,201 
doses were administered across all 3 rounds with 68,751 (86.8%) people 
receiving at least one dose. Of the 45,391 people who provided a post-
treatment stool sample, 235 had taeniasis. 210 provided a follow-up 
stool sample and 59 had evidence of persistent infection after 30 days, 
representing a treatment efficacy of 71.90% (151/210). The prevalence of 
adverse events related to ingestion of NSM was 0.90% (1418/158,201), of 
which 98.73% (1400/1418) were of mild intensity. There were no severe 
adverse events. Abdominal pain was the most frequently reported adverse 
event (571/1418; 40.27%). Adverse events were more common among 
females [PR=2.33; 95% CI 2.06-2.65] and among those that received NSM 
in more than one treatment round [2 doses PR 1.18; 95% CI 0.97-1.44; 
3 doses PR 1.46; 95% CI 1.27-1.67). NSM is a safe drug for use in mass 
drug administration although the treatment efficacy is substantially less 
than previously reported which may reduce control effect.
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OF CYSTS ON EPILEPTOGENESIS USING INTERACTIVE 3D 
MODELS
Michelle Lamont, Jesica Herrick, Kevin Brennan, Leah Lebowicz
University of Illinois at Chicago, Chicago, IL, United States
Neurocysticercosis (NCC) is a preventable, disabling disease that affects 
approximately 50 million people worldwide; it is in critical need of 
research, medical education and increased global awareness and has been 
classified as a neglected tropical disease by the World Health Organization. 
A person contracts NCC by ingesting eggs from Taenia solium, a parasitic 
tapeworm. The eggs migrate through the body tissues into the brain 
where they develop into cysts. Eventually, these cysts can trigger a massive 
inflammatory response in the host and debilitating symptoms emerge 
such as seizures and the development of epilepsy. Seizures are the most 
common symptom associated with NCC, occurring in 70-80% of infected 
individuals, and NCC is the most common cause of adult acquired 
epilepsy in the world. This research investigates whether 3D modeling 
and interactive visualization aid researchers in comparing the neural cysts 
of patients with NCC to better understand why some infected individuals 
develop chronic epilepsy while others suffer from isolated seizures or do 
not seize at all. Patient data was segmented out to create interactive 3D 
models, which were embedded in a user interface. Emphasis was placed 
on the location and stage of cysts and surrounding edema. Patient EEG 
data was represented in the 3D models to visualize which parts of the 
brain are involved in seizure activity. The final application was embedded 
in a globally accessible web based user interface. The user can rotate the 
models in 3 dimensions, control the transparency and visibility of the EEG 
data, and view patient lesions on a generalized brain to account for the 
high variability of neuroanatomy between individuals. This project helps 
researchers explore the relationship between cyst location, stage, and 
number and the development of seizures or chronic epilepsy. This project 
uses biomedical visualization to enable research on NCC and epilepsy 
through the creation of a multimodal interactive. It demonstrates the 
critical role of biocommunciation in shaping medical research, clinical 
decisions, and patient outcomes through visual translation of clinical data.
141
astmh.org
450
EPIDEMIOLOGIC CHARACTERIZATION OF HYMENOLEPIS 
NANA INFECTION IN CHILDREN AGED 2 TO 15 YEARS OLD 
ON THE NORTH COAST OF PERU
Percy Vilchez1, Ricardo Gamboa1, Claudio Muro1, Victor 
Benavides1, Saul Santivanez2, Seth E. ONeal3, Andres G. Lescano4, 
Luz Maria Moyano1, Guillermo E. Gonzalvez5, Armando E. 
Gonzalez6, Robert Gilman7, Victor C.W. Tsang8, Hector H. Garcia9, 
for The Cysticercosis Working Group in Peru2
1Center for Global Health - Tumbes, Universidad Peruana Cayetano 
Heredia, Tumbes, Peru, 2Universidad Peruana Cayetano Heredia, Lima, 
Peru, 3School of Public Health, Oregon Health & Sciences University and 
Portland State University, Portland, OR, United States, 4Facultad de Salud 
Publica y Administracion, Universidad Peruana Cayetano Heredia, Lima, 
Peru, 5Enfermedades Transmisibles y Analisis de Salud, Organizacion 
Panamericana de la Salud, Managua, Nicaragua, 6School of Veterinary 
Medicine, Universidad Nacional Mayor de San Marcos, Lima, Peru, 
7Bloomberg School of Public Health, Johns Hopkins University, Baltimore, 
MD, United States, 8Georgia State University, Atlanta, GA, United States, 
9Department of Microbiology, School of Sciences, Universidad Peruana 
Cayetano Heredia, Lima, Peru
Hymenolepis nana is among the most common intestinal parasites 
and an important public health disease in impoverished areas given 
it’s morbidity in children and ease of transmission. Understanding the 
risk factors for transmission in endemic regions may guide strategies to 
reduce the burden of infection. We conducted a cross-sectional secondary 
analysis of data collected during a large community-based study of 107 
villages (73,161 people) in Tumbes, Peru, to evaluate risk factors for H. 
nana infection among children. Of the 20,249 eligible residents based 
on age (2-15 years old), 14,671 provided a single stool sample that was 
analyzed by sedimentation and microscopy for the presence of H. nana 
eggs. We used binomial family generalized linear models with log link 
to calculate crude and adjusted prevalence ratios of sociodemographic 
factors that may influence infection risk. The crude overall prevalence 
of H. nana infection was 7.61% (1124/14,761), and was slightly higher 
among males (8.59%; 95% CI 7.95-9.22) than among females (6.65%; 
95% CI 6.08-7.21). In the multivariable model, the prevalence of H. nana 
infection increased 8% (adjusted prevalence ratio, aPR 1.08, 95% CI 1.06-
1.09) with each additional year of age, was 30% higher among females 
than males (aPR 1.30, 95% CI 1.16-1.46), and 27% lower among rural 
dwellers compared to urban dwellers (aPR 0.73, 95% CI 0.64-0.84), after 
controlling for household clustering and other variables. Water source, 
particularly in-ground storage tanks filled by water truck, also increased 
the risk compared to piped water (PR 2.70, 95% CI 2.34-3.11), as did the 
lack of latrine (PR 2.00 95% CI 1.73-2.33). H. nana infection is a relatively 
common intestinal infection in northern Peru. Improvements to water and 
sanitation infrastructure may help reduce the burden of this and other 
intestinal infection in the region.
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Taenia solium has two stages, the adult tapeworm in the human 
intestine (Taeniasis) and the larval cyst in humans and pigs (cysticercosis). 
Praziquantel (PZQ) is considered the first line treatment for taeniasis, 
although there are concerns for potential adverse effects in people with 
neurocysticercosis (NCC) with viable cysts. Niclosamide is a safe alternative 
although its availability is limited. The objective of this study was to 
assess the efficacy of PZQ for intestinal taeniasis in an area endemic 
for Taenia solium at the usual single oral doses of 5 mg/kg or 10mg/kg 
(maximum dose 900 mg) under controlled conditions to ensure the safety 
of participants. Taeniasis was prospectively identified from the endemic 
region of Piura, Peru, in a series of mass stool screening interventions 
between 2011-2013. People with taeniasis 12-65 years old were eligible 
for participation and underwent a battery of screening tests to rule out 
NCC before treatment, including a) non-contrast brain CT scan to identify 
viable cysts, b) EITB for cysticercosis antibodies and c) cysticercosis antigen 
detection. Participants with viable cysts on CT or those with positive 
circulating antigen received niclosamide as an alternative to PZQ. The 
remaining cases received a single oral dose of PZQ at either 5 mg/kg or 10 
mg/kg, with stool samples collected 30 days post treatment to evaluate 
cure. Of the 67 age-eligible cases, 10 refused treatment, 14 (21%) were 
given NSM because of positive antigen results. CT scan demonstrated 30 
patients (44.7%) with parenchymal calcifications and apparently none 
with viable cysts. Of the remaining 43 participants with taeniasis, 33 
(76.7%) received 5 mg/kg PZQ and 10 received 10 mg/kg of PZQ. Rates of 
cure as assessed in those who provided a 30-day follow-up stool sample 
were 26/29 (89.6%) for the 5 mg group and 10/10 (100%) for the 10 mg 
group. In conclusion, PZQ at 5 or 10 mg/kg was highly effective to treat T. 
solium taeniasis with few side effects in this selected subgroup of patients 
with no viable cysts on CT and negative circulating antigen.
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Taenia solium is a parasite that is the leading cause of preventable epilepsy 
in the developing world. Taenia eggs are released into the environment 
through the stool of humans infected with an adult intestinal tapeworm 
(taeniasis), and cause cysticercosis when ingested by pigs or other humans. 
Ring strategies for the control of T. solium operate by screening and/or 
treating human for taeniasis if they live near pigs heavily infected with T. 
solium cysts. Traditionally, these heavily infected pigs have been diagnosed 
by examining the tongues of pigs for cysts, but higher sensitivity methods, 
such as improved serologic testing or ultrasonographic imaging, are 
needed in order to advance current control efforts. These tests require 
that we define thresholds of heavy infection that will perform best in 
the context of ring strategies. For this study, we performed necroscopic 
examination to determine the total body burden of viable T. solium cysts in 
pigs purchased from eight villages as part of a concurrent prospective ring 
intervention. Human stool was collected and processed for the presence of 
Taenia sp. coproantigen indicative of active taeniasis, and the geographic 
coordinates for each household were recorded. We assessed the 
prevalence of taeniasis inside rings of 50 and 100 meters around pigs of 
different cyst burdens in order to determine the rings that best indicated 
high-risk geographic foci for taeniasis. Of 152 seropositive pigs necropsied, 
12 (8%) had ≥ 100 viable cysts, 9 (6%) had 10-99 cysts, and 27 (18%) 
had 1-9 cysts. There were 33 cases of taeniasis among all 1,323 people 
tested for a prevalence of 2.4%. Pigs with ≥100 cysts were significant 
indicators of local taeniasis when assessed at a distance of 50 meters 
(PR=2.74; 95% CI: 1.09, 6.91), but did not show an effect at greater 
distances. Pigs with fewer than 100 cysts did not significantly predict 
for local increases in the prevalence of taeniasis. The results of this study 
indicate that tests intended to diagnose heavily infected pigs should aim 
to detect pigs with at least 100 cysts. Lower detection limits are unlikely to 
yield additional cases of taeniasis in the context of ring interventions.
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PATHOGENESIS OF SEIZURES IN NEUROCYSTICERCOSIS: 
FROM CYSTICERCOTIC LESIONS TO SEIZURE SEMIOLOGY
Kevin R. Duque1, Javier A. Bustos1, Isidro Gonzales2, Javier 
Pretell3, Hector H. Garcia1, for The Cysticercosis Working Group in 
Peru
1Center of Global Health - Tumbes, Universidad Peruana Cayetano Heredia, 
Lima, Peru, 2Cysticercosis Unit, National Institute of Neurological Sciences, 
Lima, Peru, 3Hospital Nacional Alberto Sabogal, Essalud, Callao, Peru
Neurocysticercosis (NCC) is the most common parasitic infection of the 
central nervous system and constitutes a major health problem. The 
aim of this study is to determine the concordance between semiologic 
manifestations and lesion topography in patients with NCC and seizures. 
In this retrospective cohort analysis patients with one or two NCC lesions 
in any stage were selected from participants in three randomized clinical 
trials of antiparasitic treatment. Out of 220 randomized patients, 58 
(26.4%) had one or two lesions and 8 (13.8%) of them apparently had 
only primarily generalized tonic clonic seizures and were excluded, leaving 
50 patients for analysis. Forty-two (84%) had the symptomatogenic 
zone, solely determined by seizure semiology, and at least one NCC lesion 
in the same sublobar brain region. Twelve (24%) patients had seizures 
semiologically arising from the peri-operculum region (perisylvian part 
of the frontal, parietal and temporal lobes), characterized by speech 
arrest, face motor or somatosensory seizures and epileptic vertigo or 
dizziness. Fifteen (30%) patients showed concordance between semiologic 
manifestations with the superior sublobar central region (parts of the 
frontal and parietal lobes), characterized by clonic motor or somatosensory 
seizures of extremities. In the 10 (20%) patients who had a calcified lesion 
and a viable cyst, the calcified lesions had not relation with the semiology 
of seizures. Out of 23 (46%) patients who had seizures after antiparasitic 
treatment was given in the randomized clinical trials, two (8.7%) had a 
new symptomatogenic zone and both showed a suitable semiological-
topographical concordance for another viable lesion. In conclusion, 
roughly 85% patients with one or two NCC lesions and seizure history 
exhibit semiologic-topographic concordance suggesting a direct influence 
of the parasitic lesions in the very near surrounding brain tissue such the 
main sustainable cause of seizures. Follow-up studies including modern 
neuroimaging techniques and ictal-EEG to appropriate establishing the 
ictal onset zone should help us to better understand epileptogenesis in 
human NCC.
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A POTENTIAL CANDIDATE ENOLASE FROM TAENIA 
SOLIUM EXPRESSED IN BACULOVIRUS SYSTEM FOR 
INMUNODIAGNOSIS OF SWINE CYSTICERCOSIS
Nancy León Janampa, Sueliene Luis, Ruddy Liendo, Elisa Roncal, 
Mirko Zimic, Patricia Sheen, Pajuelo Mónica, Hugo García
Cayetano Heredia University, Lima, Peru
Taenia solium, is a zoonotic parasite that infects both humans (as a final 
host) and swine (as an intermediate host). The pig acquires cysticercosis 
when it eats contaminated food with human feces with viable T. solium 
eggs. In endemic countries it is considered a serious public health 
problem. In the search for new antigens for immunodiagnostic of swine 
cysticercosis, we have annotated a glycolytic enzyme called enolase, 
whose function in Taenia species is not yet well understood. We have 
expressed the enolase of T. solium with their respective posttranslational 
modifications in the baculovirus-insect cell expression system (BES). We 
cloned the coding sequences in pFastBac HTA and the gene rearrangement 
was made in the baculovirus genome (bacmid) in E. coli DH10 Bac. We 
used bacmids for viral particles production and we obtained 3x108 viral 
particles in the infected sf9 insect cells. These were used to express 740 
µg/mL of recombinant enolase (52 kDa), also it was identified by Western 
blot with polyclonal rabbit antibodies (1/5000) specific for enolase. The 
BES is efficient to express recombinant enolase with posttranslational 
modifications. Low titers of antibodies to recognize enolase suggest that 
they are highly antigenic. Finally, we evaluated the usefulness of the 
recombinant protein for the diagnosis of porcine cysticercosis through 
the detection of antibodies in sera samples of infected and non-infected 
pigs using ELISA test. We obtained 98,7 % of sensibility and 66,7 % of 
specificity.
143
astmh.org
455
USEFULNESS OF TOURNIQUET TEST FOR DIAGNOSING 
DENGUE INFECTION IN ADULT
Anastasia Putri1, Chatporn Kittitrakul1, Watcharapong 
Piyaphanee1, Suda Sibunruang2, Borimas Hanboonkunupakarn1, 
Pongdej Wichianprasart1, Noppadon Tangpukdee1, Weerapong 
Phumratanaprapin Putraprasert1, Udomsak Silachamroon1, 
Terapong Tantawichien3
1Mahidol University, Bangkok, Thailand, 2Queen Saovabha Memorial 
Institute, the Thai Red Cross Society, Bangkok, Thailand, 3Division of 
Infectious Diseases, Department of Medicine, Faculty of Medicine, King 
Chulalongkorn Memorial Hospital, Bangkok, Thailand
Dengue infection becomes an important cause of fever among adult 
patients in the tropics. Tourniquet test (TT) is a classical bedside diagnostic 
tool which may aid clinician in the rural area where specific laboratory 
tests are not available. This study aims to determine the accuracy of TT in 
adult patients presenting with fever in the Bangkok Hospital for Tropical 
Diseases. A retrospective study was conducted in adult patients (age 
>18 years) presenting with acute febrile illness during 2012-2013. A TT 
performed using the standard technique once at presentation. Dengue 
infection was diagnosed by any of the following criteria: positive dengue 
specific NS-1 Ag. Total 1,157 adult patients with a median age of 30 years 
(18-96 years) were enrolled in this study. The male to female ratio was 
1:1.4 and the mean duration of fever was 3.5 days. 259 cases (22.4%) 
had dengue infection. TT positive was found in 27.3% of patients. In our 
study, TT showed sensitivity 51.4%, specificity 79.5%, positive predictive 
value 41.9%, negative predictive value 85.0% and accuracy 73.2%. These 
parameters are varied by the day of fever on which TT was performed. The 
sensitivity of TT increased but the specificity decreased among patients 
with a longer history of fever. Patients with dengue infection were more 
likely to have positive TT than other febrile illness (OR 4.09, 95% CI 3.06-
5.49). Among patients with dengue infection, the TT had no predictive 
value on the severity of dengue, risk of bleeding and length of stay in 
the hospital. Tourniquet test might be a useful predictor of the dengue 
infection in adult patient with acute febrile illness. However, among 
patients with confirmed dengue infection, tourniquet test had very little 
predictive value in the clinical course and outcome.
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SPIDR-WEB: AN NGS BIOTECHNOLOGY PLATFORM FOR 
DIAGNOSTIC, BIOSURVEILLANCE AND TRANSCRIPTOMIC 
APPLICATIONS
Andrew Hatch, Jason Gans, Patrick Chain, Momchilo Vuyisich
Los Alamos National Lab, Los Alamos, NM, United States
We are transforming the field of infectious disease diagnostics with 
the development of the Sample Prep for Infectious Disease Recognition 
With EDGE Bioinformatics (SPIDR-WEB). SPIDR-WEB is a sample-to-result 
biotechnology platform that enables efficient use of next generation 
sequencing (NGS) for pathogen detection in clinical samples. NGS has 
become a powerful tool for detection and characterization of both 
known and emerging pathogens. The main advantage of NGS is its 
non-biased approach that identifies all organisms in a sample. This is in 
contrast to traditional molecular assays that force us to look for a set of 
specific pathogens. In most clinical samples, the relative abundance of 
pathogen nucleic acids (DNA or RNA) is vanishingly small. Therefore, vast 
amounts of sequence data must be generated and analyzed to identify 
rare pathogen sequences. SPIDR-WEB is a sample-to-result process that 
relies on efficient laboratory and in silico steps. Clinical samples mostly 
comprise non-informative host RNAs or abundant housekeeping gene 
transcripts. SPIDR-WEB incorporates removal of non-informative RNAs 
(RNR), thereby enriching all other RNAs, including those from pathogens. 
This step enables either higher sensitivity and specificity, or less expensive 
and faster sequencing. Our custom EDGE bioinformatics data analysis 
platform provides rapid read classification at all taxonomic levels, and 
reliably detects all organisms present in a sample. EDGE is an efficient 
process, as it uses databases with pre-computed signatures, instead of 
aligning sequencing reads to the entire Genbank. In addition to RNR and 
EDGE, SPIDR-WEB includes robust, inexpensive and rapid sample lysis, 
RNA extraction, and library preparation steps. We want to implement 
SPIDR-WEB in both research and clinical settings to support a multitude 
of applications, such as discovery of novel mechanisms and biomarkers, 
study host-pathogen interactions, improve vaccines and therapeutics, and 
complement current diagnostic tools and help improve their utility.
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EPIDEMIOLOGY OF LEPTOSPIROSIS AMONG PATIENTS 
PRESENTING WITH ACUTE FEBRILE ILLNESS TO LAKESIDE 
HEALTH CENTERS IN RURAL RWANDA
Marc Munyengabe, DeVon Hale, Tim Walker, Cyprien 
Ntirenganya, Etienne Ntabanganyimana
University Teaching Hospital Butare, Huye, Rwanda
Leptospirosis is an infectious disease caused by leptospires, which are 
transmitted directly or indirectly from animals to humans. Minimal data 
are available on leptospirosis epidemiology in Africa, including Rwanda. 
This study aimed to determine the frequency of leptospirosis infection 
as cause of acute febrile illness in patients presenting to three lakeside 
health centers in rural Rwanda. Included patients were 21 years old and 
above, with axillary temperature 37.50C or more, and a negative test for 
malaria. Serum samples were collected and tested with a Rapid Diagnostic 
Test {Standard Diagnostic Bioline) for anti-Leptospira IgG/IgM antibodies. 
Among 421 acute febrile patients, the study found a seroprevalence of 
22.1% (93/421) for leptospira IgG positivity and an incidence of 5.5% 
(23/421) for IgM positivity; all IgM positive patients also had IgG antibodies 
and 85/93 cases with positive leptospira serology came from a single 
health center. Both IgG and IgM antibodies were strongly associated 
with lake swimming, livestock exposure and fish farming. Conjunctival 
suffusion was the physical examination finding most strongly linked 
with seropositivity. This study demonstrates the presence and localized 
endemicity of human leptospirosis infection in Rwanda. National mapping 
of prevalence, and enhanced clinician awareness supported by greater 
diagnostic resources, are needed to combat this under-recognized disease.
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PREVALENCE OF TRYPANOSOMA CRUZI AMONG NON-
ISCHEMIC CARDIOMYOPATHY PATIENTS PRESENTING FOR 
CLINICAL MANAGEMENT AT THREE MEDICAL FACILITIES IN 
SOUTHEASTERN TEXAS, USA
Melissa Nolan Garcia1, David Aguilar2, Arunima Misra3, Biykem 
Bozkurt4, Sarah M. Gunter1, Rodion Gorchakov1, Kristy O. Murray1
1Baylor College of Medicine, Houston, TX, United States, 2CHI St. Luke’s 
Health-Baylor St. Luke’s Medical Center, Houston, TX, United States, 
3Harris Health System-Ben Taub Hospital, Houston, TX, United States, 
4Michael E. Debakey Veterans Affairs Medical Center, Houston, TX, United 
States
Infection with the parasite Trypanosoma cruzi (Chagas disease) causes a 
progressive dilating cardiomyopathy in approximately 30% of affected 
patients. Anecdotally referred to as the “silent killer”, most patients 
are unaware of their disease status due to an asymptomatic or mild, 
non-specific acute infection period. Sudden cardiac disease is the first 
presenting symptom in 35% of patients with cardiac manifestations, and 
is the most common cause of mortality. Disease burden estimates suggest 
7 million patients are living with chronic Chagas in Latin America. In the 
United States, we have a substantial burden of Chagas disease among 
immigrant populations, and we have recently started to recognize a 
growing number of locally acquired cases. Our current study aimed to 
understand the prevalence of T. cruzi infection in patients presenting for 
clinical management of known non-ischemic idiopathic cardiomyopathy 
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at one of three medical facilities. All housed in Houston, Texas, the three 
medical facilities serve distinct and unique populations: 1) Latin American 
immigrants living in Texas, 2) impoverished Texas residents with increased 
vector exposures, and 3) Texas residents with a high socioeconomic status. 
From this large cohort of cardiac patients, we identified a considerable 
proportion of previously undetected T. cruzi infection. We will discuss the 
clinical presentations and transmission risk factors of those patients who 
tested positive for Chagas disease compared to idiopathic cardiomyopathy 
patients with a negative serology. Our findings have important clinical 
implications for cardiologists practicing throughout the United States, as 
well as clinicians in other non-endemic countries providing healthcare to 
Latin American immigrants.
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OUTCOMES OF PATIENTS WITH SEVERE INFECTION 
IN UGANDA ACCORDING TO ADHERENCE TO WHO 
INTEGRATED MANAGEMENT OF ADOLESCENT AND ADULT 
ILLNESS FLUID RESUSCITATION GUIDELINES
Abdallah Amir1, Kacie Saulters2, Rose Muhindo1, Christopher C. 
Moore3
1Mbarara University of Science and Technology, Mbarara, Uganda, 
2Georgetown University, Washington, DC, United States, 3University of 
Virginia, Charlottesville, VA, United States
The World Health Organization’s Integrated Management of Adolescent 
and Adult Illness (IMAI) recommendations for fluid resuscitation of 
patients with septic shock (IMAI-shock) and severe respiratory distress 
without shock (IMAI-SRDS) have not been validated. Therefore, we 
sought to describe outcomes in hospitalized patients in Uganda meeting 
these clinical criteria based on whether or not they received IMAI 
recommended fluid resuscitation. We performed a secondary analysis of 
data from a prospective cohort of severely septic adult patients admitted 
to Mbarara Regional Referral Hospital in Uganda that included the 
volume of intravenous fluids patients received during the first 6 hours 
of resuscitation. We selected patients meeting criteria for IMAI-shock 
or IMAI-SRDS and used logistic regression to determine predictors of 
outcomes. We evaluated 136 patients with IMAI-shock and 41 patients 
with IMAI-SRDS. During the first 6 hours of resuscitation, for patients 
with IMAI-shock, those that received IMAI recommended fluid volume 
(N=28) received more than those that did not (3L vs 1.5L, p<0.001) and 
there was no difference in mortality (30% vs 36%, p=0.788). Receipt 
of IMAI recommended fluid volume was associated with admission O2 
saturation <90% (aOR 2.9, 95%CI 1.1-7.1, p=0.025) and in-hospital 
mortality was associated with wasting (aOR 3.9, 95%CI 1.4-11.0, 
p=0.026) and ambulation (aOR 0.2, 95%CI 0.09-0.6, p=0.005). For 
patients with IMAI-SRDS, those that received IMAI recommended fluid 
volume (N=9) received less than those that did not (0.5L vs 1L, p<0.001) 
and there was no difference in mortality (22% vs 57%, p=0.08). Receipt 
of IMAI recommended fluid volume and in-hospital mortality were both 
associated with a Glasgow Coma Scale score <15 (aOR 0.07, 95%CI 
0.007-0.7, p=0.021; aOR 6.9, 1.04-45.7, p=0.045). In conclusion, IMAI 
recommended fluid resuscitation did not improve outcomes for patients 
with IMAI-shock or IMAI-SRDS. Further studies are needed to better 
understand the optimal resuscitation strategy for patients with severe 
infection in resource-limited settings such as Uganda.
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A RETROSPECTIVE STUDY OF MALARIA-RELATED DEATHS 
IN CHILDREN THAT DIED ON ADMISSION WITH SYMPTOMS 
OF FEVER MANIFESTATION IN A SECONDARY HEALTH CARE 
INSTITUTION IN WESTERN REGION OF GHANA
Adekunle Sanyaolu1, Verner Orish2, Chuku Okorie1, Onyekachi 
Onyeabor3, Mahama FranÇois4, Bruku Silverius5
1AMOOF Consulting, Calgary, AB, Canada, 2Department of Internal 
Medicine, Effia-Nkwanta Regional Hospital, Sekondi-Takoradi, Ghana, 
3Morehouse School of Medicine, Department of Community Health and 
Preventive Medicine-The Satcher Health Leadership Institute, Atlanta, 
GA, United States, 4Ho polytechnic, Sekondi-Takoradi, Ghana, 5Takoradi 
Polytechnic, Sekondi-Takoradi, Ghana
Malaria contributes significantly to deaths in children. Children are 
vulnerable to severe consequences of malaria due to lack of anti-parasite 
and clinical immunity. Malaria causes death either directly being the 
underlying cause of death as in the case of cerebral malaria and severe 
malaria anemia (SMA) or indirectly by contributing to the cause as in 
the case of malaria in a child with pneumonia or hypoglycemia. This is a 
retrospective study which evaluated the malaria-related deaths among 
children who died on admission over a 3 year period. The study was 
done in the children’s ward of Effia nkwanta hospital. A total of 223 
dead children medical records were reviewed. Percentage mortality was 
15.7% and Case fatality rate for malaria was 13.7%. All-cause mortality 
and malaria-specific deaths decreased from 21.5% and 24.3% in 2010 
to 11.1% and 4.4% in 2012 respectively. 17.9% (40/223) tested positive 
for malaria with Cerebral malaria 37.5% (15/40), Severe malaria anemia 
30 %( 12/40), and Severe malaria 25% (10/40). A continuous unrelenting 
implementation of child survival and malaria control programs is very 
necessary to protect children from malaria and other childhood killer 
diseases.
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INFECTIOUS ETIOLOGIES OF FEBRILE ILLNESSES IN 
CAMEROON
Obadia Mfuh Kenji1, Samuel Tassi Yunga1, Obase Bekindaka2, 
Calixt Mbakop3, Olivia A. Achonduh-Atijegbe2, Diane W. Taylor1, 
Rose G. Leke2, Vivek R. Nerurkar1
1University of Hawaii, Honolulu, HI, United States, 2University of Yaounde 
I, Yaounde, Cameroon, 3National Medical Research Institute, Yaounde, 
Cameroon
Fever is a common cause of patients seeking treatment in healthcare 
facilities in most tropical countries and poses a diagnostic and therapeutic 
challenge to healthcare workers in resource limited areas. Diagnosis of 
febrile illnesses in most malaria endemic countries mostly focuses on 
confirming or ruling out malaria. Thus, healthcare workers are often 
faced with the challenge on the course of action to take in treating 
febrile patients negative for malaria. The lack of information on the 
specific etiologic agents of non-malaria febrile illnesses prevents 
effective management of otherwise often treatable diseases. Despite 
their importance, there is no published data on the epidemiology of 
non-malaria febrile illnesses in Cameroon and their true burden remains 
unknown. In this study, we sought to identify pathogens that cause febrile 
illnesses in Cameroon. We recruited 551 febrile patients (6 months and 
older) in three different geographical regions of Cameroon. Blood and 
stool specimens were collected to perform rapid diagnostic test, ELISA, 
microsphere immunoassay, microscopy, culture and PCR to identify 
various etiologic agents of febrile illnesses. Of the 551 participants, 50% 
had malaria, 41.5% had one or more acute respiratory viral infections 
(influenza A (9%), influenza B (9%), adenovirus (10%), respiratory syncytia 
virus (17.5%), and parainfluenza virus (8%)), 7% had typhoid, 1.8% had 
acute toxoplasmosis, 18% had gastroenteric infections, 2% had dengue, 
6% had West Nile virus infection, 0.5% had leptospirosis, 1% had acute 
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chikungunya virus infection, while 13% of the participants were co-
infected with malaria and one or more non malarial pathogens. Moreover, 
91% participants were presumed to have malaria based on fever, of which 
41% were negative for malaria by PCR. Our results show evidence of 
non-malaria febrile illnesses in a malaria endemic region, which should be 
considered by clinicians in the differential diagnosis of febrile illnesses. But, 
lack of access to diagnostic tests impedes precise clinical management of 
febrle illnesses.
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EVALUATION OF SAFETY TOOL FOR AMBULATORY LEPROSY 
PATIENTS AT RISK OF ADVERSE OUTCOME
Swana Kopalakrishnan1, Cara Macrae1, Michael Klowak2, 
Adrienne Showler3, Stefanie Klowak4, Andrea K. Boggild1
1University of Toronto, Toronto, ON, Canada, 2McMaster University, 
Hamilton, ON, Canada, 3Johns Hopkins Bloomberg School of Public 
Health, Baltimore, MD, United States, 4Tropical Disease Unit, Toronto 
General Hospital, Toronto, ON, Canada
Leprosy treatment requires a complex management approach consisting 
of ongoing laboratory monitoring, screening for factors that will adversely 
affect response to corticosteroids, engagement of allied health services, 
and prolonged follow-up. Given that leprosy is complicated to manage, 
a novel safety tool was developed and implemented in our practice in 
March 2015. Our objective was to evaluate its utility through retrospective 
chart review. We reviewed charts of patients with leprosy treated over a 
3.5-year period: 3 years pre-implementation, and the 6-months following 
implementation. Outcomes included: loss to follow-up; monitoring of 
key laboratory parameters; allied health services engagement; baseline 
ophthalmologic assessment; and risk mitigation interventions such as 
prescription of GI and bone protection if on steroids. Seventeen patients 
with leprosy were treated during the enrolment period: 10 males (58.8%), 
and 7 females (41.2%). Of 17 patients enrolled, 8 were treated pre-
implementation, and 9 post-implementation. Seven patients (41.2%) 
were classified as paucibacillary, and 10 (58.8%) as multibacillary. Five 
patients (29.4%) were lost to follow-up, all of whom were lost prior to 
implementation of the safety tool. One (12.5%) pre-implementation 
patient was sent for baseline ophthalmologic assessment vs. 8 (88.9%) 
post-implementation, (p=0.01). Only post-implementation patients 
received referrals for occupational therapy and social work. Seven (77.8%) 
patients were referred for in-home occupational therapy assessments 
and 33.3% (n=3) were referred for social work assessments. Laboratory 
parameters were routinely monitored for both groups. GI and bone 
protection were provided for all patients on steroids. Implementation of 
the safety tool has established a user-friendly method for systemizing all 
elements of care that are critical to appropriate management of leprosy. 
The tool has been particularly useful in ensuring the involvement of all 
consulting and allied health services necessary for optimizing outcomes of 
leprosy patients.
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EVALUATION OF A CLINIC-BASED QUALITY STRUCTURE FOR 
MEDICINES TO TREAT PARASITIC INFECTIONS
Rochelle Melvin1, Shaqil Peermohammed1, Michael Klowak2, 
Stefanie Klowak3, Andrea K. Boggild1
1University of Toronto, Toronto, ON, Canada, 2McMaster University, 
Hamilton, ON, Canada, 3Tropical Disease Unit, Toronto General Hospital, 
Toronto, ON, Canada
Frequently used drugs in the Tropical Disease Unit (TDU) of Toronto 
General Hospital, including albendazole and ivermectin, are only available 
through the Special Access Programme (SAP) of Health Canada. As there 
are multiple points at which errors can occur in this process, a tracking 
system was implemented to ensure quality control of SAP-supplied 
medications and to evaluate the turnaround time (TAT) and success rate of 
SAP applications for drugs to treat common illnesses evaluated in the TDU. 
We aimed to evaluate the utility of this tracking system. A retrospective 
review of the TDU SAP logs for 2013-2015 was undertaken, and data 
including the TAT for each drug, incomplete notification rate (i.e., request 
by SAP for additional details before approval), and final approval rates over 
time were analyzed by one-way ANOVA or Yates’ correction Chi square 
analysis, respectively. The mean TAT decreased progressively from 2013 
to 2015, from 9.27 ± 10.3 days to 7.38 ± 8.03 days to 5.15 ± 1.93 days 
(p=0.04). The rates of incomplete notifications for albendzole in each of 
2013 to 2015 were 25%, 54%, and 31%, respectively. For ivermectin, the 
incomplete notification rates in each of 2013 to 2015 were 4%, 16%, and 
17%, respectively. Overall final approval rate for albendazole or ivermectin 
was 100% in all years. First time success and incomplete notifications 
differed between ivermectin and albendazole, with 87% of applications 
for ivermectin approved immediately compared to 64% for albendazole 
(p=0.0033). For the indication of Strongyloides hyperinfection (n=6), 
specifically, the mean TAT for ivermectin was 5.11 ± 0.694 days. It is critical 
that patients receive the necessary medications for their helminthiases , 
as rejections or delays in drug approval increase the likelihood of patient 
adverse outcomes including death. This is especially true for entities such 
as disseminated strongyloidiasis or ruptured hydatid cyst. Prior studies have 
demonstrated increased patient morbidity and mortality resulting from 
delays associated with the SAP drug approval process. Our clinic-based 
system may have contributed to the improved TAT noted over time.
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IMMUNIZATION AGAINST TETANUS DURING PREGNANCY: 
SEROLOGICAL INVESTIGATION FOR MATERNAL AND 
NEONATAL ANTIBODIES IN WEST REGION OF BURKINA 
FASO, BOBO DIOULASSO
Frederic W. Nikiema, Serge R. Yerbanga, Aminata Fofana, 
Fabrice A. Some, Zachari Kabre, Jean-Bosco Ouedraogo
Institut de Recherche en Science de la Sante/Bobo Dioulasso, Bobo 
Dioulasso, Burkina Faso
In Burkina Faso, neonatal tetanus often occurs often during aseptic 
childbirth and is related to infection of the umbilical cord in a baby born of 
an unimmunized mother. The Centers for Disease Control and Prevention 
(CDC) estimate that over 270,000 deaths occur annually worldwide as a 
result of neonatal tetanus. It accounts for about one-half of tetanus deaths 
in Burkina Faso. This study aims to assess risk factors linked to inadequate 
immunization against tetanus and immunity status of the newborn. One 
hundred venous blood plasmas were collected from pregnant women 
during eutocic childbirth and were compared with blood sample umbilical 
cordon from their newborns. The tetanus antibody titers were determined 
by enzyme-linked immunosorbent assay (ELISA kit; IBL International 
GMBH, Germany) in accordance with the manufacturer’s recommendation. 
The results were reported in IU/mL, and they were standardized by 
comparing them to calibrated World Health Organization (WHO) reference 
sera. Overall, 100 women were assessed, 74% are illiterate, 57% are in 
age group 18-25 years old and 26% are on their second pregnancy. Most 
of these women, 93% have tetanus antibody titers upper than 1.00 IU/mL. 
Geometric mean of tetanus antibody titers was 3.66 (95%CI 3.13-4.28) in 
mothers and 3.87 (95%CI 3.28-4.58) in newborns. There is a significant 
correlation between antibody titer in the two groups (Spearman’s 
coefficient=0.86, p<0.05). But there is no obvious link between tetanus 
antibody titers, the number of doses of tetanus vaccine given during 
pregnancy on the one hand (coeff=0.3, p<0.5) and the interval since the 
last dose on the other hand (coeff=0.3, p=0.85). Pregnant women and 
their newborns are well immunized against tetanus in Bobo Dioulasso. 
There is no reliable evidence related with gravidity, number of tetanus 
vaccine doses given during pregnancy and the tetanus antibody titer.
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EVALUATING TREATMENT OUTCOMES OF AMBULATORY 
LEPROSY PATIENTS RECEIVING OFLOXACIN-CONTAINING 
MULTIDRUG THERAPY REGIMENS
Lena E. Faust1, Michael Klowak2, Cara Macrae1, Swana 
Kopalakrishnan1, Adrienne Showler3, Stefanie Klowak4, Andrea K. 
Boggild1
1University of Toronto, Toronto, ON, Canada, 2McMaster University, 
Hamilton, ON, Canada, 3Johns Hopkins Bloomberg School of Public 
Health, Baltimore, MD, United States, 4Tropical Disease Unit, Toronto 
General Hospital, Toronto, ON, Canada
There is an ongoing need to evaluate the efficacy of treatment options for 
leprosy, as the standard dapsone and clofazimine-containing multidrug 
therapy (MDT) continues to face barriers such as safety and tolerability. The 
fluoroquinolone ofloxacin has shown promise as an effective component 
of MDT, however, few data on the efficacy of ofloxacin-containing MDT 
for the treatment of leprosy in non-endemic areas are available. We 
evaluated the treatment outcomes of leprosy patients receiving ofloxacin-
containing MDT regimens in our practice. We performed a retrospective 
chart review of all patients treated for leprosy in our practice over a 3.5-
year period. Primary outcomes evaluated were cure rate; frequency of 
occurrence of leprosy reactions; frequency of dapsone-associated adverse 
effects; and treatment adherence. Analysis was descriptive, but data 
were also stratified by age, sex, spectrum of disease (paucibacillary vs. 
multibacillary), region of origin, and treatment regimen, and compared 
by odds ratios (ORs). During the enrolment period, 17 patients were 
treated with ofloxacin-containing MDT regimens: 10 males (58.8%) and 
7 females (41.2%). Ten patients were classified as multibacillary, and 7 
as paucibacillary. At the time of analysis, 5 patients (29.4%) had fully 
completed MDT, and all were deemed cured clinically, with a median 
duration of follow-up of 35 months (range 27 to 66 months). Five patients 
(29.4%) were lost to follow-up after completion of treatment, and 7 
(41.2%) are still in active treatment. Ten patients (58.8%) experienced 
either ENL (n=3, 17.6%) or reversal reactions (n=5, 29.4%) or both 
(n=2, 11.8%). Of those receiving a dapsone-containing regimen (n=12), 
5 (41.7%) developed clinically significant methemoglobinemia, and 2 
(16.7%) developed hemolysis. Patients from the Philippines (n=5) were 
more likely to undergo reversal reactions than those from the Indian 
subcontinent or Africa (n=12) (p=0.028). Although limited by sample size, 
our results demonstrate high cure rates and positive treatment outcomes 
with ofloxacin-containing MDT, with reaction rates comparable to those 
documented in other studies.
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Intussusception (IS) is a major cause of bowel obstruction in infants 
that has been linked to infective agents and more recently to rotavirus 
vaccination. As rotavirus vaccine introduction proceeds in GAVI-eligible 
countries, where few studies of IS have been performed to-date, there is 
keen interest in documenting the epidemiology of IS. This retrospective 
study provides baseline data among children from 0 to 15 years with 
IS admitted to the major pediatric surgery unit in Bamako, Mali at the 
Hôpital Gabriel Touré (HGT) from 2009 to 2014 (when rotavirus vaccine 
was introduced). We reviewed operating room and hospital registers 
to identify cases who met the definition of IS at Level 1 of Diagnostic 
Certainty from the IS Brighton Collaboration Working Group (2004). 
During the 6 year study period, IS was diagnosed in 458 (6.1%) of 
7,429 children hospitalized on the pediatric surgery unit of HGT; 66.8% 
were male and 61.6 % were younger than 1 year of age. The mean 
period incidence was 84.6 per 100,000 infants (range 29-81). The most 
common symptoms of IS were abdominal mass (78.4%), rectal bleeding 
(54.4%), vomiting (70.3%), crying/colic (54.8%) and abdominal distention 
(34.9%). IS was confirmed pre-operatively by sonogram in 381 (83.2%) 
and /or by X-ray in 7 (5.0%). Surgery was the sole therapeutic modality 
used, and was performed in 441 patients (96.3%), while 5 were lost 
to follow-up, 9 improved, and 3 died before surgery. Among 433 with 
surgically-confirmed IS, there were 23 spontaneous reductions, 309 
manual reductions, 28 intestinal resections, and 35 ileostomies; 61 
required a second surgical procedure. After surgery, 378 (82.5 %) of cases 
were discharged in good condition, 11 (2.4%) had complications and 64 
(13.9%) died. Children who died were younger, had a longer duration of 
symptoms, and were more systemically ill. Intussusception is a relatively 
frequent occurrence in children under 1 year of age in Bamako, Mali 
and is associated with a high mortality. The ability to monitor changes in 
incidence related to vaccine is complicated by natural annual variation. 
Efforts are needed to improve outcome of IS and to detect possible 
vaccine-related cases.
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Basel, Switzerland, 6Burnet Institute, Melbourne, Australia, 7James Cook 
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As efforts to eliminate malaria scale up, a range of practical challenges 
in conducting research in these settings arise which makes quality 
clinical research increasingly difficult. This analysis sought to gain a more 
comprehensive understanding of the difficulties encountered by research 
and field staff based in the field in these settings to improve the success 
of future research projects in malaria elimination settings. Reports from 
field-based studies were reviewed using content analysis to identify the 
challenges that were reported while conducting the research. In depth 
interviews were conducted with Village Malaria Workers (VMWs) involved 
in the research to identify challenges that may not have been reported 
in official reports. Informal interviews were conducted to provide more 
insight into the common themes identified from the report content 
analysis. As malaria elimination progresses, the smaller numbers of study 
participants available presents a range of practical field challenges that can 
impact upon the study outcomes. This is further affected by the selection 
of exclusion criteria. We found that in Western Cambodia migrant and 
mobile populations (MMPs) were frequently excluded from studies because 
of potential difficulties in study follow-up. This led to significantly reduced 
numbers for study enrolment and the exclusion of a critical high-risk 
group. We also also found that implementation challenges are reported 
sporadically and are often not formally reported. Conclusions This is the 
first study reporting the implementation challenges faced in conducting 
clinical trials in malaria elimination and drug resistance settings. The 
findings of the analysis will assist in informing the design of future projects 
to increase the likely success of these studies. The inclusion of MMPs as 
participants in future studies, although presenting some challenges will 
also reduce potential biases and makes the research more relevant for 
elimination in these settings.
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PARASITE AND MYCOBACTERIUM TUBERCULOSIS CO-
INFECTION IN IMMIGRANTS
Lauren A. Saag1, Rachel L. Epstein2, Jackson B. Mesick1, Sondra 
S. Crosby2, Sarah L. Kimball2, Elizabeth D. Barnett2, Natasha S. 
Hochberg2
1Boston University School of Public Health, Boston, MA, United States, 
2Boston University School of Medicine, Boston, MA, United States
Tuberculosis (TB) is the leading infectious cause of mortality worldwide, 
and parasitic infections are endemic in 21 of the 22 countries with the 
highest TB burden. Although data suggest that parasitic infections alter 
susceptibility to infection with Mycobacterium tuberculosis (Mtb), it 
remains unclear whether this association varies by parasite species. We 
aim to assess differences in susceptibility to Mtb infection and immune 
response to Mtb based on parasite species. Immigrants receiving routine 
clinical care at Boston Medical Center are enrolled (anticipated sample 
size of 400). Information on the social and medical history of participants 
is collected from medical records. Participants are tested for TB infection 
with the Quantiferon Gold-in-Tube (QGIT) assay and for parasites with 
stool microscopy and antigen testing and with serology for those with 
eosinophilia or relevant symptoms. QGIT supernatants are analyzed to 
quantify Th1, Th2, and Treg responses and compare these between 
individuals with protozoal infections, helminths, and no parasites. Thirty-
nine participants have been enrolled to date: median age is 28 (range 
10-76) and 25 (64.1%) are male. Of 36 with QGIT results, 8 (22.2%) are 
positive and, among 23 with stool testing results, 8 (34.8%) have at least 
one parasite. Among those with parasites, 7 (87.5%) have at least one 
protozoal infection (5 (71.4%) Blastocystis hominis, 1 (14.3%) Endolimax 
nana and Blastocystis hominis, 1 (14.3%) Endolimax nana, Dientamoeba 
fragilis and Blastocystis hominis), and 1 (12.5%) with schistosomiasis 
(based on serology). Comparing those with protozoa (n=7) to those with 
no parasites (n=15), 4 (57.1%) and 3 (20.0%) are QGIT positive (p=0.08). 
Those with protozoa are of similar age (median age 28 vs. 29) and more 
likely to be female (4 (57.1%) vs. 4 (26.7%), p=0.17) than those with no 
parasites. Immunologic analyses are pending. This ongoing study of newly 
arrived immigrant patients at Boston Medical Center will provide data to 
delineate the association between protozoa and helminth response to 
latent tuberculosis infection. Participant enrollment and data analyses are 
ongoing.
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and parasitic infections are endemic in 21 of the 22 countries with the 
highest TB burden. Although data suggest that parasitic infections alter 
susceptibility to infection with Mycobacterium tuberculosis (Mtb), it 
remains unclear whether this association varies by parasite species. We 
aim to assess differences in susceptibility to Mtb infection and immune 
response to Mtb based on parasite species. Immigrants receiving routine 
clinical care at Boston Medical Center are enrolled (anticipated sample 
size of 400). Information on the social and medical history of participants 
is collected from medical records. Participants are tested for TB infection 
with the Quantiferon Gold-in-Tube (QGIT) assay and for parasites with 
stool microscopy and antigen testing and with serology for those with 
eosinophilia or relevant symptoms. QGIT supernatants are analyzed to 
quantify Th1, Th2, and Treg responses and compare these between 
individuals with protozoal infections, helminths, and no parasites. Thirty-
nine participants have been enrolled to date: median age is 28 (range 
10-76) and 25 (64.1%) are male. Of 36 with QGIT results, 8 (22.2%) are 
positive and, among 23 with stool testing results, 8 (34.8%) have at least 
one parasite. Among those with parasites, 7 (87.5%) have at least one 
protozoal infection (5 (71.4%) Blastocystis hominis, 1 (14.3%) Endolimax 
nana and Blastocystis hominis, 1 (14.3%) E. nana, Dientamoeba fragilis 
and B. hominis), and 1 (12.5%) with schistosomiasis (based on serology). 
Comparing those with protozoa (n=7) to those with no parasites (n=15), 
4 (57.1%) and 3 (20.0%) are QGIT positive (p=0.08). Those with protozoa 
are of similar age (median age 28 vs. 29) and more likely to be female (4 
(57.1%) vs. 4 (26.7%), p=0.17) than those with no parasites. Immunologic 
analyses are pending. This ongoing study of newly arrived immigrant 
patients at Boston Medical Center will provide data to delineate the 
association between protozoa and helminth response to latent tuberculosis 
infection. Participant enrollment and data analyses are ongoing.
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THE IMPACT OF SYSTEMATIC POINT-OF-CARE ULTRASOUND 
ON MANAGEMENT OF PATIENTS IN A RESOURCE-LIMITED 
SETTING
Alastair Stanley1, Rachel Purcell2, Lauren Byrne1, Felicity 
Williams1, Lucas Kiyeji1, Patrick Laws1, Tshepo Leeme1, Emanuel 
Mwabutwa1, Candace Rypien1, Abigail Sharpe1, Robert Peck3, 
Matthew Stephens4, Daniel Kaminstein5
1London School of Hygiene & Tropical Medicine, London, United Kingdom, 
2The University of Notre Dame Australia School of Medicine, Sydney, 
Australia, 3Weill Cornell Medical College, New York, NY, United States, 
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Augusta, GA, United States
Although target point-of-care (POC) ultrasonography has been shown 
to benefit patients in resource-limited settings, it is not clear whether a 
systematic POC ultrasound assessment in these settings can also lead 
to similar changes in patient management. A pre-defined systematic 
set of POC ultrasound scans were performed on inpatients at a tertiary 
referral hospital in Tanzania to see if this resulted in changes to patient 
management. Of the 55 patients scanned, an abnormality was detected 
in 75% (n=41), and a change in patient management was recommended 
or implemented on the basis of POC ultrasound findings in 53% (n=29). 
The main impact was earlier initiation of treatment due to more rapid 
and accurate diagnosis. Further research is warranted to determine 
whether systematic POC ultrasonography would result in improved patient 
outcomes in resource-limited settings.
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INTRODUCTION OF THE MISGAV-LADACH CAESAREAN 
SECTION TECHNIQUE TO A NIGERIAN TEACHING HOSPITAL
Jeffrey Cho, Jason Lohr, Kelly Morton
Loma Linda-Inland Empire Consortium for Healthcare Education, Loma 
Linda, CA, United States
When compared to the traditional Caesarean section technique, the 
Misgav-Ladach method for Caesarean section has been shown to be more 
efficient, leading to decreased operating time, peri-operative bleeding, 
and need for post-operative painkillers . We compared the two techniques 
sequentially after the introduction of the Misgav-Ladach method to a 
teaching hospital in Nigeria via a teaching DVD provided by the World 
Health Organization. 144 patients who underwent Caesarean-sections 
between March 2007 and November 2009 were compared. The first 72 
received a traditional Caesarean section before the WHO training had been 
completed. The second group of 72 after the training received the Misgav-
Ladach method. The two groups were analyzed with a multivariate analysis 
of covariance controlling for patient age and the acuity of the indication 
for surgery (emergent vs. urgent). Overall, mean surgical time was lower 
in the Misgav-Ladach group (55.8 minutes) compared to the traditional 
method group (72.3 minutes; p < 0.001). There were no significant 
differences in blood loss, number of transfusions, or pain medication doses 
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between the two groups. To examine differences in resident and attending 
use of the techniques; 25 resident cases were compared to 119 attending 
cases. The residents had longer surgical times (69.2 minutes) than 
attendings (58.9 minutes; p <0.034) there were no technique interactions. 
As such, the Misgav-Ladach group had significantly lower surgical times 
regardless of resident vs. attending physician. The Misgav-Ladach method 
appears to be faster than the traditional technique. In general, there were 
trends indicating less blood loss and pain medications in the Migav-Ladach 
group though only surgical time was significant. These differences could 
have systems implications , especially in low-to-middle income countries, 
where resources are less available. The fact that the training took place 
through a DVD and that the benefit was seen in both attendings and 
resident physicians shows promise for an effective means of disseminating 
the skills needed to incorporate this technique in areas of high need.
471
NEW STRATEGIES FOR THE DEVELOPMENT OF ANTIVENOM 
THERAPIES TO TREAT SNAKEBITE
Nicholas Casewell, Gareth Whiteley, Camila Renjifo, Sarah King, 
Fiona Bolton, Simon Wagstaff, Robert Harrison
Liverpool School of Tropical Medicine, Liverpool, United Kingdom
Snakebite is a neglected tropical disease that affects ~1.8 million people 
each year. Of these cases, upwards of 94,000 deaths occur, primarily in 
the rural regions of south Asia and sub-Saharan Africa. The mainstay of 
snakebite therapy is antivenom - polyclonal antibodies from hyperimmune 
animal serum derived from horses or sheep immunised with small 
amounts of snake venom. Different antivenoms are produced to treat 
bites by different medically important snakes, as the venom toxins that 
cause pathology vary from species to species. This process of generating 
commercial antivenoms has remained largely unchanged for the past 
century and, consequently, these therapeutics have many limitations: 
(i) limited paraspecifity at treating bites by different snake species, (ii) 
low specificity in terms of the number of antibodies that are specific to 
venom proteins and (iii) high incidences of adverse reactions due high 
volumes of foreign protein being delivered to patients. Here we describe 
new experimental strategies that we have developed to produce ‘next-
generation’ antivenoms that display increased paraspecific cross-reactivity 
and specificity to toxic snake venom proteins. Using ‘omic’ technologies to 
characterise toxin gene expression in the venom gland and toxin proteins 
in secreted venom, we have elucidated the variation in venom composition 
observed in many snakes of medical importance. This facilitates the 
identification of conserved regions of venom-encoding genes that can 
be used as antigens to stimulate the production of antibodies with 
paraspecific activities. We show that experimental antivenoms developed 
using few epitope-string DNA immunogens are capable of stimulating 
antibody repertoires with comparable cross-reactivity to traditional 
antivenom, and which are capable of neutralising venom-induced 
pathology in vitro and in vivo. Such approaches provide new tools 
amenable for the development of ‘pathology-specific’ or ‘continent-
specific’ antivenoms that are based on mixtures of monoclonal antibodies 
and will be more specific and efficacious at lower doses than existing 
treatments for snakebite.
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The Kayes region of Mali has historically had a large trachoma burden. 
Implementation of the World Health Organization’s SAFE strategy (Surgery, 
Antibiotics, Facial cleanliness and Environmental improvements) has led to 
significant reductions in trachoma prevalence. The Mali national program 
has a long standing surgery program to treat the trachomatous trichiasis 
(TT) cases and reduce the estimated national TT backlog. High quality 
data regarding surgical outcomes are essential to timely and accurate 
evaluation of trachoma programs. The aim of this study was to assess the 
quality of TT surgery by following up patients who underwent TT surgery 
in Kayes region, Mali, three to six months following the operation. A 
cross-sectional study was conducted in 8 health districts in Kayes region 
from June 2014 to February 2016. To be eligible patients must have been 
operated by mobile surgery teams within three to six months prior to the 
field trip and on the national surgery record. Fifteen to 20 patients were 
randomly selected from the national program’s operated patient registry 
for each field visit. In total, 206 patients were enrolled and completed a 
structured interview and ophthalmological assessment. Concordance of 
collected data with that sent to the PNSO was verified for each patient 
interviewed. 143 of the 206 enrolled patients (69.4%) were interviewed, 
with a median age of 62.5 (range 9-94) and a ratio of 2.6:1 for females 
to males. Among the 143 patients interviewed, 27 (18.9%) patients have 
not been operated. Of the 116 patients operated for TT, in 24 (20.7%) 
cases, the reported operated eyelid did not match the actual operated 
eyelid. Suture removal did not occur in the recommended timeframe in 
16 cases. Post-operative TT was found in 33/116 (28.4%) patients, and 
28/116 (24.1%) had continued tearing in the operated eye after surgery. 
This study underscores the importance of post-operative follow-up to 
verify data completeness and quality, as well as surgical outcomes of 
patients. Refresher training for operators and TT surgery supervision must 
be strengthened to ensure high quality TT surgery to achieve trachoma 
elimination in Mali.
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A national survey of Cambodian women of childbearing age was 
conducted in 2012 to assess immunity to vaccine preventable diseases 
such as polio, measles, and rubella. The availability of a nationally 
representative serum panel offered an opportunity to measure IgG 
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antibody levels to a number of parasitic diseases using a multiplex bead 
assay previously developed in our lab. Recombinant antigens from 
Plasmodium falciparum, P. vivax, Toxoplasma gondii, Taenia solium, 
Strongyloides stercoralis, and lymphatic filariasis were included in the 
multiplex assay panel, and national and regional prevalence values were 
estimated from the IgG antibody data. Few women were positive for 
cysticercosis or toxoplasmosis (<6% seroprevalence) and no geographic 
clustering was obvious. Malaria and lymphatic filariasis were mainly 
confined to the North region of the country with several distinct hotspots. 
Infection with S. stercoralis was widespread in the population (45.9% 
prevalence): urban residents (32% seroprevalence) had lower levels 
of infection than rural residents (50% seroprevalence). Integration of 
multiplex bead assays into nationally representative population serosurveys 
can provide valuable information on the presence, prevalence, and 
distribution of parasitic disease and can be used to evaluate the impact of 
public health interventions.
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Scabies is a global health problem and common in closed communities. It 
represents a significant problem in residential care facilities (RCF) for the 
elderly in the UK and other countries. Clinical presentations in the elderly 
can differ from those in younger individuals. In RCFs where a scabies 
outbreak was suspected and prior to treatment, two physicians including a 
dermatologist performed examinations of residents, including dermoscopy 
and skin scrapings. . Scabies diagnosis was classified as definite/probable/
possible. Outbreaks were defined as ≥2 suspected cases. Residents were 
treated with a topical scabicide twice. A second visit after treatment 
was performed. 230 residents were examined across 10 RCFs between 
February 2014 and February 2015. The median age was 86.9 years and 
175 (76.1%) were female. 157 individuals (68.3%) had dementia. 61 
(26.5%) were diagnosed with scabies. Of these 3 had crusted scabies. 
The median number of cases/RCF was 6 (2-11). The number of cases of 
scabies categorised as definite was 8 (13.1%). The mite was visualised 
using dermoscopy in 7 cases (11.5%) and identified on skin scraping 
in 3. Burrows were detected in 41.0% of cases. 31 (50.8%) individuals 
were asymptomatic. Dementia was significantly associated with having 
scabies (OR=2.37 95% CI 1.37-4.09). At the second visit (median interval 
of 44 days, range 37-81 days) there were no new cases of scabies. 10 
individuals diagnosed with scabies at the first visit were identified as still 
having possible (8) or probable (2) scabies. Scabies is a difficult diagnosis 
to make in this population with more than half of affected individuals 
being asymptomatic often with subtle clinical signs. Dermoscopy and skin 
scrapings were of limited value in identifying affected individuals. This is 
the first study to confirm that dementia is a risk factor for scabies in this 
group. Our findings are of potential relevance to the understanding and 
management of scabies in highly endemic communities, RCFs in tropical 
settings and other closed communities. Elderly members of communities 
should be carefully examined as they may have no symptoms or typical 
signs.
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WEST AFRICA
Fatou Secka, Isatou Sarr, Kalifa Bojang, Suzanne Anderson, 
EUCLIDS Consortium (www.euclids-project.eu)
Medical Research Council Unit The Gambia, Fajara, Gambia
Despite the importance of severe bacterial infections as a major cause of 
morbidity, disability and mortality in African children, data on the factors 
contributing to poor outcome of severe childhood bacterial infection in 
West African children is limited. We aimed to prospectively identify factors 
related to poor outcome. Patients aged 1 month to 16 years presenting 
with suspected sepsis and/or severe focal infections to two urban 
hospitals in The Gambia recruited for the European Union Life-threatening 
Infectious Disease study (www.euclids-project.eu) were part of this 
analysis. Basic demographic data, clinical features, outcome and pathogen 
identified using standard bacterial culture and molecular diagnostics were 
documented. From January 2013 to September 2015 we recruited 411 
children, 96(23.3%) developed poor outcome; 54(13.1%) died and 42(10. 
2%) developed sequelae. The common bacterial pathogens identified were 
Staphlococcus aureus (37,24.7%), S. pneumoniae (31,20.7 %), Neisseria 
meningitidis (25,16.7% ), and Haemophilis influenzae (20,13.3 % ). 
The factors that were associated with poor outcomes were young age, 
presence of a cor-moridity, prior stay at another health facility and duration 
of symptoms prior to presentation. More than half of the mortality cases 
were less than 24 months with median age (IQR) of 16.3(5.9-60.0) months 
and sepsis was present in 39/54(72.2%) of those who died (p=0.004). 
29/54 (69%) died within 48 hours of admission and gram negative 
organisms were the commonest(12/42(22.2%) associated with mortality. 
Abnormalities in the musculoskeletal system and central nervous system at 
presentation were more often associated with development of sequelae. 
Poor outcome is common (23.3%) in childhood life-threatening infections. 
A potential vaccine preventable disease was found in 27/96 (28.1%) of 
those with poor outcome. The attainment of MDG 4 of reduction of 
childhood mortality requires a review and improvement of vaccine policies 
as well as research into the production of novel effective vaccine against S. 
aureus.
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The contribution of malaria to sickle cell disease (SCD) morbidity in 
sub-Saharan Africa is unclear, particularly for children receiving chronic 
care including malaria preventive measures. In a Malawian pediatric 
SCD cohort, we describe use of preventive measures and prevalence for 
malaria, and explore associations with levels of hemoglobin (Hb) and 
lactate dehydrogenase (LDH). Weekly sulfadoxine/pyrimethamine (SP) was 
the local standard-of-care for malaria chemoprophylaxis. SP adherence, 
bed net use, and malaria history were assessed using a standardized 
survey. Overall, 94 children with SCD were evaluated with mean age 8.2 
(SD 4.5) and median Hb 7.2 g/dL (IQR 6.6-7.7). 92 (98%) were receiving 
SP at evaluation. Of these, 53 (58%) reported perfect adherence to SP 
and 88 (96%) reported adherence to ≥75% of doses. The most common 
reasons for missed doses were running out of SP and guardian traveling. 
66 (70%) reported regular bed net usage, with costs reported as the 
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major barrier to nonuse. 6 (6%) reported a history of malaria, and of 72 
cross-sectional blood smears collected over three months including the 
transmission season, no malaria parasites were seen. Neither self-reported 
history of malaria, Hb, nor LDH correlated with SP adherence or bed net 
use. In conclusion, we observed high rates of adherence to SP and bed net 
use in a pediatric SCD cohort in Lilongwe. Self-reported malaria was very 
infrequent and laboratory-confirmed malaria was not detected, suggesting 
good effectiveness of malaria preventive measures in this population under 
routine care conditions.
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MALARIA PREVENTIVE MEASURES DURING ROUTINE CARE 
AMONG CHILDREN WITH SICKLE CELL DISEASE IN MALAWI
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1Howard University College of Medicine, Washington, DC, United States, 
2UNC Project Malawi, Lilongwe, Malawi, 3Baylor College of Medicine, 
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NC, United States, 5University of Pittsburgh Medical Center, Pittsburgh, PA, 
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The contribution of malaria to sickle cell disease (SCD) morbidity in 
sub-Saharan Africa is unclear, particularly for children receiving chronic 
care including malaria preventive measures. In a Malawian pediatric 
SCD cohort, we describe use of preventive measures and prevalence for 
malaria, and explore associations with levels of hemoglobin (Hb) and 
lactate dehydrogenase (LDH). Weekly sulfadoxine/pyrimethamine (SP) was 
the local standard-of-care for malaria chemoprophylaxis. SP adherence, 
bed net use, and malaria history were assessed using a standardized 
survey. Overall, 94 children with SCD were evaluated with mean age 8.2 
(SD 4.5) and median Hb 7.2 g/dL (IQR 6.6-7.7). 92 (98%) were receiving 
SP at evaluation. Of these, 53 (58%) reported perfect adherence to SP 
and 88 (96%) reported adherence to ≥75% of doses. The most common 
reasons for missed doses were running out of SP and guardian traveling. 
66 (70%) reported regular bed net usage, with costs reported as the 
major barrier to nonuse. 6 (6%) reported a history of malaria, and of 72 
cross-sectional blood smears collected over three months including the 
transmission season, no malaria parasites were seen. Neither self-reported 
history of malaria, Hb, nor LDH correlated with SP adherence or bed net 
use. In conclusion, we observed high rates of adherence to SP and bed net 
use in a pediatric SCD cohort in Lilongwe. Self-reported malaria was very 
infrequent and laboratory-confirmed malaria was not detected, suggesting 
good effectiveness of malaria preventive measures in this population under 
routine care conditions.
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PRE-TRAVEL HEALTH CARE AMONG PEDIATRIC U.S. 
MILITARY BENEFICIARIES
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Fairchok3, Elizabeth Schnaubelt4, David Tribble1, Indrani Mitra1, 
Anuradha Ganesan1, Mark D. Johnson5, Robert Deiss1, Tahaniyat 
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1Infectious Disease Clinical Research Program, Bethesda, MD, United 
States, 2San Antonio Military Medical Center, San Antonio, TX, United 
States, 3Madigan Army Medical Center, Tacoma, WA, United States, 
4Landstuhl Regional Medical Center, Landstuhl, Germany, 5Naval Medical 
Center San Diego, San Diego, CA, United States
An increasing number of children are traveling to developing countries, 
placing them at risk for travel-related infections. There is limited data 
comparing pre-travel care, exposures and illnesses in pediatric and adult 
travelers. We used a prospective, observational cohort of US Department 
of Defense beneficiaries traveling overseas (TravMil), to compare pediatric 
and adult travelers using a case-control methodology. Pediatric subjects 
were matched 1:1 with adult military dependents by travel region, malaria 
risk at destination, and duration of travel. Outcomes of interest included 
pre-travel preventive care and associated compliance, travel exposures, 
and reported illnesses. 83 pediatric and adult subjects were matched. The 
median ages of pediatric and adult subjects were 11 years (IQR: 7-16) 
and 63 years (IQR: 44-67) years, respectively. Common regions of travel 
included South-East Asia (42%), South/Central America (34%), and 
Africa (26%). Pediatric travelers was more likely than adults to visit friends 
and relatives (39% vs. 10%; p <0.05). Travel related vaccine coverage 
rates were similar, except Hepatitis A (pediatrics: 90% vs. adults: 71%; p 
<0.05) and B (84% vs. 48%; p<0.05). Malarone was the most common 
antimalarial prescribed in children and adults, with no difference in non-
compliance. Poor compliance with skin insect repellent use (55% vs. 67%), 
and frequent skin exposures including insect bites (94% vs. 89%), animals 
bites or scratches (52% vs. 27%) were reported among pediatric subjects 
(p<0.05). Subjects < 10 years of age were less likely to be prescribed 
antibiotics (RR=0.65; 95% CI: 0.50-0.86) and anti-diarrheals (RR=0.09; 
95% CI: 0.03-0.28) for TD self treatment than adults, despite similar rates 
of high risk behavior for TD acquisition. Strategies to improve compliance 
with preventive measures, and standardization of TD treatment guidelines 
are needed for pediatric travelers.
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IRON DEFICIENCY IS COMMON IN UGANDAN CHILDREN 
WITH SICKLE CELL ANEMIA
Aubri S. Carman1, Andrea L. Conroy1, Robert O. Opoka2, Adam 
Lane3, Russell E. Ware3, Sarah E. Cusick4, Chandy C. John1
1Ryan White Center for Pediatric Infectious Disease and Global Health, 
Indiana University School of Medicine, Indianapolis, IN, United States, 
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Children’s Hospital Medical Center, Cincinnati, OH, United States, 
4Division of Global Pediatrics, The University of Minnesota Medical School, 
Minneapolis, MN, United States
African children have a high prevalence of sickle cell anemia (SCA), which 
causes significant morbidity and early mortality. Previous studies of iron 
deficiency (ID) and the degree to which it contributes to anemia in children 
with SCA in malaria endemic areas have produced conflicting results. Our 
objective was to determine the prevalence of ID and its relationship to 
erythrocyte parameters in Ugandan children with SCA living in a malaria 
endemic area. 205 Ugandan children <4 years of age with SCA were 
assessed for ID by testing plasma levels of four iron-related biomarkers 
(ferritin, soluble transferrin receptor (sTfR), C-reactive protein (CRP), and 
hepcidin) by ELISA. ID was defined using previously established cutoffs: 
(1) ferritin <12 µg/L if CRP <10 mg/L or ferritin <30 µg/L if CRP ≥10 
mg/L; or (2) hepcidin <5.5 ng/mL. Iron markers collectively reflected low 
iron stores and poor erythrocyte iron availability. Median (IQR) values 
for ferritin, sTfR, hepcidin, and CRP were 12.2 µg/L (7.5-26.2); 7.2 mg/L 
(5.5-9.0); 7.8 ng/mL (1.2-23.2); and 6.7 mg/L (2.6-16.7), respectively. The 
prevalence of ID was high (62.9% by ferritin cutoff, 42.4% by hepcidin 
cutoff). Children with ID as defined by low ferritin had similar hemoglobin 
levels (mean (SD)) to children without ID (7.6 g/dL (1.0) vs 7.4 g/dL (1.0), 
p=0.12) but had a lower MCV (78 fL (10) vs 82 fL (8), p=0.005). The 
data provide strong evidence that ID is common in children with SCA 
in a malaria endemic area. Studies are needed to assess the clinical and 
neurodevelopmental consequences of ID in children with SCA in malaria 
endemic areas, and to assess whether iron supplementation can be given 
to children with SCA in malaria endemic areas without increasing their risk 
of malaria and other infections.
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African children have a high prevalence of sickle cell anemia (SCA), which 
causes significant morbidity and early mortality. Previous studies of iron 
deficiency (ID) and the degree to which it contributes to anemia in children 
with SCA in malaria endemic areas have produced conflicting results. Our 
objective was to determine the prevalence of ID and its relationship to 
erythrocyte parameters in Ugandan children with SCA living in a malaria 
endemic area. 205 Ugandan children <4 years of age with SCA were 
assessed for ID by testing plasma levels of four iron-related biomarkers 
(ferritin, soluble transferrin receptor (sTfR), C-reactive protein (CRP), and 
hepcidin) by ELISA. ID was defined using previously established cutoffs: 
(1) ferritin <12 µg/L if CRP <10 mg/L or ferritin <30 µg/L if CRP ≥10 
mg/L; or (2) hepcidin <5.5 ng/mL. Iron markers collectively reflected low 
iron stores and poor erythrocyte iron availability. Median (IQR) values 
for ferritin, sTfR, hepcidin, and CRP were 12.2 µg/L (7.5-26.2); 7.2 mg/L 
(5.5-9.0); 7.8 ng/mL (1.2-23.2); and 6.7 mg/L (2.6-16.7), respectively. The 
prevalence of ID was high (62.9% by ferritin cutoff, 42.4% by hepcidin 
cutoff). Children with ID as defined by low ferritin had similar hemoglobin 
levels (mean (SD)) to children without ID (7.6 g/dL (1.0) vs 7.4 g/dL (1.0), 
p=0.12) but had a lower MCV (78 fL (10) vs 82 fL (8), p=0.005). The 
data provide strong evidence that ID is common in children with SCA 
in a malaria endemic area. Studies are needed to assess the clinical and 
neurodevelopmental consequences of ID in children with SCA in malaria 
endemic areas, and to assess whether iron supplementation can be given 
to children with SCA in malaria endemic areas without increasing their risk 
of malaria and other infections.
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RESPONSE TO ORAL POLIOVIRUS VACCINE
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Oral poliovirus vaccine(OPV) immunogenicity is sub-optimal, in developing 
countries with high enteric infection prevalence. Enteropathogen 
presence in asymptomatic children in such settings is hypothesized to 
lead to impaired oral vaccine efficacy. We studied the relationship of 
enteropathogens and biomarkers of gut inflammation in asymptomatic 
6-11 month old Indian infants with the immune response to a dose of 
monovalent OPV3 (mOPV3). Infants included were from a randomized 
clinical trial evaluating effect of a short course of azithromycin on 
mOPV3 seroresponse (CTRI/2014/05/004588). Enteropathogen profile 
in these infants (n=729) was evaluated using Taqman array card assays 
for enteropathogens, including bacterial, virus and parasite targets, from 
stool samples collected on the day of mOPV3 vaccination. In a subset of 
infants (n=299), fecal biomarkers of gut inflammation like calprotectin, 
myeloperoxidase, alpha-1antitrypsin and neopterin were estimated. 
Immune response to a mOPV3 dose was assessed by serum neutralization 
assays for anti-poliovirus 3 antibodies on samples collected 21 days after 
vaccination. Significantly higher proportion of infants failing to seroconvert 
were found to be infected with one or more enteropathogens on the day 
of the vaccination (94.3% of PV3 seronegatives vs 86.8% of seropositives, 
OR=2.5, 95CI=1.43-4.55). Enteric viruses were found in a significantly 
higher proportion of seronegative infants compared to seropositives 
(62% vs 46%, OR=1.9, 95CI=1.4-2.59). The difference with respect to 
bacterial enteropathogens or intestinal parasites even at higher pathogen 
loads was not significant. Among enteric viruses, non-polio enteroviruses 
(NPEV) were significantly associated with non-response to mOPV3(44% in 
seronegatives vs 29% in seropositives, OR=1.9, 95CI=1.4-2.6). Levels of 
fecal biomarkers like calprotectin, MPO and alpha-1AT were higher among 
seronegatives compared to seropositives, however, this difference was not 
significant. To conclude, this study adds to the evidence of association of 
enteric viruses, specifically NPEV, with OPV non response in developing 
settings.
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DEMOLISHING ACCESS BARRIERS TO HEALTHCARE IN TWO 
DIFFERENT CHAGAS DISEASE SCENARIOS: ENDEMIC AND 
NON-ENDEMIC AREAS IN ARGENTINA
Diego Weinberg, Ana Pereiro, Favio Crudo, Marcelo C. Abril
Fundación Mundo Sano, Ciudad de Buenos Aires, Argentina
Approximately 1.6 million people are infected with Trypanosoma cruzi in 
Argentina and less than 1% has access to etiological treatment. Within 
the country there are three distinct epidemiological scenarios that can 
be characterized for Chagas Disease (CD): 1) areas with a recent history 
of vector transmission (VT) currently controlled with entomological 
surveillance (S1); 2) areas with uncontrolled VT and/or without current 
entomological surveillance (S2), and 3) a historically non-endemic area 
(S3). In both in SI and in S3, it is necessary to conduct actions of timely 
diagnosis and treatment (D&T) of affected individuals; which is where 
this study was conducted. It is worth mentioning that in S2 these actions 
should not be promoted given the risk of possible re-infection through 
vector transmission. According to the recommendations of the Pan 
American Health Organization, a model of D&T was developed for the 
first level of healthcare. In order to achieve this, it was first necessary to 
provide primary healthcare centers with the technical capacity to be able 
to treat the patient in one place, minimizing the economic burden on the 
families and loss to follow-up. Mundo Sano participated in the training 
and motivation of the healthcare teams and provided the equipment to 
allow the centers to perform electrocardiograms in site. The process of 
D&T was free of charge (including clinical analysis, medical consultations 
and anti-parasitic drug). As of March 2016 a total of 12,096 people were 
diagnosed, of which 1,101 were positive for CD and 999 of these were 
treated. This experience shows the great potential of the first level of 
healthcare to provide access to D&T for CD.
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A NOVEL ELECTRONIC ALGORITHM USING HOST 
BIOMARKER POINT-OF-CARE TESTS FOR MANAGEMENT 
OF FEVER IN UNDER-FIVES IN RESOURCE-POOR SETTINGS 
(E-POCT): A CONTROLLED, NON-INFERIORITY STUDY
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Infections cause the majority of deaths in under-fives in resource poor 
settings. Management of febrile illnesses at outpatient level remains 
inadequate and antibiotic overuse is a great challenge. The objectives 
were to determine whether a novel, electronic algorithm using point-of-
care test results (e-POCT) is noninferior to a validated electronic algorithm 
derived from IMCI (ALMANACH) in treating fever in under-fives and 
to compare the proportion of antibiotic prescription between the two 
algorithms. E-POCT is an electronic algorithm developed by our group 
based on current evidence of pediatric fever management. It is built into 
an android application, which guides through the entire consultation 
and recommends treatment based on a few clinical signs, as well as 
point-of-care laboratory tests. We performed a randomized, controlled 
non-inferiority study of patients aged 2-59 months presenting with fever 
(axillary temperature ≥37.5°C) at 10 outpatient clinics in Dar es Salaam, 
Tanzania. The primary outcome was a noninferiority comparison between 
e-POCT and ALMANACH on the proportion of clinical failure by day (D) 
7 of follow-up. Noninferiority would be declared if the percent of clinical 
failure with e-POCT was no worse than the proportion of clinical failure 
with ALMANACH, within statistical variability, by a margin of 3% in a 
modified intention to treat analysis. The secondary outcome was the 
comparison between both arms on the proportion of antibiotic prescribed 
on D0. We enrolled 1583 patients into the e-POCT-, and 1581 into the 
ALMANACH-arm between December 2014 and February 2016 with 
lost to follow-up of 0.5% and 0.8%, respectively. The percent of clinical 
failure by D7 was 2.1 for e-POCT and 3.4 for ALMANACH. The 97.5% 
lower confidence limit was a -2.4 difference in percent, establishing 
noninferiority. The Antibiotics were prescribed at D0 in 10.9% of patients 
(95% confidence interval [CI] 9.4-12.5) using e-POCT, compared to 29.0% 
using ALMANACH (CI 26.8 - 31.3). In conclusion, e-POCT is noninferior 
to ALMANACH in terms of clinical outcome by D7 while significantly 
reducing (by 62%) the proportion of antibiotic prescription at D0.
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Lymphatic filariasis (LF) caused by Brugia malayi, B. timori, and Wuchereria 
bancrofti, potentially affects an estimated 1.2 billion people, with over 
120 million people infected, and about 40 million people disfigured and 
incapacitated by the disease. The disease manifestations include painful 
and profound disfigurement of the skin, lymphedema, elephantiasis and 
scrotal swelling which may eventually lead to permanent disability. Hence, 
individuals infected not only suffer physical disability, but also suffer 
mental, social and economic losses, thus resulting in depression, stigma 
and poverty. Current control of LF relies on mass drug administration 
either a combination of ivermectin and albendazole or DEC and 
albendazole. However, these drugs are only effective against the 
microfilariae (mfs), with limited activity against the adult worms, which 
may live for up to 18 years. Effective control is therefore hindered by the 
lack of adulticides (macrofilaricides). There is a pressing need for new 
macrofilaricidal compounds. Medicinal plants used in traditional medicine 
have been identified to play a potential role in the remedy of diseases. 
Preliminary studies in our lab showed crude extracts of Daniellia oliveri and 
Psorospermum febrifugum inhibited adult B. malayi motility, when the 
Worminator system was used. In this study, we screened crude extracts 
and chromatographic fractions of D. oliveri and I for activity against adult 
I, a suitable animal model for B. malayi. Remarkably, the active crude 
extracts had IC50 values in the range of 44 - 154 µg/mL, the cleaned-up 
extracts had IC50 values in the range of 27 - 331 µg/mL, and the active 
chromatographic fractions caused a 100% inhibition of motility when 
tested at 300 µg/mL. This indicates that, D. oliveri and P. febrifugum may 
serve as sources of lead compounds for the development of the much 
needed macrofilaricidal drugs.
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Recent experiments have indicated that the DNA of both Brugia malayi 
and Plasmodium vivax parasites is detectable in the pooled excreta/feces 
of vector mosquitoes. Utilizing real-time PCR, proof-of-concept work has 
demonstrated the high-throughput potential of this alternative approach 
to molecular xenomonitoring (MX). Yet despite these encouraging results, 
excreta/feces testing remains largely unexplored, and further work is 
required to more completely evaluate this novel methodology and gage 
its operational feasibility. Accordingly, we have performed comparative 
studies, aimed at assessing the detectability of parasite DNA within the 
excreta/feces obtained from mosquitoes under a variety of experimental 
conditions. Analyses have evaluated the impact of mf-blood density on 
parasite detection, while also examining DNA detection rates at various 
time-points post-exposure. The potential for DNA detection within the 
voided material of recently blood-fed, gravid, and host-seeking mosquitoes 
has also been explored, helping to better inform future trapping efforts 
intended for excreta/feces collection. Furthermore, as non-vector species 
clear B. malayi rather than harboring its development, the detectability 
of parasite DNA within the excreta/feces of non-vector mosquitoes 
was evaluated and results were compared with those for vector hosts. 
While a number of important questions remain to be addressed, the 
results described here provide a foundation for future studies aimed at 
operationalizing this novel approach to MX.
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PLACENTAL EXPRESSION OF IRON TRAFFICKING GENES IN 
THE CONTEXT OF HUMAN HELMINTHIASIS
Emily McDonald1, Remigio Olveda2, Luz Acosta2, Veronica Tallo2, 
Palmera Baltazar2, Jonathan Kurtis1, Jennifer Friedman1
1Rhode Island Hospital, Providence, RI, United States, 2Research Institute of 
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Iron deficiency during pregnancy and early infancy is a leading cause of 
poor growth and neurocognitive delays in childhood. Pregnant women 
and children in low and middle income countries (LMICs) are at increased 
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risk for iron deficiency due to iron poor diets and extra corporeal iron 
loss in stool due to helminthiasis. Herein, we examined the expression of 
ferroportin (FPN) and ferritin, key genes involved in iron trafficking across 
the placenta. Ferritin is the main storage protein for intracellular iron and 
FPN has been implicated at the primary exporter for iron from the placenta 
into fetal circulation. We isolated RNA from whole placental tissue stored 
in RNAlater (n=72) collected as part of a randomized controlled trial in 
Leyte, the Philippines, evaluating the impact of Praziquantel treatment 
during pregnancy on birth outcomes. Total RNA was reverse transcribed 
using random primers, and FPN, ferritin and 18S gene expression assessed 
using quantitative real-time PCR. FPN and ferritin gene expression were 
highly correlated in this cohort. Neither FPN nor ferritin gene expression 
in the term placenta was altered by Praziquantel treatment or maternal 
anemia status. Women who were infected with T. trichuria displayed 
significantly lower levels of both ferritin and FPN gene expression in the 
placenta. In addition, maternal levels of hepcidin, a key regulator of 
iron metabolism, at 32 weeks gestation were negatively associated with 
FPN gene expression in the placenta, while cord blood hepcidin was not 
associated with either FPN or ferritin gene expression. FPN expression was 
also positively associated with gestational age, and both FPN and ferritin 
expression were positively associated with birth weight in this sample of 
infants. Taken together, these data suggest that maternal factors such as 
trichuria infection and high hepcidin levels may have a greater influence 
on transplacental iron flux than fetal factors. In addition, effective 
iron trafficking is instrumental to successful pregnancy, and placentas 
challenged to transport adequate iron may result in newborns with lower 
birthweight.
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Flubendazole (FBZ) is a promising macrofilaricidal drug candidate for the 
elimination of onchocerciasis. Recently a new bioavailable oral formulation 
was developed and its efficacy was investigated in the jird Litomosoides 
sigmodontis model. Microfilariae-positive jirds were divided into 11 groups 
of 12 jirds each and FBZ was tested at single (40 mg/kg) or repeated (2, 6 
or 15 mg/kg for 5 or 10 days) oral (OR) doses and at single subcutaneous 
(SC) injections (2 or 10 mg/kg). Positive controls received 5 SC injections 
at 10 mg/kg, negative controls remained untreated. Jirds were euthanized 
8 weeks post treatment end for adult worm counts. Single and 5 x 10 
mg/kg SC FBZ completely cleared the adult worms in all animals (100%). 
Single 2 mg/kg SC and 10 x 15 mg/kg OR FBZ reduced the adult worm 
burden by 94% and 90%, respectively; single 40 mg/kg OR and 5 x 15 
mg/kg OR by 80 and 85%, respectively. At necropsy, all animals in the SC 
groups had no detectable microfilariae within the peripheral blood, while 
the oral FBZ treatment regimens reduced the microfilaremia in a dose 
and duration dependent manner. FBZ was measured in plasma by LC/
MS/MS. After OR, AUC 0-24h increased dose proportionally from 2 to 40 
mg/kg and was similar between days 5 and 10. After SC, FBZ was slowly 
released from the injection site and plasma levels remained constant up 
to necropsy. Results of this study demonstrate that single and repeated 
SC injections and repeated oral administrations of FBZ have an excellent 
macrofilaricidal effect and achieve efficacies of ≥ 90% adult worm 
reduction. Histopathological analyses of the remaining female adult worms 
could be considered to determine whether a permanent sterilization was 
achieved, which would guarantee that the transmission is stopped and 
microfilariae-driven pathology in Onchocerciasis is reduced.
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Flubendazole (FBZ) is a validated macrofilaricide in preclinical models 
of lymphatic filariasis (LF) and onchocerciasis when administered by 
multiple subcutaneous injections. A new amorphous solid dispersion 
(ASD) formulation of FBZ, with improved oral bioavailability, has been 
developed by Janssen. This formulation is currently undergoing testing in 
rodent models of filariasis to evaluate its in vivo efficacy as a candidate 
macrofilaricide. Preclinical macrofilaricides also require evaluation of direct 
microfilaricidal activity, especially considering potential indications in 
loiasis co-endemic foci, where severe adverse events have been reported 
following ivermectin (IVM) treatment. The Brugia malayi microfilaraemic 
mouse model is a validated screen to test activity of filaricidal compounds 
in inducing rapid decline of circulating blood mf in vivo. The purpose of 
this study was to assess whether single dose oral FBZ ASD (2 and 40 mg/
kg) has direct microfilaricidal efficacy in SCID mice intravenously infused 
with B. malayi mf. In parallel, efficacy of standard FBZ suspension given 
by injection was evaluated (10mg/kg x 5 days). Human bioequivalent oral 
IVM (0.2 mg/kg) induced 81% average reduction in circulating mf at +48h 
compared with pre-treatment levels (n=5, P=0.0003). Circulating mf did 
not significantly decline at +48h in either single oral dose regimens (12 or 
49% reductions in 2 or 40 mg/kg dose groups) or multiple injections of 
FBZ (35% reduction). Reductions observed in FBZ groups were similar to 
reductions in vehicle control circulating mf at +48h (38%). After 7 days, 
microfilaraemias were reduced significantly in single dose IVM group 
only compared to vehicle controls (85% efficacy, n=5 / group, F=3.733, 
P=0.0234). FBZ groups showed 0% efficacy when compared with vehicle 
controls. In conclusion, this counter-screening model demonstrates a lack 
of direct microfilaricidal activity of parenteral or oral FBZ formulations 
against circulating B. malayi. It is therefore unlikely that such bioequivalent 
FBZ regimens would mediate substantial direct effects against bloodborne 
microfilarial infections of humans.
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INDUSTRIAL SCALE SCREENING OF 1.3 MILLION 
COMPOUNDS IDENTIFIED 14 NOVEL CHEMOTYPES 
AS PROMISING NEW LEADS FOR THE TREATMENT 
OF LYMPHATIC FILARIASIS AND ONCHOCERCIASIS: A 
COLLABORATION BETWEEN THE ANTI-WOLBACHIA 
CONSORTIUM AND ASTRAZENECA
Rachel H. Clare1, Catherine Bardelle2, Neil Berry3, Paul Harper2, 
Ulf Börjesson2, Paul O’Neill3, David Hong3, Laura Myhill1, Andrew 
Cassidy1, Matthew Collier2, Jaclyn Bibby3, Darren Plant2, Helen 
Plant2, Roger Clark2, Kelly L. Johnston1, Louise Ford1, Kirsty Rich2, 
Mark Wigglesworth2, Mark J. Taylor1, Stephen A. Ward1
1Liverpool School of Tropical Medicine, Liverpool, United Kingdom, 
2AstraZeneca, Cheshire, United Kingdom, 3University of Liverpool, 
Liverpool, United Kingdom
A screening collaboration between the anti-Wolbachia consortium and 
AstraZeneca has identified 14 novel areas of diverse chemical space with 
potential for ongoing development into treatments for lymphatic filariasis 
and onchocerciasis. This was accomplished through the first industrial scale 
screening of a 1.3 million compound collection housed by AstraZeneca 
against Wolbachia, the A·WOL drug target and endosymbiotic bacteria 
of the filarial worms which cause onchocerciasis and lymphatic filariasis. 
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Following a primary screen at 10µM in a model insect cell line (C6/36) 
stably infected with Wolbachia we obtained ~20,000 hits which were 
triaged through a chemoinformatic analysis to select 6,000 compounds 
for secondary dose response screening. Again chemoinformatics were 
used to cluster the resultant hits into 58 distinct areas of chemical space. 
Representatives from all 58 clusters were then screened at 5µM in a 
microfilarial (larval worm) assay. From these representatives 14 clusters 
demonstrated equivalent Wolbachia reduction to our gold standard 
drug doxycycline after 6 days in vitro exposure. These novel chemotypes, 
including one related to known oxazolidinone antibiotics, are extremely 
promising new leads against lymphatic filariasis and onchocerciasis, 
diseases which afflict 157 million people worldwide resulting in severe 
disability globally.
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THAT FEELING OF BEING OUT OF PLACE: A MICROFILARIAL 
TALE
Marthe Kenny Charles1, Sarah Mansour1, Pauline Tomlin2, Kinga 
Kowalewska-Grochowska3
1University of Alberta, Edmonton, AB, Canada, 2Provincial Laboratory for 
Public Health, Edmonton, AB, Canada, 3University of Alberta-Provincial 
Laboratory for Public Health, Edmonton, AB, Canada
In, Alberta, Canada, a 27-year-old man presented to the Emergency 
Department with a complaint of pruritic swelling on his chest. His past 
medical history was unremarkable. He was born and raised on a farm 
in Sudan, and drank water from the river. At the age of 12, he fled to 
Kenya with his family, where he lived in a refugee camp, worked in 
construction, ate the food provided and drank water from a well. He 
immigrated to Canada in 2006 and has not returned to Africa since. His 
symptoms started in January 2016, when he noticed skin eruptions to his 
right chest. These eruptions were painful, pruritic and at times felt like 
slowly spreading movement underneath his skin. He presented to a local 
emergency department where he underwent a minor surgical procedure 
resulting in removal of a worm from the chest wall lesion. The worm was 
submitted to the laboratory for identification. Ten days later, the patient 
felt similar symptoms over his right eyelid; he returned to the hospital for 
removal of what turned out to be a second worm. He was referred to 
the Infectious Diseases Clinic. He was completely asymptomatic except 
for night sweats. His physical examination was unremarkable. There were 
no ocular findings and no serpiginous lesions on skin examination. Both 
worms were referred to US Centers for Disease Control and Prevention 
(CDC) for identification. Blood smear and stool were received in our 
laboratory; parasitic serology was referred to the National Centre for 
Parasitology (McGill). The patient was found to have a microfilarial load 
of >=8,000 microfilariae/ml. Coincidentally, his stool examination revealed 
rhabditiform larvae of Strongyloides stercoralis . His serology was negative 
for HIV and positive for Strongyloides sp. and schistosomiaisis (the latter 
possibly representing a cross-reaction or past exposure). Loa loa can live up 
to 17 years and is not considered endemic in Kenya. Most likely the patient 
acquired it while in Sudan. This case reports an unusual presentation 
of loiasis, further complicated by co-infection with S. stercoralis. It 
emphasizes the importance of obtaining a detailed travel history reaching 
far beyond the customary few years.
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ELIMINATION OF ONCHOCERCIASIS WITH IVERMECTIN: A 
VALIDATION OF THE EPIONCHO AND ONCHOSIM MODELS 
USING DATA FROM MALI AND SENEGAL
Martin Walker1, Wilma A. Stolk2, Matt Dixon1, Christian 
Bottomley3, Lamine Diawara4, Mamadou O. Traoré5, Sake J. de 
Vlas2, Maria-Gloria Basáñez1
1Imperial College London, London, United Kingdom, 2Erasmus MC, 
Rotterdam, Netherlands, 3London School of Hygiene & Tropical Medicine, 
London, United Kingdom, 4World Health Organization, Ouagadougou, 
Burkina Faso, 5Mali Ministry of Health, Bamako, Mali
EPIONCHO and ONCHOSIM are two independently developed models 
for the transmission and control of onchocerciasis. Both models have 
been used to explore the feasibility of eliminating onchocerciasis from 
Africa within the timeframes outlined by the World Health Organization 
(WHO) and endorsed by the 2012 London Declaration on Neglected 
Tropical Diseases. A recent comparison of projected timeframes to 
elimination by mass treatment with ivermectin highlighted similarities 
but also discrepancies between these two models that warranted further 
investigation and subsequent model refinement. Here we describe 
refinements to and re-fit the model to parasitological data from human 
populations in Cameroon and Ghana. We compare the refined version of 
EPIONCHO and ONCHOSIM in their ability to predict trends in infection 
prevalence from baseline to elimination in the three West African 
transmission foci in Mali and Senegal where infection was successfully 
eliminated circa 2007-2009. We also compare projected timeframes to 
elimination in terms of programmatic prevalence thresholds, stochastic 
fade-out and transmission breakpoints and evaluate the impact of 
uncertainty in key epidemiological and programmatic parameters. We 
conclude that both EPIONCHO and ONCHOSIM capture epidemiological 
trends towards elimination with sufficient accuracy to serve as useful 
decision-support tools for estimating when elimination is likely to be 
achieved in a variety of epidemiological and programmatic settings and for 
identifying foci where alternative intervention strategies might be required 
to reach the WHO targets.
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INTEGRATED LYMPHATIC FILARIASIS AND PODOCONIOSIS 
CLINICAL CASE MAPPING USING SMS MHEALTH TOOLS AND 
COMMUNITY NETWORKS IN HAWELLA TULA AND BENSA 
DISTRICTS OF ETHIOPIA
Biruk Kebede1, Abraham Tamiru1, Fikre H/Kiros1, Belete 
Mengistu2, Anna Kruger3, Hayley Mableson4, Louise Kelly-Hope4, 
Charles Mackenzie4, Sarah Martindale4
1National Podoconiosis Action Network, Addis Ababa, Ethiopia, 2Federal 
Ministry of Health, Addis Ababa, Ethiopia, 3George Washington University, 
Washington, DC, United States, 4Liverpool School of Tropical Medicine, 
Liverpool, United Kingdom
Lymphatic filariasis (LF) and podoconiosis are disabling neglected tropical 
diseases (NTDs) that affect the world’s poorest people and pose a 
significant economic burden. In Ethiopia, an integrated mapping project 
confirmed that 112 districts are LF-endemic, 345 districts podoconiosis-
endemic and 53 districts are co-endemic for both diseases, however 
limited information is available on the number of clinical cases. Such 
information is crucial for the effective planning and delivery of a basic 
package of care. The aim of this study was to identify cases using a 
bespoke SMS reporting tool, MeasureSMS, in two co-endemic districts, 
Bensa and Hawella Tula (population 430,439), of the Southern Nations, 
Nationalities, and Peoples’ (SNNP) Region. In July 2015, a total of 59 
Health Extension Workers (HEWs) and four district supervisors were trained 
on how to identify lymphoedema and hydrocele cases in their catchment 
area (including multiple kebeles) and to report the information by SMS 
using their own, basic mobile phones. This data was then sent to a local 
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smartphone with the MeasureSMS app installed, and uploaded to a cloud 
server where the automatically collated data was accessible via a web 
browser. A total of 2,197 lymphoedema cases and 134 hydrocele cases 
were reported, with 42 cases reported as having both conditions. The 
mean age of all cases was 45.2 years, with 45.4% of lymphoedema and 
100% of hydrocele cases being males. All HEWs reported cases with a 
mean of 40 cases per HEW, with a range of 3 to 210 cases across their 
multiple kebeles. To ensure data quality, 129 patients were randomly 
selected to be visited and verified by a trained clinician; 79.1% were 
confirmed as having the same condition as reported through SMS by the 
HEW. Network problems and power outages lasting up to two days were 
some of the challenges faced by the HEWs when using the mHealth tool in 
the field. Nevertheless, given the high numbers of cases reported in these 
districts, particularly of lymphoedema, MeasureSMS was shown to be a 
valuable mHealth tool to obtain patient estimates and guide the allocation 
of limited resources to those most in need.
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SCALING-UP A ‘PACKAGE OF CARE’ FOR LYMPHATIC 
FILARIASIS CASES IN MALAWI USING SMS MHEALTH TOOLS 
FOR MORBIDITY MAPPING, AND COMMUNITY HEALTH 
WORKER NETWORKS AND DISTRICT HOSPITALS FOR 
PATIENT CARE
John Chiphwanya1, Square Mkwanda1, Dorothy Emmie Matipula1, 
Paul Ndhlovu1, Michelle Stanton2, Hannah Betts2, Charles 
Mackenzie2, Sarah Martindale2, Louise A. Kelly-Hope2
1Ministry of Health, Lilongwe, Malawi, 2Liverpool School of Tropical 
Medicine, Liverpool, United Kingdom
After six successful rounds of mass drug administration (MDA) for 
lymphatic filariasis (LF), MDA in Malawi was stopped in 2014 following 
nationwide Transmission Assessment Survey (TAS) results. With evident 
success in interrupting transmission, Malawi, with partner support is now 
focussed on morbidity management and disability prevention (MMDP) 
for those affected by clinical manifestations, namely lymphoedema and 
hydrocele. To begin to scale-up MMDP, three key activities have been 
implemented in the two most endemic districts, Chikwawa and Nsanje 
in the Southern Region, and planned in a third district, Karonga in the 
Northern Region. Firstly, case estimates were obtained using the SMS 
reporting tool, MeasureSMS, which is an efficient and cost-effective tool 
by which community health workers (CHWS) identify and report clinical 
cases of LF in their communities by SMS to develop a clinical database 
of cases. To then provide access to care for these identified cases, 
lymphoedema management training of CHWs and hydrocele camps 
were organised. In Chikwawa district, 369 lymphoedema cases (71 % 
female) and 986 hydrocele cases were identified by SMS with 11 cases 
reporting both hydrocele and lymphoedema. In Nsanje district, 265 cases 
of lymphoedema (77% female) and 866 cases of hydrocele were reported 
with 9 cases reporting both conditions. To date, 123 of the hydrocele 
cases have been visited and verified by a clinical to ensure data quality 
and accuracy. Of these, 99 (80.5%) were confirmed to have the same 
condition as was reported by the CHWs. In December 2015, 326 of these 
reported cases had their hydrocele operated at six hydrocele camps across 
Nsanje and Chikwawa districts with impact assessments conducted to 
demonstrate an improvement in quality of life. In total, 468 CHWs were 
trained on lymphoedema management (integrated with leprosy) and 
hydrocele referral in early 2016. These results demonstrate that Malawi 
has made significant progress in scaling up MMDP activities and will 
continue to move these activities forward with a commitment from the 
Ministry of Health and partners with the aim of meeting the 2020 global 
and national elimination goal.
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LESSONS FROM MASS DRUG ADMINISTRATION FOR THE 
ELIMINATION OF LYMPHATIC FILARIASIS (LF) IN AN URBAN 
SETTING IN HAITI
Cudjoe Bennett1, Carl Fayette2, Franck Monestime2, Alain 
Javel2, Lior Miller1, Sarah Craciunoiu1, Abdel Direny3, Jean-Franze 
Lemoine4
1IMA World Health, Washington, DC, United States, 2IMA World Health, 
Port au Prince, Haiti, 3RTI International, Washington, DC, United States, 
4National Program to Eliminate Lymphatic Filariasis, Ministry of Public 
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The world is increasingly urbanized as 54% of the world’s population lives 
in urban areas, including 57% of the population in Haiti. Urbanization 
has far-reaching health consequences, as these highly mobile and 
heterogeneous populations have varying experiences and perceptions 
of the health system. As lymphatic filariasis (LF) is endemic throughout 
Haiti, the NTD Control Program has a goal to eliminate LF as a public 
health problem by 2020 through mass drug administration (MDA). To 
achieve elimination, at least five rounds of MDA with ≥ 65% coverage 
must be completed for the population at risk. High coverage rates are 
necessary for MDA to effectively reduce LF prevalence to a level at which 
transmission is not sustainable. Peri-urban settings in Haiti typically require 
additional rounds of MDA. Two communes were selected, the peri-urban 
Croix-des-Bouquets and rural Thomazeau in the West department for 
a Knowledge, Attitudes and Practice (KAP)/coverage survey supported 
through USAID’s ENVISION Project. A two-stage 30-cluster sample was 
used to ensure random selection. Data collection took 7 days and analyzed 
with STATA version 14. The survey coverage for Croix-des-Bouquets was 
53.3% compared to reported coverage of 67.09%; 80% for Thomazeau 
(61.3% reported coverage). The peri-urban nature of Croix-des-Bouquets 
may influence how and why respondents participate in MDA. Croix-des-
Bouquets is of interest as Haiti nears LF elimination, since success relies on 
high coverage urban MDAs. When asked how they heard about the MDA 
campaign, the most popular response was megaphones (35% Croix-des-
Bouquets and 65% in Thomazeau). The survey also found that population 
movement and general mistrust of the health system and participating in 
projects supported by international aid, contribute to low coverage rates. 
Further, those in urban settings have access to a greater variety of media 
therefore diluting the effectiveness of MDA messaging. Focusing on more 
direct ways to reach the population and alternative social mobilization 
strategies tailored to specific needs of the urban community may help 
overcome these barriers.
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LESSONS FROM LYMPHATIC FILARIASIS TRANSMISSION 
INTERRUPTION IN HAITI: ARE FIVE ROUNDS OF ANNUAL 
MASS DRUG ADMINISTRATION (MDA) NECESSARY IN LOW-
PREVALENCE SETTINGS?
Franck Monestime1, Carl Fayette2, Alain Javel2, Lior Miller1, Sarah 
Craciunoiu1, Luccene Desir3, Abdel Direny4, Ryan R. Hemme5, Jean-
Aaron M. Samuels6, Thoma G. Streit3, Caitlin Worrel6, Kim Won6, 
Patrick Lammie7, Jean-Franz Lemoine8
1IMA World Health, Washington, DC, United States, 2IMA World Health, 
Port au Prince, Haiti, 3Hopital Ste. Croix/University of Notre Dame (UND), 
Leogane, Haiti, 4RTI International, Washington, DC, United States, 5U.S. 
Centers for Disease Control and Prevention, Kisimu, Kenya, 6U.S. Centers 
for Disease Control and Prevention, Atlanta, GA, United States, 7NTD 
Support Center, the Task Force for Global Health, Atlanta, GA, United 
States, 8National Program to Eliminate Lymphatic Filariasis, Ministry of 
Public Health and Population, Port au Prince, Guyana
Lymphatic filariasis (LF) is endemic throughout Haiti. In line with World 
Health Organization’s (WHO) LF elimination targets, the Haiti NTD Control 
Program (HNTDCP) has a goal to eliminate LF as a public health problem 
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by 2020. Currently WHO recommends 5 rounds of consecutive annual 
mass drug administration (MDA) with ≥65% coverage, after which a 
transmission assessment survey (TAS) can be carried out to determine 
whether MDA can be stopped. Ile de la Tortue, a commune in the 
Northwest department, is a remote island that had an antigen prevalence 
of 6.0% in 2000 and only 0.8% by 2006 sentinel site evaluation. Two 
rounds of MDA were conducted in Ile de la Tortue 2003 and 2005 
with 110% and 87% reported coverage, respectively. MDA was then 
suspended due to resource constraints. In 2012, the HNTDCP with 
assistance from CDC and UND carried out TAS1 in order to determine if 
additional rounds of MDA were necessary to reduce antigen prevalence 
to below 2%. School-based TAS was carried out on a sample of 1,308 
11-12 year olds, with 13 immunochromatographic card test (ICT) positive 
cases, which was below the calculated critical cut-off for sample size of 
14. This older age group was used because school enrollment for 6-7 
year-olds was significantly below the recommended 75%, and enrollment 
did not exceed 75% until the 11-12 age group. Further, using an older 
age group is appropriate in settings where MDA has not been recently 
carried out. In 2016, the HNTDCP and IMA World Health/ENVISION carried 
out a school-based TAS2 in Ile de la Tortue. A total of 928 6-7 year olds 
were tested, and 0 were ICT-positive. These results indicate that 12 years 
since the last treatment, there is no evidence of ongoing LF transmission 
and additional MDA is not indicated. The results suggest that 5 rounds 
of annual consecutive MDA may not be necessary in areas with adequate 
MDA coverage and low baseline prevalence. Further research is warranted 
to determine the number of rounds of MDA required, as reducing these 
could help resource-poor settings with low initial prevalence reach their 
2020 LF elimination goals.
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PROJECTIONS OF ATTAINING ONCHOCERCIASIS 
ELIMINATION IN OGUN STATE, NIGERIA: A CROSS-
SECTIONAL REPORT OF THE OV-16 SEROLOGY (RAPID 
DIAGNOSTIC TEST) AMONG CHILDREN BORN AFTER 10 
YEARS OF TREATMENT WITH IVERMECTIN
Olabanji A. Surakat1, Sammy O. Sam-Wobo1, Monsuru A. 
Adeleke2, Oladunni N. Adekunle1, Samuel O. Bankole1, Ehigozie E. 
Egbeobawaye3, Atinuke Awoyale1, Naomi Oyinloye1
1Federal University of Agriculture, Abeokuta, Abeokuta, Nigeria, 2Osun 
State University, Osogbo, Osogbo, Nigeria, 3University of Benin Teaching 
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Evidence based studies using the Ov-16 serology among children below 10 
years of age is one of the key components of the revised WHO course of 
action for indicating interruption of transmission of Onchocerca volvulus 
among human population receiving treatment with ivermectin. In view 
of this background, this study conducted between March and July 2015 
investigated the sero-prevalence of onchocerciasis in endemic communities 
of Ogun State, Nigeria after 10 years of treatment with ivermectin. Using 
the Ov16 Rapid Diagnostic Test (RDT), 719 children between the age 5-9 
years residing in 32 firstline communities in 8 endemic Local Government 
Areas (LGA’s) provided whole blood specimen which were tested for IgG4 
antibodies against the O. volvulus antigen Ov-16. Data were analysed 
using Pearson’s Chi square in SPSS 20. Results showed a cumulative sero-
prevalence of 21(2.9%), Relationship between age and prevalence was 
statistically insignificant (p > 0.05). Thirteen females and eight males were 
exposed to O. volvulus respectively. The low sero-prevalence recorded 
among children within the age range (5-9 years) born after the inception 
of ivermectin implementation implies that they may have had diminutive 
historic exposure. Although this finding is somewhat greater than the 
0.1% threshold set by the guideline for this study population. The 
Information obtained will serve as a baseline serological information and 
a guide to prepare Ogun State for Post Treatment Surveillance (PTS) in the 
nearest future.
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INTEGRATING NOVEL PEPTIDES AND REPORTER 
NANOPARTICLES IN A RAPID TEST FOR ONCHOCERCIASIS
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This study describes a lateral flow assay (LFA) to detect exposure to 
Onchocerca volvulus. The assay features two innovations: a novel peptide 
biomarker and novel nanoparticles. The advent of high throughput 
peptide synthesis and micro-array technology enables new avenues 
for the discovery of diagnostic targets. Scanning the O. volvulus 
proteome for immunodominant linear epitopes revealed at least three 
highly immunogenic motifs, as reported previously. In parallel, we have 
introduced new plasmonic reporter nanoparticles to increase the analytical 
sensitivity of LFAs. These nanoparticles are gold shells, consisting of a 
gold layer deposited over a low-density silica gel core. The shells are 
blue to black and absorb visible light 35 times more efficiently than the 
red colloidal gold typically employed in LFAs. The increase in absorption 
translates into a stronger visual readout and an increase in analytical 
sensitivity. The two technologies were merged into a prototype LFA that 
employs gold shells to detect circulating antibodies to one of the recently 
discovered peptide motifs. A total of 20 plasma samples (FR3 repository) 
from individuals suffering from onchocerciasis and 16 samples from non-
endemic healthy controls were tested i) in the Ov16 LFA, ii) in a peptide 
ELISA, and iii) in the peptide LFA using gold shells. The Ov16 LFA showed 
85% and 100% sensitivity and specificity, respectively. The peptide ELISA 
gave 90% sensitivity and 100% specificity. The peptide LFA was 80% 
sensitive and 100% specific. The peptide LFA results correlated with 
the peptide ELISA data, and the four samples that scored negative in 
the LFA gave no or very low signal in the ELISA. Onchocerciasis samples 
lacking Ov16 antibodies did recognize the peptide in ELISA and LFA, 
and conversely, samples lacking antibodies against the peptide reacted 
in the Ov16 LFA. Thus, a peptide LFA was assembled which, when used 
in combination with the Ov16 LFA, and when tested on a small sample 
collection, detects antibodies to O. volvulus with a sensitivity of 100% and 
specificity of 100%.
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IMMUNOREACTIVITY OF AN ONCHOCERCA VOLVULUS 
LINEAR EPITOPE IN INDIVIDUALS FROM DIFFERENT REGIONS 
IN GHANA
Ole Lagatie1, Ann Verheyen1, Erik Nijs1, Bieke Van Dorst1, Linda 
Batsa Debrah2, Alex Debrah3, Lieven J. Stuyver1
1Janssen Diagnostics, Beerse, Belgium, 2Kumasi Centre for Collaborative 
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Using proteome-wide high-density peptide microarrays we have identified 
an immunodominant linear epitope, as reported previously. We have used 
peptide ELISA to assess the immunoreactivity of a 15-mer peptide 02-
052 containing the identified motif 2, in individuals from Ghana. Plasma 
samples were collected from nodule-positive individuals (n=94), endemic 
controls (n=48), non-endemic controls (n=20) and lymphatic filariasis 
patients (n=45). A healthy control group of 10 samples from South 
Africa was included to assess specificity. All samples were tested on the 
Ov16 IgG4 lateral flow test (LFA) (Standard Diagnostics). None of healthy 
controls from South-Africa and non-endemic controls were positive 
in this test, while 24/48 endemic controls, 68/94 nodule-positive, and 
12/45 LF patients were positive for Ov16 IgG4 antibodies. ‘No peptide’ 
controls were included for all samples to assess non-specific binding of 
antibodies (i.e. background). A cut-off for positivity was set at the average 
background + 3SD. None of the healthy control samples had detectable 
antibodies against the peptide. In the non-endemic control group, 3/20 
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were positive in the peptide ELISA. In the endemic control group, 17/24 
and 14/24 of the Ov16 positive and negative individuals, respectively, were 
positive in the peptide ELISA. 40/68 of the Ov16 positive nodule-positive 
individuals, and 13/26 of the Ov16 negative nodule-positive individuals, 
had detectable antibodies against the peptide. Also in the LF group, 8/12 
and 23/33 of the Ov16 positive and negative individuals, respectively, were 
positive in the peptide ELISA. In conclusion, the new O. volvulus linear 
epitope showed perfect specificity in healthy controls from South Africa. 
This peptide ELISA identifies more cases of exposed/infected individuals 
as compared to the Ov16 IgG4 test. Reactivity in LF patients residing 
in onchocerca endemic areas requires in depth analysis and will drive 
the use case for peptide LFA. This peptide has been used previously for 
development of a LFA.
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DEWORMING IN PRE-SCHOOL AGE CHILDREN IN NIGERIA: 
ARE THOSE WHO NEED IT THE MOST RECEIVING 
TREATMENT?
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Pre-school age children are at high risk for nutritional and growth 
impairments from soil transmitted helminths (STH) and yet, despite the 
World Health Organization’s recommendation of periodic treatment for 
those in that age group in endemic areas, they are currently not receiving 
the deserved attention from national control programs. We examined 
the deworming status of pre-school aged children in 12 high prevalence 
states in Nigeria and whether those at increased risk of infection or with 
related symptoms received treatment. Children aged 12-59 months 
were selected from the 2013 Nigeria Demographic and Health Survey, a 
national representative sample survey of adults aged 15-49 years. Markers 
of risk for infection with STH were state prevalence levels (≤ 20%), 
socioeconomic status and other demographic variables. Symptomology 
was represented by the presence of stunting. Weighted logistic regression 
was used to determine the association of infection risk factors and 
stunting with mother’s reports of whether children received treatment. 
Of the 3,062 children considered in the analysis, 39% received treatment 
for worm infections. Compared to children with normal height, severely 
and moderately stunted children were less likely to access treatment with 
OR=0.45 (95Cl: 0.31 - 0.64) and OR =0.69 (95Cl: 0.51 - 0.93) respectively. 
Uneducated mothers and fathers were less likely to report treating their 
children with OR = 0.52 (95Cl%: 0.35 - 0.75) for mothers and OR =0.42 
(95Cl%: 0.25 - 0.72) for fathers. Poorer children were less likely to access 
treatment than the richest children with OR = 0.41 (95Cl%: 0.26 - 0.64). 
The disparities in treatment access among stunted children as well as the 
potential influence of socio-economic factors call for increased need for 
deworming coverage of pre-school aged children in Nigeria. Deworming 
interventions can prevent children from becoming more stunted and 
may even reverse it. Control programs must identify the most-at-risk 
populations in order to leverage existing resources to decrease intestinal 
worm prevalence and break transmission.
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SITUATIONAL ANALYSIS OF NEGLECTED TROPICAL DISEASES 
MANAGEMENT INFORMATION SYSTEM IN ETHIOPIA
Mesfin S. Kassa
RTI International, Addis Ababa, Ethiopia
Health Management Information System (HMIS) is critical for neglected 
tropical diseases (NTDs) services delivery and informed decision making. 
In Ethiopia the current situation of the NTD-HMIS is not clearly known. 
This study is therefore conducted to assess the existing NTD management 
information system and thereby generate evidence for formulating 
interventions for improving the system in Ethiopia. The situational 
analysis involved collection of both quantitative and qualitative data using 
structured self-administered questionnaire, observation and key informant 
interview among district monitoring and evaluation officers, district 
managers, health extension workers and regional NTD program managers. 
Data was analyzed by using Epi-Info version 3.5.4 and descriptive 
statistics was conducted using the software. A total of 11 NTD endemic 
regions in Ethiopia were included in this study. Of these, the largest 
proportions (66.6%) had no NTD team at regional level, thus the program 
was executed by focal person. About a third (33.1%) of respondent in 
the sample had not received a training workshop or technical briefing 
on monitoring & evaluation of NTDs. According to the NTD data 
management, it was reported that (83.3%) of the respondent were using 
simple Excel file to store their data, and the remaining (16.7%) were using 
paper based mechanism to keep. Regarding data quality assurance, all of 
the regions (100%) had not carried out data quality assessment. Findings 
for the NTD medicine supply and management revealed that most of the 
region (83.3%) had a system for tracking medicines remaining in stock 
and wastage in the region while only (16.7%) of the overall sampled had 
no tracking system. This study recommends that collaboration among 
the stakeholders on capacity buildings of management information 
system, supportive supervisions with timely and concrete feed backs, 
and establishment of functional NTD monitoring and evaluation working 
group at regional level is encouraged. Continual presence of standardized 
data collection tools and use of information technology for management 
information system should be given due attention.
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TREATMENT COVERAGE VALIDATION SURVEY AFTER 
A SCHOOL-BASED MASS DRUG DISTRIBUTION OF 
PRAZIQUANTEL AND MEBENDAZOLE IN SELECTED 
DISTRICTS OF ETHIOPIA
Kalkidan M. Begashaw1, Gemechu Leta1, Addisu Alemayehu2, 
Markos Sleshi2, Michael D. French2
1Ethiopian Public Health Institute, Addis Ababa, Ethiopia, 2Schistosomiasis 
Control Initiative, London, United Kingdom
The Ethiopian Ministry of Health is scaling up programs to deliver regular, 
large-scale schistosomiasis (SCH) and soil-transmitted helminths (STH) 
treatment for at-risk populations, through repeated rounds of preventative 
chemotherapy (PCT) using Praziquantel (PZQ) and Mebendazole (MEB). 
One of the key indicators of program success is program coverage. The 
aim the surveys presented here is to produce validated coverage estimates 
of reasonable precision following mass drug administration round in April 
2015 in randomly selected district. To assess the coverage of mass drug 
administration in the dewormed districts of Ethiopia. A community-based 
cross-sectional study design was employed. Accordingly, 960 households 
from 96 kebeles found in the sampled 8 districts were selected. The survey 
covered districts in Amhara, Oromia and Southern Nations Nationalities 
and Peoples Region. Participation in the treatment campaign and other 
related Information was collected from school age children (SAC) between 
the age ranges of 5 to 14 years. 960 households were selected for the 
validation survey and a total of 1910 (97.2%) school age children (SAC) 
residing in the selected households between the age ranges of 5 to 14 
years were interviewed. During the house hold visit, 55(2.8%) households 
were not available for interview. While 81.2% of the school age children 
interviewed were attending school, 18.8% were non-enrolled. 91% of 
the interviewed children were present in schools during the mass drug 
administration campaign. During the treatment campaign 84.9% and 
85.3% interviewed SACs swallowed Praziquantel and Mebendazole 
respectively and there was no difference by gender. Our current finding 
shows that approximately 85% of school age children interviewed 
received the treatment and the coverage is very high in enrolled school age 
children. Based on these findings, we recommend creating mechanisms to 
158
astmh.org
reach non-enrolled school age children and awareness in the community 
if targeting 2020 to control both schistosomiasis and soil-transmitted 
helminths in Ethiopia.
500
TO INTEGRATE OR NOT TO INTEGRATE? DEVELOPING AN 
EVIDENCE-BASED TOOL FOR NEGLECTED TROPICAL DISEASE 
CONTROL
Claire J. Standley1, Ellie Graeden2, Justin Kerr2, Erin M. Sorrell1, 
Rebecca Katz1
1George Washington University, Washington, DC, United States, 2Talus 
Analytics, Boulder, CO, United States
While evidence from clinical and modeling studies have demonstrated the 
potential benefit of integrating vertical disease programs, few evidence-
based tools exist to assist decision makers in evaluating and comparing 
approaches for integration of control measures, to determine the most 
impactful and cost-effective approaches for their setting. We have created 
an application available for mobile devices or on the web, with a simple 
user interface, to support on-the-ground decision-making for integrating 
disease control programs or their components, given local conditions and 
practical constraints. The model upon which the tool is built provides 
predictive analysis for the effectiveness of integration of schistosomiasis 
and malaria control, two common parasitic diseases with extensive 
geographical and epidemiological overlap, and which result in significant 
morbidity and mortality in affected regions. Working with data from 
countries across sub-Saharan Africa and the Middle East, we present here 
a proof of principle for the use of our tool in providing guidance on how 
to optimize integration of vertical disease control programs.
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SURGICAL MANAGEMENT OF MORBIDITY DUE TO 
LYMPHATIC FILARIASIS: HYDROCELE SURGERY IN HEALTH 
DISTRICT HOSPITALS IN MALI
Massitan Dembélé1, Benoit Dembele2, Zana Berthé2, Seydou 
Goita2, Salif Seriba Doumbia3, Boubacar Guindo2, Modibo Keita2, 
Abdoul Karim Sidibé1, Steven Reid4, Marily Knieriemen2, Yaobi 
Zhang5
1Direction Nationale de la Santé, Ministère de la Santé et de l’Hygiène 
Publique, Bamako, Mali, 2Helen Keller International, Bamako, Mali, 
3Malaria Research and Training Center, Filariasis Research Unit, Bamako, 
Mali, 4Helen Keller International, New York, NY, United States, 5Helen 
Keller International, Regional Office for Africa, Dakar, Senegal
Mali is committed to national lymphatic filariasis (LF) elimination by 
2020. The program has two main components: interrupting transmission 
of LF through mass drug administration and managing morbidity 
and preventing disability. Mali has achieved great progress toward LF 
elimination: to date, 31 of the 63 health districts (HDs) have reached the 
criteria to stop MDA. However, improvements in morbidity management 
and disability prevention are more difficult to achieve. Interventions for 
the surgical management of hydrocele and lymphedema management 
were introduced in 2012. These interventions are very demanding by 
the patients because of social impacts in their daily live. From 2014-15, 
the national program, with the support of HKI with funding from the 
End Fund, performed surgical treatment of 369 LF patients in 16 HDs. 
General practitioners performing surgery were trained on hydrocele case 
management and hydrocele cases were identified at the community level. 
Surgeons obtained informed consent prior to the surgical procedure 
and maintained patient records. A descriptive analysis to show the 
impact of hydrocele management was performed on 175 patients who 
were included in this analysis based on the completeness of the patient 
record. The median age of patients was 52 years and 75% (132/175) 
were married. The majority of patients 82.3% (144/175) did not report 
postoperative complications. The median duration of hospitalization 
was 4 days (ranging 2-55 days). Results showed that 32.6% (57/175) 
patients reported a considerable positive impact on their work and 44.6% 
(78/175) reported improved sex lives. Of those patients operated, 77% 
(54/70) indicated satisfaction after surgery and noted improvement in their 
daily lives. Dissatisfied patients had developed postoperative secondary 
infections that were managed with supportive therapy. This study shows 
that the management of hydrocele surgery can be done in a district 
hospital setting in Mali without major complications and achieve general 
patient satisfaction. Consequently, the LF morbidity management and 
disability prevention project will be expanded to other HDs.
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ACHIEVING THE ENDGAME: IMPROVING INTEGRATED CASE 
SEARCHES FOR GUINEA WORM DISEASE AND TRACHOMA 
TO ACHIEVE ERADICATION AND ELIMINATION TARGETS
Lucas E. Buyon1, Randall Slaven2, Paul Emerson3, Jonathan King4, 
Donald Hopkins2, Kelly Callahan2
1Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United 
States, 2The Carter Center, Atlanta, GA, United States, 3International 
Trachoma Initiative, Atlanta, GA, United States, 4World Health 
Organization, Geneva, Switzerland
Guinea worm disease and trachoma are both neglected tropical diseases 
(NTDs) slated for eradication and elimination as a public health problem, 
respectively, by the World Health Organization. In 2010, The Carter Center, 
the Ghana Ministry of Health and local partners, carried out integrated 
case searches for rumors of possible cases of Guinea worm disease and 
persons with trachomatous trichiasis (TT), the end stage of trachoma. 
These case searches were conducted to meet eradication and elimination 
targets. The first series of case searches were carried out in four districts, 
which were searched community to community, with patients referred to 
a centralized surgical facility. This method of searching did not adequately 
cover the target population and resulted in low surgical uptake. The 
second series of case searches, which were conducted house-to-house 
with patients being offered immediate investigation of suspected Guinea 
worm disease cases and TT surgical care either in the home or an adjacent 
primary care facility. This method resulted in higher surgical uptake. 
The house to house immediate resolution approach was also shown to 
be more cost effective. The cost to investigate suspected cases of both 
diseases in the house to house immediate response approach was about 
USD$13.99 per case examined, compared to a cost of $19.78 per case 
examined in the community with referral to surgical facilities approach. 
A review of the two approaches showed significant cost differences and 
favorable outcomes to the house to house immediate response approach. 
This approach should be considered an option for disease “end game” 
where case searches are required to meet targets. This approach should 
be considered in an integration fashion with other NTDs to maximize cost 
saving and efficient use of resources.
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ARE WE REACHING EVERYONE AS WE MOVE FROM 
CONTROL TO ELIMINATION OF NTDS: FINDINGS FROM AN 
INTEGRATED TREATMENT COVERAGE SURVEY IN NORTHERN 
NIGERIA
Nazaradden Ibrahim1, Safiya Sanda1, Laura Senyonjo2, Sunday 
Isiyaku1
1Sightsavers, Kaduna, Nigeria, 2Sightsavers, Haywards Heath, United 
Kingdom
Countries like Nigeria have developed and are implementing programmes 
for integrated control of Neglected Tropical Diseases (NTDs). Sightsavers 
is leading consortium of partners in scale-up for elimination of NTDs 
in northern Nigeria. However, little data are available to verify reported 
coverages of previously conducted Mass Drug Administration (MDA). 
The purpose of this presentation is to validate the reported coverage 
from Community Drug Distributors (CDD) through integrated post-MDA 
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coverage survey in Kaduna, Katsina and Niger states. This also highlights 
differences by drug type, persons with disabilities (PWD) and reasons 
for non-compliance. A population based survey using two-stage cluster 
sampling methods was conducted to verify the proportion of individuals 
who ingested the drugs during last rounds of MDA. Washington Group 
(WG) questions were integrated into the questionnaire. Since not all drugs 
were distributed at the same time, to reduce recall bias, drug samples 
were shown to participants during the survey. A total of 7,688 persons 
were enrolled from six Local Government Arears (LGAs) in three states. 
Overall, the therapeutic coverages in survey population were lower than 
those reported by CDDs. 58.6% (95% CI 56.0-61.2) and 68.7% (95% 
CI 66.1-71.3) swallowed Mectizan/Albendazole in Kubau and Soba 
LGAs of Kaduna state respectively. Two LGAs in Katsina had coverage of 
54.9% and 50.4% (95% CI 52.3-57.4 and 47.6-52.9) while the reported 
coverage was 18% and 102% respectively. Niger had survey coverage 
of 66.2% (95% CI 64.9-70.4) in one LGA while they reported 32%. 
Large proportions of eligible persons with severe disability were missed 
during MDA for all drugs. Among eligible population in Kaduna, 3.5% of 
PWD reported ingesting Mectizan/Albendazole, while 96.5% were non-
disabled. Similar lower coverages were seen in other two states. Despite 
the intervention being community driven, more efforts are required to 
ensure adequate and equitable coverages are reached, and maintained at 
WHO levels for elimination to be attained. These reported levels should be 
verified so that appropriate measures are taken to improve coverage.
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THE IMPACT OF MASS DRUG ADMINISTRATION ON 
HOOKWORM AND SCHISTOSOMIASIS IN LOFA COUNTY, 
LIBERIA BEFORE AND AFTER THE OUTBREAK OF EBOLA 
VIRUS DISEASE
Lincoln Gankpala1, Emanuel Brooks1, Abakar Gankpala1, Aaron T. 
Momolu1, Kerstin Fischer2, Joshua Bogus2, Fatorma Bolay1, Gary J. 
Weil2, Peter Uwe Fischer2
1Liberian Institute for Biomedical Research, Charlesville, Liberia, 
2Washington University School of Medicine, St. Louis, MO, United States
Lofa County was an epicenter of the 2014 Ebola virus disease (EVD) 
outbreak, and an extensive hand washing and hygiene campaign was 
launched in the summer of 2014 that lasted about 18 months. We are 
comparing the impact of annual (1x per year) vs semiannual (2x) mass 
drug administration (MDA) with ivermectin, albendazole and praziquantel 
on lymphatic filariasis, onchocerciasis, soil transmitted helminths (STH), 
and schistosomiasis in 32 villages. This study focuses on results for STH 
and schistosomiasis. Between 1,850 and 2,678 subjects aged 5 years and 
older were screened each year by duplicate Kato Katz stool exams. Rates 
and intensities of ascariasis and trichuriasis were low at baseline in 2012, 
but hookworm and Schistosoma mansoni infections were rampant with 
prevalence rates of 61% and 88% and geometric mean egg counts of 232 
and 213 epg, respectively. Prevalence rates in the spring of 2014 following 
MDA were essentially unchanged, but egg counts for hookworm and 
S. mansoni were reduced from baseline by 51% and 31%, respectively. 
Ebola prematurely ended our survey in 2014 and prevented MDA for 1 
year, but the epidemic brought extensive changes in hygiene in the study 
communities. MDA was reintroduced in April 2015, and the communities 
were re-tested in the spring of 2016. At that time the hookworm 
prevalence rate was only 27% (a 45% reduction from 2014), and with 
only 47 epg (a 59% reduction from 2014). In contrast, the reductions 
in S. mansoni prevalence (10%) and intensity (20%) during this time 
interval were unimpressive. These results suggest that local elimination of 
hookworm may be easier to achieve with MDA than local elimination of 
schistosomiasis. We also suspect that the dramatic reduction in hookworm 
after the EVD outbreak was due to improved hygienic practices that 
reduced reinfection rates following MDA. The EVD outbreak provided 
a unique opportunity to study the additive impact of hygiene on top of 
MDA.
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FINDINGS FROM A SITUATIONAL ANALYSIS FOR 
INTEGRATED COMMUNITY CASE MANAGEMENT IN RURAL 
HEALTH ZONES OF HAUT-KATANGA IN THE DEMOCRATIC 
REPUBLIC OF THE CONGO
Jean-Yves Mukamba1, André Bope Bope2, Annie Ndaya B3, Eric 
Swedberg4, Troy Martin5
1PATH, Kinshasa/Gombe, Democratic Republic of the Congo, 2PSI, 
Kinshasa/Gombe, Democratic Republic of the Congo, 3National Program 
on Diarrhea Prevention, Kinshasa/Gombe, Democratic Republic of the 
Congo, 4Save the Children, Fairfield, CT, United States, 5PATH, Seattle, WA, 
United States
Though rich with resources, the population of Katanga province in the 
Democratic Republic of Congo (DRC) is primarily rural, poor and harbors 
some of the highest child mortality rates in country. The province also has 
the lowest ratio of health care workers (HCWs) to inhabitants, particularly 
nurses (4 per 10,000 persons), and health coverage is very low: only 25% 
have access to health facilities (HFs) within 5 km of distance. In response, 
the DRC recently developed guidelines for implementation of integrated 
community case management (iCCM). In response, the MalariaCare 
partnership assessed nine health zones (HZs) in Katanga for opportunities 
to develop community health sites (CHS). Following national criteria - 
which include parameters for population density and preference for higher 
difficulty of access to and >5km distance from the local health center - the 
project found 96 eligible villages in 52 health areas (HAs) during a pre-
visit screen. Following on-site assessments, MalariaCare further modified 
selection criteria to only include sites >10km & <30km from health center 
with head nurses able to supervise CHS. A final group of 53 villages in 45 
HAs were ultimately identified for CHS development. Several challenges 
were encountered during this site selection process. For example, the 
average population per village site is 2,389 persons (median population 
is 2,003; range 912-7,400), exceeding the recommended 1,000 persons 
(500 per community health worker—CHW) per CHS. Additionally, the 
average distance between a CHS and an HF was 17.3 km [5.6-48 km], 
with a median of 15 km - raising challenges for adequate supervision 
and adequate resupply. This mapping exercise demonstrated that using 
reasonable CHS criteria, widespan implementation of CHW-based 
iCCM in this province will be challenging due to the lack of supporting 
health facility infrastructure. Consequently, supervision models should 
be developed to allow for the higher population densities and longer 
distances from health facilities, than were originally anticipated for 
implementation of iCCM in Katanga province.
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DEVELOPING EVIDENCE BASED COMMUNICATION AND 
SOCIAL MOBILIZATION STRATEGIES 26MASS DRUG 
ADMINISTRATION
Geordie Woods1, Leah Wohlgemuth1, Brian Fuller2, Rachel 
Stelmach2, Alexis Serna2, Jean Jacques Tougoue2, Kathryn 
Crowley2, Abdel Direny2, Margaret Davide-Smith2, Arianna Serino3, 
Lisa Rotondo2, Philip Downs2, Margaret Baker2
1Sightsavers, New Orleans, LA, United States, 2RTI International, 
Washington, DC, United States, 3U.S. Agency for International 
Development, Washington, DC, United States
There is a need for stronger, evidence based, social mobilization 
approaches and information education and communication (IEC) materials 
to support behavior change for mass drug administrations (MDA) in the 
control of neglected tropical diseases (NTDs). In order to address this 
problem a draft guide on how to design effective social mobilization 
strategies and IEC materials for MDAs was developed. Results of the study 
that served to guide the development of this document are presented 
here. The study consisted of a desk review and four rapid case studies 
- from national NTD programs supported by ENVISION, funded by the 
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U.S. Agency for International Development (USAID) and managed by RTI 
International. Case studies included a budget and expenditure analysis 
of IEC and social mobilization budget lines, information extracted from 
knowledge attitudes and practices (KAP) surveys, review of IEC and social 
mobilization materials and strategies, and in-depth interviews with key 
informants. The total dollar amount spent on IEC and social mobilization 
as a percentage of total program costs ranged from 4.2% to 11.8%. 
The items that account for the highest portion of this budget were print, 
wearable items, events, town criers and radio, but this varied considerably 
by county. Practices identified with potential for success across different 
country settings included use of community distributors as trusted 
sources of information and inclusion of messages focused on side-effects. 
Opportunities for strengthening social mobilization included: revise IEC 
materials that were often too technical and lacked information related to 
taking part in MDAs, strengthen social mobilization and communication in 
training of drug distributors, develop simple strategies based on evidence, 
and evaluate materials and strategies. The resulting guide, including 
templates and planning tools, is briefly presented.
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A COMPREHENSIVE SUSTAINABILITY FRAMEWORK FOR 
NEGLECTED TROPICAL DISEASES ELIMINATION PROGRAMS
Irene Wangeci Thuo
The George Washington University, Washington, DC, United States
Neglected tropical diseases (NTDs) are a group of 17 parasitic and bacterial 
infections that cause disability and kill more than 500,000 people a year 
worldwide (Hotez, 2008). The World Health Organization (WHO), the 
world’s leading authority on health issues, has declared at least 10 of 
these NTDs as controllable and in some cases eliminable (WHO, 2014). 
Lymphatic Filariasis (LF) and onchocerciasis are two of the NTDs that are 
targets for elimination by 2020 and 2025 respectively (WHO, 2014). In 
order to reach the elimination goals, WHO has overseen the development 
of more than 74 country specific multi-year national plans for the control 
and elimination of NTDs (NTD Master Plans). These plans provide the 
framework for countries to start elimination programs, rapidly scale 
the programs up to reach all those in need of treatment, and to sustain 
treatment for the needed duration and initiate long-term environmental 
changes that prevent re-infection, as reported previosly. Sustainability 
research however, reveals that the approaches recommended by WHO do 
not address all the necessary steps that NTD programs must take in order 
to sustain program activities and outcomes to ensure disease elimination. 
More specifically, while the plans provide the necessary technical guidance 
to reach control or elimination, they lack adequate guidance on how 
to address non-technical aspects of sustaining the programs beyond 
suggesting the strengthening of government ownership, enhancing 
planning for financial sustainability and integrating control of NTDs 
into national primary health care systems, as reported previously. Using 
multi-case study methodology, this qualitative research adopts available 
sustainability frameworks in health and development sectors to LF and 
onchocerciasis elimination programs in two states, four local government 
areas in Nigeria. The result is a sustainability framework that defines the 
critical components of NTD programs that need to be sustained and the 
means by which each of these components can be sustained.
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THE ROAD TO ELIMINATION OF SCHISTOSOMIASIS AND 
SOIL-TRANSMITTED HELMINTHS AS PUBLIC HEALTH 
PROBLEMS: THE MALAWI STORY SO FAR
Jane M. Whitton1, Samuel Jemu2, Fiona Fleming1, Michelle 
Clements1
1Schistosomiasis Control Initiative, London, United Kingdom, 2Malawi 
Ministry of Health, Lilongwe, Malawi
Since 2012, the Malawi Ministry of Health (MoH) with technical support 
of the Schistosomiasis Control Initiative, have successfully carried out four 
national preventive chemotherapy (PC) campaigns totalling 14.6 million 
treatments with praziquantel and albendazole to reduce schistosomiasis 
(SCH) and soil transmitted helminth infections (STH). Impact surveys 
have shown the Malawi programme is at a critical stage on the road to 
elimination of SCH and STH as public health problems. Results from WHO 
recommended monitoring and evaluation activities to assess a program 
by measuring impact, performance and process are combined to illustrate 
the programmes achievements. For impact evaluation, twenty-two sentinel 
schools were randomly sampled for data collection in approximately 2,500 
school-age children, prior to each national PC campaign. Cross-sectional 
parasitological data was used to evaluate prevalence and high-intensity 
infection of Schistosomiasis and STH. To validate programme performance 
in terms of treatment coverage, multi-stage cluster surveys were used. 
The first conducted after the 2012 treatment campaign, with subsequent 
surveys carried out in 2014 and 2016. A data quality assessment (DQA) 
study allowed the Malawi programme to review the effectiveness and 
efficiency of the MoH reporting systems for treatment numbers. Despite 
numerous challenges, reductions in prevalence and high-intensity infection 
have been observed for both Schistosoma species and STH in all target 
groups. Results from the coverage surveys have shown the need to 
increase treatment coverage of non-attending school-age children and 
adults in areas known for high transmission. Finally the DQA survey has 
highlighted weaknesses in reporting process which the programme has 
now adapted. The results of the surveys will be presented and illustrate 
how subsequent programmatic adaptions to a program in its infancy, in 
training, communication and delivery, have led to improved efficiency 
and effectiveness of control efforts. The next steps, taking this program 
beyond control to an elimination of as a public health problem phase, will 
be discussed.
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SHRINKING THE NEGLECTED TROPICAL DISEASE MAP IN 
TANZANIA: TRACHOMA AND LYMPHATIC FILARIASIS
Upendo Mwingera1, Maria Chikawe1, Andreas Nshala1, Jeremiah 
Ngondi1, Mathias Kamugisha2, Sarah Craciunoiu3, Katie Crowley4, 
Mwele Malecela2
1Tanzania Neglected Tropical Disease Control Program, Dar es Saalam, 
United Republic of Tanzania, 2National Institute for Medical Research, Dar 
es Saalam, United Republic of Tanzania, 3IMA World Health, Washington, 
DC, United States, 4RTI International, Washington, DC, United States
The Tanzania Neglected Tropical Diseases (NTD) Control Program has 
made significant progress since its launch in 2009, achieving complete 
geographic coverage for mass drug administration (MDA) for the 5 
preventive chemotherapy (PCT) NTDs including lymphatic filariasis (LF), soil 
transmitted helminths (STH), onchocerciasis, trachoma and schistosomiasis 
in 2016. The results of LF transmission assessment surveys to date indicate 
that transmission in some implementation units has stopped, reducing 
the number of endemic districts from166 to 103, with LF remapping 
confirmation in 2015. In 2009, one district met the criteria for stopping 
MDA; 5 additional in 2014, and 33 additional districts by 2015 making a 
total of additional 39 districts reaching criteria for stopping MDA. Thus in 
2016, only 63 districts will need LF MDA. A total of 56 districts were ever 
trachoma endemic above the treatment threshold (greater than or equal to 
10%). Another 4 districts were endemic with prevalence between 5-9.9% 
at baseline. The program also completed trachoma mapping nationwide 
in 2014; only 3 districts (Chunya, Ngara and Chemba) were found to 
be endemic with above 5% trachomatous inflammation, follicular (TF), 
thus requiring Zithromax MDA. Impact surveys indicated that trachoma 
MDA could be stopped in 22 districts, thus further shrinking the Tanzania 
trachoma map. By the end of 2015 only 18 districts needed Zithromax 
MDA. Additional districts are expected to achieve the TF level of <5% 
and meet the WHO criteria to stop MDA in 2016. Tanzania is on track 
to reach its 2020 trachoma and LF elimination targets, in line with WHO 
goals provided that the program is able to sustain the scale-down trend 
in MDA and strengthen other disease control and elimination intervention 
measures.
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HEALTH-SEEKING BEHAVIOR FOR EPILEPSY IN AN 
ONCHOCERCIASIS ENDEMIC AREA OF CAMEROON
Julia Irani1, Maya Ronse1, Alfred K. Njamnshi2, Adam Hendy1, 
Katja Siling1, Joseph Kamgno3, Bob Colebunders4, Tine Verdonck1, 
Sarah O’Neill1, Koen P. Grietens1
1Institute of Tropical Medicine, Antwerp, Belgium, 2The University of 
Yaoundé 1, Yaoundé, Cameroon, 3Centre for Research on Filariasis and 
other Tropical Diseases, Yaoundé, Cameroon, 4University of Antwerp, 
Antwerp, Belgium
Certain onchocerciasis-endemic areas in central Africa, such as Northern 
Uganda, South Sudan, Tanzania, the Democratic Republic of Congo, 
and potentially Cameroon are affected by a severely debilitating form of 
epilepsy called Nodding Syndrome (NS). In certain areas of Cameroon an 
increased prevalence of epilepsy might constitute a form of NS although 
diagnosis is unclear as the exact cause of the disease is still unknown. To 
inform policy on health provision for epilepsy and/or NS, an ethnographic 
study was carried out on local health seeking itineraries of people severely 
affected by epilepsy in 5 onchocerciasis-endemic villages in the Sanaga 
basin area in Cameroon. Patients generally chose between treatment in 
the biomedical sector, traditional healing or religious services. Treatment 
choice was mainly influenced by the cost of treatment, accessibility of 
health providers and perceived aetiology of the disease. The sudden 
increase of epilepsy over the last 40 years is often attributed to sorcery. 
As such, epilepsy is believed to be ‘thrown at’ or ‘injected’ into people 
using mystical means. While some people with epilepsy do not attend 
health facilities due to these aetiological beliefs, most seek a combination 
of biomedical and traditional care. As biomedical treatment is commonly 
perceived to have a merely calming effect on the disease, traditional 
healers are consulted to address the root of the problem, usually referring 
to increased social tensions or accusations of unnatural acquisition of 
wealth through sorcery. In terms of biomedical care, once satisfying 
medication is found, usually no medical follow-up consultations are 
solicited and additional medicine can be obtained from both official and 
unofficial sources. Alternatively, a religious path can be chosen, potentially 
leading to the interruption of biomedical treatment in order to let God 
cure the disease. Strengthening access to appropriate care is urgently 
needed as research in similar contexts has shown that even when the 
disease aetiology is perceived to be sorcery, people will attend biomedical 
care if this is perceived to improve patients’ condition.
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DELIVERING INTEGRATED PREVENTIVE CHEMOTHERAPY EN-
MASSE FOR NEGLECTED TROPICAL DISEASES IN TANZANIA
Andreas Nshala, Maria Chikawe, Oscar Kaitaba, Edward 
Kirumbi, Upendo Mwingira
Tanzania Neglected Tropical Disease Control Program, Dar es Salaam, 
United Republic of Tanzania
Neglected tropical diseases (NTD) cause a serious public health problem 
in sub-Saharan Africa, mostly due to poverty and inadequate sanitation. 
In Tanzania, lymphatic filariasis, trachoma, onchocerciasis, soil transmitted 
helminthiasis and schistosomiasis are endemic, putting all 50 million 
inhabitants at risk of infection. The World Health Organization urges 
member states to initiate integrated control programs using available 
highly effective low cost interventions like preventive chemotherapy (PCT). 
In 2009, Tanzania launched an integrated NTD program that works to 
deliver mass treatments to affected communities. Program has expanded 
in phases from a geographic coverage of just 27% in 2010 to 100%- 
in 2010 for onchocerciasis, in 2014 for LF, and in 2016 for STH and 
Schistosomiasis. By 2016, the program covers (all) 166 implementation 
units with required PCT packages. The program is uniquely designed as 
all interventions are delivered through the central ministry of health’s 
decentralized healthcare delivery system. PCT is planned and implemented 
at the district level. Treatments are distributed through community and 
school mechanisms with one reporting system countrywide. This design 
makes it possible for the program to deliver large numbers PCT per 
annum. A total of 55 million treatments were delivered to over 22 million 
people in 2014, and 45 million treatments to over 19 million people in 
2013. In 2016, the program aims at delivering 60 million treatments to 
23 million people. Key to this success is an army of dedicated medicine 
distributors; community based drug distributors and primary school 
teachers. Their involvement increases as the program expands, from 
21,902 in 2009 to 113,689 community based drug distributors in 2016 
and from 3,065 to 36,985 primary school teachers. They receive training 
yearly on PCT administration and are supervised by over 14,047 health 
workers. Over the past 7 years, great success in delivering PCT to large and 
diverse populations has been registered and Tanzania is close to reaching 
the targeted end points.
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TANZANIA ON TRACK TOWARDS ACHIEVING GLOBAL 
GOALS FOR CONTROL AND ELIMINATION OF NTDS BY 2020, 
EVIDENCE FROM THE FIELD
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Ngondi3, Luke King4, Mathias Kamugisha5, Edward Kirumbi5, Delali 
Bonuedi6, Maria Chikawe5, Upendo Mwingira1
1IMA World Health, Washington, DC, United States, 2IMA World Health, 
Dar es Saalam, United Republic of Tanzania, 3RTI International, Dar es 
Salaam, United Republic of Tanzania, 4IMA World Health, Dar es Salaam, 
United Republic of Tanzania, 5Tanzania Neglected Tropical Disease Control 
Program, Dar es Salaam, United Republic of Tanzania, 6RTI International, 
Washington, DC, United States
The Regional Strategic Plan for NTDs in the African Region 2014-2020 is 
guided by three key objectives which national NTD programs are working 
to achieve by 2020. The objectives are to scale up access to interventions 
and systems capacity strengthening; enhance planning for results, resource 
mobilization and financial sustainability of National NTD programs; and 
strengthen advocacy, coordination and national ownership. NTDs are 
endemic in all parts of Tanzania, with an estimated 47 million people at 
risk of infection with two or more NTDs. Tanzania’s NTD program targets 
schistosomiasis, trachoma, lymphatic filariasis, onchocerciasis, and soil 
transmitted helminthiasis through community and school-based mass drug 
administration (MDA) of preventive chemotherapy. The program evaluated 
the achievements of the Tanzania NTD control program toward the African 
Regional Strategic goals for NTD control and elimination for the period 
2014-2016. By 2014, the geographical coverage for specific disease 
preventive chemotherapy was 97.94% for LF, 100% for onchocerciasis, 
35.54% for schistosomiasis, 59% for STH and 100% for trachoma. With 
program expansion geographical coverage rose from 64% in 2014 to 
100% by end of 2016. All 26 regions and 166 districts have government 
employed NTD coordinators and trained NTD secretariats managing NTD 
activities. Each health facility has staff trained in NTD control program 
implementation. Advocacy and sensitization for NTD control has reached 
all senior government and political leaders in all regions and districts. There 
are pockets of lower MDA coverage rates in hard to reach communities 
and where the estimated number of school-aged children is not well 
established. Evaluation results indicate that Tanzania has made progress 
toward all four African regional strategy key objectives. In order for the 
program to build on these significant improvements, further steps are 
needed to address insufficient MDA coverage in some districts, and to 
address the morbidity caused by these diseases.
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WHILE YEMEN IS HEADING TOWARDS SCHISTOSOMIASIS 
ELIMINATION, WAS IT SUCCESSFUL IN ENSURING EQUITY?
Dhekra A. Annuzaili1, Abdulhakim Alkohlani2, Sami AlHaidari2, 
Alaa Hamed3, Nehad Kamel3, Ahmed Alsofi4, Ryadh Bin Ismail4, 
Albis Gabriele4, Michael French1
1Imperial College London, London, United Kingdom, 2Ministry of Public 
Health and Population, Sana’a, Yemen, 3The World Bank, Egypt, Egypt, 
4World Health Organization, WHO/EMRO, Cairo, Egypt and, Geneva, 
Switzerland
The SCH (Schistosomiasis Control Programme ) ( soil transmitted 
helminths) STH programme in Yemen has been suspended two times 
during its cycle (2010-2016). The first was in 2011-2012 due to the 
involvement of Yemen in the Arab spring that led to a revolution 
against the former regime, and in 2015- until current due to civil war 
between several armed militias from one side and an external war with 
neighbouring countries from the other side. The programme has resumed 
since February 2016 despite the continuation of war. Meanwhile, over 
25 million free treatments (using 62 million tablets of praziquantel and 
25 million tablets of albendazole) have been provided to Yemenis living 
in endemic areas for schistosomiasis and soil transmitted helminths 
during the years of 2010 -2015. Yemen NTD programme mainly the 
schistosomiasis and the soil transmitted helminths has reached to a stage 
that following treatment the proportion of infected districts that are low 
has risen from 14.9% in 2010 to 87.1% in 2014 indicating that the large 
majority of the country is now classified as low infection. The Infection 
levels in districts followed-up have more than halved from 19.8% to 8.4 
and the proportion of heavy or heavy/medium infections the prevalence 
before and after treatment has also fallen substantially (less than 4%). The 
programme implemented MDAs and surveys in some conflict areas and 
even targeted marginalized groups. In addition, it has been successful in 
keeping the gender balance among females and males SAC by the MDAs, 
and have achieved a considerable coverage among enrolled and non-
enrolled SAC.
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IDENTIFICATION AND BIOLOGICAL CHARACTERIZATION 
OF NOVEL PHARMACOLOGICALLY ACTIVE COMPOUNDS 
OBTAINED FROM HIGH THROUGHPUT SCREENING OF 
LEISHMANIA PARASITE
Bilal Zulfiqar, Amy J. Jones, Todd B. Shelper, Vicky M. Avery
Griffith University, Brisbane, Australia
Leishmania is a trypanosomatid protozoan parasite which causes the 
disease leishmaniasis. The mode of transmission of this disease is via the 
bite of a sandfly, genus Phlebotomus (old world) and Lutzomyia (new 
world). Leishmaniasis is endemic in 88 countries worldwide and each day 
new cases emerge with increased morbidity and mortality. Presently, 12 
million people are infected and around 350 million people are constantly 
at risk of acquiring this disease. The life cycle of Leishmania parasite 
exists between the sand fly (promastigote form) and the mammalian 
host (amastigote form). According to clinical manifestations leishmaniasis 
can be characterized as cutaneous, muco-cutaneous or visceral 
leishmaniasis; the latter being fatal. The disease itself is treatable but 
faces many challenges mainly due to emerging resistance and increased 
toxicity from current drugs. The therapeutic efficacy varies depending 
upon the disease pattern, species and geographical distribution of the 
parasite. An automated assay suitable for high throughput screening 
(HTS) is desperately needed which is cost effective and robust for the 
selection of a hit molecules for optimization as a therapeutic candidate. 
In an aim to identify compounds with activity against L. donovani DD8 
parasites, a primary screen of 5000 structurally diverse compounds was 
performed using the promastigote viability assay (extracellular form) and 
an intracellular amastigote assay. Confirmation of activity was performed 
together with cytotoxicity studies against THP-1 (host cell) and HEK-293 
cell lines. The HTS approach employed here resulted in the discovery of a 
new anti-leishmanial compound with an IC50
 of 0.592 ± 0.139 µM against 
the intracellular form of the parasite and IC50 of 2.374 ± 0.859 µM against 
the extracellular form. Screening data and results from additional assays 
such as cidal-static and time to kill assays, plus % infectivity in the host 
cells after pre-incubation with the compound will be presented.
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VALIDATION OF POINT-OF-CARE MOLECULAR TESTING FOR 
DIAGNOSIS OF ULCERS DUE TO LEISHMANIA, FUNGI AND 
MYCOBACTERIA
Braulio M. Valencia1, Rachel Lau2, Ruwandi Kariyawasam3, 
Alejandro Llanos-Cuentas1, Andrea K. Boggild3
1Instituto de Medicina Tropical, Lima, Peru, 2Public Health Ontario 
Laboratories, Toronto, ON, Canada, 3University of Toronto, Toronto, ON, 
Canada
Due to the highly toxic nature of standard drugs used in the treatment 
of cutaneous leishmaniasis (CL), and overlapping clinical features of CL 
with ulcers due to fungal and mycobacterial infections, confirmatory 
diagnostic testing must be undertaken. We evaluated the performance 
characteristics of a handheld battery operated device for differentiation 
of Leishmania from known fungal and mycobacterial causes of cutaneous 
ulcers. Using ATCC strains of Leishmania (L. V. braziliensis, L. V. 
panamensis, L. V. guyanensis), mycobacteria (M. abscessus complex) and 
fungi (Paracoccidioides brasiliensis), we validated PalmPCR for detection of 
Leishmania, fungal, and mycobacterial species known to cause cutaneous 
ulcers. We further validated the device for detection of Leishmania from 
clinical specimens including filter paper lesion impressions, cytology 
brushes, and tissue. Respective primers targeted a conserved region of 
kinetoplast DNA (kDNA) for detection of Leishmania, pan-mycobacterial 
Hsp65, and pan-fungal D1D2 regions. PCR products were visualized 
using the EGel Go reader, a portable battery-operated system for agarose 
electrophoresis. Outcome measures were sensitivity and specificity, where 
conventional end-point or real time PCR was the reference standard. 
Compared to the reference standard, the PalmPCR device detected 
100% of ATCC strains of Leishmania, fungi, and mycobacteria. There 
was no cross-reactivity of primers with any negative control. The PalmPCR 
device accurately categorized clinical specimens as positive or negative 
for Leishmania 94.1% of the time (16/17 specimens), yielding sensitivity 
and specificity of 91.7% and 90.0%, respectively. Positive predictive 
value and negative predictive value were 91.7% and 90.0%, respectively, 
for detection of Leishmania. We have verified that the PalmPCR device 
performs comparably to conventional end-point or real time PCR for 
the detection of Leishmania, fungi, and mycobacteria. This work has 
implications for CL diagnostic process improvement, and has the potential 
to improve point-of-care diagnostic sensitivity compared to conventional 
tests such as smear.
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EVALUATION OF MACROPHAGE ACTIVATION MARKER 
NEOPTERIN AS A PHARMACODYNAMIC BIOMARKER IN 
VISCERAL LEISHMANIASIS
Antonia E. Kip1, Ahmed Musa2, Eltahiri A. Khalil2, Monique 
Wassuna3, Fabiana Alves4, Thomas P. Dorlo5
1Antoni van Leeuwenhoek Hospital/Slotervaart Hospital, Amsterdam, 
Netherlands, 2Institute of Endemic Diseases, University of Khartoum, 
Khartoum, Sudan, 3Drugs for Neglected Diseases initiative, Nairobi, Kenya, 
4Drugs for Neglected Diseases initiative, Geneva, Switzerland, 5Dept. 
Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden
Visceral leishmaniasis (VL) is caused by the Leishmania parasite, which 
replicates within host macrophages, thereby increasing the overall 
macrophage biomass which decreases again with waning parasitic 
infection. The aim of this study was to evaluate neopterin - a macrophage 
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activation marker - as possible pharmacodynamic (PD) marker to monitor 
VL treatment response, for which recrudescence of parasites is a long-
term event which is difficult to predict. Samples were collected from 
VL patients in Sudan and Kenya receiving 1) a combination therapy of 
1 liposomal amphotericin B (L-AmB) infusion followed by 10 days of 
miltefosine (L-AmB+MIL, 48 patients) or 2) 28 days of miltefosine (MIL, 
48 patients). Neopterin was quantified with an ELISA kit in 498 plasma 
samples collected on miltefosine treatment day 1, 7, 11 (L-AmB+MIL), 
14 and 28 (MIL) and 1 and 6 months after treatment. Baseline neopterin 
levels were elevated in all VL patients with a mean±SD of 135±93.4 
nmol/L, regressing during treatment to 45.4±40.0 nmol/L (L-AmB+MIL) 
and 34.0±29.4 nmol/L (MIL). Neopterin levels were stable during the first 7 
treatment days for monotherapy patients (111±70.4 nmol/L to 109±56.4 
nmol/L), while levels of combination therapy patients halved (160±107 
nmol/L to 74.0±65.8 nmol/L). 19 patients received rescue treatment within 
6 months after treatment. These relapsed patients showed a significantly 
higher fold-increase in neopterin levels within 1 month after treatment 
(2.17±0.91) than patients that cured (1.04±0.81, p<0.001, Mann-Whitney 
U test). In combination therapy, neopterin concentrations one day after 
L-AmB infusion were significantly higher for cured (173±112 nmol/L) than 
for relapsing patients (98.2±49.6 nmol/L, p<0.01, Mann-Whitney U test). 
In conclusion, neopterin dynamics differed between the two treatment 
arms. The, possibly prognostic, initial surge in neopterin levels in cured 
combination therapy patients could imply an instant immunomodulatory 
effect of L-AmB on the Th1 response. Another possible marker in 
predicting treatment failure in VL is the relative neopterin concentration 
increase within 1 month after treatment.
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CHARACTERIZATION OF NEW CHEMICAL SCAFFOLDS FOR 
THE TREATMENT OF HUMAN AFRICAN TRYPANOSOMIASIS
Amy J. Jones1, Marcel Kaiser2, Vicky M. Avery1
1Eskitis Institute for Drug Discovery, Brisbane, Australia, 2Swiss Tropical and 
Public Health Institute, Basel, Switzerland
Trypanosoma brucei rhodesiense and T. b. gambiense are the aetiological 
agents of Human African Trypanosomiasis (HAT), a neglected, parasitic 
disease prevalent in sub-Saharan Africa. The number of cases of HAT 
has declined by over 80% in the last 20 years due to the introduction 
of rigorous surveillance and treatment programs. However, to achieve 
the goal of eliminating HAT as a public health problem by 2020, new 
molecules are needed as currently available drugs have limited efficacy, 
poor safety profiles and protracted, impractical administration schedules. 
This abstract describes preliminary ADME and mechanism of action 
studies of a novel class of promising anti-trypanocidal compounds. A 
novel class of anti-trypanocidal compounds was previously identified 
through a HTS whole cell screening campaign against T.b. brucei. 
Analogues were evaluated against T.b. brucei and the human infective 
subspecies T.b. gambiense and T.b. rhodesiense to build basic structure 
activity relationships and aid prioritization of lead compounds. Lead 
compounds underwent physiochemical and metabolism assessment and 
development of resistant strains was initiated to gain insights into possible 
molecular targets. Following evaluation of over >30 structural analogues, 
3 compounds were prioritized based on anti-trypanocidal activity and 
medicinal chemistry properties. The compounds exhibited IC50 values 
ranging from 0.32 to 4.83 µM against the human infective subspecies 
T.b. rhodesiense and T.b. gambiense . Preliminary metabolism studies in 
human and murine microsomes reveled extensive non-NADPH mediated 
degradation that will need to be addressed through chemical modification 
of the molecules. In conclusion, the compounds identified in this study 
are potent, selective trypanocidal agents. Preliminary mechanism of action 
studies are currently in progress to identify to the molecular target of 
the molecules to allow the development of more potent analogues with 
improved metabolic stability which can be progressed along the drug 
discovery pipeline for HAT.
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A RETROSPECTIVE REVIEW OF THE HOSPITAL FOR TROPICAL 
DISEASES LEISHMANIASIS CASES IN 2013-2015
Katherine M. Gaskell, Rachael Burke, Margaret Armstrong, 
Diana Lockwood
Hospital for Tropical Diseases, London, United Kingdom
The Hospital of Tropical Diseases (HTD) at University College Hospital 
London (UCLH) is a national center for treatment of Leishmaniasis. 
Guidelines for the Treatment of Leishmaniasis in travelers differ 
worldwide with varying outcomes. We retrospectively reviewed 38 cases 
of Leishmaniasis treated at HTD during 2013-15. We collected data on 
demographics, travel exposure, causative species, lesion location and 
number, treatment regimens and outcomes. 25(66%) were male, median 
age was 33.5 years old, range (17-81 years). We describe the severity at 
presentation by lesion number, size and location. 17(45%) of cases were 
Old World Leishmania infections. We used Leishmania DNA PCR to identify 
species of which 21(55%) patients had infections with Leishmania Vianna, 
a subspecies of L. braziliensis. 10 (26%) were acquired in the Peruvian 
Amazon. Amastigotes were identified in 20 (61%) of PCR positive 
biopsies. 3(9%) presented mucocutaneous leishmaniasis (MCL), 2 of 3 
were L.Donovani infections acquired in Spain with vocal cord lesions and 
without skin involvement. 4(11%) presented with Visceral Leishmaniasis 
and treated with Intravenous (IV) Ambisome. All Cutaneous Leshmaniasis 
(CL) cases are managed as outpatients. 21(64%) Received daily IV 
Sodium Stibogluconate (SSB), 17(81%) of these L. Vianna infections. 
Most patients reported side effects with a wide range in severity. 6(18%) 
received treatment with oral Miltefosine with no treatment failures. In 
patients receiving IV SSB 2 (9%) failed on first line treatment, one was 
subsequently treated with oral Miltefosine and one with intra-lesional 
SSB both successfully. Side effects included mild reversible transaminitis, 
reversible QT prolongation, mild anaemia and Leucopenia. The majority 
of CL presenting to the HTD is in young adults with L.Viannia from the 
Peruvian Amazon and Central America. Risk of progression to MCL is low; 
treatment is well tolerated with a low relapse rate in our setting.
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A LOOP-MEDIATED IS OTHERMAL AMPLIFICATION (LAMP) 
KIT FOR MOLECULAR DETECTION OF TRYPANOSOMA CRUZI 
DNA: A FEASIBILITY STUDY
Susana A. Besuschio1, Mónica Llano Murcia2, Alejandro Benatar1, 
María de los Angeles Curto1, Israel Cruz3, Séverine Monnerat3, 
Albert Picado3, Concepción Puerta2, Joseph Ndung’u3, Alejandro 
G. Schijman1
1Laboratorio de Biología Molecular de la Enfermedad de Chagas, INGEBI-
CONICET, Buenos Aires, Argentina, 2Pontificia Universidad Javeriana, 
Bogota, Colombia, 3FIND, Geneva, Switzerland
Loop-mediated isothermal amplification (LAMP) tests have been developed 
as molecular tests for neglected parasitic diseases such as leishmaniasis 
or sleeping sickness. A LAMP test for Trypanosoma cruzi, the etiological 
agent of Chagas Disease (ChD), would allow a rapid and reliable diagnosis, 
in particular in cases of acute and congenital ChD (CChD). We evaluated 
the performance a Trypanosoma cruzi LAMP kit using purified DNA, spiked 
blood and clinical specimens. Quantitative PCR (qPCR) was used as a 
reference. Different extraction methods for LAMP were also evaluated. The 
LAMP reaction was performed at 62.5°C for 45 min. Analytical sensitivity 
was measured in ten-fold dilutions of CL Brener (TcVI) and Silvio X10 
(TcI) DNA. Analytical specificity was measured using ten-fold dilutions of 
different Leishmania species and Trypanosoma rangeli DNAs as well as 
non-infected human DNA. Seronegative blood in EDTA (EB) or heparin (HB) 
was spiked with ten-fold dilutions of CL Brener. EB spiked blood was also 
used as dried blood spot (DBS). Stored DNA from EB clinical samples was 
tested, including 4 Congenital ChD cases, 5 Chronic ChD cases with low 
parasite loads, 10 immunosuppressed ChD patients and 5 seronegative 
controls. DNA extraction was done with a commercial kit (EB, HB and DBS 
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samples) and using the boil & spin (B&S) method (HB samples only). The 
T. cruzi LAMP kit showed better analytical sensitivity than qPCR in purified 
DNA specimens, especially for TcI DNA. Analytical sensitivity was 10-2 and 
10-1 par.eq/mL from spiked EB and HB extracted by columns, respectively, 
and 10-2 par.eq/mL from HB using B&S. The analytical sensitivity in DBS 
samples was 10-2 par.eq/mL. T. cruzi LAMP was positive in congenital and 
immunosuppressed ChD samples spanning from 4.8 to 3,684 par.eq/ml, 
in agreement with qPCR. Chronic ChD samples were only detectable by 
qPCR, with Ct values below the limit of quantification. The kit was specific 
for T. cruzi DNA and samples from seropositive patients. The preliminary 
results demonstrate the potential of using T. cruzi LAMP as a molecular 
test for CChD and Chagas reactivation.
520
ANALOGS OF THE NATURAL PRODUCT CHAMUVARININ 
TARGET THE TRYPANOSOMATID FOF1-ATP SYNTHASE 
MITOCHONDRIAL COMPLEX V
Stefanie K. Menzies, Lindsay B. Tulloch, Andrew L. Fraser, 
Eoin R. Gould, Elizabeth F. King, Marija K. Zacharova, Gordon J. 
Florence, Terry K. Smith
University of St Andrews, St Andrews, United Kingdom
Current treatments for trypanosomatid diseases are outdated, 
increasingly ineffective and associated with severe adverse effects. We 
recently reported trypanocidal activity of a series of novel synthetic bis-
tetrahydropyran 1,4-triazole (B-THP-T) analogs based on the framework 
of the natural product chamuvarinin, an acetogenin first synthesized by 
our groups. Acetogenins are potent inhibitors of the human mitochondrial 
Complex I, however our compounds show potent inhibitory activity against 
bloodstream form Trypanosoma brucei, in which Complex I is absent, 
thus chamuvarinin must target another protein in the trypanosomatids. 
The mode of action of our B-THP-T compounds is unknown so this 
work aimed to identify their target in Leishmania major and T. cruzi. We 
synthesized a series of B-THP-T analogs for use in photo-affinity labeling 
(PAL), to covalently tag our target for protein target identification in vivo. 
We subsequently identified the FoF1-ATP synthase (mitochondrial complex 
V) as a potential target of our compounds using pull-down experiments. 
Next we undertook a series of biological analyses to validate this pull-
down. By labeling B-THP-T-tagged proteins with the Cy5.5 fluorophore we 
confirmed that the target is mitochondrial by fluorescence co-localization. 
Using a luciferase-based ATP quantitation assay we show that B-THP-T 
compounds inhibit cellular ATP production and that they ablate oxidative 
phosphorylation. Taken together, these data indicate that our B-THP-T 
compounds are trypanocidal through their mitochondrial targeting of the 
FoF1-ATP synthase. We are using genetic manipulation of T. cruzi and L. 
major FoF1 ATP synthase subunits to validate these findings. With the 
target of our bis-tetrahydropyran 1,4-triazoles identified as mitochondrial 
complex V a structure-based approach can be used to optimize inhibitor 
potency and specificity.
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MULTIPLEX BEAD ASSAY FOR DETECTION OF ANTIBODY 
RESPONSES AGAINST TRYPANOSOMA CRUZI USING NOVEL 
PENTAVALENT ANTIGENS TCF26 AND TCF43
Guilherme Maerschner Ogawa1, Circe McDonald2, Malcolm 
Duthie3, Steven Reed3, Vitaliano A. Cama4
1Centers for Disease Control and Prevention-CNPq Fellowship, Atlanta, GA, 
United States, 2IHRC Inc., Atlanta, GA, United States, 3Infectious Disease 
Research Institute, Seattle, WA, United States, 4Centers for Disease Control 
and Prevention, Atlanta, GA, United States
Serological assays for Chagas disease are important for case detection, 
screening of donated biological materials, and could also be used in 
serosurveillance. We evaluated two novel multivalent antigens TcF26 
and TcF43 in a multiplex bead assay (MBA). Each of these recombinant 
antigens expresses 5 reactive epitopes, previously reported to increase 
the sensitivity and specificity in single-plex assays. Each pentavalent 
antigen was optimally coupled to a specific classification of Seromap 
polystyrene beads for use in MBA. Assay performance parameters were 
determined with a panel of 108 samples previouslly characterized by 
radioimmunoprecipitation assay (RIPA) (44 were RIPA +, 64 RIPA -) plus 24 
samples from a non-endemic area, and results were analyzed by receiver 
operating characteristic (ROC). For TcF26, positive samples had a average 
reactivity of 14,307 fluorescent units (range 68-25,419) and negatives 
98.5 units (7-1,157) respectivelly. The cut-off for positivity was 711.5, 
providing 98.9% specificity, 93.3% sensitivity, negative predicted value 
(NPV) of 96.6% and positive predicted value (PPV) of 97.3%. For TcF43, 
positive samples had a average of 20,272 units (range 2,670-28,542) 
while negatives had 1,434 units (29-10,955); a positive cut-off was 
established at 3,654 units and provided 89.8% specificity, 97% sensitivity, 
NPV of 98.75% and PPV of 80.85%. The combined analysis of these 
results, using TcF43 for first line screening followed by confirmation with 
TcF26 results, resulted in sensitivity of 92.5%, specificity of 98.9%, NPV 
of 96.8% and PPV of 97.4%. The incorporation of these antigens into 
MBA would allow parallel testing against multiple analytes for Chagas. 
Although preliminary, these results suggest the potential advantages of 
detecting antibodies against these antigens in MBA testing for Chagas 
disease.
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MINIMIZING THE COST OF CONGENITAL CHAGAS DISEASE 
IN THE UNITED STATES THROUGH MATERNAL SCREENING
Eileen Stillwaggon, Victoria Perez-Zetune
Gettysburg College, Gettysburg, PA, United States
Chagas disease, caused by Trypanosoma cruzi, is transmitted by 
insect vectors, as well as through blood transfusion, organ transplant, 
consumption of insect feces in food and water, and from mother to 
child during gestation. Programs of vector control and screening of 
blood products and transplant organs have been successful in reducing 
transmission. Congenital infection, however, could perpetuate Chagas 
indefinitely, even in countries with no or almost no autochthonous 
vector transmission. Even mothers who themselves have been infected 
congenitally and who are not symptomatic can transmit to their babies. 
About 30% of infected persons will develop lifelong cardiac or digestive 
complications that can be fatal. Treatment of infants with benznidazole 
has close to 100% cure rate, and efficacy in adults is estimated between 
40% and 70%. This is the first study of the costs of screening and 
treatment for Chagas in the United States. We construct a decision-
analytic model to find the cost-minimizing option, comparing the costs 
of testing and treatment, as indicated, for mothers and infants with 
the lifetime societal costs of no testing and consequent morbidity and 
mortality due to lack of treatment or late treatment. We find that a 
protocol of screening and treatment is cost-minimizing for all rates of 
congenital transmission between 1% and 10% and all levels of maternal 
prevalence above 0.2%. Lifetime societal savings due to screening and 
treatment are more than $4000 per Hispanic birth. There are more than 
900,000 births to Hispanic women in the United States per year. Educating 
obstetricians to offer prenatal or cord blood serologic screening to Hispanic 
mothers makes it possible to treat mothers, infants, siblings, and other 
family members at risk of serious Chagas morbidity.
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SODIUM STIBOGLUCONATE AND PAROMOMYCIN FOR 
TREATING VISCERAL LEISHMANIASIS UNDER ROUTINE 
CONDITIONS IN EASTERN SUDAN
Atia A. Mohammed Atia
KalaCORE DfID, UK-London and SUDAN-Khartoum, Sudan
objectives Among patients with primary and relapse visceral leishmaniasis 
(VL) in eastern Sudan, we determined the proportion eligible for treatment 
with sodium stibogluconate and paromomycin (SSG/PM) and, of these, 
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their demographic and clinical characteristics; initial treatment outcomes 
including adverse side effects requiring treatment discontinuation; 
treatment outcomes by 6 months; and risk factors associated with initial 
(slow responders) and late treatment failure (relapses and postkala- azar 
dermal leishmaniasis, PKDL). methods A retrospective cohort study in 
Tabarak Allah Hospital, Gedaref Province, eastern Sudan, from July 2011 
to January 2014. results Of 1252 individuals diagnosed with VL (1151 
primary and 101 relapses), 65% were eligible for SSG/PM including 83% 
children, almost half of them malnourished and anaemic. About 4% of 
individuals discontinued treatment due to side effects; 0.7% died during 
treatment. Initial cure was achieved in 93% of 774 primary cases and 77% 
of 35 relapse cases (P < 0.001). Among the 809 patients eligible for SSG/
PM, 218 (27%) were lost to follow-up. Outcomes by six months among 
the 591 patients with available follow-up data were: definitive cure (n = 
506; 86%), relapse (n = 38; 6%), treatment discontinuation (n = 33; 6%), 
PKDL (n = 7; 1%) and death (n = 7; 1%). Among those completing a full 
course of SSG/PM, relapses and under-fives were at significantly higher 
risk of early and late treatment failure, respectively. conclusion Whether 
SSG/PM as a first-line regimen is an undeniable progress compared to SSG 
monotherapy, it excluded a considerable proportion of VL patients due to 
drug safety concerns. We call for accelerated development of new drugs 
and treatment regimens to improve VL treatment in Sudan.
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CLINICAL EVALUATION OF A RAPID DIAGNOSTIC TEST 
FOR GAMBIENSE HUMAN AFRICAN TRYPANOSOMIASIS 
DEVELOPED USING RECOMBINANT ANTIGENS
Crispin Lumbala1, Sylvain Bieler2, Simon Kayembe1, Jacquies 
Makabuza1, Stefano Ongarello2, Joseph Ndung’u2
1PNLTHA, Kinshasa, Democratic Republic of the Congo, 2FIND, Geneva, 
Switzerland
Diagnosis and treatment are the cornerstones of strategies to control 
Trypanosoma brucei gambiense human African trypanosomiasis (HAT). 
Screening using serological tests is the entry point in diagnostic algorithms. 
Until recently, the Card Agglutination Test for Trypanosomiasis (CATT) 
was the only screening tool used routinely. This test has a number of 
limitations, including bulk packaging and need for equipment and 
electricity. These have recently been addressed by the introduction of 
rapid diagnostic tests (RDTs). However, current RDTs are manufactured 
using native antigens that are costly and challenging to produce. An RDT 
developed using recombinant antigens was evaluated by passive screening 
in 10 sites, and by active screening in 5 mobile teams in the Democratic 
Republic of the Congo. CATT, an RDT produced using native antigens 
(SD BIOLINE HAT), and the new RDT (SD BIOLINE HAT 2.0) were used to 
screen 57,632 individuals and interpreted blindly by two readers. 260 
HAT cases were confirmed by parasitology. When results of both active 
and passive screening were combined, the sensitivity of the screening 
tests was 62.5%, 59.0% and 71.2%, and the specificity was 99.2%, 
98.9% and 98.1%, respectively. Sensitivity estimates were lower than 
previously reported, as some HAT cases were detected by one test and not 
the others. Sensitivity in passive screening (74.6%, 70.0% and 90.1%) 
was higher than in active (51.8%, 49.2% and 54.8%). The difference 
may be attributed to differential expression of antigens by parasites over 
time, resulting in immune responses to multiple antigens with advancing 
disease. While sensitivity of the tests was already high in passive screening, 
combining the SD BIOLINE HAT with the SD BIOLINE HAT 2.0 resulted 
in higher sensitivity (98.4%). This effect was more pronounced in active 
screening, where the sensitivity of all 3 tests was low, and combining the 
two RDTs resulted in a greatly improved sensitivity (83.0%). While the 
cost-effectiveness of algorithms including several screening tests should be 
investigated, this study has demonstrated that using two or more tests to 
screen for HAT greatly improves sensitivity.
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IMPROVED ACCESS TO DIAGNOSTICS FOR RHODESIENSE 
SLEEPING SICKNESS AROUND A CONSERVATION AREA 
IN MALAWI RESULTS IN EARLIER CASE DETECTION AND 
REDUCED MORTALITY
Marshal Lemerani1, Sylvain Bieler2, Fredrick Jumah1, Paul Bessell3, 
Joseph Ndung’u2
1Ministry of Health, Malawi, Lilongwe, Malawi, 2FIND, Geneva, 
Switzerland, 3Epi Interventions Ltd., Edinburgh, United Kingdom
Trypanosoma brucei rhodesiense human African trypanosomiasis (HAT) 
presents as an acute form of disease that develops rapidly, advancing into 
a neurological form that can only be treated with melarsoprol, an arsenic 
drug that has been reported to cause death to 5-10% of treated patients. 
It is a zoonosis that is transmitted by tsetse flies from wild and domestic 
animals, which are the main reservoirs. Elimination of rhodesiense HAT 
is challenging, particularly when the reservoirs are in conservation areas. 
Bringing diagnostic services for rhodesiense HAT closer to the populations 
that are at risk would increase chances of detecting cases in early 
stages of disease, when treatment is safer and more effective. Malawi is 
endemic for rhodesiense HAT, especially among populations living around 
conservation areas. Since 2010, between 18 and 35 new HAT cases 
have been reported annually in the country. Most of the infections occur 
around Vwaza Marsh Game Reserve, located in the north of Malawi. Until 
2013, diagnosis of HAT in the region was only available at the Rumphi 
District Hospital, more than 60 km away from the game reserve. In 2013, 
the Ministry of Health of Malawi, in a partnership with FIND, initiated a 
project that radically enhanced passive detection of HAT in health facilities 
located around Vwaza Marsh. The capacity of 5 facilities to confirm the 
disease in clinical suspects was strengthened by upgrading laboratories 
and training technicians. Facilities were also supplied with equipment for 
parasitological diagnosis of rhodesiense HAT, including centrifuges and 
LED fluorescence microscopes. One facility was upgraded to perform 
LAMP, a highly sensitive and field applicable molecular test for detecting 
parasite DNA. Between August 2014 and March 2016, 49 HAT cases were 
diagnosed with this new strategy. Between January and March 2016, all 
of the 13 cases that were diagnosed were treated successfully. Compared 
to years before the project was initiated, data obtained so far indicate that 
the availability of diagnostic services closer to where people get infected 
promotes earlier case detection, better prognosis and reduced mortality.
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IMPROVED ACCESS TO PASSIVE SCREENING FOR 
GAMBIENSE HUMAN AFRICAN TRYPANOSOMIASIS DETECTS 
MOST PATIENTS IN FIRST STAGE DISEASE
Crispin Lumbala1, Simon Kayembe1, Jacquies Makabuza1, Albert 
Picado2, Paul Bessell3, Sylvain Biéler2, Joseph M. Ndung’u2
1National Sleeping Sickness Control Programme, Kinshasa, Democratic 
Republic of the Congo, 2Foundation for Innovative New Diagnostics, 
Geneva, Switzerland, 3Epi Interventions Ltd, Edinburgh, United Kingdom
Majority of gambiense human African trypanosomiasis (HAT) cases 
detected in a new passive screening strategy implemented in Kongo 
Central province, Democratic Republic of the Congo, are in early or 1st 
stage disease, which is easier and safer to treat than late or 2nd stage 
disease. The strategy, which is integrated in the primary healthcare 
system, involves performing a HAT rapid diagnostic test (RDT) on a patient 
with symptoms suggestive of HAT but negative for malaria (or positive 
for malaria but still symptomatic after malaria treatment). If the HAT 
RDT is positive, the patient is referred for parasitological testing, and if 
confirmed, is treated. When a patient is negative by microscopy, further 
testing is done using a molecular test for parasite DNA known as LAMP. If 
a patient is at a facility that does not have LAMP, a blood sample is dried 
on filter paper and taken to a LAMP facility by a project motorcycle. LAMP 
positive patients are considered strong HAT suspects and undergo further 
166
astmh.org
tests by microscopy, a requirement for case confirmation according to 
WHO guidelines. Roll-out of the strategy was preceded by introduction 
of HAT RDTs in all 597 public health facilities in the endemic region; 23 
strategically located facilities were upgraded to perform confirmatory 
testing, including LED fluorescence microscopy, and 5 among them to also 
perform LAMP, with appropriate training in all facilities. This reduced the 
median distance travelled by referred patients to 11.2km, and the median 
distance that samples are transported for LAMP to 33km. 32 HAT cases 
were detected from July 2015 to March 2016; 19 (59%) of them were 
identified as suspects after testing positive with HAT RDTs at facilities that 
were not previously screening for HAT. Furthermore, 21 (66%) were in 
1st stage disease, a significant paradigm shift from the past when most 
cases identified passively would be in late or 2nd stage disease. With the 
new strategy, the population at risk is fully covered, patients are screened 
for HAT on their first contact with the health system, and access to 
confirmatory diagnosis is improved. This is an important approach in the 
push to eliminate gambiense HAT.
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DIRECT MEMBRANE FEEDING AS SAYS FOR ESTABLISHING 
XENODIAGNOSIS STUDY IN VISCERAL LEISHMANIASIS: A 
PROOF OF CONCEPT STUDY
Shyam Sundar1, Puja Tiwary1, Shakti Kumar Singh1, Om Prakash 
Singh1, Anurag Kushwaha1, Edgar Rowton2, Phillip Lawyer3, David 
Sacks3
1Institute of Medical Sciences, Banaras Hindu University, Varanasi, India, 
2Division of Entomology, Walter Reed Army Institute of Research, Silver 
Spring, MD, United States, 3Laboratory of Parasitic Diseases, National 
Institute of Allergy and Infectious Diseases, National Institutes of Health, 
Bethesda, MD, United States
The role of reservoir in transmission of anthroponotic VL is inadequately 
understood, and needs to be quickly elucidated in the context of an 
elimination program. With this view, a xenodiagnosis study to investigate 
the role of Leishmania donovani-infected individuals from across the 
infection spectrum in driving the transmission of endemic VL is need to be 
established. Further, to gain an insight into the mechanism that governs 
Leishmania infection, it is important to understand the context of the 
dose of parasite which is likely to affect the evolution of the disease. In 
the present study, we performed chick skin membrane feeding using sand 
fly to find out infective dose requisite for detection of the parasite in the 
sand fly midgut. colony of Phlebotomus argentipes developed using at 
Kala Azar Medical Research Center (KAMRC), Muzaffarpur, Bihar (India). 
Females of P. argentipes were fed on heat inactivated human blood for 
1-2hr through a chick-skin membrane feeder containing 2×103, 2×104, 
2.5×104, 5×104 and 2×105 promastigotes/0.5ml. A group of 20-30 unfed 
flies kept in feeding cup and the membrane feeders were placed upon 
the feeding cups. Membrane feeders were fixed in a circulating water 
bath maintained at 400C. Blood fed females were separated and kept 
in one pint paper cup provided with 30% sugar solution in incubator. 
Midguts of fully blood fed females were dissected at 24, 48, 72, and 96 
hours post-infection and observed under microscope for the presence 
Leishmania promastigotes. The dose at which parasite detected was 2×105 
promastigotes/0.5ml among several concentration used. Although the 
parasite detection was very less at 24 hr (1or 2) but at 48 and 72hr many 
parasite were observed. Further, no parasite was seen after 96 hr. Different 
promastigote forms were seen in the infected flies. Among these included 
procyclic promastigotes, nectomonads and haptomonads, metacyclic 
promastigotes. In conclusion, with this experiment, it can be concluded 
that sand flies colony developed is permissive for Leishmania parasite 
intake from human blood and outfitted for xenodiagnostic experiments.
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EFFECT OF N6-(FERROCENMETHYL)QUINAZOLIN-
2,4,6-TRIAMINE ON MURINE MODEL OF CUTANEOUS 
LEISHMANIASIS
Norma Galindo-Sevilla1, Francisco Hernandez-Luis2, Cesar 
Mendoza-Martinez3, Alejandro Rodriguez-Lezama4, Laura 
Quiñonez-Diaz5
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de Mexico, Mexico, City, Mexico, 3Programa de Maestria y Doctorado en 
Ciencias Quimicas, Universidad Nacional Autonoma de Mexico, Mexico, 
City, Mexico, 4Teqsiquim, S.A. de C.V., Toluca, Edo. Mexico, Mexico, 
5Division de Ciencias de la Salud, UJAT, Villahermosa, Tabasco, Mexico
Treatment for leishmaniasis began more than 100 years ago with the 
introduction of antimonials. Efforts have been done to improve efficacy, 
increase tolerability, diminish toxicity and parasite resistance as well 
as abate the cost. However, we are still far from reaching even half of 
those goals, meaning an urgent need to increase efforts in the search for 
compounds with improved characteristics. Recently, the synthesis, chemical 
characteristics, IC50 (50% inhibitory growth concentration) and in vitro 
parasite effects were described for N6-(ferrocenmethyl)quinazolin-2,4,6-
triamine (H2). Here, we are reporting H2 effect over Leishmania mexicana 
infected mice on foot pad. BALB/c infected mice with MNYC/BZ/62/M379 
Leishmania strain were treated IM with 4 mg kg-1 daily during 28 days 
in groups of five animals per cage. All mice had visible and measurable 
lesions at the beginning of the compound administration. One group for 
vehicle (20% DMSO) and other for meglumine antimoniate 120 mg kg-1 
were used for comparison, with four groups of treatment for compound. 
Mice receiving vehicle or meglumine antimoniate shown the expected 
lesion growing, while mice receiving H2 compound stop the lesion growth 
during treatment, showing 50% less lesion size than vehicle or meglumine 
antimoniate in a model of resistant Leishmania mexicana infection. Any 
death was registered during this scheme of treatment, with dynamic 
animals. Lesion growth resumed two weeks after treatment ended, 
reaching 25% less lesion size than vehicle at third week after treatment 
end, while meglumine antimoniate was 10% up of the vehicle lesion 
size. This is our fifth experiment, with similar results. As a conclusion, 
N6-(ferrocenmethyl)quinazolin-2,4,6-triamine (H2) had better effect than 
meglumine antimoniate over lesion size by Leishmania mexicana infection. 
A complete parasite elimination has not been reached yet, however dose 
and treatment length could be increased in the future.
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ANTI-LEISHMANIA ANTIBODIES IN SAMPLES OF BLOOD 
DONORS FROM ENDEMIC AREAS OF BRAZIL
Mahyumi Fujimori1, Luiza da Cruz Caramelo1, Marina Portanova 
Dornelas1, Beatriz Julieta Celeste1, Silvano Wendel2, Hiro Goto1, 
Maria Carmen Sanchez1
1São Paulo University, São Paulo, Brazil, 2Sírio Libanês, São Paulo, Brazil
In Brazil, in 2014, the incidence of visceral leishmaniasis (VL) was 
3,453 cases. In endemic areas (EA), around 95% of VL individuals are 
asymptomatic and likely be undetected and accepted as blood donors. We 
assessed the prevalence of anti-L. infantum-rK39 antibodies among blood 
donors from Brazilian EA. IgG antibodies were surveyed by ELISA using 
recombinant K39 antigen provided by Infectious Disease Research Institute, 
USA (ELISA-rK39). The study was carried out with 6,125 blood donors 
from 13 Brazilian states. Reactivity index (RI) was calculated for each 
sample and the median of RI≥1.0 were determined for each state. Samples 
yielding RI≥1.0 in ELISA-rK39 were tested in ELISA using Leishmania major-
like antigen (ELISA-L. major), using K28 recombinant antigen (ELISA-rK28), 
DAT, indirect fluorescent immunoassay (IFI) and Kalazar rapid diagnostic 
test (RDT) (Inbios). Anti-rK39-IgG antibodies were detected in 322/6,125 
samples (5.2%). RI≥1.0 varied from 1.003 to 10.770 (median = 1.470). 
Anti-rK28-IgG antibodies were detected in 28/322 samples (8.7%). RI≥1.0 
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varied from 1.013 to 9.546 (median = 1.732). For DAT were considered 
positive titres > 1,600, and 3 samples were positive (0.9%). In ELISA-L. 
major, 141 samples were positive for (43.8%); in IFI, 11 (3.4%) and in 
RDT, 17 (5.3%). From these results, it seems that rK39 is more sensitive 
to detect asymptomatic infections. Anyhow, the great prevalence of IgG 
antibodies achieved in blood samples from asymptomatic donors points 
out to the risk of transfusional leishmaniasis in endemic areas. As in 
those areas, it is not easy to differentiate transfusion- or vector-mediated 
transmission; the occurrence of transmission by transfusion is probably 
underestimated and raises concerns on blood transfusion safety.
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DETECTION AND QUANTITATION OF LEISHMANIA DNA BY 
REAL TIME PCR IN WHOLE BLOOD AND SKIN LESION BIOPSY 
OF ETHIOPIAN CUTANEOUS LEISHMANIASIS (ECL) PATIENTS 
PRESENTING WITH VARIED SKIN LESION TYPES
Habtamu Belay, Tedla Mindaye, Asrat Hailu
Addis Ababa University, Addis Ababa, Ethiopia
Parasitological diagnosis of Old World Cutaneous Leishmaniasis (CL) in 
skin lesion specimens remains to be insensitive. This study was conducted 
to explore if PCR-based diagnosis of Ethiopian Cutaneous Leishmaniasis 
(ECL) could be a feasible option. The study aimed to detect Leishmania 
DNA in skin lesions and peripheral blood specimens of ECL patients using 
real time PCR, and to determine the sensitivity in patients presenting 
with localized CL (LCL) and mucocutaneous leishmaniasis (MCL). Patients 
were those referred to Leishmaniasis Research and Diagnostic Laboratory 
(LRDL) at Addis Ababa University. 48 patients with diagnosis of LCL 
(n=27) and MCL (n=21) were included. NNN cultures and smears were 
made alongside PCR using dermal scraps, cotton swabs, PBMC, whole 
blood, and buffy coat specimens. Primers 13A and 13B were used to 
amplify a region of 120bp mini-circle DNA sequences. Nodular and 
ulcerative lesions were commonest in LCL; while in MCL single ulcers 
involving mucosa and accompanying inflamed and edematous tissue 
were common. 70.4% of LCL and 71.4% of MCL patients were positive 
parasitologically. Using kDNA real time PCR, 74.1% of LCL and 71.4% 
of MCL patients were positive in skin biopsies; whereas in cotton swab 
samples, positivity rates by real time PCR were 81.5% and 90.5% in LCL 
and MCL patients respectively. The sensitivity of kDNA real time PCR using 
biopsy specimen from LCL patients varied from 74.1% to 89.5% cf. rates 
of 71.4 - 75.0% in MCL. Skin biopsies cf. skin slit specimens gave higher 
yields of parasitological diagnosis by NNN medium. The later gave higher 
yield by microscopy. Swabs of skin slit specimens gave higher PCR positive 
rates cf. biopsied material. PBMC or buffy coat specimens gave a negative 
parasitology or kDNA real time PCR. These results indicate that cotton 
swab specimens obtained from skin slit of lesions are preferred samples for 
the diagnosis of ECL using real time PCR. Inability to diagnose ECL from 
buffy coat and PBMC by PCR and parasitological procedures has major 
implications about diagnosis and transmission. Our data indicate that sand 
flies have to feed directly on the lesions for transmission to take place.
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SEROPREVALENCE AND RISK FACTORS OF BRUCELLOSIS IN 
SMALL RUMINANTS SLAUGHTERED AT DEBRE ZIET AND 
MODJO EXPORT ABATTOIRS, ETHIOPIA
Amanuel T. Kifle
Makerere University, Kampala, Uganda
Brucellosis is a global zoonotic disease and major public and animal 
health problem in many parts of the world, particularly in places where 
livestock is a major source of food and income. This cross-sectional study 
was conducted between November 2012 and May 2013 to determine 
the seroprevalence and assess potential risk factors of brucellosis in small 
ruminants in five export abattoirs at Debre Ziet and Modjo, Oromia 
Regional State, Ethiopia. Serology and questionnaire were the methods 
used. In this investigation, 853 sera samples of 485 caprines and 368 
ovines brought for slaughter were selected randomly. The Rose Bengal 
plate test and complement fixation test were conducted using sera 
samples at National Animal Health Diagnostic and Investigation Center 
(NAHDIC) serology laboratory. Data collection sheets were used to gather 
information on possible risk factors believed to influence the occurrence 
of Brucella infection in small ruminants such as age, species, breed, body 
condition score, and origin of small ruminants. Brucellosis was found in 17 
(1.99%) and 15 (1.76%) small ruminants using the Rose Bengal plate test 
and complement fixation test, respectively. The univariate and multivariate 
logistic regression analysis showed that age and body condition score 
of the animals were risk factors to Brucella infection (p = 0.008 and p = 
0.001, respectively) in small ruminants. In conclusion, based on this survey, 
brucellosis is a potential problem in small ruminants in Ethiopia that should 
be further explored.
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INFLUENCE OF CO-INFECTION ON CARRIAGE OF HUMAN 
PATHOGENS IN BROWN RATS FROM AN URBAN SLUM 
SETTING
Ticiana S. Carvalho Pereira1, Fábio Souza2, Luana Santos2, 
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Rapid urbanization in developing countries has led to the spread of slum 
settlements and high infestation with the brown rat, Rattus norvegicus, 
which harbours multiple pathogenic and commensal agents. Yet we know 
little about the prevalence of pathogens in this reservoir and how co-
infection influences transmission of these agents and the risk of spillover 
infection to humans. We conducted a survey of brown rats in 2014 in 
a slum community in the city of Salvador (Bahia-Brazil) to elaborate an 
interaction network between rat-borne infectious agents. We sampled 
rat urine and kidney imprints and feces to identify/quantify Leptospira 
interrogans and helminth species. We performed generalized linear models 
to identify significant effects of coinfection on the presence and intensity 
of each helminth species and L. interrogans controlling for environmental 
factors and the demographics and body condition of rats. Final models 
were combined to build the interaction network. We trapped a total of 
299 rats of which 71% and 39% were carriers of the human pathogens 
Leptospira interrogans and the nematode Angiostrongylus cantonensis, 
respectively. We identified 10 other helminths among rats; the most 
prevalent were Strongyloides sp. (97%) and Nippostrongylus brasiliensis 
(41%), of which the latter was present at higher intensity with higher 
intensities of both Strongyloides sp. and L. interrogans. The intensity 
of A. cantonensis was also higher when rats had higher intensities of 
Strongyloides sp.. However no influence of L. interrogans was found. 
Moreover, the prevalence of A. cantonensis was negatively associated with 
co-parasitism with N. brasiliensis and Heterakis spumosa. Our findings 
confirm that rats carry zoonotic pathogens, such as A. cantonensis (the 
causal agent of eosinophilic meningitis in humans), which are under-
recognized and expanding causes of human disease in urban slum 
settings. Furthermore, coinfection with parasites may significantly modify 
carriage of human pathogens in rats and contribute to variation in the 
transmission risk between regions.
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FIELD OBSERVATIONAL STUDY EVALUATING THE SPILLOVER 
OF ANTIBIOTIC-RESISTANT BACTERIA BETWEEN DIFFERENT 
VARIETIES OF CHICKENS AND RURAL IN NORTHERN 
ECUADOR
Hayden D. Hedman1, Lixin Zhang2, Karla V. Vasco Aguas3, Carl F. 
Marrs1, Gabriel Trueba3, Johannes Foufopoulos1, Joseph Eisenberg1
1University of Michigan, Ann Arbor, MI, United States, 2Michigan State 
University, East Lansing, MI, United States, 3Universidad San Francisco, 
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The twentieth century industrialization of animal husbandry has resulted in 
dramatic increases in animal production. It has also led to departures from 
traditional agricultural techniques including the pervasive and widespread 
administration of antimicrobial agents. Antibiotics are administered 
in animal production facilities for both prophylactic and therapeutic 
purposes. Over-exposure of growth promotion antibiotics has resulted 
in the worldwide emergence of antibiotic-resistant bacterial strains 
in most species of livestock and poultry. Such strains are increasingly 
spreading from large animal production facilities into human populations, 
which presents a pressing public health concern. Both physicians and 
veterinarians are faced with a declining supply of effective antibiotics. 
In Ecuador, small scale farming operations in rural communities often 
prescribes high amounts of antibiotics for poultry raised for meat 
consumption known as “production chickens” (e.g. broilers). In contrast, 
free-ranging local varieties of household chickens receive almost no 
antibiotics and are important as potential bridge hosts introducing 
antibiotic-resistant strains from production chickens to humans. Through 
a cross-sectional village-scale approach, we analyze the relationships 
between antibiotic-resistant prevalence between household and 
production chickens along with a subset of humans living near household 
chickens. For each household, we evaluate the prevalence of antibiotic-
resistant Escherichia coli in household chickens and the spatial relationship 
to the nearest production chicken coop. This investigation is relevant to 
many other tropical countries where development agencies commonly 
introduce production chickens as means of supporting micro-development. 
There is a pressing concern to better understand how antibiotic-resistant 
bacteria spread from conventional to non-conventional animal breeds and 
these impacts on surrounding human populations.
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EXAMINING RATS IN THE MARSHALL ISLANDS AS A 
POSSIBLE ANIMAL RESERVOIR FOR MYCOBACTERIUM 
TUBERCULOSIS AND ATYPICAL MYCOBACTERIA
Jerry R. Scott
University of Hawaii at Manoa John A. Burns School of Medicine, 
Honolulu, HI, United States
The Marshall Islands have some of the highest rates in the world for both 
Mycobacterium tuberculosis and Atypical mycobacteria infection. The 
Marshall Islands and specifically Majuro General Hospital, in the capital, 
have significant problems with rat infestations and rodent control. To 
investigate the possibility of an animal reservoir for these diverse groups 
of Mycobacteria a total of ten rats from two areas in the hospital were 
captured in live traps. Five rats were captured in and around the nurses 
station of the intensive care unit. The other five rats were captured in the 
storage area near the surgical ward. More rats could have been captured, 
however hospital staff sometimes turned the rats loose or tripped the traps 
closed during the night. All of the captured rats were drowned in fresh 
water the the surgical pathology department, washed and then autopsied 
for evidence of granulomas and lymphadenopathy. The heart and lungs 
were then harvested and saved in formalin containers. Histologic sections 
of the heart and lungs showed no evidence of granulomas and acid fast 
staining was negative for mycobacterial organisms. Three of the rats 
appeared well nourished, but ill. None of the rats had lymphadenopathy or 
grossly evident liver disease. However, nine out of ten of the rats showed 
evidence of chronic lymphocytic bronchitis in a pattern that would be 
significant in human patients. A control group of two rats was trapped. 
One from the mountains of New Mexico and one rat from the area of 
China town near the medical school. Both rats were processed in the same 
manner. These rats showed no evidence of bronchitis, although the rat 
from New Mexico did have several foci of coccidioidomycosis. This is only 
intended to be a preliminary study. It was not possible to culture the lungs 
for infectious agents and the urine and feces of the rats was not examined 
during this study. Some hospital staff were concerned that other animal 
reservoirs might be present such as feral dogs, cats and domesticated 
pigs. Further studies might include wild dogs or local pigs as well as larger 
numbers of rats analyzed with more sensitive technology such and the 
Genexpert and lung cultures.
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MODELING ENVIRONMENTAL TRANSMISSION OF ZOONOSIS 
IN MULTISPECIES SYSTEMS
Leon Espira, Nancy Hernandez-Ceron, Joseph N. Eisenberg
University of Michigan, Ann Arbor, MI, United States
Animals harbor important pathogens that impact both livestock and 
human health. In addition, the increased use of transmission models 
to study animal disease has highlighted the need to consider the host-
pathogen interaction in the context of environmental and ecosystem 
drivers of infection transmission. We developed a novel use of disease 
transmission models to study the environmental transmission of zoonotic 
disease in multispecies herding systems characteristic of many pastoral 
economies in the emerging world. Specifically, we examine the role of 
diversity on pathogen persistence demonstrating that, depending on 
environmental factors and the mechanisms of host species interaction, 
diversity can have differing effects on the transmission dynamics. Our 
results extend prior work of the role of diversity in pathogen persistence 
by providing a mechanistic understanding of how environmental processes 
can impact modes of transmission. These models will not only help inform 
public health interventions but could be crucial for conservation decisions 
in areas characterized by livestock-wildlife interphases.
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RISK FACTORS FOR ACUTE HUMAN BRUCELLOSIS IN 
NORTHERN TANZANIA
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Dunedin, New Zealand, 6Boyd Orr Centre for Population and Ecosystem 
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Brucellosis is an important zoonotic cause of febrile illness with chronic 
sequelae, but little is known about transmission pathways in sub-Saharan 
Africa hampering the design of control programs. We conducted a 
prospective cohort study of acute human brucellosis in northern Tanzania. 
We enrolled pediatric and adult patients with fever from two referral 
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hospitals in Moshi, Tanzania. We administered a standardized risk factor 
questionnaire and performed Brucella microagglutination testing on acute 
and convalescent serum. Cases were patients who had either a four-fold 
rise in titer between paired serum samples or a single reciprocal titer ≥160. 
Controls had titers <20 in both serum samples. We calculated odds ratios 
(OR) for individual behaviors and combined behaviors to form exposure 
scales to livestock and livestock body fluids. Of 1,446 patients enrolled 
from February 2012 through September 2014, we identified 50 (3.5%) 
acute brucellosis cases and 512 controls. Remaining participants either 
had titers >20 - <160 or supplied only acute serum. Median (interquartile 
range) age of cases was 31 (23, 40) years, 33 (66.0%) of 50 were female, 
and 20 (43.5%) of 46 were from rural areas. On bivariate analysis, 
increasing age was associated with brucellosis (OR 1.1 per year, p<0.01). 
Birthing goats (OR 8.8, p=0.01) or livestock (OR 6.2, p=0.02); consuming 
raw livestock blood (OR 2.7, p=0.03); exposure to goat (OR 4.0, p<0.01) 
or pig blood (OR 3.7, p<0.01); feeding cattle (OR 3.9, p<0.01), goats (OR 
2.8, p<0.01), or pigs (OR 7.0, p<0.01); and cleaning waste of cattle (OR 
4.1, p<0.01) or pigs (OR 5.6, p<0.01) were associated with brucellosis. 
Brucellosis was associated with high levels of contact with livestock 
measured by the exposure scales (OR 3.2, p<0.05). No association was 
found between raw milk consumption and acute disease. We found 
that livestock contact was an important risk factor for brucellosis in 
northern Tanzania, and that risk varied both by type of livestock contact 
and by livestock species. Many of the risk factors identified are behaviors 
potentially modifiable by targeted interventions.
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INFLUENZA A VIRUS AMONG PIG AND DUCK POPULATIONS 
IN RURAL BACKYARDS IN GUATEMALA, 2013-2014
Maria L. Müller1, Lucia Ortiz1, Danilo A. Alvarez1, Patricia Herrera1, 
Ana S. Gonzalez-Reiche2, Ana L. Barrios1, S. Cornelia Kaydos-
Daniels3, Celia Cordon-Rosales1
1Universidad del Valle de Guatemala, Guatemala, Guatemala, 2University 
of Georgia, Athens, GA, United States, 3Centers for Disease Control and 
Prevention, Atlanta, GA, United States
The human-animal interface may favor the emergence of novel influenza 
A virus (IAV) strains that might pose a threat to human and animal health. 
We conducted monthly cross-sectional surveys of backyard pigs and ducks 
from November 2013-October 2014 on the Pacific coast of Guatemala 
where IAV was isolated from migratory waterfowl. We collected nasal 
swabs (pigs), tracheal and cloacal swabs (ducks), and blood from both 
species. Households with each of the species were selected randomly 
based on an expected IAV prevalence of 10%. One of every two pigs and 
1/7 ducks were selected by convenience within each household; animals 
could be re-tested in different months. We tested swabs for IAV RNA by 
rRT-PCR targeting the universal IAV matrix gene, and subtyped the matrix 
positive samples by rRT-PCR targeting the 2009 pandemic N1 gene. 
We tested sera to detect exposure to IAV using a commercial ELISA kit, 
and subtyped ELISA positive sera from ducks by HI against a H5N3 low 
pathogenic strain isolated from waterfowl. An average of 32 households 
with pigs and 46 households with ducks were sampled monthly. We 
collected a total of 669 samples from pigs and 1090 samples from ducks. 
We detected 7/669 (1%; CI 95%: 0.4-2) rRT-PCR positive pig samples; 
none tested positive for pandemic N1. Only 1/1090 (0.1%; CI 95%: 
0.1-0.5) of tracheal swabs from ducks tested positive by rRT-PCR (cloacal 
results pending). We detected antibodies against IAV in 85/669 (13%; 
CI 95%: 10-16) of sera from pigs and 98/1090 (9%; CI 95%:7-11) from 
ducks. Among seropositive ducks, 1/98 (1%; CI 95%: 1-6) were reactive to 
the H5N3 virus. HI results may suggest exposure of ducks to IAV from wild 
waterfowl, but isolation and sequencing of IAV strains from positive swab 
samples to identify IAV viruses circulating in pig and duck populations is 
pending. We found low percentages of current IAV infections in these 
backyard animals. Serologic results are limited by potential re-testing of 
individuals and knowing the animal age, but suggest low exposure to IAV. 
Interspecies transmission of IAV and the implementation of an integrated 
surveillance of IAV at this setting, where multiple hosts interact, should be 
evaluated.
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LEPTOSPIRA SEROPREVALENCE AND RISK FACTORS IN 
HEALTH CENTER PATIENTS IN HOIMA DISTRICT, WESTERN 
UGANDA
Jonathan Dyal1, Anou Dreyfus2, Raewynne Pearson3, Clovice 
Kankya4, Charles Kajura5, Lordrick Anaitwe4, Steven Kakooza4, 
Katey Pelican6, Dominic Travis6, Michael Mahero6, David R. 
Boulware7, Lawrence Mugisha4
1Baylor College of Medicine, Houston, TX, United States, 2University of 
Zurich, Zurich, Switzerland, 3Massey University, Palmerston North, New 
Zealand, 4College of Veterinary Medicine, Makerere University, Kampala, 
Uganda, 5Hoima District Government, Hoima, Uganda, 6College of 
Veterinary Medicine, University of Minnesota, Minneapolis, MN, United 
States, 7Department of Medicine, University of Minnesota, Minneapolis, 
MN, United States
The burden of human leptospirosis in Uganda is unknown, but is 
suspected to comprise a significant portion of undifferentiated febrile 
illnesses. The study objectives were to estimate the prevalence of 
Leptospira antibodies and risk factors for seropositivity in humans visiting 
two health centers in Hoima District, Uganda. 359 patients were recruited 
at the Kikuube and Kigorobya Health Center IV’s during March and April 
2014. Every non-pregnant adult over the age of 18 presenting to the 
health center, either as a patient or as a caregiver, was eligible. Interviews 
were conducted by clinical officers and a blood sample was taken by 
lab technicians. Exposure variables included demographics, exposure 
to animals, past medical history and domestic environment. Sera were 
tested by the Microscopic Agglutination Test (MAT) using eight Leptospira 
serovars from different serogroups. 126 study participants (35.0%, 95% 
CI 30.2-40.3%) were seropositive (MAT titer >= 100) against any serovar. 
The highest prevalence (19.8%, 95% CI 15.9-24.4%) was against L. 
borgpetersenii sv Nigeria (serogroup Pyrogenes) with 71 seropositive cases. 
The prevalence of probable leptospirosis (MAT titer >=800) was 1.9% 
(95% CI 0.9-4.2%) and was uniquely related to serovar Nigeria. Probable 
leptospirosis was statistically significantly associated with self-reported 
malaria in the past year (p=0.048). The few participants who reported 
having skinned cattle in the two weeks prior to their blood sample (n=6) 
had a relative risk of 2.6 (p=0.036) for seropositivity against any serovar. 
This is to our knowledge the first study of the prevalence of antibodies to 
Leptospira serovars in humans in Uganda. The seropositivity to leptospirosis 
and the specific seroprevalence of 20% against L. borgpetersenii sv Nigeria 
suggests high exposure in this population. Individuals participating in cattle 
skinning may also be at higher risk for exposure. Overall, leptospirosis may 
represent an underappreciated burden of illness in Hoima, Uganda.
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IMPACT OF REV1 LIVESTOCK VACCINATION ON THE RISK OF 
HUMAN BRUCELLOSIS IN AZERBAIJAN
Ian Kracalik1, Rita Ismayilova2, Mehriban Baghirova3, Jason K. 
Blackburn1
1University of Florida, Gainesville, FL, United States, 2Anti-Plague Station, 
Baku, Azerbaijan, 3State Veterinary Service, Baku, Azerbaijan
Brucellosis is one the most common and widely spread zoonotic diseases 
in the world. Effective control of the disease is, in general, focused on 
reducing or eliminating brucellosis in livestock through vaccination. 
However, despite the availability of effective control measures, brucellosis 
continues to pose a public health risk in both developed and developing 
countries. The objective of our study was to evaluate the impact of Rev1 
small ruminant brucellosis vaccination on the risk of human brucellosis in 
Azerbaijan. We used monthly time-series data on human brucellosis cases 
in Azerbaijan before and after a Rev1 small ruminant vaccination campaign 
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(1995-2013). We used an interrupted time-series framework to estimate 
the relative and absolute indirect effect of the livestock vaccination 
policy on human risk. Incident risk was calucated for age groups before 
and after vaccination. To identify spatial variations in temporal reporting 
trends, we used the scan statistic. Additionally, we mapped temporal 
trajectories of human brucellosis incidence, by administrative district, using 
a spatially lagged incidence rate in a segmented regression model. Our 
results showed a post vaccination decline in human brucellosis of ~1% 
per month. Overall, human brucellosis was reduced by 34% by 2013. 
Risk reduction was greatest in the 20-29 age group. Despite national 
declines in human brucellosis, we identified spatial changes in the case 
distribution characterized by a geographic expansion and an increasing 
incidence among districts clustered in the south-east, compared to a 
decrease elsewhere in the country. In conclusion, our findings support the 
human health benefits of livestock vaccination. However, we found spatial 
variation in the impact of the vaccination program that can be used to 
target future efforts. Our findings highlight the use of integrating spatial 
and quasi-experimental techniques to evaluate the progress of public 
health interventions.
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CLIMATE CHANGE AND VECTOR-BORNE DISEASES: USE 
OF PARTICIPATORY EPIDEMIOLOGY TO INVESTIGATE 
EXPERIENCES IN VULNERABLE, CATTLE-KEEPING 
HOUSEHOLDS IN TANZANIA
Esther Kimaro, Jenny-Ann L. Toribio, Siobhan M. Mor
The University of Sydney, Sydney, Australia
Climate change is predicted to increase incidence of vector-borne diseases 
(VBDs) in humans, however little is known about the impact on animal 
VBDs in vulnerable areas where livestock are a primary livelihood strategy. 
In the absence of historical data with which to examine the inter-relation 
between climate and disease, participatory epidemiological (PE) methods 
were used with Maasai pastoralists of Monduli district, Northern Tanzania 
to establish local observations on two major VBDs of cattle, namely East 
Coast Fever (ECF) and Animal Trypanasomiasis (AT). Data were collected 
between November 2014 and January 2015 in ten randomly selected 
villages of arid and semi-arid lands involving gender segregated groups 
(10 men groups and 9 women groups). Matrix scoring for both men and 
women groups confirmed that Maasai easily recognise these VBDs. ECF 
and AT ranked amongst the top five most important cattle diseases in the 
district with strong agreement between informant groups (Kendall’s W 
= 0.399 for men and 0.451 for women; p < 0.01). All groups associated 
ECF with the wet season or directly after rainy season while AT was more 
variable throughout the year, with more cases reported in dry seasons. 
Likewise, different villages reported seasonal differences in occurrence of 
disease vectors (Rhipicephalus appendiculutus and Tsetse flies). Comparing 
2014 to 1984, participant groups consistently reported declines in rainfall, 
vegetation cover and quality pasture, as well as increases in severe 
drought. Experiences with ECF/AT and vector abundance between these 
time periods was more variable across villages, and likely relates to changes 
in climate and animal management practices over the last 30 years. This 
baseline study is the first to document the inter-relation between climate 
and cattle diseases from the pastoralist perspective. Preliminary analyses 
reveal a complex interplay between human, animal and environmental 
factors, understanding of which is urgently required to devise approaches 
to mitigate effects of climate change in vulnerable areas.
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ONE HEALTH WORLDWIDE: EMERGING INFECTIOUS 
DISEASES, GLOBAL HEALTH VETERINARIANS, AND 
ZOONOTIC SURVEILLANCE
Kali Holder, Devin Tunseth, Megan Vodzak, Benjamin Norton, 
Suzan Murray
Smithsonian Institution, Washington, DC, United States
What do zoos have to do with Global Health? How are veterinarians 
engaging in pandemic prevention? Do non-zoonotic veterinary pathogens 
impact human health? Given that most zoonotic pathogens are from 
wildlife, surveillance of pathogens in wildlife is garnering more attention 
from domestic and international health organizations. The National 
Zoological Park’s Smithsonian Global Health Program (SGHP) is a team 
of wildlife veterinarians, veterinary pathologists, biologists, physicians, 
and other public health professionals tasked with investigating and 
combatting emerging diseases worldwide. One Health ventures that 
SGHP is invested in include: human-animal interface surveillance 
(through USAID|PREDICT), xenosurveillance for MERS coronavirus and 
Zika virus, and emerging ulcerative dermatitides in African megafauna. 
SGHP engages in international collaboration and capacity building of 
diagnostic and public health infrastructure in developing tropical countries. 
Veterinarians form an integral part of this corps of experts, and their 
unique and often overlooked understanding of the interactions between 
humans and wildlife make them an essential presence on the front lines 
of emerging zoonoses detection and prevention. Although much has 
been devoted to understanding the human consequences of well-known 
zoonotic outbreaks, such as the Ebola virus, very little focus has been 
placed on poorly studied zoonoses or non-zoonotic wildlife diseases 
and the potential risk they present to human health. This has led to the 
emergence of serious threats from previously “benign” diseases such as 
Zika virus. There is even evidence that non-zoonotic animal pathogens may 
play a role in the severity and transmissibility of zoonotic diseases, as when 
the competency of certain arbovirus vectors increases as a result of co-
infection with animal-borne filariasis. It is the mission of multidisciplinary 
One Health groups such as SGHP to tackle these challenges from all 
angles and combat pandemic threats. Collaboration with other health 
professionals is a vital component of ongoing integrated strategies in 
improving health outcomes globally.
542
SEROPREVALENCE AND THE RISK FACTORS ASSOCIATED 
WITH TOXOPLASMOSIS IN WOMEN RECEIVED ANTENATAL 
CONSULTATION (ANC) AND DOMESTIC CARNIVORES IN 
DAKAR
Fatoumata Coulibaly1, Abdrée Ndour2, Jean-Louis Ndiaye1
1Universite Cheick Anta Diop Dakar, Dakar, Senegal, 2Ecole Veterinaire 
Dakar, Dakar, Senegal
Toxoplasmosis is a cosmopolitan zoonosis caused by Toxoplasma gondii 
manifested by fetal loss mainly in sheep and humans. The identified 
definitive host is the cat while all domestic mammals such as wild birds 
and humans are intermediate hosts. Disease sporadic pace, its modes of 
transmission are manifold. The object of this study was to evaluate the 
seroprevalence of toxoplasmosis and the risk factors in pregnant women 
and domestic carnivores in Dakar. For this, blood samples of 100 pregnant 
women, 141 cats and 120 dogs were collected and sera were analyzed. 
Regarding the acquisition of risk factors, a questionnaire was associated 
with each sample. Two agglutination series tests showed that the women 
surveyed were infested at 50 ± 9.8% for toxoplasmosis. Multivariate 
analysis showed that 43% of these women have had an abortion and 
of those, 53% were positive for toxoplasmosis. After analysis of risk 
factors, professional status and milk consumption predispose women to 
be contaminated (p <0.05 and odds ratio> 1) with toxoplasmosis. For 
carnivores, the agglutination test shows that the infestation is higher for 
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definitive hosts (cats 55.37 ± 9%) compared to dogs (43.97 ± 8%). These 
high prevalence confirms that this parasite is prevalent in an endemic 
form in the region especially with the close cohabitation between women 
and cats. They must motivate the strengthening and systematization of 
screening tests during pregnancy.
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UPDATE Q FEVER STATUS FROM THE RUMINANT 
PLACENTAS, THAILAND 2014-2015
Pattarin Opaschaitat1, Sawanya Nu-iat1, Seksit Singjam2, 
Petcharat Sakdinun3, Kanthanis Limwibulpong4, Pornpun 
Laolue5, Yaowarat Sawasdee6, Gamonsiri Coygasem7, Netchanok 
Jiwakanon8, Maza John9, Samuel Yingst10
1National Institute of Animal Health, Bangkok, Thailand, 2Veterinary 
Research and Development Center, Lower-North Region, Pitsanulok, 
Thailand, 3Veterinary Research and Development Center, West Region, 
Ratchaburi, Thailand, 4Veterinary Research and Development Center, 
East Region, Chonburi, Thailand, 5Veterinary Research and Development 
Center, Upper North Region, Lampang, Thailand, 6Veterinary Research and 
Development Center, Lower Northeast Region, Surin, Thailand, 7Veterinary 
Research and Development Center, South Region, Nakornsrithammarat, 
Thailand, 8Veterinary Research and Development Center, Upper Northeast 
Region, Khonkaen, Thailand, 9Epidemiology and Disease Surveillance, 
Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand, 
10Purdue University College of Veterinary Medicine, West Lafayette, IN, 
United States
Q fever, caused by Coxiella burnetii is a zoonotic disease, found 
worldwide. The ruminants such as cows, buffalo, goats, and sheep 
are reservoirs. The most common clinical sign in livestock is abortion, 
but infected adult animals almost never show clinical signs. The main 
transmission route is by inhalation in humans, and possibly animals 
as well. As ruminant placenta is occasionally sold in wet markets in 
Thailand for human consumption, at-risk people include the farmers, 
veterinarians, animal husbandry workers, placenta-merchants, and cooks, 
and potentially the general public. Human Q Fever cases were reported in 
Thailand. We aimed to know the Q fever status in ruminants in Thailand. 
Approximately 300 samples of the cotyledon part of ruminant placenta 
were collected by convenience sampling from each region. The samples 
were grossly normal, though some were retained placentas. The samples 
were extracted for DNA and tested with the real-time polymerase chain 
reaction (PCR) technique, which targets the IS1111. The tests were run 
in the Thai governmental veterinary laboratory system, comprised of 
the National Institute of Animal Health (the central region), and seven 
Veterinary Research and Development Centers (regional labs). The positive 
percentage of results, by region in Thailand was 63.84 (203/318) in the 
east, 50.9 (170/334) in the upper north, 45.62 (151/331) in the west, 
38.82 (125/322) in the central, 24.77 (81/327) in the lower north-east, 
19.73 (59/299) in the upper north-east, 8.46 (28/331) in the lower north, 
and 7.51 (16/213) in the south region. The total percentage for the whole 
country was 32.46 (833/2475). Q fever occurred in ruminants in Thailand 
without showing abortions, as occasionally seen in other countries. Good 
sanitation such as disinfection, wearing personal protective equipment, 
including gloves, masks, and boots, especially during the parturition time, 
and routinely cleaning the animal house should be done by the farmers, 
and veterinarians. The placenta-merchants and cooks should wear gloves 
when handling raw placenta and thoroughly cook placenta if served for 
human consumption.
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DOCUMENTING THE SEROPREVALENCE OF ZOONOTIC AND 
VECTOR BORNE DISEASES IN RURAL NICARAGUA
Rebecca S. B. Fischer1, Christiane Duttmann2, William Jiron 
Toruno2, Melissa N. Garcia1, Rodion Gorchakov1, Sarah M. Gunter1, 
Kristy O. Murray1
1Baylor College of Medicine, Houston, TX, United States, 2Universidad 
Nacional Autónoma de Nicaragua, Leon, Nicaragua
Rural communities, particularly in low and middle income nations, are at 
high risk of zoonotic and vector borne diseases. The rural poor in these 
parts of the world are disproportionately affected, but the extent of which 
is largely undescribed, in part due to limitations on surveillance capacity 
in resource constrained settings. In Nicaragua, the tropical climate is 
particularly conducive to transmission of mosquito borne viruses, such as 
Dengue, Chikungunya, and Zika, and frequent close contact with domestic 
and other animals in rural communities facilitates transmission of zoonotic 
pathogens. In order to understand the extent to which infections like these 
are circulating within the region, we undertook a cross-sectional study 
to estimate the seroprevalence of infectious diseases among agricultural 
workers in the Pacific lowlands of Nicaragua. Workers of a large sugar 
estate underwent routine, annual occupational health screenings from 
October 2015-June 2016. Age and sex of workers were available. From 
June-October 2015, blood was also collected from domestic animals in the 
same region. Serum from humans and animals were available for testing 
and were subjected to ELISA assay for detection of antibodies to various 
pathogens (ELISA for IgM or IgG and and MAT for Leptospira reactivity). 
Workers were mostly male (89%) and young (median age 29yrs). In 
humans, we detected a high prevalence of antibodies to Leptospira 
(33%) and also detected antibodies to hantavirus (6%) and Trypanosoma 
cruzi (0.5%). Dogs had evidence of leptospirosis (12%) and T. cruzi 
(5%). Testing for seroprevalence of other infections, including Dengue, 
Chikungunya, West Nile, and Zika are ongoing. Our data suggests that 
zoonotic and vector borne pathogens are likely established and endemic, 
provides evidence that hantavirus may be a threat, and documents the 
presence of Chagas disease in this region of Nicaragua. This new data 
can inform public health and veterinary practices and suggest areas for 
targeted surveillance and intervention strategies.
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SURVEILLANCE OF AMOEBIC KERATITIS-CAUSING 
ACANTHAMOEBAE FOR BACTERIAL ENDOSYMBIONTS
Andrew Purssell1, Nessikha Karsenti2, Rachel Lau3, Filip Ralevski3, 
Ann Chong-Kit3, Andrea K. Boggild2
1University of British Columbia, Vancouver, BC, Canada, 2University of 
Toronto, Toronto, ON, Canada, 3Public Health Ontario Laboratories, 
Toronto, ON, Canada
Acanthamoebae are causative pathogens of several infections 
including amoebic keratitis (AK), a potentially blinding eye infection. 
Acanthamoebae isolated from the environment and from corneas 
of patients with AK are known to harbor bacterial endosymbionts 
belonging to chlamydiales, rickettsiales, or legionellales. Acanthamoebae 
harboring Chlamydia-like endosymbionts have demonstrated enhanced 
production of cytopathic effect on fibroblast monolayers, suggesting 
that endosymbionts may increase virulence. We sought to illuminate 
the potential bacterial endosymbionts present in clinical isolates of 
acanthamoebae identified at our reference parasitology laboratory. Isolates 
of Acanthamoeba spp. obtained from our biobank of surplus, anonymized, 
corneal scrapings from 2012-2015 were screened for endosymbionts by 
PCR. Isolated DNA was amplified in PCR reactions with 3 separate primer 
pairs,detecting bacteria belonging to orders chlamydiales, rickettsiales, 
or legionellales. 3 primer pairs specific to the 18s rRNA gene of 
Acanthamoeba spp. were used for amplification of Acanthamoeba DNA. 
Sanger sequencing of PCR products was performed, followed by BLAST 
analysis for sequence homology and species identification. We screened 
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27 clinical isolates of Acanthamoeba spp. for organisms known to act as 
endosymbionts as described above. Five strains of Acanthamoeba (19%) 
from corneal scrapings were found to contain bacterial DNA belonging to 
legionellales (2 A. polyphaga (40%), others not speciated). 3 of the clinical 
isolates (11%) contained members of the rickettsiales (2 A.castellani 
(66%), 1 A. palestinensis (33%)). One strain (4%, not speciated) contained 
a member of the chlamydiales, and sequencing revealed this to be 
Neochlamydia hartmannellae. The remaining isolates of Acanthamoeba 
may contain other endosymbionts undetectable by our assays. Organisms 
known to act as bacterial endosymbionts are prevalent in corneal 
scrapings containing AK-causing Acanthamoeba. Whether these potential 
endosymbionts contribute to virulence is unknown, but offers a potential 
avenue for investigation of novel therapeutics in AK.
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OPTIMIZED METHODS OF GENOMIC DNA EXTRACTION 
AND MYCOPLASMA DECONTAMINATION FROM DIFFERENT 
SPECIES OF PATHOGENIC AMOEBAE
Biniam Hagos, Ioana Brasov, Robert E. Molestina
BEI Resources, ATCC, Manassas, VA, United States
Free-living amoebae (FLA) are generally regarded as innocuous soil 
organisms; however, a handful of species are capable of causing 
human disease. Naegleria fowleri, Acanthamoeba spp. and Balamuthia 
mandrillaris are recognized as etiologic agents of amoebic encephalitis. 
Acanthamoeba are also responsible for the sight-threatening infection 
amoebic keratitis, particularly among contact lens wearers. A rate-
limiting step in genomic analyses of pathogenic FLA is DNA extraction. 
Many commercially available DNA isolation kits are useful for PCR but 
fail to provide high yields of pure genomic DNA for molecular studies. 
We examined different in-house methods for the capacity to extract FLA 
DNA. We found that an optimized phenol-chloroform-based purification 
method was applicable to different species of amoebae when compared 
to a commercial kit. While similar to other standard methods of extraction, 
this modified procedure resulted in DNA of high yield and quality as it 
likely takes into consideration the high amounts of carbohydrates and 
nucleases found in amoebic cells. Mycoplasma contamination is also of 
great concern in cultures of pathogenic amoebae, especially in strains 
propagated in mammalian cell lines. We examined different methods 
of decontamination of Balamuthia cultures harboring mycoplasma that 
were resistant to commonly used antibiotics. The methods were based 
on the rapid treatment of amoebic cysts with non-amoebicidal levels 
of detergents and/or acids to eliminate the contaminating bacteria as 
determined by PCR. Our non-antibiotic-based approach was effective in 
curing cultures of Balamuthia from mycoplasma without affecting viability 
of the amoebae. Taken together, the use of reliable methods of DNA 
extraction combined with simple and economic procedures of bacterial 
decontamination offers an effective approach to produce genomic DNA 
from pathogenic amoebae on a large scale for a range of molecular 
genetic analyses.
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DIAGNOSTIC ACCURACY OF AMEBIC COLITIS BY 
COLONOSCOPY
Yasuaki Yanagawa1, Koji Watanabe1, Naoyoshi Nagata1, Kumiko 
Tsukui2, Seiki Kobayashi3, Tomoyoshi Nozaki2, Hiroyuki Gatanaga1, 
Yoshimi Kikuchi1, Shinichi Oka1
1National Center of Global Health and Medicine, Tokyo, Japan, 2National 
Institute of Infectious Disease, Tokyo, Japan, 3Keio University, Tokyo, Japan
Amebiasis, caused by Entamoeba histolytica, is rapidly increasing as a 
sexually transmitted infection in Japan. It has been also reported that 
asymptomatic amoebic colitis incidentally diagnosed by colonoscopy 
recently increased. Although etiologic diagnosis of intestinal ulcer mostly 
relies on histological examination of biopsy specimen, it is still unclear 
whether the method has enough sensitivity to rule out amoebic colitis. We 
collected samples from suspected cases of amoebic colitis by colonoscopy. 
Microscopic examination, culture and PCR of aspirated fluid, as well as 
histological examination of biopsy specimen, were performed. Diagnosis 
of amoebic colitis was made when either test was positive. Of the 23 
suspected cases, amoebic colitis was diagnosed in 13 cases (57%). 
The proportions of co-infection with HIV, HBV, HCV, and syphilis were 
54%, 54%, 8% and 39%, respectively. At the colonoscopy, 10 patients 
(77%) had clinical symptoms, including diarrhea (62%), abdominal pain 
(23%), bloody stool (15%), fever (15%), and nausea/vomiting (15%), 
whereas 3 (23%) were completely asymptomatic. One case accompanied 
amoebic liver abscess. The sensitivities of microscopy, culture, PCR and 
histopathology were 69%, 23%, 67% and 46%, respectively. The 
proportion of cases with abdominal symptom was statistically higher 
in histological negative than that in histological positive (p 0.04). Three 
clinical isolates, including 2 isolates from asymptomatic cases, were stably 
passaged as a xenic culture. Either diagnostic tool including histological 
examination used in this study doesn’t have enough sensitivity (23-69%) 
for the diagnosis of amoebic colitis by colonoscopy, indicating that 
combination of multiple methods be needed for the accurate diagnosis. 
Also, we established 3 clinical isolates from aspirated fluids of the lesions. 
We will perform genetic and phenotypic analyses of these clinical isolates 
in order to elucidate the pathogenesis of amoebic colitis, especially 
asymptomatic chronic infection.
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GUT MICROBIOME CHANGE PRIOR TO THE ONSET OF 
AMEBIASIS
Carol A. Gilchrist1, Brittany N. Schneider1, Masud Alam2, Jeffrey 
R. Donowitz3, Mamun Kabir2, William A, Petri Jr1, Rashidul Haque2
1University of Virginia, Charlottesville, VA, United States, 2International 
Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh, 
3Children’s Hospital of Richmond at Virginia Commonwealth University, 
Richmond, VA, United States
Amebiasis is one of the causes of severe diarrhea in young infants <5 
years of age in low and middle income countries. In our previous work we 
observed that the composition of the microbiota was markedly different 
in ≤ 2 year old children experiencing amebic diarrhea compared to those 
asymptomatically colonized. In particular, a high level of the pathobiont 
Prevotella copri was associated with symptomatic amebiasis. We 
postulated that either gut dysbiosis and the domination of the microbiota 
by P. copri increased the probability that an Entamoeba histolytica infection 
would be symptomatic or the resistance of P. copri to host-derived 
reactive oxygen allowed it expand after the amebic parasite caused gut 
inflammation and diarrhea. To distinguish between these two possibilities, 
we examined the 16S microbiome profile in 16 surveillance specimens 
collected and stored in the study biobank 89 ± 77 days prior to the 
occurrence of E. histolytica positive diarrhea. In our preliminary analysis we 
have observed a stronger P. copri signal in the samples preceding disease. 
This seems to indicate that a preexisting P. copri expansion dispose children 
to symptomatic disease and the previous result was not a consequence of 
E. histolytica infection. We also observed that even although P. copri was 
higher in diarrheal cases than the amount detected in E. histolytica positive 
surveillance samples the onset of diarrhea actually led to an expansion of 
the Enterobacteria at the expense of both P. copri and Bifidobacteriales 
species which dominate the pre- diarrhea microbiome in these children. 
The Shannon diversity index was as expected lower in pre-diarrheal and 
diarrheal samples compared to samples from 2-year old controls p<0.05. 
Additional studies are planned to determine the significance of these 
results.
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GENOMIC AND TRANSCRIPTOMIC COMPARISON OF 
CLINICAL AND NON-CLINICAL STRAINS OF “BRAIN-EATING” 
AMEBA NAEGLERIA FOWLERI
Ibne K. Ali, Alyssa Kelley, Shantanu Roy
Centers for Disease Control and Prevention, Atlanta, GA, United States
The “brain-eating” free-living ameba, Naegleria fowleri, causes rare, but 
severe brain infection, known as primary amebic meningoencephalitis 
(PAM) that is almost always fatal. The ameba is found globally in warm 
fresh waters, hot springs, and waterparks. Recently, N. fowleri has been 
found to colonize public tap water systems in US linking the death of 
a young child. This coincides with an observed geographical spread in 
PAM cases to the colder Northern States. A major issue affecting our 
ability to investigate and prevent PAM infections is the ubiquitous nature 
of this pathogen. It is unclear why PAM cases are so rare while people 
are likely to be routinely exposed to N. fowleri. Variability in the ameba 
virulence may explain this. However, a genotyping system capable of 
categorizing N. fowleri strains based on their virulence does not exist. 
The existing genotyping categorizes the US strains of N. fowleri into only 
three broad genotypes. Thus, this genotyping is also not ideal for linking 
exposures with cases. Here, we performed Illumina Hiseq to do whole 
genome sequencing of 38 N. fowleri strains (30 from clinical cases and 
8 from environmental samples) representing all three genotypes. We 
also performed RNAseq in a subset of N. fowleri strains to identify gene 
expression differences between the clinical and environmental strains. The 
de novo assembly of mitochondrial genome shows that it is ~49.5 KB in 
size. Preliminary analysis identifies SNPs in the mitochondrial genomes, 
some of which are genotype-specific and some are unique (“private”) 
to a particular strain. The private SNPs can be utilized to develop a more 
discriminatory genotyping system, which will allow source tracking in 
clinical cases, and conduct molecular epidemiological surveys. The de 
novo assembly of nuclear genome of N. fowleri shows that it is ~27.5 
MB in size, and contained in <600 contigs with a G-C content of ~34%. 
The only reference genome of N. fowleri available publicly is dispersed in 
>1100 contigs suggesting a superiority of our assembly. Analysis of nuclear 
genome and transcriptomic data is currently ongoing. Key findings will be 
presented in the ASTMH Meeting.
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IMPACT OF NOVEL ENTAMOEBA SPECIES ON DIARRHEAL 
INFECTIONS IN SOUTH AFRICA
Renay Ngobeni1, Samie Amidou1, Shannon Moonah2, William A. 
Petri2, Carol Gilchrist2
1University of Venda, Thohoyandou, South Africa, 2University of Virginia, 
Department of Medicine, Division of Infectious Diseases, Charlottesville, 
VA, United States
South Africa has been significantly impacted by diarrheal infections. The 
purpose of our study is to identify the etiology, including novel species 
and burden of parasitic diarrheal disease in South Africa. We collected 
diarrheal and non- diarrheal stool samples from the rural and urban 
communities of South Africa. DNA was extracted and a diagnostic taqman 
qPCR assay capable of identifying protozoan parasites (Entamoeba 
histolytica, Cryptosporidium and Giardia) was performed. In both locations 
approximately half of the samples were qPCR positive: 105 (49%) from 
rural areas; Cryptosporidium (24%) E. histolytica (3%) and Giardia 
(22%) and 113 (42%) from the urban areas; Cryptosporidium (11%), 
E. histolytica (9%) and Giardia (22%). We further identified Entamoeba 
species using a new assay with increased sensitivity. Our main finding was 
the presence of E. bangladeshi in eight different stool samples. This was 
an interesting finding as E. bangladeshi has not been previously reported 
outside Bangladesh. Consistent with previous findings, E. moshkovskii 
was not found in these populations and as predicted E. histolytica and, 
non-pathogenic E. dispar positive samples were also identified. Novel 
Entamoeba spp have been identified in different endemic regions of 
the world but have not been studied in S. African populations. We are 
currently performing additional analysis on the unspeciated Entamoeba 
positive samples as a part of a systematic approach to identify novel 
clinically relevant species. Our preliminary results suggest that novel 
Entamoeba species may potentially exist in the South African population.
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WHOLE GENOME SEQUENCING OF CYCLOSPORA 
CAYETANENSIS OOCYSTS PURIFIED FROM HUMAN STOOL 
SAMPLES
Fernanda Nascimento1, Yvonne Qvarnstrom1, Yuping Wei-
Pridgeon1, Wen Li1, Hediye Nese Cinar2, Helen R. Murphy2, Gopal 
Gopinath2, Alexandre J. da Silva2, Delynn Moss1, Michael J. 
Arrowood1
1Centers for Disease Control and Prevention, Atlanta, GA, United States, 
2Food and Drug Administration, Laurel, MD, United States
Cyclospora cayetanensis is a coccidian parasite that causes cyclosporiasis, 
an intestinal infection characterized by acute diarrhea in humans. Since 
the 1990s, CDC and local public health departments have conducted 
numerous investigations of cyclosporiasis outbreaks. These investigations 
are currently hampered by the lack of molecular epidemiological tools. 
In order to improve outbreak response, we aim to develop a subtyping 
method that would allow linkage of cases to clusters and to implicated 
food sources. Attempts to propagate Cyclospora in vitro and in vivo have 
so far been unsuccessful, so stool samples from infected humans are the 
only available source for this parasite. Here, we describe the optimization 
of methods to purify Cyclospora oocysts from stool, extract genomic DNA 
and prepare next generation sequencing libraries from ultra-low quantities 
of DNA. Using these methods, genomic sequences from 10 geographically 
distinct C. cayetanensis samples were obtained by Illumina sequencing. 
The genome is approximately 44.5 Mbp with a GC content of 51.9%. 
Preliminary genomic comparisons indicated an overall low intra-species 
genomic variation. More detailed sequence comparisons are now in 
progress to develop SNP profiling of annotated regions of the genomes for 
epidemiological purposes, and to identify subtyping markers that can assist 
in future outbreak investigations. A public Bioproject database in NCBI is 
being created to host whole genome assemblies as part of this work.
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GENOME-WIDE SEARCH TO IDENTIFY IMMUNODOMINANT 
BABESIA MICROTI ANTIGENS FOR DIAGNOSTICS AND 
VACCINATION
Nitin K. Verma1, Richard Skelton1, Essuman Edward1, Hong 
Zheng1, Ankit Puri1, Peter Krause2, Sanjai Kumar1
1CBER/FDA, Silver Spring, MD, United States, 2Yale School of Public Health 
and Yale School of Medicine, New Haven, CT, United States
Babesiosis, caused by intraerythrocytic protozoan of the genus Babesia is 
transmitted by Ixodid ticks but also through blood transfusion. The highest 
prevalence of both tick and transfusion-transmitted infection occurs in the 
United States where Babesia microti infection is endemic in the Northeast 
and upper Midwest. Clinical manifestations range from asymptomatic 
infection to fulminant disease that could be fatal. There is no FDA-
licensed vaccine to ameliorate parasite burden and clinical disease and no 
laboratory test for diagnosis of acute infection or for screening of blood 
donors. In spite of the recent availability of the full genome sequence of 
B. microti, there is a scarcity of well-defined, immunodominant B. microti 
antigens for development of diagnostic assays for blood donor screening 
or for vaccine efficacy studies. By applying a combination of genomics data 
mining and screening of whole-genome-fragment-phage-display libraries 
expressing the open reading frames of B. microti on immune sera from B. 
microti infected patients, we have identified over 50 immuno-dominant 
antigens of unknown biological function. Twenty-four of the highest 
reactivity B. microti antigens have been produced as recombinant protein 
in E. coli. Of these, 12 antigens displayed a strong EIA reactivity with sera 
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from B. microti infected individuals from endemic areas in Connecticut 
suggesting their potential as diagnostic antigens. Bioinformatics analyses 
and studies on their biochemical and cellular characterization as well as 
their value as diagnostic vaccine antigens are in progress.
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GAMMA IRRADIATED SOLUBLE EXTRACTS OF TOXOPLASMA 
GONDII TACHYZOITES INDUCED BETTER HUMORAL AND 
CELLULAR IMMUNE RESPONSE DUE TO PREFERENTIAL 
UPTAKE BY APCS SCAVENGER RECEPTORS
Andrea da Costa1, Nahiara E. Zorgi2, Nanci do Nascimento3, 
Andrés J. Galisteo Jr.1, Heitor F. de Andrade Jr.1
1Instituto de Medicina Tropical de São Paulo, São Paulo, Brazil, 2Instituto 
de Ciências Biomédicas da Universidade de São Paulo, São Paulo, Brazil, 
3Instituto de Pesquisas Energéticas e Nucleares, São Paulo, Brazil
Toxoplasmosis occurs in one-third of the adult world population, without 
adequate vaccines and causing disease in fetus or specific groups. Aside 
to sterilizing effect, gamma radiation acts on antigens inducing enhanced 
antisera production against snake venoms or cell and humoral response 
to recombinant leprosy proteins. Gamma radiation affects proteins directly 
or indirectly in water by action of oxidant radicals from water radiolysis. 
Early reports showed gamma irradiated crotoxin had enhanced uptake by 
macrophages, limited by scavenger receptors competitors, as probucol. 
Irradiated tachyzoites induced adequate immune response with protection, 
attributed to mitotic death and DNA damage. Irradiated proteins could 
take a part in this process and we study the immune response induced 
by gamma irradiated soluble extracts of Toxoplasma gondii tachyzoites, 
using mice immunized with native proteins as controls. Mice immunized 
with irradiated extracts without adjuvants showed significant protection 
after challenge with ME-49 (p<0.05) and RH (p<0.0001) strains compared 
to controls. There are increased specific and high avidity IgG production 
(p<0.05) when compare d to controls group. By flow cytometry and in 
vitro culture, spleens of mice immunized irradiated extract presented 
increased proliferation of CD4+, CD8+ and B cells and IFN-γ production 
as compared to controls. J774 cells had increased uptake of biotinylated 
irradiated extracts as compared to the uptake of native extract (p<0.05), 
due to longer and continuous uptake. All these data points to an 
alternative and effective uptake and immune processing of irradiated T. 
gondii extracts, probably due to specific receptor of oxidized proteins 
as scavenger receptors, resulting in enhanced immunity. This data also 
implies that irradiated proteins could be involved in the protection induced 
by irradiated parasites. Use of antigen gamma radiation can be a simple 
process to enhance vaccine efficiency, avoiding the use of adjuvants.
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PHYLOGENETIC ANALYSIS OF BLASTOCYSTIS SPP. ISOLATES 
IN CLINICAL STOOL SAMPLES FROM BRAZIL
Ronaldo Gryschek1, Gessica Melo2, Fabiana Paula3, Fernanda 
Malta4, Celina Maruta3, Paulo Criado3, Marcello Magri3, Vera 
Castilho3, Elenice Goncalves3
1University of Sao Paulo Medical School, Sao Paulo, Brazil, 2Instituto de 
Medicina Tropical de Sao Paulo, Sao Paulo, Brazil, 3Hospital das Clinicas, 
Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil, 
4Hospital das Clinicas, University of Sao Paulo Medical School, Sao Paulo, 
Brazil
Blastocystis spp. is an organism described as enteroparasite protozoan, 
commonly found in stool samples from humans. Several subtypes 
have been described in humans, but pathogenic potential and aspects 
epidemiological are still controversial. The aim of the present study was 
to investigate Blastocystis subtypes (STs) from patients of Hospital das 
Clínicas da Faculdade de Medicina da Universidade de São Paulo (HC/
FMUSP), Brazil. Blastocystis spp. positive stool samples diagnosed in 
Section of Parasitology of Central Laboratory (HC-FMUSP) were used for 
DNA isolation. Polymerase chain reaction (PCR) was performed using 
specific primers targeting the small subunit of rRNA gene. Direct DNA 
sequencing of PCR products was performed, and the DNA sequences 
were aligned and compared to other sequences present in GenBank 
database. Phylogenetic analysis was inferred using the Neighbor-Joining 
method by MEGA6 software. Additionally, Blastocystis STs were identified 
by determining the exact match or closest similarity against all known 
Blastocystis STs using www.pubmlst.org/blastocystis. Four STs were 
identified: ST1 (16.0%), ST2 (8.0%), ST3 (68.0%) and ST6 (8.0%). Allele 
nos. 34 and 36 were the most frequent haplotypes. The present study is 
one of the few that generates STs data from human population in Brazil, 
confirming the absence of ST4. Another important finding is the presence 
of ST6, rarely detected in human isolates. Subtype prevalence involving 
human samples may contribute to the monitoring of infection transmission 
of Blastocystis spp in endemic areas, and in future, explain any pathogenic 
aspects related to distinct subtypes.
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DISTRIBUTION AND HUMAN-INFECTIVE POTENTIAL 
OF CRYPTOSPORIDIUM, GIARDIA DUODENALIS AND 
ENTEROCYTOZOON BIENEUSI GENOTYPES IN STORM 
OVERFLOW AND WASTEWATER IN SHANGHAI, CHINA
Chengchen Huang1, Yaoyu Feng1, Na Li1, Lihua Xiao2
1East China University of Science and Technology, Shanghai, China, 
2Centers for Disease Control and Prevention, Atlanta, GA, United States
Few data are available on the distributions of Cryptosporidium, Giardia 
duodenalis, and Enterocytozoon bieneusi genotypes and subtypes in 
storm overflow from urban areas. In the present study, 40 overflow 
samples were collected from two pump stations during July-September 
in 2012 and 2014 in Shanghai, China, with 40 raw wastewater samples 
from the same stations as controls. They were analyzed by using PCR 
for Cryptosporidium spp. (targeting the small subunit rRNA gene), G. 
duodenalis (targeting the triosphosphate isomerase, β-giardin, and 
glutamate dehydrogenase genes), and E. bieneusi (targeting the ribosomal 
internal transcribed spacer). Genotypes of these pathogens were identified 
by sequence analysis of PCR products. Samples that contained C. hominis, 
C. parvum, C. viatorum, C. ubiquitum, and C. meleagridis were further 
subtyped by sequence analyses of the 60-kDa glycoprotein gene. C. 
hominis, C. parvum, C. ubiquitum and C. viatorum were the dominant 
Cryptosporidium species. C. baileyi, C. muris, and C. meleagridis were 
also found in both wastewater and overflow samples. The C. hominis 
and C. parvum subtypes were common ones previously found in humans 
in China, but C. ubiquitum belonged to two novel subtype families and 
C. viatorum was found in China for the first time. There were eight 
Group 1 E. bieneusi genotypes in wastewater and storm overflow with 
genotype D as the dominant one. For G. duodenalis, subassemblage AII 
was the dominant genotype in these samples. There were no significant 
differences in the distribution of Cryptosporidium species and E. bieneusi 
and G. duodenalis genotypes between wastewater and overflow samples. 
These results reaffirm that storm overflow is potentially a significant 
contamination source of human pathogens in surface water and more 
attention should be paid to its roles in environmental transport of 
waterborne pathogens.
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DETECTION OF CYCLOSPORA CAYETANENSIS IN FOOD AND 
CLINICAL SAMPLES USING A GELIFIED REAL-TIME PCR AS 
SAY
Alexandre J. da SIlva1, Fernanda S. Nascimento2, Yvonne 
Qvarnstrom2, Hediye N. Cinar1, Gopal Gopinath1, Marco A. 
Krieger3, Rita C. Rampazzo3, Alexandre D. Costa3, Helen Murphy1
1U.S. FDA, OARSA, Division of Virulence Assessment, Laurel, MD, United 
States, 2Centers for Disease Control and Prevention, Division of Parasitic 
Diseases and Malaria, Center for Global Health, Atlanta, GA, United 
States, 3FIOCRUZ, Instituto de Biologia Molecular do Parana, Curitiba, 
Brazil
Cyclospora cayetanensis is a coccidian parasite associated with numerous 
foodborne outbreaks. Current diagnostic detection of C. cayetanensis 
relies on microscopy, albeit this technique does not identify the parasite 
to the species level. PCR methods in general are more complex than 
microscopy and most protocols require multiple steps to set up reactions. 
The gelified PCR technology allows the development of ready-to-use PCR 
assays that minimize labor and quality issues. By using a pre-mixed, pre-
loaded and gelified reagents the execution of PCR tests is reduced to a 
few very simple steps; i.e., (i) addition of DNA template to pre-mixed, pre-
aliquoted gelified reagents, (ii) mixing of content, and (iii) centrifugation 
and placement into the real-time PCR thermal cycler for execution of 
PCR run. We developed a streamlined real-time gelified PCR method to 
detect C. cayetanensis to the species level in foods and clinical samples. 
The assay was designed with an internal amplification quality control to 
monitor amplification, ensure adequate quality of the DNA preparations, 
and troubleshoot technical glitches. The evaluation of the method 
in food samples were performed with cilantro spiked with different 
concentrations of C. cayetanensis oocysts. Preliminary results indicated 
that this assay can detect approximately 10 oocysts of C. cayetanensis 
seeded in 25g of cilantro. The sensitivity and specificity of the technique 
was evaluated using a total of 38 human stool specimens, of which 34 
were microscopically positive for Cyclospora sp, collected during outbreak 
investigations in the U.S. No false-positive or false negative results were 
obtained. The gelified assay was also evaluated regarding its stability at 
different temperatures, including room temperature, and 30°C. The results 
from these experiments revealed that the assay may be stable for up to 2 
months when pre-loaded vessels with the gelified qPCR mix were stored at 
30°C and 4 months at room temperature.
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AMIXICILE: A POTENTIAL ALTERNATIVE TREATMENT FOR 
TRICHOMONIASIS
Eisha Jain, Edna Zaenker, Katelynn Atwood, Catherine Gineste, 
Paul Hoffman, Cirle Warren
University of Virginia, Charlottesville, VA, United States
Trichomoniasis is a sexually transmitted infection in humans caused by 
Trichomonas vaginalis. This parasitic infection is the leading causative 
agent of vaginitis in women and urethritis in men worldwide. Currently, 
metronidazole is the most common drug therapy for this infection, but 
resistance is becoming increasingly prevalent. Amixicile is a novel inhibitor 
of pyruvate:ferrodoxin oxidoreductase in anaerobic parasites. This study 
compared the efficacy of a newly synthesized drug, amixicile, to that of 
both metronidazole and the synthetic precursor of amixicile, nitazoxanide, 
in inhibiting or killing T. vaginalis in vitro. One standard strain from ATCC 
and six unidentified patient-isolated strains of the T. vaginalis parasite were 
included in the study. The three drug treatments were compared, each at 
concentrations varying from 1.56 - 200µM. Under anaerobic conditions in 
vitro, the minimum inhibitory concentrations were determined for each of 
the three drugs against the seven T. vaginalis strains tested. The MIC for 
metronidazole, nitazoxanide, and amixicile were approximately 12.5µM, 
100µM, and 6.25µM, respectively. To determine whether the inhibitory 
effect was reversible, antibiotic-exposed isolates were again placed in fresh 
culture media and incubated for 48 hours. Amixicile appeared to have 
the greatest efficacy in clearing the parasite at low drug concentrations. 
These sensitivity tests show amixicile’s potential in serving as an alternative 
to metronidazole in the treatment of the T. vaginalis infection in humans. 
Further testing is required to confirm the effect of amixicile in more clinical 
isolates and in vivo.
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DRUG RESISTANCE IN BABESIA PARASITES THAT INFECT 
HUMANS
Matthew Simon1, Alexis Dziedziech1, Lars Westblade1, Audrey 
Schuetz1, Stephen Jenkins1, J, Stone Doggett2, Laura Kirkman1
1Weill Cornell Medical College, New York, NY, United States, 2OHSU/
Veterans Affairs Medical Center, Portland, OR, United States
In our previous work screening compounds against Babesia in vitro, we 
found that atovaquone was the most potent available agent against 
this parasite of growing significance in human health. We then studied 
atovaquone resistance in the parasite in vitro using continuous drug 
pressure on B. divergens cultures. In our mixed culture base pair changes 
resulted in M64V/I amino acid changes. These amino acid changes were 
associated with an increase in IC50 to atovaquone. Sequence analysis of 
the cytochrome b gene revealed that these mutations are likely in the Qo 
region and correlate with the M133V mutation described in Plasmodium. 
We then compared these in vitro results to those from patients with smear 
positivity for B. microti over several transmission seasons. In most samples 
we found a wild type cytochrome b gene. In one patient with documented 
chronic disease we identified a base pair change leading to an amino 
acid change adjacent to the conserved PEWY region, a Y202C amino 
acid change that correlated with the described Y268C mutation seen in 
Plasmodium. As the number of immunosuppressed patients that are at risk 
of B. microti infection increases, there is concern for worsening treatment 
failures. We propose that more formal studies of partner drugs and novel 
agents should be done given the current limited options to treat B. microti 
infections.
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A RAPID MOLECULAR TEST TO DIAGNOSE TOXOPLASMA 
GONDII IN MICE AND HUMAN SAMPLES
Janet Acosta1, Jaeson S. Calla-Choque1, Andrea Diestra1, Noelia 
Angulo1, Francesca Schiaffino2, Maritza Calderón1, Alejandro 
Castellanos-Gonzalez3, Roberth H. Gilman2, Toxoplasmosis 
Working Group in Peru
1Cayetano Heredia University, Lima, Peru, 2Johns Hopkins University, 
Baltimore, MD, United States, 3University of Texas Medical Branch, 
Galveston, TX, United States
Toxoplasmosis is a parasitic disease caused by Toxoplasma gondii. This 
infection is prevalent in humans and animals worldwide. It has been 
estimated that one-third of the world population has been exposed to 
this parasite. It is acquired by ingesting tissue cysts from undercooked or 
raw meat, consuming food or drink water contaminated with oocysts 
shed by felids, or by accidentally ingesting oocysts from the environment. 
Although the course of the primary infection is usually subclinical and 
the vast majority of infected human populations remain asymptomatic, 
the infection can cause significant morbidity and mortality in certain 
groups. The symptoms include encephalitis, chorioretinitis, congenital 
infection and neonatal mortality. Current diagnosis is based on detection 
of Toxoplasma-specific IgM and IgG. In this study, we established and 
optimized a diagnostic test using Recombinase Polymerase Amplification 
(RPA) assay for the molecular diagnosis of T. gondii in Lima. . The RPA 
assay does not require a thermocycler or other specialized equipment 
and can be adapted to lateral flow detection, so it may be performed on 
the field. For identification and amplification by RPA, we selected a gene 
fragment within a gene (B1) that was conserved across T. gondii strains. 
The limit of the RPA assays that we performed has a sensibility of detection 
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of 0.5 parasites (about 50 fg of DNA), while the conventional PCR detects 
about 1 parasite (100 fg of DNA). We also analyzed eight samples (all of 
them were given a positive diagnosis for Toxoplasmosis), five were positive 
by RPA and only three were positive by conventional PCR. The specificity 
was 100 % and did not detect other parasites like Trypanosoma cruzi, 
Cryptosporidium, Cyclospora, Leishmania and Plasmodium, Therefore, we 
observe that this assay can be applied to human samples for the diagnosis 
of the infection. The sensitivity of our methodology is 63% (5/8) and that 
of conventional PCR is 38% (3/8), The RPA assay can be further improved 
by combining it with lateral flow test. These results are very encouraging 
and suggest that RPA could be used as a novel molecular diagnosis 
technique for T. gondii infection.
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IMMUNOBLOT FOR DIFFERENTIATION BETWEEN ACUTE AND 
CHRONIC INFECTION OF TOXOPLASMA GONDII USING A 
MURINE MODEL
Yomara Romero1, Noelia Angulo1, Edith Arocutipa1, Janet 
Acosta1, Miguel Mogollon2, Alejandro Florentini1, Cristina 
Montoya2, Raul Ynocente2, Jaeson S. Calla-Choque1, Juan 
Jimenez2, Maritza Calderón1, Roberth H. Gilman3, Toxoplasmosis 
Working Group in Peru
1Cayetano Heredia University, Lima, Peru, 2Universidad Nacional Mayor de 
San Marcos, Lima, Peru, 3Johns Hopkins University, Baltimore, MD, United 
States
Toxoplasmosis is caused by the obligate intracellular parasitic protozoan, 
Toxoplasma gondii. This infectious agent is generally foodborne and 
enters the host through ingestion of raw or undercooked meat derived 
from infected animals. Usually the acute toxoplasmosis occurs in 
immunosuppressed patients, while most of the people remain in the 
chronic phase without symptoms. Current diagnostic tests are not able 
to differentiate between acute and chronic infection. In this study we 
validated the response against T. gondii antigens in an experimental 
mouse model of Toxoplasmosis in two stages of infection. Five female 
Swiss Webster mice were infected orally with cyst of T. gondii ME49 strain 
and four mice were inoculated with saline solution (control group). Blood 
was collected 8, 15, 30 and 60 days post-infection. The mouse brain 
infections were confirmed by conventional PCR and by optical microscopy. 
The immunoblot was performed using the tachyzoite lysate proteins of 
RH strain as antigen, and IgM and IgG as detection antibodies. For the 
IgM immunoblot we identified three immunogenic proteins with low 
molecular weight (25, 30 and 39 kDa); these bands appeared within 8 
and 15 days post infection and gradually disappeared until 60 days. For 
the IgG immunoblot we observed the same antigenic bands and also the 
specific recognition of a 28 kDa protein. The band corresponding to this 
protein was observed after 30 days (chronic stage) post-infection, and 
afterwards its intensity increased progressively. We can also detect other 
high molecular weight immunogenic proteins. The detection of these 
proteins by immunoblotting might be useful to estimate the stage and 
development of infection in the diagnosis of the toxoplasmosis disease.
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STANDARDIZATION OF AN ON-BEAD SANDWICH ELISA FOR 
THE DETECTION OF TOXOPLASMA GONDII ANTIGEN SAG1
Cusi Ferradas1, Edith Malaga1, Noelia Angulo1, Yomara Romero1, 
Alejandro Florentini1, Cristina Montoya2, Raul Inocente2, Miguel 
Mogollon2, Juan Jimenez2, Maritza Calderon1, Robert H. Gilman3
1Universidad Peruana Cayetano Heredia, Lima, Peru, 2Universidad Nacional 
Mayor de San Marcos, Lima, Peru, 3Johns Hopkins Bloomberg School of 
Public Health, Baltimore, MD, United States
Toxoplasmosis is a disease caused by Toxoplasma gondii. Infected adults 
generally develop a chronic infection and remains asymptomatic. However, 
if a person becomes immunosuppressed, the infection can be reactivated 
and cause severe damage in different tissues, mainly leading to a diffuse 
encephalopathy. The diagnosis of this disease is principally done by 
the detection of antibodies in blood; nonetheless, IgG antibodies can 
persist live long in immunocompetent toxoplasma-infected individuals, 
making it difficult to differentiate between a recent and an older 
infection. On the other hand, the antibody production can be impaired 
in immunocompromised patients. For these reasons, it is important to 
design new diagnostic tests that can detect circulating antigens (CAg). 
Although some tests have been already developed, it is necessary to 
create more easy, simple and accurate approaches for the detection of 
CAg. The use of microparticles provides a large surface-to-volume ratio 
that facilitates detection, stability, and manipulation. The aim of this study 
is to standardize an on-bead sandwich ELISA for the detection of the 
main surface antigen of T. gondii (SAG1 or P30). In order to do this, we 
used magnetic microparticles Dynabeads-M270 Epoxy and got a good 
performance using a concentration of 0.05 mg. The standardization 
process was done using Total Lysate Antigen from parasite culture of the 
RH strain. The optical density (OD) of the positive control was 2.6 times 
the OD of the negative control and the minimum amount of SAG1 that 
could be detected was 100 ng (considering that it accounts for 3 to 5% of 
the total T. gondii protein). We processed 7 mice serum samples (4 were 
infected with RH strain and 3 with ME49 strain). The ODs of the samples 
from RH-infected mice were 4 to 7 times higher than the ODs of the 
negative control. However, the ODs of the serum samples from the ME49-
infected mice were very similar to negative controls. The future direction of 
this project is to perform this assay using other types of microparticles and 
new commercially available antibodies in order to increase the sensibility 
and specificity in the toxoplasmosis diagnosis.
562
URBAN PIGEONS (COLUMBA LIVIA DOMESTICA) AS SOURCE 
OF ENVIRONMENTAL SPREAD OF CRYPTOSPORIDIUM WITH 
ZOONOTIC POTENTIAL
Teresa Cristina Bomfim, Alexandre de Pina Costa
Federal Rural University of Rio de Janeiro, Veterinary Institute, Department 
of Animal Parasitology, Rio de Janeiro, Brazil
Urban pigeons, also known as domestic pigeons or Rock Pigeons (Columba 
livia domestica), are birds of Columbiformes order quite common in many 
urban centers, living in close contact with humans. Three hundred and 
eleven pigeons were captured with appropriate cages found at home and 
in human’s peridomicile in the state of Rio de Janeiro, Brazil. The bottom 
of the cages was protected by a plastic, to facilitate the collection of feces; 
after the birds defecated they were released. Microscopic diagnosis was 
performed to verify the presence of Cryptosporidium oocysts using the 
technique of centrifugal flotation in sugar solution. In positive samples a 
DNA extraction was performed, followed by PCR technique for the 18S 
target gene. All samples obtained from the Nested-PCR reaction were 
stained and observed on agarose gel and subsequently purified. After 
this procedure they were sequenced at BLAST platform, and a search 
of sequences obtained was performed to determine their identities and 
possible similarities and homologies with previously deposited species 
in GenBank ‘. Phylogenetic analyzes were performed using the MEGA 6 
software. Of a total of 387 fecal samples 16.31% (54/311) were positive in 
microscopy, and of these, 5,68% (22/387) were sequenced and identified 
two species C. meleagridis and C. baylei. Species C. meleagridis is worrying 
in terms of public health, because the pigeons are easily adapted to 
human environment, whether for the abundant supply of shelter, lack of 
predators, lots of food available; in addition, C. meleagridis is the third 
most prevalent species in humans.
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GENETIC DIVERSITY AND TRANSMISSION DYNAMICS OF 
CRYPTOSPORIDIUM PARASITES IN CATTLE OF SOUTHERN 
GHANA
Bethel Kwansa-Bentum, Fred Aboagye-Antwi, Henrietta T. 
Kwansa-Bentum, Ato Mensah, Eric A. Okrah, Joseph Otchere, 
Michael D. Wilson
University of Ghana, Legon, Accra, Ghana
The coccidian parasite Cryptosporidium causes enteric disease in human 
beings, domestic animals and wild vertebrates. Infection is often self-
limiting in immunocompetent individuals, but could be severe and chronic 
in persons with compromised immune system. Studies have shown a 
strong association between human cryptosporidiosis and contact with 
potentially infected cattle, particularly pre-weaned calves. Whereas studies 
on cryptosporidiosis in Ghana have focused on microscopy identification of 
the pathogen in immunocompromised people, limited information exists 
on the genetic composition of this zoonotic parasite species. The study 
reported in this paper investigated the genetic diversity of Cryptosporidium 
parasite across different age groups of cattle from the southern part of 
Ghana. Stool samples were collected from cattle and were processed by 
formol-ether concentration. After morphological identification of the 
oocysts, genomic DNA was extracted from the concentrate, followed by 
polymerase chain reaction assay to identify the species of the parasites. 
PCR positive samples were subjected to Restriction Fragment Length 
Polymorphism analysis using SspI for species diagnosis or VspI for 
genotyping of C. parvum. Out of the 90 stool samples analysed so far, 11 
were positive for C. parvum. Further analysis are ongoing to ascertain if 
the strain is similar to those in human beings.
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PATHOGENICITY OF DIENTAMOEBA FRAGILIS
Damien Stark1, Joel Barratt2, John Ellis2
1St. Vincent’s Hospital, Darlinghurst, Australia, 2University of Technology 
Sydney, Broadway, Australia
Dientamoeba fragilis is a trichomonad protozoan which is commonly 
reported throughout the world. Despite its initial discovery over 100 years 
ago remarkably little is known about this parasite. The parasites life cycle 
and mode of transmission are poorly defined, and controversy surrounds 
the pathogenic potential of this organism. This talk will highlight the latest 
clinical studies, animal studies and the recent publication of the D. fragilis 
transcriptome from which several potential markers of pathogenicity were 
described. Molecular detection of the parasite will also be discussed.
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COMPARISON OF TWO RECOMBINANT ANTIGENS FOR 
DIAGNOSIS OF CHRONIC HUMAN FASCIOLIASIS
Angel Hsu1, Isabel McAuliffe2, Lorna Cruz3, Ana M. Espino3, 
Sukwan Handali2
1Emory University, Atlanta, GA, United States, 2Centers for Disease Control 
and Prevention, Atlanta, GA, United States, 3University of Puerto Rico, San 
Juan, PR, United States
Fascioliasis has been recognized as an emerging/reemerging zoonotic 
disease with an estimated prevalence of up to 17 million people infected 
and 180 million at risk for infection worldwide. In the United States, 
fascioliasis should be considered in immigrants, refugees or travelers with 
eosinophilia. Public health laboratories need a simple and reliable method 
for diagnosis of fascioliasis to identify and treat cases. The recognized 
laboratory test of choice for diagnosis of fascioliasis is detection of disease 
specific antibodies, most commonly using excretory-secretory antigens 
for detection of IgG antibodies. Recently, recombinant proteins such as 
FhSAP2 and Fh-CLP-1, have been used in an ELISA based format to detect 
IgG antibodies. To develop a better assay that could be used for diagnostic 
and surveillance, we used the GST-FhSAP2 recombinant antigen and 
Fh-CLP-1 to develop Western blot (WB) to detect Fasciola hepatica total 
IgG antibodies. We evaluated the assays using well-characterized sera 
from persons with or without fascioliasis. The sensitivity and specificity of 
GST-FhSAP2 and FhCLP1 WB were similar at 94% and 98% and 100% 
and 99%, respectively. For the multiplex immunoblot, the sensitivity and 
specificity were 100% and 98%. Although the defined positive sample 
size is small, the study supports the previous study results. In conclusion, 
the GST-FhSAP2 and FhCLP1 antigens perform well in immunoblot format 
separately or combined and can be readily adopted by public health and 
commercial reference laboratories for clinical diagnosis of F. hepatica 
infection in refugees, immigrants, and travelers with eosinophilia in the 
United States.
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APICAL SODIUM-DEPENDENT BILE ACID TRANSPORTER 
OF CLONORCHIS SINENSIS: 3D STRUCTURE AND 
FUNCTIONALITY
Won Gi Yoo, Fuhong Dai, Ji-Yun Lee, Sung-Jong Hong
Chung-Ang University, Seoul, Republic of Korea
Apical sodium-dependent bile acid transporter (ASBT, SLC10A2) 
plays a key role in the bile acid recycling. Bile acid uptake of ASBT is 
electrophysiologically coupled with co-transport of sodium ion. When 
Clonorchis sinensis survive in the bile duct, an extreme environment 
of bile juice, C. sinensis ASBT (CsASBT) could serve as an important 
contributor in its bile-taxis and survival. In this respect, we report here 
a homology modeling and molecular docking of CsASBT as a drug 
target. Its complete coding sequence was 1,641 bp long and encoded 
a polypeptide of 546 amino residues. Inward-facing (IF) and outward-
facing (OF) conformations of CsASBT 3D model were generated by 
homology modeling using the crystal structures of Neisseria meningitidis 
(PDB ID: 3zuy) and Yersinia frederiksenii (PDB ID: 4n7x) as templates. The 
modeled structures were further refined and verified for higher reliability. 
IF- and OF-CsASBT were built in region of 185-492 aa and 189-489 aa, 
respectively, whereas remaining region was predicted to be disordered 
and showed few homologues in the trematodes. Similar to the ASBTs, 
CsASBT was predicted to have 10 transmembrane domains (TM) divided 
into two groups: a core group formed with TM3-5 and 8-10; a panel 
group formed with TM1, 2, 6 and 7. TM1-5 and TM6-10 were structurally 
homologous but oppositely oriented, thus producing an internal twofold 
pseudosymmetry. IF-CsASBT had three sodium binding sites. One binding 
site was coordinated by TM4b, TM5 and TM9a, and the other by TM3, 
TM4 and TM9. A third binding site was predicted to be coordinated by 
TM4a. Taurocholate binding pocket was located in an intracellular cavity. 
Structure-based virtual screening was carried out using a reliable IF- and 
OF-CsASBT model. Inhibitors, not working on human ASBT, were selected 
through a pharmacophore-based filtering. Taken together, we report the 
refined models of CsASBT important for further study on function of the 
ASBTs and on structure-based drug design targeting the ASBTs.
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OPISTHORCHIS FELINEUS HEMOZOIN DEPRESSES INTEGRIN 
CELL SURFACE EXPRESSION ON CHOLANGIOCYTES
Irina Saltykova1, Alexandra Pershina1, Irina Salkina1, Victoria 
Mann2, Sergey Ryzhov3, Paul Brindley2
1Siberian State Medical University, Tomsk, Russian Federation, 2George 
Washington University School of Medicine and Health Sciences, 
Washington, DC, United States, 3Center for Molecular Medicine Maine 
Medical Center Research Institute, Portland, ME, United States
Infection with the fish borne liver fluke Opisthorchis felineus is common 
in the Eastern Europe (Ukraine, European part of Russia), Northern Asia 
(Siberia) and Central Asia (Northern Kazakhstan). The pathophysiology of 
the liver and bile duct tract due to parasitism coincides with the presence 
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of adult worms in the bile ducts, implicating worm excretory-secretory 
products acting on cholangiocytes, the epithelial cells lining the biliary 
tree. Excretory-secretory products of O. felineus include hemozoin, a 
byproduct of digestion of ingested host blood, which sequesters the 
toxic heme moiety. Hemozoin release from O. felineus accumulates in 
ectasia in the bile ducts -- hemozoin ‘knobs’. We investigated the spread 
of hemozoin in the host circulation during distant organs during acute 
and chronic opisthorchiasis infection, and also the influence of hemozoin 
on cell growth. Using spectrophotometry and luminometry, we detected 
highest concentration of hemozoin in the bile ducts. Hemozoin was 
present in the parenchyma of the liver of hamsters during acute and 
chronic opisthorchiasis felinea, but not detected n heart, spleen, lung and 
muscles. The human cholangiocyte cell line H69 was exposed to hemozoin 
(O.F. hemozoin) isolated from bile ducts of hamsters, as well to synthetic 
hemozoin, and cell growth monitored in real time (xCELLigence System, 
Acea). O.F hemozoin lead to the changes of the adhesion characteristics 
of cells that dramatically decreased the cell index. By multiparametric flow 
cytometry, we found that both O.F and synthetic hemozoin depressed 
integrin beta-1, integrin beta-5 at the surface of H69 cells, and O.F 
hemozoin lead to the increasing of CD49a, an integrin alpha subunit. 
These findings indicated that liver fluke hemozoin induced raid and 
marked changes in the growth and adherence of cholangiocytes, findings 
that warrant further investigation.
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HYDROLOGICAL IMPACTS ON DISEASE TRANSMISSION OF 
OPISTHORCHIS VIVERRINI IN THE LAWA LAKE COMPLEX: A 
MODELLING PERSPECTIVE
Tomas Leon1, Robert C. Spear1, Kittiwet Kuntiyawichai2, Vichian 
Plermakamon2, Banchob Sripa2
1University of California Berkeley, Berkeley, CA, United States, 2Khon Kaen 
University, Khon Kaen, Thailand
Several stages of Opisthorchis viverrini’s transmission cycle are mediated 
by water: from contaminated feces to snail as an egg, from snail to fish 
as cercariae, and from fish to definitive host as the infected fish is caught 
and consumed. All three of these processes are dependent on hydraulic 
connectivity, which changes seasonally in the floodplain ecosystem around 
the Lawa Lake complex in Khon Kaen Province, Thailand, our study site 
of interest. The prevailing theory, with limited empirical evidence to 
support, is that there are very limited circumstances and geographical 
areas in which these processes occur. Biology, parasitology, and ecology 
research inform us of some guiding assumptions that provide a tentative 
picture of how and where transmission is occurring in the environment. 
However, an exhaustive hydrologic model has never been developed and 
integrated into a transmission framework in order to explain the liver 
fluke development cycle. To that end, the development of a site-specific 
hydrodynamic model to understand connectivity between Lawa Lake, 
the Chi River, and surrounding wetlands is key to helping us identify 
“hot zones” of transmission, understand the scale of these transmission 
processes, and interpret historical and present data about infection 
levels in snails, fish, and humans. The model outputs flow vectors that 
elucidate the relationship between the villages around the lake, the scale 
of transmission, and proximity to susceptible habitats for snails and fish. 
The full model integrates the hydrologic model outputs as time-varying 
parameters into the disease model to describe transmission patterns. 
Results generated can be used to inform sustainable environmental control 
strategies in northeast Thailand and across Southeast Asia to reduce 
parasite and subsequent cancer burden.
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OPISTHORCHIS VIVERRINI INFECTION EXACERBATES THE 
SEVERITY OF DIABETIC LIVER INJURY AND NON-ALCOHOLIC 
FATTY LIVER DISEASE
Apisit Chaidee1, Sudarat Onsurathum1, Ornuma Haonon1, 
Patchareewan Pannangpetch1, Chatlert Pongchaiyakul1, Victoria 
H. Mann2, Chawalit Pairojkul1, Wannaporn Ittiprasert2, Paul J. 
Brindley2, Somchai Pinlaor1
1Khon Kaen University, Khon Kaen, Thailand, 2George Washington 
University, Washington, DC, United States
The highest co-prevalence between infection with Opisthorchis viverrini 
and diabetes mellitus (DM) is found in the northeastern Thailand. 
Inflammatory responses that lead to hepatobiliary disease is seen during 
opisthorchiasis. Moreover, non-alcoholic fatty liver disease (NAFLD) and 
diabetic liver injury caused by DM lead to the majority burden of liver 
disease at large. However, the association among opisthorchiasis, DM and 
hepatobiliary disease have not been clarified. The aim of these studies 
was to investigate the effect of O. viverrini infection on the development 
and progression of DM, NAFLD and diabetic liver injury in models using 
hamsters and cell lines. An experiment was carried out on four groups 
of hamsters: (1) normal control (NC), (2) chronic opisthorchiasis (OV), (3) 
NC and HFD fed with 10% fructose in drinking water for short-term (one 
month) and long-term (four months) (HF), and (4) O. viverrini infection 
at 4 months and followed by HFD fed with 10% fructose in drinking 
water for one and four month(s) (OVHF). Hamsters were euthanized at 
designated time points at five and eight months following infection. 
The fasting blood glucose levels of all experimental groups did not differ 
significantly. Intriguingly, the homeostatic model assessment of insulin 
resistance (HOMA-IR) in short-term HF treatment of group 3 was higher 
than other groups at the same time point. However, the HOMA-IR of 
long-term HF treatment of group 3 was not different from OVHF group 
but higher than OV group at the same time point. Histological features of 
hamster livers revealed that the highest amount of lipid droplet was found 
in short-term HF treatment of OVHF group. In addition, we observed 
that excretory/secretory products of O. viverrini suppressed the growth of 
HepG2 cell line by dose-dependent manner when monitored under real-
time monitoring system. These findings indicate the effect of O. viverrini 
on the improvement of insulin sensitivity. Infection with O. viverrini might 
inhibit regeneration of hepatocytes and increase the severity of diabetic 
liver injury, and hence chronic opisthorchiasis might represent a risk factor 
for NAFLD.
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DEVELOPMENT OF A NOVEL METHOD FOR OPISTHORCHIS 
VIVERRINI DNA DETECTION IN URINE BY PCR ASSAY
Andrew Ancharski1, Paiboon Sithithaworn2, Chanika Worasith2, 
Nadda Kiatsopit2, Elizabeth Carlton1
1Colorado School of Public Health, University of Colorado, Anschutz 
Medical Campus, Aurora, CO, United States, 2Khon Kaen University 
Department of Parasitology, Liver Fluke and Cholangiocarcinoma Research 
Center, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand
Opisthorchis viverrini infects 9 million people worldwide and is endemic 
in Thailand, Laos, Vietnam and Cambodia. Treatment is the most effective 
tool we have to reduce the transmission and burden of disease while 
increasing the quality of life for persons infected. In order to effectively 
treat, we must diagnose those who are infected. Microscopy is the current 
diagnostic standard for O. viverrini through the identification of eggs in 
stool but is hampered by under diagnosis and misclassification. Our goal 
is to develop a protocol for O. viverrini DNA detection in urine for future 
diagnostic purpose. We developed and validated an extraction technique 
to isolate O. viverrini DNA from urine using BioMatrix Resin by adapting 
a method recently developed for Schistosoma mansoni. PCR, using 
O. viverrini -specific primers (pOV-6) was performed and optimized to 
detect the isolated DNA. 5ml of clean negative human urine was spiked 
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with 3500 ng of O. viverrini DNA and a serial dilution was performed to 
determine the detection limit. A 5ml pooled sample of 10 positive human 
samples was made and we performed a serial dilution to determine the 
profile of O.viverrini DNA by PCR. The PCR using pOV-6 primers on DNA 
extracted from urine worked successfully in spiked samples and human 
samples. The extraction method resulted in the retention of 33% of the 
original DNA amount. The detection limit of O. viverrini DNA in urine 
is 0.077 pg. The pooled samples showed DNA presence at a 10-25% 
dilution but not at higher or lower concentrations. This is the first report 
of the detection of Opisthorchis viverrini DNA in urine. Urine is easier to 
obtain from humans than feces or blood samples because of cost, time, 
and intrusiveness. Overall we were able to achieve the detection of O. 
viverrini DNA in urine, which prompts potential investigation as to why 
the DNA is there and allows for further develop a sensitive and specific 
diagnostic assay for opisthorchiasis with the goal of reducing morbidity 
and mortality.
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MOLECULAR CHARACTERIZATION OF THE LARVAL PHASE 
OF SCHISTOSOMA MANSONI IN BIOMPHALARIA GLABRATA 
MOLLUSKS UNDER EXPERIMENTAL CONDITIONS
Marcia Oliveira Casotti1, Roseli Tuan Tuan1, Michele Gomes2, 
Emmanuel Dias-Neto2, João Renato Rebello Pinho2, Fabiana 
Martins Paula2, Flair José Carrilho José Carrilho2, Expedito José 
Albuquerque Luna3, Ronaldo Cesar Borges Borges Gryschek2, 
Maria Cristina Espírito-Santo4
1Superintendência de Controle de Endemias (SUCEN), São Paulo, Brazil, 
2Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, 
3Instituto de Medicina Tropical, São Paulo, Brazil, 4Faculdade de Medicina 
da Universidade de São Paulo, São Paulo; Centro Universitário Fundação 
Oswaldo Aranha, Rio de Janeiro, Brazil
Schistosomiasis mansoni affects approximately 207 million people in the 
world. In Brazil, a major goal of the Control Program for this parasitosis 
is to reduce the risk of geographic expansion. The main intermediate 
host of Schistosoma mansoni is Biomphalaria glabrata. The detection of 
larval stages in intermediate hosts is an important challenge to public 
health once it can indicate early natural infections rates. The objective 
of this study is to standardize the detection of S. mansoni from primary 
sporocysts developed in B. glabrata mollusks tissue artificially infected with 
Belo Horizonte S. mansoni lineage, using the Polymerase Chain Reaction 
(cPCR), a Two Sequential PCR-amplification (Re-PCR) and TaqMan® Real-
Time PCR system (qPCR). Twenty B. glabrata mollusks were infected with 
thirty miracidia obtained from a laboratorial cycle of S. mansoni. For 
S. mansoni DNA extraction, after thirty days, four daughter-sporocysts 
were collected. Moreover, the head-foot portion was removed from four 
additional specimens of B. glabrata. The nucleic acid was extracted using 
the DNeasy Blood and Tissue Kit (Quiagen). Extracted DNA was quantified 
using Nanodrop and amplified with the three molecular techniques 
cited above, using primers that amplify 121bp S. mansoni DNA tandem 
sequences. The amplification product was detected in agarose gel 2%. 
The extraction process of daughter-sporocysts yielded around 6.1 ng/µL 
of S. mansoni DNA. The amplification products of cPCR were faint, but 
the results were better after Re-PCR and qPCR, which showed a mean 
of 20.07 Cycle Treshold (Ct). S. mansoni DNA extraction from complete 
head-foot portion yielded an average of 487.5ng/µL, with good results in 
cPCR, Re-PCR and qPCR that pointed a Ct average of 15.92. S. mansoni 
sporocyst molecular detection from the head-foot portion demonstrated 
a high sensibility and specificity. Therefore, it could represent a new tool 
in early characterization of snail susceptibility to S. mansoni in natural 
conditions and assist in the control of this parasitosis.
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IDENTIFICATION OF GENES TARGET OF REGULATION BY 
MAPKS IN SCHISTOSOMA MANSONI
Sandra G. Gava1, Naiara C. Paula1, Anna C. Salim1, Flávio M. 
Araújo1, Guilherme C. Oliveira2, Marina M. Mourão1
1CPqRR, Belo Horizonte/MG, Brazil, 2ITV, Belém, PA, Brazil
Eukaryotic protein kinases (ePKs) are important for the regulation 
of several cellular functions. It is known that 252 ePKs are encoded 
by the Schistosoma mansoni genome, which corresponds to 2% of 
the predicted proteome. However, only 24 ePKs have experimental 
functional evidence. The family of mitogen-activated protein kinase 
(MAPKs) influences various biological activities and are widely studied 
as drug targets. Our group identified MAPKs orthologs in S. mansoni by 
in silico analyses and demonstrated by functional studies that MAPKs 
(SmCaMK2, SmJNK, SmERK1, SmERK2 and Smp38) are involved in 
parasite development, reproduction and survival and may therefore be 
considered potential targets for the development of new drugs. In this 
study, we aim to contribute to the experimental characterization of ePKs 
by the identification of specific genes regulated by MAPKs pathways. To 
elucidate these target genes, the five selected genes were knocked down 
by RNA interference in schistosomula and RNA-Seq analysis of treated 
parasites were performed, including three biological replicates. For all 
genes selected, we observed approximately 75% reduction on transcript 
levels, except for SmERK-2. RNA-Seq libraries were then prepared with 
RNA derived from knockdown parasites according to the Truseq stranded 
mRNA Library Prep protocols and were sequenced on Illumina HiSeq 
2500 platform. We generated 27 paired-end libraries that generated 
100 bp reads. Sequences were aligned to the latest S. mansoni reference 
genome (version 5.0) and differentially expressed genes were identified by 
comparing each MAPK knockdown against control parasites (treated with 
unspecific GFP-dsRNA). We also checked the occurrence of potential off-
targets by using GFP or mCherry dsRNA as unspecific controls. RNA-seq 
analyzes were performed comparing schistosomules treated with these 
unspecific dsRNAs and schistosomules untreated. This work will allow a 
better understanding of these signaling pathways, helping to elucidate the 
functional roles of MAPKs, as well as assisting in the future development 
of therapeutic intervention tools for schistosomiasis control.
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HISTONE MODIFYING ENZYMES ARE POTENTIAL 
THERAPEUTIC TARGETS AGAINST SCHISTOSOMIASIS AS IT IS 
ESSENTIAL TO VIABILITY AND REPRODUCTION
Pedro H. Aguiar1, Naiara C. Paula1, Fernanda S. Coelho1, 
Policarpo A. Sales1, Juliano M. Araujo1, Luiza F. Andrade1, 
Wolfgang Sippl2, Manfred Jung3, Antonello Mai4, Raymond J. 
Pierce5, Guilherme C. Oliveira6, Marina M. Mourao1
1CPQRR/FIOCRUZ, Belo Horizonte, Brazil, 2Martin Luther Universität Halle, 
Wittenberg, Germany, 3Albert Ludwigs Universität, Freiburg, Germany, 
4Università degli Studi di Roma La Sapienz, Roma, Italy, 5Institut Pasteur de 
Lille, Lille, France, 6Instituto Tecnológico Vale, Belém, Brazil
Schistosomiasis is the second most prevalent parasitic disease in the 
world. The treatment rely on a single drug, Praziquantel, and due to 
the identification of drug resistant parasites, the development of new 
chemotherapy against schistosomiasis is required. Histone modifying 
enzymes (HMEs) play a central role in regulating chromatin epigenetic 
modifications and are implicated as therapeutic targets in various diseases. 
In this work, we employed RNA interference to validate 1 histone 
deacetylases (SmHDAC8), 5 demethylases (HDM) and 10 methyltranferases 
(HMT) as drug targets in Schistosoma mansoni, from those, 4 were chosen 
for experimental validation. Additionally, specific inhibitors developed by 
the A-PARADDISE consortium were used to interrogate HMEs as drug 
targets against S. mansoni. To elucidate the roles of HMEs, schistosomula 
were exposed to dsRNAs, injected in mice and evidenced that SmHDAC8 
is important to parasite development and survival. Additionally, HDAC8, 
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PRMT3 and KDM1/KDM2, seem to be associated in egg production 
since infected mice had significantly lower egg burdens and female 
worms presented underdeveloped ovaries. For the inhibitors screening, 
schistosomula were exposed to 300 inhibitors and parasite viability was 
assessed by measurement of lactate produced in the medium and by 
propidium iodide staining. These inhibitors were also tested on adult 
worms, in which parasites mobility were evaluated using the WormAssay 
software. In the lactate and propidium iodide assays, 60 and 76 active 
inhibitors were identified, respectively. Using the WormAssay, 76 
compounds were active in male worms, 101 were active in female worms, 
from those, 54 were active in both genders. Also, the IC50 was established 
for the active compounds and cytotoxicity was tested in mice fibroblast 
cells. These results indicate that HMEs are essential to parasite viability, 
oviposition and/or development of reproductive system, confirming its 
potential as drug targets. In addition some inhibitors seem to be potential 
candidates for drugs against schistosomiasis.
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CLONING AND CHARACTERIZATION OF A SCHISTOSOMA 
JAPONICUM AQUAGLYCEROPORIN THAT FUNCTIONS IN 
OSMOREGULATION
Yuzheng Huang1, Wei Li2, Chunrong Xiong3, Ying Zhang3, Kun 
C. Liu4, Peng Cao1
1Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing, 
China, 2Jiangsu Institute of Parasitic Diseases, Wuxi, China, 3Jiangsu, 
Wuxi, China, 4Johns Hopkins Malaria Research Institute, Dept. Molecular 
Microbiology and Immunology, Bloomberg School of Public Health, The 
Johns Hopkins University, Baltimore, MD, United States
As one of the three major human pathogens that cause schistosomiasis, 
Schistosoma japonicum is the only one that is endemic in China. Despite 
great progress on schistosomiasis control over the past 50 years in China, 
S. japonicum transmission still occurs in certain endemic regions, which 
causes significant public health problems and enormous economic 
losses. During different life stages, parasites are able to survive dramatic 
osmolality changes between its vector, fresh water, and mammal host. 
However, the molecular mechanism of parasite osmoregulation remains 
unknown. To address this challenging question, we report the first 
cloning of an S. japonicum aquaglyceroporin (SjAQP) from an isolate from 
Jiangsu province, China. Expressing SjAQP in Xenopus oocytes facilitated 
the permeation of water, glycerol, and urea. The water permeability of 
SjAQP was inhibited by 1 mM HgCl2, 3 mM tetraethylammonium, 1 mM 
ZnCl2, and 1 mM CuSO4. SjAQP was constitutively expressed throughout 
the S. japonicum life cycle, including in the egg, miracidia, cercaria, and 
adult stages. The highest expression was detected during the infective 
cercaria stage. Our results suggest that SjAQP is very likely to play a role in 
osmoregulation throughout the S. japonicum life cycle, especially during 
cercariae transformation, which enables parasites to survive osmotic 
challenges.
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THERAPEUTIC EXPLOITATION OF IPSE, A UROGENITAL 
PARASITE-DERIVED HOST MODULATORY PROTEIN, FOR 
CHEMOTHERAPY-INDUCED HEMORRHAGIC CYSTITIS
Evaristus C. Mbanefo1, Luke Pennington2, Theodore Jardetzky2, 
Michael Hsieh1
1Bladder Immunology Group, Biomedical Research Institute, Rockville, 
MD, United States, 2Department of Structural Biology, Stanford University 
School of Medicine, Stanford, CA, United States
The vast majority of urogenital schistosomiasis-infected individuals lack 
day-to-day hematuria, a cardinal sign of urinary tract injury. This suggests 
that parasite factors may help balance life cycle propagation via bladder 
wall penetration to allow egg passage into urine, against inducing life-
threatening hemorrhagic cystitis (HC) that would preclude life cycle 
completion. IL-4-inducing principle from Schistosoma mansoni eggs 
(IPSE) is the most abundant egg-secreted protein of S. mansoni, which 
induces IL-4 release from basophils via binding to cell-surface IgE. IPSE also 
sequesters chemokines and alters host gene transcription by translocating 
into host nuclei. We hypothesized that the S. haematobium homolog of 
IPSE (H-IPSE) may regulate HC. Because schistosome transgenesis remains 
elusive, we tested host-modulatory properties of H-IPSE using a model 
of HC based on nitrogen mustard alkylating agents (cyclophosphamide 
and ifosfamide), which are used to treat cancers but often result in HC. 
Current options to prevent ifosfamide-induced HC using Mesna can 
have significant side effects. IL-4 has been shown to ameliorate HC in 
mice, but systemic IL-4 administration results in unacceptable morbidity. 
Given the IL-4-inducing properties of IPSE, we postulated that H-IPSE may 
ameliorate ifosfamide-induced HC. Mice were administered combinations 
of ifosfamide, IL-4, Mesna, anti-IL-4 antibody and H-IPSE. Readouts include 
bladder wet weight, histology (i.e., edema, hemorrhage), and hemoglobin 
content, spontaneous and evoked pain, voided urine spot assay, cytokine 
analysis and transcriptional profiling. We found that H-IPSE is comparable, 
and possibly superior, to IL-4 in suppressing ifosfamide-induced HC in 
mice, including associated urinary frequency and spontaneous pain 
behavior. Through use of anti-IL-4 antibody and a nuclear localization 
sequence mutant of H-IPSE, we determined that the therapeutic effect 
was dependent on IL-4 and nuclear localization. To our knowledge, our 
work is one of the first successful therapeutic exploitation of uropathogen-
derived molecule in a clinically relevant bladder disease model.
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SCHISTOSOMA HAEMATOBIUM IPSE, A CANDIDATE PRO-
ONCOGENIC FACTOR
Evaristus Mbanefo1, Irina Saltykova2, Luke Pennington3, 
Theodore Jardetzky3, Paul Brindley2, Michael Hsieh1
1Bladder Immunology Group, Biomedical Research Institute, Rockville, MD, 
United States, 2Department of Microbiology, Immunology and Tropical 
Medicine, and Research Center for Neglected Diseases of Poverty, George 
Washington University, Washington, DC, United States, 3Department of 
Structural Biology, Stanford University School of Medicine, Stanford, CA, 
United States
Urogenital schistosomiasis (UGS) affects over 112 million people globally. 
Adult worm pairs in the pelvic venous plexus deposit eggs in the bladder. 
The eggs secrete antigens that induce granuloma formation, in turn 
provoking immunopathogenic sequelae that include urothelial hyperplasia 
and carcinogenesis. The IL-4-inducing principle of Schistosoma mansoni 
eggs (IPSE) is a prominent antigen released by schistosome eggs. IPSE 
binds immunoglobulins and chemokines, translocates into host nuclei 
and modulates gene transcription, and induces basophils, mast cells, and 
NK T-cells to release IL-4, thereby orchestrating a dominant Th2 response. 
Given that the IPSE gene is only found in Schistosoma, it is a candidate 
pro-carcinogenic factor in schistosomal bladder cancer. We hypothesize 
that the Schistosoma haematobium homolog of IPSE (H-IPSE) plays a 
major role in driving the inflammation-associated urothelial proliferation 
and bladder carcinogenesis during UGS. Recombinant H-IPSE was co-
cultured with a panel of urinary bladder cell lines derived from primary 
and transformed tissues, representing diverse species of origin and stages 
of carcinogenesis: HTB-9 (Grade II human bladder carcinoma), HCV-29 
(from normal human bladder urothelium) and MB49 (mouse urothelial 
carcinoma). Readouts included CFSE proliferation assays, cell cycle analysis, 
TUNEL apoptotic assays, real-time monitoring of cell migration and 
invasion using the xCELLigence platform, and qPCR-based transcriptional 
profiling. Whereas an influence of H-IPSE on proliferation and apoptosis 
of HTB-9 cells was not seen, it stimulated proliferation of HCV-29 and 
MB49 cells in a concentration-dependent manner. Moreover, cell cycle 
analysis showed that H-IPSE increased the proportions of MB49 cells in the 
S-phase. These findings indicate that H-IPSE might contribute to bladder 
cancer progression in the context of UGS. Ongoing work will define 
the mechanisms by which H-IPSE promotes S. haematobium-associated 
oncogenesis.
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577
PROTON CHANNELS IN BIOMPHALARIA GLABRATA 
EMBRYONIC CELL MEMBRANES: PUTATIVE TARGET FOR 
SCHISTOSOMA MANSONI LARVAL TRANSFORMATION 
PROTEINS
Utibe R. Buckram-Wright, Brandon J. Wright, Jackson B. Meyer, 
Timothy P. Yoshino
University of Wisconsin, Madison, WI, United States
The Biomphalaria glabrata embryonic (Bge) cell line was derived from 
the freshwater snail B. glabrata, an intermediate host for Schistosoma 
mansoni, a causative agent of intestinal schistosomiasis. Bge cells share 
characteristics with hemocytes, the immune effector cells of B. glabrata 
snails, and therefore, were used as an in vitro model for the study of 
host cell-larval parasite interactions. This study employed the whole-cell 
patch clamping technique to identify the major ion channel channels in 
the cell’s plasma membrane and to explore their possible role in host-
parasite interactions. Bge cells were exposed to pH gradients that resulted 
in changes in proton channel current. Exposure to Zn2+, a potent proton 
channel blocker, reduced response amplitude in Bge cells by 3-fold, further 
supporting the presence of proton channel activity. A series of voltage 
steps (-70 mV to 20 mV) applied to Bge cells evoked current responses 
that were significantly enhanced by S. mansoni larval transformation 
proteins (LTP), indicating an LTP-modulation of these channels. Since 
proton channels can play a role in the production of reactive oxygen 
species (ROS) in mammalian immune cells, we tested this function in 
Bge cells. Using the fluorescent probe 2’,7’-dichlorofluorescein-diacetate 
(DCFH-DA) to detect intracellular ROS, we found that cells generated 
an ROS response that was significantly reduced by Zn2+, indicating the 
involvement of proton channels in ROS production. LTP had no significant 
effect on ROS production suggesting that LTP-induced flux increases 
through proton channels may not extend to its modulation of the oxidative 
response. Lastly, immunofluorescence analyses of Bge cells and B. glabrata 
hemocytes revealed the expression of a HVCN1-like proton channel 
demonstrating that B. glabrata hemocytes also express a proton channel 
that may mediate ROS production. Thus, this channel could be important 
for the killing of larval S. mansoni by hemocytes of resistant B. glabrata 
snail strains.
578
CHARACTERIZATION AND FUNCTIONAL STUDIES OF SERINE/
THREONINE PROTEIN PHOSPHATASE 1 (PP1) ENCODING 
GENES FROM SCHISTOSOMA JAPONICUM
Min Hu, Lu Zhao, Xin He, Junlong Zhao, Qing Ye
Huazhong Agricultural University, Wuhan, China
Serine/threonine protein phosphatase1 (PP1) play a wide range of 
physiological roles including cell cycle regulation, glycogen metabolism, 
contractility, morphogenesis and spermatogenesis. However, little is 
known about the functions of PPs in the reproductive biological processes 
of schistosomes. In the present study, three PP1 genes were identified 
in Schistosoma japonicum. The sequence alignments and phylogenetic 
analyses showed that three PP1 proteins (Sj-PP1-1, Sj-PP1-2 and Sj-PP1-3) 
belong to PP1 beta, PP1 gamma and PP1 alpha subfamily, respectively. 
RT-PCR analysis revealed that three PP1 genes were all transcribed in both 
sexes and throughout development. In-situ hybridization indicated that 
Sj-pp1 were predominantly expressed in gonad related organs such as 
the testis of male, the ovary and vitellarium of female as well as ootype 
surrounding area. RNA interference with combined three Sj-PP1 dsRNAs by 
soaking for 7d caused stunted growth of female and male worms. CLSM 
observation found distinct morphological changes in Sj-PP1 dsRNA treated 
female worms with significantly smaller ovaries which were dominantly 
occupied by immature oocytes and low maturity of vitellarium surrounding 
by immature vitelline cells. In addition, no significant changes were 
observed on males treated for 7d, except for a reduced diameter of the 
testicular lobes accompanied by a reduction of cell density in testes and 
empty seminal vesicles with prolonged RNAi by 12d. Edu corporation assay 
detected evident decrease of cellular mitosis activities in ovary, vitellarium 
of females and testis and parenchyma of males. With extension of RNAi 
process, remarkable reduction in egg production were observed and 
serious interference on paring behavior was found between female and 
male. These findings suggested that PP1 may function in developmental 
and reproductive processes of Schistosoma japonicum.
579
INTERACTIONS BETWEEN HOST IMMUNE STATUS AND 
PARASITE METABOLIC ACTIVITY IN SCHISTOSOMA 
MANSONI
Kasandra S. Hunter, Ellen Fox, Stephen J. Davies
Uniformed Services University of the Health Sciences, Bethesda, MD, 
United States
Schistosomes are obligate parasites that lack genes required for the 
synthesis of many lipids (i.e. cholesterol and long-chain fatty acids), and 
therefore rely solely on the mammalian host to supply these essential 
molecules. Lipid acquisition appears to be particularly important for 
female schistosome reproductive activity. Here we show that lipid is 
specifically concentrated in the ovary of the female parasite. Interestingly, 
reproductively inactive females, in both unisexual infections and 
immunodeficient hosts, exhibit reduced accumulation of lipid in the 
ovary, underlining the connection between lipid metabolism and parasite 
reproduction. Coincident with these changes in lipid accumulation, 
schistosomes from immune competent and immunodeficient hosts 
also exhibit alterations in ATP metabolism. At 6 weeks post-infection, 
schistosomes isolated from immunodeficient animals have significantly 
higher ATP content than those isolated from immune competent animals. 
However, at 8 weeks post-infection the situation is reversed, with 
schistosomes isolated from immunodeficient animals having significantly 
lower ATP content than those isolated from immune competent animals. 
These findings suggest that parasites in immunodeficient hosts are unable 
to synthesize sufficient ATP once egg production is underway. To explore 
the molecular pathways connecting parasite lipid acquisition, energy 
metabolism, and reproduction, we are characterizing the parasite [mTOR] 
and [AMPK] signaling pathways to assess their status in these different 
developmental states. These findings suggest that a link between host 
immune status and parasite energy metabolism is an important aspect of 
the host-schistosome relationship.
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DUAL RNA-SEQ RESPONSES OF FIELD-DERIVED SPECIMENS 
OF THE AFRICAN SNAIL BIOMPHALARIA PFEIFFERI TO 
INFECTION WITH THE HUMAN PARASITE, SCHISTOSOMA 
MANSONI PROVIDE INSIGHT INTO HOST-PARASITE 
RELATIONSHIPS AND REPRODUCTIVE IMPLICATIONS OF 
PARASITISM
Sarah K. Buddenborg1, Lijing Bu1, Si-Ming Zhang1, Gerald M. 
Mkoji2, Eric S. Loker1
1University of New Mexico, Albuquerque, NM, United States, 2Kenya 
Medical Research Institute, Nairobi, Kenya
Biomphalaria pfeifferi exhibits extraordinary compatibility with Schistosoma 
mansoni and likely transmits more cases of this parasite to people than 
any other snail species. Ironically, we know relatively little at the molecular 
level regarding the interactions of B. pfeifferi and S. mansoni from early-
stage sporocyst transformation to the development of cercariae. To 
redress this shortcoming, using field-derived west Kenyan representative 
of schistosomes and snails, we have undertaken dual RNA-seq of three 
intramolluscan developmental stages (1- and 3-days post exposure and 
cercariae producing infections). Parasite sequences were first separated 
by screening against the S. mansoni genome. Then, a de novo B. pfeifferi 
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transcriptome was assembled from over a half billion non-S. mansoni 
paired-end reads. Transcripts were annotated using protein and nucleotide 
databases, including the B. glabrata genome database. Snail reproductive 
inhibitory peptides like ovipostatin and developmentally regulated 
albumen gland protein were up-regulated in shedding snails, suggesting 
that host castration is not merely a passive response to diminished energy 
supplies. The lack of expression of snail sex pheromones may be related 
to the strong self-fertilizing preferences of B. pfeifferi. Fibrinogen-related 
proteins (FREPs) showed complex patterns of responses. Distinctive profiles 
of expressed S. mansoni features were seen, including up-regulation of 
defense and stress response proteins. Five S. mansoni venom allergen-like 
proteins, known for host immunomodulatory functions, were highly up-
regulated in shedding snails. These field-derived snails harbored several 
notable symbionts including Capsaspora owczarzaki, microsporidians, 
Perkinsus-like protists, and ectosymbionts like Trichodina and 
Chaetogaster. Our database provides unique insights into schistosome-
snail interactions taking place in a natural transmission focus, potentially 
including candidate molecules amenable to manipulation to facilitate new 
control approaches targeting the ability of larval schistosomes to succeed 
in their snail hosts.
581
SEX-BIASING GENE DRIVE TO ELIMINATE SCHISTOSOMES: A 
PROPOSAL
Sergey Iordanskiy1, Kevin M. Esvelt2, Paul J. Brindley1
1The George Washington University, Washington, DC, United States, 2MIT 
Media Lab, Massachusetts Institute of Technology, Cambridge, MA, United 
States
Sex-biasing gene drives ensure that nearly all offspring are of one sex in 
order to progressively reduce the reproductive potential of the population. 
One strategy confers a fitness advantage to a sex chromosome by 
shredding the “opposing” sex chromosome during meiosis such that 
the driving chromosome is preferentially inherited by offspring. We 
propose a population suppression drive intended to locally or globally 
eradicate the schistosomes. Draft versions of the genome sequences of 
Schistosoma mansoni, which causes hepato-intestinal schistosomiasis, and 
S. haematobium, the cause of urogenital schistosomiasis, are available. 
Because the genetics and chromosomal architecture of S. mansoni are 
better understood, we are focusing on S. mansoni and will follow with 
S. haematobium once comparable information is available. We propose 
to deploy CRISPR/Cas9- and pseudotyped retrovirus–based techniques 
to introduce the gene drive components into the schistosome germ line. 
Schistosomes are a ZW species; females are ZW, males ZZ. The Z and W are 
largely homologous, but there are unique regions of both. It is therefore 
feasible to make a female-biasing ‘Z-shredder’ and a male-biasing 
‘W-shredder’. From a fitness perspective the Z-encoded W-shredder may 
be superior because it can also act as a conventional drive in ZZ males. 
That is, in ZW females it will shred the W, thereby ensuring that offspring 
inherit the driving Z chromosome and are consequently male, but will also 
copy itself from the driving Z to the wild-type Z in heterozygous males. 
Both activities are advantageous and should consequently be evolutionarily 
favored over time, albeit opposed by any unlikely suppressors that might 
evolve on the W or autosome. The gene encoding ribosomal protein 
S4 resides on Z, is single copy, and is expected to be critical for survival, 
while numerous repeats on the W are suitable for evolutionarily stable 
shredding. We are assaying components for building drive systems and 
are optimistically assembling and testing a W-shredder rps4 drive; and as a 
safeguard, an immunizing reversal rpS4 drive. Our proposal, approach and 
preliminary findings will be discussed.
582
ADVANCING WATER TREATMENT FOR RESOURCE RECOVERY 
TO ENHANCE DISEASE MITIGATION
Elysse Noel Grossi-Soyster, A. Desiree LaBeaud
Stanford University School of Medicine, Stanford, CA, United States
Despite being a fundamental resource required for the sustainment of 
life, water plays an integral part in the lifecycle and transmission of many 
pathogens, including bacteria, viruses, and parasites. This dichotomy 
presents an increased risk of exposure to a wide range of pathogens 
for humans and animals living in regions without regular access to 
clean water and waste processing systems, such as flush toilets. A large 
number of the technologies that have been designed solely for water 
and waste treatment fail in the field because they are not economically 
viable, whether through initial costs or long-term maintenance, or they 
have not been designed to withstand the unique environmental or 
cultural challenges presented by differing regions of application. In order 
to eliminate water as a reservoir for disease transmission, technologies 
designed for water treatment need to provide effective filtration or 
sterilization while allowing for the recovery of valuable resources. Examples 
of such resources may include, but are not limited to fertilizer, harvestable 
energy, and chemical components that may lead to the production of 
larger commodities. By providing waste and/or water treatment to reduce 
the transmission of disease while recovering harvestable products, the 
cost of initial construction and maintenance on such systems can me 
offset by the sustainability of the system and the potential for economic 
stimulation through the creation of technical maintenance jobs and new 
trade industries. This study will review a number of currently available 
technologies, describe the advantages and challenges for each technology, 
and discuss the potential for adaptation for use in resource-limited 
environments.
583
PREVALENCE OF SOIL TRANSMITTED HELMINTHS IN WATER, 
SANITATION AND HYGIENE (WASH) SUPPORTED AND NON-
SUPPORTED SCHOOLS IN OGUN STATE, NIGERIA
Hammed O. Mogaji1, Gabriel A. Dedeke1, Jaiyeola O. Omotola1, 
Quudus A. Yussuf2, Hakeem A. Yussuf2, Dorcas O. Adeaga3, 
Johnson E. Monday4, Uwem F. Ekpo1
1Federal University of Agriculture Abeokuta, Abeokuta, Nigeria, 2Ogun 
State Ministry of Health, Oke Imosan, Abeokuta, Nigeria, 3Rural Water 
Supply and Sanitation Agency, Ogun State, Abeokuta, Nigeria, 4UNICEF, 
Abuja, Nigeria
Water, Sanitation, and Hygiene (WASH) interventions have been 
advocated as a complementary tool in the control of soil-transmitted 
helminths (STH) infection. We therefore assessed the prevalence of STH 
in WASH supported and non-supported schools in Odeda, a rural local 
government area of Ogun state, Nigeria. Eight schools were randomly 
selected across the study area; three WASH supported (S-schools) and five 
non-supported schools (NS-schools). Stool samples were collected from 
428 pupils and screened for STH infection, followed by an assessment of 
school-based WASH resource using WHO recommended guide. Results 
showed significant differences (p < 0.05) in the provision of safe water and 
environmental hygiene for S-schools (100% and 73.3%) and NS-schools 
(16% and 26.9%) respectively. There exist no significant differences (p > 
0.05) in the sanitation condition between S-schools (44.4%) compared to 
NS-schools (20.0%). Overall prevalence of STH infection was 33.4%, while 
specific prevalence of 26.2% was recorded for Hookworm, 18.2% for 
Ascaris lumbricoides and 1.6% for Trichuris trichiura. STH Prevalence were 
significantly lower (p<0.05) in S-schools (27.4%) compared to NS-schools 
(37.5%). Mean intensities of hookworm and Trichuris trichiura infections 
were higher in NS-schools than S-schools (0.6097epg and 0.4247epg for 
hookworm) and (0.1193epg and 0.0epg for Trichuris trichiura) respectively. 
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This study provides evidences that WASH interventions have the potentials 
of reducing intestinal helminthiasis burden in public primary schools and 
should be scaled up to include more public schools in the state.
584
WATER SUPPLY AND SANITATION CONDITIONS IN RURAL 
SOUTHERN MOZAMBIQUE AND ITS AS SOCIATION WITH 
MORBIDITY AND MORTALITY INDICATORS DURING 2012-
2015
Berta Grau-Pujol1, Augusto Nhabomba2, Llorenç Quintó3, Aina 
Casellas3, Carme Subirà3, Charfudin Sacoor2, Ricard Gine4, Jose 
Muñoz3
1Institut de Salut Global de Barcelona (ISGlobal)/Centro de Investigaçao 
em Saúde da Manhiça (CISM)/Fundación Mundo Sano, Vila de Manhiça, 
Mozambique, 2Centro de Investigaçao em Saúde da Manhiça (CISM), 
Vila de Manhiça, Mozambique, 3Institut de Salut Global de Barcelona 
(ISGlobal), Barcelona, Spain, 4Universitat Politècnica de Catalunya (UPC), 
Barcelona, Spain
Water, sanitation and hygiene (WASH) are major health determinants, 
with an estimated total disease burden of 5.7% occurring worldwide.The 
situation of access to safe water and sanitation facilities and its impact 
on morbidity and mortality in southern Mozambique remains unknown.
The aim of this study is to describe the current situation of safe water 
supply and sanitation facilities in the Manhiça Health Research Centre 
(CISM) study area and evaluate its association with several morbidity and 
mortality indicators. We conducted a retrospective cohort study with 
61,900 children living in the center study area followed up until 15 years 
of age during the period 2012-2015. Water and sanitation household 
data was obtained from the CISM demographic surveillance system 
in Manhiça district, an area of around 2,380km2. Clinical data for all 
children under 15 was obtained from CISM round-the-clock morbidity 
surveillance system covering pediatric outpatient and hospital admission 
at the Manhiça District Hospital and rural health posts. A negative 
binomial regression model using Wald test was performed to assess the 
incidence rate ratio for every morbi-mortality indicator. Preliminary data 
showed that 86% of the children lived at least once in a household with 
unimproved sanitation facilities, 27% with unimproved water source 
and 77% with the main water source located outside the household 
during 2012-2015.Unexpectedly, the incidence rate ratios to develop 
diarrhea for children using unimproved sanitation and water facilities were 
significantly protective. Only the use of rivers and lakes as water sources 
significantly increased the children’s rate to develop diarrhea by 20%. 
Other morbidity indicators (malnutrition, parasitemia, anemia) did show 
a rate increase with the use of unimproved water and sanitation facilities. 
Spatial distribution and clustering for the water, sanitation and morbidity 
variables will be also analyzed.The possible explanation of the findings will 
be discussed.This analysis will help to plan evidence-based interventions 
to improve access to safe drinking water and sanitation in rural southern 
Mozambique.
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ASSOCIATION OF HOUSEHOLD, COMMUNITY AND SCHOOL 
SANITATION WITH HOOKWORM INFECTIONS AMONG 
SCHOOL-AGED CHILDREN IN KWALE COUNTY, KENYA
William E. Oswald1, Katherine E. Halliday1, Carlos Mcharo2, Paul 
M. Gichuki3, Stefan Witek-McManus1, Elizabeth Allen1, Sammy 
Njenga3, Charles Mwandawiro3, Roy Anderson4, Rachel Pullan1
1London School of Hygiene & Tropical Medicine, London, United Kingdom, 
2Evidence Action, Nairobi, Kenya, 3Eastern and Southern Africa Centre of 
International Parasite Control, Kenya Medical Research Institute, Nairobi, 
Kenya, 4Centre for Neglected Tropical Disease Research, School of Public 
Health, St. Mary’s Campus, Imperial College, London, United Kingdom
Most of our understanding of the association between sanitation and 
STH infection is focused separately on schools and households, and few 
studies simultaneously assess the relative importance of sanitation in 
the household, wider community, and schools. Yet, understanding the 
relative impact of sanitation on STH transmission between these domains 
is necessary to target disease control interventions for greatest impact. 
Here we investigate associations and interactions between hookworm 
infection and household, community, and school sanitation among 
children aged 5-14 in Kwale County, Kenya. Data were collected during 
a cross-sectional parasitological survey between March-May 2015 as 
the baseline for the TUMIKIA study. Data were available from 22,864 
households randomly selected across the county using a two-stage 
sampling design. In each household, one member was randomly selected 
and invited to provide a stool sample. Sanitation was assessed using 
structured observations and questionnaires. Sanitation conditions for 
every school in Kwale County were assessed during a survey in June 2015. 
Records from school and household surveys were linked for each child. 
Generalized linear mixed models were used to estimate the association 
between measures of household, community, and school sanitation 
with presence and intensity of hookworm infection. In total, the analysis 
included 5,251 school-aged children in 841 villages. Overall hookworm 
infection prevalence was 17.4% (16.4--18.4%), while mean intensity was 
156.2 epg (141.4--172.6). Household sanitation coverage was estimated, 
as the proportion of households with reported access to a toilet, to be 
49.2% (47.9--50.6%), and village sanitation coverage had an IQR of 25.0-
-78.4%. Multilevel analysis revealed associations across various domains, 
highlighting important areas of exposure for school-aged children in 
endemic communities. This study contributes further to our understanding 
of the impact of sanitation on hookworm infection in respective domains, 
and provides insight into effective targeting of programs to maximize 
reductions in hookworm infection.
586
THE DRIVERS OF THE CHOLERA EPIDEMIC IN BAUCHI, 
NORTHEAST NIGERIA 2014
Hannatu Janada Dimas1, Patrick Nguku1, Charles Akatobi 
Akatobi2, Olufemi Ajumobi3
1Nigeria Field Epidemiology and Laboratory Training Programme, Abuja, 
Nigeria, 2African Field Epidemiology Network (AFENET), Abuja, Nigeria, 
3National Malaria Elimination Programme, Abuja, Nigeria
On 19th February, 2014, the Nigerian Federal Ministry of Health (MOH) 
was alerted of an ongoing outbreak of cholera in Bauchi State, Nigeria. 
The State has experienced repeated cholera outbreaks almost yearly with 
the 2010 outbreak, recording one of the highest case burdens among the 
states in Nigeria. We investigated the outbreak to assess the magnitude 
of the outbreak and identify risk factors for transmission. We collected 
the line-list from the State MOH and conducted a case-control study. We 
collected data on demographic characteristics, hygienic practices, and 
on food and water consumption using a structured questionnaire. We 
identified 2998 cases among the 1,444,393 residents of the 4 affected 
Local Government areas. Overall attack rate and case fatality rate were 
0.21% and 0.77% respectively. Among the 248 case-control study 
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participants, 113 (45.6%) were female and 135 (54.4%) were male. 
There were 124 cases and 124 controls. Compared to controls, cases were 
more likely to have been exposed to diarrhoea case (OR:6.72, 95% CI 
3.87-11.75), live as an Islamic Mendicant ‘almajiri’ (OR:5.22, 95%CI 1.94 
- 14.78), not wash hands with soap after toileting (OR:4.71, 2.59 - 8.62), 
not wash hands before eating (OR:3.82, 95%CI 1.13 - 14.20), be ≤25 
years (OR:3.32, 95%CI 1.97 - 5.60), drink street vended locally processed 
cereal drink ‘kunu zaki’ and custard ‘koko’ (OR:3.28, 95%CI 1.15 - 9.31) 
and (OR:2.91, 95%CI 1.10-7.71) respectively. In conclusion, ‘Almajiris’ 
were found to be key players boosting the epidemic and consumption 
of food from street vendors was a major risk factor for the spread of the 
disease. Sanitary inspection officers should mobilize the ‘Almajiris’ to 
maintain clean environment around them and food hygiene. The health 
department should train hawkers of foods on the street on personal and 
food hygiene.
587
PREVALENCE OF ROTAVIRUS INFECTION OVER TIME IN 
RURAL, COASTAL ECUADOR
Alicia N. Kraay, Joseph N. Eisenberg
University of Michigan Ann Arbor, Ann Arbor, MI, United States
Rotavirus is a key cause of diarrheal disease in the developing world. 
However, patterns of infection over time have not been well characterized. 
Using 10 years of population based case-control data from rural coastal 
Ecuador, we investigate the prevalence of rotavirus infection over time and 
differences by subgroup in a region that has been experiencing continuous 
road construction. The prevalence of rotavirus infection has steadily 
declined over time from 7.0% in 2003 to 1.3% in 2012. This decrease 
was 3.4 times faster for symptomatic infection (rates of 1.3% and .4% 
respectively). Rotavirus infection was highest among individuals under age 
5 (OR=3.19, 95% CI: 2.58, 3.94) but all age groups except children under 
1 year of age exhibited decreases in prevalence of infection over time. 
In contrast, younger children showed patterns characteristic of a long 
epidemic, with a peak infection risk of 16.7%. Despite their higher levels 
of exposure, household and community controls had similar prevalence 
of infection (p=.82), suggesting that community interactions may be 
important for transmitting asymptomatic rotavirus infection in our study 
region.
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A RANDOMIZED CONTROLLED TRIAL OF A HOSPITAL-BASED 
HANDWASHING WITH SOAP AND WATER TREATMENT 
INTERVENTION (CHOBI7) TO REDUCE CHOLERA AMONG 
HOUSEHOLD CONTACTS OF CHOLERA
Christine Marie George1, Shirajum Monira2, David A. Sack2, 
Mahamud-ur Rashid2, K.m. Saif-Ur-Rahman2, Toslim Mahmud2, 
Zillur Rahman2, Munshi Mustafiz2, Sazzadul Islam Bhuyian2, Peter 
J. Winch1, Elli Leontsini1, Jamie Perin1, Farzana Begum2, Fatema 
Zohura2, Shwapon Biswas2, Tahmina Parvin2, Xiaotong Zhang1, 
Danielle Jung1, Danielle Jung1, R. Bradley Sack1, R. Bradley Sack1, 
Munirul Alam2
1Johns Hopkins University, Baltimore, MD, United States, 2International 
Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh
Household contacts of cholera patients are at a 100 times higher risk of 
developing a cholera infection than the general population during the 
week post-presentation of the index patient at the hospital. In an effort 
to initiate a standard of care for highly susceptible household contacts of 
cholera patients, we developed a hospital-based handwashing with soap 
and water treatment intervention entitled CHoBI7(Cholera-Hospital-Based-
Intervention-for-7-days). The CHoBI7 intervention includes: (1) a cholera 
prevention package containing chlorine tablets for water treatment, 
soapy water bottles, a handwashing station, and a sealed water vessel 
with cover to ensure safe water storage, and (2) a pictorial (“Chobi” in 
Bangla) module on handwashing with soap and water treatment delivered 
by a health promoter through hospital and home visits during the week 
post-presentation of the index cholera patient at the hospital. The efficacy 
of the CHoBI7 intervention was evaluated by conducting a randomized 
controlled trial of 219 intervention household contacts of cholera 
patients and 220 control contacts of patients in Dhaka, Bangladesh. Case 
households were followed over a one week period at 5 timepoints for 
clinical and environmental surveillance which included collection of rectal 
swab and source and stored water samples to test for the presence of 
Vibrio cholerae by bacterial culture. Five hour structured observation was 
also conducted to assess handwashing practices. Compared to control 
contacts, intervention contacts had a significant reduction in symptomatic 
cholera infections (OR: 0.00 (95% CI: 0, 0.623)), and a 47% reduction 
in overall cholera infections (OR: 0.50 (95% CI: 0.21, 1.18). Intervention 
households had no stored drinking water with detectable Vibrio cholerae, 
and a 14 times higher odds of handwashing with soap at key events 
than control households during the intervention period (OR: 14.68 
(95% CI:8.32, 25.90)). In conclusion, the CHoBI7 intervention presents 
a promising approach for cholera control among highly susceptible 
household contacts of cholera patients.
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THE ASSOCIATION BETWEEN HEAVY RAINFALL EVENTS 
AND DIARRHEAL DISEASE: THE INFLUENCE OF URBAN AND 
RURAL GEOGRAPHY
Aniruddha Deshpande, Howard H. Chang, Karen Levy
Emory University, Atlanta, GA, United States
Climate change is expected to have downstream impacts on health 
outcomes in the 21st century. Changes in precipitation are expected 
with greater contrasts between wet and dry periods and increase in 
extreme weather events. Heavy rainfall events (HRE) have been shown 
to be associated with diarrheal disease. Diarrheal disease remains an 
important cause of mortality amongst children under five years of age 
with causing over 700,000 deaths per year and is associated with long 
term health outcomes such as stunting. Differences in urban and rural 
settings could play an important role in driving the relationship between 
precipitation and diarrhea due to underlying differences in infrastructure 
and social factors. The study aims to analyze the role of urban and rural 
contexts in affecting the relationship between HRE and diarrheal disease. 
Mixed effects Poisson regression was conducted on daily case counts 
of diarrhea in all public hospitals and clinics from all 68 parishes in the 
Esmeraldas province in northwestern coastal Ecuador across 2013-14 
with heavy rainfall estimates and antecedent conditions lagged up to 
14 days. Average daily rainfall estimates from the TRMM 3B42 platform 
were used to define heavy rainfall events as daily rainfall higher than the 
90th percentile and antecedent conditions as wet or dry depending on 8 
week total rainfall being in the highest or lowest tertile for the respective 
parish. In rural areas, there was a protective effect of HRE on daily case 
counts of diarrhea during the wet season whereas a positive association 
was observed in the dry season. In urban areas there was no protective 
effect observed and the expected counts of diarrhea were higher in all 
environmental conditions analyzed when compared to rural areas in the 
wet season. Factors associated with urbanization, such as crowding or 
infrastructure, seem to dominate over climate related factors. Despite this, 
dry conditions appear to be highly associated with increased diarrhea in 
all areas. Further work is needed to elucidate the mechanistic structure of 
what factors are driving the differences between urban and rural areas in 
how rainfall is associated with diarrhea.
185
astmh.org
590
MULTI-SECTORAL COLLABORATION BETWEEN THE NTD AND 
WASH SECTORS: EXPERIENCE FROM UGANDA
Angelia Sanders1, Edridah Tukahebwa2, Peace Habomugisha3, 
Patrick Turaguma2, E. Kelly Callahan1
1The Carter Center, Atlanta, GA, United States, 2Uganda Ministry of 
Health, Kampala, Uganda, 3The Carter Center, Kampala, Uganda
In order to eliminate blinding trachoma all components of the SAFE 
strategy (Surgery, Antibiotic, Facial cleanliness and Environmental 
improvement) must be in place; however, the F & E components are often 
given less attention and financial resources. Many national programs 
are eager to implement F & E activities but do not know where or how 
to start. In Uganda, the Ministry of Health (MOH), in partnership with 
the Ministry of Water and Environment, Ministry of Education and 
Sports, various Water, Sanitation and Hygiene (WASH) and trachoma 
organizations came together to develop a comprehensive F & E plan. 
This process involved conducting an F & E situational analysis, organizing 
multiple multi-sectoral meetings and reaching a consensus on program 
priorities. Ultimately, four main activities were identified: 1) integration 
of face washing and trachoma messages into existing WASH strategies 
and activities in trachoma endemic regions; 2) revision and dissemination 
of school sanitation guidelines; 3) revision and dissemination of national 
sanitation guidelines; and 4) development of a Social and Behavior 
Change Communication (SBCC) strategy to be used as part of mass 
media campaigns. A review committee composed of representatives from 
different government ministries and organizations evaluated different 
WASH organization’s proposals and selected the best proposal for each 
activity. As of December 2015, three WASH/SBCC organizations have 
been working successfully to achieve the above four objectives. In addition 
to the F & E activities identified, there has been an increase in cross-
collaboration between the MOH and WASH partners through the sharing 
of data and participation in relevant stakeholder technical meetings 
such as the Uganda National Sanitation Working Group and the Uganda 
Neglected Tropical Disease Technical Committee. The Uganda Trachoma 
Control Program provides an excellent example of what can be achieved 
when different government, public health and WASH sectors collaborate 
towards a common goal.
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BURDEN OF DISEASE ATTRIBUTED TO WATER-BORNE 
TRANSMISSION OF SELECTED GASTROINTESTINAL 
PATHOGENS, AUSTRALIA 2010
Katherine B. Gibney, Joanne O’Toole, Martha Sinclair, Karin 
Leder
Monash University, Melbourne, Australia
Water is an important source of infectious diseases transmission, 
however the burden of water-borne disease is not well characterized. 
We have previously published estimates of the burden of disease caused 
by Campylobacteriosis, non-typhoidal salmonellosis, cryptosporidiosis, 
giardiasis, and norovirus in Australia in 2010 using number of cases, 
number of deaths and disability adjusted life years (DALYs). Post-infectious 
sequelae were included in DALY estimates for Campylobacteriosis (irritable 
bowel syndrome [IBS], reactive arthritis [ReA] and Guillain-Barré syndrome]) 
and salmonellosis (IBS and ReA). Here we have applied regional WHO 
estimates of the pathogen-specific proportion of cases attributable to 
water-borne transmission in 2010 (point estimates and 95% uncertainly 
intervals [UI]) to our published point estimates of overall disease burden 
for these pathogens. The WHO estimates for the Western Pacific Region 
Stratum A (WPR A) included Australia, Brunei, Japan, New Zealand and 
Singapore. The proportion of cases attributed to water-borne transmission 
ranged from 0.01 [95%UI 0.00-0.22] for salmonellosis to 0.39 [95%UI 
0.03-0.72] for cryptosporidiosis. Norovirus had the greatest number of 
water-borne cases (479,632 [95%UI 0-1,111,874]) followed by giardiasis 
(178,275 [95%UI 6,147-418,023]) and Campylobacteriosis (85,140 
[95%UI 0-247,681]). Deaths were attributed to water-borne transmission 
of Campylobacteriosis (six [95%UI 0-17]), norovirus (four [95%UI 0-9]), 
and salmonellosis (one [95%UI 0-20]). The water-borne DALY burden 
was greatest for Campylobacteriosis (2,004 [95%UI 0-5,831]), giardiasis 
(280 [95%UI 10-658]) and norovirus (244 [95%UI 0-566]). Attribution 
was made at the point of human exposure and disease caused by food 
contaminated through exposure to dirty water was not attributed to 
water-borne transmission. Therefore, improvements in water quality has 
potential to lessen the burden of both water- and food-borne disease. 
These data can inform Australian guidelines relating to water used for 
drinking, food production and recreation.
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DETECTING AND ENUMERATING SOIL-TRANSMITTED 
HELMINTH EGGS IN SOIL: NEW METHOD DEVELOPMENT 
AND RESULTS FROM FIELD TESTING IN BANGLADESH AND 
KENYA
Lauren Steinbaum1, Laura Kwong1, Ayse Ercumen2, Makeda 
S. Negash2, Amira J. Lovely2, Sammy M. Njenga3, Alexandria B. 
Boehm1, Amy J. Pickering1, Kara L. Nelson2
1Stanford University, Stanford, CA, United States, 2University of California 
Berkeley, Berkeley, CA, United States, 3Kenya Medical Research Institute 
(KEMRI), Nairobi, Kenya
Globally, about 1.5 billion people are infected with at least one species of 
soil-transmitted helminth (STH). Soil is a critical environmental reservoir of 
STH, yet there is no standard method for detecting STH eggs in soil. We 
developed a field method for enumerating STH eggs in soil and tested it 
in Bangladesh and Kenya. We optimized a method, based on a US EPA 
method for enumerating Ascaris in biosolids, through a series of recovery 
efficiency experiments; we seeded soil samples with a known number of 
Ascaris suum eggs and assessed the effect of protocol modifications on 
egg recovery. We found the recovery efficiency increased when we used 
1% 7X as a surfactant compared to 0.1% Tween 80 and two centrifuge 
flotation steps compared to one. Other protocol modifications, such as 
sample mixing and sedimentation time, did not impact recovery efficiency. 
Soil type affected the egg recovery efficiency; sandy samples resulted in 
higher recovery efficiency compared to loamy samples processed using the 
same method. We documented a recovery efficiency of 73% for the final 
optimized method. Soil samples from 100 households in Bangladesh and 
100 households in Kenya were processed with the optimized method from 
June to November 2015. Field staff collected soil samples from the surface 
layer of soil directly adjacent to the doorway of the house entrance. 
Both the prevalence and concentration of STH eggs in soil was higher in 
Bangladesh than in Kenya. In our field tests, we found the prevalence 
of any STH egg in soil was 78% in Bangladesh and 37% in Kenya. In 
Bangladesh and Kenya, Ascaris was the most common STH (67% and 
22%) followed by Trichuris (36% and 21%). We did not detect hookworm 
eggs in either country, suggesting the method may not be appropriate for 
hookworm enumeration. The median concentration of STH eggs in soil in 
positive samples was 0.64 eggs/g dry soil in Bangladesh and 0.15 eggs/g 
dry soil in Kenya. The proportion of STH eggs determined to be viable 
was similar in both countries (85.7% in Bangladesh and 83.6% in Kenya). 
This new method is feasible for detecting STH eggs in soil in low-resource 
settings and could be a key tool for standardizing soil STH detection 
globally.
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EVALUATING BEHAVIOR CHANGE IN SINGLE AND COMBINED 
INTERVENTIONS OF A LARGE-SCALE WATER, SANITATION, 
HYGIENE AND NUTRITION INTERVENTION TRIAL (WASH 
BENEFITS), IN RURAL BANGLADESH
Sarker Masud Parvez1, Rashidul Azad1, Md. Mahbubur Rahman1, 
Leanne Unicomb1, Pavani K. Ram2, Abu Mohd Naser3, Christine P. 
Stewart4, Musarrat J. Rahman1, Kaniz Jannat1, Elli Leonstini5, Peter 
Winch5, Stephen P. Luby6
1International Centre for Diarrhoeal Disease Research, Bangladesh, 
Dhaka, Bangladesh, 2Department of Epidemiology and Environmental 
Health, University of Buffalo, Buffalo, NY, United States, 3Department of 
Environmental Health Sciences, Emory University, Rollins School of Public 
Health, Atlanta, GA, United States, 4University of California Davis, Davis, 
CA, United States, 5Johns Hopkins Bloomberg School of Public Health, 
Baltimore, MD, United States, 6Stanford University, Stanford, CA, United 
States
Promoting multiple behavioral interventions together risks limiting 
sustained adoption of the individual behaviors. WASH Benefits, a large 
scale efficacy trial, randomly allocated 720 clusters of 5551 pregnant 
women to a control group, single interventions (water [W], sanitation 
[S], handwashing [H], nutrition [N]), or combined interventions (WSH and 
WSHN). Enabling hardware and behavior change was promoted by trained 
local community health promoters through periodic household visits. In 
samples of intervention households, we conducted monthly observations 
beginning 3 months after initiation of the intervention, starting November 
2012 to October 2014, to monitor intervention uptake. We analyzed 
and compared uptake among households receiving single (W, S, H or N) 
versus combined (WSH & WSHN) interventions. Observed dual pit latrine 
uptake did not differ significantly among the arms (S: 70%, WSH: 70%, 
WSHN: 72%; p>0.05). A slightly higher proportion of of households 
in the single handwashing arm (93%) had water and soap present at 
the handwashing station near the latrine, compared to the combined 
intervention arms (WSH: 85%, WSHN: 87%; p<0.01). Detectable residual 
chlorine in stored water was somewhat higher in households receiving the 
single water intervention (76%) than combined interventions (WSH: 68%, 
WSHN: 67%; p<0.05). Among households who received the nutrition 
intervention, report of feeding lipid-based nutrient supplementation 
(LNS) to the child (6-24 months) was similar across the arms (N & WSHN: 
84%; p>0.05). Rigorous implementation of interventions deployed 
at large scale achieved high levels of uptake in single and combined 
intervention arms. However, we found somewhat lower uptake of fully 
stocking handwashing stations and treating water among households 
receiving combined interventions compared to households receiving single 
intervention; uptake differences were small. High uptake of large scale 
combined WASH and WASHN interventions is possible in the context of an 
efficacy trial, though further work should assess their effectiveness under 
programmatic conditions.
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WHO CAN AFFORD GPS POINTS? SCALING A VILLAGE-LEVEL 
WATER ACCESS INFORMATION SYSTEM IN RURAL ZAMBIA
Laurie Markle1, Amy Tiwari1, Alexandra Hoehne2, Abel Manangi3, 
Engervell Musonda3, Oswell Katooka3, Rabson Zimba1, Illenga 
Nhkata1, Nicolas Osbert2, Anna M. Winters1, Benjamin Winters1, 
David Larsen1
1Akros, Lusaka, Zambia, 2UNICEF Zambia, Lusaka, Zambia, 3Ministry of 
Local Government and Housing, Lusaka, Zambia
An ideal information system for monitoring a country’s water system 
incorporates geocoordinates for all improved water points. However, 
the generation and maintenance of such an information system is 
extremely expensive in terms of both finances and human power. 
Furthermore, a database of geo-located water points alone is insufficient 
to determine water access of the population – the database must be 
matched to a population database to determine access. The Ministry 
of Local Government and Housing (MLGH) leveraged an established 
mobile-to-web information system of village-level access to sanitation 
to monitor village-level access to improved water points. The addition 
of 4 separate data elements allowed for the creation of two indicators: 
the percent village access of improved water and villages with improved 
water points that are not functioning. Using District Health Information 
System (DHIS2), we have seen large disparity in village-level water access 
within districts and have been able to utilize the information system to 
direct borehole drilling operations to areas most in need. Furthermore, 
the approximate geolocation of the water point is being made available 
through village geo-coordinates. Zambia is now scaling village-level water 
access monitoring to all rural districts. In addition to demonstrating the 
power of monitoring water access, we discuss challenges, solutions and 
opportunities in developing and sustaining nationwide village-level water 
access monitoring in Zambia.
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QUANTIFYING THE ROLE OF FAILING WATER AND 
SANITATION INFRASTRUCTURE ON HEALTH, HEALTHCARE 
COSTS AND SOCIETAL WELLBEING DURING VARYING 
DISASTER SCENARIOS
Alejandro Cravioto1, Warren Stevens1, Edward J. Mills2, Jamie I. 
Forrest2, Aranka Anema3, Tracey Koehlmoos4
1Precision Global Health, Seattle, WA, United States, 2Precision Global 
Health, Vancouver, BC, Canada, 3Epidemico, Boston, MA, United States, 
4Uniformed Services University of the Health Sciences, Bethesda, MD, 
United States
The United Nations Office for Disaster Risk Reduction (UNISDR) estimates 
that 100 million people are affected by disasters annually, while climate 
change remains the biggest global health threat of the 21st century. The 
relationship between climactic variation, environment and zoonotic and 
vector-borne diseases is well established. A mounting body of evidence 
further suggests that climate change poses a significant threat to food 
security, and to microbial, chemical and physical food and water safety. 
Climate-related food-borne illnesses are predicted to disproportionately 
affect poor, elderly and young populations, and to be pronounced in low 
resource settings, where public health infrastructure and human resource 
capacity is limited or fragile. We created a series of models to estimate the 
impact of various disaster scenarios that result in varying levels of levels 
and trends in the quality and scope of key water provision, sanitation and 
health care delivery infrastructure. A multi-level model was developed 
encompassing a matrix-map of the interactions between key drivers of 
water quality, access, provision, and scarcity. Key inputs to health care 
service quality, accessibility and coverage were used to determine the 
change in the likely consequences of any breakdowns on these key drivers. 
This model uses variables from four categories of data; disease incidence, 
critical infrastructure, climactic variables and food security, to develop 
estimates of changes in population wide disease burden. These results 
are then used, along with data on healthcare infrastructure, to estimate 
marginal impact on healthcare costs, and resulting impact on households, 
as well as the wider social burden resulting from greater disease burden 
within the population, such as growth and cognitive development in 
children and impacts on education, and lifetime earnings. Ultimately the 
value of this model will be in developing a ‘currency’ for risk that not just 
improves our understanding of the true costs to society of various levels of 
risk of major adverse events, but also allows us to measure the return on 
investment on early interventions.
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A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-
BLIND PILOT STUDY OF SINGLE-DOSE HUMANIZED ANTI-
IL5 ANTIBODY (RESLIZUMAB) FOR THE REDUCTION OF 
EOSINOPHILIA FOLLOWING DIETHYLCARBAMAZINE 
TREATMENT OF LOA LOA INFECTION
Fanny Legrand1, Jesica Herrick2, Michelle Makiya1, Shakuntala 
Rampertaap3, Jennifer Stoddard3, JeanAnne Ware1, Michael P. Fay4, 
Nicole Holland-Thomas5, Thomas B. Nutman1, Amy Klion1
1National Institutes of Health, Bethesda, MD, United States, 2University of 
Illinois at Chicago, Chicago, IL, United States, 3Department of Laboratory 
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4Biostatistics Research Branch, DCR, National Institute of Allergy and 
Infectious Diseases, Rockville, MD, United States, 5Clinical Research 
Directorate/Clinical Monitoring Research Program, Leidos Biomedical 
Research, Inc., NCI, Frederick, MD, United States
Diethylcarbamazine citrate (DEC) treatment of loiasis is complicated by 
adverse reactions that are correlated with the number of circulating 
microfilariae (mf). The cause of these reactions is unknown, but they 
are accompanied by a dramatic interleukin-5 (IL-5)-dependent increase 
in eosinophilia and evidence of eosinophil activation. To explore the 
role of IL-5 driven eosinophilia on post-DEC reactions, 8 adults with 
parasitologically-confirmed loiasis and <5000 mf/mL blood were enrolled 
on a randomized, double-blind, placebo-controlled trial of the humanized 
anti-IL-5 antibody, reslizumab, (1.0 mg/kg IV) administered 3 to 7 days 
prior to initiation of DEC treatment (9 mg/kg/day for 21 days). Subjects 
were assessed prior to, at days 1, 2, 3, 5, 7, and 14 and months 1, 3, 
6, 12, 18 and 24 post-DEC treatment. The primary endpoint was the 
reduction in absolute eosinophil count (AEC) during the first week of DEC 
treatment. Secondary outcomes included the severity of post-treatment 
adverse events (AE), markers of eosinophil activation, and mf clearance. 
Baseline characteristics were comparable between the two groups. 
Single dose reslizumab lowered the AEC by 77% prior to initiation of 
DEC therapy (vs. a 12% decrease in the placebo group, p<0.05). More 
importantly, reslizumab significantly reduced AEC in the first week of DEC 
treatment, with peak AEC remaining below baseline in all subjects who 
received reslizumab and in none of the placebo subjects. Mf clearance 
occurred within 2 days of initiation of DEC in all 7 mf+ subjects. Mild 
to moderate AEs were seen in all 8 subjects and were not significantly 
different between the reslizumab and placebo groups. In summary, 
although reslizumab was able to block peripheral eosinophilia post-
DEC treatment in subjects with loiasis and had no effect on microfilarial 
clearance, the reduction in AEC appears to have been insufficient to 
prevent post-treatment AEs. Assessment of eosinophil activation and 
cytokine profiles is ongoing.
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MOLECULAR DETECTION OF ONCHOCERCA VOLVULUS IN 
SKIN BIOPSIES FROM THE DEMOCRATIC REPUBLIC OF THE 
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Defining the optimal diagnostic tools for evaluating onchocerciasis 
elimination efforts is paramount. The sensitivity of skin skip microscopy 
decreases as microfiladermia is suppressed, highlighting the need for 
molecular tools. We assessed the ability of a pan-filarial real-time PCR 
with melt curve analysis (qPCR-MCA) tool to detect Onchocerca volvulus 
(OV) in residual skin snip biopsies and evaluated the performance of this 
tool relative to microscopy. Residual skin snip biopsies were collected from 
471 people during an onchocerciasis survey in Kisangani, DRC, an area 
co-endemic for OV, Mansonella spp. (MSPP) and Loa loa (LL). Melting-
temperature (Tm) ranges for species identification were determined 
using known gDNA. By qPCR-MCA, 43.5% (205) of the samples were 
negative, 47.5% (224) had OV, 3.8% (18) had MSPP, and 5.1% (24) 
had LL. An OV specific qPCR (qPCR-O150) was run as validation for all 
qPCR-MCA(+) samples and 25% of the qPCR-MCA(-) samples. There 
was 100% concordance for negative samples, and 97% concordance 
among positive samples: 5 were qPCR-MCA(+) but qPCR-O150(-) while 
3 were qPCR-O150(+) but qPCR-MCA(+) for either LL or MSPP but not 
OV. Sequencing was done for 61 samples because they had a non-OV 
Tm or a dissociation curve suggestive of mixed infection. Of these, 15 
had LL, 30 had M. perstans (MP), 6 had OV, and 8 had mixed template 
chromatograms. Overall, 43.5% of skin snips were negative, 43.7% had 
OV, 3.0% had LL, 3.2% had MP, and 6.6% had ≥ 1 species. The sensitivity 
and specificity of microscopy was 79.5% and 95.5% compared to qPCR-
MCA and 80.6% and 96% compared to qPCR-O150. Skin snip microscopy 
was less sensitive than qPCR even in a hyper-endemic setting that received 
yearly ivermectin. The qPCR-MCA identified 30 cases other filariae that 
were sequence confirmed. Although this assay detected OV, it was not 
sufficiently robust to differentiate all species in mixed infections, which 
had to be resolved by species-specific PCRs. Nevertheless, the qPCR-MCA 
assay is a useful, rapid screening method able to detect OV and identify 
samples with mixed infections which will be invaluable for validating other 
diagnostic assays.
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TOLL-LIKE RECEPTOR 2 EXPRESSION ON IMMUNE CELLS 
IS ELEVATED IN CURED ASYMPTOMATIC INDIVIDUALS IN 
LYMPHATIC FILARIASIS
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Hoerauf2, Alex Debrah3
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Nkrumah University of Science and Technology, Kumasi, Ghana, 2Institute 
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Various clinical manifestations observed in lymphatic filariasis-endemic 
(LF-endemic) areas may be partly due to alterations in innate and adaptive 
immune cell populations expressing toll-like receptor 2 (TLR2) and toll-
like receptor 4 (TLR4). The endosymbiotic bacteria Wolbachia, have been 
shown to induce inflammatory responses that are mediated primarily 
by the toll-like receptors. The use of the mass control drugs, ivermectin 
and albendazole, and the macrofilaricide doxycycline introduces a new 
dynamic in the immune response profiles of individuals in LF-endemic 
areas. In a study conducted in the Western region of Ghana where 
therapy has been ongoing for a minimum of 5 years, whole blood from 
a cohort of 428 individuals comprising 15 patent, 64 latent, 98 endemic 
normals, 101 lymphedema and 150 previously asymptomatic infected 
but now uninfected (“cleared infection”), were stimulated in 96-well 
microtiter plates with the TLR-specific ligands PamCSK4, LPS and HKLM. 
The expression of TLR2 and TLR4 on innate and adaptive immune cells 
were measured by flow cytometry. Expression of TLR2 was highest 
on monocytes (CD14+), a dendritic cell sub-population (CD11c+int), a 
macrophage sub-population (CD33+high) and CD4+ T cells in “cleared 
infection” individuals. Additionally, significant differences in TLR2 
expression were observed between the “cleared infection” and latent 
individuals (p < 0.05) on monocytes; “cleared infection” and lymphedema 
pathology individuals (p < 0.0001) and “cleared infection” and endemic 
normal individuals (p < 0.0001) on CD11c+int; “cleared infection” and 
lymphedema individuals (p < 0.0001 and p < 0.05) on CD33+high and 
CD4+ T cells, respectively. However, no trend or pattern was observed in 
TLR4 expression on innate and adaptive immune cells in both infected and 
uninfected individuals, with observed levels being <4% in all cell types 
examined. Our findings show that therapy leads to heightened recognition 
of pathogen-associated molecular patterns by TLR2 on innate and adaptive 
immune cells, and a recovery in immune response in asymptomatically 
infected LF individuals who have cleared the infection.
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IN VITRO-GENERATED AND EX VIVO-ISOLATED HUMAN 
DENDRITIC CELLS RESPOND SIMILARLY TO LIVE 
MICROFILARIAE OF BRUGIA MALAYI
Kathleen R. Elliott, Prakash Babu Narasimhan, Sasisekhar 
Bennuru, Thomas B. Nutman, Roshanak Tolouei Semnani
National Institutes of Health, Bethesda, MD, United States
Infection by Brugia malayi- one of the two major species causing lymphatic 
filariasis in humans- has been classified by dysregulation of dendritic cells 
(DC) most associated with microfilarial (mf) antigen exposure. Our previous 
data have shown that live mf both induce apoptotic cell death and 
inhibit the mammalian target of rapamycin (mTOR) in human monocyte-
derived DC (moDC) generated in vitro. The mTOR signaling pathway is 
an important regulator of cellular metabolism, proliferation, growth, and 
autophagy. Recent data suggest phenotypic and functional differences 
exist between in vitro generated moDCs and the myeloid DC (mDC) 
isolated directly ex vivo from blood that could lead to a misconstruing 
of the importance of our in vitro findings. Therefore, we sought to 
compare the responses of these two DC populations to live mf. Elutriated 
monocytes from healthy volunteers were either cultured with IL-4 and 
GM-CSF to generate moDCs or sorted ex vivo using an antibody cocktail 
to isolate mDCs (CD11c+/HLA-DR+/CD14-/CD16-/CD1c+). Once generated, 
both cell types were exposed to either media alone, live mf, LPS (an mTOR 
activator), or rapamycin (mTOR inhibitor) for 1 hr. Using immunoblot 
analysis, we demonstrate that mf, similar to rapamycin, significantly 
downregulate the phosphorylation of mTOR (and its downstream effectors 
p70S6K, and 4EBP1 p<0.05) in both moDC and mDC. Interestingly, the 
rapamycin-like effects of mf are also observed when mf are physically 
separated from DC using transwells. Because cell contact is not required 
for mf impairment of the mTOR pathway in DC, we suggest that excretory/
secretory products from live mf may mediate this effect. The similarity of 
these two cell types (moDC and mDC) in response to mf extends beyond 
mTOR inhibition to the induction of apoptotic cell death. When exposed 
to live mf, both cell types have a marked (~7-fold) increase in cell death as 
measured by propidium iodine positivity by flow cytometry. Together, these 
data suggest that while there are phenotypic and functional differences 
between moDC and mDC, with respect to responses to live mf (and mTOR 
inhibitors), they appear to function similarly.
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ONCHOCERCA VOLVULUS PROTEOME-WIDE LINEAR EPITOPE 
SCANNING USING HIGH-DENSITY PEPTIDE MICROARRAYS 
AND CONFIRMATION OF IMMUNODOMINANT MOTIFS BY 
ELISA
Ole Lagatie, Bieke Van Dorst, Lieven J. Stuyver
Janssen Diagnostics, Beerse, Belgium
We have employed high-density peptide microarrays containing 832,709 
partially overlapping 15-mer peptides covering the entire Onchocerca 
volvulus proteome, and screened serum samples of Onchocerciasis patients 
(n=12) and controls (n=6) for immunoreactivity. After selection of cut-offs 
for signal intensity and significance, approximately 2000 immunoreactive 
peptides were identified, of which at least 290 could be considered 
immunodominant. This pool of immunodominant peptides was further 
divided into clusters, each cluster characterized by the presence of a motif 
of 5 or 6 amino acids with invariant anchor points and variability around 
these anchors. Hence, all peptides belonging to a cluster had at least one 
such motif. Three of these motifs were strongly represented, e.g. motif 
1 was found in 74 peptides, motif 2 in 39 peptides, and motif 3 in 37 
peptides. These peptides were found in a large variety of apparently non-
related OVOC proteins. For each of these three motifs, we have used at 
least four peptides for development of a peptide ELISA. Sensitivity and 
specificity for each peptide was determined using 21 plasma samples 
from Onchocerca-confirmed individuals (FR3 repository), and 187 control 
plasmas from non-Onchocerca endemic regions (healthy, and infections 
with HIV, HCV, Dengue, Brugia, Wuchereria and Loa). Within one cluster, 
the antibody reactivity against e.g. peptide 1 could be inhibited by adding 
e.g. peptide 2 (from a non-related gene) in solution in ELISA. Sensitivity 
range for peptides containing motif 1 was between 90.5 % and 100%; 
and specificity range was between 91.4 % and 94.1 % (results for motif 
2 and 3 are pending). The immune response against these peptides was 
mainly IgG1, IgG3, IgM and IgE. The key amino acids responsible for the 
immune recognition were determined by micro-array epitope scanning. 
Taken together, our data demonstrate that part of the humoral immune 
response induced by infection with O. volvulus is directed against a 
small number of highly abundant peptide motifs present in apparently 
structurally nor functionally related OVOC genes.
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THE EFFECT OF LITOMOSOIDES SIGMODONTIS INFECTION 
ON IGE-MEDIATED ANAPHYLAXIS IN SENSITIZED MICE
Laura E. Kropp, Edward Mitre
Uniformed Services University, Bethesda, MD, United States
IgE-mediated anaphylaxis is a life-threatening condition. Binding of 
IgE with its cognate antigen causes basophils and mast cells to rapidly 
release pre-formed inflammatory mediators. While numerous animal 
studies have reported that helminths can prevent allergic sensitization, 
only 4 studies have evaluated the effects of infection on pre-existing 
allergy. Since chronic helminth infection suppresses basophil and mast cell 
function, we hypothesized that chronic infection would protect against 
the clinical symptoms of anaphylaxis in previously sensitized mice. Mice 
were sensitized by weekly intraperitoneal (IP) injection of either ovalbumin 
(OVA)/alum or PBS/alum for 3 weeks. At 5 weeks, mice were infected 
with Litomosoides sigmodontis (L.s.), a rodent filarial parasite, or mock-
infected. Ten weeks post-infection, immunological and clinical parameters 
were measured before and after IP challenge with OVA. In sensitized mice, 
chronic L.s. infection resulted in serum levels of OVA-specific IgE that were 
an average of 50% lower than those observed for mock-infected mice 
(6,296 vs. 13,056 pg/mL, p-value- 0.1494). Chronic infection also caused a 
modest reduction in OVA-specific IgG2a levels. Following challenge, serum 
levels of murine mast cell protease 1 were significantly lower in sensitized 
mice that were L.s.-infected as compared to mock infected (86,276.81 vs. 
276,635.2 pg/mL, p- value= 0.0385). With respect to clinical symptoms, 
L.s.-infected mice that had been previously sensitized exhibited an average 
drop in core body temperature of 4.3 °C after 1 hour. Although less than 
the average 6.3°C drop observed in sensitized and mock-infected mice, 
the difference was not statistically significant. These results suggest that 
chronic helminth infection reduces allergen-specific IgE levels and allergen-
driven mast cell degranulation in previously sensitized animals.
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MIXTURE MODELING TO DETERMINE POPULATION-SPECIFIC 
CUTOFFS FOR IMMUNOLOGIC ASSAYS IN NEGLECTED 
TROPICAL DISEASE SETTINGS APPROACHING ELIMINATION
Sarah M. Sullivan1, Howard H. Chang1, Amanda Barry2, Patrick J. 
Lammie3, Melissa Torres4, Kimberly Y. Won2, Katherine Gass3
1Rollins School of Public Health, Emory University, Atlanta, GA, United 
States, 2Centers for Disease Control and Prevention, Atlanta, GA, United 
States, 3NTD Support Center, Task Force for Global Health, Decatur, GA, 
United States, 4Smith College, Northampton, MA, United States
As Neglected Tropical Disease (NTD) programs succeed and transmission 
intensity declines, the ability to discriminate between positive and negative 
antibody tests becomes increasingly challenging. Previous techniques for 
defining diagnostic test cutoffs are no longer sufficient as prevalence rates 
decline towards zero. With varying degrees of non-specific background 
reactivity across populations and the absence of a gold standard, an 
objective yet flexible approach for cutoff determination is needed. Mixture 
modeling allows for the probabilistic representation of subpopulations 
within an overall population. By fitting a mixture model to continuous 
data, members of the overall population can be assigned to groups (e.g., 
positive and negative), and the uncertainty of that classification can be 
calculated based on the associated conditional probabilities. These groups 
can be used to create an absolute cutoff and a pre-specified indeterminate 
range (e.g. greater than 5% uncertainty), resulting in positive, negative 
and indeterminate classifications. The number of groups may be specified 
in advance or optimized by an algorithm using model selection criteria, 
such as the Bayesian Information Criterion. We performed mixture 
modeling on standardized ELISA results from two post-treatment NTD 
settings. Antibody responses to a lymphatic filariasis recombinant antigen 
(Wb123) were analyzed via normal mixture modeling utilizing a two-group 
model which yielded a cutoff of 0.092 and an indeterminate range of 
(0.082, 0.100). This corresponded to 96.1% negative, 2.3% indeterminate 
and 1.5% positive results. The same methods were used to analyze 
responses to a recombinant onchocerciasis antigen (Ov-16), resulting in 
a cutoff of 0.63 (0.57, 0.68) with 96.7% negative, 1.5% indeterminate 
and 1.8% positive results. These results demonstrate the utility of mixture 
modeling as a tool to provide population-specific diagnostic cutoffs with 
a corresponding indeterminate group that reflects our certainty regarding 
the cutoff. Such an approach may benefit other neglected and infectious 
disease programs driving towards elimination.
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THE LIVE ATTENUATED CHIMERIC VACCINE RWN/DEN4Δ30 
IS WELL-TOLERATED AND IMMUNOGENIC IN HEALTHY 
FLAVIVIRUS-NAÏVE ADULT VOLUNTEERS 50-65 YEARS OF 
AGE
Kristen K. Pierce1, Anna P. Durbin2, T. Grier2, C. Tibery2, A. 
Janiak2, J. Lovchik2, A. Jarvis1, Marya Carmolli1, Heather Kenney3, 
Alexander Pletnev3, Steve S. Whitehead3, Beth D. Kirkpatrick1
1University of Vermont College of Medicine, Burlington, VT, United States, 
2Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United 
States, 3National Institutes of Health, Bethesda, MD, United States
West Nile Virus (WNV) is the leading vector-borne cause of 
meningoencephalitis in the U.S. Many infections are asymptomatic. Severe 
illness is most common in the elderly, including hepatitis and meningitis. 
Complications include: paralysis, coma, and death. The second largest 
outbreak of WNV in the U.S. occurred in 2012 (5,674 cases, including 
2,873 cases of severe neurologic disease, 286 deaths). The NIH candidate 
vaccine is a recombinant live attenuated (LA) WNV vaccine based on the 
chimerization of wild type WNV (NY99 genome) with the LA dengue virus 
serotype 4 vaccine rDEN4Δ30. Previous vaccine studies were conducted 
in healthy volunteers at 103, 104 and 105. Based on the safety and 
immunogenicity data of previous studies, a dose of 104 was chosen. A 
randomized placebo controlled phase I trial was performed. 28 healthy 
flavivirus-naïve volunteers aged 50-65 were enrolled and randomized 
to receive 104 PFU of rWN/DEN4Δ30 or placebo at 0 and 6 months. 
Neutralizing antibody (Nab) to WNV was measured at day 28, 56, 90, and 
180 following first vaccination and days 208, and 236 following second 
vaccination. Nab was measured to PRNT50 against WT WNV conducted in 
a BSL3 lab at LID. Seroconversion was defined as > 4 fold rise in Nab titer 
to the wild-type WNV parent virus at study day 90 post first vaccination 
compared with day 0. Following first dose, 3 subjects had detectable 
viremia with a maximum peak titer of 0.7log10 PFU/mL. No subject was 
viremic following second dose. 95% of vaccines seroconverted following 
first dose. The Geometric mean peak titer (GMT) at day 90 was 65.3, 
D180 was 27.63 and D360 was 34.52. Main AEs reported were similar in 
placebos: headache (25% vaccinees (V), 12.5% placebo (P)), Fatigue 10% 
(V), 37% (P), and nausea 25% (V), 12.5 (P). rWN/DEN4Δ30 was found 
to be well tolerated and immunogenic in adults aged 50-65. Vaccination 
induced a 95% seroconversion rate at day #90 after a single dose. As WN 
is more severe in patients over 50, these results underscore the potential 
use for rWN/DEN4Δ30 vaccine in this population, given the unpredictable 
and sporadic outbreaks of WNV.
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ACUTE AND DELAYED MORTALITY FOLLOWING WEST NILE 
VIRUS INFECTION IN TEXAS
David Philpott1, Melissa Garcia1, Nicole Evert2, Dawn Hesalroad2, 
Bonny Mayes2, Eric Fonken2, Kristy O. Murray1
1Baylor College of Medicine and Texas Children’s Hospital, Houston, TX, 
United States, 2Texas Department of State Health Services, Austin, TX, 
United States
West Nile virus (WNV) has a well characterized acute disease process; 
however, the long term survival and contributors of death at a population 
level are not well understood. In this study, we sought to investigate all-
cause and cause-specific mortality following WNV infection.Our study 
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population consisted of 4144 Texas residents who were infected with WNV 
from 2002-2012. Out of this population, we identified 554 deaths (13%). 
Our analysis focused on both acute deaths (n=286) occurring < 90 days 
after infection, and delayed deaths (n=268) occurring among those who 
survived the first 90 days. Standardized mortality ratios (SMRs) adjusted for 
age, sex, and calendar year were calculated according to ICD10 chapters. 
We found a substantial number of reported WNV cases died within the 
first 90 days of infection (286 out of 4144; 7%), primarily due to their 
WNV illness or an unspecified infectious origin. Delayed mortality occurred 
in 10% (210/2113) of initially surviving patients diagnosed with West Nile 
Neuroinvasive disease (WNND) and in 3% (58/1742) of those diagnosed 
with West Nile Fever (WNF). WNND cases experienced increased risk of 
delayed death due to infectious (SMR: 4.7, 95%CI: 3.2-6.9) and renal 
causes (2.6, 1.4-4.7). We also found increased risk for all-cause mortality 
in those who were under 60 years of age at the time of infection (SMR 
1.98, 95% CI: 1.5-2.6) but not among those over 60 years (0.99, 0.8-1.2). 
Cases under 60 years exhibited increased risk of delayed mortality due to 
renal (11.4, 4.7-27.3), infectious (5.3, 2.5-11.2), digestive (3.9, 1.9-8.1), 
and circulatory (2.0, 1.2-3.4) causes. We present the first population-level 
evidence of acute and delayed mortality among a considerable proportion 
of patients with a history of WNV infection. Our data provide further 
evidence to the literature supporting continued morbidity and mortality 
years after WNV infection.
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A SINGLE MUTATION IN THE ENVELOPE PROTEIN ALTERS 
FLAVIVIRUS ANTIGENICITY, STABILITY AND PATHOGENESIS
Leslie Goo1, Laura A. VanBlargan2, Kimberly A. Dowd1, Michael S. 
Diamond2, Ted C. Pierson1
1National Institutes of Health/National Institute of Allergy and Infectious 
Diseases, Bethesda, MD, United States, 2Washington University, St. Louis, 
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Flaviviruses include clinically significant pathogens such as West Nile 
(WNV), dengue (DENV), and Zika (ZIKV) viruses. Flaviviruses particles are 
covered with a dense array of three-domain (DI, DII, DIII) envelope (E) 
proteins, which are targeted by neutralizing antibodies following infection 
or vaccination. The structural flexibility or ‘breathing’ of flavivirus envelope 
(E) proteins allows virions to sample an ensemble of conformations at 
equilibrium. The molecular basis and functional consequences of virus 
conformational dynamics are poorly understood. By analyzing a large 
panel of WNV E variants, we identified mutations capable of changing the 
structural ensemble sampled by virions at equilibrium. Here, we describe 
the antigenic and biological consequences of a mutation at residue 198 
(T198F) of the E DI-DII hinge. T198F displayed increased sensitivity to 
neutralization a monoclonal antibody targeting a poorly exposed epitope 
in the DII fusion loop. Increased exposure of this cryptic epitope was 
accompanied by changes in virus stability; following prolonged incubation 
in solution at physiological temperatures, the T198F mutation resulted 
in a 3-fold reduction in the half-life of infectious WNV. Introduction of a 
mutation at the analogous residue of the dengue virus E protein similarly 
increased accessibility of the fusion loop epitope and decreased virus 
stability in solution, suggesting that this residue modulates the structural 
ensemble sampled by distinct flaviviruses at equilibrium. Despite resulting 
in a 3-fold reduction in the stability of WNV in solution, the T198F 
mutation did not substantially impair in vitro replication kinetics. However, 
in vivo studies in mice revealed that the T198F mutation attenuates lethal 
WNV infection in a B-cell dependent manner. Overall, our study provides 
insight into the molecular basis and the in vitro and in vivo consequences 
of flavivirus breathing that has the potential to inform the design of 
effective vaccines and therapeutic agents.
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AN OPTIMIZED SYNTHETIC TLR-4 AGONIST ADJUVANT 
FORMULATION INDUCES DURABLE AND FUNCTIONAL 
IMMUNITY WHEN COMBINED WITH A CLINICAL-STAGE 
RECOMBINANT WEST NILE VIRUS VACCINE ANTIGEN
Neal Scott Van Hoeven1, Brian J. Granger1, Tajanna Stinn1, 
Sharvari W. Joshi1, Ghislain I. Nana1, Christopher Fox1, Angela 
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Martyak3, D. Elliot Parks3, Scott Winram4, Susan L. Baldwin1, 
Steven G. Reed1, Rhea N. Coler1
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West Nile virus (WNV) is a mosquito-transmitted member of the 
Flaviviridae family that has emerged in the 21st century to become a 
public health threat. Given the sporadic nature of WNV epidemics both 
temporally and geographically, there is an urgent need for a vaccine that 
can rapidly provide effective immunity. Protection from WNV infection is 
correlated with antibodies to the viral envelope (E) protein, which encodes 
receptor binding and fusion functions. Despite many promising E-protein 
vaccine candidates, there are currently none licensed for use in humans. 
This study reports the optimization of a WNV vaccine candidate containing 
a clinical-stage WNV recombinant E-protein antigen (WN-80E) and a TLR-4 
agonist adjuvant containing a synthetic Lipid A TLR-4 agonist (SLA) and 
the saponin QS21 (SLA-LSQ). We have optimized adjuvant components for 
rapid induction of potent antiviral immunity in murine models, and find 
that both SLA and QS21 individually stimulate the production of multi-
functional Th1 CD4+ T-cells (IFNγ+/TNFα+/IL-2+), as well as an increase in 
the number of germinal center B-Cells (CD95+/GL7+) in a dose dependent 
manner. Consistent with induction of Th1 biased cellular immunity, the 
humoral response following adjuvanted immunization in mice is focused 
toward production of class-switched IgG2c antibodies, resulting in high 
levels of virus neutralization activity. Importantly, we observe significantly 
increased neutralizing titers in mice given formulations which contain both 
SLA and QS21 compared to either component alone. Using an optimized 
vaccine formulation, we demonstrate induction of durable immunity 
(300 days) following a single immunization in mice, and stimulation of 
functional protective immunity in a Syrian hamster challenge model of 
WNV disease. Taken together, these studies demonstrate the utility of SLA-
LSQ adjuvant formulations for induction of functional and durable West 
Nile Virus immunity.
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DIFFERENTIAL MECHANISMS OF WEST NILE VIRUS-INDUCED 
PATHOGENESIS IN BIRDS
Nisha Duggal1, Angela Bosco-Lauth2, Richard A. Bowen2, Aaron 
C. Brault1
1Centers for Disease Control and Prevention, Fort Collins, CO, United 
States, 2Colorado State University, Fort Collins, CO, United States
West Nile virus (WNV) is maintained in North America in an enzootic cycle 
between highly susceptible passerine birds and mosquitoes. However, 
the mortality rates and viremia profiles of birds in response to WNV 
infection vary dramatically between viral strains and avian species. For 
example, American crows (AMCRs) inoculated with the NY99 strain of 
WNV manifest high viremias with concomitantly high mortality rates. 
However, AMCRs inoculated with a strain of WNV containing a pro-to-thr 
mutation at amino acid 249 of NS3 (NS3-249T) exhibit significantly lower 
viremias and mortality rates. These viremia profiles are inversely correlated 
with interferon (IFN)-α expression. In contrast, we found that the viremia 
and mortality rate of the NS3-249T virus is higher than that of the WT 
NS3-249P virus in 2-day-old chicks. In order to better understand these 
viral- and host-specific differences in WNV replication, a chicken fibroblast 
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cell line was infected with NS3-249T or 249P viruses, with and without 
chicken IFN-α pre-treatment. While both viruses were sensitive to IFN-α 
treatment, the NS3-249T virus replicated to a higher titer, suggesting 
the increase in chick viremia in vivo may be due to increased intracellular 
replication, rather than a differential innate immune response. To identify 
the cell populations contributing to the replication of WNV in chicks, 2 
day-old chicks were inoculated with a WNV mutant restricted for leukocyte 
replication through the insertion of multiple leukocyte-specific miRNA 
target sequences into the 3’ UTR. Previous studies have shown that a 
leukocyte-restricted WNV mutant replicates poorly in AMCRs, suggesting 
leukocytes are important sites of replication. Unexpectedly, the leukocyte-
restricted virus exhibited increased viremia and mortality in chicks. This 
suggests that chick and AMCR leukocytes play very different roles during 
in vivo WNV infection as critical sites of viral replication or effectors of 
innate immune responses, respectively. Further studies of infected birds, 
including sequencing of the avian transcriptome, will help to define the 
avian innate immune response to WNV infection.
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THE EFFECT OF CO-INFECTION WITH DENGUE, 
CHIKUNGUNYA AND ZIKA VIRUS ON VECTOR COMPETENCE 
OF AEDES MOSQUITOES
Claudia Rückert, James Weger-Lucarelli, Joseph R. Fauver, Selene 
M. Garcia-Luna, Gregory D. Ebel
Arthropod-borne and Infectious Diseases Laboratory, Department of 
Microbiology, Immunology and Pathology, Colorado State University, Fort 
Collins, CO, United States
With the recent emergence of both Chikungunya virus (CHIKV) and Zika 
virus (ZIKV) in the Americas, there are now three arboviruses cocirculating 
in large areas of South and Central America that are all transmitted by 
Aedes mosquitoes: dengue virus (DENV), CHIKV and ZIKV. Clinical signs 
can be similar and while cases of coinfections have been reported to occur, 
the incidence rate of these is unknown and may be underestimated due to 
the lack of virus specific diagnostic tools. Coinfected viremic patients could 
expose feeding mosquitoes to multiple arboviruses. Interestingly, in 2015 
an increase in CHIKV infections coincided with a drop in dengue cases in 
Mexico and Colombia. While this could be due to yearly variation, it could 
also be related to the introduction of CHIKV which may be outcompeting 
DENV in mosquitoes. However, the impact of coinfection on the ability 
of relevant mosquitoes to transmit any of these viruses (i.e. their vector 
competence) has not been determined. Therefore, we determined the 
competence of Ae. aegypti (Poza Rica, Mexico) and Aedes albopictus 
(Florida) mosquitoes exposed to bloodmeals containing more than one 
Aedes-borne arbovirus. Specifically, mosquitoes were given a blood meal 
containing American strains of DENV-2, CHIKV or ZIKV in single infections, 
as well as combinations of the three viruses as double and triple infections. 
Mosquitoes were kept for 5, 7, 9 and 14 days extrinsic incubation, at 
which point mosquito bodies, legs and saliva were collected to determine 
infection, dissemination and transmission rates. Presence of viral RNA was 
determined by multiplex qRT-PCR for DENV-2, CHIKV and ZIKV in order 
to determine RNA levels for the individual viruses in mosquitoes exposed 
to more than one virus. Preliminary results suggest that coinfection may 
impact vector competence in a virus-specific manner.
609
THE INFLUENCE OF GENETIC BOTTLENECKS, RNA 
INTERFERENCE-MEDIATED DIVERSIFICATION AND SELECTIVE 
CONSTRAINT ON THE EVOLUTION OF A TICK-BORNE VIRUS
Nathan Grubaugh1, Claudia Ruckert1, Philip Armstrong2, Angela 
Bransfield2, John Anderson2, Gregory Ebel1, Doug E. Brackney2
1Colorado State University, Fort Collins, CO, United States, 2The 
Connecticut Agricultural Experiment Station, New Haven, CT, United States
Within hosts, flaviviruses exist as a heterogeneous population of closely 
related viral variants termed a mutant swarm. While considerable attention 
has been directed toward studying the population dynamics of mosquito-
borne flaviviruses, little is known about tick-borne flavivirus populations. 
This is disconcerting due the increased public health relevance of Powassan 
virus (POWV), the sole North American member of the tick-borne 
encephalitis complex. Therefore, we assessed the population complexity 
of POWV lineage II (deer tick virus; DTV) in both a vertebrate host and 
invertebrate vector and examined the influence of RNAi targeting on DTV 
populations. 11-week old mice were intra-peritoneally infected with DTV 
and subsequently fed upon by Ix. scapularis larvae and nymphs. Infected 
ticks were collected at each life stage through adulthood and RNA-Seq 
and sRNA libraries were prepared, sequenced and analyzed. We found 
that DTV populations were subject to a strong bottleneck once introduced 
into mice, but then rapidly diversified. Subsequently, the populations 
experienced another severe bottleneck during horizontal transmission 
to ticks. During transstadial transmission, however, diversification was 
constrained by strong purifying selection. Despite the relatively limited 
diversity observed in ticks, we found that RNAi targeting intensity was 
significantly positively correlated with the presence of intrahost single 
nucleotide variants (iSNVs); findings similar to what has previously been 
described for West Nile virus (WNV) in mosquitoes. While the overall DTV 
population dynamics greatly differ from those of WNV, these findings 
provide experimental evidence consistent with DTV ecology and support 
their slow long term evolutionary trends. Together, these data highlight 
that selective pressures incurred at a molecular level, such as RNAi, may be 
similar for most if not all arthropod-borne flaviviruses, but that differences 
in viral ecology can greatly influence the population dynamics of individual 
flavivirus members.
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MOSQUITO MIDGUT FREP1 IS A POTENTIAL UNIVERSAL 
MALARIA TRANSMISSION-BLOCKING VACCINE
Caio Martinelle França1, Guodong Niu1, Genwei Zhang1, 
Wanlapa Roobsoong2, Nguitragool Wang2, Xioahong Wang1, Jang 
Kim1, Jetsumon Prachumsri2, Noah Bulter3, Jun Li1
1University of Oklahoma, Norman, OK, United States, 2Mahidol University, 
Bangkok, Thailand, 3Oklahoma Health Sciences Center, Oklahoma City, 
OK, United States
Malaria remains a devastating disease. Transmission-blocking vaccines 
(TBVs) have been recently considered as a promising approach for the 
elimination and eradication of malaria. We recently discovered a mosquito 
midgut protein FREP1 that facilitates parasite transmission through direct 
binding to parasites and it is easily accessible to antibodies co-ingested 
with blood. Here, we demonstrated that anti-FREP1 antibodies blocked 
transmission of multiple Plasmodium species (Plasmodium berghei, 
Plasmodium vivax, and P. falciparum) to multiple Anopheles species 
(A. gambiae and A. dirus). Sequence comparison of FREP1 orthologs 
found that a fibrinogen-like (FBG) domain is highly conserved (>90% 
identity) among Anopheles species from different continents, while the 
sequence similarity between FBG and human fibrinogens is only about 
10%. Immunization of mice with purified recombinant FREP1 shows 
no significant difference of alanine aminotransferase activity between 
anti-FREP1 serum and the pre-immune serum. Moreover, the anti-FREP1 
serum did not show any cross-reactions with human fibrinogens. Thus, 
FREP1 is non-toxic or unlikely to cause autoimmune response in mammals. 
Notably, mice immunized with purified FBG effectively blocked P. berghei 
transmission (82.1% and 70.1% blockade) to An. gambiae in two 
independent bioassays respectively. Anti-FREP1 serum from the immunized 
mice also blocked over 90% infection of P. falciparum in standard 
membrane-feeding assays (SMFA). In summary, our data support that 
FREP1 is a promising universal TBV antigen to block the transmission of 
multiple Plasmodium species to multiple Anopheles species.
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SKIN SCARIFICATION WITH PLASMODIUM FALCIPARUM 
CS PEPTIDE VACCINES USING SYNTHETIC TLR AGONIST 
ADJUVANTS ELICITS CHEMOKINE/CYTOKINE PATTERNS 
THAT CORRELATE WITH INDUCTION OF SPOROZOITE 
NEUTRALIZING ANTIBODIES
Robert Mitchell, Roshawn Johnson, Rita Altszuler, Ute Frevert, 
Elizabeth Nardin
New York University School of Medicine, New York, NY, United States
Sterile immunity can be elicited by immunization with sporozoites, 
however, the production, storage and administration of whole parasite 
vaccines present numerous logistical hurdles. Vaccination by skin 
scarification (SS), as used for mass immunization during the Smallpox 
Eradication Programme, may more closely mimic the natural route of 
sporozoite inoculation by mosquito bite. We investigated SS immunization 
using synthetic peptides containing minimal T and B cell epitopes of 
Plasmodium falciparum CS protein combined with TLR agonists as 
adjuvants. In a murine model, SS immunization with CS peptide in 
the oil emulsion AddaVax containing TLR-7/8 and -9 agonists, but not 
AddaVax without TLR agonists, elicited high levels of systemic sporozoite 
neutralizing antibody, Th1- type CD4+ T cells and resistance to challenge 
by bites of mosquitoes infected with transgenic rodent parasites expressing 
P. falciparum CS repeats. Immunogenicity of SS delivered vaccine was 
demonstrated with either branched or linear peptide containing minimal 
T and B cell epitopes, indicating that induction of sporozoite neutralizing 
antibody was not dependent on antigen form. Standard serological assays 
for measuring the magnitude, fine specificity or affinity of anti-repeat 
antibodies were not predictive of the differences in levels of sporozoite 
neutralizing antibodies detected in functional assays based on transgenic 
parasites. To determine the immunological mechanisms relevant to the 
initiation of the enhanced levels of sporozoite neutralizing antibodies, we 
examined a panel of cytokines and chemokines elicited by SS using various 
TLR agonists alone and in combination. Cellular sources of these cytokines/
chemokines were examined by immunohistology and flow cytometry 
using fluorescent reporter cells including Langerhan cells and dendritic 
cells. Patterns of chemokines/cytokines were detected in serum at early 
time points that correlated with enhanced immunogenicity of SS delivered 
vaccines.
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HUMORAL IMMUNE RESPONSES TO AN ADJUVANTED 
SELF-ASSEMBLING PROTEIN NANOPARTICLE (SAPN) 
MALARIA VACCINE DISPLAYING THE NANP REPEAT AND 
αTSR REGIONS OF THE PLASMODIUM FALCIPARUM 
CIRCUMSPOROZOITE PROTEIN
Stephen A. Kaba1, Labdhi Seth1, Karen Bingham1, Casey Storme1, 
Amanda Wessal1, Yuwei Zhu1, Andrew K. Collin1, Zoltan Beck1, 
Gary R. Matyas1, Carl R. Alving1, Peter Burkhard2, David E. Lanar1
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2Alpha-O Peptides AG, Riehen, Switzerland
The Circumsporozoite Protein (CSP) is the predominant protein on the 
surface of the sporozoite and the most thoroughly studied pre-erythrocytic 
vaccine candidate. It is composed of an N-terminal domain, a conserved 
pentapeptide protease cleavage site termed region I, a tetra peptide 
NANP repeat region, a short conserved sequence termed region III, and 
a C-terminal region with sequence homology to the thrombospondin 
type-1 repeat superfamily (TSR). We have previously reported that a self-
assembling protein nanoparticle, PfCSP-KMY-SAPN, presenting NANP 
repeats and three human HLA epitopes of the CSP induced very strong 
protective immune responses in mice. However, when tested in NHP, 
immune responses were low even when an adjuvant was used. To improve 
the vaccine induced immune response we have produced FMP014, a SAPN 
displaying NANP repeats and the entire αTSR domain of CSP. The αTSR in 
the SAPN uses two Cys-Cys disulfide bonds to stabilize the hydrophobic 
pocket and core link found in the native protein. Here we report the 
analysis of the humoral immune responses of C57Bl/6 mice to FMP014 
combined with three different Army Liposomal Formulations containing 
monophosphoryl lipid A with or without QS-21, and Alhydrogel® 
(ALFA, ALFQ and ALFQA). Intramuscular injection of C57Bl/6 mice with 
each FMP014/ALF formulation induced high titer anti-NANP repeat, 
anti-αTSR domain, and cytophilic IgG2b antibodies with high avidity. 
However, FMP014 adjuvanted with ALF containing QS-21 (ALFQ) induced 
significantly higher anti-CSP specific antibodies to the NANP repeats and 
the αTSR domain compared to those without QS-21. Antibodies to both 
the NANP repeat region and the αTSR domain conferred protection to 
mice against challenge from an otherwise lethal dose of a transgenic P. 
berghei parasite expressing the full-length Plasmodium falciparum CSP.
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IMMUNOMECHANISM OF PROTECTION FOR E140, A PRE-
ERYTHROCYTIC VACCINE CANDIDATE
Emily Smith1, Keith Limbach1, Nonenipha Rangel2, Arnel 
Belmonte1, Kyosuke Oda3, Andrea Renner2, Sharvari Sonawane1, 
Kalpana Gowda3, Jessica Bolton1, Rebecca Danner1, Martha 
Sedegah3, Noelle Patterson1, Eileen Villasante3, Joao Aguiar2
1Henry M. Jackson Foundation, Rockville, MD, United States, 2Camris 
International, Bethesda, MD, United States, 3Naval Medical Research 
Center, Silver Spring, MD, United States
A malaria vaccine to prevent infection is greatly needed and essential for a 
comprehensive malaria eradication program. Pre-erythrocytic (PE) antigens 
are capable of inducing an immune response resulting in sterile protection, 
as shown by the RTS,S vaccine. Plasmodium falciparum PE antigens are 
also targeted by efficacious whole sporozoite vaccines and could be the 
basis of a subunit vaccine. We have identified a single PE P. yoelii antigen 
(E140) capable of sterilely protecting CD1 mice in the range of 71% to 
100%, alone and in combination with other antigens, respectively. Initial 
examination of E140-specific immune responses showed significant CD4+ 
and CD8+ T cell responses upon DNA-prime/Ad5-boost immunization. We 
also observed an antibody response that statistically correlated with sterile 
protection. We have further characterized the T cell responses to E140 
immunization evaluating the function of CD4+ and CD8+ T cells, including 
IFN-gamma, TNF, IL-2, and MIP1alpha. In vivo T cell depletion experiments 
in mice are being conducted to ascertain the requirement of these cell 
types for protection. We are also conducting concomitant antibody 
transfer studies in mice to establish the role of anti-E140 antibodies to 
protection. These promising data are evidence of the potential of E140 
and support further development of the P. falciparum E140 ortholog in a 
subunit malaria vaccine.
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DEVELOPMENT OF A SEMI-SYNTHETIC WHOLE PARASITE 
VACCINE
Michael F. Good1, Ashwin Kumar Giddam2, Jennifer M. Reiman1, 
Mehfuz Zaman1, Mariusz Skwarczynski2, Istvan Toth2
1Institute for Glycomics, Gold Coast, Australia, 2School of Chemistry and 
Molecular Biosciences, Brisbane, Australia
We are developing whole parasite vaccines to protect against the blood 
stages of malaria and showed that chemically attenuated vaccines 
can protect against rodent malaria parasites. This approach is being 
translated to the clinic. However, issues relating to production, storage 
and delivery present obstacles that impede development of this vaccine 
and other whole parasite approaches. We are therefore developing a 
synthetic vaccine delivery system in which killed blood stage parasites are 
encapsulated within liposomes that are targeted to dendritic cells using 
mannosylated lipid core peptides (MLCPs). MLCP-liposomes were taken-up 
efficiently by antigen presenting cells which then upregulated expression 
of MHC-ll and co-stimulatory molecules, CD80 and CD86. Immunization 
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of mice with MLCP-liposome vaccine formulations, without adjuvant, 
generated enhanced levels of activated T cells in peripheral blood and 
vaccinated mice were completely protected from challenge infection with 
different species of rodent malaria. Liposome formulations are highly 
promising delivery systems for a human malaria vaccine.
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CORD BLOOD ANTI-PFSEA-1 AND PROTECTION FROM 
SEVERE MALARIA IN INFANTS
Jennifer F. Friedman1, Ian Michelow1, Sangshin Park1, Dipak K. 
Raj1, Christina E. Nixon1, Emily A. McDonald1, Christian P. Nixon1, 
Sunthorn Pond-Tor1, Ambris Jha1, Edward Kabyemela2, Michal 
Fried3, Patrick E. Duffy3, Jonathan D. Kurtis1
1CIHR, Brown University, Providence, RI, United States, 2Muhimbili 
University of Health and Allied Sciences, Dar es Salaam, United Republic of 
Tanzania, 3National Institutes of Health, Bethesda, MD, United States
Plasmodium falciparum malaria is a leading cause of morbidity and 
mortality in developing countries, infecting hundreds of millions of 
individuals and killing up to one million children in sub-Saharan Africa 
each year 1,2. In holoendemic areas, children suffer the most from 
malaria, particularly after six months of age. Both the relative resistance 
to infection and severe malarial disease (SM) expressed by neonates and 
young infants, as well as the hypothesis that this resistance is mediated by 
maternally derived IgG has been recognized for decades 3-5. Despite these 
early observations, the targets of protective, maternally derived cord blood 
antibodies remain elusive. Recently, we demonstrated that antibodies to Pf 
Schizont Egress Antigen-1 (PfSEA-1) predict decreased risk of SM in 1.5-4 
yr olds living in a holoendemic area of Tanzania 6. Here we demonstrate, 
in the same cohort, that maternally derived anti-PfSEA-1 antibodies cross 
the placenta, are detectable in cord blood, and cord blood levels of these 
antibodies predict significantly decreased risk of SM in infants for up to 
12 months after birth. Further, in maternal vaccination studies in mice, 
pups born to dams that were immunized with PbSEA-1 prior to pregnancy 
had significantly lower parasitemia and longer survival times following 
lethal P. berghei ANKA challenge compared to pups born to dams treated 
with adjuvant alone. Together, these results identify, for the first time, a 
parasite specific target of maternal antibodies that transfer to the fetus 
and are associated with protection from SM and suggest that vaccination 
of pregnant women with PfSEA-1 may afford a survival advantage to their 
offspring.
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IMMUNOGENICITY OF CHAD63/MVA ME-TRAP 
MALARIA VECTORED VACCINE IS NOT AFFECTED BY CO-
ADMINISTRATION WITH ROUTINE EPI VACCINES IN A 
RANDOMIZED CONTROLLED TRIAL IN GAMBIAN INFANTS 
AND NEONATES
Sophie Roetynck1, Victorine Mensah2, Ebrima Kanteh1, Georgina 
Bowyer3, Amy Ndaw2, Francis Oko1, Carly Bliss3, Riccardo Cortese4, 
Alfredo Nicosia4, Rachel Roberts3, Flavia D’Alessio5, Odile Leroy5, 
Babacar Faye2, Beate Kampmann1, Badara Cisse2, Kalifa Bojang6, 
Stephen Gerry7, Nicola Viebig5, Alison Lawrie3, Ed Clarke1, Egeruan 
Imoukhuede3, Katie Ewer3, Adrian Hill3, Muhammed Afolabi1
1Medical Research Council Unit, Fajara, Gambia, 2Universite Cheikh Anta 
Diop, Dakar, Senegal, 3The Jenner Institute, University of Oxford, Oxford, 
United Kingdom, 4Reithera, Rome, Italy, 5European Vaccine Initiative, 
Heidelberg, Germany, 6Medical Research Council Unit, F, Gambia, 7Centre 
for Statistics, University of Oxford, Oxford, United Kingdom
Recent global estimates show that Plasmodium falciparum malaria remains 
a major public health concern. An effective vaccine could complement 
existing control measures. Heterologous prime-boost vaccinations using 
chimpanzee adenovirus 63 (ChAd63) and modified vaccinia Ankara 
(MVA) encoding ME-TRAP have consistently shown acceptable safety, 
excellent immunogenicity and substantial efficacy in African adult and 
paediatric populations. If licensed, this vaccine will be given to infants, 
who receive routine childhood immunizations. Here, we evaluate the 
immunogenicity and possible interference of ChAd63/MVA ME-TRAP 
when co-administered with routine Expanded Programme Immunization 
(EPI) vaccines in young infants. We enrolled 65 Gambian infants and 
neonates into 3 groups aged either 16, 8 or 1 week old at first vaccination 
and randomized them to receive either ME-TRAP vaccine or control. All 
participants received EPI vaccines according to the national programme. 
Safety was assessed by the description of vaccines-related adverse events 
including clinical assessments, biochemical and haematological tests. 
Immunogenicity was evaluated using anti-TRAP IgG ELISA, interferon-
gamma ELISPOT and flow cytometry. Serology was performed to confirm 
all infants achieved protective titres to EPI vaccines. The vaccines were 
well tolerated in all age groups with no vaccine-related serious adverse 
events. High-level TRAP specific IgG and T cell responses were generated 
after boosting with MVA. Particularly, CD8+ T cell responses, previously 
found to correlate with protection, were induced in all groups. Antibody 
responses to EPI vaccines remained at protective levels. While difficult 
to induce in neonates with protein or polysaccharide vaccines, potent 
humoral and cellular immunity were generated by heterologous prime-
boost immunization with ChAd63/MVA ME-TRAP in young infants and 
neonates. Co-administration of routine EPI vaccines did not interfere 
with these responses. The EPI vaccines also retained protective antibody 
titres following administration of the malaria vaccines, supporting further 
evaluation of this regimen in infants.
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FIVE-YEAR OUTCOMES OF A RANDOMIZED TRIAL 
OF SCHOOL VS. COMMUNITY-BASED MASS DRUG 
ADMINISTRATION FOR SCHISTOSOMA MANSONI CONTROL 
IN WESTERN KENYA
Pauline N. Mwinzi1, Susan P. Montgomery2, Ryan E. Wiegand2, 
Kennedy Andiego1, Martin Omedo1, Geoffrey Muchiri1, Michael O. 
Ogutu1, Fredrick Rawago1, Maurice R. Odiere1, Diana M. Karanja1, 
W. Evan Secor2
1Kenya Medical Research Institute, Kisumu, Kenya, 2Centers for Disease 
Control and Prevention, Atlanta, GA, United States
Current WHO mass drug administration (MDA) recommendations for 
schistosomiasis control are based on prevalence in school aged children. 
At the time they were developed, the guidelines were contingent upon 
two hypotheses: 9-12 year old children are a reliable indicator of the 
overall level of infection in the population, and once annual MDA will 
be sufficient to reduce infection levels. Further, the guidelines were 
originally developed for morbidity control and may no longer be adequate 
for the WHA 54.19 and 65.21 resolution targets which now includes 
elimination of schistosomiasis. We conducted a large trial involving 150 
communities in western Kenya as part of the Schistosomiasis Consortium 
for Operational Research and Evaluation (SCORE) to compare different 
MDA distribution approaches and frequency of delivery on Schistosoma 
mansoni infection prevalence and intensity. For 4 years, community wide 
(CWT) or school based treatment (SBT) was provided annually, every 
other year or only the first 2 years to 25 randomly assigned communities 
in each of 6 study arms. In the fifth year, communities in all arms were 
evaluated. At the end of the 5 years, communities that had received a 
total of 4 treatments had lower prevalence (P = 0.0041) and intensity (p = 
0.0024) than those that had received 2 treatments. However, calculating 
impact relative to cost suggests that even though 2 treatments reduced 
prevalence less than 4 treatments, the 2 treatment approach may be 
more cost effective. We evaluated first year pupils in years 1, 3 and 5 as 
a proxy measure of the force of transmission and showed that both CWT 
and SBT approaches appeared to impact community transmission levels. 
Despite the general reduction in prevalence and intensities of S. mansoni 
infections, 44% of the 50 communities that received annual treatment, 
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either by CWT or SBT, had < 20% change in prevalence over the five year 
period, indicating that MDA alone may not be sufficient to achieve control 
or elimination.
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FEMALE GENITAL SCHISTOSOMIASIS IN ABEOKUTA, NIGERIA
Uwemedimo F. Ekpo1, Oluwatosin M. Opeyemi1, Sammy O. 
Sam-Wobo1, Hammed Mogaji1, Hameedat O. Abdussalam2, 
Akinola S. Oluwole1
1Federal University of Agriculture Abeokuta, Abeokuta, Nigeria, 2Federal 
Medical Centre Abeokuta, Abeokuta, Nigeria
Female Genital Schistosomiasis (FGS) is an emerging public health problem 
for young girls and women of childbearing age living in urogenital 
schistosomiasis endemic areas. The disease is associated with vaginal 
itching and discharge, post-coital bleeding, genitopelvic discomfort, 
marital discord, infertility, preterm labour, anaemia, menstrual disorders, 
and painful sexual intercourse. Over 44 million women living in sub-
Saharan Africa (SSA) are currently affected by FGS. However, this disease 
has received little or no attention in Nigeria, which is the most endemic 
country in sub-Saharan Africa. A study was conducted in four Schistosoma 
haematobium endemic communities of Abule-titun, Imala-Odo, Apojola 
and Ibaro in Abeokuta to investigate the occurrence of FGS and its 
associated risk factors in young girls and women of childbearing age (age 
range 5-49 years). A total of 317 females were examined, of which 150 
(47.3%) of them had haematuria (blood in urine), and 149 (47.0%) had 
pre-patent ova of Schistosoma haematobium in their urine respectively. 
There was significantly (p <0.05) higher prevalence (121, 64.7%) and 
intensity of infection (1.0659±0.1251) in younger girls (aged 5-15 years) 
than their older counterparts. Using the standardised virgina discharge 
colour chart, 4(1.3%) cases of FGS were identified. Full gynaecological 
examination of 20 participants confirmed 14 (70.0%) cases of FGS. 
Gynaecological abnormalities included 10 (71.4%) of the females with 
grainy-sandy patches, 6 (42.9%) with yellow sandy patches, 1 (7.1%) with 
nabothian cysts and rubbery papules in their vaginal and cervical wall. 
Bathing (92.7%), fetching (52.4%), fishing (93.4%) and washing clothes 
(96.5%) at the local dam were reported risk factors associated with S. 
haematobium infection. This study has confirmed that the presence of 
FGS in Abeokuta, Nigeria. Its impacts and implications on the reproductive 
health of young girls and women of childbearing age living in urogenital 
schistosomiasis endemic communities are yet to be documented.
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PROGRESS TOWARDS SCHISTOSOMIASIS CONTROL AND 
ELIMINATION FROM 2004 TO 2015 IN 28 HEALTH DISTRICTS 
IN MALI
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Publique, Bamako, Mali, 2Helen Keller International, Bamako, Mali, 
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Bamako, Mali, 4Helen Keller International, New York, NY, United States, 
5Helen Keller International, Regional Office for Africa, Dakar, Senegal
Mali has implemented the national schistosomiasis control program since 
2005, supported initially by Schistosomiasis Control Initiative and then by 
Helen Keller International with funding from the USAID’s NTD projects 
managed by RTI International. The main activities include mass drug 
administration (MDA) and impact evaluations. During 2014-15, 28 health 
districts (HDs) in Segou, Sikasso, Kayes, Mopti and Koulikoro regions were 
evaluated. Two or three sites in each HD with 50-60 school-age children 
at each site, for a total of 59 sentinel sites and 3575 children assessed. All 
HDs had received six or seven rounds of MDA, except two untreated. The 
aim of the studies was to evaluate the current status of schistosomiasis 
and adjust the MDA strategies in each district. The data from 2014-15 
were compared to data from the baseline in 2004-05 to understand how 
prevalence has decreased over time. At baseline, the median prevalence of 
infection was 49.7% (range 0.29% to 98.5%) and the median prevalence 
of heavy infection was 12.6 % (0.3% to 78.9%). During the 2014-15 
evaluation, the median prevalence of infection was 13.2% (range 0.6% 
to 83.6%) and the median prevalence of heavy infection was 3.4% 
(range 0.03% to 25.8%). Thus the median prevalence decreased greatly 
following the rounds of MDA. As a result ten out of 28 HDs (35.7%) will 
change their MDA cycle and targets for 2017. Eight out of 28 (28.6%) 
have achieved schistosomiasis morbidity control, meaning less than 5% 
of heavy infections in the sentinel population and another eight (28.6%) 
HDs had achieved the criteria for schistosomiasis elimination, meaning less 
than 1% of heavy infections in sentinel populations. To move towards the 
control and elimination goals, additional activities have been identified: 
snail control, sanitation improvements of river banks and health education. 
Despite the success, some questions remain, for example, understanding 
the reasons for persistence of elevated prevalence in three HDs. The 
evaluation provided an opportunity for the national program to accelerate 
progress towards elimination and/or control in districts with differing 
epidemiological profiles.
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COMMUNITY DIALOGUES FOR PREVENTION AND CONTROL 
OF SCHISTOSOMIASIS IN MOZQAMBIQUE
Christian Rassi1, Sandrine Martin2, Kirstie Graham1, Ana Cristina 
Castel-Branco2, Ercílio Jive3
1Malaria Consortium, London, United Kingdom, 2Malaria Consortium, 
Maputo, Mozambique, 3Direcção Provincial de Saúde, Nampula, 
Mozambique
A prerequisite for successful schistosomiasis prevention and control is 
that affected communities have an understanding of the disease. Malaria 
Consortium conducted a study in four districts of Nampula province 
to explore whether the community dialogues approach is effective in 
improving schistosomiasis prevention and control at community level. The 
approach prompts communities to select volunteers who subsequently 
receive training and conduct regular dialogues. This allows communities 
to explore how they are affected, identify locally relevant solutions and 
plan for taking communal action. For this study, 157 volunteers were 
trained and equipped with a visual toolkit. Two six-month cycles of 
community dialogues were conducted. The study used a mixed-methods 
design: i) representative household surveys of knowledge, attitudes and 
practices (KAP) at baseline (n=791) and endline (n=795), ii) 25 focus 
group discussions with volunteers and community members and four in-
depth interviews with district health officials, iii) analysis of monitoring 
and evaluation forms (n=1,462) and observation reports (n=11), and 
iv) analysis of stories of change written up by community dialogue 
participants (n=51). At baseline, correct knowledge of how schistosomiasis 
is transmitted or prevented was low. KAP indicators improved over the 
lifetime of the project. At baseline 18% could name at least one risk 
behaviour correctly. At endline, this had increased to 30%. Community 
participation also increased; for example, several communities initiated the 
construction of latrines. Volunteers appreciated being agents of change 
within their own communities. Participation levels were high, with an 
average of 70 participants per dialogue. The approach was particularly 
well received by women. Efforts to maximise prevention and control 
of schistosomiasis need to take community perceptions into account. 
Community dialogues are an effective tool to improve KAP and to increase 
community ownership of health issues. The approach has potential 
applicability in other health areas requiring communal behaviour change in 
resource-poor settings.
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EXPERIENCES WITH A URINE-BASED RAPID DIAGNOSTIC 
TEST FÜR SCHISTOSOMA MANSONI INFECTION IN 
MIGRANTS
Sören L. Becker1, Mathias Herrmann1, Jürg Utzinger2
1Institute of Medical Microbiology and Hygiene, Saarland University, 
Homburg, Germany, 2Swiss Tropical and Public Health Institute, Basel, 
Switzerland
Schistosomiasis affects more than 250 million people, mainly in 
sub-Saharan Africa. Intestinal schistosomiasis is primarily caused by 
Schistosoma mansoni. Morbidity in chronically infected individuals can 
be subtle, but severe long-term consequences may arise (e.g. hepatic 
fibrosis). While the diagnosis of intestinal schistosomiasis relies on stool 
microscopy, it is important to note that low-intensity infections are easily 
missed. Here, we present experiences with a new point-of-care (POC) test 
that detects a schistosome-specific circulating cathodic antigen (CCA) in 
the urine of infected individuals. Since March 2015, individuals presenting 
to the University Medical Center in Homburg, Germany were tested for 
schistosomiasis upon specific infectious disease consultation. If the patients 
had lived in an endemic area and signs and symptoms were compatible 
with a parasitic infection (e.g. abdominal pain, eosinophilia), a urine 
sample was subjected to a POC-CCA test and stool and urine microscopy 
for parasites were performed. Patients with confirmed schistosomiasis 
were treated with praziquantel. Within 12 months, eight patients with 
a positive POC-CCA urine test have been identified. Upon further 
investigation, S. mansoni eggs were detected by stool microscopy in six 
of these patients. Of note, examination of a single stool sample failed 
to detect the infection in four patients. All individuals with confirmed 
schistosomiasis were migrants from Eritrea (age range: 16-34 years). 
Peripheral blood eosinophilia was present in three patients and ranged 
between 6% and 34%. Follow-up samples were obtained from three 
patients and gave a negative result on the POC-CCA test within 7-10 days 
after treatment. Our findings suggest that a POC-CCA urine cassette test is 
highly sensitive for detection of intestinal schistosomiasis in migrants from 
endemic areas. The high rates of migration into Europe and elsewhere 
will likely lead to an increase of imported schistosomiasis cases. Hence, a 
wider implementation of POC-CCA tests in hospitals will contribute to an 
improved diagnosis and management of otherwise undetected S. mansoni 
infections.
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ASSOCIATION OF SCHISTOSOMIASIS WITH IMPAIRED 
FERTILITY IN EAST AFRICA
Patricia A. Woodall
Emory University, Atlanta, GA, United States
Many case reports and pathology series have suggested associations 
of Female Genital Schistosomiasis of the Fallopian tubes with infertility 
and ectopic pregnancy. Geographic distribution of infertility (which in 
Africa is most commonly due to tubal disease) has been reported but not 
explained. In this cross-sectional study, interpolated prevalence maps for 
Schistosoma haematobium and S. mansoni in East Africa were created 
using data from two open-access Neglected Tropical Diseases databases. 
Prevalence was extracted to georeferenced survey sample points for 
Demographic and Health Surveys for Ethiopia, Kenya, Tanzania and 
Uganda for 2009-2011 and 1999-2001. Outcomes included primary 
and secondary infertility (no births) and infecundity (no pregnancies) 
and history of pregnancy loss. Exploratory spatial analyses of outcomes 
(Moran’s I, univariate and bivariate Local Indices of Spatial Autocorrelation) 
showed that outcomes were not spatially random and mapped clustering, 
hotspots, and areas of co-location of outcomes and exposures. Weighted 
multilevel logistic regression analysis found that women living in high 
compared to absent S. haematobium locations had significantly higher 
odds of secondary infertility (1999-2001: OR 1.8 [CI95 1.4, 2.3]; 2009-
2011: OR 1.23 [1.1, 1.5]) and of primary infertility (1999-2001: OR 1.8 
[1.3, 2.7]; 2001-2011: OR 1.58 [1.1, 2.3]). Living in high compared to 
absent S. mansoni locations did not affect the odds of any outcome. 
Women living in high S. haematobium compared to high S. mansoni 
locations had significantly higher odds of secondary infertility (1999-2001: 
OR 1.7 [1.3, 2.3]; 2009-2011: OR 1.6 [1.1, 2.0]), and of primary infertility 
(2010: OR 2.7 [1.5, 4.9]). For 1999-2001, history of pregnancy loss was 
significantly associated with high compared to absent S. haematobium 
(OR 1.3 [1.1, 1.6]) and with high S. haematobium compared to high S. 
mansoni (OR 1.4 [1.0, 1.8]). There is increasing evidence of the clinical and 
public health consequences of schistosomiasis to women’s health and the 
importance of inclusion of girls and women in control strategies.
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REDUCED EFFICACY OF PRAZIQUANTEL AGAINST 
SCHISTOSOMA MANSONI IS ASSOCIATED WITH 
MULTIPLE-ROUNDS OF MASS DRUG ADMINISTRATION: 
EPIDEMIOLOGICAL AND GENOMIC DATA FROM UGANDA
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Mass drug administration (MDA) with praziquantel is the cornerstone of 
schistosomiasis control in sub-Saharan Africa. The effectiveness of this 
strategy is dependent on the continued high efficacy of praziquantel, 
however drug efficacy is rarely monitored using appropriate statistical or 
genomic approaches that can detect early signs of wane. We conducted 
a repeated cross-sectional study, examining children infected with 
Schistosoma mansoni from 6 schools in Uganda that had previously 
received between 1 and 9 rounds of MDA with praziquantel. We collected 
up to 12 S. mansoni egg counts from 414 children aged 6-12 before and 
25-27 days after treatment with praziquantel. We estimated individual 
patient egg reduction rates (ERRs) using a statistical model to explore the 
influence of covariates, including the number of prior MDA rounds. In 
addition we sequenced whole-genomes of S. mansoni parasites before 
and after treatment. The average ERR among children within schools 
that had received 8 or 9 previous rounds of MDA (95% Bayesian credible 
interval (BCI) 88.23%, 93.64%) was statistically significantly lower than 
the average in schools that had received 5 (95% BCI 96.13%, 99.08%) or 
1 (95% BCI 95.51%, 98.96%) round of MDA. We estimate that 5.11%, 
4.55% and 16.42% of children from schools that had received 1, 5, 
and 8/9 rounds of MDA respectively had ERRs below the 90% threshold 
of optimal praziquantel efficacy set by the World Health Organization. 
The genomic population structure of parasites collected before and 
after treatment were compared to elucidate targets of selection against 
praziquantel. The reduced efficacy of praziquantel in schools with a higher 
exposure to MDA may pose a threat to the effectiveness of schistosomiasis 
control programs. We call for the efficacy of anthelmintic drugs used in 
MDA to be closely monitored.
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THE PREMONITION TRAP: LABORATORY TRIALS OF A 
ROBOTIC SMART TRAP FOR MOSQUITOES WITH SPECIES 
AND SEX RECOGNITION
Douglas E. Norris1, Anandasankar Ray2, Tom Guda2, Eamonn 
Keogh3, Shailendra Singh3, Yan Zhu3, Alex Ching4, Patrick Therien4, 
Ethan K. Jackson4
1John Hopkins Bloomberg School of Public Health, Baltimore, MD, United 
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Riverside, CA, United States, 3Department of Computer Science, University 
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Redmond, WA, United States
Using traps for surveillance of vector and pathogen populations is an 
important component of many vector management programs, but 
this technology has remained largely unchanged over many years. It is 
inaccessible in developing countries and limited in developed countries, 
largely due to costs and personnel requirements. Project PREMONITION is 
developing a robotic “smart” mosquito trap that captures live mosquitoes 
individually for higher-throughput lower-cost pathogen surveillance and 
elucidation of host associations. The PREMONITION trap uses infrared 
sensors and algorithms to identify flying insects by wing beat frequency, 
capturing only target mosquito species and reducing non-targeted 
captures. In addition to recording putative species identification, additional 
parameters including precise time of capture, temperature, humidity 
and ambient light, are recorded, effectively providing foraging activity 
data throughout the collection period and association with key abiotic 
factors. Due to a unique design, each specimen is tagged with the data it 
produced, enabling new bioinformatic analyses. Greenhouse trials of the 
PREMONITION trap with Aedes aegypti and Culex quinquefasciatus and 
different bait regimes including CO2, skin odor and UV light evaluated the 
ability to trap mosquitoes, test behavioral activity throughout the collection 
period and differentiate between these taxa. Field testing will further 
evaluate the PREMONITION trap under native environmental conditions 
and exposure to a myriad of flying arthropods.
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REFINING ESTIMATES OF DENGUE VIRUS TRANSMISSION 
POTENTIAL IN WILD TYPE AND WMEL-INFECTED AEDES 
AEGYPTI: FIELD REARING CONDITIONS ALTER VIRUS 
SUSCEPTIBILITY
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T. Duong1, Long T. Pham3, Hung Q. Luu3, Le H. Nguyen2, Bridget 
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Vietnam, 4University of Melbourne, Melbourne, Australia
Wolbachia- (wMel) infected Aedes aegypti have been released at field 
sites in Australia, Southeast Asia and now South America, with the 
intention of curbing dengue virus (DENV) transmission using wMel’s virus 
inhibition phenotype. Under optimal rearing conditions in the laboratory, 
wMel induces reliable protection against DENV. However, mosquitoes 
reared in the field are subject to changeable conditions (eg: exposure 
to pathogens, fluctuating temperatures, variable nutrition/rearing 
densities), and such factors may alter wMel-induced blocking of DENV 
infection. We aimed to quantify the effect of field and laboratory rearing 
conditions on DENV susceptibility of wild type (WT) and wMel-infected 
Ae. aegypti, and to examine how this might influence virus transmission 
dynamics. Our approach utilised weekly deliveries of both WT and wMel 
mosquitoes collected directly from our Vietnamese field site. ‘Lab-reared’ 
eggs were hatched and reared under standard laboratory conditions. 
‘Field-reared’ 4th instar larvae and pupae completed only the final stages 
of development (without added nutrition) in the laboratory. All adults 
were fed in parallel with the blood of 33 NS1-positive dengue patients 
admitted to the Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam. 
As expected wMel mosquitoes were less susceptible to DENV than WT 
females. At the level of abdomen infection, logistic regression subgroup 
analysis showed that field rearing increased virus susceptibility in WT 
females, but did not affect wMel females. For virus transmission, WT 
field females more frequently transmitted virus in their saliva compared 
to lab-reared counterparts, suggesting lab experiments underestimate 
WT transmission potential in the field. The opposite held true for wMel 
females; wMel field females were less susceptible to DENV transmission 
than those reared in the lab, suggesting previous lab estimates of wMel-
induced virus protection are conservative.
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ESTIMATING HUMAN/MOSQUITO CONTACT AND RISK OF 
EXOTIC ARBOVIRUS TRANSMISSION FROM EGGS COUNTS IN 
OVITRAP: A CASE STUDY FOR AEDES ALBOPICTUS IN ROME 
(ITALY)
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1University of Rome SAPIENZA, Rome, Italy, 2Fondazione Edmund Mach, 
San Michele all’Adige, Italy
Aedes albopictus public health relevance is not only associated to its 
aggressive daytime biting behaviour, but also to its capacity to transmit 
arboviruses, such as Chikungunya (CHIKV), Dengue and Zika. The Zika 
epidemics occurred in 2015-16 in Latin America, in addition to the large 
number of Dengue cases/year worldwide, increases the possibility of virus 
importation to non-endemic countries where the species has now become 
a permanent pest. The likelihood of vector-borne disease transmission 
and spread is commonly estimated by assessing R0, i.e. the number of 
secondary infection arising from a primary case. However, R0-models 
heavily rely on the accuracy of estimates of relevant biological parameters 
for Ae. albopictus which may be very difficult to be determined and 
universally applied. We here exploited the most easily obtainable field 
data on Ae. albopictus density and dynamics (i.e. egg counts in ovitraps) 
to estimate one of the key epidemiological parameters for risk model (i.e. 
human/mosquito contact). Based on results from extensive field activities 
carried out in summer 2014 in two sites in Rome - one of the most heavily 
Ae. albopictus infested urban areas in Europe - we found a positive 
relationship between counts of eggs in ovitraps (N=25120) and host-
seeking females collected by Human Landing Catches (HLC; N=5578). The 
estimated linear regression coefficient for the mean number of eggs/site/
day was 0.21, meaning that an increase of 10 in the mean number of eggs 
in ovitraps corresponded to an increase of 2 in the mean number of daily 
host-seeking Ae. albopictus. Computation of R0 for CHIKV using observed 
HLC data showed values >1 in several periods along the sampling season. 
The computation of CHIKV outbreak probability highlighted two phases 
with a >75% probability of successful transmission of imported CHIKV. 
The approach proposed, if validated in different ecological/geographical 
settings, would represent a valuable and affordable option for assessing 
risk of exotic arbovirus transmission in non-endemic countries based on 
ovitrap data gathered during routine Ae. albopictus monitoring activities.
197
astmh.org
627
IMPACT OF SEASONAL PATTERNS AND PARASITE ASEXUAL 
STAGE ON ANOPHELES GAMBIAE SUSCEPTIBILITY TO 
PLASMODIUM FALCIPARUM INFECTION IN BURKINA FASO
Awa Gneme1, Gustave B. Kabre1, Wamdaogo M. Guelbeogo2, 
Michelle M. Riehle3, N’Falé Sagnon2, Kenneth D. Vernick4
1Université Ouaga I Pr Joseph KI-ZERBO, Ouagadougou, Burkina Faso, 
2Centre National de Recherche et de Formation sur le Paludisme, 
Ouagadougou, Burkina Faso, 3Department of Microbiology, University of 
Minnesota, Minnesota, MN, United States, 4Unit of Insect Vector Genetics 
and Genomics, Department of Parasites and Insect Vectors, Institut 
Pasteur; CNRS Unit of Hosts, Vectors and Pathogens (URA3012), Paris, 
France
Transmission reduction is a key component of global efforts to control 
and eliminate malaria. A wide range of novel transmission-reducing 
drugs and vaccines are currently under development. Human to mosquito 
transmission is influenced by many factors. Actually, it is unclear how 
the densities of parasites stages or season influence infection rate and 
intensity. Here, we describe the importance of the parasites stages 
seasonal pattern in infections success. Gametocytes carriers’ infectiousness 
to mosquitoes was determined at the peak/end of transmission season 
and dry season via membrane feeding assay. Asexual parasites prevalence 
was higher in the peak of the wet season (69.1%, 329/476) compared to 
the dry (56.8%, 50/88) and the end of the wet season (60.5%, 161/266). 
Of gametocytes positive slides (N=189), 86.2% had asexual parasites. 
Gametocytes prevalence did not significantly vary between seasons. 
Asexual forms median density was 993 (IQR: 317-3759) with a significant 
difference between seasons (p=0.0004). However gametocytes median 
density 40 (IQR: 16-78) did not shown any seasonal variation (p = 0.1). For 
feeding, around 28062 mosquitoes offered blood meal and 29.6% fed 
and survived until dissection. The average number of dissected mosquitoes 
75 (range 18 - 207) was quite the same according to the assays period. 
In 71.8% (79/110) of feeding experiments, at least one mosquito was 
infected. The median percentage of infected mosquitoes per infectious 
experiment was 15.7% (IQR: 07.3- 89. 2 %) with a median oocyst 
number of 2 (range 1 - 101). The prevalence of infected blood meal was 
similar across season (70.0%, 72.7% to 70.1% at the dry, the peak, and 
the end of the wet season. Mosquitos’ infection rate also did not show 
any significant variation within season. The infection success was higher 
for asexual parasites carriers (91%) than non carriers (9%). However, 
mosquitoes’ infection rate and oocyst load did not significantly vary 
according the asexual forms carriage. This highlights the need to carefully 
interpret evaluations, regarding asexual parasites and transmission season 
for malaria control program.
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INVESTIGATING THE INFLUENCE OF PLASMODIUM 
INFECTION ON THE HUMAN VOLATILE ODOUR PROFILE IN 
AN ENDEMIC SETTING
Ailie Robinson1, Jetske de Boer2, Annette O. Busula3, Stephen 
Powers4, John Caulfield4, Mike Birkett4, John A. Pickett4, Willem 
Takken2, James Logan1
1London School of Hygiene & Tropical Medicine, London, United Kingdom, 
2Wageningen University, Wageningen, Netherlands, 3International Centre 
of Insect Physiology and Ecology, Nairobi, Kenya, 4Rothamsted Research, 
Harpenden, United Kingdom
There is some evidence to suggest that Plasmodium parasites 
manipulate the attractiveness of human hosts to Anopheles vectors. 
This is in accordance with the theory of parasite manipulation, whereby 
transmission is favoured by an effect of the parasite on host biology 
or behaviour. If malaria parasites can alter human attractiveness, the 
repercussions would be far reaching: this would likely have a profound 
influence on the way that malaria spreads through populations. Despite 
evidence that variations in human host attractiveness to biting insects 
are manifested through differences in the human odour profile, the 
association between such odour profile and malaria infection has never 
been studied. In this large-scale, field-based trial we used air entrainment 
techniques to capture the chemicals released by individuals’ skin (the 
‘volatile odour profile’, VOP). We measured the VOP of both uninfected 
school-age children in Western Kenya, and those with parasitaemia 
of both sexual and asexual Plasmodium stages. The same volunteers 
were measured following treatment with antimalarials. In addition to 
field diagnostics, parasite infection profile was characterised by the use 
of molecular techniques, including qt-NASBA and qPCR, for parasite 
stage and density respectively. Chemical odour profiles were examined 
using gas chromatography, then further investigated using coupled 
GC-electroantennography to determine entomological responses to 
constituent compounds. We will present results showing associations 
between human odour profile, parasitological parameters of infection 
and electrophysiological responses of the Anopheles vector. Malaria 
remains one of the most important diseases worldwide. As the global 
strategy for malaria control and elimination evolves to combat both 
parasite and vector resistance to drugs and insecticides, the need for 
innovative tools intensifies. Greater understanding of the factors that 
influence transmission will allow more precise epidemiological modelling. 
Additionally, measurable changes in the VOP of infected individuals could 
form the basis of a novel diagnostic tool.
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CHANGE IN MOSQUITO BEHAVIOR AFTER DISTRIBUTION OF 
BEDNETS RESULTS IN DECREASED PERSONAL PROTECTION 
FROM INFECTIVE BITES
Edward Thomsen1, Gussy Koimbu2, John Keven3, Manuel Hetzel4, 
Lisa Reimer1
1Liverpool School of Tropical Medicine, Liverpool, United Kingdom, 2Papua 
New Guinea Institute of Medical Research, Madang, Papua New Guinea, 
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Behavioral resilience in mosquitoes poses a significant challenge to the 
control and elimination of malaria. Generalist host-seeking behaviors 
enable mosquito populations to evade indoor interventions which target 
host-seeking or resting mosquitoes. It is unclear whether behavior 
changes, as seen in anopheline vectors over the last decade, compromise 
the efficacy of vector control in reducing malaria transmission. In this 
study, we quantified human exposure to both bites and infective bites 
of a major malaria vector in Papua New Guinea over the course of 
four years surrounding a nationwide long-lasting insecticidal bednet 
distribution. Using age-stratified sleeping patterns and the biting density 
indoors and outdoors, we estimated the protective efficacy of LLINs 
against the biting population just prior to the distribution and for the 
next three years. We observed a shift in bite exposure to earlier hours 
of the evening, before individuals are protected, following the bednet 
distribution. Protective efficacy was greatest in children under five years 
old (65%), but significantly lower in the adult population (35%) who may 
be an important reservoir for transmission. The personal protection in all 
age groups decreased significantly over the study period and infective 
mosquitoes were found host-seeking before 10pm. As a result, exposure 
to infective bites was higher in net users and non-users alike, following the 
distribution. The result of the decrease in personal protection over several 
years appears to be a rebound in the entomological inoculation rate to 
levels that surpass pre-intervention estimates. This study highlights the 
necessity of validating and deploying vector control measures targeting 
outdoor exposure if malaria is to be controlled and eliminated.
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ACCELERATED ARBOVIRAL TRANSMISSION AND MORE 
EXPLOSIVE OUTBREAKS IN A WARMER WORLD
Amir S. Siraj1, Rachel J. Oidtman1, John Huber1, Moritz U. 
Kraemer2, Oliver J. Brady2, Michael Johansson3, Alex T. Perkins1
1University of Notre Dame, Notre Dame, IN, United States, 2University 
of Oxford, Oxford, United Kingdom, 3Center for Disease Control and 
Prevention, San Juan, PR, United States
Arboviruses are expanding into new regions, and outbreaks of these 
diseases are becoming more common. Several studies have quantified 
basic reproduction number, R0, based on temperature. However, none 
have quantified epidemic growth rate, r, an important temporal measure 
in the dynamics of these highly epidemic arboviral diseases. We seek 
to characterize the sensitivity of the epidemic growth rate to changes 
in both R0 and the generation interval, which is defined as the average 
time elapsed between consecutive cases in humans and also depends on 
temperature. We first developed a description of R0 for dengue based on 
temperature and, for the first time, a fully characterized generation interval 
distribution for dengue, also as a function of temperature. We then 
combined these estimates of R0 and the generation interval as functions 
of temperature to obtain a description of epidemic growth rate r as a 
function of temperature. To assess the implications of this temperature 
relationship for projected future temperature increases, we calculated r as 
a function of monthly, location-specific temperatures globally to identify 
areas of the world and associated populations that may be subject to 
increases or decreases in arboviral epidemic growth rates under future 
climate change. By 2050, as many as 3.2 billion people are projected 
to live in areas expected to experience increasingly rapid epidemics of 
arboviral diseases, indicating the need for surveillance systems to remain 
vigilant as the future explosiveness of outbreaks worsens in many areas.
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EXPOSURE OF EPITOPE RESIDUES ON THE OUTER FACE OF 
THE CHIKUNGUNYA VIRUS ENVELOPE TRIMER DETERMINES 
ANTIBODY NEUTRALIZING EFFICACY
Rachel H. Fong1, Soma S. Banik1, Jin Jing2, Graham Simmons2, 
Benjamin J. Doranz1
1Integral Molecular, Inc., Philadelphia, PA, United States, 2Blood Systems 
Research Institute, San Francisco, CA, United States
Chikungunya virus (CHIKV) is a reemerging alphavirus that causes a 
debilitating arthritic disease and infects millions of people and for which 
no specific treatment is available. Like many alphaviruses, the structural 
targets on CHIKV that elicit a protective humoral immune response in 
humans are poorly defined. Here we used phage display against virus-like 
particles (VLPs) to isolate seven human monoclonal antibodies (MAbs) 
against the CHIKV envelope glycoproteins E2 and E1. One MAb, IM-
CKV063, was highly neutralizing (50% inhibitory concentration, 7.4 ng/
ml), demonstrated high-affinity binding (320 pM), and was capable of 
therapeutic and prophylactic protection in multiple animal models up to 
24 h post-exposure. Epitope mapping using a comprehensive shotgun 
mutagenesis library of 910 E2/E1 mutants with alanine mutations 
demonstrated that IM-CKV063 binds to an intersubunit conformational 
epitope on domain A, a functionally important region of E2. IM-CKV063 
blocks both virus entry and release steps. MAbs against the highly 
conserved fusion loop have not previously been reported but were also 
isolated in our studies. The fusion loop MAbs were broadly cross-reactive 
against diverse alphaviruses but were non-neutralizing. Fusion loop 
MAb reactivity was affected by temperature and reactivity conditions, 
suggesting that the fusion loop is hidden in infectious virions. Visualization 
of the binding sites of 15 different MAbs on the structure of E2/E1 
revealed that all epitopes are located at the membrane-distal region of 
the E2/E1 spike. Interestingly, epitopes on the exposed topmost and outer 
surfaces of the E2/E1 trimer structure were neutralizing, whereas epitopes 
facing the interior of the trimer were not, providing a rationale for vaccine 
design and therapeutic MAb development using the intact CHIKV E2/E1 
trimer.
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BRIDGING THE GAP BETWEEN IMMUNOGENICITY AND 
SAFETY: AN INSECT-ONLY VIRUS AS A VACCINE PLATFORM
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Luo1, Tian Wang1, Farooq Nasar4, Scott C. Weaver1
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Birmingham, Birmingham, AL, United States, 4U.S. Army Medical Research 
Institute of Infectious Diseases, Frederick, MD, United States
Traditional approaches in vaccine development have typically involved live-
attenuation or inactivation strategies. However, these approaches tend to 
offer unbalanced safety and immunogenicity profiles with live-attenuated 
vaccines providing robust yet reactogenic immune responses, while 
inactivated vaccines present a safer alternative often requiring multiple 
doses for protective immunogenicity. We propose the use of an insect-
specific virus, Eilat virus (EILV), as a novel platform for alphavirus vaccines 
that provides exceptionally safe yet long-term, robust immunogenicity. 
EILV was isolated from a pool of mosquitoes collected in the Negev desert 
of Israel and is completely restricted to replication in insects only due to 
an inability to enter and replicate its RNA genome in vertebrate cells. To 
address the growing concern over chikungunya disease as it has now 
become a global threat, we developed a proof-of-concept chikungunya 
vaccine using the EILV platform. Here we report that EILV chimeras 
with chikungunya structural proteins are antigenically identical to their 
pathogenic counterpart, mimic early stages of the virus replication-
cycle from attachment and entry to viral genome delivery, yet remain 
restricted to replication in mosquito cells only, providing an extremely 
safe phenotype in vertebrate animals with balanced, long-lived humoral 
and cellular immune responses following a single-dose vaccination. In 
non-human primates, EILV/CHIKV elicited rapid and robust neutralizing 
antibodies against chikungunya virus and provided protection against 
telemetrically-monitored disease. The EILV platform represents the first 
application of an insect-only virus in vaccine development and highlights 
the broader application of such viruses in vaccinology.
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PROTECTION AGAINST TWO LETHAL HETEROLOGOUS 
VIRUSES AFTER SIMULTANEOUS DUAL-AEROSOL 
CHALLENGE USING A NOVEL IMMUNOTHERAPEUTIC
Thomas C. Luke1, Eddie Sullivan2, Hua Wu2, Jin-an Jiao2, Christina 
L. Gardner3, William Klimstra3, Kanakatte Raviprakash4
1Naval Medical Research Center, The Henry Jackson Foundation, Silver 
Spring, MD, United States, 2SAB Biotherapeutics, Inc., Sioux Falls, SD, 
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No specific therapeutic prevents or treats Venezuelan Equine Encephalitis 
(VEE) or other alphaviruses. VEE causes human epidemics and is a select 
agent. Influenza can cause severe mono-infection or a nosocomial co-
infection in hospitalized patients admitted for other infections. Passive 
immunotherapeutics with mono-specific immunoglobulin (IgG) effectively 
treats toxin, venom and pathogen-mediated diseases and are either 
polyclonal IgGs, derived from human or animal plasma, or monoclonal 
antibodies. Effective multi-pathogen/toxin hIgGs could have great clinical 
benefits. Transchromosomic bovines (Tc-bovine) provide an alternative 
method to economically produce large quantities of multi-target IgG 
with fully-human antibodies. Tc-bovines have had their repertoire of 
bovine antibody genes deleted, and instead carry a human artificial 
chromosome containing the full repertoire of human antibody genes. Tc-
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bovines can rapidly produce up to 600 grams per month of hyperimmune, 
multi-pathogen, fully-human immunoglobulin (hIgG). Tc-bovines were 
hyperimmunized with psoralen inactivated Trinidad-Tobago (Td-Tb) VEE 
virus and a trivalent spilt virion seasonal influenza virus (pH1N1, H3N2, 
type B) and a Tc-bovine hIgG with very high titers to these viruses was 
produced. Multiple groups of BALB-C or DBA2 mice (n=5) were aerosol 
challenged with 300 PFU of wild-type pDNA electroporated strain Td-Tb 
VEE (.5 PFU LD50) or dual challenged with 30 PFU Td-Tb VEE and 600 PFU 
pH1N1 (30 PFU LD50) on day 0. VEE aerosol challenged mice received 
100 ug (5 mg/kg) IP at -12/+48h (prophylactic) or +12/48h (therapeutic). 
Dual VEE and pH1N1 aerosol challenged mice received 200 ug (10 mg/kg) 
IP at -12/+48h (prophylactic) or +12/48h (therapeutic). Controls received 
irrelevant hIgG. Prophylactic and therapeutic groups had 80-100% 
survival. All controls had 0% survival. To our knowledge, this is the first 
study demonstrating protection after simultaneous challenge with two 
lethal heterologous viruses (alphavirus + orthomyxovirus) by any route in 
any animal model. Multi-pathogen Tc-bovine hIgGs could be produced and 
tested in human clinical trials.
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A VIRUS-LIKE PARTICLE VACCINE ELICITS BROAD 
NEUTRALIZING ANTIBODY RESPONSES IN HUMANS 
AGAINST DISTINCT CHIKUNGUNYA VIRUS GENOTYPES
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E. Ledgerwood, Ted C. Pierson
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Chikungunya virus (CHIKV) is a mosquito-borne alphavirus that is endemic 
to many regions of Asia and Africa, and has recently emerged in the 
Western hemisphere. The rapid emergence of CHIKV is partly attributed 
to an adaptive mutation that facilitated efficient transmission by a widely 
distributed mosquito species, Aedes albopictus, highlighting the threat 
of further CHIKV spread and the need to prioritize vaccine development. 
There are three CHIKV genotypes: Asian, East/Central/South African 
(ECSA), and West African, which share 95.2 to 99.8% amino acid identity. 
CHIKV particles are enveloped, and encapsidate a positive-sense, single-
stranded genomic RNA that encodes four non-structural and five structural 
polyproteins. Expression of the structural polyproteins gives rise to virus-
like particles (VLPs), which are highly immunogenic. In a recent phase 
1 trial, we demonstrated a CHIKV VLP vaccine based on a West African 
strain to be safe, tolerable, and to elicit robust neutralizing antibody (NAb) 
responses against an ECSA strain. Here, we investigated the breadth of the 
VLP vaccine-elicited NAb response against eight additional CHIKV strains 
representing all three genotypes to further evaluate the potential of this 
vaccine candidate to reduce CHIKV spread. We generated fully infectious 
chimeric viruses in which the non-structural genes of Semliki Forest virus 
(SFV), a related alphavirus, were complemented with CHIKV structural 
genes for use in neutralization assays against sera obtained from 12 CHIKV 
VLP vaccine recipients. SFV-CHIKV viruses encoding the structural genes 
from all nine CHIKV strains were infectious, demonstrated similar in vitro 
growth kinetics, and were potently neutralized by sera from vaccinees 
(average half-maximum inhibitory dilution per vaccinee: 2209, range: 315 
- 6423). These results suggest that the CHIKV VLP vaccine-elicited NAb 
response could confer cross-protection against diverse CHIKV genotypes, 
further supporting the potential of this vaccine candidate to combat 
CHIKV spread. This vaccine is currently being evaluated in a phase 2 clinical 
trial in the Caribbean.
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HIGH-RESOLUTION IMAGING OF CENTRAL NERVOUS 
SYSTEM INVASION BY ALPHAVIRUSES DELIVERED BY 
SUBCUTANEOUS OR AEROSOL ROUTES OF EXPOSURE
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Reed, Simon C. Watkins, Amy L. Hartman, William B. Klimstra
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Encephalitic alphaviruses, including Venezuelan and Eastern equine 
encephalitis viruses (VEEV, EEEV), have caused sporadic outbreaks in the 
human population and can result in severe neurologic impairment and 
death. Although in nature virus is delivered subcutaneously by the bite 
of a mosquito, these viruses have potential for use as bioweapons, and 
in this case, they are likely to be delivered by aerosolization. Currently, no 
specific anti-viral treatments or FDA approved vaccines are available for 
VEEV or EEEV. Thus, a detailed understanding of the routes of brain entry 
and the dynamics of spread that differentiate the two will be important for 
the development of prophylactics or post-exposure interventions that may 
mitigate disease. In mouse models of disease, VEEV and EEEV demonstrate 
distinctly different cellular tropisms due to microRNA binding sites in 
EEEV that limit its growth in myeloid cells and natural heparan sulfate 
(HS) binding by the virus, which further limits myeloid cell infection but 
exacerbates brain replication. As a result of these phenotypic differences, 
the dynamics of neuroinvasion and spread within the brain are also 
expected to differ between the viruses. Using high speed ribbon scanning 
confocal microscopy and the prototypic strains VEEV Trinidad Donkey and 
EEEV FL93-939, we are collecting large-area, high resolution, images of 
brain tissue in three-dimensions. With these data we can resolve, at the 
cellular and macro levels, early sites of virus infection. Importantly, we can 
differentiate patterns of infection following different routes of exposure 
for both VEEV and EEEV. Initial results indicate that, while the timing of 
neuroinvasion differs between the two viruses, primarily dependent upon 
the HS binding phenotype, the olfactory bulb is a principal site of early 
infection for both viruses when delivered peripherally and via aerosol. We 
expect these data to provide a guide for the development of therapeutics 
that can be specifically targeted for the post exposure timing and route of 
infection.
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ATTACK RATE OF CHIKUNGUNYA IN NICARAGUAN 
CHILDREN DURING THE FIRST TWO WAVES OF THE 
EPIDEMIC, 2014-2016
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Chikungunya was recently introduced into the Americas, causing 
explosive epidemics throughout the region. Autochthonous transmission 
of Chikungunya was detected in September 2014 in Nicaragua. To study 
the introduction and transmission of Chikungunya in Nicaragua, we 
included testing for chikungunya virus (CHIKV) in an ongoing pediatric 
dengue cohort study in District II of Managua, the capital city. Children 
were enrolled prospectively, and data was systematically recorded on 
all medical visits. Participants are encouraged to come in at first sign 
of illness, and all medical care is provided free-of-charge through the 
study. Participants who present to the health center with suspected 
chikungunya or undifferentiated fever are tested for chikungunya by RT-
PCR and serological assays. Between September 2014 and March 2016, 
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3,788 children participated in the study. From September 2014 to March 
2015, the first wave of the epidemic, the clinical attack rate of laboratory-
confirmed CHIKV infection was 2.9% (95% CI: 2.3%, 3.4%). From July 
2015 to January 2016, the second wave of the epidemic, the clinical 
attack rate of laboratory-confirmed CHIKV infection was 13.9% (95% 
CI: 12.7%, 15.1%). Age was significantly associated with symptomatic 
CHIKV infection, with 2-4 year olds experiencing the lowest attack rate 
(9.4%) and 11-14 year olds experiencing the highest attack rate (20.2%). 
In the first year of the study, the proportion of children in the study with 
inapparent infections was 58.3% (95% CI: 51.5%, 65.1%). Poverty was 
an independent risk factor for CHIKV infection, with a prevalence ratio 
(PR) 1.33 (95% CI: 1.11, 1.58), as was having ≥8 hours per day without 
running water in the home, PR 1.31 (95% CI: 1.05, 1.63). The number of 
inapparent infections and the ratio of symptomatic:inapparent infections, 
along with risk factor analysis, is ongoing for the second wave of the 
epidemic. This study is providing critical data on the epidemiology and 
transmission of chikungunya in the Americas.
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TWELVE-MONTH ASSESSMENT OF PERSISTENT ARTHRALGIA 
ASSOCIATED WITH THE 2014-2015 CHIKUNGUNYA VIRUS 
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Chikungunya virus (CHIKV), an alphavirus transmitted by Aedes spp. 
mosquitoes, causes fever and polyarthralgia. Symptoms often resolve 
within 7-10 days; however, up to 79% of cases in previous outbreaks 
have reported persistent arthralgia (defined as joint pain at least once 
per week) for up to 36 months following acute infection. To enhance 
our understanding of the long-term impact of CHIKV illness, persistent 
arthralgia and functional outcomes of laboratory-positive cases in the U.S 
Virgin Islands (USVI) were evaluated at 6 and 12 months after symptom 
onset. Outcomes of individuals with similar healthcare seeking behaviors 
were compared to those of cases. A similar healthcare seeker was defined 
as a USVI resident who did not report experiencing sudden onset of fever 
and joint pain in June 2014-June 2015, and attended a healthcare facility 
during the last week of June 2015. Six months after illness onset, 165 
cases (65% female, median age: 52) were interviewed and 12 months 
after illness onset, 128 of the 165 cases were interviewed. During the 
12-month follow-up of cases, 167 similar healthcare seekers (64% female, 
median age: 34 years) were interviewed. The difference in prevalence of 
persistent arthralgia between cases and the comparison group at 6 months 
was 32% (95% confidence interval [CI]: 23-40%) after adjusting for age, 
sex and self-reported history of arthritis; at 12 months after onset, the 
difference in prevalence was 19% (95% CI: 11-28%). Twelve months after 
illness onset, cases were 1.81 (95% CI: 1.08-3.02) times more likely to 
have difficulty walking, 1.96 (95% CI: 1.24-3.12) times more likely to have 
difficulty climbing stairs and 2.63 (95% CI: 1.31-5.29) times more likely to 
have difficulty getting in and out of a car compared to similar healthcare 
seekers. Furthermore, 22% (95% CI: 15-29%) of cases compared to 10% 
(95% CI: 5-14%) of the comparison group reported that their health 
was either somewhat or much worse compared to one year prior. These 
findings highlight the long-term impaired physical functionality of CHIKV 
cases and the need for therapeutic and vaccine research to manage and 
prevent acute illness and long-term morbidity.
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HIGH SEROPREVALENCE OF MIDDLE EAST RESPIRATORY 
SYNDROME CORONAVIRUS (MERS-COV) IN CAMELS IS NOT 
ASSOCIATED WITH MERS-COV SERO-POSITIVITY AMONG 
CAMEL PASTORALISTS IN KENYA
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High seroprevalence of MERS CoV among camels has been reported in 
Kenya and other countries in Africa. To date, the only report of MERS CoV 
sero-positivity among humans in Kenya is of two livestock handlers with 
no known contact with camels. We assessed whether persons exposed 
to seropositive camels at household level had serological evidence of 
infection. A total of 798 human and 879 camel sera were collected from 
265 households in Marsabit County in 2013. Household data collected 
included human and animal demographics, animal ownership and type 
of contact with camels. Human and camel sera were tested for antiMER-
CoV IgG using a commercial ELISA test. Human samples were considered 
positive if positive on both ELISA and a confirmatory plaque reduction 
neutralization test (PRNT). PRNT was not performed on camel samples. 
Multivariable logistic regression was used to identify factors associated 
with MERS CoV sero-positivity and adjusted odds ratios (aORs) reported. 
The median age of persons sampled was 30 years (range 5-90) and 50% 
were males. A quarter (197/760) of the participants reported having had 
contact with camels defined as milking, feeding, watering, slaughtering 
or herding. Of the 798 human sera tested, 18 (2.2%) were positive on 
ELISA but negative by PRNT. Of the 879 camels sera tested, 90% (n=791) 
were positive. On multivariate analysis, older camels > 4 years and those 
raised under nomadic pastoral versus agro-pastoral production system 
had significantly increased odds (aOR 21.3; 95% CI 10.3, 43.6 and 
18.5; 95% CI 7.4, 46.1, respectively) of being sero-positive, while the 
number of cattle in the herd and in households that had sold livestock 
were associated with decreased odds (aOR 0.9; 95% CI 0.96, 0.97 and 
0.3; 95% CI 0.1, 0.9) of being seropositive. Despite high sero-prevalence 
among camels, there was no serological evidence of MERS CoV infection 
among camel pastoralists in Marsabit County. High seropositivity 
among camels suggests that MERS CoV or other closely related virus 
continues to circulate in camel herds particularly those raised in nomadic 
production systems, and highlights ongoing potential for animal to human 
transmission.
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REDRAWING THE BOUNDARIES OF KYASANUR FOREST 
DISEASE (KFD) IN INDIA- EARLY RESULTS OF GHSA-
SUPPORTED ACUTE FEBRILE ILLNESS SURVEILLANCE
Govindakarnavar Arunkumar1, Shaikh Shah Hossain2, Devadiga 
Santhosh1, Sushama Aswathyraj1, Nittur Sudheesh1, Abdulmajeed 
Jazeel1, Jayaram Anup1, Prabhu G. Suresha1, Chameettachal 
Akhil1, Maity Hindol1, D’Souza Raiza Giselle1, Sasidharan Pillai 
Sabeena1, Jagadesh Anitha1, Aithal Anjali1, Bhasker Revti1, Kayla F. 
Laserson2
1Manipal University, UDUPI, Karnataka, India, 2Centers for Disease Control 
and Prevention, New Delhi, India
Kyasanur Forest Diseases (KFD) is a tick-borne flavivirus disease first 
described in 1957 from the Shimoga district of Karnataka, India.KFD 
detection remained restricted to persons living in the Shimoga forest 
region until 2012 when it was identified in Chamarajanagar, 400km away. 
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Characteristically, this disease presents as an acute haemorrhagic febrile 
illness. In 2014 we initiated hospital-based laboratory-supported acute 
febrile illness (AFI) surveillance) at sub-district level sentinel hospitals across 
several states to map the aetiology of AFI in general, and KFD in particular. 
The project is supported under the Global Health Security Agenda (GHSA). 
All admitted AFI patients from June 2014 to March2016 with fever <15 
days were enrolled. We recorded the demographic and clinical parameters 
of all cases, and tested for bacterial, viral and parasitic diseases, including 
leptospirosis, dengue, influenza, scrub typhus, chikungunya, typhoid, 
brucellosis, and KFD. Serological and molecular diagnostic assays were 
performed, including real-time PCR to detect viral RNA in serum for KFD 
confirmation. We enrolled 4693AFI patients from five contiguous Indian 
states. Of these, 302 (6.4%) were KFD-positive: Karnataka (98/2970), 
Kerala (45/1290), Tamil Nadu (1/29), Goa (143/391), and Maharashtra 
(15/15). KFD-positive patients ranged from 5 to 65 years (median age 40 
years); 59% were female. Their clinical spectrum included myalgia (89%), 
generalized weakness (79%), prostration (22%), nausea (60%), vomiting 
(51%), abdominal pain (34%), diarrhea (24%), hemorrhagic fever (2%), 
and altered sensorium and or seizures (1%). Of 302 cases, 80% were 
living near the forest edge and 84% reported visiting the forest in the last 
2 weeks. This study documents that KFD is not restricted to the Shimoga 
forest region, and has a more diverse clinical presentation than previously 
observed. Further, in our surveillance, we recorded cases without 
confirmed forest incursion.AFI platforms, as are being built under GHSA, 
are critical for the comprehensive characterization of known pathogens 
and may lead to detection of novel pathogens.
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RISK FACTORS FOR ACUTE LEPTOSPIROSIS IN NORTHERN 
TANZANIA
Michael J. Maze1, Shama Cash-Goldwasser2, Holly M. Biggs3, 
Matthew P. Rubach3, Renee L. Galloway4, Katrina J. Sharples5, 
Kathryn J. Allan6, Jo E. Halliday6, Sarah Cleaveland6, Michael C. 
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Mathematics and Statistics, University of Otago, Dunedin, New Zealand, 
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Leptospirosis is increasingly recognized as a major cause of febrile illness 
in Africa but little is known about risk factors for human infection. 
Patterns of sero-reactivity in Tanzania have indicated that livestock may 
be important sources of human leptospirosis. To test this hypothesis we 
conducted a prospective cohort study of acute leptospirosis in northern 
Tanzania. We enrolled pediatric and adult patients with fever from 
two referral hospitals in Moshi, Tanzania and performed Leptospira 
microagglutination antibody testing on acute and convalescent serum. 
Cases were patients who had either a four-fold rise in Leptospira antibody 
titers or a single reciprocal titer ≥800, seropositivity required a single 
titer ≥100, and controls had titers <100 in both sera. We administered a 
standardized questionnaire to assess behaviors over the preceding month. 
We calculated odds ratios (OR) for individual behaviors, and combined 
behaviors to form exposure scales to livestock, rodents, and surface water. 
Of 1,446 patients enrolled from February 2012 through September 2014 
the analyzed cohort included 24 (1.7%) cases, 179 (12.4%) seropositive 
participants and 592 (40.9%) controls. Among cohort members the 
median (range) age was 26.0 (0.2, 95.3) years and 422 (54.7%) were 
female. On bivariate analysis, acute leptospirosis was associated with age 
>12 years (OR 7.7, p<0.01), high level of cattle contact (OR 3.3, p=0.05), 
feeding cattle (OR 3.9, p=0.02), cleaning cattle waste (OR 4.3, p=0.03), 
working in fields (OR 2.9, p=0.02) and rice fields (OR 14.4, p<0.01). 
Seropositivity was associated with age >12 years (OR 2.2, p<0.01), Maasai 
ethnicity (OR 7.0, p=0.03), high level of cattle contact (OR 1.7, p=0.04), 
keeping cattle inside the house (OR 4.7, p=0.04), high level of goat 
contact (OR 1.9, p=0.03), slaughtering livestock (OR 1.7, p=0.02), and 
working in rice fields (OR 3.9, p=0.01). Behaviors and scales for exposure 
to rodents and surface water were not associated with either acute 
leptospirosis or seropositivity. Our findings suggest livestock contact and 
working in rice fields are important risk factors for leptospirosis in northern 
Tanzania.
641
PRODUCTION FARMS, CLASS-1 INTEGRONS, AND 
ANTIBIOTIC RESISTANCE IN E. COLI ISOLATES FROM RURAL 
ECUADOREAN CHICKENS AND HUMANS
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While it is clear that industrial-scale farming operations affect antibiotic 
resistance (AbR) in livestock and humans, the extent to which smaller 
community-level farming operations impact AbR in surrounding 
communities, particularly in developing nations, is poorly described. 
We hypothesized that small-scale production operations contribute to 
elevated levels of AbR bacterial isolates in livestock and people living 
in close proximity to these operations by selecting for genetic mobile 
elements such as integrons that allow sharing of resistant gene cassettes 
between isolates. To investigate the relationship between community-level 
farming, mobile elements, and AbR, we conducted a serial cross-sectional 
community-based study collecting E. coli fecal isolates from over 1,000 
chickens and humans in rural villages from northern Ecuador. Isolates were 
typed for 4 mobile elements using a DNA microarray platform; phenotypic 
resistance was assessed for 12 antibiotics using standard disc diffusion 
assays. We compared AbR levels in isolates from production chickens 
(broiler and laying hens raised for sale and fed commercial feed containing 
antibiotics) to AbR among isolates from household chickens (raised for 
domestic use and fed antibiotic-free feed). AbR for all markers was higher 
in production chickens compared to household chickens. There was a 
significant downward trend in AbR levels across birds from production 
operations, household birds in villages with production operations, and 
household birds in villages with no production operations, suggesting that 
proximity to a production operation can influence AbR in non-production 
chickens. In addition, the risk of phenotypic AbR appears to be modified 
by the presence or absence of class-1 integrons, suggesting a complex 
relationship between the environment, integrons, and AbR. These analyses 
(which will be expanded to include humans in houses associated with 
production or household chickens) suggest that small-scale production 
poultry farming selects for class-1 integrons in both chicken types, which 
has important public health implications.
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Aboubacar S. Diakite3, Lamine Koivogui4, Mamady S. Keita5, Seny 
Mane6, Lise Martel7, Rebecca L. Katz1
1George Washington University, Washington, DC, United States, 2Carlin 
Communications, New York, NY, United States, 3Ministry of Health, 
Conakry, Guinea, 4Institut National de Santé Publique, Conakry, Guinea, 
5Ministry of Environment, Conakry, Guinea, 6Ministry of Livestock, 
Conakry, Guinea, 7Centers for Disease Control and Prevention, Conakry, 
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The recent Ebola virus disease outbreak in West Africa highlighted the 
importance of emerging zoonotic diseases, and provided an impetus for 
renewed emphasis on “One Health” capacity building with respect to 
zoonotic disease control. To guide capacity building efforts in Guinea, 
we sought to first identify the existing systems and structures in place for 
zoonotic disease control, specifically highlighting existing multi-sectoral 
approaches. Adapting our methodology for compatibility with the 
Global Health Security Agenda targets, we worked with the government 
ministries responsible for human, animal, and environmental health to 
identify a list of diseases - rabies, anthrax, brucellosis, viral hemorrhagic 
fevers (including Ebola fever, Lassa fever, yellow fever, and Rift Valley 
fever), trypanosomiasis and highly pathogenic avian influenza - as the 
Government of Guinea’s top priorities. We then used each priority 
disease as a case study to identify existing processes for prevention, 
surveillance, diagnosis, laboratory confirmation, reporting and response 
across all sectors, with an emphasis on examining elements of cross-
sectoral coordination or communication. Results were used to produce 
disease-specific systems “maps,” which highlighted commonalities 
across all systems, as well as gaps and opportunities. Overall, we 
identified five major categories of gaps, each with a corresponding set 
of recommendations: 1) Coordination; 2) Training; 3) Infrastructure; 4) 
Public awareness; and 5) Research. These recommendations have been 
provided to the Government of Guinea to assist with the development of 
a One Health strategic plan. Overall, the project demonstrates an effective 
methodology for mapping systems and structures for zoonotic diseases, 
and the benefit of conducting a baseline review of systemic capabilities 
prior to embarking on capacity building efforts.
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PARASITES IN THE PARK: AN EPIDEMIOLOGIC STUDY OF 
NYC PARKS FOR TOXOCARA SPECIES
Donna L. Tyungu1, Carla Lee Lau1, Rojelio Mejia2, Henry Pollack1
1New York University, New York, NY, United States, 2National School of 
Tropical Medicine, Baylor College of Medicine, Houston, TX, United States
Toxocara species are common pet parasites that can be found in the stool 
of dogs and cats. The infective larvae released in the stool survive in soil for 
many years and can subsequently be ingested by children who encounter 
them in sandboxes or on playgrounds. The CDC lists Toxocariasis as one 
of five neglected parasitic infections in the US and states that ‘we urgently 
need to know more about who is at risk and how they are affected’. It is 
considered a neglected disease of poverty in the US, posing a significant 
disease burden in certain groups, remaining largely underdiagnosed. 
Infection in humans, paratenic hosts, can lead to visceral or ocular 
larva migrans, blindness, and silent brain infection that can diminish 
neurological cognition. New York City is pet-friendly, and known for its 
sprawling parks and play areas. It has been suggested that certain NYC 
neighborhoods may pose a higher risk for Toxocara infection, particularly 
in lower socioeconomic and predominately immigrant communities, 
although no study of actual Toxocara burden in NYC has been reported. 
The goals of this study are to:1)determine the burden of Toxocara in parks 
by examining sand/soil in playgrounds, 2) to determine if a disparity exists 
in neighborhood distribution, and 3) to explore which species of Toxocara 
is more prevalent. To accomplish these objectives multiple samples will 
be taken from more than 100 parks and playgrounds and analyzed by 
standard flotation and microscopy methods. Species will be identified by 
multi-parallel quantitative real-time PCR (qPCR) using specific primers to T. 
cati and T. cani. Parasite burden will be calculated. Results will be tabulated 
geospatially and correlated with US Census maps of income, housing and 
ethnicity. Preliminary results from 10 of 100 sites in this study identified 
Toxocara eggs in 40% of samples, suggesting that Toxocara is common 
in many play areas. At the conclusion of this project, we hope to provide 
the first epidemiologic geospatial survey of Toxocara species in NYC parks 
that may be helpful in identifying parks that may pose the highest risk of 
Toxocara transmission.
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USE OF TRACKING PLATES TO IDENTIFY HOTSPOTS OF RAT 
ABUNDANCE IN SLUM COMMUNITIES WITH HIGH ENDEMIC 
TRANSMISSION OF LEPTOSPIROSIS
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At present, there are no effective measures to prevent leptospirosis in 
slum environments, where the domestic rat is the primary reservoir. A 
critical barrier to mounting rodent control strategies is the lack of reliable 
approaches to estimate rat abundance and their distribution in complex 
urban settings. We developed a tracking plate method that quantifies 
the abundance of rats by identifying rat-specific markings on lampblack-
coated tiles. We used this method to create high-resolution risk maps 
for rat abundance by placing tracking plates at 440 spatially randomized 
locations in a Brazilian slum community (0.46 km2) with high leptospirosis 
infection rates (35.4% CI, 30.7 - 40.6 per 1,000). We performed 
environmental surveys at sampling points and used satellite imagery to 
derive spatially relevant covariates. We analyzed the data using an interval-
censored mixed model to evaluate the association between tracking 
board metrics and environmental characteristics. Among the 402 (91.4%) 
points that were successfully sampled, 173 (43%) had signs of rat-specific 
markings. Tracking plate-ascertained rat abundance was associated 
with the number of rat burrows (OR 1.32 CI 1.18 - 1.48), rat trails (OR 
2.10 CI 1.8 - 2.62) and sites with rat feces (OR 1.39 CI 1.17 - 1.64). The 
distribution and intensity of rat abundance was highly heterogeneous. 
Clustering of rat abundance was identified throughout the study site and 
generally <20m in diameter. Clusters were associated with domestic areas 
(OR 1.47 CI 1.21 - 1.79) and areas with access to open sewers (OR 2.05 
CI 1.69 - 2.48). Conversely, impervious surfaces (OR 0.55 CI 0.38 - 0.80) 
and increasing distance from flood-prone areas (OR 0.29 CI 0.17 - 0.50) 
and public trash dumps (OR 0.74 CI 0.60 - 0.96) were associated with 
decreased risk of rat abundance. By using tracking boards to create 
high-resolution risk maps, we identified defined environmental features 
of slum communities, which predict rat abundance. We also found that 
while rat abundance is high, there is marked spatial heterogeneity in the 
microenvironment, which may offer an opportunity for targeted rodent 
control for leptospirosis.
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FRACTION OF ALL UNDER FIVE DEATHS CAUSED DIRECTLY 
OR INDIRECTLY BY MALARIA IN SUB-SAHARAN AFRICA 
FROM 2000-2015
Donal Bisanzio1, Bonnie Mappin2, Harry S. Gibson1, Samir Bhatt1, 
Daniel J. Weiss1, Ewan Cameron1, Ursula Dalrymple1, Peter W. 
Gething1
1Oxford University, Oxford, United Kingdom, 2University of Queensland, 
Brisbane, Australia
Malaria cases have declined in sub-Saharan Africa due to the scale-up of 
interventions, and a consistent reduction in child mortality since 2000 has 
been recorded. In order to quantify the effect of malaria interventions 
on child mortality rates, we estimated the proportion of all-cause deaths 
attributed to malaria by direct and indirect causes. A detailed dataset of 
978253 birth histories was assembled using cross sectional household 
surveys. The dataset included information on social and health factors. 
Birth history data were merged with Plasmodium falciparum prevalence 
rates and environmental and socioeconomic covariates obtained by remote 
sensing. Bias analysis was applied to identify confounders and effect 
modifiers among social and health covariates. A spatio-temporal hazard 
model was applied to estimate the relative risk of malaria for the surveyed 
communities. A structured additive regression (STAR) model was applied to 
generate a risk map for sub-Saharan Africa. The results of the STAR model 
were used to estimate the proportion of all-cause under 5 deaths due to 
malaria as direct and indirect cause at country level from 2000 to 2015.
The proportion of all-cause deaths linked with malaria reduced drastically 
from 2000 to 2015. The reduction was more marked in Western and 
South Africa than in Central and Eastern Africa. Countries which have 
increased artemisinin-based combination treatments for children with 
non-complicated malaria showed a marked reduction of child deaths. 
The estimates of under 5 deaths indirectly or directly caused by malaria 
were higher than those calculated for malaria as direct one-cause-one 
death. The reduction of malaria transmission had significant impact on 
child mortality rates. The number of lives saved by the scale-up of malaria 
interventions was higher than previously estimated.
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AND THEIR ASSOCIATION WITH DRUG PRESSURE AND 
TRANSMISSION INTENSITY
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Sulphadoxine-pyrimethamine (SP) was formerly widely used as a first-line 
treatment for Plasmodium falciparum, and continues to be important 
for prevention of malaria in pregnant women and children. Parasite 
mutations which confer resistance to SP spread earlier and more rapidly 
in some areas than others. Understanding why some areas are vulnerable 
to resistance could help inform surveillance and resistance prevention, 
and assess whether currently available data are sufficient to identify areas 
at risk. Here, we updated a systematic review on the K540E and A581G 
mutations in the dhps gene in Africa to 2016, previously completed in 
2011. We geolocated each estimate, and linked each resistance data 
point with data from the same area and time, where available, on (a) 
slide prevalence, using Malaria Atlas Project estimates, and (b) SP use 
amongst febrile under five year olds, and coverage of intermittent 
preventive treatment in pregnancy (IPTp) from Demographic & Health 
Surveys and MICS Surveys, as well as SP market share from ACTWatch. 
Associations between resistance, drug pressure and transmission intensity 
were analysed using weighted regression. The systematic review resulted 
in 362 estimates of the prevalence of K540E and 220 A581G. In East 
Africa, the prevalence of both mutations generally increased or remained 
high, despite the end of first-line SP treatment policies. Here, the A581G 
emerged in locations where the prevalence of K540E was >50%. In West 
Africa, the K540E prevalence still did not reach levels as high as East 
Africa. In some sites where it emerged, later surveys no longer detected 
it. However, here the A581G mutation occurred when K540E was absent. 
We found a strong association between SP drug use in under-fives 
and K540E prevalence (p<0.001), but not A581G prevalence. Neither 
mutation was associated with IPTp coverage, nor SP market share data, 
nor transmission intensity. We are currently adding further covariates to 
the analysis, including age, presence of symptoms, and cotrimoxazole use. 
Our analysis could help inform surveillance for SP resistance mutations and 
potentially future emergent strains resistant to other antimalarials.
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CARRIAGE IN SOUTH AMERICA, ASIA AND THE SOUTH 
PACIFIC
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Reducing human-to-mosquito transmission is crucial to control and 
eliminate malaria, yet not everybody infected is infective to mosquitos. 
To identify those contributing most to transmission, cross-sectional 
surveys of the general population were conducted in Brazil, Thailand, 
Papua New Guinea and Solomon Islands, including 18,979 individuals. 
Plasmodium falciparum and P. vivax were diagnosed using microscopy 
and highly sensitive qPCR assays. Over 80% of individuals were 
asymptomatic, yet they accounted for 84% of P. falciparum and 86% of 
P. vivax gametocyte carriers. Blood-stage parasite density was the main 
predictor for gametocyte positivity in all surveys. Each 10-fold increase in 
parasite density resulted in a 1.5-fold and 3.9-fold increase in the odds 
of P. falciparum and P. vivax gametocyte positivity. For P. vivax a close 
correlation between parasite and gametocyte densities was found. By 
microscopy asexual stages and/or gametocytes were detected in 37-72% 
of individuals positive for P. falciparum gametocyte by RT-qPCR, and in 
42-91% of P. vivax gametocyte carriers. Across all surveys, 95-99% of the 
total gametocytes biomass was found in microscopy positive samples, with 
no apparent correlation between transmission level and the proportion 
gametocyte carriers identified by microscopy. Microscopy is thus a 
valuable tool to identify asymptomatic infections contributing to malaria 
transmission. While in high transmission settings a large proportion of 
all gametocyte carriers and 85-99% of all gametocytes were found in 
children below 6 years, gametocytes were evenly distributed across all ages 
in low transmission settings. This suggests that interventions to reduce 
transmission in high transmission areas will have the greatest effect when 
targeted towards children, but in order to achieve elimination in low 
transmission settings individuals of all ages must be targeted.
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DIABETES AND OBESITY AS RISK FACTORS FOR SEVERE 
MALARIA: AN OBSERVATIONAL STUDY OF COMORBIDITIES 
IN PLASMODIUM FALCIPARUM CASES DIAGNOSED IN 
SWEDEN OVER 20 YEARS
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Saddudin1, Pontus Naucler1, Anna Färnert1
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Non-communicable diseases and obesity are increasing global health 
problems, also in malaria endemic countries. The impact of these 
conditions on the severity of malaria needs to be established. The aim 
of this study was to assess if comorbidity, in terms of chronic diseases 
and obesity, is associated with severe malaria in adults with Plasmodium 
falciparum. Patients aged >18 years with P. falciparum malaria diagnosed 
at multiple sites throughout Sweden 1995-2015 were included in 
the study. Medical records were retrospectively reviewed regarding 
demographics, travel history, clinical presentation, weight, height, and 
comorbidity. Severe malaria was defined according to WHO criteria 
and hyperparasitaemia >5%. Obesity was defined as body mass index 
(BMI) ≥30, according to WHO classification. Data was analysed using 
multivariable logistic regression models. 937 patients with P. falciparum 
malaria were included in the study, 547 (58.4%) originated from endemic 
countries in Sub-Saharan Africa and 388 (41.4%) from non/low endemic 
countries. In total, 92 patients fulfilled the criteria of severe malaria, of 
which 22 (23.9%) had at least one comorbidity included in the Charlson 
Comorbidity Index compared to 84 (9.9%) among non-severe cases 
(p <0.001). Age, health care delay, origin in non/low endemic country, 
diabetes, hypertension, cardiovascular disease, HIV and BMI ≥30 were 
associated with severe malaria in univariable analyses. In multivariable 
analysis adjusted for age, health care delay, patient origin and HIV, 
both diabetes and obesity were associated to severe malaria. Patients 
with obesity together with another metabolic risk factor (hypertension, 
dyslipidaemia or diabetes) had an even more pronounced risk of severe 
malaria in adjusted analysis. In conclusion, diabetes and obesity were 
independently associated with an increased risk of severe malaria in adults 
diagnosed with P. falciparum in Sweden. These metabolic comorbidities 
need to be considered in the acute management and prevention of 
malaria in adults. Moreover, their role in human malaria pathology needs 
to be further investigated.
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THE DESCRIPTIVE EPIDEMIOLOGY OF PEDIATRIC SEVERE 
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Severe malarial anemia, defined as hemoglobin <5 g/dL in the presence 
of a Plasmodium falciparum infection, is the most common manifestation 
of severe malaria among young children in regions with very high malaria 
transmission. However, basic questions persist about the natural history 
of this profound anemia and the factors that contribute to an individual’s 
risk of developing this syndrome during malaria infections. Drawing on 
birth cohort data collected from over 75,000 study visits with 880 children 
in the Mother Offspring Malaria Studies Project (2002-2006) in Muheza, 
Tanzania, and 1647 children in the Malaria Research and Training Centre-
Laboratory of Malaria Immunology and Vaccinology Immuno-Epidemiology 
Observational Study (2010-2016) in Ouélessébougou, Mali, we aimed to 
describe in detail the epidemiology and pathogenesis of severe malarial 
anemia in early life. While severe malarial anemia occurred at older 
ages in the seasonally endemic Malian study site (median (IQR): 63 (39, 
100) weeks) than in the perennially endemic Tanzanian setting (median 
(IQR): 34 (29, 52) weeks), these data suggest that the pathogenesis of 
malarial anemia is largely conserved across transmission settings. We will 
present data describing the associations between severe malarial anemia 
risk and parasite density, baseline hemoglobin levels, and bioavailable 
iron in early life. We will also use individual case data to illustrate that, 
although a subset of cases arise from gradually declining hemoglobin 
profiles associated with repeated infections, severe malarial anemia more 
commonly presents as an acute drop in hemoglobin. From a public health 
perspective, these findings reinforce the value of campaigns designed to 
interrupt malaria transmission and to reduce high density infections.
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OF MALARIA CASES: THE CASE STUDY OF SWAZILAND, 
2010-2014
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Menach5, Nyasatu Ntshalintshali4, Bongani Dlamini4, David Smith6, 
Andrew Tatem2, Simon Kunene4
1National Malaria Control Programme, Swaziland, Mbabane, Swaziland, 
2WorldPop Project, University of Southampton, Southampton, United 
Kingdom, 3Clinton Health Access Initiative, Nairobi, Kenya, 4Clinton Health 
Access Initiative, Mbabane, Swaziland, 5Clinton Health Access Initiative, 
Boston, MA, United States, 6University of Washington, Seattle, WA, United 
States
As Swaziland gets closer to its 2018 national elimination goal, importation 
of parasites into receptive areas becomes increasingly important; imported 
infections have the potential to instigate local transmission and sustain 
local parasite reservoirs. Travel history (reported travel in the last 8 weeks) 
from Swaziland’s routine surveillance data from 2010 to June 2014 was 
extracted to describe and compare travel patterns of RDT-confirmed index 
cases (identified passively) to travel patterns of individuals that tested 
negative (during re-active case detection, where the contacts in the vicinity 
of an index case within receptive areas were tested). Reported destinations 
of travel were geo-located to the smallest administrative boundary 
possible. Of 1,517 confirmed index cases 67% reported travel history, 
whilst 105 (1%) of the 9,859 contacts screened during the reactive case 
detection were RDT positive. 876 index cases travelled internationally. The 
proportion of index cases reporting travel history increased by year with 
a 48% increase per annum for international travel and 27% increase for 
travel within Swaziland. 25% of screened contacts reported international 
travel, of which 22% tested positive for malaria. Mozambique was the 
most likely travel destination of positive individuals, with Maputo City, 
Inhambane and Gaza being the most likely destinations in Mozambique. 
97% percent of RDT positive international travellers were either Swazi 
(52%) or Mozambican (45%), however Swazis were more likely to test 
negative. All international travellers were unlikely to have a bed net at 
home or use protection while travelling. 84% of the 755 males and 
60% of the 440 females that travelled abroad tested positive. Overall, 
24 to 45 year olds were most likely to report travel. Additionally, paths 
of transmission, important border crossings and means of transport were 
identified. Results from this analysis can be used to direct national and well 
as cross-border targeting of interventions, over space, time and by sub-
population. Collaboration between neighbouring countries is needed to 
tackle the importation of malaria at the regional level.
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PLASMODIUM KNOWLESI MALARIA IN CHILDREN IN 
MALAYSIA: NO SEVERE DISEASE DESPITE AN INCREASED 
RISK OF ANAEMIA COMPARED TO ADULTS
Matthew J. Grigg1, Timothy William2, Bridget E. Barber1, Giri S. 
Rajahram2, Jayaram Menon2, Christopher S. Wilkes1, Kaajal Patel1, 
Arjun Chandna1, Christopher J. Drakeley3, Tsin W. Yeo1, Nicholas 
M. Anstey1
1Menzies School of Health Research and Charles Darwin University, 
Darwin, Australia, 2Infectious Disease Society Kota Kinabalu Sabah 
- Clinical Research Centre Queen Elizabeth Hospital, Kota Kinabalu, 
Malaysia, 3London School of Hygiene & Tropical Medicine, London, United 
Kingdom
Plasmodium knowlesi is now the most common cause of malaria in 
Malaysia, but prospective studies describing the clinical spectrum have 
only detailed adult disease. In our prospective study (2012-ongoing) at 3 
district hospitals in Sabah, Malaysia, previously untreated, non-pregnant 
patients of any age hospitalised with PCR-confirmed malaria includes: 500 
P. knowlesi (49 [9.8%] children ≤12 yrs), 204 P. vivax (83 [40.7%] children), 
103 P. falciparum (33 [32%] children), 26 P. malariae, 1 mixed Pk/Pf and 
1 mixed Pv/Pf. Preliminary data include a lower baseline parasite count 
for P. knowlesi malaria patients (median 2480/µL, IQR 538-8481) than 
P. falciparum (9600/µL [IQR 1446-25440]; p<0.001), and P. vivax (3882/
µL, [1454-9608]; p=0.016). Parasite counts were higher in adults with 
P. knowlesi compared to children (median 2800 vs. 1535/µL; p=0.019). 
Anaemia (WHO criteria) was present in 32% (95%CI 27-36) of adults 
vs. 81% (95%CI 70-93) of children with knowlesi malaria (p<0.001); 
comparable to that seen in children with P. vivax (82%; p=0.948) or P. 
falciparum (76%; p=0.551). Acute kidney injury (AKIN criteria and/or 
creatinine >132mmol/L) was found in 26% (95% CI 22-30) of those with 
P. knowlesi malaria including 111/437 (25%) of adults and 13/46 (26%) 
of children (p=0.673). There was a higher prevalence of acute kidney 
injury in children with P. knowlesi malaria (26%) compared to P. vivax 
(12.5%; p=0.027) but not P. falciparum (30.3%; p=0.844). Severe malaria 
(modified WHO 2010 criteria) was present in 6.4% (95%CI 2.4-9.6%) 
of those with P. knowlesi overall: 32/451 (7.1%) in adults but none in 
children. In comparison, severe disease was seen in 6/204 (2.9%; p=0.065) 
with P. vivax and 4/103 (3.9%; p=0.326) with P. falciparum. There were no 
treatment failures in knowlesi malaria patients seen at 28 days. There was 
one P. knowlesi malaria death, an adult (age 62) with delayed parenteral 
artesunate due to misreported hyperparasitaemia. Overall P. knowlesi 
malaria predominantly affected adults, and while anaemia was more 
common in children, parasitemia was lower and severe disease was not 
seen.
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ASSESSMENTS OF WILDLIFE RESERVOIRS OF 
TRYPANOSOMA CRUZI AND THEIR INTERACTIONS WITH 
TRIATOMINE VECTORS ACROSS TEXAS
Sarah A. Hamer, Rachel Curtis-Robles, Carolyn L. Hodo, Gabriel 
L. Hamer
Texas A&M University, College Station, TX, United States
Despite the importance of various wildlife species for perpetuating 
Trypanosoma cruzi, agent of Chagas disease, in nature, little is known 
about the relationship between infection and cardiac disease in wildlife, 
or the relative importance of wildlife species for feeding bugs. Using a 
cross-sectional study design, we collected cardiac tissue and blood from 
potential T. cruzi reservoirs across Texas, a state with widespread endemic, 
infected triatomines. Target species included migratory bats, nuisance rats 
(Rattus rattus), feral swine (Sus scrofa), and hunter-harvested predators 
including raccoon (Procyon lotor), coyote (Canis latrans), gray fox (Urocyon 
cinereoargenteus), and bobcat (Lynx rufus). Concurrently, we collected 
triatomines from regions of wildlife trapping and through a statewide 
citizen science campaign. Wildlife samples were tested for T. cruzi and 
parasite lineage was ascertained from the TcSD5D gene sequence. Vector-
host interactions were determined using a bloodmeal analysis to amplify 
the vertebrate cytB gene in bug hindguts. No rats (n=152), a single bat 
(n=593), 5.6% of feral swine (n=54), 13.8-14.3% of bobcats, coyotes, 
and foxes (n=156), and 70% of raccoons (n=70) were infected with T. 
cruzi. The bat harbored lineage TcI, whereas TcIV was found in all raccoons 
that were typed. Although a histologic survey of right ventricles showed 
21.1% of PCR-positive raccoons had mild lymphoplasmocytic infiltration, 
no other lesions were observed in raccoons, and none of the positive 
pigs showed cardiac pathology, suggesting infection is associated with 
minimal cardiac disease in these species. Diverse wildlife species were 
identified as bloodmeal hosts in an analysis of 76 bugs, including rats, 
raccoons, rabbits, feral swine, squirrel, fox, skunk, opossum, deer, and 
toads, but the majority of hosts were dogs (50%) and humans (22.4%), 
likely reflecting the nature of bugs encountered in the citizen collection 
program. Characterization of the robust sylvatic transmission cycles of T. 
cruzi combined with analyses of local triatomine feeding patterns will lead 
to ecological interventions to reduce Chagas disease risk.
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LEISHMANIA INFANTUM PARASITEMIA IN ASYMPTOMATIC 
BLOOD DONORS IN AN ENDEMIC REGION OF NORTHEAST 
BRAZIL
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Macedo-Silva1, Jose W. Queiroz1, Francisco S. Bezerra4, Kathryn M. 
Dupnik5, Richard D. Pearson6, Mary E. Wilson2
1Federal University of Rio Grande do Norte, Natal, Brazil, 2University of 
Iowa, Iowa City, IA, United States, 3Emory University, Atlanta, GA, United 
States, 4Universidadae Federal Rural do Semi Arido, Mossoro, Brazil, 
5Cornell University, New York, NY, United States, 6University of Virginia, 
Charlottesville, VA, United States
Leishmania infantum causes fatal visceral leishmaniasis (VL), but a majority 
of infections are asymptomatic.  Transmission by blood transfusion 
has been documented in Europe, but the potential impact of L. 
infantum in blood donations in Latin America has not been assessed.  We 
hypothesized that blood donations contaminated with L. infantum would 
be found at the blood bank serving Natal, northeastern Brazil, a city with 
a high prevalence of periurban L. infantum infection.  Blood donations 
were examined for occult Leishmania infection in the Natal blood 
center. Three-hundred blood units initially rejected on the basis of positive 
screening for pathogens including T. cruzi or insufficient volume, and 
254 samples from routine blood donors were assessed for Leishmania by 
culture, qPCR, and serology (ELISA). Remarkably, 18 of 300 (4%) rejected 
blood units were culture positive for L. infantum.  qPCR was positive for 
Leishmania in 8.7%, and 22% were seropositive for Leishmania. Anti-
Leishmania antibody levels correlated with Leishmania load by qPCR. Of 
the 254 blood samples that tested negative for other pathogens, 28.4% 
were seropositive for Leishmania, 7.7% were qPCR positive and one 
was culture positive. T. cruzi ELISA detected only 14/18 culture positive, 
38/107 seropositive, and 22/37 qPCR positive donations.  In conclusion, 
asymptomatic Leishmania infantum infections are associated with infected 
blood donations in northeastern Brazil.  DNA testing by qPCR seemed the 
most sensitive and specific donor screening method.  Serological assays 
for T. cruzi detected many but not all of the Leishmania-infected donors, 
likely due to cross-reacting antibodies and/or dual infections. The data 
suggest a need to screen blood donations for L. infantum in residents of, 
and immigrants from endemic regions.
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CUTANEOUS AND MUCOCUTANEOUS LEISHMANIASIS 
IN INTERNATIONAL TRAVELERS: RESULTS FROM THE 
GEOSENTINEL SURVEILLANCE NETWORK
Andrea K. Boggild1, Eric Caumes2, Bradley A. Connor3, Sumontra 
Chakrabarti4, Philippe Parola5, Noreen A. Hynes6, Jay S. Keystone1, 
Michael Libman7, Theodore Nash8, Eli Schwartz9, Adrienne J. 
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NY, United States, 4Trillium Health Sciences Centre, Mississauga, ON, 
Canada, 5University Hospital Institute for Infectious Diseases, Aix-Marseille 
University, Marseille, France, 6Johns Hopkins University School of Medicine, 
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Due to increasingly exotic travel, displacement of migrant populations, 
and expanding vector ranges, cutaneous leishmaniasis (CL) is emerging 
among international travelers and migrants, and limited data exist 
on mucocutaneous leishmaniasis (MCL) in travelers. We describe the 
epidemiology of travel-associated CL and MCL among international 
travelers and immigrants over an 8-year period through descriptive analysis 
of GeoSentinel data. Demographic and travel-related data on returned 
international travelers diagnosed with CL or MCL at a GeoSentinel 
Surveillance Network site between March 15, 2007 and August 31, 
2015, were analyzed. Eight-hundred, twenty-eight returned travelers 
or new immigrants were diagnosed with CL or MCL during the study 
period, 824 (99.5%) of which were travel-acquired. Of travel-acquired 
cases, immigrants accounted for 8% (n=66). For all non-immigration 
travelers, the most common source countries were Bolivia (n=150, 19.8%) 
and Costa Rica (n=89, 11.7%), while for new immigrants, they were 
Afghanistan (n=18, 27.3%) and Syria (n=15, 22.7%). Eighty-one travelers 
(9.8%) acquired their disease on trips of ≤2 weeks. Species identification 
was available for 218 cases (26.5%). Leishmania Viannia braziliensis 
was the most well represented strain (n=93, 45.6%), followed by L. 
major (n=31, 15.2%), and L. V. panamensis (n=27, 13.2%). Thirty-five 
cases of MCL occurred, most of which were in tourists (n=26, 74.3%) 
and acquired in Bolivia (n=16, 45.7%). CL is predominantly a disease 
of tourist travelers to areas such as Bolivia where risk of acquiring L. V. 
braziliensis and subsequent MCL is high. That many travelers acquired 
their illness on trips lasting ≤2 weeks challenges the common notion 
that CL is a disease of prolonged travel. New immigrants from areas of 
conflict and political instability, such as Afghanistan and Syria, were well 
represented, suggesting that as mass migration of refugees continues, CL 
will be increasingly encountered in intake countries. Initiatives to enhance 
awareness and assure adequate resources for diagnosis and management 
of leishmaniasis are needed.
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SEROLOGICAL INDICATORS OF INFECTION AND THE 
DEVELOPMENT OF CLINICAL VISCERAL LEISHMANIASIS IN 
ETHIOPIA
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Visceral leishmaniasis (VL) is a vector-borne parasitic disease that results 
in 40,000 deaths annually. In East Africa, human infection by Leishmania 
donovani occurs via anthroponotic transmission, while the role of 
zoonotic routes remains unclear. Increased risk for VL is associated with 
malnutrition, male sex, and animal ownership. A recent upsurge in case 
counts and spatial spread of the disease in Ethiopia have demonstrated 
the need for more effectively implemented control policies. Data from 
a prospective cohort study conducted between 2011-2013 in northern 
Ethiopia provided longitudinal distributions of infection intensities 
(assessed by qPCR) and rates of seropositivity (assessed by direct 
agglutination test, DAT). Multivariate logistic regression with model 
selection allowed for evaluating independent risk factors for L. donovani 
exposure, seropositivity, and development of clinical VL. At baseline, 
14.1% of 4,722 individuals had >0 parasites per ml of blood and 3.3% 
were seropositive at DAT titers >1:800. Despite similar distributions of 
infection intensity to females, males were significantly more likely to be 
seropositive during the study (6.8% vs 3.6%, P<0.001). After adjustment 
for age and body mass index, seropositivity was associated with infection 
intensities >100 parasites per ml blood. Seventy-five incident VL cases 
were recorded during the study period. Progression to clinical disease 
was significantly related to male sex (OR: 1.68, 95% CI: 1.01, 2.80), DAT 
positivity (OR: 4.60, 95% CI: 2.25, 9.41) and high infection intensity, 
specifically 101-1000 parasites per ml blood (OR: 4.67, 95% CI: 1.80, 
12.13). Significantly increased odds of infection, seropositivity, and clinical 
disease were associated with having a seropositive household member. 
Simultaneous seropositivity and high infection intensity were significantly 
associated with progression to clinical VL. Males tended to exhibit these 
risk factors more than females. Identifying people with DAT titers >1:800 
and then performing routine qPCR to determine the subset with high 
infection intensity could be a strategy for targeted intervention.
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PROGRESSION AND MORTALITY RATES FOR MODELLING 
THE BURDEN OF CHAGAS DISEASE
Zulma Cucunubá, Pierre Nouvellet, Omolade Okuwoga, Lesong 
Conteh, María-Gloria Basañez
Imperial College London, London, United Kingdom
Accurate estimates of morbidity and mortality due to Chagas disease 
are needed to improve burden of disease evaluations. For parasitic 
infections, disease burden models link infection frameworks with 
associated morbidity (sequelae) and mortality, a much needed area of 
research for a better understanding of the impact and cost-effectiveness 
of control interventions. Such modelling efforts require elucidating the 
relationship between infection and disease as well as its rigorous and 
robust parameterisation. A systematic review was conducted to identify 
observational (longitudinal) studies comparing disease progression and 
mortality rates in populations with and without Chagas disease. Literature 
databases were searched without restrictions on publication language or 
date; 8,935 potentially relevant references were screened. Information on 
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selected papers was extracted and analysed using a random-effects model 
for both disease progression and mortality rates. The results of a previously 
developed force-of-infection model (for Colombia), yielding incidence 
and prevalence trends were linked to the progression and mortality rates 
thus quantified. This disease model was used to calculate the Disability 
Adjusted Life Years (DALYs) attributed to Chagas disease in Colombia. For 
assessment of progression rates, 19 studies were selected which provided 
49,792 patient-years of follow-up. The general progression rate was 2% 
per year (95%CI: 1.7-3.4). For mortality rates, 25 studies were selected, 
providing data on 53,346 patient-years of follow-up, and 2,739 events. 
Pooled estimates revealed that Chagas disease patients have significantly 
higher annual mortality rates (AMR) compared with non-Chagas disease 
patients (0.18 vs. 0.10; RR = 1.74, 95 % CI 1.49-2.03). The application of 
these progression and mortality rates to burden of disease models allows 
us to estimate figures and burden metrics by clinical stage. A more refined 
analysis would allow us to estimate progression to megaesophagous, 
stroke and other outcomes.
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DEFINITIONS AND FEASIBILITY OF ELIMINATION OF 
VISCERAL LEISHMANIASIS
Epke Le Rutte1, Lloyd A. Chapman2, Luc E. Coffeng1, Sarah 
Jervis2, Graham F. Medley3, Deirdre T. Hollingsworth2, Sake J. de 
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United Kingdom
Visceral leishmaniasis (VL) is the second deadliest parasitic disease globally 
and has been targeted by the WHO for elimination and control by 2020. 
Two separate modeling approaches have been used to look into the 
feasibility of reaching the targets with current intervention strategies. 
‘Elimination of VL as a Public Health problem’, the target for the Indian 
subcontinent, is predicted feasible in low and medium endemic regions 
with optimal implementation of interventions. However, highly endemic 
areas and regions with suboptimal interventions are likely not to achieve 
the target on time and will require additional efforts. ‘Elimination of 
Disease’, the target for the rest of the world, can be achieved by more 
regular serology testing, to identify which individuals are likely to develop 
clinical symptoms, so that they can be treated promptly. This should 
reduce the intensity of transmission and could lead to ‘Elimination of 
Transmission’. The remaining knowledge gaps in the disease dynamics of 
VL, such as the contribution of asymptomatic individuals to transmission, 
present a challenge to reaching and sustaining the elimination targets.
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HOW MUCH DO ASYMPTOMATICS CONTRIBUTE TO 
TRANSMISSION AND HOW DOES TRANSMISSION DECREASE 
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Programme, Dhaka, Bangladesh, 3University of California San Francisco, 
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A key unknown in the transmission of visceral leishmaniasis is how much 
asymptomatically infected individuals contribute to transmission. Since 
they significantly outnumber individuals who develop clinical symptoms 
(by 4-10 times in the Indian subcontinent) and are often infected for a 
long period, they may contribute substantially to transmission even if 
their relative infectivity to sandflies is low. This has important implications 
for attempts to control and eliminate the disease, as there is currently no 
safe treatment for asymptomatic infection, and interventions are focussed 
on reducing transmission through rapid diagnosis and treatment of 
symptomatic cases combined with indoor residual spraying of insecticide 
in endemic areas. Efforts to determine the infectivity of asymptomatic and 
symptomatic individuals via xenodiagnostic trials are ongoing, but these 
critical parameters are not known. Another unknown factor that has major 
implications for control is how the risk of transmission varies with distance 
from infectious individuals. This is key to determining whether responsive 
insecticide spraying strategies, in which houses within a certain radius of 
an index case are sprayed, will reduce transmission. To start to address 
these questions we have developed an individual-based spatiotemporal 
model of visceral leishmaniasis transmission and fitted it to detailed 
epidemiological and serological data from three highly endemic villages in 
Bangladesh to estimate the infectivity of asymptomatic individuals and the 
spatial kernel of transmission. Using Bayesian MCMC methods we have 
been able to account for the unknown times of infection of asymptomatic 
and symptomatic individuals, variation in infected individuals’ infectivities 
over time, and potential false positives from serological tests. Our results 
suggest that the contribution of asymptomatic individuals to transmission 
in this highly endemic setting was small compared to that of individuals 
with clinical VL, and that the risk of infection was greatest for individuals 
within 40m of a VL case within 6 months of their onset of symptoms.
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DOES ARTIMISININ BASED COMBINATION THERAPY 
INFLUENCE MOSQUITO FITNESS AND HOST-SEEKING 
BEHAVIOR?
Jetske de boer, Annette Busula, Willem Takken
Wageningen University, Wageningen, Netherlands
Artemisinin-based combination therapy (ACT) is recommended against 
malaria in many endemic areas, and thus widely used. Surprisingly little 
is known about the effect of ACTs on mosquitoes that transmit malaria 
parasites. Our objectives were to (1) determine whether ACTs have a 
direct impact on mosquito fitness when added to the bloodmeal, and 
(2) evaluate whether ACTs influence mosquito host-seeking behavior by 
changing the intrinsic attractiveness of human skin odor. Our study was 
done with Anopheles gambiae s.l., which is the main vector of malaria 
in sub-Saharan Africa. Mosquitoes that were fed on blood with ACT 
survived equally long as mosquitoes fed on control blood. ACT-fed and 
control mosquitoes also laid equal numbers of eggs, thus fitness was 
not affected by the treatment. To investigate host-seeking behavior of 
mosquitoes, adult malaria-free men were given a treatment dose of an 
ACT, and skin odor was collected on nylon socks before, during and three 
weeks after treatment. A screenhouse choice test showed no preference 
of An. gambiae females between socks worn by the same person before, 
during or after ACT-treatment. Relative attractiveness of nylon socks to 
An. coluzzii in a dual-choice olfactometer was also not influenced by ACT-
treatment although mosquitoes appeared to be more responsive to skin 
odor collected three weeks after ACT-treatment. We conclude that ACT-
treatment does not affect fitness and host-seeking behavior of malaria 
mosquitoes. Our results are important in light of possible transmission of 
gametocytes from ACT-treated people to malaria vectors.
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UNEXPECTEDLY LOW HUMAN BLOOD INDEX ASSOCIATED 
TO HIGH PLASMODIUM SPOROZOITE RATES IN ANOPHELES 
GAMBIAE COMPLEX SPECIES FROM A LLIN-PROTECTED 
VILLAGE IN BURKINA FASO
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The global effectiveness of long-lasting insecticidal nets (LLINs) in 
reducing malaria transmission is indisputable. However, in areas where 
malaria transmission levels are extremely high, substantial reductions 
in transmission intensity only led to a modest reduction in human 
parasitaemia. A paradigmatic case is represented by Burkina Faso where, 
after a few years of mass distribution of LLINs, the burden of malaria 
has not significantly changed as highlighted by WHO Country statistics 
and statistical bureau of Burkina Faso. We here report the results of a 
longitudinal survey on host choice and Plasmodium sporozoite rate (SR) in 
malaria vectors belonging to Anopheles gambiae complex in a rural village 
of Burkina Faso where LLINs were broadly distributed the year before the 
sampling (August - November 2011). The human blood index (HBI) was 
18.8% (N=112) and 8% (N=75), in An. coluzzii and An. arabiensis, the 
two most abundant malaria vectors in the area. These values are much 
lower than usually reported particularly for An. coluzzii, which is known 
as a highly anthropophilic species, but consistent with the hypothesis that 
LLINs reduced the availability of human hosts to mosquitoes. Unexpectedly, 
Plasmodium sporozoite rates (An. coluzzii: 7.6%, N=449; An. arabiensis: 
5.2%, N=229) were found to be in the range of those reported in 
the region before LLIN implementation when much higher HBIs were 
observed. This suggests that, despite LLINs have significantly reduced 
human/vector contact, this has not apparently yielded to a substantial 
reduction of mosquito infection rates. Further investigations are needed 
to confirm these results; however, they are fully consistent with the lack of 
effectiveness of LLINs in stemming malaria transmission in the study area.
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THE WMEL STRAIN OF WOLBACHIA REDUCES 
TRANSMISSION OF ZIKA VIRUS IN AEDES AEGYPTI
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Zika virus (ZIKV) is an arbovirus that belongs to the family Flaviridae. 
It currently is causing an explosive outbreak of febrile disease in the 
Americas. During the current outbreak, a causal relationship has been 
established between prenatal ZIKV infection and microcephaly and other 
serious brain anomalies. Most human cases around the globe result from 
ZIKV emergence into a human-mosquito cycle involving Aedes aegypti 
and/or other urban or peri-urban Aedes species. Despite the continued 
spread of the virus, there remain no effective antiviral therapies or licensed 
vaccines. Thus, with its continued invasion of the new world, the only 
tools presently available to combat Zika target mosquito populations, 
mostly with insecticides and larval source reduction. But, these strategies 
have not prevented invasion of this virus into new locales and have not 
been adequate to control the virus upon arrival. A promising candidate 
for arbovirus control and prevention relies on the introduction of the 
intracellular bacterium Wolbachia into Ae. aegypti mosquitoes. This 
primarily has been proposed as a tool to control dengue virus transmission; 
however, evidence suggests Wolbachia infections confer protection for Ae. 
aegypti against chikungunya virus as well. Although this approach holds 
much promise for limiting virus transmission, at present our understanding 
of the ability of ZIKV to infect, disseminate, and be transmitted by wMel-
infected Ae. aegypti currently being used at Wolbachia release sites is 
unknown. Using Ae. aegypti infected with the wMel strain of Wolbachia 
that are being released in Medellin, Colombia, we report that these 
mosquitoes have reduced vector competence for ZIKV. In fact, we were 
not able to detect infectious ZIKV in the saliva of mosquitoes at any 
timepoint assayed. These data argue for the expansion of this technology 
to ZIKV in South and Central America and are useful and germane in the 
broader context of ZIKV-mosquito interactions. Finally, we also describe 
a biologically relevant model for studying ZIKV transmission dynamics 
(feeding on a viremic host) that does not rely on animal blood spiked with 
cultured virus.
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COMBINING CONTACT TRACING WITH TARGETED INDOOR 
RESIDUAL SPRAYING SIGNIFICANTLY IMPACTS DENGUE 
TRANSMISSION
Gonzalo M. Vazquez-Prokopec1, Brian Montgomery2, Peter 
Horne3, Julie Clennon1, Scott Ritchie4
1Emory University, Atlanta, GA, United States, 2Queensland Health, 
Brisbane, Australia, 3Queensland Health, Cairns, Australia, 4James Cook 
University, Cairns, Australia
The current paradigm for dengue virus (DENV) control relies on reactive 
measures aimed at containing virus transmission around the home 
residence of confirmed symptomatic cases. Unfortunately, the impact of 
such strategy on preventing virus transmission is very limited. Furthermore, 
the recent emergence of Chikungunya and Zika infections in the Americas 
elevates the need for more efficacious tools for virus surveillance, Aedes 
aegypti control and disease mitigation. We quantitatively investigated 
the epidemiological value of performing location-based contact tracing 
(incorporating potential out-of-home exposure locations by phone 
interviews associated with ongoing DENV passive surveillance) in improving 
identification of local dengue transmission foci across a metropolitan 
area (Cairns, Australia). Using space-time interaction tests applied to 
2,064 potential exposure locations reported by contact tracing from 902 
DENV-confirmed cases we statistically identified DENV transmission chains 
across the metropolitan area. We used such estimates of transmission to 
empirically evaluate the epidemiological impact of targeted indoor residual 
spraying (TIRS) with insecticides (application of residual insecticides at Ae. 
aegypti indoor resting sites). The city of Cairns was identified as a central 
hub for DENV transmission (95.2% of transmission events of Cairns 
residents and 60.4% of transmission events of residents of satellite towns 
were tracked to locations found within Cairns). Out-of-home exposure 
accounted for 57.2% of all putative transmission sites. Performing IRS in 
contact locations lead to a significant protective efficacy (0.86-0.96) in 
preventing DENV transmission. We provide quantitative evidence of the 
positive value of enhancing surveillance of urban DENV by performing 
location-based contact tracing and targeting indoor residual spraying 
operations at putative transmission sites identified from such data. While 
this approach was applied in a developed urban center, the potential for its 
implementation in DENV endemic areas will need to be evaluated.
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ZIKA VIRUS IN THE AMERICAS: A MODEL-BASED 
ASSESSMENT OF FACTORS AFFECTING EMERGENCE
Courtney D. Shelley, Christopher M. Barker
University of California Davis, Davis, CA, United States
Zika virus is a mosquito-borne pathogen that has emerged as a major 
threat to human health as the virus continues to spread throughout Latin 
America. Zika virus has now been linked to severe birth defects, as well 
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as an increase in Guillain-Barré syndrome. The parameters that affect 
transmission of the virus between mosquitoes and humans are still poorly 
understood beyond extrapolations from similar viruses. It is known that the 
virus is transmitted by mosquitoes in the genus Aedes (Ae. aegypti and Ae. 
albopictus), two invasive species that are both well-established within the 
United States. These species are closely associated with human habitation 
and breed in a diverse array of peridomestic containers that hold standing 
water. We have developed a deterministic model accounting for spatio-
temperal heterogeneities in temperature throughout the United States to 
predict seasonal limits and peaks of Zika virus infection in order to focus 
vector control efforts and anticipate potential diagnostic testing demands. 
The model is informed by emerging field and laboratory data, including 
vector studies from our laboratory, and we contrast our Zika estimates for 
the U.S. to those for a dengue-endemic area in Iquitos, Peru to understand 
whether housing characteristics such as the availability of window 
screening and air conditioning in the U.S., are adequate to prevent Zika 
outbreaks.
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WIND-ASSISTED LONG-DISTANCE MIGRATION OF MALARIA 
MOSQUITOES IN THE SAHEL
Tovi Lehmann1, Diana Huestis1, Alpha Yaro2, Jenna Florio1, 
Moussa Diallo2, Zana Sanogo2, Samake Djibril2, Roy Faiman1, Jason 
W. Chapman3, Donald R. Reynolds4, Laura E. Burgin5, Adama Dao2
1National Institute of Allergy and Infectious Diseases/National Institutes 
of Health, Rockville, MD, United States, 2ICER Mali, Bamako, Mali, 
3Department of AgroEcology, Rothamsted Research, Harpenden, United 
Kingdom, 4Department of AgroEcology, Rothamsted Research, Harpenden, 
United Kingdom, 5Met Office, London, United Kingdom
Over the past decade, malaria control efforts have greatly reduced its 
burden even in its home base - Africa, raising hopes for malaria eradication 
in some reader’s lifetime. Malaria transmission in Africa extends from the 
Equatorial Zone to the Sahel where it is confined to the short rainy season. 
Persistence of anopheline vectors in areas without surface waters for 3-8 
months a year attests for the sophisticated strategies employed by the 
vectors. Recent evidence suggests that Anopheles coluzzii persists locally 
throughout the dry season by a form of diapause (aestivation), whereas 
A. gambiae and A. arabiensis rely on long-distance migration from areas 
where reproduction continues year round. This contradicts the widely 
accepted view that these vectors do not disperse beyond a few kilometers 
in a lifetime. Here, we summarize aerial sampling of insects 100-300 m 
above ground conducted between May 2012 and November 2015 in four 
Sahelian villages. A total of 30 A. gambiae s.l. and 117 A. pharoensis were 
captured among >3,000 mosquitoes and over half a million other insects 
during 747 aerial night collections. No mosquitoes were captured in 502 
control captures raised briefly to 120 m during launches and retrievals, 
corroborating that these species were intercepted at high altitudes 
rather than near the ground. A high proportion of the mosquitoes were 
gravid, indicating that they might carry human pathogens. Because such 
movements of mosquito vectors are regular and involve many thousands 
of mosquitoes per night, they have important implications for disease 
emergence and reemergence as well as for disease elimination programs. 
A comprehensive analysis of these data will be presented.
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GENERIC AND STANDARDIZED DATA COLLECTION FORMS 
AND DATABASE APPLICABLE TO DIVERSE ENTOMOLOGICAL 
STUDIES OF MOSQUITOES
Samson S. Kiware1, Alpha Malishee1, Dickson Msaky1, George 
Corliss2, Gerry Killeen1
1Ifakara Health Institute, Dar Es Salaam, United Republic of Tanzania, 
2Marquette University, Milwaukee, WI, United States
Studies of malaria vectors and other vector-bone diseases encompass 
a remarkably diverse array of designs and rapidly generate large data 
volumes. Such data is normally collected or recorded using experiment-
specific forms that require frequent, error-prone redesign leading to 
badly or inconsistently structured data, difficulty in sharing or linking. 
Standardised data schema, databases and even public data repositories 
exist for genetic data for malaria parasites and for their human and 
mosquito hosts and similar controlled and standardised systems are 
available for epidemiological studies of malaria-infected human beings. 
However, equivalent systems for studies of the mosquitoes which mediate 
transmission do not exist. We have developed 1) a generic schema, 2) 
paper-and electronic-based customizable data collection forms, and 3) 
a database web-based application - to provide structure to data at the 
point of mosquito data collection and streamline use of databases that 
consistently link field and laboratory data. The database is built in such a 
way that it can be linked to other system such demographic surveillance 
systems and epidemiological based-databases. As a result, data from 
diverse mosquito studies conformed to a developed generic schema, 
with data collection forms recording the experimental design, sorting 
of collections, details of sample pooling or subdivision, and additional 
observations using standardized formats. The database stores and 
links data, generates summarized reports, enhances data sharing and 
dissemination from multiple experiments, projects, and studies. Currently, 
the user uptake includes 20 experiments, 10 projects, and 20 users at 3 
research and control institutes in 3 African countries, resulting in 13 peer-
reviewed publications. This vector database is expected to advance vector 
control research especially for resource-limited tropical settings lacking 
specialized software or informatics support.
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IMPLEMENTATION OF A MULTI-COUNTRY RESPONSE TO THE 
EBOLA VIRUS DISEASE EPIDEMIC IN WEST AFRICA: LESSONS 
FROM THE FIELD
Reshma Roshania1, Nelson Dunbar2, Michaela Mallow1, Pranav 
Shetty1, Taralyn Lyon1, Kacey Pham1, Matthew Abad1, Erin Shedd1, 
Alexander Tran1, Sarah Cundy1, Adam Levine3
1International Medical Corps, Los Angeles, CA, United States, 2Ministry 
of Health, Monrovia, Liberia, 3Warren Alpert Medical School of Brown 
University, Providence, RI, United States
The recent West African outbreak of Ebola virus disease (EVD) is the 
largest ever recorded. Starting from September 2014, International 
Medical Corps (IMC) opened five Ebola Treatment Units (ETUs) in Liberia 
and Sierra Leone, which cumulatively collected nearly 25,000 pages of 
epidemiologic, clinical, and laboratory data. To extract this data, each 
chart was either manually copied across the fence between the high-risk 
zone and low-risk zone or was imaged in the high-risk zone using a GoPro 
camera. Data were then entered into separate electronic databases, which 
were combined into a single relational database. Data quality assurance 
identified an overall final error rate of 1.2%. The full IMC database 
includes 2768 patient presentations, of which 2485 were admitted to 
an ETU, and 2329 had outcome data available. Of these, 1506 (65%) 
patients were from Sierra Leone while 823 (35%) were from Liberia. 54% 
of patients were male, and the median age was 30 (IQR 18-43). 10% of 
admitted patients were < age 5 and 11% were > 55. Among all admitted 
patients, 461 (20%) tested positive for EVD. 192 recovered to discharge, 
5 were transferred to other facilities, and 264 died, for a case fatality 
ratio (CFR) of 58%. Among EVD negative patients, 154 of 1868 died, 
for a CFR of 8%. Average length of stay was 14.6 days for EVD positive 
patients who recovered and 5.6 days for those who died. Although more 
males were admitted as suspect patients than females, a larger proportion 
of females were diagnosed as EVD positive (26% vs 15%). EVD positive 
patients aged 15-24 had the lowest CFR (37%), while patients < 5 and 
> 55 had the highest CFRs (93% and 70%, respectively). CFRs were 
also higher in Sierra Leone (61%) than Liberia (53%). While several prior 
reports have documented the experiences of individual ETUs, this study 
is the first to present data from multiple ETUs across two countries run 
by the same organization with similar clinical protocols. Our experience 
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demonstrates that even in austere settings under difficult conditions, it is 
possible for humanitarian organizations to collect high-quality clinical and 
epidemiologic data during a major infectious disease outbreak.
667
THE NATURAL HISTORY OF EBOLA VIRUS DISEASE: A 
RETROSPECTIVE STUDY OF THE WEST AFRICA EPIDEMIC
Reshma Roshania1, Kelly Skrable2, Ryan Burbach1, Nelson 
Dunbar3, Adam Levine2
1International Medical Corps, Los Angeles, CA, United States, 2Warren 
Alpert Medical School of Brown University, Providence, RI, United States, 
3Ministry of Health, Monrovia, Liberia
This retrospective study documented the natural history of EVD among 
confirmed patients utilizing data from five Ebola Treatment Units operated 
by International Medical Corps in Sierra Leone and Liberia in 2014-2105. 
All patients were treated as per standard treatment protocols based on 
guidelines developed by the World Health Organization and Medecins 
Sans Frontieres. Self-reported and observed data on presence of symptoms 
were collected at admission and during daily rounds by clinical staff. 
Progression of EVD symptoms were explored using descriptive statistics, 
differences in mean number of days symptomatic among subgroups were 
analyzed using t-tests and ANOVA, and survival analyses were conducted 
utilizing Kaplan-Meier estimators and Cox proportional hazards models. Of 
470 confirmed EVD cases treated, 297 met the inclusion criteria of positive 
EVD diagnosis, known outcome, and reported symptom onset date. To 
assess progression of symptoms by week, a subset of patients for whom 
rounding dates were also present were analyzed (n=253). The mean 
number of symptomatic days at admission was 4.3; this varied significantly 
by sex (females: 3.9, males: 4.8, p = 0.036) and by age category (0-4: 
2.4, 5-24: 3.7, 25-44: 4.6, 45+: 5.0, p = 0.009). The three most common 
symptoms by week symptomatic were: Week 1 (n=253) - weakness (67%), 
anorexia (63%), fever (55%); Week 2 (n=134) - weakness (70%), fever 
(69%), diarrhea (63%); Week 3 (n=52) - fever (44%), bone/muscle/joint 
pain (35%), headache (33%). The overall survival rate was 36.9% with 
no significant difference by sex. All age groups had a lower risk of death 
when using patients 0-4 years as the reference: 5-24 years, hazard ratio 
(HR)=0.34 (95% confidence intervals (CI): 0.19-0.59, p<0.001); 25-44 
years, HR=0.45 (95% CI: 0.27-0.77; p=0.003); 45+ years, HR=0.54 (95% 
CI: 0.31-0.93; p<0.025). Among patients who died, mortality occurred 
in 86% by day 13 of experiencing symptoms. The natural history of EVD 
among patients in Liberia and Sierra Leone demonstrated consistent 
progression of nonspecific symptoms and high overall mortality with 
significantly higher mortality among patients 0-4 years.
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BIAS ADJUSTMENT OF CASE FATALITY RATE ESTIMATES IN 
THE EBOLA OUTBREAK IN WEST AFRICA
Tini Garske, WHO Ebola Response Team
Imperial College, London, United Kingdom
The recent Ebola outbreak in West Africa caused an officially reported 
28,646 cases and 11,323 deaths by 30 March 2016, however, the true 
burden was likely considerably higher. The case fatality rate (CFR), defined 
as the proportion of cases that die, is the most important indicator of 
severity. It is however surprisingly difficult to estimate accurately from data 
collected routinely during an outbreak. The most reliable estimates in this 
outbreak were obtained by only considering cases for which the outcome 
(death or survival) was recorded, however, with only half of the reported 
cases having an outcome recorded there is substantial scope for biases in 
this simple estimate if the probability of reporting the outcome depends 
on the outcome itself. By considering the strong age-dependence of CFR 
and comparing the proportion of cases with recorded outcome between 
age groups we assess the differential outcome reporting probability 
between survivors and fatalities, and adjust CFR estimates accordingly. 
While in Guinea outcome reporting was near complete for cases entered 
into the VHF database, we estimated that fatal cases were more likely 
than survivors by 31% in Liberia and 131% in Sierra Leone to have the 
outcome reported, leading to an upwards bias in raw CFR estimates. 
When adjusting for this bias, CFR estimates were corrected from 65.6% 
(95% CI 63.8 - 67.3%) to 58.8% (51.4 - 65.4%) in Liberia and from 
71.2% (69.7% - 72.7%) to 51.7% (45.2 - 61.4%) in Sierra Leone, while 
estimates in Guinea remained ad 59.2% (57.1 - 61.4%). CFR estimates 
adjusted for differential reporting were therefore more consistent between 
countries. Accurate estimates of disease severity are crucially important for 
public health planning, but are challenging to obtain from data collected 
typically during an outbreak. The bias of differential outcome reporting 
is likely a problem in many settings, and the method developed here will 
therefore be useful in future outbreaks of novel pathogens.
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QUANTIFICATION OF THE IMPACT OF SAFE AND DIGNIFIED 
BURIALS DURING THE 2013-2016 WEST AFRICAN EBOLA 
VIRUS DISEASE EPIDEMIC
Amanda Tiffany1, Benjamin Dalziel2, Ginger Johnson3, Juliet 
Bedford4, Amanda McClelland5
1Epicentre, Geneva, Switzerland, 2Princeton University, Princeton, 
NJ, United States, 3Anthrologica, Washington, DC, United States, 
4Anthrologica, Oxford, United Kingdom, 5International Federation of the 
Red Cross and Red Crescent Societies, Geneva, Switzerland
Over 28,600 people were infected with Ebola virus disease (EVD) and over 
11,000 died in the 2013-2015 West African epidemic. The EVD status 
of individuals who die in the community, outside of Ebola Treatment 
Centers, is unknown at the time of death however burial of EVD infected 
individuals poses a serious risk for continued transmission. Consequently 
an important component in EVD response is safely burying infected 
individuals. This pillar of the response was led by the International 
Federation of the Red Cross and Red Crescent Societies, who buried 
47,505 individuals, 2,205 of which were EVD positive. Here we quantify 
the impact of the Red Cross Safe and Dignified Burial Program (SDB) on 
the EVD epidemic. Epidemiological and anthropological investigations 
were completed in communities in Sierra Leone, Guinea and Liberia that 
had carried out unsafe burials. Forty-five unsafe burials were investigated 
and 310 contacts identified. Approximately 7 individuals per unsafe 
burial were reported to have had contact with the index case (IC) and 1.8 
infected secondary cases were generated, although this varied by district 
(range: 0.6-5.5). Contact with the IC during their acute illness and post-
mortem was reported for 46% of contacts. Contact with fluids of the 
IC was the most strongly predictive of transmission followed by physical 
contact with the IC during their acute illness. Those having contact with 
the IC before death were 2.5 - 6 times more likely to be infected with 
EVD, relative to those with post-mortem contact only. By averting 1,477 
to 10,452 secondary EVD cases, SDB reduced the size of the epidemic by 
5.2 to 36.5%. Through this study it is impossible to ascertain, for those 
individuals who had contact with the index case before and after death, 
the exposure that caused their infection. Nevertheless, these results 
underline the importance of isolating individuals infected with EVD early 
in order to further limit community transmission. We also quantify for the 
first time, the importance of SDB as a fundamental EVD control measure 
and provide an estimate the number of additional infections averted by 
SDB.
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MORTALITY OUTCOMES AMONG PATIENTS WITH VARIABLE 
INFECTION STATES WITH EBOLA VIRUS DISEASE AND 
MALARIA IN SIERRA LEONE: A RETROSPECTIVE COHORT 
STUDY
Adam Aluisio1, Matthew Waxman2, Adam Levine1
1Warren Alpert Medical School of Brown University, Providence, RI, United 
States, 2Olive View – University of California Los Angeles Medical Center, 
Los Angeles, CA, United States
This retrospective cohort study investigated the relationship between 
infection with Ebola Virus Disease (EVD) and/or malaria and case fatality 
ratio (CFR) among patients admitted to three Ebola Treatment Units 
(ETU) in Sierra Leone between December 2014 and September 2015. 
Standardized care with artemisinin-based combination therapy for empiric 
malaria treatment was provided to all patients based on International 
Medical Corps protocols. The cohort was stratified by infection status as: 
malaria negative/EVD negative (m-/e-), malaria positive/EVD negative (m+/
e-), malaria negative/EVD positive (m-/e+) and malaria positive/EVD positive 
(m+/e+). Mortality outcomes were explored using descriptive statistics and 
Cox proportional models. Survival regression analyses adjusted for age, 
and the m-/e- group was set as the baseline comparator. Mortality time 
of event was derived from chart documentation and all survivors were 
censored at 28 days from admission. Among 1548 cases treated, 753 
met inclusion criteria. The cohort cases included 431 m-/e-, 180 m+/e-, 
108 m-/e+ and 34 m+/e+. In the m-/e- group, the CFR was 11%. For 
m+/e- cases the CFR was 5%, with an adjusted hazard ratios (aHR) of 0.5 
(95% CI: 0.3-1.0, p=0.07). Cases found to be m-/e+ had 53% mortality 
and a greater than five-fold increased risk of death (aHR=5.7, 95% CI: 
3.9-8.5, p<0.001). The m+/e+ group had the highest CFR, at 59%, with 
an aHR of 7.7 (95% CI: 4.5-13.1, p<0.001). Patients admitted to ETUs 
with confirmed EVD had the highest mortality, and concomitant infection 
with malaria increased the risk of death in the studied population. Among 
patients without EVD who were admitted to ETUs, risk of death was nearly 
twice as high in those without malaria infection as opposed to those 
with malaria infection, likely due to empiric treatment of all patients with 
antimalarial medications.
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IMPLEMENTING SEASONAL MALARIA CHEMOPREVENTION 
(SMC) IN THE CONTEXT OF EBOLA VIRUS DISEASE (EVD) IN 
GUINEA
Suzanne Van Hulle1, Timothee Guilavogui2
1Catholic Relief Services, Baltimore, MD, United States, 2National Malaria 
Control Program of the Republic of Guinea, Conakry, Guinea
An overlap of symptoms of the EVD and malaria in Guinea created a 
context for integrated case management of the two diseases, as untreated 
malaria cases were linked to increased malaria mortality and fever cases 
(a shared symptom for both diseases) which was deemed to impede 
the EVD response. SMC began in Guinea during the onset of EVD and 
in the context of severely diminished demand for health services; EVD 
was the estimated cause of approximately 74,000 fewer malaria cases 
seen at health facilities in 2014. The NMCP used EVD case management 
structures and implemented SMC through a house-to-house strategy in six 
SMC-eligible districts targeting 210,000 children 3-59 months. A Health 
Service Delivery Coverage exercise designed to examine perceptions of 
service delivery acceptability (including SMC) was conducted through 
focus group discussions and key informant interviews in each of the SMC 
Districts. It engaged caregivers, local leaders and CHWs who observed a 
flattening in demand for health services throughout Guinea in reaction 
to EVD - contributing to the 46,968 confirmed cases of malaria and 86 
deaths within the under-five target population in 2014. The total cases of 
confirmed malaria in the areas that received SMC in 2015 decreased by 
29% and by 26% for malaria deaths among the under-five population. 
Whereas in the two SMC-eligible Districts of Siguiri and Madiana where 
SMC was not implemented in 2015 there were increases in malaria cases 
in the under-five population from 2014 to 2015. In Siguiri there was an 
increase in confirmed malaria cases by 92% (3,352 cases in 2014 and 
6900 cases in 2015) and an increase in malaria deaths 7,350% (4 deaths 
in 2014 and 298 deaths in 2015); while in Madiana there was an increase 
in confirmed malaria cases by 2,450% (740 confirmed cases in 2014 and 
19,633 confirmed cases in 2015) and no increase in malaria deaths. SMC 
in Guinea, reached 100% of eligible children: demonstrating that even in 
the context of EVD or potentially other outbreaks, SMC can be delivered 
at scale and save lives. In 2016, SMC will be scaled up to cover Siguiri and 
Madiana and the NMCP will continue SMC implementation in all eligible 
areas in 2017 and beyond.
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EFFECTS OF FUNCTIONAL LATRINE DENSITY ON HOUSEHOLD 
DRINKING WATER CONTAMINATION, SOIL-TRANSMITTED 
HELMINTH INFECTION AND DIARRHEA: A SPATIAL ANALYSIS
Heather K. Amato1, Howard Chang1, Sophie Boisson2, Thomas F. 
Clasen1
1Emory University, Atlanta, GA, United States, 2London School of Hygiene 
& Tropical Medicine, London, United Kingdom
India accounts for 60% of the 2.4 billion people practicing open 
defecation worldwide. A large cluster-randomized trial (CRT) in Orissa 
found no village-level health impacts of the Government of India’s Total 
Sanitation Campaign. Village-level coverage varied greatly; latrines went 
unused, often due to poor construction/functionality. Using geospatial 
data from households in 50 intervention villages of the CRT in Orissa, 
we assessed environmental health impacts of functional latrine density 
on a fine spatial scale. Coverage of all latrines and functional latrines 
within 25m, 50m, 100m, and 200m of households was calculated via 
a multiple ring buffer analysis in ArcGIS. Outcomes were household 
drinking water contamination (N=1009), soil-transmitted helminth (STH) 
infection (N=822), diarrhea among all ages (N=1275) and children <5 
(N=1017). Multivariate regressions adjusted for village-level clustering 
with Generalized Estimating Equations. Covariates included location of 
water source, household population, and whether or not a household, 
itself, owned a functional latrine. Increased latrine coverage in 200m 
was associated with decreased levels of thermotolerant coliform (TTC) in 
household drinking water (β=-5.05, 95% CI -9.81, -0.29). Each additional 
functional latrine in 25m was associated with a decrease of 28.9 cfu TTC 
per 100 mL (CI -57.5, 9.8). Odds of STH infection decreased by 10% 
for each additional latrine, regardless of functionality, in 25m (β=0.903, 
CI 0.819, 0.994). For every 10 additional latrines in 25m, regardless 
of functionality, household longitudinal diarrhea prevalence (all ages) 
increased by 2.13 days per 1,000 person days (CI 0.06, 4.2). A 10% 
increase in functional latrines in 25m was associated with 1.4 fewer days 
of diarrhea per 1,000 person days (CI -5.5, -0.1). Households owning 
functional latrines, themselves, had 8 fewer days of childhood diarrhea 
per 1,000 person days (p<0.05). Ensuring 100% sanitation coverage and 
functionality within the immediate surroundings of the home is critical for 
reducing exposure to pathogenic feces that cause diarrheal diseases.
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FECAL CONTAMINATION ALONG MULTIPLE 
ENVIRONMENTAL PATHWAYS IS ASSOCIATED WITH 
SUBSEQUENT DIARRHEA AMONG CHILDREN IN RURAL 
BANGLADESH
Amy J. Pickering1, Ayse Ercumen2, Benjamin F. Arnold2, Laura H. 
Kwong1, Sarker Masud Parvez3, Craig Kullmann4, Rokeya Ahmed5, 
Claire Chase4, Leanne Unicomb3, John M. Colford2, Stephen P. 
Luby1
1Stanford University, Stanford, CA, United States, 2University of California 
Berkeley, Berkeley, CA, United States, 3International Centre for Diarrhoeal 
Disease Research, Bangladesh, Dhaka, Bangladesh, 4The World Bank, 
Washington, DC, United States, 5The World Bank, Dhaka, Bangladesh
Pathogens associated with diarrhea are transmitted from feces to new 
hosts through multiple environmental pathways: drinking water, ambient 
water, hands, soil, food, and flies. Understanding the relative risks of 
exposure to fecal contamination along each pathway could be valuable 
in the design of interventions to interrupt transmission and reduce 
diarrhea. We conducted a prospective study among 1843 households in 
rural Bangladesh to quantify levels of fecal contamination along multiple 
environmental pathways and assess their association with subsequent risk 
of under-five child diarrhea. Measurements were collected during two 
sequential visits to each study household. During the first visit, sampling at 
each household included: child hand rinse, stored drinking water, source 
drinking water (tubewells), pond water, soil from the child’s play area, food 
served to young children and flies captured from the food preparation 
area. All samples were analyzed for fecal indicator bacteria (most probable 
number [MPN] of E. coli and fecal coliforms) using the IDEXX Colilert-18 
Quanti-Tray system. During the second visit (conducted 4-10 days after 
the initial visit to encompass typical incubation periods for gastrointestinal 
pathogens), interviewers collected caregiver-reported child gastrointestinal 
symptoms. We used generalized linear models with robust standard errors 
to estimate the relationship between the presence and concentration of 
fecal indicator bacteria and subsequent diarrhea prevalence. Child diarrhea 
prevalence following the field team’s previous visit to the household 
increased by 31% with E. coli presence on child hands (PR=1.31, 1.06-
1.63) and 17% for each log10 increase in fecal coliform counts in 
soil (PR=1.17, 1.04-1.32). Our findings suggest that child hands and 
household soil are important transmission pathways for diarrheal illness 
among children under five in rural Bangladesh.
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QUANTIFYING FECAL CONTAMINATION LEVELS OF 
DRINKING AND AMBIENT WATERS, HANDS, FOOD, SOIL 
AND FLIES IN THE DOMESTIC ENVIRONMENT IN RURAL 
BANGLADESH
Ayse Ercumen1, Amy J. Pickering2, Benjamin F. Arnold1, Laura 
H. Kwong2, Sarker Masud Parvez3, Craig Kullman4, Claire Chase4, 
Rokeya Ahmed5, Leanne Unicomb3, Stephen P. Luby2, John M. 
Colford, Jr.1
1University of California Berkeley, Berkeley, CA, United States, 2Stanford 
University, Stanford, CA, United States, 3International Centre for Diarrhoeal 
Disease Research, Bangladesh, Dhaka, Bangladesh, 4Water and Sanitation 
Program, World Bank, Washington, DC, United States, 5Water and 
Sanitation Program, World Bank, Dhaka, Bangladesh
Fecal-oral pathogens are transmitted from feces to hosts through a 
variety of environmentally mediated pathways. Characterizing levels of 
fecal contamination along these pathways can inform the development 
of targeted interventions to reduce fecal exposures. We quantified fecal 
indicator bacteria along different transmission routes in the domestic 
environment in 1843 households in rural Bangladesh. We collected 
samples of source (tubewell) and stored drinking water, pond water, child 
hand rinse, weaning food, flies caught in the food preparation area and 
soil collected from children’s outdoor play area. We analyzed samples for E. 
coli with the IDEXX most probable number (MPN) method and calculated 
the geometric mean of E. coli concentration for each type of sample. 
24% of tubewells and 58% of stored water samples were contaminated 
with E. coli. A typical pond water sample contained almost 4-log MPN E. 
coli per 100 mL. 40% of children had E. coli on their hands; children ≥ six 
months old had 0.3-log MPN per two hands more E. coli than children 
< six months of age (p<0.001). A typical soil sample had approximately 
5-log MPN E. coli per dry gram. Soil in the vicinity of human or animal 
feces had 0.2-log MPN higher E. coli than soil collected from areas with 
no feces (p<0.001). Soil from sunlit areas had 0.2-log MPN fewer E. coli 
than soil from shaded areas (p<0.001), and levels of E. coli were positively 
correlated with the moisture content of samples (p<0.001). 59% of stored 
food samples contained E. coli; food stored in a covered container had 
0.2-log MPN fewer E. coli than food from uncovered or partially covered 
containers (p=0.02). 54% of captured flies had E. coli contamination; a 
typical fly had approximately 3-log MPN E. coli. Fecal indicator bacteria 
levels were higher among all seven pathways in the rainy season (p≤0.01). 
Our findings demonstrate ubiquitous fecal contamination along multiple 
pathways in rural Bangladeshi households and highlight the occurrence 
of high levels of fecal indicator bacteria in ponds and especially courtyard 
soil in this setting, drawing attention to these understudied pathways for 
diarrheal disease transmission.
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UNSAFE CHILD FECES DISPOSAL IS ASSOCIATED WITH 
ENVIRONMENTAL ENTEROPATHY AND IMPAIRED GROWTH
Christine Marie George1, Lauren Oldja1, Shwapon Biswas2, Jamie 
Perin1, R. Bradley Sack1, Shahnawaz Ahmed2, Shahnawaj Ali2, 
Rashidul Haque2, Tahmina Parvin2, Ishrat J. Azmi2, Sazzadul Islam 
Bhuyian2, Kaisar A. Talukder2, Abu G. Faruque2
1Johns Hopkins University, Baltimore, MD, United States, 2International 
Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh
This study was undertaken to investigate the relationship between unsafe 
child feces disposal, environmental enteropathy (EE), and impaired growth, 
we conducted a prospective cohort study of 216 young children in rural 
Bangladesh. Unsafe child feces disposal, using the WHO/ UNICEF Joint 
Monitoring Program definition, was assessed using 5 hour structured 
observation and caregiver reports. Anthropometric measurements were 
collected at baseline and at a nine month follow-up. Stool was analyzed 
for fecal markers of EE: alpha-1-antitrypsin, myeloperoxidase, neopterin 
(combined to form an EE disease activity score), and calprotectin. Eighty 
four percent of households had an unsafe child feces disposal event during 
structured observation and 75% had caregiver reported events. There was 
no significant difference in observed unsafe child feces disposal events 
for households with or without an improved sanitation option (82% vs. 
85%, p=0.72) or by child age (p=0.96). Children in households where 
caregivers reported unsafe child feces disposal had significantly higher 
EE scores (0.82 point difference, 95% confidence interval (CI): 0.11, 
1.53), and significantly higher odds of being wasted (Weight for Height 
z-score (WHZ) <-2 SDs) (9% vs. 0%, p= 0.024). In addition, children 
in households with observed unsafe feces disposal during structured 
observation had a significantly reduced change in Weight for Age z-score 
(-0.34 (95% CI: -0.68, -0.01) and WHZ (-0.52 (95% CI: -0.98, -0.06)). In 
conclusion, unsafe child feces disposal was significantly associated with 
EE and impaired growth in a pediatric population in rural Bangladesh. 
Interventions are needed to reduce this high risk behavior to protect the 
health of susceptible pediatric populations.
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THE MAPUTO SANITATION (MAPSAN) TRIAL: ASSESSING A 
SANITATION INTERVENTION’S IMPACT ON HELMINTHIASIS 
IN CHILDREN <5 YEARS OLD IN MAPUTO, MOZAMBIQUE
Trent Sumner1, Jacqueline Knee1, Rassul Nala2, Joseph Brown1
1Georgia Institute of Technology, Atlanta, GA, United States, 2Ministério de 
Saúde, Maputo, Mozambique
The MapSan study, in Maputo, Mozambique, is a first of its kind, 
controlled before and after trial of the impact of a shared sanitation 
intervention (pour-flush latrines) on soil-transmitted helminth (STH) and 
enteric infections in children <5 years. Despite progress in urban sanitation 
coverage, residents of urbanizing, unplanned communities in large 
cities of Sub-Saharan Africa experience elevated disease risks associated 
with poor sanitation. Dense urban environments are critical settings for 
targeted sanitation improvements since the risks of unsafe excreta disposal 
can be much greater within a dense urban population compared with a 
low-density rural population. For the study, stools were collected from 
children in intervention and matched-control arms to assess baseline STH 
prevalence prior to intervention exposure. Stools were analyzed by Kato 
Katz (N=671) to quantify several STHs (including Trichiura trichuris, Ascaris 
lumbricoides, and hookworm) and will be shipped to the US for multiplex-
STH qPCR analysis. Overall baseline prevalence for any STH infection 
by Kato-Katz is 46% and is similar between study arms. As expected, 
prevalence increases with age [in years (OR 1.96, CI: 1.67, 2.31)]. T. 
trichuris and A. lumbricoides are the most commonly observed STHs with 
prevalences of 23% and 38%, respectively. Coinfection with multiple 
STH was observed in 16% of samples. Post-exposure sample collection 
is ongoing and data will be available starting in Summer 2016. The most 
recent nationwide survey of STH in school-aged Mozambican children 
(2005-2007) found a combined prevalence of 53.5%. Our baseline results 
provide a more complete picture of the STH burden in Mozambique by 
reporting on younger children who are often missed in school-based 
prevalence surveys. Our pending endline results will add evidence to the 
conversation of how to best serve the approximately 2.5 billion people 
who currently lack access to safe sanitation.
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WATER, SANITATION AND HYGIENE (WASH) AND 
ENVIRONMENTAL RISK FACTORS FOR SOIL-TRANSMITTED 
HELMINTH INTENSITY OF INFECTION IN TIMOR-LESTE, USING 
REAL TIME PCR
Suzy J. Campbell1, Susana Nery1, Rebecca Wardell1, Catherine 
D’Este1, Darren Gray1, James McCarthy2, Rebecca Traub3, Ross 
Andrews4, Stacey Llewellyn2, Andrew Vallely5, Gail Williams6, 
Archie Clements1
1Australian National University, Canberra, ACT, Australia, 2QIMR Berghofer 
Medical Research Institute, Brisbane, QLD, Australia, 3University of 
Melbourne, Melbourne, VIC, Australia, 4Charles Darwin University, 
Casuarina, NT, Australia, 5University of New South Wales, Sydney, NSW, 
Australia, 6University of Queensland, Brisbane, QLD, Australia
No investigations have been undertaken of risk factors for intensity of 
soil-transmitted helminth (STH) infection in Timor-Leste. We present 
the first analysis of combined water sanitation and hygiene (WASH), 
environmental, and socioeconomic risk factors undertaken using intensity 
of infection classes developed from qPCR diagnosis of STH. Questionnaires 
were used to collect WASH and demographic data from 24 villages in 
Manufahi District, Timor-Leste. An algorithm was developed to correlate 
PCR cycle threshold values to eggs per gram of faeces equivalents, using 
seeding experiments. Open-access environmental variables were obtained. 
A socioeconomic quintile was developed using principal component 
analysis. Multinomial mixed-effects regression was used to assess risk 
factors for intensity of Necator americanus and Ascaris infection in 2152 
participants. In adjusted models incorporating WASH, socioeconomic 
and environmental variables, environmental variables were generally 
associated with infection intensity for both N. americanus and Ascaris 
spp. Precipitation (in centimetres) was associated with increased risk of 
moderate-intensity (adjusted relative risk (ARR) 6.1; 95% confidence 
interval (CI) 1.9-19.3) and heavy-intensity (ARR 6.6; 95%CI 3.1-14.1) 
N. americanus infection, as was sandy-loam soil around household 
(moderate-intensity ARR 2.1; 95%CI 1.0-4.3; heavy-intensity ARR 2.7; 
95%CI 1.6-4.5; compared to no infection). For Ascaris, alkaline soil around 
the household was associated with reduced risk of moderate-intensity 
infection (ARR 0.21; 95%CI 0.09-0.51), and heavy-intensity infection (ARR 
0.04; 95%CI 0.01-0.25). Few WASH risk factors were significant. Our 
novel approach of assigning infection intensity classes to PCR-diagnosed 
STH infection requires further research. In this high-prevalence setting, 
significant risk associations with environmental factors suggest that 
anthelmintic treatment should be integrated with other interventions, 
as conditions are favourable for ongoing environmental transmission. 
Integrated STH control strategies should be explored as a priority.
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WASH FOR WORMS: END-POINT RESULTS FROM A CLUSTER 
RANDOMIZED CONTROLLED TRIAL OF THE IMPACT OF A 
COMMUNITY-BASED INTEGRATED WASH AND DEWORMING 
PROGRAM ON SOIL-TRANSMITTED HELMINTH INFECTIONS
Susana Vaz Nery1, James S. McCarthy2, Rebecca Traub3, Edmund 
Weking4, Darren Gray1, Ross Andrews5, Andrew Vallely6, Gail 
Williams7, Archie Clements1
1Australian National University, Canberra, Australia, 2QIMR Berghofer 
Medical Research Institute, Brisbane, Australia, 3University of Melbourne, 
Melbourne, Australia, 4WaterAid, Australia, Dili, Timor-Leste, 5Charles 
Darwin University, Darwin, Australia, 6University of New South Wales, 
Sydney, Australia, 7University of Queensland, Brisbane, Australia
Soil-transmitted helminth (STH) infect an estimated 1.45 billion people 
worldwide, therefore remaining a global health problem. Deworming 
programmes are effective in reducing STH prevalence but rapid reinfection 
occurs in the absence of decreased environmental contamination. 
Therefore WASH interventions are obvious candidates for sustainable 
control. WASH for WORMS is a cluster-randomised controlled trial to 
quantify the impact of a community-based WASH intervention integrated 
with periodic mass distribution of albendazole on infections with STH 
and protozoa, compared to mass deworming alone. In this trial, initiated 
in 2012, all participating communities in Timor-Leste received mass 
deworming every 6 months (for 2 years) and half of them also received 
the WASH intervention. The WASH intervention was implemented by 
WaterAid, Australia and included promotion of household latrines (based 
on “Community Led Total sanitation”), improved access to water and 
hygiene promotion. Infection prevalence and intensity were measured 
by qPCR. At baseline, the prevalence of STH in the 24 villages was high, 
with 62.3% of the participants infected with Necator americanus. In the 
intervention arm, N. americanus decreased from 62.8% to 32.2% at the 
1st follow-up (FU1), with a further decrease to 21.7% at the 2nd follow-
up (FU2), one year after completion of the WASH intervention. In the 
control group, N. americanus decreased from 61.8% to 36.9% at FU1, 
reaching 20.5% at FU2. At this time point, 77.7% of households in the 
intervention arm had a latrine whereas in the control arm 20.5% of the 
houses had one. Participating villages were followed for an additional year, 
with data collection ending in April 2016. Results will be presented for the 
study end-points and discussed in the context of the uptake of the WASH 
intervention. This trial is the first reported RCT evaluating the impact of 
integrated WASH and deworming interventions on STH infection; and 
will provide essential evidence for optimizing integrated STH control 
programmes.
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THE NEW WORLD HEALTH ORGANIZATION APPROACH TO 
SURVEILLANCE FOR TRACHOMA, EXPERIENCE IN NEPAL 
AND ADDED BENEFIT OF ANTIBODY PREVALENCE TO 
CHLAMYDIA TRACHOMATIS PGP3 PROTEIN: NESTS STUDY
Andrea I. Zambrano1, Beatriz E. Muñoz1, Shekhar Sharma2, 
Sailesh Mishra2, Laura Dize3, Katherine Crowley4, Lisa Rotondo4, 
Sheila K. West1
1Johns Hopkins University, Baltimore, MD, United States, 2Nepal Netra Jyoti 
Sangh, Kathmandu, Nepal, 3International Chlamydia Laboratory, Baltimore, 
MD, United States, 4RTI International, Washington, DC, United States
As part of the global effort to eliminate trachoma, the leading cause 
of preventable infectious blindness in the world, the World Health 
Organization (WHO) requires a second survey for trachoma at least two 
years after districts have stopped mass drug administration, to determine if 
re-emergence has occurred. Useful markers, like antibodies to chlamydial 
antigens, and chlamydial DNA testing for elimination of trachoma, are 
being investigated for utility in these surveillance situations. Using the 
new WHO guidelines, this study was undertaken to conduct surveillance 
surveys and to evaluate the possible role of tools in surveillance programs 
in 4 districts in Nepal. 15 randomly selected clusters within four districts 
were chosen. In each cluster, 50 randomly selected children ages 1-9 
year olds and 100 adults ≥15 years old were examined for TF±TI and 
TT respectively. Eye swabs were taken from all children to test for C. 
trachomatis (CT) infection using the Cepheid GeneXpert platform. Dried 
blood spots were collected from children to determine antibody positivity 
to the C. trachomatis antigen pgp3. Blood spots were processed on the 
Luminex-100 platform following standard procedures. Data were analyzed 
as simple frequencies, and age stratified proportions. Results: Districts 
were 2, 4, 8, and 10 years from last program activities. In the sampled 
4,042 children, only 11 TF cases and 3 CT infection were found. Overall 
antibody positivity was found in 1.9% of samples with no increase in 
frequency by age. There was no evidence for clustering of antibody 
positivity by community. Once adjusting for TT already known to the 
health system, rate was <1/1,000 population in all districts. In conclusion, 
no evidence of re-emergence of trachoma was found in four districts in 
Nepal during surveillance surveys as late as 10 years after cessation of 
all program activities. The absence of an increase in age seroprevalence 
suggests this tool may measure interruption of transmission of C. 
trachomatis. This study provides an even stronger empirical basis for 
the new WHO guidelines for surveillance of trachoma, and adds new 
knowledge on surveillance for trichiasis.
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SERO-SURVEILLANCE IS AN INFORMATIVE INDICATOR OF 
TRACHOMA TRANSMISSION INTENSITY
Amy Pinsent1, Michael T. White2, Manoj Gambhir1, Diana L. 
Martin3
1Monash University, Melbourne, Australia, 2Imperial College London, 
London, United Kingdom, 3Centers for Disease Control and Prevention, 
Atlanta, GA, United States
Trachoma remains the world’s leading infectious cause of blindness. 
The World Health Organization (WHO) has a target of elimination of 
trachoma as a public health problem by 2020. Validation of elimination 
of trachoma requires that the clinical sign trachomatous inflammation—
follicular (TF) be less than 5% in children aged 1-9 years old. However, 
in settings where transmission is low, grading TF can be challenging, as 
other bacterial infections and dust may aggravate the eyelid, producing 
TF-like inflammation that may not be associated with ocular chlamydia 
infection. Serology has been successfully used as an indicator of 
transmission intensity for a number of pathogens, and recent work has 
evaluated the potential for antibody-based testing in children for trachoma 
surveillance. We used serological data collected from a range of trachoma 
transmission settings—including high (TF greater than 30%), medium (TF 
10-30%), and low (TF less than 10%) prevalence settings with ongoing 
transmission in Tanzania as well as post-elimination validation surveys in 
Nepal—to estimate the sero-conversion and reversion rates with a sero-
catalytic model for all sites for which appropriate data was available. We 
then developed a mixed effects regression model to assess which key 
epidemiological variables (age, gender, number of known past rounds 
of antibiotic treatment) across multiple surveillance sites were significant 
predictors of antibody titre, allowing them to vary by trial site. We found 
that TF prevalence and age are good predictors of antibody titre within 
the community. Our findings demonstrate that prevalence of antibodies 
against chlamydial antigens may be informative indicators of transmission 
intensity and that serological surveillance could be a valuable approach 
for-post-elimination validation surveys.
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INFLUENCE OF INDIVIDUAL AND ENVIRONMENTAL FACTORS 
ON THE PREVALENCE OF TRACHOMA IN THE HEALTH 
DISTRICT OF MOKOLO AFTERTHREE YEARS OF MASS 
TREATMENT WITH ZITHROMAX AND TETRACYCLINE
Assumpta Lucienne Bella1, Emilienne Epée2, Armelle Ngomba3, 
Godefroy Koki4, Fabrice Nembot Djouma5, Georges Nko’o Ayissi2, 
Julie Akame6, Patrick Mbia6, Henri Moungui6, Yaobi Zhang7
1National Programme for the Prevention of Blindness, Ministry of Public 
Health, Yaoundé, Cameroon, 2National NTD Coordination Unit, Ministry of 
Public Health, Yaoundé, Cameroon, 3Department of Public Health, Faculty 
of Medicine and Pharmaceutical Sciences, University of Douala, Douala, 
Cameroon, 4Faculty of Medicine and Biomedical Sciences, University of 
Yaoundé, Yaoundé, Cameroon, 5Department of Epidemiology, University 
of Dschang, Dschang, Cameroon, 6Helen Keller International, Yaoundé, 
Cameroon, 7Helen Keller International, Regional Office for Africa, Dakar, 
Senegal
It is commonly believed that personal hygiene and the state of cleanliness 
of the environment are significant factors in the spread of trachoma. 
The strategy for control is through SAFE (Surgery, Antibiotic treatment, 
Facial cleanliness and Environmental improvement). The health district 
of Mokolo in the Far-North Region of Cameroon, recognized as endemic 
with trachoma in 2010, benefited from the azithromycin and tetracycline 
mass distribution during three consecutive years, supported by HKI with 
funding from USAID’s ENVISION Project, managed by RTI International. 
Rarely actions in F and E components were registered. We aimed at 
evaluating the influence of facial cleanliness and the environmental factors 
on the residual infection of trachoma after the treatment. We carried out 
a descriptive cross-sectional study based on a stratified random sampling 
in Mokolo in 2015. Selected were 20 communities representing clusters; 
with 25 households in each. After an interview with the households and 
ophthalmic assessments by trained trachoma graders, data were collected 
using the numerical tablets transferred to a central base, before being 
analyzed using Software SPSS. Among the 827 children aged 1 to 9 years 
examined, the prevalence of active trachoma (TF&TI) was 1.7% in 2015 
against 18.1% in 2010. The proportion of children having dirty faces was 
14.85%. A strong association was found between the facial uncleanliness 
and active trachoma infections (OR = 14.79; p<0.01). Out of 91.6% of 
houses with cattle, 94.7% cohabited with the animals inside the homes. 
However 60.8% of the households were located within less than 30 min 
from a source of water. Despite drastic reduction of the disease prevalence 
to the threshold of the stopping MDA, the individual and environmental 
factors remain a strong influence. This could compromise the sustainable 
elimination of trachoma in this health district. More efforts on the F and E 
components of the SAFE strategy is needed.
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A SPATIAL ANALYSIS OF ENVIRONMENTAL FACTORS AND 
TRACHOMATOUS-INFLAMMATION FOLLICULAR AMONG 
CHILDREN 1-9 YEARS IN SOUTH GONDAR, ETHIOPIA
Kelly Fletcher1, Aisha Stewart2, Mulat Zerihun3, Demelash 
Gessesse3, Berhanu Melaku3, Tekola Endeshaw3, Eshetu Sata3, 
Melsew Chanyalew4, Birhan Gaudie4, Zerihun Tadessse3, Kelly 
Callahan2, Scott Nash2
1Emory University, Rollins School of Public Health, Atlanta, GA, United 
States, 2The Carter Center Atlanta, Atlanta, GA, United States, 3The Carter 
Center Ethiopia, Addis Ababa, Ethiopia, 4Amhara Regional Health Bureau, 
Bahir Dar, Ethiopia
South Gondar zone in the Amhara region of Ethiopia has a high 
prevalence of trachomatous-inflammation follicular (TF), a clinical sign 
of trachoma, among children ages 1-9 (25.9%). This may not be entirely 
explained by individual behaviors such as facial cleanliness or household 
factors like latrine access. Environmental covariates like rainfall, altitude, 
vegetation, and temperature may impact TF prevalence but there are few 
published studies assessing the spatial relationships of environmental 
factors and TF clustering in a hyperendemic setting. Using a multi-stage, 
cluster randomized design, 12,108 households were surveyed in 313 
villages in 12 districts in South Gondar in 2011. We assessed TF prevalence 
in all children 1-9 years in each household. TF prevalence was aggregated 
by village for those with valid GPS coordinates. A point pattern analysis 
of 313 villages was performed using weighted K functions for global 
clustering and a Getis G* for local clustering (|z|>3.71). Altitude, global 
precipitation measurement (GPM), naturalized difference vegetation index 
(NDVI), and land surface day temperature raster images were overlaid with 
TF clusters. The weighted K function did not identify aggregation up to 
100km. Local Getis G* tests identified clustering starting at 10km. Hot 
spots, areas where high prevalence villages tend to occur near each other, 
were identified in northern districts of Ebinat and Libo Kemkem. Cold 
spots, areas where low prevalence villages occur near each another, were 
identified in central districts of Debre Bahir Town, Lay Gayent, and Estie. 
Preliminary descriptive analyses suggest that cold spots may be associated 
with higher elevations and NDVI. Hot spots may be associated with lower 
elevations and NDVI. Subsequent analyses will include descriptive mapping 
of select environmental factors and multivariate logistic regressions to 
identify environmental factors associated with TF clustering. Risk maps will 
be generated with the associated environmental factors to identify areas 
of heightened risk which may help inform trachoma control activities in 
these areas.
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USE OF MULTIPLE STRATEGIES TO MOBILIZE 
TRACHOMATOUS TRICHIASIS CASES FOR SURGERY IN 4 
DISTRICTS OF KATSINA STATE, NIGERIA
Shamsudeen Yahaya1, Aliyu Mohammed2, Olufunto Adewusi2, 
Moses Odenyi2, Nicholas Olobio3, Yaobi Zhang4
1Ministry of Health, Katsina, Nigeria, 2Helen Keller International, Abuja, 
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International, Regional Office for Africa, Dakar, Senegal
Trachomatous Trichiasis (TT) is blinding stage of trachoma and could cause 
blindness if not treated. To prevent the blindness, surgical intervention is 
required. In Katsina State, Nigeria, the ultimate intervention goal (UIG) 
for TT surgery in 8 Local Government Areas (LGAs) is 15,760. With the 
support of the Queen Elizabeth Diamond Jubilee Trust, 19 ophthalmic 
nurses were trained to provide surgeries using the bilateral tarsal rotation 
(BTR) method. A single TT case mobilization strategy was recommended 
and initially implemented, i.e. by trained TT case finders to identify and 
refer cases for surgery. There was a low turn-out of TT cases. To maximize 
the productivity of surgery, different methods were then tested in order 
to mobilize patients to access the free service. Barriers to access, such as 
fear of surgery, distance, poverty level of the affected people and gender 
barrier, informed the decision to adopt context specific case mobilization 
method in 4 selected LGAs. TT surgery camps were organized in Daura 
emirate comprising of Zango, Daura, Mai’adua and Baure LGAs between 
October and December 2015. A combined strategy of mobilization of TT 
patients was used in the weeks preceding the outreaches. These included 
radio announcements, town announcers, announcements in public places 
such as mosques and market places, in addition to trained TT case finders. 
With combined mobilization strategy, there was a resultant spike in the 
productivity as well as the frequency of outreaches being conducted. 
Two surgery camps were conducted in October and December which 
resulted in high turn-out of TT cases for surgery. Thus 7 outreaches were 
conducted within December alone, yielding 245 persons operated in 293 
eyes. This caused an increase in productivity as compared to previous 
months when only the case finder method was used. The number of 
persons presenting themselves for surgery more than doubled during 
the same period. Regular outreaches are very important for TT surgery. 
However, multiple mobilization strategies employed for outreach activities 
are required in order to reach the UIG and achieve the year 2020 trachoma 
elimination goal in Nigeria.
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CHLAMYDIA TRACHOMATIS INFECTION IN AMHARA, 
ETHIOPIA 2011-2015
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Trachoma is caused by the bacteria Chlamydia trachomatis (Ct). Infection 
data, collected in the programmatic setting, would help in understanding 
the impact of mass drug administration (MDA) interventions as well as 
the relationship between the clinical signs of trachoma and infection. 
This study aimed to understand the effect of multiple years of MDA on 
Ct infection in the Amhara region, Ethiopia by describing the prevalence 
of Ct infection in a representative sample of children ages 1-5 years. 
Population-based trachoma impact surveys were conducted in all districts 
of Amhara, from 2011 to 2015, following 5 years of SAFE interventions. 
Ocular specimens were collected from randomly selected children ages 
1-5 years whose households were included in the surveys to estimate 
the zonal prevalence of Ct infection. Samples from each district were 
pooled and the Abbott Realtime PCR assay was used to detect Ct DNA 
using the m2000 system. District prevalence was determined from the 
district pooled prevalence using maximum likelihood techniques. Zonal 
prevalence and confidence intervals (CI) were estimated using survey 
procedures in Stata. A total of 15,636 samples were collected across 10 
zones of Amhara. The prevalence of trachomatous-inflammation follicular 
(TF) in children ages 1-9 years in Amhara region was 26.1%, (95%CI: 
25.1, 27.1), zonal range: 13.6% to 54.6%, and the regional prevalence 
of trachomatous-inflammation intense (TI) was 5.6% (95%CI: 5.2, 6.0), 
zonal range: 3.4% to 13.6%. The prevalence of Ct infection in children 
ages 1-5 years was 5.5% (95%CI: 4.2, 6.7), with zonal estimates ranging 
from 1.0% in Awi zone to 15.3% in Waghemra. Ct infection and TI were 
very highly correlated at the zonal level (Spearman correlation(r)= .92; 
P=0.0002), while Ct infection and TF were moderately correlated (r= .57; 
P=0.084). To our knowledge, this is the first report of Ct infection data 
at a regional level within a programmatic setting. Despite over 5 years of 
MDA, a considerable amount of Ct infection remains in Amhara. TI was 
highly correlated with Ct infection and may represent a potential marker 
of infection that programs could use in measuring impact.
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TRACHOMA IMPACT SURVEYS IN MAINLAND TANZANIA: 
LESSONS LEARNED FROM IMPLEMENTATION OF THE SAFE 
STRATEGY
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1RTI International, Dar Es Salaam, United Republic of Tanzania, 2Neglected 
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United Republic of Tanzania, 4IMA World Health, Dar es Salaam, United 
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Tanzania started implementation of the surgery, antibiotics, facial 
cleanliness and environmental change (SAFE) strategy for trachoma control 
in 1999. Tanzania has made substantial progress towards meeting Global 
Elimination of blinding Trachoma by the year 2020 (GET2020) objectives. 
By the end of 2015, 37 out of 55 districts under SAFE implementation 
had achieved the goal for stopping mass drug administration (MDA) of 
trachomatous inflammation-follicular (TF) prevalence <5% in children 
aged 1-9 years. We investigated the trends of TF prevalence and annual 
MDA coverage. Data from 13 districts were analyzed: 2 had TF<5% 
(Handeni and Kwimba); 2 had TF>10% after 1st impact survey (Kilindi 
and Kongwa); 2 had TF=5-9.9% after 1st impact survey (Manyoni and 
Mpwapwa); 3 had stopped MDA due to programmatic challenges 
(Monduli, Longido and Ngorongoro); and 4 had baseline TF=5-9.9% and 
no MDA (Morogoro Rural, Mvomero, Singida Urban and Rombo). Time 
trends of TF prevalence and MDA coverage were plotted. In 2 districts with 
TF<5% at 1st impact survey, Handeni had 3 consecutive years of MDAs 
while Kwimba had 1 year of MDA. In 2 districts with TF>10% at 1st impact 
survey, Kilindi had no change in TF prevalence despite 4 MDA rounds of 
varying coverage while in Kongwa, TF was >10% despite 14 MDA rounds 
of varying coverage. Among districts with TF=5-9.9% (at the 1st impact 
survey), Manyoni had no change in prevalence (at the 2nd impact survey) 
despite a high coverage MDA; while Mpwapwa had TF<5% after a high 
coverage MDA. MDA implementation was delayed in Monduli, Longido 
and Ngorongoro, then implemented with low coverage in Monduli and 
Longido, and high coverage in Ngorongoro but stopped in all 3 districts 
due programmatic challenges. In 4 districts where baseline TF=5-9.9%, 
follow-up surveys after 10 years showed that TF was <5% in absence of 
interventions. The reduction of TF varied by district. Results suggest that 
low MDA coverage may contribute to the reduced impact on TF decline. 
To achieve GET 2020 objectives: MDA needs to be started promptly and 
sustained to achieve maximum impact; high MDA coverage needs to be 
achieved; and prompt impact surveys and action are needed.
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COMPARISON OF EPIDEMIOLOGY, TRANSMISSION 
DYNAMICS AND CLINICAL PRESENTATIONS OF GENITAL AND 
SKIN ULCERATIONS CAUSED BY HAEMOPHILUS DUCREYI: 
EXPERIENCE FROM HYPER-ENDEMIC AREAS IN AFRICA AND 
PACIFIC ISLANDS
Tun Ye, Cheng Y. Chen, Allan Pillay, Ronald C. Ballard
Centers for Disease Control and Prevention, Atlanta, GA, United States
Haemophilus ducreyi (HD), a fastidious gram-negative bacterium, has been 
known to cause the sexually transmitted genital ulcerations (i.e. Chancroid) 
in tropical countries and hyper-endemic situations were reported in 
Southern Africa during the 1990s. Recently, HD has been found to be 
associated with cutaneous ulcerations among children under 15 years 
old in yaws endemic areas. A retrospective case review was conducted 
on 117 laboratory-confirmed HD genital ulcer cases (genital HD) that 
presented to the Sexually Transmitted Disease (STD) clinic in Johannesburg, 
South Africa and 60 laboratory-confirmed cutaneous ulcerations (non-
genital HD) in children seen during the community-based surveillance 
activities in Vanuatu. The demographic, clinical presentations (including 
photographs of lesions) and laboratory findings of two patient population 
were compared. The laboratory investigations include syphilis serology 
using RPR and TPPA; multiplex real-time PCRs for HD, herpes simplex virus 
(HSV), Treponema pallidum subspecies (TP), and Mycobacterium ulcerans 
(buruli ulcer). In addition, culture for HSV and HD, and HIV serology were 
performed on samples from the genital-HD group. The mean ages of 
patients with genital and non-genital HD lesions were 33 years (± 9) and 8 
years (± 3), respectively. The majority of patients in both groups presented 
with large, multiple, punched-out ulcerations with soft edges and purulent 
bases which are clinically indistinguishable between genital and non-
genital HD lesions. Purulent inguinal lymphadenopathy (i.e. Bubo) was 
observed in 38 (32.5%) genital HD cases compared to none in non-genital 
HD patients. RPR seropositivity was 15.5% in genital HD group and 35.5% 
in non-genital HD group. In conclusion, clinicians should be aware of the 
presence of non-sexual transmission of HD and TP in some geographical 
areas and carefully consider the potential etiology of cutaneous genital 
and non-genital ulcerations in residents from those areas. Laboratory 
confirmation and differentiation of ulcer etiology at a reference laboratory 
would be required to support the clinical diagnosis and management.
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DIFFERENCES IN THE CLINICAL AND LABORATORY FEATURES 
OF ONCHOCERCIASIS IN ENDEMIC AND NONENDEMIC 
POPULATIONS REFLECT IMMUNE-MEDIATED PROCESSES
Adrienne J. Showler, Thomas Nutman
National Institutes of Health, Bethesda, MD, United States
Some filarial infections including Loa loa and Wuchereria bancrofti may 
have different presenting features in endemic populations compared 
with immunologically naïve expatriate hosts. However, few studies have 
examined this relationship in Onchocerca volvulus infection. To study this 
question more directly, we identified all patients diagnosed with active 
Onchocerca volvulus infection at the National Institutes of Health between 
1976 and 2016. Study subjects received a detailed baseline assessment 
including history, physical examination, ophthalmologic evaluation, and 
extensive laboratory investigations. Forty returned travellers (TR) and 36 
endemic (END) subjects had onchocerciasis acquired almost entirely in 
West and Central Africa. The TR more frequently reported a pruritic rash 
and 28% had acute papular dermatitis on examination compared with 
only 2.8% of END (p = 0.004). Skin pigmentation changes, excoriation 
or lichenification occurred in 47% of the END but in only 18% of TR 
(p = 0.007). Although similar numbers in both groups reported ocular 
symptoms, documented onchocercal eye involvement occurred in 
16.7% of the END and in none of the TR (p = 0.009). There were no 
differences in any other clinical parameters including pruritus, arthralgia, 
edema, lymphadenopathy, or of the presence of onchocercomata (2 in 
the TR, 6 in the END; p = 0.14). Fourteen (35%) TR and 7 (19%) END 
patients had microfiladermia (p =0.43). Geometric mean (GM) absolute 
eosinophil counts were significantly (p<0.05) higher in the TR (850/mm3) 
compared to the END (438/mm3). By contrast, we observed higher serum 
polyclonal IgE levels in endemic patients (GM = 826.1 IU/mL) compared 
to the TR (206.3 IU/mL; p < 0.001). Parasite-specific IgG4 levels were 
also significantly higher in END than in TR patients (p = 0.026). Although 
there is substantial overlap in the presentation of O. volvulus infection in 
TR and END populations, the TR had more frequent acute (and possibly 
eosinophil-mediated) findings that may reflect differences in chronicity and 
immune tolerance felt to underlie the relative hyporesponsiveness seen in 
lifelong onchocerciasis.
217
astmh.org
688
DIAGNOSIS OF LOW-INTENSITY SCHISTOSOMA INFECTION 
IN A NON-ENDEMIC SETTING USING THE ULTRASENSITIVE 
LATERAL FLOW TEST FOR DETECTION OF SCHISTOSOME 
CIRCULATING ANODIC ANTIGEN (CAA)
Lisette van Lieshout, Rebecca Van Grootveld, Claudia De Dood, 
Jutte De Vries, Leo G. Visser, Darius Soonawala, Paul Corstjens, 
Govert J. Van Dam
Leiden University Medical Center (LUMC), Leiden, Netherlands
Schistosomiasis in travelers and migrants is mostly diagnosed by detecting 
specific antibodies in serum, as microscopy has a pronounced low 
sensitivity in this particular population. Although serology is sensitive and 
specific, it cannot distinguish active from past infection and it may take 
up 6 to 10 weeks for seroconversion to occur. An alternative diagnostic 
tool is detection of adult worm-derived circulating antigen in serum 
or urine. Here we explored the diagnostic value of an ultrasensitive 
robust lateral flow based test for the quantification of the Schistosoma 
Circulating Anodic Antigen (CAA) utilizing fluorescent up-converting 
phosphor reporter particles (UCP-LF CAA assay) within a non-endemic 
routine diagnostic laboratory setting. Serum samples from 81 serology 
positive cases were tested, including 36 travelers of which 14 had 
proven seroconversion. CAA (>0.1 pg/ml) was detected in 68% of all 
schistosomiasis cases, including 56% of the travelers and 64% of those 
who seroconverted. All 19 controls were CAA negative, while all 11 
subjects who were positive for microscopy and/or PCR in stool or urine 
were CAA positive. In travelers CAA was seen as early as four weeks 
after exposure and the antigen could be demonstrated in four out of five 
samples collected days to weeks before antibodies were observed. On the 
other hand, most of the CAA positive travelers (18/20) had marginally to 
low (<10 pg/ml) serum CAA concentrations, while higher levels were seen 
in the subjects with chronic schistosomiasis. Consecutive samples were 
tested in 16 subjects and all showed a rapid decline in CAA concentration, 
reflecting decreasing worm loads due to anti-schistosomal therapy. This 
explorative retrospective study indicates the UCP-LF CAA assay to be 
a highly accurate test for diagnosing schistosomiasis in a non-endemic 
setting.
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FIELD-TESTING OF A COST-EFFECTIVE MOBILE-PHONE 
BASED MICROSCOPE FOR SCREENING OF SCHISTOSOMA 
HAEMATOBIUM
Isaac I. Bogoch1, Hatice Koydemir2, Derek Tseng2, Richard K.D. 
Ephraim3, Evans Duah3, Joseph Tee4, Jason R. Andrews5, Aydogan 
Ozcan2
1Toronto General Hospital, Toronto, ON, Canada, 2University of California 
Los Angeles, Los Angeles, CA, United States, 3University of Cape Coast, 
Cape Coast, Ghana, 4Volta River Authority, Accra, Ghana, 5Stanford 
University, Palo Alto, CA, United States
Schistosomiasis is a parasitic and neglected tropical disease, and affects 
>200-million people across the world, with school-aged children 
disproportionately affected. Here we present field-testing results of a 
handheld and cost effective smartphone-based microscope in rural Ghana, 
Africa, for point-of-care diagnosis of Schistosoma haematobium infection. 
In this mobile-phone microscope, a custom-designed 3D printed opto-
mechanical attachment (~150g) is placed in contact with the smartphone 
camera-lens, creating an imaging-system with a half-pitch resolution of 
~0.87µm. This unit includes an external lens (also taken from a mobile-
phone camera), a sample tray, a z-stage to adjust the focus, two light-
emitting-diodes (LEDs) and two diffusers for uniform illumination of the 
sample. In our field-testing, 60 urine samples, collected from children, 
were used, where the prevalence of the infection was 72.9%. After 
concentration of the sample with centrifugation, the sediment was placed 
on a glass-slide and S. haematobium eggs were first identified/quantified 
using conventional benchtop microscopy by an expert diagnostician, and 
then a second expert, blinded to these results, determined the presence/
absence of eggs using our mobile-phone microscope. Compared to 
conventional microscopy, our mobile-phone microscope had a diagnostic 
sensitivity of 72.1%, specificity of 100%, positive-predictive-value of 
100%, and a negative-predictive-value of 57.1%. Furthermore, our 
mobile-phone platform demonstrated a sensitivity of 65.7% and 100% 
for low-intensity infections (≤50 eggs/10 mL urine) and high-intensity 
infections (>50 eggs/10 mL urine), respectively. We believe that this 
cost-effective and field-portable mobile-phone microscope may play an 
important role in the diagnosis of schistosomiasis and various other global 
health challenges. We discuss the use of these instruments in clinical and 
public health settings.
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THE EMERGENCE AND EPIDEMIOLOGY OF ENDEMIC (FLEA-
BORNE) TYPHUS IN TEXAS, 2003-2013
Kristy O. Murray1, Nicole Evert2, Bonny Mayes2, Eric Fonken2, 
Timothy Erickson1, Melissa N. Garcia1, Tom Sidwa2
1Baylor College of Medicine and Texas Children’s Hospital, Houston, TX, 
United States, 2Texas Department of State Health Services, Austin, TX, 
United States
Endemic or murine typhus, a disease spread by fleas and caused by 
the organism Rickettsia typhi, is a neglected tropical disease in Texas. 
The purpose of this study was to characterize the epidemiology of 
murine typhus in the state, identify seasonality of disease transmission, 
and identify high-risk geographic and demographic populations. We 
analyzed data on all confirmed and probable cases reported to the Texas 
Department of State Health Services’ Zoonosis Control Branch between 
2003 and 2013. Over this time period, 1762 cases were reported (770 
confirmed and 992 probable cases). Evidence of emergence was seen 
both in increased numbers of cases over time (27 cases in 2003 versus 
222 cases reported in 2013) and geographical location (9 counties in the 
southern-most part of the state in 2003 to 40 counties reporting cases 
by 2013). With regards to demographics, females had a slightly higher 
attack rate compared to males (7.3 vs. 6.7 per 100,000 population, 
respectively). When examining risk of disease by age, the highest attack 
rate (10.4/100,000 population) was found among 5-19 year olds. Of these 
cases, 1047 (59.6%) were hospitalized. Most commonly reported signs 
and symptoms included fever (99.7%), headache (77.2%), chills (70.1%), 
malaise (64.1%), anorexia (52.8%), nausea/vomiting (51.4%), and 
myalgias (50.8%). Rash was reported by 42.5% of cases, with pediatric 
cases being statistically more likely to present with a rash when compared 
to adults (odds ratio = 2.2). Fatality was rare, with 4 deaths being reported 
(0.2% case fatality rate). Median age of fatal cases was 51.5 years (range 
36-55 years). With the increase in reported cases, high percentage of 
hospitalizations, and geographic expansion of transmission, we want 
to highlight the importance of public education and raising physician 
awareness to identify and treat suspected cases. Additionally, further 
research is needed to better understand the dynamics of transmission and 
risk of infection in these newly identified geographic regions.
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ZIKA VIRUS DISEASE AMONG TRAVELERS RETURNING FROM 
THE AMERICAS BETWEEN JANUARY 2013 AND FEBRUARY 
2016: A GEOSENTINEL ANALYSIS
Davidson H. Hamer1, Kira Barbre2, Susan Anderson3, Elizabeth D. 
Barnett4, Andrea Boggild5, Emmanuel Bottieau6, Gary Brunette7, 
Eric Caumes8, Marty Cetron7, Lin H. Chen9, Gilles Eperon10, 
Philippe Gautret11, Abraham Goorhuis12, Martin P. Grobusch12, 
Stefan Hagmann13, Noreen Hynes14, Phyllis Kozarsky15, Sanne 
Jespersen16, Michael Libman17, Rogelio Lopez-Velez18, Denis 
Malvy19, Frank Mockenhaupt20, Israel Molina21, Cecilia Perret22, 
Camilla Rothe23, Patricia Schlagenhauff24, Eli Schwartz25, Perry Van 
Genderen26, Annelies Wilder-Smith27, Doug Esposito7
1Center for Global Health and Development, Boston University, Boston, 
MA, United States, 2Task Force for Global Health, Decatur, GA, United 
States, 3Travel Medicine and Emergency/Urgent Care - Palo Alto Medical 
Foundation, Palo Alto, CA, United States, 4Maxwell Finland Laboratory for 
Infectious Diseases - Boston Medical Center, Boston, MA, United States, 
5Centre for Travel and Tropical Medicine - Toronto General Hospital, 
Toronto, ON, Canada, 6Institute of Tropical Medicine, Antwerp, Belgium, 
7Centers for Disease Control and Prevention, Atlanta, GA, United States, 
8Service des Maladies Infectieuses et Tropicales - Hôpital Pitié-Salpêtrière, 
Paris, France, 9Travel Medicine Center - Mt. Auburn Hospital, Cambridge, 
MD, United States, 10Travel and Tropical Medicine - Division of Tropical 
and Humanitarian Medicine - Geneva University Hospitals, Geneva, 
Switzerland, 11Infectious and Tropical Diseases Unit - Hôpital Nord, 
Marseille, France, 12Center for Tropical and Travel Medicine - University of 
Amsterdam, Amsterdam, Netherlands, 13Division of Pediatric Infectious 
Diseases - Bronx-Lebanon Hospital Center, Bronx, NY, United States, 14John 
Hopkins Univ. School of Medicine - Geographic Medicine Center - Division 
of Infectious Diseases, Baltimore, MD, United States, 15TravelWell, Atlanta, 
GA, United States, 16Department of Infectious Disease - Aarhus University 
Hostpital, Arrhus, Denmark, 17McGill University Centre for Tropical 
Diseases - Montreal General Hospital, Montreal, QC, Canada, 18Unidad de 
Medicina Tropical - Servicio de Enfermedades Infecciosas - Hospital Ramon 
y Cajal, Madrid, Spain, 19Santé-Voyages et Médecine tropicale - Niveau -1, 
Hôpital Saint-André, Bordeaux, France, 20Institute of Tropical Medicine and 
International Health - Charité - Universitätsmedizin Berlin, Berlin, Germany, 
21Anexos 6ª Planta. Hospital General Vall d’Hebron, Ba
Since first identified in Brazil in 2015, Zika virus (ZIKV) has rapidly spread 
to >30 countries and territories in the Americas. Travelers, important 
sentinels of new disease outbreaks, can facilitate global disease spread. 
ZIKV disease acquired in the Americas and evaluated at GeoSentinel 
Surveillance Network sites from January 1, 2013 to February 29, 2016 
were analyzed. Interim Council of State and Territorial Epidemiologists 
classification criteria were used to classify patients as clinically suspect, 
probable, or confirmed cases of ZIKV disease. There were 62 confirmed, 
13 probable, and 16 clinically suspect ZIKV cases of 100 cases submitted. 
Of the 91 cases, 64% were female, and median age was 41 y (range 
3-77 y). Major reasons for travel were tourism (48%) and visiting friends 
and relatives (40%). Infections were acquired in South America (59%), 
the Caribbean (24%), and Central America/Mexico (16%); the top three 
countries were Suriname (22%), Colombia (16%), and Brazil (11%). 
Diagnoses were made in Western Europe (73%), North America (15%), 
Middle East (9%), and South America (3%). The first two cases were 
reported in May 2015 and November 2015, after which there was a rapid 
rise in cases. The most common sign/symptoms were rash (88%), fever 
(76%), arthralgia (72%), headache (60%), myalgia (60%), fatigue (47%), 
conjunctivitis (41%), and pruritus (23%). Less common were nausea, 
diarrhea, paresthesia, dysgeusia, and arthritis. Of 4 pregnant patients, 2 
had normal ultrasounds, one underwent elective termination due to major 
fetal neurological abnormalities, and one had no documented outcome. 
Two patients were diagnosed with Guillain-Barré syndrome. This large 
case series demonstrates the range of symptoms associated with ZIKV 
infection. While sentinel surveillance does not reflect true incidence and is 
biased towards identifying more severe disease and influenced by testing 
availability, GeoSentinel data are important for tracking the geographic 
spread of emerging infections. We show that travelers infected in the 
Americas return to locations where they can potentially transmit the virus 
to sexual partners or competent vectors.
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OUTCOMES OF PREGNANT PATIENTS PRESENTING TO 
EBOLA TREATMENT UNITS IN SIERRA LEONE AND LIBERIA: A 
RETROSPECTIVE COHORT STUDY
Patricia Henwood1, Lisa Babell1, Reshma Roshania2, Michaela 
Mallow2, Adam Levine3
1Brigham and Women’s Hospital/Harvard Medical School, Boston, MA, 
United States, 2International Medical Corps, Los Angeles, CA, United 
States, 3Warren Alpert Medical School of Brown University, Providence, RI, 
United States
Pregnant women are thought to have increased risk for severe illness and 
death when infected with Ebola virus disease (EVD). This retrospective 
cohort study investigated the presenting symptoms and outcomes of 
pregnant women compared with non-pregnant women of reproductive 
age admitted to five Ebola Treatment Units (ETUs) in Sierra Leone and 
Liberia between September 2014 - 2015. Data analysis was completed for 
women of reproductive age with results for EVD testing, with a focus on 
those with the report of pregnancy. Standardized care, including empiric 
malaria treatment and oral antibiotics, was provided to all patients based 
on International Medical Corps protocols. Among 2,323 patients admitted 
with outcome data, 723 women of reproductive age were included for 
analysis. Forty-four women were documented as pregnant; the median 
gestational age reported was 26 weeks (range of 4 to 40 weeks). There 
was no significant difference in overall mortality between pregnant and 
non-pregnant women (13.9% vs 18.9%, p=0.42). Pregnant patients were 
no more likely to have EVD than non-pregnant women (29.6% vs 23.9%, 
p=0.39), and were less likely to have fever, bone/muscle pain, nausea, 
vomiting, diarrhea, anorexia and asthenia as presenting symptoms when 
compared to non-pregnant women. Thirteen pregnant patients were 
EVD positive. Six died, six survived to discharge, and one was transferred 
to a nearby ETU with specialized care for pregnant women (outcome 
unknown). There was no difference in mortality between pregnant 
and non-pregnant women with EVD (50% vs 53.7%, p=0.80). There 
were two live births in the ETU; both infants died before hospital day 9. 
Training guidelines for providers working in Ebola treatment units focus 
on maternal deliveries without assistance to minimize risk to healthcare 
workers considering historical data suggested poor maternal or fetal 
survival. Our data points to comparable maternal outcomes, though fetal 
survival in the context of an EVD gestation remained poor. Based on this 
data, re-evaluating the approach to management of pregnant patients in 
the ETU setting may be warranted.
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DECIPHERING THE BIOLOGY OF THE DORMANT MALARIA 
PARASITE, PLASMODIUM VIVAX, VIA AN IN VITRO 
PLATFORM
Nil Gural
Massachusetts Institute of Technology, Cambridge, MA, United States
Liver stage malaria is an attractive target for all Plasmodium species since 
it provides the opportunity to attack the parasite at an early, obligate, 
yet clinically silent stage. Of the 4 strains of malaria that infects humans, 
P. vivax is the most frequent and widespread cause of human malaria 
and poses unique challenges to treatment and eradication because liver 
stage parasites can develop into dormant small forms, hypnozoites, that 
remain in this state for prolonged periods. This strain of malaria causes 
chronic, relapsing infection months to years after the initial infection 
via reactivation of hypnozoites. Drug discovery could be informed by 
targeting the hypnozoite stage, however the biology behind hypnozoite 
formation and reactivation remains to be elucidated. In vitro platforms 
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for studying P. vivax are lacking because of challenges associated with 
keeping primary human hepatocytes phenotypically stable over the long 
periods of time required for studying dormant parasites. Benefiting from 
the longevity of our micropatterned primary human hepatocyte cultures, 
we were, for the first time, able to culture P. vivax hypnozoites in vitro. To 
validate the system as an in vitro surrogate for P. vivax biology applications, 
we have shown (1) complete P. vivax liver stage development, including 
release of merozoites and subsequent infection of overlaid reticulocytes 
and (2) formation, persistence and reactivation of hypnozoites. Using 
the system as a potential discovery tool, we presented evidence of 
differential drug sensitivity of schizonts and hypnozoites towards both 
clinically available and yet-in-development liver-acting drugs. Furthermore, 
leveraging the power of an in vitro culture in facilitating rapid testing 
of biological hypotheses that are otherwise clinically difficult to test, we 
created a simple deterministic model that recapitulates the behavior of 
P. vivax parasites over time. Fitting experimental data into this model, we 
addressed two hallmarks of P. vivax liver stage biology: lifetime in the liver 
and hypnozoite reactivation frequency.
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CELL TRAVERSAL BY MALARIA PARASITES: PLASMODIUM 
CELTOS BINDS AND DISRUPTS PLASMA MEMBRANES 
FROM THE CYTOPLASMIC FACE TO ENABLE THE EXIT OF 
PARASITES FROM CELLS DURING HOST AND VECTOR CELL 
TRAVERSAL
John R. Jimah, Nichole D. Salinas, Monica Sala-Rabanal, 
Nathaniel G. Jones, L. David Sibley, Colin Nichols, Paul Schlesinger, 
Niraj H. Tolia
Washington University School of Medicine, St. Louis, MO, United States
Traversal of host and vector cells by Plasmodium parasites is required 
for malaria infection and transmission. Plasmodium CelTOS has been 
identified by genetic studies to be critical for the traversal of parasites 
through the mammalian host and mosquito vector. Additionally, CelTOS is 
a leading malaria vaccine candidate in clinical trials. Even though CelTOS 
has critical roles in Plasmodium biology and is a malaria vaccine target, the 
molecular function and mechanism of CelTOS remains unknown primarily 
due to its lack of sequence similarity to proteins of known function. We 
determined the structure of Plasmodium CelTOS to obtain insight into 
its molecular function. Unexpectedly we discovered CelTOS is structurally 
similar to viral fusion proteins and a bacterial pore-forming toxin that bind 
membranes. Unlike other membrane binding proteins, CelTOS specifically 
lipids predominantly present in the inner leaflet of plasma membranes. We 
also observed that CelTOS disrupts liposomes composed of these lipids, 
and further in vivo studies demonstrate that CelTOS disrupts cell plasma 
membranes. Taken together, these studies demonstrate that CelTOS is the 
only known malaria parasite protein that enables the exit of parasites from 
host and vector cells during traversal by having nearly universal activity 
in binding and disrupting plasma membranes from the cytoplasmic face. 
By providing insight into the function and mechanism of CelTOS, this 
study facilitates the design of therapeutics which target CelTOS to protect 
against malaria.
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MECHANISM OF FETAL GROWTH RESTRICTION IN PLACENTA 
MALARIA
Kris Genelyn Dimasuay1, Fredrick Rosario2, Jocelyn Glazier3, 
James Beeson4, Stephen Rogerson1, Thomas Jansson2, Philippe 
Boeuf4
1University of Melbourne at the Peter Doherty Institute for Infection and 
Immunity, Melbourne, Australia, 2University of Colorado Anschutz Medical 
Campus, Denver, CO, United States, 3University of Manchester, St. Mary’s 
Hospital, Manchester, United Kingdom, 4Burnet Institute, Melbourne, 
Australia
Placental malaria can trigger intervillositis; a local inflammatory response 
more strongly associated with fetal growth restriction (FGR) than placental 
malaria infection alone. The underlying mechanisms are unknown but we 
have shown that placenta malaria-associated intervillositis impairs placental 
amino acid transport. The mechanistic target of rapamycin (mTOR) 
signaling pathway regulates fetal growth by modulating transplacental 
amino acid transport. mTOR activity has also been observed to be 
decreased in non-malarial cases of FGR. We hypothesized that placenta 
malaria-associated intervillositis inhibits mTOR signaling pathway, resulting 
in reduced placental amino acid uptake. Using placental tissue biopsies 
from Malawian women, we demonstrated that mTOR signalling activity 
is i) decreased specifically in placenta malaria-associated intervillositis 
compared to uninfected controls (p≤0.03); ii) negatively correlated with 
the degree of inflammation (p≤0.03; R < -0.42) and iii) positively correlated 
with amino acid uptake (p≤0.03; R > 0.36). Using our established in 
vitro model of placental response to intervillositis, we demonstrated that 
primary human trophoblast (PHT) cells exposed to placental malaria-
associated intervillositis have decreased mTOR signalling activity (p≤0.02) 
and reduced amino acid uptake (-63%, p≤0.02), recapitulating our ex 
vivo findings. Furthermore, constitutive mTOR activation (by silencing 
the endogenous inhibitor of mTOR) partially restores amino acid 
uptake (+30%, p≤0.0001) in PHT cells exposed to placental malaria-
associated intervillositis. In summary, we determined that inhibition of 
placental mTOR activity mechanistically links placental malaria-associated 
intervillositis and reduced amino acid transport, which may contribute 
to the pathogenesis of FGR. We propose that restoring mTOR signaling 
in placental malaria may increase fetal growth and complement malaria 
control strategies to improve pregnancy outcomes in pregnant women 
exposed to malaria.
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THROMBOSPONDIN RELATED SPOROZOITE PROTEIN IS 
IMPORTANT FOR THE ESTABLISHMENT OF PLASMODIUM 
FALCIPARUM LIVER STAGE INFECTION
Charlie Jennison1, Matthew T. O’Neill1, Jennifer S. Armistead1, 
Annie S. Yang1, Sash Lopaticki1, Norman M. Kneteman2, Justin A. 
Boddey1
1Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia, 
2University of Alberta, Edmonton, AB, Canada
From oocyst to vertebrate host cell, malaria sporozoites must traverse 
and recognize multiple cell types if they are to successfully continue 
the parasite’s lifecycle. Proteins previously recognized to be important 
for sporozoite-host-cell interactions; circumsporozoite protein (CSP) 
and thrombospondin related anonymous protein (TRAP), contain 
thrombospondin type 1 repeats (TSR). Another less well characterized 
TSR protein, highly expressed in sporozoites, is thrombospondin related 
sporozoite protein, which contains a TSR, a transmembrane domain and 
a putative PEXEL motif, suggesting it may localize to the surface of the 
sporozoite and/or be exported. TRSP has previously been shown to be 
important for the successful invasion and establishment of liver stage 
infection in P. berghei. In order to investigate the role and localization of 
this protein in P. falciparum, the species responsible for the vast majority 
of human malarial morbidity and mortality worldwide, we generated 
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P. falciparum TRSP knockout parasites, as well as lines expressing GFP 
and HA tagged TRSP. TRSP deficient parasites show no defect until the 
sporozoite stage, where they display a mild hepatocyte traversal defect 
in vitro. This does not however result in an in vitro invasion defect as 
seen in P. berghei. To further investigate the importance of this traversal 
defect in vivo, ΔTRSP sporozoites were injected into uPA/SCID mice with 
humanised livers, where a 95% reduction in parasite load was observed 
six days post infection by qPCR. Preliminary data indicate that ΔTRSP liver 
schizonts can develop with a morphology and size similar to wildtype and 
morphological characteristics will be discussed. These data show that TRSP, 
in common with other TSR containing sporozoite proteins, is important for 
the establishment of liver stage infection, most likely during the invasion 
process, however work is ongoing to further define the exact function of 
TRSP in this important human pathogen.
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A SYSTEMATIC APPROACH TO THE OPTIMIZATION OF 
PLASMODIUM VIVAX IN VITRO CULTURE
Gabriel Rangel1, Martha A. Clark1, Kathryn Shaw-Saliba1, Usheer 
Kanjee1, Caeul Lim1, Marcelo U. Ferreira2, Anjali Mascarenhas3, 
Laura Chery3, Edwin Gomes4, Pradipsinh K. Rathod3, Manoj T. 
Duraisingh1
1Harvard University, Boston, MA, United States, 2University of São Paulo, 
São Paulo, Brazil, 3University of Washington, Seattle, WA, United States, 
4Goa Medical College, Goa, India
The WHO estimates that 35% of the global population was at risk for 
and approximately 16 million people suffered from clinical Plasmodium 
vivax infection in 2013, making P. vivax the most globally widespread 
malaria parasite and an immense health and economic burden. 
Unfortunately, largely due to its unique biology, a continuous, in vitro 
culture system for this parasite has remained elusive, hindering our 
ability to make scientific advancements and combat P. vivax. A major 
obstacle to continuous, in vitro culture is our lack of understanding 
the nutrient requirements of P. vivax for successful asexual maturation 
and survival. To enhance P. vivax ex vivo growth and to understand the 
nutrient requirements of the parasite, we designed and executed a 
screen to identify an optimal culture media. Twenty different media were 
commercially acquired that represent a range of defined and proprietary 
formulations, with an emphasis on media developed for cultivation of 
erythrocytes and erythrocyte precursors. From this screen, we identified a 
formulation that significantly enhances the survival and asexual maturation 
of human ex vivo P. vivax isolates from ring stages to schizogony and 
egress. Furthermore, the increased survival and maturation has enhanced 
our ability to perform invasion assays. While it has been previously 
demonstrated that P. vivax preferentially invades very young red blood 
cells, reticulocytes, our assays indicate that a currently uncharacterized, 
more specific subset of reticulocytes is required for efficient invasion and 
subsequent asexual maturation. To enable the identification of a host cell 
that fully enables P. vivax invasion and maturation, we have developed 
methods to fractionate very specific subpopulations of human reticulocytes 
from multiple sources representing the full range of erythropoiesis. In all, 
this systematic approach to the optimization of in vitro culture of P. vivax 
has enabled us to reliably perform short-term growth assays, establish 
more robust invasion assays, and it has brought us closer to continuous in 
vitro culture.
698
MOLECULAR TECHNIQUES IDENTIFY ANCYLOSTOMA 
CEYLANICUM AND NECATOR AMERICANUS AS THE MAJOR 
HOOKWORM PATHOGENS AMONG MYANMAR REFUGEES 
PRE-RESETTLEMENT AND DEFINE THEIR DIFFERENTIAL 
RESPONSE TO ANTHELMINTIC THERAPY
Elise M. OConnell1, Tarissa Mitchell2, Georgiette Oduro-Boateng1, 
Marina Papaiakovou3, Nils Pilotte3, Deborah Lee2, Steven Williams3, 
Michelle Weinberg2, William Stauffer4, Thomas B. Nutman1
1National Institutes of Health, National Institute of Allergy and Infectious 
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GA, United States, 3Department of Biological Sciences, Smith College, 
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Human hookworm infection, typically caused by Necator americanus 
(Na) and Ancylsotoma duodenale (Ad), remains an important source 
of childhood growth restriction, iron deficiency, and anemia. Using 
multi-parallel real-time PCR (qPCR) on stool samples from 233 subjects 
that were part of a larger study (n=2000) assessing the prevalence of 
intestinal parasites in refugees from Myanmar (domiciled in refugee 
camps in Thailand) and the efficacy of pre-resettlement anthelmintic 
therapy, we assessed Na and Ad prevalence in all subjects from 3 time 
points (1-following arrival in refugee camps in Thailand, 2-after treatment 
with albendzaole/ivermectin (A/I) prior to departure for the United States 
(US), and 3-following arrival in the US after a second treatment with 
A/I). At entry, 51 of 233 (22%) were infected with Na. QPCR targeting 
the ITS2 region of Ancylostoma spp. revealed 17 of 233 (7%) stool 
samples were positive upon entry to the refugee camp. However, qPCR 
targeting a repeated sequence specific for A, duodenale was negative for 
all 17 samples. Sequencing and follow up qPCR revealed all 17 of these 
samples to be positive for the zoonotic hookworm A. ceylanicum (Ac). 
Following A/I therapy, all subjects with Ac cleared their infection. Of the 
51 subjects infected with Na at baseline, 20 (39%) remained infected 
with Na following the first A/I dose and 14 (27%) remained Na-infected 
despite 2 courses of A/I. Six previously hookworm-uninfected subjects 
acquired Na infection while in the refugee camp (positive at timepoint 3), 
and 2 acquired Ac (positive timepoint 2). Studies are ongoing to sequence 
the beta-tubulin genes of those Na parasites that responded and failed 
to respond to A/I. These data identify the zoonotic Ac as an emerging 
and important human pathogen in Myanmar. Thus, the availability of 
increasingly sophisticated molecular diagnostic techniques to assess the 
differential responses of the various hookworm species to anthelmintics 
and to provide evidence of ongoing acquisition of hookworm infection 
within refugee camps should guide future planning of pre-departure 
medical treatment for refugees in Southeast Asia.
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MULTI-PARALLEL QUANTITATIVE REAL-TIME PCR BASED 
DIAGNOSTICS AS THE NEW GOLD STANDARD FOR SOIL 
TRANSMITTED HELMINTHS
Marina Papaiakovou1, Nils Pilotte2, Steven A. Williams1, Paola 
Vargas3, Reynaldo Nicolás Caro3, Rubén Cimino3, Alejandro 
Krolewiecki4, Rojelio Mejia5
1Smith College, Northampton, MA, United States, 2University of 
Massachusetts, Amherst, MA, United States, 3Instituto de Investigaciones 
en Enfermedades Tropicales, Universidad Nacional de Salta, Orán, 
Argentina, 4Instituto de Patología Experimental/CONICET, Salta, Argentina, 
5Laboratory of Clinical Parasitology and Diagnostics, National School of 
Tropical Medicine Baylor College of Medicine, Houston, TX, United States
Due to its simplicity and cost-effectiveness, microscopy has seen extensive 
field-use as the diagnostic standard for the detection of soil-transmitted 
helminths (STH) in stool samples. However, the sensitivity of microscopy-
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based detection is inadequate in reduced-transmission settings where 
worm burden is oftentimes low. Equally problematic, eggs of closely 
related species oftentimes have indistinguishable morphologies, leading 
to species misidentification. In light of these shortcomings, the purpose 
of this study was to demonstrate multi-parallel quantitative real-time 
PCR (qPCR) as the new “gold standard” for STH detection. Accordingly, 
stool samples from non-endemic participants were spiked with limited 
numbers of eggs or larvae (1 to 40) of five different species of STH. DNA 
extracts were tested using two unique multi-parallel real-time PCR-based 
diagnostic methods. These methods employed different target sequences 
(ribosomal internal transcribed spacer, or highly repetitive non-coding 
regions), to evaluate the detection of DNA from as little as one egg per 
sample. There was a statistically significant spearman correlation between 
egg/larvae counts and qPCR from both methods for each one of the multi-
parallel assays; for Ascaris lumbricoides (0.806), Ancylostoma duodenale 
(0.961), Necator americanus (1.00), Strongyloides stercoralis (0.835), and 
Trichuris trichiura (0.956) (p < 0.05 for all STH). Both methods had similar 
detection rates for 104 stool samples from a rural population in northern 
Argentina with less than a 25% variance between them for most STH. 
As parasitic targeting of two independent genomic regions provided 
reproducible results, we believe that, low cost multi-parallel quantitative 
real-time PCR-based diagnostics should supplant microscopy as the new 
gold standard for stool-based detection of soil transmitted helminths in 
public-health and community settings.
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DIAGNOSIS OF STRONGYLOIDES STERCORALIS FROM 
FILTERED URINE RESIDUE BY DETECTING CELL-FREE DNA
Nilanjan Lodh1, Reynaldo Caro2, Shterna Sofer3, Alan Scott3, 
Alejandro Krolewiecki2, Clive Shiff3
1Marquette University, Milwaukee, WI, United States, 2Universidad 
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One of the most neglected of the neglected tropical diseases is the 
infection caused by nematodes in the genus Strongyloides. Of the two 
species of Strongyloides, S. stercoralis is the most prevalent that infect 
humans and found in tropical and subtropical regions. Detection of S. 
stercoralis infection is arduous and has low sensitivity. This is a major 
problem because chronic infections may disseminate in the host and 
lead to a life threatening condition. Even now, the true prevalence of 
this parasite is practically unknown because the standard practice for 
stool examinations usually misses evidence of this infection. We present 
here the evidence for the first time that the infection can be detected by 
amplifying S. stercoralis specific cell-free repeat DNA from urine residue 
on filter paper that has been collected and processed in the field. We 
collected 125 specimens from people living in two types of endemic 
regions in Northern Argentina (rural and peri-urban). Stool specimens were 
processed fresh using three different coprological methods and 40-50 
ml of urine was filtered through a 12.5cm Whatman No. 3 filter paper in 
the field. The filters were dried and packed individually in sealable plastic 
bags with desiccant and shipped to Johns Hopkins University where DNA 
was isolated and amplified with species-specific primers. The estimate 
of prevalence of infection was almost doubled when detecting the S. 
stercoralis specific repeat compared with coprological diagnosis (from 28% 
to 44.8%). Only 21.6% positive cases were congruent, as were 27.3% 
of negative cases. There were 6.4% of cases where parasite larvae were 
seen but DNA was not amplified. The species-specific DNA detection 
from urine residue reveals significantly more cases of infection than 
combined stool examinations and the method is simple and easy to carry 
out. This is crucial not only to determine the overall public health impact 
of the pathogen, but also to understand the extent of the infection in 
communities so that attempts to control or eliminate these pathogens are 
efficient and cost-effective.
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Health and nutrition interventions targeting the critical growth and 
development period before the age of two years can have the greatest 
impact on health trajectories over the life course. Compelling evidence 
suggests that interventions in the postpartum period can be beneficial 
for both mothers and their children. One such potential intervention is 
deworming. In this seminal randomized controlled trial, we sought to 
evaluate the effectiveness of maternal postpartum deworming on infant 
growth. A total of 1010 mother-infant pairs were recruited in Iquitos, 
Peru. Prior to delivery, mothers provided stool specimens to determine the 
presence of soil-transmitted helminth (STH) infection. Following delivery, 
mothers were randomly assigned to receive either single-dose 400 mg 
albendazole, or matching placebo. Mother-infants pairs were followed-up 
at 1 and 6 months postpartum. At 6 months postpartum, there was no 
statistically significant difference in mean weight gain between infants 
in the albendazole and placebo groups (4.3 kg ± 0.04 vs. 4.4 kg ±0.04). 
However, ad hoc subgroup analyses restricted to mothers who tested 
positive for STH infections at baseline suggest that infants whose mothers 
received albendazole had greater growth in terms of mean length gain 
in cm (mean difference: 0.8; 95% CI: 0.1, 1.4) and length-for-age in 
Z-score (mean difference: 0.5; 95% CI: 0.1, 0.8). In a study population 
composed of both infected and uninfected mothers, maternal postpartum 
deworming with single-dose albendazole was insufficient to impact 
infant growth indicators at 1 or 6 months of age. Among STH-infected 
mothers, however, important infant growth benefits were observed. The 
benefits of postpartum deworming should be further investigated in study 
populations having different prevalences and intensities of STH infections 
and, in particular, where the prevalences and intensities of whipworm and 
hookworm infections are of public health concern.
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SOIL-TRANSMITTED HELMINTHS (STH) CONTROL, 
ELIMINATION, AND DEVELOPMENT OF DRUG RESISTANCE: 
REPERCUSSIONS OF SYSTEMATIC NON-PARTICIPATION TO 
PREVENTIVE CHEMOTHERAPY
Luc E. Coffeng, Wilma A. Stolk, Roel Bakker, Sake J. de Vlas
Erasmus MC, University Medical Center, Rotterdam, Netherlands
Preventive chemotherapy (PCT) is a widely applied strategy to control 
soil-transmitted helminths (STH). However, mathematical models 
predict that effective control and/or elimination are easily impeded by 
suboptimal PCT coverage and/or systematic non-participation to PCT 
by a subset of individuals. Further, suboptimal coverage and systematic 
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non-participation may on the one hand facilitate the development of 
drug resistance through prolonged programme duration until elimination, 
but on the other hand may also delay it by allowing for parasite refugia 
in suboptimally treated populations. We present a novel individual-
based model for evolution of polygenic drug resistance in helminth 
populations that accounts for aggregation of helminths in human hosts, 
human demography, patterns in PCT uptake (including systematic non-
participation), sexual mating of parasites, genetic drift, and variation 
and heritability of parasite traits for drug resistance. The model has been 
quantified for transmission and control of the three major STH species 
(ascariasis, trichuriasis, hookworm), and has been used to simulate and 
explore the impact of various levels of drug efficacy, PCT coverage, and 
systematic non-participation to PCT on the speed at which polygenic drug 
resistance evolves in STH populations under varying assumptions about 
variation and heritability of parasite traits for drug resistance. Based on 
these explorative simulations, we provide a first-time estimate of the time 
horizon within which we can expect polygenic drug resistance to develop 
in STH populations as a result of PCT.
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DIFFERENTIAL IMPACT OF MASS AND TARGETED 
DEWORMING CAMPAIGNS FOR SOIL-TRANSMITTED 
HELMINTH CONTROL IN CHILDREN: A SYSTEMATIC REVIEW 
AND META-ANALYSIS
Susana Vaz Nery, Archie C. Clements, Suhail A. Doi, Dongxu 
Wang, Suzy J. Campbell, Darren Gray, Naomi E. E. Clarke
Australian National University, Canberra, Australia
Soil-transmitted helminth (STH) infections are an important global 
health issue, causing significant morbidity among the world’s poorest 
populations. Regular delivery of anthelminthic chemotherapy is the 
principal strategy for STH control. As children harbour the largest burden 
of STH-associated morbidity, deworming medications are often targeted 
to school-aged children. However, recent modelling studies suggest that 
deworming campaigns should be expanded community-wide to have 
an impact on STH transmission.This systematic review and meta-analysis 
aimed to compare the impact of community-wide and child-targeted 
anthelminthic delivery strategies on STH prevalence in school-aged 
children.Studies reporting STH prevalence before and after child-targeted 
or community-wide treatment were identified searching MEDLINE, 
EMBASE, and Web of Science. Data extracted included drug administration 
strategy, drug dose, number of deworming rounds, treatment coverage, 
diagnostic method, follow-up interval, and STH prevalence before and 
after treatment. Inverse variance weighted generalised linear models were 
used to examine the impact of community-wide vs child-targeted drug 
administration on prevalence reduction in school-aged children.56 studies 
were included. Results of the regression models show a significantly 
greater prevalence reduction in children following community-wide 
deworming, compared to child-targeted deworming, for both Ascaris 
lumbricoides (OR 16.39; 95%CI 2.14-125.85) and hookworm (OR 
4.62; 95%CI 1.85-11.57).The results of this meta-analysis suggest 
that expanding periodic chemotherapy for STH from child-targeted to 
community-wide is likely to result in reduced prevalence of STH among 
the high-risk group of school-aged children, which may lead to decreased 
morbidity. Findings are in support of recent calls for a re-evaluation of 
global STH control guidelines.
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AGAINST STRONGYLOIDES STERCORALIS IN AN 
ARGENTINIAN ENDEMIC REGION MONITORED THROUGH 
NIE-ELISA
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Northwestern Argentina is a hyperendemic area for soil transmitted 
helminth infection, where annual deworming programs are carried out 
in prioritized areas for its control. In the particular case of Strongyloides 
stercoralis, high prevalence was reported in this area (30-50%); therefore, 
ivermectin has been included in the chemotherapy. In this context, 
assessing the S. stercoralis response to therapy in the treated population 
has become a major concern. The NIE ELISA was used for this purpose 
since it proved to be more sensitive than conventional parasitological 
techniques for the diagnosis of S. stercoralis. This community trial was 
conducted in two groups of patients, classified according to differences 
in housing and living conditions. After the first sampling and deworming 
(Massive Drug Administration, MDA), Group 1 (G1) was moved to new 
households with drinking water access and improved sanitation facilities 
(MDA+WAS intervention); while Group 2 (G2) remained living in less 
developed conditions with unimproved drinking water and sanitation 
(MDA intervention). The mean interval times between baseline (Base) 
and the follow up (F/U) were 359 days for G1 and 478 for G2. Anti-NIE 
antibody titers (Optical Density, OD) were measured for each individual 
before and after interventions (paired sera). A follow up OD ratio (ODF/U/
ODBase) was calculated to quantify the variation in antibody titers. A 
significant decrease of the anti-NIE titers (p<0.0001) between Base and 
F/U was observed in both groups. Nonetheless the number of patients 
who achieved the cure criteria (ODratio<0.6) was different between 
groups: G1: 75% (24/32); G2: 45% (17/38) (p=0.038). We found that 
NIE ELISA is a useful test for assessing the response to treatment and to 
evaluate the outcome of control interventions in the population. Following 
the anthelminthic treatment, we could observe a marked decrease of 
anti-NIE antibodies over the time. Furthermore, our results support that 
a combined intervention including deworming and improvements in life 
conditions is more effective, in terms of number of subjects cured, than 
deworming only.
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COMPARISON OF ALPHAVIRUS AND FLAVIVIRUS 
PREVALENCE IN WESTERN KENYA
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Chikungunya virus (CHIKV) and dengue virus (DENV) are emerging 
mosquito-borne viruses that are endemic in tropical environments, such 
as Africa, Asia, South America, and the Caribbean. In rural areas of Africa, 
DENV and CHIKV infections often go undiagnosed and unreported, as 
fever presentation is commonly assumed to be a sign of malaria. The 
goal of this study was to measure and compare the seroprevalence of 
CHIKV and DENV (serotypes 1-4) among children (ages 5 to 14, n=250) 
and adults (ages 15 to 85, n=250) in a rural village community centered 
around Busia, Kenya. Samples were screened for anti-CHIKV and anti-
DENV IgG by indirect ELISA. As expected, children were less likely to be 
223
astmh.org
exposed to CHIKV (p < 0.001) than adults. For children, 141 samples 
(56.4%, CI95 0.500 to 0.626) were positive for anti-CHIKV IgG, and 2 
samples (0.8%, CI95 0.001 to 0.029) were positive for anti-DENV IgG. 
Comparatively, 195 samples (78.0%, CI95 0.724 to 0.83), and 6 samples 
(2.4%, CI95 0.009 to 0.052) of the 250 samples from adult participants 
were positive for anti-CHIKV IgG and anti-DENV IgG, respectively. Overall, 
67.0% of participants showed seropositivity for CHIKV (CI95 0.627 to 
0.711), and 1.6% of participants were seropositive for DENV (CI95 0.007 
to 0.031). These results confirm the presence of alphavirus and flavivirus 
exposure in western Kenya, and illustrate a significantly higher severity of 
transmission compared to previous studies. Given the expansive spread of 
the endemic in recent years, understanding the true severity, prevalence 
and burden of infection of DENV and CHIKV is critical for predicting the 
future impacts of each virus.
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Elysse Noel Grossi-Soyster1, Francis Mutuku2, Saidi Lipi3, Charles 
Ng’ang’a3, A. Desiree LaBeaud1
1Stanford University School of Medicine, Stanford, CA, United States, 
2Department of Environment and Health Sciences, Technical University 
of Mombasa, Mombasa, Kenya, 3Vector Borne Disease Control Unit, 
Msambweni, Kenya
Some of the most emergent and destructive diseases are mosquito-
borne viruses. The non-specific symptoms of such viral infections lead to 
misdiagnosis and minimal case reporting, making the true impact of such 
infections difficult to determine. This cross-sectional study aims to describe 
the true prevalence of flaviviruses, such as dengue virus (DENV) and West 
Nile virus (WNV), and alphaviruses, such as chikungunya virus (CHIKV) 
and o’nyong n’yong virus (ONNV), in an urban community on the coast 
of Kenya in 2015. A subset of 700 afebrile children, aged 1-17 years, was 
selected from an ongoing community cohort study. Questionnaire data, 
including health history, socioeconomic status, home environment, and 
mosquito exposure, was used to determine potential risk factors associated 
with exposure to alpha- and/or flaviviruses. InBios CHIKjj Detect™ and 
DENV Detect™ IgG ELISA kits were used to identify IgG antibodies 
against DENV1-4 and CHIKV in follow-up samples. IgG seroprevalence 
was 2% for CHIKV (CI95 0.8-2.9%) and 1.4% for DENV (CI95 0.6-
2.6%). Genus-specific cross-reactivity is anticipated with IgG ELISAs. 
Seropositivity for anti-CHIKV IgG, indicating previous alphavirus exposure, 
was associated with frequent outdoor activity (p=0.003) and lack of 
utilization of mosquito avoidance measures (p=0.025). Seropositivity for 
CHIKV (p=0.025) and DENV (p=0.046) was associated with mosquito 
bites at night. Gender was not significantly associated with prior alpha- or 
flavivirus exposure. Children as young as 5 were seropositive for either 
anti-CHIKV or anti-DENV IgG, indicating active alpha- and flavivirus 
transmission within the last 5 years. Children aged between 7 and 12 
years were more likely to be seropositive for anti-CHIKV and anti-DENV 
IgG (p<0.001) when compared to younger participants. Prevalence data 
may not accurately represent the severity of exposure, infection, and 
disease throughout Kenya, as the varied reports of prevalence in other 
regions indicates differences that may be dependent on geographic 
region. These results confirm the continued presence of alphavirus and 
flavivirus exposure in children in coastal Kenya.
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Several chikungunya virus (CHIKV) outbreaks have occurred in Africa, Asia, 
and the Americas in the last decades. However, due to limited surveillance, 
few serologic data are available in Africa and as a result, there is a gap in 
our understanding of ongoing endemic transmission of CHIKV. Thus the 
risk for CHIKV infection in African peoples remains unknown. In order 
to prevent disease emergence, the dynamics of CHIKV infection must be 
understood and the risk factors for transmission need to be evaluated. For 
our study, we enrolled children with acute febrile illness who presented to 
one of four Kenyan health centers (in Chulaimbo and Obama Children’s 
Hospital in western Kenya, and Msambweni and Ukunda on the Kenyan 
coast). In each region, one of the sites is localized in an urban area and 
the other in a rural area, in order to determine whether the differences 
between the two environments have an effect on the transmission rate 
of CHIKV infection in humans. Serum samples were collected at an 
initial visit and at a one-month follow-up visit for CHIKV ELISA testing. 
Questionnaire data were collected to describe demography, education, 
and household environment, along with clinical data. In our preliminary 
screening of 125 paired acute and convalescent serum samples by ELISA 
for anti-CHIKV IgG, we identified 5 cases (4%, 95% CI 1.3% to 9.1%) 
of seroconversion. These cases demonstrate recent active transmission 
of CHIKV in Kenya, both on the coast and in the west. Because of the 
small number of seroconversions in our preliminary analyses, we did not 
identify any differences in risk of infection associated with either urban or 
rural locale. We also did not detect any link between exposure to different 
water sources and seroconversion, however we did find that people 
who use a river or a pond as water source were more likely to report 
mosquito bites than people who have access to a public well (88.7% vs 
70.2%, respectively, p<0.0001 by Fisher’s test). Further testing may reveal 
important risk factors for seroconversion and will help identify potential 
interventions to reduce risk of developing CHIKV infection in Kenya.
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Chikungunya virus (CHIKV) is a rapidly re-emerging arboviral pathogen 
worldwide. In July 2014, an explosive CHIKV outbreak occurred in 
Grenada, West Indies, infecting around 90% of the population, with a 
wide spectrum of disease reported. In an estimated 50% of cases, CHIKV 
infection transitions to a non-communicable painful arthritis that can 
persist for years. Our understanding of the risk factors and mechanisms 
underlying chronic disease are limited. Here, we conducted one-year 
follow up with 240 people who were tested for CHIKV during the Grenada 
outbreak and performed analyses on demographic, behavioral, exposure, 
and co-morbid health factors to identify associations with chronic disease. 
Physical examinations were performed and current arthritis/arthralgia 
symptoms, as well as prior medical history was recorded. Participants 
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also completed extensive questionnaires so that physical, psychological, 
social and environmental factors could also be assessed. “Chronic” CHIKV 
disease cases were defined as individuals who continue to experience 
arthralgia and/or arthritis >6 months after onset of their acute CHIKV 
disease that impacts activities of daily living. Demographic factors 
including age (p=0.56), gender (0.058), ethnicity (0.58) and socioeconomic 
status did not have an effect on the likelihood of suffering from chronic 
persistent CHIKV disease. Increased mosquito avoidance behavior also 
did not reduce the risk of chronic sequelae. Patients who suffered joint 
pains (0.005), muscle pains (0.042), generalized body ache (0.013) and 
weakness in the extremities (0.013) during acute CHIKV disease were 
more likely to have chronic arthritis and arthralgia symptoms, and an 
increased duration of acute disease (0.001) also increased risk. None 
of the co-morbidities measured were associated with increased disease 
risk. These data demonstrate that chronic CHIKV disease affects people 
across the age, gender, ethnic and socioeconomic spectrum, and is not 
reduced by vector avoidance activity. Management of acute symptoms and 
minimization of acute disease duration could reduce chronic sequelae.
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The first chikugunya epidemic in the Americas was reported between 
2013 and 2016. In this period, around 1.7 million clinical cases were 
reported. Due to the lack of a vaccine, vector control was the only resource 
to halt the epidemic. The response of governments to the emergency 
faced challenges because of uncertainty in the possible magnitude of 
the epidemic and in the cost-benefit ratio of vector control programs. 
We developed an agent-based model as a tool to predict transmission 
dynamics of vector-borne diseases and to assess the value of vector 
control. We applied the model to chikungunya in Colombia, where half a 
million cases were reported. By representing large-scale populations with 
an agent-based model, we are able to reproduce population-level patterns 
of the epidemic while accounting for heterogeneity of transmission using 
high-resolution demographic, geographic, and climate characteristics of 
the population. Also, our model allows for the evaluation of the impact 
on the epidemic of individual actions, such as vector control. In the model, 
transmission of the virus occurs upon human contacts with mosquitoes 
in specific locations. We used population density and climate grids to 
reproduce the mosquito abundance in space. Moreover, we created and 
calibrated a synthetic population to represent human demographics, 
contact patterns, and activities of 45 million inhabitants of Colombia. We 
calibrated the model with and without vector control to incidence reports 
of the first 24 weeks of the outbreak. To predict the possible spread of 
the epidemic, we evaluated various schemes of geographical distribution 
of vector control. Also, we validated the model predictions using the 
incidence reports in Colombia available from 2014 to early 2016. These 
simulation results show that giving priority to dengue-endemic areas, 
notably reduces the impact of the epidemic. Furthermore, the model 
predicted the shape and magnitude of the incidence curves reported in 
five out of six regions of Colombia. Finally, we believe that this platform 
can be used to evaluate the impact of similar transmitted viruses such as 
zika or dengue.
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VACCINES AGAINST EMERGING ALPHAVIRUSES
A. B. Silva, M. P. López-Deber, P. Reis, S. Thapa, S. Ghimire, S. 
Nallet, A. Michalec, A. Serra, D. T. Hickman, M. Pihlgren, J. G. 
Wettstein, A. Pfeifer, A. Muhs
AC Immune SA, Lausanne, Switzerland
Emerging and re-emerging alphaviruses are responsible for several 
important infectious diseases. Although previously confined to mainly 
tropical areas, the geographic occurrence of alphaviruses now overlaps 
temperate regions including urban areas due to environmental and 
ecological changes, vector-host interactions and more competent viral 
strains. While some alphavirus infections can be asymptomatic, others 
such as those caused by Chikungunya, Ross River or O’nyong’nyong virus 
can cause high fevers, debilitating myalgia, rashes and arthritic disease. In 
addition, these infections are also accompanied by more severe symptoms 
such as life-threatening encephalitis, myocarditis or hemorrhagic fevers. 
At present, there is no specific FDA-approved medical treatment for 
infection with these viruses although some concerted efforts are directed 
at vaccine development. AC Immune has developed a number of various 
vaccines that can generate robust and long lasting antibody responses, 
independently of T cells. T cell responses raised during natural infection 
or alphavirus vaccination have been linked to more severe pathology. 
Moreover, T cell mediated responses are likely associated with brain 
encephalitis and arthritic disease. Therefore, a highly desirable feature 
in alphavirus vaccines is to induce a robust antibody response that can 
neutralize the virus infection and confer lifelong protection against 
recurrent re-infections, while avoiding reactive T cells. We have designed 
new vaccines with different linear and conformational relevant CHIKV 
peptide sequences. Results in murine models suggest that robust and 
long-lasting antibody responses are raised upon vaccination and are 
accompanied by low or no T cell responses. Therefore, our vaccines show 
promising results against alphaviruses causing arthritis-like symptoms, 
as well as other infectious diseases where T cell mediated responses are 
preferably avoided.
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IMMUNE PROFILING AND NETWORK MODELING OF 
CHIKUNGUNYA INFECTION IN A HOSPITAL-BASED STUDY IN 
NICARAGUA
Daniela Michlmayr1, Adeeb Rahman2, Lionel Gresh3, Seunghee 
Kim-Schulze2, Guajira P. Thomas4, Theodore Pak5, Federico 
Narvaez6, Andrew Kasarskis5, Steven M. Wolinsky4, Angel 
Balmaseda7, Miriam Merad8, Eva Harris1
1Division of Infectious Diseases and Vaccinology, School of Public Health, 
University of California Berkeley, Berkeley, CA, United States, 2Human 
Immune Monitoring CoRE, Icahn School of Medicine at Mount Sinai, 
New York, NY, United States, 3Sustainable Sciences Institute, Managua, 
Nicaragua, 4Division of Infectious Diseases, Feinberg School of Medicine, 
Northwestern University, Chicago, IL, United States, 5Department of 
Genetics and Genomic Sciences, Icahn School of Medicine at Mount 
Sinai, New York, NY, United States, 6Hospital Infantil Manuel de Jesús 
Rivera, Ministry of Health, Managua, Nicaragua, 7Laboratorio Nacional de 
Virología, Centro Nacional de Diagóstico y Referencia, Ministry of Health, 
Managua, Nicaragua, 8Department of Oncological Sciences, Tisch Cancer 
Institute and the Immunology Institute, Icahn School of Medicine at Mount 
Sinai, New York, NY, United States
Chikungunya virus (CHIKV) is an important emerging, mosquito-borne 
arithrogenic alphavirus that causes both explosive epidemics of debilitating 
rheumatic disease with fever, asthenia, skin rash and occasionally more 
severe complications that can be fatal. In December 2013, an outbreak 
of chikungunya in the Caribbean was reported; since then, over one 
million CHIKV cases are estimated to have occurred, and most countries 
of the Americas are reporting autochthonous transmission of CHIKV. It is 
of global concern that the chikungunya epidemic in the Americas is still 
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growing and the number of CHIKV-infected people is rising every year, 
yet much remains to be defined regarding the human immune response 
to CHIKV infection, especially in children. In our study, we collected acute 
(day 2 or 3) and convalescent (day 15 or 16) samples from symptomatic 
CHIKV-infected pediatric cases (n=42) presenting to the national pediatric 
reference hospital in Managua, Nicaragua. Comprehensive innate and 
adaptive immune responses were investigated by CyTOF, Luminex cytokine 
assays, and RNA-seq. Initial analyses revealed that the frequencies and 
phenotype of several major circulating leukocytes, particularly monocytes 
and dendritic cells, as well as the cytokine and chemokine profile, 
are significantly different between acute and convalescent samples. 
Additionally, we have performed RNA-seq analysis at both phases 
of CHIKV infection to identify differences in gene expression at the 
transcriptomic level. These data are being analyzed to identify immune 
signatures and potential biomarkers of CHIKV infection. All data are 
being integrated for network modeling, consisting of weighted gene 
co-expression network analysis (WGCENA), dynamic Bayesian networks 
and key driver analysis to generate global, unbiased maps of regulatory 
relationships and to uncover novel host-virus pathways and driver genes. 
Our study will provide the most comprehensive immune profiling and 
network analysis of the human response to CHIKV infection to date and 
will help inform future diagnostics and drug therapies.
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ATYPICAL CHIKUNGUNYA PRESENTATION DURING THE 2014 
EPIDEMIC IN VENEZUELA
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In 2014, Venezuela witnessed one of the worst epidemics ever seen 
caused by a mosquito-borne virus: Chikungunya (CHIK). The virus 
rapidly spread through the country affecting ~60% of the population. 
Although CHIK was not considered a severe disease, during the epidemic 
in Carabobo State, one of the first Venezuelan regions to be affected, 
patients developing atypical CHIK presentation were soon observed. We 
aimed to characterize the atypical clinical presentation of these patients 
and their possible association with CHIK virus infection. Data on socio-
epidemiological factors, clinical presentation, co-morbidities, laboratory 
parameters and other paraclinical investigations were collected after 
informed consent from patients admitted to the main tertiary hospital of 
Valencia, the capital of Carabobo State, between September-December 
2014. We present data on 16 patients with a mean age of 59 years (range: 
34-81) and 62.5% males. All patients reported symptoms compatible with 
a previous or current CHIK infection. All presented fever and arthralgia 
while 12 (75%) had also arthritis and/or rash. Incapacitating arthralgias 
were reported by 10 (62.5%) patients. Thirteen patients (81.3%) 
presented cardiovascular complications, mainly myocardial infarction (MI, 
77%), as well as angina pectoris, heart arrhythmias, acute pulmonary 
edema and hypertension. The remaining patients presented renal and 
neurological complications (Guillain-Barré Syndrome and viral encephalitis). 
Of those initially diagnosed with a MI, one patient developed a cardiogenic 
shock, resulting in death. Patients were hospitalized on average for 12 
days (range: 4-35). Thirteen (81.3%) patients had underlying diseases 
of which hypertension was the most common (56.3%) followed by 
diabetes (31%) and obesity (25%). The combination of hypertension 
and diabetes type II (n= 4; 25%) was the most common comorbidity 
combination. Detailed clinical data and further analysis on a bigger sample 
size will be presented. Knowledge on atypical presentations will improve 
early diagnosis and management of these patients avoiding possible life 
threatening conditions.
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PREDICTORS OF PLASMA LEAKAGE IN ADULT DENGUE 
PATIENTS
Ananda D. Wijewickrama1, Gaveshika Abeyrathna1, Chalaka D. 
Chandima1, Sunethra Gunasena2, Damayanthi Idampitiya1
1National Institute of Infectious Diseases, Angoda, Sri Lanka, 2Medical 
Research Institute, Colombo, Sri Lanka
It is estimated to have 390 million Dengue infections with 96 million cases 
worldwide. Mortality rate can be high ranging from 0.1% to 5%. Plasma 
leakage is the commonest complication in Dengue resulting Dengue 
Haemorrhagic Fever (DHF). The severity of leaking varies from individual 
to individual. Severe leaking can have a high morbidity and mortality 
if not detected and treated early. Therefore, it is important to detect 
plasma leakage early as such patients can be monitored carefully and fluid 
management can be manipulated according to the degree of leakage. 
Identifying predictors of plasma leakage would enable clinicians to closely 
monitor patients with such predictors to detect leaking early. Objective of 
this study was to determine predictors of plasma leaking in adult Dengue 
patients. All serologically confirmed Dengue patients admitted to Dengue 
Management Unit, National Institute of Infectious Diseases (formerly IDH), 
Angoda, Sri Lanka for four months from 1st of July 2014 were included 
in a prospective Case Control Study. Patients with plasma leakage were 
identified with serial ultra sound examination and were compared with 
others on predetermined parameters. There were 1000 patients with 
confirmed Dengue infection with 546 males and 454 females. Age ranged 
from 12 to 86 years. (mean 31 yrs.). 43.8% (n= 438) patients had plasma 
leakage (DHF) while 56.2% (n=562) did not have. There was no sex 
difference in patients with and without fluid leakage. Out of the warning 
signs in the WHO 2009 classification severe vomiting, abdominal pain and 
tenderness were significantly associated with plasma leakage (p<0.05) 
but not mucosal bleed or restlessness. In addition postural dizziness and 
platelet counts <50,000/microliter had higher risk (p<0.05) of developing 
plasma leakage as well as both overweight (BMI 23-27) and obesity 
(BMI >27). This study identifies several easily identifiable and observable 
parameters as predictors of plasma leakage in Dengue. These can be used 
identify patients likely to develop plasma leakage and to monitor them 
carefully to detect and to treat plasma leaking promptly thereby reducing 
morbidity and mortality.
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EARLY SEASON INCIDENCE, SUSCEPTIBILITY, AND WEATHER 
PREDICTS ANNUAL DENGUE HEMORRHAGIC FEVER 
INCIDENCE IN THAILAND
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Clapham2, Suthanun Suthachana3, Paphanij Suangtho3, Soawapak 
Hinjoy3, Sopon Iamsirithaworn4, Derek A. Cummings5, Justin 
Lessler2, Nicholas G. Reich1
1University of Massachusetts, Amherst, Amherst, MA, United States, 
2Johns Hopkins University, Baltimore, MD, United States, 3Bureau of 
Epidemiology, Department of Disease Control, Nonthaburi, Thailand, 
4Office of Disease Prevention and Control 1, Ministry of Public Health, 
Bangkok, Thailand, 5University of Florida, Gainesville, FL, United States
Dengue is a mosquito-borne infectious disease that places an immense 
public health and economic burden upon Thailand. Annual outbreaks 
of varying sizes pose a particular challenge to the public health system 
because treatment of severe cases requires significant resources. 
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Accurately forecasting these outbreaks could help public health decision-
makers implement and evaluate the efficacy of interventions. Here, we 
present a statistical model to predict annual dengue hemorrhagic fever 
(DHF) incidence for each Thai province in April using weather data and 
observed case counts through March. We used cross validation on data 
from 2000-2009 to select covariates a negative binomial generalized 
additive model. Two models - the model that performed best in cross 
validation and a model including only preseason incidence - were applied 
to data from 2010-2014 as if conducted in real time. We compared 
the results of these models to those of a baseline model that predicts 
the median incidence over the past ten years. The performance of each 
model varied across the administrative health regions of Thailand. The 
preseason incidence model performed best overall with better predictions 
than the baseline model in 63% of observed province years with a 22% 
reduction in absolute error, averaging across all province years. The best 
cross-validated model, including covariates for preseason incidence, 
estimated relative susceptibility, rainfall, temperature, and humidity made 
better predictions in Northern Thailand where weather and DHF incidence 
fluctuate from year-to-year. The baseline model had the best performance 
in Central Thailand, where annual DHF incidence is relatively stable. These 
results demonstrate that a combination of location-specific prediction 
models for dengue can aid public health decision-makers in assessing the 
potential risk of an epidemic in different geographic locations.
715
SOCIAL CONNECTIONS AND CONTEXT IN DENGUE 
TRANSMISSION
Jeon-Young Kang, Jared Aldstadt
University at Buffalo, Amherst, NY, United States
Dengue Virus (DENV) is a common arboviral disease in tropical and 
subtropical countries. Given the restricted range of mosquito movement 
(i.e., <100 m) and long-term immunity against the four DENV serotypes, 
human activities and herd immunity play critical roles in the spread of 
dengue. Specifically, individual activity spaces are socially constructed, 
and are shaped by activities (e.g., daily commuting, household tasks, 
social activities). Herd immunity is a limit on the number of potentially 
infectious hosts in a region and provides indirect protection for susceptible 
community members. In spite of a consensus on the importance of human 
activities and herd immunity, it is still difficult to accurately estimate their 
influence on dengue transmission. Epidemiologically significant measures 
of vector population density are also difficult to obtain. This uncertainty 
may be responsible for apparent conflicts in the findings of community-
scale studies of DENV transmission. In this study agent-based models 
(ABM) have been used to jointly assess the effects of social networks, herd 
immunity, and vector density. Sensitivity analysis was used to understand 
the importance of social network attributes in terms of network type and 
number of social ties. The local context, in terms of herd immunity and 
mosquito density, significantly modulated sensitivity to social network 
specification. The results highlight the importance of characterizing host 
and vector population heterogeneity in studies of DENV transmission. 
Variation in model outcomes also helps us to understand factors that 
regulate the character of dengue transmission in terms of the overall 
intensity and focality of infections. The findings indicate that ABMs 
designed to test the effects of vaccination programs, where herd immunity 
is artificially increased, could be sensitive to the structure of social 
connections.
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ZIKA VIRUS INFECTION IN A COHORT STUDY TO ASSESS 
THE INCIDENCE OF DENGUE, STATE OF SÃO PAULO, BRAZIL, 
2015, 2016
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Zika virus (ZIKV) was first identified in Brazil in 2015 by reverse-
transcriptase polymerase-chain-reaction (RT-PCR) assays of serum 
specimens from patients in Northeastern Brazil, who presented with 
a dengue like illness that was characterized by rash, fever, myalgia, 
arthralgia, and conjunctivitis. Up to the 9th 2016 epidemiologic week, 
22 Brazilian states notified ZIKV infection confirmed by PCR. In August 
2014, in Araraquara, a city in the State of São Paulo, Southeastern 
Brazil, a prospective cohort for dengue surveillance was initiated through 
weekly phone calls to access the incidence of dengue among children 
and adolescents aged 2-16 years. 3,514 children and adolescents and 
their parents agreed to participate in the study and signed an Informed 
Consent Form. The follow-up showed 1,140 fever episodes and 314 
confirmed dengue cases by laboratory diagnosis (NS1, qPCR IgM positive 
for dengue) in December 2015. PCR was performed for 492 children 
and adolescent negative for dengue, but with fewer and any sign or 
symptom, to investigate Zika virus circulations. The RNA isolated was 
subjected to a Real-Time PCR of a single step (“one-step”) using TaqMan 
Fast Virus 1-Step Master Mix (ThermoFisher, Brazil) and the set of 
primers and probe as following: Primer Name Sequence SEQ 5’ 3’ 1086F 
CCGCTGCCCAACACAAG 1162R CCACTAACGTTCTTTTGCAGACAT 
1107-FAM AGCCTACCTTGACAAGCAGTCAGACACTCAA In Araraquara, 
in 2015 occurred 1,804 dengue cases, being the largest epidemic of 
recent years. In 2016, 376 autochthones cases had already occurred up 
to now. In our cohort dengue cases appeared between November 2014 
and August 2015 with a peak in April (117 cases). No case was positive 
for ZIKV in 2014 and 2015. In 2016, until the 16th epidemiologic week 
occurred 190 fever episodes with 9 dengue laboratory confirmed and 7 
ZIKV confirmed by PCR in plasma with 2 also by urine. The most common 
symptoms were sore though, conjunctival hyperemia, headache, rash 
and pruritus. The two viruses are circulating in Araraquara, but it seems 
that there has been a susceptible depletion in relation to dengue with the 
concurrence of the emergence of the movement Zika virus.
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INAPPARENT DENGUE VIRUS INFECTION INCIDENCE, SAO 
PAULO, BRAZIL, 2014-2015
Expedito J. Luna, Gerusa M. Figueiredo, Sergio R. Campos, Jose 
E. Levi, Walter M. Figueiredo, Angela A. Costa, Alvina C. Felix, 
Ana C. Souza, Nathalia C. Souza, Maria R. Cardoso, Claudio S. 
Pannuti
Universidade de Sao Paulo, Sao Paulo, Brazil
Inapparent dengue virus infections have implications on the agent’s 
transmission. They should be considered when evaluating control 
interventions such as vector control and vaccines. We have attempted 
to quantify the incidence of inapparent infections that occurred during 
the 2014 - 2015 dengue transmission season. A cohort study to assess 
the incidence of dengue among children and adolescents, from 2 to 16 
years of age, in a previously recognized as a low endemic setting has 
started in August, 2014. A random sample of children and adolescents 
was selected from the population of Araraquara, a city in Central São 
Paulo State. Home visits were made to the families of selected children, 
to present the study and invite them to participate. The one who agreed 
to participate signed an Informed Consent Form. An interview on socio-
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demographic characteristics was carried out and blood samples from the 
selected children were drawn for dengue baseline serology. Dengue IgG 
antibodies were tested by enzyme-linked immunosorbant assay (ELISA). 
Families are being contacted weekly for fever surveillance. Fever cases are 
submitted to dengue diagnosis tests. One year after recruitment a new 
blood sample was collected for IgG serology, in order to assess inapparent 
infections. The baseline seroprevalence of dengue IgG antibodies among 
the cohort participants was 15.3%. In the 2014/2015 dengue epidemic 
season the cumulative incidence of symptomatic laboratory confirmed 
dengue was 8.9%. The analysis of the one-year follow up samples is still 
ongoing. So far, results from 3,019 (85.9%) participants are available. 
Considering those who were seronegative for dengue at baseline and did 
not present symptomatic dengue infection, the seroprevalence after one 
year was 14.0% (320/2285), which may be interpreted as the incidence of 
inapparent infections. The rate inapparent/symptomatic dengue infections 
was estimated in 1: 1.6. It is lower than reported elsewhere. The sensitive 
suspect case definition (fever >37.5°C) may be responsible for this result. 
Unlike the incidence of symptomatic cases, the incidence of inapparent 
infections was not associated to age nor sex.
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DENGUE VIRAL INFECTION INDUCED CD95 EXPRESSIONS IN 
DIFFERENT B CELL SUBSETS
Nattawat Onlamoon, Ampaiwan Chuansumrit, Kulkanya 
Chokephaibulkit, Kanchana Tangnararatchakit, Chonnamet 
Techasaensiri, Nopporn Apiwattanakul, Siyu Wang, Premrutai 
Thitilertdecha, Kovit Pattanapanyasat
Mahidol University, Bangkok, Thailand
Excessive expansion of antibody secreting cell (ASC) was observed during 
acute dengue viral infection. While ASC is directed against dengue viral 
antigen, a marked increase in plasma cytokine levels and soluble immune 
function molecules may drive these cells to become more susceptible to 
undergo apoptosis. Moreover, as previous studies showed that alterations 
of B cell subsets were observed by a remarkable decrease in naïve and 
memory B cells. It might be possible that these cells undergo apoptosis 
induction through interactions between Fas or CD95 expressed on these 
cells and Fas-L expressed by cross talking immature pDC or activated 
NK cells. In our study, peripheral blood samples from acute dengue viral 
infected patients were stained with fluorochrome conjugated monoclonal 
antibodies against CD3, CD14, CD19, CD20, CD21, CD27, CD38, CD45, 
CD95 and CD138. The frequency and density of CD95 expression in ASC 
and B cell subsets based on the expression of CD19, CD20, CD21, CD27, 
CD38 and CD138 were determined by flow cytometry. Results showed 
that CD95 expression was observed in all B cell subsets. However, the 
high levels of surface expression density were observed in plasmablast 
and memory B cell subsets. Interestingly, the frequency of naïve B cells 
that express CD95 was increased when compared to healthy subjects. 
Our study, therefore, provides important information on apoptosis 
induction of B cell subsets during acute dengue viral infection via the 
interaction between Fas and Fas-L. The results demonstrated that all B cell 
subpopulations, especially plasmablast, have a potential susceptibility to 
apoptosis through Fas signaling pathway. The study also suggested that 
a decrease in naïve B cells might be due to apoptosis induction in this 
subset.
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The micro-scale transmission dynamics of dengue ultimately determine 
who gets sick and the impact of interventions. Phylogeographic methods 
have been used to characterize pathogen dispersal at global and regional 
scales, but have yielded few insights into the local spatio-temporal 
structure of endemic transmission. Dengue virus infects >300 million 
people annually. Key mechanisms of introduction and maintenance 
remain unknown, including the number of distinct transmission chains 
that co-circulate within populations across different spatial scales. We 
geolocated 17,291 serotyped cases from Thailand from a 17 year period 
(1994-2010) and sequenced 800 viruses. We developed methods that 
compare the genetic similarity between viruses with the spatial distance 
between their locations to estimate the number of discrete transmission 
chains circulating within any area. We found that on average, 64% (95% 
CI: 41%-75%) of cases <200m apart in Bangkok were from the same 
chain (defined as having a common ancestor from the same dengue 
season) compared to 3% for cases <5km apart (95% CI: 1%-4%). Within 
200m there were on average 1.7 transmission chains during a season, 
and with every 10-fold increase in population the number of chains 
increased 7-fold. However, there were significant heterogeneities across 
the city. Further, we found saturation in the number of chains circulating 
in equal sized areas at population densities >7,000/km2. We replicated 
these patterns using simulations where incidence is driven by local, 
density-dependent transmission; suggesting that ecological interactions in 
high-density environments limit the number of independent chains. We 
also found evidence for separation between national epidemics across 
Southeast Asia, suggesting minimal viral flow across borders. These results 
reveal hyper-local epidemics within a season and self-supporting dynamics 
within Thailand over the long-term. This study provides a framework for 
characterizing the number of independent transmission chains circulating 
within any community, with key implications for understanding local 
trends, including the impact of control efforts.
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AEDES ALBOPICTUS MIDGUT CELL LINE: A PRISTINE CELL 
LINE FOR IN VITRO STUDY OF ARBOVIRAL PATHOGENESIS
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The successful vaccine production for many arboviral diseases is hindered 
due to a very common problem i.e. non-availability of appropriate cell 
line, which mimics the microenvironment of the viral pathogenesis 
inside a host, providing an artificial cellular milieu for the virus to grow 
and multiply in vitro. Till date, many cell lines have been prepared from 
embryo, eggs and larvae of mosquitoes, which are extensively used for 
culturing arboviruses, but most of the arboviruses like Dengue virus, West 
Nile virus, Chikungunya virus, Japanese encephalitis virus, etc mainly 
infect the midgut of the mosquitoes; rendering available mosquito cell 
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lines inappropriate models for study of host-viral interactions. In this 
study, wild Aedes albopictus mosquitoes collected from different parts of 
Kolkata, India, were identified by an entomologist and were dissected to 
separate the midgut. Light microscopic and electron microscopic study of 
the cellular pattern on the mosquito midgut surface revealed the presence 
of stem cells, columnar cells, goblet cells and regenerative cells. Stained 
histological sections of midgut showed mucous coat enclosing the basal 
lamina on which the cells are embedded. Depending on the number 
of microvilli and microvilli-associated network, the posterior part of the 
midgut was targeted for preparation of the cell culture as it is the primary 
entry site for most of the arboviruses. The prepared cell culture was found 
stable without any lot to lot variation. The midgut cell culture was then 
challenged with dengue virus and then one alternative medicine “Rhus 
toxicodendron 6c” which is believed to be effective in dengue fever was 
tested for its efficacy as entry barrier and/or escape barrier in the primary 
cell line along with controls. Morphological changes were also analyzed. 
The medicine appeared to provide effective protection of the cell lines 
from dengue virus infection. Thus, the results of this study open up a new 
platform to study how arboviruses are normally able to surmount midgut 
infectivity barrier and midgut escape barrier, which will provide a better 
understanding of the innate host-viral interaction mechanism.
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No specific therapeutic is available to prevent or treat classical or 
severe dengue infections. Passive immunotherapy with target-specific 
immunoglobulin (IgG) is effective in the treatment of toxin, venom and 
pathogen mediated diseases. Current target-specific immunotherapeutics 
are either polyclonal IgGs, derived from human or animal plasma, or 
monoclonal antibodies. Each production approach has limitations. 
Human derived IgG (or convalescent plasma) require the recruitment of 
convalescent human donors in sufficient numbers. Monoclonal antibodies 
require lengthy development periods and pose the risk of escape mutants. 
Both these approaches can be prohibitively expensive. Animal derived 
heterotypic-antibody IgGs can cause severe reactions. Transchromosomic 
bovines (Tc-bovine) provide an alternative method to economically produce 
large quantities of target-specific IgG with fully-human antibodies. Tc-
bovines have had their repertoire of bovine antibody genes deleted, and 
instead carry a human artificial chromosome containing the full repertoire 
of human antibody genes. Tc-bovines can rapidly produce up to 600 grams 
per month of hyperimmune, multi-pathogen, fully-human immunoglobulin 
(hIgG) to prevent and treat human diseases. Tc-bovines were 
hyperimmunized with psoralen inactivated tetravalent dengue vaccine 
(serotypes 1-4) and a purified Tc-bovine hIgG (SAB-123) with tetravalent 
dengue virus neutralization titers up to 2560 was produced. Four groups 
of Cynomolgous monkeys (n=3) infected with 5E5 PFU of dengue 1 on 
day 0 were infused with 100 mg/kg of SAB-123 on days -1 (prophylactic), 
+2 or +1&3 (therapeutic) or negative control hIgG on day -1. Control 
animals infused on day -1 all had detectable viremia on days 2-6. Those 
receiving SAB-123 on day -1 and day 1&3 had no detectable viremia at 
any time. Those receiving SAB-123 on day 2 only had detectable viremia 
for one day prior to transfusion. Similar hIgG therapeutic products for two 
separate infectious disease indications have obtained FDA clearance for 
clinical testing. These results warrant human evaluation of this product for 
treatment of dengue infections.
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CHARACTERIZATION OF CYD DENGUE VACCINE VIRUSES 
WITH HUMAN MONOCLONAL ANTIBODIES TARGETING KEY 
CONFORMATIONAL EPITOPES
Valérie Lecouturier1, Catherine Berry1, Aure Saulnier1, Sophie 
Naville1, Catherine Manin1, Gopal Sapparapu2, James E. Crowe2, 
Florence Boudet1, Bruno Guy1
1Sanofi Pasteur, Marcy l’etoile, France, 2Vanderbilt Vaccine Center, 
Vanderbilt University, Nashville, TN, United States
The Sanofi Pasteur CYD tetravalent dengue vaccine, which is now licensed 
in several dengue endemic countries, demonstrated significant efficacy 
in phase III studies with differences between serotypes. To characterize 
the quality and specificity of vaccine-induced antibody responses, we 
investigated the surface epitopes on each vaccine virus serotype using 
human monoclonal antibodies (MAbs). These antibodies have previously 
been shown to target conformational/quaternary epitopes, to be highly 
neutralizing, and either serotype-specific against DENV1 (1F4), DENV2 
(2D22) or DENV3 (5J7) or cross-reactive against the 4 serotypes (1C19). 
A DEN4-specific antibody was not available at the time of the study. We 
monitored the binding of 1F4, 2D22, 5J7 and 1C19 with the vaccine 
monovalent lots included in Phase III clinical formulations using the 
following assays: Dot Blots, ELISA, Biacore® and PRNT. We used attenuated 
DENV as positive controls and some immature viruses or VLPs as negative 
controls for anti-DENV reactivity. Assays were set up and calibrated with 
cross-reactive anti-Envelope mouse monoclonal antibodies. In each assay, 
the CYD1, 2 and 3 vaccine viruses were found to be recognized by the 
MAbs with the expected specificity, and were strongly neutralized at 
levels comparable with those previously reported with wild type DENV. 
Biacore® further indicated a high functional affinity. Overall, these 
findings demonstrate that the CYD dengue vaccine viruses display 
key conformational and functional epitopes of wild type DENV. Future 
investigations will assess the neutralizing antibody response elicited by the 
CYD tetravalent vaccine against these critical epitopes, and how it relates 
with vaccine efficacy.
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PERIODICITY (LONG-TERM AND SHORT-TERM CYCLES) OF 
DENGUE IN VENEZUELA
Maria F. Vincenti-Gonzalez1, Maria E. Grillet2, Erley Lizarazo3, 
Francisco Laguna2, Adriana Tami3
1University Medical Center Groningen, Groningen, Netherlands, 
2Laboratory of Vector Biology and Parasite, Institute of Tropical Zoology 
and Ecology, Faculty of Science, Central University of Venezuela, Caracas, 
Bolivarian Republic of Venezuela, 3University Medical Center Groningen., 
Groningen, Netherlands
Mosquito-borne viruses are becoming major public health problems 
throughout the tropical and subtropical regions of the world. In Venezuela 
(South America), despite control measures, transmission of dengue virus 
(DENV) has become perennial with three large epidemics in the past 
decade. The long-term pattern of this disease has involved not only a 
general upward trend in cases but also a dramatic increase in the size 
of epidemic outbreaks. Previous studies indicate that DENV multiyear 
cycles are the result of both extrinsic (e.g. climate variability) and intrinsic 
(e.g. herd immunity and host susceptibility) factors. Here, we first 
explored the periodicity of dengue incidence in time-series of data (24 
years) from several regions of Venezuela using wavelet analyses (WA), 
a statistical approach specifically developed for non-stationary patterns. 
Significant cycles of 1- to 3-year periods were identified. Additionally, 
we determined whether disease epidemics were related to local climate 
variability and regional climate anomalies such as the El Niño Southern 
Oscillation (ENSO) using WA to identify time- and frequency-specific 
associations. Understanding the periodicity of dengue in Venezuela can 
give useful insights about arbovirosis outbreaks. Indeed, the years 2014 
and 2015 were marked by two relevant outbreaks of the emergent viruses: 
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chikungunya and zika. Therefore, our findings may be used to forecast 
dengue and other vector-borne viral epidemics and to improve disease 
surveillance and control strategies.
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USE OF THE DENGUE HUMAN CHALLENGE MODEL TO 
CHARACTERIZE THE ROLE OF HETEROTYPIC ANTIBODY IN 
PROTECTION AGAINST DENGUE INFECTION
Anna P. Durbin1, Beth D. Kirkpatrick2, Kristen K. Pierce2, Gina 
Meza Hults1, Eve Ostrowski1, Cecilia M. Tibery1, Palmtama L. 
Grier1, Beulah P. Sabundayo1, Cathy J. Larsson2, Yolanda Eby1, 
Helen He1, Sean A. Diehl2, Cassandra Ventrone2, Marya P. 
Carmolli2, Aravinda de Silva3, Stephen S. Whitehead4
1Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United 
States, 2University of Vermont College of Medicine, Burlington, VT, United 
States, 3University of North Carolina, Chapel Hill, NC, United States, 
4National Institute of Allergy and Infectious Diseases, National Institutes of 
Health, Bethesda, MD, United States
Dengue has become the most important mosquito-borne virus in the 
world resulting in nearly 400 million infections annually. There are four 
dengue virus (DENV) serotypes, each capable of causing the full spectrum 
of illness. This can range from an asymptomatic or mildly symptomatic 
infection to a life-threatening vascular leak syndrome. It is generally 
believed that infection with one DENV serotype confers long-lived 
protection against symptomatic re-infection with that same serotype 
but only short-lived (~3 months) protection against infection with a 
heterotypic DENV. We sought to test this paradigm using our controlled 
dengue human challenge model. Twenty-four flavivirus-naïve subjects 
were enrolled in a randomized, placebo-controlled, double-blind trial. The 
treatment assignments remained blinded until study day 270. Eighteen 
subjects received a trivalent mixture of the live attenuated candidate 
DENV vaccines rDEN1∆30, rDEN3∆30/31, and rDEN4∆α30. Eight subjects 
received placebo. Six months later, all returning subjects were given 
the DENV-2 challenge virus DEN2∆30. Following receipt of the trivalent 
admixture 15 subjects developed rash (83%) and 11/18 (61%) had one or 
more DENV recovered from the blood. rDEN3∆30/31 was recovered from 
7 subjects, rDEN1∆30 from 5 subjects, and rDEN4∆30 from 2 subjects. 
Twenty-one subjects returned for challenge (15 trivalent recipients and 
6 controls). Following challenge with DEN2∆30, only 3 (20%) of those 
subjects who had received the trivalent mixture developed rash compared 
with 83% of the controls, indicating that the trivalent mixture imparted 
some protection against the challenge virus. The clinical, virologic, and 
serologic responses following administration of the trivalent admixture 
and following DENV-2 challenge will be presented. The role of heterotypic 
antibody and cellular immune responses will be discussed.
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LONGITUDINAL ANALYSIS OF B CELL RESPONSE TO 
INFECTION WITH A DENGUE-2 CHALLENGE VIRUS
Huy Tu1, Usha K. Nivarthi2, Daniel Emerling3, Douglas G. 
Widman4, Ralph Baric4, Kristen Pierce5, Stephen S. Whitehead6, 
Beth D. Kirkpatrick5, Anna P. Durbin7, Aravinda M. de Silva2, Sean 
A. Diehl1
1Department of Medicine-Infectious Diseases, Vaccine Testing Center, 
and Cellular and Molecular Biomedical Sciences Program, University of 
Vermont, Burlington, VT, United States, 2Department of Microbiology 
and Immunology, University of North Carolina School of Medicine, 
Chapel Hill, NC, United States, 3Atreca, Palo Alto, CA, United States, 
4Department of Epidemiology, Gillings School of Global Public Health, 
University of North Carolina, Chapel Hill, NC, United States, 5Department 
of Medicine-Infectious Diseases, Vaccine Testing Center, University of 
Vermont, Burlington, VT, United States, 6National Institute of Allergy and 
Infectious Diseases, National Institutes of Health, Bethesda, MD, United 
States, 7Johns Hopkins Bloomberg School of Public Health, Johns Hopkins 
University, Baltimore, MD, United States
The four dengue virus (DENV) serotypes are the leading cause of arboviral 
disease globally, with 390 million new infections annually, and more than 
40% of the world’s population at risk. Both serotype-specific and cross-
reactive antibody responses are observed at the population level, but the 
temporal patterns of how such antibodies emerge on an individual basis 
after primary DENV infection are not clear. A better understanding of 
the antibody response to primary infection can elucidate how circulating 
DENV-specific antibodies afford protection versus lead to risk of disease 
enhancement in secondary heterologous infection or vaccination. To 
address this, we analyzed the clonal evolution of B cells from the early 
plasmablast stage to the late memory stage in subjects from a controlled 
DENV human infection model. In a representative subject infected with 
DENV2 challenge virus we used Immune Repertoire Capture (IRC™) 
technology to identify over 400 unique, natively paired antibody heavy 
and light chains in the plasmablast repertoire. At six-month post challenge, 
we isolated and immortalized memory B cells from the same donor, and 
found that approximately 0.7% of IgG+ memory B cells exhibited reactivity 
to DENV. Most of the response was DENV2-specific though cross-reactive 
responses were also observed. Understanding the kinetics of the humoral 
response in this primary infection model will increase our understanding 
of the B cell evolution in response to DENV infection, and reveal insights 
on how specific vaccine components may be tailored immunogenically to 
maximize protective effect while minimizing risk.
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DENV PREEXISTING IMMUNITY EFFECT ON ZIKV INFECTION 
AND THE RELIABILITY OF DIAGNOSIS IN AN AREA WITH CO-
CIRCULATION OF SEVERAL ARBOVIRUSES
Berlin L. Londono-Renteria1, Andrea Troupin1, Jenny C. 
Cardenas2, Miguel A. Sanabria2, Elsi Entrena3, Tonya M. Colpitts1
1University of South Carolina, Columbia, SC, United States, 2Hospital Los 
Patios, Los Patios, Colombia, 3Hospital Erasmo Meoz, Cucuta, Colombia
Previous studies have demonstrated the effect of cross-reactive sub-
neutralizing antibodies in DENV severe clinical presentation. Since, DENV 
and ZIKA are closely related viruses, we tested whether there is any impact 
of previous DENV antibodies on ZIKV infection. To do this, we tested 
serum samples collected pre and post ZIKV epidemic and evaluate ZIKV 
neutralization capacity by PRNT50. On the other hand, there are several 
obstacles for accurate diagnosis of vector-borne viruses in endemic areas. 
The problem is significantly higher when several pathogens, with similar 
clinical characteristics, co-circulate in the same area. With the latest 
emergence of African arboviruses in South America, there is a need for 
reliable, cost-effective tools to help in differential diagnosis, especially in 
rural areas. Thus, we decided to compare the sensitivity and specificity 
of a rapid test for dengue virus infection (Dengue Duo-Antigen) versus a 
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molecular biology technique (qRT-PCR). We evaluated whether a particular 
test is better for differential diagnosis in an endemic region of Colombia 
where Dengue (DENV), Chikungunya (CHIV) and Zika (ZIKV) are often 
concurrently transmitted. We will show the sensitivity and specificity 
of qRT-PCR vs. Dengue Duo test, and discuss the impact of preexisting 
immunity on arbovirus transmission dynamics.
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VECTOR GENOTYPE INFLUENCES DENGUE VIRUS INTRA-
HOST GENETIC DIVERSITY IN MOSQUITOES
Sebastian Lequime, Albin Fontaine, Meriadeg Ar Gouilh, Isabelle 
Moltini-Conclois, Louis Lambrechts
Institut Pasteur, Paris, France
During infection of their arthropod vectors, arthropod-borne viruses 
(arboviruses) such as dengue viruses traverse several anatomical barriers 
that are believed to cause dramatic reductions in population size. Such 
population bottlenecks challenge the maintenance of viral genetic 
diversity, which is considered critical for fitness and adaptability of 
arboviruses. Anatomical barriers in the vector were previously associated 
with both maintenance of arboviral genetic diversity and alteration of the 
variant repertoire. However, the relative role of random processes and 
natural selection, and the influence of vector genetic heterogeneity have 
not been elucidated. In this study, we used high-throughput sequencing 
to monitor dengue virus genetic diversity during infection of several 
genetic backgrounds of their mosquito vector. Our results show that 
initial infection of the vector is randomly founded by only a few tens 
of individual virus genomes. The overall level of viral genetic diversity 
generated during infection was predominantly under purifying selection 
but differed significantly between mosquito genetic backgrounds. Thus, 
in addition to random evolutionary forces and the purging of deleterious 
mutations that shape dengue virus genetic diversity during vector 
infection, our results also point to a role for vector genetic factors in the 
genetic breadth of arbovirus populations.
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A CLOSER LOOK AT ADE AND OAS IN THE SECONDARY 
DENGUE PLASMABLAST RESPONSE
Lalita Priyamvada1, Alice Cho1, Nattawat Onlamoon Onlamoon2, 
Kulkanya Chokephaibulkit2, Kovit Pattanapanyasat2, Rafi Ahmed1, 
Patrick Wilson3, Jens Wrammert1
1Emory University, Atlanta, GA, United States, 2Mahidol University, 
Bangkok, Thailand, 3University of Chicago, Chicago, IL, United States
Epidemiological studies have linked heterologous secondary DENV 
infections with increased disease severity, implicating pre-existing immunity 
in the form of antibody titers as a risk factor for severe disease. In this 
study, we focus on B cell responses generated during the acute phase 
of secondary DENV infection, and describe their potential to participate 
in antibody dependent enhancement (ADE) and original antigenic sin 
(OAS). We isolated plasmablasts from four Thai patients during ongoing 
DENV2 infection and generated 53 monoclonal antibodies by single-cell 
immunoglobulin gene expression. The antibodies were largely cross-
reactive to two or more DENV serotypes, with a small subset exhibiting 
serotype-specific binding and neutralization activities in vitro. Interestingly, 
although all patients were infected with DENV2 at the time of the study, a 
majority of the antibodies generated from two patients displayed stronger 
neutralization of DENV1 than DENV2. These findings were echoed at the 
serum level, where a clear bias in neutralization was observed towards 
DENV1 compared to DENV2. This neutralization bias is strongly reminiscent 
of OAS. Additionally, a majority of DENV-neutralizing mAbs either 
moderately or potently enhanced DENV infection of U937 cells indicating 
that the potential for ADE is not limited to cross-reactive mAbs. Our 
studies provide basis for future work examining the impact of antibody 
responses on dengue immunopathology.
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DISPLAY OF QUATERNARY EPITOPES RECOGNIZED BY 
DENGUE VIRUS NEUTRALIZING ANTIBODIES
Stefan Metz, Michael Miley, Jason Coffman, Shaomin Tian, Chris 
Luft, Joe DeSimone, Aravinda de Silva
University of North Carolina, Chapel Hill, NC, United States
Dengue virus (DENV) is the causative agent of dengue fever and dengue 
hemorrhagic fever. DENV and its mosquito vectors are widely distributed 
in tropical and subtropical regions and the disease is endemic in over 100 
countries. Dengue vaccine development is challenging because of need 
to protect against four antigenically distinct DENV serotypes and evidence 
that, under some conditions, specific immunity to the virus can enhance 
disease. Recent studies have led to the identification of epitopes on the 
DENV envelope (E) protein targeted by human neutralizing antibodies. 
Some epitopes are preserved on the monomeric E protein, while other 
epitopes are complex and require the assembly of higher order E protein 
structures required for virion assembly. Here we describe studies to 
optimize the display of quaternary epitopes on artificial surfaces. The 
ectodomain of DENV E protein was expressed as a soluble recombinant 
protein (recE), which was secreted from cells. RecE was purified from 
the culture media and conjugated to a solid matrix. Using a large panel 
of human and mouse derived monoclonal antibodies, we confirmed 
that the conjugated protein was properly folded. Moreover, by adjusting 
factors such as pH, salinity and protein density, we optimized the display 
of quaternary structure neutralizing epitopes known to be critical for 
inducing protective antibody responses. These results have implications 
for developing novel subunit vaccines displaying quaternary epitopes from 
flaviviruses.
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RAPID ACTIVE SEROPREVALENCE SURVEYS AS A TOOL TO 
MEASURE DENGUE VIRUS DISEASE BURDEN IN RESOURCE-
LIMITED SETTINGS
Daniel Olson1, Molly M. Lamb2, Alma Zacarias3, Maria Renee 
Lopez4, Maria Alejandra Paniagua5, Gabriela Samayoa-Reyes6, 
Ricardo Zambrano7, Sergio Rodriguez7, Celia Cordon-Rosales4, 
Edwin J. Asturias1
1University of Colorado School of Medicine and Public Health, Aurora, CO, 
United States, 2University of Colorado School of Public Health, Aurora, CO, 
United States, 3Fundacion para la Salud Integral de los Guatemaltecos, 
La Blanca, Guatemala, 4Universidad del Valle de Guatemala, Guatemala 
City, Guatemala, 5University of Pennsylvania Perelman School of Medicine, 
Philadelphia, PA, United States, 6University of Colorado School of 
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Cost-effective surveillance systems capable of accurately detecting 
acute febrile illness (AFI) are necessary to evaluate the endemic burden 
of diseases such as dengue virus (DENV) and to estimate the potential 
effectiveness of vaccines. Cross-sectional seroprevalence surveys are 
commonly used for outbreak investigations, but they have not been 
validated as a timely, cost-effective alternative to active surveillance. 
We used a 2-stage cluster design (30 clusters of 7 households) to enroll 
children age 0-17 years in a rural, resource-limited region of Guatemala 
into two parallel surveillance systems to estimate the burden of AFI 
and DENV. In the prospective Participatory Syndromic Surveillance (PSS) 
arm, 207 households with 483 children (enrolled Apr-Sep 2015) were 
provided a wireless internet-connected smartphone with a symptom diary 
application and asked to submit weekly self-reports of fever. Subjects 
reporting 2+ days of fever were visited and offered DENV testing (PCR and 
IgM). In the Rapid Active cross-sectional Surveys (RAS), 377 children from 
209 households (cycle 1), and 369 children from 210 households (cycle 
2) from the same community were surveyed for self-reported fever within 
the preceding 7 days and offered testing for DENV by IgM regardless of 
symptoms, and by PCR if fever was present for 2+ days. In the PSS arm, 
71 children reported AFI during 362 person-years of observation (19.6 
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cases/100 person-years), and 3 of 40 (8%) tested were DENV+. In RAS 
cycles 1 (Oct-Nov 2015) and 2 (Jan-Feb 2016), 74 (20%) and 53 (14%) 
children reported AFI in the preceding week and 3/13 (23%) and 6/29 
(21%) tested were DENV+, respectively. In logistic regression models 
adjusted for sex, younger age was a significant predictor of AFI symptoms 
in the RAS cycles but not in the PSS subjects. Younger age was not 
associated with DENV+ AFI. Our data demonstrate a significant burden 
of AFI and DENV in the community. The more cost-effective RAS cross-
sectional surveys provided more sensitive estimates of AFI incidence and 
DENV infection rates than the smartphone-based PSS active surveillance 
cohort, though further surveillance and data collection are needed.
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NATURAL AND LABORATORY-DERIVED GENETIC VARIATION 
IN DENGUE VIRUS TYPE 2 AT ENVELOPE PROTEIN POSITIONS 
202 AND 203 MODULATES ANTIGENIC AND IMMUNOGENIC 
PROPERTIES
Leah Katzelnick1, Chunling Wang1, Theodore C. Pierson2, Derek 
J. Smith3, Stephen S. Whitehead2, Eva Harris1
1Division of Infectious Diseases and Vaccinology, School of Public Health, 
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Institutes for Allergy and Infectious Diseases, National Institutes of Health, 
Bethesda, MD, United States, 3Department of Zoology, University of 
Cambridge, Cambridge, United Kingdom
The four dengue virus types (DENV1-4) cause up to 400 million infections 
each year. There is antigenic variation within and among the dengue 
types, but the genetic determinants of DENV antigenic variation are poorly 
understood. Others have shown that a single mutation at K204R (at the 
dimer interface of envelope [E] domain II) in DENV1 prototype strains 
drastically alters neutralization by a monoclonal antibody that targets 
a cryptic epitope exposed through virion breathing. Using antigenic 
cartography with primary infection African green monkey (AGM) antisera, 
we have found that a single amino acid substitution at a neighboring 
position, E202K, dramatically increases neutralization by homologous 
and heterologous antisera. Further, the AGM inoculated with E202K had 
a response highly focused to the homologous strain and remained the 
AGM’s only detectable neutralization titer five months post-inoculation, 
while the AGM inoculated with the wild-type strain had balanced 
neutralization of diverse DENV2 strains. We are testing for differential 
neutralization of DENV2 E202K compared with the wild-type strain using 
monoclonal antibodies directed at cryptic epitopes as well as for improved 
neutralization with extended incubation times, suggestive of virion 
breathing. We also analyzed available E sequences in GenBank for natural 
variation and found that while positions 202 and 204 are highly conserved 
within and across serotypes, position 203 is naturally variable and differs 
between genotypes of DENV2 as well as DENV4. Interestingly, strains with 
203D, including American genotype DENV2 strains shown by others to 
be cross-neutralized by primary DENV1 antisera, cluster closer to DENV1 
antisera on antigenic maps, while Asian DENV2 genotypes with 203N are 
more distant from DENV1. We are testing if this antigenic difference is 
caused by exposure of a cryptic epitope. Understanding the mechanistic 
basis of the antigenic and immunogenic effects of genetic variation at 
202-204 may provide insights into the antigenic representativeness of 
laboratory-adapted strains as well as if virion flexibility is important to 
DENV antigenic evolution.
732
CO-INFECTION OF DENGUE VIRUS BY SEROTYPES 1 AND 2 IN 
A PATIENT FROM STUNG TRENG PROVINCE, CAMBODIA
Jamal Dejli1, Catherine Berjohn1, Vireak Heang1, Agus Rachmat1, 
Pichit Pin1, Sophal Ouk1, Chonthida Supaprom1, Rithea Leang2, 
Rekol Huy2, Andrew Vaughn1
1U.S. Naval Medical Research Unit - 2, Phnom Penh, Cambodia, 2National 
Center for Parasitology Entomology and Malaria Control, Phnom Penh, 
Cambodia
Dengue virus (DENV), the etiological agent for dengue fever and dengue 
hemorrhagic fever/dengue shock syndrome is a significant contributor to 
the morbidity and mortality rates in tropical and subtropical regions of 
the world, especially in Southeast Asia. There are currently four circulating 
clinical serotypes, and all of them have circulated in Cambodia during the 
past five years, with serotype1 (DENV-1) having historically been described 
as the predominating serotype and co-infection has not been commonly 
identified. Here, we describe a case of DEN-1 and DENV-2 co-infection 
that represents the first reported case of this serotype combination from 
Cambodia. The case was from Stung Treng Province, Cambodia, and 
was enrolled in a passive febrile surveillance study cohort administered 
by US Naval Medical Research Unit-2 (NAMRU-2). The case had classic 
dengue fever symptoms. Both dengue rapid test and serology were 
positive. Flavivirus screening was performed with Real Time-PCR and 
then confirmed as DENV-1 and DENV-2 co-infection by semi-nested PCR. 
The remainder of his hospital course was uncomplicated and recovered 
six weeks later without sequel, corroborating with previous reports. This 
case highlights the importance of dengue surveillance with serotyping. 
It demonstrates that dengue co-infection with different serotypes can 
occur naturally, and can go undetected if only rapid testing is performed. 
Absence of serotype-specific information in individual cases may impede 
clinical management, resulting in potentially unnecessary or detrimental 
treatment. With such high dengue incidence rates on national and 
regional levels, the availability of such information has substantial potential 
benefits to population health.
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TO DENGUE VIRUS SEROTYPE 4
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Doranz3, Daniela Weiskopf4, Alessandro Sette4, Anna Durbin5, 
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Dengue viruses (DENVs) are mosquito-borne flaviviruses consisting of 
four serotypes (DENV1-4). Primary DENV infections develop protective 
type-specific neutralizing antibodies, only to the serotype of exposure 
that target predominantly the quaternary structure epitopes. While 
specific quaternary epitopes responsible for the neutralization of DENV 
serotypes 1, 2 and 3 have been well defined, very little is known about 
the molecular basis of serotype 4 neutralization by human antibodies. This 
is a significant gap because a successful dengue vaccine has to induce 
protective antibodies to all 4 serotypes. We aimed to characterize the 
human long lived plasma cell (LLPC) and memory B-cell (MBC) derived 
neutralizing antibody responses in people exposed to primary DENV4 
infections. To characterize the LLPC-derived responses, specific populations 
of antibodies were depleted from naturally infected DENV4 immune 
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subjects and DENV4 NIH monovalent vaccine recipients. In parallel, MBCs 
from naturally infected DENV4 immune subjects were transformed with 
Epstein Bar virus (EBV) to produce human hybridomas secreting DENV4-
specific hMAbs. Two type-specific DENV4 neutralizing hMAbs were 
isolated and epitope mapped using binding and neutralization assays with 
wild type and recombinant DENVs. Further, shotgun mutagenesis studies 
aided in mapping the critical residues for these monoclonal antibodies. 
Antibody depletion studies showed that the DENV4 immune subjects had 
type-specific antibodies that strongly neutralized DENV4 only. These serum 
properties were also reflected in two hMAbs that strongly neutralized 
DENV4 only. The epitopes of the two DENV4 antibodies were mapped 
to the EDI/EDII hinge region. Importantly, LLPCs and MBCs in the subject 
from which the mAbs were isolated targeted the same epitope regions. 
A significant proportion of the type-specific responses induced in the 
NIH DENV4 monovalent vaccine recipients were also directed to the EDI/
II region. We will discuss the specific location of the DENV4 neutralizing 
site and also the implications of our work for natural infection and dengue 
vaccine induced antibody responses.
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DETERMINING THE EFFICACY OF LARVIVOROUS FISH, 
COMMUNITY ENGAGEMENT, AND A NOVEL SLOW 
RELEASE PYRIPROXYFEN FORMULATION SUMILARV® 
2MR ON DENGUE VECTORS (AEDES AEGYPTI AND AEDES 
ALBOPICTUS) IN CAMBODIA: A CLUSTER RANDOMIZED 
TRIAL
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Rithea Leang2, Jeffrey Hii6
1Malaria Consoritum, Phnom Penh, Cambodia, 2Cambodian National 
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Asia records 70 percent of the 390 million dengue infections occurring 
each year, and Cambodia has one of the highest per-capita incidence 
rates in the region. Due to the relatively high cost of the current vector 
control methods and documented insecticide resistance in Cambodia 
there is an urgent need to find alternative cost-effective solutions for 
Aedes vector control that are operationally feasible by the National 
Dengue Control Program. A cluster randomized, controlled superiority 
trial was developed to establish the effectiveness of an integrated vector 
management approach using guppy fish (Poecilia reticulata), a new slow 
release pyriproxyfen matrix (Sumilarv® 2MR), and community engagement 
through a clear Community for Behavioral Impact (COMBI) strategy. 
The trial based in Kampong Cham, Cambodia includes 30 clusters with 
approximately 200 households (1000 individuals) per cluster and runs 
from October 2015-October 2016. The clusters were randomly assigned 
with a 1:1:1 allocation through a public randomization process to one 
of three arms; (1) all interventions, (2) guppies and COMBI activities, and 
(3) control. The control area receives only interventions currently available 
through the government, which currently includes insecticide distribution 
and health education during outbreaks. To avoid spillover effects, clusters 
are at least 200 meters from the nearest household as Aedes aegypti in 
this region have an average flight range of 50-100m. The primary outcome 
is the population density of adult female Aedes, and will be evaluated 
through four entomological surveys. Secondary outcomes include classical 
Stegomyia indexes, coverage rates of the intervention, and changes in 
Knowledge, Attitudes, and Practices (KAP) indicators evaluated through 
monthly monitoring forms and baseline/endline KAP surveys. Polymerase 
chain reaction will be used to determine dengue virus rates in adult female 
Aedes mosquitoes. The results of the trial will be used to inform policy 
recommendations for Cambodia.
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DENGUE OUTBREAK IN EAST DELHI, DELHI STATE, INDIA, 
2015
Dundaiah Somashekar, Venkatesh B. Govindappa
East Delhi Municipal Corporation, Delhi, India
Dengue has emerged as a major vector borne public health problem in 
India. It is endemic in capital city-state, Delhi, which experienced its largest 
ever dengue outbreak in 2015. An outbreak investigation was conducted 
in the East Delhi Municipal Corporation (EDMC) area with objectives to 
characterize outbreak features and to assess risk factors. A case of dengue 
was defined as “any person residing in EDMC area and had fever (2-7 
days duration) between 14th May and 18th December, 2015 and tested 
positive for IgM ELISA or NS1 antigen ELISA”. We prepared a line list and 
conducted descriptive analysis. We analyzed larval survey data. A 1:2 case 
control study was conducted to assess risk factors. Controls were persons 
from case’s neighborhood with no fever history. We collected data on 
living conditions, domestic mosquito breeding sites, vector control and 
personal protection measures. There were 1775 dengue cases including 
8 deaths. Age group 10 to 14 years (273 cases, 16.5%) most affected. 
Males were 1038 (61%). Median age was 21 years (Range: 7 months to 
88yrs). Attack rate was 44 per 100,000 population. NS1 antigen ELISA test 
was positive in 1169(66%) cases. There was circulation of DENV 2 and 4 
sero-types. In August, Aedes mosquito breeding detected in 14 per 1000 
house visits and Breteau index was 15. Risk of dengue was more in those 
lived in overcrowded houses (OR 2.02, 95% CI 1.2-3.2), stored water in 
containers (OR 1.8, 95% CI 0.8-3.9), dumped waste disposables around/
over the house (OR 1.6, 95% CI 0.7-3.6), spent day time in work place 
or school (OR 1.6, 95% CI 0.9-2.8) and low education (OR 1.4, 95% CI 
0.8-2.3). Less risk was among those used larvicide in desert cooler (OR 
0.3, 95% CI 0.08-1.1), worn trouser and full sleeved clothes (OR 0.6, 
95%CI (0.4-1.1) and covered windows with mesh (OR 0.8, 95% CI 0.5-
1.3). Factors like increased Aedes mosquito breeding in key domestic sites, 
circulation of multiple DENV sero-types, overcrowding and low education 
led to the outbreak. Concurrent anti-larval and anti-adult measures are 
needed to control Aedes mosquito. Active community participation to 
monitor key breeding sites and personal protection advocacy are needed.
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CORRELATION OF CLINICAL DIAGNOSIS AND DENGUE 
ASSAYS IN CAMBODIA OVER SIX YEARS
Catherine M. Berjohn1, Agus Rachmat1, Chenda Yi1, Vireak 
Heang1, Chonthida Supaprom1, Bolin Chum1, Sim Kheng2, Sokhal 
Buth3, Andrew F. Vaughn1
1U.S. Naval Medical Research Unit-2, Phnom Penh, Cambodia, 
2Communicable Disease Control Department, Phnom Penh, Cambodia, 
3National Institute of Public Health, Phnom Penh, Cambodia
Dengue fever is a flavivirus infection endemic to tropical regions, estimated 
to be responsible for 50-100 million infections annually. As a part of 
an ongoing febrile cohort study in Cambodia, febrile patients (>38C) 
presenting to regional health centers are enrolled and tested for a variety 
of febrile illnesses. During the period of Jan 2010-Feb 2016, specimens 
were tested for dengue with varying combinations of rapid test (NS1), 
PCR, or paired ELISA, with the follow-up performed at four weeks. Of the 
19,823 enrolled patients, 1,572 were given a clinical diagnosis of dengue, 
but 4070 patients ultimately had at least one positive confirmatory test of 
NS1, PCR, acute IgM, or convalescent IgG. Positive results were obtained 
in 876 samples tested for NS1, 1272 for PCR, 1243 for acute IgM, and 
2500 for convalescent IgG, resulting in 349 positive paired serologies. 
Clinical diagnosis had a sensitivity of 57.5% and specificity of 90.2%, but 
a PPV of 33.4 for correlation with NS1. NPV was 96.1. PCR performed 
similarly in relation to clinical diagnosis (Se 43.8%, Sp 94.8%, PPV 38.7, 
NPV 95.8; p<0.001). Analysis of a subset of 4667 patients for whom all 
tests were performed showed only marginal differences in comparison to 
the whole cohort. Clinical diagnosis performance decreased when used in 
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combination with the historical gold standard of paired serologies, with a 
sensitivity of 40.7%, specificity of 87.5%, and PPV of 17.1. NPV was 95.9 
(p<0.001), and showed an overall positivity rate of 6.0%, as opposed to 
7.3% for NS1 and 10.7% for conventional PCR. Distinct seasonality was 
observed for all measures. Serotyping was performed for 1271 samples. 
Predominance varied by year, but across the six years, serotype-1 was most 
common (62.3%), followed by serotype-2 (23.3%), type-4 (12.5%) and 
type 3 (1.9%). Dengue fever continues to be an illness with significant 
morbidity in Cambodia. Newer diagnostic tools such as rapid NS1 antigen 
tests and PCR should be used in resource-limited settings to supplement 
clinical diagnosis. Their improved accuracy may help reduce unnecessary 
antimicrobial use and improve quality of care.
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REGULATION OF PROTEIN TRANSLATION IN MOSQUITO 
CELLS INFECTED BY DENGUE 2 VIRUS
Wei-June Chen, Jion-Nan Hou, Tien-Huang Chen, Ching-Yun 
Perng
Chang Gung University, Tao-Yuan, Taiwan
Dengue virus (DENV) is naturally transmitted between humans by Aedes 
mosquitoes. The virus generally replicates and amplifies to a high level 
of virus progeny population in mosquito cells which usually survive 
the infection. As many other viruses, DENV can modulate host protein 
translational machinery that benefits for viral infection. In order to explore 
its regulatory mechanism, we applied a technique of SUnSET which is 
a nonradioactive measurement of protein synthesis in C6/36 cells with 
DENV-2 infection. The result revealed a significant shutdown of newly 
synthesized proteins in C6/36 cells infected by DENV-2. As UV-inactivated 
DENV-2, it seems that virus replication after entry is required to trigger 
signals for protein synthesis in mosquito cells. It has been reported that the 
initiation of cap-dependent translation is a key step during the process of 
protein synthesis via the assembled eIF4F complex which targets 5’-cap of 
mRNA, and may be hindered by the phosphorylation status of eIF4E-BP, a 
component of the eIF4F complex. Expression level and phosphorylation of 
eIF4E-BP has been observed to reduce in C6/36 cells with DENV-2 infection 
for 24 h. It suggested that the eIF4E-BP is one important factor involving in 
host cap-dependent translation of mosquito cells, particularly in the status 
of DENV-2 infection. On the other hand, PERK is a signaling pathway 
which may be triggered by DENV infection, causing attenuation of 
protein translation, in virus-infected cells. In this study, the PERK inhibitor 
(GSK2606414) was implemented to DENV-2-infected C6/36 cells, resulting 
in recovery of protein synthesis, implying that this signaling pathway was 
rather likely involved in modulating protein synthesis. However, it remains 
to be work out for understanding how these two factors involving in 
protein synthesis work together.
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RECENT SCIENTIFIC AND CLINICAL ADVANCES IN SANOFI 
PASTEUR’S DENGUE VACCINE PROGRAM
Nicholas Jackson1, Janice Moser2, Antony Byers2, Valerie 
Lecouturier3, Ernesto Luna2, Laurent Chambonneau3, Bruno Guy1, 
Fernando Noriega4
1Sanofi Pasteur, Lyon, France, 2Sanofi Pasteur Vaxdesign, Orlando, FL, 
United States, 3Sanofi Pasteur, Marcy-l’Étoile, France, 4Sanofi Pasteur, 
Swiftwater, PA, United States
The first dengue vaccine has been licensed by several dengue-endemic 
countries in Asia and Latin America for use in 9-45 or 9-60 year-olds. 
Licensure was supported by two pivotal phase 3 trials conducted in Asia, 
with 10,275 participants aged 2-14 years, and in Latin America, with 
20,869 participants aged 9-16 years [NCT01373281 and NCT01374516 
respectively]. Long-term safety follow-up studies, as recommended by 
the WHO, are currently ongoing and available data will be presented. 
Pooled efficacy results for the active surveillance period from both trials 
in subjects ≥ 9 years old demonstrated 65.6% (95%CI 60.7-69.9), 
80.8% (70.1-87.7) and 93.2 (77.3;-98.0) efficacy against all symptomatic 
virologically-confirmed dengue (VCD) cases, hospitalized cases and 
severe dengue cases, respectively. During long-term follow-up in the 
third year of phase 3 and 2b trials, the pooled relative risk of hospitalized 
VCD cases among participants ≥ 9 years of age was 0.50 (0.28-0.89). In 
totality, these efficacy and safety data determined the currently licensed 
indication. Post-phase 3 investigations focusing on the quality of vaccine-
induced responses: i) affinity and serotype-specific neutralization of 
antibodies, ii) infectivity and immunogenicity of the vaccine in a relevant 
in vitro tissue module (MIMIC), and iii) detection of key epitopes on 
the vaccine using clinically relevant human monoclonal antibodies, 
were initiated to understand the biological basis of these observed trial 
results. To complement findings, immune correlates derived from PRNT50 
antibody neutralization data will be presented. Together, these data 
further support a vaccination strategy targeting high disease burden age 
ranges, combining routine vaccination with several catch-up cohorts at 
introduction would substantially reduce the burden of dengue disease in 
endemic regions.
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IMMUNITY TO ZIKV, DENV AND CHIKV IN A NON-ENDEMIC 
HUMAN IMMUNE COHORT IN PORTLAND, OREGON
William Messer, Adam Brady, Sarah Gabriel, Brian Booty, Claire 
Dorfman, Jules Weinstein
Oregon Health & Sciences University, Portland, OR, United States
Zika (ZIKV), dengue (DENV) and chikungunya (CHIKV) are the most 
important emergent and epidemic mosquito-borne viruses worldwide. 
These viruses often share the same vectors and frequently co-circulate. 
The determinants of natural human immunity to these viruses are not 
fully characterized, nor are the degrees to which immunity to one cross-
reacts with the other viruses. Moreover, their co-circulation potentially 
complicates traditional serological diagnoses and poses a particular 
challenge for safe and effective vaccine design. Cohorts of naturally 
immune individuals are vital resources for defining the critical correlates 
of ZIKV, DENV and CHIKV immunity. While international immune cohorts 
are often used to study natural arboviral immunity, local immune cohorts 
offer advantages over internationally based cohorts, including: 1) recruited 
individuals are unlikely to be confounded by repeat infection over study 
periods 2) adult recruits can provide large volume serum and cell samples 
serially that can be processed locally and contemporaneously, 3) given 
time, a local cohort is expected to include donors with diverse exposures 
that vary over time, geography, and viruses beyond what would be found 
at any single international site. Here we report demographic, travel, 
medical and virus exposure data, baseline serum neutralization values, 
cross-neutralizing activity between ZIKV, CHIKV and DENV immune sera 
against each other as well as West Nile Virus, Yellow Fever Virus and 
Japanese encephalitis virus for a human immune cohort in Portland, 
Oregon. We characterize persistence of neutralization over time, evaluate 
neutralizing antibody decay and report results of virus specific B-cell 
frequency. Long-term we expect this cohort to provide high-value immune 
sera and cells for both dissecting components of protective ZIKV, DENV 
and CHIKV immunity and validating candidate targets and correlates of 
long-term arboviral immunity.
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SPATIOTEMPORAL ANALYSES OF DENGUE 
HOSPITALIZATIONS CODED IN BRAZIL
Juliane Wunderlich1, Wladimir J. Alonso2
1McGill University, Montreal, QC, Canada, 2Division of International 
Epidemiology and Population Studies, Bethesda, MD, United States
Dengue is the most rapidly spreading vector-borne viral disease and now 
a global health threat due to its presence in almost every tropical region 
and its alarming incidence increase within the last decade. Here, we have 
studied the temporal and regional epidemiological patterns of dengue in 
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Brazil in order to identify factors that were associated with higher numbers 
of hospitalizations from 1998 to 2013. We found that this number 
had increased in recent years, with a lower incidence in the southern 
part of the country. A marked seasonality was observed, with cases 
peaking during periods of the year in which mosquito abundance and 
activity were higher due to optimal levels of humidity and temperature. 
A novel contribution of our analyses is that the seasonality of dengue 
hospitalizations had a clear West-East gradient in Brazil. The analyses 
also revealed a higher proportion of children that were hospitalized due 
to dengue within the last 15 years, especially during strong outbreaks. 
These changes are likely to be a result of multiple factors, such as the 
accumulation of multitypic immunity in adults during the 20 years 
following re-introduction of dengue virus into Brazil in 1986 and thus 
the higher probability for children to be susceptible or monotypically 
immune, and the re-emergence of the more aggressive dengue virus 
strain DENV2 in 1990. Alternative explanations for the higher number 
of dengue outbreaks and hospitalizations and the higher proportion of 
children affected are fluctuations in serotype-specific transmission intensity, 
regional variations in circulating DENV serotypes, and the density of the 
vector population. Based on these results, we may speculate that the 
number of children hospitalized due to dengue is likely to increase in the 
southern part of the country within the next years. Our findings may allow 
health systems to improve control interventions and contribute to reducing 
dengue morbidity and mortality by using integrated vector control in 
conjunction with early diagnosis.
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HYPOXIA ENHANCES ANTIBODY-DEPENDENT DENGUE
Esther S. Gan1, Wei Fun Cheong2, Kuan Rong Chan1, Eugenia 
Ong3, Xiaoran Chai1, Hwee Cheng Tan1, Sujoy Ghosh1, Markus R. 
Wenk2, Eng Eong Ooi1
1Duke-NUS Medical School, Singapore, Singapore, 2National University 
of Singapore, Singapore, Singapore, 3Experimental Therapeutic Centre, 
Singapore, Singapore
Dengue virus (DENV) has been found to replicate in lymphoid organs, 
such as lymph nodes and spleen, as well as the liver in post mortem 
examination. These organs universally have significantly lower oxygen 
levels (lymphoid organs~0.5-4.5% O2) compared to atmospheric air 
(~20% O2) due to the vascular anatomy. How physiological oxygen levels 
in the organs where DENV replicates, affect DENV infection through 
hypoxia-induced changes in the immune response has, however, never 
been investigated. We report here that, compared to cells cultured at 20% 
O2, infection of THP1 and primary monocytes at 3% O2 (hypoxia) required 
4-fold more antibody for complete neutralization. Furthermore, sub-
neutralizing levels of antibodies produced 2-3 fold higher enhancement 
in DENV infection under hypoxic conditions. We show that these 
observations were mediated by the hypoxia-induced upregulation of 
FcγRIIA but not FcγRIIB expression. High-resolution microscopy shows 
that FcγRIIA directly mediates internalization of DENV immune complexes 
under hypoxic conditions. Mechanistically, the stabilization of hypoxia 
inducible factor (HIF1α) by hypoxia or chemically with desferrioxamine 
(DFX) under 20% O2 conditions both upregulated FcγRIIA. However, 
DFX induced FcγRIIA expression only resulted in increased DENV immune 
complex attachment but not internalization into cells. In addition to the 
upregulation of FcγRIIA, a hypoxia driven but HIF1α independent increase 
in membrane ether lipid concentrations is required to synergistically 
increase internalization of DENV immune complexes for enhanced 
infection. Our findings thus indicate that the increased viral burden 
associated with secondary DENV infection is thus antibody-dependent but 
hypoxia-mediated and suggest a role for targeting hypoxia-induced factor 
for anti-dengue therapy.
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VIREMIA AT PRESENTATION IS ASSOCIATED WITH LONG-
LIVED ANTIBODY RESPONSES TO DENGUE VIRUS
Jesse J. Waggoner1, Lionel Gresh2, Alisha Mohamed-Hadley1, 
Angel Balmaseda3, K. James Soda4, Janaki Abeynayake1, Malaya K. 
Sahoo1, Yuanyuan Liu1, Guillermina Kuan5, Eva Harris6, Benjamin 
A. Pinsky1
1Stanford University, Palo Alto, CA, United States, 2Sustainable Sciences 
Institute, Managua, Nicaragua, 3Centro Nacional de Diagnóstico y 
Referencia, Managua, Nicaragua, 4Florida State University, Tallahassee, 
FL, United States, 5Centro de Salud Sócrates Flores Vivas, Managua, 
Nicaragua, 6University of California Berkeley, Berkeley, CA, United States
Infection with one of four related dengue virus (DENV) serotypes is 
thought to elicit life-long, serotype-specific immunity but only short-lived 
immunity to the remaining 3 serotypes. This theory has been derived from 
the study of typical, symptomatic DENV infections. In the current study, 
we evaluated the humoral immune response to DENV infections that were 
detected in febrile children clinically diagnosed with a non-dengue illness 
(referred to here as atypical cases). 2,892 acute-phase serum samples 
were tested for DENV by real-time RT-PCR (rRT-PCR), and viremia was 
quantitated using a serotype-specific DENV multiplex rRT-PCR. Samples 
were collected as part of an ongoing pediatric dengue cohort study in 
Managua, Nicaragua. As part of the study, patients had healthy annual 
serum samples tested using a specific Inhibition ELISA to detect total anti-
DENV antibodies. These data were used as a measure of the long-term 
humoral immune response to DENV. 130 atypical cases tested positive 
for DENV, and 111 had Inhibition ELISA results from paired pre- and 
post-infection annual samples. 53 cases (47.8%) showed seroconversion 
or a >4-fold increase in titer in pre- vs post-infection samples (referred 
to as a positive Inhibition ELISA result), which was significantly lower 
than expected based on data from typical, symptomatic cases (79.7%; 
p<0.01). Viremia at presentation was significantly higher in atypical 
cases with positive Inhibition ELISA compared to cases with negative 
Inhibition ELISA [mean 7.6 (SD 1.5) vs 4.5 (SD 1.6) log10 copies/mL 
serum, respectively; p<0.01), and this remained significant in multivariable 
analysis (p<0.01). Atypical cases also appeared to alter the response to 
subsequent (secondary) typical, symptomatic cases. All 16 patients with 
two typical cases developed the expected rise in Inhibition ELISA titer 
following a second DENV infection (reciprocal titer ≥ 2560). However, 
in patients with an atypical primary case, only 1/8 patients developed 
the expected response (p<0.01). These data have important implications 
for understanding DENV immunology, estimating DENV incidence, and 
modeling virus transmission.
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CHARACTERIZATION OF THE OVERWINTERING PROCESS 
OF JAPANESE ENCEPHALITIS VIRUS IN CULEX SPECIES 
MOSQUITOES
Yan-Jang S. Huang1, Susan M. Hettenbach2, So Lee Park1, 
Stephen Higgs2, Alan D. Barrett3, Lee W. Cohnstaedt4, Dana L. 
Vanlandingham1
1Department of Diagnostic Medicine and Pathobiology, College of 
Veterinary Medicine, Kansas State University, Manhattan, KS, United 
States, 2Biosecurity Research Institute, Kansas State University, Manhattan, 
KS, United States, 3Department of Pathology, University of Texas Medical 
Branch, Galveston, TX, United States, 4Arthropod-Borne Animal Disease 
Research Unit, Agriculture Research Services, United States Department of 
Agriculture, Manhattan, KS, United States
Japanese encephalitis virus (JEV) is a mosquito-borne flavivirus endemic in 
the Asia-Pacific region and has been continuously regarded as a potential 
threat to human and veterinary public health in North America. Previously, 
we and others have identified potential competent vector species and 
amplification hosts of JEV in North America. These studies suggest that the 
establishment of enzootic transmission is highly likely in the event of its 
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introduction. A significant gap in determining the likelihood of establishing 
endemic transmission of JEV in North America is whether or not the virus 
can successfully overwinter in persistently infected animals. As observed 
with West Nile virus, successful overwintering allows the initiation of 
transmission in the spring and would ultimately lead to its establishment in 
North America. Whilst persistent infection of amplification hosts can serve 
as one mechanism for overwintering, persistently infected arthropods 
are also considered an important mechanism for overwintering. In this 
study, the overwintering process was investigated by maintaining orally 
infected American mosquitoes species at 16°C. Infectious virus was 
successfully recovered from infected mosquitoes demonstrating that JEV 
can lead to persistent infection at lower extrinsic temperatures. Therefore, 
we conclude that infection of arthropod vectors can serve as a potential 
overwintering mechanism for JEV in the event of its introduction in to the 
United States.
744
PROPOSED GUIDELINES FOR ADMINISTERING LIVE YELLOW 
FEVER VACCINE TO TRAVELERS
Stephen J. Seligman
The Rockefeller University, New York, NY, United States
The risk of acquiring yellow fever (YF) remains high in large parts of sub-
Saharan Africa and South America. Travelers to endemic areas should 
expect that one in seven infected individuals will become symptomatic 
and 20 to 60% of symptomatic persons will succumb. Effective antivirals 
are not available. The principal control mechanisms involve mosquitoes, 
principally Aedes aegypti in the case of urban YF, and administration of 
the effective YF vaccine. The development of large urban slums in tropical 
areas facilitates the growth of Ae. aegypti in water filled containers 
making mosquito control difficult. In 2001 recognition of the rare 
possibility of vaccine-associated severe viscerotropic disease (YEL-AVD) 
with a case fatality rate of ~63% has made it necessary to consider the 
relative risks of acquiring YF and developing YEL-AVD. New guidelines 
for the administration of the live YF vaccine have been proposed. The 
guidelines begin with a risk assessment of prospective vaccinees in 
established groups associated with increased susceptibility to YEL-AVD: 
Males older than 55, women between the ages of 19 and 34 living in 
non-endemic areas of Peru, people of either gender older than 76, persons 
with a variety of autoimmune diseases and patients with thymomas. The 
risk assessment is then used in connection with an estimate of the risk of 
acquiring YF in the area of intended travel. The risk for a particular area 
is influenced by continent (the risk in Africa being substantially greater 
than the risk in S. America), current reports of YF activity and rainfall. In 
some instances in areas of S. America the risk of YEL-AVD may be equal or 
greater than the risk of YF. In situations in which the risks of both entities 
are high, the recommendation is don’t travel. Although currently available 
information from official sources may be uninformative, judicious use of 
weather and map websites may be surprisingly helpful even for isolated 
rural communities in Africa and S. America. The decision to vaccinate with 
the live YF vaccine has become more complex, but the vaccine remains the 
most significant method for prevention of YF.
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COMPREHENSIVE MUTAGENESIS OF HCV E1/E2 ENVELOPE 
TO EPITOPE MAP ANTI-ENV ANTIBODIES AND FUNCTIONAL 
RESIDUES CRITICAL FOR HCV INFECTIVITY
Jennifer Pfaff, Trevor Barnes, Edgar Davidson, Benjamin J. 
Doranz
Integral Molecular, Inc., Philadelphia, PA, United States
To obtain epitope maps for anti-HCV Envelope (E1/E2) monoclonal 
antibodies (MAbs), we individually mutated 552 residues of HCV (H77 
strain) E1/E2 to alanine. Each mutant was expressed in human cells and 
analyzed for its effects on MAb reactivity. This ‘Shotgun Mutagenesis’ 
approach offers the capability of mapping both linear and conformational 
epitopes, even for structurally complex proteins such as the oligomeric 
and glycosylated HCV Envelope protein. This approach identified critical 
amino acids required for the binding of dozens of MAbs, and has also 
been used to propose E2 disulfide bond cysteine pairs that are not resolved 
by the available E2 crystal structures. This approach has helped define the 
range of immunodominant structures on HCV E1/E2 and identify novel 
neutralizing antibody epitopes that can be used for the development of 
improved therapeutics, diagnostics, and vaccine candidates. In addition, 
to identify residues important for HCV infectivity we produced infectious 
HCV pseudoviruses from each mutant Env clone in the library. These 
pseudoviruses were used to evaluate each Env clone for infectivity on 
target cells. This allowed us to identify critical E1/E2 residues whose 
mutation eliminated HCV infectivity, identifying crucial HCV E1/E2 
structural components that enable HCV infectivity.
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ANALYZING THE IMMUNE RESPONSE TO ZIKA VIRUS: A 
REPORTER VIRUS PARTICLE (RVP) SYSTEM FOR SERUM 
AND ANTIBODY NEUTRALIZATION ASSAYS, AND A 
COMPREHENSIVE ALA-SCAN MUTATION LIBRARY OF ZIKV 
PRM/E TO EPITOPE MAP ANTI-ZIKV ANTIBODIES
Chuck Whitbeck1, Anu Thomas1, David Tucker1, Trevor Barnes1, 
James E. Crowe Jr.2, Edgar Davidson1, Benjamin J. Doranz1
1Integral Molecular, Inc., Philadelphia, PA, United States, 2Departments of 
Pathology, Microbiology and Immunology, Vanderbilt University, Nashville, 
TN, United States
We have developed a reporter system, using pseudoinfectious reporter 
virus particles (RVPs), to facilitate analyses of the immune response to Zika 
virus (ZIKV) infection and anti-ZIKV vaccines. RVP-based assays provide 
a rapid reliable alternative to PRNT-based assays and are particularly 
suitable for high throughput screens of large panels of patient sera or 
isolated MAbs. ZIKV RVPs are replication-incompetent virus particles, 
antigenically equivalent to live viruses, containing the ZIKV prM and E 
envelope proteins, capsid protein, and a sub-genomic replicon encoding a 
reporter protein (luciferase or GFP). After infecting permissive cells, RVPs 
express their reporter protein, providing a convenient and reproducible 
quantitative assay for measuring the neutralizing capabilities of serum 
or individual monoclonal antibodies (MAbs). To further characterize the 
immune response to ZIKV infection, we have also developed a high-
throughput strategy that enables the rapid identification of both linear 
and conformational antibody epitopes on ZIKV prM/E envelope proteins. 
We used Shotgun Mutagenesis technology to create a comprehensive 
library of 660 single mutations in ZIKV prM/E. The individual mutant 
expression plasmids were arrayed into 384 well plates and transfected 
into human cells to achieve native protein expression and folding. The 
immunoreactivity of MAbs to the prM/E variant in each individual well 
was quantified by high-throughput flow cytometry, enabling us to map a 
number of anti-ZIKV MAbs. The epitopes obtained are being correlated 
with MAb abilities to neutralize ZIKV in vitro and to protect against ZIKV 
infection in vivo.
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EVALUATION OF SELECTED REAL-TIME RT-PCR PROTOCOLS 
AIMING AT THE BEST POSSIBLE MOLECULAR DIAGNOSIS OF 
ZIKA VIRUS INFECTIONS
Flávia M. Moraes, Danillo L. Esposito, Taline M. Klein, Benedito A. 
Fonseca
School of Medicine of Ribeirão Preto, Ribeirão Preto, S.P., Brazil
Zika is an emerging infectious disease resulting from Zika virus (ZIKV) 
infections and usually presenting itself by dengue-like symptoms. Clinical 
manifestations of Zika, dengue and chikungunya are somewhat similar, 
making it difficult to reach the diagnosis based only on clinical grounds. 
To make the diagnosis even more difficult, there is an intense cross-
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reactivity between Zika and other flavivirus antibodies. Thus, the correct 
diagnosis of Zika is better achieved by molecular methods, but due to 
the short-lived and low titer viremia, molecular methods need to have a 
high analytic sensitivity. Real-time RT-PCR (rRT-PCR) is the best diagnostic 
approach available since it is possible to design protocols with no cross-
reactivity with other flaviviruses. In this study, the analytic sensitivity of 
some published probe-based rRT-PCR protocols to detect ZIKV genome 
was evaluated. Ten-fold serial dilutions of ZikaSPH2015 strain, titrated in 
Vero cells, with a final virus concentration ranging from 1000000 to 1 
virus/dilution was spiked in the serum of a flavivirus naïve healthy donor. 
ZIKV RNA from all dilutions, as well as from serum and urine samples 
obtained from patients, was extracted and amplified by rRT-PCR with 
five different pairs of primers (ZIKVA, B, C, D and E) and their respective 
probe. The analytic sensitivity of each rRT-PCR protocol was evaluated 
by the cycle threshold (Ct), where the lower the value the higher the 
sensitivity. Among all rRT-PCR protocols, ZIKVD and ZIKVC had the lowest 
and highest Ct values, respectively. Besides, ZIKVC detected only to 1000 
copies/µL, while the other primers could detect virus in all dilutions. ZIKVD 
also had the best sensitivity when using patients’ samples. ZIKVD rRT-PCR 
protocol consistently detected ZIKV genome in serum and urine samples 
while ZIKVA and ZIKVB were more reliable in urine, and ZIKVC and ZIKVE 
were usually negative in any sample. In conclusion, ZIKVD rRT-PCR is the 
best protocol to detect ZIKV genome in any sample. The presence of 
possible mismatches between the ZikaSPH2015 strain and the sequence 
used by Tappe et al to design ZIKVC primers might be the cause of its low 
sensitivity.
748
WHOLE GENOME SEQUENCING AND PHYLOGENETIC 
ANALYSIS OF ZIKA VIRUS ISOLATED IN INDONESIA
Amin Soebandrio1, Frilasita Yudhaputri1, Aditya Perkasa1, 
Benediktus Yohan1, Sotianingsih Haryanto2, Ageng Wiyatno1, 
Ungke Antonjaya3, Hidayat Trimarsanto1, Jeremy P. Ledermann4, 
Ronald Rosenburg4, Ann M. Powers4, R. Tedjo Sasmono1, Khin 
Saw Aye Myint1
1Eijkman Institute for Molecular Biology, Jakarta, Indonesia, 2Siloam 
Hospital, Jambi, Indonesia, 3Eijkman-Oxford Clinical Research Unit, Jakarta, 
Indonesia, 4Centers for Disease Control and Prevention, Fort Collins, CO, 
United States
Zika virus (ZIKV) was isolated from serum of a febrile patient in Jambi 
municipality, Sumatra, Indonesia during an outbreak of dengue-like illness 
in 2014. Although human ZIKV infections are normally associated with 
mild illness, WHO has declared the ZIKV outbreak a global public health 
emergency because of its strong association with Guillain-Barré syndrome 
and microcephaly. To understand the ZIKV evolution and its genetic 
characteristics, whole genome sequencing and phylogenetic analysis was 
performed on the ZIKV isolate (JMB-185). ZIKV RNA was extracted from 
cell culture supernatant and subjected to sequencing employing the Ion-
Torrent Next-Generation Sequencing technology. The complete genome 
sequence of JMB-185 was assembled and aligned with all available ZIKV 
complete genome sequences retrieved from GenBank. To evaluate the 
evolutionary history of this isolate, we performed phylogenetic analysis 
using the Bayesian MCMC inference method. The molecular clock 
phylogeny analysis shows that the ZIKV JMB-185 strain, which shares 
common ancestry and time to the most recent common ancestor (TMRCA) 
with 2014 and 2013 Thailand strains around year 2008, has older lineage 
than the Polynesian and the Brazilian strains linked with microcephaly 
and is not closely related to those strains. The TMRCA result indicates 
that the ZIKV Jambi JMB-185 strain may have been in circulation in the 
South East Asia region, including Indonesia since 2008. We observed high 
nucleotide sequence identity and similarity between Indonesia, Thailand, 
and American strains. Further analysis including those of amino acid 
substitutions is in progress.
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CLINICAL CHARACTERIZATION OF ACUTE ZIKA PATIENTS IN 
BRAZIL, VENEZUELA, AND EL SALVADOR IN 2015/16
Patricia Brasil1, Ernesto T. Marques2, Adriana Tami3, Ernesto Pleitess 
Sandoval4, Andrea Caprara5, Tereza Magalhaes2, Guilherme 
Calvet1, Sarah Bethencourt6, Maria G. Guzman7, Cameron P. 
Simmons8, Ana Bispo1, Marli Tenorio Cordeiro2, Bridget Wills8, 
Kerstin Rosenberger9, Thomas Jaenisch9
1Oswaldo Cruz Foundation, Rio de Janeiro, Brazil, 2Oswaldo Cruz 
Foundation, Recife, Brazil, 3University Medical Center Groningen, 
Groningen, Netherlands, 4Hospital National de Ninos Benjamin Bloom, San 
Salvador, El Salvador, 5Ceara State University, Fortaleza, Brazil, 6University 
of Carabobo, Valencia, Bolivarian Republic of Venezuela, 7Pedro Kouri 
Institute, Havana, Cuba, 8Oxford University Clinical Research Unit, Ho Chi 
Minh City, Vietnam, 9Heidelberg University Hospital, Heidelberg, Germany
Latin America and the Caribean are currently facing an epidemic of three 
co-occuring arboviruses - Dengue, Chikungunya, and Zika. The multi-
center observational IDAMS study is one of the few prospective studies 
capturing incident zika cases alongside with dengue and chikungunya. The 
study was initiated in 2011 and patients ≥ 5 years with undifferentiated 
febrile disease within the first 72 hours were enrolled in three sites in 
Brazil, Venezuela, and El Salvador. In 2015, 574 patients were recruited 
in total, among them 334 in Brazil (194 in Recife, 55 in Fortaleza, 85 
in Rio de Janeiro), 72 in Venezuela, and 168 in El Salvador. The aims of 
the IDAMS study are to evaluate risk factors for severe dengue disease 
and validate the case definition for presumptive dengue in the absence 
of confirmatory laboratory testing. A broad range of clinical signs and 
symptoms and laboratory values are assessed daily during the acute illness, 
and at follow-up 1 week later. The study is currently ongoing and the 
inclusion criteria were adapted to presence of fever and/or rash in 2016. 
PCR for dengue , zika (and possibly chikungunya) viruses will be performed 
on all samples from 2015 and 2016, following strict protocols. Dengue is 
diagnosed by an algorithm including PCR, NS1, and IgM seroconversion. 
Preliminary results show a considerable proportion of zika-PCR-positive 
cases. We will describe the spectrum of clinical manifestations in zika 
patients and analyze clinical and laboratory parameters associated with 
zika vs. dengue at enrolment and over the course of the disease. We will 
carry out multivariable regression, stratified by age group, day of illness, 
and country, and assess the heterogeneity between the sites before 
pooling the data. Results to be presented will include patients recruited 
up to June 2016 and are expected to have considerable impact on the 
validation of the zika interim case definition issued by WHO.
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DETECTION AND DIFFERENTIATION OF IGM RESPONSE TO 
RECENT EXPOSURE TO ZIKA AND OTHER VECTOR BORNE 
VIRUSES USING A MULTIPLEXED, BEAD BASED SEROLOGY 
ASSAY
Christy Weiss, Michele M. Bush, Arturo Cowes, Diamela Nunez, 
Félix W. Santiago, Amy Altman
Luminex Corporation, Austin, TX, United States
Since May 2015, South and Central America have experienced an 
epidemic outbreak of Zika Virus. Several travel related cases have already 
been identified in the United States. Zika infection during pregnancy has 
been implicated in the development of microcephaly in the developing 
fetus and is thought to be responsible for an increased incidence of 
Guillain-Barre syndrome. The expanding footprint of the disease, along 
with the devastating neurological effects associated with Zika Virus 
warrant a cost effective and specific diagnostic. In Zika infection, the 
detection of viral RNA in serum is transient and is only detectable for a 
few days post infection. Therefore, specific detection of IgM representing 
a recent infection from a vector borne virus as a companion to molecular 
detection is required in order to expand the diagnostic window. In areas 
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with co-circulating vector borne viruses, serological responses must 
not only be detected, but differentiated in order to provide accurate 
results. An effective test also must distinguish a recent infection from 
historical infections and vaccinated individuals. A serology based, 
multiplex microsphere assay was developed to detect and differentiate 
IgM response to Zika Virus, Chikungunya Virus, Dengue Virus (Serotypes 
1-4), West Nile Virus, Yellow Fever Virus, Japanese Encephalitis Virus, 
Tick Borne Encephalitis Virus, St. Louis Encephalitis Virus, and Usustu 
Virus. Assay performance was established using clinical samples. The 
assay demonstrates required analytical specificity and is able to detect 
and differentiate each virus. The multiplex serological assay eliminates the 
need for sequential testing and complicated patient care algorithms. The 
multiplex format allows for simultaneous identification of IgM responses 
to a group of viruses that have historically been difficult to distinguish due 
to strong immunological cross reactivity and challenges with distinguishing 
old verses new infections.
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MAPPING THE GLOBAL DISTRIBUTION OF YELLOW FEVER
Freya Shearer
University of Oxford, Oxford, United Kingdom
The spread and recent outbreaks of Zika, dengue, yellow fever and 
chikungunya viruses across the globe in 2015/16, highlight the need to 
reassess our understanding of these arboviruses, including their current 
distributions and potential for spread into new areas. Yellow fever is 
vaccine preventable, yet incomplete coverage means that it is widely 
distributed in the tropics of South America and Africa where infections 
cause an estimated 29,000 to 60,000 deaths annually. Epidemiologists 
have long been concerned about the introduction of yellow fever into 
large urban populations of naïve individuals where it can spread rapidly 
from human-to-human transmitted by Aedes aegypti mosquitoes. 
Earlier this year, the confirmation of yellow fever cases, imported 
from an outbreak in Angola, in areas of China with established vector 
populations, coupled with the depletion of vaccine stockpiles, raised 
concerns that yellow fever could gain an uncontrollable foothold in Asia. 
The disease has been conspicuously absent from Asia to date, despite 
multiple opportunities for introduction and the apparent presence of 
all components of a suitable transmission cycle, but no barriers to its 
introduction have been identified so vigilance is vital. We produced high 
resolution evidenced-based maps of the current distribution of yellow 
fever in Africa and the Americas. These maps were derived from a boosted 
regression trees model that used geo-positioned data on occurrences of 
yellow fever infection, environmental and socio-economic variables, as well 
as vaccination coverage data. The outputs were then used to predict areas 
of suitability for yellow fever transmission in South and South East Asia. 
This work furthers our understanding of the current global distribution of 
yellow fever and the potential for its spread in parts of Asia.
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ACUTE ENCEPHALITIS SYNDROME IN ASSAM, INDIA: 
IMPORTANCE OF JAPANESE ENCEPHALITIS IN THE ADULT 
POPULATION, 2014-2015
Ravi Vasanthapuram1, Lahari Saikia2, Sanjeeb Kakati2, Aditi 
Baruah2, Pritikar Bowerah2, BC Bhagabati3, Reeta Mani1, Shafeeq 
Hameed1, Vijayalakshmi Reddy1, Anita Desai1, Vijaykiran Reddy1, 
Leena Inamdar4, Sharon Daves4, Kayla Laserson4, Padmini 
Srikantiah4
1National Institute of Mental Health and Neuro Sciences, Bangalore, India, 
2Assam Medical College and Hospital, Dibrugarh, Dibrugarh, India, 3Assam 
State Department of Health, Guwahati, India, 4U.S. Centers for Disease 
Control and Prevention, New Delhi, India
In India, thousands of cases of acute encephalitis syndrome (AES) are 
reported each year, predominantly among children. Japanese encephalitis 
virus (JEV) accounts for 13-18% of reported AES. From 2011-2015, 
Assam, a highly affected northeastern state, has reported over 1,000 
AES cases annually. We conducted facility-based surveillance at Assam 
Medical College (AMC) hospital to characterize illness and evaluate 
potential etiologies of disease. Between Jan 2014-Dec 2015, serum 
and cerebrospinal fluid (CSF) samples were collected from each patient 
admitted to AMC with AES, defined as acute onset fever (>38°C) and ≥1 
of altered mental status or seizures. Serum and CSF were tested for JEV 
IgM antibodies. A diagnosis of JEV was confirmed if JEV IgM was detected 
in CSF and probable if JEV IgM was detected in serum only. JEV-negative 
patients were evaluated for scrub typhus IgM, dengue virus IgM, and West 
Nile Virus (WNV) IgM in serum, and for bacterial/viral nucleic acids for 
Streptococcus pneumoniae, Hemophilus influenzae, and herpes simplex 
virus-1 (HSV) in CSF. Of 925 patients admitted with AES, 606 (66%) were 
male and 491 (53%) were ≥15 years old. CSF was collected from 772 
(83%) patients and serum from 772 (83%). Among the 925, 329 (36%) 
were diagnosed with either confirmed (254, 28%) or probable (75, 8%) 
JEV. Of these 329, 174 (53%) were ≥15 years old, and 52 (16%) died. 
Among 596 JEV-negative patients, the following additional pathogens 
were detected in serum: scrub typhus IgM (67/485, 14%), dengue IgM 
(17/408, 4%). WNV IgM was not detected in any patient. CSF molecular 
testing in 254 patients indicated evidence of S. pneumoniae in 4 (2%) 
and H. influenzae in 2 (1%). Of 351 evaluated, HSV was detected in 6 
(2%). JEV is the most common cause of AES in Assam, is associated with 
high mortality, and disproportionately affects adults, highlighting the need 
for ongoing adult JEV vaccination efforts in the region. The identification 
of additional treatable etiologies of illness, such as scrub typhus and 
pyogenic meningitis, has important clinical management implications, 
and underscores the need to employ a standardized laboratory testing 
algorithm for AES.
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HOSPITALIZATIONS BY HEPATITIS C BETWEEN 1998 AND 
2013 IN BRAZIL: AN INTRIGUING AMAZONIAN TALE
Elisavet Serti1, Wladimir J. Alonso2
1National Institute of Diabetes and Digestive and Kidney Diseases/National 
Institutes of Health, Bethesda, MD, United States, 2Fogarty International 
Center/National Institutes of Health, Bethesda, MD, United States
Hepatitis C (HCV) infection is a public health problem of global 
dimensions, affecting 3% of the world’ s population. In Brazil, between 
2.5% and 4.9% of the population is infected with HCV. The Brazilian 
Amazon region has been reported to be hyper endemic for HCV and 
two other hepatotropic viruses (Hepatitis B and D). Here we explore the 
temporal patterns of incidence of hospitalizations attributed to HCV in 
Brazil per state and age group. We used hospitalization data from 1998 to 
2013, from the nationwide administrative database of the Unified Health 
System (SUS). The records of hospitalizations coded as Hepatitis C were 
filtered using the codes B171 and B182 and aggregated in monthly time-
series by state and age groups. Incidences were obtained using census-
interpolated matrices. Visual inspection and spatio-temporal parameters 
were obtained using the analytical software epipoi. Between 1998 and 
2013, 24210 patients were hospitalized with a principal diagnosis of HCV 
infection. As expected, the majority of new HCV cases (12038 patients) 
were recorded in Sao Paolo that has an estimated population of 44.39 
million people. However, the incidence rate of HCV-related hospitalization 
was significantly higher in the region of the state of the Acre (mean 
incidence rate > 0.12 and linear trend < 16x10^-4) compared to all other 
Brazilian states. A total of 340 hepatitis C cases were recorded in the SUS 
database, the majority of which (186 cases) aged between 40 and 59 
years. We detected worrying high incidence rates of HCV hospitalizations 
in the Western Brazilian Amazon Region. An increased prevalence of HCV 
among health care workers in Rio Branco located at the State of the Acre 
has been previously reported (Parana J et al, Am J Trop Med Hyg, 2007). 
If it is ruled out that the detection of HCV is exceptionally better in this 
region, then the infection control services in the hospitals of the State of 
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the Acre need to be urgently evaluated. Our findings indicate the need for 
the implementation epidemiological awareness, prevention and control 
programs for Hepatitis C in this region.
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DESIGN AND VALIDATION OF A RAPID ASSAY FOR ZIKA 
VIRUS IN BIOFLUIDS AND INSECT VECTORS
Rushika Perera1, Nunya Chotiwan1, Connie D. Brewster2, James 
Weger-Lucarelli1, Claudia Rückert1, Chilinh Nguyen1, Selene M. 
Garcia Luna1, Joseph R. Fauver1, Meg Gray1, William C. Black 
IV1, Brian Foy1, Rebekah C. Kading1, Gregory D. Ebel1, Sandra L. 
Quackenbush2, Joel Rovnak2
1Arthropod-borne and Infectious Disease Laboratory, Dept. of 
Microbiology, Immunology and Pathology, Colorado State University, 
Fort Collins, CO, United States, 2Dept. of Microbiology, Immunology and 
Pathology, Colorado State University, Fort Collins, CO, United States
Understanding the dynamics of Zika virus transmission and formulating 
rational strategies for its control require diagnostic tools that are 
appropriate for resource-poor environments. We have developed a rapid 
and sensitive loop-mediated isothermal amplification (LAMP) assay that 
is highly specific for the Puerto Rican Zika virus isolate, PRVABC59, and 
related isolates in the Asian clade. The assay does not detect Senegalese or 
Ugandan Zika isolates, or dengue, yellow fever, West Nile, or chikungunya 
viruses. The conditions described for the PRVABC59-LAMP assay allow 
direct detection of virus in infected cells, mosquitos, serum and blood 
without reverse transcription or RNA isolation. Time to detection of a 
single infectious particle in blood is 60 minutes in laboratory or field 
settings. It offers rapid, specific, sensitive and inexpensive detection of the 
Zika viruses currently circulating in the western hemisphere. Results from 
this assay will be presented.
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MAPPING GLOBAL SEASONAL SUITABILITY FOR ZIKA VIRUS 
TRANSMISSION
Oliver J. Brady1, Moritz U. Kraemer2, Isaac I. Bogoch3, Matthew 
German3, Alexander Watts3, Simon I. Hay4, Kamran Khan3
1London School of Hygiene & Tropical Medicine, London, United Kingdom, 
2University of Oxford, Oxford, United Kingdom, 3University of Toronto, 
Toronto, ON, Canada, 4Institute for Health Metrics and Evaluation, Seattle, 
WA, United States
Zika is a zoonotic mosquito-borne disease that became a global public 
health emergency in late 2015 when it spread throughout the Americas. 
While genetically similar to other globally distributed arboviruses such 
as dengue and chikungunya, Zika is of particular concern due to its link 
with neurological birth defects among infected pregnant mothers. Given 
this potential threat and the alarming rate of spread of the virus global 
predictions are urgently needed to assess where and when the virus may 
spread next with enough warning to deploy surveillance, control and 
diagnostic measures to protect those most at risk. Key insights into Zika 
seasonality can be gained through analysing the seasonal drivers of its 
principle mosquito vectors: Ae. aegypti and Ae. albopictus and their ability 
to transmit viruses. Here we combine habitat suitability analyses of these 
mosquito species with viral incubation period models to produce a series 
of global maps that depict when the arboviral season begins and ends 
around the world. This revealed broad areas of potential Zika transmission 
in temperate latitudes for long periods of the year, while also showing that 
the outbreak in some parts of South America may have been prematurely 
ended due to seasonal forcing instead of depletion of susceptible hosts. 
This could mean some populations in South America could potentially see 
a return of Zika sooner than previously estimated. The resulting predictions 
can be used for real time prediction of risk, better understanding past 
outbreaks and preparing appropriately for future Zika outbreaks.
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WORKING WITH ZIKA AND USUTU VIRUSES IN VITRO
Kelli Barr
University of Florida, Gainesville, FL, United States
Usutu (USUV) and Zika (ZIKV) viruses are emerging arboviruses of 
significant medical and veterinary importance. These viruses have not 
been studied as well as other medically important arboviruses such as 
West Nile (WNV), dengue (DENV), or chikungunya (CHIKV) viruses. As 
such, information regarding the behavior of ZIKV and USUV viruses 
in the laboratory is dated. Usutu virus re-emerged in Austria in 2001 
and has since spread throughout the European and Asian continents 
causing significant mortality among birds. Zika virus has recently 
appeared in the Americas and has exhibited unique characteristics of 
pathogenesis, including birth defects and transmission. Information 
about the characteristics of USUV and ZIKA viruses are needed to better 
understand the transmission, dispersal, and adaptation of these viruses 
in new environments. Since their initial characterization in the middle 
of last century, technologies and reagents have been developed that 
could enhance our abilities to study these pathogens. Currently, standard 
laboratory methods for these viruses are limited to 2-3 cell lines and many 
assays take several days to generate meaningful data. The goal of this 
study was to characterize these viruses in cell culture to provide some 
basic parameters to further their study. Cell lines from 17 species were 
permissive to both ZIKA and USUV. These viruses were able to replicate 
to significant titers in most of the cell lines tested. Moreover, cytopathic 
effects were observed in 8 of the cell lines tested. These data indicate that 
a variety of cell lines can be used to study ZIKA and USUV and may provide 
an updated foundation for the study of host-pathogen interactions, model 
development, and the development of therapeutics.
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PREDICTING INTENSITIES OF ZIKA INFECTION AND 
MICROCEPHALY USING TRANSMISSION INTENSITIES OF 
OTHER ARBOVIRUSES
Isabel Rodríguez Barraquer1, Henrik Salje1, Justin Lessler1, Derek 
A. Cummings2
1Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United 
States, 2University of Florida, Gainesville, FL, United States
The World Health Organization has declared Zika Virus (ZIKV) a Public 
Health Emergency of International Concern due to the virus’ emergence 
in multiple countries globally and the possible association of ZIKV with 
microcephaly and neurological disorders. There is a clear need to identify 
risk factors associated with ZIKV infection and microcephaly in order to 
target surveillance, testing and intervention efforts. Using data collected 
by surveillance systems, we modeled the correlation between transmission 
intensity of dengue and chikungunya, with reported microcephaly 
incidence in Brazilian states and ZIKV incidence in Colombia, as very 
few microcephaly cases have been reported up to now. We show that 
there is a strong correlation between the incidence of ZIKV in Colombian 
departments and the force of infection (but not the crude incidence) of 
dengue (R2 = 0.41, p<0.001). Furthermore, we show that there is also 
a strong correlation between the incidence of microcephaly in Brazilian 
states and the force of infection of dengue (R2 = 0.48, p<0.001). Because 
dengue and ZIKV are transmitted by the same vector, these associations 
provide further support to the supposition that ZIKV infection during 
pregnancy causes microcephaly, and raise questions about potential 
interactions between these two flaviviruses. In addition, they provide 
an opportunity to project the expected incidence of microcephaly in 
multiple dengue endemic locations across Colombia and the American 
continent. If the relationship between dengue FOI and microcephaly 
incidence seen in Brazil holds in Colombia, we should expect to see 387 
cases (95%CI 166-621) of ZIKV associated microcephaly to be reported 
over the next 7 months. These results are being updated as the ZIKV 
epidemic progresses and will be expanded to include other countries in the 
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American continents where data on dengue and ZIKV is available. Detailed 
knowledge of dengue transmission should be used to target surveillance, 
testing and intervention efforts against ZIKV and other flaviviruses.
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CORRELATION BETWEEN SABIN POLIOVIRUS SHEDDING 
AND SUBSEQUENT SEROCONVERSION IN INDIAN CHILDREN 
VACCINATED WITH MONOVALENT TYPE 3 ORAL POLIOVIRUS 
VACCINE (MOPV3)
Sidhartha Giri1, Jacob John1, Asha Mary Abraham1, Miren 
Iturriza-Gomara2, Nicholas C Grassly3, Gagandeep Kang1
1Christian Medical College, Vellore, Vellore, India, 2Institute of Infection 
and Global Health, University of Liverpool, Liverpool, United Kingdom, 
3Imperial College London, London, United Kingdom
OPV (oral poliovirus vaccine) shedding in stool after vaccination indicates 
vaccine virus replication in the gut which results in an optimal immune 
response to OPV, as evidenced by few studies. The objective of the 
study was to evaluate the correlation between mOPV3 shedding on day 
7 after vaccination and subsequent seroconversion in Indian children 
aged 6-11 months. A total of 300 infants aged 6-11 months who were 
seronegative to type 3 poliovirus (neutralizing antibody titre <8) and 
recruited from Vellore, India as part of a clinical trial evaluating the effect 
of azithromycin on the immunogenicity of mOPV3 given to healthy infants 
aged 6-11 months, were included in the study (CTRI/2014/05/004588). 
Serum samples were collected after 21 days of vaccination with mOPV3 
to evaluate seroconversion (antibody titre ≥8). Neutralization test was 
performed on the serum samples according to the WHO protocol to 
determine antibody titres against serotype 3 poliovirus. Stool samples 
were collected 7 days after vaccination to determine Sabin 3 shedding 
using quantitative real-time polymerase chain reaction (PCR). A Ct value 
of 40 was used as a cut-off value for positive samples. 160 infants 
(53.3%) were found to shed Sabin 3 poliovirus on day 7 after vaccination 
while 140 infants (47.7%) did not shed. Of the 160 infants who shed 
vaccine virus, 136 infants (85%) seroconverted while 24 infants (15%) 
did not seroconvert. Of the 140 infants who did not shed vaccine virus, 
only 14 (10%) seroconverted in contrast to 126 infants (90%) who 
remained seronegative. Shedding of Sabin poliovirus and seroconversion 
were strongly correlated (Fisher’s <0.001). To conclude, our study 
found a significant association between mOPV3 shedding on day 7 and 
subsequent seroconversion (after 21 days of vaccination) in Indian children.
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CHIKUNGUNYA, ZIKA, AND DENGUE IN CALI, COLOMBIA: 
PRELIMINARY RESULTS OF EPIDEMIOLOGICAL AND 
GEOSPATIAL ANALYSES
Amy R. Krystosik
Kent State University, Kent, OH, United States
Vector born disease control is expensive, time consuming, and difficult 
to achieve. Here, we propose a new method of describing environmental 
risks in order to more efficiently control Aedes born disease in Santiago 
de Cali, Colombia, an area which is endemic for dengue and chikungunya 
and currently controlling an outbreak of zika. Geospatial video narratives 
are a new method of capturing street level data for environmental risks 
with expert and community based opinion. These data, consisting of 
local expert interviews and video, are coded and analyzed in a laboratory 
and compared across space and time as GIS map-layers. Epidemiological 
analyses are being conducted including geospatial components 
(geographically weighted regressions, kernel density analysis, hotspot 
analysis) in addition to traditional incidence data measures. Preliminary 
dengue and chikungunya data from October 2014 - April, 2016, obtained 
from the local ministry of health database, SIVIGILA, suggest two primary 
hotspots (areas with higher than expected case data) which are related 
to local environmental risks (open sewers, homeless population, lack 
of trash and sanitation services). Local partners are being engaged to 
provide expert opinion and guide the work in the neighborhoods most in 
need. We expect to present the final results of the analysis to community 
partners and the secretary of health of Santiago de Cali as they continue 
to control these neglected tropical diseases affecting the most vulnerable 
populations of the city. New data is currently being cleaned and analyzed 
and final results are expected by July, 2016.
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A TRIAL TO ASSESS THE THERMOTOLERANCE OF AN 
INACTIVATED RABIES VACCINE
Felix J. Lankester1, Pieter A. Wouters2, Anna Czupryna3, Imam 
Mzimbiri4, Sarah Cleaveland5, Mike J. Francis6, David J. Sutton6, 
Denny G. Sonnemans2
1Washington State University, Arusha, United Republic of Tanzania, 2MSD 
Animal Health, Boxmeer, Netherlands, 3Lincoln Park Zoo, Chicago, IL, 
United States, 4Serengeti Health Initiative, Arusha, United Republic of 
Tanzania, 5University of Glasgow, Glasgow, United Kingdom, 6MSD Animal 
Health, Milton Keynes, United Kingdom
Mass dog vaccination is the most efficient way to eliminate human 
rabies. This study provides the first robust data that the immunogenicity 
(a surrogate of protection) of an inactivated rabies vaccine (Nobivac® 
Rabies), stored at temperatures in excess of recommended conditions, 
is not inferior to that of the vaccine stored in cold-chain conditions. A 
non-inferiority study was carried out comparing the serological response 
at 4 weeks post vaccination in dogs inoculated with vaccine stored at 
elevated temperatures for different durations, with dogs vaccinated with 
the product stored according to label recommendations. The results 
showed that the effectiveness of the vaccine at stimulating antibody 
was not inferior to cold-chain stored vaccine when it was stored for up 
to 6 months at 25°C or for 3 months at 30°C. Despite being unlikely to 
result in changes to the authorized storage conditions of this product, the 
development of thermotolerant vaccines will increase delivery options. 
For example vaccines could be stored in remote communities with no 
electricity, thus allowing dogs to be vaccinated throughout the year 
rather than annually when campaigns pass through. As such, puppies 
born after a campaign could be vaccinated in a timely manner, reducing 
the rate at which the inter-campaign vaccination coverage decreases. 
This will be useful where the 70% coverage target, required for local 
elimination of the virus from the canine reservoir host, has not been 
reached. Thermotolerant vaccines stored in remote areas will also provide a 
human life-saving resource in emergency outbreak situations where rapid 
vaccination of the dog population is required to control the epidemic. We 
have not confirmed a 3-yr duration of immunity for the high temperature 
stored vaccine, however annual re-vaccination is usually practiced for all 
dogs presented during vaccination campaigns in Africa and Asia. As such 
this should not be a cause for concern. Given the recent tripartite (WHO, 
OIE, FAO) commitment to eliminating canine-mediated human rabies by 
2030, these results are extremely timely.
761
RISK FACTORS FOR ANTIBODY LOSS AFTER HEPATITIS E 
VIRUS NATURAL INFECTION OR VACCINATION: RESULTS OF 
A MULTI-SITE COHORT STUDY
Brittany L. Kmush1, Ting Wu2, Tuly Rahman3, Huan Yu2, Kenrad 
Nelson1, James W. Shih2, K. Zaman3, Alain B. Labrique1
1Johns Hopkins School of Public Health, Baltimore, MD, United States, 
2National Institute of Diagnostics and Vaccine Development in Infectious 
Diseases, The Key Laboratory of the Ministry of Education for Cell 
Biology and Tumour Cell Engineering, Xiamen University, Xiamen, China, 
3International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, 
Bangladesh
Hepatitis E virus (HEV) is a vaccine-preventable emerging infection causing 
20 million infections in developing countries per year. In South East 
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Asia HEV causes yearly outbreaks, with the majority of disease seen in 
adults. This is unexpected for an enteric pathogen, suggesting that HEV 
antibody persistence after exposure is not long-lasting. We revisited 170 
subjects with a documented HEV infection from Bangladesh and China 
and 97 subjects vaccinated with the HEV239 vaccine during a phase III 
trial in China to retest their serum for anti-HEV antibodies 6 to 10 years 
after exposure. Overall, 22.1% (95%CI: 17.3-27.6%) no longer had 
detectable antibodies at follow-up. Antibody loss was greater among the 
naturally infected subjects compared to the vaccinated subjects, 24.1% 
(95%CI: 17.9-31.3%) versus 18.6% (95%CI: 11.4-27.7%), although not 
statistically significant (p=0.292). Among all the subjects, age at exposure 
was associated with antibody loss, with younger age increasing the risk 
of antibody loss (RR: 0.87 per 10 years, 95% CI: 0.76-1.00, p=0.057). 
Among the subjects from Bangladesh, each 10 year increase in age at 
infection decreased the risk of antibody loss by 50% across univariate 
and multivariate Poisson regression models (p<0.05). This age-dependent 
antibody loss could partially explain the wide body of cross-sectional 
seroprevalence data from SE Asia where a paucity of pediatric infections 
has been observed. In multivariate models, factors that increased the 
risk of HEV were generally associated with antibody persistence among 
the naturally infected subjects, suggesting repeated exposures over time 
contribute to antibody persistence. This pattern was not found in the 
vaccinated subjects. This is the first study to compare long term antibody 
persistence after HEV exposure in naturally infected and vaccinated 
individuals, exploring host characteristics. The development of a successful, 
subunit vaccine has increased the need to understand the duration of 
antibodies and protection after HEV infection and vaccination in order 
to implement the most cost effective disease control and vaccination 
strategies.
762
ANTIBODIES TO EBOLA IN INTERNATIONAL RESPONDERS TO 
THE WEST AFRICA EBOLA EPIDEMIC
Catherine F. Houlihan, Catherine McGowan, Chrissy Roberts, 
Marc Baguelin, David Mabey, Richard S. Tedder, Judith Glynn
University College London, London, United Kingdom
The 2014/5 Ebola (EVD) epidemic in West Africa (WA) resulted in a 
large international humanitarian and research response. Health care 
workers (HCWs) from WA were disproportionately affected, and a few 
international HCWs were infected. Since asymptomatic and pauci-
symptomatic EVD has been described, we tested international returnees 
for EVD antibodies. An online consent and survey link were distributed 
using a snowball technique. Eligibility criteria included never having tested 
positive for Ebola virus, and not ever having received a filovirus vaccine. 
Oral fluid collection devices were posted to participants and returned using 
standard mail. Samples will be analysed using an IgG capture ELISA. Non-
exposed controls in the UK will also be tested. Data are stored on a secure 
database, and analysed using STATA 14. A total of 270 individuals who 
travelled to WA during the 2014/5 Ebola epidemic completed an online 
survey. Of these, 155 (57.4%) were women. The majority (253, 93.7%) 
travelled to Sierra Leone; 13 (4.8%) to Liberia and 14 (1.5%) to Guinea. 
Roles included, but were not limited to; laboratory (95, 35.2%), clinical 
(71, 26.3%), epidemiologist/research (23, 8.5%), community engagement/
burial (14, 5.2%) and water/sanitation/engineer (4, 1.5%). A total of 
139 (51.5%) returnees spent time in the red zone, of whom 21 (7.8%) 
described direct physical contact with suspected/confirmed EVD patients 
or their children outside of the red zone, and 99 (36.7%), direct physical 
contact with survivors. A total of 56 (20.7%) experienced a febrile illness 
in WA, or within a month of return. Twenty-five (9.3%) had a negative 
PCR test for Ebola. Of 236 individuals who wore personal protective 
equipment (PPE), 22 (9.3%) had concerns regarding Ebola exposure 
during removal. Serological results will be available. A high proportion 
of international responders reported potential exposure outside of PPE, 
concerns about exposure when removing PPE, and reported a febrile illness 
during the incubation period for Ebola. Improvements in training and 
procedures, and consistency in PPE equipment and removal may mitigate 
some of this perceived risk.
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MEN’S HEALTH SCREENING PROGRAM: EBOLA VIRUS 
DISEASE (EVD) SURVIVOR SEMEN TESTING PRELIMINARY 
FINDINGS — LIBERIA, 2015-2016
Lawrence J. Purpura1, Moses Soka2, Mary Choi1, April Baller3, 
Stephen White4, Emerson Rogers2, Nuha Mahmoud3, Christine 
Wasunna4, Moses Massaqoui2, Neetu Abad1, Jomah Kollie3, 
Straker Dweh4, Phillip Bemah2, Athalia Christie1, Victor Ladele3, 
Onyekachi Subah4, Satish Pillai1, Margaret Mugisha3, Jonathan 
Kpaka4, Emilio German1, Mark Stenger1, Stuart Nichol1, Ute 
Stroeher1, Kristin VanderEnde1, Shauna Mettee-Zarecki1, Hugh 
Green1, Jeff A. Bailey4, Pierre Rollin1, Marston Barbara1, Tolbert 
Nyenswah2, Alex Gasasira3, Barbara Knust1, Desmond Williams1
1Centers for Disease Control and Prevention, Atlanta, GA, United States, 
2Ministry of Health, Monrovia, Liberia, 3World Health Organization, 
Geneva, Switzerland, 4ACCEL, Monrovia, Liberia
Ebola virus (EBOV) RNA has been detected in semen of EVD survivors > 
9 months after disease onset. However, information regarding duration 
and risk factors for sustained viral persistence in semen is limited. 
Liberia’s Men’s Health Screening Program, created to prevent EBOV 
sexual transmission, offers counseling and semen testing for EBOV RNA 
by RT-PCR. Males ≥15 years of age with proof of EVD survivorship (e.g., 
discharge certificate from an Ebola Treatment Unit) were enrolled in a 
study launched in July 2015. Participants are provided semen testing for 
EBOV RNA by RT-PCR; counseling on safe sexual practices; condoms with 
instructions on use; and referrals for healthcare services as needed or 
requested. In accordance with WHO guidelines, participants are eligible 
to graduate from the program after receiving two consecutive RT-PCR 
negative semen tests; with samples collected at least 2 weeks apart. As 
of February 2016, RT-PCR results were available for 307 participants. In 
total, 35 (11%) participants had at least one RT-PCR positive semen test. 
Of these, 21 (7%) participants were ≥ 12 months from ETU discharge at 
the time the RT-PCR positive semen sample was collected. The longest 
time after ETU discharge to collection of a semen sample that tested 
positive for EBOV RNA was 523 days. The median age of participants who 
had a RT-PCR positive test at program enrollment was significantly older 
than those who never had a RT-PCR positive test (p=.0031). Excluding 
participants who enrolled within 90 days from ETU discharge, men aged 
≥35 years were more likely to have at least one semen sample test RT-PCR 
positive compared to men aged <35 years (p=.0024). Frequency of sexual 
intercourse was not associated with age (p=0.2208). We found persistence 
of EBOV RNA in semen up to 523 days from ETU discharge, far exceeding 
previous reports. Sustained viral RNA persistence in semen appears to 
be associated with older age, an association not previously reported. As 
frequency of sexual intercourse was not associated with age, differences in 
viral RNA persistence may be related to other age-related factors such as 
changes in semen composition or immune function.
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HEPATITIS E INFECTION IN ARGENTINA, FROM 
IMMUNOCOMPETENT TO IMMUNOCOMPROMISED
Jose Daniel Debes1, Maribel Martinez Wassaf2, Maria Belen 
Pisano3, Leonardo G. Marianelli4, Martin Lotto3, Hernan Coseano5, 
Domingo Balderramo5, Viviana Re3
1University of Minnesota, Minneapolis, MN, United States, 2LACE 
laboratorios, Cordoba, Argentina, 3Instituto de Virologia, “Dr. JM Vanella”, 
Universidad Nacional de Cordoba, Cordoba, Argentina, 4Hospital Rawson, 
Cordoba, Argentina, 5Hospital Privado, Cordoba, Argentina
Hepatitis E virus (HEV) is an RNA virus that can cause hepatitis in an 
epidemic fashion. In immunocompetent individuals, infection with HEV 
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usually leads to silent seroconversion or to acute self-limited disease. 
In immunosuppressed individuals, HEV can develop into a chronic 
infection. Information about prevalence of HEV in immunocopromised 
subjects outside of Europe or North America is scarce. In this study 
we addressed the seroprevalence of HEV in immunocompetent and 
immunocompromised subjects in Argentina and associated risk factors. We 
performed third generation enzyme immunoassay for determination of IgG 
and IgM specific antibodies against HEV in 204 subjects infected with HIV, 
81 subjects on hemodialysis (HD) and 58 solid-organ transplant recipients. 
HEV PCR was performed in all samples. Subjects on HD and transplant 
recipients were evaluated regarding social habits and potential risk 
factors. Results were compared to 433 HIV-negative, immunocompetent 
controls from our center. In our entire HIV-positive group we found 15 of 
204 samples to be positive for HEV IgG (7.3%), compared to 19 of 433 
samples (4.4%) in the control group. Interestingly, we found significantly 
lower CD4 counts on HEV-positive samples compared to HEV-negative 
samples (average CD4 count of 234 vs 422 mm3, p=0.01) indicating that 
patients with lower CD4 counts were more likely to be HEV IgG positive. 
Eight out of 81 subjects (9.8%) on HD and 5 of 58 (8.6%) of transplant 
recipients were positive for HEV IgG. Half of HEV seropositive patients in 
the HD group had positive IgM for HEV. There was no association between 
HEV serostatus and consumption of pork, alcohol, potable water or 
history of blood transfusion. There was a weak, but significant, association 
between fish consumption and HEV positivity. Only 1 sample showed a 
positive PCR for HEV, within the HIV group. In conclusion, our study found 
an increased seroprevalence of HEV IgG in subjects infected with HIV, on 
HD and solid-organ transplant recipients in Argentina. However, the only 
significant difference compared to controls was on HIV-infected patients 
with low CD4 counts.
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CHARACTERISTICS AND OUTCOMES OF PEDIATRIC 
PATIENTS WITH EBOLA VIRUS DISEASE (EVD) ADMITTED 
TO TREATMENT UNITS IN LIBERIA AND SIERRA LEONE: A 
RETROSPECTIVE COHORT STUDY
Michael Smit, Ian Michelow, Justin Glavis-Bloom, Adam Levine
Warren Alpert Medical School of Brown University, Providence, RI, United 
States
This retrospective cohort study describes the clinical characteristics 
and outcomes of children <18 years with PCR-confirmed EVD among 
patients evaluated for suspected EVD in West Africa. Demographic, 
epidemiological and clinical data were collected systematically from 
patients with documented EVD admitted to five Ebola Treatment Units 
(ETU) in Liberia and Sierra Leone during 2014/2015. Standardized care 
was provided to all patients based on International Medical Corps 
protocols. The pediatric cohort was described in aggregate and stratified 
by age group. We analyzed associations between mortality and patient 
characteristics. Among the 128 pediatric cases admitted, 122 had PCR-
confirmed EVD. Incidence in females (56%) and males (44%) was similar. 
The overall mortality rate was 57%. Stratified by age, mortality was 89% 
for <5 years, 43% for 5-9 years, 41% for 10-14 years, and 25% for 14-
17 years (p<0.001). Mortality for children aged <5 years was significantly 
higher than children 5-17 years old (89% vs 38%, p<0.001). At triage, 
prominent features included fever (79%), anorexia (68%), and weakness 
(64%). Throughout the duration of illness, the most frequent features 
were weakness (92%), fever (85%), anorexia and diarrhea (both 80%). 
Of those presenting without fever (n=26), 73% developed fever after 
triage. Of those patients without fever throughout hospitalization, 3 of 
6 (50%) died. Hemorrhagic features were present in 5% at triage and 
45% anytime during admission. The mortality of patients that developed 
bleeding at any time during admission was significantly higher (58% vs 
27%, p=0.002). The median length of stay was 9 days (range 1-31 days). 
Length of stay was significantly higher for those that survived compared 
to those that died (16 vs 6 days, p=0.001). In summary, pediatric EVD 
patients aged <5 years had significantly higher mortality. One out of 
every five children presented without fever. Prominent features of EVD in 
children included constitutional and gastrointestinal signs and symptoms. 
Hemorrhagic features developed in less than half of pediatric patients, but 
were associated with significantly higher mortality.
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SALIVA FOR DETECTION OF ANTIBODIES FOR MEASLES, 
MUMPS AND RUBELLA TO CONFIRM VACCINE STATUS IN 
TEENAGERS
Barbara F. Sampaio, Jaqueline Polizeli Rodrigues, Heitor Franco 
de Andrade, Jr.
Institute of Tropical Medicine Sao Paulo, Sao Paulo, Brazil
Vaccines had resulted in the fall of prevalence of several childhood 
viral infections in the past decades, also affecting boosting exposure to 
environmental viruses. Previous concepts of lifelong immunity induced 
by live virus vaccine have been abandoned due to several outbreaks 
occurring in vaccinated young adults, obliging revaccination specially for 
preventing congenital rubella. Serology has been considered the main 
approach to measure individual protection but demands low adherence 
blood collection. Saliva could be an alternative for the detection of 
Toxoplasma gondii specific antibodies, due to IgG exuded from crevicular 
liquid. Saliva collection is noninvasive, simple and inexpensive, with high 
adherence for children and other protected groups. In this work, we 
show the development of ELISA for detection of specific IgG against 
measles, mumps and rubella virus, using a protein A IgG capture and 
biotinylated recombinant antigens as probes. Anti T.gondii IgG detection 
was used as control. Samples were collected in public high schools, 
during an exposition of transmissible diseases, with voluntary collection 
after parental approval. Vaccination was identified by individual vaccine 
files. Negative samples were obtained from discarded sera from Pediatric 
Center Lab, from children below vaccine age. All samples were tested on 
384 wells plates, adsorbed with Protein A (10mg/ml), reacted with saliva 
IgG 10 x concentrated by clearing and ethanol precipitation. Commercial 
recombinant antigens from measles, mumps, rubella and T. gondii 
extracts were biotinylated and allowed to react to bound IgG, followed 
by avidin peroxidase and TMB reaction. All the assays were efficient for 
distinction of reactive sera, without false negative or false positive results 
as compared to unvaccinated young children sera. These tests could be 
easily transformed in high throughput assays, allowing the determination 
of individual vaccine status with consequent preventive measure as 
revaccination. Saliva IgG will enable vaccine control without the need for 
blood collection.
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PRESENTING SYMPTOMS AND CHARACTERISTICS OF 
PATIENTS WITH EBOLA AND MALARIA ADMITTED TO EBOLA 
TREATMENT CENTERS IN SIERRA LEONE
Matthew Waxman1, Adam Aluisio2, Adam Levine2
1Olive View-University of California Los Angeles Medical Center, Los 
Angeles, CA, United States, 2Warren Alpert Medical School of Brown 
University, Providence, RI, United States
Discriminating between Ebola Virus Disease (EVD) and malaria is difficult 
when clinical testing is not immediately available. This retrospective study 
describes characteristics of patients admitted to Ebola Treatment Units 
(ETU) in Sierra Leone during the recent epidemic in West Africa with 
variable states of EVD and malarial infections. Data was collected from 
three International Medical Corps ETUs in which all patients received 
standardized care including Artesunate combination treatment (ACT). 
The population was stratified by infection status as malaria negative/
EVD negative (m-/e-), malaria positive/EVD negative (m+/e-), malaria 
negative/EVD positive (m-/e+) and malaria positive/EVD positive (m+/e+). 
These groups were analyzed for inter-group variation in characteristics, 
symptomatology and outcomes. Among 1548 admitted patients, 753 
patients had diagnostic test results available for EVD and malaria. There 
were 431 (57.2%) m-/e-, 180 (23.9%) m+/e-, 108 (14.4%) m-/e+, 
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and 34 (4.5%) m+/e+ analyzed in the cohort. Patients diagnosed with 
malaria had significantly younger median ages at 23 and 20 years for the 
m+/e- and m+/e+ respectively versus 32 years among both the m-/e- and 
m-/e- groups (p<0.001). Females accounted for a larger proportion of EVD 
cases than males (42% m-/e-, 42% m+/e-, 65% m-/e+ and 68% m+/
e+; p<0.001). Patients were significantly more likely to have abdominal 
pain if they had malaria rather than EVD (49% m+/e-, 36% m-/e+; 
p=0.043). Presence of anorexia, diarrhea, bone pain, vomiting, cephalgia, 
dyspnea and abnormal bleeding were not significantly different between 
m-/e+ and m+/e- groups. Distinguishing between EBV and malaria 
before rapid diagnostic testing is available presents a difficult diagnostic 
challenge. Significant overlap exists in the clinical presentation of patients 
with variable EVD and malarial infection statuses. This may justify the 
continued use of ACT in an EBV epidemic. Better understanding of such 
characteristics among variably infected patients may enhance development 
of response protocols and care in future EVD epidemics.
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CHARACTERIZATION OF SEVERE FEVER WITH 
THROMBOCYTOPENIA SYNDROME VIRUSES (SFTSV) FROM 
PATIENTS IN KOREA, 2015
Won-Ja Lee, Sun-Whan Park, EunByeol Wang, WooYoung Choi
KNIH, Chungju, Republic of Korea
Introduction Severe fever with thrombocytopenia syndrome (SFTS) 
is emerging infectious disease characterized by acute febrile, 
thrombocytopenia and gastrointestinal symptoms. It is caused by SFTS 
virus (SFTSV), in the genus of Phlebovirus (family Bunyaviridae). Since 
the first reported case of SFTS in South Korea in 2013, we collected 
serum samples from hospitalized patients who experienced symptoms 
of SFTS. The major clinical symptoms and laboratory parameters of SFTS 
are fever, thrombocytopenia, leukopenia, and elevated serum hepatic 
enzymes, and SFTS patients usually die due to multiple organ failure. 
SFTSV was presumably transmitted by ticks, because it has been detected 
in Haemaphysalis longicornis ticks. Methods and Materials Total RNA 
extracted from serum was amplified with one-step reverse-transcriptase 
polymerase chain reaction (RT-PCR), designed to detect a portion of the 
viral N and Gc protein gene using specific primers for S or M segment. 
After analyzing aligned nucleotide sequences, we constructed the 
phylogenic tree based on partial S or M segment sequences. We tried 
to isolate viruses from patient by infection VeroE6 cells with the sera. 
Results We conducted RT-PCR with total RNA which is extracted from the 
patient sera. Among the 833 samples, seventy-nine samples are resulted 
in positive. The nucleotide sequences were assembled by the SeqMan 
program implemented in DNASTAR software (version 5.06; Madison, WI, 
USA) to determine the consensus sequences. Nucleotide sequence of the 
Korean strains showed 93 to 98 % homology to Chinese and Japanese 
strains. We also isolated 45 SFTSVs among the virus-detected 79 samples. 
Conclusion We examined the clinical specimen from the suspected case 
of SFTS in Korea. We detected 79 SFTSVs of 833 patient sera by RT-PCR, 
and isolated 45 viruses among them. Nucleotide sequences of positive 
samples were not only included in SFTSV by the phylogenic analysis but 
also formed the Korean strain group.
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EFFICACY AND SAFETY OF A LOW-COST, HEAT-STABLE 
ORAL ROTAVIRUS VACCINE AGAINST SEVERE ROTAVIRUS 
GASTROENTERITIS IN NIGER
Sheila Isanaka1, Ousmane Guindo2, Celine Langendorf1, Rebecca 
Grais1, ROSE Trial Study Team
1Epicentre, Paris, France, 2Epicentre, Maradi, Niger
Prevention of rotavirus disease through vaccination is a public health 
priority, and in 2009, the World Health Organization recommended 
rotavirus vaccination be introduced in all countries to reduce disease 
burden and mortality among young children. Two live oral attenuated 
rotavirus vaccines are globally licensed and WHO prequalified for the 
prevention of rotavirus gastroenteritis. Safety and efficacy of these 
vaccines has been established in high- and middle-income countries, 
but vaccination in sub-Saharan Africa, where there is the largest burden 
of rotavirus-related mortality, presents certain logistical and financial 
challenges. BRV-PV is a low-cost and heat-stable rotavirus vaccine 
manufactured by the Serum Institute of India, Limited whose introduction 
may help minimize the burden on already-strained national immunization 
programs throughout sub-Saharan Africa. We conducted a double-
blind, placebo-controlled randomized phase III event-driven trial in Niger 
to assess the efficacy and safety of BRV-PV against severe rotavirus 
gastroenteritis in infants in Niger. Infants were randomized in a 1:1 ratio 
to receive three doses of BRV-PRV or placebo at approximately 6, 10, and 
14 weeks of age. Facility and home-based surveillance is being conducted 
from 28 days post Dose 3 (gastroenteritis) and from the moment the 
first dose (serious adverse events) until 2 years of age. As an event-driven 
trial, the primary efficacy analysis was planned when 117 cases of severe 
rotavirus gastroenteritis are confirmed. Vaccine efficacy against severe 
rotavirus gastroenteritis and risk of serious adverse events, including 
hospitalization, intussusception and death will be presented. Evidence 
supporting the efficacy and safety of BRV-PV vaccine in an African setting 
would support the pre-qualification of and increased access to rotavirus 
vaccine across Africa.
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CROSS-REACTIVE ANTIBODIES INFLUENCE 
IMMUNOGENICITY OF LIVE ATTENUATED VACCINES
Kuan Rong Chan, Xiaohui Wang, Hwee Cheng Tan, Esther Gan, 
Darren Mok, Eng Eong Ooi
Duke-NUS Medical School, Singapore, Singapore
Epidemic viral diseases have become increasingly prevalent, as evidenced 
by the spread of ebola and zika. Among the different anti-viral strategies, 
vaccination, particularly with live attenuated vaccines (LAV), has seen 
exceptional success. However, due to previous exposure to pathogens 
and vaccines during the lifetime of an individual, many would have 
pre-existing cross-reactive antibodies that can potentially affect efficacy 
of live-attenuated vaccines (LAVs). To understand how cross-reactive 
antibodies affect LAVs, we designed a randomized trial design where 
subjects were subjected to Japanese encephalitis (JE) inactivated vaccine 
followed by the LAV yellow fever (YF) vaccine. We observed that YF 
vaccine immunogenicity is affected by the levels of cross-reactive JE 
antibodies. Transcriptional profiling of the patients highlighted that 
semaphorins and T-cell related cytokines were significantly correlated with 
YF immunogenicity. Further laboratory studies reveal that semaphorins 
that are expressed in Fc-receptor bearing antigen-presenting cells were 
directly upregulated by activating Fc-receptor signaling. That semaphorins 
have crucial roles in antigen presentation and T-cell responses suggest that 
cross-reactive antibodies can be exploited to improve LAV efficacy.
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VERTICAL TRANSMISSION OF CYTOMEGALOVIRUS IN A 
RURAL MOZAMBICAN HOSPITAL
Lola Madrid1, Rosauro Varo Cobos1, Antonio Sitoe2, Carmen 
Muñoz Almagro3, Enrique Calderón4, Quique Bassat1
1ISGlobal, Barcelona Ctr. Int. Health Res. (CRESIB), Hospital Clínic - 
Universitat de Barcelona, Barcelona, Spain, 2Centro de Investigação em 
Saúde de Manhiça (CISM), Maputo, Mozambique, 3Hospital Sant Joan de 
Deu - Universitat de Barcelona, Barcelona, Spain, 4Instituto de Biomedicina 
de Sevilla, Hospital Universitario Virgen del Rocío/CSIC/Universidad de 
Sevilla, Sevilla, Spain
Congenital cytomegalovirus (CMV) infection is the most prevalent 
congenital infection worldwide, varying the prevalence from 0.2% to 2%. 
This prevalence is higher in developing countries and among HIV infected 
newborns although it is decreasing among exposed but not infected 
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infants, following the increasing use of antiretroviral therapy for prevention 
of mother-to-child transmission (MTCT). We aimed to assess CMV vertical 
transmission prevalence and risk factors associated among newborns born 
in a rural Mozambican maternity. A cross sectional study was conducted 
on pregnant mothers attending Manhiça District Hospital at delivery. Blood 
cord samples in filter paper and placenta biopsy were collected for CMV 
detection measure by PCR. CMV seroprevalence and HIV status were 
also investigated in recruited pregnant women. One hundred and twenty 
mothers were recruited at delivery, mean age was 25,1 (±7,6) years and 
mean of gestational age at recruitment was 38,8 (±0,6) weeks. Prevalence 
of HIV infection among them was 27.5% (33/120) and only 28.3% were 
taking antiretroviral to prevent MTCT. One hundred and twenty three 
pregnancy outcomes were delivered. 5.8% (7/120) were premature, 1.7% 
(2/120) were stillbirths, 2.5% (3/120) born with malformations (2 with 
polydactyl and one with spine bifida) and 12.5% (15/20) had low birth 
weight. Data of three newborns were missing. CMV PCR was positive in 3 
of 116 cord samples collected (2.6%) and only one child was exposed but 
not infected to HIV. 100% of them born asymptomatic at birth and at 6 
months follow-up. Risk factors associated to vertical transmission of CMV 
were not found. We will present results of placental biopsies and maternal 
seroprevalence. Our results showed a higher prevalence of congenital 
CMV than studies in developed countries but lower than reports from 
low-income countries. Although it is an important cause of hearing loss 
completely neglected, it would be premature to consider newborn CMV 
screening in resource-poor settings because the disease burden from 
congenital CMV and the cost/benefit ratio of long term follow-up have not 
been defined.
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IDENTIFICATION AND FUNCTIONAL CHARACTERIZATION OF 
MATING-DELIVERED MALE SEMINAL FLUID PROTEINS IN THE 
MALARIA VECTOR AEDES
Enzo Mameli1, Sara N. Mitchell1, Evidoxia G. Kakani1, Gennifer 
E. Merrihew2, Rory D. Kirchner1, Michael J. MacCoss2, Flaminia 
Catteruccia1
1Harvard T.H. Chan School of Public Health, Boston, MA, United States, 
2University of Washington, Seattle, WA, United States
Anopheles gambiae mosquitoes are one of the primary vectors of 
human malaria, which represents a major public health burden globally. 
Reproductive success in these mosquitoes relies on a single mating, 
therefore characterizing their reproductive biology could offer a promising 
opportunity to interfere with their life cycle. An. gambiae male mosquitoes 
produce a complex cocktail of seminal fluids in their accessory glands 
(MAGs), including proteins (Acps), and lipids that are packed in a 
gelatinous mating plug and transferred to females during copulation. 
Female receipt of this plug induces large physiological and behavioral 
changes including refractoriness to further insemination, egg laying and 
activation of sperm storage mechanisms. We recently demonstrated that 
the steroid hormone 20-hydroxyecdysone (20E) in part mediates these 
change in females. However the identity and function of seminal fluid 
proteins in regulating the female post mating response remains largely 
unknown. We employed an in vivo stable isotope labeling technique 
coupled to mass spectrometry to identify male proteins transferred to 
females during mating. Female mosquitoes were labeled via feeding 
yeast containing stable isotope 15N, which masked the female proteome, 
allowing identification of male specific proteins. First, the proteomic 
composition of unlabeled male reproductive tissues (MAGs and testes) 
was determined, which facilitated the spatio-temporal localization of male 
proteins within 5 female tissues (atrium, spermatheca, ovaries, hemolymph 
and head) at three time points after mating (3h, 12h and 24h). Notably 
we detected a total of 180 unique male proteins transferred to females, 
including 45 novel Acps. Male proteins transferred to the spermatheca 
maybe essential in coordinating sperm viability, and strikingly a MAG 
specific protein of unknown function was detected at all time points after 
mating in this tissue, suggestive of a stable, long term association with 
sperm. Ongoing functional knock-out analysis of this and other candidates 
are revealing the fundamental role of male transferred proteins in female 
reproductive success.
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FBN30 IS A PATHOGEN RECOGNITION RECEPTOR AGAINST 
PLASMODIUM INFECTION IN ANOPHELES GAMBIAE
Guodong CF Niu
The University of Oklahoma, Norman, OK, United States
Malaria is a worldwide health problem that affects two thirds of the world 
population. Invasion of Plasmodium through anopheline mosquitoes 
is an obligatory step for malaria transmission. Through genome-wide 
association studies, we identified significant association between genetic 
variations in FBN30 and the P. falciparum parasite infection in Anopheles 
gambiae mosquito populations from malaria endemic areas in Kenya. 
FBN30 sequence analysis shows that the fibrinogen-like domain (FBG) 
at the C-terminal is conserved across a range of mosquito species. In 
this study, we hypothesize that FBN30 works as a pathogen recognition 
receptor (PRR) in the defense against Plasmodium infection. Firstly, we 
expressed FBN30 in insect High Five cells and studied its biochemical 
features. The results show that insect cell expressed FBN30 is a secreted 
protein which can form a dimer through disulfide bond between two 
subunits which indicate four disulfide-bond linked homodimers to form a 
tetramer by non-covalent bond. In addition, we determined the cysteines, 
which are involved in the intra-chain and inter-chain disulfide bridge 
respectively. Secondly, we evaluated the expression efficiency of two 
FBN30 variants (FBN30(C/C) and FBN30 (T/T)) in mosquito cells, Moss55 
and Sau5B. The results support that wild type mosquitoes in Kenya, 
with the genotype of FBN30(C/C), were more susceptible to Plasmodium 
infection than those with the genotype of FBN30 (T/T). The susceptibility 
is attributed to a lesser expression of FBN30 observed in mosquitoes with 
the non-synonymous mutation, which results in Phe10Leu in the signal 
peptide. Also we determined that FBN30 in An. gambiae only exists in 
hemolymph. Finally, ELISA and indirect immunofluorescence assay proved 
that FBN30 proteins bind to asexual and sexual stage of both P. berghei 
and wild type of P. falciparum. Based on all these data, we concluded that 
FBN30 is a PRR molecule in the mosquito innate immune system, which is 
critical for An. gambiae defense against Plasmodium infection.
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IDENTIFICATION OF GLYCOSAMINOGLYCANS IN ANOPHELES 
NEIVAI AND A. ALBIMANUS AND ITS ROLE IN MALARIA 
TRANSMISSION
Erika F. Garrido1, Raúl L. Rocha2, Juan D. Suaza3, Sebastian 
Bernal4, Joshuwa L. Shilo1, Sandra Uribe3
1Corporación Universitaria Remington - Grupo de Investigación en 
Ciencias Biomédicas - Facultad de Ciencias de la Salud, Medellin, 
Colombia, 2Corporación Universitaria Remington - Grupo de Investigación 
en Ciencias Biológicas - Facultad de Ciencias de la Salud, Medellin, 
Colombia, 3Universidad Nacional de Colombia - Grupo de Investigación 
en Sistemática Molecular - Facultad de Ciencias, Medellin, Colombia, 
4Universidad Nacional de Colombia - Grupo de Investigación en Ciencias 
de la Desición - Facultad de Minas, Medellin, Colombia
Despite the advances in research related to malaria it is accepted and 
clear that interventions to limit transmission by the vector are not enough, 
therefore the search for new strategies for malaria control is necessary. 
The sexual cycle of Plasmodium or sporogonic cycle occurs in mosquitoes 
of the genus Anopheles. It has been reported that malaria transmission is 
due to glycosaminoglycans (GAGs) which are present in the epithelium of 
the midgut and salivary glands of the mosquito and its interactions with 
lectins in the parasite, it is thought that the presence of such molecules 
is necessary to promote maturation from ookinete to oocysts. Although 
some GAGs such as chondroitin sulfate and heparan sulfate have been 
identified in experimental models of interaction between host-parasite, 
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the real participation of those GAGs in malaria transmission is unknown. 
Therefore An. albimanus and An. neivai from the department of Chocó-
Colombia has been taken as a natural model with the purpose of identify 
the GAGs present in its tissues and to establish its relationship in the 
transmission of malaria. Adult mosquitoes were collected and larvarian 
forms were cultured in the laboratory. All adult forms were used for 
identification by classical taxonomy and confirmed by BarCode technique. 
The midgut tissue of two sets of malaria vectors were obtained and 
were used for GAGs analysis by mass spectrometry. We will discuss 
about some subtle differences in the GAGs profiles between different 
species of Anopheles. This fact could explain the ability to permit or 
inhibit the Plasmodium parasites maturation and transmission by vectors. 
This knowledge will help to find out new strategies for blocking the 
transmission cycle.
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DISCOVERING THE BINDING PARTNER(S) OF MOSQUITO 
MIDGUT FREP1 IN PLASMODIUM PARASITES
Genwei Zhang, Guodong Niu, Jun Li
University of Oklahoma, Norman, OK, United States
We previously identified a mosquito midgut protein FREP1 in peritrophic 
matrix that can facilitate Plasmodium infection in Anopheles gambiae 
mosquitoes through binding to gametocytes and ookinetes. We proposed 
a FREP1-mediated parasites invasion model. This project aims to identify 
the parasite-expressed FREP1-binding partners (FBPs). Incubating insect 
cell-expressed recombinant FREP1 with P. berghei infected cell lysates 
pulled down several specific bands by anti-FREP1 antibodies. One of the 
bands was identified by mass spectrometry to be a 27 kDa, PEXEL motif-
containing protein. This protein also has a trans-membrane domain. Insect 
cell-expressed this candidate protein confirmed its interaction with FREP1. 
The FBPs discovered in this report will improve our understanding of the 
molecular mechanism of FREP1-mediated Plasmodium invasion pathway, 
which can be targeted by novel approaches for malaria control.
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NEW USES FOR AN OLD TECHNOLOGY TO CONTROL ZIKA 
VECTORS IN URBAN TROPICAL ENVIRONMENTS
James Cilek1, Jennifer Knapp1, Catherine Pruszynski2
1Navy Entomology Center of Excellence, Jacksonville, FL, United States, 
2Keys Mosquito Control District, Key West, FL, United States
The recent epidemic of Zika virus transmission in the Southern Hemisphere 
has brought heightened awareness for the control of its vector Aedes 
aegypti. Dumping, removing or treating every water-holding container, 
especially in large urban neighborhoods, maybe impractical. The dense 
clouds of insecticide produced by the “old” thermal fog technology 
may now be advantageous for penetrating cryptic habitats. Compatible 
aqueous mosquito adulticide formulations for use in thermal foggers 
are commercially available that replace the dense fog with a fine mist. 
Therefore, we speculated “Could currently available aqueous larvicide 
formulations be applied by a thermal fogger and remain efficacious in 
cryptic larval habitats for the control of Zika vectors?” We initiated semi-
field studies to determine penetration distance and associated Ae. aegypti 
larval mortality in a forest canopy (cryptic) environment using Bacillus 
thuringiensis var israelensis (Bti) (Vectobac WDG, AI 37.5%). Vectobac 
was applied at the maximum label rate with a hand held IGEBA TF 34 
thermal fogger (fitted with water conversion kit) to empty 0.5-L clear 
plastic containers placed at 7, 14, 21, and 28m from application source 
at Camp Blanding, FL. Treated containers were returned to the laboratory 
where dechlorinated water and late second to early third instar Ae. aegypti 
were added to each container. The greatest amount of mortality (91-
100%) occurred at 7m. We then operationally applied the Bti product, 
at maximum label rate, to a 0.2 ha urban tropical urban environment 
located in Key West, FL using the same larval evaluation bioassays 
above. Containers were placed randomly in cryptic areas within the area. 
Vectobac provided 99.9% larval mortality at 24h and 100% at 48h. 
Operationally, we found that thermal fog technology can be an effective 
tool for control of larval Ae. aegypti in cryptic tropical urban environments.
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INFLUENCE OF BLOOD MEAL ON SUSCEPTIBILITY TO 
PYRETHROIDS IN ANOPHELES GAMBIAE FROM WESTERN 
KENYA
Maxwell M. Gesuge1, Maxwell M. Gesuge2, Erick Ochomo1, 
David G. Sang2, Mariangela Bonizzoni3, Andrew Githeko1, Guiyun 
Yan3, Yaw A. Afrane1, Yaw A. Afrane4
1Climate and Human Health Research Unit, Centre for Global Health 
Research, Kenya Medical Research Institute, Kisumu, Kenya, 2School of 
Public Health and Community Development, Maseno University, Kisumu, 
Kenya, 3Program in Public Health, College of Health Sciences, University 
of California Irvine, Irvine, CA, United States, 4Department of Medical 
Microbiology, College of Health Sciences, University of Ghana, Accra, 
Ghana
Vector control is based on the use of insecticides. To ensure sustainable 
vector control we need to understand the other factors driving insecticide 
resistance and consequently threatening the sustainability of malaria vector 
control programs targeting the indoor resting mosquitoes. The aim of this 
study was to determine the influence of blood meal status on pyrethroid 
tolerance in field collected population of Anopheles gambiae from western 
Kenya. Field-collected mosquito larvae were reared to adulthood alongside 
the laboratory susceptible reference Kisumu strain. Female adults from 
the two populations were monitored for deltamethrin resistance using 
WHO bioassays at different gonotrophic stages. Metabolic assays were 
then performed to assay the level of detoxification enzymes. The WHO 
bioassay results showed increased resistance on younger female’s (2-5 
days old) field collected population with different gonotrophic status 
(mortality ranged from 36-83%). Older females (14-15 days) from the 
same population with different gonotrophic status showed reduced 
resistance to the same insecticide (85-98%). Biochemical estimations on 
younger females (2-5 days old) revealed significantly (P<0.05) higher levels 
of oxidase, non-specific esterase and glutathione-s-transferases activity 
in the blood fed and half gravid survivors of An. gambiae as compared 
to unfed survived individuals. For older females (14-15 days) of the same 
population, blood fed and half gravid survivors showed significantly 
higher oxidase and glutathione-s-transferases activity as compare to 
unfed and gravid survivors. Kisumu susceptible population showed 100% 
susceptibility with no significant elevation in enzyme activities following 
a blood meal. These results indicate that blood feeding status plays an 
important role in the toxicity of deltamethrin due to some physiological 
changes following feeding that confers increased tolerance to mosquitos.
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NEW MATRIX-RELEASE FORMULATION, SUMILARV®2MR 
CONTAINING PYRIPROXYFEN FOR LONG LASTING CONTROL 
OF AEDES AEGYPTI LARVAE
Kazunori Ohashi1, Yousif E. Himeidan2, Minoru Takano1, Issaku 
Nakatani3, Toshimasa Nishiyama3, John F. Invest4, John R. Lucas4, 
Yoshinori Shono5
1Sumitomo Chemical Co. Ltd., Takarazuka, Japan, 2African Technical 
Research Centre, Vector Health International, Arusha, United Republic 
of Tanzania, 3Department of Public Health, Kansai Medical University, 
Osaka, Japan, 4Environmental Health Division, Sumitomo Chemical, UK, 
Plc, London, United Kingdom, 5Environmental Health Division, Sumitomo 
Chemical Co. Ltd., Tokyo, Japan
Aedes aegypti is a vector of human viral diseases, such as dengue, 
Zika, chikungunya, and yellow fever. Indoor and outdoor water storage 
containers are the main breeding habitats for this species in Southeast 
Asia, Central and South America, and also in some savannah areas of 
Africa. A new long lasting “matrix-release” formulation, SumiLarv®2MR, 
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containing 2% pyriproxyfen has been developed to control container-
breeding Ae. aegypti. Pyriproxyfen is an insect growth regulator with 
a very low mammalian toxicity that inhibits the emergence of adult 
mosquitoes. Pyriproxyfen is recommended for use in drinking water by 
the World Health Organization (WHO). The key feature of SumiLarv®2MR 
is the controlled slow release of pyriproxyfen so that an effective 
concentration of active ingredient is maintained in treated water for at 
least six months after treatment. A simulated-field evaluation using plastic 
vessels containing 40 L water showed that the efficacy of SumiLarv®2MR 
lasted for at least 36 weeks, irrespective of the frequency of water 
replacement (half or full water replacement every week). A field trial 
conducted over a year in a rural village in Lao PDR where Ae. aegypti 
breeds throughout the year, with SumiLarv®2MR applied every 6 months 
to domestic water storage containers, resulted in a significant reduction in 
larval density. The long-lasting efficacy of SumiLarv®2MR demonstrated in 
these trials will reduce the number of treatments required per year and will 
therefore enable significant reductions in operational costs. These results 
are promising for the future long term control of Ae. aegypti and the 
diseases that this insect transmits. SumiLarv® is a registered trademark of 
Sumitomo Chemical Company Ltd.
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INHIBITION OF ADULT EMERGENCE OF AEDES AEGYPTI 
USING A CONTROLLED RELEASE FORMULATION OF 
PYRIPROXYFEN (SUMILARV® 2MR) OVER SIX MONTHS IN 
CAMBODIA: A CLUSTER RANDOMIZED TRIAL
Dyna Doum1, John Hustedt1, Vanney Keo1, Sokha Ly2, BunLeng 
Sam2, Vibol Chan3, Neal Alexander4, John Bradley4, Didot B. 
Prasetyo5, Agus Rachmat5, Sergio Lopes1, Muhammad Shafique6, 
Rithea Leang2, Jeffrey Hii6
1Malaria Consortium, Phnom Penh, Cambodia, 2Cambodian National 
Dengue Control Program, Phnom Penh, Cambodia, 3World Health 
Organization, Phnom Penh, Cambodia, 4London School of Hygiene & 
Tropical Medicine, London, United Kingdom, 5U.S. Naval Medical Research 
Unit-2, Phnom Penh, Cambodia, 6Malaria Consortium, Bangkok, Thailand
Dengue is one of the most rapidly spreading mosquito-borne viral 
diseases in the world, and without a cure or widely available effective 
vaccine the best measures to control dengue are through vector control 
and the avoidance of mosquito bites. Pyriproxyfen (PPF) is a juvenile 
hormone analogue that interferes with the metamorphosis of juvenile 
mosquitoes and due to its favorable mammalian toxicity profile is ideal 
for use in vector control activities. A new slow-release PPF matrix release 
formulation (Sumilarv® 2MR) was developed and is recommended for six 
months (considerably longer than alternatives which reduces operational 
costs). While small scale field studies have been conducted, this is the first 
large scale field evaluation, where site-specific processes may modify the 
duration of residual effects relative to controlled experiments. Such large 
scale field trials therefore measure effectiveness, rather than efficacy, and 
are of strategic importance to control programs. A cluster randomized, 
controlled superiority trial was developed to assess the effectiveness of 
Sumilarv® 2MR. The trial based in Kampong Cham, Cambodia includes 
96 sentinel containers from 20 clusters and runs from November 2015 
to May 2016. The clusters were randomly assigned to an intervention 
or control arm. Within randomly selected households the small water 
jars most commonly used were selected as sentinel containers. Due to 
the large amount of water replacement the results likely indicate the 
lowest inhibition values in the household. The primary outcome was the 
percentage inhibition of emergence in monthly 250 mL water samples. 
Each lab assay was conducted with 25 lab reared third instar larvae. 
The beakers were monitored for larvae and pupal mortality and adult 
emergence once daily for eleven consecutive days or until the last adults 
emerged or all remaining pupae died. The amount of water replacement 
in water jars was also recorded to adjust the IE results from sentinel 
containers. The results can be used by the control programs to assess 
the long term efficacy and cost effectiveness of Sumilarv® 2MR under 
operational conditions.
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STUDIES ON KNOCKDOWN RESISTANCE (KDR) MUTATIONS 
IN AEDES AEGYPTI AND AEDES ALBOPICTUS IN INDIA
Raja Babu Singh Kushwah1, Taranjeet Kaur2, Prashant Kumar 
Mallick2, Tridibes Adak2, Neera Kapoor3, Om Prakash Singh2
1International Centre for Genetic Engineering and Biotechnology, New 
Delhi, India, 2National Institute of Malaria Research, New Delhi, India, 
3Indira Gandhi National Open University, New Delhi, India
Knockdown resistance (kdr) is one of the mechanisms of insecticide 
resistance in insects caused by the reduced target site sensitivity i.e. 
voltage gated sodium channel (VGSC) rendering it less sensitive to 
DDT and pyrethroids. We evaluated insecticide susceptibility and its 
underlying kdr mechanism in eight Aedes aegypti and five Ae. albopictus 
field populations from India. Field population were collected from four 
different geographical regions of India viz. North, South, East and Central 
covering 18 districts of ten states. Adult bioassays revealed varying levels 
of resistance to DDT, permethrin and deltamethrin in all Ae. aegypti 
populations and susceptibility to pyrethroids in Ae. albopictus populations 
tested. Molecular screening for common kdr mutations, revealed the 
presence of five mutations viz. S989P, V1016G, T1520I, F1534C/L. 
Three PCR based assays; DNA sequencing, ASPCR, PCR-RFLP were used 
for genotyping of twelve global kdr alleles. Two novel mutations were 
observed, first at T1520 (ACC) residue where a C>T substitution at the 
second position of codon results in amino acid change to Isoleucine (ATC). 
Second mutation was an alternative point mutation at F1534 (TTC) residue 
where a substitution of T>C at the first position of codon results in an 
amino acid change to Leucine (CTC). No kdr mutation was observed in 
any field population of Ae. albopictus. ASPCRs were not accurate so three 
PCR-RFLP assays were developed. Representative samples of all genotypes 
were sequenced to validate the newly developed PCR based assays for Ae. 
aegypti. DNA sequencing data were in agreement with the genotyping 
results. Genotyping results showed that 989P is linked to 1016G and 
novel mutation 1520I was always found with 1534C allele. Present study 
confirmed the presence of DDT and pyrethroid resistance among Ae. 
aegypti populations in India and for the first time reported kdr mutations 
in this species from India including two novel mutations. Results of present 
study lead us to infer that, at least five kdr mutations (S989P, V1016G, 
T1530I, F1534C and F1534L) can be seen as a potential marker for DDT/
pyrethroid resistance.
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EVALUATING THE POTENTIAL OF REUSING LARVAL REARING 
WATER IN SUPPORT FOR THE STERILE INSECT TECHNIQUE 
(SIT) OR OTHER MASS PRODUCTION PROGRAM: EFFECT ON 
DEVELOPMENT AND QUALITY OF ANOPHELES ARABIENSIS 
MOSQUITOES
Wadaka Mamai
Insect Pest Control Laboratory, Joint FAO/IAEA Division of Nuclear 
Techniques in Food and Agriculture, Vienna, Austria
The success of a mosquito mass rearing operation for sterile insect 
technique (SIT) or other release application relies on a reliable supply of 
water of sufficient quality for optimal larval development. An estimated 
250 litres of water is required to raise 200,000 eggs in one larval rearing 
rack. Yet, many arid and/or seasonally arid countries face the difficulties of 
acute water shortage, deterioration of water quality, and environmental 
constraints. The reuse of water to rear successive generations of larvae 
is attractive as a way to reduce water usage and running costs, and help 
to make this control method viable. Therefore, we have initiated work at 
the IPCL to assess whether dirty water is a suitable rearing medium that 
could replace the clean dechlorinated water that is currently routinely 
used. Results indicated that reusing dirty water or using a 50:50 mix of 
clean and dirty water did not affect egg hatching. Moreover, no difference 
was found in time to pupation, larval mortality or sex ratio when first-
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instar larvae were added to clean water, dirty water, or a 75:25, 50:50 or 
25:75 mix of clean and dirty water and reared until emergence. When 
late-instar larvae were put back into their own rearing water, there 
was no effect on pupation rate, emergence rate or female longevity, 
though male longevity was reduced. When reared from first-instar larvae, 
however, dirty water decreased pupation rate, emergence rate, body size, 
and adult longevity. However no response variable differed significantly 
between recycled water (reverse osmosis and ultrafiltration) and clean 
water. This suggests that recycling dirty water necessarily restore overall 
performance or mosquito quality. Re-used larval-rearing water has no 
impact on egg hatching, development time or mortality of the immature 
stages of Anopheles arabiensis. However, dirty water is not suitable for 
the production of high quality adult mosquitoes. Recycling processes 
improve water quality and increase insect quality. These findings may have 
important implications for the implementation of the SIT in areas where 
clean water is a scarce or costly resource.
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DISTRIBUTION AND FREQUENCY OF INSECTICIDE 
RESISTANCE IN ANOPHELES GAMBIAE S.L. POPULATION IN 
LIBERIA
Ibrahima Baber1, Chrispin Williams2, George Gweh2, Agnes 
Nador2, George Dehnue2, James Lama2, Paye Konah Nyansaiye2, 
Oliver Pratt2, Ramlat Jose3, Christie Reed4, Aklilu Seyoum5, Christen 
Fornadel6
1PMI Africa Indoor Residual Spraying (AIRS) Project, Abt Associates, 
Monrovia, Liberia, 2National Malaria Control Program, Monrovia, 
Liberia, 3U.S. President’s Malaria Initiative, U.S. Agency for International 
Development, Monrovia, Liberia, 4U.S. President’s Malaria Initiative, 
Centers for Disease Control and Prevention, Monrovia, Liberia, 5PMI Africa 
Indoor Residual Spray (AIRS) Project, Abt Associates, Accra, Ghana, 6U.S. 
President’s Malaria Initiative, U.S. Agency for International Development, 
Washington, DC, United States
Liberia’s malaria vector control program relies on insecticide-based 
interventions and may be compromised by the emergence, intensity, and 
spread of insecticide resistance among malaria vectors in the country. 
The distribution and frequency of Anopheles gambiae s.l. resistance to 
five insecticides were examined in six counties from June to December 
2015. Three of the six counties included in this survey (Bong, Grand Bassa, 
Margibi) conducted indoor residual spraying (IRS) from 2009 to 2013, 
while in the other three counties (Nimba, Gbarpolu, Grand Gedeh), IRS 
was not done. Non-blood-fed, 3 to 5-day old, female mosquitoes reared 
from field-collected larvae were exposed to WHO insecticide impregnated 
and control papers. Four classes of insecticides were tested against An. 
gambiae s.l.: pyrethroid (deltamethrin 0.05% and alpha-cypermethrin 
0.05%), carbamate (bendiocarb 0.1%), organophosphate (pirimiphos-
methyl 0.1%), and organochlorine (DDT 4%). About 100 female An. 
gambiae s.l. were tested. Mortality was recorded after the 24-hour 
holding period. An. gambaie s.l. populations from all six sites were fully 
susceptible to pirimiphos-methyl (100% mortality rate). Full susceptibility 
to bendiocarb was observed only in Grand Gedeh. Probable resistance to 
bendiocarb was detected in four sites (Bong, Nimba, Margibi, and Grand 
Bassa), with 97%, 94%, 97%, and 94% mortality rates, respectively, 
while resistance to bendiocarb was detected in Gbarpolu (89% mortality). 
Tested mosquitoes were resistant to deltamethrin (22%-73% mortality) 
and to alpha-cypermethrin (5%-47% mortality) in all sites. The 24-hour 
mortality for DDT tested in five of the six sites was 2%-49%. Comparison 
of susceptibility of An. gambiae s.l. populations between counties with 
and without IRS did not show a significant difference (p >0.05). Additional 
assays are needed over time to map the rest of Liberia and track insecticide 
resistance as interventions are scaled up.
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IMAGING AND QUANTITATIVE MICROANALYSIS OF 
PYRETHROID INSECTICIDES ON THE SURFACE AND 
INTERIOR REGIONS OF LLIN FIBERS USING TIME-OF-FLIGHT 
SECONDARY ION MASS SPECTROMETRY
Stephen C. Smith1, Chuanzhen Zhou2, Fred A. Stevie2
1Centers for Disease Control and Prevention, Atlanta, GA, United States, 
2North Carolina State University, Raleigh, NC, United States
Quantitative chemical mapping of permethrin and deltamethrin on the 
surface of and within polyethylene long-lasting insecticidal net (LLIN) fibers 
was carried out using time-of-flight secondary ion mass spectrometry 
(ToF-SIMS). This method uses a highly focused (0.3µm) Bi3+ primary beam 
to sputter the fiber surface, and ionic molecular fragments (secondary 
ions) from the top 1-2 monolayers of the fiber are extracted into a mass 
analyzer for chemical identification. By rastering the primary beam, 
a two-dimensional chemical map can be generated for a larger (e.g., 
500µm2) sampling area at submicron resolution. Subsurface regions were 
exposed for analysis by using a Cs+ beam to remove overlying material, 
thereby permitting three-dimensional mapping. Calibration standards for 
quantitative analysis were prepared by implanting known quantities of 
Cl- and Br- ions in polyethylene films and LLIN fibers. Limits of detection 
were determined to be 0.051 and 0.0088 weight percent for permethrin 
and deltamethrin, respectively. Both insecticides were observed as discrete 
deposits on fiber surfaces in as-received samples. The regeneration process 
was directly observed in samples that were washed and incubated, and 
the regenerated insecticide was more diffusely distributed on the surface 
than in the as-received samples. For permethrin-containing fibers, discrete 
high-concentration domains of insecticide were found within the fibers 
suggesting that they are supersaturated with insecticide at ambient 
temperatures. This method shows great potential for measuring the 
portion of bioavailable insecticide on LLIN fibers and directly observing the 
insecticide regeneration dynamics in “insecticide-incorporated” LLINs. It is 
also potentially applicable to the microanalysis of other active ingredients 
being considered for use in LLINs, such as piperonyl butoxide (PBO).
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ANOPHELES ALBIMANUS MICROBIOTA AND LINKS TO 
INSECTICIDE RESISTANCE: A SHOTGUN METAGENOMIC 
SEQUENCING APPROACH
Nsa Dada, Audrey Lenhart
United States Centers for Disease Control and Prevention, Atlanta, GA, 
United States
Understanding the factors that contribute to insecticide resistance is 
needed to mitigate its threat to vector control, particularly in Latin 
America, where vector control is being intensified as part of regional 
malaria elimination strategies. Next Generation sequencing has been 
applied to investigate the role of mosquito microbiota in various 
mosquito behaviors and functions. We report here for the first time 
the results of shotgun metagenomic DNA sequencing to characterize 
mosquito microbiota in relation to insecticide resistance phenotypes. 
Following evidence of a link between insecticide resistance and insecticide 
detoxifying endosymbionts such as Burkholderia sp. in stinkbugs, we 
hypothesized that the mosquito microbiota may contribute to insecticide 
resistance. Anopheles albimanus from northern Peru were sequenced 
using the Illumina MiSeq platform. Resulting data were quality checked 
using PRINSEQ and Trimmomatic quality control tools, and taxonomic 
composition analysis was performed using GOTTCHA, Kraken and 
MG-RAST. Similar to other mosquito species, our data showed that An. 
albimanus microbiota was dominated by a single taxon: Proteobacteria at 
the phylum level, and Enterobacter at the genus level. Up to 50 bacterial 
genera, including Burkholderia sp., constituted the remaining microbiota. 
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Our ongoing analyses will further identify the core microbiota and their 
functions in insecticide resistant and susceptible strains of An. albimanus 
from Peru, Guatemala, and Mexico.
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A CLUSTER RANDOMIZED TRIAL TO COMPARE BENDIOCARB 
AND DELTAMETHRIN FOR INDOOR RESIDUAL SPRAYING ON 
BIOKO ISLAND, EQUATORIAL GUINEA
John Bradley1, Dianna Hergott2, Guillermo Garcia1, Jo Lines1, 
Jackie Cook1, Michel Slotman3, Wonder Phiri2, Christopher 
Schwabe2, Immo Kleinschmidt1
1London School of Hygiene & Tropical Medicine, London, United Kingdom, 
2MCDI, Malabo, Equatorial Guinea, 3Texas A&M University, College Station, 
TX, United States
Indoor residual spraying (IRS) - spraying the interior walls of houses with 
insecticide - has been used on Bioko for malaria control since 2004. The 
insecticide bendiocarb was used biannually from 2005 until 2012; and 
during this period prevalence of malaria and under 5 mortality dropped 
substantially. To reduce costs, biannual IRS with bendiocarb was replaced 
by an annual round of IRS with a long lasting formulation of deltamethrin 
in 2013, based on reported susceptibility of local vectors to both 
insecticides. A marked increase in malaria prevalence in children 2 to 14 
years in the same year prompted a cluster randomised trial to be carried 
out to compare the effectiveness of bendiocarb and deltamethrin for IRS 
on Bioko and to investigate whether the rise in malaria prevalence was 
related to the change in insecticide. Twenty four clusters of houses were 
randomly allocated to receive IRS with either bendiocarb or deltamethrin 
in 2014. Approximately three months after the intervention, prevalence 
of malaria infection and levels of haemoglobin were measured in 
children aged 2 to 14 in each cluster. Prevalence of infection was lower 
in the bendiocarb arm (16.8%, 95% CI 11.1 - 24.7, N = 1374) than 
in the deltamethrin arm (23.2%, 95% CI 16.0 - 32.3, N = 1330) but 
this difference was not significant (p = 0.390), even after adjusting for 
confounders (p = 0.119). Mean haemoglobin was significantly higher in 
the bendiocarb clusters (11.6g/dl, 95% CI 11.5 - 11.8, N = 1326) than 
in the deltamethrin clusters (11.5g/dl, 95% CI 11.3 - 11.7, N = 1329), 
(p = 0.049 after adjusting for confounders). The results of this study are 
somewhat inconclusive by themselves, but they suggest that, on Bioko, 
bendiocarb may offer better protection against malaria infection than 
deltamethrin. Subsequent data on phenotypic and metabolic resistance 
to pyrethroids of local vectors would suggest that pyrethroid resistance 
renders deltamethrin IRS ineffective for malaria control on Bioko.
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INSECTICIDE SUSCEPTIBILITY LEVELS OF ANOPHELES 
GAMBIAE S.L MOSQUITOES IN AWKA, NIGERIA
Edith N. Nwankwo1, Patricia N. Okorie2, Chineme T. Acha1, Obed 
E. Okonkwo1
1Nnamdi Azikiwe University, Awka, Nigeria, 2Institute of Advance Medical 
Research and Training, College of Medicine, University of Ibadan, Ibadan, 
Nigeria
Long-lasting insecticide nets (LLINs) and indoor residual spraying (IRS) are 
the main methods used for malaria vector control. However the success 
of these methods has been hampered by the development and spread 
of insecticide resistance in major malaria vectors. The emergence of 
insecticide resistance in Anopheles mosquitoes in Nigeria has enormous 
implications for vector control in the country. This study was therefore 
carried out to investigate the susceptibility status of An. gambiae s.l 
mosquitoes to the four main classes of insecticides used for vector control 
in Amansea community, Awka North LGA, Anambra State, Southeast 
Nigeria. Larval mosquitoes were collected from different breeding sites 
and reared in the insectary. Mosquitoes were identified morphologically 
and two to five day old adult female mosquitoes were used to conduct 
WHO susceptibility assays. Susceptibility assays were carried out against 
pyrethroids (0.75% permethrin and 0.05% deltamethrin), organochlorine 
(4% DDT), organophosphate (0.25% pirimiphos-methyl) and carbamates 
(0.1% bendiocarb and 0.1% propoxur) insecticides. All mosquitoes 
collected were identified as members of the Anopheles gambiae s.l. 
Susceptibility assays showed that the mosquitoes were completely 
susceptible to bendiocarb (100% mortality). Percentage mortality recorded 
for the other insecticides were as follows: DDT (1.3%), pirimiphos-methyl 
(15.6%), permethrin (26.3%), deltamethrin (38.8%) and propoxur 
(87.5%) respectively. The KDT50 recorded were bendiocarb (36.7 minutes), 
propoxur (39.8 minutes), deltamethrin (50.9 minutes), permethrin (91.4 
minutes), Pirimiphos-Methyl (116.3 minutes) and DDT (119.1 minutes).
On the other hand, the KDT95 recorded were bendiocarb (52.3 minutes), 
propoxur (62.3 minutes), deltamethrin (85.6 minutes), permethrin (171.1 
minutes), Pirimiphos-Methyl (185.3 minutes) and DDT (170.1 minutes). 
The results show that there is very high frequency of insecticide resistance 
in the study area and calls for prompt implementation of resistance 
management practices in the area.
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THE EFFECT OF IVERMECTIN ON THE AMAZONIAN MALARIA 
VECTOR ANOPHELES DARLINGI: LC50 DETERMINATION
Karín S. Escobedo-Vargas1, Victor M. López-Sifuentes1, Salomon 
Durand1, Geral C. Baldeviano1, Robert V. Gerbasi1, Gissella M. 
Vásquez1, Kevin Kobylinski2
1U.S. Naval Medical Research Unit - 6, Callao 2, Peru, 2Armed Forces 
Research Institute of Medical Sciences, Bangkok, Thailand
Current malaria vector control measures target mainly endophagic 
Anopheles vectors; yet malaria transmission in South America is dominated 
by exophagic and exophilic vectors, indicating the need to evaluate 
novel control tools effective against such vectors. Ivermectin mass drug 
administration has been shown to be lethal to wild Anopheles in West 
Africa and has the potential to target exophagic and exophilic vectors. 
Although lethal to numerous Anopheles vectors, there is no information 
on the effects of ivermectin on South American vectors. Here, we 
evaluated the impact of ivermectin on the dominant Amazonian malaria 
vector, An. darlingi through in vitro experiments. We estimated the lethal 
concentration of ivermectin that kills 50% (LC50), 25% (LC25) and 5% (LC5) 
of mosquitoes in membrane feeding experiments. Varying concentrations 
of ivermectin were blood fed to 3-5 day old, laboratory-reared (F23-F29) 
An. darlingi mosquitoes; survivorship was monitored and recorded daily 
for 7 days post blood meal. Ten replicates with four to ten ivermectin 
concentrations per replicate, including a control, were tested across a 
range of 4 – 1000 ng/ml. The LC50, LC25, and LC5 of ivermectin fed to An. 
darlingi was calculated as LC50 = 36.4 ng/ml [29.7, 42.7], LC25 =20.7 ng/
ml [14.1, 26.1], and LC5 = 9.2 ng/ml [4.5, 13.7] (n = 4333, 10 replicates). 
These LC50 values demonstrate that An. darlingi is susceptible to ivermectin 
concentrations found in humans post oral drug administration. Future in 
vitro experiments will determine if ivermectin inhibits the ability of An. 
darlingi to re-feed as was demonstrated in An. gambiae previously, and 
investigate whether ivermectin inhibits the development of P. vivax in An. 
darlingi as has been shown with P. falciparum in An. gambiae and more 
recently with P. vivax in An. dirus. In vitro ivermectin mosquito-lethal 
effects against An. darlingi would suggest that ivermectin mass drug 
administration could be a novel, powerful malaria vector control tool in 
Peru and other Amazonian countries.
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USING STABLE ISOTOPES OF CARBON AND NITROGEN TO 
MARK WILD POPULATIONS OF ANOPHELES AND AEDES 
MOSQUITOES IN SOUTHEASTERN TANZANIA
Mercy Opiyo1, Gabriel L. Hamer2, Dickson W. Lwetoijera1, Silas 
Majambere3, Fredros O. Okumu1
1Ifakara Health Institute, Dar es Salaam, United Republic of Tanzania, 
2Texas A&M University, College Station, Texas, TX, United States, 
3Innovative Vector Control Consortium, Liverpool, United Kingdom
Marking wild mosquitoes is important for understanding their ecology, 
behaviours and role in disease transmission. Traditional insect marking 
techniques include using dyes, biological agents and tags but such 
techniques have various limitations like low marker retention and inability 
to mark wild mosquitoes at source. Stable isotopes are gaining wide 
spread use for non-invasive marking of arthropods, permitting greater 
understanding of mosquito dispersal and responses to interventions. We 
describe here a simple technique for marking naturally-breeding malaria 
and dengue vectors using stable isotopes of nitrogen (15N) and carbon 
(13C), and describe potential field applications. We created man-made 
aquatic mosquito habitats and added either 15N-labelled potassium nitrate 
or 13C-labelled glucose, leaving non-adulterated habitats as controls. We 
then allowed wild mosquitoes to lay eggs in these habitats and monitored 
their development in situ. Pupae were collected promptly as they appeared 
and kept in netting cages. Emergent adults (in pools of ~4 mosquitoes/
pool) and individually stored pupae were desiccated and analysed using 
Isotope Ratio Mass Spectrometry (IRMS).Anopheles gambiae s.l and Aedes 
spp. from enriched 13C and enriched 15N larval habitats had significantly 
higher isotopic levels than controls (P=0.005), and both isotopes produced 
sufficient distinction between marked and unmarked mosquitoes. 
Mean δ15N for enriched females and males were 275.64±65.12 and 
247.95±54.55, while mean δ15N in controls were 2.1±0.1 and 3.9±1.7 
respectively. Similarly, mean δ13C for enriched females and males were 
36.08±5.28 and 38.5±6.86, compared to -4.3±0.2 and -7.9±3.6 in 
controls respectively. In all cases, there were variations in standardized 
isotopic ratios between mosquito species. Enrichment of semi-natural 
mosquito larval habitats with stable isotopes of nitrogen and carbon 
resulted in effective marking of Anopheles and Aedes mosquitoes 
colonizing these habitats. This approach can significantly enhance studies 
on mosquito eco-physiology, dispersal, pathogen transmission and 
responses to control measures.
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THE ROLE OF IMMUNE PATHWAYS IN WOLBACHIA-
MEDIATED BLOCKING OF DENGUE VIRUS IN AEDES AEGYPTI
Gerard Terradas, D. Albert Joubert, Elizabeth A. McGraw
Monash University, Melbourne, Australia
The bacterial endosymbiont Wolbachia pipientis has been shown to 
protect its host against many pathogens, including dengue virus (DENV). 
DENV’s main vector, Aedes aegypti, is not a natural carrier of the 
bacterium but a stable transinfection was achieved some years ago using 
the Wolbachia strain wMel. Due to the protection conferred by Wolbachia, 
the symbiont is being developed as a means of vector control to reduce 
disease incidence long-term. Although, Wolbachia-induced priming of 
the immune system has been suggested as a mechanism conferring 
pathogen protection its role is poorly understood. Here we attempted to 
determine the individual contribution of several insect immune pathways 
to Wolbachia’s protective ability. Using RNAi techniques, knockdown of 
genes representing each of the five major insect immune pathways (TOLL, 
Imd, Autophagy, JAK/STAT and RNAi) was achieved in A. aegypti cells 
(+- wMel). Simultaneous knockdown of more than one gene was also 
performed to assess for multifactorial effects. Cells were challenged with 
a DENV-2 strain after the manipulation of host immune gene expression 
and DENV copy number was evaluated 5 days post-infection. We found 
that wMel based blocking was dependent on 2 of the pathways; JAK/
STAT and RNAi pathways. Both pathways are known to be involved in 
the antiviral response and are known to be manipulated by dengue virus 
infection. A weaker interaction was found between Wolbachia and the 
Toll and Autophagy, but not Imd pathways. Our results suggest that both 
the JAK/STAT and RNAi pathways are the main immune contributors to 
Wolbachia-mediated DENV blocking, since suppression of its effectors lead 
to a dramatic increase in the dengue virus titre.
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COMPARISON OF MORPHOLOGICAL AND MOLECULAR 
IDENTIFICATION OF OUTDOOR ANOPHELINE MOSQUITO 
SPECIES IN AN AREA TARGETED FOR ELIMINATION IN 
SOUTHERN ZAMBIA
Saidon Mbambara
Macha Research Trust, Choma, Zambia
Malaria was once a leading cause of morbidity and mortality in Macha, 
Choma District, Southern Zambia. However, in the past decade malaria 
incidence has declined and elimination strategies are now being rolled 
out. In conjunction with this decline, few numbers of the primary local 
malaria vector, Anopheles arabiensis caught indoors are still present in 
the vector population. Malaria cases are reported at health facilities with 
severe cases and deaths recently rising at Macha Hospital. To investigate 
the contribution that other anopheline species that forage outdoors 
make to malaria transmission, collections from homesteads within the 
catchment area of Macha Hospital were conducted. Standard morphology 
in conjunction with molecular tools were used for identification of 
mosquitoes caught between February 2015 and April 2015 from UV 
traps set outdoors next to animal enclosures. A total number of 1283 
mosquitoes were collected of which 650 (50.7%) were anophelines. 
Morphological identifications revealed seven different species. Following 
DNA extractions of the abdomen, PCR was employed which amplified 
the intergenic-spacer -2 region of the nuclear rDNA. Of the 640 
samples successfully analyzed, 11 different anopheline species were 
identified molecularly with the majority (53.8%) being An. squamosus. 
Morphological identification of specimens accurately identified 85% 
of An. squamosus, and 62% of the second been An. arabiensis. As 
malaria control targets and impacts the major malaria vectors in Zambia, 
surveillance of previously understudied species is important as they begin 
to constitute a larger proportion of potential vector collections. The 
use of molecular-based techniques for the identification of anopheline 
mosquitoes is vital to confirm identities, assign behaviors to particular 
species and accurately determine each species contribution to malaria 
transmission.
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IS ANOPHELES PALUDIS A VECTOR OF MALARIA IN THE 
DEMOCRATIC REPUBLIC OF CONGO?
Francis Wat’senga1, Emile Manzambi1, Oscar Lodi2, Tania 
Mampangulu1, Richard Oxborough3, Djenam Jacob4, Joris Likwela5, 
Filiberto Hernandez6, Seth Irish6
1Institut National de Recherche Biomedicale, Kinshasa, Democratic 
Republic of the Congo, 2Hopital de Lodja, Lodja, Democratic Republic of 
the Congo, 3Abt Associates, London, United Kingdom, 4Abt Associates, 
Washington, DC, United States, 5Programme National de Lutte contre 
le Paludisme, Kinshasa, Democratic Republic of the Congo, 6Centers for 
Disease Control and Prevention, Atlanta, GA, United States
Anopheles paludis was the most common Anopheles mosquito collected 
in human landing collections in Lodja, central DRC, during sentinel site 
collections in 2013 and 2014. Anopheles paludis had been previously 
collected in the neighboring province of Bandundu with sporozoite rates 
of 6%. To see if An. paludis was acting as a vector in Lodja, monthly 
human landing catches and pyrethrum spray catches were conducted 
over the course of 2015. Mosquitoes were identified to species and 
Anopheles mosquitoes were tested for presence of circumsporozoite 
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protein using ELISA. An. paludis was the most common I mosquito 
collected in 2015. An. gambiae s.l. and An. funestus were also collected. 
An. paludis displayed an early biting peak, with the highest numbers 
collected between 1900 and 2000h. None of 1366 An. paludis females 
tested positive for sporozoites. Despite high densities of anthropophilic 
An. paludis present in Lodja, it does not appear to be an important vector 
of malaria. Further work is needed to understand whether there are 
differences between An. paludis populations in Lodja and Bandundu.
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DOMINANT ROLE OF ANOPHELES FUNESTUS GILES, IN A 
RESIDUAL TRANSMISSION SETTING IN SOUTHEASTERN 
TANZANIA
Emanuel W. Kaindoa, Dickson W. Lwetoijera, Halfan S. Ngowo, 
Nancy S. Matowo, Arnold Mmbando, Alex J. Limwagu, Said 
Abbasi, Deogratius K. Roman, Gustav Mkandawile, Lina Finda, 
Doreen Siria, Fredros O. Okumu
Ifakara Health Institute, Environmental Health and Ecological Sciences 
Thematic Group, Morogoro, United Republic of Tanzania
Malaria is transmitted by more than one anopheline mosquito species, 
but the roles of these species vary in different epidemiological settings. 
We assessed the role of the two dominant Anopheles mosquito species 
in selected villages in Ulanga and Kilombero districts in south-eastern 
Tanzania. Monthly mosquito sampling was done in randomly selected 
households in three villages using CDC light traps, back pack aspirators 
and HLC between January -2015 and January-2016. Multiplex polymerase 
chain reaction (PCR) was used to identify members of the An. funestus 
group mosquitoes and An. gambiae s.l, to species level. Enzyme-linked 
immunosorbent assay (ELISA) was done to detect Plasmodium sporozoites 
in the mosquito salivary glands, and to identify sources of mosquito 
blood meals. The geographical distribution of infected An. funestus and 
An. arabiensis mosquitoes was determined by ArcGIS 10 (ESRI-USA) 
software. A total of 22,391 An. arabiensis and 4,802 An. funestus were 
collected. Among the An. funestus group mosquitoes, An. funestus s.s. 
predominated (76.6%), An. rivulorum (2.9%) and An. leesoni (7.1%) 
and unamplified samples (13.4%). About 86% of all infected mosquitoes 
were An. funestus s.s. while 14% were An. arabiensis. Overall, An. 
funestus group contributed to 93.4% and An. arabiensis contributed 
to 5.6% respectively of the annual EIR. In the An. funestus group, An. 
funestus s.s contributed to 96% of the transmission while An. rivulorum 
contributed 4%. Mosquito blood meal sources included: humans, 79.2%, 
bovine, 17.1%, dog, 2.4% and chicken, 1.2%. Infected An. funestus 
were distributed across the study area while infected An. arabiensis were 
confined to small part in the middle of study area. Though An. arabiensis 
are still the most prevalent of the vector species in the study area, ongoing 
residual malaria transmission could is predominantly mediated by An. 
funestus. The evidence from this study demonstrates that An. funestus 
have a significant role as the main driver of malaria transmission in these 
study villages. An. funestus could be responsible for resurging malaria 
transmission in communities where LLINs are widely distributed.
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COMPARATIVE FLAVIVIRUS SUSCEPTIBILITY AMONG AEDES 
AEGYPTI STRAINS UNDER LABORATORY AND SIMULATED 
FIELD CONDITIONS
David S. Kang1, Diane D. Lovin1, Joanne M. Cunningham1, 
Matthew W. Eng1, David D. Chadee2, David W. Severson1
1University of Notre Dame, South Bend, IN, United States, 2University of 
the West Indies, St. Augustine, Trinidad and Tobago
The mosquito Aedes aegypti is the primary global vector of dengue virus 
and Zika virus. Previous investigations have demonstrated variable levels of 
virus susceptibility, and subsequently vector competence, due to genetic 
variability between Aedes aegypti strains. However, previous studies 
uniformly employed optimal laboratory mosquito rearing conditions 
that do not reflect the effects of environmental variability encountered 
by larvae under natural conditions. Our previous studies have shown 
significant differences in body size between field vs laboratory reared 
individuals of the same genetic background. Here, we characterized 
and compared differences in susceptibility of three A. aegypti laboratory 
strains and a recent A. aegypti field isolate from Trinidad to dengue virus 
(DENV2 JAM1409) and two isolates of Zika virus (Zika CAM, Zika MAL) 
under both optimized laboratory regimes and conditions simulating 
realistic, nutrient deficient field habitats. We present dissemination rates 
of each mosquito strain to each virus as well as quantify viral load in 
female A. aegpyti mosquitoes 14 days post infection. The implications of 
gene by environment interaction, and the role of phenotypic plasticity are 
then further discussed in the contexts of capitalizing on increasing our 
knowledge on heritable differences in flavivirus susceptibility to better 
inform disease prevention programs.
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EVALUATING NEW TOOLS FOR MONITORING BRAZILIAN 
AND EAST AFRICAN MALARIA VECTORS
Elis P. Batista1, Alvaro E. Eiras1, Fredros O. Okumu2
1Universidade Federal de Minas Gerais, Belo Horizonte, Brazil, 2Ifakara 
Health Institute, Ifakara, United Republic of Tanzania
To sufficiently monitor ongoing malaria transmission and evaluate whether 
interventions are achieving desired effects, adequate mosquito surveillance 
methods are essential. It is important that such tools are applicable in 
several environments and different countries, rather than just in specific 
localities. This study aimed to assess the BG-Malaria trap (BGM), which 
has recently been demonstrated as effective against the Brazilian malaria 
vector, Anopheles dalingi, as a practical method for monitoring malaria 
vectors also in east Africa. We compared BGM with BG-Sentinel trap 
(BGS) and Human Landing Catches (HLC) for sampling African malaria 
mosquitoes, using a set of two separate 3 by 3 Latin square experiments 
replicated 4 times each. The field study was conducted in rural Ulanga 
district, in southeast Tanzania for 12 nights (06:00pm - 06:00am). 
Separately we evaluated 5 different mosquito lures, all using BGM and 
parity ratios were assessed for all traps and compared. We collected a 
total of 1003 Anopheles mosquitos, almost half of whichit were caught 
by BGM (49.7%). HLC and BGS caught 34.0% and 16.3% respectively, 
with a significant difference between the methods (P=<0,0001). The 
mean numbers of An. gambiae and An. funestus caught in the BGM per 
night were19.0 [CI: 17.45 - 20.96] and 3.5 [2.22 - 5.49]. HLC caught 11.7 
[CI: 10.09 - 13.58] and 1.3 [0.68 - 2.44] and BGS caught 6.0 [CI: 4.60 
- 6.76] and 1.2 [0.62 - 2.24] respectively. The others Anopheles species 
corresponded to 2% of total mosquitos caught. Data on the comparative 
evaluation of the lures, and also on parity status of the mosquitoes is 
being analysed and will be presented at the meeting. The BGM trap was 
considerably more effective than BGS, a trap widely used for monitoring 
vectors, and performed better as HLC as well, which is considered the 
“gold standard” method for catching mosquitos. The results described 
here for BGM are promising and hence could be used as a surveillance 
tool for malaria vectors. More tests are underway to validate the results in 
other sites in the district and will be presented at the meeting.
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EVALUATION OF A NOVEL POLYTETRAFLUOROETHYLENE 
(P.T.F.E) - BASED MEMBRANE FOR BLOOD-FEEDING MALARIA 
AND DENGUE FEVER VECTORS
Doreen J. Siria, Mercy Opiyo, Robert Sumaye, Fredros O. Okumu
Ifakara Health Institute, Ifakara, Morogoro, United Republic of Tanzania
Blood feeding of female mosquitoes is an essential activity for colonization 
and maintenance of mosquitoes which are often required for research 
on vector-borne diseases. Common laboratory blood feeding strategies 
for rearing mosquito colonies use direct host feeding (DHF) such as on 
human arms or on live animals. The aim of this study was to evaluate the 
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artificial way of blood-feeding mosquitoes which is simple, affordable, 
sustainable and efficient in comparison to existing method DHF. We 
adapted and validated an artificial feeding (AF) method to replace DHF 
for the maintenance of Aedes aegypti, Anopheles arabiensis and An. 
gambiae s.s mosquito colonies. This blood feeding system uses fresh 
bovine blood as blood meal source, stored in vacutainer tubes containing 
the anticoagulant, ethylenediaminetetraacetic acid (EDTA). The blood 
was placed at the bottom surface of the disposable styrofoam cups and a 
simple membrane made of polytetrafluoroethylene (P.T.F.E) was stretched 
thinly over the bottom surface of the cup for mosquitoes to access the 
membrane and were fed for 20 min. Blood feeding rate, fecundity and 
survival rates of mosquitoes fed using the AF were compared to those 
mosquitoes fed using direct human arm feeding.The preliminary results 
show that Ae. aegypti mosquitoes had similar feeding rates on AF and 
DHF of about 100%. However the feeding rates of An. arabiensis and 
An. gambiae s.s on DHF had the highest rates compared to membrane 
feeding. Artificial feeding rates on An. arabiensis and Anopheles gambiae 
were (40%, 47.5%) and (52%, 48.5%) for the first and second replicate 
respectively while DHF the feeding rate was about 99% in malaria vectors 
for both replicates. The results show that bovine blood meal source has 
impact on the feeding rates of malaria vectors the An. gambiae s.s and 
An. arabiensis in comparison to Ae. aegypti species. Data of fecundity and 
survival will be presented at the meeting.The procedure can be adopted 
by laboratories due to its simple and affordable materials and design and 
it could be used as an alternative to the direct feeding method in different 
biological studies and studies on parasite transmission by vectors.
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JAPANESE ENCEPHALITIS IN SIVASAGAR, ASSAM, INDIA, 
2011-2014
Takujungla Jamir1, B C Bhagabati2, Aakash Shrivastava1, Srinivas 
Venkatesh1
1National Centre for Disease Control, Delhi, India, 2State Surveillance Unit, 
Integrated Disease Surveillance Programme, Assam, Guwahati, India
Japanese encephalitis (JE) is a vaccine-preventable cause of acute 
encephalitis syndrome (AES) with high (20-30%) case fatality rate (CFR). 
India has a high JE global burden;however, 50% JE cases are in Assam 
state. We estimated JE burden by time, place, and person in Sivasagar 
district, a high burden district within Assam, from 2011-2014. We 
reviewed records and reports of all AES patients who attended three 
hospitals in Sivasagar from January 1, 2011 to December 31, 2014. We 
evaluated AES/JE by time, place, and person, including disease trends and 
patients’ vaccination status.In 2011-2014, Assam had 7,498 AES patients 
of which 647 (9%) were from Sivasagar (2011: 246; 2012: 140; 2013: 
133; and 2014: 128). All were tested for JE virus and 314 (49%) were 
positive (2011: 128, 52%; 2012: 58, 41%; 2013: 64, 48%; and 2014: 
64, 50%). During 2011-14, the majority of JE (291/314, 93%) and AES 
(313/333, 94%) patients were from rural areas and most JE patients were 
reported in July (65%). Median age of JE patients was 43 years (0.9-97 
years) and AES was 29 years (0.1-85 years). Among JE patients, males 
(62%) were more affected whereas among AES, gender proportions were 
similar (males: 51%). Among 647 patients, 54 AES (16%) and 29 JE (9%) 
patients were vaccinated against JE. The CFR of AES and JE were similar 
(AES:38%; JE:38%) in Sivasagar and were both higher than the Assam 
average (AES: 17%; JE: 23%). JE/AES in Sivasagar with a low vaccination 
coverage and high CFR calls for urgent public health attention especially 
for rural areas and older persons. Analysis of risk factors and prevention 
strategies is recommended.
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THE IMPACT OF SOCIODEMOGRAPHIC FACTORS ON AEDES 
ALBOPICTUS DISTRIBUTION AND ABUNDANCE IN ATLANTA, 
GEORGIA
Sarah Witter1, Joseph McMillan2, William Koval2, Gonzalo 
Vazquez-Prokopec2
1Rollins School of Public Health, Emory University, Atlanta, GA, United 
States, 2Department of Environmental Sciences, Emory University, Atlanta, 
GA, United States
Since its invasion to the continental United States in 1985, the Aedes 
albopictus mosquito has become a well-established nuisance mosquito. 
Breeding in both natural and artificial containers, the distribution of this 
mosquito may be strongly influenced by humans. Although considered 
a secondary vector of certain arboviruses, recent outbreaks have caused 
its vector status to be reevaluated. Determining the sociodemographic 
factors which affect the distribution of this mosquito throughout distinct 
geographical locations is paramount in limiting future establishments 
and preventing the transmission of pathogens. A total of 142 houses 
were sampled across three neighborhoods with varying house values in 
Georgia, USA between July and August 2015. Non-parametric tests were 
utilized to determine if differences existed between container type and 
the three neighborhoods. The importance of house value was assessed 
within neighborhoods using simple linear regression. Finally, negative 
binomial generalized linear models with and without random effects 
were created in order to identify significant predictors of Ae. albopictus 
and container abundance across the three neighborhoods. The median 
number of rubber containers differed significantly between the low house 
value neighborhood and the high and middle neighborhoods (p-value 
= <0.001 and p-value= <0.001, respectively). None of the simple linear 
regressions yielded significant results; however, clear associations were 
present. The Akaike weights from the model which best accounted for 
number of mosquito-positive containers was 35.3% and IV instar Ae. 
albopictus larvae was 41.5%. House value was determined to be either 
the best predictor or one of the best predictors in the chosen models. 
The non-parametric tests and simple linear regressions suggest that 
house value does impact breeding site abundance and Ae. albopictus 
distribution. The multivariate hierarchical models support the hypothesis 
that the distribution of Ae. albopictus larvae depends, at least in part, on 
sociodemographic factors.
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COMPARATIVE EVALUATION OF SIX OUTDOOR SAMPLING 
TRAPS FOR DISEASE- TRANSMITTING MOSQUITOES 
IN REFERENCE TO HUMAN LANDING CATCH IN RURAL 
TANZANIA
Alex J. Limwagu, Emmanuel Kaindoa, Nancy S. Matowo, Salum 
Mapua, Arnold Mmbando, Halfan Ngowo, Lina Finda, Fredros O. 
Okumu
Ifakara Health Institute, Morogoro, United Republic of Tanzania
There is a growing concern on how mosquito sampling methods can be 
safely performed in malaria endemic countries. Human landing catch is the 
best mosquito sampling method, it is labor intensive and exposes induvial 
to malaria transmission risks. This is an ongoing study which assesses 
the different mosquito sampling traps aiming to find an alternative for 
HLC in terms of effectiveness, densities, diversities and behaviors of 
disease- transmitting mosquitoes.Seven traps were introduced to sample 
mosquitoes. These were Mosquito Magnet (MMX), BG-Sentinel, Suna 
trap, Ifakara Tent Trap-C (ITT-C), M-Trap and M-Trap fitted with CDC 
Light trap. The traps were comparatively evaluated and calibrated with 
reference to the Human Landing Catch (HLC). A series of multiple 7*7 
latin square experiments were conducted in 6 different villages over a 
total of 12 months, working in dry and wet season in each of the villages, 
to comparatively evaluate 6 different trap types against human landing 
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catches, the current gold-standard sampling tool. Seven position identified 
to each of this villages with the distance of 100m from one trap to 
another. The different traps rotated to the seven positions, that at the end 
of a 7 day rotation, each trap type had been to each of the seven locations 
at least once. The experiment were replicated 3 times for a total of at least 
21 nights, start from 18:00hrs to 06:00hrs. The outcome measure will be 
the comparisons of effectiveness of different traps in terms of capturing 
high density and diversities of outdoor host seeking mosquitoes relatively 
to the reference method (HLC).A total of 62317 of all female mosquitos 
were collected for six villages for both seasons wet and dry, where BG-
Sentinel n=5571 (8.94%), HLC n=13909 (22.32%) ITT-C n= 3775 (6.06) 
MMX n= 4468(7.17%) M-Trap n= 8429 (13.52) M-Trap with CDC Light 
trap n=12011(19.27%) and Suna trap n=14003 (22.47%) The result is 
showing there is no significant different between HLC, Suna trap and 
M-trap fitted with CDC for all total number of female mosquitoes but 
there is a different between HLC, against M-trap, BG-Sentinel, MMX and 
ITT-C in the first round.
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CHARACTERIZATION OF SURFACE LAYER MICROBIAL 
COMMUNITIES OF ANOPHELES GAMBIAE COMPLEX LARVAL 
HABITATS IN BURKINA FASO
Marco Pombi1, Valentina Totino2, Bruno Fosso3, Monica 
Santamaria3, Francesca Guerrieri4, Imael Bassole5, Wamdaogo M. 
Guelbeogo6, N’Fale Sagnon6, Valerio Iebba2, Graziano Pesole7, 
Alessandra della Torre2, Serena Schippa2, Carlo Costantini8
1Dip. Sanità Pubblica e Malattie Infettive - Università di Roma “Sapienza”, 
Rome, Italy, 2Dip. Sanità Pubblica e Malattie Infettive - Università di 
Roma, Rome, Italy, 3Istituto di Biomembrane e Bioenergetica – CNR, Bari, 
Italy, 4Center For Life - Nanoscience IIT - Università di Roma “Sapienza”, 
Rome, Italy, 5Université de Ouagadougou, Laboratoire de Biochimie 
Alimentaire Enzymologie Biotechnologie Industrielle et Bioinformatique, 
Ouagadougou, Burkina Faso, 6Centre National de Recherche et Formation 
sur le Paludisme, Ouagadougou, Burkina Faso, 7Istituto di Biomembrane 
e Bioenergetica – CNR; Dipartimento di Bioscienze, Biotecnologie e 
Biofarmaceutica, Università di Bari, Bari, Italy, 8Institut de Recherche pour 
le Développement, UMR MIVEGEC (UM1, UM2, CNRS 5290, IRD 224), 
Centre IRD France-Sud, Montpellier, France
Afro-tropical malaria vectors of the Anopheles gambiae complex 
represents a remarkable example of adaptive radiation thought to be 
driven by ecological divergence operating predominantly on the larval 
stages. Some ecological factors involved in larval niche partitioning, such 
as different ability to escape predators or tolerate abiotic stress, have 
been identified. Little is known, however, about the role in this process of 
environmental microbial communities occurring in the larval habitats. Thus, 
we tested the hypothesis that members of the An. gambiae complex are 
preferentially associated with different microbial communities.To this aim, 
we sampled An. gambiae s.l. larvae and the surface layer of 63 randomly 
chosen water collections in the village of Goundry (Burkina Faso). The 
microbiological profile of each site was obtained by PCR amplification 
using consensus primers flanking the V6-V8 region of bacterial 16S rDNA, 
and subsequent sequencing by Illumina Miseq. Paired-end reads were 
taxonomically analysed using the two bioinformatic pipelines BioMaS, 
for identification at species level, and QIIME, for OTU based analysis. The 
relative frequencies of mosquito species occurring in the larval sites (i.e. 
An. arabiensis, An. gambiae, and An. coluzzii) were associated to the 
inferred bacterial composition by Canonical Correspondence Analysis 
(CCA).Preliminary analysis of a subsample of 37 breeding sites based 
on 1,620 molecularly-identified mosquitoes (45% An. coluzzii, 38% 
An. arabiensis, 17% An. gambiae) showed that bacterial composition 
accounted for 6% of the total variance in larval relative frequencies. 
The first two canonical axes, which accounted for ~75% of the 
explained variance, separated the three species and associated bacterial 
communities.The results indicate that microbial communities occurring 
in larval habitats can be informative about the composition of sympatric 
species of the An. gambiae complex, supporting the hypothesis that 
particular environmental bacteria may represent an ecological marker of 
niche partitioning for these malaria vector species.
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A DRAMATIC DECLINE OF MALARIA TRANSMISSION IN 
AND AROUND IFAKARA, A RAPIDLY GROWING TOWN IN 
SOUTHEASTERN TANZANIA, SINCE 2000
Marceline F. Finda
Ifakara Health Institute, Ifakara, United Republic of Tanzania
Ifakara is a small but rapidly growing town of about 60,000 people in 
South-eastern Tanzania. A steady but high increase of population in 
Ifakara area has resulted in a rapid urbanization of the area, which in 
turn has had a negative impact on malaria transmission. In 2003, Ifakara 
had an estimated annual entomological inoculation rate (EIR) of 29. Our 
study aimed at determining changes in malaria transmission over the past 
decade. A total of 110 households were randomly sampled from across 
the five wards of Ifakara area. Mosquito collection was done between 
June 2015 and January 2016, using CDC light traps indoors, and Suna® 
traps outdoors. Comparison of indoor and outdoor mosquito density was 
done using the Human Landing Catches (HLC). Anopheles mosquitoes 
were morphologically identified, and analysed for Plasmodium sporozoites. 
Blood fed mosquitoes were also examined for blood-meal sources. A total 
of 2658 Anopheles mosquitoes were caught from 800 trap nights and 
80 Human Landing Catches, including: 2,131 Anopheles gambiae sensu 
lato, 355 Anopheles funestus group, and 172 Anopheles coustani. Of 
all the malaria vectors, 85% were collected only from two wards, which 
were the most rural of the 5 Ifakara wards. All the An. gambiae s.l. were 
identified as An. arabiensis, and 95% of the An. funestus were identified 
as An. funestus funestus, the rest being An. rivulorum. Enzyme-linked 
immunosorbent assays were performed on 2,658 Anopheles mosquitoes 
and only one was found positive, which was an An. funestus caught 
outdoors by HLC in Katindiuka ward. Plasmodium sporozoite rate was 
calculated as 0.04% in all An. gambiae and An. funestus combined, and 
2.8% in just the An. funestus. Overall mean nightly biting rates by malaria 
vectors were 3.02 mosquitoes per night, thus the EIR was estimated as 
0.128. In conclusion, the EIR in Ifakara has dropped by over 99% in just 
over a decade, compared to what was observed in previous reports. The 
on-going transmission is concentrated in only a small and more rural 
section of the Ifakara area, which could be readily targeted with improved 
control measures towards local elimination.
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SPATIAL SEGREGATION OF VECTOR MOSQUITOES IN URBAN 
BALTIMORE, MD
Megan E. Saunders, Paul T. Leisnham
University of Maryland, College Park, MD, United States
Understanding processes that govern vector mosquito coexistence can 
help predict disease risk and guide public health interventions. Theoretical 
and empirical ecology indicate that under resource-limiting conditions 
in a constant environment, competition between species should result 
in the exclusion of the inferior competitor. Multiple vector mosquito 
species coexist in southwest Baltimore, MD, where vacant lots containing 
high densities of water-filled trash containers are interspersed within a 
matrix of maintained lots with fewer containers. One hypothesis that 
may help explain the coexistence of Culex mosquitoes with the superiorly 
competitive Ae. albopictus in Baltimore is a colonization-competition 
tradeoff, which predicts species coexistence in an environment with ideal 
habitats when an inferior competitor in a metapopulation can escape 
exclusion by having a superior ability to colonize vacant or sparsely 
populated patches. In this study, we tested the prediction that there would 
the highest abundances of Cx. species and Ae. albopictus in vacant lots 
compared to intervening occupied lots. We placed 5 oviposition traps 
in each of 6 vacant lots and 6 randomly selected sites in intervening 
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maintained lots in early and late mosquito season in paired city blocks in 
southwest Baltimore. Resident containers at each site were also surveyed 
for mosquito larvae during the late season session. In the early season, 
Cx. species and Ae. albopictus made up 80.8% and 15.2% of the 2619 
total collected larvae, respectively. 75% of early season larvae came from 
abandoned lots. In the late season, Culex species and Ae. albopictus 
comprised 16.8% and 83.2% of larvae, respectively. 45 resident containers 
were identified with the majority (36) found in vacant lots. 51% of the 
resident containers contained larvae, with 87% of the larvae coming from 
abandoned lots. Resident container data and early season ovitrapping 
support the prediction that vacant lots support both higher abundances 
of larval habitat and abundances of Culex and Ae. albopictus compared 
to maintained lots, and should be targeted for mosquito reduction 
interventions in the future.
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EXPERIMENTAL PERTURBATIONS OF CULEX RESTUANS 
POPULATIONS AND THEIR EFFECT ON WEST NILE VIRUS 
TRANSMISSION BY MEMBERS OF THE CX. PIPIENS COMPLEX
Joseph R. McMillan1, Rebekah A. Blakney1, Daniel Mead2, 
Sarah Witter1, Lyndsey Grey1, William Koval1, Gonzalo Vazquez 
Prokopec1
1Emory University, Atlanta, GA, United States, 2University of Georgia, 
Athens, GA, United States
In the eastern United States, the mosquito species Culex restuans and 
members of the Culex pipiens complex transition in abundance and 
epidemiological importance as vectors of urban arboviruses. Cx. restuans 
is most active during periods of West Nile virus (WNv) reemergence (early 
season) and the Cx. pipiens complex is most active during periods of 
peak WNv transmission (summer) and is considered the primary vector 
of WNv in the U.S. Previous studies have suggested evidence for early 
season enzootic WNv transmission by Cx. restuans, yet an empirical 
connection between the two species’ transmission networks has not been 
established. We designed a semi-natural treatment-control experiment to 
test the hypothesis that the seasonal reemergence of the enzootic WNv 
transmission cycle is linked to the presence and blood feeding activities 
of early season Cx. restuans populations. To test this hypothesis, from 
March 21st to June 1st, 2016 we applied a rotating combination of 
methoprene (8.62%) and Bacillus thuringiensis (Bti) (10.31%) larvicides 
in road-side catch basins and storm drains in two urban parks in Atlanta, 
GA at temporal intervals corresponding with peak abundance of Cx. 
restuans populations. We then monitored WNv infection in the enzootic 
cycle during and post treatment by 1) testing blood samples obtained 
from the resident passerine birds for evidence of WNv antibodies and 2) 
testing all Culex spp. mosquitoes collected with aspirators, gravid traps, 
and CDC light traps for WNv infections. These surveillance methods were 
paired with collections from two untreated parks in Atlanta. Preliminary 
Before-After Control Intervention analyses show that Cx. restuans breeding 
populations were successfully suppressed in the treatment parks relative 
to the controls; however there was no effect of larval control on adult Cx. 
restuans population abundance. Avian WNv antibody seroprevalence and 
Culex spp. mosquito WNv infection data are currently being processed.
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PRESENCE OF SPECIES WITHIN THE ANOPHELES GAMBIAE 
COMPLEX IN THE DEMOCRATIC REPUBLIC OF CONGO
Thierry L. Bobanga1, Solange E. Umesumbu2, Alain S. Mandoko3, 
Célestin N. Nsibu1, Ellen B. Dotson4, Raymond F. Beach4, Seth R. 
Irish4
1University of Kinshasa, Kinshasa, Democratic Republic of the Congo, 
2National Malaria Control Program, Kinshasa, Democratic Republic of the 
Congo, 3National Institute of Biomedical Research, Kinshasa, Democratic 
Republic of the Congo, 4Centers of Disease Control and Prevention, 
Atlanta, GA, United States
Anopheles gambiae s.l. is the primary vector of malaria in the Democratic 
Republic of Congo, however, there is little data on the species from this 
complex present in the country. This paper presents the species collected 
(as determined by PCR) between 2004 and 2011 in 16 locations across 
the country. The two species from the An. gambiae complex that were 
detected were An. coluzzii and An. gambiae s.s. An. gambiae s.s. was 
predominant in eastern DRC, whereas An. coluzzii was the main species 
found in several locations in Bandundu. The species were also found in 
sympatry in several locations (Kinshasa, Kisangani, Lodja). These results 
provide a basis for future work, which is needed to accurately describe the 
distribution of the An. gambiae complex species in DRC.
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MAPPING PAST, PRESENT, AND FUTURE CLIMATIC 
SUITABILITY FOR INVASIVE AEDES AEGYPTI AND AE. 
ALBOPICTUS IN THE UNITED STATES: A PROCESS-BASED 
MODELING APPROACH
Marisa A. Donnelly1, Matteo Marcantonio2, Marcus Neteler2, 
Forrest Melton3, Annapaola Rizzoli2, Christopher M. Barker4
1University of California Davis, Davis, CA, United States, 2Fondazione 
Edmund Mach, San Michele, Italy, 3NASA, Moffett Field, CA, United States, 
4Department of Pathology, Microbiology and Immunology, University of 
California Davis, Davis, CA, United States
Rapid changes in the distributions of the mosquitoes, Aedes aegypti and 
Ae. albopictus in the continental United States alter the potential for 
local transmission of dengue, chikungunya, and Zika viruses. All three 
viruses have caused major disease outbreaks in the Americas recently with 
infected travelers returning regularly to the U.S. Recent outbreaks of Zika, 
dengue, and chikungunya have proven that these diseases are capable 
of invading and being transmitted within the ranges of Ae. aegypti and 
Ae. albopictus, mostly in warm and tropical regions. The expanding 
range of these mosquitoes and discovery of new populations within the 
U.S. raises questions about whether recent spread has been enabled by 
climate change or other anthropogenic influences. In this analysis, we used 
daily average temperatures for the United States to model Ae. aegypti 
and Ae. albopictus population growth rates using a stage-structured 
matrix population model in order to understand past and present habitat 
suitability of these vectors, and to project future habitat suitability under 
IPCC climate change scenarios. We applied our model to the continental 
U.S. using temperature data on a 4-km grid. Our results indicate that, as 
expected, much of the southern U.S. is suitable for both Ae. aegypti and 
Ae. albopictus year-round; however, a surprisingly large proportion of the 
U.S. in addition to the southern states is suitable for positive population 
growth for much of the year. While the amount of suitable habitat in 
some regions of the U.S. has contracted within the past 50 years, the 
range of suitable habitat for both Ae. aegypti and Ae. albopictus has 
expanded in many regions across the country. Additionally, IPCC CMIP5 
model projections of future climate change suggest that climate change 
will reshape the range of Ae. aegypti and Ae. albopictus in the U.S., and 
potentially the risk of the viruses they transmit. Understanding the range 
of these mosquitoes should be considered a high priority for public health 
officials and vector control agencies.
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ABUNDANCE OF AEDES ALBOPICTUS AND PRESENCE OF 
DENGUE VIRUS IN PROXIMITY TO A PINEAPPLE PLANTATION 
IN COSTA RICA
Olger Calderon-Arguedas, Eugenia Corrales-Aguilar, Rolando 
D. Moreira-Soto, Amanda Vicente-Santos, Diana Rojas-Araya, 
Adriana Troyo
Universidad de Costa Rica, San Jose, Costa Rica
The role of Aedes albopictus in the transmission of dengue viruses 
(DENV) in the Americas is unknown. Considering that development of 
larvae can occur in bromeliads, the aim of this study was to determine 
the abundance of Ae. albopictus at three sites in proximity of an organic 
pineapple plantation, as well as to evaluate the presence of DENV. For 
adult collections, CO2 traps were placed for 20-24 hrs in forested areas 
and houses adjacent to the plantation, as well as houses >1 km from the 
plantation. Pineapple plants were evaluated for mosquito larvae or pupae 
(8 clusters of 40 plants), as well as containers in and around 27 houses 
adjacent and 29 far from the plantation. Pools of Ae. albopictus were 
analyzed by RT-PCR, and DENV serotype was identified by sequencing. 
Adult mosquitoes at all sites included mainly Anopheles apicimacula, Culex 
coronator, Cx. quinquefasciatus, Cx. nigripalpus, Cx. inflictus, and Ae. 
albopictus. Biodiversity index (Shannon-Wiener) was higher in forested 
areas (1.39) than in houses adjacent (1.1) or far (0.75) from the plantation. 
Cx. nigripalpus and Cx. quinquefasciatus were the most abundant species 
in the forested area and houses, respectively. Adult Ae. albopictus were 
more common in forested areas and adjacent houses. Only 2 mosquito 
larvae were collected from pineapple plants. Ae. albopictus was the most 
frequent species in containers from houses; although house (HI) and 
container (CI) indices were higher in houses farther from the plantation 
(HI: 51, CI: 49) than those adjacent to it (HI: 41, CI: 29). DENV-2 and 
DENV-3 were detected in 2 of 20 pools of Ae. albopictus heads, and 
DENV-1 in 2 of 74 pools of larvae. Results suggest that nearby forested 
areas, which provide a natural habitat, may be the preferred sites for Ae. 
albopictus. However, the abundance and types of breeding sites in these 
forested areas is still to be determined. Moreover, results confirm that local 
Ae. albopictus harbor DENV, and that horizontal transmission is occurring. 
Further investigations will be required to determine the source of DENV 
and weather mosquitoes in forested areas are biting humans, monkeys, or 
other animals.
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FLIGHT APTITUDE OF TETHERED MOSQUITOES AS A 
MEASURE FOR LONG DISTANCE MIGRATION BEHAVIOR
Roy Faiman1, Zana L. Sanogo2, Alpha S. Yaro2, Moussa Diallo2, 
Djibril Samake2, Ousman Yossi2, Adama Dao2, Margery A. 
Sullivan1, Tovi Lehmann1
1National Institutes of Health, Laboratory of Malaria and Vector Research/
National Institute of Allergy and Infectious Diseases, Rockville, MD, United 
States, 2International Center for Excellence in Research, Bamako, Mali
Malaria kills over 500,000 people every year in sub-Saharan Africa. 
During the dry season in the Sahel, surface water required for larval 
sites disappears from this vast region, halting mosquito reproduction 
and bringing malaria transmission almost to a standstill. Recent studies 
have suggested that both Anopheles gambiae s.s and An. arabiensis 
(but not An. coluzzii) persist in this region by migrating from distant 
locations, where breeding occurs year round, though direct evidence 
for long-distance migrating malaria vectors to date is scant. In many 
insects worldwide, windborne long-distance migration occurs seasonally, 
facilitating exploitation of renewed resources far beyond their locomotor 
capabilities. In this study, our aim was to measure flight behavior in 
stationary-tethered, wild mosquitoes, and evaluate if flight intensity 
exhibits bimodality, consistent with “weak” and “strong” flying 
mosquitoes. Additionally, we evaluated the seasonal variation in flight 
behavior and compared it to the expected migration time of each 
species. Mosquito flight sound was recorded individually over 10 hour 
experiments. This assay enables us to characterize flight behavior of 
individual mosquitoes controlling for species, sex, and physiologic state. 
In the laboratory, this assay revealed the effect of age on flight aptitude. 
Preliminary results on data obtained using the assay on wild mosquitoes in 
Mali since July 2015 suggest that flight aptitude exhibits a wide variance 
among species and over seasons. Flight aptitude was elevated a few weeks 
after the first rains, consistent with results obtained using our free-flight 
assay (see poster ), and in agreement with season-specific long-distance-
migration. Comprehensive analysis of year-long data will be presented.
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THE RELATIONSHIP BETWEEN ENTOMOLOGICAL 
INDICATORS OF AEDES AEGYPTI ABUNDANCE AND DENGUE 
INFECTION
Elizabeth A. Cromwell1, Steven T. Stoddard2, Chris Barker3, 
Steven Meshnick1, William Messer4, Annelies Van Rie5, Amy C. 
Morrison3, Thomas W. Scott3
1University of North Carolina Chapel Hill, Chapel Hill, NC, United States, 
2San Diego State University Graduate School of Public Health, San Diego, 
CA, United States, 3University of California Davis, Davis, CA, United States, 
4Oregon Health and Science University, Portland, OR, United States, 
5University of Antwerp, Antwerp, Belgium
Routine entomological monitoring is a method to identify individuals at 
risk of dengue virus (DENV) infection. Using longitudinal entomological 
and serological data from Iquitos, Peru, we estimated the six-month risk 
of DENV for several Aedes aegypti monitoring indicators to determine 
whether Ae. aegypti abundance measures are associated with human 
DENV infection. Entomological survey data were linked with 8,157 
paired serological observations taken approximately six months apart. 
Indicators of Ae. aegypti density were calculated from cross-sectional 
entomological data and linked by date to serological observations. Risk 
ratios estimating the association between Ae. aegypti abundance at the 
household and block levels and the six-month risk of dengue virus (DENV) 
seroconversion were obtained using log binomial models in a generalized 
estimating equation to control for repeated measures and clustering due 
to household membership. Risk ratios estimated using cross-sectional data 
were compared to risk ratios estimated from density measures calculated 
with entomological data collected up to 12 months prior to the start of 
the seroconversion interval. Cross-sectional Ae. aegypti densities (adult 
and immature mosquitoes) were not associated with an increased risk of 
DENV seroconversion. Larval and pupal measures showed no difference 
in risk. Incorporation of up to 12 months of prior entomological data into 
density estimates resulted in plausible risk ratio estimates for adult stage 
measures at the household and block levels, with adjusted risk ratios 
ranging from 1.02 (95% CI: 1.01,1.02) to 1.39 (95% CI: 1.17, 1.66), 
which was the strongest association with DENV seroconversion. Our results 
are likely due to the temporal variability in adult Ae. aegypti measures that 
result in areas with low levels of infestation being misclassified as having 
no entomological risk.
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ADEQUACY OF DIETARY DIVERSITY FOR YOUNG CHILDREN 
IN THE DOMINICAN REPUBLIC AS A FUNCTION OF CHILD 
AGE AND HOUSEHOLD WEALTH
Gurleen Gill, John D. McLennan
University of Calgary, Calgary, AB, Canada
Dietary diversity is one critical domain indexing the adequacy of children’s 
diets. However, research to date has not adequately examined deficits in 
dietary diversity by child age despite marked changes in diets and dietary 
needs that occur over the first several years of life. Such information may 
guide the tailoring of nutrition education by child age. The aim of this 
study was to determine the extent and nature of deficits in dietary diversity 
as a function of (i) age of young children and (ii) household wealth in the 
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Dominican Republic. Data obtained from maternal interviews on 24-hour 
dietary recall were extracted from the Dominican Republic Demographic 
and Health Survey data from 2013. Dietary consumption was classified 
as per the World Health Organization-Minimum Dietary Diversity 
Indicator (WHO-MDDI) and findings stratified by six-month age bands 
and household wealth quintiles (examining those currently breastfeeding 
and not-breastfeeding separately). Despite recommendations to avoid 
complementary foods in the first six months of life, substantial minorities 
of children less than six months of age were consuming dietary items 
other than breast milk or infant formula. Among non-breastfeeding 6-11 
month olds, 59.7% met the recommended minimal WHO-MDDI score 
of four. This increased to 81.8% for those 12-17 months of age, with 
no subsequent consistent trend upwards with increasing age. Eggs and 
vitamin-A rich fruits and vegetables were the WHO-MDDI food groups, 
which had the most infrequent use across age groups for both those 
currently breastfeeding and not breastfeeding. Promotion of these food 
groups, particularly in the 6-11 month age period may improve dietary 
diversity. Unexpected was little to no difference in mean and minimal 
dietary diversity by wealth quintile. This may suggest nutrition education 
initiatives aimed at improving young child dietary diversity may not need 
specific tailoring by wealth strata although examination of food cost 
affordability by wealth strata would be important to further evaluate this 
recommendation.
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IS INTESTINAL PARASITE INFECTION ASSOCIATED WITH 
OBESITY? AN ECOLOGICAL ANALYSIS IN MEXICO
Gerardo A. Zavala1, Colleen M. Doak1, France Portrait1, Olga P. 
Garcia2, Jorge L. Rosado2, Tatiana Jarquin2, Katja Polman3, Maiza 
Campos-Ponce1
1VU Amsterdam University, Amsterdam, Netherlands, 2Universidad 
Autonoma de Queretaro, Queretaro, Mexico, 3Institute of Tropical 
Medicine, Antwerp, Belgium
Obesity is a worldwide healthcare challenge. Recent studies have shown 
an association between both viral and bacterial infection with obesity. 
However, studies on the association between intestinal parasites and 
obesity are scarce. The aim of this ecological study is to evaluate the 
association between the approximated probability of infection with 
Ascaris lumbricoides or intestinal protozoa (all reported intestinal protozoa 
excluding Entamoeba histolytica or Giardia lamblia) in 2000, 2006 and 
2012 with BMI for age z-score (BMIz) in 2012 in Mexico. For this purpose, 
we used publicly available individual-level data for BMIz in 2012 and state-
level data on the incidence of infection with A. lumbricoides or intestinal 
protozoa in 2000, 2006 and 2012 as a proxy for probability of infection. 
A higher approximate probability of infection with A. lumbricoides in 
2012 was associated with a lower BMIz in 2012. In contrast a higher 
approximate probability of infection with intestinal protozoa in 2012 was 
associated with a higher BMIz in 2012. A higher approximate probability 
of infection with A. lumbricoides and intestinal protozoa in 2000 and 
2006 were associated with a higher BMIz in 2012. In summary our results 
suggest that there may be species specific effects of intestinal parasitic 
infection that may have both, short and long term consequences on 
health. Further research is needed to confirm these ecological associations 
and study the possible mechanisms. These findings have important 
implications for Mexico, given the context of a high incidence of parasitic 
infection and emerging obesity epidemic.
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TEAMING UP AGAINST MALARIA: THE STORY OF SENEGAL’S 
SUCCESSFUL PARTNERSHIP
Yacine Djibo
Speak Up Africa, Dakar, Senegal
Senegal’s National Malaria Control Program has a long tradition of 
consultation with its partners. The effective partnership of government, 
nongovernmental organizations, donors, and communities, coordinated 
by strong local leadership, has enabled Senegal to achieve significant 
progress in the fight against malaria in the past decade. Several 
coordination mechanisms have helped to democratize the national 
response to malaria and have led the non-public sector to invest in the 
implementation of policies in a manner and at a level never seen before. 
A strong National Coordination Committee has ensured effective pooling 
of resources and the steady coordination of activities. In addition to 
activities implemented in collaboration with its traditional partners, the 
NMCP is also strengthening its longstanding partnership with research 
and training institutions. Communities have been an integral part of 
the NMCP’s action plan since 2005. To leverage the momentum toward 
malaria elimination, Senegal strives to couple treatment and prevention 
efforts with a systematic drive to mobilize resources and catalyze the 
leadership of not only domestic and international governing bodies and 
policy-makers but communities as well to increase levels of support in 
the malaria fight. With campaigns such as Zero Malaria Starts With Me, 
the NMCP launched an inclusive national movement in favor of malaria 
elimination throughout communities in Senegal. Networks of community 
champions will be trained to raise awareness among their communities 
on malaria prevention and treatment and contribute to the national effort 
toward malaria elimination. In order for Senegal to sustain its intensive 
malaria control and elimination activities and achieve economic benefits, 
the country needs diverse and robust partnerships, both domestic and 
international, to ensure long-term, reliable financing for its program. 
Our poster presentation aims to shed light on the tremendous progress 
Senegal has been able to achieve thanks to strong partnerships with like-
minded institutions and individuals who share the same objective: malaria 
elimination in Senegal.
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EVALUATION OF A MOBILE HEALTH APPROACH TO A LLIN 
UPTAKE INTERVENTION AMONG PREGNANT WOMEN: THE 
HATI SALAMA STUDY
Jessica Sleeth1, Eleonora Kinnicutt2, Thom Dixon3, Michael Sarco4, 
Kenneth Nchimbi5, Karen Yeates1
1Queen’s University, Kingston, ON, Canada, 2Pamoja Tunaweza Women’s 
Centre, Moshi, United Republic of Tanzania, 3Mennonite Economic 
Development Associates, Waterloo, ON, Canada, 4Mennonite Economic 
Development Associates, Bethesda, MD, United States, 5Mennonite 
Economic Development Associates, Dar es Salaam, United Republic of 
Tanzania
The Hati Salama (HASA) cluster-randomized controlled trial aims to 
increase malaria awareness among pregnant women using mhealth 
technology in Tanzania. HASA utilized an electronic system whereby 
nurses issue vouchers to pregnant women, allowing them to redeem a 
Long Lasting Insecticidal bednet (LLIN) at a retailer for a highly subsidized 
cost. A RCT was selected to test efficacy of SMS behaviour change 
communication messages aimed to increase the uptake of LLINs in areas 
of Tanzania identified as malaria hotspots with overall low uptake of 
LLINs. HASA was implemented in 97 antenatal health facilities; where 49 
clinics were assigned to the control group (no targeted SMS messages 
sent to beneficiaries) and the other 49 in the intervention group (targeted 
messages sent to beneficiaries). A major study objective is evaluating the 
process of distributing the vouchers and understanding why they were 
not redeemed (approximately 30%). The investigators utilized a post-study 
phone survey to speak directly to those who did not redeem. The most 
common responses were: I went to redeem but the shop did not have 
any bednets; I cannot afford the co-payment; I do not live close enough 
to a shop that accepts the vouchers; I went to the shop but the retailer 
did not know how to redeem the voucher; and I did not know how to 
redeem the voucher. These responses demonstrate significant barriers that 
deter women from obtaining life-saving bednets. The process evaluation 
showed significant insights - the nurses revealed a large learning curve in 
the technology to distribute the vouchers; a trained nurse was consistently 
away from clinic, leaving the others overwhelmed; overall network 
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connectivity across Tanzania remains low, leaving women waiting for 
prolonged periods to receive vouchers or not at all; and many women 
do not have their own mobile phone. The responses collected from the 
participants and nurses are extremely valuable in understanding why 
highly subsidized bednets are not redeemed. It is imperative for donors to 
critically appraise these program shortcomings and barriers as many can 
be improved or overcome, thereby increasing bednet uptake in malaria 
hotspots.
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PUBLIC HEALTH INTERVENTIONS TO PROTECT AGAINST 
FALSIFIED MEDICINES: A SYSTEMATIC REVIEW OF 
INTERNATIONAL, NATIONAL AND LOCAL POLICIES
William L. Hamilton1, Cormac Doyle2, Mycroft Halliwell-Ewen2, 
Gabriel Lambert2
1Wellcome Trust Sanger Institute, Hinxton, United Kingdom, 2University 
of Cambridge School of Clinical Medicine, Addenbrooke’s Hospital, 
Cambridge, United Kingdom
Falsified medicines are deliberately fraudulent poor quality drugs that pose 
a direct risk to patient health and undermine healthcare systems, causing 
global morbidity and mortality. We aimed to produce a comprehensive 
overview of healthcare and pharmaceutical policies that could be 
deployed at international, national, and local scales to reduce the burden 
of falsified medicines in low and middle income countries (LMIC). We 
identified 660 studies in a systematic search of the PubMed, Web of 
Science, Embase, and Cochrane Library databases, of which 203 met 
title/abstract inclusion criteria and were categorised according to their 
primary policy focus: international; national; local pharmacy; internet 
pharmacy; and drug analysis tools. 84 were included in the qualitative 
synthesis, along with 108 articles and website links retrieved through 
secondary searches. On the international stage, we discuss the need for 
accessible pharmacovigilance (PV) global reporting systems, international 
leadership and funding incorporating multiple stakeholders (healthcare, 
pharmaceutical, law enforcement), and multilateral trade agreements that 
emphasise public health. On the national level, we explore the importance 
of establishing adequate medicine regulatory authorities and PV capacity, 
with drug certification requirements and screening along the supply chain. 
Local healthcare professionals can receive training on medicine quality 
assessments, drug registration, and pharmacological testing. Finally, we 
discuss novel techniques for drug analysis which allow rapid identification 
of fake medicines in low-resource settings. Innovative point-of-purchase 
systems like scratch-off mobile phone verification codes allow consumers 
to check the authenticity of their medicines. Such technology will be 
increasingly relevant to LMIC as mobile phone coverage expands, offering 
opportunities for integration with other “mHealth” initiatives. In summary, 
we describe how anti-falsifying strategies that target different levels of the 
pharmaceutical supply chain can be combined to protect against falsified 
medicines.
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CONTRIBUTION OF REMOTELY SENSED DATA FOR MALARIA 
RISK SURVEILLANCE IN MADAGASCAR
Anthonio H. Rakotoarison, Fanjasoa Rakotomanana, Florian 
Girond, Patrice Piola
Institut Pasteur de Madagascar, Antananarivo, Madagascar
In the Central Highlands (CHs), the history of malaria was marked by 
deadly epidemics due to the existence of unstable malaria. Disease 
surveillance using remote sensing becomes crucial because of 
environmental and climate change. It allows a better understanding of the 
vector behavior and disease transmission patterns. This decision tool is not 
yet adopted by the Malagasy National Malaria Control Program. There are 
no regular updates of Malagasy land cover maps and number of weather 
stations are not sufficient. This study aims at updating environmental 
and climate data. Malaria risk presents many variations at spatial scale. 
Second objective is to compare the relevance of information obtained from 
remotely sensed data with two different spatial resolutions (SR). Satellite 
images from Spot 5 and Landsat 8 sensors were used to classify land 
cover in Ankazobe district and CHs. The SR of each image was increased 
using pan-sharpening method. Object based image analysis method was 
used to classify images according to wetness, vegetation index. Climate 
data were acquired from NOAA and MODIS sensors. Kappa index (KI) 
quantifies the concordance between classification and ground truth and 
was used to evaluate the accuracy of the land cover classification. Two 
maps with five land cover classes were obtained, including rice fields, 
wetland, water bodies, bare soil, wood. The first three classes were 
highlighted because these are the preferred breeding sites of the mosquito 
responsible of transmission in CHs. First map is to Ankazobe district with 
KI of 87%. CHs are represented by the second map with a KI of 84%. The 
correlation between both classified images is 86%. To cover CHs, Landsat 
8 needs five scenes against 40 for Spot 5 and its data processing takes 
less time. A 79% correlation was obtained by comparing the temperature 
map with the thermal band of Landsat 8 images. Landsat 8 is preferred 
because of its free access, satisfactory SR, wide study area and its less time 
consuming process. In limited resource countries like Madagascar, where 
national updated geographic data are rare, this allows integrating recent 
information in malaria risk assessment.
814
DISTANCE LEARNING: REVITALIZING ANESTHESIOLOGY 
TRAINING IN RESOURCE-LIMITED ETHIOPIA
Krupa B. Patel, Morgan Dooley, Vanessa Moll
Emory University, Atlanta, GA, United States
Ethiopia has a significant paucity of available healthcare workers for 
its population of 94 million. There are an estimated 0.027 physicians 
per 1,000 people and specifically, 0.02 trained medical anesthetists per 
100,000 people. Despite the increasing number of medical schools, there 
are not enough physician instructors at the schools. Furthermore, there 
is a lack of availability and standardization of post-graduate training. 
Modalities of e-learning have been shown to be successful when used 
to impart medical education in other resource-limited countries. The 
Emory University and Addis Ababa University (AAU) Departments of 
Anesthesiology have formed a collaboration with the intent of improving 
the AAU Anesthesiology Residency program, the only post-graduate 
training program for anesthesiology in Ethiopia. An initial educational 
needs assessment identified areas in the existing training program that 
require improvements. Interviews with faculty and residents led to study 
topics. In this pilot study, we describe how the current classroom-based 
curriculum is augmented by the introduction of interactive educational 
sessions and distance learning in the form of video lectures. Video lectures 
cover topics based on areas identified by local residents and faculty. 
Interactive sessions include journal clubs, problem-based learning sessions, 
and oral board review-type sessions. Assessment of the additions of the 
newly introduced blended learning technique are conducted via pre- and 
post-tests on the topics presented. An expansion of educational resources 
and modes of didactics are needed. Incorporating interactive and distance 
learning educational sessions into the existing didactic structure leads to 
improved trainee satisfaction.
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IMPROVING PREGNANCY OUTCOMES: ALLEVIATING STOCK-
OUTS SITUATION OF SULFADOXINE PYRIMETHAMINE IN 
BUNGOMA, KENYA
Augustine M. Ngindu1, Gathari G. Ndirangu2, Waqo Ejersa3, 
David O. Omoit4, Mildred Mudany5
1Maternal and Child Survival Program, Kisumu, Kenya, 2Maternal and Child 
Survival Program, Nairobi, Kenya, 3National Malaria Control Program, 
Nairobi, Kenya, 4Bungoma County, Ministry of Health, Bungoma, Kenya, 
5Jhpiego, Nairobi, Kenya
WHO recommends intermittent preventive treatment of malaria in 
pregnancy using sulfadoxine pyrimethamine (IPTp-SP) to be provided at 
antenatal care (ANC) clinic. Ministry of Health (MOH) used to procure 
SP until 2013 when health services were devolved to counties and 
procurement of became the responsibility of county governments. This 
presented a major challenge as counties had not factored SP in their 
budgets. Consequently, counties experienced SP stock-outs from October 
2014. In Bungoma County the number of pregnant women receiving 
IPTp dropped by 51% from 7,845 in October 2014 to 3,865 in February 
2015. To alleviate the situation (MOH) at national level requested counties 
to procure SP. Advocacy efforts with Bungoma County by the Maternal 
and Child Survival Program focused on prioritization of SP procurement 
at least once every quarter. As a result of this intervention, Bungoma 
County procured SP from February to July 2015. The county advised health 
facilities to procure additional SP doses if the supplied stocks ran out. The 
procurement led to a 117% increase in the number of pregnant women 
receiving IPTp; from 3,865 in February to 8,404 in July 2015. The fiscal 
year ended in June 2015 and no funds were available to procure additional 
SP until October 2015. This contributed to a 33% decrease in the number 
of pregnant women receiving IPTp from 8,404 in July to 5,672 in October 
2015. As a response to support counties, MOH at national level procured 
2.24 million SP doses in November/December for 14 MIP-focus counties 
which were received at health facilities in February 2016. In conclusion, 
Bungoma County applied feasible mitigation measures including county-
level procurement of SP, supplemented by additional procurement at 
health facility and national levels. This is a practice which is replicable in 
other counties to ensure continued availability of SP to protect pregnant 
women from effects of malaria in pregnancy.
816
MALARIA RISK ASSESSMENT USING MULTI-CRITERIA 
EVALUATION TO IDENTIFY PRIORITY AREAS FOR INDOOR 
RESIDUAL SPRAYING IN THE CENTRAL HIGHLANDS OF 
MADAGASCAR
Fanjasoa Rakotomanana, Anthonio H. Rakotoarison, Florian 
Girond, Patrice Piola
Institut Pasteur de Madagascar, Antananarivo, Madagascar
The malaria control strategy appropriate for the Central Highlands (CH) of 
Madagascar differs from the rest of the country. Indoor residual spraying 
(IRS) with insecticide is only implemented in the CH and Fringe regions 
of Madagascar due to vector behavior and efficacy of IRS. Two models of 
malaria risk gradient were performed in 2014 and in 2015. Malaria risk 
gradient was calculated for inhabited areas the CH, using Multi-Criteria 
Evaluation (MCE) of factors associated with malaria transmission (land 
cover, altitude, climate, and population data). MCE was performed by 
weighted linear combination method, to obtain the gradient of risk. Factor 
weights were determined by pair-wise comparison based on literature 
review and expert knowledge. In our study, fuzzy set theory was used to 
perform the factors’ weighting. Change of risk magnitude between the 
two consecutive years was calculated to assess areas which shift from one 
risk category to another risk category within the year. The mapping of risk 
magnitude showed wide variation across the CH. Malaria risk gradient was 
categorized in five groups: very low, low, moderate, high and very high 
for the mapping. Risk magnitude between 2014 and 2015 showed an 
increase, with 1.3% and 7% risk for low risk groups and high risk groups, 
respectively. We observed a decrease of 1.1% for areas in the very low 
risk group, 2% for areas in the moderate risk group and 1.3% for areas in 
the very high group. However, risk status remained unchanged for 87.4% 
of the areas in CH. It is crucial to focus IRS efforts according to the risk 
gradient to improve its effectiveness, targeting only areas with the most 
need while optimizing available resources. Integrating data on previous 
intervention, malaria prevalence data from national routine surveillance or 
existing malaria early warning system in a Multi Criteria Decision Analysis 
may help improve the prioritization process for applying IRS to specific 
areas.
817
RESISTANCESIM - DEVELOPMENT AND FEASIBILITY STUDY 
OF A SERIOUS GAME TO IMPROVE UNDERSTANDING 
OF INSECTICIDE RESISTANCE MANAGEMENT IN VECTOR 
CONTROL PROGRAMS
Edward Thomsen1, Charlotte Hemingway1, Andy South2, Marlize 
Coleman1
1Liverpool School of Tropical Medicine, Liverpool, United Kingdom, 
2Independent Consultant, Norwich, United Kingdom
Insect vectors transmit many human pathogens, and the cornerstone 
of most vector-borne disease control programs is the use of chemical 
insecticides. Unfortunately, the development and spread of insecticide 
resistance threatens the continued efficacy of these interventions, and is 
poised to create a public health disaster in the context of malaria control. 
Considerable efforts to develop new active ingredients and interventions 
are underway. However, it is clear that strategies to mitigate the impact 
of insecticide resistance must be deployed now, both to maintain the 
efficacy of currently available tools as well as to ensure the sustainability 
of new tools as they come to market. Although best practice guidelines 
for insecticide resistance management (IRM) have been disseminated by 
the World Health Organization, the lack of understanding of IRM has 
been identified by Rollback Malaria’s Vector Control Working Group as 
the primary gap in the translation of evidence into policy. We developed 
a serious game called ResistanceSim to fill this gap. The first part of 
the development process convened stakeholders to define the learning 
objectives, target audience, and the role of mathematical models in the 
game. A series of learning domains were identified, and a set of specific 
learning objectives for each domain were defined to be communicated 
to vector control programme personnel. A simple “game model” was 
proposed as a way to produce realistic game behaviour while also capable 
of running in real-time. The second part of the development process was 
to engage software developers to map the defined learning objectives 
to game elements. A game design document was produced that guided 
the development process. An internal beta-testing phase was organized 
to identify any bugs in preparation for final release. The third part of 
the development process convened stakeholders to define the most 
effective strategies to roll out the tool. Finally, a feasibility study was 
conducted among members of the target audience in Zimbabwe. We used 
questionnaires and focus group discussions to evaluate users’ perceptions 
of the tool and to identify areas of improvement.
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THE IMPACT OF LOCAL DISTRIBUTORS ON THE QUALITY OF 
MEDICINES IN RESOURCE-LIMITED SETTINGS: FIELD-BASED 
RECOMMENDATIONS
Raffaella Ravinetto, Kerlijn Van Assche, Corinne Pouget, Jean-
Michel Caudron, Jean-Michel Cann, Vera Melotte, Ariadna Nebot 
Giralt, Bruno Meessen
Institute Tropical Medicine, Antwerp, Belgium
The Sustainable Development Goal 3.8 aims at universal health coverage, 
including “quality and affordable essential medicines and vaccines for all”. 
But the increasing globalization of pharmaceutical production, coupled to 
the lack of resources of regulatory authorities in low- and middle-income 
countries (LMICs), makes it difficult to thoroughly assess the quality of 
medicines manufactured, imported or distributed in these territories. In 
these contexts, the pharmaceutical distributors and wholesalers play a 
key-role in defining the local qualitative standards. In a previous study, we 
had showed the weaknesses of some international procurement agencies, 
in particular concerning the capacity to select pharmaceutical products 
based on stringent quality criteria, and to re-evaluate them regularly. As 
a follow-up to that study, we now looked at the compliance with WHO 
standards of about 30 private local distributors of medicines and medical 
products, located in different sub-Saharan Africa countries. The evaluation 
was conducted according to a set of standardised criteria, inspired by the 
WHO Model Quality Assurance System for Procurement Agencies (MQAS). 
Our preliminary findings confirm the existence of significant weaknesses, 
especially concerning the selection criteria for procured products and the 
capacity to reassess them on an ongoing basis, which means that the 
potential for exposure to sub-standard medicines is high. Also, clients’ 
complaints systems may be weak or absent, which limits the possibility to 
identify post-marketing quality problems and to implement batch recalls if 
needed. To efficiently fight the plague of poor-quality medicines, there is 
a urgent need to improve the quality systems of private local distributors 
in sub-Saharan Africa. To achieve this objective, the use of harmonized 
evaluation tools based on the WHO Model Quality Assurance System for 
Procurement Agencies should be encouraged for regulatory supervision, 
audits and self-assessments.
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COMMUNITY EXPERIENCES WITH BEDNET DISTRIBUTION 
AND INDOOR RESIDUAL SPRAYING CAMPAIGNS FOR 
MALARIA PREVENTION IN RURAL GHANA: A QUALITATIVE 
INVESTIGATION
Swati P. Sudarsan1, Tara A. Von Mach1, Anisa Shaw2
1Johns Hopkins University, Baltimore, MD, United States, 2University of 
Michigan, Ann Arbor, MI, United States
Malaria remains one of the primary causes of morbidity and mortality in 
the Upper-East Region of Ghana (Ghana Statistical Service 2011). Control 
methods for malaria in rural areas include long-lasting insecticidal nets 
(LLINs) and indoor residual spraying (IRS) campaigns. This research study 
seeks to understand the experience residents had with LLIN distribution 
and the IRS campaign for possible explanations of why transmission has 
not significantly reduced in Nangodi (World Malaria Report, 2015). Data 
was collected in the town of Nangodi. Researchers conducted interviews 
with semi-structured interview guides. Participants were sampled based 
on district, and included community members (46), insecticide sprayers 
(3), and healthcare providers (2). Participants were interviewed in Nabte 
and English, using a translator if needed. All interviews were recorded, 
transcribed, and analyzed manually for key themes. Data were cross-
checked between the three authors. Information on malaria interventions 
was intermittent and incomplete amongst participants. Issues that 
came up frequently included ineffective communication of timing and 
instructions for spraying and worn bednets not being replaced in a timely 
manner. Community members who lived far from the main road reported 
poor bednet access and fewer visits from IRS sprayers. Community 
members experienced adverse events including skin irritation, stomach 
aches, stains on walls, and loss of fowl. In conclusion. although residents 
reported adverse effects from spraying, they were initially hesitant to 
address adverse events. Almost all would accept IRS if offered again. 
Residents provided important design suggestions for the campaign, 
such as reducing potency of the chemical and provision of face masks. 
Additionally, residents reported varying knowledge about the IRS campaign 
and many barriers to accessing new bednets. Quality and uniform 
distribution of information and bednets must occur in order to reduce 
transmission rates. Further research is needed to understand determinants 
of access and how best to improve current LLIN and IRS campaigns.
820
PEPFAR 3.0: OPPORTUNITIES FOR ENHANCED NCD CARE 
WITH DIFFERENTIATED MODELS OF HIV SERVICE DELIVERY
Michael Smalky, Benjamin Kasdan, Jessica Wilkinson
United States Agency for International Development, Washington, DC, 
United States
Since its creation more than a decade ago, PEPFAR has provided millions 
with life-saving ART and improved access to prevention, care, and 
treatment services that have drastically reduced HIV/AIDS related mortality. 
PLHIV can now enjoy lifespans on par with people not living with HIV. 
As this population ages, many also find themselves affected by a variety 
of non-communicable diseases such as CVD, diabetes, and a variety of 
cancers. Thus the treatment services provided to PLHIV could begin to 
change to meet these evolving needs. With the introduction of PEPFAR 
3.0 and the 90-90-90 goals, HIV programs now find themselves providing 
even greater levels of testing, testing yield, and ART, often within the 
context of a flat budget. This has led to the creation of a variety of 
innovative solutions and approaches to both testing and treatment of 
PLHIV. At the forefront of these innovations are differentiated models 
of service delivery. Instead of offering a one size fits all approach to 
PLHIV care, the focus is now moving to service delivery that is tailored 
to the specific patient, context, and health systems within a country. As 
we rethink the package of services offered, and how these services are 
delivered to the population, there exists a great opportunity to incorporate 
NCD services. Multi-month prescriptions for ARVs can provide benefits 
to patients and providers by reducing burdens on clinics and lessening 
work time lost to doctor visits; however, these benefits are lessened 
if PLHIV continue to have monthly visits to fill their NCD medications. 
Multi-month prescription services require robust supply chain systems 
which ensure timely delivery of medications while avoiding stock outs. 
Looking at current developments in HIV service delivery, we identify areas 
and activities where the integration of NCD services would provide more 
holistic treatment while also working towards the 90-90-90 goals by 
ensuring better uptake and adherence.
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THE GLOBAL HEALTH SERVICE PARTNERSHIP: AN 
ACADEMIC-CLINICAL PARTNERSHIP TO BUILD CAPACITY IN 
NURSING AND MEDICINE IN SUB-SAHARAN AFRICA
Eileen Stuart-Shor1, Bonaventure Ahaisibwe2, Julie Anathan3, 
Elizabeth Cunningham3, Laura Foradori4, Elizabeth Glaser5, Linda 
Jacobsen3, Esther Johnston6, Bridget Malewezi7, Folasade May8, 
Kiran Mitha9, Deogratias Ngoma10, David Ries11, Maureen Ries12, 
Sadath Sayeed13, Vanessa Kerry14
1Seed Global Health and College of Nursing and Health Sciences, 
University of Massachusetts, Boston, MA, United States, 2Seed Global 
Health, Kampala, Uganda, 3Seed Global Health, Boston, MA, United 
States, 4Global Health Service Partnership, Peace Corps, Washington, 
DC, United States, 5Seed Global Health and the Global Health Service 
Corps, Blantyre, Malawi, 6Seed Global Health and Wright Center Family 
Medicine Residency at HealthPoint, Auburn, WA, United States, 7Seed 
Global Health, Lilongwe, Malawi, 8Seed Global Health and Department 
of Medicine, David Geffen School of Medicine at University of California 
Los Angeles, Los Angeles, CA, United States, 9Seed Global Health and 
Department of Pediatrics, David Geffen School of Medicine at University 
of California Los Angeles, Los Angeles, CA, United States, 10Seed Global 
Health, Dar es Salaam, United Republic of Tanzania, 11Seed Global Health 
and Department of Hospital Medicine, University of California San Diego, 
San Diego, CA, United States, 12Seed Global Health and Department 
of Obstetrics and Gynecology, University of California Irvine, Irvine, CA, 
United States, 13Seed Global Health; Department of Global Health and 
Social Medicine, Harvard Medical School; and Division of Newborn 
Health, Department of Medicine, Boston Children’s Hospital;, Boston, 
MA, United States, 14Seed Global Health; Department of Global Health 
and Social Medicine, Harvard Medical School; Center for Global Health, 
Massachusetts General Hospital; Division of Pulmonary and Critical Care, 
Department of Medicine, Massachusetts General Hospital, Boston, MA, 
United States
Thirty-one countries in sub-Saharan Africa (SSA) have a critical shortage 
of health care professionals, limiting healthcare delivery, response to 
emerging needs, and teaching and retention of future professionals. 
As a result, nursing and medical schools are increasing enrollment, 
further increasing demand on limited faculty. To address this shortage, 
the Global Health Service Partnership (GHSP; Seed Global Health/Peace 
Corps) places US nurses and physicians at institutions in SSA, working 
with local faculty to strengthen health education and delivery. A mixed 
method evaluation examined feasibility, outcomes and impact in GHSP’s 
first 2 years (quantitative measures of productivity; qualitative data 
from stakeholder interviews). Between July 2013-June 2015, 69 GHSP 
educators were deployed to 13 universities in Malawi, Tanzania, and 
Uganda. They provided 85,612 service-hours, taught 300 courses to 7,219 
trainees, participated in curricula revision and development (including 
new post-graduate MSN and MMed programs), enhanced the teaching 
infrastructure, and made academic-clinical linkages to facilitate practice 
improvement projects. Qualitative data revealed the largest impact on 
students (the provision of quality, consistent education, particularly clinical 
supervision; value added to the learning environment; and increased 
student confidence and empowerment). Impact on faculty was significant 
in the areas of workload reduction, mentoring, and value added to 
the learning environment. Taken together, these data suggest that an 
innovative, locally tailored and culturally appropriate academic partnership 
is feasible and generated new knowledge and best practices relevant to 
capacity strengthening for nursing and medical education. Key features of 
GHSP include the intentional pairing of US/African educators, emphasis on 
faculty supervised clinical instruction, and a sustained commitment over 
time. Continued evaluation will inform optimizing classroom and clinical 
pedagogy in resource-constrained settings and improve the health and 
wellbeing of populations who suffer a high burden of disease.
822
ANTIMICROBIAL ACTIVITIES OF SIX SELECTED MEDICINAL 
PLANTS AGAINST STAPHYLOCOCCUS AUREUS
Felix C. Mills-Robertson1, Gloria Adjapong2, Mark Appenteng2, 
Salomey Acheampong2, Jerry Asiedu-Larbi2
1Kwame Nkrumah University of Science and Technology, Kumasi, Ghana, 
2Centre for Plant Medicine Research, Mampong-Akwapim, Ghana
The problem of microbial resistance is growing and the outlook for 
the use of antimicrobial drugs in the future is still uncertain. For a long 
period of time, plants have been a valuable source of natural products for 
maintaining human health. Therefore, such plants should be investigated 
to better understand their antimicrobial properties, safety and efficacy. 
The study evaluated in vitro antimicrobial activities of aqueous and 
ethanol fractions of six selected medicinal plants, including Eugenia 
cryophyllata, Psidium guajava, Alchornea cordifolia, Cinnamomum 
zeylanicum, Zanthoxylum xanthoxyloides (fagara), and Tridax procumbens 
against 19 clinical isolates and a standard strain of Staphylococcus aureus 
using a modification of the agar diffusion method. The potency of 16 
formulations from five of the medicinal plants that showed significant 
antimicrobial activity was also evaluated. The ethanol fractions inhibited 
the growth of the test organisms with zones of inhibition ranging from 
4.0-20.5 mm averaging 8.6 mm whereas that of the aqueous fractions 
ranged from 4.0-20.5 mm averaging 7.4 mm. Formulations from the 
combinations of Alchornea cordifolia and Eugenia cryophyllata showed 
inhibition zones ranging from 9.0-16mm and 7-16 for the aqueous and 
ethanol extracts respectively. There was significant difference between the 
ethanolic and aqueous plant extracts against S. aureus used in this study. 
Minimum inhibition concentrations (MICs) of the herbal preparations 
used against the control strain (S. aureus ATCC® 29213™) and the clinical 
S. aureus isolates showed that, both the aqueous and ethanolic extracts 
of Alchornea cordifolia and ethanol extract of Cinnamomum zeylanicum 
produced the lowest MICs of 2 mg/ml. Considering the fact that these 
extracts are crude, it could be inferred that they possess antibacterial 
activities that need further investigations to identify the compound(s) 
responsible for the antibacterial activities.
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CREATING A HOLISTIC FRAMEWORK FOR UNDERSTANDING 
THE FULL IMPACT OF THE ZIKA VIRUS ON MOTHERS, 
INFANTS, HEALTH SYSTEMS AND SOCIETY
Alejandro Cravioto1, Warren Stevens1, Edward J. Mills2, Jamie I. 
Forrest2, Aranka Anema3
1Precision Global Health, Seattle, WA, United States, 2Precision Global 
Health, Vancouver, BC, Canada, 3Epidemico, Boston, MA, United States
In February of 2016, the World Health Organization (WHO) declared 
Zika Virus as a Public Health Emergency of International Concern under 
the International Health Regulations. Zika is projected to take a huge 
toll on the health and wellbeing of people across the Americas as well 
as globally, given international climactic and transport pathways for 
dispersion. Zika now presents a new challenge, with implications beyond 
generalized mild infections, suggesting considerable risk in pregnancy 
of a clear malformation in the child and longer-term effects on proper 
brain development and this will have important effects on costs of health 
and social care. The most likely impact on the majority of households is 
that someone, usually the mother, will become a long-term caregiver, 
often taking women out of the workforce and creating extra strain on 
household finances leading to a greater risk for financial shocks that tend 
to lead to poverty. In many low- and middle-income countries, the increase 
in women in the workforce has been a stabilizing factor in household 
welfare, pulling many households out of poverty. Mothers forced to 
become full-time caretakers could see that progress reversed. Alternatively 
the threat of having a malformed child can lead the mother to search for 
a way to terminate her pregnancy. In countries with strong anti-abortion 
policies, unsafe abortions could negatively affect maternal mortality. If 
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a period of high fertility is followed by a sudden period of low fertility, 
after which the rate picks up again, there will be a risk for the balance of 
dependents in future generations. Tax and public service provision systems 
rely on there being a good match between working age populations and 
dependents, such as the young and the retired. Using widely available 
data sets containing data both fertility rates, formal and digital incidence 
trends of Zika, unsafe abortions, health care utilization, female workforce 
participation and income and poverty levels we developed a simple 
epidemiological-economic model to estimate the likely long term impact 
on the health, health care costs social welfare and poverty of households 
across the Americas.
824
USING AMR DATA IN DATA-RICH COUNTRIES IN 
COMBINATION WITH UNIVERSAL ‘MEDIA’ DATA TO MAP 
ANTIMICROBIAL TRENDS AND DRIVERS ACROSS DATA-POOR 
AREAS OF AFRICA
Warren Stevens1, Edward J. Mills2, Aranka Anema3, Jamie I. 
Forrest2, Alejandro Cravioto1
1Precision Global Health, Seattle, WA, United States, 2Precision Global 
Health, Vancouver, BC, Canada, 3Epidemico, Boston, MA, United States
The World Health Organization has highlighted antimicrobial resistance 
(AMR) as a “major global threat” to public health. Resistance is growing 
in every region of the world, including resistance to ‘last resort’ antibiotics. 
In the United States, an estimated two million illnesses and 23,000 deaths 
are attributed to antibiotic resistant bacteria or fungi each year. The 
key drivers of AMR are largely known; antimicrobial overuse or misuse, 
suboptimal dosing, including from substandard and falsified drugs, 
suboptimal diagnostics and vaccination. Despite this knowledge, the 
complexity of the interaction between these factors and how each affects 
the scale of the problem in different contexts is heavily reliant on the 
health care system, rules around prescription and use of antibiotics, and 
the prevalence, mix and concentration of disease burden from bacterial 
diseases in each country. In addition to this context specific complexity, the 
countries that suffer most from bacterial infections are often those that 
are most data-poor in terms of both routine laboratory testing of patients 
and systematic data collation on the existence and trends of AMR drivers. 
To better assess the risk of AMR across countries where the impact could 
be most devastating requires a more novel approach to generating real 
time estimates of both the prevalence and rate of growth of AMR. We 
have developed a data collection and analytic framework that utilizes 
three distinct sources of routine data, but which mixes data from data-
rich settings and data-poor settings, using a method of triangulation to 
extrapolate gaps in prevalence and growth of AMR in data-poor countries. 
These data sources are: 1) data on annual incidence of AMR in data rich 
countries from official government surveillance reports; 2) digital real-time 
reports acquired from HealthMap Resistance Open, which aggregates 
online news, social media and hospital reports of AMR events; and 3) data 
on key AMR drivers from routine healthcare and pharmacy data, and local 
drug policy and regulation data. We show how this framework could be 
used to monitor real time trends in AMR and its relationships to key drivers 
of AMR.
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ZIKA VIRUS-RELATED PHOTO SHARING ON PINTEREST AND 
INSTAGRAM
Isaac Chun-Hai Fung1, Elizabeth B. Blankenship1, M. Elizabeth 
Goff1, Lindsay A. Mullican1, Kwun Cheung Chan2, Nitin Saroha3, 
Carmen H. Duke1, Marina E. Eremeeva1, King-Wa Fu2, Zion Tsz Ho 
Tse3
1Georgia Southern University, Statesboro, GA, United States, 2University of 
Hong Kong, Hong Kong, Hong Kong, 3University of Georgia, Athens, GA, 
United States
Communicating accurate, accessible and actionable information to diverse 
populations is a key component of emergency responses against the Zika 
virus outbreak. Public health agencies are engaging the public using fast-
growing photo-sharing social media sites such as Pinterest and Instagram. 
In this cross-sectional study, 616 Pinterest photos (keyword: “zika” AND 
“virus”; the maximum number of photos that we were able to retrieve 
via web scraping) and 616 Instagram photos (#zikavirus; randomly 
selected from 9370 Instagram photos retrieved via Instagram Application 
Programming Interface) were retrieved on April 3, 2016. Two trained 
individuals manually coded photos based on their relevance to Zika virus, 
words embedded, language and their content categories (any category 
that applies). Among our samples, 47% (290/616) of Pinterest photos 
and 23% (144/616) of Instagram photos were relevant to Zika virus. 
Words were embedded in 57% (164/290) of relevant Pinterest photos and 
100% (144/144) of relevant Instagram photos. Among the photos with 
embedded words, more Instagram photos were in Spanish and Portuguese 
(77/144, 53%) than Pinterest (14/164, 9%) (P<0.0001). There were 
more Zika virus-related photos on Instagram than on Pinterest containing 
prevention information (59/144, 41%, versus 41/290, 14%, P<0.0001), 
issues relevant to effects on pregnancy (27/144, 19%, versus 32/290, 
11%, P=0.04) and deaths associated with this infection (4/144, 2%, versus 
0/290, 0%, P=0.01). Given the relatively international demographics of 
Instagram (vis-à-vis Pinterest that is more American), it is reasonable to 
suggest that Latin American users were more concerned about Zika virus 
prevention and its impact on pregnancy outcomes. In conclusion, Pinterest 
and Instagram have similar representation of Zika virus-related photos. 
Health communicators may use both Pinterest and Instagram as similar 
platforms to disseminate Zika virus information to the public.
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IMPROVEMENT OF CHILD NUTRITIONAL STATUS IN THE 
DEMOCRATIC REPUBLIC OF CONGO OVER TIME: SERIAL 
CROSS-SECTIONAL ANALYSIS OF THE DEMOGRAPHIC AND 
HEALTH SURVEY
Vivian H. Alfonso1, Manon Billaud1, Adva Gadoth1, Nicole A. 
Hoff1, Reena H. Doshi1, Emile Okitolonda2, Anne W. Rimoin1
1Department of Epidemiology, Fielding School of Public Health, University 
of California Los Angeles, Los Angeles, CA, United States, 2Kinshasa 
School of Public Health, Kinshasa, Democratic Republic of the Congo
In the Democratic Republic of Congo (DRC), prolonged conflict, high 
levels of infectious disease and severe poverty take a toll on the health and 
development of children. Approximately one in seven children die before 
reaching the age of five and approximately half of these deaths are due to 
malnutrition and nutrient deficiencies. To assess the change in child health 
status over time, we utilized nationally representative, cross-sectional 
data from the 2007-2008 and 2013-2014 DRC-Demographic and Health 
Surveys. Data from those under 5 years of age included but was not 
limited to height, weight, anemia and health outcomes among 3,951 
children in the first and 8,552 children in the second wave of the survey. 
According to child anthropometric measures, a significant improvement 
(p<0.0001) was observed between 2007 and 2013 for stunting (height-
for-age, 55% and 46%), wasting (weight-for-height, 27% and 13%) and 
underweight (weight-for-age, 38% and 27%). Such improvements varied 
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by province (percent change range: stunting, 4% to 45%; wasting, -12% 
to 69%; underweight, -13% to 68%) and place of residence (with the 
greatest improvements observed in urban compared to rural settings). 
Additionally, while significant improvements (p<0.0001) were observed 
for anemia between 2007 and 2013 (hemoglobin count <11 g/dl, 71% 
and 50%, respectively), little change was observed in moderate to severe 
estimates during this time (hemoglobin count <10 g/dl, 2007: 23%, 2013: 
21%). While location of residence (urban/rural) was not associated with 
anemia, estimates did vary by province (percent change range: 15% to 
53%). As poor growth performance during infancy and early childhood is 
commonplace in many developing countries, it is important to track how 
these measures change over time. Malnutrition is a major contributor to 
impaired intellect, increased mortality and susceptibility to infection, thus 
such surveillance allows for the identification of vulnerable subgroups to 
whom intervention efforts may be targeted to improve the health and 
development of children.
827
CAN WE TARGET MOBILE POPULATIONS WITH AN 
INTEGRATED DISEASE CONTROL APPROACH? A 
QUALITATIVE STUDY ON RISK BEHAVIOR FOR MALARIA 
AND HIV ALONG THE THAI-CAMBODIA BORDER
Charlotte Gryseels1, Sambunny Uk2, Sokha Suon2, Srun Set2, 
Therese Delvaux1, Dysoley Lek2, Vichea Ouk3, Koen Peeters 
Grietens1
1Institute of Tropical Medicine Antwerp, Antwerp, Belgium, 2National 
Centre for Parasitology, Entomology and Malaria Control, Phnom Penh, 
Cambodia, 3National Centre for HIV/AIDS, Dermatology and STD, Phnom 
Penh, Cambodia
The border zone in Oddor Meanchey province in Cambodia is 
characterized by high human mobility, as economic opportunities such 
as logging, farming and plantations attract migrants. Malaria parasite 
resistance has been detected in this region, requiring active case detection 
and management. High prevalence rates for HIV also occur among high-
risk groups such as female entertainment workers, active around the 
border casinos and catering to loggers and the military. This qualitative 
study, carried out in collaboration with the national control centers of 
Malaria (CNM) and HIV (NCHADS), aimed to characterize the vulnerabilities 
of different types of mobile groups in order to propose integrated control 
activities. Between December 2014 and 2015, semi-structured and open-
ended interviews (N=195) were conducted in Oddor Meancheay with 
theoretically and snowball-sampled informants. Four main categories 
of mobile populations were identified whose activities exposed them 
to malaria and HIV: (i) military men, (ii) local farmers, (iii) rural migrants 
working on plantations, (iv) female entertainment workers. The first three 
categories of people support their families by forest and farm work, which 
increases the risk of malaria since during nightly logging or overnight 
farm stays people lack malaria preventive measures. Additionally, income 
produced by these activities is partly spent in entertainment places, both in 
temporary camps in the forest and around casinos along the border, where 
alcohol consumption and drug use lead to unsafe sexual practices. Tests 
and treatment for HIV and malaria from the public sector or the Village 
Malaria Worker are less popular than those bought in the private sector, 
where privacy and quality are expected. As such, many HIV and malaria 
cases go undetected or are not followed up by adequate treatment. As 
certain risk behaviors tie these mobile populations together, integrated 
HIV and malaria control activities are feasible, potentially through the 
active detection of at-risk individuals by both HIV and malaria programs in 
collaboration with the military and private medical sectors.
828
BANGLADESH OBSERVED NATIONWIDE MEASLES-RUBELLA 
VACCINATION CAMPAIGN
Muhammad Shariful Islam
EXpanded Programme on Immunization (EPI), Dhaka, Bangladesh
Bangladesh observed nationwide Measles-Rubella (MR) vaccination 
campaign from 25 January to 13 February 2014. This three weeks rolling 
campaign supplemented and complemented the routine immunization 
effort to achieve and maintain high population immunity against measles 
and rubella as well as to provide a second opportunity for measles-rubella 
(MR) vaccination among the susceptible children. About 52 million 
children aged 9 months- <15 years were targeted for MR vaccination 
through this campaign. The key objective of the MR campaign was to 
achieve at least 95% coverage of measles and rubella to develop high 
population immunity against these two diseases. 52,745,231 children 
aged 9 months to <15 years were enlisted to vaccinate with MR vaccine 
through educational institutions and community EPI sites. School going 
children were vaccinated in educational institutions and non-school going 
children were vaccinated in community sites. There were about 157,983 
community sites and 158,555 educational institution sites to give MR 
vaccine. For successful outcome, efforts were given on advocacy and 
communication. All vaccinators received training on MR vaccination and 
campaign activities. Orientation programs were organized for volunteers 
and school teachers in view to seek their cooperation during campaign. 
The national EPI team and partner organizations observed that the 
presented administrative coverage data were good at national level and for 
most of the districts and city corporations. As per micro-plan 53,644,603 
(101.7%) had been vaccinated, among them 32,933,783 (62.4%) children 
were vaccinated in educational institutions and 20,710,820 (39.3%) 
children were vaccinated in community sites. MR campaign was conducted 
safely and minimum number of AEFI happened and reported.
829
MOTHER AND CHILD PAIRS DOUBLE BURDEN OF 
MALNUTRITION IN THE SAME HOUSEHOLD, IN BENGO 
PROVINCE, ANGOLA
Miguel Brito, Ania Soares, Claudia Fançony
CISA - Health Research Centre of Angola, Caxito, Angola
The coexistence of undernutrition and over nutrition, known as double 
burden of malnutrition, presents significant threats to human health, 
especially in countries that are undertaking rapid economic development. 
In this countries, factors as the diet transition from high carbohydrates, 
low fat diet to a diet with refined grains, meat, oils and dairy products, 
all high fat content is happening. The present study, included in a cross 
sectional study in Bengo Province Angola, aims to identify modifiable 
factors associated with the occurrence of mother overweight and child 
underweight in the same household. A total of 622 mother child pairs 
were included in the analysis. From the total of 622 mothers, 6.4% were 
underweight (BMI < 18.5), 60.3% were normal weight and 23,3% were 
overweight (BMI 25-30) and 10% were obese (BMI >30). In what concerns 
the children, wasting was observed in 20,1 % (WHZ score under -1), 
stunting in 61.9% (HAZ score under -1) and underweight in 42,9 % (WAZ 
score under -1). Concerning mother/child pairs, 11,1 % of the pairs revels 
a relation of overweight mother/underweight child, 32,2% normal weight 
pair, 22.2% overweight mother /normal weight child, 28.1% normal 
weight mother /underweight child and 3.7% were both underweight. 
The pairs overweight mother / underweight child (n=200), and normal 
weight mother and child (n=69) were included in a case control analysis. 
Overweight mothers tend to be older, and with lower frequencies 
attending secondary or university studies. The study did not report any 
association between dual burden of malnutrition and mother employee, 
age and gender of the child, household size or Household month income. 
A significant association was observed in the multivariate analysis with 
place of birth, with an apparent risk reduction with home born. The 
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present study confirms the existence of dual forms of malnutrition in the 
same household in Angola. Further studies are necessary to understand 
the factors responsible for this coexistence. Moreover, this information is 
vital in the preparation of food intervention programs addressed to the 
adoption of proper and healthy behaviors.
830
JOINING THE HALVES: A PRIVATE PUBLIC PARTNERSHIP 
TO MAKE ROUTINE HEALTH REPORTING ATTRACTIVE TO 
PRIVATE SECTOR PROVIDERS IN UGANDA
Tonny Kyagulanyi1, Ronald Sserufusa2, Robert Mugerwa1, 
Elizabeth Streat3
1Malaria Consortium Uganda, Kampala, Uganda, 2Wakiso District Local 
Government, Wakiso, Uganda, 3Malaria Consortium AfRO, Kampala, 
Uganda
An estimated 50% of fever cases seek care from private-for-profit (PfPs) 
providers, highlighting their significant role in serving the population in 
Uganda. Although all PfPs are mandated to report health data, there are 
challenges with non-availability of private sector friendly tools and this 
has hindered regular reporting of health data by PfPs, resulting in limited 
knowledge of the private sector contribution to disease control and 
surveillance. As part of the UNITAID-funded project to expand malaria 
rapid diagnostic tests (mRDTs) use in Wakiso, Uganda, 289 participating 
outlets were trained and availed with a user friendly individual-level data 
register to strengthen routine monitoring. The register was developed in 
collaboration with the District Health Team (DHT) and was compatible with 
the Health Management Information System (HMIS). Reporting outlets 
were incentivized by awarding certificates of recognition during district-
led provider meetings. The creation of this tool, improved capacity for 
reporting on HMIS malaria indicators was achieved, with 10 (3.5%) outlets 
reporting at baseline in August 2014 and 210 (72.7%) outlets reporting in 
June 2015. The collaborative involvement fostered a partnership between 
the PfPs and the DHT and provided a platform for PfPs to transition to 
directly report into the HMIS. Customizing data collection tools to the 
private sector, administering trainings that highlight the benefits of 
reporting, promoting public-private partnerships and provision of non-
monetary incentives has demonstrated improvement in compliance of 
reporting essential routine health indicators. Strategies for expansion will 
be presented.
831
IMPACT OF MEASLES MASS-VACCINATION CAMPAIGN 
AMONG THE CHILDREN UNDER FIVE YEARS OLD IN THE 
DEMOCRATIC REPUBLIC OF THE CONGO
Kamy K. Musene1, Cyrus S. Sinai1, Reena H. Doshi1, Nicole A. 
Hoff1, Patrick K. Mukadi1, Sue Gerber2, Anne Rimoin2
1University of California Los Angeles-DRC Research Program, Kinshasa, 
Democratic Republic of the Congo, 2University of California Los Angeles, 
Los Angeles, CA, United States
Measles is a highly contagious viral infection. Initial signs and symptoms 
typically include fever >40°C, rash, cough, runny nose, and inflamed eyes. 
Measles continues to be a leading cause of vaccine-preventable deaths 
worldwide, most of which occur in resource-limited countries. In 2014, 
an estimated 17,574 measles cases were reported in the African region. 
In the Democratic Republic of Congo (DRC) epidemics of measles have 
been reported since 2010 due to postponed supplementary immunization 
activities (SIAs). Since, provincial level SIAs have been conducted in each 
province.Using dried blood spots collected during the 2013 Demographics 
and Health Survey (DHS), we assessed the seroprevalence of anti-measles 
IgG among children children 6-59 months of age in the DRC. We overlaid 
SIA data obtained from DRC’s Expanded Programme on Immunization (EPI) 
to determine if there were correlations between vaccination campaigns 
and measles immunity, and calculated the Correlation Coefficient.
In provinces that experienced an SIA in 2013, 77% of children were 
seropositive for measles, while in provinces with no SIA, only 59% of 
children were seropositive. The correlation coefficient is 0.420.Our findings 
suggest the importance of a strong routine immunization program 
coupled with frequent SIAs. While we were unable to determine whether 
Repeated occurrences of large-scale outbreaks in DRC suggest the need to 
reevaluate and modify DRC’s measles prevention and control strategies to 
meet regional elimination goals.
832
SEVERE MATERNAL MORBIDITY AND ASSOCIATED FACTORS 
IN TWO LARGE HOSPITALS IN THE ASHANTI REGION, 
GHANA
Nana Y. Peprah
National Malaria Control,Ghana Health Service, Accra, Ghana
Ghana’s maternal mortality ratio is one of the highest in the world. To 
achieve significant reduction in maternal mortality there is a need to 
go beyond analyzing mortality and explore the risk factors of maternal 
morbidity. Studying Severe Maternal Morbidity (SMM) enables faster 
quantitative analysis and makes it possible to obtain in-depth information 
on the affected woman herself. The research was therefore conducted to 
determine factors contributing to severe maternal morbidity in Suntreso 
and Kumasi South Government hospitals in the Ashanti region of Ghana. 
A case control study was conducted at the Suntreso and Kumasi South 
Government Hospitals of Ghana between January 2015 and June 2015. 
WHO near miss classification system was used to identify maternal 
near-miss. Univariate analyses of categorical variables were expressed 
as frequencies and proportions. Factors independently associated with 
severe maternal morbidity were determined by multivariate analysis 
with a significance level of 5%. Among 2,238 pregnant women, 15 
maternal near miss (MNM), 7 maternal deaths (MD) and 71 potentially 
life-threatening conditions (PTLC) were identified. The maternal mortality 
ratio was 229.6 cases/ 100,000 LB with a mortality index of 31.8%. The 
most diagnosed potentially life threatening condition was postpartum 
hemorrhage (57.7%). Risk factors of severe maternal morbidity identified 
were preterm delivery (<37 weeks) [aOR 7.8 95%CI (3.0 - 20.2)], 
caesarean section in current pregnancy [aOR 9.7 95% CI (3.1-30.2)], 
and anemia during the current pregnancy [aOR 8.1 95% CI (2.9 - 22.2)]. 
Factors associated with SMM were preterm delivery, caesarean section 
in current delivery and anemia in current pregnancy. The use of herbal 
preparation during pregnancy though not associated with SMM was used 
by almost half of the study participants.
833
FACTORS AFFECTING REPORTING RATES OF COMMUNITY 
VOLUNTEERS IN AN MHEALTH INTERVENTION REPORTING 
DATA THROUGH CELL PHONES
Sanford Cheelo1, Illenga Nhkata1, Nadaizja Bollin2, Oswell 
Katooka3, Abel Manangi3, Engervell Musonda3, Rabson Zimba1, 
Anna M. Winters1, Benjamin Winters1, David Larsen1
1Akros, Lusaka, Zambia, 2Syracuse University Department of Public Health, 
Syracuse, NY, United States, 3Ministry of Local Government and Housing, 
Lusaka, Zambia
In lower-income countries, many mHealth solutions have been devised to 
empower health workers and facilitate information systems. For example, 
in Zambia, cellular phones are used to transmit information on malaria 
trends as well as water and sanitation access using community volunteers. 
mHealth solutions, and particularly those using volunteers, are attractive 
to global health programs for a number of reasons including the rapid 
transmission and availability of data as well as the cost-efficiency of using 
community volunteers to generate and send data. The strength of these 
mHealth information systems lies in the reporting rates of the data and the 
opportunity to gather data from community-level. Little research however 
is available on what influences reporting rates. From our experience in 
mHealth we have seen systems with <15% reporting each time period, 
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but also other systems with >85% reporting each time period. We utilize 
information system data from the WASH information system in Zambia to 
determine factors associated with reporting rates first at the district level, 
and then by community volunteer. We measure the impact of seasonality, 
remoteness (an indicator of cell coverage), increasing the number of 
data elements reported and follow-up from national-level staff. These 
analyses are planned for April 2016, with results available by May 2016. 
In this presentation we will discuss what factors influence reporting rates 
for mHealth surveillance solutions and the implications for global health 
programs utilizing mHealth.
834
IMPACT OF COMPUTERIZED PHYSICIAN ORDER ENTRY 
(CPOE) SYSTEM IN PREVENTING PRESCRIPTION ERRORS IN 
ADMITTED PEDIATRIC PATIENTS IN A DEVELOPING COUNTRY
Mian Khalid Masud1, Junaid Bhatti2, Ramzan Tahir3, Akmal 
Laeeq1
1Mayo Hospital, King Edward Medical University, Lahore, Pakistan, 
2Sunnybrook Research Institute, Toronto, ON, Canada, 3University of 
Montreal Health Centre Research Centre, Montreal, QC, Canada
Prescription errors could account for up to three-quarters of iatrogenic 
deaths especially in the pediatric settings. Computerized Physician Order 
Entry (CPOE) with decision-support analysis has shown to be effective 
in reducing errors in resourceful settings. In resource-limited setting, the 
implementation of CPOE is challenging. This study evaluates the impact 
of CPOE in preventing prescription errors in a low-income setting.In this 
quasi-experimental study, patients admitted to the pediatric department 
Mayo Hospital Lahore, Pakistan were studied. The main intervention was a 
CPOE system with decision support analysis that was installed and piloted 
over the period from January to May 2014. Prescriptions of patients 
admitted in the period from seven months before the implementation 
and after the implementation were assessed by a resident. Physician only 
prescriptions continued to be issued in the post-implementation period 
and were included in the comparison. The final analysis compared the 
physician errors per 100 patient days between the physician only and 
the CPOE system.The sample included 2156 patients, 1103 in the pre-
implementation phase and 1053 in the post-implementation period. The 
error rate for physician only prescriptions was 29.4 per 100 patient days. 
The error rate for CPOE system (3.9 per 100 patient-days) were nearly 
seven times less than the physician only system (Incidence Rate Ratio = 
0.13; 95% Confidence Interval = 0.11 - 0.13). The error rate in physician 
only prescriptions was almost two times higher for patients who died than 
those who were discharged (47.4 vs. 23.5 per 100 patient-days). The error 
rates were also higher in patients in the CPOE group who died compared 
to those discharged (6.0 vs. 3.5 per 100 patient-days).CPOE system is 
feasible and effective in a resource-limited pediatric setting. Healthcare 
stakeholders in the resource-limited settings might need to prioritize CPOE 
like systems to prevent iatrogenic deaths.
835
LINKING HOUSEHOLD AND POINT-OF-CARE DATA TO 
ESTIMATE COVERAGE OF APPROPRIATE MANAGEMENT OF 
CHILDHOOD ILLNESS IN SOUTHERN PROVINCE, ZAMBIA
Emily Carter1, Micky Ndhlovu2, Emmy Nkhama2, Melinda Munos1, 
Joanne Katz3, Thomas P. Eisele4
1Institute for International Programs, Johns Hopkins School of Public 
Health, Baltimore, MD, United States, 2Chainama College of Health 
Sciences, Lusaka, Zambia, 3Johns Hopkins School of Public Health, 
Baltimore, MD, United States, 4Center for Applied Malaria Research and 
Evaluation, Tulane School of Public Health and Tropical Medicine, New 
Orleans, LA, United States
Studies of indicator validity have demonstrated that household surveys 
may inaccurately estimate coverage of health interventions, including 
treatment of key child illnesses. Where household surveys are insufficient 
to estimate coverage, there is need for new methods for generating 
accurate measures of health intervention coverage for measuring global 
progress. Linking population-based data with point-of-care (POC) 
information on service readiness and quality of care (QOC) has been 
proposed as a means of generating more accurate coverage estimates. 
A 2016 survey was prospectively designed to collect temporally and 
geographically proximate population-based care-seeking data and POC 
readiness / QOC data to estimate coverage of appropriate management 
of child illness. Mothers of children <5 years old in Southern Province, 
Zambia were randomly sampled. Reported care-seeking events were 
ascertained in each household using a questionnaire modeled off the 
Zambia Demographic and Health Survey. Information on service readiness 
and QOC for child curative services was collected within 6 weeks of the 
household survey from all significant POCs in the study area, including 
public, private, informal, and traditional providers. Service readiness was 
assessed using a survey tool modeled off the WHO service availability and 
readiness assessment (SARA). Care-seeking data were collected for 537 
children in urban areas and 547 children in rural areas. Service readiness 
and QOC data were collected for 75 POCs. Household and POC data were 
combined using an exact-match linking method, which assigned each 
illness episode a value for likelihood of appropriate treatment based on 
the POC readiness / QOC score of the reported source(s) of care. These 
values were then used to generate coverage measures for appropriate 
management of child illness. Analogous coverage measures were 
generated using 4 common geographic linking methods, and compared 
against the estimates generated through the exact-match method to 
assess bias introduced through geographical linking methods. Implications 
and recommendations for coverage measurement will be discussed.
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USING THE KEMRI-CDC HEALTH AND DEMOGRAPHIC 
SURVEILLANCE SYSTEM TO DEMONSTRATE THE CHANGING 
NEONATAL MORTALITY RATE BETWEEN 2003 AND 2012 IN 
RURAL WESTERN KENYA
David K. Obor1, Peter Otieno1, Jennifer R. Verani2, Frank O. 
Odhiambo1, Kayla Laserson3, Daniel Feikin3
1Center for Global Health Research, Kenya Medical Research Institute, 
Kisumu, Kenya, 2Division of Global Health Protection, Centers for Disease 
Control and Prevention, Nairobi, Kenya, 3Centers for Disease Control and 
Prevention, Kisumu, Kenya
Understanding the burden and causes of neonatal mortality is necessary 
for making progress towards Millennium Development Goal #4. We 
examined the overall rate, trends, epidemiology, and factors associated 
with neonatal mortality in the Western Kenya Health and Demographic 
Surveillance System (KHDSS), 2003 to 2012. The KHDSS, located in Bondo 
and Siaya Counties in rural Western Kenya, covers an area of 371 sq. 
km and a population of 159,000 people. Village reporters notify about 
all births and deaths. Standardized verbal autopsy questionnaires were 
completed by trained interviewers and the cause of death was assigned by 
a panel of three clinical officers, using ICD10 codes. Neonatal (≤28 days) 
and early neonatal (≤7 days) mortality rates were calculated per 1,000 live 
births. We explored factors associated with neonatal death using logistic 
regression to compare deaths to non-deaths among neonates. During 
2003-2012, there were 52,385 live births, 899 neonatal deaths and 634 
(70.5%) early neonatal deaths. The overall neonatal mortality rate (NMR) 
was 20.1 per 1000 live births (95% confidence intervals [CI] 19.7 -25.2) 
and early NMR was 14.4 per 1000 LB (95%CI 11.5-18.2). Neonatal deaths 
represented 18.3% of infant deaths. Higher maternal age, secondary 
education, and higher SES were significantly less common among 
neonates that died compared with those that survived. Verbal autopsies 
were done for 533 (71.3%) of neonatal deaths. Overall, the leading causes 
of death were neonatal sepsis (39%), pre-maturity (18%), and respiratory 
distress (10%). The leading causes of death in the first week of life were 
neonatal sepsis (28.8%) and pre-maturity (18.6%). Medical care was 
sought prior to death for 106 (11.8 %) neonates overall, including 45 
(7.1%) of those that died in the first week of life. The burden of neonatal 
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mortality in Western Kenya is high, and the majority of neonatal deaths 
occur in the first week of life. Most neonates die without having received 
medical attention for their illness. Deaths from neonatal sepsis might be 
reduced through community-based management to ensure earlier access 
to antibiotic treatment.
837
STUDENTS AS AGENTS OF CHANGE: EXPERIENCES FROM 
SUDAN IN UPDATING NATIONAL SCHOOL CURRICULA TO 
INCLUDE TRACHOMA MESSAGING
Angelia Sanders1, Zeinab Abdalla2, Balgesa Elshafie3, Nabil 
Mikhail2, E. Kelly Callahan1
1The Carter Center, Atlanta, GA, United States, 2The Carter Center, 
Khartoum, Sudan, 3Sudan Federal Ministry of Health, Khartoum, Sudan
Beginning in 2014, the Sudan national trachoma control program (NTCP) 
began developing methods to incorporate trachoma messaging into their 
respective national and regional school sanitation guidelines. The aim was 
to focus attention on school-based programming that would result in 
schools and students becoming more involved in sanitation campaigns in 
the community thereby becoming agents of change within their homes 
and communities. In the Republic of Sudan, the NTCP has worked to 
engage the Federal Ministry of Health (FMOH) and the Federal Ministry of 
Education (FMOE) in an effort to coordinate the development of school 
health education materials. As part of this process, The Carter Center and 
NTCP developed school health education materials, while the National 
Centre for Curriculum and Education Research and FMOE revised and 
approved the trachoma curricula. Together, the FMOH, FMOE, NTCP and 
The Carter Center produced teachers’ guidelines for basic and secondary 
schools on how to deliver information related to trachoma control. In 
2015, 72 state coordinators, education inspectors and school hygiene 
coordinators were trained on how to be trainers of others. An additional 
2,000 teachers were trained on the trachoma curricula and over 105,000 
trachoma curricula and 1,900 manuals have been distributed in basic 
and secondary schools. Though the implementation of these activities 
are currently limited to the areas in which The Carter Center is assisting 
the FMOH and NTCP, it is hoped that they will provide a model that can 
be expanded to other parts of the country and used as an example for 
neighboring endemic countries that seek to integrate trachoma messaging 
into their own curriculum.
838
GENERATING AN ELECTRICITY ACCESS MAP ACROSS AFRICA
Ricardo Andrade-Pacheco1, David J. Savory1, Alemayehu 
Midekisa1, Peter W. Gething2, Hugh J. Sturrock1, Adam Bennett1
1MEI, Global Health Group, University of California San Francisco, San 
Francisco, CA, United States, 2Big Data Institute, Nuffield Department of 
Medicine, University of Oxford, Oxford, United Kingdom
For many health outcomes, there is a strong relationship with 
socioeconomic status. Demographic and Health Surveys (DHS) collect 
information about household indicators related to wealth in different 
countries across time. One such indicator is access to electricity. 
Unfortunately, due to the varying periodicity and spatial coverage of these 
surveys, the information they contain is not representative at a regional 
scale. Fortunately, unlike other indicators such as access to drinking water 
or education, access to electricity can be indirectly measured via remote 
sensing. National Oceanic and Atmospheric Administration satellites 
have been capturing images of nighttime light globally since 1992. While 
nighttime light images do not immediately translate into electricity access 
of households, we define a model to learn the association between both. 
We use information from 73 DHS surveys, light intensity extracted from 
inter-calibrated night light images and population density. We follow a 
Bayesian model based geostatistics approach, and use integrated nested 
Laplace approximation (INLA) to make inference on household’s electricity 
access in Africa. Results show that access to electricity has a positive log-
linear relationship with nighttime light intensity and population density. 
The model is used to predict the probability of a household having 
electricity annually from 2000-2015 across Africa at 5km resolution. These 
freely available maps describe the story of electrification across Africa and 
will be provide insight, in future work, on the link between infectious 
diseases and socioeconomic resources in the region.
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VOTING FOR BETTER HEALTH IN DEPRIVED COMMUNITIES
Anna Quine1, Gladys U. Obuzor2, Nthusi Nthula3, Lilian 
Ndomoto4, Charlotte Tulinius5, Arthur Hibble6, Prit Chahal1, Njeri 
Nyanja7, Sammy Barasa8
1Health Education East Midlands, Nottingham, United Kingdom, 2Health 
Education East of England, Brampton, United Kingdom, 3Moi University, 
Eldoret, Kenya, 4Nazareth Hospital, Nairobi, Kenya, 5The Research Unit 
for General Practice, University of Copenhagen, Copenhagen, Denmark, 
6Anglia Ruskin University, Cambridge, United Kingdom, 7Kabarak 
University, Nakuru, Kenya, 8Presbyterian University of East Africa, Kikuyu, 
Kenya
The Global Health Exchange Fellowship was a pilot project, designed to 
make global health real through experiential learning for UK and Kenyan 
trainees in family medicine/general practice and public health.Using 
Qualitative research methods, a health needs analysis was performed in 
two deprived areas- a rural Maasai community in Kenya and an inner 
city in the UK. Health issues identified were categorised into themes, 
which were prioritised by the community using an innovative voting 
methodology developed by the fellows. The same methods were applied 
in both countries.The voting method allowed each community a voice, in 
prioritising their health needs. Using the Capability Approach sustainable 
solutions were sourced within the community. Findings were presented to 
local health authorities to inform local resource allocation, improve health 
and reduce inequalities.The fellows learned a great deal about global 
health challenges in both high and low income countries. A methodology 
of community voting was established, providing insight to the true health 
needs of each community.This methodology provides new understanding 
from the perspective of two communities on global health, including social 
determinants of health. There is remarkable potential for its widespread 
use. Similarities in themes in areas of deprivation in low and high income 
countries is noteworthy. In Kenya, access to healthcare was voted as the 
number one priority. Had we taken an epidemiological approach, we 
may have found ourselves tackling specific diseases. However, the voting 
method identified the health issues that were much closer to the true 
health needs of the community. This was particularly important in Kenya, 
where there was no data available for our community. In the UK there 
is a wealth of data, therefore this project sought to address the “Why” 
and the “How”, thus developing sustainable strategies to address health 
needs, whilst encouraging community ownership through Sen’s Capability 
Approach.
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A MULTI-‘OMIC SYSTEMS BIOLOGY APPROACH TO 
IDENTIFYING HOST AND PARASITE FEATURES THAT CONFER 
RESILIENCE TO MALARIA INFECTION
Regina Joice1, Rabin Tirouvanziam1, Juan B. Gutierrez2, Alberto 
Moreno1, Jessica C. Kissinger2, Mary R. Galinski1, MaHPIC 
Consortium
1Emory University, Atlanta, GA, United States, 2University of Georgia, 
Athens, GA, United States
The Malaria Host-Pathogen Interaction Center (MaHPIC) and the Host 
Acute Models of Malaria to study Experimental Resilience (HAMMER) 
Project are intertwined systems biology investigations that are generating 
a wide array of biological, clinical and multi-omic data sets of diverse 
Plasmodium species in their non-human primate (NHP) and human hosts. 
Using NHP models, the MaHPIC project is investigating changes in host 
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immune status, erythrocyte phenotype, and metabolic state alongside 
changes in parasite abundance, stage, and gene expression through the 
use of clinical and multi-omic measurements. Using both mathematical 
modeling and data integration approaches, we are identifying multi’-omic 
profiles that are associated with the observed variation in the severity 
of malarial disease in the animal cohort studies. These studies involve 
Plasmodium cynomolgi and P. coatneyi infections of Macaca mulatta 
(rhesus monkey) to model P. vivax and P. falciparum, respectively; as well 
as P. vivax infections of the New World monkey species Aotus nancymaae 
and Saimiri boliviensis. Further, we are conducting high-resolution 
metabolomics analyses in plasma from human clinical cohort studies led 
from South America, Southeast Asia and Sub-Saharan Africa. Upcoming 
work will focus on characterizing multi-omic profiles of infection by P. 
knowlesi in two different host species with differing susceptibility to 
malaria disease, M. mulatta and M. fascicularis. The aim of this work 
is to identify host features that confer resilience to malarial disease. 
Altogether, we aim to identify novel host and parasite factors involved in 
malaria disease progression in NHPs, and translate these findings to what 
is observed in humans. The MaHPIC and HAMMER projects include an 
extensive bioinformatics infrastructure to generate and release datasets for 
use by the broad scientific community.
841
MOLECULAR DISSECTION OF THE PLASMODIUM 
SPOROZOITE SURFACE GAPDH FOR MALARIA LIVER 
INVASION
Sung-Jae Cha, Marcelo Jacobs-Lorena
Johns Hopkins University, Baltimore, MD, United States
Malaria, caused by parasites of the genus Plasmodium, is among the 
most devastating parasitic diseases worldwide. The bite of an infected 
Anopheles mosquito releases less than 100 sporozoites in the skin but 
after liver infection up to 10,000 merozoites per sporozoite are produced 
and released into the circulation. Therefore, the pre-liver hepatic stages 
represent a severe bottleneck in parasite numbers and constitute a prime 
target for induction of sterile immunity. To infect the mammalian host, 
parasites must leave the circulation in the liver by preferentially traversing 
Kupffer cells that together with endothelial cells, line the liver blood vessels 
(sinusoids). Previously we have identified CD68 on the Kupffer cell surface 
as a receptor for sporozoite traversal. We now report that Plasmodium 
GAPDH on the sporozoite surface serves as a ligand that interacts with 
CD68. Current experiments seek to define GAPDH domains involved in 
this interaction. Such domains are potential epitopes for the development 
of a pre-erythrocytic vaccine.
842
PFEBA-175 MEDIATED ROSETTING ENHANCES GROWTH OF 
PLASMODIUM FALCIPARUM AND OVERCOMES INHIBITORY 
ANTIBODIES: IMPLICATIONS FOR SEVERE MALARIA
May M. Paing, Nichole D. Salinas, Niraj H. Tolia
Washington University School of Medicine, St. Louis, MO, United States
Severe malaria is defined by high parasetemia and anemia and results 
in the majority of fatalities due to Plasmodium falciparum infection. 
The mechanisms that enable high parasite burdens in patients resulting 
in severe malaria and death are poorly defined. Here, we show that 
PfEBA-175 shed from parasites during invasion to form infected RBCs 
(iRBCS) facilitates the recruitment of uninfected RBCS (uRBCS) to 
form rosettes. This recruitment increases parasite growth resulting in 
a defined fitness advantage that enables high parasitemia observed in 
severe malaria. This is the first demonstration of growth enhancement 
directly due to rosetting. We show that rosette formation is dependent 
on PfEBA-175 engagement of the receptor Glycophorin A and identifies 
a novel role for the PfEBA-175:Glycophorin A interaction in addition to 
RBC invasion. We propose that rosetting allows for invasion of adjacent 
uRBCs from one iRBC, bypassing the need for daughter merozoites to 
search and identify uRBCs to invade in the bloodstream. This may be one 
mechanism by which parasites achieve the high parasite burden seen in 
severe malaria. Rosetting also reduces the time in which the merozoite 
can be targeted by the immune system resulting in immune evasion. 
Further, we show that rosetting overcomes the effectiveness of antibodies 
known to inhibit growth. The results emphasizes the need to include 
PfEBA-175 in anti-malarial combination therapies that aim to block rosette 
formation and enable the function of neutralizing antibodies. Lastly, these 
data demonstrate that shed proteins may confer additional functions to 
enhance parasite survival and opens new avenues of research for severe 
malaria.
843
PLASMODIUM VIVAX INFECTIONS AMONGST DUFFY-
NEGATIVE INDIVIDUALS IN THE DEMOCRATIC REPUBLIC OF 
THE CONGO: POSSIBLE ACQUISITION FROM APES
Nicholas F. Brazeau1, Stephanie M. Doctor2, Amy Whitesell2, 
Christian M. Parobek1, Sandra Mendoza Guerrero3, Jonathan J. 
Juliano3, Steven R. Meshnick2
1University of North Carolina School of Medicine, Chapel Hill, NC, United 
States, 2Department of Epidemiology, Gillings School of Global Public 
Health, Chapel Hill, NC, United States, 3Division of Infectious Disease, 
University of North Carolina School of Medicine, Chapel Hill, NC, United 
States
The World Health Organization estimates that 10% of global malaria cases 
and deaths occur in the Democratic Republic of the Congo (DRC) annually. 
Plasmodium falciparum, P. ovale, and P. malariae account for the great 
majority of cases. However, little is known about P. vivax infection in the 
DRC. We selected 618 dried blood spots in the 2013-2014 Demographic 
and Health Survey of the DRC, a large population-based survey. Four cases 
of P. vivax infections were identified by PCR, each in a geographically 
different survey cluster. Using these as index cases, we tested all the 
samples from the four clusters. With this approach, an additional ten 
cases of P. vivax were identified. Among the fourteen P. vivax cases, nine 
were coinfected with P. falciparum. To assess host susceptibility to P. vivax, 
we PCR-amplified and sequenced each host’s Duffy antigen/chemokine 
receptor gene (DARC) for the single point mutation in the GATA motif that 
represses the expression of the Duffy antigen. All fourteen hosts infected 
by P. vivax were Duffy-negative. This finding is consistent with a growing 
body of literature that suggests that P. vivax can infect Duffy-negative 
individuals in Africa. Next-generation sequencing of the mitochondria 
of four of these infections suggests that at least one of these infections 
contains strains of both human and ape origin. Currently, we are exploring 
the origins of these P. vivax infections using phylogenetically informative 
regions on six loci that have been previously used to distinguish non-
human ape from human P. vivax strains. These results suggest that both 
human and ape strains of P. vivax exist within the DRC and the apes 
may represent a potential reservoir of P. vivax for at least some human 
infections.
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CEREBROSPINAL FLUID CYTOKINE AND CHEMOKINE LEVELS 
AND NEUROCOGNITIVE FUNCTION IN UGANDAN CHILDREN 
WITH CEREBRAL MALARIA
Dibyadyuti Datta1, Robert O. Opoka2, Gregory S. Park3, Paul 
Bangirana4, Chandy C. John1
1Ryan White Center for Pediatric Infectious Disease and Global Health, 
Department of Pediatrics, Indiana University School of Medicine, 
Indianapolis, IN, United States, 2Department of Paediatrics and Child 
Health, Makerere University, Kampala, Uganda, 3Division of Global 
Pediatrics, Department of Pediatrics, University of Minnesota Medical 
School, Minneapolis, MN, United States, 4Department of Psychiatry, 
Makerere University, Kampala, Uganda
Inflammation appears to play an important role in cerebral malaria 
(CM), but little is known about which inflammatory factors contribute to 
development of CM or neurocognitive sequelae after CM. Assessment 
of cerebrospinal fluid (CSF) cytokines and chemokines in children with 
CM may provide the best available measure of the central nervous 
system (CNS) inflammatory process in these children. We measured CSF 
and plasma cytokine levels of 15 pro- and anti-inflammatory cytokines, 
chemokines and growth factors in 146 Ugandan children with CM and 
10 North American control (NAC) children. Overall cognition, attention 
and associative memory were tested in children with CM 12 months 
after the CM episode. CSF levels of all factors were significantly higher 
in children with CM than in NAC. In children with CM, CSF and plasma 
values correlated significantly for 11 of 15 factors, suggesting that these 
proteins cross an impaired blood-brain barrier (BBB) into the CNS. CSF 
interleukin-8 (CXCL-8/IL-8) and monocyte chemoattractant protein 1 
(CCL-2/MCP-1) levels were higher in CSF than plasma. Increased CSF IL-8 
levels were the only factor associated with mortality (P=0.05). In children 
<5 years, increased CSF granulocyte-colony stimulating factor (G-CSF), IL-1 
receptor agonist (IL-1ra) and MCP-1 levels correlated with worse cognitive 
ability, while in children ≥5 years, increased IL-1ra, MCP-1, macrophage 
inflammatory protein (MIP-1) and CCL5/RANTES correlated with worse 
cognitive ability (P value range, 0.006-0.04). No association was seen 
for any CSF protein with attention or associative memory. Children with 
CM have increased levels of pro- and anti-inflammatory cytokines and 
chemokines, likely due to passage from plasma to CNS across an impaired 
BBB, except in the case of IL-8 and MCP-1, which appear to be produced 
in the CNS. The association of increased CSF IL-1ra and MCP-1 with 
worsened cognitive scores in all ages suggests that these factors may be 
involved long-term brain injury in children with CM, but further study in 
other cohorts is needed, as these factors were not strongly associated with 
cognitive impairment.
845
A NOVEL FACS TECHNIQUE TO MEASURE AUTOPHAGY IN 
PLASMODIUM FALCIPARUM
Kimberly F. Faldetta1, Rick Fairhurst1, David Roberts2, Katja 
Simon2
1National Institutes of Health, Rockville, MD, United States, 2University of 
Oxford, Oxford, United Kingdom
Autophagy is a normal homeostatic process by which cells degrade waste. 
The purpose of this research project is to develop a novel FACS technique 
to measure autophagy in Plasmodium falciparum. At least 26 homologs 
of established autophagic proteins exist in P. falciparum and recent 
publications suggest that autophagy occurs in the parasite in response 
to stressors; however, a robust assay has not yet been developed for the 
measurement of autophagy in this parasite. A recently developed assay 
to measure autophagy in mammalian cells involves the use of FACS to 
measure autophagosomes and lysosomes using pH-specific dyes. LysoID 
specifically stains lysosomes by staining low pH. Although lysosomes have 
not been specifically identified in P. falciparum, LysoID appears to stain the 
food vacuole—the acidic compartment of P. falciparum—as confirmed 
by confocal imaging. In other organisms, CytoID stains autophagosomes 
by staining intermediate pH and using Atg8/LC3 as an anchor. Previous 
studies have observed upregulation of autophagy in P. falciparum 
following a 6-hour amino acid starvation period. We incubated 3D7 for 6 
hours in amino acid-free media, and found that intraerythrocytic ring-stage 
parasites stained with LysoID had significantly higher mean fluorescence 
intensity (MFI) than those that were incubated in complete media (979.3 
vs. 555.5, p<0.001). In other systems, an increased LysoID signal alone 
can be used as a marker of autophagy induction. CytoID stained starved 
intraerythrocytic parasites with slightly greater intensity than normal 
parasites, though this was not significant (MFI 63.0 vs. 58.1, p=0.27). This 
project demonstrates the potential for using FACS to measure autophagy 
in P. falciparum.
846
DEVELOPMENTAL CYCLE AND TISSUE SEQUESTRATION OF 
PLASMODIUM VIVAX TRANSMISSION STAGES IN THE NON-
HUMAN PRIMATE MODEL
Elamaran Meibalan1, Nicanor Obaldia III2, Juliana Sa3, Siyuan 
Ma1, Pedro Mejia1, Roberto Moraes Barros3, William Otero2, Manoj 
T. Duraisingh1, Danny Milner1, Curtis Huttenhower1, Dyann F. 
Wirth1, Tom Wellems3, Matthias Marti1
1Harvard T.H. Chan School of Public Health, Boston, MA, United States, 
2Instituto Conmemorativo Gorgas de Estudios de la Salud, Panama City, 
Panama, 3National Institute of Allergy and Infectious Diseases, Bethesda, 
MD, United States
The recently launched global effort to eradicate malaria has been 
stimulated by the dramatic decrease of the disease incidence in sub-
Saharan Africa. While Plasmodium falciparum is the deadliest of human 
malaria parasites, P. vivax is a major cause of malaria morbidity within and 
outside of Africa. P. vivax is now a major focus of the ongoing elimination 
agenda, with particular emphasis on development of in vitro culture 
systems and understanding of key biological features, such as latency and 
transmission, as a basis for better diagnosis and new interventions. Though 
not well studied it is believed that transmission stages, or gametocytes, of 
P. vivax take 48 hours to develop and are present in circulation throughout 
their cycle. They appear in blood circulation 3-5 days after the first asexual 
parasites are detected microscopically, and therefore transmission can 
occur well before the patient is symptomatic. The goal of the present 
study was to develop diagnostic markers to characterize the P. vivax 
transmission cycle in the Aotus non-human primate model and for future 
field studies. Comparative transcriptional analysis of P. falciparum versus 
P. vivax gametocytes demonstrated a conserved cascade of stage specific 
gene expression until maturity despite significantly different cycle length. 
A subset of conserved gametocyte stage-specific markers was successfully 
validated by quantitative Real-Time PCR (qRT-PCR) and antibody assays 
in peripheral blood samples from infected Aotus monkeys. Systematic 
investigation of different tissues from infected monkeys indicated an 
enrichment of gametocytes in the bone marrow and sub cutaneous 
fat by a multiplex qRT-PCR assay with our stage-specific markers. To 
investigate possible tissue specific sequestration of P. vivax gametocytes 
during infection, detailed histological analyses are ongoing to determine 
localization of specific parasite stages across the organs.
847
BIOENERGETIC CHARACTERIZATION OF MUTANT 
PLASMODIUM FALCIPARUM STRAINS RESISTANT TO 
MITOCHONDRIAL INHIBITORS
Tomoyo Sakata-Kato, Dyann F. Wirth
Harvard T.H. Chan School of Public Health, Boston, MA, United States
The Plasmodium mitochondrion, in particular the ETC enzymes, has 
been considered as a promising drug target and there have been many 
reports of antimalarial agents targeting cytochrome bc1 complex and 
DHODH. However, there are little bioenergetic studies regarding resistant 
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strains against mitochondrial inhibitors and fitness cost of the mutations. 
Previously, we developed a robust bioenergetic assay protocol utilizing 
an Extracellular Flux Analyzer that enables simultaneous investigation 
of mitochondrial respiration and glycolysis of Plasmodium falciparum in 
a physiologically relevant microenvironment with readout of an oxygen 
consumption rate (OCR) and extracellular acidification rate (ECAR). Using 
this assay protocol, we observed OCR increase by substrates of the ETC 
complexes, such as succinate, glycerol-3-phosphate and dihydroorotate 
in saponin-freed schizont stage parasites. In this study, we first compared 
OCR responses to the ETC substrates between Dd2 and mutant strains, 
BTZR, ATVR and IDI-5994R which are resistant to cytochrome bc1 inhibitors, 
benzothiazepine, atovaquone, and IDI-5994 respectively. As a result, 
we found that all resistant strains had smaller OCR elevation compared 
to their parental Dd2 and that the degree of OCR response decreased 
in the following order: IDI-5994 R, BTZR and ATVR. IDI-5994R strain has 
mutation in Qi site of cytochrome b, while BTZ1R and ATVR strains have 
mutations in Qo site, and therefore our observation might suggest that 
Qo site mutations have more impact on electron transfer to cytochrome 
c. Interestingly, ECAR readout showed that glucose increased glycolytic 
activity more slowly in BTZR and ATVR strains than in IDI-5994 R and Dd2 
strains. In addition, glucose titration revealed that ECAR elevation reached 
a plateau with 4mM of glucose in BTZR strain, while 8mM is required 
in Dd2. These observations might indicate that BTZR strain enhances its 
dependency to glycolysis to overcome fitness cost caused by the mutation. 
Further bioenergetic profiling of various strains including DHODH mutant 
strains will be discussed.
848
DEVELOPMENT OF A NOVEL MOUSE MODEL FOR 
PREGNANCY MAINTENANCE DURING MATERNAL MALARIA 
INFECTION
Catherine D. Smith, Caitlin A. Cooper, Julie M. Moore
University of Georgia, Center for Tropical and Emerging Global Diseases, 
Athens, GA, United States
Placental malaria, a severe clinical manifestation of Plasmodium falciparum 
infection observed in pregnant women, is a major cause of pregnancy loss, 
neonatal mortality, and severe maternal illness. Mouse models for malaria 
infection during pregnancy are vital to understanding the mechanisms 
underlying these outcomes. Here, we describe a novel mouse model 
for pregnancy maintenance during maternal malaria infection utilizing 
outbred Swiss Webster mice. When infected with P. berghei or P. chabaudi 
in early gestation, most mouse strains will abort their pregnancies at mid-
gestation. However, outbred Swiss Webster mice infected with P. chabaudi 
AS in early gestation carry their pregnancies to term, providing a model for 
pregnancy maintenance during maternal malaria infection. Furthermore, as 
previously observed in non-pregnant mice, the gut microbiota of pregnant 
Swiss Webster mice influences the severity of malaria infection. Mice with 
‘susceptible’ gut microbiota develop higher parasite burdens compared to 
mice with ‘resistant’ gut microbes. Despite the severe infections observed 
in ‘susceptible’ mice, these mice do not abort their pregnancies although 
litter sizes at term are reduced. Overall, this model provides a tool for 
exploring the mechanisms of embryo and fetal survival during maternal 
malaria infection, as well as the influence of the gut bacterial community 
on the severity of malaria infection in the context of pregnancy.
849
INVESTIGATING THE ROLE OF ACS5 IN PLASMODIUM 
FALCIPARUM FATTY ACID METABOLISM
Allison Demas1, Selina Bopp1, Erik Allman2, Sarah K. Volkman1, 
Manuel Llinás2, Dyann F. Wirth1
1Harvard T.H. Chan School of Public Health, Boston, MA, United States, 
2The Pennsylvania State University, University Park, PA, United States
The remarkable plasticity of the Plasmodium falciparum genome allows 
for adaptation in response to selective pressures and challenges efforts to 
combat this important human pathogen. Evidence of the adaptive nature 
of this genome includes the expansion and recent positive selection of the 
acyl Co-A synthetase (ACS) gene family, which includes four orthologs 
predicted to activate exogenous fatty acids (FAs) and play important 
roles in fatty acid scavenging as well as nine paralogs with unknown 
function. The evolutionary and functional significance for the expansion 
of the PfACS9 ortholog to nine paralogs, including PfACS5, is unknown. 
In this study we sought to functionally characterize these molecules to 
understand their biological role in the parasite. Using the CRISPR-Cas9 
gene editing system, we successfully knocked out ACS5, a member of this 
expanded family. The ACS5 knockout (KO) line shows reduced growth 
in vitro. This phenotype is exacerbated by limiting growth conditions to 
45% glucose supplemented with minimal fatty acids. Here, we explore 
this growth defect and the functional role of ACS5 in the parasite using 
molecular and biochemical approaches. We compare changes in the 
FA profile of the ACS5 KO line and its 3D7 parent. Using an LC-MS/
MS approach, we profile the metabolome of the ACS5 KO and the 3D7 
parent, and identify changes in key lipid species in the KO. Using these 
approaches, we are exploring the role of ACS5 in downstream metabolic 
pathways, including desaturation and elongation pathways, as well as 
phospholipid biosynthesis. We hypothesize that the expansion and recent 
positive selection of the PfACS gene family are the consequence of 
metabolic pressures driving parasite evolution. Therefore, understanding 
FA metabolism will give us insight into key metabolic pathways that might 
serve as potential targets for novel antimalarials.
850
METABOLIC CONVERSION OF CARBOXY-PRIMAQUINE, 
A MAJOR METABOLITE OF PRIMAQUINE, TO POTENTIAL 
HEMOTOXIC INTERMEDIATES
Jagrati Jain1, Narayan D. Chaurasiya1, Bharathi Avula1, N. P. 
Nanayakkara1, James D. McChesney2, Larry A. Walker1, Babu L. 
Tekwani1
1University of Mississippi, Oxford, MS, United States, 2Ironstone 
Separations Inc., Etta, MS, United States
Plasmodium vivax malaria has broader geographical distribution than 
falciparum, forms dormant hard to kill hypnozoites liver stages, which can 
activate weeks to years after primary infection causing relapsing malaria 
episodes. Primaquine (PQ) is the only drug approved for prevention of 
malaria relapse. PQ also has activity against stage V mature gametocytes 
of Plasmodium falciparum and a key transmission-blocking agent. 
However, PQ causes severe hemolytic anemia in individuals with genetic 
deficiency of enzyme glucose 6-phosphate dehydrogenase (G6PD). 
Metabolism of PQ through oxidative deamination pathway generates high 
plasma levels of carboxyPQ (CPQ). This pathway determines characteristic 
pharmacokinetic properties of PQ and is primarily responsible for its short 
half-life. This is considered as a major therapeutic limitation of PQ, which 
requires a 14 days long treatment for malaria radical cure. The plasma 
levels of CPQ remain high even after 24 hours of treatment with PQ. CPQ 
has been considered to be a non-toxic and inactive metabolite of PQ. 
However, recent studies suggested further metabolism of CPQ through 
CYP mediated pathways generating potential hemotoxic metabolites. 
CPQ with pooled human liver microsomes (HLM) generated marked 
hemolytic toxicity response in vitro. Further, CYP profiling analysis showed 
that CYP1A2 and CYP2B6 were the major CYPs, which can elicit the 
in vitro hemotoxic response to CPQ, with CYP3A4 and CYP2D6 having 
less prominent effects. Incubation of CPQ with pooled HLM resulted 
in more than 35% depletion of CPQ within 2 hours. Hydroxy CPQ 
(m/z 291) and quinone-imine (m/z 289) were identified as the major 
metabolites. Interestingly, metabolism of CPQ with pooled HLM was not 
enantioselective. The studies confirm further metabolism of CPQ through 
CYP mediated pathways, which generated reactive quinone-imine CPQ 
and hydroxyl CPQ, the potential hemolytic metabolites. The studies 
indicate interesting differences in CYP mediated pathways for metabolism 
of PQ and carboxyPQ. These results warrant further evaluation of CPQ for 
the potential to cause red cell damage in G6PD-deficient individuals.
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PHOSPHORYLATION OF PLASMODIUM EUKARYOTIC 
INITIATION FACTOR 2α IN RESPONSE TO ARTEMISININ 
THERAPY
Min Zhang
Department of Pathology, New York University School of Medicine, New 
York, NY, United States
Artemisinin and its derivatives are the most potent anti-malaria drugs. 
Nevertheless, artemisinin monotherapy is associated with accumulation 
of dormant ring stages and with recrudescence of Plasmodium infection, 
which is considered a treatment failure. The molecular mechanism(s) 
leading to parasite dormancy are under investigation. Here we report 
that dormancy is associated with phosphorylation of the parasite’s 
eukaryotic initiation factor-2α (eIF2α). In an attempt to reveal which 
one of three Plasmodium kinases, eIK1, eIK2, or PK4 is involved we 
generated knockouts of the enzymes. Following artesunate treatment, 
the eIK1(-) and eIK2(-) parasites phosphorylated their eIF2α and entered 
dormancy like wild type. We could not obtain knockouts of PK4 because 
it is essential for blood stage development where the gene targeting 
takes place. Nevertheless minutes after drug treatment PK4 dimerized, 
autophosphorylated and phosphorylate eIF2α indicating that it is the 
enzyme that controls dormancy. Artesunate-induced dormancy is extended 
by salubrinal, a selective inhibitor of the eIF2α-P phosphatases, which 
provides evidence for the mechanism that Plasmodium phophorylates 
eIF2α causing dormancy in response to artemisinin treatment.
852
EFFECTIVE SCALING-UP OF SEASONAL MALARIA 
CHEMOPREVENTION IN BURKINA FASO
Jean Bosco Ouedraogo1, Issaka Zongo1, R. Serge Yerbanga1, 
Fabrice A. Somé1, Paul Snell2, Matthew Cairns2, Yacouba 
Savadogo3, Eleonore Fosso4, Harriet Kivumbi5, Diego Moroso5, Paul 
J. Milligan2
1Institut de Recherche en Sciences de la Santé, Bobo-Dioulasso, 
Burkina Faso, 2London School of Hygiene & Tropical Medicine, London, 
United Kingdom, 3Programme National de Lutte contre le Paludisme, 
Ouagadougou, Burkina Faso, 4Malaria Consortium, Ouagadougou, Burkina 
Faso, 5Malaria Consortium, Kampala, Uganda
Burkina Faso scaled-up SMC implementation in 2015, covering 17 
districts with a population of about 900,000 children under 5 years of 
age. Delivery, primarily door-to-door, was for four months starting late 
July. Each month the first dose of the 3-dose regimen was administered 
by a health worker and the remaining doses left with the caregiver. 
To evaluate the effectiveness of SMC delivery at scale, a survey was 
conducted at the end of the transmission season in 11 districts where 
SMC was delivered through the ACCESS-SMC project. 50 villages were 
selected with probability proportional to size, and households selected 
using compact segment sampling. SMC record cards were inspected and 
caregivers were asked about adherence, side effects, reasons for missed 
treatments, the time and any costs involved to obtain SMC for their child, 
the caregiver’s level of education and socioeconomic status. Utilisation 
of insecticide-treated bednets by household members was also recorded. 
Children up to 7 years old were included in order to determine if children 
above the recommended age limit were being treated. Data were collected 
using Android tablet devices. 1000 children were surveyed. 741 of these 
were eligible to have received 4 cycles of SMC (aged between 3months 
and 5years at the first cycle). Of these 94% had received an SMC card 
and at least one SMC treatment. 83% received at least 3 cycles. 97% of 
caregivers reported that they had administered both unsupervised doses 
of amodiaquine the month before the survey. The mean percentage of 
children who attended for SMC who did not receive the treatment from 
the health worker, obtained from health worker tally sheets, was about 
1% to 2%, mostly because the child was unwell. Of 95 children aged 
6 to 7 years at the survey, 80% reported having received SMC. 89% of 
children slept under a bednet the night before the survey. In conclusion, 
a high level of coverage was achieved during 2015, in the first phase 
of implementing SMC on a large scale in Burkina Faso. Sustaining this 
achievement will be challenging.
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PREVALENCE OF MUTATIONS ASSOCIATED WITH 
SULPHADOXINE-PYRIMETHAMINE (SP) RESISTANCE IN 
PLASMODIUM FALCIPARUM SAMPLES FROM THE GENERAL 
POPULATION AND PREGNANT WOMEN IN NANORO, 
BURKINA FASO
Esmee Ruizendaal1, Petra F. Mens2, Henk D. Schallig1
1Royal Tropical Institute, Amsterdam, Netherlands, 2Academic Medical 
Centre, Amsterdam, Netherlands
Pregnant women are at increased risk of Plasmodium falciparum infection, 
which can result in maternal anemia, low birth weight babies and other 
sequelae. Most Sub-Saharan African countries have therefore implemented 
intermittent preventive treatment for pregnant women (IPTp) using 
sulphadoxine-pyrimethamine (SP). However, concerns are rising about 
its continuous efficacy because of increasing resistance against SP. Point 
mutations in the Dhps and Dhfr genes of P. falciparum are associated with 
resistance, especially combinations like the triple Dhfr mutant (51I, 59R, 
108N), the double Dhps mutant (437G, 540E) and moreover the quintuple 
mutant. The aim of our study was to estimate the current levels of SP 
resistance in Nanoro, Burkina Faso and to test whether the mutation rate 
increases during pregnancy. Filter paper samples from pregnant women 
at first antenatal care visit (ANC1) and at delivery were collected from 
March 2014 till September 2015 as part of an intervention trial (COSMIC). 
Furthermore, samples from the general population (GP) were collected 
from March till May 2015. DNA was extracted and P. falciparum positive 
samples were detected by qPCR. Next, nested PCR was used to amplify the 
Dhps and Dhfr genes and products were sent for sequencing. We found 
a high prevalence of Dhfr-51, -59 and -108 overall, with a trend of higher 
levels in GP and delivery samples compared with ANC1 samples (70.7%, 
74% and 61.5% triple Dhfr mutants respectively). Statistical analyses will 
follow, but this trend could possibly indicate selection of resistant parasites 
during pregnancy. However, the concurrent higher mutation rate in GP 
samples needs to be explored. Dhps-437 also showed high mutation rates 
(89.4%, 84% and 83.4% respectively) without a clear trend. The Dhps-
540 mutation was found in one GP sample and in two delivery samples, of 
which one was a quintuple mutant. To our knowledge this is the first time 
the Dhps-540 mutation is found in Burkina Faso. This finding and the high 
prevalence of the other mutations raises concerns about efficacy of IPTp-
SP in the future. Other drug combinations to tackle malaria in pregnancy 
should therefore be explored.
854
ON THE ADEQUACY OF A 28 DAY FOLLOW-UP PERIOD FOR 
ARTEMETHER LUMEFANTRINE AGAINST UNCOMPLICATED 
PLASMODIUM FALCIPARUM MALARIA
Prabin Dahal, on behalf of the WWARN Methods Study Group
WorldWide Antimalarial Resistance Network, Oxford, United Kingdom
Clinical trials are the gold-standard for deriving information on antimalarial 
efficacy from which policy decisions can be made. These estimates are 
vulnerable to methodological approaches such as the duration of study 
and loss to follow-up. The aim of this work is to explore the optimal 
duration of follow-up for capturing PCR confirmed recrudescences 
following treatment with artemether-lumefantrine (AL), and to assess 
the sensitivity of the recommended minimum follow-up duration of 28 
days in patients from Africa and Asia. The cumulative baseline hazard, 
estimated from Cox regression models with shared frailty on study-sites 
and fractional polynomials to capture nonlinear associations, was used 
to estimate the probability density of recrudescences. The area under the 
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density curve (AUC) was calculated to determine the optimal follow-up 
period; accuracy of which was evaluated using simulation techniques. 
Data were available from 54 efficacy trials on AL (n=7,735; 2002-2014) 
in children less than 5 years in Africa and 10 trials in Asia in patients of all 
ages (n=1859, 2000-2010) with a minimum follow-up of 28 days. There 
were 221 (2.9%) recrudescent infections in Africa and 41 (2.2%) in Asia 
within 63 days. In studies with follow-up duration of 42 days or longer, 
43% (47/109) of these recrudescences in Africa and 24% (10/41) in Asia 
were missed with a day 28 follow-up. The missed proportions were even 
higher when estimated using the AUC approach, which makes use of all 
available data. A shift to the left of the probability density function (i.e. 
recrudescences occur earlier) was observed for Asia compared to Africa. 
Effects of baseline parasitaemia and treatment dose on the shape and 
location of the density function were also studied. This pooled analysis 
confirms that the current recommended follow-up duration of 28 days 
remains inadequate for accurately determining AL efficacy and fails to 
identify an estimated 62% of the recrudescences in Africa and 49% in 
Asia. The feasibility and cost-effectiveness of a longer follow-up duration 
warrants further investigation while also considering misclassification 
errors associated with genotyping.
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PLASMODIUM FALCIPARUM PARASITE CLEARANCE IN THE 
PERUVIAN AMAZON AS PART OF A DOD HARMONIZED 
CLINICAL TRIAL
Edward S. Smith1, Salomon Durand2, Laura L. Tapia1, Cesar 
Cabezas3, Paul E. Pachas3, Moises Sihuincha4, Kimberly A. Edgel5, 
Geral C. Baldeviano1, Andres G. Lescano6, Sarah B. Ballard1
1U.S. Naval Medical Research Unit - 6, Lima, Peru, 2U.S. Naval Medical 
Research Unit - 6, Iquitos, Peru, 3Instituto Nacional de Salud, Lima, Peru, 
4Hospital Iquitos Cesar Garayar García, Iquitos, Peru, 5Naval Medical 
Research Center, Bethesda, MD, United States, 6Universidad Peruana 
Cayetano Heredia, Lima, Peru
There is a global threat of Plasmodium falciparum resistance to artemisinin-
based combination therapies observed in South-East Asia. Three DoD 
laboratories in Kenya, Peru and Thailand conducted a harmonized clinical 
trial to determine parasite clearance time after receiving artesunate. 
Data from Peru is presented.Participants between 5-65 years old with 
uncomplicated, microscopy confirmed, P. falciparum mono-infection, 
with asexual parasite density between 1,000 - 100,000 parasites/µL were 
enrolled. Participants were hospitalized for three days and received 4 
mg/kg artesunate on Days 0, 1 and 2; 15 mg/kg mefloquine on Day 3, 
and 10 mg/kg mefloquine on Day 4. The parasite clearance rates were 
determined by microscopy every 4 h during first 12 h and then every 
6 h until 72 h after first being treated with artesunate. Clinical and 
parasitological responses were assessed for 42 days.Between June 2014 
and November 2015, 482 people with P. falciparum mono-infection 
were identified at eight health centers in Iquitos, in the Peruvian Amazon 
Basin, but most did not comply with the study requirements. Seventy-four 
subjects were consented and screened, and among them, 55 subjects with 
uncomplicated P. falciparum malaria were enrolled. Two participants were 
excluded due to serious adverse events and mixed infection. Participants 
cleared parasitemia by hour 42 (PCR uncorrected).The mean age of 
participants was 31.2 (95% CI 26.8 - 35.6), and 22 (41.5%) were female. 
The geometric mean parasite count at admission was 5514 parasites/
µL (95% CI 4095-7426). The clearance rate constant (by hour) median 
was 0.32 (IQR: 0.29-0.39). The slope half-life median is 2.18 hours (IQR: 
1.78-2.39). Finally, 50% and 99% parasite clearance median times (PC50 
and PC99) were 5.84 (IQR: 3.07-7.28) and 17.02 (IQR: 15.22-19.35) 
respectively. All participants completed Day 42 follow-up and met the 
adequate clinical and parasitological response endpoint.No suggestion of 
resistance to artesunate was found among the participants evaluated in 
the Peruvian Amazon. However, surveillance using molecular markers such 
as K13 should be used as a complementary regional strategy.
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DOES METHYLENE BLUE ENHANCE THE EX VIVO 
ANTIMALARIAL BLOOD SCHIZONTOCIDAL ACTIVITY OF 
ARTESUNATE-AMODIAQUINE?
Nguyen Ngoc Quang1, Nguyen Trong Chinh1, Chu Xuan Anh1, 
Geoffrey W. Birrell2, Karin van Breda2, Thomas Travers2, Kerryn 
Rowcliffe2, G. Dennis Shanks2, Marina Chavchich2, Michael D. 
Edstein2
1Central Military Hospital 108, Hanoi, Vietnam, 2Australian Army Malaria 
Institute, Brisbane, Australia
Reports of falciparum malaria patients in Cambodia and Vietnam failing 
treatment with dihydroartemisinin-piperaquine highlights the urgent 
need to contain and reduce the spread of artesunate based combination 
therapy (ACT) resistant strains. As part of this effort a triple drug strategy 
approach should be investigated to extend the useful life of ACTs. The 
objective of the present study was to determine whether methylene blue 
(MB) can enhance the pharmacodynamic (PD) ex vivo antimalarial activity 
of artesunate-amodiaquine (ASAQ). If ASAQ+MB can be demonstrated 
to be more potent than ASAQ alone, then the triple combination may 
provide a better option to treat ACT resistant malaria infections. In an 
open labelled, randomized cross-over design, a single oral dose of either 
ASAQ (2 tablets, with each tablet containing 100 mg AS and 270 mg AQ) 
or ASAQ (2 tablets)+MB (5 tablets, with each tablet containing 65 mg 
MB) was administered to 16 healthy Vietnamese volunteers. After an 8 
week washout period the same participants received the alternative drug 
combination. Serial blood samples were collected up to 28 days after the 
last dose of either ASAQ or ASAQ+MB. The ex vivo antimalarial activity of 
ASAQ and ASAQ+MB was assessed by subjecting the participant’s plasma 
samples collected after drug administration against an artemisinin-sensitive 
and an artemisinin-resistant Plasmodium falciparum line in vitro. Based on 
the participant’s plasma inhibitory concentration profiles the preliminary 
ex vivo data revealed MB to enhance the blood schizontocidal activity 
of ASAQ by at least 2-fold against both P. falciparum lines. Additionally, 
using LC/MS/MS we determined the pharmacokinetic (PK) properties 
of the partner drugs including their principal active metabolites. The 
PK-PD relationship of ASAQ and ASAQ+MB will be compared and their 
implications for the treatment of multidrug-resistant falciparum malaria 
will be discussed.
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PARASITE CLEARANCE AND DECLINES IN ARTEMETHER 
EXPOSURE OVER THE COURSE OF ARTEMETHER-
LUMEFANTRINE TREATMENT FOR PLASMODIUM 
FALCIPARUM MALARIA IN UGANDAN CHILDREN
Richard Kajubi1, Liusheng Huang2, Moses M. Were1, Sylvia 
Kiconco1, Joshua Ssebuliba1, Myaing Nyunt3, Norah Mwebaza1, 
Francesca T. Aweeka2, Sunil Parikh4
1Makerere University, Kampala, Uganda, 2University of California San 
Francisco, San Francisco, CA, United States, 3University of Maryland, 
Baltimore, MD, United States, 4Yale School of Public Health, New Haven, 
CT, United States
We sought to assess the association between parasite clearance 
parameters and artemether (AR) and dihydroartemisinin (DHA) 
pharmacokinetic (PK) exposure in HIV-infected and HIV-uninfected children 
in Uganda treated with artemether-lumefantrine (AL) for malaria. Children 
≤8 years underwent intensive PK sampling post-1st dose of AL followed 
by every 12-hour blood smears. AR and DHA exposure was compared 
to post-last AL dose PK in concurrently enrolled children using non-
compartmental analysis. Parasite clearance parameters were calculated 
using the WWARN Parasite Clearance Estimator. Post-1st and last dose 
PK parameters were estimated in 103 children (77 HIV-uninfected and 26 
HIV-infected) and 142 children (51 HIV-uninfected and 91 HIV-infected), 
respectively. In HIV-uninfected children, post-last dose AR area-under-
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the-curve from 0 to 8 hours (AUC) was 3-fold lower as compared to the 
AUC post-1st dose of AL (ratiolast/first dose 0.31; p<0.0001), while DHA 
exposure increased (AUC ratiolast/first dose 1.75; p=0.0003). Additionally, 
AR exposure post-1st dose was 3 to 6-fold lower in HIV-infected children 
on efavirenz and nevirapine compared to HIV-uninfected children (AUC 
ratio 0.16; p<0.0001 and AUC ratio 0.35; p=0.001, respectively). Post 
1st-dose DHA exposure was similarly lower in efavirenz-treated vs HIV-
uninfected children (AUC ratio 0.45; p=0.028). Parasite clearance slope 
half-life was significantly longer in HIV-infected (3.51 hrs; 95% CI 2.98, 
4.03) vs HIV-uninfected children (2.8 hrs; 95% CI 2.38, 3.36); p=0.003. AR 
exposure demonstrates a significant time-dependant decrease following 
the 1st dose of AL in all malaria-infected children, with those on efavirenz 
exhibiting dramatic reductions to AR and DHA throughout the dosing 
interval. Parasite clearance parameters are also prolonged in HIV-infected 
vs HIV-uninfected children. These findings have important implications 
for AL efficacy and the risk of selection for artemisinin resistance in this 
vulnerable population. Multivariate regression to explore the relationship 
between PK and parasite clearance parameters is underway and will be 
presented.
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DEFINING THE DESIRED ATTRIBUTES OF NEXT GENERATION 
SEASONAL MALARIA CHEMOPREVENTION (SMC) DRUG
Andre Tchouatieu
Medicines for Malaria Venture, Geneva, Switzerland
Seasonal Malaria Chemoprevention (SMC) is implemented using 
sulfadoxine-pyrimethamine (SP) and amodiaquine (AQ) in areas where 
malaria transmission and 60% of clinical malaria cases occur during a short 
transmission period (~4 months), and where SPAQ remains efficacious 
(>90% therapeutic efficacy) -in the Sahel sub-region of Africa.Medicines 
for Malaria Venture (MMV) is working to identify alternative molecules 
with chemoprevention properties that may be suitable as next generation 
SMC tools. To help refine the target product profile (TPP) for potential 
new medicines, MMV commissioned a survey to identify the preferred 
attributes of next generation SMC drugs.Research focused on The 
Gambia and Burkina Faso, countries that have successfully implemented 
two SMC campaigns using a door to door approach, with >90% 
coverage. A varied range of international, regional and local interviewees 
(n=112) were selected to provide input on three TPPs in the context of 
a hypothetical scenario in which SPAQ would no longer be effective for 
chemoprevention.The TPPs tested contained fourteen attributes including 
indication, efficacy, dosing, administration and taste; each TPP varied in its 
protective efficacy and administration regimen. For each TPP, participants 
were asked to score the overall product and each product attribute on 
a scale from 1 to 5.Out of this survey, four attributes were emphasized 
for the development of new SMC products: (1) A well tolerated product, 
suitable for MDA; (2) protective efficacy at least equal to current SPAQ; 
(3) a child-friendly formulation to facilitate administration and adherence; 
(4) a monthly administration schedule to support the current effective 
door-to-door campaign. A fixed distribution point closer to the community, 
with a weekly administration could be considered if incentivized by a 
high protective efficacy (>80%). An alternative with a single injectable 
administration (before rainy season) and protective efficacy levels greater 
than 75% were included in the survey. Interviewees generally considered 
an injection to be most effective and to offer less logistical stress.
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TARGETING ADENYLATE CYCLASE AS A NOVEL AVENUE FOR 
ANTIPARASITIC DRUG DESIGN
Greg LaMonte1, Sabine Ottilie1, Edgar Vigil1, Jacob Durant1, 
Maxim Kostylev2, Greg Goldgof1, Laura-Isobel McCall1, Jake 
Schenken1, Nelissa Figueroa1, Yo Suzuki2, Elizabeth Winzeler1
1University of California San Diego, La Jolla, CA, United States, 2J. Craig 
Venter Institute, La Jolla, CA, United States
Cyclic AMP (cAMP) is an essential, and highly conserved, secondary 
messenger molecule with critical signaling roles in all eukaryotes. 
While the function of cAMP is largely conserved, the proteins within 
the cAMP signaling pathway possess significant structural differences 
across organisms. Here, we used directed evolution and comparative 
chemogenomics in both S. cerevisae and Plasmodium falciparum to 
show that a novel class of antimalarial compounds, the phenyl-amino-
methyl-quinolinols (PAMQs), specifically target the homodimeric class of 
adenylate cyclases (ACs), the enzyme(s) responsible for cAMP synthesis in 
fungi and protozoa parasites. We isolated S. cerevisiae resistant against 
two MMV malaria box compounds, MMV0570 and MMV7181, which 
harbored mutations in several members of the cAMP pathway, including 
cyr1, the S. cerevisae homolog of AC. In P. falciparum, we found that 
these compounds both possess potent (20-50 nM) activity against asexual 
and sexual blood stages of P. falciparum and strongly inhibited parasite 
cAMP levels. This analysis extended to 113 highly related analogs, which 
identified several additional compounds with strong antimalarial activity 
and inhibition of parasitic cAMP levels. The antiparasitic mechanism of 
action of these compounds was further interrogated via in silico molecular 
docking of the PAMQs with AC, recombinant expression of P. falciparum 
AC and genetic engineering to manipulate the expression level of the 
two parasite ACs. These compounds also show activity against several 
additional human pathogens that contain homodimeric ACs, including 
numerous fungi, Trypanosoma cruzi and Leshmania infantum. Importantly, 
we show that the PAMQs are highly selective, as they do not significantly 
affect cAMP levels in human cells. This specificity for homodimeric AC 
suggests that the cAMP/AC pathway is a promising pathway to target for 
chemotherapeutic intervention against these parasitic species. Given the 
increasing lack of effective antiparasitic drugs, the identification of the 
cAMP pathway as a candidate for small molecule intervention represents a 
promising new avenue for drug development.
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KELCH PROTEIN GENE (K13) MUTATIONS IN PLASMODIUM 
FALCIPARUM POPULATIONS IN THREE MALARIA HOT SPOTS 
OF VIETNAM
Thuy-Nhien Nguyen1, Tuyen Kim Nguyen1, Tong Thanh Nguyen1, 
Thanh Viet Ngo1, Quang Hong Huynh2, Maciej Boni1, Olivo 
Miotto3, Christiane Dolecek3, Guy Thwaites1, Nicholas White4, Hien 
Tinh Tran1
1Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam, 
2Institute of Malariology, Parasitology and Entomology-Quy Nhon, Quy 
Nhon, Vietnam, 3University of Oxford, Oxford, United Kingdom, 4Mahidol 
Oxford Tropical Medicine Research Unit, Bangkok, Thailand
Malaria remains a public health challenge in Vietnam despite a substantial 
reduction in the incidence of disease over the last twenty years. Moreover, 
the spread of artemisinin resistance of Plasmodium falciparum which 
compromises the therapeutic efficacy of artemisinin combination 
therapies is the great threat to current global initiatives to control and 
eliminate malaria. An understanding of genetic factors that determine 
how it emerges and spreads is necessary. K13 propeller polymorphism 
mutations are important determinants of artemisinin resistance.In the 
study, propeller domain gene of K13 were successfully sequenced in 1060 
isolates collected in 3 malaria hot spots of Vietnam from 2009-2016. 
Ten genotypes of K13 were found including 8 mutations (T474I, Y493H, 
R539T, I543T, P553L, C580Y, V568G and P574L) after the position of 
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440th amino acid. The prevalence of K13 mutations were 29%, 6% and 
44% in each hot spot Binh Phuoc, Ninh Thuan, Gia Lai respectively. The 
most important C580Y became dominant genotype in recent year with 
81% in Binh Phuoc and 67% in Gia Lai Province. There is the association 
between K13 mutations and prolonged parasite clearance half-life. 
Identification of K13 mutations and its frequency in population of P. 
falciparum in Vietnam will support surveillance efforts to contain, prevent 
the artemisinin resistance and facilitate the development of effective 
strategy to combate drug resistance.
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INTERMITTENT PREVENTIVE TREATMENT CONTINUES TO 
PROVIDE BENEFIT TO MALAWIAN PREGNANT WOMEN
Julie Gutman1, Dyson Mwandama2, Jomo Banda2, Peter Troell3, 
Andy Balueni2, Zhiyong Zhou1, Austin Gumbo4, Misheck Luhanga4, 
Doreen Ali4, Don P. Mathanga2
1Malaria Branch, Division of Parasitic Diseases and Malaria, U.S. Centers for 
Disease Control and Prevention, Atlanta, GA, United States, 2Malaria Alert 
Centre (MAC), University of Malawi College of Medicine, Blantyre, Malawi, 
3U.S. President’s Malaria Initiative, Malaria Branch, Division of Parasitic 
Diseases and Malaria, U.S. Centers for Disease Control and Prevention, 
Lilongwe, Malawi, 4National Malaria Control Program, Lilongwe, Malawi
Drug resistance, particularly the Pfdhps-581G mutation, when present 
with the quintuple dhps/dhfr mutant haplotype, may undermine 
the efficacy of intermittent preventive treatment in pregnancy with 
sulphadoxine-pyrimethamine (IPTp-SP). We conducted a cross-sectional 
study at delivery in an area with high prevalence of SP resistance in order 
to assess whether IPTp-SP remains efficacious. HIV-uninfected women 
with singleton pregnancies were enrolled at delivery from June to October, 
2015 at two sites in southern Malawi. Demographics, clinical data, 
peripheral blood, and placental samples were collected, and infants were 
examined. Samples were tested for malaria using rapid diagnostic tests 
(RDT), microscopy, and polymerase chain reaction (PCR); PCR positive 
samples will be genotyped for mutations at dhps-540 and dhps-581. We 
enrolled 506 women: mean age was 24.2 years (range 15-45); mean 
gestational age at delivery was 39.4 weeks (range 28-43); 35% were 
primigravid, 17% were secundigravid, and 48% were multigravid; 81% 
owned an insecticide treated net, 65% of whom slept under it on the 
previous night. 11% received no IPTp, while 6%, 24%, and 58% received 
1, 2, and 3 or more doses, respectively. Overall, 18% had evidence of 
malaria: 10.5% by RDT, 7.7% by peripheral smear, 5.6% by placental 
smear, and 15% by PCR. Malaria was more common among women 
who received <3 vs ≥3 doses of IPTp-SP: 15% vs 7%, p=0.003 by RDT; 
10% vs 5%, p=0.04 by maternal peripheral smear; 7% vs 5%, p=0.33 
by placental smear; and 14% vs 16%, p=0.69 by PCR; 20% vs 17%, 
p=0.42 for any malaria. Birthweight was significantly higher among 
women who had received ≥3doses of IPTp-SP (3121gm) compared to 
those who received <3 doses (3032gm, p=0.03). IPTp-SP continues to 
provide benefit to Malawian pregnant women, with a significantly higher 
mean birthweight and less maternal malaria among women who received 
3 doses; the effect on patent parasitemia was greater than on malaria 
detected by PCR. Additional data on the prevalence of Pfdhps-581G and 
the relationship of this mutant to birth outcomes will also be presented.
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UNCOMPLICATED MALARIA TREATMENT FAILURES AFTER 
ARTESUNATE-AMODIAQUINE COMBINATION THERAPY IN 
TWO ECOLOGICAL ZONES IN GHANA
Benjamin Abuaku1, Benedicta Mensah1, James Hansen1, Abigail 
Derkyi-Kwarteng2, Moses Dokurugu3, Kwadwo Koram1, Michael 
Ofori1, Anita Ghansah1
1Noguchi Memorial Institute for Medical Research, Accra, Ghana, 2Ewim 
Polyclinc, Ghana Health Service, Cape-Coast, Ghana, 3Begoro Government 
Hospital, Ghana Health Service, Begoro, Ghana
Continuous monitoring of the therapeutic efficacy of artemisinin-based 
combination therapy for the treatment of uncomplicated malaria has 
become critical, within the context of malaria control, in an era of the 
development and spread of artemisinin resistance. The therapeutic 
efficacy of artesunate-amodiaquine (AS-AQ) was studied from June to 
September 2015 among children, aged 6months to 14 years, reporting 
with uncomplicated malaria at two sentinel health facilities in the forest 
and coastal zones of Ghana. A total of 237 children were recruited for 
the study: 110 in the forest zone and 127 in the coastal zone. These 
children were followed up for 28-days using the 2009 WHO protocol 
for monitoring antimalarial drug efficacy. Preliminary results show no 
early treatment failure in the 2 ecological zones. Overall pcr-uncorrected 
late clinical and parasitological failure rates were 6.7% (95% CI: 3.0-
13.7) in the forest zone and 11% (95% CI: 6.4-18.1) in the coastal zone 
(p=0.357). There were no significant differences in treatment failure rates 
between children aged less than 5 years and children aged 5-14 years in 
both ecological zones. The main adverse event reported in the 2 ecological 
zones was vomiting. Prevalence of vomiting in the forest zone was 6.4% 
(95% CI: 2.8-13.2) on day-0; 6.5% (95% CI: 2.9-13.4) on day-1, and 
10.3% (95% CI: 5.5-18.0) on day-2 (p=0.474). Prevalence of vomiting in 
the coastal zone was 5.5% (95% CI: 2.4-11.4) on day-0; 0.8% (95% CI: 
0.1-5.0) on day-1; and 2.4% (95% CI: 0.6-7.3) on day-2 (p=0.076). We 
conclude that AS-AQ remains efficacious and safe for the treatment of 
uncomplicated malaria in the forest and coastal zones of Ghana.
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DOSE-RESPONSE EFFECT OF SULFADOXINE-PYRIMETHAMINE 
ADMINISTERED AS INTERMITTENT PREVENTIVE TREATMENT 
OF MALARIA IN PREGNANCY REDUCES ADVERSE BIRTH 
OUTCOMES RELATED TO SEXUALLY TRANSMITTED AND 
REPRODUCTIVE TRACT INFECTIONS
R. Matthew Chico, Enesia Banda Chaponda, Cono Ariti, Daniel 
Chandramohan
London School of Hygiene & Tropical Medicine, London, United Kingdom
The World Health Organization recommends intermittent preventive 
treatment with sulphadoxine-pyrimethamine for pregnant women 
resident in areas of moderate (stable) or high malaria transmission at every 
scheduled antenatal care visit from the second trimester until delivery to 
prevent the adverse consequences of malaria infection during pregnancy. 
A prospective cohort study was conducted between November 2013 
and April 2014 among 1086 pregnant women attending antenatal care 
facilities in the Nchelenge District of Zambia. Recipients of ≥ 2 doses of 
intermittent preventive treatment were one-half as likely to have any 
adverse birth outcome - a composite measure of (1) stillbirth, (2) low 
birthweight, (3) preterm delivery, or (4) intrauterine growth retardation - 
compared to recipients of 0-1 dose (adjusted odds ratio [OR] 0.49; 95% 
confidence intervals [CI] 0.33, 0.75). In the sub-population of women who 
had an adverse birth outcome, odds ratios for mono- and co-infection 
with malaria and/or curable sexually transmitted and reproductive tract 
infections (STI/RTI) were also lower among women who received ≥ 2 
doses versus 0-1 dose: malaria mono-infection (OR 0.25; 95% CI 0.09, 
0.68); malaria plus trichomoniasis or bacterial vaginosis (OR 0.89; 95% 
CI 0.44, 1.83); trichomoniasis or bacterial vaginosis (OR 0.85; 0.38, 
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1.91); gonorrhoea or chlamydia (OR 0.08; 95% 0.01, 0.80); syphilis and 
malaria or other curable STI/RTI (OR 0.34; 0.14, 0.85). This dose-response 
protective effect was observed consistently across the four individual 
adverse birth outcomes, and in 25 of 28 categories of malaria and curable 
STI/RTI mono- and co-infection. Interestingly, ≥ 2 doses compared to 0-1 
dose reduced the odds of an adverse birth outcome even among pregnant 
women who had neither malaria nor curable STIs/RTIs (OR 0.34; 0.14, 
0.85), suggesting that sulfadoxine, a broad-spectrum antimicrobial drug, is 
protective against pathogens beyond malaria and curable STIs/RTIs.
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POPULATION GENETICS OF THE CHLOROQUINE-RESISTANT 
GENE PFCRT IN CAMEROONIAN FIELD PLASMODIUM 
FALCIPARUM ISOLATES
Huguette Gaelle Ngassa Mbenda1, Aparup Das2
1University of Witwatersrand, Johannesburg, South Africa, 2National 
Institute of Malaria Research, New Delhi, India
Understanding the population genetics of genes which shape resistance to 
antimalarial drugs can help in devising novel control strategies. One of the 
major hurdles in malaria control lies on the evolution and dispersal of the 
drug-resistant malaria parasite, Plasmodium falciparum. Specific mutations 
in the P. falciparum chloroquine resistant transporter gene “Pfcrt” have 
been associated with resistance to not only chloroquine, but also to 
amodiaquine, one of the artemisinin partners used in Cameroon for the 
treatment of uncomplicated malaria. We here present data on genetic 
variation at the single nucleotide polymorphisms (SNPs) level in the Pfcrt 
gene in five distinct geographical settings of the Southern-Cameroon (the 
most malaria endemic part), i.e. Ebolowa, Yaounde, Bertoua, Douala and 
Kye-ossi (a city bordering Cameroon and two others African countries). 
Two novel mutations, hitherto unreported (in Cameroon) were found 
in the Pfcrt gene and variable genetic diversity was observed across the 
populations. High linkage disequilibrium was found between few SNPs in 
all the populations traducing a synergic work for conferring/maintaining 
a higher level of resistance. The inference of evolutionary pattern of this 
gene in Cameroon based on genetic diversity data depicts a signature 
of Darwinian positive natural selection on these loci. While observation 
of novel mutations might traduce new varieties in chloroquine/or 
amodiaquine resistance (proposal awaiting an experimental verification), 
signal of positive selection can be the result of drug pressure exerted by 
misuse of chloroquine (though officially banned from the country) and/
or amodiaquine. Our findings thus, provide a baseline understanding of 
the evolution of a malaria drug resistant gene in Cameroon and suggest 
a successful establishment of chloroquine-resistant strains which requires 
urgent attention of malaria control programme in Cameroon.
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THE PROTECT STUDY: MATERNAL AND CHILD MALARIA 
CHEMOPREVENTION TO ENHANCE CHILD DEVELOPMENT
Paul Bangirana1, Robert O. Opoka1, Andrea L. Conroy2, Margaret 
Semrud-Clikeman3, Maria Kroupina3, Michael Georgieff3, Abel 
Kakuru4, Patricia Awori4, Grant M. Dorsey5, Moses R. Kamya1, 
Diane Havlir5, Chandy C. John2
1Makerere University, Kampala, Uganda, 2Indiana University, Indianapolis, 
IN, United States, 3University of Minnesota, Minneapolis, MN, United 
States, 4Infectious Diseases Research Collaboration, Kampala, Uganda, 
5University of California San Francisco, San Francisco, CA, United States
More than 30 million pregnancies occur annually in Plasmodium 
falciparum malaria endemic areas. The systemic and placental changes that 
occur with malaria in pregnancy could adversely affect the developing fetal 
brain, which could in turn affect long-term childhood neurodevelopment 
(ND). Asymptomatic malaria, uncomplicated malaria and severe malaria 
in childhood have also been associated with ND deficits. However, the 
effects of maternal and child malaria chemoprevention on child ND have 
not been assessed to date. We assessed child ND at ~1 year of age in 
Ugandan children enrolled in a randomized, double-blinded, clinical trial 
of maternal and child malaria chemoprevention. In this trial, 300 pregnant 
HIV-uninfected women were randomized at 12-20 weeks of gestation to 
malaria chemoprevention with 3 doses of sulfadoxine-pyrimethamine, 3 
doses of dihydroartemisinin-piperaquine (DP), or monthly DP, and their 
children were then randomized to receive DP chemoprevention monthly 
or every 3 months from 2 to 24 months age. Of the 272 children still in 
the study and eligible for testing, 193 have been assessed for ND outcome 
at ~1 year of age (mean (SD) 12.6 (0.6) months) using the Bayley Scales 
of Infant and Toddler Development (Third Edition). To date, the mean 
(standard deviation) composite scores for Cognition, Language and Motor 
scales are 103.2 (12.55), 99.47 (9.38) and 105.4 (12.51) respectively. 
There is no difference in test performance by sex. Treatment arm allocation 
remains concealed until June 2016, when the one year assessments will be 
completed. We hypothesize that monthly DP in both mothers and children 
will be associated with better ND outcomes than the other arms. The final 
one year results of the PROTECT study, the first prospective study of child 
ND outcomes after maternal and child malaria chemoprevention, will be 
presented at the national meeting of the American Society of Tropical 
Medicine and Hygiene.
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THE EFFECT OF ARTEMISININ-BASED COMBINATION 
THERAPY (ACT) OPTIONS ON HEMATOLOGICAL RESPONSE 
IN PLASMODIUM FALCIPARUM MALARIA: A SYSTEMATIC 
REVIEW AND POOLED ANALYSIS OF INDIVIDUAL PATIENT 
DATA
Kasia Stepniewska, on behalf of the WWARN Hematology Study 
Group
World Wide Antimalarial Resistance Network, Oxford, United Kingdom
Malaria-associated anemia has a complex etiology related to increased 
red cell destruction and hemopoeitic suppression, compounded by 
malnutrition and helminth carriage. Recent reports describe variable 
reductions in hemoglobin after treatment of P. falciparum (Pf) with 
different ACTs, but precise quantification of the hemoglobin fall 
attributable to ACTs has not been evaluated widely. Understanding the 
normal hematological response and recovery following treatment of 
uncomplicated Pf malaria is crucial to quantify the risks and benefits of 
different ACTs and other antimalarials such as primaquine, a drug with 
a potentially important role in malaria elimination.A systematic search 
of literature databases was conducted to identify studies published from 
1990 to June 2015 in which hematological data were recorded in Pf 
malaria patients before and after treatment with artemether-lumefantrine, 
dihydroartemisinin-piperaquine, artesunate (AS)-amodiaquine or AS-
mefloquine. The WorldWide Antimalarial Resistance Network (WWARN), 
in collaboration with relevant investigators, organized an individual patient 
data pooled analysis standardizing and collating nearly 200 studies, with 
over 72,000 patients of which 70% from African countries. An a priori 
data analysis plan was developed to identify factors associated with 
anemia prevalence and hemoglobin changes following treatment with 
an ACT.The full analysis will be presented, including the contributions of 
asexual parasitemia, age, transmission intensity and drug concentration. 
The effect of different ACTs on hemoglobin changes (absolute and 
fractional) in the 7 days following treatment will be examined in relation to 
ACT regimen, parasite clearance time, transmission intensity and human 
host factors. The results of this study will be critical for better assessing 
safety issues and guiding the optimal therapeutic strategies for regional 
malaria elimination efforts.
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ANTIMALARIAL DRUG-RESISTANCE: WHAT DO HIV AND 
IMMUNITY HAVE TO DO WITH IT?
Silvie Huijben1, Eusebio Macete2, Ghyslain Mombo-Ngoma3, 
Michael Ramharter4, Ya Ping Shi5, Meghna Desai5, Grace 
Mwangoka6, Achille Massougbodji7, Michel Cot8, Nicaise Tuikue 
Ndam8, John Aponte1, Raquel González1, Clara Ménéndez1, 
Alfredo Mayor1
1ISGlobal, Barcelona, Spain, 2FM-CISM, Manhiça, Mozambique, 3MRU, 
BarcelonaLambaréné, Gabon, 4ITM, Tübingen, Germany, 5KEMRI, Kisumu, 
Kenya, 6IHI, Ifakara, United Republic of Tanzania, 7FSS, Cotonou, Benin, 
8IRD, Paris, France
The rise and spread of drug resistant malaria parasites is one of the 
major challenges for malaria control, and indeed will be a huge obstacle 
for malaria eradication. Successful drug treatment is dependent on 
both the killing effect of the drug and the killing effect of the immune 
system. In addition, the immune system is known to play an important 
role in within-host competition between parasites, which in turn has 
been shown to be a key part of resistance evolution. Moreover, there 
are the historical observations that resistance initially occurs in area of 
low transmission intensity and hence low level of antimalarial immunity. 
It is thus hypothesized that the immune system is a critical factor in the 
emergence and spread of drug resistant mutants. If immunity indeed 
plays a role, this has significant implications for malaria elimination 
where reduced immunity is a natural consequence yet this is achieved 
by using a high amount of drug pressure. Using data of clinical trial on 
IPTp use in pregnant women in Benin, Gabon, Kenya and Mozambique, 
we present the occurrence of resistant mutants in a variety of immune 
contexts: (i) HIV-co-infections, (ii) women with different levels of antibody 
titers, (iii) placental and peripheral infections, and (iv) primigravidae and 
multigravidae women.
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EFFICACY OF ARTEMETHER-LUMEFANTRINE FOR 
TREATMENT OF UNCOMPLICATED PLASMODIUM 
FALCIPARUM MALARIA IN CRUZEIRO DO SUL, ACRE, BRAZIL
Megumi Itoh1, Suiane Negreiros do Valle2, Samela Farias2, Thayna 
Maria Holanda de Souza2, Giselle R. Viana3, Stella Chenet1, Naomi 
W. Lucchi1, Paola Marchesini4, Marinete Póvoa4, Ana Carolina Faria 
e Silva Santelli4, Alexandre Macedo de Oliveira1
1Centers for Disease Control and Prevention, Atlanta, GA, United States, 
2Acre State Health Secretariat, Cruzeiro do Sul, Brazil, 3Instituto Evandro 
Chagas, Brazilian Ministry of Health, Ananindeua, Brazil, 4National Malaria 
Control Program, Brazilian Ministry of Health, Brasilia, Brazil
Plasmodium falciparum malaria has high morbidity and mortality; there 
were 143,551 cases in the Brazilian Amazon Region in 2014, of which 
15.9% were P. falciparum monoinfection. Artemether-lumefantrine 
(AL) is the first-line treatment. Following the World Health Organization 
recommendation to routinely evaluate antimalarial treatment policies, 
we are conducting a therapeutic efficacy in vivo trial of AL for treatment 
of uncomplicated P. falciparum malaria in Cruzeiro do Sul, Acre, Brazil 
from December 2015 to May 2016. The objectives of this study are to 
evaluate the efficacy of the first-line antimalarial regimen for treatment 
of uncomplicated P. falciparum malaria and ensure effective case 
management practices are maintained in Brazil. Febrile participants ≥5 
years old with microscopically confirmed P. falciparum monoinfection 
with parasitemia between 250 and 200,000 asexual parasites/microliter 
were enrolled and treated with a supervised 3-day course of AL, dosed 
according to Brazilian guidelines for malaria control. Clinical and 
parasitological parameters are monitored for 28 days. Recrudescence is 
differentiated from reinfection by comparing parasite genotypes from 
Day 0 and the day of failure. Genetic markers associated with artemisinin 
resistance, including the K13 gene mutation will be assessed. A total 
of 127 patients have been screened, and all 85 participants have been 
enrolled. Four participants were excluded after enrollment; two due to 
parasitemia below inclusion range, one due to P. vivax infection upon slide 
review, and one due to absence of fever in the previous 48 hours. Among 
enrolled patients, 61 have completed follow-up, 17 are still being followed 
and three have been lost to follow-up. No patient has met criteria for 
treatment failure, although one participant was diagnosed with P. vivax on 
day 28. Patient follow-up will be completed by May, 2016. Final results will 
be presented. Preliminary results suggest that AL remains highly efficacious 
for treatment of uncomplicated P. falciparum in the Brazilian Amazon 
Region. These results will be corroborated by molecular testing for the K13 
resistance gene.
869
SHOULD WE STILL USE QUININE IV FOR SEVERE MALARIA?
Ghassan N. Al Awar
AUBMC, Beirut, Lebanon
Malaria represents a significant health problem in patients coming 
back from endemic areas. Severe malaria is life threatening and the 
acute respiratory distress syndrome (ARDS) is among the more serious 
complications that invariably leads to death. We have noted the 
occurrence of ARDS in a few patients with severe malaria being treated 
with quinine IV, the only available recommended drug at the time. The 
question of whether quinine IV is a triggering or contributing factor of 
ARDS in those cases was raised. A retrospective analysis of several cases 
of malaria was initiated and a literature search was done. Both outcomes 
were not definitive in corroborating evidence against quinine IV, but the 
suspicion remains. In the USA, quinine IV has not been available or used 
in severe malaria for over 20 years! Quinidine is available in the USA. In 
the era of better antimalarial therapy, especially with the recommended 
relatively recent and effective artemisinin derivatives, or the fairly safer 
quinidine, should quinine IV still be listed among the treatments or used 
for severe malaria?
870
SAFETY AND TOLERABILITY OF DIHYDROARTEMISININ-
PIPERAQUINE AS INTERMITTENT PREVENTIVE TREATMENT 
FOR MALARIA IN A REFUGEE CAMP, ADJUMANI, UGANDA
Matthew E. Coldiron1, Estrella Lasry2, Malika Bouhenia1, 
Debashish Das1, Richard Mathela3, Leon Salumu2, Rebecca F. Grais1
1Epicentre, Paris, France, 2Médecins Sans Frontières, Paris, France, 
3Médecins Sans Frontières, Kampala, Uganda
The use of dihydroartemisinin-piperaquine (DP) is increasing in sub-
Saharan Africa, though safety data in Africa is sparse. DP was used by 
Médecins Sans Frontières in an Intermittent Preventive Treatment (IPT) 
program in a refugee camp in northern Uganda in 2015. All children aged 
6 months to 14 years resident in the camp were eligible for participation in 
the program, which consisted of three mass distributions of DP at 8 week 
intervals. Weight-based dosing following 2014 guidelines was used and 
a total of 40 611 doses of DP were administered during 3 distributions. A 
health-center based pharmacovigilance system was implemented during 
the program, and an existing community-based mortality surveillance 
system was continued. Signs and symptoms of both common and severe 
side effects due to DP were part of key sensitization messages during the 
campaign. Participants experiencing any symptoms were encouraged to 
present to the health centers in the camp, where free health care was 
provided. A total of 56 adverse events (AE) were reported during the 24 
week follow-up period. All AEs were reported in the 10 days following DP 
administration. Of the 56 AEs, 28 were judged to be probably or definitely 
related to DP; the most common symptoms were rash or itching (12) and 
vomiting (6). One case of urticaria was notified. Symptom severity was 
noted for all AEs regardless of causality: 75% were mild and 25% were 
moderate. One SAE was reported: an unexplained death in the community 
which occurred in a 12-year old girl who was diagnosed with varicella 
12 days after taking the first distribution of DP. On the 8th day of her 
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varicella, she developed swelling of her face and limbs over several hours, 
lost consciousness at home, and was pronounced dead on arrival to the 
health center. Her mother reported her taking only paracetamol and using 
a zinc oxide cream in the days prior to her death. The SAE was considered 
possibly related to DP, but the concomitant varicella provides an alternative 
explanation. These data show that DP is well-tolerated and safe when 
given in repeated doses in an IPT setting. Its use in similar contexts in sub-
Saharan Africa should be considered.
871
FALSE SECURITY FROM OBSOLETE MALARIA DRUG-
RESISTANCE MARKERS
John White, III1, Anjali Mascarenhas2, Rimi Chakrabarti2, Devaraja 
G. Mudeppa1, Ambika Sharma2, Riaz Basha2, Ligia Pereira2, Rashmi 
Dash2, Jennifer N. Maki1, Jennifer Guler3, Edwin Gomes2, Laura 
Chery1, Pradipsinh Rathod1
1Department of Chemistry, University of Washington, Seattle, WA, United 
States, 2Department of Medicine, Goa Medical College and Hospital, 
Bambolim, Goa, India, 3Department of Biology, University of Virginia, 
Charlottesville, VA, United States
Malaria kills 500,000 people every year and this toll may increase if 
Plasmodium parasites evolve resistance to the artemisinin combination 
therapies that are the current mainstay of treatment. For the last two 
decades, artemisinin derivatives have been the frontline treatment 
for malaria-infected individuals and have prevented the public health 
catastrophes that followed the previous failure of chloroquine. To 
protect them as potent antimalarials for as long as possible, Artemisinin 
Combination Therapy (ACT) pairs artemisinins with other classes of 
antimalarials with the presumption that simultaneous development of 
resistance to all ACT components is improbable. Despite this approach, 
artemisinin resistance has recently been established in Southeast Asia. It 
is now important to understand how parasite populations may acquire 
resistance to ACTs. Here we report an ominous finding: P. falciparum 
isolates collected in Southwest India in 2012 displayed antifolate resistance 
in cell-based assays that was as high as the most resistant parasites in 
the world, but these parasites did not contain the full set of classic DNA 
sequence markers for the highest antifolate resistance. Parasites from 
regions using artemisinin-antifolate combinations for decades display 
novel mechanisms of antifolate resistance that escape routine surveillance 
methods. The unwitting use of ineffective partner drugs threatens to 
undermine the last remaining effective antimalarial.
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ASSESSMENT OF THE USE OF MALARIA RAPID DIAGNOSTIC 
TESTS IN HEALTH FACILITIES IN GHANA
Andrew Paanii Quao, Solomon Atinbire, Felicia Amoo-Sakyi, 
Peter Segbor, Raphael Ntumy
PATH, Accra, Ghana
Malaria rapid diagnostic tests (RDTs) have become the mainstay diagnostic 
tool for acute malaria infection in most health facilities in Ghana. However, 
in spite of the generally good performance of these tests, their use by 
health care providers at health facilities can be challenging. Data on the 
performance, reading and interpretation of RDTs under routine program 
conditions are limited. Since 2012, the US President’s Malaria Initiative 
(PMI) has supported the MalariaCare partnership to collaborate with the 
National Malaria Control Program (NMCP) to improve quality of malaria 
diagnosis using RDTs in health facilities. As part of MalariaCare’s quality 
assurance program for case management, trained clinicians and laboratory 
staff act as supervisors who conduct outreach training and supportive 
supervision (OTSS) visits to health facilities in five of Ghana’s ten regions. 
These visits focus on skills observation and on-the- job mentoring and 
problem solving, with the primary aim of improving clinical assessment 
and evaluation skills, preparation and accuracy of malaria diagnostic tests, 
and adherence by clinicians to test results. A key component of the OTSS 
system is observing facility staff perform RDTs and providing coaching 
to staff on weaknesses and errors observed. Following four rounds of 
OTSS data tracking in focus regions, 7,502 RDT tests observed gathered 
information on each step in the preparation and reading of an RDT 
performance during 5,088 health facility visits. MalariaCare will present 
the findings on common errors made in conducting RDT tests, but also 
track progress over time in addressing these weaknesses.
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STRUCTURAL AND FUNCTIONAL EFFECTS OF HEME BINDING 
TO RCPFHRP2: IMPLICATIONS FOR MALARIA DIAGNOSIS
Anna L. Bitting1, Christine F. Markwalter1, Robert A. Burton2, 
David W. Wright1
1Vanderbilt University, Nashville, TN, United States, 2PATH, Seattle, WA, 
United States
Early diagnosis of malaria is a key element of elimination strategies 
because individuals with low parasite loads can serve as transmission 
reservoirs. Rapid diagnostic tests (RDTs) are often used in widespread 
malaria screening efforts to quickly and easily detect the malaria 
biomarker PfHRP2, a histidine-rich protein produced by the malaria 
parasite Plasmodium falciparum, in a small drop of blood. However, 
PfHRP2 protein sequence variation coupled with manufacturing issues 
can make these tests unreliable. This work is focused on investigating 
the structure of PfHRP2 and its relationship to the effectiveness of 
current RDTs. Past studies have indicated that PfHRP2 may play a role 
in the parasite’s heme detoxification process by binding free heme and 
promoting its crystallization into hemozoin. We hypothesize that heme-
bound protein adopts a different conformation from free protein, and that 
this conformational change may affect protein binding to antibodies on 
an RDT. This is especially a concern since native protein will be exposed 
to heme in blood, but purified recombinant protein used for industrial 
antibody production will not. This work investigates the conformational 
changes of rcPfHRP2 in the presence of heme using circular dichroism 
(CD), and the effects of heme on antibody-based PfHRP2 detection using 
ELISA and RDT formats.
874
IMPROVING QUALITY OF MALARIA RAPID DIAGNOSTIC 
TESTING AND TEST ADHERENCE THROUGH QUALITY 
ASSURANCE
Goodluck Elias Tesha1, Sarah Burnett2, Frank Chacky3, Troy 
Martin4, Jackson Mugyabuso1, Gerald Mng’ong’o5, Sigsbert 
Mkude3, Zahra Mkomwa1, Lynn A. Paxton6, Chonge Kitojo7
1PATH, Dar Es Salaam, United Republic of Tanzania, 2PATH, Washington, 
DC, United States, 3NMCP, Dar Es Salaam, United Republic of Tanzania, 
4PATH, Seattle, WA, United States, 5MCDI, Dar Es Salaam, United Republic 
of Tanzania, 6U.S. President’s Malaria Initiative, U.S. Centers for Disease 
Control and Prevention, Dar Es Salaam, United Republic of Tanzania, 7U.S. 
Agency for International Development, Dar Es Salaam, United Republic of 
Tanzania
As malaria prevalence in Tanzania declines, universal diagnostic testing 
for malaria becomes increasingly important to identify and manage other 
causes of febrile illness and reduce the threat of antimalarial resistance. 
In 2013, the Tanzania National Malaria Control Programme (NMCP) 
revised the National Guidelines for Diagnosis and Treatment of Malaria 
in line with the World Health Organization’s universal diagnostic testing 
recommendations. MalariaCare, a partnership that provides technical 
assistance to rapidly scale high quality malaria diagnosis and treatment, 
is supporting the NMCP to design and implement a malaria case 
management quality assurance (QA) system with a focus on malaria rapid 
diagnostic tests (mRDTs). After finalizing an mRDT QA training package, 
the NMCP and MalariaCare trained regional and district trainers from the 
Lake Zone, who then trained 1,539 health care workers from 883 public 
health facilities in May and-June 2015. Following training, MalariaCare and 
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the NMCP conducted outreach, training and supportive supervision (OTSS) 
at a subset of facilities in July and September 2015. OTSS aims to reinforce 
skills developed during the mRDT training and improve adherence to test 
results through skills observation, mentoring and on-the-spot problem 
solving. At the first OTSS visit, 197 health workers from 193 facilities 
scored an average of 93% during mRDT observations, showing a high 
level of competence post-training. This visit also revealed high average 
adherence to positive (96%) and negative (91%) test results. Adherence 
to negative test results varied by facility level, with dispensaries having 
higher adherence (93%) than health centers (86%) and hospitals (85%). 
The NMCP and MalariaCare will also present results from the continuation 
of OTSS, expansion of training and OTSS in the Eastern Zone, and malaria 
testing rates among these facilities based on HMIS data.
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ALL-IN-ONE, MULTIPLEXED ON-BEAD ELISA FOR MALARIAL 
BIOMARKERS PLDH AND PFHRPII
Christine F. Markwalter, Keersten M. Ricks, Anna L. Bitting, 
David W. Wright
Vanderbilt University, Nashville, TN, United States
As malaria transmission declines, accurate diagnosis becomes increasingly 
important for defining disease prevalence and distribution, as well as 
monitoring impact of interventions. Further, in low-transmission settings, 
identification and treatment of asymptomatic carriers are critical for 
eliminating the disease. Current antigen-detecting rapid diagnostic 
tests (RDTs) for malaria are unreliable in the asymptomatic regime (< 
200 parasites/µl), and laboratory protein-based detection strategies, 
such as well-plate ELISAs, can require 5 - 8 hours of incubation time 
and are limited to one analyte. To address this, we have developed 
a multiplexed, magnetic bead-based ELISA for Plasmodium lactate 
dehydrogenase (pLDH) and Plasmodium falciparum histidine-rich protein 
II (PfHRPII) with incubation times totaling less than 1 hour and detection 
limits rivaling those of well-plate ELISAs. In this assay, magnetic particles 
functionalized with antibodies specific for pLDH and PfHRPII are added 
to parasitized lysed blood samples along with detection antibodies with 
distinct enzymes for each biomarker. Sandwich complexes for pLDH and 
PfHRPII form on the surface of the magnetic beads, which are washed 
and sequentially re-suspended in detection enzyme substrate for each 
antigen. Assay detection limits are 2.7 and 1.2 parasites/µl for pLDH 
and PfHRPII, respectively. Detection of both biomarkers is advantageous 
because it avoids false-positives due to slow PfHRPII clearance and allows 
for differentiation between falciparum and non-falciparum infections, 
ultimately informing treatment. With these advantages, as well as 
high sensitivity and detection limits in the single parasite/µl regime, 
the developed multiplexed assay for pLDH and PfHRPII is an attractive 
alternative to well-plate ELISAs and a promising detection strategy for an 
elimination setting. Further, the modularity of the multiplexed on-bead 
ELISA makes it applicable to any series of infectious disease biomarkers for 
which there are antibody pairs available.
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MALARIA MICROSCOPY COMPETENCY IN LIBERIA POST 
EBOLA DISEASE OUTBREAK
Mohammed Alhassan Adams1, Patrick Hardy2, Paye Nyansaiye2, 
Nicole Whitehurst3, Yatta Walker2, Arthur Brown2, Rachael 
Watson3
1Yizura Hospital, Kintampo, Ghana, 2Liberia Ministry of Health and Social 
Welfare, Monrovia, Liberia, 3MCDI, Silver Spring, MD, United States
Since 2010 Liberia has progressively moved toward parasitological 
diagnosis of malaria. However in the last two years - since the first 
confirmed case of Ebola virus disease (EVD) on March 17, 2014, through 
January 14, 2016, when the World Health Organization (WHO) declared 
an end to the most recent outbreaks - the public health system has 
been overwhelmed managing this new disease. Due to risk from blood 
exposure, national policy mandated returning to clinical diagnosis of 
malaria instead of drawing blood. Now the Ministry of Health and Social 
Welfare is in the process of restoring essential and quality-assured health 
services in governmental and non-governmental health facilities. As a first 
step, County Health Team Diagnostic Focal Persons (CHT-DFPs) supporting 
decentralized training, and supervision activities were prioritized for 
retraining and competency assessment in malaria diagnostics. In 
February 2016, the National Malaria Control Program, with support 
from MalariaCare, conducted the first refresher training and microscopy 
competency assessment for CHT-DFPs from 13 of 15 counties post-the 
EVD outbreak. Trainees were assessed on parasite detection and parasite 
quantitation and scored against WHO minimum grades for expert level 
microscopists. Twelve (12) of 13 participants scored greater than 80% (M 
93%; Mdn 94%) on parasite detection and all (100%) participants scored 
above 50% (M 66%; Mdn 67%) on parasite quantitation, resulting in 
equivalent designations of WHO Levels 1 (n=12) and 2 (n=1) for these 13 
microscopists. There was an 11% improvement between pre- and post-
test scores for parasite detection and a 47% improvement was observed 
for parasite quantitation. Despite an almost two-year interruption in 
malaria diagnostic services, microscopy capacity within the County Health 
Teams appears to remain strong. Continued training and monitoring of 
this cadre using proficiency test panels can be achieved using a recently-
procured slide bank, putting Liberia on track to move forward with plans 
to decentralize training and supervision activities to the county level.
877
FIELD EVALUATION OF A REAL TIME LOOP-MEDIATED 
ISOTHERMAL AMPLIFICATION ASSAY (REALAMP) FOR 
MALARIA DIAGNOSIS IN CRUZEIRO DO SUL, ACRE, BRAZIL
Giselle Maria Viana1, Luciana Silva-Flannery2, Danielle Regina 
Barbosa1, Naomi Lucchi2, Suiane Costa do Valle3, Samela Farias3, 
Paola Marchesini4, Juliana Chedid Rossi4, Venkatachalam 
Udhayakumar5, Marinete Marins Póvoa1, Alexandre Macedo de 
Oliveira2
1Instituto Evandro Chagas - IEC/SVS/MS, Belém, Brazil, 2Centers for Disease 
Control and Prevention, Atlanta, GA, United States, 3Secretaria Estadual de 
Saúde do Acre - Hemonúcleo, Cruzeiro do Sul, Brazil, 4Coordenação Geral 
do Programa Nacional de Controle da Malária - CGPNCM, Brasília, Brazil, 
5Centers for Disease Control and Prevention, Atlanta, GA, United States
Traditional molecular methods, such as nested-polymerase chain 
reaction (PCR), are very sensitive to detect malaria parasites, but require 
advanced laboratory equipment and trained personnel. Real-time loop-
mediated isothermal amplification (RealAmp), a LAMP-based molecular 
tool, facilitates rapid target amplification at a single temperature 
setting, reducing the need for sophisticated equipment. There is limited 
information on the performance of this method for the malaria diagnosis 
in clinical settings and field conditions. We evaluated the performance 
of RealAmp for malaria diagnosis in Cruzeiro do Sul, Acre state, Brazil. 
We enrolled 1,000 patients with fever (axillary temperature >= 37.5 C) or 
history of fever in last 24h presenting for malaria diagnosis from February 
through August 2015. DNA was extracted from dried blood spots using 
a crude method (heat treatment) at the sample collection site (field site), 
and using commercial kits at a Brazilian national reference laboratory. 
Genus-specific RealAmp was performed at both the reference laboratory 
and field site after appropriate training. In addition, Giemsa-stained blood 
smears were prepared and examined by two independent well-trained 
study microscopists. A combination of real-time PCR and nested PCR was 
used as reference test. The sensitivity and specificity of RealAmp from 
heat treatment DNA in the field laboratory were 94.1% (95% confidence 
interval [CI]: 90.1-96.8) and 83.9% (95% CI: 81.1-86.4), respectively, 
while the sensitivity and specificity of RealAmp at the reference laboratory 
were 83.2% (95% CI: 77.6-87.9) and 97.0% (95% CI: 95.5-98.0), 
respectively. Microscopy showed sensitivity of 96.4% (95% CI: 93.0-98.4) 
and specificity of 98.2% (95% CI: 97.0-99.0). Our findings highlight that 
it is possible to implement simple molecular tests at point of care in remote 
areas of countries such as Brazil. However, RealAmp performance was 
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inferior to that of microscopy performed by skilled professionals. Attempts 
to develop and evaluate molecular tools should continue, especially in 
countries targeting pre-elimination.
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CAN PHARMACY PROVIDERS PROVIDE QUALITY MALARIA 
DIAGNOSTIC IN KENYA: RESULTS FROM EXIT INTERVIEW 
AND MYSTERY CLIENT STUDIES FROM THE KENYAN COAST
Anne M. Musuva1, Nancy Njoki1, Stephen Poyer2
1Population Services Kenya, Nairobi, Kenya, 2Population Services 
International, Washington, DC, United States
In Kenya, 32% of people seek treatment in the private sector where 
availability of diagnostics testing has been low. Pharmacies often serve 
as the first or only point of accessing care but have not been allowed 
to perform blood tests, and evidence is required to show that tests can 
be conducted safely by this cadre. Between 2014 and 2015 PS Kenya 
implemented a project seeking to increase malaria testing using RDTs 
among private clinics and pharmacies in Kwale, Mombasa and Kilifi 
counties.Studies were conducted at a random sample of project facilities in 
Q4 2014 and Q4 2015 to track provider performance. Exit interviews were 
held at 130 sites with 526 clients in 2014, and 534 clients in 2015. Eligible 
cases were adults seeking treatment for fever for themselves or on behalf 
of someone else. Confirmed RDT-negative volunteers conducted 260 
mystery client visits at 155 sites in 2014 and 262 visits at 113 sites in 2015. 
Data were analyzed using Stata v13. At endline, exit interview clients were 
more likely to be tested for malaria at clinics than at pharmacies (86.6% 
vs 59.4%, p<0.001). Between 2014 and 2015 testing by RDT increased 
by 22.4 points in clinics (30.1% to 52.0%); prior to the intervention RDTs 
were not formally available at pharmacies. Overall 83% of 238 malaria 
test-positive clients received an ACT in 2015, with no difference between 
facility types (p=0.5). However, positive clients at clinics remained twice 
as likely to receive an antibiotic (46.7% vs 17.1%, p<0.001). Over time 
untested pharmacy clients were less likely to receive an antimalarial 
(2014: 40.7%, 2015: 29.4%, p=0.006) while the level at clinics remained 
unchanged (average: 16%). Mystery clients at pharmacies were more 
likely to receive the correct diagnosis(negative) (2014: 72.8%, 2015: 
79.6%, p<0.001), than in clinics ( 2014: 58.9%, 2015: 75.7%, p<0.001) 
At endline, 0% of test-negative clinic clients and 2% of pharmacy clients 
received any antimalarial, both down from over 7% in 2014.Results from 
this project show comparable fever management at pharmacies and 
clinics on the Kenyan coast. To scale up testing the MOH should consider 
allowing RDT testing at pharmacy-level in Kenya.
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PFHRP2 DETECTING MALARIA RDTS: ALARMING FALSE 
NEGATIVE RESULTS IN ERITREA
Araia Berhane1, Selam Mihreteab1, Saleh Mohammed1, 
Ghirmay Embaye1, Filmon Hagos1, Assefash Zehaie2, Anderson 
Chinorumba3, Jane Cunningham4
1Eritrea Ministry of Health, Asmara, Eritrea, 2World Health Organization, 
Eritrea WCO, Eritrea, 3World Health Organization, WHO IST ESA, 
Zimbabwe, 4World Health Organization, WHO GMP, Switzerland
In Eritrea over 75% of suspected malaria cases are diagnosed using rapid 
diagnostic tests. Despite following WHO recommended procurement 
and quality assurance practices, frequent complaints of false negative 
RDT results were reported from most geographical settings in Eritrea in 
2015. Initial investigations involved cross checking RDT results with quality 
assured microscopy. This exercise confirmed that SD Bioline Malaria Ag 
Pf/Pv (05FK80) targeting histidine rich protein 2 (HRP2) and Plasmodium 
vivax-plasmodium lactate dehydrogenase (Pv-pLDH), failed to diagnose 
microscopically confirmed P. falciparum malaria, across a range of parasite 
densities. RDTs were retrieved from the field and found to react against 
WHO-FIND quality control samples. A product recall was implemented and 
investigations carried out to delineate causal parasite factors. Specifically, 
some Pf microscopy positive samples were assessed against other brands 
of good performing HRP2-detecting RDTs and found to be negative. In 
February 2016, 50 consecutive microscopically confirmed P. falciparum 
malaria patients presenting at two regional hospitals were screened with 
non-HRP2 detecting RDTs. Patient specimens returning positive on pf-
pLDH test line and negative on HRP2 test line provided blood samples 
for Plasmodium species identification PCR and hrp2/hrp3 PCR. The mean 
patient age was 29 yrs; parasite density range was 32-89,120 parasites/
µl; mean of 15,347). The overall prevalence of falciparum-infected blood 
specimens with positive RDT results for PfpLDH band but negative to 
PfHRP2 band was 58% [95% C.I: 44-71]. PCR results for pfhrp2 and/or 
pfhrp3 gene expression and ELISA for hrp2 are pending but preliminary 
findings support HRP2/3 gene deletion or variation amongst P. falciparum 
parasites. Furthermore, these findings should be an early warning to 
neighbouring African countries to follow up reports of false negative RDT 
results and to consider adding investigations for hrp2/hrp3 gene deletions 
into surveys and surveillance activities.
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DIRECT, HIGH-THROUGHPUT QUANTIFICATION OF 
PARASITIC DNA IN MULTIPLE SAMPLE TYPES WITHOUT DNA 
EXTRACTION
Ya Ling Zhao1, Ye Zhao1, Min Hou2, Min Jun Ji2, Chuanxin Yu3, Zhi 
Zheng1
1Department of Biochemistry and Molecular Biology, Institute of Basic 
Medical Sciences, Chinese Academy of Medical Science and School 
of Basic Medicine, Peking Union Medical College, Beijing, China, 
2Department of Pathogen Biology, Najing Medical University, Nanjing, 
China, 3Jiangsu Institute of Parasitic Disease, Jiangsu, China
Accurate diagnosis is essential for successful management of infectious 
diseases. While most molecular diagnostics are sensitive enough for clinical 
application, new diagnostic tools with simplified procedure and improved 
throughput are still needed. Capture and Ligation Probe-PCR (CLIP- 
PCR) has been demonstrated as a high throughput RNA quantification 
technology for extreme sensitive identification of malaria, but its role in 
DNA quantification remains to be demonstrated. In this study, we adopted 
CLIP-PCR for identification of DNA directly in saliva, buccal swab and 
whole blood samples. Target DNA from saliva, buccal swab or blood was 
released by lysis, heat-denatured and captured directly to 96-well plate 
by sandwich hybridization using multiple oligo probes with universal tail 
sequences. After enzymatic ligation of the probes, the single-stranded 
template is quantified with universal primers targeting the tail sequences 
by qPCR with SYBR green chemistry. To avoid false negatives caused by 
target polymorphism and reduce turnaround time, we adopted a multi-
section strategy: multiple sets of probes that target at a continuous/ 
semi continuous region of targeted DNA were used simultaneously, 
each of which being sufficient for DNA quantification by CLIP-PCR. Our 
DNA quantification CLIP-PCR assay was tested for direct quantification 
of plasmodium 18S rDNA, human 18S rDNA and schistosoma DNA. 
Without the need for DNA purification, CLIP-PCR quantifies DNA in 
multiple samples types within 4 hours. Plasmodium can be detected at a 
concentration as low as 0.19 parasites/ul in blood samples. Human 18S 
rDNA can be detected directly in both saliva and buccal swab samples, 
while Schistosoma DNA can also also be identified from serum samples of 
infected mice. These data indicate that CLIP-PCR has the same sensitivity 
as regular qPCR, but much reduced complexity and cost, making it suitable 
for large scale molecular surveillance studies.In conclusion, our study 
showed CLIP-PCR provides a highly sensitive, simple and low-cost means 
for direct identification of parasitic DNA in multiple sample types in a high 
throughput fashion.
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HIGH-THROUGHPUT, MULTIPLEX GENOTYPING DIRECTLY 
FROM SALIVA AND BUCCAL SWABS WITHOUT DNA 
PURIFICATION
Ye Zhao, Jun Zhou, Yaling Zhao, Zhi Zheng
Department of Biochemistry and Molecular Biology, Institute of Basic 
Medical Sciences,Chinese Academy of Medical Science and School of Basic 
Medicine, Peking Union Medical College, Beijing, China
SNPs have been found associated with disease susceptibility, drug response 
and complex phenotypes. Clinical population screening of significant 
SNP markers calls for multiplexed genotyping of SNPs on a large scale. 
Current SNP genotyping tools, despite many advantages, invariably 
require DNA extraction, which remains a key throughput-limiting step for 
population screening. In addition, multiplex-PCR amplification employed 
by these genotyping methods suffers from complex primer design and/or 
amplification bias. Here, we describe a novel high-throughput genotyping 
approach, MELPA , which has multiplex SNP genotyping capability, 
eliminates DNA extraction, achieves uniform PCR amplification using a 
single pair of universal primers, and is suitable for saliva and buccal swab 
samples. In brief, instead of nucleic acid extraction, MELPA lysed saliva/ 
buccal swabs and captured the target DNA directly to 96-well plate by 
sandwich hybridization using multiple oligo probes with universal tail 
sequences. After enzymatic extension and ligation of the probes, a single-
stranded template for each target SNP site was formed, and all templates 
were PCR-amplied using universal primers targeting the tail sequences. 
Multiplexed genotyping by single-base primer extensions were analyzed 
with a MALDI-TOF mass spectrometry platform. We tested the feasibility 
of the new assay for saliva and buccal swabs, and evaluated the accuracy 
by comparing MELPA with commercial multiplex SNP assay (iPLEX), for the 
detection of 20 G6PD gene variants known to be at risk for primaquine-
induced hemolysis in antimalarial therapy. We successfully developed a 20-
plex panel for G6PD genotyping. A typical 50 ul saliva or one buccal swab 
sample is sufficient for running 2 assays. Six 384-samples can be processed 
from sample to result in a 24-hour workflow, with a hands-on time of 2 
hours. Results were consistent with iPLEX, and 100% concordant with 
sequencing. Saliva and swab samples can be stored at room temperature 
for at least 24h without affecting the performance. MELPA represents 
an efficient and cost-effective approach to multiplex SNP genotyping at 
population level.
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UPTAKE OF MALARIA DIAGNOSTIC TESTS AND ADHERENCE 
TO NEGATIVE TEST RESULTS AMONG FEVER CARE SEEKERS 
AT INFORMAL DRUG SHOPS IN UGANDA
Hamsa Subramaniam1, Alex Ogwal2, Irene Ochola2, Damien 
Kirchhoffer2, Shreya Agrawal1, Felix Lam1, Luke Rooney1, Arnaud 
Le Menach1
1Clinton Health Access Initiative, Boston, MA, United States, 2Clinton 
Health Access Initiative, Kampala, Uganda
There has been a steep decline in malaria prevalence in Uganda from 
43% in 2009 to 19% in 2014. In light of this, the Ministry of Health 
changed the policy in 2010 to diagnosis prior to treatment for suspected 
cases to ensure patients are provided appropriate treatment for their 
illness and to prevent antimalarials being wasted on uninfected patients. 
Although a third of fever care seeking occurs in the informal private sector, 
there is scant reliable data on testing rates and appropriate dispensing 
of antimalarials in that sector. The objective of this study is to provide 
national estimates for malaria testing rates and to quantify antimalarial 
misuse. A cross-sectional survey was conducted in March 2016 using 
two-stage cluster sampling where up to three informal sector drug 
shops were sampled per cluster. Data were collected using a structured 
questionnaire on demographics, fever care seeking, and malaria case 
management. Clients were included if they exited any informal drug shop 
within the observation period and provided consent. Primary outcomes 
were proportion of clients seeking care for fever, proportion of fever care 
seekers testing for malaria by blood slide or malaria rapid diagnostic test 
(mRDT), and proportion of fever care seekers who tested negative and 
received an antimalarial. A total of 711 clients from 324 informal drug 
shops in 124 enumeration areas were interviewed. Seventy percent of all 
clients sought care at a shop where mRDTs were available. The proportion 
of clients seeking care for fever was 38%. Among fever care seekers 
(n=270), 33% were tested at the shop and 11% were tested elsewhere. 
Ten percent of clients testing negative still received an antimalarial. Among 
fever care seekers not taking a test (n=153), 60% received an antimalarial. 
Given the declining trend in prevalence, a sizable proportion of clients 
with fever are receiving malaria treatment without having malaria, leading 
to wastage and untreated illness. Educating providers on the decline of 
malaria prevalence as well as increasing testing availability is necessary to 
ensure that antimalarials are not presumptively dispensed.
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A MINIATURIZED FLOW CYTOMETRY PLATFORM FOR 
MALARIA DIAGNOSTICS
Brett Chromy1, Kimvan Tran1, Julie Clor1, John Mcdonald2, Beatrice 
Greco3, JIm Mulry1, John Ambroziak4, Kamala Tyagarajan1
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The diagnosis and treatment of malaria remains a challenging global 
problem due to limitations of highly sensitive and specific tests that 
identify and type the malarial parasites and due to the long turn-around 
time and expertise needed for microscopy based tests for determining the 
degree of red blood cell (RBC) infection. While flow cytometry has been 
shown to be capable of providing answers in diagnosis of malaria, the 
traditional use of expensive and sophisticated platforms and highly skilled 
operators, has restricted the speed and ease with which such diagnostic 
information can be provided. In this study, we evaluate the potential of 
a small low-cost, touch screen based miniaturized cytometer, the Muse 
Cell Analyzer for providing solutions related to malaria diagnostics. The 
platform is based on microcapillary cytometry, generates low biohazardous 
waste, uses small sample volume and provides the potential to add 
multiple diagnostic assays related to global health. A CE/IVD assay for CD4 
T cell monitoring was recently released on the platform demonstrating 
capability of the system for use in resource-constrained settings. We have 
developed novel multiplexed bead based immunoassay for detection of 
plasmodium released antigens in blood/serum to enable parasite typing. 
Initial results demonstrate superior sensitivity for detection of plasmodium 
antigens to current RDT measurement range. In addition the platform 
demonstrates capability to provide percentage of infected red blood cells 
which is also critical to diagnostic decisions. The availability of a simple, 
easy to use and affordable platform like the Muse Cell Analyzer, that can 
provide results on plasmodium typing and percentage of infected RBC’s 
can greatly increase capability to provide affordable and timely malaria 
diagnostics.
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EVALUATION OF THE PARASIGHT PLATFORM FOR RAPID 
AND HIGHLY ACCURATE MALARIA DIAGNOSIS
Seth Salpeter
Sight Diagnostics, Jerusalem, Israel
The WHO estimates that nearly 500 million malaria tests are performed 
annually. While several diagnostic assays are available, the need for an 
inexpensive, quick and highly sensitive malaria test remains a priority for 
world-wide malaria treatment. Two recent studies from our group have 
demonstrated a computer vision platform capable of meeting these needs. 
Here we present the commercially available version of this technology, the 
SightDx Parasight platform which provides malaria diagnosis, speciation 
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and parasite quantification. We conducted studies at Apollo Hospital 
in Chennai, India where 205 samples were tested, and at Aga Khan 
University Hospital Nairobi Kenya where 263 samples were evaluated. At 
both centers the device diagnoses were compared to microscopy, RDT 
and PCR results. For identification of malaria, the device demonstrated a 
sensitivity of 99% and a specificity of 100% at Apollo Hospital India, and 
a sensitivity of 100% and a specificity of 98.9% at Aga Khan University 
Hospital Kenya. For speciation, the device correctly identified 100% for 
Plasmodium vivax and 100% for P. falciparum at Apollo Hospital and 
100% P. vivax and 99.3% P. falciparum at Aga Khan University Hospital. 
Lastly, comparing the device parasite count with that of a trained 
microscopist produced an average pearsons correlation of 0.83 at Apollo 
Hospital and 0.88 at Aga Khan University Hospital.
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NO MORE HIDING: PICOGRAM DETECTION OF HISTIDINE-
RICH PROTEIN 2 FROM PLASMODIUM FALCIPARUM
Eric Rogier1, Mateusz Plucinski1, Kimberly Mace1, Michelle 
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John W. Barnwell1
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Histidine-rich protein 2 (HRP2) is produced by one of the human malarias, 
Plasmodium falciparum, and is widely used for diagnostic purposes. 
Detection of HRP2 provides evidence for active or recent infection, but 
current HRP2 immunoassays are hindered by high detection limits. Here 
we present a novel HRP2 immunoassay for antigen capture through 
a bead-based system which is capable of reliable HRP2 detection at 
low picogram levels in a highly-specific and cost-effective manner. We 
compared this assay with HRP2-based rapid diagnostic test (RDT) results 
from community surveys in different P. falciparum transmission settings 
to assess RDT reliability in the general population. In the holoendemic 
setting of northern Mozambique (RDT: SD Bioline Pf), agreement between 
the two tests was good, with a kappa coefficient of 0.77 (95% CI: 0.74-
0.79). Of 2,280 persons tested, 199 (8.7%) of were found to be positive 
for the HRP2 protein, but RDT negative, giving a receiver operating 
characteristic area under the curve (ROC AUC) of 0.95 (0.94-0.96) for 
the novel test. Additionally, 57 (4.3%) of all RDT positives were found 
to have no detectable HRP2 by the bead assay, suggesting the RDT false 
positive rate for this community survey. There was a clear trend for higher 
HRP2 concentrations in younger age groups and consequent reliability of 
true-positive RDT results, but this reliability diminished in older individuals. 
Sampling from the low-endemic nation of Haiti (RDT: First Response HRP2) 
revealed poor agreement between the tests (kappa: 0.30, 0.14-0.45). Of 
4,350 persons tested, 62 (1.4%) were positive by the bead assay, but 53 of 
these persons were RDT negative (ROC AUC: 0.75, 0.62-0.89), illustrating 
the low HRP2 concentrations of persons in the population harboring the 
protein. Of the 24 RDT positive persons from this community survey, 15 
(63%) had no detectable HRP2 by the bead assay, showing a high degree 
of false positive tests in asymptomatic individuals. The low detection limit 
and high specificity of the bead assay can potentially provide a national 
malaria control program with an objective indication of the performance 
of HRP2-based RDTs in an area.
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APTAMER-BASED LOW RESOURCE DIAGNOSTICS FOR 
DETECTION OF MALARIAL BIOMARKER PLASMODIUM 
LACTATE DEHYDROGENASE
Andrew G. Kantor, David Wright
Vanderbilt University, Nashville, TN, United States
Early diagnosis of malaria is critical to disease intervention, as 
asymptomatic individuals with malaria can serve as a transmission reservoir 
for the disease. Diagnostic testing has doubled since 2010 due to the 
rise of rapid diagnostic tests, most of which are designed using a lateral 
flow assay (LFA) format. LFAs overcome many shortcomings of more 
resource-dependent techniques (i.e. microscopy and PCR) but perform 
poorly at low parasitemias, thus preventing the diagnosis of asymptomatic 
individuals. LFAs for malaria often employ monoclonal antibodies (mAbs) 
for biomarker capture and detection. However, over the past twenty 
years aptamers have emerged as a potential alternative to mAbs in 
diagnostic applications. Aptamers are synthetic nucleic acid sequences 
that bind to target molecules with high (~nM) affinity, and offer several 
advantages over antibodies, namely a non-immunological origin, increased 
thermal stability, and affordable automated chemical synthesis. Our lab 
has characterized the kinetics of binding for a multitude of mAbs and 
aptamers specific for P. falciparum LDH, P. vivax LDH, or both. Moreover, 
we have developed a strategy for capturing native P. falciparum LDH from 
large volume (50-100 µL) whole blood samples using commercial magnetic 
beads functionalized with an X-aptamer, which is a next generation 
aptamer that incorporates druglike moieties into various nucleotides of 
the aptamer sequence to increase target affinity. The captured pLDH is 
subsequently concentrated and eluted in a small volume (10 µL) of single-
stranded DNA that is complementary to the X-aptamer, and the eluent is 
then spotted on a lateral flow assay. This initial processing step overcomes 
the sample volume constraints (only 5-10 µL) of commercial LFAs, allowing 
more biomarker to be delivered to the LFA test line for signal enhancement 
in samples with low parasitemia.
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GUIDING THE DEVELOPMENT OF IMPROVED DIAGNOSTICS 
FOR MALARIA: LIMIT-OF-DETECTION OF CURRENT RAPID 
DIAGNOSTIC TESTS
Xavier C. Ding1, Roxanne R. Rees-Channer2, Alfons Jimenez3, 
Laura Puyol3, Alfredo Mayor3, Peter C. Chiodini2, Iveth J. González1
1FIND, Geneva, Switzerland, 2Department of Clinical Parasitology, Hospital 
for Tropical Diseases, University College London Hospitals NHS Foundation 
Trust, London, United Kingdom, 3ISGlobal, Barcelona Ctr. Int. Health Res. 
(CRESIB), Hospital Clínic - Universitat de Barcelona, Barcelona, Spain
The simplicity, rapidity and affordability of lateral flow 
immunochromatographic assays, referred to as rapid diagnostic tests 
(RDTs), have transformed our ability to diagnose malaria. The performance 
of quality-assured RDTs is typically equal or superior to routine microscopy 
and these tests can be used by community health workers effectively 
and with minimal training requirements. Since 2010, the World Health 
Organization recommends that all suspected cases of malaria should be 
diagnosed by either technique to prevent presumptive treatment. As a 
result, the WHO African Region has seen the proportion of diagnosed 
cases increasing from 36% of all suspected cases in 2005 to 65% in 
2014, with almost three quarters of those being tested by RDTs. This 
and other improvements in antimalarial interventions led to a global 
decrease in malaria prevalence with a number of countries shifting 
from control to elimination strategies.Current RDTs are considered 
appropriate for the diagnosis of febrile patients, however more sensitive 
RDTs would be needed to support detection of asymptomatic infections 
in a context of malaria elimination. In order to guide the development 
of improved tests, the exact analytical limit-of-detection (LOD) of a set 
of current RDTs has been determined. The best-in-class RDTs detecting 
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the histidine-rich protein II (HRP2) or Plasmodium lactate dehydrogenase 
(pLDH) antigens were selected and then tested with serial dilutions of 
various reference materials, including recombinant HRP2 and pLDH 
proteins, Plasmodium falciparum culture samples as well as field isolates 
of both P. falciparum and P. vivax.With this study, we report for the first 
time the lowest concentrations of target analytes that can be detected 
by the best RDTs currently in the market. The determination of this 
key performance parameter allows for a better understanding of the 
advantages and limitations of current good-quality RDTs as well as of the 
potential improvement that could be achieved for the detection of parasite 
populations able to sustain malaria transmission.
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LAMP VERSUS MICROSCOPY AND RDT TO DETECT MALARIA 
IN PREGNANT WOMEN: A CROSS SECTIONAL STUDY IN NW 
ETHIOPIA
Banchamlak Tegegne1, Sisay Getie1, Abu Naser Mohon2, 
Wessenseged Lemma1, Dylan R. Pillai2
1University of Gondar, Gondar, Ethiopia, 2University of Calgary, Calgary, 
AB, Canada
Timely diagnosis followed by effective treatment is the best strategy for 
prevention, control and elimination of malaria in pregnancy. Detection of 
malaria by microscopy or rapid antigen tests in resource-limited settings 
is hampered by quality control, infrastructure limitations, training, and 
poor analytical sensitivity. Low sensitivity of current testing modalities is 
of concern in pregnancy where parasite levels are low in the peripheral 
blood due to placental sequestration. We evaluated the performance of 
loop-mediated isothermal amplification (LAMP) compared to microscopy 
for the diagnosis of malaria among pregnant mothers in NW Ethiopia. 
A cross sectional study was conducted from January to April 2016 at 
Koladiba Health Center in North Gondar. Eight-seven blood samples were 
collected from pregnant mothers suspected of having malaria and tested 
by Giemsa-stained thick and thin peripheral bloodfilm, RDT, LAMP and 
nested PCR. Diagnostic accuracy measures (analytical sensitivity, specificity, 
predictive values, and Kappa scores) of microscopy, RDT (HRP2/pLDH(Pf/
PAN) Combo) and LAMP (Eiken LoopAMP) was compared to nested PCR 
by using Simple Interactive Statistical Analysis (SISA) software and Cohen’s 
Kappa reliability measure. A total of 87 women were enrolled, 50.6% 
with a previous history of malaria, 74.7% were multigravidae, 17.2% 
were in the first trimester, 41.4% second trimester, and 41.4% third 
trimester. Ten samples were positive for malaria by microscopy, 9 by RDT, 
and 15 by LAMP. P.falciparum, P.vivax, and mixed infections of the two 
species were detected. Using nested PCR as gold standard, the sensitivity 
of microscopy and RDT was 90 and 70%, specificity 98.7% and 97.4%, 
respectively. LAMP showed a sensitivity and NPV of 100%, specificity of 
93.5%, with k=0.768 with nested PCR. We conclude that LAMP is a rapid 
molecular method and more sensitive than both microscopy and RDT for 
the detection of malaria in pregnancy. Mass screen and treat strategies to 
reduce the burden of malaria in pregnancy and reduce infant mortality will 
benefit from more sensitive methods like LAMP.
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MALARIA STRATIFICATION FOR ELIMINATION ACTIVITIES
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7Programme National de Contrôle de la Malaria, Port-au-Prince, Haiti
Eliminating malaria and preventing resurgence will require targeting 
appropriate packages of interventions to places with ongoing transmission 
while managing the risk of importation and re-establishment, which 
relies primarily on the capacity of the health system to detect and 
treat new infections. Here, we describe a process for operational 
stratification and decision making using three available metrics in the 
context of a malaria elimination program in Haiti. Maps of malaria 
incidence data, parasite movement, and treatment seeking rates were 
generated and used to stratify the country into operationally relevant 
units. Thresholds for categorizing units by the required intervention 
packages, including improved routine case detection and management, 
indoor residual spraying (IRS), active case detection (ACD), mass drug 
administration (MDA), and measures targeting imported infection, were 
estimated by analyzing the relationships among the interlinked metrics. 
This methodology was applied to evaluate interventions required for 
elimination in Haiti. Results suggested that 75% of the population 
was at low risk of malaria transmission, requiring only stronger passive 
case detection and management. Grand Anse in the South West and 
Commune Ganthier in the West, near Etang Saumatre lake were identified 
as remote areas with the highest malaria transmission and relatively poor 
access to malaria treatment, requiring aggressive measures including 
simultaneous ACD, IRS, and MDA. Most imported infections are found 
in Port-au Prince suggesting that additional measures targeting travelers 
would be needed. This methodology provides a potential framework to 
help national malaria programs to develop evidence-based operational 
plans for targeting aggressive interventions. In a resource-limited 
environment, this sort of approach will be critical to ensuring optimal 
intervention packages are targeted to the places where they will have 
greatest impact, increasing the probability of interrupting transmission and 
maintaining malaria elimination.
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INCREASED PREVALENCE OF ASYMPTOMATIC PLASMODIUM 
FALCIPARUM INFECTION IN DIENGA, SOUTHEASTERN 
GABON
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Bernard Lekana-Douki1, Marielle Bouyou-Akotet3, Dieudonne 
Nkoghe Mba1, Fousseyni S. Toure Ndouo1
1Centre International de Recherches Medicales de Franceville, Franceville, 
Gabon, 2Département d’Epidémiologie et des Affections Parasitaires, 
MRTC, Faculté de Médecine et d’Odontostomatologie, Université de 
Bamako, Bamako, Mali, 3Département de Parasitologie-Mycologie 
Médecine Tropicale, Faculté de Médecine, Université des Sciences de la 
Santé, Libreville, Gabon
Control strategies implemented a decade ago led to a marked reduction 
in the prevalence of malaria in many countries. In Dienga, southeastern 
Gabon, the prevalence of microscopic Plasmodium falciparum infection 
was 7% in 2003, close to the pre-elimination threshold of 5%. The aim 
of this work was to determine the prevalence of P. falciparum infection in 
the same community a decade later.A cohort of 370 individuals aged from 
3 to 85 years living in Dienga was investigated for P. falciparum infection; 
during six passages (P) in 15-month period. Demographic data were 
collected, along with behaviors and attitudes towards malaria. Plasmodium 
infection was diagnosed by microscopy (ME), followed by PCR to detect 
submicroscopic infection.The prevalence of P. falciparum infection in P1, 
P2, P3 , P4 , P5 and P6 was respectively 43.5% (25.1% ME+, 18.4% 
PCR+); 40.9% (27.0% ME+, 13.9% PCR+), 52.7% (26.1% ME+, 26.6% 
PCR+); 34.1% (14.1% ME+, 20% PCR+), 57.7% (25.4.% ME+, 32.3% 
PCR+);and 46.2% (21.4% ME+, 24.8% PCR+) with an overall average 
of 45.9% (95%CI [37.0 - 54.7], 23.2% ME+ and 22.7% PCR+). P4 and 
P5 prevalences were statically different throughout the six passages. 
Microscopic prevalence was significantly higher than that observed ten 
years ago (23% [n=370] vs 7% [n=323], p < 0.001). Asymptomatic 
infections were the most frequent (96%). Gametocytes were detected 
in levels ranging from 5.9% to 13.9%. Insecticide-treated nets, indoor 
residual insecticides, and self-medication were used by respectively 33.2% 
(95%CI [29.0 - 37.4]), 17.7% (95%CI [15.5 - 19.9]) and 12.1% (95%CI 
[10.6 - 13.6]) of the study population.A near-threefold increase in P. 
falciparum infection has been observed in a rural area of southeastern 
Gabon during a 10-year period. Most infections were asymptomatic, but 
these subjects likely represent a parasite reservoir. These findings call for 
urgent reinforcement of preventive measures.
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FALCIPARUM MALARIA IN BOTSWANA
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of Namibia, School of Medicine, Windhoek, Namibia
Botswana is one of eight SADC countries targeting malaria elimination by 
2018. Through upscaling of control activities, significant reductions in case 
incidence of Plasmodium falciparum (0.96 - 0.01) was achieved between 
2008 and 2012. As part of the elimination campaign, active detection 
of asymptomatic Plasmodium species was carried out to determine 
asymptomatic Plasmodium species carriage by nested PCR in the country, 
in 2012. A cross-sectional study involving 3924 apparently healthy 
participants were screened for Plasmodium species in 14 districts (5 
endemic: Okavango, Ngami, Tutume, Boteti and Bobirwa; and 9 epidemic: 
North East, Francistown, Serowe-Palapye, Ghanzi, Kweneng West, 
Kweneng East, Kgatleng, South East, and Good Hope). Venous blood was 
taken from each participant for a nested PCR detection of Plasmodium 
species. The parasite rates of asymptomatic Plasmodium species detected 
were as follows: P. falciparum, 0.16%; P. vivax, 4.66%; P. malariae,(Pm) 
0.16%; P. ovale, 0%, mixed infections (P. falciparum and P. vivax), 
0.055%; and (P. vivax and P. malariae ), 0.027%, (total: 5.062%). The high 
proportion of asymptomatic reservoir of P. vivax was clustered in the East, 
South Eastern and Central districts of the country. High rates of P. vivax 
infection correlated linearly with high rates of P. malariae infections with 
a predictive value of 27.9 P. vivax infections for each P. malariae infection 
(95% CI 22.6-33.2, p<0.001). The median age for P. vivax infection was 5 
years (Mean 5.13 years, interquartile range 3-7 years).The odds of being 
infected with P. vivax decreased by 7% for each year increase in age (OR 
0.93, 95%CI 0.87-1.00, p=0.041) when gender was adjusted for in a 
logistic regression. In conclusion, we have confirmed low parasite rate of 
asymptomatic Plasmodium species in Botswana, with the exception of P. 
vivax which was unexpectedly high. This has implication for the elimination 
campaign, requiring a follow up study taking this evidence into account in 
the elimination campaign.
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USE OF ACTIVE AND PASSIVE SURVEILLANCE TO 
DETERMINE THE RISK FACTORS FOR MALARIA INFECTION 
IN ACEH BESAR, INDONESIA, A LOW-ENDEMIC, MULTI-
SPECIES SETTING (PLASMODIUM KNOWLESI, P. VIVAX, 
AND P. FALCIPARUM INFECTION) AIMING FOR MALARIA 
ELIMINATION
Herdiana Herdiana1, Chris Cotter2, Farah Coutrier3, Yusrifar K. 
Tirta3, Iska Zarlinda3, Brittany W. Zelman2, Roly D. Gosling2, Peter 
Baker1, Maxine Whittaker1, Michelle S. Hsiang4
1University of Queensland, School of Public Health, Brisbane, Australia, 
2Malaria Elimination Initiative, Global Health Group, University of California 
San Francisco, San Francisco, CA, United States, 3Eijkman Institute for 
Molecular Biology, Jakarta Pusat, Indonesia, 4Department of Pediatrics, 
University of Texas Southwestern Medical Center, Dallas, TX, United States
As the number of malaria cases declines, the risk factors for infection 
change and transmission becomes more geographically focal and likely 
due to asymptomatic and non-falciparum infections. To inform malaria 
elimination planning, local risk factor assessments using acquired data 
are necessary. To identify risk factors for malaria infection, a population-
based passive and active surveillance study was conducted in Aceh Besar 
District, Indonesia from 2014 to 2015. Malaria infection was defined as 
symptomatic PCR-confirmed infection passively reported from five health 
facilities, or asymptomatic or symptomatic PCR-confirmed infection 
identified in reactive case detection (RACD). Potential risk factors were 
assessed through a questionnaire. Multi-level logistic regression models 
were used to measure the associations between potential risk factors and 
malaria infection. Risk factors associated with species-specific infection 
and secondary cases were analysed by chi-squared/Fisher-exact test and 
Kruskal-Wallis/Wilcoxon test. Passive surveillance identified 19 Plasmodium 
knowlesi, 11 P. vivax, and six P. falciparum infections. Of 1,495 individuals 
screened in RACD, six (one Pk, three Pv, and two Pf) had PCR-confirmed 
infection. Compared to non-infected subjects screened in RACD, infections 
identified through passive or active surveillance were more likely to be 
male (AOR 12.24, 95%CI:2.84-51.05), young adults (15-30 years) (AOR 
14.11, 95%CI:2.01-98.79), and work requiring overnight stays in the 
forest (AOR 8.19, 95%CI:1.54-43.70). Clustering of species by sub-district 
of residence was determined. For secondary case detection in RACD, 
cases were mainly afebrile (4/6), resided within 100 meters or in the same 
household as the index case, and had the same risk factors as index cases. 
The risk factors for infection in index cases and RACD identified cases were 
related to forest-related work. In low transmission settings, utilization of 
data available through routine passive and active surveillance can support 
targeted efforts for individuals at high risk.
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USE OF ‘EASY ACCESS GROUPS’ TO GUIDE MALARIA 
ELIMINATION INTERVENTIONS IN HAITI - SURVEYS AMONG 
PRIMARY SCHOOL, HEALTH FACILITY AND CHURCH 
ATTENDEES TO REFINE TRANSMISSION RISK AREAS AND 
TARGET INTERVENTIONS
Thomas Druetz1, Gillian Stresman2, Ruth Ashton1, Michelle A. 
Chang3, Jean F. Lemoine4, Chris Drakeley2, Thom Eisele1
1Tulane University, New Orleans, LA, United States, 2London School of 
Hygiene & Tropical Medicine, London, United Kingdom, 3Centers for 
Disease Control and Prevention, Atlanta, GA, United States, 4Programme 
national contre la malaria, Port-au-Prince, Haiti
“Malaria Zero: the Alliance for a Malaria-Free Haiti” was formed to assist 
Haiti in achieving malaria elimination by 2020. Plasmodium falciparum 
prevalence is estimated to be <1% nationally. In such low transmission 
settings, infections are likely to be spatially clustered. Targeting elimination 
activities to these clusters rather than the whole population will be a 
more effective use of resources and is expected to have a greater impact 
on transmission. This study investigates the use of surveys among easy 
access groups (EAG) to identify areas of ongoing transmission where 
aggressive parasite elimination activities can then be focused. Three EAG 
venues were identified to enable rapid sampling of populations: primary 
schools, health facilities (all attendees) and churches. A concurrent large-
scale household survey was conducted to validate which, if any, EAG 
sampling approach(es) can identify areas of ongoing transmission in the 
community to support decision making for targeting elimination activities. 
EAG surveys were conducted in 25 primary schools, eight churches and 
10 health facilities across four communes of Grande Anse, with 2,100 
individuals randomly sampled from each venue type. Each individual was 
tested for a P. falciparum infection using an HRP2-based rapid diagnostic 
test (RDT) and exposure to malaria by screening for a panel of antimalarial 
antibodies by Luminex. Data on demographic and socio-economic factors, 
treatment seeking behavior, travel patterns, and prevention practices 
were also collected. Information on residence was collected from all RDT 
positive and a random selection of RDT negative individuals using a variety 
of approaches (GPS loggers, interactive digital maps) compared with direct 
tracing of households. Residence information is used to estimate the 
approximate catchment area for each EAG venue, as well as locate the 
household of detected P. falciparum infections. Data collected from the 
household survey will be used to calibrate EAG data, and determine if EAG 
surveys successfully identified areas of ongoing malaria transmission.
894
PRIMAQUINE SAFETY IN G6PD-DEFICIENT MILITARY 
COHORT IN CAMBODIA USING THE LOWER-DOSE, 
EXTENDED COURSE REGIMEN AS PART OF MASS DRUG 
ADMINISTRATION FOR MALARIA ELIMINATION
Mariusz Wojnarski1, Chanthap Lon1, Somethy Sok2, Bun 
Rathvicheth1, Soklyda Chann1, Michele Spring3, David Saunders4, 
Panita Gosi1, Sovanveasna Kin2, Nillawan Buathong1, Mali 
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Rekol5, Muth Sinoun5, Khengheng Thay5, Mary So2, Jessica Lin6, 
Satharath Prom2, Philip Smith1, Mark Fukuda1
1U.S. Armed Forces Research Institute of Medical Sciences, Bangkok, 
Thailand, 2Ministry of National Defense, Department of Health, Phnom 
Penh, Cambodia, 3Walter Reed Army Institute of Research, Silver 
Spring, MD, United States, 4U.S. Army Medical Materiel Development 
Activity, Frederick, MD, United States, 5National Center for Parasitology, 
Entomology and Malaria Control, Phnom Penh, Cambodia, 6University of 
North Carolina School of Medicine, Chapel Hill, NC, United States
Primaquine (PQ) implementation in malaria-endemic areas is hindered by 
the fear of precipitating primaquine induced hemolytic anemia in G6PD-
deficient subjects. We report on safety of a modified dosing regimen of 
primaquine in G6PD-deficient subjects, with G6PD activity ranging from 
0.04 to 2.67 U/g Hb (median 0.59 U/g Hb) who got treated with a lower 
dose, extended 12 week course of primaquine as part of the Malaria 
Elimination Pilot Study in Cambodia. This dose of PQ was well tolerated 
even in subjects with severe G6PD deficiency and appears to carry a low 
risk of significant hemolysis. 87 of G6PD-deficient volunteers were started 
on a weekly PQ at a dose of 22.5 mg (approximately 0.45 mg/kg) for 12 
weeks, for a total dose of 270 mg. All subjects who had >10% drop of 
HCT and/or Hgb on day 3 post PQ, had additional CBC performed on day 
7 with safety follow up until their counts stabilized. Thirteen of 87 (15%) 
G6PD-deficient volunteers, treated under the modified PQ regimen, had 
more than 10% drop in HCT and/or Hgb on day 3, the highest drop being 
16%. On day 7, 2/13 had no change, 2/13 showed recovery (rise in HCT 
and less than 10% down from baseline), and 9/13 showed continued 
HCT reductions in the range of 13-22% from baseline. 3/13 volunteers 
had additional small drops of HCT in week 2 but none exceeded 25% 
safety threshold or required PQ discontinuation. The lowest Hgb value 
measured post PQ was 11 g/dL. No volunteers had serious adverse event 
due to PQ or significant symptoms of anemia or hemolysis. This is the 
largest cohort of G6PD-deficient subjects from Southeast Asia treated 
with weekly PQ and followed prospectively. These results contrast recent 
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report of significant safety concerns with the CDC-recommended 45 mg 
weekly PQ regimen in G6PD-deficient subjects in SE Asia. The better safety 
profile of this lower 22.5 mg weekly dose offers a more feasible strategy 
for targeting hypnozoites in malaria elimination settings where P. vivax and 
G6PD deficiency are common.
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COMPARATIVE ACCURACIES OF THREE MODELS OF 
HOTSPOT PREDICTION IN THE PRE-ELIMINATION SETTING OF 
ZAMBEZI REGION, NAMIBIA
Oliver Medzihradsky1, Davis Mumbengegwi2, Kathryn Roberts1, 
Carmen Cueto1, Hugh Sturrock1, Patrick McCreesh1, Adam 
Bennett1, Munyaradzi Tambo2, Lucille Dausab2, Petrina Uusiku2, 
Stark Katokele3, Griffith Siloka3, Immo Kleinschmidt4, Danica 
Helb1, Kevin Tetteh4, Chris Drakeley4, Roland Gosling1, Bryan 
Greenhouse1, Michelle Hsiang5
1University of California San Francisco, San Francisco, CA, United States, 
2University of Namibia, Windhoek, Namibia, 3National Vector-borne 
Diseases Control Programme, Windhoek, Namibia, 4London School of 
Hygiene & Tropical Medicine, London, United Kingdom, 5University of 
Texas Southwestern, Dallas, TX, United States
As malaria transmission in pre-elimination settings is geographically 
heterogeneous, successful programs will target hotspots efficiently. These 
are foci with transmission intensity greater than that of surrounding areas, 
inside which parasite reservoirs can persist. Programs often use historical 
health facility (HF) case data to predict hotspots, though these are coarse 
data and can miss new hotspots. We compare the predictive abilities of 
a model utilizing solely historical HF case data, to models incorporating 
prevalence and/or serologic measures. The study was conducted in the 
catchment areas (tot. pop.~35381) of 6 randomly selected HFs in Zambezi 
region, Namibia, a low transmission eliminating nation. The region’s 
annual incidence of 26/1000 contrasts with 2/1000 nationally. Potential 
hotspots were identified as cases clustered in space/time using SaTScanTM. 
The datasets were: (i) HF case data extracted from registries for Jan 
2012 - May 2014; (ii) PCR-confirmed parasite prevalence in a 2015 cross-
sectional survey; (iii) seropositivity to AMA-1 and MSP-1 antigens in the 
cross-sectional survey. Receiver operating characteristic (ROC) curves are 
generated for clusters identified by each method. The reference value is 
confirmed hotspots: villages with ≥2 laboratory confirmed, locally acquired 
cases reported in the 2015-16 season, with geo-location confirmation. A 
model based solely on HF incidence (1914 total cases) revealed 2 clusters 
of 58 and 36 cases with radii 3.2km and 4.4km and relative risks 2.04 
and 2.33, respectively (p<0.001). A model using prevalence (25/2017, 
1.2%) demonstrated no statistically significant clusters. Serologic assays 
are complete and undergoing quality control. Final analyses of dataset 
combinations with ROC comparison are anticipated before May 30. If a 
hotspot prediction model including serologic data is more accurate than 
those using only historical incidence and/or point parasite prevalence, 
serologically defined hot spots may represent a useful surveillance tool in 
Zambezi region. Evaluation of an even broader array of candidate antibody 
responses can help further refine the model.
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ENTOMOLOGICAL MONITORING ACTIVITIES DURING A 
MALARIA ELIMINATION PILOT PROJECT IN SOUTHERN 
MOZAMBIQUE
Lucia Fernández1, Celso Alafo2, Pedro Aide2, Beatriz Galatas1, 
Ana Paula Abilio3, James Colborn4, Maria Ponja5, Pedro Alonso6, 
Francisco Saúte2, Krijn Paaijmans1
1ISGlobal, Barcelona, Spain, 2FM-CISM, Manhiça, Mozambique, 3INS, 
Maputo, Mozambique, 4CHAI, Boston, MA, United States, 5NMCP, 
Maputo, Mozambique, 6World Health Organization, Geneva, Switzerland
The National Malaria Control Programme (NMCP) of Mozambique, in 
collaboration with key in-country malaria control stakeholders under the 
umbrella of the Mozambican alliance towards the elimination of malaria 
in Mozambique (MALTEM) and the Mozambique, South Africa, Swaziland 
(MOSASWA) Cross-Border Malaria Initiative, is currently designing and 
piloting activities to eliminate malaria from southern Mozambique 
by 2020. Here we show the first data from ongoing entomological 
monitoring in Magude, a rural district in the southern Mozambique, where 
we carry out a pilot malaria elimination project. We address critical issues 
such as (i) the anopheline species present and their vectorial capacity, (ii) 
how species distribution and intensities change over space and time, and 
(iii) which species act as a reservoir of parasites during the dry season. In 
addition, changes in species distribution, densities and behavior can be 
observed as a result of vector control interventions.
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TIMED AND TARGETED MALARIA TESTING DURING 
LOW SEASONAL MALARIA TRANSMISSION IN LUAPULA 
PROVINCE AS A POTENTIAL STRATEGY TOWARDS 
ACHIEVING MALARIA ELIMINATION IN ZAMBIA
Gagik Karapetyan1, Mulambwa Alibandila2, Melissa Cornejo3
1World Vision United States, Washington, DC, United States, 2World Vision 
Zambia, Lusaka, Zambia, 3World Vision United States, Federal Way, WA, 
United States
According to the Zambia National Malaria Control Centre (NMCC), about 
98% of malaria cases are caused by Plasmodium falciparum. From May 
to August, malaria transmission is at its lowest level partly because female 
Anopheles mosquitos are in aestivation, and malaria vector population 
is reduced. To contribute to Zambia’s health strategic plan of eliminating 
malaria by 2020, World Vision implemented the Stop Malaria Project 
in 11 districts of Luapula province (Kawambwa, Nchelenge, Mansa, 
Samfya, Chiyengi, Mwense, Chembe, Mwansabobwe, Chipili, Lunga 
and Milenge) from April 2014 to March 2016 and distributed 1,172,790 
long-lasting insecticidal nets (LLINs) to over 2 million people. Reducing 
parasite prevalence in an intermediate host is an important step in 
malaria elimination. As the use of rapid diagnostic tests (RDTs) are the 
most recommended way of detecting malaria in high incidence areas and 
in low-resources settings with limited malaria microscopy services, the 
timed and targeted malaria testing strategy was used to identify parasite 
prevalence. Two approaches for detecting malaria carriers were used: a) 
testing household members who received a LLIN after mass distribution 
and b) testing household members where a malaria patient came from. 
Malaria parasite detection increased about three times through index 
case testing or active case surveillance (1,540 per 1000 people) compared 
to households where random testing was done (464 per 1000 people). 
Through both approaches, a total of 24,937 were tested for malaria 
(8,735 people tested through index case testing and 16,202 people 
randomly tested) and 8,393 were positive (4,570 and 3,823 people tested 
positive respectively). The malaria timed and targeted testing strategy 
using the index case approach during low transmission helps to increase 
detection of malaria parasites in human reservoirs. It should be used 
during vector aestivation and should be supported by proven vector 
control interventions that can further reduce malaria transmission by 
Anopheles mosquitoes.
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ASSESSING ASSOCIATIONS BETWEEN RECENT TRAVEL AND 
MALARIA PARASITE PREVALENCE DURING A MASS DRUG 
ADMINISTRATION CAMPAIGN IN SOUTHERN ZAMBIA
Travis Porter1, Timothy Finn1, Kafula Silumbe2, Victor Chalwe3, 
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Province, Livingstone, Zambia, 6University of California San Francisco, 
San Francisco, CA, United States, 7PATH-Malaria Control and Elimination 
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Southern Province, Zambia has seen substantial reductions in malaria 
incidence over the past few years; as malaria incidence approaches zero, 
challenges remain in preventing importation from neighboring areas of 
higher transmission. The effect of human mobility on malaria incidence is 
unknown in this area of Zambia and efforts to identify high-risk scenarios 
for importation are needed. During a mass drug administration campaign 
conducted in diverse malaria settings in Southern Province from late 2014 
to early 2015, participants were tested for Plasmodium falciparum using 
rapid diagnostic tests (RDTs) and asked about recent travel away from 
their place of residence. Of those that travelled in the past 14 days, both 
the origin and destination of each trip were categorized as low or high 
transmission according to area-specific malaria incidence rates (10% IR 
threshold). In total 2,862 (0.9%) reported traveling at least once during 
the 2-week period prior to the campaign visit, of which 762 were to high 
transmission areas; these travelers accounted for 270 (1.4%) identified 
infections. After adjusting for confounding factors such as vector control, 
age, sex and malaria incidence around their home, logistic regression 
showed that those traveling were twice as likely to be infected [adjusted 
odds ratio (AOR) = 2.3, 95% Confidence Interval (CI) 1.9-2.6] compared 
to those who had not traveled recently. Each day of travel conferred an 
average 6.4% (95% CI: 3.3-9.4%) increase in the odds of RDT positivity. 
Parasite prevalence was 4.9 and 9.5 times higher among participants 
traveling to high transmission areas for 3 or less days and 4 or more days, 
respectively, compared to those traveling to areas of low transmission. The 
increased malaria prevalence among those traveling, especially to high 
incidence areas, as well as the incremental increase in the odds of infection 
per day of travel, suggests that importation back to low incidence areas 
is a potential concern for elimination efforts and, though currently only a 
marginal contribution to overall incidence within this region, will be import 
to reassess as malaria programs approach elimination goals.
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DEMOGRAPHICS AND MALARIA PREVENTION IN MOBILE 
AND MIGRANT POPULATIONS IN SOUTHERN LAO PDR
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Lao PDR is committed to malaria elimination by 2030. Although 
transmission is endemic, 97% of confirmed cases are reported from 
the 5 southernmost provinces. Mobile and migrant populations (MMPs) 
in these provinces are considered to be at risk for malaria and may be 
missed by surveillance systems. Appropriately targeted interventions are 
constrained by a shortage of information on MMP demographic, travel 
and health patterns. The objective was to improve understanding of these 
populations by describing demographics, movement, labor practices, 
and malaria prevention among MMPs in southern Lao PDR. Participants 
were confirmed malaria cases recruited from health facilities between 
February 25 and March 25 2015 and were eligible if they had moved 
from their residence within the past 12 months to stay or work elsewhere. 
Family and work contacts identified by enrolled cases were also invited to 
participate. The resulting sample population (MMPs) included all initially 
enrolled cases and contacts. Information on MMPs was collected via 
semi-structured face-to-face or telephone interviews. Descriptive statistics 
and logistic regression were used to characterize MMPs and compare 
malaria prevention methods between occupational groups. Of 189 MMPs, 
69% were male. While most MMPs (78%) reported a province within 
Lao PDR as their place of origin, 20% were from Vietnam and 2% from 
other countries. Three quarters (76%) of MMPs traveled with at least one 
immediate family member. While 95% reported sleeping under a net 
or hammock the night prior to being surveyed, 82% described the net 
or hammock as untreated. Twenty-six percent of construction workers 
slept under treated nets compared with 4% of logging workers. Odds 
of sleeping under treated nets increased with family members present 
(OR=1.3 for each additional family member; p=0.033). Demographic 
differences and variation in malaria prevention behaviour observed in this 
study may indicate sociological patterns that could inform future targeted 
long-lasting insecticide-treated net or hammock campaigns among MMPs 
in southern Lao PDR.
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AN INVESTMENT CASE FOR MALARIA ELIMINATION IN THE 
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Control Bureau, Department of Health, Manila, Philippines, 4University of 
California, San Francisco, San Francisco, CA, United States
The Philippines has made significant progress in malaria control, with an 
83% reduction in cases and 89% reduction in deaths since 2005. The 
country has launched a subnational approach towards malaria elimination 
and aims to reach countrywide elimination by 2030. To attain this goal, 
the National Malaria Control Program (NMCP) of the national Department 
of Health must secure sufficient funding and political commitment 
amid waning focus on malaria and declining donor funding for malaria-
eliminating countries, including the Philippines. To support advocacy and 
resource mobilization efforts of the NMCP, we developed an investment 
case for malaria elimination and prevention of reintroduction (POR) in 
the Philippines. For this, we estimated the costs of malaria elimination 
and POR efforts in the Philippines for year 2015 using a micro-costing 
approach and projected the costs of eliminating malaria in the next 5 years 
(2016-2020). We estimated the economic benefits of investing in malaria 
under a hypothetical scenario of resurgence that would likely occur if 
all efforts on malaria are halted. The benefit of sustained investments in 
malaria was estimated based on the cost and impact of a potential malaria 
resurgence on the health system, households, and economic productivity. 
Cost data were collected from the NMCP and from five sample districts 
that were in varying phases of elimination. Our preliminary results indicate 
the total cost of elimination and POR activities in the Philippines in 2015 
was US$ 1.03 per capita. The key cost drivers were consumables (61% 
of total cost) and human resources (21% of total cost). Among malaria 
activities, prevention and vector control incurred the highest share of the 
total cost (42%), followed by diagnosis (24%) and program management 
(15%). The benefits of investing in malaria under the hypothetical 
resurgence scenario were estimated to be around US$1 billion yielding 
a return on investment of 8.19. This remarkable return on investment in 
malaria makes a compelling case for sustaining investments for malaria 
elimination efforts in the Philippines.
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REACTIVE CASE DETECTION FOR MALARIA ELIMINATION
Peter Pemberton-Ross, Nakul Chitnis, Thomas A. Smith
Swiss Tropical and Public Health Institute, Basel, Switzerland
The transmission mechanism of many infectious diseases results in 
spatiotemporal clustering of cases. In near-elimination scenarios we can 
take advantage of this structure, by using the passive detection of an index 
case as the basis for active searches for further cases. This strategy, known 
as reactive case detection, is particularly attractive for moving towards 
elimination in settings where effective universal surveillance is not feasible. 
We report on microsimulations and analytical models for Plasmodium 
falciparum malaria, based on epidemiological and programmatic data from 
elimination projects in the Lake Kariba region of southern Zambia, which 
we use to quantify thresholds for success for realistic implementations in 
terms of transmission context, case-enrichment ratios and health system 
capacities. Mass drug administration has been proposed as a useful 
adjunct intervention to elimination programs, and we use our models to 
establish the contexts where this is likely to have a significant effect on 
the outcome and timeline of the overall strategy. The models provide an 
insight into the limits and potential of such strategies, which is applicable 
in other malarial regions and indeed in other disease areas where the focus 
has moved from control towards elimination.
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MALARIA ELIMINATION IN INDIA: LARVIVOROUS FISH 
PLAY AN IMPORTANT ROLE UNDER LARVAL SOURCE 
MANAGEMENT STRATEGY
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Uragayala Sreehari1, Neena Valecha2
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National Framework for Malaria Elimination in India was launched on 11 
February 2016. The aim is to eliminate malaria i.e. zero indigenous malaria 
transmission in the entire country by 2030. Based on annual parasite 
incidence (<1 case per 1000 population/year), the country has been 
classified in to three categories. Karnataka state, south India falls under 
category 2. Karnataka was endemic for malaria till 2009. Currently, except 
two coastal cities malaria in rural areas has attained pre-elimination phase. 
The fish-based malaria control was initiated in the early 1990’s. The main 
compulsion of this strategy was scientifically adopted in sericulture areas 
in the state from 1994. Seeing this result this method of malaria control 
was extended in the state. Two self-sustained larvivorous fish - mosquito 
fish Gambusia affinis in ponds and tanks, while guppies in open-dug 
wells formally reduced the main vector Anopheles culicifacies population. 
In most of the rural areas malaria has reached a phase which needs to 
prevent the residual transmission possibilities. Efforts are being made 
to mitigate the elimination challenge in the state and aim to eliminate 
malaria before by 2022.
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EVALUATING STRATIFIED MALARIA CONTROL 
INTERVENTIONS IN BIOKO ISLAND: DIFFERENT APPROACHES 
TO FOCALIZED INTENSIFIED MALARIA CONTROL 
INTERVENTIONS THROUGH SPATIAL CLUSTERING AND RISK 
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The Bioko Island Malaria Control Project (BIMCP) created a geo-referenced 
mapping system in 2012 assigning a unique identifier to all households 
similar to an address. In 2014 this mapping system, based on ArcGIS 
software and satellite imagery, was linked to the Campaign Management 
Information System (CIMS), an Android-based tablet application, and 
is currently used to plan, implement, and monitor field malaria control 
activities on Bioko; ultimately allowing the BIMCP to accurately track 
all malaria control interventions at the household and community level 
over time. To account for budget constrains essential for long term-
sustainability of malaria control programs, a stratified control strategy 
can provide a possible sustainable and reproducible solution. In 2015, 
the BIMCP developed a framework for Indoor Residual Spraying (IRS) 
using a stratified methodology to target communities with higher risk 
of malaria prevalence. The model used: pre-existing Malaria Indicator 
Survey (MIS) data focusing on prevalence and risk of importation, 
housing characteristics for all households, spray coverage, and slope 
and altitude. Information is linked to the unique household identifier 
and a risk score is created at the community level identifying the most 
vulnerable communities that would be selected for IRS. Using this pre-
existing model for stratification, additional analysis will be carried out 
focusing on two different spatial clustering techniques: 1) Kulldorff’s 
spatial scan statistics using SaTScan v9.4.2 and 2) Anselin’s Local Moran’s 
I statistics using ArcGIS v10.4; as well as regression analysis including data 
on socio-economic status, bed net coverage, and malaria incidence. Due 
to the unique characteristics of the methodologies that will be used for 
stratification, the parameters will not be analogous, but various thresholds 
will be taken into consideration in order to achieve a higher degree of 
comparability. Once all models have been completed and quantitatively 
verified, maps will be created for each methodology, overlaying the results 
into one map, in order to provide evidence of visual clustering of malaria 
risk areas.
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THE USE OF SCHOOL RECORDS TO MEASURE THE IMPACT 
OF A MALARIA CONTROL INTERVENTION ON ATTENDANCE 
IN RURAL WESTERN KENYA
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Job Osewe1, Grant Ritter1, Donald S. Shepard1, George Olang2, 
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Malaria control in school-age children is an important priority in 
endemic countries due to the detrimental effect of malaria on academic 
performance and school attendance. Additionally, the high frequency 
of malaria infection and gametocytemia in this age-group may 
contribute substantially to transmission. We reviewed public primary 
school attendance records of children living in villages in Siaya County 
Kenya that had been in enrolled in a cluster randomized trial (CRT) of a 
malaria intervention in 2010. The CRT showed a 42% reduction in the 
incidence of malaria infection in children ages 5-11 years who lived in 
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the intervention villages compared with those in control villages. We 
assessed attendance records from 2010 at 7 schools serving 8 of the 12 
villages in the CRT for evidence of spillover effects from the home-based 
intervention. There were no records available for 2010 in 4 additional area 
schools. We evaluated school records for data quality by the four domains 
of the Prism tool: completeness, accuracy, timeliness, and relevance. We 
used several methodological approaches to assess attendance: time series 
analysis, mixed effects, and GEE, with and without imputation to adjust 
for missing data. Attendance records on 914 children were included in the 
analysis. We noted 43.7% missing data; evidence of over writing and post-
date marking of registers; sample means higher than national and local 
mean by head count. Data quality was not adequate in any of the four 
Prism domains. Attendance was higher in the treated versus control group 
ranging from 0.67% to 0.96% (SE 0.3%, p<0.05), but this finding was 
not retained following imputation. We were unable to show an increase 
in school attendance associated with an intervention that reduced malaria 
incidence. The lack of detectable effect from the intervention may be due 
to asymptomatic parasitemia in this age-group, or bias from missing and 
poor quality data. School attendance records are not a reliable source of 
observational data in developing countries. Routine records should be 
fully vetted using a quality framework before being used as a data source 
document to evaluate interventions.
905
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The effectiveness of the mass drug administration (MDA) to prevent 
and control malaria transmission is, in part, dependent upon the 
patient’s adherence to the medication regimen and achieving high 
population treatment coverage rates. In late 2014 in Southern Province, 
the National Malaria Control Center of Zambia embarked upon a 
community randomized controlled trial of two MDA strategies with 
dihydroartemisinin-piperaquine (DHAp): focal MDA (fMDA), where 
treatment was provided to all household members if at least one 
household member tested positive; and, community-wide MDA, where 
treatment was provided to all people irrespective of test positivity. Study 
participants were tested for malaria, provided three doses of DHAp if 
treatment eligible, and visited on the third day for follow-up monitoring. 
The first dose of DHAp was directly observed. Analysis from the first two 
rounds among 75,376 persons treated indicate that 84.6% were fully 
adherent by reporting taking three doses of DHAp and had blister-pack 
confirmation and 2.9% reported taking no doses. The proportion of full 
adherence was greater in fMDA (91%) than MDA (81%) (p<0.01). The 
odds of full adherence in fMDA were more than two times than that 
in MDA, when controlling for individual RDT status and whether first 
dose was observed (OR 2.39, 95% CI 1.26-4.53, n=73,703). Reasons 
provided for incomplete adherence were forgot doses (13.6%), felt better 
(13.2%) and lost medication (7.4%). These results suggest that individuals 
recognized that if they their household qualified for treatment, they were 
either at risk for malaria and/or sought to clear their infection. MDA 
treatment campaigns may enhance treatment adherence by assuring direct 
observation of the first dose and sensitization efforts in areas where non-
RDT positive individuals are provided treatment. Results will be updated 
with additional treatment rounds and expanded with comparison to 
household malaria indicator survey data.
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TRANSMISSION IN KANEL, RANÉROU AND LINGUÈRE 
DISTRICTS (SENEGAL): CASE INVESTIGATION WITH FOCAL 
DRUG ADMINISTRATION
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Systematic investigation of malaria cases and neighboring households is a 
key strategy in the path to elimination in low malaria transmission settings. 
A pilot quasi-experimental study to evaluate whether case investigation 
with focal drug administration (FDA) can decrease malaria incidence 
was conducted during the 2015 transmission season in six health post 
catchment areas in the districts of Kanel, Linguère, and Ranérou (Senegal) 
that had received a mass test and treat campaign in 2014. Seven adjacent 
health posts with similar characteristics but lower malaria incidence were 
selected as comparison. Malaria cases passively diagnosed at the health 
posts or by community health workers were visited at home and all 
members of the household were tested with a rapid diagnostic test (RDT) 
and treated with dihydroartemisinin-piperaquine (DHAP). The closest five 
households in a 100 meter radius were also visited, all members were 
tested with an RDT, and in households with at least one positive RDT, 
all members were treated with DHAP. From September to December 
2015, 1560 malaria cases in catchment area residents were passively 
detected (57% were male, 9% were <5 years old and 60% were aged 
5-19 years old). Among these cases, 794 (51%) were investigated and 
1887 households were visited, in which >95% of the members were 
tested. Among the 766 non-investigated cases, 71% recently received 
the intervention through the investigation of another case or an FDA 
conducted in response to an outbreak. The RDT positivity rate in the case 
households was 4.4% (285/6480), whereas in neighboring households 
it was 3.5% (250/7053). Treated individuals received a follow-up visit 
a median of 3 days after the initial visit; compliance with the 3-day 
treatment was high (>95%) and all adverse events were mild. To evaluate 
the impact of the interventions, the incidence of passively detected, RDT-
confirmed malaria cases at the health posts will be compared before and 
after the intervention and between intervention and comparison villages 
using a difference-in-differences analysis. Results from the full transmission 
season and the impact evaluation will be available mid-2016.
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HETEROGENEOUS PREVALENCE OF SUBCLINICAL MALARIA 
MEASURED BY ULTRASENSITIVE PCR IN MYANMAR
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A malaria elimination campaign underway in the Greater Mekong 
Sub-region (GMS) aims to prevent the spread of artemisinin-resistant 
falciparum malaria beyond the region. Elimination may require drug 
treatment of all malaria infections, including low density, subclinical 
infections that may represent a previously unrecognized transmission 
reservoir. In Myanmar, targeted mass drug treatment is being evaluated 
using ultrasensitive PCR-based testing that is thousands-fold more sensitive 
than rapid diagnostic tests (RDT) and hundreds-fold more sensitive 
than standard PCR. In collaboration with seven governmental and non-
governmental malaria elimination partners, we conducted cross-sectional 
surveys of malaria prevalence in 43 villages located in 13 malaria endemic 
rural townships of in nine State and Regions of Myanmar. Finger-prick 
blood was collected for rapid diagnostic testing and for standard PCR 
and ultrasensitive multiplex reverse transcription real-time PCR (usPCR) 
analyses. In preliminary analyses, P. falciparum prevalence (both mono-
infection and mixed with P. vivax) ranged from 0-10% by RDT, and 0-30% 
by usPCR; and P. vivax (both mono- and mixed with P. falciparum) 0-3% by 
RDT and 0-28% by usPCR. Prevalence by standard PCR, regression analysis 
of the data adjusted for covariates, and comprehensive village-level 
geospatial mapping of malaria prevalence will be presented. Subclinical 
malaria at very low densities can be reliably detected by a new, DNA 
and RNA-based, fingerstick usPCR method. The prevalence of malaria in 
Myanmar is highly heterogeneous from village to village, even within the 
same township, highlighting the need for microstratification of malaria 
risk to target interventions. Prospective longitudinal studies assessing the 
clinical and transmission risks posed by this subclinical malaria reservoir 
are being planned. Results are expected to guide decisions about whether, 
when, where and how to implement targeted mass treatment and other 
interventions to eliminate this reservoir.
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In low malaria transmission areas, case investigation—of individual malaria 
cases, their household, and neighboring households is an important tool 
to contain and prevent the spread of transmission. Case investigation 
for malaria was implemented in six health post catchment areas in 
Kanel, Linguère, and Ranérou (Senegal) and ten villages in Amhara 
Region (Ethiopia) during the 2014 and 2015 transmission seasons. 
When a malaria case was passively detected at the health post or by a 
community health worker, it was considered an index case and a field 
team started an investigation targeting the case’s household and the 
closest neighboring households (up to 5 households in Senegal and 10 in 
Ethiopia) within a 100-meter radius. All household members were tested 
with a rapid diagnostic test (RDT) and treated with an antimalarial drug 
if positive. Operational indicators were calculated to inform the planning 
and training and to understand the field teams’ compliance with the 
standard operating procedures. The mean number of households visited 
per investigation by health post catchment area ranged from 1.9 to 3.1 in 
Senegal and 1.4 to 6.4 in Ethiopia. In Senegal, the mean distance between 
the index case household and the neighboring households was of 77.29 
meters and that between the index case household and neighboring 
households with positive RDTs was of 47.5 meters. The following 
additional indicators will be calculated when final data are available: the 
average number of households existing within 100 meters of an index 
case household, the percentage of these that were visited by the field 
teams during the investigations, the percentage of visited households that 
were within 100 meters of the index case household, and the average 
distance to households that were visited beyond the 100 meters radius. 
The relationship between distance from index case household and RDT-
positivity rate will also be evaluated. Final results using complete data from 
both countries will be available by mid-2016.
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DO DASHBOARDS MATTER TO DISTRICT HEALTH 
MANAGERS? DOCUMENTED EXPERIENCE FROM THE 
DEVELOPMENT AND TESTING OF VISUALIZATIONS, 
DASHBOARDS AND ALERTS FOR MALARIA ELIMINATION IN 
SOUTHERN PROVINCE, ZAMBIA
Jeff Bernson1, Michael Hainsworth1, Prudence Malama2, Marie-
Reine Rutagwera2, Christopher Lungu2, John Miller2
1PATH, Seattle, WA, United States, 2PATH, Lusaka, Zambia
As more National Malaria Control Programs focus on malaria elimination, 
real time, accurate, and actionable data are critical to target interventions 
to specific geographies and populations and to optimize the allocation 
of resources. With decentralization of decision making in Ministries of 
Health across Sub-Saharan Africa, decision making power will be in the 
hands of district health and facility managers. Efforts to date have focused 
on collecting data and ensuring data quality so district managers can 
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manage scarce resources effectively. Questions remain as to what format 
and frequency should these data be available to district managers and 
how to use the data to facilitate stronger analysis and action especially 
at the district level. As the Zambian Ministry of Health is embarking on 
an ambitious effort to eliminate malaria with significant investment in 
the surveillance infrastructure and data quality, we examined different 
visualization, dashboard and alert mechanisms tailored for district 
health managers and community health worker cadres. Our user group 
assessments were conducted in 15 districts in Southern and Lusaka 
Provinces. District health manager input was used to co-design and 
develop dashboards to facilitate better planning and action including 
dashboards assessing reporting, data quality, malaria case rates, case 
investigation and commodity stocks. We also developed and tested 
the usefulness of different alert systems using SMS, email and web-
based communication. This co-development approach, produced well-
documented promising practices on how to create and test dashboards 
that can help or hinder decision making for district health managers. The 
process of producing dashboards provided further insights into optimizing 
visualizations and focusing training of country counterparts. In sum, joint 
development of data visualization appears to improve data use for decision 
making.
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Malaria is the leading cause of mortality in children <5 years in Benin. 
National guidelines on reporting malaria death were established in 2010. 
Despite recent improvements in malaria case management and case 
reporting, the annual number of malaria specific deaths (MSD) – 1,869 
in 2014 – remains high. To investigate Benin’s MSD burden, the National 
Malaria Control Program conducted a cross-sectional study to examine 
case reporting and the quality of care for severe malaria cases. Using 
patient health records from 24 health facilities reporting at least 10 malaria 
deaths in 2014, we randomly sampled 20% of malaria deaths captured 
by the routine malaria information system and verified diagnosis, cause 
of death, and treatment consistency with national guidelines. A case 
was confirmed an MSD if the record included time and cause of death, 
confirmed malaria diagnosis by microscopy or rapid diagnostic test, and 
documented at least one sign of severe malaria. Quality of care was 
assessed based on: diagnostic confirmation of malaria, injection of the 
recommended intravenous antimalarial at the right dosage, and correct 
case management according to clinical signs of severity. We identified 
294 records reporting malaria deaths. Of these, 210 (71%) were correctly 
reported as MSD. None of the health facilities surveyed had a copy of 
national guidelines on defining MSD. Among the 210 MSD, we were able 
to assess quality of care in 204. Of these, 151 (74%) deaths occurred 
in the first 24 hours of care and 186 (88%) were < 5 years of age. Of 
204 MSD with signs of severe malaria, 190 (93%) received intravenous 
antimalarials, but only 34 (17%) received treatment that followed national 
guidelines. Anemia and convulsions were the most reported severe signs, 
occurring in 125 (61%) and 97 (48%) of cases, respectively. Seventeen 
anemia cases (14%) received a blood transfusion. Ten convulsions cases 
(10%) received diazepam as indicated. Poor knowledge of national 
reporting guidelines may influence the high number of reported malaria-
specific deaths in Benin, however poor adherence to severe malaria 
treatment guidelines likely contributes to high malaria mortality as well.
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Malaria is a principal cause of morbidity and mortality among children 
in Mozambique, with the northern provinces among the highest-burden 
areas in the world. One of the chief strategies to reduce this burden is 
the mass distribution and promotion of long-lasting insecticidal nets 
(LLINs). In 2013, the Ministry of Health implemented a universal coverage 
distribution of LLINs in highly endemic Nampula Province. An evaluation 
was commissioned to measure the coverage and impact of the campaign. 
Two cross-sectional household surveys, two weeks after the distribution 
in 2013 and one year later, were performed in Nacala-a-Velha and 
Mecubúri Districts of Nampula. Households chosen using two-stage 
cluster sampling were visited by survey teams. Surveyors interviewed 
the head of household, directly observed nets and sleeping spaces, and 
performed malaria rapid diagnostic tests (RDTs) on all household members, 
regardless of symptoms. Indicators of LLIN ownership, access, and use 
were calculated, and malaria RDT positivity in children under five was 
compared between years. A total of 1,027 households visits were made, 
with 2,419 individuals tested by RDT. In Nacala-a-Velha, 80% (95%CI: 72-
86) of households received at least one LLIN, corresponding to 66% (58-
74) of sleeping spaces. In Mecubúri, 54% (44-65) of households received 
at least one LLIN and 43% (35-52) of sleeping spaces were covered. The 
proportion of the population that reported using LLINs more than 4 times 
per week during the wet season was 43% (29-58) in Nacala-a-Velha 
and 26% (20-33) Mecubúri, falling to 22% (15-30) and 18% (14-23), 
respectively, during the dry season. Malaria RDT positivity in children under 
five was 52% (36-67) in 2013 and 61% (44-76) in 2014 in Nacala-a-Velha 
and 67% (53-80) in 2013 and 87% (76-94) in 2014 in Mecubúri. In the 
two districts, the government-led campaign did not reach the crucial 
coverage and usage threshold to result in a reduction in malaria positivity. 
The results reinforce the need for close monitoring of universal coverage 
campaigns, where the true achieved net use might be significantly lower 
than the administrative measure of ownership would suggest.
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HIGH LEVEL OF SUBMICROSCOPIC INFECTIONS OF FOUR 
PLASMODIUM SPECIES DURING PRE-ELIMINATION PHASE IN 
NORTH SUMATERA, INDONESIA
Inke N. Lubis1, Hendri Wijaya2, Munar Lubis2, Khalid Beshir1, 
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In the effort to eliminate malaria in Indonesia by 2030, the Indonesian 
Ministry of Health is implementing a four-stage elimination plan 
comprising different strategies across the archipelago. One strategy 
is to support all primary health centres with the capacity of malaria 
diagnostic testing. However, this strategy is limited by a surveillance system 
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which highly relies on passive clinical cases and diagnostic test using 
conventional microscopy examination. In the low malaria endemic areas 
which predominate in Indonesia, the true burden of malaria cases remains 
undiscovered, and the extent that asymptomatic and submicroscopic 
infections contribute to transmission is unknown. Therefore, this study 
aimed to determine the baseline epidemiological profile of Plasmodium 
species and to investigate the proportion of submicroscopic infections 
among all malaria cases in North Sumatera province, Indonesia. A cross-
sectional survey was conducted in Batubara regency, Langkat regency 
and South Nias regency between January and June 2015. A total of 3635 
participants were screened for Plasmodium infection by microscopy, rapid 
diagnostic tests, and molecular analysis using nested polymerase chain 
reaction. Primers targeting the Plasmodium small subunit ribosomal RNA 
were used to identify Plasmodium species, and an additional novel assay 
targeting the SICAvar gene was performed for P. knowlesi identification. 
All Plasmodium species except Plasmodium ovale spp. contributed 
to symptomatic and asymptomatic malaria cases in North Sumatera 
province. Overall positivity rate by nested PCR was 34.1% (1049/3080) 
with 10.8%, 17.1%, 6.5% and 13.3% positive for each P. falciparum, P. 
vivax, P. malariae and P. knowlesi infection. We found 61.1% of all malaria 
infections were not detected by microscopy, with P. knowlesi the most 
common submicroscopic infection. Despite the little known of the role 
of submicroscopic infection in malaria transmission, these results suggest 
that submicroscopic infections should also be targeted in malaria control 
and elimination programmes as they comprise a significant proportion of 
malaria infections.
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In sub-Saharan Africa, approximately 45% of the 32 million pregnancies 
occurring annually are estimated to be exposed to malaria infection, 
leading to an estimated 900,000 low birthweight deliveries. WHO 
recommends use of insecticide treated nets and intermittent preventive 
therapy with sulphadoxine-pyrimethamine (IPTp-SP) for prevention, 
though the latter is threatened by high levels of parasite resistance. 
Despite a decade’s worth of intensive multicentre trials, the search for 
safe, effective, and well-tolerated alternative drugs to replace SP for IPTp 
has proven elusive. These have shown that neither amodiaquine, alone 
or combined with SP, mefloquine, or the fixed- dose combination of 
chloroquine-azithromycin are tolerated well enough to replace SP for IPTp 
in Africa. More recently, trials from Ghana, Malawi and Kenya, looked at 
intermittent screening and treatment in pregnancy (ISTp) as an alternative 
strategy to IPTp, consisting of intermittent rapid diagnostic testing (RDT) 
for malaria and treatment of RDT-positive cases with dihydroartemisinin-
piperaquine (DP). The results from these trials were disappointing, showing 
either lack of cost-effectiveness in west Africa or up to 20% higher 
incidence of malaria during pregnancy in east/southern Africa, rendering 
this test-and-treat strategy as an unsuitable alternative to IPTp-SP in high 
SP resistance areas. However, two recent exploratory trials have shown 
promise for DP as IPTp in areas of high malaria transmission and SP 
resistance for reducing malaria infection (Incidence Rate Ratio [IRR]=0.32) 
and clinical malaria (IRR=0.16). The risk of fetal loss and early neonatal 
death was halved (61% to 47% lower) in the IPTp-DP arm, but the 
lower impact on fetal growth and preterm birth led to a more restricted 
overall pooled impact on “adverse pregnancy outcome” of 17% (95% 
CI 10-37%) using fixed effects meta-analysis. We will present results of a 
systematic review of evidence for prevention of malaria in pregnancy both 
in HIV-negative and HIV-positive women in sub-Saharan Africa, with a 
focus on the recent data and remaining gaps in knowledge.
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Although malaria is declining in India and Asia, it is still important to 
find out what factors are impacting prevalence and incidence, to assist 
in the development of effective strategies to reduce the burden. Malaria 
in pregnancy has been recognized as a clear risk factor for malaria, but 
it is not clear if there are additional differences by gender, and if these 
differences are related to exposure, or other factors. For decades it has 
been observed that gender differences in the prevalence of malaria exist 
in some areas in Asia. We examined gender differences in our studies in 
India, and combined our results with additional studies from the region 
identified in the literature using meta-analysis. Among clinic studies in five 
different sites in India, the pooled risk ratio (PRR) for men to be diagnosed 
with malaria compared to women was 1.83, 95% CI 1.48-2.27, I2 78% 
(n=12) for Plasmodium falciparum, and 1.92, 95% CI 1.72-2.13, I2 34% 
(n=12) for P. vivax. The difference was mainly among adults (any species: 
PRR 1.95, 95% CI 1.67-2.27, n=12), but not among children ≤15 years 
(any species: 1.05, 0.87-1.27, I2 42%, n=12). Results were similar for 
surveys in Asia, with a PRR of 1.55, 95% CI 1.16-2.06, I2 72% (n=7) 
for P. falciparum, and 1.25, 1.06-1.48, I2 0% (n=8) for P. vivax. Gender 
differences for malaria in the same direction were also noted in studies 
identified in the literature in Ethiopia and Uganda. We are currently in the 
process of adding information from the literature from other malarious 
areas in the world in a database to assist in an assessment of the most 
likely explanation for the gender differences seen in some parts of Asia.
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Malaria in pregnancy is associated with maternal morbidity, placental 
malaria, and adverse birth outcomes. However, data are limited on the 
relationships between longitudinal measure of malaria during pregnancy 
and outcomes measured at the time of delivery. Data came from a RCT 
of intermittent preventive therapy during pregnancy among 282 HIV 
uninfected women followed to delivery with histopathologic assessment 
for placental malaria. During pregnancy, malaria was measured using 
passive surveillance and asymptomatic parasitemia (AP) measured every 
month using a sensitive molecular assay (LAMP). Placental malaria was 
defined as either the presence of parasites in placental blood by LAMP or 
the presence of parasites or pigment detected by histopathology. Adverse 
birth outcomes included low birth weight (LBW, < 2500 gm) and preterm 
delivery (< 37 weeks). Associations were made between longitudinal 
measures of malaria during pregnancy and placental malaria and these 
same measures and adverse birth outcomes. Exposure to malaria during 
pregnancy was divided into 3 categories: 1) No malaria or AP (n=52, 
18.4%), 2) 0-1 episodes of malaria and < 50% of samples positive for 
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AP (n=157, 55.7%), 3) 2-3 episodes or malaria or > 50% of samples 
positive for AP (n=73, 25.9%). The risk of placental malaria by LAMP 
was significantly higher among women in category 3 (25.0%, p=0.01) 
compared to categories 1 (1.9%) and 2 (3.2%). The risk of placental 
malaria by histopathology was significantly higher among women in 
categories 2 (29.9%, p=0.01) and 3 (74.0%, p<0.001) compared to 
category 1 (7.7%). Longitudinal measures of malaria during pregnancy 
were not associated with adverse birth outcomes. Placental malaria by 
LAMP was associated with significantly higher risk of LBW (45.8% vs. 
10.2%, p<0.001) and preterm delivery (29.2% vs. 7.0%, p<0.001). 
Placental malaria by histopathology was not associated with adverse 
birth outcomes. Longitudinal measures of malaria during pregnancy were 
strongly associated with placental malaria but not adverse birth outcomes. 
Placental malaria by LAMP was associated with an increased risk of 
adverse birth outcomes.
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RECENT TRENDS IN MALARIA INCIDENCE AND 
SURVEILLANCE IN CAMBODIA
Pengby Ngor1, Siv Sovannaroth2, Po Ly2, Tol Bunkea2, Lisa J. 
White1, Arjen M. Dondorp1, Rekol Huy2, Richard J. Maude1
1Mahidol-Oxford Tropical Medicine Research Unit (MORU), Bangkok, 
Thailand, 2National Center for Parasitology, Entomology and Malaria 
Control, Phnom Penh, Cambodia
Cambodia has the target of eliminating malaria by 2025. There are 
currently intensive efforts towards achieving this aim. However, there is 
great concern about the potential threat to elimination from increasing 
ACT treatment failure rates with artemisinin and ACT partner drug 
resistance. It is thus important to monitor trends in incidence rates of 
malaria in Cambodia and to understand their possible causes. Malaria 
surveillance data collected from multiple sources by the Cambodia national 
malaria control programme (CNM) from 2006 to 2016 were analysed. 
Overall there have been substantial decreases in malaria burden over this 
period, particularly for P. falciparum. The burden of P. vivax increased 
with roll-out of the village malaria worker (VMW) programme and wider 
availability of multi-species rapid diagnostic tests, peaking in 2011. In 
recent years, around half of malaria cases reported to CNM in Cambodia 
were diagnosed by VMWs. From 2013 to 2014, both falciparum and 
vivax malaria increased in incidence. This appears to have been at least 
partly due to a substantial increase in testing for malaria by village malaria 
workers (VMW) over the same period. In 2015, the number of people 
tested for malaria by VMWs fell and there was a decrease in the total 
number of cases of similar magnitude. In Western Cambodia, there was an 
increase in cases in 2015 due principally to a large rise in P. falciparum in 
only two operational districts with increased testing for malaria by VMWs, 
and a smaller increase in testing by health facilities. The data collection 
and analysis are ongoing and at the time of the meeting we aim to provide 
updated results and potential additional explanations for the observed 
trends. Studies are also underway to investigate the current rates of ACT 
treatment failure and antimalarial drug resistance and assess their potential 
impact on trends in malaria incidence. These preliminary results illustrate 
the important role of village malaria workers in diagnosing malaria in 
Cambodia and highlight the importance of maintaining a stable, high 
quality surveillance system to underpin efforts for malaria elimination.
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PREVALENCE OF MALARIA FROM BLOOD SMEARS 
EXAMINATION: A TWENTY YEAR RETROSPECTIVE STUDY 
FROM NATIONAL MALARIA REFERENCE LABORATORY, 
OUAGADOUGOU, BURKINA FASO 
Alphonse Ouedraogo, Nébié Issa Ouédraogo, Amidou Diarra, 
Amadou Konaté, Alfred Tiono, Sodiomon B. Sirima
Centre National de Recherche et de Formation sur le Paludisme, 
Ouagadougou, Burkina Faso
Malaria is still a major public health problem in Burkina Faso. According 
to the Burkina Faso ministry of health statistic unit, malaria prevalence 
is increasing. In the WHO 2014 malaria report, the trend of malaria 
is decreasing in sub-Sahara. Therefore, the aim of this study was to 
determine real malaria morbidity based on the twenty year slide positive 
rate of malaria. A retrospective study was conducted at “Centre National 
de Recherche et de Formation sur le Paludisme” laboratory from 1990 
to 2013. Twenty year malaria cases data had been collected from 
laboratory registration book. A total of 65464 patients were examined 
for suspected malaria; of these, 12922 (19.74%) had objective fever; 
13159 (20.10%) study subjects were positive for malaria. A slide positive 
rate of Plasmodium within the last twenty years (1990-2013) decreased 
from 25.8% in 1990 to 9.3% in 2013 (p< 0,0001) with slight fluctuation 
during the study period. A rate of gametocytemia decrease from 3.52% 
in 1990 to 1.09% 1n 2013 (p< 0.0001). High slide positive rate of malaria 
occurred during high malaria transmission season 82.97%, followed by 
dry season 17.02% (p< 0.0001). The age groups of 5-14 years old were 
highly affected by malaria infection. During the study period, the trend 
was to the reduction. The predominant Plasmodium species detected was 
P. falciparum (97.83%) followed by P. malariae (1.61%).. In conclusion, 
slide positive rate of malaria was still high in study area. During the last 
twenty years, Plasmodic index & gametocytemia decreased based on the 
microscopy diagnosis. MoH should reinforce health system capacity to 
improve the data report.
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CHARACTERIZING THE IMPACT OF DYNAMIC VECTOR 
ABUNDANCE ON INDIVIDUAL MALARIA PREVALENCE IN A 
HIGH TRANSMISSION AREA OF NORTHERN ZAMBIA
Marisa A. Hast1, Jennifer C. Stevenson1, Mbanga Muleba2, Mike 
Chaponda2, Jean-Bertin Kabuya2, Modest Mulenga2, Christine M. 
Jones1, Justin Lessler1, Timothy Shields1, William J. Moss1, Douglas 
Norris1
1Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United 
States, 2Tropical Diseases Research Centre, Ndola, Zambia
Vector control is a key strategy in reducing community malaria burden, 
however, little is known about the impact of vector population dynamics 
on individual malaria risk in multispecies systems. Malaria transmission in 
Nchelenge District, Zambia is complex due to the presence of two highly 
competent malaria vectors with distinct spatial and seasonal distributions, 
resulting in year-round hyperendemic transmission. From April 2012 to 
December 2015, the Southern Africa ICEMR enrolled 2,296 participants 
in active malaria surveillance and collected over 10,000 Anopheles 
funestus and 1,000 An. gambiae from indoor CDC light traps. Average 
mosquito counts per household were aggregated by species to each 
1x1 km sampling grid by month of data collection. Multivariate spatial 
and temporal smoothing analyses will be conducted to further account 
for variation. A mean of 18.0 An. funestus and 1.7 An. gambiae were 
caught per household (range: 0-226 and 0-32). In preliminary regression 
analyses, mean An. funestus per household was significantly higher in 
the dry season, in inland areas, and in grids with higher use of insecticide 
treated nets (ITNs), and were lower in grids with greater coverage of 
indoor residual spraying (IRS). An. gambiae per household were correlated 
with climactic and environmental factors, including temperature, rainfall, 
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and altitude. Both species were highly predictive of individual malaria 
prevalence in multivariate logistic models. The odds of having a positive 
RDT increased 7.7% for each increase in 10 An. funestus (P=0.02) 
and 5.1% for each increase in 1 An. gambiae (P=0.04), controlling for 
clustering by household, age, ITN use, recent malaria treatment, history 
of IRS, education level, and distance to roads. Inclusion of environmental 
variables and distance to streams attenuated the association between 
malaria prevalence and An. gambiae and funestus, respectively, 
highlighting potential ecological drivers of mosquito and malaria dynamics. 
These findings illustrate the complexity of vector bionomics as a predictor 
of malaria risk and the need to target interventions to the unique ecology 
of each vector species.
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SPATIAL CHANGE IN THE RISKS OF PLASMODIUM VIVAX 
AND P. FALCIPARUM MALARIA IN CHINA, 2005-2014
Samuel H. Hundessa1, Gail Williams1, Wenyi Zhang2, Shanshan 
Li1, Linping Chen1, Yuming Guo1
1University of Queensland, Brisbane, Australia, 2Institute of Disease Control 
and Prevention, Academy of Military Medical Science, Beijing, China
Despite the declining trend of malaria incidence over the last decades, 
Plasmodium falciparum malaria has increased in China both in terms of 
the number of case and geographical coverage. To help with the disease 
elimination, this study examined a spatial change in the risk of both P. vivax 
and P. falciparum malaria across China during 2005-2014. We applied 
logistic regression model to understand change in the risk of P. vivax and P. 
falciparum in each county across study period, and linear regression model 
to examine annual change in longitude and latitude of affected counties. 
The risk of P. falciparum malaria significantly increased with latitude and 
longitude, indicating that incidence rate of P. falciparum malaria increased 
in the northern and eastern, or decreased in south and western China. 
Similarly, latitude and longitude of counties with P. falciparum significantly 
associated with year. However, longitude of P. vivax affected counties 
significantly decreased, showing an annual declining number of P. vivax 
affected counties in eastern or increased in western China. The risk of P. 
vivax malaria had decreased whereas, the risk P. falciparum malaria had 
increased in the northern and eastern China. For successful elimination of 
malaria, underlying causes of the increased P. falciparum malaria risk needs 
further investigation.
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EVALUATING A REACTIVE TEST-AND-TREAT PROGRAM 
FOR SUB-PATENT MALARIA IN MACHA, ZAMBIA: OPTIMAL 
STRATEGIES TO ACHIEVE ELIMINATION
Molly Deutsch-Feldman1, Harry Hamapumbu2, Michael 
Musonda2, Ben Katowa2, Jailos Lubinda2, Tamaki Kobayashi1, Kelly 
M. Searle1, Timothy M. Shields1, Jennifer C. Stevenson1, Philip E. 
Thuma2, William J. Moss1
1Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United 
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In Choma District, Southern Province, Zambia, malaria prevalence by rapid 
diagnostic test (RDT) declined from 8% in 2008 to 1% in 2013. As part of 
an effort to achieve elimination, the Zambian government implemented 
a reactive test-and-treat (RTAT) program in parts of Southern Province in 
2013. Individuals with confirmed malaria by health workers are followed-
up within two weeks of diagnosis. All individuals living in households 
within 140 meters of the index case are tested with an RDT and treated if 
positive. This study aimed to optimize the RTAT strategy by characterizing 
infected individuals missed by both the RDT and the current screening 
radius. Health workers notified the study team of individuals with RDT 
confirmed malaria. For each study participant, a questionnaire was 
administered and a blood sample collected. To evaluate the optimal RTAT 
radius and assess the frequency of sub-patent, RDT negative infections, 
the radius was expanded to 250 meters and quantitative polymerase 
chain reaction (qPCR) testing was introduced. Spatial-temporal cluster 
detection was conducted to identify clusters of index households. From 
January 2015 to January 2016, 101 index cases were identified at health 
centers and health posts and followed up by the health workers with the 
study team. A total of 2504 individuals residing in 394 households were 
screened. Parasite prevalence was 2.5% by qPCR (53 positives of 2108) 
and 1.2% by RDT (26 positives of 2225). Of the qPCR positive cases, 
66% of 53 individuals tested negative by RDT. 24 households had at least 
one qPCR+/RDT- individual. Nearly half of those infected resided within 
the index case household. The cluster detection revealed no clustering of 
index case households. The low number of secondary cases indicates low 
efficiency of RTAT beyond the index case household and the sensitivity 
of the RDT was too low to be an effective screening tool. Focal drug 
administration in which all individuals within index case households are 
treated may be a more efficient approach to achieving malaria elimination 
in southern Zambia.
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PREVALENCE OF ASYMPTOMATIC MALARIA INFECTIONS 
AND ASSOCIATED RISK FACTORS IN A HIGH TRANSMISSION 
REGION IN WESTERN KENYA
Judith Nekesa Mangeni1, Andrew Obala1, Dismas Ongore2, Ann 
Mwangi1, Wendy Prudhomme O’Meara3
1Moi University, Eldoret, Kenya, 2University of Nairobi, Nairobi, Kenya, 
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Asymptomatic infections pose a major threat to malaria control programs 
since they act as silent reservoirs for the malaria parasites. Targeting the 
asymptomatic reservoir is key for the success of elimination efforts. We 
sought to determine the prevalence of asymptomatic malaria infections, 
whether they show heterogeneity and their determinants in a high 
transmission geographically homogenous region. This was part of a larger 
prospective cohort study that we set up in Bungoma East sub-County. We 
conducted quarterly parasitological surveys for a cohort of 400 participants 
from randomly selected households located in known fever ‘hotspots’ and 
“cold spots”. Follow-up continued for a period of one year. Generalized 
estimating equations were used to model risk factors associated with 
asymptomatic parasitemia. A total of 321 malaria infections were 
detected during the five cross-sectional surveys over the course of one 
year. Almost half (46.3%) of these were asymptomatic. Overall, most 
of the asymptomatic cases (67%) were in households within known 
‘fever hotspots’. The proportion of infections that were asymptomatic in 
the coldspots were 73.1%, 31.8%, 13.3%, 55.6% and 48.2% during 
the first, second, third, fourth and fifth visits respectively. In the known 
fever hotspots, the proportion of infections without symptoms was 
47.7%, 48.5%, 35%, 41.3% and 47.5% during the first, second, third, 
fourth and fifth visits respectively. Factors associated with asymptomatic 
malaria include; the village one lives: people living in Maruti village were 
twice likely to be asymptomatic (A.O.R: 2.141, C.I: 0.03 - 1.488), age: 
children aged between 6 to 15 years were more than twice likely to be 
asymptomatic (A.O.R: 2.67, C.I. 0.434 - 1.533) and the season: infections 
during the dry season (January) were less likely to be asymptomatic (A.O.R: 
0.26, C.I: -2.289 - 0.400). The prevalence of asymptomatic infections in 
this region is very high. There is a need for active surveillance to detect the 
asymptomatic cases as well as treat them in-order to reduce the reservoir. 
Targeting interventions to the asymptomatic individuals will further reduce 
the transmission.
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GEOGRAPHIC DISTRIBUTION AND SPATIAL CLUSTERING OF 
SUBMICROSCOPIC MALARIA IN KAYIN STATE, MYANMAR
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Diamond Khin2, Ed Marta3, Gilles Delmas1, Francois Nosten1
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Unit, Mae Sot, Tak Province, Thailand, 2Karen Department of Health and 
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In the Greater Mekong Subregion (GMS) malaria is spatially heterogeneous 
and seasonal. Since infections are relatively rare it is thought that few 
people should have asymptomatic and submicroscopic infections. 
However, recent work has revealed communities with high prevalences 
(>40%) of asymptomatic and submicroscopic malaria in several areas of 
the GMS. These preliminary studies focused on small numbers of villages 
and the distribution of such populations across landscapes in the GMS isn’t 
known. The goal of this work was to assess and analyze the frequency and 
geographic distribution of submicroscopic malaria across four townships 
of Kayin State, Myanmar as part of a Plasmodium falciparum malaria 
elimination project. We used field-based geographic surveys to map a 
target area consisting of over 1,200 villages (approximately 16,500 km2). 
Villages were then randomly selected for blood surveys. Survey teams 
visited selected villages, randomly selected villagers for participation in the 
survey and took 2cc of whole, venous blood. Blood samples were analyzed 
using a highly sensitive quantitative PCR approach. Villages with an 
overall Plasmodium prevalence higher than 40%, of which 20% or more 
was falciparum malaria, were considered “hotspot” villages (43 villages 
out of 204 surveyed have been thus categorized so far). Clustering also 
occurs at scales larger than the community. Villages with high prevalences 
of either falciparum or vivax malaria occur near other villages with high 
prevalences. Most “hotspot” villages occurred within 5km of at least one 
other “hotspot” village. Finally, over 85% (37/43) of all “hotspot” villages 
occurred within a single subregion (less than 3,500 km2) of the overall 
target area. Our results indicate that submicroscopic malaria clusters at 
multiple scales. Populations with high prevalences of submicroscopic 
malaria may act as important reservoirs of the disease and could frustrate 
elimination efforts. These results have implications for planning and 
implementing interventions such as reactive screening and treatment or 
targeted mass drug administration.
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MALARIA PREVALENCE IN THE URBAN AREAS OF 
MANGALURU IN SOUTH INDIA
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Mangaluru city, located on the Southwestern coastal area of Karnataka 
State in India, is the government headquarter of Dakshina Kannada 
district. In late 1940s, malaria was common in the rural areas of the 
district with parasitemia rate of 5-12% and splenomegaly case rate of 
17-46%, whereas incidences were low at urban areas of Mangaluru city. 
The malaria control program initiated in the district in 1948 succeeded 
in reducing the parasitemia and splenomegaly rates to 0.5% and 9.4% 
respectively by 1951. However, resurgence of transmission resulted in 
440 deaths between 1956 and 1959, and with renewed control efforts, 
there were no deaths by 1961. From 1969 malaria started resurging 
again, reaching a peak of 5225 cases in 1975, and with the modified 
plan of National Malaria Eradication Program, it declined to 86 cases in 
1988. Again, the numbers of malaria cases in the district increased to 
340, 4027, 6692, 21159, and 11413, respectively, in 1991, 1993, 1995, 
2005 and 2015; there were 26 deaths in 1995. While 95 (83%) of 114 
cases reported in 1990 occurred in rural areas of the district, during 1993 
to 2015, 86% cases have occurred in the urban areas of Mangaluru city 
and 14% in the rural areas. The average annual parasite incidence (API) 
has been 16 for Mangaluru city and 0.7 for rural areas of the district. The 
surges in malaria cases in Mangaluru city during 1995-97 and 2004-06 
were accompanied by increased incidence in the adjoining rural areas. 
Industrial constructions, rapid expansion of urbanization and housing 
constructions, and migration of workers from malaria endemic areas are 
the likely causes for the resurgence of malaria in Mangaluru city, while 
the spread to rural areas of the district has been likely occurring through 
the people commuting from rural areas for work in Mangaluru city. The 
persistence of markedly higher API in the city compared to the rural areas 
suggests that Mangaluru city is a substantial malariagenic locality in the 
district. The increasing contribution of Mangaluru city to the total cases of 
malaria in Karnataka state, from 1.2% in 1994 to 67% in 2015, suggests 
the need for more effective control measures in Mangaluru city.
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MALARIA SURVEILLANCE DURING THE TRANSIT FROM 
CONTROL TO PRE-ELIMINATION
José L. Segura1, Eugenio Edu2, Giovanna Baltazar1, Luis 
Benavente1, Christopher Schwabe1, Dianna Hergott1
1Medical Care Development International, Silver Spring, MD, United States, 
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The 2012 WHO manual of surveillance for malaria control proposed the 
monitoring of suspected cases, however the same manual fostered the 
use of confirmed malaria cases. On other hand to ensure that lab results 
do not influence the condition of “suspected” in the registers, has been 
proven to be a challenge. Following WHO guidance, Bioko Island Malaria 
Control Project (BIMCP) has been reporting the number of suspected 
cases, composed by adding a) the number of outpatients lab tested for 
malaria plus b) the number of presumed malaria cases (clinical diagnosis 
or diagnosed without lab confirmation). After 11 years of BIMCP’s activity, 
Bioko is in transit from control phase to the pre-elimination, and a malaria 
surveillance system able to provide support for both phases is required. 
We have assessed the trends and composition of the group “suspected 
cases” to assess its contribution to the malaria surveillance. Between 2013 
and 2016 the reduction in the average monthly number of suspected 
cases was quite slower (30%) compared with the decrease in its sub-group 
of confirmed malaria cases (75%), or the sub-groups with diagnostic 
behaviors potentially deviant of WHO guidelines (1. cases diagnosed as 
malaria without lab test, 2. cases diagnosed as malaria with negative test 
results, and 3. cases with a diagnosis other than malaria with a malaria 
test positive) which shown a decrease in the range of 68-71%. Conversely, 
among the suspected cases the average monthly number of cases with 
a malaria test negative and reported with a diagnosis other than malaria 
experienced an increase of 219%. We conclude that a) the number of 
suspected cases is not as sensitive as of confirmed cases to monitor the 
burden of disease, b) the training, supervision and availability of supplies 
for lab testing has allowed the reduction of undesirable diagnostic 
behavior, and c) clinicians may have in fact adopted more inclusive criteria 
to classify outpatients as malaria suspected cases along with the reduction 
of parasitemia in Bioko. NHIS data from at least the last four years will be 
analyzed to identify changes in the definition of suspected cases informally 
adopted by clinicians.
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THE RELATIONSHIP BETWEEN ANEMIA AND MALARIA 
INFECTION AMONG CHILDREN UNDER FIVE YEARS IN 
MALAWI
Doris P. Yimgang1, Andrea G. Buchwald1, Jenna E. Coalson2, 
Lauren M. Cohee1, Jenny A. Walldorf1, Nelson Chimbiya3, Andy 
Bauleni3, Kondwani Nkanaunena3, Andrew Ngwira3, Atupele 
Kapito-Tembo3, Don Mathanga3, Terrie E. Taylor4, Miriam K. 
Laufer1
1Division of Malaria Research, Institute for Global Health, University of 
Maryland School of Medicine, Baltimore, MD, United States, 2University of 
Michigan School of Public Health, Ann Harbor, MI, United States, 3Malaria 
Alert Center, University of Malawi College of Medicine, Blantyre, Malawi, 
4Michigan State University, East Lansing, MI, United States
Anemia is a public health concern in resource limited settings. Although 
the causes are multi-factorial, a major contributor is malaria. The World 
Health Organization has proposed using anemia prevalence as a surrogate 
measure of the burden of malaria infection. Despite the fact that several 
studies have demonstrated a correlation between the prevalence of 
anemia and the prevalence of malaria infection, none have explored the 
relationship between anemia and malaria prevalence over time or whether 
widespread rollout of malaria interventions is associated with a change in 
the prevalence of anemia. Six cross-sectional studies were conducted in 
southern Malawi during the rainy and dry seasons from 2012 to 2014. A 
mass distribution of insecticide-treated nets (ITNs) occurred after the first 
survey. Children 6 to 59 months of age for whom hemoglobin data were 
available were included in this analysis. Blood samples were collected by 
fingerprick, and hemoglobin was measured using Hemocue® photometer. 
Malaria infection was detected by qPCR. Zero-inflated Poisson mixed-effect 
regression models were used to assess the relationship between anemia 
prevalence and malaria prevalence or ITN use accounting for clustering at 
the neighborhood level. Hemoglobin data and PCR results were collected 
on approximately 3,100 children under 5 years of age. Malaria prevalence 
followed a seasonal trend with the highest prevalence in the rainy seasons. 
In contrast, anemia prevalence and ITN use did not show consistent 
patterns. Additional analyses are planned for confirmation. From our initial 
analysis, we found no evidence of association between changes in anemia 
prevalence and either changes in malaria infection prevalence or ITN use 
in children. Anemia may not be a useful surrogate for changes in malaria 
prevalence.
926
ASSOCIATION BETWEEN CARRIAGE OF ASYMPTOMATIC 
INFECTIONS AND TIME TO CLINICAL MALARIA IN MALAWI: 
DATA FROM A LONGITUDINAL COHORT STUDY
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Mabvuto Chimenya2, Andy Bauleni2, Syze Gama2, John D. Sorkin1, 
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It is unknown whether asymptomatic Plasmodium falciparum 
infections lead to clinical malaria. However, there is some evidence that 
asymptomatic infections may protect against development of clinical 
disease. This study uses longitudinal data to examine the effect of 
asymptomatic infections on time to clinical malaria in a high-transmission 
region of Malawi. Individuals attending a health center with acute 
uncomplicated malaria were treated with artemether/lumefantrine (AL) 
and followed for up to 470 days. Blood samples were collected monthly 
for qPCR detection of infection. Passive surveillance for clinical malaria was 
conducted and, if RDT positive, participants were treated with AL. Mixed 
effect Cox models with time-varying exposure (asymptomatic infection) 
and random effects for repeated measures were used to estimate the 
effect of carriage of asymptomatic infection on time to clinical malaria. 
Models were adjusted for age, season, and ITN use. Follow up time for 
the current analysis began 30 days after each treatment with AL. There 
were 62 individuals with 192 periods of observation after a treatment, 
137 ending in clinical malaria episodes and 55 censored observations. 
Median follow up time for all observations was 95 days (IQR = 39 - 202); 
122 days (IQR = 51-265) for observations with asymptomatic infections 
and 59 days (IQR = 26 - 111) for observations without asymptomatic 
infection. After adjustment, individuals with asymptomatic infections 
had an increased time to clinical malaria compared to individuals without 
asymptomatic infection (Hazard Ratio = 0.67, p < 0.05). Asymptomatic 
infections are associated with decreased risk of clinical disease compared 
to those without asymptomatic infection. This could be attributed to a 
protective effect of asymptomatic infection against symptomatic malaria. 
Alternatively, the ability to maintain an infection without symptoms may 
be an indicator of host immunity. Understanding the mechanism that 
underlies the relationship between asymptomatic infection and clinical 
disease is essential to developing interventions and may provide insight 
into the basis of acquired immunity.
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COST ANALYSIS OF AN LLIN KEEP-UP CHANNEL IN 
TANZANIA: THE SCHOOL NET PROGRAM
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United Republic of Tanzania, 5President’s Malaria Initiative, Dar es Salaam, 
United Republic of Tanzania
Although school distribution has been named by World Health 
Organization as a channel for maintaining universal coverage of long 
lasting insecticide treated bed nets (LLIN), little is known about the cost 
or cost-effectiveness of this approach. In 2011-2012, Tanzania attained 
universal coverage, reaching over 90% ownership of at least one LLIN. 
Since then, in the southern zone LLINs have been distributed to school 
children in primary school classes (1, 3, 5 and 7) and secondary school 
classes (2 and 4) once a year as a keep-up strategy. A cost analysis of the 
third round of the School Net Program (SNP3) was implemented in 2015. 
During SNP3, the government distributed 494,407 LLINs to 1,919 schools 
in 19 districts. The study utilized the provider perspective and estimated 
both economic and financial costs. Costs were collected retrospectively 
from financial and operational records and through stakeholder interviews 
at the national and regional level. A survey instrument was utilized to 
collect resource use and expenditure information at the district and 
school level. Fifteen out of the 19 districts were sampled along with two 
schools from each of those districts. Average costs for each activity were 
calculated from the sampled districts and schools and applied to those 
not included in the sample. Overall, SNP3 was able to deliver LLINs at an 
economic cost of 7.70 USD per net distributed during 2015. This translates 
into an estimated economic cost per person year of protection of 1.28 
USD. Of the total economic cost, approximately 4.33 USD (56%) was for 
distribution while the remainder of costs related to the cost of the net 
itself. These costs, as well as the cost per treated net year and cost per 
person year of protection appear comparable to other LLIN continuous 
distribution systems.
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DO MALARIA HOTSPOTS REALLY FUEL TRANSMISSION?
Gillian H. Stresman1, Julia Mwesigwa2, Jane Achan2, Gian Luca 
di Tanna1, Chris Drakeley1, Umberto D’Alessandro2
1London School of Hygiene & Tropical Medicine, London, United Kingdom, 
2Medical Research Council Unit, The Gambia, Fajara, Gambia
Spatial heterogeneity in malaria transmission has been recognized for 
some time and the idea of using these ‘hotspots’ of intense transmission 
for targeting control and elimination interventions have received 
considerable attention. However, despite the biological plausibility of 
the hotspot idea, both in terms of these areas seeding transmission and 
that targeting these areas with interventions can have a disproportional 
impact on transmission, the evidence to support this concept has been 
mixed. Evidence suggests that some hotspots are consistent between years 
while others are not which has important implications for how to inform 
control practices. Similarly, malaria heterogeneity exists on all scales and 
transmission intensities however; identifying when and whether identifying 
hotspots becomes operationally feasible is unknown. To study the spatial 
and temporal dynamics of malaria transmission, data from a longitudinal 
cohort in The Gambia was analyzed. All consenting individuals residing in 
twelve villages across the country were sampled monthly from June (dry 
season) to December (wet season) 2013. A study nurse stationed within 
each village recorded all malaria episodes between visits. Plasmodium 
falciparum infections were determined by polymerase chain reaction. 
Spatial and spatio-temporal analysis was conducted using the PrevMap 
package in R. Results indicate that malaria is focal around high burden 
households suggesting that such households seed transmission. However, 
this pattern was only observed in low transmission villages. As transmission 
intensity increases, households with a consistently high burden of malaria 
exist, but the high burden households change over time and infections 
are present in the majority of houses making a targeting strategy less 
appropriate. This study provides the first detailed assessment of the 
transmission patterns at the village level and has important implications for 
understanding the applicability of spatially targeted control approaches in 
this setting.
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HEALTH WORKER ADHERENCE TO MALARIA CASE 
MANAGEMENT GUIDELINES AT PUBLICLY FUNDED 
OUTPATIENT HEALTH FACILITIES — SOUTHERN MALAWI, 
2015
Ruth Namuyinga1, Dyson Mwandama2, Dubulao Moyo3, Austin 
Gumbo3, Peter Troell4, Miwako Kobayashi1, Monica Shah1, Andrew 
Bauleni5, Don Mathanga5, Laura Steinhardt1, Alex Rowe1
1Centers for Disease Control and Prevention, Atlanta, GA, United States, 
2Malaria Alert Center, Malawi, Blantyre, Malawi, 3Malawi Ministry of 
Health, Lilongwe, Malawi, 4Centers for Disease Control and Prevention, 
Lilongwe, Malawi, 5Malaria Alert Center, Blantyre, Malawi
Six million episodes of malaria occur in Malawi annually. Gaps in quality 
malaria treatment persist. We conducted a cross-sectional outpatient 
health facility (HF) survey in southern Malawi in January–February 2015 
to identify opportunities for promoting adherence to the 2013 national 
malaria case management (CM) guidelines. Using the 2013 CM guidelines, 
surveyors classified patients as suspect uncomplicated or suspect severe 
malaria. Main outcomes were appropriate testing (suspect uncomplicated 
malaria only) and treatment (confirmed or suspect uncomplicated and 
suspect severe malaria) based on the CM guidelines. Weighted descriptive 
and logistic regression analyses of patient, health worker (HW) and HF 
characteristics were performed. We evaluated 105 HFs and interviewed 
150 HWs and 2342 patients. Of 1427 suspect uncomplicated malaria 
patients at HFs with malaria testing, 1072 (75.7%) were tested, and 547 
(53.2%) tested positive. In total, 511 (92.7%) confirmed and 98 (60.3%) 
suspect malaria patients (at HFs without testing) were appropriately 
treated. Only 8 (5.7%) suspect severe malaria patients received appropriate 
pre-referral treatment. Patients were more likely to get tested for malaria 
if they reported fever (odds ratio [OR] = 2.6; 95% confidence interval [CI]: 
1.7–4.0), headache (OR = 1.5; 95% CI: 1.1–2.1) or vomiting (OR = 2.0; 
95% CI: 1.0–4.0) to HWs and less likely to be tested if they reported a skin 
problem (OR = 0.4; 95% CI: 0.2–0.6). For patients with suspect malaria, 
appropriate treatment was more likely with elevated temperature (OR = 
1.5 per 1°C increase; 95% CI: 1.2–1.9), patient reported fever (OR = 7.2; 
95% CI: 2.6–20.2), being seen by HWs with a copy of the 2013 malaria 
CM guidelines (OR = 11.8; 95% CI: 3.9–34.8) or HWs with additional 
supervision visits in the last 6 months (OR = 1.3 per additional visit; 95% 
CI: 1.1–1.5), but less likely for those attending rural hospitals versus health 
centers (OR = 0.2; 95% CI: 0.1–0.3). HW solicitation of patient symptoms 
may improve malaria testing practices. Appropriate treatment of malaria 
may be improved by extra supervision visits to HWs, plus better access to 
tests and guidelines.
930
THE CHANGING BURDEN OF MALARIA IN PREGNANCY AND 
CURRENT EFFECTIVENESS OF INTERVENTIONS
Patrick Walker1, Jessica Floyd1, Feiko O. ter Kuile2, Matt Cairns3
1MRC Centre for Outbreak Analysis & Modelling, London, United 
Kingdom, 2Liverpool School of Tropical Medicine, Liverpool, United 
Kingdom, 3London School of Hygiene & Tropical Medicine, London, United 
Kingdom
The risk of malaria in pregnancy (MiP) has fallen considerably in the 21st 
century as interventions have successfully reduced prevalence within the 
general population. Combining an existing mathematical model of MiP 
with estimates of endemicity between 2000 and 2015, we estimate that 
the risk of MiP has fallen on average by 37% across all areas of sub-
Saharan Africa at risk. The per-pregnancy risk of MiP-attributable low 
birthweight (LBW) faced by women not covered by interventions such as 
Intermittent Preventative Treatment (IPTp) with sulfadoxine-pyrimethamine 
(SP) has fallen by 32%. However, the risk of MiP remains substantial: in 
the absence of pregnancy-specific intervention we estimate 8.5 million 
women would have experienced MiP leading to 660,000 LBW deliveries in 
2015. We combined these estimates of MiP risk with current intervention 
coverage from population based surveys. Across 26 countries median 
use of LLINs in multigravidae (1 previous child or more) was 40%, but 
in primigravidae was substantially lower (median 25%). Only 21.1% 
of pregnant women at risk are receiving any IPTp, lagging well behind 
antenatal clinic (ANC) attendance (64.1% of these women attended ANC 
at least three times). We then combined our maps of the MiP burden 
with maps of SP resistance mutations. IPTp efficacy in different areas 
was estimated based on IPTp studies in areas with different mutation 
frequencies. Based upon 2010 levels of resistance, 9 million women reside 
where IPTp-SP is still likely to be highly effective and attended ANC at least 
three times during pregnancy, but did not receive any IPTp. This represents 
200,000 LBWs which could be averted highly cost-effectively. We found 
24% (6.2 million) deliveries occurred in settings where the quintuple SP 
resistance mutation had saturated by 2010, with 2 million occurring in 
settings with appreciable levels of the sextuple haplotype. Increasing LLIN 
use, particularly in primigravidae, and providing IPTp to women already 
attending ANC should be key priorities. Increased monitoring of the effects 
of SP resistance, as well as research into suitable alternatives to current 
IPTp regimens is also crucial.
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PREVALENCE OF ASYMPTOMATIC MALARIA AND ANAEMIA 
AMONG SCHOOL AGE CHILDREN IN TWO ECOLOGICAL 
ZONES IN GHANA
Benedicta Ayiedu Mensah, James L. Myers-Hansen, Benjamin 
Abuaku, Kwadwo Koram, Anita Ghansah
Noguchi Memorial Institute for Medical Research, Accra, Ghana
Asymptomatic Malaria in school children is a public health challenge 
because of its implication in anaemia and cognitive functioning of school 
children. We compared the prevalence of Plasmodium spp. and anemia 
among school children in the forest and the coastal zones of Ghana over 
a three year period. A cross sectional survey was conducted yearly for 
3 years in randomly selected schools in a coastal savanna town (Cape 
Coast) and a town located in the Forest zone (Begoro). A total of 2751 
children aged 6 to 14 years were screened between 2013 and 2015 
during the rainy season (September to November). The pupils provided 
their clinical and medication history two weeks prior to the screening 
and their heights body weights and axillary temperatures were taken. 
Each pupil provided a finger-prick blood for the preparation of thick and 
thin blood films for detection of parasitaemia by microscopy. The overall 
prevalence of asymptomatic malaria ranged from 17.5% to 23.1% over 
the 3 years period. The prevalence was higher in Forest zone (Begoro) 
than in coastal savanna town (Cape Coast) consecutively over the 3 
years however significant deference was only observed in 2014 with a 
prevalence of 24.2% and 11.3% respectively (P value < 0.0001). Highest 
prevalence of malaria was observed in children age between 9 and 11 
years (36.5% in 2013, 43.1% in 2014 and 42.1% in 2015). P. falciparum 
is the predominant species in both sites (79%, 86.2% and 94.3% for 
2013 to 2015 respectively). Other species identified in Begoro (forest 
zone) were P. malariae and in Cape Coast were P. malariae and P. ovale. 
The prevalence anaemia were 10.2%, 14.5% and 16.5% respectively 
from 2013 to 2015. Anaemia was associated with asymptomatic malaria 
(OR=0.42, p value <0.0001 in 2013, OR=0.62, p value = 0.049 for 2014 
and OR=0.46, p value <0.0001 for 2015). We conclude that malaria 
parasite prevalence is relatively high among school children in the coastal 
and forest zones of Ghana. Anaemia in school children increased from 
2013 to 2015 and is associated with asymptomatic malaria. Asymptomatic 
malaria in basic schools can be used to monitor the effectiveness of the 
malaria intervention.
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FAILURE OF AVAILABLE MALARIA CONTROL INTERVENTIONS 
IN DANGASSA, MALI: CONTINUOUSLY HIGH PREVALENCE 
OF PLASMODIUM FALCIPARUM INFECTION IN A COHORT OF 
1,400 INDIVIDUALS FROM 2012 TO 2015
Mahamoudou Toure1, Daouda Sanogo1, Sory Diawara1, 
Mahamadou Diakite1, Nafomon Sogoba1, Donald Krogstad2, 
Seydou Doumbia1
1l’Université des Sciences, des techniques et des technologies de Bamako, 
Bamako, Mali, 2Tulane University, New Orleans, LA, United States
During the past decade, major investments have been made in sub-
Saharan Africa leading to improved case management, greater coverage 
and use of LLINs and scale up of Seasonal Malaria Chemoprevention 
(SMC). We have examined changes in the seasonal prevalence of 
Plasmodium falciparum infection over a 4 year period in the context 
of malaria control interventions such as universal coverage with LLINs, 
IPTp for pregnant women, free ACT treatment for malaria and have 
recently introduced SMC. Our hypothesis is that long-term carriage 
in asymptomatic subjects is essential to maintain transmission in such 
populations/conditions. From 2012 to 2015, seven (7) blood smear 
surveys were performed in both the dry and rainy seasons in a well 
characterized cohort of adults and children in Dangassa (n=1500). 
Clinical and parasitological measurements to detect both symptomatic 
and asymptomatic infections were performed during each survey. 
Asymptomatic infection was defined as a positive smear for P. falciparum 
asexual parasites with an axillary temperature ≤ 37.5o C and no history of 
fever in the previous 24 hours. Seven point-prevalence of asymptomatic 
carriage across age groups and among pregnant women was assessed. 
The overall prevalence of asymptomatic infection varied from 13.3% to 
51.3% in June 2015 and October 2015. Symptomatic carriage was most 
frequent at the end of the rainy season with 12.2% in 2012 and 11.9% 
in 2014. High frequencies of asymptomatic infection were observed in 
the dry season for children 5 to 14 years of age: 57.2% in 2013 and 
64.5% in 2014. Prevalence of asymptomatic infection was also higher 
in pregnant women during the low transmission varying from 24.3% 
in 2013 to 28.6% in 2014. In conclusion, these results suggest that in 
Dangassa, despite multiple interventions against malaria, the prevalence 
of asymptomatic P. falciparum infection remains high, emphasizing the 
need for additional control approaches targeting the dry season reservoir 
and persistent transmission in order to reduce the continuing burden of 
malaria.
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TREATMENT SEEKING BEHAVIOR, DIAGNOSIS AND 
TREATMENT PRACTICES IN TANZANIA: COMPARISON 
BETWEEN COMMUNITY SURVEYS CONDUCTED SOON AFTER 
THE IMPLEMENTATION OF THE AFFORDABLE MEDICINES 
FACILITY - MALARIA AND THE MRDTS ROLL OUT, AND 
THREE YEARS LATER
Joanna Gallay1, IMPACT2 Study Team2, Blaise Genton3, Emilie 
Pothin4
1Department of Epidemiology and Public Health, Swiss Tropical and Public 
Health Institute, Basel, Division and Laboratory of Clinical Pharmacology, 
Service of Biomedicine, Department of Laboratories, University Hospital, 
Lausanne, Switzerland, 2Ifakara Health Institute, Dar es Salaam, Tanzania. 
Malaria Branch, Centers for Disease Control and Prevention, Atlanta, GA, 
United States, London School of Hygiene & Tropical Medicine, London, 
United Kingdom, 3Department of Epidemiology and Public Health, Swiss 
Tropical and Public Health Institute, Basel; Division of Infectious Diseases 
and Department of Community Medicine, University Hospital, Basel, 
Switzerland, 4Department of Epidemiology and Public Health, Swiss 
Tropical and Public Health Institute, Basel, Switzerland
Considerable efforts have been made to increase access to first-line 
antimalarials and mRDTs across Africa. In Tanzania mRDTs were rolled 
out in the public sector from 2009-12, while ACTs are subsidized in the 
public and private sectors. We present findings from community surveys 
conducted in 2012 and three years later to assess the degree to which 
these interventions have led to sustained changes in case management. 
Both surveys took place in the same regions of Tanzania (Mwanza, Mbeya 
and Mtwara) after the rainy season. In each region, community surveys 
were conducted in randomly selected wards of urban and rural districts. 
Health seeking behavior and drug use were inquired from individuals 
reporting fever in the previous two weeks. All participants were tested 
for malaria using mRDTs. Between 2012 and 2015, parasite prevalence 
increased from 16% (1428/8834) to 21% (497/2351) in Mwanza, 2% 
(125/5941) to 4% (82/1980) in Mbeya and 16% (837/5327) to 26% 
(554/2138) in Mtwara. A larger proportion of febrile cases who sought 
treatment were tested in 2015 (20% (210/1037)) than in 2012 (10% 
(169/1653)). This also translates into more antimalarials delivered. Results 
from both surveys show that in private as in public sectors, febrile cases 
were more likely to be treated than tested for malaria (14% (379/2690) 
tested and 35% (949/2690) received an antimalarial), especially in regions 
of high parasite prevalence. The majority of antimalarial therapies were 
obtained from private sector (25% (669/2690) and 10% (280/2690) in 
public sector), which is also the sector where the febrile cases were the 
least tested (10% (108/1096) of individuals seeking treatment in private 
sector tested against 55% (195/354) in public sector). Despite increasing 
between 2009 after roll-out of RDTs and 2012, testing still remains poorly 
used, especially in private sector. Increase of drug use consumption may 
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reflect better health seeking behavior but probably more a remaining 
overuse of antimalarials. These results highlight the importance of 
targeting the private sector for improving and encouraging the use of 
mRDTs in order to ensure rational and adequate use of antimalarials.
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ACCESSING VIVAX MALARIA WITH OVERLOOKED GENES: 
THE DIVERSITY OF VIR GENES IN PLASMODIUM VIVAX 
FROM NORTHERN REPUBLIC OF KOREA
Youn-Kyoung Goo, Ui-han Son, Yeonchul Hong, Dong-il Chung
Kyungpook National University, Daegu, Republic of Korea
Plasmodium vivax is the most prevalent human malaria parasite causing 
most of the cases outside of sub-Saharan Africa. Since 1993, P. vivax has 
been consistently arising in the northern area of Gyung-gi and Gang-won, 
Republic of Korea (ROK). The vir proteins, variant surface antigens (VSAs) 
of P. vivax, are considered as the key proteins to escape a host immune 
system through their antigenic variation, to infect erythrocyte’s surface, 
and partially to induce the adherence of P. vivax-infected reticulocyte to 
the endothelial cell receptor. In these regards, vir genes were proposed to 
be the candidates for a target of vaccine development, but variant nature 
of VSAs have been an obstacle to develop a potent vaccine. In this study, 
genetic diversity of four vir genes, vir 27, vir 21, vir 12, and vir 4, was 
evaluated using 85 venous blood samples collected from vivax malaria 
patients in 2011-2013, ROK. The number of SNPs was distributed from 
low as 5 (vir 4) to high as 143 (vir 21). The average number of haplotypes 
of all vir genes was 8.25, and average Hd was 0.727. Vir 12 (H= 9, Hd= 
0.795) showed the most genetically diverse followed by vir 21 (H= 9, 
Hd= 0.752), vir 27 (H= 6, Hd= 0.774), and vir 4 (3, 0.530,). Tajima`s D 
values of vir 27 (1.08530, P > 0.1), vir 12 (3.22553, P < 0.01), and vir 
21 (0.52098, P > 0.1) were all positive, meaning decreased size of these 
genes’ population and process of balancing selection. Moreover, Tajima`s D 
value of vir 12 was statistically significant, indicating that vir 12 was under 
balancing selection and/or decreasing population size. This study was the 
first survey about the vir gene in ROK, which provides the information 
of vir gene in ROK on genetic level. Among the four vir genes, it seemed 
that the most divergent gene was vir 12 and the vir 4 gene the most 
conserved. However, the sample sequences used in this study have shown 
a clear difference with Sal 1 reference gene sequence, while vir 4 gene 
was very similar to Indian isolate.
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PACBIO TECHNOLOGIES FACILITATE GENERATION OF 
A HIGH-QUALITY PLASMODIUM COATNEYI GENOME 
SEQUENCE AND ASSEMBLY
Jung-Ting Chien1, Suman B. Pakala2, Juliana A. Geraldo2, Stacey 
A. Lapp1, John W. Barnwell3, MaHPIC Consortium1, Jessica C. 
Kissinger4, Mary R. Galinski5
1Malaria Host–Pathogen Interaction Center, Emory Vaccine Center, Yerkes 
National Primate Research Center, Emory University, Atlanta, GA, United 
States, 2Institute of Bioinformatics, University of Georgia, Athens, GA, 
United States, 3Centers for Disease Control, Atlanta, GA, United States, 
4Institute of Bioinformatics, University of Georgia, Center for Tropical and 
Emerging Global Diseases, Department of Genetics, University of Georgia, 
Athens, GA, United States, 5Malaria Host–Pathogen Interaction Center, 
Emory Vaccine Center, Yerkes National Primate Research Center, Emory 
University, Division of Infectious Diseases, Department of Medicine, Emory 
University, Atlanta, GA, United States
High-quality genome sequence assembly and annotation are imperative 
for system biology-based studies to understand the complexity of 
parasite-host interactions in malaria. After decades of research, the first 
Plasmodium whole genome sequence, P. falciparum was published in 
2002 and both genome and other technologies have been advancing 
ever since, to the benefit of research aimed at understanding the biology 
of the parasite and the disease. Plasmodium coatneyi infection of rhesus 
macaques is an exceptional model to study malaria severity, given the 
biological and clinical features that are shared with P. falciparum. However, 
a complete genome sequence and annotation of P. coatneyi has not been 
available. As a solution, we developed a P. coatneyi assembly using PacBio 
(RS SMRT®) sequencing. This long-read technology (at least 10kb) has 
resulted in an assembly with high coverage and statistical confidence, 
with only one gap existing in the parasite’s14 chromosomes. A technology 
comparison as well as an evaluation of the current P. coatneyi genome 
sequences (nuclear, mitochondrial, and apicoplast), gene annotation, and 
repetitive regions will be presented.
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GENETIC POPULATION STRUCTURE IN HOTSPOTS OF 
PLASMODIUM VIVAX INFECTIONS IN THE PERUVIAN 
AMAZON: CLOSING THE GAP BETWEEN GENETICS AND 
EPIDEMIOLOGY
Gabriel Carrasco-Escobar1, Paulo Manrique2, Oscar Nolasco2, 
Marta Moreno3, Jan Conn4, Alejandro Llanos-Cuentas1, Dionicia 
Gamboa2, Joseph Vinetz3
1Instituto de Medicina Tropical “Alexander von Humboldt”, Lima, Peru, 
2Universidad Peruana Cayetano Heredia, Lima, Peru, 3University of 
California, San Diego, CA, United States, 4Wadsworth Center, Slingerlands, 
NY, United States
Molecular analysis and spatial statistics provide new insights toward 
understanding the complexity of malaria transmission in the Peruvian 
Amazon as well as to better design interventions to move toward 
elimination. In this study, we evaluated the genetics of parasite 
populations in hotspots of Plasmodium vivax detected by microscopy in a 
seasonal endemic community (Lupuna, Iquitos) of the Peruvian Amazon. 
A population-based surveillance was conducted from March 2013 - March 
2014. Every three months, we georeferenced houses and took blood 
samples for light microscopy examination. Samples on filter paper were 
collected by finger-prick for RT-PCR diagnostic and microsatellite (MS) 
genotyping. Of 4,090 samples (902 individuals) collected, 210 were 
positive by microscopy and 154 were analyzed with 9 previously reported 
and 7 new MS. Although four main subpopulations were identified by 
Bayesian analysis (STRUCTURE v2.3.4), only subpopulation 4 was stable 
across all surveys. Statistically significant hotspots with Satscan v9.4.2 
(applying a Bernoulli model) were identified in every survey except in 
December (low transmission). A logistic regression showed that infections 
inside hotspot (n=31.2%; RR=2.62; p=0.024) during the high transmission 
month of June were two times more likely to be from subpopulation 
4 than those located outside hotspot (OR=2.73; 95%CI=1.02-7.29). 
Concurrent vector biology analysis determined that in June, indoor and 
outdoor human biting rates by Anopheles darlingi decreased dramatically, 
supporting the hypothesis of bottleneck and clonal expansion of 
subpopulation 4 despite introduction of many other parasite populations. 
Our study findings confirmed the endogenous parasite population source 
of local transmission and hotspots in riverine Amazonian communities.
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TEMPORAL DYNAMICS OF GENOME-WIDE TRANSCRIPTION 
IN MALARIAL CHILDREN IN BURKINA FASO
Aissatou Diawara1, Massar Dieng1, Aboubacar S. Coulibaly2, 
Alfred B. Tiono2, Sodiomon Sirima2, Issiaka Soulama2, Youssef 
Idaghdour1
1New York University Abu Dhabi, Abu Dhabi, United Arab Emirates, 
2Centre National de Recherche et de Formation sur le Paludisme (CNRFP), 
Ouagadougou, Burkina Faso
Malaria is a complex infectious disease with many genetic and 
environmental determinants influencing host immune response to 
infection, the progression of the disease and its severity. To date, surveys 
of host transcriptional responses used largely on cross-sectional study 
designs. Here we investigate the temporal dynamics of peripheral blood 
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transcription response to Plasmodium falciparum infection using RNA 
sequencing of a pediatric cohort in Burkina Faso. Children from 2-10 
years living in two malaria-endemic villages of Banfora health district in 
Burkina Faso were sampled between May and November 2015 before 
and during the course of infection. Hundred bp Paired-End RNASeq 
profiles were generated and sequenced on an Illumina HiSeq instrument. 
Supervised statistical analysis of host genome-wide gene expression 
profiles revealed the nature, magnitude and significance of transcriptional 
changes taking place during the course of malaria infection. Gene set 
and pathway enrichment analysis identified key signature pathways, 
molecular and biological processes of host immune system modulated in 
response to infection. Integrated genotype and gene expression analysis 
allowed quantification of the contribution of host genotype to response 
to infection. The study provides a high-resolution picture of temporal 
transcriptional changes in a highly malaria-endemic region.
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GENOMIC SIGNALS OF CHANGING MALARIA TRANSMISSION
Robert Verity
Imperial College London, London, United Kingdom
Levels of genetic variation in the malaria parasite Plasmodium falciparum 
are known to vary by transmission intensity. The chance of the exact same 
multi-locus pattern of variation occurring several times in the population 
tends to be very low when transmission is intense, due to the increased 
opportunity for sexual reproduction and recombination. In contrast, in 
regions approaching elimination the same haplotypes tend to be found 
repeatedly due to clonal propagation. The tipping point at which this 
change in the population occurs is a crucial consideration for surveillance 
programmes, where genetic technologies are likely to play an increasingly 
important role in future. Here we use a fully integrated model of malaria 
genetics and epidemiology to explore the bottlenecks in the P. falciparum 
lifecycle that are capable of generating the observed patterns. Our results 
are able to capture the major trends in genomic variation over a range 
of transmission intensities, while also providing insight into the relative 
strengths of the different processes that lead to a loss of variation in 
decreasing transmission. We apply this model to a range of elimination 
and pre-elimination scenarios to explore the ways in which malaria 
epidemiology can influence and shape parasite population genetics. 
These results add to an expanding body of evidence that highlight the 
importance of genetic data as part of future control and elimination 
schemes.
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DEVELOPMENT OF A MULTIPLEX QPCR ASSAY 
FOR THE QUANTITATION OF PLASMODIUM 
FALCIPARUM GAMETOCYTOGENESIS IN A COHORT OF 
ASYMPTOMATICALLY INFECTED ADULTS IN WESTERN 
KENYA
Deborah M. Stiffler1, Carolyne M. Kifude2, Shirley Luckhart3, 
John N. Waitumbi2, Janet N. Oyieko4, V. Ann Stewart1
1Uniformed Services University of the Health Sciences, Bethesda, MD, 
United States, 2U.S. Army Medical Research Directorate, Kenya, Kisumu, 
Kenya, 3Department of Medical Microbiology and Immunology, School of 
Medicine, University of California Davis, Davis, CA, United States, 4Kenya 
Medical Research Institute-Walter Reed Project, Kombewa, Kenya
Plasmodium falciparum gametocytogenesis and gametocyte carriage 
remain poorly understood in areas of endemic malaria transmission, in 
spite of the important correlation between malaria transmission and 
gametocyte carriage. A sensitive and efficient method for quantitation of 
gametocytes in field samples is needed to determine transmission potential 
and evaluate mechanisms leading to increased gametocyte production. 
A multiplex quantitative PCR (qPCR) assay is well suited for this purpose 
because it uses multiple different fluorescent probes to simultaneously 
quantify the expression of several markers, reducing the amount of time 
and sample needed as compared to running multiple individual assays, 
and it is capable of detecting even very low levels of gene expression. 
Using the TaqMan qPCR chemistry, we are developing and validating 
a multiplex assay for simultaneous quantification of the expression of 
Pfs25, Pfs230p, and PfAP2-G. Pfs25 and Pfs230p are markers of female 
and male gametocytes, respectively, and are being quantified because 
the ratio of female to male gametocytes can have implications on 
transmission, and because together, they represent total gametocytemia. 
PfAP2-G is an important master regulator of gametocytogenesis, and 
its expression correlates strongly with gametocyte commitment in 
cultured parasites. Additionally, we are further validating the utility of the 
multiplex assay by quantifying the expression of our markers of interest 
in a large cohort of adults with asymptomatic P. falciparum infections in 
western Kenya. Multivariate analysis of this expression data could revel 
trends in gametocyte development in this population. In turn, a better 
understanding of gametocyte development and prevalence could inform 
vector control programs to focus resources on the areas with the highest 
transmission potential, and educate clinical decision making to benefit 
patients while also reducing malaria transmission.
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TURNING BACK THE CLOCK: A HISTORY OF APICOMPLEXAN 
SPECIES DIVERGENCE
Kyle Tretina, Kara Moser, Olukemi O. Ifeonu, James B. Munro, 
Joana C. Silva
University of Maryland Baltimore, Baltimore, MD, United States
An accurate timescale of the evolutionary history of apicomplexan 
parasites is critical for understanding rates of speciation, interactions 
between parasites and their hosts, the acquisition of new virulence 
traits, and the emergence of new diseases. Despite the tremendous 
public heath, socio-economic and agricultural impact of diseases caused 
by apicomplexan parasites such as Plasmodium, Cryptosporidium and 
Theileria, key phylogenetic aspects remain controversial or unknown, and 
an extensive estimate of the age of speciation of many lineages has never 
been attempted. Some studies have calibrated divergence times with 
substitution rate estimates for rRNA or organellar genes, which are not 
adequate for all levels of divergence, and may not be representative of the 
entire genome. Recently, we developed and validated a novel statistical 
approach to estimate the age of speciation events, using genome-wide 
protein sequence divergence. We used this approach to date the relative 
age of evolutionary lineages of several mammal-infecting Plasmodium 
species. Here, we re-apply this method to updated and expanded 
Plasmodium genomic data, including avian parasites, and further widen 
the taxonomic breadth of the study to include other genera, such as 
Cryptosporidium, Theileria and Eimeria. We find that protein divergence 
within genera, but not between genera, can be aptly described by a 
molecular clock model, and provide a comprehensive timeframe for the 
evolution apicomplexan parasites that yield novel insights into the co-
evolution of these species and their hosts.
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DETERMINATION OF THE PLASMODIUM VIVAX RECURRENCE 
PATTERN IN INDIVIDUALS OF THE COMMUNITIES OF 
CAHUIDE AND LUPUNA OF THE PERUVIAN AMAZON
Jhonatan J. Alarcón Baldeón1, Oscar Nolasco Cárdenas1, Paulo 
Manrique Valverde1, Gabriel Carrasco-Escobar1, Mitchel Guzmán1, 
Elmer Llanos-Cuentas2, Joseph Vinetz3, Dionicia Gamboa1
1Universidad Peruana Cayetano Heredia, Lima, Peru, 2Instituto de Medicina 
Tropical Alexander von Humbold, Lima, Peru, 3University of California San 
Diego, San Diego, CA, United States
Plasmodium vivax is a major cause of malaria in Perú, and most cases are 
concentrated in the region of Loreto. The presence of latent hypnozoites 
makes it difficult to classify recurrent P. vivax infections as relapses, 
recrudescences or re-infections. The characteristic of the different 
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recurrences has not been defined adequately in this region despite obvious 
relevance to malaria control and elimination. This study determined the 
P. vivax recurrence pattern in individuals of the communities of Cahuide 
(CAH) and Lupuna (LUP) in the region of Loreto. A total of 50 individuals 
of both communities with P. vivax recurrence that were followed up 
monthly from August 2012 to March 2014 were screened for parasitemia 
determination by qPCR 18S rRNA and subsequently all P. vivax infections 
were genotyped using 17 microsatellites. STRUCTURE analysis were 
performed and the recurrences pattern were determined. After the 
analysis only 44 individuals where evaluated for recurrence pattern, 24 
from CAH and 20 from LUP; of 24 individuals of CAH 6 individuals had 
one homologous recurrence, 15 had one heterologous recurrence, 1 had 
two homologous recurrences, 1 had two heterologous recurrences and 
1 had three heterologous recurrences. In LUP of 20 individuals 6 had one 
homologous recurrence, 13 had one heterologous recurrence and 1 had 
one homologous and one heterologous recurrence. In both communities, 
the presence of individuals with recurrent P. vivax infections were observed, 
the majority of these cases were heterologous recurrences and most of 
them were detected in the seasons of intense malaria transmission of this 
region. Finally the parasitemia in recurrences were lower than first episode 
despite the greater amount of heterologous recurrences which could 
indicate that although they can be reinfections these would generate an 
immune response that controls the parasitemia.
942
A PARASITE GENETICS APPROACH TO EVALUATE MALARIA 
TRANSMISSION DYNAMICS IN ZAMBIA
Julia C. Pringle1, Tamaki Kobayashi1, Giovanna Carpi1, Stephanie 
M. Doctor2, Jonathan Juliano2, Steven Meshnick2, Modest 
Mulenga3, Mike Chaponda3, Mbanga Muleba3, Thierry Bobanga4, 
Solange Umesumbu5, Douglas E. Norris1, William J. Moss1
1Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, 
United States, 2Gillings School of Global Public Health, University of North 
Carolina, Chapel Hill, NC, United States, 3Tropical Diseases Research 
Center, Ndola, Zambia, 4Universite Protestante au Congo, Kinshasa, 
Democratic Republic of the Congo, 5National Malaria Control Program, 
DRC, Kinshasa, Democratic Republic of the Congo
Malaria endemicity is highly heterogeneous in Zambia with Plasmodium 
falciparum prevalence by rapid diagnostic test ranging from 50% in 
Nchelenge District, located in northern Zambia, to 1% in Choma District 
in the south. Committed to malaria elimination by the year 2020, 
Zambia is faced with developing control strategies which will be effective 
in diverse epidemiological settings. Moving forward, it will be critical 
to understand the mechanisms by which transmission is sustained in 
these various settings. In particular, we are interested in evaluating the 
extent of cross-border transmission between Nchelenge District and the 
Democratic Republic of Congo (DRC). Parasite genetics offers a means 
through which we can assess this threat to local control efforts and better 
understand transmission dynamics in Zambia. We performed amplicon 
deep sequencing at the var2CSA locus of P. falciparum samples collected 
from Nchelenge District, Zambia and Haut-Katanga District, DRC, on the 
opposite side of Lake Mweru. Deep sequencing allows us to enumerate 
the haplotypes present in a given population. Subsequent comparisons 
of genetic relatedness and diversity between samples, including Principal 
Component Analysis will enable us to evaluate genetic diversity with the 
aim of determining the extent to which cross-border transmission occurs 
between Nchelenge District and the DRC.
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ORIGIN AND SPREAD OF PLASMODIUM VIVAX AND P. 
FALCIPARUM IN THE AMERICAS
Priscila T. Rodrigues1, Hugo O. Valdivia2, Thais C. Oliveira1, 
Susana Barbosa1, Ana Maria R. Duarte3, Crispim C. Junior4, Julyana 
C. Buery4, Cristiana F. Brito5, Ivo Mueller6, Ananias A. Escalante7, 
Maria A. Pacheco7, Rosely S. Malafronte1, João M. Alves1, Ingrid 
Felger8, Marcelo U. Ferreira1
1University of São Paulo, Sao Paulo, Brazil, 2Federal University of Minas 
Gerais, Minas Gerais, Brazil, 3Laboratory of Biochemistry and Molecular 
Biology, SUCEN, Sao Paulo, Brazil, 4Federal University of Espírito Santo, 
Espirito Santo, Brazil, 5Centro de Pesquisa René Rachou (CPqRR), Fundação 
Oswaldo Cruz (Fiocruz), Minas Gerais, Brazil, 6Population Health and 
Immunity Division, Walter and Eliza Hall Institute, Victoria, Australia, 
7Institute for Genomics and Evolutionary Medicine, Philadelphia, PA, 
United States, 8Swiss Tropical and Public Health Institute, Switzerland and 
University of Basel, Basel, Switzerland
Plasmodium falciparum is thought to have been introduced in the 
continent from Africa, over the past 400 years, as a result of to the 
transatlantic slave trade, although evidence to support this hypothesis 
is lacking. The date(s) and routes of spread of P. vivax to the Americas 
is unknown. Here we examine patterns of genetic divergence between 
malaria parasite populations from the Americas and other continents 
with the purpose of inferring their origins and time of divergence from 
putative founding populations. We sequenced the mitochondrial genome 
of 114 isolates of P. vivax (including 9 isolates from howler monkeys from 
southeast Brazil that have been identified as P. simium) and 223 isolates 
of P. falciparum from different continents and compared these data with 
publicly available sequence data. Most P. vivax parasites from the Americas 
clustered together, in phylogenetic analysis, with samples from Africa and 
South Asia, consistent with a recent spread of this species throughout 
these regions. However, one highly differentiated cluster (including mostly 
samples from Eastern Brazilian Amazon and Venezuela) was observed, 
which may suggest an independent introduction (but geographically 
restricted) of this parasite in the Americas. Plasmodium I samples clustered 
together, being clearly differentiated from the rest of American P. vivax 
samples. There greatest P. falciparum diversity was found in South Asia and 
Africa, while South American parasites were the least diverse. Interestingly, 
nearly all P. falciparum samples from the Americas clustered together and 
were clearly differentiated from those from other continents, consistent 
with a major population bottleneck during the (recent) introduction of this 
parasite into the Americas.
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EVOLUTION OF THE TRANSMISSION-BLOCKING VACCINE 
CANDIDATES PVS28 AND PVS25 IN PLASMODIUM VIVAX: 
GEOGRAPHIC DIFFERENTIATION AND EVIDENCE OF POSITIVE 
SELECTION
M. Andreina Pacheco1, Ricardo A. Chaurio2, Omar E. Cornejo3, 
Ester Durrego4, Craig E. Stanley1, Andreina I. Castillo5, Socrates 
Herrera6, Ananias A. Escalante1
1Temple University, Philadelphia, PA, United States, 2Instituto Venezolano 
de Investigaciones Cientificas, Caracas, Bolivarian Republic of Venezuela, 
3Washington State University, Pullman, WA, United States, 4Instituto 
Venezolano de Investigaciones Cientificas, Philadelphia, Bolivarian Republic 
of Venezuela, 5Arizona State University, Tempe, AZ, United States, 
6Caucaseco, Cali, Colombia
Transmission-blocking (TB) vaccines are considered an important tool for 
malaria control and elimination. Among all the antigens characterized 
as TB vaccines against Plasmodium vivax, the ookinete surface proteins 
Pvs28 and Pvs25 are leading candidates. These proteins likely originated 
by a gene duplication event that took place before the radiation of the 
known Plasmodium species to primates. We report an evolutionary genetic 
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analysis of a worldwide sample of pvs28 and pvs25 alleles. Our results 
show that both genes display low levels of genetic polymorphism when 
compared to the merozoite surface antigens AMA-1 and MSP-1; however, 
both ookinete antigens can be as polymorphic as other merozoite antigens 
such as MSP-8 and MSP-10. We found that parasite populations in Asia 
and the Americas are geographically differentiated with comparable levels 
of genetic diversity and specific amino acid replacements found only in the 
Americas. Furthermore, the observed variation was mainly accumulated in 
the EGF2- and EGF3-like domains for P. vivax in both proteins. This pattern 
was shared by other closely related non-human primate parasites such as 
Plasmodium cynomolgi, suggesting that it could be functionally important. 
In addition, examination with a suite of evolutionary genetic analyses 
indicated that the observed patterns are consistent with positive natural 
selection acting on pvs28 and pvs25 polymorphisms. The geographic 
pattern of genetic differentiation and the evidence for positive selection 
strongly suggest that the functional consequences of the observed 
polymorphism should be evaluated during development of TBVs that 
include Pvs25 and Pvs28.
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ASSOCIATION BETWEEN THE ALPHA THALASSEMIA TRAIT 
AND PLASMODIUM FALCIPARUM GAMETOCYTEMIA IN A 
MALARIA ENDEMIC AREA IN GHANA
Helena Lamptey1, Michael F. Ofori1, Eunice Owusu-Yeboa1, 
Kwadwo Asamoah Kusi1, Bright Adu1, Andrea T. Arku1, Michael 
Alifrangis2, Isabella Quakyi3
1Noguchi Memorial Institute for Medical Research, University of Ghana, 
Accra, Ghana, 2Center for Medical Parasitology and Immunology, 
University of Copenhagen, Copenhagen, Denmark, 3School of Public 
Health, University of Ghana, Accra, Ghana
The gametocyte stage of Plasmodium falciparum represents an 
important stage in human/vector malaria transmission and a highly 
relevant target for disrupting transmission. The alpha thalassemia trait 
has been associated with protection against severe malaria, however 
its influence of parasitemia carriage remains unclear. This study aimed 
to determine the prevalence of P. falciparum asexual stage parasitemia 
and gametocytaemia in association with alpha thalassaemia. The study 
involved three cohorts of children, non-pregnant male and female adults, 
and pregnant women from Asutsuare, a malaria endemic community in 
Ghana. The prevalence of sub-microscopic gametocytaemia was detected 
by Pfs25 real time PCR. The prevalence of α-thalassaemia was determined 
by genotyping the African α -globin deletion, α 3.7, by PCR. Children 
with wild type or heterozygous α-thalassemia were two times less likely 
to harbour parasites, compared with those having the mutant allele (OR; 
0.52; 95% CI, 0.28-0.97; P=0.037), however, this association was not 
present in adults and pregnant women. Sub-microscopic gametocytaemia 
prevalence was 39.5% in children, 29.7% in pregnant women and 8.7% 
in adults. There was no association between any α-thalassemia allele 
and gametocyte carriage in any of the cohorts. In conclusion, children 
and pregnant women had higher asymptomatic parasitemia and may 
potentially serve as reservoirs of transmission. Wild type and heterozygous 
α-thalassemia alleles were protective against asymptomatic parasitemia 
in children but not in adults and pregnant women. This study found 
no association of alpha-thalassaemia with increased risk of gametocyte 
carriage, perhaps due to the limited data on the gametocyte prevalence in 
the study community.
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PLASMODIUM VIVAX ISOPRENOIDS BIOSYNTHESIS 
PATHWAY ENZYMES AS PROBABLE DRUG TARGETS
Vishal Saxena, Shilpi Garg, Gagandeep S. Saggu, Zarna R. Pala
Department of Biological Sciences, Birla Institute of Technology & Science, 
Pilani, Jhunjhunu, Rajasthan, India
Malaria remains one of the world’s major infectious disease imposing 
significant economic burden on various developing countries. Among the 
major Plasmodium species causing human malaria, Plasmodium vivax is 
now known to cause severity similar to that caused by P. falciparum, which 
has attracted a lot of attention towards the parasite. There are reports 
on parasitic strains showing drug resistance with the current therapeutic 
regimen and vaccine trials are still underway. Thus, there is a constant 
demand for a stable and effective antimalarial. In this context, apicoplast, 
a relict plastid in the Plasmodium is looked upon as a putative drug target 
due to its prokaryotic origin. It acts as a site for four major metabolic 
pathways which includes a prokaryotic type (Non-mevalonate) Isoprenoids 
biosynthesis or MEP pathway. All four pathways are hypothesized to be 
essential for the survival of the parasite. Majority of the enzymes involved 
in all these pathways are encoded by the parasite nuclear genome and are 
targeted to the apicoplast via a bipartite leader sequence. In the present 
study we have characterized two major enzymes IspD and IspG from P. 
vivax isoprenoid biosynthesis pathway. This pathway is responsible for the 
synthesis of isoprene units and is indispensible for the erythrocytic stages 
of the parasite. We have cloned and expressed PvIspD and PvIspG proteins 
from Indian field isolates. The proteins were purified and tested for their 
biochemical activity. The purified proteins were used to raise antibodies 
which were further used to co-localize the protein in the apicoplast of the 
parasite, indicating to the transcriptional activity of these proteins in the 
parasite. In-silico studies of proteins indicate the presence of conserved 
domains across all apicomplexans and prokaryotes. We have tested 
binding of different drugs with these enzymes and hypothesize a strong 
probability of using these enzymes as targets to inhibit erythrocytic stages 
of parasite.
947
NOVEL CLUSTERING ALGORITHM IMPROVES HAPLOTYPE 
DETERMINATION FROM PACBIO TARGETED AMPLICON 
SEQUENCING DATA
Nicholas J. Hathaway1, Jaymin C. Patel2, Christian M. Parobek2, 
Jonathan J. Juliano2, Steven R. Meshnick2, Jeffrey B. Bailey3
1University of Massachusetts Medical School, Worcester, MA, United 
States, 2University of North Carolina at Chapel Hill, Chapel Hill, NC, United 
States, 3University Of Massachusetts Medical School, Worcester, MA, 
United States
Next-generation sequencing of targeted PCR amplicons provides improved 
understanding of microbial population structures such as those found in 
Plasmodium infections. While Ion Torrent and Illumina are regularly used 
for amplicon sequencing, these technologies are limited to amplicons 
less than 500 bp. Longer amplicons and read lengths can capture more 
complete haplotypes and transverse highly variable or repetitive regions. 
Technologies such as PacBio circular consensus sequencing can generate 
sequences kilobases in length, but suffer from higher error rates, which 
make analysis difficult when attempting fine resolution in determining 
haplotypes (e.g. detecting one base pair difference). Several approaches 
have been used to help correct for these errors including using Illumina 
in conjunction with PacBio to help correct the error prone long reads as 
well as several clustering and data curation methods. However, de novo 
assembly and clustering of long haplotypes remains a challenge. We 
have developed a novel clustering algorithm to mitigate the error rates 
of PacBio without the aid of Illumina. This algorithm outperforms current 
clustering methods and will be integrated into our SeekDeep software 
suite (baileylab.umassmed.edu/SeekDeep). The algorithm is based on 
rapidly creating clusters using kmer distance between sequences. Once 
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sequences have been clustered, a consensus sequence for each cluster is 
generated creating a high-fidelity haplotype. We have tested the algorithm 
on mixtures of P. falciparum lab strains from 1.6kb and 3kb fragments of 
the VAR2CSA gene and detected all known haplotypes perfectly down 
to 1% abundance. The algorithm has performed well on clinical samples 
including the 1.6kb VAR2CSA P. falciparum fragment and the protein 
sequences of P. vivax CRT and P. vivax CSP, both of which contain repetitive 
regions. Thus, our new algorithm provides researchers with the ability 
to further detail and define the diversity within microbial and parasitic 
populations.
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EVIDENCE OF SELECTION AND GENE COPY NUMBER 
VARIATIONS IN VIRULENCE FACTORS AND RESISTANCE 
GENES IN PLASMODIUM FALCIPARUM FROM LORETO - PERU
Hugo Oswaldo Valdivia1, Andres G. Lescano2, Viviana Pinedo-
Cancino3, Lastenia Ruiz4, Julian Rayner5, Oralee Branch6
1Universidade Federal de Minas Gerais, Belo Horizonte, Brazil, 
2Universidade Peruana Cayetano Heredia, Lima, Peru, 3Fundación para el 
Desarrollo Sostenible de la Amazonia Baja del Perú, Iquitos, Peru, 4Centro 
de Investigación de Recursos Naturales de la Amazonia, Universidad 
Nacional de la Amazonia Peruana, Iquitos, Peru, 5Malaria Programme, 
Wellcome Trust Sanger Institute, Hinxton, Peru, 6New York University 
Langone Medical Center, New York, NY, United States
Malaria is affects more than 300 million people causing more than 2 
million deaths per year. Of the four Plasmodium species known to infect 
humans, P. falciparum stands out as the most severe. There is increasing 
evidence that the emerge of resistance to anti-malarial drugs, migration 
and limited access to adequate health care contribute to the spread of 
malaria in endemic regions. This data underscores the need of constant 
surveillance in these settings. In this study, we analyzed the genomes of 
16 P. falciparum strains isolated from the endemic Amazonian region of 
Loreto in Peru during a high incidence period between 2004 to 2008. For 
this purpose, we conducted a genomic population analysis focused on the 
detection of SNPs, gene copy number variations and selection. Our results 
identified the presence of four subpopulations with a very recent origin 
in the region with evidence of gene flow between them and presence 
of polyclonal infections. Read depth analysis detected five clusters with 
increased gene copy numbers in chromosomes 4,5,10,11 and 12 that 
affected genes with roles in invasion and immune evasion like reticulocyte 
binding proteins, MSPs, duffy binding-like merozoite surface protein and 
others. Additionally, we found increased gene copy number in GCH1 in 
five isolates and MSP1, MSP2 and VP2 in one single isolate. The genomic 
analysis of neutrality employing TajimasD and FuFst identified two genomic 
regions under balancing selection. Genes located in these regions include 
reticulocyte binding proteins, erythrocyte membrane protein and SURFIN. 
The finding of increased copy number in genes mediating host-parasite 
interaction can result in different expression profiles potentially influencing 
parasite development and severity of certain strains. Increase in copy 
number in genes associated with resistance pose a potential threat to anti-
malarial drugs employed in this setting and underscore the need to track 
the origin of the VP2 expansion. Finally, the evidence of selection in genes 
mediating invasion point towards the effect of immune pressure in positive 
selection on diversity.
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INFLUENCE OF SEASONAL MALARIA CHEMOPREVENTION 
ON MARKERS OF T CELL EXHAUSTION AND 
IMMUNOREGULATION
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Fried2
1Malaria Research and Training Center, Bamako, Mali, 2Laboratory of 
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In addition to causing acute and sometimes fatal illnesses, Plasmodium 
falciparum infections may also compromise immune responses to some 
vaccines, and thus antimalarial treatments have been considered in 
conjunction with vaccination. Here, in the context of Seasonal Malaria 
Chemoprevention (SMC), we examined whether malaria prevention 
decreases the frequency of exhausted T cells and regulatory T cells. The 
study was conducted in two villages in the district of Ouelessebougou in 
Mali, an area of intense seasonal transmission. Children either received 
SMC (Beneko village) or not (Ferekoroba village), and were followed for 
6 months with monthly assessment of T cell markers in ex vivo assays. 
In the group that received SMC, 42% of children (21/50) remained free 
of P. falciparum (as assessed by blood smears) during the follow-up 
period compared to only 16% (8/50) in children who did not receive 
SMC. Despite the impressive effect of SMC treatment on blood stage 
parasitemia rates, there was no discernible effect on the level of exhausted 
T cells as measured by the expression of PD-1, LAG3 and CD160. The 
levels of T regulatory cells (CD4+FOXP3+ T cells) were increased in the 
non-SMC group and in a subset of the SMC group that were infected. We 
speculate that under intense malaria transmission, frequent antimalarial 
treatment (45/50 children in the group that did not receive SMC and 
28/50 in the group that received SMC) complicates the ability to observe 
the effect of SMC on the immune system. We are currently evaluating 
the effect of malaria prevention during the low transmission season when 
malaria incidence and treatment is low, and we will present these data for 
comparison.
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SEASONAL MALARIA CHEMOPREVENTION IS ASSOCIATED 
WITH A REDUCTION IN SEROPOSITIVITY TO BLOOD-STAGE 
ANTIGENS
Almahamoudou Mahamar1, Kadidia B. Cisse1, Kalifa Diarra1, 
Harouna Soumare1, Djibrilla Issiaka1, Tiangoua Traore1, Adama 
Dembele1, Moussa B. Kanoute1, Bacary S. Diarra1, Oumar Attaher1, 
Amadou Barry1, Alassane Dicko1, Patrick E. Duffy2, Michal Fried2
1Malaria Research and Training Center, Faculty of Pharmacy and Faculty 
of Medicine and Dentistry, University of Science, Techniques and 
Technologies (USTT), Bamako, Mali, 2Laboratory of Malaria Immunology 
and Vaccinology, National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, Rockville, MD, United States
Seasonal Malaria Chemoprevention (SMC) entails 3-4 therapeutic doses 
of antimalarials given to children at monthly intervals. SMC was approved 
by WHO in March 2012 for malaria control in countries with seasonal 
malaria transmission, and implementation is being scaled up in Mali. 
While SMC has substantial benefits against malaria infection and disease, 
the long-term impact on immunity to malaria is not well understood. We 
conducted cross sectional surveys at the beginning (N=579) and at the end 
(N=559) of the 2014 transmission season. Antibody levels to Plasmodium 
falciparum antigens MSP-142, AMA-1 and CSP were measured by ELISA. 
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Seropositivity was defined as OD above the mean plus three standard 
deviations of naïve donors. P. falciparum infection was diagnosed by blood 
smear. In August 2014, 53.4% of the children were infected prior to first 
SMC dose, compared to 22.2% in November one month after last dose. 
Seropositivity rates prior to and after dosing among uninfected children 
were 85.9% vs 73.6% to MSP-142, p<0.001; 42.2% vs 30.3% to AMA-
1, p=0.001; and 19.4% vs 15.2% to CSP, p=0.2. Among P. falciparum-
infected children, the rates prior to and after SMCwere 95.1% vs 91.1% 
to MSP-142, p=0.1; 54.0% vs 43.3% to AMA-1, p=0.05; and 30.4% 
vs 25.0% to CSP, p=0.3. The lower seropositivity rates at the end of the 
malaria season among children who received 3 monthly doses of SMC 
suggest that the reduced exposure to blood stage parasites is reducing 
immune recognition of blood stage antigens like AMA-1 and MSP-1. 
We are currently evaluating the effect of SMC given over 2 or 3 years on 
seroreactivity rates to blood stage and preerythrocytic malaria antigens.
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IDENTIFICATION OF IMMUNE SIGNATURES UNDERLYING 
CLINICAL IMMUNITY TO PLASMODIUM FALCIPARUM 
MALARIA
Mario Recker, John Joseph Valletta
University of Exeter, Penryn, United Kingdom
Naturally acquired immunity to malaria is a complex and poorly 
understood process, with increasing evidence pointing towards an 
orchestration of multiple immune mechanisms triggered by a highly 
diverse set of antigens. Various studies have shown how the acquisition 
of antibodies against individual or subsets of surface antigens correlate 
with increased protection against clinical malaria in an exposure and/
or age-dependent manner. Nevertheless, inconsistent and sometimes 
contradictory results raise the question if the observed correlates are 
indeed the functional components of a protective immune response or 
to what degree they proxy previous exposure and are indicative of other 
underlying immune mechanisms. Furthermore, limited efforts have so far 
been made in relating these immune correlates to a particular degree of 
individual-level protection. Here we analysed cohort-based, P. falciparum-
specific antibody profiles using a machine learning approach to identify 
immune signatures predictive of an individual’s protective status against 
clinical infection. We demonstrate that due to small effect sizes, antibody 
responses against commonly assumed immune correlates and potential 
vaccine targets are poor predictors of clinical immunity. On the other hand, 
highly predictive immune signatures can be found in data incorporating 
a much broader set of internal and surface-expressed parasite proteins. 
Models build on these signatures show a high degree of accuracy in 
predicting individual-level protection against symptomatic infections during 
the next transmission season. Our results suggest that naturally acquired 
protection is the consequence of a focused accumulation of responses to 
a variety of both conserved and polymorphic antigens but with no single 
antigen offering high-level protection on its own.
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EFFECT OF ALLELIC POLYMORPHISM ON MALARIA PARASITE 
SPECIFIC EX VIVO IFN-GAMMA (IFN-γ) RESPONSES TO 
APICAL MEMBRANE ANTIGEN 1 (AMA1) IN A MALARIA 
EXPOSED POPULATION
Omarine Nlinwe Nfor Epse Njimanted
Noguchi Memorial Institute for Medical Research, Accra, Ghana
One of the leading causes of morbidity and mortality, especially in children 
in Africa, has been malaria caused by Plasmodium falciparum species. 
However, the delivery of core malaria interventions is responsible for the 
percentage decrease in malaria death rate since the year 2000. But the 
global technical strategy and targets for malaria 2016-2030 cannot be 
attained with these interventions because, malaria has not been controlled 
by widespread deployment of existing control tools in many endemic 
areas. An effective vaccine would complement these efforts. Effective anti-
malaria vaccine will likely require vaccine constructs designed to induce 
protective CD8+ T cells against malaria liver stages. The leading malaria 
vaccine candidate antigen expressed by sporozoite, liver and blood stage 
parasites is the P. falciparum Apical Membrane Antigen-1(AMA1), but its 
allelic polymorphism is a stumbling block for vaccine development. Limited 
data exists on the effect of AMA1 polymorphisms on T cell responses. This 
study is therefore designed to investigate the effect of allelic polymorphism 
on malaria parasite specific ex vivo IFN-γ response to AMA1 in a malaria 
exposed population. Five study volunteers with the following HLA A and/
or B super types (A01, B27, B07, B58, A02, A01A03, A03, B44, and A03) 
were selected from a previous study. Bioinformatically selected MHC class 
I-specific AMA1 epitopes from 3D7 strain, were aligned with sequences 
from 7G8, FVO, tm284, FC27 and AAN35928 AMA1 strains for selection 
and synthesis of peptides with variability. A total of 133 peptides were 
selected and synthesized, for stimulation of volunteers’ peripheral blood 
mononuclear cells in IFN-γ Enzyme Linked Immunospot Assay (ELISpot). 
The Fisher’s exact test will be used to compare proportions of IFN- γ 
responders between the different allelic forms of AMA1. Pairwise post 
hoc test for differences in proportions will be performed if statistically 
significant differences are observed in proportions of positive responders 
to the various antigens.
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CONTRIBUTION OF PARASITE AND HOST DIVERSITY TO 
MALARIA TRANSMISSION IN GHANA
Aminata C. Lo, Linda E. Amoah, Kwadwo E. Mensah, Ben Gyan
Noguchi Memorial institute for Medical Research, Accra, Ghana
The transmission of malaria parasites depends on the presence of the 
sexual stages (gametocytes) of Plasmodium falciparum in the blood. 
The probability of establishing an infection in the mosquito depends on 
several factors including the densities of male and female gametocytes 
as well as their sex ratio. This then makes it interesting to determine how 
gametocytes are rendered infectious as well as understand the dynamics of 
the development of transmission blocking antibodies which are developed 
against these gametocytes and also better understand how these work 
together to cause malaria trasnmission. We intend to i)- compare the 
prevalence of gametocytes and transmission blocking antibodies against 
Pfs48/45 and Pfs230 and ii)- determine the diversity of factors such as 
cytokines which also influence malaria transmission in two areas with 
different malaria transmission intensities. Blood samples were collected 
from P. falciparum infected and uninfected patients living in two different 
malaria transmission intensity. Total IgG (and subclasses IgG1 and IgG3), 
IgM, IgE levels were determined by ELISA. The levels of cytokines in the 
plasma (TNF, INF-γ and IL-10) were estimated by Multiplex. Gametocyte 
prevalence was measured by microscopy and qRT-PCR. Highly variable 
seroprevalence of antibody responses against sexual stage parasite 
antigens was found. A marked prevalence and significantly higher level 
of antibodies was found in volunteers from the high malaria transmission 
intensity. However the cytokines profiling is negatively correlated to 
antibody level. But these results are preliminary we expect to have more 
before the meeting and better interpreted.
954
PURIFICATION OF PLASMODIUM SPOROZOITES ENHANCES 
PARASITE-SPECIFIC CD8+ T CELL RESPONSES
Zachary P. Billman, Annette M. Seilie, Sean C. Murphy
University of Washington, Seattle, WA, United States
Malaria infection caused by Plasmodium parasites continues to cause 
enormous morbidity and mortality in endemic populations, and 
there is no licensed vaccine capable of inducing sterile protection. 
Hyperimmunization with attenuated whole sporozoites can induce sterily 
protective immune responses targeting pre-erythrocytic antigens. Most 
animal models of hyperimmunization rely on sporozoites dissected from 
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mosquito salivary glands and injected without further purification. In 
BALB/c mice, repeated small doses of P. yoelii sporozoites progressively 
expand the population of sporozoite-specific CD8+ T cells. In this study, 
large secondary doses of unpurified sporozoites unexpectedly led to 
contraction of sporozoite-specific CD8+ T cell responses in sporozoite-
primed mice. While sporozoite-primed CD8+ T cells can alternatively be 
expanded by secondary exposure to Listeria monocytogenes expressing 
recombinant Plasmodium antigens, such expansion was potently inhibited 
by co-injection of large doses of unpurified sporozoites and by uninfected 
salivary glands alone. Purification of sporozoites away from mosquito 
salivary gland debris by density gradient centrifugation eliminated salivary 
gland-associated inhibition. Thus, the inhibitory effect appears to be 
due to exposure to uninfected mosquito salivary glands rather than 
sporozoites. To further assess the effect of salivary gland exposure on later 
sporozoite vaccinations, mice were immunized with uninfected salivary 
glands from a single mosquito. Compared to naïve mice, salivary gland 
pre-sensitization reduced subsequent liver burdens by 71%. These data 
show that component(s) in mosquito salivary glands reduce liver infection, 
thereby limiting antigen dose and contributing to lower magnitude T cell 
responses. These findings suggest that sporozoite immunogenicity studies 
be performed using purified sporozoites whenever feasible.
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T-CELL DYNAMICS REVEAL A POTENTIAL ROLE FOR CD8+ 
T-CELLS DURING BLOOD-STAGE PLASMODIUM CYNOMOLGI 
INFECTION OF RHESUS MACAQUES
Chet Joyner1, Cristiana F. Brito2, Yan Tang1, Swetha Garimalla3, 
Chris C. Ibegbu1, Monica Cabrera-Mora1, the MaHPIC 
Consortium, Tracey J. Lamb4, Mary R. Galinski5
1Malaria Host–Pathogen Interaction Center, Emory Vaccine Center, Yerkes 
National Primate Research Center, Emory University, Atlanta, GA, United 
States, 2Research Center Rene Rachou, Oswaldo Cruz Foundation, Belo 
Horizonte, MG, Brazil, 3School of Biology, Georgia Institute of Technology, 
Atlanta, GA, United States, 4Division of Infectious Diseases, Department 
of Pediatrics, Emory University School of Medicine and Emory Children’s 
Centre, Atlanta, GA, United States, 5Division of Infectious Diseases, 
Department of Medicine, Emory University, Atlanta, GA, United States
T-cells play a critical role in malaria immunology. They are important for 
the development of protective immunity against the parasite but can 
cause immunopathology when over-exuberant or dysregulated. The 
roles of CD4+ T-cells are well-appreciated in these processes, but the role 
of CD8+ T-cells during blood-stage malaria has received less attention. 
Most studies to-date have focused on studying T-cell responses against 
Plasmodium falciparum or mouse models of malaria. Contrastingly, 
T-cell responses during P. vivax infection are less understood, in part due 
to the lack of appropriate and tractable animal models for this malaria 
parasite. In this study, the P. cynomolgi –rhesus macaque model of P. vivax 
infection was used to monitor the T-cell dynamics during primary and 
relapse blood-stage infections. Immunophenotyping of T-cells during acute 
infection revealed a decrease in the total number of T-cells compared to 
pre-infection values as expected based on previous experiments. Although 
both CD4+ and CD8+ T-cell numbers decreased at this point, the CD8+ 
compartment was the most affected. Interestingly, the loss of CD8+ 
T-cells in the periphery appeared to correlate with clinical presentation. 
In agreement with the flow cytometry data, whole-blood transcriptomic 
analysis also indicated that the peripheral T-cell compartment, in particular 
CD8+ T-cells, was altered during acute infection. These results corroborate 
previous findings showing decrease in CD8+ T-cell subsets in P. vivax-
infected patients. Interestingly, the transcription of IL-15 and Granzyme 
B was decreased in peripheral cells but this did not correlate with protein 
levels that were increased in the plasma. Collectively, these data suggest 
that activated Granzyme B-secreting CD8+T cells, although reduced in 
number in the circulation, may be homing to other organs and releasing 
inflammatory mediators during the infection. Overall, these data indicate 
that CD8+ T-cells are involved in blood-stage P. cynomolgi infection and 
may be related to disease severity.
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DECREASED MALARIA TRANSMISSION IN KENYA LED TO 
DELAYED ACQUISITION OF ANTI-MALARIAL ANTIBODIES IN 
CHILDREN AND ADULTS
Grace E. Weber1, Peter Odada Sumba2, John Vulule2, Elisabeth 
Baum3, Huw Davies3, Joseph Smith4, James W. Kazura1, Arlene E. 
Dent1
1Case Western Reserve University, Cleveland, OH, United States, 2Kenya 
Medical Research Institute, Kisumu, Kenya, 3University of California Irvine, 
Irvine, CA, United States, 4University of Washington Seattle Biomedical 
Research Institute, Seattle, WA, United States
Malaria transmission is declining worldwide due to interventions such 
as insecticidal treated bed nets and indoor residual spraying. In our 
study population in western Kenya, we have observed a decline in the 
prevalence of asymptomatic Plasmodium falciparum (Pf) infection in 
children from 81% in 2003 to 14% in 2013. It has long been known 
that antibodies play an important role in the development of immunity 
to malaria. We sought to analyze changes in acquisition of anti-malarial 
antibodies over a 10-year period of declining transmission. Bioplex was 
used to measure immunoglobulin (Ig) G antibodies specific for 34 malarial 
proteins in healthy Kenyan children and adults from two cross-sectional 
cohorts (n=82 children, n=95 adults in 2003, and n=97 children, n=50 
adults in 2013). The antibody magnitudes, prevalence, and seroconversion 
rates were directly compared between the two cohorts (2003 and 2013). 
Compared to the 2013 cohort, children and adults in 2003 had higher 
antibody magnitudes and prevalence, and faster seroconversion rates for 
the majority of the antibodies measured. For example, in 2003 the age 
groups 1-3, 4-6, 7-10, and 18+ years had prevalence values for merozoite 
surface protein (MSP) 6 of 50.0%, 58.3%, 83.3%, and 88.4%; in 2013 
prevalence values for the same age groups were 17.2%, 27.0%, 32.3%, 
and 68.0%, respectively. Antibody magnitudes and prevalence in both 
cohorts tended to increase with age, as expected. An exception to this 
pattern was seen in antibodies to 4 out of 5 domains of Pf Erythrocyte 
Membrane Protein 1 (PfEMP1), in which children in 2003 and had 
higher antibody magnitudes than adults in 2003, while in 2013 antibody 
magnitudes increased with age. In summary, decreasing Pf transmission 
is associated with a decline in several anti-Pf antibodies across age 
groups. Lower transmission rates may lead to a slower acquisition of anti-
malarial immunity and longer duration of susceptibility to symptomatic Pf 
infections.
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ANTIBODY RESPONSES IN MALARIA-NAÏVE ADULTS AFTER 
IMMUNIZATION VIA MOSQUITO BITE WITH RADIATION-
ATTENUATED PLASMODIUM FALCIPARUM SPOROZOITES 
(IMRAS)
Joanne Lumsden1, Nimfa Teneza-Mora2, Bradley Hickey2, Selma 
Akan3, Danielle Jateng3, Sharina Reyes1, Jo Glenna Banania1, 
Charlotte Fedders1, Ivelese Padilla1, Alicia Simmons1, Harini 
Ganeshan1, Megan Dowler3, Lindsey Garver3, Silas Davidson3, 
Martha Sedegah2, James Moon3, Eileen Villasante2, Judith Epstein2
1Henry M. Jackson Foundation, Rockville, MD, United States, 2Naval 
Medical Research Center, Silver Spring, MD, United States, 3Walter Reed 
Army Institute of Research, Silver Spring, MD, United States
Immunization with radiation-attenuated Plasmodium falciparum 
sporozoites (PfRAS) via mosquito bite serves as the gold standard for 
protective immunity against malaria and provides a relevant model 
for studying protective immune effector mechanisms. We recently 
completed a phase 1 clinical trial (Immunization via Mosquito bite with 
Radiation-Attenuated Sporozoites, or IMRAS), a comprehensive systems 
biology-based effort to identify biomarkers of protection, including host 
response and antigenic targets, by comparing protected, non-protected, 
and mock-immunized subjects. There is evidence that humoral immunity 
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contributes to RAS-induced protection in that immune serum from 
RAS-immunized humans can block the invasion of Pf sporozoites into 
hepatocytes. In addition, high titers of CSP-specific antibodies in humans 
correlate with protection against infectious challenge. In the present study, 
we investigated the generation of malaria-specific antibody responses in 
PfRAS-immunized subjects, and assessed their associations with sterile 
protection from controlled human malaria infection (CHMI). Serum IgG 
antibodies specific for pre-erythrocytic antigens (CSP, AMA-1, and CelTOS) 
were quantified by the International Reference Center for Malaria Serology 
Laboratory (WRAIR) using validated ELISA assays at the following time 
points: pre-immunization, day 14 post 3rd immunization, day of CHMI 
and day 28 post CHMI. In addition, sporozoite-specific antibodies were 
measured by an immunofluorescence antibody (IFA) assay using imaging 
analysis software at the pre-immunization and day of CHMI time points. 
Results from this study will be integrated with those from current and 
future studies with IMRAS samples using advanced immunobiology 
systems analysis to identify immune signatures of protection elicited by 
whole sporozoite vaccination.
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IDENTIFICATION OF PFEMP1 EPITOPES USING A DIVERSITY-
COVERING ULTRADENSE PEPTIDE MICROARRAY
Mark A. Travassos1, Andrea A. Berry1, Andrew Pike1, Jason A. 
Bailey1, Emily M. Stucke1, Antoine Dara1, Sonia Agrawal1, Amed 
Ouattara1, Drissa Coulibaly2, Kirsten E. Lyke1, Matthew B. Laurens1, 
Matthew Adams1, Shannon Takala-Harrison1, Amadou Niangaly2, 
Bourema Kouriba2, Abdoulaye K. Kone2, J. Alexandra Rowe3, 
Ogobara K. Doumbo2, Mahamadou A. Thera2, Myaing M. Nyunt1, 
Philip L. Felgner4, Jigar J. Patel5, John C. Tan5, Christopher V. 
Plowe1
1University of Maryland School of Medicine, Baltimore, MD, United States, 
2University Science, Techniques and Technologies of Bamako, Bamako, 
Mali, 3University of Edinburgh, Edinburgh, United Kingdom, 4University 
of California Irvine, Irvine, CA, United States, 5Roche NimbleGen Inc., 
Madison, WI, United States
Plasmodium falciparum erythrocyte membrane protein-1 (PfEMP1) 
antigens play an important role in parasite sequestration and host immune 
system evasion. PfEMP1s are encoded by the extraordinarily diverse var 
gene family, present in 40 to 60 copies per genome. Acquired antimalarial 
immunity is at least partially due to antibodies directed against highly 
variable antigens like PfEMP1 that are present on the red blood cell 
surface. While we have previously identified PfEMP1 fragments whose 
seroreactivity is associated with increased malaria exposure and thus 
potential immunity, the critical PfEMP1 epitopes that drive such immune-
mediated protection have not yet been identified. A peptide microarray is 
a tool that, with carefully chosen serum samples, allows for recognition of 
peptides that may harbor epitopes critical for natural protection against 
malaria. We designed a pilot PfEMP1 peptide array to identify such 
PfEMP1 epitopes. Eighty-three thousand 16-amino acid (aa) peptides 
were spotted onto an array, spanning the complete var repertoires of 
the reference genome 3D7, the Indochina strain DD2, and an Indian 
isolate, RAJ116, with 12-aa overlap. This included a total of 151 PfEMP1s, 
providing coverage of both extracellular and intracellular PfEMP1s and all 
previously described PfEMP1 domain cassettes. We probed this array with 
sera from children aged 1-6 years old and adults from rural Mali. Among 
extracellular and intracellular PfEMP1 fragments recognized more intensely 
by adults than children, potentially representing an effective immune 
response, we identified key peptides associated with this seroreactivity. 
We also identify such peptides in domain cassettes associated with severe 
malaria. We anticipate that this approach will allow targeted identification 
of specific regions in PfEMP1 constitutive domains that harbor epitopes 
critical to natural immunity. We present plans for future work with this 
powerful new tool.
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AN ULTRA-DENSE PEPTIDE ARRAY FOR IDENTIFYING 
HUMAN ANTIBODY BINDING SITES ON MALARIA PARASITE 
ANTIGENS
Andrea A. Berry1, Andrew Pike1, Jason A. Bailey1, Mark A. 
Travassos1, Amed Ouattara1, Sonia Agrawal1, Antoine Dara1, 
Lauren M. Cohee1, Drissa Coulibaly2, Kirsten E. Lyke1, Matthew B. 
Laurens1, Matthew Adams1, Shannon Takala-Harrison1, Amadou 
Niangaly2, Issa Diarra2, Modibo Daou2, Bourema Kouriba2, 
Abdoulaye K. Kone2, Ogobara K. Doumbo2, Mahamadou 
A. Thera2, Tracking Resistance to Artemisinin Collaboration, 
Myaing M. Nyunt1, Philip L. Felgner3, Jigar J. Patel4, John C. Tan4, 
Christopher V. Plowe1
1Institute for Global Health, Division of Malaria Research, University of 
Maryland School of Medicine, Baltimore, MD, United States, 2Malaria 
Research and Training Center, University of Sciences, Techniques and 
Technologies, Bamako, Mali, 3University of California, Irvine, Irvine, CA, 
United States, 4Roche NimbleGen Inc., Madison, WI, United States
A high-throughput means of identifying epitopes involved in antibody 
recognition of malaria antigens would heighten our understanding of 
natural immunity to malaria. Previous epitope mapping approaches do not 
enable simultaneous study of multiple antigens or antigenic variants. We 
designed an ultra-dense peptide array containing multiple P. falciparum 
antigens and field sample-derived diverse variants. Arrays were fabricated 
in situ using light-directed maskless array synthesis. We included vaccine 
candidate antigens, gametocyte antigens, variant surface antigens, and 
mosquito salivary antigens to inform vaccine design, development of 
serosurveillance assays, transmission capacity, naturally acquired immunity, 
and species-specific vector exposure. 172,396 peptides representing 209 
antigens were included. Sequences were derived from Sanger and genome 
sequencing of samples from Mali, including those from a phase II pediatric 
vaccine study, and Southeast Asian samples from an artemisinin resistance 
study. PfEMP1s (n=151) were included as 16-amino acid (aa) peptides 
overlapping by 12-aa (16/12 overlap). Other antigens were included in 
triplicate with 16/12 overlap; a subset was additionally included with 
16/15 overlap. The most diverse antigen, AMA1, had 331 variants (14,153 
non-redundant peptides). PfEMP1s represented the greatest proportion 
of the array with 83,760 peptides. Reactivity of sera extracted from dried 
blood spots (DBS) on Whatman® 903 cards and from whole blood was 
highly correlated, albeit with some loss of dynamic range for DBS samples, 
thus justifying future field sample collection without a cold chain. Sera 
collected from Mali and Southeast Asia recognized previously described 
and novel epitopes in pre-erythrocytic and blood stage antigens including 
CSP, AMA1, and variant surface antigens. We identify antigens and 
peptides underlying the higher reactivity of adult sera as compared with 
pediatric sera. With this approach, an ultra-dense peptide array illuminates 
acquisition of natural immunity to malaria and can provide insights 
applicable to vaccine design and serosurveillance.
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THE TRANSCRIPTION FACTOR T-BET COMPROMISES 
HUMORAL IMMUNITY TO BLOOD-STAGE MALARIA BY 
INHIBITING THE EFFICIENT DEVELOPMENT OF GERMINAL 
CENTRE RESPONSES
Diana S. Hansen, Ann Ly, Lisa J. Ioannidis, Axel Kallies
The Walter and Eliza Hall Instiute of Medical Research, Parkville, Australia
Naturally acquired immunity to malaria develops only after many years 
of repeated exposure to Plasmodium parasites. Despite the key role 
that antibodies play in protection against malaria, the cellular processes 
underlying the slow acquisition of immunity are unclear. Children in high 
transmission settings that experience frequent malaria clinical episodes 
are characterized by a delayed development of parasite-specific memory 
B cells, suggesting that the inflammatory factors contributing to disease 
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hinder these responses. We have recently addressed this hypothesis 
using a pre-clinical model of severe malaria and found that the same 
inflammatory pathways mediating disease syndromes impair T follicular 
helper cell differentiation and the development of germinal centre (GC) 
responses required for antibody-mediated control of parasitemia. To 
further define the impact of inflammation in the induction of protective 
immunity, the development of GC responses to P. berghei ANKA was 
examined in mice deficient in the pro-inflammatory transcription factor 
T-bet. Genetic deletion of T-bet significantly improved T follicular helper 
cell differentiation rates, which translated in enhanced GC and parasite-
specific antibody responses to infection. Infection of T-betfl/flCD23Cre 
mice, with specific deletion of T-bet in their B cell compartment revealed 
that antibody production and isotype-switching was also regulated by 
B-cell-intrinsic expression of T-bet. Moreover, the induction of GC B cells 
and total plasma cell responses to infection were significantly improved 
in the absence of T-bet expression specifically in B cells. Thus these data 
suggest that inflammatory pathways elicited in response to clinical malaria 
negatively impact the development of long-term humoral immunity not 
only by inhibiting T cell help for antibody formation but also by directly 
modulating B cell responses to infection.
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REDUCED PLASMODIUM BURDEN IN HUMANS ASSOCIATES 
WITH CD38+ CD4+ T CELLS DISPLAYING CYTOLYTIC 
POTENTIAL
Julie G. Burel1, Simon H. Apte1, Penny L. Groves1, Kere Klein1, 
James S. McCarthy1, Denise Doolan2
1QIMR Berghofer Medical Research Institute, Brisbane, Australia, 2James 
Cook University, Cairns, Australia
Malaria is associated with complex multi-factorial immune responses, 
and the exact molecular mechanisms required to control parasite burden 
remain largely unknown. The recent discipline of systems immunology 
integrates immunology with molecular and computational sciences to 
enable comprehensive and quantitative evaluation of human immune 
responses at a level of detail previously restricted to murine models. We 
are applying systems immunology approaches to characterize the host 
response to the Plasmodium spp parasite in humans. Using a unique 
resource of samples from a controlled human malaria infection study, 
we identified a novel population of CD4+ T cells whose frequency in 
peripheral blood was inversely correlated with parasite burden following 
P. falciparum infection. These CD4+ T cells expressed the multifunctional 
ectoenzyme CD38 and had unique features distinguishing them from 
other CD4+ T cells. Specifically, their phenotype was associated with 
proliferation, activation and cytotoxic potential as well as significantly 
impaired production of IFN-γ and other cytokines and reduced basal levels 
of activated STAT1. A CD38+ CD4+ T cell population with similar features 
was identified in healthy uninfected individuals, at lower frequency. This is 
the first report of a population of CD4+ T cells with a cytotoxic phenotype 
and markedly impaired IFN-γ capacity. The expansion of this population 
following parasite infection and their ubiquitous presence in humans 
suggests that they may have a broad role in host-pathogen defense.
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HOST IMMUNITY TO MALARIA INFECTION, ANAEMIA AND 
SOCIO-ECONOMIC IMPACT AMONG CHILDREN LESS THAN 
10 YEARS IN NORTHERN CAMEROON
Nobelle I. Sakwe
University of Yaounde I, Yaounde, Cameroon
Malaria and anaemia are key public-health challenges in Cameroon. 
However, little has been reported on the interaction between these 
interconnected health determinants. The present study was designed 
to investigate the relationship between malaria occurrence, immunity, 
anaemia and socio-economic impact among under - ten children living in 
an area of intense seasonal malaria transmission in Northern Cameroon. 
A Cross- sectional survey was conducted in November 2013, in Pitoa 
and Mayo-Oulo Health Districts, Northern Cameroon. Total, 368 children 
aged 6months - 10 years were recruited. Finger-prick blood samples 
collected were used for haematocrit; immunoglobulin gamma level 
determination using ELISA; malaria parasite prevalence, specie and density 
by microscopy; Plasmodium DNA extraction from filter paper for PCR. A 
structured questionnaire was used to assess Socio-economic status.Data 
analysis was by SPSS 20.Overall prevalence of malaria and anaemia were 
32.9% and 20.6% respectively. Globally, 46.4% of the children (95% 
CI: 41.1 - 51.8) were low anti-malarial Total IgG producers, 36.2% (95% 
CI: 31.2 - 41.5) low IgG1 producers and 19.8% (95% CI: 15.7- 24.3) 
were low IgG3 producers. There was no statistically significant (p>0.05) 
association between immunity and malaria status for all the categories of 
IgG. The Socio-economic status of the population was poor. Malaria was 
not the cause of anaemia in the children. Therefore, other factors may 
have accounted for anaemia. Since no effect of malaria and immunity 
was observed in the low production of IgGs, the IgG levels observed could 
not be an indicator of any protection against malaria but may be due to 
humoral response to malaria infection.Malaria programmes should rapidly 
scale up on improving the health and immunity status of the anaemic in 
poor communities.Future studies should focus on finding out the causes of 
anaemia in malaria - infected children.
963
PROFILES OF PFEMP1-SPECIFIC IGG ANTIBODIES FROM BIRTH 
TO 12 MONTHS OF AGE IN BENINESE INFANTS
Azizath Moussiliou1, Gilles Cottrell1, Louise Turner2, Thomas 
Lavstsen2, Nadine Fievet1, Achille Massougbodji3, Thor Theander2, 
Philippe Deloron1, Nicaise Ndam4
1Institut de Recherche pour le Developpement (IRD), Paris, France, 2Centre 
for Medical Parasitology, University of Copenhagen, Copenhagen, 
Denmark, 3Centre for Medical Parasitology, University of Copenhagen, 
Paris, Benin, 4Institut de Recherche pour le Developpement (IRD), Accra, 
Ghana
The cytoadherence properties of Plasmodium falciparum infected 
erythrocytes (IE) represent a major contributor to the pathogenesis of 
malaria through interactions with various endothelial cell surface receptors. 
These interactions are mediated by members of the highly variable P. 
falciparum erythrocyte membrane protein 1 (PfEMP1) expressed on the IE 
surface. One particular component of PfEMP1 proteins, the cysteine-rich 
interdomain region (CIDR), is known to play a very important role in the 
adhesive interactions between IE and endothelial receptors, making this 
region a potential vaccine target of interest. Here, we investigated the 
dynamics of maternally-transferred IgG antibodies targeting the CIDR of 
a panel of different PfEMP1 proteins, as well as infants’ own acquisition 
of antibodies with the same specificities during the first year of life. We 
used plasma samples collected longitudinally from the offspring of a 
cohort of pregnant women who had themselves been followed closely 
through pregnancy. We show that the levels of all anti-CIDR antibodies 
quantified declined to the point of disappearing over the 6 first months 
of life. Antibodies with specificity for the CIDR predicted to adhere to 
selected receptors (CD36, EPCR) or for the CIDR associated with the 
unknown phenomen were subsequently acquired by infants between 
7-12 months of age, their levels being a function of P. falciparum history 
during infancy. Infected infants developed stronger antibody responses 
to the CIDR associated with either EPCR binding or unknown compared 
to uninfected infants. The transcriptional profile of var genes showed no 
obvious difference between parasites infecting the children before and 
after 6 months except for some genes of group B var.
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PLASMODIUM FALCIPARUM EPIDEMIOLOGY IS GOVERNED 
BY MULTI-SCALE IMMUNE SELECTION AND A DIVERSITY-
TRANSMISSION FEEDBACK
Thomas Holding, Mario Recker
University of Exeter, Falmouth, United Kingdom
The human malaria parasite Plasmodium falciparum displays an extensive 
degree of antigenic diversity that facilitates long periods of infections 
and high re-infection rates. Of particular interest are the variant surface 
antigens (VSA) encoded by several multi-gene families, including the var 
genes whose protein products PfEMP1 are implied in malaria infection 
pathology and immune evasion. Within-host clonal antigenic variation 
of PfEMP1 limits host exposure to the parasite’s antigen repertoire by the 
predominant and cyclic expression of single variants during infection. At 
the population level, high levels of antigenic diversity between parasites 
result in hosts acquiring protection against severe and symptomatic 
infections in a piecemeal process over years of repeated exposure. As 
antigenic diversity is predominantly generated through recombination it is 
expected to respond dynamically to changes in transmission and immune 
selection. On the other hand, population-level prevalence and incidence 
can be seen as a direct consequence of antigenic diversity, thus forming 
a non-linear feedback between transmission intensity and diversity. To 
explore this feedback and its consequences on malaria epidemiology 
in more detail we developed an individual-based, multi-scale modelling 
framework in which antigen diversity emerges as a dynamic property 
from the underlying transmission dynamics. New antigenic variants are 
generated through recombination and mutation during infection and the 
mosquito-stage and are subjected to within and between-host selection 
pressures. Our results show that immune selection severely limits the level 
of antigenic diversity that can be stably maintained at any given time 
and that the transmission-diversity feedback can significantly affect how 
population-level prevalence responds to changes in disease transmission 
due to natural fluctuation or intervention measures, which has important 
implications for our understanding of malaria epidemiology and disease 
control efforts.
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A PROSPECTIVE STUDY OF B CELL DYNAMICS IN PATIENTS 
WITH MALARIA USING MASS CYTOMETRY
Caroline Rönnberg1, Caroline Rönnberg2, Victor Yman3, Klara 
Sonden3, Adnane Achour3, Adnane Achour4, Adnane Achour5, 
Lakshmikanth Tadepally4, Jaromir Mikes4, Yang Chen4, Kristina 
Persson6, Petter Brodin3, Petter Brodin4, Petter Brodin7, Anna 
Färnert3, Anna Färnert5
1Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, 
Solna, Stockholm, Sweden, 2Department of Clinical Microbiology, 
Karolinska University Hospital, Huddinge, Stockholm, Sweden, 3Unit of 
Infectious Diseases, Department of Medicine Solna, Karolinska Institutet, 
Stockholm, Sweden, 4Science for Life Laboratory, Department of Medicine 
Solna, Karolinska Institutet, Stockholm, Sweden, 5Department of Infectious 
Diseases, Karolinska University Hospital, Stockholm, Sweden, 6Laboratory 
Medicine, Clinical Chemistry, Skåne University Hospital, Lund, Sweden, 
7Department of Pediatrics, Karolinska University Hospital, Stockholm, 
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Clinical immunity to malaria is largely mediated by humoral immune 
responses. Protective immunity, however, appears to require repeated 
exposure and wane in the absence of continuous infection. It has been 
proposed that malaria impairs the function of B cells and contributes to 
the slow development and incomplete immunity observed in malaria. The 
mechanisms behind this are as of yet unclear. In the current study we have 
investigated the dynamics of B cell phenotypes at six time points over the 
course of one year, in patients treated for Plasmodium falciparum malaria 
at the Karolinska University Hospital in Stockholm. Study participants were 
stratified according to previous malaria exposure in order to compare 
immune responses of malaria-naïve individuals (n=3), with individuals from 
malaria-endemic areas (n=3). We present an extensive mass cytometry 
(CyTOF™) characterisation of B cell phenotypes. Our results demonstrate 
the existence of specific B cell subpopulations that arise at different time 
points and differently in individuals with previous malaria exposure.
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LONGITUDINAL ASSESSMENT OF PFSPZ-SPECIFIC T CELL 
RESPONSES IN MALARIA-NAÏVE ADULTS VACCINATED WITH 
PFSPZ VACCINE
Andrew S. Ishizuka1, Kirsten E. Lyke2, Sumana Chakravarty3, 
Andrea A. Berry2, Adam DeZure1, Eric R. James3, Thomas L. Richie3, 
Adam J. Ruben3, Tao Li3, B Kim Lee Sim3, Julie E. Ledgerwood1, 
Stephen L. Hoffman3, Robert A. Seder1
1National Institutes of Health, Bethesda, MD, United States, 2Institute for 
Global Health, University of Maryland School of Medicine, Baltimore, MD, 
United States, 3Sanaria Inc., Rockville, MD, United States
An attenuated Plasmodium falciparum (Pf) sporozoite vaccine (PfSPZ 
Vaccine) is being evaluated in humans for efficacy. Here we present T cell 
responses after vaccination with 9.0x10^5 PfSPZ administered 3 times 
at 8 week intervals to malaria-naïve adults. The phenotype and effector 
functions of Pf-specific memory CD4, CD8, and γδ T cells were assessed 
by 14-16-color flow cytometry throughout the course of vaccination. 
Pf-specificity was determined by incubating PBMCs with aseptic PfSPZ or 
the vaccine diluent (HSA). PfSPZ Vaccine induced high magnitude multi-
functional IFNγ, IL-2, and/or TNFα cytokine-producing memory CD4 T cell 
responses. Surprisingly, these responses peaked at 1.5% (mean) after the 
1st immunization, and declined to 0.57% and 0.51% after the 2nd and 
3rd immunizations, respectively. PfSPZ-specific cytokine-producing memory 
CD8 T cell responses also peaked after the 1st immunization (0.39% 
mean) and declined to pre-vaccine levels after the 3rd immunization. 
The activation markers HLA-DR and CD38 on T cells were used to 
provide a sensitive measure of T cell activation in vivo. The frequency of 
HLA-DR+CD38+ memory CD4 T cells peaked two weeks after the 1st 
immunization, but returned to baseline (pre-vaccine) levels two weeks 
after the 2nd and 3rd immunizations. Last, the Vδ2+ sub-family of γδ 
T cells expanded 2.8-fold above pre-vaccine levels, and this increase 
persisted after all immunizations. γδ T cells showed a very high level of 
HLA-DR+CD38+ co-expression, peaking at a mean of 34% two weeks 
after the 2nd immunization, and declining after the 3rd immunization. 
In conclusion, PfSPZ Vaccine induced high frequency Pf-specific CD8, 
CD4, and γδ T cells after the first vaccination with 9.0x10^5 PfSPZ. The 
magnitude of Pf-specific CD8 and CD4 T cells was dramatically reduced 
after the 2nd and 3rd immunizations, suggesting that PfSPZ Vaccine 
induced rapid anti-PfSPZ immunity that limited subsequent boosting with 
PfSPZ Vaccine at the dose and interval tested here. Based on these data, 
it may be possible to achieve equivalent protective efficacy with fewer 
immunizations.
967
ASSESSING THE IMPACT OF NON-ADHERENCE TO 
ANTIMALARIALS USING WITHIN-HOST MODELING OF 
FALCIPARUM MALARIA
Joseph D. Challenger, Lucy C. Okell, Azra C. Ghani
Imperial College London, London, United Kingdom
Artemisinin combination therapy regimens typically contain 3 or 6 doses 
spread over 3 days. This ensures that the blood concentration of the 
drugs remains high enough for a sustained period of time, reducing the 
probability that parasites survive and recrudesce. Taking the correct doses 
of antimalarials at the right time will maximise their clinical impact. The 
efficacy of ACTs is usually compared in clinical trials where there is a high 
level of patient adherence to the drug regimen, but adherence can be 
much lower in routine health care settings, and is likely to vary according 
to the complexity and length of the regimen, as well as side effects of the 
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drugs amongst other factors. Much information on patient adherence has 
been collected, but it is difficult to assess the clinical impact of incomplete 
adherence in research settings. In this work, we have developed a 
stochastic within-host model of asexual parasitaemia in individuals with 
no previous exposure to malaria, which we calibrated against data from 
malariatherapy patients. Combining this model with a pharmacokinetic-
pharmacodynamic (PKPD) framework enables us to estimate potential 
levels of treatment failure following poor adherence to malaria treatment. 
We include variability between individuals both in terms of parasite 
dynamics and pharmacokinetics. We simulate treatment with artemether-
lumefantrine (AL) and estimate the probability of treatment failure 
after taking different numbers of doses, or taking the doses at the wrong 
time, using values based on adherence studies. Our modeling structure 
also allows other drug combinations to be scrutinized in this way.
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FORECASTING MALARIA ADMISSIONS AT A RURAL DISTRICT 
HOSPITAL IN WESTERN KENYA USING REMOTE SENSING 
DATA
Maquins O. Sewe1, Yesim Tozan2, Joacim Rocklöv3, Clas Ahlm4
1Kenya Medical Research Institute/Center for Disease Control, Kisumu, 
Kenya, 2College of Global Public Health, New York University, New York, 
NY, United States, 3Department of Public Health and Clinical Medicine, 
Epidemiology and Global Health, Umeå University, Umeå, Sweden, 
4Department of Clinical Microbiology, Infectious Diseases, Umeå University, 
Umeå, Sweden
In sub-Saharan Africa, malaria kills a child every two minutes. In response 
to still high incidence of malaria, WHO developed the new global technical 
strategy for malaria 2016-2030. One of the three pillars of this strategy is 
to use surveillance as a key intervention in malaria control and elimination. 
Malaria surveillance data provides opportunity to develop a malaria 
early warning system and tracking of progress towards elimination. 
Therefore, in this study we use malaria admission data of children under 
five years of age at Siaya district hospital in Western Kenya to develop 
models to forecast malaria admissions incorporating remotely sensed 
environmental data. Three models were developed assessing forecast 
accuracy at 1-month, 2-month and 3-month lead times. We used 
monthly totals of malaria admissions and precipitation. For Normalized 
Difference Vegetation Index and Land Surface Temperature we computed 
monthly means. The data covered the period from 2002 to 2013. Malaria 
admissions were modelled using a general additive model with a smooth 
function of time to capture trend; a cyclic cubic spline of month to capture 
seasonality; and splines of the environmental variables for each lead time. 
To adjust for residual autocorrelation, we incorporated autoregressive 
term of order 1 as random effect in the models. Malaria admissions were 
assumed to follow quasi-Poisson distribution adjusting for over dispersion. 
The period from 2002 to 2012 was used for model training and the year 
2013 for model validation. The 1-month lead time model had the least 
Root Mean Squared Error for both the training and the test periods with 
values of 19.30 and 6.02 respectively. The 3-month model had the least 
mean absolute percentage error (MAPE) of 39.31% for the 2013 forecast 
values while 1-month lead time model had the least MAPE for the training 
period. The 3-month lead time model provided better forecast accuracy 
in terms of absolute differences between forecast and observed values for 
the 2013 malaria admissions. The 3-month lead time model can potentially 
be utilized as an early warning system allowing sufficient lead time for 
control activities.
969
A QUANTITATIVE ANALYSIS OF THE IMPROBABILITY OF 
FERTILIZATION AT LOW GAMETOCYTEMIAS IN THE ABSENCE 
OF TRANSMISSION-ENHANCING MECHANISMS
Philip A. Eckhoff1, Mara Lawniczak2
1Institute for Disease Modeling, Bellevue, WA, United States, 2Wellcome 
Trust Sanger Institute, Hinxton, United Kingdom
Successful infection of an Anopheles mosquito by Plasmodium falciparum 
gametocytes can occur over many orders of magnitude of gametocyte 
density in the human host, from levels that are not detectable with light 
microscopy to thousands of gametocytes per microliter of blood. The 
empirical curves for the success of infecting a mosquito as a function of 
gametocyte density are difficult to fit, as the success of infection at low 
gametocyte densities can be higher than expected, while the success 
of infection at high gametocyte densities rises slower than expected. 
Indeed, even at high densities, there is often incomplete infection success. 
We are particularly interested in the low-end of gametocyte densities 
because people carrying undetectable gametocytes contribute heavily 
to the infectious reservoir. At the low-end of densities, overdispersion 
of gametocytes in a bloodmeal partially helps to explain the observed 
success rate, but it is not the full story. Within the mosquito midgut, a 
male gamete searches a crowded environment in which there can be more 
than one million uninfected red blood cells per female gametocyte. We 
reexamine the sexual phase of malaria transmission from gametocytes 
in the human host up to gametes finding each other and fertilization 
occurring in the mosquito midgut. We construct a detailed analysis of the 
within-midgut dynamics and study the effects of male gamete swimming 
rate, gametocyte density, overdispersion of gametocytes per feed, 
clustering, and diuresis of the bloodmeal on the probability of successful 
infection at different human host gametocyte densities. Finally, we 
show residual under-prediction of success probability at low gametocyte 
density that could be explained by possible alternative mechanisms such 
as clustering or chemotaxis in the mosquito midgut and then provide 
estimates of the magnitude of these possible mechanisms based on 
observed success probability.
970
A SIMULATION STUDY OF WHEN MALARIA CONTROL AND 
ELIMINATION PROGRAMS CAN SAFELY REDUCE VECTOR 
CONTROL EFFORTS
Joshua Yukich1, Nakul Chitnis2
1Tulane University, New Orleans, LA, United States, 2Swiss Tropical and 
Public Health Institute, Basel, Switzerland
Scale up of the coverage of malaria vector control interventions has 
led to significant reductions in malaria disease burden globally. Due to 
the considerable resources currently devoted to vector control, there 
is a need to determine if this expenditure should be sustained after 
significant reductions in transmission. We use a simulation model of 
malaria epidemiology and immunology (OpenMalaria) to predict malaria 
transmission and disease outcomes after stopping the deployment 
of vector control interventions under various settings. We conduct 
regression analysis of simulation results to derive predicted probabilities of 
resurgence, severity of resurgence and time to resurgence under scenarios 
defined by the pre-intervention entomological inoculation rate (EIR), case 
management coverage, and vector control coverage, amongst other 
parameters. Results indicate that, in the absence of secular changes in the 
underlying determinants of transmission (historically called receptivity), 
there are few scenarios under which vector control can be removed 
without a strong expectation of resurgence. These, potentially safe, 
scenarios are characterized by low historic EIR, successful vector control 
programs that achieve elimination or near elimination, and effective 
surveillance systems with high coverage and effective treatment of 
malaria cases. Programs and funding agencies considering scaling back or 
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withdrawing vector control from previously malaria endemic areas need to 
first carefully consider current receptivity and other available interventions 
in a risk assessment. Surveillance for resurgence needs to be continuously 
conducted over a long period of time in order to ensure a rapid response 
should vector control be withdrawn.
971
EPIDEMIA: AN ONLINE PLATFORM FOR DATA ACQUISITION, 
INTEGRATION, AND ANALYSIS TO SUPPORT ECOLOGICAL 
FORECASTING OF MALARIA OUTBREAKS
Christopher L. Merkord1, Michael C. Wimberly1, Yi Liu1, Michael 
DeVos1, Adam Dosch1, Abere Mihretie2, Alemayehu M. Lemma3, 
Teklehaymanot Gebrehiwot4, Mastewal W. Lake4, Estifanos 
Bayabil2
1South Dakota State University, Brookings, SD, United States, 2Health, 
Development and Anti-Malaria Association, Addis Ababa, Ethiopia, 3Addis 
Ababa University, Addis Ababa, Ethiopia, 4Amhara National Regional State 
Health Bureau, Bahir Dar, Ethiopia
Malaria early detection and early warning systems are important tools 
for public health decision makers. Here we present technical information 
on the design and implementation of the EPIDEMIA online platform 
which serves as an automated tool for forecasting and early detection of 
malaria outbreaks in the Amhara Region of Ethiopia. The platform uses 
freely available, community-driven open source software including the R 
language for statistical computing, MySQL and PostgreSQL for relational 
data storage, and PHP, HTML, and CSS for web front-end. The R language 
was chosen because it is widely accessible and allows for the use of 
advanced statistical modeling techniques. As a result of these choices, the 
EPIDEMIA data platform can easily be modified to incorporate potential 
future statistical models, applied to other geographic areas, or applied 
to other diseases linked to environmental conditions. The EPIDEMIA 
platform’s epidemiological data acquisition subsystem consists of a 
securely hosted and encrypted website where public health collaborators 
in Amhara upload malaria morbidity data which is then parsed and stored 
in a MySQL database. The environmental data acquisition subsystem uses 
our previously-developed EASTWeb software to continuously monitor, 
download, and summarize earth-observation data derived from satellite 
remote-sensing products that are freely-available on the internet. When 
new environmental data has been processed in EASTWeb’s PostgreSQL 
database, a listener triggers a PHP script to import the new data into 
EPIDEMIA’s MySQL database. The data integration subsystem, which 
is a series of scripted actions written in PHP, R, and MySQL stored 
procedures, integrates the various datasets. After each weekly upload 
of epidemiological data, the forecasting subsystem uses dynamic linear 
models implemented in R to analyze the integrated dataset for early signs 
of malaria outbreaks and to generate malaria forecasts. The reporting 
subsystem uses R to generate a weekly malaria forecast in PDF format 
and allows users to generate custom reports, visualizations, and data 
summaries using a query interface on the website.
972
MATHEMATICAL MODELLING OF TAFENOQUINE FOR 
PLASMODIUM FALCIPARUM MALARIA ELIMINATION
Richard J. Maude1, Rapeephan R. Maude2, Lisa J. White1
1Mahidol-Oxford Tropical Medicine Research Unit (MORU), Bangkok, 
Thailand, 2Division of Geographic Medicine and Infectious Diseases, Tufts 
Medical Center, Boston, MA, United States
The 8-aminoquinolines are the only known class of antimalarials 
with action against Plasmodium vivax hypnozoites and P. falciparum 
gametocytes. Primaquine is widely used as part of treatment of P. vivax 
malaria to clear hypnozoites from the liver and thus prevent relapses. 
This requires a 14-day course to be taken. Primaquine has also been 
recommended by WHO since 2012 as a single dose for P. falciparum 
infection to kill gametocytes and thus interrupt transmission. A recent 
mathematical modelling consensus exercise for WHO to predict the 
efficacy of mass drug administration (MDA) for P. falciparum elimination 
found the additional impact of single dose primaquine to MDA with 
artemisinin combination therapy (ACT) to be very small. Tafenoquine is 
an investigational 8-aminoquinoline antimalarial currently being trialled 
as a hypnozoiticidal for treatment of P. vivax infection. Its mode of action 
and side effect profile are very similar to primaquine however it has the 
advantage of a much longer half-life. It has thus been proposed as a 
single dose alternative to 14 days of primaquine for P. vivax. However, 
tafenoquine is not currently being considered as a gametocytocidal for 
P. falciparum infection. In this role, its long half-life may confer greater 
transmission blocking activity than primaquine which could make it a 
valuable tool for falciparum elimination. In the absence of trial evidence, 
a mathematical model was developed to predict the efficacy of single 
dose tafenoquine alone and when given with ACT for P. falciparum 
malaria elimination. Using this model, a range of scenarios is being 
explored including its use for treatment of clinical cases, in mass drug 
administration, and as part of a combined strategy with vector control 
measures. In addition, its impact in low, medium and high transmission 
settings in Asia and Africa and for the elimination of artemisinin and ACT 
partner drug-resistant falciparum malaria. The results of this mathematical 
modelling exercise will be presented with recommendations for the 
possible role of tafenoquine in P. falciparum elimination and for potential 
clinical study designs to assess its efficacy in the field.
973
IDENTIFYING MALARIA RISK FACTORS IN A HYPERENDEMIC 
SETTING USING BAYESIAN MODEL SELECTION
Justin Millar1, Punam Amratia1, Paul Psychas2, Benjamin Abuaku3, 
Collins Ahorlu3, Kwadwo Koram3, Samuel Oppong4, Denis Valle1
1School of Forest Resources and Conservation, University of Florida, 
Gainesville, FL, United States, 2Emerging Pathogens Institute, University 
of Florida, Gainesville, Gainesville, FL, United States, 3Noguchi Memorial 
Institute for Medical Research, University of Ghana, Accra, Ghana, 
4National Malaria Control Programme - Ghana, Accra, Ghana
The epidemiological dynamics of malaria, as with many other vector-borne 
diseases, have been linked to a wide variety of environmental, socio-
economic, and demographic factors. Traditional statistical approaches 
for evaluating the contribution of each of these potential disease 
drivers present critical tradeoffs. Modeling all possible combinations 
can be computationally intensive and make it difficult to draw definitive 
conclusions when numerous disease factors are considered. Conversely, 
selecting a subset of potential drivers can fail to describe the relative 
importance of a particular covariate and can exclude important risk 
factors. To address these issues we propose a Bayesian probit regression 
model that contains a model selection procedure which proposes new 
candidate models through the random addition, subtraction, or swapping 
of covariates. A new model is proposed and evaluated at each step of 
the iterative Markov Chain Monte Carlo algorithm, generating parameter 
estimates and inclusion frequencies for each potential disease driver. We 
used this approach to simultaneously evaluate the relative importance of 
a wide range of environmental, socio-economic, and medical risk factors 
for malaria in the Bunkpurugu-Yunyoo district of northern Ghana, using 
existing data from six malaria surveys conducted in 2010-13. Our analysis 
identifies substantial protective socio-economic and medical factors 
related to the two modest “urban” centers in this small geographic area, 
indicating that the small towns in this hyperendemic setting may buffer 
nearby rural areas from environmental conditions that are traditionally 
linked to high malaria transmission. This Bayesian model selection 
technique offers a promising solution for dealing with the practical and 
computational constraints of evaluating numerous diverse risk factors for 
malaria and other diseases.
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ATTACKING THE MOSQUITO ON MULTIPLE FRONTS: 
INSIGHTS ON OPTIMAL COMBINATIONS OF VECTOR 
CONTROL INTERVENTIONS FOR MALARIA ELIMINATION 
FROM A MATHEMATICAL MODEL
Samson S. Kiware1, Allison Tatarsky2, Sean Wu3, Héctor M. 
Sánchez4, Nakul Chitnis5, John Marshall3
1Ifakara Health Institute, Dar Es Salaam, United Republic of Tanzania, 
2The Malaria Elimination Initiative, Global Health Group, University of 
California, San Francisco, CA, United States, 3Divisions of Biostatistics 
and Epidemiology, School of Public Health, University of California 
Berkeley, Berkeley, CA, United States, 4School of Medicine, Tecnol o gico 
de Monterrey, Mexico, Mexico, 5Department of Epidemiology and Public 
Health, Swiss Tropical and Public Health Institute, Basel, Switzerland
Despite great achievements by long-lasting insecticide-treated nets (LLINs) 
and indoor residual spraying (IRS), research demonstrates that these 
tools are insufficient to eliminate malaria transmission in many settings 
today. Protective coverage from these interventions is attenuated where 
mosquitoes can access blood resources from non-human hosts or from 
humans when they are outdoors. Fortunately, field experiments indicate 
that there are many promising vector control interventions that can 
be used to complement LLINs and/or IRS by targeting a wide range of 
biological and environmental mosquito resources. The majority of these 
experiments were performed to test a single vector control intervention in 
isolation; however, there is growing evidence and consensus that effective 
vector control will require a combination of interventions tailored to the 
target ecological and epidemiological setting. We present a mathematical 
modeling framework designed to examine combination interventions prior 
to empirical field trials. The model framework incorporates all stages of the 
mosquito life cycle from egg, larva, pupa, adult, and, crucially, the female 
gonotrophic cycle whereby females blood feed and lay eggs. We describe 
how the framework may be used to evaluate the impact of combining 
existing and novel interventions in synergistic ways in areas where LLINs 
and/or IRS are widely used but where malaria transmission persists. We 
consider the following vector control interventions in addition to LLINs 
and IRS: larvaciding (conventional and aerial), attractive toxic sugar baits 
(ATSBs), insecticide spraying of male mating swarms, mosquito-proofed 
housing, spatial and topical mosquito repellents, systemic and topical 
insecticide-treatment of cattle, odor-baited traps and space spraying. 
We describe optimal combinations of these interventions needed 
to significantly reduce entomological inoculation rate (EIR), a widely 
accepted measure of malaria transmission, in a range of ecological and 
epidemiological settings.
975
IMPACT OF SEASONAL MALARIA CHEMOPROPHYLAXIS IN A 
HIGH AND SEASONAL MALARIA TRANSMISSION SETTING IN 
BURKINA FASO
André Lin Ouedraogo, Philip A. Eckhoff, Edward A. Wenger
Institute for Disease Modeling, Bellevue, WA, United States
Seasonal malaria chemoprophylaxis (SMC) is a strategy endorsed by the 
WHO to prevent malaria in children aged 3-59 months living in seasonal 
malaria transmission areas. In Burkina Faso where malaria transmission is 
highly endemic and seasonal, more than 60% of malaria cases (clinical 
malaria) occur during the rainy season from June to October with the 
majority falling on younger children. In 2015, the SMC campaign in 
Burkina aimed at giving sulphadoxine-pyrimethamine and amodiaquine 
anti-malarial treatments (SP+AQ) to children below 5 years at one month 
interval during the rainy season. At each time point, children were treated 
with one dosage regimen (three unit doses over three days). About 
8,000 community health workers were recruited to administer the SMC 
preventive treatment to about 650,000 children across 17 health districts. 
Here we aim at modeling the long term impact of SMC on Plasmodium 
falciparum clinical incidence and prevalence in the targeted population as 
well as in the general population. We used baseline and post intervention 
data on clinical and parasite rate detected by RDT and accounted for the 
selection of parasites with decreased drug sensitivity to calibrate the EMOD 
agent-based mechanistic model. Our 5 years simulations with a scenario 
of 80% SMC coverage were proven to substantially drop the prevalence 
of clinical malaria and parasite rate with a community based effect on P. 
falciparum prevalence in the general population.
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SPRAYING OF MALE MATING SWARMS AS A NOVEL 
VECTOR CONTROL INTERVENTION: INSIGHTS FROM A 
MATHEMATICAL MODEL
Sean L. Wu1, John M. Marshall1, Sawadogo P. Simon2, Bilgo 
Etienne2, Abdoulaye Diabaté2
1University of California Berkeley, Berkeley, CA, United States, 2Institut de 
Recherche en Sciences de la Santé (IRSS)/Centre Muraz, Bobo-Dioulasso, 
Burkina Faso
Despite the success of long-lasting insecticide treated nets (LLINs) 
and indoor residual spraying (IRS) in controlling malaria transmission, 
challenges posed by elimination in residual transmission settings and 
waning effectiveness of current interventions prompt the investigation of 
novel vector control tools. Interventions that target hitherto unaddressed 
elements of vector biology may be of particular interest. Targeted 
insecticidal spraying of male mating swarms is a novel intervention 
that reduces the mating rate of female mosquitoes, thereby decreasing 
population density and biting rates. The only field trial of this intervention 
to date was undertaken in 2013 in Burkina Faso where it proved highly 
effective at reducing densities of Anopheles gambiae, one of the most 
dangerous African malaria vectors. Trial results showed that over a single 
month, mosquito densities were reduced by 80% in an ecological setting 
characterized by exceptionally high vector density. To understand the 
mechanisms through which spraying of male mating swarms impacted 
vector populations, a differential equation based model was developed 
and fitted to data. Parameters estimated through the model fitting 
procedure can give insight into mosquito mating dynamics in the natural 
setting as well as under an extreme external stressor. These results can 
give insight into how other interventions targeting mating dynamics may 
function. Results also allow an understanding of how female mating 
rate changes as males become scarce, indicating the importance of Allee 
effect driven population dynamics. The model-based analysis of these 
data suggest further research into targeting mosquito mating dynamics 
for vector control should be explored across a variety of ecological 
settings, both to better understand mosquito mating dynamics, as well 
as to evaluate the potential impact of swarm spraying across a variety of 
settings.
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DEVELOPING AN EARLY WARNING SYSTEM FOR MALARIA 
IN THE AMAZON: PROGRESS IN PERU
William Pan1, Ben Zaitchik2, Francesco Pizzitutti1, Beth Feingold3, 
Carlos Mena4, Cristina Recalde2, Gabriela Salmon-Mulanovich1, 
Elisa Vidal5, Edward Smith5, Sarah Ballard5
1Duke University, Durham, NC, United States, 2Johns Hopkins University, 
Baltimore, MD, United States, 3Albany School of Public Health, Albany, NY, 
United States, 4Universidad San Francisco de Quito, Quito, Ecuador, 5U.S. 
Naval Medical Research Unit-6, Lima, Peru
Reported cases of malaria in the Peruvian Amazon have increased 5-fold 
since 2011, from 11,779 to 60,254 in 2015. Given the rate of detection 
up to April of this year, the number of cases are likely to exceed 70,000 in 
the region of Loreto. Responding to this epidemic has been challenging 
given the reduced financial support from the Peruvian government 
combined with large-scale environmental impacts that have affected Peru, 
including massive flooding in 2012 and the current “mega” El Nino. An 
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underappreciated driver of malaria transmission is the human-environment 
interface resulting in increased human contact with high-risk transmission 
environments. With support from NASA, a team of investigators from 
the US, Peru and Ecuador are developing a 2-component system that will 
improve detection of high-risk environments using large-scale prediction 
models, followed by application of focused agent-based models (ABMs) 
to predict local transmission dynamics and simulate potential intervention 
strategies. This presentation will provide an update of the system after 
one year of development. Data include: weekly case detection reports for 
2000-2015 from all health posts in the region of Loreto in the northern 
Peruvian Amazon; satellite-derived estimates for meteorology, land cover, 
hydrology, and eco-region; and estimates of population density. The large-
scale model identifies districts with high spatial and temporal clustering 
using polynomial distributed lag models. Initial formulations of these 
models have been presented previously. The small-scale ABMs, described in 
Pizzitutti et.al. 2015, have been improved to incorporate human mobility. 
This long-term project has both scientific and political (implementation) 
challenges that will be discussed.
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REQUIREMENTS FOR EFFECTIVE CRISPR-CAS9-BASED 
GENE DRIVE FOR THE CONTROL OF MALARIA AND OTHER 
VECTOR-BORNE DISEASES
John M. Marshall1, Omar S. Akbari2
1University of California Berkeley, Berkeley, CA, United States, 2University 
of California Riverside, Riverside, CA, United States
Recent demonstrations of CRISPR-Cas9-based gene drive by Gantz et al. 
and Hammond et al. highlight the huge potential of this technology for 
the control of mosquito-borne diseases such as dengue, Zika and malaria 
through genetic modification of their vectors. Two promising strategies 
have been proposed - one in which the gene drive system is used to 
spread a disease-refractory gene into the mosquito population, and 
another in which the gene drive system is used to spread a fitness load 
or male gender bias, thus suppressing the mosquito population. While 
encouraging as a proof-of-concept, these constructs are highly error-prone 
and induce large fitness costs, leading to certain failure in the wild. Using 
a population modeling framework, we determine minimal properties 
that these systems must have in order to be successfully implemented. 
Required improvements address the following issues: a) disruption of the 
CRISPR-Cas9 target site through non-homologous end-joining (NHEJ); b) 
fitness costs induced by the transgene and/or gene drive system; and c) 
evolution of pathogen resistance to the disease-refractory gene. We use 
our modeling framework to explore potential solutions to these issues. For 
instance: a) the use of second or third-generation CRISPR-Cas9 systems to 
enable sustained population replacement or suppression; and b) the use 
of CRISPR-Cas9 systems that prevent the accumulation of NHEJ-generated 
mutant alleles by cleaving a target sequence in an essential gene while 
also containing a recorded copy of the essential gene. Finally, we project 
the dynamics of the constructs of Gantz et al. and Hammond et al. beyond 
the experimental data, and explore tailored improvements. High homing 
rates were observed for both constructs, with over 90% transmission 
of the CRISPR-Cas9 system to offspring of heterozygous parents (c.f. 
50% expected for purely Mendelian inheritance); however, high rates of 
NHEJ were also recorded, and females heterozygous for the construct 
of Hammond et al. had their fertility reduced by 90%. We recommend 
specific improvements for each system and thus suggest research priorities 
for the CRISPR-Cas9 gene drive field.
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MODELING THE USE OF A 20-HYDROXYECDYSONE STEROID 
AGONIST FOR MALARIA CONTROL
Francisco Y. Cai1, Lauren M. Childs1, Evdoxia G. Kakani1, Sara 
N. Mitchell1, Doug Paton2, Paolo Gabrieli2, Flaminia Catteruccia1, 
Caroline O. Buckee1
1Harvard T. H. Chan School of Public Health, Boston, MA, United States, 
2Universita di Perugia, Perugia, Italy
Mathematical models have played an important role in designing malaria 
control policies by relating aspects of mosquito biology and behavior to 
malaria transmission. We developed a discrete-time compartmental model 
of the mosquito lifecycle to investigate the use of a novel compound 
for impregnated bed nets. This compound, a dibenzoylhydrazine, is a 
20-hydroxyecdysone (20E) steroid hormone agonist with multiple effects 
on Anopheles gambiae, an important vector of the malaria parasite 
Plasmodium falciparum. The application of this 20E agonist to lab-reared 
mosquitoes reduced their mating success and egg development, shortened 
their lifespan, and blocked parasite development - effects that interfere 
with their ability to transmit malaria. We incorporated these varied 
effects into our model to predict the impact of this 20E agonist on the 
mosquito population and malaria transmission when applied via bed nets 
at varying levels of coverage. We find a non-linear relationship between 
bed net coverage and the mosquito population size, with a slightly 
increased population size at low coverage due to density-dependent larval 
mortality. However we predict, at all coverages, a shift in the mosquito 
age distribution toward younger mosquitoes, which are unable to transmit 
malaria, and reduced malaria prevalence in the human population, with 
the possibility of elimination at high coverage. These results show the 
potential of 20E agonists as new compounds for malaria control and 
highlight the utility of mathematical models when studying multiple 
aspects of mosquito biology that are simultaneously affected.
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WITHIN-HOST MATHEMATICAL MODELS OF MALARIA BUILT 
FROM MULTI-OMIC DATASETS
Juan B. Gutierrez, Yi Heng Yan
University of Georgia, Athens, GA, United States
The characterization of a malaria infection via a mathematical model 
that takes into account essential molecular interactions has been elusive. 
In the recent past, mathematicians trying to characterize the behavior 
of molecular and/or cellular quantities relied on simple diagrams (i.e. 
involving a reduced set of quantities) of processes described by biologists. 
Now instruments produce up to billions of measures in a single run 
from samples isolated from a particular biological domain (genomics, 
transcriptomics, metabolomics, proteomics, etc). The -omics revolution 
has changed the overall situation from data-poor to data-rich and thus 
has put many modelers in a situation of data overload. In this talk we 
address the integration of multiple -omic technologies to characterize 
the pathogenesis of malaria. Particularly, we will see how metabolic, 
transcriptional, lipidomic, and clinical data collected from a non-human 
primate infection with Plasmodium Cynomolgy can be used in unison 
to produce a mathematical model capable of differentiating between 
susceptible and resilient individuals. Such model is based on transport 
partial differential equations involving red blood cells, the immune system, 
and parameters that are functions of molecular quantities. This model 
makes use of a novel approach to cluster time series. The outcome of 
this model is a quantitative prediction of the course of a malaria infection 
based on known and anticipated molecular interactions that take place 
within a single individual. The lessons learned and methods developed 
during the course of this research are of ample applicability, thus the 
benefit of this aggregated knowledge expands beyond the field of malaria 
and outside the realm of research.
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ORDE WINGATE’S SUICIDE ATTEMPT, CAIRO, 1942: A CASE 
STUDY IN ACUTE ATABRINE PSYCHOSIS
David P. Adams1, Femi Taiwo2, Sarah Jillson2, Chidinma Okafor2
1Mercer University School of Medicine, Savannah, GA, United States, 
2Armstrong State University, Savannah, GA, United States
One of the best known field commanders of the Second World War was 
Orde Wingate. His daring guerilla tactics in British-mandated Palestine, 
Ethiopia, and Burma have become legendary among military historians. 
Indeed, Wingate’s military career in the field has rightly attracted the bulk 
of attention of biographers and military historians. Such well-deserved 
attention to Wingate’s military career, however, has tended to divert 
attention from a 1942 suicide attempt. Suffering from malaria—possibly 
cerebral malaria--Wingate received atabrine therapy from his physician. 
According to his biographers, he abruptly increased its recommended 
doses. In a botched suicide attempt that followed, Wingate thrust a knife 
into his neck. This proposal will examine the probable cause of Wingate’s 
suicide attempt. Was it, as some observers suggest, the severity of 
Wingate’s malarial condition? Was it the high dose of atabrine with which 
Wingate recklessly self-medicated that caused his acute psychosis. Or 
was it, in fact, a combination of the two, exacerbated by an undiagnosed 
psychiatric condition? The authors conclude that pre-existing psychiatric 
issues (which the overdose of atabrine exacerbated)—not cerebral 
malaria—precipitated his 1942 suicide attempt.
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JOINT EFFORTS, A KEY TO SUCCESS FOR THE MALARIA IN 
PREGNANCY PROGRAM IN LUANDA, ANGOLA
Jhony Juarez1, Adolfo Sampaio1, William Brieger2, Domingos F. 
Gueve3
1Jhpiego, Luanda, Angola, 2Jhpiego, Johns Hopkins Bloomberg School 
of Public Health, Baltimore, MD, United States, 3Provinvial Health 
Department, Luanda, Angola
Angola, in response to WHO’s 2012 updated guidance on Intermittent 
Preventive Treatment in pregnancy (IPTp), revised its national malaria 
protocol to better address the fact that 25% of maternal mortality is 
caused by the disease. The new protocol was a collaborative effort of a 
national technical working group assisting the National Malaria Control 
Program (NMCP) including the National Reproductive Health Program, the 
national AIDS Institute, WHO, UNICEF, UNFPA and implementing partners 
of the U.S. Presidents Malaria Initiative (PMI). The updated Prevention 
and Treatment Manual for Malaria in Pregnancy, based on the revised 
protocol, was approved in 2014, and efforts continued with reviewing 
and updating training modules, job aids and monitoring tools that 
would reflect the additional doses of IPTp. The Ministry of Health, with 
support from partners, then disseminated these materials in the provinces 
and municipalities where they worked. USAID’s ForçaSaúde program, 
with support from PMI, worked with the Provincial Health Directorate 
of Luanda to build capacity of 297 health professionals to implement 
the new guidance in 78 health facilities of four municipalities, Belas, 
Cazenga, Cacuaco and Viana, with a combined population of 4.3 million. 
Comparing the IPTp data from the four municipalities between 2014 and 
2015, one can see that the new guidance has started to take effect. In 
both years approximately 70,000 pregnant women received the first dose 
or around 60% of women registering for antenatal care (ANC). For the 
new third dose there was an increase of 85% (from 12,490 women to 
23,046), and receipt of the fourth dose rose by 164% (3,345 to 8,839). 
Two major challenges remain: increasing ANC registration and addressing 
missed opportunities to provide ANC doses for those who do attend 
including ensuring regular supplies of sulfadoxine-pyrimethamine for 
IPTp. Future progress requires continued inter-departmental collaboration 
among NMCP, Reproductive Health and the AIDs Institute, on-the-job 
training, enhanced statistical capacity, and supervision.
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STUDY ON PATIENT ADHERENCE TO CHLOROQUINE AND 
PRIMAQUINE TREATMENT FOR PLASMODIUM VIVAX 
MALARIA IN MANAUS, STATE OF AMAZONAS
Paola B. Marchesini
Ministry of Health, Brasilia, Brazil
Compliance to treatment is one of the most important factors to ensure 
radical cure, avoid relapses, prevent the emergence of parasite resistance 
to anti-malarial drugs and decrease transmission. Brazil has been using 
the “short” treatment scheme for Plasmodium vivax malaria - 3 days 
chloroquine +7 days primaquine - for many years trying to ensure patient`s 
adherence. Currently the country also use, when adherence could be 
secured, the “long” scheme with 14 days primaquine (or primaquine 
adjusted by weight). This study was conducted in Manaus, Amazonas to 
assess patient adherence to the standard P. vivax malaria scheme with 3 
days chloroquine+7 days primaquine in the health centers’ routine care; 
and identifying factors that determine low treatment adherence and 
adverse events associated with the treatment of P. vivax malaria. It was 
a transversal study conducted with patients seen in 11 health centers 
and designed to quantify adherence by conducting home interviews and 
verifying how many pills were remaining one day after the last treatment 
day. Sample size was determined by using an expected 15% proportion of 
low adherence, a 95% confidence range, and a 5% level of significance. 
165 patients were interviewed, 98 were male and 67 female, and 100 
were the patients themselves and 65 their guardians.There were a total 
of 31 patients who failed to adhere, representing 18.8% of the total, of 
which 6.1% had blisters with pills and 12.72% reported non-adherence. 
The study demonstrated problems in adhering to primaquina related to 
various factors that vary from the instructions given by the dispensers but 
not really understood by patients to the presentation of the medications. 
The value found for non-adherence/probable non-adherence may still be 
understated due to the possible introduction of selection biases: patients 
who are available for a visit and interview may cooperate more, for 
example. The result of this study reinforces an important problem with 
the P. vivax scheme that need to be addressed. In view of the malaria 
elimination interest it is important to show problems that need to be 
solved in order to reach the elimination goal.
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PRE-SERVICE TRAINING INSTITUTIONS: AN IMPORTANT 
CONTRIBUTOR TO SCALE UP OF HIGH QUALITY MALARIA 
CASE MANAGEMENT SERVICES IN MALAWI
McPherson Gondwe1, Augustine Chikoko1, Petros Chirambo2, 
Fozo Alombah3, Holly Greb3, Jamie Eliades3
1PATH, Lilongwe, Malawi, 2MCDI, Lilongwe, Malawi, 3PATH, Washington, 
DC, United States
Pre-service training institutions are an important, but often neglected, 
component of improving the quality of malaria case management. 
In 2007, Malawi updated its national guidelines on first line malaria 
treatment (from sulfadoxine-pyrimethamine to the artemisinin-based 
combination therapy (ACT) artemether-lumefantrine). By 2012, the 
Ministry of Health began reviewing the corresponding national training 
curriculum to orient health providers to the new malaria case management 
treatment guidelines. To support rollout, MalariaCare partnered with the 
National Malaria Control Program to train 3,035 health care providers 
(across 14 districts) on the updated national case management guidelines. 
Between 2007 and 2014, limited efforts were made to target pre-
service training institutions as well. To enhance timely scale up of high 
quality case management services, MalariaCare trained 22 lecturers from 
eight training institutions, representing half of all training institutions 
in Malawi. Participants’ knowledge and competencies related to the 
updated malaria case management guidelines were evaluated through 
pretests and posttests. Key findings include that average scores increased 
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from thirty eight percent (38%) at pretest to seventy three percent 
(73%) at posttest - indicating that baseline knowledge of the updated 
malaria case management guidelines was low among this group. Next 
steps for ensuring that new graduates continue to be well prepared 
will also be shared, including partnering with training institutions and 
Malawi’s National Malaria Control Program to orient final year students 
to Malawi’s updated malaria case management guidelines and support 
for incorporating the updated national guidelines into pre-service training 
curricula. In addition to practicing health providers, training institutions 
should be engaged to ensure that new health providers entering the 
workforce are up to date on changes to national guidelines, allowing them 
to contribute to the scale up of high quality malaria case management 
services.
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IMPROVING QUALITY OF MALARIA CASE MANAGEMENT IN 
MALAWI THROUGH TARGETED CLINICAL MENTORING
Fozo Alombah1, McPherson Gondwe2, Augustine Chikoko2, 
Petros Chirambo3, Holly Greb1, Jamie Eliades1, Don Mathanga4, 
Doreen Ali5, Dubulao Moyo5
1PATH, Washington, DC, United States, 2PATH, Lilongwe, Malawi, 3MCDI, 
Lilongwe, Malawi, 4Queen Elizabeth Central Hospital, Lilongwe, Malawi, 
5NMCP, Lilongwe, Malawi
The Malawi Ministry of Health estimates that malaria accounts for 
34% of all outpatient visits and 40% of all hospital admissions, with 
approximately 5 million cases treated each year. MalariaCare seeks to test 
promising new methods for more rapidly improving the quality of malaria 
diagnosis and treatment. In Malawi, the project is working closely with 
the National Malaria Control Program, Malaria Alert Center and Queen 
Elizabeth’s Hospital to enhance routine outreach training and supportive 
supervision (OTSS) efforts by supporting a core group of clinical experts 
to provide intensive clinical mentoring to health facilities that are not 
meeting the project’s minimum standards for quality case management. 
Intensive mentoring is used to target areas of weakness using problem-
solving approaches and experiences that have worked in similar settings 
to address challenges and improve performance. Intensive mentoring 
is a collaborative approach engaging the commitment of both mentor 
and mentee. MalariaCare’s hypothesis is that intensive mentoring will 
improve performance in a sustainable way on gaps identified during OTSS. 
Given the lack of literature on the contributions of clinical mentoring 
towards improved quality of malaria case management, MalariaCare will 
share findings regarding the use of mentoring toward this purpose in 
select health facilities. A core group of clinical mentors has been trained 
to provide intensive clinical mentoring in selected high-volume low-
performing health facilities, following supervision rounds and through 
remote support by phone and email. Data will be collected using a 
standardized malaria case management evaluation tool developed by 
MalariaCare. A brief competency-based pre-post assessment tool will be 
used to assess provider competencies at the beginning and end of the 
mentoring process. The primary outcomes, however, will be changes in 
performance on case management indicators after mentoring and over 
time compared with a baseline. Results and lessons learned are expected 
to generate evidence on the potential role of clinical mentorship for 
improving the quality of malaria case management.
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CLINICAL, DEMOGRAPHIC AND LABORATORY DATA AND 
METADATA COLLECTION FOR HUMAN MALARIA BLOOD 
SAMPLES COLLECTED FROM INDIVIDUALS LIVING IN 
DIVERSE EPIDEMIOLOGICAL SETTINGS
Suman B. Pakala1, Regina Joice2, Mustafa Nural1, Jay Humphrey1, 
MaHPIC Consortium, Mary R. Galinski2, Jessica C. Kissinger1
1Institute of Bioinformatics, University of Georgia, Athens, GA, United 
States, 2Malaria Host–Pathogen Interaction Center, Emory Vaccine Center, 
Yerkes National Primate Research Center, Emory University, Atlanta, GA, 
United States
Malaria is a leading cause of disease and death in many developing 
countries and is a severe public health problem worldwide. Independent 
research centers are active in many malaria endemic countries in Asia, 
Africa, and South America. To enhance the effectiveness of global malaria 
research and help accelerate progress, collaboration and data sharing 
between and among national and international research centers and 
other facilities is critical. Such collaboration is possible when easy to 
follow standards for data and metadata collection and dissemination are 
available and widely adopted. The NIH/NIAID-supported Malaria Host 
Pathogen Interaction Center, MaHPIC, consortium involves international 
collaborators from Brazil, Thailand, Colombia, Malaysia and Nigeria, with 
more coming onboard. We have collected clinical, demographic and 
laboratory data and metadata from diverse research collaborations from 
around the world, and developed easy to use data entry templates that are 
compatible with the data standards developed by the International Centers 
for Excellence in Malaria Research (ICEMRs) and the NIH/NIAID Clinical 
Data Working Group. The challenges faced with respect to mapping terms 
to the currently available and accepted ontologies will be discussed and 
solutions provided.
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USING OUTREACH TRAINING AND SUPPORTIVE 
SUPERVISION (OTSS) RESULTS TO MONITOR ADHERENCE 
TO REVISED MALARIA TREATMENT GUIDELINES IN THE 
EASTERN REGION OF GHANA
Felicia Amoo-Sakyi, Andrew Quao, Solomon Atinbire, Peter 
Segbor, Raphael Ntumy
PATH, Accra, Ghana
Following WHO’s 2010 recommendation, Ghana revised its national 
malaria case management guidelines in 2014 to include laboratory 
confirmation for all suspected malaria cases before treatment with ACT. 
Training was conducted for public health facility workers on the new 
guidelines, but training numbers were inadequate. MalariaCare supports 
the National Malaria Control Program to conduct regular outreach 
training and supportive supervision (OTSS) visits to health facilities as 
part a strategy to improve adherence to the new guidelines and overall 
provision of febrile case management in five supported regions. The first 
round of OTSS following the training on updated guidelines resulted 
in a total of 426 health facilities receiving supervision visits. These visits 
included observations, practical demonstrations, interviews and patient 
record reviews to identify weaknesses, encourage problem solving and 
strengthen performance through on-the-job training and mentoring. 
OTSS data from this round shows that 82.9% of staff interviewed had 
participated in case management training, and that the overall score for 
clinical fever evaluations observed was 92.7%. The clinical fever evaluation 
score is a composite of the following: in 92.2% of observations, clinicians 
appropriately classified fever and 95.5% requested a malaria test to 
confirm the clinical diagnosis. Following a diagnostic test, 81.8% adhered 
to a negative test result and 87.6% prescribed according to guidelines as 
observed by supervisors during patient encounters. In a review of facility 
clinical records, adherence to a negative test result was higher at 92.7% 
of the sampled records. Comparison with the two previous rounds of 
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OTSS, which occurred before training on the updated guidelines, indicated 
improvement in performance of all four clinical fever evaluation indicators 
to above 80%, and an improvement in adherence to negative test results 
from 57.2% to 81.2%.
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LESSONS LEARNED: MALARIA CASE MANAGEMENT 
TRAINING IN MADAGASCAR
Pharath Lim1, Marie Ange Rason2, Alexandria Alberto3, 
Reed Thorndahl1, Luis Benavente1, Omega Raobela4, Arsene 
Ratsimbasoa4, Lee Yellott1, Fozo Alombah3, Paul Hamilton3, Chris 
Schwabe1
1MCDI, Silver Spring, MD, United States, 2MCDI, Antananarivo, 
Madagascar, 3PATH, Washington, DC, United States, 4NMCP, Antananarivo, 
Madagascar
To help scale up high-quality diagnosis and case management services 
for malaria and other febrile illnesses, MalariaCare is supporting 
Madagascar’s National Malaria Control Program (NMCP) to conduct clinical 
case management training in the Menabe region, with training sites in 
Morondava, Belo, Miandrivazo and Mahabo. Training materials were 
aligned with NMCP guidelines, with emphasis on orienting participants 
to Madagascar’s updated policy around first-line treatment (three days 
of ACT), use of artesunate injection for severe malaria, as well as clinical 
and diagnostic practices. Participants were assessed using pretests and 
posttests. Of the 55 participants, 71% were nurses and 29% were 
physicians. Overall, 85% of participants stated that the training met their 
expectations. In addition, 87% of participants in Morondava improved 
their knowledge and skills after training - with an average increase of 
16 percentage points between pretest and posttest. Similarly, 80% of 
participants in Belo improved their scores by an average of 17 percentage 
points, 94% of participants in Miandrivazo increased their scores by an 
average of 18 percentage points, and 93% of the participants in Mahabo 
increased their scores by an average of 18 percentage points. Average 
pre and posttest scores (out of 30) were 20 and 25 for Morondava; 18 
and 23 for Belo; 19 and 25 for Miandrivazo, and 20 and 25 for Mahabo. 
Participants will use the knowledge gained from this training to improve 
the quality of diagnostic and treatment in their communities, aimed at 
reducing malaria related morbidity and mortality rate in remote areas of 
Madagascar.
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ASSESSING THE PERFORMANCE OF AN INTEGRATED 
DISEASE SURVEILLANCE AND RESPONSE SYSTEM IN THE 
CONTEXT OF VARYING MALARIA TRANSMISSION: A CASE 
STUDY FROM MADAGASCAR
Jean-Marie NGbichi1, Moussa Ly2, Julio Rakotonirina3, Jean-
Claude Andrianirinarison3, Lantonirina Ravaorisoa3, Julie Harisoa4, 
Arsene Ratsimbasoa5, Mayeri Ratsitorahina6, Theo Lippeveld2, Ye 
Yazoume1
1ICF International, Rockville, MD, United States, 2John Snow Inc., 
Arlington, VA, United States, 3Cabinet Consultus, Antananarivo, 
Madagascar, 4Service de Statistique Sanitaire Demographique Ministry 
of Health, Antananarivo, Madagascar, 5Direction de la Lutte contre le 
Paludisme, Antananarivo, Madagascar, 6Diresction de la Veille Sanitaire et 
la Surveillance Epidemiologiquue, Antananarivo, Madagascar
The Madagascar’s ministry of health (MOH) is building an integrated health 
information system to streamline reporting at all levels. One component 
of this is an integrated disease surveillance and response system (IDSR) 
for notifiable diseases. Madagascar’s entire population is at risk of 
malaria with epidemic prone areas. As malaria transmission decreases 
and Madagascar considers pre-elimination, a specific surveillance system 
is also required. In October 2015, the MOH conducted an assessment of 
the IDSR in 93 randomly selected health facilities (HF), 218 community 
workers, and 19 sentinel sites. Results showed that 70% of HF reported 
accurate data, 62% of expected reports sent to district, 50% of expected 
reports received on time. IDSR guidelines were found in 20% of HF, 37% 
of HF have the official list of diseases under surveillance, and 54% have 
the weekly reporting form. Only 50% of IDSR staff at the district level, 
57% at the region level were trained in surveillance. Supervision was 
irregular with 50% of HF supervised in the past six months. Only 52% 
of districts and 3/10 regions have an epidemic management committee. 
Data use was limited, only 40% of districts could investigate all epidemic 
alerts in the past 12 months. These findings suggest the need to develop 
and implement a comprehensive IDSR-strengthening strategy including 
data quality assurance procedures, use of new technologies, staff capacity 
building, coordination among partners, and use of data to respond to 
disease control in Madagascar.
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MONITORING AND EVALUATION WORKSHOPS: AN 
APPROACH TO IMPROVE MALARIA INFORMATION 
SYSTEMS AND DATA USE TO BETTER INFORM PROGRAM 
IMPLEMENTATION
Ashley Garley1, Erin Eckert2, Ali Sie3, Maurice Ye3, Keziah Malm4, 
Edwin Afari5, Mamadou Sawadogo6, Samantha Herrera1, Elizabeth 
Ivanovich7, Yazoume Ye1
1ICF International, Rockville, MD, United States, 2President’s Malaria 
Initiative, U.S. Agency for International Development, Washington, DC, 
United States, 3Centre de Recherche en Santé de Nouna, Nouna, Burkina 
Faso, 4National Malaria Control Program, Accra, Ghana, 5University 
of Ghana, School of Public Health, Accra, Ghana, 6Université de 
Ouagadougou, Ouagadougou, Burkina Faso, 7United Nations Foundation, 
Washington, DC, United States
Malaria control interventions in most endemic countries have intensified 
in recent years and there is a need for robust monitoring and evaluation 
(M&E) systems to measure progress and achievements. Providing 
program and M&E officers with appropriate skills is a way to strengthen 
malaria’s M&E systems and enhance information use for programs’ 
implementation. From 2010 to 2015, capacity strengthening efforts 
included organizing regional in-person workshops for M&E of malaria 
programs for Anglophone and Francophone countries in sub-Sahara 
Africa in collaboration with academic institutions from Ghana and 
Burkina Faso. Open-sourced online courses were also available in English. 
A post-workshop assessment was conducted after five years to assess 
the effects of these regional workshops and identify gaps in capacity. 
The regional workshops trained two hundred and eighteen participants 
from 28 countries from 2010 to 2015. Trained participants were from 
ministries of health, national malaria control programs, non-governmental 
organizations, and development partners. The average score (%) for 
participants’ knowledge tests increased from pretest to posttest for the 
Anglophone workshops (2011: 59 vs. 76, 2012: 41 vs. 63, 2013: 51 vs. 
73; 2014: 50 vs. 74, 2015: 52 vs. 69). Similarly, Francophone workshop 
posttest scores increased, but were lower than Anglophone due to higher 
scores at pretest. (2011: 70 vs 76, 2012: 74 vs 79, 2013: 61 vs 68; 2014: 
64 vs 75, 2015: 70 vs 79). Results of the post-workshop assessment 
revealed that participants retained practical M&E knowledge and skills for 
malaria programs, but there is a need for a module on malaria surveillance 
adapted to the pre-elimination context. The workshops were successful 
because of the curriculum content, the facilitation quality, and the 
engagement of partner institutions with training expertise. Results from 
the post-workshop assessment will guide the curriculum’s development 
and restructuring for the next phase of workshops. Country-specific 
malaria M&E capacity needs assessments may also inform this process as 
countries reduce malaria burden.
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MAPPING MALARIA RESEARCH FOCUS, CAPACITY AND 
INTERNATIONAL COLLABORATION IN NIGERIA
Patricia Nkem Okorie1, Louise A. Kelly-Hope2
1Institute for Advanced Medical Research and Training, College of 
Medicine, University of Ibadan, Ibadan, Nigeria, 2Filarial Programmes 
Support Unit - Liverpool School of Tropical Medicine, Liverpool, United 
Kingdom
Nigeria has the highest burden of malaria globally with the entire 
population (est. 182 million) at risk of infection and disease. Nigeria is 
scaling up its efforts to control and eliminate malaria, which requires a 
wide range of country-specific technical support and scientific expertise 
for mapping, monitoring and evaluating, operational research and 
documenting programmatic impact and success. To better understand 
the distribution of skills and institutional capabilities that may provide 
programmatic support within Nigeria, this study aims to identify and 
map malaria research focus, areas of scientific capacity and international 
collaborative links by analyzing data from published scientific articles. 
Using electronic searches in online bibliographic archives, a systematic 
collation of articles from the past 5 years with at least one Nigerian-based 
author is being conducted. From this, a comprehensive geo-referenced 
database is being developed by categorizing key information including 
authors, institutions, location (i.e. state, zone, place), research type 
(i.e. molecular, parasitological, immunological, epidemiological and/or 
entomological), journal, journal impact factor, number and country of 
international collaborators and main sources of funding. To date, more 
than 400 articles on malaria research in Nigeria have been identified and 
being entered into the database. Maps will be presented on the number 
of articles, institutional type, and research focus with key collaborative 
networks and funding sources highlighted. The study will provide a useful 
resource for the national malaria programme as well as national and 
international scientists. It will highlight the current technical and scientific 
potential that could be maximized for programmatic purposes, and also 
provides a model approach that can be applied in other endemic counties.
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THE INCUBATION PERIOD OF MALARIA AMONGST 
TRAVELERS RETURNING TO THE UK
Amy Pinsent1, Usman Qureshi2, Christl Donnelly3, Geoffrey 
Pasvol3, Deirdre T. Hollingsworth2
1Monash University, Melbourne, Australia, 2University of Warwick, 
Coventry, United Kingdom, 3Imperial College London, London, United 
Kingdom
The introduction of imported cases of malaria to non-endemic countries 
remains an on-going concern for healthcare professionals. The United 
Kingdom (UK) alone continues to receive and treat ~ 1,500 cases of 
imported malaria each year. This number remained roughly constant 
between 2003 - 2013. Accurate quantification of the mean and variance 
of this key epidemiological parameter is essential to inform public health 
policy and specify case definitions. To reduce the risk of severe malaria and 
death associated with infection, rapid diagnosis has been demonstrated 
to be key for prevention. However, to date, few studies have estimated 
the incubation period of malaria collectively from a large number of 
individuals. Current UK guidelines available to the public suggest that the 
incubation period of malaria is approximately 7 -18 days. We use data 
on clinically confirmed cases of Plasmodium falciparum and Plasmodium 
vivax imported to the UK between 1991 - 2006. Amongst cases of in 
travellers arriving in the UK, onset of symptoms occurred within a mean of 
19 days after arrival for P. falciparum. For P. vivax the observed incubation 
period distribution was bimodal with the first peak of infections reported 
with a mean of 22 days, the data showed the classic second peak around 
265 days post infection for P. vivax. For a subset of cases, the use of anti-
malarials and less severe malaria infection lengthened the mean incubation 
period of  P. falciparum from 13.4 days, by 4 days and 5.1 days respectively 
in a multivariate regression model. For P. vivax our findings demonstrated 
that women had shorter incubation periods. Our findings highlight 
that while for some cases the incubation period falls within the current 
recommended guidelines, on average the reported estimated incubation 
period duration was longer, particularly for P. vivax.
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THE USE OF RESPONDENT-DRIVEN SAMPLING TO ASSESS 
MALARIA KNOWLEDGE, TREATMENT-SEEKING BEHAVIORS 
AND PREVENTIVE PRACTICES AMONG MOBILE AND 
MIGRANT POPULATIONS IN AN ARTEMISININ RESISTANCE 
SETTING IN WESTERN CAMBODIA
Sara E. Canavati1, Po Ly2, Julie Thwing3, Colleen McGinn4, 
Narann Top-Samphor4, Najibullah Habib4, Jack S. Richards5, Seshu 
Babu Vinjamuri2, Chea Nguon2
1Center for Biomedical Research, Burnet Institute, Phnom Penh, Cambodia, 
2The National Center For Parasitology, Entomology and Malaria Control, 
Ministry of Health., Phnom Penh, Cambodia, 3Malaria Branch, Division of 
Parasitic Disease and Malaria, Centers for Disease Control and Prevention, 
Atlanta, GA, United States, 4WHO Representative Office in Cambodia, 
Phnom Penh, Cambodia, 5Centre for Biomedical Research, Burnet Institute, 
Melbourne, Australia
The movement of populations within and between malaria-endemic 
regions is a major contributor to the spread of artemisinin resistance 
along the Cambodian borders. Mobile and migrant populations are poorly 
connected to public health and surveillance systems. Their high mobility 
makes them difficult to survey and reach with health interventions. The 
objective of this study was to determine knowledge of malaria, treatment-
seeking behaviours and preventive practices among migrant/mobile 
workers in Western Cambodia. A structured survey of mobile and migrant 
populations was implemented in two provinces of Western Cambodia 
along the Thai-Cambodian border using a Respondent Driven Sampling 
(RDS) approach. Results: There were 764 participants in Pailin and 737 in 
Veal Veng. Most respondents (93.7% in Pailin and 96.1% in Veal Veng) 
received health messages, predominantly on malaria. Knowledge of 
malaria transmission, prevention, and symptoms was found to be very 
high (94.4% in Pailin and 98.2% in Veal Veng); however, other beliefs 
persist, predominantly in Veal Veng (24.4% listed a dirty or unsanitary 
environment and 57.6% listed contaminated food or drink in Veal Veng). 
Knowledge of using a mosquito net was high (95.5% in Pailin and 99.1% 
in Veal Veng), however specific knowledge of the use of an insecticide 
treated bed net (ITN) for prevention was relatively low. Stated ownership 
of an ITN or treated hammock net was low (25.3% in Pailin and 53.2% 
in Veal Veng). Of those that took an antimalarial, greater than 60% used 
artemisisnin-based combination therapy (ACT) or atovaquone-proguanil. 
In conclusion, RDS sampling methodologies were used to effectively 
statistically robust data to evaluate malaria risk and to assess protective 
behaviours of this difficult-to-survey population. There is a need for 
sustained public health efforts to reach these populations within an 
elimination context. These findings are critical for informing strategies to 
more effectively deliver health services and promote behaviour change 
among a population at high risk for contracting and spreading artemisinin-
resistant malaria.
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LACK OF MORTALITY IN CHILDREN WITH SICKLE CELL 
DISEASE AND SEVERE MALARIAL ANEMIA WHO RECEIVE 
TIMELY BLOOD TRANSFUSION
Robert O. Opoka1, Paul Bangirana2, Estela Shabani3, Richard 
Idro1, Ruth Namazzi1, Andrea L. Conroy3, Chandy C. John3
1Department of Pediatrics, College of Health Sciences, Makerere University, 
Kampala, Uganda, 2Department of Psychiatry, College of Health Sciences, 
Makerere University, Kampala, Uganda, 3Ryan White Center for Pediatric 
Infectious Disease and Global Health, Indiana University School of 
Medicine, Indianapolis, IN, United States
Hemoglobin AS (sickle cell trait) has a strong protective effect against 
malaria, particularly severe malaria, but studies with small numbers of 
children with HbSS (sickle cell anemia, SCA) and severe malaria have 
suggested that children with SCA who develop severe malaria have a high 
mortality rate. To better characterize hematologic parameters and risk of 
mortality in children with SCA and severe malaria, we compared these 
factors according to HbS genotype (AA, AS, SS) in a cohort of children 
18 months – 12 years of age with severe malarial anemia (SMA, n= 184), 
cerebral malaria (CM, n= 213) or healthy community controls (CC, n= 
197). All children with SMA received blood transfusion. HbAS (41, 6.9%) 
was more frequent in CC (37, 18.8%) than in SMA (2, 1.1%) or CM (2, 
0.9%, P<0.001), confirming the protective effect of HbAS against severe 
malaria. HbSS (18, 3.0%) was more frequent in SMA (17, 9.2%) than 
CM (1, 0.5%, P<0.001). Among children with SMA, children with HbSS 
and HbAA had similar hemoglobin levels, but children with HbSS had a 
higher WBC count and lower parasite density (both P<0.001). There was 
no mortality in children with SMA, even in those with HbSS. Our findings 
show that SCA is a major risk factor for SMA in this population, but SCA 
is not associated with increased mortality in SMA if timely transfusion is 
available.
995
AGE- AND PREVALENCE-RELATED MALARIA INFECTION 
RISK AND TREATMENT BEHAVIOR: EVIDENCE FROM A 
HOUSEHOLD SURVEY IN UGANDA
Indrani Saran, Jessica Cohen
Harvard School of Public Health, Boston, MA, United States
In Sub-Saharan Africa, both under-treatment and over-treatment of 
malaria are common since illnesses are often diagnosed and treated on 
the basis of symptoms. Using data on fever treatment and malaria rapid 
diagnostic testing from 2,285 households in 92 villages in Uganda, we 
find that although households treated 40% of clinical malaria episodes 
with artemisinin-based combination therapies (ACTs)—the first-line, most 
effective, class of drugs for the disease—households also treated the 
same proportion of non-malarial febrile illnesses (Unadjusted Difference: 
-0.036, 95% CI: [-0.111 0.039], p=0.345). We show that both the age 
of the patient and the village prevalence rate are strongly associated 
with the probability that a febrile patient is infected with malaria: each 
additional age year is associated with a 0.6 percentage point decline in 
the probability of testing positive for malaria (95% CI: [-0.008 -0.005], 
P<0.001), and a one standard deviation increase in the village malaria 
prevalence rate is associated with a 13 percentage point increase in the 
probability that a febrile patient is infected with malaria (95% CI: [0.105 
0.154], P<0.001). However, ACT treatment rates for febrile illnesses 
are not significantly associated with either age (Unadjusted Coefficient: 
-0.001, 95% CI: [-0.003 0.001], P=0.180) or with standardized village 
malaria prevalence rates (Unadjusted Coefficient: -0.032, 95% CI: [-0.074 
0.009], P=0.121). We also present some evidence that whether a caregiver 
believes a febrile illness is malaria is unrelated to the febrile patient’s age 
and to the local prevalence rate, suggesting that information gaps on 
malaria risk may play a large role in the under-treatment of malaria.
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RELATIONSHIP BETWEEN THE PREVALENCE OF PARASITEMIA 
IN PREGNANT WOMEN AND CHILDREN: BIOKO ISLAND 
MALARIA INDICATOR SURVEY 2008-2015
Aveika A. Akum
Medical Care Development International, Silver Spring, MD, United States
Pregnant women have been one of the main targets in the efforts to 
control malaria and in some settings they are routinely screened and 
treated or provided anti malaria prophylaxes and also provided ITNs. 
Studies have indicated that they are more likely to have detectable malaria 
due to higher parasite densities. Prevalence in children (2-14 years) is 
one of the main standard measures used to monitor the outcomes and 
impacts of malaria control programs in moderate to high transmission 
areas. Pregnant women attend ANC and blood samples are routinely 
taken and could be used to screen for parasitemia, allowing for an insight 
into the monthly variation of the incidence of malaria without need for 
extra sampling. Knowing the relationship of the prevalence of malaria 
in children and pregnant women could have far reaching implication 
the various control interventions in terms of timeliness of data and the 
implementation of the routine MIS. Using 8 years data of the annual MIS 
Bioko islands of Equatorial Guinea from 2008-2015, the yearly prevalence 
of parasitemia in children and pregnant women was calculated and 
Pearson’s product-moment correlation was run to assess the relationship. 
Prevalence among children is relatively higher, there exist similar trends 
in the two groups; There was a very strong positive correlation between 
prevalence of the two groups r(6) =0.909, p < .002. In conclusion, ANC 
attendees can be used as a sentinel group to monitor malaria prevalence 
because they are readily available and show similar trends with the 
children whose malaria prevalence is a standard measure to estimate 
malaria endemicity. More importantly, there will be timely and seasonal 
data for decision making.
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ONE YEAR STABILITY ANALYSES OF PFS25-EPA AND PFS230-
EPA CONJUGATES ADJUVANTED WITH ALHYDROGEL®
Daming Zhu, Weili Dai, Holly McClellan, Katerina 
Christodoulides, Sarah Brockley, Lynn Lambert, Kelly Rausch, 
Patrick E. Duffy
Laboratory of Malaria Immunology and Vaccinology, Rockville, MD, United 
States
Plasmodium falciparum Pfs25 and Pfs230 proteins are important malaria 
transmission-blocking vaccine candidates. Pfs25 is expressed as a surface 
protein during zygote and ookinete stages in infected mosquito, while 
Pfs230 is expressed in gametocytes in the human host and on the surface 
of gametes in the mosquito host. To increase immunogenicity, the 
recombinant Pfs25 and domain 1 of Pfs230 (referred to as Pfs25M and 
Pfs230D1M) were conjugated to the recombinant, nontoxic Pseudomonas 
aeruginosa ExoProtein A (rEPA) in conformance with current good 
manufacturing practices (cGMP). The resultant clinical grade conjugates 
(Pfs25M-EPA and Pfs230D1M-EPA) were formulated on Alhydrogel at 78 
µg/mL for Pfs25M and 50 µg/mL for Pfs230D1M. To ensure the vaccines 
are in compliance with the regulatory specifications during the phase 
1 human clinical trial period, annual evaluation of these vaccines was 
performed. The one year stability analyses on the clinical lots included 
appearance, endotoxin content, sterility, strength (protein content tested 
by o-Phthaldialdehyde assay), identity (SDS-PAGE and Western blot after 
antigen extraction from Alhydrogel), integrity (pH, percent protein bound 
to Alhydrogel, SDS-PAGE, Intrinsic Fluorescence CD, Direct Alhydrogel 
Formulation Immunoassay), and efficacy (the mouse potency assay). Our 
results showed that the Drug Products Pfs25M-EPA and Pfs230D1M-EPA 
formulated on Alhydrogel are biochemically, biophysically, and biologically 
stable after storage for one year at 4oC. Thus, we conclude that sufficient 
stability of these candidates supports further studies in human clinical 
trials.
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LONG TERM IMMUNE RESPONSES INDUCED AGAINST 
PLASMODIUM VIVAX CSP AND MSP-1 CHIMERIC VACCINE 
CANDIDATES DELIVERED BY NOVEL ADENOVIRAL VECTORS
Jessica N. McCaffery1, Jairo A. Fonseca1, Igor Dmitriev2, David 
Curiel2, Alberto Moreno1
1Emory University, Atlanta, GA, United States, 2Washington University 
School of Medicine, St. Louis, MO, United States
Protection against malaria based on pre-erythrocytic and erythrocytic 
antigens depends on IFN-γ production by CD4 and CD8 T cells. Adenoviral 
vectors have been used to induce robust cellular immune responses in 
recent malaria vaccine clinical trials and reports indicate that adenoviruses 
are capable of long periods of transgene expression, a desirable for 
malaria vaccines since immune responses lasting several transmission 
cycles are necessary to exert a substantial effect on disease incidence. To 
test the durability of the immune responses induced by adenoviral vectors 
encoding a multistage Plasmodium vivax chimeric protein vaccine including 
promiscuous T cell and B cell epitopes from the circumsporozoite protein 
(CSP) and merozoite surface protein-1 (MSP-1), we primed BALB/c mice 
with one of two different recombinant adenoviral vectors and assessed 
their immune responses and ability to induce memory T cells by boosting 
the mice one year post priming. We found that mice immunized with 
the recombinant proteins or one of the two protein-encoding adenoviral 
vectors - Simian Adenovirus 36 (SAd36) or a recombinant human 
adenovirus 5 modified to contain the fiber-knob region of adenovirus 
serotype 3 (Ad5/3) - displayed no significant decrease in antibody titers 
against the CSP and MSP-1 protein chimeras when antibody titers were 
compared between day 20 and 1 year post priming. We subsequently 
boosted mice with the heterologous adenoviral vector 1 year post 
priming, followed by two protein boosts 20 and 40 days later. We found 
that in comparison to mice receiving only protein immunizations, both 
heterologous adenoviral regimens induced CD4 and CD8 T cells capable of 
producing higher levels of IFN-γ, IL-2, and TNF-α upon ex vivo stimulation 
with the MSP-1 or CSP chimeric recombinant proteins or peptide pools 
representing T or B cell epitopes derived from these chimeric proteins. 
Taken together, the data demonstrate that our novel multistage malaria 
vaccine is able to induce long lasting humoral and cellular immune 
responses able to recognize two different Plasmodium antigens when 
delivered by a regimen that includes adenoviral vectors.
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A HYBRID PLASMODIUM VIVAX BLOOD STAGE-
TRANSMISSION BLOCKING VACCINE CANDIDATE ELICITS 
ROBUST CELLULAR IMMUNE RESPONSES AND LONG-LIVED 
FUNCTIONAL ANTIBODIES
Jairo A. Fonseca1, Balwan Singh1, Caitlin Bohannon1, Monica 
Cabrera-Mora1, Joshy Jacob1, Myriam Arevalo-Herrera2, Alberto 
Moreno1
1Emory Vaccine Center, Atlanta, GA, United States, 2Caucaseco Scientific 
Research Center, Malaria Vaccine and Drug Development Center (MVDC), 
Cali, Colombia
Malaria control efforts focused on the use of vector based interventions 
have resulted in a significant reduction of Plasmodium falciparum cases. 
Unfortunately, the unique biological features of P. vivax make vector 
control interventions ineffective against this parasite. Transmission Blocking 
Vaccines (TBVs) are considered the best alternative for achieving malaria 
control as antibodies induced by TBVs taken up by the mosquito during 
the blood meal interrupt parasite development. However, a major concern 
for post-fertilization TBVs is a short lived antibody response as the human 
host is not exposed to these mosquito stage antigens, needed to induce 
a natural boosting effect. A transmission blocking formulation could 
also result in low compliance since it would not be protective against the 
disease. To address these problems, we designed a multistage chimeric 
vaccine denominated P. vivax erythrocytic stage-transmission blocking 
chimera (PvES-TBC). This vaccine candidate includes 5 promiscuous 
T helper cell epitopes derived from the erythrocytic antigen MSP-1 
which were genetically linked to the MSP-1 19kDa fragment and to the 
transmission blocking antigen Pvs25. PvES-TBC was tested in comparative 
experiments with Pvs25 in mice. PvES-TBC induced a strong cellular and 
humoral immunity able to recognize both MSP-1 and Pvs25. Additionally, 
when compared to Pvs25, PvES-TBC elicited a more robust antibody 
response as determined by a significantly higher avidity and a bias toward 
IgG2a production. This response was determined to last for a period 
longer than 2 years after the final boosting in mice immunized with PvES-
TBC, an effect not observed in the Pvs25 group. The long lasting response 
was related to a significantly higher proportion of long lived plasma cells 
in mice immunized with PvES-TBC. When the transmission blocking ability 
of antibodies was tested by membrane feeding assays using wild P. vivax 
isolates, the antibodies produced in response to PvES-TBC were able to 
block 90% of mosquito infections. These characteristics make PvES-TBC 
a promising transmission blocking vaccine candidate that warrants clinical 
development.
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SAFETY AND IMMUNOGENICITY OF THE NOVEL 
PLASMODIUM FALCIPARUM BLOOD-STAGE VACCINE 
CHAD63-MVA RH5 IN A PHASE IA CLINICAL TRIAL
Ruth Payne1, Sarah E. Silk1, Sean C. Elias1, Kazutoyo Miura2, 
Ababacar Diouf2, Daniel G. Alanine1, Jing Jin1, Genevieve M. 
Labbe1, Iona J. Brian1, Ian D. Poulton1, Oliver Griffiths1, Nick J. 
Edwards1, Eleanor Berrie3, Loredana Siani4, Alexander D. Douglas1, 
Rachel Roberts1, Johan Vekemans5, Fay Nugent1, Adrian V. Hill1, 
Carole A. Long2, Alison M. Lawrie1, Simon J. Draper1
1University of Oxford, Oxford, United Kingdom, 2Laboratory of Malaria 
and Vector Research, National Institute of Allergy and Infectious Diseases/
National Institutes of Health, Bethesda, MD, United States, 3Clinical 
Biomanufacturing Facility, Oxford, United Kingdom, 4Reithera Srl, Rome, 
Italy, 5GSK Vaccines, Rixensart, Belgium
The development of an effective malaria vaccine remains a vital goal 
if eradication is likely to be achieved. Candidate antigens for blood-
stage Plasmodium falciparum vaccines have been hampered with issues 
of polymorphism and the need to induce extremely high antibody 
concentrations for these vaccines to be effective. The reticulocyte-
binding protein homologue 5 (RH5) is the most promising blood-stage P. 
falciparum candidate antigen to date. It is essential for parasite survival 
and erythrocyte invasion and, unlike other blood-stage antigens (e.g. 
AMA1 and MSP1) RH5 does not appear to come under significant 
immune pressure in endemic settings, and there is limited polymorphism. 
Vaccination with an RH5-based vaccine confers protection against 
malaria challenge in non-human primates and the antibodies induced 
by vaccination are able to cross-inhibit in vitro all P. falciparum isolates 
tested to date. We report on a first-in-human Phase Ia clinical trial 
(NCT02181088) of an RH5-based vaccine delivered using the viral vectors 
chimpanzee adenovirus serotype 63 (ChAd63) and modified vaccinia 
virus Ankara (MVA) in a heterologous prime-boost strategy. The trial was 
conducted in Oxford and Southampton, United Kingdom and recruited 
twenty-four healthy, malaria-naïve volunteers aged 18-50. The first four 
volunteers (Group 1) received a lead-in dose (5 x 109 viral particles, vp) of 
the ChAd63 RH5 vaccine alone before dose escalation to the full dose (5 x 
1010 vp) in Group 2. The first four volunteers in Group 2 received ChAd63 
alone, and the final sixteen were boosted with MVA RH5 eight weeks 
after ChAd63 RH5 at doses of 1 – 2 x 108 plaque-forming units, pfu. Data 
on all adverse events were recorded for 28 days after each vaccination 
and serious adverse event (SAE) data were collected for the duration of 
the study. This is the first RH5-based vaccine to be tested in humans. The 
vaccines were well tolerated, with no safety concerns and there were 
no SAEs. T cell and serum antibody responses were assessed by ex-vivo 
interferon-γ ELISpot, ELISA and in vitro growth inhibition activity (GIA) 
assays. The vaccines were immunogenic and these data will be presented.
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ENHANCED PROTECTIVE EFFICACY OF A PLASMODIUM 
FALCIPARUM MALARIA VACCINE USING A HETEROLOGOUS 
PRIME-BOOST IMMUNIZATION WITH A BACULOVIRAL 
VACCINE AND CHAD63 EXPRESSING PFCSP AGAINST 
CHALLENGE WITH TRANSGENIC P. BERGHEI SPOROZOITES
Kunitaka Yoshida1, Ahmed M. Salman2, Pawan Dulal2, Shahid M. 
Khan3, Chris J. Janse3, Sumi Biswas2, Masaharu Tokoro1, Mitsuhiro 
Iyori4, Shigeto Yoshida4, Adrian V. S. Hill2
1Kanazawa University Graduate School of Medical Sciences, Kanazawa, 
Japan, 2The Jenner Institute, University of Oxford, Oxford, United 
Kingdom, 3Leiden Malaria Research Group (LMRG), LUMC, Leiden, 
Netherlands, 4Kanazawa University School of Pharmacy, Kanazawa, Japan
We have recently developed a new vaccine platform system based on 
the baculovirus Autographa californica nucleopolyhedrosis virus (AcNPV) 
called the baculovirus dual-expression system (BDES). BDES is capable of 
displaying an antigen on the viral envelope by the use of a baculovirus-
derived polyhedrin promoter and expressing it upon transduction 
of mammalian cells by cytomegalovirus (CMV) promoter and so can 
function as both a vaccine component and a DNA vaccine, respectively. 
In our study, a heterologous prime-boost immunization regime using the 
newly-developed BDES vaccine and the clinically relevant recombinant 
chimpanzee adenovirus 63 (ChAd63) expressing the Plasmodium 
falciparum CSP (PfCSP) transgene was assessed for its protective efficacy 
and immunogenicity in a mouse model, using a rodent malaria P. berghei 
chimeric parasite expressing PfCSP as in vivo challenge model. We 
performed a series of animal experiments to evaluate protective efficacy 
of the heterologous immunization regime. BALB/c mice were primed with 
ChAd63 and boosted with BDES, and then challenged by intravenous 
injection of 1,000 P. berghei chimeric sporozoites. ChAd63-BDES 
immunization elicited higher protection than BDES alone with statistical 
difference. Assessment of immunological analysis is ongoing to find the 
relationship between immunogenicity and protective efficacy. These 
findings serve to inform us new insight to develop a new malaria vaccine 
using the ChAd63-BDES platform.
1002
CRYOPRESERVATION RELATED LOSS OF ANTIGEN SPECIFIC 
IFNγ PRODUCING CD4+ T-CELLS: LESSONS FROM A MALARIA 
VACCINE TRIAL SUBSTUDY
Tom P. Ford1, Claire Wenden1, Alison Mbekeani1, Len Dally2, 
Josephine H. Cox3, Nicola Winstone1, Jill W. Gilmour3, Adrian V. 
Hill4, Katie J. Ewer4
1IAVI-Human Immunology Laboratory, Imperial College London, London, 
United Kingdom, 2The EMMES Corporation, Rockville, MD, United States, 
3IAVI-Human Immunology Laboratory, Imperial College London, New York, 
NY, United States, 4The Jenner Institute, University of Oxford, Oxford, 
United Kingdom
Ex vivo functional immunoassays such as ELISpot and intracellular cytokine 
staining (ICS) by flow cytometry are crucial tools in vaccine development 
both in the identification of novel immunogenic targets and in the 
immunological assessment of samples from clinical trials. Cryopreservation 
and consequent thawing of PBMCs via validated processes has become 
a mainstay of clinical trials due to processing restrictions inherent in the 
disparate location and capacity of trial centres and also in the logistical 
and financial requirement to batch process samples from multiple study 
timepoints. Using ELISpot and ICS assays to assess antigen specific 
immunogenicity in blood samples taken from subjects enrolled in a phase 
II malaria heterologous prime-boost vaccine trial, this study has shown 
that the freeze thaw process can result in a 3-5 fold reduction of malaria 
antigen specific IFNγ producing CD3+CD4+ effector populations from 
PBMC samples taken post vaccination. We have also demonstrated that it 
is likely that peptide responsive CD3+CD8+ T-cells are relatively unaffected 
as well as more persistent CD3+CD4+ populations that do not produce 
IFNγ. These findings contribute to a growing body of data that could be 
consolidated and synthesised as guidelines for clinical trials with the aim of 
improving the analysis of vaccine candidates.
1003
RTS,S MALARIA VACCINE EFFICACY DOES NOT VARY WITH 
SEASONAL PRECIPITATION: RESULTS FROM LILONGWE, 
MALAWI
Larry Han1, Michael Hudgens1, Michael Emch1, Cory Keeler1, 
Jonathan Juliano1, Francis Martinson2, Portia Kathmunzi2, Gerald 
Tegha2, Irving Hoffman1
1University of North Carolina Chapel Hill, Chapel Hill, NC, United States, 
2UNC Project Tidziwe Center, Lilongwe, Malawi
Phase 3 trials of the efficacy and safety of the candidate malaria vaccine 
RTS,S are complete, but site-specific data are limited. This study assesses 
the interaction of precipitation and vaccine efficacy and corresponding 
estimates of clinical malaria episodes averted in a seasonal-transmission 
region of sub-Saharan Africa. We followed children (5-17 months of 
age) and infants (6-12 weeks of age) who were randomly assigned to 
a vaccine group, vaccine with booster group, or control group. Primary 
efficacy was defined as development of clinical malaria (fever ≥37.5°C 
and  P. falciparum parasitemia >5,000 per microliter). Precipitation data 
were obtained from the Chitedze Agricultural Center in Lilongwe. Cox 
proportional hazards models were used to assess time until first malaria 
case. Effect modification was assessed by including interaction terms for 
vaccination status and precipitation. Vaccine efficacy against multiple 
malaria cases was estimated using negative binomial regression. Over the 
duration of follow-up, 744 of 1513 (49.1%) children and infants had at 
least 1 case of clinical malaria. Among children, vaccine efficacies were 
42.7% (95% CI 25.7%, 55.8%, p<0.001) for the vaccine with booster 
group and 33.1% (95% CI 14.5%, 47.7%, p=0.001) for the vaccine 
group for first malaria case. Precipitation was significantly associated 
with increased malaria incidence, with each 1-inch increase in rainfall 
per month elevating the hazard of malaria by 12.6% (95% CI 9.6%, 
15.6%, p<0.001) among children. There was no evidence of modification 
of vaccine efficacy by precipitation (p=0.85). The estimated numbers 
of cases averted were 9.4 (95% CI 2.5, 11.3) per 100 children per year 
in the vaccine group and 17.7 (95% CI 4.6, 32.0) in the vaccine with 
booster group, compared to the control group. In Malawi, an area of 
malaria mesoendemic, seasonal transmission, RTS,S vaccine efficacy was 
not modified by seasonal variation in precipitation. The WHO has selected 
Malawi as one of the sites to pilot roll-out of RTS,S to children. Our 
findings could be used by program implementers to help determine the 
most effective roll-out strategies.
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ANALYSIS OF THE CELLULAR IMMUNE RESPONSE IN 
C57BL/6 MICE TO FMP014 - A SELF-ASSEMBLING PROTEIN 
NANOPARTICLE BASED MALARIA VACCINE - DELIVERED IN 
ALF ADJUVANTS
Casey K. Storme1, Stephen A. Kaba1, Labdhi Seth1, Gary Matyas2, 
Zoltan Beck1, Carl Alving2, Peter Burkhard3, David Lanar2
1Henry M. Jackson Foundation for the Advancement of Military Medicine, 
Silver Spring, MD, United States, 2Walter Reed Army Institute of Research, 
Silver Spring, MD, United States, 3Alpha-O Peptides AG, Riehen, 
Switzerland
In the past decade, new developments in particle based vaccines and 
adjuvant systems have improved antigen presentation and immune system 
stimulation. These particle based vaccine platforms show great potential 
due to their ability to present high-density repetitive epitopes on the 
surface of the particle, which facilitates the presentation and processing of 
antigens by the innate and adaptive immune system. We have previously 
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reported promising results with the use of a self-assembling protein 
nanoparticle (SAPN) malaria vaccine that displays epitopes from the 
Plasmodium falciparum circumspozorzoite protein (PfCSP). These studies 
have shown that this vaccine platform induced long-lived and protective 
immune responses against infection in a mouse model incorporating an 
otherwise lethal challenge with a transgenic P. berghei parasite containing 
the full-length PfCSP gene (Tg-Pb/PfCSP). We have made additional 
modification of the PfCSP based SAPN particle and produced under 
cGMP conditions the falciparum malaria protein 14 (FMP014). FMP014 
contains improved antigenic display of the αTSR and NANP repeat regions 
in addition to several CD4+, CD8+ and universal TH epitopes. We have 
combined the FMP014 antigen with several new liposome based adjuvant 
formulations referred to as ALF or Army Liposome Formulation. We have 
examined various FMP014/ALF vaccines with and without the addition 
of the aluminum hydroxide Alhydrogel® and the saponin QS21. These 
formulations produce strong humoral, cellular and protective immune 
responses in C57Bl/6 mice. Here we report on the cellular analysis of 
the FMP014/ALF vaccine formulations as determined by flow cytometry, 
ELISpot and multiplex cytokine arrays (Mesoscale Discovery). The 
FMP014/ALF vaccine formulations are currently undergoing safety and 
immunogenicity evaluation in non-human primates and are expected to 
enter a phase 1/2a study followed by a controlled human malaria infection 
(CHMI) challenge in 2017.
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ANTIBODY RESPONSES TO VACCINATION WITH 
PLASMODIUM FALCIPARUM APICAL MEMBRANE 
ANTIGEN 1 ARE BIASED TOWARD THREE CONSERVED 
IMMUNODOMINANT EPITOPES AND DO NOT MIMIC THOSE 
TO NATURAL INFECTION
Jason A. Bailey1, Andrew Pike1, Mark A. Travassos1, Amed 
Ouattara1, Shannon Takala-Harrison1, John Tan2, Jigar J. 
Patel2, Matt B. Laurens1, Drissa Coulibaly3, Amadou Niangaly3, 
Bourema Kouriba3, Issa Diarra3, Modibo Daou3, Philip L. Felgner4, 
Ogobara K. Doumbo3, Mahamadou A. Thera3, Andrea A. Berry1, 
Christopher V. Plowe1
1Institute for Global Health, Division of Malaria Research, Baltimore, 
MD, United States, 2Roche NimbleGen Inc., Madison, WI, United States, 
3Malaria Research and Training Center, University of Science, Techniques, 
and Technology, Bamako, Mali, 4Division of Infectious Diseases, 
Department of Medicine, University of California Irvine, Irvine, CA, United 
States
Plasmodium falciparum apical membrane antigen 1 (AMA1) is a highly 
polymorphic blood stage malaria vaccine antigen. The AMA1 subunit 
vaccine FMP2.1/AS02A, tested in a Phase 2 clinical trial in Bandiagara 
Mali, elicited strong antibody responses, but limited and strain-specific 
protective efficacy against clinical malaria. When sera from FMP2.1-
vaccinated children was probed on a whole-protein microarray containing 
263 variants of the AMA1 ectodomain, anti-AMA1 antibody titers 
increased several-fold, regardless of AMA1 sequence. We hypothesized 
that the vaccine was biased towards cross-reactive, highly immunogenic 
epitopes that saturated the signal, obfuscating the smaller, strain-specific, 
response. To test this, we used sera from 20 of the same Malian children 
before and 90 days after AMA1 or control vaccination to probe a diversity-
reflecting, ultra-dense, small linear peptide array, created using the 
same AMA1 sequences as the whole protein array, and an additional 68 
AMA1 sequences derived from publically-available databases. The array 
was constructed using unique 16 amino acid long peptides covering the 
entire length of AMA1 and overlapping by 15 amino acids. Sera from 
AMA1-vaccinated children showed an increase in antibody titers at three 
conserved epitopes several-fold higher than control sera over the same 
time period. Sera from controls who experienced symptomatic malaria 
illness during the 90 days of follow-up had elevated titers of antibodies 
targeting different AMA1 epitopes; including epitopes that fell outside 
the AMA1 vaccine sequence. The high and broad vaccine-induced 
seroreactivity seen on the whole-ectodomain protein microarray can 
be attributed to three conserved and cross-reactive immune-dominant 
epitopes identified by the peptide array. While seroreactivity to tiled, linear 
peptides may not pinpoint the location of functional conformational 
epitopes, it may be useful to test whether the patterns acquired after 
malaria parasite exposure match antibody signatures generated by 
vaccines.
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LESSONS LEARNED FROM THE MANAGEMENT OF THE 
INVESTIGATIONAL PRODUCT DURING PHASES 1B &2B 
MALARIA VACCINES TRIAL IN BURKINA FASO
Edith C. Bougouma, Adama Gansane, Alphonse Ouedraogo, 
Issiaka Soulama, Jean Baptiste Yaro, Alfred B. Tiono, Sodiomon 
Sirima
Centre National de Recherche et de Formation sur le Paludisme, 
Ouagadougou, Burkina Faso
An effective malaria vaccine will be a powerful tool that will contribute to 
reduce malaria burden. We report here experiences gathered in managing 
investigational product during many vaccines trial in CNRFP. All the trials 
were double-blind randomized controlled and have involved in total 925 
children and 75 adults who have received three doses of either the malaria 
vaccine candidate or the control. The main storage of study vaccines was 
in CNRFP headquarters with frequent shipments to the two field sites, 
namely Balonghin and Banfora located respectively at around 45 minutes 
and 6 hours drive where participants were immunized. More than 2000 
doses of malaria vaccine and 4000 doses of control were received from 
the various sponsors. Logistical constraints were increased since in some 
trials, the two vaccines required different condition of storage: Between 
+2°C and 8°C for control and - 65°C or -20°C for the malaria vaccine. 
In addition, the two vaccines were different in colours. Strategies for 
masking were used to keep the blinding for the subject and the vaccinator. 
We have experienced three temperature deviations of a cumulative 
duration of 13 hours. Main causes of deviation were material failure and 
power failure. Vaccines quality was not affected. More than 3500 doses 
were given with less than 3% of doses lost. In conclusion, despite many 
challenges, it was possible to ensure that vaccines were managed in 
accordance with international standards that protect the safety and well-
being of trial participant in an African setting with resources limitation 
constraints.
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BIVALENT CONJUGATE VACCINE TO BLOCK MALARIA 
TRANSMISSION AND TYPHOID FEVER
SoJung An, Emma Barnafo, Beth Chen, Christopher Rowe, 
Charles Anderson, Olga Muratova, Sarah Brockley, Lynn Lambert, 
Kelly Rausch, David Narum, Patrick E. Duffy, Puthupparampil 
Scaria
Laboratory of Malaria Immunology and Vaccinology/National Institute of 
Allergy and Infectious Diseases, Rockville, MD, United States
Conjugation of bacterial polysaccharide to a carrier protein is an effective 
tool to overcome poor immunogenicity of polysaccharide vaccines and to 
transform the T-cell independent immune response to T cell dependent 
one. Recent studies evaluating conjugates of Vi polysaccharide from 
Salmonella Typhi (Vi) to carrier proteins revealed the remarkable finding 
that conjugation to Vi may enhance immunogenicity of proteins in 
certain instances. Based on this observation, we have explored the 
possibility of generating a bivalent vaccine against malaria and typhoid 
fever, two diseases co-endemic in many parts of the world with high 
levels of morbidity and mortality, by conjugating malaria antigens to Vi, 
an approved vaccine for typhoid fever. A malaria Transmission Blocking 
Vaccine (TBV) that targets the mosquito stages of the parasite is being 
pursued as a product to interrupt transmission and contribute to 
elimination. Our laboratory has been evaluating a number of TBV antigens 
as chemical conjugates with protein carriers to enhance immunogenicity. 
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Here we describe our efforts to develop a bivalent vaccine consisting of 
TBV antigen conjugated to Vi to block malaria transmission and typhoid 
fever. We synthesized a number of conjugates of Vi polysaccharide with 
Pfs25, a TBV antigen, and evaluated their immunogenicity in mice. Our 
results showed that chemical conjugation results in enhancement of 
antibody responses against both Vi polysaccharide and Pfs25 compared 
to un-conjugated Vi and Pfs25. This increase in antibody titer was also 
found to be dependent on the conjugation method used for the synthesis. 
Functional studies using Standard Membrane Feed Assay showed 
enhancement of functional activity consistent with the increase in antibody 
titer. This Vi-malaria antigen conjugate concept will be further developed 
and tested for efficacy in other animal models as well as in human clinical 
trials if warranted.
1008
IMPACT OF THE ADDITION OF A SIGNAL SEQUENCE ON 
THE IMMUNOGENICITY OF A MULTI-STAGE VACCINE 
AGAINST PLASMODIUM VIVAX DELIVERED BY A NOVEL 
RECOMBINANT SIMIAN ADENOVIRUS VECTOR
Juan Caceres1, Jairo A. Fonseca1, Monica Cabrera-Mora1, Igor 
Dimitriev2, David Curiel2, Alberto Moreno1
1Emory University, Atlanta, GA, United States, 2Washington University in 
St. Louis, St. Louis, MO, United States
Plasmodium infections still pose a serious threat to public health 
worldwide. Several vaccine candidates have been tested but none of the 
formulations has been able to induce both robust cellular and humoral 
responses. Here, we describe a proof-of-concept study testing the effect 
of the inclusion of the signal peptide leader sequence, derived from 
the murine immunoglobulin kappa light chain, on the immunogenicity 
of a multistage malaria vaccine delivered as a transgene using the 
simian adenoviral vector serotype 36 (SAd36). The adenoviral transgene 
included the signal sequence in frame with the coding sequences of 
two P. vivax chimeric recombinant proteins previously developed by our 
group: PvRMC-CSP and PvRMC-MSP1, which targets the pre-erythrocytic 
antigen circumsporozoite protein (CSP) and the erythrocytic stage antigen 
merozoite surface protein 1 (MSP-1) respectively. Comparative experiments 
were conducted in mice using the recombinant vectors with, or without 
the signal sequence and heterologous adenoviral prime-protein boost 
regimens. Mice immunized with the adenoviral vector that included 
the signal sequence exhibited significantly higher antibody titers after 
the priming and significantly higher levels of IgG2a when compared 
to mice receiving the adenoviral vector without the signal sequence. 
The cellular response was also improved by the addition of the signal 
sequence as T cells produced higher levels of IFN-γ, TNF-α, and IL-2 upon 
ex vivo stimulation with the P. vivax chimeric proteins. Overall, our results 
demonstrate that the addition of a signal sequence is able to increase the 
immunogenicity of malaria vaccines delivered through adenoviral vectors.
1009
ANTIBODY RESPONSES TO HEPATITIS B SURFACE ANTIGEN 
FOLLOWING ADMINISTRATION OF RTS,S/ASO1E TO HIV- 
INFECTED AFRICAN INFANTS AND CHILDREN
Valentine C. Sing’oei1, Lucas Otieno1, Martina Oneko2, Walter 
Otieno1, Joseph Abuodha2, Chris Odero2, Yolanda Mendoza3, Ben 
Andagalu1, Nobert Owino2, Karen Ivinson4, Nekoye Otsyula1, Maria 
Oziemkowska2, Allan Otieno1, Kephas Otieno2, Jessica Cowden1, 
Simon Kariuki2, Janet Oyieko1, Laurence Slutsker5, Marc Lievens3, 
Bernhards Ogutu1, Mary J. Hamel2
1Kenya Medical Research Intitute/United States Army Medical Research 
Directorate/Walter Reed Project, Kisumu, Kenya, 2Kenya Medical Research 
Institute/Centers for Disease Control and Prevention, Kisumu, Kenya, 
3GlaxoSmithKline, Wavre, Belgium, 4PATH Malaria Vaccine Initiative, 
Washington, WA, United States, 5Division of Parasitic Diseases and 
Malaria, U.S. Centers for Disease Control and Prevention, Atlanta, GA, 
United States
The RTS, S/AS01E malaria vaccine has been evaluated for efficacy, safety 
and immunogenicity in infants and children in sub-Saharan Africa. It 
consists of sequences of the circumsporozoite (CS) protein and hepatitis 
B surface antigen (HBsAg), making it also a hepatitis B vaccine. During 
a Phase III trial(NCT01148459) conducted at two centers in Kenya 
from July 2010 to May 2013, the vaccine was evaluated for safety and 
immunogenicity against the CS protein and HBsAg. Two hundred infants 
and children aged 6 weeks to 17 months who had HIV stage 1 or 2 
disease, were randomized in a ratio of 1:1 to receive either the RTS,S/
AS01E or rabies control vaccine each administered in 3 doses 1 month 
apart. Study participants received Hepatitis B vaccine prior to or during the 
study according to the Kenya vaccination schedule where it is administered 
at 6, 10 and 14 weeks of age. Anti-HBs antibody titers were measured 
prior to vaccination, 1 month post Dose 3 and 12 months post Dose 3 
and the percentage of subjects with seroprotective levels of anti-HBs (10 
mIU/ml and 100 mIU/ml) determined. Based on a threshold of 10mlU/ml, 
at baseline 57.1% (95%CI: 45.4-68.4) of individuals on the RTS,S/AS01E 
arm and 54.8% (95%CI: 42.7-66.5) of individuals on the rabies vaccine 
arm had seroprotective titers of anti-HBs with anti-HBs Geometric Mean 
Titers (GMTs) of 24.1 mIU/ml ( RTS,S/AS01E arm) and 19.2 mIU/ml( rabies 
arm). One month post-dose 3, 100% (95%CI: 95.1-100) of subjects in 
the RTS,S/AS01E arm and 52.3% (95%CI: 39.5-64.9) in the rabies arm 
were seroprotected for anti-HBs with anti-HBs GMTs of 13,637.6 mIU/ml 
( RTS,S/AS01E arm) and 19.9 mIU/ml (rabies arm). Twelve months post-
dose 3, 100% (95%CI: 94.9-100) of subjects in the RTS,S/AS01E arm 
and 39.1% (95%CI: 27.1-52.1) in the rabies arm were seroprotected for 
anti-HBs with anti-HBs GMTs of 2,294.8 mIU/ml(RTS,S/AS01 arm) and 
11.8 mIU/ml (rabies arm).The RTS,S/ASO1E malaria vaccine generated a 
strong immune response to Hepatitis B Surface antigen. Therefore, it could 
have the additional benefit of providing protection against Hepatitis B to 
children who have not been fully protected through routine vaccination 
programmes.
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A CLINICAL TRIAL TO EVALUATE THE SAFETY AND 
INFECTIVITY OF DIRECT VENOUS INOCULATION OF ASEPTIC, 
PURIFIED, CRYOPRESERVED PLASMODIUM FALCIPARUM 
(7G8 AND NF54) SPOROZOITES IN MALARIA-NAÏVE ADULTS 
IN BALTIMORE, USA
Matthew B. Laurens1, Andrea A. Berry1, Mark A. Travassos1, 
Kathy A. Strauss1, Matthew Adams1, Biraj Shrestha1, Tao 
Li2, Abraham Eappen2, Anita Manoj2, Yonas Abebe2, Tooba 
Murshedkar2, Anusha Gunasekera2, Thomas L. Richie2, Kirsten E. 
Lyke1, Christopher V. Plowe1, B Kim Lee Sim3, Stephen L. Hoffman2
1Division of Malaria Research, Institute for Global Health, University of 
Maryland School of Medicine, Baltimore, MD, United States, 2Sanaria, 
Inc., Rockville, MD, United States, 3Protein Potential, Rockville, MD, United 
States
Controlled human malaria infection (CHMI) by the bites of infected 
Anopheles mosquitoes is a safe and reproducible method to assess 
malaria vaccine and drug efficacy, but requires considerable capital 
and labor investment. Direct venous injection (DVI) of aseptic, purified, 
cryopreserved Plasmodium falciparum (Pf) NF54 sporozoites (SPZ) (Sanaria® 
PfSPZ Challenge) closely mimics CHMI by mosquito bite, simplifying 
malaria vaccine and therapeutics testing. As multiple, genetically diverse 
Plasmodium strains with varying susceptibility to antimalarial drugs 
circulate in endemic areas, testing malaria vaccines and therapeutics 
using a single parasite strain is not optimal. Development of additional 
strains for CHMI by DVI would facilitate vaccine and therapeutics testing 
against parasites that represent strains circulating in nature and that 
are heterologous to vaccine strains. Pf7G8 is a Brazilian strain with a 
divergent genomic sequence from PfNF54. Unlike PfNF54, Pf7G8 parasites 
are resistant to chloroquine, but both are susceptible to atovaquone-
proguanil. This single center, randomized controlled human study aims to 
identify the dose of Pf7G8 SPZ administered by DVI that achieves 100% 
infection rates. Thirty-six participants will be randomized to one of five 
groups. Four groups receive escalating doses of Pf7G8 (800, 1600, 3200 
and 4800 SPZ) and one control group receives standard dose PfNF54 
that infects 100% of malaria-naïve participants (3200 SPZ). Participants 
will be monitored clinically and malaria positivity will be determined by 
qPCR. Study objectives compare increasing doses of 7G8 versus NF54 with 
respect to safety and reactogenicity, infectivity, and time to patency. The 
study is planned for summer 2016 and initial results will be presented. This 
clinical trial will serve to standardize optimization testing of other strains 
slated for CHMI by DVI.
1011
EVALUATION OF THE SAFETY AND IMMUNOGENICITY OF 
NANOPARTICLE FORMULATIONS WITH RECOMBINANT 
PLASMODIUM FALCIPARUM TRANSMISSION-BLOCKING 
ANTIGEN PFS25
Zahra Heidari1, Robert Hart1, Grace Ledet2, Richard Graves2, Paresh 
C. Ray3, Tarun Mandal2, Nirbhay Kumar1, Geetha P. Bansal1
1Tulane University, New Orleans, LA, United States, 2Xavier University, New 
Orleans, LA, United States, 3Jackson State University, Jackson, MS, United 
States
An important consideration for vaccine development is the identification 
of an appropriate adjuvant, which is capable of eliciting an optimal 
protective immune response without raising any safety concerns. The 
objective of this work was to screen various nanoadjuvants and to 
evaluate the toxicity and immunopotentiating ability in vitro and in vivo. 
We compared Alum, nanoemulsions (NE), poly (lactic-co-glycolic acid) 
(PLGA), gold nanospheres (GNP) and gold nanoprism (GNPR) formulated 
with a malaria vaccine candidate, CHrPfs25, which has been extensively 
investigated in our lab. We assessed in vitro cytotoxicity using human 
monocytic cell line (THP-1, bone marrow derived dendritic cells (BMDC) 
and hepatic carcinoma cell line (HepG2). Cells were exposed to the 
nanoadjuvanted vaccine for 24h, and an MTT assay was used to assess the 
viability of cells. THP-1 and BMDC did not demonstrate any cytotoxicity. 
HepG2 cells showed varying levels of mild cytotoxicity. GNP was most 
the biocompatible and PLGA exhibited more cytotoxicity. CHrPfs25 
formulated with different nanoadjuvants were also evaluated in mice for 
in vivo cytotoxicity and immune-potentiating effects. The results revealed 
that CHrPfs25 delivered with GNP elicited stronger humoral responses 
than other groups. There was no apparent toxicity associated with the 
administration of these formulations. PLGA elicited the lowest response. 
In an attempt to understand the action of these adjuvants in vivo, mice 
were immunized intramuscularly with different CHrPfs25-nanoadjuvanted 
formulations followed by assessment of DC and Macrophageϕ ((antigen 
presenting cells) infiltration at site of injection, sera cytokine and blood 
profiles after 3, 7 and 14 days of immunization. The results from these 
studies will be presented.
1012
EVALUATING THE POTENTIAL TO TRANSMIT MALARIA FROM 
HUMANS TO MOSQUITOES DURING CONTROLLED HUMAN 
MALARIA INFECTION WITH PLASMODIUM FALCIPARUM 
AND P. VIVAX
Katharine A. Collins1, Matthew Adams1, Hayley Mitchell1, Romal 
Stewart1, Claire Wang2, Caroline Dobbin1, Teun Bousema3, Robert 
Sauerwein3, Stephan Chalon4, Joerg Moehrle4, James McCarthy1
1QIMR Berghofer Medical Research Institute, Brisbane, Australia, 2QPID Pty 
Ltd, Brisbane, Australia, 3Radboud University Medical Centre, Nijmegen, 
Netherlands, 4Medicines for Malaria Venture, Geneva, Switzerland
The controlled human malaria infection (CHMI) model has been used 
successfully to assess efficacy of drugs and vaccines targeting the pre-
erythrocytic and blood stages of malaria infection. However, existing 
models are yet to be used to assess the ability of interventions to interrupt 
transmission of malaria from humans to mosquitoes. Such a model 
would be an invaluable tool for selecting the most promising transmission 
blocking interventions (TBIs) for further evaluation. Our ongoing work uses 
the induced blood stage malaria (IBSM) model with either Plasmodium 
falciparum- or P. vivax- infected red blood cells to initiate blood stage 
infection in malaria naïve volunteers. Volunteers are subsequently treated 
with licensed or experimental antimalarials to assess drug activity. As 
a secondary aim, we are investigating if the gametocytes that appear 
in peripheral circulation during these CHMI studies, either before drug 
treatment in the case of P.v infection or after drug treatment in the case 
of P.f infection, can be transmitted to Anopheles mosquitoes. During 
these studies the development of parasitemia and gametocytemia are 
monitored in the volunteers by qPCR and qRT-PCR, respectively. Following 
detection of gametocytes, transmission studies are performed using both 
direct feeds on volunteers and membrane feeding assays on venepuncture 
blood. Mosquito infection is then determined 7-10 days post feeding 
assay by detecting oocysts in the mosquito midgut. In recent clinical trials 
we have achieved successful transmission of both P.f and P.v at low levels. 
Current work now aims to optimise this system to enable assessment of its 
potential for evaluating TBIs. Analysis of specific quantitative biomarkers 
is being undertaken to improve our understanding of factors that may 
contribute to transmission efficiency, including male:female gametocyte 
sex ratios and gametocyte commitment, and in addition we are aiming to 
optimise the susceptibility of vector mosquitoes to infection. This work will 
contribute to the development of a reproducible model for rapid selection 
of effective transmission-blocking drugs and vaccines.
318
astmh.org
1013
CLINICAL DEVELOPMENT OF A VAR2CSA-BASED PLACENTAL 
MALARIA VACCINE PLACMALVAC: DECRYPTION OF 
THE ANTIBODY ACQUISITION AGAINST THE VACCINE 
CANDIDATE ID1-ID2
Guillaume Escriou1, Firmine Viwami2, Atikatou Mama2, Saadou 
Issifou2, Yannelle Dossou2, Achille Massougbodji2, Adrian Luty1, 
Jean-Philippe Chippaux1, Morten Agertoug Nielsen3, Ali Salanti3, 
Philippe Deloron1, Nicaise Tuikue Ndam1
1Institut de Recherche pour le Développement, MERIT UMR D216 Mère 
et enfant face aux infections tropicales, Paris, France, 2Centre d’Etude 
et de Recherche sur le Paludisme Associé à la Grossesse et à l’Enfance 
(CERPAGE), Faculté des Sciences de la Santé, Université d’Abomey-
Calavi, Cotonou, Benin, 3Department of International Health, Institute 
of International Health, Immunology and Microbiology, University of 
Copenhagen, Copenhagen, Denmark
Placental malaria (PM) is an important cause of maternal anemia, stillbirth 
and delivery of low birth weight babies, the latter representing a major 
risk factor for infant mortality in Africa. Many studies have underlined 
the key role of the parasite protein VAR2CSA in placental malaria (PM), 
the leading PM vaccine candidate. A specific immune response against 
VAR2CSA is acquired during the first pregnancies and reduces the harmful 
effects of placental malaria during subsequent pregnancies. This has led 
to the development of a candidate vaccine by an EU-funded consortium 
(PlacMalVac project) which is currently under Phase I trial in Germany and 
Benin.As part of the PlacMalVac project, we quantified anti-Id1-Id2 IgG 
and subtype responses to the VAR2CSA subunit vaccine candidate using 
ELISA in a cohort of Beninese pregnant primigravidae enrolled before the 
beginning of pregnancy. Clinical and parasitological data were collected 
monthly from 37 nulligravid women who became pregnant and followed 
through to delivery. Similar antibody measurements were performed 
in samples from a sub-cohort of 470 pregnant women of different 
parities who were followed up throughout pregnancy in the stoppam 
study. Preliminary analysis shows that antibody levels are dependent 
on pregnancy, parity status, and are associated with the occurrence of 
infection during pregnancy. These analyzes highlight the key role of anti-
Id1-Id2 IgG3 in protection against placental malaria.
1014
ANTIBODIES TO PLANT-PRODUCED PLASMODIUM 
FALCIPARUM SEXUAL STAGE PROTEINS EXHIBIT 
TRANSMISSION BLOCKING ACTIVITY
R. Mark Jones, Jessica Chichester, Stephen Tottey, Konstantin 
Musiychuk, Joey Norikane, Stephen Streatfield, Vidadi Yusibov
Fraunhofer-Center for Molecular Biotechnology, Newark, DE, United States
Transmission blocking vaccines are considered a critical component in the 
overall strategy for control and eventually elimination of malaria world-
wide. Sexual-stage proteins expressed by Plasmodium falciparum, Pfs230 
and Pfs25, are the main transmission blocking antigens moving through 
clinical trial development. Antibodies generated upon vaccination with 
either of these results in interruption of sporogonic development in the 
mosquito, and transmission to the next host. Using a plant based transient 
expression system, we have produced Pfs25 and Pfs230 fused to various 
carrier proteins in Nicotiana benthamiana, purified and characterized 
the proteins, and evaluated the vaccine candidates in animal models 
for generation of transmission reducing antibodies (TRA)/ transmission 
blocking antibodies (TBA). The Pfs25 and Pfs230 vaccine candidates are 
expressed at high levels, and induced TBA that persist up to 6 months post 
immunization. These data demonstrate the potential of the new malaria 
vaccine candidate and also support feasibility of expressing Plasmodium 
antigens in a plant-based system.
1015
QUANTIFICATION OF BED-NET LOSS AND LEAKAGE 
FOLLOWING A MASS-DISTRIBUTION CAMPAIGN ON 
BIOKO ISLAND USING THE CAMPAIGN INFORMATION 
MANAGEMENT SYSTEM (CIMS)
Dianna Hergott1, Thomas Stabler2, Jackie Cook2, Guillermo 
Garcia3, Aveika Akum3, Immo Kleinschmidt2, Christopher 
Schwabe1
1Medical Care Development International, Silver Spring, MD, United States, 
2London School of Hygiene & Tropical Medicine, London, United Kingdom, 
3Medical Care Development International, Malabo, Equatorial Guinea
Between December 2014 and June 2015, the Bioko Island Malaria Control 
Project (BIMCP) distributed 149,287 long lasting insecticidal nets (LLIN) to 
61,000 households on Bioko Island, achieving an Island-wide coverage 
of at least 1 LLIN per household of 87%. Of the 87% of households 
contacted who received a net, universal coverage (at least one net per 
two people) was achieved in 89% of them, for an Island-wise universal 
coverage of at least 77%. The BIMCP planned and implemented the 
distribution campaign through a tablet-based Campaign Information 
Management System (CIMS) that contains a georeferenced listing of all 
households on the Island, linked to a unique household identifier. Using 
the CIMS, data were collected on household size, number of pre-existing 
nets, and number of nets distributed. Between August and October of 
2015, approximately 7 months after the mass distribution, the BIMCP 
carried out a Malaria Indicator Survey (MIS), taking a representative sample 
of all communities in the Island. The MIS included questions about bed-net 
ownership and usage. The MIS showed that net ownership had dropped 
by 22% between the time of distribution and the 2015 MIS, with 69% 
of households reporting owning at least one LLIN in the MIS. Universal 
coverage dropped by 45%, with only 42% of households reporting having 
at least one net per every two people. Using the geo-referenced unique 
household identifier, we were able to compare net ownership in 4,992 
households. Fifty seven percent of these households reported having at 
least one less net at the time of the MIS than were distributed during the 
distribution campaign, and 34% reported at least two fewer nets. While 
many households reported a loss of nets, others reported a gain of nets. 
An in-depth analysis of the net code inscribed during the distribution 
and reported in the MIS, which reveal the original community LLINs were 
distributed to, will be conducted to investigate possible redistribution of 
nets. Additionally, results from the 2016 MIS will be analyzed to quantify 
net loss one year following the mass-distribution and better evaluate the 
characteristics of households with net gain and loss.
1016
DYNAMICS OF ENTOMOLOGICAL INOCULATION RATES 
FOLLOWING INDOOR RESIDUAL SPRAYING IN MALI
Moussa B. Cisse1, Dereje Dengela2, Richard Oxborough2, 
Bradford Lucas2, Abdourhamane Dicko3, Jules Mihigo4, Aboubacar 
Sadou5, Kristen George6, Christen Fornadel6, Laura Norris6, Allison 
Belemvire6, Suzanne Powell7, Raymond F. Beach8
1U.S. Agency for International Development AIRS Project, Abt Associates, 
Bamako, Mali, 2U.S. Agency for International Development AIRS Project, 
Abt Associates, Bethesda, MD, United States, 3Programme National 
de Lutte contre le Paludisme, Bamako, Mali, 4U.S. President’s Malaria 
Initiative, U.S. Centers for Disease Control and Prevention, Bamako, 
Mali, 5U.S. President’s Malaria Initiative, U.S. Agency for International 
Development, Bamako, Mali, 6U.S. President’s Malaria Initiative, U.S. 
Agency for International Development, Washington, DC, United States, 
7U.S. President’s Malaria Initiative, U.S. Centers for Disease Control and 
Prevention, Atlanta, GA, United States, 8Entomology Branch, U.S. Centers 
for Disease Control and Prevention, Atlanta, GA, United States
Entomological monitoring is used to assess the impact of indoor residual 
spraying (IRS) on entomological indicators such as the entomological 
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inoculation rate (EIR). We assessed the impact of IRS on EIR in sprayed 
and un-sprayed areas over four years in one district in Mali. Anopheles 
gambiae s.l. were sampled using human landing catches. Baseline data 
(pre-IRS) were collected at the beginning of the high malaria transmission 
season one week before spraying. Post-spray campaign follow-up data 
were collected during the high malaria transmission season for two 
months in 2012, three months in 2013 and 2014, and five months in 
2015. Intervention areas were sprayed with bendiocarb in 2012, 2013 
and 2014 and pirimiphos-methyl (300CS) in 2015. An enzyme-linked 
immunosorbent assay estimated the proportion of mosquitoes positive 
for Plasmodium falciparum sporozoites. In 2012, the pre-spray EIR/night 
was 0 and 2.64 in the intervention and control areas, respectively. Post-
spray EIR was 0.35 in the intervention area and 8.88 in the control area. 
In 2013, pre-spray EIR/night was 0.60 in the intervention area and 0.97 
in control area. Post-spray EIR was 0.49 in the intervention area and 1.47 
in control area. In 2014, pre-spray EIR/night was 0.58 in the intervention 
area and 3.32 in control area. Post-spray EIR was 0.27 in the intervention 
area and 2.31 in the control area. In 2015, pre-spray EIR/night was 0.75 in 
the intervention area and 0.84 in the control area. Post-spray EIR was 0.89 
in the intervention area and 3.53 in the control area. IRS was effective 
in maintaining or reducing An. gambiae s.l. EIR, which is a measure of 
malaria transmission. Further malaria case reporting is needed to monitor 
the impact of IRS.
1017
USE AND USER CHARACTERISTICS OF INTACT OR “TOO 
TORN” INSECTICIDE-TREATED MOSQUITO NETS IN 
TANZANIA
Lena Maria Lorenz1, Sarah J. Moore2, Zawadi D. Mageni3, Dennis 
J. Massue4, Jason D. Moore1, Hans J. Overgaard5
1London School of Hygiene & Tropical Medicine, London, United Kingdom, 
2Swiss Institute of Tropical and Public Health, Basel, Switzerland, 3Ifakara 
Health Institute, Dar-es-Salaam, United Republic of Tanzania, 4National 
Institute for Medical Research, Muheza, United Republic of Tanzania, 
5Norwegian University of Life Sciences, Ås, Norway
Sleeping under insecticide-treated mosquito nets (ITNs) is one of the 
most effective ways for people in malaria-endemic countries to protect 
themselves against malaria. As most of Sub-Saharan Africa is moving 
towards universal coverage of the population with mass ITN distribution 
campaigns, net use rates have been increasing. However, there is still 
a lack of data on user characteristics, especially of nets with different 
degrees of physical damage. Two cross-sectional household surveys 
were carried out in eight districts in Tanzania in 2014 and 2015 to 
collect data on net ownership, use and physical condition (hole surface 
area and proportionate Hole Index) combined with household member 
characteristics. The surveys were conducted in 2,944 households with 
15,627 household members and 4,793 used mosquito nets. This data 
will be analysed to assess who uses mosquito nets of what quality 
under different ITN ownership scenarios. Results will be presented on 
characteristics of ITN users (e.g. age, gender, pregnancy status, role 
in household), whether certain user groups are more likely to sleep 
underneath “good” or “too torn” nets and whether household ownership 
of ITNs has any effect on who uses nets of different qualities. This study 
provides important information, to our knowledge for the first time, on 
who uses mosquito nets of varying physical integrity, and whether this 
depends on the access of household members to ITNs. These factors will 
help malaria policy makers target the right audiences when developing 
behavioural communication strategies and net replacement campaigns.
1018
ENTOMOLOGICAL INDICATORS OF MALARIA TRANSMISSION 
AFTER IRS WAS DISCONTINUED: FINDINGS FROM SAVELUGU 
NANTON DISTRICT AND ITS IMPLICATIONS FOR MALARIA 
CONTROL IN GHANA
Sylvester Coleman1, Samuel Dadzie2, Aklilu Seyoum1, Yemane 
Yihdego1, Ernest A. Fletcher1, Dereje Dengela3, Kristen George4, 
Maxwell Appawu2, Daniel Boakye2
1U.S. Agency for International Development President’s Malaria Initiative 
Africa Indoor Residual Spraying Project, Accra, Ghana, 2Noguchi Memorial 
Institute for Medical Research, University of Ghana, Legon, Accra, Ghana, 
3U.S. Agency for International Development President’s Malaria Initiative 
Africa Indoor Residual Spraying Project, Abt Associates Inc., Bethesda, 
MD, United States, 4U.S. President’s Malaria Initiative, U.S. Agency for 
International Development, Washington, DC, United States
Savelugu Nanton District (SND), in the northern region of Ghana, was 
a beneficiary of the President’s Malaria Initiative (PMI) supported indoor 
residual spraying (IRS) program between 2008 and 2014. Entomological 
monitoring data showed that parity rates of An. gambiae s.l. had been 
reduced from 44.8% in 2011 to 28.1% by 2014. Sporozoite infection 
rates ranged between 0.23% and 1.89% between 2011 and 2012, and 
remained significantly low at a level that could not be detected for two 
consecutive years (2013 and 2014). IRS was withdrawn from the district 
after the 2014 IRS campaign due to low coverage and indications of 
emerging insecticide resistance.Monthly entomological data from three 
sentinel communities in the district revealed a significant increase in parity, 
sporozoite rate and entomological inoculation rates (EIR) of the local 
vector species just one year after the withdrawal of IRS. Parity rate of An. 
gambiae s.l. increased from 28.1% in 2014 to 51.2% in 2015 (p<0.0001) 
after IRS withdrawal. The sporozoite infection rate increased from a level 
that could not be detected for two consecutive years (2013 and 2014) 
to 1.10% (4/361 mosquitoes analyzed). Consequently, the EIR increased 
from undetectable levels in 2013 and 2014 to 14.7 infective bites/man/
year in 2015. In Bunkpurugu Yunyoo District, where spraying continued 
without interruption, EIR declined from 3.3 ib/m/yr in 2014 to 0.82ib/m/
yr in 2015. The results from the surveys show that the IRS program 
maintained low levels of the two most important indicators of malaria 
transmission: parity and infectivity rates of the malaria vectors. However, 
there was a significant resurgence following withdrawal of IRS from the 
area. Epidemiological data is needed to understand the impact of IRS on 
malaria transmission.
1019
A COMPARISON OF THE EFFECTIVENESS OF BEHAVIOR 
CHANGE COMMUNICATION (BCC) PLUS REPAIR KITS AND 
BCC ALONE IN PROMOTING REPAIR OF LONG-LASTING 
INSECTICIDAL NETS IN BENIN
Andre Houtoukpe1, Luis Benavente1, Liscovich Ademikpo1, 
Manzidatou Alao1, Hilary Adjala1, Jean Adjidja1, Peter Thomas2, 
Steve Smith3, Martin Akogbeto4
1U.S. Agency for International Development PADNET Project, Medical Care 
Development International, Cotonou, Benin, 2U.S. President’s Malaria 
Initiative, US Centers for Disease Control and Prevention, Cotonou, Benin, 
3Entomology Branch, U.S. Centers for Disease Control and Prevention, 
Atlanta, GA, United States, 4Centre de Recherche Entomologique de 
Cotonou, Cotonou, Benin
We compared strategies to increase net durability in 2014. Three groups 
of 300 households (HH) were randomly assigned to two intervention 
and one control arm. Arm 1 received behavior change communication 
(BCC) messages; Arm 2 received BCC plus a net repair kit; Arm 3 was the 
control. Twelve villages in southeastern Benin were enrolled. Community 
health workers delivered BCC messages about preventing damage to 
long-lasting insecticidal nets (LLIN) caused by fire or sharp objects, and 
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promoting repair as soon as holes appeared. Data were collected from 
all HH at 4-5 month intervals for 20 months. Net damage was measured 
using the WHO Proportional Hole Index (pHI). At 20 months the overall 
HH dropout rate was 21% (17% for Arm 1, 23% for Arm 2 and 24% for 
Arm 3). Only one of five control HH (Arm 3) reported hearing messages 
about net care or repair. Net attrition (LLIN not available to sleep under) 
was significantly lower in Arms 1 and 2 (9%), than in Arm 3 (16%) 
(p<0.0001). LLIN use among children under five years was higher among 
those receiving BCC and repair kits (83%) than those receiving only BCC 
(73%) (p=0.02). Intervention Arms 1 and 2 reported more net use (73% 
and 83%, respectively) than the control arm (63%) (p<0.0001). Frequent 
LLIN washing (>1 wash/3 months) resulted in reduced net integrity in the 
control group. Reduced insecticide activity was also more common in 
the control arm (78%) than Arm 1 (69%) and Arm 2 (56%) (p<0.0001). 
The proportion of nets without holes was significantly higher in Arm 2 
(53%) than in Arm 3 (38%) (p=0.019), but no difference was observed 
in the prevalence of holes between Arm 1 (41%) and the control arm 
(38%). Nets in Arms 1 and 2 showed more signs of repair (57% and 58%, 
respectively) than controls (22%) (p<0.0001). The proportion of nets with 
large and/or numerous holes (pHI >63) was significantly lower in Arm 1 
(13%) and Arm 2 (9%) than in Arm 3 (36%) (p<0.0001). All LLIN in all 
three arms had good insecticide retention measured by x-ray fluorescence 
and WHO cone test. BCC messaging significantly increased care and repair 
practices in intervention villages in Benin. Whether these practices can 
prolong LLIN durability requires further study.
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DRY SEASON MALARIA TRANSMISSION REDUCES THE 
IMPACT OF SEASONAL INDOOR RESIDUAL SPRAYING IN 
BENIN
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Indoor residual spraying (IRS) in Benin is based on a single round of 
spraying to coincide with the annual period of highest transmission (peak 
vector density). It is assumed that during the dry season, when IRS is not 
done, vectors should be few and the level of malaria transmission low. 
In this study, we tested this assumption by measuring the intensity of 
malaria transmission during the peak transmission and low transmission 
(dry season periods) using entomologic measures. We assessed Anopheles 
population dynamics over a five year period by measuring human-
biting behavior and entomological ( Plasmodium falciparum sporozoite) 
inoculation rates during periods when IRS was done and during the dry 
season when it was not carried out. A total of 3,752 Anopheles (An. 
gambiae, An. coluzzii and An. funestus) were collected. During the period 
of IRS impact (June-October: rainy season) An. gambiae was the most 
abundant species (87.8% in Atacora and 94.3% in a similar comparison 
area, not under IRS). In dry season, when IRS insecticidal effect was not 
operating (November to May), the percentage of An. gambiae dropped to 
approximately 20%, but two other species, An. coluzzii and An. funestus 
made up 68.4% and 12%, respectively, of the Anopheles caught). More 
importantly, however, transmission of  P. falciparum, continued, estimated 
to be approximately three infective bites per human per month for An. 
gambiae s.s. and one infective bite per human per month for An. funestus, 
which was higher than expected for a period when the most An. gambiae 
s.s. breeding sites were assumed to dry up. The abundance of An. coluzzii 
and An. funestus in dry season probably owes its origin to breeding sites 
maintained by permanent and semi-permanent streams in the Atacora 
foot hills.
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EFFECT OF IVERMECTIN ON PLASMODIUM VIVAX IN ITS 
INTERACTION WITH ANOPHELES AQUASALIS
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Gisely Melo1, Marcus Lacerda1, Wuelton Monteiro1, Paulo 
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Amazonas, Brazil, 2Centro de Pesquisas Rene Rachou FIOCRUZ-MG, Belo 
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The use of insecticide-treated nets and indoor residual insecticides 
targeting adult mosquito vectors is a key element in malaria control 
programs. However, mosquito resistance to the insecticides used in these 
applications threatens malaria control efforts becoming in a major public 
health issue. Alternative methods like Ivermectin administration to humans 
has been suggested as a possible vector control to reduce Plasmodium 
transmission. Anopheles aquasalis isa competent vector for P. vivax and it 
has been responsible for various malaria outbreaks. This study analyzed 
the effect of Ivermectin on vector competence of An. aquasalis for P. 
vivax using two experimental protocols: (A) One single Ivermectin dose 
(200 µg/mL) was taken by volunteers and blood samples were drawn 
at distinct times. An. aquasalis was infected by membrane feeding with 
different concentration of these blood samples mixed with P. vivax from 
malaria patients. Seven days after the infective bloodmeal, the mosquitoes 
were dissected to check the oocyst presence and the infection rate. (B) 
Additionally, the in vitro effect of the addition of Ivermectin on cultivated 
P. vivax was observed. Ivermectin significantly reduced the proportion of 
An. aquasalis that developed oocysts (40ng/mL concentrationor plasma 4 
h, but with the metabolized Ivermectin on 5, 10 and 14 d post-treatment 
it was not reduced (p=0.06; p=0.91; p=0.80 respectively). Plasmodium 
vivax infection was significantly reduced in the survived An. aquasalis that 
ingested Ivermectinin the 40ng/mL concentration and plasma 4h post-
treatment. In the in vitro cultures, Ivermectin (plasma 4 h concentration) 
significantly affected the P. vivax asexual development, reducing the 
number of schizonts (50% of inhibition). In conclusion, Ivermectin reduces 
the infection rate of P. vivax in An. aquasalis and increased the mortality 
of mosquitos. These findings support the idea that Ivermectin is useful to 
reduce P. vivax transmission in endemic areas.
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DETECTION OF PLASMODIUM FALCIPARUM INFECTION 
IN ANOPHELES SQUAMOSUS IN AN AREA TARGETED FOR 
MALARIA ELIMINATION, SOUTHERN ZAMBIA
Jennifer C. Stevenson1, Limonty Simubali2, Saidon Mbambara2, 
Michael Musonda2, Sydney Mweetwa2, Twig Mudenda2, Julia C. 
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Southern Zambia is the focus of strategies to create malaria-free zones. 
Interventions being rolled out include reactive test and treat strategies 
(‘Step D’) and distribution of insecticide-treated bed nets. Step D involves 
the identification of index cases, i.e. non travelers who test positive 
for malaria at health facilities, who are subsequently followed up at 
their homes for malaria screening and treatment of all residents and of 
neighboring households. In 2015 in Macha, Choma District, mosquitoes 
were collected monthly by light trap from Step D homesteads, set both 
indoors next to occupied bed nets and outdoors next to goat enclosures 
to study vector foraging patterns around clusters of malaria cases. 
Anopheline mosquitoes were identified to species using molecular 
methods and Plasmodium falciparum infectivity was determined by ELISA 
and real time qPCR methods. Comparing indoor collections of anophelines 
from Step D households to those of a random selection of households 
within the community, species composition was similar with domination 
of the vector Anopheles arabiensis, however household densities were 
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four fold higher in Step D houses suggesting local and focal transmission. 
Catches from outdoor traps were nine times greater than indoor 
collections with more than 60% identified as An. squamosus. Analysis 
of a subset (n=1006) of anophelines were analysed by ELISA for malaria 
sporozoites. Seven were found positive, of which four were confirmed as 
harboring parasites by qPCR. All seven specimens were caught outdoors. 
Six were morphologically identified as An. squamosus and one as An. 
coustani. Parasite-positive specimens as well as a subset of An. squamosus 
specimens from either the same study or archive collections underwent 
sequencing of the mitochondrial COI gene. Maximum parsimony trees 
indicated presence of at least 2 clades of An. squamosus with infectious 
specimens falling in each clade. The single infectious specimen identified 
morphologically as An. coustani could not be matched to reference 
sequences. This is the first report from Zambia of infections in An. 
squamosus and from outdoor collections.
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FIELD TESTING OF A PYRETHROID QUANTIFICATION 
KIT (PQK) IN TANZANIA - AN EASY-TO-USE TOOL FOR 
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Insecticide treated nets (ITN) and indoor residual spraying (IRS) are two 
of the primary methods of malaria prevention in Africa. In order for 
these methods to be effective it is essential that adequate concentrations 
of insecticide are present on nets and wall surfaces to kill mosquitoes. 
There is no easy assay to quantify insecticide levels without expensive 
laboratory equipment and procedures. To address this, LSHTM has 
developed a simple field-applicable kit for monitoring pyrethroid residues 
on insecticide-treated nets- the Pyrethroid Quanitification Kit (PQK)-which 
can be adapted to other types of treated surfaces. During the initial trial 
the PQK kit was calibrated against a variety of sprayed surfaces and with 
different concentrations of lambdacyhalothrin before being taken into 
the field. Mosquito cone bioassay was conducted to show whether the 
surface concentrations of insecticide detected by the PQK were sufficient 
to kill a susceptible strain of mosquitoes. Houses in six villages were 
visited 3 months after IRS had been conducted in Muleba, Tanzania. The 
samples were analysed in the field using a handheld spectrophotometer. 
In each house, five areas of the wall were examined to give an indication 
of insecticide distribution and within-wall variation. Results showed that 
the actual spraying results differed from expectation. Preliminary results 
showedthat only 28% of houses had all rooms sprayed, leaving 72% of 
housespartially sprayed, and insecticide concentration varied dramatically 
across sprayed walls. The PQK is an easy to use quality assurance tool for 
monitoring of pyrethroid application rates and improving the quality of IRS 
campaigns.
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A COMPREHENSIVE ACCESS METRIC FOR ESTIMATING THE 
GAP IN INSECTICIDE TREATED NET USE CONDITIONAL ON 
ACCESS
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The complement of the proportion of people who use insecticide treated 
nets (ITNs) out of those who have access is a measure of the behavioural 
gap (BG) in ITN use. The updated Global Malaria Action Plan’s access 
measure (UGMAPAM) is based on the assumption that two people 
can sleep under one ITN. However, often ITNs are shared by more than 
two people, and the number of people using an ITN can be larger than 
the UGMAPAM (resulting in a use : access ratio larger than one, and 
consequently a negative BG if not floored at zero), while there may 
still be people not using ITNs despite having access. The fact that the 
UGMAPAM-based use : access ratio is not a true proportion makes it 
unsuitable for standard statistical analyses. For the purpose of estimating 
the BG, we propose a comprehensive access measure (CAM), counting 
those who slept under an ITN as having access, as well as those who 
could have used spare spaces under an ITN, with one spare space for 
a single-occupied ITN and two spaces for an unoccupied ITN. The use : 
access ratio with the CAM as denominator is a true proportion, and its 
complement, the proportion of people who had access to a full person-
size space under an ITN but did not use it, is an easy interpretable measure 
of the BG. We analyzed 85 Demographic and Health Surveys and 20 
Multiple Indicator Cluster Surveys with specific information on mosquito 
nets from 44 countries over 2001-2015. An average of 46.2% (range: 
15.1-71.8) of ITN users shared their net among three people or more. 
Compared to the CAM-based BG, the UGMAPAM-based BG (floored at 
zero) was on average 8.0 percent-points (range: 0-18.8) smaller, and the 
difference was largest at intermediate BG. We conclude that the use of 
the UGMAPAM-based BG has underestimated the potential for ITN use-
stimulating interventions such as behavioural change communication and 
ITN improvements to increase acceptability.
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Uganda has registered significant declines in malaria prevalence in the 
recent past. However, concerns about maintaining the gains made are 
apparent. Starting 2009, indoor residual spraying (IRS) was implemented 
in 10 high burden districts in Northern Uganda resulting in suppressed 
transmission to very low levels. Based on this achievement and the 
country’s deployment of long-lasting insecticidal nets universally in 
2013 - 2014, IRS was withdrawn in November 2014. However, in March 
2015 routine surveillance showed a marked increase in malaria cases 
and deaths suggestive of an epidemic in that region. We describe here 
the investigation and confirmation of the epidemic. Following reported 
increases in malaria cases, an epidemic preparedness and response team 
was constituted to investigate the upsurge in affected districts. A review 
of hospital records and malaria parasite testing of 11,000 blood smears 
collected between June-August 2015 was done to confirm the malaria 
case load. Mean indoor resting density of malaria vectors was done for 
entomological assessment. Reported malaria cases and slide positivity 
rate (SPR) were compared for the period during and after withdrawal 
of IRS. Out of 11,000 blood smears examined, 81% were positive for 
P. falciparum. Seventy two percent of hospital admissions were due to 
confirmed malaria. Based on hospital records, malaria incidence increased 
from 61 to 142 cases per 1,000 population and SPR from average 11% 
to 75% [difference 64%, CI:63.7-64.3] p < 0.001, before and after IRS 
withdrawal respectively. Entomological assessment indicated re-bound 
of vectors with mean indoor resting density of 4 female Anopheles 
mosquitoes per house visited. A dramatic increase in reported malaria 
cases, an SPR above the established epidemic thresholds confirmed 
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presence of a malaria epidemic in this region. Indoor Residual Spraying 
gains are fragile and can potentially be lost in the absence of a clear exit 
strategy.
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Mbita, Kenya, 5NUITM-KEMRI Project, Nagasaki University, Kenya, Kenya, 
6Eastern and Southern Africa Centre of International Parasite Control, 
Nairobi, Kenya
Long-lasting insecticidal bed nets have been widely used for reducing 
malaria cases. A persisting challenge is how to protect children who do 
not adhere to net use. This study examined whether covering house eave 
gaps and ceilings with a fabric made of Olyset®Net (ceiling nets) reduces 
risk of Plasmodium falciparum parasite infection among children under 10 
years of age. Bed nets (Olyset®Net) were provided to cover all residents 
in the study area in western Kenya. Then, the area was divided to eight 
sub-areas, and four sub-areas were randomly selected for the treatment. 
Ceiling nets were installed in all houses in the selected sub-areas. The 
PCR-based pre-intervention infection rate of P. falciparum was 68.9%, 
and reduced to 27.3% (OR: 0.84; p<0.001) in the sub-areas covered 
with ceiling nets and bed nets. Similarly, the PCR-based infection rate 
significantly reduced from 60.9% to 44.9% in the sub-areas with bed 
nets only (OR: 0.94; p<0.001). The post-intervention infection rate in the 
sub-areas with ceiling nets was significantly lower than that in the sub-
areas without them (OR: 0.45; p=0.031). While bed nets reduced risk of P. 
falciparum parasite infection, ceiling nets provided additional protection.
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REPELLENCY OF THREE ESSENTIAL OIL AND MAJOR 
CONSTITUENTS TO WILD ADULT ANOPHELES KLEINI
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Repellency of 20 plant essential oils to malaria main vector in the Republic 
of Korea (ROK), Anopheles kleini, was evaluated using skin direct contact 
bioassay. An. kleini showed the highest repellency to Pelargonium 
graveolens(Geranium oil)with EC50 value of 0.244 mg/cm2, followed 
by Pinus sylvestris (Pine oil) and Cinnamomum camphora (camphora 
oil) with EC50 values of 0.484 mg/cm2 and 0.862 mg/cm2. The lowest 
repellency of An. kleini was revealed from Clary sage oil with EC50 value 
of 4.665 mg/cm2. An. kleini did not demonstrated any repellency to 
Lemon, Orange, Neem, Cocount and Olive oil over 20 mg/cm2. Major 
repellent constituents of Geranium, Pine and Camphora oil were analyzed 
and identified using Mass-data, GC and GC-Mass. Major constituent of 
Geranium were β-citronellol (37.0%) and Camphora, 1,8-cineole (35.8%) 
and Pine, α-terpineol (39.5%). An. kleini showed higher repellency to 
β-citronellol and 1,8-cineole than to DEET and IR3535 and did not showed 
any repellency to sabinene and γ-eudesmol over 20 mg/cm2. Residual 
repellent time of 1,8-cineole and β-citronellol were 26 and 41 min, 
respectively and DEET, 84 min and IR3535, 102 min. In the light of global 
efforts to reduce the level of highly toxic synthetic repellents, the three 
essential oils and their major constituents described merit further study as 
potential biorepellents for the control of An. kleini populations .
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PREVALENCE OF SOME ENTEROPATHOGENS AMONG 
DIARRHOEIC AND APPARENTLY HEALTHY CHILDREN IN EKET 
AND IBENO, AKWA IBOM STATE, NIGERIA
Inyang Asuquo Atting, Ofonime Alfred Akpan
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In this study, some intestinal bacterial pathogens involved in diarrhoea 
causation was investigated in Eket and Ibeno between October, 2013 
to April, 2014. A total of 150 freshly - voided diarrhoeic samples of 
children attending Primary Health Care Centre, Eket and General Hospital, 
Ibeno, and 50 non - diarrhoeic samples were collected which served as 
controls. Standard bacteriological media and procedures were used in 
the identification of bacterial isolates. Antibiotic susceptibility test was 
done by standard procedures.The overall prevalence rates recorded for 
enteropathogens among children were 74% and 72% in Eket and Ibeno, 
respectively and the mean prevalence was 73%. Data obtained from 
the questionnaires given to subjects’ mothers for socio - demographic 
information showed a high prevalence of enteropathogens in the 
following parameters examined; subjects within the age group of 7 - 12 
months, subjects whose source of drinking water was stream, subjects’ 
mothers in the civil service and self - employed groups, exclusively 
breastfed subjects. A decrease with increase in educational level of 
subjects’ mothers was observed. The bacterial pathogens considered 
were Escherichia coli, Salmonella enteritidis, Shigella dysenteriae and 
Enterobacter species. Escherichia coli was the most prevalent with rates 
of 43.5% and 45% in Eket and Ibeno, respectively. Enteropathogenic 
Escherichia coli (EPEC) O26 and O111 were identified with an overall 
prevalence of 46.7%. In the antibiotic susceptibility test done, the 
organisms were mostly susceptibility to Ciprofloxacin and resistant 
to Cotrimoxazole. The study has revealed that the incidence of 
enteropathogens in children could be traced primarily to poor personal 
hygiene and faulty weaning practices. Therefore, a systematic effort to 
teach nursing mothers and children to practice good personal hygiene are 
the best approaches to reduction of the scourge of intestinal pathogens.
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SHIGELLOSIS IN RURAL ASEMBO, WESTERN KENYA, 2007-
2014
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Ochieng1, George Aol1, Jane Juma1, Godfrey Bigogo1, Marc-Alain 
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Shigella is a leading cause of diarrhea and dysentery in low- and middle-
income countries. Population-based data on the Shigella burden in 
African settings are very limited. We describe the incidence of medically 
attended shigellosis in a population of ~25,000 who reside ≤5 kilometers 
from a surveillance clinic in Asembo, rural western Kenya that provides 
free medical care. From January 1, 2007-December 31, 2014, stools 
and demographic data were collected from all patients presenting with 
diarrhea (≥3 loose stools within 24 hours). The specimens were cultured 
and isolates identified biochemically and confirmed by serotyping. 
Participants were visited at home biweekly and queried about acute 
illnesses and care-seeking. We calculated the incidence of Shigella 
infections per 1000 person-year-observation (pyo); we adjusted for the 
proportion of diarrhea cases with no stool sample, and for the proportion 
of diarrhea cases reported during household visits that sought care at a 
health facility other than the surveillance clinic. A total of 11,775 cases 
of diarrhea presented to the clinic during the study period. Of these a 
stool specimen was collected from 1,658 (14%), and Shigella was isolated 
from 418 (25%). The overall adjusted incidence rate was 11.1/1000 pyo; 
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among those aged <5 and ≥5 years, it was 9.1 and 11.2 per 1000 pyo 
respectively. Peaks in incidence were seen in young children (<12months 
15.0/1000 pyo, 12-23 months 12.7/1000 pyo) and older adults (35-49 
years 19.0/1000 pyo, ≥50 years 23.7/1000 pyo). The annual adjusted 
incidence was highest in 2011 (13.8/1000 pyo) and lowest in 2013 
(7.4/1000 pyo). Shigella species isolated included: S. flexneri 251 (60%), 
S. dysenteriae 57 (14%), S. sonnei 42 (10%), S. boydii 39 (9%) and non-
typeable 29 (7%). We found an important burden of Shigella, particularly 
S. flexneri, among children and adults, with both age extremes most 
heavily affected. Prevention strategies, such as access to safe water and 
sanitation and future vaccines, should address disease burden across all 
age groups.
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Typical enteropathogenic Escherichia coli (tEPEC) infection is a major 
cause of diarrhea and contributor to mortality in children <2 years old in 
developing countries. Limited data are available on risk factors associated 
with tEPEC infection in young children. Data were analyzed from the 
Global Enteric Multicenter Study (GEMS) examining children <5 years 
old seeking care for moderate-to-severe diarrhea (MSD) in Siaya County, 
Kenya. MSD was defined as ≥3 loose stools in the previous 24 hours, 
with onset in the previous 7 days, and ≥1 of the following characteristics: 
loss of skin turgor, sunken eyes, dysentery, required IV rehydration or 
hospitalization. Stool specimens were tested for enteric pathogens, 
including by multiplex PCR for the gene targets of tEPEC (i.e. positive 
for both eae and bfpA). Demographic, clinical, and anthropometric data 
were collected at enrollment and at a ~60-day follow-up visit. To examine 
factors associated with tEPEC among MSD cases, a multivariable logistic 
regression model was constructed. Linear regression was used to assess 
linear growth faltering. Of the 1,778 cases enrolled between Jan 31, 
2008 and Sep 30, 2012, 135 (7.6%) children tested positive for tEPEC. 
Among these, 85 (63%) had ≥1 additional enteric pathogen. Overall, 
65% of tEPEC cases were infants 0-11 months old. There was a 3-fold 
greater odds of identifying tEPEC among infant MSD cases than among 
children in older age groups (adjusted odds ratio [aOR] 3.02, 95% CI: 
1.73-5.24). The odds of tEPEC were higher for MSD cases with loss of 
skin turgor (aOR 2.86, 95% CI: 1.08-4.82) and convulsions (aOR 2.95, 
95% CI: 1.17-7.45), compared to those without. Infant cases with tEPEC 
compared to those without were associated with linear growth faltering 
(p=0.002) between enrollment and follow-up. Among 36 infant MSD 
cases who died, 9 (25.0%) had tEPEC compared with 77 (10.8%) of 764 
infants who survived (OR 2.98, 95% CI: 1.35-6.56). Typical EPEC was a 
significant contributor to morbidity and mortality among infants with MSD 
in rural Kenya. Interventions aimed at reducing the burden of tEPEC and 
its sequelae should be urgently investigated, prioritized and implemented.
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Giardia is a common enteropathogen detected in both diarrheal and non-
diarrheal stools among children in low-resource settings. We describe the 
epidemiology of Giardia in the first two years of life in MAL-ED, a multisite 
birth cohort study. From 2,089 children, 34,916 stools collected during 
monthly surveillance and diarrhea were tested for Giardia by enzyme 
immunoassay. We quantified the risk of Giardia acquisition, identified risk 
factors, and assessed the associations with micronutrients, gut biomarkers, 
diarrheal risk, and growth using multiple linear regression with general 
estimating equations. Incidence of at least one Giardia detection varied by 
site, from 37.7% in Brazil to 96.4% in Pakistan, and was more common in 
the second year of life. Exclusive breastfeeding (hazard ratio (HR) for first 
Giardia detection in monthly surveillance stools: 0.46, 95% CI: 0.28, 0.75), 
higher socioeconomic status (HR: 0.74, 95% CI: 0.56, 0.97) and recent 
metronidazole treatment (risk ratio for any surveillance stool detection: 
0.69, 95% CI: 0.56, 0.84) were protective. Associations with hygiene and 
environmental risk factors suggest that the fecal-oral and waterborne 
routes may both be important modes of transmission. Giardia persistence 
(2+ consecutive detections) in the first 6 months of life was associated 
with reduced subsequent diarrheal rates in Pakistan, but not in any other 
site. Giardia was also associated with an increase of 0.25 (95% CI: 0.10, 
0.40) in lactulose-mannitol ratio. Across sites, Giardia persistence in the 
first 6 months was associated with -0.29 z-score (95% CI: -0.53, -0.05) 
deficit in weight and -0.29 z-score (-0.64, 0.07) deficit in length. Because 
detection of Giardia in non-diarrheal stools was common, attributing 
diarrheal etiology to Giardia may often be inappropriate. However even 
in the absence of diarrhea, Giardia infection, especially when persistent 
in the first 6 months, may impact child development through stunted 
growth. Interventions to interrupt transmission may better reduce the 
burden and impact of Giardia than mass drug administration since 
metronidazole only transiently reduced detection.
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DETERMINANTS OF HEALTH AND PREVALENCE OF 
INFECTIOUS GASTROINTESTINAL DISEASE IN CHILDREN 
LIVING IN THE PERUVIAN AMAZON RIVER BASIN
Rolfy Perez-Holguin1, Darya Nesterova1, Wilbert Beachy1, Anne 
Huyler1, Olivia Munizza1, Ivana Marji1, Henry Montilla-Guedez1, 
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Diarrheal disease continues to be a leading cause of childhood morbidity 
and mortality in resource-poor settings, lacking proper water sanitation 
infrastructure. The community of Belen in Iquitos, Peru experiences 
intermittent seasonal flooding from the Ataya river, a tributary of the 
Amazon River. This project studied the differences in prevalence of various 
enteric pathogens as well as qualitative differences between “high” and 
“low” zones. Zone distinctions were based on levels of recent seasonal 
flooding, with low zones experiencing flooding throughout the majority 
of the year. Households involved in the study completed a questionnaire in 
Spanish and water was collected from the home’s source and storage for 
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analysis of fecal coliforms and the presence of chlorine. Additionally, stool 
samples from a child under the age of five were obtained and screened 
for presence of bacteria and parasites. Samples were collected from 232 
households. 100 households were determined to be in the low zone and 
the remaining 132 in the high zone. The overall prevalence of enteric 
pathogens in the high zone was 50% (66/132), compared to the 70% 
(70/100) prevalence in the low zone (p=0.0022). In both source and stored 
water, there was a higher rate of coliform contamination in the low zone 
(both p<0.0001). In addition, there was a difference in education levels 
between high and low zones (p<0.0001). Distinct educational differences 
between the high and low zones were observed in Belen that were 
associated with the presence of fecal coliforms in source and stored water 
and enteric pathogen prevalence.  Overall, households in the low zone had 
lower education levels and experienced higher coliform contamination of 
their water and higher prevalence of enteric pathogens in stool samples. 
Additional studies or analysis will include sources of contamination 
of household water with respect to previously identified geographical 
differences.
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THE SHIFTING PATTERN OF VIBRIO CHOLERAE O1 
SEROTYPES OVER A PERIOD FROM 1996 TO 2016 IN 2016 IN 
BANGLADESH
Fahima Chowdhury, Muhammod Ikhtear Uddin, Firdausi Qadri
International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, 
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Vibrio cholerae O1, the primary cause of epidemic cholera, has two 
biotypes, El Tor and Classical, and two major serotypes, Ogawa and Inaba. 
They have distinct phenotypes and differ with respect to the severity of 
the disease they can cause, the ability to survive outside the human host, 
and the seasonal pattern of infection. The changes of these serotypes 
with time and associated immune response in patients is important to 
understand the pathogenesis of cholera. We therefore followed the 
data for cholera for the last 20 years to determine the variability of the 
serotypes and its impact on demographic characteristics, clinical disease 
and on immune responses generated in cholera patients attending the 
diarrheal hospital at the icddr,b in Dhaka, Bangladesh. We analysed data 
from cholera patients at the icddr,b hospital from 1996 to 2016. Based 
on this data, we observed that the Ogawa serotype dominated during the 
period from 1996 to 1999 (80-99%), while the Inaba dominated from 
2000 to 2002 (63-85%). From 2003 to 2007 we saw an alternative shift 
from Ogawa to Inaba (65% Ogawa, 74% Inaba,71% Ogawa, 60% Inaba, 
52% Ogawa). However, in 2007 both serotypes were prevalent. However, 
following this cholera due to the Ogawa serotype started to increase and 
peaked in 2009-2010 (95-99%) and remained prevalent until December 
2015 (89%). Interestingly, after 8 years of prominence of the Ogawa 
serotype, hospitalization of patients with V. cholerae O1 Inaba starts to 
increase in 2016 (January to March 2016) and reached a predominance 
of 92%. The cholera vaccine studies that we have been conducting in the 
urban slum of Dhaka city from the year 2011 to 2016 also enabled us to 
track this shift in 2016 to the V. cholerae O1 Inaba serotype. We found 
patients infected with Ogawa serotype were younger, presented with 
shorter duration of diarrhoea and frequent abdominal pain, vomiting and 
need for intravenous fluids though they had similar status of dehydration. 
We are also analyzing the immunological responses in the host as well 
as the genotypic and phenotypic characteristics of V. cholerae O1 strains 
isolated during this shift to the V. cholerae O1 Inaba serotype.
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Evidence suggests that cholera during pregnancy has adverse effects on 
pregnancy outcome. A low cost oral cholera vaccine (OCV; Shanchol) 
appears to be an effective intervention to prevent cholera incidence. 
However, the vaccine is not recommended for pregnant women possibly 
due to lack of evidence of safety. In an efficacy study of a single-dose 
OCV in an urban slum of Dhaka city, some pregnant women took the 
vaccine unknowing of their pregnancy status. We therefore carried out 
this study to determine if the OCV is safe to administer during pregnancy. 
The objective of the study was to compare the differences in adverse 
pregnancy outcomes between the vaccine and placebo groups. A 
pregnancy screening visit among women of reproductive age (15-49 yrs) 
was conducted two months after the mass vaccination. We interviewed 
pregnant women whose pregnancy ended before the screening visit 
and collected necessary information related to their pregnancy outcome 
retrospectively. For women whose pregnancy was ongoing at the time 
of the screening visit, were followed up by visits until the pregnancy 
outcome occurred. The screening visit was conducted on 71,202 women 
of reproductive age and identified 1323 pregnancies: of these 550 were 
exposed to OCV during pregnancy and 773 exposed to OCV right before 
conception. Of 550 women, 405 had pregnancy outcome after the 
screening visit and were included in the primary analysis. We identified 
7 (3.4%) adverse outcome from vaccine arm and 6 (3.0%) from placebo 
arm. OCV-exposure during pregnancy had no significant effect on adverse 
pregnancy outcome (Adj. OR: 1.11, 95% CI: 0.36, 3.53). We identified 
7 (3.6%) preterm delivery from vaccine arm and 12 (6.1%) from placebo 
arm. We also found a non-significant protective effect of OCV on low birth 
weight. This study gave us no evidence of harmful effect on pregnancy 
outcome due to OCV exposure during pregnancy. The information from 
this study gives policy makers evidence to create awareness for offering 
OCV during pregnancy. This will be useful in reducing the number of 
cholera during pregnancy and also reduce adverse pregnancy outcome.
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ENHANCING DISTRICT-LEVEL CAPACITY TO INVESTIGATE 
AND RESPOND TO ACUTE DIARRHEAL DISEASE OUTBREAKS 
- TAMIL NADU, INDIA, 2013-2015
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Acute diarrheal diseases (ADD) account for 46% of reported outbreaks in 
India. Effective district-level response is constrained by lack of specimen 
collection, limited laboratory capacity, and incomplete epidemiologic 
investigation. In October 2013, Tamil Nadu introduced standard 
investigation tools and initiated focused training to strengthen ADD 
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outbreak response in two pilot districts, Cuddalore and Kanchipuram 
(population 2.6 million and 4.0 million, respectively). We reviewed 
investigation reports to characterize outbreak response over the two-
year pilot period. We abstracted standard data for all ADD outbreak 
investigations conducted in both districts between November 2013-2015 
to determine timeliness of response, proficiency in specimen collection and 
testing, completeness of epidemiologic investigation, and identification 
of outbreak source. Testing for Salmonella, Shigella, and Vibrio species 
was conducted at the district microbiology laboratory. In the two-year 
period, 17 ADD outbreaks were investigated in the two districts. District 
teams detected and responded to all outbreaks within 24 hours; patient 
specimens were collected in 13 (76%) outbreaks; bacterial etiology (Vibrio 
cholerae and Shigella sonnei) was confirmed in two (12%). Systematic 
case ascertainment was conducted in 13 (76%); an epidemic curve was 
developed in 8 (47%), and standard food-history questionnaires were 
utilized in 4 (29%). A case-control or cohort study was conducted in 
5 (29%) investigations. A specific water (n=3) or food (n=7; including 
shellfish=2, fish=1, rice dishes=4) source was identified in 10 (59%) 
outbreaks. Over two years, pilot districts demonstrated the ability to lead 
timely and complete detection and response to ADD outbreaks. Systematic 
epidemiologic investigation methods supported the identification of food 
or water sources of illness in the majority of outbreaks. Focused efforts 
to strengthen district laboratory diagnostic and surveillance capacity will 
further enhance the ability to detect outbreak etiologies and contribute to 
global health security in India.
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INCREASING ANTI-ADHESIN IMMUNE RESPONSES BY 
MODIFYING FIMBRIAL GENE STEM-LOOP STRUCTURE IN LIVE 
ATTENUATED SHIGELLA/ETEC VACCINES
Kurt Hanevik1, Christen Grassel2, Eileen Barry2
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Antibodies blocking the function of the adhesin protein of ETEC fimbriae 
are likely to be effective at preventing ETEC induced diarrheal disease. 
A way to increase the ratio of tip-adhesins to stem-proteins is desirable 
for live attenuated vaccines, not only to increase the amount of tip 
adhesin molecules presented to the vaccinee’s immune system, but also 
to decrease the metabolic strain on the live attenuated vaccine candidate. 
Using RNA modeling in Geneious software we examined 15 ETEC operons 
of Chaperone-Usher (CU) type fimbriae and searched for genetic features 
controlling the production of tip and stem proteins. A stem-loop region 
was found to follow the stem-encoding genes in all fimbrial operons. We 
hypothesized that decreasing the stem-loop (SL) region would lead to 
decreased production of stem proteins, and therefore shorter fimbriae. 
Operon modification was performed by site-directed-mutagenesis in SL 
regions in CFA/I and CS5 operons cloned in plasmids and transformed into 
the live attenuated Shigella strain CVD 1208S. Clones CFA/I SLD1 and CS5 
SLD6 with modified SL regions were examined with electron microscopy 
using negative staining. The lengths of fimbriae were measured in these 
and in non-modified clones using ImageJ open source software. Guinea 
pigs were immunized with the CVD 1208S-expressing CS5 SLD6 construct 
and serum and tears were analysed by ELISA for IgG and IgA responses 
the CS5 and Shigella LPS respectively. Clone CS5 SLD6 had mean fimbrial 
lengths of 96.5µm, while the wild type operon mean length was 306.7µm, 
p<0.001. Clone CFA/I SLD1 had a mean fimbrial length of 77.0 µm, while 
the wild type operon mean fimbrial length was 613.5 µm, p<0.001. 
In three guinea pigs immunised with CVD 1208S(CS5 SLD6) we found 
strong increases in IgG and IgA antibody towards both Shigella LPS and 
ETEC CS5. Modifying the stem-loop structure in ETEC fimbrial operons 
can be used to increase the tip-to stem protein ratio in live attenuated 
vaccines. The method is also likely to be applicable to other CU fimbriae. 
Further characterization of the CFA/I and CS5 short fimbriae live vaccine 
candidates are ongoing, and results will be presented.
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Diarrheagenic Escherichia coli (DEC) are common pathogens of childhood 
gastrointestinal infections worldwide. To date, research tracking DEC has 
mainly been completed in urban areas. This study aimed to determine 
the prevalence and pathotype distribution of DEC strains in children 
from rural Peruvian communities and to establish their association with 
malnutrition. In this prospective cohort, 93 children aged 6 to 13 months 
from rural communities of Urubamba (Andes) and Moyobamba (jungle) 
were followed for 6 months. Diarrheal and control stool samples were 
analyzed using Multiplex Real-Time Polymerase Chain Reaction (mRT-PCR) 
to identify the presence and virulence genes of DEC strains. A total of 
820 specimens were collected, of which 46 (5.6%) were diarrheal and 
774 (94.4%) were non-diarrheal. A median of 10 stool samples per child 
were collected. The overall isolation rate of DEC was 43.0% (352/820). 
Enteroaggregative (EAEC, 20.4%), Enteropathogenic (EPEC, 14.2%) and 
Diffusely aggregative E. coli (DAEC, 11.0%) were the most prevalent 
pathotypes. EAEC was more frequently found in Moyobamba samples (p 
< 0.01). EPEC was the only strain significantly more frequent in diarrheal 
than asymptomatic control samples (p < 0.01). DEC strains were more 
prevalent among younger children (aged 6-12 months, p < 0.05). A 
decline in Height-for-age Z-score (HAZ) was observed in 75.7% of children 
who completed follow-up (74/93). EAEC was more frequently isolated 
among children who had a greater HAZ decline (p < 0.05). Compared to 
periurban coastal areas, DEC strains were more frequently found in stool 
samples from children in rural communities of the highlands and jungle. 
Additionally, children with a greater decline in their growth rate had higher 
EAEC isolation rates, highlighting the importance of this pathogen in child 
malnutrition.
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BURDEN OF CHOLERA IN THE WHO EASTERN 
MEDITERRANEAN REGION (EMR): A MAPPING EXERCISE
Heather McKay1, Sean Moore1, Abdinasir Abubakar2, Malik 
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Cholera is a persistent public health burden in the WHO Eastern 
Mediterranean Region, but the geographical distribution of risk in the 
region is not well characterized. We conducted an assessment of the 
region’s cholera risk in collaboration with the WHO. Cholera incidence 
data at the lowest available spatial and temporal level between 2005-
2015 were obtained from Ministry of Health focal points in 8 countries: 
Afghanistan, Iran, Iraq, Pakistan, Somalia, Sudan, Syria, and Yemen. A 
literature review of cholera incidence was done to bolster data quality. 
For each country, we searched PubMed for “cholera” and the country 
name, restricted to January 1, 2005-October 31, 2015. A similar search 
of Index Medicus for the Eastern Mediterranean Region was conducted 
to retrieve regional publications not indexed internationally. A search of 
ProMED cholera reports for each country from January 1, 2005 was also 
conducted. Population data were obtained from the WorldPop project. 
Hierarchical models incorporating aggregated counts at different spatial 
scales were used to estimate cumulative incidence. Country-specific maps 
of 5-year cumulative incidence were created. Based upon the received 
cholera surveillance data, a total of 850,869 cases of acute watery 
diarrhea/suspected cholera were reported, including 3,037 confirmations 
and 2,679 deaths. There was notable variability in the quality, 
completeness and type of surveillance data received, both in terms of 
326
astmh.org
geographical resolution (district level: Afghanistan, Pakistan, Sudan (2006 
only), Iraq (2015 only), and Yemen; province level: Iran, Syria, Yemen; and 
national level: Somalia) and time period covered. Afghanistan, Pakistan 
and Somalia experienced seasonal outbreaks associated with the summer 
months. For countries with district-level data, outbreak severity varied, 
with the highest case fatalities observed in Sudan and Somalia. The results 
offer a preliminary characterization of cholera risk in 8 EMR countries. 
The identification of hotspots can inform targeted prevention and control 
efforts, including oral cholera vaccine use and water, sanitation and 
hygiene strategies.
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UNDERSTANDING HOW THE FEEDBACK BETWEEN 
DIARRHEAL DISEASE AND MALNUTRITION IMPACTS THE 
DYNAMICS OF ENTERIC PATHOGEN TRANSMISSION: A 
MATHEMATICAL MODELING APPROACH
Velma Lopez, Marisa Eisenberg, Joseph Eisenberg
University of Michigan, Ann Arbor, MI, United States
There is growing concern that environmental exposure to enteric 
pathogens influences long-term malnutrition-related morbidities- such 
as growth faltering, cognitive development, and chronic inflammation- 
among children under five in the developed world. Indeed, a dangerous 
feedback loop exists between infection and nutrition. This feedback-loop is 
influenced by interacting transmission pathways: nutritional status impacts 
susceptibility to infection, and diarrheal disease impacts absorption of 
nutrients to influence overall nutritional status. Thus, use of standard 
public health tools, such as regression analyses, to study this phenomenon 
violate assumptions of independence and provide little insight into the 
system. Rather, in order to appropriately assess the interconnectedness 
of infection and nutrition pathways a systems-based analysis is required. 
We use a stratified compartmental model, based on ordinary differential 
equations (ODE), to understand the mechanisms through which 
environmental-mediated enteric pathogens transmission is influenced 
by a child’s nutritional status. This model accounts for subclinical and 
clinical infection states with diarrhea causing enteric pathogens stratified 
by malnourished and well-nourished children. Where appropriate, 
bidirectional transmission between nutritional states may occur. Model 
parameters were identified using enteric pathogen transmission rates as 
described in the literature. Through use of this model we present a holistic 
understanding of mechanisms by which environmental enteric dysfunction 
(EED) may be occurring at the community-level, highlighting potential 
opportunities for intervention.
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Maria J. Soto-Giron1, Angela Peña-Gonzalez1, Janet K. Hatt1, 
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The gut microbiota plays a key role in health and prevention of invasion by 
pathogens. Environmental factors as well as host genetics and physiology 
shape the gut microbiota composition. Previous studies have reported 
that urban lifestyles impact the gut microbiota structure, revealing higher 
fecal bacterial diversity in less industrialized compared to industrialized 
settings. In this study, we sought to understand how geographical factors, 
including access to clean water and sanitation facilities, influence the 
signature of commensal gut microbiota in healthy individuals sampled 
as part of a case control study of diarrhea in four sites along a rural to 
urban gradient in Ecuador. Because diarrheal diseases are an important 
global health concern mainly in developing countries and little is known 
about the protective role of microbial diversity during diarrhea infection, 
we also evaluated the response of the gut microbiota during acute 
diarrheal disease (ADD). Preliminary taxonomic surveys based on 16S rRNA 
gene sequences in a group of 13 individuals living across a gradient of 
remoteness in Northern Ecuador showed that non-ADD (healthy) samples 
from individuals living in remote villages (rural areas) presented higher OTU 
richness than those living close to the main city. The estimated number 
of bacterial species in ADD samples was significantly decreased upon 
infection (paired t-test, p = 0.01). Based on these promising results, we are 
currently profiling the gut microbiota of 120 fecal samples obtained from 
60 individuals living along a more extensive urban-rural gradient and we 
will report on the results of this analysis. This study combines the effects 
of enteric infection and geographical factors on the gut microbiome into 
the same analysis to gain a better understanding on how resilience and 
geography modulate the gut microbial response during an acute infection.
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THE USE OF ZINC FOR TREATMENT OF CHILDHOOD 
DIARRHEA IN RURAL WESTERN KENYA, 2010-2014
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Diarrhea is a leading cause of morbidity and mortality among children 
globally. The World Health Organization Integrated Management of 
Childhood Illness recommends zinc and oral rehydration solution (ORS) for 
treatment of all childhood diarrhea irrespective of concurrent symptoms or 
diagnoses. ORS has been used for decades while the recommendation for 
zinc in Kenya was implemented in March 2010. Limited data are available 
on the uptake of zinc for diarrhea management. From June 2010 to May 
2014 we examined factors associated with use of zinc among children 
aged <5 years with medically-attended diarrhea within a population-based 
infectious disease surveillance platform in rural western Kenya (population 
<5 years ~4,200). Participants received free care at a study clinic where 
history of illness, signs/symptoms, diagnosis and management were 
captured in a structured questionnaire. Diarrhea was defined as ≥3 loose 
stools in 24 hours. Overall 1,561 cases of diarrhea among 1,123 children 
were managed at the clinic; 870 (56%) cases were treated with both zinc 
and ORS, 44 (3%) cases received zinc without ORS, and 657 (41%) cases 
received no zinc. Factors positively associated with use of zinc included a 
history of vomiting everything (OR 1.4, 95% CI 1.1-1.8), sunken eyes (OR 
2.3, 95% CI 1.4-3.9), unable to feed/ breastfeed (OR 2.6, 95% CI 1.2-5.6) 
and treatment with ORS (OR 19.7, 95% CI 13.6-28.5). Children aged ≥24 
months were less likely to receive zinc compared to children aged <24 
months (odds ratio [OR] 0.6, 95% confidence interval [CI] 0.5-0.8). Other 
factors negatively associated included mucus in diarrhea (OR 0.7, 95%CI 
0.6-0.9), malaria diagnosis (OR 0.5, 95%CI 0.3-0.9), treatment with 
antibiotics (OR 0.3, 95%CI 0.2-0.4) and anti-malarials (OR 0.5, 95%CI 
0.3-0.9). Overall the use of zinc for diarrhea management was low. Young 
children at risk for dehydration are more likely to receive zinc. However 
clinicians seem to be underutilizing zinc for older children and those with 
a concurrent clinical diagnosis such as malaria. Further training of health 
care workers on recommendations for zinc use is needed.
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DECREASED VIRULENCE ASSOCIATED WITH INCREASE 
EARLY PRO-INFLAMMATORY CYTOKINE INDUCTION BY 
MYCOBACTERIUM AFRICANUM INFECTED IN MATURE 
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Mycobacterium africanum (MAF) having been sub-divided into MAF West 
African 1 (MAF1) (Lineage 5) and MAF West African 2 (MAF2) (Lineage 6), 
are 2 distinct phylogenetical lineages within Mycobacterium tuberculosis 
complex (MTBC) and together with Mycobacterium tuberculosis sensu 
stricto (MTBss) (Lineage 4) are the cause of human tuberculosis (TB) in 
West Africa. However within central West Africa, Ghana represent one of 
the few countries (Sierra Leone, Ivory Coast and Benin) that are known 
to have both distinct phylogenetic lineages of MAF. Thus there is little or 
no knowledge available as to whether their genetic diversity may have a 
significant variation in terms of virulence in a host-pathogen interaction 
compared to MTBss.Strains of Lineage 5 and Lineage 6 circulating in 
South-Western Ghana as well as a comparator Lineage 4 (Cameroon 
sub-lineage) were identified. We assessed two virulence associated 
characteristics: mycobacterial growth in mature human monocyte-derived 
macrophages (MDM) and early pro-inflammatory cytokine induction 
from 4hrs to 72hrs.In MDM, Lineage 5 strains grew significantly slower 
than Lineage 4 strains from 24hrs to 72hrs (p&lt0.05). Similarly Lineage 6 
strains also grew significantly slower than Lineage 4 strains over the same 
time period (p&lt0.05). In contrast the mean doubling time of Lineage 
5 strains was significantly higher than Lineage 4 strains (p&lt0.05) at 
72hrs. Likewise Lineage 6 strains were significantly higher than Lineage 
4 strains (p&lt0.05). Lineage 5 strains induced higher levels of early pro-
inflammatory cytokines (TNF-α, IL-6 and IL-12p70) than Lineage 4 strains 
from 24hrs to 72hrs (p&lt0.05). Similarly Lineage 6 strains also induced 
higher levels of pro-inflammatory cytokines than Lineage 4 strains over the 
same time period (p&lt0.05).The data shows MAF had a low intracellular 
growth rate and a higher doubling time in MDM. Likewise MAF induced 
hyper-inflammatory response thereby inducing a ‘slow growth’ phenotype 
highlighting the point that MAF indeed has lower virulence and longer 
latency leading to slower progression to active disease in the host.
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ANTIBIOTIC RESISTANCE PATTERNS OF COMMON GRAM-
NEGATIVE UROPATHOGENS IN ST. PAUL’S HOSPITAL 
MILLENNIUM MEDICAL COLLEGE, ETHIOPIA
Yeshwondm Gebresilasie Mamuye
St. Paul’s Hospital Millennium Medical College, Addis Ababa, Ethiopia
The resistance of bacteria causing urinary tract infection (UTI) to 
commonly prescribed antibiotics is increasing both in developing as 
well as in developed countries. Resistance has emerged even to more 
potent antimicrobial agents. The study was undertaken to report the 
last three year antibiotic resistance pattern among common bacterial 
uropathogens in St.paul’s Hospital Millennium Medical College. A total 
of 2544 urine samples were processed in the last three years starting 
from September 2012 to 2015. Inoculation was performed onto blood 
agar and MacConkey agar symoultaniously. Significant bacteriuia was 
considered with colony counts greater than 105cfu/ml, for a single isolated 
bacterium. Isolated organisms were identified by conventional biochemical 
methods. Antibiotic susceptibility was done by Kirby Bauer disk diffusion 
method. Data entry and analysis was done using SPSSv20. Of the total 
2544 samples, 569(22.4%) showed significant growth. Gram negative 
organisms totaled 508(20.0%), and 61(2.4%) isolates were gram positive. 
The most frequently isolated gram negative bacterium was E. coli followed 
by Proteus and Klebsiella spp. 305 (12.5%), 102(4.0%), and 42(1.7%) 
respectively. Between 2012 and 2013, the resistance rate to Tetracyclin, 
Ampicilin, Amoxycilin, and Nalidixic Acid was reported as 69%, 64% 
and 67% respectively. In 2014, the study showed that resistance pattern 
for all except to tetracycline becomes increased 65%, 78% and 78%. 
In 2015, however, there was no a single organism which is sensitive to 
the above listed drugs. The study also showed an emerging resistance 
to Ciprofloxacilin and Ceftriaxone especially for common gram-negative 
bacteria. There was relatively low resistance rate to Nitrofurantoin, 
Gentamycin, and Trimethoprim-Sulfamethoxazole throughout the years. 
In conclusion, in this study setting resistant rate to Tetracyclin, Ampicilin, 
Amoxycilin, and Nalidixic Acid were high. Increasing antibiotic resistance 
trends indicate that it is imperative to rationalize the use of antimicrobials 
in the community and also use these conservatively.
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FIVE-YEAR SURVEILLANCE OF DIPHTHERIA OUTBREAK IN 
INDONESIA
Dominicus Husada1, Dwiyanti Puspitasari1, Leny Kartina1, 
Ismoedijanto Moedjito1, Parwati S. Basuki1, Bambang W. Kartiko2
1School of Medicine. Airlangga University, Surabaya, Indonesia, 2East Java 
Provincial Health Office, Surabaya, Indonesia
Diphtheria outbreak has become a major problem in Indonesia since 2011. 
East Java province in Java Island is the most severely affected area. The 
objective of this study is to analyze the five-year (2011-2015) surveillance 
report of diphtheria outbreak in East Java Indonesia. This study was based 
on surveillance data collected at East Java Provincial Health Office from 
all districts since January 2011 until December 2015. The data came from 
the district and provincial hospitals, the local health officers, the family 
of the patients, and the contacts. Microbiology data were collected from 
one international standard diphtheria laboratory in Surabaya. Here are the 
results. For five years period since 2011, there were 3004 cases reported 
from 38 districts (100%), with the peak at 2012 (955 cases). Based on 
WHO data, this number was the second rank in the world after India. 
The case fatality rate was 3.4% (103 patients). Male (1607, 53.4%) 
slightly outnumbered female. Although most patients were below 15 
years old (2111, 70.2%), the trend showed the increasing proportion of 
adults. In 2012, based on the immunization status, the percentage of 
unimmunized patients, partially immunized, and completely immunized 
by age were 39%, 49.3%, and 11.7%, respectively. Among those 
deceased, the youngest and oldest age were 11 month and 70 years, 
respectively. Only 187 nasal and throat swab specimen were positive for 
toxigenic Corynebacterium diphtheriae. Despite many efforts such as 
multiple outbreak response immunization (ORI) especially in 2011-2013 
this outbreak could not be stopped. As the conclusion, for five years since 
2011 there was a diphtheria outbreak in East Java Indonesia. The highest 
number of patient was in 2012. Most of the patients were not completely 
immunized. The positivity rate of microbiology culture was low. Many 
actions in affected area has not been enough to stop the problem.
1045
TRENDS OF SEVERITY AND OUTCOMES OF PATIENTS 
WITH PNEUMOCOCCAL PNEUMONIA IN RELATION TO 
SEASONALITY IN NORTHERN AND SOUTHERN HEMISPHERES
Ahmed Babiker1, Siddartha Bhandary1, Jennifer Fuh2, Jose 
Bordon1, Community Acquired Pneumonia Organisation (CAPO)
1Providence Hospital, Washington, DC, United States, 2A.T. Still University 
School of Osteopathic Medicine, Mesa, AZ, United States
Despite efficacious antibiotics and vaccines, pneumococcal pneumonia 
remains a major cause of morbidity and mortality. Incidence of invasive 
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pneumococcal disease demonstrates a distinct seasonal course in 
temperate climates, with infection incidence peaking in winter months, 
the forces which drive this seasonality remain poorly understood. 
Understanding the trends of invasive pneumococcal pneumonia can 
aid prevention of pneumococcal pneumonia mortality, which has been 
reported as upwards to 60% in susceptible populations. We investigated 
the trends and outcomes of patients with invasive pneumococcal 
pneumonia in relation to seasonality in the northern and southern 
hemispheres using data from the Community Acquired Pneumonia 
Organization (CAPO) databas, an international database of confirmed 
community-acquired pneumonia cases. Cases of blood cultures positive 
Streptococcus pneumoniae from multiple sites from both northern and 
southern hemispheres were included in the anyalsis. Cases from sites 
with tropical climates were excluded. Prevalence by season was analyzed 
by chi square testing. Mortality by season was analyzed by multivariable 
logistic regression, adjusting for pneumonia severity index score, ICU 
admission, history of chronic obstructive pulmonary disease, and 
pneumococcal bacteremia. Time to clinical stability and length of hospital 
stay were analyzed using Kaplan Meier survival curves. Of 4,507 cases of 
pneumococcal pneumonia, 425 cases met the inclusion criteria. Winter, 
spring, summer, and fall accounted for 36%, 29%, 9%, and 26% of 
the cases, respectively. There was a significant decrease in the incidence 
of invasive pneumococcal pneumonia during the summer (p<0.001). Of 
the 425 cases, 317 (75%) occurred in the northern hemispheres and 108 
(25%) in the southern hemisphere. There was no significant difference 
in mortality, time to clinical stability, or length of hospital stay between 
these two groups. We found that incidence of pneumococcal pneumonia 
exhibited a marked seasonality in both hemispheres. However, we found 
no association between clinical outcome and season of the year.
1046
MOLECULAR-BASED ASSAYS REVEAL STREPTOCOCCUS 
PNEUMONIAE AS THE LEAD ETIOLOGICAL AGENT IN THE 
ONGOING MENINGITIS EPIDEMIC IN GHANA
Alexander Kwarteng
Kumasi Centre for Collaborative Research in Tropical Medicine, Kumasi, 
Ghana
Like most other countries within the meningitis belt, Ghana experiences 
sporadic outbreaks of bacterial meningitis frequently; however, the current 
epidemic in Ghana has received significant impact and media attention. 
In response to the current bacterial meningitis epidemic in Ghana, rapid 
diagnostic test kits such as Pastorex, a family of rapid, latex agglutination 
test and Gram stain are used for detecting meningitis within affected 
health facilities. However, these tests fail to identify the serotype of the 
bacteria causing the infection, which is critical to initiating population-
level interventions such as vaccination. We therefore aimed to use 
molecular techniques to aid in the characterization of suspected agents 
responsible for the current epidemic of meningitis in Ghana. To determine 
the prevalence and etiology of meningitis, we investigated cerebrospinal 
fluid (CSF) specimen from 161 individuals suspected of meningitis using 
standard microbiological methods and a Fast Track Diagnostics (FTD, 
Luxemburg) real time multiplex polymerase chain reaction (PCR) assay. This 
multiplex PCR assay consists of primer/probe mix and allows simultaneous 
detection of N. meningitidis, S. pneumoniae and H. influenzae. In all, 
93.3% (148/161) of the cases were from the Brong-Ahafo region, while 
the remaining were from Greater Accra and Ashanti regions. In total, 
53% (85/161) were female with median age of 21 (0.3 - 83 years) for 
both sexes. A total, 48% (77/161) of the patients were positive for 
bacterial meningitis; 73% (56/77) were Streptococcus pneumoniae, 
26% (20/77) were Neisseria meningitidis, while 1% (1/77) was positive 
for Haemophilus influenzae. Interestingly, 2.6% (2/77) patients were co-
infected with both S. pneumoniae and N. meningitidis. PCR-based assay 
implicates S. pneumoniae as the principal etiologic agent followed by N. 
meningitidis in the ongoing meningitis epidemic in Ghana. In addition to 
providing necessary logistics and other interventional measures, we highly 
recommend existing research institutions and referral hospitals within the 
affected regions should be equipped with molecular based-capacities.
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THE MOLECULAR EPIDEMIOLOGY OF STAPHYLOCOCCUS 
AUREUS SKIN AND SOFT TISSUE INFECTIONS IN THE LAO 
PEOPLE’S DEMOCRATIC REPUBLIC
Alicia D. Yeap1, Kate Woods2, David Dance2, Bruno Pichon1, 
Sayaphet Rattanavong2, Viengmon Davong2, Paul N. Newton2, 
Nandini Shetty1, Angela M. Kearns1
1Antimicrobial Resistance and Healthcare Associated Infections Reference 
Unit, National Infection Service, Public Health England, London, United 
Kingdom, 2Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit, 
Microbiology Laboratory, Mahosot Hospital, Vientiane, Lao People’s 
Democratic Republic
This is the first report of the molecular epidemiology of Staphylococcus 
aureus from skin and soft tissue infections (SSTI) in Laos. Neighbouring 
countries report high MRSA rates but these are rare in Laos. We selected a 
randomized sample of 96 S. aureus isolates from SSTI samples received at 
Mahosot Hospital Microbiology Laboratory, Vientiane, between July 2012 
- June 2014, including representation from 7 referral sites. All isolates 
underwent susceptibility testing by CLSI methods, spa typing and DNA 
microarray analysis (Alere Technologies). Whole genome sequencing was 
performed for rarely described lineages. 43 spa types, representing 17 
different lineages, were identified. Median age was 19.5 years (IQR 2-48.5 
years); 52% were female. The dominant lineage was CC121 (n=39; 41%): 
all but one encoded Panton-Valentine leukocidin (PVL) and 49% (n=19) 
were recovered from children aged <5 years. 58% of all isolates (n=56) 
encoded PVL (representing 6 lineages); half of these (28/56) had abscesses; 
3 had positive blood cultures. S. argenteus (part of the S. aureus-related 
complex) was identified in 6 (6%) cases; mostly adults >50 years and 
diabetics. 6 isolates (6%) belonged to a rare lineage, ST2885, with 3 
possibly associated with cross-infection in a paediatric intensive care unit. 
One previously undescribed strain was identified (sequence type pending). 
Resistance to antibiotics was uncommon, except for penicillin (93; 97%), 
tetracycline (48; 50%) and fosfomycin (64; 67%) predominantly encoded 
by blaZ, tet(K) and fosb respectively. 7 (7%) MRSAs were identified, 
belonging to ST239-MRSA-III, CC59-MRSA-V(T) Taiwan Clone, ST2250-
MRSA-IV, ST2885-MRSA-V and CC398-MRSA-V: 3 patients had had recent 
healthcare contact and 1 had recently travelled. Globally widespread 
CC5 and CC30 were absent. Our report shows parallels between Laos 
and neighbouring countries, highlights the prominence of PVL in SSTI 
and suggests infiltration of MRSA clones of epidemic potential from 
surrounding countries. Continued vigilance is warranted considering the 
paucity of antibiotic options in Laos and challenges for robust infection 
prevention and control.
1048
DISTINCT ARRANGEMENTS OF VIRULENCE GENE 
EXPRESSION IN UROPATHOGENIC ESCHERICHIA COLI 
STRAINS
Gloria Luz Paniagua Contreras, Eric Monroy Pérez, Tania 
Hernández Jaimes, Ma. Patricia Sánchez Yáñez, Susana Esther 
González Almazán, Sergio Vaca
Universidad Nacional Autonoma de Mexico FES Iztacala, Tlalnepantla, 
Mexico
Most urinary tract infections (UTIs) are caused by uropathogenic 
Escherichia coli (UPEC). The aim of this study was to determine the 
patterns of expression of genes coding for iron uptake (iuc, iroN and irp2), 
adhesins (fim, afa1, sfa, iha, tsh, papGI, papGII and papGIII ), protectins 
(KpsMT, ompT and iss) and toxins (cnf1, hlyA, set-1, astA, vat, usp and 
cva/cvi) in UPEC strains. Using standard biochemical tests, followed by 
PCR amplification of 16S rRNA gene, we identified 194 strains as E. coli, 
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which were isolated from patients with UTIs at Unidad Médica Familiar 
No. 64 (Instituto Mexicano del Seguro Social), Estado de México. Virulence 
gene expression in UPEC strains was determined by real-time PCR after 
infection of in vitro cultured A431 human vaginal cells. Sixty-eight percent 
(n=132) of UPEC strains expressed iuc gene; 65% (n=126) iha; 61.3% 
(n=119) KpsMT; 59.2% (n= 113) fim; 48.4% (n=94) irp2; 31.4% (n=61) 
set-1; 31% (n=60) astA; 15.5% (n=30) papGII; 12.3% (n=24) afaI; 11.8% 
(n=23) hlyA; 10.3% (n=20) iroN; 9.8% (n=19) ompT; 5.7% (n=11) papGIII 
and vat, in each case; 4.1% (n=8) papGI and iss, in each case; 3.1% (n=6) 
iuc; 2.6% (n=5) sfa and tsh, in each case; 1.5% (n= 3) cva/cvi and 0% 
cnf1. A total of 106 distinct arrangements of virulence gene expression 
were identified in the UPEC strains. The most abundant of them (irp2/
fim/iha/kpsMT/usp: iron acquisition system/ adhesins/protectin/toxin) was 
represented by 28 strains (14.1%). Findings of this study revealed that 
combinations of virulence genes are expressed during infection of A431 
cells with UPEC strains, showing that these strains could be highly virulent 
and cause more severe infections as cystitis or pielonephritis.
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METHICILLIN-SENSITIVE AND METHICILLIN-RESISTANT 
STAPHYLOCOCCUS AUREUS (MRSA) CARRIAGE AT A 
UGANDAN REGIONAL REFERRAL HOSPITAL
Lisa M. Bebell1, Arnold Ayebare2, Yap Boum II3, Mark J. 
Siedner1, Joel Bazira2, Steven J. Schiff4, Joshua P. Metlay1, David R. 
Bangsberg1, Stephen Ttendo2, Paul G. Firth1
1Massachusetts General Hospital, Boston, MA, United States, 2Mbarara 
University of Science and Technology, Mbarara, Uganda, 3Epicentre 
Research Base, Mbarara, Uganda, 4The Pennsylvania State University, 
Hershey, PA, United States
Despite increasing antimicrobial resistance globally, data are lacking on 
the prevalence and associated risk factors for Staphylococcus aureus (SA) 
and methicillin-resistant SA (MRSA) carriage in low-resource settings. 
We enrolled a cross-sectional sample of 500 Ugandan adults from a 
predominantly rural agricultural area seeking care at a regional referral 
hospital or clinic, swabbed anterior nares, and tested for SA and MRSA 
carriage using Cepheid Xpert SA Nasal Complete assay. Mean age was 
37 years and 322 (65%) were female. Of 498 participants reporting 
clinical data, 368 (74%) were currently taking antibiotics, 118 (24%) 
were recently hospitalized, and 315 (63%) had known risk factors for 
SA infection including open wounds (188; 38%), rash (99; 20%), recent 
immunosuppression (66; 13%), or HIV infection (166; 33%). Of 499 
samples with a valid Xpert result, 145 (29%) were SA positive and 14 
(2.8%) were MRSA positive. SA carriers were more likely than SA non-
carriers to be male (44 vs. 32%, P=0.008) or have a chronic disease (61 
vs. 47%, P=0.005), but less likely to report recent β-lactam antibiotic use 
(63 vs. 73%, P=0.02) or open wounds (32 vs. 40%, P=0.07). SA carriage 
ranged from 19% on maternity ward to 36% on medical ward (P=0.04). 
Though cases were few, MRSA carriers did not differ from non-carriers 
by sex (50 vs. 35% male, P=0.25) or chronic disease status (71 vs. 50%, 
P=0.17), but were more likely to be inpatients (86 vs. 59%, P=0.05), 
have an open wound (71 vs. 37%, P=0.01) have contact with pigs (21 vs. 
5%, P=0.04); and less likely to report recent β-lactam use (43 vs. 71%, 
P=0.02). MRSA carriage ranged from 0% in HIV clinic to 8% on surgical 
ward (P=0.01). Using multivariable logistic regression, independent 
predictors of SA carriage were chronic illness (OR 1.73, P=0.007) and 
female sex (OR 1.69, P=0.01). β-lactam use was protective (OR 0.6, 
P=0.02). In Uganda, we found low overall prevalence of MRSA carriage, a 
protective association between β-lactam use and SA and MRSA carriage, 
and no association between carriage and HIV status. Further research 
should explore possible increased prevalence of MRSA carriage among 
hospitalized surgical patients.
1050
DEFINING THE MECHANISMS OF PROTECTIVE IMMUNITY 
ELICITED BY TWO VACCINE CANDIDATES AGAINST ORIENTIA 
TSUTSUGAMUSHI INFECTION
Chien-Chung Chao1, Wei-Mei Ching1, Lindsey Ledbetter2, Laura 
Schoenlaub2, Guoquan Zhang2
1Naval Medical Research Center, Silver Spring, MD, United States, 
2University of Missouri-Columbia, Columbia, MO, United States
Scrub typhus is an acute, febrile and potentially fatal disease and 
caused by infection with the obligate intracellular bacterium, Orientia 
tsutsugamushi. It is the most common rickettsial disease seen in the 
Asia-Pacific region. Since there is no vaccine available, creation of a 
safe and effective vaccine remains an important goal for public health. 
Recombinant antigens r56kp and r47kp have been shown to provide 
up to 100% protection in a mouse challenge model with two different 
strains. However, the mechanisms of protective immunity against O. 
tsutsugamushi challenge induced by these antigens remain unclear. To 
determine whether r56kp or r47kp subunit vaccine-induced protection 
depends on antibody- or T cell-mediated protective immunity in mouse 
models, we investigated 1) if adoptive transfer of either immune sera or 
T cells from r56kp- or r47kp-vaccinated mice would provide protection 
against O. tsutsugamushi challenge in naive recipient C3HeB/FeJ mice; 2) 
whether depletion of CD4+ T cells or CD8+ T cells would affect the ability 
of r56kp and r47kp vaccine to confer protection against O. tsutsugamushi 
challenge in C3HeB/FeJ mice; and 3) if B cell, T cell, CD4+ T cell or CD8+ 
T cell deficiency in mice would significantly affect the ability of r56kp and 
r47kp vaccine to confer protection against O. tsutsugamushi challenge. 
Our results suggest that i) both B cells and T cells contributed to r56kp 
and r47kp vaccine induced protection; ii) antibody and B cells may play 
a critical role in r56kp vaccine-induced protection; and iii) T cells may be 
more crucial for r47kp vaccine-induced protection.
1051
SCRUB TYPHUS: A LONG NEGLECTED PUBLIC HEALTH 
THREAT IN THE ASIA-PACIFIC AREA AND WORLDWIDE
Guang Xu, Christine M. Arcari, Daniel Jupiter, Peter C. Melby, 
David H. Walker
The University of Texas Medical Branch, Galveston, TX, United States
Scrub typhus is a serious public health problem in the Asia-Pacific area. 
It threatens one billion people globally, and causes illness in one million 
people each year. It can cause severe multiorgan failure with a case-
fatality rate up to 30% without appropriate treatment. The antigenic 
heterogeneity of Orientia tsutsugamushi results in reinfection with scrub 
typhus. As a neglected disease, there is still a large gap in our knowledge 
of the disease, as evidenced by the sporadic epidemiologic data and other 
related public health issues regarding scrub typhus in its endemic areas. 
Our objective is to provide a systematic analysis of current epidemiology, 
diagnosis, treatment, prevention and control of scrub typhus in its endemic 
area and the rest of the world. Preliminary studies have demonstrated 
the wide and long existence of this endemic disease. We analyzed 
the epidemiology of scrub typhus through a thorough review of the 
epidemiology and public health impact of the disease. This study leads us 
to understand the disease, and provides a foundation for prevention and 
control. We then described the diagnosis and treatment of scrub typhus, 
which facilitates the development of the next generation of diagnostics 
and treatment. Atypical flu-like symptom and repeated failure to respond 
to antibiotics make the diagnosis and treatment considerably challenging. 
The last part of the project focuses on the prevention and control of scrub 
typhus in the Asia-Pacific region and worldwide. The antigenic diversity 
impedes vaccine development for the prevention of the disease. Our 
laboratory has been working on the interactions between host immunity 
and the pathogen. This analysis could largely benefit the control and 
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prevention of scrub typhus. The research also provides foundations for 
exploring new measures for other infectious diseases and public health 
threats.
1052
PERSISTENCE OF ST217 CLONAL COMPLEX LINEAGE B OF 
SEROTYPE 1 PNEUMOCOCCAL MENINGITIS IN NORTHERN 
GHANA - THE PROSPECT OF PNEUMOCOCCAL VACCINES IN 
AFRICAN MENINGITIS BELT
Eyako K. Wurapa
Walter Reed Army Institute of Research, Silver Spring, MD, United States
Sporadic outbreaks of Serotype 1 pneumococcal meningitis were observed 
in Northern Ghana between 1998 and 2005 period. To monitor the 
molecular epidemiology of this strain, a hospital case- based surveillance 
was maintained from 2006 to 2011 period. Case and Laboratory based 
surveillances on pneumococcal meningitis were conducted. Specimens 
collected were analyzed using classical and molecular microbiology. The 
incidence rate was 18/100,000/population-year. Since the detection of 
ST217 clonal complex lineage B of serotype 1 pneumococci in this region, 
this clone persisted for 13 years as the main aetiology. The risk population 
shifted from the very younger children to adult age group. The host age 
distribution pattern was more associated with the biology of the strain 
than the exposure history of the study population. In conclusion, the 
incidence and case-fatality rates declined by 3 and 7 percentage points, 
respectively Nevertheless, the changes in age distribution pattern has 
major policy, programmatic and research implications. The immunization 
strategy ought to be refined to cover the new at risk population. Strategic 
platform ought to be developed to coordinate research outcomes of 
other allied scientist in Ghana to manage pneumococcal infection 
comprehensibly. Sero-surveillance should be conducted to evaluate the 
impact of PCV13 introduced in Ghana in 2012. Further research will be 
needed to consolidate our understanding on the association between 
strains’ biology and host-age trends.
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PREVALENCE OF MATERNAL CARRIAGE OF GROUP B 
STREPTOCOCCUS AND ESCHERICHIA COLI IN SOUTHERN 
MOZAMBIQUE
Lola Madrid1, Sonia Maculuve2, Alba Vilajeliu3, Emma Sáez-
López1, Sergio Massora2, Anelsio Cossa2, Sara Soto1, Betuel 
Sigaúque2, Clara Menéndez1, Quique Bassat1
1ISGlobal, Barcelona Ctr. Int. Health Res. (CRESIB), Hospital Clínic - 
Universitat de Barcelona, Barcelona, Spain, 2Centro de Investigação 
em Saúde de Manhiça (CISM), Maputo, Mozambique, 3Department of 
Preventive Medicine and Epidemiology. Hospital Clínic - Universitat de 
Barcelona, Barcelona, Spain
Group B streptococcus (GBS) and Escherichia coli are leading causes of 
neonatal sepsis in many industrialized countries. Reports from low-income 
countries infrequently identify those pathogens among newborns with 
sepsis. We assessed the prevalence of GBS and E.coli colonization among 
pregnant women in a rural Mozambican hospital. A cross sectional 
study was conducted on pregnant women attending Manhiça District 
Hospital at two different time-points during their pregnancy (1: during 
routine antenatal clinics (AC) at gestational age >34 weeks; 2: at delivery, 
regardless gestational age). Samples from lower genital tract and rectum 
for GBS and a vaginal sample and urine for E.coli determination were 
cultured. Thirty-six of the 200 pregnant mothers recruited at the AC (18%) 
were GBS carriers. Twenty-five of them (12.5%) had positive E.coli culture 
in their vaginal samples and 4/200 (2.0%) in the urine cultures for E.coli. 
One hundred and twenty mothers were recruited at delivery. Prevalence 
of GBS carriers in this group was 26.7% (32/120) and 22.5% (27/120) 
had positive E.coli culture in vaginal samples and 5% (6/120) in urine. 
Colonization by E. coli vaginal was significantly more common in women 
recruited at delivery (OR: 2.0, 95% CI 1.1-3-7). HIV-positive status was 
positive for 117/320 women (36.6%). There was no association between 
being colonized by GBS and HIV-positive status or others maternal risk 
factors. Almost 10% of the GBS isolates were resistant to penicillin (5.8% 
intermediate resistance and 3.8% fully resistant), the usual antibiotic 
utilized in the developed world to prevent GBS vertical transmission. All 
GBS isolates except three (2.9%) were sensitive to ampicillin, two of which 
were highly resistant to both ampicillin and penicillin. We will present 
results of serotyping and maternal antibodies. The study showed that 
GBS colonization among near term pregnant mothers is reasonably high 
in our community. Since screening and intrapartum antibiotic prophylaxis 
is difficult to implement in low-income countries, effort to prevent GBS 
vertical transmission should lead to provide effective vaccines.
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QUANTIFYING THE INDIRECT EFFECTS OF HAEMOPHILUS 
INFLUENZAE TYPE B VACCINATION IN CHILDREN UNDER AGE 
5 YEARS
Anwesha Majumder, Brian Wahl, Maria D. Knoll, Katherine L. 
O’Brien
Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United 
States
Haemophilus influenzae type b (Hib) was a significant cause of morbidity 
and mortality among children under 5 years before an effective vaccine 
became available. Hib vaccine reduced disease beyond that expected 
from direct protection alone, indicating indirect effects in those not 
vaccinated provide meaningful protection. We modeled the magnitude 
of indirect effects as a function of time and population-level vaccine 
coverage. We regressed the observed disease reduction from pre-post 
vaccine introduction on the proportion vaccinated among children <5 
years. We also compared the observed disease reduction to the expected 
disease reduction (calculated using the <5 age distribution of invasive 
Hib disease before vaccine introduction and vaccine rollout schedule) due 
to direct effects alone to estimate an indirect effect multiplier that can 
be used to calculate vaccine “effective coverage” to more completely 
estimate the proportion of the population protected against disease. 
We validated results by comparing to a study that empirically measured 
indirect effects on individuals. Using 23 data points identified from 10 
studies, the model estimated that 40% vaccine coverage results in 39% 
(95%CI: 23%, 55%) additional children protected by indirect effects (i.e., 
79% effective coverage), the highest indirect effect multiplier (x1.39) 
estimated; with 60% vaccine coverage over 85% (95%CI: 69%, 100%) 
disease reduction was predicted. The magnitude of the indirect effect 
reduces as vaccine coverage increases. Modeled results were similar to 
those measured empirically. In conclusion, the indirect effects of Hib 
vaccine in unvaccinated children have substantial impact on disease and 
in conditions of moderate (e.g., 40%) vaccine coverage can almost equal 
direct effects. These results can be used to improve estimates of expected 
disease reduction due to vaccines and should be incorporated into cost-
effectiveness analyses. This approach can be applied to other vaccines, 
such as pneumococcal conjugate vaccine, which may impact vaccination 
policy decisions regarding introduction.
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BACTERIAL VAGINOSIS IN DAKAR (SENEGAL) IN 2015
Awa Ba Diallo1, Abdou Salam Mbengue2, Makhtar Camara1, 
Halimatou Diop Ndiaye1, Farba Karam2, Habsa Diagne Samb2, 
Safietou Ngom Cisse2, Coumba Toure Kane1, Souleymane Mboup1, 
Aissatou Gaye Diallo1
1Cheikh Anta Diop University, Dakar, Senegal, 2Bacteriology Virology 
Laboratory at Dantec Hospital, Dakar, Senegal
To point-out the importance of bacterial vaginosis (BV) in genital infections 
and to determine epidemiological, clinical and paraclinical factors linked to 
BV in Dakar. 1509 females patients enrolled in this study were interviewed 
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prior to the vaginal fluid collections. Prior to microscopic examination, 
both genital area and fluids were observed macroscopically. Cultures were 
performed for bacterial and fungal microorganisms. BV diagnosis was 
based on the presence of clue cells, pH > 4.5, and absence of Lactobacilli. 
Statistical analysis was done by Khi2 test and the Odds ratio. Among 1509 
females, 33.5% had BV, 21% had Candida, 2.3% Trichomonas vaginalis 
infection and only 0.4% (N=6) were with gonorrhea. We found more BV 
from females aged from 25-34 than those aged from 35-44. But Odds 
ratio shows that BV is not linked to any age. BV is more found in married 
women than in celibate. In most of cases, genital area was normal. 35.7% 
cervix were found in association with BV. 39.8% of inflammatory reaction 
were linked to BV. In 23.1% of BV Gardnerella vaginalis was associated 
with Mobilluncus. Vagina flora was type III or IV in 99.2% of cases. In 
Dakar, BV belongs to the major genital infections and its management 
must be effective in Gynecologic and Obstetric services and also in 
National Campaign against AIDS since it eases the transmission of HIV.
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Antibiotic resistance is one of the greatest threats to the global health. 
Methicillin-resistant Staphylococcus aureus (MRSA) is distributed 
worldwide and asymptomatic carriers can be a source of transmission. 
Military personnel are exposed to some characteristics such as being in 
close quarters, less opportunities for hygiene during training and combat 
operations, etc., that make them susceptible to being colonized by S. 
aureus, and increasing the risk of infections by S. aureus as it occurs in 
military trainees. We conducted a prospective cohort study at the four 
largest bases of the Peruvian Air Force, collecting nasal swabs from 756 
active duty military personnel (655 at baseline, and 101 at 6 month visit) 
during 1-year. The goal was to assess the rates of nasal colonization with 
S. aureus at baseline, after 6 months and 1-year follow-up. The samples 
were cultured to identify the presence of S. aureus, and the antimicrobial 
resistance profile was assessed via disk diffusion. We analyzed the change 
in the nasal colonization status among those participants who provided 
at least 2 samples. Only 484 participants met this requirement (390 after 
6 months and 94 after 1 year). Nasal colonization with S. aureus was 
lower at baseline (9.7%, n=73/655), but increased over the study period 
up to 20.4% (n=70/343) among those who supplied a sample at 1-year 
visit. The incidence rate of nasal colonization (those who changed from 
negative to positive status) was 11.2%, while the percent clearance was 
51%. Two participants were colonized with a MRSA strain (USA 300, 
SCCmec type IV) after 6 months of follow-up. At 12 months we did not 
isolate MRSA strains among our participants. The risk of being colonized 
with S. aureus among those participants with a first negative sample, 
increased in those with a diagnosis of skin and soft tissue infections or 
who were mobilized to different geographic areas due to military missions 
but none of them was statistically significant. This was the first study to 
systematically determine the prevalence and the molecular characteristics 
of MRSA among Peruvian active duty military population in multiple cities 
in the country.
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BY REDUCING ACTIVATION OF CD8+ T CELLS AND 
INCREASING PRODUCTION OF IL-10 BY T CELLS IN MURINE 
ORIENTIA TSUTSUGAMUSHI INFECTION
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Jacobs2, Bernhard Fleischer2
1Institute of Virology, Marburg, Germany, 2Bernhard Nocht Institute for 
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Post-acute persistence is a hallmark of Orientia tsutsugamushi infection in 
humans and rodents. We hypothesized that negative T cell co-stimulation 
plays a role in reducing the effector response to O. tsutsugamushi, 
thereby facilitating pathogen persistence. We had shown before that 
highest bacterial loads are found in the lung in our C57BL/6 mouse 
model of intradermal O. tsutsugamushi infection. Thus, we studied the 
role of negative costimulation and particularly CTLA-4 in pulmonary T 
lymphocytes. During the acute phase of infection, a significant reduction 
in CD4+foxp3+CTLA-4+ regulatory T cells was observed in the lung. 
However, on CD4+ and CD8+ T cells, expression of CTLA-4, PD-1, TIM-
3 and LAG3 increased significantly during acute infection. In order to 
study the functional significance of CTLA-4 in this model, we blocked 
CTLA-4 using a monoclonal antibody before and during infection, and 
analyzed its influence on the pulmonary immune response and bacterial 
clearance. Other than expected, CTLA-4 blockade had profound effects on 
composition and phenotype of the pulmonary lymphocyte compartment: 
(1) more CD4+ and less CD8+ T cells invaded the lung, (2) expression of 
the activation markers CD44, KLRG1 and CD11a on CD8+ T cells was 
significantly reduced, and (3) PD-1 expression was increased. Moreover, 
CTLA-4 blockade caused a significant increase of bacterial loads in the 
lung. This was not due to decreased production of cytokines, since neither 
the ability of CD4+ nor CD8+ pulmonary T cells to produce IFN-gamma 
and IL-2 was impaired. However, re-stimulated splenocytes from mice 
receiving anti-CTLA-4 treatment revealed an increased production of IL-
10. Thus, unlike in other infection models, our data suggest that CTLA-4 
blockade is unable to increase effector responses in O. tsutsugamushi 
infection. Instead, its blockade reduces activation of CD8+ T cells and 
increases production of the regulatory cytokine IL-10, pointing to a novel 
role of CTLA-4 in O. tsutsugamushi infection.
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ANTIBIOTIC RESISTANCE PATTERNS IN BACTEREMIC 
CHILDREN FROM HOLOENDEMIC PLASMODIUM 
FALCIPARUM MALARIA REGION OF WESTERN KENYA
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Bloodstream bacteria commonly complicate malaria and other illnesses 
in children residing in Plasmodium falciparum holoendemic areas of 
sub-Saharan Africa. The emergence of antibiotic resistance by blood-
borne bacteria increasingly complicates the clinical management of sick 
children. However, the paucity of data on the prevalence and patterns 
of antimicrobial resistance of bloodstream isolates continues to hinder 
rationale management and antibiotic use in pediatric populations. This 
study investigates antibiotic resistance patterns in bacteremic children 
(N=158) with malaria [+] (n=90) and without malaria [-] [n=50] upon 
enrollment at the hospital and during subsequent acute illnesses [n=18]. 
The study was conducted in a P. falciparum malaria holoendemic region, 
in Siaya County, western Kenya. Antibiotic susceptibility patterns of 
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the bacterial isolates were determined using disk diffusion according to 
the Clinical Laboratory Standards Institute guidelines where antibiotic 
resistance was defined as resistance of a microorganism to an agent to 
which it was previously sensitive. The results revealed that Escherichia coli 
had high resistance (80%-100%) to ampicillin/ sulbactum, gentamicin, 
and chloramphenicol, while non-typhodial salmonella (NTS) showed high 
resistance (71%-100%) to ampicillin/salbactum, amoxicillin/clavulanic 
acid, trimethoprim/sulfamethoxazole, chloramphenicol, nalidixic acid 
and ceftriaxone. Staphylococcus aureas displayed the least resistance 
(<41%) to ampicillin/sulbactam, gentamicin, amoxicillin/clavulanic acid, 
trimethoprim/sulfamethoxazole, and chloramphenicol. Further analysis 
showed that NTS resistance to chloramphenical was significantly higher 
in the acute visit group compared to malaria [+] and malaria [-] groups, 
(p=0.028). Additionally, NTS demonstrated higher resistance to ampicillin/
sulbactam in the acute illness relative to malaria [+] and malaria [-] groups 
(P=0.010). The current study shows that most bloodstream NTS, E. coli and 
S. aureus isolates are resistant to commonly used antibiotics and that NTS 
characterize acute illness in western Kenya.
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Gonorrhea is a common sexually transmitted disease that if not treated 
may lead to chronic reproductive health complications, especially in 
women. Increasing rates of antibiotic-resistant Neisseria gonorrhoeae (NG) 
has become a public health concern worldwide and continued surveillance 
for NG is critical, especially in developing countries and underreported 
areas. We established a NG surveillance network in collaboration with 
two hospitals and a reference laboratory in the city of Iquitos located in 
the Peruvian Amazon. NG cultures of urethral and vaginal swabs were 
plated immediately on GC and Modified Thayer-Martin agar prior to 
transport to our nearby laboratory. Presumptive identification of colonies 
was determined by colony morphology, oxidase test, Gram stain, and 
biochemical identification with the API NH (Biomerieux) kit. Antibiotic 
susceptibility was determined by E-test (Biomerieux). From February 2013 
to March 2016, a total of 189 cases were screened with 70/189 (37%) 
positive for NG. From 69 isolates with available susceptibilities, 49/69 
(71%) and 32/69 (46%) of isolates showed resistance to penicillin and 
ciprofloxacin, respectively, whereas only 5/69 (7%) were susceptible 
to both antibiotics. Additionally, 25/69 (36%) showed resistance to 
tetracycline whereas 15/69 (22%) and 32/69(46%) exhibited intermediate 
susceptibility to penicillin and ciprofloxacin, respectively. No resistance was 
found for ceftriaxone, cefixime and azithromycin. Our results shows very 
high rates of fluoroquinolone resistance among NG in Iquitos, which is 
still widely used as first line therapy in Peru. The results highlight the need 
to update Peruvian MoH treatment guidelines to current U.S. Centers for 
Disease Control and Prevention (CDC) standards.
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Anneka M. Hooft1, Kelsey Ripp2, Bryson Ndenga3, Francis 
Mutuku4, David Vu5, Kimberly Baltzell6, A. Desiree LaBeaud5
1University of California San Francisco Benioff Children’s Hospital Oakland, 
Oakland, CA, United States, 2Brown Alpert Medical School, Providence, 
RI, United States, 3Kenya Medical Research Institute, Kisumu, Kenya, 
4Technical University of Mombasa, Mombasa, Kenya, 5Stanford School 
of Medicine, Stanford, CA, United States, 6University of California San 
Francisco School of Nursing, San Francisco, CA, United States
Clinicians in low resource settings where malaria is prevalent face many 
challenges in diagnosing and treating febrile illnesses in children. Given the 
change in WHO guidelines in 2010 recommending malaria testing prior 
to treatment in any child presenting with fever, clinicians are now required 
to expand the differential when malaria testing is negative. Prior studies 
have indicated that resource availability, need for additional training in 
differentiating non-malarial illnesses, and lack of understanding within 
the community of when to seek care play a role in effective diagnosis and 
treatment. We interviewed 20 clinicians (2 pediatricians, 1 medical officer, 
2 nurses, and 15 clinical officers) working at 5 different government-
sponsored public clinic sites (2 rural clinics, 1 urban clinic, and 2 larger 
referral hospitals) in two areas of Kenya where malaria is prevalent. 
Clinicians were interviewed one-on-one using a structured interview 
technique. Interviews were then analyzed qualitatively for themes. Themes 
included the following: 1) Primary reliance of history and physical exam 
in diagnosis of febrile illness; 2) Strong familiarity with IMCI guidelines 
and recognition of the “danger signs” but lack of comfort with the 
diagnosis and treatment of illnesses that deviate from the protocol; 3) Use 
of antibiotics as a fallback when diagnosis is unknown; 4) Difficulty with 
community understanding of febrile illness; 5) Lack of resources including 
diagnostics, medications, and training modalities. These themes persisted 
across the 5 sites, despite variation in levels of medical care. Within these 
themes, clinicians consistently expressed a need for reliable basic testing, 
especially hemograms and bacterial cultures. Providers discussed the use 
of counseling and education to improve community understanding of 
febrile illness in order to decrease preventable deaths in children. Our 
results suggest that since malarial testing has become more widespread, 
revisions to provider training and diagnostic tools are necessary to improve 
diagnosis and effective treatment of febrile illness in children in malaria 
endemic regions.
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HIGH PREVALENCE OF PARASITIC INFECTIONS AMONG 
RECENT IMMIGRANTS IN CHICAGO
Monica Nordstrom1, Miguel Rodriguez1, Patrick Maloney1, E. 
Scott Elder2, Patricia Wilkins2, Ronald Hershow1, Jesica Herrick1
1University of Illinois at Chicago, Chicago, IL, United States, 2Centers for 
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Extensive testing for infectious diseases is performed on refugees. This 
testing is not provided to the 42.1 million immigrants living in the US, 
many of whom share similar risk factors and migrated from countries 
where parasites are highly prevalent. We recruited 119 asymptomatic 
recent immigrants into a cross-sectional study to assess the prevalence 
of parasitic infections in this population. All 119 participants were asked 
about symptoms and provided stool and blood samples for Ova & Parasite 
exam, eosinophil count, and Immunoglobulin E (IgE) level; a subset of the 
samples (73/119) were randomly selected for additional parasite serologic 
testing. Enrolled subjects had a mean age of 33 years (SD 17.7) and 65 of 
the 119 subjects were female (55%). Subjects had immigrated primarily 
from Mexico (30/119, 25%), India (26/119, 22%), other Asian countries 
(30/119, 25%), and Central and South America (23/119, 19.3%). 
Twenty of 119 subjects (17%) tested positive for a parasitic infection and 
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4/20 subjects (20%) with parasites had multiple infections. The most 
commonly identified infections were: Blastocystis hominis (9/119 subjects, 
7.6%), followed by Toxocara (6/73, 8.2%), schistosomiasis (5/73, 6.8%), 
strongyloidiasis (3/73, 4.1%), and Chagas disease (1/73, 1.4%). There 
was no difference in gender (p=.63) or recency of immigration (p=.23) 
between those with and without parasitic infections. Immigrants from 
Asian countries had a significantly higher likelihood of infection compared 
to the other regions (p<.001). IgE was significantly higher in those with 
a parasitic infection (GM 136.7 IU/mL) compared to those without (GM 
65.53 IU/mL, p=.03), but mean AEC did not differ between the groups 
(p=.69). There was no difference in clinical symptoms between groups 
(all p values >.05). Based on our preliminary data, parasitic infections 
likely represent a large and as-yet-unidentified burden of disease in 
the immigrant population. The lack of symptoms or signs predictive of 
parasitic infections suggests immigrants might benefit from the same 
screening provided to refugees, as all of these treatable infections can 
have significant health impacts.
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Chagas disease, caused by the flagellate parasite Trypanosoma cruzi 
affects 5-6 million people mainly in Latin America and causes over 10,000 
deaths per year according to the WHO. The underlying mechanisms that 
lead to the development of complications from chronic Chagas disease are 
not fully understood. To identify host genetic factors, we focused on the 
MHC class I chain-related molecule A (MICA) gene polymorphism, which 
could change the responsiveness of Natural Killer (NK) cells through its 
ligand. A single nucleotide polymorphism at residue 129 of the MICA gene 
change a single amino acid from strong binder (methionine) to a weak 
binder (valine) of the NKG2D receptor, a C-type lectin receptor expressed 
on effector cells including NK, αβ- and γδ-T cells. Recently MICA 129 
met homozygote was associated to left ventricular systolic dysfunction 
(LVSD) in patients with Chagas Chronic heart disease. Therefore, we 
asked whether MICA 129 met/val polymorphism affects the clinical forms 
of Chagas disease in Bolivia. A total of 303 chronic Chagas patients, 80 
cardiac, 99 megacolon, and 72 indeterminate forms, and 87 seronegative 
controls in Santa Cruz, Bolivia were diagnosed by electrocardiogram and 
Barium enema colon X-ray. MICA129 polymorphism (A > G, rs1051792) 
was genotyped by TaqMan Allelic discrimination assay. Here, we report 
that the MICA 129 A allele (methionine) was significantly decreased in 
frequency in the megacolon patients compare to indeterminate (OR=0.24, 
Pcorrected=0.0021) suggesting this allele is resistant against megacolon. 
Thus, the strong binding between NKG2D and MICA 129 met may be 
related to the protection against the tissue damage in the colon.
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Nowadays, Myanmar becomes an attractive destination. The number 
of traveler visiting Myanmar is rapidly increasing every year. However, 
little is known about their pre-travel preparation and incidence of health 
problems during their trip. We, therefore, conducted a cross-sectional 
study at the arrival halls of Bangkok International airports. Travelers who 
just completed their trip in Myanmar were invited to fill the questionnaire. 
They were asked about their demographic profile, pre-travel health 
preparations, and their health problem during their stay in Myanmar. From 
March to December 2015, 397 questionnaires from Thais and 301from 
foreigners were collected and analyzed. 48.7% of travelers were male, 
and the median age was 37 years in both groups. Among foreigner group, 
most of them were from Europe (73%). Up to 82% of foreigners sought 
pre-travel health information before their trip, while only 36.5% of Thais 
did so. The main reason for travel was tourism in 91% of foreigners while 
only 58.1% of Thais traveled for tourism. Foreigners were more likely to 
travel as backpackers, and engaging in outdoor activities such as trekking, 
cycling or swimming than Thais. There was also significant difference in 
the average length of stay between foreigners and Thais (21.7 days vs 
7.08 days, p<0.001). Overall health problems were reported in 29.2% of 
foreigners, the most common being diarrhea which reported in 22.3% of 
foreigners followed by upper respiratory tract symptoms, fever, and skin 
problems. While only 12.6% of Thais reported some health problems. 
The most common one was upper respiratory tract symptoms followed 
by diarrhea, fever and skin problem. Most health problems were mild and 
self limited in both groups. However, six foreign travelers had to visited 
doctor and two had to be admitted. While only one Thai traveler had to 
visit a doctor in an out-patient department. In conclusion, health problem 
was fairly common among travelers to Myanmar. Nearly 30% of foreign 
travelers reported some health problems. Most health problems were mild 
and spontaneous recovery; however up to 2% of foreign travelers need to 
visit a doctor while traveling in Myanmar.
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EVALUATION OF A BOOSTER DOSE OF ROTAVIRUS VACCINE 
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Rotavirus vaccines, administered early in the 1st year of life, are modestly 
effective in low resource countries and immunity may wane. Rotavirus is 
still a major cause of moderate to severe diarrhea in the 2nd year of life, 
and a booster dose of rotavirus vaccine might extend protection. We 
evaluated whether a booster dose of pentavalent rotavirus vaccine given 
to 9-11 month old Malian infants would interfere with immune responses 
to routine vaccines. Infants were randomized 1:1 to receive PRV or no 
PRV co-administered with measles and yellow fever vaccines. Serum was 
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collected before and 28 days after vaccination. Anti-measles IgG was 
measured by ELISA; seroconversion was defined as a positive result among 
baseline seronegatives. Yellow fever neutralizing antibodies were measured 
by plaque reduction; seroresponse was defined as >4-fold increase in 
post-vaccination titer. Noninferiority (<10% difference in seroconversion 
or seroresponse rates) for measles and yellow fever were co-primary 
objectives. Anti-rotavirus IgA and IgG concentrations were measured by 
ELISA. From October 15, 2014 to December 18, 2014, 600 infants were 
enrolled with 300 receiving PRV. 513 were baseline measles seronegative 
with 255/261 (97.7%) (PRV group) seroconverting compared to 246/252 
(97.6%) (no PRV group); difference, 0.1% (95% CI, -4.0 to 4.2). In 
the yellow fever analysis, 141/293 (48.1%) (PRV group) seroresponded 
compared to 153/293 (52.2%) (no PRV group); difference -4.1% (95% 
CI, -12.2 to 4.0). However, with yellow fever seroresponses defined as 
>2-fold rise, 202/293 (68.9%) (PRV group) seroresponded compared to 
206/293 (70.3%) (no PRV group); difference -1.4% (95% CI, -8.8 to 6.1). 
Post-vaccination anti-rotavirus IgA and IgG geometric mean concentrations 
rose to 118 (95% CI, 91 to 154) and 364 (95% CI, 294 to 450) in the 
PRV group compared to 68 (95% CI, 50 to 92) and 153 (95% CI, 114 
to 207) in the no PRV group. Concomitant administration of PRV did not 
appear to interfere meaningfully with immune responses to MV and YFV 
and substantially increased rotavirus antibody levels. Clinical benefit of a 
booster dose of PRV in the 2nd year of life should be studied.
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In 2012, the WHO recommended the addition of single low single low 
(0.25 mg base/kg body weight) dose primaquine (SLDPQ) to artemisinin 
based combinations to block the transmission of Plasmodium falciparum 
without testing for glucose 6 phosphate dehydrogenase deficiency. The 
targeted group was non pregnant patients aged ≥ 1 year (later changed 
to ≥ 6 months) with acute uncomplicated falciparum malaria, primarily 
in countries with artemisinin resistant P. falciparum (ARPf). No dosing 
regimen was suggested. We, therefore, designed a user friendly, age 
based, SLDPQ regimen for Cambodia, the country most affected by ARPf. 
By reviewing PQ’s pharmacology, we defined a therapeutic dose range of 
0.15-0.38 mg base/kg (9-22.5 mg in 60 kg adult, therapeutic index 2.5). 
Primaquine doses (1-25 mg) were tested using a modelled, anthropometric 
database of 28,138 Cambodians (23,338 healthy individuals, 4,199 with 
malaria, and 1,292 other infections); age distributions were: < 5y [19.35% 
(n=5,383)], 5 to 17y [20.37% (n=5,469)] and adults [59.65% (n=15,531)]. 
Optimal age dosing groups were selected according to calculated mg base/
kg doses and proportions of individuals receiving a therapeutic dose. Four 
age dosing bands were defined: (i) 6m-4y, (ii) 5-9y, (iv) 10-14y, (v) ≥ 15y to 
receive 2.5, 5, 7.5 and 15 mg of PQ base, resulting in therapeutic doses 
in 97.41% (5,494/5,640), 90.53% (1,511/1,669), 97.68% (1,473/1,508), 
and 95.69% (18,489/19,321), respectively. Corresponding median (1st, 
99th centiles) mg base/kg doses of PQ base are: (i) 0.23 (0.15-0.38), 
(ii) 0.29 (0.18-0.45), (iii) 0.27 (0.15-0.39), and (iv) 0.29 (0.2-0.42). In 
conclusion, this SLDPQ regimen could contribute substantially to malaria 
elimination and requires urgent evaluation in Cambodia and other Greater 
Mekong Subregion countries with similar anthropometric characteristics. 
It also guides primaquine manufacturers on suitable tablet strengths and 
doses for paediatric friendly formulations. Development of similar age 
based dosing recommendations for Africa is needed.
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The health of children under five remains worrying in developing countries. 
Indeed, nearly ten million children still die annually before reaching the age 
of five. Since 2008, community health workers (CHWs) in Rwanda have 
been trained to carry out integrated community case management (iCCM) 
in children under five. We carried out this study in 2014 to determine 
the effect of socio-demographic characteristics on CHWs performance. 
A cross-sectional study was conducted in 25 districts in Rwanda. Data 
was collected using a structured questionnaire and client satisfaction. We 
used STATA for data analysis. Descriptive statistics were calculated. Odds 
ratios (OR) and 95% confidence intervals (CI) for the predictors of the 
performance were calculated. Relationships were determined using logistic 
regression. Results A total of 19,402 CHWs were observed delivering 
iCCM package among sick children. Of these CHWs, 51.2% (10,075) 
were females. The level of performance was estimated to 87.6% for 
malaria treatment, 88.7% for pneumonia treatment, 85.4% for diarrhea 
treatment, 76% for malnutrition assessment, 28.1% for counseling on 
diseases prevention, and 99% for detection of danger signs. The study 
showed significant relationships of sex with pneumonia treatment. 
Females CHWs were 1.08 more likely to treat pneumonia than males 
(OR=1.089, 95%CI: 1.027-1.156). In addition, CHWs aged 35 and above 
are 1.09 more likely to give more advices on disease prevention than other 
age group (OR=1.098, 95%CI: 1.029-1.173). CHWs with at least one 
year of secondary school were 1.06 and 1.08 more likely to treat malaria 
correctly (OR=1.062, 95%CI: 1.024-1.101) and pneumonia (OR=1.088, 
95%CI: 1.050-1.124) when compared to CHWs with education level of 
primary school. Conclusion Socio-demographic characteristics of CHWs 
in Rwanda affect iCCM performance in different ways. We recommend 
targeted interventions and appropriate intensive refresher training for 
CHWs on iCCM package.
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SURGERY IN THE FAR NORTH REGION OF CAMEROON
Julie Akame1, Assumpta Lucienne Bella2, Georges Nko’ayissi2, 
Godefroy Koki3, Emilienne Epee2, Rebecca Djao2, Henri Moungui1, 
Yannick Nkoumou1, Ibrahim Mallam Salli4, Yaobi Zhang5, Awa 
Dieng5, Whitney Goldman6
1Helen Keller International, Yaoundé, Cameroon, 2Ministry of Public 
Health, Yaoundé, Cameroon, 3Ministry of Defense, Yaoundé, Cameroon, 
4Sightsavers International, Yaoundé, Cameroon, 5Helen Keller 
International, Dakar, Senegal, 6Helen Keller International, New York, NY, 
United States
In Cameroon, trachoma mapping conducted in 2010-2011 identified 
13 health districts (HDs) in the Far North region with a prevalence of 
trachomatous inflammation-follicular (TF) of over 10% in children aged 
1-9 years. Out of these HDs, 8 were identified with trachomatous trichiasis 
(TT) over 1% in persons aged 15 and over in the population. Surgery 
is an important component of the SAFE (Surgery, Antibiotic treatment, 
Facial cleanliness and Environmental improvement) strategy to achieve 
trachoma elimination. Cameroon conducted the TT surgery campaign in 
the region with the support of the United States Agency for International 
Development’s MMDP Project, managed by Helen Keller International. Six 
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months following the TT surgery campaign during which 1,080 patients 
were operated, a patient follow-up survey was conducted to evaluate 
patients’ perception of the surgery and surgery outcomes. A convenience 
sampling of 213 patients that received TT surgery in the previous 6 months 
was realized and a questionnaire was administered to assess patients’ 
perception and satisfaction. Median age of patients at surgery was 60 
years. 126 (59.2%) of the surveyed patients were female and 86 (40.4%) 
were male. The following outcomes were recorded: 10 (4.7%) returned to 
the hospital because of the sand sensation in the operated eye, 6 (2.3%) 
returned due to excessive tearing and 16 (7.5%) returned for eye pain. 
The following patients’ perceptions were recorded: 210 (98.6%) reported 
improved vision, 205 (96.2%) patients with less difficulty in performing 
daily activities after surgery, 210 (98.6%) patients would recommend 
surgery to others, 211 (99.1%) patients with less pain after surgery. 
Patient perception on TT surgery is one way to evaluate the quality of 
surgery in order to help investigate on surgery refusals and improve the 
quality of care. The results showed a successful TT surgery campaign in the 
region.
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MEASURING THE EFFECT OF SOIL-TRANSMITTED HELMINTH 
(STH) INFECTIONS ON COGNITIVE FUNCTION IN CHILDREN: 
SYSTEMATIC REVIEW AND CRITICAL APPRAISAL OF 
EVIDENCE
Kei Owada1, Mark Nielsen2, Colleen Lau3, Archie Clements3, Laith 
Yakob4, Ricardo J. Soares Magalhães5
1School of Medicine, the University of Queensland, Brisbane, Australia, 
2School of Psychology, the University of Queensland, St Lucia, Australia, 
3Research School of Population Health, Australian National University, 
Canberra, Australia, 4Department of Disease Control, London School 
of Hygiene & Tropical Medicine, London, United Kingdom, 5School of 
Veterinary Science, The University of Queensland, Gatton, Australia
Recently the role of STH infections in cognitive developmental impairment 
of children has been under intense scrutiny. We conducted a systematic 
review of the evidence for associations between STH infections and 
cognitive function of children. We aimed to summarise the effect size by 
domains of cognitive function in three age strata (i.e. children <24 months; 
children 24-59 months and school-aged children). Using the Preferred 
Reporting Items for Systematic reviews and Meta-Analysis (PRISMA) 
protocol we searched relevant databases including PubMed, CINAHL, 
EMBASE, Medline via Web of Science, Cochrane, ScienceDirect, Psych 
Articles and PsychINFO via APA PsychNET and Scopus. A total of 42 papers 
fulfilled the inclusion criteria for the systematic review; these include 
10 studies from a recent Cochrane review. We next conducted a critical 
appraisal of the variability of cognitive function measurement tools used 
to assess the effect of STH infections on different domains of cognitive 
function of children of different age groups. Our findings demonstrate 
remarkable variation in tested domains and lack of consistency in the 
use and analysis of measurement tools. Cognitive function measures 
in children under five years of age has been mainly limited to domains 
of gross motor, fine motor and language skills, whereas in school-aged 
children most studies tested domains such as memory and processing 
speed. Even within the same age group the results on the association 
between STH infections and measures of cognitive development were 
often conflicting. This study demonstrates the need for the establishment 
of methodological consensus in the deployment and analysis of adequate 
measurement tools to detect the effect of STH infections on different 
domains of cognitive function in children at different ages. This will be 
an imperative next step to improve study validity and generate conclusive 
evidence of the role of STH infections in cognitive development in children.
1069
VARICELLA ON SHIPS: IS THERE A RISK TO TRAVELERS?
Marion Rice, Joanna Regan
Centers for Disease Control and Prevention, Atlanta, GA, United States
Masters of ships with U.S. ports of call are required to report certain 
illnesses to CDC Quarantine Stations. We describe varicella case reports 
recorded in CDC Quarantine Activity Reporting System from January 2010 
to February 2016. Denominators vary according to the number of cases for 
which data were available. There were 1,000 reports of varicella from ships 
during the study period. Most case-patients were male (79.79%, 525/658) 
and older than age 15 years (89.66%, 503/561). Cruise ships reported 
93.30 (933/1,000) of cases, and 6.30% (63/1,000) of cases were reported 
by cargo ships. On cruise ships and cargo ships, 83.82% (782/933) and 
98.41% (62/63) of cases, respectively, were in crew members. Crew 
member cases were most often from the Philippines (23.46%, 99/422), 
Indonesia (18.72%, 79/422), and India (17.06%, 72/422). Passenger cases 
were most often from the United States (21.95%, 18/82), the United 
Kingdom (10.98%, 9/82), Canada (8.54%, 7/82), and Sweden (8.54%, 
7/82). Case-patients typically presented with a rash (99.80%, 998/1,000) 
and fever (54.30%, 543/1,000). Cases were reported every month of the 
year. Cruise ship case-patients were isolated, on average, 0.65 days (n = 
292, SD 0.96) after rash onset and reported to CDC, on average, 2.32 
days (n = 793, SD 4.66) after rash onset. Cargo ship case-patients were 
isolated, on average, 1.15 days (n=20, SD 1.39) after rash onset and 
reported to CDC, on average, 5.17 days (n=59, SD 9.56) after rash onset. 
Varicella cases resulted in hospitalization in 3.52% (20/568) of reports; 
one case was fatal (0.10%, 1/1,000). Crew members on cargo and cruise 
ships frequently are from tropical regions where there usually is a higher 
susceptibility to varicella among adults, or varicella vaccination is not 
routinely provided. A majority of cases reported were crew members, who, 
as adults, are at higher risk of complications due to varicella. Given that 
exposure to varicella on ships can occur year round, varicella vaccination 
prior to boarding a ship is advisable for those without evidence of 
immunity.
1070
SPLENOMEGALY IN CONGOLESE REFUGEES APPLYING FOR 
RESETTLEMENT FROM UGANDA TO THE UNITED STATES
Matthew Goers1, Maurice Ope2, Natalia Gitu3, Aaron Samuels4, 
Saul Akandwanaho3, Gladys Nabwami3, Raymond Nyoka2, Warren 
Dalal4, Paul Cantey5, Andrea Conroy6, Chandy John6, Marty 
Cetron2, Marwan Naoum3, Michelle Weinberg2, Nina Marano2, 
William Stauffer1
1University of Minnesota Internal Medicine Residency, Minneapolis, MN, 
United States, 2Immigrant Refugee, Migrant Health Branch, Division 
of Global Migration and Quarantine, Centers for Disease Control and 
Prevention, Atlanta, GA, United States, 3International Organization of 
Migration (IOM), Kampala, Uganda, 4Malaria Branch, Division of Parasitic 
Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, 
GA, United States, 5Parasitic Diseases Branch, Division of Parasitic Diseases 
and Malaria, Centers for Disease Control and Prevention, Atlanta, GA, 
United States, 6Ryan White Center for Pediatric Infectious Diseases and 
Global Health, Indiana University School of Medicine, Indianapolis, IN, 
United States
In 2014, the International Organization for Migration (IOM) reported 
a high number of United States (US)-bound Congolese refugees from 
Uganda with splenomegaly of unknown etiology. In March and July 
2015, refugees with splenomegaly on physical examination were 
offered evaluation and treatment, including abdominal ultrasonography 
and laboratory testing. Among 987 persons screened, 145 (14.7%) 
had splenomegaly and received further testing. Of the 144 who had 
abdominal ultrasound, 122 (84.7%) had massive splenomegaly (defined 
as >4 a standard mean for splenic size adjusted for height), 135 (93%) 
had normal liver architecture, and 8 (5.5%) had hepatic nodules/masses. 
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Thirty-nine (26.9%) were positive for malaria by RDT® (Bioline HRP2/
Pan LDH); all tested negative by thin blood smear (thick films were not 
performed). Eighty-six percent (135/145) were positive for PFMSP-1 IgG 
(indicating past exposure to Plasmodium falciparum). Three (2.1%) tested 
positive for Schistosoma mansoni ova by stool wet prep. Urine ova and 
parasite were negative. All tested negative for Leishmania by rK39 testing, 
but 1 (0.7%) was positive by serology. Five (3.5%) had positive HBsAg, 
and 10 (6.9%) had detectable HCV antibodies. Refugees with palpable 
splenomegaly were treated with antimalarials at the time of diagnosis, and 
all refugees are given presumptive treatment with artemether-lumefantrine 
prior to departure to the US - thus those with splenomegaly received 
two treatment courses. CDC issued recommendations to US providers 
to conduct additional laboratory and radiology testing. Due to concerns 
of malaria as an etiology, and reports of non-falciparum malaria in this 
population, treatment for hypnozoites with primaquine (after glucose-6-
phosphate dehydrogenase testing) following arrival in the United States 
was recommended. Pre- and post-malaria treatment total IgM is currently 
pending. This initial evaluation did not identify a definitive unifying 
etiology of splenomegaly and while pending results may indicate a likely 
etiology, further study of this prevalent condition in Congolese refugees in 
western Uganda is needed.
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IMPROVING THE QUALITY OF CARE FOR COMMON 
CHILDHOOD ILLNESSES AMONG PATENT AND PROPRIETARY 
MEDICINE VENDORS IN EBONYI STATE, NIGERIA
Sarah Burnett1, Tiffany Clark1, Onyekachi Amajor1, Jolene Wun1, 
Jamie Eliades1, Wapada Balami2, Jennifer Anyanti3, Beth Brennan1
1PATH, Washington, DC, United States, 2Federal Ministry of Health, Abuja, 
Nigeria, 3Society for Family and Health, Abuja, Nigeria
In Nigeria, malaria, pneumonia and diarrhea are the leading causes of 
death in children under five. As patent and proprietary medicine vendor 
(PPMV) shops are the origin of a high proportion of treatments, they could 
be a strategic partner in increasing the proportion of children that receive 
appropriate treatment for common childhood illnesses. MalariaCare and 
the Expanded Social Marketing Project in Nigeria, in collaboration with the 
Federal Ministry of Health (FMOH) and Ebonyi State Ministry of Health, 
are conducting a pilot evaluation to assess the ability of trained PPMVs 
to manage cases of common childhood illnesses according to national 
health standards. The pilot intervention includes integrated community 
case management training, covering the use of RDTs, ACTs, ORS, zinc, 
respiratory timers and amoxicillin, followed by on-site mentoring; and 
targets poor-performing, high-volume PPMV shops for more cost-
effective resource allocation. The evaluation is a quasi-experimental study 
with 2 intervention and 2 control areas in Ebonyi State. At baseline, we 
conducted household and outlet surveys to determine the quality of care 
provided by PPMV shops. Household surveys identified 2,614 children 
with fever, diarrhea or pneumonia symptoms; 83% had fever, 24% 
percent had diarrhea, and 4% reported pneumonia symptoms. In 37% of 
cases treatment was received from a PPMV shop. Of these, 13% of fever 
cases received an ACT, 1% of diarrhea cases received ORS and zinc, and 
2% of pneumonia cases received amoxicillin. Among cases treated at a 
PPMV shop (68%), rather than treating at home with products previously 
purchased from PPMVs (32%), only 5% of fever cases had a diagnostic 
test and 9% of pneumonia cases had their respiratory rate checked. Of 
the 198 PPMV providers included in the outlet survey, 65%, 4%, and 21% 
knew the correct first line treatment for malaria, diarrhea and pneumonia, 
respectively; 67% were not aware of RDTs. End line evaluation results that 
demonstrate whether the pilot was effective in improving the proportion 
of children under five with common childhood illnesses receiving 
appropriate treatment will be presented.
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HIGH PROTEIN DIETARY SUPPLEMENT IMPROVES 
NUTRITIONAL STATUS AND RECOVERY IN CHILDREN WITH 
BURKITT’S LYMPHOMA: A NON-RANDOMIZED CONTROLLED 
STUDY
Charles Apprey
KNUST, Kumasi, Ghana
Each step of the cancer continuum from diagnosis to recovery poses 
nutritional challenges. In children with cancers, poor nutritional status 
will lead to faster disease progression, slower recovery and poorer 
survival. The effect of nutritional intervention using a soya milk powder 
(SMP) supplement on nutritional status, recovery and mortality among 
children undergoing chemotherapy for Burkitt’s lymphoma (BL) was 
studied. Sixty-four subjects were recruited for this non-randomised 
controlled intervention study. The intervention group was provided the 
supplement measured to provide 80% RDA for protein and was followed 
for 6 months, taking measurements at the 0, 3 and 6-months follow-
up. Baseline characteristics of the study population were similar except 
for haemoglobin and prealbumin. SMP supplementation was associated 
with reduced prevalence of malnutrition (<-2 sd BMI-for-age) from 50% 
baseline up to 0% six months after the intervention (p=0.005). Likewise, 
the SMP improved anaemia status (100%, 76.9% and 15.8% anaemia 
between baseline, 3-months and 6-months follow up respectively), 
serum zinc deficiency (87.5%, 50% and 52.6%, p=0.004) and reduced 
glutathione deficiency (GSH) (21.9%, 0 and 0, p=0.045). Same cannot 
be said in the non-intervention group. Recovery from BL 1 year after 
the intervention was 47% compared with 16% in the non-intervention, 
whereas mortality was 19% versus 28% between the intervention and 
non-intervention groups respectively. Dietary supplementation using a 
high protein-based SMP improved nutritional status, recovery and survival 
in children with BL hence the need for larger studies to assess the efficacy 
of nutritional intervention as non-conventional treatment of childhood 
cancers in limited resource settings.
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DENGUE AND LEPTOSPIROSIS CO-INFECTION IN THE 
PERUVIAN AMAZON, 2013-2014
Crystyan Siles1, Manuel Cespedes2, Stalin Vilcarromero1, Carolina 
Guevara3, Robert Hontz1, Hermann Silva4, Amy C. Morrison5, 
Christopher Mores3, Alberto Laguna6, Julia Sonia Ampuero3
1U.S. Naval Medical Research Unit-6, Iquitos, Peru, 2Instituto Nacional 
de Salud, Lima, Peru, 3U.S. Naval Medical Research Unit-6, Lima, Peru, 
4Direccion Regional de Salud de Loreto, Iquitos, Peru, 5University of 
California, Davis, Iquitos, CA, United States, 6Ministerio de Salud del Peru, 
Lima, Peru
Dengue is a major public health problem associated with high morbidity 
and mortality rates in developing countries. In Iquitos, the largest city 
in the Peruvian Amazon, dengue and leptospirosis are responsible for 
40% and 30% of acute undifferentiated febrile illness (AUFI) cases, 
respectively. Despite this data, few studies have discussed about co-
infection, which could explain some atypical or severe cases. Passive clinic-
based surveillance conducted by NAMRU-6 in 12 Iquitos health facilities, 
provided an opportunity to evaluate the clinical impact of leptospirosis 
infection in dengue confirmed cases (co-infections). From January 2013 
to December 2014, 4,211 AUFI patients enrolled in our study provided 
acute and convalescent blood samples, and were evaluated clinically 
and epidemiologically. A dengue case was defined as any patient where 
dengue virus or viral RNA was detected through real -time PCR or viral 
isolation in an acute sample, or demonstrated a seroconversion (4-fold 
increase IgM antibodies) between acute and convalescent samples. 
Leptospira infection was defined by seroconversion of IgM antibodies 
plus the presence of a titer of Microscopic Agglutination Test (MAT) in 
convalescent sample of ≥1/400 or a titer of MAT≥1/800 in any of the 
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paired sample. Of the febrile cases where complete dengue and leptospira 
testing and clinical data was available, 1,533 of 1,572 (97.5%) had a 
confirmed dengue infection. Of these, 39 (2.4%) cases had leptospira 
co-infection. None of the clinical findings (constitutional, gastrointestinal 
and respiratory symptoms) or complications were associated to co-
infection (p > 0.05, Pearson Chi square test). The hospitalization rate and 
shock syndrome (p>0.05) were similar in both groups with no fatal cases. 
Asymptomatic infections due to leptospirosis occur commonly in this city 
and may explain this finding, even though both dengue and leptospirosis 
have been associated with severe and fatal disease in Iquitos. In dengue 
and leptospirosis endemic areas, serological results should be interpreted 
in the context of the clinical presentation.
1074
A PROSPECTIVE ASSESSMENT OF ANTIBIOTIC PRE-
TREATMENT, USING A URINE ANTIBIOTIC BIOASSAY, AMONG 
PATIENTS ATTENDING AN INFECTIOUS DISEASE HOSPITAL IN 
MANILA AND THE RELATIONSHIP BETWEEN ANTIBIOTIC USE 
AND SOCIOECONOMIC STATUS
Nobuo Saito1, Noriko Takamura1, Grace Retuerma2, Carina 
Frayco2, Rontgene Solante2, Winston Go2, Motoi Suzuki1, Koya 
Ariyoshi1, Christopher M. Parry1
1Nagasaki University, Nagasaki, Japan, 2San Lazaro Hospital, Manila, 
Philippines
The widespread unregulated use of antibiotics contributes to the rising 
prevalence of antibiotic resistance in Southeast-Asian countries. Antibiotic 
usage before a medical consultation also reduces the possibility of 
identifying the casual pathogen due to the reduced sensitivity of bacterial 
culture. We conducted a hospital-based observational study investigating 
prior antibiotic usage in patients attending San Lazaro Hospital (SLH) for 
a medical consulation. SLH is the National Infectious Disease Hospital and 
provides free-health care to a low-income population in Metro Manila, 
Philippines. Patients attening the ER with a history of fever were enrolled. 
A urine bioassay was used to detect antibiotic activity in urine using 
three organisms: Bacillus stearothermophilus (ATCC7953); Escherichia 
coli (ATCC25922); and Streptococcus pyogenes (ATCC19615). Patients 
or caregivers reported their medication history, clinical information and 
socioeconomic status. During the study period (2nd February 2015 to 
2nd July 2015) 410 patients were enrolled and provided a urine. The 
median (IQR) age was 14 (7 to 23) years and 158 (39%) reported prior 
antibiotic use, predominantly a beta-lactam antibiotic. A total of 164 
(40%; 95%CI 35 to 45) patients were positive by urine bioassay with any 
of three organisms. The Bacillus assay detected 162 (99%; 95%CI 96 to 
100) cases. Many patients with a positive urine bioassay were clinically 
considered to have dengue (n=91, 55%; 95%CI 48 to 63). Patients with 
a positive bioassay were significantly more likely to be from the lowest-
income group (AOR 1.7; 95%CI 1.1 to 2.6) and require hospital admission 
(AOR 2.1; 95%CI 1.3 to 3.5). Antibiotics are widely used in the community 
setting in Manila by fever patients before the medical consultation, and 
this antibiotic use is significantly more common among those with the 
lowest-income.
1075
DIGITAL GANGRENE DUE TO RICKETTSIAL VASCULITIS - 
UNCOMMON MANIFESTATION OF AN UNDERAPPRECIATED 
DISEASE
Husain Poonawala1, Soumya Umesh2, Thenmozhi N2, David J. 
Riedel1
1University of Maryland, Baltimore, MD, United States, 2St John’s Medical 
College, Bangalore, India
Rickettsiae are a common but underdiagnosed cause of acute febrile 
illness in India. Indian tick typhus caused by Rickettsia conorii indica 
belongs to the spotted fever group of Rickettsiae and is less frequently 
reported than scrub typhus (caused by Orientia tsutsugamushi). A healthy 
45-year-old woman presented with fevers, chills, dysuria, vomiting, and 
headache. She was admitted to a community hospital and started on 
broad spectrum antibiotics. After failing to improve, she was transferred to 
our institution. On presentation she was febrile, hypotensive, tachycardic 
and tachypneic. She appeared critically ill with physical examination 
significant for periorbital edema, conjunctival suffusion and bibasilar 
rales. She was admitted to the ICU. Laboratory values showed anemia, 
thrombocytopenia, abnormal LFTs, proteinuria and lactic acidosis. Initial 
workup was negative for bacteremia, malaria, dengue, leptospira, typhoid 
fever and HIV. Weil-Felix titers were inconclusive. A tentative diagnosis of 
rickettsial infection was made and doxycycline was added. After 48 hours 
the patient improved and was transferred to the medical floor, but began 
to develop gangrene of the toes and fingers. Repeat testing showed 
persistent thrombocytopenia, abnormal LFTs and prolonged APTT. Repeat 
Weil-Felix OX-2 titer was 1:160, supporting a diagnosis of spotted fever 
group rickettsial infection. The patient was discharged home but there was 
no improvement in the condition of her digits on follow-up. Rickettsiae 
invade endothelial and smooth muscle cells of the microcirculation causing 
increased vascular permeability and microthrombi with resulting multi-
organ dysfunction and thrombosis. While multi-organ dysfunction is 
common, gangrene is a rare complication. The epidemiology of Indian tick 
typhus is poorly defined, but serological surveys and case reports suggest 
widespread occurrence across the Indian subcontinent. It is characterized 
by a purpuric rash and unlike scrub typhus, an eschar is rarely seen. Early 
diagnosis and treatment with doxycycline is crucial to reduce morbidity 
and mortality due to Rickettsiae.
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ADVERSE EVENTS FOLLOWING PURIFIED CHICK EMBRYO 
CELL (PCEC, RABAVERT®) VACCINE IN THE VACCINE ADVERSE 
EVENT REPORTING SYSTEM, 2006 - 2015
Pedro L. Moro, Paige Lewis, Maria Cano
Centers for Disease Control and Prevention, Atlanta, GA, United States
In 1997, the Food and Drug Administration licensed Purified Chick 
Embryo Cell (PCEC, RabAvert®) vaccine against human rabies. A previous 
post-licensure study in the Vaccine Adverse Event Reporting System 
(VAERS) during 1997-2005 did not find any safety concerns. This study 
was undertaken to assess the safety of PCEC vaccines in VAERS during 
1/1/2006–12/31/2015. We searched the VAERS database for US reports of 
adverse events (AEs) among persons who received PCEC during 1/1/2006–
12/31/2015. We reviewed all serious (those resulting in death, life-
threatening illness, hospitalization, prolongation of existing hospitalization, 
or permanent disability) and accompanying medical records. Physicians 
assigned a primary clinical category to each reviewed report. During the 
study period, VAERS received 490 reports following PCEC vaccination; 
38 (7.8%) were serious. No deaths were reported. Females accounted 
for 301 (61.4%) reports. PCEC was given alone in 407 (83.1%) reports. 
The median age was 28 years (range 0 - 88 years). The median time from 
vaccination to onset of an AE was ,<1 day. The most frequently reported 
AEs were headache (99; 20.2%), nausea (19.0%), pyrexia (91; 18.6%), 
dizziness (65; 13.3%), and pain (59; 12.0%). Among serious reports, 
the most common diagnostic categories were general disorders and 
administration site conditions (18;47.3%), and nervous system disorders 
(10; (26.3%). In conclusion, a review of VAERS reports did not identify any 
new or unexpected safety concerns for PCEC vaccines.
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TRICHOSTRONGYLUS INFECTION IN ITALY: REPORT OF FOUR 
AUTOCHTHONOUS OUTBREAKS DIAGNOSED IN A SINGLE 
CENTER
Federico Giovanni Gobbi, Dora Buonfrate, Andrea Angheben, 
Manuela Mistretta, Monica Degani, Zeno Bisoffi
Sacro Cuore Don Calabria Hospital, Negrar, Italy
Trichostrongylus spp are nematodes of herbivores, with a worldwide 
distribution. Humans get occasionally infected through the ingestion 
of vegetables and water contaminated with the larvae. Hence, the 
infection is more frequent in people in close contact with livestock 
and/or with vegetable gardens fertilized with organic manure. In 
industrialized countries, human infection has been rarely reported. At 
the Center for Tropical Diseases of Negrar (Verona), Italy, four outbreaks 
of trichostrongyliasis were diagnosed between August 2010 and July 
2015. The four clusters occurred in three different Italian regions: 
Lombardy (Varese province and Brescia province), Piedmont, and Veneto. 
All outbreaks affected several/all members of the same household. Of 
the 12 patients involved, four had no symptoms. The others reported 
symptoms of different intensity, mostly abdominal pain (8 of 12 patients, 
67%) and diarrhea (5 patients, 42%). Some also complained of myalgias 
(three), pruritus (two), nausea (one), and fever (one). Eosinophilia was 
present in all subjects, with or without symptoms, and was severe (>5000 
eosinophils/mmc) in 5 patients. Medical history revealed in all cases the 
ingestion of vegetables exposed to sheep/goat manure. Trichostrongylus 
eggs were found at stool examination of only 4 patients. All patients 
from Piedmont were negative at stool examination, but the goat manure 
resulted positive for Trichostrongylus larvae. The patients were treated 
either with pyrantel pamoate (750 mg tablets, 4 tablets stat dose) or 
albendazole 400 mg x 2 for 10 days. Three patients with no symptoms 
preferred to defer treatment. All treated patients but one (complaining 
mild symptoms one year and a half after treatment) reported resolution 
of symptoms. A decrease in the eosinophil count was observed for all 
patients, including the ones who were not treated. Although not common 
in areas of temperate climate, Trichostrongylus infection should be 
considered in case of eosinophilia, in particular when present in different 
members of the same household.
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CLINICAL CHARACTERISTICS OF EBOLA SURVIVORS 40 
YEARS POST INFECTION IN THE DEMOCRATIC REPUBLIC OF 
CONGO
Alexis Kabongo Mwanza1, Daniel Mukadi1, Patrick Mukadi1, 
Nicole A Hoff1, Reena H Doshi1, Joseph Wasiswa1, Vivian H 
Alfonso2
1University California Los Angeles/Democratic Republic of Congo, 
Kinshasa, Democratic Republic of the Congo, 2University of California Los 
Angeles, Kinshasa, CA, United States
Ebola virus disease (EVD) is associated with a mortality rate ranging from 
25 to 90% and to-date no cure or approved vaccine is available to the 
general public. The first cases of EVD were reported in 1976 in Yambuku, 
the north-eastern part of Democratic Republic of Congo (DRC-former 
Zaire) in the current province of Mongala. During this outbreak, 318 
cases of EVD were recorded with 280 deaths, and 38 confirmed survivors. 
EVD is hypothesized to put suvirors at increased risk of adverse health 
courses, however, there is limited information regarding long-term health 
consequences .We enrolled 11 survivors 40 years after the Yambuku 
outbreak based on original line listings and case data from the DRC 
Ministry of Health. After informal consent was obtained, we collected 
information on clinical profiles at 3 times points: prior, during, and present 
day. The youngest survivor (15 at time of outbreak) is now 55 years old, 
and the oldest (46 during the outbreak) is 86 years old, with a mean age 
of 67.25 years. Four survivors were women and 7 men. The mean heart 
rate was 92 beats per minute with a peak of 128 beats per minute. The 
average systolic blood pressure was 142mmHg with a peak of 162mmHg. 
The most common symptoms reported were: muscle pain 82%, 
headache 64%, joint pain and fatigue 55%, continual cough 36% and 
ocular problems 27%. Our results add to the small body of the scientific 
literature that suggest EVD survivors may be at increased risk for long-term 
sequelae. Additional research with age and sex matched controls is needed 
to correlate current symptoms with EVD. Understanding the long-term 
consequences of EVD could lead to improvements in patient care and a 
better understanding of virus pathogenesis.
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EOSINOPHILIA IN PATIENTS PRESENTING TO A LARGE 
TRAVEL CLINIC: SPECTRUM OF DISEASE AND IMPLICATIONS 
FOR A SYSTEMATIC DIAGNOSTIC WORK-UP
Thierry Rolling1, Helmut J. Salzer2, Marylyn M. Addo1, Stefan 
Schmiedel1, Christof D. Vinnemeier1, Jakob P. Cramer1
1University Medical Centre Hamburg-Eppendorf, Hamburg, Germany, 
2Division of Clinical Infectious Diseases, Research Center Borstel, Borstel, 
Germany
Eosinophilia is an immunological host response to a variety of triggers - 
ranging from allergens and malignancy to helminthic infections. Patients 
presenting to travel clinics with eosinophilia present a challenging task to 
physicians, as the underlying disease spectrum is as heterogeneous as the 
patient population and no standardized diagnostic work-up exists. In this 
study, we describe the spectrum of diseases in patients presenting to our 
travel clinic with eosinophilia. Additionally we assessed whether additional 
patients’ characteristics or laboratory work-up could inform in order to 
define a more rational and effective diagnostic work-up. We analyzed 
data from 6,622 consecutive patients between September 2007 and May 
2014. Eosinophilia, defined as an absolute eosinophil count of >500 /µl, 
was present in 2,4% (155/6,622). The median age was 33 years (range: 
5-77 years) and 40% (60/155) were female. Most patients presented as ill-
returning travelers (78%, 121/155), others were classified as immigrants, 
expatriates or tourists visiting Germany. An infectious cause was 
detectable in 57% (89/155) - with the most common specific infections 
being schistosomiasis (19%, 29/155) and strongyloidiasis (8%, 12/155). 
Atopic disease and asthma accounted for 10% (16/155), while no specific 
cause could be identified in 14% of patients (21/155). Patients with a 
confirmed infectious cause of eosinophilia had slightly higher eosinophil 
counts (835 vs 712 /µl, p=0.04) but equal levels of IgE (152 vs 176 kU/L, 
p=0.70) compared to those without an infectious cause. In travelers 
who visited friends and relatives and in immigrants, an infectious cause 
was identified more often than in classical tourist travelers (p<0,01). In 
conclusion, eosinophilia is an important condition in patients presenting to 
a travel clinic. Our data show that IgE did not yield any added diagnostic 
value. Instead a systematic diagnostic approach could help to identify the 
majority of underlying conditions.
1080
MALARIA AND LASSA FEVER VIRUS CO-INFECTION IN 
SOUTHERN MALI
Nafomon Sogoba1, Sory Ibrahim Diawara1, Ousmane Maiga1, 
Sekou Fantamady Traore1, David Safronetz2, Heinz Feldmann2, 
Seydou Doumbia1
1International Center for Excellence in Research/FMOS/USTTB, Bamako, 
Mali, 2National Institutes of Health., Hamilton, MT, United States
Lassa Virus (LASV) was unknown in Mali until an exported case of 
Lassa fever (LF) was reported in 2009. Since then, multiple rodent 
surveys have been conducted and shown evidence of LASV infected 
Mastomys natalensis in several communities restricted to the southern 
tip of the country near the border of Côte d’Ivoire. LF has similar clinical 
manifestation with malaria and maybe misdiagnosed. To date only a 
single case of LF has been confirmed in Mali and little is known about the 
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prevalence of LASV exposure in human population. The goal of this study 
is to determine the prevalence of LASV exposure and malaria parasite 
prevalence in three villages in southern Mali, where infected rodents have 
been documented and where malaria is endemic. About 1 ml of blood 
was drawn by technicians for haemoglobin measurement and Plasmodium 
detection by standard microscopy of blood smears from 600 participants 
under a light microscope for evidence of malaria infection and parasite 
quantification and an enzymelinked immunosorbent assay (ELISA) was 
used to screen serum samples for the presence and quantification of Lassa 
fever virus IgG and IgM. The overall IgG sero-prevalence of LFV was 33.2% 
and the IgM 1.27% (n =600). The IgG sero-prevalence was as high as 
malaria parasite prevalence in Bamba (44.0%, vs 40.0%) and soromba 
(41.0% vs 48.5), and lower in Banzana (14.5 vs 45.0). The majority of 
malaria infection was due to P. faciparum (95.1%). Our results show for 
the first time that LASV is circulation in human population of Southern 
Mali and the prevalence of LASV exposure is as high as malaria parasite 
prevalence. More investigation is needed to identify and monitor hot spot 
areas which are potential epidemic prone areas.
1081
PROGNOSIS PREDICTION FOR PATIENTS WITH CONFIRMED 
EBOLA VIRUS DISEASE IN SIERRA LEONE AND LIBERIA: 
CLINICAL IMPLICATIONS AND FUTURE APPLICATIONS
Andres Colubri1, Adam Levine2, Pardis Sabeti1
1Broad Institute of Massachusetts Institute of Technology and Harvard, 
Cambridge, MA, United States, 2Warren Alpert Medical School of Brown 
University, Providence, RI, United States
We used a computational framework called FMA to derive prognosis 
prediction models for confirmed Ebola Virus Disease (EVD) patients, with 
demographic information, clinical symptoms, and Cycle Threshold (CR) 
values from RT-PCR as covariates. Our goals are (1) to determine which are 
the factors that better prognosticate patient survival upon presentation, 
and (2) to explore the possibility of improved patient triage in emergency 
settings based on the predicted risk scores. We obtained retrospective 
cohort data from a total of 476 confirmed EVD patients admitted to 
five Ebola Treatment Units (ETU) in Sierra Leone and Liberia, between 
2014 and 2015. Data was recorded as part of routine clinical care at 
each ETU, and was combined and deposited in International Medical 
Corps’ secure database. The overall mortality in this cohort is 58%, and 
univariate regression analysis yields the following variables with a P-value 
under 0.05: CT measurement in first day (P=8×10-9, OR=0.28), Age 
(P=9×10-3, OR=1.15), Jaundice (P=10-2, OR=3.9), and Hemorrhagic 
eyes (P=4.5×10-2, OR=0.65). We trained a Logistic Regression model 
with Elastic Net regularization on these variables, augmented with a 
number of additional clinical factors above P=0.05: Coma (P=6.2×10-2, 
OR=undefined as all patients with coma died), Confusion (P=7.1×10-2, 
OR=3.1), Breathlessness (P=7.7×10-2, OR=1.5), and Headache (P=10-1, 
OR=0.7). The CT, Coma, and Confusion variables have missing entries for 
60% of the patients. We addressed this issue by using Multiple Imputation 
(MI) to complete the records, and observed that mortality of patients 
with missing values is similar to that of the entire dataset, which indicates 
that the data is Missing Completely At Random (MCAR). Our best model 
has non-zero coefficients for CT (OR=0.89), Age (OR=1.006), Jaundice 
(OR=2.7), Hemorrhagic eyes (OR=0.67), Coma (OR=3.7), and Confusion 
(OR=3.2). The AUC of this model is 0.74, with a 95% CI of (0.74, 0.86), 
and it shows low overfitting and good calibration. Decision curve analysis 
suggests that interventions based on this model would be better than a 
treat-all policy for decision thresholds above 0.45.
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COMMON FINDINGS AND EXCLUSIONS DURING 
ENROLLMENT OF ADULT MALIAN VOLUNTEERS FOR 
MALARIA VACCINE STUDIES
Assadou H. Mahamadoun1, Issaka Sagara1, Mamady Kone1, 
Kourane Sissoko1, Bourama Kamate1, Yacouba Samake1, Merepen 
Agnes Guindo1, Sintry Sanogo1, M’Bouye Doucoure1, Amadou 
Konate1, Boucary Ouologuem1, Souleymane Traore1, Sara Anne 
Healy2, Erin Gabriel3, Patrick E. Duffy2, Ogobara K. Doumbo1
1Malaria Research and Training Center, Mali, Bamako, Mali, 2Laboratory 
of Malaria Immunology and Vaccinology, National Institute of Allergy and 
Infectious Diseases, Rockville, MD, United States, 3Biostatistical Research 
Branch, National Institute of Allergy and Infectious Diseases, Rockville, 
MD, United States
For malaria vaccine testing, volunteers must be enrolled from a suitable 
site. Screening is a critical step to identify and enroll healthy volunteers. 
We conducted two malaria transmission blocking vaccine studies in 
Malian adults in Bancoumana and surroundings from 2013 to 2015. 
Once informed consented is obtained, each individual undergoes clinical 
and laboratory assessment. This study aimed to assess the frequency 
of different conditions or findings that preclude the enrolment of adult 
subjects into vaccine studies. In 2013, we screened 277 and enrolled 120 
volunteers into the malaria vaccine study of Pfs25H-EPA/Alhydrogel®. The 
eligibility rate was 43.3 % (120/277), and 14.1% (39/277) of volunteers 
withdrew their consent before or at the time of enrollment. The most 
frequent reasons for screening failure were positive Hbs antigen (6.9%, 
19/277) and neutropenia (6.1%, 17/277). HIV frequency was 3.6% 
(10/277). No differences were seen among villages for causes of screening 
failure. In 2015, we screened 478 volunteers and the eligibility rate was 
47.1 % (225/478), with 21.3% (103/478) withdrawing consent before 
or at the time of enrollment. The most frequent reasons for screening 
failure were positive Hbs antigen (8.8%, 42/478), HIV (7.5%, 36/478) 
and positive HCV (4.0%, 19/478). Frequencies of HIV (15.9% (7/44) ) 
and hepatitis C (6.8% (3/44)) were higher in Djoliba village than in other 
villages. In this area, more than half of volunteers failed to be enrolled. 
Positives Hbs antigen, HCV and HIV are the most frequent laboratory 
screening failure reasons, and public health authorities should investigate 
the high rates of these infections in these study communities.
1083
THE SNAKEBITE ATLAS: A GROUND-BREAKING, OPEN-
ACCESS PORTAL FOR SHARING AND GATHERING GLOBAL, 
COUNTRY-SPECIFIC INFORMATION ON SNAKEBITE DEATHS, 
ANTIVENOM AVAILABILITY AND VENOMOUS SNAKES
Stephen Lacey1, Robert A. Harrison2, Alice Hawash1, Nicholas 
Casewell2
1Manta Ray Media, London, United Kingdom, 2Liverpool School of Tropical 
Medicine, Liverpool, United Kingdom
Venomous snakebites are medical emergencies that annually kill over 
95,000 people residing in some of the most disadvantaged, rural and 
remote tropical communities, and leave 2-300,000 surviving victims with 
permanent physical disabilities/disfigurements. Victims require instantly-
available First Aid information and rapid access to effective treatment. 
Attending physicians require immediately-available information as to 
the most effective, locally-available antivenom. Ministries of Health and 
medical charities require data and information to plan antivenom-provision 
and snakebite-management strategies. Acquiring this essential life-saving 
information is currently laborious, problematic and overly dependent 
upon personal contact networks. The Snakebite Atlas is a free, open-
access resource providing geographically-specific information on the 
venomous snake fauna (including images aiding snake identification), 
snakebite incidence, morbidity and mortality data, the brand name 
and manufacturer details of recommended antivenoms, and links to 
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recommended First Aid and clinical snakebite-management protocols. 
The system will also allow data capture, and as such, will be a growing 
resource. The Snakebite Atlas will comprise a database with Geographic 
Information System (GIS), a visually rich web interface optimized for 
mobile, an API for 3rd party integration, and an online/offline smartphone 
app. The provision of the Atlas as a mobile-optimized website and 
smartphone app will meet the needs of all users, irrespective of their 
location. Most rural tropical communities have very limited fixed-line 
internet access, but good mobile coverage. The online/offline app will 
allow users to access the information even when mobile coverage is 
not available, and the app will sync with the central database whenever 
connectivity is sufficient. The Snakebite Atlas therefore offers a much-
needed information-sharing tool for clinical and public health practitioners, 
biologists and the public.
1084
RESPONSE TO FEVER AND UTILIZATION OF STANDBY 
EMERGENCY TREATMENT (SBET) FOR MALARIA IN 
TRAVELERS TO SOUTHEAST ASIA: A SURVEY-BASED 
COHORT STUDY
Christof D. Vinnemeier1, Camilla Rothe2, Marylyn M. Addo2, 
Jakob P. Cramer1, Thierry Rolling1
1University Medical Center Hamburg-Eppendorf, Section Infectious 
Diseases and Tropical Medicine; Bernhard Nocht Institute for Tropical 
Medicine, Hamburg, Germany, 2University Medical Center Hamburg-
Eppendorf, Section Infectious Diseases and Tropical Medicine, Hamburg, 
Germany
Guidelines in several European countries recommend standby emergency 
treatment (SBET) for travellers to regions with low or medium malaria 
transmission (e.g. Southeast Asia (SEA)) instead of continuous 
chemoprophylaxis. For this approach travellers are advised to seek for 
medical assistance within 24 hours in case of onset of fever and to self-
administer SBET only if they are not able to consult a doctor within the 
time period specified. Data on health care seeking behaviour of febrile 
travellers and utilization of SBET is however scarce as only two studies 
were performed in the mid-1990s. Since tourism to SEA is constantly 
increasing and malaria epidemiology has dramatically changed in the 
meantime more knowledge is urgently needed. For this study 876 
travellers to destinations in SEA were recruited in the travel clinic of the 
University Medical Center Hamburg-Eppendorf. Demographic and travel-
related data were collected by using questionnaires, pre-travel advice was 
carried out and SBET was prescribed in accordance to national guidelines. 
Post-travel phone interviews were performed to assess health incidents 
during travel and individual responses of travellers to febrile illness. Out of 
714 patients who were monitored, 130 (18.2%) reported onset of fever 
during travel or 14 days after return. Of those travellers who reported 
fever, 100 (76.9%) carried SBET during travel. The vast majority of 79 
(79%) of febrile travellers did not seek for medical assistance. Overall, 16 
(16%) of febrile patients who carried SBET and 6 (20%) of patients who 
did not carry SBET took the correct measure (doctor visit or SBET intake) as 
a response to febrile illness, respectively. Only 2 travellers self-administered 
SBET, but both of them applied the wrong regimen. In view of declining 
malaria transmission and improving medical infrastructure in most 
countries of SEA and obvious obstacles concerning SBET as shown in this 
study we propose to re-evaluate the current strategy. Pre-travel advice for 
travellers to SEA should focus on the simple message to immediately see a 
doctor in case of febrile illness.
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MORTALITY AMONG EXTREMELY LOW BIRTH WEIGHT 
INFANTS IN PERU
Theresa J. Ochoa1, Jorge Gonzales2, Aasith Villavicencio2, Maria 
S. Rueda2, Christie G. Turin2, Alonso Zea-Vera2, Sicilia Bellomo2, 
Jaime Zegarra3, Anne Castañeda4, Luis Cam5
1Baylor College of Medicine, Houston, TX, United States, 2Universidad 
Peruana Cayetano Heredia, Lima, Peru, 3Hospital Cayetano Heredia, Lima, 
Peru, 4Hospital Guillermo Almenara, Lima, Peru, 5Hospital Alberto Sabogal, 
Lima, Peru
Infant mortality has decreased in recent years given improvements in 
health care policies all over the world. However, neonatal mortality 
continues to be a major public health issue, especially among very low 
birth weight and extremely low birth weight (ELBW) infants. There is no 
data regarding mortality in ELBW infants in developing countries. The 
aim of the study was to determine the mortality in ELBW infants and to 
describe the most common etiologies in three neonatal units in Lima, Peru. 
We enrolled 77 ELBW (<1000g); 21 with a birth weight of 500-750g and 
56 with 751-1000g as part of an ongoing clinical trial in three neonatal 
units in Lima. All patients were followed until death or discharge. Mean 
birth weight was 831.9 ± 123g, mean gestational age was 27.4 ± 2.3 
weeks and length of hospitalization was 43 days (IQR 13-67). Patients 
with a birth weight ≤750g had an overall mortality of 85.7% while 
patients with 751-1000g had an overall mortality of 44.6%. Mortality 
for infants ≤750g was 23.8% within the first 7 days, 42.9% within the 
first 14 days and 76.2% within the first 28 days of life. For infants 751-
1000g, mortality rates were 8.9%, 21.4% and 28.6% within 7, 14 and 
28 days, respectively. Neonatal sepsis was the leading cause of death in 
both groups (50% for infants ≤750g and 76% for infants 751-1000g). 
Other causes of deaths included intraventricular hemorrhage, extreme 
prematurity and respiratory distress syndrome. Mortality was high among 
ELBW infants, especially in those with a birth weight less than 750g. The 
greatest risk of neonatal death occurred within the first two weeks of 
life. More studies focusing on mortality and morbidity in ELBW infants in 
developing countries are needed. This would help to establish prevention 
strategies that reduce the risk of sepsis and sepsis-related deaths.
1086
MANAGING THE FEBRILE CHILD IN THE ERA OF SPREADING 
ANTIBIOTIC RESISTANCE: DEVELOPMENT OF E-POCT, AN 
ELECTRONIC ALGORITHM THAT USES HOST BIOMARKER 
POINT-OF-CARE-TESTS
Kristina Keitel1, Clotilde Rambaud-Althaus2, Alain Gervaix3, Blaise 
Genton4, Valérie D’Acremont5
1Swiss Tropical and Public Health Institute/Boston Children’s Hospital, 
Basel, Switzerland, 2Médecins Sans Frontières Suisse, Geneva, Switzerland, 
3University Children’s Hospital Geneva, Geneva, Switzerland, 4Swiss 
Tropical and Public Health Institute/University Hospital Lausanne, Basel, 
Switzerland, 5Swiss Tropical and Public Health Institute/ Policlinique 
Universitaire Médicale Lausanne, Basel, Switzerland
The objective was to review the available knowledge on epidemiology, 
diagnosis, and management of acute infections in children aged 2 to 59 
months in the outpatient setting and develop an evidence-based electronic 
algorithm suitable for resource-poor settings that uses available point-of-
care tests to achieve optimal clinical outcome while increasing the rational 
use of antibiotics. Through a structured literature review in Medline, 
Embase and the Cochrane Database of Systematic Review targeting 
outpatients aged 2-59 months, we searched for i) available disease 
prevalence in resource-poor settings, ii) accuracy of clinical predictors, and 
iii) performance of point-of-care tests for targeted disease management 
strategies (biomarkers of inflammation, hemoglobin (Hb), blood sugar, and 
oximetry). A novel electronic algorithm for the management of childhood 
illness (e-POCT) was designed based on evidence retrieved. The major 
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changes compared to IMCI (2014 version) are the following: i) use of vital 
signs (in particular oxygen saturation and heart rate), Hb and glycemia 
for classification of severe disease, ii) automated temperature- and age-
correction of heartrate and respiratory rate, iii) replacement or elimination 
of clinical signs with low accuracy, iii) classification of bacterial pneumonia 
based on a combined respiratory-rate and C-reactive protein cutoff (CRP), 
iv) antibiotic prescription based on CRP and procalcitonin in fever without 
source patients, v) use of Hb for depiction of severe disease, vi) increased 
resources for management of skin infections. This novel smartphone-run 
algorithm based on new evidence and two point-of-care tests should 
improve the quality of care of under-fives and lead to more rational use of 
antibiotics.
1087
INCREASING PREVALENCE OF HUMAN DIROFILARIASIS IN 
THE UNITED STATES AND EUROPE
James H. Diaz
Louisiana State University Health Sciences Center, New Orleans, LA, United 
States
Dirofilariasis is a mosquito-borne filarial infection of carnivores. Since 
the zoonotic seroprevalence of dirofilariasis has increased, the objectives 
of this study were to determine human prevalence rates of dirofilariasis 
and compare them for significant increases over the period, 1999-
2012. Internet search engines identified reports of human dirofilariasis 
in the United States (US) and Europe with cases defined by positive 
histopathology. Proportional increases in disease prevalence were stratified 
by nations and compared for statistically significant differences by chi 
squares (X2) with significance defined by p-values < 0.05. By 2012, 372 
cases of human pulmonary dirofilariasis caused by Dirofilaria immitis 
had been reported worldwide representing a 121% increase since 
1999. The greatest increases occurred in Italy and the US with the most 
significant increase in the US (X2=6.4, p=0.011). By 2012, 1,410 cases of 
subcutaneous and/or ocular dirofilariasis, caused by Dirofilaria repens had 
been reported worldwide representing a 67% increase since 1999. The 
greatest increases in cases occurred in Russia (X2=66.4, p <0.0001) and 
Italy (X2=185.9, p<0.0001). Dirofilariasis is an emerging parasitic disease 
of dogs and man resulting from a combination of factors including warmer 
year-round global temperatures with shorter winters extending vector 
transmission cycles; failing regional mosquito control programs; increasing 
seroprevalence of Dirofilaria infections in wild carnivores; increasing 
parasite resistance to chemoprophylaxis in domestic dogs with macrocyclic 
lactones, especially ivermectin; and more frequent international travel 
to Dirofilaria-hyperendemic regions, especially the Southern US, Eastern 
Russia, and the Italian Piedmont. Residents and vacationers in these 
high-risk regions need to protect themselves from dirofilariasis with 
mosquito repellents. More effective chemotherapeutics and improved 
immunodiagnostics and are needed to control and monitor sentinel 
animal reservoirs. More frequent regional mosquito control will interrupt 
prolonged vector-transmission cycles.
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DETERMINATION OF BREAK IN TRANSMISSION IN VECTORS 
OF LYMPHATIC FILARIASIS GHANA
Irene Offei Owusu1, Francis Anto1, Moses Bockarie2, John 
Gyapong1
1School of Public Health, University of Ghana, Legon, Accra, Ghana, 
2Liverpool School of Tropical Medicine, Liverpool, United Kingdom
Since the implementation of the Global Programme for the Elimination 
of Lymphatic Filariasis (GPELF) in 2000, MDA has been on-going in many 
LF endemic countries. Post-MDA monitoring of parasite transmission is to 
assess the efficacy of MDA, when to stop MDA and for the certification of 
elimination of the disease. Monitoring of the transmission pattern in the 
mosquito vectors is as essential as detecting levels of infection the human 
population, since mosquitoes offer real time estimates of transmission. 
This study aims to provide evidence of break in transmission in vectors 
of lymphatic filariasis in some endemic areas of Ghana. A total of 7,072 
mosquitoes were collected from 53 communities in two selected districts 
in Ghana in 2013 and 2014. A total of 4,733 (66.9%) Anopheles sp. 
(comprising of An. gambiae s.l, An. funestus and An. pharoensis), 2,274 
(32.2%) Culex species and 65 (0.9%) Mansonia species were identified 
and tested. Mosquitoes were tested in pools of 1 to 20 with an average 
pool size of 15 using Loop-mediated Isothermal Amplification LAMP). 
All LAMP positive samples were confirmed with PCR. Three pools (2 
Anopheles and 1 Culex) and 2 pools of Anopheles tested positive for W. 
bancrofti in 2013 and 2014, respectively. Infection rates for Anopheles and 
Culex mosquitoes for 2013 were found to be 0.97 and 0.86, while that 
for 2014 were 1.35 and 0.00, respectively. The average biting rates for 
both years did not show any significant difference (p > 0.99). Surveillance 
in humans has shown low levels of microfilariae prevalence but in areas 
where there is residual infection; xenomonitoring offers real time estimates 
of transmission in areas where very low levels of microfilaremia may not 
be detected in humans. Therefore the detection of infection in mosquito 
vectors is an indication that there may be positive individuals in the area of 
interest.
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EVALUATION OF ONCHOCERCIASIS TRANSMISSION IN 
TANZANIA: RESULTS FROM THE TUKUYU FOCUS, 2015
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Onchocerciasis, or river blindness, is the second most prevalent infectious 
cause of blindness in Sub-Saharan Africa. Tanzania implemented annual 
ivermectin mass drug administration (MDA) in 2000 in the Tukuyu focus, 
which had pre-control endemicity as high as 63%. Recent MDA coverage 
was 69-86%. World Health Organization (WHO) guidelines require Ov-
16 antibody positivity to be <0.1% in children at risk before stopping 
MDA. This study compared diagnostic tests in the Tukuyu focus in 
relation to the guidelines and examined age-group specific differences in 
prevalence. Eleven villages near vector breeding sites were selected, and 
an age-stratified random sample was performed. Participants underwent 
a questionnaire, skin examination, skin snips for microfilaria count and 
PCR (≥5 years-old only), and blood draw for: rapid Ov-16 antibody test 
(RDT), Ov-16 ELISA, immunochromatograph (ICT) filariasis rapid test, and 
daytime blood smears. A total of 695 households (HH) were selected; 
617 (98%) HH participated yielding 948 individual participants. A total 
of 499 (52.7%) participants were male; the median age was 12 years 
(interquartile range: 6-26 years). Past-year ivermectin use was reported 
by 522 (65.7%) of eligible participants; itchy skin was reported by 207 
(21.9%). Only 12 (1.3%) participants had nodules; manifestations of 
onchodermatitis occurred in <1% of participants. All skin snips, ICT card 
tests, and daytime blood smears were negative; 38 (5.5%) participants 
had a positive RDT. Weighted, adjusted age group specific prevalence 
was: 0-5 years, 0.5%; 6-10 years, 0.4%; 11-15 years, 0.8%; 16-20 years, 
2.2%; >20 years, 10.5%. The low burden of symptomatic disease and 
few positive RDTs demonstrates that annual MDA has had a significant 
impact on the disease in the Tukuyu focus. However, the Ov-16 positivity 
in children failed to meet the WHO guidelines for stopping MDA. Results 
of skin snip PCR, OV-16 ELISA, and a simultaneous vector collection will 
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add to the data presented here. Further consideration is needed to assess 
if the 0.1% threshold is too strict and if extended age groups (≥10 years-
old) should be included in future assessments.
1090
NEW METHODS TO MEASURE CHANGES IN INFECTIOUS 
DISEASE TRANSMISSION FROM QUANTITATIVE ANTIBODY 
MEASUREMENTS: EXAMPLES USING WUCHERERIA 
BANCROFTI, PLASMODIUM FALCIPARUM AND ENTERIC 
PATHOGENS
Benjamin F. Arnold1, Mark J. van der Laan1, Alan E. Hubbard1, 
Cathy Steel2, Joseph Kubofcik2, Katy L. Hamlin3, Delynn M. Moss3, 
Thomas B. Nutman2, Jeffrey W. Priest3, Patrick J. Lammie3
1University of California Berkeley, Berkeley, CA, United States, 2National 
Institute of Allergy and Infectious Diseases, Bethesda, MD, United States, 
3United States Centers for Disease Control and Prevention, Atlanta, GA, 
United States
Global elimination efforts for neglected tropical diseases and malaria 
rely on accurate estimates of pathogen transmission intensity to target 
control programs and evaluate their effectiveness. Serological antibody 
levels have proven to be a sensitive marker of pathogen exposure, and 
advances in multiplex serological assays have created enormous potential 
for large-scale, integrated infectious disease surveillance. We developed a 
novel, nonparametric method using recent advances in ensemble machine 
learning and statistical estimation to measure changes in transmission 
from quantitative antibody levels that can be applied to diverse pathogens 
of global importance. We compared age-dependent immunoglobulin G 
curves in intervention (Nigeria, Cook Islands) and observational (Haiti, 
United States) settings with differences in transmission intensity for 
multiple pathogens, including: lymphatic filariasis (Wuchereria bancrofti), 
malaria ( Plasmodium falciparum), enteric protozoans (Cryptosporidium 
parvum, Giardia intestinalis, Entamoeba histolytica), enteric bacteria 
(enterotoxigenic Escherichia coli, Salmonella spp.), and norovirus groups 
I and II. Age-dependent antibody curves followed a characteristic shape 
across pathogens that aligned with predictions from basic mechanisms of 
humoral immunity. Changes in pathogen transmission led to shifts in fitted 
antibody curves that were remarkably consistent across pathogens, assays, 
and populations. Summary differences between curves provided a robust 
and sensitive measure of changes in transmission, with greatest sensitivity 
among young children. Summary P. falciparum antibody measures 
correlated strongly with the entomological inoculation rate (Spearman’s ρ 
= 0.75). We will illustrate easy to use, open source software to implement 
the approach. The method generalizes to pathogens that can be measured 
in high-throughput, multiplex serological assays, and scales to estimation 
problems requiring high spatiotemporal resolution -- features that make 
the approach well-suited to integrated surveillance of global infectious 
disease elimination efforts.
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THE FIRST SUCCESSFUL CONFIRMED ELIMINATION OF AN 
ONCHOCERCIASIS FOCUS IN AFRICA: ABU HAMED, SUDAN
Isam Zarroug1, Kamal Hashim1, Wigdan A. ElMubark1, Zainab A. 
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Charles D. Mackenzie5, Frank Richards3, Tarig B. Higazi6
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Sudan, 3The Carter Center, Atlanta, GA, United States, 4University of South 
Florida, Tampa, FL, United States, 5Michigan State University, Lansing, MI, 
United States, 6Ohio University, Zanesville, OH, United States
Mass treatment with ivermectin for onchocerciasis was stopped in 2012 
in Abu Hamed, an isolated focus on the River Nile in northern Sudan. 
A three year post-treatment surveillance (PTS) ensued, at the end of 
which an evaluation was conducted in 2015 following the current WHO 
guidelines for verification of onchocerciasis elimination. Vector black flies 
were collected from sentinel breeding sites and fingerprick bloodspots 
were collected from children ≤ 10 years old resident in 35 communities 
within the focus. O-150 PCR screening of 19,191 flies from 4 sites found 
no flies carrying Onchocerca volvulus larvae (0%, 95% Upper Confidence 
Limit = 0.16), and serological testing of 5266 children identified only one 
Ov16 seropositive child (0.019%, 95% UCL = 0.074); who was negative 
when screened by O-150 PCR assay. These results indicate that for the first 
time in Africa, onchocerciasis elimination has been verified following a 
successful PTS in Abu Hamed.
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UTILIZING THE SD BIOLINE ONCHOCERCIASIS IGG4 RAPID 
TEST IN ONCHOCERCIASIS SURVEILLANCE IN SENEGAL
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Allison Golden2, Marie Khemesse Ngom Ndiaye3, Ngayo Sy3, 
Malang Mané3, Babacar Faye4, Mamadou Sarr5, Elhadji Mamadou 
Dioukhane5, Roger Peck2, Philippe Guinot1, Tala de los Santos2
1PATH, Dakar, Senegal, 2PATH, Seattle, WA, United States, 3Senegal 
Ministry of Health and Social Action, Dakar, Senegal, 4University of Cheikh 
Anta Diop, Dakar, Senegal, 5Medical Region of Kédougou, Kédougou, 
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Global efforts toward control and elimination of onchocerciasis have 
made significant progress through community-directed treatment with 
ivermectin (CDTI). After years of successful CDTIs, control programs 
need to determine whether Onchocerca volvulus transmission has 
been interrupted and therefore treatment can be stopped. In many 
communities, the current testing method is skin snip microscopy; 
however, this method is less acceptable and has declining sensitivity in 
low-prevalence settings. The 2016 World Health Organization “Guidelines 
for Stopping Mass Drug Administration (MDA) and Verifying Elimination 
of Human Onchocerciasis” recommend using Ov16 serology tests, in 
addition to entomological evaluations, for post-treatment and post-
elimination surveillance. The SD BIOLINE Onchocerciasis IgG4 rapid test 
(Standard Diagnostics, South Korea) is a rapid Ov16 serological diagnostic 
test (Ov16 RDT) that is field friendly, noninvasive, simple to use, and low 
cost. Our hypothesis is that the Ov16 RDT is an improved tool over skin 
snip microscopy for country programs to monitor their progress toward 
stopping MDA and reaching elimination. The study incorporates the 
Ov16 RDT in ongoing onchocerciasis surveillance activities in Senegal in 
15 villages among 1,250 individuals over the age of 5 years. The study 
compares age-prevalence curves, workflow, and cost analyses of the 
Ov16 RDT and skin snip microscopy. Additionally, usability and community 
acceptance of the Ov16 RDT are assessed using a mixed methods 
research design, and a mobile phone-based data collection tool is piloted 
along with traditional data collection systems. This study provides key 
evidence of the feasibility of implementing the Ov16 RDT to make critical 
decisions about whether to continue, halt, or re-initiate MDA efforts in 
communities. The results of this study may be informative to other country 
programs interested in adopting this new tool, particularly as these country 
programs quickly move from control to elimination of onchocerciasis.
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THE FEASIBILITY OF A ‘RE-MAPPING’ PROTOCOL FOR 
LYMPHATIC FILARIASIS IN AREAS WHERE TRANSMISSION IS 
UNCERTAIN IN ETHIOPIA
Heven Sime Firew1, Sindew Mekasha Feleke1, Ashenafi Assefa 
Bahita1, Sonia Pelletreau2, Adugna Woyessa Gemeda1, Yibeltal 
Assefa Alemu1, Amha Kebede Hailemikael1, Maria Rebollo Pollo3
1Ethiopian Public Health Institute, Addis Ababa, Ethiopia, 2Centers for 
Disease Control and Prevention, Atlanta, GA, United States, 3Task Force for 
Global Health, Atlanta, GA, United States
Lymphatic filariasis (LF) is one of the world’s leading causes of permanent 
disability. WHO proposed a comprehensive strategy to eliminate LF 
by 2020, interruption of transmission through MDA and morbidity 
management. The global program to eliminate lymphatic filariasis (GPELF) 
recommends mapping as an initial step to determine the need of MDA in 
Implementation units (IUs). The existing WHO guideline recommends two 
sites per IU should be selected for mapping and a sample of 100 adults 
should be tested for antigenaemia. In low transmission setting this strategy 
has limitations. An alternative complementary mapping method that could 
resolve this situation is useful. This study was, therefore, designed to assess 
the Lf endemicity level of IUs in Ethiopia which have low transmission 
setting. The 2013 mapping in Ethiopia resulted in 45 IUs with antigenemia 
result not enough for programmatic decision making. To solve this gap 
the school based re-mapping study was conducted in two phases; phase 
I was conducted last year in 8 IUs, to evaluate the protocol itself. The 
study proceeded to Phase II after the result of the phase I re-mapping was 
analyzed and interpreted. In this survey, schools were selected by either 
systematic or cluster sampling, based on the number of schools in the 
IUs. From each selected school children of grade 4 to 8 were sampled 
systematically and tested for antigenemia. The number of positive result 
was compared against the critical value. From 41 IUs involved in second 
phase re-mapping survey, antigenesimia was tested from 16,365 children 
of target grades in selected schools. In 39 of the IUs, the number of 
antigen positive identified in the re-mapping surveys was below the critical 
cut off, suggesting transmission of LF is not ongoing in these IUs. Where 
as in two of the IUs, the number of antigen positive identified was above 
the critical value suggesting that the LF transmission is ongoing. In low 
prevalence areas, where the current WHO protocol has several limitations, 
this re-mapping study design will provide enough information on the LF 
transmission situation which may help programs to make evidence based 
decision.
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LONGITUDINAL EVALUATION OF ONCHOCERCIASIS 2012- 
2015 IN THE MID NORTH FOCUS IN UGANDA
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Onchocerciasis is a neglected tropical disease that is targeted for 
elimination. Uganda implemented annual mass drug administration (MDA) 
with ivermectin (IVM) in this focus in 2009 and began twice yearly MDA 
in October 2012. Late in 2012 it also implemented a 1-year vector control 
program. We conducted an initial survey of 500 people in September 2012 
and a follow-up survey in September 2015. All participants underwent 
questionnaires, skin examination for Onchocerca-associated lesions, two 
skin snips and a venous blood draw. Skin snip microscopy, PCR and OV-
16 ELISA were performed on the collected specimens. A total of 343 
(68%) people re-enrolled in the 2015 study; 209 (60%) were female, and 
the median age was 36 years (range 10-90 years). The use of IVM was 
high at both time points (86% vs. 88%). Comparisons between 2012 
and 2015 showed that significantly fewer people at follow up had skin 
nodules (54% vs 24%), positive skin snip results (25% vs 6%), as well 
as skin lesions: acute papular onchodermatitis (3% vs. 0.3%), chronic 
papular onchodermatitis (6.5% vs 0.6%), lichenified onchodermatitis 
(6% vs 0%), and skin depigmentation (9.7% vs 1.6%) (McNemar’s test, 
p<0.05). Significant reductions in microfilarial density in skin snips (2.3 
vs 0.2 microfilariae/2 snips/person) and OV-16 ELISA optical density (OD) 
values (2.08 [SD=1.58] vs 0.92 [SD=1.14]) (paired t-test, p<0.05) were 
also observed; however, the prevalence of OV-16 positivity did not change 
(85% vs 79%). Taken together, these results show that a significant 
reduction in disease morbidity occurred in North Uganda after three years 
of twice per year IVM MDA and one year of vector control. Both skin snip 
microscopy and quantitative OV-16 ELISA provided important information 
on MDA program impact. Correlating OV-16 ELISA results to other 
markers of infection might allow for the differentiation of on-going versus 
suppressed transmission. Furthermore, the decline in OV-16 ELISA values 
suggest its potential use as an alternative to skin snip PCR when assessing 
those few individuals with OV-16 positive results in program evaluations to 
stop MDA.
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Paul Cantey1
1Centers for Disease Control and Prevention, Atlanta, GA, United States, 
2Universidad del Valle, Guatemala, Guatemala, 3Imperial College London, 
London, United Kingdom, 4Vassar College, Poughkeepsie, NY, United 
States, 5Universidad del Valle de Guatemala, Guatemala, Guatemala
Current WHO guidelines recommend testing for OV-16 serologic responses 
in children to determine when it is appropriate to stop mass drug 
administration (MDA) for onchocerciasis. Understanding the decrease 
in antigen-specific seropositivity over time might allow the inclusion of 
older age groups for these assessments or post-treatment surveillance 
(PTS). In the Central Endemic Zone (CEZ) of Guatemala, interruption 
of onchocerciasis transmission was observed in 2011 and confirmed in 
2014. A follow-up study was conducted in October 2014 to assess the 
serological response to onchocerciasis among people tested between 2003 
and 2009, while transmission was ongoing. Comparisons were based on 
a normalized OV-16 ELISA, with a positive cutoff of 40 Activity Units (AU). 
Results from participants with positive serology at baseline were used to 
conduct a preliminary estimation of temporal antibody decay rates using a 
mixed effects linear regression model. A total of 230 people (120 female, 
52%) were enrolled, 85 with previous positive OV-16 ELISA results and 
145 who were negative. The 85 positives contributed 93 retrospective data 
points with mean AUs of 86 (n=11), 174 (n=59), 108 (n=19) and 82 (n=4) 
in years 2003, 2006, 2007 and 2009, respectively, and 40 [95% CI 23.8-
55.8] in the 2014 follow up. Those considered negative contributed 155 
data points, with mean AUs of 30 (n=18), 19 (n=59), 10 (n=67) and 0.1 
(n=11) in 2003, 2006, 2007 and 2009, respectively, and 6 [95% CI 3.9-
7.7] in the 2014 follow up. Additionally, none of the 77 study participants 
under the age of 20 years had a positive serologic result. Temporal analysis 
of AUs showed a mean decay rate of 0.31/year (SD= 0.20) and an average 
half-life of 2.25 years. These results concur with previous assessments that 
onchocerciasis transmission had been interrupted in the CEZ. The antibody 
responses to OV-16 appear to have decreased over time, presumably due 
to the lack of exposure to viable adult worms. These findings also highlight 
the importance of conducting further studies to determine if people ≥10 
years of age could be included in evaluations for stopping MDA, PTS, or 
post-elimination surveillance.
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A DELPHI CONSULTATION TO ASSESS INDICATORS OF 
READINESS TO PROVIDE QUALITY HEALTH FACILITY-BASED 
LYMPHEDEMA MANAGEMENT SERVICES
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The World Health Organization (WHO) in collaboration with partners 
is developing a toolkit with resources to guide lymphatic filariasis (LF) 
morbidity management and disability prevention (MMDP) implementation 
and evaluation. Assessment of the readiness of programs to provide 
quality lymphedema management services is recommended via a direct 
facility inspection. As part of tool development, a Delphi consultation 
was implemented to gain consensus on the proposed themes and tracer 
indicators to measure readiness to provide quality health facility-based 
lymphedema management services. A seven-point Likert-type scale was 
used to rank the importance of proposed themes and tracer indicators. 
Consensus for inclusion of the indicator was defined a priori as 70% or 
more of respondents ranking the proposed indicator in the top three 
points (5-7). Purposive sampling was used to select 43 representative 
experts including neglected tropical disease (NTDs) country representatives, 
program implementers, and technical experts. A 55.8% response rate 
(n=24) was achieved for the first round of the survey. The majority of 
respondents had ten or more years of expertise (n=17, 70.8%) in MMDP 
or NTDs. Analysis of the first round of data demonstrated that consensus 
for inclusion had been reached across all proposed indicators including 
trained staff (mean=6.9, standard deviation (SD)=0.34), case management 
and education materials (mean=6.1, SD=0.65), water infrastructure 
(mean=6.3, SD=0.81), medications and commodities (mean=6.3, 
SD=0.69), patient tracking system (mean=6.3, SD=0.85), and staff 
knowledge (mean=6.5, SD=6.5, SD=0.66). The results from this analysis 
were used to inform revisions of the direct inspection which will be piloted 
in several countries to further refine tools to assess readiness to provide 
quality lymphedema management services.
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Sri Lanka was one of the first countries to initiate a lymphatic filariasis 
(LF) elimination program based on WHO guidelines. Following several 
years of mass drug administration (MDA) with DEC alone, the Anti-
Filariasis Campaign (AFC) provided 5 annual rounds of MDA with DEC 
plus albendazole in all endemic districts in the country from 2002-2006. 
The AFC and other groups have conducted extensive surveillance activities 
since 2006. Microfilaremia (Mf) rates have been consistently <1% in all 
sentinel and spot check sites since that time, and all 11 evaluation units 
passed school-based transmission assessment surveys (TAS) in 2013. We 
have previously reported results from comprehensive surveillance studies 
conducted in 2011-2013 that documented low-level persistence of LF in 
19 high risk Public Health Inspector areas (PHI, mean population 25,000) 
spread across 8 endemic districts. We now present results from repeat 
comprehensive surveys conducted in 2015 (8 to 9 years after the last 
round of MDA) in 5 PHI areas that had the strongest LF signals in the 
prior study. These surveys assessed community CFA and Mf rates, CFA 
and anti-filarial antibody rates in school children (ages 6-8), and filarial 
DNA rates in Culex quinquefasciatus collected with gravid traps. Two 
areas had encouraging results with improved LF parameters (Pw and KN), 
but three other areas (Uw, Amb, Wg) showed no significant change. Our 
study also identified a new hotspot in Galle district with alarmingly high 
LF parameters (community CFA 3%, Mf 1%, anti-Bm14 antibodies in 
school children 5.7%, and a filarial DNA rate of 5.2% in the vector). Thus 
areas with persistent LF in Sri Lanka appear to be close to the transmission 
breakpoint; LF is likely to disappear without further intervention in 
most areas, while other areas may require more work. We think that LF 
elimination programs should consider using methods other than school-
based TAS to identify areas with persistent LF following completion of 
MDA. In addition, long term surveillance may be needed to verify that LF 
has been eliminated, and this may be especially true in areas like Sri Lanka 
where the parasites are transmitted by Culex mosquitoes.
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Mass drug administration (MDA) with ivermectin is the cornerstone 
of global efforts to eliminate onchocerciasis (river blindness). Several 
epidemiological studies in Ghana and Cameroon have reported so-called 
suboptimal or atypical responses to ivermectin in patients infected with 
Onchocerca volvulus, the causative filarial parasite of onchocerciasis. 
These responses are characterised by a faster than expected rate of skin 
repopulation by parasite microfilariae following treatment and have been 
interpreted as warning signs of decreased efficacy of the anti-fecundity 
effects of ivermectin on adult female worms, potentially caused by 
emerging (reproductive) resistance. Yet, there is currently no clear and 
objective definition of what constitutes a suboptimal response nor any 
reliable method for detangling the true underlying drug response from 
the high degree of statistical sampling error incurred when counting 
microfilariae in skin snips. Here we tackle this problem using an individual-
based statistical model which we fit in a Bayesian framework to individual 
patient data from the first set of clinical trials of ivermectin against human 
onchocerciasis conducted in the mid 1980s, before the widespread use 
of ivermectin for MDA. We use the fitted model to define predictive 
distributions of typical responses to ivermectin in drug-naïve patients and 
validate these using both censored data from the same set of (historical) 
trials and contemporary data from ivermectin-treated control patients 
who participated in the recent phase II clinical trial of moxidectin. We 
discuss how the analytical framework can be used to identify and monitor 
suboptimal responses to ivermectin in populations undergoing long-term 
MDA.
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THE EFFICACY OF PREVENTATIVE CHEMOTHERAPY DRUGS 
FOR THE TREATMENT OF LYMPHATIC FILARIASIS: A 
SYSTEMATIC REVIEW AND MODEL-BASED META-ANALYSIS
Isabelle Pearson, Julia B. Halder, Maria-Gloria Basáñez, Martin 
Walker
Imperial College London, London, United Kingdom
The principal intervention strategy to control and eliminate lymphatic 
filariasis (LF) is so-called preventative chemotherapy (PCT) by mass drug 
administration (MDA) with combinations of albendazole and either 
ivermectin or diethylcarbamazine. These therapies, although of uncertain 
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efficacy against adult parasites (macrofilariae), suppress numbers of blood-
borne microfilariae for approximately one year after treatment. Because 
microfilariae are infectious to the mosquito vectors of lymphatic filariae, 
if enough infected people are treated, transmission between treatment 
rounds will be markedly reduced or interrupted completely. Local 
elimination is possible if this can be maintained for at least as long as the 
natural life-span of the macrofilariae. While compelling, a key uncertainty 
in this elimination algorithm, is for how long following treatment 
microfilariae are sufficiently suppressed such that individuals adhering to 
MDA are essentially removed as contributors to transmission. Indeed, the 
efficacy of PCT drugs is currently incorporated into LF transmission models 
(that are used to predict timeframes for elimination) with considerable 
uncertainty, based on expert opinion and semi quantitative ultra-
sonographic data on macrofilariae. Here, we present a literature review 
to identify clinical and field trials of the efficacy of the PCT drugs used to 
treat LF and extract relevant data on numbers of microfilariae at different 
times following treatment. We develop a simple mathematical model to 
describe the population dynamics of microfilariae following treatment and 
fit this to the available data. We use the fitted model to characterise the 
efficacy of PCT combinations against LF and discuss the application of our 
results to mathematical transmission models of LF and to the detection of 
suboptimal or atypical drug responses.
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The African Programme for Onchocerciasis Control (APOC) coordinated 
from 1995-2015 annual ivermectin mass treatment to control morbidity 
of onchocerciasis (river blindness). These efforts should be maintained 
even after 2015 to achieve elimination in 80% of all endemic countries 
by 2025, although this may not be achievable everywhere due to late 
onset of infection and/or low treatment coverage. Even if elimination is 
realised, a considerable chronic disease burden remains due to earlier 
infection. To understand the need for alternative interventions and new 
drugs, we predict trends in infection and onchocercal morbidity over time 
up to 2025, stratified by age and sex. We use the individual-based model 
ONCHOSIM to predict trends for a range of scenarios, varying by type of 
onchocerciasis (forest / savannah), baseline endemicity, history and future 
of control. The model was extended to make detailed predictions for a 
wide spectrum of forms of onchocercal skin disease, which so far were 
considered to only include itch. Model parameters were quantified to 
reproduce association between infection and morbidity using data from 
a TDR-funded multi-country field study on onchocercal skin disease as 
well as literature on visual impairment and blindness. The prevalence of 
infection, morbidity and excess mortality decline progressively over time 
up to 2025. The prevalence of reversible skin disease (e.g. troublesome 
itch, acute and chronic papular, and lichenified onchodermatitis) declines 
rapidly with waning infection prevalence, with the rate of the decline 
depending on achieved therapeutic coverage. Irreversible manifestations 
i.e. visual impairment, blindness, atrophy, depigmentation, and hanging 
groin decline much more gradually. This study provides better insight 
in expected trends of infection and onchocercal morbidity. We discuss 
expected trends in disease burden for endemic countries and Africa as a 
whole, which will be useful to policy makers and national onchocerciasis 
control programmes.
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A number of methods have been used to estimate lymphatic filariasis 
(LF) morbidity, including: routine programmatic data, cluster random 
surveys and the “town crier” method. Currently, few accurate data exist 
on the global LF morbidity burden. We aimed to estimate prevalence of 
lymphedema and hydrocele in Mtwara Municipal Council using mobile 
phone based survey. A cross-sectional survey was conducted among 
adults of Mtwara municipal council with access to mobile phones. A 
sample size of at least 384 completed surveys was required to estimate 
prevalence of lymphedema (both males and females) and hydrocele 
(males only) morbidity of 50% within a 5% error margin given a 5% level 
of significance and 95% confidence level. Eligible mobile phone users 
received a short message text (SMS) requesting consent to participate 
in the survey. A total of 10 questions were administered via interactive 
SMS through GeoPoll, a survey platform developed by Mobile Accord 
(research.geopoll.com). The survey was completed over a period of 4 
days. A total of 8,759 surveys were sent to mobile phone subscribers of 
whom 1,330 (15.2%) opted-in to complete the survey. A total of 492 
(37.0% or those opted-in, 384 male and 108 female) people completed 
the survey. Lymphedema and hydrocele signs were reported by 20.9%; 
(95% confidence interval [CI] 17.4 - 24.8) and 20.6%; (95% CI 16.6-
25.0) of respondents, respectively. Majority of hydrocele patients (59.5%) 
and 46.6% of lymphedema patients reported having sought treatment. 
The proportion of patients reporting similar symptoms among friends 
are relatives was 35.8% and 70.9% for lymphedema and hydrocele, 
respectively. The findings suggest that mobile phone based surveys are 
a practical and rapid approach of undertaking morbidity surveys. While 
further methods of clinical examination are needed to verify the findings, 
this approach can be expected to encourage identification of lymphedema 
and hydrocele morbidity at community level and provide evidence where 
morbidity management services are warranted.
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STEPS TOWARDS ELIMINATION: RE-EVALUATION OF 
LYMPHATIC FILARIASIS PREVALENCE IN TANZANIA
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Despite positive strides made in the control of lymphatic filariasis (LF), this 
disease continues to cause morbidity and mortality in Tanzania. In order 
to inform targeted and effective mass drug administration (MDA) in the 
country, the national neglected diseases program (NTDCP) conducted 
remapping in 2015. The purpose of the re-mapping surveys was to to 
assess LF prevalence levels and to identify new LF transmission hotspots 
in areas where MDA had not been implemented before. The 2015 LF 
remapping exercise was conducted in nine regions covering 63 districts 
in the Lake, Western and Northern zones in Tanzania, with support from 
USAID through the ENVISION Project and from the Task Force for Global 
Health. The 9 regions included Geita, Simiyu, Mwanza, Arusha, Shinyanga, 
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Mara, Kagera, Kigoma and Kilimanjaro. This was a randomized 30-cluster 
school survey design, in which 30 primary schools were randomly selected 
from each district. Fifteen children aged from ≥10 years were selected 
randomly from each school. A total of 1,770 primary schools were 
randomly sampled and 29,054 students aged ≥10yrs old were tested for 
LF. Each child was tested using the immunochromatographic card test (ICT) 
for LF. Of these, six positive LF tests were confirmed, equivalent to 0.021% 
of the total number of students tested. The confirmed positive LF tests 
were found in Magu DC, Ukerewe DC, Misenyi DC, Moshi DC and Bariadi 
TC. The results of the re-mapping indicated that these districts do not 
require MDA. This is an important step in scaling down MDA interventions 
in Tanzania and now the NTD program will focus on the remaining districts 
to achieve elimination.
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MOSQUITO BITE HETEROGENEITY INFLUENCES LYMPHATIC 
FILARIASIS PREVALENCE, INTENSITY AND OPPORTUNITIES 
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University, Cleveland, OH, United States, 3Liverpool School of Tropical 
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Global efforts to eliminate lymphatic filariasis have achieved many 
successes in the local elimination of this debilitating neglected tropical 
disease. An emerging challenge to the elimination program are 
heterogeneities in village-specific characteristics within district-level 
interventions. One important question is how aggregated exposure 
to infective bites and aggregated worm burden impact the choice of 
intervention and the optimum coverage needed to achieve elimination 
and how this varies spatially. We test the hypothesis that heterogeneous 
disease patterns are derived primarily from the distribution of infective 
bites received by an individual over their lifetime. We also test the 
hypothesis that vector control results in more heterogeneous exposure 
which may influence the time to local elimination. We employed a dataset 
from five villages in Papua New Guinea characterized by moderate to high 
transmission of LF. These included spatially resolved anopheline densities 
surrounding the bednet distribution, and individual antigenemia and 
microfilaremia. We calculated the heterogeneity of biting density and mf 
by the fitting of a negative binomial distribution at both village-level and 
at the level of individuals. This was complimented with a full geospatial 
model of filariasis infection based on the underlying distribution of bites. 
We found that the heterogeneity of bites at the village level is a very poor 
indicator of heterogeneity in the mf count (correlation less than 0.1). 
We observed a significant increase in bite risk heterogeneity, however 
the decrease in biting density achieved by bednets more than offset the 
increase in bite aggregation, resulting in a shorter recommended course of 
mass drug administration. At the individual level, the biting density was a 
stronger indicator of mf burden, although there was a significant variation 
in the distribution unaccounted for. This highlights the need for further 
investigation on how the population-level distribution of parasites arises 
from environmental, geographic and individual factors.
1104
ONGOING TRANSMISSION OF ONCHOCERCIASIS IN 
THREE COMMUNITIES IN MASSANGAM DISTRICT IN WEST 
CAMERON AFTER 18 YEARS OF MDA OF IVERMECTIN
Didier K. Bakajika1, Laura Senyonjo2, Peter Enyong3, Daniel 
Boakye4, Serge Akongo5, Didier Biholong6, Joseph Oye5
1Sightsavers, Accra, Ghana, 2Sightsavers, UK, United Kingdom, 3Buea 
University, Buea, Cameroon, 4Noguchi Memorial Institute for Medical 
Research, Accra, Ghana, 5Sightsavers, Yaounde, Cameroon, 6Ministry of 
Health, Yaounde, Cameroon
The West Region of Cameroon has been under annual ivermectin mass 
distribution (MDA) for more than 15 years but transmission is on-going. 
High Onchocerca volvulus (O.V) infections have been identified through 
studies conducted by Sightsavers in collaboration with the Ministry of 
health of Cameroon, in the Massangam health district and Makoupsap 
village in particular. There was therefore a need to clearly delineate the 
boundaries of this potential high transmission focus. We conducted 
epidemiological and entomological surveys to evaluate the prevalence 
of Onchocerciasis in the communities around Makoupsap, map out 
the breeding sites of Simulium damnosum s.l. and thus delineate the 
boundaries of such a potential focus. Nodule prevalence in communities 
within 20 Km of Makoupsap were determined through clinical 
examination and prevalence of OV microfilaria was determined in children 
up to 10 years using the IgG4 (Ov 16) and positive children to OV-16 
were skin sniped . Breeding sites were prospected for blackfly larvae and 
adult blackflies were collected on Esperanza Window traps using hand-
held battery powered aspirators. In total 2375 persons participated in 
the study. The nodule prevalence was 3.4% with children of 6-10 years 
having nodules in two communities. 898 persons were skin snipped and 
115 were positive giving a microfilaria rate of 12.9%. 1530 children 
were assessed using OV-16 and 148 were positive giving a prevalence 
of 1.5%. 4598 blackflies were caught during the 9 days of collection. 
Morphological identification revealed that S. squamosum s.s. was the 
only vector in this region. 3162 females were dissected. Of these, 633 
(20.02%) were parous, while 8 (0.25%) were infected and 2 (0.06%) 
were infective. Mbam River is probably the most important source of biting 
S. squamosum s.s. during the high biting season. These surveys showed an 
on-going transmission of onchocerciasis in 3 communities despite 18 years 
of Ivermectin MDA.
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IMPLEMENTATION OF A FACILITY-BASED INSPECTION TOOL 
TO ASSESS QUALITY OF LYMPHEDEMA MANAGEMENT 
SERVICES IN VIETNAM
Vu T. Binh1, Caitlin M. Worrell2, Do T. Dung1, Molly Brady3, 
Victoria Walsh2, Aya Yajima4, Zeina Sifri5, LeAnne Fox2, Tran T. 
Duong1
1National Institute of Malariology, Parasitology and Entomology, Hanoi, 
Vietnam, 2Centers for Disease Control and Prevention, Atlanta, GA, United 
States, 3RTI International, Washington, DC, United States, 4Western Pacific 
Regional Office, World Health Organization, Manila, Philippines, 5Helen 
Keller International, Washington, DC, United States
Lymphedema (LE) management activities in Vietnam were initiated in 
2004, when staff were trained to provide facility-based services for 
patients with LE. With the support of USAID’s MMDP Project, Vietnam 
piloted a WHO-developed direct inspection tool to measure the quality of 
health facility-based LE management services. A list of all commune health 
stations (CHS) in areas with known LE patients was compiled. Patients 
were reported from 213 CHS in the Northern region, 2 CHS in Central 
region, and 2 CHS in Southern region. About 10% of facilities in the north 
were randomly selected, whereas all facilities with patients were selected 
in the Central and Southern regions. A standardized questionnaire was 
administered at each facility capturing data on 14 equally-weighted tracer 
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indicators across six quality themes: trained staff, case management 
and education materials, water infrastructure, medications and 
commodities, patient tracking system, and staff knowledge; as well as 
patient knowledge. Scores were generated for the 32 CHS surveyed, 
as well as national scores for each tracer indicator. The average facility 
score was 8.8 out of 14.0 possible points (62.9%), and ranged from 4.0 
(28.6%) to 13.0 (92.9%). The national average score for each of the 
tracer indicators was: staff trained in last two years (0.0%); availability 
of LE management guidelines (56.3%), availability of information, 
education, and communication materials (15.6%); reliable improved water 
infrastructure (93.8%); availability of antiseptics (81.3%), antifungals 
(43.8%), analgesics or anti-inflammatories (96.9%), oral/injectable 
antibiotics (93.8%), supplies for LE and acute attack management 
(100.0%); LE patients recorded in last 12 months (9.4%); staff knowledge 
about LE signs/symptoms (62.5%); staff knowledge about LE management 
strategies (71.9%); staff knowledge about signs/symptoms of acute 
attacks (81.3%); and staff knowledge about acute attack management 
strategies (75.0%). Attrition of trained health staff and depletion of 
education materials are some areas where Vietnam is planning to reinforce 
to ensure quality LE services.
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ASSESSING AN IMPORTANT BARRIER TO ONCHOCERCIASIS 
ELIMINATION: DETERMINANTS AND CHARACTERISTICS OF 
LOA LOA INFECTION AND INTENSITY IN CAMEROON AND 
GABON
Kira A. Barbre1, Joseph Kamgno2, Julienne Atsame3, Benjamin D. 
Biholong4, Maria P. Rebollo1, Honorat Zoure5
1The Task Force for Global Health, Decatur, GA, United States, 2Faculty 
of Medicine and Biomedical Sciences, University of Yaounde I, Yaounde, 
Cameroon, 3Ministry of Health Gabon, Libreville, Gabon, 4Ministry of 
Public Health Cameroon, Yaounde, Cameroon, 5Regional Office for Africa, 
World Health Organization, Brazzaville, Republic of the Congo
As the 2020 deadline for elimination of onchocerciasis approaches, it is 
essential to determine the mapping and treatment needs of areas with 
untreated hypo-endemic onchocerciasis (<40% prevalence) currently 
ineligible for mass drug administration (MDA) with ivermectin due to co-
endemicity of Loa loa infection. Intensity of L. loa infection is associated 
with likelihood and severity of serious adverse events (SAEs) to ivermectin 
MDA. To inform guidelines for future testing and treatment decisions in 10 
L. loa endemic countries, we used existing L. loa prevalence and intensity 
data from Gabon (10214 individuals tested in 2014-2015) and Cameroon 
(5574 individuals tested in 2012-2013) to describe demographic predictors 
of L. loa infection. We used the following guidelines to characterize 
intensity of L. loa infection: no infection detected (0 mf/mL), low intensity 
(<8,000 mf/mL), medium intensity (8,000-<30,000 mf/mL), and high 
intensity (>=30,000 mf/mL). In Gabon, 8355 (82%) had no infection, 
1503 (15%) had low-intensity infection, 265 (3%) had medium-intensity 
infection, and 91 (1%) had high-intensity infection. In Cameroon, 3929 
(70%) had no infection, 1346 (24%) had low-intensity infection, 215 (4%) 
had medium-intensity infection, and 44 (2%) had high-intensity infection. 
Males had a higher prevalence of infection in both Gabon (21% vs. 16%, 
p<0.0001) and Cameroon (34% vs. 25%, p<0.0001). In both countries, 
L. loa prevalence increased with age. In Gabon, 5% of individuals under 
age 15 were infected compared to 26% of individuals ages 60 and older. 
In Cameroon, 13% of individuals under age 15 were infected compared 
to 37% of individuals 60 and older. High intensity infections were rare but 
found in all age groups in both countries. These results suggest that L. 
loa testing targeting males and older individuals would be most likely to 
detect L. loa infection in a community.
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LOSS OF CROSS-REACTIVE FILARIAL ANTIGENEMIA IN 
PERSONS WITH LOIASIS IN CENTRAL CAMEROON
Philip J. Budge1, Hugues C. Nana-Djeunga2, Jean Bopda2, Stève 
Mbickmen-Tchana2, Joseph Kamgno2, Gary Weil1
1Washington University in St. Louis, St. Louis, MO, United States, 2Centre 
for Research on Filariasis and Other Tropical Diseases (CRFilMT), Yaoundé, 
Cameroon
Recent reports have shown that some persons with loiasis have positive 
Wuchereria bancrofti antigen tests, and this problem is more common in 
persons with high Loa loa microfilaria (Mf) counts. False-positive antigen 
tests present a challenge for mapping and monitoring of LF elimination 
efforts in central Africa. We collected blood samples from adult volunteers 
in L. loa-endemic areas in central Cameroon to obtain material for research 
on cross-reactive filarial antigen(s). We collected blood samples from 183 
persons living in the Akonolinga and Awae health districts. Eighty-nine 
(49%) of these participants had tested positive for loiasis in prior studies, 
and 18 (10%) had tested positive for W. bancrofti antigenemia by ICT in 
2013 or 2015. None of the new blood samples ICT positive, and only 3 of 
183 plasma samples from the same participants were weakly positive by 
Alere FTS. L. loa Mf counts in the 18 persons previously ICT positive were 
slightly higher during the present study (median 17, 540, IQR 12,120 - 
36,620) than in the prior studies (median 11,870, IQR 5,240 - 32,540). 
Loa Mf counts were lower among participants with previously negative ICT 
results (median 2,000, IQR 340 - 4,480), and comparable to their counts 
in the prior studies (median 2,720, IQR 840 - 6,900). No participant had 
W. bancrofti Mf in night blood smears. These results suggest that persons 
with loiasis may spontaneously clear a cross-reactive filarial antigen 
detected by ICT card tests and that this is independent of their clearance 
of Mf. Our results may also help to explain why many areas in Africa with 
loiasis do not report falsely positive filarial antigen tests. This variability may 
be related to differences in infection intensity and/or variable clearance of 
filarial antigenemia in different regions or seasons.
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PREVALENCE OF ANTIBODIES TO WB123 SIX YEARS AFTER 
ELIMINATION OF LYMPHATIC FILARIASIS AS PUBLIC HEALTH 
PROBLEM IN TOGO
Ameyo M. Dorkenoo1, Kossi Yakpa1, Kossi Komlan2, Adjaho 
Koba2, Yao M. Agbo3, Mawèké Tchalim1, Koffi S. Sognikin1, Gbati 
Datagni4, Abiba Banla2, Anders Seim5, Rachel N. Bronzan6
1Ministère de la Santé, Lomé, Togo, 2Institut National d’Hygiène, Lomé, 
Togo, 3Université de Lomé, Lomé, Togo, 4HDI, Lomé, Togo, 5HDI, Oslo, 
Norway, 6HDI, Seattle, WA, United States
Togo has successfully eliminated lymphatic filariasis (LF) as a public health 
problem. The last mass drug administration (MDA) targeting LF was in 
2009. Since then, LF surveillance has included lab-based screening of 
nighttime blood films for microfilaria in patients tested for malaria and 
regular testing of a convenience sample of persons across Togo using the 
Binax Now® ICT, with follow-up blood films in those who test positive. 
Togo has also passed two post-MDA transmission assessment surveys. 
During six years of surveillance, only 8 individuals have tested positive for 
active infection, and only 3 of those were residents of Togo. In 2015, Togo 
employed the InBios Filaria Detect IgG4 ELISA to establish the prevalence 
of antibodies to Wb123 six years after interrupting LF transmission and to 
assess the utility of the Wb123 ELISA for LF surveillance. The survey was 
integrated with an integrated NTD impact assessment. At two schools 
in all 157 peripheral health units of the 8 districts previously endemic 
for lymphatic filariasis, a convenience sample of 8 school-going children 
age 6 to 9 years old provided blood spots on filter paper (DBS) for 
testing by Wb123 ELISA. DBS were obtained from 2344 children. Wb123 
ELISA testing is ongoing. All samples run to date appear to be negative 
for Wb123 antibodies but interpretation of test results is challenging; 
negative and positive cut-off values are not established and results are 
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best interpreted using the expectation maximization algorithm (EMA). 
ELISA directions recommend testing 100 confirmed LF-positive samples, 
100 known LF-negative samples, and 100 samples from individuals with 
other known filarial infections or non-filarial febrile illness. This proves 
challenging in the setting of LF elimination, and limits utility of the test. 
Once all samples have been run, the EMA should yield interpretable 
results. The Wb123 ELISA may be useful for tracking antibody prevalence 
over time as a means of surveillance for resurgence of LF in Togo, but 
the need for skilled technicians and difficulty with interpretation pose 
challenges.
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A BIOINFORMATICS APPROACH TO ASSESS PARASITE 
KINASES AS DRUG TARGETS USING ANTI-CANCER DRUGS
Claudia Machicado1, Luis Marcos2
1Universidad Peruana Cayetano Heredia, Lima, Peru, 2Stony Brook 
University, New York, NY, United States
The role of human kinases in carcinogenesis has been largely 
demonstrated. Such knowledge has allowed the development of a variety 
of kinase inhibitors that target mutated kinases in their kinase domains. 
At the contrary, protein kinases expressed by parasites have been less 
studied and their participation in infection remains poorly understood. The 
present work aimed to determine similarities and differences, at sequence 
and structure levels, in a set of human 21 kinases and their orthologs 
from 9 parasites. Microorganisms were divided in carcinogenic parasites 
(i.e. Schistosoma hematobium, Ophistorchis viverrini, Clonorchis sinensis) 
and non-carcinogenic parasites (i.e. Plasmodium falciparum, Taenia 
solium, Trypanosoma cruzi, Fasciola hepatica, Leishmania donovani, and 
Echinococcus granulosus). By applying sequence alignment, phylogeny 
algorithms and 3D-structure analysis, the comparison of human kinases 
and their counterparts in parasites was established. Human cancer-related 
kinases had homologs in parasites, with up to 69% amino acid sequence 
identity. Such level of conservation was considerably high given the large 
phylogenic distances among the species analyzed. The human cytosolic 
kinases showed higher amino acid sequence conservation than human 
membrane kinases when compared to their homologs in parasites. 
The cytosolic kinases BRAF, AKT-1, ABL-1, c-SRC, and CDK8 had the 
higher level of conservation and were present in carcinogenic and non-
carcinogenic organisms. A coevolution of kinases in both the host and the 
parasite is plausible to explain the highly conservation observed among 
kinases. Residues involved in binding of inhibitors to the active site were 
inspected in human BRAF, AKT-1, ABL-1, c-SRC, CDK8 and found that 
most of them were conserved in the corresponding sequences of parasite 
orthologs. This observation can be exploited and taken as an advantage to 
repurposing human kinases inhibitors into their homologues in parasites.
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DEVELOPMENT OF IMMUNOCOMPETENT ANIMAL MODELS 
FOR SIMULTANEOUS AND SEPARATE TESTING OF DRUGS 
ON ONCHOCERCA AND LOA LOA MICROFILARIAE, AND 
ONCHOCERCA ADULT WORMS
Fidelis Cho Ngwa1, Rene Ayiseh1, Glory E. Mbah1, Emmanuel 
Ndi1, Elvis Monya1, Irene Memeh1, Judy Sakanari2, Sara Lustigman3
1University of Buea, Buea, Cameroon, 2University of California San 
Francisco, San Francisco, CA, United States, 3New York Blood Center, New 
York, NY, United States
Onchocerciasis is the second leading infectious cause of blindness globally, 
with over 99% of all patients residing in tropical Africa. The only currently 
recommended drug for treatment of the disease, ivermectin, kills the 
microfilariae (mfs) of the causative parasite, Onchocerca volvulus, but 
also Loa loa mfs in the blood of co-infected patients, resulting in severe 
adverse events and fatalities in some cases. Ivermectin does not kill the 
adult worms, which can linger on for more than 14 years, aggravating the 
burden of the disease. The search for new drugs against onchocerciasis 
has been seriously hampered by the lack of suitable animal models. The 
present study was aimed at developing immunocompetent small animal 
models that can better mimic the natural infection and that can be used 
to simultaneously or separately test new drugs on L. loa and Onchocerca 
ochengi mfs and adult O. ochengi worms. The co-infection model would 
permit selection for drugs that kill only Onchocerca and avoid fatalities 
in L. loa co-endemic areas during mass drug administration with current 
microfilaricides. Of several animals tested, the Mongolian gerbil (Meriones 
unguiculatus) was the only one permissible to both parasite species, 
with good parasite recoveries and excellent viabilities recorded on day 30 
post experimental infections. Syrian hamsters were highly permissible to 
Onchocerca mfs and adult worms, but not to the L. loa mfs. Treatment 
of the gerbil co-infection with ivermectin at 150 µg/kg body weight 
resulted in complete elimination of L. loa mfs in blood and O. ochengi 
mfs in skin, and viability reduction of L. loa mfs in the peritoneum. Further 
development of the models is on-going, but so far we have developed and 
validated a new small animal co-infection model for the development of 
onchocerciasis drugs that do not kill L. loa mfs, and established suitable 
small animal hosts for adult Onchocerca worms.
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DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF 
NOVEL 7-AMINO PYRAZOLOPYRIMIDINE COMPOUNDS 
POSSESSING POTENT ANTI-WOLBACHIA ACTIVITY FOR 
THE TREATMENT OF ONCHOCERCIASIS AND LYMPHATIC 
FILARIASIS
Paul McGillan1, Neil G. Berry1, David W. Hong1, Andy Cassidy2, 
Rachel Clare2, Darren Cook2, Kelly Johnston2, Stephen Ward2, Paul 
M. O’Neill1, Mark Taylor2
1University of Liverpool, Liverpool, United Kingdom, 2Liverpool School of 
Tropical Medicine, Liverpool, United Kingdom
Filarial nematodes are a group of human pathogens that affect more 
than 157 million people worldwide, contributing to serious public health 
and socio-economic challenges. These parasites are responsible for the 
Neglected Tropical Diseases lymphatic filariasis and onchocerciasis, which 
is the second leading infectious cause of blindness. The main causative 
agents of these diseases are the nematodes, Wuchereria bancrofti and 
Onchocerca volvulus respectively. These infections are currently treated 
using mass drug administration programmes with chemotherapeutics 
donated by large pharmaceutical companies. Elimination however, remains 
hampered by insufficient activity against adult worms and serious adverse 
effects. The nematodes responsible for causing filarial diseases, share 
an essential endosymbiotic relationship with the bacterium, Wolbachia. 
Although the exact nature of this relationship is not understood, Anti-
Wolbachia therapy has been identified as a viable treatment for filarial 
diseases, which delivers safe macrofilaricidal activity with superior 
therapeutic outcomes compared to current anti-filarial drugs. Doxycycline 
is the current gold standard for Anti-Wolbachia activity, but requires 
treatment for at least four weeks and is contraindicated in children under 
9 years of age and pregnant women. The Anti-Wolbachia (AWOL) drug 
discovery and development programme aims to identify alternative drugs 
which are suitable for a wider patient range and shorter treatment plan. 
This work describes the development of Anti-Wolbachia agents of the 
pryazolopyrimidine chemotype. Despite high potency demonstrated by 
the original hit, DMPK experiments highlighted poor metabolic stability. 
Organic synthesis has enabled functionalization of key positions within 
our template, generating a broad library of compounds of which many 
analogues possess nanomolar activity against Wolbachia in vitro as well as 
display improved DMPK parameters. Further work is in progress to achieve 
our goal of providing a candidate that can achieve a 90% Wolbachia 
reduction in fewer than 14 days of treatment in the in vivo model system.
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ECONOMIC COSTS AND BENEFITS OF SCALING UP 
DISABILITY PREVENTION FOR LYMPHATIC FILARIASIS 
ACROSS INDIA
Eileen Stillwaggon1, Larry Sawers2
1Gettysburg College, Gettysburg, PA, United States, 2American University, 
Washington, DC, United States
Lymphatic filariasis (LF) is endemic in 73 countries, with 68 million people 
infected, of whom 36 million suffer serious disability (17 million with 
lymphedema, 19 million with hydrocele). Repeated acute attacks of 
fever and disabling pain (acute dermatolymphangioadenitis or ADLA) 
aggravate lymphedema and prevent work for 4-7 days per attack. The 
Global Programme to Eliminate Lymphatic Filariasis (GPELF) has two 
goals: interrupting LF transmission by 2020, and caring for people already 
infected through morbidity management and disability prevention 
(MMDP). By 2014, 60 countries had ongoing mass drug administration 
to end LF transmission, but only 24 had begun MMDP, in part due to 
its perceived high cost and low return. Simple, low-cost interventions at 
the community level, including instruction in limb washing and provision 
of soap, topical antibiotics, and antifungals can reduce ADLA and slow 
progression of lymphedema. MMDP programs attenuate disability and 
productivity loss. For Khurda District, Odisha State, India, we estimated 
lifetime medical costs and earnings losses due to chronic lymphedema and 
acute dermatolymphangioadenitis (ADLA) with and without a community-
based limb-care program. The program would reduce economic costs 
of lymphedema and ADLA over 60 years by 55%. Savings of US$ 1 648 
for each affected person in the workforce are equivalent to 1 258 days 
of labor. Per-person savings are more than 130 times the per-person cost 
of the program. We then estimate the costs of scale-up for all Indian 
states for community-based programs of limb care for lymphedema. India 
has great diversity in levels of wages (and thus foregone earnings from 
disability that prevents working), prevalence of lymphatic filariasis, health 
systems, NGO involvement, and other factors that influence community 
health programs. In spite of the diversity of conditions, our cost estimates 
demonstrate the long-term economic benefits of simple limb care and 
provide an economic rationale in addition to the ethical mandate for 
MMDP, the second pillar of GPELF.
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APPLICATION OF ULTRASONOGRAPHY TO DETECT 
PERITONEAL FILARIAL DANCE SIGN IN PRECLINICAL RODENT 
BRUGIA MALAYI MACROFILARICIDAL DRUG SCREENING 
MODELS
Amy E. Marriott, Hanna Sjoberg, Darren Cook, Andrew Steven, 
Mark J. Taylor, Joseph D. Turner
Liverpool School of Tropical Medicine, Liverpool, United Kingdom
Ultrasonography (USG) has been successfully used in placebo-controlled 
clinical trials to evaluate macrofilaricidal (curative) drug efficacy in 
onchocerciasis and lymphatic filariasis. Here we describe the application of 
a portable ultrasound machine (SonoSite MTurbo) to detect ‘filarial dance 
sign’ (FDS) in preclinical Brugia malayi rodent drug screening models. In 
these models, defined numbers of B. malayi adults were implanted into 
the peritoneum or, alternatively, variable B. malayi adult burdens were 
established from a unit intraperitoneal inoculum of infectious stage larvae 
either within inbred Severe-Combined ImmunoDeficient mice or outbred 
Meriones unguiculatus (Mongolian) gerbils. USG successfully detected FDS 
of mixed sex or single sex adult worm burdens to a degree of sensitivity 
of a single female worm or 2 male worms. USG could also be applied to 
semi-quantify worm loads based on strength and multiplicity of FDS signal 
within different peritoneal anatomical locations. In both non-blinded and 
blinded preclinical drug studies, USG detection of peritoneal FDS has 
subsequently been utilised to accurately predict macrofilaricidal outcome. 
This technique could therefore be highly beneficial in refining and 
reducing the number of animals used during drug screens and accelerating 
preclinical macrofilaricidal drug by being able to more rapidly detect 
drug efficacy by longitudinal exam of the same study group without the 
necessity of invasive surrogate filarial viability sampling.
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INVESTIGATING EARLY INFECTION STATUS OF THE FILARIAL 
PARASITE BRUGIA MALAYI IN THE CAT, THE LABORATORY 
MODEL FOR LYMPHATIC FILARIASIS
Erica J. Burkman, Katherine E. Hogan, Molly D. Savadelis, 
Michael T. Dzimianski, Andrew R. Moorhead
University of Georgia, College of Veterinary Medicine, Athens, GA, United 
States
Human lymphatic filariasis (LF) is a mosquito-borne disease primarily 
caused by the parasitic nematodes Wuchereria bancrofti and Brugia 
malayi. These parasites are a major cause of morbidity globally, with an 
estimated 120 million people infected. Brugia malayi is the preferred 
laboratory model for LF due to W. bancrofti requiring the use of primate 
hosts. Currently, the domestic cat is utilized as the primary non-rodent 
animal model for B. malayi. However, on average only 25%-50% 
of felines become patent, so a method of early detection would be 
invaluable. Currently, the only test to determine infection status is 
the detection of circulating microfilariae, which are usually detectable 
4-6 months post-infection. In other filarial parasites such as Dirofilaria 
immitis, the Enzyme Linked Immunosorbent Assay (ELISA) is used to 
detect circulating female uterine antigen. Recently, it was suggested that 
heat treatment of serum or plasma may dissociate the antibody-antigen 
complex, potentially releasing the antigen so that it may be detected. Due 
to the close relationship of these filarial worms, there could be detectable 
cross-reactivity after heat treatment for B. malayi antigen in these 
capture-antibody tests. We hypothesized that we would be able to detect 
circulating antigen after heat treatment in the serum of these infected 
cats. Ten male domestic cats were infected by subcutaneous injection of 
400 B. malayi third-stage larvae. Serum was collected at key time points 
post-infection. Both heat-treated and room temperature serum was tested 
for circulating antigen using the DiroCHEK® ELISA kit. Of the six cats that 
became microfilaremic, five tested antigen-positive, whereas only one cat 
with a low microfilaremia tested antigen-negative. These data may indicate 
a methodology other than microfilarial counts may be used to detect B. 
malayi infections in cats. Furthermore, heat treatment of serum could 
expose epitopes that cross-react with the antibody used in commercial D. 
immitis tests.
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CELLSCOPE-LOA: DISTRICT-WIDE DEPLOYMENT OF A POINT 
OF CARE TOOL FOR THE PREVENTION OF POST IVERMECTIN 
SERIOUS ADVERSE EVENTS IN LOA LOA ENDEMIC AREAS
Sebastien Pion1, Joseph Kamgno2, Matthew Bakalar3, Jean 
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Bethesda, MD, United States
Because of the marked adverse effects (functional impairment) and 
serious adverse events (SAEs, occasionally fatal but more often with 
potentially irreversible neurologic manifestations) that can occur when 
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Loa loa microfilariae (mf) levels exceed 8,000 mf/mL and 30,000 mf/
mL, respectively, implementation of ivermectin (IVM)-based elimination 
programs for lymphatic filariasis (LF) and onchocerciasis in areas where 
loiasis is co-endemic has been extremely problematic. Identifying those 
individuals “at risk” for such SAEs would allow them to be excluded 
from IVM community treatment and prevent SAEs. This strategy, termed 
“Test and not Treat” (TNT), relies on the development of a rapid field-
friendly test to quantify L. loa mf in peripheral blood. To this end, we 
developed a mobile phone-based video microscope (CellScope-Loa) that 
automatically quantifies L. loa mf in whole blood in less than 2 minutes 
without the need for conventional sample preparation or staining. 
Between August and October 2015, a field evaluation was conducted in 
a health district of Central Cameroon to assess the performance of the 
Cellscope-Loa in comparison to examination of a calibrated blood smear 
(the current standard method to assess L. loa mf densities). Among the 
15,298 participants, 226 (1.5%) had mf densities above 30,000 mf/mL, 
when assessed by calibrated thick smear. There was a strong correlation 
(rho=0.84, p<0.0001) between mf densities estimated by the CellScope-
Loa and those measured by the calibrated thick smear. Receiver operating 
characteristic (ROC) analysis demonstrated that the CellScope-Loa could 
identify individuals harboring > 30,000 mf/mL with 94.0 and 99.6% 
sensitivity for CellScope-Loa thresholds set at 20,000 and 10,000 mf/
mL, respectively. Most importantly, it had a negative predictive value 
(probability that the mf density is actually below 30,000 mf/mL) of 99.9 
and 100% for the same threshold values. The TNT strategy based on the 
Cellscope-Loa is an extremely promising and practical approach to the safe 
implementation of large-scale treatment for LF and onchocerciasis in L. loa 
co-endemic areas.
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SYNERGY OF ALBENDAZOLE AND RIFAMPICIN 
COMBINATION THERAPY IN A MURINE INFECTION MODEL 
OF HUMAN LYMPHATIC FILARIASIS
Raman Sharma, Joseph D. Turner, Ghaith Al Jayoussi, Hayley E. 
Tyrer, Joanne Gamble, Laura Hayward, Richard Priestly, Jill Davies, 
David Waterhouse, Darren A. Cook, Andrew Steven, Kelly L. 
Johnston, Louise Ford, Stephen A. Ward, Mark J. Taylor
Liverpool School of Tropical Medicine, Liverpool, United Kingdom
An estimated 120 million people are infected by lymphatic filariasis 
throughout the tropics leading to a profound public health and socio-
economic burden in severely affected communities. Wolbachia is an 
essential endosymbiont of the filarial nematodes Wuchereria bancrofti, 
Brugia malayi the causative agents of lymphatic filariasis. Doxycycline is 
currently the gold standard for the targeting of Wolbachia in lymphatic 
filariasis chemotherapy. However, the current drug regimen is a 100-200 
mg/day doxycycline dose given for 4 to 6 weeks to patients. The A·WOL 
consortium plan to reduce the current treatment time to 7 days or less 
to improve drug regimen adherence and to reduce drug resistance and 
costs of treatment. To achieve a rapid 7-day or less kill rate of Wolbachia, 
a number of drug combinations will be employed. These include different 
tetracyclines (Doxycycline and minocycline) rifamycins (Rifampicin or 
Rifapentine), Moxifloxacin as well as anti-helminthic drugs. The complexity 
of multiple drug combinations necessitates a rational approach in the 
identification and choice of the best treatments in in-vivo models and 
translating the animal treatments in the lab into clinical trials on the field. 
In this current study we apply a rational drug development approach using 
our on in our murine infection model of B. malayi and pharmacokinetic 
(PK) analysis to investigate the synergy of Albendazole and Rifampicin 
combination therapy on the macrofilaridal and anti-Wolbachia efficacy. 
Pharmacokinetic modelling and simulation allowed the administration of 
rifampicin dosages equivalent to a standard 10 mg/Kg or 600 mg dose 
or a 35 mg/Kg super-dose and albendazole equivalent to a 400-800mg 
clinical dose in our murine infection model of B. malayi, making drug 
exposure and efficacy results clinically relevant in comparison to traditional 
efficacy studies. We have found synergistic interaction between rifampicin 
and albendazole for both macrofilaricidal and anti-Wolbachia activities and 
have used PK analysis and parasitological methods to dissect the origins of 
these interactions.
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FACTORS PREDICTING TRANSMISSION ASSESSMENT SURVEY 
OUTCOMES FOR LYMPHATIC FILARIASIS
Katie Zoerhoff1, Maureen Kelly1, Rachel Stelmach1, Angela 
Weaver2, Margaret Baker1, Molly Brady1
1RTI International, Washington, DC, United States, 2U.S. Agency for 
International Development, Washington, DC, United States
National programs are progressing towards elimination of lymphatic 
filariasis (LF) as a public health problem. Nearly 300 transmission 
assessment surveys (TAS), population-based cluster surveys to determine 
whether prevalence has been lowered to a level at which mass drug 
administration (MDA) can be stopped, supported by USAID have been 
implemented in 14 countries. Since both failing TAS and continuing 
to implement MDA have financial and opportunity costs, TAS should 
be conducted at an appropriate time. A key question, which has 
not yet been analyzed using survey data, is therefore which factors 
increase the likelihood of passing TAS. We performed logistic regression 
analysis to examine whether the odds of passing TAS was related to 
baseline prevalence, number of MDA rounds implemented, or median 
epidemiological coverage. The analysis included data from 14 countries 
implementing 296 stop-MDA TAS between 2012-2015. Of these TAS, 
90% of districts passed. We found that passing TAS was significantly 
associated with both baseline prevalence (OR 0.945, CI 0.915-0.976) 
and median epidemiological coverage (OR 1.044, CI 1.008-1.082) at 
alpha =0.05. While the number of MDA rounds was not significantly 
associated with passing TAS, it was important to control for as otherwise 
it confounded the relationship between baseline prevalence, median 
coverage, and passing TAS. The R-square value was low (0.0714), 
however; this indicates that this model does not include all of the factors 
that affect the likelihood of passing TAS. Ongoing analysis will incorporate 
additional factors that may affect the likelihood of passing TAS, such as 
vector species, diagnostic tests used to determine eligibility for TAS, and 
consecutive versus missed rounds of MDA, among others. These results 
confirm that it is important to achieve high coverage when implementing 
MDA, especially in districts with high baseline prevalence, and additional 
rounds of MDA may be necessary. National programs can increase the 
likelihood of passing TAS—and therefore achieving elimination—by 
implementing high-quality MDA throughout the program, rather than only 
in response to a failed TAS.
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THREE-DIMENSIONAL VISUALIZATION OF THE INTERNAL 
ARRANGEMENT OF ONCHOCERCAL (ONCHOCERCA 
VOLVULUS) NODULES USING HIGH-RESOLUTION MAGNETIC 
RESONANCE IMAGING
Maïda Cardoso1, Cédric B. Chesnais2, Sébastien D. Pion2, Michel 
Boussinesq2, Frédéric Ben Naïm3, Christophe Goze-Bac1, Michel 
Zanca4
1Laboratoire Charles Coulomb (L2C-UMR5221), BioNanoNMRI Group, 
University of Montpellier, Montpellier, France, 2Institut de Recherche pour 
le Développement, Montpellier, France, 3Intrasense society, Montpellier, 
France, 4Laboratoire Charles Coulomb (L2C-UMR5221), BioNanoNMRI 
group, Nuclear Medicine, CMC Gui de Chauliac, University Hospital 
Montpellier, Montpellier, France
Adult stages of Onchocerca volvulus live in subcutaneous or deep nodules. 
For descriptive biology or drug effect assessment purpose, the nodules are 
generally processed using either histology (fixation and section, followed 
by staining) or enzymatic digestion (incubation in collagenase to eliminate 
host tissue and isolate adult worms). Non-invasive detection of adult O. 
volvulus using ultrasound has also been used, but has little indications 
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because of the low optical resolution of the nodule content. None of these 
techniques enable to have a tridimensional view of how an onchocercal 
nodule is organized, and how the different worms arrange themselves 
relative to each other. Here, we had the opportunity to examine nodules 
using high-resolution magnetic resonance imaging (MRI). The nodules had 
been placed in a fixative just after their collection, and stored in the latter 
for about 20 years before the present study. To reduce the background 
noise and artifacts during image acquisition, nodules were immersed 
in Fluorinert FC-77 liquid, which is a proton-free fluid with low water 
solubility and similar magnetic susceptibility to the tissue. MRI experiments 
were done using a 9.4 Teslas apparatus equipped with a MAGNEX 
TS1276D, a Quadrature Volume Coils 400 MHz RF43 and associated 
with a VnmrJ Imaging acquisition system. 3D gradient echo images were 
acquired during14 hours with 100 ms repetition time, 4.44 ms echo time, 
8 averages, a 30° flip angle, a 40 x 20 x 20 mm3 field-of-view and a 512 
x 256 x 256 matrix. 3D reconstruction was processed using Myrian 1.21.1 
(Intrasense, Montpellier, France) on the basis of DICOM data, in both 
Maximum Intensity Projection and average rendering modes. This study is 
a proof of concept that MRI can provide clear images of adult worms in 
onchocercal nodules fixed for many years. These results warrant further 
developments including adapted MRI coil and fine image analysis to assess 
the worm’s viability. Studies could be conducted with recently collected 
nodules that have not been stored in a fixative, as well with small animals 
(rodents) naturally or experimentally infected with various filarial species.
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IDENTIFICATION OF NEW MACROFILARICIDAL COMPOUNDS 
FOR TREATMENT OF ONCHOCERCIASIS
Marc P. Hübner1, Achim Hoerauf1, Simon Townson2, Suzanne 
Gokool2, Coralie Martin3, Agnieszka Chojnowski4, Tamara Kreiss4, 
Monika Prorok4, John Siekierka4, Jerome Zeldis5, Stacie Canan6, 
Vikram Khetani5, Ivan Scandal7, Natalie A. Hawryluk6
1Institute for Medical Microbiology, Immunology & Parasitology, 
University Hospital of Bonn, Bonn, Germany, 2Park Institute for Medical 
Research, London, United Kingdom, 3Biodiversité et Adaptation des 
Microorganismes Eucaryotes à leur Environnement, Muséum National 
d’Histoire Naturelle, Paris, France, 4Sokol Institute of Pharmaceutical Life 
Sciences, Montclair State University, Montclair, NJ, United States, 5Celgene 
Global Health, Summit, NJ, United States, 6Celgene Global Health, San 
Diego, CA, United States, 7Drugs for Neglected Diseases initiative, Geneva, 
Switzerland
Current efforts to control and eliminate onchocerciasis are hindered 
by the lack of compounds that target the adult worm stage. In a 
joint collaboration with DNDi, academia and Celgene, a pipeline was 
established to identify macrofilaricidal compounds. To date, more 
than 400 compounds have been screened in vitro against Onchocerca 
gutturosa adults, identifying 120 compounds with EC50 <1µM 40 of 
which having EC50 <100nM. From this set of 400 compounds, a select 
set of 160 compounds were tested against both O. lienalis microfilariae 
and Onchocerca gutturosa adults, identifying 43 compounds with 
specific activity against the adult parasites in vitro. Active compounds 
with EC50 in the 0.015-1µM range and suitable pharmacological profiles 
were prioritized for in vivo testing. 23 lead candidates were tested by 
oral gavage in mice that harbored adult worms of the rodent filarial 
nematode Litomosoides sigmodontis. Two compounds significantly 
reduced the L. sigmodontis adult worm burden by 98 and 93% after 10 
days of TID treatment and 1 day of BID treatment, respectively. Presence 
of microfilariae in the treated animals suggest that both compounds do 
not have a strong microfilaricidal effect. Current efforts to further assess 
the impact of both compounds on microfilariae in the L. sigmodontis 
jird model are scheduled. The current study demonstrates the successful 
establishment of a screening cascade which resulted in the identification 
of two promising novel macrofilaricidal compounds. The identification 
of such macrofilaricidal compounds which lack microfilaricidal effects 
are ideal candidates for the treatment of onchocerciasis, as they have a 
reduced risk for microfilariae-driven adverse events.
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COMPARISON OF THE ONCHOCERCIASIS OV16 IGG4 RAPID 
TEST AND OV16 ELISA AMONG CHILDREN IN TOGO: 
EXPERIENCES WITH A NEW SURVEILLANCE TOOL
Rachel Bronzan1, Adjaho Koba2, Kossi Komlan3, Kossi Yakpa2, 
Allison Golden4, Koffi Padjoudoum2, Potchoziou Karabou2, Efoe 
Sossou2, Koffi S. Sognikin2, Ameyo Dorkenoo5
1HDI, Seattle, WA, United States, 2Ministère de la santé, Lomé, Togo, 
3Institut National d’Hygiène, Lomé, Togo, 4PATH, Seattle, WA, United 
States, 5Ministry of Health, Lomé, Togo
The Alere SD BIOLINE Onchocerciasis IgG4 rapid test (RDT) is a new 
field tool for on-site identification of antibodies to the Ov16 protein 
of Onchocerca volvulus, the parasite that causes river blindness. WHO 
recommends using Ov16 ELISA to decide when to stop mass treatment 
with ivermectin. In 2015, in preparation for a move towards onchocerciasis 
elimination, the Ministry of Health of Togo used the Ov16 RDT in a 
national survey to obtain preliminary data on the prevalence of antibodies 
to Ov16 in school-age children and to compare Ov16 RDT to Ov16 ELISA. 
The survey was integrated with an NTD impact assessment. At each of 
1126 schools serving as NTD sentinel sites, a convenience sample of 8 
children age 6 to 9 years had finger-stick blood drawn for Ov16 RDT. A 
subset of children provided blood spots on filter paper (DBS) for testing 
by Ov16 ELISA. In total, 9007 children were tested by RDT, of whom 60 
(0.7%) were positive. DBS were obtained from 2600 children. Ov16 ELISA 
testing is ongoing; of 294 RDT-negative samples tested to date, 50 of 294 
(17%) were positive by ELISA. The significant discrepancy between RDT 
and ELISA results prompted additional investigations. Confirmatory Ov16 
ELISA testing will be conducted at a US laboratory. The protein glutathione 
S-transferase (GST) is fused to the Ov16 protein. To assess whether Ov16 
ELISA positives may be due to antibody cross-reactivity with GST, a GST-
specific ELISA will be run on a subset of samples. To assess whether the 
RDT was properly conducted in the field, it will be repeated using the 
same DBS samples as for ELISA, using a modified protocol for testing DBS 
on Ov16 RDT. Application of the expectation maximization algorithm to 
our ELISA findings may improve classification of results. The 60 children 
who tested positive by RDT and a subset of those who are RDT-/ELISA+ 
will be revisited to document residency and travel history, repeat the RDT, 
and conduct skin snip testing with treatment if indicated. Resolution of 
these test discrepancies is important for onchocerciasis elimination in Togo. 
These findings highlight some of the challenges of employing these tests 
and our results should illuminate where pitfalls lie.
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DESIGN AND EVALUATION OF A HEALTH EDUCATIONAL 
BOARD GAME FOR THE CONTROL OF SOIL-TRANSMITTED 
HELMINTHIASIS AMONG PRIMARY SCHOOL CHILDREN IN 
ABEOKUTA, NIGERIA
Uwemedimo F. Ekpo, Dorcas B. Olabinke, Bolanle Akeredolu-
Ale, Gabriel A. Dedeke
Federal University of Agriculture Abeokuta, Abeokuta, Nigeria
Despite repeated annual treatment with anti-helminthic drugs, soil-
transmitted helminthiasis (STH) remains an important factor in school 
children morbidity in sub-Saharan Africa as school children are rapidly re-
infected within 3 months after treatment. We designed a health education 
board game “Worms and Ladders” inscribed with health education and 
STH preventive messages and evaluated its potential for promoting good 
hygiene practices among school children for the integrated control of 
STH during mass drug administration (MDA). The evaluation employed a 
randomized control trial across six primary schools in Abeokuta, Nigeria. 
A total of 372 pupils were enrolled in the study, of which 212 were in the 
intervention group in three schools, and 160 were in the control group in 
three schools.  Baseline knowledge, attitude and practices (KAP) relating 
to STH were obtained with a questionnaire followed by the collection 
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of fresh stool samples for STH diagnosis. All the participants were 
then treated with Albendazole according to their height. The designed 
“Worms and Ladders” board game were introduced and distributed to 
the intervention group to play for six months under the supervision of 
their class teachers. No game was given to the control group to play. 
Prevalence of STH dropped from 25.0% to 10.4% in the intervention 
group and 49.4% to 33.3% in the control group at three months’ post 
treatment. The prevalence further dropped to 5.6% in the intervention 
group but increased to 37.2% in the control group at six months’ post 
treatment. There was a significant difference (p<0.05) in post-treatment 
prevalence among the two groups. Knowledge, attitude and practices 
on transmission, control and prevention of STH significantly improved 
(p<0.05) from 5.2% to 97.9% in the intervention group compared to 
(6.2% to 7.1%) in the control group. The “Worms and Ladders” board 
game have shown its potential to promote good hygiene behaviour 
among school children and should be integrated into Mass deworming 
programme to prevent reinfection.
1122
RISK FACTORS ASSOCIATED WITH PREDISPOSITION TO 
SOIL-TRANSMITTED HELMINTH INFECTION IN SOUTHERN 
MYANMAR
Julia C. Dunn1, Alison A. Bettis1, Nay Yee Wyine2, Aye Moe Moe 
Lwin3, Nay Soe Maung3, Roy M. Anderson1
1London Centre for Neglected Tropical Disease Research, Department 
of Infectious Disease Epidemiology, Imperial College London, London, 
United Kingdom, 2London Centre for Neglected Tropical Disease Research, 
Yangon, Myanmar, 3University of Public Health, Yangon, Myanmar
Southeast Asia has a substantial burden of soil-transmitted helminths 
(STH). In Myanmar, a mass drug administration (MDA) programme 
targeting STH in school-aged children (SAC), in conjunction with a 
community-wide MDA programme targeting lymphatic filariasis, has been 
implemented for the last 3-5 years and coverage has been consistently 
high. Past STH studies have identified the phenomenon of predisposition 
to STH infection in human hosts; individuals predisposed to STH infection 
may act as persistent reservoirs of infection. Parasitological data were 
analysed in conjunction with epidemiological data, collected during two 
MDA rounds in two villages in southern Myanmar (n=584). Baseline 
STH prevalence was 27.05%; 5.14% for Ascaris lumbricoides, 16.95% 
for Trichuris trichiura and 8.9% for hookworm. There was no statistical 
difference in presence of predisposition to STH infection (defined here 
as positive STH infection in both rounds) between the two villages. 
Preliminary analysis suggests that predisposition to STH infection is 
associated with individual adults’ main form of employment (P<0.0001), if 
the main toilet is shared with other households (P=0.003) and household 
income (P=0.03). There was no evidence to suggest that predisposition 
was associated with age or gender. Aggregation of predisposed individuals 
was observed at a household level. It is concluded that predisposition to 
STH infection is associated with socioeconomic and water and sanitation 
hygiene (WASH) factors. Further analysis will include identifying factors 
associated with predisposition to single STH species infections.
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IMPLEMENTATION AND EVALUATION OF A QUALITY AND 
SAFETY TOOL FOR AMBULATORY STRONGYLOIDIASIS 
PATIENTS AT HIGH RISK OF ADVERSE OUTCOME
Sabrina Yeung1, Omar Mourad1, Michael Klowak2, Adrienne 
Showler3, Stefanie Klowak4, Andrea K. Boggild1
1University of Toronto, Toronto, ON, Canada, 2McMaster University, 
Hamilton, ON, Canada, 3Johns Hopkins Bloomberg School of Public 
Health, Baltimore, MD, United States, 4Tropical Disease Unit, Toronto 
General Hospital, Toronto, ON, Canada
Although simple intestinal strongyloidiasis is curable, infections are 
frequently asymptomatic and unknown, leading to potential adverse 
patient outcomes upon immunosuppression. Given the potential 
complexity of care of patients with strongyloidiasis, a safety tool may help 
to improve patient outcomes and standardize care for strongyloidiasis 
patients. We developed a novel safety tool, and implemented it in June 
2015. Our aim was to evaluate the utility of the tool using a retrospective 
chart review. Patients diagnosed with strongyloidiasis were identified 
through our clinic “Special Access Programme” log from January 1, 
2013 to December 31, 2015. Patients were categorized as treated for 
strongyloidiasis pre-implementation of the tool (prior to June 2015), or 
post-implementation of the tool (June 2015 to December 2015). Outcome 
measures included loss to follow-up; documentation of seroreversion 
post-treatment; documentation of stool clearance post-treatment, if 
positive at baseline; and screening for factors known to confer risk of 
hyperinfection and dissemination (e.g, HTLV1 infection) During the study 
period, 37 patients were treated for strongyloidiasis: 23 males (62%), and 
14 females (38%). Median age was 44 yrs (range 5-85 yrs). 24 patients 
were treated pre-implementation of the tool, while 13 were treated after 
implementation. Loss to follow-up after treatment occurred in 25% of 
patients pre-implementation, and for no patients in the assessible post-
implementation group (p=0.148). Proof of seroreversion occurred in 47% 
of assessible patients pre- implementation, and 66% of assessible patients 
in the post implementation group (p=0.635). Proof of stool clearance and 
seroreversion occurred in 50% (2/4) of patients pre-implementation, and 
50% (1/2 assessible patients) post implementation (p=1.000). Evaluation 
of HTLV-1 co-infection occurred in 33% of patients pre-implementation, 
and in 69% post-implementation (p=0.021). Our findings suggest that a 
safety tool may of benefit in preventing future adverse outcomes due to 
strongyloidiasis, though a larger prospective evaluation is warranted.
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STRONGYLOIDIASIS IN ONTARIO: INFORMING THE 
DIAGNOSTIC EVALUATION BY ESTABLISHING THE NUMBER 
NEEDED TO EXAMINE (NNE)
Michelle Dao Dong1, Michael Klowak2, Nessikha Karsenti3, Omar 
Mourad3, Rachel Lau4, Filip Ralevski4, Karamjit Cheema4, Andrea K. 
Boggild3
1University of Western Ontario, London, ON, Canada, 2McMaster 
University, Hamilton, ON, Canada, 3University of Toronto, Toronto, ON, 
Canada, 4Public Health Ontario Laboratories, Toronto, ON, Canada
In order to provide a diagnostic strategy that offers sensitivity, specificity, as 
well as larval staging and quantification, clinical guidelines suggest using a 
combination of serologic and microscopic diagnostic tests for confirmation 
of strongyloidiasis. We aimed to evaluate the performance of stool 
microscopy, serology, and real time PCR (qPCR) for the optimal diagnosis 
of strongyloidiasis at our reference laboratory. We included all specimens 
submitted for O&P examination and Strongyloides serology between April 
1, 2014 and May 31, 2015. All stool specimens positive for any stage of 
Strongyloides stercoralis, as well as 5-times that number of random stool 
specimens negative for Strongyloides were included in our verification of a 
Strongyloides-specific qPCR assay. Positivity rates were calculated, and the 
total number of examined specimens divided by the number of positive 
specimens was calculated as the “Number Needed to Examine” (NNE). 
During the enrolment period, 17,933 stool specimens were processed 
for O&P examination, 14 of which were positive for Strongyloides 
larvae, yielding an overall NNE for stool microscopy of 1281. During the 
enrolment period, 3258 specimens were processed for Strongyloides 
serology, 200 of which were reactive (6.1%), 210 indeterminate (6.5%), 
and 2848 non-reactive (87.4%), yielding an NNE for reactive serology 
of 16. Two patients shedding larvae and known to the laboratory as 
undergoing iatrogenic immunosuppression had negative serology. qPCR 
was positive in 10 of 12 (83.3%) stool specimens containing larvae, 
and negative in all stool specimens without larvae by microscopy. There 
was no cross-reactivity of Strongyloides-specific qPCR to other common 
stool protozoa or helminths. In the absence of immunosuppression, 
larval burden in strongyloidiasis is low, limiting the utility of microscopy 
for diagnosis, and favoring serologic testing. However, false negative 
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serology can occur in those with hyperinfection necessitating a combined 
diagnostic approach. The qPCR assay was insufficiently sensitive to replace 
microscopy for detection of larvae.
1125
EOSINOPHILIA, ANEMIA AND INTESTINAL PARASITES IN 
CHILDREN FROM RURAL COMMUNITIES OF VENEZUELA
Gladymar Perez
Universidad Central de Venezuela Escuela de Medicina JM Vargas, Caracas, 
Bolivarian Republic of Venezuela
A cross-sectional epidemiological survey was conducted in four rural 
communities in the north of Venezuela. One stool sample of school-age 
and unschooled children between 0 and 15 years old was requested 
(n=438/909) and examined for ova and parasites, using direct smear 
(428/438) and Kato-Katz techniques (n=400/438). Hemoglobin (Hb), 
hematocrit and relative eosinophil value (REV) were also determined 
(n=803/909). A questionnaire was performed before processing the 
samples. Eosinophilia (REV ≥ 5%) was detected in 90,6% (n=763/842) 
and was more prevalent in UBP (94,5%) and Palo Negro schools (95,1%) 
p <0,001. Anemia (Hb < 11,5 g/dl) was demonstrated in 7% (n= 56/803) 
with the highest prevalence in TK (21,7%) and EH schools (30,4%) p 
<0,001. Giardia intestinalis (n=86/428; 20,1%), Ascaris lumbricoides 
(n=26/400; 6,5%) and Trichuris trichiura (n=19/400; 4,8%) infections did 
not show a significant statistical association with anemia (Fisher’s exact 
p=0.284; p=0.532; p=0.167 respectively). Mean parasitic loads for both 
helminths were low according to WHO cut offs. We reccomend that in 
settings of developing countries, with high prevalence of eosinophilia and 
low prevalence of intestinal nematodes according to stool examination, 
the burden of soil-transmitted helminthiasis may also take in consideration 
other variables suchs as unsatisfied basic needs and undiagnosed 
strongyloidiasis, to assess the most adequate therapeutic intervention in 
order to reduce the associated morbidity.
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PREVALENCE OF STH AT A COASTAL AREA IN INDIA - ROLE 
OF STUDENTS’ HYGIENE PRACTICES, SCHOOL AND HOME 
SANITATION FACILITIES
Vinay K. Garg
National Centre for Disease Control, New Delhi, India
Soil transmitted helminth infestation is a global health concern affecting 
two billion population worldwide. Mainly three species viz. Ascaris 
lumbricoides, Trichuris trichiura and hookworm inflict considerable 
morbidity and mortality amongst infected persons. Present study was 
conducted among school children of Allepey city, Kerala state, India after 
having prior consent from respective authority. Sample size was estimated 
according to WHO guidelines as 200-250 children per ecological zone. 
Children were informed about the purpose of study. Information regarding 
their social and personal hygiene practices was recorded with the help of 
semi structured questionnaire and they were provided with a container 
to bring stool sample on the following day. Samples collected were 
subjected to examination for helminthic eggs using Kato-Katz technique. 
Statistical analysis was done by using Chi-square test. Total 219 samples 
were collected in which 79 (36%) were positive. A. lumbricoides infection 
was found in all samples. 76 (95%) samples had monotypic infection. 
data was analyzed to find out the factors associated with occurrence of 
STH infection. The factors like not having household latrine, not washing 
hands before meal and practice of eating food fallen on ground/unwashed 
vegetables/fruits were found associated with having STH infection among 
children and this was found statistically significant. Significant association 
was found between presence of anaemia and having STH infection. 
Preventive chemotherapy along with social awareness about good hygienic 
practice go hand in hand in reducing morbidity associated with STH. 
Hand washing and in-house sanitary latrine qualify as the most important 
preventive measures.
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HIGH PREVALENCE RATES OF SOIL-TRANSMITTED 
HELMINTHS IN CHILDREN WHO RECEIVE MASSIVE DRUG 
ADMINISTRATION IN A REMOTE AMAZONIAN COMMUNITY 
IN PERU
Renato A. Errea1, George Vasquez-Rios1, Kevin R. Duque2, Diego 
Siu1, Maria L. Calderon3, Luciana H. Juarez4, Celene Uriol4, Claudia 
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Angelica Terashima1, Jorge D. Machicado5, Frine Samalvides6, Luis 
A. Marcos7
1Institute of Tropical Medicine “Alexander von Humboldt” - Universidad 
Peruana Cayetano Heredia, Lima, Peru, 2Department of Microbiology and 
Center for Global Health – Universidad Peruana Cayetano Heredia, Lima, 
Peru, 3Facultad de Medicina “Alberto Hurtado”- Universidad Peruana 
Cayetano Heredia, Lima, Peru, 4Sociedad Cientifica de Estudiantes de 
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Lima, Peru, 5University of Pittsburgh Medical Center, Pittsburgh, PA, United 
States, 6Hospital Cayetano Heredia, Lima, Peru, 7Stony Brook University, 
Stony Brook, NY, United States
Following the recommendations from the WHO to control soil-transmitted 
helminth (STH) infections, a school-based deworming program with 
albendazole 400mg oral single dose every 3 months was recently 
implemented in the Amazon rainforest of Peru. In order to evaluate the 
prevalence of STHs in children from a community within the program’s 
scope, we collected stool samples from 2-14 years old children from Padre 
Cocha, Loreto.  All samples were analyzed for the presence of Ascaria 
lumbricoides, Trichuris trichiura, hookworm and Strongyloides. stercoralis; 
by using the following techniques: spontaneous sedimentation in tube, 
Kato-Katz, modified Baermann and agar plate culture. Stool samples of 
their mothers were also collected and examined. Additional information 
including weight, height, sociodemographic and epidemiological risk 
factors (i.e. water supply, sanitation and hygiene practices) were collected 
by interview. Out of 124 children, 32 (25.8%) were infected with one or 
more STH. Twenty (16.1%) had A. lumbricoides; 2 (1.6%), hookworm; 2 
(1.6%), T. trichiura; and 13 (10.5%) had S. stercoralis. Malnutrition was 
present in 72 (60.8%) of the children, although no association was found 
with STH infection (OR:1.02; IC:0.41-2.63). Among risk factors, walking 
barefoot was associated with any STH (OR:3.47; IC:1.16-12.5). Prevalence 
of STHs was higher in the mothers from the children infected (36.4%) 
compared with the mothers from those uninfected (14.1%) (p<0.02). 
In conclusion, children from this particular Amazonian community have 
high prevalence rates of STHs even after an intensive MDA program. 
The mothers infected with STHs could play an important role in the 
dissemination of the eggs and larvae (S. stercoralis) from these parasites, 
which could eventually contribute to reinfections.  High prevalence of S. 
stercoralis prompt further evaluation of the inclusion of ivermectin within 
the local MDA program. Integration of more control measures for STHs 
-including clean water supply, adequate sanitation services and hygiene 
education- should be taken into account to develop a successful program, 
particularly in remote populations from this region in Peru.
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AN AUTOCHTHONOUS CASE OF GNATHOSTOMIASIS 
ACQUIRED IN QUEENSLAND, AUSTRALIA
Yi dan Lin, Nicholas Anstey
Royal Darwin Hospital, Darwin, Australia
Gnathostomasis is an uncommon foodborne zoonosis, which is caused 
by infection with the larvae of Gnathostoma spp, most commonly 
Gnathostoma spinigerum. In Australia, G. spinigerum has been identified 
in cats and bandicoots, and G. hispidum in wild pigs. Only two locally 
acquired gnathostomiasis cases have been reported from Australia. We 
present the case of a previously well 30-year-old man presenting to a 
Darwin Hospital with left forearm swelling and eosinophilia, positive 
354
astmh.org
gnathostomiasis immunoblot and an epidemiological plausible link to 
infection from undercooked mudcrabs caught in Yeppoon, Queensland 
after heavy flooding.
1129
MODELING COGNITIVE DEFICITS IN SOIL-TRANSMITTED 
HELMINTHIC INFECTION USING GOLDEN SYRIAN HAMSTER
Samuel Chi-yu Pan1, Thanh Nguyen2, Yan Hu2, Raffi Aroian2, 
Robert Clark1
1University of California San Diego, San Diego, CA, United States, 
2University of Massachusetts Medical School, Worcester, MA, United States
Soil-transmitted helminthic (STH) infection, which includes Ascaris, 
whipworm, and hookworm (Ancylostoma duodenale, Necator americanus, 
and A. ceylanicum), remains a significant public health issue today. 
Previous studies in humans, both retrospective and prospective, have 
linked STH infections with anemia, nutritional deficiency, growth stunting, 
and impaired memory and cognition, potentially leading to lower 
socioeconomic status and perpetuation of poverty. However, the results to 
date have been conflicting with regard to the nature of cognitive deficit 
and benefit of anthelmintic therapy. Using Gold Syrian hamsters, which 
are susceptible to acute A. ceylanicum infection, we wanted to isolate, 
observe, and study potential cognitive defects from confounding factors 
normally present in work with humans. Hookworm infection did not 
impair the hamster’s ability to recognize previously encountered objects 
(Novel Object Recognition task), but did impair performance on a spatial 
memory task (Displaced Object Recognition task; control vs infected, 
p=0.02). Further, the severity of deficit was dependent on infection burden 
(control vs severe infection, p=0.01) and the impairment appeared to 
be reversible with clearance of infection. Accordingly, acute hookworm 
infection resulted in deficits in cognitive function, which resolved with 
the clearance of STH infection. It will be important to determine if the 
cumulative effects of repeated infections produce long-term cognitive 
deficits.
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SOIL TRANSMITTED HELMINTHS IN BENIN: EVIDENCE OF 
COUNTRYWIDE HOOKWORM PREDOMINANCE
Moudachirou Ibikounle1, Wilfrid Batcho2, Jean Jacques 
Tougoue3, Aboudou Dare4, Achille Kabore3
1University Abomey Calavi, Cotonou, Benin, 2Ministry of Health Benin, 
National NTD Program, Cotonou, Benin, 3RTI International, Washington, 
DC, United States, 4RTI International, Cotonou, Benin
From 2013 to 2015, mapping of soil-transmitted helminths (STH) was 
conducted in all 77 of Benin’s communes as part of the baseline surveys 
for schistosomiasis and STH. The aim of the mapping was to provide 
epidemiological data needed to develop a national strategy for the 
control of neglected tropical diseases (NTDs) in Benin by 2020. In each 
commune, 5 schools were purposively selected; and in each school 50 
children (25 girls and 25 boys) ages 8 to 14 were randomly selected. In 
total, 19,250 stool (from 9,625 girls and 9,625 boys) from 385 schools 
were examined using Kato-Katz technique. STH are present in all districts. 
National prevalence of STH is 22.74% (95% CI 2.00% - 62.80%) and 
58.44% of the communes (45/77) have prevalence of ≥20% and therefore 
require mass drug administration (MDA) for STH. Four species of STH 
(Hookworm, Ascaris, Trichuris and Enterobius) were observed with intra-
specific and inter-specific variation in the prevalence and density of the 
parasites. Hookworm constitute the highest proportion of STH parasites 
and the prevalence was 17.40% (95% CI 0.40% - 60.00%; n=76); Ascaris 
5.35% (95% CI 0.40% - 26.40%; n=62); Trichuris 1.15% (95% CI 0.40% 
- 9.60%; n=37); and Enterobius: 1.92% (95% CI 0.40% - 18.80%; 
n=32). Hookworm was present in 100% of the surveyed communes 
with a national mean prevalence of 17.14% (95% CI 0.40% - 60.00%). 
Most infections were of light density except in the communes located 
in the department of Atacora. This mapping provides a global view of 
the epidemiological pattern of STH needed for the implementation of a 
control strategy (which could potentially include MDA and the provision 
of potable water, sanitation and health education). Multiple infections 
with several STH are commonplace among the school-age children 
surveyed, possibly due to poor hygiene and sanitation. In Benin, the high 
prevalence of hookworm and its predominance in all communes calls 
for a strengthening of maternal and child health policy through health 
education and routine screening of pregnant women. In addition, STH 
MDA should be tailored to target not only school-age children, per the 
standard guidance, but also women of child-bearing age.
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REPEATED ROUNDS OF MASS DEWORMING 
ADMINISTRATION STILL LEAVE HOUSEHOLD CLUSTERING OF 
SOIL-TRANSMITTED HELMINTH INFECTIONS
Rita G. Oliveira1, Alice V. Easton1, Jimmy H. Kihara2, Cassian 
Mwatele2, Sammy M. Njenga2, Charles S. Mwandawiro2, Poppy H. 
Lamberton3, Simon J. Brooker4, Roy M. Anderson1
1Imperial College London, London, United Kingdom, 2Kenya Medical 
Research Institute, Nairobi, Kenya, 3University of Glasgow, Glasgow, 
United Kingdom, 4Bill & Melinda Gates Foundation, Seattle, WA, United 
States
Kenya is one of the many countries endemic for soil-transmitted helminth 
(STH) infections. Since 2012, a national school-based deworming 
programme has provided preventive anthelminthic treatment to 
over 6 million children annually. While this control strategy reduces 
overall infection levels, infection bounces back soon after treatment 
administration. In order to improve the efficiency of control programmes, 
further knowledge on the factors driving reinfection is still required. A 
study conducted in 2014 in western Kenya investigated the clustering 
of STH infections at the village and household levels. A cross-sectional 
survey was conducted in four rural villages near Bungoma Town, targeting 
over 1000 residents from 2-81 years of age. Epidemiological data were 
collected at two time-points, at study baseline and three months post-
treatment with 400mg albendazole. Treatment was administered to all 
study participants to simulate a mass drug administration campaign. At 
study baseline, Ascaris lumbricoides and Necator americanus infections 
had an overall prevalence of 9.8% and 6.7% (n=763), respectively, and A. 
lumbricoides was significantly more prevalent in one of the villages (17.7% 
vs. 6.0%, 4.0% and 3.9%; Pearson Χ2=35.7, p<0.001). Three months 
post-treatment, levels of A. lumbricoides and N. americanus infection 
were reduced to 1.8% and 1.4%, respectively, with no significant 
difference between villages. Clustering at household level was observed 
for A. lumbricoides, with 1.3 and 1.75 persons infected per house at the 
first and second time-point, respectively. This clustering was found to be 
associated with predisposition to A. lumbricoides infection, with 62.5% of 
the infected households at the second time-point also having participants 
infected at the first time-point. This study highlights the importance of 
household clustering and predisposition to infection in the maintenance 
of A. lumbricoides infection in endemic communities, a factor to take into 
account if elimination of STH infections is to be successful.
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UNDERSTANDING THE EPIDEMIOLOGY OF HOOKWORM 
INFECTION IN A LOW-TRANSMISSION SETTING IN 
SOUTHERN INDIA: ANALYSIS OF DATA FROM A CLUSTER-
RANDOMIZED MASS DEWORMING TRIAL
Rajiv Sarkar1, James E. Truscott2, Vasanthakumar Veluswamy1, 
Sheela Roy1, Anuradha Rose1, Rajan Srinivasan1, Venkata R. 
Mohan1, Vinohar Balraj1, Jayaprakash Muliyil1, Gagandeep Kang1, 
Roy M. Anderson2
1Christian Medical College, Vellore, India, 2Imperial College London, 
London, United Kingdom
Hookworms are a leading cause of malnutrition and anemia in resource 
poor settings. Periodic mass deworming of at-risk populations (particularly 
school-going children) with anthelminthic drugs remains the cornerstone 
of hookworm control efforts worldwide. Reinfection rates following 
treatment are high, suggestive of an untreated reservoir of transmission. 
Also, recent modeling-based estimates suggest that school-based 
deworming may have limited impact in interrupting the community 
transmission of hookworm infections. In a recently concluded cluster-
randomized community-intervention trial of a modified population-based 
mass deworming strategy, 8681 participants aged 2-70 years, residing in 
45 tribal villages in southern India were randomized into 3 groups: one 
received one round of treatment with albendazole (400 mg) at month 1, 
the second received two rounds of treatment at months 1 and 2, and the 
third received four rounds of treatment - two rounds at months 1 and 
2, followed by another two at months 8 and 9. Stool samples collected 
from a subset of participants pre- and post-intervention were tested 
for hookworm by microscopy to evaluate the effect of the treatment 
with albendazole and at 3-monthly intervals for one year to test for re-
infection. The baseline prevalence of hookworm infection ranged from 
2-44% (overall prevalence: 19%; 95% CI: 16-21%); majority of infections 
(90%) were of low intensity (<2000 epg). The prevalence and intensity of 
infection increased with increasing age. Following deworming, hookworm 
prevalence decreased after the first two doses, but remained stable 
thereafter. Data from this trial will be used to estimate the key parameters 
for hookworm transmission models. Deterministic, age-structured models 
will be fitted to assess the transmission dynamics of hookworm infection. 
The effect of individual, household and village-level predisposition to 
hookworm infection will be explored. The models derived from this 
study will help identify the drivers of hookworm transmission in a low-
transmission setting and can be used to further refine the end-game 
strategy for hookworm control.
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MODELLING THE EFFECT OF PATTERNS OF ADHERENCE AND 
NON-ADHERENCE TO TREATMENT IN PURSUIT OF HELMINTH 
ELIMINATION BY MASS DRUG ADMINISTRATION
Sam H. Farrell
Imperial College London, London, United Kingdom
In mass drug administration (MDA) aimed at elimination of disease and/
or disease, sufficient treatment coverage is essential for success. Non-
adherence to treatment is a barrier to achieving adequate coverage. A 
critical question concerns the likelihood of non-adherence at one round 
of treatment predisposing to non-treatment at subsequent rounds. 
In addition the transmission dynamics may be affected by patterns of 
treatment or non-treatment over multiple rounds - for example, individuals 
untreated over multiple rounds of MDA may act as a reservoir of infection. 
We address the importance of these issues through the construction 
and analysis of a stochastic computational model in which the effects 
of systematic non-adherence on coverage and treatment pattern are 
examined in detail and conclusions drawn about the importance of non-
compliance to achieve policy goals.
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TO WHAT EXTENT IS PREVENTIVE CHEMOTHERAPY FOR 
SOIL-TRANSMITTED HELMINTHIASIS ‘PRO-POOR’? EVIDENCE 
FROM THE 2013 DEMOGRAPHIC AND HEALTH SURVEY, 
NIGERIA
Cameron Seider1, Katherine Gass2, Jedidiah Snyder3, Nathan C. 
Lo4, David G. Addiss3
1George Washington University, Washington, DC, United States, 2NTD 
Support Center - Task Force for Global Health, Decatur, GA, United States, 
3Children Without Worms - Task Force for Global Health, Decatur, GA, 
United States, 4Division of Infectious Diseases and Geographic Medicine, 
Stanford University School of Medicine, Stanford, CA, United States
Health equity is a guiding principle for the control and elimination of 
neglected tropical diseases (NTDs), including those addressed through 
so-called ‘preventive chemotherapy’ (PC), such as soil-transmitted 
helminthiasis (STH). NTD advocacy messages frequently emphasize the 
‘pro-poor’ potential of PC, with the aim of ‘rescuing the bottom billion.’ 
Available evidence suggests that poverty, lack of education, and residence 
in rural areas are all significant risk factors for STH. Little information is 
available, however, on the extent to which PC reaches those at highest 
risk within STH-endemic communities. To identify demographic and 
socioeconomic factors associated with drug coverage for STH, we 
analyzed data from the 2013 demographic and health survey from 
Nigeria. In this nationally-representative survey, mothers were asked 
whether their young children received deworming medication during the 
previous 6 months. We conducted multivariable logistic regression that 
controlled for child age, gender, immunization status and having received 
vitamin A supplementation in the previous 6 months. Overall, 19.9% of 
children 6-59 months of age were reported to have received deworming 
medication in the previous 6 months. Reported six-month deworming 
prevalence was 15.2% in rural areas, compared to 28.4% in urban 
areas. Prevalence of deworming increased linearly with level of maternal 
education (9.4% for children whose mothers had no formal education, 
compared to 42.5% with more than secondary education) and wealth 
quintile (7.9% for the lowest wealth quintile, compared to 39.1% for the 
highest). Deworming prevalence remained significantly associated with 
maternal education (odds ratio [OR] 2.2, 95% confidence interval [CI] 1.8-
2.7), wealth (OR 2.3, CI 1.9-2.7), and urban residence (OR 1.6, CI 1.3-2.0) 
in the multivariate analysis. These results highlight systemic challenges to 
actualizing a ‘pro-poor’ NTD policy and raise questions about the degree 
to which current NTD policies and practices, particularly for STH, actually 
reach those at greatest risk.
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THE SECOND GLOBAL NGO DEWORMING INVENTORY: 
ASSESSING SOIL-TRANSMITTED HELMINTHIASES 
TREATMENT REPORTING
Jedidiah S. Snyder1, Alexei Mikhailov2, Alexander Jones1, Pamela 
Mbabazi2, David Addiss1
1Children Without Worms - Task Force for Global Health, Decatur, GA, 
United States, 2World Health Organization, Geneva, Switzerland
Affecting nearly one billion children globally, soil-transmitted helminthiases 
(STH) is the most common parasitic infection. To combat the disease, 
the World Health Organization (WHO) target for 2020 is to reach ≥75% 
of children at-risk of STH with regular preventive chemotherapy (PC). 
Ministries of Health (MoH) provide routine STH treatment reports to the 
WHO PCT Databank to monitor treatment coverage. In 2014, 47% of at-
risk children were reported to receive PC. Non-governmental organizations 
(NGOs) also play a key role in administering PC. However, according to the 
first Global NGO Deworming Inventory (DI) for data of 2009 and 2010, 
over a third of the NGO administered treatments were unreported to WHO 
in 2010. To assess progress made in improving coordination of NGO-MoH-
WHO reporting of STH treatments, a second DI was conducted after a 5 
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year period. From August to October, 2015, 40 NGOs were surveyed, of 
which 17 (43%) reported administered STH treatments in 2014. NGO-
delivered treatments were again compared with those reported by MoHs 
to WHO. Comparing 2014 to 2010, the total number of reported STH 
treatments increased from 261 million to 441 million globally; treatments 
delivered by NGOs increased from 65.4 million (25%) to 187.2 million 
(42%); and the number of NGO treatments unreported to WHO decreased 
from 23.3 million (36%) to 10.5 million (6%). The NGO unreported 
treatments constitute 2.4% of the global total in 2014, compared to 8.9% 
in 2010. These findings demonstrate improved NGO-MoH data reporting 
and collaboration at the country level. Only six countries accounted for 
>90% of NGO unreported STH treatments in 2014. While the DI is not 
intended to provide an alternative data collection process, periodically 
comparing the DI and PCT Databank can further strengthen reporting by 
prioritizing support to countries with large gaps in reporting. Combining 
data from these two sources highlights important reporting gaps, 
demonstrates the effect of systematized efforts to reduce them, and helps 
to increase confidence in the accuracy of national treatment coverage 
reporting to the global level of children at-risk of STH infection.
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GUIDANCE IN DESIGNING SURVEYS FOR MONITORING 
SURVEYS FOR MONITORING THE PROGRESS OF SCHOOL-
BASED DEWORMING PROGRAMS TO CONTROL SOIL-
TRANSMITTED HELMINTHIASIS
Bruno Levecke1, Aklilu H. Ghebretinsae1, Roy M. Anderson2, 
Dirk Berkvens3, Johnny Vlaminck1, Brecht Devleesschauwer4, Niko 
Speybroeck5, Jozef Vercruysse1, Stefan Van Aelst6
1Ghent University, Merelbeke, Belgium, 2Imperial College, London, United 
Kingdom, 3Institute of Tropical Medicine, Antwerp, Belgium, 4Scientific 
Institute of Public Health, Brussels, Belgium, 5Université Catholique de 
Louvain, Brussels, Belgium, 6KU Leuven - University of Leuven/Ghent 
University, Leuven/Ghent, Belgium
There is a worldwide upscale in school-based deworming programmes 
to control the morbidity caused by soil-transmitted helminths (STH). 
However, there is a lack of guidance in designing surveys to verify whether 
these programmes progress as anticipated. We expanded an existing 
2-level hierarchical model that accounts for variation in egg counts 
within individuals due to the egg counting procedure (level 1; Poisson 
distribution) and between individuals within a school due to host-parasite 
interactions (level 2; negative binomial distribution (NB)), to a 3-level model 
that also accounts for clustering of STH infections between schools (level 
3; NB or zero-inflated NB distribution). In addition, we adapted the model 
for variation in the effectiveness of deworming programmes at both the 
individual and the school level. To maximize the flexibility in survey design, 
the framework was worked out for the examination of both individual 
and pooled stool samples. From the derived formulae to estimate the 
variance, we updated the methodology to calculate the number of schools 
and the number of individuals per school required for assessing (i) the 
intensity of infections, (ii) the effectiveness of programmes and (iii) the 
absence of infections for any scenario of disease epidemiology, diagnostic 
strategy and programmatic effectiveness. To bridge the gap between this 
mathematical framework and the end-users we further developed an 
online interface that guides the user in designing an appropriate survey 
without the need of prior mathematical or statistical knowledge. At the 
meeting we will briefly outline the underlying mathematical framework. 
Subsequently, we illustrated its applications using available data on 
the effectiveness of deworming and the related costs to diagnosis STH 
infections in epidemiological surveys in Eastern Africa. Finally, we will 
demonstrate selective features of the online tool.
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IMPACT OF HELMINTH INFECTIONS DURING PREGNANCY ON 
HUMORAL VACCINE IMMUNOGENICITY IN INFANTS
Meral Esen1, Josiane Honkpehedji2, Sina Brückner3, Vera Kühne3, 
Esther Askani3, Wiebke Lessmann3, Johanna Hass3, Marguerite 
Massinga Loembe4, Sonja Killinger3, Mohammed Duali2, Benjamin 
Mordmüller1, Bertrand Lell1, Peter G. Kremsner1, Akim Ayola 
Adegnika1
1Institut für Tropenmedizin; University of Tübingen, Tübingen, Germany; 
Centre de Recherches Médicales de Lambaréné, Lambaréné, Gabon, 
2Centre de Recherches Médicales de Lambaréné, Lambaréné, Gabon, 
3Institut für Tropenmedizin; University of Tübingen, Tübingen, Germany, 
4Centre de Recherches Médicales de Lambaréné, Lambaréné, Gabon; 
Université des Sciences de la Santé, Libreville, Gabon
Infection with helminths is considered as a neglected tropical disease and 
is a major public health problem especially in the tropics. The influence 
on cognitive and physical development as well as on the immune system 
is well recognized. Recent studies showed that individuals infected with 
helminths have a reduced antibody response to vaccination. Furthermore, 
there is evidence that infants born to helminth-infected mothers display 
changes of their immune system that might lead to a reduced antibody 
response towards vaccines. In this ongoing study we investigate the 
influence of maternal helminth infection on the immunogenicity 
of vaccines administered within the national Expanded Program on 
Immunization (EPI) in Gabon. Infants of mothers either with or without 
helminths are compared (NCT02714348; BMBF 01KA1307). More than 
300 mothers have been enrolled and helminth status assessed prior to 
delivery. Blood has been collected at delivery from the mother and the 
cord, and additionally from the infants at 9 months and 12 months of age. 
The antibody profile to the vaccines are measured with ELISA. Here we 
present preliminary study data.
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INTESTINAL PARASITIC INFECTIONS IN HIV INFECTED AND 
NON-INFECTED PATIENTS IN A HIGH HIV PREVALENCE 
REGION, ADAMAOUA-CAMEROON
Celine N. Nkenfou1, Sandrine M. Tchameni2, Carine N. Nguefeu3, 
Gabriel Kengne2, William Estrin4
1Molecular Biology Center, Yaounde, Cameroon, 2Catholic University of 
Central Africa, Yaounde, Cameroon, 3University of Yaounde I, Yaounde, 
Cameroon, 4California Pacific Medical Center, San Francisco, CA, United 
States
The magnitude of intestinal parasitic infection in acquired 
immunodeficiency syndrome patients requires careful consideration 
in the developing world where poor nutrition is associated with poor 
hygiene and many tropical diseases. Studies have addressed this issue in 
Cameroon, mainly in the low HIV prevalence settings. This study aimed 
to determine the prevalence of intestinal parasites in HIV/AIDS patients 
in Adamaoua (with HIV prevalence 5.1%) Stool and blood specimens 
from HIV/AIDS patients and control group were screened respectively 
for intestinal parasites and for HIV antibodies. Intestinal parasites were 
identified using direct microscopy, formalin-ether concentration, Ziehl 
Neelsen and giemsa stains methods. Out of 235 participants recruited 
among patients consulting at hospital, 69 (29.24%) were HIV positive, 
Thirty-one of them treatment naïve (44.93%). The prevalence of intestinal 
parasites was 32.34%. Out of 69 HIV/AIDS patients, 31.88% (22/69) 
were infected with intestinal parasites, while 32.53% (54/166) of the HIV 
negative patients were infected with intestinal parasites. The parasites 
detected in the population included: Blastocystis hominis (18.30%), 
Entamoeba histolytica (6.36 %), Entamoeba coli (5.96 %), Endolimax 
nanus (3.83%), Iodamoeba buetschlii (2.13%), Crystosporidium spp 
(2.98%), Trichomonas intestinalis (1.70%), Embadomonas intestinalis 
(0.43%), Cyclospora cayetanensis (0.43%), Ascaris lumbricoides (0.43%). 
There was no difference between the prevalence of intestinal parasites 
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amount people living with HIV and people living without HIV. The parasitic 
density instead was higher in the group of HIV positive patients compared 
to HIV seronegative people. 38 out 69 HIV infected patients were on ARV 
and 31 were still treatment naïve. Being on treatment or not did not affect 
infection by intestinal parasites. Poor hygiene conditions were associated 
to parasites infections (p=0). In conclusion, HIV patients should be 
screened routinely for intestinal parasites and treated for their overall well 
being. Emphasis should be placed on their hygiene as well.
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OLDER AND FORGOTTEN; SEXUAL BEHAVIOR AND 
PERCEIVED HEALTH STATUS AMONG HIV POSITIVE AND 
NEGATIVE MENOPAUSAL WOMEN IN NIGERIA
Olubukola C. Omobowale1, Olubukola Adeponle Adesina2
1University College Hospital, Ibadan, Nigeria, 2University of Ibadan, Ibadan, 
Nigeria
Not only are people living longer with the Human Immunodeficiency 
Virus, but there is also a significant increase in older individuals becoming 
infected. Women in the menopausal transition may constitute a group that 
is vulnerable to HIV infection with less likelihood of using a condom and 
low perception of the risk of HIV infection with inadequate knowledge 
of HIV transmission and prevention. This study assessed sexual behavior 
and perceived health status among HIV positive and negative menopausal 
women in Ibadan, Nigeria. Focus group discussions were conducted 
among HIV positive and negative menopausal women attending the ARV 
and General Outpatient clinics at the University College Hospital Ibadan, 
Nigeria with the use of a focus group discussion guide. Opinions of 
discussants on condom use, having multiple sexual partners, knowledge 
of HIV transmission and prevention and perceived health status were 
explored. Ten focus group discussions were conducted among women 
aged 40 and 60 years in each of the two groups. Data was analysed 
thematically. A total of 90 HIV positive and 92 HIV negative women aged 
between 40 to 60 years were sampled. While all the women opined that 
condom use protects against STIs and unwanted pregnancy, condom use 
was low among both groups. More HIV negative women opined that 
having multiple sexual partners was unbecoming and any older woman 
with multiple sexual partners is promiscuous, however, HIV positive older 
women strongly affirmed that men often run away when they disclose 
their HIV status to them, hence the need for multiple sexual partners. 
Knowledge of HIV transmission and prevention was poor among both 
groups. Interestingly, more HIV positive women perceived their health 
status as good, compared to HIV negative women. Coping strategies 
include belonging to a support group and seeking information from 
health care workers. Menopausal women are vulnerable to HIV infection 
and its impact on this group should not be ignored. There’s a need for 
risk reduction strategies and health promoting interventions that will help 
these women in coping with the double burden of HIV infection and 
ageing.
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PREVALENCE OF PREECLAMPSIA AMONG HIV-POSITIVE 
PREGNANT WOMEN AS COMPARED TO HIV-NEGATIVE 
WOMEN IN IBADAN
Richard O. Olayide, Timothy A. Oluwasola, Olubukola A. 
Adesina
University College Hospital, Ibadan, Nigeria
Preeclampsia is a common complication of pregnancy and a major cause 
of maternal morbidity. Pathogenetic explanations for preeclampsia 
include; maladaptation of the immune system to paternal antigens and 
exaggerated maternal inflammatory response to trophoblastic tissue. 
Immune deficiency, induced by HIV or any other cause, could therefore 
inhibit a tendency to immune hyper-reactivity and thus theoretically 
prevent the development of preeclampsia. The study aimed to explore the 
role of the immune theory of pre-eclampsia by comparing the prevalence 
of preeclampsia among HIV-positive and HIV-negative pregnant women. 
The study is a cross-sectional survey of pregnant women, beyond 28 
weeks gestation, who delivered at the University College Hospital, Ibadan, 
Nigeria between 1st October 2011 and 31st December 2011. Data was 
collected using a pre-specified proforma. Analysis was done using SPSS 
version 17.0 and p-value was set at <0.05. A total of 766 women who 
gave birth during the period of the study met the inclusion criteria. Among 
the cohort, HIV prevalence rate was 7.2% while preeclampsia was 10.7%. 
None of the HIV-positive women had preeclampsia. This study concluded 
that the prevalence and perhaps, risk of developing preeclampsia is 
reduced among HIV positive women. This is similar to other studies done 
in various countries in the world.
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HTLV AND HIV CO-INFECTION AMONG KEY POPULATIONS, 
DOMINICAN REPUBLIC
Robert Paulino-Ramirez1, Rebecca Charow2, Xelenia DePeña3, 
Luis Rosario3, Jorge Rosa3, Rosana Rosa3
1Research Department, Universidad Iberoamericana, Gazcue, Dominican 
Republic, 2Centro de Orientación e Investigación Integral, Santo Domingo, 
Dominican Republic, 3School of Medicine, Universidad Iberoamericana, 
Gazcue, Dominican Republic
HTLV and HIV coinfections are not well characterized among most at-risk 
populations. Overall, there has been a decline in HTLV research in the 
past 24 years with few studies reporting current data on its prevalence 
in endemic countries. Past studies have shown that HTLV-1 and HIV 
coinfection causes increased HTLV-1 seropositivity and subsequent risk for 
tropical spastic paraparesis/HTLV-1 associated myelopathy (TSP/HAM) and 
other neurological diseases in addition to reduced survival time. Based on 
the fact that HTLV and HIV share the same modes of transmission, the 
purpose of this investigation was to estimate the seroprevalence of HTLV 
IgG and HIV antibodies and to establish the prevalence of coinfection 
among two key populations, transactional sex workers (SWs) and drug 
users. A demographic, stratified sample of 200 sera was randomly selected 
in four high burden regions of Santo Domingo, Dominican Republic. 
Informed consent was obtained from each participant and each received 
pre- and post-counselling about HIV and HTLV transmission. Blood samples 
were drawn from each participant and screened for HIV and HTLV-1/2 
IgG antibodies using ImmunoComb®II (Orgenics, Israel) products. Overall 
weighted seroprevalence of HTLV-1/2 IgG antibodies was 13.91% (CI: 
±6.32%) in men and 10.59% (CI: ±6.54%) in women and for HIV-1 was 
13.91% (CI: ±6.32%) in men and 17.65% (CI: ±8.10%). Of those HTLV 
positive, 50% of those men and 44.44% of those women were coinfected 
with HIV and half of whom were SWs. Seroprevalence of both HTLV and 
HIV antibodies detected among heterosexual SWs (33.33%) appears 
to be the most important route of transmission. Results call attention 
for more public health preventive strategies among key populations in 
the Dominican Republic and further investigation on the neurological 
complications experienced and clinically relevant effect of HTLV-1 on HIV 
positive patients in endemic regions.
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FACTORS ASSOCIATED WITH DEFAULTING FROM CARE 
AMONG ADULTS ON ANTI-RETROVIRAL TREATMENT 
PROGRAM IN ONDO STATE, NIGERIA, 2015
Olayinka S. Ilesanmi1, Olufunmilayo Fawole1, Patrick M. Nguku2
1University of Ibadan, Ibadan, Nigeria, 2Nigeria Field Epidemiology and 
Laboratory Training Programme, Abuja, Nigeria
Nigeria has one of the highest burden of Human Immunodeficiency Virus 
(HIV), with a prevalence of 3.4%, and over 700,000 on antiretroviral 
therapy (ART). Defaulting from care is an emerging threat to successful 
control of HIV. This study explored factors associated with default among 
adults on ART in Nigeria. An unmatched 1:2 case control study was 
conducted at Federal Medical Centre, Owo, Ondo State. Cases were 
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adults who defaulted clinic visit at least three consecutive times and 
have not returned to care, while controls were consistent in clinic visit 
for at least 6 months. Defaulters identified from the clinic register were 
interviewed at home. Controls were selected from the ART clinic using 
systematic sampling technique. Semi-structured questionnaire was used 
to collect data on respondents’ socio demographics, disclosure status 
and knowledge on ART treatment. Four in-depth interviews (IDI) with 
defaulters were conducted to document the barriers to retention in care. 
A total of 102 cases and 204 controls were enrolled. Respondents mean 
age was 41.4±10.3 years and 118(38.6%) were males. Defaulting from 
treatment was associated with non-disclosure of status to partner (AOR: 
2.8; CI 95%: 1.6-4.9), receiving fewer counselling sessions (AOR: 2.3; 
CI 95%: 1.3-4.2), perception that quality of service received was poor 
(AOR: 2.6; CI 95%: 1.4-4.7), and sub-optimal quality of life (AOR: 2.7; 
CI 95%: 1.5- 4.8). Major reasons for defaulting included: traveling out of 
base 10(67%) and lack of support from workplace 9(50%). IDI revealed 
clinic not operating on weekend as a cause of defaulting. In conclusion, 
the clinic management team increased the number of patient counselling 
sessions and reviewed its content to include training on disclosure 
techniques. Commencing weekend clinic days was recommended.
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MOLECULAR AND CLINICAL IMMUNE STATUS OF HIV 
EXPOSED BUT UNINFECTED (HIV EU) INFANTS COMPARED 
TO CONTROL HIV UNEXPOSED (HIV UU) INFANTS: A 
COHORT STUDY IN KISUMU DISTRICT, KENYA
Jessica E. Ray1, Maxwel Omenda2, Peter Sumba2, John Vulule2, 
Rosemary Rochford3, Arlene Dent1
1Case Western Reserve University, Cleveland, OH, United States, 2Kenya 
Medical Research Institute, Kisumu, Kenya, 3University of Colorado, 
Denver, CO, United States
Kenya has one of the world’s greatest HIV burdens; nearly 1.5 million 
adults are infected. Due to increased access to antiretroviral therapy and 
mother to child transmission interventions implemented in Kenya, the 
number of babies infected with HIV is low. But as the number of HIV 
positive adults in Kenya remains steady and transmission to infants is 
decreased, there is now a growing population: HIV exposed but uninfected 
(HEU) infants. These infants, while healthier than HIV positive infants, have 
increased morbidity and mortality compared to HIV unexposed uninfected 
(HUU) infants. We hypothesized that in utero exposure to HIV and/or the 
chronically activated maternal immune environment resulting from HIV 
infection affects the fetal immune system leading to prolonged elevation 
of pro-inflammatory biomarkers, decreased antibody production, and 
increased clinical events of infants. This study is investigating the following 
aims: (1) Determining the magnitude and duration of elevated pro-
inflammatory biomarkers in HEU vs. HUU infants using MagPix analysis of 
plasma samples at birth, 6, 10, 14, 18 weeks, and 6, 9, and 12 months (2) 
Determining the prevalence and magnitude of antibodies against multiple 
Plasmodium falciparum antigens by serology up to two years of age and 
(3) Characterizing the clinical events (such as pneumonia, meningitis, 
malaria) experienced by HEU vs. HUU infants over the first two years of 
life. Preliminary results suggest that there is no significant difference in the 
levels of pro-inflammatory biomarkers present in plasma of HEU vs. HUU 
infants at all of the time points tested between birth and one year. These 
results suggest that perhaps the immune system of HEU infants is actually 
more stable than initially hypothesized. This finding is further supported 
by preliminary results from the clinical database that suggest there is no 
significant difference in the number of sick visits, severe infections, or 
hospital admissions between the HEU and HUU infants.
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HIV EPIDEMIOLOGY AND COVERAGE OF HIV HEALTH 
SERVICES IN GEM COUNTY, SIAYA COUNTY, WESTERN 
KENYA, 2013-2014
Barbara K. Burmen, Kennedy Mutai
Kenya Medical Research Institute Center for Global Health Research, 
Kisumu, Kenya
According to the Kenya AIDS Indicator Survey (KAIS) of 2012, the former 
Nyanza province of Kenya had the highest HIV prevalence among persons 
aged 15-64 years; 15.1% (against the country’s national average of 
5.6%) with 18.3% among females and 13.9% among males. In the 
same survey, 71.3% and 79.9% of persons had ever been tested for HIV 
in the past country-wide and in Nyanza province respectively. Among 
all males, 91.2% were circumcised country-wide and 66.3% in Nyanza. 
HIV prevalence in uncircumcised and circumcised men was 16.9% and 
3.1% and 25.9% and 8.1% in Kenya and Nyanza respectively. Among 
the HIV infected, 89.3% were enrolled in HIV care countrywide of whom 
88.6% were on Cotrimoxazole Preventative Therapy (CPT); CPT coverage 
was 90.0% in Nyanza. We present more recent results of a home based 
HIV counseling (HBCT) survey in Gem Sub-County, Siaya County (one of 
the five counties in the former Nyanza province). We reviewed data for 
persons aged between 15 and 64 years of age who participated in the 
HBCT Survey, between June 2013 and August 2014. We compared HIV 
prevalence and coverage of selected HIV health services for former Nyanza 
province in KAIS 2012 to HBCT. Of 21,879 persons who participated in the 
survey; 63% were female. Among all participants, 19,417 (89%) had ever 
been tested for HIV in the past of whom 2084 (10.7%) tested positive; 
majority (98%) of HIV positive persons had been enrolled into HIV care 
and were on CPT (98%). Among the larger group (89.3%) who had tested 
negative for HIV in the past, HIV prevalence during survey testing was 4.1 
% (n=704) and 7.1 % (n=171) among those who had never been tested. 
The overall HIV prevalence was 13.8 %. HIV prevalence was significantly 
higher among females compared to males (16.4% vs. 9.4%). Among 
all men, 64.5% had been circumcised. HIV prevalence was significantly 
higher among circumcised compared to uncircumcised men (4.9% vs. 
11.8%). The current HIV prevalence in this region reflects the country’s 
downward trend in HIV prevalence and maybe due to increased coverage 
of HIV health services. More comprehensive comparisons should routinely 
be made to illustrate trends in the HIV response.
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USING THE LIVERPOOL HIV ICHART TO PREDICT THE 
SPECTRUM OF DRUG-DRUG INTERACTIONS IN A COHORT OF 
HAART- EXPOSED PERSONS LIVING WITH HIV (PLHIV) IN A 
TREATMENT CENTRE IN SOUTH-SOUTH NIGERIA
Fubara Adienbonye1, Omosivie Maduka1, Igbiks Tamuno2
1University of Port Harcourt, Port Harcourt, Nigeria, 2University of 
Liverpool, Liverpool, United Kingdom
Drug-drug interaction (DDI) occurs where two or more drugs interacts in 
a manner that alters their therapeutic effects. HAART may interact with 
co-medications in HIV patients and present severe complications. Objective 
We used the Liverpool iCHART application to describe the pattern of drug-
drug interactions between HAART and other medications in a cohort of 
HAART-exposed PLHIV at the University of Port Harcourt Teaching Hospital. 
This was a review of client records at the HAART clinic of the University 
of Port Harcourt Teaching Hospital in the South-South region of Nigeria 
conducted in September 2014. Folders of 480 patients who reported for 
clinic consultations and drug refills were selected via systematic sampling 
over a 20 day period. We used simple random sampling to identify two 
drug prescriptions from client folders. A data extraction form was used to 
record data on socio-demographic details, co-morbidities, co-prescribed 
drugs as well as the specific HAART regimen employed. The Liverpool 
HIV iChart Application was used to screen for possible interactions such 
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as potential drug interactions and clinical significant drug interactions 
(CSDI) between the ARV drugs and co-medications. Results The study 
involved record from 157(33.1%) male and 321 (66.9%) female PLHIVs 
with mean age of 38.82±9.68 years with ages ranging from 20 to 84 
years. Prevalence of potential drug interactions (PDI) was as high as 
463 (96.5%) while the prevalence of CDSI was 216 (45%). All client 
prescriptions reviewed using the app had elements in the green indicating 
no interactions, 464 clients (96.7%) had elements in amber indicating 
presence of potential interactions for which caution was needed while 48 
clients (10%) of elements of their drug treatments in the red/danger zone 
indicating an absolute contra-indication to co-administration of HAART 
and the particular co-medication. In conclusion, the Liverpool HIV ICHART 
is an inexpensive and useful resource for predicting drug-drug interactions 
for PLHIV on HAART. Its routine use is advocated in HIV treatment centres 
especially in resource poor settings.
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DIAGNOSIS OF TOXOPLASMOSIS REACTIVATION IN HIV 
PATIENTS IN URINE USING NANOPARTICLE TECHNOLOGY
Hannah Steinberg1, Maritza Calderon2, Natalie M. Bowman3, 
Francesca Schiaffino1, Ruben Magni4, Deanna Zhu1, Edwardo 
Ticona5, Lance Liotta4, Robert Gilman1, Alessandra Luchini4, 
uana Cayetano Heredia The Toxoplasmosis Working Group at 
Universidad Per
1John Hopkins University Bloomberg, Baltimore, MD, United States, 
2Universidad Cayetano Peruana Heredia, Lima, Peru, 3University of North 
Carolina, Chapel Hill, NC, United States, 4George Mason University, Fairfax, 
VA, United States, 5Hospital National Dos de Mayo, Lima, Peru
The most devastating opportunistic diseases associated with HIV are 
those that affect the central nervous system (CNS). Their nonspecific 
presentation makes diagnosis difficult even in the best-resourced settings. 
In many cases, diagnosis by exclusion is the only option. Toxoplasma 
gondii is one such malady. Thus we present a point of care western blot 
for the detection of T. gondii antigen, SAG1. T. gondii seroprevalence 
varies by continent and socioeconomic status, but is estimated to be 
highest in Latin America ranging from 39-90%. An estimated 33% of 
patients with advanced immunosuppression and previous seropositivity for 
T. gondii will develop toxoplasmic encephalitis (TE). Diagnosis of T. gondii 
in HIV positive patients is difficult without CT or MRI in resource-poor 
settings. PCR of cerebral spinal fluid (CSF) has a sensitivity of 12-to-70%. 
Safe collection of CSF is difficult in locations without medical facilities and 
expertise. Obtaining a culture of the parasite is possible, but requires at 
least 6 weeks for completion, rendering results diagnostically irrelevant. 
When TE is treated early, the disease boasts a 90% clinical response rate. 
Thus, a rapid point of care test with high sensitivity and specificity, using 
an easily obtained body fluid is absolutely necessary if LMIC treatment 
is to surmount the aforementioned diagnostic challenges. Nanoparticle-
concentrated urinary-antigen diagnostic assays are noninvasive, safe, and 
inexpensive; they provide a rapid, accurate, and precise parasitological 
test in resource-constrained zones where PCR is not readily available. 
Sensitive and specific urinary tests combined with clinical assessment will 
aid in the diagnosis and treatment of TE in HIV-infected patients. Briefly, 
nanoparticles were circulated in murine or human urine samples, collected, 
and the contents eluted. Said contents were separated by polyacrylamide 
electrophoresis and detected by western blot. Results illustrate detection 
of all positive and negative samples in accordance with previous qPCR 
results. We are intrigued by these results and will continue pilot testing this 
assay as patient samples become available.
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COULD ACCELERATION TOWARDS GLOBAL 90:90:90 HIV 
TARGET ALONE END TB BURDEN AMONG UNDIAGNOSED 
PEOPLE LIVING WITH HIV? A FOUR YEAR PRE- AND POST-
ISONIAZID PREVENTIVE THERAPY IMPLEMENTATION 
COMPARATIVE DATA FROM COMPREHENSIVE HOSPITAL IN 
NORTHWESTERN NIGERIA
Abiola V. Adepoju1, Isaac O. Ogbaji2, Emmanuel I. Okpetu3, 
Slyvester A. Akande4, Peace S. Igene5
1Management Science for Health, Birnin Kebbi, Nigeria, 2Federal Medical 
Center, Birnin Kebbi, Nigeria, 3Deputy Primary Health Care Coordinator 
(Disease Control) Kuje Area Council Primary Health Care Department Kuje, 
Federal Capital Territory, Abuja, Nigeria, 4Senior Health Finance Advisor 
- HFG Project., Abt Associates, Nigeria, 5Loveworld International School, 
Ikeja, Lagos, Nigeria
Early access to HIV testing and counselling provides opportunity to 
start antiretroviral therapy (ART) and Isoniazid Preventive Therapy (IPT) 
for eligible people living with HIV (PLHIV). There is paucity of data that 
demonstrate comparative programmatic analysis of the impact of IPT 
intervention on the incidence of TB among PLHIV on ART and those not 
on ART. In August 2013, the PRO-ACT project funded by USAID and 
implemented by Management Science for Health started implementation 
of 6 month of IPT in General Hospital Koko, northwestern Nigeria. The 
objective of the study is to assess and compare impact of IPT in reducing 
TB incidence among PLHIV on ART and those previously undiagnosed 
and not on ART. Using the Hospital TB register between July 2011 
to September 2015, TB/HIV co-infection cases were extracted into 2 
groups i.e. group 1/pre-IPT (July 2011-July 2013) and group 2/post-IPT 
implementation era (September 2013-September 2015). TB/HIV co-
infected cases in each group were then categorized into 2 cohorts each. 
Cohort 1 are those not on ART, not on IPT, not previously diagnosed as 
HIV positive until they develop TB. Cohort 2 patients are those previously 
diagnosed HIV positive, not on IPT but on ART before they develop TB. 
Cohort 3 was on IPT, not previously diagnosed as HIV positive until they 
develop TB and not on ART. Cohort 4 was on IPT, previously diagnosed 
as HIV positive before they develop TB and on ART. Data from the 4 
cohorts were then compared to demonstrate impact of IPT and ART in 
reduction of TB burden and incidence among PLHIV. The lowest incidence 
(23.4%) of new TB cases was found in post-IPT era among cohort 4 while 
the worst incidences of new TB cases of 53.3% and 76.6% were found 
among cohorts 2 and 3 respectively. The study demonstrates the combined 
multiplier effects of both IPT and ART in reducing the incidence of TB 
among PLHIV and increased TB incidence among previously undiagnosed 
HIV cases in Northwestern Nigeria. In line with global 90:90:90 target, 
scaling up HIV testing and counselling will ensure early diagnosis as entry 
point for improved access to lifesaving ART and IPT thereby reducing the 
incidence of TB among undiagnosed HIV cases.
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THE GENETIC VARIATION WITHIN SUB-SAHARAN 
POPULATIONS ENDEMIC TO HUMAN AFRICAN 
TRYPANOSOMIASIS
Julius Mulindwa1, Hamidou Ilbodou2, Harry Noyes3, TrypanoGEN 
Consortium
1Department of Biochemistry, Makerere University, Kampala, Uganda, 
2Centre International de Recherche-Developpment sur l’Elevage Zone 
subhumide, Bobo-Dioulasso, Burkina Faso, 3Institute of Integrative Biology, 
University of Liverpool, Liverpool, United Kingdom
Human African trypanosomiasis (HAT) is one of the neglected tropical 
diseases that affect thousands of individuals in sub Saharan Africa. Within 
these populations, some individuals are highly susceptible to infection 
whereas others remain asymptomatic. The TrypanoGEN consortium was 
setup to study the Human genetic determinants of disease susceptibility 
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and trypano-tolerance in 6 African countries. In order to identify loci that 
are associated with disease, whole genome sequencing was carried out 
on 250 individuals from five populations; Guinea (GUI), Ivory Coast (CIV), 
Cameroon (CAM), Democratic republic of Congo (DRC) and Uganda 
(UGA) to discover SNPs for a planned Genome wide association study 
(GWAS). Approximately 2 million SNPs within the TrypanoGEN population 
samples were called. Principal component analysis (PCA) and Admixture 
analysis were used to identify population structure that could confound 
the GWAS. The samples clustered into 4 distinct groups; West African 
Bantu (CIV & GUI), Central African Bantu (DRC), Ugandan Bantu (UGB) 
and Ugandan Nilotics (UGN). Further population structure analysis showed 
that the Uganda Bantu (UGB) had substantial admixture with the Nilotic 
(UGN) ancestry (approximately 50%), were as the Nilotic are a distinct 
population with no Bantu admixture. There is some evidence that HAT 
is a relatively recent infection associated with agriculture and livestock 
domestication. Consequently, loci such as APOL1 associated with disease 
response may show signs of positive selection. Preliminary Fst analysis 
has already identified loci with high Fst which have known associations 
with malaria or methotrexate toxicity. An analysis of loci under positive 
selection that may be associated with response to trypanosomiasis will be 
presented.
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EVIDENCE OF AUTOCHTHONOUS CHAGAS DISEASE 
TRANSMISSION IN SOUTH TEXAS
Sarah M. Gunter1, Kristy O. Murray2, Rodion Gorchakov2, Eric L. 
Brown1, Melissa N. Garcia2
1The University of Texas Health Science Center, Houston, TX, United States, 
2Baylor College of Medicine, Houston, TX, United States
Chagas disease (Trypanosoma cruzi infection) is one of the most significant 
neglected tropical diseases affecting the Americas. There are an estimated 
8-9 million prevalent cases worldwide with an estimated 300,000 infected 
people residing in the United States. Chagas disease is often referred 
to as the ‘silent killer’ due to its long (up to 3 decades) asymptomatic 
period. During this period, progressive cardiac damage can occur in up to 
one-third of infected individuals. In fact, sudden cardiac death is the first 
presenting symptom in 35% of those with cardiac manifestations. Due 
to concern for transmission of the parasite from infected blood products, 
national blood donation screening became mandatory in the United 
States in 2007. Since screening started, 47 seropositive donors have 
been identified in the greater San Antonio area. From this convenience 
sampling, we aimed to gain a better understanding of the transmission 
sources for Chagas positive donors in south Texas. Our case investigation 
found 71% (12 out of 17) of enrolled donors had evidence of acquiring 
the infection locally. Risk factors for disease in those with autochthonous 
transmission included rural residence, outdoor occupations, and outdoor 
hobbies. Of most concern, 58% (5 out of 12) had evidence of Chagasic 
cardiac disease as detected on electrocardiogram. This study adds to the 
growing body of evidence for autochthonous Chagas disease transmission 
in the southern United States. In fact, from this population, we identified 
the largest percentage of autochthonous cases to date. This has important 
implications for public health officials and clinicians as our understanding 
of the global epidemiology of this disease changes. Following this 
presentation, the audience will have a better understanding of the 
epidemiology of Chagas disease in the southern United States.
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PAN-AMERICAN MIGRATION PROMOTES THE SPREAD OF 
PATHOGENIC TRYPANOSOMA CRUZI HYBRID STRAINS
Louisa A. Messenger1, Juan-David Ramirez2, Martin S. Llewellyn1, 
Felipe Guhl3, Michael A. Miles1
1London School of Hygiene & Tropical Medicine, London, United Kingdom, 
2Universidad del Rosario, Bogota, Colombia, 3Universidad de Los Andes, 
Bogota, Colombia
The principal reproduction strategy of Trypanosoma cruzi, the aetiological 
agent of Chagas disease, is the subject of an intense, decades-old 
debate. Despite the existence of two recent natural hybrid lineages (TcV 
and TcVI), which are sympatric with severe disease in southern endemic 
areas, a pervasive view is that recombination has been ‘restrained’ 
at an evolutionary scale and is of little epidemiological relevance to 
contemporary parasite populations. With improved sampling strategies, 
the geographical distribution of TcV and TcVI appears to be expanding. 
High resolution nuclear and mitochondrial genotyping of potential 
hybrid isolates from domestic vectors and human infections in Colombia 
was undertaken, in comparison to representative strains from across 
South America, to resolve their putative status as novel recombinants. 
All suspected Colombian hybrids were highly heterozygous, minimally 
diverse and possessed intact parental alleles at each loci. Compared to 
local Colombian isolates, hybrids were distinct from, but more closely 
related to, those identified in southern reference TcVI strains. Based on 
independent inheritance patterns of microsatellite loci, our data support 
the hypothesis that two recombination events led to the formation of TcV 
and TcVI. However, more private alleles among Colombian hybrids and 
the sharing of mitochondrial haplotypes between southern TcV isolates 
and a Colombian TcVI strain, suggests the evolution of these recombinant 
lineages may be more complicated than previously assumed. The origin of 
these Colombian hybrids is unclear; they are unlikely to be predecessors 
of southern TcVI strains, but were also not clear descendants, and may 
instead represent a sibling group, which diverged and anthroponotically 
dispersed northwards, following a single hybridization event between 
heterozygous southern TcII and TcIII isolates. We discuss the important 
implications the geographical range expansion of TcVI has for emergent 
human Chagas disease in Colombia, considering the successful, epidemic 
establishment of this low-diversity genotype among domestic transmission 
cycles in the South.
1151
EVIDENCE AND IMPORTANCE OF GENETIC EXCHANGE 
AMONG FIELD POPULATIONS OF TRYPANOSOMA CRUZI
Louisa A. Messenger
London School of Hygiene & Tropical Medicine, London, United Kingdom
Many eukaryotic pathogenic microorganisms that were previously assumed 
to propagate clonally have retained cryptic sexual cycles. The principal 
reproductive mode of Trypanosoma cruzi, the aetiological agent of Chagas 
disease, remains a controversial topic. Strong linkage disequilibrium, 
deviations from Hardy-Weinberg allele frequencies and structuring of 
parasite populations into stable, distinct genetic clades have been used 
to argue that recombination has been restrained at an evolutionary scale 
and has little influence on contemporary field populations. However, with 
improved sampling strategies and the development of higher resolution 
nuclear and mitochondrial genotyping techniques, mounting evidence 
now indicate that natural hybridization in T. cruzi may be frequent, non-
obligatory and idiosyncratic; potentially involving independent exchange 
of kinetoplast and nuclear genetic material as well as canonical meiotic 
mechanisms. Asymmetric mitochondrial introgression is emerging as a 
common feature of some transmission cycles, which given their crucial role 
in growth, development and metabolism, satisfies the elevated necessity 
to escape from Muller’s ratchet, and may be exploitable as a method 
of host range extension. A clear understanding of the implications of 
genetic exchange for the ecological and geographical distributions and 
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pathological characteristics of T. cruzi strains is crucial to establish the 
epidemiological risk associated with hybrid genotypes, with respect to 
virulence, transmissibility and drug susceptibility. We discuss the growing 
number of field studies which now challenge the traditional paradigm 
of preponderate clonal evolution in T. cruzi, the caveats underlying 
why detecting genetic exchange is inherently complicated, given that 
parasites most likely to be recombining may be closely related and 
potentially indistinguishable, and describe experimental strategies which 
must be adopted to resolve these fundamental biological phenomena in 
trypanosomatids as we enter the post-genomic era.
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CHAGAS DISEASE IN PREGNANT WOMEN AND SCREENING 
BY PCR IN NEWBORNS FROM GUANAJUATO, MÉXICO
Lucio Galaviz-Silva, Zinnia J. Molina-Garza, Laura M. Montes-
Rincon
Universidad Autonoma de Nuevo Leon, San Nicolas de los Garza, Mexico
Chagas disease is caused by an infection with the protozoan 
hemoflagellate Trypanosoma cruzi, and it is a major endemic health 
problem in Latin America. The congenital route is one of the main non-
vectorial pathways of transmission, which can arise either in the chronic 
or acute phase of maternal infection. Serological screening of T. cruzi 
infection was performed in 520 pregnant women and newborns at the 
Hospital General Regional de León, Guanajuato, Mexico, between 2014 
and 2015. Anti-T. cruzi antibodies were detected in 20 mothers (4%) by 
ELISA and HIA with four PCR-positive newborn cases. Risk factors were 
identified according to an epidemiological survey, and the most significant 
(P <0.050) factors associated with T. cruzi infection were the building 
materials of dwellings, the presence of pets and dwellings located in 
rural areas. This study constitutes the first systematic study on congenital 
Chagas disease and the epidemiological risk factors in Guanajuato. Our 
results represent the probability of an incidence of 770 cases per 100,000 
births during a period of 12 months, with a vertical transmission rate by 
0.8%, which highlights the necessity to establish reliable serological and 
PCR tests in pregnant women to prevent vertical transmission. However, it 
is also important to follow-up the newborns from seropositive mothers for 
one year, which is necessary, as many children yielded negative results.
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TRYPANOSOMA CRUZI PREVALENCE AND SEROPREVALANCE 
IN A COHORT OF U.S. SERVICE MEMBERS IN SOUTH TEXAS
Bryant Webber1, Mary Pawlak1, Sandra Valtier1, Candelaria 
Daniels2, Audra Blasi1, Thomas Cropper1, Sallie Hall1, Charla Tully3
159th Medical Wing, San Antonio, TX, United States, 2Public Health 
Command-Central (Provisional), San Antonio, TX, United States, 3Defense 
Institute for Medical Operations, San Antonio, TX, United States
Although the vast majority of the estimated 300 thousand U.S. residents 
infected with Trypanosoma cruzi, the causative parasitic agent of Chagas 
disease, are among immigrants from endemic areas of Latin America, 
autochthonous transmission is possible in some parts of the United States. 
A study is being conducted at Joint Base San Antonio-Lackland, Texas, to 
determine the prevalence and seroprevalence of Chagas disease among 
military members who may be at increased risk due to field training 
activities in an area where a large number of T. cruzi-infected triatomines 
have been identified. We offered voluntary enrollment to U.S. Air Force 
technical training students graduating from security forces training, Basic 
Military Training field instructors, and military working dog instructors. 
Volunteers completed a questionnaire regarding risk factors for Chagas 
disease and had their blood drawn. Real-time polymerase chain reaction 
(PCR) and two serologic tests (enzyme-linked immunosorbent assay 
[ELISA] for IgG and IgM and immunofluorescence assay [IFA] for IgG) were 
conducted on the collected samples. Descriptive statistics were used to 
analyze the prevalence and seroprevalence of T. cruzi and risk factors. A 
total of 473 individuals have been enrolled to date. Of the tests conducted 
(PCR [N=460]; ELISA [N=465]; IFA [N=465]), all have been negative for T. 
cruzi. The participants reported a mean of 7 weeks spent in a triatomine-
endemic field environment, 273 weeks living or traveling in the Southwest 
United States and Latin America, and 15 weeks camping or hunting in 
the Southwest United States and Latin America. Chagas disease does not 
constitute a significant operational risk to service members who conduct 
or undergo field training in south Texas. The lack of positive cases may 
demonstrate the effectiveness of countermeasures that prevent triatomine 
bites (e.g., trainees are issued insect repellent and permethrin-treated bed 
nets) and/or the poor efficacy of stercorarian transmission of T. cruzi.
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TRANSMISSION DYNAMICS OF VISCERAL LEISHMANIASIS IN 
THE INDIAN SUBCONTINENT - A SYSTEMATIC LITERATURE 
REVIEW OF THE ROLE OF ASYMPTOMATIC LEISHMANIAL 
INFECTION, POST-KALA-AZAR DERMAL LEISHMANIASIS AND 
RELAPSE RATES
Siddhivinayak Hirve
World Health Organization, Mont-sur-Rolle, Switzerland
As Bangladesh, India and Nepal progress towards visceral leishmaniasis 
(VL) elimination, it is important to understand the role of asymptomatic 
Leishmania infection (ALI), VL treatment relapse and post kala-azar 
dermal leishmaniasis (PKDL) in transmission. We systematically reviewed 
evidence on ALI, relapse and PKDL as potential reservoirs of infection. We 
searched multiple databases to include studies on burden, risk factors, 
biomarkers, natural history, and infectiveness of ALI, PKDL and relapse. 
After screening 292 papers, 98 were included. ALI, PKDL and relapse 
studies lacked a reference standard and appropriate biomarker. The 
prevalence of ALI was 4-17-fold that of symptomatic VL. The risk of ALI 
was higher in VL case contacts. Most infections remained asymptomatic 
or resolved spontaneously. The proportion of ALI that progressed to 
VL disease within a year was 1.5-23%, and was higher amongst those 
with high antibody titres and those who had a VL case in the family. The 
natural history of PKDL showed variability; 3.8-28.6% had no past history 
of VL treatment. About 49% of PKDL resolved spontaneously without 
treatment. The infectiveness of PKDL was 32-53%. Relapse following VL 
treatment occurred in 0.14-20% and the risk was higher with HIV co-
infection. Modelling studies produced a range of scenarios. One model 
predicted that early diagnosis was unlikely to eliminate VL in the long 
term. Another model estimated the infectiveness of ALI to be 1-3% and 
that ALI contributed to 82% of the overall transmission, VL to 10% and 
PKDL to 8%. In contrast, another model predicted that VL cases were the 
main driver for transmission. Another model predicted that VL would be 
eliminated if the sandfly density was reduced by 67% by killing the sandfly 
or by 79% by reducing their breeding sites. Another model predicted VL 
elimination with 4-6y of optimal IRS or 10y of sub-optimal IRS and only in 
low endemic setting. There is a need for xenodiagnostic and longitudinal 
studies to understand the potential of ALI and PKDL as reservoirs of 
infection.
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MOLECULAR DETECTION OF LEISHMANIA (VIANNIA) 
PANAMENSIS IN ANTHROPOPHILIC AND ZOOPHILIC 
SANDFLIES FROM AN ENDEMIC FOCUS OF CUTANEOUS 
LEISHMANIASIS IN PANAMA
Chystrie A. Rigg1, Kadir González1, Anayansi Valderrama1, Milixa 
Perea1, Aracelis Miranda1, Luis F. Chaves2, Nicole Gottdenker3, José 
E. Calzada1, Azael Saldaña1
1Gorgas Memorial Institute for Health Studies, Panama, Panama, 2Institute 
of Tropical Medicine (NEKKEN), Nagasaki University, Nagasaki, Japan, 
3Department of Veterinary Pathology, College of Veterinary Medicine, 
University of Georgia, Athens, GA, United States
Cutaneous leishmaniasis (CL) is a parasitic zoonosis prevalent in many 
rural areas of Panama. Leishmania Viannia panamensis is considered the 
main involved etiologic agent. The transmission of this parasitic disease 
is conditioned by the bite of infected sandflies, most of them belonging 
to the genus Lutzomyia. The abundance and diversity of these vectors 
in Panama is high with about 76 described species. However, only six 
of these species feed on human blood frequently (anthropophilic), and 
therefore have been considered important vectors. Little is known about 
the infection rates with confirmed Leishmania species in these putative 
vectors and even less in those considered zoophilic vectors, although the 
latter are abundant in many foci of transmission. In this study, sandflies 
were collected using light traps HP inside and around 24 houses from 
Trinidad de Las Minas, a rural community where CL transmission is 
high. More than 5,600 sandflies were collected. The most abundant 
anthropophilic especies were Lu. panamensis (967), Lu. gomezi (1,146) 
and Lu. trapidoi (1,151). Among the zoophilic vectors, Lu. dysponeta 
(490) and Lu. triramula (1,150) were the most frequently species found. 
Female sandflies were pooled in 5 to 10 individuals per species. Leishmania 
infection and species discrimination was performed by ITS-1 and kDNA 
PCR and by HSP70 PCR-RFLP and sequencing analysis respectively. The 
results confirm the high infection rate with L. (V.) panamensis in the 
anthropophilic vectors, predominantly Lu. trapidoi. Interestingly, it was 
also demonstrated the infection in the zoophilic Lu. triramula and Lu. 
dysponeta pools. This is the first molecular detection and identification 
of L. (V.) panamensis within naturally infected Lu. triramula and Lu. 
dysponeta from an endemic focus of CL in Panama. This finding concluded 
that Lu. triramula and Lu. dysponeta are susceptible to L. (V.) panamensis 
infection and suggest that more attention should be paid to zoophilic 
sandflies vectors regarding the ecoepidemiology of CL.
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EFFECT OF GEOGRAPHICAL DIFFERENCES, TRYPANOSOMA 
CRUZI INFECTION AND BLOOD MEAL ON MICROBIOME OF 
TRIATOMA INFESTANS
Sandra Mendoza Guerrero1, Katty Borrini Mayori2, Renzo S. 
Salazar Sanchez2, Sujata Balasubramanian1, Carlos Condori Pino2, 
Alexandra C. Willcox1, Jonathan J. Juliano1, Steven R. Meshnick1, 
Robert H. Gilman3, Michael Z. Levy4, Natalie M. Bowman1
1University of North Carolina Chapel Hill, Chapel Hill, NC, United States, 
2Universidad Peruana Cayetano Heredia, Arequipa, Peru, 3Johns Hopkins 
Bloomberg School of Public Health, Baltimore, MD, United States, 
4University of Pennsylvania, Philadelphia, PA, United States
The protozoan parasite Trypansoma cruzi causes Chagas disease, which 
is considered one of the neglected tropical diseases by the WHO. Chagas 
disease is primarily transmitted by triatomine bugs, which bites a human 
for a blood meal and defecates near the bite site. Infection occurs when 
the person rubs feces containing the parasite into the bite wound or 
a mucous membrane. We examined the fecal microbiome of Triatoma 
infestans bugs captured in Arequipa, Peru during vector control campaigns 
in 2011 and 2014-2015. Frozen, ethanol-preserved bugs were thawed, 
and fecal contents were expressed onto filter paper. DNA was extracted 
from the fecal spots using a modified phenol chloroform technique. 
Quantitative real time polymerase chain reaction (qPCR) was used to 
test for T. cruzi infection. Blood meal source for each bug was identified 
using conventional PCR targeting a 355-bp segment of the cytochrome 
B gene followed by Sanger sequencing. Sequences were run through 
the BLAST database on the NCBI website to identify the species of the 
bug’s last blood meal. MEGA was used to align sequences and QIIME to 
examine genetic diversity and relatedness between samples. 16S ribosomal 
rRNA was amplified using universal primers and deep sequenced using 
Illumina technology. 90 insect fecal samples were extracted and sent for 
16S sequencing and cytochrome B could be amplified from 58 of those. 
From the samples that amplified cytochrome B 74% (43/58) of those were 
found to have human mitochondrial DNA, 12% (7/58) had various rodent 
DNA, 9% (5/58) had dog DNA and 5% (3/58) had chicken DNA. We will 
compare diversity and composition of triatomine gut microbiome by T. 
cruzi infection status, bug stage, geographic location, and blood meal 
source. These findings may have implications for the development of new 
non-traditional vector control interventions.
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OUTCOMES OF A COMMUNITY INTERVENTIONAL-
EVALUATIVE MODEL FOR NEGLECTED DISEASES IN EAST 
POKOT, KENYA
Grace Grifferty, Richard Wamai
Northeastern University, Boston, MA, United States
Neglected tropical diseases (NTDs) are the primary barriers for low-
income individuals to escape poverty. Population based cross-sectional 
surveys conducted in 2012 and 2013 in East Pokot, Kenya showed high 
seroprevalence of visceral leishmaniasis (VL) with 23 rK39-confirmed 
cases out of 1,324 screened, compounded by high rates of poverty, 
hunger, illiteracy and conflict. This necessitated the need to develop an 
interventional program using community strategies. Focusing on three 
administrative locations in the East Pokot sub-county, the ongoing model 
is comprised of public health education, provision of rapid diagnostics, 
screening and treatment, training of clinicians and community outreach 
workers, environmental control and operations research. Between 2015-
2016, 552 rk39 rapid diagnostic kits (Bio-Rad) were distributed to seven 
health facilities. As a result, 326 individuals were screened for VL, of which 
60 displayed rK39 positive results. A community-based screening of 441 
individuals who meet clinical case-definitions identified 14 rk39-positive 
individuals. Seven coordination meetings were held with national, regional 
and local stakeholders. Ten health workers (laboratory technicians, nurses 
and clinicians) were trained on recognition, treatment, management 
and referral of potential VL cases. Fifteen community health volunteers 
were trained on recognition, referral of suspected VL cases and health 
education. Integrated public health education campaigns on VL and 
trachoma prevention and treatment were conducted in nine villages and 
six schools. Additionally, 200 VL educational posters were distributed to 
nearby schools, churches, health facilities and market areas. Integrated 
mobile clinics reached 516 patients. Vector control activities were 
conducted in five villages. An entomology assessment was conducted 
to investigate the distribution of the sandfly vector and the relationship 
between the ecology and socio-cultural context impacting disease. A 
mixed model for research and community-based interventions can be a 
successful approach in impacting NTDs in hard-to-reach populations.
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PREDICTORS OF CHAGAS INFECTION AMONG INDIGENOUS 
COMMUNITIES IN THE SIERRA NEVADA DE SANTA MARTA IN 
COLOMBIA
Gabriel Parra-Henao1, Kathryn Colborn2, Andrés F. Henao-
Martínez2
1Red Chagas Colombia, Centro de Investigación en Salud para el Trópico 
(CIST), UCC, Santa Marta, Colombia, 2University of Colorado Denver, 
Aurora, CO, United States
Chronic Chagas cardiomyopathy is the main contributor to mortality in 
endemic regions and is caused by the protozoan parasite Trypanosoma 
cruzi. Many factors affect the susceptibility to the infection, including 
environmental, genetic, parasite-driven and vector-mediated. However, 
additional clinical features contribute to the determination of infections, 
and the aim of this study was to rank the importance of these factors for 
classifying participants as Chagas positive or negative in an indigenous 
community in Sierra Nevada de Santa Marta, Colombia. A cross-sectional 
case-control study was implemented, with 232 patients with positive 
dual Chagas serologies and 261 negative serologies enrolled. Among 
study participants residing in areas with greater than 10% infestation by 
Triatoma dimidiata (TD), 64% were positive for Chagas disease compared 
to 46% in areas with less than 10% infestation (chi-square p<.001). 
Variables associated with positive Chagas serologies were chest pain (37% 
vs. 18%, p<.001), paroxysmal nocturnal dyspnea (PND) (20% vs. 8%, 
p=0.02), syncope (24% vs. 9%, p<.001), edema (20% vs. 9%, p=0.05) 
and abnormal EKG (28% vs. 17%, p=.02). Participants with Chagas 
positivity were significantly older than participants that were negative 
for Chagas (33 years vs. 25 years, respectively, p<.001). Random forest 
classification was implemented by fitting 500 bootstrap aggregated trees 
with 5 variables randomly chosen among a list of 16 possible at each 
node. The top five variables according to the mean decrease in accuracy 
were infestation by TD, age, chest pain, syncope and PND. The top five 
variables with respect to mean decrease in Gini were age, infestation by 
TD, chest pain, syncope and edema. Abnormal EKG was in the top 10 
for both importance measures. Older age, higher infestation of TD, chest 
pain, PND, edema, syncope and abnormal EKG are important indicators 
of potential Chagas infection in this region. These findings highlight the 
critical importance of vector-driven factors for infection rate and useful 
and practical clinical variables that can increase the pre-test probability of 
Chagas infection in low-resource settings.
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LONGITUDINAL CHANGES IN VECTOR BORNE DISEASE 
PREVALENCE IN A UNITED STATES DOG POPULATION
Angela J. Toepp1, Mandy Larson1, Tara Grinnage-Pulley1, 
Carolyne Bennett1, Michael Anderson1, Hailie Fowler1, Jill Saucier2, 
Jesse Buch2, Ramaswamy Chandrashekar2, Christine Petersen1
1The University of Iowa, Iowa City, IA, United States, 2IDEXX Laboratories, 
Inc., Westbroook, ME, United States
Zoonotic vector-borne diseases, such as Lyme disease, have increased 
in prevalence in both animals and humans over the past decade. While 
these diseases spread due to various factors, little is understood about 
the progression of these diseases over time in animals with other co-
morbidities, such as leishmaniasis. Within a cohort of approximately 600 
dogs enrolled in a phase-III clinical trial of an experimental vaccine for 
leishmaniasis, a subset of 200 dogs were included in a longitudinal study 
to assess long term changes in ehrlichiosis, anaplasmosis, borreliosis, 
and heartworm infection status and to determine if there is a causal 
relationship between these comorbid infections and presentation with 
clinical leishmaniasis. The cohort included dogs from the Western, 
Midwestern, Eastern, and Southern regions of the United States. Dogs 
were tested by serology and PCR both pre- and post-primary vector 
season. Diagnostics used to assess these changes in vector borne diseases 
included the IDEXX SNAP® 4Dx® Plus Test and PCR to identify specific 
species of Anaplasma, Ehrlichia, Borellia and Dirofilaria immitis (dog 
filarial heartworm). At 6 months, a small geographic subset was also 
assessed for acute infection with Anapaslma phagocytophilum, Anaplasma 
platys, and Ehrlichia canis. All dogs were evaluated for clinical signs of 
erhlichiosis, anaplasmosis, Lyme disease, and heartworm at enrollment and 
at 6 months via physical examination. Additional information, including 
information regarding each dog’s age, sex, Leishmania status (combination 
of PCR, serology, and clinical signs), and leishmaniasis vaccination 
status were assessed to determine how vector borne comorbidities 
affect progression of leishmaniasis in a dog population endemic for 
leishmaniasis. Initial results from trial enrollment indicated that 100% 
of dogs symptomatic for leishmaniasis and 65% of asymptomatic dogs 
had a co-infection with at least one of four other vector-borne diseases. 
This prospective cohort study will help to better understand the potential 
causal relationship between co-infection with vector borne diseases and 
progression of leishmaniasis.
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SERIAL EVALUATIONS OF THE PARASITE LOAD OF 
LEISHMANIA (VIANNIA) SPECIES BY QPCR (QUANTITATIVE 
POLYMERASE CHAIN REACTION) OF NATURAL INFECTED 
WILD AND SYNANTHROPIC RODENTS FROM AN ENDEMIC 
AREA OF SOUTH FOREST ZONE OF PERNAMBUCO, BRAZIL
J. F. Marinho-Junior1, J. F. Lima1, L. P. Brito1, A. W. Carvalho1, F. 
G. Carvalho1, M. P. Cavalcanti1, J. J. Shaw2, O. Courtenay3, S. 
Brandão-Filho1
1Centro de Pesquisas Aggeu Magalhães, Recife, Brazil, 2Instituto de 
Ciencias Biomedicas, Sao Paulo, Brazil, 3Warwick University, Coventry, 
United Kingdom
This study was undertaken to evaluate parasite levels of Leishmania 
( Viannia) species in wild and synanthropic rodents from an endemic 
American Cutaneous Leishmaniasis (ACL) foci in the South Forest Zone 
of Pernambuco, Brazil and assess their importance in the enzootic cycles. 
Wild and synanthropic rodents were captured tagged released and 
recaptured between May 2012 and August 2014. L. (Viannia) infections 
were evaluated by qPCR of skin and blood samples. Xenodiagnosis 
was performed with Nyssomyia. whitmani and Lutzomyia longipalpis. 
A total 603 rodents were marked with microchips. 40.6% (245/603) 
were Nectomys squamipes, 24.5% (148/603) were Rattus rattus,13.8% 
(83/603) were Necromys lasiurus. Of these 186 animals were monitored 
at 394 recaptures (Recapture 1 (R1) = 186, R2 = 97 R3 = 52 R4 = 27 R5 
= 18, R6 = 6, R7 = 3, R8 = 2, R9 = 2 and R10 = 1). 29.2% (176/603) 
showed natural L. (Viannia) infections. The infection rates determined by 
qPCR were as follows: N.squamipes 43.8%, N.lasiurus 30.1%, R.rattus 
16.2%, Oxymycterus angulares 16.3%, Holochilus sciureus 25%, Akodon 
arviculoides 9.4%. The infections in Rattus rattus – a synanthropic 
rodent – was 4.2%, 54.2% in plantations and 41.7% in houses. The 
only species recaptured 5 times was N. squamipes. The parasite load of 
rodents during recaptures (0- 50060.71 fg DNA) and remained high being 
highest during October and November 2012 and June 2013 and January 
2014. Parasitamia fell in animals kept in the laboratory. There was no 
difference in xenodiagnoses positivity between the two sand fly species 
nor was there a positive association between parasite load and positive 
xenodiagnoses. In conclusion, the results reinforce the hypothesis that the 
enzootic is maintained in a mosaic rodent species and that parasitemia 
levels are maintained by re-infections. The presence of infected R.rattus 
in plantations and houses strongly supports peri-domestic transmission, 
especially as Ny. whitmani populations are highest in these niches. We 
consider that the detected infections were L.(V.) braziliensis as this species 
has previously been isolated from wild animals, sand flies and man in this 
very same area.
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ESTIMATING THE COSTS AND COST-EFFECTIVENESS OF 
EARLY DIAGNOSIS AND TREATMENT OF CHAGAS DISEASE 
IN COLOMBIA
Zulma M. Cucunubá1, Elisa Sicuri1, Diana Díaz2, Maria-Gloria 
Basáñez1, Pierre Nouvellet1, Lesong Conteh1
1Imperial College London, London, United Kingdom, 2Red Chagas 
Colombia, Bogotá, Colombia
Chagas disease still remains an important public health problem in Latin 
America. Early stage treatments for curbing the progression of the disease 
have proved effective. However, access to Chagas disease diagnosis and 
treatment still remains very low in most endemic countries. In Colombia 
it is estimated that 5 million people are at risk of acquiring the infection, 
436,000 people are already infected and 30% of these are prone to 
develop heart complications, yet access to diagnosis is estimated at <1% 
of the at-risk population. In Colombia the costs and cost-effectiveness of 
preventive and treatment strategies have not been quantified. We estimate 
the unit costs of (i) preventing Chagas by mass screening school-aged 
children and (ii) treating inpatient and outpatient episodes of those with 
Chagas (according to disease stage). Costs are presented in 2014 USD and 
based on (i) primary data collected from a provider perspective at national, 
departmental and municipality levels; (ii) in-depth interviews from Ministry 
of Health officials and municipal and departmental secretaries of Health 
in Boyacá, Casanare, and Santander and, (iii) a third-payer perspective, 
using the National Registry of Health Services between 2008 and 2014 
for 7,227 patients. Having calculated unit cots as median and interquartile 
range (IQR), cost-effectiveness is modelled using the authors’ previously 
developed burden of disease model, to estimate the incremental cost per 
DALY averted by scaling up mass screening. Early diagnosis was costed 
at $18 (IQR: 4-46) per school-child screened. Average treatment cost per 
patient per year was estimated at $29 (IQR: 15- 94) for mild Chagas and 
$211 (IQR: 104-541) for severe Chagas. On average a hospital admission 
for a patient with a primary diagnosis of Chagas cost $340 (IQR: 310-882, 
and maximum $16,685). However, outpatient clinic services, (doctor visits 
and ambulatory procedures) were the main cost driver, at 86% of total 
Chagas treatment costs. Preliminary modelling results suggest that mass 
screening for Chagas amongst school-aged children is cost-effective in a 
variety of epidemiological contexts.
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UNDERSTANDING LONG-TERM CYCLES OF VISCERAL 
LEISHMANIASIS IN BIHAR
Rinki M. Deb, Michelle C. Stanton, Geraldine M. Foster, Michael 
C. Coleman
Liverpool School of Tropical Medicine, Liverpool, United Kingdom
Visceral leishmaniasis (VL) is a vector-borne disease of public health 
importance in India, with the highest burden of disease in the states of 
Bihar, Jharkhand, West Bengal and Uttar Pradesh. VL is currently targeted 
for elimination by 2017; the primary interventions used for elimination 
are indoor residual spraying, active case detection and treatment. 
Historically the disease trend in India has been regarded as cyclical with 
case resurgence characteristically occurring every 15 years. However, the 
cause of this pattern remains unclear and as the Bihar VL programme 
nears the elimination target, explaining previous trends to use within 
predictive tools to avoid future epidemics has become essential. To 
interpret observed cyclical trends, annual climatic indicators including 
rainfall, temperature and humidity over time periods known to influence 
disease and vector trends over the year were compared with annual VL 
case incidence data. Rainfall was found to have a strong association with 
annual VL case patterns during the monsoon season (June to September) 
(p=0.0383) and prior to sand fly peaks (February to May, September and 
October) (p=0.0253). Whilst annual rainfall was also found to have a close 
association with annual case incidence (p=0.0398), rainfall during the 
sand fly peaks (March to June, October and November) was not significant 
(p=0.0911). No association between humidity or temperature and VL 
incidence was detected (all values p=>0.05). The VL programme in Bihar 
has made significant progress in recent years, adopting improved practices 
for vector control, diagnostics and treatment strategies: changing from 
DDT and stirrup pumps to alpha-cypermethrin and hand compression 
pumps, introduction of the rk39 test and wide-scale availability of 
amphotericin B. Such concerted efforts may lead to short term success, 
however to achieve and sustain elimination, a better understanding of 
external causative factors is required.
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CHAGAS DISEASE PREVALENCE AND RISK FACTORS IN 
WORKING DOGS ALONG THE TEXAS-MEXICO BORDER
Alyssa Meyers1, Marvin Meinders2, Sarah Hamer1
1Department of Veterinary Integrative Biosciences,Texas A&M University, 
College Station, TX, United States, 2Office of Health Affairs, Department of 
Homeland Security, Washington, DC, United States
Chagas disease is a neglected tropical disease caused by the protozoan 
parasite Trypanosoma cruzi and transmitted by hematophagous triatomine 
vectors. Chagas disease is estimated to affect 6 million people throughout 
Latin America and is increasingly recognized in humans and dogs across 
the southern U.S., where studies have found that exposure of shelter 
and stray dogs ranges from 3.6-22.1%. Our objective was to assess the 
prevalence and distribution of canine Chagas disease in dogs along the 
Texas-Mexico border, a suspected focus for local transmission of the 
parasite. Department of Homeland Security (DHS) working dogs play 
important security roles including detection of narcotics and concealed 
humans, and may be at high risk due to prolonged work outdoors in 
borderland regions with established kissing bug populations. From 
fall 2015 to summer 2016, we collected blood samples from dogs in 
five different geographical management areas, including dogs along the 
geopolitical border as well as north of the border. Canine plasma was 
screened for anti-T. cruzi antibodies by rapid immunochromatographic 
serological tests, and positivity was confirmed by indirect fluorescent 
antibody testing and an independent immunochromotagraphic assay. To 
test for active infection, buffy coat samples were tested by qPCR to amplify 
T. cruzi satellite DNA. The preliminary results (n=528) indicate over 11.9% 
[9.2, 14.7] of dogs are positive for anti-T. cruzi antibodies by two or more 
serology assays, and parasite DNA was detected in three blood samples. 
Seropositivity did not differ across age, sex, breed, geographic location 
or canine discipline. Ongoing work aims to track canine infection over 
time in relation to clinical status and vector occurrence. Understanding 
the epidemiology of Chagas disease along the border is a prerequisite for 
implementing vector control measures to protect the health of not only 
these high value working dogs, but also local human populations.
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EPIDEMIOLOGICAL EVIDENCE OF CANINE VISCERAL 
LEISHMANIASIS IN IÑAPARI-PUERTO MALDONADO, PERU, 
BORDER WITH BRAZIL AND BOLIVIA
Gloria Sonia Minaya - Gomez1, André Reynaldo Santos Périssé2, 
Fabiano Borges Figueiredo3, Nyshon M. Rojas Palomino1
1Instituto Nacional de Salud, Lima, Peru, 2Fundação Oswaldo Cruz, Rio de 
Janeiro, Brazil, 3Escola Nacional de Saúde Pública Sergio Arouca, Rio de 
Janeiro, Brazil
Visceral Leishmaniasis (VL) is lethal when it is not detected and treated 
promtly. In Latin America, it is caused by Leishmania (L.) chagasi being 
endemic in 11 countries such as Colombia, Bolivia and Brazil, neighbouring 
countries of Peru, where still not reported cases of LV. The aim of this 
study was to verify the presence of epidemiological risk factors involved in 
the transmission of LV at Iñapari locations, border district with Brazil and 
Bolivia. An exploratory cross-sectional descriptive study was conducted 
in two stages: i) Serological search using the Inmunocromatográfico Dual 
Path Platform and Indirect Immunofluorescence tests, to detect specific 
365
astmh.org
antibodies against L. (L) chagasi in canine population of: a) Iñapari, urban 
locality b) Villa Primavera, rural location, c) Belgium, native rural location; 
ii) entomological survey with CDC traps and taxonomic identification with 
Young & Duncan’s keys. Data and clinical signs of dogs were recorded 
in a Veterinary Protocol Field. We sampled 134 dogs, detecting specific 
antibodies against I in 7/134 (5.22%) of the population in study; the 
percentage distribution by localities was 2/28 (7.14%) for Belgium, place 
where it was observed a close coexistence between the settlers and their 
similar Brazilian beyond right of the Acre River; 4/87 (4.6%) for Iñapari and 
1/19 (5.26%) in Villa Primavera; general clinical condition was fair to poor 
with eczematous pictures, alopesia and oncinogrifosis in 12% of dogs. 
Sampling of sand flies were captured in the three locations highlighting 
the identification of Lutzomyia nevesi, belonging to Lu verrucarum group, 
near Lu. evansi, vector of LV. This is the first study of LV performed in Peru, 
in which we bring a prevalence of 5.22% for canine visceral leishmaniasis 
in Iñapari, district border with Brazil and Bolivia; this finding, is significant 
because up to now Peru is considered to be a country free of LV. Therefore 
it is recommended to implement epidemiological surveillance studies in 
search of the vector and the etiologic agent of the LV in high risk living 
borders in Peru, in order to control the spread of LV into new geographic 
areas in Latin America.
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THE IMPACT OF TEN-VALENT PNEUMOCOCCAL CONJUGATE 
VACCINE (PCV10) ON STREPTOCOCCUS PNEUMONIAE 
NASOPHARYNGEAL CARRIAGE RATE: PHENOTYPIC AND 
GENETIC DIVERSITY OF ISOLATES FROM VACCINATED 
CHILDREN IN ADDIS ABABA, ETHIOPIA
Wondewosen Tsegaye Sime1, Abraham Aseffa2, Sara Browall3, 
Eva Morfeldt4, Yimtubezenash Woldeamanel5, Birgitta Henriques-
Normark Henriques-Normark3
1Saint Paul’s Hospital Millennium Medical College, Addis Ababa, Ethiopia, 
2Aramuer Hansen Research Institute, Addis Ababa, Ethiopia, 3Karoliniska 
Institutet, Stockholm, Sweden, 4Public Health Agency, Stockholm, Sweden, 
5Addis Ababa University, Addis Ababa, Ethiopia
Streptococcus pneumoniae (Pneumococcus) among the most 
important human pathogens, with high morbidity and mortality rates. 
Nasopharyngeal colonisation is the necessary first step in the pathogenesis 
of associated invasive pnuemococcal diseases. Ethiopia, introduced the 
ten-valent pneumococal conjugate vaccine (PCV110) since October, 
2011, there is nevertheless lack of adequate baseline information on 
epidemiological factors for subsequent impact assessment. The aim 
of this study was to determine phenotypic and genotypic diversity 
nasopharyngeal isolates of Streptococcus pneumoniae. A total of 789 
newborn babies were enrolled at the age of six weeks when they came 
for the first PCV10 vaccine, and 206 were re-sampled at the age of nine 
months and 201 at two years after final dose of PCV10. Nasopharyngeal 
swabs were taken for bacteriological analysis before vaccination at 
the age of six weeks, and after completion at the age of nine months 
and two years. Isolates were tested for commonly used antibiotics by 
disc diffusion method and those that isolates showed resistance for 
penicillin and erythromycin the minimum inhibition concentration were 
determined by E-test A total of 325 pneumococcal isolates were serotyped 
and characterized by Pulsed Field Gel Electrophoresis and 12 isolates 
were analyzed by multilocus sequence typing. The carriage rate of S. 
pneumoniae at the age of six weeks, nine months and two years was 
26.6%, 56.8% and 47.6% respectively. A total of 61 serotypes of S. 
pneumoniae were identified from 325 isolates, and 6A, 11A, 15B, 23F,15A 
and 19F dominated in decreasing order. The proportion of serotypes 
covered by PCV10 vaccine among the isolates at 6 weeks and 9 months 
were 20.2% and 11.1% respectively. Molecular typing further showed 
a presence of high genetic diversity.The antibiotic test indicated that 
resistance rates were ranging from 4.3% for chloramphenicol to 27.7% 
for Trimethoprim/sulfamethoxazole. In conclusion, this study highlights 
the presence of very diverse serotypes in the country, and PFGE and MLST 
result indicates case of a possible capsular switching event.
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ASSESSING THE BURDEN OF STIGMA AMONG 
TUBERCULOSIS PATIENTS IN A PASTORALIST COMMUNITY IN 
KENYA
Grace W. Mbuthia1, Charles Olungah2, Tom Ondicho2, Henry 
Nyamogoba1
1Moi University, Eldoret, Kenya, 2University of Nairobi, Nairobi, Kenya
Tuberculosis (TB) epidemic is one of the important global humanitarian 
and development challenges. Stigma associated with TB has been termed 
as a barrier to prompt diagnosis and treatment compliance. Although TB 
stigma is recognised as a serious problem, it has been difficult to describe 
the magnitude and therefore the public health importance of the problem 
due to lack of quantitative measures of stigma in the African context. Due 
to lack of an instrument to measure TB stigma in Kenya at the time of our 
study, we examined the adaptability of the TB stigma scales previously 
developed and validated in Thailand. The purpose of this study was to 
assess and quantitatively measure TB-related stigma as well as identify 
factors associated with it among patients in rural Kenya. This was a mixed 
method study. Data were collected using questionnaires, four focus group 
discussions and ten patient’s narratives. A questionnaire containing socio-
demographic characteristics and scales measuring perceived TB stigma 
and experienced/felt TB stigma, was administered to 220 patients on 
TB treatment in the period between July-December 2015. Assessment 
of psychometric properties of the scales included basic statistical tests, 
evaluation of Cronbach’s alpha and factor analysis. Multiple linear 
regressions were performed to determine factors associated with higher 
TB stigma scores. The study showed that internal consistency reliability 
coefficients were satisfactory with Cronbach alphas of 0.87 and 0.86 for 
the 11-item and 12-item scale. The investigation revealed that experienced 
TB stigma was high and symptoms similar to those of AIDS, as well as 
fear of infection through casual contact, such as eating with friends and 
touching others were significant determinants of TB stigma. Low level 
of education (mean difference of 1.85; 95% CI: 0.09, 3.62) and female 
gender (mean difference of 3.61; 95% CI: 2.11, 5.11) were significantly 
associated with higher stigma scores while age, marital status, occupation 
and the patient’s religion were not. There is need to implement stigma 
reduction interventions to mitigate the impact of stigma and improve TB 
program outcomes.
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PREVALENCE OF PNEUMOCOCCAL CARRIAGE AND 
ANTIMICROBIAL SUSCEPTIBILITY AMONG CHILDREN 
TARGETED BY VACCINATIONS PROGRAM IN BURKINA FASO
Ouangraoua Soumeya1, Issaka Zongo2, Yves Daniel Compaore2, 
Halidou Tinto2, Daniel Chandramohan3, Jean-Bosco Ouedraogo2, 
Brian Greenwood3
1Centre Muraz, Bobo Dioulasso, Burkina Faso, 2Institut of Research in 
Health Sciences (IRSS), Bobo Dioulasso, Burkina Faso, 3London School of 
Hygiene & Tropical Medicine, London, United Kingdom
In Western Africa Pneumococcus is the most common pathogen isolated 
in purulent meningitis. In Burkina Faso the fatality rate remains high (up 
to 46%) among Pneumococcus infected patients treated with Penicillin 
or ceftriaxone which are the most common drugs used in this country. 
This study aims to describe the prevalence of pneumococcal carriage and 
antimicrobial susceptibility among children targeted by pneumococcal 
vaccinations program in Burkina Faso. The data were collected during 
the baseline assessment of an interventional cluster randomized 
controlled study (SMC-AZ project) evaluating the impact of Sulfadoxine-
Pyrimethamine (SP)+Amodiaquine (AQ) combined with azithromycin 
(Z) on children mortality rate years in the district of Hounde (located in 
the Western Region of Burkina Faso). In August 2014 nasopharyngeal 
swabs were collected among 430 children aged 0-5 years old before they 
have been randomized to receive either “Sulfadoxine-Pyrimethamine 
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(SP) + Amodiaquine (AQ) combined with azithromycin (Z)” or “SP + 
AQ + placebo”. We used pneumococcal positive cultures to determine 
resistance profile. The pneumococcal identification was made from 
morphology and conventional characterization methods. (Azythromycin, 
Oxacillin, Ceftriaxone, Norfloxacin, Vancomycin, Gentamicin, Erythromycin. 
Resistance to penicillin and macrolides will be confirmed by E-test strips. 
Among 430 nasopharyngeal specimens collected, 189 (43.96 %) had 
positive cultures of pneumococcus. The prevalence of pneumococcal 
resistant strains was 26.46 % (16/189) and 1.06% (2/189) for penicillin 
and ceftriaxone respectively: This resistant prevalence for azithromycin 
was 4.23% (8/189). In conclusion, due to the emergence of penicillin 
resistance as shown by our study, ceftriaxone becomes the most suitable 
antibiotic for the treatment of pneumococcal infections. However the 
presence of Pneumococcal strains resistant to ceftriaxone highlights the 
need to closely monitor this cephalosporin antibiotic.
1168
EFFECT OF OVEREXPRESSION OF MYCOBACTERIUM 
TUBERCULOSIS RPSA PROTEIN IN MOLECULAR MECHANISM 
OF RESISTANCE TO PYRAZINAMIDE IN M. SMEGMATIS
Ricardo Antiparra, Patricia Sheen, Mirko Zimic
Universidad Peruana Cayetano Heredia, Lima, Peru
Tuberculosis remains a major cause of illness and death worldwide causing 
1.6 millions of deaths annually, being exacerbated by the epidemic co-
infection of HIV-TB and the emergence of multidrug-resistant strains and 
extremely resistant in developing countries like Peru. Pyrazinamide (PZA) is 
one of the most important drugs used in the combined anti-tuberculosis 
therapy, drug that is used as a first option to treat Tuberculosis. After 
the drug enters Mycobacterium tuberculosis (MTB) is hydrolyzed by the 
pyrazinamidase to the bactericidal molecule, pyrazinoic acid (POA). A 
recent study identified a target of pyrazinoic acid, ribosomal protein 
S1 (RpsA). RpsA is a protein involved in the process ribosomal trans-
translation, which has been associated with bacterial survival in stress 
conditions, nutrient starvation and virulence. Despite its importance, 
some of PZA action mechanism involved are still poorly understood. M. 
smegmatis presents highly POA active efflux pumps, 900 times faster 
than M. tuberculosis, largely explaining part of their natural resistance 
to PZA. To further understand M. smegmatis PZA action mechanism, we 
evaluate the role of M. tuberculosis-RpsA overexpression in M. smegmatis. 
To evaluate this effect, M. tuberculosis-RpsA recombinant protein was 
expressed in M. smegmatis system, followed by a PZA- drug susceptibility 
test using the minimum inhibitory concentration. Our results showed a 
phenotypic change from naturally resistant M. smegmatis (MIC: > 15 
mg/ml) to sensitive (MIC: 0.468 mg/ml). This evidence suggests that M. 
tuberculosis-RpsA proteins, which are part of ribosomes might be binding 
POA in M. smegmatis, therefore inhibiting trans-translation system and its 
viability.
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TB OR NOT TB? A MODEL FOR INTEGRATING 
PARAGONIMIASIS SURVEILLANCE AND CONTROL WITH 
TUBERCULOSIS CONTROL PROGRAM
Vicente Belizario1, Manuel Jorge1, Janice V. Ng1, Myra Mistica1, 
Hilton Lam1, Lenny Joy Rivera2, Maria Reiza Anino2, John Paul 
Caesar R. delos Trinos1
1University of the Philippines Manila, Manila, Philippines, 2Department of 
Health Regional Office IX, Zamboanga City, Philippines
Misdiagnosis of paragonimiasis as pulmonary tuberculosis (TB) due to 
similar clinical manifestations results in continuing morbidity and loss of 
productivity. Integration of surveillance and control of paragonimiasis with 
the TB control program may be important especially in co-endemic areas 
to prevent misdiagnosis. This study aimed to describe the prevalence of 
paragonimiasis, TB, and coinfections in six municipalities in Zamboanga 
Region, Philippines using a model for integrating paragonimiasis 
surveillance and control with tuberculosis control program, as well as 
to analyze the cost of implementing the aforementioned model. Active 
surveillance for TB and paragonimiasis was conducted in nine barangay 
clusters, while passive surveillance was implemented in two rural health 
units (RHUs) for at least three months. A simple cost analysis compared 
the cost of implementing the model with the National Tuberculosis 
Control Program (NTP). Four hundred patients were included in the active 
surveillance, seven of whom had paragonimiasis (2%), while three had 
TB (1%). Out of the 54 patients included in the passive surveillance, 
one (2%) had paragonimiasis. A simple cost analysis showed that the 
marginal cost of implementing the model is lower than the average 
cost of implementing the NTP. The study showed that the integration of 
surveillance and control of paragonimiasis with the TB control program 
is feasible and contributed in describing new paragonimiasis foci, as 
well as finding and treating misdiagnosed paragonimiasis and TB cases. 
Optimization of the model and scaling up of its implementation are 
recommended prior to its proposed integration with NTP.
1171
TUBERCULOSIS OUTBREAK INVESTIGATION IN A COLONY 
OF AOTUS MONKEYS: DIAGNOSIS, EPIDEMIOLOGY AND 
CROSS-SECTIONAL RANDOMIZED SCREENING USING 
ANTIBODY AND WHOLE-BLOOD IN VITRO INTERFERON-γ 
RELEASE TESTING
Nicanor Iii Obaldia1, Marlon Nuñez2, Santiago Montilla2, Camilo 
Marin2
1ICGES/Harvard T.H. Chan School of Public Health, Boston, MA, United 
States, 2Instituto Conmemorativo Gorgas de Estudios de la Salud (ICGES), 
Panama, Panama
Tuberculosis (TB) caused by Mycobacterium tuberculosis (MTB) is a 
devastating and terminal disease in non-human primates (NHPs). Regular 
TB screenings using the intradermal tuberculin test (TST), despite its low 
specificity, have been the mainstay of TB surveillance and control in NHPs. 
However, the lack of a reliable source of old tuberculin has hampered 
TB screening programs in NHP colonies around the world. Historically, 
Aotus monkeys have been considered less susceptible to TB than Old-
World NHPs. Here we present the diagnosis and epidemiology of a TB 
outbreak in a colony of ~400 Aotus monkeys at The Gorgas Memorial 
Institute in Panama during the first half of 2015 that killed 7 animals 
and the results of two cross-sectional randomized TB screening studies, 
using antibody (Ab) and IFN- γ release assay based testing, eight years 
apart. The outbreak started on January 6th, 2015, with the death of a 
lab-bred 9 year-old 600 g male splenectomized Aotus that died with 
signs of a chronic wasting disease (index case). M. kanssasi was isolated 
from a lung tubercle of this animal. Between January-June, 2015, six 
additional TB cases occurred, three confirmed with MTB isolation and 
three suspicious by histopathology. Control measures included, quarantine, 
disinfection and TST screening of all personnel. In the Ab based screening 
study of 2008, only one animal out of 50 tested, reacted weakly to the 
Immunochromatographic PrimaTB STAT PAK® assay. This reaction was 
considered a false positive. In the second study in 2016, 34/34 animals of 
a total adult population of 313 Aotus resulted negative in the Primagam® 
IFN-γ release assay. TST screening was negative in all animal handlers after 
the outbreak. The source of infection was not identified, though human 
to monkey transmission is suspected. Genotyping of MTB isolates and 
a screening program based on the Primagam® IFN- γ release assay are 
underway. This is considered to be the first Aotus TB outbreak reported at 
the Gorgas Memorial Institute Aotus monkey colony since its inception in 
1976.
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DETERMINATION OF PLASMA LEVELS OF LEVOFLOXACIN BY 
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY FOR USE 
AT A MULTIDRUG-RESISTANT TUBERCULOSIS HOSPITAL IN 
TANZANIA
Andrew Ebers
University of Virginia Department of Infectious Disease, Charlottesville, VA, 
United States
Therapeutic drug monitoring may improve multidrug-resistant tuberculosis 
(MDR-TB) treatment outcomes. Levofloxacin demonstrates significant 
individual pharmacokinetic variability. Thus, we sought to develop and 
validate a high-performance liquid chromatography (HPLC) method 
with ultraviolet (UV) detection for levofloxacin in patients on MDR-TB 
treatment. The HPLC-UV method is based on a solid phase extraction 
and a direct injection into the HPLC system. Human plasma was loaded 
onto Oasis SPE cartridges, conditioned, washed and eluted. The assay 
parameters of accuracy, precision, recovery and limits of quantification 
were determined using human plasma spiked with known concentrations 
of levofloxacin. This method was then utilized to measure levofloxacin 
concentrations from patients’ plasma samples from a retrospective cohort 
of consecutive enrolled subjects treated for MDR-TB at the national TB 
hospital in Tanzania during 5/3/2013- 8/31/2015. Plasma was collected 
at 2 hours after levofloxacin administration, the time of estimated peak 
concentration (eCmax), after 2 and 4 weeks of treatment. Forty-one MDR-
TB patients had plasma available and 39 had traceable programmatic 
outcomes. Only 13 (32%) patients had any plasma concentration that 
reached the lower range of the expected literature derived Cmax of 8 
µg/mL. In patients with an eCmax ≥ 7.0 µg/mL compared to those with 
eCmax <7.0 µg/mL, the time to sputum culture conversion was 37.6 
± 22.1 days vs. 48.7 ± 26.8 days (p=0.19) but a trend was observed 
in greater proportion of cure in 10 out of 17 (58.8%) vs. 6 out of 222 
(27.3%) (p=0.05). Furthermore, one patient with an eCmax/minimum 
inhibitory concentration (MIC) of only 1.13 µg/ml acquired extensively 
drug resistant (XDR)-TB while undergoing treatment. The HPLC-UV 
methodology for determination of levofloxacin concentrations achieved 
excellent accuracy and reproducibility along a clinically meaningful 
range. The individual variability of levofloxacin concentrations in MDR-TB 
patients from Tanzania supports further study of the application of onsite 
therapeutic drug monitoring and MIC testing.
1173
MOLECULAR CHARACTERIZATION OF CIRCULATING STRAINS 
OF INFLUENZA A BETWEEN 2014-2015 IN EGYPT
Ehab A. Ayoub1, Mustafa Abd AlAziz1, Nirvana N. Yassa1, Samir 
El-Refaay2, Mohamed Genedy2, Amr Kandil2, Gabriel Defang1
1U.S Naval Medical Research Unit-3, Cairo, Egypt, 2Ministry of Health and 
Population, Cairo, Egypt
Influenza viruses are continuously evolving with the potential for new 
subclades with altered antigenicity. Hence, tracking genetic changes 
is crucial for selection of effective vaccine strains, detection of drug 
resistance and determination of virulence markers. Herein, we analyzed 
the hemagglutinin (HA) and neuraminidase (NA) genes of influenza 
A/ H3N2 and H1N1 pdm09 circulating in Egypt during the winter of 
2014/15. Patients were considered to have influenza-like illness (ILI) if 
they met the WHO criteria. Oropharyngeal swabs in viral transport media 
collected from ILI patients from seven sites within Egypt were tested 
by real-time PCR to determine influenza subtypes. Positive influenza 
A samples were inoculated in MDCK cells and representative isolates 
chosen for HA and NA sequencing. Phylogenetic analysis of the HA 
gene obtained from 13 H3N2 viruses showed that nine clustered within 
genetic subgroup 3C.2a, and four clustered within clade 3C.3 with three 
in subgroup 3C.3b. All sequences showed 97.6 - 98.3% nt similarity 
to clade 3C.1 vaccine strain of 2014/15 season (A/Texas/50/2012), and 
98.4 - 98.9% nt similarity to clade 3C.3a 2015/16 candidate vaccine 
strain (A/Switzerland/9715293/2013). Of note, viruses in which HA genes 
clustered within subgroup 3C.3b had three distinct mutations in their 
NA protein (Y155F, D251V, and S315G) that define a distinct cluster with 
other recently collected viruses. The HA gene sequences obtained from 
four Influenza A H1N1 isolates clustered within clade 6B, with a notable 
observation in one sequence of a D222G mutation previously reported 
to be associated with severe disease outcome. The NA gene sequences 
of A/H3N2 and H1N1did not reveal mutations previously reported to be 
associated with resistance to NA inhibitors. Sequence analysis results of 
influenza A/H3N2 revealed that more than 60% of sequences clustered 
within the 2014/15 3C.2a subgroup. Clade 6C clustering was not 
observed among A/H1N1 viruses. Representative influenza A strains 
analyzed during this season remain susceptible to NA inhibitors. We report 
the first observance of a severe disease marker (D222G) among H1N1 
viruses.
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UNDERSTANDING THE IMMUNE RESPONSE TO 
STREPTOCOCCUS PNEUMONIAE FROM VACCINATION AND 
CARRIAGE ON A PROTEOME SCALE
Joseph J. Campo1, Nicholas J. Croucher2, Paul Turner3, Andrea 
Tate4, Tim Le1, Jozelyn Pablo1, Chris Hung1, Andy Teng1, William 
P. Hanage5, Marc Lipsitch5, David Goldblatt6, Mark Alderson4, 
Xiaowu Liang1
1Antigen Discovery, Inc., Irvine, CA, United States, 2Department of 
Infectious Disease Epidemiology, Imperial College London, London, United 
Kingdom, 3Centre for Tropical Medicine and Global Health, Nuffield 
Department of Medicine, University of Oxford, Oxford, United Kingdom, 
4PATH, Seattle, WA, United States, 5Center for Communicable Disease 
Dynamics, Department of Epidemiology, Harvard T.H. Chan School of 
Public Health, Boston, MA, United States, 6Immunobiology Unit, Institute 
of Child Health, University College London, London, United Kingdom
Antigenic diversity presents a challenge for pneumococcal vaccine 
development. Technological limitations have hindered characterization 
of immune responses to the diverse protein repertoires observed within 
pneumococcal populations. Proteome microarrays permit exploration of 
the antibody response against entire proteomes. We profiled IgG responses 
against a S. pneumoniae (Sp) whole cell vaccine (SPWCV) in a Phase I trial 
with 42 U.S. adult participants, and against nasopharyngeal colonization 
in a longitudinally-sampled birth cohort of 63 infants residing in the Maela 
refugee camp near the Thailand-Myanmar border under natural exposure 
to pneumococci. We used the TIGR4 core proteome and 90 isolates from 
Massachusetts, United States to construct a “pan-genomic” Sp whole 
proteome microarray and probed serum samples. Large differences in the 
IgG response to Sp array proteins were reproducible between individuals. 
Protein traits significantly associated with elevated immunogenicity 
included increased length, signal peptides for secretion, and cell surface 
attachment domains. IgG responses to 166 unique Sp proteins increased 
after vaccination with SPWCV, and a dose response was observed. In the 
Maela infant cohort, the antibody kinetic profile against hundreds of Sp 
proteins followed a trend of sharply declining antibody levels between 
birth and 6 months of life, followed by a gradual increase during the 
following 18 months of follow-up. Both variable antigens, including 
zinc metalloproteases and choline binding proteins, and more conserved 
peptidoglycan synthesis machinery and transporters elicited high IgG 
responses. Proteome microarrays can facilitate vaccine development and 
test hypotheses relating to bacterial evolution, population genetics and 
epidemiology.
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EXPANSION AND EVALUATION OF TUBERCULOSIS 
MICROSCOPIC-OBSERVATION DRUG-SUSCEPTIBILITY ASSAY 
(TB-MODS) IN EGYPT, 2014-2015
Hoda Mansour1, A. Hegazy2, Mostafa Maroof1, Erik J. Reaves3
1U.S. Naval Medical Research Unit-3, Cairo, Egypt, 2Ministry of Health and 
Population, Cairo, Egypt, 3Centers for Disease Control and Prevention, 
Cairo, Egypt
Microscopic-Observation Drug-Susceptibility (TB-MODS) assay is a liquid 
culture-based test that detects Mycobacterium tuberculosis and assesses 
isoniazid (INH) and rifampicin (RIF) resistance directly from sputum samples. 
Like Mycobacteria Growth Indicator Tube (MGIT) culture, the method 
markedly reduces growth time compared to solid media and enables 
detection of multidrug-resistant tuberculosis (MDR TB). However, TB-
MODS is less expensive and has produced faster results than MGIT in low-
resource settings. Our objectives were to implement TB-MODS in Egypt 
for routine TB diagnosis and treatment decisions, compare it to MGIT, and 
expand its use in high-TB burden governorates. Between October 2014 
and September 2015, TB-MODS was implemented at the central and three 
high-TB burden governorate laboratories in Egypt where MGIT culture 
and drug susceptibility testing (DST) are used. Test characteristics of TB-
MODS were compared to MGIT using the results of sputum samples from 
presumptive TB patients. There were 521 sputum samples cultured by 
both TB-MODS and MGIT techniques. Compared to MGIT, the sensitivity 
and specificity of TB-MODS in detecting TB was 99.5 % and 97.1%, 
respectfully. The time from specimen processing to DST results was 11.3+6 
days for TB-MODS and 18.9+13.9 days for MGIT (p<0.01). The proportion 
of samples tested by TB-MODS with cultures resistant to INH was 31.0% 
(118/381), RIF was 28.1% (107/381), and both (i.e. MDR TB) was 22.9% 
(86/376). Compared to MGIT, the sensitivity and specificity of TB-MODS in 
detecting resistance to INH was 86.8% and 94.9%, to RIF was 86.5% and 
95.9%, and to both drugs was 88.1% and 95.9%, respectfully. TB-MODS 
appears to be a reliable and more rapid alternative to MGIT for detecting 
TB and performing first-line DST, including for MDR TB, in Egypt.
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THE SPATIAL-TEMPORAL DISTRIBUTION OF ONCOMELANIA 
HUPENSIS ALONG YANGTZE RIVER AFTER IMPLEMENTATION 
OF AN INTEGRATED CONTROL STRATEGY IN JIANGSU, P.R. 
CHINA
Jian He, Wei Li, Jian feng Zhang, Liang Shi, Feng Wu, Kun Yang
Jiangsu Institute of Parasitic Disease, WuXi, China
Using spatial-temporal analysis to explore the distribution and of 
Oncomelania hupensis, the intermediate host of Schistosoma japonicum, 
along Yangtze River under an integrated control strategy in Jiangsu, 
P.R.China,. The density and spatial location of live and infected snails from 
2001 to 2013 were collected in fields. Descriptive analysis and mapping 
were respectively used to detect the changes and distribution of live and 
infected snail in different years. Global and local spatial autocorrelation 
analysis were carried out to find the trend and area of spatial cluster at 
different years. The spatial-temporal scan analysis was used to identify the 
risk area and temporal during the study period. The number and area of 
habitats, densities of live and infected snails were increasing before 2004, 
then went into a rapid decreasing after implementation of an integrated 
control strategy, and went into a relatively slow declining after 2009. 
The distribution map showed the number of high density habitats was 
declining, and the location was transferring from west to east. Global 
spatial autocorrelation showed there were spatial clustering of live and 
infected snails when the density was relatively high at the province scale. 
Local spatial autocorrelation revealed that the number of specific clustering 
area were declining and transferred to the middle reaches of Jiangsu 
province. Two high risk area of live snails located in upper and middle 
reaches of Yangtze river, and one high risk area of infected snail located 
in upper reach. In conclusion, the integrated control strategy was more 
effective in Jiangsu province. Next, more control resource should be settled 
in the middle of Yangtze river, Jiangsu.
1177
THE SEROLOGICAL DIAGNOSIS METHODS OF 
SCHISTOSOMIASIS AT DIFFERENT PREVALENCE: A META-
ANALYSIS
Yao Xin Wang
Jiangsu Institute of Parasitic Diseases, Wuxi, China
Use meta-analysis of diagnostic tests to comprehensive evaluation of 
indirect hemagglutination test (IHA), enzyme-linked immunosorbent assay 
(ELISA) and dipstick dye method (DDIA) in the diagnosis of schistosomiasis 
japonica at different prevalence. Through literature reveiw according with 
the inclusion and exclusion criteria to establish a database, and use Meta-
disc and R software to make Meta-analysis of threshold test, heterogeneity 
test, weighted by the quantitative effect of merger and SROC curve 
fitting, etc. Results A total of 84 papers were included in the final analysis. 
The sensitivity of IHA respectively were 0.84, 0.76 and 0.94 in heavy, 
medium and low endemic areas, and specificity were 0.73, 0.64 and 
0.73; sensitivity of ELISA respectively were 0.88, 0.80 and 0.93 in heavy, 
medium and low endemic areas, and specificity were 0.59, 0.59 and 
0.62; sensitivity of DDIA respectively were 0.93, 0.81 and 0.93 in heavy, 
medium and low endemic areas, and specificity were 0.66, 0.69 and 0.59. 
Weighted sensitivity of IHA, ELISA and DDIA were 0.83, 0.87 and 0.90; 
The weighted specificity was 0.69, 0.60 and 0.62. The areas under the 
curve of SROC respectively were 0.89, 0.96 and 0.92 in the IHA, ELISA 
and DDIA. In conclusion, in different prevalence, there is some differences 
effectiveness of methods for serological diagnosis of schistosomiasis. 
The method of IHA, DDIA and ELISA is relatively high effectiveness in 
low, moderate and severe endemic areas, respectively. The sensitivity and 
specificity of all diagnostic methods of schistosomiasis are required further 
improved.
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A PILOT STUDY ON HUMAN SCHISTOSOMIASIS IN A RURAL 
COMMUNITY OF FIANGA, REPUBLIC OF CHAD
Romuald Isaka Kamwa Ngassam
University of Maroua, Maroua, Cameroon
Schistosomiasis, a water-associated parasitic disease and part of neglected 
tropical diseases (NTDs), still poses a significant public health threat in 
many part of Africa. In recent years there have been increasing national 
control programs against schistosomiasis and other NTDs. This was 
encouraged by the World Health Assembly resolution WHA 54.19. Human 
schistosomiasis is an important public health problem in Cameroon 
and Chad but the control program is only implemented in Cameroon. 
Dacheka (Cameroon) and Fianga (Chad) are 2 neighboring sub-divisions 
located across the border of the 2 countries. People from both sides 
constantly move across the border and this can affect the epidemiology 
of schistosomiasis in both sides. The aim of this study is to assess current 
schistosomiasis situation in villages in the Chadian side and how it might 
impact the situation in Cameroon. Here we present preliminary results 
concerning the parasitological survey and environmental characterization 
on potential transmission sites. This study was conducted in December 
2014 and 5 schools were selected in Fianga, based on the geographic 
localisation. In each school, 50 schools children were randomly selected 
to be part of the survey. Upon receiving approval of parents and local 
authorities, selected children were asked to provide stool and urine 
specimens which were examined using the Kato-Katz and sedimentation 
techniques, respectively. Overall, only Schistosoma haematobium eggs 
were found in urine samples: prevalence of infection of 53.4% ±0.5 and 
an average of 13±23 eggs/20µl of sediment. Prevalence of infections in 
Kiriou, Tchangbele and Deheing were ≥ 50% whereas in Gabra and Kaski 
they were between 10% and 49%. From our investigation we observed 
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that villages were very poor and relied mostly on temporary water bodies 
for their daily activities. In kiriou, population create natural reservoirs to 
retain rainfall water during rainy period to help cultivation during the dry 
season. Urinary schistosomiasis is a real public health problem in Fianga 
and poor life and environmental condition seem to be important factors to 
be considered for future control plan.
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EFFICACY AND DRUG ACTION MECHANISM OF ARTESUNATE 
AND A SYNTHETIC ENDOPEROXIDE COMPOUND N-89, 
AGAINST ADULT STAGE SCHISTOSOMA MANSONI
Emmanuel A. Blay1, Masafumi Yamabe1, Reiko Shimogawara1, 
Akina Hino1, Hye-Sook Kim2, Irene Ayi3, Takashi Kumagai1, Nobuo 
Ohta1
1Tokyo Medical and Dental University, Tokyo, Japan, 2Okayama University, 
Okayama, Japan, 3Noguchi Memorial Institute for Medical Research, Accra, 
Ghana
Treatment and morbidity control of schistosomiasis largely relies on a 
single drug, praziquantel (PZQ), thus creating concerns about the selection 
of resistant worms due to repeated therapy. PZQ is also known to kill only 
adult Schistosoma worms and shows inability to abort early infection or 
prevent re-infection and its lack of prophylactic effect demands the need 
for novel drugs. N-89 a synthetic compound based on the endoperoxide 
structure of artemisinin has been previously shown to have anti-
schistosomicidal effects against S. mansoni in both larvae stages and adult 
stages. In a murine model infected with S. mansoni, oral administration 
of 300 mg/kg of N-89 and artesunate showed significant worm burden 
reduction, hepatomegaly reduction and inhibiting granuloma formation at 
2 weeks post-infection and a significant reduction in fecundity, egg burden 
and a significant reduction in body length for the N-89 treated group at 
5 weeks post-infection. Scanning electron microscopy results revealed no 
tergumental damages suggesting that the drug targets may be internal. 
In vitro assessment of the survivability of S. mansoni worms cultured with 
50 µM to 6.25 µM concentrations in 2-fold dilutions of N-89 and N-251 (a 
derivative of N-89) revealed IC50 values of 6.1±3.6 µM and 10.72±2.5 µM 
respectively. Artesunate however did not have any effects in vitro at the 
same concentrations. These results suggest that N-89 and artesunate may 
be possible drugs for schistosomiasis. This study therefore explores the 
exact biochemical action mechanism related to worm killing and fecundity 
reduction using molecular and immune-chemical techniques.
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DRUG DISCOVERY: IN VITRO EVALUATION OF EXTRACTS 
FROM MEDICINAL PLANT BALANITES AEGYPTIACA (LINN) 
DEL FOR ANTI-SCHISTOSOMA CERCARIAL PROPERTIES
Dzidzo Yirenya-Tawiah1, Daniel Boamah2, Daniel Nukpezah1, 
Kwabena M. Bosompem3, Christian Gordon1, William K. Anyan1, 
Mark Ofosuhene3, Mabel D. Tetteh3, Francis Glah4, Anim 
Amposah1
1Institute for Environment and Sanitation Studies. University of Ghana, 
Legon, Accra, Ghana, 2Center for Plants Medicine Research, Mampong, 
Ghana, Mampong, Ghana, 3Noguchi Memorial Institute for Medical 
Research. University of Ghana, Legon, Accra, Ghana, 4Department of 
Science Laboratory Technology. Accra Polytechnic, Accra, Ghana
Schistosomiasis is a parasitic disease caused by schistosomes which 
manifests mainly in two forms; intestinal schistosomiasis caused by 
Schistosoma mansoni, S. japonicum, S. intercalatum and S. mekongi which 
is associated with bloody stool, and urinary (or urogenital) schistosomiasis 
caused by only S. haematobium with by bloody urine. Schistosomiasis 
continues to persist in many endemic communities with at least 261 
million people need treatment in 2013. Successful control effect would 
largely depend on prevention of cercarial penetration of the human skin at 
the point of water contact. There is scarce information on preventive drug 
that is topically applied to prevent schistosomal cercaria from penetrating 
the human skin. Medicinal plants offer unique platforms for novel drug 
discoveries for treatment and prevention of many diseases including 
Neglected Tropical Diseases. The aim of this work was to screen medicinal 
plant extracts for anti-schistosomal cercaria activities. Aqueous (Aq), 70% 
(70EtoH) and absolute ethanol (Abs) extracts were prepared from Balanites 
aegyptiaca stem-bark and tested against cercariae at concentrations of 
1000 to 10,000 ppm in 24-well culture plate at room temperature. The 
cytotoxic activities of the extracts on CHANG, PC-3 and MCF-7 cell lines 
were assessed by MTT assay. The Aq at 10,000 ppm demonstrated high 
anti-cercarial activity by killing the cercariae (20 to 80/test) within 7 mins 
and up to 36 mins at 1,000 ppm. However, the cercariae incubated with 
deionized water only had a mortality rate of 10.4% even after 240 mins. 
The Abs extract had IC50 values of >1000 µg/ml on PC-3 with 31.76 
and 26.57 on MCF-7 and CHANG cells respectively. While the 70EtoH 
recorded 40.01, 60.80 and 64.25 against PC-3, MCF-7 and CHANG cells 
respectively. The IC50 for Aq were 44.96, 40.90 and 32.45 accordingly. 
While the curcumin control had 4.69, 15.22 and 11.67 against PC-3, 
MCF-7 and CHANG cells respectively. Extracts showed promising anti-
cercarial activities that can be explored further for development of novel 
anti-cercarial drug that could be topically applied on the skin of population 
at risk to prevent cercaria penetration.
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OUTBREAK OF URINARY SCHISTOSOMIASIS IN A SCHOOL 
FOR MIGRANT CHILDREN, GYALLESU WARD, ZARIA, 
KADUNA STATE, NIGERIA. JANUARY 1ST-MAY 15TH, 2015
Aishatu Mamie Sadiq1, Anthony Suleiman1, Aisha Abubakar2, 
Patrick Nguku1
1Nigeria Field Epidemiology and Laboratory Training Programme, Abuja, 
Nigeria, 2Department of Community Medicine, Ahmadu Bello University, 
Zaria, Kaduna State, Kaduna, Nigeria
Urinary schistosomiasis is a disease of poverty that leads to chronic ill 
health more than 700 million people live in endemic areas worldwide. 
The disease infects 240 million people globally with over 50% in African 
countries. School age children in regions with poor sanitation and contact 
with fresh water constitute the majority of cases in endemic areas of 
Nigeria. Urine mapping using rates of blood in urine of school age children 
showed multiple areas of endemicity in Kaduna state. We investigated to 
identify the cause of heamaturia among students and the associated risk 
factors. A descriptive study and a 1:1 unmatched case control study with 
100 respondents were conducted to identify the source of infection. Cases 
were students with a history of visible heamaturia or with possible reagent 
slip for heamaturia residing in the school hostel, 1st January-15th May 
2015. Ten Urine specimens and two water samples from the Galma River 
were sent for laboratory testing. We identified 50 cases (Overall attack 
rate 13.3%, CFR: 0%). Male: female ratio (1:0) between January-June, 
2015. Mean age of cases was 10.2 years ± 1.4 years; mean age of controls 
10.0 years ± 1.3 years. The attack rate was highest among 10-13 year old 
(35%). Compared with controls, the cases did not differ in terms of state 
of origin and environmental exposure. Cases were more likely to Swim in 
the river (odds ratio: 36; 95% CI: 7.3-241.4) and wash with contaminated 
water (OR: 7.4; 95% CI: 2.8-20.0). 30% of 10 Urine specimens tested 
positive for Ova, 50% of 2 water samples from Galma River were positive 
for cercariae of Schistosoma haematobium. The outbreak was confirmed 
to be Urinary schistosomiasis. The risk factors associated with the outbreak 
were: Swimming in the river and washing with contaminated water. We 
provided mass chemotherapy with Praziquantel and albendaxole, health 
education using community health teams and facilitated provision of 
portable water to the school. Findings will be used in mapping endemic 
areas for planned mass chemoprophylaxis, disseminated to stakeholders 
for use in planning public health policy and utilized for health education to 
populations at risk.
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ASSESSMENT OF THREE SCHISTOSOMIASIS ENDEMIC AREAS 
USING KATO-KATZ TECHNIQUE AND ENZYME-LINKED 
IMMUNOSORBENT ASSAY (ELISA) ANTIGEN AND ANTIBODY 
TESTS
Chiqui de Veyra1, Vicente Belizario Jr.2, Alice Alma Bungay3, 
Glenn Sia Su4, Jana Denise Lacuna1
1Neglected Tropical Diseases Study Group, National Institutes of Health, 
University of the Philippines Manila, Manila, Philippines, 2Department of 
Parasitology, College of Public Health, University of the Philippines Manila, 
Manila, Philippines, 3Department of Medical Microbiology, College of 
Public Health, University of the Philippines Manila, Manila, Philippines, 
4Department of Biology, College of Arts and Sciences, University of the 
Philippines Manila, Manila, Philippines
Schistosomiasis is endemic in 12 out of the 16 administrative regions 
of the Philippines and undertaking surveillance to monitor endemic 
areas is necessary. The Department of Health (DOH) Philippines currently 
undertakes surveillance through parasitological examination using Kato-
Katz technique. However, in areas where there is low level of endemicity, 
case detection through Kato-Katz technique may pose a major challenge 
due to the low sensitivity of the test. This study aimed to determine 
the prevalence of schistosomiasis in selected schistosomiasis-endemic 
provinces using Kato Katz technique and ELISA Antigen (Ag) and Antibody 
(Ab) tests. Areas identified as endemic and near elimination level for 
schistosomiasis were purposively selected. School-based collection of stool 
and blood samples was conducted and samples were examined using 
Kato-Katz technique and ELISA Ag and Ab tests, respectively. Results 
showed zero prevalence of schistosomiasis in Davao City, 0.5% in Davao 
del Sur, and 3.6% in Compostela Valley using Kato-Katz technique. Higher 
prevalences of schistosomiasis were observed for Davao City, Davao del 
Sur, and Compostela Valley with 5.0% and 34.4%; 3.0% and 19.2%; and 
14.4% and 56.5% using ELISA Ag and Ab tests, respectively. Results of 
the study showed that the use of Kato-Katz technique in highly endemic 
areas is still helpful in diagnosis of infected individuals. In low endemic 
areas, surveillance of schistosomiasis using ELISA Ab test may provide a 
better evaluation of the transmission status of the infection at population 
level necessary in the policy formulation for appropriate surveillance and 
implementation of control measures. ELISA Ag test, on the other hand, 
may provide more accurate diagnosis of the infection in low transmission 
areas necessary in the treatment of the infection that could contribute 
to the control of transmission of the infection in the community. Further 
studies are needed to support the use of these diagnostic techniques 
in a stratification scheme to be utilized by Schistosomiasis Control and 
Elimination Programs in light of the other strategies being implemented at 
the community level.
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DETERMINING THE IMPACT OF SCHISTOSOMA MANSONI 
INFECTION ON PUBLIC HEALTH IN A HIGH PREVALENCE 
REGION IN REMOTE MADAGASCAR
Stephen Spencer1, James Penney2, Cortland Linder2, 
Hannah Russell2, Anthony Howe2, Andriamahitsisambatra 
Rakotomampianina3, Anjara Nandimbiniaina3, Alain Rahetilahy4
1East Lancashire Hospitals NHS Trust, Blackburn, United Kingdom, 2The 
University of Manchester, Manchester, United Kingdom, 3The University of 
Antananarivo, Antananarivo, Madagascar, 4Ministère de la Santé Publique, 
Madagascar, Antananarivo, Madagascar
Schistosomiasis is widespread in Madagascar but many treatment 
campaigns are unable to reach some of the more rural and remote regions 
of the country. The aims of our research expeditions were to determine 
the prevalence and level of disease burden of schistosomiasis in the 
Marolambo district of Eastern Madagascar (one of Madagascar’s most 
remote regions), to provide treatment for schistosomiasis and initiate a 
health education program. We screened school aged children (five to 
fourteen years of age) for schistosomiasis from six schools along the 
Nosivolo River in Marolambo, using circulating cathodic antigen (CCA) 
testing and Kato-Katz procedures. We found an overall prevalence of 
94% attributed to Schistosoma mansoni infection, and a mean of 482 
eggs per gram of stool. The preliminary results from this study have 
revealed an extremely high prevalence of Schistosoma mansoni infection 
in Marolambo, and high parasite loads are indicative of significant 
disease morbidity. A repeat research expedition in May-June 2016 
aims to assess the impact of schistosomiasis on this remote population 
using anthropometrics, questionnaires, tests for anaemia and assessing 
cardiovascular fitness.
1184
EVOLUTION OF IMMUNOLOGICAL MARKERS OF INFECTION 
WITH SCHISTOSOMA MANSONI IN PATIENTS TREATED WITH 
PRAZIQUANTEL IN THE KOU VALLEY (BURKINA FASO)
Nina Gouba, Jean Bosco Ouedraogo, Sorgho Hermann
Institut de recherche en science de la santé DRO- Bobo-Dioulasso, Bobo-
Dioulasso, Burkina Faso
The parasitic diagnosis of infection with Schistosoma mansoni using the 
Kato-Katz technique lacks sensitivity in zones with low prevalence of 
infection or after chemotherapeutic treatment. The present study aims 
to evaluate the evolution of immunological markers of Schistosoma 
mansoni’s infection in patients following treatment with praziquantel in 
the Vallée du Kou. In 2007, 980 subjects having at least 6 years old have 
been screened at Vallée du Kou (Burkina Faso). Among them, 216 having 
positif S. mansoni stools samples using Kato-Katz test method received 
a single dose of praziquantel of 40mg/kg, and were followed up from 
February 2007 to March 2008. During the screening and at each follow-
up visits (days 45, 3, 6 and 12 months) stools and blood samples were 
collected. Subjects found positive were treated with the same single dose 
of of praziquantel. Kato-Katz test method was used to detect schistosome 
eggs in stools and the ELISA test was used to detect in the serum 
antibodies (IgG, IgM, IgA, IgG1, IgG2, IgG3, IgG4), targeting the antigens 
of schistosome eggs. Results A total of 980 subjects were screened. 
Their mean age was 23,29±19,42. Schistosoma mansoni prevalence in 
stools samples was 22%. This prevalence significantly decreased overtime 
(11,4% at 12 month, p=0.001). We observed a regular and significant 
decrease (p=0.001) of the level of immunoglobulin IgG4. We observed 
a non-significant reduction in the levels of immunoglobulin IgA et 
IgG1. There was a positive linear correlation between parasitic load and 
immunoglobulin IgG4 level before treatment (r=0, 82). During the follow-
up this IgG4 immunoglobulin level was significantly lower in subjects 
having negative Kato-Katz results. In conclusion, the study demonstrated 
a good efficacy of praziquantel in reducing parasitic infection in treated 
patients. Immunoglobulin IgG4 is the best marker associated with the 
therapeutic efficacy of praziquantel in treating S. mansoni and could be a 
possible cure marker.
1185
RELIABILITY OF COMMUNITY HEALTH WORKER REPORTED 
TREATMENT COVERAGE FOR SCHISTOSOMIASIS IN 
WESTERN KENYA-THE SCHISTOSOMIASIS CONSORTIUM FOR 
OPERATIONAL RESEARCH & EVALUATION PROJECT
Rosemary Musuva
Kenya Medical Research Institute, Kisumu, Kenya
Community health workers (CHWs) are key drivers in mass drug 
administration programs (MDA). Although the community-directed 
treatment approach has shown good results in the control of 
onchocerciasis and lymphatic filariasis,some reports from CHW’s treatment 
coverage have in the past been shown to be inaccurate. We compared 
CHW reported and household survey coverage for schistosomiasis 
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to identify factors that may influence CHW reporting. We employed 
CHWs  to conduct community-wide treatment (CWT) in 75 villages 
in western Kenya. A census was done prior to the MDA to collect 
demographic data, and all the treatments were recorded in treatment 
booklets to determine the reported treatment coverage. A household 
survey was carried out to determine the compliance coverage rates.  A 
structured questionnaire was used to determine treatment coverage levels 
as well as levels of drug-related side effects.Twenty-four villages were 
randomly selected for the survey where 1479 households covering 6183 
persons were visited in 2012, 2013 and 2014. The eligible population 
was 5551. Up to 62.9% (53.9-71.9%) reported having been treated 
compared to CHW’s reported coverage of 88.9% (84.2-93.7%) in the 
same villages (P<0.0047). 33.9% reported being absent during the 
treatment with 51.3% reporting that the CHW did not visit their homes 
to offer treatment. More females (50.7%) compared to males (49.2%) 
complied with treatment. Few people declined treatment for fear of side 
effects (5.0%). About 2.5% of the population surveyed reported having 
not heard about the program. Only 1.8% felt they were not sick hence 
didn’t need drugs, while 1.6% reported were pregnant, 1.4% did not 
take drugs for religious reasons, and 0.05% were influenced by rumors. 
Of the total population surveyed, only 25.9% experienced side effects 
with abdominal pains being most frequent (46.0%) followed by diarrhea 
(31.7%) and dizziness (25.0%).We noted a significant difference between 
CHW-reported and house-hold survey coverage. The CHW coverage 
(as validated by the household surveys) improved over time probably 
attributable to the additional training of the CHWs over the years.
1186
MODELING THE WITHIN-HOST DYNAMICS OF 
SCHISTOSOMA MANSONI: THE CONSEQUENCES OF 
INCONSISTENT TREATMENT EFFICACY FOR DISEASE 
CONTROL
Larissa Anderson
University of New Mexico, Albuquerque, NM, United States
Schistosomiasis is a neglected parasitic disease caused by various 
trematode species of the genus Schistosoma, for which 249 million people 
needed treatment in 2012. Substantial variability in treatment efficacy 
has been observed despite comparable Schistosoma mansoni prevalence 
between populations prior to treatment. Praziquantel is the most common 
pharmaceutical used to control schistosomiasis, due to its applicability over 
several species and its negligible side effects. However, Praziquantel is not 
very effective against juvenile schistosomes in humans. This limited efficacy 
on the juvenile life-stage of the parasite may be an important factor in the 
persistence of the disease, yet when forecasting the impacts of control 
measures this factor is usually neglected. We developed a stochastic model 
to investigate the consequences of inconsistent drug efficacy among 
parasite life-stages and variation in parasite population structure within the 
human host. These results were used to parameterize a population-level 
model to explore control options, including alternatives to the prevalent 
annual treatment strategy. The effects of anti-helminths on schistosome 
population age and sex composition within the human host may obfuscate 
the effectiveness of chemoprophylactic control strategies. Furthermore, we 
found the effectiveness of the treatment to be heavily dependent on the 
force of infection to humans, the initial schistosome population size and 
structure, and the frequency at which pharmaceuticals are administered. 
Ultimately our results can be used to design optimal control treatments 
under differing risk scenarios.
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SYSTEMATIC REVIEW OF ANTISCHISTOSOMAL TREATMENT 
EFFICACY STUDIES AND THE SIGNIFICANCE OF INDIVIDUAL-
LEVEL PARTICIPANT DATA FOR META-ANALYSES
Amélie M. Julé1, Julia B. Halder2, Michel Vaillant3, Maria-Gloria 
Basáñez2, Trudie A. Lang1, Martin Walker2, Piero L. Olliaro4
1Centre for Tropical Medicine and Global Health, Nuffield Department of 
Medicine, University of Oxford, Oxford, United Kingdom, 2Department 
of Infectious Disease Epidemiology and London Centre for Neglected 
Tropical Disease Research, Imperial College, London, United Kingdom, 
3Competence Center in Methodology and Statistics, Luxembourg Institute 
of Health, Luxembourg, Luxembourg, 4UNICEF/UNDP/World Bank/WHO 
Special Programme on Research and Training in Tropical Diseases (TDR), 
World Health Organization, Geneva, Switzerland
Schistosomiasis control mainly relies on preventive chemotherapy with 
praziquantel distributed through mass drug administration. With a 
target of 260 million treatments a year, reliably monitoring efficacy is 
all-important. We performed a systematic review of published literature 
to identify studies that included investigation of antischistosomal drug 
efficacy, performed since 2000. Out of 914 unique references, we 
identified 90 studies involving an outcome assessment within 60 days 
post-treatment, enrolling a total of 20,517 participants infected with 
Schistosoma spp., treated mostly with praziquantel. We extracted study-
level characteristics (Schistosoma species, treatment, country, methods 
used for diagnosis and reported estimates of drug efficacy, etc.). This 
has allowed us to depict the landscape of schistosomiasis research 
reporting on anthelmintic efficacy assessment, and to highlight the 
associated diversity in methodological and reporting approaches. We 
complete this descriptive exercise by meta-analyses, exploring spatial 
and temporal heterogeneity among estimates of antischistosomal drug 
efficacy. We will discuss our results in the context of global efforts to 
control schistosomiasis. Our work highlights the general limitations of 
aggregate-data meta-analyses. We argue that individual participant-level 
data (IPD) would allow application of standardised analytical approaches 
to efficacy and safety assessments, and more powerful investigation of 
treatment effects in target sub-populations (as demonstrated by our prior 
IPD meta-analyses on a subset of up to 4,740 participants). This leads us 
to discuss the importance of initiating and sustaining efforts to collect and 
share clinical and epidemiological data, and the potential benefits of this 
approach to the effective monitoring of antischistosomal drug efficacy.
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OUTBREAK OF GASTROENTERITIS ASSOCIATED WITH BORE 
WELL WATER - GANESHPUR VILLAGE, BIDAR DISTRICT, 
KARNATAKA STATE, INDIA, 2015
Sree Kalpana Mohan Kumar1, Bhavani Gopinath2, Samir V. Sodha1, 
Manoj Murrhekar2, Prakash Kumar3, Doddamallappa Ramanna3, 
Jabbar M.A.4, Ninganagouda N. Biradar4, Pallavi Fattepurkur5, 
Sathish S.5, Aakash Shrivastava1, Agarwal C.S.1, Srinivas 
Venkatesh1
1National Center for Disease Control, Delhi, India, 2National Institute of 
Epidemiology, Chennai, India, 3Integrated Disease Surveillance Project, 
Bangalore, India, 4District Surveillance Unit, Bidar, India, 5Bidar Institute of 
Medical Sciences, Bidar, India
Diarrhea and foodborne outbreaks account for half of outbreaks in India 
but few investigations identify the source. On October 9, 2015, Bidar 
district of Karnataka state, India, reported a gastroenteritis outbreak in 
Ganeshpur village. We investigated to identify risk factors and provide 
recommendations. We defined a case as ≥3 loose stools within 24 hours 
between September 3 and November 3, 2015 in a Ganeshpur village 
resident. We conducted a retrospective cohort study to assess risk factors 
and collected stools for Vibrio cholerae culture. We collected one water 
sample from bore well A and six water samples from bore well B to 
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test for faecal contamination. We interviewed 947/1040 villagers (91% 
response rate) and identified 180 cases (attack rate=19%) and 2 deaths. 
Among 180 cases, 90% were admitted. The outbreak occurred between 
September 5 and November 1 and peaked October 5-8. Having family 
members with diarrhoea (RR=4.9, 95% CI=3.5 – 7.1) and using water 
from bore well A for drinking or cooking (RR=2.6, 95% CI=2.0 – 3.4) 
were associated with illness. Using water from bore well B for drinking or 
cooking (RR=0.4, 95% CI=0.3-0.5), drinking filtered water (RR=0.4, 95% 
CI=0.3 – 0.6), washing hands before eating (RR=0.6, 95% CI=0.4 – 0.7) 
and having a toilet at home (RR=0.2, 95% CI=0.1 – 0.6) were protective 
against illness. Stool cultures from four case-patients were negative 
for Vibrio cholerae. Water from bore well A was positive for faecal 
contamination by most probable number test. All other water sources 
were potable. This gastroenteritis outbreak was likely due to consuming 
contaminated water from bore well A. We recommend avoiding bore 
well A, using bore well B water, promoting hand washing practices, and 
improving access to indoor toilets.
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QUANTITATIVE ASSESSMENT OF EXPOSURE TO FECAL 
CONTAMINATION FOR YOUNG CHILDREN IN A CROWDED, 
LOW-INCOME URBAN ENVIRONMENT IN THE SANIPATH 
STUDY OF ACCRA, GHANA
Yuke Wang1, Christine L. Moe1, Clair Null2, Suraja J. Raj1, Kelly K. 
Baker3, Katharine A. Robb1, Habib Yakubu1, Joseph A. Ampofo4, 
Nii Wellington5, Matthew Freeman1, George Armah6, Heather E. 
Reese1, Dorothy Peprah7, Peter FM Teunis8
1Emory Univeristy, Atlanta, GA, United States, 2Mathematica Policy 
Research, Washington, DC, United States, 3The University of Iowa, 
Iowa City, IA, United States, 4Water Research Institute (WRI), Council 
for Scientific and Industrial Research (CSIR), Accra, Ghana, 5Training 
Research and Networking for Development (TREND Group), Accra, Ghana, 
6University of Ghana - Legon, Accra, Ghana, 7London School of Hygiene & 
Tropical Medicine, London, United Kingdom, 8Centre for Infectious Disease 
Control (RIVM), Utrecht, Netherlands
Diarrheal diseases are a leading cause of death for children under five 
globally. In the developing world, lack of adequate sanitation results in 
fecal contamination of the environment and poses a risk of enteric disease 
transmission via multiple exposure pathways. To better understand how 
different sources and transmission routes contribute to overall exposure 
to fecal contamination, we identified eight different fecal exposure 
pathways for children under five years old in four high-density, low-income 
neighborhoods in Accra, Ghana, and quantified the contribution of each 
pathway to oral intake of fecal contamination. Data collection for the 
SaniPath study was from 2011 to 2012, and comprised 500 hours of 
structured observations for behaviors of 156 children, questionnaires from 
800 households, and 1855 environmental samples for microbiological 
testing. Data were analyzed using Bayesian models, estimating the 
environmental and behavioral factors associated with exposure to 
fecal contamination. These estimates were applied in exposure models 
simulating sequences of behaviors and transfers of fecal indicators from 
the environment to oral ingestion. This approach allows us to identify the 
contribution of any sources of fecal contamination in the environment to 
child exposure and use dynamic fecal microbe transfer networks to track 
fecal bacteria from the environment to oral ingestion. Exposure pathways 
were categorized into four types (high/low by dose and frequency), as a 
basis for prioritizing pathways by their potential to reduce fecal exposure. 
Although we observed variation in exposure (magnitude ranged from 
108 to 1016 CFU/day for E. coli) between different age groups and 
neighborhoods, the greatest contribution consistently was through the 
food pathway (contributing >99.9% to total exposure) in Accra, Ghana. 
Hands played a pivotal role in fecal microbe transfer from the environment 
to ingestion. The fecal microbe transfer network provides a systematic 
approach to study the complex interaction of poor sanitation infrastructure 
and human behavior on exposure to fecal contamination.
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OBSERVATIONAL AND LABORATORY HYGIENIC ANALYSIS OF 
RESTAURANTS IN IQUITOS, PERU
Olivia Munizza1, Ivana Marji1, Colin Andrews1, Mona Lotfipour1, 
Andrew Rogers1, Ricardo Abadie2, Rosa Burga2, Claudio Rocha2, 
Hamilton Tilley2, David Craft1
1Pennsylvania State University College of Medicine, Hershey, PA, United 
States, 2U.S. Naval Medical Research Unit - 6, Lima, Peru
Poor sanitation contributes to foodborne infections associated with 
food consumption. Specific risk factors associated with contamination 
include unsafe handling and preparation of food, hygiene, sanitation, 
and water quality. Fifteen restaurant owners in Iquitos, Peru participated 
in a study to assess sanitation and hygienic practices. The study included 
an observational survey and laboratory analysis of samples collected from 
food, water, and the restaurant environment. Participants were given a 
final report of the findings. Survey questions included food handling and 
preparation, restaurant cleanliness, sanitation, and standardized hygienic 
practices. Observations were numerically graded and an average sanitation 
score was calculated. Restaurant contact surfaces, food, and beverages 
were cultured for enteric bacterial pathogens via sample collection onto 
rayon or polyester swabs in Stuart’s transport media with same day 
culture according to standard microbiology protocols. Water samples were 
collected for fecal coliform testing. Statistical significance was determined 
using a chi-square analysis. There was no significant correlation between 
average sanitation scores and the presence of enteric pathogens found 
on contact surfaces or food samples. The sanitation scores for the 15 
restaurants ranged from 26 to 43.38. Presence or absence of enteric 
bacteria was assessed and results ranged from none isolated to one or 
more present. Coliform counts ranged from to <1 to 21 UFC/100mL. 
The restaurant with the lowest sanitation score average (26) yielded no 
growth of enteric pathogens and no fecal coliforms. Conversely, the 
restaurant with the highest sanitation score average (43.38) yielded enteric 
pathogens but no fecal coliforms. Overall, no statistical significance was 
noted between bacterial growth and the presence of fecal coliforms in 
the cooking water. Additionally, there does not appear to be a correlation 
between  In observational analysis and results of coliform analysis 
or enteric bacterial culture. Future studies may include a resurvey of 
restaurants to assess reproducibility and potential interventions.
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LATRINE LEARNING: USING CONDITIONAL INFERENCE TREES 
TO EXPLORE HOW LATRINE CONDITIONS CAN PREDICT 
LATRINE USE IN RURAL BANGLADESH
Andrew Nute1, Maryann G. Delea2, Katherine Gass3, Corey 
Nagel4, Thomas Clasen1
1Rollins School of Public Health at Emory University, Atlanta, GA, United 
States, 2London School of Hygiene & Tropical Medicine, London, United 
Kingdom, 3The Task Force for Global Health, Atlanta, GA, United States, 
4Oregon Health & Science University, Portland, OR, United States
Global public health efforts to eliminate open defecation specifically 
on the Indian subcontinent have recently begun focusing on improving 
latrine use. In this study, we attempt to identify a latrine’s likelihood 
of use based on observations of physical characteristics of the latrine 
and the surrounding premises (i.e., latrine spot-check indicators [SCIs]). 
Recursive partitioning algorithms, often called decision trees, are typically 
used in machine learning and data mining because they do not require 
the assumptions made by traditional regression models. Conditional 
inference trees (CIT) specifically apply unbiased statistical inference tests 
as a method of variable selection based on a priori partitioning criteria. 
Unlike other regression trees, the selected partitions are conditional 
of all other covariates in the model. In this study we measured latrine 
usage in rural Bangladesh in 2014 using average daily ‘likely defecation 
events’ recorded by a motion sensing device called a passive latrine use 
monitor (PLUM). Using this continuous distribution, we dichotomized the 
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measurement along its median so that we had a “Most used” group (≥ 
median) and a “least used” group (< median). We then employed CIT to 
separately predict the continuous and dichotomous forms of the outcome 
using 15 SCIs as independent variables. After implementing a Bonferroni 
correction for multiple tests of significance, the CIT analysis identified a 
tree with three partitions using three SCIs for the dichotomous outcome. 
The primary partition was the presence/absence of water for the purpose 
of flushing or anal cleansing with two secondary partitions being 1) the 
presence/absence of flies and 2) having a wet floor. The primary partition 
shows the strongest SCI but the secondary partitions show that a latrine 
with water for cleansing that does not attract flies and latrines that do 
not have water for this purpose but keep a dry floor draw the most 
use from their users. This interaction suggests a latrine’s cleanliness and 
structural maintenance is an important indication of its use. The CIT for 
the continuous outcome could indicate some measurement error within 
the PLUMs.
1192
WOMEN AND WATER USE IN THE EASTERN REGION OF 
GHANA: A QUALITATIVE APPROACH
Liliana Schmitt
Tufts University, Medford, MA, United States
Despite efforts to expand access to improved water sources in sub-Saharan 
Africa, countries like Ghana continue to face significant heterogeneities 
in water source coverage and quality. When multiple water sources are 
available for use, it is critical to understand the decision-making process 
in water source selection. Given the key role played by women in Ghana 
with respect to household water resources management, we interviewed 
50 women from 11 communities in the Eastern Region of Ghana and 
asked about preferences for improved and unimproved water source use. 
Data was used to compare water source coverage with actual water use 
and women’s water source preferences; questions relate to perceptions 
of “good” and “bad” water, availability and accessibility, and seasonality 
of water sources. Concepts such as “improved water” do not always 
match the definitions women have of “good” water. Women assess 
water appropriateness for various domestic tasks using a complex set of 
factors, such as contextual indicators, social conceptualizations of “good” 
and “bad” water, organoleptic assessments, and seasonally-determined 
quality and availability. Distance to the water source plays a key role in 
source acceptability. While rainwater is overwhelmingly preferred for 
domestic use and is used by all participants during the rainy season, 
source preferences change in the dry season. Women can articulate their 
water source preferences, but many find it challenging to consistently 
access a water source that provides “good” quality water. This is due 
to factors like distance, unmaintained or unavailable infrastructure, and 
visible and/or biochemical contamination. Water source availability is 
partially determined by the season and impacts women’s water source use 
year-round. Our research contributes to a qualitative, community-based 
approach to assessing the need for improvements in water quality and 
accessibility in a schistosomiasis-endemic part of Ghana.
1193
IDENTIFICATION OF CAUSAL PATHWAYS DETERMINING THE 
RELATIONSHIP BETWEEN PATHOGEN-SPECIFIC INFECTION 
AND IMPAIRED GROWTH AMONG CHILDREN < 59 MONTHS 
IN MIRZAPUR, BANGLADESH
Kurt Z. Long1, Abu. Faruque2, Sumon Kumar Das2, Shahnawaz 
Ahmed2, James P. Nataro3, Dilruba Nasrin4, Karen Kotloff5, Myron 
M. Levine5
1Swiss Tropical and Public Health Institute, Basel, Switzerland, 
2International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, 
Bangladesh, 3School of Medicine, University of Virginia, Charlottesville, VA, 
United States, 4Pediatrics, Center for Vaccine Development, University of 
Maryland School of Medicine, Baltimore, MD, United States, 5Departments 
of Medicine and Pediatrics, Center for Vaccine Development, University of 
Maryland School of Medicine, Baltimore, MD, United States
The burden of childhood diarrhea and malnutrition remains high in South 
Asia due to inadequate household sanitation, lack of access to improved 
water and poor hygiene practices. We evaluated causal pathways linking 
household factors, enteric pathogen infections (EPI) and impaired growth 
using data from Mirzapur, Bangladesh that is part of the Global Enteric 
Multicenter Study. Stool specimens collected at enrollment from children 
with moderate-to-severe diarrhea and matched controls were screened 
for bacterial, viral and protozoa EPI. Height measurements of children 
were taken of children at enrollment and information was collected 
on sanitation facilities, water sources, and household animals, cooking 
fuel type, caretaker education and hand washing practices. Structural 
equation models tested pathways directly linking household factors with 
stunting (< - 2 height-age-Z score) or indirectly through their effects 
on EPI transmission. The modifying effects of hand washing behaviors, 
water sources and caretaker education were also tested. Giardia lamblia 
and Cryptosporidium infections were associated with increased stunting 
among older children. In turn, a higher prevalence of Cryptosporidium 
was associated with cow dung fuel use when caretakers reported no 
hand washing before eating. Traditional latrine use was associated with 
a greater prevalence of G. lamblia and Cryptosporidium infections when 
caretakers reporting no hand washing before cooking. A higher prevalence 
of Cryptosporidium was also associated with child feces disposal when 
caretaker had no formal education. Increased caretaker education had 
the greatest effect on stunting through direct associations with reduced 
stunting and indirectly through effects on Cryptosporidium and Giardia 
infections.  Overall, causal pathways were identified that linked animal 
and environmental reservoirs with childhood stunting that were modified 
by distinct hygiene-related behaviors. These results can be used as 
tools to inform the design, implementation and evaluation of different 
interventions to more effectively reduce diarrhea burden and stunting.
1194
HIGH PREVALENCE OF BLASTOCYTIS SP IN POPULATION 
LIVING IN URBAN AREAS OF GABON
Denise Patricia Mawili Mboumba, Noé Patrick M’Bondoukwe, 
Fernande Manga, Marielle Karine Bouyou Akotet
Faculty of Medicine, Libreville, Gabon
Intestinal parasitic infections (IPIs) are one of the major public health 
problems, especially in the rural area of developing countries with low 
socio-economic status and poor sanitation. The aim of the study was to 
establish the profile of intestinal parasites diagnosed at the Department 
of Parasitology-Mycology (DPM) of the Faculty of Medicine in Gabon 
over a period of 10 years. A retrospective study was carried out. Socio 
demographic and clinical/biological data of patients, who consulted at the 
DPM between 2004 and 2014 and who benefited of stool examination, 
have been collected from archived files. During the survey, 1251 patients 
have been selected; 81% of them were adults. Half of them lived in urban 
areas, a quarter (25.1%; n=118) in slums and 20.4% (n=96) in rural 
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and semi-rural areas. IPIs have been found in 39.8% (497/1251) of the 
patients, mostly Protozoan: 84.9% (n=422/497) vs 15.1% (n=78/497) 
of helminths. Overall, 13 parasites species have been identified, the 
predominant was sp (45.1%; n=224/497) followed by Entamoeba (E.) 
coli (42.5%; n=211/497).  Blastocystis sp (41.6% (n=42/101), E. coli 
32.7% (n=33/101) and E. nanus 27.7% (n=28/101) were more frequently 
detected among populations living in slums (p=<0.0001). Prevalence 
of intestinal parasites increased between 2004 and 2014 (p<0.01) 
ranging from 34.1% to 65.3% between 2011 and 2014; due to the 
elevated frequency of Protozoan. None  Blastocystis sp was found in 
samples collected in 2004, but its prevalence rose significantly from 2010 
reaching 23.7%, in 2013 and 22.3% in 2014. Soil Transmitted Helminths 
prevalence varied during the study period. A decrease of the prevalence 
was observed being below 10%. An increase of the Protozoan frequency 
was found among patients living in urban areas and slum compared 
to populations living in rural areas (p<0.01). These data showed a non 
negligible rise of frequency of  Blastocystis sp infections in populations 
living in urban areas of Gabon. Integrated efforts, such as improving 
infrastructure to provide clean water source and educating the inhabitants 
for appropriate hygienic lifestyle are needed.
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FORMATIVE RESEARCH TO INFORM DESIGN OF A 
BEHAVIOR CHANGE INTERVENTION FOR THE “F” AND “E” 
COMPONENTS OF THE SAFE STRATEGY FOR TRACHOMA 
CONTROL IN OROMIA, ETHIOPIA
Katie Greenland1, Sian White1, Nazif Jemal2, Matthew Burton1, 
Wondu Alemayehu Gebremichael3
1London School of Hygiene & Tropical Medicine, London, United Kingdom, 
2Fred Hollows Foundation Ethiopia, Addis Ababa, Ethiopia, 3Berhan Public 
Health and Eye Care Consultancy, Addis Ababa, Ethiopia
Trachoma, caused by Chlamydia trachomatis, is thought to be transmitted 
from eye to eye via hands, fomites and eye-seeking flies which breed in 
human faeces. Little research has been conducted to understand hygiene 
and sanitation-related behavioural risk factors for trachoma transmission 
or how these might be addressed through the “F” and “E” (face 
washing and environmental change) components of the SAFE strategy. 
This impedes progress towards the 2020 trachoma elimination goal. 
A study was carried out in a trachoma hyper-endemic area in Oromia, 
Ethiopia to identify behaviours potentially associated with trachoma risk, 
namely: water use for hygiene purposes; defecation and stool disposal 
practices; sleeping arrangements and laundry. Data were collected in five 
communities in January 2016 through direct observation in households 
with young children (n=10), semi-structured interviews with caregivers 
(n=10), focus groups with mothers (n=3), grandmothers (n=1) and fathers 
(n=1) and stakeholder interviews (n=4). Data collection and analysis were 
guided by an ecological model of the determinants of behaviour: “Evo-
Eco”. A range of sub-optimal hygiene practices were documented, but 
none were consistently poor across households. Open defecation within 
or next to a compound was a normative practice, particularly for young 
children. Latrines, when present, had been built under threat of a fine, 
and were unhygienic and poorly constructed. Faces were washed with 
hands and feet, occasionally in response to a cue (food or dirt) or for 
refreshment. Frequency of face washing differed within and between 
households and soap was intermittently used. Children’s dirty faces with 
visible discharge were not viewed to be disgusting and were rarely wiped 
by mothers who felt the ideal behaviour was unattainable for them. 
Families slept closely together and shared bedding. Laundry was done 
infrequently. Laundry and bedding were not thought to transmit germs. 
Behaviour change activities should focus on making face washing feasible 
and a priority for all family members, generating demand for sanitation 
and promoting use and laundry of affordable pillows.
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INCORPORATING WASH INDICATORS INTO NATIONAL 
CONTROL PROGRAM SURVEYS FOR SCHISTOSOMIASIS AND 
STH IN MADAGASCAR
Clara F. Rasoamanamihaja1, Neerav A. Dhanani2, Alain M. 
Rahetilahy1, Bruno Ranjatoarivony3, Luciano Andriamaro4, Samuel 
H. Andrianarisoa5, Peter M. Jourdan6
1Ministry of Public Health, Antananarivo, Madagascar, 2Schistosomiasis 
Control Initiative, London, United Kingdom, 3Ministry of National 
Education, Antananarivo, Madagascar, 4Réseau International 
Schistosomose Environnement Aménagement et Lutte, Antananarivo, 
Madagascar, 5World Health Organization, Antananarivo, Madagascar, 
6Natural History Museum, London, United Kingdom
Access to clean water, sanitation and hygiene (WASH) has been 
recognised as a key element of socio-economic development, and has 
been adopted as one of the Sustainable Development Goals. Recent 
studies show interesting links between access to WASH and the reduction 
of transmission of schistosomiasis and soil-transmitted helminthiasis 
(STH); however, reports also highlight the need for more data collection 
to better understand the factors involved. In October 2015, a baseline 
study was conducted in the western half of Madagascar prior to scale-up 
of the schistosomiasis and STH control programme. Primary outcomes 
were to determine the prevalence and intensity of schistosomiasis and 
STH in the treatment area. Indicators of access to, and use of, WASH 
facilities as defined through consensus-defined observed and reported 
factors were included as secondary outcomes in order to determine the 
feasibility of incorporating collection of school-level data on access to 
WASH, and to determine the relationship between access to school-level 
WASH and schistosomiasis and STH. A total of 1,958 children were tested 
from 29 primary schools across the treatment area. The prevalence of S. 
haematobium infection and heavy-intensity infection was 30.5 % and 
15.1 %, respectively. The prevalence of S. mansoni infection and heavy-
intensity infection was 5.0 % and 0.9 %, respectively. The prevalence of 
any STH was 4.7%. Of a total WASH score of 12, 75% of schools scored 
less than 3, and the maximum score was 7. This study demonstrates the 
feasibility of including WASH indicators in monitoring and evaluation 
surveys for neglected tropical disease control programmes. The results 
show an extremely limited access to WASH in the study sites. No 
significant relationships were observed between WASH score and school 
level infection rates, perhaps due to sample size limitations. The national 
control programme will aim to integrate interventions to improve access to 
WASH alongside mass treatment of infection.
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ESTIMATING THE GLOBAL RISK OF DIARRHEAL DISEASE 
ATTRIBUTABLE TO INTERMITTENT WATER SUPPLIES
Aaron W. Bivins, Trent Sumner, Joseph Brown
Georgia Institute of Technology, Atlanta, GA, United States
Approximately 925 million people globally are served by an intermittent 
water supply (IWS). These supplies are often fecally contaminated and 
are associated with increased risks of gastrointestinal illness. The global 
burden of disease associated with such supplies however is unknown. 
A quantitative microbial risk assessment (QMRA) was performed using 
Monte Carlo techniques to estimate the risk of infection for three 
reference pathogens (Campylobacter, Cryptosporidium, rotavirus) 
attributable to consuming contaminated tap water supplied by an 
IWS. The stochastic model utilized E. coli measurements in intermittent 
distribution systems along with reference pathogen to indicator bacteria 
ratios in three potential sources of contamination (sewage, surface water, 
groundwater) to characterize risks of infection. These risks of infection 
were then used to calculate the annual diarrheal cases, DALYs, and deaths 
that might plausibly be associated with IWS. Results indicate that when 
considering contamination of an IWS by sewage, the daily risks of infection 
are 1 in 480 for Campylobacter, 1 in 885,000 for Cryptosporidium, and 1 
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in 61,000 for rotavirus. Collectively, these reference pathogens and their 
median daily risks of infection are estimated to lead to approximately 
143.5 million cases of diarrhea annually and cause 1.98 million associated 
DALYs and 31,250 deaths. Calculated DALYs and deaths associated with 
IWS in this analysis account for 6.6% and 7% respectively of the total 
diarrheal DALYs and deaths attributable to inadequate water according 
to recent burden of disease estimates. This is the first attempt to estimate 
the risk of specific enteric infections, and global diarrheal disease burden 
expressed in cases, DALYs and deaths, associated with intermittent water 
supplies using QMRA. These results suggest that there may be significant 
health risks associated with intermittency of water supplies to which 
almost 1 billion people are exposed.
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IMPACT OF COMMUNITY HEALTH CLUBS ON DIARRHEA, 
ANTHROPOMETRY AND WATER QUALITY IN WESTERN 
RWANDA
Sheela S. Sinharoy1, Ronald Wendt2, Leodomir Mfura3, Wolf-
Peter Schmidt4, James Habyarimana5, Thomas F. Clasen1
1Emory University, Atlanta, GA, United States, 2Innovations for Poverty 
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Kigali, Rwanda, 4London School of Hygiene & Tropical Medicine, London, 
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The Community-Based Environmental Health Promotion Programme 
(CBEHPP) is a cluster-randomized controlled trial that covers 150 villages 
in Rusizi district, western Rwanda. The intervention was community health 
club meetings led by trained facilitators. Villages were randomly assigned 
to one of 3 study arms: control (no intervention), Lite (8 meetings), or 
Classic (20 meetings). We aimed to evaluate the impact of the community 
health club approach on diarrhea among children <5, anthropometry 
among children <2, and household water quality. The CBEHPP endline 
survey collected data in late 2015 on diarrhea in the previous 7 days 
for children <5 (N=10,261), anthropometry for children <2 (N=3,179), 
and water quality for a random sub-sample of households (N=1,085). 
To analyze impact on diarrhea, we used log-binomial regression with 
a log link function and generalized estimating equations (GEE). For 
anthropometry, we calculated length-for-age and weight-for-length 
z-scores (LAZ and WLZ) then used linear regression with GEE. For water 
quality, we measured colony forming units of thermotolerant (fecal) 
coliforms (TTC) per 100ml water then used linear regression with GEE. All 
analyses accounted for clustering at the village level and the household 
level as appropriate. The prevalence of caregiver-reported diarrhea for 
children <5 in the previous 7 days was 14.2%, 14.2%, and 14.3% in the 
control, Lite, and Classic arms respectively. Mean (SD) LAZ among children 
<2 was -1.54 (1.26), -1.59 (1.28), and -1.61 (1.32) in control, Lite, and 
Classic respectively. Mean (SD) WLZ among children <2 was 0.18 (1.11), 
0.18 (1.09), and 0.10 (1.11) in control, Lite, and Classic respectively. Mean 
(SD) TTC was 139.8 (230.9), 165.4 (251.1), and 155.5 (243.7) in control, 
Lite, and Classic respectively. The differences between study arms were 
not statistically significant for any outcomes (p=0.96, 0.20, 0.83, 0.47 
for diarrhea, LAZ, WLZ, and TTC respectively). The community health 
club model, as implemented in this setting in western Rwanda, had no 
impact on prevalence of diarrhea or anthropometry among children or on 
household water quality.
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THE ROLE OF PUBLIC-PRIVATE PARTNERSHIPS FOR 
NEGLECTED TROPICAL DISEASES (NTDS) PREVENTION 
AND CONTROL: THE SUPER SCHOOL OF FIVE TRACHOMA 
PROGRAM
Beatrice Wasunna1, Sarah Maiywa1, Peter Otinda1, Stacie June2, 
Myriam Sidibe3, Elizabeth Owuor-Oyugi1, Geordie Woods4
1Sightsavers, Nairobi, Kenya, 2Unilever, London, United Kingdom, 3Unilever, 
Nairobi, Kenya, 4Sightsavers, New Orleans, LA, United States
Public Private Partnership (PPP) is an increasingly popular model for 
implementing important public health intiatives. Sighstavers international 
through its partnership with Unilever launched a school-based trachoma 
program that integrates face washing into the existing Unilever’s Lifebuoy 
brand school of five handwashing programs, towards the prevention and 
control of trachoma. This program is delivered in collaboration with local 
ministries of health and education in-country. The super-school of five 
(SS5) program seeks to increase hygiene behaviors and in particular the 
practice of hand and face washing with soap among school children and 
their mothers/caregivers. Specifically, it addresses the facial cleanliness 
component of the SAFE strategy for trachoma control. This program 
adopts the Unilever behavioral change model and takes school children 
through a four-step journey of awareness, commitment, reinforcement 
and reward/recognition. Each step on the behavioral change pathway 
has a corresponding communication material. The SS5 program has 
been rolled out in 41 primary schools in the trachoma endemic county of 
Turkana in Kenya. Currently, the SS5 is being scaled-up across trachoma 
endemic countries in the region. Pre-and post-evaluation comparisons 
following the roll out of the SS5 showed marked improvements in facial 
washing and handwashing events (21.2% vs. 75.6%) and face and 
handwashing events using soap (0 vs. 75.4%). Public private partnerships 
have the potential for meaningful benefits to be gained for the public 
partner and the overall health sector. The super school of five program 
demonstrates that partnerships with the private sector can also be 
particularly valuable as a method of leveraging on existing models and 
technical expertise all of which can lead to the ultimate goal of trachoma 
elimination. The super school of five model and adapted materials along 
with results from the current ongoing programs is briefly presented.
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RELATIONSHIP OF INFANT DIET TO CHILDHOOD HEALTH: 
ROUTES OF PARASITIC INFECTIONS FROM CONTAMINATED 
WEANING FOODS
James R. Palmieri, Susan L. Meacham, Jenna Warehime, Sarah 
Stokes
Virginia College of Osteopathic Medicine, Blacksburg, VA, United States
There is a deficit of published data on the prevalence and intensity of 
gastrointestinal parasitic infections in Honduras and routes of parasitic 
transmission especially in infants and young children. Historically, many 
of the surveys of water-borne, vector borne and soil-transmitted parasites 
were published more than 30 years ago. Transmission of parasitic 
infections in Honduras are the result of many factors which include 
zoonotic transmission, contaminated water and foods, direct transmission 
from child care providers, food handlers, and agricultural workers; each 
playing a contributing role in the transmission of parasitic diseases. From 
November 2014 through February 2015, the Department of Microbiology, 
VCOM, conducted a preliminary 3 month-long study in Honduras where 
175 mothers were extensively interviewed. This study investigated weaning 
practices used by mothers when transitioning infants from breast milk to 
complementary foods and the role these foods have in the transmission of 
gastrointestinal parasites. Of those surveyed, 98.9% of mothers reported 
at least one of their children infected with a gastrointestinal parasite. Out 
of the 322 children of the mothers surveyed, 42% of the children had 
been previously diagnosed with a gastrointestinal parasitic infection. In 
376
astmh.org
this study routes of infection of protozoan and helminth parasites could 
have resulted from contaminated complementary foods and water given 
to infants while still breastfeeding or from contaminated foods after 
breastfeeding was completed. Contaminated water is a likely source of 
protozoan parasites. Contaminated water was fed to infants directly, 
used to mix with formula or complementary foods, or to wash bottles 
for infant feeding. There was an absence of hand washing by children 
and mothers before eating or while preparing foods. The major source 
of soil transmitted helminth infections was the result of environmental 
contamination, unwashed or uncooked complementary foods, 
unpasteurized animal milk, unsanitary food storage, poor living conditions 
with exposed dirt floors, and exposure to roaming domestic animals.
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DETERMINANTS OF LIFE-THREATENING DIARRHEAL DISEASE 
AT HOSPITAL PRESENTATION: EVIDENCE FROM 22 YEARS OF 
ADMISSIONS IN BANGLADESH
Jason R. Andrews1, Daniel T. Leung2, Shahnawaz Ahmed2, M. 
a. Malek2, Dilruba Ahmed2, Yasmin Begum2, Firdausi Qadri2, 
Tahmeed Ahmed2, A.S.F. Faruque2, Eric J. Nelson1
1Stanford University School of Medicine, Stanford, CA, United States, 
2International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, 
Bangladesh
To take advantage of emerging opportunities to reduce morbidity and 
mortality from diarrhoeal disease, we need to better understand the 
determinants for life-threatening disease in resource-poor settings. We 
analyzed records of patients admitted with acute diarrhoeal disease 
over twenty-two years at the International Centre for Diarrhoeal Disease 
Research, Bangladesh (1993-2014). Patients presenting with and without 
severe dehydration (SD) were compared by multivariable logistic regression 
models, which included socio-demographic factors and pathogens 
isolated. Generalized additive models evaluated non-linearities between 
age or household income and SD. Among 55,956 admitted patients, 
13,457 (24%) presented with SD. Vibrio cholerae was the most common 
pathogen isolated (12,405 patients; 22%), and had the strongest 
association with SD (AOR 5.88; 95% CI: 5.52-6.27); detection of multiple 
pathogens did not exacerbate SD risk. The highest proportion of severely 
dehydrated patients presented in a narrow window only 4-12 hours after 
symptom onset. Patients between 10-15 years had the highest probability 
of presenting with SD, with dramatic increase per year of life up to age 
10. Adult women had a 38% increased odds (AOR 1.38; 95% CI: 1.30-
1.46) of SD compared to adult men. The probability of SD increased 
sharply at low incomes. These findings were consistent across pathogens. 
There remain underappreciated populations vulnerable to life-threatening 
diarrhoeal disease that include children 10-15 years-old and adult women. 
In addition to efforts for children under 5 years, there is an urgent need to 
develop interventions for these older sub-populations that are accessible 
within 4 hours of symptom onset.
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BISMUTH SUBSALICYLATE REDUCES ANTIMICROBIAL 
USE AMONG ADULT DIARRHEA PATIENTS IN PAKISTAN: A 
RANDOMIZED, PLACEBO-CONTROLLED, TRIPLE-MASKED 
CLINICAL TRIAL
Anna Bowen1, Mubina Agboatwalla2, Adam Pitz3, Jose Brum3, 
Brian D. Plikaytis4
1Centers for Disease Control and Prevention, Atlanta, GA, United States, 
2HOPE, Karachi, Pakistan, 3Procter & Gamble, Mason, OH, United States, 
4BioStats Consulting, Jasper, GA, United States
The World Health Organization has declared antimicrobial resistance a 
global crisis. Antimicrobial medications are used inappropriately for many 
of the 2 billion annual cases of diarrhea. We assessed whether providing 
bismuth subsalicylate (BSS) to adults with acute diarrhea could reduce 
antimicrobial use in a setting where antimicrobials are easily obtained. 
We included adult outpatients from 22 clinics in Karachi, Pakistan, who 
presented from Apr - Oct 2014 with acute diarrhea and who had not 
taken antimicrobial or antidiarrheal medications during the present illness. 
Twenty patients from each clinic were randomized 1:1 to BSS or placebo. 
We requested stool specimens for bacterial culture upon enrollment 
and assessed antimicrobial use during 5 days of follow-up. We present 
unadjusted odds of antimicrobial use by intervention because we did not 
detect interactions with clinic, age, sex, wealth, or diarrhea severity. We 
concealed group assignment from patients, healthcare providers (HCPs), 
field staff, and the principal statistician. Among 440 participants, those 
who received BSS were less likely than those who received placebo to 
use antimicrobials (odds ratio [OR] 0.55, 95% confidence interval [CI] 
0.30 - 0.98), particularly when ≥1 pathogen was detected (OR 0.26, 95% 
CI 0.09 - 0.81). Fifty-four (12%; BSS, 20; placebo, 34) participants took 
antimicrobial medications; all received them from a HCP, 36 (67%) began 
taking them within 1 day of enrollment, 25 (46%) were treated with >1 
antimicrobial agent (mean 1.6 ± 0.7 oral and 0.6 ± 0.8 intravenous agent), 
and nitrofurantoin (n=46 [85%]) and ciprofloxacin (n=28 [52%]) were the 
most commonly used agents. Six (1%) patients were hospitalized (BSS, 3; 
placebo, 3); no patients died. Providing BSS to adults with acute diarrhea 
reduced antimicrobial use by 45% in a setting with high rates of diarrhea 
and antimicrobial usage for diarrhea. Encouraging HCPs and pharmacists 
in similar settings to recommend BSS as front-line treatment for adults 
with diarrhea, and promoting BSS for diarrhea self-management, may 
reduce antimicrobial use and rates of antimicrobial resistance globally.
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CONTINUED FEEDING DURING DIARRHEA MANAGEMENT 
AT HOME AND GROWTH FALTERING: SECONDARY DATA 
ANALYSIS OF THE KENYA GLOBAL ENTERIC MULTICENTER 
STUDY (GEMS) OF DIARRHEAL DISEASE IN INFANTS AND 
YOUNG CHILDREN IN DEVELOPING COUNTRIES
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Richard Omore3, Dilruba Nasrin4, Karen Kotloff4, Tamer H. Farag4, 
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3Kenya Medical Research Institute-Center for Global Health Research, 
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In 2013, 587,000 child deaths were attributed to diarrhea. WHO 
guidelines recommend commercially available oral rehydration salts (ORS), 
zinc, and continued feeding of an age-appropriate diet for diarrhea. 
From 2006-2011, 34% of children in sub-Saharan Africa received 
continued feeding and ORT during diarrhea. Among case data from the 
Global Enteric Multicenter Study (GEMS) Kenya site, we investigated the 
association between continued feeding at home during a moderate-
to-severe diarrhea episode (MSD) in children< 5 years old (reported 
at enrollment by a caregiver) and growth faltering 50-90 days after 
enrollment. At enrollment, caregivers were asked about feeding practices 
at home during the MSD episode, with continued feeding defined as 
offering a usual or more than usual amount of food during MSD. Weight 
and height were measured at enrollment and at follow-up 50-90 days 
later. Growth faltering was defined as a reduction in weight-for-height 
Z-score (WHZ) category by >1 SD from enrollment to follow-up. We 
evaluated the association between continued feeding during MSD and 
growth faltering using log binomial regression analysis. Data from 1,363 
of 1,476 enrolled children with MSD (92%) was complete; 20% received 
continued feeding and 26% experienced growth faltering. The mean 
age of children provided continued feeding was higher (20 months, SD 
13) than of those who had feeding discontinued (17 months, SD 13). 
Vomiting 3 or more times a day was inversely associated with continued 
feeding (RR=0.69, 95% CI=0.58, 0.82). Caregiver’s wealth and education 
were not associated with continued feeding. In bivariate analysis, children 
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reported to have received continued feeding during MSD had 25% lower 
risk of growth faltering (267, 20%), compared to those who had feeding 
discontinued (1096, 80%) (RR=0.75, 95% CI=0.59, 0.97); the association 
was confounded by age (RR=0.86, 95% CI=0.67 - 1.09). Kenyan children 
with MSD were rarely provided continued feeding but age-adjusted 
analyses suggested that continued feeding did not significantly alter the 
risk of growth faltering. Barriers to feeding during diarrhea include young 
age and frequent vomiting.
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DISRUPTIONS OF THE HUMAN GUT MICROBIOME DURING 
DIARRHEA INFECTIONS CAUSED BY ROTAVIRUS AND 
ENTERO-PATHOTYPES OF ESCHERICHIA COLI
Angela V. Pena Gonzalez1, Maria J. Soto-Giron1, Janet K. Hatt2, 
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Biomedicina, Universidad Central de Ecuador, Quito, Ecuador, 5Rollins 
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Little is known about the disturbances that enteropathogens cause in 
the ecology of the normal gut during diarrheal infections. For example, 
it is unclear whether viral and bacterial pathogens produce similar or 
distinctive alterations in the structure of the human gut microbiome and 
it remains undetermined whether pathogen-specific signatures in the sick 
gut microbiome exist that discriminate among different pathotypes. In this 
study we report on an analysis of 74 cases of human diarrhea in Northern 
Ecuador where six different pathotypes of Escherichia coli were identified 
as the probable causative agent and compare these to 11 cases of diarrhea 
where rotavirus was detected. We compared these samples to those from 
54 healthy samples and 13 samples from other cases of diarrheal disease 
of undefined etiology, from individuals living in the same geographical 
locations. We used 16S rRNA taxonomic profiling combined with 
metagenomic sequencing to assess OTU richness, evenness and diversity in 
both diarrhea and healthy samples and evaluated the effects of additional 
demographic variables in the variation observed at the taxonomic and 
functional level. Our preliminary results have shown a significant reduction 
in OTU richness and diversity in individuals with diarrhea of undefined 
etiology when compared with healthy samples (paired t-test, p = 0.01) 
and that when the causative agent was specified, such as in rotavirus and 
E. coli infections, the diarrheal samples were distinguishable from healthy 
ones based on distinct taxonomic and metabolic differences. We have 
also observed that geographical location and age (but not sex or ethnicity) 
are important factors determining the structure of the healthy gut 
microbiome in individuals from Northern Ecuador and play a significant 
role in the response of the gut microbiota to perturbations generated 
during diarrheal disease. Together, our results advance our understanding 
of how the ecology of the healthy gut microbiota is disrupted during 
pathogen-specific diarrheal infections and provides insight into the role of 
demographic factors in determining gut microbiome response to enteric 
infections.
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Small intestine bacterial overgrowth (SIBO) has been associated with 
intestinal inflammation, linear growth delay, and poor sanitation in 
children from low-income countries. Neither the microbiota that comprises 
SIBO in this setting nor association with enteric pathogens has been 
reported. We tested for SIBO via glucose hydrogen breath testing at 2 
years of age in a cohort of 90 Bangladeshi infants. These children had 
their stool microbiome assessed via 16s rDNA sequencing and analyzed 
via linear discriminant analysis (LDA) effect size (LEfSe) to determine the 
influence of the fecal microbiome on presence of SIBO. Additionally, 
multiplex PCR for 30 enteric pathogens was conducted utilizing a 
Taqman array and analyzed via Fisher’s Exact Test. 15 (16.6%) of the 90 
children tested were SIBO positive. Children with SIBO had a statistically 
significant increase in Lactobacillus spp. (LDA score 3.46, p value 0.03) 
and a decrease in Megasphaera spp. (LDA score 2.38, p value 0.04). There 
was no difference in Shannon Diversity indices between SIBO positive 
and negative children. Pathogen carriage did not differ between the two 
groups for any of the pathogens studied. However, SIBO positive children 
carried more pathogens on average in their stool than the SIBO negative 
group (4.2 vs 3.75 pathogens, p value 0.037). Although changes in the 
stool microbiome were noted, the duodenal microbiome needs further 
investigation. No association with a particular pathogen was found and 
increased asymptomatic pathogen burden is likely a marker of poor 
sanitation, which is known to predispose to SIBO.
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EVALUATION OF THE TEST-NEGATIVE CASE-CONTROL 
DESIGN TO ESTIMATE ROTAVIRUS VACCINE EFFECTIVENESS 
IN LOW-INCOME SETTINGS
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The test-negative case-control study design (TND) is an epidemiologic 
method currently used to measure rotavirus vaccine (RV) effectiveness. 
In this design, vaccination status is compared between rotavirus-positive 
cases and rotavirus-negative controls presenting to the clinic and meeting 
a pre-defined case definition for acute gastroenteritis. Despite the use 
of this study design in low-income settings, the TND has not been 
validated to measure rotavirus vaccine effectiveness. This study builds 
upon prior methods to evaluate the TND for influenza vaccine by using 
a randomized controlled clinical trial database. Similarly, test-negative 
vaccine effectiveness (VE-TND) estimates were derived from three large 
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randomized placebo-controlled trials (RCTs) of monovalent (RV1) and 
pentavalent (RV5) rotavirus vaccines in sub-Saharan Africa and Asia. 
Derived VE-TND estimates were compared to the original RCT vaccine 
efficacies (VE-RCTs). VE-TND and VE-RCT estimates were almost identical 
during the first year of life (RV1: VE-TND (95% Confidence Interval): 
58.2% (35.5-72.9), VE-RCT: 61.2% (44.0-73.2); RV5- sub-Saharan Africa: 
VE-TND: 66.9% (42.7-80.9), VE-RCT: 64.2% (40.2-79.4); RV5- Asia: VE-
TND: 44.4% (-13.2-72.2), VE-RCT: 51.0% (12.8-73.3)). Point estimates 
were also comparable using additional diarrheal surveillance into the 
second year of life, though the VE-TND overestimated the VE-RCT in the 
RV5 trial in sub-Saharan Africa. Analyses restricted to the second year of 
life replicated the limited vaccine efficacy demonstrated in the RCTs. In 
conclusion, TND vaccine effectiveness estimates were nearly equivalent to 
original RCT vaccine efficacies, with some country-specific differences. In 
the RV1 and RV5 trials there were challenges in case capture and varied 
methods of surveillance between study sites. Limitations of the original 
RCTs should be considered when comparing derived effectiveness and 
primary efficacy results. Nevertheless, this study supports the feasible 
and efficient TND as a valid study design to measure rotavirus vaccine 
effectiveness in low-income settings.
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An efficacious Shigella vaccine is a coveted public health intervention. The 
intranasal (IN) route of mucosal delivery has shown promise for subunit 
vaccine administration. The Shigella artificial invasin complex (termed, 
InvaplexAR) contains IpaB, IpaC and S. flexneri 2a LPS. The primary 
objective of this study was to evaluate the safety of InvaplexAR given by 
IN immunization (without adjuvant) assessed by active monitoring during 
the vaccination stage and for 28 days following the third vaccine dose. 
The secondary objectives were to evaluate immune responses and thus 
identify a safe and immunogenic dose of InvaplexAR for advancement 
to preliminary efficacy studies or expanded Phase 1 trials. The study is 
an open-label, dose-escalating first-in-human trial in which volunteers 
received one of four vaccine doses (10, 50, 250 or 500 µg). We have 
immunized all four cohorts enrolling 37 subjects with safety data available 
for the first three cohorts (27 volunteers). The vaccine was administered on 
Days 0, 14, and 28 in a total volume of 200 µL split equally between both 
nostrils and delivered with a nasal spray device (VaxINator ™ distributed 
by Teleflex). Blood, stool, saliva and ocular secretions were collected at 
specified intervals to examine systemic and mucosal immune responses 
directed to Invaplex, LPS, IpaB and IpaC. Peripheral blood mononuclear 
cells were also collected to determine IgA antibody secreting cells and 
antibody lymphocyte supernatant responses. IN immunization with 
InvaplexAR was well tolerated. The overall safety and tolerability profiles 
were consistent with prior IN immunizations. There were no adverse events 
(AEs) that met the vaccination stopping criteria. Most vaccine-related 
AEs were of mild severity. Only three subjects reported AEs of moderate 
severity. The most commonly observed AEs were rhinorrhea (0-33%), nasal 
congestion (11-33%), nasal tenderness, itching and burning (0-33%). 
The VaxINator ™ consistently delivered 200 µl ± 10% of InvaplexAR. 
Immunological assessments are currently underway and will help inform 
future clinical evaluations of the subunit Shigella vaccine.
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The outbreak of Ebola Virus Disease (EVD) in Liberia in 2014-15 infected 
about 10,675 and claimed the lives of more than 4,809 individuals. 
During this period the NTD, NCD and Eye health programmes were 
suspended. By June 2015 the EVD outbreak was under control, the 
Ministry of Health conducted an assessment of communities, health 
facilities and county health teams to understand their perception and 
readiness to resume programmes. The assessment was conducted in all 
counties including surveys of communities and health facilities affected 
and unaffected by EVD. All 36 communities surveyed reported they were 
ready and anticipating the resumption of programmes, especially MDA. 
All the communities desired increased engagement in the programme 
when it restarts as they recognized the benefits it presented. The survey 
also revealed disparities between individual programmes, though there 
is a high degree of acceptance of the lymphatic filariasis programme, 
the awareness and acceptance of the schistosomiasis programme was 
limited. Awareness for leprosy and Buruli ulcer is increasing but is limited. 
The number of trained personnel for these programmes, particularly at 
local health facilities, was found to be very low. This challenge has been 
exacerbated by high turnover of staff, during and following the EVD 
outbreak. Communities which were aware of one or more NCDs (22%) 
wanted treatment but felt they did not have access. Furthermore, eye care 
was very limited with 39% of communities reporting no access while the 
rest reported sporadic visitations by health workers or NGO groups over 
the last 5 years. The assessment highlighted the magnifying role that EVD 
had on the existing gaps within the NTD, NCD and Eye health programme, 
the desire within communities to resume NTD preventative treatment and 
also identified opportunities to build on the lessons learned during the 
outbreak for community mobilisation. The assessment also identified key 
recommendations related to leadership and governance, management and 
coordination, and planning and implementation to enable the programme 
to successfully move forward and increase its impact in post-EVD Liberia.
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EFFECT OF THE NATIONAL SCHISTOSOMIASIS CONTROL 
PROGRAM ON TAENIA SOLIUM TAENIOSIS AND PORCINE 
CYSTICERCOSIS IN RURAL COMMUNITIES OF TANZANIA
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Taenia solium is found throughout sub-Saharan Africa and co-endemic 
with schistosomiasis in many regions. T. solium leads to taeniosis and 
neurocysticercosis - the leading cause of preventable epilepsy globally. 
This study aimed to assess the effects of the National Schistosomiasis 
Control Programme (NSCP) on prevalence of T. solium and porcine 
cysticercosis over a four year period in Tanzania. School-based mass 
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drug administration (MDA) of praziquantel was carried out based on 
schistosomiasis endemicity. Four human and five porcine cross-sectional 
surveys were carried out from 2012 to 2015 in Mbozi and Mbeya district 
in Tanzania. Three rounds of school-based MDA of praziquantel were 
delivered in Mbozi and two in Mbeya by the NSCP. The prevalence of 
taeniosis and porcine cysticercosis was estimated annually. Stool samples 
were collected from humans and prevalence of taeniosis estimated by 
copro-Ag-ELISA. Blood samples from pigs were collected to estimate 
cysticercosis prevalence by Ag-ELISA. “Track and treat” of taeniosis cases 
were carried out after each survey. In total 12,082 stool samples and 
4,579 porcine serum samples were collected. There was a significant 
higher prevalence of taeniosis in Mbozi compared to Mbeya prior to 
the intervention, but no difference at the end of the study. Significantly 
fewer children (≤15) from Mbozi were infected throughout the study than 
children from Mbeya who showed a significant decrease in copro-Ag 
prevalence after the first treatment only. During the final survey in Mbozi 
the prevalence of taeniosis in adults was significantly lower (p=0.031, OR 
0.40, CI: 0.17-0.89), compared to baseline. The prevalence of porcine 
cysticercosis had also dropped significantly (p=0.002, OR 0.49, CI: 
0.32-0.76) in this district compared to baseline, whereas no significant 
difference was seen in Mbeya. The study suggests that three rounds of 
MDA targeting schistosomiasis in school aged children contributed to a 
reduction in prevalence of infection with T. solium in this population, and 
also had a spill over effect on adults in treated areas as well as reducing 
the prevalence of T. solium in the pig population.
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The Togolese Ministry of Health (MOH) utilized their highly successful 
Integrated Neglected Tropical Diseases (NTD) Control Program to identify 
and treat people with trachoma and hydrocele. Every year, Community 
Drug Distributors (CDDs) distribute medication to treat soil-transmitted 
helminths, onchocerciasis, and schistosomiasis. In 2015, the MOH received 
funding from the Bill & Melinda Gates Foundation to pilot a program to 
identify and treat individuals with trichiasis or hydrocele. CDDs identified 
persons with suspected trichiasis or hydrocele while conducting their drug 
distribution activities. A total of 5,665 suspected cases of trichiasis and 
3,573 suspected cases of hydrocele were identified by CDDs nationwide. 
Funding for surgeries was limited, so case confirmation was performed 
first in the districts with the highest numbers of suspected cases. Trichiasis 
confirmation rates were low. Among the 3,269 cases reported in the 
Kara and Savanes regions, 2,143 were examined by ophthalmology 
technicians and only 17 (0.8%) were found to have trichiasis. The most 
common ocular issues identified were conjunctivitis (52%) and cataracts 
(17%). Sixteen of the 17 individuals with trichiasis were successfully 
treated, and one refused surgery. Among the 479 people with suspected 
hydrocele, surgeons examined 121, plus another 81 suspected cases that 
were identified in the field. A total of 202 suspected cases of hydrocele 
were examined, of which 101 were confirmed (50%). The most common 
finding among individuals who did not have hydrocele was hernia (99/101, 
98%). All 101 individuals with confirmed hydrocele had surgical repair, 
with an average hospitalization period of eight days. Togo’s integrated 
NTD drug distribution platform can be an effective means of identifying 
people in need of surgery for trichiasis and hydrocele. CDDs were better 
at identifying hydrocele than trichiasis, and better training of the CDDs 
is needed to help them correctly identify trichiasis. The approach should 
be repeated in subsequent years to identify additional individuals who 
warrant surgery.
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The success of mass drug administration (MDA) for neglected tropical 
diseases is dependent upon achieving adequate drug coverage, which 
is validated through household coverage surveys. Coverage surveys 
rely on respondent recall and often permit proxy responses, whereby 
another household member is allowed to respond on behalf of an 
absent individual. This study used data from coverage surveys for 
lymphatic filariasis in Malawi, Burkina Faso, and Uganda to determine the 
demographic characteristics of individuals for whom a proxy response was 
required and the extent to which a proxy response was associated with 
reported drug coverage. According to our results, teenagers and young 
adults (10 - 25 years) were more likely to be absent during the coverage 
survey and require a proxy response, compared with older adults (OR 1.96, 
p<0.001). Similarly, males were more likely to require a proxy response 
than females (OR 1.76, p<0.001). Adults who were eligible to receive 
MDA for lymphatic filariasis (i.e. everyone, excluding women who are 
pregnant or in the first week of breastfeeding and the severely ill) were 
more likely to be absent and require a proxy response than individuals 
who were ineligible for MDA (OR 2.86, p<0.001). A multivariate analysis 
found that individuals for whom a proxy response was provided had 
1.52 times the odds of being recorded as having swallowed the drugs 
compared to self-reporting individuals, controlling for age and sex (95% 
CI (1.03, 2.24)). This finding is unexpected given that individuals who 
are unavailable at the time of a coverage survey may also have been 
unavailable at the time of MDA, and suggests that proxy respondents 
may be inflating drug coverage. While this finding could be explained in 
part by the fact that self-reporting individuals are more likely to have been 
ineligible to receive MDA and thus are expected to have lower coverage, 
this does not account for the entire increase in odds. This study highlights 
the possibility for recall bias in proxy responses to MDA coverage and 
suggests that further research is necessary to determine the best method 
for obtaining information on drug coverage when individuals are absent.
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Mass drug administration (MDA) has made a major contribution to the 
public health control of neglected tropical diseases across the world. 
The practical benefit of linking programs to increase efficiencies is well 
recognised, but limited in practice by uncertainties about the practical 
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and biological implications of co-administration of drugs. In the Solomon 
Islands, trachoma MDA with azithromycin was implemented in nine 
out of 10 provinces. When a decision was made to extend the program 
to the province of Choiseul, we had an opportunity to investigate the 
feasibility, safety and efficacy of co-administering ivermectin to control 
scabies and impetigo, diseases that were recognised as endemic in a 
number of countries of the Pacific region. The drug delivery infrastructure 
was established using the framework for trachoma. The MDA regimen 
was a single dose of oral azithromycin combined with a single dose of 
oral ivermectin. A second dose of ivermectin was given a week later to 
ensure elimination of scabies eggs that may have been present at first 
visit. Participants in 10 randomly selected villages were asked to undergo 
skin examination to collect scabies and impetigo baseline data. The study 
enrolled 26,188 participants, 99.3% of the total resident population. 
Of those, 98.2% received azithromycin and 98.5% received a first dose 
of ivermectin. A second dose of ivermectin was received by 83.7% of 
participants. In the survey villages, baseline scabies prevalence was 18.7% 
and highest in children aged 5-9 years (34%). Impetigo was present in 
24.8% of participants, and highest in the 5-9 age group (46.4%). There 
were no serious adverse events. Adverse events were noted in 2.6% 
of the entire study population and 4.3% of participants in the more 
closely monitored skin survey sites. At present, this is the world’s largest 
scabies MDA and the first large scale co-administration of Ivermectin and 
Azithromycin. Co-administration of ivermectin and azithromycin appears 
to be safe, well tolerated and feasible.
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Gambian sleeping sickness or HAT (human African trypanosomiasis) is 
a neglected tropical disease caused by Trypanosoma brucei gambiense 
transmitted by riverine species of tsetse. A global programme aims to 
eliminate the disease as a public health problem by 2020. The Mandoul 
area of Chad is a persistent focus of Gambian sleeping sickness where 
more than 100 HAT cases are still diagnosed and treated annually. Up to 
2013, control of HAT relied solely on case detection and treatment, and 
did not lead to a clear and consistent decrease in the annual incidence of 
HAT despite annual screening of the population. We assessed whether the 
addition of vector control to case detection and treatment could reduce 
annual incidence of HAT in Mandoul. In particular, we investigated the 
impact of deploying ‘tiny targets’ which attract and kill tsetse. Before 
tsetse control commenced, a census of the human population was 
conducted and their settlements mapped. A pre-intervention survey of 
tsetse distribution and abundance was implemented in November 2013 
and 2600 targets were deployed in the riverine habitats of tsetse in 
early 2014 and 2015. Impact on tsetse and on the incidence of sleeping 
sickness was assessed through six tsetse monitoring surveys and four 
medical surveys of human population in 2014 and 2015. The census 
indicated that a population of 26600 inhabitants lived in the vicinity of the 
Mandoul focus. Within this focus, the vector is Glossina fuscipes fuscipes 
and the mean catch of tsetse from traps was 0.7 flies/trap/day (range, 
0-26). The catch of tsetse from 44 sentinel biconical traps declined after 
target deployment with only five tsetse being caught in five surveys giving 
a mean catch of 0.009 tsetse/trap/day. Simultaneously, HAT transmission 
declined from a mean of 127 cases/year between 2009 and 2013, to 52 
cases in 2014 and only 25 new cases in 2015 with a similar medical effort.
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Worldwide an estimated 6 billion of the world’s most impoverished 
people, including 875 million children are affected by Neglected Tropical 
Diseases (NTDs) which cause severe pain, long-term disability, and are 
the cause of death for over 500,000 people per year. In 2008, 65.8% 
of Rwandan schoolchildren were affected by Soil-Transmitted Helminth 
(STH) infections. Rwanda Ministry of Health in collaboration with its 
partners had started to implement large-scale NTD control through 
regular Mass Drug Administration (MDA) against these infections as per 
World Health Organization guidelines. Two national mapping surveys 
were conducted in 2008 and 2014 in order to assess schistosomiasis and 
STH prevalence at national level and geographic distribution. In 2008, a 
total of 8,313 schoolchildren aged between 10 and 17 years were tested 
for STH and schistosomiasis using Kato-Katz method. Prevalence of 
urinary schistosomiasis was established by testing for micro-haematuria 
using dipsticks and urine filtration technique. In 2014, a total of 9,250 
schoolchildren aged between 8 and 18 years were tested for STH and 
schistosomiasis using Kato-Katz method while 19,371 schoolchildren were 
tested for schistosomiasis also using Circulating Cathodic Antigen (CCA) 
urine Assay. We carried out trend analysis for schistosomiasis and STH data 
from 28 schools that were randomly selected in both mapping surveys. 
All 28 schools are located in districts that reached at least 75% MDA 
therapeutic coverage for all treatment campaigns. For schistosomiasis, 
eleven (11) schools are located in areas that received praziquantel. Of 
these 11 schools 7 had 100% reduction in prevalence; three (3) had 
reduction between 39.4% and 93.0%. The comparison for STH infections 
showed a remarkable reduction in prevalence for only hookworm with 10 
schools having 100% reduction and 17 schools with a reduction between 
39.4% and 96.4%. These data demonstrate an encouraging quick impact 
of MDA in controlling schistosomiasis and STH and call for continuous 
support to NTD control programs of endemic countries.
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In Senegal scaling-up of control measures has reduced the incidence 
of malaria but transmission persists and new tools are needed to move 
towards elimination. We evaluated a targeted approach, employing IRS 
and chemotherapy implemented in transmission hotspots, on a large 
scale. 40 clusters (health posts) were randomized. In 30 clusters, hotspot 
villages were targeted to receive IRS with Actellic 300CS in July, followed 
381
astmh.org
in 15 clusters by MDA with dihydroartemisinin-piperaquine (DHA-PQ) 
administered to all persons except pregnant women and children under 
3 months of age, at the end of August and again in October. In the other 
15 clusters, persons were screened using a malaria RDT and positives 
treated with DHA-PQ. 10 clusters served as controls. In all three arms, 
health promotion encouraged care seeking for fever, and a free LLIN was 
provided to each malaria patient at health facilities. The intervention 
strategy was delivered over two years. Primary outcomes were malaria 
incidence, and the prevalence of parasitaemia just after the main peak of 
transmission, in year 2. Adherence to treatment, and adverse events, were 
monitored after each round. Acceptability was investigated using in-depth 
interviews, and provider costs of the interventions were assessed. The year 
before intervention, malaria incidence was 11 per 1000, and parasitaemia 
prevalence by microscopy 1.9%. Interventions reduced annual incidence 
within hotspots by 46% (IRS+MDA) and by 52% (IRS+MSAT). Incidence 
in non-target communities within 2km of treated hotspots reduced by 
41% (IRS+MDA) and 24% (IRS+MSAT). The overall efficacy against malaria 
(including target and non-target villages) was 37% (95% CI 31%,44%) 
in the IRS+MDA arm and 44% (38%,49%) in the IRS+MSAT arm. The 
strategies were well accepted and achieved high coverage. The cost of 
MSAT was 30% higher than for MDA. Adding IRS approximately doubled 
the cost. Where scaling-up of existing policies has reduced malaria 
transmission but additional measures are needed for elimination, targeted 
control with IRS and MDA or MSAT could be used to reduce transmission, 
but MDA was cheaper and slightly more effective than MSAT.
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COMPARISON OF MASS DRUG ADMINISTRATION VS. MASS 
SCREENING AND TREATMENT HIGH-RISK, MILITARY MOBILE 
POPULATIONS TO SUPPORT MALARIA ELIMINATION IN 
CAMBODIA
Somethy Sok1, Mariusz Wojnarski2, Satharath Prom1, Soklyda 
Chann2, Michele Spring3, Panita Gosi2, Rathvicheth Bun2, 
Sovanveasna Kin1, Nillawan Buathong2, Mali Ittiverakul2, 
Sabaithip Sriwichai2, Worachet Kuntawunginn2, Huy Rekol4, Muth 
Sinoun4, Thay Khengheng4, Mary So1, Jessica Lin5, Kong Saly1, 
Jessica Manning6, David Saunders7, Philip Smith2, Mark Fukuda2, 
Chanthap Lon2
1Ministry of National Defense, Department of Health, Phnom Penh, 
Cambodia, 2U.S. Armed Forces Research Institute of Medical Sciences, 
Bangkok, Thailand, 3Walter Reed Army Institute of Research, Silver Spring, 
MD, United States, 4National Center for Parasitology, Entomology and 
Malaria Control, Phnom Penh, Cambodia, 5Division of Infectious Diseases, 
University of North Carolina School of Medicine, Chapel Hill, NC, United 
States, 6National Institute of Allergy and Infectious Diseases, National 
Institutes of Health, Bethesda, MD, United States, 7U.S. Army Medical 
Materiel Development Activity, Fort Detrick, MD, United States
The Cambodian government has set a goal for malaria elimination by 
2025. However, the effectiveness of elimination strategies in hard-to-
reach mobile populations, including the military, is largely unknown. We 
are conducting a two-arm, controlled, cluster-randomized, open-label 
pilot study to determine the effectiveness of monthly malaria prophylaxis 
(MMP), using dihydroartemisinin-piperaquine (DP) and weekly primaquine 
(22.5 mg), compared to monthly focused screening (microscopy and 
PCR) and treatment (FSAT) of malaria positive subjects according to the 
national treatment guidelines. After 3 months of interventions, both arms 
will be actively followed for 3 more months to assess malaria incidence 
in the rainy season when malaria usually peaks. Of 1,114 active duty 
military and dependents screened in Oddor Meanchay province near the 
Thai-Cambodian border, 1,050 volunteers were enrolled into 8 clusters. 
We noted reductions of malaria incidence within 2 months in both arms 
from a baseline prevalence of 53/516 (10.3%; 39 cases of Plasmodium 
falciparum (P.f), 13 cases of P. vivax (P.v) (P.v, 1 cases of mixed) and 91/534 
(17.0%; 45 cases of P.f, 38 cases of P.v, 8 cases of mixed) malaria positive 
at screening in the FSAT and MMP arms, respectively. In the first month, 
8/509 (1.6%) subjects from the FSAT arm and 2/529 (0.4%) from the 
MMP arm had a P. falciparum requiring an unscheduled visit, with an 
additional 10/509 (1.9%) in the FSAT and 16/529 (3.0%) in the MMP 
being malaria positive on the day 30 follow-up visit (p=0.906). On day 
60 follow up, only 6/489 (1.2%; 0 cases of P.f and 6 cases of P.v) and 
2/504 (0.4%; 1 cases of P.f, 0 cases of P.v) subjects were malaria positive 
by microscopy or PCR in FSAT and MMP arms, respectively, showing 
low parasitemia in both treatment arms (p=0.172), reaching statistical 
significance by month 3 follow-up, with 20/472 and 0/502 cases of 
malaria in FSAT and MMP arms, respectively (p<0.001). The number of 
subjects withdrawn or lost to follow up remains low at around 3% in each 
arm. Most malaria cases in the MMP arm occurred within 1 month of 
follow-up and likely represent P.f treatment failures of DP. Final outcome 
data from 6 months of follow-up will be presented.
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RELATIVE CONTRIBUTION OF GENERALIZED EARLY 
DIAGNOSIS AND TREATMENT AND OF TARGETED 
MASS TREATMENT TO ELIMINATION OF PLASMODIUM 
FALCIPARUM MALARIA IN EASTERN MYANMAR
Jordi Landier1, Daniel M. Parker1, Aung Myint Thu1, Ladda 
Kajeechiwa1, May Myo Twin1, Stephane Proux1, Khin Maung 
Lwin1, Saw Diamond Khin2, Ed Marta3, Gilles Delmas1, François 
Nosten1
1Shoklo Malaria Research Unit - Mahidol Oxford Tropical Medicine Unit, 
Mae Sot, Thailand, 2Karen Department of Health and Welfare, Mae Sot, 
Thailand, 3Karen Department of Health and Welfare, Hpa’an, Myanmar
Plasmodium falciparum (PF) malaria elimination is on the agenda of 19 
countries. In the Greater Mekong Sub-region, elimination is of particular 
interest and urgency because of the threat of spreading artemisinin 
resistance. In coordination with community-based health organizations 
and the Myanmar National Malaria Control program, the Malaria 
Elimination Task Force was set up to develop strategies and to implement 
a regional approach towards PF elimination in 4 districts of Eastern 
Myanmar. Malaria Posts (MP) were deployed in each community of the 
target area to provide access to early diagnosis and treatment of malaria. 
MP reported PF and P. vivax (PV) case data weekly. Village-level malaria 
prevalence was measured in surveys analyzed by ultrasensitive qPCR. 
Hotspots of asymptomatic malaria prevalence were defined by malaria 
prevalence > 40% with PF representing >20% of all malaria infections. 
Hotspots were addressed by 3 rounds of targeted mass treatment (TMT) 
using dihydroartemisin-piperaquine. A generalized linear mixed model 
adjusting for season and location was used to analyze PF case counts, 
monitor trends in PF incidence and determine the relative contribution 
of MP and TMT to malaria elimination. From May 2014 to April 2016, 
>800 villages were equipped with MP and reported weekly data. Out of 
218 surveys performed, 43 hotspots were identified and addressed with 
3 consecutive months of TMT between January 2015 and March 2016. 
The probability of an MP declaring ≥1 PF case during its first month of 
operation was 26% and decreased to below 10% after 18 months, while 
the probability of declaring ≥1 PV case remained stable around 30%. 
The PF incidence rate ratio (IRR) for 10 additional weeks of MP operating 
in a village was 0.78 (95%CI=0.74-0.82). Before TMT IRR for hotspot 
villages compared to non-hotspot villages from the same area was 2.6 
(95%CI=1.3-5.0). After TMT incidence in hotspot villages was similar to 
non-hotspot villages (IRR=1.4; 95%CI=0.6-3.5). Over 24 months of follow-
up, the deployment of an MP network in 4 districts triggered a strong 
decrease of PF incidence rate. TMT proved to accelerate the decrease in 
high prevalence villages.
382
astmh.org
1218
IMPACT OF MASS DRUG ADMINISTRATION WITH 
DIHYDROARTEMISININ-PIPERAQUINE ON MALARIA 
TRANSMISSION IN A HIGHLY SEASONAL TRANSMISSION 
SETTING IN THE GAMBIA
Julia Mwesigwa1, Jane Achan2, Muna Affara2, Cessay Sainey2, 
Archibald Worwui2, Koen Peeters Grietens3, Jean-Pierre Van 
Geertruyden4, Umberto D’Alessandro5
1Medical Research Council Unit, The Gambia and Epidemiology for Global 
Health Institute, University of Antwerp, Banjul, Gambia, 2Medical Research 
Council Unit, The Gambia, Banjul, Gambia, 3Institute of Tropical Medicine, 
Antwerp, Belgium, 4Epidemiology for Global Health Institute, University of 
Antwerp, Antwerp, Belgium, 5Medical Research Council Unit, The Gambia 
and London School of Hygiene & Tropical Medicine, Banjul, Gambia
There is renewed interest in mass drug administration (MDA) as a strategy 
to interrupt malaria transmission in settings approaching elimination. Data 
on its impact in areas with seasonal and heterogeneous transmission are 
limited. The objective of the study is to evaluate the impact of MDA with 
Dihydroartemisinin-Piperaquine (DHA/PPQ) on Plasmodium falciparum 
carriage in low-moderate transmission settings in The Gambia. In June 
2014, the start of the transmission season DHA/PPQ was administered 
using weight based dosing to residents between ≥6 months and <75 
years of age in twelve villages across the five regions of the country. A 
baseline community survey was conducted prior to MDA. Participants 
were followed up with monthly surveys from July to December. Finger 
prick blood samples were collected for parasite detection using diagnostic 
PCR. A total of 3888/4677 (83.1% of the population) were eligible and 
received DHA/PPQ. All pregnant participants or elderly participants over 
75 years were excluded (4.2%, 172/4060). The prevalence of P. falciparum 
post-MDA was 5.43% (170/3130; 95%CI 4.6-6.2%). The villages in the 
eastern region where transmission is moderate had a 44.03% reduction 
in prevalence (12.9%, 327/2527 in 2014 vs 23.1%, 1185/5141 in 2013) 
while in the rest of the country where transmission is low villages in the 
central and western regions there was a 17.0% reduction in infection 
prevalence 3.9% (81/4691) in 2014 and 4.6% (637/13727) in 2013. 
Preliminary results show, the overall incidence rate of P. falciparum 
parasitemia was 0.2 (95%CI: 0.2-0.2) episodes per person-year at risk in 
the 2014 transmission season. The risk of P. falciparum decreased with 
increase in age; children 5-15 years (HR=1.7, 96%CI: 1.3-2.2) and adults 
15-29.9 years; HR=1.4, 95%CI: 1.10-1.9). The risk of infection increased 
with severity of anaemia (severe anaemia; HR=3.1, 95%CI: 1.6-6.4). 
The most significant impact of MDA on P. falciparum carriage was in 
communities located in areas with moderate transmission compared to 
areas with very low prevalence. MDA might be considered as an additional 
intervention in areas of on-going moderate malaria transmission.
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FREEDOM FROM INFECTION: MEASURING THE 
INTERRUPTION OF MALARIA TRANSMISSION
Gillian H. Stresman1, Nuno Sepulveda1, Kimberly Fornace1, 
Thomas P. Eisele2, Justin M. Cohen3, Chris Drakeley1
1London School of Hygiene & Tropical Medicine, London, United Kingdom, 
2Center for Applied Malaria Research and Evaluation, Tulane School of 
Public Health and Tropical Medicine, New Orleans, LA, United States, 
3Clinton Health Access Initiative, Brooklyn, NY, United States
Good malaria surveillance is the foundation for effective malaria 
elimination efforts and should generate timely and actionable information 
for decision makers. Measuring elimination poses a specific challenge in 
that it involves proving a negative: when a country shifts into the scenario 
of zero-malaria reporting, improved strategies are required for identifying 
areas where there is more or less certainty in having achieved elimination. 
Here, we present quantitative tools by which the probability of having 
achieved freedom from malaria infections can be calculated. These 
tools are applied to the malaria context in order to provide accessible 
and actionable tools for countries engaging in malaria elimination and 
are evaluated against the current WHO guidelines. Assuming a single 
population of 100,000 people (i.e. a health facility catchment area), 
reporting zero cases per month over three years, results suggest we can 
achieve a 95% probability that there are in reality fewer than 100 cases. 
We can be sure that there are fewer than 50 cases with a probability of 
80% or 95% in 5 or 15 years of monthly zero reporting, respectively if 
relying solely on passive surveillance. To improve the probability of freedom 
achieved within 3 years, programs have the option for supplementing 
passive surveillance with active ‘freedom’ surveys that will increase the 
system sensitivity for that reporting month. To achieve a high probability 
of achieving freedom within 3 years, at least 2 population-based ‘freedom 
surveys’. Therefore, the freedom tools can be used for estimating the level 
of confidence that has been achieved in asserting a malaria-free status 
and for informing programs where and how to target efforts to boost 
to the desired level of certainty that elimination has been achieved. Such 
an approach is particularly important in settings that are accelerating the 
timeline to elimination where it is paramount to measure the absence 
transmission on a shortened timeline.
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THE NATURAL HISTORY OF MALARIA ELIMINATION IN 
SOUTHERN ZAMBIA
Kelly M. Searle1, Timothy M. Shields1, Ben Katowa2, Jailos 
Lubinda2, Harry Hamapumbu2, Tamaki Kobayashi1, Philip E. 
Thuma2, Frank Curriero1, William J. Moss1
1Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United 
States, 2Macha Research Trust, Macha, Zambia
As areas transition from malaria control to elimination, targeted 
interventions will be needed. Knowledge of changing spatial and temporal 
patterns of transmission and parasite genetic structure and divergence 
can guide elimination efforts. This study describes the natural history of 
malaria elimination in the catchment area of Macha Hospital in Choma 
District, Southern Province, Zambia. Passively-detected, symptomatic 
cases of malaria were reported from six rural health centers from August 
2008 to September 2015. Seasonal malaria incidence was estimated for 
each catchment area and spatial patterns were evaluated. Asymptomatic, 
infected individuals were identified through active case detection using 
rapid diagnostic tests and PCR for Plasmodium falciparum in population-
based, longitudinal and serial cross-sectional cohort studies conducted 
from February 2008 to October 2013. Spatial clusters of asymptomatic 
cases were estimated and seasonal overlap was assessed. A 24 single 
nucleotide polymorphism molecular barcode was used to determine the 
genetic relationship between P. falciparum parasites from symptomatic and 
asymptomatic cases. Genetic relatedness was analyzed using phylogenetic 
trees and genomic divergence was calculated for each season. After the 
2009-2010 transmission season, the incidence of symptomatic cases 
shifted from an annual to a biannual pattern and parasite prevalence by 
active case detection decreased substantially. A fractured spatial pattern 
was observed for symptomatic cases after the 2010-2011 transmission 
season. Phylogenetic trees showed independent clustering of symptomatic 
and asymptomatic cases, suggesting asymptomatic infected individuals 
were not contributing substantially to on-going transmission. Genetic 
complexity was high in asymptomatic cases, consistent with a chronically-
infected reservoir, and low in symptomatic cases. Parasite genetic 
divergence decreased among asymptomatic cases, indicating loss of 
parasite diversity in this chronically-infected reservoir, but remained high in 
symptomatic cases, consistent with some degree of parasite importation.
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GENOMIC TOOLS REVEAL TRENDS IN PLASMODIUM 
FALCIPARUM PARASITE DIVERSITY ACROSS TRANSMISSION 
GRADIENTS WORLDWIDE
Rachel Fath Daniels1, Awa B. Deme2, Amy K. Bei2, Adam 
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Research Unit (MORU), Bangkok, Thailand, 12London School of Hygiene 
& Tropical Medicine, London, United Kingdom, 13Radboud University 
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of Medicine, Blantyre, Malawi, 17The Broad Institute, Cambridge, MA, 
United States, 18Michigan State University, East Lansing, MI, United 
States, 19Weill Medical College of Cornell University, New York, NY, United 
States, 20Malaria Control Program (PATH), Seattle, WA, United States, 
21National Institutes of Health, Rockville, MD, United States, 22World 
Health Organization, Geneva, Switzerland, 23Centers for Disease Control 
and Prevention, Atlanta, GA, United States, 24Cheikh Anta Diop University, 
Dakar, Senegal, 25Harvard University, Cambridge, MA, United States
Recent progress in malaria control and elimination has underscored the 
need for development of new tools and methodologies to assess progress 
towards programmatic milestones and signal program reorientation. 
The renaissance of genomic approaches to complement epidemiological 
tools has offered unparalleled opportunities to better assess the parasite 
population underlying characteristic epidemiological signals, such as 
transmission intensity. However, there are few data relating the signals of 
parasite diversity to transmission intensity levels from global populations. 
The current study assessed the correlation of genetic-based signals of 
parasite populations to determine their usefulness as a proxy for relative 
transmission levels. Plasmodium falciparum complexity of infection (COI), 
relatedness, and clonality from a worldwide population of parasites from 
Southeast Asia (Bangladesh and Cambodia), the Americas (Panama, 
Peru, and Haiti), and Africa (Zambia, Mozambique, Malawi, Burkina Faso, 
Uganda, and Senegal) were assessed using the molecular barcode. The 
results of this analysis showed clear trends in parasite populations along 
the gradient of transmission intensity, both within and between countries. 
Samples from regions with relatively low intensity, such as those from the 
Americas, showed increased clonality and a clear ability to track individual 
parasite lineages during epidemic outbreaks. In contrast, areas with high 
transmission had reduced clonality and overall relatedness compared to 
low transmission settings. Furthermore, sampling of 6 surveillance sites 
within Senegal also demonstrated that relative transmission intensity 
was associated with characteristic population diversity, as well as several 
instances of parasite lineages shared between regions, suggestive of 
importation. The findings of this study support the usefulness of genomic 
tools such as the molecular barcode for programmatic surveillance. These 
tools require sampling a small number of individuals to provide real-time, 
informative data with operational applications and the potential to impact 
national and regional policies.
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HOST EXPOSURE TO EARLY LIFE STAGES OF SCHISTOSOMA 
HAEMATOBIUM DOES NOT ALTER THE BLADDER RESPONSE 
TO EGGS
Loc Le, Michael Hsieh
Biomedical Research Institute, Rockville, MD, United States
Despite the significant impact of urogenital schistosomiasis (Schistosoma 
haematobium infection) in endemic regions, relatively little is known 
regarding the pathophysiology of this disease. Primate models remain a 
powerful tool to approximate human schistosomiasis, yet many technical 
reasons prevent widespread use of these models, including high costs, low 
availability, and ethical considerations. Infecting rodents percutaneously 
with S. haematobium cercariae, the route of natural human infection, 
results in low or no involvement of the urogenital system. Previously, 
we have developed a mouse model of urogenital schistosomiasis that 
bypasses this limitation via microinjection of viable S. haematobium eggs 
directly into the bladder wall. This model recapitulates many relevant 
sequelae found in human disease, including granuloma formation, urinary 
tract fibrosis and dysfunction, and systemic Th2 responses. However, it 
is unclear whether the absence of host exposure to the early parasite life 
stages (cercariae, schistosomules, and worms) prior to egg deposition in 
the bladder affects the resulting systemic and local immune response. We 
addressed this question by comparing mice that underwent bladder wall 
injection with S. haematobium eggs to mice that were percutaneously 
infected with S. haematobium cercariae followed 8 weeks later by 
microinjection of their bladder walls with S. haematobium eggs. Portions 
of these mouse cohorts were also treated with praziquantel following 
bladder wall injection. Based on worm counts, histology, and cytokine 
analyses, we conclude that while subtle differences exist, bladder wall 
injection with S. haematobium eggs alone may be sufficient to model 
urogenital schistosomiasis in mice. These findings also have implications 
for understanding chronic egg-induced bladder inflammation in people 
who have been cured of schistosomiasis by drug therapy and/or acquired 
immunity. Namely, the absence of continued antigenic stimulation by 
early parasite life stages may not impact ongoing bladder inflammation 
triggered by previously deposited S. haematobium eggs.
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MATERNAL SCHISTOSOMA MANSONI INFECTION ALTERS 
THE IMMUNE RESPONSE OF OFFSPRING TO TETANUS AND 
DIPHTERIA IMMUNIZATION
Diana Cortes Selva, Andrew Ready, Keke C. Fairfax
Purdue University, West Lafayette, IN, United States
Maternal helminth infections have been implicated in the reduced efficacy 
of critical life saving neonatal and childhood vaccines. Approximately 40 
million women of childbearing age are at risk for schistosomiasis and at 
least 10 million women in Africa have schistosomiasis during pregnancy, 
yet little is known about the impact of prenatal exposure on the immune 
responsiveness of offspring. Findings from previous studies indicate that a 
fetus can be exposed to helminth antigens in utero, so the high frequency 
of schistosomiasis in this population represents a significant potential 
public health problem. The underlying mechanisms through which 
maternal infection with helminths, such as Schistosoma mansoni, function 
to negatively impact neonatal vaccine responses, however, remain to be 
discovered. We sought to determine the immunological mechanism(s) 
through which responses to immunization with tetanus/diphtheria are 
altered following prenatal S. mansoni infection in an experimental mouse 
model of S. mansoni infection. Interestingly, offspring from infected 
mothers exhibited smaller germinal centers after immunization with 
Tetanus/Diphteria than pups born to uninfected mothers. In addition, 
384
astmh.org
the offspring from infected mothers presented decreased numbers of 
IL-4 secreting TFH cells and decreased expression of B cell co-stimulatory 
markers in comparison to age-matched offspring of uninfected mothers. 
These profound alterations suggest a possible mechanism for the 
previously reported reductions in vaccine specific titers in offspring born to 
helminth infected mothers in endemic countries.
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RECOMBINANT PARAMYOSIN IN MONTANIDE ISA 206 
PROTECTS WATER BUFFALO FROM SCHISTOSOMA 
JAPONICUM INFECTION
Hannah Wu
Brown University, Providence, RI, United States
Schistosomiasis japonica is a zoonosis and a major disease risk for more 
than 40 million people in China and 7 million more in the Philippines. 
Because water buffalo play a critical role in transmission to humans, a 
veterinary vaccine would have a significant impact on prevalence and 
incidence of human infection while also improving animal health and 
economic output. Paramysin (Sj97) is a 97 kDa myofibrillar protein with a 
coiled-coil structure found only in invertebrates. We successfully produced 
pilot-scale recombinant full-length paramyosin (rSj97) and assessed its 
safety and efficacy in vaccine challenge experiments in water buffalo. A 
three-dose regimen with 250 or 500 mg rSj97/dose in ISA206 was well 
tolerated with no severe adverse events, no differences in body condition 
score and no differences in serum chemistry assays compared to controls. 
In our first challenge trial, buffalo were immunized three times at 4-week 
intervals with 250 mg /dose rSj97 in ISA206 (n=7) or ISA206 alone (n=6). 
Buffalo were challenged with 1,000 S. japonicum cercariae and perfused 
8 weeks post challenge. Worm burdens were reduced by 51.5%, but this 
reduction did not achieve statistical significance, likely due to small sample 
size. In a second vaccine-challenge experiment of similar design, buffalo 
immunized with 500ug/dose of rSj97 in ISA206 had 60.9% lower worm 
burdens compared to adjuvant controls (p=0.05). A similar reduction 
(57.8%) was observed with animals immunized with 250ug rSj97/dose. 
Egg recovery from liver tissue was positively correlated with worm burden 
(R2=0.4876, p<0.001), while anti-rSj97 specific IgG2 titers at 4 weeks 
after 3rd immunization were negatively correlated with worm burden 
(R2= -0.275, p=0.03). Moreover, rSj97 stimulated markedly increased 
IFN-gamma levels in whole blood cultures from rSj97-ISA206 immunized 
animals compared to controls. These findings indicated that rSj97 is a safe 
and promising schistosomiasis veterinary vaccine and mandate further 
evaluation of rSj97 based vaccine safety and efficacy.
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A MICROFILTRATION DEVICE FOR DIAGNOSIS OF 
UROGENITAL SCHISTOSOMIASIS
Yuan Xiao1, Yi Lu1, Michael Hsieh2, Joseph Liao3, Pak K. Wong1
1Pennsylvania State University, University Park, PA, United States, 
2Children’s National Medical Center, Washington, DC, United States, 
3Stanford University School of Medicine, Stanford, CA, United States
Urogenital schistosomiasis, infection of the urinary tract by Schistosoma 
haematobium worms, is a cause of urologic disease in over 112 million 
people worldwide. The diagnostic standard of care, counting eggs in 
urine, is slow, making it difficult to use as a point-of-care test for infection. 
This is a major barrier to mass drug administration campaigns seeking 
to eliminate S. haematobium. Herein we describe the development of a 
microfiltration device for trapping, isolation, and on-chip fluorescence 
characterization of schistosome eggs toward rapid diagnostics of 
urogenital schistosomiasis. The device comprises a linear array of 
microfluidic traps to immobilize and separate eggs of S. haematobium 
from urine. The trap array allows sequential loading of individual eggs 
by flow resistance to facilitate observation and enumeration of samples 
with low-abundance targets. Computational fluid dynamics modeling and 
experimental characterization are performed to optimize the trap design 
for enhancing the trapping efficiency and throughput. The microfiltration 
device is capable of isolating schistosome eggs from urine and the trapped 
eggs can be recovered for downstream analysis. The trapping efficiency 
of the device is 100% with 300 µl/min and 83% with 3000 µl/min. The 
filtration procedure can be finished within 10 min. The microfiltration 
device is capable of isolating schistosome eggs from urine and the trapped 
eggs can be recovered for downstream analysis. On-chip staining is 
demonstrated in the microfiltration device for fluorescence analysis of 
schistosome eggs. In conclusion, our results are proof of concept that a 
microfluidics device can be used to more efficiently trap and separate S. 
haematobium eggs in urine. Further optimization of this device may lead 
to a point-of-care diagnostic suitable for use in the field.
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AN EGG PROTEIN FROM SCHISTOSOMA MANSONI IS 
PROMISING FOR DEVELOPMENT OF HIGH-SPECIFICITY 
DIAGNOSTICS IN THE ERA OF INTENSIFIED CONTROL
Vanessa Silva-Moraes1, Paulo M. Coelho1, Donald A. Harn2, 
Flavia F. Couto1, William C. Borges3, Rafaella F. Grenfell1, Ana Lucia 
T. Rabello1, Lisa M. Shollenberger2
1Rene Rachou Research Center - Oswaldo Cruz Foundation, Belo 
Horizonte, Brazil, 2University of Georgia, Athens, GA, United States, 
3University Federal of Ouro Preto, Ouro Preto, Brazil
Schistosomiasis is a serious global public health problem. The standard for 
diagnosis is the Kato-Katz method, which has low sensitivity and therefore 
does not work well on patients with low-level infections, representing the 
majority of cases. Adding tests such as ELISAs using soluble egg antigens 
(SEA), increases diagnostic accuracy in low burden areas of Minas Gerais, 
Brazil. However, crude SEA antigens have low-specificity and cross-react 
with other helminthes. Therefore, the goal of this work is to identify SEA 
proteins with high schistosomiasis specificity, as well as the sensitivity to 
differentiate between active (acute and chronic) and cured (post-treatment 
phase) infections, in order to develop point-of-care (POC) tests as well 
as improve others diagnostic methodologies. To complete these studies, 
SEA was generated from mice 45 days after infection with Schistosoma 
mansoni. Using a protocol approved by the Brazilian Ethical Committee, 
human serum was obtained in Minas Gerais from each group: healthy 
volunteers (negative controls); schistosome acute, chronic and post-
treatment patients; and patients infected with other helminthes. The 
sample from each group were submitted to two-dimensional Western 
blot (2D-WB) using native and sodium metaperiodate (SMP) treated SEA. 
The immunoreactive spots were identified by mass spectrometry and 
analyzed by bioinformatics tools. A total of 23 spots were identified by 
serum from Schistosoma infected patients. Among these, 22 spots were 
identified by serum from patients infected with other helminths, and 9 
by negative control samples. One spot was uniquely recognized by sera 
from Schistosoma-infected patients and detection remained after sugar 
denaturation by SMP treatment, suggesting serum antibodies were 
binding to peptide epitopes. We identified a potential egg protein from 
this unique spot, for which we are developing monoclonal antibodies, 
toward the development of POC immunodiagnostic test and highly specific 
ELISAs. Further, the fast, simple POC assay requires minimal equipment 
and will be an accurate screening tool for epidemiologic surveying in low 
resource regions.
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MAPPING OF SCHISTOSOMIASIS IN RWANDA: USE OF POC-
CCA VERSUS KATO-KATZ
Corine K. Karema1, Irenee Umulisa1, Daniel G. Colley2, Eugene 
Ruberanzinza1, Jamie Tallant3, Tharcisse Munyaneza4, Ortu 
Giussepina5, Jean Baptiste Mazarati6, Carl H. Campbell7, Agnes 
Binagwaho8, Alan Fenwick5
1Malaria and Other Parasitic Diseases Division, Kigali, Rwanda, 2SCORE, 
University of Georgia, Athens, GA, United States, 3The END FUND, 
London, United Kingdom, 4National Reference Laboratory, Ministry of 
Health, Kigali, Rwanda, 5Schistosoma Control Initiative, London, United 
Kingdom, 6Biomedical Services Department-RBC, Ministry of Health, 
Kigali, Rwanda, 7SCORE, University of Georgia, Athens, GA, United States, 
8Global Health and Social Medicine at Harvard Medical School, Ministry of 
Health, Kigali, Rwanda
Worldwide an estimated 240 million of the world’s most impoverished 
people are affected by schistosomiasis. Classic severe schistosomiasis-
related morbidities include periportal fibrosis in intestinal schistosomiasis 
caused by Schistosoma mansoni and S. japonicum, and bladder deformity 
and hydronephrosis caused by S. haematobium. However, the more subtle, 
but nonetheless disabling morbidities of anemia, growth stunting, and, 
cognitive impairment likely represent the wider public health challenge. 
In 2008, the Rwanda Ministry of Health in collaboration with its partners 
began implement large-scale NTD control, including schistosomiasis, 
through regular mass drug administration (MDA) against these infections 
as per WHO guidelines. A national NTD mapping survey was carried out 
from June to mid-July 2014, using both the Kato-Katz and the Point-Of-
Care Circulating Cathodic Antigen (POC-CCA) assays for detection of 
Schistosoma mansoni. Fifty children of the required age (primarily 13-14 
years) were randomly selected in each of 399 schools. For diagnosis of S. 
mansoni duplicate fecal Kato-Katz thick smears and the urine POC-CCA 
test were performed. A total of 19,934 pupils were included, with 19,371 
from 388 schools tested with POC-CCA and 9,250 from 186 schools 
tested with Kato-Katz. There was an approximately equal number of boys 
and girls sampled in each school. Ages of the sampled children ranged 
from 8 to 18 years, although 88% of children sampled were 13 or 14 
years, and 98% of children were in the range of 10-14 years. When POC-
CCA Traces readings were considered negatives, overall schistosomiasis 
prevalence was 7.4% (95%CI: 5.7%-9.5%) with 0.6%-16.7% as range 
in mapping units; when POC-CCA Traces readings were considered 
positives, overall schistosomiasis prevalence was 36.1% (95%CI: 32.6%-
39.8%) with a range of 10.8%-63.8% in mapping units; With Kato-Katz 
overall schistosomiasis prevalence was 1.9% (95%CI: 1.1%-3.3%) with a 
range of 0.0%-9.4% in mapping units. Results from this mapping survey 
demonstrate issues in the use of POC-CCA in the implementation of 
national program and the need for related WHO guidelines.
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A NOVEL CELL FREE DNA DETECTION ASSAY FOR THE 
DIAGNOSIS OF SCHISTOSOMIASIS JAPONICA
Kosala G. Weerakoon, Catherine A. Gordon, Geoffrey N. 
Gobert, Pengfei Cai, Donald P. McManus
QIMR Berghofer Medical Research Institute, Brisbane, Australia
Accurate diagnostics play a pivotal role in achieving current schistosomiasis 
control and elimination goals. Lack of accuracy and inability to detect pre-
patent infections are major limitations of current diagnostic procedures. 
We have optimised a novel droplet digital PCR duplex assay for the 
diagnosis of schistosomiasis japonica which provides improved detection 
sensitivity and specificity. The assay involves the amplification of two 
specific and abundant target gene sequences in Schistosoma japonicum; 
a retrotransposon (SjR2) and a mitochondrial gene (nad1). The assay 
detects target sequences from different schistosome lifecycle stages (adult 
worms, schistosomules and eggs) and exhibits a high level of specificity, 
representing an ideal tool for the detection of low levels of parasite DNA in 
different clinical samples. Following optimization, the assay was validated 
using a S. japonicum-infected mouse model. It detected both pre-patent 
and patent infections using serum, urine and faecal DNA collected at 
different time points. There was a positive correlation between the gene 
copy numbers and the intensity of infection determined by egg and worm 
counts. The assay is quantitative and can be used to determine parasite 
infection intensity and will be an important diagnostic tool, particularly for 
the detection of low intensity infections in low prevalence schistosomiasis-
endemic areas.
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MATURATION OF FLAVIVIRUSES AND ROLE IN DISEASE
Richard J. Kuhn1, Devika Sirohi1, Zhenguo Chen1, Victoria 
Hendrik1, Andrew S. Miller1, Valorie D. Bowman1, Swati 
Mukherjee42, Michael G. Rossmann1, Theodore C. Pierson2
1Purdue University, West Lafayette, IN, United States, 2National Institute of 
Allergy and Infectious Diseases, Bethesda, MD, United States
Many viruses are initially assembled in host cells in a non-infectious 
immature form and are converted to their mature infectious state 
through a series of coordinated events requiring specific triggers. This 
prevents premature disassembly of these viruses during egress from 
host cells. For flaviviruses, the maturation process involves pH-driven 
structural rearrangements of precursor Membrane (prM) and Envelope 
(E) glycoproteins and furin protease-mediated cleavage of prM during 
transit through the trans-Golgi network. Despite the cleavage of prM 
being crucial for virus infectivity, this process is inefficient for dengue 
virus (DENV). Virus preparations comprise a continuum of particles with 
variable maturity from immature ‘spiky’ (having high prM content) to fully 
mature ‘smooth’ particles (having low or zero prM content) determined 
using cryo-electron microscopy. The consequence of inefficient maturity 
is structural heterogeneity that may be advantageous for the virus 
for immune evasion and pathogenesis. We have developed sensitive 
biochemical and biophysical tools to quantitate the maturity of DENV and 
other flaviviruses and explore the role of prM in virus dynamics, disease 
pathogenesis and vaccine design/quality control. We have developed a 
mass spectrometry-based selected reaction monitoring assay and use it 
in tandem with cryo-electron microscopy to probe prM content/ maturity 
of different serotypes of DENV produced in cell culture and are currently 
developing protocols to study virus produced from natural infection of 
mosquitoes (vector) and humans (host). Using these methods, we have 
detected differences in the cleavage efficiency of prM among different 
serotypes of DENV that have implications in virus breathing, structural 
dynamics and specific infectivity. These studies have been broadened 
to examine this cleavage and its effect on virus structure using other 
flaviviruses.
1230
FLAVIVIRUS NS1 PROTEINS DIFFERENTIALLY INDUCE 
HYPERPERMEABILITY IN HUMAN ENDOTHELIAL CELL 
MONOLAYERS FROM DISTINCT TISSUE TYPES
Henry N. Puerta-Guardo, Dustin R. Glasner, Eva Harris
Division of Infectious Diseases and Vaccinology, School of Public Health, 
University of California Berkeley, Berkeley, CA, United States
Dengue (DENV), Japanese encephalitis (JEV), West Nile (WNV), yellow 
fever (YFV) and Zika (ZIKV) viruses belong to the Flavivirus genus, 
Flaviviridae family. Severe dengue disease is characterized by increased 
vascular leakage leading to pleural effusion, causing hypotension and 
death. In contrast, WNV and JEV infections can result in neurological 
diseases, including encephalitis. ZIKV appears to cause pathology in 
both the placenta and the fetal brain. Evidence suggests that disruption 
of physiological barriers such as the microvascular endothelium or the 
blood brain barrier can play a critical role in flavivirus pathogenesis. 
Recently, we described a direct effect of DENV non-structural protein 1 
(NS1) in triggering endothelial barrier dysfunction in human pulmonary 
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microvascular endothelial cells (HPMEC) in vitro and systemic vascular 
leakage in vivo. Here, we examined the ability of flavivirus NS1 proteins to 
interact and modulate endothelial barrier function of different endothelial 
cell (EC) types: HPMEC, human dermal EC (HMEC-1), brain microvascular 
EC (HBMEC), and umbilical vein EC (HUVEC). We show that flavivirus 
NS1 proteins interact with the surface of human EC and alter the barrier 
function, as measured by Trans-endothelial Electrical Resistance (TEER), 
in a cell-type dependent manner. DENV2 NS1 induced permeability in all 
endothelial cell types tested. However, WNV and JEV NS1 only significantly 
reduced TEER of HBMEC. ZIKV increased permeability only in HUVEC. YFV 
NS1, a flavivirus that causes severe hepatic injury, moderately increased 
permeability of only HPMEC. Ongoing TEER experiments using hepatic 
endothelial cells will further explore this specificity. These in vitro EC 
permeability results appear to reflect the tropism of the disease caused 
by each virus. Our findings propose a mechanism by which flavivirus NS1 
proteins differentially cause endothelial barrier dysfunction, potentially 
resulting in increased plasma leakage, inflammation, or virus dissemination 
through different biological barriers as a part of the flavivirus pathogenesis 
process.
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DISCOVERY OF SMALL MOLECULE BIOMARKERS THAT 
PROVIDE METABOLIC SIGNATURES TO DIFFERENTIATE 
DENGUE, CHIKUNGUNYA AND ZIKA VIRUS INFECTIONS AND 
DENGUE DISEASE SEVERITY
Rushika Perera1, Kimberly Anderson1, Kristofor Webb1, Barbara 
G. Andre1, Lionel Gresh2, Angel Balmaseda3, Barry Beaty1, Eva 
Harris4, Carol D. Blair1
1Colorado State University, Fort Collins, CO, United States, 2Sustainable 
Sciences Institute, Managua, Nicaragua, 3Laboratorio Nacional de 
Virología, Centro Nacional de Diagnóstico y Referencia, Ministry of Health, 
Managua, Nicaragua, 4Division of Infectious Diseases and Vaccinology, 
School of Public Health, University of California, Berkeley, CA, United 
States
Chikungunya (CHIKV) and Zika viruses (ZIKV) are now co-circulating 
with dengue viruses (DENV) in over 30 countries in the Americas. 
Accurate diagnoses and prediction of disease severity using acute 
phase clinical specimens is critical for appropriate triaging and better 
clinical management of diseases caused by these viruses. We have 
developed a versatile metabolomics platform to identify small molecule 
biomarkers (SMBs) in serum that predict dengue disease severity and 
are currently defining metabolic signatures that differentiate the three 
arboviral diseases. This platform combines reverse phase ultra-high 
performance liquid chromatography-mass spectrometry (RP-UPLC-MS) 
and hydrophilic interaction liquid chromatography (HILIC) -MS and was 
used to characterize the acute phase serum metabolome of patients 
from Nicaragua and Mexico who were diagnosed with different grades 
of dengue disease severity, dengue fever (DF), dengue hemorrhagic 
fever (DHF), or dengue shock syndrome (DSS). Patients with laboratory-
confirmed infections with DENV, CHIKV, or ZIKV contributed serum, urine 
and saliva samples during the 2015/2016 transmission season, and we 
have used these samples to validate SMBs for dengue diagnosis and 
prognosis and explore similarities and differences unique to CHIKV and 
ZIKV infections. We will discuss the biochemical classes of metabolites 
identified by the combined platform and highlight SMB signatures that 
are specific for each disease type. Metabolic markers that are specific 
to flavivirus (DENV and ZIKV) infections versus an alphavirus (CHIKV), or 
differentiate between the flaviviviruses could potentially provide important 
information on differential pathogenesis and could be exploited for 
development of therapeutics. These comparative studies are particularly 
important, as the clinical presentation of these diseases in the acute phase 
can be similar.
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HUMAN DENV2 MONOCLONAL ANTIBODIES TARGET 
MULTIPLE EPITOPES ON THE ENVELOPE GLYCOPROTEIN
Emily Gallichotte, Doug Widman, Ralph Baric, Aravinda de Silva
University of North Carolina at Chapel Hill, Chapel Hill, NC, United States
Dengue virus (DENV) infection causes dengue fever and more severe 
disease, and it is estimated that a third of the world is at risk for infection. 
Dengue serotype 2 (DENV2) is widespread, causes severe epidemics, and 
the recently licensed live tetravalent dengue vaccine was not protective 
against DENV2, despite protecting against the other three serotypes. 
DENV2 infections stimulate durable, serotype-specific neutralizing and 
protective antibodies in people. Previous work from our group has 
shown that the majority of DENV2 type-specific neutralizing polyclonal 
antibodies targets a complex epitope containing EDIII of the envelope 
(E) glycoprotein. While the crystal structure of a single human DENV2 
type-specific neutralizing antibody, 2D22, has been solved, it was not 
known if this epitope is representative of a diverse panel of DENV2 type-
specific antibody epitopes. Using a DENV infectious clone system, we 
have generated a panel of recombinant DENV viruses that were then 
used in binding and neutralization assays. With these experiments we 
have mapped the epitopes of additional DENV2 type-specific neutralizing 
antibodies. While some of these antibodies share a similar epitope to 
2D22, others use entirely different domains in their epitopes. Our results 
reveal that there are multiple epitopes targeted by DENV2 neutralizing 
antibodies. Future work aims to determine what the proportion of each of 
these antibody epitopes are in polyclonal immune sera, and test whether 
antibodies targeting one epitope is more important for neutralization that 
the other.
1233
USE OF THE DENGUE HUMAN CHALLENGE MODEL TO 
CHARACTERIZE THE CLINICAL AND IMMUNOLOGICAL 
RESPONSE TO SEQUENTIAL HETEROTYPIC DENGUE 
INFECTION
Anna P. Durbin1, Beth D. Kirkpatrick2, Denise Adams1, Cecilia 
M. Tibery1, Palmtama L. Grier1, Beulah P. Sabundayo1, Helen 
He1, Yolanda Eby1, Sean A. Diehl2, Aravinda de Silva3, Stephen S. 
Whitehead4
1Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United 
States, 2University of Vermont College of Medicine, Burlington, VT, United 
States, 3University of North Carolina, Chapel Hill, NC, United States, 
4National Institute of Allergy and Infectious Diseases, National Institutes of 
Health, Bethesda, MD, United States
Dengue is recognized as the most important mosquito-borne virus 
worldwide. There are 4 dengue viruses (DENV), each capable of causing 
the full spectrum of disease which ranges from an asymptomatic or 
mildly symptomatic infection to a live-threatening illness characterized by 
vascular leak syndrome. Epidemiologic studies have demonstrated that 
the greatest risk for developing severe dengue occurs with a second, 
heterotypic DENV infection. This is thought to be mediated by antibody-
dependent enhancement of infection in which antibodies from the primary 
DENV infection opsonize the secondary, heterotypic DENV but instead of 
neutralizing the virus, the antibody-virus complex is able to enter target 
cells through the FcγR2a leading to higher titers of virus. Interestingly, third 
and fourth DENV infections appear to result in less severe illness. Using 
our controlled dengue human challenge model, we studied the clinical 
and immunological response to sequential heterotypic DENV infection 
to characterize the neutralization and enhancement qualities following 
primary and secondary dengue infection. Twelve flavivirus-naïve subjects 
were enrolled and randomized to receive the live attenuated DENV-
1 DENα30 (n=9) or placebo (n=3). Nine months later 8 subjects were 
received the DENV-2 challenge virus DEN2α30 (6 had received DEN1α30; 2 
had received placebo). The treatment assignments remained blinded until 
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study day 360. Following primary infection, 9/9 subjects were viremic with 
DENV-1 (mean peak titer = 0.9 log10 PFU/mL), 8/9 seroconverted to DENV-
1, 2/9 seroconverted to DENV-2 NGC, 4/9 seroconverted to DENV-3, and 
0/9 serconverted to DENV-4. Antibody to DENV-2 decreased to <1:5 by 
study day 90. Following challenge with DENV-2 9 months later, 6/6 DENV-
1 recipients had detectable DENV-2 viremia and 3/6 had rash compared 
with 2/2 controls with detectable viremia and rash. The virologic and 
immunologic responses following primary and secondary DENV infection 
will be discussed.
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HLA DRB1 ALLELIC VARIANTS ARE ASSOCIATED WITH 
DIFFERENT RESPONSE MAGNITUDE OF DENV SPECIFIC CD4 T 
CELL RESPONSES AND DISEASE SEVERITY OUTCOMES
Daniela Weiskopf1, Michael A. Angelo1, Alba Grifoni1, John 
Sidney1, Sinu Paul1, Aruna D. de Silva2, Aravinda de Silva3, Sunil 
Premawansa4, Gayani Premawansa5, Ananda Wijewickrama6, 
Bjoern Peters1, Alessandro Sette1
1La Jolla Institute for Allergy and Immunology, La Jolla, CA, United States, 
2Genetech, Colombo, Sri Lanka, 3University of North Carolina, Chapel Hill, 
NC, United States, 4Department of Zoology, Science Faculty, University 
of Colombo, Colombo, Sri Lanka, 5North Colombo Teaching Hospital, 
Ragama, Colombo, Sri Lanka, 6National Institute of Infectious Diseases, 
Gothatuwa, Angoda, Sri Lanka
All four dengue virus serotypes are now simultaneously circulating 
worldwide being responsible for 400 million human infections each year 
with around 100 million resulting in apparent infections. The observation 
that only a minority of patients develops severe disease suggests that 
host genetic factors may play an important role in disease severity. 
HLA molecules that restrict CD4 and CD8 T cell responses are one of 
the most polymorphic host factors in humans with several thousand 
variants thus far known. While DENV-specific CD8+ T cell responses 
have been extensively studied, the breadth and specificity of CD4+ T cell 
responses remains to be defined. Here we map CD4 T cell responses in 
individuals previously exposed to dengue virus. To identify HLA class II 
candidates, we utilized a panel of algorithms for sixteen common HLA 
DR molecules representative of the main DR supertypes. These efforts led 
to the identification of 365 epitopes derived from all 10 DENV proteins. 
In contrast to CD8 T cell targets, the highest number of epitopes was 
associated with the structural capsid protein (C), followed by nonstructural 
NS3, NS2A, NS5 and envelope proteins (E). Similar to CD8 T cell responses 
we noticed a wide variation in magnitude of T cell responses as a function 
of the restricting DRB1 allele. To investigate if HLA specific variations in 
magnitude of response might actually predict as yet unknown associations 
between DENV disease outcomes and HLA DRB1 alleles we assembled a 
set of 411 samples from hospitalized patients with confirmed diagnosis of 
Dengue fever or dengue hemorrhagic fever. We found several HLA alleles 
that were associated with stronger responses and showed significant 
OR<1 indicating a lower risk of hospitalized disease (protective effect). 
Phenotyping of the responding CD4+ T cell subsets revealed a DENV 
specific T cell subset, specifically expanded in donors carrying an allele 
associated with protection from severe disease and which is absent in 
DENV negative donors. Detailed knowledge of phenotype and function 
of DENV-specific T cells will aid in the establishment of correlates of 
protection against severe disease.
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ORGAN DAMAGE AND IMMUNOPATHOLOGICAL FEATURES 
IN FATAL DENGUE CASES
Jaime Gonzalez-Cardona1, Carlos Pardo-Villamizar2, Diego 
Vargas1, Julio Mantilla3, Beatriz Parra1, Anilza Bonelo1
1Universidad del Valle, Cali, Colombia, 2Johns Hopkins School of Medicine, 
Baltimore, MD, United States, 3Universidad Industrial de Santander, 
Bucaramanga, Colombia
Dengue is the most common arthropod borne infectious disease 
worldwide. The infection may be asymptomatic or mild, some 
subjects develop severe dengue with hemorrhagic manifestations, 
fluid leakage and organ failure leading to death. The extent of organ 
involvement in disease and death is not clear. A systematic analysis of 
the immunohistopathological reactions of these organs will provide 
important clues on the pathogenesis of severe dengue. 50 fatal dengue 
cases which underwent autopsy between 2010 and 2015 were analyzed. 
Most of them positive for dengue by RT-PCR in tissue. FFPE tissues from 
liver, lung, heart, kidney, brain, spleen, and lymph node were stained with 
H&E and immunostained for T cells, CD4+ and CD8+T cells, macrophages 
and dengue antigen. Vascular congestion, hemorrhagic changes and 
inflammation were prominent in all tissues, being more common and 
severe in lungs and livers. The livers exhibited acute hepatitis, necrosis 
and steatosis. Portal space inflammation was characterized by infiltration 
of T cells and macrophages. Both CD4+ and CD8+T cells were observed 
however most of them were CD8+, these cells were also found infiltrating 
parenchyma. Dengue antigen was visualized mostly in macrophages. In 
lungs alveolar hemorrhage, diffuse alveolar damage, hyaline membrane 
formation, type II pneumocyte hyperplasia and septal thickening 
was observed. The alveolar septum showed abundant mononuclear 
infiltration with macrophages and T cells, predominantly CD8+T cells. 
Macrophages were abundant also in the alveolar space, some of them 
with appearance of foamy histiocytes. Dengue antigen was observed 
in alveolar macrophages and type II pneumocytes. The lungs were the 
most affected organ, with alveolar diffuse hemorrhagic damage being a 
prominent pathological feature in fatal dengue. Abundant macrophages 
and moderate CD8+T cell infiltration were typical features in lung and 
liver lesions. Dengue antigen was present in alveolar macrophages and 
type II pneumocytes but rarely present in liver. These results highlight the 
participation of T cells and macrophages immune mediated responses in 
dengue induced organ pathology.
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CHRONIC MALNUTRITION DOES NOT IMPAIR THE MEMORY 
T CELL RESPONSE TO CRYPTOSPORIDIAL INFECTION IN 
INDIAN CHILDREN
Sudhir Babji1, Nisha Vincy Jose1, Deepthi Kattula1, Honorine 
Ward2, Gagandeep Kang1
1Christian Medical College, Vellore, India, 2Tufts Medical Center, Boston, 
MA, United States
Approximately 48 % of children <5 years of age are stunted in India, 
and chronic malnutrition is believed to predispose to impaired immune 
responses and repeated infections. Cryptosporidium spp., an intracellular 
parasite is responsible for 3.1-7.6 million diarrheal episodes in children 
<2 years of age in India. Immune response to Cryptosporidium is 
primarily CD4 T cell based, with a poorly defined role for CD8 cells. This 
study aimed to assess the role of chronic malnutrition on memory T cell 
responses in children with cryptosporidial infections. In a birth cohort 
study of the natural history of cryptosporidium infection, infants from 
a semi-urban slum in Vellore, Southern India, were followed up from 
birth till 3 years of age, documenting all symptomatic and asymptomatic 
cryptosporidial infections. Morbidity and monthly anthropometric 
measurements were recorded, and children’s growth classified using WHO 
guidelines. Peripheral blood mononuclear cells (PBMCs) were isolated at 
3 years of age and were stimulated using Cryptosporidium oocyst lysate 
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and stained using florescent tagged antibodies to define the memory 
component of the CD4, CD8 T cells and markers to define Th1 (IFNγ), 
Th2(IL-4) and Th-17 (IL-17A) responses. Samples were acquired on a 
BD Aria III and analyzed. Thirty -four children who had symptomatic 
cryptosporidial infections were included for this preliminary analysis. Five 
children were persistently stunted (defined as having a HAZ score <-2SD 
at 6, 12, 18, 24, 30, 36 month time points) during the 3 year study period 
whereas 29 children were never stunted. Analysis of memory activated 
CD4 and CD8 cells expressing either the Th1, Th2 or Th17 phenotypes 
did not reveal any significant differences between the persistently 
stunted children compared to the never stunted children (p values not 
significant). The persistently stunted children had a robust IL-17A and 
IL-4 CD4 memory response, though they had a slightly lower IFNγ CD8 
memory response as compared to the never stunted children. Chronically 
malnourished children with symptomatic cryptosporidial infections develop 
and maintain a good memory T cell response.
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GENETIC LINKS BETWEEN SYMPTOMATIC ENTAMOEBA 
HISTOLYTICA INFECTION AND INFLAMMATORY BOWEL 
DISEASE
Genevieve L. Wojcik1, Chelsea Marie2, Josyf C. Mychaleckyj2, 
Stephen Rich2, Patrick Concannon3, Rashidul Haque4, Beth 
Kirkpatrick5, William A. Petri Jr.2, Priya Duggal6
1Stanford University School of Medicine, Stanford, CA, United States, 
2University of Virginia School of Medicine, Charlottesville, VA, United 
States, 3University of Florida, Gainesville, FL, United States, 4International 
Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh, 
5University of Vermont College of Medicine, Burlington, VT, United States, 
6Johns Hopkins University Bloomberg School of Public Health, Baltimore, 
MD, United States
Diarrhea is the second leading cause of death for children globally, causing 
760,000 deaths each year in children under the age of 5. Amoebic 
dysentery contributes significantly to this burden, especially in developing 
countries. To investigate possible genetic susceptibility to symptomatic 
Entamoeba histolytica (EH) infection in Bangladeshi infants, we conducted 
a genome-wide association study (GWAS) in two independent birth 
cohorts of symptomatic EH infection. Cases were defined as children 
with at least one diarrheal episode positive for EH through either PCR or 
ELISA within the first year of life, while controls were children without 
any episodes positive for EH in the same time frame (DBC: 65 cases, 309 
controls; PROVIDE: 112 cases, 323 controls). The NIH Birth Cohort and 
the PROVIDE cohort were analyzed separately, using univariate logistic 
regression with an additive mode of inheritance. Results were meta-
analyzed under a fixed-effects inverse variance weighting model. The top 
results were found within two neighboring genes on chromosome 10: 
CUL2 (cullin 2) and CREM (cAMP responsive element modulator). A total of 
4 SNPs (single nucleotide polymorphisms) met genome-wide significance 
(P<5E-08) in the joint analysis. The top SNP was rs2148483 with a Pmeta of 
6.48E-09, with additional risk allele at this locus conferred 2.3 times the 
odds of a symptomatic EH infection. This SNP is found within an intron 
of CUL2 (cullin 2), which has previously been implicated as a susceptibility 
locus for Inflammatory Bowel Disease and Crohn’s Disease. Despite 
neither individual analyses reaching significance due to their limited 
power, the meta-analysis of two independent studies shows genome-
wide significant results in two genes previously implicated in IBD. These 
genetic associations reinforce the pathological similarities observed in gut 
inflammation between EH infection and IBD. Further research is needed to 
elucidate the underlying mechanisms for the proposed pleiotropy.
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RESPIRATORY TRACT CRYPTOSPORIDIOSIS IS COMMON 
IN HIV-SERONEGATIVE CHILDREN WITH INTESTINAL 
CRYPTOSPORIDIUM AND COUGH
Grace Ndeezi1, Siobhan M. Mor2, Luke R. Ascolillo3, Josephine 
Tumuhamye1, Christine Sheema1, Jerlyn Sponseller4, Lucy Asio1, 
Peace Ahumuza1, Hannington B. Tasimwa1, Harriet Namiiro1, 
Ritah Nakato1, Lilian Namuli1, Sylvia Namande1, Naome Kilama1, 
Gloria Kauda1, Jolly Rubambarama1, Saul R. Tzipori4, Jeffrey K. 
Griffiths3, James K. Tumwine1
1Makerere University College of Medicine, Kampala, Uganda, 2University 
of Sydney, Sydney, Australia, 3Tufts University School of Medicine, Boston, 
MA, United States, 4Tufts University Cummings School of Veterinary 
Medicine, Grafton, MA, United States
We studied respiratory tract cryptosporidiosis (RTC) in children aged 
9-36 months presenting to the Acute Care Unit at Mulago Hospital 
(Kampala, Uganda) with a 2 different chief complaints: A) diarrhea, with 
cough (n=1023); and B) cough or pneumonia, with or without diarrhea 
(n=776). Children were screened for Cryptosporidium (CR) in stool using 
RT-PCR. Stool-positive children were selected for further diagnostic tests, 
including sputum induction. In addition, for every CR stool-positive child 
in Group B, a CR stool-negative child in this group was selected for further 
workup. Sputum samples were subjected to RT-PCR for Cryptosporidium, 
bacterial culture and sensitivity, auramine-smear for TB, and RT-PCR 
for RNA viruses (subject to adequate sample volume). Prevalence of 
intestinal cryptosporidiosis was 10.7% (89 C. hominis, 17 C. parvum, 3 C. 
meleagridis or mixed) and 4.8% (27 C. hominis, 9 C. parvum, 1 mixed) in 
Group A and B, respectively. Of the stool-positive children that underwent 
sputum induction, 28/85 (32.9%; Group A) and 8/29 (21.6%; Group B) 
had RTC. Strikingly, 2 stool-negative children in Group B, neither with 
diarrhea, also had RTC. All 38 children with RTC were HIV-seronegative. 
Preliminary data suggests C. hominis may have a greater propensity for 
infection at this site (e.g. RTC occurred in 37.1% of C. hominis enteric 
infections versus 16.7% of C. parvum enteric infections; Group A). 
Notably, RTC with C. hominis occurred even when C. parvum was the 
species detected in the intestinal tract. No bacterial pathogens were 
cultured from sputum of 8/28 children in Group A and 6/10 children in 
Group B with RTC. Results of respiratory virus testing were pending at the 
time of writing, however at least 3 children in Group B had no alternative 
explanation for their respiratory symptoms. Clinically, in Group A, children 
with RTC had significantly lower oxygen saturation SpO2 compared to 
those who were sputum-negative for Cryptosporidium (median 96% vs 
98%, p=0.004). Enrolment continues with the aim of further elucidating 
the clinical and epidemiological significance of RTC.
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AZITHROMYCIN AND DOXYCYCLINE ATTENUATE 
ACANTHAMOEBA VIRULENCE IN A HUMAN CORNEAL 
TISSUE MODEL
Andrew Purssell1, Rachel Lau2, Andrea K. Boggild3
1University of British Columbia, Vancouver, BC, Canada, 2Public Health 
Ontario Laboratories, Toronto, ON, Canada, 3University of Toronto, 
Toronto, ON, Canada
Amoebic keratitis (AK) is a potentially blinding eye infection caused by the 
parasite Acanthamoeba, a ubiquitous, free-living organism. This organism 
exhibits resistance to anti-acanthamoebal chemotherapy necessitating 
long treatment courses; despite this, treatment failures are common. 
Acanthamoebae isolated from the environment and from the corneas 
of AK patients have been found to harbour bacterial endosymbionts 
belonging to Chlamydiales, Rickettsiales, and Legionellales. Previous 
studies demonstrated that a Chlamydia-like endosymbiont enhanced 
Acanthamoeba virulence in vitro, although it is unclear if this translates 
to a significant effect in vivo. We sought to elucidate the potential effect 
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of Acanthamoeba-endosymbiont co-infection in a human corneal tissue 
model representing clinical AK infection. Several environmental and clinical 
Acanthamoeba isolates from the ATCC were screened for endosymbionts 
by amplifying and sequencing bacterial 16S DNA. Each Acanthamoeba 
isolate was used to infect EpiCorneal cells, a 3D human corneal tissue 
model. EpiCorneal cells were then treated with azithromycin (AZT), 
doxycycline (DOX), or control media to determine if antibiotics targeting 
common classes of bacterial endosymbionts attenuated Acanthamoeba 
virulence as indicated by a decrease in observed cytopathic effect and 
inflammatory biomarker production. Infection of EpiCorneal cells with 
A. castellanii 50493 and A. polyphaga 50372 increased TNFα and IL-1 
expression. This was attenuated with addition of AZT or DOX. IL-6 and 
Cu-Zn SOD expression also increased upon infection with either strain, yet 
attenuation with antimicrobials was only observed in A. castellanii 50493. 
Cytopathic effects on EpiCorneal cells were evident in the presence of A. 
castellanii 50493 and A. polyphaga 50372, and this was reduced with 
the addition of antimicrobials. Treatment of two Acanthamoeba strains 
with the endosymbiont-targeting antibiotics AZT and DOX, was shown to 
attenuate inflammatory cytokine production and reduce cytopathic effects. 
These drugs may present an alternative avenue of therapy in treatment of 
AK.
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CRYPTOSPORIDIOSIS IN A HUMANIZED MURINE INTESTINAL 
TRACT
Andrew Nafziger, Katelynn Atwood, Jae Shin, David Bolick, Cirle 
A. Warren
University of Virginia, Charlottesville, VA, United States
Cryptosporidiosis is as a major cause of persistent diarrhea worldwide. 
It has been recently cited as one of only 4 pathogens causing moderate 
to severe diarrhea in infants and young children in developing countries. 
Mouse models of enteric infections remain as powerful tools to study host 
response, susceptibility to disease and response to treatment. However in 
majority of the models, significant manipulation has been employed to 
attain infection, including genetic alteration, chemotherapy, irradiation, 
antibiotic exposure, germ-free condition, infection at neonatal period, or 
harsh dietary restriction, complicating potential relevance of findings to 
human disease. We tested the effect of Cryptosporidium parvum infection 
in a humanized murine model attained by gut flora conditioning using a 
child’s fecal specimen. Dams were treated with an antibiotic cocktail and 
transplanted with human fecal material soon after conception. Control 
dams were treated with murine feces. Upon weaning, pups were fed with 
2% protein diet and infected with C. parvum oocysts one week later. 
Pups were monitored for weight loss and stool specimens were collected 
up to 21 days post infection. Infected pups from dams transplanted with 
human feces lost weight, similar to infected pups from dams transplanted 
with murine feces. Interestingly, infected pups from dams transplanted 
with human feces shed the parasite longer than the control counterpart. 
Conditioning the murine intestinal tract with human flora in utero may 
increase susceptibility to cryptosporidial infection and result to prolonged 
shedding.
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IMPACT OF ENTERIC PARASITES ON INTESTINAL 
MICROBIOTA DIVERSITY AND METAGENOMIC CHANGES IN 
RURAL ARGENTINIAN AND ECUADORIAN CHILDREN
Rojelio Mejia1, Rubén O. Cimino2, Ashish Damania1, Rebecca 
Jeun1, Patricia E. Bryan1, Paola Vargas2, Marisa Juarez2, Pamela 
S. Cajal2, Philip J. Cooper3, Julio Nasser2, Alejandro Krolewiecki2, 
Barton Slatko4
1Baylor College of Medicine, Houston, TX, United States, 2Universidad 
Nacional de Salta, Salta, Argentina, 3Universidad Internacional De Ecuador, 
Quito, Ecuador, 4New England BioLabs, Inc., Ipswich, MA, United States
Approximately 30% of children worldwide are infected with 
gastrointestinal (GI) parasites. Parasites can disrupt intestinal flora affecting 
nutritional status. We implemented a multi-parallel quantitative real-time 
PCR and whole genome sequencing analysis for bacterial microbiota 
and Ascaris lumbricoides, Ancylostoma duodenale, Necator americanus, 
Strongyloides stercoralis, Trichuris trichiura, Cryptosporidium, Entamoeba 
histolytica, and Giardia lamblia. Stool samples were collected from 122 
asymptomatic children (under 10 years old) from rural Argentina and 
Ecuador. Separate analyses were done by country for uninfected, Giardia 
only, Giardia/helminth co-infections, and helminth only groups. For 
Giardia only infected children, sequencing data showed a decrease in 
microbiota biodiversity compared to those uninfected that correlated with 
increasing Giardia burden (Spearman r = -0.5491, p = 0.0244). Clustering 
was statistically significant using Canonical Correspondence Analysis 
ordination and shannon alpha diversity (Giardia only 2.1; uninfected 2.7, p 
< 0.05). A non-significant increase in diversity was observed for helminth 
only infections (3.0) with a compensatory decrease in Giardia/helminth 
co-infections (2.3). In Giardia only infections, microbiome taxonomy 
shifted from Firmicutes towards increasing proportions of Prevotella, with 
degree of shift related to intensity of infection compared to uninfected 
(37.1 % versus 23.5%, p = 0.037). Abundance of Prevotella bacteria 
was decreased in the helminths only group, but increased for Giardia/
helminth co-infections (16.5% versus 38.3%, p = 0.019). Metagenomic 
analysis of the microbiota showed a significant increase in genes required 
for anaerobic activity among the Giardia only group compared to all 
children without Giardia (p = 0.012). Our data provides possible evidence 
for an affect of Giardia infections on the intestinal environment allowing 
permissive growth of anaerobic bacteria such as Prevotella and a decrease 
in microbiota diversity. Future work will explore the contribution of such 
changes to growth delays in parasite-infected children.
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THE GENOME SEQUENCE OF ANTHROPONOTIC 
CRYPTOSPORIDIUM PARVUM
Olukemi O. Ifeonu1, Giovanni Widmer2, Myron M. Levine3, Saul 
Tzipori2, Joana C. Silva1
1Institute for Genome Sciences, University of Maryland School of 
Medicine, Baltimore, MD, United States, 2Department of Infectious Disease 
and Global Health, Cummings School of Veterinary Medicine at Tufts 
University, North Grafton, MA, United States, 3Institute for Global Health, 
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Cryptosporidiosis is a life-threatening disease in immune-compromised 
individuals worldwide, and a major cause of diarrhea-induced death 
of young children in developing countries. The large Global Enteric 
Multicenter Study (GEMS) revealed that cryptosporidiosis infections in 
the developing world are caused primarily by Cryptosporidium hominis, 
followed by C parvum. Recent studies revealed that the majority of C. 
parvum infections are due to anthroponotic genotypes. Specifically, it 
has been observed that, in developing countries, the transmission of C. 
parvum occurs typically from human to human, while zoonotic infections 
seem to be dominant in developed countries. Until now, C. parvum 
genomic resources have been based on zoonotic isolates, particularly 
the isolate IOWA II, the source of the reference genome for the species, 
390
astmh.org
and the first Cryptosporidium genome to be published. Here, we re-
sequenced the genome of the anthroponotic C. parvum isolate TU114 
using Pacific Biosciences technology, and generated a comprehensive, 
genome assembly with few sequencing gaps. Comparison between this 
genome and those of zoonotic isolates will enable a more comprehensive 
understanding of transmission mechanisms of cryptosporidiosis in humans 
and animals, and aid vaccine development research against anthroponotic 
subtypes of C. parvum.
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POPULATION GENOMICS OF PLASMODIUM FALCIPARUM TO 
INFORM THE DESIGN AND EFFICACY OF WHOLE ORGANISM 
MALARIA VACCINES
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Stephen L. Hoffman8, Christopher V. Plowe1, Joana C. Silva1
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The Sanaria® PfSPZ Vaccine is a radiation-attenuated whole-organism 
vaccine based on the sporozoite stage of Plasmodium falciparum (Pf). 
The vaccine isolate NF54 (West Africa) is the isolate from which the Pf 
reference 3D7 was cloned. While vaccine efficacy after immunization with 
moderate doses of PfSPZ is high and similar against controlled human 
malaria infection (CHMI) with homologous (3D7) and heterologous (7G8 
from Brazil) clones, at lower doses protection is higher against CHMI 
with 3D7 compared to 7G8. Furthermore, at lower doses protection 
may be lower in the field than against CHMI. These results suggest that 
while broad efficacy can be achieved by increasing the dose, it may be 
achieved more efficiently and at lower doses by including additional Pf 
strains in the vaccine. This goal requires rigorous characterization of NF54 
and comparisons to Pf populations in malaria endemic regions so that 
complementary vaccine strains can be selected. To this end, NF54 was 
sequenced with PacBio and Illumina platforms resulting in a high-quality 
assembly and SNP calls. The resulting assembly consists of 24 contigs 
with a cumulative length of 23.28 Mbp, similar to the 3D7 reference 
genome (23.26 Mbp). Of the 5,542 genes in the 3D7 genome, all but 
15 map completely and accurately to the NF54 genome. Both SNP calls 
and the assembly indicate that NF54 is very similar to 3D7, with <3K 
SNP differences between them. We then sequenced and assembled the 
genomes of 3 additional Pf clones proposed as vaccine constituents: 7G8, 
NF135.C10 (Cambodia), and NF166 (Guinea). Along with NF54, these 
were then compared to several hundred Pf clinical isolates from around 
the globe using whole-genome sequence data. Principle coordinate and 
admixture analyses based on SNP calls show that cloned and clinical 
isolates cluster based on geographic origins. Focusing on pre-erythrocytic 
antigens, we investigate allele and epitope frequency of the four proposed 
vaccine strains among global Pf populations to inform vaccine design and 
to interpret the outcome of upcoming vaccine trials.
1244
GLOBAL LANDSCAPE OF MOLECULAR NETWORKS FOR 
MALARIA PATHOLOGY REVEALED BY INTEGRATIVE MULTI-
OMICS ANALYSIS USING NON-HUMAN PRIMATE ANIMAL 
MODEL
Yan Tang1, the MaHPIC Consortium, Mary R. Galinski2, Mark P. 
Styczynski1
1Georgia Institute of Technology, Atlanta, GA, United States, 2Emory 
University, Atlanta, GA, United States
Non-Human Primate (NHP) animal models infected with Plasmodium 
pathogens can provide insights into mechanisms and help discover 
biomarkers for human malarial disease conditions. We adopted a systems 
biology strategy to comprehensively measure host physiological response 
to P. cynomolgi and P. coatneyi infection longitudinally at various molecular 
layers, including transcriptomics, metabolomics, lipidomics, immunological 
profiling, proteomics and clinical traits in Peripheral Blood (PB) and Bone 
Marrow (BM). We developed a novel network biology analysis method, 
CLR-Directed Bayesian Network Analysis (CDBNA), to integrate Omics 
data for interrogating differential and common multi-omics network 
modules perturbed by P. cynomolgi and P. coatneyi and for deciphering 
network dynamics in the course of infection. This method integrates 
the advantages of both information theory-based methods (Context 
Likelihood Relatedness, CLR) and Bayesian Network Analysis (BNA): 
CLR empowering genome-scale network reconstruction and nonlinear 
relationship discovery, with BNA enabling high-resolution focused study 
of CLR-identified sub-networks. We first applied CLR to integrate Omics 
data from PB and BM infected with P. coatneyi or P. cynomolgi, providing 
a low-resolution overview on genome-scale networks. Then, we applied 
BNA to derive conditional dependencies between nodes in the network 
for focused pathways. We illustrate the power of CDBNA by identifying 
roles of INF-gamma related pathway in malaria. An atlas of species-specific 
(between P.coatneyi and P. cynomolgi) and tissue-specific (between PB and 
BM) network modules of malaria were identified, which highlights tissue-
specific mechanisms as well as convergent and divergent mechanisms 
between P. coatneyi and P. cynomolgi affecting host network. We illustrate 
the power of integrative multi-omics analysis by identifying roles of key 
processes related to immune memory and inflammation in malaria. This 
global multi-omics map of malaria pathology provides a scaffold for 
disease mechanism study and potential novel therapeutic targets for 
prevention and treatment of malaria.
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PIGGYBAC MUTAGENESIS SCREENING OF THOUSANDS 
OF PLASMODIUM FALCIPARUM GENES REVEALS WHAT A 
MALARIA PARASITE CAN’T LIVE WITHOUT
Min Zhang1, Chengqi Wang1, Thomas D. Otto2, Jenna Oberstaller1, 
Iraad F. Bronner2, Suzanne Li1, Kenneth Udenze1, Mathew Mayho2, 
Elizabeth Huckle2, Michael A. Quail2, Julian C. Rayner2, Rays H. 
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Sanger Institute, Hinxton, United Kingdom
Malaria remains an important global health problem and emerging 
resistance to frontline drugs may reverse recent progress. More robust 
genomic tools are needed to accelerate progress to identify and validate 
essential candidate targets to develop the most effective new antimalarial 
therapies. The efficiency of the piggyBac transposon system for insertion 
within a wide range of genomes and its propensity for random selection 
of its highly preferred TTAA tetranucleotide insertion site has led to its 
growing use for functional genomics studies in multicellular eukaryotes. 
Using Quantitative Insertion-site Sequencing (QIseq), our newly developed 
next-gen sequencing tool to identify piggyBac insertion sites, a high 
density of insertions revealed a dramatically skewed distribution relative to 
the frequency of expected genomic piggyBac TTAA insertion sites in the 
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Plasmodium falciparum genome. Through analysis of >5000 new unique 
insertions generated via a method that primarily produces single-insertion 
mutant parasites, we can discern genes and pathways essential and 
dispensable for intraerythrocytic growth of an NF54 clone grown in routine 
in vitro culture. Most importantly, regions significantly void of insertions 
are calculated to represent regions of genes with essential functions in 
blood-stage development whereas genes with insertions are considered 
to be dispensable. Over 1500 insertions are estimated to be lethal in the 
mutagenesis screen, which was validated by comparison with results for 
P. berghei knock out screens. We will present results from our study that 
includes analysis to identify approximately 500 high-confidence essential 
P. falciparum genes, representing crucial biological processes associated 
with core metabolic functions during intraerythrocytic growth. Our results 
establish piggyBac mutagenesis as an effective genetic tool to distinguish 
essential and dispensable genes that will help accelerate development of 
new antimalarial therapies.
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WHOLE GENOME SEQUENCING OF PLASMODIUM 
FALCIPARUM MALARIA PARASITES FROM DRIED BLOOD 
SPOTS: GATEWAY TO HIGH-RESOLUTION GENOMIC 
SURVEILLANCE
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Plasmodium falciparum malaria is hyperendemic and seasonal in the 
Kassena-Nankana Districts (KNDs) of the Upper East Region of Ghana, 
causing significant morbidity and mortality. Medications used for 
disease control include sulfadoxine-pyrimethamine (SP) prophylaxis 
during pregnancy, and artemisinin-based combination therapies (ACT). 
Monitoring the parasite evolutionary response to such measures can 
inform public health, e.g. by tracking genetic markers that confer or 
predispose to SP and ACT resistance. But genome-wide epidemiology is 
limited by technical and logistical difficulties in obtaining sequenceable 
material from clinical samples. Here, we describe a method for generating 
P. falciparum whole genome sequences from dried blood spots (DBS), 
collected from finger-pricks (~30µl of blood) in resource-limited rural 
settings in the KNDs. Using selective whole genome amplification (sWGA), 
parasite DNA with high (>95%) host contamination was selectively 
amplified using oligo nucleotides that preferentially bind to the parasite 
genome. We analysed P. falciparum genomes from 156 patients with 
clinical malaria, including 120 paired DBS and leucocyte-depleted venous 
blood (VB) samples for head-to-head comparison of sWGA vs genomic 
DNA. More than 90% of DBS samples produced parasite-enriched DNA 
with >95% of the core P. falciparum genome covered with ≥5x sequence 
reads, allowing drug resistance loci such as crt, dhfr, dhps, mdr1, and 
kelch13 to be genotyped. Concordance across ~1 million single nucleotide 
polymorphisms between VB and DBS samples was >94%, despite there 
being 50x less blood and no leucodepletion in the DBS samples. Quality 
sequence data was obtained from DBS down to parasitaemias of 0.03% 
(~40 parasites per 200 white blood cells). Thus, sWGA makes large-scale, 
high-resolution genomic epidemiology possible, as DBS collection is better 
tolerated by most patients and more suitable for remote, resource-limited 
settings than VB. Genomic data can then inform proactive public health 
strategies to combat evolving pathogens.
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CULTURE-ADAPTATION OF MALARIA PARASITES IS 
ASSOCIATED WITH NONSENSE MUTATIONS IN SPECIFIC 
GENES
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Substantial developments in understanding malaria parasite biology have 
been derived from studies of Plasmodium falciparum cultured in vitro. 
However, culture-adapted laboratory strains may differ from parasites 
in clinical isolates. To investigate the genetic basis of parasite culture 
adaptation, 50 new Gambian clinical isolates were introduced to standard 
in vitro culture conditions. Fourteen (28%) of the isolates were successfully 
grown for at least 48 days, and some were subsequently continued for 
longer periods. Six of these contained unmixed haploid genotypes at 
day 0, and were chosen for genome sequence analysis of samples taken 
during the culture period. In three of the isolates new single nucleotide 
polymorphism (SNP) variants emerged to frequencies of above 20% 
during culture, becoming the majority sequences in two isolates. Out of 
five novel SNPs, four were nonsense mutations resulting in stop codons. 
Three of these were in the same gene encoding an ApiAP2 transcription 
factor, with each isolate having a different nonsense mutation, and one 
was in a serine/threonine protein kinase gene (SRPK1). These results 
prompted survey for nonsense SNP alleles in genomes of eight widely 
cultured laboratory-adapted parasite strains, revealing four different 
nonsense mutations in other ApiAP2 genes, one of which has been 
previously reported. Remarkably, five of the eight laboratory strains each 
had a different nonsense mutation in the rap guanine nucleotide exchange 
factor (Epac) gene. A global database of uncultured clinical samples 
revealed that nonsense mutations were very rare overall, and never 
found in Epac, SRPK1, or ApiAP2 genes. In conclusion, loss-of-function 
mutations in a small number of specific genes are associated with P. 
falciparum growth in culture.
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TRANSCRIPTIONAL AND PROTEOMIC CATEGORIZATION OF 
THE ETIOLOGY OF PNEUMONIA SYNDROME IN PEDIATRIC 
PATIENTS IN MALARIA ENDEMIC AREAS
Danny A. Milner1, Jacob Silterra2, Michael A. Gilette3, Miguel 
Lanaspa4, Karell G. Pelle2, Clarissa Valim5, Rushy Ahmad2, Sozinho 
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Alonso4, Steven A. Carr2, Roger C. Wiegand2, Quique Bassat4, Jill 
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Mozambique, 7University of California San Diego, San Diego, CA, United 
States
Pneumonia and malaria are common causes of pediatric respiratory 
distress in tropical settings. Bacterial pneumonia in particular is a major 
contributor to morbidity and mortality among children, principally 
due to delay in antibiotic therapy. Proper clinical treatment requires an 
actionable and accurate diagnosis. A rapid test that could distinguish 
between bacterial, malarial, and viral infections would have great clinical 
utility in directed life-saving antibiotic therapy. We first performed 
RNA-Seq and analyzed the transcriptomes of 68 pediatric patients with 
well-characterized clinical phenotype to identify transcriptional features 
associated with each disease class. Next, we refined those features and 
used them to create predictive models using elastic net and support vector 
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machine algorithms. Finally, we validated those models on an independent 
test set of 37 patients. We developed 4 RNA-based models based on gene 
expression to distinguish between bacterial, malarial, and viral infections. 
Support vector machine models fit the training set perfectly utilizing 600 
marker genes, suggesting overfitting; elastic net models by contrast had 
a more uniform performance between train and test sets while utilizing 
significantly fewer genes. In a second approach, we performed Luminex-
based and aptamer-based proteomic analysis and characterized the 
peripheral blood protein response of 161 pediatric patients from the same 
population. The pipeline for analysis initially included partial least squares, 
PAM (prediction analysis for microarrays, a Tibshirani method), random 
forests, and elastic nets (with genetic algorithms). This study demonstrates 
that human transcriptional features and proteomic signatures in patients 
with infectious disease diagnoses recapitulate the underlying biology and 
provide models for predicting diagnosis. We have identified sets of genes 
and specific groups of proteins that are expressed in pediatric patients with 
pneumonia syndrome attributable to different infections and requiring 
therapeutic interventions. These may provide the foundation for a clinical 
point of care diagnostic.
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RISK FACTORS FOR SECONDARY HOUSEHOLD 
TRANSMISSION OF INFLUENZA VIRUS AH3N2 IN THE 
PERUVIAN NORTHERN COAST
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Influenza virus is associated with 250,000 to 500,000 deaths worldwide 
and household transmission accounts for approximately one third of all 
cases. We evaluated risk factors associated with secondary household 
transmission of influenza virus AH3N2 in a rural community in the 
northern coast of Peru through a prospective population-based cohort 
study of influenza-like illness (ILI). We made household visits three times 
per week to detect cases of ILI, collect nasopharyngeal samples from 
cases and testing them by RT-PCR. We identified index cases as the first 
ILI case reported in a household with laboratory-confirmed influenza 
AH3N2. People residing in the same household as the index case were 
considered household contacts. Secondary cases were household contacts 
who developed laboratory-confirmed influenza AH3N2 ILI within seven 
days after the index case. The household secondary attack rate (SAR) 
was calculated and generalized linear models were fitted to identify the 
potential risk factors for transmission, accounting for household clustering, 
population size, number of primary cases, and other relevant descriptors. 
The SAR was 6.9% [CI 95% 4.3-10.2] with 22 secondary cases among 
321 household contacts. In multiple regression analysis, secondary risk 
increased 3.6 times in household contacts <5 years old versus those 
older [Adjusted Prevalence Ratio(PR)=3.6, 95%CI: 1.4-9.3] and risk was 
increased 4.7 times to siblings of the index case compared to other 
contacts [Adjusted PR=4.7, 95%CI: 1.4-15.4]. Household transmission 
of influenza AH3N2 virus was frequent in this cohort, especially to young 
siblings, who are likely to have especially close contact with the index 
case. Seasonal vaccinations of children as well as non-pharmaceutical 
interventions may mitigate this risk. More studies with a better proxy of 
close contact between household members are recommended.
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IN MALAWI, 2000-2014
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In Malawi, under-5 mortality fell from 247 deaths per 1000 live births in 
1990 to 71 in 2013, meeting the target set by Millennium Development 
Goal 4. This decline was due, in part, to a reduction in pneumonia 
mortality, which fell from 27.5 under-five pneumonia deaths per 1000 
live births to 10.1 from 2000 to 2014. The study objective is to document 
variability in the decline in under-five pneumonia mortality in Malawi from 
2000 to 2014 across 28 districts and describe the contribution of health 
interventions to this decline. We used the Lives Saved Tool (LiST, version 
5.41, Beta 6) to estimate the impact of change in intervention coverage on 
under-five pneumonia mortality by district from 2000 to 2014. Estimates 
of intervention coverage were drawn from the Demographic Health Survey 
(2000, 2004, 2010) and Multiple Indicator Cluster Survey (2006, 2014), 
and interpolated for years when survey data were unavailable. Populations 
and cause of death data came from World Population Prospects 2015. 
We compared the contribution of preventive (breastfeeding, vaccination, 
nutrition) and curative (antibiotics) interventions on district change in 
pneumonia mortality. Results for two districts, Blantyre and Kasungu, with 
different baseline care-seeking, are presented as an illustrative example. 
The proportion of deaths attributed to pneumonia among children 1-59 
months decreased from 17.7% to 15.5% in Blantyre from 2000 to 2014 
and from 20.7% to 11.6% in Kasungu. Blantyre had higher care-seeking 
for pneumonia, 36.2%, while Kasungu was lower at 13.1% in 2000. In 
2014, 86.5% of children in Kasungu received 3 doses of PCV while 74.9% 
did in Blantyre. Vaccination averted >2800 additional pneumonia deaths 
in Blantyre from 2001 to 2014, accounting for 75% of deaths averted. 
Vaccination averted 34.2% of additional pneumonia deaths in Kasungu 
and increase in care-seeking prevented >3000 (30.7%) of pneumonia 
deaths. Health interventions were scaled up at different rates across 
districts, which resulted in variations in change in pneumonia mortality 
over time. Planners should disaggregate data to ensure all districts are 
served by interventions.
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EPIDEMIOLOGY OF INFLUENZA AMONG SEVERE ACUTE 
RESPIRATORY INFECTIONS — DAMANHOUR, EGYPT, 2009-
2015
Erik J. Reaves1, Adel Mansour2, Hoda Mansour2, Sahar El 
Alkamy3, Mostafa Maroof2, Sahar El Shorbagy3, Samir Refaey3, 
Mohammad Genidy3, Salma Afifi2, Mark Wooster1, Amr Kandeel3
1Centers for Disease Control and Prevention, Cairo, Egypt, 2U.S. Naval 
Medical Research Unit - 3, Cairo, Egypt, 3Ministry of Health and 
Population, Cairo, Egypt
Influenza infections cause substantial morbidity and mortality. We sought 
to estimate the incidence and describe the characteristics of influenza 
infections among severe acute respiratory infections (SARI) cases in 
Damanhour, Egypt. We analyzed surveillance data of SARI cases from 3 
public hospitals from June 2009-December 2015. SARI was defined as 
history of fever or measured temperature ≥38°C, cough with onset in 
the last 10 days, and requiring hospitalization. Polymerase chain reaction 
(PCR) of naso/oropharyngeal specimens were tested for influenza A and 
B viruses, adenovirus, parainfluenza virus, respiratory syncytial virus, 
human metapneumovirus, and coronavirus. Data from a 2012 healthcare 
utilization survey were used to estimate incidence. Among 10,431 SARI 
cases, 9,992 (95.8%) had PCR testing; of these, 3,664 (36.7%) were 
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positive for one of the tested pathogens and 1,569 (15.7%) for influenza. 
Among influenza infections, the proportion positive was 57.5% (n=902) 
for influenza A, 35.9% (n=563) for influenza B, and 6.6% (n=104) for 
co-infection with other tested viruses. Frequencies for influenza A subtypes 
were 58.1% (n=524) for seasonal H1N1, 48.9% (n=441) for H3, and 
0.8% (n=7) for H5. Overall incidence of influenza infection was 96.9 per 
100,000 person-years. The highest proportion of influenza infections 
occurred during October-February (769/3,409, 22.6 %) compared to other 
months (206/4,488, 4.6%), (p<0.001). Influenza A infections were 4.9 
times more likely between October-November compared to other months. 
Mean duration of symptoms was 5.17+2.3 days and hospitalization was 
4.0+3.1 days; 28 (1.8%) patients were admitted to intensive care for 
a mean duration of 5.9+5.9 days. Patients with influenza A infection 
were 2.2 times more likely to be admitted to intensive care compared to 
patients with influenza B infection. Three cases died, two of whom had 
influenza A infection. Influenza infection peaked during winter primarily 
from influenza A seasonal H1N1 and H3. Infection with influenza A 
was associated with more severe disease and higher mortality. Routine 
vaccination is essential to decrease influenza burden.
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QUALITY OF CASE MANAGEMENT OF PNEUMONIA AND 
DIARRHEA IN CHILDREN AGED <5 YEARS: RESULTS FROM 
A HEALTH FACILITY SURVEY IN SOUTHERN MALAWI IN 
JANUARY-MARCH 2015
Miwako Kobayashi1, Dyson Mwandama2, Humphreys Nsona3, 
Ruth Namuyinga1, Minica Shah1, Andy Bauleni2, Alexander Rowe1, 
Don Mathanga2, Laura Steinhardt1
1Centers for Disease Control and Prevention, Atlanta, GA, United States, 
2Malaria Alert Centre, Blantyre, Malawi, 3Ministry of Health, Lilongwe, 
Malawi
Globally, pneumonia and diarrhea are leading causes of child deaths. 
Integrated Management of Childhood Illness (IMCI) is a widely adopted 
approach to manage these and other childhood illnesses in resource-
poor settings, but studies show that many children are inappropriately 
treated. The objectives of this analysis are to describe case management 
in Malawi, a malaria-endemic country, in children aged 2-59 months for 
pneumonia per IMCI and aged <5 years for diarrhea, and to determine 
factors associated with case management quality. During January-March 
2015, we conducted a cross-sectional survey of 95 health facilities (HFs) 
in southern Malawi using patient exit interviews, healthcare worker 
(HCW) interviews, and HF assessments. Results were weighted and logistic 
regression models examined patient, HCW, and HF factors associated 
with pneumonia and diarrhea case-management quality, using local IMCI 
guidelines as the gold standard. Of 694 children aged 2-59 months, 132 
(19.4%) met IMCI criteria for uncomplicated pneumonia. Of those, HCWs 
gave correct treatment (cotrimoxazole, amoxicillin, or erythromycin) to 
90 (62.8%) and diagnosed pneumonia in 24 (15.1%). Of 724 children 
aged <5 years, 222 (27.2%) met criteria for uncomplicated diarrhea. Of 
the 222, HCWs diagnosed 135 (63.7%) and correctly treated 94 (38.2%) 
with oral rehydration solution (ORS) with or without zinc. Multivariable 
analyses showed that HCW ascertainment of cough or difficult breathing 
was associated with correct pneumonia treatment (odds ratio [OR]: 3.1; 
95% confidence interval [CI]: 1.01-9.8). Children were more likely to 
receive correct diarrhea treatment if female (OR: 2.7; 95% CI: 1.3-5.6), 
if HCWs diagnosed diarrhea (OR: 6.3; 95% CI: 3.1-12.6), or at facilities 
with ORS in stock (OR: 4.6; 95% CI: 1.8-11.4). Malaria diagnosis was 
negatively associated with correct management of both pneumonia (OR: 
0.4; 95% CI: 0.2-0.8) and diarrhea (OR: 0.3; 95% CI: 0.1-0.7). To improve 
quality of care, HCWs should be encouraged to solicit patient symptoms 
systematically and consider alternative common illnesses in children even 
when malaria is suspected.
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NEGLECTED TROPICAL POPULATIONS: THE BURDEN OF 
INFLUENZA IN THE ELDERLY, THAILAND
Kim A. Lindblade1, Prabda Praphasiri1, Malinee Chittaganpitch2, 
Supakit Sirilak2, Siriluk Jaichuang2, Darunee Ditsungnoen1, Fatimah 
Dawood3, Kriengkrai Prasert2
1CDC-Thailand, Bangkok, Thailand, 2Thailand Ministry of Public Health, 
Bangkok, Thailand, 3Centers for Disease Control and Prevention, Atlanta, 
GA, United States
As the global population ages, infectious diseases of older adults may 
increase in importance. Influenza virus infections disproportionately affect 
the very young and the very old, but little attention is given to influenza 
in the elderly in tropical countries, where influenza was not recognized as 
an important cause of illness until recently. We used systematic, random 
sampling to recruit a population-based cohort of persons aged ≥65 
years in Nakhon Phanom province, northeastern Thailand, to measure 
the burden of influenza and the effectiveness of the influenza vaccine to 
prevent influenza-associated acute respiratory infections (ARI). Participants 
were contacted weekly to identify those with ARI, and samples were 
taken by participants at home by self-swabbing their anterior nares. Nasal 
swabs were tested for influenza viruses using PCR. In May 2015, we 
enrolled 3,219 elderly persons into the study. Influenza vaccination was 
offered to the elderly population at large in Nakhon Phanom but was 
not linked to study enrollment. The cohort contributed 2,512 person-
years of observation through the end of March 2016. The median age 
at enrollment was 71 years (interquartile range, 68-76), 59% of the 
participants were female and 52% received an influenza vaccine in 2015. 
There were 1029 ARI cases, with 1013 (98%) samples tested; 42 (4%) 
samples were positive for influenza, of which 31 (74%) were influenza A/
H3N2, 7 (17%) were influenza A/H1N1pdm09 and 4 (10%) were influenza 
B. Most (83%) of the influenza infections were detected between 
June and November 2015 (the influenza season), and the incidence of 
influenza-associated ARI during the influenza season was 3 per 100 p-y 
(95% confidence interval, 2-4). In this population of Thai elderly with 
a high influenza vaccination rate, the incidence of influenza-associated 
ARI was moderate and most illness was associated with influenza A/
H3N2. Further analysis will be conducted to determine the burden of 
hospitalization caused by influenza and the effectiveness of the influenza 
vaccine in preventing illness in this cohort. This information may be useful 
to prioritize limited vaccine resources in Thailand.
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ROLE OF NASOPHARYNGEAL PNEUMOCOCCAL DENSITY 
IN THE EVOLUTION OF ACUTE RESPIRATORY ILLNESSES IN 
YOUNG PERUVIAN CHILDREN
Roger R. Fan1, Leigh M. Howard2, Marie R. Griffin3, Kathryn M. 
Edwards2, Yuwei Zhu4, John V. Williams5, Jorge E. Vidal6, Keith P. 
Klugman6, Ana I. Gil7, Claudio F. Lanata7, Carlos G. Grijalva3
1School of Medicine, Vanderbilt University, Nashville, TN, United States, 
2Department of Pediatrics, School of Medicine, Vanderbilt University, 
Nashville, TN, United States, 3Health Policy, Vanderbilt University, Nashville, 
TN, United States, 4Biostatistics, Vanderbilt University, Nashville, TN, United 
States, 5Pediatrics, University of Pittsburgh, Pittsburgh, PA, United States, 
6Rollins School of Public Health, Emory University, Atlanta, GA, United 
States, 7Instituto de Investigacion Nutricional, Lima, Peru
Streptococcus pneumoniae commonly colonizes the nasopharynx of young 
children, with colonization a critical initial step in the development of 
pneumococcal disease. We analyzed surveillance data from a prospective 
cohort of young children to examine pneumococcal nasopharyngeal 
density patterns surrounding acute respiratory illness (ARI) in a rural 
community setting of the Peruvian highlands. We assessed ARI with 
weekly household visits and collection of nasal swabs for viral detection. 
We also collected monthly nasopharyngeal samples to quantify 
pneumococcal colonization. We defined pre- and post-ARI periods as the 
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14 days before and after an ARI, and compared pneumococcal densities 
among samples collected during non-ARI, pre-ARI, ARI and post-ARI 
periods. Nasopharyngeal samples (n=3,579) from 837 children (median 
age 1.39 years) were included; 69% of samples had pneumococcal 
colonization. Relative to non-ARI, median pneumococcal density increased 
during pre-ARI periods and peaked during ARI. In secondary analyses 
of samples collected during ARI, both the presence of rhinovirus and 
persistent detection of colonization (with a new or previously detected 
serotype) were associated with higher pneumococcal density. These 
data suggest that nasopharyngeal pneumococcal density is dynamic 
surrounding episodes of ARI.
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DEVELOPMENT AND CLINICAL PERFORMANCE OF A 
HIGH THROUGHPUT LOOP-MEDIATED ISOTHERMAL 
AMPLIFICATION SYSTEM FOR THE DETECTION OF MALARIA
Rushini S. Perera1, Xavier C. Ding2, Frank Tully3, James Oliver3, 
Nigel Bright4, David Bell5, Peter L. Chiodini1, Iveth J. Gonzalez2, 
Spencer D. Polley1
1Department of Clinical Parasitology, Hospital for Tropical Diseases, 
University College London Hospitals NHS Foundation Trust, London, 
United Kingdom, 2FIND, Geneva, Switzerland, 342 Technology Ltd., 
Cambridgeshire, United Kingdom, 4Porvair Sciences Ltd., Norfolk, United 
Kingdom, 5Global Health Technologies, Global Good Fund (Intellectual 
Ventures Lab), Bellevue, WA, United States
As malaria prevalence declines in many parts of the world, the accurate 
and efficient detection of very low density malaria parasite infections 
is crucial for enabling rapid treatment and interruption of disease 
transmission. This is increasingly important as more endemic countries 
move towards elimination with community surveillance and treatment of 
sub-patent and asymptomatic infections. Common detection methods, 
based on microscopy and rapid diagnostic tests (RDTs), allow quick and 
accurate detection but are unable to identify most blood-stage infections 
below 50 parasites/µl. Nucleic acid amplification techniques (NAATs), such 
as PCR, are capable of detecting trace amounts of parasite DNA but are 
costly and complex to establish and maintain in endemic settings. Loop 
mediated isothermal amplification (LAMP) is a NAAT where amplification 
occurs in one step under isothermal conditions and is commercially 
available. The LAMP malaria kit (Loopamp® from Eiken Chemical Co.) 
was demonstrated to have excellent diagnostic performance in simple 
laboratories of various endemic countries. However its sample processing 
and overall throughput was low, limiting the deployment of this technique 
for large scale screening campaigns. In this study, we evaluate the 
clinical performance of a newly developed high throughput (HTP) sample 
processing system to be used in conjunction with the malaria LAMP kit. 
This system is based on a 96 well format that significantly reduces the 
need for individual sample pipetting by the use of a simple vacuum system 
and is compatible with the use of fresh blood and dried blood spots. 
The turnaround time from sample processing to reading results for 96 
samples is less than 2 hours. Our results show that this relatively simple 
high throughput DNA extraction method for LAMP is capable of detecting 
low density infections down to 1p/µl, with similar diagnostic accuracy to 
the gold standard PCR. These characteristics show the HTP-LAMP system 
is a robust and highly sensitive diagnostic test, with the potential to 
allow large scale sensitive population screening in the context of malaria 
elimination campaigns.
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DEVELOPMENT OF HIGHLY ACCURATE QPCR ASSAYS 
FOR QUANTIFICATION OF SUB-MICROSCOPIC MALARIA 
PARASITES IN ASYMPTOMATIC POPULATION
Carolyne M. Kifude1, Deborah M. Stiffler2, Robin H. Miller2, 
Emily Parsons2, Claire Wortmann2, Stephen O. Ocholla1, John N. 
Waitumbi1, Shirley Luckhart3, Janet Oyieko1, V. Ann Stewart2
1U.S. Army Medical Research Directorate-Kenya, Kisumu, Kenya, 
2Uniformed Services University of Health Sciences, Bethesda, MD, United 
States, 3Medical Microbiology and Immunology, School of Medicine, 
University of California Davis, Davis, CA, United States
In malaria endemic areas, most infections with the parasite in older 
children and adults are asymptomatic, and are often characterized by 
sub-microscopic parasitemia. These often accounts for the majority of the 
total prevalence of infection as opposed to clinical disease. Asymptomatic 
malaria inadvertently contributes to malaria transmission due to the long 
duration of infection and high incidences of gametocyte carriage in both 
high and low transmission areas. Therefore, the need for highly sensitive 
malaria diagnostic tools cannot be over emphasized. Here, we describe 
the development and validation of sensitive plasmodium real time qPCR 
assays for the detection of low-level malaria parasites in blood. We will 
also report the prevalence of malaria parasitemia as determined by the 
assays. Using 700 samples collected in a HIV/malaria co-infection study in 
a malaria endemic region in western Kenya, the presence of any species 
of malaria was first determined using an improved assay based on genus-
conserved sequences of the Plasmodium 18S ribosomal gene. All infections 
with ≥1 parasite per 50ul sample were detectable by our assay. Second, 
if positive for malaria, a panel of highly species-specific qPCR assays were 
developed to determine the presence and quantity of mixed species 
infections including P. falciparum, P. ovale and P. malariae. Finally, due to 
the importance of asymptomatic parasitaemia in malaria transmission, the 
presence and quantity of gametocytes was determined using stage-specific 
reverse-transcriptase qPCR. We will report the assay parameters including 
the limit of detection (LOD) and limit of quantification (LOQ), the linearity 
of the standard curves over a range of plasmid concentrations, coefficient 
of variation scores and the PCR efficiency. Overall, these results show 
sensitive quantitative PCR assays that can be used on samples from malaria 
endemic areas where high prevalence of sub-microscopic parasitemia have 
been reported. Such data can be used to inform public health measures 
aimed at reducing malaria transmission in communities.
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VALIDATION OF ULTRASENSITIVE DETECTION OF 
ASYMPTOMATIC MALARIA USING DRIED BLOOD SPOTS
Kayvan Zainabadi1, Matthew Adams1, Zay Yar Han2, Hnin Wai 
Lwin2, Kay Thwe Han2, Myaing Nyunt1, Christopher Plowe1
1Institute for Global Health, Division of Malaria Research, University of 
Maryland School of Medicine, Baltimore, MD, United States, 2Department 
of Medical Research, Ministry of Health, Yangon, Myanmar
Southeast Asian countries are committed to eliminating artemisinin-
resistant Plasmodium falciparum malaria in the region by 2030. Recently, 
ultrasensitive PCR techniques capable of detecting ultralow parasitemias 
have been used to select target populations for mass drug administration 
to eliminate malaria infections in asymptomatic carriers who may represent 
a transmission reservoir. However, these techniques require the use of 
either venous blood or preserved capillary blood. An ultrasensitive test for 
malaria infection that can be done using dried blood spots (DBS) would 
have potential to be scaled up for widespread surveillance. Here we report 
an optimized method for the highly sensitive detection of P. falciparum 
and P. vivax infections using DBS that is both high-throughput and cost-
effective, with a similar sensitivity to methods based on whole blood. 
Laboratory experiments demonstrate a lower limit of detection (LoD) of 
20 parasites/mL for DBS collected on Whatman 3MM papers and of 23 
parasites/mL for Whatman 903 Protein Saver cards, about 5,000-fold more 
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sensitive than rapid diagnostic tests and similar to the 16-22 parasites/
mL reported for other non-DBS ultrasensitive methods. We validated the 
sensitivity of the method in two field studies in Myanmar that took place 
during the wet and dry season. Nearly identical prevalence estimates of 
subclinical malaria were obtained from DBS samples as with preserved 
capillary blood samples, as well as with an independent ultrasensitive 
method using venous blood samples. These data validate the utility of 
DBS for use in asymptomatic surveillance studies. We are currently using 
DBS-based ultrasensitive PCR for large-scale surveillance studies across 
Myanmar in support of malaria elimination.
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DETECTION OF PLASMODIUM FALCIPARUM DNA IN SALIVA 
SAMPLES STORED AT ROOM TEMPERATURE : POTENTIAL 
FOR A NON-INVASIVE SALIVA-BASED DIAGNOSIS OF 
MALARIA
Obadiah Mfuh Kenji1, Livo Esemu2, Samuel Tassi Yunga1, Obase 
Bekindaka2, Jessica Yonga2, Palmer Masumbe Netongo2, Diane W. 
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1University of Hawaii, Honolulu, HI, United States, 2Biotechnology Center, 
University of Yaounde I, Yaounde, Cameroon
Current malaria diagnostic methods are invasive, requiring blood collection 
with inherent risk of contracting blood-borne pathogens, pain and poor 
compliance when repeated sampling is required. On the other hand, the 
use of saliva, which is a minimally invasive sample for the diagnosis of 
malaria, has not been widely evaluated. We aim to evaluate the diagnostic 
test performance of saliva collected and stored at room temperature using 
the OMNIgene®•ORAL kit, in the diagnosis of malaria. Concurrent blood 
and saliva samples were collected from 224 febrile patients in Cameroon. 
Saliva samples were collected in the OMNIgene•ORAL (OM-501) kit and 
stored at room temperature. Detection of Plasmodium falciparum (Pf) 
DNA was based on amplification of the multicopy 18s rRNA gene using 
nested-polymerase chain reaction (nPCR). Light microscopy was used to 
detect Pf blood-stage parasites. Microscopy, nPCR-saliva and nPCR-blood 
based prevalence of malaria was 22%, 29% and 35%, respectively. When 
microscopy was used as gold standard, the sensitivity of nPCR-saliva and 
nPCR-blood in detecting Pf was 91% and 100%, respectively; however, 
the specificity was 92% and 87%, respectively. When nPCR-blood was 
used as gold standard, the sensitivity of nPCR-saliva and microscopy was 
80% and 68% respectively; whereas the specificity was 99% and 100%, 
respectively. Nested PCR-Saliva had a “very good” agreement with both 
microscopy (kappa value 0.8) and blood PCR (kappa value 0.8). Nested 
PCR-Saliva detected 16 sub-microscopic malaria infections whereas 30 
sub-microscopic infections were identified by nPCR-blood. At parasitemia 
>10,000 parasites/ml of blood, the sensitivity of nPCR-saliva was 100%. 
Saliva can be used, as an alternative non-invasive sample for the diagnosis 
of malaria and the OM-501kit is effective at transporting and preserving 
malaria parasite DNA in saliva at room temperature.
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STIMULATING THE MARKET FOR MALARIA RDTS: NOVEL 
INSIGHTS FROM REAL-WORLD PROGRAMMING FOCUSED 
ON PRIVATE SECTOR SERVICE DELIVERY AND MARKET 
DEVELOPMENT
Nikki Charman, Andrea Cutherell, Stephen Poyer, Stephanie 
Dolan, Cristina Lussiana, Victor Lara
Population Services International, Nairobi, Kenya
Almost 8 out of every 10 suspected malaria patients received a diagnostic 
test in the public sector in 2014. Estimates of the level of private sector 
testing are much lower. This is a public health concern given that a 
significant proportion of patients (estimated at 40%) in many malaria 
endemic countries seek care for febrile illnesses from private sector 
providers. Malaria rapid diagnostic tests (RDTs) are considered a viable 
option for resource-constrained settings. The success of national diagnostic 
strategies will depend on increased availability and appropriate use of 
quality-assured RDTs in the private sector. Recent small-scale studies 
have introduced RDTs into the private sector to estimate their impact on 
fever case management. Given their controlled settings, these studies 
offer limited insight into the real world issues of supply chain reliability, 
RDT affordability, marketing and demand creation among providers and 
clients, acceptability of test results to providers and clients, post-market 
quality control of RDTs, and interface with country diagnostic policy and 
guidance. In response to these knowledge gaps, PSI in collaboration 
with partners (Malaria Consortium, FIND, and Johns Hopkins School of 
Public Health) implemented a three-year initiative funded by UNITAID to 
stimulate a private sector market for RDTs in five sub-Saharan African 
countries: Kenya, Tanzania, Madagascar, Uganda and Nigeria. Designed 
as an operations research project, the consortium successfully completed 
44 studies across the 5 countries. This presentation will offer an overview 
of the project design, findings and lessons learned, situating them in 
relation to results from other interventions in this area. In doing so, the 
presentation will enable participants to understand to 1) the important 
role the private sector can play in fever case management in Africa; 2) 
key market shortcomings, quality concerns and policy challenges related 
to the scale-up RDTs in the private sector in Africa; and 3) how the new 
WHO Roadmap for public-private engagement (expected release date of 
September 2016) can help address these challenges.
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SINGLE CELL FUNCTIONAL ARTEMISININ RESISTANCE IN 
CLINICAL STRAINS OF PLASMODIUM FALCIPARUM MALARIA
Alassane Mbengue1, Carolyn Shirey2, Souvik Bhattacharjee1, 
Innocent Safeukui1, Robert Stahelin2, Kasturi Haldar1
1Notre Dame University, Notre Dame, IN, United States, 2Indiana University 
School of Medicine, South Bend, IN, United States
Emergence and spread of artemisinin resistance raises risk of wiping out 
recent gains achieved in reducing worldwide malaria burden and threatens 
future malaria control and elimination on a global level. Plasmodium 
falciparum Kelch13 (PfKelch13) and the ring stage survival assay (RSA) 
respectively provide important tools to screen for and validate the spread 
of artemisinin resistance. But they fail to detect Kelch-independent 
mechanisms and a large proportion of clinical strains cannot be adapted 
for RSA, hampering comprehensive mapping and understanding the 
global biology of artemisinin resistance, in particular its heterogeneity in 
individual parasites and clinical infection. Our prior studies have shown 
that artemisinins target P. falciparum phosphatidylinositol-3-kinase 
(PfPI3K), which binds Kelch13. Kelch13 mutations of artemisinin resistance 
decrease kinase binding to elevate the lipid product phosphatidylinositol-
3-phosphate (PI3P), as reported previously. PI3P increase is predictive 
of resistance across clinical and engineered laboratory parasites even 
in absence of PfKelch13 mutations, suggesting that quantitative 
detection of PI3P in individual parasites may provide a powerful index 
of resistance. However separation of PI3P from phosphatidylinositol-4-P 
(PI4P) is challenging since both lipids have identical mass and charge. 
Here we report on functional assays that quantitatively detect PI3P as 
well as downstream pathways and distinguish them from PI4P in single 
P.falciparum parasites. Evidence will be presented for rapid measurements 
of artemisinin resistance applicable to clinical strains eliminating need for 
culture adaptation and providing powerful mechanistic portals for both 
the biology of resistance and its heterogeneity in infection.
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DELETIONS OF PFHRP2 AND PFHRP3 IN RDT-NEGATIVE 
PLASMODIUM FALCIPARUM ISOLATES FROM UGANDA
Sam L. Nsobya1, Elizabeth Namirembe2, Andrew Walakira2, 
Moses Kiggundu2, Emma Ruhamyankaka2, Emmanuel Arinaitwe2, 
Moses Kamya2, Doresy Grant3, Philip J. Rosenthal3
1Makerere University, Kampala, Uganda, 2Infectious Diseases Research 
Collaboration, Kampala, Uganda, 3Department of Medicine, University of 
California San Francisco, San Francisco, CA, United States
Malaria rapid diagnostic tests (RDTs) play a key role in malaria case 
management. The most widely-used RDT identifies Plasmodium falciparum 
based on immunochromatographic recognition of PFHRP2. Deletion of 
pfhrp2 was reported to be common in P. falciparum isolates from Peru 
and Ghana, and uncommon in isolates from Mali, Senegal, and India. 
We investigated the presence of deletions in pfhrp2 and the homologous 
gene pfhrp3 in samples collected from cross-sectional surveys conducted 
in 3 regions of Uganda in 2012-13. The surveys included annual blood 
smears and HRP2-based RDTs (SD BIOLINE) in children and adults from 
randomly identified households. Of 1,493 samples with positive blood 
smears, 96 were RDT negative and selected for further investigation. 
DNA was extracted from dried blood samples using Chelex-100. Analysis 
included amplification of subunit ribosomal DNA for P. falciparum-specific 
sequences, amplification of pfhrp2 and pfhrp3 by nested PCR followed 
by electrophoresis of PCR products to identify gene deletions, and 
amplification and electrophoresis of polymorphic regions of msp2 to assess 
complexity of infection. Of the 96 samples, P. falciparum was identified 
by PCR in 56 (58%). All 56 samples had at least one deletion in pfhrp2, 
pfhrp3, or flanking regions. Of these samples, 25 (45%) had a deletion 
in pfhrp2, 39 (70%) a deletion in pfhrp3, and 19 (34%) deletions in both 
genes. Geometric mean parasite density for the 56 samples was 291/µl 
and mean complexity of infection was 1.8. Of all positive blood smears in 
survey subjects, 3.8% appear to have had infections with pfhrp deletions 
and 1.3% deletions in both pfhrp2 and pfhrp3. Our results suggest that 
deletions in pfhrp2 or pfhrp3 may explain some false negative malaria RDT 
results in Uganda, generally in the setting of low parasite densities.
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THE DILEMMAS OF CONGENITAL CHAGAS DISEASE 
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Chagas disease has shifted from a neglected, endemic parasitic infection 
of the rural poor to an urbanized chronic disease and now a potentially 
emergent global health problem. Congenital transmission is estimated 
to account for 22% of all new Trypanosoma cruzi infections. Treatment 
during infancy is significantly more efficacious and better tolerated, but 
current diagnostic methods, fail to detect over half of infected neonates 
and <20% of infants complete 9-months of follow-up. We recruited 
pregnant women presenting for delivery in two urban hospitals in Santa 
Cruz department, Bolivia and monitored infants of infected women at 
birth, 1, 6 and 9 months to evaluate the performance of quantitative 
PCR (qPCR), IgM Western blots (using TESA-blots) and micromethod 
(microscopically detectable trypomastigotes) for newborn screening for 
congenital Chagas disease. Of 518 at-risk infants from 507 seropositive 
women, unequivocal congenital transmission was identified in 32 infants 
of 29 mothers, including 3 sets of infected twins (5.7% transmission rate). 
Vertical transmission was more likely to occur in younger (23.5 years; [CI: 
19.6-28.1] vs. [26.9; CI: 22.0-34.0]), first time mothers. Congenital T. 
cruzi infection was significantly associated with severe clinical outcomes 
including, premature birth (6 vs. 11 infants) and low birth weight (<2500g; 
7 vs. 245). Furthermore, uninfected infants of seropositive mothers 
suffered from respiratory distress (10 vs. 119 infants) and premature 
labour. In combined birth and 1 month specimens qPCR, TESA-blot and 
micromethod displayed sensitivity/specificity of 82.8%/97.3% (median of 
7143.6 parasites/ml; interquartile range of 5.0-187788.9 parasites/ml), 
71.4%/99.5% and 20.7%/100%, respectively. qPCR has the potential to 
facilitate earlier diagnosis and circumvent loss to follow-up. We critically 
discuss the technical, logistical and economic obstacles of implementing 
routine molecular screening for congenital Chagas disease in resource-
limited settings and describe the future prospects for improvement.
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TARGETING TRYPANOSOMA CRUZI METHIONYL-TRNA 
SYNTHETASE FOR NOVEL TREATMENT OF CHAGAS DISEASE
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Verlinde, Wim G. Hol, Erkang Fan
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Chagas disease is endemic throughout Latin America infecting 
approximately 5.7 million people and causing ~7000 deaths per year. 
New drugs with improved safety and efficacy are needed to replace the 
antiquated drugs that are currently available. Our group works on a novel 
drug target in Trypanosoma cruzi that is vital for protein synthesis, the 
methionyl-tRNA synthetase (MetRS). Guided by structure-based drug 
design, more than 500 novel MetRS inhibitors have been synthesized and 
tested for activity against recombinant trypanosomal MetRS. The most 
potent compounds were tested against intracellular T. cruzi amastigotes 
revealing EC50 values as low as 4 nM. The same compounds have 
minimal toxicity on mammalian cells (selectivity index >5000). Chemical 
modifications have led to much improved oral bioavailability (up to 80%) 
and pharmacokinetic properties compared to the parent compounds from 
which they were derived. A lead MetRS inhibitor was orally administered 
to mice at 50 mg/kg twice per day for 20 days resulting in no apparent 
side effects. Experiments testing the efficacy of MetRS inhibitors in the 
murine model of chronic T. cruzi infection are underway. These data 
support ongoing efforts to develop MetRS inhibitors as novel drugs for 
Chagas disease.
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NOVEL EXTRACTION PROTOCOL AND RECOMBINASE 
POLYMERASE AMPLIFICATION ASSAY FOR DETECTION OF 
LEISHMANIA DONOVANI IN 30 MINUTES
Dinesh Mondal1, Prakash Ghosh1, Md. Anik Ashfaq Khan1, Faria 
Hossain1, Susanne Böhlken-Fascher2, Greg Matlashewski3, Axel 
Kroeger4, Piero Olliaro5, Ahmed Abd El Wahed2
1International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, 
Bangladesh, 2Georg-August University, Goettingen, Germany, 3McGill 
University, Montreal, QC, Canada, 4University Medical Centre Freiburg, 
Freiburg, Germany, 5UNICEF/UNDP/World Bank/WHO Special Programme 
for Research and Training in Tropical Diseases, Geneva, Switzerland
Leishmania donovani (LD) is a protozoan parasite transmitted to humans 
by sand flies, which causes Visceral Leishmaniasis (VL). Currently, 
diagnosis is based on presence of anti-LD antibodies and clinical 
symptoms. Molecular diagnosis would require real-time PCR, which is 
not easy to implement at field settings. In this study, we report on the 
development and testing of a novel extraction protocol in combination 
with recombinase polymerase amplification (RPA) assay for the detection 
of LD. The LD RPA assay detected equivalent to one LD genomic DNA. The 
RPA assay was performed at constant temperature (42°C) and the total 
assay runtime including the extraction procedure was 30 minutes. The 
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RPA assay also detected other Leishmania species (L. major, L. aethiopica 
and L. infantum), but did not identify nucleic acid of other pathogens. 
Forty-eight samples from VL, asymptomatic and post-kala-azar dermal 
leishmaniasis subjects were detected positive and 48 LD negative samples 
were negative by both LD RPA and real-time PCR assays, which indicates 
100% agreement. To allow the use of the assay at field settings, a mobile 
suitcase laboratory (56+45.5+26.5 cm) was developed and operated at 
the local hospital in Mymensingh, Bangladesh by using a solar-powered 
battery. DNA extraction was performed by a novel magnetic bead based 
method, in which a simple fast lysis protocol was applied. Moreover, All 
reagents were cold-chain independent. The mobile suitcase laboratory 
using RPA is ideal for rapid sensitive and specific detection of LD especially 
at low resource settings and could contribute to VL control and elimination 
programmes.
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SPECTRUM OF BACTERIAL PATHOGENS IN INFLAMMATORY 
CUTANEOUS ULCERS OF AMERICAN TEGUMENTARY 
LEISHMANIASIS
Ruwandi Kariyawasam1, Rachel Lau2, Jordan K. Mah1, Braulio 
Valencia3, Alejandro Llanos-Cuentas3, Andrea K. Boggild1
1University of Toronto, Toronto, ON, Canada, 2Public Health Ontario 
Laboratories, Toronto, ON, Canada, 3Instituto de Medicina Tropical 
“Alexander von Humboldt”, Lima, Peru
Approximately 10% of New World cutaneous leishmaniasis (CL) ulcers 
manifest with a severe inflammatory phenotype characterized by pain, 
erythema, and purulent exudate, leading to near-universal treatment 
with antibiotics prior to anti-leishmanial therapy. Although these ulcers 
have a “secondarily infected” appearance, the contribution of potential 
bacterial co-pathogens in the pathogenesis and natural history of severe 
inflammatory CL is unknown. Understanding the ulcer microbiome in CL 
has important implications for antimicrobial stewardship, and evidence-
based management strategies. Our objective was to illuminate the 
represented bacterial species in ulcers of CL manifesting with the severe 
inflammatory phenotype. Pre- and post-antibiotic treatment filter paper 
lesion impressions (FPLIs) (n=16) from patients with severe inflammatory 
CL and baseline FPLIs (n=9) from patients with non-inflammatory CL 
were evaluated using 16S rDNA end-point PCR, 16S real-time PCR and 
species-specific real time PCR assays targeting Streptococcus pyogenes, 
Escherichia/Shigella spp, Citrobacter freundii, Enterobacter/Klebsiella 
spp, and Enterococcus spp. Confirmation to genus and species-level 
was performed using Sanger sequencing. Six of 16 (37.5%) FPLIs from 
inflammatory lesions were positive for bacterial pathogens by real 
time PCR, versus 2 of 9 (22%) FPLIs from non-inflammatory lesions. 
Six organisms were confirmed to be Staphylococcus spp (n=2), S. 
pyogenes (n=1), K. pneumonia (n=1), Pseudomonas aeruginosa (n=1), 
and Enterobacter spp (n=1). Two FPLIs retrieved from patients with 
inflammatory CL post-antibiotic treatment demonstrated pathogen 
durability. Our findings suggest that, in addition to usual skin flora, 
Gram-negative enterobacteriaceae and beta-hemolytic streptococci may 
contribute to the microbiome of severe inflammatory CL ulcers. It remains 
unknown if empiric antibiotic treatment of the severe inflammatory CL 
phenotype changes outcome, however, such regimens should include both 
Gram-positive and Gram-negative coverage.
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CHAGAS DISEASE: A PROSPECTIVE THERAPEUTIC COHORT 
WITH 12 MONTHS FOLLOW-UP, ANALYZING ADVERSE DRUG 
REACTIONS, THERAPEUTIC FAILURE AND SEEKING FOR 
BIOMARKERS”
Carlos H. Moreira1, Noemia B. Carvalho2, Rosário Q. Ferrufino2, 
Lea C. Oliveira3, José A. Lindoso4, Erika Manuli5, Marcela De 
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São Paulo, School of Medicine, University of São Paulo, Sao Paulo, Brazil, 
4Laboratory of Seroepidemiology from Institute of Tropical Medicine 
from São Paulo, Brazil; Institute of Infectology Emílio Ribas, Sao Paulo, 
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Paulo, Brazil
Treatment of chronic phase of Chagas disease with benznidazole (Bz) 
remains controversial mainly because of its weak evidence allowing its use. 
Its response is variable and presents, commonly, adverse drug reactions 
(ADRs). There are few studies, describing the ADRs during the treatment 
of adult patients with Bz and its failure using molecular methods. We 
established a prospective cohort study that followed, for 12 months, 87 
T. cruzi infected adults, (age between 18 – 65 years), with the chronic 
indeterminate form, mild to moderate cardiac or digestive involvement 
without advanced forms, during Bz use (5mg/kg/day, up to 300mg/day 
for 60 days). Patients were evaluated in 5 schedules visits for adhesion, 
ADRs, blood sample collection (near 15th, 30th, 60th days, 6th month and 
1st year after Bz initiation). Blood samples were collected to perform 
biomarkers identification of failure or cure, to perform transcriptomics and 
mass spectrometry studies. Of the 87 patients that complete the follow-
up (FU), 58 (66.7 %) informed at least one ADR, 63.8% dermatological, 
41.4% gastrointestinal and 36.2% neurological related. The majority of 
the ADRs, 45 (77.6%), occurred in the first 15 days of treatment, mainly 
dermatological related (55.6%). On the 30th visit, 23 (39.7%) patients 
related ADRs of which, 60.9% were also dermatological related. On 
the 60th day visit, 27 (46.6%) patients related ADRs, of which, 48.1% 
neurological related. Regarding the therapeutic efficacy by the PCR 
(protein chain reaction) positivity for Trypanosoma cruzi was assessed 
(treatment failure was defined as at least 2 positive PCR out 8 replicates). 
On 60th day of treatment, 15 (17,9%) patients presented positive (+) PCR; 
up to 6th month, 37 (44.%) presented + PCR and, on the end of the first 
year after initiation of therapy, from the PCRs analyzed (70% of the total 
until this date), 40 (66.7%) patients presented +PCR. Although high failure 
rate demonstrated by PCR, the gold-standard method for cure still being 
the serology, that may persists reagent for decades, even after effective 
treatment. Last FU visit was performed on beginning March, 2016 and 
data is still on final analysis.
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TOWARDS SENSITIVE AND LESS INVASIVE DIAGNOSIS OF 
VISCERAL LEISHMANIASIS IN SUDAN USING LAMP
Maowia Mukhtar1, Sababil S S. Ali1, Salah M. Boshara1, Sahar 
M. Bakiet1, Audrey Albertini2, Séverine Monnerat2, Paul Bessell2, 
Joseph Ndung’u2, Israel Cruz2
1Institute of Endemic Diseases, University of Khartoum, Khartoum, Sudan, 
2Foundation for Innovative New Diagnostics-FIND, Geneva, Switzerland
Confirmatory diagnosis of visceral leishmaniasis (VL) usually requires 
examination by microscopy of samples collected by invasive means, such 
as splenic, bone marrow or lymph node aspirates, which cause discomfort 
to patients, with risks of bleeding and iatrogenic infections, and requires 
technical expertise. Molecular tests such as PCR have great potential for 
diagnosis of VL using peripheral blood, but are expensive, require well-
equipped facilities and trained personnel. More user-friendly, cost-effective, 
and field-amenable options are therefore needed. One method that 
could meet these requirements is loop-mediated isothermal amplification 
(LAMP): amplification of the target occurs at a constant temperature, the 
reagents are dried down, can be stored at room temperature, is highly 
specific, and results can be visualized using simple detection methods. A 
LAMP assay based on dried reagents, developed by Eiken Chemical Co. 
(Japan), FIND and partners, was evaluated in the diagnosis of VL at the 
Institute of Endemic Diseases (IEND), Sudan. A total of 198 VL suspects 
were tested by microscopy of lymph node aspirates (the reference test) 
and two serological tests: DAT (produced in house at IEND) and Leishmania 
Ab Rapid Test CE (CTK Biotech, USA). LAMP was performed on peripheral 
blood previously processed by i) a simple direct boil and spin method, 
and ii) the QIAamp DNA Mini Kit (QIAgen). The sensitivity and specificity 
obtained for each of the tests was: Leishmania Ab Rapid Test CE 98.96% 
and 100%; DAT 85.57% and 78.22%; LAMP-boil and spin 97.65% and 
99.01%; LAMP-QIAgen 100% and 99.01%. The excellent performance 
of LAMP on blood indicates that it can be included in the algorithm for 
diagnosis of VL and eliminate the need for invasive lymph node aspirates. 
The simplicity of the test makes it a promising candidate for confirmatory 
diagnosis in settings that are lower than the reference laboratory.
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ASSESSING IN VITRO AND IN VIVO ACTIVITY OF 
MILTEFOSINE AGAINST TRYPANOSOMA CRUZI
Julián E. Gulin1, Jaime Altcheh1, Margarita Bisio1, Daniela M. 
Rocco1, María E. Solana2, Facundo García-Bournissen1
1Service of Parasitology and Chagas Disease - “Dr. Ricardo Gutiérrez” 
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University of Buenos Aires, Buenos Aires, Argentina
Chagas disease treatment options are limited to Benznidazole (BZ) and 
Nifurtimox (NFX). These drugs have high efficacy in acute phase but its 
use in chronic phases is still under debate, and severe adverse effects are 
frequent. Alternative treatments are not currently available, in part due 
to high cost of developing new effective molecules. Drug repurposing 
is a cost-effective potential solution to fulfill current needs of better 
and safer therapy for Chagas disease. In primary screening at 10 µM, 
we found that Miltefosine (MLT; a phosphatidylcholine analog with 
antineoplastic and anti-Leishmania activity) exhibited higher relative anti-T 
cruzi activity (%RA) against trypomastigotes of Trypanosoma cruzi VD 
strain compared to BZ and NFX, and equal %RA against amastigotes. 
Consequently, MLT was moved to secondary screening, obtaining a 
dose-response curve with lytic concentration 50% (LC50) of 14.25 µM 
(CI95%: 8.23; 24.67) on trypomastigotes and inhibitory concentration 
50% (IC50) of 1.44 (CI95%: 0.634; 1.716) µM on amastigotes. These 
results supported further evaluation in an acute murine model of T. cruzi 
infection. Experimental protocol was approved by Faculty of Veterinary 
Sciences (UBA) (IACUC#2014/4). BALB/c females were infected with 500 
trypomastigotes by intraperitoneal (ip) route and treated orally after 8 days 
of infection with MLT at 25, 50, 75 or 100 mg/kg for 20 consecutive days. 
Infected non-treated (NT) and BZ or NFX treated groups (100 mg/kg) were 
included. MLT treatment decreased parasitemia levels in a dose-response 
manner, with 100% of survival in mice from 50 to 100 mg/kg dosing. 
Mice with negative parasitemia were subjected to an immunosuppression 
cycle (cyclophosphamide 200 mg/kg, ip, 1/week, up to four weeks). 
Parasitemia reactivation was recorded in 100% of mice in all MLT treated 
groups, as well as in all mice from BZ group, and in 57% of animals 
from NFX group. MLT exhibited an excellent in vitro parasiticidal effect, 
especially against amastigotes, but parasitostatic activity in vivo. Further 
studies on combined therapies with BZ or NFX and the evaluation of other 
repurposed candidates are needed and currently performed.
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OPTIMIZING SEASONAL MALARIA CHEMOPREVENTION 
(SMC) IN AFRICA: ESTIMATING THE IMPACT OF INCREASING 
THE NUMBER OF SMC CYCLES ON THE NUMBER OF 
CHILDREN PROTECTED, THE MALARIA BURDEN AND COST-
EFFECTIVENESS
Matthew Cairns1, Patrick G. Walker2, Jamie T. Griffin3, Paul J. 
Milligan1, Azra C. Ghani2
1London School of Hygiene & Tropical Medicine, London, United Kingdom, 
2Imperial College London, London, United Kingdom, 3Queen Mary 
University of London, London, United Kingdom
Seasonal malaria chemoprevention (SMC) is currently recommended by 
the WHO for malaria control in children in areas of the Sahel and sub-
Sahel with highly seasonal malaria transmission. SMC consists of up to 4 
monthly cycles of sulfadoxine-pyrimethamine plus amodiaquine (SP-AQ) 
given to all children between 3 and 59 months of age, and offers highly 
effective protection against malaria. However, large populations reside in 
areas with seasonal malaria transmission outside the area where SMC is 
currently recommended, mainly where the rainy season is slightly longer 
than in the Sahel. Many of these areas have a high malaria burden, 
despite scale-up of existing control measures. SMC over a longer period 
could be an important additional control strategy, but evidence on its 
likely effectiveness, and delineation of the areas where it would be cost-
effective are lacking. We used an individual-based malaria transmission 
model, fitted to data from SMC trials, to estimate and map the impact 
of SMC with additional monthly cycles across the African continent. It 
has previously been estimated that around 25 million children live in 
areas suitable for SMC in areas with a season up to 4 months in length. 
Model estimates suggest that a wider area, with a population of about 
40 million children, could be protected by four monthly cycles of SMC. 
The population protected by SMC could be further increased, by about 
20 million children, by using 5 or 6 rounds of SMC in areas with a longer 
season, where approximately 60% of the annual burden occurs within a 
5 or 6 month period. This could avert approximately 10.5 million malaria 
cases in young children per year, and many young deaths. These gains are 
likely to be highly cost-effective, at less than 10 USD per case averted in 
many areas, due to the relatively low cost of SMC, its high effectiveness 
where SP and AQ remain effective, and the high malaria burden. 
Additional monthly cycles of SMC may also be important within the area 
where SMC is currently recommended, by allowing national programmes 
to successfully hit the ‘moving target’ of seasonal cycles which vary in 
length and intensity from year to year.
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EVALUATION OF THE IMPACT OF SEASONAL MALARIA 
CHEMOPREVENTION ON MORTALITY AND MORTALITY IN 
YOUNG CHILDREN IN NORTHERN GHANA
Patrick O. Ansah1, Nana Akosua Ansah1, Keziah Malm2, Dennis 
Awuni1, Nana Yaw Peprah2, Timothy Awine1, Charles Manful1, 
Abraham R. Oduro1
1Navrongo Health Research Centre, Navrongo, Ghana, 2National Malaria 
Control Programme, Accra, Ghana
Malaria remains a major health concern in sub-Saharan African though 
global burden has reduced from 262 to 214 million from 2000 to 
2015. Across the Sahel sub-region, most childhood morbidity and 
mortality from malaria occurs during the short rainy season. Seasonal 
Malaria Chemoprevention(SMC) during this period has been shown to 
prevent illness and death from malaria in children. WHO recommended 
SMC implementation in the Upper West region of Ghana due to this 
seasonal pattern. This evaluation was to determine the impact of 
this implementation. Fourteen communities (clusters) were selected 
from Lawra District of Upper West Region with 731 children selected 
as an intervention area with similar selection in the West Mamprusi 
District(WMD) in the Northern Region with 711 children without SMC 
for comparison. Blood samples for hemoglobin and malaria parasitaemia 
were taken before and after the intervention and parameters of malaria 
morbidity and mortality were also collected during the intervention. 
Incidence rates of severe malaria were 0.01 and 0.02 per person years 
follow up in the Lawra District and WMD respectively with P.E of 
45%(p=0.62). For mild malaria, it was 0.22 and 0.17 per person years in 
intervention and control area respectively with PE of - 25%(p=0.31). For 
children developing anaemia(Hb< 11.0g/dl) from baseline to endline, there 
was a reduction of 16%(p=0.000) in Lawra and increase of 12%(p=0.002) 
in WMD. Mean Haemoglobin reduced by 0. 24g/dl(p=0.000) in WMD 
and increased by 0.39g/dl(p=000) in Lawra District at the end of SMC. 
At the end of the intervention, proportion of children with asexual 
parasites reduced by 19%(p=0.000) in Lawra District and increased 
by12%(p=0.000) in WMD. Morbidity data collection was a challenge in 
WMD due to health care seeking behaviour and reduced access to health 
facilities there due to geographical barriers. In summary, effectiveness 
of SMC in reducing parasite carriage among children in the intervention 
area has been demonstrated and its protective effectiveness on the 
haemoglobin level of children.
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EVALUATING THE COMMUNITY-LEVEL IMPACT 
OF INTERMITTENT PREVENTIVE TREATMENT OF 
SCHOOLCHILDREN FOR MALARIA IN JINJA, UGANDA: A 
CLUSTER-RANDOMIZED TRIAL
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Intermittent preventive treatment (IPT) for malaria in schoolchildren 
has been shown to benefit individual children, and has the potential to 
decrease malaria transmission at the community level. To evaluate the 
community-level impact of IPT of schoolchildren with dihydroartemisinin-
piperaquine (DP), a cluster-randomized trial was conducted in Jinja, 
Uganda. A total of 84 clusters, including one primary school and the 
100 closest households, were randomized in a 1:1 ratio to intervention 
and control. Children were enrolled into the intervention (March-Dec 
2014) and monthly IPT with DP was delivered (June-Dec 2014), with 
participants receiving up to 6 rounds of DP. The evaluation included 
cross-sectional surveys of schoolchildren (Nov-Dec 2014, N=1092) 
and community members (Jan-April 2015, N=8922), and continuous 
entomology surveillance in households from 40 randomly selected clusters 
(April 2014 – April 2015, N=200). In total, 25,630 students were listed on 
the 42 intervention school registers; 10,079 (39%) were enrolled in the 
intervention and received at least one dose of DP. Parasite prevalence by 
microscopy was lower in the intervention arm than in the control in both 
the school survey (9.2% vs 44.1%, adjusted risk ratio [aRR] 0.22 [95% CI: 
0.16-0.30] p<0.001), and the community survey (19.0% vs 23.1%, aRR 
0.85 [95% CI 0.73–1.00] p=0.05). Overall, the annual EIR was lower in 
the intervention arm than in the control (10.9 vs 18.8 infective bites per 
person/year) and was significantly lower during October-December 2014, 
when delivery of DP peaked (7.0 vs 24.7, adjusted incidence RR 0.03 [95% 
CI 0.001-0.46] p=0.01). Despite not reaching coverage targets, we found 
that IPT with DP had a positive impact on key malaria indicators measured 
in individual schoolchildren, and within the community. By targeting a 
demographic ‘hot-pop’, IPT of schoolchildren provides an operationally 
attractive option for malaria control that can benefit school-aged children, 
and potentially reduce transmission of malaria.
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BASELINE FREQUENCIES OF MOLECULAR MARKERS OF 
DRUG RESISTANCE BEFORE SCALING-UP ACCESS TO 
SEASONAL MALARIA CHEMOPREVENTION IN SEVEN 
COUNTRIES ACROSS THE SAHEL
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Nigeria, 9WWARN, Oxford, United Kingdom, 10Malaria Consortium, 
London, United Kingdom, 11Universite Cheikh Anta Diop, Dakar, Senegal, 
12Special Programme for Research and Training in Tropical Diseases, World 
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A major concern for SMC is that its widespread deployment will lead to 
the selection of drug resistant parasites with progressive loss of efficacy. It 
is essential that national SMC programmes incorporate a drug sensitivity 
monitoring component, using standardised methods so that trends over 
time can be interpreted and data across countries can be combined. 
Through the ACCESS-SMC project, we aimed to establish a monitoring 
system that will continue to be used in the longer term to monitor SMC 
programmes, through monitoring of molecular markers of resistance, and 
case-control studies. Surveys were conducted in January and February of 
2016, in Burkina Faso, Chad, Gambia, Guinea, Mali, Niger and Nigeria, 
to establish a baseline for the prevalence of molecular markers associated 
with resistance to sulfadoxine-pyrimethamine and amodiaquine, using 
standardised methods. Each survey included two age groups, children 
under 5 years of age, and a group of older children and adults, aged 10 to 
30 years, a group not exposed to SMC drugs, for assessment of the extent 
of changes in the circulating parasite population. The sample size, 2200 
in each age group in each country, was chosen to be able to estimate 
frequencies of the molecular makers with precision and in order to detect 
changes in frequency that might give early warning of loss of effectiveness 
when the surveys are repeated in January 2018 and at future intervals. At 
monitoring locations in each country, where possible in areas that had not 
started SMC, probability sampling was used to select participants, a short 
questionnaire was completed to record date of birth, recent antimalarial 
treatment and other details, and a finger-prick blood sample taken to 
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make at least two blood spots onto filter paper. These baseline samples are 
being genotyped to identify mutations at pfcrt, pfmdr1, pfdhfr and pfdhps 
known to impact on the efficacy of AQ or SP. The baseline survey results 
will be presented including PCR-determined prevalence of P. falciparum 
and the resistance genotyping data from each country.
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DIHYDROARTEMISIN-PIPERAQUINE FOR SEASONAL 
MALARIA CHEMOPREVENTION
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Seasonal Malaria Chemoprevention (SMC) using sulfadoxine-
pyrimethamine+amodiaquine (SPAQ) is used in the Sahel to prevent 
malaria in children. Dihydroartemisinin piperaquine (DHAPQ) is an 
alternative drug that could potentially be used if SPAQ starts to lose 
efficacy, and in parts of Africa outide the Sahel with seasonal transmission 
where there are high levels of resistance to SP. We assessed the effect 
of DHAPQ dose on efficacy as part of a randomized trial to evaluate the 
use of DHAPQ for SMC in Burkina Faso. 757 children received DHAPQ 
on three occasions, in August, September and October. Children were 
weighed each month to determine dosage, which was rounded to the 
nearest quarter tablet. PQ plasma concentration was measured in capillary 
samples in a subset of 159 children on day 7 after treatment with DHAPQ. 
Mean concentration was 48 ng/ml in August, 52 ng/ml in September, and 
60 ng/ml in October. To assess the association between PQ concentration 
on day 7 and protection against malaria during the same month, these 
children were divided into three groups according to the tertiles of the 
day 7 concentration, and the incidence compared using a logrank test 
for trend. Malaria incidence decreased with increasing concentration. 
The mean total monthly dose of PQ administered was 50 mg/kg. In linear 
regression, a 10-mg/kg increase in dose of PQ administered was associated 
with an increase of 4.7 ng/ml in the day 7 plasma concentration of PQ in 
August, 5.7 ng/ml in September, and 7.7 ng/ml in October, showing an 
accumulation of PQ in successive months. Cox regression was then used 
to assess the relationship between the dose of PQ administered and the 
incidence of malaria in the subsequent month, in the 757 children who 
received DHAPQ. An increase in PQ dose administered was associated with 
a reduction in the incidence of malaria, with a hazard ratio of 0.62 for a 
10-mg/kg increase in dose administered in August, 0.52 in September, 
and 0.85 in October. DHAPQ is effective, with the advantage of a fixed 
dose combination, but it will be important to ensure children receive an 
adequate dose. There are limited alternatives for SMC if SPAQ fails.
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COMPARATIVE IMPACTS OF ANTENATAL MALARIA 
PREVENTION STRATEGIES ON PLASMODIUM FALCIPARUM 
SP-RESISTANCE ALLELES IN MALAWI
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The efficacy of intermittent preventive therapy during pregnancy 
(IPTp) with sulfadoxine-pyrimethamine (SP) is continually threatened 
by parasite resistance to SP. Alternative strategies like intermittent 
screening and treatment with artemisinin-combination therapies (ISTp) 
are being considered. We hypothesized that, compared to ISTp with 
dihydroartemisinin-piperaquine, IPTp-SP would select for higher levels of 
SP resistance mutations in women infected with Plasmodium falciparum 
at delivery. We analyzed parasites collected from women participating 
in a randomized trial of ISTp and IPTp-SP at three sites in Southern 
Malawi, where parasite resistance to SP is high. We pooled P. falciparum 
parasites into populations and sequenced the phenotypically-relevant loci 
in the parasite genes dhfr and dhps using an Ion Torrent PGM platform. 
Reads were quality-filtered, aligned to reference sequences, and scored 
bioinformatically at the loci of interest to compute the frequencies of 
mutant alleles. Overall, we input 1,410 P. falciparum parasitemias into 
the analysis, comprising 18 pools of between 19 and 104 parasites. After 
stringent quality-filtering, median read depth was 1,682 at relevant loci 
in dhfr and 1,552 in dhps. In each population, the frequencies exceeded 
97% of the N51I, C59R, and S108N mutations in dhfr and the A437G 
and K540E mutations in dhps. The I164L mutation in dhfr was absent. The 
frequency of the dhps A581G mutation was 2.7% in parasites collected 
at second trimester enrollment. At delivery, the frequency of the A581G 
mutation in placental parasites was <1% in women who received ISTp and 
6.3% in women who received IPTp with SP (p < 0.001). This effect was 
most pronounced at a single study site, where the frequency of A581G 
in women receiving IPTp-SP increased from 4.3% at baseline to 23.1% 
in placental parasites (p < 0.001). These data indicate that, compared to 
an ISTp strategy, IPTp-SP promotes the emergence of parasites bearing 
dhps A581G. Understanding the clinical impact of parasites bearing this 
mutation on birth outcomes will be critical in areas of East Africa where 
these parasites circulate.
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EVALUATION OF TARGETED MASS TREATMENT OF MALARIA 
IN TANINTHARYI REGION, MYANMAR: PRELIMINARY 
RESULTS
Aye Aye Khaing1, Phyo M. Maung1, Kayvan Zainabadi2, Matthew 
Adams2, Kay Thwe Han3, Aung Thi4, Adam Richards1, Christopher 
V. Plowe2, Myaing M. Nyunt2, Si Thura1
1Community Partners International, Yangon, Myanmar, 2University of 
Maryland School of Medicine Institute for Global Health, Baltimore, MD, 
United States, 3Department of Medical Research, Ministry of Health, 
Yangon, Myanmar, 4National Malaria Control Program, Department of 
Public Health, Ministry of Health, Yangon, Myanmar
Targeted mass treatment (TMT) may be a useful intervention for malaria 
elimination, and is being evaluated for eliminating asymptomatic 
Plasmodium falciparum and P. vivax infections detected by active 
surveillance in malaria endemic populations in eastern Myanmar. A 
community-based study was conducted in Tanintharyi Region, southern 
Myanmar to evaluate the feasibility and efficacy of TMT. In preparation, 
malaria posts were established with trained malaria heath workers, and 
malaria prevalence was estimated using rapid diagnostic tests (RDT) and 
ultrasensitive real-time PCR (usPCR) in a total of 35 villages in three rural 
townships of the Region. Based on the prevalence of subclinical malaria 
by usPCR, three villages with the highest malaria prevalence were selected 
to receive TMT, and six control villages were selected. The TMT villages 
were treated with three daily therapeutic doses of dihydroartemisinin-
piperaquine (DHP) and low-dose primaquine, monthly for three months. 
No treatment was provided in the control villages. Standard diagnosis 
and treatment for malaria were available in all nine villages. No serious 
or unexpected adverse effects reported. In pre-TMT screening, only two 
of 1,750 blood samples collected were positive for P. falciparum by RDT, 
and none were positive for P. vivax. By usPCR, the pre-TMT prevalence 
of malaria ranged from 0-20.8% (P. falciparum 0-10.2% and P. vivax 
prevalence 0-18%). The percent reduction for P. falciparum was higher 
in the TMT than the control villages (92.3% versus 72.7%), however the 
difference was not statistically significant (p-value, xxxxx). The percent 
reduction in P. vivax is significantly higher in the TMT than the control 
villages (66.7% versus 10.3%, p-value 0.xx). Data for the 12-month 
follow-up are pending. Results from regression analysis adjusted for a 
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various covariates will be presented. We conclude that TMT with DHP and 
low-dose primaquine to eradicate subclinical malaria was well tolerated. 
The impact of TMT may be greater for vivax malaria than falciparum, but 
larger studies are needed to differentiate the impact of TMT from seasonal 
and other variations in prevalence.
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AEDES ALBOPICTUS AT ALTITUDE: WHAT COST FOR 
CHIKUNGUNYA AND DENGUE TRANSMISSION?
Fadila Amraoui1, Aurélien Mercier1, Enkelejda Velo2, Ada 
Shukullari2, Anna-Bella Failloux1, Paul Reiter1
1Institut Pasteur, Paris, France, 2Institute of Public Health, Tirana, Albania
The spectacular colonization of Europe by Aedes albopictus is testimony to 
its high physiological and ecological plasticity; the species is now present 
in 27 countries from Spain to Romania and is moving rapidly northward. 
Although its presence is frequently attributed to importations of used 
tires in Italy-first detection in 1991-it was already present in Albania in 
the 1970s. An outbreak of nearly 300 cases of chikungunya in Italy in 
2007 and subsequent sporadic autochthonous cases of dengue and 
chikungunya in other countries confirm the public health significance of 
the invading species. The strains of the mosquito established in Europe 
have a marked winter diapause and cold-hardiness, strong evidence 
that they originated in temperate Asia. If temperature is the limiting 
factor in its geographic range it could become established as far north 
as Scandinavia. The critical question is how far north transmission could 
occur. In this context, the Albanian infestation is of interest because the 
species is present in isolated mountain villages to at least 1209 m; this 
allows us to use altitude as a proxy for latitude. We collected eggs at 
149, 542, 762 and 1209 m during the summer of 2014 and reared them 
to F4 generation. Mosquitoes were orally infected with DENV (serotype 
2) and CHIKV (East-Central-South African genotype) at 107 FFU/mL and 
maintained at 28°C, 20°C as well as on a daily cycle of Tmin=15°C and 
Tmax=25°C. Dissemination and transmission rates were assessed on 
days 3, 7, 10, 14 and 21 post-infection. We found that titers of CHIKV 
in saliva compatible with high transmission rates were attained on days 
7 and day 10 at 28°C and 20°C respectively. Interestingly, transmission 
rates for low-altitude strains were higher at 28°C than at 20°C whereas 
populations collected at high altitude had higher transmission rates at 
20°C. By contrast, although all populations became infective with DENV 
at 28°C, no infection occurred at 20°C. Mean temperatures of 20°C and 
above are normal for several months in much of Europe. We conclude that 
if temperature is the key environmental factor limiting transmission, then 
CHIKV, but not DENV is feasible in much of Europe.
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ASSESSING THE POTENTIAL RISK FACTORS ASSOCIATED 
WITH NODDING SYNDROME IN NORTHERN UGANDA
Brooke E. Miers1, Jonathan Kayondo2, Richard Echodu3, Julius 
Lutwama2, John Grieco1, Lacey Ahern1
1University of Notre Dame, South Bend, IN, United States, 2Uganda Virus 
Research Institute, Entebbe, Uganda, 3Gulu University, Gulu, Uganda
Nodding Syndrome (NS) is a neurological disease of unknown etiology 
primarily affecting children between the ages of 5 and 15 in a few districts 
in northern Uganda. NS has been classified as a form of atonic epilepsy 
and symptoms include uncontrolled head nodding, stunted growth and 
intellectual disability. Not only does NS cause debilitating symptoms in 
those affected, but also provokes stigma and unrest throughout affected 
communities. Although the etiology is unknown, some studies show an 
association between NS and onchocerciasis, and propose that the vector 
carrying the causative agent of NS is the Simulium spp. black flies. This 
project aimed to support the hypothesis of Simulium spp. as the vector 
for NS by exploring the prevalence of these black flies in areas affected 
by NS, and through the creation of a spatial map of potential risk factors. 
This goal was achieved through two specific objectives. The two objectives 
of this project were: 1) to better understand and spatially map possible 
Nodding Syndrome risk factors through household assessments and 
surveys, and 2) to determine density and distribution through collection 
and identification of Simulium spp. black flies as well as screening of a 
subset for potential NS pathogens. Demographic and characteristic data 
was collected from area households both with and without the known 
presence of a NS case. Black flies were collected, classified, and screened 
for pathogens. The Simulium spp. densities, statistically significant data 
obtained from the households, and remotely sensed data was mapped 
atop NS case prevalence data in order to visualize possible patterns and 
associations of risk factors of the disease. It is our hope that this research 
will contribute to alleviating suffering in the communities affected by 
Nodding Syndrome over time by increasing knowledge on this disease and 
its hypothesized vector.
1278
ACHIEVING THE VISCERAL LEISHMANIASIS ELIMINATION 
TARGET IN INDIA WITH EFFECTIVE VECTOR MONITORING
Rinki M. Deb1, Geraldine M. Foster1, Rudra P. Singh2, Vijay 
Kumar2, Pradeep Das2, Michael C. Coleman1
1Liverpool School of Tropical Medicine, Liverpool, United Kingdom, 
2Rajendra Memorial Research Institute of Medical Sciences, Patna, India
Visceral leishmaniasis (VL) is a vector-borne neglected tropical disease 
of public health importance in Bihar and is transmitted by the bite of 
an infected Phlebotomus argentipes sand fly. Since the inception of 
the VL elimination programme in 1934, indoor residual spraying (IRS) 
has been conducted with dichlorodiphenyltrichloroethane (DDT) 50% 
wettable powder (WP). In 2015, in response to evidence showing a 
rapid decline in Ph. argentipes susceptibility, the elimination programme 
switched to pyrethroid class insecticide, alpha-cypermethrin 5% WP. 
Entomological monitoring is crucial to ensure insecticide efficacy during 
the transmission season. Surveys conducted to determine susceptibility 
status of F1 and field caught Ph. argentipes from Bihar showed 100% 
corrected mortality rates when exposed to 0.1% alpha-cypermethrin and 
0.05% deltamethrin. Reduced corrected mortality rates were observed 
when field caught sand flies were exposed to 0.05% alpha-cypermethrin 
(87.5-100%) and 4% DDT (24.6-37.5%). To assess the intensity of DDT 
resistance, CDC bottle bioassays were conducted using F1 Ph. argentipes. 
After 45 minutes of exposure at the diagnostic dose (100µg/bottle) 30% 
of sand flies were killed and 69% at 10x the diagnostic dose. Mortality 
breaching the 98% WHO limit for susceptibility was only found at 10x 
the diagnostic dose after 75 minutes and 5x the diagnostic dose after 150 
minutes, demonstrating the intensity of resistance. The efficacy of IRS was 
assessed by a two stage testing process treating tiles and then artificial 
walls made of three of the most common surfaces in Bihar (mud, brick 
and limewash), with either DDT or alpha-cypermethrin. Efficacy of DDT on 
F1 Ph.argentipes sand flies exposed for 30 minutes, was 13.45-21.97% 
on tiles treated at 1g/m2, whilst walls treated with the same dose showed 
mortality of 35.01-67.50%. Observed mortality on alpha-cypermethrin 
treated walls was within the acceptable WHO range (81.61-90.91%). 
Monitoring entomological indicators across Bihar provides early indications 
of sub-optimal impact and could support the programme in achieving its 
2017 elimination target.
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SANDFLY OCCURRENCE, DISTRIBUTION AND DIVERSITY IN 
LEISHMANIA ENDEMIC REGIONS IN KENYA
Damaris K. Matoke-Muhia1, Tobias Landmann1, Philip Ngumbi2, 
Milkah Mwangi2, Johnstone Ingonga2, Hellen Nyakundi3, Richard 
Wamai4, Joseph Wang’ombe3, Daniel Masiga1
1International Centre of Insect Physiology and Ecology, Nairobi, Kenya, 
2Kenya Medical Reserch Institute, Nairobi, Kenya, 3University of Nairobi, 
Nairobi, Kenya, 4Northeastern University, Boston, MA, United States
Phlebotomine sandflies are the only proven vectors of visceral leishmaniasis 
(VL) but knowledge of their distribution and diversity in Kenya is partial. 
Accurate knowledge of this is fundamental to implementation of vector 
control strategies. We explored the occurrence, distribution and diversity 
of sandflies in leishmaniasis endemic areas in Kenya. Vector sampling was 
done from three Counties: Baringo, Nakuru and Marsabit. Leishmanaises 
hot spots were identified using health facility screening and treatment 
records. Trapping was done indoors and outdoors around termite mounds, 
vertisols, sleeping areas, animal sheds and burrows using CDC light 
traps and sticky papers. Morphological and molecular identification of 
vector species was done using taxonomic keys and sequencing of the 
mitochondrial cytochrome c oxidase subunit 1 (COI) gene. Dissected 
midguts of sandflies suspected to harbor promastigotes were cultured 
in NNN media overlaid with complete Schneider’s media or blood agar. 
Vector density from each collection site was recorded. 14,000 sandflies 
were collected: Baringo (52.3%), Nakuru (8.6%), Marsabit (37.2%). 
Overall 40% were Phlebotomus martini. In Baringo, Marigat sub-county, 
P. martini  was the only vector trapped while in East Pokot P. duboscqi  
(40%) and P. martini  (30%) were the most prevalent. In Gilgil (Nakuru), 
P. guggiesbergi  (60%) was prevalent, P. saevus  (6%) and P. sergenti 
(5%) were also identified. In Marsabit, two main vectors were collected, 
P. martini  and P. orientalis. Outdoor trapping yielded the highest number 
with P. martini , P. orientalis and P. duboscqi  found both indoor and 
outdoor. 95% of the P. orientalis were from acacia dried swampy cracked 
soils areas while P. duboscqi  was collected along the river bed. Presence of 
P. duboscqi  in East Pokot, here identified for the first time, could indicate 
the presence of cutaneous leishmaniasis. Leishmaniasis transmission 
could be occurring outdoors as many people slept outside. Vector control 
strategies should target both indoor and outdoor settings. Vector studies 
add to understanding dynamics of leishmaniases’ transmission which is 
important for disease control.
1280
EVOLUTION OF GLOSSINA FUSCIPES S.L IN HUMAN AFRICAN 
TRYPANOSOMIASIS FOCI - EVIDENCE FOR CRYPTIC SPECIES
Allan Muhwezi1, Enock Matovu1, Martin J. Donnelly2, Stephen J. 
Torr2
1Makerere University, Kampala, Uganda, 2Vector Group, Liverpool School 
of Tropical Medicine, Liverpool, United Kingdom
Human African Trypanosomiasis (HAT) or sleeping sickness is a neglected 
parasitic disease endemic to rural sub Saharan Africa. Gambiense HAT 
which accounts for more than 95% of all HAT cases has been targeted 
for elimination by 2030 through the scale up of novel, and highly cost-
effective, vector control tools such as ‘tiny targets’ in combination with 
drugs. However there are long standing gaps in our understanding of the 
heterogeneity of HAT transmission and the ecology of tsetse flies (genus 
Glossina). HAT foci have historically remained spatially stable despite 
the high mobility of both the host and the vector. We hypothesised 
that some of this spatial heterogeneity in HAT may be driven in part by 
vector population structure. Information on the evolutionary relationships 
within and among populations of G. fuscipes s.l that accounts for 
>90% of HAT transmission is limited. We carried out a preliminary study 
using both mitochondrial (cytochrome oxidase sub unit 1 (CO1), NADH 
dehydrogenase sub unit 2 (ND2) and 16S ribosomal (16S)) and nuclear 
(internal transcribed spacer 1 of ribosomal (ITS1)) DNA markers to examine 
the phylogenetic relationships within G. fuscipes s.l in HAT foci in Uganda 
and the Democratic Republic of Congo, with a particular emphasis on G. 
f. fuscipes and G. f. quanzensis. Our results suggest that there is marked 
interspecific divergence between these two sub-specific forms. Further, in 
areas where there is a single sub-species we have generated evidence of 
marked differentiation between sub-populations and even within sampling 
locations. The public health importance of these preliminary findings is 
vector diversity may be contributing to the epidemiological complexity of 
HAT transmission and its control.
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SPATIO-TEMPORAL ANALYSIS AND TRYPANOSOMA CRUZI 
(AGENT OF CHAGAS DISEASE) INFECTION PREVALENCE OF 
CITIZEN-COLLECTED TRIATOMINE VECTORS ACROSS THE 
SOUTHERN USA
Rachel Curtis-Robles1, Lisa D. Auckland1, Sage Lane1, Michael Z. 
Levy2, Gabriel L. Hamer1, Sarah A. Hamer1
1Texas A&M University, College Station, TX, United States, 2University of 
Pennsylvania, Philadelphia, PA, United States
Due to increased reports of local transmission and widespread media 
and public interest in Chagas disease in the southern United States, 
defining the spatial and temporal occurrence of triatomine vectors and 
their infection with Trypanosoma cruzi is critical for public and veterinary 
health protective measures. Through a citizen science program and 
field collections from 2013 to 2015, we collected 2,812 kissing bugs 
from diverse ecological regions in Texas, as well as 66 bugs from 7 
additional southern states. The majority of citizen-collected bugs were 
found in homes, kennels, patios, or other peridomestic settings.  Using a 
combination of morphological and molecular identification, we identified 
7 different species of Triatoma.  Most commonly (97% of adults), 
triatomines were encountered between May and October. The two most 
common species, T. gerstaeckeri and T. sanguisuga, exhibited activity peaks 
in mid-summer and early fall, respectively. A point pattern analysis revealed 
unique geographic occurrences of the different Triatoma spp., suggesting 
that suitable habitat varies among the triatomine species. Using real-time 
PCR to detect T. cruzi DNA in bug hindguts, we found an overall T. cruzi 
infection prevalence of 63%. T. cruzi infection prevalence varied among 
triatomine species, ranging from 29% (95% CI: 19-39%) in T. rubida 
to 69% (95% CI: 65-73%) in T. gerstaeckeri. Parasite lineages revealed 
through strain typing were TcI (43%) and TcIV (57%).  These results 
demonstrate wide-spread occurrence of triatomine bugs in Texas, with 
ubiquitous infection with T. cruzi infection of strain types TcI and/or TcIV. 
However, heterogeneity existed in triatomine species’ spatial and temporal 
occurrence, and infection with different lineages of T. cruzi. Consideration 
of local temporal and spatial heterogeneity of Triatoma spp. occurring in 
Texas will allow targeting of vector control and medical/veterinary outreach 
initiatives to reduce human and animal vector contact.
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BARCODED LIVE ARTHROPOD SCREENS FOR HIGH 
THROUGHPUT DISCOVERY OF NOVEL VECTOR CONTROL 
AGENTS
Maarten Eldering1, Angelika Sturm1, Martijn Vos1, Rob Henderson1, 
Sijia Li2, Geert-Jan van Gemert3, Robert Sauerwein1, Matthew 
Tremblay2, Koen Dechering1
1TropIQ Health Sciences, Nijmegen, Netherlands, 2California Institute for 
Biomedical Research, San Diego, CA, United States, 3Radboud University 
Medical Center, Nijmegen, Netherlands
To accelerate the search for new vector control agents we have 
developed a high throughput screening method for phenotypic screens 
on live arthropods. This new method relies on DNA-barcoding to trace 
individual insects during experiments. To identify novel mosquitocidal 
agents, we mixed DNA-barcoded microspheres with a bloodmeal and 
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test compound prior to membrane feeding of Anopheles stephensi on 
96-well plates. Each well contained a unique barcode and test specimen. 
Twenty-four hours post feeding we pooled dead mosquitoes and used 
PCR amplification and Luminex-based multiplex detection of barcode 
sequences to identify compounds with mosquitocidal activity. Similarly, 
the fraction of live mosquitoes was analyzed to assess sampling of every 
well. Plate feeding was very efficient, with over 90% of fed mosquitoes 
and minimal cross-feeding between different wells. The barcoding 
approach reliably detected positive control compounds that were spiked 
in different wells on the plate. Screening of a chemical library identified a 
number of compounds with potent adulticidal activity against Anopheles. 
Two of these compounds appeared to have excellent pharmacokinetic 
properties in Beagle dogs and showed plasma levels well above the IC90 
for more than eighty days at well-tolerated doses. These compounds are 
promising candidates for development of mosquitocidal drugs for human 
or veterinary use. We explored other barcoded screening modalities and 
have generated proof of concept for repellent and attractant screens, 
which lead to an underrepresentation and overrepresentation of sample 
barcodes, respectively. Using this technique we can screen 96 different 
test specimens on a single container of mosquitoes, which exceeds the 
current throughput capacity substantially and will significantly contribute 
to discovery and optimization of novel vector control agents.
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A RANDOMIZED CONTROLLED TRIAL OF THE 
NEUROPSYCHOLOGICAL BENEFITS OF COMPUTERIZED 
COGNITIVE REHABILITATION TRAINING IN UGANDAN 
CHILDREN SURVIVING SEVERE MALARIA
Michael J. Boivin1, Noeline Nakasujja2, Alla Sikorskii1, Horacio 
Ruisenoir-Escudero1, Itziar Familiar-Lopez1, Robert O. Opoka2, 
Bruno Giordani3
1Michigan State University, East Lansing, MI, United States, 2Makerere 
University, Kampala, Uganda, 3University of Michigan, Ann Arbor, MI, 
United States
We have previously documented persisting neurocognitive deficits from 
cerebral malaria (CM) and severe malaria anemia (SMA). In this RCT, 150 
Ugandan CM/SMA survivors (two years after illness) 5 to 12 yrs old and 
150 non-malaria children from their households were randomly assigned 
to 3 treatment arms. One treatment arm was computerized cognitive 
rehabilitation training (CCRT) with 9 games for enhancing attention, 
working memory, and visual-spatial processing in which game difficulty 
increased with proficiency. The limited CCRT arm was the same only with 
training cycling through simpler levels of difficulty. Children in the passive 
control arm received no CCRT. Before and after 24 sessions of training 
over 8 weeks, and one year following training, children were evaluated 
with tests previously used to establish persisting neurocognitive deficits 
for CM/SMA. These were the Kaufman Assessment Battery for Children, 
2nd ed. (KABC-2), computerized Tests of Variables of Attention (TOVA), 
computerized CogState cognitive tests, the Behavior Rating Inventory for 
Executive Function (BRIEF; caregiver rating), and the Achenbach Child 
Behavior Checklist (CBCL; caregiver rating). Malaria survivors receiving 
either full or limited CCRT showed significant improvements (compared 
to passive controls) on KABC-II Mental Processing Index (MPI; composite 
of all scales), visual-spatial processing (VSP), and the executive functioning 
(EF) test of conceptual reasoning; persisting to 1-yr follow-up only for 
VSP. BRIEF and CBCL behavior measures significantly improved, but not 
until 1-year post CCRT. Non-malaria children receiving CCRT benefited on 
KABC-II Story Completion (EF), not persisting to 1-yr follow-up. CogState 
maze chase (visual-motor tracking/attention), and maze learning improved, 
and these benefits continued at 1-yr follow-up. We present RCT evidence 
that CCRT is viable for evaluating and enhancing some domains of 
cognitive performance in brain-injured children in resource-limited settings. 
However, additional follow-up CCRT intervention components are needed 
for extending the long-term benefits for clinical populations.
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ASSESSING THE POTENTIAL TOXICITY HAZARD TO 
AQUATIC LIFE FROM IMMERSION OF INSECTICIDE-TREATED 
MOSQUITO NETS DURING FISHING AND WASHING
Jessica A. Lawson, Ciaran J. Harman, Edward J. Bouwer
Johns Hopkins University, Baltimore, MD, United States
The combination of efficacy and a favorable environmental and human 
health profile has made the pyrethroid insecticides a mainstay of malaria 
vector control. Pyrethroids are extremely toxic to fish and other aquatic 
life, but appropriate indoor usage is unlikely to contaminate lakes, rivers, 
or coastal environments. Long-lasting insecticidal nets (LLINs) were 
expected to mitigate the potential environmental impacts of bednets by 
eliminating the need for on-site (re)treatment and thus the possibility 
of concentrated insecticide dipping solutions ending up in local water 
bodies. However, LLINs have brought new concerns: enhanced durability 
makes these nets appealing for misuse as fishing gear. Furthermore, LLINs 
contain more insecticide than conventional treated nets, but local practices 
for washing nets - often in a nearby lake or stream - have not changed. 
We present a rigorous, quantitative assessment of the potential toxicity 
hazard to aquatic life from LLIN immersion during washing or fishing. 
Fourteen LLINs currently recommended by the WHO were included in our 
analysis. We aggregated existing data on insecticide release from nets, 
physicochemical properties of pyrethroids, and environmental breakdown 
pathways, as well as on pyrethroid toxicity. A model was built to simulate 
insecticide release and persistence in the environment following immersion 
of LLINs. Aggregated data were used to bracket concentrations and 
environmental transformations for a number of simplified, hypothetical 
scenarios. The results were compared to toxicity data to determine the 
potential threat to aquatic organisms. Although limitations in the currently 
available data precluded a full risk assessment, our results suggested 
that there is evidence to support concerns that immersion of LLINs could 
pose a threat to aquatic life, particularly in small water bodies or areas 
with limited circulation. Aquatic macroinvertebrates may be at greater 
risk than fish species. This is the first assessment to consider the potential 
ecotoxicological impacts from LLINs in such quantitative terms, including 
sorption, net-, and compound-specific interactions.
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EVALUATING THE IMPACT OF THE NATIONAL SCALE-UP OF 
MALARIA CONTROL INTERVENTIONS IN LIBERIA FROM 2004 
TO 2013
Samantha Herrera1, Victor S. Koko2, Levi Hinneh2, Kwabena 
Larbi3, Tajrina Hai1, Sumo Zeze4, Forkpa Karmon4, James 
Thompson4, William Belleh4, Christie Reed5, Christie Hershey6, 
Ramlat Jose7, Kaa Williams7, Gabriel Ponce-de-Leon8, Michael 
Aidoo8, Christen Fornadel6, Yazoume Ye1, Oliver Pratt2
1ICF International, Rockville, MD, United States, 2National Malaria 
Control Program, Monrovia, Liberia, 3National Malaria Control Program/
Management Sciences for Health, Monrovia, Liberia, 4Subah-Belleh 
Associates, Monrovia, Liberia, 5President’s Malaria Initiative, U.S. Centers 
for Disease Control and Prevention, Monrovia, Liberia, 6President’s Malaria 
Initiative, U.S. Agency for International Development, Washington, DC, 
United States, 7President’s Malaria Initiative, U.S. Agency for International 
Development, Monrovia, Liberia, 8President’s Malaria Initiative, U.S. 
Centers for Disease Control and Prevention, Atlanta, GA, United States
Beginning in 2004, after the civil war, significant investments were made 
to expand malaria control and prevention in Liberia. To assess these efforts, 
an impact evaluation was conducted using a pre and post design with a 
plausibility assessment. Trends in all-cause childhood mortality (ACCM) 
were analyzed against trends in coverage of malaria control interventions 
and contextual factors that affect child survival. Data from Demographic 
and Health Surveys, Malaria Indicator Surveys, and the health information 
system were used in the evaluation. Household coverage of at least one 
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insecticide-treated bednet (ITN) rose from 30% in 2007 to 55% in 2013. 
Increases were observed in ITN use among children under-five (26% to 
38%), pregnant women (33% to 37%), and the general population (23% 
to 32%) from 2009 to 2013 (no previous data available). Coverage of 
intermittent preventive treatment in pregnancy (two or more doses of 
sulfadoxine-pyrimethamine), introduced in Liberia in 2005, rose to just 
under 50% by 2013. Care seeking for children with fever remained stable 
during the evaluation period (65% in 2007 and 69% in 2013), while 
diagnostic testing for malaria among children with fever rose from 24% in 
2009 to 42% in 2013, and treatment with first-line antimalarials increased 
from 13% in 2007 to 40% in 2011. ACCM gradually declined during this 
same period from 109 (95% CI: 99-120) in 2007 to 94 (95% CI: 84-103) 
deaths per 1,000 live births in 2013; however, this decline was mainly due 
to a decrease in infant mortality from 71 (95% CI: 62-80) to 54 (95% CI: 
46-61) deaths per 1,000 live births as child mortality (mortality between 
age 1 and 4 years) remained stable during this period (41 and 42 deaths 
per 1,000 live births in 2007 and 2013, respectively). The evaluation period 
occurred within an overall environment of improvement in the country 
post-civil war, where the healthcare system was being rebuilt, GDP was 
rising, and other improvements in maternal and child health were taking 
place. The gradual expansion of malaria control interventions may have 
partially contributed to the decrease in mortality, but other factors also 
likely contributed to the decline.
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THE RELEVANCE OF OUTDOOR RESTING AND SLEEPING FOR 
BED NET USE IN THE GAMBIA
Susan Dierickx1, Katja Siling2, Julia Mwesigwa3, Charlotte 
Gryseels2, Fatou Jaiteh3, René Gerrets4, Umberto D’Alessandro3, 
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Gambia, 4Amsterdam Institute of Social Science Research, Amsterdam, 
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Despite the level of coverage of Long-Lasting Insecticide-treated Nets 
(LLIN) and Indoor Residual Spraying (IRS) has steadily increased, malaria 
persists in The Gambia. This persistent transmission offers new challenges 
for malaria elimination. In order to gain further understanding in the 
human-vector interaction and its effect on malaria control, a social science 
study assessed human activity, resting and sleeping behaviour during the 
evening and at night in rural Gambia. Using a sequential mixed-methods 
study design, quantitative survey data and the direct observation of 
bed net use and evening activities (n=201) were complemented with 
qualitative research. Out of 76.1% respondents who slept under a 
mosquito net, 57.5% were adequately protected from malaria by the nets. 
In addition to net availability, net use was affected by sleeping patterns 
inside and outside the house. Adolescents (57.2% male and 50.2% 
female) and adults (57.2% male and 51.2% female) often socialize, rest or 
sleep unprotected outside their houses during the early evenings (18.00-
21.00). Of the respondents, 16.4% moved between different resting 
and sleeping spaces during the evening, potentially leading to higher 
exposure to malaria. Qualitative data showed that specific subgroups are 
unlikely to use their bed nets, such as farmers protecting crops, herding 
cattle, burning charcoal or hunting during the evening. These findings 
suggest that unprotected resting or sleeping and evening activities might 
contribute to on-going transmission.
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COST-EFFECTIVENESS OF SEASONAL MALARIA 
CHEMOPREVENTION IN UPPER WEST REGION OF GHANA
Justice Nonvignon1, Genevieve Cecilia Aryeetey1, Shamwill 
Issah2, Moses Aikins1
1University of Ghana/School of Public Health, Accra, Ghana, 2UK 
Department for Inrternational Development, Ghana Office, Accra, Ghana
In Ghana, malaria is endemic and perennial (with significant seasonal 
variations in the three Northern Regions), accounting for 33% of all 
deaths among children under-five years, with prevalence rates in children 
under-five years old ranges from 4% in Greater Accra to 51% in Upper 
West Region. Ghana adopted the WHO-recommended Seasonal Malaria 
Chemoprevention strategy with a trial in the Upper West Region in 2015. 
The objective of this study was to estimate the cost-effectiveness of 
SMC. Costs were analysed from the provider and societal perspectives 
and are reported in 2015 USD. Data on resource use (direct and indirect 
costs) of the SMC intervention were collected from intervention records 
and a survey in all districts and at the regional level. Additional number 
of malaria cases and deaths averted by the intervention were estimated 
based on prevalence data obtained from an SMC effectiveness study in 
the region. Incremental cost-effectiveness ratios (ICERs) were estimated 
for the districts and region. Sensitivity analyses were conducted to test the 
robustness of the ICERs. The total financial cost of the intervention was 
US$1,142,040.80. The total economic cost was estimated to be US$7.96 
million and US$2.66 million from the societal and provider perspectives 
respectively. The additional number of cases averted additional deaths 
estimated to be averted by the intervention were 24,881 and 808 
respectively. The economic cost per child dosed was US$67.35 from 
societal perspective and US$22.53 from the provider perspective. The 
economic cost per additional case averted was US$107.06 from the 
provider perspective and US$319.96 from the societal perspective. The 
economic cost per additional child death averted by the intervention was 
US$3,298.36 from the provider perspective and US$9,858.02 from the 
societal perspective. The financial cost per the SMC intervention delivered 
to a child under-five was US$9.66. The ICERs were sensitive to mortality 
rate used. The SMC intervention is economically beneficial in reducing 
morbidity and mortality in children under-five years and presents a viable 
approach to improving under-five health in Ghana.
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EXPANDING THE TOOLBOX: A SYSTEMATIC REVIEW 
LOOKING AT OLD AND NEW VECTOR CONTROL TOOLS
Yasmin A. Williams1, Lucy S. Tusting2, Sophia Hocini1, Patricia 
Graves3, Gerry Killeen4, Allison Tatarsky1, Roly Gosling5
1University of California San Francisco, San Francisco, CA, United States, 
2Big Data Institute, Nuffield Department of Medicine, University of Oxford, 
Oxford, United Kingdom, 3Australian Institute of Tropical Health and 
Medicine and College of Public Health, Medical and Veterinary Sciences, 
James Cook University, Cairns, Australia, 4Environmental Health and 
Ecological Sciences Thematic Group, Ifakara Health Institute, Ifakara, 
United Republic of Tanzania, 5University of California San Francisco, San 
Francisco, CA, United States
To achieve the new global targets for malaria elimination, additional vector 
control tools (VCTs) are critical to supplement long-lasting insecticide-
treated nets (LLINs) and indoor residual spraying (IRS). We conducted a 
systematic review and expert consultations to identify VCTs with existing 
or future potential to reduce malaria transmission, to assess their readiness 
for implementation and to identify gaps in the supporting evidence. In 
consultation with expert groups, a total of 22 malaria VCTs were identified 
a priori, including larval source management, topical and spatial repellents, 
attractive toxic baits and endectocide treatment of humans and livestock, 
among other interventions. Six electronic databases and grey literature 
sources were searched from 1 January 1980 to 28 September 2015 to 
identify systematic reviews, Phase I-IV studies and models that assessed 
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the effect of each VCT on epidemiological and/or entomological outcomes 
across all age groups in all malaria-endemic settings. Eligible studies 
were summarized qualitatively and quality and risk of bias assessments 
undertaken where relevant. Recommendations of the Preferred Reporting 
Items for Systematic Reviews group were followed. Operational readiness 
and potential for impact were additionally assessed through consultations 
with field experts and national malaria control program managers. We 
will present search results and compare the current availability and quality 
of evidence (for systematic reviews and Phase III studies) for each VCT, 
in addition to the findings of the expert consultations on the relative 
potential of existing and nascent malaria VCTs to contribute to malaria 
elimination. Identifying VCTs to supplement LLINs and IRS will be central to 
global malaria elimination and eradication efforts.
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COMMUNITY HEALTH WORKERS’ PERCEPTIONS OF AND 
SATISFACTION WITH THEIR ROLE IN IMPLEMENTING 
A COMMUNITY CASE MANAGEMENT FOR MALARIA 
PROGRAM: IMPLICATIONS FOR FEASIBILITY AND SCALE-UP
Adriane Lesser1, Diana Menya2, Laura Winn3, Jeremiah Laktabai2, 
Wendy Prudhomme O’Meara4, Joy Noel Baumgartner1
1Duke Global Health Institute, Durham, NC, United States, 2Moi University 
(School of Public Health and School of Medicine), Eldoret, Kenya, 3Duke 
University, Durham, NC, United States, 4Duke University Medical Center, 
Duke Global Health Institute, Moi University School of Public Health, 
Academic Model Providing Access to Healthcare (AMPATH), Eldoret, Kenya
Community case management for malaria (CCMm) programs target 
prompt diagnosis and treatment of the disease in populations with 
inadequate access to formal health facilities. The World Health 
Organization recently launched the Rapid Access Expansion Programme 
to scale-up integrated community case management (iCCM), a strategy 
which addresses other childhood illnesses in addition to malaria. The 
feasibility and sustainability of many CCMm and iCCM programs depend 
largely on community health workers (CHWs) consistently providing 
high-quality services. We implemented a CCMm program which provides 
training and support (but no direct compensation) for established CHWs 
to provide free rapid diagnostic tests for malaria (mRDTs), along with 
results-conditional coupons redeemable for discounted antimalarials 
at retail shops. Assessing CHWs’ perceptions of and satisfaction with 
their volunteer role is essential to maintaining high-quality performance, 
identifying opportunities for program improvement, and demonstrating 
the potential for replication and scale-up. We therefore surveyed 
participating CHWs to determine the intrinsic and extrinsic factors that 
motivate (or conversely, discourage) their sustained involvement in 
providing CCMm services. Following training, 274 CHWs out of 287 had 
acceptable performance and were provided with commodities to perform 
mRDTs. Over the first six months of the program, six CHWs discontinued 
participation or were not invited to continue participation based on 
performance. We implemented a structured questionnaire to assess 
CHWs’ perceptions of, and satisfaction with, their CCMm role as well as 
any perceived externalities of participation on their other activities and 
responsibilities both within and outside the context of their CHW position. 
The questionnaire captured diverse aspects of CHWs’ perceptions of 
their role with regards to internal motivation, effectiveness, sustainability, 
community trust, and logistics. Our findings have implications for the 
sustainability and scale-up potential of CCMm and iCCM, especially for 
models dependent on a volunteer workforce.
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DISEASE-SPECIFIC CYTOKINE PROFILES IN PEDIATRIC 
PATIENTS WITH MALARIAL, HIV, AND SYSTEMIC BACTERIAL 
INFECTIONS
Benjamin H. McMahon1, Nicolas Hengartner1, Harshini 
Mukundan1, Sarah Voter1, Shailja Jakhar1, John M. Ong’echa2, 
Prakasha Kempaiah3, Zachary Karim3, Douglas J. Perkins3
1Los Alamos National Laboratory, Los Alamos, NM, United States, 2KEMRI, 
Kisumu, Kenya, 3University of New Mexico, Albuquerque, NM, United 
States
We present 680 cytokine profiles of blood drawn from well-characterized 
pediatric malaria patients in the high-disease-burden environment of 
Siaya, Kenya. High levels of co-infections were observed in this group, 
including HIV and bacteremia from non-Typhoidal Salmonella (NTS) and 
Staphylococcus sp. Cytokine profiles were placed into one of nine disease 
categories, including healthy controls, reflecting the bulk of seriously ill 
suspected malaria patients accepted into our study at the Siaya County 
Hospital. Distinct cytokine signatures were identified using LASSO, a model 
selection algorithm. Bootstrapping of the model selection procedure 
provided robustness to our answers against artifacts arising from the 
complexity of our data. Linear models using selected cytokines were able 
to identify comorbidities as the most important complexity impacting the 
cytokine profile. We were able to distinguish bacteremia from malaria with 
ROC areas under curve of 0.98, 0.85, and 0.88 for differentiating mono-
infection with NTS, co-infection of NTS with malaria, and mono-infection 
with Staphylococcus bacteremia, from mono-infection with malaria, 
respectively. Uninfected controls could be distinguished from the malaria 
background with an AUC of 0.91. IL-7, IL-8, TNFα, and MIG were the most 
informative cytokines for distinguishing NTS bacteremia from malaria, 
while IL-10 and IL-7 were the most able to distinguish Staphylococcal 
bacteremia from malaria. Progression of malaria to SMA was indicated by 
high levels of IL-2R and low levels of IP-10, while malaria was distinghished 
from the healthy controls with IL-2R, IL-10, MIP1b, and RANTES. 
Additional significant correlations of cytokine profiles with death (IL-8), 
malnutrition (IL-8, IP-10, TNFα, and IL-15), respiratory distress (Eotaxin and 
IL-8), high fever (IL-6, IP-10, and IL-10), hemoglobin level (IL-2R, IL-6, and 
RANTES), age (IL-1b, IL-2R, and Eotaxin), and the reticulocyte production 
index (RANTES and TNFα), were observed.
1291
COMPARISON OF THE INCIDENCE OF ACUTE LEPTOSPIROSIS 
IN THE KILIMANJARO REGION OF TANZANIA BETWEEN 
2007-08 AND 2012-14
Michael J. Maze1, Holly M. Biggs2, Matthew P. Rubach2, Renee 
L. Galloway3, Shama Cash-Goldwasser4, Kathryn J. Allan5, Jo E. 
Halliday5, Julian T. Hertz4, Wilbrod Saganda6, Bingileki Lwezaula6, 
Sarah Cleaveland5, Blandina T. Mmbaga7, Venance Maro7, John A. 
Crump1
1University of Otago, Dunedin, New Zealand, 2Duke University Medical 
Centre, Durham, NC, United States, 3Centers for Disease Control and 
Prevention, Bacterial Special Pathogens Branch, Atlanta, GA, United 
States, 4Duke Global Health Institute, Durham, NC, United States, 
5University of Glasgow, Glasgow, United Kingdom, 6Mawenzi Regional 
Hospital, Moshi, United Republic of Tanzania, 7Kilimanjaro Christian 
Medical Centre, Moshi, United Republic of Tanzania
The sole report of annual leptospirosis incidence in continental Africa of 
75-102 cases per 100,000 population is from a study performed in August 
2007 through September 2008 in the Kilimanjaro Region of Tanzania. 
To evaluate the stability of this estimate over time, we estimated the 
incidence of acute leptospirosis in Kilimanjaro Region, northern Tanzania 
for the time period 2012-2014. Cases were identified among febrile 
patients at two sentinel hospitals in the Kilimanjaro Region. Leptospirosis 
was diagnosed by serum microscopic agglutination testing using a panel 
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of 20 serovars belonging to 17 separate serogroups. Serum was taken at 
enrolment and patients were asked to return 4-6 weeks later to provide 
convalescent serum. Confirmed cases required a 4-fold rise in titer and 
probable cases required a single titer of ≥800. Findings from a healthcare 
utilization survey were used to estimate multipliers to adjust for cases not 
seen at sentinel hospitals. Among 1,115 patients presenting with fever, 19 
(1.7%) had confirmed or probable leptospirosis. Of cases, the predominant 
reactive serogroups were Australis 8 (42.1%), Sejroe 3 (15.8%), 
Grippotypphosa 2 (10.5%), Icterohaemorrhagiae 2 (10.5%), Pyrogenes 2 
(10.5%), Djasiman 1 (5.3%), and Tarassovi 1 (5.3%). We estimated the 
annual incidence as 11-18 cases per 100,000 population. We estimated a 
much lower incidence of acute leptospirosis than previously, with a notable 
absence of cases due to the previously predominant serogroup Mini. 
Our findings support the value of multi-year surveillance to understand 
leptospirosis epidemiology.
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FINE-SCALE GPS TRACKING TO QUANTIFY HUMAN 
MOVEMENT PATTERNS AND EXPOSURE TO LEPTOSPIROSIS 
IN THE URBAN SLUM ENVIRONMENT
Katharine A. Owers1, Juliana Odetunde2, Rosan B. de Matos3, 
Gielson Sacramento3, Mayara Carvalho3, Nivison N. Júnior3, 
Federico Costa4, Mitermayer G. Reis3, Mike Begon5, James E. 
Childs1, José E. Hagan1, Peter J. Diggle6, Albert I. Ko1
1Yale School of Public Health, New Haven, CT, United States, 2University 
of Kentucky College of Medicine, Lexington, KY, United States, 3Centro 
de Pesquisas Gonçalo Moniz, Salvador, Brazil, 4Federal University of Bahia, 
Salvador, Brazil, 5University of Liverpool, Liverpool, United Kingdom, 
6Lancaster University, Lancaster, United Kingdom
Understanding fine-scale movement of individuals is critical for 
understanding the dynamics of environmentally transmitted diseases, such 
as leptospirosis, for which the mechanisms underlying proxy associations 
with environmental sources of contamination are unknown. We recruited 
male and female participants from an ongoing cohort study in an urban 
slum community in Brazil with high leptospirosis infection rates (6.3% and 
3.4% per year, respectively). We conducted 24 hours of GPS tracking at 30 
second intervals, which resulted in data with a fine temporal and spatial 
resolution. We validated the data with diaries and exit interviews. GPS 
data were cleaned with a velocity filter and analyzed to estimate activity 
spaces and time spent in proximity to the household and to transmission 
sources for leptospirosis. Among the 172 recruited cohort subjects, 130 
agreed to participate and 100 wore the GPS for a full 24 hours. Both male 
and female participants spent the majority of their timepoints near their 
residence (male mean 81.2%, female mean 85.0% within 50 meters of 
the home, p = 0.32) and within the slum community (male mean 86.4%, 
female mean 88.3%, p = 0.58). However, males had a significantly larger 
activity space during the sampling period than did females (61034m2 
vs 42101m2, p = 0.015). The activity space within the urban slum 
environment was characterized by high density of open sewers, flood-
prone regions, and rat activity as ascertained by tracking board studies. 
In summary, we found that slum residents spend most of their time near 
their households, indicating that exposures to leptospirosis occur in the 
environment where they reside. The finding that males visited a larger 
area within the peridomestic environment may explain the high infection 
rates observed in this group. GPS tracking therefore is able to delineate 
fine-scale movement patterns within complex slum environments, provide 
useful insights into the mechanisms of environmental exposures, and 
identify opportunities for targeted prevention.
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POSTPARTUM INFECTION AT A UGANDAN REGIONAL 
REFERRAL HOSPITAL: MICROBIOLOGY AND ANTIMICROBIAL 
RESISTANCE PATTERNS
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The World Health Organization estimates that puerperal sepsis causes 
10% of maternal deaths in Africa, but prospective studies on sepsis 
incidence, microbiology and outcomes are scant. We performed a 
prospective cohort study of 4,235 Ugandan women presenting to a 
regional referral hospital for delivery or postpartum care, measured vital 
signs after delivery, performed microbiologic evaluation of all febrile and 
hypothermic women, and followed them until 6 weeks postpartum by 
phone. Mean age was 24.9 years, 487 (12%) were HIV-1 infected, and 
50% had cesarean delivery. Temperature was measured for 4179 (99%); 
201 (4.8%) were febrile or hypothermic, and blood and urine samples 
were collected from 186 (93%). Of these, 58 (31%) had infection 
confirmed, 52 (90%) of whom were febrile. Five (8.6%) had malaria, 
5 (8.6%) had bloodstream infection, 7 (12%) had pyelonephritis, 13 
(22%) had catheter-associated urinary tract infection, and 43 (74%) had 
postpartum endometritis. Postpartum infection incidence did not differ 
by delivery mode or HIV status. Of 5 bloodstream infections, 3 were 
Gram-negative rods (GNRs, S. typhi, Acinetobacter, and E. coli), of which 
2 demonstrated extended-spectrum β-lactamase (ESBL) phenotype. Of 7 
women with pyelonephritis, 5 associated organisms (71%) were GNRs, 
all of which (100%) were ESBL phenotype. Of 13 catheter-associated 
urinary tract infections, 8 organisms (62%) were GNRs (6 Acinetobacter 
spp. and 2 E. coli), 7 of which (88%) were ESBL phenotype. Maternal 
mortality incidence was 0.06% in-hospital and rose to 0.26% by 6 weeks 
postpartum. Combined stillbirth and neonatal mortality incidence was 
4.7% in-hospital, rose to 5.9% by 6 weeks postpartum, and did not 
differ between women with or without postpartum infection (P=0.17 in-
hospital, P=0.32 at 6 weeks). Here, we demonstrate infection is common 
among febrile Ugandan women hospitalized for delivery or postpartum 
care. The microbiology of urine and bloodstream infections is dominated 
by antibiotic-resistant Gram-negative rods. Increasing availability of 
microbiology testing to inform appropriate antibiotic use should be a high 
priority in this setting.
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EMERGING PATHOGENIC BACTERIUM ELIZABETHKINGIA 
ANOPHELIS: DIVERSE MOBILE GENETIC ELEMENTS ARE 
PRESENT ACROSS STRAINS AROUND THE WORLD
Jiannong Xu, Dong Pei, Yuhao Lan
New Mexico State University, Las Cruces, NM, United States
Genus Elizabethkingia was separated from Chyseobacterium in 2005, 
with two member species, E. meningoseptica, a notorious pathogen 
causing meningitis, and E. miricola, an isolate obtained from condensation 
water of Space Station Mir. The third species, E. anophelis was originally 
isolated from the gut of Anopheles mosquitoes and described in 2011. 
In 2013, E. anophelis caused human infections were documented in 
Central Africa, and an outbreak in an intensive-care unit in Singapore 
was reported. In 2015, evidence came to light that E. anophelis infections 
could be transmitted from mother to infant. In 2016, an E. anophelis 
outbreak occurred in Wisconsin. The genome annotation revealed a large 
genetic capacity of the antibiotic resistance, defense against oxidative 
stress and TonB dependent transporters. Those features may contribute 
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to the virulence and pathogenesis. In this study, we reciprocally compared 
genomes of mosquito isolates and human isolates in different geographic 
locations including Central Africa, Singapore, Hong Kong, China and 
Wisconsin, in an attempt to recognize mobile DNA elements that may 
provide clues to identify genome signature that is related to pathogenesis. 
The comparison revealed the presence of variable discrete integrative 
conjugative elements (ICE) across the isolates. These ICEs contain genes 
that are involved in pathogenicity functions such as antibiotic resistance 
and virulence. The ICEs in mosquito isolates were degenerated with 
missing necessary Tra genes for mobility. Interestingly, a Type II CRISPR 
cas unit was identified in the pathogenic isolate from Central Africa. The 
genome comparison provided valuable information for further studies of 
pathogenesis, ecology and evolution of the species.
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FAILURE OF STRAIN-SPECIFIC IMMUNE INDUCTION TO 
GROUP A STREPTOCOCCUS MAY UNDERLIE THE EPIDEMIC 
OF STREPTOCOCCAL PYODERMA: OVERCOMING IMMUNE 
RESISTANCE THROUGH VACCINATION
Michael F. Good1, Manisha Pandey1, Victoria Ozberk1, Ainslie 
Calcutt1, Emma Langshaw1, Jessica Powell1, Mei-Fong Ho1, Zachary 
Philips1, Michael Batzloff1, Tania Rivera Hernandez2
1Institute for Glycomics, Gold Coast, Australia, 2School of Chemistry and 
Molecular Biosciences, Brisbane, Australia
The epidemic of streptococcal pyoderma is responsible for Australia’s 
Indigenous populations suffering the highest rates of rheumatic heart 
disease worldwide. The cause of the epidemic is poorly understood from 
an immunological perspective. There are in excess of 200 different strains 
of group A streptococcus (GAS) based on sequence differences in the M 
protein and it is known that antibodies to the serotypic amino-terminal 
segment of the protein can kill organisms in vitro. It is assumed that M 
protein sequence diversity is solely responsible for the prolonged period of 
time required to develop immunity, with immunity developing to common 
strains one at a time as a result of individual infections. We used four 
endemic pyoderma strains of GAS from patients in the Northern Territory 
to model the acquisition of natural immunity. Surprisingly, infection with 
one strain led to short-term protection only against a challenge infection 
with that particular strain. Immunological memory did not develop. 
Two sequential infections with the same strain were required to induce 
enduring strain-specific immunity. Sequential infections with different 
strains resulted in partial short-term immunity and only to the last strain 
to which the mice had been exposed. Mice exposed to multiple strains, 
either sequentially or simultaneously, did not develop antibodies to a 
conserved M protein vaccine peptide, J8, demonstrating that this epitope 
is cryptic to the immune system. However, in contrast to the lack of strain-
specific immunity that follows infection, immunity following vaccination 
with J8 protects against multiple strains delivered sequentially or as a co-
infection. Moreover, vaccine-mediated immunity was maintained following 
sequential heterologous infections. This study describes a major reason 
why immunity to GAS pyoderma is so slow to develop, but also shows that 
vaccination with a conserved peptide vaccine can prevent infections with 
multiple strains.
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HOUSEHOLD MODELLING OF YAWS DATA INDICATES 
THAT TARGETING TREATMENT USING CASE FINDING 
AND CONTACT TRACING MAY BE UNSUCCESSFUL AT 
ERADICATING THE DISEASE
Louise Dyson1, Oliver Crooks1, Alex Bishop1, Anthony Solomon2, 
David Mabey2, Oliver Sokana3, Michael Marks2, Deirdre 
Hollingsworth1
1University of Warwick, Coventry, United Kingdom, 2London School of 
Hygiene & Tropical Medicine, London, United Kingdom, 3Solomon Islands 
Ministry of Health and Medical Services, Honiara, Solomon Islands
Yaws is a painful and disabling infectious disease that causes skin and 
bone lesions. It is most commonly seen in children in warm, humid 
tropical areas. Individuals with the disease can be effectively treated with 
a single dose of oral azithromycin. Yaws is known to be clustered, even 
within endemic regions, but the spatial epidemiology remains poorly 
understood. Previous eradication campaigns used either mass treatment 
with benzathine-penicillin or more targeted treatment of cases and 
their contacts, depending on the prevalence of clinical disease. As many 
individuals are latently infected without clinical evidence of disease, this 
often resulted in failure to adequately treat latently infected individuals, 
resulting in subsequent rebound in disease incidence and ultimately 
failure of the eradication programme. The new WHO strategy mandates 
an initial round of MDA followed either by further MDA or active case 
finding and treatment of cases and their contacts. Multiple rounds of 
MDA can be expensive and requires large amounts of antibiotics, which 
are not currently donated for yaws eradication. We employ a household 
model to study the transmission of the disease using data collected from 
a pre-Mass Drug Administration (MDA) survey conducted in the Solomon 
Islands. We used this model to assess whether targeting cases and their 
household contacts would be sufficient to interrupt transmission. Our 
data indicate that a limited number of rounds targeting cases and their 
household contacts would leave 75% of latently infected individuals 
untreated, leading to the need for either many more rounds of treatment 
or a broader treatment strategy to successfully break transmission.
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LONG-TERM EFFECT OF MASS DRUG ADMINISTRATION FOR 
SCABIES IN FIJI: EXPERIENCE FROM THE SHIFT TRIAL
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Kama3, Handan Wand1, Lisi Tikoduadua3, John Kaldor1, Ross 
Andrews4, Andrew Steer5
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Control of scabies based on treatment of individual cases is difficult 
because of frequent re-infestation. We implemented a community 
intervention trial of mass drug administration (MDA) for scabies to 
ascertain the efficacy and safety of two alternative regimens (topical 
permethrin and oral ivermectin MDA), compared with standard care. We 
identified three isolated island communities in Fiji and randomly assigned 
one of the three treatment regimens: ivermectin MDA, permethrin MDA 
or standard care with permethrin. All participants were sought for re-
examination at 12 months, and at 24 months via a 20% sample. The 
study enrolled 2051 people. At baseline, scabies prevalence was high in 
all arms (32.1%, 41.7% and 36.6% in the three arms respectively). After 
one year the prevalence of scabies, previously reported, fell to 1.9% in 
the ivermectin arm corresponding to a reduction in prevalence of 94%. 
Scabies prevalence was also reduced to a lesser extent in the two other 
arms. At two years, scabies prevalence in the ivermectin arm was 3.7%, 
compared to 13.4% and 15.4% in the other two arms. In conclusion, the 
effect of MDA, particularly with ivermectin, was long lasting, with very 
low prevalence maintained even after two years following administration. 
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The study was the first to compare MDA for scabies with the conventional 
approach of treating symptomatic cases and contacts, and the first to 
undertake two year follow up. This strategy is likely to be highly beneficial 
for communities where this disease is endemic.
1298
PLAGUE IN MADAGASCAR: LIMITING THE TRANSMISSION 
BY IMPROVING THE CONTROL OF XENOPSYLLA CHEOPIS, 
THE MAIN FLEA VECTOR OF YERSINIA PESTIS
Adélaïde Miarinjara, Dora M. Rajohnson, Soanandrasana 
Rahelinirina, Sébastien Boyer
Institut Pasteur de Madagascar, Antananarivo, Madagascar
Madagascar is the second country most affected by plague worldwide, 
with around one thousand cases per year. The bubonic plague, resulting 
directly from infected fleas bite, is the more encountered plague form 
in Madagascar. Insecticide dusting is the method used to control rat 
fleas during epidemic season. In this study our two mains objectives 
are: evaluating the current status of flea population’s susceptibility to 
insecticides and improving the methods allowing better control of fleas 
involved in plague transmission. Primarily, 12 insecticides, clustered in four 
families: organophosphate, carbamates, organochlorine and pyrethroid, 
were used to test the resistance level of Xenopsylla cheopis, the main 
plague vector. We found that X. cheopis from 30 out to 32 localities 
was found resistant to deltamethrin, a pyrethroid the first-line insecticide 
used to control plague during at least one decade. More, deltamethrin 
resistant fleas were resistant to nearly all tested insecticides, except 
dieldrin, an organochlorine. Besides, resistance level to each insecticide 
was different according to flea’s origin, complicating the vector plague 
management. Thus, it becomes crucial to find more targeted approach 
to fight against rat fleas. One way which worth to be explored is the use 
of systemic insecticide, by incorporating insecticide in rodents baits. We 
assessed acute toxicity of fipronil, by contact and by the systemic way, on 
highly deltamethrin resistant fleas. No resistance to this compound was 
noticed at 0.05% when applied to fleas by contact, with 100% mortality. 
However, the toxicity against fleas was 90 fold higher when mixed to 
Rattus rattus and R. norvegicus baits. The use of systemic insecticide as a 
method for controlling vectors of Y. pestis has many benefits compared 
with insecticide dusting, by targeting rat fleas directly on their host, then 
reducing the cost and the amount of insecticide spilled in the environment.
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SOURCE OF HOST BLOOD AFFECTS LOCALIZATION OF THE 
BLOOD MEAL AND INFECTION PREVALENCE OF YERSINIA 
PESTIS IN THE FLEA VECTOR
David M. Bland, Christopher F. Bosio, Clayton O. Jarrett, Bernard 
J. Hinnebusch
Rocky Mountain Laboratories, National Institute of Allergy and Infectious 
Diseases, National Institutes of Health, Hamilton, MT, United States
Flea-borne transmission of Yersinia pestis, the etiologic agent of 
plague, can occur during the first four days of infection by an unknown 
mechanism termed early-phase transmission (EPT). One week or later post-
infection, Y. pestis is transmitted by the biofilm-dependent regurgitation 
mechanism. In laboratory studies of flea vector competence, infection 
rates and transmission efficiencies vary considerably between flea species 
as well as among conspecifics from different studies. One variable that 
may explain this variation is the species of animal blood used in the 
infectious blood meal. To investigate the effect of host blood source on 
flea vector competence, we determined the infection prevalence in groups 
of Xenopsylla cheopis rat fleas one day after they had fed on mouse, 
rat, or sheep blood containing equivalent concentrations of Y. pestis. In 
addition, we examined the flea digestive tract to determine the localization 
pattern of recently ingested blood. Consistent with previous studies, 
fleas fed on infected rodent blood had high infection rates (85-100%). 
In contrast, most fleas that fed on sheep blood cleared the infection (10-
20% infection rate) within one day. Interestingly, 15-30% of fleas that fed 
on infected rat blood were observed to have blood in the esophagus (BIE), 
in addition to the midgut, within 24 hours after an infectious bloodmeal. 
In contrast, little to no BIE (≤1%) was observed in fleas that fed on sterile 
blood or fleas that fed on infected mouse or sheep blood. Upon feeding 
again, within three days of infection, a subset of fleas with BIE retained 
a combination of older blood and the developing mass of plague bacilli 
in the esophagus which appeared to obstruct passage of the most recent 
blood meal. Our results indicate that the source of host blood influences 
the likelihood that a flea will become persistently infected with Y. pestis. 
In addition, the presence of rat blood and bacteria in the flea foregut 
may impede feeding sufficiently to influence the efficiency of EPT and is 
suggestive of a regurgitative mechanism for this type of transmission.
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VECTOR COMPETENCY OF TICK-BORNE RELAPSING FEVER 
SPIROCHETES
Job E. Lopez, Aparna Krishnavajhala
Baylor College of Medicine, Houston, TX, United States
Tick-borne relapsing fever (RF) spirochetes are globally distributed 
pathogens that cause significant morbidity and mortality if left untreated. 
Most species are primarily transmitted by argasid ticks in the genus 
Ornithodoros. A defining characteristic between Ornithodoros species 
and RF spirochetes is vector specificity, where a given species of tick only 
transmits a specific species of spirochete. We have developed the Borrelia 
turicatae-Ornithodoros turicata model of RF spirochetes. The vector 
is distributed in the southern United States into Latin America. In the 
United States there is a western population of O. turicata ranging from 
California to Texas, a gap through Louisiana, Mississippi, and Alabama 
where the tick has not been identified, and an isolated eastern population 
in Florida. This eastern population has previously been designated a 
subspecies, O. turicata americanus. A current gap in knowledge is vector 
competency between western and eastern populations of O. turicata for 
geographic isolates of B. turicatae. In this study we established uninfected 
tick colonies of O. turicata that originated in Floirda, Texas, and Kansas. 
Vector competency and transmission studies were performed with the Oz 
(Ozona, Texas) and Florida canine Borrelia (Sumter County, Florida) isolates 
of B. turicatae. Furthermore, with salivary gland colonization essential 
for transmission of RF spirochetes, the tissues from each group of tick 
were assessed for infection by B. turicatae isolates. Our results indicate 
significant differences in the ability of Florida, Texas, and Kansas ticks to 
maintain and subsequently transmit geographically distinct B. turicatae 
isolates.
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RETROTRANSPOSON-TARGETED BLOODMEAL REMNANT 
IDENTIFICATION IDENTIFIES MEADOW VOLES AS THE MAIN 
HOST FOR SUBADULT DOG TICKS
Heidi Goethert, Sam Telford
Tufts University School of Veterinary Medicine, N. Grafton, MA, United 
States
Martha’s Vineyard, MA has continuously sustained endemic transmission 
of Francisella tularensis for over 15 years. Our study site comprises a stable 
natural focus that depends on dog ticks (Dermacentor variabilis). However, 
efforts to identify the F. tularensis reservoir have been hindered by low 
trap success and failure to detect evidence of infection from any sampled 
animals. It is likely that most infected hosts die rapidly of infection and 
are thus less likely to be trapped. We have previously reported on results 
of bloodmeal remnant identification analyses to determine which animals 
serve as the major host for subadult dog ticks in our site and thereby 
incriminate a potential reservoir. Assays described in the literature fail 
to amplify more than half of sampled ticks; we find them to be poorly 
sensitive, unreliable and difficult to reproduce. We report on an assay with 
greater sensitivity and reproducibility that will work with all ticks regardless 
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of extraction method. Retrotransposons integrate into genomes and 
replicate themselves; 40% of a mammalian genome can be made up of 
such “junk DNA”, yielding more than a thousand copies of any particular 
one. In addition, retrotransposons have ancient origins and have coevolved 
with different families of mammals making it possible to design host-
specific PCR primers. Accordingly, we designed real time retrotransposon 
PCR primers that can distinguish between the possible host species found 
on the island: mice, voles, rabbits, shrews, chipmunks/squirrels, deer, rats 
and raccoon/skunks. Archived dog tick DNA templates from 2006 were 
screened by real-time PCR, including samples that had previously failed 
to yield host bloodmeal remnant identification using existing protocols. 
Of the 137 ticks tested, all amplified with at least one set of primers. The 
majority of ticks, 75% (103) tested positive for vole DNA, 13% (18) for 
mouse, 10% (14) for deer, and 2 samples had multiple positives results. 
We conclude that voles are the primary host for immature dog ticks 
on Martha’s Vineyard and likely critical hosts for the maintenance of F. 
tularensis.
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UPREGULATION OF SPHERICAL BODY PROTEIN 2 COPY 11 IN 
BABESIA BOVIS IS A SIGNATURE OF ATTENUATION
Gina M. Gallego López1, Jacob M. Laughery1, Carlos E. Suarez2, 
Donald P. Knowles2, Audrey O. T. Lau1
1Department of Veterinary Microbiology and Pathology, College of 
Veterinary Medicine, Washington State University, Pullman, WA, United 
States, 2Animal Disease Research Unit, Agricultural Research Service, 
United States Department of Agriculture, Pullman, WA, United States
Babesia bovis is the causative agent of bovine babesiosis, a tick-borne 
hemoparasitic disease that affects more than 500 million cattle annually 
worldwide. Currently, the only effective strategy to alleviate economic 
losses caused by this disease is the use of a live, attenuated vaccine 
which has some inherent risks. Better understanding of how attenuation 
is acquired and the identification of factors expressed in the vaccine 
strains that contribute to protective immunity, are essential for vaccine 
improvement. Our long-term goal is to understand the biological processes 
behind virulence loss and acquisition in Babesia so that a safe and effective 
subunit vaccine, incorporating all the necessary attenuation components 
can be developed. Our published work comparing genomes of three 
geographically distinct virulent parental and attenuated strain pairs 
illustrated no changes at the shared coding level among the phenotypic 
strains although all attenuated derivatives consist of significantly reduced 
genomic diversity. Our subsequent transcriptomic investigation of two of 
the strain pairs revealed that spherical body protein 2 truncated copy 11 
(sbp2t11) transcript was differentially regulated. Thus, we hypothesized 
that sbp2t11 is a B. bovis attenuation marker. Using additional virulent 
and attenuated strain pairs, we confirmed that sbp2t11 is translated 
and that expression of SBP2t11 is significantly higher in the attenuated 
strains. Further analysis of SBP2t11 demonstrated proteolytic processing 
of the full length 30 kDa protein into a 17 KDa carboxyl terminal-
derived fragment via a PEXEL-like domain, a cleave signal shared with 
Plasmodium, Toxoplasma, Cryptosporidium but not Theileria. To determine 
if upregulation of sbp2t11 directly contributes to the attenuated 
phenotype, stable transfected virulent B. bovis over expressing sbp2t11 
was successfully generated. Ongoing in vivo experiments will determine 
if sbp2t11 upregulation in virulent B. bovis recovers the attenuated 
phenotype.
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LARGE-SCALE DRUG SCREENING AGAINST BABESIA 
DIVERGENS PARASITE USING A FLUORESCENCE-BASED 
HIGH-THROUGHPUT SCREENING ASSAY
Mohamed A. Rizk1, Shimaa A. El-Sayed1, Mahmoud AbouLaila2, 
Bumduuren Tuvshintulga3, Naoaki Yokoyama3, Ikuo Igarashi3
1Faculty of Veterinary Medicine, Mansoura University, Mansoura, Egypt, 
2Faculty of Veterinary Medicine, University of Sadat City, Sadat City, Egypt, 
3National Research Center for Protozoan Diseases, Obihiro University of 
Agriculture and Veterinary Medicine, Obihiro, Japan
Babesia divergens causes a serious infection in both humans and cattle in 
Europe. A severe B. divergens infection is a rapidly fatal disease showing 
clinical symptoms such as fever, malaise, hemolytic anemia, and end fatally 
with general organ failure 4–7 days after hemoglobinuria. Chloroquine 
was the initial pharmacologic agent thought to be effective against B. 
divergens. Diminazene aceturate, an antiprotozoal compound known 
to be effective in veterinary cases, failed to cure a patient with a severe 
B. divergens infection. Recently, antibabesial drugs commonly used in 
veterinary medicine have shown problems regarding parasitic resistance 
and toxicity to the host. Thus, the search for novel alternative compounds 
for the veterinary market is urgent. In this study, the validation of a 
fluorescence-based high-throughput screening (HTS) assay for determining 
the efficacies of large chemical libraries against B. divergens (bovine 
strain) in in vitro cultures is evaluated. Hematocrits (HCTs) of 2.5%, 5%, 
and 10% were used for the in vitro culture at 1% parasitemia without 
daily replacement of the medium. Linearity and HTS assay results revealed 
that the best HCTs were 5% and 10%. The obtained IC50 values of 
diminazene aceturate, either by fluorescence-based HTS assay with and 
without daily replacement of medium or by fluorescence- and microscopy-
based methods, did not differ significantly at 5% HCT. Actinonin was the 
most effective drug against the in vitro growth of B. divergens, followed 
by diminazene aceturate and then chloroquine diphosphate, while 
moderate activity was observed with pyronaridine tetraphosphate- and 
luteolin-treated cultures. On the contrary, tetracycline hydrochloride and 
(-)-epigallocatechin-3-gallate from green tea exhibited poor activity as 
compared with diminazene aceturate (positive control drug). The data 
indicated that 5% HCT without daily replacement of the culture medium 
mixed with bovine serum in vitro using a fluorescence-based HTS assay 
creates the best conditions for large-scale drug screening against B. 
divergens that infect cattle.
1304
EVALUATION OF INHIBITORS OF LEISHMANIA 
PARASITOPHOROUS VACUOLE DEVELOPMENT
Evan M. Craig1, Charles-Eugene Huyghues-Despointes1, Samiksha 
Prasad1, Jason Sello2, Peter E. Kima1
1University of Florida, Gainesville, FL, United States, 2Brown University, 
Providence, RI, United States
Leishmania parasites are able to evade host immune responses during 
infection by residing within parasitophorous vacuoles (PVs), which are 
specialized phagocytic compartments formed within phagocytic immune 
cells during Leishmania infection. Our lab has previously shown that 
PVs contain molecules from both the secretory and endocytic pathways 
that are actively recruited by live parasites during infection. Disruption 
of this recruitment through the knockdown of secretory pathway vesicle 
fusion molecules such as Sec22b and Syntaxin-5 (Stx5) reduced the 
size of PVs that harbored L. mexicana parasites and inhibited parasite 
growth within Raw264.7 macrophages. In follow up studies we showed 
that Retro-2, a member of a novel class of small retrograde inhibitor 
molecules, specifically inhibits Stx5 localization, which results in reduced 
PV sizes and parasite numbers during L. mexicana infections. Moreover, 
Retro-2 reduced mouse foot pad lesions and parasite burden during in 
vivo infections of Balb/C mice. In addition, Retro-2 had a direct inhibitory 
effect on parasite replication in axenic culture. The purpose of this study 
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was to determine if secondary derivatives of Retro-2 are more effective at 
killing parasites and controlling parasite replication in axenic culture and 
during in vitro infections. We have found that the secondary derivative 
dihydroquinolinone 36 (DHQZ 36), kills L. amazonensis parasites with 
an IC50 of 10µM, which demonstrates that it is more potent at killing 
Leishmania parasites than the parent drug. In light of the fact that this 
class of drugs targets the secretory pathway, specifically Stx5 and in light 
of the fact that Leishmania parasites have been shown to have a limited 
number of secretory pathway SNARE genes, we evaluated the effect 
of DHQZ 36 on parasite secretion. We will show that prior to killing 
Leishmania parasites, DHQZ 36 limits secretion from by the parasite. 
This effect on parasite secretion by this new class of molecules has 
important implications for its function within macrophages where parasite 
secretion appears to play important roles in the parasite-induced evasion 
mechanisms.
1305
EVALUATING PKB/AKT AS THE TARGET OF MILTEFOSINE IN 
LEISHMANIA TREATMENT
Naixin Zhang, Charles-Eugene Huyghues-Despointes, Samiksha 
Prasad, Peter E. Kima
University of Florida, Gainesville, FL, United States
Miltefosine is an orally administered drug that is currently used to treat 
Leishmania infections. In light of the fact that some Leishmanias exhibit 
inherent resistance to Miltefosine and that there is increasing concern 
of the emergence miltefosine-resistant Leishmania strains, there is 
urgency to identify miltefosine’s target and the mechanism of miltefosine 
resistance. Our previous studies had shown that Leishmania infection of 
macrophages induces sustained activation of PKB/AKT, a downstream 
kinase in the PI3K signaling pathway. In light of the fact that miltefosine 
was originally shown to target PKB/AKT in tumor cells we set out to test 
the hypothesis that PKB/AKT is the target of miltefosine in Leishmania 
infections. To evaluate whether PKB/AKT is the target of miltefosine, we 
have generated macrophages that express inducible shRNAs specific for 
AKT1 by transduction of a single lentivirus vector constructed to express 
oligos that target the AKT1 gene. Control cells expressing either the 
lentivirus alone or lentiviruses expressing PGK were generated as well. 
After infecting with Leishmania parasites, suppression of PKB/AKT levels 
was induced by adding doxycycline which induced shAKT1 production. 
Even prior to adding Miltefosine, reduction of PKB/AKT levels in cells 
resulted in death of 40% of parasites within infected cells. Remarkably, 
Miltefosine even at relatively high concentrations was unable to reduce 
the number of parasites further. To further assess PKB/AKT as a target for 
killing Leishmania parasites, we evaluated other specific inhibitors of PKB/
AKT. Cells in which the AKT1 specific shRNA was induced were refractory 
to killing by the specific inhibitors of PKB/AKT. These parasites could be 
killed with paramomycin, whose mechanism of action is known not to 
include PKB/AKT signaling. Taken together, these results implicate PKB/
AKT as the target of miltefosine. We are presently evaluating whether the 
capacity to induce activation of PKB/AKT by Leishmania parasites correlates 
with their relative resistance or susceptibility to miltefosine.
1306
THE COMPOSITION OF MICROVESICLES DERIVED FROM 
LEISHMANIA DONOVANI INFECTED MACROPHAGES 
PROVIDES PERSPECTIVES INTO THEIR BIOGENESIS AND 
CONTRIBUTIONS TO PARASITE PATHOGENESIS
Anna E. Gioseffi, Peter E. Kima
University of Florida, Gainesville, FL, United States
Extracellular microvesicles have emerged as important mediators of 
cell-to-cell communication and have been shown to contribute to the 
pathogenesis of microorganisms. To better understand the properties 
of extracellular vesicles produced by Leishmania donovani infected 
macrophages, we performed comparative proteomics of microvesicles 
derived from RAW 264.7 mouse macrophages uninfected or infected 
with L. donovani. We have obtained a preliminary profile of the host 
and parasite derived proteins in the microvesicles released from infected 
and uninfected macrophages. In addition to host cell derived molecules 
previously identified by others in exosome preparations, we have observed 
in microvesicle preparations obtained from infected cell cultures significant 
representation of the exocyst complex component 3 (Exoc3), which has 
been implicated as a mediator of the release of some microvesicles. In 
additional analyses we have compared the proteomic profiles obtained 
from these experiments with recently published studies of the composition 
of exosomes released by axenically cultured L. donovani. The putative 
40S ribosomal protein S3a and RPL3 found in exosomes from axenically 
grown parasites were not found in the microvesicles from Leishmania-
infected macrophages. Conversely, a putative condensin subunit 1, 
phosphatidylinositol 3-kinase, and signal recognition particle molecules 
were found in microvesicles from Leishmania-infected macrophages 
but were not found in exosomes from axenically grown parasites. To 
confirm the identification of Leishmania derived molecules, comparable 
preparations were obtained from infections with parasites that lack 
the centrin gene, making these parasites unable to mature into the 
intracellular amastigote form. Our results show a significant diminution 
of the parasite derived molecules from macrophages derived from centrin 
knockouts. Taken together, we will present a comprehensive molecular 
profile of the molecules released in extracellular microvesicles from L. 
donovani-infected macrophages. Insight in the mechanism of their 
biogenesis will be presented as well.
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CHARACTERIZATION OF THE TRYPANOSOMATID 
SECONDARY ALTERNATIVE OXIDASE - A NOVEL POTENTIAL 
DRUG TARGET
Stefanie Kate Menzies, Lindsay B. Tulloch, Andrew L. Fraser, 
Eoin R. Gould, Elizabeth F. King, Marija K. Zacharova, Gordon J. 
Florence, Terry K. Smith
University of St Andrews, St Andrews, United Kingdom
Kinetoplastid parasites of the Trypanosoma and Leishmania genera cause 
widespread disease and death in much of the developing world. Current 
treatments are outdated, increasingly ineffective and associated with 
severe adverse effects, and new therapies are urgently needed. One of 
the limiting factors in the drug discovery pipeline is the identification 
of useful drug targets. The trypanosome alternative oxidase (TAO) has 
been well characterized as a drug target in T. brucei, but is absent from 
T. cruzi and Leishmania spp. Here we report evidence of a previously 
uninvestigated secondary alternative oxidase (AOX2) that is expressed in 
all three parasites, but importantly has no mammalian ortholog, making 
it an attractive drug target. Using reverse genetics we have shown that 
AOX2 is an essential protein in L. major, T. cruzi and bloodstream form T. 
brucei. By overexpressing AOX2 in vivo we have confirmed the subcellular 
localization of AOX2 to be mitochondrial, as it is for TAO in T. brucei. 
We are examining the effects of AOX2 overexpression/underexpression 
on cell growth and mitochondrial respiration in T. brucei and T. cruzi to 
determine the role of this protein in these parasites. We have established 
optimal conditions for recombinant expression of the T. brucei, T. cruzi and 
L. major AOX2 in E. coli. We have solubilized and purified all three AOX2s 
allowing enzyme activity studies. We are screening for selective inhibitors 
of these AOX2s using our in-house natural product-like library and a 
fragment library to identify lead compounds. Therefore we are genetically 
and chemically validating AOX2 in trypanosomatids.
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UNDERSTANDING THE ROLE OF LEISHMANIA RNA 
VIRUS-1 (LRV-1) IN THE PATHOGENESIS OF AMERICAN 
TEGUMENTARY LEISHMANIASIS USING A HUMAN 
MACROPHAGE MODEL
Ruwandi Kariyawasam1, Jugvinder Grewal1, Andrew Purssell2, 
Rachel Lau3, Braulio M. Valencia4, Alejandro Llanos-Cuentas4, 
Andrea K. Boggild1
1University of Toronto, Toronto, ON, Canada, 2University of British 
Columbia, Vancouver, BC, Canada, 3Public Health Ontario Laboratories, 
Toronto, ON, Canada, 4Instituto de Medicina Tropical “Alexander von 
Humboldt”, Lima, Peru
Leishmania RNA virus-1 (LRV-1) is a double stranded RNA virus primarily 
identified in the Leishmania Viannia complex endemic to Latin America. 
LRV-1 has been documented in 20-25% of Leishmania Viannia guyanensis 
and L. V. braziliensis strains, known to progress to mucocutaneous 
leishmaniasis, found in Brazil and Peru, and has been been correlated 
to increased levels of proinflammatory cytokines and chemokines. Our 
objective was to compare biomarker expression in human macrophages 
infected with LRV1-positive or negative strains of Leishmania. Human 
monocytes (U937) were transformed to macrophages over 72 hrs at 37 
C. Promastigotes of LRV-1 positive (L. V. guyanensis, L. V. braziliensis) 
and LRV-1 negative (L.V. braziliensis, L. tropica, L. infantum) strains 
of Leishmania were inoculated into macrophage cultures, and culture 
supernatants were obtained at 24-, 48-, and 72-hrs. Proinflammatory 
markers measured by ELISA at 24-, 48-, and 72-hrs of incubation included 
IL-1β, IL-4, IL-5, IL-6, IL-12, TNF-α, CXCL10, CCL5, iNOS, and superoxide 
dismutase (SOD). Virulence factor transcript expression, including Heat 
Shock Protein 20 (HSP20), HSP70, HSP83, Mannose Phosphate Isomerase 
(MPI), Cysteine Proteinase B (CPB), zinc-metalloproteinase (GP63) was 
quantified in by real time RT-PCR. LRV-1 status did not affect expression 
of TNF-α, CXCL10, or IL-6, however, LRV-1 positive strains had increased 
CCL5 (p=0.022) and reduced IL-1 (p=0.023) expression at 24- and 48- 
hours, respectively. SOD expression was reduced in all macrophages 
infected with Leishmania spp. regardless of LRV-1 status. The LRV-1 
positive L. V. braziliensis strain showed higher levels of HSP20, HSP83 
and GP63 expression compared to the LRV-1 negative L. V. braziliensis 
strain with 41-, 14- and 92% increases, respectively. LRV-1 status remains 
a potential biomarker of disease severity in American tegumentary 
leishmaniasis. Our observation of varying cytokine, chemokine, and 
virulence factor expression by LRV1 status suggests that LRV-1 could 
potentially contribute to the mechanism by which L. V. braziliensis, in 
particular, leads to pathogenicity.
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INVESTIGATING VIRUS PERSISTENCE IN BODY FLUIDS OF 
EBOLA SURVIVORS IN SIERRA LEONE
The Ebola Virus Persistence Study Group, Barbara Knust
U.S. Centers for Disease Control and Prevention, Atlanta, GA, United 
States
At the start of the West African Ebola epidemic, there was limited 
evidence on persistence and duration of Ebola virus (EBOV) and viral 
ribonucleic acid (RNA) in semen or other body fluids of Ebola Virus 
Disease (EVD) survivors. The Sierra Leone Ebola Virus Persistence Study 
(VPS) is an observational cohort that aims to assess the presence and 
duration of EBOV and viral RNA in semen and other body fluids of EVD 
survivors. A pilot study launched in May 2015, which enrolled 100 male 
EVD survivors in the Western area, collecting and testing semen biweekly 
until two consecutive qRT-PCR negative results were obtained. The main 
study launched in November 2015, enrolling 120 male and 120 female 
EVD survivors primarily from Western and Port Loko districts. Sweat, 
saliva, tears, urine, rectal swab, and as appropriate semen or vaginal 
swab, menstrual blood, and breast milk were collected. Virus isolation 
was attempted on qRT-PCR positive specimens. Participants from the 
pilot and main studies received qRT-PCR test results and risk reduction 
counseling. To date, the longest period of EBOV RNA detected in semen 
of pilot participants was 406 days post-onset of symptoms. Proportions 
of participants with qRT-PCR positive semen decreased with increasing 
time post-onset. Four semen specimens yielded EBOV isolates; the longest 
period of time post-onset that viable EBOV was detected was 157 days. To 
date, 84 women and 92 men have enrolled in the main study. For males 
and females tested at 6 to 19 months post-onset, all body fluids were 
qRT-PCR negative, with the exception of 15 men who had EBOV RNA 
detected in semen and a single male participant who had qRT-PCR positive 
urine detected to 292 days post onset, during which time his semen also 
tested positive. A female participant enrolled in the study on the day of 
discharge from an Ebola Treatment Unit had qRT-PCR positive vaginal 
swab specimens until day 35 post-onset. All other body fluids tested in 
this woman were negative. These preliminary descriptive results provide 
valuable information regarding EBOV persistence in EVD survivors long 
after recovery.
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MAPPING ANTIBODY EPITOPES ON THE EBOLA VIRUS 
ENVELOPE PROTEIN BY SHOTGUN MUTAGENESIS
Edgar Davidson1, Srikar Reddy1, Andrew Flyak2, Katie A. Howell3, 
M. Javad Aman3, James E. Crowe, Jr.2, Benjamin J. Doranz1
1Integral Molecular, Inc., Philadelphia, PA, United States, 2Departments of 
Pathology, Microbiology and Immunology, Vanderbilt University, Nashville, 
TN, United States, 3Integrated BioTherapeutics, Inc., Gaithersburg, MD, 
United States
To characterize the detailed immune response to Ebola virus (EBOV), 
we applied high throughput epitope mapping to the EBOV envelope 
glycoprotein (GP). We used Shotgun Mutagenesis to create a 
comprehensive alanine scan library comprising 641 single mutations in 
GP individually arrayed in 384 well plates. GP variants were expressed in 
human cells and assayed for reactivity with monoclonal antibodies (MAbs) 
using high-throughput flow cytometry to identify GP residues required for 
the binding of each MAb. Cocktails of MAbs that target EBOV GP have 
great promise as therapeutics. However, for ZMapp, the most advanced 
cocktail, the detailed epitopes are not known. We epitope mapped the 
ZMapp and related ZMAb and MB-003 cocktails, resolving the amino acid 
epitopes for all six MAbs in these cocktails and for the standard reference 
MAb KZ52. We have also epitope mapped over 90 additional MAbs that 
recognize EBOV GP, including 6 MAbs obtained from a human survivor 
of Bundibugyo ebolavirus infection, and a MAb, cross-reactive with 
ebolavirus species, that binds to GP1 head and blocks the interaction of 
EBOV GP with its endosomal receptor Niemann-Pick C1. Identification of 
epitope residues for the ZMapp MAbs helps to: distinguish between MAbs 
that bind competitively in the same GP region but use different epitope 
residues, explain their reactivity against different EBOV species, predict viral 
evasion against these MAbs, and design new cocktails of MAbs that may 
offer improved functional complementarity. Epitope mapping is expanding 
our understanding of how the immune system recognizes EBOV GP. 
Correlating MAb epitopes with their neutralizing capabilities is being used 
to develop anti-EBOV therapeutics and vaccines.
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IDENTIFICATION OF HUMAN T CELL EPITOPES IN THE 
EBOLAVIRUS GLYCOPROTEIN FOLLOWING VACCINATION 
WITH CHAD3 EBO Z GP AND MVA BN
Danny Wright1, Mark Giza1, Tommy Rampling1, Antra Zeltina2, 
Georgina Bowyer1, Jonathan Powlson1, Navin Venkatraman1, 
Egeruan Imoukhuede1, Ruth Payne1, Alfredo Nicosia1, Nancy 
Sullivan3, Barney Graham3, Ariane Volkmann4, W. Ripley Ballou5, 
Sarah Gilbert1, Adrian Hill1, Katie Ewer1
1The Jenner Institute, University of Oxford, Oxford, United Kingdom, 
2STRUBI, University of Oxford, Oxford, United Kingdom, 3National 
Institutes of Health, Bethesda, MD, United States, 4Bavarian Nordic, 
Martinried, Germany, 5GlaxoSmithKline Biologicals, Rixensart, Belgium
Despite research into the immune response to Ebolavirus for several 
years, no human CD8+ T cell epitopes have been described following 
either natural infection or vaccination with any of the candidate vaccines. 
Here we present several novel 9 amino acid-long peptide epitopes in the 
Zaire Ebolavirus glycoprotein from humans vaccinated with the ChAd3-
MVA regime. Primary studies of T cell immunogenicity were performed 
using IFNγ ELISPOT assays with ten pools of overlapping peptides 13-17 
amino acids long on samples from 43 volunteers that had received a 
priming immunisation of ChAd3 EBO Z GP and a booster immunisation 
with MVA BN Filo between 3 and 10 weeks later. We then analysed 
seven pools in detail using individual 15mer peptides to select the most 
immunodominant sequences in a subset of volunteers. Overlapping 9mer 
peptides were then synthesised spanning the 18 dominant 15mers in 
these pools and assayed by ELISPOT in the same samples. The responses 
to epitopes were further categorised with intracellular cytokine staining 
to show large production of IFNγ and TNFa in the CD8+ cytotoxic T cell 
lineage. The epitopes described span the length of the GP protein and 
were found in both the GP1 and GP2 domains. We also performed HLA 
typing on these volunteers and demonstrate broad recognition of these 
epitopes on multiple HLA backgrounds, suggesting that this vaccine is 
likely to be immunogenic in genetically diverse populations. Analysis of 
the position of the epitopes within the 3-dimensional structure of the 
protein is ongoing and will be presented. The novel human T cell epitopes 
discovered could be utilised for future vaccine development, as well as in 
further understanding the immune response to the ChAd3-MVA vaccine 
and EBOV infection.
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THE SIERRA LEONE TRIAL TO INTRODUCE A VACCINE 
AGAINST EBOLA (STRIVE)
Mohamed Samai1, The STRIVE Study Team, Anne Schuchat2, Abu 
Bakkar Fofanah3
1College of Medicine and Allied Health Sciences, Freetown, Sierra Leone, 
2Centers for Disease Control and Prevention, Atlanta, GA, United States, 
3Ministry of Health and Sanitation, Freetown, Sierra Leone
In response to the 2014-16 Ebola epidemic, clinical development of 
candidate Ebola vaccines was accelerated. By late 2014, Phase 1 studies 
of candidate vaccines started, and multiple organizations began planning 
phase 2/3 studies with collaborators in the most heavily Ebola-affected 
countries. The US Centers for Disease Control and Prevention sponsored 
a phase 2/3 vaccine trial In Sierra Leone, in collaboration with the College 
of Medicine and Allied Health Sciences, University of Sierra Leone and the 
Ministry of Health and Sanitation. STRIVE was designed as an individually 
randomized trial for phased introduction of a single 2 x 107 pfu/mL dose 
of candidate rVSV∆G-ZEBOV-GP vaccine in healthcare and frontline Ebola 
response workers, while simultaneously evaluating vaccine safety and 
efficacy. No placebo was used. Participants were randomized to immediate 
(≤7 days) or delayed (18-24 weeks) vaccination and followed for 6 months 
after vaccination for serious adverse events (SAE) and Ebola virus disease 
(EVD). Reactogenicity data were collected through a safety sub-study 
of the first ~400 participants (200 vaccinated, 200 unvaccinated). An 
immunogenicity sub-study of ~500 participants assessed IgG levels at 
baseline, 28 days, 6 months, and 9-12 months after vaccination using a 
glycoprotein Elisa assay. Enrollment began on April 9th, and vaccination 
ended December 12th 2015 with ~8,650 participants enrolled and ~8,000 
vaccinated. As of 1 April 2016, preliminary data from ongoing safety 
follow up indicates no vaccine-related deaths or other vaccine-related 
SAEs; 48 participants were evaluated for EVD and had negative test 
results. Systemic symptoms more commonly reported in vaccinated safety 
sub-study participants included headache, fever/feverishness, fatigue, 
muscle pain and joint pain; few were graded as severe. Ebola response 
measures successfully interrupted transmission, so vaccine efficacy could 
not be assessed. STRIVE provides the largest SAE database on this vaccine 
and will yield critical immunogenicity data to support a vaccine licensure 
application. Preliminary immunogenicity data will also be presented.
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SAFETY, IMMUNOGENICITY, AND EFFICACY OF THE MERCK 
RVSVΔG-ZEBOV-GP EBOLA VACCINE
Jakub Simon1, Rita Das1, Frans Helmond1, Ashley Wivel1, Jayanthi 
Wolf1, Mike Dekleva1, Ken Liu1, Ivan Chan1, Gray Heppner2, Rick 
Nichols2, Brian Martin2, Thomas Monath2, Swati Gupta1, Beth-Ann 
Coller1
1Merck & Co., Kenilworth, NJ, United States, 2NewLink Genetics, Ames, IA, 
United States
The 2013-2016 Ebola outbreak has caused over 28,000 cases and 11,000 
deaths. Merck & Co., Inc. is working with private and public partners 
to develop an Ebola vaccine that has demonstrated efficacy during this 
outbreak. The vaccine is a live recombinant vesicular stomatitis virus (VSV) 
with complete substitution of the VSV-G envelope glycoprotein (GP) with 
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Zaire ebolavirus GP. Phase 1-3 clinical trials have been conducted to assess 
safety, immunogenicity, and/or efficacy of rVSVΔG-ZEBOV-GP in humans. 
One intramuscular dose of 2x107 plaque forming units is well-tolerated 
when administered to healthy adults. Injection site reactions following 
vaccination are typically mild or moderate and self-limited. There is a 
predictable period of generally mild reactogenicity, including fever and a 
flu-like syndrome typically lasting 1-3 days. Joint pain is a common part 
of the early flu-like syndrome. In a small proportion of subjects (<5% in 
most studies), joint swelling (arthritis) may develop in the weeks following 
vaccination. Arthritis is generally mild to moderate in severity and is likely 
mediated by direct viral infection of joint tissues; the vast majority of 
arthritis events resolve spontaneously, though persistent and recurrent 
symptoms have also been reported. Anti-GP antibodies are detectable by 
ELISA by 14 days postvaccination in 95% of vaccinees; to date, 100% 
seroconversion has been observed by 28 days. Durability of the anti-GP 
response response has also been demonstrated for at least 6 months. A 
ring vaccination trial in Guinea randomized 7,651 subjects in 90 clusters 
to receive immediate or delayed vaccination. Interim analysis identified 
no cases of Ebola virus disease with symptom onset at least 10 days after 
randomization in the immediate vaccination group, whereas in the delayed 
vaccination group there were 16 cases of Ebola virus disease (vaccine 
efficacy 100%, 95% CI: 74.7, 100.0; p=0.0036). No new cases of Ebola 
virus disease were diagnosed in vaccinees from the immediate or delayed 
groups from day 6 postvaccination. In this presentation we will provide the 
current status of the rVSVΔG-ZEBOV-GP development program.
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PHASE 1 EVALUATION OF A LIVE ATTENUATED HUMAN 
PARAINFLUENZA VIRUS TYPE 3 VECTORED VACCINE 
CANDIDATE EXPRESSING EBOLAVIRUS ZAIRE GLYCOPROTEIN
Kawsar R. Talaat1, Ruth A. Karron1, Noreen A. Hynes2, Anna 
P. Durbin1, Kathryn M. Chang1, Brittany Feijoo1, Beulah P. 
Sabundayo1, Beverly Plunkett1, Weiyun Sun1, Rachel Adkinson1, 
Cindy L. Luongo3, Lijuan Yang3, Peter L. Collins3, Alexander 
Bukreyev4, Ursula J. Buchholz3
1Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, 
United States, 2Johns Hopkins University School of Medicine, Baltimore, 
MD, United States, 3National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, Bethesda, MD, United States, 4University of 
Texas Medical Branch, Galveston, TX, United States
The 2013 outbreak of Ebola Virus Disease in West Africa brought 
into sharp focus the urgent need for safe and effective medical 
countermeasures. The primary objectives of this open label vaccine 
clinical trial were to determine the safety, tolerability and immunogenicity 
of a 2-dose regimen of a live, recombinant parainfluenza virus type 
3 expressing the Ebola virus (Zaire) glycoprotein (HPIV3-EbovZ-GP) as 
a vaccine candidate in healthy adults. Thirty subjects were enrolled 
sequentially into 2 cohorts of 10 and 20 subjects, respectively. The 
investigational new drug (IND)-approved protocol plan was for both 
cohorts to receive 2 doses of the vaccine candidate intranasally 4 to 8 
weeks apart as follows: Cohort 1 to receive 106 plaque forming units 
(PFU) of HPIV3-EbovZ-GP vaccine and Cohort 2 to receive 107 PFU. During 
protocol implementation, two doses of 106 PFU of HPIV3-EbovZ-GP 
vaccine were administered to Cohort 1 subjects 4 weeks apart. The vaccine 
was well tolerated and infectious (7/10 subjects had detectable virus by 
rRT-PCR with a mean peak titer 3.8 log10 genomic equivalents/mL and 4/10 
with vaccine virus on culture.) The viral shedding period was longer than 
expected with a mean of 7.9 days after vaccination. Little shedding was 
detected after the second dose. Cohort 2 received one of two planned 
doses of 107 PFU of HPIV3-EbovZ-GP vaccine. Vaccine virus infectiousness 
in Cohort 2 was similar to Cohort 1 but shorter in duration, with a mean 
of 3.7 days of shedding. In both Cohorts, the vaccine was well tolerated; 
the majority of symptoms mild. Asymptomatic ALT elevations were 
noted in 5 volunteers in Cohort 2 after vaccination: 3 mild elevations, 2 
moderate (68-184 U/L). ALT elevations were associated with viral shedding, 
all had resolved by day 28. The study was halted due to these elevations 
of ALTs and the volunteers in Cohort 2 were not given the second dose. 
Expression of Ebola virus GP was stable in the virus shed by volunteers. 
Little to no detectable neutralizing antibody was induced in the subjects. 
We conclude that the HPIV3-EbovZ-GP vaccine virus is more infectious but 
less immunogenic than anticipated with longer viral shedding periods.
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SEROPREVALENCE OF FILOVIRUS INFECTION IN VILLAGES 
WITH NO HISTORY OF OUTBREAK IN THE DEMOCRATIC 
REPUBLIC OF CONGO
Vivian H. Alfonso1, Nicole A. Hoff1, Reena H. Doshi1, Graham 
Simmons2, Kai Lau2, Imke Steffen2, Prime Mulembakani3, Jean-
Jacques Muyembe3, Neville Kisalau3, Emile Okitolonda4, Anne W. 
Rimoin1
1University of California Los Angeles, Los Angeles, CA, United States, 
2Blood Systems Research Institute, University of California, San Francisco, 
San Francisco, CA, United States, 3National Institute for Biomedical 
Research, Kinshasa, Democratic Republic of the Congo, 4Kinshasa School 
of Public Health, Kinshasa, Democratic Republic of the Congo
The Democratic Republic of Congo (DRC) has experienced the most 
Ebola Virus Disease (EVD) outbreaks on record. While evidence is limited, 
previous studies suggest that there may be a significant number of cases 
of Ebola and other viral hemorrhagic fevers (VHFs) that go unreported 
because they are non-progressing or asymptomatic. In 2007, a population-
based survey was conducted to assess human exposure to monkeypox in 
healthy, rural populations in the Kole and Lomela health zones within the 
Kasai Oriental province of DRC. Fourteen villages were randomly selected 
and all healthy individuals ≥1 year of age were eligible. Among the 5,687 
individuals eligible for enrollment, 4,574 were enrolled in the original 
study population, of whom a subset (n=810) were randomly selected for 
serologic assessment of antibody response to Ebola (EBOV) and Marburg 
(MARV) viruses. In this preliminary study, nearly all subjects (>99%) were 
from Lomela health zone. Overall, 7% of subjects tested positive for EBOV 
in either neutralizing assay (confirmed with titration assay), viral matrix 
protein (VP40) ELISA or nucleoprotein (NP) ELISA, while 2% tested positive 
for MARV in either neutralizing assay (confirmed with titration assay) or 
nucleoprotein (NP) ELISA. Prevalence of filovirus antibody varied slightly by 
age; specifically 1-4 year olds had the highest prevalence for both EBOV 
and MARV (11% and 3%, respectively). Additionally, seropositivity was 
significantly associated with gender; EBOV seropositivity was higher in 
males than females (5% and 9%, respectively), while MARV seropositivity 
was higher in females than males (3% and 1%, respectively). While 
analyses are preliminary, we found evidence of infection in vulnerable 
subgroups of the population in non-outbreak locations in the DRC. Such 
sero-surveillance studies are of paramount importance as they may provide 
key information about asymptomatic or non-progressing infections that 
can better prepare health care workers and policy makers for future 
outbreaks.
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IMMUNOASSAYS FOR CHARACTERIZING AND EVALUATING 
VACCINE CANDIDATES THAT TARGET PRE-ERYTHROCYTIC 
STAGES OF PLASMODIUM VIVAX AND P. FALCIPARUM
Alison E. Roth1, Steven P. Maher1, Swamy Rakesh Adapa1, Rays 
H. Jiang1, Ratawan Ubalee2, Amy Conaway1, Nicole D. Salinas3, 
John Jimah3, Lenore Carias4, Sebastien Dechavanne4, Sokunthea 
Sreng5, Suon Seila5, Chanaki Amaratunga6, Rick M. Fairhurst6, 
Christopher L. King4, Niraj Tolia3, Friedrich Frischknecht7, Dennis E. 
Kyle1, Silas Davidson2, John H. Adams1
1University of South Florida, Tampa, FL, United States, 2Armed Forces 
Research Institute of Medical Sciences, Bangkok, Thailand, 3Washington 
University, St. Louis, MO, United States, 4Case Western Reserve University, 
Cleveland, OH, United States, 5National Center for Parasitology, 
Entomology and Malaria Control, Phenom Penh, Cambodia, 6National 
Institutes of Health, Rockville, MD, United States, 7Heidelberg University, 
Heidelberg, Germany
Evaluating pre-erythrocytic (PE) vaccine candidates is challenging due 
to the biological complexity of Plasmodium parasites and their host 
interactions. In particular, identifying and characterizing new PE vaccine 
candidates has been hampered by the inefficiency of functional assays to 
assess targets in the PE stages of P. vivax and P. falciparum. To overcome 
this obstacle, we developed novel functional assays to immunologically 
assess potential PE targets of Plasmodium sporozoites and early liver 
stages. The functional assays recapitulate the pivotal period of sporozoite 
transition from mosquito to human by physical modification of the in vitro 
culture microenvironment and exposure to biological stimulatory factors. In 
this study, liver-stage development was assessed by sporozoite inoculation 
into an in vitro human liver model platform where high content image 
analysis was used to quantify parasite invasion and initial development 
in primary human hepatocytes. As proof of concept for assessing PE 
vaccine candidates, inhibition of liver-stage development assays (ILSDA) 
targeted the P. vivax and P. falciparum circumsporozoite (CSP) protein with 
species-specific, anti-CSP monoclonal antibodies. The modified ILSDA was 
sensitive and efficient, showing blocking of early PE stages of both P. vivax 
and P. falciparum in a concentration-dependent manner. Further ILSDA 
experiments were conducted with a second target antigen, which showed 
nanomolar activity with 80% inhibition of liver-stage development. 
To refine functional analysis of PE targets in early infection phases, we 
analyzed sporozoite migration in real-time in a ‘live’ motility assay and 
a hepatocyte cell traversal assay, and also by high-content imaging. 
Finally, micro-pillar arrays were designed for real-time study of sporozoite 
migration and mechanical flexibility in a structured microenvironment 
mimicking in vivo conditions. Together, these novel functional assays 
simulate key development and transition phases that enable us to 
evaluate potential PE vaccine candidates and analyze complex Plasmodium 
sporozoite phenotypes.
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GAMETOCYTE-SPECIFIC IMMUNITY PROVIDES A RATIONALE 
FOR NOVEL TRANSMISSION BLOCKING INTERVENTIONS IN 
PLASMODIUM FALCIPARUM
Kathleen Dantzler1, Sanna Rijpma2, Siyuan Ma1, Dingying 
Tao3, Will Stone2, Karl Seydel4, Miriam Laufer5, Huw Davies6, Phil 
Felgner6, Rhoel Dinglasan3, Terrie Taylor4, Curtis Huttenhower1, 
Teun Bousema2, Matthias Marti1
1Harvard T.H. Chan School of Public Health, Boston, MA, United States, 
2Radboud University Nijmegen Medical Center, Nijmegen, Netherlands, 
3Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United 
States, 4Michigan State University, E. Lansing, MI, United States, 5University 
of Maryland School of Medicine, Baltimore, MD, United States, 6University 
of California Irvine, Irvine, CA, United States
Drugs and vaccines targeting Plasmodium falciparum transmission 
stages have recently gained prominence as necessary tools for malaria 
elimination. Though most current transmission-blocking approaches focus 
on mosquito stages, targeting gametocytes - the form developing in the 
human host - provides a more convenient endpoint for validation, and has 
tremendous potential to reduce global transmission of malaria. Antibodies 
recognizing immature (stage I-IV) gametocytes could confer protection 
by 1) inhibiting binding interactions between specific host receptors and 
adhesins on the surface of infected red blood cells (iRBCs), 2) increasing 
killing by effector cells, and/or 3) inducing uptake by other immune cells. 
Hypothesizing that early-stage gametocytes are targets of host antibody 
responses, we performed the first systematic characterization of immune 
responses recognizing these stages. Utilizing a gametocyte-enriched 
protein array, we identified a subset of exported parasite antigens whose 
reactivity correlates with exposure and/or reduced parasite burden. We 
next characterized recognition of the gametocyte-iRBC (giRBC) surface in 
a cohort of Malawian sera by flow cytometry. A subset of sera recognize 
both giRBCs and asexual-iRBCs (aiRBCs) while others uniquely recognize 
giRBCs. The strength and prevalence of both aiRBC and giRBC surface 
recognition increase with age, though this increase occurs more slowly 
for gametocytes. Immunofluorescence microscopy confirms that early 
(stage I-IIA) gametocytes are recognized more than later gametocytes, and 
Western blots using giRBC and aiRBC membranes provide evidence for 
both shared aiRBC-giRBC and unique giRBC antigens. Candidate antigens 
have been identified by mass spectrometry and their surface expression is 
being validated through various methodologies. We are also investigating 
various mechanisms of antibody-mediated protection, including 
opsonization for phagocytosis, and inhibition of binding to host receptors. 
Our study suggests a new paradigm for transmission stage immunity and 
provides a rational basis for novel transmission-blocking therapeutics.
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REPEATED MALARIA INFECTIONS ACCELERATES BIOLOGICAL 
AGEING IN CHILDREN IN DISEASE ENDEMIC AREA
Muhammad Asghar, Sara Babiker, Victor Yman, Anna Färnert
Karolinska Institutet, Stockholm, Sweden
Accelerated ageing and reduced lifespan mediated through faster 
telomere shortening has recently been shown in birds chronically infected 
with malaria parasites. Furthermore, we have found that single malaria 
infection accelerates telomere degradation for up to three months after 
cured infection in human. Here, we have analyzed whether multiple 
malaria episodes accelerate telomere attrition in disease endemic area. 
Children living in Nyamisati village in the Rufiji river delta, coastal Tanzania 
were followed with passive case detection and repeated cross-sectional 
surveys between 1993 and 2010. Parasite prevalence in children declined 
from 90% in 1993 to 10% in 2010. Telomere length was analysed in 
peripheral blood by real time quantitative PCR in repeated cross-sectional 
surveys 1993-2010. Our preliminary findings show that telomere 
shortening was more pronounced in the children during the 1990s when 
transmission was moderate to high, compare to between 1999 and 2010 
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when transmission had declined. Children those were malaria positive in 
surveys have shorter telomere length and antimalarial antibodies levels 
were negatively correlated with telomere length, irrespective of age. These 
findings suggest that repeated malaria infections accelerate telomere 
shortening and might contribute to biological ageing in human. These 
results further urge the need for upscaling efforts to eliminate malaria.
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ATYPICAL ACTIVATION OF HUMAN PRIMARY DENDRITIC 
CELLS BY PLASMODIUM FALCIPARUM
Anton Goetz, Maureen Ty, Ana Rodriguez
New York University School of Medicine, New York, NY, United States
Malaria is characterized by high levels of inflammation and while an early 
inflammatory response is important for parasite clearance, excessive and 
persistent inflammation can contribute to severe forms of the disease. 
At the same time, P. falciparum infections fail to induce sterile immunity. 
Reports about the role of dendritic cells (DCs) in the immune response 
to P. falciparum and how they contribute to the activation of CD4+ T 
cells during blood stage have been contradictory. To analyze this critical 
part of the malaria immune response we enriched primary human DCs 
from peripheral blood of naïve donors and co-incubated them with P. 
falciparum-infected red blood cells in vitro. Although DCs up-regulated 
surface expression of HLA-DR, co-stimulatory markers, and secretion of 
chemokines, they did not secrete significant amounts of inflammatory 
cytokines. Surprisingly, these parasite-activated DCs were able to activate 
and polarize naïve autologous CD4+ T cells into Th1-like cells secreting 
high levels of IFNγ and TNF. A re-stimulation with autologous P. falciparum-
activated DCs specifically increased proliferation and cytokine secretion of 
the primed CD4+ T cells, indicating that the DCs were able to induce an 
antigen-specific response. We further analyzed the activation phenotype 
of the two major DC subsets, myeloid and plasmacytoid DCs, upon 
stimulation with P. falciparum. Co-culture of both subsets was essential to 
up-regulate parasite-induced chemokine secretion. Although plasmacytoid 
DCs were activated by the parasite through TLR9 and secreted IFNα, they 
were dispensable for CD4+ T cell activation. To further address whether 
this phenotype might involve activation molecules other than MHC class 
II we analyzed CD1-restricted T cell activation. Preliminary results indicate 
that a proportion of CD4+ T cells that expand in co-cultures recognize 
lipids presented by CD1. Our findings might contribute to a better 
understanding of the mechanisms involved in the initiation of the adaptive 
immune response against P. falciparum.
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ATYPICAL MEMORY B CELLS AND CIRCULATING MARGINAL 
ZONE-LIKE B CELLS CHANGES ASSOCIATED TO MALARIA 
CHRONIC EXPOSURE
Itziar V. Ubillos1, Pilar Requena2, Joseph Joe Campo3, Diana 
Barrios1, Alfons Jimenez1, Alexandra J. Umbers4, Maria Ome5, 
Leanne J. Robinson5, Peter M. Siba5, Ivo Mueller6, Carlota Dobaño1
1ISGlobal, Barcelona, Spain, 2Universidad de Granada, Granda, Spain, 
3Antigen Discovery, Irvine, CA, United States, 4University of Melbourne, 
Parkville, Victoria, Australia, 5Papua New Guinea Institute of Medical 
Research, Madang, Papua New Guinea, 6Walter and Eliza Hall Institute, 
Parkville, Victoria, Australia
Malaria exposure affects circulating B and T cell populations, inducing 
increased frequency of “atypical” memory B cells (MBCs) and reduced 
proportion of circulating marginal zone (MZ)-like B cells. Although the 
role of antibody responses in reducing clinical symptoms is well known, 
little is known about the role of atypical MBC and MZ-like B cells against 
malaria infection. We characterized the status and function of B cell 
subpopulations in a malaria-exposed and unexposed populations and 
tested the hypothesis that impaired immune response was associated with 
anergic stage of B cells related to Pf exposure. We selected 45 adults from 
high malaria transmission area in Papua Nueva Guinea and classified them 
as high, medium and low exposure based on responses to 8 Plasmodium 
falciparum and P. vivax antigens. Peripheral blood mononuclear cells were 
assayed by flow cytometry to identify expression of activation-, inhibition-, 
lineage- and survival-associated markers. In exposed individuals, active 
atypical MBCs (aaMBCs) had high frequency of IgG, PD1, CD95, CCR3 
and CD71 and low proportion of CD62L expression. The expression of 
PD1, CD95 and CD71 on aaMBCs was associated with level of exposure. 
As a result of chronic antigen exposure, aaMBCs have dual expression of 
both of CD40-CD95, leading aaMBC to an anergic state and at the same 
time preventing cell death. We found higher IgG- and PD1-expressing 
peripheral MZ-like B cells in malaria exposed compared to non-exposed 
adults. Conversely, TACI expression was greatly reduced in exposed 
individuals. Our findings suggest that in chronically exposed adults, the 
expression of PD1, CCR3 and CD95 on aaMBCs could be the result of 
immune homeostatic mechanisim for mantaining B cell development 
and function while simultaneously inhibiting hyper-reactive B cells. Thus, 
keeping B-cell activation threshold high enough to control but impaired 
enough to tolerate chronic infection. Increased IgG- and PD1- and 
decreased TACI-expressing MZ-like B cells confirm the role of germinal 
center-independent responses in chronically exposed individuals, being a 
potential target for reversion in anti-malarial therapies.
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KENYAN CHILDREN AND ADULTS WITH ACUTE 
UNCOMPLICATED MALARIA HAVE DYSFUNCTIONAL 
MEMORY B CELL RECALL RESPONSES TO POLYCLONAL 
STIMULATION
Grace E. Weber1, Anna Babakhanyan1, Paula Embury1, Peter 
Odada Sumba2, John Vulule2, James W. Kazura1, Arlene E. Dent1
1Case Western Reserve University, Cleveland, OH, United States, 2Kenya 
Medical Research Institute, Kisumu, Kenya
The development of acquired immunity to Plasmodium falciparum (Pf) 
is not fully understood. It takes years of repeated exposure to Pf before 
immunity to clinical disease develops, implying that B cell memory is 
impaired and incomplete. B cells are a heterogeneous cell population, 
consisting of subtypes differentiated by their surface markers (naïve B cells 
CD19+CD21+CD27-, classical memory B cells (MBC) CD19+CD21+CD27+, 
activated B cells CD19+CD21-CD27+, and atypical MBC CD19+CD21-
CD27-). ELISPOT assays were used to measure immunoglobulin (Ig) G 
secretion in peripheral blood mononuclear cells (PBMC) from Kenyan 
children aged 1-10 years at presentation of acute uncomplicated malaria 
and six weeks following treatment. Quantities of antibody secreting cells 
(ASC) were greatly reduced in children with active malaria, and restored 
6 weeks following treatment (average numbers of ASC per 5000 plated 
PBMC were 6.67 and 52.67, respectively, p=0.0039). We also found that 
PBMC from an adult with acute malaria showed a similar outcome (4 ASC 
per 5000 PBMC during acute malaria versus 28 ASC six weeks following 
treatment). This suggests that there is a deficiency in the MBC recall 
response during acute illness, regardless of patient age. Flow cytometry 
was performed on PBMC in order to compare B cell subtype frequencies. 
Children with acute malaria and at 6 weeks follow-up had very similar 
frequencies of circulating classical MBC (average frequencies 14.49% 
and 17.56%, respectively, p=0.0419), which indicates the MBC were 
present in circulation at the time of acute malaria, though not functioning 
similarly. Interestingly, activated B cells were not increased at the time 
of acute malaria (average frequencies 4.98% and 3.42%, respectively, 
p=0.2663), while the acute cases showed some increase in proportions of 
atypical MBC during acute malaria versus recovery (average frequencies 
were 26.53% and 12.3%, respectively, p=0.0007). Future experiments will 
focus on determining if B cells or T cells play key roles in the lack of IgG 
secretion during acute malaria.
416
astmh.org
1322
CYNOMOLGI MALARIA IN RHESUS MACAQUES INDUCES 
PHENOTYPIC AND FUNCTIONAL CHANGES IN NEUTROPHILS
Chet Joyner1, Tracey J. Lamb2, Chris C. Ibegbu1, the MaHPIC 
Consortium, Rabindra Tirouvanziam3, Mary R. Galinski4
1Malaria Host–Pathogen Interaction Center, Emory Vaccine Center, Yerkes 
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States, 2Division of Infectious Diseases, Department of Pediatrics, Emory 
University School of Medicine and Emory Children’s Center, Atlanta, 
GA, United States, 3Emory Children’s Center for CF and Airways Disease 
Research, Emory University School of MedicineEmory University/MaHPIC, 
Atlanta, GA, United States, 4Division of Infectious Diseases, Department of 
Medicine, Emory University, Atlanta, GA, United States
The innate immune system likely plays a key role in Plasmodium vivax 
infection, but studies focusing on its impact have been limited. Neutrophils 
are the most abundant innate immune subset in blood and serve as a 
primary defense against microorganisms via phagocytosis, as well as the 
production and release of inflammatory mediators that amplify immune 
responses. However, excessive neutrophilic responses can lead to tissue 
damage and impact subsequent adaptive immune responses negatively. 
Thus, more detailed study of neutrophilic responses during malaria are 
warranted. In the context of P. vivax infection, previous studies have 
reported significant neutrophil activation, although more studies are 
needed to dissect out their diverse and dynamic functions. Here, the 
rhesus macaque – P. cynomolgi model was used as a model for vivax 
malaria to assess functional changes in neutrophils during infection. Five 
rhesus were infected with P. cynomolgi and their neutrophil function 
assessed during acute infection using flow cytometry-based assays. 
Neutrophils became activated based on expression of surface markers such 
as CD63 during infection, demonstrating a role for this cellular subset 
during P. cynomolgi infection. Additionally, neutrophil caspase-1 activity, 
measured by the fluorescent substrate FLICA, increased and correlated 
with an increase in IL-1β in the plasma. By contrast, neutrophils were 
impaired in both phagocytic ability and reactive oxygen species production 
during acute infection. Changes in neutrophil function correlated with 
parasitemia. Following these pilot data, our group is now examining the 
role of the various circulating neutrophil subsets (e.g., bands, segmented, 
and hypersegmented) to determine if a relationship exists between the 
functional changes observed during cynomolgi malaria and the abundance 
of such subsets. Indeed, humans with vivax malaria display changes in 
the frequency of neutrophil subsets in the blood during infection, which 
emphasize the relevance of our P. cynomolgi model. Overall, this model 
will be useful for better understanding neutrophil dynamics and potential 
functions during malaria.
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SPECTRUM-MALARIA: A USER-FRIENDLY PROJECTION 
TOOL FOR HEALTH IMPACT ASSESSMENT AND STRATEGIC 
PLANNING FOR MALARIA PROGRAMS IN SUB-SAHARAN 
AFRICA
Matthew Hamilton1, Guy Mahiané1, Elric Werst1, Olivier Briët2, 
Richard Cibulskis3, Ewan Cameron4, Samir Bhatt4, Carel Pretorius1, 
Eline L. Korenromp5
1Avenir Health, Glastonbury, CT, United States, 2Swiss Tropical and Public 
Health Institute, Basel, Switzerland, 3World Health Organization, Geneva, 
Switzerland, 4Oxford University, Malaria Atlas Project, Oxford, United 
Kingdom, 5Avenir Health, Geneva, Switzerland
The Spectrum suite of policy planning models is used by over 120 
countries to support estimation of burdens, trends, service needs and 
program impact. We developed the Spectrum-Malaria module, that 
projects impact of malaria interventions on case incidence and deaths in 
0-4 year, 5-14 year and 15+ year olds, and falciparum infection prevalence 
(PfPR) among children 2-9 years, based on user-specified targets for 
people sleeping under insecticide-treated nets (ITNs), people protected 
by indoor residual spraying (IRS), children 6-59 months old receiving 3 
courses of seasonal malaria chemoprophylaxis, and uncomplicated and 
severe cases effectively managed. Intervention effectiveness was estimated 
by generalized linear statistical models that emulate impact drivers as 
simulated by the dynamic OpenMalaria model. ITN and IRS effectiveness 
were validated on child health outcomes in 3 ITN trials. Spectrum projects 
impacts at province level starting from 2015 case, death and coverage 
levels, PfPR and seasonality estimated by the Malaria Atlas Project and 
World Health Organization. Pilots for Democratic Republic of the Congo 
(DRC) and Zambia, Nigeria and Senegal show that intervention scale-up 
reduces malaria burdens in the three age groups by similar proportions, 
but most cases and deaths are averted in under-5s. Proportional burden 
reductions are larger in lower-endemic settings, but numbers of cases and 
deaths averted for a given coverage increase are larger in higher-endemic 
settings, within and across countries. For DRC, given high ITN coverage 
but low effective case management coverage in 2015, case management 
is the intervention for which scale-up could have most additional impact 
by 2030 but programmatic inputs and resources to achieve this remain to 
be assessed by linking to the Spectrum costing module OneHealth Tool. 
In initial pilots, users appreciated the tool’s alignment with monitoring 
indicators also as used in performance frameworks for program target 
setting and impact evaluation, and its graphical interface embedded in 
Spectrum’s demographic platform for relatively quick comparison of policy 
scenarios.
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ASSESSING METHODS FOR ESTIMATING HOUSEHOLD 
BITING PROPENSITIES, SEASONALITY AND NOISE IN COUNTS 
OF MALARIA VECTORS
Su Yun Kang1, Donal Bisanzio1, Laura Cooper2, David L. Smith3
1University of Oxford, Oxford, United Kingdom, 2Princeton University, 
Princeton, NJ, United States, 3University of Washington, Seattle, WA, 
United States
Heterogeneity in malaria transmission varies with the intensity of 
transmission and it does not follow a Pareto rule. The distributions instead 
follow power laws across households or seasons in that the variance S and 
mean m are related by S=amb. Understanding what drives these power 
laws and assessing the likely benefits of targeting requires having some 
quantitative understanding of heterogeneity and its underlying causes. 
These include seasonality, all the factors that make some households 
more attractive or easier to enter than others, environmental noise, and 
measurement error. The study focuses on mosquito counts data from an 
entomological surveillance conducted between October 2011 and March 
2015 for 330 households at three study sites in Uganda and a simulation 
study investigating pseudo-data with known properties. We evaluate the 
performance of several statistical methods for partitioning the variance 
in mosquito biting into household biting propensities, seasonality, and 
environmental and measurement noise. We consider specific probability 
models that are capable of handling excess zeros while modeling non-
zero counts properly. Seasonal adjustment of the time series data is 
performed using a range of temporal smoothing techniques, including a 
Gaussian smoothing kernel for sampling days and several Bayesian prior 
distributions for the temporally structured random effects. Using a range 
of model selection criteria, a zero-inflated negative binomial model was 
found to be robust and well-suited in modeling the mosquito counts 
across various simulated scenarios and real settings. The choice of the 
temporal smoothing technique differed slightly for each dataset. The 
information on household-level biting heterogeneity permits interventions 
to be targeted towards the locations of households with high malaria risk 
within them. Once transmission in an area has decreased but is maintained 
in hotspots of malaria transmission, such targeted interventions are likely 
to become increasingly important tools in malaria elimination efforts.
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SYSTEMS METABOLIC MODELING REVEALS DIFFERENTIAL 
NETWORKS PERTURBED AT PRIMARY INFECTION AND 
RELAPSE, IMPLICATING POTENTIAL BIOMARKERS FOR 
ACUTE AND CHRONIC MALARIA
Yan Tang1, Luis Fonseca1, the MaHPIC Consortium, Mary R. 
Galinski2, Eberhard Voit1, Mark P. Styczynski1
1Georgia Institute of Technology, Atlanta, GA, United States, 2Emory 
University, Atlanta, GA, United States
We applied Flux Balance Analysis (FBA) to model stage-specific metabolism 
of Non-Human Primate (NHP) model animals infected with Plasmodium 
cynomolgi or P. coatneyi. We derived genome-scale metabolic models 
(GEMs) for peripheral blood (PB) and bone marrow (BM), using 
transcriptomics data as constraints for metabolic fluxes. By bridging 
transcriptome and in silico metabolomics/fluxomics data, we identified key 
pathways that were perturbed during each stage of the parasite infection, 
highlighting key host metabolic modules in different tissues responding to 
parasite invasion. We further interrogated species-specific mechanisms by 
comparing GEMs constructed for P. cynomolgi and P. coatneyi. Focusing on 
purine metabolic pathway discovered by GEMs, we developed Generalized 
Mass Action (GMA) models to simulate kinetics of purine metabolism in 
PB and BM in P. coatneyi or P. cynomolgi infection. Notably, we found non-
linear relationships between gene expression and corresponding fluxes. 
Tissue-specific comparisons showed that RNA metabolism is more active 
and more tightly regulated in BM compared to PB at primary infection, 
which is common for both parasites. Importantly, we observed positive 
correlation between increased fluxes toward hypoxanthine/uric acid 
and higher parasitemia in P. coatneyi infection, whereas in P.cynomolgi 
infection, the same fluxes were shown to be correlated with severity 
of disease. Strikingly, fluxes toward hypoxanthine and inosine were 
only shown to be constantly up-regulated across chronic infection in P. 
coatneyi but not in P. cynomolgi infection. Furthermore, this work derived 
a comprehensive map of temporal differential fluxes by longitudinal 
comparison in both P. coatneyi and P. cynomolgi infection, providing 
a resource for characterizing dynamics of purine metabolic pathways 
perturbed by malarial pathogens. These identified common and distinct 
fluxes and metabolites provide a paradigm to understand convergent 
and divergent molecular mechanism of host response to infections by 
two malaria species. This study showcases the application of metabolic 
modeling in biomarker discovery.
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JOINT MODELING OF PLASMODIUM FALCIPARUM AND 
P. VIVAX INFECTIONS USING A BIVARIATE POISSON 
LOGNORMAL MODEL
Kathryn Colborn1, Ivo Mueller2, Terence Speed2
1University of Colorado Denver, Aurora, CO, United States, 2Walter and 
Eliza Hall Institute, Melbourne, Australia
We utilized a bivariate Poisson lognormal model (BPLM) to estimate a 
covariate-adjusted association between Plasmodium falciparum and 
P. vivax infections and malaria clinical episodes. These two parasites 
are commonly seen as coinfections in Papua New Guinea (PNG). It is 
unclear whether they are positively associated with one another, or if 
one parasite suppresses the other. This was the primary motivation for 
fitting a BPLM, because it permits estimation of negative correlation, 
unlike most other multivariate Poisson models. We first simulated data 
similar to a cohort study that was conducted in PNG and compared 
two available methods for estimating the parameters of a BPLM. One 
method was a Bayesian model fit using MCMC methods and the other 
used adaptive Gaussian quadrature (AGQ) to estimate the model. We 
then estimated the association between two measures of burden from 
the PNG data using BPLMs: 1) the count of clinical episodes caused by P. 
falciparum and P. vivax parasites and 2) the count of genetically unique 
P. falciparum and P. vivax infections over an interval of observation. Our 
findings suggest that when the means of the two variables are large 
and exhibit overdispersion, it is possible to get estimates with low bias 
and correctly estimate the standard errors using either available method. 
However, when the means and variances are small, the MCMC method 
tends to produce biased estimates with slightly inflated standard errors 
and the AGQ method produces slightly biased estimates with extremely 
large standard errors. When the BPLM was fit to the PNG data, there 
was a moderate positive association between P. falciparum and P. vivax 
infections (correlation from BPLM 0.4, 95% CI [0.1, 0.8]), while adjusting 
for use of an insecticide treated bednet and age. Although there were 
higher rates of P. vivax infections (15.3 per child per year) in these children 
compared to P. falciparum (5.4 per child per year), there were more clinical 
episodes caused by P. falciparum (1.9 per child per year) than those caused 
by P. vivax (1.6 per child per year) over the entire cohort. We found no 
indication that P. vivax is protective against P. falciparum infections.
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PHARMACOKINETICS AND ACCUMULATION OF 
PIPERAQUINE WHEN USED FOR INTERMITTENT PREVENTIVE 
TREATMENT IN PREGNANCY (IPTP)
Joel Tarning1, Kephas Otieno2, Julie Gutman3, Simon Kariuki2, 
Feiko O. ter Kuile4, Fracois Nosten5, Meghna Desai3
1Department of Clinical Pharmacology, Mahidol-Oxford Tropical Medicine 
Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, 
Thailand, 2Kenya Medical Research Institute, Center for Global Health 
Research, Kisumu, Kenya, 3Centers for Disease Control and Prevention, 
Center for Global Health, Division of Parasitic Diseases and Malaria, 
Malaria Branch, Atlanta, GA, United States, 4Liverpool School of Tropical 
Medicine, Liverpool, United Kingdom, 5Shoklo Malaria Research Unit, 
Faculty of Tropical Medicine, Mahidol University, Tak, Thailand
While pharmacokinetic (PK) studies of dihydroartemisinin-piperaquine 
(DP) suggest that dose adjustment may not be necessary for treatment 
of malaria illness in pregnancy, similar data are needed for its use as 
intermittent preventive treatment in pregnancy (IPTp). We evaluated 
the PK and accumulation of piperaquine (PQ) when used as IPTp-DP 
in the context of a randomized controlled trial in Kenya. Among 371 
HIV-negative pregnant women, 6, 57, 127, 121, and 60 received 1, 2, 
3, 4, and 5 or more full 3-day treatment courses of IPTp, respectively. 
Plasma samples were collected at each antenatal care visit, following 
a breakthrough symptomatic malaria infection, and at delivery. PQ PK 
properties were evaluated using nonlinear mixed-effects modelling. PQ 
PK was described adequately by a 3-compartment disposition model 
with a flexible absorption model. Predicted median trough plasma 
concentrations accumulated (152%) during monthly IPTp; 10.7, 14.4, 
15.7, 16.1, and 16.3 ng/mL following 1, 2, 3, 4, and 5 treatment courses, 
respectively. Simulations using the final PK model indicated much lower 
steady-state trough plasma concentrations of PQ after 5 treatment 
courses of IPTp at intervals of 45 (7.90 ng/mL) and 60 days (4.22 ng/
mL) compared to monthly administration (16.3 ng/mL). Fifty pregnant 
women presented with breakthrough malaria infections at a median (IQR) 
observed PQ concentration of 4.94 ng/mL (2.80-8.65 ng/mL); no malaria 
occurred in women with a trough concentration above 34 ng/mL. No 
increases in adverse events were seen with increasing courses of IPTp-DP. 
Approximately monthly dosing of IPTp-DP resulted in PQ accumulation, 
though less than that reported among non-pregnant adults in Thailand 
(336%), likely due to the effect of pregnancy on PK properties. In the 
context of previously reported high efficacy, tolerability and safety, these 
data suggest that the standard DP dose regimen for P. falciparum is likely 
adequate and safe for monthly IPTp in a high malaria transmission area, 
with an advantage over bi-monthly IPTp. These are the first data on PK 
and accumulation of DP used for IPTp. Final PK modeling results will be 
presented.
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BROTHERS, SISTERS, AUNTS AND UNCLES: TRANSMISSION 
OF RELATED PARASITES IN POLYGENOMIC INFECTIONS OF 
PLASMODIUM FALCIPARUM
Wesley Wong1, Edward Wenger2, Rachel F. Daniels3, Stephen 
F. Schaffner4, Allison Griggs4, Daouda Ndiaye5, Fatou Ba Falle6, 
Medoune Ndiope6, Mady Ba6, Danny A. Milner Jr1, Sarah K. 
Volkman1, Philip Eckhoff2, Daniel E. Neafsey4, Daniel L. Hartl3, 
Dyann F. Wirth1
1Harvard T.H. Chan School of Public Health, Boston, MA, United States, 
2Institute of Disease Modelers, Bellevue, WA, United States, 3Harvard 
University, Cambridge, MA, United States, 4Broad Institute, Cambridge, 
MA, United States, 5Cheikh Anta Diop University, Dakar, Senegal, 6Senegal 
National Malaria Control Program, Dakar, Senegal
Genomic analysis of natural Plsmodium falciparum populations can 
give us key insights into changes in population biology as malaria 
transmission is reduced following intensive interventions. Such data is 
valuable both as a direct assessment of transmission and in modeling the 
impact of interventions. There has been a strong correlation between 
declining genetic diversity and transmission intensity, suggesting that 
genetic diversity metrics could serve as proxies for declining transmission 
rates. Most studies have focused on the genetic diversity found within 
monogenomic infections, or those infections composed of a single 
parasite type. This is limiting and not representative of many transmission 
settings, since the proportion of multiple strain infections, or polygenomic 
infections, tends to be high. Polygenomic infections are largely assumed 
to be the result of superinfection, or infection by multiple mosquito 
bites, which would imply that the genetic diversity within polygenomic 
infections are directly linked to transmission intensity. However, the 
mosquito may influence the genetic diversity of parasites in subsequent 
infections, particularly if multiple strains are co-transmitted, or introduced 
simultaneously with a single mosquito bite. We analyzed the genetic 
relatedness of parasites within 32 polygenomic infections collected from 
Senegal and found that these infections are most likely the result of co-
transmission. We also simulated the co-transmission process and found 
that the genetic diversity within polygenomic infections is influenced most 
strongly by the complexity of infection, or the number of unique parasite 
types, within the initial human host, and the number of oocysts that 
form within the mosquito midgut. Our results suggest that the genetic 
relatedness within polygenomic infections is a reflection of both the overall 
transmission intensity and the dynamics within the mosquito vector. We 
anticipate that polygenomic infections could greatly aid our understanding 
of transmission dynamics within malaria endemic regions, since it could be 
used to derive information from both the human and mosquito hosts.
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VECTOR “VACCINATION”: OPTIMIZATION OF NON-
MENDELIAN-BASED GENE DRIVES FOR MOSQUITO 
POPULATION REPLACEMENT
Milen Nikolov1, Andre Ouédraogo1, Edward Wenger1, Dave 
Summa2, Philip Eckhoff1
1Institute for Disease Modeling, Bellevue, WA, United States, 2BMI, 
Mountain View, CA, United States
As the efforts towards malaria control and elimination expand 
across socio-geographical strata, the penetration, accessibility, and 
correspondingly success rates of established interventions vary. Difficult to 
reach and/or dangerous locations render implementation of interventions 
requiring sustained complex logistical coordination and robust 
infrastructure hard, if at all feasible. Recently, advances in the CRISPR/
Cas9-mediated constructs, along other genetic modification technologies, 
have allowed for gene drives altering mosquito populations at scale. 
Homing endonucleases, TALENs and more recently CRISPR constructs, for 
instance, could be used to express anti-falciparum antibodies in target 
mosquito species. We implemented such a gene drive, replacing wildtype 
populations with mosquitoes resistant to Pl. falciparum within the EMOD 
modeling framework. We studied four distinct use cases in Tanzania, 
Nigeria, DRC, and Somalia - each characterized by distinct climates, disease 
prevalence and mosquito densities, etc. -- representing a realistic range of 
mosquito habitats and seasonality intensity. We investigated the optimal 
parametrization of genetic constructs - e. g. in terms of fitness penalty 
tolerance, infection modification and population replacement rates - along 
with gene drive logistics - e.g. mosquito release numbers, schedules, etc. 
We demonstrate feasible parameter ranges, where infection modification 
gene drives can replace wildtype mosquito populations in each of the 
four use casses. We caution that the resulting parasite prevalence and 
hence the success of a gene drive depends significantly on the infection 
modification rate and provide the respective thresholds for successful 
genetic constructs. The robustness of parasite prevalence reduction under 
different gene drive strategies in all use cases was evaluated with respect 
to malaria re-importation and mosquito species heterogeneity.
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PENTOSE PHOSPHATE PATHWAY INHIBITION ELEVATES 
OXIDATIVE STRESS AND IMPEDES FECUNDITY IN 
ANOPHELES GAMBIAE
Cody J. Champion, John Xu
New Mexico State University, Las Cruces, NM, United States
Blood digestion in hematophagous insects is associated with elevated 
reactive oxygen species (ROS) resulting from pro-oxidant heme ingestion. 
Mosquito capacity for defense against oxidative stress is limited and an 
overabundance of ROS can lead to reduced fecundity and death. Reducing 
power from internal sources is essential for oxidative stress defense which 
can impact insecticide sensitivity and defense against pathogens. The 
primary system used to alleviate oxidative stress is the pentose phosphate 
pathway (PPP). The major role of PPP is the regeneration of NADPH by 
reducing NADP+, and 6AN is a competitive inhibitor of G6DPH, the 
rate-limiting enzyme of PPP. PQ is an exogenous stress inducer, and PPP 
inhibition results in the accumulation of endogenous stress. We examine 
the dynamics of oxidative stress by induction by paraquat (PQ), inhibition 
of the PPP by 6-aminonicotinamide (6AN) and alleviation of oxidative 
stress by lycopene by oral feeding followed by egg counts and biochemical 
assessment of females. We hypothesis that PQ and 6AN will induce 
oxidative stress and result in reduced fecundity. Lycopene should rescue 
this phenotype by scavenging ROS. Both PQ and 6AN feeding increased 
oxidative stress levels and decreased fecundity. Co-feeding with lycopene 
attenuated these adverse effects. 6AN when fed with PQ results in a 
normal egg number possibly due to inactivation of NADPH production 
which is required for PQ toxicity. Lycopene also improves 6AN reduction 
in egg number suggesting that lycopene can alleviate ROS species 
induced by reducing NADPH production. 6AN reduced NADPH production 
resulting in a high NADP+:NADPH ratios indicating that the PPP is inhibited 
by 6AN in our model system. GSSG:GSH ratio also was increased by 
both 6AN feeding and PQ indicating both of these compounds result 
in increased oxidative stress. These antioxidants and pro-oxidants can 
provide a manipulatable link between mosquitoes and egg production 
capacity. This knowledge can be used to design novel and effective vector 
control strategies which may influence insecticide sensitivity, infection 
susceptibility, fecundity and longevity.
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INVESTIGATING ANOPHELES FUNESTUS SUSCEPTIBILITY 
AND IMMUNE RESPONSE TO PLASMODIUM FALCIPARUM 
INFECTION
Cyrille Ndo1, Edmond Kopya1, Benjamin Menze2, Parfait Awono-
Ambene1, Gareth Lycett3, Charles Wondji3
1OCEAC, Yaoundé, Cameroon, 2OCEAC/LSTM, Yaoundé, Cameroon, 
3Liverpool School of Tropical Medicine, Liverpool, United Kingdom
Anopheles funestus is a major vector of malaria in Africa. However, 
because it is difficult to colonize, research on this mosquito species 
has lagged behind other vectors, particularly the understanding of its 
susceptibility and interactions with the Plasmodium parasite. In order to fill 
this important knowledge gap, experimental infections were conducted 
from March to June 2015. 3-5 day old An. funestus F1 mosquitoes derived 
from wild-caught females from Cameroon were fed with infected blood 
taken from gametocyte carriers using an artificial glass-parafilm feeding 
system. Feeding rate was recorded, and fed mosquitoes were dissected 
at day 7 for oocysts count. Comparative and parallel experiments 
were performed with the known Plasmodium-susceptible, An. coluzzii 
Ngousso laboratory strain. Microarrays analysis was performed to assess 
the molecular basis of An. funestus immune response to P. falciparum 
invasion.The results revealed that An. funestus displays a similar level 
of susceptibility to Plasmodium infection compared to An. coluzzii. The 
prevalence of infection in fed An. funestus mosquitoes was 38.52% 
(range: 6.25-100%) and the median oocyst number was 12.5 (range: 
1-139). In parallel, the prevalence in An. coluzzii was 39.92% (range: 
6.85-97.5%), while the median oocyst number was 32.1 (range: 
1-351). Genome-wide microarray-based transcription analysis showed 
that An. funestus innate immune system is activated during midgut 
invasion. A total of 222 genes were found to be differentially expressed 
between infected and non-infected mosquitoes including several known 
immune response genes such as C-type Lectine, APL1 family genes, 
LRIM1, Serine protease, Serine collagenase and niemann-pick type c. 
However, genes such as TEP1 were not over-expressed in contrast to 
An. gambiae suggesting possible differences between both species. The 
high susceptibility of An. funestus to P. falciparum and its widespread 
distribution across Africa highlight the need to also tackle this vector for 
significant malaria vector control program.
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ELUCIDATING THE ROLE OF LIPOGENIC AND LIPOLYTIC 
PATHWAYS IN MOSQUITO REPRODUCTION AND 
PLASMODIUM FALCIPARUM TRANSMISSION
Maurice A. Itoe, Flaminia Catteruccia
Harvard T.H. Chan School of Public Health, Boston, MA, United States
Female Anopheles mosquitoes undergo a number of blood feeding cycles 
on a vertebrate host in order to produce multiple egg batches, and these 
obligatory steps in the mosquito life cycle are exploited by Plasmodium 
parasites for their own transmission. Blood feeding is therefore a key step 
for both mosquito reproduction and parasite transmission. Indeed these 
two processes are temporally and physiologically coupled and can be 
exploited to impact malaria dynamics in endemic areas. Previous studies 
revealed a correlation between blood meal digestion and major changes 
in transcriptional profiles of metabolic genes involved in lipid biosynthesis, 
transport, and breakdown, suggesting the occurrence of de novo lipid 
synthesis triggered by blood feeding followed by lipid mobilization. 
Here, we aim to elucidate the specific role of blood meal-derived lipids 
(and/or of lipids synthesized de novo after a blood meal) in Anopheles 
reproduction and parasite development in mosquito stages. To address 
this, we performed targeted depletion of key lipogenic and lipolytic 
enzymes in the main African malaria vector using RNA interference (RNAi) 
and assessed their impact on oogenesis and P. falciparum infection. 
Strikingly, knockdown of acetyl-CoA carboxylase (ACC), one of the rate-
limiting enzymes in de novo fatty acid synthesis (lipogenesis), reduced egg 
development and P. falciparum infection in An. gambiae. On the other 
hand, inhibition of triglyceride (TAG)-lipase, involved in lipolytic breakdown 
of TAGs to yield free fatty acids and diacylglycerol (DAG), had opposing 
effects on egg development and Plasmodium infection: depletion of 
TAG-lipase significantly impaired the number of eggs developed but 
resulted in a significant increase in oocyst size without any apparent 
impact on the number of oocysts per midgut. The latter results suggest 
occurrence of possible scavenging of host TAGs by malaria parasites to 
meet developmental needs within the Anopheles vector. While further 
characterization is underway, these data provide the first direct evidence 
of the requirement of host lipids by human malaria parasites for successful 
transmission.
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DISRUPTING STEROID HORMONE SIGNALLING IN ADULT 
ANOPHELES GAMBIAE FEMALES BLOCKS PLASMODIUM 
DEVELOPMENT AND OFFERS ALTERNATIVE TARGETS FOR 
MOSQUITO CONTROL
Douglas G. Paton, Evdoxia Kakani, Francisco Cai, Sara Mitchell, 
Flaminia Catteruccia
Harvard T.H. Chan School of Public Health, Boston, MA, United States
Human malaria is a major public health burden in tropical and subtropical 
countries and is transmitted exclusively by female Anopheles spp. 
mosquitoes. Malaria control strategies based upon the deployment of 
pyrethroid-impregnated long lasting insecticide treated nets (LLINs) are 
threatened by the continued spread and intensification of insecticide 
resistance. This represents a major obstacle to malaria elimination and as 
such new means of protection against the mosquito vector are desperately 
needed. Here we report that treatment with non-steroidal ecdysone 
receptor agonist dibenzoylhydrazines (DBHs) such as methoxyfenozide 
impact a number of parameters key to the vectorial capacity of the 
principal malaria vector Anopheles gambiae. Topical application of 
methoxyfenozide causes extensive apoptosis in the primary ovarian 
follicles of treated females, significantly reducing egg production while 
also impacting lifespan, oviposition and - in virgin females - mating 
refractoriness. Importantly, application of methoxyfenozide prior to 
females receiving an infectious Plasmodium falciparum blood meal 
triggered up to an 87% reduction in oocyst prevalence 7 days after blood 
feeding, suggesting that female susceptibility to infection is mediated 
in part via ecdysone signalling. This work provides critical insights into 
vector/parasite interactions and - in the face of the potential collapse of 
existing vector control methods - sets forth the case for the use of DBH 
compounds in malaria control strategies.
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THERE AND BACK AGAIN: A MOSQUITO SPERM’S JOURNEY 
FROM INSEMINATION TO FERTILIZATION
Ethan Degner, Laura Harrington
Cornell University, Ithaca, NY, United States
Interfering with mosquito reproduction to control vector populations holds 
significant promise. Most investigative effort to develop novel control 
targets has focused on females, yet male contributions to reproduction 
are often overlooked. In particular, sperm biology and sperm’s movement 
through the female reproductive tract are poorly understood, but studying 
sperm may provide various opportunities to interrupt reproduction. During 
insemination, sperm are deposited in a semen-receiving organ, where 
they display hyperactivated motility. They quickly localize to ducts leading 
to long-term storage organs called spermathecae. Within minutes, they 
travel up these ducts and are maintained by the female for her entire life. 
Ultimately, they are carefully released for fertilization as eggs are laid. 
Completion of this journey requires the precise coordination of motility, 
interactions with the ejaculate, nourishment by the female, and possibly 
modifications to sperm that make them fertilization competent. These 
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processes have been superficially examined microscopically, but very little is 
known about how sperm function on the molecular level. We discuss what 
is known of mosquito sperm’s path through the female, highlighting areas 
for future exploration and discussing possible molecular targets that could 
be exploited by vector control strategies. We also provide unprecedented 
footage of mosquito sperm motility inside the female reproductive tract 
that will aid our understanding of how sperm function in vivo.
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SICPIN, A MULTIFUNCTIONAL IMMUNOMODULATORY 
SALIVARY PROTEIN FROM THE BLACK FLY SIMULIUM 
NIGRIMANUM
Andrezza C. Chagas1, Anderson B. Guimarães-Costa1, Fabiano 
Oliveira1, Anderson Sá-Nunes2, Jose M. Ribeiro1, Eric Calvo1
1National Institute of Allergy and Infectious Diseases-National Institutes of 
Health, Rockville, MD, United States, 2Instituto de Ciências Biomédicas, 
Universidade de São Paulo, Sao Paulo, Brazil
Hematophagy is key to blood feeding arthropods reproductive success 
and an important link in pathogen transmission cycles. Salivary 
gland homogenates from blackflies have been shown to contain 
immunomodulatory activity on murine splenocytes. However, the 
molecule(s) responsible for this salivary activity remains elusive thus far. 
Here, we report the first immunosuppressive protein from blackfly salivary 
glands. Sicpin (Simulium cell proliferation inhibitor) was produced in E. 
coli and purified using size exclusion and ion exchange chromatography. 
Sicpin inhibited cell proliferation in a dose-response manner independently 
of the mitogen utilized (ConA, LPS, CD3/CD28 and Pokeweed). LPS or 
ConA stimulated cells had a significant lower proliferation rates (P<0.001) 
in the presence of Sicpin (IC50=0.5µM) with 10uM completely abrogating 
cell proliferation. Flow cytometry analysis showed that Sicpin inhibits 
proliferation of CD19+ B-cells and CD4+/CD8+ T-cells; also inhibiting 
antigen-specific cell proliferation without inducing apoptosis in resting or 
mitogen-induced splenocytes. The production IFN-α, IL4, IL5, IL6 and IL10 
by splenocytes stimulated by ConA or LPS was dose-dependently reduced 
by Sicpin. Additionally, carrageenan-induced paw-edema model showed 
that the intensity of edema significantly decreases in the presence of 
Sicpin. The molecular mechanism of Sicpin on cell proliferation inhibition 
is currently under investigation; however, initial binding experiments using 
SPR analysis showed a direct binding to soluble CD4 receptor with a 
calculated KD of 17.77 nM. Direct binding of Sicpin to CD4 could inhibit 
the subsequent TCR ligation-induced T cell signaling at the earliest steps 
including tyrosine phosphorylation of the receptors, downstream effector 
proteins, and lipid raft reorganization. The immune suppressive and anti-
inflammatory properties of Sicpin should be explored as a strategy to 
modulate immune responses in infection and tumor proliferation as well as 
its involvement in parasite transmission.
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A LOOK AT TWO FACTORS THAT MODULATE AEDES 
AEGYPTI MOSQUITO VECTOR COMPETENCE FOR DENGUE 
VIRUS
Celia Demby
Johns Hopkins University, Baltimore, MD, United States
Dengue virus (DENV) is a single stranded, RNA virus principally transmitted 
by the Aedes aegypti mosquito. While there is currently no vaccine or 
treatment available for those infected with the virus, DENV transmission 
can be prevented via vector control strategies. However, both biological 
and physical methods that have been employed thus far have had minimal 
success in curtailing the virus; and without a thorough understanding 
of how the mosquito modulates DENV infection; we may never be able 
to achieve this goal. Studies have shown that interactions between 
the mosquito’s immune system, the pathogen, and the mosquito’s 
endogenous midgut microbiota are critical determinants of the outcomes 
of transmission. Viral replication in the midgut results in the activation of 
a signaling cascade that turns on the mosquito’s immune response. Thus 
far, we have isolated two key restriction factors, DVRF1 and DVRF2, which 
are downstream effectors of the JAK-STAT immune signaling pathway 
that have anti-dengue activity. But very little is known about how these 
specific effector molecules mediate this anti-pathogenic effect. The natural 
microbiota of mosquitoes is also a great influence on the mosquito’s 
biology. Interactions between the mosquito microbiota and the virus also 
modulate vector competence for DENV infection via mechanisms such as 
immune response activation, anti-viral molecule production and resource 
competition. We have started the process of screening several mosquito- 
gut associated fungus for their effects on DENV susceptibility, from which 
we hope to characterize their mechanisms for infection modulation. 
Studying theses two important factors that modulate DENV infection is a 
step in the right direction toward developing alternative strategies for viral 
transmission control.
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CHIKUNGUNYA FEVER IN CLINICALLY DIAGNOSED PATIENTS: 
COMPARATIVE STUDY BETWEEN LABORATORY CONFIRMED 
VERSUS NEGATIVE CASES DURING THE 2015 OUTBREAK IN 
YUCATAN, MEXICO
Reinhard Janssen-Aguilar1, Salvador Gomez-Carro2, Victoria 
Novelo-Alcocer1, Mauricio Serna-Lorenzo1, Freddy Pacheco-
Tucuch3, Martin Inurreta-Diaz1, Nina Mendez-Dominguez4
1Universidad Marista de Merida, Merida, Mexico, 2OHoran General 
Hospital, Merida, Mexico, 3Universidad Autonoma de Yucatan, Merida, 
Mexico, 4CINVESTAV del IPN, Merida, Mexico
In the second half of 2015, chikungunya and dengue outbreaks took place 
simultaneously in the state of Yucatan, Mexico. This coexistence of both 
outbreaks posed a challenge to differential clinical diagnosis. During the 
outbreak, only a subsample of chikungunya dengue cases were confirmed 
by laboratory standard methods. This study was undertaken to identify 
signs and symptoms useful for clinically discriminate chikungunya from 
other endemic infections in early febrile stage. In this comparative, cross 
sectional study, we analyzed the data from the chikungunya surveillance 
cases at the main public general hospital in the state of Yucatan, including 
for our analyses only those whose blood samples were referred for its 
confirmation by the epidemiologic reference laboratory in the period 
between August and December of 2015. We compared the clinical 
manifestations of confirmed cases versus discarded cases using a logistic 
regression model. We included 181 of which 152 tested positive for 
Chikungunya virus, finding that pruritus is a suggestive symptom of an 
acute infection caused by CHIKV. Osteoarticular manifestations did not 
differ significantly, between confirmed or discarded cases, but pruritus 
was twice as common among chikungunya confirmed cases. Pruritus was 
a suggestive symptom of an acute infection caused by CHIKV. In 2015, 
Yucatan Mexico experienced a simultaneous occurrence of chikungunya 
and dengue outbreak. Clinical differentiation between CHIKV and 
dengue represented a diagnostic challenge, after statistical analyses, we 
can conclude that pruritus was an early suggestive symptom of an acute 
infection caused by chikungunya.
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EVOLUTIONARY INFLUENCES ON THE REDUCTION IN 
ENZOOTIC CIRCULATION AND HUMAN INCIDENCE OF 
WESTERN EQUINE ENCEPHALITIS
Nicholas A. Bergren1, Shannan L. Rossi1, Richard A. Bowen2, 
Scott C. Weaver1
1University of Texas Medical Branch, Galveston, TX, United States, 
2Colorado State University, Fort Collins, CO, United States
Understanding the evolutionary and ecological circumstances in which 
arboviruses emerge into naïve geographical areas is critical for the 
development of targeted maintenance and prevention strategies. This 
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need was highlighted by the recent emergence of chikungunya and Zika 
viruses in the Americas. In order to develop a complete understanding of 
the ways in which viruses emerge, the factors surrounding a reduction in 
virus activity (submergence) must also be studied, and Western equine 
encephalitis virus (WEEV) provides a unique opportunity to study this. 
WEEV caused several epizootic events in the early 20th century that 
account for the death of thousands humans and equids. However, the 
last human case in North America occurred in 1994 even though virus 
can still be detected in mosquito pools, albeit at reduced levels. Previously, 
we identified six nonsynonymous mutations that were phylogenetically 
significant and have a phenotypic effect on WEEV’s enzootic hosts. 
Competitive fitness assays show contemporary mutations have a 
competitive advantage in both Culex tarsalis and house sparrows, but have 
no effect on virulence in the Syrian golden hamster. These data suggest 
mutations have accumulated by positive selection only enhance the ability 
to transmit between its enzootic hosts and vector. We also hypothesize 
the mutations that confer mammalian virulence were purified out of the 
population by negative selection due to a reduction in selective pressure 
on those residues. Overall, the evolutionary profile of WEEV over the 20th 
century trends away from disease in mammals and toward its enzootic 
cycle. Several factors could account for this including vaccination and 
drastic reduction of the US equine population, the use of screens on 
windows and doors, and/or changes in irrigation practices. In summary, 
the submergence of WEEV presents a case study where its reduction was 
likely precipitated by an ecological shift critical for the virus’ maintenance 
of the mutations that connote virulence in mammals and subsequently 
compensated by increasing its adaptability to its enzootic hosts.
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THE BURDEN OF CHRONIC CHIKUNGUNYA DISEASE AND 
QUALITY OF LIFE IN CURAÇAO
Jelte Elsinga1, Symkje vd Ploeg2, Izzy Gerstenbluth3, Yaskara 
Halabi3, Norediz T. Lourents3, Joyce O’Neil3, Deniz Emre2, Johannes 
G. Burgerhof4, Ajay Bailey5, Alex Friedrich1, Adriana Tami1
1Department of Medical Microbiology, University of Groningen, University 
Medical Center Groningen, Groningen, Netherlands, 2University of 
Groningen, University Medical Center Groningen, Groningen, Netherlands, 
3Medical and Health Service Curaçao, Department of Epidemiology and 
Research, Curaçao, Netherlands Antilles, 4Department of Epidemiology, 
University of Groningen, University Medical Center Groningen, Groningen, 
Netherlands, 5Population Research Center, Faculty of Spatial Sciences, 
University of Groningen, Groningen, Netherlands
The burden of chronic chikungunya disease and quality of life in Curaçao 
Curaçao, an island in the southern Caribbean Sea, was affected by a major 
chikungunya (CHIK) epidemic in 2014 resulting in an estimated 25.000-
30.000 cases of CHIK at the end of the outbreak (January 2015). After the 
epidemic culminated, CHIK remained a public health problem given the 
chronic phase of the disease which can include joint pain, arthritis, fatigue 
and depression for up to five years. However, studies on the chronic phase 
of CHIK remain scarce, especially in the Americas. The aim of this study 
was to estimate the burden of the CHIK outbreak in Curaçao in terms of 
duration of disease, symptoms and impact on quality of life 3-16 months 
after diagnosis. Following the CHIK epidemic of 2014-2015 on Curaçao, 
a comprehensive cross-sectional survey was performed in June and July 
2015. A total of 411 adult participants were contacted and invited to join 
the study, of which 339 consented (response rate= 82.5%). Interviews 
took place 92-460 days after disease onset. Of those interviewed, 306 
individuals had a laboratory confirmed CHIK virus infection. Symptoms 
of the chronic disease course were evaluated, and quality of life was 
assessed using the RAND-36 score. We will present a comparison of 
the fully recovered and the still affected population of chikungunya 
patients. The mean age of the participants was 52 years (range: 18-94 
years). Preliminary results show that the degree in which subjects were 
affected by chronic chikungunya disease differs: 37.2% were defined 
as fully recovered, while the remaining 62.8% were defined as still 
being mildly affected (35.7%) or highly affected (27.1%). Of the total 
population, only 21.4% reported to be fully recovered from CHIK within 
one month. We will give a detailed description of the clinical spectrum 
of chronic chikungunya disease and will show the impact on the quality 
of life aspects reported by the studied population. We believe that this 
comprehensive study will provide important insight in the disease course 
of chronic chikungunya in the Americas and its impact on its population.
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CHIKUNGUNYA EPIDEMIC IN CARABOBO STATE, VENEZUELA 
2014: A STUDY ON EPIDEMIOLOGICAL DEVELOPMENT, 
CLINICAL MANIFESTATIONS AND RISK FACTORS
Erley F. Lizarazo1, Anne M. Ross2, Iris W. Riemersma2, Daniela 
Jou-Valencia2, María F. Vincenti-Gonzalez1, Noheliz Ojeda3, Oscar 
Diaz3, María A. Rangel3, Haydee Ochoa3, Adriana Tami1
1University Medical Center Groningen, Groningen, Netherlands, 2University 
of Groningen, Groningen, Netherlands, 3Fundación Instituto Carabobeño 
para la Salud (INSALUD), Carabobo, Bolivarian Republic of Venezuela
Chikungunya (CHIK) was a relatively uncommon and poorly documented 
illness. However, in the last decade this re-emerging viral vector-borne 
disease caused an increasing number of outbreaks in the tropical and 
subtropical regions of Africa and Asia. At the end of 2013, CHIK reached 
the Americas spreading rapidly through most countries. By mid 2014, 
Venezuela was hit by a devastating CHIK epidemic that swept the country 
with an estimated attack rate of 60%. Carabobo State, one of the first 
Venezuelan regions to be affected, reported its first autochthonous case in 
June 2014. We aimed to characterize the epidemic, clinical manifestations 
and risk factors associated with CHIK transmission in Carabobo State. 
Epidemiological and clinical data of patients attending health centers was 
obtained from the surveillance system of the Regional Ministry of Health. 
Between June-December 2014, data from 613 patients were included, of 
which 167 laboratory confirmed (103 (61.7%) positive). Univariate and 
multivariate analysis of laboratory-confirmed and suspected cases were 
performed. We detected an epidemic peak in week 34, 74 days (10.6 
weeks) after the first reported case. The mean of the epidemic curve 
was 14.3±3.7 weeks. A two week lag was observed between the time 
of symptom onset and that of case notification. In laboratory confirmed 
patients, rash alone (OR=3.39, p=0.018) and the combination of fever, 
rash and arthralgia (OR=2.39, p=0.066) were associated with CHIK. 
Housewives and domestic workers had 79% lower risk of being CHIK 
positive (p=0.050). Similar findings were obtained when comparing the 
study group of suspected and laboratory-confirmed CHIK cases showing a 
relatively accurate clinical diagnosis from physicians. In addition, crowding 
(≥1.5 people/bedroom), a marker for lower socio-economic status, was 
positively associated with acquiring CHIK (OR=1.75, p=0.059). Our 
findings may add to the current diagnosis guidelines and give insights 
about CHIK associated risk factors in Venezuela. Additionally, by improving 
the time response of case notification, earlier preventive measures may be 
put in place to reduce CHIK transmission.
1341
SEASONAL PREVALENCE OF ALPHAVIRUSES AND 
FLAVIVIRUSES IN CHILDREN IN WESTERN KENYA
Elysse Grossi-Soyster1, Sandra Musaki2, Bryson Ndenga2, Charles 
H. King3, A. Desiree LaBeaud1
1Stanford University School of Medicine, Stanford, CA, United States, 
2Kenya Medical Research Institute, Nairobi, Kenya, 3Center for Global 
Health and Diseases, Case Western Reserve University, Cleveland, OH, 
United States
Arboviruses present a significant threat in many regions of the world, 
continuing to spread through explosive expansion to previously unaffected 
areas. Many elements may influence the dynamics of exposure through 
environmental, behavioral, and biological factors, as well as the related 
spectrum of disease. This study aims to describe the prevalence of 
alphaviruses, such as chikungunya virus (CHIKV) and o’nyong n’yong 
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virus (ONNV), and flaviviruses, such as dengue virus (DENV) and West 
Nile virus (WNV), in western Kenya over time. Serum samples were taken 
from healthy afebrile children in two inland communities, Chulaimbo and 
Kisumu, at enrollment and during a 3-month follow up visit. Enrollment 
took place in March-May of 2014 for Kisumu, and October-December 
2014 for Chulaimbo. Questionnaires on health history, socioeconomic 
status, home environment, and mosquito exposure were collected during 
each visit to determine risk for arbovirus transmission. Sera were tested 
using indirect IgG ELISAs using CHIKV and DENV antigens to identify 
previous exposure to alphaviruses or flaviviruses (cross-reactivity within 
each viral genus is common). Of 748 children, 8% (CI95 6-10%) were 
seropositive for CHIKV indicating previous exposure to alphavirus, and 
11% (CI95 9-13%) were seropositive for DENV indicating previous 
exposure to a flavivirus. At follow-up, 30% (CI95 25-36%) and 36% (CI95 
32-39%) of participants were seropositive for alphaviruses and flaviviruses, 
respectively. Flaviviruses seropositivity was significantly higher in Chulaimbo 
(p = 0.01) at follow-up in January-March 2015. Comparatively, prevalence 
at the time of the follow-up visit differed significantly between villages 
for both alphaviruses (p = 0.0004) and flaviviruses (p < 0.0001). These 
data indicate suggest an event, such as flooding with an increase in local 
mosquito populations increased exposure. Because alphavirus infections 
increased prior to June and flavivirus infections prior to January, their 
exposure may also correlate with seasonal variation. Additional ecological, 
social, and demographic risk factors will be discussed.
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RISK FACTORS FOR CHIKUNGUNYA PATIENT 
HOSPITALIZATION — PUERTO RICO, 2014
Fabiola Cruz López1, Christopher H. Hsu2, Janice Perez-Padilla3, 
Olga Lorenzi3, Aidsa Rivera3, Esteban Lugo4, Danulka Vargas4, 
Jorge Munoz-Jordan3, Elizabeth Hunsperger3, J. Erin Staples5, 
Marc Fischer6, Harold S. Margolis3, Brenda Rivera Garcia7, Luisa 
Alvarado1, Tyler M. Sharp3
1Ponce Health Sciences University, Ponce, PR, United States, 2Centers 
for Disease Control and Prevention Poxvirus and Rabies Branch, Atlanta, 
GA, United States, 3Centers for Disease Control and Prevention Dengue 
Branch, San Juan, PR, United States, 4San Lucas Episcopal Hospital, Ponce, 
PR, United States, 5Centers for Disease Control and Prevention Arboviral 
Diseases Branch, Fort Collins, CO, United States, 6Centers for Disease 
Control and Prevention Poxvirus and Rabies Branch, Fort Collins, CO, 
United States, 7Puerto Rico Department of Health, San Juan, PR, United 
States
The Sentinel Enhanced Dengue Surveillance System (SEDSS) is an acute 
febrile illness (AFI) surveillance and research platform that determines the 
etiology and clinical outcome in febrile patients presenting to two hospitals 
in Puerto Rico. Chikungunya emerged in the Caribbean in late 2013, 
and diagnostic testing was incorporated into SEDSS in March 2014. The 
objectives were to estimate the proportion of chikungunya virus (CHIKV) 
infection in patients presenting with AFI, estimate the incidence and 
identify risk factors for chikungunya patient hospitalization. Demographic 
and clinical information were collected at presentation. Medical records 
were reviewed to collect information about clinical manifestations and 
outcomes. Of 3,035 patients enrolled in SEDSS during May-December 
2014, 1,469 (48%) had confirmed CHIKV infection by RT-PCR. In total, 
157 (10.7%) patients with evidence of CHIKV infection were hospitalized, 
6 (0.4%) were admitted to the intensive care unit, and 2 (0.1%) died. 
Median age among hospitalized and non-hospitalized patients was 
10 years (range: 0 to 93) and 26 years (range: 0 to 97), respectively 
(p-value=0.00). Rate of hospitalization was highest in infants (67%) 
and the elderly (17%). Neither the presence of co-morbid conditions 
nor day of presentation for care post-illness onset were associated with 
patient hospitalization. Clinical and laboratory findings associated with 
hospitalization (relative risk >1.5 or p-value= 0.00) included white blood 
cells, hematocrit, platelet count, pale or cold skin, skin rash, bruises, 
cyanosis, seizures, and irritability. Additional analyses will adjust for age 
in identification of risk factors for chikungunya patient hospitalization. 
The most common atypical manifestations among hospitalized patients 
were cardiac arrhythmia (7%), encephalitis (4%), and vesiculobullous skin 
lesions (3%). Fatal cases were associated with exacerbation of underlying 
chronic medical conditions. Although chikungunya is a self limiting illness, 
some patients - particularly infants and the elderly - may develop severe 
manifestations and merit closer monitoring.
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PROTEIN SPECIFICITY OF ANTIBODY RESPONSES TO SOUTH 
AMERICAN ALPHAVIRUS INFECTIONS USING A NOVEL 
MULTIPLEXED ASSAY
Jessica L. Smith1, Emily D. Cisney1, Christine L. Pugh1, Sarah 
L. Keasey1, Carolina Guevara2, Julia S. Ampuero2, Guillermo 
Comach3, Doris Gomez4, Margarita Ochoa4, Robert D. Hontz2, 
Robert G. Ulrich1
1United States Army Medical Research Institute of Infectious Diseases, 
Frederick, MD, United States, 2U.S. Naval Medical Research Unit - 6, 
Lima, Peru, 3LARDIDEV/BIOMED-Universidad de Carabobo, Aragua, 
Bolivarian Republic of Venezuela, 4Universidad de Cartagena - SUE Caribe, 
Cartagena, Colombia
Arboviruses are a leading cause of emerging and re-emerging diseases 
around the world. Members of the Alphavirus, Flavivirus, and Bunyavirus 
genera are primarily responsible for causing disease in humans, with 
infections ranging from asymptomatic to mild symptomatic, and 
can sometimes turn severe. Because many arboviral infections cause 
mild, undifferentiated symptoms, illnesses are often undiagnosed or 
misdiagnosed, especially in Dengue-endemic regions, often leading to 
improper estimations of disease incidence rates. In addition, diagnostic 
testing may be attempted post-acute phase after viral clearance, often 
limiting detection of past infection to serological-based assays only. 
Unfortunately, commercially available serological diagnostics are not readily 
available for many such diseases, and antibody cross-reactivity with related, 
non-etiologic agents may occur, leading to misdiagnosis. To gain a better 
understanding of disease prevalence, particularly in resource-limited areas, 
a detection platform with high specificity is needed to cover a wide range 
of endemic and emerging diseases. Towards this goal, we have developed 
a multiplexed alphavirus protein microarray to perform serological-based 
assays to identify specific viral exposures. The protein microarray contains 
three purified, recombinant structural proteins from multiple arthrogenic 
or encephalitic alphaviruses, including Chikungunya virus (CHIKV), Mayaro 
virus (MAYV), and Venezuelan Equine Encephalitis virus (VEEV). To detect 
specific antibody binding to alphaviral antigens, convalescent sera from 
patients in South America with PCR-confirmed alphavirus exposures were 
tested for antibody binding to antigens in the protein microarrays. In 
particular, IgG in early convalescent sera from patients with MAYV, VEEV or 
CHIKV infections were tested for specific antigen binding. We determined 
that by using purified alphavirus proteins, we were able to detect IgG 
binding to one or more specific viral antigens, with minimal cross-reactivity 
occurring with viral antigens with high levels of sequence homology.
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ALTERING BLOOD BRAIN BARRIER PERMEABILITY: HOW 
ROUTE OF INFECTION, CYTOKINE INDUCTION AND HEPARAN 
SULFATE BINDING CONTRIBUTE DURING ENCEPHALITIC 
ALPHAVIRUS INFECTIONS
Christina L. Gardner, Alan M. Watson, Chengqun Sun, Amy L. 
Hartman, Douglas S. Reed, William B. Klimstra
University of Pittsburgh, Pittsburgh, PA, United States
Alphaviruses are arthropod-borne, enveloped viruses that contain a 
single-stranded, positive-sense RNA genome. Alphaviruses are generally 
categorized into two categories based on geographic location and disease 
manifestations: old world alphaviruses mainly cause febrile/arthritogenic 
disease while new world alphaviruses can cause encephalitis. Encephalitic 
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alphaviruses have a range of morbidity and mortality in humans with the 
most virulent causing ~40% mortality, while all can cause permanent 
neurological sequelae. There are currently no licensed vaccines or antiviral 
therapies, therefore it is important to understand how the encephalitic 
viruses enter the central nervous system (CNS) and alter the blood brain 
barrier (BBB) so that therapeutic strategies can be designed to target 
these events. Our initial hypothesis, based on previous studies, was that 
an initial early opening of the BBB occurs, presumably due to cytokine 
induction, allowing the virus to gain entry into the CNS, and then a later 
opening of BBB occurs due to viral replication within the CNS. Our goal is 
to determine if route of exposure (subcutaneous vs aerosol) and the ability 
to bind heparan sulfate (HS) alters entry into the CNS and permeability 
of the BBB. Using fluorescently labeled molecules of different molecular 
weights, our data suggest that there is an initial opening of the BBB for 
lower molecular weight molecules, likely due to cytokine induction, but 
it may not be large enough for the alphaviruses to enter into the CNS. 
Additionally, the opening of the BBB to larger particles, of similar size to a 
virion, does not occur until late in infection. Interestingly, route of infection 
can play a role in the ability of certain encephalitic alphavirus to cause 
leakage of the BBB to small molecules, but not for all the encephalitic 
alphaviruses and this may be greatly influenced by the ability to naturally 
bind HS. Taken together, our data suggest that encephalitic alphaviruses 
do not alter the permeability of the BBB to gain entry into the CNS, 
however route of infection, innate immune responses and bind HS binding 
impact the ability each virus to induce BBB permeability.
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COMPREHENSIVE MUTAGENESIS OF DENGUE VIRUS 
ENVELOPE PROTEINS TO MAP ANTIBODY EPITOPES AND 
IDENTIFY RESIDES ESSENTIAL FOR FUNCTION
Benjamin J. Doranz
Integral Molecular, Inc., Philadelphia, PA, United States
To characterize the immune response to dengue virus (DENV) infection, 
we have developed a high-throughput strategy that enables the rapid 
identification of both linear and conformational epitopes on DENV 
prM/E envelope proteins from all four DENV serotypes. For each DENV 
serotype (1-4), we used Shotgun Mutagenesis technology to create a 
comprehensive library of single mutations in DENV prM/E, 3,380 mutations 
in total. Each library of individual mutant expression plasmids was arrayed 
into 384 well plates and transfected into human cells to achieve native 
protein expression and folding. The immunoreactivity of MAbs to the 
prM/E variant in each individual well was quantified by high-throughput 
flow cytometry, resulting in approximately 200 MAb epitopes. The 
epitopes obtained have been correlated with their abilities to protect 
against DENV infection. We have also produced DENV virions from all four 
mutation libraries using a previously developed DENV reporter virus particle 
(RVP) system, allowing us to screen each individual DENV Env variant 
protein for DENV particle budding and infectivity. For DENV3, analyses of 
budding and infectivity, along with the MAb binding studies, identified 
residues whose mutation eliminated virus infectivity, but did not impact 
E protein expression, antigenicity, virion assembly, or particle budding. 
We identified variants that showed increased DENV virion budding, up to 
5-fold above wild-type, indicating the ability to engineer highly expressed, 
non-infectious DENV variants that can be used for vaccine design. Our 
research has identified neutralizing epitopes in DENV prM/E and specific 
sites that are critical for DENV infectivity, providing new targets and 
opportunities for vaccine development.
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THE CLINICAL OVERLAP OF SEVERE DENGUE CATEGORIES
Thomas Jaenisch1, Kerstin Rosenberger1, Neal Alexander2, Eric 
Martinez3, Lucy Lum Chai See4, Thomas Junghanss1, Bridget Wills5
1Heidelberg University Hospital, Heidelberg, Germany, 2London School 
of Hygiene & Tropical Medicine, London, United Kingdom, 3Pedro Kouri 
Institute, Havana, Cuba, 4University of Malaya, Kuala Lumpur, Malaysia, 
5Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam
The WHO (2009) classification has the following three categories of severe 
dengue i) dengue shock / respiratory distress with fluid accumulation 
(vascular leakage), ii) severe bleeding, and iii) severe organ manifestation. 
The prospective multicentre DENCO study provides one of the largest 
datasets of hospitalised dengue patients from 7 Countries in Asia and 
Latin America (N=1734). All patients were followed daily throughout the 
evolution of their illness by trained physicians using a single comprehensive 
case report form. Here we analyse the frequency and overlap between 
these categories in 271 confirmed severe dengue patients. The overall 
proportion and categories of severe disease did not differ significantly 
between Asia and Latin America, but between age groups. Severe dengue 
occurred in 17.3% of children (< 15 years) compared to 12.9% of adults 
(≥ 15 years). Within the severe children, 94.0% were diagnosed with 
vascular leakage and 12.0% with severe bleeding, whereas in severe 
adults 81.6% had vascular leakage and 19.5% severe bleeding. The 
trajectories of the platelet counts between patients with severe bleeding 
and severe vascular leakage diverged at day of illness 3 with significantly 
lower platelet counts in patients with severe bleeding on days 5 and 
6. Severe vascular leakage occurred in 244 patients (90% of all severe 
patients), of whom 213 (87%) did not experience severe bleeding or 
severe organ dysfunction, 210 were diagnosed with clinical shock, 79 
with fluid accumulation with respiratory distress, and 45 with both clinical 
shock and fluid accumulation with respiratory distress over the course of 
the illness. Severe bleeding and severe organ dysfunction accounted for 
39 and 28 cases respectively, of whom 12 (31%; severe bleeding) and 14 
(50%; severe organ dysfunction) did not overlap with the other categories. 
Thus, the majority of the vascular leakage cases and 30-50% of the cases 
with severe bleeding or severe organ manifestations were classified as 
severe in only one category, highlighting the usefulness of these categories 
and their potential as research endpoints.
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A PHASE 1 EVALUATION OF THE SAFETY AND 
IMMUNOGENICITY OF RDEN3Δ30 AS A DENGUE 3 HUMAN 
CHALLENGE STRAIN
Kristen K. Pierce1, Steve S. Whitehead2, Beth D. Kirkpatrick1, 
Marya Carmolli1, Cecilia Tibery3, Yolanda Eby3, Cathy Larsson1, 
Palmtama Grier3, Eve Ostrowski3, Anna P. Durbin3
1University of Vermont College of Medicine, Burlington, VT, United 
States, 2National Institutes of Health, Bethesda, MD, United States, 3Johns 
Hopkins Bloomberg School of Public Health, Baltimore, MD, United States
As human experimental medicine models become important in the 
testing of candidate dengue vaccines, we developed a Dengue 3 model. 
DENV-3 Sleman/78, isolated from central Java, and was associated with a 
clinical illness milder than from other circulating DEN3 strains. To attempt 
to further attenuate the strain for possible use as a candidate DENV-3 
vaccine, 30 nucleotides were removed from the 3´ untranslated region 
and the virus was designated rDEN3Δ30. During pre-clinical testing of 
this virus in rhesus macaques, rDEN3Δ30 was indistinguishable from 
the DEN3 Slemen/78 wild type parent virus; there was no difference in 
mean peak titer of virus or number of days of viremia. For this reason, 
rDEN3Δ30 was evaluated as a potential DENV-3 challenge virus in a 
dengue human infection model. We describe the clinical manifestations 
and viremia associated with this DENV strain in healthy human subjects, 
and its future role as part of DENV challenge studies.14 subjects were 
enrolled;10 subjects received 103 PFU of DENV3 vaccine and 4 received 
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placebo. Viremia and safety labs were measured at Days 2,4,6,8,10,12 
and 16. Subjects were followed for evidence of illness or fever alternating 
days (QOD) in clinic or by phone. The most common side effects headache 
and fatigue were the same in rDEN3Δ30 recipients and placebos. 80% of 
rDEN3Δ30 recipients developed a transient Dengue-like rash and 100% 
had rDEN3Δ30 recovered from the blood; no subject had fever. The major 
lab findings in vaccines were mild thrombocytopenia (n=2) and one mild 
Neutropenia. No SAEs were reported. This was first time rDEN3Δ30 was 
administered to healthy human volunteers. No volunteer developed fever 
or dengue like illness. Overall, the strain appeared well-tolerated with 
the exception of mild- moderate transient rash in 80% of vaccines. The 
virus was recovered from 100% of treated subjects. The high incidence 
of viremia and rash induced by this virus supports its use in dengue 
human infections studies. Previous studies have demonstrated the LATV 
formulation prevents against infection with DEN2 challenge. The results of 
this phase 1 study will provide a foundation for future challenge studies.
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ANALYSIS OF THE CURRENT MAJOR DENGUE OUTBREAK 
IN ARGENTINA IN AN AREA WITH PERMANENT CONTROL 
ACTIVITIES AGAINST AEDES AEGYPTI SINCE 2009
Manuel O. Espinosa, Andrea Gómez-Bravo, Marcelo C. Abril
Fundación Mundo Sano, CABA, Argentina
The city of Tartagal (Salta Province) is located in the northeast of 
Argentina, 100 km north of the Tropic of Capricorn and 50 km south of 
Bolivia. It has a population of 69,225 inhabitants and 18,052 households. 
Mundo Sano has a Surveillance and Vector Control Program for Aedes 
aegypti in place since October 2009 in collaboration with the Municipality 
of Tartagal with the objective of diminishing the incidence of dengue 
cases in the locality. Until epidemiological week (Epi week) 14 of 2016, 
the quantity of dengue infected people registered in Argentina reached 
55,431 (2,909 from Salta), with circulation of both DEN1 and DEN4 
serotypes. In Tartagal, the number of infected people until the same Epi 
Week was 106. The last major epidemic in Argentina occurred in during 
2008/2009, where Tartagal presented 665 cases, including the first death 
by severe dengue reported in in the country. The actions included in the 
program for integrated control of Aedes aegypti and the eco-epidemiology 
of dengue in Tartagal are the following: a) Focal Cycles (during the 
Summer Season), b) Entomological monitoring (throughout the entire 
year), c) evaluation of the gonadotrophic activity through the use of 
ovitraps (throughout the entire year), d) environmental manipulation to 
remove breeding sites (previous to the Summer Season), e) organization 
and development of focal blocking activities (in coordination with the 
J.D. Perón Hospital from the city of Tartagal), e) capture of adults for the 
detection of viral infection and f) evaluation of insecticide resistance in 
Ae. aegypti populations in the city. The objective of the present study is 
to show the importance of a permanent Surveillance and Vector Control 
Program, with planned activities, continued and uninterrupted, in order to 
reduce the abundance of Ae. aegypti through the control of larval stages 
and their breeding sites, especially during outbreaks of dengue and other 
arboviruses transmitted by Ae. aegypti.
1349
DISSECTING ANTIBODY RESPONSE INDUCED BY CHIMERIC 
YELLOW FEVER-DENGUE, LIVE-ATTENUATED, TETRAVALENT 
DENGUE VACCINE (CYD-TDV) TO UNDERSTAND VACCINE 
EFFICACY IN NAÏVE AND DENGUE EXPOSED INDIVIDUALS
Sandra Henein, Matthew Bonaparte, Ralph Baric, Ar Jesica 
Swanstrom, Tony Byers, Janice Moser, Bruno Guy
University of North Carolina at Chapel Hill, Chapel Hill, NC, United States
Dengue vaccine development is complicated by the presence of 4 virus 
serotypes. Sanofi Pasteur has developed a chimeric yellow fever-dengue, 
live-attenuated, tetravalent dengue vaccine (CYD-TDV) that is approved 
for use in children >9 years of age in several countries. In two large scale 
phase III efficacy trials, CYD-TDV was efficacious at reducing laboratory-
confirmed dengue cases. Efficacy varied by serotype, in addition to 
being higher in DENV exposed than in DENV-naïve participants. While 
these results are encouraging, they highlight the complexity of human 
immune response to vaccination, which is often not balanced across the 4 
serotypes and is influenced by prior immune status of vaccinees. Our study 
compare the properties of DENV-specific antibodies in naïve and DENV 
exposed individuals who received three doses of CYD-TDV. Our results, 
which demonstrate differences in the quality of neutralizing antibodies 
depending on virus serotype and pre-vaccination immune status, provide 
better understanding of the efficacy data from dengue vaccine trials. 
Samples from DENV naïve subjects at baseline were analyzed, and DENV 
neutralizing antibodies induced by CYD-TDV were measured. There was 
considerable variability in the levels of neutralizing antibodies to the 
different serotypes, where the mean levels to serotype 2 and 4 were 
higher than 1 and 3. Further analysis showed that the majority of these 
antibodies were cross-reactive (CR) with the exception being DENV4 
which was mostly type-specific (TS) antibodies. Samples from pre-immune 
vaccinees, at one month post the final dose were similarly analyzed. Data 
shows that the neutralizing antibody titers are higher compared to the 
naïve recipients. The majority of these neutralizing antibodies are CR, with 
the highest titers to DENV1, 2 and 3. In contrast to the other serotypes 
DENV4 neutralizing antibodies in pre-immune individuals were at similar 
levels as the naïve vaccinees and mostly CR. Our depletion studies showed 
that CYD-TDV boosts CR antibodies in pre-immune individuals, while 
maintaining the proportion of TS antibodies the subject developed after 
natural DENV infection.
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SAFETY AND IMMUNOGENICITY OF AN AS03B-ADJUVANTED 
DENGUE PURIFIED INACTIVATED VACCINE ADMINISTERED 
ON THREE SCHEDULES TO HEALTHY U.S. ADULTS
Leyi Lin1, Kirsten E. Lyke2, Richard G. Jarman1, Kenneth H. 
Eckels1, Edith Lepine3, Alix Collard4, Monica A. McArthur2, Paul 
Keiser1, Rafael De La Barrera1, Bruce L. Innis3, Stephen J. Thomas1, 
Alexander C. Schmidt4
1Walter Reed Army Institute of Research, Silver Spring, MD, United States, 
2Institute for Global Health, Center for Vaccine Development, University 
of Maryland, Baltimore, MD, United States, 3GlaxoSmithKline Vaccines, 
Rockville, MD, United States, 4GlaxoSmithKline Vaccines, Rixensart, 
Belgium
The number of vaccine doses and their intervals influence a vaccine’s 
immunogenicity. We evaluated the safety and immunogenicity of a 
candidate AS03B-adjuvanted tetravalent dengue purified inactivated 
vaccine (DPIV) administered intramuscularly in a 0.5mL volume on 3 
schedules to healthy, adult subjects 20-49 years of age in a phase 1/2, 
randomized, observer-blind study (NCT02421367). One hundred forty 
subjects were randomized to receive either 2 doses of DPIV (1µg per 
serotype) 1 month apart (N=35) or 3 months apart (N=70), or 3 doses 
of DPIV at 0, 1 and 6 months (N=35). Primary study objectives were i) to 
evaluate the safety and reactogenicity of DPIV+AS03B from Day 0 to Day 
28 following each dose, ii) to demonstrate the added value of a third, 
booster dose at Month 6, based on humoral immunogenicity, and iii) to 
demonstrate the benefit of a longer interval between doses. Humoral 
immunogenicity was measured using a microneutralization (MN50) assay. 
The primary immunogenicity endpoints were MN50 titers to each DENV 
serotype for sera collected prior to Dose 1 and 28 days after the second 
and third dose. Primary reactogenicity and safety endpoints included the 
occurrence, intensity, and relationship to vaccination of solicited injection 
site and general adverse events (AEs) for Days 0-6 after each dose and 
for unsolicited AEs for Days 0-27 after each dose. Grade 2 and Grade 3 
laboratory abnormalities were determined at Days 0 and 7 after each dose. 
Occurrence of potential immune-mediated diseases (pIMDs), medically 
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attended AEs, and serious adverse events (SAEs) were reported from Day 0 
through Day 28 after the last dose (Month 7 Visit). The results generated 
in this ongoing clinical trial and their clinical implication will be presented.
1351
STOCHASTIC SPREAD OF WOLBACHIA THROUGH AEDES 
AEGYPTI POPULATIONS IN SPATIALLY HETEROGENEOUS 
LANDSCAPES
Gemma Nedjati-Gilani, Lorenzo Cattarino, Neil M. Ferguson
Imperial College London, London, United Kingdom
Infection with Wolbachia bacteria suppresses Aedes aegypti populations 
and reduces their competence as a vector for dengue. Because Wolbachia-
infected mosquitoes have a reproductive advantage over their wild 
type counterparts, widespread introduction of Wolbachia into wild Ae. 
aegypti populations is considered an efficient, long term control measure 
for dengue. However, the success of this strategy depends on whether 
Wolbachia can spread spatially through the mosquito population from a 
small number of initial releases. In particular, variations in habitat may slow 
or halt the spread. Using a two-dimensional, stochastic metapopulation 
model which incorporates the full dynamics of the mosquito life cycle, we 
investigate how spatial heterogeneities in habitat affect the likelihood and 
speed of Wolbachia spread. We generate clustered landscapes containing 
both good and bad habitat. Landscapes are classified according to the 
proportion of good habitat they contain and how clustered together good 
habitat is. We also consider landscapes in which good and bad habitat 
are randomly interspersed. For each landscape we simulate the release of 
Wolbachia mosquitoes multiple times. Overall we find that for random 
landscapes the speed of spread is independent of the amount of good 
habitat. For clustered landscapes, the speed of spread is high when the 
amount of good habitat is either very low or very high, but decreases 
for intermediate values. This reduction in speed is more prominent 
for highly clustered landscapes. However, the likelihood and speed of 
spread also depends on habitat quality in the release patch; in highly 
clustered landscapes with a high proportion of good landscape, released 
Wolbachia-infected mosquitoes will fail to invade if they are released in 
an island of low quality habitat. These results highlight the importance of 
understanding and accounting for habitat diversity when modelling and 
planning for large scale Wolbachia releases as a dengue control measure.
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EXPLORING THE ROLE OF ASTHMA IN DENGUE PATIENTS
Johanna Vélez1, Nicole Rodríguez1, Ernesto Santini1, Mariana 
Tavárez1, Vylma Velázquez1, Luzeida Vargas1, Janice Pérez2, Luisa 
Alvarado1
1Hospital Episcopal San Lucas/Ponce Health Sciences University School of 
Medicine, Ponce, Puerto Rico, 2Dengue Branch, Division of Vector-Borne 
Diseases, Centers for Disease Control and Prevention, San Juan, Puerto 
Rico
Dengue is a self-limited, systemic viral infection transmitted by mosquitoes 
that has a wide spectrum of clinical presentations, ranging from 
undifferentiated fever to severe dengue. Severe dengue can lead to serious 
complications and death, but if identified early morbidity and mortality 
can be reduced. Since epidemiologic studies had associated asthma with 
severe dengue, our study aims to describe demographic characteristics 
and clinical manifestations of laboratory confirmed dengue cases with 
past medical history of asthma. Data was collected from patients enrolled 
in the Sentinel Enhanced Dengue Surveillance System (SEDSS) established 
in St. Luke’s Episcopal Hospitals in Ponce and Guayama, Puerto Rico from 
May 7, 2012 to May 6, 2015. We will compare asthmatic cases with 
acute, intermittent and persistent disease to determine their risk for severe 
dengue. SEDSS collects clinical and demographic data and specimens for 
testing with RT-PCR and immunodiagnostic methods as appropriate for 
21 pathogens that cause acute febrile illness, including DENV. Of 1,691 
enrolled patients with history of asthma, 169 had laboratory confirmed 
dengue. half (50.9%) of which were male ;and median age was 14.0 
years (range: 1 - 73). One hundred thirty nine (77.5%) were patients 
under 19 years. Seventy nine cases (46.7%) were admitted to the hospital, 
of which 55.7% were between 10-19 years. One case was transferred 
to another institution (0.6%) and no deaths were reported. The most 
common symptoms upon presentation were headache (148, 88.1%), 
fever (126, 76.4%), muscle pain (114, 68.7%), facial flush (100, 59%) 
and rash (81, 50.3%). Other co-morbidities of asthmatic cases were 
diabetes (14, 8.3% and hypertension (13, 7.7%). Patients with a history of 
asthma and laboratory confirmed dengue had similar symptoms as dengue 
cases described in the medical literature. Admission rates were high for 
this group, therefore further analysis is being conducted to characterize 
and compare asthma severity among patients enrolled in SEDSS who 
developed severe dengue during their clinical course.
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ESTIMATION OF THE MAGNITUDE OF DENGUE INCIDENCE 
UNDERREPORTING THROUGH A MODELLING WITH DISMOD 
II SOFTWARE
Esteban Puentes-Rosas1, Elsa Sarti1, Hector Gomez-Dantes2, 
Leon Ochiai3
1Sanofi Pasteur, Ciudad de México, Mexico, 2Instituto Nacional de Salud 
Publica, Cuernavaca, Mexico, 3Sanofi Pasteur, Lyon, France
National surveillance systems have as a main goal to provide information 
on imminent threats to public health and to help in the monitoring of 
priority diseases. However, it is not uncommon to use figures coming from 
surveillance systems as proxies of real incidence rates. Surveillance data 
usually underestimates the real incidence, either because some patients 
might not look for care, or because symptoms may lead to misdiagnosis, 
as well as other organizational reasons influencing quality of report. In 
the specific case of dengue surveillance, the underreporting is linked to 
the high frequency of mild cases and the difficulty for some physicians to 
recognize the disease. The magnitude of the underreporting is a matter of 
concern, since the adequate gauge of the economic and sanitary burden 
of this disease, as well as the solid assessment of control measures, require 
robust data. Consequently, several approaches have been used to correct 
this issue and to obtain a better proxy of real dengue incidence. We used 
an IPM (incidence, prevalence, mortality) model to adjust dengue incidence 
estimates in order to have a better perspective of dengue epidemiology 
in Mexico. We used data correspondent to Yucatan, an endemic Mexican 
State located at the east of the country. To obtain our model, we used 
the DISMOD II software, developed by WHO in collaboration with 
Erasmus University at Rotterdam, in Netherlands. The inputs were dengue 
seroprevalence data of 2015, and official incidence and dengue specific 
mortality of the period 2010-2014. We assumed that all people infected 
by dengue virus stay seropositive for the rest of their life. Our results show 
that the real magnitude of dengue incidence is 6 times higher than the 
officially reported, reaching a rate of 1330 cases per 100,000 inhabitants. 
As an additional positive feature, this model allows to associate specific 
levels of incidence with predicted seroprevalence levels. We conclude that 
the use of DISMOD II and the IPM models in general, are useful to answer 
questions related to the internal consistency of epidemiology variables 
or to solve the lack of some parameter in order to understand dengue 
epidemiology.
1354
CHANGING CLIMATE AND TRAVEL ACTIVITY MIGHT 
EXACERBATE DENGUE TRANSMISSION IN TAIWAN
Ting-Wu Chuang, Bo-Jiang Chen, Ka-Chon Ng
Taipei Medical University, Taipei, Taiwan
Southern Taiwan has been a hotspot of Dengue Fever (DF) transmission 
since 1998. The incidence of dengue fever in Taiwan shows strong 
seasonality. Mosquito ecology and the transmission of dengue fever 
are influenced by multiple environmental factors, especially for climate 
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variations. Thus, interannual variability in climatic conditions could 
be important drivers for annual outbreaks. Taiwan has experienced 
tremendous dengue outbreaks in 2014 and 2015. Whether the sharp 
increase of dengue cases was due to recently climate changes or other 
factors should be investigated carefully. This study explored the spatial 
patterns of dengue outbreaks in Tainan and Kaohsiung City in Southern 
Taiwan throughout 1998 to 2015. Multiple climatic indices generated from 
weather stations and satellite remote sensing images at these two study 
regions were used to develop models to evaluate the impacts of changing 
climate on dengue transmission. Two strategies have been applied in the 
analysis. (1) Distributed lag non-linear model (DLNM) has been used to 
capture the lag effects of local climatic parameters. (2) Regional El Niño 
Southern Oscillation (ENSO) and Indian Ocean Dipole (IOD) effects have 
been evaluated by wavelet analysis. Travel statistics has been acquired to 
analyze the increasing patterns and their countries or origin. The Inter-
annual variability of dengue outbreaks is obvious and the large-scale 
outbreaks might be related to a 4-year interval, however, the periodicity 
has been reduced after 2006. The results of DLNM have highlighted the 
important short effects of temperature and rainfall. However, ENSO and 
IOD have demonstrated different coherency patterns in the whole study 
period and partially explained the significant outbreaks in 2014 and 2015. 
Non-climatic factors, including the gas pipeline explosion in 2014 and 
increasing trends of tourists from endemic regions might play certain roles. 
Our study has revealed that dengue transmission might become more 
complicated due to the interaction between climate changes and human 
activity.
1355
SEROTYPE-SPECIFIC CHARACTERISTICS OF THE 
NEUTRALIZING ANTIBODY RESPONSE TO THE SANOFI 
PASTEUR DENGUE VACCINE IN PHASE III EFFICACY TRIALS
Anthony M. Byers1, Shanti Ross1, S. Farzana Shaik1, Michael 
Peredelchuk1, Charlotte Vernhes1, Aymeric de Montfort2, Robert 
Small1, Matthew Bonaparte3, Aravinda de Silva4, Janice M. Moser1, 
Bruno Guy5
1Sanofi Pasteur, Orlando, FL, United States, 2Sanofi Pasteur, Marcy L’ Etoile, 
France, 3Sanofi Pasteur, Swiftwater, PA, United States, 4University of North 
Carolina, Chapel Hill, NC, United States, 5Sanofi Pasteur, Lyon, France
Two Phase III efficacy trials (NCT01373281 and NCT01374516) of Sanofi 
Pasteur’s tetravalent dengue vaccine (CYD-TDV) were conducted in dengue 
endemic areas of Asia-Pacific and Latin America, with subjects between 
the ages of 2 and 14 and between the ages of 9 and 16, respectively. 
The vaccine was administered in 3 doses: baseline, month 6, and month 
12. The primary per-protocol analysis of vaccine efficacy was assessed 
for 12 months from 28 days after the third dose with hospital phase 
safety outcomes followed for 4 years beginning in month 25. The goal 
of this study is to assess characteristics of the anti-dengue neutralizing 
antibody (nAb) response generated in subjects in the vaccine efficacy 
studies outlined above. We employed a bead-based virus-depletion 
approach combined with a flow cytometry-based neutralization assay 
using U937 DC-SIGN, a known receptor for dengue virus attachment, 
cells to qualitatively assess whether the serum nAbs to each of the 4 
dengue serotypes from these subjects were homotypic and/or heterotypic 
(cross-reactive). Employment of this method on post-dose 3 (PD3) samples 
from a clinical trial in a non-dengue-endemic region (NCT01134263) 
demonstrated that nAb responses to DENV1, DENV2, and DENV3 were 
primarily heterotypic while the responses to DENV4 were primarily 
homotypic. In endemic populations, vaccination has triggered a stronger 
and broadly cross-reactive neutralizing Ab response. Additional analysis of 
dengue-endemic sera from PD3 CYD-vaccinated or placebo subjects that 
subsequently developed a dengue case requiring hospitalization during 
the monitoring phase for serotype-specific homotypic and heterotypic 
nAbs. These nAb profiles of these samples were compared with age- 
and center-matched controls that did not acquire a hospitalized dengue 
case to determine whether the homotypic and heterotypic profile of the 
dengue-specific antibody responses in CYD-TDV-vaccinated and placebo-
vaccinated individuals affects the likelihood of an individual acquiring a 
hospitalized/severe case of dengue.
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USE OF A BIOLAYER INTERFEROMETRY-BASED ASSAY TO 
DETERMINE ANTIBODY AFFINITY TO DENV FOLLOWING 
IMMUNIZATION WITH THE SANOFI PASTEUR DENGUE 
VACCINE IN PHASE II AND PHASE III CLINICAL TRIALS
Alina Munteanu1, Alexander Karol1, Aymeric de Montfort2, 
Matthew Bonaparte3, Bruno Guy2, Janice Moser1
1Sanofi Pasteur, VaxDesign Campus, Orlando, FL, United States, 2Sanofi 
Pasteur, Lyon, France, 3Sanofi Pasteur, Swiftwater, PA, United States
The goal of this study was to measure the affinity of the Sanofi Pasteur 
dengue vaccine-induced antibodies to each of the four serotypes, to help 
assess the role in protection of the quality of the antibodies induced by 
vaccination. A biolayer interferometry-based assay was developed using 
Octet RED384 (ForteBio) to determine dengue-specific antibody affinity 
and concentration. The method was developed and optimized using sera 
from naturally-infected dengue-experienced donors. An initial proof of 
concept study analyzed sera from adults in a phase II trial (NCT00740155) 
in a dengue non-endemic area which compared affinity changes after 
the first and second doses of Sanofi Pasteur’s tetravalent dengue vaccine 
(CYD-TDV). In a second step, we used sera from the CYD14 and CYD15 
phase III clinical efficacy trials (NCT01373281 and NCT01374516, 
respectively). The trials were conducted in dengue endemic regions in 
children between 2 and 14 years of age (CYD14, in Asia-Pacific), and 
9 and 16 years of age (CYD15, in Latin America). Vaccine efficacy was 
assessed during an initial 25 month active phase, after which a 4-year 
follow-up safety study is still ongoing, called long-term follow-up (LTFU) 
hospital phase. Post-dose 3 sera samples from the active phase were 
selected from subjects that developed a confirmed dengue case that 
required hospitalization during the LTFU surveillance phase along with 
age and site-matched controls who did not have a confirmed dengue 
case. The difference in antibody concentration and affinity for vaccinated 
individuals versus placebo-treated subjects was assessed, in addition to 
comparing the antibody levels and binding strength between hospitalized 
and non-hospitalized subjects, and <9 and ≥9 year old age groups. This 
investigation could contribute to determining the role of antibody quality, 
including affinity, for protection from dengue virus infection.
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ENHANCED DENGUE SENTINEL SURVEILLANCE IN 
METROPOLITAN SRI LANKA: 2012 TO 2015
Hasitha Tissera1, Sunethra Gunasena2, Dharshan De Silva3, 
October Sessions4, Paba Palihawadana1, Ananda Amarasinghe1, 
Jayantha Weeraman1, Oshane Chandrasoma1, Yee Leong5, 
Wolfgang Lohr6, Peter Byass6, Annellies Wilder-Smith5, Duane 
Gubler4
1Epidemiology Unit Ministry of Health Sri Lanka, Colombo, Sri Lanka, 
2Medical Research Insitute Ministry of Health, Colombo, Sri Lanka, 
3Genetech Research Insitute, Colombo, Sri Lanka, 4Duke-NUS Graduate 
Medical School, Singapore, Singapore, 5Lee Kong Chian School of 
Medicine - Nanyang Technological University, Singapore, Singapore, 
6Umea University, Umea, Sweden
Dengue poses significant disease burden in Sri Lanka. Geographic spread, 
incidence and severity has increased since the first reported dengue 
hemorrhagic fever (DHF) epidemic in 1989. Nationwide routine disease 
surveillance established two decades ago is based on clinical diagnosis, 
with infrequent laboratory confirmation. To obtain robust disease burden 
data, a laboratory based enhanced sentinel surveillance was established 
in metropolitan Colombo. Here we present study design and results 
of three years. Three tertiary government hospitals and 3 outpatient 
clinics were selected. Following informed consent patients presenting 
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with acute undifferentiated fever were enrolled. Blood samples were 
collected and tested for dengue-specific PCR, NS1, and IgM-ELISA at first 
presentation. Sub-set of samples were sent to Duke-NUS Singapore for 
quality assurance, virus isolation and serotyping. Total of 5,436 patients 
were enrolled from April 2012 to March 2015 with 2,058 (37.5%) as 
outpatients and 3,389(62.3%) as inpatients. Mean age was 20.4 years 
(range 1moth to 90years). Mean duration of illness at first presentation 
was 4 days. For inpatients and outpatients, 2,851(78.5%) and 471 
(22.9%) had laboratory-confirmed dengue respectively. Mean duration of 
hospitalization was 4 days. Proportion of DHF in lab-confirmed hospitalized 
dengue cases was 20.8% and 5(0.26%) died. Serotypes 1 (86.5%) and 4 
(13.5%) were the only viruses detected. Clinicians’ diagnosis of dengue at 
the time of first presentation had a sensitivity of 95.7% and specificity of 
46.1%. Dengue infection was responsible for high proportion of febrile 
illnesses during the study period, with co-circulation of serotypes 1 and 
4. One fourth of hospitalized dengue cases in Colombo developed DHF, 
but the case fatality rate was low. Clinicians’ judgement was associated 
with good sensitivity, but to enhance specificity laboratory confirmation is 
important.
1358
GENETIC VARIABILITY OF DENGUE VIRUS TYPE 2 AND 
CLINICAL OUTCOME DURING THE 2009-2010 EPIDEMIC OF 
DENGUE IN COLOMBIA
Margarita Gelvez1, Jorge Andres Castillo2, Francisco Javier Díaz3, 
Victor Mauricio Herrera1, Luis Angel Villar1
1Centro de Investigaciones Epidemiológicas, Universidad Industrial 
de Santander, Bucaramanga, Colombia-Red AEDES: Abordando 
el Dengue y otras Arbovirosis en áreas endémicas para disminuir 
su impacto en la sociedad, Bucaramanga, Colombia, 2Grupo de 
Inmunovirologia, Universidad de Antioquia, Medellín, Colombia, 3Grupo 
de Inmunovirologia, Universidad de Antioquia-Red AEDES: Abordando el 
Dengue y otras Arbovirosis en áreas endémicas para disminuir su impacto 
en la sociedad, Medellín, Colombia
The pathogenesis of the severe outcome in dengue is the result of multiple 
factors attributed to both, the host and the virus. The aim of this study 
was to determine the serotype associated with severity and the variation 
within NS4B and E genes among strains of DENV-2 isolated from patients 
with different outcomes in Colombia. Severe cases were defined according 
to a compound outcome (hypotension or bleeding) in the baseline 
or follow-up. The serotype was determined by RT-PCR. Phylogenetic 
reconstruction was performed by the Maximum Likelihood method. Single 
nucleotide polymorphisms (SNPs) were identified using MEGA v6.06. One 
hundred ninety eight patients were evaluated at baseline and follow-up. 
Serotype distribution was heterogeneous across outcomes with DENV-2 
being predominant in complicated patients (OR 6.06, 95% CI: 2.10, 17.5). 
The type of infection (primary vs. secondary) was not associated with the 
presence of the compound outcome (OR 1.58, 95% CI 0.83, 3.00). In 
54 DENV-2 sequences three distinct lineages within the Asian-American 
genotype were identified. Neither lineages nor NS4B or E polymorphisms 
were associated with clinical outcome; they rather were associated with 
the place of residence. In summary, the DENV-2 serotype was associated 
with the development of severe forms of the disease but no SNP in NS4B 
or E genes was identified as associated with severe outcomes.
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A DENGUE VIRUS TYPE 2-SPECIFIC MONOCLONAL 
ANTIBODY BINDS TO THE DENGUE VIRUS-COMPLEX-
REACTIVE ANTIGENIC SITE ON ENVELOPE PROTEIN DOMAIN 
3
Vanessa V. Sarathy1, Trevor J. Pitcher2, Gregory D. Gromowski3, 
John T. Roehrig4, Alan D. Barrett1
1Univ of Texas Medical Branch, Galveston, TX, United States, 2The Binding 
Site, San Diego, CA, United States, 3Walter Reed Army Institute of 
Research, Silver Spring, MD, United States, 4Centers for Disease Control 
and Prevention, Fort Collins, CO, United States
Dengue disease is caused by four phylogenetically and serologically-
related dengue viruses (DENV) throughout the tropics and subtropics 
worldwide. The envelope (E) protein is the major component of the 
viral surface and is structurally subdivided into three domains ED1, ED2, 
and ED3. The majority of antibodies target ED2, and ED3 elicits potent 
neutralizing antibodies. Two major DENV-2 antigenic sites were previously 
mapped to ED3: the DENV-type specific and the DENV-complex reactive 
antigenic sites, which are composed of a limited subset of residues that 
are required for monoclonal antibody (mAb) binding. In the present study, 
binding to recombinant ED3 mutants and neutralization of DENV-2 strain 
New Guinea C mutants demonstrated that the amino acid side-chains 
K307, V308, K310, I312, P332, L387, L389, and N390 are functionally 
critical for DENV-2-type-specific mAb 9A3D-8. Surprisingly, the binding 
footprint of mAb 9A3D-8 is predicted to overlap primarily with the DENV-
complex-reactive antigenic site on ED3. This unique binding site enabled 
mAb 9A3D-8 to neutralize virus infectivity at relatively low occupancy of 
virions compared to other mouse mAbs. Monoclonal antibody 9A3D-8 is 
a unique DENV-2-type-specific mAb due to its virus species specificity and 
its high neutralization potency, the DENV-complex reactive site for physical 
binding, and exhibits increased occupancy efficiency. This is a new DENV-2 
type-specific antigenic site on ED3.
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PERFORMANCE OF A RAPID TEST FOR THE DETECTION 
OF DENGUE DURING THE OUTBREAK OF ZIKA VIRUS IN 
COLOMBIA
Luis Angel Villar1, Andres Paez2, Lizeth Pardo2, Angélica Rico3, 
Francisco Javier Díaz4, Margarita Gélvez1, Victor Mauricio Herrera1
1Centro de Investigaciones Epidemiológicas, Universidad Industrial de 
Santander, Bucaramanga, Colombia-Red AEDES: Abordando el Dengue 
y otras Arbovirosis en áreas endémicas para disminuir su impacto en la 
sociedad, Bucaramanga, Colombia, 2Grupo de Virología, Instituto Nacional 
de Salud, Bogotá, Colombia-Red AEDES: Abordando el Dengue y otras 
Arbovirosis en áreas endémicas para disminuir su impacto en la sociedad, 
Bogota, Colombia, 3Grupo de Virología, Instituto Nacional de Salud, 
Bogotá, Colombia-Red AEDES: Abordando el Dengue y otras Arbovirosis 
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otras Arbovirosis en áreas endémicas para disminuir su impacto, Medellín, 
Colombia
Diagnosis of Zika virus (ZIKV) infection is done by detection of viral RNA 
(real time PCR) as serological tests have shown cross-reactivity with other 
genetically related viruses such as dengue (DENV). The aim of this study 
was to evaluate the performance of SD BIOLINE Dengue test for the 
diagnosis of DENV and to determine cross-reactivity with ZIKV in febrile 
patients. We evaluated 60 serum samples from patients with history of 
fever (less than or equal to 5 days of duration) for the detection of dengue 
NS1 antigen, IgM, and IgG antibodies. Thirty samples were randomly 
selected from participants of a dengue passive-facilitated surveillance study 
conducted in Piedecuesta, Colombia, before the introduction of ZIKV in 
the country (August to December 2014). The samples were positive for 
428
astmh.org
dengue using RT-PCR and negative for ZIKV (real time RT-PCR, CDC). 
The Laboratory of the National Health Institute of Colombia provided a 
second set of 30 samples collected after the introduction of the ZIKV in 
the country (September of 2015), which were confirmed as positive for 
this virus (real time RT-PCR, CDC) and negative for DENV (real time RT-PCR, 
CDC). All 60 samples were tested for dengue NS1 antigen, IgM, and IgG 
(SD BIOLINE dengue DUO [NS1/IgM/IgG]) by the same operator and in a 
single batch. Two trained observers independently interpreted the results. 
We estimated sensitivity and specificity (95% confidence interval; 95%CI) 
of the NS1 antigen, IgM, and IgG. The two observers fully agreed on the 
interpretation of all the tests. Twenty out of 30 samples of confirmed cases 
of DENV were positive for NS1, that is, a sensitivity of 66.7% (95%CI: 47.2 
- 82.7). There were no false positive results of the NS1 (100% specificity). 
Sensitivity of IgM and IgG was the same (3.3%, 95%CI: 0.1 - 17.2) and 
specificities were 93.3% (95% CI: 77.9 - 99.2) and 86.7% (95% CI: 69.3 
- 96.2), respectively. In this study, the rapid test SD BIOLINE showed cross-
reactivity for IgM and IgG antibodies but not for NS1. Further studies will 
test the reproducibility of our findings and control for variables such as 
viral serotype, duration of disease, type of infection and host genetics.
1361
EARLY CLINICAL INDICATORS OF DEVELOPING SEVERE 
DENGUE IDENTIFIED FROM A PROSPECTIVE ACUTE FEBRILE 
ILLNESS STUDY IN PUERTO RICO
Janice Perez-Padilla1, Brenda Torres-Velazquez1, Tyler M. Sharp1, 
Aidsa Rivera1, Eric Gonzalez2, Juan P. Torres2, Esteban Lugo2, Jose 
Vidal2, Luisa Alvarado3, Kay M. Tomashek1
1Centers for Disease Control and Prevention, San Juan, PR, United States, 
2Saint Luke’s Episcopal Hospital, Ponce, PR, United States, 3Ponce Health 
Sciences University, Ponce, PR, United States
Because dengue is a dynamic disease characterized by progression in some 
to a life-threatening disease, early identification of at-risk patients could 
enable timelier follow-up and initiation of supportive care. To identify early 
clinical features associated with severe dengue, data from a prospective 
AFI study conducted in Puerto Rico during May 7, 2012-May 6, 2015 was 
analyzed. Febrile patients presenting to the emergency department were 
enrolled and followed through their illness. Blood and nasopharyngeal 
specimens were collected and tested by RT-PCR and immunodiagnostic 
methods for dengue viruses 1-4 and 16 other pathogens. Dengue patients 
who were not severe at enrollment but later developed severe dengue 
(Cases) were compared with dengue patients who never developed 
severe dengue (Controls). Of 684 laboratory-positive dengue patients 
with complete follow-up, 174 (25%) met criteria for severe dengue, 90 
(52%) at enrollment and 84 (48%) later in their clinical course. Cases 
and controls were similar with regard to age, but cases were more likely 
to be female (62%, p = 0.003). At enrollment, cases were more likely to 
have anorexia (91% vs. 76%, p = 0.01), nausea (80% vs. 63%, p = 0.01), 
and leukopenia (87% vs. 72%, p = <0.01). Controls were more likely to 
present with rash (51% vs. 38%, p = 0.05) and hemoconcentration (37% 
vs. 17%, p = <0.01). After controlling for age and sex in logistic regression 
analysis, cases were more likely to have nausea at enrollment (OR = 2.70, 
95% CI: 1.28-4.90) and leukopenia (OR = 2.67, 95% CI: 1.34-6.58), while 
controls were more likely to have rash (OR = 0.47, 95% CI: 0.28-0.80) and 
hemoconcentration (OR = 0.39, 95% CI: 0.19-0.78). Cases were more 
likely to have history of asthma (OR = 2.33, 95% CI: 1.12-3.78). Enrolling 
febrile patients at initial presentation enabled an unbiased determination 
of early clinical predictors of severe dengue. These data suggest that 
nausea and leukopenia may be predictors of developing severe dengue. 
Clinicians should be aware that patients with asthma or those presenting 
with nausea are at increased risk for developing severe dengue after initial 
presentation.
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DECODING THE SANOFI PASTEUR DENGUE VACCINE 
INFECTIVITY AND IMMUNOGENICITY USING THE HUMAN IN 
VITRO MIMIC® SYSTEM
Ernesto Luna1, Mounir Chehtane1, Pankaj Agrawal1, Riyaz 
Mehta1, Anthony Byers1, Brian Schanen1, Bruno Guy2, Nicholas 
Jackson2, William Warren1, Janice M. Moser1
1Sanofi Pasteur, Orlando, FL, United States, 2Sanofi Pasteur, Lyon, France
Sanofi Pasteur’s licensed tetravalent dengue vaccine generates equivalent 
neutralizing titers against all 4 serotypes and pooled phase III clinical data 
in subjects over 9 years of age demonstrated conclusive, but differential 
levels of efficacy against the serotypes. To better understand the efficacy 
trial results, we studied the infectivity of the phase III lots using the innate 
arm of the MIMIC® system. The MIMIC system’s peripheral tissue construct 
was adapted to assess DC viral infectivity and viral progeny levels in the 
supernatants for each of the 4 serotypes from the CYD vaccine as well 
as DC activation and cytokine profiles. The hierarchy of response for 
infectivity and viral progeny as measured by RT-PCR and plaque assay, 
respectively, for CYD vaccines in MIMIC was CYD4>CYD3>CYD1>CYD2. 
Previous published data and current experiments show that in vitro 
infectivity studies in IL-4 and GM-CSF derived mDCs do not show any 
differences between CYD serotypes, which could be due to the high level 
of DC-SIGN expression on the cytokine-derived mDCs. We also tested 
whether the difference in infectivity was due to interference between 
vaccine serotypes by evaluating them individually as monovalents. We 
show that no competitive inference was detected among the CYD 
serotypes in the MIMIC system and showed the same infectivity hierarchy 
for the monovalent lots. We assessed the immune profile induced by the 
CYD dengue vaccine and were able to detect up-regulation of CD86, and 
secretion of CXCL10/ IP-10 which have been reported as protective innate 
signatures in dengue infections. We also show that the pro-inflammatory 
cytokines such as Macrophage Inhibitory Factor (MIF) and IL-8 are secreted 
at markedly lower levels after infection with the dengue vaccine than by 
parental DENV controls. Further studies have been initiated to investigate 
how in vitro infectivity in the MIM aligns with clinical results in endemic 
populations following vaccination. These analyses demonstrate that the 
CYD dengue vaccine induces a protective innate immune signature and 
that the MIMIC system is a valuable preclinical tool for future vaccine 
candidate evaluations.
1363
CLINICAL IMPACT OF DENGUE AND RESPIRATORY VIRUS CO-
INFECTION IN A PASSIVE SURVEILLANCE, IN THE PERUVIAN 
AMAZON, PERU
Stalin Vilcarromero1, Crystyan Siles1, Carolina Guevara1, Robert 
Hontz1, Yohani Aguilar2, Hermann Silva-Delgado3, V. Alberto 
Laguna-Torres4, Manuel Cespedes5, Brett M. Forshey6, Christopher 
N. Mores1, Julia S. Ampuero1
1U.S. Naval Medical Research Unit - 6, Lima and Iquitos, Peru, 2Hospital 
Santa Gema de Yurimaguas, Yurimaguas, Loreto, Peru, 3Direccion Regional 
de Salud (DIRESA Loreto), Iquitos, Peru, 4Ministerio de Salud (Peruvian 
Ministry of Health), Lima, Peru, 5Instituto Nacional de Salud, Lima, Peru, 
6Armed Forces Health Surveillance Center, Silver Spring, MD, United States
Dengue virus is an important cause of morbidity and mortality in 
developing countries. In the Peruvian Amazon where dengue is highly 
endemic, respiratory viruses also have significant public health impact, 
especially in the cities of Iquitos and Yurimaguas. In some periods, both 
viruses co-circulate resulting in co-infections whose clinical characteristics 
remain poorly characterized. Clinic-based passive febrile surveillance 
established by NAMRU-6 in both cities provided the opportunity to 
analyze these viral co-infections. From 2010-2014, patients with acute 
undifferentiated febrile illness and/or influenza like-illness who sought 
medical evaluation in one of the thirteen hospitals or primary health 
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care facilities, supplied clinical data and paired blood samples and/or an 
oropharyngeal swab. Acute samples were tested for dengue or respiratory 
virus by cell culture or PCR, while acute and convalescent blood samples 
were tested by ELISA for dengue IgM. Of 7,150 febrile cases, 2,145 (30%), 
597(8.3%), and 15 (0.2%) had laboratory evidence of dengue, respiratory 
virus, and co-infection, respectively. Most of the dengue infections (1616 
cases, 75%), were due to serotype 2. Of the fifteen co-infections, 8 (53%) 
were due to Influenza B, 3 (20%) to Influenza A/H1N1pdm09, 2 (13.3%) 
to Influenza A/H3N2, and 2 were unidentified subtypes of Influenza A. 
Eleven cases (73%) were detected between February and June 2014. 
Rhinorrhea, cough, and shortness of breath were associated with co-
infection in contrast to dengue alone (p < 0.05, Pearson Chi square test), 
while hospitalization rate (26.6 vs. 25.3%) and shock (0 vs. 0.1%) were 
similar in both groups (p>0.05). There were no fatal cases. Co-infections 
reported here, did not display enhanced severity compared to DENV-2 
infections. Considering that asymptomatic/non-febrile cases are reported 
for both types of infections were not included, and despite seem to be 
a temporal correlation there was not a correlation spatial circulation at 
fine-scale foci (house). A cohort study with geo-spatial analysis would be 
important for continuing this work.
1364
ROLE OF SKIN MAST CELLS IN DENGUE VIRUS INFECTION
Andrea J. Troupin, Berlin Londono-Renteria, Devon Shirley, Cody 
McHale, Alex Hall, Jerel Lee, Gregorio Gomez, Tonya M. Colpitts
University of South Carolina, Columbia, SC, United States
Dengue virus (DENV) causes the most common vector-borne viral disease 
in humans living in the tropics. Transmission of DENV occurs when a 
mosquito vector takes a blood meal from a DENV infected host. The 
DENV-containing saliva is deposited in the skin of the host during probing. 
Human skin contains many types of immune cells, including mast cells. 
Here, we show that mast cells are a target of DENV in human skin and 
that DENV infection of skin mast cells induces degranulation. Additionally, 
DENV infection of primary human skin mast cells results in altered cytokine 
and growth factor expression profiles. Importantly, we also demonstrate 
for the first time that DENV localizes within secretory granules in infected 
skin mast cells. In addition, DENV within extracellular granules was 
infectious in vitro and in vivo, trafficking through lymph to draining lymph 
nodes in mice. We demonstrate an important role for human skin mast 
cells in DENV infection and identify a novel mechanism for systemic spread 
of DENV infection from the initial peripheral mosquito injection site. 
Together, these findings demonstrate a critical previously unrecognized role 
for skin mast cells in the infection and propagation of DENV in humans.
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DENGUE VIREMIA IN KENYAN CHILDREN WITH ACUTE 
FEBRILE ILLNESS
David M. Vu1, Noah Mutai2, Claire Heath1, Bryson A. Ndenga2, A. 
Desiree LaBeaud1
1Stanford University School of Medicine, Stanford, CA, United States, 
2Centre for Global Health Research, Kenya Medical Research Institute, 
Kisumu, Kenya
Dengue virus (DENV) remains the most prevalent arboviral infection 
worldwide, causing an estimated 400 million infections per year. By 
mathematical modeling, 16% of DENV infections occur in Africa. However 
due to lack of routine surveillance programs, the burden of DENV 
infection in many African countries is largely unknown. As a part of an 
ongoing study on arboviral infection in Kenyan children, we collected 
blood samples from subjects 1 to 17 years of age who presented with 
fever of unclear etiology to one of four centers located either in western 
(Kisumu and Chulaimbo) or coastal Kenya (Ukunda and Msambweni). 
We tested the samples for the presence of DENV RNA by RT-PCR. DENV 
RNA positive samples were then serotyped by PCR. Testing is ongoing, 
however, preliminary results have identified DENV viremia more frequently 
in subjects with acute febrile illness in western vs. coastal Kenya (9.2% 
positive [75 of 814 subjects] vs. 0.9% [4 of 435 subjects], respectively, 
p<0.001). In western Kenya, all four serotypes were identified; 51 samples 
had serotype 1 (DENV-1), two had DENV-2, thirteen had DENV-3, and two 
had DENV-4. There were also subjects who had dual infection with two 
DENV serotypes: one subject with DENV-1+3, three with DENV-1+4, and 
one with DENV-2+3. Only DENV-1 was identified in samples from coastal 
Kenya. To investigate the phylogeny of the DENV strains, we performed 
exploratory next-generation sequence (NGS) on a limited subset of the 
samples. DENV-1 sequences were over-represented from blood samples 
of seven subjects from western Kenya (five from Chulaimbo, two from 
Kisumu) and mapped to a strain from Thailand (accession AF180818) with 
98.5-99.4% homology. Further sequencing experiments will be important 
for developing a better understanding of the phylogeny of DENV strains 
currently circulating in Kenya. Together, our preliminary results suggest 
that DENV may be an important cause of acute febrile illness in Kenyan 
children, but the incidence and disease burden may differ by geographic 
location.
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DEFINING THE CLINICAL MANIFESTATIONS OF ZIKA AND 
DENGUE PATIENTS ATTENDED IN RIBEIRÃO PRETO, BRAZIL
Fernanda P. Torres, Danillo L. Esposito, Taline M. Klein, Flávia M. 
Moraes, Michelli R. Persona, Benedito A. Fonseca
University of São Paulo, Ribeirão Preto, Brazil
Zika is an emergent arthropod-borne disease that is circulating in 
Brazil since 2015. Since last year, we suspected that zika virus (ZIKV) 
was circulating in Ribeirão Preto (RP) at the same time of dengue virus 
(DENV). Up to this moment, little is known about the clinical aspects of 
this disease. Hence, the present study aimed to investigate the clinical 
presentation of Zika in patients with a probable diagnosis of Zika or 
Dengue referred to a tertiary hospital of RP. We conducted a retrospective 
analysis of the 162 patients attended from January to March 2016. Of 
these, 43 had positive results for ZIKV by RT-PCR in blood, 44 had dengue 
confirmed by detection of NS1 antigen and/or ELISA for IgM antibodies 
against DENV and 75 had other febrile illnesses. Rash was found in all 
Zika patients, predominantly macular or maculopapular and one had 
petechial rash; 57% had a malar rash. The rash usually appeared in the 
first day of symptoms. Among dengue patients, 75% and 37.5% had 
exanthematic and malar rash, respectively. Zika and dengue presented 
with malaise in 81.8% and 80%; myalgia in 63.0% and 78.3%, 
respectively. Arthralgia was more frequent in zika than in dengue (82.6% 
and 55.7%, respectively) although in both groups, about 20% of the 
patients with arthralgia had periarticular swelling or arthritis. Fever was 
present in 69.2% of dengue but was not common in Zika (37.9%). 
Conjunctival injection was reported in 59.1% of Zika and only in 28.6% of 
dengue patients. Less common symptoms in Zika patients were headache 
(52.2%), retro-orbital pain (53.3%), nausea (18.2%) or vomiting (9.1%), 
diarrhea (13.6%), and bleeding (4.0%). Upper respiratory tract symptoms 
were observed only in dengue patients (16.7%). Characterization of 
disease presentation is important for diagnosis to differentiate between 
other arboviral diseases that could occur simultaneously in the same 
area, especially in epidemic situation where laboratory testing become 
impracticable. Although there were some distinction between Zika and 
dengue, our data show the clinical hurdles to differentiate these diseases 
and justify the need for developing a fast and specific laboratory test for 
Zika.
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BINDING OF HUMAN MONOCLONAL ANTIBODIES TO 
DENGUE VIRUS WITH DIFFERENT MATURATION STATUS: A 
COMPARATIVE ANALYSIS
Wen-Yang Tsai, Hui-Ling Chen, Wei-Kung Wang
JABSOM, University of Hawaii at Manoa, Honolulu, HI, United States
The four serotypes of dengue virus (DENV) cause the most important 
arboviral disease in humans. Envelope (E) protein is the major target of 
neutralizing (NT) antibody. The ectodomain of E protein consists of 3 
domains (DI, DII and DIII). Previous studies have shown that monoclonal 
antibodies (mAbs) recognizing DIII are more potent neutralizing (NT) 
than those recognizing fusion-loop (FL) of DII. During the maturation 
process, the precursor membrane (prM) protein on immature particles is 
inefficiently cleaved by furin, resulting in a mixture of mature, immature 
and partially immature virions in the culture supernatants. We studied 
the relationships between epitope accessibility, binding avidity and NT 
potency of mAbs on DENV virions produced from two cell lines with 
differential maturation status. To generate immature, mixed and mature 
virions from 293T and BHK cells, DENV1 were inoculated in the presence 
or absence of ammonia chloride, and furin over-expression, respectively. 
A virion-capture ELISA were carried out to examine the relative prM 
content in various particles with differential maturation status, and the 
binding of human anti-FL and anti-DIII mAbs. Maximum binding (Bmax) 
and dissociation constant (Kd) were determined (GraphPad Prism 6). 
NT potency, accessibility and avidity were assessed by 1/FRNT50, Bmax 
and 1/Kd, respectively. Regardless the sources of DENV particles, anti-
DIII mAbs showed significantly lower Kd to mature virions than anti-FL 
mAbs, suggesting the higher binding avidity on the infectious virions 
may contribute to stronger NT activities of anti-DIII mAbs compared to 
anti-FL mAbs. Some anti-FL mAbs showed different Kd to mixed virions 
derived from 293T and BHK cells, which can be attributed to differential 
maturation status of virions from the two sources. The results on DENV 
virions are generally in agreement with our previous study using DENV 
virus-like particles and have implication for immunogen design to induce 
more potent NT antibodies against DENV.
1368
SUPERENSEMBLE FORECASTS OF DENGUE OUTBREAKS
Teresa K. Yamana, Jeffrey Shaman
Columbia University, New York, NY, United States
Dengue is a mosquito-borne viral disease prevalent in the tropics and 
subtropics, with an estimated 2.5 billion people at risk of transmission. In 
many areas with endemic dengue, disease transmission is seasonal but 
prone to high inter-annual variability with occasional severe epidemics. 
Predicting and preparing for periods of higher than average transmission is 
a significant public health challenge. Recent work has demonstrated that 
accurate forecasts of the timing and severity of disease outbreaks can be 
generated using a framework combining a dynamical model of disease 
transmission and data assimilation methods. However, because no model 
perfectly represents transmission dynamics in the real world, infectious 
disease forecasts made by a single model are prone to error due to this 
model misspecification. In weather and climate forecasting, this problem 
has been addressed by combining forecasts from multiple competing 
models in a superensemble. The intent is that some of the biases inherent 
in the different models will offset so that the superensemble produces 
more accurate predictions than those generated by any individual model. 
Here, we develop three distinct forecasting systems for dengue outbreaks 
in San Juan, Puerto Rico and then use Bayesian averaging methods to 
combine the predictions from these systems and create a superensemble 
forecasts. We demonstrate that on average, this approach leads to more 
accurate forecasts than those made from any of the individual forecasting 
approaches.
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LESSONS LEARNED FROM THE LARGEST AND MOST SEVERE 
EPIDEMIC OF DENGUE VIRUS SEROTYPE 2 (DENV-2) IN 
TAIWAN, 2015
Chwan-Chuen King1, Hwa-Lung Yu2, Ta-Chien Chan3, Yun-
Cheng Chang1, Shu-Yu Lin1, Chi-Hang Chin1, Hui-Ying Ko1, Yao-
Tsun Li1, Thomas C. Tsai4, Yung-Chen Marie Wu4, Shu-Chuan Hsu5, 
Chih-Huan Chung5, Ishiou Hwang1, Chia-Chi Ku6, Sheng-Che Fred 
Lin7, Chaur-Dong Chen8, Chi-Kung Ho8, Pei-Yun Shu9
1Inst. of Epidemiology, College of Public Health, National Taiwan University 
(NTU), Taipei, Taiwan, 2Department of Bioenvironmental Systems 
Engineering, NTU, Taipei, Taiwan, 3Research Center for Humanities and 
Social Sciences, Academia Sinica, Taipei, Taiwan, 4College of Med., NTU, 
Taipei, Taiwan, 5Kuo General Hosp., Tainan, Taiwan, 6Inst. of Immunology, 
College of Med, NTU, Taipei, Taiwan, 7Tainan City Dept. of Health, Tainan, 
Taiwan, 8Kaohsiung City Dept. of Health, Kaohsiung, Taiwan, 9Taiwan 
Centers for Disease Control, Taipei, Taiwan
Most of dengue outbreaks in Taiwan in each year start from imported 
cases coming from South East Asia, except for the four over-wintering 
years (1987-88, 2001-02, 2009-10, 2014-15). Among all indigenous 
dengue cases, DENV-1 was the most common in the years before 2000, 
2007, and 2014 whereas DENV-3 was isolated more frequently in 2005-06 
and 2009-10 and DENV-2 was highly prevalent in 2001-03, 2011, 2013, 
and 2015. Therefore, DENV-2 had lower occurrence for recent 11 years 
until 2015. The epidemic started from dengue cluster cases occurring in 
the flea market of Tainan in May, 2015 and spread to Kaohsiung in July. 
Retrospective big data analyses identified that age groups of 19-34 and 
35-49 years in Tainan played a major role of initial spreading since June 
18 till July in Tainan. At the end of August, Advisory Committee was 
appointed by the Mayor. Health education began to target at these age 
groups and geographical information system (GIS) was implemented to 
daily evaluate emerging cases and predicting cases in future weeks, using 
the smallest neighborhood area (Li). By September, DENV-2 has become 
the dominant serotype in Kaohsiung till April of 2016, even though DENV-
1 was predominant serotype from 2014 to August, 2015. Viral sequence 
and phylogenetic analyses of the E region found that the causing agent 
was the DENV-2 came from Indonesia Cosmopolitan genotype that 
was different from the DENV-2 in 2001-02 arisen from the Philippines 
Cosmopolitan genotype and the DENV-2 Asian 2 genotype in 1981 
imported from the Philippines. By November, Tainan City government 
successfully controlled the epidemic before winter season. In conclusion, 
this is the first time that open-data resources and timely big data analyses 
were applied to be integrated with epidemiological analysis in Tainan. 
Most of severe dengue cases were elderly with chronic illness. Our valuable 
experiences indicate that web-based epidemiological information was very 
helpful for local residents and government officials at different levels and 
agencies to have rapid communication and contain the epidemic much 
earlier. More experiences will be shared in this meeting.
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WHAT NOW? CIRCULATION OF ZIKA, DENGUE AND 
CHIKUNGUNYA VIRUSES IN A CITY FROM BRAZIL
Arianne Fagotti Gusmão, Paulo Eduardo Lima Lopes-Filho, 
Adriano Mondini
UNESP - São Paulo State University, Araraquara - São Paulo, Brazil
Dengue (DENV) is undeniably a public health problem that cannot be 
put aside. Nor its importance can be lessened due to Zika virus (ZIKV) or 
any other arboviral disease. Brazil presented one of the worst outbreaks 
in 2015, with 1,6 million cases officially reported. There has also been 
an increase in disease severity and number of deaths. But Aedes aegypti 
mosquitos are not transmitting only dengue in Brazil. Chikungunya and 
Zika viruses are spread all over the country, including Araraquara, central 
portion of the State of São Paulo. The idea was to establish a potential 
collaboration between the Municipal Department of Health and a 
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research institution of the city to search for arbovirus in humans. People 
presenting dengue-like illness were directed to a particular Health Unity, 
where a trained person of our team was collecting blood and performing 
epidemiological surveys. We collected 362 serum samples and tested 
them for the presence of ZIKV, CHIKV and the four DENV serotypes by 
RT-PCR. DENV-1 was detected in 60 patients. DENV-4, as well as CHIKV, 
was detected in one patient. Eight patients were infected with ZIKV. 
Symptoms such as fever, arthralgia, myalgia, and rash were common. 
No microcephaly cases were reported in the city. The circulation of four 
different viruses within the urban space indicates that vector control and 
prevention strategies have to be reevaluated. The collaboration between 
two different public institutions provided epidemiological information that 
had never been evaluated until that point and may be an opportunity 
to detect virus introductions when they occur with a real possibility of 
avoiding viral spread.
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POTENTIAL IMPACT OF DENGUE VACCINE IMPLEMENTATION 
ON SURVEILLANCE AND DIAGNOSIS - INSIGHTS FROM 
SEROLOGICAL PROFILES OF FEBRILE CASES IN PHASE III 
DENGVAXIA® EFFICACY TRIALS
Eric Plennevaux1, Annick Moureau2, Jose Luis Arredondo3, Luis 
Angel Villar4, Punnee Pitisuttithum5, Tran Ngoc Huu6, Matthew 
Bonaparte7, Danaya Chansinghakul8, Diana Leticia Coronel9, 
Maïna L’Azou10, Leon Ochiai10, Myew-Ling Toh10, Fernando 
Noriega7, Alain Bouckenooghe8
1Sanofi Pasteur, Lyon Cedex 07, France, 2Sanofi Pasteur, Marcy l’Etoile, 
France, 3Instituto Nacional de Pediatria, Mexico, Mexico, 4Universidad 
Industrial de Santander, Bucaramanga, Colombia, 5Mahidol University, 
Bangkok, Thailand, 6Pasteur Institute, Ho Chi Minh City, Vietnam, 7Sanofi 
Pasteur, Swiftwater, PA, United States, 8Sanofi Pasteur, Singapore, 
Singapore, 9Sanofi Pasteur, Mexico, Mexico, 10Sanofi Pasteur, Lyon Cedex, 
France
Dengue surveillance is widely based on detecting IgM/IgG dengue 
antibodies in one post-infection sample. We previously communicated 
results showing that CYD-TDV vaccination induces false positive cases 
detected by IgM/IgG ELISA. In a post-hoc analysis of a subset of individuals 
from two PhIII efficacy studies (CYD14/CYD15), we describe IgM/IgG 
serological profile of febrile sera samples in 145 virologically confirmed 
dengue cases (VCD) and of 2646 febrile sera from non-confirmed dengue 
episodes (non-VCD) according to their dengue baseline status. This allows 
us to further assess the impact of dengue vaccination on serological 
detection of probable dengue cases IgM profile of 145 VCD cases shows 
that 95.9% (95%CI: 91.2-98.5) were IgM positive regardless of baseline 
dengue status or study group. Among 1825 febrile non-VCD episodes 
in seropositives, a lower but similar proportion were IgM positive in both 
groups (22% [19.3-24.0] in vaccine; 21% [18.0- 24.5] in control). On the 
other hand, among 821 non-VCD in seronegatives, a statistical difference 
is observed with 33% (28.7-37.0) IgM positives in vaccine and 15% (11.4-
19.8) in controls, highlighting, in seronegatives, the previously reported 
vaccine-induced IgM positive samples. IgG profile in VCD cases indicates 
no difference between vaccine & control groups (100% for both in 
seropositives & in seronegatives 100% [89.4-100] vaccine vs. 89% [70.8-
97.5] control). Among non-VCD episodes in seropositives, a trend for 
higher rate of IgG positive samples in vaccine is observed (97% [95.5-97.6] 
vs. 88% [85.6-90.8] for control). In seronegatives, a significant difference 
is observed (77% [73.2; 80.6] vaccine vs. 14% [10.2; 18.3] control; 5.5-
fold difference). This highlights the impact of CYD-TDV vaccination on IgG 
detection in febrile non-VCD episodes. In conclusion, Dengue vaccination 
impacts IgM and IgG ELISA detection of probable cases in seronegative 
individuals. This presents a challenge for IgM/IgG ELISA based surveillance 
in countries where Dengue vaccine is implemented. New practical, dengue 
specific diagnostic algorithms are needed. * confirmed by PCRs or NS1-
antigen ELISA.
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SUSCEPTIBILITY OF MEDICALLY IMPORTANT CULEX SPECIES 
MOSQUITOES TO JAPANESE ENCEPHALITIS VIRUS
Yan-Jang S. Huang1, Susan M. Hettenbach2, So Lee Park1, 
Stephen Higgs2, Alan D. Barrett3, Lee W. Cohnstaedt4, Dana L. 
Vanlandingham1
1Department of Diagnostic Medicine and Pathobiology, College of 
Veterinary Medicine, Kansas State University, Manhattan, KS, United 
States, 2Biosecurity Research Institute, Kansas State University, Manhattan, 
KS, United States, 3Department of Pathology, University of Texas Medical 
Branch, Galveston, TX, United States, 4Arthropod-borne Animal Disease 
Research Unit, Agriculture Research Services, United States Department of 
Agriculture, Manhattan, KS, United States
Japanese encephalitis virus (JEV) is a mosquito-borne flavivirus that 
is considered an important human and animal pathogen. Whilst 
transmission of JEV is mainly achieved by Culex tritaeniorhychus in 
endemic countries, it has been demonstrated that the virus is capable 
of infecting multiple mosquito species, which can subsequently become 
competent vectors for disease transmission. Previously, our group has 
demonstrated Cx. quinquefasciatus in the United States is a competent 
species for JEV. However, susceptibility of other medically important Culex 
species mosquitoes in North America remains undetermined. Based on 
the importance in the transmission of arboviruses in North America, 
susceptibility of three American Culex species mosquitoes to JEV was 
determined through oral infection. Cx. pipiens was chosen based on its 
importance in the transmission of West Nile virus (WNV) and Saint Louis 
encephalitis virus. Cx. restuans and Cx. tarsalis were tested because of 
their role as competent vectors for WNV and Western equine encephalitis 
virus, respectively. Infection and dissemination were observed at 7 and 14 
days post infection in all three species, indicating that multiple medically 
important Culex species mosquitoes are susceptible to JEV. As observed 
with WNV, which rapidly established itself in the United States by utilizing 
multiple species of mosquitoes as vectors, JEV is a significant public 
health threat to the United States as it also possesses the capacity of 
infecting multiple species of mosquitoes. In the event of its introduction, 
establishment of enzootic transmission can take place by infecting multiple 
species of mosquitoes.
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DECREASED ZIKA VIRUS REPLICATION IN MOSQUITO CELLS 
CO-INFECTED WITH NHUMIRIM VIRUS
Hannah E. Romo1, Silvina Goenaga2, Joan L. Kenney3, Gregory D. 
Ebel1, Aaron C. Brault3
1Colorado State University, Fort Collins, CO, United States, 2Instituto 
Nacional de Enfermedades Virales Humanas, Pergamino, Argentina, 
3Division of Vector-borne Diseases, Centers for Disease Control and 
Prevention, Fort Collins, CO, United States
Nhumirim virus (NHUV) is a flavivirus isolated from Brazil with an apparent 
insect-specific host restrictive phenotype. Previous studies in Aedes 
albopictus cells (C6/36) have demonstrated the ability of NHUV to restrict 
West Nile virus (WNV) growth more than a million fold, Saint Louis 
encephalitis virus (15,000-fold) and Japanese encephalitis virus (80-fold). 
Similar viral growth reduction was demonstrated for WNV/NHUV co-
infection in alternative Ae. albopictus cells (C7-10). Culex quinquefasciatus 
and Cx. pipiens mosquitoes were intrathoracically inoculated with WNV 
or NHUV/WNV and transmission assessed. A decreased proportion of 
WNV transmitting Cx. quinquefasciatus mosquitoes was observed in 
NHUV/WNV mosquitoes at 7 and 9 days post-inoculation (dpi) compared 
to WNV-only, suggesting NHUV could act as a potential transmission 
barrier for other medically important flaviviruses. Currently, there are no 
approved vaccines or prophylaxis treatments for human Zika virus (ZIKV) 
infections so reduction in exposure rates to ZIKV infected mosquitoes is 
the principal means available to reduce human disease. To asses whether 
ZIKV replication is affected by pre- or concurrent NHUV infection, C6/36 
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cells were concurrently inoculated with NHUM (MOI 5) and ZIKV (MOI 
0.1) or similarly inoculated with NHUV at 5, 3, or 1 day(s) prior to ZIKV 
inoculation and titers determined by plaque assay. ZIKV-only cultures 
achieved significantly higher titers at 1-7 dpi than dually inoculated cells. 
Mean peak titer of ZIKV-only cultures was 10.5 log10 (PFU/ml) while 
peak titers for pre- or concurrently inoculated NHUV/ZIKV cultures ranged 
from 3.4 - 5.5 log10 (PFU/ml), resulting in an approximate 100,000-fold 
reduction. No effects on timing of NHUV infection compared to ZIKV 
inoculation were observed. These in vitro results suggest NHUV could 
serve as a possible ZIKV transmission barrier, thus potentially modulating 
Zika vector competence and force of transmission in geographic areas in 
which NHUV and similar flaviviruses exist. Dual infection in vivo studies in 
prospective western hemisphere ZIKV vectors are being planned to address 
this potential.
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AVAILABILITY OF ZIKA VIRUS INFORMATION ON OBSTETRIC 
PRACTICE WEBSITES AND SOCIAL MEDIA ACCOUNTS IN THE 
UNITED STATES
Grace Goryoka, Allison T. Chamberlain, Mallory K. Ellingson, 
Raghuraj Kasturi, Jonathan D. Lehnert, Emily Maier, Ruth L. 
Berkelman
Emory University Rollins School of Public Health, Atlanta, GA, United 
States
Provider to patient communication, whether domestically or 
internationally, is critical during a public health emergency. Understanding 
health care providers’ utilization of the Internet for dissemination of health 
information is useful for emergency public health messaging strategies. 
In early 2016, the Centers for Disease Control and Prevention and the 
American College of Obstetricians and Gynecologists advised health 
care providers to communicate the risks of Zika virus (ZIKV) infection 
and prevention methods to their patients. This study’s objective was to 
estimate the proportion of obstetric practice websites in the U.S. providing 
information on ZIKV within two weeks following initial release of interim 
guidance for care of obstetric patients. Out of 1,004 obstetric practice 
websites examined, only 244 (24.3%) posted information pertaining to 
ZIKV on their websites or website-linked social media accounts. Among 
those posting on ZIKV, information was more often found on their 
practice-sponsored social media accounts (74.2%; p=0.006) or elsewhere 
on their website (45.9%; p=0.35) compared to the homepage (17.2%). 
Practices affiliated with non-academic hospital systems and academic-
hospital systems were significantly more likely to post ZIKV information 
(31.3%, odds ratio [OR] 2.71, 95% confidence interval [CI] 1.90-3.87; 
51.3%; OR 6.29, 95% CI: 3.99-9.91, respectively) compared to obstetric 
practices (14.4%). 84.8% of the content posted mentioned international 
travel advisories and 62.3% provided information on the use of insect 
repellent. Although there is growing use of the Internet and social media 
to provide patients with health information, ZIKV information was not 
readily available on most obstetric care practice websites within two weeks 
following the release of national guidance on care of obstetric patients. 
Ensuring that providers around the world have the information they need 
to confidently utilize their practice websites and social media accounts for 
provision of urgent health information could keep patients as informed as 
possible during an evolving public health emergency.
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ZIKA AND OTHER MOSQUITO-BORNE VIRUS DETECTION 
AND DIFFERENTIATION USING A MULTIPLEXED, BEAD BASED 
RT-PCR ASSAY
Ramin Saberi1, Cora Lahey1, Jamie Hale1, Tiffany Wang1, Abbegail 
King1, Doreen Robinson2, R. Paul Schaudies2, Amy Altman1
1Luminex Corporation, Austin, TX, United States, 2GenArraytion Inc., 
Rockville, MD, United States
Since May 2015, South and Central America have experienced an 
epidemic outbreak of Zika Virus. Several travel related cases have already 
been identified in the United States. Zika infection during pregnancy has 
been implicated in the development of microcephaly in the developing 
fetus and is thought to be responsible for an increased incidence of 
Guillain-Barre syndrome. The expanding footprint of the disease, along 
with the devastating neurological effects associated with Zika Virus 
warrant rapid and early detection of Zika Virus during the critical viremic 
phase. In areas with co-circulating mosquito borne illnesses, viruses must 
not only be detected, but differentiated in order to provide accurate 
results. An RT-PCR based multiplex microsphere assay was developed 
to detect and differentiate Zika Virus, Chikungunya Virus, Dengue 
Virus (Serotypes 1-4), West Nile Virus, and Yellow Fever Virus. Assay 
performance was established using representative virus strains and clinical 
samples. The assay demonstrates required analytical sensitivity and is 
able to detect and differentiate each virus. The multiplex RT-PCR assay 
eliminates the need for sequential testing and complicated patient care 
algorithms. The multiplex format allows for simultaneous identification 
of viruses among a group of viruses that are difficult to distinguish due 
to simultaneous circulation of the viruses and strong similarities in the 
associated symptoms.
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ARBOVIRUS IMMUNOHISTOCHEMISTRY: 
CHARACTERIZING CROSS-REACTIVITIES OF DIFFERENT 
IMMUNOHISTOCHEMISTRY ASSAYS
Luciana M. Flannery, Roosecelis B. Martines, Brigid Bollweg, 
Tara Jones, Pamela Spivey, Julu Bhatnagar, Dominique Rollin, Kelly 
Keating, Joy Gary, Gillian Hale, Jana Ritter, Wun-Ju Shieh, Sarah 
Reagan-Steiner, Atis Muehlenbachs, Sherif Zaki
Centers for Disease Control and Prevention, Atlanta, GA, United States
Dengue (DENV), Zika (ZIKV), yellow fever (YFV), chikungunya (CHIKV), 
West Nile (WNV) and Japanese encephalitis (JEV) viruses are mosquito-
borne arboviruses. Several other viruses share the same Aedes vectors, 
overlap in their endemic areas, have recently re-emerged globally, and 
pose a major threat to public health. While RT-PCR in general is the most 
specific and sensitive test for these arboviruses in pathology specimens, 
immunohistochemistry (IHC) has value in demonstrating the presence of 
viral antigens in tissue and can provide insight into pathogenesis. Because 
serological cross-reactivity is well documented, particularly for flaviviruses, 
it is imperative to evaluate the level of cross-reactivity of arbovirus 
antibodies (Ab) used in immunohistochemical assays. In a diagnostic 
reference laboratory, we tested six different arbovirus Ab against cell 
controls, made with cells infected with different flaviviruses, and RT-PCR 
confirmed clinical specimens to characterize cross-reactivities. IHC assays 
were performed on 4µm sections of FFPE tissue using a polymer-based 
indirect immunoalkaline phosphatase detection system with colorimetric 
detection of antibody/polymer complex with Fast Red Chromogen. 
The JEV showed cross-reaction with all flavivirus-infected tissue tested. 
WNV and ZIKV assays had minimal cross reactivities with only one other 
arbovirus (CHIKV and DENV respectively), and YFV and DENV assays had 
intermediate cross-reactivities with 2-3 other arbovirus (YFV cross-reacts 
ZIKV and DENV, and DENV cross-reacts WNV, ZIKV and JEV). The observed 
assay cross-reactivity are directly related to genetic similarities among the 
viruses. Importantly however, different viruses have characteristic tissue 
433
astmh.org
and cellular tropism by IHC which contributes to its diagnostic utility. These 
cross-reactivity data provide insight to the strengths and limitations of IHC 
assays for certain arboviruses in a diagnostic reference laboratory.
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CHARACTERIZATION OF PATIENTS WITH GUILLAIN-BARRÉ 
SYNDROME DURING THE ZIKA EPIDEMIC IN VENEZUELA
Adriana Tami1, Sandra Mendoza2, Fe M. Salazar3, Robert Tovar4, 
Sarah Bethencourt4, Hubert Niesters1, Guillermo Rojas5, Haydee 
Ochoa6, Luis Scribani7
1University of Groningen, University Medical Center Groningen, 
Groningen, Netherlands, 2Servicio de Neurología, Ciudad Hospitalaria 
“Enrique Tejera”, Valencia, Bolivarian Republic of Venezuela, 3Servicio de 
Cardiología, Ciudad Hospitalaria “Enrique Tejera”, Valencia, Bolivarian 
Republic of Venezuela, 4Unidad de Investigación en Inmunología 
(UNIVENIN), Facultad de Ciencias de la Salud, Universidad de Carabobo, 
Valencia, Bolivarian Republic of Venezuela, 5Dirección de Epidemiologia 
Regional, Fundación Instituto Carabobeño para la Salud (INSALUD), 
Valencia, Bolivarian Republic of Venezuela, 6Dirección Médica, Ciudad 
Hospitalaria “Enrique Tejera”, Valencia, Bolivarian Republic of Venezuela, 
7Servicio de Epidemiología, Ciudad Hospitalaria “Enrique Tejera, Valencia, 
Bolivarian Republic of Venezuela
Guillain-Barré syndrome (GBS) is an acute or subacute autoimmune 
inflammatory demyelinating polyradiculoneuropathy. It is the most 
common cause of flaccid paralysis and can be life threatening. GBS is 
characterized by a rapid-onset acute symmetrical muscle weakness, 
habitually ascending, affecting 1:100,000 people. In most cases GBS has 
been preceded in the last 6 weeks by gastroenteritis or a respiratory tract 
infection. During the zika virus epidemic that affects Venezuela since 
December 2015, a massive and rapid increase in the number of GBS 
patients presenting to the emergency department of the main referral 
hospital (CHET) of Valencia city, Venezuela has been reported. Typically, 
one GBS patient per month is recorded at CHET however, during the zika 
epidemic around 45 cases were admitted during the months of January 
and February 2016. We aim to characterize the clinical presentation of 
GBS patients and the possible association with a previous or current 
zika virus infection. A study is ongoing to collect clinical, laboratory and 
paraclinical tests data of confirmed GBS patients after informed consent 
along with a blood sample to perform differential diagnosis between 
zika, chikungunya and dengue virus infection, as these three arboviruses 
currently co-circulate. Preliminary results of 12 patients indicate a mean 
age of 56 years (range 37-83 years) with a predominance of male patients 
(67%). A short time (average= 6.5 days, range 1-15 days) is described 
between the onset of symptoms compatible with Zika infection and the 
beginning of neurological symptoms. Most patients rapidly progressed 
to life threatening disease within 24-48h. Five patients were admitted to 
intensive care unit of which three died (mortality=25%) despite treatment 
with plasmapheresis and/or immunoglobulin. A detailed description of 
the clinical spectrum, possible risk factors and serological diagnosis of 
arboviruses will be presented on the totality of patients included in the 
study.
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VIREMIA AND CLINICAL PRESENTATION AMONG 
NICARAGUAN PATIENTS WITH ZIKA VIRUS AND DENGUE 
VIRUS INFECTIONS
Jesse J. Waggoner1, Lionel Gresh2, Maria Jose Vargas3, Gabriela 
Ballesteros3, Yolanda Tellez3, Andrea Nunez3, Angel Balmaseda3, 
Eva Harris4, Benjamin Pinsky1
1Stanford University, Palo Alto, CA, United States, 2Sustainable Sciences 
Institute, Managua, Nicaragua, 3Centro Nacional de Diagnóstico y 
Referencia, Managua, Nicaragua, 4University of California Berkeley, 
Berkeley, CA, United States
The first autochthonous cases of Zika virus (ZIKV) were reported in 
Nicaragua in January 2016. ZIKV now co-circulates with dengue virus 
(DENV) and chikungunya virus (CHIKV) throughout the country. Although 
the duration of viremia in Zika fever is reportedly shorter than the 
duration observed in DENV infections, little quantitative viremia data 
has been published. In the current study, we tested acute-phase serum 
from sequential patients with a suspected arbovirus infection. Serum 
was collected as part of a national surveillance system in Nicaragua. 346 
samples were tested using a single-reaction multiplex real-time RT-PCR 
for ZIKV, CHIKV and DENV (the ZCD assay), and viremia in ZIKV- and 
DENV-positive samples was quantitated. Overall, 263 (76.0%) serum 
samples were positive for one or more pathogens. 75 patients (28.5%) 
tested positive for ZIKV (47 mono-infections, 28 co-infections). 109 
(41.4%) patients were positive for DENV (54 mono-infections, 55 co-
infections). Identified co-infections included all combinations of the 3 
viruses: ZIKV-CHIKV (n=16), ZIKV-DENV (n=6), DENV-CHIKV (n=43), and 
ZIKV-CHIKV-DENV (n=6). The mean duration of symptoms was similar 
for ZIKV-positive (3.4 days, SD 1.1) and DENV-positive patients (3.4 days, 
SD 1.3; p=0.81). Quantitated viremia in ZIKV-positive samples (mean 4.7 
log10 copies/mL serum, SD 1.0) was significantly lower than DENV-positive 
samples (5.8 log10 copies/mL serum, SD 1.8; p<0.01). The distribution in 
viremia also differed significantly (p<0.01 by Kruskal-Wallis test), and only 
39/75 (52.0%) ZIKV-positive samples had quantifiable viremia compared 
to 94/109 (86.2%) DENV-positive samples. For both viruses, viremia 
was significantly lower in co-infections than mono-infected samples. 
Finally, an analysis of clinical signs and symptoms in relation to viremia 
at presentation will be presented. Results from this study have important 
implications for ZIKV diagnosis in the acute phase and expand upon the 
available literature regarding viremia in ZIKV infected patients.
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EFFECTS OF TEMPERATURE ON ZIKA, DENGUE AND 
CHIKUNGUNYA TRANSMISSION BY AEDES AEGYPTI AND AE. 
ALBOPICTUS
Erin Mordecai1, Jeremy Cohen2, Michelle Evans3, Leah R. 
Johnson4, Prithvi Gudapati1, Kerri Miazgowicz3, Courtney C. 
Murdock3, Jason Rohr2, Sadie J. Ryan5, Van Savage6, Anna Stewart 
Ibarra7, Matthew B. Thomas8, Marta Shocket1, Daniel Weikel9
1Stanford University, Stanford, CA, United States, 2University of South 
Florida, Tampa, FL, United States, 3University of Georgia, Athens, 
GA, United States, 4Virginia Polytechnic Institute and State University, 
Blacksburg, VA, United States, 5University of Florida, Gainesville, FL, United 
States, 6University of California Los Angeles, Los Angeles, CA, United 
States, 7State University of New York Upstate Medical University, Syracuse, 
NY, United States, 8Pennsylvania State University, State College, PA, United 
States, 9University of Michigan, Ann Arbor, MI, United States
The geographic distribution of vector-borne diseases is shaped by many 
ecological and evolutionary factors, including the response of vectors and 
pathogens to environmental drivers. Mosquito-transmitted diseases such 
as Zika, dengue, and chikungunya are intimately linked with environmental 
temperature and humidity because of mosquito and pathogen 
physiological responses, including growth, development, survival, 
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reproduction, and behavior. Current models often inaccurately predict that 
warmer temperatures will tend to increase mosquito transmission even as 
temperatures warm above 30°C. In contrast, models that include more 
physiologically accurate, nonlinear thermal responses of the mosquito 
and pathogen vital rates that drive transmission predict intermediate 
optimal temperatures. Here, we develop a model of arbovirus transmission 
(particularly dengue, chikungunya, and Zika viruses) by Aedes aegypti and 
Ae. albopictus mosquitoes that includes physiologically accurate, nonlinear 
mosquito and parasite thermal responses. Ae. aegypti and Ae. albopictus 
development rates, longevity, fecundity, and biting rates, as well as dengue 
virus vector competence and extrinsic incubation rates have hump-shaped 
responses to temperature with intermediate optima. As a result, dengue, 
chikungunya, and Zika virus transmission are optimal at intermediate 
temperatures (27-29°C) and decline steeply above 32-36°C and below 
15-17°C). The model predictions are consistent with field data from the 
Americas on the number of human dengue, Zika, and chikungunya cases 
across space and time. These intermediate optimal temperatures are 
robust to uncertainty in trait thermal responses. We quantify sources of 
uncertainty in transmission across temperatures and make prescriptions for 
future experimental work to resolve this uncertainty. Together, the results 
imply that much of tropical, sub-tropical, and temperate North, Central, 
and South America and the Caribbean are suitable for seasonal or year-
round transmission.
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GUILLAIN-BARRÉ SYNDROME RISK AMONG INDIVIDUALS 
INFECTED WITH ZIKA VIRUS
Luis Mier-y-Teran1, Michael Johansson2
1Dengue Branch, Division of Vector-Borne Diseases, Centers for Disease 
Control and Prevention, Washington, DC, United States, 2Dengue Branch, 
Division of Vector-Borne Diseases, Centers for Disease Control and 
Prevention, San Juan, PR, United States
As of early April, 2016, local Zika virus (ZIKV) transmission had been 
confirmed in 33 countries in the Americas where transmission had never 
previously been reported, and 9 of those countries had reported notable 
increases in the number of cases of the neurological disorder Guillain Barré 
Syndrome (GBS). These increases were spatio-temporally correlated with 
reports of Zika cases and ZIKV infection has been confirmed in some of 
the GBS cases. A potential connection between ZIKV infection and GBS 
was first noted during an outbreak of Zika in French Polynesia. It was 
later shown that all forty-two reported GBS cases in French Polynesia 
had evidence of previous ZIKV infection, compared to only approximately 
half of non-GBS controls. Estimated GBS risk in French Polynesia was 
approximately 2.4 cases per 10,000 ZIKV infections, more than 10 times 
the expected baseline risk. We built an inference framework to combine 
data on ZIKV infections, Zika cases, and GBS cases from locations with 
previous outbreaks (Yap and French Polynesia) with real-time Zika and 
GBS case data from the ongoing outbreak in the Americas to estimate the 
risk of GBS that may be associated with ZIKV infection. These estimates 
indicated that ZIKV-associated GBS risk in the ongoing outbreak may 
be similar to the risk estimated in French Polynesia, though current 
point estimates are slightly lower. Sensitivity analyses highlighted how 
integrating data from previous, better described outbreaks with current 
estimates can help improve confidence in estimating current risks. These 
methods and the estimates they produce are of paramount importance 
for response and preparedness planning in locations experiencing Zika 
outbreaks .
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RELATIVE FITNESS OF ZIKA VIRUS LINEAGES IN 
MOSQUITOES AND CELLS
Gregory D. Ebel, James Weger, Claudia Rueckert, Nathan 
Grubaugh, Joseph Fauver
Colorado State University, Fort Collins, CO, United States
Zika virus has undergone a dramatic range expansion in recent years, 
including a dramatic outbreak that is currently ongoing in South America. 
Interestingly, it is likely that ZIKV, for the first time in its evolutionary 
history, is replicating extensively in human beings. In addition, a hallmark 
of arbovirus introductions into new ecological niches has been increased 
fitness in local vector populations. This has been clearly observed with 
WNV and CHIKV as they have colonized new regions. It seems likely that 
this may also occur as ZIKV spreads within the Americas. Therefore, we 
assessed the relative fitness of Asian lineage ZIKV from the new world 
compared to West African (Senegal 41525) and East African (Uganda 
MR766) lineage viruses. Briefly viruses were mixed 1:1 and allowed 
to compete in several test systems including: Mexican Ae. aegypti 
mosquitoes, US Ae. albopictus mosquitoes, US Cx. quinquefasciatus 
mosquitoes, BHK-21 cells, and human neuroblastoma, dorsal root 
ganglion and CRL-1973 (pluripotent testicular) cells. After an appropriate 
period of competition, virus was harvested from mosquitoes and relevant 
tissue cultures and the proportion of each competitor determined by 
analysis of sequence chromatograms (i.e. “quantitative sequencing.) 
Results of these competition studies, and their implications for virus 
adaptation, will be discussed.
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EVALUATING THE EFFECTS OF TEMPERATURE VARIATION ON 
ARBOVIRUSES
Blanka Tesla, Kerri Miazgowicz, Melinda Brindley, Courtney 
Murdock
University of Georgia, Athens, GA, United States
Emerging and re-emerging mosquito-borne diseases represent a 
substantial global health burden. Viruses like Chikungunya, Zika and 
Dengue are all transmitted by the Aedes aegypti and Ae. albopictus 
mosquitoes. The U.S. is home to both mosquito vectors with Ae. aegypti 
constrained to highly urban environments in southern coastal states 
and A. albopictus distributed throughout urban, suburban, and rural 
areas in 26 states. This study investigates the effects of temperature on 
Chikungunya virus (CHIKV) and Zika virus (ZIKV) growth dynamics in 
mosquito tissue culture cells derived from both mosquito hosts. Aag2 (Ae. 
aegypti), C6/36 (Ae. albopictus) and U4.4 (Ae. albopictus) mosquito larval 
cell lines were inoculated with attenuated CHIKV (vaccine strain 181/25) 
and ZIKV (MEX 1-44). Samples maintained at six constant temperatures 
(16°C, 24°C, 28°C, 30°C, 32°C and 34°C) were collected at different 
time points for att. CHIKV and ZIKV. Viral titer was calculated as plaque 
forming units (PFUs) per milliliter through standard plaque assays on 
Vero cells. As expected from the literature, Aag2, C6/36 and U4.4 cell 
lines had differential growth responses to temperature. Cell lines grew 
slower at the lowest temperature and displayed slower viral replication. 
At the higher temperature conditions, virus growth was reduced, but to 
differential effect between the cell lines. These data suggest that there 
may be differences in viral growth kinetics at different temperatures in 
the two vector hosts (Ae. aegypti and Ae. albopictus) and future work will 
investigate these interactions in vivo.
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ZIKA VIRUS INFECTIONS: PAYING ATTENTION TO ATYPICAL 
PRESENTATIONS
Danillo L. Esposito, Flávia M. Moraes, Taline M. Klein, Michelli R. 
Persona, Beatriz S. Ribeiro, Vinicius C. Molla, Marco Andrey C. 
Frade, Benedito A. Fonseca
School of Medicine of Ribeirão Preto, Ribeirão Preto, S.P., Brazil
Zika disease has reemerged recently and its most common clinical 
manifestations are still being described. Low-grade fever, pruritic rash, 
conjunctivitis, arthralgia, myalgia and other minor constitutional symptoms 
are reported more often. Brazil has been experiencing an important Zika 
outbreak since May 2015, and since the beginning of this year a great 
number of patients was attended in our teaching hospital due to a Zika-
like disease. Interestingly, patients sought medical attention primarily 
because the presence of a rash and not because they were feeling ill. 
Most patients presented with the symptoms described above and had 
an uneventful course; there was not a single case of microcephaly, but 
an increased number of Guillain-Barré Syndrome was admitted to our 
ICUs. Additionally, we report here three Zika confirmed cases of patients 
(2 males and a female) who had an atypical disease presentation. One of 
the patients presented with an orchiepididymitis about five weeks after 
an acute Zika presentation. Real-time RT-PCR was positive for Zika virus 
in blood and urine in both occasions. The patient recovered completely 
with standard treatment and remains asymptomatic. The other patient 
presented with muscle pain and Zika classical symptoms, but his creatine 
phosphokinase level (CPK) was initially 13,500 µg/L. Patient was treated 
for rhabdomyolysis, CPK levels reached normal levels in a week and 
he recovered without any renal sequelae. Finally, a young woman was 
referred to our hospital due to an extensive petechial rash and arthritis 
on knees and ankles. Lab results were all normal and prednisone was 
prescribed to the patient. Five days later, she was able to walk without 
pain and the petechial rash had faded. Real-time RT-PCR was also positive 
for Zika virus in blood and urine for both patients. Although all three 
patients recovered completely, if they were not promptly diagnosed and 
treated, they could have had a complicated course of the disease. Thus, 
although the great majority of patients will recover from Zika, we must pay 
attention to details of disease presentation to detect the atypical findings 
of this disease.
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MODEL-BASED PROJECTIONS OF ZIKA VIRUS INFECTIONS IN 
CHILDBEARING WOMEN IN THE AMERICAS
Alex Perkins1, Amir Siraj1, Corrine Ruktanonchai2, Moritz 
Kraemer3, Andrew Tatem2
1University of Notre Dame, Notre Dame, IN, United States, 2University of 
Southampton, Southampton, United Kingdom, 3University of Oxford, 
Oxford, United Kingdom
Zika virus is a mosquito-borne pathogen that is rapidly spreading 
across the Americas. Due to a probable association between Zika virus 
infection and a congenital neurological disorder called microcephaly, 
the epidemic trajectory of this viral infection poses a significant concern 
for the nearly 15 million children born in the Americas each year. The 
potential magnitude of the ongoing Zika epidemic is exceedingly difficult 
to gauge based on existing data, due to a number of uncertainties that 
cloud the relationship between observed cases and true infections. As an 
alternative to methods that depend on unreliable case data, we developed 
and applied a new method that leverages highly spatially resolved data 
about drivers of Zika transmission to project that 1-2 million infections 
in childbearing women and approximately 100 million infections across 
all demographic strata could occur before the first wave of the epidemic 
concludes. Our projection is largely consistent with annual, region-wide 
estimates of 53.8 (40.0–71.8) million infections by dengue virus, which has 
many similarities to Zika. Based on independent estimates of microcephaly 
rates, our results suggest that the current epidemic has the potential 
to negatively impact tens of thousands of pregnancies. Uncertainties in 
these projections and up-to-date comparisons against case reports will be 
discussed.
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EVALUATING STRAIN SPECIFICITY OF THE ZIKA VIRUS 
NEUTRALIZING ANTIBODY RESPONSE
Kimberly A. Dowd1, Christina DeMaso1, Rebecca S. Pelc1, Leslie 
Goo1, Scott Speer1, Alex Smith1, Michael S. Diamond2, John R. 
Mascola3, Barney S. Graham3, Julie E. Ledgerwood3, Theodore C. 
Pierson1
1National Institute of Allergy and Infectious Diseases, National Institutes 
of Health, Bethesda, MD, United States, 2Washington University School of 
Medicine, St. Louis, MO, United States, 3Vaccine Research Center, National 
Institutes of Health, Bethesda, MD, United States
Zika virus (ZIKV) is a mosquito-borne flavivirus that has emerged as a 
significant global health problem. Recent outbreaks of ZIKV infection 
in French Polynesia and Brazil have been associated with more severe 
manifestations, including microcephaly and intrauterine growth 
retardation in fetuses and infants born to women infected with the virus 
while pregnant. There are two lineages of ZIKV, African and Asian, that 
share ≥ 95% amino acid identity. The spread of ZIKV to the Americas has 
been attributed to the Asian lineage. No vaccines are available for use in 
humans, and little is known regarding the ability of neutralizing antibodies 
elicited against one lineage to protect against another. The primary target 
of neutralizing antibodies is the envelope (E) protein, of which 180 copies 
comprise the ZIKV virion surface. To facilitate the study of ZIKV antibody 
responses, we generated pseudo-infectious ZIKV reporter virus particles 
(RVPs) by co-transfection of a DNA-launched West Nile virus sub-genomic 
replicon that expresses GFP with a second plasmid encoding the ZIKV 
structural genes (capsid, pre-membrane, and E). ZIKV RVPs representing 
both African and Asian strains were used to assess neutralizing antibody 
responses in a panel of ZIKV-confirmed convalescent human serum 
samples collected 3-12 weeks post onset of symptoms. Our results 
demonstrated minimal strain-specific differences in neutralizing antibody 
responses. These findings were confirmed using a flow cytometry-based 
infectious Zika virus assay; comparisons of antibody titers obtained using 
ZIKV RVPs and fully infectious virus revealed excellent agreement. These 
findings suggest that vaccination with a single ZIKV strain may elicit 
cross-protective neutralizing antibody responses against both lineages. 
Furthermore, our studies establish ZIKV RVPs as a high-throughput and 
quantitative alternative to the use of fully infectious virus for assessing 
ZIKV-specific antibody responses.
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DURATION OF INTESTINAL IMMUNITY FOLLOWING 
ADMINISTRATION OF INACTIVATED POLIO VACCINE (IPV) 
IN INDIAN CHILDREN PRIMED WITH ORAL POLIO VACCINE 
(OPV)
Sidhartha Giri1, Jacob John1, Asha Mary Abraham1, Miren 
Iturriza-Gomara2, Nicholas C. Grassly3, Gagandeep Kang1
1Christian Medical College, Vellore, India, 2Institute of Infection and Global 
Health, University of Liverpool, Liverpool, United Kingdom, 3Imperial 
College London, London, United Kingdom
As per “The Polio Eradication and Endgame Strategic Plan 2013-2018”, 
IPV has been introduced in all OPV using countries since the last quarter 
of 2015. Few studies have demonstrated boosting of short term mucosal 
immunity after IPV administration in children already primed with OPV, 
but no study has evaluated the duration of intestinal immunity after IPV 
administration. The aim of the study was to compare intestinal immunity 
to poliovirus, in OPV immunized children, 6 months and 12 months 
after a single supplemental dose of IPV to children who did not receive 
a supplementary IPV dose, measured by shedding of Sabin types 1 and 
3 poliovirus in stool samples collected 7 days after a “challenge” dose 
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of type 1 and 3 bivalent OPV (bOPV). It was a single centre, open-label 
randomized controlled trial (CTRI/2014/09/004979) conducted in Vellore, 
India, with 3 groups enrolling a total of 900 children aged 12-59 months 
(300 each in control, IPV-6 month, and IPV-12 month arms). Blood samples 
were collected at recruitment from the control group and 28 days after IPV 
administration in the IPV-6 and IPV-12 groups, to evaluate anti-poliovirus 
neutralizing antibodies against all three poliovirus serotypes (PV1, PV2, 
PV3). Shedding of Sabin poliovirus 1 and 3 were determined by one-step 
multiplex real-time PCR. The geometric mean titres (GMT) of neutralizing 
antibodies against PV1, PV2, and PV3 respectively were: control arm 
(103.14, 186.64, 53.01), IPV-6 arm (737.34, 847.68, 839.55), IPV-12 arm 
(833.08, 910.61, 851.06). The proportion shedding Sabin1 poliovirus 7 
days after challenge in the three arms were: control (22.3%,66/296), IPV-
6 (15.8%,45/284), IPV-12 (17.8%,53/297). For Sabin3, the proportion 
shedding were: control (25%,74/296), IPV-6 (15.1%,43/284), IPV-12 
(13.8%,41/297). There was a significant reduction in shedding of Sabin3 
in the IPV-6 (p=0.004) and IPV-12 (p=<0.001) groups compared to 
controls. For Sabin1, shedding was significantly less in the IPV-6 (p=0.048) 
but not in the IPV-12 (p=0.17) group compared to controls. Thus, the 
study demonstrated effective long term intestinal immunity after IPV 
administration in OPV primed children.
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EVALUATION OF A MEASLES ROUTINE IMMUNIZATION 
PROGRAM IN THE DEMOCRATIC REPUBLIC OF CONGO
Ado M. Bwaka1, Kaya Guylain, MD, MPH, Reena H. Doshi2, 
Nicole A. Hoff2, Patrick Mukadi3, Sue Gerber4, Jean-Jacques 
Muyembe5, Emile Okitolonda-Wemakoy6, Anne W. Rimoin2
1McKing Consulting Corporation, Kinshasa, Democratic Republic of the 
Congo, 2University of California Los Angeles Fielding School of Public 
Health, Los Angeles, CA, United States, 3National Institute for Biomedical 
Research, Kinshasa, Democratic Republic of the Congo, 4Bill & Melinda 
Gates Foundation, Seattle, WA, United States, 5Institut National de 
Recherche Biomedicale, Kinshasa, Democratic Republic of the Congo, 
6Kinshasa School of Public Health, Kinshasa, Democratic Republic of the 
Congo
Estimates of population-immunity to vaccine preventable diseases 
(VPDs) are useful to assess the performance of immunization programs, 
identify susceptible groups and at-risk populations. A comparison of 
seroprevalence and coverage data can be useful in quantifying the impact 
immunization programs have on reducing vaccine-preventable diseases 
such as measles. In collaboration with the 2013-14 Demographics and 
Health Survey (DHS) conducted in the Democratic Republic of the Congo 
(DRC), we evaluated the seroprevalence of IgG antibodies to measles 
using a multiplex format (M2) from dried blood spots from children 6 
- 59 months of age and compared these results to 2013 administrative 
vaccination coverage data provided by the DRC Expanded Programme 
on Immunization (EPI) to evaluate the DRC Routine Immunization (RI) 
program. The lowest seropositivity rates were seen in Kasai Occidental 
(53.6%), Kasai-Oriental (51.9%), Katanga (51.4%), and Maniema (51.9%) 
provinces. Average measles vaccination coverage rates were 92%, 91%, 
93.3%, 88% respectively. Of the 516 health zones in DRC, 71 reported 
vaccination coverage rates above 100%. Our findings suggest that gaps 
in measles immunity exist throughout the country and administrative 
coverage rates may be overestimated. Vaccine effectiveness and 
vaccination coverage rates should be thoroughly assessed to understand 
the drivers of immunity gaps that should be addressed to improve the RI 
system.
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DETECTION OF HUMAN ENTEROVIRUS 71 FROM AN 
OUTBREAK OF HAND FOOT AND MOUTH DISEASE IN 
BANJARMASIN, INDONESIA
Ageng Wiyatno1, Ungke A. Jaya2, Chairin N. Ma’roef1, Tina 
Kusumaningrum1, Aghnianditya K. Dewantari1, Dodi Safari1, Khin 
S. Myint1, David McIver3, Edi Hartoyo4
1Eijkman Institute, Jakarta, Indonesia, 2Eijkman-Oxford Clinical Research 
Unit, Jakarta, Indonesia, 3Metabiota, San Francisco, CA, United States, 
4University of Lambungmangkurat, Banjarmasin, Indonesia
Enterovirus 71 (EV71), a single-stranded RNA virus of the Picornavirus 
family, is a common cause of Hand, Foot and Mouth Disease (HFMD). The 
infection usually manifests with fever, rash, blister and in severe cases may 
proceed to encephalitis. EV71 epidemics have occurred in the Asia-Pacific 
region, including Taiwan, mainland China, Hong Kong, Malaysia, Vietnam, 
Singapore, and Thailand for the past decade. We identified EV71 virus in 9 
specimens from children presenting with fever and HFMD in Banjarmasin, 
South Kalimantan (n=13) in early 2016. Viral RNA was isolated from nasal 
swab, followed by cDNA synthesis using random primers. Specimens were 
tested by conventional PCR using enterovirus genus-level primers, followed 
by specific primers to determine the strain using DNA sequencing. 
Sequencing analysis demonstrated 98-100% similarity with the Malaysian 
strain and was shown to belong to subgenotype B5. Phylogenetic analysis 
of the VP1 gene suggests that the EV71 strain causing the outbreak in 
Banjarmasin could have originated from Malaysia. In parallel, virus was 
isolated in Green Monkey Kidney Epithelial Cells (Vero 81) which displayed 
severe cytophathic effects (n=7) after 2 passages. We report the finding 
of EV71 as a causative agent of HFMD outbreak in Banjarmasin. To our 
knowledge, this is the first detection and isolation of EV71 in Indonesia.
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DYNAMIC MODEL OF ROTAVIRUS TRANSMISSION WITH 
IMPACT OF TEMPERATURE
Nan Lin, Alicia Kraay, Joseph Eisenberg
University of Michigan, Ann Arbor, MI, United States
Although rotavirus exhibits seasonality, water quality risk assessments do 
not consider temperature. Additionally, prior rotavirus transmission models 
have not previously considered the water as a driver of transmission. 
We conducted a meta-analysis to estimate the effect of temperature on 
rotavirus decay rate separately for monophasic and biphasic decay. We 
then used these estimates in a rotavirus transmission model that explicitly 
modelled the water reservoir. The model was seeded by allowing water to 
flow into the water reservoir from an upstream community. We assessed 
the critical transmissibility from water to humans necessary to seed the 
outbreak and assessed how this might vary by temperature. Temperature 
was significantly associated with decay rates for monophasic decay, with 
8.77°C increasing in temperature related to 1 log increase in rotavirus 
decay rate (p = 0.0003). For biphasic decay, temperature had a marginally 
significant effect on the first phase of decay with 3.37°C being associated 
with a 1 log increase in rotavirus decay rate (p = 0.0735). Temperature did 
not appear to effect the second phase of decay. In our transmission model, 
we found that a rotavirus outbreak was inevitable as long as pathogen 
existed in water source regardless of the transmission rate from water 
to humans, because of the combination of high shedding rates and low 
infectious dose for rotavirus. Temperature altered the time period before 
peak of infected arrived, with higher temperatures leading to slower 
outbreaks. These results show a mechanism by which temperature may 
affect risk of rotavirus and suggest that the water may be an effective 
conduit of disease between communities.
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FIRST LABORATORY CONFIRMATION OF AN OUTBREAK OF 
RIFT VALLEY FEVER VIRUS IN 50 YEARS IN KABALE DISTRICT, 
SOUTHWESTERN UGANDA
Trevor Shoemaker1, Stephen Balinandi1, Like Nyakarahuka2, 
Joseph Ojwang1, Alex Tumusiime1, Sophia Mulei2, Jackson 
Kayondo2, Jeff Borchert1, Julius Lutwama2, John Klena3, Pierre 
Rollin3, Stuart Nichol3
1CDC, Entebbe, Uganda, 2UVRI, Entebbe, Uganda, 3Centers for Disease 
Control and Prevention, Atlanta, GA, United States
On March 10, 2016, the Uganda Virus Research Institute/Centers for 
Disease Control (UVRI/CDC) Viral Hemorrhagic Fever (VHF) laboratory 
was notified of 2 suspect VHF cases from Kabale district, South Western 
Uganda. Both cases were confirmed as RVF by RT-PCR and IgM serology. 
Within 24 hours a team from UVRI, the Uganda MOH, and CDC-
Uganda traveled to Kabale to carry out epidemiological and ecological 
investigations. Both cases presented with febrile illness and reported fever, 
vomiting, fatigue, abdominal pain, headache, epistaxis, and melena. The 
initial case was a butcher who worked in the central Kabale abattoir. 
The second case was a student who resided approx. 12Km south from 
central Kabale. The two cases were not epidemiologically linked. There 
were a total of 8 suspect cases and 2 probable deaths identified. The 
team performed an initial investigation to determine the extent of the 
outbreak. Samples from 21 family member and community members of 
the confirmed and probable cases were collected, along with 86 livestock 
specimens from the same locations. One suspect human case was positive 
for RVF by IgG, but negative for IgM and RT-PCR, and classified as a 
convalescent confirmed case. No additional human cases were confirmed 
from the samples collected. 9% of livestock specimens tested positive 
for RVF by IgG, and one caprine from the village of one of the confirmed 
cases also tested positive by RT-PCR. An expanded district-wide human 
and livestock serosurvey was initiated following these results to determine 
how widespread RVF transmission is in the region. A total of 657 human 
and 1052 livestock samples were collected and are currently being tested. 
Extensive outbreaks of RVF have occurred elsewhere in East Africa, notably 
in 1997-8 and 2006-7. This RVF outbreak in Kabale represents the first 
reported laboratory confirmed human cases in Uganda since 1968. It also 
represents the 11th independent VHF outbreak confirmation in Uganda 
since the beginning of enhanced VHF surveillance in 2011.
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A RETROSPECTIVE COHORT STUDY OF SEROPREVALENCE OF 
EBOLA AND MARBURG VIRUSES IN HUMANS FROM TWO 
DIFFERENT ECOLOGICAL ZONES IN UGANDA
Like Nyakarahuka1, Alex Tumusiime2, Stephen Balinandi2, Ilana 
Schafer3, Barbara Knust3, Jackson Kyondo1, Sophia Mulei1, Julius 
Lutwama1, Trevor Shoemaker2
1UVRI, Entebbe, Uganda, 2CDC, Entebbe, Uganda, 3Centers for Disease 
Control and Prevention, Atlanta, GA, United States
Filoviruses cause high morbidity and mortality and pose a threat to human 
and animal populations. Uganda has experienced eight filovirus outbreaks 
in the past 15 years; five caused by Ebola virus and three by Marburg virus. 
The aim of this study was to determine if people living in and around bat 
inhabited mines in medium-high mountainous areas in Western Uganda 
might have increased exposure to filovirus infection compared to those in 
wooded savannah in Central Uganda. A retrospective cohort study was 
conducted. The exposed groups were miners and their family members; 
and communities within 50km from Kitaka mine in Ibanda district, 
Western Uganda. The control group was located in Central Uganda with 
no mining activity. A risk factor questionnaire was administered and blood 
samples collected from 740 people. Blood samples were tested for the 
presence IgG against Sudan Ebolavirus and Marburg virus at the Uganda 
Virus Research Institute. The exposed group comprised 60% (444/740) and 
controls were 40% (296/740). Filovirus seroprevalence was 3.2% (24/740) 
overall; Sudan ebolavirus 2.4% (18/740) and Marburg virus 0.8% (6/740). 
Although not statistically significant, the exposed group had 2.5 times 
the risk of being infected with filovirus compared to the control group; 
RR=2.5(95%CI, 0.96 - 6.7) whereas miners or their family members were 
2.2 times as likely to be infected compared to other occupations (RR=2.2, 
0.98 - 4.7). Other risk factors include going into mines or caves inhabited 
by fruit bats (RR=2.5, 1.12 - 5.66), residing in a village that had a previous 
outbreak of filovirus (RR=2.7, 1.24 - 6.04) and having had contact with a 
suspect case of filovirus infection (RR=4.5, 1.66 - 12.56). This sero-survey 
in Uganda indicates there may be an underestimate of filovirus infections 
occurring, thus more outbreaks going undetected. Health facilities need to 
increase their level of suspicion for Uganda viral hemorrhagic fever (VHF) 
as a possible cause of acute febrile illness. The Uganda VHF surveillance 
program has initiated enhanced febrile illness surveillance strategies to 
detect and respond to potential sub-clinical filovirus infections.
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THE POTENTIAL ECONOMIC IMPACT OF THE ZIKA VIRUS
Dagna O. Constenla, Jorge Martin del Campo, Alexandra 
Greenberg, Gatien de Broucker
Johns Hopkins University, Baltimore, MD, United States
The sudden rise of Zika cases is unnerving. This situation has forced the 
World Health Organization (WHO) to declare the epidemic of microcephaly 
cases in regions affected by Zika virus a matter of public health emergency 
of international concern. Beyond the silent suffering among those directly 
affected by the Zika virus, there are many concerns about the negative 
impact that the Zika outbreak will have on the economy of countries 
affected by Zika. One concern is the potential negative impact of the 
Zika virus on the tourism industry. Though currently there are no travel 
restrictions imposed by the WHO, there have been anecdotal reports 
about international airlines already cancelling or rescheduling flights for 
passengers that are traveling to the region that are pregnant or may 
become pregnant. Moreover, evidence is emerging on the impact that 
Aedes aegypti diseases have on tourism revenues. Added to the potential 
significant losses associated with tourism, the possible decline on foreign 
direct investment due to the Zika outbreak is a major concern. Investments 
in outbreak control and surveillance infrastructure may also be impacted 
by the recent Zika outbreak. The loss of productivity due to the Zika 
outbreak is an even greater concern. At a macro level, the Zika outbreak 
could have other long-term repercussions. There are several challenges 
that affected communities in the Americas face to contain the spread of 
the virus. In the current systematic review we will explore these challenges 
and delve deep into the potential economic impact of the Zika virus. 
Evidence of the economic potential of the Zika virus is critical to informing 
policy decisions and securing financial support for future Zika prevention 
and control strategies.
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THE EVOLUTION AND DIVERSITY OF HUMAN 
METAPNEUMOVIRUS IN PERU
Simon Pollett1, Tany Tan2, John-Sebastian Eden3, Víctor Ocaña4, 
Silvia Mendocilla5, Carlos Álvarez6, Maria E. Calixto7, Christopher 
Mores8, Julia S. Ampuero8, Martha I. Nelson9
1University of California, San Francisco, San Francisco, CA, United States, 
2J. Craig Venter Institute, Rockville, MD, United States, 3University of 
Sydney, Sydney, Australia, 4Pachitea Health Center, Ministerio de Salud, 
Piura, Peru, 5Hospital Daniel Alcides Carrión, Ministerio de Salud, Callao, 
Peru, 6Dirección Regional de Salud, Loreto, Peru, 7Hospital Nacional 
Edgardo Rebagliati Martins, Seguro Social de Salud-EsSalud, Lima, Peru, 
8U.S. Naval Medical Research Unit-6, Callao, Peru, 9Fogarty International 
Center, National Institutes of Health, Bethesda, MD, United States
Human metapneumovirus (HMPV) causes substantial morbidity in the very 
young, elderly and immunosuppressed, yet there is limited knowledge 
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of the diversity and epidemiology of this virus in Peru and other tropical 
countries. Therefore, we examined the evolution and spatial patterns 
of HMPV in Peru through phylogenetic analysis of 61 whole-genome 
sequences of HMPV collected in three regions of Peru; the largest 
genomic dataset from any tropical country to date. 61 HMPV PCR positive 
respiratory specimens archived from an influenza-like-illness sentinel 
and active surveillance study in Lima (temperate capital), Piura (northern 
coastal desert) and Loreto (tropical Amazon) from 2008-2012 underwent 
high-throughput whole genome sequencing using Illumina and Ion Torrent 
platforms. A 375 F-gene sequence dataset was constructed that included 
Peruvian and other global background sequences available from GenBank. 
A Maximum Likelihood tree, with 100 bootstrap replicates, was inferred by 
the RAxML package using a GTR + gamma nucleotide substitution model. 
Extensive genetic diversity of HMPV was identified in Peru, including the 
A2, B1 and B2 subgroups (A1 was not identified). Within a single year, the 
genetic diversity of HMPV identified in Peru represented nearly the entire 
global diversity of HMPV, owing primarily to multiple independent viral 
introductions into Peru each year. Possible multi-year persistence of HMPV 
was observed in Loreto and Piura, although low background sampling 
from other countries and locations in Peru complicates conclusions about 
local persistence. The high diversity observed in more isolated tropical 
locales such as Loreto and Piura is attributable to both viral introductions 
from other countries as well as gene flow within Peru. There is evidence 
of substantial HMPV viral traffic within Peru and between Peru and other 
global regions. Significant HMPV diversity exists even in more isolated 
regions of Peru. These findings underscore the rapid and extensive 
diffusion of respiratory viruses in tropical countries, which may have 
implications for the effectiveness of a HMPV vaccine across diverse global 
regions.
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EVALUATION OF THE BIOJECT NEEDLE FREE VACCINE 
DELIVERY DEVICE FOR VACCINATING RATS WITH RIFT 
VALLEY FEVER VACCINE CANDIDATES
Pedro M. Palermo, George Bettinger, Douglas Watts
University of Texas at El Paso, EL Paso, TX, United States
Rift Valley Fever virus (RVFV) is a major public health and agricultural 
concern in Africa and the neighboring region. The only potential approach 
for preventing epidemics of RVFV is to develop and deliver an effective 
vaccine for livestock and humans. The aim of this study was to evaluate 
a Bioject needle free vaccine delivery device for potential use to vaccinate 
animals. In this study as preliminary assessment the Bioject device were 
conducted in laboratory Wistar rats, using the device with and without a 
spacer, suggesting a route of delivery to be intradermal and intramuscular 
respectively. Two doses of the RVF MP-12NSm-del vaccine of 1 x 103 and 1 
x 105 plaque forming units (PFU) were used. Blood samples were collected 
on day -1 before being vaccinated and at days 7, 11, 15, and 25 post-
vaccination (PV), and tested for IgG antibodies by ELISA, and using 80% 
reduction in the MP-12 virus dose as the endpoint for determining the 
neutralizing antibody (NA) titers. Most all animals vaccinated with the RVF 
MP-12NSm-del vaccine with or without a spacer developed detectable NA 
by day 7 PV and persisted at or above the titers on day 7 through 25 days 
PV or the duration of the experiment, with titers ranging from 1:10 to 
1:1280. In contrast, the ELISA optical density (OD) values were below IgG 
antibody positive levels on day 7 PV and not until day 11 PV that positive 
OD values started to become detectable, with the OD values being higher 
for the animals that were vaccinated without the spacer. In contrast to the 
animals vaccinated with the Bioject device, the NA titers and the ELISA OD 
values were lower for the animals vaccinated with 1 x 105 PFU of the RVF 
MP-12NSm-del and 1 x 105 PFU of the RVF MP-12 vaccines using a needle, 
thus suggesting that the Bioject needle free delivery device may be a more 
convenient and effective method of vaccinating animals with RVF vaccines. 
Finally, these preliminary data are very exciting and promising in regard 
to our goal of utilizing a needle free delivery method for vaccinating 
animals with RVF vaccines in Africa. Acknowledgement/Disclaimer: This 
work was made possible by the generous support of the American people 
through the United States Agency for International Development (USAID) 
DISCLAIMER The author’s views expressed in this publication do not 
necessarily reflect the views of the United States Agency for International 
Development or the United States Government.
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MODEL FOR NIPAH VIRUS INFECTION
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Vincent Munster3, Michael R. Holbrook1
1National Institute of Allergy and Infectious Diseases Integrated Research 
Facility, Frederick, MD, United States, 2Center for Infectious Disease 
Imaging, Bethesda, MD, United States, 3Rocky Mountain Laboratories, 
Hamilton, MT, United States
Nipah virus (NiV) is a zoonotic pathogen endemic to parts of Indonesia and 
the Asian subcontinent, particularly Bangladesh. Infection in humans can 
lead to severe respiratory or neurologic disease and death. Mechanisms of 
NiV-related disease and discriminators between respiratory or neurologic 
disease are unknown. Here, we focused on expanding the understanding 
of NiV infection in African Green Monkeys (AGM) by quantifying multiple 
parameters of the immune response to NiV infection. We also used 
Computed Tomography (CT) and Magnetic Resonance Imaging (MRI) 
to assess disease progression following intratracheal (IT) and aerosol 
administration of virus. Animals developed a primarily respiratory disease, 
with those infected by the IT route developing pulmonary lesions with 
significant edema and consolidation. Animals infected by small particle 
aerosol developed a more diffuse disease. Two animals developed changes 
in the brain vasculature with suggestion of slightly engorged cortical 
veins late in the disease process, of unknown clinical significance. Survival 
times post-challenge were equal in the two groups (~8 days). Five of 6 
animals developed a profound thrombocytopenia, manifested by severe 
subcutaneous hemorrhage at necropsy. Assessment of leukocytes revealed 
evidence of lymphopenia and neutrophilia, but with apparent expansion of 
activated CD8+ T cell populations in two of the aerosol exposed animals. 
These findings correlated with increases in serum cytokine levels indicating 
a proinflammatory response and Th1 differentiation of T cell populations. 
Populations of immune cells in the lungs were largely unremarkable except 
for elevated monocyte populations in the aerosol group relative to the 
IT inoculated group. These data demonstrate that IT and small particle 
aerosol inoculation of AGM results in a rapidly progressing respiratory 
disease largely devoid of neurological indications. These studies support 
previous work demonstrating a significant role for endothelial cell 
dysfunction in disease. It was evident that the rate of disease progression 
limited development of an effective immune response.
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SEROEPIDEMIOLOGICAL STUDIES FOR INFECTIONS BY 
VECTOR-BORNE AND ZOONOTIC PATHOGENS AMONG U.S. 
MILITARY PERSONNEL
Brett M. Forshey
Armed Forces Health Surveillance Branch/Cherokee Nation Technology 
Solutions, Silver Spring, MD, United States
Vector-borne and zoonotic pathogens have long detracted from 
operational readiness of U.S. forces stateside and deployed around the 
world. Notable historical examples include the impact of malaria and 
dengue during World War II, hantavirus infections during the Korean War, 
and more recently, a 2003 outbreak of Plasmodium falciparum among 
marines deployed to Liberia. Military populations present a challenge for 
public health surveillance, as they are highly mobile and often deploy to 
austere settings in remote and, at times, unstable regions of the world, 
which limits available diagnostic and treatment options. Vector-borne and 
zoonotic infections are often associated with acute undifferentiated febrile 
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illness and thus are difficult to distinguish clinically, further exacerbating 
challenges for diagnosis and control. As a result, the burden of vector-
borne diseases among U.S. military personnel remains poorly defined. 
To address this gap, we initiated seroepidemiological studies among U.S. 
military personnel, capitalizing on serum samples available through the 
Department of Defense Serum Repository (DoDSR). The DoDSR has been 
utilized to measure infections among DoD personnel to a diverse set of 
pathogens, including Rickettsia spp. in South Korea, Coxiella burnetii 
in Iraq, and Plasmodium falciparum in Liberia. Recently initiated studies 
will address infections by vector-borne and zoonotic pathogens among 
DoD personnel deployed to West Africa and to measure the incidence 
of infections by emerging viral pathogens, including dengue virus, 
chikungunya virus, and Zika virus, in the Caribbean. Results from these 
analyses, in conjunction with associated febrile illness data reported 
through electronic surveillance systems, can be used to inform force health 
protection measures and prioritize the development of diagnostics and 
medical countermeasures.
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DETERMINATION OF HEPATITIS B VIRUS (HBV) INFECTION IN 
FAMILY MEMBERS OF HBSAG CARRIERS: SEARCH STRATEGY 
OF CARRIERS FOR A ELIMINATION PLAN OF HBV
Cesar Cabezas-Sanchez1, Johanna Balbuena Torres2, Luis Crispin-
Huamani1, Kevin Landa-Huaman1, Katia Rios-Rojas1, Andrea 
Sucari-Idrogo1, Andrea Anampa-Guzmán1
1National University of San Marcos, Lima, Peru, 2Instituto Nacional de 
Salud, Lima, Peru
Huanta was a city with a high endemic of hepatitis B virus (HBV). However, 
now a HBV elimination plan HBV is feasible because the immunization 
in people under the age of 20 that started in 1994 have had a good 
impact. The aim of our study is to determine the prevalence of hepatitis 
b virus (HBV) infection in family members of HBsAg carriers as a search 
strategy of carriers for an HBV elemination plans. This cross-sectional study 
included the family members (n=40) of 15 HbsAg (+) patients at Huanta’s 
Hospital. Demographic data, vaccination status, relationship with the 
patient and risk factors were reviewed by a questionnaire. Blood samples 
were taken to determine HBV and hepatitis D virus (HDV) markers. Data 
were analyzed using t-test and chi-square. The protocol of this study was 
approved by the Ethics Committee of the Institute of Tropical Medicine of 
the National University of San Marcos. The 5.5% of the family members 
have an acute infection and 22.2% were chronically infected. All of them 
were over the age of 23. Family members that have or had HBV infection 
were significantly older, consumed significantly more alcohol and traveled 
significantly more to endemic zones than those who never had the 
infection (p=0.00, p=0.04 and p=0.02 respectively). None of the family 
members were infected with the HDV. The main limitation of this study 
is that it is only a pilot study before establishing a global search strategy 
of HBsAg carriers. In conclusion, the HBV carriers search in families found 
a high prevalence of HBV and would help to identify chronic carriers 
that can be treated and contribute to a HBV elimination plan Key-words: 
Hepatitis B, intrafamiliar, carriers.
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IS IT EBOLA OR IS IT A VACCINE REACTION? EVALUATION OF 
SUSPECTED EBOLA CASES IN A VACCINE TRIAL DURING AN 
EBOLA EPIDEMIC: SIERRA LEONE TRIAL TO INTRODUCE A 
VACCINE AGAINST EBOLA (STRIVE)
Samuel Kargbo1, Abbass Conteh2, Jane Gidudu3, the STRIVE 
study team
1Sierra Leone Ministry of Health and Sanitation, Freetown, Sierra Leone, 
2College of Medicine and Allied Health Sciences, Freetown, Sierra Leone, 
3Centers for Disease Control and Prevention, Atlanta, GA, United States
STRIVE is a phase 2/3 trial of rVSV-ZEBOV (Merck) candidate Ebola 
vaccine among healthcare and frontline response workers in Sierra Leone. 
The early symptoms of Ebola virus disease (EVD) typically include fever, 
headache, fatigue, and muscle/joint pain, similar to immediate vaccine 
reactions. Rapidly distinguishing EVD from vaccine reactions was a key 
component of STRIVE. Isolation and treatment were essential for true 
EVD, but referring participants with vaccine reactions to Ebola Holding 
Units (EHU) could increase the risk of Ebola exposure. In consultation with 
national response authorities, we developed a modified algorithm for 
management of EVD-like illness following vaccination. The national EVD 
case definition was temperature > 38.0oC and > 3 of the following 11 
symptoms: headache, loss of appetite, fatigue, muscle/joint pain, diarrhea, 
unusual bleeding, difficulty breathing, nausea/vomiting, abdominal pain, 
difficulty swallowing, hiccups. The case definition was modified for 
participants vaccinated within the past 48 hours to require that one of 
the three symptoms be EVD-specific (diarrhea, unusual bleeding, difficulty 
breathing, nausea/vomiting, abdominal pain, difficulty swallowing, 
hiccups). Those vaccinated participants who did not meet the modified 
case definition could remain home and be followed for up to 24 hours 
if improving rather than referral to an EHU unless they reported direct, 
unprotected Ebola exposure or breach in the use of personal protective 
equipment in the prior 21 days. Participants referred to an EHU were 
tested by PCR for Ebola virus. To implement the modified algorithm, we 
trained EHU staff and Ebola hotline telephone operators to ask about 
participation in STRIVE and on post-vaccination symptoms and the 
modified algorithm. As of April 5, 2016, 48 STRIVE participants had been 
evaluated for suspect EVD; all were negative. The most common diagnosis 
was malaria, reported in approximately half. STRIVE was able to develop 
and implement a modified Ebola case definition to evaluate suspected 
EVD cases and prevent unnecessary admissions to EHUs during an Ebola 
outbreak.
1399
DEFINING A MULTIVALENT VACCINE AGAINST 
HEMORRHAGIC FEVER VIRUSES BASED ON INSECT CELL 
EXPRESSED RECOMBINANT SUBUNITS
Axel Lehrer, Teri-Ann S. Wong, Madhuri Namekar, Michael M. 
Lieberman
University of Hawaii, Honolulu, HI, United States
We have previously developed a preclinical Ebola vaccine candidate based 
on soluble recombinant Ebola virus (EBOV) glycoproteins (GP) and matrix 
proteins (VP24 and VP40) produced using the Drosophila S2 cell expression 
system combined with antigen-specific immunoaffinity chromatography 
purification. The immunogenicity and efficacy of this candidate has 
successfully been evaluated in mice, guinea pigs and macaque models. The 
lead candidate, which is protective in non-human primates, is undergoing 
additional pre-clinical development with a focus on defining correlates of 
protection. To broaden the efficacy profile of the core vaccine, GP subunits 
of Sudan virus (SUDV), Marburgvirus (MARV), and Lassa virus (LASV) 
have been expressed and purified using the same production platform. 
Having achieved a similar level of purity for the additional subunits, we 
started immunogenicity and preliminary efficacy testing in rodent models. 
As expected, GP subunits of the additional filoviruses show a similar 
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immunogenicity profile as EBOV GP with SUDV GP showing greater 
cross-reactivity with EBOV GP than MARV GP. With the use of clinically 
relevant adjuvants, potent antigen-specific IgG titers were observed after 
two or three immunizations of Swiss Wester (outbred) mice. Antigen 
balancing studies using the three filovirus GP proteins allowed the 
selection of candidate formulations that consistently achieve balanced 
humoral immunity to all three viruses. Current work focuses primarily on 
incorporation of the LASV GP to achieve a broadly effective formulation 
targeting all major hemorrhagic fever viruses with epidemic potential in 
sub-saharan Africa.
1400
DENGUE, ZIKA AND CHIKUNGUNYA CO-INFECTIONS 
AMONG ACUTE FEBRILE ILLNES PATIENTS IN SALVADOR, 
BRAZIL
Laura B. Tauro
Centro de Pesquisas Gonçalo Moniz/FIOCRUZ-BA, Salvador, Brazil
Chikungunya (CHIKV) and Zika viruses (ZIKV) have recently emerged in 
tropical countries of the western hemisphere, causing large epidemics in 
settings where dengue virus (DENV) transmission is endemic. Since all of 
these RNA arboviruses transmitted to humans by the same Aedes spp. 
mosquitoes, co-infections may occur regularly during outbreaks. However, 
as the manifestations in the initial stages of illness asued by thee viruses 
aresimilar and laboratory diagnosis are not widely available, detection 
of co-infections is uncommon. We investigated the frequency of DENV, 
CHIKV and ZIKV co-infections among acute febrile illness outpatients 
during a period of high arboviral transmission in Salvador, Brazil. RT-PCRs 
specific for DENV, CHIKV and ZIKV, as reported previously, were performed 
on acute-phase serum samples of 180 acute febrile illness patients who 
visited an Emergency Center in Salvador, Brazil between September 2014 
and October 2015. An arboviral infection was detected in 46 (25.5%) 
of the 180 tested samples. Arboviral co-infections were detected in 5 
samples (2.8% of the 180 tested samples and 10.9% of the 46 arboviral 
positive samples). DENV was detected in 16 (8.9%), CHIKV in 18 (10.0%), 
and ZIKV in 7 (3.9%) of the samples. DENV and CHIKV co-infection 
was detected in 4 (2.2%) samples, while DENV and ZIKV co-infection 
was detected in 1 (0.6%) sample. Among the samples that were solely 
positive for DENV, four were type 1, six were type 3, and five were type 
4. All four samples that tested positive for DENV and CHIKV were DENV 
type 4, while the sample positive for DENV and ZIKV, wasDENV type 
3. All five co-infected patients had fever, headache, retro-orbital pain, 
myalgia, arthralgia, prostration and rash, and recovered completely.  In 
conclusion, our study indicates that arboviral co-infections are not a rare 
event in settings where DENV, CHIKV and ZIKV co-circulate. Apparently, 
co-infections do not change disease presentation and disease course, but 
further studies with larger number of patients are warranted to confirm 
this observation.
1401
KNOCK DOWN RESISTANCE (KDR) GENE IN ANOPHELES 
COLUZZII AND AN. GAMBIAE THAT SURVIVED THE 
DIAGNOSTIC CONCENTRATION OF PYRETHROIDS AND 
DDT IN TWO ECO-EPIDEMIOLOGICAL ZONES (GUINEA 
SAVANNAH AND COASTAL MANGROVE) OF NIGERIA
Lazarus M. Samdi1, Petrus U. Inyama1, Henry Nsa1, Nduka 
Iwuchukwu1, Joseph I. Okeke1, Samson T. Awolola2, Greg Ike 
Anyanwu3, Nnenna Ezeigwe4, Joel D. Akilah4, Aklilu Seyoum5, 
Dereje Dengela6, Uwem Inyang7, Richard W. Niska8, Jessica 
Kafuko7, Pamela Dasher6, Laura Norris9, Christen Fornadel9, Peter 
Obenauer10
1PMI AIRS Project, Abuja, Nigeria, 2Nigeria Institute for Medical Research, 
Yaba, Lagos, Nigeria, 3Nasarawa State University, Keffi, Nigeria, 4National 
Malaria Elimination Program, Federal Ministry of Health, Abuja, Nigeria, 
5PMI AIRS Project, Abt Associates, Tamale, Ghana, 6PMI AIRS Project, 
Abt Associates, Bethesda, MD, United States, 7U.S. President’s Malaria 
Initiative/U.S. Agency for International Development, Abuja, Nigeria, 8U.S. 
President’s Malaria Initiative, Division of Parasitic Disease and Malaria, 
U.S. Centers for Disease Control and Prevention, Abuja, Nigeria, 9U.S. 
President’s Malaria Initiative/U.S. Agency for International Development, 
Washington, DC, United States, 10Navy and Marine Corps Public Health 
Center Detachment-Centers for Disease Control and Prevention, Atlanta, 
GA, United States
The scale-up of long-lasting insecticidal nets (LLINs) has contributed 
significantly to the reduction of malaria morbidity and mortality in 
Nigeria. However, insecticide resistance remains a challenge. Here, we 
report susceptibility status to insecticides and the frequency of the kdr 
alleles in Anopheles coluzzii and An. gambiae. Susceptibility tests were 
carried out on An. gambiae s.l. mosquitoes from larval collections, with 
deltamethrin and DDT using standard WHO procedures. Additionally, adult 
mosquitoes were sampled inside houses using human-baited CDC Light 
Trap collections between May and September 2015 and were identified 
using morphological keys. These samples were subjected to polymerase 
chain reaction (PCR) assays for species identification and detection of An. 
coluzzii and An. gambiae. The kdr genotypes were determined both in An. 
gambiae s.l. collected indoors and those that survived insecticide exposure 
using allele-specific PCR tests. PCR results show that An. coluzzii and 
An. gambiae occurred in sympatry at both sites. However, An. gambiae 
predominated, representing 71.2% and 84.4% of the 500 An. gambiae 
s.l. tested in Nasarawa and Lagos, respectively. There was no detection 
of An. coluzzii + An. gambiae bands in any specimen suggesting the 
absence of hybrid state. The kdr diagnostic PCR showed the presence of 
the kdr-west mutation in 3.3% of samples collected indoors at Nasarawa, 
but in 27.0% of samples that survived deltamethrin exposure. In Lagos, 
kdr-west was present in 10.0% of samples collected indoors versus 28.8% 
in those that survived deltamethrin exposure. The difference between 
both sets of samples was statistically significant (p<0.0001) with a higher 
kdr frequency on samples that survived the diagnostic dosages than 
those collected indoors. More homozygotes were found among samples 
that had kdr, while none of An. coluzzii in both sites was positive for the 
kdr mutation. Overall, kdr frequencies were within the range recorded 
earlier in Southwestern Nigeria between 2002-2005. Further investigation 
is needed to learn the operational implication of the frequency of kdr 
genotype observed.
1402
INTERCEPTOR G2: A NOVEL LN FOR MALARIA CONTROL 
AND BEYOND
James William Austin
BASF Corporation, Research Triangle Park, NC, United States
The utility of bed nets to combat the scourge of malaria has been 
undeniably successful. However, a negative consequence of the 
441
astmh.org
widespread use of long-lasting insecticidal nets or LNs, has been the 
accompaniment of selection which further exacerbates well-known 
resistance issues to neuro-toxic chemistries (like pyrethroids) for 
mosquitoes. The technical difficulties of utilizing other insecticidal active 
ingredients with alternative modes of action (beyond pyrethroids) has been 
a limiting factor for LN development, largely owed to mitigation needs 
for safety to sleepers (like pregnant mothers and children) that would use 
them and the physical-chemical nature of the insecticides’ opportunity 
to be incorporated into LNs—most notably solubility of insecticides is 
challenging to overcome in order to insure they adhere to both the wash-
resistance and efficacy performance profile recommended by WHOPES. 
Interceptor G2 achieves this difficult balance of needs. Interceptor G2 is a 
novel net unique among LNs, because it is truly the first net which includes 
two discrete adulticides, each with unique modes of action with both 
an excito-repellent component (alpha-cypermethrin) and a physiological 
insecticide (chlorfenapyr) that work in a concerted way to provide 
improved protection to LN users. This unique combination can provide 
significantly better efficacy to resistant mosquitoes. Field testing results 
from Benin, Burkina Faso and Tanzania have unequivocally demonstrated 
significantly higher efficacy to resistant mosquito strains (40-60% 
increased mortality to resistant strains). This net, developed by BASF 
through a partnership with IVCC holds great promise as a remarkable LN 
that can complement any area-wide efforts to protect malaria transmission 
unlike any other LN currently in the market, exploiting mosquito resistance 
mechanisms against themselves and affording improved protection to its 
users.
1403
WHO SUSCEPTIBILITY TEST VS. CDC BOTTLE BIOASSAY: 
COMPARISON OF THE CURRENT METHODOLOGIES FOR 
CONDUCTING INSECTICIDE RESISTANCE MONITORING
Laura Leite, Dustin Miller, Pauline Schopp, Paul Howell, Ellen 
Dotson
Centers for Disease Control and Prevention, Atlanta, GA, United States
Malaria incidence has dropped by 37% among populations at risk 
between 2000 and 2015 and death rates have decreased by 60% 
globally. Vector control interventions, namely insecticide treated nets and 
indoor residual spraying, have proven to be the largest contributors to 
the reduction in malaria incidence over the past 15 years. The extensive 
use of these insecticide based vector control techniques have selected 
for resistance in the Anopheles mosquitoes, the principal vectors of the 
malaria parasite. Numerous studies have demonstrated the presence 
of insecticide resistant mosquito populations throughout Sub-Saharan 
Africa. The World Health Organization (WHO) susceptibility test and the 
Centers for Disease Control and Prevention bottle assay are used to detect 
insecticide resistance within mosquito populations. To determine if the two 
methods are comparable, both assays were conducted on six laboratory 
reared insecticide resistant mosquito strains from three different Anopheles 
species: An. gambiae (RSP, ZAN/U and TORORO), An. coluzzi (AKDR, 
AKRON), and An. arabiensis (SENN). The six strains were tested against five 
compounds from three of the four classes of insecticides recommended 
by WHO: organochlorides (dieldrin and DDT), carbamates (bendiocarb) 
and pyrethroids (permethrin and deltamethrin). Results indicate definite 
differences in 24 hour mortality and knockdown rates between the two 
test methods with the CDC bottle assay often yielding significantly higher 
mortality. Significant variability, between methods as well as test reps, was 
seen across all mosquito strains when testing for organochloride (DDT) 
resistance. Both tests use the same standard for determining resistance: 
98% to 100% mortality indicates susceptibility, 90% to 97% mortality 
suggests the possibility of resistance with additional tests needed, and 
<90% mortality confirms insecticide resistance. These test methods are 
important instruments for insecticide resistance surveillance systems and 
inconsistency between the two can lead to different insecticide resistance 
classifications and subsequent vector control program actions.
1404
CAN CHICKEN FEATHERS BE USED TO PRODUCE EFFECTIVE, 
RE-USABLE, DURABLE AND LOW-COST MOSQUITO NETS?
Isaac Lyatuu1, Walter Schmidt2, Samson Kiware1
1Ifakara Health Institute, Dar-es-Salaam, United Republic of Tanzania, 
2United States Department of Agriculture, Agricultural Research Service, 
Beltsville, MD, United States
Treated mosquito nets have dramatically reduced indoor malaria 
transmission. However, they are not readily accessible and affordable. 
Among challenges of existing nets include easily torn-out and fail to 
inhibit blood feeding after few years of use. Here we study possibilities 
of using chicken feathers, a waste by-product, to produce low cost, 
durable, reusable, effective, and community affordable mosquito nets 
that adheres to WHO standards. Initial stages prior to making the nets 
involved laboratory tests similar to WHO cone test (i.e., regeneration 
time, wash-resistance, and efficacy) against pure feathers, and on fabrics 
material made from chicken feathers. The tests were performed on Aedes 
aegypti using permethrin. The preliminary results indicate that pure 
feathers and made fabric material can absorb and retain insecticide. Pure 
feathers had 100% knockdown and mortality effect, and made fabric 
had 80-100% knockdown and mosquito mortality. These results were 
read after 3 consecutive washes (i.e., 48, 72, and 96 hrs). The promising 
findings from initial stages indicate that there are possibilities of using 
chicken feathers to potentially produce effective, re-usable, durable, and 
affordable mosquito nets. Such nets will be subjected to semi-field WHO 
cone test using malaria vectors with different insecticide before comparing 
them against commercialized mosquito nets. Although initial thought of 
the study is based on mosquito carrying malaria parasite, the same net can 
also be effective against mosquitoes carrying Zika virus.
1405
TRANSCRIPTOME ANALYSIS OF GENES ASSOCIATED WITH 
DELTAMETHRIN RESISTANCE IN ANOPHELES ALBIMANUS
Lucy Mackenzie Impoinvil1, Nicole Dzuris1, Lucrecia Vizcaino1, 
Gareth Weedall2, Jacob Riveron2, Charles Wondji2, Audrey Lenhart1
1Centers for Disease Control and Prevention, Atlanta, GA, United States, 
2Liverpool School of Tropical Medicine, Liverpool, United Kingdom
Malaria remains one of the most important and debilitating diseases in the 
tropical world. One of the greatest emerging threats to malaria prevention 
and control is the development of insecticide resistance in the mosquitoes 
that transmit malaria. In the Americas, as malaria programs begin to shift 
their focus to regional malaria elimination, insecticide-based vector control 
strategies will intensify. Decades of unmanaged insecticide use and routine 
exposure to agrochemicals have left many populations of malaria vectors 
in the Americas resistant to multiple classes of insecticides, including 
pyrethroids, which are most cost-effective class of public health insecticides 
currently available. Comparatively little is known about the molecular basis 
of this resistance. Diagnostic tools are urgently needed to understand how 
malaria vector control interventions could be compromised by insecticide 
resistance. Applying a genomics approach utilizing advanced molecular 
detection tools, this project aims to comprehensively characterize 
mechanisms of deltamethrin (a pyrethroid insecticide) resistance in one of 
the most important malaria vectors in the Americas, Anopheles albimanus. 
An. albimanus were collected from Tumbes, Peru in 2015 and phenotyped 
as deltamethrin-resistant or susceptible using the CDC bottle bioassay. 
Whole non-ribosomal RNA from field-collected resistant, field-collected 
non-exposed, and a susceptible laboratory strain of An. albimanus are 
being analyzed using Illumina-Hiseq sequencing for comparison of 
gene expression profiles. Preliminary data will be presented, as well as a 
discussion of how these data will be used to develop mechanism-specific 
assays.
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1406
INSECTICIDE RESISTANCE PROFILE OF ANOPHELES GAMBIAE 
SENSU LATO IN AREAS WITH AND WITHOUT INDOOR 
RESIDUAL SPRAYING IN MALI, WEST AFRICA
Moussa Keita, Boïssé Traoré, Fousseyni Kané, Sekou Fantamady 
Traoré, Seydou Doumbia, Nafomon Sogoba
International Center for Excellence in Research (ICER), Bamako, Mali
In Mali, long lasting insecticide-treated nets (LLINs) are at the frontline of 
malaria vector control tools. Since 2008, US President Malaria Initiative 
(PMI) is supporting the implementation of an Indoor Residual Spraying 
(IRS) in three districts (Koulikoro, Baroueli, and Bla) in addition of the LLINs. 
Insecticide used for IRS has been changed from pyrethroid to carbamate 
and then to organophosphate because of the development of insecticide 
resistance by malaria vectors. The objective of this study is to determine 
the insecticide resistance profile of Anopheles gambiae s.l. in areas 
where LLINs together with IRS (Koulikoro district) are being implemented 
compared to areas with LLINs alone (Banamba & Kati districts). WHO 
bioassay tests were performed on F0 and/or F1 progeny of An. gambiae 
s.l. from larvae and/or from female adults, respectively, to assess their 
phenotypic resistance. The Taqman method was used to determine the 
different resistance mechanisms underlying the phenotypic resistance. A 
very strong phenotypic resistance was observed in all investigated localities 
in both areas. The 24 mortality rates were 6%, 29%, 29% and 30% 
(N=100) respectively in Koula, Karadie (in IRS area), and in NGalamadibi 
and Dangassa (non IRS area). Both West (L1014F) and East (1014S) kdr 
resistance mechanisms were observed in all localities. The frequency of 
the West form (43.54%; N = 182) was 2.5-fold higher than that of the 
East form (17.22%; N = 206) in LLINs+IRS areas compared to LLINs areas. 
Glutathione S transferase genes “GSTe2” (L119) and the Ace gene (N645I) 
were observed only in IRS+LLINs areas. This study showed that metabolic 
resistance mechanisms were encountered in area where IRS is associated 
to LLINs and absent in nearby area where LLINs are being implemented.
1407
EVALUATING HETEROGENEITY IN INSECTICIDE 
SUSCEPTIBILITY FOR IMPROVED RESISTANCE MANAGEMENT 
STRATEGIES TO AID MALARIA ELIMINATION
Silvie Huijben1, Mara Maquina2, Lucia Fernández1, Pedro Aide2, 
Ana Paula Abilio3, James Colborn4, Maria Ponja5, Francisco Saúte2, 
Krijn Paaijmans1
1ISGlobal, Barcelona, Spain, 2FM-CISM, Manhiça, Mozambique, 3INS, 
Maputo, Mozambique, 4CHAI, Boston, MA, United States, 5NMCP, 
Maputo, Mozambique
Southern Mozambique is currently designing and piloting activities to 
eliminate malaria by 2020. Insecticidal vector control measures are an 
important component of the elimination strategy. However, insecticide 
resistance in malaria vectors is a critical threat to malaria control and 
elimination programs. As such the longitudinal monitoring of insecticide 
susceptibility is crucial to select appropriate vector control tools, but also 
to inform insecticide resistance management plans and generate the 
essential biological data needed for mathematical modeling aimed at 
designing novel resistance management plans. Here we show detailed 
insecticide resistance data for the major malaria vectors (Anopheles 
funestus and An. arabiensis) in Manhiça and Magude districts, obtained 
by WHO tube and CDC bottle bioassays. We studied spatial heterogeneity 
in insecticide susceptibility on different spatial scales at district, village 
and neighborhood level, aimed at identifying the barriers to the spread of 
resistance that will affect insecticide resistance management strategies.
1408
INSECTICIDE RESISTANCE IN ANOPHELES GAMBIAE AND AN. 
FUNESTUS IN TWO RURAL SITES IN TANZANIA
Sophie J. Weston1, Natacha Protopopoff1, Bernard Batengana2, 
Robert Malima2, Wema Sudi2, Frank Mosha3, Mark Rowland1
1London School of Hygiene & Tropical Medicine, London, United Kingdom, 
2National Institute of Medical Research, Muheza, United Republic of 
Tanzania, 3Kilimanjaro Christian Medical University College, Moshi, United 
Republic of Tanzania
Over the last decade, considerable reductions in global malaria burden 
have been achieved by scaling-up key vector control strategies across 
endemic areas. However, long-term effectiveness of both long-lasting 
insecticidal nets (LLINs) and indoor residual spraying (IRS) is currently 
under threat from widespread emergence of insecticide resistance, 
especially resistance to pyrethroids. To characterize levels of insecticide 
resistance across Tanzania, CDC bottle bioassays were undertaken in two 
rural sites: Muleba (Northwest, Kagera region) and Muheza (Northeast, 
Tanga region). Insecticides tested were pyrethroids permethrin and 
alphacypermethrin. Anopheles gambiae and An. funestus were collected 
through resting indoor catches (Muleba) and larval collections (Muheza). 
Kisumu (susceptible An. gambiae strain) were used as a comparison where 
available. Resistance frequency was tested by exposing mosquitoes to 
the diagnostic dose of each insecticide and resistance intensity by using 
a range of doses. In Muheza, mortality in An. gambiae after 30 minutes 
exposure was 73% for 21.5µg/ml of permethrin and 70% for 12.5µg/
ml of alphacypermethrin. All insecticides produced 100% mortality in 
Kisumu. In Muleba, only 42% of An. gambiae died after exposure to 
permethrin (21.5µg/ml), as well as 430µg/ml (20x the diagnostic dose) 
producing only 79% mortality and 645µg/ml (30x the diagnostic dose) 
94% mortality. 56% of An. funestus died after exposure to 21.5µg/ml of 
permethrin. These results suggest that pyrethroid resistance is present in 
An. gambiae and An. funestus in both locations, and at particularly high 
levels in Muleba. Research into pyrethroid resistance, as well as resistance 
to other insecticide classes, is ongoing in Muheza. This research is vital 
in determining the appropriate vector control strategies to continue the 
decrease in malaria prevalence in these locations.
1409
KDR MUTATIONS CONFER FITNESS COST AND COMPETITIVE 
DISADVANTAGE IN FIELD POPULATIONS OF AEDES AEGYPTI
Marissa Grossman1, Valentin Uc Puc2, Adriana Flores3, Pablo 
Manrique-Saide2, Gonzalo Vazquez-Prokopec1
1Emory University, Atlanta, GA, United States, 2Universidad Autónoma de 
Yucatán, Merida, Mexico, 3Universidad Autónoma de Nuevo León, San 
Nicolás de los Garza, Mexico
Vector control strategies for Aedes aegypti are being threatened by the 
evolution of insecticide resistance. Point mutations in the para-orthologous 
sodium channel gene confer resistance to pyrethroid insecticides, named 
kdr for “knock-down resistance.” While these mutations increase survival 
in the presence of insecticide, they also carry a fitness cost which could 
allow populations to recover susceptibility in the absence of insecticides. 
Additionally, resistant individuals could be inferior competitors to 
susceptible ones when subjected to density dependent competition. 
To investigate the fitness cost and competitive ability of kdr individuals, 
we conducted experiments with two field populations of Ae aegypti: a 
susceptible population with 1% kdr frequency of I1016 and zero C1534 
mutations, and a resistant population with 100% frequency of C1534 
and 73% frequency of I1016. First instar larvae from each population 
were placed in separate 1L buckets in two density treatments: 50 larvae 
or 500 larvae. A third population consisted of a 50/50 mix of individuals 
from each original population to test competitive ability. After all 
mosquitoes emerged, a subset of adults were bloodfed and eggs per 
female were enumerated to estimate fecundity. All populations laid fewer 
eggs per female in the high density treatment than the low (ANOVA, 
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F=5.6, p=0.031), though both the susceptible and mixture populations 
produced 4.3 times more eggs per female than the resistant population 
after controlling for density (GLM, F=9.68, p=0.0008), indicating a 
significant fitness cost to the kdr mutations. CDC bottle bioassays were 
also conducted on each treatment with the diagnostic dose of permethrin. 
The resistant population performed significantly worse in the high density 
treatment than the low, with a 93% knock-down rate at the diagnostic 
time in the high density compared to 52% in the low density (t-test, t=-
2.6, p=0.05). These results suggest that the resistance phenotype can 
be altered by ecological interactions in the larval stage. Future control 
strategies could exploit the fitness and energetic cost of kdr to regain 
susceptibility into populations.
1410
DYNAMIC OF MALARIA VECTORS SUSCEPTIBILITY TO 
PYRETHROIDS AND MECHANISMS OF RESISTANCE IN 
SENEGAL
Libasse Gadiaga1, Ousmane Faye2, Mamadou Demba Sy2, Elhadji 
Amadou Niang2, Ellen Dotson3, Julie Thwing4, lassana Koante2, 
Abdoulaye Diop5, Moussa Diagne6
1National Malaria Control Programm, Dakar, Senegal, 2University of Dakar, 
Dakar, Senegal, 3Centers for Disease Control and Prevention, Atlanta, GA, 
United States, 4PMI, Atlanta, GA, United States, 5PMI AIRS Abt, Dakar, 
Senegal, 6SLAP, Thies, Senegal
Malaria vector control in Senegal rests on long-lasting insectidal 
nets (LLINs) and indoor residual spraying (IRS). Since 2007, IRS was 
implemented in selected districts, with pyrethroids until 2010, and then 
with carbamates. LLINs are distributed nationwide, with a universal 
coverage strategy since 2010. To monitor vector sensitivity to insecticides, 
sentinel sites were established to reflect the epidemiological strata 
of Senegal and the use of IRS. Annual monitoring was carried out at 
sentinel sites from 2008-2013 using World Health Organization (WHO) 
insecticide-impregnated papers. Tests were performed on an F1 generation 
aged 2 to 5 days, collected from wild Anopheles gambiae s.l., with 
25 female subjects in each of four tests, and a control of 25 females. 
Tests were interpreted according to the following criteria: mortality 
of 98-100% was considered sensitive, 80-97% considered suspected 
resistance, and less than 80% resistant. Sensitivity to the pyrethroids, 
deltamethrin and permethrin was assessed in 2 IRS districts (Velingara 
and Nioro) and 2 control district (non IRS). “ The vector susceptibility to 
pyrethroids increased in IRS districts after the shift to carbamates (2011), 
even though universal coverage of LLINs started the same year (2010-
11). “ The same tendency is not observed in non IRS districts. “ Increase 
in resistance to pyrethroids not convincingly seen with introduction of 
universal coverage of LLINs. “ The vectors are susceptible to carbamates 
and organophophates in both IRS and non-IRS districts, but resistant to 
organochlorines in both IRS and non-IRS districts. The presence of Kdr-
east is preliminarily detected in Nioro and this allelic frequency seems 
to show a fixation of this gene in field Anophelines. Additional analyses 
are underway to search for other mechanisms of resistance, other than 
the mutation of the target involving the Kdr gene. Preliminary evidence 
indicated the presence of the metabolic resistance among vector 
populations from several localities in the country.
1411
SPATIO-TEMPORAL EVOLUTION OF RESISTANCE TO 
DELTAMETHRIN AND KDR MUTATIONS IN AEDES AEGYPTI 
POPULATIONS IN FRENCH GUIANA: A WORRYING SITUATION 
FOR VECTOR CONTROL
Amandine Guidez, Johana Restrepo-Zabaleta, Mathieu Luana, 
Sandra Augustin, Pascal Gaborit, Romuald Carinci, Jean Issaly, 
Romain Girod, Isabelle Dusfour
Institut Pasteur de la Guyane, Cayenne, French Guiana
Aedes aegypti is vector of dengue, chikungunya and zika viruses in urban 
area of French Guiana, a French territory in South America. Deltamethrin 
remains the sole insecticide molecules authorized for adult control in the 
European Union to which French Guiana belongs. Since 2009, resistance 
to deltamethrin has been monitored in several populations of Ae. aegypti 
from French Guiana, by using WHO test kit at a diagnostic dose of 0.06%. 
In complement, mutations located at the position 1016 and 1534 of the 
sodium voltage-gated channel gene were monitored in some of these 
populations by Taqman Allelic Discrimination Assays. These mutations were 
already linked to pyrethroid resistance in Ae. aegypti populations from 
Latin America. A high resistance level was observed even before 2010, 
year from which deltamethrin has been outdoor sprayed. Our study also 
demonstrated a spatial and temporal heterogeneity of both mortalities 
at the diagnostic dose (from 1% to 92%) and resistant allele frequencies 
(from 14 to 98% of I1016 and from to 31 to 100% of C1534). Those 
frequencies have increased from 2009 to 2015. These results highlight a 
worrying situation for vector control efficacy and public health concern in 
French Guiana with no other insecticide yet authorized. Alternative control 
strategies will be discussed regarding these results.
1412
ONE YEAR OF COMMUNITY LED LARVICIDING :BIOKO 
ISLAND
Aveika A. Akum, Abrahan Matias, Wonder P. Phiri
Medical Care Development International, Silver Spring, MD, United States
Background Larviciding has historically recorded success in vector 
control, known to be effective in urban setting where breeding sites are 
generally and easily assessable. This study is aimed accessing acceptability 
and implementation of a community led larviciding in a rural setting. 
Methods Community Agents (ACPs) were identified and recruited in 13 
communities with the help of the community leaders; trained and provided 
materials. At baseline , the entomology team and the ACP identified and 
characterized existing habitats; type of habitat, existence of larvae and 
the stages of larvae. Weekly, the ACPs were expected to visit and treat all 
habitats that the owners consented and identify and treat new ones. The 
leader of the ACPs kept a register of attendance. The entomology team 
visits the community on the same day of the week but at a later time to 
monitor the activities of the ACP and recorded; if the each habitat has 
been treated, habitats are categorized as being old or new, the stages 
of larvae and updated the ACP’s attendances register. Periodically, the 
ACPs were given a feedback on their activities at a community meeting. 
Result: At baseline there were 1100 habitats in the 13 communities, about 
64.0% of the habitats were in only 2 communities, there were 92 ACPs. 
About 83.2% of the habitats were household water containers, 4.6% car 
tracks, and the drainage system being 4.5%. In all 2.9% of the habitats 
were Anopheles positive and 38.5% were positive for another culicine 
mosquitoes. Weekly an average of 1376 habitats were to be treated, 
25(1.9%) were new, 82(6.0%) were not treated because the owners 
rejected treatment. The weekly average of habitats treated by ACPs was 
76.0 %(std 7.8%), the average attendances to treatment activities is 
82.0%(std 9.2%) Conclusion: Larviciding requires 100% treatment of all 
known habitats to be successful. The degree of refusal to accept larviciding 
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and the non-attainment of the 100% coverage by the ACPs suggest 
community led larviciding needs a closer look at regards community entry 
and how the ACPs were chosen.
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INDOOR RESIDUAL SPRAYING FOR MALARIA CONTROL 
USING BENDIOCARB REDUCES KDR L1014S HOMOZYGOTE 
FREQUENCY IN ANOPHELES GAMBIAE S.S.
Tarekegn A. Abeku1, Michelle E. Helinski1, Irene Kyomuhangi2, 
James Ssekitooleko2, Godfrey Magumba2, Chris Bass3, Sylvia R. 
Meek1
1Malaria Consortium, London, United Kingdom, 2Malaria Consortium, 
Kampala, Uganda, 3Rothamsted Research, Harpenden, United Kingdom
Resistance of malaria vectors against pyrethroid insecticides has been 
attributed to selection pressure from long-lasting insecticidal nets 
(LLINs), indoor residual spraying (IRS), and agricultural chemicals. The 
use of different classes of insecticides in combination or by rotation has 
been recommended for resistance management. The aim of this study 
was to evaluate the role of using carbamate insecticides for IRS in the 
management of resistance against pyrethroids used in LLINs. Anopheles 
gambiae s.s. were collected from 33 different sites in nine districts of 
Uganda, three of which were under bendiocarb spraying. The kdr L1014S 
homozygote (RR) frequency (kdr homozygosity) was used as the outcome 
variable to test the effects of various factors using a logistic regression 
model. Spray status with bendiocarb, annual rainfall, altitude, collection 
type (larvae or adults), long-term LLIN use estimated from old nets found 
hanging, LLINs distributed in the previous five years, household use of 
agricultural pesticides, and intensity of malaria transmission (prevalence 
in children 2-9 years old) were entered as explanatory variables. Spray 
status, collection type and annual rainfall had statistically significant 
effects. A. gambiae s.s. collected from areas sprayed with bendiocarb 
had significantly lower kdr homozygosity than those collected from non-
sprayed areas. Mosquitoes collected as adults from indoor collections 
had significantly higher frequency of kdr homozygotes than mosquitoes 
collected as larvae, possibly indicating selective sampling of resistant 
adults following exposure to insecticides inside houses. Sites with high 
rainfall had significantly lower kdr homozygosity. The results indicate 
that bendiocarb spraying may potentially increase susceptibility of A. 
gambiae s.s. to pyrethroids by reducing kdr resistant genotypes. Although 
bendiocarb spraying did not result in elimination of the kdr resistant 
genotypes, the analysis indicated that IRS with carbamates, or possibly 
also organophosphates, could have a role in pyrethroid resistance 
management.
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ENGINEERED ANOPHELES GAMBIAE IMMUNITY TO 
PLASMODIUM INFECTION
Maria L. Simoes1, Yuemei Dong1, Andrew M. Hammond2, Tony 
Nolan2, Andrea Crisanti2, George Dimopoulos1
1Johns Hopkins University, Baltimore, MD, United States, 2Imperial College 
London, London, United Kingdom
Impairing sporogonic development of Plasmodium using the transgenic 
manipulation of its mosquito vector has been achieved in different 
malaria-transmitting species. We have previously generated immune-
enhanced Anopheles stephensi mosquitoes with greater resistance to 
Plasmodium and microbial infection through transgenic over-expression 
of the IMD pathway-controlled Rel2 transcription factor, as reported 
previously. Despite the relevance of Anopheles gambiae (A. gambiae) as 
the major human malaria vector in sub-Saharan Africa, it has not been 
extensively used as a vector model for transgenic research because of 
being technically more cumbersome to transform. In the present study, 
we have successfully developed a genetically modified immune-enhanced 
A. gambiae line, by over-expression of the FBN9 gene, hence overcoming 
previous technical challenges. Engineered anti-Plasmodium activity of the 
IMD pathway has been further explored by investigating the potential 
of the Rel2-regulated anti-Plasmodium immune factor FBN9 (fibrinogen 
immunolectin 9) to confer resistance to Plasmodium. We used the fat 
body-specific blood meal-inducible Vitellogenin 1 promoter to drive 
transgene expression of this anti-Plasmodium factor. The promoter, FBN9 
gene and the Trypsin 1 terminator were ligated into an entry vector 
containing the DsRed marker. Newly laid eggs from female A. gambiae 
mosquitoes (G3 strain) were injected and larvae screened for transient 
fluorescence. Transient mosquitoes were outcrossed with wildtype ones 
and, following blood feeding, the offspring was screened for transgenics. 
FBN9-transgenic mosquitoes showed increased resistance to Plasmodium, 
by reduction of both infection prevalence and intensity at the oocyst 
stage. The temporal expression pattern of the recombinant FBN9, the 
antibacterial response of the immune-enhanced transgenic mosquitoes 
and the impact of this genetic modification on mosquito fitness have been 
analysed.
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DISPERSAL AND THE SPREAD OF A DENGUE-SUPPRESSING 
BACTERIUM IN THE DENGUE VECTOR AEDES AEGYPTI
Tom Schmidt, Gordana Rašić, Ary A. Hoffmann
University of Melbourne, Parkville, Australia
Wolbachia is a promising tool for arbovirus control, with its potential 
to suppress virus transmission and to establish and spread through wild 
mosquito populations under the right conditions. Aedes aegypti infected 
with the wMel strain of Wolbachia were released into two suburbs 
of Cairns, Australia. At each site, Wolbachia spread was spatially 
heterogeneous, and slower than initially expected. Also, the invasion 
appeared to stall at the boundary of a major road, suggesting this to 
be a strong barrier to mosquito dispersal. Conversely, a rapid influx of 
uninfected mosquitoes to the centre of one of the sites was observed 
suggesting long distance dispersal of Ae. aegypti in Cairns. To test this 
further, we investigated spatial genetic structure among 161 field-caught 
Ae. aegypti from the same area using ddRADseq. We observed little 
genetic structuring across the range of our study site (4 km²) and found 
a weak barrier effect of roads. These findings support our hypothesis 
that long-range dispersal is common in Ae. aegypti in Cairns. A highly 
leptokurtic distribution of dispersal distances can lead to slower Wolbachia 
spread and the potential reinvasion of infected regions in seasonally 
dynamic populations, these findings thus inform future releases of 
Wolbachia.
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IDENTIFICATION OF MIDGUT ACTIVE CIS-REGULATORY 
SEQUENCES TO EVALUATE THE IMPACT OF NON-CODING 
VARIATION ON AEDES AEGYPTI SUSCEPTIBILITY TO DENGUE 
VIRUS INFECTION
Veronica Valverde-Garduno1, Manuel Castillo-Méndez2, Graciela 
Gleason-Rodríguez2
1Instituto Nacional de Salud Pública, Cuernavaca, Mexico, 2Escuela de 
Salud Pública de México, Cuernavaca, Mexico
The basal level of expression of immunity genes is correlated with Aedes 
aegypti strain susceptibility to Dengue virus, as reported previously. The 
basal level of expression is determined in large part by the set of cis-
regulatory sequences that are active in midgut cells. A portion of the 
variation in the basal level of gene expression in the midgut is potentialy 
related to variations in cis-regulatory sequences. Therefore, in order to 
have a genomic template cis-regulatory sites to analyse the impact of 
non-coding variations on strain susceptibility, we set out to identify and 
characterize cis-regulatory sequences active in the non-stimulated midgut 
of Ae. aegypti. Since open chromatin is a hallmark of cis-regulatory 
function we carried out open chromatin profiling on pools of disected 
midguts from 3 to 5 day old female mosquitoes. Genomic libraries were 
constructed with DNA samples enriched for cis-regulatory fragments. 
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These genomic libraries were then sequenced by NGS in an Illumina GAx 
II instrument. More than ten million non-redundant, uniquely mapping 
sequence tags were used to map enriched peaks corresponding to cis-
regulatory sequences. Analysis of these sequence tags by MACS and 
DFilter identified more than 30 thousand cis-regulatory sequences. 
Characterization of these cis-regulatory sequences allowed identification 
of motifs and cis-regulatory modules (CRMs) for the binding of a diversity 
of transcription factors. This set of cis-regulatory sequences, motifs and 
CRMs will be useful to assess the potential impact of non-coding variation 
on Aedes aegypti susceptibility to Dengue virus infection.
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MOLECULAR CHARACTERIZATION OF GLUCOSE-6-
PHOSPHATE DEHYDROGENASE DEFICIENCY SPECIFIC 
VARIANTS IN AMHARA REGION, ETHIOPIA
Yeshwondm Gebresilasie Mamuye1, Getachew Abebe 
Ewunetu2
1St. Paul’s Hospital Millennium Medical College, Addis Ababa, Ethiopia, 
2Debrebirhan University, Addis Ababa, Ethiopia
Glucose 6-phosphate dehydrogenase deficiency (G6PDd) is an X-linked 
hereditary genetic defect, affects an estimated 400 million people 
worldwide. Severe clinical manifestation associated with G6PDd (e.g., 
chronic hemolytic anemia) depends on the type of G6PD molecular 
variants and exposure to hemolytic triggers (e.g., antimalarial like 
Primaquine). However, scarce studies on G6PDd renders the use of 
Primaquine for effective therapeutic treatment of malaria. This study 
was undertaken to determine the availability and characterize selected 
molecular variants of G6PDd specific genes among selected populations 
in malaria endemic area of Ethiopia. Using cross sectional study design a 
total of 156 dried blood samples were randomly selected from 360 stored 
samples of national malaria indicator survey of 2011 starting from July 
30/2014 to January 30/2015. Polymerase chain reaction and restricted 
fragment length polymorphism technique was applied to characterize 
G6PDd variants as G6PD*A, G6PD*A- and/or G6PD*Mediterranean. 
Binary logistic regression was applied to see association (P<0.05 is 
significant) among different parameters. Of 156 studied dried blood 
spot samples, 10(6.4%) had G6PD genotype available. G6PD*A (100%) 
was the only genotype characterized, while neither G6PD*A- nor 
G6PD*Mediterranean genotypes were detected. There was no statistical 
significant difference between G6PDd and other socio demographic and 
risk related variables (P>0.05). In conclusion, G6PD*A variant was the 
only G6PDd genotype detected in this study. G6PD*A variant has almost 
(90%) the same enzymatic activities with the wild type. Therefore; this 
result supports the safe use of primaquine, especially the single low dose 
for transmission interruption of Plasmodium falciparum gametocyte and 
radical cure of P. vivax, as a part of malaria elimination toolkit, among 
selected populations in malaria endemic areas of Amhara region.
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UNIDIRECTIONAL HYBRIDIZATION AND REPRODUCTIVE 
BARRIERS BETWEEN TWO BIOTYPES OF CULEX PIPIENS 
COMPLEX
Sungshil Kim, Cheolho Sim
Baylor University, Waco, TX, United States
Understanding the processes of reproductive behavior in mosquitos 
is crucial for improving mating competitiveness and mating specificity 
for sterile insect release program. Culex pipiens form pipiens and form 
molestus, two biotypes for Cx. pipiens complex, are vectors for West Nile 
Virus, St. Louis encephalitis virus, and lymphatic filariases. Hybridization of 
these biotypes is shown to occur in nature, even though f. pipiens mate 
above ground in larges spaces (eurygamy) and f. molestus preferentially 
in small spaces (stenogamy) like subways and sewage tunnels. The 
hybridization between two biotypes may allow gene flow of biotype-
specific characteristics that are crucial in the disease transmission cycle. In 
the present study, we examined the mating behaviors, insemination rates, 
fecundity and fertility in F1 hybrids between Culex pipiens form pipiens 
and f. molestus in stenogamy conditions (cage 27.5cm x 17cm x 20cm). 
The F1 hybrid crosses along with parent backcrosses were also accessed 
for mating success. Despite the considerably high insemination rates from 
hybrid males to females and likewise in backcross lines to parent females, 
the fertility and fecundity rates from the respective females were varied 
among different crosses. This observation could suggest the asymmetric 
allele introgression in the hybrid zone. We also document a failure of 
heterospecific males to produce fertile eggs in f. pipiens females, which 
may be due to gametic incompatibilities and may serve as an additional 
barrier to gene exchange.
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SMALL INSERTION AND DELETION MUTATIONS IN 
ANOPHELES COLUZZII AND AN. GAMBIAE
R. Rebecca Love, Nora J. Besansky
University of Notre Dame, Notre Dame, IN, United States
Whole genome resequencing experiments now routinely leverage large 
data sets to explore genomic variation in organisms from diverse taxa, 
including arthropod vectors of disease. In these vectors, resequencing has 
the potential to detect cryptic populations, uncover signals of insecticide 
resistance, and monitor the progress of control campaigns, along with 
other contributions to disease eradication. However, these experiments 
often focus wholly on single nucleotide polymorphisms (SNPs), excluding 
small insertions and deletions (indels) as well as large structural variants. 
While current short-read technology makes examination of the latter 
fraught with technical artifacts, routinely including indels in the analysis 
of resequencing data is a way to increase the power of these experiments 
as well as detect patterns that cannot be uncovered using SNPs alone. 
We reanalyzed previously published short read data from 38 samples of 
Anopheles gambiae and An. coluzzii, focusing on variants longer than one 
base pair. We find that similar numbers of base pairs are involved in indel 
variants as in SNPs in this data set, suggesting that indels are indeed an 
important category of variation in these malaria vectors. We also find that 
pipelines commonly used for the detection and quality control of SNPs can 
easily be adapted for indels, and that indels analyzed this way show similar 
population genomic trends to SNPs, suggesting their reliability. Finally, we 
examine patterns of frameshifts in these malaria vectors, identifying genes 
whose expression may be radically altered in a way SNP data cannot easily 
detect.
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MOLECULAR AND MORPHOLOGICAL CHARACTERIZATION 
OF ANOPHELES MELAS POPULATIONS IN ENDEMIC AND 
NON-ENDEMIC LYMPHATIC FILARIASIS COMMUNITIES IN 
COASTAL GHANA
Dorcas Atibilla1, Dziedzom Komi De Souza2, Millicent Opoku2, 
Michael David Wilson2, Joseph Harold Osei3, Rosina Kyerematen4, 
Fred Aboagye-Antwi5, Seth Owusu-Agyei1
1Kintampo Health Research Center, Kintampo, Ghana, 2Noguchi Memorial 
Institute for Medical Research, University of Ghana, Legon, Accra, Ghana, 
3Noguchi Memorial Institute for Medical Research, University of Ghana, 
Legon, Accra, Ghana, 4African Regional Postgraduate Programme in 
Insect Science, University of Ghana, Accra, Ghana, 5African Regional 
Postgraduate Programme in Insect Science, University of Ghana, Legon, 
Accra, Ghana
Anopheles melas, known to be an efficient vector of lymphatic filariasis 
occurs along the coastal part of Ghana, especially in estuarine areas. This 
study was aimed at seeking explanation to why there is different patterns 
of lymphatic filariasis distribution along coastal Ghana. The hypothesis 
was that the eastern An. melas populations could be different from those 
occurring to the west of Accra at both morphological and molecular 
levels. Two sites representing communities to the east of Accra in the Ga 
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Adangme District and two communities in the Ahanta West District were 
selected for the study. The mosquitoes were molecularly identified as An. 
melas. Deoxyribonucleic acid (DNA) of each identified An. melas was then 
used as the template for COI analysis. Polymerase chain reaction products 
obtained were purified, sequenced and analyzed using BioEdit and MEGA 
V6 software for construction of phylogenetic tree.In-silico restriction 
enzyme digest was done to determine restriction site differences between 
the two An. melas populations and Similarity index determined using 
Sørensen’s formula. The study found no significant differences between 
the sequences of the two An. melas populations (Z-test of neutrality = 
0.33). Results of the phylogenetic analysis though not significant, revealed 
a geographic relationship only between two eastern populations clustering 
together, with one population branching off on a different node. Analysis 
of the in-silico showed eight mutational differences with QS value of 0.99. 
The restriction site analysis however revealed 16 unique site differences 
between them. The mean numbers (n, median and range) of cibarial 
teeth were 14.54 (n = 13, 15, 11 = 18) and 14.1 (n=13, 14, 11-19) for 
western (Azizanya) and eastern (Asemko) respectively, which were not 
statistically different (t=1.53, P = 0.14). In conclusion the two An. melas 
populations could be said to be similar in all aspects, however restriction 
enzyme differences could be potential markers for distinguishing the two 
populations.
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POPULATION STRUCTURE OF ANOPHELES FUNESTUS IN 
SOUTHERN AFRICA
Christine M. Jones1, Yoosook Lee2, Travis Collier2, Julia C. 
Pringle1, Giovanna Carpi1, Jennifer Stevenson3, Maureen Coetzee4, 
Mbanga Muleba5, Youki Yamasaki2, Anthony J. Cornel2, Douglas 
E. Norris1
1Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, 
United States, 2University of California Davis, Davis, CA, United States, 
3Macha Research Trust, Macha, Zambia, 4University of Witwatersrand, 
Johannesburg, South Africa, 5Tropical Diseases Research Center, Ndola, 
Zambia
Malaria control and eradication faces many challenges; among these 
is Anopheles funestus, one of three major malaria vectors in sub-
Saharan Africa. An. funestus poses a significant threat because of its 
expansive distribution and high rates of insecticide resistance. However, 
relatively little is known about the population structure and dynamics 
of An. funestus compared to other major malaria vectors such as An. 
gambiae and An. arabiensis. In this study, individual samples (N=44) from 
geographically distant sites in Zambia, Democratic Republic of the Congo, 
and Tanzania were subject to whole genome sequencing for determining 
the degree of population structure of An. funestus in Southern Africa, 
and for the development of genome-wide markers suitable for population 
genetic studies at the spatial scale of this region. A reliable set of single 
nucleotide polymorphism markers will allow for high-throughput and 
cost-effective population genomic analyses at the spatial scale required 
by this study. Preliminary assessment suggests that more gene flow than 
expected exists between populations from Zambia and DRC, however a 
more detailed analysis is required. Robust estimate of gene flow between 
populations, especially related to insecticide resistance genes, could be 
used to assess efficacy of vector control. Moreover, association of whole-
genome-based genetic clusters in relation to our discovery of sympatric 
An. funestus mitochondrial Clade I and Clade II in northern Zambia could 
illuminate if mitochondrial clades are relevant to mating structure within 
the An. funestus complex. Additional structure within the complex, if 
related to ecological or behavioral traits, would have implications for 
vector control strategies.
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GENERATION OF AEDES GENE KNOCKOUTS TO 
CHARACTERIZE LIGHT-DRIVEN PHOTORECEPTOR RESPONSES
Ryan C. Engert, Alison E. Dawson, Staff R. Maddison, Cheryl A. 
Kurcharsk, Alexander J. Metoxen, Morgan O. Petersen, Matthew 
T. Leming, Malcolm J. Fraser, Jr., Michelle A. Whaley, Joseph E. 
O’Tousa
University of Notre Dame, Notre Dame, IN, United States
Daily shedding and rebuilding of the photoreceptor’s photosensitive 
rhabdomeric membranes is common in invertebrate species. Aedes 
aegypti shows a robust response and loses all Aaop1 rhodopsin from the 
rhabdomeric membranes during the shedding process at dawn. We seek 
to characterize these cellular processes and determine how modulation 
of visual capabilities during this daily cycle impacts mosquito vision and 
behavioral responses. The shedding process at dawn is a light-triggered 
event. The rhodopsin is moved to cytoplasmic vesicles and degraded 
during the daytime. However, the rhodopsin is capable of being rapidly 
moved back to the rhabdomeric membranes if dark conditions are restored 
prior to degradation. During the daytime period, vesicles containing 
newly synthesized Aaop1 rhodopsin accumulate within the cytoplasm. 
At dusk, these vesicles rapidly deposit newly synthesized Aaop1 into 
the rhabdomere. These results show that light is a negative regulator 
of rhodopsin maturation and document the extensive management of 
rhodopsin content during the daily light-dark cycle in Aedes mosquitoes. 
We propose that these events give the mosquito exceptional visual 
capabilities in the low light environments of dawn and dusk without 
triggering light-induced damage to photoreceptors upon exposure to 
brighter daylight. We are testing this proposal by creating germ-line 
mutations in the Aaop1 rhodopsin gene using CRISPR-CAS9 technology. 
We also will create mutations in the two arrestin genes coding for adapter 
proteins responsible for initiation of the membrane shedding process. 
These three mutant strains will be examined for rhodopsin movement, 
retinal degeneration, and behavioral responses to determine the 
importance of proper rhodopsin management to Aedes fitness.
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USE OF THE OXFORD NANOPORE MINION MKI FOR 
SIMULTANEOUS VECTOR AND PATHOGEN IDENTIFICATION
Erica Lindroth1, Alden Estep1, Hanayo Arimoto2, Nermeen 
Fahmy2, Reham Tegeldin2, Neil Sanscrainte3, James Becnel3
1Navy Entomology Center of Excellence, Jacksonville, FL, United States, 
2Navy Medical Research Unit 3, Cairo, Egypt, 3Center for Medical, 
Agricultural and Veterinary Entomology, United States Department of 
Agriculture-ARS, Gainesville, FL, United States
Vector-borne disease surveillance in remote locations is difficult at best. 
The vast majority of sequencing and antibody detection equipment on 
the market is bulky, delicate, and expensive. The MinION is a pocket-
sized DNA sequencer that has previously been used in the field to track 
the Ebola outbreak in West Africa. The MinION has the potential to 
greatly expand vector surveillance capability in the US military. To this 
end, the Navy Entomology Center of Excellence, the USDA Center for 
Medical, Agricultural, and Veterinary Entomology, and Naval Medical 
Research Unit 3 (Cairo) are developing a protocol for simultaneous vector 
and pathogen identification using the MinION. Whole DNA is extracted 
from vectors using standard kits and prepared for sequencing using the 
simplest available protocol. The prepared libraries are sequenced using the 
MinION and locally BLASTed against a database of vector sequences for 
identification. A test run consisting of 5 mosquito species combined into 
a single library shows that a sufficient number of high quality 2D reads 
are produced to allow genus-level identifications within just a few hours. 
Next steps include expanding the reference database to include pathogen 
sequences, protocol testing on laboratory-infected mosquitoes, and 
further simplification of the protocol for field expediency.
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HUMAN-DISEASE CAUSING ARBOVIRUS PREVALENCE IN 
KENYAN MOSQUITOES
Claire Jane Heath1, Malaya K. Sahoo1, Bryson Ndenga2, Francis 
Mutuku3, Njenga Ngugi4, Joel Mbakaya2, Peter Siema5, Peter 
Aswani2, Warren P. Macdonald6, Nayer Zahiri6, Jesse J. Waggoner1, 
Benjamin A. Pinsky1, A. Desiree LaBeaud1
1Stanford University, Palo Alto, CA, United States, 2Kenya Medical Research 
Institute, Kisumu, Kenya, 3Technical University of Mombasa, Mombasa, 
Kenya, 4Chuka University, Chuka, Kenya, 5Vector Borne Disease Control 
Unit, Msambweni, Kenya, 6San Mateo County Mosquito and Vector 
Control District, Burlingame, CA, United States
Arboviruses comprise some of the most important emerging pathogens 
due to their geographic spread and increasing impact on vulnerable 
human populations. Despite this significant global health burden, the 
transmission, epidemiology, and incidence of arboviruses remains poorly 
defined, particularly in sub-Saharan Africa. In Kenya, the continued 
population growth and associated urbanization are conducive to 
proliferation of mosquito vectors and arboviral transmission; thus the 
characterization of arboviral circulation in this region is imperative to 
better inform human risk assessments and vector control practices. We 
used a variety of trap types and capture methods to collect Aedes and 
Anopheles species mosquitoes, at varying stages of the life cycle and 
during different seasons, at four sites in Kenya: Msambweni and Ukunda 
on the coast, and Chulaimbo and Kisumu in the west. Mosquitoes were 
then sorted by species, sex, trap type and date of capture, and grouped 
into 391 pools of ~25 individuals. Tissue was mechanically lysed and 
total RNA was extracted. Using a multiplex real-time reverse transcriptase 
PCR assay, mosquitoes were tested for dengue (DENV) and chikungunya 
(CHIKV) viruses, as well as for the five Plasmodium species known to cause 
human disease. CHIKV was detected in 14 of 290 (4.8%) of Aedes spp.
pools. Of these, 3 were from the western sites, caught between March 
and May 2014, and 11 were from the coastal sites caught between July 
and December 2014 in ovitraps, human-landing catches and BG sentinel 
traps. Interestingly, 8 of these CHIKV positive pools were male mosquitoes 
bred in the laboratory from ovi- and larval traps, suggesting transovarial 
transmission of these viruses. DENV was detected in 1 pool (0.3%) from 
the coastal sites from September 2014. Of the 101 Anopheles pools tested 
for the five Plasmodium spp., 1 pool (1.2%) tested positive for falciparum 
falciparum. These data suggest a considerable prevalence of CHIKV in 
Kenyan mosquitoes, and that viral distribution varies both geographically 
and temporally. These data contribute to arboviral surveillance in Kenya, 
and suggest that the prevalence of CHIKV is underestimated.
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ECOCLIMATIC DRIVERS OF SPATIO-TEMPORAL HOT 
SPOTS OF AEDES ALBOPICTUS ABUNDANCE IN A SOUTH 
EUROPEAN URBAN AREA
Mattia Manica1, Federico Filipponi1, Roberto Rosa’2, Markus 
Neteler2, Angelo Solimini1, Alessandra della Torre1, Beniamino 
Caputo1
1University of Rome Sapienza, Rome, Italy, 2Fondazione Edmund Mach, 
San Michele all’Adige, Italy
The stable colonization of several south European urban areas by Aedes 
albopictus represents an increasing public health threat due to the species 
competence in transmitting Dengue, Chikungunya and Zika arboviruses, 
whose expanding worldwide distribution is increasing the risk of an 
infected traveller to reach Europe. In fact, a Chikungunya outbreak has 
already occurred in northern Italy in 2007 and cases of autochthonous 
Dengue transmission have been recently reported from France and 
Croatia. Despite in the absence of vaccines the only way to prevent the 
risk of outbreaks of these diseases in Europe is mosquito control, this 
is rarely efficiently carried out by public administrations due to lack of 
appropriate resources to cover the large areas colonized by the species. It 
has been proposed that a more cost-effective method to prevent arbovirus 
outbreaks could be the focal treatment of hot-spot of highest mosquito 
densities. The aim of this work was to identify eco-climatic drivers of 
higher Ae. albopictus abundance on the basis of data from seasonal-
round monitoring carried out in 2012-2013 across and beyond the urban 
area of Rome. A fine scale (300 m radius) spatio-temporal dataset was 
built within each sampling site and exploited to analyse the effect of 
climatic (Land Surface Temperature, Daily Rainfall, Growing Degree Days), 
environmental (Land Cover as retrieved from digital multispectral aerial 
imagery) and demographic (human population density) variables on Ae. 
albopictus spatial abundance and temporal dynamics. Generalized additive 
mixed models highlighted a strong positive relationship between mosquito 
abundance and anthropic surfaces and population density and identified 
climatic drivers of the seasonal population dynamics. These results 
provide useful indications to prioritize public mosquito control measures 
in temperate urban areas in space and time for a more feasible and cost-
efficient prevention of the risk arbovirus transmission in Europe.
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OUTDOOR EARLY BITING BEHAVIOR AND INSECTICIDE 
RESISTANCE IN ANOPHELES ARABIENSIS MIGHT CHALLENGE 
MALARIA ELIMINATION IN SOUTHERN PROVINCE OF 
ZAMBIA
Javan Chanda, Kochelani Saili, Christopher Lungu, John M. Miller
PATH MACEPA, Lusaka, Zambia
In Zambia, long-lasting insecticidal nets (LLINs) and indoor residual 
spraying (IRS) are the principal malaria vector control interventions. The use 
of these interventions depends on vector susceptibility to insecticides and 
indoor biting and resting behavior. However, there is limited information 
on the behavior of malaria vectors and their susceptibility to insecticides 
in Southern Province, an area targeted for malaria elimination. This study 
assessed vector behavior and susceptibility to insecticides commonly 
used in malaria vector control strategies. Indoor host seeking mosquitoes 
were collected during April and May 2015 to determine mosquito biting 
behavior. Species identification by PCR and insecticide susceptibility tests 
were conducted on 0.05% deltamethrin, 0.1% bendiocarb, 4% DDT 
and 0.25% pirimiphos-methyl following the WHO standard protocol. 
Metabolic resistance were determined in populations of An. gambiae s.l 
and An. funestus s.l. by using a synergist piperonyl butoxide (PBO). A total 
of 5,507 adult Anopheles mosquitoes were collected from April to May 
2015. An. gambiae s.l constituted 66.7% (n = 3675) and 33.3% (n = 
1832) were An. funestus s.l. An. arabiensis, An. quadriannulatus and An. 
funestus s.s. were identified. An. arabiensis was more frequently observed 
biting humans outdoors (0.567) than indoors (0.443) while An. funestus 
was observed biting indoors (0.532) more than outdoors (0.468). An. 
arabiensis was resistant to deltamethrin with mortality rates of 90-95% 
while resistance to deltamethrin (14-42%) and bendiocarb (41-56%) 
was detected in An. funestus s.s. Both species of mosquitoes were 100% 
susceptible to DDT and pirimiphos-methyl. Pre-exposure of An. arabiensis 
and An. funestus s.s. to PBO nullified both pyrethroid and carbamate 
resistance in populations of mosquitoes tested. Outdoor early biting of 
An. arabiensis may hinder malaria elimination efforts by extending residual 
transmission of malaria, while the detection of pyrethroid and carbamate 
resistance mediated by oxidases in vector populations might compromise 
the protective efficacy of ITNs and IRS using these ingredients.
1427
MODELLING POPULATION DYNAMICS OF THE VECTOR 
CULEX PIPIENS IN THE ATLANTA URBAN ENVIRONMENT
William T. Koval, Gonzalo Vazquez-Prokopec
Emory University, Decatur, GA, United States
Members of the Culex pipiens complex play a critical role in the spillover 
of urban abroviruses such as West Nile Virus or St. Louis Encephalitis. 
Mechanistically understanding the drivers of mosquito population 
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dynamics at larval stages is critical for better informing predictive models 
and vector management strategies. Despite this recognized need, 
there is a paucity of empirically fitted mathematical models explaining 
variable demographic parameters within the vector’s main habitat in 
the USA: urban roadside catch basins. Here, we show results of a series 
of interlinked experimental and observational studies performed in the 
city of Atlanta, GA, to quantify the key life history parameters of Culex 
pipiens quinquefasciatus needed to develop a stage-structured population 
model predicting catch basin productivity. Parameters needed for such 
a model included survivorship and time to emergence under different 
nutrient and detritus levels as well as female fecundity on emergence. 
Larval experiments under controlled temperature conditions showed that 
in low nutrient environments, survivorship linearly increases with leaf litter 
presence (Generalized Linear Model, GLM, -4.2765 ± 0.363; p < 0.001). 
As nutrient availability increases, leaf litter has a positive and quadratic 
effect on survivorship and a negative effect on time to emergence (GLM, 
19.3848 ± 0.9385; p < 0.001). The non-linear interaction between 
nutrients and leaf litter was statistically significant and indicative of an 
additive relationship between both trophic conditions. Ongoing work 
is incorporating these results into a stage-structured matrix projection 
model that will be used to predict the population dynamics of Cx. 
pipiens quinquefasciatus in catch basins. Mechanistic characterization 
of population dynamics of Cx. pipiens quinquefasciatus in catch basins 
can lead to an improved understanding of mosquito productivity in 
urban areas and the identification of more effective targets for vector 
management.
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FLIGHT APTITUDE OF FREE-FLYING MOSQUITOES AS A 
MEASURE OF LONG DISTANCE MIGRATION BEHAVIOR
Zana L. Sanogo1, Roy Faiman2, Alpha S. Yaro1, Moussa Diallo1, 
Djibril Samake1, Ousman Yossi1, Adama Dao1, Anish Prasanna2, 
Margery A. Sullivan2, Tovi Lehmann2
1International Center for Excellence in Research, Bamako, Mali, 2National 
Institutes of Health, Laboratory of Malaria and Vector Research/National 
Institute of Allergy and Infectious Diseases, Rockville, MD, United States
Malaria kills over 500,000 people every year in sub-Saharan Africa alone. 
During the dry season in the Sahel, surface water required for larval 
sites disappears, halting mosquito reproduction and bringing malaria 
transmission almost to a standstill. Recent studies have suggested that 
both Anopheles gambiae s.s and An. arabiensis (but not An. coluzzii) 
persist in this region by long-distance, wind-assisted migrations, migrating 
from locations where breeding occurs year round. Direct evidence of long-
distance migrating malaria vectors to date is scant. In other insect taxa, 
in sub-Saharan Africa and elsewhere, windborne long-distance migration 
occurs seasonally and facilitates exploitation of renewed temporal 
resources. Our aim here was to measure flight behavior in free-flying, wild 
mosquitoes, and evaluate if flight propensity exhibits seasonal variation, 
in accordance with expected movement to- and from the Sahel. We have 
adapted an assay originally developed for the study of migratory flights 
in aphids, to measure flight behavior in a group of 100 mosquitoes of 
predetermined sex, physiology and origin, housed within a 200x30x30 cm 
vertical flight chamber. The assay involves the measurement of the total 
displacement of the mosquitoes, over an 18-hours experiment. Mosquito 
resting positions were captured by a series of digital photographs taken 
at intervals of 30 minutes, and displacement was calculated by indexing 
‘arrivals’ and ‘departures’. Initial laboratory studies revealed a typical 
circadian rhythm in flight and sugar-feeding patterns. The assay is 
currently used with field mosquitoes in Mali. Preliminary results suggest 
that flight propensity was elevated a few weeks after the first rains (June 
2015), consistent with our results using a tethered mosquito flight assay. 
Comprehensive analysis of these experiments will be presented.
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SPATIAL DISTRIBUTIONS OF ANOPHELES SPECIES IN 
RELATION TO MALARIA INCIDENCE AT 70 LOCALITIES IN THE 
HIGHLY ENDEMIC NORTHWEST AND SOUTH PACIFIC COAST 
REGIONS OF COLOMBIA
Martha L. Ahumada1, Lorena I. Orjuela1, Paula X. Pareja1, 
Marcela Conde2, Diana M. Cabarcas3, Eliana F. G. Cubillos4, Jorge 
A. López5, John C. Beier6, Socrates Herrera4, Martha L. Quiñones2
1Grupo de Entomologia, Instituto Nacional de Salud, Bogotá D.C., 
Colombia, 2Departamento de Salud Pública, Facultad de Medicina, 
Universidad Nacional de Colombia, Bogota D.C., Colombia, 3Secretaria 
de Desarrollo de la Salud de Córdoba, Cordoba, Colombia, 4Caucaseco 
Scientific Research Center, Universidad del Valle, Cali, Colombia, 5Instituto 
Departamental de Salud de Nariño, Nariño, Colombia, 6Department of 
Public Health Sciences, Miller School of Medicine, University of Miami, 
Miami, FL, United States
A proper identification of malaria vectors is essential for any attempt to 
control this disease. Between 40 and 47 Anopheles species have been 
recorded in Colombia, and 8 species complexes have been revealed in 
the last decade. An update of Anopheles species distribution and its 
relationship with malaria is required, particularly for newly identified 
members of species complexes. A cross-sectional entomological study 
was conducted at 70 localities in the highest malaria transmission areas in 
Colombia. In each locality, immature and adult mosquitoes were collected. 
All specimens were determined using morphological characters and 
Cytochrome c Oxidase I sequence gene. To detect natural Plasmodium 
infections, enzyme-linked immunosorbent assay and nested PCR analysis 
were used. Anopheles species distribution was spatially associated with 
malaria prevalence. A total of 1,736 larvae and 12,052 adult mosquitoes 
were determined. Thirteen Anopheles species were identified. COI 
sequence analysis suggested 4 new lineages for An. albimanus (An. 
albimanus B), An. pseudopunctipennis s.l., An. neivai (An. neivai nr. 
neivai 4), and An. apicimacula. Two members of species complexes were 
identified as An. nuneztovari C and An. albitarsis I. Another 7 species 
were confirmed. Four mosquitoes were infected with Plasmodium species: 
An. albimanus B (n=1) and An. nuneztovari C (n=3). In Northwest of 
Colombia, An. nuneztovari C, An. albimanus, and An. darlingi were 
present in the municipalities with API>35 cases/1,000 inhabitants. In 
the north of South Pacific coast, with a similar API, An. nuneztovari C 
were widely distributed inland, and the main species in coastal regions 
were An. albimanus B and An. neivai s.l. In the south of South Pacific 
coast, 3 Anopheles species were found in municipalities with API=15-88 
cases/1,000 inhabitants: An. albimanus B, An. calderoni and An. neiva s.l. 
In conclusion, in the highest malaria areas, 13 Anopheles species and 4 
new lineages were found. A DNA barcode analysis allowed the taxonomic 
identification, particularly for species complexes, and to improve the 
understanding of their relation with malaria transmission.
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STORM DRAINS AS LARVAL DEVELOPMENT AND ADULT 
RESTING SITES FOR AEDES AEGYPTI AND ALBOPICTUS IN 
SALVADOR, BRAZIL
Igor A. Paploski1, Moreno S. Rodrigues2, Vánio A. Mugabe1, 
Mariana Kikuti1, Aline S. Tavares3, Mitermayer G. Reis3, Uriel D. 
Kitron4, Guilherme S. Ribeiro1
1Universidade Federal da Bahia, Salvador, Brazil, 2Universidade Federal de 
Rondônia, Porto Velho, Brazil, 3Fundação Oswaldo Cruz, Salvador, Brazil, 
4Emory University, Atlanta, GA, United States
Brazil reports the larger number of dengue cases in the world (1.6 million 
in 2015), and simultaneous transmission of dengue, chikungunya and Zika 
viruses was firstly documented in 2015. Dengue control in Brazil is based 
on the search for breeding sites in an area, followed by their elimination 
or treatment. The failure to identify so-called cryptic locations may hinder 
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the finding of breeding sites, which can be important in diverse areas and 
circumstances. We studied the importance of storm drains as Aedes larval 
development and adult resting sites in four neighbourhoods, representing 
different socio economic, infrastructure and topographic conditions, 
of Salvador, Brazil. A total of 122 storm drains identified in the four 
study sites were surveyed twice during a 3-month period (total of 241 
inspections), and in 49% of the inspections we observed the presence 
of accumulated water. Adults and larvae of Ae. aegypti were captured 
in two of the four sites, and adults and larvae of Ae. albopictus were 
captured in one of these two. A total of 468 specimens were collected, 
148 Ae. aegypti (38 adults, 110 larvae), 79 Ae. albopictus (48 adults, 31 
larvae), and 241 non-Aedes (mainly Culex spp.) mosquitoes (42 adults, 199 
larvae). The presence of Aedes mosquitoes was independently associated 
with the presence of non-Aedes mosquitos and with lower accumulated 
rainfall during the preceding week. We demonstrated that in Salvador, an 
epicentre of the recent Zika virus outbreak, storm drains often accumulate 
water and serve both as larval development sites and as adult resting areas 
for Ae. aegypti and Ae. albopictus. These potential key environments for 
Aedes reproduction are located in public areas and are often overlooked 
by vector control campaigns. Targeting alternative breeding sites for 
surveillance and control needs to be incorporated into vector control 
programs in Salvador and other urban areas. Targeted efforts to control 
Aedes mosquitoes in these sites need to be developed and applied. In the 
long term, we advocate for a better design of storm drains that restrict the 
accumulation of water – though they still may serve as important adult 
resting sites.
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COMPLEX INTERACTIONS BETWEEN TEMPERATURE AND 
DIET IN MOSQUITOES REVEAL NEW INSIGHTS INTO 
MALARIA TRANSMISSION UNDER PROJECTED CLIMATE 
CHANGE SCENARIOS
Shelley Whitehead, Janet Teeple, Matthew Thomas
Pennsylvania State University, University Park, PA, United States
There is great concern as to how global climate change may affect vector-
borne diseases. Numerous studies demonstrate a link between mean 
temperature and mosquito survival; however, in the field, temperature 
fluctuates dynamically throughout the day. Furthermore, temperature has 
been shown to significantly affect mosquito blood feeding behavior. Here, 
we observed the effect of several temperature regimes on daily mosquito 
survival. Mosquitoes were divided into six temperature groups: 27°C, 
30°C, 34°C, as well as three treatments of the same mean, but allowed 
to fluctuate a total of 10°C over the course of the day. Females were then 
further allocated to one of four dietary regimes: 1) water feeding only, 
2) sugar feeding only, 3) water feeding with the provision of a human 
blood meal every three days, or 4) sugar feeding with a blood meal every 
three days. Across all temperature treatments, blood feeding significantly 
improved survivorship compared to those maintained exclusively on sugar 
or water. Females imbibing both blood and sugar experienced the greatest 
increased survivorship; when compared to those feeding on blood and 
water, it is clear that sugar consumption provided an additional source 
of energy. As temperatures increase, the time to complete development 
of the malaria parasite within the mosquito decreases; these data show 
that in hotter temperatures, the daily survival rate of Anopheles stephensi 
females would be sufficient to effectively transmit malaria parasites. These 
results suggest a complex relationship between diet and temperature; 
not only are blood meals the source of disease transmission, but they 
also increase vector survival. It is crucial that these intricacies be taken 
into account when determining the best control programs for individual 
countries in the face of global climate change.
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INTERROGATING THE ROLE OF STEROID HORMONES IN 
THE REPRODUCTIVE ECOLOGY OF ANOPHELES GAMBIAE 
MOSQUITOES
Adam South, Andrea Smidler, Enzo Mameli, Perrine Marcenac, 
Evdoxia Kakani, Douglas Paton, Flaminia Catteruccia
Harvard T.H. Chan School of Public Health, Boston, MA, United States
Human malaria is a major public health burden in tropical and subtropical 
countries and is transmitted exclusively by female Anopheles mosquitoes. 
Malaria control strategies aimed at inducing sexual sterility in natural 
vector populations are an attractive alternative due to increasing levels of 
insecticide resistance within medically important anophelines. However, 
the development of these strategies is hampered by a profound lack 
of knowledge regarding the most basic elements of Anopheles mating 
ecology. Recently, our group has demonstrated that the suite of mating 
induced changes in An. gambiae females is largely mediated by male 
transference of the steroid hormone 20-hydroxyecdysone (20E) during 
copulation. We have also demonstrated that precopulatory female choice 
is likely predicated upon the differential ability of males to synthesize 20E 
in their male accessory glands (MAGs). Females accept matings from males 
that not only have double the titers of 20E relative to their unsuccessful 
rivals, but also have distinctly different chemical contact cue profiles. 
In order to investigate this relationship further, we created a line of 
transgenic An. gambiae males that expresses a MAG specific 20E-targeting 
oxidase that inactivates the hormone. Here we show that this transgenic 
line of males is deficient in 20E synthesis, as males transfered ~ 70% less 
20E to females than control males. Moreover, mating assays revealed 
that these transgenic males exhibit reduced mating success, with females 
refusing ejaculate transfer from these males even after forming a mating 
pair. Through GC/MS analysis of transgenic males, we have also tested the 
relationship between male 20E titers and chemical contact cue profiles. 
Taken together, these results provide compelling evidence for the first 
time that An. gambiae females exhibit both pre- and pericopulatory 
mechanisms of choice, with male 20E being a key factor, a critical insight 
into the mating ecology of a major disease vector.
1433
APPLICATION OF BAYESIAN MAXIMUM ENTROPY TO 
ESTIMATE THE ASSOCIATION BETWEEN ADULT AEDES 
AEGYPTI DENSITY AND SIX-MONTH RISK OF DENGUE VIRUS 
SEROCONVERSION
Elizabeth A. Cromwell1, Steven T. Stoddard2, Chris M. Barker3, 
Steven Meshnick1, Annelies Van Rie4, William Messer5, Amy C. 
Morrison3, Thomas W. Scott3, Marc Serre1
1University of North Carolina Chapel Hill, Chapel Hill, NC, United States, 
2San Diego State University Graduate School of Public Health, San Diego, 
CA, United States, 3University of California Davis, Davis, CA, United States, 
4University of Antwerp, Antwerp, Belgium, 5Oregon Health and Science 
University, Portland, OR, United States
Efforts to characterize Aedes aegypti indicators of abundance have 
not consistently identified associations with increased risk of dengue 
virus (DENV) seroconversion. This is partly the result of cross-sectional 
measures of mosquito density in which no mosquitoes are observed 
when low levels of infestation may truly be present. We created cross-
sectional entomological monitoring indicators by incorporating the spatial 
distribution of adult mosquitoes to estimate the association between 
mosquito density and DENV seroconversion. Categorical density variables 
were generated based on the presence of any adult Ae. aegypti in an 
adjacent household as well as households within 30, 50 and 100 meters, 
respectively. Continuous density was calculated as adult mosquitoes per 
square meter, per resident reported and per household room surveyed; 
these measures were also analyzed as categorical variables (comparing 
≥0.01 to <0.01). The spatial and temporal covariance of these continuous 
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measures were then modeled and mosquito density was estimated 
using the Bayesian Maximum Entropy (BME) geostatistical framework. 
Spatially-modified densities were used to estimate the six-month risk 
of DENV seroconversion using log binomial models. Construction of 
density variables by inclusion of adjacent households resulted in a weak 
association (risk ratio: 1.10 (95% CI: 0.99, 1.23), but measures within 
30, 50 and 100 meters did not demonstrate an increased seroconversion 
risk. Adult Ae. aegypti per household area (RR: 1.01; 95% CI: 0.86, 1.18) 
and density predictions generated using BME (RR: 1.03; 95% CI: 0.91, 
1.16) were not associated with risk. The spatial covariance model suggests 
that spatial correlation among entomological data occurs at a very fine 
scale, within approximately 25 meters. The lack of association with DENV 
seroconversion suggests that the inability of cross-sectional entomological 
measures of mosquito density to identify individuals at an elevated risk of 
DENV is not improved by incorporating measurements at various spatial 
scales.
1434
QUANTUM DOT LABELLING OF AEDES ALBOPICTUS 
BACTERIA: A NEW METHOD TO STUDY MOSQUITO 
DISPERSAL BEHAVIORS
Xiaoming Wang1, Daibin Zhong1, Jimmy Lin1, Bernadine Dizon1, 
Guofa Zhou1, Xiaoguang Chen2, Guiyun Yan1
1University of California Irvine, Irvine, CA, United States, 2Southern Medical 
University, Guangzhou, China
Aedes mosquito transmits important human diseases such as dengue and 
Zika. Bacterial microbiota-mosquito holobiont plays an important role in 
various aspects of mosquito life history and vector competence. The life 
table study using water from natural habitats but depleted with bacteria 
by filtering or antibiotics showed very high larval mortality in Aedes 
albopictus, demonstrating important role of bacteria in Ae. albopictus 
larval development in nature. Using Miseq pyrosequencing of the 16S 
rRNA gene V4 hyper-variable region, mosquito bacterial microbiota was 
examined at different developmental stages from major types of larval 
habitats. Despite of highly diverse bacterial microbiomes in aquatic 
habitats and mosquito larvae, Wolbachia, Aromonas, Novisprillum and 
several other genera were the dominant bacteria in adult mosquitoes. 
We applied the knowledge on the dominant and cultured bacteria in 
adult mosquitoes to determine whether bacteria can be used as a new 
labeling method to study mosquito dispersal behaviors. To prove the 
principle of this method, mannose-modified fluorescent carbon quantum 
dots (Man-CQDs) were synthesized and used to label Escherichia coli. 
Aedes albopictus fed with Man-CQDs labeled E. coli showed a constant 
fluorescence. Larval life table study found that Man-CQDs had low or 
no toxicity to the mosquitoes. We are currently testing this labeling 
method with the dominant and cultured bacteria found in natural adult 
mosquitoes, and conducting field experiments to determine mosquito 
dispersal behaviors. Mosquito fluorescence labeling through Man-CQDs 
labeled bacteria may provide a potential new method to explore the 
function of bacteria in mosquitoes and to study mosquito behaviors.
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MODELING THE IMPACTS OF CO-CIRCULATING 
HEMOPARASITES IN MOSQUITOES ON WEST NILE VIRUS 
TRANSMISSION
Andrew Golnar, Matthew Medeiros, Gabriel Hamer
Texas A&M University, College Station, TX, United States
Polyparasitism, or the simultaneous infection with two or more parasites in 
a single host, is a widespread phenomenon that may influence infectious 
disease dynamics. Because of the abundance of parasitic coinfections in 
nature, blood-feeding arthropods are often exposed to multiple parasites 
during a single blood meal. Culex mosquitoes, the main vectors of West 
Nile virus (WNV), may ingest a variety of viral, protozoan, and macro-
parasitic hosts found among avian and mammalian bloodmeal hosts. 
However, the downstream transmission consequences of mosquitoes 
ingesting these organisms are unknown. SIR-based mathematical models 
were used to explore outcomes where WNV-hemoparasite co-ingestion 
altered vector survival, vector competence, the extrinsic incubation period, 
or vector feeding ecology. We conducted a sensitivity analysis to highlight 
the parameters with the greatest effect on the reproductive number 
of WNV. Results highlight the potential for population-level impacts of 
within-host interactions and identify mechanisms capable of driving fine-
scale transmission of WNV.
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MIDGUT COMMENSALS REGULATE INFECTION BY ZIKA AND 
SINDBIS VIRUSES IN AEDES AEGYPTI
Sarah Sneed, Letitia Thompson, Michael Povelones
University of Pennsylvania, Philadelphia, PA, United States
In recent years, mosquito-borne viruses such as Dengue (DENV), 
Chikungunya (CHIKV), and Zika (ZIKV) have become globally disseminated 
and are a significant cause of human morbidity and mortality. In order 
for transmission to occur, viruses must first infect the mosquito midgut 
and subsequently pass into the hemolymph where they can circulate 
to infect other tissues. Numerous studies have demonstrated that the 
mosquito midgut is an important barrier that bloodmeal-acquired viruses 
must overcome. Therefore, understanding the mechanisms underlying 
successful infection of the midgut is crucial. The mosquito microbiome 
plays an important role in shaping the midgut environment and has 
been previously shown to regulate susceptibility to infection by different 
arboviruses. To contribute to this body of knowledge, we have tested 
whether reducing midgut commensal bacteria affects Aedes aegypti 
infection by both Zika virus (ZIKV) and Sindbis virus (SINV). Our preliminary 
data suggests that depletion of commensals by antibiotics during both of 
these viral infections results in a decrease in viral transcript levels. We are 
validating these results by assaying virus at the protein level by western 
blot and determining localization by confocal microscopy. Specifically, we 
are interested in exploring the mechanism behind this phenotype. 16S 
sequencing and CFU plating will be used to define the bacterial signals 
that elicit infection-permissive responses from the intestinal epithelium. Toll 
and Imd NF-κB signaling pathways are important for regulation of the gut 
microbiome. Bacterial products bind to cell surface receptors and activate 
signaling in the intestinal epithelium. Therefore, we are using RNA-seq to 
characterize the differences between antibiotic and sugarfed Ae. aegypti 
in activation of these pathways during viral infection. Results from these 
studies will lead to mechanistic insights that may yield novel strategies to 
block disease transmission.
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VECTORBASE: THE USE OF THIS DATABASE FOR NEW 
ANALYSES, DESCRIPTIONS AND HYPOTHESIS TESTING
Gloria I. Giraldo-Calderón1, Scott J. Emrich1, Daniel Lawson2, 
Frank H. Collins1, VectorBase consortium
1University of Notre Dame, Notre Dame, IN, United States, 2Imperial 
College London, London, United Kingdom
VectorBase is a NIAID/NIH-funded bioinformatics resource center for 
invertebrate vectors of human pathogens. This database has the genomes 
of vectors of medical importance such as Anopheles gambiae, Aedes 
aegypti, Culex quinquefasciatus, others in the groups Diptera, Hemiptera, 
Phthiraptera, Acari and the snail Biomphalaria glabrata, the intermediate 
host of Schistosoma mansoni. In the last year the number of genomes 
hosted has increased to 40, with new additions including Aedes albopictus 
and non-vector but useful key species for comparative genomics of traits 
of interest such as Sarcoptes scabiei var. canis, Stomoxys calcitrans and 
Cimex lectularius. In addition to genomes, transcriptomes and proteomes, 
VectorBase also hosts lab and field collected metadata, genetic variation 
(e.g., SNPs), expression (microarrays and RNAseq) and insecticide-
resistance phenotypes. We will demo how the freely available VectorBase 
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data can be visualized, browsed and queried, creating the possibility of 
new analyses, descriptions and hypotheses testing. Thesis or publications 
using this resource, are kindly ask to reference the paper or papers were 
the data was originally published and VectorBase most recent paper, as 
explained in the website under the “Help” navigation tab. We will also 
demo how to export or download big or small data sets, both for simple 
and complex queries. Analyses of these data can be performed with the 
site tools, which include Galaxy, a web-based platform for data intensive 
biomedical research, or any other external tool. Follow this link for the 
latest data, tool and resources updates called releases, www.vectorbase.
org/releases, send questions or comments to info@vectorbase.org, and 
visit the site YouTube channel for video tutorials in this link, https://goo.gl/
mChdGh.
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ECOLOGY OF LA CROSSE VIRUS (LACV) VECTORS ALONG 
FOREST-TO-FIELD ECOTONES IN WESTERN NORTH CAROLINA
Gideon Wasserberg1, Marcelo Sschwarz1, Brian Byrd2
1University of North Carolina at Greensboro, Greensboro, NC, United 
States, 2Western Carolina University, Cullowhee, NC, United States
La Crosse Encephalitis (LACE) is a pediatric disease with a recent 
emergence in the number of reported cases in Appalachia. This increase 
may be due to improved reporting and/or a greater exposure to La 
Crosse virus (LACv) vectors. The LACv is historically transmitted by the 
sylvan eastern tree-hole mosquito (Aedes triseriatus). However, recently 
invasive species (Ae. albopictus and Ae. japonicus), likely secondary peri-
domestic vectors known to co-occur with Ae. triseriatus, complicate the 
understanding of LACv ecology. The goal of this study was to determine 
the effect of landscape structure (i.e., forest-to-field ecotones) and artificial 
container introduction (i.e., tires) on the distribution and abundance of 
the LACv in western NC. We hypothesized that 1) Canopy-associated 
environmental variables determine LACv vectors’ distribution and 
clustering along these ecotones; and that 2) Tire introduction increases 
local (habitat-specific) and overall (across ecotone) abundance of LACv 
vectors. We ran 2 parallel transects per site (6 sites total), each 200-meters 
in length, 15 ovitraps per transect; we also deployed traps for gravid (BG 
Sentinels and Landing-Biting) and resting (Nasci aspirator) mosquitoes. 
We incorporated 9 tires in each experimental plot: 2 sites received 
treatment in the field, 2 sites in the forest, and 2 sites served as control. 
Preliminary results suggest habitat preferences with Ae. albopictus more 
abundant in the field habitats, and Ae. japonicus as well as Ae. triseriatus 
more common in the forest and edge habitats. The artificial container 
introduction appeared to increase the abundance of all species, particularly 
in their “preferred” habitats; however, it did not result in altered 
oviposition patterns along the ecotone.
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EVALUATION OF KNOWLEDGE AND PRACTICES OF 
RESIDENTS FOR THE PREVENTION OF MOSQUITO-BORNE 
VIRUSES IN NEW ORLEANS, LOUISIANA
Sarah R. Michaels, Rindcy Davis, J. Clint Welty, Dawn Wesson
Tulane University, New Orleans, LA, United States
To understand local transmission potential for the emergence of arboviral 
epidemics including Zika, dengue and chikungunya, the abundance of 
competent vector populations and residential sources should be evaluated. 
This study assessed the knowledge, attitudes and practices of New Orleans 
residents regarding mosquitoes and arboviruses and identified frequent 
breeding habitats on residential properties. Residents indicated frequent 
mosquito exposure including mosquitoes being a problem in the yard 
(63.2%), being bitten by mosquitoes frequently (45.9%) and spending 
time outside in evening daily (37.8%). Central air conditioning was 
common (70.5%) however, 30.0% reported opening windows frequently 
and sometimes finding mosquitoes inside the house (54.5%). Property 
inspections in November and December 2015 yielded an average of 1.4 
water-holding containers per residence and a House Index of 31.8. Of the 
115 containers surveyed 36.5% were positive for mosquito larvae and 
13.9% for pupae. The most common mosquito species was Aedes aegypti 
(85.9%); far less common were Culex quinquefasciatus (11.3%) and 
Ae. albopictus (3.3%). Additional container surveys and questionnaires 
are planned for May-July 2016, and adult mosquito surveillance will be 
conducted using BG Sentinel traps. Large urban populations of Aedes 
aegypti and Ae. albopictus are present in New Orleans, Louisiana and 
the potential of introduction of Zika virus by a viremic individual is of 
great concern. It is essential to identify, educate, and eliminate residential 
mosquito breeding locations for Ae. aegypti on a community-wide 
level, and the results from these surveys will be used to produce tailored 
educational outreach materials. The long-term control of arboviral diseases 
is only possible through an integrated public health approach, rapid case 
identification, and sustainable vector control strategies.
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VECTORIAL CAPACITY OF AEDES ALBOPICTUS ACROSS THE 
UNITED STATES
Kerri Miazgowicz1, Tayla Shragai2, Laura Harrington2, Michael 
Reiskind3, Courtney Murdock1
1University of Georgia, Athens, GA, United States, 2Cornell, Ithaca, NY, 
United States, 3North Carolina State University, Raleigh, NC, United States
There is accumulating evidence that predicting vector-borne disease 
transmission is fraught with complexity. Recent work in a variety of 
transmission systems suggest that climate patterns have important direct 
impacts on vector-borne disease and define the potential environmental 
ranges of vector-borne pathogens. However, the realized distribution 
and extent of vector-borne disease transmission will also depend upon a 
variety of non-climatic factors, such as genotypic differences in local vector 
and pathogen populations, as well as socioeconomic and demographic 
factors that define variation in human exposure. The proposed study will 
investigate the invasive Aedes albopictus (Asian tiger mosquito) - arbovirus 
transmission system. Ae. albopictus is highly abundant, has a large and 
expanding distribution within the U.S., is a highly competent vector for 
dengue, chikungunya, and potentially Zika viruses, and has been linked 
to explosive arbovirus outbreaks in temperate zones.The goal of this 
project is to identify which environmental and genetic factors contribute 
to variation in vectorial capacity. To do this we first empirically quantified 
how fitness and transmission potential vary across the U.S. distribution 
of Ae. albopictus by running large-scale, common garden transplant 
experiments under semi-field conditions across a latitudinal cline. Using 
life table analysis, we compared the fitness differences in sympatric vs. 
allopatric populations to determine if populations are adapted to local 
environmental conditions and to generate age-specific estimates of key 
mosquito life history traits that drive transmission (e.g. larval development 
rates, longevity, fecundity, and biting rates). From this study, we generate 
age-dependent models of vectorial capacity to predict how lifetime 
transmission potential varies across latitude and populations of Ae. 
albopictus in the United States.
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DETECTION OF MAMMALIAN ANTIBODIES AGAINST ROSS 
RIVER VIRUS IN MOSQUITO BLOOD MEALS AND POTENTIAL 
FOR ARBOVIRUS SURVEILLANCE
Leon E. Hugo1, Jonathan Darbro1, Elise Kho1, Narayan Gyawali2, 
Greg Devine1
1QIMR Berghofer Medical Research Institute, Herston, Australia, 2Central 
Queensland University, Rockhampton, Australia
Mosquito-borne alphaviruses are the causative agents of several 
debilitating diseases that have been associated with large, cross 
continental outbreaks, as demonstrated recently by chikungunya virus. 
Ross River virus (RRV) is an alphavirus endemic to Australia and the Pacific 
which is the agent of a debilitating disease with symptoms including fever, 
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arthritic joint pain and rash. RRV is characterized by a broad association 
with a variety of mosquito vectors and vertebrate hosts. A number of these 
hosts are native Australian marsupials, including kangaroos, wallabies 
and koalas. The complex ecology of the virus present large challenges for 
disease surveillance, epidemiology and control. We are developing a novel 
xenodiagnostic assay strategy to determine the seroprevalence of RRV 
antibodies among vertebrate host populations. The strategy avoids animal 
ethics dilemmas by harnessing the natural behavior of resident mosquito 
populations to sample blood from a wide variety of vertebrate hosts. We 
demonstrate the ability to detect RRV IgG from within mosquitoes that 
originate from any vertebrate host species. We are utilizing a population 
of koalas with a seroprevalence for RRV IgG of 75% and a colony of 
flying foxes (Pteropus spp.) in a suburb of Brisbane. This work will provide 
insights and strategies for improved epidemiology of RRV and potentially 
other mosquito-borne diseases.
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TARGETED XENOMONITORING FOR LYMPHATIC FILARIASIS 
IN HIGH RISK COMMUNITIES AS PART OF POST-MASS 
DRUG ADMINISTRATION AND ENDGAME SURVEILLANCE IN 
MALAWI
Themba Mzilahowa1, Veronica Uzalili1, Bagrey Ngwira2, 
Daniel Boakye3, Moses Bockarie4, John Chiphwanya5, Charles 
Mackenzie4, Ben Koudou4, Louise A. Kelly-Hope4
1Malaria Alert Centre, College of Medicine, University of Malawi, Blantyre, 
Malawi, 2The Polytechnic, University of Malawi, Blantyre, Malawi, 3The 
Noguchi Memorial Institute for Medical Research, Accra, Ghana, 4Liverpool 
School of Tropical Medicine, Liverpool, United Kingdom, 5Ministry of 
Health, Lilongwe, Malawi
Malawi is on track for the elimination of lymphatic filariasis (LF), with 
more than five rounds of annual mass drug administration (MDA) and 
successful transmission assessment surveys (TAS) to indicate transmission 
has been interrupted. Now there is a need to implement post-MDA 
surveillance strategies, including xenomonitoring to provide further 
evidence of elimination, especially in high risk communities identified 
in baseline prevalence surveys. The Neglected Tropical Disease (NTD) 
laboratory in Blantyre provides essential support to the National LF 
Elimination Programme, and in 2010-2011 collected and analysed 
>12,000 mosquitoes from across the country during the initial stages of 
the MDA programme. Relatively high rates of LF infections by RT-PCR (8%) 
were found, and the majority of infections were in Anopheles funestus 
from Chikwawa District in the high risk Southern Region of the country. 
Co-incidentally high levels of pyrethroid insecticide resistance were also 
reported in this species, which has implication for the effectiveness of 
additional vector control interventions, especially long-lasting insecticidal 
nets (LLINs). The aim of this study therefore was to conduct a follow-up 
post-MDA assessment in the three high risk villages where high mosquito 
infection rates were found in the initial MDA stages. In addition, an 
assessment of five highly endemic villages where >10 morbidity cases 
have been reported during recent mapping activities in Chikwawa and 
Nsanje will be conducted. The work will specifically focus on collecting 
mosquitoes using pyrethrum spray catches (PSCs) and window traps over a 
three month period across 8 high risk villages from >20 individual trapping 
sites. More than 7000 mosquitoes are expected to be processed, including 
species identification, examination for Wuchereria bancrofti microfilaria 
infections using RT-PCR and insecticide resistance standard laboratory 
protocols. This study will help to establish a targeted xenomonitoring 
protocol in high risk areas and provide information to the LF programme 
as part of its post-MDA and endgame surveillance strategy.
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TROPICAL DISEASE IN LATE 18TH SURINAM: THE CASE OF 
CAPT. JOHN STEDMAN, 1772-1777
David Adams1, Joseph MIller2, Chidinma Okafor2, Tatiana 
Eversley2
1Mercer University School of Medicine, Savannah, GA, United States, 
2Armstrong State University, Savannah, GA, United States
Historians of tropical medicine have largely ignored John Gabriel Stedman’s 
The Narrative of a Five Years Expedition against the Revolted Negroes 
of Surinam (1796). Contemporaries commandeered his writings as a 
cruelly vivid indictment of slavery in Surinam. Although a mercenary on 
the payroll of Dutch planters, Stedman himself condemned the brutally 
that he witnessed daily—observations often redacted from early editions. 
Stedman’s five-year tale of life in Surinam represents far more than a 
graphic indictment of slavery. Rather, it provides a vivid window into late 
18th century tropical medicine in South America. Drawing on Stedman’s 
own first-hand observations, this project will examine his daily encounters 
with tropical disease, insect vectors, and medical therapy within the 
context of late 18th century colonial medicine in the Americas.
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DIFFERENCES IN PRELACTEAL FEEDING ON THE ISLAND OF 
HISPANIOLA: THE DOMINICAN REPUBLIC AND HAITI
Lauren A. Taylor, John D. McLennan
University of Calgary, Calgary, AB, Canada
Despite sharing the island of Hispaniola, the Dominican Republic (DR) has 
significantly lower rates of exclusive breastfeeding (EBF) than Haiti in the 
first six-months of life. Prelacteal feeding (PLF), the use of non-breastmilk 
feeds in the first three days of life and/or before breastmilk comes in, is 
common in the DR and is known to undermine EBF. Whether PLF is more 
common in the DR than Haiti has not been examined in recent data, 
nor while controlling for other factors that influence PLF (e.g., caesarean 
sections [C-section]). This study aimed to determine (i) whether PLF differs 
between the DR and Haiti, and (ii) whether such differences persist after 
controlling for potential confounding variables. This study used data from 
the most recent Demographic and Health Surveys from the DR (2013) 
and Haiti (2012). PLF was found to be much higher in the DR (62.5%) 
than Haiti (20.3%). Infant formula and other non-breast milks were the 
most common PLF choices in the DR, but were rarely used in Haiti. In 
contrast, Haitians more often administered sugar water to newborns than 
Dominicans. In bivariate analysis, the prevalence of PLF increased as a 
function of increasing household wealth in the DR, but was unrelated to 
wealth quintiles in Haiti. In a final multivariate model, being Dominican 
substantially increased the odds of PLF despite controlling for multiple 
other variables. Having had a C-section and not having put the child to the 
breast within one hour after delivery also significantly and independently 
increased the odds of PLF. Further investigation is warranted to identify 
what other factors contribute to the significantly higher PLF rates amongst 
Dominicans versus Haitians. In addition, intervention studies are required 
to determine approaches to reduce PLF, which may increase EBF rates in 
the DR and elsewhere.
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POOLING KNOWLEDGE AND EXPERIENCE TO IMPROVE 
CLINICAL RESEARCH STANDARDS IN LOW- AND MIDDLE-
INCOME COUNTRIES: THE EXPERIENCE OF THE SWITCHING 
THE POLES NETWORK (2008-2016)
Raffaella Ravinetto1, Yves Claeys1, Ermias Diro2, Jan Jacobs1, 
Harry van Loen1, Pascal Lutumba3, Paritosh Malaviya4, Yodi 
Mahendrahata5, Alain Nahum6, Sayouba Ouedraogo7, Suman 
Rijal8, Shyam Sundar4, Halidou Tinto7, Marleen Boelaert1, Anne 
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1Institute Tropical Medicine, Antwerp, Belgium, 2University of Gondar, 
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of the Congo, 4Banaras Hindu University, Varanasi, India, 5Gadjah Mada 
University, Yogyakarta, Indonesia, 6Centre de Recherches Entomologiques, 
Cotonou, Benin, 7Clinical Research Unit Nanoro, Nanoro, Burkina Faso, 8BP 
Koirala Institute of Health Sciences, Dharan, Nepal
The Switching The Poles Clinical Research Network, started in 2008, brings 
together 13 research institutions from Belgium, Benin, Burkina Faso, 
Cambodia, Cuba, the Democratic Republic of Congo, Ethiopia, India, 
Indonesia, Nepal, Peru, The Gambia and Vietnam. It aims at strengthening 
partners’ capacity to set-up, conduct and lead non-commercial clinical 
research programs that address the priority health needs of these regions 
and comply with appropriate ethical and Good Clinical (Laboratory) 
Practice (GC(L)P) standards. The Network adopted an approach based on 
practical thematic working groups, that favour the involvement of young 
researchers and traditionally ‘neglected profiles’ (e.g. data managers, 
laboratory staff), with the potential of bringing a direct benefit to research 
projects. The main groups include GCP, GCLP, clinical data management 
(DM) and clinical monitoring in resource-constrained settings, and 
informed consent in vulnerable communities. We developed a theoretical 
and practical approach to teaching GCP and GCLP; a set of standardised 
DM procedures; and an e-platform (admitnetwork.org) for consultation 
and peer advice among clinical data managers, who are traditionally quite 
isolated in small non-commercial research groups. We also started the 
field coaching of clinical monitors, facilitated South-South collaboration 
in different aspects of clinical research and took public positioning 
on research ethics issues, e.g. the double ethical review in externally-
sponsored trials and the approach to informed consent in socially 
vulnerable populations. The inclusion of partners from three continents, 
with different linguistic and cultural features, resulted in cross-fertilization 
and enrichment, while the small size of the network favored interpersonal 
collaboration, and it could make some achievements sustainable also in 
absence of prolonged external funding. Our experience shows that small 
but multi-cultural networks are flexible, can rapidly adapt to address the 
partners’ needs, and provide an excellent platform for supporting young 
researchers and promoting South-South collaboration.
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TELEPATHOLOGY FOR RAPID TURNAROUND TIME IN 
MALIGNANCY DIAGNOSIS IN LOW-MIDDLE INCOME 
SETTINGS
Danny A. Milner1, Lauren Greenberg2, Kiran Bhai2, Tharcisse 
Mpunga3, Lawrence Shulman4, Gaspard Muvugabigwi3, Irenee 
Nshimiyimana3, James R. Pepoon1, Paul Park5, Emmanuel 
Hakizimana3, Origene Benewe3, Deo Ruhangaza3
1The Brigham and Women’s Hospital, Boston, MA, United States, 
2Partners In Health, Boston, MA, United States, 3Butaro District Hospital, 
Butaro, Rwanda, 4University of Pennsylvania, Abramson Cancer Center, 
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Delivering cancer care in low-resource settings is dependent on developing 
efficient and accurate pathology systems. In this study, we analyzed the 
efficacy of implementing a telepathology system to remotely provide 
cancer diagnostics to Butaro District Hospital in rural Rwanda. Our system 
consisted of static images obtained by histotechnologists using a standard 
protocol, uploaded to ipath-network.com, and reviewed by a team of 
pathologists with various areas of expertise in common malignancies. 
Over the 9-month implementation of telepatholgy, we divided the study 
into three segments—training, technical workflow, and testing segment. 
In this presentation, we will breakdown the efficacy of the telepathology 
system in Butaro District Hospital for oncology cases. For the three 
implementation phases over the 9-month study period, we will present 
the turn-around time, from procedure date to result, as well as the volume 
of cases triaged for pathologist review that were unable to be diagnosed 
through telepathology. Over the three implementation phases, the turn-
around time of cases drastically decreased, allowing clinicians to receive 
results and initiate more accurate and timely treatment for cancer patients. 
Simultaneously, the percentage of cases triaged for pathologist review 
that could not be properly diagnosed through telepathology significantly 
decreased through improvements in technical imaging, communication, 
and workflow management.
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EVALUATION OF A HANDHELD MOLECULAR ASSAY AS A 
RAPID CLOUD BASED POINT OF CARE ASSAY FOR THE FIELD 
DETECTION OF RESPIRATORY VIRUSES IN KENYA
Clayton O. Onyango1, Jennifer M. Radin2, Shirley Lidechi3, 
Jesse VanWestrienen4, Maria F. Chacon-Heszele4, Nancy Otieno3, 
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1Division of Global Health Protection, Centers for Disease Control and 
Prevention-Kenya, Nairobi, Kenya, 2Digital Medicine, Scripps Translational 
Science Institute, La Jolla, CA, United States, 3Kenya Medical Research 
Institute (KEMRI), Kisumu, Kenya, 4Biomeme Inc., Philadelphia, PA, United 
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Influenza and respiratory syncytial viruses (RSV) are important causes of 
respiratory morbidity and mortality. Polymerase chain reaction (PCR) is the 
most reliable diagnostic test, but requires advanced laboratory facilities. 
Point of care (POC) rapid tests for influenza characteristically have low-
moderate sensitivity, varying substantially with age and the time of testing 
related to illness onset. Rapid and accurate detection of respiratory 
pathogens in less resourced, often rural settings is key for effective public 
health interventions. The Biomeme real-time PCR mini thermocycler with 
iPhone offers several advantages to traditional PCR, including temperature-
stable reagents, simplified protocols allowing for use at POC with limited 
laboratory experience, and instant communication of results. We evaluated 
the performance of this thermocycler against traditional Center for Disease 
Control and Prevention (CDC) real-time PCR assays. A total of 119 stored 
nasal and oral pharyngeal samples were identified, and RNA extracted 
and tested using both assays. CDC assays detected 35 Influenza-A, 
11 Influenza-B, 45 RSV and 28 influenza/RSV-negative specimens. For 
Influenza A, Biomeme detected 30/35 positives compared with CDC 
assay, for a sensitivity, specificity and agreement of 86 (95% confidence 
interval (ci) 74,97), 96 (95% ci 90,100) and 81% (Kappa= 81(95% ci 
67,95)) respectively. For Influenza B, Biomeme detected 7/11 positives 
compared with CDC assay, for a sensitivity, specificity and agreement of 
64 (95% ci 35,92), 96 (95% ci 90,100) and 66% (Kappa=66 (95% ci 
38,93)) respectively. For RSV, Biomeme detected 37/45 positives compared 
with CDC assay, for a sensitivity, specificity and agreement of 82 (95% ci 
71,93), 100 and 78% (kappa=78(95% ci 64,92)) respectively. Generally, 
there was good test agreement between Biomeme and CDC assays. 
Biomeme has potential as an accurate alternative POC diagnostics in 
sub-Saharan Africa, allowing detection of Influenza and other respiratory 
pathogens in medical facilities with limited laboratory capacity.
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IDENTIFYING AVENUES IN THE MANAGEMENT OF FEBRILE 
ILLNESS BY EXAMINING COMMUNITY HEALTH SEEKING 
PATTERNS
Mercy Rop1, Betty Lelei1, Jeremiah Laktabai2, Wendy Prudhomme 
O’Meara3, Diana Menya2
1Academic Model Providing Access to Healthcare, Eldoret, Kenya, 2Moi 
University, Eldoret, Kenya, 3Duke University, Durham, NC, United States
Malaria remains a major public health problem in Kenya. Early appropriate 
diagnosis and treatment can prevent severe illness. This depends on the 
recognition of the symptoms and signs and on treatment actions taken. 
We describe health seeking behavior for febrile illness in 3 rural malaria 
endemic areas prior to implementation of a large cluster randomized 
study. A population based household survey was conducted in western 
Kenya in a random sample of households. 2,065 participants who 
reported a malaria-like illness in the past four weeks were enrolled. 21% 
of respondents used drugs that were available at home as a first action, 
53.5% visited drug shops and 24.6% went to a health facility. 44% of 
participants had a malaria test for the illness, and 82.2% of tests were 
positive by self-report. Adults (OR 1.29 95%CI: 1.08-1.55), those less 
educated (OR 1.29 95%CI: 1.08-1.55) and those not employed were more 
likely to go to drug shops as a first action. More educated participants 
were more likely to be tested (OR 1.42, 95%CI: 1.22-1.65), but less likely 
to have a positive test. Overall, 76.4% reported taking an Artemisinin 
Combination Therapy (ACT), including 53.3% of malaria-negative 
participants, and 68.6% of participants with no test. 60% of those who 
took an ACT purchased it from a shop. The odds of taking an ACT did not 
differ based on whether the participant had a malaria test or whether the 
test was positive or negative, but the odds of taking an ACT was three-
times higher if they purchased drugs in a shop (OR 3.2, 95%CI: 2.6-4.0). 
42.9% of those who took action for their illness also took a second follow 
up action, usually visiting a health facility (72%). Those who initially took 
drugs available at home and from drug shops were more likely to take a 
second action (34.74%, 56.21% respectively) as compared to those who 
had initially visited health facilities (8.7%). Most ACTs are obtained from 
the private retail sector but targeting of ACTs to those with a confirmed 
malaria infection is inadequate. This is underscored by the large proportion 
of people who do not recover after seeking treatment in the retail sector 
and go on to attend a health facility.
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EXPERIENCES AND CHALLENGES OPERATING AN EBOLA 
VIRUS DISEASE DIAGNOSTIC LABORATORY IN RURAL 
LIBERIA
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Bailey1
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In August 2014, the World Health Organization declared the Ebola 
Virus Disease (EVD) outbreak in the West African nations of Guinea, 
Liberia, and Sierra Leone a public health emergency of international 
concern. As part of the international response to the outbreak in Liberia, 
laboratories were opened and dedicated to testing specimens for EVD 
infection across the nation. These laboratories served to provide rapid and 
accurate information to assist epidemiologists and other public health 
workers in controlling the spread of the outbreak by testing specimens 
from both living and deceased patients thought to be infected with the 
virus. In February 2015, the Academic Consortium Combating Ebola 
in Liberia (ACCEL), in coordination with the United States Centers for 
Disease Control and Prevention and the Liberia Ministry of Health and 
Social Welfare, began performing EVD testing in Tappita, Liberia. Since 
that time, the laboratory has processed and tested over 9,000 specimens 
and continues to be one of four enduring EVD laboratories in the 
nation. In addition to providing rapid molecular diagnostic capability for 
epidemiological investigations, the Tappita EVD Laboratory also provides 
rRT-PCR testing for the semen of male EVD survivors in support of Liberia’s 
Men’s Health Screening Program. Although testing for highly pathogenic 
agents presents inherent challenges, operating in rural Liberia offers 
unique challenges including further issues with logistics management, 
workforce development, sustainability, infrastructure improvement, 
and the implementation of new technologies. This requires both a 
knowledgeable and adaptable organization. Herein, we present our 
experiences running one of the largest EVD laboratories in Liberia and the 
challenges encountered.
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THE COSTS AND IMPACT OF COMMUNITY HEALTH SERVICES 
IN MALAWI AND SIERRA LEONE
Colin Gilmartin1, David Collins2, Jerome Pfaffmann3, 
Management Sciences for Health
1Management Sciences for Health, Arlington, VA, United States, 
2Management Sciences for Health, Medford, MA, United States, 3UNICEF, 
New York, NY, United States
In Malawi and Sierra Leone, community health workers (CHWs) play a 
critical role in extending access to health services and addressing priority 
issues ranging from Ebola prevention to malaria case management. 
Despite evidence on the benefits of community health services (CHS), there 
is limited information on the required financing for effective, integrated 
CHW programs, and, consequently, programs frequently lack long-term 
financing plans and are under-funded. In February and March 2015, MSH, 
through funding from UNICEF, piloted a methodology and tool to calculate 
the costs and the estimated return on investment (i.e. lives saved) of 
national CHS packages in Malawi and Sierra Leone. Using an “ingredients-
based” approach, MSH staff collected actual service and financial data 
through semi-structured questionnaires administered to 48 CHWs and 
22 supervisors in four districts and program managers at all levels of the 
health system. Following data entry into the tool, MSH health economists 
conducted cost and impact analyses of the current CHS packages and 
projections of utilization scenarios up to ten years. Based on preliminary 
study findings in Sierra Leone, the total recurrent cost per CHW averaged 
$767.25 and the recurrent cost per live saved was $3,176. The main 
cost-drivers of CHW program were program management followed 
by CHW supervision and equipment and medicines. A comprehensive 
understanding of the costs and impact of CHS packages provides evidence 
for policy makers and planners to advocate for future funding and allocate 
financial and human resources based on cost and impact projections. 
However, to be cost-effective and affordable, CHW programs must be 
well-utilized and key bottlenecks such as stock-outs of medicines, human 
resource shortages, and inadequate CHW financial incentives must be 
addressed. This methodology and tool can be adapted for use in other 
countries for investment case advocacy, service package planning, resource 
allocation, and cost-effectiveness and financial gap analyses.
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IN RURAL WESTERN KENYA: DATA FROM REPEATED 
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Branch, Division of Parasitic Diseases and Malaria, Center for Global 
Health, Centers for Disease Control and Prevention, Nairobi, Kenya, 
4Liverpool School of Tropical Medicine, Liverpool, United Kingdom
Socio-economic disparity is well recognized as a barrier to achieving 
health-related international development goals. Socio-economic data are 
not always analysed or fully utilised for guiding decisions or monitoring 
the impact of health interventions and programs. In malaria-endemic 
western Kenya, we examined the trends in malaria parasitemia, malaria 
medication usage, and care-seeking behaviour at the household level 
by socio-economic status. We analysed data from annual malaria cross-
sectional surveys from 2006 to 2013 based on systematic, cluster, and 
stratified sampling of 7,253 households in rural western Kenya. Data 
collected included socioeconomic status (SES), demographics, malaria 
parasitemia by microscopy, medication usage and care-seeking behaviour. 
A composite SES score was created from multiple correspondence analyses 
of household assets, and households were classified as poor (i.e., lowest 
three quintiles) or less-poor (i.e., highest two quintiles). The gap in the 
odds of malaria between poor and less-poor (for all ages) was significant 
in 2007 (OR=1.86, 95% CI: 1.1–3.1, p=0.016) but not in 2013 (OR=1.2, 
95% CI: 0.9–1.6, p=0.331). Overall, the declining equity gap in the 
odds of malaria from 2006–2013 formed a polynomial curve (R2=0.99; 
trend p<0.001). Amongst children aged <5 years, the trend in the odds 
of malaria gap between poor and less-poor was not significant over the 
study period (p=0.688). The trends in the inequalities in medication usage 
(p=0.876) and care-seeking behaviour (p=0.181) were not statistically 
significant over the study period. In western Kenya, substantial inequalities 
in health indicators, such as malaria parasitemia prevalence, medication 
usage and care-seeking behaviour, continue to exist. However, the health 
inequality gap in malaria parasitemia prevalence has decreased over time. 
These findings provide evidence that targeted malaria prevention and 
control efforts can help reduce health inequalities among the poorest 
households in western Kenya.
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The growth of urban centers and the transition of rural settlements to 
urban environments has a broad range of public health implications.  
Sub-Saharan Africa currently has the world’s highest urban growth rate 
of any continent at roughly 4.2% annually and better understanding 
the spatiotemporal evolution of this process is key to many geospatial 
disease modelling and burden estimation efforts. Nighttime lights imagery 
(NTL) captured by National Oceanic and Atmospheric Administration’s 
satellites offer a unique viewpoint for studying urban trends.  These data, 
available as annual composites from 1992-2013 at 1 km resolution, 
provide a means for spatiotemporal analysis on a global basis.  However, 
inter- and intra-annual differences between satellites make the raw 
imagery unsuitable for temporal analysis. The objective of this study was 
to generate a time series of annual inter-calibrated NTL images (2000-
2013) to describe patterns of urbanization in Africa and provide input for 
studies on the relationship between urban land cover and electrification 
on malaria transmission. Processing included a regression based procedure 
for inter-calibration of images from different satellite/years.  This method 
used a 1999 image as a reference and values in all other images were 
adjusted to match its data range. Subsequently, a weighted 5-year moving 
average was used to reduce annual variability.  Low-light thresholding 
was also used to remove ‘overglow’, an exaggeration of brightness in 
urban peripheries.  Urban agglomerations were identified using a region 
grouping function to detect contiguous lighted pixels.  Urban cluster sizes 
were grouped into 6 categories on a log scale (1-100K km2) and trends 
in total area assessed temporally.  The maximum size and frequency of 
agglomerations increased in the 10K–100K and 100–1K km2 categories 
for densely and sparsely populated countries, respectively. The processed 
NTL time series will be made openly available to global health researchers 
as well as the broader scientific community.
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1University of Cape Town, Cape Town, South Africa, 2Liverpool School 
of Tropical Medicine, Liverpool, United Kingdom, 3University of Oxford, 
Oxford, United Kingdom, 4London School of Hygiene & Tropical Medicine, 
London, United Kingdom, 5World Health Organization, Regional Office for 
the Western Pacific, Manila, Philippines
Drug safety signals may remain undetected in resource-poor settings due 
to a lack of infrastructure for surveillance, under-developed regulatory 
oversight and poor access to guidance on research methods. Online 
resources are available but may be unaffordable. Moreover some websites 
lack maintenance, or provide guidelines and regulations without support 
for implementation. Few facilitate interaction about the successes 
and challenges in assessing harm. More tools, discussion and learning 
opportunities would advance drug safety research in these areas. The 
ACT Consortium (ACTc) took a comprehensive approach to antimalarial 
pharmacovigilance (PV); trials on the effects of repeated exposures of 
artemisinin-based combination therapies (ACTs), and interactions between 
ACTs and antiretrovirals; the participatory design of adverse event data 
collection tools; qualitative exploration of influences on participant 
safety data reports; and a web-based Drug Safety Repository (www.
actconsortium.org). Sharing these experiences and resources should 
benefit others interested in drug safety in tropical infectious diseases and 
global health, particularly those struggling to access relevant information. 
As such, ACTc researchers have collaborated with the online open-
access science park, The Global Health Network, TGHN (www.tghn.
org), to develop a dedicated space for this field. Aside from creating a 
comprehensive PV resource of relevant information within TGHN, www.
globalpharmacovigilance.org brings useful, high quality, up-to-date 
external resources together in one place. In addition there are original 
articles on pertinent PV topics, interviews with experts, and fora for 
discussing drug safety research in the real world. Links are provided 
to education and training providers, while new free eLearning courses 
are being developed in-house. The website coordinators make periodic 
contact with its user group to explore experiences and needs. By engaging 
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the website community, this contribution to global drug safety will develop 
iteratively to improve the practice of safety evaluations in resource-poor 
settings.
1454
EVALUATION OF CAPACITY BUILDING FOR LEADERSHIP AND 
GOVERNANCE IN ORDER TO STRENGTHEN HEALTH SYSTEMS 
IN DEVELOPING COUNTRIES
Nadia Ben Meriem1, Nick Astbury2, Covadonga Bascaran2, Amy 
Brockbank3, Clare Inkster4, Marcia Zondervan2
1Schistosomiasis Control Initiative, London, United Kingdom, 2London 
School of Hygiene & Tropical Medicine, London, United Kingdom, 3NHS 
North West Leadership Academy, Manchester, United Kingdom, 4Bolton 
NHS Foundation Trust, Bolton, United Kingdom
In many countries, teaching the topic of leadership is not part of the 
medical curriculum, however with the recent Ebola outbreak, it clearly 
showed how a lack of leadership can be a threat to an entire health 
system. A training course in leadership was taught to 24 medical doctors 
from eight sub-Saharan countries. The aim of the project was to evaluate 
the leadership training course and it is application in the context of health 
systems strengthening in developing countries. The evaluation study was 
designed using a qualitative methodology whereby individual interviews 
with all the participants and trainers from the leadership training course 
were conducted. Focus group discussions were organised in four countries. 
Questions from the individual interviews were designed following the 
Kirkpatrick Model for evaluating training programmes, which include, the 
reaction to the training; learning uptake; behaviour change; and results 
of the training. The themes generated from the interviews which were 
highlighted as important to effective leading and governing of health 
systems in developing countries were, enthusiasm; being a better leader; 
need for a change; communication; teamwork; personal development; 
process of implementation of activities; responsibility and governance. 
During the focus group discussions the themes discussed were non-
governmental organizations and representation at the ministry level. The 
presenter will explore these themes further and demonstrate subsequent 
changes following the capacity building initiative. The discussion will 
include positive reaction from all the trained participants, which has 
enabled them to keep track of their progress through their actions. 
Training also determined the essential skills required for a leader in 
healthcare and how participants are able to apply the knowledge gained 
during the training to their work setting. Additional factors to improve 
healthcare services by increasing collaboration with Governments and 
the MOH in order to increase sustainability of healthcare services were 
addressed.
1455
HEALTH CARE WORKER MOTIVATION ONE YEAR AFTER THE 
EBOLA OUTBREAK IN LIBERIA
Anne Langston1, Jude Senkungu2, Laura Miller1, Theresa Jones2, 
John Shakpeh3
1International Rescue Committee, New York, NY, United States, 
2International Rescue Committee, Monrovia, Liberia, 3Redemption 
Hospital, New Kru Town, Liberia
Staff motivation is an often overlooked ingredient of quality health 
services. After a crisis like Ebola, particular attention should be paid to 
helping health care workers recover. During the Ebola Virus Disease (EVD) 
outbreak in Liberia, Redemption Hospital, the only free secondary care 
facility in the city, became the physical and emotional epicentre of the 
disease. Twenty health care workers became infected and twelve died. 
The hospital ceased providing most services and was transformed into 
a holding unit for suspected Ebola cases. In January 2015, Redemption 
Hospital resumed comprehensive health services with the support of 
the International Rescue Committee (IRC). Initially it lacked the systems 
to maintain proper IPC, physical infrastructure for safe waste disposal, 
personal protective gear, and a sufficient number of skilled staff. Staff 
morale had been destroyed by the trauma of the outbreak; many did not 
return and those that did expressed fear and distress. From the outset, 
the IRC prioritized the mental and physical safety of staff, in addition 
to focusing on quality services. A year after the resumption of health 
services, the IRC assessed perceptions of change and factors affecting 
motivation for staff at Redemption. The qualitative findings revealed that 
staff expressed an improved sense of safety coming to work, increased 
confidence in their ability to deliver quality care to patients, and improved 
sense of pride and value as individuals. A quantitative survey verified these 
findings: the most important motivating factors reported by staff included 
commitment to the job (94%), smooth working relationship among staff 
(86%), and availability of PPE (83%). The least significant factors were 
monthly salary (27%) and transportation to work (31%). While monetary 
incentives are important, these findings show that they are not the primary 
motivator for health care workers at Redemption Hospital, a year after it 
resumed full services after being closed due to Ebola.
1456
ESTIMATING THE POTENTIAL DEMAND OF A DENGUE 
VACCINE TO INFORM VACCINE INTRODUCTION IN THE 
YUCANTAN PENINSULA: CASE STUDY FOR MEXICO
Jorge Martin del Campo, Gatien De Broucker, Alexandra 
Greenberg, Dagna Constenla
Johns Hopkins University, Baltimore, MD, United States
Dengue has become a disease of growing importance in Mexico with 
disease prevalence in endemic areas as high as 80%. In 2015, Sanofi 
Pasteur’s Dengvaxia® became the first dengue vaccine to be licensed for 
use in Mexico in the 9-45 year olds. As governments at the national and 
state levels discuss and plan strategies in response to dengue fever and 
the industry develops and prepares to scale up the production of vaccines, 
there is a need for estimates of the demand for dengue vaccine and for 
insights on where the introduction of the vaccine would have strong social 
and economic impact. In this perspective, strategic demand forecasts 
can be used to accelerate vaccine access by providing stakeholders with 
vital information on supply, potential demand, and vaccine costs of 
vaccine introduction scenarios. Demand estimates will be presented to 
accelerate vaccine access in the Yucatan peninsula. We will estimate the 
potential demand, costs, and impact of introducing a dengue vaccine 
in the Yucatan peninsula based on key stakeholder preferences for 35-
year analytic horizon. The Yucatan Peninsula is formed by three states 
(Yucatan, Campeche and Quintana Roo) in Mexico where dengue fever is 
on the increase with 2,117 and 2,990 confirmed cases, 8,459 and 31,559 
probable cases and 729 and 785 hospitalized cases reported in 2014 and 
2015, respectively. We developed an Excel-based model to estimate the 
potential demand in the Yucatan peninsula from the public and private 
healthcare perspectives. Introduction scenarios are developed along 
with model algorithms to model the 35-year analytic horizon based on 
stakeholder interviews. Model assumptions are derived from government, 
funders and industry stakeholder interviews and from administrative and 
surveillance data produced by the Federal Government of Mexico.
1457
ESTIMATING THE POTENTIAL DEMAND FOR DENGUE 
VACCINES IN HONDURAS AND PARAGUAY: PRELIMINARY 
FINDINGS
Alexandra Greenberg, Jorge Martin del Campo, Gatien De 
Broucker, Dagna Constenla
Johns Hopkins University, Baltimore, MD, United States
Honduras and Paraguay, both Latin American countries with a national 
GDP per capita below $US31 billion, continue to report growing 
incidence of and morbidity attributed to dengue fever. The increasing 
burden of dengue in these countries and the recent approval of the first 
Dengue vaccine, Dengvaxia®, in neighboring Latin American countries 
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has highlighted the need for country-specific, equitable dengue vaccine 
introduction strategies. Currently, there are no studies that quantify the 
demand and supply of the dengue vaccine to inform the value of vaccine 
introduction in Honduras and Paraguay. Strategic demand forecasts 
are a decision-making tool that can evaluate the temporal demand for 
vaccination, estimate the costs associated with vaccine implementation 
strategies, and approximate the funding requirements for the vaccine 
according to different introduction scenarios. This study aims to generate 
new evidence on the potential demand for two dengue vaccine 
candidates. We adopt an existing strategic demand forecast model to 
assess the potential demand for the two vaccine candidates and estimate 
the implementation costs and health impact of this demand in Honduras 
and Paraguay. Preliminary findings about the potential demand for 
dengue vaccines in Honduras and Paraguay will be presented based on 
extensive stakeholder consultations and a number of vaccine introduction 
scenarios. Results will rest on country- and state-specific sociodemographic 
characteristics, dengue epidemiology, price, supply constraints, and timing 
of licensure. Understanding the potential demand for and associated 
impact of a dengue vaccine can help develop a viable vaccine introduction 
strategy, which can significantly accelerate vaccine introduction and 
decrease the time it takes for countries to begin vaccination following 
licensure.
1458
A THRESHOLD ANALYSIS OF THE COST-EFFECTIVENESS OF A 
DENGUE VACCINE PROGRAM IN YUCATÁN, MEXICO
Gatien de Broucker, Jorge Martin del Campo, Dagna Constenla
International Vaccine Access Center, Baltimore, MD, United States
The past few months have been pivotal in the effort to prevent and 
alleviate the burden of dengue fever worldwide. Mexico, Brazil, the 
Philippines, El Salvador and Paraguay have approved the first dengue 
vaccine - CYD-TDV, developed by Sanofi Pasteur, paving the way for 
vaccination campaigns in other endemic countries. The Philippines began 
its first public, school-based dengue immunization program in selected 
high-risk areas. Several other dengue vaccine candidates are currently 
in clinical development. Yucatán is one of Mexico’s state that is most 
challenged with the burden of dengue with an annual incidence rate 
of 70.89 per 100,000 person-years in 2015, compared to the national 
average of 22.04 per 100,000 person-years. The cost of introducing the 
dengue vaccine in this region is likely to be significant. It is important 
to examine the level of cost per unit of outcome below which this new 
vaccine might be described as cost-effective to inform vaccine introduction 
policy. We use a decision tree model, embedded in a strategic demand 
forecast model, to estimate the incremental cost-effectiveness of using 
the new dengue vaccine program compared with the status quo, over 5-, 
10-, and 15-, 20- and 30-year periods from a government perspective. 
Standard acceptability curves will be constructed to represent uncertainty 
around the incremental cost-effectiveness ratio decision rule, and to make 
cost-effectiveness results comparable to opportunity costs resulting from 
other health care strategies. Initial results about the cost-effectiveness 
threshold of a dengue vaccine program in the Yucatán region will be 
presented and analytic issues will be discussed. The results of the threshold 
analysis will highlight the importance of threshold values in dengue 
vaccine introduction decisions.
1459
TREATMENT AND REFERRAL OF SICK CHILDREN PRESENTING 
WITH ILLNESSES AT PRIVATE HEALTH CARE FACILITIES IN 
UGANDA
Anthony Mbonye1, Esther Buregyeya2, Elizeus Rutebemberwa3, 
Siân Clarke4, Sham La4, Kristian Hansen4, Pascal Magnussen5, 
Philip LaRussa6
1Ministry of Health Uganda, Kampala, Uganda, 2School of Public Health, 
College of Health Sciences, Makerere, Kampala, Uganda, 3School of Public 
Health- Makerere University, Kampala., Kampala, Uganda, 4London School 
of Hygiene & Tropical Medicine, London, United Kingdom, 5University of 
Copenhagen, Copenhagen, Copenhagen, Denmark, 6College of Physicians 
& Surgeons, Columbia University, New York, NY, United States
Objectives: The main objective of this study was to assess treatment and 
referral practices for sick children seen at private health care facilities in 
order to explore ways of improving quality of care in this sector. Methods: 
A survey was conducted within 57 geographical areas (parishes) from 
August to October 2014 in Mukono district, central Uganda. Data was 
collected using a structured questionnaire supplemented by focus group 
discussions and key informant interviews with community members and 
private providers. Results: A total of 241 private health facilities were 
surveyed; 170 (70.5%) were registered drug shops, 59 (24.5%) private 
clinics and 12 (5.0%) pharmacies. The majority of facilities were selling 
artemesinin-based-combination therapy, (>96%), Amoxicillin (>90%), 
Zinc tablets (>77%) and oral rehydration salts, (>76%) all important 
in treating malaria, pneumonia and diarrhoea among children. Few 
drug shop (7.1%) and some private clinics (33.9%) had guidelines on 
integrated management of childhood illnesses. Similarly, only a few drug 
shop vendors (17.6%) and staff at private clinics (15.3%) knew that 
amoxicillin was the first-line treatment for pneumonia. Overall, 104/241 
(43.2%) of the private health facilities reported that they had referred 
sick children to higher levels of care in the two weeks prior to the survey. 
The main constraints to follow referral advice by caretakers were: not 
appreciating the importance of referral, gender-related decision making 
and negotiations at household level, poor quality of care at referral 
facilities, inadequate finances at household level; while the perception that 
referral leads to loss of prestige and profit was a constraint at facility level, 
Conclusion: In conclusion, the results show that treatment and referral 
of sick children at private health facilities faces many challenges. Thus 
interventions to address constraints to referral of sick children are urgently 
needed.
1460
THE CARTER CENTER INTERNATIONAL HEALTH PROGRAM 
REVIEWS—A UNIQUE MODEL TO ASSESS PROGRAM 
PROGRESS, CHALLENGES AND IMPROVE PERFORMANCE
Shandal Sullivan, Kenya Casey, Donald R. Hopkins, Ernesto Ruiz-
Tiben, P. Craig Withers, E. Kelly Callahan, Scott Nash, Nina Bloch
The Carter Center, Atlanta, GA, United States
The Carter Center has provided assistance to national programs to 
interrupt transmission of Guinea worm disease (dracunculiasis) since 
1986. The collaborative effort of The Carter Center, ministries of health, 
WHO, CDC, UNICEF and other partners has reduced cases from an 
estimated 3.5 million in 1986 to 22 in 2015. The assistance provided 
by The Carter Center included development of operating procedures 
and monthly monitoring and reporting of program indicators. These 
requirements emphasized the need for all components of the programs 
to be accountable, and programs to be accountable to each other and to 
partner organizations and donors. In order to keep all staff informed of 
the status of the national eradication campaign, it became necessary to 
hold national Guinea Worm Eradication Program (GWEP) reviews, as well 
as an international review for national programs to report on the status 
of eradication efforts to partners and donors. This unique forum allows 
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partners to convene to peer review program progress, discuss challenges 
and make recommendations focused on improving performance and 
achieving the goal of eradication. Since its inauguration in Atlanta, GA 
in 1986, the program review has become the model used to measure 
program progress and inform programmatic decisions by both The 
Carter Center and national GWEPs. By 1996 the review had expanded 
to over 150 participants from 20 countries. In 2006 the review included 
representation from 21 countries, after the establishment of a separate 
program in Southern Sudan.
 Due to its impact on successful program implementation, the program 
review model has been adopted by other Carter Center health programs. 
In 2016, the Center hosted 5 program reviews at its headquarters. While 
the review has evolved over the past 30 years, it remains an integral part 
of programming that has informed the Carter Center GWEP as it has 
helped stop transmission of Guinea worm disease in 17 countries in Africa 
and Asia. With 4 endemic countries (Chad, Ethiopia, Mali, South Sudan) 
remaining, The Carter Center will continue to coordinate review meetings 
at the national and international levels until eradication is achieved.
1461
LAND COVER MAPPING FOR CONTINENTAL AFRICA
Alemayehu Midekisa1, Felix Holl1, David J. Savory1, Ricardo 
Andrade-Pacheco1, Peter W. Gething2, Adam Bennett1, Hugh J. 
Sturrock1
1University of California San Francisco, San Francisco, CA, United States, 
2University of Oxford, Oxford, United Kingdom
Land cover type influences transmission of a number of diseases, including 
vector-borne diseases such as malaria. However, high spatial resolution 
land cover data through time are lacking for continental Africa, hindering 
the ability to model and test hypotheses. The objective of this study was 
to develop a high spatial resolution (30 meter) land cover dataset for 
continental Africa for the years 2000 and 2015. To generate gold standard 
model data, high resolution satellite imagery was visually inspected and 
used to identify (7212 sample points) Landsat pixels that were entirely 
made up of 1 of 7 classes (water, impervious surface, high biomass, low 
biomass, rock, sand and bare soil). For model validation purposes, 80% of 
points from each class were used as training data, with 20% withheld as a 
validation dataset. Cloud free Landsat 7 and 8 annual composites for 2000 
and 2015 were generated. Spectral bands from the Landsat image were 
then extracted for each of the training and validation points and a random 
forest model using the full dataset was used to classify the 2000 and 
2015 Landsat images into each of the 7 classes. In addition to the Landsat 
spectral bands, spectral indices such as normalized difference vegetation 
index (NDVI) and normalized difference water index (NDWI) were used as 
covariates in the model. Additionally, calibrated night time light imageries 
from the National Oceanic and Atmospheric Administration (NOAA) 
were included as a covariate. Using the validation dataset, classification 
accuracy including omission error and commission error were computed 
for each land cover class. Model results showed that overall accuracy of 
classification was over 90 percent. This high resolution land cover product 
developed for the continental Africa will be available for public use and 
can potentially enhance the ability to test models and hypotheses.
1462
USING TREATMENT SEEKING DATA TO DEFINE HEALTH 
CATCHMENT AREA MODELS: EVIDENCE FROM ZAMBIA
Ricardo Andrade-Pacheco1, Hugh J. Sturrock1, Samir Bhatt2, 
Daniel J. Weiss3, Busiku Hamainza4, Kafula Silumbe5, John Miller5, 
Peter W. Gething3, Thomas P. Eisele6, Adam Bennett1
1MEI, Global Health Group, University of California San Francisco, San 
Francisco, CA, United States, 2Imperial College London, London, United 
Kingdom, 3Big Data Institute, Nuffield Department of Medicine, University 
of Oxford, Oxford, United Kingdom, 4Zambia National Malaria Control 
Centre, Lusaka, Zambia, 5Malaria Control and Elimination Partnership in 
Africa, Lusaka, Zambia, 6Tulane University, New Orleans, LA, United States
While routine health facility outpatient data are a vital source for tracking 
numbers of clinical disease cases in space and time, they are an imperfect 
measure of disease incidence in communities. Two main difficulties arise 
when trying to estimate community level incidence from cases reported 
at the health facility level. First, health records are only representative 
of those individuals who sought treatment. Thus, the number of cases 
captured and recorded via health facilities is likely to be an underestimate 
of the actual number of cases. Second, as information on the location of 
residence of cases is often lacking, catchment boundaries and populations 
are often uncertain. A better understanding of the drivers of treatment 
seeking, as well as the spatial distribution of the patients attending a 
health facility can help better estimate true incidence rates. Using data 
from eight rounds of parasite censuses amongst a population of over 
300,000 in Southern Province, Zambia, where information on health 
facility choice and residence location of those seeking treatment for fever 
was collected, we define a probabilistic model that encodes the decision 
process of an individual when seeking for treatment and choosing a health 
facility to attend. Our model factors travel time (based on travel distance 
and maximum speed allowed by the terrain) as well as the types of health 
facilities in close proximity (Hospital, Health Center or Health Post). Results 
demonstrate a negative relationship between travel time to the closest 
health facility and the decision to seek treatment. Results also demonstrate 
that individuals are sometimes willing to undergo longer travel times to 
receive treatment at a specific type of health facility, rather than going to 
the closest facility available. The model allows for overlapping weighted 
catchment areas to be defined for each health facility depending on its 
type, travel time and location of other facilities. This catchment area model 
will be used in future geospatial modeling work to develop high resolution 
estimates of the incidence of malaria infection across Zambia.
1463
A CROSS-SECTIONAL SURVEY OF PERCEPTIONS RELATED 
TO SYMPTOMS OF MALARIA, CURABLE REPRODUCTIVE 
TRACT INFECTIONS AND ASSOCIATED TREATMENTS AMONG 
PREGNANT WOMEN AT HEALTH FACILITIES IN TANZANIA
R. Matthew Chico1, Joyce Wamoyi2, Myles-Jay Linton3, Catherine 
Bunga2, Nnko Soori2, John Changalucha2, Daniel Chandramohan1, 
Antonieta Medina-Lara3
1London School of Hygiene & Tropical Medicine, London, United Kingdom, 
2National Institute for Medical Research, Mwanza, United Republic of 
Tanzania, 3University of Exeter, Exeter, United Kingdom
Malaria and curable sexually transmitted/reproductive tract infections 
(STIs/RTIs) in pregnancy are unacceptably high in sub-Saharan Africa 
due, in part, to poor coverage of antenatal interventions. Investigating 
the perceptions about these infections and related treatments among 
pregnant women may help to identify key barriers and facilitators to 
care-seeking and care provision. A cross-sectional survey of 397 pregnant 
women was conducted in rural Tanzania to examine perceptions of 
risk related to symptoms of malaria infection and curable STIs/RTIs, 
and associated treatments. Overall, 52% of pregnant women reported 
having a febrile episode in the last four weeks, of whom 79% received 
459
astmh.org
antimalarial treamtent, this despite only 46% of them being diagnosed 
with malaria. Fever during pregnancy was considered somewhat, very, 
or extremely harmful by 11%, 25%, and 34% of pregnant women, 
respectively, whereas 7%, 7%, and 10% believed fever to be not at all 
harmful, slightly harmful, or somewhat harmful, respectively. Over 20% 
of participants did not know if malaria treatment was harmful. In the 
previous four weeks, 53%; 41%; 13% and 9% of pregnant women 
reported experiencing symptoms of curable STIs/RTIs - lower abdominal 
pain, genital or vaginal itchiness, vaginal discharge with fishy smell, and 
genital or vaginal ulcers - respectively. Only 24%, 27%, 33%, and 26% of 
these women received treatment for their STIs/RTIs symptoms, respectively. 
The public health implications of these results are evident. Although 
between 65-70% of pregnant women recognise the potential harm of 
malaria infection and curable STIs/RTIs in pregnancy, 20-25% of women 
do not know, or do not believe, that these infections may be harmful 
to their pregnancies. Malaria treatment is given too commonly without 
diagnosis, and only one-quarter to one-third of pregnant women with 
symptoms of curable STIs/RTIs are treated.
1464
CURABLE REPRODUCTIVE TRACT INFECTIONS: A CROSS-
SECTIONAL SURVEY OF PERCEPTIONS RELATED TO 
SYMPTOMS AND ASSOCIATED TREATMENTS AMONG 
HEALTH-CARE PROVIDERS AT HEALTH FACILITIES IN 
TANZANIA
R. Matthew Chico1, Joyce Wamoyi2, Myles-Jay Linton3, Catherine 
Bunga2, Nnko Soori2, John Changalucha2, Daniel Chandramohan1, 
Antonieta Medina-Lara3
1London School of Hygiene & Tropical Medicine, London, United Kingdom, 
2National Institute for Medical Research, Mwanza, United Republic of 
Tanzania, 3University of Exeter, Exeter, United Kingdom
A cross-sectional survey was conducted among 131 health-care providers 
in rural Tanzania to examine the knowledge and availability of treatment 
for syndromes related to curable sexually transmitted and reproductive 
tract infections (STIs/RTIs) in pregnancy: (1) lower abdominal pain 
(gonorrhoea and chlamydia), (2) vaginal discharge (bacterial vaginosis, 
trichomoniasis and yeast infection), (3) genital or vaginal ulcers (syphilis, 
gonorrhoea, chlamydia, and chancroid), and (4) genital or vaginal itchiness 
(yeast infection). Perceptions of harm attributable to these syndromes, 
and to treatment, were recorded. Nine of ten providers believed lower 
abdominal pain, vaginal discharge, genital or vaginal ulcers were extremely 
harmful to mothers (89%, 93%, and 95%, respectively); three-quarters 
(78%) responded similarly about genital or vaginal itchiness. Comparable 
proportions of providers said syndromes 1-3 were extemely harmful to 
unborn babies (88%, 94%, and 90%, respectively); three-quarters (76%) 
considered symdrome 4 to be extremely harmful. Nearly one-third of 
providers reported that the treatment of lower abdominal pain, vaginal 
discharge, genital or vaginal ulcers was harmful to mothers (32%, 30%, 
and 32%, respectively); whereas one in six (16%) providers said treatment 
of genital or vaginal itchiness was harmful to mothers. Similar proportions 
of providers reported syndromes 1-3 would be extremely harmful to 
unborn babies (31%, 35%, and 33%, respectively); one in five (19%) 
providers believed that treatment of syndrome 4 was harmful to unborn 
babies. Treatment for these four syndromes was available in 59%, 65%, 
46%, and 47% of facilities, respectively, but only one-quarter of 397 
pregnant women at the same facilities who reported having an STI/RTI 
syndrome in the previous four weeks received treatment. These findings 
suggest that reducing the burden of curable STIs/RTIs during pregnancy 
will, in part, require investment in retraining to reduce the occasions 
when some providers may withhold treatment of curable STIs/RTIs out of 
concern that treatment may be harmful to mothers or unborn babies.
1465
MAPPING MEASLES IMMUNITY GAPS AT THE 
SUBPROVINCIAL LEVEL IN THE DEMOCRATIC REPUBLIC OF 
THE CONGO (DRC) USING 2013-2014 DEMOGRAPHIC AND 
HEALTH SURVEY (DHS) DATA
Cyrus S. Sinai1, Kamy Musene2, Nicole A. Hoff1, Reena H. Doshi1, 
Patrick Mukadi3, Sue Gerber4, Ado Bwaka5, Emile Okitolonda6, 
Jean-Jacques Muyembe3, Anne W. Rimoin1
1University of California Los Angeles Fielding School of Public Health, Los 
Angeles, CA, United States, 2University of California Los Angeles-DRC 
Research Program, Kinshasa, Democratic Republic of the Congo, 3Institut 
National de Recherche Biomedicale, Kinshasa, Democratic Republic of 
the Congo, 4Bill & Melinda Gates Foundation, Seattle, WA, United States, 
5Expanded Program on Immunization, Kinshasa, Democratic Republic 
of the Congo, 6Kinshasa School of Public Health, Kinshasa, Democratic 
Republic of the Congo
Disease surveillance in the Democratic Republic of Congo (DRC) is 
logistically challenging due to years of debilitating civil war, insufficient 
funding and poor infrastructure. Under resource-limited conditions, 
it is crucial to identify high-priority regions within the country where 
vaccination efforts should take precedence. We mapped measles immunity 
gaps throughout the country by geographic survey cluster using data 
obtained from the 2013-14 DRC Demographics and Health Survey (DHS) 
with ArcGIS 10.2 software. To estimate measles antibody seroprevalence 
within areas that were not surveyed during the DHS, we produced a 
smoothed, interpolated prediction surface to visualize possible differences 
in measles immunity at the subprovincial level. “Hotspot” spatial clusters 
of low measles immunity within the country were identified through a 
Kulldorff spatial scan statistics analysis. Both the interpolated surface 
map and the spatial scan analysis identified southern Kasai province 
and western Lualaba province as the most significant hotspots of low 
measles immunity within the DRC. This study demonstrates that the 
use of geostatistical mapping methods can be a useful tool for the DRC 
Expanded Program on Immunization to identify specific areas at the 
subprovincial level that should be of the highest priority for future measles 
catch-up campaigns, and offers a novel alternative strategy compared to 
previous efforts which have treated heterogeneous populations within 
large administrative areas with the same treatment.
1466
EBOLA VACCINATION KNOWLEDGE, ATTITUDES, AND 
BEHAVIOR AMONG HIGH-RISK HEALTH CARE AND FRONT 
LINE WORKERS, DECEMBER 2014 - JANUARY 2015
Mohamed Jalloh1, Mohamed Samai2, Lansana Conteh3, The 
STRIVE Study Team
1Centers for Disease Control and Prevention, Atlanta, GA, United States, 
2College of Medicine and Allied Health Sciences, Freetown, Sierra Leone, 
3Ministry of Health and Sanitation, Freetown, Sierra Leone
The Centers for Disease Control and Prevention’s (CDC) sponsored a phase 
2/3 clinical trial of the candidate rVSV-ZEBOV vaccine that was conducted 
with the College of Medicine and Allied Health Sciences (COMAHS), 
University of Sierra Leone and the Ministry of Health and Sanitation 
(MoHS). CDC and MoHS approved the Sierra Leone Trial to Introduce 
a Vaccine against Ebola (STRIVE) with provisos that 1) communications 
around the vaccine and trial, including rumor control, were carefully 
managed and 2) clinical trial activities not impede or conflict with any 
outbreak response activities. Formative communications research was 
conducted In December 2014 - January 2015, focusing on health care and 
frontline workers and the general public to ascertain their understanding 
and acceptance of an experimental Ebola vaccine. The research was a 
mixed-methods approach consisting of 1) in-depth interviews with 31 
public health official and decision-makers, 2) 35 focus group discussions 
(FGD) with a total of 316 participants from the target populations, 
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and 3) a survey of 146 health care and frontline Ebola workers. The 
findings of the formative research were used to inform a field based 
communications strategy that focused on three objectives: 1) to build 
trust in the community by proactively countering potential inaccurate 
negative perceptions that could impact both the success of the trial and 
larger response efforts; 2) providing culturally understandable information 
about the vaccine and STRIVE to potential participants so they could 
make informed decisions about participation in the trial; 3) to ensure 
communications supported human subjects protection throughout the 
trial. We will present the formative research results as well as how that 
research was applied to the communications strategies and materials for 
STRIVE. The success of the communication strategy was demonstrated 
both by the support STRIVE received from the community and by the 
absence of any sustained negative public concern about the study. This 
success contributed to the enrollment and vaccination of ~8,000 high-risk 
health care and frontline Ebola response workers.
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OUTBREAK-RELATED ANXIETY AND PUBLIC POLICY: THE 
CASE OF EBOLA VIRUS DISEASE AND POLICY PREFERENCES
Rachael Singer, Joshua Busby
University of Texas at Austin, Austin, TX, United States
Public health officials rely on state-citizen communication and public 
cooperation to maximize success of emergency preparedness and 
response endeavors. The role of the public’s emotions, particularly fear 
and anxiety, in behavior and political support during an outbreak is 
under-investigated yet may yield useful insights for infectious disease 
policymaking. Data from a nationally representative survey of 1,425 
Americans conducted in December 2014 were analyzed using multiple 
ordered logistic regression models to determine whether fear-based 
claims about the 2014 West Africa Ebola outbreak, as opposed to claims 
appealing to morality and human rights, will increase support for the 
Obama administration’s proposed $6.2B appropriations to fund disease 
control measures. Additional analyses were performed to determine 
whether fear-based claims have the additional effect of increased support 
for more exclusionary policies, such as quarantine, isolation, deportation, 
flight bans, and the destruction of personal property. Respondents’ self-
rating of both higher anxiety and sadness was positively associated with 
support for emergency Ebola appropriations. Identification as Republican 
and conservative was negatively associated with support for Ebola 
appropriations. For respondents who considered the likelihood of an 
Ebola outbreak in the next 12 months to be high, there was a positive 
association with support for appropriations. Respondent belief that Ebola 
is dangerous was positively associated with support for appropriations. 
Support for a 21-day quarantine for health workers returning from 
West Africa was negatively associated with support for appropriations. 
Support for Obama’s executive order suspending deportation orders for 
undocumented immigrants was positively associated with support for 
appropriations.
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EBOLA SURVIVOR NETWORKS IN WEST AFRICA: A 
STRUCTURED APPROACH TO ESTABLISHING EBOLA 
SURVIVOR SUPPORT NETWORKS AS AN EFFECTIVE 
COMMUNITY ENGAGEMENT STRATEGY TO HELP FIGHT 
FUTURE EBOLA EPIDEMICS
Amos Ndhere1, Francis Kombe2, Lucas Tina1, Joseph Sgherza3, 
Mark Sprenz3, Claudia Christian3, Jacob Apollo1, Victoria Tifft3
1Africa Clinical Research Management, Kisumu, Kenya, 2KEMRI-Welcome 
Trust, Kilifi, Kenya, 3Clinical Research Management, Hinckley, OH, United 
States
West Africa was disproportionately affected by recent Ebola outbreak. 
Meaningful engagement of Ebola survivors is increasingly important in the 
prevention, care and support of Ebola patients in future Ebola epidemics. 
Engaging with Ebola survivors may speed the translation of discoveries 
into improved health outcomes. Ebola survivor support networks provide a 
non-traditional route for authentic engagement of Ebola survivors, patients 
and communities. As a follow-up to our clinical trial of plasmapheresis 
of convalescent plasma to treat Ebola victims in West Africa, Clinical 
Research Management in 2015 began testing new approaches for 
community engagement which led to the establishment of Ebola Survivor 
Support Networks in Liberia, Sierra Leone and Guinea. This structured 
program facilitated project-specific input from governments, communities, 
academic research institutions and Ebola survivor stakeholders. Peer-
to-peer approach was used to recruit, train and organize survivors into 
networks. The networks were registered as legal entities by respective 
governments. Basic demographic data of the survivors was systematically 
collected and stored and a registry of Ebola created for Guinea, Liberia 
and Sierra Leone. The networks set up offices to support operations. 
Developers prepared networks to engage with stakeholders and facilitated 
regular in-person and virtual meetings. A total of six (6) Ebola Survivor 
Networks were registered. The networks opened national offices in Liberia, 
Guinea and Sierra Leone. A total of 2800 Ebola survivors were recruited 
into the Networks and one registry of Ebola survivors created in each 
country. The Networks engaged 15 research community stakeholders. 
Participating researchers, reported that partnership with Networks was 
valuable and that the Networks helped to determine project feasibility and 
enhanced research implementation. Stakeholders found the Networks to 
be an acceptable method of engagement. A tool kit was developed to 
replicate this model and to disseminate this approach.
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THE IMPACT OF CLUSTERING OF UNVACCINATED 
INDIVIDUALS ON RISK OF OUTBREAKS
Shaun Truelove, Justin Lessler
Johns Hopkins University, Baltimore, MD, United States
The foundation of efforts to control and eliminate vaccine-preventable 
diseases like measles rely on estimates of the effective reproduction 
number (R) and critical vaccination threshold (Vc). Commonly calculated 
as R = R0*(proportion susceptible), we assume evenly-mixed populations. 
However, in real populations this assumption fails, and thus true outbreak 
risk is likely underestimated. We developed a novel methodology to 
produce an R that captures heterogeneity through scaling the R estimate 
by the relative probability of susceptible individuals being in contact with 
one another. We used data available through Demographics and Health 
Surveys (DHS), which are conducted every 3-5 years in over 90 countries 
(dhsprogram.com). We developed methods to estimate the clustering 
of susceptibles that accounts for the clustered sample structure of these 
data. Applying these methods to Zambia and Tanzania to examine the 
impact of clustering and its effects on the 2009-10 outbreak in Zambia, 
we found Tanzania to have a relative level of clustering of 1.37 times that 
of Zambia (95% CI = 1.04-1.89). We found a ratio 0.96 comparing the 
estimated R of Tanzania and Zambia. Thus, while Tanzania experienced 
greater clustering, they counter with higher overall vaccination, resulting 
in comparable outbreak potential to Zambia. While measles attack rates 
in Tanzania were relatively constant (mean (SD): 9.3(10.5) per 100,000), 
in Zambia they were highly variable (mean (SD): 51.2(81.8) per 100,000). 
This contrast might be partially the consequence of the vaccination and 
clustering levels, whereby Tanzania experienced more frequent, smaller 
outbreaks, possibly from higher clustering, while Zambia had a large, 
population-wide outbreak from lower vaccination coverage and a build-up 
of susceptibles during non-epidemic years. Our novel approach accurately 
quantifies the increasing potential for measles outbreaks with increasing 
clustering of unvaccinated individuals, and our model provides an 
accessible method to estimate this outbreak potential.
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FAMILY PLANNING IN THE DEMOCRATIC REPUBLIC OF 
CONGO: UNWANTED PREGNANCY AND ASSOCIATED 
SOCIODEMOGRAPHIC CHARACTERISTICS
Adva Gadoth1, Vivian H. Alfonso1, Hayley R. Ashbaugh1, 
Reena H. Doshi1, Nicole A. Hoff1, Patrick Mukadi2, Jean-Jacques 
Muyembe2, Emile Okitolonda3, Anne W. Rimoin1
1University of California Los Angeles, Los Angeles, CA, United States, 
2National Institute for Biomedical Research, Kinshasa, Democratic Republic 
of the Congo, 3Kinshasa School of Public Health, Kinshasa, Democratic 
Republic of the Congo
Unintended or mistimed conceptions, collectively referred to as unwanted 
pregnancies, are associated with adverse outcomes for both the mother, 
as they may not be in optimal health for childbearing, and infant, as 
prenatal care may be delayed. As factors such as educational attainment 
and socioeconomic status may impact knowledge and attitudes regarding 
family planning practices, a clear understanding of both the determinants 
and effects of unmet contraceptive needs is indispensable in low resource 
settings such as in the Democratic Republic of Congo (DRC). Using 
2013 Demographics and Health Survey (DHS) cross-sectional data, we 
assessed associations between sociodemographic characteristics and 
select health outcomes with family planning history and attitudes for 
18,716 female respondents 15-49 years of age. Of 1164 women reporting 
an unwanted pregnancy, 75% were not using contraception of any 
kind, citing breastfeeding (25%), postpartum amenhorrhea (20%), and 
unknown source for contraceptive attainment (17%) as the most common 
reasons for nonuse. Unwanted pregnancy was positively associated 
with maternal age, birth order, and number of children under 5 years of 
age, while inversely associated with maternal education. Interestingly, 
head of household sex was also associated with desire for pregnancy, 
and 706 respondents reported a female head of household. In these 
preliminary analyses of DRC-DHS nationally representative data, we 
identified associations between sociodemographic variables and pregnancy 
intention. Shedding light on the family planning landscape can help to 
inform public health policy, and programming and, if assessed over time, 
may indicate changing societal attitudes regarding planning practices. 
Additionally, unintended and unwanted childbearing can have negative 
health, social and psychological consequences in children; therefore it is 
of great importance to assess relationships between pregnancy intention 
and child health indicators. Such investigations may identify vulnerable 
subgroups of the population to whom family planning and other public 
health services may be targeted.
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THE GLOBAL HEALTH EXCHANGE FELLOWSHIP: A PILOT 
PROGRAM
Gladys U. Obuzor1, Anna Quine2, Nthusi Nthula3, Lilian 
Ndomoto4, Charlotte Tulinius5, Arthur Hibble6, Prit Chahal2, Njeri 
Nyanja7, Sammy Barasa8
1Health Education East of England, Brampton, United Kingdom, 2Health 
Education East Midlands, Nottingham, United Kingdom, 3Moi University, 
Eldoret, Kenya, 4Nazareth Hospital, Nairobi, Kenya, 5The Research Unit 
for General Practice, University of Copenhagen, Copenhagen, Denmark, 
6Anglia Ruskin University, Cambridge, United Kingdom, 7Kabarak 
University, Nakuru, Kenya, 8Presbyterian University of East Africa, Kikuyu, 
Kenya
The Global Health Exchange Fellowship was a six month pilot project 
aimed at making global health real through experiential learning for 
UK and Kenyan trainees in General Practice/Family Medicine and 
Public Health. The multi-professional and multi-cultural team had two 
consecutive placements in areas of deprivation, in a low income and high 
income country. The first was within a rural Maasai community in Kenya, 
and next was an inner city area in the UK. Using Qualitative research 
methods, a health needs analysis was carried out in each community. 
Challenges to health, including socio-economic determinants, were 
identified and organised into themes by the fellows. These themes were 
prioritised by the communities using an innovative voting methodology 
developed by the fellows. Findings were presented to the local health 
authorities with the aim of informing resource allocation to improve health 
and reduce inequalities. and fed back to the communities. The Capability 
Approach was incorporated to encourage community ownership of 
solutions. Access to healthcare was voted as the number one priority in 
the rural Maasai community while Education was the top priority in inner 
city UK. Surprisingly there were a number of similarities in the results 
from both communities. For instance, Gender Inequality and Culture 
gave us significant concern as healthcare professionals, however these 
themes received the fewest votes in the “Very Important” category in 
Kenya (a low income country) and in the UK (a high income country). The 
Fellowship was a true exchange between a diverse team of healthcare 
professionals in terms of knowledge, location, culture and experience. 
Through their participation, the fellows experienced remarkable personal 
and professional development. We learned that the challenges to health 
facing deprived communities globally are complex but similar, and require 
context specific solutions which take into account social determinants like 
culture and poverty. This calls for improved interdisciplinary collaboration 
to improve health and reduce inequalities.
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FACILITATING TRAVEL READINESS IN A GLOBAL 
ORGANIZATION: SUCCESS OF A PILOT
Caryn Frith
World Bank Group, Washington, DC, United States
Our developmental organization has approximately 18000 employees in 
180 different countries globally and is known for a high number of staff 
members traveling away from their duty-stations, known as mission travel. 
Staff based in Washington DC have access to a full service travel clinic, 
used by all our staff, however staff based out of other locations have less 
access, although are covered under our insurance. In 2015, a travel pilot 
was launched based out of Johannesburg and Pretoria, South Africa to 
assess the impact of having similar access to travel medicine preventive 
care. South Africa was chosen as an appropriate location for the pilot 
because of the size of the offices as well as the fact that most of the travel 
taking place is to Sub-Saharan Africa where there are a number of tropical 
risks not present in South Africa. Data was analyzed from the health risk 
survey performed in 2014 to assess both knowledge as well as staff habits 
with respect to pre-trip travel vaccination as well as utilization of malaria 
prophylaxis. An active intervention was staged over 4 months, with an 
onsite doctor, education campaigns and travel kits being provided. At the 
end of 4 months, clinical data was analyzed and staff were surveyed for 
change in behavior. Significant change was seen in malaria prophylaxis 
usage as well as increased vaccination. Staff satisfaction was increased 
greatly as well. This pilot served to demonstrate the value of an active 
intervention campaign in a high-risk traveling population. Although the 
staff had coverage for care under their insurance, ease of access helped 
to facilitate greater coverage and change in behavior. With one on one 
consultation providing significant value in persuading staff as to the usage 
of malaria prophylaxis.
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REDUCING HEALTH DISPARITIES IN REFUGEES FROM SUB-
SAHARAN AFRICA ENTERING THE UNITED STATES FOR 
RESETTLEMENT: RETROSPECTIVE REVIEW
Infanta M. Spence-Lewis1, Albert Dempsy2
1Emory University School of Medicine, Atlanta, GA, United States, 
2Georgia State University, Department of Mathematics, Atlanta, GA, 
United States
During 2014 there were an estimated 60,000,000 refugees globally. 
18,000,000 or 30% of this population was in Sub-Sahara Africa (SSA). 
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Approximately 75,000 or 0.42% from Sub-Sahara Africa were resettled 
in the United States. Peer reviewed medical literature and evidence based 
research for the past two decades described the exposure of refugees 
to the detrimental effects of pathogenic parasites from countries of 
origin or while in refugee camps. The aim of the Study is to contribute 
to a reduction of health disparities that may challenge the effective 
implementation of interventions and strategies to reduce or eliminate 
asymptomatic and reactivated diseases. Misdiagnosis of endemic diseases 
in Sub-Saharan refugees arriving to settle in the United States was also 
included. We examined peer reviewed medical literature and evidence 
based research from 2002-2015 using: National Vital Statistics System 
(NVSS), MEDLINE, PubMed, Cochrane Library, and Science Direct. Data 
on prevalence of asymptomatic or reactivated pathogens as well as 
clinical misdiagnosis amongst refugees entering the United States to 
settle was included in the search. Five medical conditions were selected: 
Latent TB, Malaria, Schistosomiasis, Strongyloidiasis and Oral health. 
The criteria applied were: Eosinophil count, regional diagnosis disease, 
geographical analysis, mapping, screening and surveillance. Although the 
population of Sub-Saharan refugees entering the United States is small 
(0.42% or approximately 75,000) findings of the Study indicate that 
hospital departments are concerned with the economic burden of treating 
refugees and immigrants. Hospitals may lack health care professionals 
with sufficient training and skills to treat refugees with tropical or endemic 
disease. Medical schools must include differential diagnosis in their syllabi 
that train students to: diagnose, treat and manage the health of the 
growing foreign born population in the United States that will become 
patients before or after resettlement. This requires skills and knowledge 
of diseases endemic to country of origin and risk to the foreign born 
resettling in the United States. Public Health policy and surveillance does 
not always include preventative health initiatives or programs that consider 
the health disparities of refugees born in Sub-Sahara Africa.
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RELAPSES VERSUS REINFECTIONS: ASSESSING THE 
PARASITOLOGICAL AND CLINICAL IMPLICATIONS USING 
PLASMODIUM CYNOMOLGI AS A MODEL FOR P. VIVAX
Chet Joyner1, Monica Cabrera-Mora1, the MaHPIC Consortium, 
Alberto Moreno2, John W. Barnwell1, Mary R. Galinski3
1Malaria Host–Pathogen Interaction Center, Emory Vaccine Center, Yerkes 
National Primate Research Center, Emory University, Atlanta, GA, United 
States, 2Emory Vaccine Center, Yerkes National Primate Research Center, 
Emory University, Atlanta, GA, United States, 3Division of Infectious 
Diseases, Department of Medicine, Emory University, Atlanta, GA, United 
States
Plasmodium vivax causes significant morbidity and mortality worldwide 
and remains a major obstacle to global malaria eradication. One of the 
obstacles this parasite presents is its liver-stage reservoir comprised of 
hypnozoites that are capable of reactivating and causing relapses. Relapses 
are thought to contribute significantly to the prevalence and transmission 
of P. vivax, but it is unclear if either relapses or reinfections are more 
responsible for clinical vivax malaria cases. To assess the contribution 
of relapses as well as homologous and heterologous re-infections to 
clinical vivax malaria, a series of experiments using the rhesus macaque 
- cynomolgi malaria model were conducted. Clinical and parasitological 
data were collected daily for 100 days during the initial infection and for 
45 – 60 days during the re-infections. Relapses did not induce significant 
clinical alterations, and when minor changes were observed, they resolved 
without the need for clinical intervention. Homologous reinfections 
resulted in considerably lower parasite burden and minimal alterations, if 
any, in clinical parameters, similar to relapses. Interestingly, infection with 
a heterologous strain of P. cynomolgi did result in significant changes in 
clinical parameters, although there may have been some clinical protection 
conferred by the initial infections given the evidence of self-controlled 
acute parasitemia upon heterologous challenge. Collectively, the data from 
these experiments suggest that relapses caused by P. vivax parasites that 
are genetically similar to parasites in primary infections and homologous 
re-infections likely do not contribute significantly to clinical vivax malaria 
cases. Contrastingly, infections with genetically dissimilar strains of P. vivax 
can have pathological consequences, although severity may be less than 
with the initial infection. Overall, these studies demonstrate that there is 
much to learn about the clinical consequences of relapses and re-infections 
and also highlight that the dynamics of P. vivax infections are complicated.
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PLASMODIUM FALCIPARUM FIELD ISOLATES TRIGGER 
APOPTOSIS PREFERENTIALLY IN HUMAN BRAIN 
ENDOTHELIAL CELLS COMPARED TO PULMONARY 
ENDOTHELIAL CELLS
Jean Claude Biteghe Bi Essone1, Nadine N’Dilimabaka1, Julien 
Ondzagha1, Jean Bernard Lekana-Douki1, Dieudonné Nkoghe 
Mba1, Philippe Deloron2, Dominique Mazier3, Frédrérick Gay4, 
Fousseyni S. Toure Ndouo1
1Centre International de Recherches Medicales de Franceville, Franceville, 
Gabon, 2IRD, UMR 216–Mère et Enfant Face aux Infections Tropicales, 
Faculté de Pharmacie, Paris, France, 3Inserm 511, Université Pierre et Marie 
Curie, Paris, France, 4AP-HP Groupe hospitalier Pitié-Salpêtrière, Service 
Parasitologie-Mycologie, Paris, France
Plasmodium falciparum infection can progress unpredictably to severe 
forms including respiratory distress and cerebral malaria. The mechanisms 
underlying the variable natural course of malaria remain elusive. Here 
we used cocultured brain and pulmonary endothelial cells challenged 
with P. falciparum field isolates taken directly from malaria patients 
and scrutinized their capacity of inducing endothelial apoptosis via 
cytoadherence or not. A total of 27 falciparum falciparum isolates were 
collected from patients with uncomplicated malaria (n=25) or severe 
malaria (n=2). About half the isolates (n=17) were able to bind brain 
endothelial cells (12 isolates, 44%) or lung endothelial cells (17 isolates, 
63%) or both (12 isolates, 44%). Sixteen (59%) of the 27 isolates were 
apoptogenic for brain and/or lung endothelial cells. The apoptosis stimulus 
could be cytoadherence, direct cell-cell contact without cytoadherence, or 
diffusible soluble factors. While some of the apoptogenic isolates used two 
stimuli (direct contact with or without cytoadherence, plus soluble factors) 
to induce apoptosis, others used only one. Among the 16 apoptogenic 
isolates, eight specifically targeted brain endothelial cells, one lung 
endothelial cells, and seven both. These results suggest that falciparum 
falciparum field isolates killing brain endothelial cells are more prevalent 
than those killing pulmonary endothelial cells and may provide new 
insights into host-parasite interactions.
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CHARACTERIZATION OF ANTIBODIES AGAINST 
PLASMODIUM FALCIPARUM INVASION PROTEIN PFMSP10
Elizabeth M. Villasis, Jorge Bendezu, Katherine Garro, Oscar 
Nolasco, Katherine Torres, Beronica Infante, Dionicia Gamboa, 
Joseph Vinetz
Universidad Peruana Cayetano Heredia, Lima, Peru
The aim of this study is to evaluate monoclonal antibodies (mAb) 
generated against pfMSP10 (Merozoite surface protein 10) and their 
functional role to inhibit the invasion of Peruvian Plasmodium falciparum 
isolates using the Growth inhibition Assay (GIA) in vitro as well as the 
potential use of pfMSP10 in malaria diagnostics. Seven mAb (Gen Script 
and Abmart) and a polyclonal antisera were evaluated by Western Blot 
(WB) against the recombinant MSP10 full protein (rMSP10). Synchronized 
and purified schizonts from P. falciparum 3D7 and their concentrated 
supernatant were obtained by ultrafiltration. Detection of pfMSP10 
protein was also evaluated in synchronized ring stage of P. falciparum 
cultures from 1 to 12 hours post-invasion. IFA assays were also carried out. 
In addition a quantitative direct sandwich ELISA for rMSP10 was developed 
using all the possible combination of the eight antibodies in evaluation. 
From all the eight evaluated antibodies, only one mAb (anti pfMSP10-1) 
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and the polyclonal antisera showed a strong reaction band against 
pfMSP10 and no cross reaction bands against non-infected RBC. Results 
by WB showed the presence of an approximately 68 kDa band in purified 
schizonts and rings stages parasites from 1 to 4 hours post invasion and 
faint band at 12 hours post-invasion, the binding of these antibodies to 
mature schizonts was corroborated by IFA. Results from the quantitative 
ELISA showed that three antibodies combinations were able to detect 
concentrations from 10,000 - 312.5 pg/ml of rMSP10 (OD 2.0 - 0.5 DS 
0.04 R2, 0.92) within a standard curve. Quantification of pfMSP10 will be 
performed using patient serum and culture samples. GIA in vitro assays 
are underway using Peruvian P. falciparum isolates in order to evaluate 
whether the mAb against MSP10 is capable of binding to erythrocytes to 
inhibit the invasion of merozoites into erythrocytes.
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CHARACTERIZATION OF A NOVEL ERYTHROCYTE BINDING 
PROTEIN OF PLASMODIUM VIVAX
Francis B. Ntumngia1, Richard Thomson-Luque1, Leticia Torres2, 
Luzia H. Carvalho2, John H. Adams1
1University of South Florida, Tampa, FL, United States, 2Centro de Pesquisas 
René Rachou/FIOCRUZ, Belo Horizonte, Brazil
Erythrocyte invasion by malaria parasites is essential for blood stage 
development. In Plasmodium vivax the interaction between the Duffy 
binding protein (DBP) and its cognate receptor, the Duffy antigen receptor 
for chemokines (DARC), on human erythrocytes is central to blood-stage 
infection. Contrary to this established pathway of invasion, recent studies 
have reported evidence of P. vivax transmission among Duffy blood-group 
negative individuals, suggesting that the parasite might have evolved 
an alternative pathway to infect this group of individuals. Recently, a 
second distinct DBP-like erythrocyte binding protein (EBP2) that may 
be the ligand in an alternate invasion pathway has been discovered in 
P. vivax. This study characterizes this novel ligand and determines its 
potential role in reticulocyte invasion by P. vivax merozoites. Our data 
demonstrates that EBP2 preferentially binds to young (CD71High) Duffy 
positive (Fy+) reticulocytes with minimal binding capacity for Duffy 
negative reticulocytes. EBP2 is antigenically distinct from DBP and can 
be functionally inhibited by anti-EBP2, but not anti-DBP antibodies. 
Consequently, our results do not support EBP2 as a ligand for invasion 
of Duffy negative blood cells, but instead EBP2 may be a ligand for an 
alternate invasion pathway of Duffy positive reticulocytes.
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PATHWAY GROUP LASSO INTEGRATION OF METABOLOMICS 
AND TRANSCRIPTOMICS TO CHARACTERIZE MALARIA 
INFECTION IN RHESUS MACAQUES
Sophia Banton1, Ruiyan Luo2, Regina Joice1, Alberto Moreno1, 
Mary R. Galinski1, MaHPIC Consortium, Dean P. Jones1, Shuzhao 
Li1
1Emory University, Atlanta, GA, United States, 2Georgia State University, 
Atlanta, GA, United States
We have conducted a detailed systems biology study of malaria using 
an infection model of Plasmodium cynomolgi in rhesus macaques - a 
model for P. vivax malaria. To this end, we have generated a wide array 
of biological, clinical and multi-omic data sets on NHPs. Among the 
various -omic data types, transcriptomics and metabolomics are among 
the most widely used high-throughput technologies. Integration of these 
two data types is therefore critical to the advancement of contemporary 
biomedical science. Here, we report a novel approach of such integration 
in a framework of group LASSO, and demonstrate its application to 
understand metabolic changes that occur during malaria infection. For this 
study, five rhesus macaques were infected with P. cynomolgi sporozoites 
and studied for 100 days post inoculation to enable the study of early 
infection, acute disease, and relapses. Additionally, five uninfected rhesus 
were studied with antimalarial treatment only. LASSO is widely used for 
feature selection and shrinkage estimation, which reduces the variance of 
regression coefficients. Group information from well-curated pathways 
was added to these regression models, as a means of incorporating 
prior knowledge into the analysis. The leading principal components 
of each pathway group from each omic data type were combined into 
an integrated matrix that was then used to test for association with 
clinical measures of malaria illness. Using this method, we identified key 
differences in metabolism between infected and non-infected rhesus 
macaques. In both groups, changes in porphyrin metabolism, which 
is central to heme synthesis, was selected as an important biological 
pathway. Other pathways that were shared between infected and 
uninfected primates were glycerophospholipid metabolism and linoleate 
metabolism. Tyrosine and tryptophan metabolism were significantly 
changed in infected primates, and not in the uninfected animals. Overall, 
pathway group LASSO is a novel and effective method of integrating 
metabolomics and transcriptomics data from large-scale studies, and is a 
useful tool to provide high-quality mechanistic hypotheses.
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MARKERS OF ANEMIA IN KENYAN CHILDREN WITH 
PLASMODIUM FALCIPARUM MALARIA
Lily E. Kisia, Steven B. Bradfute, Zachery S. Karim, Angela O. 
Achieng, Elly O. Munde, John M. Ong’echa, Prakasha Kempaiah, 
Douglas J. Perkins
University of New Mexico School of Medicine, Albuquerque, NM, United 
States
Severe malarial anaemia (SMA) is the most common complication of 
Plasmodium falciparum infections, resulting in mortality rates that 
may exceed 30% in children (less than 5years) living in holoendemic 
transmission areas. One strategy for reducing the morbidity and mortality 
associated with SMA is to identify biomarkers that can be utilized for 
prompt diagnosis and treatment of the disease. Currently, there are no 
such reliable comprehensive biomarkers for SMA from the inflammatory, 
iron, hypoxia, and erythropoietic pathways. As such, we measured anemia 
markers in Kenyan children (3-36 months, n=278) presenting with acute 
illness at a rural hospital in Siaya, Kenya. Children were categorized 
into three groups based on anemia status and any density parasitemia: 
aparasitemic (n=56); non-SMA (Hb>5.0g/dL, n=168); and SMA (Hb<5.0g/
dL, n=54). The following measures were obtained and compared across 
the groups: C-reactive protein (CRP); total iron; total iron binding capacity 
(TIBC); ferritin, carbon(IV)oxide; creatinine; bilirubin; total bilirubin; and 
glucose. The results indicated significantly higher median levels in SMA 
group compared to the other anemia phenotypes for CRP (130mg/dL, 
p=0.0001), total iron (89ug/dL, p=0.019), ferritin (200ng/ml, p=0.0001), 
direct bilirubin (2.5mg/dL, p=0.008) and total bilirubin (2.25mg/dL, 
p=0.0001), while creatinine levels were significantly lower in anemia 
groups compared to the aparasitemic controls (0.35mg/dL, p=0.030). Data 
here suggest that the levels of these markers may be useful predictors of 
anemia disease severity in P.falciparum malaria holoendemic transmission 
areas.
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CLINICAL AND LABORATORY PROFILE OF COMPLICATED 
MALARIA IN THE COLOMBIAN PACIFIC COAST
Myriam Arévalo-Herrera1, Lina M. Rengifo2, Juliana Henao2, 
Mary Lopez-Perez2, Johanna Trejos2, Angélica Castellanos2, Nora 
Céspedes2, María Isabel Arce2, Sócrates Herrera1
1Caucaseco Scientific Research Center, Cali, Colombia, 2Malaria Vaccine 
and Drug Development Center, Cali, Colombia
Complicated malaria remains an important public health problem 
especially in low-income settings, where access to health services is 
difficult and most of the fatal outcomes occur. Although several studies 
have been conducted in Colombia, most of them are retrospective and 
present inherent limitations. A cross-sectional study was performed in 
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hospitalized patients with complicated malaria in four low-to-moderate 
endemic regions on the Colombian Pacific Coast during 2014-2016, to 
describe the clinical, laboratory, and sociodemographic characteristics of 
study participants. A total of 169 complicated malaria patients between 
zero and 82 years old were enrolled, including 27 children ≤5 years old 
and 16 pregnant women. Plasmodium falciparum was the main parasite 
species (70%), followed by P. vivax (27%) and mixed malaria (3%). 
Most common laboratory complications were severe thrombocytopenia 
(30%), hepatic failure (28%) and severe anemia (16%). Main clinical 
complications were oral intolerance (33%) and prostration (17%). Two 
deaths due to P. vivax and P. falciparum malaria were registered. Patients 
with P. falciparum had significantly higher creatinine levels (1.0 vs 0.6 mg/
dL, p=0.0002) and aminotransferases (AST: 102.5 vs 34.0 IU, p<0.0001, 
ALT: 104.0 vs 47.5 IU, p=0.0014) levels than P. vivax cases. In contrast, 
P. vivax patients presented significantly lower hemoglobin levels than P. 
falciparum cases (8.0 vs 9.9 g/dL, p=0.0109). Patients who presented 
more than one complication simultaneously (52%) had significantly lower 
platelet counts and higher bilirubin levels regardless of parasite species, 
as well as higher parasitemias, AST/ALT, creatinine and BUN levels in P. 
falciparum cases. No bacterial co-infections were found. Quibdó was 
the region with the highest proportion of complicated malaria cases 
(57%), with transmission of both Plasmodium species. Therefore, the 
high prevalence of complicated malaria in this region, together with 
more severe anemia in P. vivax and worse renal and hepatic function in P. 
falciparum infections, demands particular attention to prevent the higher 
morbidity and potential mortality.
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PLASMA HAPTOGLOBIN AS A MARKER OF CLINICAL 
SEVERITY IN GAMBIAN AND MALAWIAN CHILDREN 
INFECTED WITH PLASMODIUM FALCIPARUM
Allison K. Ikeda1, Carol Rowley1, Yu Yang1, Joseph Okebe2, 
Augustine Ebonyi2, Madi Njie2, Simon Correa2, Shamanthi 
Jayasooriya2, Aubrey Cunnington3, Climent Casals-Pascual4, 
Michael Walther2, Terrie Taylor5, Karl Seydel5, Hans Ackerman1
1National Institutes of Health, Atlanta, GA, United States, 2MRC Unit, 
Fajara, Gambia, 3Section of Paediatrics, Imperial College London, London, 
United Kingdom, 4Wellcome Trust Centre for Human Genetics, Oxford, 
United Kingdom, 5Blantyre Malaria Project, University of Malawi College of 
Medicine, Blantyre, Malawi
Elevated cell-free hemoglobin (Hb) is associated with disease severity in 
adults infected with Plasmodium falciparum. However, cell-free Hb can 
be elevated not only by intravascular hemolysis, but also by hemolysis 
induced by blood drawing/sample processing. Plasma haptoglobin (Hp), 
an endogenous Hb scavenging protein, binds cell-free Hb and the Hp-Hb 
complex is removed from circulation via CD163 on reticuloendothelial 
cells. Thus Hp falls during intravascular hemolysis, but is minimally affected 
by in vitro red cell lysis. We measured Hp concentration in plasma obtained 
from children presenting with uncomplicated or severe malaria, as well as 
healthy children of similar age, using an ELISA (Alpco). Clinical severity was 
defined per WHO criteria as uncomplicated (UM) or severe malaria (SM). 
In The Gambia, plasma Hp concentration was 44.5 [15.6-79.9], 4.8 [2.4-
50.2], and 2.6 [2.4-5.5] mg/dL among healthy children and children with 
UM or SM, respectively. ROC curve analysis revealed that a Hp threshold 
of 24.0 mg/dL distinguished UM from healthy children (AUC 0.68 [0.57-
0.79], sens 0.66, spec 0.72), and a threshold of 9.2 mg/dL distinguished 
SM from healthy children (AUC 0.79 [0.70-0.89], sens 0.77, spec 0.78). 
A Hp threshold of 4.4 g/dL distinguished UM from SM poorly (AUC 0.60 
[0.49-0.70] sens 0.58, spec 0.61). In Malawi, plasma Hp concentration 
was 177.2 [37.4-330.4], 1.3 [0.5-249.1], and 0.5 [0.01 - 2.4] mg/dL 
among healthy children, and children with UM or SM, respectively. ROC 
curve analysis revealed that a Hp threshold of 18.1 mg/dL distinguished 
UM from healthy children (AUC 0.64 [0.50-0.80], sens 0.57, spec 0.83) 
and a threshold of 10.6 mg/dL distinguished SM from healthy children 
(AUC 0.82 [0.71-0.92], sens 0.86, spec 0.77). A threshold of 5.5 mg/
dL distinguished UM from SM poorly (AUC 0.63 [0.50-0.77], sens 0.53, 
spec 0.75). These data reveal that Hp depletion, an indicator of massive 
intravascular hemolysis, is prevalent not only among patients with severe 
malaria, but also among patients with uncomplicated malaria. Thus 
massive hemolysis might be necessary, but it is not sufficient to cause the 
clinical syndrome of severe malaria.
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CELL-SPECIFIC DELETION OF TISSUE FACTOR ALTERS THE 
IMPACT OF PLASMODIUM CHABAUDI CHABAUDI AS 
INFECTION ON MURINE PREGNANCY OUTCOME
Tara C. Bracken1, Caitlin A. Cooper1, Nigel Mackman2, Julie M. 
Moore1
1University of Georgia, Center for Tropical and Emerging Global Diseases, 
Athens, GA, United States, 2University of North Carolina at Chapel Hill, 
School of Medicine, Chapel Hill, NC, United States
Sequestration of Plasmodium falciparum-infected erythrocytes in 
the maternal blood space of the placenta results in a severe clinical 
manifestations of this disease, placental malaria (PM). PM results in 
disruption of placental function, leading to low birth weight or fetal 
loss. Recent evidence of a procoagulant state in PM, including extensive 
fibrin deposition and Tissue Factor (TF) expression in affected tissues, 
indicates dysregulated coagulation contributes to malaria pathogenesis, 
but the molecular basis for these pathologies remains incompletely 
understood. Timed pregnancy experiments were conducted using female 
mice with floxed TF expressing Cre-recombinase under the Tie2 promoter 
(Tie2Cre+) or under the Lysozyme M promoter (LysMCre+) and their 
phenotypically normal Cre-negative littermates (Tie2Cre- and LysMCre-, 
respectively). Upon observation of a vaginal plug (gestation day (GD) 
0), mice were infected with 1000 Plasmodium chabaudi AS-infected 
erythrocytes. Embryo viability and health were assessed at sacrifice at 
GD12, and placental pathology was assessed in hematoxylin and eosin-
stained histological sections and indirect immunolocalization of TF and 
fibrin were performed in unstained sections. Malaria-infected, pregnant 
(IP) Tie2Cre+ mice exhibit improved embryo health and significantly 
increased pregnancy-associated weight gain (p=0.0338) at GD12 relative 
to IP Tie2Cre- littermates. Though there is no significant difference in 
the magnitude of peak percent weight gain or parasitemia between the 
two strains, IP LysMCre+ mice abort and reach peak parasitemia two 
days earlier than IP LysMCre- mice. These results indicate that TF on both 
myeloid cells and either maternal endothelium or fetal-derived trophoblast 
play a significant role in determining pregnancy outcome during malaria 
infection. Future experiments seek to understand the mechanisms by 
which TF on hematopoietic cells may be influencing pregnancy outcome, 
particularly in how it affects platelet activation and aggregation, and the 
source of TF causing the phenotype seen in infected Tie2Cre+ mice.
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ANTI-OXIDANT THERAPY SLIGHTLY IMPROVES PREGNANCY 
OUTCOME IN A MOUSE MODEL OF PLACENTAL MALARIA
Demba Sarr1, Tara C. Bracken1, Caitlin A. Cooper1, Tamas Nagy2, 
Julie M. Moore1
1University of Georgia, Center for Tropical and Emerging Global Diseases, 
Athens, GA, United States, 2University of Georgia, Veterinary Pathology, 
Athens, GA, United States
Placental malaria, characterized by sequestration of Plasmodium 
falciparum in the maternal placental blood space and associated 
inflammatory damage, contributes to poor birth outcomes and ~200,000 
infant deaths annually. Specific mechanisms that contribute to placental 
damage and dysfunction are not completely understood. To assess 
a potential role of oxidative stress, a marker for lipid peroxidation, 
4-hydroxynonenal was quantified by immunohistochemistry in placentas of 
C57BL/6 mice infected in early pregnancy with P. chabaudi AS and malaria-
infected Kenyan women. Widespread evidence of lipid peroxidation was 
observed and was associated with higher anti-oxidant gene expression in 
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conceptuses of infected mice. To assess the extent to which this oxidative 
damage and response might contribute to poor birth outcomes and 
be amenable to therapeutic intervention, infected pregnant mice were 
injected with N-acetylcysteine (NAC), a free radical scavenger, or tempol, 
an intracellular superoxide dismutase mimetic, or were given tempol in 
drinking water. Mice treated with NAC experienced pregnancy loss at the 
same rate as control animals; in contrast, tempol-treated mice exhibited 
subtle improvement in embryo survival at gestation day 12. However, 
immunohistochemical staining for 4-hydroxynonenal was not consistently 
reduced in placentas of tempol-treated mice. Thus, while oxidative stress is 
remarkable in placental malaria and its mitigation by anti-oxidant therapy 
may improve pregnancy outcomes, additional more effective interventions 
must be tested.
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TEMPERATURE INDUCED CHANGES IN GLOBAL GENE 
EXPRESSION PROFILES OF MALARIA-CARRYING 
MOSQUITOES
Ash Pathak1, Anthony James2, Matthew Thomas3, Courtney 
Murdock1
1University of Georgia, Athens, GA, United States, 2University of California, 
Irvine, CA, United States, 3Pennsylvania State University, University Park, 
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By regulating the abundance and distribution of the mosquito vector, 
environmental factors such as temperature may play a major role in 
shaping the worldwide incidence of the scourge that is malaria. In general, 
the relationship is non-linear and indicates distinct temperature optima 
within which transmission is maintained. Although its effect on vectorial 
capacity is well appreciated, the patterns and processes underlying the 
observed phenotypes remain largely obscure. Additionally, its effect on 
next-generation vector control measures such as transgenic mosquitoes, 
is even less characterized, but is likely to play a major role in their efficacy. 
In the current study, we employed RNA-sequencing to investigate global 
gene expression profiles in the midguts, salivary glands and carcasses 
of wild-type and transgenic Anopheles stephensi mosquitoes infected 
with Plasmodium falciparum at temperatures of 20°C, 27°C and 32°C. 
Preliminary analyses suggest large scale changes in gene expression in 
response to temperature, with distinct enrichment in specific pathways. 
Targeted knockdown of a specific set of genes with RNA interference for 
instance, will help elucidate their contribution to vectorial competence as 
well as predict their effects in the face of a variable environment.
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EXPERIMENTAL DESIGN OF PLASMODIUM KNOWLESI 
INFECTION IN SUSCEPTIBLE VERSUS REFRACTORY NON-
HUMAN PRIMATE MODEL HOSTS
Allison Hankus, Regina Joice, Alberto Moreno, Mary Galinski, 
MaHPIC, HAMMER
Emory University, Atlanta, GA, United States
The Malaria Host-Pathogen Interaction Center (MaHPIC) and the Host 
Acute Models of Malaria to study Experimental Resilience (HAMMER) are 
a large systems biology consortia investigating multi-‘omic approaches 
to study Plasmodium species host-pathogen interactions in non-human 
primate (NHP) hosts, to model human malaria infections. Longitudinal 
studies with P. knowlesi in Macaca mulatta (Rhesus monkey) and M. 
fascicularis (Kra monkey) were designed to identify features at the host-
pathogen interface conferring varying degrees of host susceptibility to 
parasite infection. We expect the susceptible Rhesus (n=8) and refractory 
Kra monkey (n=8) to manifest different disease profiles and severity at the 
host-pathogen interface following inoculation with P. knowlesi sporozoites, 
identifying targets unique to disease response. Parasite loads and stages 
are assessed daily alongside clinical parameters and continuous internal 
telemetry during the course of infection timeline to anticipate significant 
points of infection observed during the disease progression. Extensive 
samples are recovered at each time point to monitor the dynamic changes 
in the host immune status, erythrocyte phenotype, gene expression 
and metabolic state by means of immune profiling implementation, 
transcriptomics, proteomics, lipidomics, microbiome, metabolomics and 
tissue analysis. To further our understanding of pathological significance 
during the course of infection, necropsies were performed at various 
points of infection allowing deeper analysis of affected tissues and organ 
systems uniquely influenced between these NHP cohorts. Through this set 
of experiments, we aim to identify host features that confer protection 
against malaria disease and relate these observations to developments 
intended to reduce host susceptibility to Plasmodium infections.
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POPULATION PHARMACOKINETICS AND 
PHARMACODYNAMICS OF LUMEFANTRINE IN YOUNG 
UGANDAN CHILDREN TREATED IN COMBINATION WITH 
ARTEMETHER FOR UNCOMPLICATED MALARIA
Eskouhie Tchaparian1, Nancy Sambol1, Emmanuel Arinaitwe2, 
Shelley A. McCormack1, Victor Bigira2, Humphrey Wanzira2, Mary 
Muhindo2, Darren J. Creek3, Nitin Sukumar4, Daniel Blessborn5, 
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2Makerere University, Kampala, Uganda, 3Monash University, Melbourne, 
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Control and Prevention, Atlanta, GA, United States, 7Dalarna University, 
Uppsala, Sweden
Artemether-lumefantrine is the most widely recommended first-line 
treatment for malaria. The objective of this study was to describe the 
population pharmacokinetics and pharmacodynamics of lumefantrine 
when used in the combination therapy, artemether-lumefantrine, in 
Ugandan children 6 months to 2 years of age. Capillary whole blood 
samples were collected over 21 days in 105 children treated for 249 
episodes of uncomplicated Plasmodium falciparum malaria with 
standard fixed-dose artemether-lumefantrine (twice daily x 6). Population 
pharmacokinetic analysis of evaluable lumefantrine concentrations (n=806 
in 101 children) employed a 2-compartment open model with first-order 
absorption. Age was found to have a significantly positive correlation with 
bioavailability in a model that included allometric scaling. Cox proportional 
multivariate hazards regression was used to explore the relationship 
between exposure and clinical outcome. A significant interaction between 
trimethoprim-sulfamethoxazole prophylaxis and a day 7 lumefantrine 
concentration threshold of 200 ng/mL was present. Children not on 
trimethoprim-sulfamethoxazole with lumefantrine concentrations 
below 200 ng/mL had a 3-fold higher hazard of 28-day recurrent 
parasitemia compared to those with concentrations above 200 ng/mL 
(p=0.0007). In contrast, the 28-day risk of recurrent parasitemia was 
not significantly different in children on trimethoprim-sulfamethoxazole 
based on a lumefantrine threshold of 200 ng/mL (p=0.10). Lumefantrine 
concentration on day 3 was a stronger predictor of 28-day recurrence 
compared to day 7 levels. Our data demonstrate that age is a significant 
determinant of lumefantrine bioavailability, and in the absence of TS, 
lumefantrine exposure is a determinant of 28-day recurrent parasitemia 
in this age group. Further refinement of artemether-lumefantrine dosing 
guidelines in young children may be warranted.
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SURVEILLANCE FOR SULFADOXINE-PYRIMETHAMINE 
(SP) RESISTANT MALARIA PARASITES IN THE LAKE AND 
SOUTHERN ZONES, TANZANIA USING POOLING AND NEXT-
GENERATION SEQUENCING
Jeremiah M. Ngondi1, Deus S. Ishengoma2, Stephanie Doctor3, 
Kyaw L. Thwai3, Sigsbert Mkude4, Oresto M. Munishi1, Ritha A. 
Willilo1, Shabbir , Lalji1, Naomi Kaspar5, Chonge Kitojo5, Lynn A. 
Paxton6, Nick Hathaway7, Jeff Bailey7, Jonathan Juliano3, Steven R. 
Meshnick3, Julie Gutman8
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Malaria in pregnancy (MiP) remains a major public health challenge in 
areas of high malaria transmission; intermittent preventive treatment in 
pregnancy (IPTp) with sulfadoxine-pyrimethamine (SP) is recommended 
to prevent the adverse consequences of MiP. The effectiveness of IPTp-SP 
is maintained despite high prevalence of quintuple-mutant haplotypes 
associated with SP resistance (estimated by the prevalence of mutation 
at dhps540). The effectiveness of SP for IPTp may be reduced in areas 
where the dhps581 mutation is found in conjunction with the quintuple 
mutant background. The dhps581 mutation is common in the Tanga 
Region of northern Tanzania, but there are limited data from other areas. 
We investigated the prevalence of molecular markers of SP resistance 
in malaria parasites in the Lake and Southern Zones of Tanzania. A 
cross-sectional survey was conducted in 14 health facilities (HF) in seven 
regions of mainland Tanzania from April to June, 2015. A total of 1,750 
dried blood spot (DBS) samples were collected (117 to 160 samples per 
facility) from consenting patients presenting to the outpatient department 
who had positive rapid diagnostic tests for malaria. Patients with recent 
exposure to SP or related drugs were excluded. DNA was extracted from 
the DBS, pooled by HF, and analyzed by Illumina MiSeq deep sequencing 
to yield estimates of mutated parasite allele prevalence at each locus of 
interest. The dhps540 mutation was prevalent across all 14 sites, ranging 
from 55% to 98.4%, with higher prevalence in Lake Zone compared 
to Southern Zone. Prevalence of the dhps581 mutation ranged from 
0 to 2.4%, with the exception of Kayanga HF (Kagera Region, Lake 
Zone) where 24.9% of sequences were mutated. The dhfr164 mutation 
was detected only at Kanyanga HF (0.06%). Although the quintuple 
mutant was highly prevalent, dhps581 remains geographically restricted, 
suggesting that IPTp-SP may remain effective in most of Tanzania. 
However, additional surveillance, particularly in and around Tanga Region 
is warranted. In addition, a better understanding of the effect of the 
dhps581 mutant on the efficacy of IPTp-SP is needed.
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OF ATOVAQUONE-PROGUANIL AND SINGLE LOW DOSE 
PRIMAQUINE WITH OR WITHOUT ARTESUNATE IN 
CAMBODIA
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Atovaquone-proguanil (AP) is a safe, well-tolerated drug for resistant 
Plasmodium falciparum. However, concerns over rapid development of 
blood-stage resistance and cost have limited its use to high risk areas in 
Southeast Asia. While combining AP with artesunate (AS) was previously 
shown to improve efficacy against MDR P. falciparum in Thailand in 2004, 
we evaluated current efficacy in Cambodia given recent failures of first-
line therapies and assessed the effect of AP use with PQ on gametocyte 
carriage. Subjects were randomized 1:1 to an open label fixed-dose 3 day 
AP regimen with or without 3 days of co-administered artesunate (ASAP). 
Subjects were administered single low dose primaquine (15mg) on day 
1 to prevent gametocytemia. A total of 205 subjects with P. falciparum 
or mixed P. vivax infection were enrolled from December 2014-October 
2015 at two sites, Anlong Veng (AV; n=157) and Kratie (KT; n=48) 
Cambodia. Subjects were followed for 42 days for malaria recurrence and 
gametocyte carriage. PCR-adjusted ACPR at 42 days was similar for the 
two regimens - 93% (95% CI = 86-98) for AP vs. 95% (95% CI = 88-
98) for ASAP (p=0.73). However, of 17 total P.f. recurrences, 16 (9%; 13 
confirmed recrudescences) occurred at the AV site compared with only 1 
(3%) in KT. P. falciparum remained sensitive to atovoquone in-vitro, with 
mean pretreatment IC50 4.76 (95% CI=5.3-8.3) in AV and 3.21 (95% 
CI=2.9-6.7) in KT (p=0.0096). Median parasite clearance time (PCT) was 
shortest in KT at 56 hrs (p <0.001) in ASAP-treated subjects and 68 hrs for 
AP, compared to 72 hrs for both treatment arms in AV. On day 2 post PQ, 
gametocyte carriage was lower in the ASAP (17%) vs. AP (29%) treatment 
arm and reached statistical significance by day 3 (11% in ASAP vs. 29% in 
AP, p=0.0012). Drug level analysis and DNA sequencing analysis for cytb 
mutations are in progress at the time of submission. While atovaquone-
proguanil remains effective in Cambodia both clinically and in vitro, co-
administration of AS with PQ in the ASAP arm might have contributed 
to reduced gametocyte carriage, with potential implications on how AP 
should be deployed in Cambodia.
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HEMOGLOBIN E RED BLOOD CELLS DO NOT INFLUENCE THE 
ANTIPLASMODIAL ACTIVITY OF ARTEMISININ IN VITRO
Chanaki Amaratunga1, Aaron T. Neal1, Sivanna Mao2, Seila Suon3, 
Rick M. Fairhurst1
1National Institutes of Health, Rockville, MD, United States, 2Sampov Meas 
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Artemisinin (ART)-resistant Plasmodium falciparum malaria, defined as 
a parasite clearance half-life >5 h following treatment, is widespread in 
Cambodia, where hemoglobin E (HbE) is highly prevalent. HbE red blood 
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cells (RBCs) have excess α-globin chains and Hb degradation products, 
causing increased oxidative stress. The endoperoxide moiety of ARTs exerts 
antiplasmodial activity within host RBCs via oxidation reactions, suggesting 
that interaction effects involving parasites, RBCs, and ARTs may occur. In 
a clinical study of ART-resistant malaria in Cambodia, parasite clearance 
half-life was nonsignificantly increased in HbE patients (comprising 43% 
of the total) compared to HbA patients, but this difference was not 
significant (0.55 h, P=0.078). Nonetheless, we hypothesized that HbE 
diminishes the antimalarial activity of dihydroartemisinin (DHA, the active 
metabolite of ARTs). To explore this, we compared the antiplasmodial 
activity of DHA in HbE and HbA RBCs using: (i) ART-sensitive/K13-wildtype 
and ART-resistant/K13-mutant parasites from Cambodia; (ii) the in-vitro 
ring-stage survival assay (RSA), where higher % survival values associate 
with longer parasite clearance half-lives; and (iii) HbAA, HbAE, and HbEE 
RBCs that lack α-thalassemia and G6PD-deficiency genotypes. In all three 
RBC types, % survival values: were <1% for ART-sensitive parasites and 
7-70% for ART-resistant parasites; increased according to K13 mutation 
(Y493H<C580Y<R539T); and were not significantly different (Kruskal-
Wallis test, P>0.05). To test whether senescent, oxidatively-stressed RBCs 
affect % survival values in the RSA, we used Percoll to fractionate HbAA 
RBCs into young and old cells. In these cell types, % survival values 
for ART-sensitive and ART-resistant parasites were also not significantly 
different. These data indicate that neither HbE nor intraerythrocytic redox 
status influence the in-vitro antiplasmodial effect of a pharmacologically-
relevant dose of DHA, suggesting these factors do not prolong the parasite 
clearance half-life in patients treated with ART.
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ASSESSING THE IMPACT OF MALNUTRITION ON THE 
TREATMENT OUTCOME OF ARTEMISININ-BASED 
COMBINATION THERAPY IN UNCOMPLICATED PLASMODIUM 
FALCIPARUM MALARIA
Kasia Stepniewska, on behalf of the WWARN Malnutrition 
Study Group
World Wide Antimalarial Resistance Network, Oxford, United Kingdom
In children under 5 years of age little is known about the effect of 
malnutrition on the outcome of Plasmodium falciparum (Pf) malaria 
treatment with an Artemisinin-based Combination Therapy (ACT). 
Contrasting reports may reflect heterogeneity in the study population, 
diversity in transmission intensity, use of different growth metrics or 
small sample sizes. A systematic search of the WWARN data repository 
and online literature databases identified 35 Pf efficacy studies in which 
weight and height were both recorded in children under 5 years of age 
treated with artemether-lumefantrine (AL), artesunate-amodiaquine 
(ASAQ), dihydroartemisinin-piperaquine (DP) or artesunate-mefloquine 
(ASMQ). Only studies with at least 28 days of follow-up were included in 
the analysis. Four anthropometric indicators were reviewed: weight-for-
height, height-for-age, weight-for-age (calculated using WHO igrowup 
tool), and the mid-upper arm circumference. An a priori data analysis plan 
was developed to investigate the association between anthropometric 
indicators and antimalarial efficacy. Individual patient data were collated 
from 11,528 children (99% from Africa), treated with AL (44%), ASAQ 
(27%), DP (23%) or ASMQ (5%). 298 recrudescences and 1,792 
reinfections confirmed by PCR were recorded. The overall risk of failure 
(i.e. recrudescence) was greatest in children with wasting (weight-for-
height (whz)<-1). After adjusting for ACT regimen, dose administered and 
initial parasite density, the treatment failure risk by day 42 was greater in 
children 1-3 years of age compared to other children (HR=1.50 [95%CI 
1.15-1.96]; p=0.0030) and in children with wasting compared to those 
without wasting (HR=1.41 [95%CI 1.07-1.86]; p=0.013). More severe 
wasting (whz<-2) was associated with an increased risk of reinfection 
compared to children without wasting (HR=1.26 [95%CI 1.09-1.45]; 
p=0.002). This pooled analysis highlights the risk of ACT treatment failure 
and reinfection in children with wasting, especially in those aged 1-3 years. 
The consequences on mortality in children suffering from acute global 
malnutrition warrants further investigation.
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IMPACT OF DIFFERENT MALARIA CHEMOPREVENTION 
REGIMENS FOR PREGNANT UGANDAN WOMEN ON 
PLASMODIUM FALCIPARUM DRUG RESISTANCE-MEDIATING 
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In a recent randomized trial comparing intermittent preventive therapy 
regimens to prevent malaria in 300 pregnant women in Tororo, Uganda, 
dihydroartemisinin-piperaquine given once a month (DPqm) or every 
2 months (DPq2m) was superior to sulfadoxine-pyrimethamine given 
every 2 months (SPq2m). For this study we analyzed the impacts of the 
different chemoprevention regimens on Plasmodium falciparum genetic 
polymorphisms that affect sensitivity to a number of antimalarial drugs. 
Blood samples collected monthly from asymptomatic women were 
analyzed for P. falciparum DNA with a highly sensitive loop mediated 
isothermal amplification (LAMP) assay. All 635 samples positive by LAMP 
plus samples from all 75 episodes of symptomatic falciparum malaria 
are now undergoing characterization of polymorphisms in relevant 
genes encoding putative drug transporters (pfcrt and pfmdr1) and folate 
enzymes (pfdhfr and pfdhps). We report preliminary data for transporter 
polymorphisms. The prevalence of mutations at each studied allele (pfcrt 
K76T and pfmdr1 N86Y, Y184F, and D1246Y) was the same in each 
arm of the trial in parasites identified before initiation of study drugs. 
In parasites identified after initiation of study drugs, for pfmdr1 N86Y, 
the prevalence of a mixed or mutant genotype was higher in the DPqm 
(91.7%, p<0.001) and DPq2m (50.0%, p=0.001) arms compared to 
the SPq2m arm (24.9%). For pfmdr1 Y184F, the prevalence of a mixed 
or mutant genotype was higher in the DPqm (96.2%, p<0.001) and 
DPq2m (88.6%, p=0.001) arms compared to the SPq2m arm (61.4%). 
Inconsistent or non-significant trends were seen for the two other studied 
polymorphisms. Analyses of polymorphisms in pfdhfr and pfdhps are 
ongoing. Of note, monthly DP strongly selected for the pfmdr1 86Y 
mutation in subsequent infections. This mutation appears to be associated 
with decreased activity of AQ, but increased activity of lumefantrine, 
suggesting that chemoprevention with DP might optimally be utilized 
when artemether-lumefantrine is the first line drug to treat malaria, so that 
selection of resistance to partner drugs is minimized.
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DRUG RESISTANCE AND RELAPSE IN CAMBODIAN 
PLASMODIUM VIVAX
Jean Popovici1, Lindsey Friedrich2, Didier Menard1, David Serre2
1Institut Pasteur du Cambodge, Phnom Penh, Cambodia, 2Cleveland Clinic, 
Cleveland, OH, United States
Assessment of antimalarial drug resistance is complicated in Plasmodium 
vivax by the lack of in vitro culture system. Most studies of drug resistance 
in P. vivax therefore rely on patient data and the observation of parasites 
in blood after treatment. However, such studies are complicated by the 
difficulty to differentiate resistant parasites from re-infections and relapses. 
To overcome these limitations, we studied P. vivax-infected patients treated 
with chloroquine (CQ) and followed for 80 days in an area without malaria 
transmission (to exclude reinfections). We tested each patient blood for 
P. vivax DNA by PCR every 8 hours until the parasites were not detectable 
anymore and then every second day for the rest of the study. Our analyses 
showed that, for all patients, parasite DNA was not detectable 5 days 
after drug treatment suggesting that there is little CQ resistance in this 
population. However, more than half of the patients show re-occurences 
of P. vivax parasites during the 80-day monitoring period suggesting that 
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relapses occur frequently. Interestingly, none of the relapses occurred when 
the CQ concentration was above therapeutic level, and the few relapses 
leading to clinical malaria were successfully cleared by CQ treatment, 
confirming that these parasites are susceptible to CQ. To further analyze 
the susceptibility of the parasites to CQ, we genotyped at 100 SNPs 
parasite DNA extracted from the patient blood samples collected before, 
8 hours and 16 hours after treatment and determined, for each infection, 
the relative susceptibility of each clone to CQ. We also used genotyping 
and whole genome sequencing to characterize the parasites in the primary 
infections and relapses to confirm, for a subset of the patients, that the 
relapses were caused by a parasite that is not detected in the primary 
infection. Overall, our study did not reveal any CQ resistance among 
Cambodian P. vivax but suggests that pervasive relapses might have 
confounded previous assessments of drug resistance in patient studies.
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BEHAVIOR OF PLASMODIUM FALCIPARUM AGAINST 
ARTEMISININ-BASED COMBINED THERAPY FOR MALARIA: 
EVALUATION OF EX VIVO SENSITIVITY AND PARASITE 
DORMANCY
Rosa D. Vargas Rodriguez1, Andres J. Galisteo-Jr1, Maria J. 
Costa-Nascimento2, Juliana Inoue1, Silvia M. Di Santi3
1Sao Paulo University, Sao Paulo, Brazil, 2SUCEN, Sao Paulo, Brazil, 3Sao 
Paulo University, São Paulo, Brazil
Approximately 3.3 billion people live at risk of contracting malaria 
worldwide, with 198 million cases and 584,000 deaths in 2013. There 
are evidences of decreased efficacy of artemisinin and its derivatives in 
isolates of Plasmodium falciparum in some countries. The dormancy in P. 
falciparum has been proposed as a mechanism of tolerance to artemisinin. 
In this study, blood samples from patients infected in African and 
Caribean countries were processed in order to perform ex vivo sensitivity 
assays and in vitro dormancy evaluation. For ex vivo sensitivity we tested 
dihydroartemisinin (4-1,000nM), artesunate (0.1-100nM), lumefantrine 
(3.1-200nM) and mefloquine (0.2-1,000nM). Parasites were incubated in 
RPMI 1640 with a haematocrit of 5% and parasitemia of 1%. After 96 
hours thick blood films were prepared and the number of schizonts/200 
parasites was counted. Blood from wells with only rings was transfered 
to a new microplate for monitoring the dormancy phenomenon for a 
period of 41 days. Flow cytometry using 1,2,3-Rhodamine and DAPI 
was performed to assess the viability of parasites. As far as the ex 
vivo sensitivity assays is concerned, minimal inhibitory concentrations 
ranged from 10.2 to 250nM for dihydroartemisinin, from 50 to 200nM 
for lumefantrine, from 3.7 to >100nM to artesunate and from 62.5 
to 250nM for mefloquine. In the dormancy assays with clinical and 
reference samples, schizonts were observed after pressure with 62.5, 250 
e 1,000nM of dihydroartemisinin. The recovery period of parasites ranged 
from 4 to 40 days. For lumefantrine, schizonts have emerged only in the 
reference isolate in days 7 and 12 after exposition to 66.6nM and 200nM 
respectively. It is worrying to note that parasite growth inhibition was only 
achieved in high concentrations of dihydroartemisinin and lumefantrine, 
used worldwide for malaria treatment. As the flow cytometry showed 
viability of ring stages after drug pressure, our results suggest that the 
assays based on microscopy could underestimate the response of P. 
falciparum to artemisinin-based combined therapy. To our knowledge, the 
dormancy phenomenon has never been reported before for lumefantrine.
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ELUCIDATING THE MECHANISM OF PIPERAQUINE 
RESISTANCE IN PLASMODIUM FALCIPARUM MALARIA IN 
CAMBODIA
Megan R. Ansbro1, Pharath Lim1, Chanaki Amaratunga1, Hendrik 
W. van Veen2, Marcus C. Lee3, Rick M. Fairhurst1
1National Institutes of Health, Rockville, MD, United States, 2University 
of Cambridge, Cambridge, United Kingdom, 3Wellcome Trust Sanger 
Institute, Hinxton, United Kingdom
Artemisinin combination therapies (ACTs) are currently the first-line 
treatments for Plasmodium falciparum malaria worldwide. ACTs, 
which combine a short-acting artemisinin derivative with a long-acting 
antimalarial partner drug with a different mechanism of action, are 
designed to efficiently clear parasitemia and prevent the development of 
drug resistance. In some countries of Southeast Asia (SEA), the current 
treatment for P. falciparum malaria is the ACT dihydroartemisinin (DHA)-
piperaquine (PPQ). Unfortunately, the emergence and spread of DHA-PPQ 
resistance has now been reported at multiple sites in Western Cambodia, 
which poses a severe risk of widespread resistance to DHA-PPQ and 
other ACTs. Recent fieldwork by our group identified P. falciparum strains 
that show markedly reduced susceptibility to PPQ in Cambodia. In a 
genome-wide association study of parasite responses to PPQ exposure 
in vitro, we discovered a single-nucleotide polymorphism (SNP) on 
chromosome 13 coding for an exonuclease that strongly associates with 
reduced PPQ susceptibility in vitro and DHA-PPQ failures in patients. We 
are currently using the CRISPR-Cas9 system to edit the wild-type and 
mutant exonuclease SNP into PPQ-resistant and PPQ-sensitive parasites, 
respectively. After transfections and successful editing events are verified, 
we will perform PPQ survival assays to determine whether the mutant SNP 
confers PPQ resistance. We are also genotyping the exonuclease SNP in 
contemporary parasite isolates from Cambodia and neighboring countries 
to monitor the spread of PPQ resistance in SEA. In addition to validating 
the exonuclease SNP as a molecular marker of PPQ resistance, we aim 
to identify the causal genetic determinant of PPQ resistance and use 
appropriate biochemical methods to elucidate its molecular mechanism. 
These studies will provide novel insights into the mechanism of PPQ 
resistance in P. falciparum and will help to monitor and prevent the further 
spread of PPQ resistance and DHA-PPQ failures in SEA.
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IMPACT EVALUATION AFTER THREE YEARS OF SEASONAL 
MALARIA CHEMOPREVENTION IMPLEMENTATION BY MASS 
CAMPAIGNS IN SOUTHERN SENEGAL
Jean Louis A. Ndiaye1, Isaac A. Manga1, Medoune Ndiop2, 
Youssou Ndiaye3, Babacar Faye1, Maguette Ndiaye1, Daouda 
Ndiaye1, Roger Tine1, Mady Ba2, Mamadou Diouf2, Ibrahima 
Diallo2, Paul Milligan4, Oumar Gaye1
1Service de Parasitologie, Dakar, Senegal, 2PNLP/MSAS, Dakar, Senegal, 
3MSAS, Dakar, Senegal, 4London School of Hygiene & Tropical Medicine, 
London, United Kingdom
Seasonal Malaria Chemoprevention (SMC) was piloted in 2013 and 
extended in Senegal from 2014, in the southern regions where malaria 
transmission is seasonal and intense with 620,000 children under 10 years 
eligible. It is however important that scaling up of SMC by national Malaria 
Control Programs is evaluated to document its coverage, the safety profile, 
the impact on malaria morbidity and the prevalence of molecular markers 
of drug resistance. In order to monitor malaria morbidity surveillance, 230 
health structures were listed by district, with their catchment populations 
of 2 million inhabitants based on the 2012 census. A sample of 32 
health posts and 16 districts hospitals were selected with probability 
proportional per size (PPS) using systematic random sampling, with 
respect to geographical coverage and malaria incidence rates to ensure 
the sample was representative. One month after the third SMC cycle, a 
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cross sectional survey targeting 2000 children under 10 years of age in 
45 villages selected by PPS were recruited to document SMC coverage 
and drug resistance markers in 2014 and 2015. Overall 3968 mild 
adverse events were detected during SMC campaigns including 1026 by 
the national passive system and 2942 by 2 strategies to strengthen the 
existing system; and 3 serious adverse events (2 anaphylactic shocks and 
1 extra pyramidal syndrome) after the administration of almost 2 million 
SMC treatments. Ninety eighteen percent of children under 10 years 
received at least one dose of SMC. The coverage for a full treatment 
course was 74% for the last cycle. Malaria morbidity surveillance showed 
in 2014 during the months when SMC was administered, a 66% (95%CI 
57%,73%) reduction in outpatient malaria cases and a similar reduction 
in cases of severe malaria. In 2015, malaria incidence has increased in 
the targeted group due to several factors including changes in diagnosis 
flowchart with HRP2 rapid diagnostic test and an exceptional rainy season 
in 2015 showing the importance of continuous monitoring and evaluation 
programmes of SMC implementation in the Sahelian region.
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ARTESUNATE TO TREAT SEVERE MALARIA IN TRAVELERS: 
REVIEW OF EFFICACY AND SAFETY AND PRACTICAL 
IMPLICATIONS
Camille Roussel1, Benoit Henry2, Nathalie Dournon2, Marc 
Thellier3, Eric Caumes2, Pierre A. Buffet1, Papa Alioune Ndour4, 
Stéphane Jauréguiberry2
1INSERM UMR-S1134, Integrated red blood cell biology, Institut National 
de la Transfusion Sanguine (INTS), Paris, France, 2Assistance publique-
Hôpitaux de Paris, Hôpital Pitié Salpetriere, Service des Maladies 
Infectieuses et Tropicales, Paris, France, 3Assistance publique-Hôpitaux 
de Paris, Hôpital Pitié Salpetriere, Service de parasitologie, Paris, France, 
4INSERM UMR-S1134, Integrated Red Blood Cell Biology, Institut National 
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Artesunate is recommended by the WHO for the first-line treatment 
of severe malaria worldwide, in adults and children. However, despite 
solid evidence that artesunate is safe and more effective than quinine 
in endemic areas, its deployment in non-endemic areas has been slow, 
due in part to the absence of a Good Manufacturing Practice (GMP) 
qualification. Using the Prisma method for bibliographic reports we have 
analyzed published studies (12 retrospectives 1 prospective) and 7 case 
reports to assess the safety and efficacy of artesunate in travelers with 
imported severe malaria. Of 574 patients with reported outcome, 22 died 
(3.83%). No death was attributed to artesunate toxicity. Relatively few 
side effects were reported including: neurological syndrome (6 cases), 
temporary deterioration in renal function (3), cutaneous (3) and cardiac (4) 
manifestations, high blood pressure (1), elevation of liver enzymes (58) and 
hyperkaliemia (1). A new side effect of artesunate has been uncovered in 
travelers: Post-Artesunate Delayed Hemolysis (PADH), defined by delayed 
hemolytic episodes occurring 7 to 30 days after treatment initiation. PADH 
occurs in 15% of the treated patients. No death or sequelae were reported 
but blood transfusion was administered in 45% of patients. Weekly 
follow-up of hematological parameters during one month post-treatment 
is now recommended. Our analysis confirms the high efficacy and 
reasonable safety of artesunate in travelers with severe malaria thereby 
urging for a wider use in non-endemic countries. GMP qualification for the 
drug and rapid approval by drug agencies is warranted, backed by clear 
recommendations for optimal use.
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TRENDS OF HIGH REDUCTION OF MALARIA CASES IN 
SEDHIOU DISTRICT FOLLOWING SEASONAL MALARIA 
CHEMOPREVENTION FIRST CAMPAIGN: LESSONS LEARNED
Youssoupha Ndiaye1, Jean Louis Ndiaye2, Abdel Kader 
Dieye1, Ibrahima Aw3, Ababacar Mbaye1, Omar Gaye2, David 
Schellenberg4
1Ministry of Health and Prevention, Dakar, Senegal, 2University Cheikh 
Anta Diop, Dakar, Senegal, 3Ised, Dakar, Senegal, 4London School of 
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Following research on efficacy and feasibility, Seasonal Malaria 
Chemoprevention (SMC) was adopted and scaled up in eligible areas in 
Senegal. Mass campaigns were launched in 2014 in Sedhiou region and 
targeted children aged more than 2 months to less than 10 years. The 
objective of this study was to assess effects of SMC following SMC first 
mass campaign, launched in August 2014. The study was developed in 
Sedhiou district, South Senegal. Malaria incidence is still high in the region 
Most of control strategies are ongoing for a total population of 181,594 
inhabitants. Data were collected from January 2013 to December 2014 in 
all health units and in community units through smart phones with GPS. 
Patients were localized and malaria confirmation were done by Rapid 
Diagnostic Test. During these two years, 72,570 patients were visited, 
40,548 in 2013 and 32,022 in 2014. Overall 5,055 were malaria positive 
during these two years, with a 74% total reduction in 2014. There was 
disparities in malaria morbidity reduction; this was 87% among children 
more than two months to five years, 80% among those six to ten years, 
73% among 11 to 15 years and 65% reduction for patients more than 15 
years- 20 years; 70% reduction for more than 20 years. Disparities were 
also observed among health posts and villages where the reduction varied 
from 22% to 97%. SMC has been highly effective following first year 
of implementation in Sedhiou district. Major reduction of malaria cases 
happened among children under 10, but longer integrated evaluation 
is needed, especially in epidemiology trends, drugs resistance, mid term 
acceptability and impact of other interventions like universal coverage of 
Long Lasting Impregnated Nets.
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MONITORING THE RESPONSES OF PLASMODIUM 
FALCIPARUM TO ANTIMALARIAL DRUGS USING THE DAPI EX 
VIVO TEST: HIGH FREQUENCY OF P. FALCIPARUM ISOLATES 
RESISTANT TO PYRIMETHAMINE IN DIORO, MALI
Youssouf Diarra1, Lansana Sangare1, Kotou Sangare1, Sekou 
Traore1, Trevor Thompson2, Lassina Doumbia1, Daouda Ndiaye3, 
Baba Dieye3, Davis Nwakanma4, Donald Krogstad2, Ousmane 
Koita1
1l’Université des Sciences, des techniques et des technologies de Bamako, 
Bamako, Mali, 2Tulane University, New Orleans, LA, United States, 
3Universite Cheikh Anta Diop de Dakar, Dakar, Senegal, 4Medical Research 
Council, Fajara, Gambia
The greatest threat to malaria control is the development of resistance 
to the antimalarial drugs used to treat uncomplicated and severe 
Plasmodium malaria in human subjects. In order to monitor the response 
of Plasmodium falciparum to the ACTs in current use we performed an 
in vivo study in which blood samples for parasite isolates were obtained 
from 31 volunteers with uncomplicated malaria who were 2-15 years 
of age in the rural commune of Dioro within the Segou Region of Mali. 
To examine the responses of P. falciparum in that region to antimalarial 
drugs, we performed DAPI Ex vivo tests for the isolates from the 31 
subjects enrolled in that study from 2014 to 2016. The 8 drugs tested 
in this study were: Chloroquine (CQ), Piperaquine (PIP), Amodiaquine 
(AMQ), Lumefantrine (LUM), Mefloquine (MEF), Quinine (QN), Artesunate 
(ARS), Dihydroartemisinin (DHA), Artemether (ATM) and Pyrimethamine 
(PYR). Among these 8 drugs, the greatest frequency of resistance based 
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on the IC50 was found with PYR (71% of isolates with an IC50 > 2000 
nM), followed by MEF (35.5% with an IC50 > 30 nM), LUM (22.6% 
with an IC50 > 150 nM), CQ (22.6% with an IC50 > 100 nM) and DHA 
(16.1% with an IC50 > 12 nM). In contrast, only 6.5% of the P. falciparum 
isolates had an IC50 > 60 nM for AMQ, an IC50 > 800 nM for QN or an 
IC50 > 30 nM for ATM. The 71% frequency of P. falciparum isolates with 
Pyrimethamine IC50s > 2000 nM indicates this resistance is common in 
Dioro and suggests that PYR resistance may limit the efficacy of IPTp for 
pregnant women because IPTp is based on preventive treatment with SP 
during pregnancy. In addition, the 22.5% frequency of isolates resistant to 
LUM poses a threat to ACTs with LUM as the partner drug and potentially 
increases the risk of late recurrences after the initial parasite clearance due 
to the artemisinins.
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COMBINATORIAL GENETIC MODELING OF PFCRT-MEDIATED 
DRUG RESISTANCE EVOLUTION IN PLASMODIUM 
FALCIPARUM
Stanislaw J. Gabryszewski1, Charin Modchang2, Lise Musset3, 
Thanat Chookajorn2, David A. Fidock1
1Columbia University, New York, NY, United States, 2Mahidol University, 
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The emergence and spread of drug resistance poses an ongoing threat 
to the effective treatment and control of Plasmodium falciparum malaria. 
A critical parasite determinant is PfCRT, the primary mediator of CQ 
resistance (CQR) and a pleiotropic modulator of susceptibility to first-line 
artemisinin-based combination therapy (ACT) partner drugs. Aside from 
the validated CQR molecular marker K76T, P. falciparum parasites have 
acquired at least three additional pfcrt mutations, whose contributions to 
resistance and fitness have remained elusive. Focusing on the quadruple-
mutant Ecuadorian PfCRT haplotype Ecu1110 (K76T/A220S/N326D/I356L), 
we genetically modified the pfcrt locus of isogenic, asexual blood stage 
P. falciparum parasites using zinc-finger nucleases (ZFNs), producing all 
possible combinations of intermediate pfcrt alleles. Our analysis included 
the related quintuple-mutant PfCRT haplotype 7G8 (Ecu1110+C72S) that 
is widespread throughout South America and the Western Pacific. Drug 
susceptibilities and in vitro growth profiles of our combinatorial pfcrt¬-
modified parasites were used to simulate the mutational trajectories 
accessible to parasites as they evolved CQR. Our results uncover unique 
contributions to parasite drug resistance and growth for mutations beyond 
K76T and predict critical roles for the CQ metabolite monodesethyl-
chloroquine and the related quinoline-type drug amodiaquine in driving 
mutant pfcrt evolution. Modeling outputs further highlight the influence 
of parasite proliferation rates alongside gains in drug resistance in 
dictating successful trajectories. Our findings suggest that P. falciparum 
parasites have navigated constrained pfcrt adaptive landscapes by means 
of probabilistically rare mutational bursts that led to the infrequent 
emergence of pfcrt alleles in the field. We recently extended this in an 
analysis of pfcrt resistance alleles that distinguish the evolution of CQR in 
Asia and Africa.
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COMPARISON OF HIGH RESOLUTION MELT (HRM) ANALYSIS 
TO TA CLONING AND SEQUENCING FOR THE ANALYSIS 
OF A CLINICAL TRIAL USING AN INVESTIGATIONAL 
AMINOQUINOLINE, AQ-13, TO CIRCUMVENT CHLOROQUINE 
RESISTANCE IN SUBJECTS WITH UNCOMPLICATED 
PLASMODIUM FALCIPARUM MALARIA IN MALI
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of Bamako, Bamako, Mali, 3Harvard T.H. Chan School of Public Health, 
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Chloroquine resistance, which was first described in Southeast Asia and 
South America, has now complicated malaria control for more than 
50 years. To address this problem, we have developed an analogue of 
chloroquine (CQ) which is active in vitro against CQ-resistant parasites 
and is safe in human subjects (AQ-13). To test the efficacy and therefore 
the potential clinical value of this investigational antimalarial, it has been 
compared for efficacy with the current first-line treatment for patients with 
uncomplicated Plasmodium falciparum malaria (Coartem = Artémether + 
Luméfantrine, A+L) in a randomized, blinded clinical trial. As part of that 
process, the efficacy of A+L and AQ-13 has been examined in subjects 
infected with CQ-resistant vs. CQ-susceptible parasites, based on the 
K76T single nucleotide polymorphism responsible for CQ resistance. 
The HRM analyses performed in Mali have shown that parasite isolates 
obtained from subjects in both groups had specimens with only K76 
parasites, only T76 parasites and mixtures of K76 and T76 parasites. 
Because all subjects in the A+L and AQ-13 treatment groups cleared all 
asexual parasites from the blood within 3 days, both A+L and AQ-13 were 
efficacious against CQ-resistant and CQ-susceptible parasites. Based on 
that information, these samples are now being cloned and sequenced in 
order to compare the codon present at position 76 of the Plasmodium 
falciparum chloroquine resistance transporter gene (pfcrt) in these samples 
to the results of HRM analyses for the same samples. We anticipate that 
these results will be available within 2 months and that they will add to 
the information now available on comparisons of HRM with sequencing 
for important loci such as position 76 of pfcrt.
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ARTEMISININ-COMBINATION THERAPY VERSUS 
CHLOROQUINE FOR THE TREATMENT OF PLASMODIUM 
MALARIAE IN SABAH, MALAYSIA: A RANDOMIZED 
CONTROLLED TRIAL
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Background. Human infection with Plasmodium malariae is uncommon 
but remains present in the Asia-Pacific region, Africa and South America, 
and can cause severe anaemia. There have been no previous randomised 
trials to evaluate the optimal treatment for uncomplicated malaria due 
to P. malariae. Methods. An open-label, randomised controlled trial was 
conducted at three district hospitals in Sabah, Malaysia. Patients aged 1 
year or older with uncomplicated P. malariae on screening microscopy were 
randomly assigned to receive oral artesunate–mefloquine (ASMQ; target 
dose 12 mg/kg artesunate and 25 mg/kg mefloquine) or chloroquine 
(CQ; target dose 25 mg/kg). The primary endpoint was parasite clearance 
at 24 h. Analysis was by modified intention to treat. Secondary analysis 
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incorporated additional patients separately randomised to artemether-
lumefantrine (AL) or CQ. Findings. Between Jan 14, 2013, and Sep 20, 
2014, admitted patients with PCR-confirmed P. malariae infection were 
allocated treatment with either ASMQ (n=6) or CQ (n=4). 24 h after 
treatment, we recorded parasite clearance in 3 (50% [95% CI 12-88]) of 6 
patients in the ASMQ group versus none (0% [45–64]) of 4 patients in the 
CQ group (p=0.091). At 48 hours all ASMQ treated patients were negative 
for parasites versus none in the CQ arm (p=0.002), with this difference 
remaining at 72 hours with only 1 patient (25% [0-81]) in the CQ arm 
demonstrating parasite clearance (p=0.011). Fever clearance appeared 
faster in the ASMQ arm (median 6 hours [0-18]) versus 18.8 (3.8-42) 
following CQ (p=0.319). 1 patient in the ASMQ arm developed anaemia at 
day 28 during follow-up compared to none in the CQ arm (p=0.389). All 
patients had an adequate clinical and parasitological response to treatment 
at day 28 of follow-up. There were no serious adverse events due to 
either study medication. Results were consistent with the larger secondary 
analysis of patients treated with either ASMQ or AL (n=10) vs CQ (n=10). 
Interpretation. Artesunate–mefloquine demonstrated a rapid therapeutic 
response for P. malariae malaria, supporting a unified ACT treatment policy 
for for all Plasmodium species in co-endemic areas.
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THE BLOOD SCHIZONTICIDAL ACTIVITY OF TAFENOQUINE IS 
IMPORTANT FOR ITS PROPHYLACTIC EFFICACY
Geoffrey S. Dow, Bryan Smith
60° Pharmaceuticals, LLC, Washington, DC, United States
Tafenoquine is being developed by the US Army and 60 Degrees 
Pharmaceuticals for malaria prophylaxis. Recent retrospective analyses 
of clinical data from the Phase II/III program suggest that tafenoquine at 
the intended dose exhibited similar efficacy to mefloquine, with 100% 
PE in non-immune subjects and 93% PE in semi-immune subjects, as 
reported previously. It has been generally assumed that the prophylactic 
efficacy of tafenoquine was due to the known causal (elimination of 
developing Pv or Pf hepatic schizonts) or antihypnozoite (killing of 
latent Pv liver forms) modes of action of the drug. This has led to the 
suggestion that because of the known association of primaquine relapses 
with cP450 2d6 polymorphisms, individuals with genetic polymorphisms 
may also be at greater risk from contracting symptomatic malaria while 
taking tafenoquine. However, non-clinical studies demonstrating blood 
schizonticidal effects the similarity of field of efficacy of tafenoquine 
to mefloquine (per above), the apparent lack of association of P. vivax 
relapses with cP450 2D6 polymorphisms (as reported previously), and 
findings from clinical and non-clinical studies suggesting merozoite escape 
from the liver (as reported previously) imply an alternate hypothesis: 
Tafenoquine also exhibits blood schizonticidal effects that may be 
important for its prophylactic efficacy in humans.
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Artemisinin-resistant Plasmodium falciparum threatens the effectiveness 
of all artemisinin-based combination therapies. A multi-center artesunate-
mefloquine (A+M) efficacy trial is on-going in three US DoD laboratories 
in Peru, Kenya, and Thailand, to compare parasite clearance rates at 72 
hours after artesunate initiation. Here we report the results of the Thailand 
site in Sangkhlaburi district near the Thai-Myanmar border. Participants 
received 4 mg/kg artesunate at 0, 24, and 48 h, 15 mg/kg mefloquine at 
72 h, and, at 84-96 h, 10 mg/kg mefloquine plus 0.5 mg/kg primaquine 
for transmission blocking. To investigate presence of artemisinin resistance 
(ART-R) by WHO criteria, we calculated parasite clearance half-life (PC1/2), 
by microscopy per-formed every 4h for the first 12h after first artesunate 
dose and every 6h for 72h or until two consecutive negative smears. 
Mutations in the Kelch propeller gene (K13) and 42 day efficacy outcomes 
were also assessed. Between Oct 31, 2013, and Oct 7, 2015, we enrolled 
48 subjects 46 of which were evaluable for at 72h. Of these, 33 (72 %) 
had K13 wild type (WT) genotypes while 13 subjects (28%) harbored 
K13 mutations at enrollment, including the commonly de-tected C580Y 
mutation. The median PC1/2 of the mutant K13 group was significantly 
longer than the K13 WT group (4.91h 95% CI 4.4-6.5 vs. 3.3h, 95% 
CI 2.9-4.2, p=0.0003), thus meeting the WHO definition of confirmed 
ART-R. We also found polymorphisms the MAL genes associ-ated with 
delayed parasite clearance in nine subjects, including a single subject with 
both K13 and MAL mutations. Despite this, 100% of subjects achieved 
adequate clinical and parasitologi-cal response (ACPR) at 42 days. While 
our data suggest that clinical effectiveness of the tradi-tionally employed 3 
day A+M regimen has yet to be compromised, ART-R is now confirmed in 
this area of western Thailand.
1504
PREVENTION OF MALARIA IN PREGNANCY: QUANTIFICATION 
OF TARGET CONCENTRATIONS OF DIHYDROARTEMISININ - 
PIPERAQUINE
Rada Savic1, Prasanna Jagannathan1, Richard Kajubi2, Abel 
Kakuru2, Norah Mwebaza3, Liusheng Huang1, Paul Natureebe2, 
Mary K. Muhindo2, Patricia Awori2, Teddy Ochieng2, Patience 
Nayebare2, Tamara Clark1, Diane Havlir1, Moses R. Kamya3, Philip J. 
Rosenthal1, Grant Dorsey1, Francesca Aweeka1
1University of California San Francisco, San Francisco, CA, United States, 
2Infectious Disease Research Collaboration, Kampala, Uganda, 3Makerere 
University, Kampala, Uganda
In a recent randomized trial comparing intermittent preventive therapy 
(IPTp) regimens to prevent malaria in 300 pregnant women in Tororo, 
Uganda, dihydroartemisinin-piperaquine (DP) given once a month (DPqm) 
or every 2 months (DPq2m) was superior to sulfadoxine-pyrimethamine 
(SP) given every 2 months (SPq2m), and DPqm was superior to 
DPq2m for several outcomes. The aim of this analysis was to quantify 
preventive (target) concentrations of piperaquine (PQ) using population 
pharmacokinetic (PK) –pharmacodynamic (PD) analysis, with the presence 
of circulating malaria parasites during pregnancy (PD endpoint) detected 
by a highly sensitive loop-mediated isothermal amplification (LAMP) assay. 
All women contributed longitudinal PD data (2260 observations obtained 
at monthly routine visits and at the time of clinical malaria), and women 
receiving DP contributed longitudinal PK data (1293 venous and capillary 
measurements obtained at monthly routine visits). Nonlinear mixed effect 
modeling was used for joint continuous (population PK) data and repeated 
binary measurements (LAMP) analysis. The probability of parasitemia was 
46% (relative standard error RSE, 39%), 22% (RSE 9%) and 11% (RSE 
5%) in the SPq2m, DPq2m and DPqm arms, respectively. More frequent 
DP dose (DPqm) was associated with absence of malaria parasites (p<10-
21), however PQ plasma levels were far superior to DP dose interval (p<10-
95) as a predictor of parasitemia; PQ plasma concentrations of 5.5 ng/
mL, 8.7 ng/mL and 13.3 ng/mL were found to provide 95%, 99% and 
99.9% protection from parasitemia. Modeling target concentrations, 90% 
of women in the DPq2m arm, but only 15% of those in the DPqm arm 
had PQ levels below 5.5 ng/mL for at least 25% of time receiving IPTp. 
Population clearance of PQ in Ugandan women was 3140 L/day (RSE 6%), 
with modest between subject variability (CV % 35 (RSE 13%). There were 
no changes in PQ PK during the course of pregnancy. In conclusion, our 
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analysis provides evidence to define the plasma level of PQ that prevents 
malaria parasitemia during pregnancy, and offers a rational framework for 
further optimization of dosing strategies of DP in IPTp regimens.
1505
USING POLYPHARMACOLOGY TO IDENTIFY NOVEL DRUGS 
AND DRUG TARGETS AGAINST MALARIA INFECTION
Nadia Arang1, Heather Kain1, Fred D. Mast1, Taranjit S. Gujral2, 
John D. Aitchison1, Alexis Kaushansky1
1Center for Infectious Disease Research, Seattle, WA, United States, 
2Harvard Medical School, Boston, MA, United States
Malaria control and eradication efforts are hindered by drug resistance, 
difficulty targeting liver-resident hypnozoites and a prolonged process 
of de novo drug development. Chemotherapeutics which target host 
proteins within liver-stage infected hepatocytes have the capacity to 
overcome each of these roadblocks. We have recently demonstrated that 
targeting the hepatocyte P53 and Bcl-2 pathways can eliminate multiple 
species of Plasmodium parasites, including P. falciparum, from the liver. 
To expand the range of host-targeted drugs, we have applied a systems 
biology approach that identifies critical host kinases for the development 
of Plasmodium liver stage. Our approach takes advantage of 37 broad-
spectrum kinase inhibitors and their measured activity against 301 human 
kinases. By assessing the efficacy of these 37 inhibitors against liver stage 
infection, and training a model based on machine learning algorithms, 
we predicted 33 kinases with the largest role in liver stage infection. 
These kinases include several Receptor Tyrosine Kinases, and members 
of the Protein Kinase C cascade. This also includes five out of eight of 
the kinases identified by Prudêncio and colleagues in their siRNA screen 
(P=0.0005) for host kinases involved in liver stage infection. Moreover, this 
platform allows for the prediction of novel kinases inhibitors, including 
those already tested in the clinic for other indications. If effective, 
these compounds might provide a rapid path to new anti-malarials for 
prophylaxis and radical cure. Since this approach identifies key signaling 
networks from a condensed data set, it’s compatible with freshly isolated 
parasites from the field, as well as in vivo screening approaches. Our 
ongoing efforts include applying this approach to rapidly identify novel 
inhibitors against a variety of intracellular parasites and bacteria and also 
to emerging infections such as Dengue and Zika viruses.
1506
DOXYCYCLINE TARGETS THE BACTERIA-LIKE SMALL 
SUBUNIT RIBOSOMAL RNA IN THE PLASMODIUM 
FALCIPARUM MALARIA PARASITE
Amanda Wasko, Alexis Toruno, Maurice Brady, Frida Ceja, Catlyn 
Cavender, Kelsey DeCarlo, Lin Zao Mangis, Stephanie Rasmussen, 
Roland A. Cooper
Dominican University of California, San Rafael, CA, United States
Doxycycline is a tetracycline-class antibiotic that is highly effective for 
malaria chemoprophylaxis and is also used in combination with quinine 
for malaria treatment. In bacteria, like other tetracyclines, targets of 
doxycycline include the small subunit ribosomal RNA (SSrRNA) molecule 
and proteins within the 30S small subunit ribosome, which are involved 
in protein synthesis. However, the mechanism of action of doxycycline 
against the malaria parasite is uncertain. Evidence suggests that 
doxycycline inhibits protein synthesis within the plasmodial apicoplast, 
whose extranuclear genome contains homologues to bacterial genes. As 
a means to identify a molecular target(s) and the mechanism of action in 
Plasmodium falciparum, we attempted to select for doxycycline resistance. 
After several months of in vitro culture under continuous incremental 
doxycycline pressure, we generated resistant parasites. Clonal parasite 
lines showed stable and significant increases in the IC50 to doxycycline, 
determined by a 96-hour growth inhibition assay necessary to capture the 
slow acting schizonticidal activity of the cyclines. Sanger sequencing of the 
apicoplast small subunit ribosomal RNA gene (pfssrRNA; PFC10_API0057) 
revealed novel SNPs in resistant parasites. In the absence of drug pressure, 
doxycycline resistant parasites exhibited slower growth compared to 
controls, suggesting a fitness cost accompanies resistance. Our results 
suggest that in malaria parasites, doxycycline targets the plastid-encoded, 
bacterial-like SSrRNA. Similar to the action of cyclines against bacteria, 
doxycycline may prevent binding of an incoming aminoacyl-transfer RNA 
to the A site of the ribosome and thus block the elongation step of protein 
synthesis in the parasite apicoplast.
1507
ENHANCING TRANSLATIONAL SIGNIFICANCE OF 
PLASMODIUM FALCIPARUM MOUSE MODEL
Maria Jose Lafuente, Benigno Crespo, Sara Viera, Angel Santos, 
Elena Maria Garutti, Vanesa Gomez-Jimenez, Lorena Cortes, 
Carmen Cuevas, Delfina Segura, Jose-Luis Llergo, Noemi Magan, 
Elena Jimenez, Laura Sanz, Francisco-Javier Gamo
GlaxoSmithKline, Tres Cantos (Madrid), Spain
Malaria continues being a major global disease and current therapies are 
threatened by spread of resistant parasites. This situation has prompted 
antimalarial community to identify new molecules suitable to be used 
as part of new treatments that can overcome current issues. The last 
few years have seen unprecedented progress in the identification and 
early clinical testing of novel antimalarial drug candidates. However 
effective progression of candidate antimalarials depends on selecting 
optimal dosing for clinical studies. Understanding and determining 
efficacy parameters using preclinical models is critical to estimate effective 
human doses. One of the most important parameters is to estimate the 
parasite reduction rate (PRR) to determine how long efficacious drug 
concentrations should be present to fully eliminate blood parasites and 
cure the patients. Significant advances have been done in this field 
during the last years with the development of in vitro assays that can 
determine the killing profile of antimalarial compounds (1). However, a 
quantitative in vivo assay to determine rate of parasite killing was missing. 
We have adapted the Plasmodium falciparum mouse model protocol to 
allow determining simultaneously rate of clearance and killing in vivo by 
antimalarial drugs. These studies provide invaluable results that can be 
used for a robust estimation of PRR in patients to inform human dose 
predictions. Such data can inform clinical trials required for effective 
deployment of novel antimalarial treatments.
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DETECTING ANTIMALARIALS IN BLOOD FROM COMMUNITY 
SURVEYS IN TANZANIA
Emilie Pothin1, Joanna Gallay2, Dominic Mosha3, Martin Zuakulu3, 
Erick Lutahakana3, Laurent Decosterd4, Blaise Genton5
1Department of Epidemiology and Public Health, Swiss Tropical and Public 
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Public Health, Swiss Tropical and Public Health Institute, Basel, Switzerland 
; Division and Laboratory of Clinical Pharmacology, Service of Biomedicine, 
Department of Laboratories, University Hospital, Lausanne, Switzerland, 
3Ifakara Health Institute, Dar es salaam, United Republic of Tanzania, 
4Division and Laboratory of Clinical Pharmacology, Service of Biomedicine, 
Department of Laboratories, University Hospital, Lausanne, Switzerland, 
5Department of Epidemiology and Public Health, Swiss Tropical and 
Public Health Institute, Basel, Switzerland ; Division of Infectious Diseases 
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The assessment of the impact of diagnostic or treatment strategies on 
antimalarial drug use often rely on histories of drug intake in community 
surveys. Estimating accurately the levels of circulating antimalarials in a 
population allow an unbiased measure of drug consumption. Here, we 
explored the relationship between endemicity, health facility practices and 
blood drug concentration in malaria-endemic communities. The study 
took place in three regions of Tanzania (Mwanza, Mbeya and Mtwara) in 
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2015. In each region, surveys were conducted in three districts. All health 
facilities from randomly selected wards were visited to assess treatment 
and diagnosis practices. Information on demographics, health seeking 
behavior and drug use was obtained through community surveys, while 
health facility based surveys collected information on diagnosis and 
treatment practices. Finger-prick blood samples were obtained for on-site 
testing as well as for collecting samples on filter paper. Antimalarial blood 
concentration including Lumefantrine was measured later by LC-MS/MS. 
Parasite prevalence was 20% (506/2463) in Mwanza, 4% (84/1985) in 
Mbeya and 26% (559/2152) in Mtwara. Participants with any antimalarial 
in the blood were 34% (844/2463), 20% (399/1985) and 26% (554/2152) 
respectively in Mwanza, Mbeya and Mtwara. Individual who tested positive 
with a RDT had a marginally higher frequency of being detected with an 
antimalarial (29.7% vs 26.8%). Indeed, the association of RDT positivity 
and presence of drug was relatively poor (OR=1.15, 95% CI:1.00-1.33). 
Results from health facilities showed that amongst the febrile patients, 
67% (151/226) were tested for parasite. Prevalence of persons with 
residual antimalarials in the blood was relatively high, especially in Mbeya 
where endemicity was low. This indicates poor use of diagnostic testing 
and inappropriate prescription of antimalarials. This might result in high 
levels of circulating drug in a population, probably the most important 
driver of the development of drug resistant pathogens. Effort should 
therefore be made to reduce these poor practices and prevent emergence 
of resistance.
1509
ACTIVE DETECTION OF ASYMPTOMATIC MALARIA BY 
LOOP MEDIATED ISOTHERMAL AMPLIFICATION (LAMP) IN 
NORTHWEST ETHIOPIA
Sisay Getie1, Abebe Genetu Bayih2, Abebe A. Fola1, Ligabaw 
Worku1, Gebeyaw Getnet1, Robert Burton3, Dylan R. Pillai2
1University of Gondar, Gondar, Ethiopia, 2University of Calgary, Calgary, 
AB, Canada, 3PATH, Seattle, WA, United States
Despite the scale-up of universal intervention measures, asymptomatic 
malaria is one of the challenges that needs to be addressed in malaria 
endemic sub-Saharan Africa. Due to the poor sensitivity of common 
laboratory diagnosis methods of malaria like rapid diagnosis tests (RDTs) 
and microscopy, field deployable rapid molecular techniques need to be 
available to accurately diagnose malaria. This pilot study aimed to assess 
the performance of loop mediated isothermal polymerase amplification 
(LAMP) for the detection of asymptomatic malaria in North Gondar, 
Ethiopia. A community based cross-sectional study was conducted from 
February to May 2014 in North Gondar, Ethiopia. A total of 802 study 
participants were enrolled. Data on socio-demographic profile and 
associated risk factors for asymptomatic malaria were collected using 
interview-based questionnaire. Capillary blood was collected and blood 
films and dried blood spots (DBS) were prepared for malaria parasite 
detection with giemsa microscopy, nested polymerase chain reaction 
(nPCR) and LAMP using a non-instrumented nucleid acid amplification 
(NINA) device. In this study, 45.3% of the study participants had access 
to combined universal intervention measures of malaria. LAMP and 
nPCR were performed on 160 DBS samples. The overall prevalence of 
asymptomatic malaria using giemsa microscopy, LAMP and nPCR was 
3.75%, 5% and 4.375%, respectively. In conclusion, LAMP is able to 
identify two extra asymptomatic malaria carriers per 100 study population. 
This study indicated that active diagnosis of asymptomatic malaria with 
low-cost techniques like LAMP can support malaria elimination through 
enhanced active case detection.
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EVALUATING THE COSTS AND COST-EFFECTIVENESS 
OF MICROSCOPY COMPARED TO LAMP USED DURING 
REACTIVE CASE DETECTION IN ACEH PROVINCE, INDONESIA
Brittany W. Zelman1, Ranju Baral2, Iska Zarlinda3, Farah N. 
Coutrier3, Yusrifar K. Tirta3, Kelly C. Sanders4, Chris Cotter1, 
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Reactive case detection (RACD) is an active surveillance method where 
households and neighbors of a passively identified case (an index case) 
are screened to identify and treat asymptomatic infections with the goal 
of reducing further transmission. Despite being a resource-intensive 
activity, RACD is recommended and implemented widely in malaria-
eliminating countries. However, little is known about the cost to conduct 
RACD and the cost effectiveness of the various diagnostic methods used 
during RACD to identify otherwise undetected cases. The aim of this 
study was to determine the cost of conducting RACD, and compare 
the cost effectiveness of microscopy (currently standard practice) to 
the more sensitive loop mediated isothermal amplification (LAMP) as 
a diagnostic method. The study site included five subdistricts in Aceh 
Besar District, Aceh, an eliminating province located on the westernmost 
tip of Indonesia. Costs and effects were recorded for a 20 month study 
period between May 2014 and December 2015. The cost of all inputs 
used in conducting RACD (capital, consumables, personnel, services) was 
recorded. A total of 38 passively-detected malaria cases were recorded 
during the study period. Using standard procedures, these index cases 
were traced back to their community and an additional 1,495 individuals 
were screened. The average cost of conducting RACD using microscopy 
and LAMP was $2,481 per event with personnel being the main cost 
driver. The average cost of screening each individual during RACD was 
$46.96, with diagnostic testing costs $0.54 and $12.26 per person for 
microscopy and LAMP, respectively. Among the actively screened people, 
two new cases were detected by microscopy, confirmed by LAMP, and 
an additional four cases were detected only by LAMP. The incremental 
cost effectiveness ratio of LAMP versus microscopy was estimated to be 
$4,383 per case detected. LAMP was more costly, but more sensitive for 
the detection of additional cases in RACD and may play an important role 
in detecting and treating the asymptomatic reservoir and reducing onward 
transmission in eliminating settings.
1511
A FIELD-BASED POINT-OF-CARE ASSAY TO DETECT 
ANTIMALARIAL DRUGS FROM FINGERSTICK BLOOD 
SAMPLES
Erin S. Coonahan1, Maarten De Vos2, Joel Tarning3, Rick Fairhurst1
1National Institutes of Health, Rockville, MD, United States, 2University 
of Oxford, Oxford, United Kingdom, 3Mahidol Oxford Tropical Medicine 
Research Unit, Bangkok, Thailand
Malaria parasites with reduced sensitivity to several of the current first-
line antimalarial drug therapies - artemisinin-based combination therapies 
(ACTs) - have recently emerged in Cambodia. Preventing the spread of 
drug resistant parasites through Southeast Asia and to Africa is a top 
priority for global malaria elimination campaigns. The ability to detect 
these small molecule drugs in malaria patient samples at the point-of-care 
would allow healthcare workers to identify previous treatment failures 
and adjust future treatment to improve efficacy and reduce the spread 
of resistant parasites. A simple, point-of-care assay to detect ACT partner 
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drugs would also allow for real-time mapping of drug use and distribution. 
We aim to develop a low-cost, field-based test to detect several slow-
clearing ACT drug compounds from fingerstick blood samples. We will 
select drug specific aptamers via an inverted SELEX protocol in which we 
immobilize a DNA library and isolate structure-switching sequences that 
are released upon binding drug target in solution. Our assay will filter out 
blood cells and provide a colorimetric readout of drug levels in recovered 
plasma via the interaction of drug, aptamer, and colloidal gold. In order 
to remove subjectivity associated with user interpretation of the assay, we 
will develop a smartphone application to quantify colorimetric readout, 
storing results along with location and patient information. We will design 
this device with constant input from clinicians and healthcare workers to 
ensure its feasibility for use in rural clinics in malaria-endemic settings.
1512
FIRST NATIONAL INTEGRATED COMMUNITY CASE 
MANAGEMENT (ICCCM) ONSITE TRAINING AND SUPPORTIVE 
SUPERVISION ASSESSMENT IN GHANA IN JANUARY-
FEBRUARY 2015
Naa-Korkor Allotey1, Constance Bart-Plange1, Keziah Malm1, 
Samuel Ayamba Ayamba2, Raphael Ntumy2
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Development, Accra, Ghana
Integrated Community Case Management is an intervention to get sick 
children under five years of age treated at the community level as quickly 
as possible for malaria, cough or difficulty in breathing and diarrhoea. An 
Integrated Community Case Management (ICCM) Onsite Training and 
Supportive Supervision (OTSS) assessment was carried out in the months 
of January and February 2015.This became necessary because there were 
a number of challenges relating to community-based agents (CBAs) with 
some districts not reporting at all or on time. This had led to the inability 
to meet set targets of the program for the year 2014. Community health 
nurses and officers (CHNs/CHOs) (direct supervisors of CBAs) were trained 
and sent on the field. In the field CHNs/CHOs carried out training and 
supportive supervision using the OTSS checklist. After the assessment, 
members of the district health management team (DHMTs) with National 
teams and supervisors discussed findings and planned possible solutions 
for the challenges encountered. At the national level, the data was entered 
using epi info software, collated, cleaned and analysed. In all 10,393 
CBAs were assessed. CBAs were able to diagnose and treat malaria and 
diagnose diarrhoea effectively using symptomatic diagnosis. Most CBAs, 
who had been trained on malaria rapid diagnostic tests (mRDTs), could 
not carry out the test. CBAs also had difficulty in correctly assessing for 
cough and difficulty in breathing in terms of counting breaths. There was 
erratic availability of artesunate-amodiaquine for malaria treatment. There 
were little or no medicines managing cough and difficulty in breathing and 
diarrhoea; even in regions that were expected to have supplies. Referrals 
by CBAs were done but caregivers generally refused to send their children 
to the next level of care. Most CBAs require training, as a lot of them had 
their training. In conclusion, CBAs are able to diagnose and treat malaria 
and diagnose diarrhoea symptomatically. They however lack the capacity 
to use mRDTs. They also need more training on diagnosis of cough and 
difficulty in breathing. The CBAs also need to be updated.
1513
THE ROLE OF MOBILE DEVICES IN RAPID DIAGNOSTIC 
TESTING QUALITY CONTROL ON COMMUNITY HEALTH 
VOLUNTEERS IN WESTERN KENYA
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Community health volunteers (CHVs) are trained to provide basic disease 
prevention and health promotion at the household level. In order to 
improve early diagnosis of malaria amongst rural populations, CHVs are an 
avenue to provide basic malaria testing with rapid diagnostic tests (RDTs) 
and treatment for uncomplicated cases. Monitoring RDT performance 
of CHVs is vital in ensuring quality and accuracy of testing. Physical 
monitoring of CHVs in real time is complicated in large-scale programs, 
thus the need for innovative quality control approaches. As part of a larger 
study, we trained a total of 275 CHVs on how to perform malaria RDTs. 
We introduced Fio Corporation’s android based mobile diagnostic devices 
(Deki™ Readers) to remotely monitor the performance of a sample of 
CHVs in real time. These Deki Readers provided technological support for 
quality control by identifying RDT processing errors (too much/too little 
buffer, sample or buffer in wrong well, too much/too little blood) and 
interpreting rapid diagnostic tests (positive/negative/invalid). For our study 
Deki Reader software was programmed to interpret the tests only after 
the CHV provided their interpretation allowing for comparison between 
Deki Reader and CHV interpretation and real-time feedback to the CHV. 
Both results were uploaded to a secure data server for real-time review by 
the study team. The CHVs requiring additional mentorship were identified 
and followed up. Ninety (90) CHVs were randomly selected and trained for 
two days. CHVs also received technical support from Fio support staff. A 
total of 1199 clients were tested where 89.66% (1075) of the tests were 
concordant, 5.17% (62) tests had interpretation errors while 5.17% (62) 
had processing errors. The mean age of the CHVs was 41.4 years (C.I 40.9 
- 42.0). 53.42% (47) of the CHVs had secondary education and above. 
Error rates were not correlated with age and education level. The low error 
rates irrespective of age and education is encouraging and confirms the 
ability of CHVs to correctly perform RDTs. Mobile devices to monitor CHV 
performance are feasible and valuable in the quality control of malaria 
diagnosis in remote areas.
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DETECTION OF MALARIA INFECTION BY HEMOZOIN 
CONTENT COMPARED TO RDTS AND MICROSCOPY FROM 
PERUVIAN AMAZON SAMPLES
Torrey T. Byrd1, G. Christian Baldeviano2, Vincent R. Gerbasi2, 
Elisa Vidal2, Rafael Saavedra-Langer3, Katty M. Arista3, Viviana 
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Naval Medical Research Unit - 6, Lima, Peru, 3Universidad Nacional de la 
Amazonia Peruana, Iquitos, Peru
Detection of the presence of malaria parasites primarily relies upon the use 
of RDT card tests or microscopy-based methods. Microscopy testing time is 
30-60 minutes per sample and requires skilled readers. RDT testing time is 
15-20 minutes, and sensitivity is lower in some species and variants. There 
is a need for novel malaria diagnostic techniques to rapidly and accurately 
diagnose across all species and with HRP2 deletion. A multidisciplinary 
effort designed an inexpensive, rapid (one minute) malaria detection 
device that indicates the presence of hemozoin, a by-product of parasite 
digestion of hemoglobin. Polarized laser light passing through a blood 
sample is used to diagnose malaria. When the partially magnetic malaria 
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hemozoin is present in a blood sample, it aligns with a magnetic field 
decreasing the amount of polarized laser light able to pass through it. 
This decrease in light is directly proportional to parasitemia (R2=0.996). 
A test of 69 patients in Peru comparing an early prototype to microscopy 
achieved 92% sensitivity and 100% specificity for Plasmodium falciparum 
and P. vivax infections. Comparing CareStart RDTs to microscopy for 
these same samples showed 67% sensitivity and 100% specificity. The 
decreased effectiveness of RDTs in Peru is likely because of known HRP2 
deletions in Peruvian P. falciparum and higher prevalence of P. vivax which 
is difficult to detect with RDTs. Our long term goal is to translate this 
technology into a robust, low-cost device, which can be used in malaria-
endemic regions to enable rapid malaria diagnosis at the point-of-care for 
all species of malaria.
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DONORS FROM ENDEMIC AND NON-ENDEMIC BRAZILIAN 
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Malaria transmitted by blood transfusion remains one of the most 
important infections for hemotherapy services. In Brazil the incidence 
of malaria by blood transfusion is unknown, and this event may 
contribute to the spread of the disease in cases of failure in the clinical 
and epidemiological screening or due to asymptomatic donors. Donors 
that caused transfusion malaria showed very low parasitemia with an 
estimated rate of 1 to 10 parasites per unit of blood, which requires 
sensitive methods for the diagnosis and prevention. This study included 
147 Brazilian public or private blood banks located in endemic and 
non-endemic areas for malaria with 13,383 blood donors that were 
accepted by the local methods of screening. The samples were grouped 
into pools of 10 and were processed by three different real time PCR 
and one nested PCR. A rapid test It was used for antibody detection. 
Samples from the positive pools were tested individually by PCR to detect 
positive donors. Real-time PCR revealed amplification for Plasmodium in 
43 pools with samples from Amazon Region (4.72%) and Extra-Amazon 
Region (3.19%). Nested PCR detected four pools with P. vivax, two pools 
with P. falciparum and one pool with P. malariae, all related to samples 
from Extra-Amazon Region. Samples from positive pools were processed 
individually and real-time PCR revealed amplification in 25 donors, 
showing a positivity rate of 6.94% in 360 individual samples. Nested PCR 
detected two donors, one harboring P. malariae and one P. vivax. The rapid 
diagnostic test was positive for P. vivax in 13 pools from non-endemic area 
and in three pools from endemic area. Real-time PCR from Lima showed 
the best performance and was able to identify Plasmodium in pools of 
10 samples, reducing time and cost of processing. This study, which 
analyzed blood samples from donors from endemic and non-endemic 
areas revealed the risk of transfusion malaria in our country and the need 
for sensitive validated protocols for detection of low parasitaemia. These 
results may support the decision making of blood donor screening criteria 
by regulatory agencies, in order to reduce malaria transmission in Brazilian 
blood banks.
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MICROSCOPY IMAGE ANALYSIS AND MACHINE LEARNING 
IN THE FIELD
Stefan Jaeger1, Kamolrat Silamut2, Hang Yu1, Mahdieh Poostchi3, 
Ilker Ersoy3, Md Amir Hossain4, Sameer Antani1, Kannappan 
Palaniappan3, Richard J. Maude5, George Thoma1
1National Institutes of Health, Bethesda, MD, United States, 2Mahidol 
University, Bangkok, Thailand, 3University of Missouri, Columbia, MO, 
United States, 4Chittagong Medical College Hospital, Chittagong, 
Bangladesh, 5University of Oxford, Oxford, United Kingdom
Microscopy remains the main technique for diagnosing malaria, despite 
the availability of Rapid Diagnostic Tests. Hundreds of millions of blood 
films are examined using microscopy every year for diagnosing malaria 
and quantifying parasite burdens. Processing this large number of slides 
consumes scarce resources. Microscopy technicians who read these slides 
in the field may be inadequately trained or overwhelmed with the volume 
of slides to process, leading to missed and incorrect diagnoses. To ease 
the burden for microscopists and improve diagnostic and quantitative 
accuracy, we have developed a smartphone application that can assist 
field microscopists in diagnosis of malaria. The software runs on a 
standard Android smartphone that is attached to a microscope by a low 
cost adapter. Images of thin-film microscope slides are acquired through 
the eyepiece of the microscope using the smartphone’s built-in camera. 
The smartphone application assists microscopist in detecting parasites 
and estimating the parasitaemia. For each microscope field, the image 
processing software identifies infected and uninfected cells, and reports 
the parasite count per microliter of blood. The software was trained with 
more than 200,000 red blood cells from slides acquired at Chittagong 
Medical College Hospital in Bangladesh from patients with and without 
Plasmodium falciparum infection. These were manually annotated by an 
experienced professional slide reader. This is one of the largest labeled 
malaria slide image collections, enabling the application of new machine 
learning techniques such as deep learning. For each field-of-view image 
taken, an image processing pipeline is applied first to detect and segment 
cells before computing color and texture features for automatic machine 
classification to discriminate between infected and uninfected cells and 
other objects in the slide. Initial experiments show that our software 
correlates highly with both human experts and flow cytometry. We 
demonstrate the smartphone user interface, show the typical smartphone 
application work flow, and report on the diagnostic performance in field 
conditions in Bangladesh.
1517
REAL-TIME QUALITY ASSURANCE OF MALARIA 
SURVEILLANCE DATA IN MYANMAR AND ITS BORDER WITH 
CHINA
Poe Poe Aung1, Zaw Win Thein1, Kyin Hla Aye2, Hnin Wai Lwin2, 
Kay Thwe Han2, Huang Fang3, Christopher V. Plowe1, Kayvan 
Zainabadi1, Matthew Adams1, Myaing Myaing Nyunt1
1Institute for Global Health, University of Maryland School of Medicine, 
Baltimore, MD, United States, 2Department of Medical Research, Ministry 
of Health, Yangon, Myanmar, 3National Institute of Parasitic Diseases, 
China CDC, Shanghai, China
Collection of high quality data in public health surveillance and research 
studies is essential to ensure data interpretability and applicability. We 
evaluated the feasibility of systematic quality assurance procedures and 
the impact of a real-time integrated approach for large-scale malaria 
surveillance in Myanmar. We will present the data from and experience 
with evidence-based integrated monitoring and evaluation (M&E) 
procedures, with real-time feedback and quality assurance, implemented 
during the preparation and conduct of a large malaria surveillance study. 
The study was conducted in 43 villages located in 13 rural malaria-
476
astmh.org
endemic townships of nine State and Regions of Myanmar, and by a 
network of seven research and non-research partners working in the public 
and private sectors on malaria control and/or surveillance towards malaria 
elimination. M&E procedures were developed and performed manually 
and electronically using an edit-check system. Training was provided 
before and again during the study, with quality assessments before and 
after mid-study retraining. Study documents were comprehensively and 
systematically reviewed. Sample quality was evaluated by a trained team 
of laboratory experts, using a pre-specified check list. The most common 
and critical errors were site- and partner-specific, regardless of the type 
of the study. Documentation errors were related to age, travel history, 
antimalarial treatment history, evidence of consent, sample labeling, the 
quantity of blood required, and sample contamination. Findings from 
a comprehensive evaluation of approximately 5,000 study documents 
and more than 12,000 blood samples, using three different types of 
study record forms, and the quality before and after re-training, will be 
presented. Systematic and comprehensive monitoring and evaluation of 
data and related samples can be effectively integrated within a surveillance 
system, and real-time evaluation and feedback early in the process may 
significantly improve the quality of the data and samples, therefore 
subsequent usefulness of public health interventions developed and 
deployed based on these data.
1518
PLASMA-QPCR FOR DIFFERENTIAL DIAGNOSIS OF 
PLASMODIUM FALCIPARUM AND P. VIVAX
Devaraja G. Mudeppa1, Riaz Basha2, Ligia Pereira2, Rashmi 
Dash2, Shiva Matam2, Anjali Mascarenhas2, Jayashri Walke2, Pooja 
Gawas2, Ambika Sharma2, John White III1, Jennifer N. Maki1, 
Edwin Gomes2, Laura Chery1, Pradipsinh K. Rathod1
1Department of Chemistry, University of Washington, Seattle, WA, United 
States, 2Department of Medicine, Goa Medical College & Hospital, 
Bambolim, Goa, India
Accurate, sensitive detection of human malaria parasite, by species, is 
required for the treatment of the disease, and for assessing the parasite 
load in asymptomatic carriers. Microscopy and antigen-based rapid tests 
reliably detect upto 50,000 parasites per ml of blood. Newer nucleic 
acid amplification methods offer higher sensitivity and flexibility but 
use template preparations that are laborious, expensive and subject 
to carryover sample contaminations. We use as little as 4 µl of patient 
plasma as a source of parasite DNA, without a need for purification. 
This molecular diagnosis method is simple, rapid, sensitive and reliable. 
Brand new sets of primers for the detection of Plasmodium falciparum 
(Pf) and P. vivax (Pv) by qPCR were designed at a non-conserved region of 
18S ribosomal RNA genes. Species specificity of designed primers were 
confirmed by bioinformatics, by biochemical validation and by Sanger 
sequencing of amplified products. Though the presence of plasma delayed 
Ct value by four cycles with each tested standard genome sample, the 
linear range of detection was identical to reactions without plasma. With 
more than 90% amplification efficiency, the limit of detection stood less 
than 50 copies of parasite genome per ml of blood. Over 200 diverse 
patient samples were tested in triplicates on a 96-well qPCR instrument in 
parallel using Pf or Pv primer sets, with positive and no-template control 
reactions. Around 84 % of the plasma-qPCR results agreed with both 
microscopy and RDT, 9 % agreed with one of the two methods, 6 % 
displayed higher sensitivity and 1 % of the samples did not agree any of 
the two methods. This is better than any published comparison of three 
different methods. Direct plasma-based molecular diagnosis opens new 
avenues for differential screening of suspected malaria samples.
1519
QUALITY OF FEVER CASE MANAGEMENT IN THE PRIVATE 
SECTOR IN KINSHASA: RESULTS FROM BASELINE EXIT 
INTERVIEW AND MYSTERY CLIENT STUDIES
Marcel Lama, Stephen Poyer, Willy Onema, Robi Okara, Kathleen 
MacDonald, Nikki Charman
PSI, Washington, DC, United States
The private sector is the most common fever treatment source in 
Kinshasa. 70% of childhood fevers are treated in this sector and 97% 
of antimalarials are distributed through private outlets, including 89% 
through unregulated drug shops where diagnostic testing is not available. 
There is no published data on the quality of fever case management in 
private outlets, and a pressing need to fill this gap. As part of a project to 
increase RDT availability and correct use in this sector we conducted exit 
interview and mystery client surveys to benchmark standard quality of care 
indicators in late 2015. 123 mystery client visits by confirmed RDT-negative 
volunteers were conducted at 65 facilities with blood testing available. 
1,655 eligible client interviews were conducted at 83 health facilities, 
44 pharmacies and 60 drug stores. Eligible clients were adults seeking 
treatment for fever for themselves or on behalf of someone else. 79.3% 
of facility clients received a malaria test, with 26.7% tested by RDT and 
11.4% tested by both RDT and microscopy. 82.8% of test-positive facility 
clients received any antimalarial. However, fewer than half received an 
ACT (43.9%) and a similar proportion received both an antimalarial and an 
antibiotic (43.7%). The most common non-ACT treatments were quinine 
and artemisinin-based injections. 19/46 (41.3%) test-negative clients 
received any antimalarial. Testing was uncommon in pharmacies and drug 
shops (<8%) and 4 out of 10 untested clients received any antimalarial 
(40.6%). Mystery clients experienced poor quality of case management 
for fever at facilities. In 63% of visits the provider reported the client was 
positive for malaria following testing, and only 10% of clients received the 
correct diagnosis (negative) and did not receive any antimalarial. Providers 
wore gloves for only 23% of tests and waste disposal was suboptimal 
(immediate disposal of lancet in sharps box: 65% of tests). These results 
confirm there is much scope for improving private sector fever case 
management in Kinshasa, including both the provision of testing and 
availability of quality-assured ACT treatment.
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ANTIBODIES TO PLASMODIUM VIVAX MSP1-19 
RECOMBINANT ANTIGEN IN BLOOD DONORS FROM SAO 
PAULO BLOOD BANK
Maria Carmen Sanchez1, Mussya Cisotto Rocha1, Catarina 
Montenegro1, Mahyumi Fujimori1, Silvia Maria Di Santi1, Arianni 
Rondelli Sanchez1, Eduardo Milton Ramos-Sanchez1, Alfredo 
Mendrone Junior2, Jose Eduardo Levi2
1Sao Paulo University, Sao Paulo, Brazil, 2Fundacao Pro-Sangue 
Hemocentro de Sao Paulo, Sao Paulo, Brazil
Transfusion-transmitted malaria (TTM) is a challenge for blood banks due 
to asymptomatic Plasmodium infections. In non-endemic and low endemic 
areas, TTM is a rarely reported event. Sao Paulo state is not endemic 
for malaria, but sporadic autochthonous cases, mostly asymptomatic, 
have been reported and transfusional cases due to asymptomatic donors 
harboring P. malariae have been described. These donors involved in TTM 
were individuals who had visited the Atlantic Forest in different regions 
of the state and were unaware of their Plasmodium carrier status. The 
aim of this study was to evaluate the exposition of donor candidates to 
Plasmodium as a measure of TTM risk. Blood samples were collected 
from 6,328 candidates for blood donation that attended Fundacao 
Pro-Sangue/Hemocentro de Sao Paulo. IgG antibodies were surveyed 
in plasma samples by ELISA using P. vivax MSP119 recombinant antigen. 
The reactivity index (RI) was calculated for each sample and values of RI 
≥ 1.0 were considered positive. Out of 6,381 donors, 51 were positive 
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for IgG anti-PvMSP119 (0.81% - IC 95% = 0.61-1.06). RI≥1.0 varied from 
1.01 to 9.92 (media=3.15 and median=2.26). Among the 51 samples 
positive by serology, 68.63% were from donors with displacements to the 
Atlantic Forest biome in São Paulo State and/or who live in regions near 
the Atlantic Forest. Using molecular tools, researchers have detected that 
approximately 50% of Plasmodium infections related to Atlantic Forest 
biome are caused by P. vivax and 50%, to P. malariae, corroborating our 
results. The detection of anti-P. vivax IgG in blood bank donors in non-
endemic area is a measure of the exposure of candidates to Plasmodium 
antigens, but not necessarily a marker of parasitemia or disease. These 
results constitute an alert as asymptomatic donors are currently missed 
by the clinical-epidemiological screening preceding donation and no 
laboratorial test is applied. This study is part of a project that evaluates 
the power of a few specific questions on donor’s proximity to the Atlantic 
Forest in addition to laboratorial methods to disclose Plasmodium carriers, 
aiming to reduce the risk of TTM in this area.
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ASSESSMENT OF THE VARIABILITY IN THE INTERPRETATIONS 
OF MALARIA RAPID DIAGNOSTIC TEST (MRDT) RESULTS
Nora Zwingerman1, Santiago Ferro2
1University of Toronto, Toronto, ON, Canada, 2Fio Corporation, Toronto, 
ON, Canada
Malaria RDTs are accurate and relatively simple to use. However, correct 
processing and interpretations of the test results are critical for mRDTs 
to perform optimally in the field. Errors in the post-processing phase, 
properly interpreting the RDTs as positive, negative or invalid, remain 
frequent. Based on 4 field studies of FIonet, where a healthcare worker 
and an automated RDT reader provided mRDT result interpretations, 
discordance was estimated to occur in ~9% of mRDTs. Our aim was to 
investigate the discordant results, to assess the variation and repeatability 
of the interpretation of the mRDT results. We developed a questionnaire 
composed of high-resolution images of mRDTs conducted in the field 
by healthcare workers during the Fionet studies, where an image of 
each RDT processed was captured at the time for interpretation. A 
proportional stratified random sample of images was selected, where 
the healthcare worker and Fionet had discordant interpretations of the 
mRDT results. Additionally, 2 mRDTs were included as controls and 2 were 
repeated. Respondent characteristics, such as their level of experience 
were collected. So far 45 respondents have completed the survey, with 
~26% being experienced RDT users and located across 3 continents. 
Repeated mRDT images demonstrated that over 10% of respondents 
changed their interpretation between the first and second appearance 
of the image in the survey (Kappa=0.73). A large amount of variability 
in the interpretations was observed, from complete agreement to 
almost complete disagreement, for example the respondents’ results 
for one mRDT where 44% positive, 46% negative and 10% invalid. For 
>30% of the mRDT images, there was less than 75% agreement on the 
interpretation. The largest variation in interpretation was observed when 
there was a very faint line present. Interpretations were not statistically 
different between experienced and non-experienced RDT users. The 
reliability of the interpretations of the ~9% of mRDT test results, are 
variable and consequently sub-optimal to rely on user interpretations in 
the field and supports the implementation of an objective automated RDT 
reader.
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PUNCH CARD MICROFLUIDICS PLATFORM FOR MULTIPLEX 
MOLECULAR DIAGNOSIS OF PLASMODIUM FALCIPARUM 
AND P. VIVAX
George K. Korir, Manu Prakash
Stanford University, Stanford, CA, United States
Malaria continues to cause massive devastation globally. Routine 
microscopy and RDTs often fall short in diagnosing cases with low parasite 
densities. Moreover, with current elimination efforts in countries that 
are prime for such, increasing global concerns surrounding antimicrobial 
resistance and presence of co-infections, there is a need for effective 
multiplex diagnostic tests that can detect low parasitemia levels. To address 
this need, we have invented a punch card-based microfluidic platform and 
are using it to implement multiplex molecular diagnostic assays for malaria. 
Specifically, we are implementing recombinase polymerase amplification 
(RPA) assays starting with Plasmodium vivax and P. falciparum. Our 
platform is a self-contained, completely integrated hand-crank powered, 
programmable microfluidic platform. A paper tape encodes information 
as a series of punched holes. A mechanical reader/actuator reads these 
paper tapes and correspondingly executes operations onto a microfluidic 
chip coupled to the platform in a plug-and-play fashion. Enabled by 
the complexity of codes that can be represented by a series of holes in 
punched paper tapes, we harness our 30 independently controlled pumps 
and valves to implement the assays. Unlike conventional lateral flow-based 
tests, our platform has the capacity to process larger sample volumes, 
run multiple steps with the capacity to incorporate wash steps and the 
capability of implementing quantitative results if needed. Nucleic acid 
extraction is achieved using Fusion 5, a glass microfiber membrane that is 
embedded in the microfluidic chip. To achieve the optimum temperature 
of 37 degrees Celsius for the RPA assays, a heating pad is implemented in 
the device using a method that is similar to the previously described non-
instrumented nucleic acid amplification (NINA) approach. With its portable 
and robust design, low cost and ease-of-use, we envision punch card 
programmable microfluidics bringing complex control of microfluidic chips 
into field-based diagnostic applications in low-resource settings to help 
combat malaria.
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SUPPORTING THE IMPLEMENTATION OF MALARIA RAPID 
DIAGNOSTIC TESTS (RDTS): TOOLS FOR QUALITY CONTROL 
AND ASSESSMENT IN ENDEMIC SETTINGS
Christian Nsanzabana1, Daniel Kyabayinze2, Stephanie 
Dolan3, Elizabeth Streat4, Steve Harvey5, Iveth Gonzalez1, Sandra 
Incardona1
1Foundation for Innovative New Diagnostics (FIND), Geneva, Switzerland, 
2Foundation for Innovative New Diagnostics (FIND), Kampala, Uganda, 
3Population Services International (PSI), Nairobi, Kenya, 4Malaria 
Consortium, Kampala, Uganda, 5Johns Hopkins Bloomberg School of 
Public Health, Baltimore, MD, United States
The World Health Organization (WHO) recommends that every suspected 
malaria case be confirmed by parasitological testing using microscopy or 
malaria Rapid Diagnostic Tests (RDTs), and treatment of confirmed cases 
be done with artemisinin combination therapies (ACTs). Therefore there 
is a need for good quality RDTs to ensure access to prompt and accurate 
diagnosis, especially in remote settings where good quality microscopy 
may not be available. The need for RDT quality and durability, especially 
under transport and storage conditions typical in malaria-endemic 
regions, has received considerable attention. Early evidence has shown 
lot to lot variation of products and susceptibility to deterioration upon 
exposure to high temperatures and humidity which can be encountered 
along the supply chain. Moreover documented reports show that health 
worker’s poor adherence to RDTs test results is partly attributed to lack 
of confidence in the quality of tests. Tools to monitor the quality of RDTs 
at the end-users level and manage any problems have been set up in 
the frame of an RDT implementation project, with inputs from various 
implementers as well as health care staff from public and private sectors. 
A protocol was developed for countries to have a framework in which 
RDT problems will be documented, cross-checked and reported from 
the end user to the national, regional and international stakeholders. A 
troubleshooting guide provides help to RDT users and their supervisors 
to address problems that occur during use of RDTs. Positive control 
wells (PCWs) have been made available for point-of-care (POC) users, to 
reassure them on the quality of the test kits. When reconstituted with 
water and applied to a good quality RDT, the PCW solution produces a 
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positive test result. PCWs can therefore be used as POC quality control 
tool by front-line health workers to test their RDT stocks and ensure 
their validity and accuracy. Preliminary results from a pilot study assessing 
the use and acceptability of PCWs, the troubleshooting guide, and the 
problems protocol by health worker supervisors in the private and public 
health sectors in Kenya and Tanzania will be presented.
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PERCEIVED VALUE OF MALARIA RAPID DIAGNOSTIC TESTS 
AMONG PRIVATE PROVIDERS IN MADAGASCAR AND 
UGANDA: A QUALITATIVE STUDY
Steven A. Harvey1, Nina Martin1, Geoffrey Namara2, Robert 
Mugerwa2, Rova Ratsimandisa3, Jacky Raharinjatovo3, Anja 
Rakotomalala3, Stephen Poyer4, Elizabeth Streat2
1Johns Hopkins School of Public Health, Baltimore, MD, United States, 
2Malaria Consortium, Kampala, Uganda, 3Population Services International, 
Antananarivo, Madagascar, 4Population Services International, Nairobi, 
Kenya
Malaria rapid diagnostic tests (RDTs) have become ubiquitous in public 
sector health facilities throughout the malaria-endemic world, but 
private sector use is still nascent. Little is known about private provider 
perceptions of RDT credibility, how RDT results affect treatment decisions, 
and whether providers see RDTs as an asset or liability from both a health 
and a business perspective. We conducted in-depth interviews (IDIs) with 
36 private providers in Uganda and 36 in Madagascar, most enrolled in 
a private-sector mRDT promotion program. IDI topics included RDT use, 
perceived test credibility, alternative diagnostic strategies, treatment 
decisions, pricing strategies, and perceived effect on overall profitability. 
Most providers agreed that RDTs improved their profitability and standing 
in the community. However, both confidence in test results and treatment 
based on test results varied widely. This presentation will describe the 
range of private-sector provider perspectives about RDT credibility and 
situations in which providers do or do not base treatment on RDT results. 
It will also consider the implications of study findings for scaling up RDT 
use in the private sector. This qualitative study was part of a three-year 
initiative to pilot RDT use among private providers in Kenya, Madagascar, 
Nigeria, Uganda and Tanzania.
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FIVE YEARS INTO THE MALARIA DIAGNOSIS SCALE-UP, ARE 
ACTS REALLY GETTING TO INFECTED PEOPLE? ESTIMATING 
ACT MISUSE IN THE INFORMAL PRIVATE SECTOR
Hamsa Subramaniam, Aaron Woolsey, Arnaud Le Menach, 
Justin Cohen, Theodoor Visser, Patricia Njiri, Alex Ogwal, Valerie 
Scott, Omowunmi Omoniwa, Luke Rooney
Clinton Health Access Initiative, Boston, MA, United States
In 2010, the World Health Organization broadened its recommendation to 
parasitologically confirm malaria before treatment is provided, catalyzing 
the increased availability and use of malaria rapid diagnostic tests (mRDTs). 
The use of mRDTs promotes appropriate treatment for febrile illness 
and prevents antimalarials, especially the first line artemisinin-based 
combination therapies (ACTs), from being wasted on patients without 
malaria. Even so, mRDTs are not always available in the private health 
sector, where a substantial proportion of fever patients seek treatment, 
contributing to the irrational use (or misuse) of antimalarials, especially 
in the informal private sector, i.e. drug shops. A model to quantify ACT 
misuse will help in setting priorities as further scaling-up of mRDTs occurs 
in endemic contexts. The following data inputs were used in the model to 
estimate ACT misuse in a given geography: malaria prevalence, number of 
fever patients seeking treatment, proportion of fevers receiving a malaria 
test, proportion of fevers with or without a test, and proportion of fevers 
receiving ACTs. These inputs were derived from raw data or modeled from 
the Demographic Health Surveys, ACTWatch Surveys, reviews of published 
literature, and data from the national malaria control programs. The 
number of ACTs misused was estimated as the number of ACTs given to 
fever cases who had not received a test but were assumed negative based 
on prevalence figures, and to those who had received a negative test. 
For the informal private sector across three endemic countries - Kenya, 
Uganda and Tanzania - irrational ACT use was estimated at approximately 
10 million. At 64 cents a course, approximately $6.8 million worth of ACTs 
are being wasted on those without malaria. Given that this represents only 
small a subset of ACT misuse across sub-Saharan Africa, it is important 
that mRDT scale-up continues, especially in the informal private sector 
where a third of all treatment-seeking occurs. Further, drug shop owners 
must be properly trained on mRDT use and should be empowered to trust 
mRDT results in diagnosing malaria.
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EFFICACY OF DIHYDROARTEMISININ-PIPERAQUIN AND 
CHLOROQUINE IN THE TREATMENT OF UNCOMPLICATED 
PLASMODIUM FALCIPARUM AND PLASMODIUM VIVAX 
MALARIA IN VIETNAM
Quang H. Huynh
Institute of Malariology, Parasitology and Entomology Quy Nhon, Vietnam, 
Quy Nhon City, Vietnam
Resistance to antimalarial drugs is a major public health problem, which 
may hamper the control of malaria. In order to deal with the growing 
resistance of both Plasmodium falciparum and P. vivax, surveillance 
of the first choice antimalarial drugs- DHA-PPQ and chloroquine, was 
conducted in the Central Vietnam during 2012 to 2015. The surveillance 
was conducted at 3 sentinel sites in Quang Tri, Gia Lai and Ninh Thuận 
based on the World Health Organization protocol (WHO, 2009). Standard 
total dosage of DHA-PPQ 40/320 mg (8 tablets, in 3 days, chloroquine 
500 mg (10 tablets in 3 days) for adult patients, with 28 or 42 day follow-
up. K13 gene mutation identification was also done at the Institute 
Pasteur of Phnom- Penh (2014) and the Department of Microbiology, 
University of Sassari, Italy (2015). During the period from 2012 -2015 
the DHA-PPQ efficacy to P. falciparum malaria were high with APCR, 
(69/69, 100%) (46/46, 100%) in Quang Tri and Ninh Thuan province 
respectively, but APCR (57/60, 95%), ETF (2/60; 3.33%), LCF (1/60, 
1.67%) in Gia Lai sentinel site. The mean parasite clearance time (PCT) 
was 48 hours except 11 cases in Gia Lai having blood smear positive 
rate on D3 of 18.3%. In those cases there were 9 mutations in Kelch 
13 propeller gene (C580Y, R539T). The efficacy of CQ on the clearance 
of blood stage P. vivax (without primaquine) was still high with ACPR at 
100% in Quang Tri province, Gia Lai province, in Ninh Thuan province. 
There was no recurrence with 28 days follow-up. Conclusions: DHA-PPQ 
and chloroquine remain efficacious for the treatment of uncomplicated 
falciparum and vivax malaria respectively in the Central of Vietnam. 
Further investigation as detection of artemisinin resistant markers and PK/
PD are needed.
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PHARMACOKINETIC INTERACTIONS OF ARTESUNATE ON 
THE DISPOSITION OF AMODIAQUINE IN SUBJECTS WITH 
PLASMODIUM FALCIPARUM INFECTION AFTER ORAL 
ADMINISTRATION OF FIXED-DOSE COMBINATION OF 
AMODIAQUINE-ARTESUNATE
Olumuyiwa N. Adedeji1, Odusoga A. Osonuga2, Catherine O. 
Falade1, Oluseye O. Bolaji3, Olusegun G. Ademowo1
1Institute for Advanced Medical Research & Training, College of Medicine, 
University of Ibadan, Ibadan, Nigeria, 2Department of Pharmacology, 
Olabisi Onabanjo University, Sagamu, Nigeria, 3Department of 
Pharmaceutical Chemistry, Obafemi Awolowo University, Ile-Ife, Nigeria
Artemisinin-based combination therapy has been adopted by 
several African countries including Nigeria as first line treatment for 
uncomplicated falciparum malaria. There is a need to balance the 
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advantages of the combination against the possible effect of interaction 
between the component drugs. We investigated the pharmacokinetic 
interactions of artesunate (AS) on the disposition of amodiaquine (AQ) in 
subjects with Plasmodium falciparum infection after oral administration 
of fixed-dose combination of amodiaquine-artesunate (AQAS). This 
is a randomized, open-label trial in which twenty subjects with P. 
falciparum infection were assigned into two treatment arms namely, 
AQ or in combination with artesunate (AQ/AS). AQ (600mg) or a fixed 
dose combination of AQ/AS (AQ 306.3 mg/AS 100 mg × 2 tablets) was 
administered once daily for 3 days. Blood samples were collected at 
different sampling times. Subjects were followed up for 28 days to assess 
response to treatment; those who failed to respond to AQ or AQ/AS were 
treated with artemether/lumefantrine and quinine respectively. Plasma 
was obtained and assayed for AQ and desethylamodiaquine (DAQ) levels 
using hplc technique. The pharmacokinetics parameters of AQ and DAQ 
were determined and compared in the two arms. There are no statistically 
significant difference in the peak plasma concentration, Cmax (774.34 ± 
146.94 vs. 763.19 ± 89.99 ng/ml), concentration on day 7, Conc day 7 
(357.13 ± 45.06 vs. 390.88 ± 53.63 ng/ml), total drug exposure, AUC0-∞ 
(187,710 ± 14.110 vs. 197,960 ± 14, 6874 ngh/ml) and elimination half-
life, T½ (212.81 ± 1.24 vs. 212.89 ± 1.20 h) (P >0.05) of DAQ in AQAS vs. 
AQ respectively. The pharmacokinetic parameters of AQ were also similar 
in both arms (P > 0.05). Parasites cleared in all subjects in the two arms 
except in a subject in AQ arm in whom parasites were seen on Day 14. 
Although not significant, the reduced total exposure of AQ in AQAS arm 
was a concern particularly in areas with reduced AQ sensitivity. Further 
studies are needed to assess the degree of reduction in total exposure 
of DAQ observed in this study so as to design optimal dosing/tolerability 
profile for AQ use.
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UNEXPECTED FALL IN HEMOGLOBIN VALUE DURING 
THE FIRST PHASE OF MALARIA PREVENTION TRIAL: 
PRELIMINARY FINDINGS FROM A DROUGHT PRONE AREA IN 
ETHIOPIA
Taye Gari1, Eskindir Loha1, Wakgari Deressa2, Tarekegn Solomon1, 
Hanibale Atsebeha1, Meselech Assegid2, Alemayehu Hailu2, Bernt 
Lindtjorn3
1Hawassa University, Hawassa, Ethiopia, 2Addis Ababa University, Addis 
Ababa, Ethiopia, 3University of Bergen, Bergen, Norway
As part of a field trial to provide evidence on the combined use of LLINs 
and IRS for malaria prevention, we measured hemoglobin values among 
children less than five years old. Our hypothesis was that by preventing 
malaria, the mean hemoglobin values would increase by 0.5 gm/ dl. 
In this trial we followed about 3000 children 6 to 59 months old from 
August 2014 to December 2015. We did active (weekly home visit) and 
passive malaria case search. Hemoglobin (HB) concentration surveys were 
conducted after the major malaria transmission seasons in 2014 and 2015, 
and children with HB < 11 gm/dl were classified as having anemia. The 
mean HB value decreased from 11.6 gm/dl in 2014 to 11.2 g/dl in 2015 
(mean difference 0.35 gm/dl (95% CI 0.27 - 0.43; P<0.001). In 2014, the 
prevalence of anemia was 28.2% (95 % CI; 26.6 - 29.8) and increased 
in 2015 to 36.8% (95 % CI; 35.1 - 38.5). Among 171 registered malaria 
cases, 88 (51.5%) were due to Plasmodium falciparum. Among these 
children, malaria incidence rate was 8.6 (95% CI; 6.5 - 11.3) in 2014, 
and 8.3 (95% CI 6.4 - 10.8) cases per 10,000 person weeks in 2015. 
The mean hemoglobin value as well as malaria incidence increased with 
increasing age of the child. Family wealth and educational status of the 
head of households were predictors of anemia, but malaria incidence 
was not associated with anemia. This study showed an unexpected fall in 
mean HB value between the two surveys. This occurred in spite of malaria 
prevention efforts. During the same period, the region experienced one of 
the most severe droughts in decades. Even if many children in the study 
area received supplementary feeding, and we believe the worsening food 
household insecurity may explain the increase in anaemia prevalence. This 
study demonstrated that doing field trials in drought prone areas may 
bring unexpected challenges.
1529
SAFETY AND TOLERABILITY OF ROSIGLITAZONE 
ADJUNCTIVE THERAPY FOR CHILDREN WITH 
UNCOMPLICATED MALARIA: A RANDOMIZED, DOUBLE 
BLIND, PLACEBO CONTROLLED TRIAL
Rosauro Varo1, Lola Madrid1, Antonio Sitóe2, Valerie Crowley3, 
Lena Serghides3, Kevin Kain3, Quique Bassat1
1Barcelona Institute for Global Health, Barcelona, Spain, 2Centro de 
Investigação em Saúde de Manhiça (CISM), Manhiça, Mozambique, 
3Sandra Rotman Centre for Global Health, University Health Network-
Toronto General Hospital, Toronto, ON, Canada
Studies have shown that the oral antidiabetic Rosiglitazone can improve 
malaria outcomes in adults, by decreasing the levels of Angiopoietin II 
(AGII), an independent and quantitative biomarker of disease severity in 
malaria. We present the first results of a pilot clinical trial assessing the 
safety and efficacy of rosiglitazone as adjunctive therapy for Plasmodium 
falciparum malaria in Mozambican children. Thirty children (1-12 years) 
with uncomplicated malaria were randomized (2:1) to receiverosiglitazone 
(0.045mg/kg/dose) or placebo (double blind) twice-daily for four days. 
ECG, Blood glucose levels, biochemical and haematological parameters 
were monitored for safety. AGII and other biomarkers of host response 
including endothelial activation, inflammation, coagulopathy, and 
neuroprotection were measured for efficacy. Results: No significant 
differences were found in terms of the incidence of biochemical, 
haematological or electrocardiographic abnormalities. Efficacy results 
will be presented. In conclusion, this study confirmed the safety of 
Rosiglitazone in Mozambican children with malaria. Evaluation of 
Rosiglitazone as adjuvant therapy for severe malaria is warranted.
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SAFETY AND EFFICACY OF REPEATED ADMINISTRATION OF 
PYRONARIDINE-ARTESUNATE OR DIHYDROARTEMISININ-
PIPERAQUINE VS ARTESUNATE-AMODIAQUINE IN CHILDREN 
AND ADULT PATIENTS WITH ACUTE UNCOMPLICATED 
PLASMODIUM SP MALARIA OVER OF TWO YEARS PERIOD 
AT BANFORA/NIANGOLOKO SITE IN BURKINA FASO
Issiaka Soulama, Aboubacar Sam Coulibaly, Moise J. Kaboré, 
Maurice Ouattara, Edith C. Bougouma, Souleymane Sanon, Noélie 
Henry, Amidou Diarra, Daouda Ouattara, Amidou Ouedraogo, 
Alphonse Ouedraogo, Benjamin Sombie, Alfred B. Tiono, 
Sodiomon B. Sirima
Centre National de Recherche et de Formation sur le Paludisme, 
Ouagadougou, Burkina Faso
The safety and efficacy of repeated administration of three ACTs 
[(pyronaridine-artesunate (PYR) or dihydroartemisinin-piperaquine (DHA-
PQ) vs artesunate-amodiaquine (ASAQ)] were evaluated in West African 
Countries, members of the West African Network of Clinical trials for 
AntiMalarial drugs (WANECAM). In the current study we present the 
preliminaries data of repeated administration of PYR or DHA-PQ vs 
ASAQ over a period of 2 year in children and adults with uncomplicated 
Plasmodium sp malaria at Banfora/Niangoloko sites in Burkina Faso. This 
study is a comparative, randomized, open label longitudinal clinical trial 
involving children and adults with uncomplicated Plasmodium sp. malaria. 
Each of participant enrolled received during their subsequent episodes the 
same drug and went through the same trial procedures as for the initial 
episode. A total of 1090 participants were screened from which, 763 
were enrolled in ASAQ (315), DHA-PQ (224) and PYR (224) arm, from July 
2012 to December 2013. As per age 342, 357 and 64 participants aged 
< 5 years, 5-14 years and ≥ 15 years were followed respectively during 
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the two years. The preliminaries results showed that 245 of 315 (77.8%) 
patients, 166 of 224 (74.10%); and 176 of 224 (78.6%) experienced at 
least 2 malaria episodes and 108 (34.3%), 63 (28.1%) and 82 (36.6%) 
experienced at least 5 malaria episodes in the ASAQ, DHA-PQ and PYR 
arms respectively. The average time between the first and the second 
malaria episode was statistically longer (p<0.05) in DHA (157 days) 
compared to ASAQ (135 days) and PYR (117 days) arms. Adequate clinical 
and parasitological response (ACPR) by day 28 was 93.0 %, 97.8% and 
98.2% in ASAQ, DHA and PYR arm respectively during the first malaria 
episodes. The 42 day cure rate (not adjusted by PCR) was 80.3 %, 93.8% 
and 78.2% in ASAQ, DHA-PQ and PYR arms respectively during the first 
malaria episodes. Our preliminary results confirmed the two news drugs 
(DHA-PQ and PYR) are safe and their efficacy comparable to the ASAQ in 
uncomplicated malaria treatment in high malaria transmission region.
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RANDOMIZED, BLINDED CLINICAL TRIAL COMPARING AN 
INVESTIGATIONAL ANTIMALARIAL, AQ-13, TO ARTÉMETHER 
+ LUMÉFANTRINE FOR TREATMENT OF UNCOMPLICATED 
PLASMODIUM FALCIPARUM MALARIA
Ousmane A. Koita1, Lansana Sangare1, Haiyan Deng2, Sahare 
Fongoro1, Moctar Coulibaly1, Aliou Sissako1, Trevor A. Thompson2, 
Youssouf Diarra1, Mamadou Ba1, Ababacar Maiga1, Boubakar 
Diallo1, Frances J. Mather2, Asif Anwar2, Donald J. Krogstad2
1University of Bamako, Bamako, Mali, 2Tulane University Health Sciences 
Center, New Orleans, LA, United States
Chloroquine (CQ) was the treatment of choice for Plasmodium falciparum 
malaria until CQ-resistant parasites were identified in Southeast Asia and 
South America over 50 years ago. Although CQ-resistant P. falciparum 
have been an obstacle to malaria control since that time, recent studies 
have shown 4-aminoquinolines (4-AQs) with modified side chains are 
active against CQ-resistant parasites and that the lead compound (AQ-13) 
is safe in human subjects. To determine whether AQ-13 is effective for 
the treatment of uncomplicated malaria, we performed a randomized, 
blinded clinical trial in which 66 Malian men received oral treatment with 
AQ-13 or the current recommendation of artémether + luméfantrine 
(A+L) for 3 days. After all subjects completed the 42 day follow-up, the 
study was unblinded and results were compared for subjects randomized 
to A+L vs. AQ-13. There were no differences in the ages, initial parasite 
counts or Hb levels of subjects randomized to A+L vs. AQ-13. Likewise, 
High Resolution Melt (HRM) analysIs indicated that similar numbers of 
subjects with CQ-susceptible, CQ-resistant and mixtures of -susceptible 
and -resistant P. falciparum were randomized to A+L and AQ-13. Subjects 
treated with either A+L or AQ-13 cleared asexual parasites from their 
blood on or before day 7 and no serious, Grade 3 or Grade 4 AEs occurred 
in either group. There were 2 withdrawals for personal reasons from the 
AQ-13 arm on day 4 after asexual parasites had been cleared on day 3 and 
2 recurrences in the A+L arm on follow-up days 17 and 21. These results 
indicate AQ-13 is efficacious and safe for the treatment of uncomplicated 
malaria caused by CQ-susceptible and –resistant P. falciparum. Based on 
this study, the efficacy of AQ-13 cannot be distinguished from the efficacy 
of A+L for uncomplicated P. falciparum malaria. Efficacies for A+L and AQ-
13 were 94% (31/33) based on intent to treat and 94% and 100% (31/33 
and 31/31) based on per protocol analyses.
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RANDOMIZED, BLINDED CLINICAL TRIAL COMPARING AN 
INVESTIGATIONAL ANTIMALARIAL, AQ-13, TO ARTÉMETHER 
+ LUMÉFANTRINE FOR TREATMENT OF UNCOMPLICATED 
PLASMODIUM FALCIPARUM MALARIA
Ousmane A. Koita1, Lansana Sangare1, Haiyan Deng2, Sahare 
Fongoro1, Moctar Coulibaly1, Aliou Sissako1, Trevor A. Thompson2, 
Youssouf Diarra1, Mamadou Ba1, Ababacar Maiga1, Boubakar 
Diallo1, Frances J. Mather2, Asif Anwar2, Donald J. Krogstad3
1University of Bamako, Bamako, Mali, 2Tulane University Health Sciences 
Center, New Orleans, LA, United States, BTropical Medicine/Center for 
Infectious Diseases, 2Tulane University Health Sciences Center, New 
Orleans, LA, United States
Chloroquine (CQ) was the treatment of choice for Plasmodium falciparum 
malaria until CQ-resistant parasites were identified in Southeast Asia and 
South America over 50 years ago. Although CQ-resistant P. falciparum 
have been an obstacle to malaria control since that time, recent studies 
have shown 4-aminoquinolines (4-AQs) with modified side chains are 
active against CQ-resistant parasites and that the lead compound (AQ-13) 
is safe in human subjects. To determine whether AQ-13 is effective for 
the treatment of uncomplicated malaria, we performed a randomized, 
blinded clinical trial in which 66 Malian men received oral treatment with 
AQ-13 or the current recommendation of artémether + luméfantrine 
(A+L) for 3 days. After all subjects completed the 42 day follow-up, the 
study was unblinded and results were compared for subjects randomized 
to A+L vs. AQ-13. There were no differences in the ages, initial parasite 
counts or Hb levels of subjects randomized to A+L vs. AQ-13. Likewise, 
High Resolution Melt (HRM) analysIs indicated that similar numbers of 
subjects with CQ-susceptible, CQ-resistant and mixtures of -susceptible 
and -resistant P. falciparum were randomized to A+L and AQ-13. Subjects 
treated with either A+L or AQ-13 cleared asexual parasites from their 
blood on or before day 7 and no serious, Grade 3 or Grade 4 AEs occurred 
in either group. There were 2 withdrawals for personal reasons from the 
AQ-13 arm on day 4 after asexual parasites had been cleared on day 3 and 
2 recurrences in the A+L arm on follow-up days 17 and 21. These results 
indicate AQ-13 is efficacious and safe for the treatment of uncomplicated 
malaria caused by CQ-susceptible and -resistant P. falciparum. Based on 
this study, the efficacy of AQ-13 cannot be distinguished from the efficacy 
of A+L for uncomplicated P. falciparum malaria. Efficacies for A+L and AQ-
13 were 94% (31/33) based on intent to treat and 94% and 100% (31/33 
and 31/31) based on per protocol analyses.
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A TRIAL OF SEASONAL MALARIA CHEMOPREVENTION PLUS 
AZITHROMYCIN IN AFRICAN CHILDREN
Alassane Dicko1, Jean-Bosco Ouedraogo2, Issaka Zongo2, Issaka 
Sagara1, Matthew Cairns3, Irene Kuepfer3, Modibo Diarra1, 
Amadou Barry1, Samba Coumare1, Amadou Tapily1, Yves Daniel 
Compaore2, Frederic Nikiema4, Serge Yerbanga2, Abdoulaye 
Djimde1, Ogobara Doumbo1, Halidou Tinto2, Paul Milligan3, Brian 
Greenwood3, Daniel Chandramohan3
1Malaria Research & Training Center, Bamako, Mali, 2Institute de Recherche 
en Sciences de la Sante (IRSS), Bobo, Burkina Faso, 3London School of 
Hygiene & Tropical Medicine, London, United Kingdom, 4Institute de 
Recherche en Sciences de la Sante (IRSS), Bobo, Mali
Mass administration of azithromycin (AZ) on a single occasion for 
elimination of trachoma in Ethiopia was associated with a substantial 
reduction in overall child mortality in communities treated with AZ 
compared to untreated control communities. This reduction was sustained 
for 26 months after treatment (Rate Ratio 0.35; 95% C1: 0.17, 0.74). The 
impact of AZ on mortality could have been achieved through its action on 
pneumococci and other bacteria. As seasonal malaria chemoprevention 
(SMC) is implemented in countries of the Sahel and sub-Sahel, it would 
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be possible to add AZ to the antimalarial drug regimen given during 
the rainy season when the risk of both malaria and severe bacterial 
infections is highest. Thus, we are conducting a study in Mali and Burkina 
Faso to determine whether addition of AZ to SMC using sulphadoxine/
pyrimethamine (SP)+amodiaquine (AQ) provides an additional reduction 
in deaths and severe illness in young African children. This is a double 
blind, randomised, placebo-controlled trial involving 19200 children aged 
3 - 59 months who are randomised by household to receive four rounds 
of either SP+AQ+AZ or SP+AQ+ placebo at monthly intervals during the 
peak malaria transmission season over a three-year period. Administration 
of the first round of drugs started in August 2014 and the final round will 
be completed in November 2016. In 2014 and 2015, the proportion of 
children who received ≥3 monthly rounds of drug each year was >90%. 
We will present the study rationale and design, and preliminary results 
of blinded analysis of the incidence of primary (hospital admission or 
death during the transmission season) and selected secondary endpoints 
(incidence of clinical malaria, respiratory infection and diarrhoea, and the 
prevalence of malaria parasitaemia, markers of SP resistance, malnutrition 
and pneumococcal carriage at cross-sectional surveys). Final results will be 
available in 2017.
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A PROOF-OF-CONCEPT, RANDOMIZED STUDY IN NON-
IMMUNE HEALTHY ADULT VOLUNTEERS TO INVESTIGATE 
THE SAFETY, TOLERABILITY, PHARMACOKINETIC PROFILE 
AND PROPHYLACTIC ACTIVITY OF A SINGLE DOSE OF 
DSM265 IN A CONTROLLED HUMAN MALARIAL INFECTION 
CHALLENGE EITHER BY DIRECT VENOUS INOCULATION OF 
PLASMODIUM FALCIPARUM SPOROZOITES (PFSPZ) OR A 
SINGLE EPISODE OF BITES BY MOSQUITOES CARRYING P. 
FALCIPARUM
Sean C. Murphy1, Elizabeth Duke2, Kelly Shipman2, Ryan Jensen2, 
Youyi Fong2, Emma Fritzen3, Tracie VonGoedert3, Stephan Duparc4, 
Stephan Chalon4, Nicola Kerr4, Thomas Rueckle4, James G. Kublin2
1University of Washington Medical Center, Seattle, WA, United States, 
2Fred Hutchinson Cancer Research Center, Seattle, WA, United States, 
3Center for Infectious Disease Research, Seattle, WA, United States, 
4Medicines for Malaria Venture, Geneva, Switzerland
In the face of rising drug resistance, new anti-malarial drugs are needed 
for prophylaxis and radical cure. DSM265 is a novel triazolopyrimidine-
based inhibitor of dihydroorotate dehydrogenase (DHODH), a key enzyme 
in the pyrimidine biosynthesis pathway. DSM265 demonstrated promising 
in vitro and in vivo activities against liver and blood stages in preclinical 
studies and recently advanced to clinical trials for blood stage infection. In 
collaboration with the Medicines for Malaria Venture and the University 
of Tübingen, the Seattle Malaria Clinical Trials Center initiated a study to 
assess the safety, tolerability, pharmacokinetic profile and prophylactic 
activity of a single dose of DSM265 in a controlled human malarial 
infection (CHMI) challenge either by direct venous inoculation (DVI) of 
Plasmodium falciparum sporozoites (PfSPZ) or a single episode of bites by 
mosquitoes carrying P. falciparum. This study is designed to determine the 
initial dosing interval for once-weekly chemoprevention. Three cohorts 
(n=6 drug-treated plus n=2 placebo controls) are planned to assess 
DSM265 dosing 3 or 7 days prior to PfSPZ DVI CHMI or 7 days prior to 
mosquito bite CHMI. Subjects will be followed using the standard CHMI 
model using a Plasmodium 18S rRNA molecular qRT-PCR-based treatment 
threshold to initiate rescue treatment after ≥250 estimated parasites/mL 
are detected. Pharmacokinetic data on DSM265, safety laboratory data, 
adverse events and parasite growth kinetics will be assessed. The study is 
ongoing, with data from completed cohorts to be presented.
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PHASE II STUDY OF ARTEFENOMEL (OZ439) AND 
PIPERAQUINE TO INVESTIGATE SINGLE DOSE TREATMENT 
FOR UNCOMPLICATED PLASMODIUM FALCIPARUM 
MALARIA
Fiona Macintyre
Medicine For Malaria Venture, Geneva, Switzerland
We performed a clinical phase II study with single dose combinations of 
artefenomel (OZ439) and piperaquine phosphate (PQP) at three dose 
levels as part of the development of a single dose cure for uncomplicated 
Plasmodium falciparum malaria to improve patient compliance, reduce risk 
of drug resistance, and to support eradication campaigns. Patients (n=448) 
in Africa (n=365) and Asia (n=83) were recruited with 85% being children 
<5 yrs of age. OZ439/PQP combination demonstrated an acceptable safety 
profile and was well tolerated. The primary endpoint was Day 28 PCR-
adjusted ACPR (ACPR28). ACPR28 for the combination of 800mg OZ439 
with 640 mg PQP, 960 mg PQP and 1440 mg PQP was 68.4%, 70.8% 
and 78.6% respectively, in per protocol population. ACPR28 was lower 
in Asian than African patients despite achieving higher drug exposures. 
Only 1 early treatment failure occurred. The success of a single dose 
treatment is assumed to be dependent on adequate parasiticidal drug 
exposure for three parasite life-cycles (approximately 1 week). Population 
PK analyses using non-linear mixed effect modelling allowed estimation of 
concentration at Day 7 and identification of influential covariates in this 
study. The probability of achieving ACPR28 was a function of both OZ439 
and PQP concentrations at Day 7, as well as baseline parasitemia, and 
region. Neither age nor presumed immunity was identified as a covariate. 
In Asia, >70% patients had parasites with mutations in the Kelch13 (K13) 
propeller gene. K13 genotype, known to alter parasite reduction rate for 
artesunate also impacted the parasite clearance by OZ439/PQP but had 
no significant impact on the cure rate measured as ACPR28. Furthermore, 
K13 genotype was not a significant covariate in the model for ACPR28. In 
conclusion, none of the treatment arms investigated in this study met the 
regulatory efficacy threshold defined as ACPR28 >95%. Given that there 
are increasing reports of PQP resistance in South-East Asia, we decided 
not to follow up on the potential of this combination for a 3-day regimen, 
instead we plan to investigate combinations with newer compounds 
where there is less risk of pre-existing resistance.
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TOLERABILITY OF SINGLE DOSE PRIMAQUINE IN G6PD-
DEFICIENT ADULT MALES IN MALI WITHOUT MALARIA: AN 
OPEN-LABEL PHASE 2 DOSE-ADJUSTMENT TRIAL
Ingrid Chen1, Halimatou Diawara2, Almahamoudou Mahamar2, 
Amadou Barry2, Kuoaly Sanogo2, Joelle Brown3, Jimee Hwang4, 
Helmi Pett5, Teun Bousema5, Max Murphy1, Bryan Greenhouse1, 
Roly Gosling1, Alassane Dicko2
1University of California San Francisco, San Francisco, CA, United States, 
2Malaria Research and Training Centre, Bamako, Mali, 3University 
of California, San Francisco, San Francisco, CA, United States, 4U.S. 
President’s Malaria Initiative, Malaria Branch, Division of Parasitic Diseases 
and Malaria, U.S. Centers for Disease Control and Prevention, Atlanta, GA, 
United States, 5University of Nijmegen, Nijmegen, Netherlands
Single low dose primaquine (SLD-PQ) is recommended by the WHO to 
block the transmission of Plasmodium falciparum parasites to mosquitoes. 
However, uptake is limited due to concerns of hemolytic side effects in 
individuals with enzymatic glucose-6-phosphate dehydrogenase (G6PD) 
deficiency. We determined the safety of three, single-dose regimens of 
primaquine in G6PD-deficient adult males without malaria in Mali. We 
conducted an open-label, non-randomized, dose-adjustment trial of the 
tolerability of 0.40, 0.45, and 0.50 mg/kg of single dose primaquine in 
G6PD-deficient adult males in Mali without malaria. Adult males with 
a Carestart® qualitative G6PD-deficient test result were treated with a 
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0.40, 0.45, or 0.50 mg/kg dose of primaquine, followed by a 0.50 mg/
kg control group of G6PD-replete men. The primary outcome was the 
within-person percentage change in hemoglobin concentration, assessed 
using a Hemocue system, from baseline levels between day 0 and day 10. 
All individuals who received a single-dose of primaquine and completed 
safety assessments--comprising hemoglobin concentration, urine color, 
and clinical assessment--daily on days 1-10, and on days 14 and 28 
following primaquine administration, were included in the primary sample 
analysis (n=28). We enrolled 28 participants sequentially, from August 13 
to December 19, 2015. Primaquine doses of 0.40, 0.45 and 0.5 mg/kg 
were all found to be safe and tolerable. A hemolytic dose response was 
not observed at these doses in any of the participants, no serious adverse 
events were reported, and adverse events were not associated with the 
treatment group. SLD-PQ up to 0.50 mg/kg was well tolerated in healthy 
G6PD-deficient populations in West Africa, and should be rolled out using 
0.50 mg/kg as the upper bound for weight-based dosing bands.
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THE ETHICS OF USING A PLACEBO ARM IN RANDOMIZED 
CONTROLLED TRIALS: A CASE OF IN A PRIMAQUINE 
ANTIRELAPSE STUDY
Phaik Yeong Cheah1, Norbert Steinkamp2, Ric N Price3
1Mahidol Oxford Tropical Medicine Research Unit, University of 
Oxford, Bangkok, Thailand, 2Theologisch-ethische Grundlagen 
Sozialprofessionellen Handelns, Katholische Hochschule für Sozialwesen, 
Berlin, Germany, 3Centre for Tropical Medicine and Global Health, Nuffield 
Department of Clinical Medicine, University of Oxford, Oxford, United 
Kingdom
Clinical research involving randomised controlled trials is critical for 
advancing global health. However global health trials can evoke important 
ethical issues, particularly the use of placebo or non-intervention control 
arms. The issue has generated ethical consideration for many years, that 
hinges on the debate on “double standard of care”. We explore this 
through evaluation of the use of a placebo arm in the specific example 
of a large multicentred placebo-controlled, double-blinded, randomized 
trial to determine primaquine antirelapse efficacy in vivax malaria. The trial 
involves almost 2000 patients enrolled in Indonesia, Vietnam, Ethiopia, 
Pakistan and Afghanistan. There are three arms - chloroquine or an 
artemisinin combination therapy treatment plus either: 7 days primaquine 
, 14 days primaquine or 14 days placebo. The need for the study is 
justified in view of the poor evidence for the current WHO recommended 
regimen of 14 days primaquine. The ethical rationale for including a 14-
day placebo arm can be made on the grounds that the standard of care in 
most endemic countries does not include in reality widespread, routine use 
of primaquine. We argue that since there is equipoise among the study 
arms, the risk of being in the placebo arm is no greater than the risk of 
not being in the trial and that there are no double standards. This analysis 
complements others in literature with regards to the use of placebo or 
no intervention treatment arms, and highlights that such debate case be 
justified on its own merits rather than relying on general guidelines.
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INHALED NITRIC OXIDE IMPROVES NEUROCOGNITIVE 
OUTCOMES IN CHILDREN WITH SEVERE MALARIA AND 
LACTIC ACIDOSIS
Paul Bangirana1, Andrea L. Conroy2, Robert O. Opoka1, Michael 
Hawkes3, Laura Hermann4, Christopher Miller5, Sophie Namasopo6, 
Conrad W. Liles7, Chandy C. John2, Kevin C. Kain4
1Makerere University, Kampala, Uganda, 2Indiana University, Indianapolis, 
IN, United States, 3University of Alberta, Edmonton, AB, Canada, 
4University of Toronto, Toronto, ON, Canada, 5University of British 
Columbia, Vancouver, BC, Canada, 6Jinja Regional Referral Hospital, Jinja, 
Uganda, 7University of Washington, Seattle, WA, United States
Severe malaria is a leading cause of neurocognitive impairment in African 
children. Low levels of bioavailable nitric oxide (NO) are associated 
with severe malaria. Supplementation with inhaled NO (iNO) has been 
shown to be neuroprotective in term or near-term infants with persistent 
pulmonary hypertension but the neuroprotective actions of iNO have 
not been documented in systemic infections. This randomized, double-
blind, placebo-controlled trial compared the effect of inhaled nitric oxide 
(iNO) at 80ppm versus room air (placebo) on neurocognitive function 
in children with severe malaria treated with parenteral artesunate. 
Children aged 1 to 10 years received either iNO or placebo. Six months 
post-discharge, neurocognitive testing was performed to assess overall 
cognition, attention, associative memory, executive function, motor skills, 
language and visual reception. We compared test scores between the 
treatment arms and the frequency of impairment in all domains between 
the arms. At six months, 61 children in the iNO arm and 59 children in the 
placebo arm were evaluated. 35% of children had impairment (defined 
by a z-score ≤-2SD) in at least one domain. There were no significant 
differences in z-scores for overall cognition, attention, associative memory 
and executive function between iNO and the placebo group. Children 
receiving iNO were less likely to have multiple impaired domains (11.5% 
vs 25.4%, p=0.048) and to have fine motor impairment, relative to 
children receiving placebo (8.2% vs 22.0%, p=0.034). Subgroup analysis 
in children with acidosis at admission showed iNO was associated with 
improved attention (p=0.001), fine motor functioning (p=0.004), visual 
reception (p=0.028), receptive language (p=0.015), and overall cognitive 
function (p=0.009). Inhaled nitric oxide is associated with better cognitive 
outcomes in children with severe malaria presenting with acidosis.
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A RANDOMIZED TRIAL OF THE SAFETY OF LOW DOSE 
PRIMAQUINE IN THE TREATMENT OF G6PD NORMAL 
AND DEFICIENT ADULT PATIENTS WITH PLASMODIUM 
FALCIPARUM MALARIA IN SENEGAL
Roger C. Tine1, Khadime Sylla1, Doudou Sow1, Fatou B. Fall2, 
Magatte Ndiaye1, Babacar Faye1, Jean L. Ndiaye1, Mady Ba2, 
Kouakou Folly1, Oumar Gaye1
1University Cheikh Anta Diop, Senegal, Dakar, Senegal, 2National Malaria 
Control Program, Ministry of Health, Dakar, Senegal
WHO recommends the addition of a single dose of primaquine (0.25 mg 
base/kg) to artemisinin combination treatments (ACTs) as a component 
of pre-elimination or elimination programs. However, primaquine has 
been little used in Africa and there are concerns about its safety, as the 
drug can cause acute haemolytic anaemia in individuals with G6PD 
deficiency. This open randomised controlled trial was conducted to 
assess the safety of adding low-dose primaquine to the normal ACT 
regimen (AL, ASAQ, DHAP) in adult patients in Senegal. Patients with 
P. falciparum malaria (parasitaemia {1,000-100,000} trophozoites/µL) 
were randomized to receive treatment with ACT or ACT plus low-dose 
primaquine. Haemoglobin concentration was measured at enrolment, and 
on days 3, 7, 14, 21 and 28 post-treatment. G6PD status was determined 
for each patient using a qualitative field test (CareStart™). The primary 
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outcome was the change in haemoglobin concentration from day 0 to day 
7, which was compared between trial arms using analysis of covariance. 
Secondary endpoints included haemoglobin variation from day 0 to day 
28. Two hundred and seventy five patients (137 in the ACT arm and 138 
in ACT plus primaquine arm) were randomized. At enrolment, gender, 
mean weight, parasitaemia, haemoglobin, and prevalence of G6PD 
deficiency were similar in the two arms. Mean haemoglobin concentration 
on day 7, was similar in primaquine and control groups (11.9 and 12.1 
g/dL respectively). The difference in Hb concentration on day 7 in the 
primaquine group compared to controls after adjusting for Hb at baseline 
was -0.029 (95%CI -0.51,0.45) g/dL. Haemoglobin change at day 7 
was significantly associated with haemoglobin at enrolment, weight and 
gender. There was no evidence of an association with treatment drug, 
G6PD status, and parasiteamia at enrolment. Haemoglobin concentrations 
recovered and exceeded baseline level by day 28. The administration of 
single low dose primaquine (0.25 mg/kg) in addition to ACT treatment, 
to adult patients with acute P. falciparum malaria, is safe and does not 
induced significant drop in haemoglobin level both for G6PD normal and 
deficient individuals.
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MODERATE AND SEVERE LFT ELEVATIONS IN CONTROLLED 
HUMAN P. FALCIPARUM MALARIA INFECTION MODEL: 
RECENT EXPERIENCE, LITERATURE REVIEW AND 
MECHANISTIC HYPOTHESES
Stephan Chalon1, Samantha Akakpo1, Stephan Duparc1, Theresa 
Shapiro2, Paul Griffin3, James McCarthy3
1Medicines for Malaria Venture, Geneva, Switzerland, 2John Hopkins 
University, Baltimore, MD, United States, 3QIMR Berghofer Medical 
Research Institute, Brisbane, Australia
Controlled Human Malaria Infection (CHMI) in healthy subjects is a critical 
model in vaccine research and in profiling new chemical entities (NCEs). 
Documented laboratory changes induced by CHMI include mild benign 
liver function tests (LFT) elevations (<2.5xULN). In recent evaluations 
of antimalarial NCEs with the Plasmodium falciparum (P.f.) induced 
blood stage malaria (IBSM) model, we have observed cases of transient 
asymptomatic moderate/severe LFT elevations (2.6-10xULN). Among 
more than 174 healthy subjects tested in our P.f. IBSM studies with NCEs 
and approved antimalarials, 6 participants showed ALT/AST elevations of 
up to 10 x ULN. These cases were reported in two distinct studies (3/8 
subjects each) with two NCEs that were not identified as hepatotoxic in 
the initial Phase 1 studies. A liver safety review of 13 completed P.f. IBSM 
studies (7 approved antimalarials and 6 NCEs) and 44 published sporozoite 
challenge studies was performed. For sporozoite CHMIs, moderate/severe 
LFT elevations were also reported in a mosquito-bite study with a NCE 
(pafuramidine) in 6/19 subjects (4 active/2 placebo). Most of these subjects 
(including placebo) received acetaminophen with a highest cumulative 
dose of 17.5g. ALT elevations were generally higher than AST. For IBSM 
studies, only one subject showed bilirubin > 2xULN (potential Hy´s law 
reported as serious adverse event). Review of these cases by Drug-
Induced Liver Injury Experts suggest that these changes are likely to be 
multifactorial in origin with combined interaction of 3 possible causative 
factors: 1- Inflammatory state induced by CHMI, 2-Acetaminophen, 
3-NCE and additional risk factors (undiagnosed condition such as liver 
steatosis or alcohol consumption). Because these laboratory findings are 
not uncommon, specific safety provisions for the conduct of CHMI studies 
with NCEs during drug development are proposed. The recommendations 
for IBSM studies include preclinical hepatotoxicity profiling of the NCE, 
strengthened eligibility criteria, use of a positive control and symptomatic 
treatment with NSAIDs (ibuprofen) as a substitute to acetaminophen.
1541
HARMONIZATION OF A MULTI-CENTER ARTESUNATE-
MEFLOQUINE DOD CLINICAL EFFICACY STUDY FOR PATIENTS 
WITH UNCOMPLICATED PLASMODIUM FALCIPARUM 
MALARIA IN KENYA, PERU AND THAILAND
Emily D. Cisney, Brett M. Forshey
Armed Forces Health Surveillance Branch, Global Emerging Infections 
Surveillance and Response Section; Cherokee Nation Technology Solutions, 
Silver Spring, MD, United States
Artemisinin-resistant Plasmodium falciparum is of growing concern in 
Southeast Asia, with potential to spread to other P. falciparum endemic 
regions. To conduct surveillance for emerging artemisinin resistance in 
geographically distinct regions, the AFHSB-GEIS leveraged DoD laboratories 
in Kenya, Peru, and Thailand to coordinate a multi-center harmonized trial 
for artesunate-mefloquine efficacy, based on parasite clearance rates for 
72 hours after artesunate dosing, using a standardized approach based 
on WHO efficacy study methodology. Here we describe specific activities 
designed to improve synchronization and data comparability across 
study sites, as well as challenges and lessons learned. Participating DoD 
organizations jointly developed clinical and laboratory quality assurance 
programs and plans, study documents and case report forms, and a 
reciprocal monitoring strategy to facilitate harmonization across sites. 
Each site conducted self-monitoring and reciprocal monitoring of other 
sites’ progress for adherence to the clinical protocol and quality assurance 
plans. Microscopy proficiency testing was conducted at the initiation and 
evaluated at multiple points throughout the study. Data management was 
centralized among sites to ensure data integrity, including the reception 
of raw data, cleaning, querying, and producing complete datasets for 
analysis. Site personnel were trained in correctly populating clinical data 
from site-specific case report forms into harmonized case report forms for 
submission to a clinical data management system used to provide quality 
control. Challenges incurred included the removal of a participating site, 
protocol enrollment following evolving P. falciparum transmission patterns, 
and data submission technical difficulties. Future coordinated efforts will 
be directed at harmonized in vitro drug efficacy testing and genetic studies 
for markers of artemisinin resistance.
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DETERMINATION OF CYTOCHROME P-450 ISOENZYME 2D6 
(CYP2D6) GENOTYPES IN AN ACTIVE-DUTY U.S. MILITARY 
POPULATION AND THE PHARMACOGENOMIC IMPACT ON 
PRIMAQUINE METABOLISM
Michele Spring1, Jason W. Bennett2, Sean Marcsisin1, Christian 
Darko1, Jason Sousa1, Erin Milner1, Meshell Morrison3, Donna 
Tosh3, Kris Paolino3, Patrick Twomey1, James E. Moon1, Kristen 
Mills3, Adrian Kress1, Jeffrey Froude1, Thomas Oliver2, Mark 
Hickman1, Norman Waters1, Robert Paris1
1Military Malaria Research Program, Silver Spring, MD, United States, 
2Uniformed Services University of the Health Sciences, Bethesda, MD, 
United States, 3Department of Clinical Trials, Silver Spring, MD, United 
States
 Plasmodium vivax malaria is a leading cause of malaria in U.S. service 
members and radical cure therapy requires a 2-week course of primaquine 
(PQ) to eliminate the latent hypnozoites and prevent relapse infection. 
Cytochrome P450 isoenzyme 2D6 (CYP2D6) is a key enzyme involved 
in converting parent PQ into the active anti-malaria metabolite. Allelic 
polymorphisms determine CYP2D6 genotype, and these differences 
result in variations in enzyme activity or phenotype. CYP2D6 phenotypes 
are assigned based on expected impact of enzyme activity on drug 
metabolism: no activity (Poor Metabolizers (PM)), decreased activity 
(Intermediate Metabolizers (IM)), normal activity (Extensive Metabolizers 
(EM)), and increased activity (Ultra rapid Metabolizers (UM)). Given the 
risk of P. vivax infection in U.S. Service members deployed to endemic 
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areas, we sought to characterize the prevalence of CYP2D6 genotypes and 
associated phenotypes of the enzyme in this population. Approximately 
450 active duty personnel underwent CYP2D6 genotyping by a 
multiplexed cytometric bead array assay, Luminex xTAG® CYP2D6 Kit v3 
(Austin, TX) allowing for detection of the major alleles in the United States: 
1,2,3,4,5,6,7,8,9,10,11,15, 17,29, 35,41. A subset of volunteers were 
administered a one-time oral dose of 30 mg PQ. Blood and urine were 
collected at various timepoints in order to measure concentrations of PQ, 
carboxyprimaquine, and phenolic metabolites by ultra-performance liquid 
chromatography with mass spectrometry (UPLC-MS) and determine the 
pharmacokinetic (PK) parameters. The results of CYP2D6 genotypes and 
the effect of CYP2D6 phenotype on PQ metabolism will be presented. 
Results from this study will inform both DoD force health protection policy 
for the use of primaquine and future prospective in vivo studies of anti-
relapse treatment of P. vivax infection.
1543
THE ROLE OF PRIVATE HEALTH CARE PROVIDERS IN 
ACHIEVING MALARIA ELIMINATION IN ACEH BESAR 
DISTRICT
Herdiana Herdiana1, Juanita Juanita2, Siti K. Nasution2
1University of Queensland, Brisbane, Australia, 2Universitas Sumatera 
Utara, Medan, Indonesia
Malaria elimination is a goal of the Government of Indonesia. The District 
of Aceh Besar has promulgated Regent’s Regulation No. 23/2013 which 
formally commits to achieve elimination by 2015. However, the role of 
private health care providers in progressing towards malaria elimination 
has not been identified. A survey of six types of private health care 
providers through a simple random sampling method has been conducted. 
Primary and secondary data were collected from 153 providers from 
March to August 2014 on occupational characteristics, availability of 
malaria-related supplies, knowledge of malaria, and involvement in the 
malaria elimination program. Data analysis was done using Chi-Square 
test and logistic regression with EPI Info version 7. The result showed 
that educational background (p=0,045), participation in malaria training 
(p=0,004), occupational characteristics (p=0,004) and knowledge of 
malaria (p<0,001) were associated with involvement in malaria elimination 
program. Additionally, roles of private health care providers in malaria 
elimination were predominantly influenced by having good knowledge of 
malaria (OR 8.1; 95% CI 3.8-17.5) and participation in malaria training 
(OR 2.7; 95% CI 1.2-6.3). The contribution private providers to officially 
reported data for 2013 showed that, 13.5% of suspected malaria cases 
were laboratory-confirmed, 7.4% of malaria cases were treated by 
ACT, and 5.6% malaria cases treated were reported to government. At 
pharmacies and drug stores, an average of 4 people sought medication for 
malaria daily, with pharmacies selling a mean of 38 Chloroquine tablets 
monthly. Private health care providers play a pivotal role in diagnosis, 
treatment, prevention and recording-reporting of malaria in area moving 
toward malaria elimination. The private providers in Aceh Besar falls far 
short of standards for diagnosis, treatment and reporting set by the public 
section. This highlights the need for established of an effective public-
private network to ensure adherence to standards, effective monitoring, 
and good communication.
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VILLAGE MALARIA WORKER PERFORMANCE KEY TO THE 
ELIMINATION OF ARTEMISININ-RESISTANT MALARIA: A 
WESTERN CAMBODIA HEALTH SYSTEM ASSESSMENT
Sara E. Canavati1, Saranath Lawpoolsri2, Cesia E. Quintero3, Po 
Ly4, Chea Nguon4, Sasithon Pukrittayakamee5, David Sintasath6, 
Pratap Singhasivanon2, Koen Peeters Grietens7, Maxine Anne 
Whittaker8
1Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, 
Mahidol University/Centre for Biomedical Research, Burnet Institute, 
Bangkok/Melbourne, Cambodia, 2Department of Tropical Hygiene, 
Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand, 
3Centre for Biomedical Research, Burnet Institute, Melbourne, Australia, 
4The National Center for Parasitology, Entomology and Malaria Control, 
Ministry of Health, Phnom Penh, Cambodia, 5Department of Clinical 
Tropical Medicine, Faculty of Tropical Medicine, Mahidol University/
Centre for Biomedical Research, Burnet Institute, Bangkok, Thailand, 
6Malaria Consortium Asia, Faculty of Tropical Medicine, Mahidol University, 
Bangkok, Thailand, 7Medical Anthropology Unit, Department of Public 
Health, Institute of Tropical Medicine, Antwerp, Belgium/School of Tropical 
Medicine and Global Health, Nagasaki University, Nagasaki, Japan/Partners 
for Applied Social Sciences (PASS) International, Antwerp/Japan, Belgium, 
8College of Public Health, Medical and Veterinary Sciences; Division 
of Tropical Health and Medicine; James Cook University, Townsville, 
Queensland, Australia/The University of Queensland School of Public 
Health, Herston, Queensland, Australia
Village Malaria Workers (VMWs) and Mobile Malaria Workers (MMWs) 
are a critical component of Cambodia’s national strategy to eliminate 
Plasmodium falciparum malaria by 2025. Since 2004, VMWs have been 
providing malaria diagnosis through the use of Rapid Diagnostic Tests 
(RDTs), and free-of-charge Artemisinin-based Combination Therapies 
(ACTs) in villages more than 5 kilometres away from the closest health 
facility. This study aimed to assess the job performance of VMWs/MMWs, 
and identify challenges they face, which may impede elimination efforts. 
Methods. A mixed-methods assessment was conducted in five provinces 
of western Cambodia. 185 VMW/MMW participants were surveyed using 
a structured questionnaire. Qualitative data was gathered through a total 
of 60 Focus Group Discussions (FGDs) and 65 In-depth Interviews (IDIs). 
Data triangulation of the qualitative and quantitative data was used 
during analysis. Overall, VMWs/MMWs met or exceeded the expected 
performance levels (80%). Nevertheless, some performance gaps were 
identified. Misconceptions regarding malaria transmission and prevention 
were found among workers. The recommended approach for malaria 
treatment, Directly Observed Treatment (DOT), had low implementation 
rates. Stock outs, difficulties in reaching out to Migrant and Mobile 
Populations (MMPs), insufficient means of transportation and dwindling 
worker satisfaction also affected job performance. VMW/MMW job 
performance must be increased from 80% to 100% in order to achieve 
elimination. In order to do this, it is recommended for the national malaria 
program to eliminate worker malaria knowledge gaps. Barriers to DOT 
implementation and health system failures also need to be addressed. The 
VMW programme should be expanded on several fronts in order to tackle 
remaining performance gaps. Findings from this evaluation are useful to 
inform the planning of future activities of the programme and to improve 
the effectiveness of interventions in a context where artemisinin drug 
resistance is a significant public health issue.
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DESIGNING MALARIA ELIMINATION STRATEGIES TO 
ACHIEVE HIGH COMMUNITY UPTAKE: FINDINGS FROM A 
FORMATIVE RESEARCH STUDY IN THE DEPARTMENT OF 
GRAND ANSE, HAITI
Katherine M. Andrinopoulos1, Thomas Druetz1, Jean-Frantz 
Lemoine2, Louis-Marie Boulos3, Michaëlle L. Boulos3, Gregory 
Noland4, Madsen Beau De Rochars5
1Tulane School of Public Health and Tropical Medicine, New Orleans, LA, 
United States, 2Programme National de Contrôle de la Malaria, Port-au-
Prince, Haiti, 3Centre d’Évalauation et de Recherche Appliquée, Port-au-
Prince, Haiti, 4The Carter Center, Atlanta, GA, United States, 5University of 
Florida, Gainesville, FL, United States
The success of malaria elimination efforts depends on high community 
acceptance and uptake of effective interventions. This is particularly 
challenging in low transmission settings, such as Haiti, where malaria is 
one of many competing health issues. Haiti has taken on the ambitious 
goal of eliminating malaria by 2020. To do so, aggressive strategies 
such as targeted mass drug administration (MDA) will likely be used. 
We conducted formative research to inform the design of elimination 
strategies using qualitative methods. Key informant interviews (n=6), in-
depth interviews (n=9), and focus group discussions (n=7) were conducted 
from December 7-19 of 2015 with purposefully selected health agents, 
traditional healers, community leaders, and community members. Data 
were transcribed, coded and analyzed in relation to emergent themes. 
Findings indicate that elimination strategies should include multiple actors 
from the Haitian pluralistic health system. Results from social influence 
mapping suggest formal healthcare providers, as well as ‘Hougans’ 
[voodoo priests], would influence community uptake of interventions. 
Incentives and disincentives for both groups related to the goal of malaria 
elimination, and for working collaboratively, should be addressed. It is 
important to leverage community resources including community leaders 
(teachers, priests) and organizations (churches, social aid clubs, schools) so 
that positive messaging is reinforced across multiple sources, and uptake 
is modeled by appropriate social influences. This is especially important for 
harder-to-reach populations including youth and men. The intervention 
should prospectively target misinformation and rumors that may develop 
concurrent with roll-out. Uptake may benefit from ongoing monitoring of 
community perceptions during implementation of elimination strategies, 
and coupling traditional social marketing and communication techniques 
with social network strategies. Results from Haiti will likely have broader 
implications for other low transmission settings aiming to eliminate 
malaria.
1546
TARGETED COMMUNITY SENSITIZATION TO REDUCE 
ANTICIPATED REFUSALS IN MALARIA MASS DRUG 
ADMINISTRATION TRIAL: LESSONS LEARNED FROM 
SOUTHERN ZAMBIA
Elizabeth Chiyende, Kafula Silumbe, Chilumba Sikombe, 
Elisabeth Wilhelm, Todd Jennings, John M. Miller
PATH MACEPA, Lusaka, Zambia
The Zambia National Malaria Control Programme has embarked on an 
ambitious goal of eliminating malaria in Southern Province of Zambia and 
nationally by 2020. One component to accelerate toward the elimination 
goal includes selective use of mass drug administration (MDA) with 
dihydroartemisinin piperaquine (DHAp). As part of a recent trial to evaluate 
the effectiveness of MDA, 20 randomized health facility catchment areas 
were wholly targeted for this community based treatment strategy. 
In anticipation of research-based field activities, several community 
sensitization activities were conducted to promote the uptake of MDA 
at community, household, and individual levels in 2014 and 2015. High 
coverage was deemed essential to the effectiveness of MDA and refusals 
were monitored closely through household surveys carried out during 
treatment campaigns associated with the trial interventions. Brochures and 
job aids were pretested and targeted to community members and local 
leaders who might influence trial participation and treatment adherence. 
Radio scripts were developed, translated into the local language, and 
aired on local community radio stations as a program with recognizable 
jingles. Community entry meetings scheduled through the chief’s palace 
ensured community members could hear directly from their local MOH 
staff about the study, have their questions answered, and enjoy drama 
group performances which emphasized key messages with the audience. 
Campaign surveys indicated the perceived benefits of participation usually 
outweighed possible hesitation. Refusal rate among those found at the 
households at the time of the campaign visits was only 2%. The greatest 
share of any incomplete coverage was attributed to absent household 
members. Effective community sensitization is key for successful 
implementation of treatment campaigns. Understanding and working 
through local community structures which are respected by community 
members, engaging traditional leaders, and working through local district-
level health staff for community meetings all played a central part in 
achieving high levels of participation.
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SCHOOL-AGE CHILDREN ARE DISPROPORTIONATELY 
IMPORTANT PLASMODIUM FALCIPARUM TRANSMISSION 
RESERVOIRS IN SOUTHERN MALAWI
Jenna E. Coalson1, Lauren M. Cohee2, Andrea G. Buchwald2, Karl 
Seydel3, Terrie E. Taylor3, Miriam K. Laufer2, Mark L. Wilson1
1University of Michigan, Ann Arbor, MI, United States, 2Division of Malaria 
Research, Institute of Global Health, University of Maryland School 
of Medicine, Baltimore, MD, United States, 3Blantyre Malaria Project, 
University of Malawi College of Medicine, Blantyre, Malawi
Growing evidence from highly endemic malaria settings shows that 
Plasmodium falciparum infection prevalence peaks among school-age 
children (5-15 years old). These infections are frequently low density and 
asymptomatic, with less frequent antimalarial treatment-seeking than for 
younger children. The importance of school-age children to transmission 
persistence remains unknown. We evaluated the transmission contribution 
potential of young children, school-age children, and adults with data 
from southern Malawi. Six cross-sectional surveys were carried out in ~900 
households from three districts at the end of the rainy and dry seasons 
of 2012 to 2014. To estimate the relative age-specific contributions to P. 
falciparum transmission, we populated simple mathematical models with 
data on population age distribution, PCR-based parasite prevalence and 
densities, gametocyte presence and density by qRT-PCR, and mosquito 
biting risk as modified by ITN use. Approximately 74.6% of gametocyte 
infections during the dry season and 57.9% during the rainy season are 
estimated to be among school-age children. While young children were 
more likely to have higher density infections by microscopy, infections 
among school-age children were the most likely to be gametocytemic, and 
age group was not significantly associated with density of gametocytes 
among gametocytemic individuals. Even if only half of gametocyte 
infections among school-age children and adults are assumed to be 
infectious, school-age children represent 68% of the infectious human 
population during the rainy season, and 52% during the dry season. 
Furthermore, in our survey, school-age children were less likely to sleep 
under bed nets than either adults or young children, and thus less 
protected from Anopheles feeding. When incorporating heterogeneity in 
ITN use, school-age children represent 82% of the gametocyte infections 
that are available for biting during the dry season, and 66% during the 
rainy season. Interventions that do not reach school-age children are 
unlikely to interrupt transmission in this and other highly endemic settings.
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MALARIA ELIMINATION CHALLENGES IN MESOAMERICA: 
EVIDENCE OF SUBMICROSCOPIC MALARIA RESERVOIRS IN 
GUATEMALA
Shirley Evelyn Lennon1, Adolfo Miranda2, Juliana Henao1, 
Andres F. Vallejo1, Julianh Perez1, Alvaro Alvarez1, Myriam Arévalo3, 
Sócrates Herrera4
1Malaria Vaccine and Drug Development Center (MVDC), Cali, Colombia, 
2Instituto Nacional de Estadisticas, Guatemala City, Guatemala, 3Health 
School, Universidad del Valle, Cali, Colombia, 4Caucaseco Scientific 
Research Center, Cali, Colombia
Although Guatemala remains one of the countries with higher malaria 
transmission in Mesoamerica, its incidence has decreased substantially 
since 2000. Guatemala is committed to eliminating malaria as part of the 
Malaria Elimination in Mesoamerica and the Hispaniola Island (EMMIE) 
initiative and is still in the control phase. During the past decade, the 
government strengthened malaria control activities, including mass 
distribution of long lasting insecticide impregnated bed nets, early 
diagnosis and prompt treatment. This study aimed to determine the 
prevalence of malaria in three areas of Guatemala using active case 
detection and molecular diagnostic tools that are more sensitive than 
microscopy. Cross-sectional surveys were conducted in three departments 
with varying transmission intensities; Escuintla, Alta Verapaz and Zacapa. 
Blood samples from 706 volunteers were screened for malaria using 
microscopy and quantitative polymerase chain reaction (qPCR) which was 
also used to determine the prevalence of gametocytes among infected 
individuals. Malaria was only diagnosed by microscopy in 2.8% (4/141) of 
the volunteers from Escuintla. By contrast, qPCR detected a prevalence of 
7.1% (10/141) in the same volunteers, 8.4% (36/429) in Alta Verapaz, and 
5.9% (8/136) in Zacapa. Overall, 7.6% (54/706) of the screened individuals 
were positive, with an average parasitemia level of 40.2 parasites/µl (range 
1-1133 parasites/µl), and 27.8% (15/54) carried mature gametocytes. A 
total of 57.4% (31/54) of qPCR positive volunteers were asymptomatic 
and out of the 42.6% (23/54) of symptomatic individuals, only one had a 
positive microscopy result. A considerable number of asymptomatic P. vivax 
infections, mostly submicroscopic and with a proportion harboring mature 
gametocytes, was found in Guatemala. This pattern is likely contributing 
to the maintenance of transmission across the region. Robust surveillance 
systems, molecular diagnostic tests and tailored malaria detection activities 
in each endemic site may prove to be imperative in accelerating malaria 
elimination in Guatemala and possibly across all of Mesoamerica.
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ZAMBIA’S NATIONAL STRATEGY TO MOVE FROM 
ACCELERATED BURDEN REDUCTION TO MALARIA 
ELIMINATION BY 2020
Busiku Hamainza1, Mutinda Mudenda1, John Miller2, Ruben 
Conner3, Hana Bilak4, Duncan Earle2, Hannah Slater5, Patrick 
Walker5, Azra Ghani5, Elizabeth Chizema Kawesha6, Peter Mwaba6
1National Malaria Control Program, Lusaka, Zambia, 2PATH, Lusaka, 
Zambia, 3PATH, Seattle, WA, United States, 4PATH, Geneva, Switzerland, 
5Imperial College, London, United Kingdom, 6Ministry of Health, Lusaka, 
Zambia
Zambia has made substantial progress addressing malaria and in many 
districts, malaria incidence has been reduced to levels where interruption 
of transmission may be feasible. This has been achieved through the 
commitment of national and local governments, keen interest among 
partners, momentum of scientific advances, and establishment of 
mechanisms to ensure proper coordination of activities with neighboring 
countries. Through a multi-stakeholder engagement process, Zambia has 
developed its first-ever National Malaria Elimination Strategy with the 
vision of eliminating malaria by 2020. All districts will be covered through 
a stratified step-wise approach based on a package of interventions 
addressing local transmission levels. The cornerstone of the strategy is 
the use of real-time, sensitive surveillance systems to detect, characterize 
and monitor all cases, at the health facility and community levels. As 
the first step, through a strong routine surveillance system, Zambia 
classified all districts according to their level of malaria transmission 
based on confirmed cases per 1000 population (Levels 0, 1-49, 50-199, 
200-499,>500 case per 1000). The next step relies on optimizing vector 
control and case management—addressing current and local transmission 
intensities with the most appropriate and targeted population coverage 
of available interventions. To accelerate to elimination in selected areas, 
population-wide strategies to clear parasites using effective antimalarial 
drugs (such as mass drug administration) will be used in a time-limited 
manner, with the objective of bringing transmission down to a level where 
individual cases and small transmission foci can be appropriately managed 
through case investigation and community case management. Modeling 
suggests that this strategy will significantly reduce malaria across the 
country by 2020 and that regional collaboration will be key to sustaining 
success. Cost estimates will be presented for different scenarios, making 
the financial case for investing in malaria elimination in Zambia.
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TRANSITIONING AN EVIDENCE-BASED MALARIA MASS 
DRUG ADMINISTRATION (MDA) RESEARCH STRATEGY TO 
PROGRAM/ROUTINE MODE: FACTORS FOR CONSIDERATION
Kafula Silumbe1, Tim P. Finn2, Busiku Hamainza3, Victor Chalwe4, 
Hawela Moonga3, Travis Porter2, Mulakwa Kamuliwo5, Elizabeth 
Chizema Kawesha6, John Miller1, Richard W. Steketee7, Thom P. 
Eisele2
1PATH, Lusaka, Zambia, 2Tulane University, New Orleans, LA, United States, 
3National Malaria Control Program, Lusaka, Zambia, 4Institute for Medical 
Research and Training, Lusaka, Zambia, 5National Malaria Control Center, 
Lusaka, Zambia, 6Ministry of Health, Lusaka, Zambia, 7PATH, Seattle, WA, 
United States
The Zambia National Malaria Control Programme conducted a large-scale 
(60 health facility catchment areas serving nearly 330,000 participants) 
community randomized controlled trial to evaluate the effectiveness 
of treatment strategies on accelerating malaria elimination. The trial 
strategies included: mass drug administration (MDA), where all eligible 
individuals were treated with dihydroartemisinin-piperaquine (DHAp), and 
focal MDA (fMDA) where all eligible individuals residing in a household 
with at least one RDT positive member were treated with DHAp. Four 
treatment campaign rounds (two each year) were conducted during 
late dry season and early rainy season between December 2014 and 
February 2016. Informed by successful implementation of the trial, the 
new National Malaria Elimination Strategy 2016−2020 includes MDA as a 
key intervention. Reflecting on the successes and challenges of the recent 
MDA campaigns, this poster presents essential elements that implementers 
should consider when planning malaria MDA interventions. Trainings, 
logistics, and procurements were organized by health facility catchment 
area for decentralized operational management. Catchment teams were 
trained with household lists and maps for spatial orientation to maximize 
work flow and population coverage. Adverse event monitoring and post-
marketing pharmacovigilance were conducted. Community mobilization 
was a prerequisite to maximize local participation. Diverse stakeholder 
groups were engaged for appropriate community authorization and 
access. Despite exclusion of children less than 3 months of age and 
women in early pregnancy, the trial achieved coverage rates as high as 
87% and refusal rates among individuals present of less than 2% during 
house-to-house visits. Results from programme implementation experience 
will be presented in comparison to the trial methods.
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INCLUDING MOST-AT-RISK POPULATIONS IN HEALTH 
PROGRAM PLANNING AND IMPLEMENTATION: AN 
INTERCULTURAL COMMUNICATION FRAMEWORK TO 
SUPPORT MALARIA ELIMINATION AMONGST INDIGENOUS 
PEOPLES IN THE AMERICAS
Julie N. de Carvalho
Links Media, Rockville, MD, United States
Central American countries need to improve malaria interventions with 
indigenous communities in order to eliminate malaria by 2020. A 2014 
Amazon Malaria Initiative needs assessment found that national malaria 
control programs (NMCPs) in Central America had difficulty reaching 
these most-at-risk populations. Three cases in which malaria incidence had 
decreased in indigenous communities over the past 10 years were selected 
for further study. From 2015-2016, a literature review and in-depth, semi-
structured interviews were conducted to examine intercultural approaches 
that may have contributed to lower malaria incidence in the selected 
communities. Approval to conduct interviews was granted by the Pan-
American Health Organization and NMCPs of the Guatemalan, Honduran, 
and Panamanian ministries of health. In a Miskito community in Gracias a 
Dios Department, the Honduran NMCP worked with community members 
to achieve 100% coverage of a campaign to distribute and install long-
lasting insecticidal nets. From June 2010 to June 2011, a reduction from 
337 to 60 malaria cases was observed. In Bisira, in the Ngöbe-Buglé 
comarca of Panama, after the implementation of indigenous participation 
in health decision-making and environmental sanitation work, malaria 
cases fell from 71 in 2004 to zero cases by 2008. In the department of 
Alta Verapaz, Guatemala, local health authorities used a mobile phone 
system to improve surveillance, timely diagnosis, and treatment of malaria 
with the Q’eqchi Maya population. Findings were that the interventions 
studied prioritized community awareness and participation, integration of 
local languages, intercultural capacity development of health professionals, 
and adaptive design and implementation of culturally appropriate malaria 
interventions. The authors developed an intercultural communication 
framework based on best practices from the three cases. The resulting 
framework enables the adaptation of best practices to other contexts, in 
order to collaborate effectively with indigenous populations on malaria 
and meet the 2020 elimination target.
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ADVERSE EVENT REPORTING FROM MALARIA MASS DRUG 
ADMINISTRATION ROUNDS CONDUCTED IN SOUTHERN 
ZAMBIA
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The National Malaria Control Center of the Ministry of Health of Zambia 
is conducting a large-scale mass drug administration (MDA) community 
randomized controlled trial to evaluate the effectiveness of different MDA 
strategies on reducing malaria infections. The trial involved two strategies: 
MDA, where all eligible individuals were treated with dihydroartemisinin—
piperaquine (DHAp), and focal MDA (fMDA), where all eligible individuals 
residing in a household with at least one RDT-positive member were 
treated with DHAp. Implementing MDA at such a large scale provides an 
opportunity to document the extent to which potential safety issues are 
reported or adverse events occur given the level of exposure to treatments. 
Field teams composed of community health workers, enumerators, and 
adherence monitors, and supervised by facility-based staff, received 
standardized training on the treatment campaign procedures, use of DHAp 
for eligible consenting participants, adverse event monitoring, grading of 
events, and emergency and event handling procedures.. Adverse events 
were recorded on standard forms and in line with recommendations from 
national pharmacovigilance network recommendations. The principle 
aim of this data collection activity was to document and follow up on all 
adverse events (AEs) and serious adverse events (SAEs) occurring during 
the course of implementing the MDA trial for individuals taking DHAp and 
reporting an adverse event to a catchment team member or local health 
facility. During 4 rounds of MDA community-based teams recorded all 
adverse events related to taking of DHAp. During the first two intervention 
rounds, over 280,638 participants were tested and 159,696 were treated 
with DHAp in 40 health catchment areas. A total of 687 AEs (0.24% of 
participants and 0.43% of treatments) were reported; one was recorded 
as a serious AE. The most common AE reported during the campaigns 
was stomach pains, followed by dry cough and vomiting; details and 
characteristics of persons with AEs will be reported. During this large MDA 
trial, the use of DHAp for malaria treatment was generally well tolerated.
1553
THE ROLE OF THE PRIVATE SECTOR IN SURVEILLANCE FOR 
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Hispaniola, an island in the Caribbean home to Haiti and the Dominican 
Republic (DR), is targeting malaria elimination by 2020. If accomplished, 
this binational goal would create a malaria-free zone across the Caribbean. 
Haiti bears the majority of the malaria burden with >95% of the total 
malaria cases on the island. A key priority for achieving elimination will 
be ensuring that all malaria cases are diagnosed and reported in a timely 
fashion. However, it is thought that many individuals with fever first 
seek care in both the formal and informal private health sectors, and 
there is limited information on how best to engage the private sector 
in Hispaniola in effective malaria case management and reporting. This 
project aimed to gain a better understanding of the private sector to 
inform both governments and partners on how to effectively integrate 
the private sector in malaria case reporting systems, and align private 
sector activities with national policies. A mixed-methods research design 
was used, comprised of a literature review, focus groups, and semi-
structured interviews with key informants, private providers, and patients 
seeking care for fever. Private health sector is diverse and includes formal 
private, non-governmental, and mission hospitals and clinics, and informal 
shops, street vendors, and traditional healers. Preliminary results suggest 
that while the informal private sector is more utilized for care in Haiti 
than in the DR, in neither country does this sector have sufficient access 
to rapid diagnostic tests to confirm malaria cases, and to the national 
treatment strategy. In Haiti, care-seeking behavior is strongly influenced 
by spirituality, and those with more severe symptoms will often visit a 
traditional healer before they go to the formal sector. In the DR, visiting 
a traditional healer for a fever is not common, unless the cause is unable 
to be determined by a doctor. Traditional healers in both countries report 
referring patients with fever to formal healthcare facilities and would like 
to be more formally linked.
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The Governments of Ethiopia and Senegal are working toward achieving 
malaria-free zones in specifically targeted regions. Accurate, routinely 
reported information on malaria case rates is required to direct appropriate 
strategies to achieve this goal and to monitor progress. We assessed 
the accuracy of a rapid reporting system, with weekly malaria case rates 
reported to DHIS 2, in 2013 and 2014 at 20 health posts in Amhara 
Region, Ethiopia and at 13 health posts in Kanel, Linguère, and Ranérou 
districts in northern Senegal. Data on RDT-confirmed and treated malaria 
cases were extracted from paper registers at the health posts, including 
date of diagnosis, malaria RDT result, age, and area of residence Data from 
source records were compared to data reported in DHIS 2 during the 2013 
and 2014 transmission seasons. In Ethiopia according to source records, 
the average weekly incidence of malaria per 1000 population across all 
20 health posts was 0.85 (95% CI, 0.29-1.41) and 0.61 (95% CI, 0.02-
1.21) during the major transmission seasons (September-November) in 
2013 and 2014, respectively. The mean difference between DHIS 2 and 
source records in the number of malaria cases reported per week across 
all health posts was 1.33 (95% CI, 0.79-1.87) in 2013 and 0.17 (95% CI, 
-0.52-1.82) in 2014. In Senegal according to source records, the average 
weekly incidence of malaria per 1000 population across all 13 health 
posts was 53.08 (95% CI, 30.4-75.76) and 23.58 (95% CI, 12.94-34.22) 
during the major transmission seasons (July-January) in 2013 and 2014, 
respectively. The mean difference between DHIS 2 and source records in 
the number of malaria cases reported per week across all health posts 
was 1.86 (95% CI, 0.42-3.29) in 2013 and 0.22 (95% CI, -1.1-0.66) in 
2014. Malaria cases by age (<5 and ≥5 years) and species in DHIS 2 had 
varying degrees of accuracy to source records. Travel history could not be 
ascertained from source records for most cases. Routine monitoring of 
the discordance between DHIS 2 data and source records combined with 
targeted retraining in health posts with higher levels of discordance may 
result in substantial improvement in the accuracy of DHIS 2 data.
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Malaria is among the major health problems in Ethiopia. Two Malaria 
Indicator Surveys (MISs) were conducted in 2007 and 2011 to measure 
the coverage and utilization of key malaria interventions, malaria 
parasitemia, and anemia. These surveys assessed the progress on scale-up 
of malaria prevention and control interventions. A follow up MIS 2015 
was conducted between September and December 2015 to measure 
attainment of goals set in the 2011-2015 national malaria strategic 
plan. MIS 2015 was a population-based cross-sectional household (HH) 
survey. Two stage cluster probability sampling was used to select 555 
enumeration areas from all malarious areas of Ethiopia. The survey 
followed standardized MIS guidelines that included the household and 
women’s questionnaires that were uploaded on to smart phones using 
the Open Data Kit platform with GPS capability. A total of 100,159 HHs 
were mapped and 13,875 HHs were randomly selected. Overall, 64% of 
HHs had at least one long-lasting insecticidal net (LLIN) with an average of 
1.8 LLIN per household; 32% of HH achieved universal coverage (1 LLIN 
per 2 persons). IRS had been conducted in 29% of HHs in the 12 months 
preceding the survey and 71% of HHs in malarious areas were protected 
by either a LLIN or IRS. Of children less than five years of age (U5), 45% 
slept under a LLIN the night before the survey, and 70% slept under a LLIN 
if the HH owned at least one LLIN. These figures were 43% and 71%, 
respectively, for pregnant women. Sixteen percent of children U5 had 
history of fever in the two weeks preceding the survey; of these, 38% 
sought medical attention within 24 hours of fever onset and 89% took an 
antimalarial drug. Malaria parasite prevalence in areas <2,000m was 0.6% 
by microscopy blood-slide examination and 1.4 % by rapid diagnostic test 
with regional variation. The results of the current survey document the 
sustained gains in malaria control in Ethiopia while highlighting gaps in 
current utilization of interventions.
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The Zambian National Malaria Control Center (NMCC) has embarked upon 
an elimination strategy in Southern Province and has recently conducted 
a community randomized trial to compare the effectiveness of mass 
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drug administration (MDA) and focal mass drug administration (fMDA; 
treating all persons in households with any rapid diagnostic test (RDT) 
positives) using dihydroartemisinin-piperaquine (DHAp) to standard of 
care interventions. In this setting we enrolled individuals into a prospective 
cohort in December 2014 during the first mass treatment round to assess 
community infection incidence over a 12 month follow-up period and 
evaluate the impact of MDA and fMDA. After clearing all identified malaria 
infections, the cohort consisted of monthly follow-up on 2,250 individuals 
from 60 health facility catchment areas and collection of parasite infection 
samples using RDTs and dried blood spots for molecular testing, fever and 
travel history, intervention coverage, and other risk factor data. Monthly 
entomological data were collected at a sample of cohort households, and 
monthly climate and environmental data linked to each cohort-month. 
A total of 1,388 individuals under 20 years of age and 750 20 and older 
were successfully enrolled. Cumulative infection incidence by RDT was 
highest for children under 5 (0.060 infections per person-month), and 
lowest for individuals 20 years and older (0.028 infections per person-
month). Infection prevalence was highest in December 2014 preceding the 
start of the trial (7.2%) and lowest in October 2015 following the third 
MDA and fMDA round (1.4%). Cumulative infection incidence following 
trial implementation was lowest in the MDA arm (0.031 infections per 
person-month), highest in the control arm (0.048 infections per person-
month), and intermediate in the fMDA arm (0.037 infections per person-
month). Infection incidence in Southern Province has been reduced to the 
point where case-based elimination surveillance strategies are warranted: 
health facilities can now move to community case management and case 
and foci investigations and response to sustain these gains and seek local 
elimination.
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health facilities can now move to community case management and case 
and foci investigations and response to sustain these gains and seek local 
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SURVEILLANCE SYSTEMS FOR ELIMINATION: LESSONS FROM 
RAPID REPORTING ACROSS FOUR COUNTRIES
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Data-driven decision-making in national malaria control programs in Africa 
is critical for the efficient use of resources across countries with diverse 
malaria burden. Despite the need for improved information, routine 
malaria surveillance throughout sub-Saharan Africa is known to have 
many challenges including under-representation of the true burden of 
malaria circulating in communities, as well as lacking quality and timely 
data reporting. As malaria control programs pursue malaria elimination, 
timely, reliable data becomes crucial to respond to potential resurgence 
and to target malaria transmission foci with appropriate interventions. 
During the past five years our project team worked with national malaria 
control programs in Ethiopia, Kenya, Senegal and Zambia to support 
different forms of electronic, paper-based and blended malaria surveillance 
systems. In Ethiopia the system covered 213 health facility catchment areas 
(HFCAs) in eight woredas; In Kenya the system covered 25 HFCAs in one 
sub-county; in Senegal the system covered 212 HFCAs in 3 regions; and 
in Zambia the system covered 446 HFCAs in three provinces. We assessed 
different attributes and characteristics of deploying each of the systems, 
looking at the barriers and facilitators to improving system functionality 
(quality and timeliness), the performance and ultimately the use of data 
by national and subnational decision makers in each country over a two 
year period. We explored different drivers of system deployment including 
organizational culture, technical infrastructure, data collection, storage and 
reporting processes and existing talent and skills of users in each country 
context. Our findings suggest that the selection of open source platforms 
such as DHIS2 and ODK and the training and mentoring of local staff at 
all levels can lead to a well-supported system that can produce quality 
information for decision making; we will further delineate the critical 
system components in the presentation.
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DEVELOPMENT OF A CLOUD-BASED DISEASE SURVEILLANCE 
AND RISK MAPPING (DISARM) PLATFORM FOR MALARIA 
ELIMINATION SETTINGS - CHALLENGES FROM AN IT 
PERSPECTIVE
Felix Holl, Fitti G. Weissglas, Alemayehu Midekisa1, Jonathan 
Smith, Adam Bennett, Hugh J. Sturrock
University of California San Francisco, San Francisco, CA, United States
In 2015, there were around 214 million cases of malaria and 438 000 
deaths. Malaria control efforts have cut the number of deaths in half. 
Despite the enormous burden of on sub-Saharan Africa, 90% of all 
malaria deaths in 2015, a number of countries on the continent are 
pursuing malaria elimination efforts.1 The ability to track and target 
malaria transmission is vital to the success of malaria elimination 
programs, especially in elimination settings, where transmission is rare and 
clustered.2 The DiSARM platform pulls surveillance and intervention data 
in real-time, combines it with climate and environmental data, automates 
analyses by running spatial models in Google Earth Engine, and produces 
risk & decision-support maps. A key feature of the platform is that 
non-experts can run spatial models to produce risk maps. After piloting 
DiSARM in Swaziland and Zimbabwe, the goal is to introduce the platform 
to all Elimination Eight countries in southern Africa. The development 
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of DiSARM involves a number of steps, which have already taken place 
or are scheduled for this year, an in-depth evaluation of current malaria 
surveillance data processing, in-country implementation in pilot countries 
and development of platform based on pilot findings. A major barrier to 
implementing DiSARM is that malaria surveillance systems are set up for 
reporting and monitoring & evaluation. Data are often transferred to the 
surveillance system in aggregate and transfer intervals are long and often 
manual. Both proprietary surveillance systems and widely used surveillance 
platforms like District Health Information Software are common. A process 
for implementing DiSARM in both scenarios has to be developed. The 
group of potential end-users for DiSARM is large and with diverse needs. 
The interface has to be customizable to the different tasks by the different 
users. The potential of DiSARM in supporting malaria elimination efforts is 
huge. Pilots will give valuable insight for the roll-out in more countries.
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MALARIA MAPPING SYSTEM IN HAITI
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The National Malaria Control Program (NMCP) in Haiti is committed 
to eliminating malaria by 2020. National malaria parasite prevalence is 
<1%, but areas of relatively high transmission (foci) are heterogeneously 
distributed across the country. To detect malaria foci across space and 
time in this low endemic setting, the NMCP established a pilot system 
to identify laboratory-confirmed RDT and smear positive malaria cases 
from health facilities in Grande-Anse, Sud, and Sud-Est Departments and 
to geo-locate their residences. From October 2014 to September 2015, 
1,419 (58%) of 2,462 confirmed cases from 57 health facilities were 
identified, mapped, and a surveillance questionnaire was administered. 
Less than 1% of all geo-located cases traveled outside their communes in 
the month before seeking health care. Mean age of malaria cases was 22 
years (range: 0-97) and mean number of days with symptoms before care 
seeking was 2.9 days (range: 0-32). Case distribution was compared to 
a completely random spatial distribution using the Global Moran’s I test; 
clustering was present in two of ten analysis areas (p<0.01). Two space-
time permutation models were created in SatScan 9.4 to search for smaller 
significant transmission foci with parameters of a maximum cluster radius 
of 3km and two minimum time spans of 14 days and 1 month. In total, 
13 statistically significant (p<0.05) space-time case clusters were detected; 
average radii was 844 meters (118 cases) for the 14 day clusters and 1.14 
km (170 cases) for the 1 month minimum clusters. Cases were aggregated 
and joined to the 2014 LandScan dataset and malaria incidence rates 
were calculated for 1km2 areas. Local incidence rates were compared to 
a global rate using the Getis Ord-Gi* analysis and to regional rates with 
the Anselin’s Local Moran’s I analysis. The global method identified 43 
1km2 foci (p<0.05) and the regional method detected 69 foci with five 
outlier foci (isolated areas with unusually high incidence rates). This system 
detected foci at differing time and spatial scales contributing to targeting 
of malaria control and elimination activities.
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FROM A MALARIA ELIMINATION CAMPAIGN IN ZAMBIA’S 
LAKE KARIBA REGION
Caitlin A. Bever1, Jaline Gerardin1, Busiku Hamainza2, Ruben 
Conner3, John Miller3, Philip A. Eckhoff1, Duncan Earle4, Edward A. 
Wenger1
1Institute for Disease Modeling, Bellevue, WA, United States, 2Ministry of 
Health, National Malaria Control Center, Lusaka, Zambia, 3PATH, Seattle, 
WA, United States, 4PATH, Lusaka, Zambia
The Zambia National Malaria Control Centre is conducting an elimination 
campaign in the Lake Kariba region in Southern Province, with widespread 
scale-up of drug campaigns, via mass screen and treat (MSAT) and mass 
drug administration (MDA), and vector control. The survey data collected 
during the course of the campaign are highly informative with regards to 
the many factors that affect disease transmission; for example, analysis of 
local prevalence in the context of insecticide treated nets (ITNs) and indoor 
residual spraying (IRS) allowed the quantification of both individual and 
community-level protection for each method of vector control. Not to be 
disregarded, however, is the added value of the data for understanding the 
challenges of implementing surveillance and interventions across a large, 
dynamic population, spread out over a substantial and geographically 
varied region. Many of the features discovered in the data, such as a 
strong demographic dependence of coverage rates, and seasonal patterns 
of migration between smaller villages and larger centers, have major 
implications for the feasibility of elimination under existing protocols and 
suggest operational checks useful for similar programs across Sub-Saharan 
Africa.
1561
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Clinically nearly incurable strains of malaria have now reached Vietnam 
from Cambodia. Historically drug-resistant strains emerge in Cambodia 
and then spread to Africa. The new strains are not just artemisinin-
resistant; they are resistant to nearly all antimalarial drugs. From 2001 
to 2015, approximately 6.2 million malaria deaths were averted through 
massive global investments. Malaria mortality dwarfs that of highly 
publicized recent outbreaks (11,325 for Ebola, 774 for SARS and very 
few for Zika virus). The impressive gains with malaria are at risk of being 
reversed; decisive action must be taken to eliminate them. Published 
reports demonstrate dihydroartemisinin-piperaquine (DHA-PIP)-resistant 
malaria was present in Cambodia in 2010. Unfortunately, attempts to 
contain these parasites have failed - new approaches are urgently needed. 
In Binh Phuoc Province, Vietnam, in 2015, a PCR-corrected 32% (14/44) 
late clinical treatment failure rate was documented (K13 genotyping, 
drug levels pending). A confirmatory trial with early similar results is on-
going. Current results and available data from Cambodia will also be 
presented. To address this emerging threat regionally, current M&E reports, 
strategies and recommendations for malaria elimination and epidemic 
preparedness are being critically reviewed and compared. Our team has 
also developed a simple red light-green light system for cross-border 
emergency operations centers to be able to visualize, target and monitor 
real-time rapid responses and on-going adherence. The same solutions and 
methods needed to eliminate malaria will enhance the infrastructure and 
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provide indispensable experience in preparation for the next global threat. 
We will discuss why we believe these new malaria strains should be part 
of the Global Health Security Agenda. In conclusion, DHA-PIP treatment 
failures are now in Vietnam; the first reported spread beyond Cambodia. 
We recommend emerging incurable malaria be addressed and resourced 
as a crisis. Malaria and any threat agent can be rapidly addressed using the 
same new approaches.
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There has been major progress towards global malaria elimination within 
the past decades, with an estimated 1.2 billion cases and 6.2 million 
deaths averted globally since 2001. However, there is increasing evidence 
that individual ministries of health and national malaria programs may 
face major challenges in ‘getting to zero’ in isolation. As such regional 
cooperation is critical for continued progress; however there is limited 
guidance for the structure, planning or functional roles of regional 
cooperation. To address this, we review a range of global malaria 
initiatives, and provide practical guidance for future programs.
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ELIMINATE EMERGING INCURABLE MALARIA STRAINS
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Clinically artemisinin combination therapy (ACT)-resistant of Plasmodium 
falciparum (Pf) has now emerged in Vietnam. New WHO guidelines 
recommend their elimination by 2020. Since 1991, Vietnam has 
successfully reduced malaria cases by >97%. So that these impressive 
gains are not reversed, elimination of the emerging resistant strains is 
imperative. In 2015, Pf decrease by 47% nationwide as a result of many 
factors. The major exception was Binh Phuoc Province, where clinical ACT-
resistance emerged, which likely caused the 32% increase in incidence 
(the same pattern was seen in Cambodia). A country plan to eliminate 
ACT-resistant Pf has been developed. The major challenges identified are 
as follows: 1) drug resistance, 2) forest-goers/seasonal workers, 3) financial 
support, 4) access to timely, essential information, 5) cross-border and 
intersector collaboration. Potential solutions to the challenges will be 
presented. Some examples are as follows. Interagency meetings are being 
conducted to raise domestic funding. The US Navy sponsored “enhanced 
surveillance and operations research” has identified unmet needs which 
can guide new intervention programs. Lastly, partnerships with the military 
are being explored to utilize the existing network of health care facilities 
and military personnel operating in and near malaria endemic zones. 
In conclusion, we present a path to resource ACT-resistant Pf for rapid 
elimination. New tools and collaborations now make elimination possible. 
As malaria disappears, the same enabling factors can be applied to other 
health challenges related to poverty (e.g. malnutrition). We can both lead 
the elimination of ACT-resistant malaria and the next global health security 
issue that emerges.
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U.S. NAVY-NIMPE COLLABORATIONS AND OPERATIONS 
RESEARCH SUPPORT OF THE MALARIA ELIMINATION 
PROGRAM IN VIETNAM
Nicholas Martin1, Thang Duc Ngo2, Duong Thanh Tran2, Dung 
Viet Dang2, Hung Quoc Pham3, Treit Minh Kieu Bui4, Yen Hoang 
Nguyen4, Nam Dinh Nguyen3, Tuong Trinh Dinh3, Colin Ohrt3, The 
Supporting NIMPE Team, Provincial Preventive Medicine Teams
1Naval Medical Research Center – Asia, Singapore, Singapore, 2National 
Institute of Malariology, Parasitology and Entomology (NIMPE), Ha Noi, 
Vietnam, 3Vysnova Partners, Inc., Ha Noi, Vietnam, 4Center for Health 
Consultation and Community Development (CHD), Ha Noi, Vietnam
US Navy collaborations with the Vietnamese National Institute of 
Malariology, Parasitology, and Entomology began in 2014 with an 
Enhanced Surveillance and Operations Research for Malaria Elimination 
project. Phu Yen Province in central Vietnam, near areas of highly drug-
resistant malaria, is the lead study site. To better understand how to 
accelerate malaria elimination, our team conducted surveys in preparation 
for future operations research. In 2015 a survey was completed of 100 
households with and 100 households without confirmed malaria in three 
communes of Western Phu Yen. The survey included data collection 
on known risk factors, occupation, use of bed nets and preferences for 
potential interventions. The malaria burden by self-reported occupation 
was: paper planation work (47%), agarwood harvesting (15%), farming 
(13%), charcoal production (9%), trapping (6%), timber harvesting (4%) 
and hunting (3%). Although total cases were lower, greater proportions 
of farmers, charcoal producers and hunters suffered from the disease 
suggesting they may be an important part of the transmission reservoir. 
Overall, treated net use was low (19% in risk areas), despite households 
having treated nets (mean = 2.8). Households reporting not using a 
treated net had a higher risk of malaria (OR 2.6, p=0.05). A majority of 
forest-goers (85%) reported dislike of nets provided by public health 
programs, e.g. Global Fund long lasting insecticide-treated nets; 82% of 
forest-goers indicated a desire for hammocks with a zip-in treated net. 
When asked about preferences for future interventions, 94% were willing 
to use malaria prophylaxis and 90% mosquito repellent. In conclusion, the 
majority of individuals at greatest risk of malaria in our study area did not 
report routine use treated bednets or other malaria prevention products. 
Based on these preliminary findings an updated survey is planned for 4800 
households and all transmission hotspots in 2016 to confirm the 2015 
findings. These activities will provide an evidence base to plan operations 
research to tailor interventions for malaria elimination.
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AN INNOVATIVE INFORMATION SYSTEM TO ELIMINATE 
EMERGING INCURABLE MALARIA
Thang Duc Ngo1, Duong Thanh Tran1, Nicholas Martin2, Phuc 
Hong Thi Nguyen1, Hung Quoc Pham3, Dung Viet Dang1, Tuong 
Trinh Dinh4, Nam Dinh Nguyen4, Gerard Kelly5, Colin Ohrt1, The 
Supporting NIMPE Team, The Provincial Preventive Medicine Teams
1National Institute of Malariology, Parasitology and Entomology, Ha Noi, 
Vietnam, 2Naval Medical Research Center – Asia, Singapore, Singapore, 
3Vysnova Partners, Inc., Ha Noi, Vietnam, 4Vysnova Partners, Inc., Ha Noi, 
Vietnam, 5University of California San Francisco, San Francisco, CA, United 
States
Malaria resistant to nearly all drugs is again emerging in Southeast Asia, 
which must be rapidly eliminated. The goal of surveillance for malaria 
elimination is to capture every malaria case and execute a prompt and 
effective response. Here we describe the real world evaluation of an 
effective information system for rapid reporting, case investigation and 
response. Three communes in western Phu Yen (PY) Province, central 
Vietnam were selected as the lead study area. Sony smart phones, KLL 
collect data, and the Ona server were down-selected for data capture and 
management. MapInfo Professional® was utilized for enhanced mapping. 
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Five data capture forms were developed and iteratively improved during 
the study period of January to September 2015. GPS coordinates in the 
transmission sites were captured for 89% of 64 cases from January to 
September 2015. Fourteen transmission foci were identified, defined as 
more than one case within a one km radius, which accounted for 80% 
of cases. The majority of cases (97%) were from people living in PY. 
Forest (86%) and forest fringe (14%) were identified as the probable 
transmission sites. Only 16% of cases reported sleeping under a treated 
net, 30% an untreated net and 54% without any net. The sleeping sites 
were classified as houses (10%), huts (60%) and hammock only (25%). 
Routine follow-up forms were tested in 20 households; 45% were 
probably using, 35% were possibly using and 10% were not using the net 
provided to their household. By self-reporting, 10% reported not regularly 
using their net, which increased to 25% when the picture evidence of 
non-use was included. Weekly (zero) and monthly quality reporting forms 
were also successfully evaluated. New results and plans to expand to high-
priority areas also will be presented. In conclusion, the system was found 
to be user-friendly. The use of pictures revealed discordance between self-
reporting and actual net use. The described transformative technology will 
help National Malaria Control Programs and partners improve the quality 
and targeting of interventions. This new approach will facilitate rapid 
elimination of malaria.
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THE FORMULA “AVERAGE PLUS TWO STANDARD 
DEVIATIONS” APPLIED TO THE FOLLOW-UP OF THE 
MALARIA EPIDEMIC WARNING THRESHOLD OF THROUGH 
24 SITES SENTINELS OF SURVEILLANCE IN SENEGAL
Medoune Ndiop, Alioune Badara Gueye, Mady Ba, Ibrahima 
Diallo, Moustapha Cisse, Mamadou Lamine Diouf
National Malaria Control Programm, Dakar, Senegal
To predict and manage malaria epidemics, the Senegal National Malaria 
Control Program (NMCP) created an epidemiological surveillance system of 
rapid detection. This malaria sentinel system, set up in 2008, includes 24 
sentinel sites, 18 of which are distributed in low to moderate transmission 
zones at risk for epidemics. Using a standard Excel spreadsheet, sites 
report the total patients; suspected malaria cases, patients tested, and 
confirmed malaria cases every week. The quality of the transmitted data 
is assured through quarterly supervision of sites integrating on-site data 
verification. Since 2009, 100% of suspected malaria cases have been 
tested by rapid diagnostic tests, and 100 % of positive cases received 
artemisinin-based combination therapy. In 2015, the NMCP introduced a 
method of calculating epidemic threshold using historical data for each 
site dating back five years. For every site, a standardized Excel worksheet 
is used to calculate and draw a curve of the epidemic threshold. The 
following formula is used for calculation of the epidemic threshold: weekly 
average of the cases for a given epidemiologic week over the previous five 
years plus two standard deviations. During the 45 epidemiologic weeks of 
2016, the reported cases were systematically compared with the epidemic 
threshold curve weekly. This formula proved to be very sensitive, with 
detection of 99% of potential epidemic situations during 2016, compared 
to 25% using a threshold based on a formula of simple averages. In 
every sentinel site if the threshold is met or exceeded, a systematic 
documentation of the reported cases is made. In zones of moderate or 
high transmission, specific actions are taken based on the results of this 
documentation. In zones of low transmission, the threshold is one case, 
and every case is systematically documented and investigated. Since 
implementation, four sites reached or surpassed the warning level more 
than four times. Investigations showed that 80% of cases were imported, 
and 20% of autochthonous cases did not sleep under insecticide-treated 
nets.
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INCREASE OF MALARIA TRANSMISSION IN MILITARY CAMPS 
IN TANZANIA
Eyako K. Wurapa
Walter Reed Army Institute of Research, Silver Spring, MD, United States
Malaria remains a public health problem for many Tanzanians. Parasitemia 
prevalence in the population has declined markedly from 78.4% (2003) to 
13.0% (2008). Recent studies have reported high prevalence in Kigoma 
(26%), Mara(25%) and Kagera(37%). We investigated malaria burden in 
eight military camps in seven regions of Tanzania, Coastal, Tanga, Kigoma, 
Morogoro, Mara, Tabora and Kagera regions. Malaria surveillance was 
conducted using the Deki mRDT Reader for 2 years and malaria prevalence 
survey of asymptomatic military recruits at four military camps. Finger 
pricks were used to conduct malaria mRDT and blood smear microscopy. 
Studies to determine the malaria attack rate for recruits from endemic 
regions and nonendemic areas were performed. Consented recruits were 
screened negative enrolled and followed-up biweekly for six months. 
Malaria case detection with the Deki mRDT Reader showed increased 
positivity rates (PRs) over time. At Ruvu, PRs increased from 11.8 % (2013) 
to 15.7% (2014) to 30.9% (2015). PRs increased from 25.2%(2013) to 
37.5%(2014) and to 46.2%(2015) for Mgambo and from 36.4%(2014) 
to 37.0%(2015) for Rwamkoma Bulombora site showed a decreasing 
PRs, other military camp sites showed an increasing PRs. malaria attack 
rates in the Ruvu and Mgambo camps were 13% and 43.3% respectively. 
Malaria prevalence rates by mRDT for asymptomatic recruits were 2.8% 
(Bulombora), 5% (Ruvu), 47.5% (Mgambo) and 39.4% (Rwamkoma). 
Malaria prevalence rates by microscopy were 3.4%, 5.2%, 49% and 
38.5% for Ruvu, Mgambo and Rwamkoma respectively. Generally, there is 
an increasing trend of malaria prevalence in these areas which could be an 
indicator of similar trends countrywide. Further studies and an intervention 
plan are clearly recommended to address this public health problem.
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RISK FACTORS INVOLVED IN THE EPIDEMIOLOGY OF 
MALARIA IN MILITARY CAMPS IN TANZANIA
A. Kalinga1, C. Mswanya2, L. Temu3, S. Chiduo3, C. Mwanziva2, 
L. Anova4, Eyako K. Wurapa4, S. Mgata3, I. Fine3, G. Bhat5, D. 
Ishengoma6, R. Kavishe4, C. Ohrt4, M. Hickman4, D. Janga2
1National Institute of Medical Research, Tanga, United Republic of 
Tanzania, 2Walter Reed Program - Tanzania, Dar es Salaam, United 
Republic of Tanzania, 3Tanzania Peoples Defense Force, Dar es Salaam, 
United Republic of Tanzania, 4WRAIR, Silver Spring, MD, United States, 
5Fio Corporation, Toronto, ON, Canada, 6Nationl Institute of Medical 
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A total of 1380 patients were interviewed from Rwamkoma and Maramba 
camps. More than one quarter (29%; 400/1380) of respondents had 
never used insecticide treated nets (ITNs) as 31.8% did not slept always 
under an ITN 30 days prior to interview. Respondents who reported not 
using ITNs had a statistically significant probability to be diagnosed with 
laboratory confirmed malaria (p<0.0001). Factors such as male gender 
(35.7%; 280/784) or age <17 years (49.4%; 44/89) were found to be 
statistically significant contributing factors to developing malaria. Although 
the results were not statistically significant, patients coming from malaria 
non-endemic districts of origin contributed to higher rate(35.2%; 25/71) 
of laboratory confirmed cases than patients from malaria endemic 
districts of origin (31.2%; 380/1218). Patients diagnosed clinically to have 
malaria were statistically more likely to have laboratory confirmed malaria 
than those diagnosed clinically free from malaria (p<0.0001). Patients 
that presented at health facility with fever of greater than 3 days were 
statistically more likely to have confirmed malaria than patients presenting 
with a fever of less than 3 days (p<0.0001). Although statistically not 
significant, patients with clinical symptoms > 5 of malaria (≥5) were more 
likely to have confirmed malaria than those with <5 symptoms of malaria 
(35.5%; 39/110). Patients who reported to have not completed a full 
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regimen of antimalarial treatment in the two months prior to the study 
were more likely to test positive for malaria than patients who completed 
a full course of treatment (60%; 3/5). In summary, factors associated with 
the epidemiology of malaria included prior experience using ITNs, gender, 
age, delay in seeking treatment and clinical symptom presentation.
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ESTIMATING THE MALARIA ATTACK RATE IN TANZANIAN 
MILITARY CAMPS. MALARIA EPIDEMIOLOGY IN SELECTED 
MILITARY CAMPS IN TANZANIA
C. Mwanziva1, L. Temu2, M. Chiduo3, H. Mkali3, S. Chiduo2, G. 
Amoo4, L. Anova5, C. Ohrt5, Eyako K. Wurapa5, A. Kalinga3, C. 
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Republic of Tanzania, 3National Institute of Medical Research, Tanga, 
United Republic of Tanzania, 4Amethyst Technologies, LLC, Baltimore, MD, 
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In Tanzania, malaria ranks number one cause of morbidity and mortality, 
accounts for over 32% of the National disease burden. There is high 
heterogeneity of malaria transmission depending on topographical 
features and climatic conditions. The aim of this study was to look at 
malaria attack rate among recruits entering training camps in highly 
endemic areas. Recruits eligible to study in Mgambo camp -Tanga, were 
randomly selected by multistage sampling; consented and followed for 
six months. Fortnightly malaria smear was collected. Blood samples for 
serological tests were collected. Microscopy was the gold standard method 
for malaria diagnosis. Data was subjected to univariate and multivariate 
analysis, logistic regression model was used to identify the risk factors. 
Among 549 recruits who were involved in this study, 31.7% (174) were 
malaria positive. Among positive cases, those who didn’t sleep under 
treated net were found to have significantly increased odds of being 
malaria positive [OR: 7.71; 95% CI: 1.01-58.61; P=0.048]. Travelling 
outside the camps increased odds of being malaria positive [OR: 1.25; 
95% CI: 0.87-1.79; P=0.232]. There was significant difference between 
malaria positivity and place of travel [X2=40.1; P=0.015]. Female recruits 
had 54% significantly reduced chances of being malaria positive [OR: 0.46; 
95% CI: 0.28 - 0.77; P=0.003]. This study revealed failure to use bed nets 
and travel are major drivers of malaria infection. Identification of gaps in 
net use, knowledge, relevant types of human movement and development 
of strategies addressing travel is highly recommended. Mgambo camp in 
high malarial endemic area is an ideal site for malaria drug prophylaxis or 
vaccine studies, where TPDF recruits from various transmission intensity 
areas trained under similar environment.
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CHALLENGES OF MEASURING ITN EFFICACY IN HIGH 
TRANSMISSION SETTINGS: AGE, SEASON AND DETECTION 
METHODS
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States, 3Blantyre Malaria Project, Blantyre, Malawi, 4University of Malawi, 
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After universal distribution of insecticide treated nets (ITNs), malaria 
prevalence remains high in Malawi. Understanding reasons for the limited 
impact of ITNs on malaria control is critical for identifying methods to 
decrease the malaria burden. Previous studies focus on the impact of ITN 
use among children under 5. However, prevalence of infection is highest 
in school aged children (SAC), ages 5 to 15. We examined the effect 
of age, season, and detection method on estimates of ITN impact in 
Malawi. Six cross-sectional surveys using cluster random sampling were 
conducted in the rainy and dry seasons in southern Malawi from 2012 
to 2014. Data were collected on household ITN usage and demographic 
variables. Blood samples for detection of P. falciparum infection were 
obtained from all household members who were present and over six 
months of age. Statistical analyses used generalized linear mixed models 
to account for clustering at the household and neighborhood level. We 
conducted microscopy and qPCR on ~17,500 individuals. Prevalence 
was higher in SAC compared to children under 5 and adults using both 
detection methods (15% vs. 8% and 5% by microscopy and 23% vs. 
11% and 11% by qPCR respectively). The association between ITN use 
and infection was modified by season in SAC, but not in others. Using 
microscopy, ITN use was associated with protection in all age groups and 
all seasons (SAC in the rainy season: OR = 0.67 (95%CI: 0.46, 0.97), 
SAC in the dry season: OR = 0.57 (0.37, 0.88), and non-SAC: OR = 0.73 
(0.56, 0.94)), but there was no protective association among SAC in the 
rainy season when using qPCR results (OR = 0.78 (0.56, 1.10)). Sensitive 
detection methods reveal a lack of uniformity in the impact of ITN use, 
with seasonal variation among SAC when using qPCR results. This may 
be due to inadequate protection of ITNs when mosquito density is high 
or the persistence of sub-microscopic infections over time. Single time-
point cross-sectional surveillance of children under five using microscopy 
alone may fail to capture the community impact of ITN use on prevalence. 
SAC may represent persistent reservoirs of transmission and may require 
targeted interventions.
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DECLINING MALARIA BURDEN IN UGANDA BETWEEN 2009 
AND 2014: EVIDENCE FROM THE MALARIA INDICATOR 
SURVEYS
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Katureebe3, Joselyn Atuhairwe4, Denis Rubahika1, Henry Katamba1, 
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Malaria remains a major public health problem in Uganda. Although 
there is still on-going transmission and the entire population remains at 
risk of malaria infection, results from the 2014 national malaria indicator 
survey showed improvement in key malaria indicators. In this study, we 
present evidence of declining malaria burden in Uganda by comparison 
of key population-based malaria indicators from the 2009 and 2014 
national malaria indicator surveys. We extracted and compared data on 
malaria biomarkers between the 2009 and 2014 national malaria indicator 
surveys for population-based estimates of parasitemia and anaemia as 
key indicators. Both surveys used a comparable sample of children aged 
0-59 months who were all tested for malaria and anemia as the major 
outcomes. Improvement in key indicators was determined by analyzing 
the differences in proportions of parasitemia and anemia between the 
2009 and 2014 surveys. There was a reduction in parasitemia from 42% in 
2009 to 19% in 2014 (difference= 23% CI: 21.1-24.9, p < 0.001). Severe 
anemia (hemoglobin <8 g/dl) decreased from 9.7% in 2009 to 4.6% in 
2014 (difference=5.1% CI: 3.9-6.1, p <0.001). In both surveys, parasitemia 
was significantly higher in older children 48-59 months 25.9%, p<0.001 
and 53.2%, p<0.01 in 2009 and 2014 respectively. Although Plasmodium 
falciparum mono-infection and P. falciparum combined with other species 
constituted 97.1% of the malaria speciated in the 2014 survey (down 
from 99.1% in 2009), there was general increase in prevalence of non-
falciparum species: P. malariae from 2% to 6%, P. ovale from 0.02% to 
1.3%, P. vivax from 2% to less than 1% in 2009 and 2014 respectively. 
These results provide strong evidence of the declining malaria burden in 
Uganda between 2009 and 2014.
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PROXIMITY TO ENVIRONMENTAL RISK FACTORS 
INFLUENCES SPATIAL PATTERNING OF PLASMODIUM 
INFECTION PREVALENCE IN DANGASSA, MALI
Dan Frechtling1, Nafomon Sogoba2, Mahamoudou B. Toure2, 
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Malaria is highly seasonal throughout Mali, with large-scale differences 
in transmission across the broad range of Saharan to Sahelian to 
Sudano-Guinean habitats. In the tropical savanna climate of Sudano-
Guinean southern Mali, transmission is seasonally intense and spatially 
heterogeneous. This study sought to characterize community-level spatial 
patterns of malaria and examine fine-scale environmental factors that may 
influence transmission. A cross-sectional study of 1,063 people in 190 
households of Dangassa, Mali was conducted during September 2012 
(end of rainy season). Plasmodium (primarily P. falciparum) infection was 
determined by standard microscopy, and peri-domestic land cover (crops, 
trees, etc.) around each dwelling was observed/GPS-located in the field 
(2015) and through satellite images (2013). Distances to environmental 
features and health-relevant locations were calculated through GIS. 
Household-level, multivariate linear and geographically-weighted analyses 
and individual-level logistic regression was performed to evaluate 
demographic and environmental associations with malaria, as were spatial 
cluster analyses. Overall, 431/1063 (40.5%) of community members 
were Plasmodium-positive, with 5-10 year-olds exhibiting the highest 
prevalence of infection (64.8%). Household-level prevalence was positively 
associated (increased) with distances to the health center and to paths, 
but negatively associated (decreased) with distance to forest and breeding 
sites. Curiously, nearby crop cover reduced household and individual 
infection risk. Household-level clustering of infection was demonstrated, 
with geographically-weighted regression producing a better model fit 
than linear regression. Environmental risk factors contribute to variance in 
malaria risk at fine spatial resolutions. Geographically-weighted regression 
may be useful in determining areas of increased malaria prevalence.
1573
EXPLORING ENVIRONMENTAL FACTORS MEDIATING 
SPATIOTEMPORAL VARIATION IN VECTOR CONTROL IMPACT 
IN SUB-SAHARAN AFRICA 2000-2015
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Adam Bennett2, Hugh Sturrock2
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Previous work by the Malaria Atlas Project (MAP) has led to a detailed 
spatiotemporal reconstruction of the changing landscape of Plasmodium 
falciparum risk in sub-Saharan Africa since the year 2000, and an 
understanding of the overall contributions of vector control (primarily 
Insecticide treated bednets, ITNs, and indoor residual spraying, IRS) in 
driving these changes. However, the patterns of declining transmission 
are not uniform, and the likely impact of existing vector control varies 
substantially from place to place. Understanding what influences these 
variations in impact can help inform thinking around novel vector control 
approaches that may be needed to address this ‘residual’ transmission. 
Here, we develop a suite of relevant environmental covariates and a 
geospatial modelling framework to explore factors influencing observed 
trends in transmission. Of particular interest are aspects of the biophysical 
or human environment that have either: (i) mediated the impact of existing 
vector control interventions, particularly insecticide treated bednets (ITNs) 
and indoor residual spraying (IRS); or (ii) led to declines in transmission 
independent of vector control or other intervention efforts.
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RISK FACTORS FOR DEATH DUE TO SEVERE MALARIA IN 
CHILDREN UNDER FIVE YEARS, KALEMBE-LEMBE PEDIATRIC 
HOSPITAL OF KINSHASA, DEMOCRATIC REPUBLIC OF 
CONGO, 2012-2014
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Malaria remains a major public health problem in the DRC. Its prevalence 
in children 6-59 months old is 31% and up to 30% of pediatric deaths 
are due to malaria. The aim of this study is to determine the risk factors of 
death in severe malaria in children under 5 years old. A case-control study 
is conducted in 2015 at the Kalembe-Lembe pediatric hospital (Kinshasa). 
Cases (n = 71) were children hospitalized for severe malaria and whose 
outcome was fatal. Controls (n = 142) were children hospitalized for 
severe malaria and whose outcome was favorable. A questionnaire was 
used to collect the indicators (age, sex, weight, hyperthermia, nutritional 
status, delay of treatment at the hospital ≥ or < 24 hours, socioeconomic 
level⋯) from children’s mothers or guardians. The delay of treatment is the 
time between the first symptoms and the treatment at the hospital. The 
socioeconomic level is about 5 variables. Each variable has a value of 1 in 
the affirmative. The socio-economic level was good if the score was ≥ 4 
and low if it was < 4. Data were analyzed using Epi-Info7 software. The 
risk of death was estimated through the OR 95%. Both cases and controls 
were separately 14 months of median age with a maximum of 59 months. 
The median weight was 9kg (3-22Kg) for cases and 10kg (5-24kg) 
for controls. Concerning cases, 32.4% of children (23/71) had a poor 
nutritional status (Z-score < -2 SD) and 80.3% (57/71) of their households 
had a low socioeconomic level. In 59.2% of cases (42/71), the delay of 
treatment was ≥ 24 hours. Risk factors associated with the occurrence 
of death to cases included poor nutritional status [adj OR = 2.24 (1.16-
4.33)], low socioeconomic level [adj OR = 2.17 (1.08-4.35)] and delay of 
treatment ≥ 24 hours [adj OR = 2.05 (1.04-4.03)]. However, no association 
was found between death from severe malaria and rural residence, self-
medication, hyperthermia and the knowledge of the mother/guardian on 
malaria. In the fight against malaria, malnutrition, delay of treatment ≥ 
24 hours and the low socioeconomic level are risk factors considered as 
being associated with this disease. It is therefore imperative to intensify the 
awareness of these risk factors.
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MALARIA RESURGENCE IN WESTERN KENYA HIGHLAND
Guofa Zhou1, Guiyun Yan1, Harrysone E. Atieli2, Andrew K. 
Githeko2
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In the past decade malaria-induced morbidity and mortality were 
significantly reduced through the deployment of insecticide-treated nets 
(ITNs), indoor residual spraying (IRS) and artemisinin combination therapy 
(ACT). Despite very high coverage of ITNs, here we reported rapid malaria 
resurgence in the highlands of western Kenya. Longitudinal cross-sectional 
surveys of malaria prevalence in school-aged children were conducted 
monthly in Kisii from 2003 to 2015. Monthly clinical malaria incidence 
was obtained from a sub-district hospital. Indoor-resting malaria vector 
densities were determined and cross-sectional household surveys of 
ITN ownership were carried out. Malaria infection rate in school-aged 
children was reduced from monthly average of 15.9% in 2002 before 
495
astmh.org
the introduction of SP+AQ, to 3.0% before the introduction of ACT in 
early 2006. It remained very low from 2006 to 2013 (monthly average 
of 0.6%), but it increased sharply to 5.9% in 2014 and 10.2% in 2015. 
Indoor resting vector density was 1.5 females/house/night (f/h/n) during 
high season in 2003, it remained very low from 2004 to 2008 (0.03 f/h/n), 
however, it gradually increased since 2009 and reached 1.8 f/h/n in 2015. 
Malaria vectors were shifted to from An. gambiae to An. funestus as 
the dominant vector. Household ITN ownership increased gradually from 
11.7% in 2003 to 87.4% in 2015. Despite consistently high coverage 
of ITNs, malaria infections and indoor resting vector density rebounded 
dramatically in the past few years in western Kenya highland. There is a 
renewed fear of malaria epidemic in western Kenya highland, calling for 
urgent and improved malaria interventions being placed in these epidemic-
prone highland areas.
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RESULTS AND RECOMMENDATIONS FROM THE 2015 
MALARIA INDICATORS SURVEY (MIS) IN ZAMBIA
Ruben O. Conner1, Mulakwa Kamuliwo2, Mutinta Mudenda2, 
Mercie M. Ingwe2, Hawela Moonga2, Busiku Hamainza2, 
Christopher Lungu3, Kafula Silumbe3, Duncan Earle3, Elizabeth 
Chizema Kawesha4, John M. Miller3
1PATH-MACEPA, Seattle, WA, United States, 2National Malaria Control 
Center, Lusaka, Zambia, 3PATH-MACEPA, Lusaka, Zambia, 4Ministry of 
Health, Lusaka, Zambia
National, population-based cross-sectional surveys such as Demographic 
and Health Surveys (DHS) and Malaria Indicator Surveys (MIS) provide 
current and historic estimates for comparing malaria infection and 
intervention coverage to measure progress toward national and 
international targets. In Zambia, surveys were conducted in 2001-2002 
(DHS), 2006 (MIS), 2007 (DHS), 2008 (MIS), 2010 (MIS), 2012 (MIS), 
2013-2014 (DHS), and 2015 (MIS). We reviewed information from the 
2015 MIS and its cluster randomized 3,750 households to evaluate recent 
progress toward elimination and compared findings with prior surveys 
to examine lessons from 15 years of malaria control in Zambia. In 2015, 
77.0% of households had at least one insecticide-treated mosquito 
net (ITN) and 63.9% of households reported sufficient ITNs to cover all 
sleeping spaces; 55.1% of individuals reported sleeping under an ITN 
the night before the survey. Indoor residual spraying reportedly occurred 
in 28.9% of households in the previous twelve months. The overall 
malaria prevalence in children was 20.3% and varied by province from 
0.5% to 32.5%. Despite high coverage and use of key interventions, 
malaria parasite prevalence increased overall to a prevalence of 20.3% 
in 2015 compared to 14.9% in 2012. The increase in malaria prevalence 
despite high sustained coverage suggests that additional strategies will be 
needed to move Zambia towards elimination. The 2015 MIS also collected 
information relevant for monitoring the progress of the roll out of 
integrated community case management (iCCM), intermittent preventive 
treatment during pregnancy (IPTp), case management, and treatment-
seeking behavior. Information on these indicators will also be reported. 
Overall, the 2015 MIS provides the most comprehensive assessment of 
Zambia’s current malaria state, demonstrates that tremendous progress 
has been made in Zambia, and is helping to inform the planning process 
for future elimination efforts.
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MALARIA EPIDEMIOLOGY IN LOW ENDEMICITY AREAS OF 
THE NORTHERN COAST OF ECUADOR
Fabian E. Saenz1, Andrea Arévalo1, Gabriela Valenzuela1, Andrés 
Vallejo2, Angélica Castellanos3, Andrea Poveda1, Juan Gutierrez4, 
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1Pontificia Universidad Católica del Ecuador, Quito, Ecuador, 2Caucaseco 
Scientific Research Center, Cali, Colombia, 3Primates Center Foundation, 
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Vaccine and Drug Development Center, Cali, Colombia, 6Ministerio de 
Salud Publica, Guayaquil, Ecuador
The recent scale up in malaria control measures in Latin America has 
resulted in an impressive decrease in the number of reported cases in 
several countries including Ecuador, with a very low malaria incidence 
in recent years (544 reported cases in 2012 and 377 cases in 2013) and 
occasional outbreaks of both Plasmodium falciparum and P. vivax in the 
coastal and Amazonian regions. This success in malaria control in recent 
years has led Ecuador to transition its malaria policy from control to 
elimination. Nevertheless, it is unlikely that current interventions will lead 
to malaria elimination in the country unless asymptomatic parasite carriers 
are identified and treated. This study reports the general knowledge, 
attitude and practices (KAP) about malaria, as well as its prevalence in 
four communities of an endemic area in northwest Ecuador. A total of 
258 interviews to assess KAP in the community were evaluated showing 
that most people in the study area have a basic knowledge about the 
disease. Six hundred and forty-eight blood samples were collected and 
analyzed by thick blood smear (TBS) and real-time PCR, as well as by 
serology using ELISA and immunofluorescence. In addition, the distribution 
of the infections was mapped in the communities. The total malaria 
prevalence by PCR was 7.5%, comparable to that reported in endemic 
areas of neighboring countries with higher malaria transmission, indicating 
a much higher prevalence than expected. Results suggest that the 
transition from control to elimination strategies in a country like Ecuador 
would demand an improvement in malaria diagnostics to detect parasite 
asymptomatic carriers, as well as studies on the bionomy of Anopheles 
mosquitoes with potential vectorial capacity.
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MALARIA INDICATORS IN MALANGA, KIMPESE HEALTH 
ZONE IN DEMOCRATIC REPUBLIC OF THE CONGO
Mitterrand M. Moyo1, Armand Mutwadi1, Lionel Muyuku1, 
Hervé Mutoto1, Solange E. Umesumbu2, Thierry E. Bobanga1
1University of Kinshasa, Kinshasa, Democratic Republic of the Congo, 
2National Malaria Control Program, Kinshasa, Democratic Republic of the 
Congo
Background Malaria remains a public health problem in the DRC with 
a morbidity and mortality highest in the world. Knowledge of different 
indicators to better undertake the fight against this epidemic Methodology 
We conducted a community survey in 60 households in the villages 
Malanga, Nkumba, Zamba and Malanga Station. We also conducted 
human landing catches.Finally we conducted Anopheles susceptibility 
testing according to the WHO protocol Results The overall prevalence of 
infection by Plasmodium to Malanga was 41.4% with 43.4% for the age 
group of 0-5 years, 69% for the portion of 6 to 10 years and 59.1% for 
range 11 to 15 years. The capture of Anopheles returned 186 specimens 
with 5 species A. gambiae (83.8%), A. funestus (11.3%), A. nili 3.2%; A. 
moucheti 0.5% and 1.5% A. tenebrosus. The evaluation of the sensitivity 
of the Anopheles to insecticides found broad a total susceptibility to 
bendiocarb; Susceptibility to deltamethrin and permethrin was 53.4%  and 
23.7% respectively conclusions: Malaria Indicators to Malanga not allow 
to glimpse an effective control of malaria.
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UNDERSTANDING VULNERABILITY AND RESILIENCE OF 
INDIVIDUALS TO PLASMODIUM FALCIPARUM INFECTION IN 
A STABLE MALARIA TRANSMISSION AREA OF DANGASSA, 
MALI
M’Bouye Diallo1, Mahamoudou Toure1, Daouda Sanogo1, Sory 
Diawara1, Mahamadou Diakite1, Nafomon Sogoba1, Ousmane 
Koita1, Ayouba Diarra1, Donald Krogstad2, Seydou Doumbia1
1l’Université des Sciences, des techniques et des technologies de Bamako, 
Bamako, Mali, 2Tulane University, New Orleans, LA, United States
The goal of this study was to examine the factors associated with the 
absence or presence of persistent Plasmodium falciparum infection 
(parasitemia) among subjects living in the stable high transmission area 
of Dangassa in Mali. In a cohort of 750 children and adults examined 
during 4 consecutive surveys, we identified 89 subjects with positive thick 
smears at all visits (persistent positives) and 91 subjects with negative 
thick blood smears at all visits (persistent negatives) between August 
2012 and June 2014. A household survey was also performed to define 
the level of exposure to malaria control interventions and tools and 
characterize sociodemographic conditions. During each survey, clinical and 
laboratory examinations were performed in all subjects to estimate the 
frequencies of symptomatic and asymptomatic parasitemia. In addition, 
passive case detection was performed at the health center to estimate 
the incidence of uncomplicated and severe malaria in the community. 
Most persistently-negative subjects were adults (62.6%). In contrast, 
most persistently-positive subjects were children less than 17 years of 
age (98.9%). Persistently-negative subjects were more likely to seek 
care for malaria at the health clinic (72.5%) than persistently-positive 
subjects (34%) and the use of insecticide-treated nets was greater among 
persistently-negative (61.5%) than persistently-positive subjects (38.2%). 
Finally, persistently-positive subjects had 64% less risk of severe malaria 
than persistently-negative subjects (Relative Risk 0.36; 95% CI = [0.16, 
0.8]. In conclusion, most persistently-positive subjects were asymptomatic 
and sought malaria treatment at the health center clinic less frequently 
than persistently-negative subjects. However, the substantial numbers 
of persistently-positive subjects in Dangassa provide a reservoir for the 
continued transmission of malaria in the community, particularly during 
the dry season.
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MALARIA PARASITE POPULATION STRUCTURE AND HUMAN 
MOBILITY IN NORTHWEST THAILAND
Aimee R. Taylor1, Gustavo C. Cerqueira2, Standwell C. Nkhoma3, 
Shalini Nair3, Ian H. Cheeseman3, Marina McDew-White3, Aung P. 
Phyo4, Daniel M. Parker4, François Nosten4, Timothy J. Anderson3, 
Amy Wesolowski1, Kenth Engø-Monsen5, Daniel E. Neafsey2, 
Caroline Buckee1
1Harvard T.H. Chan School of Public Health, Boston, MA, United States, 
2Broad Institute of Massachusetts Institute of Technology and Harvard, 
Cambridge, MA, United States, 3Texas Biomedical Research Institute, 
San Antonio, TX, United States, 4Shoklo Malaria Research Unit, Mae Sot, 
Thailand, 5Telenor Research, Fornebu, Norway
Southeast Asia is the epicenter of antimalarial drug resistance. Its 
disposition potentially relates to regional factors, including malaria 
parasite population structure. Differences in parasite population structure 
have been associated with resistance, as well as population decline 
following elimination efforts; human mobility is also thought to play 
a role. To investigate the relationship between parasite population 
structure and human mobility, we aim to model the genetic relatedness 
of parasites sampled from four sites in Northwest Thailand under 
models excluding and including human connectivity. We estimate 
genetic relatedness between sites using published data from over 1000 
Plasmodium falciparum positive samples genotyped at 96 single nucleotide 
polymorphisms (SNPs). For a pair of samples from different sites, the 
percentage of the parasite genome that is identical by descent (IBD) is 
inferred under a hidden Markov model. To account for the relatively 
small number of SNPs, the IBD estimates are calibrated using a regression 
model trained on results derived from distinct samples sequenced 
across the entire genome. Preliminary estimates of IBD suggest the 
parasite populations are partially clonal, and that a subset of parasites 
at different sites is highly related, implying a network of interconnected 
populations. Discordance between the genetic relatedness of sites and 
their spatial distribution suggests human mobility could play a role. We 
thus hypothesize that the inclusion of human connectivity in the proposed 
model of genetic relatedness will increase its explanatory power. Model 
selection will provide a quantitative assessment of our hypothesis, yielding 
valuable insight into the host-parasite relationship at the population level, 
which can be leveraged to improve the design and maintenance of critical 
malaria elimination strategies.
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IMPACT OF ALL-CAUSE ANEMIA ON THE RISK OF 
FALCIPARUM MALARIA IN MALIAN CHILDREN
Jaymin C. Patel1, Mahamadou Diakite2, Catherine R. Lesko3, 
Tatiana Lopera-Mesa4, Steve M. Taylor5, Rick M. Fairhurst4
1University of North Carolina, Chapel Hill, NC, United States, 2University of 
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States, 4National Institute of Allergy and Infectious Diseases, Rockville, MD, 
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Anemia and falciparum malaria co-exist throughout much of sub-
Saharan Africa. Recurrent malaria can cause anemia, and some forms of 
anemia, such as iron-deficiency, can reduce the risk of severe malaria. The 
relationship between all-cause anemia and uncomplicated malaria is less 
well understood. We investigated the relationship between hemoglobin 
concentrations and subsequent risk of malaria in a large cohort of children 
in Southern Mali. The KIDS-Malaria cohort comprised over 1500 children 
who were followed over 4 successive malaria transmission seasons. 
Hemoglobin levels were measured at the start of 2 transmission seasons, 
and with each malaria episode at diagnosis and during day 4 of treatment. 
We estimated the risk of subsequent episodes of malaria using inverse 
probability weighting in models adjusted for age, ethnicity, and alpha-
thalassemia. Overall, we recorded over 4000 episodes of malaria during 
over 2500 child years of follow-up. Mean hemoglobin values were 11.0 
g/dL in the two baseline surveys, 10.6 at the time of malaria diagnosis, 
and 9.5 on day 4 of treatment during these episodes. Using hemoglobin 
values measured either at baseline surveys or at day 4 during their previous 
malaria episode, we categorized malaria episodes as occurring in a child 
with pre-existing severe anemia (<8 g/dL, n=646), mild anemia (8-11 g/dL, 
n=2379), or normal (>11 g/dL, n=1179). Compared to episodes occurring 
in children with normal hemoglobin levels, the risk of malaria was reduced 
in those with severe anemia (relative risk [RR] 0.74; 95% confidence 
interval [CI] 0.604-0.906) and unchanged in those with mild anemia (RR 
0.939; 95% CI 0.845-1.044). This effect was most pronounced in the final 
year of observation, when, relative to episodes occurring in children with 
normal hemoglobin levels, the risk of malaria was reduced in those with 
both severe (RR 0.255, 95% CI 0.16-0.4) and mild anemia (RR 0.60, 95% 
CI 0.5-0.73). These data suggest that all-cause anemia reduces the risk of 
uncomplicated malaria in this cohort of Malian children.
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CROSS-BORDER MALARIA: THE CONTRIBUTION OF 
POPULATION MOVEMENT TO SUSTAINED MALARIA 
TRANSMISSION IN MUTASA DISTRICT, ZIMBABWE
Lilly V. Siems1, Edmore Mamini2, Sungano Mharakura3, Shungu 
Munyati2, Lovemore Gwanzura4, Susan Mutambu5, William J. 
Moss1
1Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United 
States, 2Biomedical Research and Training Institute, Harare, Zimbabwe, 
3Africa University, Harare, Zimbabwe, 4University of Zimbabwe, Harare, 
Zimbabwe, 5National Institute of Health Research, Harare, Zimbabwe
Malaria persists as a public health problem in Zimbabwe despite continued 
vector control efforts with long-lasting insecticide treated nets and indoor 
residual spraying. Population movement between Mozambique and 
Zimbabwe may play a role in sustaining malaria transmission in Mutasa 
District, Zimbabwe. The aim of this study is to assess cross-border malaria 
transmission between Mozambique and Zimbabwe. Between 2012 
and 2016, passive case detection of malaria cases, determined by rapid 
diagnostic test (RDT), in 43 clinics in Mutasa District were collected using 
the country’s established health management information system. In 2015, 
six clinics in Mutasa District began reporting weekly data on confirmed 
malaria in patients from Mozambique seeking care in Zimbabwe. 
Preliminary data show that approximately 18.2% of all confirmed malaria 
cases in border clinics are patients residing in Mozambique. This study will 
address three hypotheses as to why higher numbers of incident cases of 
malaria are reported on the border of Mozambique. First, these areas may 
have a higher incidence of malaria because of ecological factors favoring 
vector breeding sites. Second, higher case numbers at clinics near the 
border may reflect the health seeking behaviors of symptomatic individuals 
residing in Mozambique. Third, movement of parasites and vectors across 
the border from Mozambique may promote malaria transmission in 
eastern Zimbabwe. Using a malaria risk map and controlling for ecological 
factors, we will quantify the increased risk due to ecological factors and 
health seeking behaviors on the Mozambique border in Mutasa District, 
Zimbabwe, providing a deeper understanding of cross-border malaria 
transmission.
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DEFINING THE MICRO-EPIDEMIOLOGY OF MALARIA
Melanie Bannister-Tyrrell, Koen Peeters Grietens
Institute of Tropical Medicine, Antwerpen, Belgium
Malaria risk varies considerably over fine spatial scales but this ‘micro-
epidemiology’ is not well understood. A systematic review and 
meta-analysis was conducted to identify factors that explain micro-
epidemiological variation in malaria risk and define the scope, theory and 
methods for malaria micro-epidemiology. PuBMed, ISI Web of Knowledge 
and LILACS databases were searched for studies assessing variation in 
malaria risk between individuals or households within villages or between 
neighbouring villages. We included 51 of 738 studies screened that 
investigate demographic, social, environmental and epidemiological risk 
factors. Most studies investigated environmental risk factors for malaria, of 
which proximity to breeding sites and housing structure most frequently 
explained variation in risk. Social characteristics beyond bed net use were 
not widely considered, though mobility patterns and access to health care 
were frequently associated with malaria risk. There is limited evidence that 
crude estimates of the effects of environmental factors are confounded by 
social and epidemiological characteristics, including village population size 
and clinical and genetic characteristics, yet these variables are not included 
in most studies. There was substantial heterogeneity in effect estimates, 
including by study design, transmission context, exposure classification 
and analysis level, as there was only partial overlap between factors 
associated with malaria risk at individual compared to cluster or village 
level. Pooled estimates could therefore not be produced. Instead, a causal 
framework for the relationships between different malaria risk factors 
associated at micro-epidemiological scales was developed. In conclusion, 
micro-epidemiological studies should measure social, epidemiological and 
environmental factors consistently associated with fine scale variation 
in malaria risk. Control of confounding and multilevel analysis could be 
improved through use of causal frameworks for design and analysis of 
micro-epidemiological studies of malaria.
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CHARACTERIZING THE ASYMPTOMATIC AND 
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ZAMBIA: ASSOCIATED RISK FACTORS AND GAMETOCYTE 
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To achieve and sustain malaria elimination, identification and treatment of 
the chronically infected, asymptomatic reservoir is critical. Such individuals 
are not likely to seek medical care yet can harbor gametocytes and serve 
as reservoirs for transmission. Characteristics of asymptomatic individuals 
infected with Plasmodium falciparum were evaluated in Choma District, 
southern Zambia where malaria transmission has declined dramatically 
over the past decade. Households were randomly selected for participation 
in community-based, cross-sectional surveys between 2008 and 2013. 
Questionnaires were administered to collect information on age, sex, 
recent history of malaria symptoms and recent anti-malarial medication 
use. Asymptomatic malaria was defined as the absence of fever (tympanic 
temperature ≥38°C) on the visit day or no self-reported fever with chills 
during the last 48 hours. Blood samples were collected by finger prick 
for Pfhrp2-based rapid diagnostic tests (RDT), blood smears and dried 
blood spots (DBS). DNA was extracted from the DBS and a cytb-targeted 
nested PCR (nPCR) and a Pfs25 RT-nPCR were performed to detect malaria 
parasites and gametocytes, respectively. Of 4,101 participants with 
complete data, 99 (2.4%) were positive by RDT or nPCR and 98% (n=97) 
of them lacked visible parasites by microscopy. Seventy-four % of these 
malaria cases (n=73) were classified as asymptomatic and 52% (n=38) of 
the asymptomatic cases were RDT negative but nPCR positive. Compared 
to RDT and nPCR negative individuals, asymptomatic, RDT negative and 
nPCR positive individuals were more likely to be male (p=0.004) and 
all were above 5 years of age. The prevalence of gametocytemia by RT-
nPCR was higher among participants who were RDT and nPCR positive 
(33%) or RDT negative but nPCR positive (24%) than those who were 
RDT and nPCR negative (1.1%; p<0.0005). In areas of declining malaria 
transmission where the majority of infected individuals are RDT negative, 
more sensitive screening tools or focal drug administration strategies 
are needed for further reduce malaria transmission and achieve malaria 
elimination.
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RETURNING TO THE PROBLEM OF MALARIA IN CHILDREN 
UNDER FIVE IN LIBERIA
Patricia McQuilkin1, Benetta Collins-Andrews2, Udhayashankar 
Kanagasabai3, Eric Adu3, Ann Moormann1
1University of Massachusetts, Worcester, MA, United States, 2Liberian Post 
Graduate Residency Program, Monrovia, Liberia, 3John F Kennedy Medical 
Center, Monrovia, Liberia
Prior to the Ebola virus (EVD) epidemic, Liberia was recovering from a 
prolonged civil war that had decimated the health care system. Malaria 
was reported to be the leading cause of inpatient admission and death 
in children under 5 years of age. Determining the cause of acute disease 
in endemic regions is often complicated by the presence of premonition - 
32% of children in Liberia test positive for malaria and are asymptomatic. 
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Thus, other causes of acute febrile illness may mimic malaria and remain 
untreated. We conducted a prospective, hospital-based study of children 
under 5 years who presented to JFK Medical Center in Monrovia with 
presumed malaria from June 2013-May 2014. Clinical data was obtained 
on admission and discharge. Malaria diagnosis was confirmed by 
microscopy and/or malaria rapid diagnostic test. Children were treated 
for malaria using national treatment guidelines. 351 children who were 
admitted to JFK and treated for severe malaria agreed to participate in 
the study. Of this cohort, 34% were previously admitted to the hospital 
from 1-4 times for treatment of malaria. 49% of this cohort met the case 
definition of severe malaria (confirmed malaria infection with resolution 
of symptoms and parasitemia by day 3). For these patients, the most 
common presenting symptoms included fever (100%) for an average of 
3.8 days prior to presentation, headache (95%), prostration (80%), cough 
(68%), seizures (33%), diarrhea (30%) and respiratory distress (25%).. 
44% of patients had anemia on admission with an average hemoglobin 
level of 9.8 mg/dl. 26% of these patients hospitalized with presumed 
severe malaria tested negative for malaria. The most common presenting 
complaints in this group were; cough (47%), headache (27%), prostration 
(20%), diarrhea (16%) and respiratory distress (4%). In conclusion, this 
pilot study clearly demonstrates that children in Liberia suffer from more 
than malaria and should be clinically assessed and treated for other febrile 
illnesses. Future studies will include defining the landscape of febrile illness 
in children in Liberia.
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In the Democratic Republic of the Congo (DRC), malaria is reported to be 
the primary cause of morbidity and mortality, estimated to account for 
>40% of outpatient visits and attributable mortality of 40% in children 
under 5. However, health information systems are not widely available 
and consequently the accuracy of field data is limited. A public-private 
partnership was established to implement a malaria case management 
and surveillance system in Haut Katanga and Lualaba provinces. Over 
250 public primary healthcare workers and managers are being equipped 
with Fionet, an integrated system with point-of-care devices to guide 
case management and analyze RDT test results combined with remote 
oversight. The implementation of Fionet commenced in January 2016 and 
will be fully implemented by November 2016. As of March 2016, there 
are 150 healthcare workers covering >20% of public health facilities in 
the two provinces that are operational with Fionet. 6,780 malaria RDTs 
have been processed with Fionet, which ensures quality processing and 
automated interpretation, and uploaded to Fionet cloud for monitoring, 
quality control, analysis and reporting. In febrile children under 5 years of 
age, we observe an 80.6% positivity rate, which is one the highest levels 
reported globally. Additionally, 62% of patients over 5 years of age and 
56% of pregnant women tested positive for malaria. Patient information 
is also routinely collected on Fionet, for example, only half of the patients’ 
report having a bed net in their household. Fionet has demonstrated 
feasibility and usability in the hands of healthcare workers in the field. 
The implementation at scale will provide accurate, population-based, real-
time data on malaria prevalence with the ability to allocate resources and 
monitor outbreaks. Field data collected using the system can be integrated 
with databases (e.g. DHIS2) and utilized for public health decision-making 
and research.
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EVALUATION OF SEROLOGICAL BIOMARKERS OF 
PLASMODIUM VIVAX AND P. FALCIPARUM TRANSMISSION 
IN THE SOLOMON ISLANDS
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In the Solomon Islands, malaria transmission is low, highly heterogeneous, 
and dominated by Plasmodium vivax (Pv), but has pockets of persistent 
P. falciparum (Pf). This study utilized a cross-sectional serological survey 
of 2000 individuals of all ages from five geographical regions of Ngella 
Province of varying transmission levels, analyzing antibody responses 
to 13 Pf and 8 Pv antigens using a bead-array immunoassay. Methods 
were developed to assess optimal cutoffs for serological positivity, cross-
reactivity between and Pv and Pf antibodies, seroconversion rates, and 
correlations between seropositivity and infection rates in the different 
transmission zones to identify the most promising antigens as biomarkers 
of transmission. Significant correlations were found for four antigens: 
Pf CelTOS (p=0.036, r=0.90), Pf MSP2 (p=0.026, r=0.92), Pv DBP-AH 
(p=0.045, r=0.89), and Pv DBP-P (p=0.019, r=0.94). The results show 
that antibody responses to these four antigens are promising biomarkers 
of malaria transmission levels and suggest that variants of the Pv Duffy 
Binding Protein are particularly indicative of malaria exposure. Additional 
analysis is underway to confirm these initial findings and to identify 
additional optimal serological biomarkers of malaria transmission.
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EPIDEMIOLOGY OF CHRONIC ASYMPTOMATIC 
PLASMODIUM FALCIPARUM INFECTIONS AMONG ALL AGES 
IN AN AREA WITH SEASONAL MALARIA TRANSMISSION IN 
BONGO DISTRICT, GHANA
Kathryn E. Tiedje1, Godfred Agongo2, Anita Ghansah3, Thomas 
Anyorigiya2, Daniel Azongo2, Aprielle Wills4, Timothy Awine2, 
Abraham Oduro2, Kwadwo A. Koram3, Mercedes Pascual5, Karen 
P. Day1
1University of Melbourne/Bio21 Institute, Parkville, Australia, 2Navrongo 
Health Research Centre, Navrongo, Ghana, 3Noguchi Memorial Institute 
for Medical Research, Legon, Ghana, 4New York University, New York, NY, 
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Despite efforts to control and eliminate Plasmodium falciparum, malaria 
still remains a major public health concern. Exposure to antigenically 
diverse P. falciparum isolates at a young age leads to the acquisition 
of protective immunity and the development of chronic asymptomatic 
malaria infections in endemic areas. Understanding the role asymptomatic 
infections play in sustaining the reservoir of infection needs to be 
examined so that countries can shift towards malaria elimination. This 
research describes a longitudinal cohort (N=2,000) study designed to 
evaluate the reservoir of asymptomatic P. falciparum infections among 
all ages in an area with seasonal transmission in Bongo District, Ghana. 
Using different methods for parasite detection we evaluated how age, 
seasonality, spatial location and other factors affect the epidemiology of 
asymptomatic malaria at the end of the 2012/13 wet and dry seasons. 
Asymptomatic P. falciparum prevalence by microscopy decreased 
significantly from 42.5% at the end of the wet to 27.5% at the end of the 
dry season (p < 0.001). Using the 18S rRNA nPCR, all microscopy negative 
samples were further screened for submicroscopic infections. Resulting 
prevalence of submicroscopic infections also decreased significantly, with 
55.4% and 20.7% at the end of the wet and dry seasons respectively (p 
< 0.001). Combining detection methods, 74.4% of the population in the 
wet and 42.5% in the dry season had evidence of an active P. falciparum 
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infection. Interestingly in those >20 years of age, we found evidence of 
infection in 64.3% of the population in the wet and 27.0% in the dry 
season. Using the combination of microscopy and PCR we have shown 
that the asymptomatic reservoir peaks at the end of the wet season and 
that infections in all age groups contribute to maintaining the reservoir of 
malaria infection. These results suggest that if elimination is to succeed, 
interventions will need to target not just children but all asymptomatic 
P. falciparum infections and be implemented towards the end of the dry 
season in this area of West Africa.
1589
DEMOGRAPHIC AND CLINICAL PROFILES OF PLASMODIUM 
FALCIPARUM AND P. VIVAX PATIENTS AT A TERTIARY CARE 
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College, Bambolim, India, 3Stanford University, Stanford, CA, United 
States, 4CIDR, Seattle, WA, United States, 5Harvard School of Public 
Health, Boston, MA, United States, 6NIMR-Goa, Panjim, India, 7NIMR, New 
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India is a highly heterogeneous country, comprising more than 1.2 billion 
people, 2000 ethnic groups and 22 official languages. On the Indian 
subcontinent, there are more than 500 million people at risk for malaria, 
with reports of up to two million cases and 50,000 deaths per year. In 
contrast with Africa, malaria transmission is more limited, severe malaria 
disease is more frequently detected in adolescents and adults, and a 
substantial proportion of cases are infected with P. vivax rather than the 
traditionally more-virulent P. falciparum in India. Expansive studies on 
determinants of severe disease and mortality among malaria-positive 
patients are fewer and smaller in scope than in Africa or SE Asia. The 
present study describes the population served by Goa Medical College 
(GMC) and the demographic, diagnostic and clinical characteristics of 
malaria-positive study participants enrolled to-date at the Centre’s principal 
research site. A total of 74,571 febrile individuals presented to GMC 
between January 2012 and December 2015 and were tested for malaria. 
Of those, 6,277 (8.4 %) were determined to be positive for malaria 
infection. Over four years of passive surveillance, the number of malaria-
positive cases presenting to GMC steadily and significantly increased, from 
873 cases in 2012 to 2,263 cases in 2015. While, a critical component of 
modern improvements in patient care are to meld clinical care, research, 
and treatment activities with the powerful potential of basic science to 
untangle variables that may contribute to susceptibility, pathogenesis, and 
resistance in malaria, this is not always possible on a large scale. Based 
on extensive statistical analysis of our patient group, the present study 
reveals three potentially valuable, simple prognostic indicators of disease 
severity in India among malaria-positive patients: increasing age, high 
fever and anaemia (others were ruled out). The predictive indicators may 
be employed by clinicians at GMC and in similar resource-limited settings 
when making hospital admissions decisions.
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CONSERVED SEQUENCE MOTIFS IN PLACENTAL MALARIA 
VACCINE CANDIDATE VAR2CSA DESPITE LARGE OVERALL 
SEQUENCE DIVERSITY
Antoine Dara1, Mark A. Travassos1, Matthew Adams1, Elliott 
F. Drábek2, Sonia Agrawal1, Drissa Coulibaly3, Mahamadou A. 
Théra3, Ogobara K. Doumbo3, Myaing M. Nyunt1, Joana C. Silva4, 
Christopher V. Plowe1, Miriam K. Laufer1
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Genome Sciences, University of Maryland School of Medicine, Baltimore, 
MD, United States, 3Malaria Research and Training Center, University 
of Science, Techniques and Technologies, Bamako, Mali, 4Institute 
for Genome Sciences, University of Maryland School of Medicine; 
Microbiology and Immunology, University of Maryland School of Medicine, 
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VAR2CSA, a member of the Plasmodium falciparum erythrocyte 
membrane protein 1 (PfEMP1) family, mediates the binding of P. 
falciparum-infected erythrocytes to chondroitin sulfate A, and is a key 
protein in the pathogenesis of placental malaria. VAR2CSA is a leading 
vaccine candidate against placental malaria, as it is a target of naturally 
acquired immunity to the disease. However, antigenic diversity presents a 
significant challenge to the development of a VAR2CSA-based vaccine. A 
broadly effective vaccine that overcomes strain specificity will likely require 
more than one allele of var2csa. To evaluate the possibility of regional 
differences in vaccine efficacy, we investigated whether sequence similarity 
among var2csa alleles is related to their geographic origin. We analyzed 
90 var2csa allelic sequences from 12, 43, and 7 samples from West Africa, 
East Africa, and a published dataset reflecting global diversity, respectively. 
The sequences from East Africa were generated using Pacific Biosciences 
(PacBio) amplicon sequencing, whereas those from West Africa were 
assembled from a combination of PacBio and Illumina whole genome 
sequence data. We analyzed patterns of similarity, based both on overall 
and partial sequences, as well as on k-mer composition. Our preliminary 
results show that VAR2CSA proteins are highly diverse (mean amino acid 
sequence similarity of 75%) and sequences did not cluster by geographic 
origin. However, we identified some conserved motifs in DBLepam4 and 
DBLepam5 among parasites collected from distant geographic regions. 
These findings support the possibility of developing a broadly protective 
VAR2CSA-based vaccine from a limited number of strains. We are 
extending our analysis with additional sequences from Southeast Asian 
isolates.
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INDEPENDENT ORIGIN AND GLOBAL DISTRIBUTION OF 
DISTINCT PLASMODIUM VIVAX DUFFY-BINDING PROTEIN 
GENE DUPLICATIONS
Jessica Hostetler1, Eugenia Lo2, Usheer Kanjee3, Pradipsinh K. 
Rathod4, Marcelo U. Ferreira5, Guiyun Yan2, Rick M. Fairhurst1, 
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Plasmodium vivax causes the majority of malaria episodes outside Africa, 
but remains a relatively understudied pathogen. The pathology of P. vivax 
infection depends critically on the parasite’s ability to recognize and invade 
human erythrocytes. This invasion process involves an interaction between 
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P. vivax Duffy-binding protein (PvDBP) in merozoites and the Duffy antigen 
receptor for chemokines (DARC) on the erythrocyte surface. Whole-
genome sequencing of clinical isolates recently established that some P. 
vivax genomes contain two copies of the PvDBP gene. The frequency of 
this duplication is particularly high in Madagascar, where there is also 
evidence for P. vivax infection in DARC-negative individuals. The functional 
significance and global prevalence of this duplication, and whether 
there are other copy number variants at the PvDBP locus, is unknown. 
Using whole-genome sequencing and PCR to study the PvDBP locus in 
P. vivax clinical isolates, we found that PvDBP duplication is widespread 
in Cambodia. The boundaries of the Cambodian PvDBP duplication 
differ from those previously identified in Madagascar, meaning that 
current molecular assays were unable to detect it. The Cambodian PvDBP 
duplication did not associate with parasite density or DARC genotype, and 
ranged in prevalence from 20% to 38% over four annual transmission 
seasons in Cambodia. This duplication was also present in P. vivax isolates 
from Brazil and Ethiopia, but not India. PvDBP duplications are much more 
widespread and complex than previously thought, and at least two distinct 
duplications are circulating globally. The same duplication boundaries 
were identified in parasites from three continents, and were found at high 
prevalence in human populations where DARC-negativity is essentially 
absent. It is therefore unlikely that PvDBP duplication is associated with 
infection of DARC-negative individuals, but functional tests will be 
required to confirm this hypothesis.
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INTERACTIONS AND COMPETITIVE GROWTH WITHIN MIXED 
INFECTIONS OF PLASMODIUM FALCIPARUM
Abigail R. Tirrell1, Lisa A. Checkley1, Marina McDew-White2, 
François H. Nosten3, Timothy J. Anderson2, Michael T. Ferdig1
1University of Notre Dame, Notre Dame, IN, United States, 2Texas 
Biomedical Research Institute, San Antonio, TX, United States, 3Centre for 
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Infections by multiple genetically distinct Plasmodium falciparum parasites 
are common in cases of human malaria. The dynamic interactions of 
parasites in mixed infections include competition between co-infecting 
strains and potential for selection of parasites with fitness advantages. 
With emerging artemisinin resistance, it is essential to understand the 
relative fitness of parasites exhibiting the delayed clearance phenotype 
that could influence their spread in populations. Although artemisinin 
resistance has been associated with the pfkelch13 gene, the in vivo 
delayed clearance phenotype does not have a corresponding in vitro IC50 
shift; furthermore, resistant parasites that lack pfkelch13 mutations have 
not been well characterized. The relative fitness of parasites displaying 
delayed clearance to artemisinin, both with and without pfkelch13 
mutations, is unknown, emphasizing the need for analyses of fitness 
costs and benefits of resistance mutations. In this research, pair wise 
competition assays were used to ascertain fitness of mutations associated 
with delayed clearance to artemisinin treatment. Slow clearance parasite 
isolates from Southeast Asia, with and without pfkelch13 mutations, 
were evaluated. Results indicate a range of relative fitness phenotypes 
associated with different mutations. Further experiments are in progress 
to implement competitions of these isolates in the presence of low level 
artemisinin drugs to elucidate which resistance associated mutations 
provide the most fitness for parasites to proliferate under drug pressure 
within mixed infections.
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MULTIPLEX BARCODED NEXT-GENERATION SEQUENCING OF 
MULTICLONAL PLASMODIUM FALCIPARUM GENOTYPES
Brandt Levitt, Wendy P. O’Meara, Scott Langdon, Steve M. Taylor
Duke University Medical Center, Durham, NC, United States
Large-scale molecular epidemiologic studies of Plasmodium falciparum 
parasites can investigate parasite biology and transmission, identify 
and predict the spread of drug resistance, and assist in the evaluation 
of vaccine candidates. The polyclonal nature of most infections in high 
transmission settings undermines many traditional genotyping approaches. 
Next-generation sequencing approaches to parasite genotyping may 
allow sensitive detection of minority variants, disaggregation of complex 
parasite mixtures and scalable processing of large samples sets. Therefore, 
we designed, validated, and applied to field parasites a new approach 
to parasite genotyping that leverages next-generation sequencing of 
individually barcoded samples in a highly scalable and multiplex manner. 
We utilize variant barcodes, invariant linker sequences and modular 
template specific primers in such a way as to allow for the simultaneous 
generation of high-dimensional sequencing data of multiple gene targets. 
The modularity of this approach permits a cost-effective and easily 
reproducible way to query many genes without experimental redesign. In 
practice, this approach generates large numbers of high quality reads in a 
manner that is robust to different sequencing technologies including both 
Ion Torrent and Illumina MiSeq. In mixtures of reference parasite genomes, 
we qualitatively and quantitatively detected unique haplotypes comprising 
0.1% of polyclonal infection. We demonstrate concordance of the 
outcomes of this method compared to traditional Sanger sequencing and 
pooled next-generation sequencing. Finally, we applied this genotyping 
approach to fresh parasites collected in Western Kenya in order to 
rapidly obtain parasites genotypes at three unlinked loci. In summary, we 
present a rapid, scalable and flexible method for genotyping individual P. 
falciparum parasites that further enable molecular epidemiologic studies of 
parasite evolution, population structure and transmission.
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THE DIVERSITY OF RNAS EXPRESSED IN PLASMODIUM 
VIVAX
Adam Kim1, Jean Popovici2, Amelie Vantaux2, Didier Menard2, 
David Serre1
1Cleveland Clinic, Cleveland, OH, United States, 2Institut Pasteur, Phnom 
Penh, Cambodia
The biology of the widespread human malaria parasite, Plasmodium 
vivax, remains largely unknown due to a lack of a robust in vitro culture 
system. Here, we used stranded RNA-sequencing technologies paired with 
depletion of highly expressed transcripts from the host (i.e. globin mRNAs 
and rRNAs) for assessing global transcriptome changes in the host and 
parasite during infection and treatment. From 100uL of patient blood, 
we isolated RNAs and sequenced >50 million paired end reads from three 
patients. 15-25% of the reads aligned to the P. vivax genome sequence, as 
a result of >80% reduction in human rRNAs and globin mRNAs. Using this 
large amount of sequence data, we de novo assembled all RNA transcripts 
expressed by intraerythrocytic P. vivax parasites. Many of our transcripts 
coincide with annotated protein-coding genes, though a very high number 
of genes have misannotated 5’ and 3’UTRs that often include unannotated 
introns likely involved in gene regulation. Additionally, we identified 
1,388 genes with multiple isoforms as a result of alternative splicing, 
intron retention, and alternative transcriptional start and stop sites. 5,207 
assembled transcripts had no coding potential and are likely noncoding 
RNAs. Because our data can separate reads that originate from different 
strands of RNA, we can assess that a large number of these noncoding 
reads are antisense RNAs for coding genes, while the rest are a mixture of 
small RNAs and intergenic long noncoding RNAs. Finally, as a result of high 
read coverage, we were able to additionally find >4,800 polymorphisms in 
each patient sample, data that can help us to determine the complexity of 
infection and how different polymorphisms affect transcription. Together, 
our study reveals the diversity and complexity of RNAs expressed by 
intraerythrocytic P. vivax parasites and show that stranded RNA-seq is a 
robust method to study host/parasite interactions using patient samples.
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EXCEPTIONALLY LONG-RANGE HAPLOTYPES IN 
PLASMODIUM FALCIPARUM CHROMOSOME 6 MAINTAINED 
IN AN ENDEMIC AFRICAN POPULATION
Alfred Amambua-Ngwa1, Bakary Danso1, Sukai Ceesay1, Davies 
Nwakanma1, David Jeffries1, Umberto D’Alessandro1, David 
Conway2
1Medical Research Council Unit The Gambia, Banjul, Gambia, 2London 
School of Hygiene & Tropical Medicine, London, United Kingdom
Previous genome-wide analyses of single nucleotide variation in 
Plasmodium falciparum identified evidence of an extended haplotype 
region on chromosome 6 in West Africa, suggesting recent positive 
selection. Such a pattern is not seen in samples from East Africa or 
South East Asia, so it could be marking a selective process particular 
to West Africa. Analyses of the haplotype structure in samples taken 
at different times could give clues to possible causes of selection. This 
study investigates chromosome 6 extended haplotypes in the Gambia by 
analysing alleles at multiple microsatellite loci using genome sequence 
data previously obtained from clinical isolates collected in 2008, followed 
by genotyping 13 loci in 405 isolates from 1991, 2008 and 2014. Multiple 
long haplotypes were evident in the population sample, and a region of 
high linkage disequilibrium was shown to span ~200 kilobases (Kb), with 
a core region of ~70 Kb having the most intact haplotype structure. Two 
of the haplotypes were detected in samples from 1991, which predates 
the time when chloroquine and antifolate resistance alleles became 
common locally, and these haplotypes were still present in 2014. The 
occurrence of several long haplotypes at intermediate frequencies suggests 
an unusual mode of selection in chromosome 6, possibly combined 
with recombination suppression on specific haplotypes. Such selection 
apparently occurred before the emergence of known antimalarial drug 
resistance alleles, and could be due to effects of other drugs or unknown 
processes that have long been operating in this endemic region.
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DE NOVO VARIANT CALLING TO RESOLVE TRANSMISSION 
DYNAMICS WITHIN CLONAL PLASMODIUM FALCIPARUM 
SAMPLES: A CRUCIAL TOOL FOR THE MALARIA ‘ENDGAME’
Seth N. Redmond1, Sarah Volkman2, Daouda Ndiaye3, Dyann 
Wirth4, Daniel Neafsey1
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Genetic studies have provided an increasingly clear view of malaria 
transmission; genotyping a small number of loci can allow us to study 
changes in transmission dynamics and relatedness in response to malaria 
control. Yet the genetic epidemiology of malaria lags far behind other 
pathogens. In bacterial or viral pathogens the higher mutation rates allow 
de novo variation to be used. With the Plasmodium falciparum genome, 
however, SNPs do not show sufficiently high mutation rates to allow us 
to distinguish between 100% related parasites. Conversely short tandem 
repeat (STR) loci, which mutate many orders of magnitude faster, are 
difficult to genotype from short-read sequence. Recent work at the Broad 
Institute - improved library preparation, read lengths, and methods of 
genotyping - now enable this kind of study to be undertaken. Applying 
these methods to P. falciparum, we show that INDEL and STR variation 
can now be called with greatly increased accuracy even in low-complexity 
regions of the P. falciparum genome, affording newfound access to 
significant amounts of de novo variation. We have employed these 
approaches to examine a set of parasites from Thies, Senegal that have 
not outbred and indistinguishable using current genotyping approaches. 
Using de novo variants only we have derived phylogenies and transmission 
networks for these parasites. As we move towards low-transmission or 
‘pre-elimination’ settings, in which highly-related parasites are the norm, 
we propose a framework to examine de novo mutation as a crucial tool 
for the ‘endgame’ of malaria eradication. By using derived mutation 
we add a valuable temporal dimension to genomic epidemiology; we 
will show how examining substitution rates in clinical sample sets can 
distinguish between different modes of transmission - potentially allowing 
us to identify superspreaders within transmission chains.
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ELUCIDATION OF THE DIVERGENT APICOPLAST GENOMES 
OF PLASMODIUM OVALE CURTISI AND P. OVALE WALLIKERI
Mary C. Oguike1, Ernest D. Benavente1, Taane G. Clark1, Hans-
Peter Fuehrer2, Arnab Pain3, Colin J. Sutherland1
1London School of Hygiene & Tropical Medicine, London, United Kingdom, 
2University of Veterinary Medicine, Vienna, Austria, 3King Abdullah 
University of Science & Technology, Thuwal, Saudi Arabia
Whole genome sequencing was attempted on parasite DNA extracted 
from the peripheral blood of malaria patients infected with Plasmodium 
ovale wallikeri. A full-length contig of the apicoplast genome was 
successfully assembled and this was compared to published sequences 
from the P. ovale curtisi apicoplast genome. Observed dimorphic regions 
are being confirmed in archived DNA from multiple isolates of both 
species. The potential for an apicoplast-mitochondrial barcode of defined 
polymorphisms that perfectly discriminates these two closely related 
parasite species will be considered.
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WHOLE-GENOME PROFILING OF DIFFERENTIALLY 
EXPRESSED GENES IN CHILDREN WITH MALARIAL ANEMIA
Angela O. Achieng1, Zachery S. Karim1, Gavin Pickett1, Zidong 
Li1, Qiuying Cheng1, Bernard Guyah1, Samuel B. Anyona2, John M. 
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Application of whole genome expression profiling is a useful approach for 
identifying important gene pathways associated with disease outcomes, 
especially in a multifocal disease such as falciparum malaria. In high 
transmission regions, malaria commonly manifests as severe malarial 
anemia [SMA, hemoglobin (Hb)<5.0 g/dL], primarily in infants and 
young children. Currently, the molecular mechanisms that condition the 
development of SMA are largely undefined. Therefore, use of unbiased 
transcriptomics is suitable in young children with SMA where sample 
volume is limited to perform individual gene quantification. Malarious 
children (n=1218, aged 3-36 mos) were stratified based on disease severity 
into ‘polarized’ extremes of non-SMA (Hb, 8.0-10.9g/dL, n=532) and SMA 
(n=228) groups after exluding children’s with co-infections (bacteremia and 
HIV-1) and hemoglobinopathies (SSD, G6PD deficient and α-thalassemia). 
RNA was isolated from leukocytes collected on first hospital enrollment 
to the study prior to treatment interventions. Based on RNA quality 
checks, 72 samples (non-SMA, n=51; SMA, n=21) were selected for 
transcriptomics analysis. Gene expression analysis was performed using 
the Illumina® HumanHT-12 beadchip covering 47,231 transcripts specific 
to 19,185 genes. Data were analyzed through step-wise procedures to 
exclude transcripts identified as having an “absent” expression. A second 
quality control filter removed transcripts with low signal values, resulting 
in 3,981 genes. Transcripts with ≥1.5-fold change in SMA relative to 
non-SMA group (P<0.05) were 629 genes; 597 upregulated and 32 
downregulated. To infer biological significance, we generated relational 
pathways, resulting in 30 networks. The networks that showed highest 
significance (P=3.53x10-19) were enriched for immune response, signal 
transduction and hematopoiesis genes. Additionally, validation of selected 
genes [HSPA1A (n=89), IL-18 (n=77) and COX2 (n=23)] showed an 
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identical trend. In summary, transcriptomic arrays identified both novel 
and known genes/gene pathways that are important for the host immune 
response to malaria infection.
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ANALYSIS OF MULTIPLICITY OF ETHIOPIAN PLASMODIUM 
VIVAX INFECTIONS AND RELAPSE PATTERNS USING PVMSP1 
AMPLICON DEEP SEQUENCING
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Parasite genetic diversity and multiplicity of infection (MOI) affect clinical 
outcomes, response to drug treatment and naturally acquired or vaccine-
induced immunity. Based on microsatellite and merozoite surface protein 
(MSP) markers, a number of studies have reported on MOI and the 
frequency of multiclonal infections in Plasmodium parasites. However, 
traditional methods often underestimate the MOI and the frequency of 
multiclonal infections due to technical sensitivity and specificity. Next-
generation sequencing techniques provide a novel opportunity to study 
parasite diversity. In this study, we conduct amplicon deep sequencing of 
PvMSP1 to determine MOI and detect the relapse pattern of Plasmodium 
vivax from Southwestern Ethiopia. A total of 139 P. vivax dry blood 
samples were pyro-sequenced on a 422 bp fragment of PvMSP1 amplicon, 
yielding a total of 231 haplotypes. The average of MOI was 4.68, ranging 
from 2 to 14 clones in a single individual. However, using 3 microsatellite 
markers, an average of MOI=2.64 was detected with only 1-5 clones 
in a single subject. Four (80%) out of 5 subjects with recurrent vivax 
malaria were found to be relapse 44-65 days after chloroquine treatment. 
Significantly different MOIs were found among age groups, locations, and 
transmission seasons as well as between symptomatic and asymptomatic 
samples. Significantly higher MOI was found in clinic samples. Young 
children and old adults showed a higher MOI than that of older children. 
These results suggest that P. vivax multiclonal infections were common 
together with high proportions of relapse in Ethiopia. This study has 
important implication for the provision of primaquine to prevent relapse, 
anti-relapsing interventions and eliminating malaria in the low transmission 
areas.
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IMPROVED, HIGH-RESOLUTION SINGLE-CELL GENOMIC 
PROFILING OF HUMAN MALARIA PARASITES
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In many cases, malaria patients suffer from complex infections caused 
by multiple parasite lineages. The prevalence of, and interactions 
between, unique parasite genotypes within such multiple genotype 
infections are wholly unknown, complicating efforts to understand the 
spread of drug resistance, genetic recombination, and transmission to 
mosquitoes. For a first look at component genotypes within complex 
infections, we previously developed a single-cell genomics platform 
where individual parasites were briefly cultured ex vivo, captured by 
flow cytometry and whole-genome amplified prior to deep sequencing. 
Our analyses showed that coverage of the genome was highly variable, 
limiting the construction of complete haplotypes. We have since further 
optimized our protocol, focusing our analysis on late-stage parasites, 
which contain a higher amount of DNA template, by increasing the 
time of culture and utilizing restrictive flow cytometry gating. Analysis 
of these replicating parasites yielded superior genomic data in terms 
of the rate of successful amplification, the fraction of reads mapped to 
the parasite genome (purity), and genome-wide coverage. With broad 
haplotype blocks in hand, it is now feasible to obtain a comprehensive 
portrait of genetic variation in each cell. Here, we report the analysis of 
several dozen individual Plasmodium falciparum genomes collected from 
patients in a region of high malaria transmission. These improvements 
enable characterization of the genetic diversity in malaria infections at 
unprecedented resolution and scale.
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POPULATIONS FROM SOUTH ASIA, WITH COUNTRY-LEVEL 
CLUSTERING OF GENOMIC RELATIONSHIPS
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India records about two to ten million cases of malaria every year, with 
about 50,000 deaths per year. Compared to the heavy emphasis of 
malaria research in Africa and in Southeast Asia, much less is known 
about genomic and phenotypic properties of parasites from the Indian 
subcontinent and such omissions need attention since Plasmodium 
falciparum isolates differ genetically as well as by phenotypes relative 
to their geographic origins. Previous genome-wide comparisons have 
analyzed stratification in global parasite populations across different 
continents. However, these studies have not included Indian isolates in 
the past. Here, we examine whole genome sequences from 23 Indian 
parasite isolates and their relationships with hundreds of other isolates 
from around the globe. Our analysis provides a rich collection of over 
360,000 high quality variants. The entire collection of these variants was 
used to calculate a nucleotide distance estimate between each pair of 
global isolates. Principle coordinate analysis showed that parasite isolates 
segregate based on geographic locations, where an entire cluster can 
be classified as originating from a single continent. Removing the highly 
variable var genes from all the genomes prior to estimating the pair-wise 
distances eliminates many of the sequencing and alignment errors and 
reveals an even higher resolution geographic segregation. Surprisingly, 
Indian isolates segregate into a unique cluster widely separated even 
from other South Asian isolates. Nearest neighbors to Indian isolates are 
Bangladesh followed by other South-East Asian countries. This, therefore, 
reveals a unique place for India in the world malaria map. Monitoring of 
global malaria elimination strategies as well as global parasite evolution 
will have to include India due to the unique history of these parasites and 
their strategic position between Southeast Asia and Africa.
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EVALUATING THE INFORMATION VALUE OF PARASITE 
GENOMICS FOR MALARIA ELIMINATION
Edward A. Wenger
Institute for Disease Modeling, Bellevue, WA, United States
As countries push towards malaria elimination, there is an increasing 
need to understand the disease transmission network and particularly 
the dynamics of residual foci. Sequencing parasite genomes has the 
potential to distinguish between local and imported cases by source, to 
assist in categorizing areas with varying capacities for transmission and 
their relative connectivity, and to validate the relevant time and space 
scales that define effectively disconnected regions. Using a dynamical 
model that tracks full parasite genomes of indiviudal Plasmodium 
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falciparum infections, we demonstrate the potential information value of 
different sequencing technologies and sampling frames to address these 
operationally critical questions.
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ABSENCE OF IN VIVO SELECTION OF K13 POLYMORPHISMS 
AFTER ARTEMETHER LUMEFANTRINE TREATMENT IN 
UGANDA
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In Southeast Asia, the Plasmodium falciparum (Pf) kelch13 
(PF3D7_1343700) gene constitutes a useful molecular marker for 
artemisinin resistance surveillance. Mutations in the Pfkelch13 are known 
to be involved in the development of delay of parasite clearance after 
artemisinin treatment. This delayed clearance has also been significantly 
associated with the following six particular SNPs in Pf; ferredoxin (fd), 
apicoplast ribosomal protein S10 (arps10), multiple resistance protein 
2+(mdr2), chloroquine resistance transporter (crt), phosphoinositide-
binding protein (pibp) and protein phosphatase (pph) genes in South 
East Asia. Individual treatment would select resistant parasites in the 
human body, namely in vivo selection. Currently, there’s a paucity of 
data about in-vivo selection of the above mentioned mutations. We 
conducted an artemether-lumefantrine (AL) follow-up study in Uganda, in 
which genotypes in Pfkelch13 and six SNPs were compared before drug 
administration and in all recurrent parasites during a follow-up period of 
28 days. We found that AL treatment was very effective with PCR adjusted 
efficacy of 95.1%. Only three cases showed late clinical failures. Among 
a total of 161 isolates before AL treatment, almost all (96.8%) had wild 
type alleles in Pfkelch13. Similarly, only wild type alleles were observed in 
fd, arps10, mdr2, pibp and pph genes. Mixed alleles (wild and mutant) 
were observed in 2.3% of isolates in crt. In all follow-up cases, presence of 
parasites was molecularly confirmed and 21 positive results were obtained. 
All these isolates harbored wild type alleles in Pfkelch13 and the six 
genes. These results suggest that very few isolates were observed after AL 
treatment in Gulu Northern Uganda, but this may not be the case because 
of the potential selection of mutant alleles in the genes that are associated 
with artemisinin resistance in Southeast Asia.
1604
EUPATHDB: A POWERFUL EUKARYOTIC PATHOGEN 
GENOMIC AND FUNCTIONAL GENOMIC DATA MINING 
RESOURCE
Susanne Warrenfeltz1, Brian Brunk2, Omar Harb2, Jessica 
Kissinger1, David Roos2, for the EuPathDB team
1University of Georgia, Athens, GA, United States, 2University of 
Pennsylvania, Philadelphia, PA, United States
The Eukaryotic Pathogen Database (EuPathDB, http://eupathdb.org) 
is a free, online data mining resource that facilitates the discovery of 
meaningful biological relationships from large volumes of data by 
integrating pre-analyzed omics data with advanced search capabilities, 
data visualization and analysis tools. EuPathDB supports over 170 
organisms within Amoebazoa, Apicomplexa, Chromerida, Diplomadida, 
Trichomonadida, Kinetoplastida and numerous phyla of oomycetes and 
fungi. For these organisms, EuPathDB integrates a wide range of data 
including genome sequence and annotation, transcriptomics, proteomics, 
epigenomics, metabolomics, population resequencing clinical and field 
isolates, and data that inform host-pathogen interactions. Data are 
analyzed using standard workflows and an in-house analysis pipeline 
generates data including domain predictions, orthology profiles across 
all genomes and GO term associations. Our unique strategies system 
offers over 100 structured searches that query the pre-computed data. 
Individual search results can be combined into strategies that easily 
merge evidence from diverse data types and across organisms. Easily 
accessible tools enhance the search strategy system and include dynamic 
data visualization, comparative genome analysis, population genetics 
tools, and functional or pathway enrichment. Forthcoming new tools and 
functionalities include a private user work-space for primary data analysis, 
functional analysis tools for result summarization, genome browser and 
query improvements. This comprehensive resource places the power 
of bioinformatics with the entire scientific community in support of 
hypothesis driven research. EuPathDB’s active user support offers an email 
help desk (help@eupathdb.org), social media, a You Tube channel with 
tutorials and a worldwide program of workshops.
1605
THE BIOLOGICAL FUNCTION OF ANTIBODIES INDUCED 
BY THE RTS,S/AS01 MALARIA VACCINE CANDIDATE IS 
DETERMINED BY THEIR FINE SPECIFICITY
Sidhartha Chaudhury1, Christian F. Ockenhouse2, Jason A. 
Regules3, Sheetij Dutta4, Anders Wallqvist1, Erik Jongert5, Robert 
Paris4, Norman C. Waters4, Franck Lemiale2, Elke S. Bergmann-
Leitner4
1Biotechnology High Performance Computing Software Applications 
Institute, Telemedicine and Advanced Technology Research Center, Fort 
Detrick, MD, United States, 2PATH Malaria Vaccine Initiative, Washington, 
DC, United States, 3United States Army Medical Research Institute of 
Infectious Diseases, Fort Detrick, MD, United States, 4Walter Reed Army 
Institute, Silver Spring, MD, United States, 5GlaxoSmithKline Vaccine, 
Rixensart, Belgium
Recent vaccine studies suggest that the magnitude of an antibody 
response is often insufficient to explain efficacy, suggesting that 
characteristics regarding the quality of the antibody response, such 
as its fine-specificity and functional activity, may play a major role in 
protection. Previous studies of the lead malaria vaccine candidate, RTS,S, 
have shown that circumsporozoite protein (CSP)-specific antibodies and 
CD4+ T cell responses are associated with protection, however the role of 
fine specificity and biological function of CSP-specific antibodies remains 
to be elucidated. Here, we addressed the relationship between fine 
specificity, opsonization-dependent phagocytic activity, and protection in 
RTS,S-induced antibodies. We developed a new method for measuring 
the phagocytic activity mediated by CSP-specific antibodies and applied 
it to samples from a completed phase 2 RTS,S/AS01 clinical trial. We also 
assessed the fine-specificity of the antibody response using ELISA against 
three antigen constructs of CSP: the central repeat region, the C-terminal 
domain, and the full-length protein. We carried out multi-parameter 
analysis of phagocytic activity and fine-specificity data across to identify 
potential correlates of protection in RTS,S. We found that phagocytic 
activity was correlated with full-length CSP and C-terminal specific 
antibody titers, but not to repeat region antibody titers. When expressing 
the phagocytic activity as ‘opsonization index’, a relative measure 
that normalizes phagocytic activity with CS antibody titers, we found, 
surprisingly, that protected subjects had a significantly lower opsonization 
index than non-protected subjects. The data suggest that the opsonization 
is a surrogate marker of protection induced by the RTS,S/AS01 vaccine 
and determined how antibody fine-specificity is linked to opsonization 
activity. Our findings suggest that the role of opsonization in protection 
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in the RTS,S vaccine may be more complex than previously thought, and 
demonstrate how integrating multiple immune measures can provide 
insight into underlying mechanisms of immunity and protection.
1606
PLACENTAL MALARIA IS ASSOCIATED WITH ALTERED FETAL 
CYTOKINE PROFILES
Sarah Boudova1, Titus Divala2, Randy Mungwira2, Patricia 
Mawindo2, Tamiwe Tamoka3, Marcelo B. Sztein4, Kirsten E. Lyke1, 
Cristiana Cairo5, Miriam K. Laufer1
1Institute for Global Health, Division of Malaria Research, University of 
Maryland School of Medicine, Baltimore, MD, United States, 2Blantyre 
Malaria Project, Blantyre, Malawi, 3University of Malawi College of 
Medicine, Blantyre, Malawi, 4Institute for Global Health,Center for Vaccine 
Development, University of Maryland School of Medicine, Baltimore, MD, 
United States, 5Institute of Human Virology, University of Maryland School 
of Medicine, Baltimore, MD, United States
Malaria during pregnancy threatens the health of mothers and newborns 
and may have long-lasting consequences on infant health. Our previous 
work shows that placental malaria is associated with increased risk of 
malaria in the infant. We hypothesize that this is due to priming of 
the fetal immune system toward immunoregulatory responses as a 
consequence of maternal malaria infection. We collected cord blood 
serum from children born to mothers with detailed antenatal histories and 
followed a subset of these children through the first year of life, collecting 
serum at 12 months of age. We used multiplexed electrochemiluminescent 
immunoassays (Meso Scale Discovery) to measure 11 cytokines (IL-1β, 
IL-2, IL-4, IL-6, IL-10, IL-12p70, IL-13, IFNγ, TNFα, TGFβ and CRP). We 
analyzed cord serum from 26 infants born to mothers with no malaria 
during pregnancy, 26 born to mothers with peripheral malaria, 87 born 
to mothers with placental malaria, and 14 North American control infants 
never exposed to malaria. We observed that children born to mothers with 
chronic placental malaria had significantly elevated levels of TNFα (a pro-
inflammatory cytokine), IL-10 (an immunoregulatory cytokine) and CRP 
(a marker of inflammation) at the time of birth as compared to children 
born to mothers with peripheral malaria during pregnancy (p=0.003, 
p=0.001, p=0.014, respectively), no malaria during pregnancy (p=0.003, 
p=0.037, p=0.006, respectively) or North American controls (p=0.002, 
p<0.001, p=0.045, respectively). Cytokine levels normalized by one year 
of age. We propose a model in which placental malaria causes chronic in 
utero inflammation with compensatory production of IL-10 and induction 
of T regulatory cells (Tregs). After birth, cytokine levels normalize, but 
Tregs are maintained preventing effective immune responses to malaria 
and resulting in increased risk of malaria during infancy. We are currently 
conducting flow cytometric studies on cord blood to further explore this 
hypothesis. Our results will inform the design and implementation of 
prenatal interventions to protect the health of pregnant women, newborns 
and infants from malaria.
1607
PLASMODIUM FALCIPARUM INFECTION AND VACCINE 
RESPONSES: SHOULD WE TREAT PRESUMPTIVELY?
Sara Anne Healy1, Irfan Zaidi1, Charles Anderson1, Issaka Sagara2, 
Mahamadou S. Sissoko2, Erin Gabriel3, Mamadou Coulibaly2, Jen 
C.C. Hume1, Karamoko Niare2, Fanta Koita2, Sumana Chakravarty4, 
B. Kim Lee Sim4, Thomas L. Richie4, Stephen L. Hoffman4, Ogobara 
Doumbo2, Patrick E. Duffy1
1National Institutes of Health/DIR/National Institute of Allergy and 
Infectious Diseases/Laboratory of Malaria Immunology and Vaccinology, 
Rockville, MD, United States, 2Malaria Research and Training Center, 
Mali-NIAID ICER, University of Science, Techniques and Technologies of 
Bamako, Bamako, Mali, 3National Institutes of Health/DIR/BRB, Rockville, 
MD, United States, 4Sanaria, Inc., Rockville, MD, United States
Individuals with malaria may have blunted immune responses to some 
vaccines, suggesting that there is an active immune suppression or 
immunomodulation during infection. How and which vaccines are 
impacted by clinical malaria or asymptomatic parasitemia is not completely 
clear, nor is whether the impacts are sufficient to recommend delaying 
or presumptively treating individuals prior to routine vaccinations or in 
malaria vaccine trials. In a series of studies, we are examining the impact 
of malaria on immune cell function and on vaccine responses in cohorts 
of adults at various study sites in Mali, West Africa. These studies have 
examined whether antimalarial treatment, or episodes of parasitemia, 
alter antibody responses, T cell markers, and/or protective efficacy/activity 
following vaccination with approved routine vaccines (N=45; Euvax® or 
TWINRIX® and Menactra®), a whole organism malaria vaccine (N=30, 
PfSPZ Vaccine) and a transmission blocking vaccine (N=120; Pfs25H-EPA/
Alhydrogel®). Data from all three studies will be presented examining the 
impact of antimalarial treatment or of incidental malaria episodes on T cell 
exhaustion and regulation, as well as on vaccine responses.
1608
PATTERNS OF ANTIBODY RESPONSES TO PLASMODIUM 
FALCIPARUM INVASION LIGANDS ACROSS DIFFERENT 
ENDEMIC POPULATIONS IN WEST AFRICA
Henrietta E. Mensah-Brown1, Harvey Aspeling-Jones2, Lindsay 
B. Stewart2, Rupert K. Delimini3, Francis Atuguba4, Kwaku Asante 
Poku3, Bismarck Dinko5, Gavin J. Wright6, James G. Beeson7, David 
J. Conway2, Gordon A. Awandare1
1West African Centre for Cell Biology of Infectious Diseases, University of 
Ghana, Accra, Ghana, 2London School of Hygiene & Tropical Medicine, 
London, United Kingdom, 3Kintampo Health Research Centre, Kintampo, 
Ghana, 4Navrongo Health Research Centre, Navrongo, Ghana, 5School of 
Basic and Biomedical Sciences, University of Health and Allied Sciences, 
Ho, Ghana, 6Malaria Programme, Wellcome Trust Sanger Institute, 
Cambridge, United Kingdom, 7The Burnet Institute for Medical Research 
and Public Health, and Department of Microbiology, Monash University, 
Melbourne, Australia
Plasmodium falciparum uses a large repertoire of parasite proteins for 
invasion of erythrocytes, which appears to serve as an immune evasion 
mechanism, making it difficult to identify targets of invasion inhibitory 
responses. It is possible that endemicity influences gene expression of 
invasion ligands and receptor preferences of P. falciparum clinical isolates. 
Therefore, we hypothesized that antibody responses to parasite invasion 
ligands in individuals living in endemic areas would differ and also 
correlate with parasite ligand gene expression. To examine this hypothesis, 
plasma samples from 528 children (2-14 yrs) with malaria across four 
endemic areas in Ghana (Accra, Kintampo, Navrongo and Hohoe) and one 
endemic site in Nioro du Sahel in Mali were tested by ELISA for antibodies 
to P. falciparum invasion ligands, including EBA 175, EBA140, EBA181, 
Rh2, Rh4 and Rh5. The seroprevalence of antibodies to the different 
antigens ranged from 8% to 70% among the clinical cases tested in this 
study. Consistent with previous reports, seroprevalence to all the antigens 
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increased in an age-dependent manner and antibody responses to all 
antigens were negatively correlated with parasite density. When expressed 
relative to total antibodies detected, anti-Rh2 levels were significantly 
higher while anti-Rh4 levels were lower in the Kintampo, Navrongo and 
Hohoe compared to Nioro du Sahel. Altogether, our data reveals patterns 
of antibody responses to specific invasion ligands that may be influenced 
by multiple host and parasite factors including parasite biology, age and 
endemicity, and deeper understanding of how these factors interplay may 
be important in identification of potential blood stage vaccine targets.
1609
ISOLATION AND CHARACTERIZATION OF HUMAN 
MONOCLONAL ANTIBODIES TO PLASMODIUM VIVAX DUFFY 
BINDING PROTEIN FROM MALARIA EXPOSED INDIVIDUALS 
FROM BRAZILIAN
Vanessa C. Nicolete1, Lenore Carias1, Sebastien Dechavanne1, 
Marcelo U. Ferreira2, Christopher L. King1
1Case Western Reserve University, Cleveland, OH, United States, 
2Universidade de Sao Paulo, Sao Paulo, Brazil
Plasmodium vivax merozoites recognize specific receptors on the host 
cell surface to selectively invade reticulocytes. A critical parasite ligand 
is the Duffy binding protein (PvDBP), expressed in micronemes, which 
binds specifically to an erythrocyte membrane glycoprotein known as 
Duffy blood group antigen/receptor for chemokines (DARC). Antibodies 
to the cysteine-rich domain II of PvDBP can inhibit binding of this parasite 
ligand to DARC and inhibit P. vivax invasion of reticulocytes in vitro. In our 
previous study with an Amazonians population, we found individuals with 
high-level BIAb responses (> 80% binding inhibition) developed in 26.6% 
of subjects under conditions of low malaria endemicity that prevail in 
Amazonia. Once acquired, high-level BIAb responses were predominantly 
PvDBP variant-transcending and that subjects with the strongest BIAb 
response had a >40% decrease in the risk of clinical vivax malaria during 
the follow-up, compared to those with the weakest BIAb response. We 
obtained PBMCs from 7 Amazonians with high levels of BIAbs, and sorted 
single PvDBPII-specific IgG+ memory B cells from two individuals, PCR 
amplified their IgG heavy and light chain variable regions, and cloned 
them into a human IgG expression vector to generate a panel of human 
monoclonal antibodies (mAbs). We found one mAb which recognized 
PvDBPII. We are now characterizing this mAb in terms of P. vivax DBPII 
strain-specificity, the PvDBPII epitopes it recognize, affinity for PvDBPII, and 
ability to block P. vivax invasion of reticulocytes in vitro.
1610
INVESTIGATING A POTENTIAL ROLE FOR TH1-POLARIZED 
TFH CELLS IN DRIVING ATYPICAL MEMORY B CELL 
EXPANSION IN MALARIA
Nyamekye Obeng-Adjei, Peter Crompton
National Institutes of Health, Rockville, MD, United States
Malaria-specific antibody responses are short lived in children, leaving 
them susceptible to repeated bouts of clinical malaria. The B and T cell 
biology underlying short-lived antibody responses to malaria remains 
unclear. We recently found that chronic malaria exposure is associated 
with a large increase in atypical memory B cells (MBCs) that express 
inhibitory receptors and exhibit stunted BCR signaling and impaired B 
cell proliferation, cytokine production and antibody secretion. T follicular 
helper (Tfh) cells are known to play a critical role in helping B cells and 
generating long-lived antibody responses. In other recent work we 
demonstrated that acute febrile malaria in children preferentially activates 
Th1-polarized PD-1+CXCR5+CXCR3+ memory Tfh (Tfh-1) cells that exhibit 
impaired B cell help. In ongoing work we aim to understand the impact 
of malaria-induced Tfh-1 activation on the B cell response to malaria. Our 
preliminary findings suggest that Tfh-1 cells contribute to the expansion 
of T-bet+ B cells that phenotypically resemble atypical memory B cells—
providing a potential link between the quality of Tfh cell responses to 
malaria and atypical MBC expansion.
1611
HUMAN ANTIBODIES IN MALARIA: STRUCTURE, FUNCTION, 
MECHANISM AND NEUTRALIZATION
Darya Urusova1, Abhishek Sethi1, Lenore Carias2, Nichole D. 
Salinas1, Edwin Chen1, Samanth J. Barnes3, Sokunthea Sreng4, 
Suon Seila4, Chanaki Amaratunga4, Rick M. Fairhurst5, John H. 
Adams3, Christopher L. King2, Niraj H. Tolia1
1Washington University School of Medicine, St. Louis, MO, United 
States, 2Case Western Reserve University, Cleveland, OH, United States, 
3University of South Florida, Tampa, FL, United States, 4National Center for 
Parasitology, Entomology and Malaria Control, Phenom Penh, Cambodia, 
5National Institute of Allergy and Infectious Diseases, Rockville, MD, United 
States
The design of effective malaria vaccines will require harnessing the human 
antibody response to produce broadly-neutralizing antibodies against 
Plasmodium antigens, which contain both protective and non-neutralizing 
epitopes. Highly-immunogenic non-neutralizing epitopes produce high-
titers of non-protective antibodies and limit the production of neutralizing 
antibodies against protective epitopes. Therefore, accurate human B 
cell epitope maps of Plasmodium antigens are necessary to identify and 
retain protective epitopes, while eliminating highly-immunogenic non-
protective epitopes for vaccine designs. We will present the first structural 
and functional data on naturally-acquired human antibodies that target 
Plasmodium antigens. Human monoclonal antibodies were isolated, 
cloned, expressed, and purified from individuals exposed to malaria. X-ray 
structures of antibodies in complex with Plasmodium antigens provided 
high-resolution definition of the epitopes and of the mechanisms of 
neutralization. In addition to crystallography, epitopes were identified by 
mutational, computational, and biophysical methods in a combinatorial 
approach. Within a given antigen, the most effective inhibitory human 
antibodies share a protective epitope, prevent the function of the antigen, 
and appear to be strain-transcending. Strikingly, the epitopes recognized 
by human monoclonal antibodies are distinct from neutralizing epitopes 
defined by mouse vaccinations, emphasizing the need to study human 
antibody responses as results derived from murine studies may not 
translate to human immunology and likely confound the design of human 
vaccines. These studies provide comprehensive explanations of human 
antibody neutralization mechanisms and expand our understanding of 
the function of Plasmodium antigens. These data, in combination with 
other data on epitopes known to be broadly-neutralizing, will improve the 
development of next-generation protective vaccines.
1612
ELUCIDATING NATURAL KILLER CELL-MEDIATED ANTIBODY-
DEPENDENT CELLULAR CYTOTOXICITY TOWARDS RED 
BLOOD CELLS INFECTED BY PLASMODIUM FALCIPARUM
Gunjan Arora, Geoffrey T. Hart, Sanjay A. Desai, Eric O. Long
National Institute of Allergy and Infectious Diseases, National Institutes of 
Health, Rockville, MD, United States
In malaria endemic areas, humans develop clinical immunity only after 
years of recurrent exposure. This naturally acquired immunity depends 
primarily on antibodies specific for parasite antigens. The underlying basis 
of this protective response remains unclear. In particular, the contribution 
of antibody-dependent cellular cytotoxicity (ADCC) to malaria immunity 
remains unclear. Primary human natural killer (NK) cells from peripheral 
blood exhibit potent ADCC through FcγRIII (CD16) binding to IgG-
coated target cells. Without specific antibodies, NK cell-mediated natural 
cytotoxicity towards both uninfected and infected RBCs was undetectable. 
Addition of serum from rabbits immunized with human RBC, however, 
resulted in NK cell-dependent lysis of both uninfected and infected 
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RBC. Rabbit serum antibodies specific for PfEMP1, an immunodominant 
P. falciparum variant antigen at the surface of infected RBC, induced 
selective lysis of infected RBC by NK cells. Plasma from malaria-immune 
individuals also triggered selective NK-mediated ADCC of infected RBCs. 
Granzyme B, a serine protease released by cytotoxic lymphocytes, is a key 
effector of target cell death. Granzyme B activity was detected in infected 
RBCs during NK-mediated ADCC using a granzyme B reporter in live 
cells. Furthermore, the general serine protease inhibitor DCI blocked RBC 
lysis. These results suggest that granzymes contribute to NK-mediated 
cytotoxicity towards infected RBCs. Using time-lapse imaging, dynamics 
of granzyme B delivery into infected RBC and subsequent outcome will be 
analyzed. Furthermore, NK-mediated ADCC triggered by antibodies from 
malaria-immune individuals inhibited Plasmodium falciparum growth, as 
determined by the re-invasion of fresh, uninfected RBC. Therefore, primary 
human NK cells have the potential to limit the growth of blood-stage P. 
falciparum through specific ADCC-mediated lysis of infected RBC.
1613
TRANSPLACENTAL TRANSFER OF MATERNAL MALARIA-
SPECIFIC IGG3 IS ALTERED BY A POLYMORPHISM IN THE 
BINDING DOMAIN TO FCRN
Celia Dechavanne1, Fernanda Alvarado1, Magalie Dambrun2, 
Jean-Michel Dugoujeon3, Evelyne Guitard3, Indu Malhorta1, Andre 
Garcia2, Florence Migot-Nabias2, Christopher L. King1
1Case Western Reserve University, Cleveland, OH, United States, 2IRD 
- Institut de Recherche pour le Développement, Paris, France, 3CNRS - 
Centre national de la recherche scientifique, Toulouse, France
Transfer of protective maternal IgG to the fetus occurs by active transport 
via the Fc Receptor (FcRN) on the syncytiotrophoblast cells of the placenta, 
contributing to antibody-mediated protection against malaria in early 
infancy. IgG1 and IgG3 subclasses are the most efficiently transported 
antibodies. Although IgG1 subclasses dominate the immune response 
to many pathogens, robust malaria-specific IgG3 often occurs to many 
malaria proteins and have been strongly correlated with protection 
against clinical malaria as it is the case for the Merozoite Surface Protein 
2. Interestingly IgG3 subclass is the only IgG subclass to contain a single 
amino acid polymorphism R435H, localized on the Fc fragment of the 
heavy chain, that affects the in vitro IgG3 binding of IgG3 to FcRN in 
vitro. Indeed, the R435 proteoform is associated with a reduced binding). 
Based on a cohort of mother-newborn pairs from a malaria endemic 
area of Benin (N=527), where the R435 allele frequency is 80%), we 
show for several asexual blood stage antigens a reduced efficiency of the 
transplacental transfer of malaria-specific IgG3 relative to IgG1 to the 
same blood stage antigen (MSP1, MSP2-3D7, MSP2-FC27, MSP3, Apical 
Membrane Antigen 1, Glutamate-Rich Protein region R0 and R2). This 
impaired transport is associated with the R435H polymorphism (p=0.01) 
after adjustment on for malaria exposure, and P. falciparum placental 
malaria infection. Thus transplacental transfer of malaria-specific IgG3 can 
be impaired by an individual polymorphism in the binding domain of the 
Fc fragment to the FcRN and may affect the efficacy by which of newborns 
acquire sufficient levels of protective antibodies to combat malaria.
1614
EVALUATING THE ANTIMALARIAL ANTIBODY RESPONSE TO 
SEVERE PLASMODIUM FALCIPARUM MALARIA IN UGANDAN 
CHILDREN: A CASE-CONTROL STUDY
Victoria Nakimbugwe1, Robert Opoka2, Joseph Smith3, Chandy 
John4, Arlene Dent5
1Cleveland Clinic Foundation, Cleveland, OH, United States, 2Makerere 
University College of Health Sciences, Kampala, Uganda, 3Seattle 
Biomedical Research Institute, Seattle, WA, United States, 4Indiana 
University, Indianapolis, IN, United States, 5Case Western Reserve 
University, Cleveland, OH, United States
Severe malaria remains a leading cause of morbidity and mortality 
worldwide. The brunt of the disease is borne by children in the sub-
Saharan region where Plasmodium falciparum is endemic. This sub-
population is at a higher risk of developing severe disease because it is 
only beginning to develop immunity to the disease. Epidemiologic studies 
have established that individuals in endemic areas acquire immunity 
through repeated exposure over many years, but this is not fully protective. 
We conducted a prospective study in Uganda, a malaria endemic area, to 
evaluate the antibody responses to several well characterized sporozoite 
and merozoite P. falciparum antigens. The study enrolled 711 children and 
followed them for a year with data collection completed every 6 months. 
We compared antibody responses in 498 children diagnosed with severe 
malaria, in the form cerebral malaria or severe anemia due to malaria, 
to that in 213 healthy controls matched for age and place of residence. 
Preliminary data indicate that, at enrollment, children with severe malaria 
had significantly higher antibody levels to CSP, EBA-140, EBA-175, 
EBA-181, MSP-2, MSP-3 and SERA5 antigens (all p < 0.0001) with no 
diminution of statistical significance following Bonferroni adjustment for 
multiple comparisons. Data analysis, including evaluation of response to 5 
unique PfEMP1 antigens, is ongoing.
1615
TESTING ANTIGEN INTERFERENCE ON A MULTIPLEX 
PLATFORM FOR MALARIA VACCINE RESEARCH
Tanmaya Atre, Kingsley Jarrett, Sheetij Dutta, Nancy Richie, 
Norman Waters, James Moon, Christian Darko
The Walter Reed Army Institute of Research, Silver Spring, MD, United 
States
The enzyme-linked immunosorbent assay (ELISA) is a technique, commonly 
used to measure antibody responses in serum or plasma samples. 
A traditional limitation of this technique is that, individual testing is 
required for every antigen against which samples are evaluated. With the 
introduction of multiplex detection assays, such as the one developed 
by the Luminex Corporation (Austin, Texas), more than one analyte can 
now be measured simultaneously. Such assays use fluorescent coded 
microspheres to which individual antigens or antibodies are covalently 
linked. The luminescence generated from each microsphere is used to 
quantify the amount of antigen/antibody present in a given test sample. 
This technique is currently being used for the multiplex detection of 
malaria antibodies in serum/plasma samples.The expanded capabilities 
of multiplex assays bring their own inherent challenges secondary to the 
potential for unintended protein- protein interactions. Such interactions 
may alter the measurable antigen concentrations or the antibody binding 
affinity, leading to antibody interference, higher background signals and 
decreased assay sensitivity. It is thus crucial to identify any interferences 
that may occur in assays, in order to provide acceptable ranges for 
each of the multiplexed antigens in the given test serum.We tested for 
the interference of different malarial antigens on a Luminex multiplex 
platform. Recombinant full length CSP, peptides of (NANP)6 antigen and 
Pf16, three antigens known to impact immunity in malaria, were used. 
These antigens were tested in various combinations of up to four antigens 
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per assay, on a standard platform with blank microspheres as controls. 
Data were presented in Median Fluorescent Intensity (MFI). The results will 
be discussed.
1616
DEFINING MOLECULAR ADJUVANT EFFECTS ON HUMAN B 
CELL SUBSETS
Jourdan K. Posner, William L. Gosnell, Sandra P. Chang
University of Hawai‘i. at Mānoa, Honolulu, HI, United States
The development of malaria blood stage antigen vaccine has been difficult 
and there has been only limited success to date in eliciting a potent and 
protective immune response in humans given these vaccines. The overall 
goal of this project is to identify and characterize new molecular adjuvants 
and adjuvant combinations that may be used in vaccines, including a 
malaria vaccine, to induce human B cell development and activation and 
to promote T follicular (Tfh) helper cell differentiation. To this end our lab 
examined the stimulation properties of six PRR ligands: R848 (TLR7/8), 
GLA (TLR4), iE-DAP (Nod1), poly(I:C) (TLR3), TDB (Mincle), and CpG (TLR9), 
on three human B cell subsets at different developmental stages, the 
immature transitional B cells, the mature marginal zone and the follicular 
B cells. These B cell subsets are part of normal B cell development and 
response to infection or vaccination via PRR ligand recognition and may 
affect the differentiation and activation of these B cell populations, as well 
as downstream Tfh cell interactions. Extensive research in mice has shown 
that PRR ligands affect B cell differentiation and activation, however the 
interaction of these molecules with these B cell populations has yet to 
be fully investigated in humans. Transitional B cells in human peripheral 
and cord blood were stimulated with various PRR ligands to determine 
their ability to mature transitional B cells to either a marginal zone or 
follicular B cell phenotype. Following stimulation, the majority of immature 
transitional B cells differentiated into a mature follicular B cell phenotype. 
Marginal zone and follicular B cells were isolated from human tonsils and 
stimulated to determine their ability to up-regulate activation markers like 
CD86. Following stimulation, tonsil-derived marginal zone and follicular 
B cell CD86 expression increased in response to TLR7/8 and TLR9 ligands. 
Understanding how PRR ligands affect human B cell subset differentiation 
and activation will give insight into their ability as vaccine adjuvants to 
drive the human adaptive immune response.
1617
IDENTIFICATION OF PROTECTIVE B-CELL EPITOPES WITHIN 
PFSEA-1, A NOVEL VACCINE CANDIDATE FOR PLASMODIUM 
FALCIPARUM MALARIA
Christina E. Nixon1, Sangshin Park1, Sunthorn Pond-Tor1, Jennifer 
F. Friedman1, Michal Fried2, Patrick E. Duffy2, Johnathan D. Kurtis1
1Rhode Island Hospital, Providence, RI, United States, 2National Institutes 
of Health, Bethesda, MD, United States
We discovered Plasmodium falciparum Schizont Egress Antigen-1 (PfSEA-1) 
by whole proteome differential screening using plasma from resistant 
and susceptible children living in a holoendemic region of Tanzania. 
Naturally occurring antibodies to the immunorelevant region of PfSEA-1 
(aa 810-1023; PfSEA-1A) protect young children from severe malaria 
and vaccination of mice with PbSEA-1A protect against P. berghei ANKA 
challenge. To identify protective B-cell epitopes in PfSEA-1A, we vaccinated 
non-human primates (Aotus sp; n=7) with rPfSEA-1A. We performed 
linear, B-cell epitope mapping of PfSEA-1A using anti-sera collected 
from vaccinated animals and screened microarrays containing 15mer 
overlapping peptides spanning PfSEA-1A. These serum samples recognized 
5 unique, linear B-cell epitopes within PfSEA-1A. We next determined 
if antibodies to these 5 epitopes were associated with protection from 
parasitemia following treatment in a cohort (males; age 7-30) from a 
holoendemic region of western Kenya. Volunteers were enrolled and drug 
cured of malaria infections at the start of a high transmission season, and 
followed with weekly blood films (18 wks) to assess reinfection. Blood was 
collected for serologic assays 2 weeks post treatment, prior to reinfection. 
We synthesized 5 peptides (~25aa) each containing one of the identified 
epitopes, coupled them to Luminex microspheres, and measured anti-
peptide IgG antibody levels in the 2wk post treatment sera collected 
(n=141). When analyzed as continuous antibody levels in GEE models, 
IgG responses to epitopes 1, 4, and 5 predicted significantly decreased 
parasitemia over 18 weeks of follow-up (P=0.005-0.015). When analyzed 
dichotomously, individuals with high antibody levels (≥median) to these 
epitopes had 25-26% decreased parasitemia (P=0.009-0.012) over the 
18 wks of follow-up compared to individuals with low antibody levels 
(<median). To advance the development of PfSEA-1 as a vaccine candidate, 
we are now designing immunogens targeting antibody responses to these 
three protective epitopes and have begun work to identify the Tfh-cell 
epitopes driving these responses.
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DISTINCT EXPRESSION PATTERN OF INHIBITORY MOLECULES 
ON CD4+ T CELLS IS ASSOCIATED WITH UNCOMPLICATED 
VERSUS COMPLICATED MALARIA
Maria S. Mackroth1, Annemieke Abel2, Christiane Steeg2, Denis 
Yar3, Otchere Addai-Mensah4, Ellis Owusu Dabo3, Thomas Jacobs2
1University Hospital Hamburg-Eppendorf, Hamburg, Germany, 2Bernhard 
Nocht Institute of Tropical Medicine, Hamburg, Germany, 3Kumasi Centre 
for Collaborative Research, Kumasi, Ghana, 4Kwame Nkrumah University 
of Science and Technology, Kumasi, Ghana
Infections with Plasmodium falciparum (Pf) can lead to a wide clinical 
spectrum, ranging from life-threatening malaria to asymptomatic 
infections. The immune response of the infected host is one of the main 
factors influencing the clinical picture of a Pf infection. In endemic areas, 
regularly exposed children over years develop a “clinical immunity” 
which protects from severe malaria and is associated with mild or 
asymptomatic Pf infections. The immunological mechanisms involved 
remain poorly understood but immune tolerance has been proposed to 
contribute to “clinical immunity”. We therefore examined the CD4+ T 
cell response of Ghanaian children with 1) complicated malaria, requiring 
inpatient treatment, 2) uncomplicated malaria, treated as outpatients; 
3) asymptomatic Pf infection and 4) uninfected children. Using flow 
cytometric analysis, we characterized the expression of inhibitory 
molecules on CD4+ T cells such as CTLA4, PD1, TIM3, LAG3 and CD39, 
which play important roles in the T cell regulation in acute and chronic 
infections. Both groups of children with acute malaria showed high 
expression of PD1 and CTLA4. But children with uncomplicated malaria 
showed a significantly higher expression of inhibitory molecules such 
as TIM3 and CD39 compared to children with complicated malaria. In 
contrast, asymptomatically infected children expressed only low levels 
of inhibitory molecules. A stronger expression of inhibitory molecules 
is associated with a clinically milder course of acute malaria. The 
identification of an “optimal” CD4+ T cell response could contribute 
to the development of new treatment and vaccination strategies for 
complicated malaria.
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USING DEEP POPULATION SEQUENCING TO INVESTIGATE 
IMMUNE-BASED SELECTION ON ANTIGENIC LOCI IN 
PLASMODIUM FALCIPARUM
Angela M. Early1, Peter B. Gilbert2, Marc Lievens3, Bronwyn 
MacInnis1, Christian F. Ockenhouse4, Sarah K. Volkman5, the RTS,S 
Clinical Trials Partnership, Dyann F. Wirth5, Daniel E. Neafsey1
1Broad Institute of Massachusetts Institute of Technology and Harvard, 
Cambridge, MA, United States, 2Fred Hutchinson Cancer Research Center, 
Seattle, WA, United States, 3GlaxoSmithKline Vaccines, Rixensart, Belgium, 
4PATH Malaria Vaccine Initiative, Washington, DC, United States, 5Harvard 
T.H. Chan School of Public Health, Boston, MA, United States
It is commonly presumed that the human immune response interacts with 
Plasmodium antigens in an allele-specific manner. Until recently, however, 
we lacked the large-scale data to rigorously address these questions in 
naturally acquired infections. As part of the recent RTS,S/AS01 phase 3 
trial, we obtained genetic data from over 5,000 infections at 11 study 
sites across Africa. This deep population sampling provides extremely 
high genetic resolution for three polymorphic P. falciparum proteins: CSP, 
SERA2, and TRAP. Previous analysis of these data compared vaccinated 
and control individuals to find that the RTS,S vaccine shows allele-specific 
efficacy at CSP. Here, we focus on the unvaccinated control individuals to 
investigate whether naturally acquired immunity exerts selective pressures 
and shapes patterns of polymorphism at these three loci. At CSP, but 
not SERA2, we found significant linkage disequilibrium both within and 
between putative T cell epitopes. Using a combination of haplotype-based 
analysis and in silico population genetic modeling, we showed that the 
linkage at CSP is most consistent with a model of long-term balancing 
selection. Further, the dataset’s unprecedented size provides the power 
to investigate intrahost selection at all three proteins. We examined 
polymorphism within each infection and found regions of reduced 
intrahost diversity in older children compared to younger children in both 
CSP and SERA2. Analysis of TRAP is ongoing. This pattern is consistent 
with a model of immune-mediated, allele-specific selection. Combining 
the signals of population-level and intra-host selection, we pinpointed 
specific amino acids that appear to drive the evolutionary dynamics at each 
protein, furthering our understanding of how the human immune system 
may interact with, and shape the diversity of, the parasite.
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ANTIGENICITY AND TRANSMISSION-BLOCKING EFFICACY OF 
PLASMODIUM VIVAX PVS48/45 PROTEIN
Angélica María Castellanos1, Myriam Arevalo-Herrera1, Carolina 
Blanco2, Xiomara Gaitan1, Andres Amado1, Manuela Herrera1, 
Nora Céspedes1, Carlos Echeverry1, Andres Vallejo3, María Isabel 
Arce2, Sócrates Herrera2
1Malaria Vaccine and Drug Development Center, Cali, Colombia, 2Cauaseco 
Scientific Research Center, Cali, Colombia, 3Caucaseco, Cali, Colombia
Plasmodium P48/45 are gametocyte antigens involved in parasite 
fertilization which induce immune responses that lead to blockage of 
parasite transmission to mosquito and are therefore considered candidates 
to develop a malaria transmission-blocking (TB) vaccines. In the process 
of developing P. vivax 48/45 as potential vaccine we recently expressed 
as a full length a recombinant product (rPvs48/45) and 5 internal 
fragments covering the entire protein. Immunogenicity studies in mice 
and Aotus monkeys indicate that anti-Pvs48/45 antibodies prevent the 
formation of oocyst in the mosquito midgut. Antigenicity studies were 
carried out in 235 plasma of individuals from malaria endemic areas of 
Colombia. Samples were assessed using the Pvs48/45 full-length protein 
and reactivity in 160 samples using five sub-fragments recombinant 
products by ELISA. Overall response indicated that 75.3% (177/235) of 
the sera recognized the full-length protein, whereas the N-term fragment 
encompassing the sequence between a.a.14 and a.a.186 was the most 
frequently recognized, 35.6% (57/160). Although all other fragments were 
recognized, their reactivity ranged between 15.5 - 21.7%. Transmission 
blocking assays in 152 samples tested showed that ~10% of these sera 
contains specific P. vivax antibodies with high TB activity (90-100 %), 51% 
showed an intermediate (50-90%) TB activity and 38% presented low (0-
50%) TB activity. Furthermore, affinity purified anti-Pvs48/45 cross-reacted 
with P. falciparum gametocytes by IFAT. These results confirm the high 
antigenicity of Pvs48/45 and identify the N-term fragment as the most 
antigenic. The functional activity of affinity purified specific anti-Pvs48/46 
N-term fragment is being tested.
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HUMAN CORD BLOOD CXCR5+ CD4 T CELLS: ASSOCIATION 
WITH IN UTERO EXPOSURE AND ANTIBODY RESPONSES TO 
PLASMODIUM FALCIPARUM
Samuel Tassi Yunga1, Lionel Ambe2, Joseph Siewe2, Matthew 
Nelson1, Obadia M. Kenji1, Jourdan Posner1, Sandra Chang1, Rose 
G. Leke2
1University of Hawaii, Honolulu, HI, United States, 2The Biotechnology 
Center, University of Yaounde 1, Yaounde, Cameroon
Fetuses exposed to Plasmodium falciparum (Pf) from infected mothers can 
make anti-malarial antibodies but it is unclear if long-lived plasma cells 
(LLPC) and memory B cells (mBC) contribute to the antibody production 
in utero. T-follicular helper cells (TFH) in adult germinal centers provide 
help for primed B cells to differentiate into LLPC and mBC and CXCR5-
expressing CD4 T cells in peripheral blood are circulating counterparts 
of TFH. The present study investigated whether CXCR5+ CD4 T cells 
are present in umbilical cord blood and if they are associated with in 
utero exposure and antibody responses to Pf antigens. Expression of 
CXCR5 messenger RNA (mRNA) was quantified by real-time PCR in 
CD4+ T cells isolated from peripheral blood mononuclear cells (PBMC) 
of 30 Cameroonian neonates and 6 Cameroonian adult controls. Day 5 
supernatants of neonatal PBMC cultures were tested for IgM and IgG to a 
panel of blood-stage Pf antigens using the MagPix. Placental malaria (PM) 
was assessed by microscopic examination of placental impression smears. 
A total of 20 out of 30 neonates (66.7%) had detectable CXCR5 mRNA 
with 20% having higher CXCR5 expression than the least expressing adult 
sample and 3.3% having expression levels comparable to the median adult 
expression. The presence of PM significantly increased CXCR5 expression 
(p=0.016) and in 55% of neonates, in vitro treatment of PBMC with 
MSP-1 antigen also increased CXCR5 expression. Also, 0% and 16.7% of 
culture supernatants tested positive for Pf IgM and IgG respectively but 
CXCR5 expression levels did not correlate with IgG levels. Collectively, the 
data show that circulating TFH-like cells can be produced in utero and their 
frequency increases in response to fetal Pf exposure. Supplemental studies 
are on thee way to determine if Pf-specific mBC and LLPC are generated 
in utero.
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PLASMODIUM FALCIPARUM WHOLE PROTEOME ANTIBODY 
PROFILES OF EUROPEAN VOLUNTEERS IMMUNIZED WITH 
SPOROZOITES UNDER CHLOROQUINE CHEMOPROPHYLAXIS
Joshua M. Obiero1, Joseph J. Campo2, Benjamin Mordmülle3, 
Anja Scholzen4, Else M. Bijker4, Sumana Chakravarty5, Andy Teng2, 
Jozelyn Pablo2, Chris Hung2, Meral Esen3, David H. Davies1, Peter 
G. Kremsner3, Stephen L. Hoffman5, Robert W. Sauerwein4, Philip 
L. Felgner1
1University of California Irvine, Irvine, CA, United States, 2Antigen 
Discovery, Inc., Irvine, CA, United States, 3Institute of Tropical Medicine 
and German Center for Infection Research, University of Tübingen, 
Tübingen, Germany, 4Radboud University Medical Center, Nijmegen, 
Netherlands, 5Sanaria, Inc., Rockville, MD, United States
Malaria remains a major disease burden in developing countries, killing 
over 438,000 people in 2015. Controlled human malaria infection 
(CHMI) has allowed for rational vaccine discovery and development. 
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Immunizations with both sporozoites from mosquito bites (CPS) and live, 
metabolically active cryopreserved sporozoites (CVac) under chloroquine 
Chemoprophylaxis in naïve healthy individuals induces dose-dependent 
sterile protection against sporozoites, but no immunity against blood 
stage infection. Understanding the antibody immune response in this 
immunization strategy is an important step in elucidating the mechanism 
of protection and designing next generation vaccine strategies. To 
understand antibody responses associated with protection, whole 
proteome microarrays covering 91% of the P. falciparum proteome 
were developed. We probed and analyzed serum samples collected 
from 39 Dutch individuals in three clinical trials who had undergone CPS 
immunization and 27 German volunteers in a trial of CVac at time points 
before and after immunization and CHMI. Protected CPS-immunized 
individuals showed a dichotomous antibody profile: low and high 
responders. High dose recipients had a broader repertoire of antibody 
reactivity compared to medium and lower dose recipients. Unprotected 
individuals showed boosting of antibody levels after CHMI. Only antibodies 
against CSP were boosted in protected individuals. In CVac recipients, liver 
stage proteins had the highest seropositive rate. The high dose group (9/9 
protected) had a larger network or immunoreactive proteins than the low 
and medium dose groups (3/9 and 6/9 protected, respectively) in bipartite 
network analysis. Dichotomous antibody profiles suggest two mechanisms 
of protection: 1) early protection that prevents increased parasitemia and 
limits antigen exposure, and 2) delayed protection at the late liver stage 
with greater antigen exposure. Correlates of susceptibility likely illustrate 
higher levels of antigen exposure due to more frequent and greater blood 
stage parasitemia.
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RAPID ASSESSMENT OF A NATIONWIDE LONG LASTING 
INSECTICIDAL (MOSQUITO) NETS DISTRIBUTION CAMPAIGN 
IN BENIN
Filemon Tokponnon1, Bella Hounkpe Do-Santos1, Peter Thomas2, 
Miriam Oke1
1Programme National de Lutte contre le Paludisme, Cotonou, Benin, 
2U.S. President’s Malaria Initiative, U.S. Centers for Disease Control and 
Prevention, Cotonou, Benin
In 2014 Benin’s National Malaria Control Program (NMCP) distributed 
more than 6 million long-lasting insecticidal nets (LLINs) through a 
national mass distribution campaign. The NMCP assessed post-campaign 
household (HH) coverage to help inform decisions about future 
campaigns and distributions. Random cluster sampling of villages and city 
neighborhoods was conducted in Benin’s 12 geographic departments. 
The final sample included all of Benin’s 34 health zones. Each health zone 
contained 30 clusters containing 10 HH each. Data were collected through 
interviews and direct observation of LLIN ownership and use. Population 
based estimates of universal coverage rate (one net per two persons), LLIN 
use and respondents’ knowledge of malaria were generated. Of 10,002 
HHs surveyed, 88% (95% CI: 87.2, 88.5) received a campaign coupon to 
claim a free net. Of these HHs, 89,857 (89%) provided information on the 
number of LLIN received and 8,528 (85.%, (95% CI: 84.5, 85.9) reported 
receiving at least one LLIN. Less than 3% of HHs received a coupon, 
but did not receive at least one LLIN. Fifty-six percent (95% CI: 55.4, 
57.5) of HH receiving an LLIN during the campaign received 2-3 LLINs. 
Approximately 76% (95% CI: 75.3, 77.2) of HHs receiving LLIN during the 
campaign reported adequate coverage (at least one LLIN for two persons). 
The gap in “adequate” coverage during the mass distribution campaign 
was in part due to an underestimate of the population in need of LLINs 
and a gap in the number of LLINs available for distribution during the 
campaign. The survey also found that 77.2% (95% CI: 76.4, 78.0) of HHs 
used an LLIN the previous night, and 89% (95% CI: 88.5, 89.7) of HHs 
demonstrated a good knowledge of the benefits of LLIN use for malaria 
prevention. Although this initial post-campaign assessment found that 
a high proportion of HHs received at least one net and the majority of 
HHs received an adequate number of nets during the national campaign, 
additional investments in campaign planning and logistics are needed to 
improve national universal coverage in Benin.
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DATA QUALITY ASSURANCE AND DATA MANAGEMENT IN A 
LARGE SYSTEMS BIOLOGY PROJECT: MAHPIC
Suman B. Pakala, Mustafa Nural, Jay Humphrey, MaHPIC 
Consortium, Jessica C. Kissinger
Institute of Bioinformatics, University of Georgia, athens, GA, United 
States
Large systems biology projects, such as the NIH/NIAID supported Malaria 
Host Pathogen Interaction Center - MaHPIC involve several collaborating 
research centers. Often, each center is specialized in different aspects of 
the system and each generates different data types such as genomics, 
transcriptomics, proteomics, metabolomics, lipidomics, immune profiling, 
clinical data, interaction models etc. Often, each center is accustomed 
to their own protocols, standards, and research practices, as dictated by 
their respective fields of specialization. However, together, they generate 
thousands of files that occupy terabytes of storage space. These data 
include raw and intermediate data (processed/normalized), result files, 
metadata, SOPs and other supporting documents. Data integration and 
mathematical modeling are the cornerstones and preferred approaches 
for systems biology research. However, for data integration and modeling 
to be possible, high-quality data in defined formats are necessary to make 
them computationally tractable. In the face of the high volume, high 
variety and high velocity of data generation, ensuring quality, accuracy, 
and accessibility to modelers, the team and the research community 
is a huge challenge. Solutions require rigorous standards, and willing 
participation by all involved. The Informatics Core of the MaHPIC works 
closely with all data producers and consumers to implement standards 
(when they exist) and to develop and/or implement rigorous protocols 
for data collection, validation, transformation, and dissemination. The 
solutions we have developed include metadata and result templates 
designed for each data type, data transfer protocols that include a pre-
transfer review of data, validation scripts and procedures, a dedicated file 
repository, a relational database for rapid data access by mathematical 
modelers, ontological mark-up of experimental processes and results, and 
several Web-based resources managed under a single project Portal. This 
high level of quality control for rich, well-curated data creates a valuable 
resource that should permit discoveries for years to come.
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FLUORESCENT LABELLING OF WILD TYPE PLASMODIUM 
SPECIES WITHIN THE MOSQUITO HOST: A NOVEL METHOD 
TO TARGET SPOROZOITES
Béatrice M. Winkel1, Anton Bunschoten2, Mick M. Welling1, Leon 
P. Munting1, Marijke C. Langenberg1, Blandine Franke-Fayard1, 
Séverine C. Chevalley1, Maria Yazdanbakhsh1, Koen Dechering3, 
Fijs W. van Leeuwen1, Meta Roestenberg1
1Leiden University Medical Center, Leiden, Netherlands, 2Wageningen 
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Netherlands
Mutant Plasmodium parasites expressing fluorescent proteins allow 
preclinical imaging of malaria development and distribution in both 
cell lines and animal models. However, the widespread application of 
genetically altered organisms is limited, due to regulatory constraints 
and the inability to culture some Plasmodium species, such as P. vivax. As 
such, reporter lines are not available for all Plasmodium species. This calls 
for more generic approaches that allow for the targeting and (molecular) 
imaging of sporozoites. Here we present a novel method to fluorescently 
label the sporozoite stage of wild-type Plasmodium species in vivo and 
without the need for genetic modification or the extraction of the parasite 
from its mosquito host. In vitro studies demonstrated a tailored fluorescent 
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cyanine-5 (Cy5) dye could efficiently stain sporozoites in vitro. By 
membrane-feeding infected Anopheles mosquitoes on glucose using the 
exact same dye we were even able to specifically label sporozoites within 
the mosquito’s salivary glands in vivo. The Cy5-dye was preferentially 
taken up by the mitochondrion of sporozoites and the uptake therein was 
higher compared to native mosquito tissue such as salivary gland cells 
or cells of the midgut. This specificity indicates that the mitochondrial 
activity of sporozoites provides a valuable (in vivo) targeting mechanism. 
To demonstrate cross-species utility of this technology, it was successfully 
applied in Plasmodium yoelii, berghei as well as falciparum. Viability of the 
fluorescently labelled sporozoites was confirmed in a hepatocyte cell line. 
Targeting plasmodium sporozoites through the feed removes the need for 
genetic modification with imaging vectors, thereby allowing more detailed 
studies for species such as Plasmodium vivax. In addition, the specificity of 
the mitochondrial uptake that we observed, suggests this to be a possible 
molecular targeting route for sporozoites residing in the mosquito host.
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THE IMPACT OF REVISED HEALTH MANAGEMENT 
INFORMATION SYSTEM (HMIS) REPORTING FORMS ON THE 
QUALITY OF MALARIA SURVEILLANCE DATA IN UGANDA: 
AN INTERRUPTED TIME SERIES ANALYSIS
Nelli Westercamp1, Sarah Staedke2, Grant Dorsey3, Simon P. 
Kigozi4, Alex Ndyabakira4, B.K. Kapella1, Steven Yoon1, Mary J. 
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4Infectious Diseases Research Collaboration, Kampala, Uganda
Malaria control programs need accurate data to implement and evaluate 
malaria interventions. In July 2015, Uganda introduced revised HMIS 
reporting forms to health facilities (HFs) to improve data quality. To 
evaluate this intervention, we assessed data completeness and accuracy 
in five HFs in Kayunga district. We abstracted data from 7,523 records in 
outpatient (OPD) registers and surveillance summary reports for 12 months 
before and four months after the intervention. Monthly completeness 
was measured as the proportion of malaria patient records with: 1) all 
data fields completed, and 2) clinically-relevant fields completed. Accuracy 
was the relative difference between numbers reported in the OPD register 
and surveillance reports for total patients, malaria patients, malaria tests 
performed, and positive malaria tests. Data were analyzed as interrupted 
time series with segmented linear regression. The current analysis is limited 
to one HF with complete time series available; data collection for other 
HFs is ongoing. Completeness for all data fields ranged from 0-14% over 
time, with no effect of the intervention (P-value of instantaneous change 
[P(i)]=.94, P-value of slope change [P(s)]=.66). Completeness of clinically-
relevant fields, which averaged 30% at baseline, showed an improvement 
of 38 percentage-points immediately following the intervention (95% 
CI: 0.28-0.49; P(i)<.0001). This increase was driven by improvement in 
recording patients’ weight. Discrepancies between surveillance reports 
and registers ranged from 0-15% for all patients, 1-9% for malaria 
patients, 24-71% for tests performed, and 0-20% for positive tests, 
with no significant intervention effect. In conclusion, revised reporting 
forms improved completeness for clinically-relevant data but had no 
effect on data accuracy. Analysis of additional HFs will assess intervention 
effectiveness in a broader setting.
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IMPACT OF THE APPLICATION OF THE NEW GUIDELINES OF 
MALARIA CASE MANAGEMENT IN SENEGAL
Alioune B. Gueye, Seynabou Gaye, Fatou Ba, Medoune Ndiop, 
Ibrahima Diallo, Moustapha Cisse, Mady Ba
National Malaria Control Program, Dakar, Senegal
Since 2013 The NMCP has made a review of its management policy 
and malaria prevention with the introduction of the new guidelines as 
recommended by the WHO. . So in February 2014, we updated the 
training book, the facilitator and participant’s guide with the support of all 
stakeholders . With the mobilization of 15 trainers from the central level, 
between February and April 2014, the agents of medical regions were 
oriented and 312 out of 328 were trained that makes a total participation 
rate of 95% with a sex ratio of 54% of men and 46% women. At the 
operational level, among the 2991 agents which were provided for, 2951 
were trained that is to say a participation rate of 98% covering all the 
districts in the country with a sex ratio of 42% women and 58% men. 
At the community level, 50 community health workers were trained with 
36 from health huts and 16 from ICCM sites with a focus on pre-referral 
treatment of severe cases. Thus between 2013 and 2015, there has been 
a positive improvement of some indicators of malaria case management 
in health structures resulting in a remarkable rise of the screening rate 
from 87.49% to 99.3%, the rate of ACT distribution from 98.3% to 
99.5%, the rate of the 2nd of IPTp coverage from 65.93% to 70.18% 
with an effective implementation of the 3rd dose of IPTp amounting to 
42.72% in 2015. In the same year, 7684 pregnant women with simple 
cases of malaria were effectively managed with ACT according to the 
new guidelines. . The management of severe cases by the injectable 
Artesunate became effective in 2015 at 07 pilot health units with a cure 
rate of 90% among the enrolled cases. All these positive results have 
shown that the implementation of the new guidelines can considerably 
improve the management of malaria at the level of prestation places and 
reduce the impact of morbidity and mortality at the same time. The NMCP 
is prospecting to continue the training of new providers but also to ensure 
a steady supervision of the trained staff to maintain the achievements 
in terms of capacity building in order to fully pre-eliminate malaria in 
Senegal.
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THE “DYNAMIC EPIDEMIOLOGY” OF MALARIA 
ELIMINATION IN EL SALVADOR: THE ROLE OF PROGRAM 
DECENTRALIZATION, STRATIFICATION, AND TIMELY 
TREATMENT IN THE RAPID AND DURABLE DECLINE IN 
MALARIA INCIDENCE SINCE THE EARLY 1980S
Robert Burton1, José Eduardo Chévez2, Mauricio Sauerbrey3, 
Angela Hartley1, Kammerle Schneider1, Caterina Guinovart1, 
Matthew Boslego1, Geoffrey Kirkwood1, Jamie Enrique Escobar2, 
Marta Alicia Ramírez2, Mirna Elizabeth Gavidia2, Richard Steketee1, 
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Salvador, 3The Carter Center, Atlanta, GA, United States
Resurgence of malaria cases in the 1970s following the end of the Global 
Malaria Eradication Program led El Salvador to re-evaluate and alter its 
national malaria control strategy. By the early 1980s, El Salvador had 
the highest burden of malaria in Mesoamerica (95,835 cases in 1980, 
~20% being Plasmodium falciparum). In 1995 El Salvador had its last 
autochthonous P. falciparum case. Today, it is on the verge of malaria 
elimination with fewer than 20 P. vivax cases per year since 2011 while 
its immediate neighbors continue to have the highest malaria incidences 
in the region. We reviewed and evaluated the policies and interventions 
implemented by the Salvadoran national malaria control program 
that likely contributed to this progress toward malaria elimination. 
Decentralization of the program, early regional stratification by risk, and 
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stratum-specific program actions resulted in the timely and targeted 
allocation of resources toward vector control, surveillance, and infection 
detection and treatment. The presumptive treatment regimen of combined 
chloroquine + primaquine was also shortened to five days, which greatly 
improved compliance. Importantly, weekly reporting by health workers 
and volunteer collaborators distributed throughout the country by 
strata, and informed via a reliable digital information system, enabled 
local malaria teams to provide rapid, adaptive, data-based responses in 
a locally focused manner leading to the description of the program in 
El Salvador in the 1980s and 1990s as “dynamic epidemiology”. Data-
based adaptation of the program continues to yield favorable results 
to maintain pre-elimination levels, with most of the current cases being 
imported from neighboring countries. Additional support for systematic 
elimination efforts in neighboring countries, potentially learning and 
adapting from the El Salvador experience, will undoubtedly benefit each 
of these countries and may be required for El Salvador to fully achieve 
malaria elimination. El Salvador provides a relevant country case study 
and learnings can guide application of similar strategies in other countries 
approaching malaria elimination.
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MOVING TOWARD IMPROVED MEASUREMENT OF MALARIA 
MORTALITY AT THE POPULATION LEVEL
Samantha Herrera1, Yeetey Enuameh2, George Adiei2, Kenneth 
Ae-Ngibise2, Kwaku Poku Asante2, Osman Sankoh3, Seth Owusu-
Agyei2, Yazoume Ye1
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Measuring malaria-specific mortality at the population level is challenging 
due to the difficulty in assessing malaria and the fact that most malaria 
deaths occur outside of the formal health system. To address this gap, the 
verbal autopsy (VA) method was developed to ascertain cause of death 
at the population level, yet there are limitations with current VA tools and 
approaches for measuring malaria-specific mortality. Given the emphasis 
in the new Global Technical Strategy for Malaria on monitoring malaria-
specific mortality, there is a strong need for the malaria community to 
develop improved methods for measuring malaria-specific mortality. To 
help inform a strategy for improving current methods, we carried out a 
systematic literature review to assess how VA tools and approaches have 
been used to measure malaria-specific mortality and the key challenges 
and limitations of existing tools and methods. A key limitation we found 
was the varying and overall low levels of sensitivity and specificity of VA 
tools for measuring malaria mortality, due to the non-specific symptoms 
of malaria and the differing malaria epidemiological contexts in which 
studies are conducted which result in misclassification bias (either over- or 
under-estimating the burden). Further, most VA validation studies use 
hospital records as the gold standard to compare VA results, yet these are 
not a true gold standard since it is a reflection of a different population 
and are often incomplete. Comparability of malaria mortality results 
across study sites was also a challenge, due to a lack of standardization 
in the application of VA tools and methods and the limited details 
provided overall in many published VA studies on the methods and tool 
used, including how malaria cause of death is determined. Given these 
limitations, we propose using community estimates of mortality measured 
through VA and complementing them with in-patient mortality data from 
health facilities that incorporate malaria parasitological confirmation to 
produce more robust population-level estimates of malaria mortality.
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MEASURING THE IMPACT OF MALARIA ON HEALTH-RELATED 
QUALITY OF LIFE OF CHILDREN IN RURAL WESTERN KENYA
Elizabeth L. Glaser1, Jane A. Odhiambo1, Job Osewe1, 
Bonface Leo2, George Olang3, M. Nabie Bayoh3, Allyala Krishna 
Nandakumar1, John E. Gimnig4, Donald S. Shepard1, Mary J. 
Hamel4, Jennifer N. Perloff1
1Brandeis University, Waltham, MA, United States, 2Saint Elizabeth Lwak 
Mission Medical Center, Lwak, Kenya, 3Kenya Medical Research Institute, 
Kisumu, Kenya, 4Centers for Disease Control and Prevention, Atlanta, GA, 
United States
The aim of our study was to assess the impact of malaria on health-related 
quality of life (HRQoL) using subjective patient reported measures. We 
used purposive sampling at outpatient and inpatient hospital wards to 
select our sample from those families seeking care at a private facility in 
rural western Kenya, an area with high baseline malaria parasitaemia. 
Our subjects met the following criteria: i. Child under age 15 years; ii. 
Laboratory-confirmed malaria. We collected information from parents 
or caregivers of 64 children, age 4 months - 13 years via audio recorded 
interviews at the time of receiving medical care and then in person or 
by phone 5-7 days after the health facility visit. Using mixed methods, 
we gathered narrative and survey information on the child’s baseline 
health prior to the current illness and data on quality of life from the 
time of illness onset through recovery, such as the ability to play, go to 
school, or participate in normal activities. Overall, 42% of our sample 
was hospitalized children. Mean HRQoL values were 0.7312 SE 0.0161. 
HRQoL values were inversely correlated with high fever (pwcorr -0.8830, 
p <0.001; Bonferroni adjustment), with the lowest rating of HRQoL 
occurring between 1 and 4.5 days after the onset of symptoms. We 
converted HRQoL to a summary outcome measure, Quality Adjusted Life 
Years (QALYs). The mean QALYs lost per child during a treated episode of 
malaria in our sample were 0.005 (SE 0.0006, 95% CI 0.0044-0.0056). 
Generalizability of our results was limited due to the high proportion of 
hospitalized children in our sample, reflecting greater severity of illness 
than would be experienced by children who were not hospitalized. 
Nevertheless, our study offers the first time that HRQOL values have been 
mapped, and QALYs calculated for pediatric malaria.
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THE CATASTROPHIC IMPACT OF MALARIA ON HOUSEHOLDS 
IN RURAL WESTERN KENYA
Elizabeth L. Glaser1, Jane A. Odhiambo1, Job Osewe1, 
Bonface Leo2, George Olang3, M. Nabie Bayoh3, Allyala Krishna 
Nandakumar1, John E. Gimnig4, Donald S. Shepard1, Mary J. 
Hamel4, Jennifer N. Perloff1
1Brandeis University, Waltham, MA, United States, 2Saint Elizabeth Lwak 
Mission Medical Center, Lwak, Kenya, 3Kenya Medical Research Institute, 
Kisumu, Kenya, 4Centers for Disease Control and Prevention, Atlanta, GA, 
United States
We measured the impact of pediatric malaria on the total value of 
out of pocket payments and opportunity costs to households in rural 
western Kenya. We used purposive sampling at outpatient and inpatient 
hospital wards to select our sample from those families seeking care 
at a private facility in rural western Kenya, an area with high baseline 
malaria parasitaemia. Our subjects were children less than 15 years of 
age with laboratory-confirmed malaria. We collected information from 
parents or caregivers of 64 children, age 4 months - 13 years via audio 
recorded interviews at the time of receiving medical care and then in 
person or by phone 5-7 days after the health facility visit. We gathered 
information on illness-associated costs from travel, treatments, medical 
care, food, lost time from work, school, and the status of children left at 
home while a parent or caregiver was attending to the ill child. Overall, 
42% of the sample was hospitalized children. A total of 11% of all 
families used herbs prior to bringing the child to the hospital, paying a 
512
astmh.org
median cost of 250 Ksh, over 83% of the cost of a full pediatric course of 
artemether/lumefantrine. Use of herbs was significantly associated with 
a longer interval between symptom onset and presenting for diagnosis 
and treatment (Pearson χ2 136.5, P < 0.000) but a lower chance of 
hospitalization. Even when there were no charges for direct medical care, 
study families incurred high costs due to lost work time and out of pocket 
costs for transport. We found that total costs for a single treated episode 
of pediatric malaria in our sample represented Ksh 1750 or USD 20.59, 
which is 34% (sd 0.24) of the estimated median monthly household 
consumption of Ksh 5000 or USD 58.82 in rural Kenya. We found that 
significant components of costs to households during an episode of 
malaria were pre-hospital payment for medicinal herbs, and the gap in 
time from the first symptoms of illness until arrival at the health facility. In 
many cases, pre and post treatment costs alone imposed a catastrophic 
burden on families, forcing parents to sell assets, borrow money, or 
reallocate existing funds for school fees to cover the costs of care.
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IMPROVING PRIVATE SECTOR MALARIA CASE SURVEILLANCE 
AND QUALITY ASSURANCE USING DHIS2: LESSONS 
LEARNED
Andrea Cutherell, Cristina Lussiana, Stephen Poyer, Vicor Lara, 
Stephanie Dolan, Nikki Charman
Population Services International, Nairobi, Kenya
Ensuring private providers report on all malaria cases accurately is critical 
to transform malaria surveillance into a core intervention as recommended 
in WHO’s Global Technical Strategy for Malaria (2016-2030). Equally 
important is ensuring the quality of fever case management (FCM) by 
private sector providers. However, in many malaria endemic countries, 
health management information systems (HMIS) for the private sector are 
parallel to the government or non-existent, and do not include quality of 
care data. In response, PSI in collaboration with partners and funded by 
UNITAID, developed a routine monitoring system for private providers, 
combining case surveillance data (provider reported) with quality of 
care data (supervisor reported). Data was managed through DHIS2 to 
allow for integration with national HMIS. Piloted in Kenya, Tanzania, and 
Madagascar from 2013-2016, this approach has resulted in valuable 
lessons learned: Provider reporting rates varied across provider type and 
country, and were difficult to track due to limitations in managing a 
dynamic network of outlets in DHIS2. Quality of care data was successfully 
integrated into DHIS2 and managed alongside case surveillance data to 
prioritize scheduling of follow-up supervision visits. Quality of surveillance 
data, measured through Data Quality Audits highlighted challenges in 
the reliability of aggregated case surveillance data; while the quality of 
supervision data could not be assessed as there is no universally accepted 
gold-standard checklist. These lessons highlight actionable conclusions. 1) 
Routine monitoring systems and analytics tools (such as DHIS2) need to 
be as dynamic as the network of providers being monitored; 2) a globally 
validated tool to measure quality of FCM will allow countries to validate 
country-specific tools; and 3) provider level reporting should be simplified 
and streamlined, while considering provider incentives to improve data 
quality. The implementation of these lessons will help strengthen malaria 
surveillance and quality assurance in the private health sector and 
therefore accelerate progress towards malaria elimination.
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METHOD FOR THE SIMULTANEOUS MEASURE OF THE LEVEL 
OF NINE ANTIMALARIAL DRUGS IN DRIED BLOOD SPOT 
SAMPLES USING LC-TANDEM MASS SPECTROMETRY AND 
RELATIONSHIP OF LUMEFANTRINE CONCENTRATIONS IN 
DRIED BLOOD SPOT SAMPLES AND IN PLASMA
Joanna Gallay1, Emilie Pothin2, Sylvain Prod’hom3, Thomas 
Mercier3, Thierry Buclin3, Blaise Genton4, Laurent Arthur 
Decosterd3
1Department of Epidemiology and Public Health, Swiss Tropical and Public 
Health Institute, Basel; Division and Laboratory of Clinical Pharmacology, 
Service of Biomedicine, Department of Laboratories, University Hospital, 
Lausanne, Switzerland, 2Department of Epidemiology and Public Health, 
Swiss Tropical and Public Health Institute, Basel, Switzerland, 3Division 
and Laboratory of Clinical Pharmacology, Service of Biomedicine, 
Department of Laboratories, University Hospital, Lausanne, Switzerland, 
4Department of Epidemiology and Public Health, Swiss Tropical and Public 
Health Institute, Basel; Division of Infectious Diseases and Department of 
Community Medicine, University Hospital, Lausanne, Switzerland
Storage and transportation of blood samples are common problems 
for studies in areas with a high prevalence of malaria. The dried blood 
spot (DBS) sampling technique is promising for that use, enabling easier 
storage and transportation requirements. We present a method for the 
analysis of antimalarials in DBS. We also show the relationship between 
the concentrations of lumefantrine in DBS and with the usual method 
of plasma sampling. We added known concentrations of amodiaquine, 
desethylamodiaquine, quinine, chloroquine, mefloquine, sulfadoxine, 
pyrimethamine, lumefantrine and desbutyl-lumefantrine in whole human 
blood. A 10µl aliquot of this blood was applied on a filter paper card 
and allowed to dry for three hours at room temperature. We took a 3 
mm punch out of each dried blood spot and extracted it with 100 µl of 
methanol containing the stable isotopically labeled Internal Standards 
for all the antimalarials. We used a multiplex chromatography coupled 
to tandem mass spectrometry (LC-MS/MS) method for the simultaneous 
measure of the 9 antimalarials. We measured the concentrations of 
lumefantrine both in DBS and in plasma obtained in 16 healthy volunteers 
after they had received a single dose of artemether-lumefantrine. Lower 
limits of quantification were 2 ng/ml for pyrimethamine, 6 ng/ml for 
desthylamodiaquine, and 20 ng/ml for the other antimalarials. The inter-
day variation coefficient was 2.1-15.2%. Lumefantrine concentrations 
measured in plasma were twice as high as those measured in DBS and 
were highly correlated (r=0.99). Our technique enables both precise 
and sensitive measurement of antimalarials in DBS, despite the low 
volume of blood sampled. The correlation between lumefantrine 
concentrations in DBS and in plasma is almost perfect. This relationship 
could thus contribute to defining the therapeutic ranges of lumefantrine 
concentrations measured in DBS. The ratio between the concentration 
in DBS and in plasma could reflect the distribution of lumefantrine in 
the different blood compartments. The DBS sampling method is suitable 
for antimalarials level measurements and could be convenient for 
epidemiological studies.
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MALARIA AND HELMINTH COINFECTION-INDUCED 
OXIDATIVE STRESS AND CHANGES IN ANTIOXIDANT 
STATUS AMONG AFEBRILE SCHOOL CHILDREN IN IBADAN, 
SOUTHWEST NIGERIA
George O. Ademowo, Ayokulehin M. Kosoko, Olawunmi 
R. Rabiu, Hannah O. Dada-Adegbola, Olatubosun G. Arinola, 
Catherine O. Falade
University of Ibadan, Ibadan, Nigeria
Malaria and helminth infections are common tropical diseases in Sub-
Saharan Africa. Little is known about the effect of co-infection of the 
513
astmh.org
two diseases on the antioxidant defense system. This study determined 
the effect of malaria and helminth co-infection on antioxidant status 
in afebrile school children. A total of 99 afebrile school children were 
chosen comprising 25 with helminth infection, 25 with malaria-helminth 
co-infection and 24 negative for both malaria and helminth infections. 
Malaria parasite was determined by microscopy while helminth infection 
was confirmed by Kato-Katz method. Plasma hydrogen peroxide (H2O2), 
malondialdehyde (MDA), protein carbonyl (PC), xanthine oxidase (XO), 
NADPH oxidase (NOX), myeloperoxidase (MPX), reduced glutathione 
(GSH), catalase (CAT), superoxide dismutase (SOD), glutathione 
peroxidise (GPX), glutathione S-transferase (GST), ascorbic acid (AA) and 
α-tocopherol (TOC) were determined. Plasma levels of H2O2, MDA, PC as 
well as activities of XO, NOX and MPX were significantly higher in children 
with co-infection of malaria and helminth followed by helminth only and 
malaria only relative to uninfected children (p<0.05). GST activity, GSH and 
AA levels were significantly reduced while SOD and GPX activities were 
significantly higher in co-infected children followed by malaria only and 
helminth only relative to uninfected children (p<0.05). CAT activity was 
significantly higher in malaria only followed by co-infection and helminth 
only infected children relative to uninfected children (p<0.05). TOC level 
was significantly lower in helminth only followed by co-infection and 
malaria only relative to uninfected children (p<0.05). Malaria and helminth 
co-infection in afebrile school children caused a reduction in plasma 
antioxidant status as evident from significant increases in oxidative stress 
markers (H2O2, MDA, PC levels and activities of XO, NOX and MPX) and 
consequent depletion of the thiol GSH, AA, TOC and GST activity.
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HIGH THROUGHPUT IDENTIFICATION OF ANOPHELES 
GAMBIAE MIDGUT GENES INVOLVED THE INVASION OF 
PLASMODIUM FALCIPARUM
Yingjun Cui, Genwei Zhang, Guodong Niu, Xiaohong Wang, Jun 
Li
University of Oklahoma, Norman, OK, United States
An anopheline mosquito midgut is an important organ for malaria 
transmission. However, the interaction between a mosquito midgut 
and Plasmodium parasites is not well elucidated. This study aims to 
investigate the molecular mechanisms of Plasmodium invasion in midguts. 
First, we developed a computational algorithm to predict candidate 
mosquito midgut proteins based on sequences and oligo-array data. 
Ninety-four candidate genes were predicted in Anopheles gambiae 
mosquito midguts and expect to involve in A. gambiae and Plasmodium 
falciparum interaction. More than 90% of these candidates are novel. 
Next, we cloned these genes and successfully expressed 68 in insect cells. 
ELISA binding assay revealed that 28 recombinant proteins bound to P. 
falciparum-infected cells. Furthermore, we determined functional effects of 
28 candidate genes on P. falciparum infection in mosquito midguts using 
dsRNA-mediated gene expression silencing assays. The results indicated 
that three genes facilitated the infection of P. falciparum parasites and 
five genes inhibited the infection of P. falciparum parasites in mosquito 
midguts. Together, these results support our hypothesis that mosquito 
midgut proteins play critical roles in regulating P. falciparum parasite 
transmission. Notably, the results from this project lay a solid foundation to 
develop novel approaches to block malaria transmission.
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RELATIONSHIPS BETWEEN TRAVEL AND RTS,S MALARIA 
VACCINE EFFICACY IN LILONGWE, MALAWI
Corinna Y. Keeler1, Michael Emch1, Larry Han1, Jonathan Juliano1, 
Francis Martinson2, Portia Kamthunzi2, Gerald Tegha2, Irving 
Hoffman1
1University of North Carolina Chapel Hill, Chapel Hill, NC, United States, 
2UNC Project Malawi, Lilongwe, Malawi
The RTS,S/AS01 vaccine was recently approved by the European Medicines 
Agency Phase III after clinical trials showed moderate levels of efficacy 
that varied between the 11 clinical trial sites throughout Africa. This 
study assesses the relationship between travel and vaccine efficacy in a 
seasonal-transmission region of sub-Saharan Africa in one of the trial sites, 
Lilongwe, Malawi. Travel and mobility have been shown to be significant 
risk factors for malaria incidence but the relationship between travel 
and malaria vaccine efficacy has not been studied. We followed children 
(5-17 months of age) and infants (6-12 weeks of age) who had been 
randomly assigned to either a vaccine group, vaccine with booster group, 
or control group. Primary efficacy was defined as development of clinical 
malaria (fever ≥37.5°C and Plasmodium falciparum parasitemia >5,000 
per microliter). A travel history was collected for the 1552 trial participants 
at 6-month intervals throughout the 3-year study period, as well as the 
spatial location of each participant’s household and destination of travel. 
During the study, 30.34% of participants who received the placebo and 
32.20% of participants who received the vaccine with or without the 
booster traveled outside the study catchment area at least once, with 
travel defined as at least one night spent outside Lilongwe. Overall vaccine 
efficacy was 34.5% among participants who traveled and 20.0% among 
those who did not. Travel was significantly associated with increased 
vaccine efficacy when controlling for socioeconomic status, participant 
age, seasonality of travel, and destination of travel (p<0.001). The reason 
the efficacy is higher for participants who travel is not well understood and 
further study is necessary. One potential explanation is that Plasmodium 
falciparum strains outside of Lilongwe are more sensitive to the RTS,S 
vaccine.
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ASSESSMENT OF A TRANSGENIC PLASMODIUM BERGHEI 
PARASITE EXPRESSING P. FALCIPARUM CELL-TRAVERSAL 
PROTEIN FOR OOKINETES AND SPOROZOITES (PFCELTOS) 
FOR USE AS A HOMOLOGOUS RODENT CHALLENGE MODEL 
TO TEST VACCINE EFFICACY
Elizabeth H. Duncan1, Kathryne D. Walker1, Katherine L. 
Mallory1, Tatyana Savransky1, Ahmed M. Salman2, Chris J. Janse2, 
Shahid M. Khan2, Evelina Angov1
1Walter Reed Army Institute of Research, Silver Spring, MD, United States, 
2The Leiden Malaria Research Group, Leiden, Netherlands
The use of animal models to simulate human malaria infection is critical 
for malaria vaccine development and down-selection. While nonhuman 
primate models may approximate clinical immunology, they do not allow 
testing of protection against Plasmodium falciparum infection. Thus, 
the majority of malaria vaccine development utilizes rodent models to 
assess immunogenicity and vaccine efficacy. Studies have shown that 
the Cell-Traversal protein for Ookinetes and Sporozoites (CelTOS), highly 
conserved among Plasmodium species, plays a major role in parasite 
invasion of both mosquitos and vertebrates. A unique feature of CelTOS 
is that cross-species protection is achievable, as evidenced by our ability to 
attain 60% heterologous protection against P. berghei malaria following 
vaccination with P. falciparum CelTOS (PfCelTOS)/ISA 720. Although 
protection is routinely observed with the wild type P. berghei challenge 
model, a heterologous challenge for PfCelTOS-specific responses is 
needed for assessing homologous responses and establishing immune 
correlates of protection. To address the homologous challenge issue, a 
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chimeric P. berghei parasite, where the gene encoding PbCelTOS has been 
replaced with coding sequence for PfCelTOS (PbPfCelTOS(r)PbCelTOS) was 
developed as a readout and preclinical analysis method for homologous 
protection in mice. Experimental data will be presented on the molecular 
and cellular characterization of the PbPfCelTOS(r)PbCelTOS parasite 
with respect to: mosquito- and mouse-stage development, antibody 
recognition of PfCelTOS on sporozoites using anti-PfCelTOS (monoclonal 
and polyclonal) antibodies , in vivo infectivity using our standard 
immunogenicity testing regimens and use as a murine parasite challenge 
model.
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LACK OF GEOGRAPHIC SIGNAL IN THE PATTERN OF ALLELE 
AND EPITOPE FREQUENCIES IN FOUR MALARIA LIVER STAGE 
CANDIDATE VACCINE ANTIGENS
Amed Ouattara1, Moser Kara1, Mahamadou Thera2, Elliott F. 
Drábek1, Drissa Coulibaly2, Sonia Agrawal1, Mark A. Travassos1, 
Matthew Adams1, Amadou Niangaly2, Youssouf Tolo2, David 
Saunders3, Chanthap Lon3, Kay Thwe Han4, Shannon Takala-
Harrison1, Myaing M. Nyunt1, Ogobara K. Doumbo2, Christopher 
V. Plowe1, Joana C. Silva1
1University of Maryland, Baltimore, MD, United States, 2University of 
Sciences, Bamako, Mali, 3U.S. Army Medical Component-Armed Forces 
Research Institute of Medical Sciences, Bangkok, Thailand, 4Department of 
Medical Research, Yangon, Myanmar
Both blood stage and pre-erythrocytic malaria vaccines, including the 
most advanced malaria vaccine, RTS,S, have shown moderate and 
strain-specific efficacy, highlighting the need for new vaccines with 
potent cross-protective efficacy. The selection of antigen variants to 
include in future vaccines, and in particular their constituent epitopes, 
will be crucial to determine the extent of cross-protection as well as 
regional differences in efficacy. We assessed the potential of Plasmodium 
falciparum circumsporozoite surface protein (CSP), liver stage antigens 1 
and 3 (LSA1 and LSA3), and sporozoite asparagine rich antigen 1 (SAP1), 
as whole antigens or deconstructed into B- or T-cell epitopes, to elicit 
strain-transcending immune responses. To evaluate the vaccine potential 
of these antigens, we determined allele and epitope frequencies among 
30 isolates collected from Mali, Malawi, Myanmar, and Cambodia, and 
the pattern of geographic distribution of those variants. DNA was isolated 
from leukocyte-depleted blood samples, and used to generate de novo 
genome assemblies using Pacific Biosciences (PacBio), and Illumina HiSeq 
sequencing data. Custom scripts were used to identify, extract and 
align the genomic sequences for each of the target loci. For CSP, only 
two variants were identified in the N-terminal region of the gene, with 
prevalences 64% and 36%; in contrast, in the C-terminal region, 17 
variants were found in the T-helper cell epitope 2 (Th2R) (range: 2.6% to 
21%), and eight variants in the Th3R region (range: 2.6% to 34.2%). The 
alleles contained between 31 and 37 NANP repeats, and three or four 
NVDP repeats. The distribution of the haplotypes was not determined by 
geography. Among these 30 isolates, we identified eight conserved B-cell 
epitopes and 11 potential CD4+/CD8+ CSP epitopes restricted by the most 
frequent HLA allele in Mali. Identical analyses were conducted for sap1, 
lsa1, and lsa3 genes. The results from this study suggest that conserved 
epitopes of CSP and LSA3 present in both West and East Africa, as well as 
in South East Asia, may be promising candidates for inclusion in a multi-
epitope malaria vaccine.
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A CONSENSUS PROTEOME OF PLASMODIUM VIVAX 
SPOROZOITES
Patricia Ferrer1, Ratawan Ubalee2, Kevin Kobylinski2, Silas 
Davidson2, Robert V. Gerbasi1
1U.S. Naval Medical Research Unit - 6, Lima, Peru, 2Armed Forces Research 
Institute of Medical Sciences, Bangkok, Thailand
Plasmodium vivax represents the most geographically distributed species 
of human malaria. Basic research studying Plasmodium vivax infectious 
stages has lagged behind P. falciparum for two principal reasons: 1. P. vivax 
infections cause morbidity, but low mortality compared to P. falciparum 
and 2. we currently lack a culture system capable of growing P. vivax in 
vitro. As a result, several research groups have characterized the proteins 
of the P. falciparum sporozoite and merozoite infectious stages but the 
P. vivax sporozoite proteome has not yet been published. A detailed 
understanding of the P. vivax proteome is critical for drug and vaccine 
development efforts against genetically distinct species of malaria. We 
performed MudPIT mass spectrometry of tryptic peptides from P. vivax 
sporozoites dissected from Anopheles dirus mosquitoes. P. vivax peptides 
were distinguished from Anopheline peptides by searching tandem 
mass spectra from tryptic sporozoite peptides against a concatenated P. 
vivax - Anopheline protein database. We identified 421 core sporozoite 
proteins, many of which are abundant proteins with unknown functions. 
Additionally we identified orthologs of previously implicated vaccine 
candidates including CSP and TRAP (expressed abundantly on the 
sporozoite surface), a putative heat shock protein, SPECT1, GAMA and 
GEST.
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PLASMODIUM FALCIPARUM CIRCUMSPOROZOITE PROTEIN 
ADJUVANTED WITH LIPOSOMAL ADJUVANT INDUCES 
HIGHLY PROTECTIVE RESPONSES IN C57BL/6 MICE AGAINST 
TRANSGENIC PARASITE CHALLENGE
Christopher J. Genito, Zoltan Beck, Timothy W. Phares, Fanta 
Kalle, Gary R. Matyas, Carl R. Alving, Norman C. Waters, Sheetij 
Dutta
Walter Reed Army Institute of Research, Silver Spring, MD, United States
Falciparum malaria continues to be a highly lethal infectious disease 
among children in tropical areas of the world. The most successful 
malaria vaccine candidate is RTS,S (GlaxoSmithKline), which targets the 
circumsporozoite protein (CSP) expressed by Plasmodium falciparum 
sporozoites. RTS,S contains the central repeat region and the C-terminal 
region of CSP expressed on a hepatitis B surface antigen particle, but 
it lacks the N-terminal region. Several lines of evidence suggest the 
N-terminal region of CSP contains residues that are critical for hepatocyte 
invasion. Furthermore, the cost of producing a soluble CSP vaccine may be 
significantly lower than particulate vaccines. We have produced a nearly 
full-length CSP soluble protein vaccine (FMP013) in the E. coli system. In 
order to select an adjuvant for this vaccine, FMP013 was tested with a 
battery of adjuvants in the C57BL/6 mouse challenge model. We report 
here the immunogenicity and protective efficacy of the GMP FMP013 
product with the Army Liposome Formulation (ALF) adjuvant. ALF contains 
immuno-stimulant 3D-PHAD (Avanti Polar Lipids) formulated in liposomes 
composed of phospholipids and cholesterol. Mice were immunized 
three times with a sub-saturating dose of CSP+ALF combined with 
either aluminum hydroxide (ALFA) or QS-21 (ALFQ). Immunogenicity and 
protection of the ALFA and ALFQ adjuvants were compared to Montanide 
ISA 720 adjuvanted FMP013. Mice were challenged with transgenic P. 
berghei sporozoites expressing P. falciparum CSP two weeks after final 
immunization. Especially high levels of protection (up to 100%) were 
observed in the CSP+ALFQ groups; this correlated with significantly higher 
CSP and NANP-specific antibody titers. ALFQ groups also showed higher 
IgG2c titers and a TH1-biased IgG2c:IgG1 ratio. Enhanced signs of early 
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B-cell development and germinal centers were observed in the ALFQ 
groups compared to the Montanide group. Initial findings suggest that 
soluble CSP and ALFQ combination may hold promise. These data are now 
being confirmed in the Rhesus model, which will be the final go-no-go 
decision point For advancing this vaccine into humans.
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MASS DIRECT SKIN FEEDS OF ANOPHELES COLUZZII IN THE 
CONTEXT OF MALARIA TRANSMISSION BLOCKING VACCINE 
TRIALS IN BANCOUMANA, MALI
Daman Sylla1, Adam Sacko1, Jen C.C. Hume2, Boubacar 
Coulibaly1, Chata Doumbia1, Lakamy Sylla1, Youssouf Sinaba1, 
Mahamadou A. Maiga1, Issaka Sagara1, Sara A. Healy2, Ogobara 
Doumbo1, Sekou F. Traore1, Patrick E. Duffy2, Mamadou Coulibaly1
1Malaria Research and Training Center, Mali-NIAID ICER, University of 
Science, Techniques and Technologies of Bamako, Bamako, Mali, 2National 
Institutes of Health/DIR/National Institute of Allergy and Infectious 
Diseases/Laboratory of Malaria Immunology and Vaccinology, Rockville, 
MD, United States
As proxy measures to assess the activity of malaria transmission blocking 
vaccines (TBV), standard membrane feeding assay (SMFA), direct 
membrane feeding assay (DMFA), and direct skin feeds (DSF) were 
previously implemented only at small scale. Here we investigate the 
performance of mass DSF in Bancoumana, Mali. From September to 
November 2015, we prepared each week ~30,000 laboratory reared 
female Anopheles coluzzii 3-8 days of age, and conducted twice-weekly 
feeding assays for 6 weeks on ~200 volunteers aged 18-50 years 
participating in Pfs25-Pfs230 TBV trials. Thirty starved mosquitoes in 
each of two cups were fed on the arms of volunteers for 15 minutes. Fed 
mosquitoes were dissected for Plasmodium falciparum oocyst counts. Of 
119,220 mosquitoes the feeding rate was 97% and the survival rate of 
fed mosquitoes was 75%. Of 87,487 dissected mosquitoes, the overall 
infection rate was 0.5% resulting from 58/2008 DSF assays (2.5%). During 
the 6 weeks of DSF assays, weekly infection rates varied from 0.1% to 
1.1%. Among infected mosquitoes, 78% had loads between 1-10 oocysts 
per midgut, 7% had between 11-20 oocysts, and 15% had more than 
20 oocysts. Of all DSF assays performed, greater than mild adverse events 
were only observed in one individual, and resolved with topical treatment. 
The results demonstrate the feasibility and safety of mass DSF for 
implementation in TBV trials, and provide a basis to calculate sample sizes 
for this community using mosquito infection as an endpoint.
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DESIGN, EXPRESSION AND SCALABLE CGMP PRODUCTION 
OF FMP014 - A SELF-ASSEMBLING PROTEIN NANOPARTICLE 
AS THE BASIS OF A VACCINE AGAINST PLASMODIUM 
FALCIPARUM MALARIA
Labdhi Seth1, Casey K. Storme1, Stephen A. Kaba1, Gary R. 
Matyas2, Zoltan Beck3, Carl R. Alving2, Peter Burkhard4, David E. 
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Spring, MD, United States, 4Alpha-O Peptides AG, Lörracherstrasse, 
Riehen, Switzerland, 5Malaria Vaccine Branch, USMMRP-Walter Reed 
Army Institute of Research, Walter Reed Army Institute of Research, Silver 
Spring, MD, United States
In spite of the best efforts of the global research community only a handful 
of vaccine candidates have shown promise in combating malaria and 
most of these vaccines have been presented as live attenuated viruses 
or as virus-like particles. We have developed FMP014, a vaccine against 
Plasmodium falciparum malaria, which is comprised of 60 identical protein 
chains that form a small icosahedral shaped self-assembling protein 
nanoparticle (SAPN) similar to the capsid of small viruses. Each monomer 
displays selected P. falciparum Circumsporozoite Protein (PfCSP) CD4 and 
CD8 epitopes, universal TH epitopes, and portions of the α-TSR domain 
and NANP repeats of the PfCSP. Here we describe the conditions that are 
required for successful scale-up and cGMP manufacturing of FMP014. 
Furthermore, we demonstrate that when assembled and formulated with 
the Army Liposomal Formulations ALFA, ALFQ or ALFQA the nanoparticle 
vaccine prevents infection of mice by an otherwise lethal dose of 
transgenic P. berghei sporozoites expressing the complete PfCSP. (In depth 
analysis of the humoral and cellular responses to FMP014 are given in 
accompanying posters by Kaba et al. and Storme et al.). The cGMP SAPN 
and ALF adjuvants are currently undergoing studies in nonhuman primates 
and will be further tested in human volunteers in 2017.
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OVERCOMING DIVERSITY OF AMA1: EVIDENCE OF 
POLYMORPHISM DILUTION MEDIATED REFOCUSING OF 
RESPONSES TOWARDS CONSERVED EPITOPES IN RHESUS 
MONKEYS VACCINATED WITH QUADVAX+AS01
Sheetij Dutta1, Lisa Dlugosz1, Kazutoyo Miura2, Carol Long2, 
Nathan Hoyt1, David Franco3, Yannick Vanloubbeeck4, Norman C. 
Waters1, Adrian Batchelor1
1Walter Reed Army Institute of Research, Silver Spring, MD, United States, 
2National Institute of Allergy and Infectious Diseases, National Institutes 
of Health, Rockville, MD, United States, 3GlaxoSmithKline Vaccines, 
Rixensaart, Belgium, 4GlaxoSmithKline Vaccines, Vanloubbeeck, Belgium
Vaccines against polymorphic antigens require strategies that cover 
the entire antigenic spectrum of prevailing strains in an endemic area. 
Given the extreme diversity of Apical Membrane Antigen-1 (AMA1) of 
Plasmodium falciparum, the down-selection of strains for a polyvalent 
vaccine remains a challenge. We propose that QuadVax (a mixture of only 
four AMA1 strains: 3D7+FVO+HB3+W2mef) may provide global coverage 
as was observed by in vitro GIA using rabbit antibodies to QV generated 
using Montanide ISA720 adjuvant (Dutta et al. PLOS Pathogens 2013). We 
now report results of a Rhesus trial that was conducted to determine if 
observations made originally in the rabbit model using Montanide adjuvant 
would hold up in the Rhesus model using QV formulated in a human-use 
adjuvant AS01 (GlaxoSmithKline). Two groups of Rhesus (n=7) received 
three immunizations of 20 ug (LO group) or 80 ug (HI group) monovalent 
3D7 AMA1 in AS01 and two comparator groups received 20 (LO) or 80 
ug (HI) QV in AS01. There was no significant difference between the 
immunogenicity and GIA activity of the LO vs. HI dose groups. Both the 
3D7 and QV vaccinated animals induced high levels of ELISA and GIA 
activity against the homologous 3D7 strain parasites. In heterologous 
ELISA and GIA the two QV groups (HI and LO) showed significantly higher 
cross-reactivity and heterologous GIA compared to the two 3D7 AMA1 
groups. The original observations of strain-broadened responses by QV 
in rabbits were reproduced whereby QV vaccination shifted the immune 
response towards cross-reactive epitopes on the domain-3 and conserved 
face of AMA1. Furthermore increased responses to the conserved regions 
correlated positively with higher cross-strain GIA. Our data pave way for 
continued development of AMA1 as a malaria vaccine. The concept of 
polymorphism dilution by mixing a small number of antigenically diverse 
strains may be applicable to developing pan-reactive vaccines against other 
diverse pathogens like dengue, HIV and influenza.
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T CELL IMMUNOGENICITY AND CORRELATES OF 
PROTECTION FROM A DOSE-ESCALATION SAFETY AND 
EFFICACY STUDY OF PFSPZ WITH CHLOROQUINE IN 
MALARIA-NAÏVE ADULTS
Andrew S. Ishizuka1, Benjamin Mordmueller2, Barbara Flynn1, 
Adam J. Ruben3, Tao Li3, B Kim Lee Sim3, Stephen L. Hoffman3, 
Peter Kremsner2, Robert A. Seder1
1National Institutes of Health, Bethesda, MD, United States, 2Institute for 
Tropical Medicine, University of Tuebingen, Tuebingen, Germany, 3Sanaria 
Inc., Rockville, MD, United States
High-level protective efficacy is induced in a dose-dependent manner by 
infectious PfSPZ administered under chloroquine prophylaxis (Pf-CVac) 
followed by controlled human malaria infection (CHMI). Here we present 
the T cell responses after three immunizations with 3.2x10^3, 1.28x10^4, 
and 5.12x10^4 PfSPZ at 4-week intervals while taking chloroquine. 
The memory phenotype and effector function of T cell responses were 
assessed by 14-16-color multi-parameter flow cytometry after the final 
immunization and at the time of homologous CHMI. Pf-specificity was 
determined by incubating PBMCs with aseptic PfSPZ, vaccine diluent 
(HSA), Pf-infected erythrocytes (PfRBC), or uninfected RBCs. The staining 
panel included CD4, CD8 and γδ T cells, chemokines, activation markers, 
and the cytokines IFN-γ, IL-2, TNF-α, IL-4, and IL-10. The magnitude of 
Pf-specific Th1 cytokine-producing CD8, CD4, and γδ T cell responses 
following Pf-CVac were dose-dependent. A high frequency of PfRBC-
specific memory CD4 T cells (median of 1.6%) was detected after final 
immunization in the highest dose group of 5.12x10^4 PfSPZ. In an 
exploratory analysis, immune responses that correlated with protection 
were assessed using a stratified Wilcoxon test controlling for vaccine dose. 
The magnitude of PfRBC-specific memory CD4 T cells simultaneously 
expressing IFN-γ, IL-2, and TNF-α correlated with protection with an 
uncorrected P-value of 0.00043. These findings demonstrate that Pf-
CVac induced high-magnitude cytokine-producing T cells in multiple 
effector lineages in a dose dependent manner and provide evidence that 
PfRBC-specific multi-functional memory CD4 T cells may be a correlate of 
protection. Establishing such responses as a correlate of protection will 
require validation in larger prospective studies.
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EQUATORIAL GUINEA’S FIRST EVER CLINICAL TRIAL: 
TOLERABILITY, SAFETY AND IMMUNOGENICITY OF PFSPZ 
VACCINE IN YOUNG EQUATOGUINEAN ADULTS
Ally Olotu1, Vicente Urbano2, Ali Hamad1, Mwajuma Chemba1, 
Elizabeth Nyakarungu1, Martin Eka2, Esther Eburi3, Dianna 
Hergott4, Carl D. Maas5, Mitoha Ondo’o Ayekaba5, Diosdado Nsue 
Milang2, Matilde Riloha Rivas2, Hassan Abuleil6, Oscar Embon6, 
Chris Schwabe7, Luis Segura3, Claudia Daubenberger8, Marcel 
Tanner8, Thomas Richie9, Peter F. Billingsley9, B. Kim Lee Sim9, Salim 
Abdulla1, Stephen L. Hoffman9
1Ifakara Health Institute, Bagamoyo, United Republic of Tanzania, 
2Equatorial Guinea Ministry of Health and Social Welfare, Malabo, 
Equatorial Guinea, 3Medical Care Development International, Malabo, 
Equatorial Guinea, 4Medical Care Development International, Silver Spring, 
MD, United States, 5Marathon EG Production Ltd., Malabo, Equatorial 
Guinea, 6La Paz Medical Center, Malabo, Malabo, Equatorial Guinea, 
7Medical Care Development International, Silver Spring, MD, United States, 
8Swiss Tropical and Public Health Institute, Basel, Switzerland, 9Sanaria, 
Rockville, MD, United States
PfSPZ Vaccine is a candidate pre-erythrocytic malaria vaccine composed 
of radiation-attenuated, aseptic, purified, cryopreserved Plasmodium 
falciparum (Pf) sporozoites (SPZ). In clinical trials in the U.S. and Africa, 
PfSPZ Vaccine administered by direct venous inoculation (DVI) provides 
durable protection against heterologous strains and heterogeneous 
populations of Pf. Trials in young children are underway. A robust malaria 
control program has substantially reduced the malaria burden on Bioko 
Island, Equatorial Guinea (EG). With an eye toward eventual elimination of 
malaria on Bioko, a malaria vaccine initiative was established to evaluate 
the potential utility of PfSPZ Vaccine, resulting in the first ever clinical trial 
in EG. This first trial was a phase 1, randomized, double blind placebo-
controlled trial to assess the tolerability, safety, and immunogenicity of 
PfSPZ Vaccine administered by DVI in young, healthy 18-35 year olds. A 
sentinel group of three volunteers received an initial PfSPZ Vaccine dose of 
1.35x105 PfSPZ and a second dose of 2.7x105 PfSPZ was given two weeks 
later. Following review by the safety monitoring committee, 30 volunteers 
were randomized to receive three doses of either 2.7x105 PfSPZ or normal 
saline placebo at 0, 8 and 16 weeks. Adverse events (AEs) were solicited 
for 7 days after each vaccination. There was enhanced surveillance 
and reporting for unsolicited AEs for 28 days after each vaccination. 
Monitoring for severe adverse events was done throughout the 40-week 
study period. Blood samples for safety monitoring of hematological, renal 
and hepatic functions were taken at baseline, 2, 7, 14 and 28 days after 
each vaccination and monthly after the last dose for six months. Blood 
samples for antibody and cellular immunology endpoints were taken at 
baseline and 1 month after the last vaccination. The results of safety, 
tolerability and immunogenicity will be presented, including a comparison 
of the immunological response to the same dose of PfSPZ in EG and 
Tanzania.
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PLACENTAL MALARIA VACCINES: COMPARING 
GLYCOSYLATED AND NON-GLYCOSYLATED N-TERMINAL 
DOMAINS OF PLASMODIUM FALCIPARUM VAR2CSA 
PROTEIN PREPARED AS RECOMBINANT PROTEIN OR DNA 
VACCINES
Shaji Daniel, Holly Torano, Joan Aebig, Lynn Lambert, Sarah 
Brockley, Emma K. Barnafo, Kelly Rausch, Michal Fried, Patrick E. 
Duffy
Laboratory of Malaria Immunology and Vaccinology, National Institute of 
Allergy and Infectious Diseases, National Institutes of Health, Rockville, 
MD, United States
Placental malaria (PM) causes poor pregnancy outcomes including severe 
maternal anemia and low birth weight, but adverse outcomes decrease 
over successive pregnancies as women acquire immunity. PM is caused 
by parasites that express the PfEMP1 variant antigen VAR2CSA and bind 
the placental receptor chondroitin sulfate A (CSA). With increasing parity, 
women acquire anti-VAR2CSA antibodies and serum activity that inhibits 
adhesion of infected erythrocytes to CSA. Naturally acquired protection 
suggests that a vaccine against PM is feasible. While multiple VAR2CSA 
domains bind CSA in in vitro assays, earlier work showed the N-terminal 
fragment binds CSA with similar kinetics as the full length protein. We 
expressed glycosylated and non-glycosylated versions of two Pf FCR3 
VAR2CSA N-terminal regions NTS–DBL1X–ID1–DBL2X and ID1–DBL2X–
ID2a in insect cells as secreted proteins. We purified the histidine-tagged 
recombinant proteins from culture media using Ni Sepharose excel 
medium. In parallel, we generated DNA vaccine constructs using the same 
boundaries. Immunization studies using these proteins and DNA vaccine 
constructs have been initiated in rats. We will report the effect of DNA 
versus protein vaccinations as well as glycosylation status on the CSA 
binding inhibition activity of the resulting antibodies.
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CHANGING THE PARADIGM OF VACCINE DEVELOPMENT: 
FROM A WESTERN-LED TO AN INTERNATIONAL, MULTI-
PARTNER, PARTIAL AFRICAN-FUNDED CONSORTIUM 
APPROACH
Peter F. Billingsley, on Behalf of the International PfSPZ 
Consortium
Sanaria Inc., Rockville, MD, United States
Publication of the first PfSPZ Vaccine trial (Epstein et al., Science. 
2011 334:475-80) offered clear scientific rationale to continue clinical 
development of Plasmodium falciparum (Pf) sporozoite (SPZ) products. 
In the absence of major continued funding, the International PfSPZ 
Consortium (I-PfSPZ-C) was established to design and execute a series 
of independently funded clinical studies of PfSPZ Vaccine and PfSPZ 
Challenge (infectious PfSPZ) by partner institutions. I-PfSPZ-C members 
have finalized the dose and route of administration of PfSPZ Challenge 
and used PfSPZ Challenge as a unique clinical research tool to understand 
malaria biology in 18 controlled human malaria infection (CHMI) studies 
in the US, and Europe and Africa. Members have completed clinical trials 
of PfSPZ Vaccine and PfSPZ-CVac in the US (N=4), Europe (N=3) and Africa 
(N=3), are currently or imminently conducting 12 new studies, and are 
developing new partnerships in Asia. Intravenous immunization with PfSPZ 
can repeatedly induce high level protection against CHMI and natural 
malaria exposure. Studies developed under a Clinical Development Plan 
are reviewed by the I-PfSPZ-C, their cross-site adaptive design being used 
to inform ongoing and future trials. The I-PfSPZ-C has remained inclusive 
- individuals, groups, institutions and funding organizations participate 
in reviewing all published and unpublished data, and planning new 
trials and strategies. The I-PfSPZ-C meeting at ASTMH Philadelphia 2015 
included 104 participants from 38 organizations in 18 countries, all with 
independent funding. Collaborating I-PfSPZ-C members provide essential 
planning and governance for PfSPZ Vaccine and PfSPZ-CVac licensure. 
Uniquely, there has been significant investment by African governments; 
first by the Tanzanian Commission on Science Technology, and the second 
and largest ($48.5M) by the Government of Equatorial Guinea (75%) 
and 3 private energy partners (25%), plus $10M from the Government of 
Gabon. The I-PfSPZ-C has changed the paradigm of vaccine development 
from a western driven effort, to one funded and led by all partners, and 
uniquely those in Africa.
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ADVANCING PARASITOLOGY, ENTOMOLOGY AND 
VACCINOLOGY BY MANUFACTURING WHOLE PARASITE 
(EUKARYOTIC CELL) ASEPTIC, PURIFIED VACCINES 
PRODUCED IN ARTHROPODS: CHALLENGES, SUCCESSES 
AND TRAJECTORY FOR PFSPZ VACCINES
Kim Lee B. Sim, on behalf of the Sanaria Manufacturing Team
Sanaria, Rockville, MD, United States
There are no 1) vaccines for parasitic diseases, 2) preventative vaccines 
composed of eukaryotic cells, or 3) vaccines produced in mosquitoes 
that are licensed by the FDA. Thus, when Sanaria proposed producing 
Plasmodium falciparum (Pf) whole parasite sporozoite (SPZ) (eukaryotic 
cell) vaccines in aseptic mosquitoes to prevent malaria, most thought 
this would be impossible. When we began there were no methods to, 
1) produce aseptic mosquitoes or aseptic PfSPZ in these mosquitoes, 2) 
aseptically harvest the parasites from mosquitoes, 3) adequately purify 
PfSPZ from the mosquito material, 4) stabilize these eukaryotic cells, 
5) do this in compliance with regulatory standards (GMPs), or 6) at a 
scale adequate to support commercial launch in a facility that cost less 
than $4M. During the last decade we have accomplished all of this, 
and demonstrated that the PfSPZ are potent: 3 doses of a PfSPZ-based 
vaccine provides the highest durable protection ever demonstrated 
against controlled human malaria infection and exposure to malaria in 
the field. In double blind, placebo-controlled trials there have been no 
differences in adverse events between vaccinees and controls validating 
that the PfSPZ are pure. Trials to finalize immunization regimens for phase 
3 trials and licensure are underway. We now produce in the same facility 
and with the same staff, >7 fold more PfSPZ in a single day than we did 
during the manufacturing campaigns that supported our first 18 clinical 
trials conducted from 2009 to 2014. Creating this disruptive technology 
has required, 1) ignoring conventional approaches to manufacturing and 
storing vaccines, 2) enormous attention to establishing highly efficient 
manufacturing teams and transparent communication with regulatory 
authorities, and 3) never forgetting that licensure and deployment of 
a highly effective vaccine for those most in need in Africa is our raison 
d’etre. We believe the principles and techniques Sanaria has followed/
established leading to this success may be of technical and inspirational 
value to those working to produce vaccines against other parasites and 
arthropod diseases, and these will be presented.
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DISTRIBUTION LOGISTICS TO SUPPLY CRYOPRESERVED 
PFSPZ VACCINE TO TRAVEL CLINICS AND MALARIA MASS 
IMMUNIZATION PROGRAMS
Eric R. James, Adam J. Ruben, Peter F. Billingsley, Thomas L. 
Richie, Anusha Gunasekera, Anita Manoj, B Kim Lee Sim, Stephen 
L. Hoffman
Sanaria, Rockville, MD, United States
Sanaria’s Plasmodium falciparum (Pf) sporozoite (SPZ)-based PfSPZ Vaccine, 
PfSPZ Challenge and PfSPZ-CVac, are live whole organism products 
thermostabilized by cryopreservation, stored and distributed in liquid 
nitrogen vapor phase (LNVP) using LNVP dry shippers. LNVP storage 
imparts extreme stability compared to conventional vaccines’ fridge or 
freezer storage, and provides many additional advantages. The LNVP cold 
chain has supplied 18 PfSPZ clinical trials to date and an additional 11 trials 
in progress (or commencing during 2016) in the USA, Europe and Africa. 
Vaccine is packaged in cryovials: until now, closure of these cryovials 
has been by standard cryovial screw caps necessitating vaccine thawing/
reconstitution and syringe preparation in a biological safety cabinet 
(BSC) at the clinic. A revolutionary new design of cryovial with tamper-
evident closure and integral co-molded septum allows for immunizations 
anywhere without need of a BSC. A new custom dry thawing device 
obviates the need for a water bath for cryovial thawing. A new high 
density packaging system delivers 1,300 cryovials per standard dry shipper 
(or 200 per backpack dry shipper for last mile) to immunization clinics. 
The highly efficient hub-and-spoke (H&S) distribution system is used for 
distributing PfSPZ directly from Sanaria to immunization sites without 
intermediate stops; dry shippers also provide the local on-site storage. 
For travel medicine clinics in the USA, Europe and Japan H&S distribution 
will incorporate reverse logistics to rotate dry shippers on a 2-4 week 
schedule of restocking and resupply, augmented where appropriate, with 
extended local LNVP or Stirling freezer storage at immunization clinics 
and be coordinated by a third party logistics company. In malaria endemic 
regions, scale up first to Phase 3 trials and then to implementation in mass 
immunization programs for malaria elimination, distribution will utilize 
the H&S system operating from major regional storage hubs. In its scope 
and scale, this application of LNVP cold chain logistics will become a new 
operational standard.
1650
EVALUATION OF RPFMSP2-BASED VACCINES FOR INCLUSION 
IN A MULTI-COMPONENT MALARIA VACCINE FORMULATION
Jacqueline J. Schneider, James M. Burns
Drexel University College of Medicine, Philadelphia, PA, United States
Naturally-acquired antibody responses to Merozoite Surface Protein 2 
(MSP2) in individuals living in Plasmodium falciparum endemic areas are 
associated with resistance to malaria. Earlier vaccine trials showed that 
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immunization-induced PfMSP2 specific antibodies correlated with partial 
protection against P. falciparum malaria. These naturally-acquired and 
vaccine-induced anti-PfMSP2 antibodies are primarily directed against 
the central variable region of two major allelic variants of PfMSP2. 
These data suggest that PfMSP2 has significant potential as a vaccine 
candidate, likely as a component of a multiantigen formulation. In prior 
studies with multivalent blood-stage antigen formulations, we showed 
that genetic fusion of PfMSP119 to the N-terminus of MSP8 facilitated 
vaccine production, minimized antigenic competition and markedly 
enhanced induction of functional antibodies. To further improve protective 
efficacy, we are working to formulate PfMSP2 in combination with the 
PfMSP1/8 candidate. A synthetic PfMSP2 (3D7) gene, codon-harmonized 
for expression in E. coli, was used to produced rPfMSP2 as an unfused 
full-length protein or as a chimeric antigen linked to the N-terminus 
of PfMSP8. Purification of rPfMSP2 and chimeric rPfMSP2/8 yielded 29 
mg/L and 54 mg/L of bacterial culture respectively. Vaccine-induced anti-
PfMSP2-specific antibodies were quantitated following immunization 
of CB6F1/J mice with unfused PfMSP2, chimeric PfMSP2/8, or an 
admixture of rPfMSP2 and rPfMSP8, each formulated with Alhydrogel as 
adjuvant. High and comparable anti-MSP2 antibody titers were elicited by 
immunization with the expected predominance of Th2-biased antibody 
isotypes. Of significance, no evidence of competition between component 
antigens was noted. Sera from immunized animals strongly recognized 
native MSP2 in both immunoblot and indirect IFA of P. falciparum blood-
stage parasites. Comparative assessment of vaccine-induced B and CD4+ T 
cell responses and antibody-mediated merozoite neutralization will inform 
selection of a highly immunogenic PfMSP2 antigen to be formulated in 
combination with PfMSP1/8.
1651
USE OF A PLASMODIUM-SPECIFIC CARRIER PROTEIN TO 
ENHANCE PRODUCTION OF RECOMBINANT PFS25, A 
LEADING TRANSMISSION-BLOCKING VACCINE CANDIDATE
Elizabeth Parzych1, Kazutoyo Miura2, Carole A. Long2, James M. 
Burns1
1Drexel University College of Medicine, Philadelphia, PA, United States, 
2National Institute of Allergy and Infectious Disease/National Institutes of 
Health, Rockville, MD, United States
Despite reductions in morbidity and mortality worldwide, eradication 
of Plasmodium falciparum malaria will most likely require a multi-stage, 
multi-antigen vaccine that incorporates a target of transmission-blocking 
antibodies. Pfs25 is one such transmission-blocking vaccine candidate. 
Antibodies directed against conformational epitopes within the highly 
constrained EGF-like domains of Pfs25 block sexual stage development 
in mosquitoes. However, the large-scale production of properly folded 
recombinant Pfs25 has been challenging. We have previously shown 
that use of PfMSP8 as a fusion partner for PfMSP1, facilitated production 
of properly folded PfMSP119 and promoted induction of high titers of 
growth inhibitory antibodies upon immunization. Here, we applied a 
similar strategy for the production of a Pfs25-based vaccine. The gene 
for Pfs25 was codon-harmonized for expression in E. coli SHuffleTm T7 
Express lysY cells. Recombinant Pfs25 was produced as a single, unfused 
antigen (uPfs25) or chimeric Pfs25-PfMSP8 fusion protein (cPfs25/8). 
uPfs25 was purified under denaturing conditions with subsequent 
refolding with a yield of ~8.4 mg/L of bacterial culture. The chimeric 
Pfs25/8 was successfully purified under non-denaturing conditions with 
a yield of 43 mg/L, highlighting value of the PfMSP8 carrier. Proper 
folding of these antigens was verified by SDS-PAGE under reducing vs 
non-reducing conditions and by immunoblot analysis with mAb 4B7 
which recognizes a conformational epitope of Pfs25. Antisera against 
both antigens were produced in NZW rabbits and assessed for titer and 
functionality. Both antigens induced strong and comparable titers against 
Pfs25 which potently inhibited parasite transmission to mosquitoes in a 
standard membrane feeding assay. Although PfMSP8 is also expressed in 
gametocytes, rabbit anti-PfMSP8 antibodies did not block transmission. 
Comparative immunogenicity studies are currently underway to further 
assess the humoral and cellular response to these antigens, to aid in 
selection of a highly efficacious Pfs25 based vaccine to include in a multi-
antigen, multi-stage vaccine formulation.
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ANTIBODY PROFILES TO WHEAT GERM CELL-FREE SYSTEM 
SYNTHESIZED PLASMODIUM FALCIPARUM PROTEINS 
CORRELATE WITH PROTECTION FROM SYMPTOMATIC 
MALARIA IN UGANDA
Bernard N. Kanoi1, Eizo Takashima1, Masayuki Morita1, Edward 
H. Ntege1, Betty Balikagala1, Nirianne M. Q. Palacpac2, Adoke 
Yeka3, Thomas G. Egwang4, Toshihiro Horii2, Takafumi Tsuboi1
1Division of Malaria Research, Proteo Science Center, Ehime University, 
Matsuyama, Japan, 2Department of Molecular Protozoology, Research 
Institute for Microbial Diseases, Osaka University, Osaka, Japan, 3Makerere 
University School of Public Health, Kampala, Uganda, 4Med Biotech 
Laboratories, Kampala, Uganda
The key targets of protective antibodies against Plasmodium falciparum 
remain largely unknown. The aim of this study was to identify proteins 
whose antibodies are correlates of malaria acquired immunity that 
could be relevant for development as malaria vaccine candidates. 
We profiled immune responses to 1827 wheat germ cell-free system 
(WGCFS) expressed proteins derived from 1586 genes representing 
~30% of the P. falciparum entire genome. We previously reported that 
several WGCFS expressed P. falciparum proteins could elicit antibodies 
in immunized animals that exhibited growth inhibition activity in vitro, 
suggesting that the recombinant proteins, at least in part, retain their 
natural conformations. Serum samples were obtained from individuals 
aged 6-20 years who are indigenous residents of a malaria holoendemic 
community in Northern Uganda. They were enrolled at the start of the 
rainy season and prospectively monitored for clinical malaria episodes for 
one year. Protein immunoreactivity to serum samples was determined by 
AlphaScreen; a homogeneous high-throughput system to detect protein 
interactions. More than 51% (936/1827) of the proteins reacted with 
the sera. Subsequently, antibody levels to 9 proteins, encoded by 8 genes 
significantly associated with time to the first symptomatic malaria episode 
in children. The 9 proteins comprised both previously characterized vaccine 
candidates and novel uncharacterized proteins. WGCFS combined with 
AlphaScreen offer an alternative approach to genome-wide screening of 
malaria antigens associated with acquired immunity.
1653
IDENTIFICATION OF PFRIPR, AN RH5-INTERACTING PROTEIN, 
AS A HIGHLY CONSERVED BLOOD-STAGE MALARIA VACCINE 
CANDIDATE AGAINST PLASMODIUM FALCIPARUM
Edward H. Ntege1, Nobuko Arisue2, Daisuke Ito1, Tomoyuki 
Hasegawa1, Nirianne M. Q. Palacpac2, Thomas G. Egwang3, 
Toshihiro Horii2, Eizo Takashima1, Takafumi Tsuboi1
1Division of Malaria Research, Proteo-Science Center, Ehime University, 
Matsuyama, Japan, 2Department of Molecular Protozoology, Research 
Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan, 
3Med Biotech Laboratories, Kampala, Uganda
Blood-stage malaria vaccine (BSV) candidates of high efficacy against 
Plasmodium falciparum (Pf) remain elusive, mainly because of genetic 
diversity and allele-specific immunity in endemic regions. Here, we 
hypothesize that in order to improve efficacy, BSV candidate antigens 
should contain conserved targets of immunity. Hence, identification of 
suitable candidates for downstream clinical studies in the quest for next 
generation vaccines requires understanding of the extent of genetic 
polymorphisms in the antigen targets and the roles played in naturally 
acquired immunity. Using field isolates from Uganda, we carried out 
genetic analyses on genes encoding four recently reported novel BSV 
candidate proteins; RH5 interacting protein (PfRipr), GPI anchored 
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micronemal antigen (PfGAMA), rhoptry-associated leucine zipper-like 
protein 1 (PfRALP1) and Duffy binding-like merozoite surface protein 1 
(PfMSPDBL1). In addition, we expressed recombinant proteins of these 
candidates based on Pf laboratory clone 3D7 sequences using wheat germ 
cell-free system, immunized rabbits to obtain specific antibodies (Abs) 
and performed functional studies (Growth inhibition Assay, GIA). The GIA 
activity of the raised Abs in blocking erythrocyte invasion was determined 
using both the homologous 3D7 and heterologous FVO strains in vitro. 
Pfgama and pfmspdbl1 are relatively polymorphic and Abs against the 
3D7 recombinant PfGAMA and PfMSPDBL1 inhibited merozoite invasion 
of 3D7 but not FVO. Although both pfripr and pfralp1 are conserved and 
Abs against their 3D7 recombinant proteins potently inhibited merozoite 
invasion of both 3D7 and FVO, the GIA activity of anti-PfRipr was much 
higher than that of anti-PfRALP1 on both 3D7 and FVO. Furthermore, 
pfralp1 is comparatively diverse, with varied number of regions having 
insertions and deletions, asparagine and 6-mer peptide repeats in the 
sequences that are lacking in pfripr. Therefore, PfRipr is a highly conserved 
promising BSV candidate in the design of next-generation vaccines against 
P. falciparum.
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MULTIPLE INSECTICIDE RESISTANCE IN AN HIGHLY INFECTED 
POPULATION OF THE MALARIA VECTOR ANOPHELES 
FUNESTUS IN BENIN
Rousseau Djouaka
IITA - Cotonou, Benin, West Africa, Cotonou, Benin
Knowledge on the spread and distribution of insecticide resistance in 
major malaria vectors such as Anopheles funestus is key to implement 
successful resistance management strategies across Africa. Here, by 
assessing the susceptibility status of an inland population of An. funestus 
(Kpome) and investigating molecular basis of resistance, we show that 
multiple resistance in this species now extends beyond the original 
coastal region of Benin and is associated with high infection rate. The 
TaqMan analysis of plasmodial infections revealed an unusually high 
infection rate (18.2%) of An. funestus in this locality. The WHO bioassays 
revealed a multiple phenotypic resistance profile for An. funestus in 
Kpome. This population is highly resistant to pyrethroids (permethrin and 
deltamethrin), organochlorines (DDT), and carbamates (bendiocarb). A 
reduced susceptibility was observed with dieldrin. Mortalities did not vary 
after pre-exposure to PBO for DDT indicating that cytochrome P450s play 
little role in DDT resistance in Kpome. In contrast, we noticed, a significant 
increase in mortalities when PBO was combined to permethrin suggesting 
the implication direct involvement of P450s in pyrethroid resistance. A 
high frequency of the L119F-GSTe2 DDT resistance marker was observed 
in this highly DDT resistant population (9%RS and 91%RR) whereas the 
A296S mutation was detected at a low frequency (1%RS and 99%SS). In 
conclusion, the extension to the inland locality of the multiple resistance in 
An. funestus populations suggests resistance could be widespread in Benin 
and this highlights the need for further studies to assess the geographical 
distribution of insecticide resistance across Benin and neighboring 
countries as well as a more comprehensive analysis of the resistance 
mechanisms involved. Keywords: Malaria, Benin, An. funestus, insecticide 
resistance, resistance mechanisms, malaria control.
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DELIVERED BY MOBILE TEAMS AT FIXED POINTS IN 14 
DISTRICTS IN MALI, THROUGH ACCESS-SMC
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Mali was one of the first countries to introduce Seasonal Malaria 
Chemoprevention (SMC), starting in one district in 2012, and reaching 48 
of the 63 districts in the country in 2015. We evaluated the effectiveness 
of SMC delivery in 14 districts where implementation was supported by 
the ACCESS-SMC project funded by UNITAID. SMC was administered 
four times at monthly intervals starting late August. Delivery was at fixed 
points by mobile teams who checked children for fever, administered 
SMC to those who were well, and tested those with fever with a malaria 
Rapid Diagnostic Test (RDT). RDT positive children were treated with 
artemether-lumefantrine, negative children received SMC drugs and if 
appropriate, an antibiotic. Most children could therefore be treated by 
the team rather than having to be referred to a health facility. Each child 
was issued with a three-year SMC record card on which the date of 
attendance, and whether the child was treated with SMC, or tested and 
treated for malaria, or excluded, was recorded. A survey was undertaken 
in December to assess coverage. 50 clusters (villages or quarters of urban 
areas) were selected with probability proportional to size in 5 districts. In 
each cluster about 20 children aged between 4 months and 7 years were 
surveyed. 1037 children were surveyed of whom 740 were eligible for all 4 
SMC cycles because they were aged between 3 months and 5 years at the 
time of the first cycle. 85% of these children had received an SMC card. 
Based on the card, and on caregiver’s recall if the card was not seen, 38% 
of eligible children who had received 4 SMC cycles. The main reasons for 
not receiving SMC were being away when the team came (50%); being 
unaware of when SMC teams would come (35%); and the caregiver 
being too busy (17%). Reported adherence to the two amodiaquine doses 
administered by the caregiver was 99% for each dose. A high proportion 
of children were reached at least once but, in this first year of national 
scale-up, less than half received the full number of cycles. Emphasis on 
sensitization of the community, and adoption of door-to-door distribution, 
may be needed to maximize the number of children protected.
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THE THIRD AND FOURTH ROUNDS OF SCHOOL NET 
DISTRIBUTION TO MAINTAIN UNIVERSAL ACCESS TO LONG-
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In 2011, the Ministry of Health and National Malaria Control Program 
of Tanzania developed a Keep Up Strategy with the goal of maintaining 
the population’s access to an ITN at or above 80%, by using school-
based distribution as an innovative distribution channel. This strategy 
was piloted in the Southern Zone beginning in 2013, when the NMCP 
and the Tanzanian Red Cross Society distributed ITNs in 2,302 schools 
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in 19 districts in Lindi, Mtwara, and Ruvuma, a total of 421,285 ITNs, 
to classes 1,3,5,7 in primary school and Form 2 and 4 in secondary 
schools. By August 2016 Tanzania will have implemented four annual 
rounds of school-based distribution in three Southern regions. SNP2 was 
implemented in 2014 by NMCP and Research Triangle Institute, delivering 
489,099 ITNs to school children, and adding classes 2 and 4 in Lindi. In the 
third round in 2015, NMCP with JHUCCP’s VectorWorks project delivered 
494,407 ITNs to 1,919 schools in the 19 districts, targeting classes 1-3, 5, 
and 7 in primary school in Ruvuma and Mtwara, and classes 1-5 and 7 in 
Lindi. The 4th round in August 2016 will continue in the three regions in 
the south and expand to four regions in the Lake Zone; 1,310,000 ITNs 
will be delivered to 5,054 schools in a total of seven regions. Working 
with a multi-sectoral task force including Ministry of Health, Ministry of 
Education, and local officials, enrolment data was gathered from each 
school, verified, and used to quantify deliveries for each school. After 
training and delivery of ITNs to schools, teachers distributed ITNs to the 
eligible students in the targeted classes, and provided behavior change 
messages on net use, care, and malaria prevention. We will discuss the 
design, implementation and outcomes of SNP3 and SNP4, including the 
process of quantifying the ITN needs, training and sensitization activities, 
data management, and logistics considerations for an ongoing, mass 
yearly distribution of nets to schoolchildren. We will also discuss changes 
from SNP1 to SNP4 in the operations management, in particular, decisions 
to adjust the number of classes targeted each year based on evaluation 
data, and implications for future national scale-up.
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The ecological context in which mosquitoes and malaria parasites interacts 
has received little attention, compared to the genetic and molecular 
aspects of malaria transmission. Plant nectar and fruits are important 
for the nutritional ecology of malaria vectors, but how the natural 
diversity of plant-derived sugar sources affects mosquito competence for 
malaria parasites is unclear. To test this, we infected Anopheles coluzzi, 
an important African malaria vector, with sympatric field isolates of 
Plasmodium falciparum, using direct membrane feeding assays. Through 
a series of experiments, we then examined the effects of nectar from 
Thevetia neriifolia and Lannea microcarpa, and fruit from Barleria lupilina 
and Mangifera indica on parasite and mosquito traits that are key for 
determining the intensity of malaria transmission. We found that the 
source of plant sugar differentially affected infection prevalence and 
intensity, the development duration of the parasites, as well as the survival 
and fecundity of the vector. These effects are likely the result of complex 
interactions between toxic secondary metabolites and nutritional quality of 
the plant sugar source, as well as of host resource availability and parasite 
growth. Using an epidemiological model, we show that plant sugar 
source can be a significant driver of malaria transmission dynamics, with 
some plant species exhibiting either transmission-reducing or -enhancing 
activities.
1658
PROCESS EVALUATION OF CONTINUOUS ITN DISTRIBUTION 
IN ZANZIBAR
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In 2013, Zanzibar designed a continuous ITN distribution strategy to 
maintain high levels of ITN ownership and use. ITNs are given to pregnant 
women and caretakers of young children through free distribution at 
1st ANC visit and 9 month measles vaccination, respectively. At the 
community level, households request a coupon from the sheha to redeem 
for a LLIN and then exchange the coupon at a health facility for a new 
ITN. Coupons are then returned to ZaMEP. In addition, coupons can be 
issued by district malaria surveillance officers during case investigations 
if LLIN need is identified. From June 2014 to January 2016, the Zanzibar 
Malaria Elimination Program (ZaMEP) reported that 289,661 ITNs were 
distributed through continuous distribution: 65,325 to pregnant women 
at ANC, 60,507 to caretakers at EPI clinics, and 163,829 through the 
community channel. A total of 40 semi-structured interviews took place in 
early April in a convenience sample of 8 shehias and 16 distribution points 
on Unguja and Pemba Islands, Central, West B, Chake Chake, and Mkoani 
districts. Interviews took place at distribution points for coupons and for 
LLINs, with central level stakeholders, and with health facility staff and 
shehas at community level to identify implementation bottlenecks and best 
practices. Record reviews of LLIN distribution, stock data, and costs were 
done at central, district, shehia, and health facility level. Ten observations 
of coupon/ITN redemption were made. Preliminary findings indicate that 
overall, the CD channels are functioning, with challenges in stockouts of 
both ITNs and coupon-books at certain health facilities and shehias, and 
in adequate storage facilities for ITNs at health facilities. Stakeholders at 
all levels felt the program has made a positive contribution to malaria 
control, but there is a need for clarity in reporting systems and increased 
supportive supervision and refresher training, particularly at the shehia 
level. Additional findings, including estimates of ITN ownership and access 
resulting from the continuous distribution, and cost per-ITN-distributed, 
will be presented after the data is fully processed and analyzed.
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ASSESSMENT OF MALARIA TRANSMISSION FROM 
HUMAN TO MOSQUITOES IN SEASONAL MALARIA 
CHEMOPREVENTION IN THE WESTERN REGION OF BURKINA 
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Seasonal malaria chemoprevention (SMC) can reduce malaria cases up 
to 80% in sahelian region. However the impact of SMC on human to 
mosquito malaria transmission is currently unkown. Here, we evaluated the 
infectiousness to mosquitoes of volunteers receiving SMC by membrane 
feeding assays. Children over the age of 2 years, participants of a SMC 
clinical trial were randomly selected. They were invited to participate after 
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a clinical examination and irrespective of their parasite carriage status. 
Blood sample were collected in 5 sites (4 under SMC treatment and 1 
control) over a period of 4 months from August to November 2015. In 
total 301 children were involved, 204 children in SMC group and 77 in 
control group. For each blood sample, 80 female Anopheles mosquitoes 
were provided a blood meal through a parafilm membrane. On day 7 
after feeding, mosquitoes were dissected and midguts were screened 
for the presence of oocysts. Generalized linear mixed models were used 
to compare mosquito infection in treatment and control group and to 
estimate intervention efficacy. Results showed that gametocytemia was 
lower in the SMC groups with respect to the control: month 1 (X22=6.14, 
p=0.046), month 2, 3, and 4 (X21=57.3, p<0.0001). There was a strong 
impact of SMC on both oocyst prevalence with a 93 % reduction in 
mosquitoes that received blood from SMC patients (X22=182, p<0.0001), 
and oocyst density with a 86% reduction (X22=70.6, p<0.0001). In 
conclusion, in an area of seasonal malaria transmission, chemoprevention 
highly reduces human to mosquitoes malaria transmission.
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Community engagement (CE) during community trials is a complex social 
phenomenon that defies simple explanation or mechanization. We present 
findings from an assessment of the sensitization process, experiences, 
and challenges in improving understanding and subsequent acceptance 
of an insecticide-treated wall lining (ITWL) program. The initial project 
sensitization plan relied on the traditional approach of inviting villagers 
to meetings with researchers. However, meeting schedules coincided 
with farming activities and Tanzania’s presidential elections, resulting on 
poor attendance. Sensitization was re-strategized to add door-to-door 
sensitization using local advocates, announcements using a megaphone, 
and designing and distributing brochures detailing the study objectives and 
consenting process. The process continued during the ITWL installation 
phase. Following re-strategizing of sensitization, the ITWL acceptance 
rose to 86.4%. However, some clusters still had some refusals. Reasons 
included gender and consent, for example, in some houses the head of 
house (generally a man) refused installation after the wife had accepted. 
Old rumors resurfaced that ITWL contributed to male impotence. Some 
installers, initially unprotected, developed skin rashes. In one case, one 
resident’s skin rashes spread fear to a whole hamlet. Households with 
better socio-economic status cited personal ability to control malaria and 
feared damage to their walls by the installation process. Directives that 
children should not touch the wall liners and confusion from installation 
delays all fed into refusal rates. Rumors of side effects from the ITWL 
contributed much on project challenges including refusals. Re-strategizing 
sensitization plus continuous sensitization throughout and after the official 
installation period increased ITWL acceptance. Future projects should 
incorporate continuous sensitization and consider using specialized village 
research committees for improved CE.
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In rural Greater Accra, in 2014, 49% of people didn’t use mosquito nets 
despite having access to a space under one. Discomfort due to heat is 
the most stated reason, but this problem is largely unaddressed. With 
advancing electrification and dropping price of solar power, ‘Bͻkͻ’ 0.8 W 
net fans equipped with a 0.1 W LED could improve comfort inside nets 
and be affordable to populations in malaria endemic areas. Ninety-two 
households (HHs) from rural communities in Greater Accra, divided into 
three groups, participated in a 10-month randomized cross-over trial, 
where fan systems (one fan per HH member in Group 1) were crossed 
over with water filters between Groups 1 and 2, while Group 3 served 
as control. Intervention HHs participated in fortnightly surveys on HH’s 
practices related to mosquito nets, fans and water filters, while control 
HHs were questioned only at start, mid-point and study end. Further, 
key-informant interviews were held before mid-point (cross-over), and 
willingness to pay for fans was assessed in individual auctions at study 
end. Baseline net use conditional on access in the study communities was 
unexpectedly high at 92, 93, and 87% for Groups 1, 2 and 3, respectively, 
and increased to 99 and 99% at cross-over and 97 and 90% at end-point 
in intervention Groups 1 and 2, respectively, while it reduced to 81 and 
84% in the control Group 3 at cross-over and end-point, respectively, 
indicating a Hawthorne / study effect. Stated fan use was 88-100% 
depending on the fortnight of survey. The main reason for using fans 
was heat, but it was also mentioned that they drove mosquitoes away. 
Key informants suggested they slept less exposed outside due to the fan 
during part of the night during the dry season. Despite the low power 
rating, nine out of 13 key informants stated that they placed the fan 
outside the bed net explaining that the air produced by the fan was 
enough to reach them through the net. The average bid price per fan was 
GH₵ 55 (~US$ 13.5), and in total 98 Bͻkͻ fans were sold to participating 
HHs. Small electric fans were accepted and desired in the study community 
and may be an affordable innovation to improve comfort inside mosquito 
nets in hot climates.
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An intermittent preventive treatment (IPT) program using 
dihydroartemisinin-piperaquine (DP) was implemented between March 
and July 2015 in a refugee camp in Adjumani District, Uganda. To our 
knowledge, this is the first implementation of IPT in the setting of a 
humanitarian emergency. Weight-dosed DP was offered to all children 
aged 6 months-14 years in the camp in March, May, and July 2015, 
at eight-week intervals. On average, 13 537 children received each 
distribution. To evaluate malaria incidence, reported cases were compared 
to the same 6-month period from 2014 taking into account population 
changes. To evaluate malaria prevalence, in the week prior to each 
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distribution and 8 weeks following the final distribution, malaria surveys 
were conducted in the camp. Thick and thin smears were collected from a 
target sample size of 250 persons in each of three age groups: <5 years; 
5-14 years; ≥15 years. Direct microscopy was performed. In 2014, among 
children <5, malaria incidence was 0.71 cases/person over the 6 month-
period running from March-August; in 2015 it was 0.52 (IRR 0.73, 95%CI 
0.69-0.77) over the same period during IPT implementation. In children 
aged 5-14 years, the incidence was 0.96 cases/person in 2014 and 0.67 
in 2015 (IRR 0.70, 95%CI 0.67-0.72). For those >15 years, the incidence 
was 0.37 cases/person in 2014 and 0.55 in 2015 (IRR 1.49, 95%CI 1.42-
1.56). Among children <5, the prevalence of parasitemia by microscopy 
was 5.1% (95%CI 3.0-8.5) at baseline and 15.1% (95%CI 12.1-18.7) 
two months following the final distribution of DP. Among children aged 
5-14 years, these figures were 8.7% (95%CI5.8-12.9) and 26.7% (95%CI 
20.9-33.6), respectively. Among those over 15, the prevalences were 6.1% 
(95%CI 3.9-9.7) and 18.7% (13.7-25.0), respectively. In the setting of 
a humanitarian emergency, IPT reduced the incidence of malaria among 
its target population. Its impact may appear mitigated because of strong 
transmission seen at the end of the program in 2015, after the protective 
effect of DP had ended, as evidenced by the high incidence and prevalence 
seen in the untreated population.
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In DRC, malaria remains a major public health problem as the first cause 
of morbidity and mortality. To remedy this, the control strategies and 
approaches have been developed including support cases and vector 
control. The insecticide-treated net (LLIN) is a component of the vector 
control implementation in the country for over a decade. To obtain data 
that could reorganize malaria control, a critical analysis of the coverage 
level spaced ten years was performed. A community survey targeting the 
effective coverage of LLINs in households through the distribution and 
use of this material treated by communities (9 sentinel sites of NMCP). 
Cluster sampling was used for data collection. The statistical analysis took 
into account the 5% significance level. Between 2004 and 2014, the 
ownership of LLINs increased between 51.3% and 92%. As to the use, it 
was between 51% and 85% depending on the sites. The proportion of 
pregnant women sleeping under LLINs was between 61.7% and 89%. The 
protection of children under 5 years by the LLIN was between 57% and 
91.6%. The sleeping places hedging average was 9.9% (3.4 to 16.4%, 
I.C 95%) in 2004, while coverage was 61.9% in 2014 (34.9 to 85%, I.C 
95%). In conclusion, the universal coverage threshold was not achieved 
globally in the country. Efforts should be made to allow universal coverage 
nationally.
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Plasmodium and Anopheles in South Asia are under constant selection 
pressure due to ecological changes and parasite/vector control strategies 
of the Government of India. Most of the vector-parasite compatibility 
studies done in South Asia have centered around 6 major malaria vectors 
(Anopheles culicifacies, An. fluviatilis, An. stephensi, An. minimus, An. 
dirus and An. sundaicus), and these vectors are estimated to contribute 
to 95 - 98% of malaria cases. Much less is known about the role of 
other Anophelines in Plasmodium transmission in South Asia. There is a 
consistent increase in P. falciparum (Pf) cases in the last 40 years. As of 
December, 2015, Pf contributes to 67.5% of malaria cases in the Indian 
subcontinent. We hypothesize that, under intense drug and insecticide 
pressures, new parasite-vector associations could emerge based on the 
right physiological and phenotypic matches. In our US NIH International 
Centers of Excellence for Malaria Research (ICEMR) study site in Goa, 
Western India, a 2-year longitudinal study identified the mosquitoes 
that are naturally transmitting malaria in this region. An. subpictus, a 
previously overlooked minor vector, has emerged as a dominant malaria 
vector overtaking the primary vector, An. stephensi, and is transmitting 
malaria throughout the year. While in nature there are two sibling species 
of An. subpictus (A and B) in our study site, salivary gland infections were 
seen only in the sibling species, B. To facilitate larger surveys involving 
sibling species A and B of An. subpictus, a multiplex PCR assay has been 
developed. We have also colonized An. stephensi and have successfully 
performed laboratory infection experiments with patient blood containing 
P. vivax and P. falciparum infected patient blood. We describe efforts 
to colonize An. subpictus and compare the vector competence of An. 
subpictus and An. stephensi through controlled feeding experiments.
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Despite widespread distribution of long lasting insecticide bed nets 
(LLINs), malaria continues to be a major cause of morbidity and mortality 
globally. Indoor residual spraying (IRS) has proved efficacious, but is 
expensive, logistically complex due to needed reapplication every 6-12 
months, and challenging due to insecticide resistance. A new technology, 
the non-pyrethroid insecticide treated wall liner (ITWL), may provide 3-4 
years of protection from a single installation. Its two insecticides with 
different modes of action should curb insecticide resistance. We computed 
the incremental cost-effectiveness ratios (ICERs) of ITWL and IRS as 
supplements to LLINs in Kenya and Tanzania. One cluster randomized trial 
of the previous pyrethroid ITWL as a supplement to LLINs was conducted 
in Kenya. A similar trial (with the non-pyrethroid ITWL) is underway in 
Tanzania. We obtained acceptance rates, financial costs to the health 
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system, and effectiveness of IRS and ITWL through original data collection 
and available literature. Costs covered outreach, projected procurement 
and installation. We incorporated savings in medical costs from fewer 
malarial episodes. Estimated ITWL acceptance rates averaged 98% in 
Kenya (where extensive prior meetings with village leaders occurred) and 
68% in Tanzania (where outreach began later). Average inpatient and 
ambulatory malaria episodes cost $59.80 and $8.06 in Kenya and $212.12 
and $23.17 in Tanzania, respectively. In Kenya, one-time ITWL costs were 
$64.23 per person in 2010 while IRS cost $3.16 per person annually. In 
Tanzania, annual IRS costs were $15.59 per household in the target areas. 
Good communications proved critical to acceptance of ITWL. In Kenya, the 
ICERs were $482 per discounted life year gained (assuming protection lasts 
3 years) for ITWL and $139 for IRS. As these ICERs were below Kenya’s 
GDP per capita ($795), both technologies are highly cost-effective based 
on World Health Organization criteria. Although the ICER of ITWL was 
initially less favorable than that for IRS in Kenya, falling prices of LLINs 
suggest ITWL should also likely become less costly and more cost-effective.
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LAND COVER DETERMINANTS OF PLASMODIUM 
FALCIPARUM PREVALENCE IN URBAN AND PERI-URBAN 
AREAS OF NORTHERN BIOKO ISLAND
Jordan M. Smith, Dianna E.B. Hergott, Christopher Schwabe, 
Wonder P. Phiri, Akum Aveika, Jose Luis Segura
MCDI, Silver Spring, MD, United States
Beginning in 2015, the Bioko Island Malaria Control Project (BIMCP) 
adopted a strategic and targeted approach of indoor residual spraying 
(IRS) for malaria prevention. Evidence suggests that hotspots of malaria 
transmission to be targeted are best evaluated by finding increased 
exposure to infectious mosquito bites. Despite routine vector monitoring 
throughout the island, mosquito collection in urban and peri-urban areas 
of northern Bioko has been logistically challenging. Remote sensing and 
geographic information systems (GIS) are frequently used to explore 
associations between land use/land cover (LULC) and mosquito-borne 
diseases by functioning as a proxy for mosquito abundance, while spatial 
scan statistics are used to detect spatial clustering of malaria prevalence. 
Data on prevalence of P. falciparum parasitaemia were collected from a 
representative sample of 5,286 households throughout the island during 
the 2015 Malaria Indicator Survey. Seven LULC types were classified 
through supervised classification of remotely sensed high resolution 
satellite imagery. Areas at higher risk of transmission were evaluated using 
a Bernoulli purely spatial scan statistic. Spatial associations of LULC and P. 
falciparum parasitaemia were performed using geographically weighted 
logistic regression analyses to determine case environmental risk factors. 
Complete data were available for 19,666 individuals. Although several 
statistically significant clusters were detected, two clusters of excess risk 
appeared to have been driven by one to two households with several 
cases. The most likely spatial clustering of malaria prevalence was detected 
in peri-urban areas, particularly in the northwestern region of the island, 
which appears to be temporally heterogenous. Results of geographic 
weighted regression will be analyzed further.Plasmodium falciparum 
malaria prevalence is heterogeneous in space in this urban and peri-
urban study area. Geographical and housing risk factors associated with 
prevalence will be explored further. This analysis improves the planning of 
IRS interventions targeting high-risk areas.
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ENTERIC PATHOGEN SURVEILLANCE IN CHILDREN AND 
ADULTS IN A CASE-CONTROL STUDY OF ACUTE DIARRHEA 
IN BATTAMBANG, CAMBODIA
Ladaporn Bodhidatta1, Lon Chanthap1, Chiek Sivhour2, Woradee 
Lurchachaiwong1, Sok Vannara3, Koy Lenin2, Brett Swierczewski4
1Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand, 
2Battambang Referral Hospital, Battambang, Cambodia, 3Military Region 5 
Hospital, Battambang, Cambodia, 4Armed Forces Research Institute of 
Medical Sciences, Bangkok, Thailand
 Diarrhea has continued to be a major public health problem in 
developing countries and surveillance for for a wide range of enteric 
pathogens is necessary to understand frequency of pathogens. Stool 
samples, demographic and clinical data were collected from cases and 
asymptomatic controls in children (< 5 years old) and adults seen at 
Battambang Referral Hospital, SvayPor Health Center and Military Hospital 
5 located in Battambang, Cambodia from July 2014 - April 2016. Standard 
microbiology for stool culture, ELISA and PCR were applied to detect 
enteric bacteria, virus and parasites. Antimicrobial susceptibility testing 
(AST) was tested by using disk diffusion method. In children < 5 years old, 
226 cases and 226 controls were enrolled in the study in which rotavirus 
(20%), norovirus (16%) and Shigella (9%) were detected significantly 
more in the cases than controls. Enteroaggregative E.coli (24%), 
Salmonella (17%), Campylobacter (11%) were found in relatively similar 
proportions of cases and controls. Of 57 adult cases and 54 controls, 
bacterial pathogens including Vibrio (7%) and Campylobacter (4%) were 
identified significantly more in cases than controls. Enteric viruses were 
infrequently detected among the adult population. AST demonstrated 
multidrug resistant Shigella as well as co-resistance to extended spectrum 
cephalosporins and fluoroquinolones. Additionally, fluoroquinolone 
resistant Campylobacter was found in 80% of the isolates. Continued 
surveillance will provide data on etiologic agents and antimicrobial 
resistance patterns that are critical for treatment guidelines, prevention 
and control of diarrheal disease in Battambang, Cambodia.
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VIRULENCE PROFILE OF ENTEROTOXIGENIC ESCHERICHIA 
COLI (ETEC) STRAINS ISOLATED FROM PERUVIAN CHILDREN
Fulton P. Rivera1, Anicia M. Medina1, María J. Pons2, Maribel 
Riveros1, Ryan C. Maves3, Joaquím Ruiz4, Theresa J. Ochoa1
1Universidad Peruana Cayetano Heredia, Lima, Peru, 2Universidad Peruana 
de Ciencias Aplicadas, Lima, Peru, 3Naval Medical Center, San Diego, CA, 
United States, 4ISGlobal, Barcelona Ctr. Int. Health Res. (CRESIB), Hospital 
Clínic - Universitat de Barcelona, Barcelona, Spain
Enterotoxigenic Escherichia coli (ETEC) is a major cause of diarrhea 
in children and travelers. The aim of this study was to determine the 
presence of virulence factors (VF) of ETEC strains isolated from Peruvian 
children. We analyzed a total of 205 ETEC strains previously isolated from 
two cohort studies in children <24 months of age in Lima, Peru. ETEC 
was identified by a multiplex real-time PCR for lt and/or st genes. The 
presence of sixteen colonization factor (CF) types, ST toxin subtypes (STh 
and STp), adhesins (Tia, TibA, EtpA), a GTPase (LeoA), an autotransporter 
(EatA), an enteroaggregative E. coli heat-stable enterotoxin (EAST1) and 
an E. coli common pilus (ECP) genes were evaluated by PCR. LT-positive 
(ETEC-lt) strains (99/205, 48%) were the most frequent, followed by 
strains with only ST (ETEC-st) (63/205, 31%) and strains positive for both 
LT and ST (ETEC-lt-st) (43/205, 21%). Among ST-positive strains (with or 
without LT) STh (estA+) was the ST-toxin type most frequently identified 
(64/106, 60%). The most common CFs were CS21 (34%), CS6 (20%), 
CS3 (15%), and CS1 (12%). Presence of at least one CF were more 
frequently detected in isolates from diarrheal than control samples (81% 
vs. 52%, p<0.001). Whereas CS6 (26% vs. 13%, p<0.001), CS5 (13% 
vs. 2%, p<0.01) and CS1 (16% vs. 6%, p<0.05) were more frequently 
detected from diarrheal than control samples, respectively. STh+ CS21 
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genotype (with or without other CFs) was the most prevalent among all 
strains (19%, 38/205). On the other hand, the most common nonclassical 
VF (other than CFs and LT/ST toxins) were ECP (89%), EAST1 (44%), EatA 
(42%) and EtpA (32%). EatA was significantly detected in ETEC isolates 
from diarrheal than control samples (53 vs. 27%, p<0.01). Strains positive 
to at least one nonclassical VF were more frequently detected in isolates 
from diarrheal than control samples (100% vs. 95%, p<0.05). Using a 
prototype vaccine (with LT toxoid, CFA/I, and CS1 to CS6) as a model, the 
estimated vaccine coverage rate in children in Lima will be 92% (189/205). 
Further studies are needed to determine the utility of these antigens as 
well as other autotransporters in ETEC vaccines.
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VACCINATION FOR THE CONTROL OF TYPHOID FEVER: 
ESTIMATING THE POPULATION-LEVEL EFFECTS OF 
HISTORICAL TY21A FIELD TRIALS IN SANTIAGO, CHILE
Jillian S. Gauld, Dennis L. Chao, Hao Hu
Institute for Disease Modeling, Bellevue, WA, United States
In the absence of water and sanitation interventions, vaccination remains a 
primary control measure for typhoid fever. Evaluating the herd protection 
of these vaccines is challenging, and is often compounded by changes in 
the environment. From 1982 to 1986, over 300,000 school children were 
vaccinated with at least one dose of Ty21a in the metropolitan region of 
Santiago, Chile. The incidence of typhoid fever declined in this area from 
over 100 per 100,000 at the beginning of this trial, to less than 50 per 
100,000 at the end of 1990. Without a control population cluster, herd 
effects of the vaccine could not be directly estimated, or contrasted with 
the water and sanitation changes that occurred during this period. We use 
a mathematical modeling approach to estimate the vaccine’s contribution 
to the decline in typhoid fever, both through the direct protection of 
the vaccine, as well as indirect protection through herd effects. Results 
from this study highlight methods for estimating the impact of typhoid 
vaccination in populations undergoing environmental change, as well as 
outline features for prospective typhoid vaccination trials important for the 
evaluation of both direct and indirect effects. These results can help inform 
strategies for global typhoid fever control, including the planning for new 
conjugate vaccine initiatives.
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ESCHERICHIA COLI PATHOTYPES FROM ECUADOR: 
ASSOCIATION WITH DIARRHEA AND ANTIBIOTIC 
RESISTANCE
Lorena Patricia Montero1, William Cevallos2, Xavier Sánchez2, 
Edison Puebla2, Pablo Endara1, Gabriel Trueba1, Karen Levy3
1Universidad San Francisco de Quito, Quito, Ecuador, 2Universidad Central 
del Ecuador, Quito, Ecuador, 3Emory, Atlanta, GA, United States
Diarrheagenic Escherichia coli (DEC) is an important cause of diarrhea 
in the developing world and the detection of these bacteria and their 
antibiotic resistance profiles are necessary for effective therapy. In this 
study, we conducted a microbiological survey of DEC in 233 stool samples, 
collected during a case control study in a hospital and health center in 
a low income neighborhood of Quito, Ecuador from April to September 
2014. We used 8 sets of PCR primers to detect distinct DEC pathotypes. 
The overall prevalence of DEC was 30.5% in cases and 20.2% in controls 
(OR 1.76 CI 95% 0.96-3.20, p=0.06), Diffusely adherent E.coli (DAEC) 
was the most frequently detected pathotype in cases and controls (15.3% 
vs. 6.1% respectively) and was the only pathotype with a statistically 
significant association with diarrhea (OR 2.78, CI 95% 1.11-6.96, p=0.03). 
To our knowledge this is the first study investigating this pathotype in 
Ecuador. Additionally, pathotypes isolated from cases exhibited significantly 
higher levels of antimicrobial resistance to specific antibiotics, as well as 
higher levels of multidrug resistance, than isolates obtained controls.
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QUALITATIVE MOLECULAR DIAGNOSTICS MAY IMPROVE 
MEDICAL MANAGEMENT OF HOSPITALIZED SEVERELY 
MALNOURISHED CHILDREN WITH DIARRHEA: PRELIMINARY 
ANALYSIS FROM HÔPITAL DE L’AMITIÉ IN N’DJAMENA, 
CHAD
Bruno Akpakpo, Ali Ouattara, Richard Kojan, Susan Shepherd
The Alliance for International Medical Action (ALIMA), Dakar, Senegal
Accurate diagnosis of infectious disease and rational use of antibiotics is 
challenging in resource-limited contexts where microbiological laboratory 
services are virtually absent. Diarrhea, for example, is typically present in 
at least 50% of children with severe acute malnutrition (SAM) admitted to 
hospital and is associated with increased risk of death. Current diarrheal 
treatment protocols for hospitalized SAM children rely on a syndromic 
approach, prioritizing fluid replacement and correction of malabsorption 
over specific treatment for pathogens. Antibiotic use is reserved for 
protracted or bloody diarrhea and is guided by a UNICEF protocol 
template applied without accounting for local or regional epidemiology. 
Studies suggest that multiplex molecular diagnostics can provide reliable 
clinically relevant information in field laboratories where infectious 
diseases like diarrhea represent a major portion of disease burden. 
Automated qualitative polymerase chain reaction (PCR) systems do not 
require a high level of expertise to operate and may provide actionable 
microbiologic information even though it gives no information regarding 
pathogen burden. ALIMA, with the support of the Institut Mérieux, is 
using qualitative PCR to test stools from hospitalized SAM children with 
diarrhoea in N’Djaména, Chad. Each sample is tested simultaneously for 
22 distinct bacterial, protozoal and viral molecular targets. The trial expects 
600 inclusions total over 12 months. Within the first 4 months, stool from 
146 children have been analyzed. A total of 537 pathogens have been 
detected, an average of 3.8 per child. 70% are bacteria, 18% viruses 
and 12% parasites. Within the bacterial group 52% are E coli pathogens 
with entero-invasive E coli (EIEC)/Shigella detected in 57 of 146 samples 
(39%). Clinicians have adapted antibiotic prescription for 54/146 children 
(37%); 42/54 prescription changes result from the identification of EIEC/
Shigella. Preliminary analysis of this trial demonstrates that the technology 
is accessible and reliable in a resource-limited context and that clinicians 
use the information to modify treatment.
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DRIED BLOOD SPOTS: AN ALTERNATE TOOL FOR THE 
ASSESSMENT OF IMMUNE RESPONSE TO CHOLERA 
INFECTION AND VACCINE
Anita S. Iyer1, Francisco J. Luquero2, Malika Bouhenia3, Randon J. 
Gruninger1, Edward T. Ryan4, David A. Sack2, Andrew S. Azman5, 
Daniel T. Leung1
1Division of Infectious Diseases, Department of Internal Medicine, 
University of Utah, Salt Lake City, UT, United States, 2Department of 
International Health, John Hopkins University, Baltimore, MD, United 
States, 3World Health Organization, Juba, South Sudan, 4Division of 
Infectious Diseases, Massachusetts General Hospital, Boston, MA, United 
States, 5Department of Epidemiology, John Hopkins University, Baltimore, 
MD, United States
Analyzing Dried Blood Spots (DBS) is an attractive tool for measuring 
antibody responses as it overcomes the challenges associated with supplies 
and expertise needed for venipuncture and sample processing, especially 
in resource-limited and challenging settings such as during cholera vaccine 
programs. The goal of this study was to evaluate DBS as a tool for the 
measurement of Vibrio cholerae O-specific polysaccharide (OSP)-antibody 
responses and to determine vibriocidal titers in volunteers immunized with 
oral cholera vaccine (OCV) Shanchol. Specifically, sera and blood spots 
were obtained from persons receiving OCV on day 0 (pre-vaccination), day 
21 (21 days post 1st vaccine dose) and day 35 (14 days post 2nd vaccine 
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dose) in South Sudan. The results of assays involving DBS were correlated 
with traditional approaches utilizing sera. Blood spots were generated on 
Whatman 903 DBS cards, and stored at ambient temperature for up to 
100 days. 4 dried blood soaked spots were punched out per volunteer 
specimen, and eluted overnight in a 24 well plate containing buffer. 
The eluates were subsequently used for determination of OSP-specific 
responses by ELISA. In a preliminary analysis involving 15 individuals, 
we noted statistically significant positive correlations between DBS and 
simultaneously sampled serum OSP-specific IgG (r=0.64, p<0.001), IgM 
(r=0.68, p<0.001) and IgA (r=0.64, p<0.001) antibody responses. Fold 
rises after the 1st OCV dose correlated between DBS and serum ELISA’s for 
OSP IgG (r=0.61, p=0.01) and OSP IgA (r=0.76, p<0.001). Seroconversion 
rates assessed by the two methods were also similar. In addition, 
preliminary experiments suggest DBS can be used for the determination 
of vibriocidal titers using drop plate culture methods as determined by 
50% growth reduction in samples compared to DBS free controls. Further 
assay optimization and validation is pending and more complete results 
will be available at time of presentation. Our data suggest a potential use 
of DBS as an inexpensive and convenient tool for the assessment of OCV 
immunogenicity and seroprevalence surveys, including in resource-limited 
settings.
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THE STUNTING SYNDROME DEVELOPS IN CHILDREN WITH 
INCREASED MICROBIAL TRANSLOCATION AND ATTENUATED 
EVOLUTION OF THE GUT MICROBIOME
Mara Zambruni1, Natalia I. Vigo2, Gonzalo J. Acosta2, Maribel 
Riveros2, Maitreyee Nigalye1, Anoma Somasunderam1, Nadim J. 
Ajami3, Miguel M. Cabada1, Theresa J. Ochoa2, Netanya S. Utay1
1University of Texas Medical Branch, Galveston, TX, United States, 
2Instituto de Medicina Tropical “Alexander von Humboldt”, Universidad 
Peruana Cayetano Heredia, Lima, Peru, 3Baylor College of Medicine, 
Houston, TX, United States
Stunting due to malnutrition is estimated to affect 165 million children 
under 5 years old. However, its pathophysiology remains elusive. We 
hypothesized that in low resource settings stunting is mediated by 
systemic inflammation due to increased microbial translocation ensuing 
from chronic intestinal damage and microbiome perturbation. We enrolled 
81 healthy infants living in rural villages of Peru and followed them for 
6 months with monthly growth assessments. Blood samples for markers 
of intestinal damage (intestinal fatty acid binding protein [I-FABP]) and 
systemic inflammation and stool samples for microbiome analysis were 
collected at months 0 (enrollment) and 6. Biomarkers were measured 
by Luminex or ELISA. Microbiome analysis was performed via 16SrDNA 
sequencing. Non parametric statistics were used to compare distribution 
of continuous variables and to measure correlations. Multivariate odds 
ratios of stunting were estimated by logistic regression. By 6 months, 18 
(22%) children became stunted. I-FABP was high in cases and controls at 
month 0 and 6 but was not significantly different between the 2 groups 
at any time point. Tumor necrosis factor α, interleukin-1 and -6 levels were 
comparable between the 2 groups at month 0 and 6. Greater increases in 
soluble CD14 (monocyte activation) and lipopolysaccharide binding protein 
were associated with increased odds of stunting after adjusting for month 
0 age and HAZ (ORs 7.24 ([95% CI 1.05- 49.84] P= 0.04) and ORs 6.32 
([95% CI 1.40-28.36] P=0.02 respectively). Children who became stunted 
had arrest of the physiologic increase in microbiome diversity over time 
and a different distribution of bacterial taxa compared to controls. Among 
Peruvian children younger than 2 years of age 1) markers of enterocyte 
damage are high 2) stunting is associated with increased microbial 
translocation/innate immune system activation and slower evolution of the 
gut microbiome. Interventions to prevent or repair intestinal damage may 
prevent the stunting syndrome.
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ANTIMICROBIAL RESISTANCE PROFILE IN ENTEROBACTERIAE 
ISOLATED FROM CHILDREN UNDER-2-YEARS-OLD IN PERI-
URBAN COMMUNITIES IN LIMA, PERU
David Durand1, Erik Mercado1, Victor Torres1, Theresa J. Ochoa2
1Universidad Peruana Cayetano Heredia, Lima, Peru, 2Baylor College of 
Medicine, Houston, TX, United States
Antimicrobial resistance is a major and growing problem worldwide, 
specially affecting low and middle-income countries. There is no recent 
data regarding antimicrobial resistance in enteric pathogens in children 
in Lima. The aim of this study was to determine the antimicrobial 
resistance patterns of important enteric bacteria isolated from stool 
samples of children under 2 years old. Stool cultures were obtained 
during a community trial in the District of Independencia, Lima, between 
2008 and 2011. A total of 711 diarrheal samples and 348 controls (from 
asymptomatic children) were collected. Shigella and Campylobacter were 
identified by routine microbiology; diarrheagenic E. coli strains were 
indentified by real time-PCR. Antibiotic susceptibility was tested by disk 
diffusion. Diarrheagenic E. coli strains included 346 enteropathogenic 
(EPEC), 253 enteroaggregative (EAEC) and 177 enterotoxigenic E. coli 
(ETEC). Diarrheagenic E. coli pathotypes (n=776) were resistant to 
ampicillin (68%), trimethroprim-sulfamethoxazole (61%) and tetracycline 
(49%); with low resistance rates to ciprofloxacin and ceftriaxone (<4%). 
Shigella isolates (n=96) were resistant to ampicillin (65%), trimethroprim-
sulfamethoxazole (83%), tetracycline (70%) and chloramphenicol (49%); 
resistance to ciprofloxacin and ceftriaxone was not found. Campylobacter 
isolates (n=187) were resistant to tetracycline (90%), ciprofloxacin (88%) 
and azithromycin (17%). There was no difference in the resistance rates 
between diarrheal and control samples. Antimicrobial resistance of enteric 
pathogens is high in this setting. There is an urgent need to implement 
intervention strategies to control the emergence and spread of resistant 
strains and large scale, prospective, multicenter surveillance studies to 
document the current trends.
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ENTEROAGGREGATIVE ESCHERICHIA COLI IS SYNERGISTIC 
WITH OTHER ENTERIC PATHOGENS TO IMPAIR GUT 
ABSORPTION, CAUSE INFLAMMATION AND IMPAIR 
GROWTH
Aldo A. Lima1, Alberto M. Soares1, José Q. Filho1, Alexande Havt1, 
Ila F. Lima1, Noélia L. Lima1, Pedro H. Quintela1, Rosa M. Mota1, 
Richard L. Guerrant2, The Mal-Ed network
1Federal University of Ceara, Fortaleza, Brazil, 2University of Virginia, 
Charlottesville, VA, United States
Enteroaggregative Escherichia coli (EAEC) is common in children in 
developing countries. We evaluated EAEC infections in monthly stools 
tested in 1226 asymptomatic children with over 90% of twice weekly 
follow up for their first 2 years of life across 8 MAL-ED sites in Asia, Africa 
and Latin America. When children with EAEC alone were compared with 
those with no pathogens, other pathogens, or EAEC with 1, 2 or 3 other 
pathogens, those with EAEC or any other pathogen had inadequate 
sanitation compared with those with no pathogen at any of the three 
periods. Poor sanitation, percent of mothers with <6 years of education, 
lower socioeconomic assessment or percent with income <$150/month 
were associated with EAEC coinfections compared to the other groups 
including those with pathogens other than EAEC. Antibiotic use and low 
percent of breastfeeding were also associated with EAEC coinfections. 
Myeloperoxidase was increased with EAEC coinfections compared also to 
all groups including the group with pathogens other than EAEC. Alpha-
glycoprotein and neopterin were reduced with EAEC coinfection compared 
to all other groups. EAEC coinfections also showed gut dysfunction as 
measured by lactulose:mannitol absorption, driven mainly by decreased 
mannitol absorption, reflecting reduced mucosal absorptive area. EAEC 
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coinfections also associated with lower changes in weight-for-age, weight-
for-length and length-for-age z scores compared with all other groups. 
The most frequent cumulative EAEC coinfections were Campylobacter, 
Giardia and atypical enteropathogenic E. coli (EPEC). We conclude that 
EAEC coinfections associate with lower socioeconomic status, sanitation, 
antibiotic use and breastfeeding. The most frequent EAEC coinfections 
were Campy, Giardia and aEPEC. EAEC interactions with pathogens 
also associate with intestinal inflammation decreased local and systemic 
immune responses and gut dysfunction especially reduced intestinal 
absorptive function. Thus subclinical EAEC infections appear to synergize 
with other pathogens more than they synergize without EAEC, to impaired 
growth in children across this multisite study.
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DOUBLE JEOPARDY: CHOLERA OUTBREAKS IN PRISONS IN 
THE 21ST CENTURY
Nandini Sreenivasan, Eric Mintz
Centers for Disease Control and Prevention, Atlanta, GA, United States
Cholera outbreaks in prisons have been described since the 1800s. In most 
countries, prisoners are among the most susceptible and neglected risk 
groups, and among the least likely to receive immediate care. To identify 
cholera outbreaks in prisons globally and the control measures used, we 
conducted a systematic search of medical journals and news sources for 
reports of cholera in prisons. Reports of outbreaks identified through 
personal communication with public health officials were also included. 
We identified 27 cholera outbreaks in 13 countries between 2000 and 
2015 (18 in Africa, 8 in the Americas, and 1 in Asia). Five outbreaks were 
reported in medical journals, 16 by media sources, 4 in non-governmental 
organization blogs or reports, and 7 by other sources. The number of 
cases ranged from 5 to 450, with case fatality rates of 0%- 50%. Control 
measures included: isolation of ill prisoners; water, sanitation and hygiene 
interventions; prophylactic use of antibiotics; suspending visits and halting 
food deliveries; and setting up an emergency treatment center. Antibiotics 
reportedly controlled the spread of cholera in 3 of 4 outbreaks. Oral 
cholera vaccines were used in two outbreaks, in one as a direct control 
measure, and in another as a preemptive measure to prevent the spread 
of the outbreak to unaffected prisons. Vaccine impact was not assessed. 
Our search identified at least 27 cholera outbreaks that had been reported 
in prisons since 2000, sometimes resulting in high case counts and 
case fatality rates. Because of limited surveillance in prisons, reported 
outbreaks, cases and deaths are likely to considerably underestimate 
the scope of the problem. Though prisons can be a challenging setting, 
chemoprophylaxis or vaccination can be delivered quickly, effectively and 
at low cost, and can supplement other measures which often take longer 
to implement. Enhanced surveillance and a systematic approach to cholera 
prevention, preparedness, and response in prisons, as well as rigorous 
post-response evaluation, could demonstrate more precisely the impact 
of various combinations of interventions and inform future prevention 
strategies.
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DISTRIBUTION OF E. COLI PATHOTYPES ALONG AN URBAN 
RURAL GRADIENT IN ECUADOR
Karen Levy1, William Cevallos2, Lorena Montero3, Maritza Paez3, 
Estefania Ortega3, Xavier Sanchez2, Edison Puebla2, Pablo Endara3, 
Gabriel Trueba3
1Emory University, Atlanta, GA, United States, 2Universidad Central del 
Ecuador, Quito, Ecuador, 3Universidad San Francisco de Quito, Quito, 
Ecuador
Pathogenic E. coli is one of the primary causes of diarrhea in developing 
countries. We report on the results of the EcoZUR study (E. coli en Zonas 
Urbanas y Rurales - E. coli in Urban & Rural Areas), a case-control study 
of diarrhea at four sample collection sites in Ecuador, along a rural-urban 
gradient. We sampled ~100 subjects with diarrhea and ~100 age-matched 
controls without diarrhea at each of the four Ecuadorian Ministry of 
Health clinics, including a large clinic in Quito, Ecuador’s capital (Pop. 1.62 
million), a hospital in the capital of Esmeraldas Province (Pop. 162,000), 
the town of Borbón (Pop. ~5,000), and outlying rural communities in 
the Borbón region, along the Onzole, Cayapas, and Santiago Rivers 
(Pops. ranging from ~10-500). The urban-rural gradient also represents a 
gradient of access to clean and safe water. We cultured E. coli from the 
fecal samples and used a set of 8 PCR primers to test them for virulence 
factors associated with diarrheagenic E. coli pathotypes. We found very 
high rates of diffuse adherent E. coli (DAEC) in study subjects in Quito 
and Esmeraldas, with ~10% and ~20% of study subjects, respectively, 
positive for this pathogen. Atypical enteropathogenic E. coli (EPEC) was 
the second most common pathotype detected. DAEC was the only 
pathotype significantly associated with diarrheal disease, although this 
may have been a function of sample size constraints, as the numbers for 
the other pathotypes were limited. We also report on association between 
a) diarrhea and b) presence of pathogenic E. coli and risk factors such as 
water treatment, sanitation type, and recent travel. Our study allows us to 
understand how factors that differ along a rural-urban gradient—such as 
diet, access to clean water and sanitation facilities, and travel patterns—
affect the set of enteric pathogens circulating within a population.
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EPIDEMIOLOGY AND RISK FACTORS FOR 
CRYPTOSPORIDIOSIS IN CHILDREN IN THE MAL-ED STUDY
Poonum Korpe1, Cristian Valencia1, William A. Petri, Jr.2, A.S.G. 
Faruque3, Rashidul Haque3, Tahmeed Ahmed3, Priya Duggal1
1Johns Hopkins University, Baltimore, MD, United States, 2University 
of Virginia, Charlottesville, VA, United States, 3Interational Centre for 
Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh
Cryptosporidium spp are enteric protozoa that cause significant 
morbidity and mortality in young children worldwide. The Etiology, Risk 
Factors, and Interactions of Enteric Infections and Malnutrition and the 
Consequences for Child Health and Development Project (MAL-ED), a 
cohort study across eight sites, allowed an ideal opportunity for defining 
the epidemiology of Cryptosporidium spp in children living in resource-
limited settings. Children were enrolled within 17 days of birth. Data on 
illness, socioeconomic variables, and nutritional intake were collected by 
survey. Stool samples were tested for Cryptosporidium parvum by ELISA. 
Anthropometric measurements were taken monthly. The final analysis 
included 1,659 children with 24 months of follow up. Across the eight 
sites, 51.1% (848/1659 ) of children had at least one infection with 
Cryptosporidium spp, and 48.9% (811/1659) remained infection-free. 
Cryptosporidium diarrheal episodes were more likely to be associated 
with dehydration (16.5% vs 8.3%, p < 0.01), and to meet the GEMS 
definition of moderate-to-severe diarrhea (20.3% vs 11.9%, p < 0.01). 
Rates of Cryptosporidium diarrhea were highest in the Peru (10.9%) 
and Pakistan (9.2%) sites. Detection rates in surveillance stools ranged 
from 2.7% in Brazil to 6.6% in Tanzania and 7.3% in Peru. Children in 
rural sites had a significantly quicker progression to first Cryptosporidium 
infection than children from non-rural sites. Stunting at baseline was not 
associated with higher risk of infection (mean HAZ -0.92 vs -0.99, p = 
0.16). Lower family income (146.94 (132.97) USD vs 199.22 (188.96) 
USD, p <0.001), overcrowding (29.6% vs 21.1%, p<0.001), fewer 
years of maternal education (6.25 (3.99) vs 7.35 (3.96), p < 0.001), and 
unimproved sanitation (chi squared 29.64, p < 0.0001) were all associated 
with Cryptosporidium infection. In this cross-site analysis, rural sites 
had greatest burden of disease, earliest onset of disease, and highest 
prevalence of unimproved sanitation, suggesting that interventions 
targeting spread of cryptosporidiosis should focus on improved sanitation 
infrastructure.
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THE SPECTRUM OF CHROMOBACTERIUM VIOLACEUM 
INFECTIONS FROM A SINGLE GEOGRAPHIC LOCATION
Yi dan Lin1, Suman Majumdar2, Robert Baird1, Jann Hennessy1
1Royal Darwin Hospital, Darwin, Australia, 2Burnet Institute, Melbourne, 
Australia
Chromobacterium violaceum is a bacterium associated with soil and 
water exposure in tropical regions and causes rare and serious clinical 
infections that are often fatal. We reviewed the demographic and clinical 
details of twenty-eight patients with C. violaceum detected over fifteen 
years from 2000 to 2015, from the Top End of the Northern Territory. 
Eighteen patients had infections attributable to C. violaceum. Patients with 
infections were more commonly male (55.6%), and in the 16-to-60 year 
(61.1%) age group. Skin and soft tissue infections (50%), predominantly 
involving the limbs, were the major clinical manifestation. Water, mud 
exposure and trauma were all noted as precipitating circumstances and 
co-morbidities were present in 61.1% of the patients with infections. 
Ten of the twenty-eight patients (35.8%) had C. violaceum isolated as an 
incidental finding or as asymptomatic colonisation; these ten patients did 
not require, or receive therapy for the presence of C. violaceum bacteria. 
There were no relapsing infections in this group. C. violaceum remains 
a serious infection, with seven patients (25%) in our series requiring 
intensive care management. However, the mortality rate (7.1%) in our 
series was far lower than previously described. This case series of C. 
violaceum infections from a single geographic area provides additional 
information of the characteristics of infection with this pathogen.
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TARGET PRODUCT PROFILE FOR A DIAGNOSTIC ASSAY TO 
DIFFERENTIATE BETWEEN BACTERIAL AND NON-BACTERIAL 
INFECTIONS TO GUIDE ANTIMICROBIALS USE IN RESOURCE-
LIMITED SETTINGS: AN EXPERT CONSENSUS
Sabine Dittrich1, Birkneh T. Tadesse1, Francis Moussy2, Arlene 
Chua3, Anna Zorzet4, Thomas Tängdén4, David L. Dolinger1, 
Anne-Laure Page5, John A. Crump6, D’Acremont Valerie7, Quique 
Bassat8, Yoel Lubell9, Norbert Heinrich10, Paul N. Newton11, Tim 
Rodwell1, Iveth J. González1
1Foundation for Innovative New Diagnostics (FIND), Geneva, Switzerland, 
2World Health Organization, Geneva, Switzerland, 3Medicine Sans 
Frontiere Access Campaign, Geneva, Switzerland, 4ReAct, Uppsala, 
Sweden, 5Epicentre MSF, Paris, France, 6University of Otago, Denedin, New 
Zealand, 7Swiss Tropical and Public Health Institute, Basel, Switzerland, 
8Barcelona Institute for Global Health, Barcelona, Spain, 9Mahidol-Oxford-
Research Unit, Bangkok, Thailand, 10Ludwig Maximilian University, Munich, 
Germany, 11Lao-Oxford-Mahosot Hospital-Wellcome Trust-Research Unit, 
Vientiane, Lao People’s Democratic Republic
Acute fever is one of the most common presenting symptoms globally. 
In order to reduce the empiric use of antimicrobial drugs and improve 
outcomes, it is essential to improve diagnostic capabilities. In the absence 
of microbiology facilities in low-income settings, an assay to distinguish 
bacterial from non-bacterial causes of fever would be a critical first step. 
To ensure that patient and market needs are met, the requirements of 
such a test should be specified in a target product profile (TPP). To identify 
minimal/optimal product characteristics for a bacterial vs. non-bacterial 
fever test, experts from academia and international organizations with 
expertise in infectious diseases, diagnostic test development, laboratory 
medicine, global health, and health economics were convened. TPP 
characteristics were proposed and reviewed by a working group, and 
consensus characteristics were defined. This working group defined non-
severely ill, non-malaria infected children as the target population for the 
desired assay. To provide access to the most patients, the test should be 
deployable to community health centers and informal health settings, 
and staff should require <2 days of training to perform the assay. Further, 
given that the aim is to reduce inappropriate antimicrobial use as well as 
to deliver appropriate treatment for patients with bacterial infections, the 
working group agreed on minimal diagnostic performance requirements 
of >90% and >80% for sensitivity and specificity, respectively. Other key 
characteristics, to account for the challenging environment at which the 
test is targeted, included: i) time-to-result <10 min (but maximally not >2 
hrs); ii) storage conditions at 0-40°C, ≤90% non-condensing humidity with 
a minimal shelf life of 12 months; iii) operational conditions of 5-40°C, 
≤90% non-condensing humidity; and iv) minimal sample collection needs 
(50-100µL, capillary blood). This expert consensus approach to define 
assay requirements for a bacterial vs. non-bacterial diagnostic assay should 
guide product development, and enable targeted and timely efforts by 
industry partners and academic institutions.
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INVASIVE NON-TYPHOIDAL SALMONELLA INFECTIONS 
IN ASIA: CLINICAL OBSERVATIONS, DISEASE OUTCOME 
AND DOMINANT SEROVARS FROM A TERTIARY REFERRAL 
HOSPITAL IN HO CHI MINH CITY, VIETNAM
Lan H. Nguyen-Phu
Hospital for Tropical Diseases, Hochiminh City, Vietnam
Invasive non-typhoidal Salmonella (iNTS) infections are now a well-
described cause of morbidity and mortality in children and HIV-infected 
adults in sub-Saharan Africa. In contrast, the epidemiology andclinical 
manifestations of iNTS disease in Asia are not well documented. We 
retrospectively identified >100 cases of iNTS infections in an infectious 
disease hospital in SouthernVietnam between 2008 and 2013. Clinical 
records were accessed to evaluate demographic and clinical factors 
associated with iNTS infection and identify risk factors associated with 
death. Multi-locus sequence typing and antimicrobial susceptibility 
testing was performed on all organisms. Of 102 iNTS patients, 71% were 
HIV-infected, >90% were adults, 71% were male and 33% reported 
intravenous drug use. Twenty-six/92 (28%) patients with a known 
outcome died; HIV infection was significantly associated with death 
(p=0.004). S. Enteritidis (ST11) (48%, 43/89) and S. Typhimurium(sequence 
types (STs)19, 34 and 1544) (26%, 23/89) were the most commonly 
identified serovars; S. Typhimurium was significantly more common in 
HIV-infected individuals (p=0.003). Isolates from HIVinfected patients 
were more likely to exhibit reduced susceptibility against trimethoprim-
sulfamethoxazole than HIV-infected patients (p=0.037). We conclude that 
iNTS disease is a severe infection in Vietnam with a mortality rate similar 
to sub-Saharan Africa. As in sub-Saharan Africa, HIV infection is the major 
risk for death, with the majority ofthe burden in this population in HIV-
infected men. Although the STs of iNTS organisms identified in this study 
were common globally, we suggest continued surveillance across Asia to 
monitor for the presence of multi-drug resistant STs.
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COXIELLA BURNETII ANTIBODIES ARE PREDOMINANT 
AMONG PATIENTS WITH UNDIFFERENTIATED FEVER IN 
AFGHANISTAN
Salwa F. Ahmed1, Momtaz O. Wasfy1, B. Abdel-Rahman1, Ms 
Motawea1, Nasir Stanikzai2, R. Alami2, Bashir Noormal2
1U.S. Naval Medical Research Unit-3, Cairo, Egypt, 2Afghan Public Health 
Institute, Ministry of Public Health, Islamic Republic of Afghanistan, Kabul, 
Afghanistan
Diagnosis of infectious diseases in Afghanistan remains a challenge with 
limited ability for pathogen isolation and identification. Baseline data on 
the prevalence of etiologies causing undifferentiated fever is lacking in 
Afghanistan. Herein we screened serum of Afghan patients suffering from 
undifferentiated fever (UF) for antibodies against number of pathogens, 
including Coxiella burnetii, Leptospira spp.and typhoid fever. Patients > 
5 years old with UF who meet the WHO case definition and presented at 
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two provincial hospitals: Kandahar (KDH, n=178), Helmand (LG, n=82) 
and a third quaternary level hospital in Kabul (KID, n=303) were enrolled 
and consented into a surveillance study between 2007 and 2012. A single 
serum sample was collected and tested by ELISA for the detection of 
IgM and IgG against Q fever (C. burnetii), Leptospia spp. IgM and total 
immunoglobulins of Salmonella enterica serovar typhi. A total of 563 
patients were screened and 50.3 % were seropositive against at least one 
pathogen. Cases from KDH showed the highest frequency of C. burnetii 
antibodies (n=80, 37 % IgG and 8.4 % IgM), followed by those from LG 
(n= 21, 20.7% IgG and 4.9% IgM) and KID (n= 55, 16.5% IgG and 1.7% 
IgM). Leptospia IgM was evident in 11.4% of patients, 13.2% in KID, 
10.7 in KDH and 6.1 in LG. Typhoid fever titers >320 were found in11.2% 
of all patients, being higher in LG (15.9%) and KDH (12.9%) than KID 
(8.9%). Almost half of the C. burnetii IgM-positive cases (12/22) did not 
mount immune responses to other pathogens. The data suggest that both 
acute and past Q fever infections were evident within patients tested. The 
increased seropositivity rates in cases from KDH and LG provincial hospitals 
compared to those of KID in Kabul city may be attributed to limited 
sanitary measures for typhoid fever. While typhoid fever is transmitted 
via ingestion of polluted food and water, both Q fever and Leptospira are 
spread by contact with animals, their contaminated products or excreta. 
The current results provide initial disease burden data for Afghanistan and 
will be useful to health authorities in guiding hygiene improvement plans 
and disease prevention strategies.
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DETECTION OF SALMONELLA BACTEREMIA IN RURAL KENYA 
USING FIELDABLE DIAGNOSTICS
Aneesa Noormohamed1, Loreen Stromberg2, Zachary Karim2, 
Priya Dighe1, Melinda Wren1, Jason Gans1, Douglas Perkins2, 
Benjamin McMahon1, Norman Doggett1, Harshini Mukundan1
1Los Alamos National Laboratory, Los Alamos, NM, United States, 
2University of New Mexico, Albuquerque, NM, United States
Invasive Non-Typhi Salmonella (NTS) are a major cause of infections in sub-
Saharan Africa, with a case fatality rate of 4-27% in children and 22-47% 
in adults. The extensive presence of other co-morbidities in the patients 
complicates diagnostics. There is a need for rapid, reliable, and fieldable 
diagnostics that can be used at the point-of-care. We are developing 
such diagnostic assays for Salmonella detection using two approaches 
- pathogen biomarker detection using a waveguide biosensor, and real-
time PCR. The former requires minimal handling of samples, and allows 
for the rapid and specific detection of antigen using fluorescent probes 
and uses a novel assay strategy called lipoprotein capture. Salmonella 
lipidic biomarkers are taken up by lipoproteins in serum, which are 
immobilized on sensor surface, and the associated biomarker is identified 
using Salmonella-specific antibodies. The assay was optimized using lipid 
lysates prepared from either control strains of Salmonella or clinical strains 
from patients in Kenya. The optimized assay was tested on four pediatric 
samples from Kenya. We saw excellent (100%) corroboration with 
culture results for the samples. Future work includes identification and 
characterization of the antigen, and testing more patient samples from 
Kenya. Real-time PCR requires more handling of samples and expertise 
to run the assays but are useful for the characterization of isolates 
and identification of resistance. For PCR assays, primers for Salmonella 
detection were designed and tested with DNA from control and clinical 
isolates. Testing is underway with a Gram detection assay to differentiate 
between Gram-positive and -negative bacteremia. We are also working on 
identifying antimicrobial resistances in the isolates from Kenya to design 
assays for their detection, and have identified resistance to first, second 
and third-line antibiotics in patients. Further validation for the PCR assays 
will be done on clinical samples. Our goal is to deploy these technologies 
to our clinical site in rural Kenya, and train local personnel to run them, 
thereby improving health care infrastructure in country.
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LEPTOSPIRAL DNA IN FEBRILE PATIENTS FROM SEMI-RURAL 
COMMUNITIES IN MANABÍ-ECUADOR
Ana Maria Salinas, Jorge Ignacio Chiriboga, Gabriel Trueba
San Francisco de Quito University, Quito, Ecuador
The aim of this study was determine whether fever is associated with the 
presence of leptospiral DNA in human sera detected with Polymerase 
Chain Reaction (PCR). DNA was extracted from 576 samples of human 
serum (513 febrile and 63 non-febrile) obtained between February 2014 to 
July 2015 from semi-urban parishes Calderón and Santa Ana in Portoviejo 
city. DNA was analyzed first with real time PCR (PCR-RT), followed by 
conventional PCR and finally amplicon sequencing. The 16s ribosomal RNA 
sequences were detected in 2 out of 513 (0.5%) febrile patients and 0 of 
63 (0.0%) from non-febrile patients.
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PROGRESS AND CHALLENGES OF TRACHOMA ELIMINATION 
IN THE FAR NORTH REGION OF CAMEROON
Assumpta Lucienne Bella1, Armelle Ngomba2, Georges Nko’o 
Ayissi1, Emilienne Epée1, Julie Akame3, Patrick Mbia3, Henri 
Moungui3, Yaobi Zhang4, Steven D. Reid5
1Ministry of Public Health, Yaoundé, Cameroon, 2University of Douala, 
Douala, Cameroon, 3Helen Keller International, Yaoundé, Cameroon, 
4Helen Keller International, Regional Office for Africa, Dakar, Senegal, 
5Helen Keller International, New York, NY, United States
In Cameroon, trachoma mapping conducted in 2010-2011 identified 
13 health districts (HDs) in the Far North region with a prevalence of 
trachomatous inflammation-follicular (TF) of over 10% in children aged 
1-9 years. These HDs qualified for district mass drug administration (MDA) 
as well as implementation of other components of the SAFE (Surgery, 
Antibiotic treatment, Facial cleanliness and Environmental improvement) 
strategy recommended by World Health Organization. These HDs 
benefitted from support from HKI with funding from USAID’s ENVISION 
Project, managed by RTI International. Of these 13 HDs, 5 successfully 
passed impact assessment in 2014 and stopped MDA. In 2015, 5 
additional HDs completed 3 rounds of MDA with coverage of >80% and 
qualified for impact assessment. However, due to continued insecurity 
caused by Boko Haram attacks, only 2 HDs (Mokolo, Guidiguis) were 
evaluated. A cross-sectional, cluster randomized survey was conducted to 
estimate the TF prevalence to determine if the stopping MDA criteria had 
been met. A sample of 1,961 children aged 1-9 years was surveyed. The 
WHO simplified trachoma grading system was used. The results showed 
that the TF prevalence decreased from 16.9% (95% CI: 15.4-18.5%) and 
13.1% (95% CI: 11.7-14.5%) in 2010 to 1.0% (95% CI: 0.5-1.8%) and 
0.8% (95% CI: 0.3-1.7%) in 2015 in Guidiguis and Mokolo respectively. 
These 2 HDs reached a TF prevalence of <5% and hence met the criteria 
of stopping MDA. While these results represent further positive steps 
towards trachoma elimination in the region, the threat of terrorism in 
these regions has formed a barrier to timely completion of surveys and 
hence measuring the progress of the program. Uncertainty remains 
for the 3 HDs not yet assessed, and according to the plan, 2 more HDs 
are scheduled for evaluation in 2016 and 1 additional HD in 2017. It is 
not clear whether these surveys can go ahead as planned. In addition, 
insecurity makes it difficult to evaluate the progress of the other SAFE 
components such as TT surgery and environmental improvements. These 
challenges are a serious threat to achieving the year 2020 trachoma 
elimination goals in Cameroon.
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THE BURDEN OF TRACHOMA IN EASTERN EQUATORIA 
STATE, REPUBLIC OF SOUTH SUDAN
Angelia Sanders1, Joy Chebbet2, Aisha E. Stewart1, Samuel 
Makoy3, Peter Magok2, Carla Blauvelt2, Aja Kuol3, E. Kelly 
Callahan1, Scott D. Nash1
1The Carter Center, Atlanta, GA, United States, 2The Carter Center, Juba, 
South Sudan, 3South Sudan Ministry of Health, Juba, South Sudan
Eleven counties in the Republic of South Sudan required trachoma impact 
surveys in order to evaluate the success of program interventions and 
to determine if additional rounds of mass drug administration (MDA) 
with azithromycin were needed. Despite security issues and population 
displacement The Carter Center supported the South Sudan Ministry of 
Health (MoH) to conduct surveys in five counties in Eastern Equatoria 
state. These were the first known trachoma impact surveys since the 
country’s independence and the first population-based clinical trachoma 
data to be collected in this region since 2006. Owing to limited in-country 
personnel capable of serving as trachoma grader trainers, the MoH 
reached out to neighboring countries Ethiopia, Sudan and Uganda who 
provided experienced grader trainers for the training. For each survey, a 
multi-stage cluster-random sampling method was used. Households within 
a cluster were selected with equal probability and all present household 
members were examined using the WHO simplified trachoma grading 
scheme for all 5 clinical signs of trachoma. Despite remoteness of villages, 
difficult terrain and weather conditions, a total of 14,462 individuals 
in 3,446 households were surveyed across the five counties in Eastern 
Equatoria state. The burden of trachoma was high in these 5 counties. 
The prevalence of trachomatous inflammation follicular (TF) in children 
age 1-9 years ranged from 21.1%, (95% Confidence Interval (CI):12.1, 
34.1) to 47.6%, (95%CI: 42.2, 53.1). Trachomatous trichiasis was also 
highly prevalent, ranging between 2.9% to 4.5% in those 15 years and 
older. The prevalence of water and sanitation indicators were low in all five 
counties, including two counties which had a complete absence of latrines 
in all surveyed villages. The results of the survey showed that all 5 counties 
will require at least 3 to 5 more years of MDA and surgical interventions. 
This experience also shows that surveys can still be carried out in extremely 
resource poor and difficult areas, and that neighboring countries are 
willing to provide valuable technical assistance.
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IMPACT OF MASS TREATMENT WITH AZITHROMYCIN FOR 
TRACHOMA ON SEXUALLY TRANSMITTED INFECTIONS AND 
ANTIMICROBIAL RESISTANCE AMONGST WOMEN IN THE 
SOLOMON ISLANDS
Michael Marks1, James Hadfield2, Christian Bottomley1, Hendrick 
Tome3, Richard Pitakaka3, Robert Butcher1, Oliver Sokana3, Henry 
Kako3, Anthony W. Solomon1, Nicholas Thomson2, David C. 
Mabey1
1London School of Hygiene & Tropical Medicine, London, United Kingdom, 
2Wellcome Trust Sanger Centre, Cambridge, United Kingdom, 3Solomon 
Islands Ministry of Health and Medical Services, Honiara, Solomon Islands
Chlamydia trachomatis is the most common bacterial sexually transmitted 
infection and is frequently asymptomatic. Population based interventions 
aiming to increase the coverage of screening for C. trachomatis and 
behavioural interventions to reduce high-risk sexual behaviour have 
shown limited efficacy in reducing its prevalence. Resistance to first line 
antimicrobials is an increasingly significant problem in the management of 
sexually transmitted infections and threatens the effectiveness of current 
treatment regimes. Ocular infection with C. trachomatis is the cause of 
trachoma, which is also endemic in the Pacific. The WHO strategy for the 
elimination of trachoma as a public health problem includes community 
mass treatment with azithromycin. Mass drug administration (MDA) 
of azithromycin for trachoma might reduce the prevalence of genital 
C. trachomatis but might also drive the emergence of antimicrobial 
resistance. We conducted a study in the Solomon Islands alongside a 
Ministry of Health trachoma elimination programme to establish the 
impact of MDA with azithromycin on sexually transmitted infections 
and look for evidence of emerging drug resistance. Women attending 
outpatient clinics before or after MDA were enrolled. Self-taken high 
vaginal swabs were tested by PCR for C. trachomatis and Neisseria 
gonorrhoeae. Whole genome sequencing was attempted on all samples 
that were positive by diagnostic PCR for either pathogen. Following MDA, 
we noted a significant decrease in the prevalence of genital C. trachomatis 
infection, but not of N. gonorrhoeae, by diagnostic PCR. We will present 
data from whole genome sequencing of genomic evidence of the 
presence/absence of antimicrobial resistance obtained from both the pre 
and post-MDA samples.
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QUALITY ASSESSMENT OF THE IMPLEMENTATION OF THE 
TRACHOMATOUS TRICHIASIS SURGERY IN POLI HEALTH 
DISTRICT, CAMEROON USING SWPO METHOD (SUCCESS - 
WEAKNESSES - POTENTIALS - OBSTACLES)
Yannick Nkoumou1, Assumpta Lucienne Bella2, Georges 
Nko’ayissi2, Godefroy Koki3, Emilienne Epee2, Souleymanou 
Yaya2, Julie Akame1, Henri Moungui1, Yaobi Zhang4, Awa Dieng4, 
Whitney Goldman5
1Helen Keller International, Yaounde, Cameroon, 2Ministry of Public 
Health, Yaounde, Cameroon, 3Ministry of Defense, Yaounde, Cameroon, 
4Helen Keller International, Dakar, Senegal, 5Helen Keller International, 
New York, NY, United States
Poli is a trachoma endemic district in the North Region of Cameroon, with 
a total population of 88,513. The TT prevalence was 1.08% at baseline 
mapping. As standardized by sex and age, the estimated backlog is 625 
cases, corresponding to an Ultimate Intervention Goal (UIG) of 536. A 
TT surgery campaign was organized in February 2016, supported by the 
United States Agency for International Development’s MMDP Project, 
managed by Helen Keller International. This was preceded by a series 
of training of trainers, surgeons and nurses using the HEAD START 
mannequin, supply of drugs and consumables, community meetings, 
and dissemination of awareness messages. During the campaign, 3203 
patients were examined and 92 TT cases were managed, including 84 
cases operated and 8 cases that refused the surgery, but received tweezers 
and advices for adequate epilation. With the aim to appreciate the quality 
of the implementation of the campaign, a self-assessment using SWPO 
method (Success - Weaknesses - Potentials - Obstacles) was carried out 
by stakeholders at different levels of the health pyramid. This consisted 
of reviews of all steps of implementation of each activity conducted, to 
identify strengths, weaknesses, obstacles and potentials that could be 
explored and taken into consideration for the planning of upcoming 
campaigns. The community meetings held in all villages were identified 
as a success that allowed the dissemination of sensitization messages. 
Challenges with timing of the surgeon training, the availability of cases 
for the surgeon training, and the procurement of surgical supplies 
constituted the main weaknesses. The spatial distribution of TT cases in 
the district does not reflect the forecasts resulting from baseline data, 
and this constituted a significant obstacle. There is a potential to use 
community meetings for preliminary screening of suspected TT cases 
before deploying surgical teams to the field. Experiences and opinions of 
stakeholders involved in the TT surgery campaign in Poli allowed us to 
collect information that will be taken into account in planning next TT 
surgery campaign in the North region.
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FACTORS PREDICTING TRACHOMA IMPACT SURVEY 
OUTCOMES
Katie Zoerhoff1, Jeremiah M. Ngondi2, Lisa Rotondo1, Maureen 
Kelly1, Kalpana Bhandari1, Hannah Frawley1, Angela Weaver3
1RTI International, Washington, DC, United States, 2RTI International, Dar 
es Salaam, United Republic of Tanzania, 3U.S. Agency for International 
Development, Washington, DC, United States
Trachoma-endemic countries are committed to achieving the elimination 
of trachoma as a public health problem by 2020. To do this, multiple 
years of the WHO-endorsed SAFE strategy are recommended, depending 
on baseline prevalence of trachomatous inflammation-follicular (TF) and 
trachomatous trichiasis (TT). Trachoma impact surveys (TIS) have been 
implemented in 9 countries supported by USAID between 2012-2015 
to determine whether TF and TT prevalence have decreased to a point 
where further intervention is no longer required. We measured the effects 
of baseline TF prevalence, number of rounds of MDA, and median MDA 
coverage on the likelihood of passing a TIS. Results from one hundred 
forty-three TIS conducted between 2012 and 2015 across 9 countries 
were analyzed using logistical regression analysis. Out of 102 surveys 
implemented in 8 countries, 83% showed that the TIS passed (range 60-
100%). Preliminary logistic regression analysis of baseline TF prevalence, 
number of MDA rounds and median coverage variables showed that 
baseline TF prevalence was statistically associated with passing TIS 
(alpha=0.05): odds ratio =0.934; 95% confidence interval 0.898-0.970. 
However, when the results from 70 TIS implemented in one highly 
endemic country—all but 2 of which failed—are included in the analysis, 
the model no longer holds. Median baseline TF prevalence in these 70 
districts was 39%, compared to 11.8% in the other 102 districts, and the 
median number of MDA rounds was 6 compared to 3. Median coverage 
in this country was high, at 94.5%, compared to 82.9% in the other 8 
countries. Districts with low baseline prevalence were significantly more 
likely to pass trachoma impact surveys in 8 countries; for every percentage 
point increase in baseline prevalence, the odds of passing TIS decrease by 
6.6%. Despite high MDA coverage over multiple rounds in one country, 
the TIS did not pass. This analysis confirms that especially in areas of 
very high baseline prevalence, high coverage of antibiotics alone is not 
sufficient for decreasing TF prevalence; F&E interventions should also be 
prioritized for sustainable elimination of blinding trachoma to be achieved.
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CAN WE ELIMINATE TRACHOMA AS A PUBLIC HEALTH 
PROBLEM BY 2020?
Amy Pinsent, Manoj Gambhir
Monash University, Melbourne, Australia
Trachoma remains the world’s leading infectious cause of blindness. 
The World Health Organization (WHO) is aiming to eliminate trachoma 
as a public health problem by 2020. In order to achieve this they have 
outlined the ultimate intervention goals, the first of which aims to achieve 
a reduction in Trachomatous Inflammation - Follicular (TF) to less than 
5% in children 1-9 years old within all endemic communities by 2020. 
We use data collected by the International Trachoma Initiative on the 
prevalence of TF in 44 trachoma endemic districts to assess the feasibility 
of achieving this goal by 2020, using a statistically validated dynamic 
mathematical transmission model. For each endemic district that had not 
reached the current target by the most recent time point of surveillance, 
we assess whether the ultimate intervention goal will be met by 2020 
using the current WHO guidelines alone and, if not, what additional 
interventions may be required. We find that for regions with greater than 
30% TF prevalence, current mass drug administration (MDA) regimes are 
not sufficient to achieve this goal. Our work suggests that an increased 
frequency of MDA treatment, in addition to enhanced facial cleanliness 
and environmental improvements (resulting in long-term transmission 
reduction) will be essential in these regions. Moreover, in regions where TF 
is less than 30% at least some degree of long-term transmission reduction, 
through enhanced facial cleanliness and environmental improvements, 
is required in order to prevent re-emergence in the community in the 
absence of sustained and on-going MDA. Our findings suggest that in 
most districts where TF is less than 30% the first ultimate intervention goal 
is achievable with the current recommended WHO guidelines. However, 
considerably more resources will be required in high prevalence settings in 
order to ensure full elimination as a public health problem and elimination 
timelines are likely to exceed past 2020 in these settings.
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TRAINING OF MASS DRUG ADMINISTRATION (MDA) 
DISTRIBUTORS, COMMUNITY MOBILIZATION AND 
COMMUNITY KNOWLEDGE OF MDA: A QUALITATIVE POST-
MDA ASSESSMENT AMHARA, ETHIOPIA
Eshetu Sata1, Aisha E. Stewart2, Nicole Devereaux2, Mulat 
Zerihun1, Demelash Gessesse1, Melsew Chanyalew3, Berhan 
Gaudie3, Zerihun Tadessee1, E. Kelly Callahan2, Scott D. Nash2
1The Carter Center-Ethiopia, Addis Ababa, Ethiopia, 2The Carter Center-
Atlanta, Atlanta, GA, United States, 3Amhara Regional Health Bureau, 
BahirDar City, Ethiopia
In communities where the prevalence of trachoma exceeds a 
predetermined threshold annual community-wide mass drug 
administration (MDA) of antibiotics is warranted. Training of MDA 
distributors, community mobilization and knowledge of MDA are 
instrumental to effectively implement MDA. Despite this, most coverage 
surveys only focus on self-reported medication use by beneficiaries 
while ignoring the methodologies and structures through which MDA is 
implemented. To evaluate the training of MDA distributors, assess the role 
of health workers in mobilizing the community, and to assess the level of 
community awareness about the MDA campaign, a qualitative post-MDA 
assessment was conducted in Amhara, Ethiopia, an area hyperendemic 
for trachoma. Following an antibiotic MDA in 2015, four districts were 
selected for the administration of key stakeholder interviews with health 
workers at various levels of the health care system and focus group 
discussions (FGDs) with community members within randomly selected 
villages. A total of 12 interviews and 4 FGDs were conducted which 
included a total of 35 participants and results were recorded, transcribed, 
and analyzed using MaxQDA qualitative software to identify the primary 
themes described by participants. The themes included key stakeholder 
engagement, training, and community mobilization. More specifically 
the results showed multi-sector involvement of stakeholders during the 
MDA was thought to be very important and although training of drug 
distributors was consistently implemented in accordance with standardized 
procedures, respondents believed more time was needed for the training. 
With respect to community mobilization, health education was described 
as “essential” to ensure participation, and a greater involvement of 
community-level health volunteers would help governmental health 
workers increase mobilization and MDA coverage at the village level. 
The results from this study can be used to improve MDA distribution 
throughout the Amhara region, and will be instructive in other regions of 
Ethiopia currently scaling up trachoma MDA.
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MORTALITY FOLLOWING DISCHARGE IN CHILDREN 
ADMITTED TO A RURAL MOZAMBICAN HOSPITAL: 
DEVELOPMENT OF A PREDICTION MODEL TO IDENTIFY 
CHILDREN AT RISK OF DEATH
Lola Madrid1, Antonio Sitoe2, Marta Aldea3, Rosauro Varo1, 
Charfudin Sacoor2, Helio Mucavele2, Pedro Aide2, Sozinho Acacio2, 
Inacio Mandomando2, Clara Menéndez1, Betuel Sigauque2, 
Quique Bassat1
1ISGlobal, Barcelona Ctr. Int. Health Res. (CRESIB), Hospital Clínic - 
Universitat de Barcelona, Barc, Barcelona, Spain, 2Centro de Investigação 
em Saúde de Manhiça (CISM), Maputo, Mozambique, 3Department of 
Preventive Medicine and Epidemiology. Hospital Clínic - Universitat de 
Barcelona, Barcelona, Spain
An important but neglected contributor to child mortality is the vulnerable 
period following hospital discharge. The objective of this study is to 
determine the burden of post-discharge mortality and what are the 
predictors of mortality following discharge in a rural Mozambican 
hospital.  A systematic review of the paediatric deaths taking place at 
community level over the last 11.5 years was done through a demographic 
surveillance ongoing in a southern district of rural Mozambique. We used 
a morbidity surveillance system ongoing in Manhiça District Hospital to 
exclude hospital deaths. We determined post-discharge mortality over 
three different time-periods: 1st: 0-30 days, 2nd: 31-60 days and 3rd:61-
90 days following hospital discharge. We identified predictors of post-
discharge mortality and derived a simple prediction tool that uses some 
of the collected variables to identify children at high risk of death after 
discharge.  Data from 21227 children were reviewed and analysed (initial 
sample were 45700 children, of which 23725 lived out of study area, 555 
were hospital deaths and 55 had missing outcome and were excluded). 
Mortality at 1st period was 2.3% (484/21227), at 2nd period was 1.4% 
(289/21227) and 3rd period was 1.0% (212/21227). Overall mortality 
was 4.6% (985/21227). The final adjusted model for the prediction of 
post-discharge mortality included the variables non breastfeeding among 
children <2 years (OR 2.4, 95%CI 1.7-3.1), orphan of both parents (OR 
9.2, 95%CI 5.4-15.9), severe dehydration (OR 3.3, 95% CI 2.2-5.2), oral 
candidiasis (OR 8.1, 95% CI 6.1-10.7), Blantyre Coma Scale score <2 (OR 
3.2, 95% CI 1.0-10.5), HIV-positive status (OR 12.1, 95% CI 5.1-28.4) and 
being <2years old (p<0.001).  Mortality following discharge is a poorly 
recognised contributor to child mortality.  A simple prediction tool that 
uses several easily collected variables can be used to identify children at 
high risk of death after discharge.
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LYMPHATIC FILARIASIS TRANSMISSION INTENSITY 
ASSESSMENT IN THE URBAN AREA OF BAMAKO, MALI
Yaya I. Coulibaly1, Abdallah A. Diallo1, Siaka Y. Coulibaly1, 
Housseini Dolo1, Salif S. Doumbia1, Lamine Soumaoro1, Michel 
E. Coulibaly1, Ilo Dicko1, Moussa B. Sangare1, Modibo Sangare1, 
Massitan Dembele2, Sekou F. Traore1, Amy D. Klion3, Thomas B. 
Nutman3, Louise Kelly-Hope4, Moses Bockarie4
1ICER-Mali, Bamako, Mali, 2National Lymphatic Filariasis Elimination 
Program, Bamako, Mali, 3Laboratory of Parasitic Diseases, National 
Institute of Allergy and Infectious Diseases, National Institutes of Health, 
Bethesda, MD, United States, 4Liverpool School of Tropical Medicine, 
Centre for Neglected Tropical Diseases, Liverpool, United Kingdom
Anopheles gambiae and An. funestus are the main vectors of LF in Mali. 
Culex spp is the most common mosquito species in urban areas of this 
region. The 2004 mapping survey using ICT found that all regions in 
Mali were endemic for lymphatic filariasis (LF). We aimed to determine if 
Culex species are incriminated in Wuchereria bancrofti (Wb) transmission 
in the capital city, Bamako, and to assess the endemicity level in Bamako 
after 3 mass drug administration (MDA). Vectors were trapped using 
CDC light traps and tested for Wb infection by PCR. Night thick smears 
were collected from volunteers >14 years in the 6 national LF elimination 
program sentinel sites in Bamako and in two additional urban sites 
selected because of a family with 3 cases of elephantiasis (Faladie) and 
the high frequency of Culex breeding sites (Bozola). A total of 6,174 
Culex spp (85.2%), 16 An. gambiae (0.2%), 26 Aedes spp (0.4%), 858 
Ceratopogonidea (11.8%) were collected. No positive Culex pools were 
detected among the 252 tested by PCR. None of the 1,002 volunteers 
had detectable Wb microfilariae. Mp microfilariae were detected in 5 
individuals in two of the localities (0.5%). These data provide no evidence 
of active LF transmission requiring intervention in Bamako. The presence 
of Mansonella perstans microfilaremia in residents of two of the eight 
localities is consistent with migration from rural to urban areas in this 
population.
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SCRUB TYPHUS AS A MAJOR CAUSE OF ILLNESS FOR 
PATIENTS WITH UNKNOWN FEVER ORIGIN IN GALLE, SRI 
LANKA
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Wasantha Kodikara-Arachichi5, Aruna Dharshan de Silva6, Ruvini 
Kurukulasooriya5, Truls Ostbye2, Duane J. Gubler3, Wei-Mei Ching1
1Naval Medical Research Center, Silver Spring, MD, United States, 2Duke 
University, Durham, NC, United States, 3Duke-NUS Graduate Medical 
School, Singapore, Singapore, 4Johns Hopkins University, Baltimore, MD, 
United States, 5University of Ruhuna, Galle, Sri Lanka, 6Genentech, South 
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Scrub typhus (ST) is an acute febrile illness that is caused by the gram 
negative intracellular bacteria, Orientia tsutsugamushi. Traditionally, the 
diagnosis of ST mainly relies on serologic tests. IFA is considered the 
gold standard for cases of seroconversion or a >4-fold rise in antibody 
titers between acute- and convalescent-phase serum specimens. ST is 
under-reported due to the nonspecific symptoms and the lack of simple 
diagnostic tests. Recent studies of acute febrile illness (AFI) in Southern Sri 
Lanka suggest a broad spectrum of infectious agents including Orientia. 
Here we used the 3-patented-recombinant-protein ELISA for the detection 
of Orientia-specific antibodies in AFI patients from Sri Lanka. Among 
all 460 pairs of serum tested, 80 of them were positive for IgG in the 
convalescent sera (17.4%). The acute sera of these 80 patients were 
further analyzed. Nine of them appeared to have IgG serocoversion, 40 
of them had positive IgM for acute sera and 3 of them were both IgG 
seroconverted and acute IgM positive. Taken together, 58 (12.6%) patients 
were considered ST positive. Additional assays for the detection of other 
disease-specific antibodies of the remaining 85% patients without a 
definitive diagnosis are needed.
1695
LEPTOSPIROSIS IS ONE OF THE MAJOR DISEASES FOR 
PATIENTS WITH UNKNOWN FEVER ORIGIN IN GALLE, SRI 
LANKA
Wei-Mei Ching1, Chris Woods2, Bradly P. Nicholson2, October M. 
Session3, Champica K. Bordinayake4, Aruna Dharshan de Silva5, 
Duane J. Gubler3
1Naval Medical Research Center, Silver Spring, MD, United States, 2Duke 
University, Durham, NC, United States, 3Duke-NUS Graduate Medical 
School, Singapore, Singapore, 4University of Ruhuna, Galle, Sri Lanka, 
5Genentech, South San Francisco, CA, United States
Leptospirosis is caused by spirochaetes of the genus Leptospira. It is 
considered to be  the most widespread bacterial zoonotic disease in the 
world. Timely diagnosis is essential for antibiotic therapy provides the 
greatest benefit when initiated early in the course of illness. Currently, 
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MAT is the standard serological method for the diagnosis of leptospirosis. 
However, it is technically complex and time-consuming. We have 
developed a 4-recombinant protein-based ELISA to detect Leptospira-
specific antibodies. A total of 460 pairs of serum collected from febrile 
patients was anlayized. Among all 460 paired serum, 148 of them were 
positive IgG in the convalescent sera (32.1%). The acute sera of these 
148 patients were further analyzed. Among these patients, 73 of them 
appeared to have IgG serocoversion between acute and convalescent sera, 
16 of them had positive IgM for acute sera and 11 of them were both IgG 
seroconverted and acute IgM positive. Taken together, 82 (21.7%) patients 
were considered leptospirosis positive. While these results suggest that 
leptospirosis is a significant cause of illness with unknown fever origin in 
this cohort, there are still high percentage of patients without a definitive 
diagnosis.
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ANTIVENOM INDUCED ANAPHYLAXIS FOR TREATING 
NEUROTOXIC SNAKE ENVENOMATION IN NEPAL
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of Charali, Charali, Nepal, 6Oxford University, Oxford, United Kingdom, 
7MORU, Bangkok, Thailand
Intravenously (IV) administered snake antivenom is a life-saving treatment 
for snakebite envenomation but adverse reactions are common, including 
life-threatening, antivenom related anaphylaxis (ARA). Herein, we report 
our experience of ARA when treating neurotoxic envenomation caused 
mostly by Naja naja (Indian cobra) and Bungarus caeruleus (Indian krait) 
in Nepal. We conducted a double blind, randomised, trial of lower vs. 
higher dose of antivenom (IV push followed by an infusion). Patient 
monitoring involved symptoms, vital and neurotoxic signs and oximeter 
measured oxygen saturation. Prestudy training emphasised immediate 
ARA treatment when first recognised: stopping antivenom, administering 
intramuscular (IM) adrenaline, IV hydrocortisone and IV chlorphenamine, 
and salbutamol nebulisers, supplemental oxygen, intubation and hospital 
transfer, as clinically indicated.  Results  From April 2011 to November 
2012, 154 envenomed patients were recruited of whom 13 [8.4 (95% 
CI: 4.6-14.0)]% had clinical features consistent with ARA: 3 children (5, 
6, 11y) and 10 adults (18-52y). Nine had clear cut ARA whilst in four 
differentiation from envenomation was difficult.  Median (range) time to 
first ARA was 5 (19-115) minutes. Typical ARA features included urticaria/
erythema (n=10), hypotension/shock (5), dyspnea with (3) or without (4) 
wheezing. Unusual features were laryngeal oedema (2) and bradycardia 
(4). Sudden deterioration with cardio-and/or respiratory arrest occurred 
in 5 patients.  Eight patients died, five within 4h and three at 13h (late 
laryngeal oedema, 24h (cardiac arrest while ventilated) and 11 days 
(ventilator associated pneumonia). Three deaths occurred in transit to 
hospital.  In conclusion, ARA was relatively common and associated with 
a poor prognosis in resource restrained Nepal. More training, better 
anaphylaxis management and quality antivenom may save more lives.
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LUNG NODULES IN CHRONIC SCHISTOSOMIASIS: A RARE 
CONDITION?
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Schistosomiasis is a neglected tropical diseases caused by the fluke worms 
of the genus Schistosoma. The infection can cause damage to the liver and 
to the genitourinary tract, depending on the species involved. The lungs 
can be affected both in the acute presentation of the infection (Katayama 
fever), and in the chronic phase. In the latter case, the damage is usually 
described as pulmonary hypertension; nodular patterns have been 
described rarely.Between May 2014 and October 2015 six immigrants of 
African origin were diagnosed at the Centre for Tropical Diseases (CTD) of 
Negrar (Verona), Italy, with lung nodules due to chronic schistosomiasis. 
A further case was found at the Infectious Diseases Clinic of Udine, Italy. 
The patients were screened for parasitic infections because of eosinophilia. 
An ELISA assay for Schistosoma mansoni resulted positive for all of 
them, and all but one had eggs (of S. mansoni and/or S. haematobium) 
in stool and/or urine. Four patients complained of respiratory symptoms 
(cough, chest pain), while the others underwent a routine, screening 
chest x ray. The radiological investigations (x ray and then CT scan) 
demonstrated, in all patients, multiple pulmonary nodules. The first five 
patients underwent a biopsy of the nodules (TB was the main suspected 
cause), and the histological examination revealed schistosome eggs. The 
last two patients had a presumptive diagnosis. All patients were treated 
with praziquantel 40 mg/Kg/day for three days, obtaining complete 
resolution of the radiological picture. In the same period, at the CTD, 120 
cases of schistosomiasis were diagnosed; hence, the pulmonary nodular 
presentation represented 5% of all cases of Schistosoma infection in the 
study period. In conclusion, schistosomiasis should be in the differential 
diagnosis of pulmonary nodules in patients coming from endemic areas. A 
specific screening is recommended and, if the index of suspicion for other 
severe conditions is reasonably low, invasive procedures can be avoided 
or postponed. Treatment with praziquantel seems to be efficacy, and the 
response can be monitored with CT scan.
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WEIGHT-FOR-AGE GROWTH-RATE FAILURE IN INFANTS IS 
ASSOCIATED WITH AN ALTERED BLOOD GENE EXPRESSION 
PROFILE INDICATING REDUCED IMMUNE RESPONSIVENESS
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4Department of Pediatrics, University of Vermont, Burlington, VT, United 
States, 5Division of Infectious Diseases and International Health, University 
of Virginia, Charlottesville, VA, United States, 6International Centre for 
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Undernutrition is associated with an increased risk of morbidity and 
mortality due to infectious disease. In addition to mucosal barrier 
dysfunction, a systemic immunodeficiency is likely at play; however, 
the molecular basis of immune dysfunction in undernutrition is largely 
unknown. Here using weight-for age Z-score (WAZ) growth trajectories 
in the Bangladeshi PROVIDE birth cohort, we analyzed the cumulative 
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effect of growth rate failure (GRF) over the first year of life on the baseline 
peripheral blood gene expression profile at one year of age. GRF was 
defined as a WAZ curve that deflected downward across at least two 
Z-lines without recovery during the 53-week observation period. RNA from 
whole blood was extracted and cDNA target preparation was optimized to 
avoid globin or ribosomal RNA transcripts. Using microarray transcriptomic 
analysis, we found 146 genes that were differentially regulated (P < 
0.05 and at least 2-fold absolute change) between the age-and gender-
matched control (n = 10) and GRF (n = 10) groups. Bioinformatics 
analysis indicated involvement of these genes in diverse cellular processes 
including metabolism, regulation of growth and apoptosis, and response 
to viral infection. These results suggest that a GRF trajectory may be 
associated with an altered baseline blood gene expression profile skewed 
towards reduced immune responsiveness. Further pathway analysis with 
additional specimens will inform novel in vitro experimental conditions for 
mechanistic studies.
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MATERNAL IRON DEFICIENCY ANEMIA, MALARIA AND SOIL 
TRANSMITTED HELMINTHS ARE A MAJOR RISK FACTOR FOR 
ANEMIA IN EARLY CHILDHOOD
Indu Malhotra1, Mary A. Uyoga2, Daniel J. Tisch1, Arlene E. Dent1, 
Penny A. Holding3, Christopher L. King1
1Case Western Reserve University, Cleveland, OH, United States, 
2International Center for Behavior Studies, Mombasa, Kenya, 3Aga Khan 
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Iron deficiency is common in pregnant women and young children 
worldwide and can lead to clinically significant anemia and impaired 
neurological development in children. We measured hemoglobin (Hb) 
levels in parallel birth cohorts (measured monthly then every three months 
from birth to age 3 years) of Kenyan children living in rural (N=246) and 
nearby urban areas (N=353). Mean Hb levels were identical in the two 
cohorts at birth, then diverged by an average of 2.6 gm/dL lower Hb levels 
in rural cohort from 6 to 18 months of age (P<0.0001), but converged 
by 21-24 months reflecting similar diets in the two cohorts. Malaria and 
soil transmitted helminth infections (STH) infections were low in both 
cohorts and did not differ. Since erythropoiesis in infancy depends heavily 
on iron stores acquired prenatally we hypothesized differences in Hb levels 
between the two cohorts arose from impaired maternal transplacental 
transfer of iron to the fetus. We examined the impact of maternal risk 
factors on Hb levels in their offspring between ages 6 through 18 months 
using a generalized linear model. Maternal risk factors included infections 
(malaria, HIV, schistosomiasis, filariasis, STH), Hb, parity, age, and markers 
of anemia (serum ferritin, soluble transferrin receptor [sTfR], C-reactive 
proteins). Three maternal risk factors independently accounted for the 
majority of reduced Hb levels in their offspring; i) sTfR >8ug/ml (-0.73 gm/
dL reduction in Hb levels, p=0.04), ii) malaria (-0.80 gm/dL Hb reduction, 
p=0.02), and iii) STH (-0.79 gm/dL Hb reduction, p=0.03). The other 
maternal risk factors were not significantly associated with low in Hb 
levels in their children. Thus iron deficiency anemia arising from malaria 
and/or STH in mothers’ results in reduced iron stores in their offspring 
and significant anemia. Improved iron supplementation and prevention 
of malaria and STH infection in pregnant women could have a profound 
impact on their child’s health.
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MAPPING AND MANAGEMENT OF A LARGE SCALE 
DROUGHT-ASSOCIATED SCABIES OUTBREAK IN ETHIOPIA
Wendemageegn E. Yeshaneh1, Ashenafie Ayalew2
1Bahirdar University, Bahirdar, Ethiopia, 2Amhara Regional Health Bureau, 
Bahirdar, Ethiopia
The impact of the severe drought in Ethiopia, attributed to El Niño 
weather conditions, has led to increase in the potential for outbreaks 
of communicable diseases. In September 2015, reports from drought 
affected regions indicated that drought affected areas were experiencing 
scabies on a very large scale. Given the likelihood that living conditions 
to be compromised by the drought, and reports of major social and 
personal impacts of scabies, we undertook a comprehensive assessment 
of scabies prevalence to plan interventions. Training was given to the 
health extension workers (HEW), who provide front-line community 
health services at the subdistrict level. A resource containing diagnosis 
and management guidelines was developed and distributed. The HEW 
were asked to conduct a house to house survey, and collect data using 
a simplified tool on the prevalence of scabies. Specificity of scabies 
diagnoses made by the health extension workers has been assessed. 
Ivermectin based treatment management has been done. A total of 
450 HEW were trained in the 3 zones, and undertook scabies screening 
in a population of 1,125,770 across 68 districts. The prevalence of 
scabies across districts ranged from 0.2 to 60.7%., with 379,000 overall 
confirmed cases for a total prevalence of 33.7%. In the specificity 
assessment, the diagnosis of scabies made by the HEW in 251 cases was 
reviewed and 248 confirmed to have scabies (98.8%). The mean reported 
duration of illness was 5 months. Severe scabies was found in 42% of 
those with scabies, and 75.1% of cases had another family member 
scabies. Of all scabies cases, 39%were school aged children and 30 % of 
affected children had bacterial super infection. 11% of the students with 
scabies had dropped out from school because of scabies or/and drought, 
and 85% of those who dropped out had bacterial super infection. 
Treatment has been given to 800,000 patient and contacts. In conclusion, 
the scabies burden in the region is enormous, and complicated by the 
nutritional shortage emergency and water scarcity. A coordinated response 
is urgently needed to control the epidemic.
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PROGNOSTIC CLINICAL INDICATORS FOR FATAL DENGUE IN 
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CASE CONTROL STUDY
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The WHO estimates that about 98% of dengue fatal cases could be 
prevented; however, countries such as Colombia have recorded higher 
rates during recent epidemics. Our aim was to identify predictors of 
mortality that allow risk stratification and timely intervention of dengue 
patients. We conducted a hospital-based, case-control (1:2) study in 2 
endemic areas of Colombia (2009-2015). Fatal cases were defined as 
having one the following: 1) positive serological test (IgM); 2) positive 
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virological test (NS1 or RT-PCR or viral isolation); 3) autopsy findings 
(macro and microscopic) compatible with death from dengue. Controls 
were inpatients with a positive serological or virological dengue test 
(frequency matching by state and year). Exposure data at admission and 
during hospitalization were extracted from medical records by trained 
physicians. We used multiple regression methods (adjusting for age, sex, 
and disease’s duration) to estimate the association between exposures and 
the case-control status. We evaluated 110 cases and 217 controls (mean 
age: 35.0 vs. 18.9 [p<0.001]; disease’s duration pre-admission: 5.9 vs. 6.7 
days [p=0.562]). History of previous hospitalization (27.9% vs. 11.2%) 
and hypertension (17.8% vs. 1.4%); respiratory distress (38.5% vs. 5.2%) 
and impaired consciousness (32.1% vs. 20.6%), were more frequent 
in cases than controls (p<0.05). In a model based on medical history, 
hypertension but not diabetes increased the odds of mortality (OR: 12.3; 
95%CI: 1.41, 108.3). Further, a model that included respiratory distress 
(OR: 9.54; 95%CI: 2.56, 35.5), impaired consciousness (OR: 3.72, 95%CI: 
1.18, 11.7), and heart rate (OR: 1.54, 95%CI: 1.37, 1.74 [per 5 bpm]) at 
admission had excellent predictive accuracy (AUC: 0.94, 95%CI: 0.90, 
0.98). During hospitalization, controls but not cases showed increments of 
systolic (1.7 vs. 0.7 mmHg/day, p=0.045) and diastolic blood pressure (1.5 
vs. -0.1 mmHg/day, p<0.001), as well as platelet count (11,605 vs. -333 
per mL/day). Our results highlight the importance of medical history and 
easily measured clinical indicators in triaging dengue patients for mortality 
in endemic areas.
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FOR TRAVELERS’ DIARRHEA: THE HOSPITAL FOR TROPICAL 
DISEASES EXPERIENCE
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Travellers Diarrhoea (TD) is the most common illness reported in returned 
travellers to the UK. A wide range of pathogens including bacteria, viruses 
and protozoa are responsible for TD. There are limited UK-based data 
on the aetiology of TD in our returned traveller population. The highly 
sensitive and specific detection and quantification of pathogen-specific 
nucleic acids in faeces, alongside cost-effective high throughput screening, 
makes PCR desirable as a diagnostic tool in ascertaining the aetiologic 
agents and informing the clinical diagnosis of TD. We present the first 
UK-based data investigating the aetiology of TD in travellers presenting 
to the Hospital for Tropical Diseases walk-in travel clinic. The objectives 
of the study were to evaluate the utility of an enteric pathogen PCR 
panel developed by Public Health England to investigate the aetiology 
of TD compared to standard microscopy and culture-based methods. A 
total of 124 unique stool specimens collected from immunocompetent 
patients presenting with symptomatic TD were processed using single and 
multiplex PCRs. Gastrointestinal pathogens were detected in 52% (64/124) 
of stool samples. The primary pathogens causing TD in this cohort were 
Giardia lamblia (12%) and norovirus (12%), followed by enteropathogenic 
Escherichia coli (EPEC) (4%), enteroaggregative E. coli (EAEC) (4%), 
Shigella spp. (2%), rotavirus (2%) and Entamoeba histolytica (1%). 
PCR diagnostics identified nine extra cases of giardiasis (increasing case 
detection from 5% to 12%) and a single case of amoebic dysentery. Use 
of PCR allowed identification of the viral causes of TD and showed greater 
sensitivity in the identification of parasites, which has public health and 
clinical implications. In conclusion, PCR diagnostics improved the detection 
of enteropathogens, allowing better assessment of the aetiology of TD. 
These important pilot data show that there is clearly a role for the routine 
use of molecular diagnostics in the clinical assessment of TD in the UK.
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RAPID, AUTOMATED EXTRACTION AND PURIFICATION OF 
NUCLEIC ACIDS FROM PATHOGENS DIRECTLY FROM WHOLE 
BLOOD SAMPLES
Cheryl Baird, Elizabeth Ott, Ashley Hillman, Heather McGirk, 
Stephanie Thatcher
Biofire Diagnostics, Salt Lake City, UT, United States
Syndromic, PCR-based diagnostics that identify multiple pathogens in a 
single sample are quickly replacing the time-consuming gold-standard 
methods of culture, plating, and microscopy. While whole blood is an ideal 
sample type to use with this technology due to its richness in diagnostic 
targets, it is also rich in PCR inhibitors. Thus, whole blood samples typically 
require extensive sample processing and nucleic acid extraction before 
analysis. We developed the FilmArray® System (BioFire Diagnostics) to 
automate and integrate sample processing and nucleic acid extraction with 
nested multiplexed PCR to identify multiple pathogens in a single sample. 
Presently, there are four FDA-cleared FilmArray® panels that directly test 
nasopharyngeal secretions, blood culture media, stool, and cerebral spinal 
fluid. We are currently working to expand our first whole blood-based 
product, the Biothreat-E test for Ebola virus, to include other pathogens 
that cause febrile illness. We report the efficacy of FilmArray® sample 
preparation for a variety of intracellular and extracellular blood pathogens 
including Gram-positive and Gram-negative bacteria, parasites and viruses 
simultaneously from a single 200 µL whole blood sample. In addition, the 
Injection Vial allows dried blood spots to be used directly in the system 
without any added extraction steps. In whole blood, the estimated LOD 
was 1 x10^3 CFU/mL for E. coli and S. agalacatiae, and between 1 and 15 
TCID50/mL for enterovirus, human parechovirus and herpes simplex virus 
2. Extraction efficiency was between 25-90% depending on organism and 
was comparable to stand alone extraction systems. PCR inhibition was 
undetectable or at a low level that did not affect sensitivity. Additional 
evaluation with more diverse pathogens is ongoing and includes the 
causative agents of malaria, chikungunya, Zika, dengue fever, visceral 
leishmaniasis, leptospirosis, and Salmonella.  This abstract contains data 
that have not been reviewed by regulatory agencies.
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PREVENTING MYCOBACTERIUM LEPRAE - ASSOCIATED 
DISABILITY: IDENTIFYING SOCIAL AND CLINICAL FACTORS 
ASSOCIATED WITH NERVE DAMAGE IN AN ENDEMIC AREA 
OF BRAZIL
Juan D. Cisneros1, Jose A. Ferreira2, Thelma de Filippis2, Ana 
Laura Grossi de Oliveira3, Maria Aparecida de Faria Grossi2, 
Laura Pinheiro Chaves2, Paola Souza dos Santos2, Luiza Navarro 
Caldeira2, Rafaella Rodrigues Costa2, Maria Cavallieri Diniz2, 
Carolina Suares Duarte2, Sandra Lyon2, Jessica K. Fairley4
1Emory University, Atlanta, GA, United States, 2Faculdade de Saude e 
Ecologia Humana, Vespasiano, Brazil, 3Centro de Medicina Especializada, 
Pesquisa e Ensino, Belo Horizonte, Brazil, 4Emory University School of 
Medicine, Atlanta, GA, United States
Hansen’s disease (leprosy) remains a significant cause of morbidity and 
disability, with India and Brazil carrying the highest number of cases 
worldwide. Mycobacterium leprae infection affects skins and nerves 
and can cause permanent disabilities, which can have lasting effects 
on individuals’ health and productivity. Addressing these preventable 
outcomes from various angles is crucial. We hypothesize that 
socioeconomic variables, such as income, occupation, and education 
level are associated with disability in patients with Hansen’s disease 
(HD). Between July and December 2015, we enrolled patients at an HD 
reference clinic in Belo Horizonte, Minas Gerais, Brazil to identify variables 
associated with morbidity of HD. Patients with multibacillary disease 
were recruited, a questionnaire on several demographic & socioeconomic 
variables administered, and data abstracted from the medical chart. A 
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cross-sectional analysis was performed to determine associations with 
Grade 1 or 2 nerve disability according to World Health Organization 
(WHO) criteria. Seventy- three patients were enrolled (73% male). The 
majority of patients had nerve damage with Grade 1 disability found in 19 
(26%) patients and Grade 2 in 29 (40%). On univariate analysis, older age 
(p=0.048) and lower education levels (OR = 5.4; 95% CI 1.4, 22.9) were 
associated with disability. Occurrence of reactions, clinical type of HD and 
other clinical and demographic variables were not found to be associated 
on preliminary analysis. Overall, our patients had a high burden of nerve 
damage consistent with prior studies in endemic areas. Additionally, older 
age and lower education were associated with disability grades of 1 or 2. 
While these findings are also consistent with other studies, overall data, 
to date, are limited and most of the literature has focused on clinical risk 
factors. These findings, along with planned multivariable analyses that 
may uncover other associations, will add to the body of knowledge on 
social factors associated with disability. This can then lead to strategies to 
target at-risk groups to reduce the burden of disease from this debilitating 
infection.
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NODDING SYNDROME/EPILEPSY IN THE SANAGA RIVER 
BASIN (CAMEROON): AN UNNOTICED EPIDEMIC?
Julia Irani1, Maya Ronse1, Alfred K. Njamnshi2, Adam Hendy1, 
Michel Boussinesq3, Joseph Kamgno4, Bob Colebunders5, Katja 
Siling1, Tine Verdonck1, Koen Peeters Grietens1, Sarah O’Neill1
1Institute of Tropical Medicine, Antwerp, Belgium, 2The University of 
Yaoundé I, Cameroon, Yaounde, Cameroon, 3Institut de recherche pour 
le développement (IRD), Montpellier, France, 4Centre for Research on 
Filariasis and other Tropical Diseases (CRFilMT), Yaounde, Cameroon, 
5University of Antwerp, Antwerp, Belgium
Nodding Syndrome (NS) is a severely debilitating form of epilepsy affecting 
children between the ages of 5 and 15 years in Northern Uganda, South 
Sudan and Tanzania. Unconfirmed cases of head nodding have also been 
reported in Cameroon and the Democratic Republic of Congo. The cause 
of the disease is unknown and there is no cure. Evidence suggests that 
there is an association between epilepsy/NS and onchocerciasis. However, 
relevant factors for the development of the condition are urgently needed. 
In order to explore these further, ethnographic research was carried out 
in 5 villages in the onchocerciasis-endemic Mbam Valley of the Sanaga 
river basin, Cameroon. Participant observations, in-depth interviews, 
informal conversations and focus group discussions suggested that there 
was a sharp increase of epilepsy about 40 years ago. Reports from older 
residents (50 years +) showed that epilepsy was uncommon during the 
1970’s, and that its prevalence increased dramatically during the 1980’s 
and has decreased in recent years. These findings suggest the existence 
of environmental or social triggers for the occurrence of epilepsy and 
potentially NS. Relevant factors may be: (i) the construction of dams 
upstream of the study area (affecting the seasonal population dynamics of 
blackflies, and increase the transmission of onchocerciasis); (ii) changes in 
the patterns of human-water contact; (iii) changes in climate (rainfall and 
temperature); (iv) changes in nutritional habits and the variety of foods 
available; (v) the annual mass ivermectin treatment through the African 
Programme for Oncocerciasis Control (APOC) launched in the late 1990’s. 
These factors may be key in determining the reported sudden occurrence 
of epilepsy/NS and need to be assessed further to contribute to the 
identification of the causes and conditions under which NS develops and 
becomes epidemic in certain locations and at specific times.
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HELMINTHS AND UNDERNUTRITION: FACILITATORS OF 
MYCOBACTERIUM LEPRAE MORBIDITY OR INNOCENT 
BYSTANDERS?
Jessica K. Fairley1, Jose A. Ferreira2, Thelma de Filippis2, Ana 
Laura Grossi de Oliveira3, Maria Aparecida de Faria Grossi2, 
Laura Pinheiro Chaves2, Paola Souza dos Santos2, Luiza Navarro 
Caldeira2, Rafaella Rodrigues Costa2, Maria Cavallieri Diniz2, 
Carolina Suares Duarte2, Parminder S. Suchdev1, Uriel Kitron4, 
Sandra Lyon2
1Emory University School of Medicine, Atlanta, GA, United States, 
2Faculdade de Saude e Ecologia Humana, Vespasiano, Brazil, 3Centro de 
Medicina Especializada, Pesquisa e Ensino, Belo Horizonte, Brazil, 4Emory 
University, Atlanta, GA, United States
While 30-50% of patients with Hansen’s disease (HD) suffer from 
immunological Type 1 and Type 2 reactions that can lead to irreversible 
nerve damage, large gaps in knowledge exist about susceptibility to 
these complications. We hypothesize that helminthic co-infections and 
micronutrient deficiencies may be risk factors for reactions. Between 
July and December 2015, we performed a pilot case-control study at 
an HD clinic in Belo Horizonte, Minas Gerais, Brazil. Adult patients 
with multibacillary disease were recruited and were considered cases if 
they had an active Type 1 (T1R) or Type 2 reaction (T2R) or controls if 
free of reactions. Data were abstracted from the medical chart, and a 
demographic questionnaire was administered. Stool was collected for ova 
and parasite testing and venipuncture was performed for Schistosoma 
mansoni serology, complete blood count, C-reactive protein, Vitamin D 
level, and biomarkers for iron and vitamin A status. Statistical analyses 
were performed with adjusted odds ratios calculated for T1R and T2R as 
separate outcomes, controlling for age, sex, race socioeconomic status, 
rural residence, type of clinical HD, bacillary index, presence of anemia, 
other co-infections and smoking status. Seventy-three patients were 
recruited with 73% male and an average age of 51.2 years. Helminth 
infections were found in 4 patients with reactions and 1 patient without 
reaction, with total prevalence of 6.9%. Helminth co-infections were not 
found to be associated with T1R (aOR =3.5; 95% CI 0.17, 73.15) nor T2R 
(aOR = 0.07; 95% CI <0.001, 80.49). Micronutrient results are pending. 
While this pilot study did not show a statistically significant association 
with helminth infections and reactions, the total numbers of co-infections 
were small. Given the overall prevalence of low socioeconomic status, 
micronutrient deficiencies may play a role in the risk of reactions in our 
study. The nutrition results, future epidemiologic studies on co-infections in 
areas with higher helminth endemicity and immune studies hold promise 
in identifying strategies to reduce the significant morbidity of reactions in 
susceptible populations.
1707
CHITOSAN MICROPARTICLES TO DNA DETECTION IN URINE 
SAMPLES
Martha Helena Jahuira Arias
Peruana Cayetano Heredia University, Lima, Peru
Chitosan is the second most abundant natural polymer in nature, derived 
by partial deacetylation of chitin. Chitin is part of the support structure 
of many living organisms, such as arthropods (crustaceans and insects), 
mollusks and fungi. Chitosan is being widely studied because of their 
advantages of biocompatibility, high charge density and non-toxicity. 
During the last years, has been reported the use of chitosan particles 
has the ability of association to peptides, proteins, oligonucleotides, 
due to the abundance of amino groups in its structure, thus allowing 
adsorption.  Urine is a valuable non-invasive sample, studies report the 
presence of DNA fragments in urine, however the low concentration is not 
detectable by conventional methods, an alternative is the use of chitosan 
biopolymer to concentrate the small amount of nucleic acides and their 
future application in the diagnosis of infectious diseases.  We infected 
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urine samples with DNA and applied the particles chitosan, previously we 
analized the pH interaction with DNA, we evaluated by PCR in real time. 
Chitosan particles has efficient to capture DNA .We hope to find the 
use of the particles could be used as a biomarker through DNA in urine 
samples.
1708
ASSESSING POSSIBLE EXPOSURE TO ZIKA VIRUS IN A 
HOSPITAL POPULATION THROUGH A TRAVEL SCREENING 
QUESTION
Aftab Iqbal1, Barbra Blair1, Robin Colgrove1, Andrew Gardner1, 
Vito Iacoviello1, Helen Jenkins2, Mary Wilson3, Lin Chen1
1Mount Auburn Hospital, Cambridge, MA, United States, 2Boston 
University School of Public Health, Boston, MA, United States, 3Harvard 
T.H. Chan School of Public Health, Boston, MA, United States
Responding to possible exposures to infections with potential 
importation, Mount Auburn Hospital incorporated a travel screening 
question “Have you traveled outside the US within the past 30 days” 
into patient registration for each visit. We describe characteristics of 
patients registered from November 1, 2015 to January 31, 2016 who 
responded “Yes” to estimate the number of patients potentially exposed 
to Zika virus. De-identified data collected prospectively in MIDAS 
database is analyzed. Services are in 5 categories: 1) Inpatients, 2) ED/
Walk-In Center, 3) Travel clinic 4) Other outpatients, and 5) Laboratory/
radiology. Destination countries are categorized by Zika transmission: 1) 
Confirmed autochthonous transmission in past 9 months [ECDC 041516], 
2) Documented prior presence (virus or serologic evidence), and 3) No 
documented Zika. All analyses are performed using SPSS 17.0. Of 1267 
total visits, 1065 with complete destination and diagnosis data were 
included.The mean age was 47y, 62% were female, 83% reported English 
as primary language, and 75% were white. The most common contact 
point was diagnostics (radiology/lab; n=584). Seventeen percent registered 
to the ED/ Walk-in clinic. Thirty-eight patients were admitted (3.6%). Top 
destinations were Canada (n=132), Mexico (n=79) and France (n=78).310 
patient visits reported travel to countries with Zika transmission (29%). 
The Caribbean was the most visited region with active Zika transmission 
(n=168). Among 660 female patient visits, 51% (n=341) were of child-
bearing age (15-49y; WHO criteria). Ninety-seven of 341 (28%) patient 
visits reported travel to an active Zika transmission area. Fifty-three 
visits were by pregnant women. Eighteen pregnant women had visited 
Zika transmission area (1st trimester=12; 2nd trimester=4; trimester 
unknown=2).A travel screening question at patient registration allowed for 
analysis of potential Zika exposure. We found over a quarter of patients 
had visited Zika transmission areas. A significant number of women were 
of child-bearing age and most pregnant women who visited Zika areas 
were in their first trimester.
1709
PODOCONIOSIS: GENETIC PREDISPOSITION NORTHERN 
PROVINCE, RWANDA, AFRICA
Jean Paul Bikorimana
Imidido Project, Musanze, Rwanda
Non-filarial elephantiasis (also known as podoconiosis) is a noninfectious 
neglected tropical disease caused by prolonged exposure of bare feet to 
irritant volcanic soils. It is a disabling and debilitating condition that left 
untreated can lead to the severest stage of lymphedema (elephantiasis). 
The Imidido Project based in Musanze Town, Rwanda, Africa has been 
providing care for those suffering with Podoconiosis since 2009. Through 
data gathering during the clinic registration process, the research indicates 
that there is a genetic predisposition to susceptibility of acquiring this 
condition through chronic exposure to irritant volcanic soils. To date, 
we have registered 342 patients with Podoconiosis in various stages of 
advancement within the Northern Province of Rwanda Africa. Of these 
342 patients, 183 (53.5%) indicated there were other family members 
that were suffering from this condition, including grandparents, parents, 
and siblings. The remaining 159 (46.5%) patients reported no familial link 
to the condition. The genetic linked group of high risk individuals has been 
a focus of our prevention education program in an effort to reduce the 
number of new cases in Rwanda, Africa.
1710
SYMPTOMS AND CLINICAL CORRELATES AS A PREDICTIVE 
MARKER FOR THE OUTCOMES IN TROPICAL FEVER: A TWO 
YEAR RETROSPECTIVE STUDY FROM CENTRAL INDIA
Deepak Jeswani1, Monika Mandal1, Dilip Kshirsagar1, Rupali 
Bhanare1, Chitra Thakare1, Navneet Wadhwa2, SCOUT
1Criticare Hospital and Research Institute, Nagpur, India, 2AUW Global, 
Mumbai, India
There has been a resurgence tropical fever in India. Management 
protocols at our specialist centre have been aligned to the tropical fevers 
management guidelines issued by Indian Society of Critical Care Medicine. 
We aim to study the trends in symptomology and relate with predictive 
outcomes. We retrospectively evaluated the cohort of tropical fever 
patients including dengue, malaria, rickettsial infections, leptospirosis, 
typhoid, bacterial sepsis and viral infections. The syndromic approach with 
presenting feature as acute undifferentiated febrile illness was utilised 
to identify patients from the SCOUT integrated database of our tertiary 
care hospital. ANOVA was used for stratified analysis. Symptoms and 
outcomes were retrospectively corroborated as a predictive tool across 
281 patients admitted during 2014-15. Year 2014 n= 180, 2015 n=101, 
Males n = 182, Females n=99. Overall, mortality rate was 4.62% (n=13; 
2014 n=7, 2015 n=6). 38.7% (n=109) were within 20 km vicinity and 
included treatment naïve patients. Majority (n=172) were referred from 
remote, rural geography and had already received primary care for the 
severe grade symptoms. Stratified analysis was performed across the 
duration of hospital stay, age, symptoms, GCS on admission, diagnosis, 
complications (p<0.0001). Hospital stay was < 10 days in 89.6% of 
patients, 49.8% were < 5 days in hospital. Mortality rate was 6.42% with 
length of hospital stay of <5 days Vs 17% in 16-20 days. Patients with 
breathlessness at admission had highest mortality 20% (n= 6/30), followed 
by cough and cold 6.4% (n=2/31), headache 5.6%, vomiting 5.38%, 
abdominal pain 5.17%. 95% (n=267) had GCS > 8 at time of admission 
with mortality rate of 4.12%. (p<0.0001). Highest mortality (29%) was 
noted in dengue with IgM/IgG (2/7) followed by Plasmodium vivax 20% 
(1/5). Patterns and the outcomes of tropical fever could be the benchmark 
for the rest of the country. The early triage of tropical fever patients could 
optimise the utilisation of the hospital resources. Symptoms at hospital 
admission with the clinical correlates could be an important predictor for 
outcomes.
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COMPREHENSIVE CARE OF CHAGAS DISEASE IN A NON-
ENDEMIC COUNTRY: THE EXAMPLE OF SPAIN
Miriam Navarro1, Jordi Gómez i Prat2, Begoña Monge-Maillo3, 
José Manuel Ramos4, Magdalena García5, Rogelio López-Vélez3, 
Isabel Claveria Guiu2, Diego Torrús4, Briggitte Jordan1, Estefa 
Choque6, Cristina Parada7, Bartolomé Carrilero8, Juan José Santos1
1Fundación Mundo Sano, Madrid, Spain, 2Drassanes-Vall d’Hebron 
International Health Unit, International Health Programme of the 
Catalonian Institute of Health (PROSICS), Barcelona, Spain, 3National 
Referral Centre for Tropical Diseases, Infectious Diseases Department, 
Ramón y Cajal Hospital, Madrid, Spain, 4Infectious Diseases Department, 
Hospital General Universitario de Alicante, Alicante, Spain, 5Infectious 
Diseases Department, Valencia’s Consorcio Hospital General Universitario, 
Valencia, Spain, 6Asociación de Afectados por la Enfermedad de 
Chagas (ASAPECHA), Barcelona, Spain, 7Asociación de Afectados por la 
Enfermedad de Chagas, Voluntarios y Amigos (ASAPECHAVAE), Valencia, 
Spain, 8Infectious Diseases Department, Hospital Universitario Virgen de la 
Arrixaca. Asociación de Afectados por la Enfermedad de Chagas-Murcia 
(ASAPECHAMUR), Murcia, Spain
Spain is the most affected country of Chagas disease (CD) in Europe, and 
the second non-endemic country globally (after US). Europe still faces 
an underdiagnosis of 90%. Among population from endemic areas, 
lack of knowledge, stigma and fear are still linked to CD. Community 
health activities are needed in order to reach population at-risk (par) 
and to overcome barriers for diagnosis and treatment.  Activities have 
been performed synergistically by several institutions/organizations, in 
different Spanish regions. Highlighted:  - CD patients’ associations since 
2008: Barcelona (ASAPECHA), Valencia (ASAPECHAVAE) and Murcia 
(ASAPECHAMUR).  - Catalonian Expert Patient Program® on CD: initiative 
started in 2011 within the Chronic Disease Program. It aims to boost 
responsibility of patients for their own health and to promote self-care. 
Results: 15 participants completed the program. Knowledge about disease 
improved after sessions.  - Mothers committed to Chagas’ disease: taking 
action here and there®: community health workers (CHW) specialized in 
CD’s training program, performed in Madrid in 2013. A second edition 
is currently in progress. Results (2014-2015): 1,401 par informed (185 in 
Bolivia); 60 par phoned the free-phoneline (900 103 209), asking mainly 
where to go for testing; 50 accompanied to the consultation by CHW; 
more than 7,000 received informative material.  - Community screening 
campaigns performed in non-clinical settings on Sundays, on the occasion 
of CD International Day or Bolivia National Day’s celebrations. Prior to the 
event, intense communicational campaigns are led by CHW and patients’ 
associations. Results (2012-Feb. 2016): 3,474 par were screened in 
Barcelona, Madrid, Valencia, Murcia and Alicante; 775 were positive (CD 
prevalence 22.3%).  - Access to treatment. 2013-2015: more than 4,000 
treatments were administered among 155 healthcare centers all over 
the country.  CD requires interdisciplinary approach including prevention, 
control, strategies and programs, being CHW and patient’s associations 
key factors. Spain has reduced underdiagnosis and offers comprehensive 
care for CD patients.
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IMPACT OF MICRONUTRIENT SUPPLEMENTATION COMBINED 
WITH MALARIA CHEMOPREVENTION ON MALARIA, 
ANAEMIA AND COGNITIVE DEVELOPMENT IN EARLY 
CHILDHOOD: FINDINGS FROM A CLUSTER RANDOMIZED 
STUDY IN SOUTHERN MALI
Sian E. Clarke1, Natalie Roschnik2, Moussa Sacko3, Niele Hawa 
Diarra4, Philippe Thera4, Seybou Diarra4, Yahia Dicko4, Renion 
Saye3, Hans Verhoef1, Kalifa Sidibe4, Modibo Bamadio4, Sham Lal1, 
Rebecca Jones5, Yvonne Griffiths6, Lauren Pisani7, Michael Boivin8, 
Fatoumata Dougnon9, Mouctar Coulibaly9, Bore Saran Diakite9, 
Bonaventure Maiga10
1London School of Hygiene & Tropical Medicine, London, United Kingdom, 
2Save the Children, London, United Kingdom, 3Institut National de 
Recherche en Santé Publique, Bamako, Mali, 4Save the Children, Bamako, 
Mali, 5University College London, London, United Kingdom, 6University 
of Leeds, Leeds, United Kingdom, 7Save the Children, Washington, DC, 
United States, 8Michigan State University, East Lansing, MI, United States, 
9Ministry of Health, Bamako, Mali, 10Ministry of Education, Bamako, Mali
Early childhood is a time of rapid growth and development and public 
health interventions during this period could yield substantial benefits 
across several developmental areas: physical, cognitive and linguistic. 
Iron is important in brain function, and interventions that reduce iron-
deficiency and anemia may improve cognitive function and learning. 
A randomized intervention study was undertaken to examine the 
combined impact of two newly-recommended interventions in early 
childhood: seasonal malaria chemoprevention and home fortification with 
micronutrient powders. Although each intervention has previously been 
shown to improve malaria morbidity, anemia and/or physical growth in 
children, the impact of combining these two complementary interventions 
is not known. No previous studies have examined effects on cognitive 
and linguistic development.  A cluster-randomized controlled study of 
this combined strategy has been carried out in 60 rural communities in 
southern Mali since 2013. Children aged less than 5 years living in the 
30 intervention communities receive seasonal malaria chemoprevention 
during the months of peak malaria risk, followed by daily supplementation 
of micronutrients for four months each year. Children living in control 
communities receive seasonal malaria chemoprevention only. The 
impact of the combined intervention after three consecutive years of 
implementation will be evaluated in May-June 2016 through cross-
sectional surveys to compare malaria infection, nutritional indices and 
cognitive performance in children aged 3 and 5 years living in intervention 
and control communities. The results of this evaluation will be presented 
and discussed.
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A COHORT STUDY TO ESTIMATE THE RISK MERS-COV POSES 
TO TRAVELERS TO THE MIDDLE EAST
Brian L. Pike1, Li-Yen Chang2, Norhayati Rusli3, Jefree Johari2, 
Chee-Sieng Khor2, Siti-Sarah Nor’e2, Jose A. Garcia-Rivera4, 
Lokman-Hakim Sulaiman3, Sazaly Abubakar2
1U.S. Naval Medical Research Center - Asia, Singapore, Singapore, 2Tropical 
Infectious Diseases Research & Education Centre, University of Malaya, 
Kuala Lumpur, Malaysia, 3Ministry of Health Malaysia, Putrajaya, Malaysia, 
4U.S. Naval Medical Research Center, Silver Spring, MD, United States
Since its appearance in 2012, the Middle East respiratory syndrome 
coronavirus (MERS-CoV) has emerged as a serious public health threat of 
global concern. As of September 2015, the World Health Organization has 
been notified of 1,626 laboratory confirmed cases and the case fatality 
rate is estimated at approximately 36%. Beyond its high fatality rate, 
significant concern lies in the potential for MERS-CoV to spread beyond 
the Middle East, as was recently witnessed in the Republic of Korea which 
saw an outbreak of 185 confirmed cases and reported 36 deaths. The 
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spread of MERS-CoV may be facilitated by high population mobility and 
mass gatherings such as the Hajj pilgrimage that an estimated two million 
Muslims make each year to the region most impacted by the virus. Indeed, 
two of the most frequently visited cities during the Hajj (Mecca and 
Medina), have contributed nearly 10% of the known cases to the present 
epidemic. Despite the global concern over the virus and its potential for 
spread, many questions about MERS-CoV remain unanswered such as the 
number of asymptomatic cases that go undetected by current surveillance 
activities. Here, we describe an established multi-year cohort of pilgrims 
departing for Hajj from Malaysia, a country that sees an annual average 
of 20-25,000 Muslims make the pilgrimage each year. Within this cohort, 
pre- and post-pilgrimage serological analysis is paired with questionnaire 
data to estimate the risk of exposure to MERS-CoV during Hajj and assess 
its potential to spread beyond the Middle East.
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ROTAVIRUS AMONG MEDICALLY-ATTENDED CHILDREN 
YOUNGER THAN FIVE YEARS OF AGE WITH AND WITHOUT 
DIARRHEA IN LIMA, PERU FOLLOWING UNIVERSAL 
ROTAVIRUS VACCINE IMPLEMENTATION
Giuliana Oyola Lozada1, Sarah-Blythe Ballard2, Mayra Ochoa-
Porras1, Gerardo Sanchez-Garcia1, Fabiola Colquechagua-Aliaga3, 
Roxana Zamudio-Zeaa1, Caryn Bern4, Mayuko Saito5, Dante 
Figueroa-Quintanilla3, Robert Gilman6, Holger Mayta1
1Infectious Diseases Research Laboratory, Departament of Molecular 
and Cellular Sciences, Universidad Peruana Cayetano Heredia, Lima, 
Peru, 2Parasitology Department, U.S. Naval Medical Research Unit - 6, 
Lima, Peru, 3Instituto Nacional de Salud del Niño, Lima, Peru, 4University 
of California San Francisco, San Francisco, CA, United States, 5Tohoku 
University Graduate School of Medicine, Sendai, Japan, 6Department of 
International Health, Johns Hopkins University Bloomberg School of Public 
Health, Baltimore, MD, United States
Before the monovalent vaccines Rotarix™ was added to the national 
immunization program in 2009, rotavirus A (RVA) was the leading cause 
of acute gastroenteritis among children in Peru. Although vaccination 
confers a high level of protection against several genotypes, continued 
monitoring of the prevalence of circulating strains that could affect vaccine 
efficacy is recommended. A case-control study was conducted in children 
younger than five years of age with and without diarrhea seeking medical 
care at Instituto Nacional de Salud del Niño in Lima, Peru between October 
2013 and May 2015. Clinical data was gathered to determine the severity 
of gastroenteritis episodes, and stool samples were collected. Presence 
of stool RVA was determined using RT-qPCR, and positive samples were 
genotyped by a multiplex hemi nested PCR assay. During the study period, 
1032 children (757 diarrhea cases 275 and controls) were analyzed. A total 
of 87.9% participants received the complete vaccine series. Prevalence of 
RVA was higher among cases (8.7%) than controls (3.6%) (p=0.0086). 
The emerging heterotypic G12P[8] was the most prevalent (54.8%) 
genotype. Among cases, no difference in the clinical severity, using either 
the Vesikari or Clark scales, was observed between RVA positive and RVA 
negative children. RVA infection remains an important cause of acute 
gastroenteritis among Peruvian pediatric populations. The identification of 
new circulating genotypes and their association with more clinically severe 
symptoms should continue to be evaluated.
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PREVALENCE AND ASSOCIATED RISK FACTORS OF DIABETES, 
CHRONIC KIDNEY DISEASE, HYPERTENSION AND OBESITY 
IN THE PERUVIAN AMAZON: THE AMARAKAERI RESERVE 
COHORT STUDY
Anthony Saxton1, John Stanifer1, Jaime Miranda2, Ernesto Ortiz1, 
William Pan1
1Duke University, Durham, NC, United States, 2Universidad Peruana 
Cayetano-Heredia, Lima, Peru
The Peruvian Amazon is in the midst of an epidemiological transition. 
Large urban population centers are growing rapidly, with non-
communicable diseases (NCDs) beginning to outpace incidence of 
infectious diseases. However, in rural and peri-urban environments, 
population-level disease burdens are undefined with both infectious and 
NCDs being reported in increasing numbers. In this study, we determine 
the prevalence of NCDs in rural areas of the Peruvian Amazon to observe 
differences in prevalence between males and females and between native 
and non-native communities, and to identify risk factors associated with 
hypertension, obesity, diabetes, and chronic kidney disease (CKD).  We 
conducted a cross-sectional study of 2,268 randomly selected adults 
(18-96 years old) in 1,122 households in communities surrounding the 
Amarakaeri Communal Reserve in the southern Amazon region of Madre 
de Dios. Disease prevalence was estimated using a finite population 
correction. WHO/ISH risk prediction charts were used to indicate the 10-
year risk of a fatal or non-fatal major cardiovascular event.  Comparing 
males vs. females, prevalence rates were: 7.0% vs. 1.8% for hypertension; 
19.7% vs. 35.7% for obesity; 1.7% vs. 2.5% for diabetes; and 10.2% 
vs. 3.3% for CKD. Significant differences between males and females 
were detected for obesity, hypertension, and CKD prevalence. Among 
adults positive for diabetes or hypertension, 30.7% self-reported having 
diabetes, and 18.6% having hypertension. Multivariate analyses indicate 
that education, sex, and community location were important risk factors 
for each of these NCD outcomes. Physical activity and waist circumference 
were additional risk factors for hypertension and obesity. Only 3% of the 
population was at moderate or high risk for a major cardiovascular event.  
NCD burden is high and differential among males and females. Risk factors 
identified in this region indicate that disease burden may increase and 
have severe cardiovascular consequences. As many of these risk factors are 
modifiable, interventions should be implemented immediately to lower the 
NCD burden in this region.
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DEVELOPMENT AND PRELIMINARY CLINICAL EVALUATION 
OF A MOBILE TECHNOLOGY FOR DIARRHEAL DISEASE 
OUTBREAK MANAGEMENT
Eric J. Nelson1, Farhana Haque2, Robyn Ball1, Stacey Maples1, 
Selina Khatun2, Mujadeed Ahmed2, M.Waliur Rahman2, Saraswati 
Kache1, Md. Jobayer Chisti3, Shafiqul Alam Sarker3, Gary 
Schoolnik1, Mahmudur Rahman2
1Stanford University School of Medicine, Stanford, CA, United States, 
2Institute for Epidemiology, Disease Control and Research, Dhaka, 
Bangladesh, 3International Centre for Diarrhoeal Disease Research, 
Banlgadesh, Dhaka, Bangladesh
The emergence of mobile technology offers new opportunities to improve 
access to clinical guidelines, especially in resource-limited settings during 
acute health crises. We conducted a multi-year design initiative to 
determine how best to adapt diarrheal disease outbreak management 
guidelines to smartphones. End-user design sessions with medical 
staff in rural Bangladesh resulted in the development of a rehydration 
calculator for use during initial resuscitation and a surveillance platform 
for real-time syndromic reporting and data visualization. The calculator 
was evaluated in a pre/post pilot study at a generalizable government 
district and sub-district hospital in Northern Bangladesh in an area prone 
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to cholera outbreaks (Netrokona). Inclusion criteria were patients with 
uncomplicated diarrheal disease (>= 3 loose stools per 24 hours) and an 
age >= to 2 months. The baseline and interventional arms were six weeks 
each. The primary outcome was adherence to guidelines for antibiotics 
(azithromycin for moderate and severe dehydration for suspected cholera), 
zinc (<5 years) and intravenous (IV) fluids. A total of 327 and 521 patients 
were enrolled during the baseline and interventional arms. For the district 
and sub-district sites, guideline adherence increased for antibiotics (13% 
to 82%, p<0.01; 63% to 99%, p<0.01, respectively), zinc (82 to 89%, 
p>0.01; 91 to 98%, p>0.01; respectively) and the use and administration 
of IV fluids. No adverse events related to the intervention were detected 
during admission and at 10-days post discharge. The surveillance platform 
(aka Outbreak Responder) was durable and reported clinical and laboratory 
endpoints in real-time. A randomized control trial is in development 
to accommodate for study limitations that included the lack of an 
independent control and implementation challenges. In this study, we 
report the successful technical first steps towards a smartphone-enabled 
platform for diarrheal disease outbreak management.
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DIFFERENTIAL CLINICAL AND LABORATORY 
CHARACTERISTICS AMONG ADULT DENGUE PATIENTS WITH 
DIABETES
Junxiong Vincent Pang, Yee Sin Leo, David C Lye, Tsin Wen Yeo
Tan Tock Seng Hospital, Singapore, Singapore
Dengue results in significant public health burden globally. It is usually 
a self-limiting disease, but about 1-5% of those symptomatic dengue 
infections results in dengue hemorrhagic fever, dengue shock syndrome 
(WHO 1997) or severe dengue (WHO 2009). Diabetes has been 
significantly associated with severe dengue progression. However, there 
is a lack of understanding of the differential clinical, laboratory, and 
immunological characteristics of these high risk group of dengue adult 
patients at presentation and during hospitalization, that potentially may 
provide insights in the disease pathogenesis of the virus and provide 
guidance on improved clinical management. Dengue patients with 
diabetes were significantly associated with hypertension, hyperlipidemia 
and severe dengue outcome. Several warning signs such as abdominal 
pain, clinical fluid accumulation and hematocrit rise and rapid platelet 
count drop were significantly associated with dengue patients with 
diabetes. Levels of white blood cells and neutrophils were significantly 
associated with dengue patients with diabetes. Immunologically, several 
chemokines and cytokines were significantly associated with dengue 
patients with diabetes. In conclusion, dengue patients with diabetes 
may have different immune responses against dengue virus, resulting 
differential clinical manifestations and disease severity. Much more 
immuno-pathogenesis studies are still required to provide understanding 
of how diabetes pre-dispose a patient with severe dengue outcome.
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ANTHELMINTHIC SCREENING FOR PARASITIC NEMATODES
Mostafa A. Elfawal1, Dan Lawler2, Dirk Albrecht2, Raffi Aroian1
1Program in Molecular Medicine, University of Massachusetts Medical 
School, Worcester, MA, United States, 2Quantitative Neurology Lab, 
Worcester Polytechnic Institute, Worcester, MA, United States
For many parasitic diseases, high-throughput phenotypic screening is an 
important tool in finding new drugs. Some of the most important parasitic 
diseases are caused by nematodes. However, these parasitic nematodes 
are not typically amenable to high throughput screening. Due to the ease 
of its maintenance and suitability for high throughput assay, the nematode 
Caenorhabditis elegans is instead used. To address whether C. elegans 
is a good model for nematode drug discovery, we compared the drug 
susceptibility of C. elegans relative to the human hookworm nematode 
parasite Ancylostoma ceylanicum at several developmental stages using 
a library of FDA approved drugs. I will present results of these studies 
that point to how well C. elegans efficacy correlates with hookworm 
efficacy and how early larval stages (easier to get) correlated with adult 
stages (more representative of what stage is targeted in human therapy). 
In addition, we are working on moderate-high throughput system for 
screening adult parasites. Using Union Biometrica, Copas, worm sorter we 
were able to sort adult parasites into 384 well format. Here I will discuss 
the capabilities of this system as well as how we are building de novo, in 
collaboration with the Albrecht laboratory at WPI, an imaging and image 
analysis platform for screening adult parasitic nematodes against large 
drug libraries.
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WHAT’S IN A NATIONAL PLAN OF ACTION? EVALUATING 
PROGRESS TOWARD GLOBAL CONTROL OF SOIL-
TRANSMITTED HELMINTHIASES?
Lauren Abrams, Jedidiah Snyder, Alexander Jones, David Addiss
Task Force for Global Health, Decatur, GA, United States
Soil-transmitted helminthiases (STH) are estimated to affect more than 2 
billion people worldwide. In effort to minimize this disease burden, the 
World Health Organization (WHO) has outlined milestones to monitor 
the progress of global STH control. Specifically, WHO has advocated 
for the development of national plans of action (PoA) for integrated 
control of neglected tropical diseases (NTDs) by all countries requiring 
preventive chemotherapy (PC) for STH by 2015. To measure progress on 
this indicator, we collected national PoA from WHO, national programs, 
and implementing partners. WHO indicates that 84 national PoA exist; of 
these, we were able to confirm and analyze 41, representing 40% of the 
102 countries requiring PC for STH in 2014. All available PoA included 
STH control. Yet, a substantial proportion failed to address key roles for 
intersectoral collaboration with education, water and sanitation, and 
nutrition sectors. Although WHO recommends deworming to reduce 
morbidity from STH in both preschool-age children (PSAC) and school-age 
children (SAC), the majority of available PoA did not address PSAC as a 
target population. Our findings suggest that developing a national PoA is 
an effective step in STH control. Of countries with reported STH treatments 
for SAC in years prior to and during an active PoA (N=33), the average 
national coverage increased by 15.4% (95% CI: 6.8 - 24. 0%) under 
PoA implementation. However, even with this increase, only 16 of the 41 
countries with available PoA reported coverage greater than 75% in the 
year 2013 or 2014. Our analysis is limited by the difficulty in collecting 
PoA. However, to date, this is the first collective review of available PoA for 
integrated control of NTDs. Most notably, our review suggests that if WHO 
milestones on STH control are to be met, improved efforts in developing 
and updating national PoA may be required.
1720
PREVALENCE OF MALARIA, GEOHELMINTHS AND ANAEMIA 
AMONG SCHOOL CHILDREN IN MUHEZA DISTRICT
Billy Ngasala1, Lwitakubi F. Matata1, Ahmed M. Abade2, Patrick 
Tungu2
1Muhimbili University of Health and Allied Science, Dar es Salaam, United 
Republic of Tanzania, 2National Institute of Medical Research, Muheza, 
United Republic of Tanzania
Malaria and intestinal helminths are an important public health issue with 
malaria-geohelminths  co-infections commonly occurring in school aged 
children. A consequence of these co-infections  in humans is anaemia. 
This cross sectional study aimed to determine the prevalence of malaria,  
geohelminths, co-infections and anaemia and associated factors among 
school children. The  prevalence of malaria was 21.5% (82/381), (95% 
CI: 20.5 to 24.1) geohelminths (6.7%) 26/387  (95%CI: 8.4 to 12.9), 
co-infections (malaria-geohelminths) (1.8%) 7/381 (95%CI: 1.7 to 2.1) 
and  anaemia was (39.1%) 149/381 (95%CI: 37.2 to 51.7). Non-use of 
insecticides treated nets (aOR  4, 95% CI: 2.24 to 8.51 P= 0.0012) was 
associated with malaria infection. Eating unwashed raw  food (aOR 2.9, 
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95%CI: 1.9 to 9.2 P-value = 0.032) and not washing hands before eating 
(aOR  5.81, 95% CI: 1.92 to17.54 P-value =0.0002) were associated with 
geohelminth infections. Malaria  and anaemia are prevalent in the study 
area while geohelminths and co-infections among school  children are low. 
Further studies are required to explore the reasons why primary school 
children  do not use insecticide treated nets and hygienic practice.
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CRYSTAL PROTEIN CRY5B AS A NOVEL AND POWERFUL 
ANTHELMINTIC
Yan Hu, David Koch, Zeynep Mirza, Thanh-thanh Thanh, Gary 
Ostroff, Raffi Aroian
University of Massachusetts Medical School, Worcester, MA, United States
Soil-transmitted helminths (STHs), most notably, hookworms, whipworms, 
and Ascaris, are nematodes that infect more than 1.5 billion of the poorest 
people and are amongst the leading causes of morbidity worldwide. 
Only two classes of de-worming drugs (anthelmintics) are available for 
treatment, and only one is commonly used in mass drug administrations. 
New anthelmintics are urgently needed to overcome emerging resistance 
and to produce higher cure rates. Crystal (Cry) proteins, in particular 
Cry5B, made by Bacillus thuringiensis (Bt) are promising new candidates. 
Cry5B has excellent anthelmintic properties against many free-living 
and parasitic nematodes, including in vivo efficacy against multiple STH 
infections in rodents (Heligomasmidoes polygyrus and Ancylostoma 
ceylanicum) and in pigs (Ascaris suum).  An enormous challenge for STHs, 
very different from most diseases worked on in the developing world, 
is the requirement that therapies be very cheap (the people infected are 
very poor and current drugs costs pennies a dose), massively scalable 
(over 4 billion people are at risk from infection), and have a long shelf 
life in harsh environments, that have high temperature and humidity and 
no cold chain.  We will update our progress in several key areas. We will 
present new data on the in vivo activity of Cry5B against a major human 
parasite of humans. We will also present data on the whether or not the 
immune system is required for Cry5B action in vivo. We will also present 
on our development efforts to produce a deployable version of Cry5B that 
is cheap, safe, scalable, and stable. These efforts are focused on bacterial 
engineering, expression, and formulation, and we believe we hit upon a 
novel bacterial expression system that meets these key requirements.
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PLANT DERIVED COMPOUNDS AS ‘RESISTANCE-BUSTING” 
ANTHELMINTIC DRUG
Zeynep Mirza, Yan Hu, David Koch, Thanh-thanh Nguyen, Raffi 
Aroian, Gary Ostroff
University of Massachusetts Medical School, Worcester, MA, United States
There is an urgent need for new therapies for parasitic helminthic diseases 
affecting 1.5-2 billion people worldwide due to the threat of wide-spread 
resistance development to existing treatments and due to problems of 
incomplete efficacies.  Plants and plant secondary metabolites have been 
used historically to treat STH infections. Although they can be effective, 
we hypothesize that the active ingredients in plants may be absorbed 
prematurely, which limits their efficacy. Our hypothesis is that modern 
formulation techniques could be used to overcome limitations.  We 
screened a number of plant extracts and metabolites for anthelmintic 
activity in vitro against adult stages of the hookworm and whipworm 
parasitic nematodes Ancylostoma ceylanicum and Trichuris muris. Here we 
will present results of this work, which shows the promising potential for 
some of these as pan-nematode anthelmintics. This work has allowed us 
to classify plant materials into at least two groups based on their in vitro 
killing kinetics. We have also shown that some are effective against an 
albendazole-resistant Caenorhabditis elegans strain suggesting that they 
may play an important role in overcoming helminthic drug resistance. We 
will also present our work on optimizing lead formulations in vitro and in 
vivo in animal models of parasitic nematode infection in order to overcome 
the challenges and realize the potential of “resistance-busting” plant-
based anthelmintic therapies.
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INVESTIGATING THE DIFFERENTIAL IMPACT OF SCHOOL AND 
COMMUNITY-BASED INTEGRATED CONTROL PROGRAMS 
FOR SOIL-TRANSMITTED HELMINTHS IN TIMOR-LESTE: THE 
(S)WASH FOR WORMS PILOT STUDY
Naomi E. Clarke1, Archie C. Clements1, Rebecca Traub2, James 
McCarthy3, Darren Gray1, Susana V. Nery1
1Australian National University, Canberra, Australia, 2University of 
Melbourne, Parkville, Australia, 3QIMR Berghofer Medical Research 
Institute, Brisbane, Australia
Soil-transmitted helminth (STH) infections remain a significant global 
health issue, with an estimated 1.45 billion people infected worldwide. 
Water, sanitation and hygiene (WASH) interventions are thought to be 
important in sustainable STH control, alongside regular distribution of 
anthelminthic drugs. Currently, large-scale STH control programs are 
most often targeted to children, through school-based delivery systems. 
However, a recent meta-analysis shows greater reductions in STH 
prevalence in children following community-wide deworming, compared 
to child-targeted deworming. The (S)WASH for WORMS pilot study aims 
to compare the impact of school- and community-based integrated WASH 
and deworming programs on STH in school-aged children. This pilot 
study includes six remote communities in Timor-Leste. STH prevalence 
and intensity were measured in school-aged children at baseline in 
June 2015, using both a flotation-based microscopic technique and a 
quantitative PCR technique. All communities then received a WASH 
and deworming program at the primary school, and three communities 
additionally received a community-wide WASH and deworming program. 
STH prevalence and intensity will be re-evaluated in May 2016, six months 
after anthelminthic delivery. Cumulative incidence and intensity of STH 
infections at six months will be compared between the two study arms. 
At study baseline, 522/563 (91%) children present were recruited for the 
study. Stool samples were obtained for 483/522 (93%). STH prevalence 
was 37.7% (95%CI 33.2-42.3%) using microscopy, and 50.3% (95%CI 
45.7-54.9%) using quantitative PCR. In summary, baseline results show 
that this pilot study achieved high participation rates and that STH are 
prevalent among school-aged children in Timor-Leste. Preliminary analyses 
suggest that quantitative PCR is more sensitive than microscopy for 
diagnosing STH infections. This presentation will discuss the pilot study in 
more detail, and will include final results comparing the two study arms.
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IS THERE EVIDENCE THAT THE SEASONAL TIMING OF MASS 
DE-WORMING FOR ASCARIS IS IMPORTANT?
Emma L. Davis1, Deirdre Hollingsworth1, Leon Danon2, Sharmini 
Gunawardena3
1University of Warwick, Warwickshire, United Kingdom, 2University of 
Bristol, Bristol, United Kingdom, 3University of Colombo, Colombo, Sri 
Lanka
Regular mass treatment programs are commonly used in areas of high 
Ascaris prevalence. It is well known that that seasonal variables can affect 
maturation and mortality of Ascaris eggs, yet the potential implications 
for incidence, transmission and control are poorly understood. A recent 
field study of 477 individuals in Sri Lanka has shown significant correlation 
between Ascaris infection rates and a number of seasonal variables, 
including temperature. To demonstrate the implications that seasonal 
variation in climate could have for mass treatment, and the potential for 
intervention optimization, we have used statistical modeling techniques 
to simulate the results of seasonal timing of mass chemotherapy in 
different settings. Using historical experimental data on A. suum eggs to 
fit relationships between temperature and egg developmental parameters, 
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we find that the optimal temperature for Ascaris eggs lies in the range 
of 25°C-30°C. Higher temperatures facilitate egg development, but 
temperatures above 30°C show a steep drop in the proportion of eggs 
that survive. Using these relationships, a mathematical model is developed 
to represent seasonal mean worm burden in a population under various 
mass treatment conditions. We demonstrate the ability of this model to 
predict seasonal Ascaris prevalence using historical data from a study of 
approximately 600 individuals in Korea, across six neighbouring villages. 
Applying this model to prevalence data from the Sri Lanka field study 
allowed us to predict the outcome of mass treatment programs with 
different annual timing. Results suggest that tuning treatment timing 
could have significant consequences for program impact, with the optimal 
annual treatment date providing up to a 55% comparative decrease in 
prevalence after four treatment rounds. Whilst different seasonal patterns 
would give different results, this implies that we may have previously 
under-estimated the importance of seasonality in driving Ascaris infections. 
Further investigation into seasonal timing of treatment could result in long-
term global implications for helminth control and elimination programs.
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SPONTANEOUS SEDIMENTATION IN TUBE TECHNIQUE 
IS AS SENSITIVE AS KATO-KATZ FOR THE DIAGNOSIS OF 
SOIL-TRANSMITTED HELMINTHS AND SUPERIOR FOR 
THE DETECTION OF STRONGYLOIDES STERCORALIS: A 
COMMUNITY-BASED STUDY IN THE AMAZON BASIN OF 
PERU
George Vasquez- Rios1, Renato A. Errea1, Diego Siu1, Rodrigo 
Gallegos2, Rossana Rondon2, Kevin Duque2, María L. Calderón2, 
Katia Baca2, Josefina Fabian2, Luciana H. Juárez3, Celene Uriol3, 
Marco Canales1, Angelica Terashima1, Jorge D. Machicado4, Luis A. 
Marcos5, Frine Samalvides1
1Instituto de Medicina Tropical Alexander von Humboldt – Universidad 
Peruana Cayetano Heredia, Lima, Peru, 2Universidad Peruana Cayetano 
Heredia, Lima, Peru, 3Scientic Society of Medical Students of Cayetano 
Heredia - Universidad Peruana Cayetano Heredia, Lima, Peru, 4Division 
of Gastroenterology, Hepatology and Nutrition, University of Pittsburgh 
Medical Center, Pittsburgh, PA, United States, 5Division of Infectious 
Diseases – Stony Brook University, Stony Brook, NY, United States
Soil-transmitted helminthiasis (STH) constitute a major health problem 
especially in developing countries, where the lack of parasitologists and 
limited laboratory resources may be contributing factors to underestimate 
the burden of disease by these parasites. According to the WHO, Kato-
Katz (K-K) method is the gold standard for the diagnosis of STH; however 
its sensitivity has been reported as low when compare to other methods. 
This study aimed to compare the sensitivity of K-K against Spontaneous 
sedimentation in tube technique (SSTT); a low-cost and rapid diagnostic 
technique for the diagnosis of STH. Fresh stool samples from residents 
of a rural community in the Amazon (Peru) were collected and analyzed 
by both techniques within 6 hours from emission. In addition, Agar plate 
culture was used as the gold standard for the diagnosis of Strongyloides 
stercoralis. One hundred seventy stools samples were collected in this 
study, mostly children. Overall, the prevalence of STH was 24.7%. In 
an individual analysis, the prevalence of these parasites by means of 
K-K or SSTT was as follows: Ascaris lumbricoides (12.4% vs. 13.5%), 
Hymenolepis nana (8.2% vs. 7.7%), Trichuris trichiura (1.2% vs. 1.2%) 
and hookworm (1.2% vs. 2.4%). Furthermore, the prevalence of S. 
stercoralis through K-K, SSTT and Culture was 0% vs. 4.1% vs. 10.6% 
(p<0.001). In conclusion, SSTT was as sensible as K-K for the diagnosis of 
STH and superior for the detection of S. stercoralis larvae in this specific 
population. Our results suggest that SSTT may be an alternative for the 
diagnosis of STH in tropical areas, and this finding warrants especial 
consideration, given the high prevalence of S. stercoralis in such regions. In 
addition, the SSTT may need further modifications in order to quantify the 
intensity of infection. Major advantages of this technique are the simplicity 
(no need for centrifuge) and low cost.
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POTENTIAL IMMUNOLOGICAL MARKERS FOR DIAGNOSIS 
OF HUMAN STRONGYLOIDIASIS USING HETEROLOGOUS 
ANTIGENS
Ronaldo Gryschek1, Marcelo Corral1, Fabiana Paula2, Dirce 
Meisel2, Vera Castilho2, Elenice Goncalves2, Debora Levy2, Sergio 
Bydlowski1, Pedro Paulo Chieffi3, William Castro-Borges4
1University of Sao Paulo Medical School, Sao Paulo, Brazil, 2Hospital das 
Clinicas, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, 
Brazil, 3Faculdade de Ciencias Medicas, Santa Casa, Sao Paulo, Brazil, 
4University Federal of Ouro Preto, Ouro Preto, Brazil
Strongyloides venezuelensis is a parasitic nematode of rodents that is 
frequently used to obtain heterologous antigens for immunological 
diagnosis of human strongyloidiasis. The aim of this study was to identify 
antigens from filariform larvae of S. venezuelensis for immunodiagnosis of 
human strongyloidiasis. Soluble and membrane fractions from filariform 
larvae of S. venezuelensis were obtained in phosphate saline (SS and SM) 
and Tris-HCl (TS and TM), and were analysed by western blotting (WB). 
Different antigenic components were recognized by IgG antibodies from 
the sera of strongyloidiasis patients. Highest recognition was observed 
for a 30-40 kDa band in all antigenic fractions. This band was then 
excised and subjected to mass spectrometry for protein identification. 
Immunoreactive proteins identified in the soluble fractions corresponded 
to metabolic enzymes, whereas cytoskeletal proteins and galectins were 
more abundant in the membrane fraction. Thus, these results represent 
the first step towards identification of S. venezuelensis antigens for use in 
immunodiagnostic assays for human strongyloidiasis.
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THE EFFECT OF MATERNAL POSTPARTUM DEWORMING ON 
INFECTION STATUS, ANEMIA AND FATIGUE
Layla S. Mofid1, Martín Casapía2, Antonio Montresor3, Elham 
Rahme4, Brittany Blouin1, Hugo Razuri4, Lidsky Pezo2, Theresa W. 
Gyorkos1
1Department of Epidemiology, Biostatistics and Occupational Health, 
McGill University, Montreal, QC, Canada, 2Asociación Civil Selva 
Amazónica, Iquitos, Peru, 3Department of Control of Neglected Tropical 
Diseases, World Health Organization, Geneva, Switzerland, 4Research 
Institute of the McGill University Health Centre, Division of Clinical 
Epidemiology, Montreal, QC, Canada
Anemia and fatigue are common consequences of infection with intestinal 
parasites in women of reproductive age living in parasite-endemic areas. 
To date, no previous study has evaluated symptoms of fatigue in infected 
individuals using standardized scales. A randomized controlled trial 
conducted in 2013-2014 in Iquitos, Peru recruited 1010 mother-infant 
pairs. One objective of the study was to determine the effectiveness 
of maternal postpartum deworming on the prevalence and intensity 
of intestinal parasites, anemia, and fatigue in lactating women up to 6 
months postpartum. Following delivery, women were randomly allocated 
to receive single-dose deworming (albendazole) or matching placebo. At 
6 months postpartum, mothers provided stool specimens for detection 
of intestinal parasite infection, and finger-prick blood samples for 
assessment of blood hemoglobin concentration. The Fatigue Assessment 
Scale (FAS) was used to ascertain the self-reported presence of physical 
and cognitive symptoms of fatigue. A total of 970 (96.1%) participants 
attended their 6-month follow-up visit. The risk of parasite infection at 
6 months postpartum was significantly lower in the group who received 
albendazole compared to placebo (RR: 0.5; 95% CI: 0.4, 0.6). At 6 months 
postpartum, no statistically significant benefit of deworming on maternal 
anemia (48.1% vs. 48.6%) or elevated fatigue (61.3% vs. 64.1%) was 
observed. Results were similar when analyses were restricted to mothers 
who tested positive for helminth infection at baseline. In the present study 
population, where baseline soil-transmitted helminth infection prevalence 
and intensity were low, deworming was highly effective at reducing the 
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burden of infection at 6 months postpartum; however, benefits in terms 
of maternal anemia or fatigue could not be detected at this time point. 
Further research is needed to determine which interventions, either during 
pregnancy or during the postpartum period, provide the most benefit to 
mother and infant at this critical time.
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SYSTEMATIC REVIEW AND META-ANALYSIS OF SOIL-
TRANSMITTED HELMINTH TREATMENT EFFICACY STUDIES 
AND THE CASE FOR SHARING INDIVIDUAL PATIENT DATA
Julia B. Halder1, Amélie M. Julé2, Michel Vaillant3, Maria-Gloria 
Basáñez1, Piero L. Olliaro4, Martin Walker1
1Imperial College London, London, United Kingdom, 2University of Oxford, 
Oxford, United Kingdom, 3Luxembourg Institute of Health, Strassen, 
Luxembourg, 4World Health Organization, Geneva, Switzerland
In 2014, over 271 million schoolchildren were treated with benzimidazoles 
as part of the World Health Organization’s plan to scale up mass drug 
administration (MDA) programmes targeting the soil-transmitted 
helminthiases (STHs) caused by roundworm, whipworm, and hookworms. 
There is consensus that drug efficacies should be monitored for signs 
of decline that could jeopardise the long-term effectiveness of MDA 
strategies. Efficacies are mostly calculated and reported as averages 
in groups of patients. However, heterogeneities in trial design and 
reporting hinder straightforward meta-analysis of these data, which could 
otherwise be used to explore varying efficacy among populations with 
different MDA histories or particular sub-populations of interest. Some 
heterogeneity issues could be avoided if individual participant data could 
be accessed, as this would facilitate the execution of standardized, state-
of-the-art statistical analyses. Such data would also allow examination of 
the distributions of individual responses to anthelmintic drugs, offering a 
more sensitive means to identify reduced efficacies potentially caused by 
emerging drug resistance. To assess the trial landscape, we systematically 
search the STH literature for published anthelmintic trials. We collate 
locations, study sizes, methodologies, reported drug efficacies and other 
aspects of the reported data. We quantify these characteristics and 
create an overview of the variety therein, exploring the limits to analysing 
aggregated data. The results indicate the volume and characteristics 
of individual patient data that may exist and could be used to create a 
database on the efficacy of the anthelmintics that are the cornerstone of 
MDA targeting STH infections.
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USING TRANSMISSION MODELS IN STUDY DESIGN: 
DETECTING ELIMINATION AND THE IMPACT OF PRE-
EXISTING TREATMENT PROGRAMS
James Truscott, Sam Farrell, Roy Anderson
Imperial College London, London, United Kingdom
The DeWorm3 project aims to investigate the feasibility of eliminating soil 
transmitted helminth (STH) infection using mass drug administration, in 
particular by leveraging existing treatment programs such as for lymphatic 
filariasis (LF). The project uses mathematical models of transmission to 
aid study design. An important component of this work is to identify a 
statistic to identify when sufficient treatment has been delivered to achieve 
long-term elimination. We discuss a number of possible candidates, their 
sensitivity, specificity and their requirements in terms of sampling strategy. 
We also examine the potential impact of existing LF treatment platforms 
on the possibility of STH elimination and its detection. We investigate 
how STH elimination efforts can best be coordinated with such programs 
to maximise the possibility of success, particularly in cases in which LF 
programs have achieved their targets and are being discontinued.
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COMPARISON OF KATO-KATZ, MINI-FLOTAC AND MULTI-
PARALLEL REAL-TIME POLYMERASE CHAIN REACTION 
TECHNIQUES FOR DETECTION OF SOIL-TRANSMITTED 
HELMINTHS IN FEIRA DE SANTANA, BRAZIL
Ryan H. Avery1, Simone S. Oliveira2, Aristeu V. da Silva2, Rojelio 
Mejia3, Marta M. Silva4, Rebecca C. Christofferson1, Laura Rinaldi5, 
John B. Malone1
1Louisiana State University, Baton Rouge, LA, United States, 2State 
University of Feira de Santana, Feira de Santana, Brazil, 3Baylor College 
of Medicine, Houston, TX, United States, 4Federal University of Bahia, 
Salvador, Brazil, 5University of Naples, Naples, Italy
Soil-transmitted helminth (STH) infections, primarily caused by the 
roundworm Ascaris lumbricoides, the hookworm species Necator 
americanus and Ancylostoma duodenale, and the whipworm Trichuris 
trichiura, affect over 1 billion people, especially in warm, moist climates. 
Current STH control efforts in Brazil are conducted using passive 
surveillance and incidental case finding, such as by the Schistosomiasis 
Control Program, which is limited to schistosomiasis endemic areas, and 
this leaves STH infections under-notified. Diagnostic testing for the STH 
relies mainly on the WHO recommended Kato-Katz method, which has 
been shown to lack sensitivity. Other economical, feasible, and more 
accurate diagnostic methods are needed to detect and combat STH, 
especially in areas of low endemicity. In the city of Feira de Santana, Brazil, 
we collected human stool from four different areas of the city, one rural 
site, two peri-urban sites and one urban site. We compared the traditional 
Kato-Katz thick smear to two newer diagnostic methods, the mini-FLOTAC 
kit and a multi-parallel quantitative polymerase chain reaction (qPCR) 
technique. The mini-FLOTAC kit allows for quick analysis of fresh or 
preserved feces with minimal equipment needed. The multi-parallel qPCR 
can accurately detect and quantitate parasites within the stool with high 
specificity and sensitivity, and is optimized to allow for inexpensive analysis 
of each sample. All three diagnostic methods were analyzed for both 
parasite detection and quantification. Both the mini-FLOTAC and multi-
parallel qPCR offer feasible, higher-accuracy diagnostics, which will enable 
a shift away from morbidity control and towards elimination, especially in 
areas of low STH endemicity.
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ANTIPARASITIC METABOLITES OF DALEA SPP (PLANTAE, 
FABACEAE)
Blaise Dondji1, Kaitlin L. Deardorff1, Kiah N. Jones1, Brianda 
Cardenas-Garcia1, Lindsey Engels1, Shannon Fulkerson1, Cassie 
Ripley1, Haley Wolhart2, Nicholas Hansen2, Gil Belofsky2
1Laboratory of Cellular Immunology & Parasitology, Department of 
Biological Sciences, Central Washington University, Ellensburg, WA, 
United States, 2Department of Chemistry, Central Washington University, 
Ellensburg, WA, United States
About a billion people are infected worldwide with hookworms. These 
intestinal parasites are the major cause of iron-deficiency anemia, weight 
loss, stunted growth and malnutrition in endemic areas. Despite control 
strategies using mass drug treatment combined with water, sanitation 
and hygiene, hookworm infection remains a major public health threat 
to the overall wellbeing of populations in endemic countries. Moreover, 
there is increasing concern with reports of lower efficacy of current 
drugs used in the treatment of hookworms and other soil-transmitted 
nematodes. Consequently, there is an urgent need of new tools to control 
the transmission of these helminths. We have explored the anthelminthic 
potentials of natural products from plants including those of the genus 
Dalea spp. The activity of Dalea metabolites against the adult Ancylostoma 
ceylanicum hookworm was assessed using an ex vivo assay. Whole 
extracts, chromatographically-enriched fractions and pure compounds 
from eight plant species (Dalea spp) were evaluated. Worm mortality due 
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to plant extracts varied from 0 to 100% by day 5 post-incubation. Some 
extracts recorded 0% worm survival i.e 100% mortality by 24 hours after 
incubating worms and plant products. Toxicity of pure compounds to 
mammalian cells was evaluated by flow cytometry and their effects on 
cell proliferation by BrdU. In vivo evaluation of pure compounds using 
our hamster laboratory model of hookworm infection is also underway. 
Detailed results will be presented.
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A COMPARATIVE ANALYSIS OF STOOL PRESERVATION 
TECHNIQUES FOR THE MOLECULAR DETECTION OF SOIL 
TRANSMITTED HELMINTHS
Nils Pilotte1, Marina Papaiakovou1, Jessica R. Grant1, Yan Hu2, 
David Koch2, Alastair Matheson3, Kristjana Asbjornsdottir3, Raffi V. 
Aroian2, Judd L. Walson3, Steven A. Williams1
1Smith College, Northampton, MA, United States, 2University of 
Massachusetts Medical School, Worcester, MA, United States, 3University 
of Washington, Seattle, WA, United States
Accompanying the growing successes of the world’s soil transmitted 
helminth (STH) treatment and elimination programs is an increasing 
need for sensitive and species-specific molecular diagnostic techniques. 
While the continued development of new tools is helping to meet this 
need, sample preservation remains a largely understudied, yet crucial 
aspect of the stool-based diagnostic process. Diagnostic test sensitivity 
is not only critical at the level of the individual, but is equally important 
for programmatic decision making. However, poor sample preservation 
renders all testing insensitive, making this aspect of diagnostics one of 
utmost importance. Accordingly, we have performed a comparative 
analysis of eight different literature-cited stool preservation techniques. 
Utilizing human stool samples spiked with hookworm eggs at 
concentrations of 60 eggs per gram (epg) and 200 epg, samples subjected 
to each preservation methodology were analyzed for the presence of 
detectable levels of hookworm DNA following storage for one, two, four, 
and eight weeks at 32 °C. Results have indicated variable preservation 
efficacy across methodologies as measured by the real-time PCR-based 
detection of parasite DNA. These results will help program managers 
to more appropriately structure their future survey efforts, allowing for 
the more informed balancing of performance needs and budgetary 
constraints.
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COST ASSESSMENT OF FIVE PARASITOLOGICAL TECHNIQUES 
FOR THE DIAGNOSIS OF STRONGYLOIDES STERCORALIS: 
EVALUATION IN A HIGHLY ENDEMIC REGION
Renato A. Errea1, George Vasquez-Rios2, Marco Canales2, 
Luciana H. Juarez3, Maria L. Calderon4, Claudia R. Rondon4, Katia 
P. Baca4, Celene Uriol3, Rosario J. Fabian4, Rodrigo Gallegos4, Diego 
Siu2, Kevin R. Duque5, Angelica Terashima2, Jorge D. Machicado6, 
Luis A. Marcos7, Frine Samalvides8
1Institute of Tropical Medicine, Lima, Peru, 2Institute of Tropical Medicine 
“Alexander von Humboldt” - Universidad Peruana Cayetano Heredia, Lima, 
Peru, 3Sociedad Cientifica de Estudiantes de Medicina Cayetano Heredia - 
Universidad Peruana Cayetano Heredia, Lima, Peru, 4Facultad de Medicina 
“Alberto Hurtado”- Universidad Peruana Cayetano Heredia, Lima, Peru, 
5Department of Microbiology and Center for Global Health – Universidad 
Peruana Cayetano Heredia, Lima, Peru, 6University of Pittsburgh Medical 
Center, Pittsburgh, PA, United States, 7Stony Brook University, Stony Brook, 
NY, United States, 8Hospital Cayetano Heredia, Lima, Peru
Inexpensive, easy to carry out and highly sensitive diagnostic techniques 
are needed to estimate the real global burden of Strongyloides stercoralis 
infection. This is especially important in tropical areas, where high 
prevalence rates of this parasite have been reported. We conducted a 
cost assessment for the detection of S. stercoralis by five parasitological 
techniques: direct microscopic examination (DME), Kato- Katz (K-K), 
Spontaneous Sedimentation in Tube (SSTT), Modified Baermann technique 
(MBT) and Agar plate culture (APC), by using fresh stool samples collected 
from an Amazonian rural community in Peru. The cost of a single sample 
was estimated considering the costs of laboratory materials and the time 
consumed in each technique. Out of 234 samples, 207 met the criteria 
for analysis (sufficient stool amount for examination). The prevalence of 
S. stercoralis was 0.48% (n=1) by DME, 0% (n= 0) by K-K, 3.86% (n= 
8) by SSTT, 9.66% (n=20) by MBT and 10.14% (n=21) by APC. The total 
cost per a single exam was 0.48$ for DMS, 0.59$ for K-K, 0.70$ for SSTT, 
0.79$ for MBT and 1.18$ for APC. The cost per case of S. stercoralis 
detected was 99.36$ (DME), 18.11$ (SSTT), 8.18$ (MBT) and 11.63$ 
(APC), respectively. Analysis of cost per positive case was not performed 
on K-K, as no larva of S. stercoralis was detected by this method. In 
conclusion, MBT and APC represent low-cost techniques when taking into 
account the rate of cases detected. However, in poor-resource settings 
where technicians and laboratory resources are scant, MBT and SSTT may 
represent cost effective parasitological techniques for the detection of S. 
stercoralis.
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PREDICTING INFECTION DISTRIBUTION AND BURDEN OF 
DISEASE USING SPATIOTEMPORAL MODELS FOLLOWING A 
SEVEN YEAR MASS DRUG ADMINISTRATION PROGRAM AND 
LONGITUDINAL STUDY IN BURUNDI: 2008 - 2014
Mohamad Assoum1, Ricardo S. Magalhaes1, Giuseppina Ortu2, 
Colleen Lau1, Archie Clements3, Maria-Gloria Basanez4, Kate 
Halton5
1The University of Queensland, Brisbane, Australia, 2Malaria Consortium, 
London, United Kingdom, 3Australian National University, Canberra, 
Australia, 4Imperial College London, London, United Kingdom, 
5Queensland University of Technology, Brisbane, Australia
Spatiotemporal models (STM) of soil transmitted helminth infections 
(STH-I) prevalence provide important information for developing effective 
control strategies. We aimed to quantify the impact of a 7-year mass-
drug administration programme (MDA) on the geographical distribution 
of STH-I and burden of disease (BOD). Longitudinal data on STH-I were 
collected from 2008-2014 in Burundi. Remotely sensed environmental 
variables (EV) were used. Associations between EV and STH-I were 
assessed using univariate and multivariate generalised linear regression 
models. Bayesian binomial geostatistical models were built to quantify 
the propensity, cluster size and produce predictive STM for each STH 
species. Our study found that after accounting for EV, trends in spatial-
dependency in STH-I still existed. Model validation found that STM for all 
parasites were accurate, with 95CI-ROC values between 0.3-1. Predicted 
infection rates/1000 children fluctuated in accordance with the prevalence. 
A. lumbricoides showed a maximum of 319/1000 in 2008, 239 in 2011 
and 324 in 2014; T. trichiura presented 173 in 2008, 103 in 2011 and 
225 in 2014; Hookworm presented 571 in 2008, 262 in 2011 and 219 
in 2014. Our findings indicate that using BOD predictions, STM based on 
longitudinal data may be helpful in maximising the effectiveness of MDAs 
through optimized resource management.
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PSYCHOSOCIAL ADJUSTMENT IN PERINATALLY HUMAN 
IMMUNODEFICIENCY VIRUS INFECTED OR EXPOSED 
CHILDREN
Amara E. Ezeamama1, Florence N. Kizza1, Sarah K. Zalwango2, 
Allan K. Nkwata1, Juliet N. Sekandi1, Robert KaKaire1, Noah 
Kiwanukah3, Christopher C. Whalen1
1The University of Georgia, Athens, GA, United States, 2Makerere School 
of Public Health, Kampala, Uganda, 3Makerere School of Public Health, 
Kampala, Uganda
This study was undertaken to determine whether perinatal HIV infection/
exposure adversely affected psychosocial adjustment (PA) between 6 and 
18 years of life (i.e. during school-age and adolescence). We enrolled 58 
perinatally HIV infected, 56 HIV-exposed uninfected and 54 unexposed 
controls from Kampala, Uganda. Perinatal HIV status was determined 
by 18 months old using DNA-polymerase chain-reaction test and was 
confirmed via HIV rapid diagnostic test at psychosocial testing when 
children were 6–18 years old. Five indicators of PA (depressive symptoms, 
distress, hopelessness, positive future orientation and esteem) were 
measured using validated, culturally adapted and translated instruments. 
Multivariable linear regression analyses estimated HIV-status related 
percent differences (β) in PA indicators and corresponding 95% confidence 
intervals (CI). During school-age and adolescence, positive outlook (β=-
3.8, 95% CI:-7.2,-0.1) and self-esteem (β=-4.3, 95% CI:-6.7,-1.8) scores 
were significantly lower whereas depressive (β=11.4, 95% CI:3.3,19.5) 
and distress (β=12.3, 95% CI:5.9,18.7) symptoms were elevated for 
perinatally HIV-infected compared to unexposed controls and HIV–exposed 
uninfected children. Similarly, positive outlook (β=-4.3, 95% CI: -7.3,-
1.2) and self-esteem was lower for exposed controls vs. HIV-unexposed 
children. Hopelessness was similar by perinatal HIV status. Likewise, 
the distress and depressive symptom levels were comparable for HIV-
exposed uninfected and HIV-unexposed children.  In conclusion, perinatal 
HIV infection predicted higher distress and depressive symptoms, while 
HIV-affected status (infection/exposure) predicted low self-esteem and 
diminished positive outlook in the long-term. However, HIV-affected status 
had no impact on hopelessness suggesting that psychosocial interventions 
as an integral component of HIV-care for infected children or primary care 
exposed uninfected children may improve PA and quality of life in these 
vulnerable groups.
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PERCEPTION OF HUMAN IMMUNODEFICIENCY VIRUS 
SCREENING AMONG PASSERSBY ALONG A STREET 
CONNECTING THE EAST AND WEST GATES OF THE 
ADVENTIST UNIVERSITY AT CARREFOUR, HAITI, AUGUST 
2ND 5TH, 2015
Miracle Destine Apollon
FETP, Port au Prince, Haiti
Screening for HIV can be a health indicator for the population. Boulevard 
Perin is the lane artery borrowed by students university. This alley is 
the junction between East and West exit out of the university campus. 
However, this artery is also used by local residents who consider this 
passage as a shortcut, Diquini and Bizoton. This survey was conducted 
among thoseestimate the importance ofscreening, and describe some 
associate risk factors. A descriptive survey conducted among 258 passers 
who borrowed this path on August 2nd5thin 2 hours of time. These 
passers-by were divided into three categories, those who enter into the 
eastgate, west gate, and those who were scattered elsewhere on campus. 
Questions were asked about their last date of testing andthought of 
importance of HIV screening. The data were collected on Google forms, 
processed and analysed on EPI info 7.  258 passerby, 129 (50%) were 
women. The average age of passerbyyears for a standard deviation of + 
/ - 9 years. For marital status,(68.5%) were single, and 108(41.86%) ofto 
havethan one sexual partner. For the perception of HIV testing,80.71% 
(205) think it is important to get tested, though 63(29.72%) say they 
have never been screened.(10.85%) do not to recall the date of their last 
screening.  In conclusion, this study allowed passerby to understand the 
importance of the testing. However, prevention campaigns should be 
conducted by Carrefour health officials in order to increase their screening 
frequency for HIV.
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PREVALENCE OF CERVICAL CANCER (CC) SCREENING AND 
THE ROLE OF KNOWLEDGE OF CC RISK AND SCREENING 
GUIDELINES FOR WOMEN LIVING WITH HIV IN LIMA, PERU
Jeanne R. Delgado1, Luis Menacho2, Eddy Segura3, Fernando 
Roman2, Robinson Cabello2
1The Warren Alpert Medical School of Brown University, Providence, RI, 
United States, 2Asociación Via Libre, Lima, Peru, 3University of California, 
Los Angeles, Lima, Peru
Cervical cancer (CC) incidence of women in Peru is twice the worldwide 
average. Awareness by women living with HIV (WLHIV) of their increased 
risk and Papanicoloau (Pap) smear frequency is understudied, particularly 
in Peru. We assessed the prevalence of adherence to the recommended 
CC screening guidelines among WLHIV and if knowledge of CC risk and 
screening was a factor. 80 HIV-infected women receiving care at Via 
Libre, a HIV clinic, were surveyed from 2014 - 2015 by a self-administered 
questionnaire. Knowledge of CC for WLHIV was assessed through 4 
questions regarding CC risk and Pap smear frequency for WLHIV. A correct 
response was worth 1 point leading to a possible score out of 4 per 
participant. “Adequate knowledge” was judged as ≥ 3/4 correct answers. 
The Wilcoxon rank sum test was used for bivariate analysis. Nearly all 
(91.3%; 73/80) WLHIV were enrolled in a HAART program. 21.3% (17/80) 
of WLHIV were adherent to the guidelines by obtaining a Pap smear 
within 12 months of study enrollment. 78.8% (63/80) were not adherent 
by having their most recent Pap smear outside of 12 months, including 
11.3% (9/80) who had never been screened. The median composite score 
for knowledge of CC risk and screening was 3 (IQR 2 -4) for adherent 
WLHIV and 2 (IQR 1-3) for non-adherent WLHIV. 58.8% (10/17) of 
adherent WLHIV met “adequate knowledge” criteria as did 41.3% (26/63) 
of non-adherent WLHIV. When asked how often WLHIV should get a Pap 
smear, 76.5% (13/17) of adherent WLHIV answered “Every year” correctly 
while 55.6% (35/63) for non-adherent WLHIV were able to. Overall, 
bivariate associations found between knowledge score and adherence 
were not significant. Prevalence of WLHIV who had on-time Pap smears 
was three times less than WLHIV who did not. Knowledge of CC risk and 
screening guidelines influenced adherence as more adherent WLHIV met 
the criteria for adequate knowledge. Larger studies of this population 
are needed to assess the educational, social, and structural barriers to 
screening and potential benefits of HIV and gynecological care integration 
services.
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HIV/NCD INTEGRATED CARE: A LITERATURE REVIEW
Jessica Wilkinson, Michael Smalky, Benjamin Kasdan
United States Agency for International Development, Washington, DC, 
United States
With advances in antiretroviral therapy, people living with HIV (PLHIV) are 
living longer lives and HIV itself is becoming a chronic disease. Since PLHIV 
are living longer lives, they are increasingly contracting other diseases such 
as diabetes and hypertension. Despite the prevalent view that NCDs are 
ailments faced only by the wealthy, NCDs burden low-and middle-income 
countries (LMICs) at ever increasing rates. In fact, 80% of global deaths 
from NCDs occur in LMICs due to weak health systems, limited access to 
information, medication, and services. As individuals, communities, and 
clinics move towards treating HIV as a chronic illness, opportunities arise 
to deliver both NCD and HIV services in an integrated way and to build 
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stronger health systems capable of delivering more patient-centered care. 
Several health-focused organizations have pursued the opportunity to 
enhance patient care by integrating HIV and NCD services. The goal of this 
paper is to present findings from a literature review of these programs, 
identify best practices, and provide recommendations for policymakers. 
We studied 23 programs from 11 different organizations operating across 
Sub-Saharan Africa and examined 4 aspects of each program: which NCDs 
were addressed, what services were offered, the level of health system 
involved, and whether the programs engaged in policy work. Diabetes 
and cardiovascular disease were the most commonly targeted diseases, 
followed by cancer and mental health illness. Services commonly included 
screening, diagnosis, and treatment for NCDs in conjunction with existing 
HIV care. Most integration occurred at the lowest level of care including 
at the home, community and HIV clinic. Services were occasionally offered 
at the tertiary level as well. Few of the programs we studied engaged in 
policy interventions. Some programs, however, did engage Ministries of 
Health at the national level on NCD protocols. Linking HIV/AIDS and NCD 
care regimens is a new concept and more research is needed. This review 
is intended to aid policymakers and program implementers design further 
integrated programs and stronger health systems.
1739
HIV CO-INFECTION WITH PLASMODIUM VIVAX MALARIA 
AND OTHER TROPICAL INFECTIOUS DISEASES IN THE 
PERUVIAN AMAZON
Deanna R. Zhu1, Viviana V. Pinedo-Cancino2, Katty M. Arista-
Flores2, Maria E. Vásquez-Ch2, Rafael J. Saavedra-Langer2, 
Stephanie Montero1, Lastenia Ruíz-Mesía3, Martin Casapia4, Cesar 
Ramal-Asayag5, Andres G. Lescano1
1Emerging Diseases and Climate Change Unit, Universidad Peruana 
Cayetano Heredia, Lima, Peru, 2Fundación para el Desarrollo Sostenible 
de la Amazonía Baja del Perú, Iquitos, Peru, 3Centro de Investigación de 
Recursos Naturales de la Amazonía, Iquitos, Peru, 4Asociacion Civil Selva 
Amazonica, Iquitos, Peru, 5Hospital Regional de Loreto, Iquitos, Peru
Interactions between HIV and other infectious diseases have the potential 
to alter course of disease, response to therapy, and epidemiology of 
some or all agents involved. In the tropics, geographic overlap of the 
“big three”–HIV/AIDS, tuberculosis, and malaria - result in millions of 
deaths and disability-adjusted life years annually. Loreto, a region in the 
Northern Peruvian Amazon, is responsible for 90% of the country’s malaria 
burden and has the second-highest prevalence of HIV. In an attempt to 
understand the overlap of infectious diseases, we began a cohort study of 
outpatient HIV patients from Loreto Regional Hospital assessing infectious 
disease history, including malaria. Out of 337 enrolled patients, 33% 
were female and 75% defined themselves as heterosexual. Most (59%) 
attended high school and were employed (65%). The median years since 
HIV diagnosis was 3.83 years (IQT=1–7.83 years) and 278 (86%) had 
disclosed their status. Patients reported on average 2 (IQT=0-2) respiratory 
infections and 2.9 bouts of diarrhea (IQR=0-2) in the last year. Further, 162 
(49.39%) reported having had tuberculosis, 120 (36.59%) hepatitis, and 
51 (15.55%) dengue. Five individuals had cerebral toxoplasmosis and live 
with lasting neurological sequelae. Microscopy detected one case each 
of Plasmodium vivax, P. falciparum, and filaria. ELISA for P. vivax using 
PvMSP1-19 confirmed microscopy result and detected 14 low (OD 0.25-
0.50) and 11 high positives (OD >0.50), a total of 25 positives by ELISA 
(7.65%). PCR confirmed both cases of malaria identified by microscopy 
and identified one unconfirmed case of P. malariae. Other ELISA P. vivax 
positives were PCR negative. Of the 27 malaria ELISA or PCR positives, 22 
self-reported cases of malaria, 7 of which occurred less than 6 months of 
enrollment. Patient reports suggest multiple infectious diseases affect this 
population, especially individuals that live and work in peri-urban and rural 
environments. P. vivax malaria co-infection is frequent but its consequences 
are little known. Research should try to more accurately identify the 
interactions and burden of co-infections in this neglected population.
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PRESENTATION, ETIOLOGY, AND OUTCOME OF FEBRILE 
INDIAN PATIENTS DIFFERS BY HIV STATUS
Dileep Kadam1, Matthew L. Robinson2, Ivan Marbaniang3, Anju 
Kagal1, Renu Bharadwaj1, Priyanka Raichur3, Savita Kanade3, 
Jonathan Sachs4, Nikhil Gupte3, Amita Gupta2, Vidya Mave3
1BJ Medical College, Pune, India, 2Johns Hopkins School of Medicine, 
Baltimore, MD, United States, 3Johns Hopkins University-BJ Medical 
College Clinical Research Site, Pune, India, 4Tulane University School of 
Medicine, New Orleans, LA, United States
Despite a <1% HIV prevalence, India has the third largest burden of 
HIV worldwide. Acute febrile illness is one of the most common reasons 
for hospital admission in India, but the clinical differences between HIV 
infected and uninfected patients are unknown. Patients >= 12 years of 
age admitted to general medicine wards at BJ Medical College - Sassoon 
General Hospital, in Pune, India with >1 day of fever were enrolled 
into a prospective cohort between July 2013 and December 2015. We 
compared clinical characteristics, laboratory data, treatment course, and 
mortality between HIV positive and negative patients using fisher exact 
test and a multivariable logistic regression model adjusted for modified 
Apache II score, age, and sex. Of 970 participants enrolled, 127 (13%) 
had HIV; 37 were newly diagnosed. Median CD4 count was 161 cells/
cumm; 61 (49%) were on ART. Vector-borne infections among patients 
living with HIV included dengue (n=5), malaria (n=2), chikungunya 
(n=2), and leptospirosis (n=1). Additional infectious disease diagnoses 
included bacteremia (n=6), pneumonia (n=7), meningitis (n=16), and 
microbiologically confirmed tuberculosis (n=10). Two patients with 
mosquito-borne illnesses also had microbiologically confirmed tuberculosis. 
Compared to patients without HIV, patients with HIV were more likely 
to have meningitis (13% vs 4%, p < 0.01), diarrhea (42% vs 16%, p < 
0.01), tuberculosis (8% vs 1%, p < 0.01), and alcoholism (21% vs 10%, 
p < 0.01), and were less likely to have dengue (4% vs 24%, p < 0.01) 
and malaria (2% vs 8%, p < 0.01). Patients with HIV more frequently 
received fluoroquinolones (24% vs 10%, p < 0.01) and antituberculosis 
drugs (24% vs 4%, p < 0.01). Mortality was more than two times higher 
in HIV infected patients (adjusted odds ratio 2.1, confidence interval 1.1-
3.8). People in India living with HIV who develop acute febrile illness more 
commonly have diarrhea, tuberculosis, and meningitis, and less commonly 
have mosquito-borne illnesses. Clinicians must recognize that patients 
living with HIV present differently with acute febrile illness, and are more 
likely to die.
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CONDOMLESS INSERTIVE ANAL SEX AND GENDER IDENTITY 
AMONG MEN WHO HAVE SEX WITH MEN IN TOGO
Horacio Ruisenor1, Ashley Grosso2, Sosthenes Ketende2, Anato 
Simplice3, Vincent Pitche4, Jules Tchalla5, Dometo Sodji6, Stefan 
Baral2
1Michigan State University, East Lansing, MI, United States, 2Johns Hopkins 
Bloomberg School of Public Health, Baltimore, MD, United States, 3Arc-en-
Ciel, Lome, Togo, 4Conseil National de Lutte contre le SIDA, Lome, Togo, 
5Espoir Vie, Lome, Togo, 6FAMME, Lome, Togo
Consistent condom use continues to be an effective preventive tool to 
control HIV transmission among men who have sex with men (MSM). Few 
studies have explored the association of condomless insertive anal sex 
(CIAS) and gender identity among African MSM. Our aim was to identify 
factors associated with CIAS among MSM living in Lomé and Kara, Togo. 
A total of 683 MSM ≥18 years of age were recruited using respondent 
driven sampling (RDS) for a cross-sectional survey (354/683 in Lomé and 
329/683 in Kara). Participants completed a structured questionnaire 
and were tested for HIV and syphilis. Statistical analysis included t-test, 
RDS-weighted (RDS-w) proportions, bootstrapped confidence intervals 
and logistic regression models. Overall median age was 23.9 years; 
62.8% were between 18 and 24 years (RDS-w Lomé=79.1%, RDS-w 
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Kara=55.5%, p<0.01). Most participants identified themselves as 
being males (RDS-w male=67.9% vs. 91.2%, p<0.01, female=18.1% 
vs.1.3%, p<0.01 and intersex=13.9% vs. 7.4%, p<0.01 in Lomé and 
Kara, respectively), were single/never married (RDS-w Lomé= 91.7% 
vs. Kara=95.4%, p=0.11), and reported their sexual identity as gay/
homosexual (RDS-w Lomé=61.2% vs. Kara: 62.6%, p=0.59). Consistent 
condom use in the past 12 months was reported by 30/270 MSM who 
had insertive anal sex (RDS-w Lomé=30.5% and Kara=6.2%, p<0.01), 
17/198 who had receptive anal sex (RDS-w Lomé=13.4% and Kara=not 
available (NA)), and by 100/223 who had vaginal/anal sex with a woman 
(RDS-w Lomé=58.6% and Kara=not available (NA)). HIV prevalence was 
62/683 (RDS-w Lomé=10.4%, RDS-w Kara=0.2%, p<0.01). Multiple 
logistic regression analysis showed a positive association between CIAS 
and intersex gender (adjusted OR=3.0, 95% CI=1.2-7.4). In Togo, local 
cultural and social norms could increase the number of condomless 
insertive anal sex acts among MSM who self identify as being of intersex 
gender. Strategies to address gender inequity should be included in HIV 
prevention programs aiming to address the needs of MSM.
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COMPARISON OF ASYMPTOMATIC AND CLINICAL MALARIA 
FREQUENCIES BETWEEN HIV POSITIVE AND HIV NEGATIVE 
INDIVIDUALS LIVING IN GABON
Marielle K. Bouyou-Akotet1, Jeanne V. Koumba Lengongo1, 
Denise P. Mawili Mboumba1, Magloire Ondounda2, Eric Kendjo1, 
Madeleine Okome Nkoumou1
1Université des Sciences de la Santé, Libreville, Gabon, 2Hôpital 
d’Instruction des Armées Omar Bongo Ondimba, Libreville, Gabon
This study was undertaken to compare the frequency of clinical and 
asymptomatic Plasmodium falciparum parasitaemia between HIV-positive 
and HIV negative individuals living in Gabon. Prospective screening for 
malaria parasitaemia of HIV-infected Gabonese adults on antiretroviral 
therapy (ART) and HIV negative individuals were performed at two 
health centers and during a survey on malaria knowledge performed in 
asymtomatic volunteers in 2015. Clinical malaria was defined as fever 
with a positive blood smear, and asymptomatic malaria as a positive blood 
smear in the absence of fever and history of fever the preceeding 7 days. 
Data from three hundred thirty seven asymptomatic and 76 febrile HIV-
1-positive patients were compared to those from 439 asymptomatic and 
130 symptomatic HIV negative adults. Clinical malaria frequency was 
31.6% among HIV positive and 29.3% among HIV negative patients. 
Asymptomatic malaria prevalence rate was comparable between both 
groups (9.6% in HIV positive and 8.4% in uninfected population). 
Cotrimoxazole prophylaxis was non significantly associated with a lower 
malaria prevalence : 4.3% versus 1.2% among asymptomatic HIV patients 
and 42.9% versus 27.8% in symptomatic ones. HIV1 infection is not 
associated with a higher frequency of asymptomatic or symptomatic 
malaria prevalence in patient on ART. The present results also suggest a 
protective effect of cotrimoxazole prophylaxis on malaria occurence in HIV-
positive individuals.
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LEVERING HIV DIAGNOSTIC AND CARE INFRASTRUCTURE 
IN RWANDA TO ACCELERATE THE ROLL-OUT OF NEW 
PEDIATRIC TB TREATMENT FORMULATIONS
Jamie I. Forrest1, Aranka Anema2, Alejandro Cravioto3, Warren 
Stevens3, Edward J. Mills1
1Precision Global Health, Vancouver, BC, Canada, 2Epidemico, Boston, MA, 
United States, 3Precision Global Health, Seattle, WA, United States
Since the end of the genocide in Rwanda, the country has made 
impressive gains in health system strengthening. In particular, the rapid 
scale up of antiretroviral therapy has been a great success story for 
Rwanda. Tuberculosis remains an important health concern in sub-Saharan 
Africa, and infants and children in particular, are at the highest risk for 
severe forms of the disease because of immature immune systems. New 
pediatric formulations of anti-tuberculosis drugs have renewed calls for 
aggressive roll-out of an aggressive diagnostic and treatment campaign in 
affected regions to reduce the burden of TB among infants and children. 
The success of Rwanda’s scale-up of ART can greatly inform the process 
of accelerated roll-out of new pediatric anti-TB formulations. Through a 
review of the history of HIV treatment scale-up in Rwanda, as well as a 
field assessment of current interventions and available evaluation data, 
we developed a framework to identify the successes of ART expansion 
in Rwanda and how lessons learned can be applied to the accelerated 
roll-out of new pediatric anti-TB formulations. Key themes of this 
framework identify a decentralized form of care administration and a 
centralized system of data collection that supports real-time monitoring 
and evaluation. Innovative health system financing strategies, including 
a universal community health insurance scheme, have improved access 
to primary care services for prevention and treatment of HIV and TB. 
Furthermore, cost-effective and responsive supply chains for drug delivery 
have permitted scale-up with limited stock outs. This framework of 
successes in the delivery of ART in Rwanda can be leveraged to improve 
pediatric care for TB immediately in Rwanda, and lessons learned can be 
applied to other countries with a high burden of infant and child TB across 
the sub-Saharan African region.
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SEXUALLY TRANSMISSIBLE INFECTIONS (STI’S) AMONG HIV 
CLIENTS ATTENDING AN URBAN UGANDAN HIV CLINIC
Peterson Stephen Kyebambe, Christine Namala
Naguru Regional Hospital, Kampala, Uganda
Naguru Hospital was established as a Regional Referral Hospital in 
February 2012.In July2012, an HIV clinic was started to take care of 
the many patients who live with the infection in Kampala City and its 
surrounding areas. To date the cumulative number of clients stands at 
6480 while the still active clients stand at 3750.We were concerned about 
the possible complications caused by sexually transmissible co-infections 
so we set out to find out their prevalence among our clients. Of the 6480 
records looked at,139 had a clinical or laboratory diagnosis of an STI. We 
found the commonest diagnoses to be: Herpes Simplex 2 (47=33.8%) 
candidiasis (38=27.3%),syphilis(20=19.4%), other genital ulcer diseases- 
other than Herpes 2 (20=19.4%), genital warts(7=5%), gonorrhea 
(5=3.5%) , Hepatitis B(5=3,5%), Bacterial Vaginosis (1=.7%). Genital 
chlamydial disease was not identified by any of our clinicians implying that 
it was probably missed. A prospective study to ascertain the true burden 
of STI’s among our HIV patients is required to avert complications and 
possible mortality from these treatable co-ailments.
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TRYPANOSOMA CRUZI INHIBITION OF SIRT1/PGC1 ACTIVITY 
CONTRIBUTES TO ANTIOXIDANT/OXIDANT IMBALANCE BUT 
NOT TO MITOCHONDRIAL BIOGENIC DEFECTS: BENEFITS OF 
SIRT1-TARGETED THERAPY IN CHAGAS DISEASE
Xianxiu Wan, Jian-jun Wen, Sue-Jie Koo
The University of Texas Medical Branch, Galveston, TX, United States
Increased oxidative/inflammatory stress and decreased mitochondrial 
function are the hallmarks of chronic chagasic cardiomyopathy. SIRT1/
PGC1 signaling of NRF1 and Nrf2 regulates mitochondrial biogenesis and 
antioxidant response. C57BL/6 mice were infected with Trypanosoma 
cruzi (Tc) and monitored during chronic phase (~150 days post-infection). 
SIRT1 and PGC1 protein levels were normal; however, SIRT1 activity and 
PGC1α deacetylation (active-form) were decreased significantly in chagasic 
myocardium. Tc-infected mice were treated with SIRT1 agonist SRT1720 
for 3-weeks after control of acute parasitemia (i.e. 45 days post-infection). 
SRT1720 therapy provided the maximal benefits in restoring the SIRT1/
PGC1 activity, and subsequently left ventricular (LV) function (stroke 
volume, cardiac output, ejection fraction etc.) was significantly improved 
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in chronically-infected/SRT1720-treated mice. SIRT1-targeted therapy did 
not improve the PGC1/NRF1-dependent mitochondrial biogenesis (i.e., 
mitochondrial DNA content, expression of subunits of the respiratory 
complexes and mtDNA replication machinery) and the disproportionate 
synthesis of collagens and LV mass in chagasic mice. Instead, SRT1720 
therapy restored the Nrf2 level and antioxidant capacity; and subsequently 
resulted in 2-10-fold inhibition of Tc-induced oxidative (H2O2 and 
advanced oxidation protein products), nitrosative (inducible nitric oxide 
synthase, 4-hydroxynonenal, 3-nitrotyrosine), and inflammatory (IFNγ, 
IL1β and TNFα) stress and inflammatory infiltrate in chagasic myocardium. 
These results suggested that Tc-inhibition of SIRT1/PGC1 activity inhibition 
was not the key mechanism in mitochondrial biogenic defects during 
Chagas disease. SIRT1/PGC1 activation enhanced the antioxidant capacity, 
and subsequently controlled the oxidative/nitrosative and inflammatory 
pathology and LV dysfunction in chronic chagasic cardiomyopathy. These 
findings indicate that activators of the sirtuin family of proteins will provide 
promising new therapeutic strategies for treating cardiac dysfunction in 
chronic chagasic disease.
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THE LEISHMANIA METAPHYLOME: A COMPREHENSIVE 
SURVEY OF LEISHMANIA PROTEIN PHYLOGENETIC 
RELATIONSHIPS
Hugo Oswaldo Valdivia1, Larissa L. Scholte2, Guilherme Oliveira2, 
Toni Gabaldón3, Daniella C. Bartholomeu1
1Universidade Federal de Minas Gerais, Belo Horizonte, Brazil, 2Centro 
de Pesquisas René Rachou, Belo Horizonte, Brazil, 3Centre for Genomic 
Regulation, Barcelona, Spain
Leishmaniasis is a neglected parasitic disease with diverse clinical 
manifestations and a complex epidemiology. It is known that the infecting 
Leishmania species is responsible for the distinct clinical presentations 
and treatment needs due to virulence factors that mediate host parasite 
interaction, infectivity and pathogenicity. However, our understanding of 
these species-specific adaptations and their evolutionary background is 
still limited. To improve our knowledge regarding the biology and adaptive 
mechanisms of different Leishmania species, we conducted a proteome-
wide phylogenomic analysis to gain insights into Leishmania evolution. 
The analysis of the reconstructed phylomes (totaling 45,918 phylogenies) 
allowed us to detect genes shared in pathogenic Leishmania species, such 
as calpain-like cysteine peptidases and 3’a2rel-related proteins, or genes 
that could be associated with visceral or cutaneous development. Our 
findings demonstrated that gene duplication constitutes an important 
evolutionary force in Leishmania, acting on protein families that mediate 
host-parasite interactions, such as amastins, GP63 metallopeptidases, 
cathepsin L-like proteases, and our methods permitted a deeper analysis 
of their phylogenetic relationships. Our results highlight the importance 
of proteome wide phylogenetic analyses to detect adaptation and 
evolutionary processes in different organisms and underscore the need 
to characterize the role of expanded and species-specific proteins in 
the context of Leishmania evolution by providing a framework for the 
phylogenetic relationships of Leishmania proteins.
1747
POLYMORPHISMS IN CASPASE-1 ARE ASSOCIATED WITH 
CHAGAS CARDIOMYOPATHY IN SANTA CRUZ, BOLIVIA
Katherine Fu1, Roxana Zamudio2, Jo Henderson-Frost3, Alex 
Almuedo4, Hannah Steinberg5, Stephen Clipman5, Gustavo 
Duran6, Rachel Marcus7, Thomas Crawford8, Daniel Alyeshmerni8, 
Rony Colanzi9, Jorge Flores6, Robert Gilman5, Caryn Bern10, Chagas 
Disease Working Group in Bolivia and Peru
1Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, 
United States, 2University of Leicester, Leicester, United Kingdom, 3Albert 
Einstein College of Medicine, Bronx, NY, United States, 4Hospital de 
Granollers, Barcelona, Spain, 5Johns Hopkins University, Baltimore, MD, 
United States, 6Hospital San Juan de Dios, Santa Cruz, Plurinational State 
of Bolivia,  7Washington Hospital Center, Washington, DC, United States, 
8University of Michigan, Ann Arbor, MI, United States, 9Hospital Japones, 
Santa Cruz, Plurinational State of Bolivia,  10University of California San 
Francisco, San Francisco, CA, United States
Trypanosoma cruzi infection is usually acquired in childhood in endemic 
areas. Chagas cardiomyopathy (CC) develops in 20-30% of infected 
individuals over decades. CC pathogenesis involves the host inflammatory 
response to T. cruzi, in which upstream caspase-1 activation prompts 
the cascade of inflammatory chemokines/cytokines, cardiac remodeling 
and myocardial dysfunction. To date, no reliable early biomarkers of CC 
risk have been identified. However, polymorphisms of caspase -1 have 
shown to be associated with susceptibility to myocardial infarction and 
cardiovascular death risk. We recruited infected (Tc+) patients (n=151) 
and uninfected (Tc-) patients (n=85) in a hospital in Santa Cruz, Bolivia, to 
examine the association of two caspase-1 single nucleotide polymorphisms 
(SNPs) with cardiomyopathy. Cardiac status was categorized as A: 
normal EKG without systolic dysfunction and/or segmental wall motion 
abnormalities; B: ECG with abnormalities consistent with CC but normal 
ejection fraction (EF); CD: systolic dysfunction (EF<50%). We compared 
A vs BCD (all cardiomyopathy) and A vs B (early cardiomyopathy) for 
Tc+ and Tc-. Genotypes were determined using Taqman probes via RT-
PCR in peripheral blood DNA. Genotype frequencies were analyzed 
by 3 inheritance patterns (dominant, recessive, additive) using logistic 
regression adjusted for sex and age in the SNPassoc R package. Caspase-1 
SNP rs501192 showed consistent differences in AA genotype frequencies 
in Tc+ BCD vs A (aOR 2.25 [0.83-6.08]) for the recessive model. The 
association was similar but stronger for Tc+ B vs A (aOR 2.84 [0.99-8.13]). 
No significant associations were found in comparisons within Tc- groups 
or between Tc- and Tc+ patients. Our data suggests that polymorphisms 
within caspase-1 play a role in CC development, identifying individuals 
with a higher risk of developing Chagas cardiomyopathy. Further 
investigation into genomic biomarkers may help identify Tc+ patients for 
whom intensified monitoring and early medical intervention could be 
beneficial.
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ARTEMISININ DIMERS AS PROMISING NEW DRUG LEADS 
FOR VISCERAL LEISHMANIASIS
Surendra K. Jain1, Waseem Gul2, Mahmoud A. Elsohly2, Babu L. 
Tekwani1
1National Center for Natural Products Research, Department of 
BioMolecular Sciences, School of Pharmacy, University of Mississippi, 
University, MS, United States, 2ElSohly Laboratories, Inc., Oxford, MS, 
United States
Visceral leishmaniasis is a major global health problem with more than 
12 million confirmed cases, about 2 million new cases being added every 
year and more than 350 million people at the risk of being exposed to 
the disease. The disease is fatal if left untreated. The current choices 
of therapies are highly limited and suffer from severe drug-toxicities 
or have become ineffective due to drug-resistance. Recent studies at 
our laboratories have identified a few novel artemisinin dimers with 
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outstanding antileishmanial activities against intracellular amastigotes of 
Leishmania donovani, the clinically relevant parasite stages for the visceral 
leishmaniasis. Antileishmanial activities of these dimers are several folds 
better as compared to the current battery of clinically used antileishmanial 
drugs. These dimers do not show any toxicity on differentiated THP1 
cells. Selectivity index (SI) has been calculated by comparing toxicity with 
antileishmanial activity. Dimer piperidine (IC50 0.073 µM, SI >198), dimer 
morpholine (IC50 0.007 µM, SI >2052), dimer valine (IC 50 0.060 µM, 
>230), dimer AB acid (IC50 0.013 µM, SI >999), dimer tryptamine (IC50 
0.045 µM, SI >165), dimer oxime HS (IC50 0.062 µM, SI >219), dimer 
benzylamine (IC50 0.099 µM, SI >141) and dimer GABA (IC50 0.013 µM, 
SI >1086)) have been selected as promising leads for extended evaluation. 
The in vitro antileishmanial activity of the lead analogs has been further 
confirmed by THP1 cells-L. donovani amastigotes digital image analysis 
counting of intracellular amastigotes. Artemisinin the parent drug 
from this class do not show noticeable antileishmanial activity up to 35 
µM concentration. This indicates selective leishmanicidal action of the 
artemisinin dimers. The artemisinin dimers thus offer promising leads, 
which can be further optimized and developed as oral treatments for 
visceral leishmaniasis.
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IDENTIFICATION AND CHARACTERIZATION OF “YINP”, A 
NOVEL GENE INVOLVED IN LEISHMANIA PATHOGENESIS. A 
POTENTIAL NEW TARGET FOR DRUG DISCOVERY
Miriam Algarabel Olona1, Celia Fernandez-Rubio1, Andres Vacas 
Oleas1, Esther Larrea2, Carmen Sanmartin3, Socorro Espuelas4, Paul 
Nguewa1
1Institute of Tropical Health, University of Navarra (ISTUN). Department 
of Microbiology and Parasitology, Pamplona, Spain, 2Institute of Tropical 
Health, University of Navarra (ISTUN), Pamplona, Spain, 3Institute of 
Tropical Health, University of Navarra (ISTUN), Department of Organic 
and Pharmaceutical Chemistry, Pamplona, Spain, 4Institute of Tropical 
Health, University of Navarra (ISTUN), Department of Pharmacy and 
Pharmaceutical Technology, Pamplona, Spain
Leishmaniasis is a neglected tropical disease caused by Leishmania spp. 
Current drug therapies are unsatisfactory due to their toxicity, long 
treatment courses and development of resistance. To improve existing 
treatments, the identification and characterization of novel therapeutic 
targets based on parasite genes involved in Leishmania pathogenesis 
is essential. One of these genes is “YinP”, identified in our research 
group. It may play a role in the acquisition of infectivity by Leishmania 
promastigotes. This gene is highly conserved and has demonstrated to 
be involved in several cellular processes such as embrionary progress, 
ribosomal biogenesis, cellular proliferation, and genetic transcription.  Our 
assays showed that YinP reaches its highest expression level in metacyclic 
promastigotes, the infective stage. Furthermore, we have performed 
several experiments to analyse the infectivity of parasites overexpressing 
YinP. Our data reveal a dramatic increase of the ratio of infection as well 
as a higher replication rate whithin macrophages exposed to Leishmania 
overexpressing YinP. All together, these results strongly suggest a relation 
between YinP gene expression and leishmaniasis pathogenesis.  Moreover, 
to localize YinP expression in the leishmanial cell, two plasmids were 
constructed: pXG-mCherry12-YinP and pXG-mCherry34-YinP. In these 
vectors, YinP gene was inserted directly next to the gene for fluorescent 
protein (mCherry), to generate fluorescent fusion proteins expressed in 
the parasites. Fluorescent microscopy disclosed that red fluorescence of 
mCherry fused with YinP was localized only in a part of nucleus. Therefore, 
our results showed that YinP protein is expressed in the nucleus. Further 
experiments need to be performed to analyze if such expression is 
nucleolar.  Finally, in order to validate YinP as a therapeutic target, we 
are carrying a screening of new compounds that have shown promising 
leishmanicidal activity. Our preliminary results have shown that YinP 
overexpressing parasites seem more resistant to these drugs. Therefore, 
this gene may be a new and good molecular target.
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PROTEOMIC ANALYSIS OF PLASMA-DERIVED 
EXTRACELLULAR VESICLES IN NATURAL INFECTIONS 
OF PLASMODIUM VIVAX, TRYPANOSOMA CRUZI AND 
FASCIOLA HEPATICA
Joan Segui Barber1, Alicia Galiano2, Isabel Diaz3, Emanuella 
Fajardo4, Antonio Marcilla5, Igor C. Almeida4, Antonio Osuna3, 
Hernando A. del Portillo6
1Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain, 
2Area de Parasitologia, Departament de Biologia Cellular i Parasitologia, 
Universitat de València, Valencia, Spain, 3Institute of Biotechnology, 
Biochemistry and Molecular Parasitology, University of Granada, Granada, 
Spain, 4Border Biomedical Research Center, Department of Biological 
Sciences, University of Texas, El Paso, TX, United States, 5Area de 
Parasitologia, Departament de Biologia Cellular i Parasitologia, Universitat 
de València, Joint Research Unit on Endocrinology, Nutrition and Clinical 
Dietetics, Universitat de València-Health Research Institute La Fe, Valencia, 
Spain, 6ICREA at ISGlobal Institute for Global Health, Hospital Clínic, 
Universitat de Barcelona, and Institut d’Investigació Germans Trias i Pujol 
(IGTP), Badalona, Spain
Chagas disease, fasciolosis and the malaria caused by Plasmodium vivax, 
are three neglected tropical diseases responsible for millions of infections 
worldwide, including disease and death. Our present research effort is 
focused on the molecular characterization of plasma-derived extracellular 
vesicles (EVs) from these neglected diseases to further study their role in 
intercellular communication, and the use of their selective-cargo as novel 
therapeutic agents and diagnostic markers, as reported previously.  EVs 
were obtained from infected patients (malaria and Chagas) and infected 
cows (Fasciola hepatica), as well as from healthy volunteers and animals 
as controls of specificity. Size exclusion chromatography (SEC) using 
sepharose CL-2B, commercially available as qEV columns (iZONTM), was 
used for isolation of EVs. Molecular characterization was done by a bead-
based assay with antibodies against tetraspanins CD9 and CD81, by cryo-
transmission electron microscopy (cryo-TEM), and by Nanoparticle Tracking 
Analysis (NTA). An extensive LC-MS/MS analysis was performed using 
different mass spectrometers and algorithms.  The proteomic composition 
of plasma-derived EVs from samples of these neglected tropical diseases 
contain parasite-specific proteins. Their identities and possible roles 
facilitating studies on mechanistic insights of pathology, as well as antigen 
discovery for vaccination and disease biomarker identification will be 
presented and discussed.
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IDENTIFICATION OF NOVEL INHIBITORS OF LEISHMANIA 
INITIATION FACTOR 4A AND ASSESSMENT OF THEIR 
BIOLOGICAL EFFECTS ON PARASITE GROWTH
Emna Harigua-Souiai1, Yosser Zina Abdelkrim1, Imen Bassouùi1, 
Ons Zakraoui1, Khadija Essafi-Benkhadir1, Michael Nilges2, Arnaud 
Blondel2, Ikram Guizani1
1Institut Pasteur de Tunis, Tunis, Tunisia, 2Institut Pasteur, Paris, France
Leishmaniases constitute a group of parasitic vector borne diseases. 
They correspond to major public  health problems that are neglected 
and ill controlled. The identification of novel targets and drugs for  
chemotherapy constitute a research priority. Different pieces of evidence 
point to Leishmania initiation  factor eIF4A (LeIF), member of the DEAD-
box protein family, as a potential drug target. Through a  structure-based 
drug discovery process, we previously identified a novel inhibitor (C208) 
of LeIF  ATPase activity (Harigua-Souiai et al., submitted). In the present 
work, C208 was used as a bait to  search chemically related molecules. 
The Morgan fingerprints were used as chemical descriptors to  assess the 
similarity between the molecules. Their use as criteria to identify moieties 
potentially  responsible for bioactivity was validated by our group and in 
drug  discovery in general, as reported previously. This virtual chemical  
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screen led to the identification of 28 analogous molecules. In a first step, 
fifteen of them were screened  out of which a second hit was retained 
(CS48). It demonstrated modest levels of inhibition of LeIF  activity 
compared to C208. Both C208 and CS48 were tested for their effects on 
the Leishmania  promastigote viability. Their respective IC50 values were 
of 3 and 4 µM. Currently, as the ATPase  screening is tedious, requesting 
high amounts of recombinant protein and compounds, we are testing  
the remaining 13 compounds for their effects on promastigote viability, 
then we will evaluate the active  molecules for their effect on the ATPase 
enzymatic activity of LeIF. Five molecules were tested so far  and a third 
hit (CT7) having an IC50=1 µM was retained. At the IC50 concentration, 
these compounds  had no to un-significant cytotoxic effect on human 
cells. Selectivity index (SI) was established for the  C208 (SI= 6.6) in a 
preliminary way. Compound C208 and its analogs may constitute a novel 
route for  drug design for anti-Leishmania treatments. Further work will be 
undertaken to understand the mode of  binding and interaction between 
LeIF and its most promising inhibitor.
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GENOTYPING OF PANAMANIAN TRYPANOSOMA CRUZI 
STOCKS USING A MAXICIRCLE MULTILOCUS SEQUENCE 
TYPING APPROACH
Jose E. Calzada1, Azael Saldaña1, Prasad Padmanabhan2, Corina 
de Juncá3, Franklyn Samudio1, Barbara A. Burleigh2
1Instituto Gorgas de Estudios de la Salud, Panama, Panama, 2Department 
of Immunology and Infectious Diseases, Harvard School of Public Health, 
Boston, MA, United States, 3Facultad de Medicina, Universidad de 
Panama, Panama, Panama
Chagas disease, caused by Trypanosoma cruzi is a major health problem in 
Central America leading to significant economic losses in this region due 
to reduced productivity from early-age mortality and disability. Differently 
from the rest of Central America, the main Chagas disease vector in 
Panama is Rhodnius pallescens, a sylvatic triatomine closely associated 
with “royal palm” trees. It has been suggested that the geographical 
heterogeneity in Chagas disease pathology and clinical outcome is related 
to parasite genotype. The present work provides information on T. cruzi 
discrete typing unit genotypes circulating in endemic areas of Chagas 
disease in Panama. Thirty T. cruzi stocks isolated from persons with 
different clinical profiles, as well as from vectors and different mammalian 
hosts were included in the study. Initial molecular analysis using mini-
exon, heat shock protein 60 and glucose-6-phosphate isomerase nuclear 
markers confirm that DTU TcI was the predominant genotype found. 
To further evaluate intra-DTU diversity within Tc1, we use a multilocus 
sequence typing (mtMLST) approach. Six maxicircle gene fragments were 
amplified: ND1 (NADH dehydrogenase subunit 1), COII (cytochrome c 
oxidase subunit II), MURF1 (Maxicircle unidentified reading frame 1, CYT b 
(cytochrome b), 12S rRNA and 9S rRNA, coding regions. For each isolate, 
maxicircle sequences were concatenated according to their structural 
arrangement. Phylogenetic analysis was performed by two types of applied 
phylogenetic techniques: neighbor-joining method and Bayesian inference. 
The results showed a low level of diversity within T. cruzi Tc1 isolates. The 
epidemiological significance of these findings is discussed.
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EVALUATION OF RHOB GENE SILENCING MEDIATED BY 
SHRNA ON INFECTION PHENOTYPE OF U937 CELL DERIVED 
MACROPHAGES INFECTED WITH LEISHMANIA (VIANNIA) 
BRAZILIENSIS
Clemencia Ovalle, Diana Londoño-Barbosa, Carlos Franco-
Muñoz
Centro Dermatologico Federico Lleras Acosta, Bogotá, Colombia
The limited knowledge of the Leishmania - macrophage interaction has 
interfered with the development of control strategies for leishmaniasis. 
Leishmania is able to modulate the immune response of the host cell by 
altering macrophage gene expression during infection. In a previous work, 
RhoB a gene that encodes for a small GTPase, was differentially expressed 
between non-infected and infected macrophages with L. (V.) braziliensis. 
The regulation of RhoB expression is related to sterols processing, pathway 
altered during Leishmania infection. The aim of this study was validate 
expression levels of RhoB in infected macrophages with L. (V.) braziliensis 
and determine the effect of RhoB silencing mediated by shRNAs on 
infection rate and burden load of infected macrophages. The expression 
levels of RhoB were measure by qRT-PCR from 0 to 120 h after in vitro 
infection. Lentiviral transduction was used to generate U937 derived cell 
lines bearing the constructs encoding for the expression of shRNAs against 
RhoB. RhoB gene silencing and active form of RhoB were assessed using 
western blot and pull down assay respectively. Generated cell lines with 
highest levels of RhoB silencing were infected and colored with fluorescent 
stain to determine the effect of RhoB silencing on infection rate and 
burden load. Results show that RhoB expression did not change between 
0 and 24 h after infection while it is up regulated between 48 and 96 h. 
In the other hand, RhoB silencing is associated with decreased infection 
rate and burden load suggesting that RhoB could be related with the 
establishment of infection.
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TRANSCRIPTIONAL PROFILE OF HUMAN WHOLE BLOOD 
CELLS STIMULATED WITH SOLUBLE LEISHMANIA ANTIGENS
Leonardo C. Ferreira, João F. Neto, Selma M. Jeronimo
Federal University of Rio Grande do Norte, Natal, Brazil
Visceral leishmaniasis (VL), caused by Leishmania infantum, affects 
many people around the world. It has been estimated that only 10% of 
infected individuals will develop symptomatic disease and this might be 
primarily due to host-associated factors (i.e. environmental and genetic 
factors). This study aimed to assess the global gene expression pattern 
of peripheral blood cells, when challenged with Soluble Leishmania 
Antigen (SLA) stimulus. Whole blood cells from symptomatic VL patients 
(n=7) and individuals within 4-12 months of VL recovery (n=4) were 
divided into two groups, non-stimulated and SLA-stimulated, upon four 
hours of incubation with and without SLA, respectively. Total RNA were 
extracted and hybridized against ~ 48,000 probes using a microarray 
platform (HumanHT-12 BeadChip). The recovered group had 604 
differentially expressed (DE) genes whereas symptomatic group had 128 
DE genes. Overall, symptomatic individuals were able to express nearly 
20% (118/604) of those genes expressed by the recovered individuals, 
suggesting an incomplete response under SLA stimulus. These 118 
common genes were most from Cell chemotaxis (GO:0060326) and 
Chemokine receptor binding (GO:0042379) pathways, as shown by 
enrichment analysis. The list of DE genes for the recovered group was 
enriched with genes from Response to lipopolysaccharide (GO:0032496), 
TNF and Toll-like receptor signaling pathways (KEGG:04668 and 04620). 
Of note, 10 genes were exclusively changed in symptomatic group, which 
included apoptosis genes (TNFRSF10B, CARD9) and a galactoside-binding 
protein (LGALS3). With a two-fold change increase under SLA stimulus 
(adjusted p=0.01), LGALS3 might play important role in VL pathogenesis 
by regulating the response to innate immunity signals as well as 
proinflammatory cytokine production.
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BACTERIAL CO-INFECTION IN MURINE CUTANEOUS 
LEISHMANIASIS
Tiffany Borbón1, Gwendolyn Clay1, Fayyaz Sutterwala2, Mary 
Wilson1
1University of Iowa, Iowa City, IA, United States, 2Cedars-Sinai Medical 
Center, Los Angeles, CA, United States
Leishmaniasis is a collection of human protozoan diseases caused by 
Leishmania inoculated through sand fly bites. Cutaneous leishmaniasis 
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(CL) causes localized skin lesions often followed by ulceration. In some 
human infections, response to treatment is best when initiated after 
ulceration. However, immune responses associated with ulceration 
and their effects on the course of disease are relatively unexplored. CL 
ulceration introduces bacteria into subdermal layers, and secondary 
bacterial infections are common. Thus, we hypothesized that bacterial 
effects are critical determinants of CL outcome. Staphylococcus aureus, a 
bacterium commonly isolated from disrupted human skin, is often found 
in CL lesions. We hypothesized that bacteria present during Leishmania 
inoculation, both before and after ulceration occurs, activate inflammatory 
responses that augment inflammation and contribute to host control of 
parasitic infection. We injected L. major, S. aureus, or both intradermally 
into the ears of female C57BL/6 mice. We monitored inflammation 
and parasitic burden by lesion volume, histology, and qPCR through 
4 weeks post-infection (p.i.). During the first week of infection, there 
were greater lesion sizes in co-infected ears compared to ears injected 
with S. aureus alone, whereas ears injected with L. major alone do not 
yet form lesions. At 4 weeks p.i., we observed greater lesions sizes and 
decreased parasite burden in ears co-infected with a higher dose of S. 
aureus compared to ears infected with L. major alone or co-infected with 
a lower dose of S. aureus. Overall, these data suggest that co-infection 
with S. aureus increases inflammation, contributing to control of L. major 
burden but potentially greater lesion pathology. Identifying the specific 
inflammatory responses activated by skin microbiota in leishmaniasis, such 
as inflammasomes, may lead to novel therapeutic approaches to parasitic 
infection.
1756
PHYLOGENETIC ANALYSIS OF RNA OF CRIMEAN-CONGO 
HEMORRHAGIC FEVER AND WEST NILE FEVER SELECTED IN 
KAZAKHSTAN
Yerlan Sansyzbayev1, P. N. Deryabin1, T. I. Nurmakhanov1, 
V. E. Berezin2, A. Shevtsov1, A. N. Vilkova1, B. B. Atshabar1, 
O. U. Yeskhodzhaev1, R. Sailaubekuly1, T. Z. Ayazbayev1, M. 
V. Kulyomin1, A. V. Andryuschenko1, F. G. Bidashko1, V. A. 
Tanitovskiy1, A. V. Parfenov1, L. B. Belonozhkina1, L. M. Atovulaeva1
1Kazakh Scientific Center of Quarantine and Zoonotic Diseases, Almaty, 
Kazakhstan, 2Microbiology and Virology Institute, Almaty, Kazakhstan
Studies performed on 14 samples of CCHF RNA extracted from ticks 
collected in South-Kazakhstan Oblast and 3 samples of WNF RNA 
extracted from mosquitos caught in Western-Kazakhstan Oblast. Prior to 
study,RNA samples were modified into cDNA. Sequencing was performed 
with the use of BigDye® Terminator v3.1 Cycle Sequencing Kit according 
to manufacturer’s instruction with following separation of fragments on 
automatic genetic analyzer 3730xlDNAAnalyzer. Nucleotide sequences 
obtained by means of direct and reverse primers were analyzed and 
combined in general sequence using SeqScape 2.6.0 software. Sequences 
of reference strains of corresponding virus deposited in international 
database NCBI were used as the matrix. Construction of dendrogramm 
was performed with Mega 5.0 software, equalization of nucleotide 
sequences was performed with Muscle algorithm, construction of 
phylogenetic trees was performed by means of Neighbor-Joining method.  
Performed sequencing of S-segment nucleotide sequence (on 7 samples 
of ticks), M-segment (1 sample) and L-segment (9 samples) CCHF genome 
and E-segment of WNF virus (on 3 mosquito samples).  Comparison of 
nucleotide sequences indicated that the samples being studied are most 
contiguous to strains from Afghanistan, Pakistan, Oman, Tadzhikistan, 
Uzbekistan and China, and are related to “Asia 1-2”CCHF groups.  
Comparison of nucleotide sequences of E-segment of WNF (with the 
length around 800 nucleotide pairs) indicated that WNF RNA in studied 
mosquito samples from Western-Kazakhstan Oblast are genetically close 
to the RNA of Russian isolates.
1757
ANTI-LEISHMANIA DONOVANI ANTIBODIES ENHANCE 
PROMASTIGOTES INTERNALIZATION INTO HOST 
MACROPHAGE
Abdalla H. Sharief1, Eltahir A. Khalil2
1Tropical Medicine Research Institute, National Centre for Research, 
Khartoum, Sudan, 2Institute of Endemic Diseases, University of Khartoum, 
Khartoum, Sudan
This study aimed to demonstrate the role of humoral immunity in 
Leishmania parasite internalization into host macrophages. First, 
informed consent sera were obtained from 67 parasitologically confirmed 
visceral leishmaniasis patients reporting to our field treatment centre, 
Eastern Sudan. Then following titre determination, sera that had a titre 
of >102,400 were selected for parasite coating. An in vitro parasite 
internalization system was developed to enhance the Leishmania/ 
macrophage interactions. The mean parasite number per monocytes was 
626 ± 91 for antibody-coated Leishmania donovani, compared to 412 
± 70 uncoated isolates (p= 0.01). On the other hand, the percentage 
of infected cells was significantly higher for all antibody-coated isolates 
(100%) compared to uncoated ones (40%). This evidence of high 
infectivity probably points to the fact that anti-Leishmania antibodies 
facilitated the parasite uptake by host macrophages and monocytes-
derived macrophages (MDM).  Conclusion  Leishmania spp. promastigotes 
preferentially infect host macrophages, where parasite internalization 
is facilitated by several host and parasite surface molecules. Moreover, 
the rate of parasite uptake by MDM was significantly higher compared 
to monocytes. This could be explained by the fact that the functional 
capabilities of fully differentiated macrophages differ from monocytes. 
In conclusion, host humoral immunity probably plays a pivotal role in 
Leishmania parasites internalization into host macrophages.
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THE ROLE OF IL-10 AND IFN-γ IN VIRULENCE OF 
DERMOTROPIC LEISHMANIA DONOVANI IN SRI LANKA
Udeshika L. Kariyawasam1, Yamuna D. Siriwardena1, Anuradha 
Dube2, Hira L. Nakhasi3, Nadira D. Karunaweera1
1Faculty of Medicine, University of Colombo, Colombo, Sri Lanka, 
2Central Drug Research Institute, Lucknow, India, 3Division of Emerging 
and Transfusion Transmitted Diseases, Food and Drug Administration, 
Bethesda, MD, United States
Cutaneous leishmaniasis (CL) in Sri Lanka is caused by an apparently 
dermotropic variant of Leishmania donovani. The visceralization potential 
of L. donovani in Sri Lanka and determinants of disease outcome is 
not yet fully understood. The current study was aimed at determining 
visceralization potential, cytokine response during local L. donovani 
infection and to explore the effects of route of infection on disease 
outcome. Parasites isolated from an ulcerated lesion of CL patient were 
used to inject BALB/c mice via intra-dermal (ID) and intra-venous(IV) 
infections (6 each with 2 controls similarly treated with normal saline). 
Similarly another set of mice were infected intra-dermaly with L. donovani 
wild type strain (Ld1S). Mice were euthanized after 10weeks following 
inoculation. Both spleen and liver were removed and cultured. The effect 
of infection on the animal including its weight, spleen, parasitic load and 
induction of IFN-γ and IL-10 in splenocytes and lymph nodes of BALB/c 
mice were measured. Skin lesions were observed in the ear piece of 
ID-infected BALB/c mice (n=4/6) and none of them showed any sign of 
visceral infection. However, infection of spleen was evident in 4 out of 
6 IV-infected mice. All BALB/c mice infected with Ld1S showed spleen 
infection. High parasite burden and IL-10 levels were observed in spleen 
and lymph nodes of the BALB/c mice infected with Ld-1S, IFN-γ was low 
in these cells. Moderate levels of IFN-γ was observed only in mandibular 
node and splenocytes of ID-infected (with local parasites) BALB/c mice, 
while minute levels of IL-10 was observed of these animals. Splenocytes 
and popliteal lymph node of IV-infected (with local parasites) BALB/c mice 
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showed a moderate level of IL-10 and low level of IFN-γ. Local strain of L. 
donovani has the capacity to establish infection in BALB /c mice, inducing 
visceral disease. The level of IL-10, IFN-γ and the route of infection play a 
role in determining disease outcome. This study also may imply that, the 
local strain, though predominantly dermotropic in humans may acquire the 
ability to visceralize over time. The use of this model is being pursued for 
detailed investigation of this parasite.
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CUTANEOUS LEISHMANIASIS DUE TO LEISHMANIA 
DONOVANI: ROLE OF IL-4 AND IFN-γ IN LESION HEALING
Nuwani H. Manamperi1, Steve Oghumu2, Nishantha Pathirana3, 
Deepani Munidasa4, Vijani Somaratne5, Vipula C. de Silva6, 
Arunasalam Pathmeswaran1, Wimaladharma Abeyewickreme1, 
Abhay R. Satoskar2, Nadira D. Karunaweera6
1University of Kelaniya, Ragama, Sri Lanka, 2Ohio State University, 
Columbus, OH, United States, 3Sri Lanka Army Medical Services, Colombo, 
Sri Lanka, 4District General Hospital, Polonnaruwa, Sri Lanka, 5District 
General Hospital, Hambantota, Sri Lanka, 6University of Colombo, 
Colombo, Sri Lanka
Sri Lanka is a newly identified focus of cutaneous leishmaniasis (CL) 
caused by the usually visceralizing Leishmania donovani. In situ cytokine 
expression plays a key role in the pathogenesis and lesion healing. This 
study describes the association between expression of Interleukin (IL)-4 
and Interferon-gamma (IFNg) and time taken for lesions to heal. Skin 
biopsies from 58 patients with parasitologically or histopathologically 
confirmed CL and 25 healthy controls were collected in RNAlater and 
quantified for local tissue expression of IL-12A, IL-4, IL-10, IFNγ and 
TNF-α by real-time RT- PCR using SYBR green. Relative copy numbers 
were calculated by 2-ΔΔCt method using β-actin as the reference gene and 
healthy controls as calibrators. Patients were treated with intra-lesional 
sodium stibogluconate. Correlation between cytokines and time taken 
to heal estimated with Spearman’s rank correlation test. Study group 
consisted of 37 males (63.8%) and 21 females (36.2%) with a mean age 
of 35 years (SD=12.05, range 18-66) and a mean lesion duration of 6.75 
months (SD=9.1, range: 1-48). Type of lesion varied from papules and 
nodules to non-healing ulcers. A total of 44 (75.8%) patients, consisting 
of 28 (63.6%) males and 16 (36.4%) females were followed up for time 
taken to heal. The mean treatment duration was 3.0 months (SD=1.75, 
range 1.5-8) and correlation coefficient between relative gene expression 
and time taken to heal for IL-12A, IL-4, IL-10, IFNg and TNF-α were 
0.073, 0.321, -0.002, 0.257 and 0.155, respectively. A significant positive 
correlation was found between IL-4 and time taken to heal (p= 0.034). A 
tendency to have increased expression of IFNg was also observed though 
statistically not significant. Increased expression of both IL-4 and IFNγ are 
predictors of poor lesion healing in CL due to L. donovani.
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OXYGEN METABOLISM REGULATES MACROPHAGE 
SUSCEPTIBILITY TO TRYPANOSOMA CRUZI
Sue-Jie Koo, Bartosz Szczesny, Imran Chowdhury, Nisha J. Garg
University of Texas Medical Branch, Galveston, TX, United States
Macrophages (MΦ) are one of the early responders to control the 
causative agent of Chagas cardiomyopathy, Trypansoma cruzi. Infection 
and incomplete clearance of T. cruzi by MΦ result in parasite dissemination 
to peripheral tissues, and is a significant cause of chronic disease 
progression. Aerobic metabolism is often dependent on mitochondrial 
oxidative phosphorylation, and is associated with the activity of 
immunomodulatory macrophages (M2). Conversely, mitochondria-
independent, glycolytic metabolism provides substrates to produce anti-
microbial mediators by pro-inflammatory macrophages (M1). Reactive 
oxygen species (ROS) and nitric oxide (NO) are key M1 molecules for 
host defense against intracellular pathogens, which are associated with 
MΦ utilizing oxygen-independent metabolism. The susceptibility of 
macrophages to T. cruzi infection and incomplete clearance has been 
previously suggested to be due to lack of substantial pro-inflammatory 
activation of MΦ, however, the required mechanisms for a potent 
macrophage response for T. cruzi clearance remain unknown. In this study, 
we report a potent induction of the TNF-α pro-inflammatory cytokine, 
and deficient production of ROS and NO by macrophages infected with 
T. cruzi. Mitochondrial gene expression and cell respiration analysis 
suggested that T. cruzi infection elicit a metabolic response in MΦ which 
is similar to M2. These findings suggest that modulation of oxygen 
metabolism may improve the macrophage function for pathogen clearance 
to limit disease progression.
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MACROPHAGE CELLULAR IMMUNE RESPONSES IN 
CUTANEOUS LEISHMANIASIS AGAINST LEISHMANIA 
DONOVANI
Hiruni D. Wijesooriya1, Nilakshi Samaranayake1, Vijani 
Somaratne2, Nadira Karunaweera1
1Faculty of Medicine, Colombo, Sri Lanka, 2District General Hospital, 
Hambantota, Sri Lanka
Leishmaniasis has a spectrum of manifestations including cutaneous, 
mucosal and visceral disease, caused by parasitic protozoa of the genus 
Leishmania. The clinical outcome of Leishmania is determined primarily by 
the infecting species and the immune response of the host. In Sri Lanka 
localised cutaneous leishmaniasis (LCL) is caused by Leishmania donovani; 
a visceralizing species. We hypothesized that the distinct alterations 
in the early immune response determines the outcome of infection 
observed in Sri Lanka. Aim of this study was to characterize the immune 
response in LCL by macrophages; which is central to both replication and 
elimination of the parasite. Peripheral blood mono nuclear cell (PBMC) 
derived macrophages from LCL patients (n=8) and healthy non endemic 
controls (n=8) were stimulated in vitro with L. donovani antigen (50µg/
ml). The production of IL-10, TNFα, TGF β and Nitric Oxide (NO) were 
measured by ELISA and Griess test at predetermined time intervals. The 
two groups were compared using Student’s T-test for parametric and 
Mann-Whitney test for non- parametric data. IL-10 production by patient 
macrophages was significantly higher (105.68±26.05vs 19.81±28.24pg/
mL;p<0.01) at 72 hours but did not vary markedly at 24 & 48 hours. 
Production of TNFα by patients macrophages was significantly higher at 
24 (15.63±16.44vs5.43±1.41;p<0.01),48(438.42±140.63vs30.06±24
.82;p<0.01)&72 hours (412.31±222.11vs14.41±11.68;p<0.01). TGF β 
production was higher at 24(1539.80±490.40vs1080.19±366.87)&48ho
urs(1962.29±754.94vs1456.77±811.99)than the controls, but the values 
didn’t vary significantly. Production of NO showed increased levels by LCL 
macrophages at 72 hours (5.40±1.15vs2.36±1.21; p<0.01). These data 
suggest IL-10; TNFα & NO play a role in determining disease outcome in 
LCL due to L. donovani. In contrast to TNFα, the contribution of IL-10, 
TGF - β and NO appear to be later in the infection. The findings should be 
interpreted in the context of changes in other imflammatory mediators, 
to better understand the underlying pathogenic mechanisms where a 
visceralizing Leishmania species is localized to the skin.
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IDENTIFICATION OF MICRORNA-21 AS A BIOMARKER IN LIVE 
ATTENUATED LEISHMANIA VACCINE INDUCED PROTECTIVE 
IMMUNITY
Parna Bhattacharya, Nevien Ismail, Amit Kaul, Sreenivas 
Gannavaram, Hira L. Nakhasi
Food and Drug Administration, Silver Spring, MD, United States
No vaccine exists against visceral leishmaniasis. In an attempt to develop 
effective vaccines, we have reported extensively on the immunogenicity 
of live attenuated LdCentrin1-/- mutant in animal models. However, for 
the use of LdCen1-/- in humans there is a need to develop biomarkers 
associated with protection and safety. As a first step, we infected ex 
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vivo normal human macrophages with LdCen1-/- and compared with 
LdWT infection. We identified several microRNAs that regulate important 
cytokine genes, significantly induced upon LdWT infection compared 
to LdCen1-/- infection. Importantly, we found a strong induction of 
microRNA-21 (miR-21), which was shown to degrade mRNA encoding 
IL12, in LdWT infection compared to LdCen1-/- infection. IL12 produced 
by DCs is critical for priming a host protective Th1 cell response during 
Leishmania infection. To validate the role of miR-21 in regulating IL12 
during Leishmania infection, we altered the miR-21 expression in murine 
DCs infected with LdWT or LdCen1-/-. Silencing of miR-21 using specific 
inhibitors resulted in an augmented induction of IL12 in LdWT infected 
BMDCs, illustrating the role of miR-21 in LdWT mediated suppression of 
IL12. In contrast, LdCen1-/- infected BMDCs, showed a strong induction 
of IL12, and miR-21 silencing resulted in a further increase in IL12 levels. 
Our data from in vitro human macrophages and mouse dendritic cell 
experiments suggests that miR-21 plays a role in early IL-12 mediated 
immunity and could be an important biomarker for LdCen1-/- vaccine 
immunity in human clinical trials.
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CTLA-4 AND ICOS COSTIMULATORS: POSSIBLE ROLE DURING 
ACTIVE VISCERAL LEISHMANIASIS
João Firmino Rodrigues-Neto1, Selma Maria Bezerra Jerônimo2
1Multicampi School of Medical Sciences of the Rio Grande do Norte, 
Caico; Institute of Tropical Medicine, UFRN, Natal, Brazil, 2Department of 
Biochemistry; Institute of Tropical Medicine, UFRN, Natal, Brazil
Visceral leishmaniasis (VL) is an endemic disease found in many countries 
around the world. In Latin America, L. is the main etiologic agent for VL. 
During symptomatic VL a temporary anergy, Leishmania antigen-specific, 
is observed, which is reversed after clinical cure. Coestimulation can 
be involved in anergy, when T lymphocytes tend to increase expression 
of molecules such as ICOS and CTLA-4. We evaluated those two 
costimulators in T lymphocytes within whole blood samples collected 
from subjects with symptomatic VL (sVL) and after their clinical recovery 
(rVL), in addition, cytokines were also measured. We found that during 
sVL there was an increase in CD4 and CD8 cells expressing CTLA-4, in ex 
vivo condition (exvc), when compared to rVL group (p< 0.05). Moreover, 
CD8 T cells from sVL expressed more CTLA-4 (p< 0.01) after stimulation 
by soluble Leishmania antigen (SLA), but not in rVL or control groups. A 
9.3 fold increase in the relative expression of CTLA-4 was observed in sVL 
when compared to rVL; however, there was no difference when cells from 
the goups were stimulated with SLA (fold change of 0.702 and 0.992, 
respectively). An increase in CD4 and CD8 cells expressing ICOS, in exvc, 
when compared to rVL (p< 0.01 to CD4, and p< 0.05 to CD8) and control 
group (p< 0.01 to CD4 and CD8) was observed. After SLA stimulation, 
both CD4 and CD8 cells from sVL showed an increase in ICOS, when 
compared to unstimulated samples (p< 0.01 to CD4 and CD8). The relative 
expression of ICOS in sVL was 3.78 fold higher when compared with 
rVL; whereas, opposite results were found after SLA stimulation (2.8 fold 
change, and 0.5 fold change, respectively). The ratio of INFγ to IL10 was 
higher after clinical recovery. These findings support the role of CTLA-4 
and ICOS in the reversible anergy observed during sVL and might indicate 
pathways to be explored for immunotherapy against visceral leishmaniasis.
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BIOMARKERS OF PROTECTIVE IMMUNITY INDUCED BY 
LIVE ATTENUATED LEISHMANIA DONOVANI PARASITES IN 
PRESENCE OF ASYMPTOMATIC INFECTION
Nevien Ismail, Amit Kaul, Parna Bhattacharya, Sreenivas 
Gannavaram, Hira Nakhasi
U.S. Food and Drug Administration, Silver Spring, MD, United States
Currently there is no vaccine against visceral leishmaniasis (VL). Towards 
developing an effective vaccine, we have reported extensively on the 
immunogenicity of live attenuated LdCentrin1-/- mutants in animal models. 
In VL endemic areas, asymptomatic carriers outnumber symptomatic cases 
of VL (9:1) and are considered to be a reservoir of infection. Vaccination of 
asymptomatic cases represents a viable strategy to eliminate VL. Studies in 
our lab using LdCen1-/- parasites that secrete model epitopes have shown 
that experimental infection of mice with LdCen1-/- results in robust CD4+ 
memory T cell induction. Protection mediated by such immune memory 
against virulent challenge was observed in hosts that have not previously 
been exposed to infection. Immunological correlates of protection thus 
derived might have limited applicability in conditions where the immunized 
host has prior exposure to virulent infection. To examine whether 
LdCen1-/- parasites can induce protective immunity in experimental hosts 
that have low-level parasitemia from a previous exposure mimicking an 
asymptomatic condition, we infected mice with wild type Leishmania 
donovani parasites expressing LLO epitope 3 weeks prior to immunization 
with LdCen-/- parasites expressing 2W epitope to characterize the 
immune responses in the same host. Flow cytometric analysis of the 
antigen experienced T cells enriched using specific tetramers showed that 
comparable memory T cell responses (CD4+ T central memory) represented 
by CD62Lhi, CCR7+, and IL-7R+ T cell populations can be induced with 
LdCen1-/- in asymptomatic hosts to that of LdCen1-/- immunization 
alone. These results demonstrate that LdCen1-/- immunization could be 
efficacious for use in asymptomatic VL individuals.
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B-CELL ACTIVATING FACTOR (BAFF) IS INVOLVED IN 
DEVELOPMENT OF SPLENOMEGALY DURING EXPERIMENTAL 
VISCERAL LEISHMANIASIS
Satoko Omachi, Wataru Fujii, Chizu Sanjoba, Yoshitsugu 
Matsumoto, Yasuyuki Goto
The University of Tokyo, Tokyo, Japan
Splenomegaly is one of the major symptoms during visceral leishmaniasis 
(VL). However, the mechanisms underlying splenomegaly remain unclear. 
We previously reported that serum levels of B-cell activating factor (BAFF) 
in VL patients were significantly higher than those in healthy controls, as 
reported previously. Since mice overexpressing BAFF are known to show 
splenomegaly along with increased number of B cells, we examined if 
BAFF is also involved in splenomegaly during VL by using an experimental 
model. BALB/cA mice inoculated i.v. with 1×107 promastigotes of 
Leishmania donovani developed splenomegaly, with higher spleen 
weight at 12 and 24 weeks post infection compared with naive mice. 
Those infected mice with enlarged spleen had significantly higher levels 
of serum BAFF compared with naive mice. Flow cytometric analyses of 
splenocytes revealed increased CD19+ (B cell marker) lymphocytes as 
a major contributor to splenomegaly in the infected mice. When BAFF 
gene knockout mice were infected with L. donovani, the spleen weights 
at 12 and 24 weeks of infection were significantly lower than those of 
infected wild-type mice. Increase of CD19+ lymphocytes in the spleen after 
infection was significantly suppressed in BAFF-knockout mice compared 
with the wild-type mice. Taken together, these results suggest that BAFF-
mediated increase of B cells is the major cause of splenomegaly during 
experimental VL.
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DETECTION OF A FLAGELLAR ANTIGEN OF TRYPANOSOMA 
CRUZI IN URINE OF PATIENTS WITH HIV/CHAGAS CO-
INFECTION USING NANOPARTICLES
Elizabeth Sofia Astupina Figueroa1, Holger Mayta1, Remo 
Gonza1, Alessandra Romero1, Yagahira Castro2, Robert Gilman2, 
Alessandra Luchini3, Lance Liotta3, Working Group on Chagas 
Disease Bolivia and Peru
1Cayetano Heredia University, Lima, Peru, 2Department of International 
Health, Johns Hopkins University, Baltimore, MD, United States, 3Center 
for Applied Proteomics and Molecular Medicine, George Mason University, 
Manassas, VA, United States
Chagas disease, caused by the protozoan parasite Trypanosoma cruzi, is 
one of the major health problems affecting Latin American population. 
In patients co-infected with HIV,the reactivation of Chagas disease is 
almost always lethal and diagnostic tests are not effective in predicting 
reactivation ahead of time, when a pharmacological treatment would be 
life-saving. Currently immunological diagnosis based on the detection 
of anti-T.cruzi antibodies have poor specificity and sensitivity because it 
is affected by the genetic makeup of both the parasite and the human 
population studied.Antigen detection tests may provide a solution to 
these issues because they directly detect the presence of the parasite 
in a body fluid. Technical and biological issues that hampered antigen 
test development in the past include:low abundance,masking by high 
abundance resident proteins and extreme labiality. In order to address 
these issues we developed a affinity hydrogel nanoparticles that performs 
in one step a)concentration of the target analyte,b)size sieving and c)
complete protection from degradation.This work aims to develop a novel 
test for the detection of T.cruzi antigens in urine. For this purpose we have 
developed new antibodies against flagellar protein of T. cruzi,from rabbits 
and chickens. The purified antibodies were evaluated by Western blot 
and were used in a magnetic ELISA assay to achieve a sensitivity of 0.5ng/
mL. Affinity hydrogel nanoparticles will be used to increase the analytical 
sensitivity 100 fold and test diagnostic specificity and sensitivity in patients 
co-infected with HIV and Chagas disease.In parallel,an affinity hydrogel 
particles enhanced quantitative protein macro array test will be developed 
in order to verify the concentration of the T. cruzi flagellar antigen in the 
urine of patients. Our previous results using this system for spiked urine 
with flagellar protein of T. cruzi showed a sensitivity of 0.1ng. One goal of 
this work is to develop a self-working,low cost,visual urine test for Chagas 
disease that achieves a clinical sample sensitivity ten to 100 fold higher 
compared to existing technology.
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IMPROVING ACCESS TO ESSENTIAL OXYGEN THERAPY AND 
PULSE OXIMETRY FOR CHILDREN
Gwen Ambler1, Jaclyn Delarosa1, Grace Wu2, Michael Ruffo1, Lisa 
Smith1, Bonnie Keith1, Darin Zehrung1
1PATH, Seattle, WA, United States, 2Boston University, Boston, MA, United 
States
An estimated 15% of children under five who are hospitalized for 
pneumonia—the leading infectious cause of child mortality worldwide—
have hypoxemia, and yearly around 1.5 million children with severe 
pneumonia require oxygen treatment. Hypoxemia is a risk factor 
for death in pneumonia—increasing mortality by five times in some 
settings—and is a complication of other common childhood diseases. 
Accurate identification of hypoxemia and provision of oxygen are 
essential components of a strategy to reduce child mortality, supported 
by new World Health Organization (WHO) guidelines on oxygen therapy 
in children and technical specifications for oxygen concentrators. 
Improvements in oxygen supply have been shown to reduce up to 35% 
of child pneumonia deaths. Despite its necessity for child survival, oxygen 
therapy is not prioritized nor included on the WHO or most national-
level essential medicines lists for children, and oxygen supplies and pulse 
oximetry are often not available in many pediatric wards. We conducted 
stakeholder consultations with over 50 key informants to assess priorities 
and challenges associated with ensuring availability of oxygen and 
pulse oximetry in settings with a high burden of childhood pneumonia. 
Informants represented global and national policy, procurement, 
manufacturing, regulatory, and programmatic decision-makers. Key 
findings from the consultations and literature suggest policy leadership 
and financial investments are needed by governments, donors, and 
global manufacturers to increase availability of oxygen and pulse oximetry 
in low-resource settings. Identifying current coverage and barriers to 
access for oxygen are key to developing a full understanding of how 
to ensure inclusion of oxygen and pulse oximetry in current normative 
policies, treatment guidelines, health budgeting, system infrastructure, 
and programmatic priorities. Utilizing this evidence to advocate for 
prioritization of oxygen for child health and increasing availability of 
appropriate oxygen concentrators and pulse oximetry could help improve 
access to essential therapy and reduce pneumonia mortality in children.
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DRUG RESISTANCE AND MOLECULAR CHARACTERIZATION 
OF MYCOBACTERIUM TUBERCULOSIS ISOLATED FROM 
PULMONARY TUBERCULOSIS SUDANESE PATIENTS
Mohamed S. Karamalla
National University - Sudan, Khartoum, Sudan
Currently, Sudan is suffering from many factors like tribal restlessness and 
poverty causing its population to be in a continuous movement in and 
outside the country in seek for a better life. These movements mostly lead 
to the transmission of diseases among which is pulmonary tuberculosis.  
WHO estimated that one third of the world‘s population are infected with 
Mycobacterium tuberculosis and approximately 9.7 million new cases 
of tuberculosis were diagnosed globally in 2013.  Sudan is considered 
as one of the countries having a high prevalence of tuberculosis.  The 
current study aimed at determining the susceptibility of M. tuberculosis 
isolates to the first line anti-tuberclosis drugs. Isolated organisms were 
also genetically identified to be allocated and compared with species 
identified elsewhere in the global.  Two hundred forty three sputum 
samples were collected in the period from May 2007-October 2013 from 
central, eastern and western Sudan. These were namely; Khartoum state, 
Portsudan and Elobeid respectively.  Sputa were examined microscopically 
after being fixed and stained with ZN stain. Sensitivity to Rifampicin; INH, 
Ethambutol and Streptomycin was tested using proportion method after 
establishing microbial culture. Moreover, Spoligotyping and MIRU-VNTR 
were used to discriminate between different strains of M. tuberculosis 
and results were compared to the international database.  From this work 
it was obvious that tuberculosis is prevalent in different parts of Sudan 
and all age groups can are affected. 58% of the cultured samples were 
positive for M. tuberculosis in L.J. medium. The overall resistance to anti-
tuberculosis drugs was 20% and Multi drug resistant strains (MDR) were 
8.7%  All strains were grouped into 28 different spoligotypes. A total of 
70 strains have unique patterns and were considered as orphan strains.  
We recommend that further studies are to be done to identify other 
mycobacteria species causing TB and to investigate its association with 
drug resistance.
554
astmh.org
1769
THE USEFULNESS OF OXIMETRY IN TRIAGING FEBRILE 
CHILDREN AT OUTPATIENT LEVEL: EXPERIENCE FROM A 
CLINICAL TRIAL IN DAR ES SALAAM, TANZANIA
Kristina Keitel1, Frank Kagoro2, John Masimba2, Josephine 
Samaka2, Zamzam Said2, Hosiana Temba2, Willy Sangu2, Blaise 
Genton3, Valérie D’Acremont4
1Swiss Tropical and Public Health Institute/Boston Children’s Hospital, 
Basel, Switzerland, 2Ifakara Health Institute, Dar es Salaam, United 
Republic of Tanzania, 3Swiss Tropical and Public Health Institute/University 
Hospital Lausanne, Basel, Switzerland, 4Swiss Tropical and Public Health 
Institute/Policlinique Universitaire Médicale Lausanne, Basel, Switzerland
The objective was to determine the usefulness of oximetry in the 
outpatient setting in detecting febrile children with severe respiratory 
distress requiring referral to a higher level of care. A sub-cohort of 
febrile children aged 2-59 months from a larger non-inferiority trial that 
investigates a novel electronic algorithm for management of fever in Dar 
es Salaam, Tanzania, was included. Oxygen measurement was performed 
in using a hand-held device in all children connected to the smartphone 
with the built-in algorithm. Children with cough and oxygen saturation of 
<90% received pre-referral antibiotic and salbutamol treatment and were 
referred to the nearest hospital. All children were followed until clinical 
cure or death. 1590 children were enrolled into this sub-cohort from 
December 2014 to February 2016 out of which 922 (58.0%) of patients 
had cough, 26 (2.6%) chest indrawing, and 20 (2.0%) a respiratory rate 
>97th %ile for age and temperature, respectively. 4 patients presented 
with hypoxemia (0.4%) of which all had other signs of respiratory 
distress, i.e. chest indrawing and respiratory rate >97th %ile for age 
and temperature. Two patients were eventually diagnosed with cyanotic 
congenital heart disease of which one patient died at the referral hospital, 
likely from incorrect administration of oxygen. The other two patients 
had lower respiratory tract infections and fully recovered. In conclusion, 
in the Tanzanian outpatient setting, hypoxemia is very uncommon and 
clinical signs and symptoms, including chest indrawing, may have superior 
performance in detecting children with severe respiratory distress requiring 
higher level of care. In resource-poor settings, oximetry and oxygen should 
be implemented in hospitals but might not be useful at peripheral level.
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EARLY TREATMENT OUTCOMES FOR THE FIRST COHORT 
OF PATIENTS INITIATED ON PULMONARY MULTI-DRUG 
RESISTANT TUBERCULOSIS TREATMENT AT PUBLIC 
REGIONAL REFERRAL HOSPITALS IN UGANDA
Martin Mbonye1, Augustin Muhwezi1, John-Paul Otuba1, 
Christopher Wandera1, Hilary Alima1, Gladys Tugume1, Beth 
Turesson2, Tisna Veldhuijzen Van Zanten2
1University Research Co., LLC, Kampala, Uganda, 2University Research Co., 
LLC, Washington, DC, United States
Multi-drug resistant tuberculosis (MDR-TB) is an emerging public health 
concern in Uganda, with over 1,000 new cases notified in 2014. Before 
2013, MDR-TB treatment was provided by Mulago National Referral 
Hospital (NRH) while Regional Referral Hospitals (RRH) only had the 
capacity to do surveillance for diagnosis and would refer patients to the 
NRH for treatment. However, patients diagnosed at RRH had challenges 
accessing the NRH. Since 2013, the USAID’s SUSTAIN project has 
supported scale-up of provision of drug resistant (DR)-TB treatment at 
six Ugandan RRH using a combination of ambulatory and hospitalization 
models of care. We analyzed data on the first cohort of patients started 
on MDR-TB treatment at SUSTAIN-supported RRHs. This study was a 
retrospective descriptive analysis of data collected on 69 patients started 
on MDR-TB treatment at six RRHs between 1st April 2013 and 30th 
June 2014. Nineteen (30.4%) patients were female, 39 (56.5%) HIV-
negative, 30 (43.5%) resistant to both isoniazid and rifampicin and 57 
(82.6%) category 1 or 2 failures. At the start of MDR-TB treatment, their 
median age was 35 years (SD ±13.5), mean time-to-treatment initiation 
96 days and out of the 30 HIV-positive patients, 27 (90%) were on anti-
retroviral treatment with a mean CD4 count of 258. Within six months 
of treatment, fifty-nine (87%) patients achieved favourable treatment 
outcomes (45:65.2% culture converted at two months and 14:20.3% 
by the sixth month) while 10 did not (1: 1.5% did not culture convert 
while three: 4.4% each died, were transferred out, or were lost-to-follow 
up). During treatment, 32 (46%) patients experienced at least one severe 
drug adverse event and all were managed clinically. The median weight 
gain was 3.0 kilograms (SD ± 4.52). Despite delays in MDR-TB treatment 
initiation after diagnosis, a reasonably high proportion of patients achieved 
early culture conversion. Reasons for the high proportion of HIV-negative 
patients started on MDR-TB treatment should be investigated. These 
encouraging interim outcomes indicate a successful scale up of DR-TB 
treatment from NRH to RRH.
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EVALUATION OF VITAMIN D LEVELS AND PREVALENT TB 
AMONG HIV INFECTED IN ZAMBIA
German Henostroza1, Amanda L. Willig1, Muyunda 
Siyambango2, Jorge M. Rodriguez1, Stewart Reid1, Douglas C. 
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3Vanderbilt University, Vanderbilt, TN, United States
Vitamin D insufficiency is highly prevalent in the general population 
of the United States and appears to play an important role in immune 
regulation and tuberculosis (TB) progression. Little is known about 
Vitamin D in African HIV-infected populations. We thus evaluated the 
association of serum vitamin D levels with prevalent TB, incident TB, HIV 
progression, and biomarkers of nutritional status among new enrollees 
at an HIV clinic in Lusaka, Zambia at baseline and up to 12 months after 
enrollment.  All consenting adults without current or recent history of TB 
were screened for TB regardless of symptoms according to current World 
Health Organization (WHO) recommended guidelines. Two sputa, one 
blood and one urine specimen were cultured. For participants consented 
to participate in a TB specimen repository for serum and urine specimens 
were stored at -80 oC. Baseline serum samples were analyzed for levels 
of Vitamin D, pre albumin, albumin, lipid profile, CD4+ count, viral load 
(VL), creatinine and hemoglobin. Vitamin D insufficiency was defined 
as <30 ng/ml, and deficiency <20 ng/ml.  A total of 285 samples were 
tested. Forty-three (16%) patients were diagnosed with bacteriologically 
confirmed TB at enrollment. Mean age was 35 years; 47% were female; 
and mean body mass index was 22. Median CD4+ was 205 cells/
mL and mean VL 4.6 Log10. Vitamin D insufficiency was detected in 
43%(127/294) and deficiency in 28% (82/294). Patients with CD4<100 
had higher pre-albumin, albumin and HDL-cholesterol (p<0.01), lower 
triglycerides (p<0.01), and were older (p,0.01)compared to other groups. 
No significant associations were found between baseline vitamin D levels 
and prevalent TB at enrollment or incident TB at 6 month. However, 
a trend was observed for baseline prealbumin levels to be lower in 
the prevalent (median 8.0 mg/dl) and incident (10.5 mg/dl) TB groups 
compared to participants without TB (16.0 mg/dl).  High prevalence of 
Vitamin D insufficiency levels were observed in this population. Although 
not associated with prevalent or incident TB, further analysis is required to 
understand the immunological effect on HIV and or recurrent TB.
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IGG ANTIBODY SECRETION IN LYMPHOCYTE SUPERNATANT 
AMONG PAKISTANI CHILDREN WITH CONFIRMED 
TUBERCULOSIS
Najeeha Talat1, Farah Qamar1, Kumail Ahmed1, Shazia Sultana1, 
Farzeen Hirani1, Aisha Mehnaz2, Fehmina Arif2, Tania Thomas3
1Aga Khan University, Karachi, Pakistan, 2Civil Hospital Karachi, Karachi, 
Pakistan, 3University of Virginia, Charlottesville, VA, United States
Antibody Secreting Cells (ASCs) are terminally differentiated B-cells 
that release pathogen-specific antibodies in response to infection. ASC 
activity has been harnessed as a diagnostic test for infections including 
tuberculosis (TB): by isolating and culturing peripheral blood mononuclear 
cells (PBMCs) for 24-72 hours, the secreted anti-mycobacterial IgGs can 
be estimated via ELISA methodology using Bacille Calmette Guerin (BCG) 
vaccine as the coating antigen. Here, we aim to compare the yield of 
the MASC assay using different incubation time points among children 
confirmed to have pulmonary TB. Among a cohort of children 1-14 
years old being evaluated for pulmonary TB, we included children with 
respiratory specimens that were positive for Mycobacterium tuberculosis 
(MTB) by GeneXpert. Venous blood (3-12mLs) was obtained for the 
MASC test. Briefly, mononuclear cells were cultured with 10% FBS at 
the concentration of 5-10x106 cells/ml in 24-well tissue culture plate 
at 37°C for 24, 48 or 72 hours. Culture supernatants were collected at 
each time point and stored at -80°C. ELISA plates were coated with 1µg /
well of BCG vaccine (Japan BCG laboratory). Culture supernatants were 
added in ELISA plates after blocking nonspecific sites and incubated for 
2 hours at 37°C. After washing, HRP labeled secondary antibody was 
added for the detection of IgG. The results were expressed as relative 
optical densities (O.D.) of IgG. A cut-off of 0.35 was used for a positive 
test [1]. Eight children with a median age of 12.5 years (IQR: 3.825) 
had GeneXpert positive respiratory samples. MASC results from six 
children were consistently above the threshold for a positive test at all 
incubation periods. The median ODs did not significantly differ across the 
selected incubation periods (p=0.727, Mann-Whitney U test; see Figure). 
Mycobacterium-specific IgG can be detected in lymphocyte supernatant 
from children with microbiologically confirmed TB. The assay demonstrates 
consistent results across the selected incubation periods, suggesting that 
this assay could be optimized to provide relatively rapid results, within 2-3 
days after collection of blood.
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CHARACTERIZATION OF AN ALGORITHM FOR LOCAL 
SEASONAL INFECTIOUS DISEASE OUTBREAK DETECTION 
USING A SIMULATION STUDY
Alexandria C. Brown, Stephen A. Lauer, Nicholas G. Reich
University of Massachusetts Amherst, Amherst, MA, United States
Control of seasonal outbreaks plays a vital role in public health, particularly 
in healthcare settings where the young, elderly, and immunocompromised 
are at the highest risk.  Early detection of seasonal virus outbreaks 
at the level of individual hospitals and community centers are key 
to controlling their epidemic potential.  The Above Local Elevated 
Respiratory Illness Threshold (ALERT; http://reichlab.github.io/alert.
html) algorithm is an online tool designed for clinicians and hospital 
epidemiologists to use in triggering enhanced protective measures for 
healthcare workers and hospital visitors. In this study, we use an influenza 
A dataset from a pediatric hospital to compare the date-based trigger 
strategy recommended by the CDC to the case-count threshold trigger 
implemented using ALERT.  We found that a threshold case count of 3 
was able to reliably out-perform the date-based threshold approach by 
reducing the median duration by 3 weeks, increasing the median percent 
cases captured from 93.5% to 95.1%, and increasing the minimum cases 
captured from 56.2% to 68.9%.  Then we fitted a model to a subset of 
the flu A dataset and tested its ability to make one-step ahead predictions 
of the reserved testing subset of the flu A data.  Once we confirmed that 
our model was representative of real seasonal influenza time-series, we 
used the model coefficients to generate data for a simulation study.  We 
then systematically characterize ALERT performance on simulated data 
generated across a range of endemic and epidemic values in order to 
develop guidelines for when ALERT may be an appropriate tool for rule-
based decision-making.  We conclude with a discussion of these guidelines 
and suggestions for how ALERT may be leveraged for other infectious 
diseases, such as dengue fever, to enable clinicians and epidemiologists to 
make evidence-based public health decisions, particularly in low-resource 
settings.
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A GLOBAL FRAMEWORK FOR STRATEGIC TUBERCULOSIS 
PREVENTION AND CONTROL IN THE WORKPLACE
Mary C. Simmons1, Amanda Brown Marusiak2, Nancy C. Wojcik3, 
Susan Ngunjiri4, Malick Diara1
1Exxon Mobil Corporation, Spring, TX, United States, 2Airswift, Houston, 
TX, United States, 3ExxonMobil Biomedical Sciences, Inc., Annadale, NJ, 
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Tuberculosis (TB) prevention and control activities in the workplace are an 
important consideration for multinational corporations with workforces 
in mixed-risk settings. Preventing TB transmission at ExxonMobil and 
its affiliated companies (EM) is especially challenging due to the global 
nature of our workforce and varied workplace settings which can 
include congregate living. Furthermore, EM operates in more than 50 
countries, some having a high incidence of TB. To protect the workforce 
and minimize operation disruptions, EM has implemented a strategic 
TB Control Program to mitigate the risk of TB transmission among its 
workforce. Components of the program include worker awareness, 
conducting screening, coordination of care, and contact tracing. Eligible 
employees and contractors live in or travel to high-risk settings for 
30 cumulative days per year. High-risk settings include all EM camps 
or dormitories in countries with TB incidence ≥ 20 cases per 100,000 
population as well as all offshore sites. Workers in the program receive a 
baseline screening test upon enrollment, and are subsequently screened 
annually. Annual screening consists of a risk-based questionnaire and, 
when indicated, a T-Spot or Quantiferon screening test. For those testing 
positive, further evaluation is conducted for potential TB diagnosis and 
referral to a healthcare provider. If an active TB case is identified, contact 
tracing is promptly initiated in conjunction with relevant health authorities. 
Surveillance of cases through data management is key to stewardship of 
the program. In 2015, 9000 TB screening tests were performed, resulting 
in 1220 latent TB infections cases being identified among employees 
and contractors. Identification of these latent infections is imperative 
to effective TB control in the workplace, as early detection improves 
outcomes and overall productivity of the workforce, preventing illness and 
therefore potential for operations disruption. EM’s TB Control Program 
is a pragmatic, tiered and scalable approach to mitigate the spread 
of TB among workers in areas of varying TB incidence, protecting our 
workplaces around the world.
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DECIPHERING LONG TERM DYNAMICS AND ASSESSING 
IMMUNIZATION CAMPAIGNS OF MEASLES IN CHINA
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Industrialization and demographic transition generate non-stationary 
dynamics in human populations that can affect the transmission and 
persistence of infectious diseases. Decades of increasing vaccination 
and development have led to dramatic declines in the global burden of 
measles, but the virus remains persistent in much of the world and measles 
is still one of the leading causes of vaccine-preventable childhood diseases. 
An international collaborative study was carried out by researchers from 
WHO, US and China CDC, and universities to decipher the dynamics of 
measles in China. Based on 50-year long term various measles surveillance 
data from national, provincial and city level sources, here we show that 
a combination of demographic transition, as a result of declining birth 
rates, and reduced prevalence, due to improved vaccination, has shifted 
the age distribution of susceptibility to measles throughout China. We 
estimate the relative change in the force of infection in 6 focal provinces 
across China as well as the impact of supplemental vaccination activities 
on the reduction of the susceptible population. The force of infection of 
measles has declined dramatically in the industrialized eastern provinces 
during the last decade, driving a concomitant increase in adult cases who 
had been protected from infection as children by herd immunity, while 
central and western provinces exhibit dynamics consistent with endemic 
persistence. The shift in the age distribution of susceptibility emphasizes 
the importance of progressive control strategies and measures to evaluate 
program success that anticipate this transition in observed incidence. 
Further, the regional differences in the persistence of measles across 
China suggest the importance of targeted efforts to interrupt transmission 
in endemic areas. We also developed novel modeling approach for 
immunization intervention effectiveness assessment when surveillance 
data is strongly biased or not available. The theoretical understanding and 
analytic approach in our study could shed light on how the ongoing global 
measles eradication campaign reaches its goal successfully.
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RESPIRATORY OUTBREAKS DURING AN OUTBREAK 
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During a one-week outbreak investigation course in South America, the 
faculty noted an increase of respiratory symptoms among students and 
then conducted a quick outbreak investigation for academic purposes. 
The course has both a plenary component (25 hours) and case study 
component (11 hours) where the class is divided in six groups of 10-12 
students. In course day 5, all 70 students were interviewed using a self-
administrated questionnaire assessing signs and symptoms, demographic 
information, and location in the plenary and workgroup. Two case 
definitions were used, one based on self-report of “disease” and another 
using the most frequent signs and symptoms. Sixteen students (23%) 
reported themselves as “sick”, 63% with headache, 56% with sneezing, 
56% with rhinorrhea, 31% with sore throat, 31% with cough and 25% 
with fever. Up to 3 cases started symptoms on each of course days 1-4 and 
seven started symptoms in day five. The attack rate differed significantly 
by case study groups (range: 0-75%, p<0.001) and also by plenary table 
row (p=0.012) but not by plenary table column, gender, age or region of 
origin. An alternative, parsimonious case definition of sneezing (24 cases) 
or headache (12 cases), led to an attack rate of 29 cases (41%), capturing 
15 cases not self-identified as “sick” and all but two cases with any 
symptoms. Most new cases (87%) only reported sneezing. Incidence of 
cases found only with the second definition differed by case study group 
(0-60%, p=0.001) but not by other characteristics. The case study groups 
with highest incidence differed for self-defined and not self-defined cases. 
A similar course was taught later in Central America without noticing 
potential outbreaks of respiratory illness. Two clearly-differentiated 
outbreaks may have presented in a five-day course, suggesting person-
to person-transmissions of separate respiratory viruses, both with short 
incubation period probably due to close proximity of students, particularly 
during case study groups.
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IMPLICATION OF SOUND RECORDING SYSTEM ON 
TREATMENT SUCCESS FOR TB PATIENTS IN PORT HARCOURT 
NIGERIA
Anastasia I. Isodje1, Omosivie Maduka2, Charles Tobin-West2
1University of Port Harcourt Teaching Hospital, Port Harcourt, Nigeria, 
2University of Port Harcourt, Port Harcourt, Nigeria
In 2006, the World Health Organisation (WHO) established a Global Task 
Force on tuberculosis (TB) Impact Measurement and one of the mandates 
was to strengthen national capacity in monitoring and evaluation. 
This requires improvement of data quality especially completeness and 
accuracy of records. In Nigeria as in most countries, each TB patient has 
a treatment card on which the most relevant processes for patient care 
are documented. Proper completion of all of these care processes in 
the patients’ treatment card is essential to survey the disease dynamics, 
assess program progress/gaps and plan for future interventions. The aim 
of this study was to determine the completeness of TB patients’ records 
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and its implication on treatment outcome. This was a facility-based cross-
sectional study, using data from treatment cards of 243 patients seen from 
November 2012 to October 2013. Following data extraction, proportions 
were calculated for completeness of patient treatment cards. Chi-squared 
statistic was computed for dependent variables such as treatment success 
and independent variables such as sputum AFB tests. Logistic regression 
was done to determine predictors of treatment success. Of the 243 patient 
treatment cards reviewed, only 23.9% were complete. Assessment of the 
individual variables revealed the following proportions of completeness: 
initial AFB test - 84.8%; 2nd AFB - 74.1%; 3rd AFB - 47.6%; weight at 
commencement - 99.2%; 2nd weighing - 72.8%; 3rd weighing - 46.5%; 
intensive phase treatment - 99.2%; continuation phase treatment - 
77%. The treatment success was 49%. Predictors of this outcome were: 
complete acid alcohol fast bacilli tests, odds ratio 5.18 and 95%CI (2.08 - 
12.89); and compliance to continuation phase, odds ratio 8.47 and 95%CI 
(3.31 - 21.68). The WHO targets for STOP TB are dependent on the 
credibility of readily available data generated from the health facilities. The 
completeness of records in the facilities assessed for this study adversely 
affects the validity of the treatment outcomes recorded.
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ANTIMYCOBACTERIAL AND PHYTOCHEMICAL ANALYSIS OF 
METHYL TERT-BUTYL ETHER EXTRACTS FROM THE FRUIT 
SKIN AND LEAVES OF ANNONA MURICATA LINN
Wisdom Iyanda-Joel, Michael Nshiogu, Emeka E. Iweala, Shalom 
Chinedu
Covenant University, Ota, Nigeria
Arising from the Millennium development goals and Stop TB strategy 
of the World Health organization into the Sustainable goals cum End 
TB strategy, there is urgent need to fast-track research along proffering 
solution to the agelong burden of Tuberculosis. The current study 
examined the antimycobacterial activity and phytochemical constituents 
of methyl tert-butyl ether (MTBE) extracts from the fruit skin (epicarp) 
and leaves of Annona muricata Linn. The extracts were prepared from 
the matured unripe fruits and leaves of A. muricata with MTBE for 
accurate lipidome profiling. Antimycobacterial activity was determined 
Drug susceptibility testing (DST) procedure on Lowenstein Jensen (LJ) 
media. Three concentrations (1, 40 and 250 µg/ml) of the extracts were 
prepared with the LJ media and subsequently inoculated with 10-3 and 
10-5 suspensions of both control (H37Rv) strain and a clinical isolate (MTB-
584) of Mycobacterium tuberculosis. LJ media prepared with Rifampicin 
at 40 µg/ml served as the standard drug for positive control while plain 
media with respective inoculum represented the negative control. Four 
Ziehl-Neelsen’s stain slides were also prepared to confirm the presence of 
organisms in the two suspensions employed for the two strains tested. 
Plain media with drops of distilled water were employed as normal control 
to check for possible contaminant. The inoculated media and control slants 
were incubated at 37oC and observed every seven days for a period of six 
weeks. The antimycobacterial analysis result showed that the organism 
strains exhibited resistance to the extracts at tested concentrations as there 
was substantial growth with typical creamy non-pigmented morphology 
on all the LJ media prepared with extracts. There was no growth on the 
media with standard drug and on those with distilled water as expected. 
Tannins, saponins, flavonoids, anto- and betacyanins, terpenoids, phenols 
and steroids were present in the extract. The conclusion from the 
foregoing is that MTBE extracts from the fruit skin and leaf of A. muricata 
at tested concentrations have no antimycobaterial activity.
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A LECTIN-BASED ASSAY FOR DETECTION OF 
SCHISTOSOMIASIS
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Schistosomiasis is a debilitating neglected tropical disease caused by 
trematodes of the genus Schistosoma. Current serological tools based on 
antibody detection lack the capacity to distinguish current from former 
infections after successful chemotherapy. A commercially available point-
of-contact test to detect adult worm circulating cathodic antigen (CCA) 
in urine has been developed and is being evaluated for use in control 
programs. However, this test only reliably detects S. mansoni infections 
and may therefore not be as useful in S. haematobium-endemic areas in 
Africa. Furthermore, it has been difficult to conclusively determine whether 
persons who are CCA+ but S. mansoni egg negative are truly infected or 
may have non-patent infections. Another adult antigen, circulating anodic 
antigen (CAA) is more sensitive than the CCA test and can detect both S. 
mansoni and S. hematobium infections. However, this optimal sensitivity 
of this test requires a concentration step and is not currently amenable 
to point-of-contact testing. Both the CCA and CAA tests use monoclonal 
antibodies for antigen capture and detection, which adds to the cost of 
the tests. Therefore, although the CCA and CAA tests show promise for 
use in schistosomiasis control programs, we were also interested to see if 
it would be possible to detect free glycans secreted from eggs of both S. 
mansoni and S. hematobium. Schistosome-specific glycans terminating 
with α (1-2) fucose attached to internal N-acetyl glycosamine and N-acetyl 
galactosamine were investigated as potential diagnostic targets for 
schistosomiasis. Lectins from Ulex aeropaus and wheat germ agglutinin 
that bind these glycans with high specificity were functionalized with 
gold nano particles, agarose beads or horseradish peroxidase and used 
to detect schistosome egg glycans in lateral flow and ELISA assays. Urine 
from persons with S. mansoni and S. hematobium infections were positive 
by this test but urines from persons living in non-endemic areas were not. 
These results show promise for development of an inexpensive point-of-
contact assay that is able to detect patent S. mansoni and S. hematobium 
infections.
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THE PERSISTENT PARASITE: WHY DO SCHISTOSOMA 
MANSONI INFECTION LEVELS REMAIN HIGH IN THE RURAL 
UGANDAN VILLAGE OF WAKAWAKA EVEN AFTER OVER A 
DECADE OF TREATMENT?
Elizabeth Hollenberg1, Fiona Fleming1, Edridah Tukahebwa2, 
Jane Whitton1, Yolisa Nalule1, Alan Fenwick1, Arminder Deol1
1Schistosomiasis Control Initiative, London, United Kingdom, 2Ministry of 
Health Uganda, Kampala, Uganda
Despite more than a decade of mass preventive chemotherapy, age-
infection profiles of Schistosoma mansoni have shown that prevalence and 
intensity of infection in Eastern Uganda are still high. With a global shift 
to the elimination of schistosomiasis in the 2012 World Health Assembly 
resolution, there is a need to identify why more than 70% prevalence 
and high intensities of infection are still identified in those most at-risk 
populations, school-aged children. The aim of this study was to identify 
possible non-biological contributors to this trend by interviewing 248 
individuals across all age groups in Wakawaka village, a large fishing 
community, in the district of Bugiri. The survey explored the social, 
behavioural and economic background of the participants, in addition to 
gathering information on living environments and access to healthcare. 
For children aged between 3 and 15 years an additional innovative activity 
was carried out which involved a colouring sheet identifying transmission 
routes. Only half of the colouring activity questions were marked correctly. 
For the survey, results revealed 80% of the participants continue to 
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use Lake Victoria as their primary water source for activities other than 
drinking. Additionally 67% thought that most ‘worm based infections’ 
came from drinking dirty water and only 18% of participants correctly 
identified that swimming in contaminated water was a source of infection. 
Knowledge of STH were similar with 98% unable to identify walking 
barefoot and not washing hands as risk behaviours and only 30% of the 
survey participants forbidding their children from defecating in the open. 
Almost 14% of the population had lived in the area for 2 years or less. 
Results show that there is still a dearth of community level understanding 
of schistosomiasis and STH and their transmission routes despite numerous 
treatment rounds and high levels of infection. If programmes are to move 
from control to elimination, then we need to strengthen current strategies 
with improved treatment coverage and sensitisation, taking into account 
communities that are mobile, access to safe clean water and community 
awareness.
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THAN TEN YEARS OF PREVENTIVE CHEMOTHERAPY FOR 
SCHISTOSOMIASIS AND SOIL-TRANSMITTED HELMINTH 
INFECTION IN UGANDA: ARE WE READY TO MOVE BEYOND 
MORBIDITY CONTROL?
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Tukahebwa3, Judy Fernandez1, Fiona Fleming1, Yolisa Nalule1, 
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1Schistosomiasis Control Initiative, London, United Kingdom, 2Imperial 
College London, London, United Kingdom, 3Ministry of Health Uganda, 
Kampala, Uganda, 4Royal Veterinary College, London, United Kingdom
In 2003, Uganda was one of the first sub-Saharan African countries to 
implement national-scale control programmes for schistosomiasis and 
soil-transmitted helminth (STH) infection, which have aimed to control 
infection-associated morbidity through mass drug administration (MDA) 
of suitable anthelmintics to school aged children (SAC) and other high risk 
groups. SAC harbour the highest prevalence and intensity of schistosome 
infections which then typically decrease with age. Control programmes 
often incorporate a monitoring and evaluation (M&E) component to 
estimate a programme’s impact on population levels of infection, using 
data collected from SAC. More data are needed, however, to understand 
the impact on the wider community when only SAC are targeted; this 
understanding is essential to determine the feasibility of shifting the focus 
towards elimination. Using baseline data from 2003 and data from a two 
year full age-infection (AI) survey from 2014 and 2015, we aim to provide 
an accurate picture of the change in infection patterns in Uganda. In the 
full AI study, data were collected from approximately 7500 individuals each 
year, across a wide age-range (<1 to >50 years) from 10 different sites 
in Uganda, which varied by initial underlying endemicity and treatment 
history. Results showed that the AI profiles for Schistosoma mansoni 
and hookworm followed similar patterns as observed at baseline and in 
other studies. Between 2014 and 2015, no significant treatment impact 
was observed for S. mansoni and hookworm. When analysing results by 
underlying endemicities, the high prevalence sites and the low prevalence 
sites, both of which had received multiple rounds of treatment since 2003, 
showed no reduction between the two years. Conversely, for the low 
prevalence sites that had not received treatment until 2014 (i.e. previously 
treatment-naïve), we observed a decrease in prevalence and intensity. We 
will discuss the age-related changes in intensity and prevalence in each 
subset; possible explanations for the trends observed and their significance 
levels; and compare the age-specific force of infection from baseline to the 
recent data.
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MODELLING THE EFFECT OF A POTENTIAL VACCINE 
APPLICATION ON THE SCHISTOSOME PARASITE DYNAMICS
Andria Stylianou1, Afzal A. Siddiqui2, Roy M. Anderson1
1Imperial College London, London, United Kingdom, 2Texas Tech University, 
Lubbock, TX, United States
Schistosomiasis affects approximately 258 million people, killing an 
estimate of 280 thousands per year. This makes the development of an 
effective vaccine to help, alongside mass drug administration (MDA), 
in the elimination of the disease within the near future a necessity. To 
date, the primary form of treatment is the drug praziquantel, which 
gives some reductions in the burden of the infection but repeated annual 
administration is required over many decades to eliminate the burden 
of disease. A potential vaccine candidate could act to reduce parasite 
establishment, survival and fecundity within the host population. Analysed 
data from experiments with a candidate prophylactic vaccine application 
in a nonhuman primate model, the baboon, gives evidence that the 
development of a partial efficacious vaccine may be a possibility. We 
describe the construction and use of mathematical models of candidate 
vaccine community based impact alongside the use of MDA. We focus 
on vaccination effect on both the host population and the parasite’s 
dynamics. We run the models under different scenarios by taking into 
account various crucial assumptions about the vaccine candidate. These 
include the effectiveness of the vaccine and the rate of loss of vaccine-
induced immunity. We also run the simulated models for the combination 
of mass drug administration (MDA) and community based cohort 
vaccination to test if the elimination of the disease can be achieved more 
quickly with a partially efficacious vaccine.
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UROGENITAL SCHISTOSOMIASIS: WHAT DO 
SCHOOLCHILDREN IN THE EASTERN REGION OF GHANA 
KNOW ABOUT THE DISEASE?
Rachel Martel, Alexandra Kulinkina, David M. Gute, Elena N. 
Naumova, David Tybor, Karen Kosinski
Tufts University, Medford, MA, United States
Urogenital schistosomiasis (UGS) is endemic in the Eastern Region 
of Ghana, particularly amongst primary-school aged children in rural 
communities. Educating children about UGS through the public school 
system in endemic areas can be an effective primary prevention strategy 
that accompanies mass drug administration. However, little is known 
about the baseline knowledge of schoolchildren in the Eastern Region 
of Ghana regarding UGS, and the individual and community-wide 
characteristics that predict levels of knowledge. The objective of this study 
was to determine the baseline knowledge of students in the Eastern 
Region of Ghana regarding UGS, and then to determine the extent to 
which year in school, sex, and district of residence predict UGS knowledge 
among schoolchildren. Over a 17-day period, we conducted a cross-
sectional study among 1813 primary and junior high school children in 
public schools across 37 randomly selected towns within 10 districts in 
the Eastern Region of Ghana. All participants were given a 22-question 
knowledge survey on the transmission, treatment, and symptoms of 
schistosomiasis and protective measures that can be taken to prevent 
infection. A score was assigned to each student representing the number 
and percentage of questions answered correctly. Overall, the average 
score on the knowledge survey was 57.5%. Junior high school students 
had a mean score of 63.0% while primary school students had a mean 
score of 51.5%. Responses indicate that knowledge of how the disease 
is transmitted and how the disease can be treated is lacking among both 
primary and junior high school students. Linear regression analyses indicate 
that sex, class year, and district of residence are predictive of student 
performance on the knowledge survey, with class year as the strongest 
predictor. Linear regression and chi-squared analyses indicate that boys 
systematically perform better than girls on the knowledge survey, and 
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junior high school students systematically perform better than primary 
students. These findings are valuable for officials engaged in the planning 
and implementation of UGS educational interventions.
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SPATIOTEMPORAL MODELING OF SCHISTOSOMIASIS IN 
GHANA: LINKING REMOTE SENSING DATA TO INFECTIOUS 
DISEASE
Madeline R. Wrable1, Alexander Liss1, Alexandra Kulinkina1, 
Magaly Koch2, Nana-Kwadwo Biritwum3, Karen Kosinski4, David 
M. Gute1, Elena Naumova1
1Tufts University, Boston, MA, United States, 2Boston University, Boston, 
MA, United States, 3Neglected Tropical Disease Division of Ghana 
Health Services, Accra, Ghana, 4Department of Community Health, Tufts 
University, Boston, MA, United States
More than 90% of the worldwide schistosomiasis burden falls on sub-
Saharan Africa. Control efforts are often based on infrequent, small-scale 
health surveys, which are expensive and logistically difficult to conduct. 
The use of satellite imagery to predictively model infectious disease 
transmission has great potential for public health applications. The 
transmission of schistosomiasis, a disease acquired from contact with 
contaminated surface water, requires specific environmental conditions 
to sustain freshwater snails. If a connection between schistosomiasis 
and remotely sensed environmental variables can be established, then 
cost effective and current disease risk predictions can be made available. 
Schistosomiasis transmission has unknown seasonality, and the disease 
is difficult to study due to a long lag between infection and clinical 
symptoms. To overcome these challenges, we employed a comprehensive 
15-year time-series built from remote sensing feeds, which is the longest 
environmental dataset to be used in the application of remote sensing 
to schistosomiasis. The following environmental variables will be used 
in the model: accumulated precipitation, land surface temperature, 
vegetative growth indices, and climate zones created from a novel 
climate regionalization technique. This technique, improves upon the 
conventional Köppen-Geiger method, which has been the primary climate 
classification system in use the past 100 years. These predictor variables 
will be regressed against 8 years of national health data in Ghana, the 
largest health dataset of its kind to be used in this context, and acquired 
from freely available satellite imagery data. A benefit of remote sensing 
processing is that it only requires training and time in terms of resources. 
The results of a fixed effects model can be used to develop a decision 
support framework to design treatment schemes and direct scarce 
resources to areas with the highest risk of infection. This framework can 
be applied to diseases sensitive to climate or to locations where remote 
sensing would be better suited than health surveys.
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EPIDEMIOLOGICAL MAPPING OF SCHISTOSOMIASIS AND 
SOIL TRANSMITTED HELMINTHIASIS IN 19 STATES AND THE 
FEDERAL CAPITAL TERRITORY (FCT), NIGERIA
Obiageli J. Nebe1, Ifeoma N. Anagbogu1, Evelyn N. Ngige1, 
Sunday Isiyaku2, William E. Adamani2, Aliyu Mohammed3, 
Francisca Olamiju4, Amy Mayberry5, Florence Nduka6, Christopher 
S. Ogoshi7, Benjamin C. Nwobi8
1Federal Ministry of Health, Abuja, Nigeria, 2Sightsavers, Nigeria, Kaduna, 
Nigeria, 3Helen Keller International, Abuja, Nigeria, 4Mission To Save The 
Helpless (MITOSATH), Jos, Nigeria, 5Children Investment Fund Foundation 
UK, London, United Kingdom, 6University of Portharcourt Nigeria, 
Portharcourt, Nigeria, 7Health and Development Support Programme, Jos, 
Nigeria, 8Research Triangle International/ENVISION Project, Abuja, Nigeria
The coordinated mapping of Schistosomiasis and Soil Transmitted 
Helminthiasis (STHs) was conducted in 19 States and the FCT of Nigeria 
from November 2013 to May 2015.Both diseases were mapped using a 
novel technique; the LINKS system developed by the Task Force for Global 
Health (TFGH), on Android devices and cloud based data reporting and 
management. The application of these devices supported the transition 
from paper-based questionnaires to electronic data collection tools. A 
total of 108,472 children from 2160 schools in 433 LGAs in 19 States 
and the Federal Capital Territory (FCT) were examined for Schistosomiasis 
and STHs. The Kato-Katz, filtration techniques were used to examine 
stool and urine samples Also, Water, Sanitation and Hygiene (WASH) 
information for schools and school children were collected. The result of 
this survey revealed that all the States and the FCT were endemic for one 
or both diseases with an overall prevalence of 9.5% for Schistosomiasis 
and 27% for STHs. However, the data captured by LGA; the intervention 
unit, showed that prevalence of infections varied from low to high risk. 
The prevalence of infections was significantly higher in males than in 
females for both diseases. STHs were more prevalent among the younger 
age group (5-10years) while Schistosomiasis was more prevalent among 
the older age group (11-16 years).Heavy intensity levels were nearly 
equal for S.haematobium (24.31%) and S. mansoni (23.48%). The 
intensity levels of S. haematobium and A. lumbricoides showed statistical 
significant difference (P<0.05) with respect to sex in this survey. STHs 
and Schistosomiasis were seen among pupils who claimed to defeacate 
in the school toilets, around the school compound and outside school 
environment. Of the 433 LGAs surveyed the number of LGAs requiring 
interventions for Schistosomiasis and STHs were 359 and 237 respectively. 
The mapping exercise provided insight into disease distribution and 
intensity in 19 States and the FCT. It is recommended that Government 
and stakeholders should scale up mass deworming alongside WASH 
interventions.
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EVALUATION OF A URINE POOLING STRATEGY FOR THE 
RAPID AND COST-EFFICIENT PREVALENCE CLASSIFICATION 
OF SCHISTOSOMIASIS
Nathan C. Lo1, Jean T. Coulibaly2, Eran Bendavid1, Eliézer K. 
N’Goran3, Jürg Utzinger4, Jennifer Keiser4, Isaac I. Bogoch5, Jason 
R. Andrews1
1Stanford University School of Medicine, Stanford, CA, United States, 
2Université Félix Houphouët-Boigny, Centre Suisse de Recherches 
Scientifiques en Côte d’Ivoire, Swiss Tropical and Public Health Institute, 
University of Basel, Abidjan, Côte D’Ivoire, 3Université Félix Houphouët-
Boigny, Centre Suisse de Recherches Scientifiques en Côte d’Ivoire, 
Abidjan, Côte D’Ivoire, 4Swiss Tropical and Public Health Institute and 
University of Basel, Basel, Switzerland, 5University of Toronto, University 
Health Network, Toronto, ON, Canada
Schistosomiasis is geographically focal, making it difficult to target 
with mass treatment through preventive chemotherapy. The aim of the 
present study was to evaluate the diagnostic performance of a urine 
pooling strategy using a Schistosoma mansoni point-of-care circulating 
cathodic antigen (CCA) test, and then use simulation modeling to test 
the classification accuracy and efficiency in determining where preventive 
chemotherapy is needed in low burden settings. We performed a cross-
sectional study in 114 children in six neighborhoods in Azaguié Ahoua, 
Côte d’Ivoire to characterize the sensitivity and specificity of the CCA 
test with urine samples that were tested individually and in pools of 4, 8, 
and 12. We used a latent class model to estimate test characteristics for 
individual CCA and quadruple Kato-Katz thick smears. We then developed 
a microsimulation model and used Lot Quality Assurance Sampling to 
test the performance of the urine pooling strategy and traditional stool 
microscopy in predicting the binary need for school-based preventive 
chemotherapy using WHO’s 10% prevalence threshold recommendation. 
We estimated the number of tests and total cost of each strategy, and 
tested robustness of the simulation through sensitivity analyses. The 
overall sensitivity of the urine pooling strategy for pool sizes of 4, 8, 
and 12 was 85.9%, 79.5%, and 65.4% when CCA trace results were 
counted as positive, and 61.5%, 47.4%, and 30.8% when CCA trace 
results were counted as negative. The modeled specificity ranged from 
94.0-97.7% for the urine pooling strategies (with trace CCA results 
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categorized as negative). The urine pooling strategies (pool size=4, 8, 
12) gave comparable, and often superior, classification performance to 
stool microscopy for the same number of tests, and the urine pooling 
strategy (pool size=4) reduced number of tests and total cost compared to 
stool microscopy. This study introduces a rapid, cost-saving urine pooling 
strategy to inform where preventive chemotherapy against intestinal 
schistosomiasis is necessary that does not depend upon slide preparation, 
microscopy, or a formal laboratory.
1787
SIZE MATTERS: CHANGING POPULATION STRUCTURE MEANS 
CHANGING SAMPLING REQUIREMENTS FOR SCHISTOSOME 
POPULATIONS
Lúcio M. Barbosa1, Luciano K. Silva2, Moreno Rodrigues2, Walter 
A. Blank3, Mitermayer G. Reis2, Ronald E. Blanton3
1Bahiana School of Medicine and Public Health, Salvador, Brazil, 2Oswaldo 
Cruz Foundation, Bahia, Salvador, Brazil, 3Case Western Reserve School of 
Medicine, Cleveland, OH, United States
Eradication or local extinction of schistosomiasis is a goal for nearly all 
control programs today. We have demonstrated how genetic markers 
can be used to evaluate control programs, indicate incipient resistance 
and perhaps predict the extinction of a local population. Our studies have 
been conducted by collecting parasites from all identified infections in 
a population to calculate individual host differentiation indices (Di) and 
community effective population size (Ne). Collecting all individuals and 
genotyping their parasites, however, would be impractical on a large-
scale, thus we sought to determine the relative error associated with 
different sample sizes. Using data collected in 2009 and 2012 from two 
villages in Bahia, Brazil, we calculated Di based on samples of different 
sizes. Individual infections were selected at random with replacement to 
produce samples ranging in size from 5-50% of the total. Each size class 
was repeated X 30. Di was calculated for each using SPADE. Error rates 
of ± 5%-10% of the true value of Di were taken as acceptable limits. 
The percent of groups outside this range was then calculated. We thus 
compared 2009 and 2012 for these communities, since the Di and Ne 
changed following community-wide treatment. Between 2009-2012 
there was no difference in Di for one, but did increase for the other. Ne 
fell by 15 fold for each site. When the Di is moderate and Ne large, taking 
samples of 30-40% of the population was within the 10% limit 60% of 
the time. When the Di increased and Ne reduced, the curves were less 
steep, but shifted upward so that samples from composed of 30% of the 
infected had only a 50% chance of being within 10% of the true value 
and where the Di was significantly higher, there was only a 40% chance 
of being in this range. The chance of obtaining differentiation indices 
outside of the acceptable error range with smaller sample sizes increases 
when the population has undergone a bottleneck. In order to acquire the 
most representative results for population genetics of S. mansoni some 
characteristics such as population size, prevalence of the parasite, history 
of treatment in the community has be taken into account.
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SCHISTOSOMIASIS DIAGNOSIS AND CLINICAL 
MANAGEMENT: USE OF IMMUNODIGNOSIS, DNA BASED 
ASSY AND DETECTION OF CIRCULATING CATHODIC 
ANTIGEN (POC-CCA) PRE AND POST-PRAZIQUANTEL IN NON 
ENDEMIC AREAS
Marta G. Cavalcanti, Aline Fernandes Cunha, José Mauro Peralta
Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
Diagnosis of Schistosoma mansoni infection in travelers and immigrants 
living in nonendemic areas can be troublesome. Parasitological methods 
and tissue biopsy underdiagnosis acute and chronic infection with no or 
low egg counts. As an alternative to traditional methods, rapid tests (RT) 
like POC-CCA has been used in some institutional settings. However, 
no consensus toward the use of RT in clinical protocols was achieved. 
The study objective was to evaluate POC-CCA in both schistosomiasis 
diagnosis and post-therapy response in non-endemic areas. Thirteen 
individuals living in the non-endemic area with a history of previous 
exposure to S.mansoni participated in the study. Fecal samples were 
tested by Kato-Katz (KK) and DNA amplification by Real-Time PCR. Tissue 
biopsy was also performed when available. Serum IgG1 anti-adult worm 
(SMMA) levels were detected by ELISA (arbitrary units:a.u., positive > 1 
a.u.). For CCA detection, urine samples were tested by POC-CCA (Rapid 
Medical Diagnostics, Pretoria, South Africa). Praziquantel (40mg/kg) was 
used for treatment. Responders to therapy were defined as KK and/or PCR 
negative (KK/PCR). Nine male and four female (mean age:34.5±15.9 years 
old) participated in the study. Seven individuals presented asymptomatic 
infection and two manifested acute schistosomiasis. Intestinal severe 
form and neuroschistosomiasis were diagnosed in two and one 
individual, respectively. Active schistosomiasis was confirmed by KK in 
7/13 individuals, being 6/13 KK negative. IgG levels detected 10/13 and 
reactivity varied from 0.1 to 4.9 a.u.(mean±std: 1.7 ± 1.19 a.u.). Real-time 
PCR showed DNA amplification in 13/13 individuals (Ct mean ± std:28.03 
± 14.09). POC-CCA was reactive in 9/13 individuals ( mostly weak 
reactivity or trace). After PZQ treatment, cure rates determined by KK/PCR 
and POC-CCA were 100% and 61.53%, respectively. KK/PCR combined 
and POC-CCA is a reliable diagnostic strategy to detect active Schistosoma 
infection in nonendemic areas. However, use of POC-CCA as a marker of 
drug response is still debatable.
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SCHISTOSOMIASIS IN SUB-SAHARAN AFRICA: SUCCESSES 
AND BARRIERS TO COMPLETE ERADICATION
Omotola M. Iranloye
Dej & K Field School, Agbara, Ogun State, Nigeria
From the narrative of the German explorer of Central and West Africa, 
Gustav Nachtigal, Schistosomiasis, a neglected tropical disease of 
poverty has plagued various nations in sub-Saharan Africa since 1881. 
Schistosomiasis exert great health, social and financial burden on the 
economies of the region having profound negative effects on child 
development, outcome of pregnancy, and agricultural productivity. Sixty-
seven percent (11.7 million) of people treated in 2008 for schistosomiasis, 
were from sub-Saharan Africa with Nigeria being the most endemic 
country for schistosomiasis, burdened by approximately 20 million people 
mostly children needing treatment. While countries such as Japan, Tunisia 
and some Caribbean Island countries have made significant progress on 
the control and management of this disease, sub Saharan countries are 
still groaning under the burden of this impoverishing disease. This review 
focuses on the history, epidemiology, successes, and barriers impeding 
the complete eradication despite significant re-awakening efforts by such 
organizations as, WHO, State Ministries of Health and the Carter Center to 
end the anguish of this silent disease.
1790
THE ASSOCIATION OF RESISTANCE TO SCHISTOSOMA 
MANSONI REINFECTION AND HOST IMMUNITY IN MBITA 
KENYA COHORT
Bao Lam, Dang My Nhi, Risa Nakamura, Daisuke Kimura, Sammy 
M. Njenga, Yoshio Ichinose, Katsuyuki Yui, Kenji Hirayama, 
Shinjiro Hamano
Nagasaki University, Nagasaki, Japan
Schistosomiasis has been a threat for inhabitant living in endemic area 
where it is inevitable to contact with the schistosome cercaria infested 
water in daily activities. Without treatment, schistosomiasis can persist 
for years and develop to chronic infection with egg-induced pathologic 
complications including liver fibrosis, bladder fibrosis and cancer. 
Identification of protective immunity against schistosomiasis is really critical 
for strategy of vaccine development. In Mbita, Kenya, a Schistosoma 
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mansoni endemic area, we enrolled 160 preschool- and school-age 
children aged 4-15 years and monitored them by Kato-Katz examination 
and circulating cathodic antigen (CCA) tests. The children with egg 
positive stools or CCA positive urine were cured twice with Praziquantel 
and 2-month interval. Three months after the last treatment, the 
examination showed that 20% (32 cases) were re-infected (susceptible) 
with egg positive stools, 55% (88 cases) non-infected (resistant) with egg 
negative stools, 7% (11) with natural non-infection and 18% (29) did not 
supply stool samples. Immunological investigation indicated that plasma 
levels of SWA-specific IgG1 was higher in resistant- than susceptible- 
children (absorbance of 450nm: 0.271 vs 0.135, p < 0.05, respectively) 
whereas there was no difference in plasma levels of SWA-specific IgG4. 
Production of IFN-γand IL-13 from blood cells under stimulation of SWA 
were higher in resistant- than susceptible- children (793 vs 15.6 pg/ml; 
272 vs 68 pg/ml, respectively, p < 0.05). Meanwhile, IL-10 production was 
similar in these two groups of children. Under non-specific stimulation, 
resistant children possess higher proportions of IFN-γproducing CD4+ T 
and non-CD4 non-CD8 T cell than susceptible children (2.2% vs 1.19 %; 
0.76% vs 0.34%, respectively, p < 0.05), whereas there was no difference 
in proportion of IL-13 producing CD4+T cells in these two groups (1.58% 
vs 1.78%, respectively). In conclusion, anti-SWA IgG1 antibody, CD4+ and 
non-CD4 non-CD8 cell derived IFN-γ and IL-13 could be protective factors 
against reinfection of S.mansoni.
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DEMOGRAPHIC COVARIATES OF CHOLERA RISK IN 
CAMEROON
Tyler Brady1, Arabi Mouhaman2, Joseph Tien1
1The Ohio State University, Columbus, OH, United States, 2University of 
Maroua, Maroua, Cameroon
Since cholera’s arrival in Cameroon in 1971, the country has experienced 
multiple outbreaks with thousands of reported cases. The outbreak 
in 2010-2011 has been Cameroon’s largest, with over 27,000 people 
infected. During the 2010-2011 outbreak, the cholera attack rates among 
Cameroon’s 179 health districts varied widely, ranging from 0 to 1,139 
cases per 100,000 people. Using data compiled in the Demographic and 
Health Surveys and national surveillance data reported by the Ministry 
of Health, this study examines the relationship between demographic 
covariates and cholera risk. In a country-wide analysis of all health districts, 
we found the number of children under five living in a home and family 
size to be positively associated with attack rate. When analyzing health 
districts outside of the southwestern part of the country, higher education, 
access to improved sanitation, and higher SES were all negatively 
associated with cholera attack rates. Access to improved water and cholera 
attack rates were not associated. In the southwest part of the country, 
the covariates were no longer sensible predictors of cholera risk. Different 
environmental conditions in the southwestern part of Cameroon may be 
driving these results, for example as a consequence of the construction of 
the Bamendjin dam. The results suggest that basic demographic variables 
may serve as useful predictors of cholera risk and, in conjunction with 
environmental variables, may inform policy including the deployment of 
the oral cholera vaccine stockpile.
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SHARED SANITATION FACILITIES AND TWO PATHWAYS OF 
DIARRHEAL DISEASE TRANSMISSION: A MODELING STUDY
Matthew R. Just1, Sheng Li2, Kelly K. Baker3, Manoj Gambhir4, 
Isaac Chun-Hai Fung1
1Georgia Southern University, Statesboro, GA, United States, 2City 
University of New York, New York City, NY, United States, 3University 
of Iowa, Iowa City, IA, United States, 4Monash University, Melbourne, 
Australia
In many low and lower-middle income countries, access to sanitation 
is limited for many individuals. Open defecation contaminates the 
environment and facilitates the transmission of diarrheal pathogens that 
are transmitted via the environment. The provision of sanitation facilities 
that are shared by many individuals, such as shared latrines in slums, are 
considered by many public health officials as the only short-term solution 
to this problem, especially in urban slums in Asia and Africa. However, 
epidemiological evidences have shown that shared sanitation may actually 
increase the prevalence of diarrheal diseases. One hypothesis that may 
explain this phenomenon is that many different pathogens may cause 
diarrhea. While sanitation facilities reduce the contamination of the 
environment by human defecation, unhygienic sanitation facilities are 
actually fomites for the transmission of other diarrheal pathogens that are 
transmitted directly between humans. We propose a mathematical model 
that seeks to explain how the alleviation of environmental transmission 
of pathogens such as cholera via shared sanitation can lead to an 
amplification of direct transmission caused by other diarrheal diseases 
such as norovirus. The model is an ordinary differential equation (ODE) 
model that runs parameters chosen from a Latin hypercube sampling. 
After sieving through the parameter space to select parameter sets 
yielding outbreaks within a specified threshold, varying levels of shared 
sanitation coverage are implemented on these sets. Changes in disease 
prevalence are then plotted with respect to these varying levels of shared 
sanitation intervention. Results give quantifiable evidence that in the 
presence of an environmental and a person-to-person spread pathogen, 
total disease prevalence can increase. Under certain conditions the model 
shows an optimal level of shared sanitation intervention that can decrease 
environmental disease prevalence while not increasing person-to-person 
transmission too much. In any case, shared sanitation is most effective 
when viewed as a long term strategy.
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NOT IN MY BACKYARD: AN INDIVIDUAL-LEVEL META-
ANALYSIS OF THE ASSOCIATION BETWEEN COMMUNITY 
OPEN DEFECATION AND STUNTING
David A. Larsen, Thomas Gershom, Erik Slawsky, Lutchmie 
Narine
Syracuse University, Syracuse, NY, United States
Approximately 1 billion people live without access to proper toilets and 
practice open defecation, a practice which the Sustainable Development 
Goals wishes to end by 2030. Open defecation facilitates the transmission 
of various diarrheal diseases as well as soil-transmitted helminthes. Access 
to sanitation decreases the risk of these diseases and any subsequent 
issues with development thereafter, including stunting. We conducted 
an individual-level meta-analysis of 177 publicly available, nationally 
representative household surveys to measure the impact that living in an 
open defecation free community has on child growth stunting among 
children aged 12-59 months. To account for selection bias we first 
matched children on the following parameters: community-level wealth, 
individual-level wealth, community-level water access, community-level 
health care access, and mother’s education. Second we stratified the 
analysis among children living in households with and without a latrine. 
We then adjusted for a variety of factors known to be associated with 
child stunting (i.e. breastfeeding, immunizations, birth order, wealth, 
drinking water) and measured the incremental impact of community-
level latrine ownership among children with and without latrines. Among 
children living in households with latrines, living in open defecation free 
communities (all households have latrines) was associated with decreased 
odds of stunting (odds ratio [OR] = 0.95, 95% confidence interval [CI] = 
0.92 - 0.99). Among children living in households without latrines, living 
in communities with less open defecation was associated with decreased 
odds of stunting (OR = 0.96, CI = 0.93 - 0.99). The elimination of open 
defecation is an important sustainable development goal and as the results 
of our study suggests can subsequently have important benefits in health 
as indicated by child stunting.
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COMMUNITY BASED METHODS FOR SCHISTOSOMIASIS 
PREDICTION AND SUSTAINABLE CONTROL
Alexandra V. Kulinkina1, Yvonne Walz2, Karen C. Kosinski1, Nana 
K. Biritwum3, Elena N. Naumova4
1Tufts University, Medford, MA, United States, 2United Nations University, 
Bonn, Germany, 3Ghana Health Service, Accra, Ghana, 4Tufts University, 
Boston, MA, United States
Schistosoma haematobium transmission is influenced by environmental 
conditions that determine the suitability of the parasite and intermediate 
host snail habitats, as well as by socioeconomic conditions, access 
to water and sanitation infrastructure, and human behaviors. We 
present a mixed-methods approach that builds on the remotely sensed 
ecological variables by exploring water and sanitation related community 
characteristics as independent risk factors of schistosomiasis transmission. 
The study area includes 74 rural communities in the Eastern Region of 
Ghana. Environmental conditions relevant for disease transmission such 
as stagnant or slow moving water bodies, riparian vegetation and water 
surface temperatures have been derived using remote sensing data from 
the Landsat 8 and Sentinel 2A satellites, as well as the 30m Advanced 
Spaceborne Thermal Emission and Reflection Radiometer Global Digital 
Elevation Model (ASTER GDEM) and integrated into a habitat suitability 
index (HSI). Additionally, for each study town, GPS coordinates and basic 
field survey data were available for all public water sources including 
improved water infrastructure according to the Joint Monitoring Program 
definition, and surface water access points. We calculated improved water 
coverage expressed as % of population with access to an improved water 
source within 100-500 meters of residence and groundwater quality score 
related to iron, salinity and hardness of the water as well as a recreation 
potential score. The HSI was complemented with community specific 
variables to predict schistosomiasis risk based on the hypothesis that 
in a small geographical area with minimal variability in environmental 
conditions, these potential community level drivers of surface water 
contact increase schistosomiasis risk. We validated the model using 
schistosomiasis prevalence data from a field survey.
1795
THE ROLE OF ENVIRONMENTAL PROCESSES IN INFECTIOUS 
DISEASE DYNAMICS
Andrew F. Brouwer, Joseph N. Eisenberg
University of Michigan, Ann Arbor, MI, United States
For many infectious pathogens, the environment plays an important role in 
transmission from one host to another. This environmental mediation may 
occur through a number of media—including air, food, and fomites—but 
water is especially of interest in the transmission, fate, and transport of 
enteric pathogens. Mitigation, therefore, often involves environmental 
WASH interventions designed to reduce one’s exposure to pathogens. 
Mathematical modeling can be used as a tool to investigate and assess 
potential interventions, allowing for more effective intervention design and 
allocation of resources, and has been used in the past to study waterborne 
outbreaks, notably in the recent cholera epidemic in Haiti. We leverage 
modeling of dose-response relationships and pathogen persistence in 
the environment to provide an improved mechanistic understanding of 
interventions. We conduct a comparative analysis to assess interventions 
that are designed explicitly to reduce per-contact pathogen load—such 
as water filtration devices—and those designed to reduce the frequency 
of contact with pathogens in the environment—such as sanitation 
interventions.
1796
INTEGRATING WATER SANITATION AND HYGIENE PRACTICES 
AND NEGLECTED TROPICAL DISEASE INTERVENTIONS: 
EXPERIENCE FROM SOUTHERN TANZANIA
Alistidia Simon
Sightsavers-NTD Programme Tanzania, Dar es Salaam, United Republic of 
Tanzania
Tanzania is endemic for NTDs particularly the 5 PCT NTD,Trachoma 
being one of them. Efforts for control and elimination of The NTDs 
are underway since 1990s,they include MDA, Health education and 
Promotion and Morbidity Control. Following mapping, Trachoma was 
found to be endemic in 54 districts in year 2004 -2006 surveys and Mass 
treatment started in a phased approach. As per WHO a comprehensive 
SAFE strategy is paramount for Trachoma elimination but there has been 
some limitations due to several factors. Moreover a clear assessment 
of Integration of Water Sanitation and Hygiene (WASH) practices has 
not been well assessed. In 2014, The programme designed a project 
to assess and operationalize Integration between WASH and NTDs 
Interventions in two districts of Tunduru and Namtumbo of Ruvuma 
region, Southern Tanzania. Baseline sanitation data was collected through 
house to house visits using a questionnaires as well as from sanitation 
registers. Trachoma prevalence for Tunduru was from the surveys and 
most updated data shows a TF 7.20%, TT 1.2% while Namtumbo TF 
of 2.20%, TT 1.10% in 2014. Local artisan Training was conducted to 
all communities of the two councils and 20 artisans were trained. At 
each level a combination of two people was made in each visit an NTD 
personnel and WASH personnel. Assessments done after 1 year indicates 
both ; Increased number of Households with improved latrines from 603 
to 2015 households out of 8063 total of households in Namtumbo and 
Tunduru. Moreover, households with fixed hand wash facilities increased 
from 57 to 1698 household in the period of March November 2015.For 
Trachoma Prevalence Namtumbo district has passed the threshold of <5% 
TF prevalence and thus do not require MDA for zithromax. These results 
signifies good cooperation/collaboration between government officials, 
partners and councils at all levels and the 2 districts can meet Trachoma 
elimination targets if integration of sanitation and hygiene with NTD 
interventions is strengthen.
1797
CHOLERA AND ENVIRONMENTAL DYNAMICS IN AN 
ECUADOREAN ESTUARINE SYSTEM
Sadie J. Ryan1, Anna M. Stewart-Ibarra2, Eunice Ordonez3, 
Winnie Chu4, Julia L. Finkelstein4, Christine A. King2, Luis E. 
Escobar2, Christina Lupone2, Froilan Heras5, Carlos Enriquez5, Erica 
Tauzer6, Egan Waggoner7, Tyler G. James1, Washington Cardenas8, 
Mark Polhemus2
1University of Florida, Gainesville, FL, United States, 2SUNY Upstate 
Medical University, Syracuse, NY, United States, 3ESPOL, Guyaquil, Ecuador, 
4Cornell University, Ithaca, NY, United States, 5Machala, Ecuador, 6SUNY 
ESF, Syracuse, Ecuador, 7SUNY ESF, Syracuse, NY, United States, 8ESPOL, 
Guyaquil, NY, United States
The emergence of waterborne diseases such as cholera, whose causative 
agent is pathogenic strains of Vibrio, is strongly linked to the local 
environmental and ecological context. Machala is a port city of 250,000 
people in El Oro province, on the southern coast of Ecuador, near the 
Peruvian border. The 1991-2004 cholera pandemic emerged in Peru and 
spread north into El Oro, making it a key sentinel site for understanding 
dynamics in the ongoing 7th pandemic. In Machala, many peoples’ 
livelihoods depend on the estuarine system, from fishing for subsistence 
and trade, to domestic water use, making the coupled human-estuarine 
system an important component of public health management. We 
sampled five estuarine locations twice weekly over a 10-month span, 
within a gradient of human use, and over a geographic range from 
inland to ocean, to measure water-specific environmental variables such 
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as pH, temperature, salinity, conductance, and algal concentration, and 
conducted PCR testing for Vibrio spp., including pathogenic strains, 
across 5 months. Our sites exhibited considerable seasonal and spatial 
heterogeneity in environmental variables, with clear peaks during specific 
months. We found evidence of an environmental reservoir for Vibrio spp., 
including pandemic strains O1 and O139, but did not confirm ongoing 
toxigenic presence. We found that the timing of positive PCR results was 
coupled to the environment. This study was conducted in a moderately 
normal climate year, providing a preliminary framework for monitoring 
coupled Vibrio – estuarine dynamics for potential emergence of cholera 
outbreaks in the region.
1798
GLOBAL TRACHOMA MAPPING PROJECT: SANITATION 
COVERAGE THRESHOLD LEVELS AND PROTECTION AGAINST 
TRACHOMA
Joshua V. Garn, Matthew C. Freeman, GTMP Consortium
Emory University, Atlanta, GA, United States
Improved sanitation is thought to reduce trachoma by reducing the 
number of fly breeding sites. No study has attempted to characterize 
the thresholds of sanitation for trachoma; particularly, if there is a lower 
sanitation coverage threshold required to reduce trachoma, and also if 
there is some upper threshold at which sanitation might reduce trachoma 
even for those who don’t use latrines through herd protection. We 
used data from the Global Trachoma Mapping Project (GTMP), collected 
between December 2012 and January 2016. To date, we have included 
data from 325,315 participants from 5 countries; additional data will 
soon be available from 17 countries in sub-Saharan Africa, Oceana, Asia, 
and Central and South America. Data cover all endemic districts in these 
countries using cluster sampling. Participants were surveyed about WASH 
access and practices and both eyes were examined for trachomatous 
inflammation - follicular (TF), trachomatous inflammation - intense (TI), 
and trachomatous trichiasis. Our outcome was combined TF/TI in either 
eye (binary), and the primary exposures of interest were household-
level access to improved sanitation, and community-level prevalence 
of improved sanitation. Community-level access was defined as the 
prevalence of sanitation aggregated at the cluster-level. We employed 
multivariable mixed-effects modified Poisson regression models to jointly 
assess the relationship between household and community toilet coverage 
on TF/TI prevalence. We graphically show and present the relationship 
between the trachoma outcomes and individual and community sanitation 
coverage. The trachoma prevalence from adjusted models was generally 
lowest among latrine owners who were also are in the top latrine coverage 
quartile (prevalence = 1.5%; 95% CI: %1.3-%1.7). Our study provides 
insights into the sanitation thresholds required to reduce trachoma and 
our findings will have considerable public health and policy implications for 
achievement of elimination of blinding trachoma by 2020.
1799
USE OF MULTI-PARALLEL QUANTITATIVE REAL-TIME PCR FOR 
GASTROINTESTINAL PARASITES IN RURAL MOZAMBIQUE: 
CORRELATION OF INFECTION INTENSITY TO WATER ACCESS, 
SANITATION AND HYGIENE (WASH)
Juliana Da Silva1, Berta Grau-Pujol2, Inocencia Cuamba3, Carlota 
Dobaño2, Alejandro Krolewiecki4, Jose Muñoz2, Rojelio Mejia1, 
Augusto Nhabomba3
1Baylor College of Medicine, Houston, TX, United States, 2Universitat 
de Barcelona, Barcelona, Spain, 3Centro de Investigaçāo em Saúde de 
Manhiça, Manhiça, Mozambique, 4Universidad Nacional de Salta, Salta, 
Argentina
Sub-Sahara Africa has the highest rates of intestinal parasites worldwide. 
More than 30% of children in these regions have a parasitic infection. 
These infections have the potential to cause morbidity and are related 
to environmental conditions. Our objectives were to deploy the first 
time use of multi-parallel quantitative real-time PCR (qPCR) to describe 
epidemiology of common soil-transmitted helminths and protozoa, and 
association with living conditions. This study involved 250 children (ages 
1 to 10 years old, Geomean = 4.98 years old) residing in rural areas in 
Manhiça, Mozambique. Participants presented for routine care, stool 
samples obtained, and extensive questionnaire on water access, sanitation 
and hygiene (WASH), clinical and laboratory data were obtained for 
all enrollees. DNA extraction of stool and qPCR was performed at the 
Centro de Investigaçāo em Saúde de Manhiça (CISM). qPCR detected 
65% of children with 1 or more parasites, these include Giardia lamblia 
61%, Ascaris lumbricoides 10.2%, Strongyloides stercoralis 8.6%, 
Cryptosporidium 4%, Necator americanus 2.8%, Ancylostoma duodenale 
and Entamoeba histolytica were not detected, Trichuris trichiura results are 
pending. Concentration of Ascaris DNA was converted to eggs per gram 
(EPG) via previous correlation studies. Greater than 60% had heavy Ascaris 
EPG burdens. Heavy Ascaris EPG burden correlated with increased Giardia 
DNA burden in co-infected children (p = 0.0177). Preliminary data points 
to a higher prevalence of helminth and protozoal infections than previous 
known. Ongoing analysis will correlate WASH data to qPCR prevalence 
and co-infections, associating the lack of sanitation to higher rates and 
intensities of infections. These studies improve our understanding of the 
interaction between sanitation and parasitic infections, and build capacity 
for ongoing public-health initiatives in endemic regions.
1800
EFFECT OF A COMBINED HARDWARE AND BEHAVIOR 
CHANGE INTERVENTION ON HANDWASHING BEHAVIORS 
IN PRIMARY SCHOOL CHILDREN: THE POVU POA SCHOOL 
PILOT STUDY
Wit Wichaidit
University at Buffalo, Buffalo, NY, United States
Kenyan schools often lack bar soap for handwashing and experience 
water scarcity. Soapy water can deter soap loss and is inexpensive. A 
behavior change intervention based on disgust and promoting social 
norm change increased handwashing in a community setting, but 
effectiveness in schools has not been assessed. In Kenyan public schools, 
we tested Povu Poa: a handwashing station with a dispenser that produces 
foam from soapy water along with a behavior change intervention 
for schoolchildren with disgust-based triggers and social norm change 
components. In a stepped-wedge cluster-randomized trial, we assessed 
effects of the intervention on 1) availability of handwashing materials, 
and 2) handwashing behavior after toilet use among schoolchildren. 
We randomly selected 30 schools in Kisumu and divided them into 3 
groups of 10 schools. After baseline data collection, we delivered the 
intervention sequentially (Group 1: 3-5 weeks post-baseline; Group 2: 
6-8 weeks; Group 3: 19-24 weeks). We observed outcomes at baseline 
and at Round 1: 3-5 weeks after baseline, Round 2: 9-12 weeks, and 
Round 3: 20-28 weeks. We compared outcomes at schools prior to 
intervention (Comparison Group) to outcomes at schools after intervention 
(Intervention Group). Water and soap / soapy water or foam were 
available at <1% of handwashing places in the Comparison Group, 
and at 50% of handwashing stations in the Intervention Group. In the 
Comparison Group, we observed handwashing with water after 13% of 
toilet use events; we did not observe any handwashing with soap. In the 
Intervention Group, we observed handwashing with water after 36% of 
toilet use events (RR = 5.14, 95% CI = 2.55, 10.34) and handwashing 
with foaming soap after 32% of the events (RR incalculable because there 
was no handwashing with soap in the Comparison Group). The Povu-Poa 
intervention increased handwashing in schoolchildren, although a sizable 
proportion of toilet use events were not followed by handwashing with 
soap. Investigation of barriers to both maintenance of the soap foamer 
and adherence to handwashing with foaming soapy water after toilet use 
would inform improvements in intervention design.
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1801
EVALUATING THE IMPACT OF SCHOOL WATER, SANITATION 
AND HYGIENE IMPROVEMENTS USING THE PRESENCE 
OF SERUM ANTIBODIES FOR ENTERIC AND NEGLECTED 
TROPICAL DISEASES AMONG SCHOOL CHILDREN IN MALI
Anna N. Chard1, Victoria Trinies1, Delynn M. Moss2, Howard H. 
Chang1, Matthew C. Freeman1
1Emory University, Atlanta, GA, United States, 2Centers for Disease Control 
and Prevention, Atlanta, GA, United States
The purpose of this study was to evaluate the biologic impact of school 
WASH improvements on enteric and NTD incidence among pupils in 
Mali. We piloted the use of dried blood spots (DBS) from school-aged 
children (SAC) to detect blood serum antibodies for 32 analytes of enteric 
and NTDs using a Luminex multiplexing assay. This method has yet to be 
employed among SAC, and has had limited employment in evaluation of 
WASH trials. We randomly selected 21 beneficiary schools participating 
in an evaluation of a comprehensive school-based WASH intervention in 
Mali, and their 21 matched control schools. In each school, 20 pupils were 
randomly selected and interviewed about their household WASH access, 
school absence, and recent illness. Capillary whole blood in the form 
of DBS was collected from each student. DBS were analyzed for blood 
antibodies for E. histolytica, Giardia, Cryptosporidium, P. falciparum, P, 
vivax, dengue, Chikungunya virus, E. coli, cholera, Salmonella, norovirus, 
Campylobacter, filariasis, Strongyloides, trachoma, cysticercosis, and 
schistosomiasis using a Luminex multiplexing assay. Data were analyzed 
using generalized linear latent and mixed models (GLLAMM). Factor 
analysis identified three distinct latent variables representing vector-
transmitted disease, food- and water-transmitted disease, and person-to-
person transmitted disease. The GLLAMM modeling framework consisted 
of a measurement model of these three latent variables, clustered at 
the school level and controlling for pupil age, and a structural model 
of the regression of intervention and household WASH access on the 
latent variables. Food/water transmitted disease and person-to-person 
transmitted disease was lower among pupils attending intervention 
schools. Vector transmitted disease was higher among pupils attending 
intervention schools. Results from this pilot support findings from the 
impact evaluation of the larger trial, which found reduced incidence of 
diarrhea among pupils attending beneficiary schools. Analysis of DBS is 
promising method to objectively evaluate WASH impacts in low-resource 
field settings.
1802
PREVALENCE OF ANTIBIOTIC-RESISTANT BACTERIA AND 
THEIR RESISTANCE GENES IN SURFACE WATERS IN A RURAL 
COMMUNITY OF BRAZIL
Vanessa T. Moretto1, Patricia S. Bartley2, Cleiton S. Santos3, 
Viviane M. Ferreira1, Rafael T. Ponce4, Mitermayer G. Reis3, Ronald 
E. Blanton2, Lúcio M. Barbosa1
1Bahiana School of Medicine and Public Health, Salvador, Brazil, 2Case 
Western Reserve School of Medicine, Cleveland, OH, United States, 
3Oswaldo Cruz Foundation, Bahia, Salvador, Brazil, 4Mercer Universitiy 
School of Medicine, Macon, GA, United States
Brazil uses less antibiotics for humans than the USA, but approximately 
the same amount in agriculture. We therefore studied the antibiotic 
resistance profile of a river system in a rural community of Bahia, Brazil. 
In this population of ~500, all homes have a flush toilet, but 50% of 
these flush to the river instead of a septic tank. Agriculture is the principle 
occupation, and cattle, pigs and chickens are kept within and around the 
community. In contrast to the USA, quinolones are not added to feed, 
except for treatments. River water was collected from 10 points where 
the population commonly has water contact as well as 2 samples of the 
local piped water. Monthly records of water quality and climate were 
made for all sites including physical characteristics, coliform count and 
qPCR for fecal microbial source tracking (MST). Bacterial susceptibility to 
ciprofloxacin, cefotaxime and meropenem was tested by disk diffusion. 
DNA was extracted from filter retentate of 500 ml collected from each site 
to identify known quinolone, cephalosporin and carbapenam resistance 
genes by PCR. Coliforms and E. coli were found at high concentrations 
at all sites. By contrast, MST indicated that the highest concentration of 
human fecal waste was downstream from the population center, and 
diminished 500 m downstream of the last home. In July of 2015, all 
sampled points showed at least one bacterial colony resistant to 1 of the 3 
antibiotics. Four Enterobacteriaceae with resistance to at least 1 antibiotic 
were isolated, including one from the drinking water supply. Citrobacter 
freundii which proved to be positive for an extended beta-lactamase (ESBL) 
was found in one of the points. PCR assays for 4 common quinolone 
resistance genes, a cephalosporinase gene and 6 carbapenamase genes 
were negative at all sites. These results indicate that MST may provide a 
more reliable estimate of human fecal contamination; that surface waters 
in this rural community do not meet national standards for human contact 
and the drinking water was doubtful for consumption. Yet the limited use 
of quinolones in veterinary practice may explain the absence of resistance 
genes in these waters.
1803
FECAL FINGERPRINTS: THE LANDSCAPE OF ENTERIC 
PATHOGEN CONTAMINATION IN LOW-INCOME, URBAN 
NEIGHBORHOODS OF KISUMU, KENYA
Kelly K. Baker1, Ananya Sen Gupta2, Jane Mumma3, Oliver 
Cumming4, Reid Senesac1
1University of Iowa College of Public Health, Iowa City, IA, United States, 
2University of Iowa College of Engineering, Iowa City, IA, United States, 
3Great Lakes University of Kisumu, Kisumu, Kenya, 4London School of 
Hygiene & Tropical Medicine, London, United Kingdom
Children in developing countries are infected with a variety of 
enteropathogens in the first years of life, suggesting they experience 
complex environmental exposure risks. Little is known about how different 
fecal transmission pathways contribute to enteric infection patterns. 
During an exposure assessment, the Social Microbes study characterized 
the spatial distribution and correlative relationships for twenty-two 
types of enteropathogens in three low-income, urban neighborhoods 
of Kisumu, Kenya. Landscape features, condition of latrines, evidence 
of open defecation, zoonotic vectors, and number of children and 
their behaviors were recorded at sixty randomly-selected sites in each 
neighborhood (N=180). Soil and surface water from each site was 
analyzed using enterococci indicator assays. A microfluoridic qPCR tool 
was used to detect twenty-two enteric viruses, bacteria, or parasites in 
nucleic acid extracted from 0.5 grams of soil and 10 mls of surface water. 
Enterococci were detected in 100% of surface water samples (N=26) and 
73% of soil samples (N=114) in two neighborhoods. Enteropathogens 
were detected in 92% of water samples (5.1 enteropathogens/sample) 
and 84% of soil samples (1.2 enteropathogens/sample). The five 
most common pathogens in water were Cryptosporidium spp. (89%), 
Enteroaggregative E. coli (EAEC) (77%), Enterotoxigenic E. coli (ETEC) ST/
LT (54%), human adenovirus (50%), and Giardia lamblia (42%). Fourteen 
other enteropathogens were detected at lower frequencies. The five 
most common pathogens in soil were Cryptosporidium spp. (70%), G. 
lamblia (16%), EAEC (8%), human adenovirus (7%), and ETEC-LT (6%). 
Twelve other enteropathogens were detected at lower frequencies. 
Multidimensional correlation between enteropathogens was observed in 
water, but not soil. The variety and prevalence of specific enteropathogens 
detected in environmental fomites in Kisumu provides powerful clues 
for explaining the etiological complexity of pediatric enteric infection in 
developing countries, and highlights the need for improved exposure 
assessment methods for identifying fecal transmission pathways.
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MULTI-PARALLEL QUANTITATIVE REAL-TIME PCR FOR 
GASTROINTESTINAL PARASITES AND INFECTION BURDEN IN 
DISTINCT COLOMBIAN COMMUNITIES
Patricia E. Bryan1, Alejandro Restrepo1, Giovanny Torres 
Lindarte2, Marcela Romero2, Wilber Gómez2, Marcos Restrepo2, 
Rojelio Mejia1
1Baylor College of Medicine, Houston, TX, United States, 2Instituto 
Colombiano de Medicina Tropical, Medellín, Colombia
Gastrointestinal (GI) parasites are globally widespread infectious 
agents disproportionately affecting children in resource-deprived areas 
with associated morbidity that is poorly understood. Environmental 
surroundings influence exposure to these parasites as does the differences 
of water access, sanitation, and hygiene (WASH) between different 
community settings (urban, peri-urban, rural). Stool samples from 194 
children in a urban slum (n = 72, mean age = 2.5 yrs), peri-urban (n 
= 50, mean age = 6 yrs), and rural (n = 72, mean age = 2 yrs) areas 
were analyzed using multi-parallel quantitative real-time PCR (qPCR) 
for Ascaris lumbricoides, Ancylostoma duodenale, Necator americanus, 
Trichuris trichiura, Strongyloides stercoralis, Cryptosporidium, Entamoeba 
histolytica, and Giardia lamblia. Prevalence was 62.5% Giardia, 23.6% 
Cryptosporidium, 19.4% Ascaris, and 5.5% Trichuris in urban slum; 
26.4% Giardia and 2.7% Ascaris in peri-urban area; and 68% Giardia, 
20% Entamoeba, 50% Ascaris, 46% Trichuris, and 2% Strongyloides 
in rural area. Children infected with polyparasitism (2 or more parasites) 
correlated to living in rural areas compared to urban and peri-urban (59%, 
19%, 0%, p = 0.001). Prevalence was lowest in peri-urban area, likely 
due to less exposures in older age group. Higher Giardia DNA burden 
correlated to living in urban slums (p = 0.008); potentially due to crowding 
and sharing contaminated water. Helminth burden was correlated to 
eggs per gram (EPG) with higher Trichuris burden found in rural areas 
compared to urban slum (9953 versus 325 EPG, p = 0.0023). Over 40% of 
helminth infections in rural area are classified as heavy burdens by WHO 
classes of intensity. Our data is useful for morbidity studies and public 
health interventions in highlighting need for improvements in WASH 
infrastructure. Ongoing work will contribute Giardia and Cryptosporidium 
spiking studies correlating trophozoite/cyst to burden. Future work will 
correlate parasite DNA to clinical outcomes and explore associations with 
childhood morbidity.
1805
ANTIBIOTIC STEWARDSHIP AND SANITATION: A MISSING 
PARTNERSHIP
Cleiton S. Santos1, Patricia S. Bartley2, Viviane T. Moretto1, 
Viviane M. Ferreira3
1Oswaldo Cruz Foundation, Bahia, Salvador, Brazil, 2Case Western Reserve 
School of Medicine, Cleveland, OH, United States, 3Bahiana School of 
Medicine and Public Health, Salvador, Brazil
Antimicrobial resistance is a major global public health problem by 
limiting treatment of patients infected with multi-resistant bacteria. We 
evaluated the presence of resistance genes for quinolones (qnrA, qnrS, 
aac(6’), oqxA), cephalosporins (blaCTX-M) and carbapenems (blaOXA-48, 
blaVIM-2, blaNDM-1, blaKPC, and blaSPM) from a lake (DC) in a major 
urban center in Brazil (Salvador, Bahia) compared with a river system in a 
rural community in the state of Bahia, Brazil, a Lake (SL) in Cleveland, Ohio 
and the Cleveland sewer system. Water was sampled from DC in 2013 
and 2015. All other sites were sampled in 2015. The 500 ml samples were 
filtered through a 0.22 µm pore nitrocellulose filter and DNA extracted 
with phenol-chloroform. Standard PCR assays were used to identify 
antibiotic resistance genes. Bacterial source tracking in DC showed high 
human fecal contamination similar to Cleveland sewage. For the DC in 
2013, 2/15 samples were positive for OXA-48 and 7/10 in 2015. Of the 7 
sites positive for OXA-48, 3 were also KPC positive. VIM-2 was identified 
at 2 sites. Quinolone resistance genes were found at multiple sites in 
2013 for DC, but this analysis is pending for 2015. The sample taken from 
the sewer system of Cleveland was positive for only VIM-2. Few or no 
resistance genes were identified in river samples from the rural community 
in Brazil and the SL in the USA. From the latter, only 1 bacterial isolate was 
resistant to any antibiotics tested in contrast to all other locations where 
there were numerous resistant isolates. The earliest report of the OXA-48 
gene family in Enterobacteriaciae in Brazil was from 3000 km south of 
Salvador in a hospital in Porto Alegre in 2013. This gene had, however, 
clearly entered the country earlier and was already widely disseminated 
in the environment in 2013. The frequency and number of antibiotic 
resistance genes in DC is alarming but not unusual for urban surface water 
that is used by the community for recreation and fishing. The presence 
of poor sanitation and feces in urban surface water is likely an important 
factor contributing to the spread of these genes to many bacterial species 
and back to humans.
1806
WHO INFLUENCES YOU? THE ROLE OF WOMEN IN 
INFORMATION DIFFUSION OF SANITATION AND WATER 
PRACTICES IN COASTAL ECUADOR
Sonia T. Hegde1, James Trostle2, Joseph Eisenberg1
1University of Michigan, Ann Arbor, MI, United States, 2Trinity College, 
Hartford, CT, United States
Despite dramatic reductions in childhood mortality in the past decade, 
diarrhea remains a major cause of preventable childhood deaths 
worldwide. Aside from vaccination, well known measures to prevent 
diarrheal infection include good water, sanitation, and hygiene practices. 
These behavioral practices, however, are influenced by a multitude of 
factors, including community-level social cohesion. Women, in particular, 
experience a continual tradeoff in daily tasks, including water-associated 
behaviors and child care, and likely play a role in influencing information 
diffusion in societies with high social cohesion. Previous studies conducted 
on coastal Ecuadorian populations have shown that a greater density of 
social ties between individuals in remote communities may lead to the 
spread of sanitation and water practices, both individual and collective, 
that help reduce the transmission of diarrheal disease. The role of women 
and the effect across time were not examined. We aim to examine 
the influential role women play on information diffusion, as defined 
by adopting improved sanitation and water practices, and diarrheal 
disease reduction in coastal Ecuador over the course of ten years. Using 
longitudinal social network data collected from villages in northern 
coastal Ecuador at multiple intervals from 2003 to 2013, we first defined 
communities with high and low social cohesion by measures of network 
density and clustering. We then measured node centrality, including 
average degree, closeness, and betweenness, by gender in networks of 
high and low social cohesion to examine the presence of influential nodes. 
We also assessed the presence of strong and weak ties. We conducted 
Markov-chain Monte Carlo models to determine the influence of women 
on the effect of high social cohesion on changes in sanitation and water 
practices and diarrheal disease over time. Qualitative data was used to 
describe difference in the role of women in communities of low and high 
social cohesion. By understanding who the influential persons are in social 
networks, we can better understand how to leverage social learning to 
reduce diarrheal disease transmission.
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CLINICAL PREDICTION RULE OPERATED BY MOBILE PHONES 
FOR EARLY DETECTION AND REFERRAL OF CUTANEOUS 
LEISHMANIASIS IN RURAL AREAS OF COLOMBIA
Luisa C. Rubiano1, Alvaro Martinez1, Ruth M. Castillo1, Lina R. 
Hurtado1, Leonardo Vargas2, Juan D. Arango2, James Cuenca2, 
Carlos Rojas3, Helena del Corral3, Andres Navarro2, Nancy G. 
Saravia1
1Centro Internacional de Entrenamiento e Investigaciones Médicas, Cali, 
Colombia, 2ICESI, Cali, Colombia, 3Universidad de Antioquia, Medellin, 
Colombia
Detection and diagnosis of cutaneous leishmaniasis (CL) in rural 
populations is a public health challenge. A Clinical Prediction Rule (CPR) 
previously validated in Tumaco could provide presumptive diagnosis of CL 
using 6 readily obtained variables. We sought to adapt the CPR as mobile 
phone app to facilitate case detection in rural areas and evaluate users 
performance and acceptability. 6 community volunteers and 3 health 
technicians were trained in the use of “Leishmaniasis App”. During Feb 
2015 to Mar 2016 patients with skin lesions were evaluated with the 
CPR and received parasitological tests. Number of confirmed cases and 
time from symptoms onset to diagnosis during were compared with 
data reported by the national surveillance system during 2012-2014. 
Agreement between community volunteers and health technicians with 
an experienced physician was estimated. Semi-structured interviews and 
focus group were used to evaluate users’ acceptance and usability of the 
app. A total of 115 patients were evaluated, 83.5% had parasitological 
confirmation and 16.5% other dermatologic conditions. Confirmed 
cases increased 27% during the study period compared to years 2012-
2014 (213 vs 167) and average time from symptoms onset to confirmed 
diagnosis decreased 53.8%, from 30.4 to 11 days. Overall agreement 
between the experienced physician and community volunteers was 
93.8% (Kappa:0.68) and 96.8% (Kappa:0.72) for health technicians. 
Variables referred by patients (i.e. risk activities, vector contact and trauma) 
had ≥ 87.5% agreement. Presence of clustered lesions had agreement 
ranging 56.3% to 100%. Ninety percent of users fully agreed with 
usefulness of the app and 72% considered use of mobile phones easy and 
relevant. Main perceived barriers were cultural differences of indigenous 
communities and armed groups. Mobile phone use was facilitated by 
familiarity with technology and relevance of having an appropriate tool 
for CL detection. The use of a mobile app adapting a validated CPR by 
community volunteers and health technicians evidences the utility and 
acceptability of an m-health tool for presumptive diagnosis of CL in rural 
communities.
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THE EFFECT OF TEXT MESSAGE REMINDERS TO HEALTH 
WORKERS ON QUALITY OF CARE FOR MALARIA, 
PNEUMONIA, AND DIARRHEA IN MALAWI: A RANDOMIZED 
CONTROLLED TRIAL
Laura C. Steinhardt1, Don Mathanga2, Dyson Mwandama2, 
Humphreys Nsona3, Dubulao Moyo3, Austin Gumbo3, Miwako 
Kobayashi1, Ruth Namuyinga1, Monica Shah1, Andy Bauleni2, Peter 
Troell4, Dejan Zurovac5, Alexander K. Rowe1
1Centers for Disease Control and Prevention, Atlanta, GA, United States, 
2Malaria Alert Centre, Blantyre, Malawi, 3Ministry of Health, Lilongwe, 
Malawi, 4U.S. President’s Malaria Initiative, Centers for Disease Control and 
Prevention, Lilongwe, Malawi, 5KEMRI-Wellcome Trust, Nairobi, Kenya
Mobile (mHealth) technologies hold promise as innovative ways to improve 
health worker (HW) performance in low-resource settings. We conducted 
a cluster-randomized controlled trial to evaluate the effect of text message 
reminders to HWs in outpatient health facilities (HFs) on the quality of 
care for malaria, pneumonia, and diarrhea in Malawi. After a baseline HF 
survey in January 2015 with patient interviews, HF assessments, and HW 
interviews, 105 HFs were randomized, stratified by baseline quality of care, 
to three arms: 1) text messages to HWs on malaria case management; 2) 
text messages to HWs on malaria, pneumonia, and diarrhea (latter two for 
children <5 years); and 3) control arm (no messages). Messages were sent 
twice a day for six months, followed by an end-line HF survey in November 
2015. Difference-of-differences logistic regression analyses, accounting 
for clustering at facility level, were performed. We interviewed 2,360 
patients at baseline and 2,536 at end-line. The proportion of patients 
with suspected uncomplicated malaria managed correctly increased from 
40.3% to 52.8% in the control arm, from 41.4% to 55.6% in arm 1 
(effect size 1.7%-points, p=0.84), and from 32.9% to 53.5% in arm 2 
(effect size 8.1%-points, p=0.34). Prescription of first-line antibiotics to 
children <5 years with clinically-defined pneumonia increased from 69.1% 
to 70.6% in the control arm, from 68.9% to 71.3% in arm 1 (effect 
size 0.9%-points, p=0.95), and from 69.6% to 76.5% in arm 2 (effect 
size 5.4%-points, p=0.68). Prescription of oral rehydration solution to 
children with diarrhea declined slightly in all arms from baseline to end-
line. Per-protocol analyses limited to patients seen by HWs in arms 1 and 
2 who reported receiving messages (39.5% and 45.5%, respectively) 
yielded similar results. We found no significant improvements in malaria, 
pneumonia, or diarrhea treatment practices after six months of twice-daily 
text message reminders to HWs, illustrating the importance of rigorously 
testing new interventions before adoption and understanding why 
interventions work well in some settings, but poorly in others.
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MULTIMEDIA TOOL FOR OBTAINING INFORMED CONSENT IN 
THE GAMBIA: A MIXED METHOD STUDY
Muhammed O. Afolabi1, Nuala McGrath2, Umberto 
D’Alessandro1, Beate Kampmann1, Egeruan Imoukhuede3, 
Raffaella Ravinetto4, Neal Alexander5, Heidi J. Larson5, Daniel 
Chandramohan5, Kalifa Bojang1
1Medical Research Council, Banjul, Gambia, 2University of Southampton, 
Southampton, United Kingdom, 3University of Oxford, Oxford, United 
Kingdom, 4Institute of Tropical Medicine, Antwerp, Belgium, 5London 
School of Hygiene & Tropical Medicine, London, United Kingdom
Communicating crucial research information to low literacy research 
participants in Africa is highly challenging in the context of several 
factors which make the participants vulnerable to poor comprehension of 
consent information. We previously developed and validated a multimedia 
consent tool and a digitized audio comprehension questionnaire. This 
study was undertaken to evaluate the effectiveness of the multimedia 
consent tool amongst adults participating in a clinical trial in The Gambia. 
Adults eligible for inclusion in a malaria treatment trial (n = 311) were 
randomized to receive information needed for informed consent using 
either a multimedia tool (intervention arm) or a standard procedure 
(control arm). A computerized, audio questionnaire was used to assess 
participants’ comprehension of informed consent. This was done 
immediately after consent had been obtained (at day 0) and at subsequent 
follow-up visits (days 7, 14, 21 and 28). The acceptability and ease of 
use of the multimedia tool were assessed in focus groups. On day 0, the 
median comprehension score in the intervention arm was 64% compared 
with 40% in the control arm (P = 0.042). The difference remained 
significant at all follow-up visits. Poorer comprehension was independently 
associated with female sex (odds ratio, OR: 0.29; 95% confidence interval, 
CI: 0.12-0.70) and residing in Jahaly rather than Basse province (OR: 0.33; 
95% CI: 0.13-0.82). There was no significant independent association 
with educational level. The risk that a participant’s comprehension score 
would drop to half of the initial value was lower in the intervention arm 
(hazard ratio 0.22, 95% CI: 0.16-0.31). Overall, 70% (42/60) of focus 
group participants from the intervention arm found the multimedia tool 
clear and easy to understand. In conclusion, a multimedia tool significantly 
improved comprehension and retention of consent information by research 
participants with low levels of literacy in The Gambia. Further evaluation of 
the tool is warrranted in similar settings.
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FIRST ORAL CHOLERA VACCINATION CAMPAIGN IN IRAQ 
DURING AN OUTBREAK AND HUMANITARIAN CRISIS: 
FINDINGS FROM THE COVERAGE SURVEY, 2015
Eugene Lam1, Wasan Al-Tamimi2, Steven P. Russell1, Muhammad 
Obaid-ul Islam Butt2, Curtis Blanton1, Altaf Sadrudin Musani3, 
Kashmira Date1
1Centers for Disease Control and Prevention, Atlanta, GA, United 
States, 2World Health Organization, Office of the WHO Representative 
in Iraq, Baghdad, Iraq, 3World Health Organization, Office of the WHO 
Representative in Iraq, Atlanta, GA, United States
As part of the 2015 cholera outbreak response in Iraq, the Iraqi Ministry 
of Health (MOH) targeted approximately 255,000 persons aged ≥1 year 
living in selected refugee camps, internally displaced persons (IDP) camps, 
and collective centers with two doses of oral cholera vaccine (OCV) during 
November-December 2015. This was the first use of the OCV in Iraq and 
the largest global OCV stockpile deployment to date. We conducted 
a multi-stage cluster survey to obtain OCV coverage estimates in 10 
governorates that were targeted during the 2015 campaign. Within 
each governorate we proportionally allocated our sample based on the 
estimated population size of each refugee/IDP camp or collective center; 
approximately 120 households were systematically sampled in each 
governorate. In each selected household, all persons aged ≥1 year were 
interviewed. In total, 1,226 household and 5,007 individual interviews 
were conducted. Overall, two-dose OCV coverage in the targeted camps 
was 87% (95% CI: 85%, 89%). Coverage was similar across age groups; 
85% (95% CI: 81%, 88%) among children 1-4 years old, 89% (95% 
CI: 85%, 92%) among children 5-14 years old, and 87% (95% CI: 
84%, 90%) among persons aged ≥15 years. Two-dose OCV coverage 
was higher in the three Northern governorates at 91% (95% CI: 89%, 
93%) (range: 89% (Dahuk) to 93% (Erbil and Sulaymaniya)) compared 
with the seven South and Central (S/C) governorates at 80% (95% CI: 
77%, 82%), where greater variation between governorates was noted 
(range: 21% (Babil) to 98% (Anbar)). Lower two-dose coverage in S/C 
governorates were likely due to civil strife, heavy rains, and challenges in 
program management. One-dose only coverage was higher (10%; 95% 
CI: 8%, 12%) among the S/C governorates compared to the Northern 
governorates (6%; 95% CI: 4%, 9%). The most common reasons for not 
receiving OCV was being absent during the campaign or teams not visiting 
their homes. No serious adverse events following immunization were 
reported. The Iraq experience demonstrates that OCV campaigns can be 
successfully implemented as part of a comprehensive response to cholera 
outbreaks among high-risk populations in conflict settings.
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TIMELINESS OF VACCINATION IN AN URBAN SLUM IN 
NAIROBI, KENYA
Jonathan S. Schultz1, Shadrack Muema2, Alice Ouma2, Leonard 
Cosmas3, Geofrey Masyongo2, Godfrey Bigogo2, Marc-Alain 
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Although routine infant immunization programs achieve high coverage 
in the first year of life in many low-resource settings, delays in vaccine 
receipt can leave very young children at risk for preventable diseases, 
precisely when they are at greatest risk for severe infection. Children living 
in urban slums are vulnerable to many diseases because of precarious 
living conditions and high population density. We assessed timeliness 
of vaccination among a cohort of fully vaccinated children within a 
population-based surveillance platform in Kibera, an urban slum in Nairobi, 
Kenya. Surveillance participants (~25,000) were visited at home biweekly 
and received free care for acute illness at a designated clinic. At each visit 
parents were queried about vaccines children had received since the prior 
visit; reported doses were verified using the child’s immunization card. 
We identified all children <5 years old with 3 card-confirmed doses of 
pentavalent (diphtheria-tetanus-pertussis-Haemophilus influenzae type 
b-hepatitis B) vaccine, which is given at 6, 10, and 14 weeks in Kenya. 
We used inverse Kaplan Meier curves and Cox proportional hazards 
models to identify factors associated with timely receipt of the 3rd dose. 
From December 2009 to December 2014, 1,874 children received 3 
pentavalent doses. The mean and median age at receipt of the 3rd dose 
was 17 and 15 weeks. The proportion with 3 doses by 4, 6, 12, and 24 
months was 76.1%, 95.3%, 98.2% and 99.6% respectively. Timeliness of 
vaccination was not significantly associated with sex, birth in rainy season, 
or household size. Residence in a geographic zone close to the clinic 
was associated with delayed vaccination (HR=0.87 95%CI: 0.77-0.99) 
and birth in December was associated with timely vaccination (HR=1.24; 
95%CI: 1.04-1.48). We found receipt of pentavalent vaccine to be quite 
timely among children who eventually received 3 doses. Although nearly 
a quarter were missing at least one dose at the age of 4 months, by 6 
months >95% had received all 3 doses. The relevance of identified factors 
associated with timeliness is unclear, particularly given the small numbers 
of children with substantial delay.
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COST-EFFECTIVENESS OF DENGUE VACCINATION IN FIVE 
LATIN AMERICAN COUNTRIES
Donald S. Shepard1, Yara A. Halasa1, Wu Zeng1, Nicolas Baurin2, 
Laurent Coudeville2
1Brandeis University, Waltham, MA, United States, 2Sanofi Pasteur, Lyon, 
France
In 2015, the first dengue vaccine was licensed in several Latin American 
countries, providing a promising tool against an expanding disease. 
However, decisions about the vaccine’s use depend on quantifying its 
health benefits, costs, and cost-effectiveness. To inform policy discussions 
in Latin America, we used a transmission model calibrated with data from 
Phase III efficacy trials. Costs of vaccine administration, procurement, and 
dengue treatment were based on publications and reports. Each vaccine 
dose was projected to cost $2 for vaccine delivery plus $20 for vaccine 
procurement. Our base case assumed that a 3-dose vaccination program 
would be offered to all 9 year-old children each year, plus a 4-cohort 
initial catch up (10-13 year-olds), phased over 3 years and achieving 80% 
coverage. Our base case expressed costs in 2013 US dollars from a health 
system perspective, conducted 100 simulations with a 30-year horizon to 
account for variability in dengue transmission and uncertainty on vaccine 
efficacy, measured health impacts in disability-adjusted life years (DALYs), 
and assessed cost effectiveness as $/DALY averted. Our base case results 
found that vaccination would save from $0.19 (Honduras) to $1.91 
(Puerto Rico) in annual per capita dengue treatment costs and would 
reduce dengue-related DALYs by 27.4% (Mexico) to 32.2% (Honduras). 
Cost-effectiveness ratios, expressed as multiples of each country’s per 
capita gross domestic product (GDP), were: Brazil (0.74), Colombia (0.27), 
Honduras (3.58), Mexico (0.18), and Puerto Rico (-0.15). In the base case, 
the vaccine is cost saving in Puerto Rico. Using WHO benchmarks of 1 
and 3 times per capita GDP, the vaccine is highly cost effective in Brazil, 
Columbia and Mexico (under the most stringent benchmark), but not cost 
effective in Honduras from a health system perspective. Cost-effectiveness 
results were similar for other programs (0 to 8 catch up cohorts) and 
coverage rates (50% to 80%). The consideration of a societal perspective, 
increasing dengue incidence, dengue’s adverse impacts on tourism, and 
rising real incomes and health care costs further strengthen the case for 
vaccination.
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SNAKEBITE: STRATEGIES TO REVERSE THE PUBLIC HEALTH 
NEGLECT OF TROPICAL SNAKEBITE VICTIMS
Robert A. Harrison1, Jose-Maria Gutierrez2
1Liverpool School of Tropical Medicine, Liverpool, United Kingdom, 
2Instituto Clodomiro Picado, San Jose, Costa Rica
Globally, snakebite kills one fifth the number of people that die from 
malaria. In India, half the number of people dying from HIV are killed 
by snakebite every year. In Africa, snakebite causes nearly twice the 
number of deaths, every year, than the recent Ebola epidemic - and 
imposes a disease burden (319,874 DALYs; 16 countries) equal or 
exceeding that of regional NTDs such as Buruli ulcer, Echinococcosis, 
Leishmaniasis, Trachoma and Trypanosomiasis. Surviving snakebite victims 
suffer substantial psychological morbidity that is typically unrecognised 
and untreated. The support and investment provided by International 
Health Agencies and tropical governments to greatly reduce the disease 
burden of malaria, HIV, Ebola and the NTDs is typically denied to tropical, 
and particularly to sub-Saharan African, snakebite victims - despite the 
high mortality rate and the physical, psychological and socio-economic 
burden of tropical snakebite. In an effort to reverse this public health 
neglect of tropical snakebite victims, the authors organised (September 
2015) a Wellcome Trust-funded workshop to identify key interventions 
(i) reduce snakebite incidence, (ii) improve access to hospital care, (iii) 
improve clinical management of hospitalised snakebite victims and (iv) 
improve post-hospital management of snakebite victims. We will report 
that progress since then includes (i) the announcement by the World 
Health Organisation of an ‘African antivenom prequalification’ program 
designed to prevent the distribution in Africa of ineffective antivenoms, 
(ii) that the NGO, Health Action International, has assumed the secretariat 
and advocacy roles for the Global Snakebite Initiative, (iii) that, with the 
advocacy support of over 13 tropical MoHs and NGOs (eg, MSF, HAI, 
DNDi), the Global Snakebite Initiative acquired a side briefing at the World 
Health Assembly in May, 2016, (iv) that a motorcycle ambulance/smart 
phone app-coordinated Snakebite Emergency Response System will be 
trialled in Kenya as an affordable, rapid means of delivering rural snakebite 
victims to effective treatment.
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A NOVEL FAMILY OF KUNITZ-TYPE INHIBITORS FROM 
FASCIOLA HEPATICA - POTENT INHIBITION OF VIRULENCE-
ASSOCIATED CYSTEINE PROTEASES
David Smith, Irina Tikhonova, Orla C. Drysdale, Jan Dvorak, Mark 
W. Robinson, Krystyna Cwiklinski, John P. Dalton
Queen’s University Belfast, Belfast, United Kingdom
Fasciola hepatica is a zoonotic food-borne helminth parasite of global 
veterinary and medical importance. The parasite expresses a family of 
seven Kunitz-type (KT) protease inhibitors that are highly regulated 
during the parasites migration and development in the mammalian host. 
Phylogenetic analysis demonstrates they separate into five subgroups 
(FhKT1 – 5), although transcriptomic data shows that the FhKT1 group 
has the highest expression over the course of infection and is upregulated 
in the infectious newly excysted juveniles (NEJs) and in adults. To date, 
KT inhibitors are ubiquitously expressed in eukaryotics and are classical 
described as inhibitors of serine proteases. Unexpectedly, we discovered 
that the FhKT1 inhibitors do not inhibit serine proteases but exhibit 
potent inhibition towards cysteine proteases. Recombinant FhKT1 is a 
potent inhibitor of the major secreted virulence-associated cathepsin 
L cysteine proteases of F. hepatica, FhCL1, FhCL2 and FhCL3, and of 
human cathepsins L and K (Ki = 0.2474 nM – 24.607 nM). FhKT1 also 
prevented the auto-catalytic activation of FhCLs and formed stable 
complexes with the mature enzymes. Pull-down experiments showed 
that rFhKT1 interacts specifically with native secreted adult FhCL1, FhCL2 
and FhCL5. Substitution of an unusual P1 Leu15 within the exposed 
reactive loop of FhKT1 for the more commonly found Arg15 (FhKT1Leu15/
Arg15) had modest adverse affects on cysteine protease inhibition but 
conferred potent activity against the serine protease trypsin (Ki = 2.28 
nM). Computational docking and sequence analysis provided molecular 
explanations for the exclusive binding of FhKT1 to cysteine proteases, 
suggested a pivotal role for the P1 Leu15 in anchoring the inhibitor into the 
S2 active site pocket, and helped explain the selectivity towards cathepsin 
L-like proteases. FhKT1 represents a novel evolutionary adaptation of 
KT protease inhibitors by F. hepatica, with its prime purpose likely in the 
regulation of the major parasite-secreted proteases and/or host proteases 
during infection, making this a novel vaccine and drug target.
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DRAFT GENOMES OF FOUR SPECIES OF THE LUNG FLUKE 
PARAGONIMUS
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Kaen University, Khon Kaen, Thailand, 6Vietnam Academy of Science and 
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Paragonimus spp, the lung fluke, is among the most injurious of the 
food-borne helminths, infecting ~20 million people worldwide, with 
an estimated 293 million people at risk for infection. Paragonimiasis 
is acquired by consuming raw or undercooked crustaceans containing 
Paragonimus metacercariae, and primarily affects the lungs, but often 
causes lesions elsewhere in the body, including the brain. The disease is 
a major public health concern in parts of Southeast Asia, West Africa, 
South and Central America, and Northeast India, where it is frequently 
mistaken for tuberculosis due to its similar respiratory symptoms. To 
substantially improve our understanding of pathogens across this genus 
at the molecular level, we have assembled, annotated and compared 
draft genomes of three Paragonimus species from Asia (P. miyazaki, P. 
westermani, P. heterotremus) and one from North America (P. kellicotti). 
The genomes range in size from 697 to 923 Mb, contain between 11,761 
and 12,762 genes, and are estimated to be between 80% and 91% 
complete. Comparative orthologous protein family (OPF) analysis spanning 
19 species (4 Paragonimus species, 3 other foodborne trematodes, 3 
schistosomes, 4 other platyhelminths, 4 hosts and an outgroup) identified 
proteins and functions of phylogenetic interest, including 364 OPFs 
conserved across and specific to the four Paragonimus species, which 
were enriched for proteins responsible for transcription factor activity, iron 
homeostasis, and serine endopeptidase activity. Transcriptomic analysis 
identified gene sets with conserved expression across Paragonimus species, 
as well as genes overexpressed during host parasitic stages, including 
179 P. miyazaki genes overexpressed in peritoneal and pleural cavities 
compared to liver and lung tissues, which were enriched for cysteine 
endopeptidase activity and microtubule processes. This study provides 
a foundation for future studies of Paragonimus and other food-borne 
trematode pathogens, and represents a major contribution to ongoing 
trematode genome sequencing efforts.
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COMPLEMENTATION OF CELLULAR PROLIFERATION 
DRIVEN BY GRANULIN BY LIVER FLUKE GRANULIN IN A 
CHOLANGIOCYTE LINE AFTER GENOME EDITING TO MUTATE 
HGRN
Wannaporn Ittiprasert1, Christina Cochran1, Chutima 
Kumkhaek2, Victoria Mann1, Alex Loukas3, Michael Smout3, Apisit 
Chaidee4, Paul Brindly1
1George Washington University, Washington, DC, United States, 2National 
Institutes of Health, Bethesda, MD, United States, 3James Cook University, 
Queensland, Australia, 4Khon Kaen University, Khon Kaen, Thailand
The highest incidence of cholangiocarcinoma (CCA), bile duct cancer, has 
been reported in northeastern Thailand, a region where infection with 
the fish-borne liver fluke, Opisthorchis viverrini is endemic. Infection with 
O. viverrini is a Group 1 biological carcinogen that induces CCA. How 
opisthorchiasis causes CCA is not yet clear, but likely is a multi-factorial 
process. Among other factors, O. viverrini secretes a mitogen termed 
granulin (Ov-GRN-1) that stimulates proliferation of cholangiocytes, and 
we have postulated Ov-GRN-1 released from the parasites contributes 
to opisthorchiasis-induced CCA. Human orthologue, hGRN (human 
granulin) is a growth factor with multiple functions in inflammation, 
would repair, and tumorigenesis. To investigate these phenomena, we 
undertook complementation of native hGRN with Ov-GRN-1 in cultures 
of a cholangiocyte cell line named H69 where the encoding hGRN gene 
had been gene-edited out by CRISPR/Cas9. In real time growth assays 
(xCELLigence), mutant (hGRN knockout) cells exhibited reduced growth 
proliferation compared to wild-type H69 cells, a deficit that was relieved 
by addition of Ov-GRN-1. Thereafter, transcripts recovered from exosomes 
of H69 cells were evaluated; annexin, c-Myc, C-met were up-regulated. 
Moreover, perioxiredoxin, Prx I, an antioxidant involved with cellular 
homeostasis and which can promote tumorigenesis through activities 
driven via mTOR exhibited marked induction in the mutant H69 cells. In 
ongoing studies, intercellular functions of endogenous and exogenous 
granulin in cellular proliferation and/or tumorigenesis upstream of the 
mTOR pathway are under investigation.
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TISSUE SPECIFIC LOCALIZATION OF NEORICKETTSIA 
ENDOSYMBIONTS IN THE INTESTINAL TREMATODE 
PLAGIORCHIS ELEGANS AND THE LIVER FLUKE FASCIOLA 
HEPATICA SHOW SIMILAR DISTRIBUTION PATTERNS
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Neorickettsia are α Proteobacteria that can cause serious diseases in 
livestock animals and humans. These intracellular bacteria are transmitted 
by digenean trematodes but little is known about their relationship. 
Neorickettsia risticii has been isolated from infected horses, cultured 
in the laboratory, and described by transmission electron microscopy 
(TEM). However, ultrastructure and tissue localization of Neorickettsia 
in digeneans is largely unknown. We expressed a surface protein of 
Neorickettsia of Plagiorchis elegans (PeNsp-3) from experimentally infected 
hamsters, and raised antibodies to it for immunolocalization. TEM studies 
of P. elegans revealed pleomorphic bacteria with a median size of 600 
x 400 nm and with characteristic double membranes. Bacteria secreted 
polymorphic vesicles into the host cell or cell syncytium. We used the 
PeNsp-3 antibody for comparative detection of Neorickettsia in adults of P. 
elegans (North Dakota) and Fasciola hepatica (Oregon). Neorickettsia from 
P. elegans and F. hepatica are closely related to each other and to N. risticii 
(Illinois). On the amino acid level PeNsp-3 is 98% identical to its ortholog 
of Neorickettsia from F. hepatica. Neorickettsia showed similar localization 
pattern in both trematode species. Endosymbionts were unevenly localized 
as single cells, or as small morula-like clusters in tegument, ovaries, 
vitelline glands, uterus, eggs, testis, seminal receptacle, intestine and oral 
and ventral sucker. Large numbers were present in the Mehlis’ gland. 
Examination of hamster small intestine infected with P. elegans showed 
bacteria at the host-parasite interface of the oral and ventral sucker. We 
conclude that in P. elegans and F. hepatica large numbers of Neorickettsia 
in the Mehlis’ gland and adjacent tissues involved in egg assembly 
participate in vertical transmission. Their presence in suckers and intestinal 
tissues may facilitate horizontal transmission to the host of the trematode. 
This first localization of Neorickettsia endsymbionts in adult trematodes of 
medical and veterinary importance provides important clues about their 
transmission modes.
1818
MATHEMATICAL MODELING OF THE TRANSMISSION 
DYNAMICS OF OPISTHORCHIS VIVERRINI IN LAO PDR
Christine Bürli1, Helmut Harbrecht2, Peter Odermatt1, Somphou 
Sayasone3, Nakul Chitnis1
1Swiss Tropical and Public Health Institute, Basel, Switzerland, 2Universität 
Basel, Basel, Switzerland, 3National Institute of Public Health, Vientiane, 
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The trematode liver fluke, Opisthorchis viverrini, which causes the chronic 
hepatobiliary disease, opisthorchiasis, is prevalent is southeast Asia. 
We develop a mathematical model of the transmission dynamics of O. 
viverrini through its life cycle in snails, fish, and humans; and a second 
model that includes potential transmission from reservoir hosts such as 
domestic cats and dogs. We calibrate these models to data collected 
from two communities in Khong Island in Southern Lao PDR. Analysis 
of the model assuming no reservoir hosts, shows that interventions 
such as behavioral changes in dietary habits (reducing transmission from 
fish to humans) and improved sanitation (reducing transmission from 
humans to snails) are most effective in reducing transmission potential 
and the mean burden of worms in humans. However, in the presence of 
reservoir hosts, snail control, if feasible, is the most effective intervention 
for reducing transmission potential, but behavioral changes in dietary 
habits remains the most effective intervention for reducing the worm 
burden in humans. Additionally, the model suggests that for the observed 
prevalence of infection in dogs and cats in Khong Island, these reservoir 
hosts are capable of maintaining transmission in the population, even if 
perfect sanitation were to be achieved for all humans. Therefore, although 
improved sanitation and mass drug administration substantially reduce the 
mean worm burden in humans, additional strategies, such as behavioral 
changes in the feeding practices of domestic pets, safe fish production 
and/or snail control, would be necessary to eliminate O. viverrini 
transmission in Khong Island.
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OUTCOME OF TWO PHASE I RELATIVE BIOAVAILABILITY 
STUDIES IN HEALTHY VOLUNTEERS AFTER ADMINISTRATION 
OF THE NEW PEDIATRIC ODT FORMULATIONS OF 
RACEMATE PRAZIQUANTEL (RAC-PZQ) AND OF THE ACTIVE 
ENANTIOMER OF PRAZIQUANTEL (L-PZQ)
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Harrison3, Peter Wolna3, Oezkan Yalkinoglu3, Elly Kourany-Lefoll4, 
Peter L. Bonate5
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Praziquantel (PZQ) was developed in the 1970s to treat schistosomiasis. 
PZQ tablets are available to treat adults and school aged children, but 
there is a pressing need to develop a suitable pediatric formulation for 
treating preschool children. New pediatric oral disintegrating tablets 
(ODTs) of racemic Praziquantel (rac-PZQ), as well as of the active 
L-enantiomer of PZQ (L-PZQ), are under development by the Pediatric 
Praziquantel Consortium. These ODT formulations were assessed for 
their relative bioavailability against the reference PZQ tablets (Cysticide) 
in 2 randomized cross-over studies in healthy males. Each study included 
resp. 32 and 36 subjects, who received single oral doses dispersed in 
water (ODT formulation) or as tablets (Cysticide), with a wash-out of 
7 days in between. Treatments were resp. rac-PZQ ODT at oral doses 
of 20, 40 and 60 mg/kg and L-PZQ ODT at doses of 10, 20 or 30 mg/
kg under fed conditions, and either 40 (rac-PZQ) or 20 (L-PZQ) mg/kg 
ODT under fasting conditions, and 40 mg/kg PZQ (Cysticide) under fed 
conditions. Plasma samples for PK were taken at pre-specified time-points 
up to 24 hours and concentrations of L- and D-PZQ were measured with 
a validated enantioselective LC-MS/MS method. PK parameters Cmax 
and area under the curve (AUC) were calculated. After administration of 
L-PZQ no conversion to the D-PZQ enantiomer was seen. PK profiles after 
administration of all formulations were quite variable, showing a food 
effect and supra-proportionality not allowing to build a compartmental 
model describing the PK profiles. Instead, a linear mixed effects model was 
built to describe the PK parameters Cmax and AUC and used to predict 
the dose-exposure relationship in children. Exposure to L-PZQ administered 
as rac-PZQ ODT or as Cysticide tablets was comparable, but both were 
higher than after administration of equivalent doses of L-PZQ as ODT. The 
low exposure (40%) of L-PZQ after administration of L-PZQ ODT compared 
to administration of equivalent amounts of racemic-PZQ tablets indicates 
the need for higher dosages of L-PZQ ODT to be administered to achieve 
therapeutic effects.
1820
COMPARATIVE EFFICIENCY OF BIOMPHALARIA PFEIFFERI 
AND B. SUDANICA AS INTERMEDIATE HOST SNAILS FOR 
SCHISTOSOMA MANSONI AND ITS IMPLICATIONS FOR 
TRANSMISSION OF SCHISTOSOMIASIS IN KENYA
Martin W. Mutuku
Kenya Medical Research Institute, Nairobi, Kenya
In Kenya, schistosomiasis infects an estimated 6 million people with >30 
million people at risk of infection. Schistosoma mansoni is commonly 
transmitted by Biomphalaria pfeifferi, an inhabitant of streams and 
small water bodies, and B. sudanica, which is mostly found along shores 
of Lake Victoria. Recent studies have accentuated the role of infected 
snails in maintaining transmission as some snails can survive for over a 
year shedding cercariae daily. We sought to determine if these two snail 
species may differ with respect to the efficiency with which they support 
S. mansoni infections. We exposed field-derived B. pfeifferi (Kirinyaga, 
central Kenya) and B. sudanica (Kisumu, western Kenya) to S. mansoni 
derived from human subjects from Kirinyaga or Kisumu. The reciprocal 
cross infection design allowed us to ascertain if local adaptation effects 
might influence infection outcomes. Juvenile (<6 mm shell diameter), 
young adult (6-9 mm) and adult snails (> 9 mm) were exposed, all to one 
miracidium/snail. Overall, B. pfeifferi consistently had higher infection 
rates than B. sudanica (39.6 - 80.7% vs. 2.4 - 21.5%), regardless of the 
source of S. mansoni or the size of the snails used. Allopatric B. pfeifferi 
- S. mansoni combinations had higher infection rates than sympatric 
combinations while B. sudanica showed the opposite trend. Infection rates 
were inversely proportional to snail size. Mean daily cercariae production 
was greater for B. pfeifferi exposed to sympatric than allopatric S. mansoni 
(62 –2465 and 100 – 1232, respectively), and this trend increased with 
snail size. Overall mean daily cercariae production amongst all B. sudanica 
was low (50–590) with no significant differences between sympatric or 
allopatric combinations, or among the different snail sizes (p < 0.05). 
In conclusion B. pfeifferi is more likely to become infected and to shed 
more cercariae than B. sudanica, suggesting that the per snail risk of 
perpetuating transmission in Kenyan streams and lacustrine habitats 
may differ considerably with noteworthy implications for understanding 
transmission dynamics and planning control efforts.
1821
DEVELOPMENT OF A NONHUMAN PRIMATE MODEL OF 
ZIKA VIRUS INFECTION IN PREGNANT AND NON-PREGNANT 
RHESUS MACAQUES
Emma L. Mohr1, Dawn M. Dudley1, Matthew T. Aliota1, Andrea 
Weiler1, Gabrielle Lehrer-Brey1, Kim L. Weisgrau1, Mariel S. 
Mohns1, Meghan E. Breitbach1, Mustafa N. Rasheed1, Dane D. 
Gellerup1, Louise H. Moncla1, Jennifer Post1, Nancy Schultz-
Darken1, Michele L. Schotkzo1, Jennifer M. Hayes1, Josh A. 
Eudailey2, M. Anthony Moody2, Sallie R. Permar2, Shelby L. 
O’Connor1, Eva G. Rakasz1, Heather A. Simmons1, Saverio 
Capuano III1, Thaddeus G. Golos1, Jorge E. Osorio1, Thomas C. 
Friedrich1, David H. O’Connor1
1University of Wisconsin Madison, Madison, WI, United States, 2Duke 
University, Durham, NC, United States
Zika virus has recently been identified as the cause of clinically significant 
disease with outcomes including fetal abnormalities in the Americas. 
However, little is known about the natural history of Zika virus, nor the 
full spectrum of associated diseases. To investigate virus dynamics and 
immune responses in vivo, we developed a rhesus macaque model for 
Zika virus infection. We also examined the effects of maternal Zika virus 
infection on fetal development at different stages of pregnancy. We 
subcutaneously inoculated non-pregnant and pregnant animals with Asian 
or African lineage Zika virus. Viral RNA was detected in plasma one day 
post-infection (dpi) in all animals, with peak viral loads reaching above 1 
x 105 viral RNA copies/mL. Viral RNA was also present in saliva, urine, and 
cerebrospinal fluid, consistent with case reports from infected humans. 
Two of four pregnant animals remained viremic for longer periods than 
non-pregnant animals. Viral RNA was detected in amniotic fluid in one 
pregnant animal infected during the third trimester. In all animals, infection 
was associated with transient increases in proliferating natural killer cells, 
CD8+ T cells, CD4+ T cells, and plasmablasts. Neutralizing antibodies were 
detected in all animals by 21 dpi. Rechallenge of non-pregnant animals 
with the Asian lineage Zika virus resulted in no detectable virus replication, 
suggesting that primary Zika virus infection elicits protective immunity 
against homologous and heterologous virus strains. Measurements of 
fetal growth by ultrasonography, examination of fetal brain abnormalities 
by magnetic resonance imaging, and tissue tropism studies in fetuses are 
ongoing. These studies establish that Asian lineage Zika virus infection of 
rhesus macaques provides a relevant animal model for studying natural 
history and pathogenesis in pregnant and non-pregnant nonhuman 
primates.
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ZIKA VIRUS INFECTION OF HUMAN PLACENTAL CELLS AND 
EXPLANTS: THE ROLE OF ZIKV RECEPTORS AND ANTI-
FLAVIVIRUS ANTIBODIES
Henry Puerta-Guardo1, Takako Tabata2, Matthew Petitt2, Daniela 
Michlmayr1, Martina Beltramello3, Davide Corti3, Federica Sallusto4, 
Antonio Lanzavecchia4, Lenore Pereira2, Eva Harris1
1Division of Infectious Diseases and Vaccinology, School of Public Health, 
University of California Berkeley, Berkeley, CA, United States, 2Department 
of Cell and Tissue Biology, School of Dentistry, University of California 
San Francisco, San Francisco, CA, United States, 3Humabs BioMed SA, 
Bellinzona, Switzerland, 4Institute for Research in Biomedicine, Università 
della Svizzera Italiana, Bellinzona, Switzerland
The Zika epidemic that began in Brazil and spread throughout the 
Americas has been reported as definitively linked to severe birth defects 
- microcephaly, miscarriage and stillbirth. Detection of ZIKV RNA in the 
placenta and fetus as well as intrauterine growth restriction suggests 
extensive infection of the placenta leading to substantial virus-induced 
pathology. Our studies in placental explants and primary cells isolated from 
human placenta reveal that prototype and recently isolated Nicaraguan 
ZIKV 2016 strains infect cells that express AXL, Tyro3 and TIM1 tyrosine 
kinase receptors, which mediate infection by ZIKV and the closely related 
dengue virus (DENV) in skin. Infected placental cells, including fetal 
amniotic epithelial cells, placental fibroblasts, umbilical vein endothelial 
cells and trophoblast progenitor cells (TBPC), developed cytopathology and 
expressed ZIKV envelope and nonstructural NS3 proteins, and virus titers 
released depended on receptors expressed and gestational age. Indicative 
of infection route, AXL was detected in decidua (uterine decidual cells, 
invasive cytotrophoblasts), chorionic villi (placental fibroblasts, Hofbauer 
cells, blood vessels) and fetal membranes (amniotic epithelial cells, TBPC). 
ZIKV-infected cells downregulated AXL, which was strongly induced in 
neighboring cells, suggesting a contribution to infection. Differential 
expression of receptors suggests how ZIKV could infect the decidua and 
spread to the placenta, fetus and amnion-chorionic membranes. Further, 
in endemic regions, cross-reactive pre-existing antibodies to DENV could 
play a critical role in protection or pathogenesis of ZIKV in placenta tissues 
during pregnancy. Thus, we are studying the neutralizing and potentially 
enhancing role of ZIKV-specific and DENV-cross-reactive antibodies on 
infection in primary placental cells and explants. These studies reveal 
molecular mechanisms of ZIKV infection and routes of virus transmission 
to the fetus, and we are using the model to assess the therapeutic 
potential of antibodies and small molecule inhibitors to block infection and 
prevent congenital disease.
1823
THE CRYO-EM STRUCTURE OF ZIKA VIRUS
Devika Sirohi1, Zhenguo Chen1, Lei Sun1, Thomas Klose1, 
Theodore C. Pierson2, Michael G. Rossmann1, Richard J. Kuhn1
1Purdue University, West Lafayette, IN, United States, 2National Institute of 
Allergy and Infectious Diseases, Bethesda, MD, United States
Zika virus (ZIKV) has recently attracted global notoriety due to its explosive 
spread through the Pacific Islands and Latin/Central America and its link to 
neurological complications such as congenital microcephaly and Guillain 
Barré syndrome. It poses a looming threat to many countries (including 
USA) infested with the Aedes species of mosquitoes that transmit the 
virus. ZIKV can also be sexually and vertically transmitted which expands 
the geographical reach of the virus. The World Health Organization 
therefore declared Zika epidemic as ‘a public health emergency of 
international concern’. ZIKV is a positive sense RNA virus belonging to the 
Flaviviridae family that includes other pathogenic viruses such as dengue 
virus, West Nile virus, yellow fever virus and tick-borne encephalitis virus. 
An understanding of the biology of the virus and the mechanism of 
disease are required to provide appropriate recommendations to tackle the 
virus and for timely development of diagnostic kits, vaccines and antivirals. 
We have determined the structure of mature ZIKV at 3.8Å resolution 
using cryo-electron microscopy The structure of ZIKV is similar to other 
known flavivirus structures except for the ~10 amino acids that surround 
the Asn154 glycosylation site found in each of the 180 surface envelope 
glycoproteins that make up the icosahedral shell. The carbohydrate moiety 
associated with this residue may function as an attachment site of the 
virus to host cells. This region varies not only among ZIKV strains but 
also in other flaviviruses and suggests that changes in this region could 
influence virus transmission and disease. The atomic structure of ZIKV and 
its comparison with other flaviviruses will be discussed.
1824
BOOSTING ALTERS THE CROSS-NEUTRALIZING CAPACITY 
OF ANTIBODY-RESPONSE FOLLOWING ZIKA EXPOSURE IN 
C57BL/6 MICE
Anna B. Kawiecki, Anu Susan Charles, Rebecca C. Christofferson
Louisiana State University, Baton Rouge, LA, United States
Zika virus (ZIKV) has recently emerged in the Americas, in areas where 
the related Flavivirus, dengue virus (DENV), is already endemic. Cross-
neutralization of antibodies among Flaviviruses has previously been 
demonstrated, and reports from diagnostic serological tests have 
suggested this cross-reactivity occurs among DENV1-4 and ZIKV. In this 
study, we investigate the cross-neutralizing capacity of the antibody 
population after subcutaneous exposure to ZIKV in C57BL/6 mice using 
plaque reduction neutralization tests (PRNTs). Exposed mice initially 
produced very highly neutralizing antibody to ZIKV (PRNT80) that also 
highly cross-neutralized DENV2 (PRNT50). After a regimen of homologous 
boosting with ZIKV, the antibody neutralization capacity remained very 
high to ZIKV (PRNT80). However, the cross-neutralization to DENV2 
decreased to almost nothing. These results indicate that C57BL/6 mice 
produce a strong antibody response in the absence of robust viremia, 
suggesting its utility as a model for investigating antibody responses to 
ZIKV and cross-neutralization to at least DENV2. These results further 
suggest that homologous boosting with ZIKV contributes to the evolving 
specificity of the antibody population toward ZIKV in these mice, as it 
decreases cross-neutralization of heterologous Flaviviruses.
1825
VECTOR COMPETENCE OF AMERICAN MOSQUITOES FOR 
MULTIPLE STRAINS OF ZIKV REPRESENTING EACH GENETIC 
CLADE
James D. Weger-Lucarelli
Colorado State University, Fort Collins, CO, United States
In 2015 Zika virus (ZIKV; Flaviviridae. Flavivirus) emerged in the Americas, 
causing millions of infections in dozens of countries from Brazil to 
Mexico. The rapid spread of the virus and the association with concerning 
disease outcomes such as Guillain-Barré syndrome and microcephaly 
make understanding transmission dynamics essential. Currently, there 
are no reports of vector competence (VC) of American mosquitoes for 
ZIKV isolates from the Americas. Further, it is not clear whether locally 
circulating strains display enhanced transmissibility by local mosquitoes. 
First, we determined if/whether freezing ZIKV prior to experiments impacts 
VC estimates as has been shown for dengue virus. Mexican Aedes aegypti 
mosquitoes were given an infectious bloodmeal with either fresh or 
frozen ZIKV that was originally isolated from an infected human in Puerto 
Rico (Strain PRVABC59, Asian clade). While infection and transmission 
rates were significantly higher in mosquitoes fed fresh virus on day 7 
post-exposure, no differences were observed in infection, dissemination 
or transmission rates by day 14, and high infection rates were observed, 
indicating that previously frozen virus could be used for ZIKV vector 
competence studies. Ae. aegypti mosquitoes were then infected with 
viruses from the other two recognized ZIKV clades, strain 41525 from the 
West African clade and strain MR766 from the East African clade along 
with the aforementioned PRVABC59 strain. Studies showed that while 
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mosquito infection and dissemination rates were different between the 
three strains, all viruses were able to infect, disseminate, and were found 
in saliva (all groups greater than 60% transmission rate by 14 days post-
exposure) in the American mosquitoes tested, indicating transmission 
potential. These data demonstrate that American mosquitoes are highly 
competent for ZIKV from all three viral clades and that emergence of viral 
strains from Africa in addition to the currently circulating Asian lineage 
strain should be monitored.
1826
MAPPING ZIKA VIRUS CROSS-NEUTRALIZING EPITOPES
Jesica Swanstrom, Jessica Plante, Ken Plante, Ellen Young, Mark 
Heise, Aravinda de Silva, Ralph Baric
University of North Carolina at Chapel Hill, Chapel Hill, NC, United States
The recent emergence and spread of Zika virus (ZIKV) in the Americas 
has presented a global Public Health emergency and new therapeutic 
strategies are needed to protect against severe life threatening infections. 
Moreover, several groups have identified a strong causal relationship 
between prenatal ZIKV infection and microcephaly in the developing fetus, 
as well as an association with other serious brain abnormalities. While 
the ZIKV adult pathologies are less severe than those caused by other 
flaviviruses, immunity in pregnant females may offer protection from the 
more devastating outcomes in infected fetuses. ZIKV is closely related to 
dengue viruses. Moreover, the close phylogenetic relationship between 
ZIKV to DENV provides an opportunity study the antigenic relationships 
between these two flavivirus strains. Using a panel of human and mouse 
monoclonal antibodies generated against various dengue virus (DENV) 
strains, we have identified some with pan-flavivirus binding reactivity. 
Using an in vitro neutralization assay, a binding assay, and an in vivo 
protection study, we have shown that many DENV antibodies bind to 
ZIKV, but only a few were broadly neutralizing and mapped onto the E 
glycoprotein dimer. As structural studies indicate that ZIKV is very mature, 
it was also not surprising that the prM targeting antibodies did not bind 
ZIKV. These experiments have revealed a set of monoclonal antibodies 
targeting a highly conserved neutralizing epitope in DENV and ZIKV. 
Using an in vivo mouse model, we are currently testing the ability of 
these broadly cross neutralizing antibodies to protect against ZIKV virus 
infection, potentially identifying a therapeutic antibody for human use.
1827
DEVELOPMENT AND CHARACTERIZATION OF LIVE 
ATTENUATED VACCINE CANDIDATES FOR ZIKA VIRUS
Stephen S. Whitehead1, Sara E. Woodson1, Caiyen Firestone1, 
Emerito Amaro-Carambot1, Anna P. Durbin2
1National Institute of Allergy and Infectious Diseases, National Institutes of 
Health, Bethesda, MD, United States, 2Johns Hopkins Bloomberg School of 
Public Health, Baltimore, MD, United States
The goal of the NIH Laboratory of Infectious Diseases (LID) vaccine 
program is the development of market-sustainable, live-attenuated 
vaccines for several medically- important flaviviruses. In the past, the 
focus has been on the development of the tetravalent dengue virus 
(DENV) vaccine, which is currently undergoing Phase III evaluation by 
the Butantan Institute in Brazil. With the recent outbreak of Zika virus 
(ZIKV) in Latin America, attention has been turned to leveraging the 
dengue vaccine platform for the creation of vaccine candidates against 
ZIKV. The live vaccine candidates should be minimally reactogenic, 
highly immunogenic across all age-groups, cost-effective, and safe for 
the community. In addition, it would be ideal if they were compatible 
with the existing tetravalent dengue formulation to allow for inclusion 
into a pentavalent dengue/Zika formulation for use in regions where 
these viruses co-circulate. Recombinant chimeric viruses expressing the 
structural proteins of ZIKV in the background of different DENV serotypes 
containing the delta-30 deletion have been generated. In addition, full-
length ZIKV cDNA molecules containing altered 3’ untranslated regions 
are also under construction. Preclinical trials in mice and rhesus monkeys 
are being used to demonstrate the attenuation phenotype of these 
ZIKV candidates and to down-select suitable strains. Phase I trials will 
evaluate the safety and immunogenicity of both monovalent ZIKV vaccine 
candidates and combinations with the tetravalent DENV vaccine. The LID 
is also developing a human challenge model for ZIKV using cGMP isolates 
or recombinant-derived strains. Such a model can be used for investigating 
vaccine-induced protection, establishing immune correlates of protection, 
and to accelerate a possible regulatory pathway toward licensure in the 
face of decreased transmission at the time of future Phase III efficacy trials. 
The challenge model will also be used to facilitate studies of ZIKV viremia 
in populations with well-defined pre-existing antibody profiles and to 
quantify the duration and level of ZIKV shedding in body fluids other than 
serum.
1828
THE ROLE OF ECDYSONE RECEPTOR IN ANOPHELES 
GAMBIAE MOSQUITO POST-MATING BIOLOGY
Kristine Werling, Evdoxia Kakani, Sara Mitchell, Maurice Itoe, 
Flaminia Catteruccia
Harvard T.H. Chan School of Public Health, Boston, MA, United States
The Anopheles gambiae mosquito is responsible for infecting millions of 
people with malaria each year throughout Africa. Female Anophelines 
mate a single time in their life making reproduction a crucial point in 
their life cycle, and a potential target for vector control. The critical insect 
steroid hormone, 20-hydroxyecdysone (20E), is essential for regulating 
larval development and egg production in numerous insect species. 
Recently, our lab identified multiple novel roles for 20E in An. gambiae 
reproduction. We demonstrated that sexual transfer of 20E during 
copulation is necessary and sufficient to induce two key female post-
mating phenotypes: oviposition and refractoriness to multiple matings. 
Here we show that male-transferred 20E induces these phenotypes 
by initiating signaling cascades following its interaction with specific 
receptors localized to the female reproductive tissues. Ecdysone Receptor 
(EcR) is known to be an ecdysone-responsive nuclear receptor regulating 
20E signaling during larval development, metamorphosis, and adult 
female vitellogenesis. Our findings suggest that EcR in An. gambiae is 
responsible for regulating 20E-induced oviposition, while female mating 
refractoriness is induced through a novel, yet unidentified, 20E receptor. 
We have also discovered that in an EcR depleted background, females 
fail to store sperm. This sensitized genetic background can be used 
to provide important biological insights into the mechanism of sperm 
storage - a critical process for the female’s lifelong fertility. Overall, 
understanding the mechanisms through which male-transferred 20E 
induces vast transcriptional and physiological changes in the female An. 
gambiae mosquito can not only advance knowledge of unique vector 
reproductive biology, but it can also reveal novel biological targets for 
mosquito control.
1829
PLASMODIUM FALCIPARUM PFS47 GENETIC DIVERSITY IN 
FIELD COLLECTED ANOPHELES GAMBIAE AND ANOPHELES 
COLUZZI FROM MALI, AFRICA
Alvaro Molina-Cruz1, Emma Taylor-Salmon1, Moussa Keita2, 
Nafomon Sogoba2, Carolina Barillas-Mury1
1National Institutes of Health, Rockville, MD, United States, 2MRTC, 
University of Bamako, Bamako, Mali
The anopheline immune system has the capacity to mount effective 
antiplasmodial responses. We have shown previously that Pfs47 is required 
by Plasmodium falciparum to evade the Anopheles immune system, which 
can be an important barrier for the adaptation of the parasite to different 
vectors. Adaptation of P. falciparum to evolutionary distant anophelines 
appears to involve natural selection of compatible Pfs47 haplotypes. Pfs47 
presents high genetic diversity in Africa and strong geographic structure at 
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continental level worldwide, consistent with natural selection of the gene 
by different anophelines. Here we test whether Pfs47 may be differentially 
selected by sympatric African malaria vectors. We studied Pfs47 genetic 
diversity being transmitted by An. gambiae and An. coluzzi in a small 
region of Mali. Pfs47 was genotyped in a total of 150 sporozoite-infected 
mosquitoes collected throughout the year. Multiple Pfs47 haplotypes 
were detected in 26% of the mosquitoes. A high diversity of Pfs47 was 
detected (11 haplotypes) with 2 haplotypes accounting for 73% of 
the P. falciparum infected mosquitoes. Temporal analysis of haplotype 
distribution showed Pfs47 haplotype present diversity throughout the 
year in both species of mosquitoes. The most frequent Pfs47 haplotypes 
were present in both An. gambiae and An. coluzzi, but there were some 
differences in the frequency between both species. An. gambiae and An. 
coluzzi don’t appear to be genetically distant to cause major differential 
selection of Pfs47 haplotypes.
1830
HYBRID ALLELIC IMBALANCE AND GENE EXPRESSION 
EVOLUTION IN THE ANOPHELES GAMBIAE SPECIES 
COMPLEX
Kevin C. Deitz1, Willem Takken2, Michel A. Slotman1
1Texas A&M University, College Station, TX, United States, 2Wageningen 
University, Wageningen, Netherlands
The accumulation of genetic incompatibilities that cause hybrid sterility 
and/or inviability between diverged populations is an important step 
in the formation and maintenance of species boundaries in the face 
of hybridization. In the Anopheles gambiae species complex, F1 hybrid 
males are sterile, while females are fully fertile and can backcross to either 
parental species. Thus, F1 hybrid females facilitate the introgression of 
genomic regions between species (e.g. chromosomal inversions) that 
may be adaptive. While some chromosomal incompatibilities that cause 
hybrid sterility and inviability between An. gambiae and An. arabiensis 
have been identified, little is understood about the nature of these 
incompatibilities. Divergence in gene expression, rather than genetic 
differences, is thought to account for a large proportion of phenotypic 
differences between species, and may also play a role in hybrid sterility 
and inviability. We analyzed gene expression in F1 hybrid male and female 
pupae and compared it to parental males and females in bi-directional 
crosses between An. gambiae, An. arabiensis, and An. quadriannulatus. By 
analyzing genome-wide, allele-specific gene expression, we explored the 
roles of cis and trans regulatory divergence between species and in male 
and female hybrid phenotypes. The relationship between allele-specific 
expression, patterns of sequence evolution, and known hybrid sterility/
inviability QTL was also explored. Our analysis provides insight into gene 
expression divergence and evolution in the An. gambiae species complex.
1831
HEMOCYTE-SPECIFIC MANIPULATION OF THE IMD PATHWAY 
AFFECTS PLASMODIUM INFECTION IN ANOPHELES 
STEPHENSI
Frank Criscione, David O’Brochta
University of Maryland, Rockville, MD, United States
Using a newly developed hemocyte specific Gal4/UAS-based expression 
system in Anopheles stephensi we have begun to investigate the role of 
the IMD pathway in the hemocyte’s ability to respond to a Plasmodium 
infection. The IMD pathway has been shown to contribute to the 
mosquito’s ability to fight a Plasmodium infection through studies using 
RNAi as a method to perturb post-transcriptional gene expression in the 
IMD pathway. However, due to the pleotropic effects of dsRNA injections 
it becomes difficult to ascertain the individual contributions of various 
tissues to the immune response against a Plasmodium infection beyond 
the midgut stage of parasite development. Using the Gal4/UAS system 
we are able to disrupt the IMD pathway specifically in hemocytes, the 
cellular component of the mosquito’s innate immune system, and analyze 
the mosquito’s response to a parasite challenge. We have found that 
manipulation of the IMD pathway by knocking down or over expressing 
Caspar leads to altered levels of infection in both midguts and salivary 
glands in comparison to controls. This suggests the IMD pathway plays 
an important role in the hemocyte’s ability to defend against infection 
during multiple stages of Plasmodium infection, independent of a normal 
IMD pathway in all other tissues. This approach allows for questions to 
be answered concerning the parasite-vector interaction during the post-
midgut stage of parasites development; a pivotal point in defense against 
salivary gland invasion by sporozoites.
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LANDSCAPE GENETICS OF PYRETHROID RESISTANCE IN 
ANOPHELES ARABIENSIS IN KENYA
Elizabeth Hemming-Schroeder, Eugenia Lo, Daibin Zhong, 
Guiyun Yan
University of California Irvine, Irvine, CA, United States
Anopheles arabiensis have become increasingly abundant in Africa and 
are playing an important role in maintaining residual malaria transmission 
in sub-Saharan Africa. Overall, insecticide resistance in An. arabiensis has 
remained relatively low with respect to An. gambiae. However, recent 
studies suggest that resistance in An. arabiensis is emerging in Africa. 
Resistance could potentially increase and spread rapidly if gene flow 
between populations is large. Knowledge of An. arabiensis population 
genetic structure is critical to understanding insecticide resistance spread. 
We test how various ecological variables affect gene flow (dispersal) 
using a landscape genetics approach utilizing techniques from population 
genetics, landscape ecology, and spatial statistics. We genotyped An. 
arabiensis collected from 14 study sites across Kenya at 10 microsatellite 
loci and at kdr L1014F/S. We created resistance surfaces in ArcGIS for 
key environmental and landscape variables hypothesized to influence 
gene flow of An. arabiensis. We optimized resistance surfaces using the 
ResistanceGA package in R which utilizes a genetic algorithm to optimize 
surfaces based on pairwise genetic distances and CIRCUITSCAPE resistance 
distances. Lastly, mixed effects models were fit by maximum likelihood in 
the lme4 package in R. We observed both kdr 1014F and 1014S alleles. 
Kdr mutation frequencies were 0.023 and 0.103 at two sites in western 
Kenya and were absent from other sites. We hypothesize that forest cover 
and elevation provide the greatest barriers to gene flow and population 
density and roads largely promote gene flow. Understanding the factors 
promoting gene flow and insecticide resistance spread is critical to 
informing antimalarial interventions, especially since pyrethroid resistance 
in An. arabiensis is relatively low and patchily distributed.
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GENOMIC ANALYSIS OF THE ANOPHELES GAMBIAE 
BAMAKO ECOTYPE
R. Rebecca Love1, Aaron M. Steele1, Mamadou B. Coulibaly2, 
Sékou F. Traore2, Scott J. Emrich1, Michael C. Fontaine3, Nora J. 
Besansky1
1University of Notre Dame, Notre Dame, IN, United States, 2University 
of Sciences, Techniques and Technologies of Bamako, Bamako, Mali, 
3University of Groningen, Groningen, Netherlands
The Bamako ecotype is a chromosomal form of Anopheles gambiae found 
in southern Mali and northern Guinea in association with rock pools 
in the Niger River. The ecotype is defined by three fixed chromosomal 
inversions on arm 2R, j, c, and u, the latter two of which also segregate 
at appreciable frequencies in sympatric An. coluzzii and non-Bamako 
An. gambiae. Previous studies have found evidence for some degree of 
assortative mating within the Bamako ecotype, but the status of this 
ecotype as an independently evolving entity remains unclear, as does the 
genomic basis of differential habitat preferences between Bamako and 
non-Bamako forms. Clarifying the status of this ecotype offers a chance 
to explore the genomic basis of habitat adaptation in An. gambiae. Using 
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pooled resequencing (pool-seq) of Bamako, non-Bamako An. gambiae, 
and An. coluzzii from southern Mali, as well as individual whole-genome 
resequencing, we present the first whole-genome analysis of the Bamako 
chromosomal form. Clustering of individual samples provides evidence 
for Bamako as an independent entity, while genome scans show that 
differentiation between Bamako and other sympatric populations is 
concentrated in the inversions that define Bamako. However, the strongest 
signals of differentiation are found not in the 2Rj inversion, which is 
relatively unique to Bamako in this geographic region, but in inversions 
2Rc and u, which are also found in sympatric populations of non-Bamako 
An. gambiae and An. coluzzii. This pattern of differentiation in shared 
inversions is partially driven by novel, Bamako-specific alleles in genes 
known to be involved in insecticide resistance, which may be candidate 
genes for habitat adaptation in this ecotype.
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Anopheles gambiae and An. coluzzii are two of the most important 
malaria vector species in sub-Saharan Africa. These recently-diverged 
sibling species are thought to be separated by strong assortative mating 
combined with selection against hybrids. At present, little is known 
about hybridization and the post-zygotic reproductive barriers between 
these cryptic taxa. Swarm segregation and assortative mating between 
An. gambiae and An. coluzzii were studied in the villages of VK7 and 
Soumousso, Western Burkina Faso. Natural swarms and pairs in copula 
were collected and genotyped, the proportion of intra and interspecific 
matings determined, and interspecific sperm transfer checked genetically. 
Females were collected resting indoors or as larvae and genotyped or 
sexed-and-genotyped via a multiplex PCR. Larval development and adult 
swarming success of hybrids were also estimated and compared to the 
parental species in semi-field experiment. A total of 3,687 males and 
220 females were collected from 109 natural swarms and genotyped. 
Amongst 187 females captured in copula, 4 An. gambiae and one An. 
coluzzii females were found paired with and inseminated by heterospecific 
males. The lower overall hybridization rates observed at the larval and 
adult indoor stages compared to cross-mating rates support post-
mating selection processes acting against hybrids. A total of 5,400 first 
instar larvae were transplanted in 36 cages in rice field with or without 
predators. Although no statistical difference was found between reciprocal 
hybrids and parental species in adult wing size, the development sucess 
varied significantly. In total 6,400 males of An. gambiae, An. coluzzii and 
the two reciprocal hybrids were randomly released in grand cages and 
swarm activities were daily monitored. A total of 428 males were captured 
in swarms but the frequencies of An. coluzzii (61.68%) followed by An. 
gambiae (37.62%) were significantely higher than those of the hybrids 
(0.70%). These findings are important for our understanding of the 
process of sympatric speciation in these important vector species.
1835
INTEGRATED PEDIATRIC FEVER MANAGEMENT AND 
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There are concerns about growing irrational antibiotic prescription 
practices in the era of test-based malaria case management. This study 
assessed integrated pediatric fever management using malaria rapid 
diagnostic tests (RDT) and Integrated Management of Childhood Illness 
(IMCI) guidelines, including the relationship between RDT-negative results 
and antibiotic over-treatment in Malawi health facilities in 2013-2014. 
A Malawi national facility census included 1,981 observed sick children 
2-59 months with fever complaints. Weighted frequencies were tabulated 
for other complaints, assessments, and prescriptions for RDT-confirmed 
malaria, IMCI-classified pneumonia, and clinical diarrhea. Classification 
trees using model-based recursive partitioning estimated the association 
between RDT results and antibiotic over-treatment and learned the 
influence of 38 other input variables at patient-, provider-, and facility-
levels. Among 1,981 clients, 72% were tested or referred for malaria 
diagnosis and 85% with RDT-confirmed malaria were prescribed first-line 
anti-malarials. 28% with IMCI-pneumonia were not prescribed antibiotics 
(under-treatment) and 59% ‘without antibiotic need’ were prescribed 
antibiotics (over-treatment). Few clients had respiratory rates counted to 
identify antibiotic need for IMCI-pneumonia (18%). RDT-negative children 
had 16.8 (95% CI: 8.6-32.7) times higher antibiotic over-treatment odds 
compared to RDT-positive cases conditioned by cough or difficult breathing 
complaints. Integrated pediatric fever management was sub-optimal 
for completed assessments and antibiotic targeting despite common 
compliance to malaria treatment guidelines. RDT-negative results were 
strongly associated with antibiotic over-treatment conditioned by cough or 
difficult breathing complaints. A shift from malaria-focused ‘test and treat’ 
strategies toward ‘IMCI with testing’ is needed to improve quality fever 
care and rational use of both anti-malarials and antibiotics in line with 
recent global commitments to combat resistance.
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Seeking care from an appropriate provider is the first step in accessing 
correct management of an episode of childhood illness. Accuracy of 
maternal-reported care-seeking timing and source of care as collected 
through household surveys has not been validated in sub-Saharan Africa. 
A 2016 survey compared reported care-seeking against a gold-standard 
of documented care-seeking events among a random sample of mothers 
of children <5 years old in Southern Province, Zambia. A total of 1,156 
enrolled children were assigned cards with unique barcodes. A total of 75 
potential providers of child curative services in the study area participated 
in care-seeking event tracking. Providers were given smartphones with 
575
astmh.org
a barcode reader and instructed to scan the cards of all children seeking 
care at the source, generating an electronic record of the care-seeking 
event. Additionally, providers gave all caregivers accessing care for a child 
<5 provider-specific tokens used to verify the point of care during the 
household survey. Reported care-seeking events were ascertained in each 
household using a questionnaire modeled off the Zambia Demographic 
and Health Survey (ZDHS). The ZDHS defines childhood illness as fever, 
cough with rapid breathing, and/or diarrhea in a child under 60 months 
of age in the two weeks preceding the survey. Recall of care-seeking 
events for childhood illnesses reported by mothers was compared 
against the gold-standard documented care-seeking events to estimate 
the accuracy of maternal recall of care-seeking behavior. Care-seeking 
data were collected for 537 children in urban areas and 547 children in 
rural areas. We present findings on the accuracy, sensitivity, and positive 
predictive value of caregiver report of care-seeking location by key socio-
demographic characteristics. This study assesses whether the current 
standard care-seeking indicator measured through household surveys 
can produce valid estimates of care-seeking for childhood illness. This 
will be used to determine whether new methods are needed to estimate 
care-seeking behavior to measure progress in global investments in child 
survival interventions.
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TESTING IN A POPULATION-BASED SURVEY OF FEBRILE 
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Many fever episodes in malaria endemic areas are treated in the informal 
sector. Minimal access to diagnostic testing, both in the formal and the 
informal sectors, lends itself to the potential for polypharmacy and other 
forms of inappropriate use of medicines. We describe the type and the 
number of medicines consumed for a febrile illness in a community 
survey conducted as part of a larger study. Data on any laboratory tests 
done for the fevers were also collected. The study population consisted 
of household members above one year of age with a history of a febrile 
illness in the preceding one month. Out of the 2,007 clients reporting a 
history of fever for which they took an action, 99.1% reported taking 
medication for the fever, mainly antipyretics/analgesics (86.7%) and 
antimalarials (76.4%). Use of antibiotics was reported at 29.8%. Forty 
seven percent of patients who took a medicine took two different drugs; 
the commonest combination being an antimalarial and an analgesic. 
Twenty eight percent (28%) took three different medications while nearly 
10% reported taking four or more medicines. Only 15.4% reported using 
a single drug. The majority of those who took an antimalarial (72.7%) 
reported using an ACT while the rest received either Sulphadoxine 
Pyremethamine (SP) or quinine. A malaria test was performed on 44.3% 
of the clients, while in 229 cases (11.4%) a test other than a malaria test 
was performed, most commonly for typhoid fever (81.7%), and brucellosis 
(18.8%). This was in addition to a malaria test for 221 (96.5%) of the 229 
for whom a non-malaria test was performed. Twelve percent reported 
being tested for both typhoid fever and brucellosis. Clients above 5 years 
of age, those who had a laboratory test, and those visiting a drug shop 
for fever management were more likely to receive more than two drugs 
(p<0.001). Clients under 5 years were more likely to have a malaria test 
done than those aged > 5 (p<0.001). There is a high rate of consumption 
of multiple drugs for fever which is exacerbated by poor access to 
diagnostic testing. There is need for strategies to promote evidence-based 
management of fevers and rational use of drugs in the community.
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Use of Community Health Workers (CHWs) in malaria diagnosis has 
been recommended as a task-shifting strategy to counter the shortage 
of health workers in resource-limited settings. However, monitoring 
their performance is a challenge. We implemented a set of strategies for 
monitoring CHW performance of malaria rapid diagnostic tests (mRDTs): 
1) Post-training evaluation, 2) regular supervision and refresher training 
visits, and 3) monitoring of error rates. In the context of a larger study, we 
trained 300 CHVs from 16 Community Units (CUs) in two sub counties 
in western Kenya on proper use of mRDTs. At the conclusion of training, 
we measured CHW proficiency with a standardized mRDT checklist 
and evaluated their interpretation of a set of used mRDTs. CHWs then 
administered and interpreted mRDTs within their CUs to any patients 
with symptoms and/or reported history of fever. Clients with a positive 
mRDT received an antimalarial discount redeemable at selected private 
medicine outlets when presented along with their positive mRDT cassette. 
We collected mRDTs interpreted as positive from the outlets, and mRDTs 
interpreted as negative from the CHWs. We then re-interpreted the mRDTs 
to confirm results and test quality. In the first 6 months, we convened a 
total of 10 supervision meetings with each CHW group in the 16 CUs, and 
provided refresher training as necessary. After 6 months, 10,872 clients 
had been tested, 2,256 (19.96%) of which had a positive mRDT and 8616 
(80.04%) of which had a negative mRDT. The total mRDT errors were 138 
tests (1.27%), with 62 (3%) false positive and 76 (1%) false negative. The 
incidences of false positive and false negative results trended downwards 
as supervision visits continued over time; month 1-2: 14.5/23, month 3-4: 
10.5/11, month 5-6: 6/3.5. The findings suggest that coupling supervision 
meetings with confirmation of mRDT results can help identify errors and 
refresher training needs, as well as improve CHW performance in accurate 
malaria diagnosis.
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FROM THE KENYA DEMOGRAPHIC AND HEALTH SURVEY, 
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Malaria in pregnancy (MIP) is associated with maternal anemia, placental 
parasitemia, low birth weight and increased perinatal mortality. 
Intermittent preventive treatment in pregnancy (IPTp) with sulphadoxine-
pyrimethamine (SP) is recommended to reduce MIP-associated risk in 
medium-to-high malaria transmission areas. In Kenya, although antenatal 
care (ANC) clinic attendance is high, the proportion of women receiving 
at least two doses of IPTp-SP has historically been low. We assessed the 
factors associated with missed IPTp opportunities during pregnancy. We 
analyzed data from the 2014 Kenya Demographic and Health Survey, a 
two-stage cluster sample, cross-sectional survey of 36,430 households. 
Missed IPTp opportunities were was defined as a woman aged 15–49 
years who attended at least four ANC visits and lived in the 14 malaria-
endemic counties with IPTp policy but received fewer than two doses 
of IPTp-SP during their last completed pregnancy. We used logistic 
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regression to compare missed IPTp-SP opportunities with demographic, 
socio-economic and geographic factors. Of the 909 women who 
attended at least four ANC visits in the 14 malaria-endemic counties, 
30.5% (n=277) had a missed opportunity for IPTp during pregnancy. 
In univariate analysis, living in the lake-endemic region (OR=1.7; 95% 
CI: 1.1–2.4; p=0.008), parity >4 children (OR=1.5; 95% CI: 1.04–2.22; 
p=0.028) and more than secondary education (OR=3.5; 95% CI: 1.6–7.5; 
p=0.001) were significantly associated with missed IPTp opportunities. 
In multivariate analysis, women with more than secondary education 
had significantly higher odds (OR=3.3; 95% CI: 1.4–7.9, p=0.007) of 
missed opportunities for IPTp. Despite high ANC attendance, almost 
one-third of pregnant women had at least one missed IPTp opportunity. 
Women with higher education were over three times more likely to have 
missed IPTp opportunities, which might be due to lack of perceived risk 
by both women and healthcare providers. Studies are needed to identify 
modifiable factors to increase IPTp uptake among pregnant women.
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Seasonal Malaria Chemoprevention was adopted in the Gambia as 
a strategy in 2012, included as part of the national policy in 2013, 
and implemented from 2014. In 2015, an electronic data system was 
introduced for monitoring delivery, through the ACCESS-SMC project 
supported by UNITAID. SMC drugs were administered from August to 
November in four cycles in Upper River Region and Central River Region. 
SMC was delivered door-to-door. Each child was issued an SMC card 
bearing a QR code that could be scanned with an android phone each 
time the child was treated. Information about the child (age, gender and 
other details) was captured on the phone using iForm, an offline data 
capture system, and then uploaded to a central database system, eValuate. 
The system provides information on all the monthly treatments a child has 
received avoiding the need for registers and allowing timely feedback to 
the malaria control programme about progress with SMC delivery. At the 
end of the transmission season, a cluster sample survey was conducted 
to measure SMC coverage. Communities selected with probability 
proportional to size, were divided into segments on a sketch map and 
all the households in one segment, which was chosen at random, were 
included in the survey. 1174 children under 7 years of age were surveyed, 
690 were eligible for 4 SMC cycles and of these, 93% had received an 
SMC card and at least one SMC treatment. 84% of children had received 
at least 3 months of SMC treatment. Coverage was lower in the 4th 
month, which coincided with harvest activities. The main reason for 
missed doses was being away when the health worker visited. Relatively 
few children outside the recommended age range were treated, among 
children 6 to 7 years of age, fewer than 30% had received SMC doses. 
Door-to-door delivery achieved high coverage of SMC in The Gambia. 
Outreach strategies may improve coverage at the end of the transmission 
season.
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The Hati Salama (HASA) cluster-randomized controlled trial aims to 
increase malaria awareness among pregnant women using mhealth 
technology in Tanzania. HASA utilized an electronic system whereby 
nurses issue vouchers to pregnant women, allowing them to redeem a 
Long Lasting Insecticidal bednet (LLIN) at a retailer for a highly subsidized 
cost. A RCT was selected to test efficacy of SMS behaviour change 
communication messages aimed to increase the uptake of LLINs in areas 
of Tanzania identified as malaria hotspots with overall low uptake of 
LLINs. HASA was implemented in 97 antenatal health facilities; 48 clinics 
were assigned to the control group (no targeted SMS messages sent to 
beneficiaries) and 49 in the intervention group (targeted messages sent to 
beneficiaries). In total, 5396 beneficiaries were randomized through cluster 
randomization of the health center and had LLIN voucher redemption 
status recorded. There were 2708 beneficiaries from the intervention 
clinics, and 2688 beneficiaries from the control clinics. There were 25 
urban clinics and 23 rural in each arm. The redemption rate was 70.4% 
in the intervention sites and 67.4% in the control sites. The absolute 
difference in the redemption rates was 3.5% (95% CI, -3.8% to 11.0%) 
p=0.35 according to a Rao-Scott estimate stratifying by urban/rural and 
clustering by clinic. The odds ratio of redemption in the intervention 
vs. control sites was 1.13 (95% CI, 0.86 to 1.51,p=0.36) according to 
the GEE method controlling for urban/rural and the prior redemption 
rate with a working exchangeable correlation to account for the cluster 
randomized design. The estimated intraclass correlation coefficient (ICC) 
is 0.11 meaning that 11% of the total variance in the redemption rates 
was attributable to the clinic and the remaining 89% was attributable to 
the beneficiary. The use of behavior change communication via SMS had 
no significant effect on increasing LLIN uptake among pregnant women 
in this large cluster randomized trial. This suggests that other factors to 
uptake of LLINs through a voucher program exist. Evaluation of these 
factors is essential for future implementation of similar programs.
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Plasmodium falciparum population genetics can inform malaria 
epidemiology, but a high prevalence of polygenomic infections (those 
with more than one genotype) can render estimation of even the most 
basic parameters, such as allele frequencies, challenging. A method, COIL, 
has been developed to estimate complexity of infection (COI) and allele 
frequency from SNP data, but relies entirely on monogenomic infections 
to estimate allele frequencies. However, allele frequency estimates limited 
to monogenomic infections are biased, and when the average COI is 
high they can be difficult or impossible to estimate. Here we develop an 
iterative approach that simultaneously estimates allele frequency and 
COI from all samples in a population, irrespective of whether they are 
monogenomic or polygenomic, and uses Markov chain Monte Carlo 
method to provide Bayesian inference. The method was tested on a 
series of simulations and then applied to a real dataset from Uganda. We 
performed Sequenom typing of 105 SNPs in 868 samples from cross-
sectional surveys performed in three regions of varying endemicities in 
Uganda including Walukuba (low-moderate, EIR 2.8), Kihihi (high, EIR 
32), and Nagongera (very high, EIR 310). Allele frequencies were used 
to calculate FST, a measure of genetic differentiation. Our results suggest 
high migration rates and little population substructure between the sites 
(0.016 Kihihi vs. Nagongera, 0.0 for Walukuba vs. Kihihi or Nagongera). 
Surprisingly, the mean COI in Walukuba (4.7) was similar to Nagongera 
(4.4) and significantly higher than Kihihi (2.0) despite much lower 
transmission in Walukuba; this unexpected finding was not explained by 
parasite density or age. One possible explanation for this finding is that 
Walukuba is peri-urban setting with a relatively high proportion of cases 
coming from surrounding regions with higher transmission intensity. This is 
also consistent with the absence of population structure observed between 
the other sites. We conclude that this method allows the interpretation of 
useful population genetic SNP data from polygenomic infections, which 
are common in high transmission settings.
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Estimates of parasite gene flow may be important in stratifying malaria 
risk, but to be useful for this purpose those estimates need to reflect 
contemporary patterns of parasite migration. Haplotypes identical-by-
descent are being increasingly used in human genomics for inference 
of recent demographic events, and can be used to estimate migration 
rates. Such methods have not been used to infer migration patterns 
for malaria parasites, and they are just now beginning to be used to 
document changes in parasite demography as a result of reduced malaria 
transmission or the rapid spread of drug resistance mutations. The 
objective of this study is to examine segments of the parasite genome 
that are identical-by-descent (IBD) to more finely map patterns of parasite 
population structure and to infer migration patterns at an increasingly 
local scale. The extent of shared IBD haplotypes was determined by the 
program Beagle using SNPs genotyped by a P. falciparum DNA microarray 
from samples collected in Southeast Asia and Bangladesh. The extent of 
IBD sharing was estimated pair-wise between all samples and aggregated 
both within each study site and between study sites. Preliminary analyses 
suggest meaningful sharing of IBD haplotypes within study sites, with 
median IBD segments upwards of 1MB. There is evidence of increased 
IBD sharing between sites in close geographic proximity, but also some 
evidence of IBD sharing between more geographically distant sites, which 
may represent parasite migration through human movement. Patterns 
of IBD sharing between sites mirror patterns of spreading artemisinin 
resistance (based on sites sharing K13 haplotypes). IBD sharing based 
on SNPs from the DNA microarray will be compared to IBD sharing 
determined from a subset of samples for which whole genome sequences 
are available. The study of temporal and geographical dynamics of shared 
IBD haplotypes is a promising approach for delineating contemporary 
patterns of parasite migration that can be used to identify sources and 
sinks of malaria transmission.
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Plasmodium vivax, the most widespread form of malaria, poses a 
significant challenge to malaria elimination due to its ability to cause 
relapsed infections from reactivation of hypnozoites. Distinguishing 
relapses from reinfections or recrudescence is essential for monitoring 
malaria transmission patterns and detecting anti-relapse therapy 
resistance. Current methods for genotyping P, vivax rely on microsatellite 
markers, which reveal a limited region of the parasite’s genome, making 
it difficult to differentiate relapses from reinfections. Whole genome 
sequencing (WGS) of P, vivax is a highly sensitive tool for genotyping 
recurrent infections that has not been widely deployed in field studies. 
One main reason is because patients with P, vivax infections have 
low parasitemias, so a small amount of human DNA greatly reduces 
sequencing efficiency. We used a novel technique called selective whole 
genome amplification (SWGA) to enrich P, vivax DNA from whole blood 
samples. We performed WGS of 81 isolates of P, vivax collected from 
symptomatic patients in Iquitos, Peru during a study to assess three 
regimens of primaquine. This included 58 paired samples from a person’s 
initial and recurrent infection after primaquine treatment. We obtained 
high quality sequences with an average coverage of 22x and up to 80% of 
the genome covered by >5 reads. We identified thousands of high quality 
single nucleotide polymorphisms, insertions and deletions, and copy 
number variants, which we will use for further analysis. We will calculate 
genetic diversity, linkage disequilibrium, complexity of infection, and genes 
under balancing or directional selection. We will compare paired samples 
from recurrent infections using a sliding window principle components 
analysis approach. In this study, we validate a cost-effective and robust 
method for genotyping P, vivax infections that will significantly improve the 
ability to track P, vivax transmission and monitor the efficacy of anti-relapse 
medication.
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A GENOME-WIDE ANALYSIS OF RECENT SELECTION IN 
AFRICAN MALARIA VECTOR POPULATIONS
Nicholas Harding1, Krzysztof Kozak2, Mara Lawniczak2, ag1000G 
consortium
1University of Oxford, Oxford, United Kingdom, 2WTSI, Cambridge, United 
Kingdom
Land use changes, increasing urbanisation and intensification of malaria 
control programmes are subjecting malaria vectors to a variety of new 
and intense selective pressures. Here we describe a genome-wide scan for 
signatures of recent selection in mosquito populations sampled from 8 
African countries, using whole genome sequence data from the Anopheles 
gambiae 1000 genomes (Ag1000G) project. We have integrated results 
from a number of statistical methods, including tests based on haplotype 
length (iHS, XP-EHH), haplotype diversity (H12), allele frequency spectra 
(SweeD, delta Tajima’s D) and population differentiation (FST, XP-CLR, PBS). 
This combination of methods allows us to identify selective events that 
are specific to a single population or shared across multiple populations, 
to identify both hard and soft selective sweeps, and to find selection 
events from recent times and the more distant past. As well as validating 
several previously observed loci, we identify a number of very strong 
signals of recent selection at novel loci. Of the top 20 strongest previously 
unseen signals, 10 coincide with metabolic insecticide resistance genes, 
2 coincide with with genes that may be involved in cuticle mediated 
resistance, 1 coincides with genes associated with gustatory behaviour, 
and 7 have no candidate phenotype. Although we observe a number of 
hard sweeps, most loci display soft sweeps involving multiple haplotypes. 
Several loci have come under selection across a broad geographical range, 
however the pattern of selection is heterogeneous with a number of hits 
being restricted to a single population or geographical region and some 
populations showing almost no evidence for recent selection. All data from 
these analyses will shortly be made publicly available for download and for 
interactive exploration via a new release of the Ag1000G web application, 
providing a community resource for further detailed study of selective 
forces and adaptive responses in natural vector populations.
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GENOME-WIDE ASSOCIATION STUDY OF SUSCEPTIBILITY 
TO SEVERE MALARIA IN 17,500 INDIVIDUALS FROM AFRICA, 
ASIA AND OCEANIA
Gavin Band, MalariaGEN Genomic Epidemiology Network
University of Oxford, Oxford, United Kingdom
Genome-wide association studies (GWAS) of susceptibility to malaria have 
until recently been limited by relatively small sample sizes. In addition, 
the complex pattern of effects observed for some association signals, and 
poor representation of relevant genetic variation in available reference 
panels has hampered progress. Here, we undertake a GWAS in 8931 
individuals hospitalised with severe malaria and 8703 population controls 
from 11 malaria-endemic populations, with replication in a further 15,000 
individuals. We sequence the genomes of a further 773 individuals from 
sub-Saharan African populations, and use this data along with publicly 
available data from the 1000 Genomes Project to accurately impute 
genotypes genome-wide. We develop methodology to test for association 
with severe malaria subphenotypes, and identify and replicate a novel 
locus on chromosome 6 associated with increased risk of cerebral malaria. 
Across the genome, at least 10 other loci show substantial evidence for 
association, and we catalogue these in detail. In specific regions, we 
survey structural variation and use further refined reference panels to 
fine-map the signal of association, including at the glycophorin region on 
chromosome 4 where we identify a strong candidate for the functional 
protective mutation. Our study represents the largest genome-wide study 
of an infectious disease to date, and will provide an important resource 
for future studies into the human genetic basis of malarial disease and, 
potentially, its interaction with parasite processes.
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COMPARATIVE TRANSCRIPTOME ANALYSIS OF THE HOST 
RESPONSE IN BLOOD AND SPLEEN DURING THE COURSE OF 
A PLASMODIUM CHABAUDI CHABAUDI INFECTION
John Joseph Valletta1, Jingwen Lin2, Mario Recker1, Jean 
Langhorne2
1University of Exeter, Penryn, United Kingdom, 2The Francis Crick Institute, 
London, United Kingdom
During the asexual blood stage of malaria in the mammalian host, 
Plasmodium parasites induce alterations in host haematopoiesis, and in 
the structure and cellular composition of the spleen. Although this organ 
plays a critical role in generating anti-parasite immunity, spleen samples 
are generally not accessible in humans; instead, blood samples are typically 
used to infer the types of immune responses important for controlling 
infections. Whether the immune signatures identified in the blood are 
representative of those within the spleen is still largely not known, 
however. The objective of our study was to compare parasite-induced 
whole transcriptome changes in blood and spleen using the rodent malaria 
model of P. chabaudi chabaudi in C57BL/6 mice. Specifically we set out to 
identify common infection signatures, and those that can only be detected 
in either the blood or the spleen. Infected blood and spleen samples 
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were collected every 2 days during the acute phase of infection, until day 
12 when the parasitaemia was first controlled. Samples collected from 
naive uninfected mice at day 0 and day 12 were used as controls. Gene 
expression was quantified using the Illumina mouse WG6 v2 microarray 
platform (consisting of 45,281 probes sets, representing 30,854 genes). 
Data were transformed to log fold change with respect to naive controls, 
and clustering of these short time-series was performed using a Mixtures 
of Hierarchical Gaussian Processes (MOHGP), which explicitly model the 
strong time dependency across successive time points. We identified 
several pathways that are commonly perturbed in blood and spleen, 
including anaemia, apoptosis and T-cell activation. We also observed that 
for some genes, expression peaked in the blood before it was measured 
in the spleen. Importantly a number of pathways, such as erythrocyte 
production, were identified that were exclusively activated in the spleen 
but not the blood. We will discuss the implications of these findings for 
the interpretation of whole blood transcriptome.
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MELDING CHEMOGENOMICS AND CHEMOINFORMATICS TO 
DEFINE MALARIA’S DRUGGABLE GENOME
Justin A. Gibbons1, Kenneth Udenze2, Chenqi Wang2, Swamy R. 
Adapa2, Min Zhang2, Christophe Bodenreiser3, Pablo Bifani3, Tierry 
Diagana3, John H. Adams2, Rays H. Jiang2
1Morsani College of Medicine, University of South Florida, Tampa, FL, 
United States, 2Department of Global Health, College of Public Health, 
University of South Florida, Tampa, FL, United States, 3Novartis Institute for 
Tropical Diseases Pte. Ltd, Chromos, Singapore
With artemisinin resistance (ART-R) spreading in South East Asia the 
discovery of new drugs to treat malaria is imperative. Thousands of 
antimalarial compounds have been identified in high-throughput 
phenotypic screens, but the mode of action (MOA) for most of these 
compounds is unknown. Efforts to discover the MOA targets of these 
compounds is hampered since much of the Plasmodium falciparum 
genome is not functionally annotated and therefore deciphering target 
information for many, if not most, new lead compounds is severely 
compromised. Combining chemogenomics and chemoinformatics offers 
the potential to functionally define the druggable genome of P. falciparum. 
Our approach can functionally link unknown genes to more clearly 
defined genes and GO pathways through the chemogenomic profiles 
related to the MOA of characterized antimalarial drugs and unknown lead 
compounds. Importantly, this type of analysis helps to rationally classify 
leads most likely to be targeting genes that can counter ART-R. More 
specifically, we are using chemogenomic profiling of isogenic P. falciparum 
single insertion piggyBac mutant clones, including several with differential 
sensitivity to ART. Specific perturbations in metabolic pathways linked to 
the genetic mutation caused by the piggyBac insertion create unique IC50 
patterns for each compound and similar IC50 profiles identify drugs with 
MOAs likely to be targeting the same pathway. This information can be 
combined with chemical similarity measures of around 500 prioritized 
compounds to increase confidence in target prediction and indicate 
which molecular features are key to the biological response. We identified 
distinct mechanisms associated with ART sensitivity and resistance in the 
current screen by RNA-seq of a dysregulated K13 mutant. Chemogenomic 
and chemoinformatic characterization of malaria inhibiting compounds 
will help focus the drug discovery agenda on the most effective targets.
1849
HOW PYRETHROIDS RESISTANCE IN AEDES AEGYPTI 
POPULATIONS FROM BRAZIL AFFECTS WOLBACHIA 
INVASION? EVIDENCES FROM SIMULATIONS AND FIELD 
RELEASES
Gabriela A. Garcia1, Rafael M. de Freitas1, Martha T. Petersen1, 
Michael Turelli2, Daniel A. Villela1
1IOC/Oswaldo Cruz Foundation, Rio de Janeiro, Brazil, 2University of 
California Davis, Davis, CA, United States
Field trials have started recently in Brazil to evaluate the spread of Aedes 
aegypti with Wolbachia, a bacteria that reduces arboviruses transmission 
such as dengue and zika viruses. Previous data reported stable and rapid 
invasion in Austrália and Vietnam using wMel strain. In Rio de Janeiro, we 
started weekly releases in Sep/2014, but Wolbachia frequency dropped 
dramatically soon after releases were suspended. Hindsight analysis 
showed that mosquito colony, which were closed after Australian Ae. 
aegypti females were backcrossed with Brazilian males, lost its alelles to 
pyrethroid (PI) resistance after only 14 generations in lab, suggesting a 
strong fitness cost due to insecticide resistance. Therefore, we released 
mosquito cohorts susceptible to PI in Rio which Ae. agypti populations 
face high insecticide resistance ratios for PI. Even releasing roughly 
10,000 mosquitoes per week for 20 weeks, kdr frequency remained 
unalterd during releases. We hypothetized the insecticide susceptibility of 
released mosquitoes hindered Wolbachia invasion in Rio. We performed 
a new backcrossing with field males to produce wMelRio, a strain with 
similar insecticide resistance profile and fitness (survival and fecundity) 
when compared with field population. Thus, Wolbachia presence in 
a kdr mutated individual may exacerbate the fitness cost and could 
hinder Wolbachia invasion into a resistant population. In Jan/2016, after 
24 weekly releases in field, wMelRio frequency was high as 80%. This 
frequency remains high (70-80%) even after a five-weeks period in which 
releases were stopped. Mathematical models were applied to test whether 
different releasing strategies (changing release number, wild population 
density, fitness cost of Wolbachia, fitness cost of insecticide resistance) 
would enhance Wolbachia invasion. Our simulations indicates a successful 
invasion in two situations: 1) releasing susceptible mosquitos in an 
environment without insecticide use (may causing a reversal in insecticide 
resistance levels); and releasing resistant mosquitoes (wMelRio) into a 
resistant population (such as Rio), even with a high insecticide use.
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WOLBACHIA INFECTION DOES NOT AFFECT THE DIVERSITY 
OF CO-INFECTING NATIVE FLAVIVIRUSES IN ADULT AEDES 
AEGYPTI IN THE FIELD
Hilaria E. Amuzu1, Cassandra Koh2, Rosemarie I. Herbert2, 
Elizabeth A. McGraw2
1Monash University, Clayton, Victoria, Australia, 2Monash University, 
Melbourne, Victoria, Australia
Wolbachia (wMel) infections that have been artificially introduced into 
Aedes aegypti limit the ability of the mosquito to become infected with 
dengue and other flaviviruses in a trait known as pathogen blocking. It 
is unclear whether these antiviral effects would extend to other native 
flaviviruses in wild populations of mosquitoes. If so, Wolbachia may be 
beneficial in cases where these viral infections have negative effects on 
host fecundity and lifespan or induce energetic investments in immune 
responses. Here we examine whether the presence of Wolbachia infection 
in wild caught adults from field release populations in northern Australia 
reduces the native flavivirus diversity. RNA was extracted from adult 
mosquitoes collected from two sites within and one site outside of field 
release zones. Flavivirus specific primers for the NS5 region were then 
used to amplify from the converted cDNA of individual samples. Six insect 
flavivirus positive individuals were then selected from each of three sites 
for deep sequencing. We found that virus diversity was greater in the 
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Wolbachia infected mosquitoes, returning 10 different viruses versus 6 
different viruses in the Wildtype samples. Cell fusion agent virus was found 
in all 18 samples across the sites and another 5 viruses were present at low 
levels in both wMel and Wildtype mosquitoes. A total of 6 viruses were 
unique to the wMel-infected mosquitoes. As the approach required PCR 
amplification prior to sequencing however it cannot address quantitative 
differences in the amount of viruses present. Future studies using non-
targeted deep sequencing of insect material may address the issue 
around quantitation and also whether non-flaviviral diversity is impacted. 
Regardless, our study does not find clear evidence of Wolbachia’s potential 
to benefit wild mosquito populations by limiting native flavivirus infections.
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LIGHT MANIPULATION OF MOSQUITO BEHAVIOR: ACUTE 
AND SUSTAINED PHOTIC SUPPRESSION OF BITING IN THE 
ANOPHELES GAMBIAE MALARIA MOSQUITO
Giles E. Duffield, Aaron D. Sheppard, Samuel S. Rund, Gary F. 
George, Erin Clark, Dominic Acri
University of Notre Dame, Notre Dame, IN, United States
Host-seeking behaviors in anopheline mosquitoes are time-of-day specific, 
with a greater propensity of biting occurring during the dark phase of the 
LD cycle. We investigated how a short exposure to light presented during 
the night or late day can inhibit biting activity and modulate flight activity 
behavior. Anopheles gambiae s.s., maintained on a 12:12 LD cycle, were 
exposed to white light at the onset of night and the proportion taking 
a blood meal in a human biting assay was recorded every 2 hr for 8 hr. 
The pulse significantly reduced biting propensity in mosquitoes for up to 
4 hr following administration, and with no differences detected after 6 
hr. Conversely, biting levels were significantly elevated when mosquitoes 
were exposed to a dark treatment during the late day, suggesting that 
light suppresses biting behavior even during the late day. These data 
reveal a potent effect of a discrete light pulse on biting behavior that is 
both immediate and sustained. We expanded this approach to develop 
a method to reduce biting propensity throughout the night by exposing 
mosquitoes to a series of 10 minute pulses presented every 2 hr. We 
reveal both an immediate suppressive effect of light during the exposure 
period and 2 hr after the pulse. This response was found to be effective 
during most times of the night: However, differential responses that 
were time-of-day specific suggest an underlying circadian property of the 
mosquito physiology that results in an altered treatment efficacy. Finally we 
examined the immediate and sustained effects of light on mosquito flight 
activity behavior following exposure to a 30 minute pulse, and observed 
activity suppression during early night, and elevated activity during late 
night. As mosquitoes and malaria parasites are becoming increasingly 
resistant to insecticidal and drug treatments, there is a necessity for the 
development of innovative control strategies beyond ITNs. These data 
revealing the potent inhibitory effects of light exposure and the utility of 
multiple photic pulses presented at intervals during the night/late day, 
may prove to be an effective tool that complements established control 
methods.
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ESTIMATION OF ALLELE-SPECIFIC ACE-1 DUPLICATION IN 
INSECTICIDE-RESISTANT ANOPHELES MOSQUITOES FROM 
WEST AFRICA
Luc S. Djogbénou1, Benoît Assogba2, John Essandoh3, A.V. 
Constant Edi3, Martin Akogbeto4, Martin Donnelly5, David 
Weetman3
1Institut Régional de Santé Publique/Liverpool School of Tropical Medicine, 
Cotonou, Benin, 2Institut Régional de Santé Publique, Cotonou, Benin, 
3Department of Vector Biology, Liverpool School of Tropical Medicine, 
Liverpool, United Kingdom, 4Centre de Recherche Entomologique de 
Cotonou, Cotonou, Benin, 5Liverpool School of Tropical Medicine/Malaria 
Programme, Wellcome Trust Sanger Institute, Liverpool, United Kingdom
Variation in Ace-1 copy number and G119S mutation genotype from 
samples of Anopheles gambiae across West Africa are used as appropriate 
strategies for identifying variation at population and individual levels. 
The most widespread and economical method, PCR-RFLP, suffers from 
an inability to discriminate true heterozygotes from heterozygotes with 
duplication. In addition to PCR-RFLP, in this study we used three different 
molecular techniques on the same mosquito specimens permitting 
comparisons. To group heterozygous individals recorded from the PCR-
RFLP analysis into different assumptive genotypes we used K-means 
clustering on the Z-scores of their correspondent data obtained from both 
TaqMan and ddPCR methods. Our data suggest that most heterozygotes 
are duplicated and that G119S mutation must now be regarded as a 
complex genotype ranging from primarily single-copy susceptible to 
Glycine and Serine allele balanced and imbalanced heterozygotes, and 
multiply-amplified resistant Serine allele homozygotes. Whilst qRTPCR-
based gene copy analysis suffers from some imprecision, it clearly 
illustrates differences in copy number among genotype groups identified 
by TaqMan or ddPCR. Based on TaqMan method properties, and by 
coupling TaqMan and ddPCR methods simultaneously on the same type of 
mosquito specimens, we demonstrated that the TaqMan genotype assays 
associated with the K-means clustering algorithm could provide a useful 
semi-quantitative estimate method to investigate the level of allele-specific 
duplication in mosquito populations. Ace-1 gene duplication is evidently 
far more complex in Anopheles gambiae than Culex quinquefasciatus, 
which consequently can no longer be considered an appropriate model 
for prediction of phenotypic consequences, which require urgent 
evaluation. Furthemore, if carbamates and organophosphate will be 
used as alternative products to pyrethroid for malaria vector control, the 
monitoring of duplicated alleles in natural populations of An. gambiae is 
essential to guide the rational use of these insecticides.
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INSECTICIDE RESISTANCE AND THE FUTURE OF MALARIA 
CONTROL
Melinda P. Hadi1, Duncan K. Athinya1, Helen Pates Jamet2
1Vestergaard, Nairobi, Kenya, 2Vestergaard, Washington, DC, United States
The emerging and rapid spread of resistance to major classes of public 
health insecticides threatens current malaria vector control efforts 
namely long lasting insecticidal nets and indoor residual spray, which 
have contributed substantially to the reduction of malaria since 2000. 
The decreased ability of current vector control tools to effectively kill 
mosquitoes may be an early indicator to an increase in malaria cases 
and attributed deaths. Visualizing the confirmed reports of insecticide 
resistance in malaria endemic countries provides an indication where 
resistance may play a role in the persisting burden of malaria. Launched in 
2012, IR Mapper is an online geospatial platform for mapping insecticide 
resistance in malaria vectors, built on a systematic review of peer-reviewed, 
published literature. The user interface enables filtering by country, year, 
vector species, insecticide class and type, and resistance mechanisms 
data including target site mutations and elevated metabolic mechanisms 
related to the detoxification of insecticides. As of March 2016, IR Mapper 
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consisted of 13,773 unique field records from 58 countries and 64 
Anopheles species or species complexes. 78% of countries have reported 
resistance to at least one of the four classes of insecticides used for adult 
mosquito control. Examining the top ten countries with the largest burden 
of malaria today, more reports of confirmed pyrethroid resistance were 
recorded in the period 2008-2015 than compared to 2000-2007. Kenya 
and the Democratic Republic of Congo reported no pyrethroid resistance 
in 2000-2007 but in 2008-2015, 77.5 and 51.0% respectively of the 
testing conducted on pyrethroids reported resistance. In Burkina Faso, 
comparing the same time periods, the proportion of reports of confirmed 
pyrethroid resistance from the total number of tests conducted increased 
from 19.4 to 94.0%. IR Mapper is a useful tool for visualizing trends in 
Anopheles insecticide resistance and can be used to assist decision making 
for deployment of the most appropriate tools, which need to be driven by 
up-to-date data on insecticide resistance in target malaria vector species.
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THE EMERGENCE AND SPREAD OF INSECTICIDE RESISTANCE 
MUTATIONS IN ANOPHELES GAMBIAE AND AN. COLUZZII: 
INSIGHTS FROM DEEP WHOLE-GENOME SEQUENCING OF 
NATURAL POPULATIONS
Alistair Miles1, Chris Clarkson2, Martin Donnelly3, Dominic 
Kwiatkowski2, The Anopheles gambiae 1000 genomes project4
1University of Oxford, Oxford, United Kingdom, 2Wellcome Trust Sanger 
Institute, Hinxton, United Kingdom, 3Liverpool School of Tropical Medicine, 
Liverpool, United Kingdom, 4Consortium, Multiple, United Kingdom
Insecticide resistance is a serious challenge to malaria elimination in Africa. 
We use haplotype data from the Anopheles gambiae 1000 genomes 
project to discover new mutations potentially linked with insecticide 
resistance, and to analyse the origin, distribution and movement of 
resistance mutations in populations spanning continental Africa. Within 
the voltage-gated sodium channel (Vgsc) we find kdr mutations in 
codon 1014 sweeping to high frequency in almost all Ag1000G phase 
1 populations. We infer at least 4 independent origins for the L1014F 
kdr mutation and a further 4 origins for the L1014S kdr mutation. Some 
kdr haplotypes are found in a single population and thus have a local 
origin, whereas others are shared between populations separated by 
thousands of kilometers. One haplotype carrying L1014F has swept widely 
throughout West and Central Africa with at least two introgression events 
between species. Within Vgsc we also find 15 previously unknown non-
synonymous mutations at high frequency. Of these, 13 occur exclusively 
on haplotype backgrounds carrying a mutation in codon 1014, suggesting 
selection for mutations that enhance or compensate for the resistance 
phenotype. We also find haplotypes sweeping to high frequency at three 
loci containing genes linked with metabolic resistance. At the glutathione 
S-transferase epsilon (gste) gene cluster at least four independent sweeps 
have occurred. One of the swept haplotypes carries the I114T mutation 
in gste2 known to enhance DDT metabolism and is found in populations 
from West, Central and East Africa indicating a continent-wide spread. The 
other high frequency haplotypes do not carry this mutation but do carry a 
large number of novel non-synonymous mutations which may be driving 
a resistance phenotype. We describe similar analyses for the cyp6 gene 
cluster and a locus on chromosome X containing cyp9k1. For all loci we 
identify SNPs tagging putatively resistant haplotypes as a basis for future 
monitoring efforts. These results reveal the threats posed by the capacity 
for mutations to spread throughout vector populations and to arise 
multiple times in different locations.
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HOUSEHOLD INTERVENTIONS, EXPENDITURES AND 
BARRIERS TO AEDES AEGYPTI CONTROL IN MACHALA, 
ECUADOR
Naveed Heydari1, Anna M. Stewart Ibarra2, David A. Larsen3, 
Marco V. Neira4
1Colorado School of Public Health, University of Colorado-Denver, Aurora, 
CO, United States, 2Center for Global Health and Translational Science and 
Department of Medicine, State University of New York Upstate Medical 
University, Syracuse, NY, United States, 3Department of Public Health, Food 
Studies and Nutrition, Syracuse University, Syracuse, NY, United States, 
4Pontificia Universidad Catolica Del Ecuador, Quito, Ecuador
The Aedes aegypti is an efficient vector for the transmission of Zika, 
chikungunya and dengue viruses. However, understanding of the 
household expenditures needed to control this mosquito is relatively 
sparse. As various countries face the rising epidemic of Ae. aegypti-
transmitted illnesses such as Zika virus, research on the extent of use 
and cost of interventions to control the Ae. aegypti is urgently needed. 
Between April to August 2015, we surveyed residents from 40 households 
in a high risk community in Machala, Ecuador on dengue knowledge and 
perceptions, vector control interventions, household expenditures, and 
barriers to employing prevention practices. Additionally, a semi-structured 
survey was recorded, transcribed and coded to identify the important 
factors that influence a household’s decision to purchase mosquito control 
products. To determine the various types and cost of products available 
for sale to households, we surveyed 10 neighborhood stores and three 
modern supermarkets. The results of this study show that households 
in this neighborhood spend about 2% of their total family income on 
Ae. aegypti control interventions. On average, households concurrently 
employed five mosquito control interventions and had access to a variety 
of products, including aerosols, liquid sprays, repellents, mosquito coils, 
and unimpregnated bed nets. From our qualitative theme analysis, we 
found that effectiveness and cost were the most important factors that 
influence people’s decisions to purchase a mosquito control product. These 
findings show a robust and healthy market for commercial mosquito 
control products even among the poorest of households in Machala, 
Ecuador. With the rise in Zika virus transmission, the need for Ae. aegypti 
control has only been exacerbated. Further research will examine how 
household economics are influenced by the rise of a new disease.
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RISK FACTORS FOR PEDIATRIC ENTERIC INFECTION IN A 
LOW-INCOME URBAN NEIGHBORHOOD: EXAMINING THE 
CONTRIBUTIONS OF THE HOUSEHOLD ENVIRONMENT, 
NEIGHBORHOOD GEOGRAPHY AND EXPOSURE BEHAVIORS 
IN VELLORE, INDIA
David Berendes1, Juan Leon1, Amy Kirby1, Julie Clennon1, Suraja 
Raj1, Habib Yakubu1, Katharine Robb1, Arun Kartikeyan2, Priya 
Hemavathy2, Annai Gunasekaran2, Ben C. Ghale2, J. Senthil 
Kumar2, Venkata R. Mohan2, Gagandeep Kang2, Christine Moe1
1Emory University, Atlanta, GA, United States, 2Christian Medical College, 
Vellore, India
Poor water, sanitation, and hygiene conditions contribute to pediatric 
enteric infection and longer-term health outcomes. In urban settings, 
child exposure to fecal contamination may be affected by the population 
density, physical characteristics of the neighborhood, and frequency of 
contact with fecal contamination both inside and outside the home. 
This study examined the contributions of a child’s household and 
neighborhood environments and exposure behaviors to enteric infection 
risk, by etiologic agent, in an urban slum in India. Diarrheal and routine 
(monthly) stool were collected from 230 children during the first two 
years of life and assayed for enteric pathogens as part of the MAL-ED 
study. Exposures were assessed using spatial data and interviews with 
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caregivers in 100 of these households and evaluated using mixed effects 
logistic regression models. Household sanitation coverage (33%) and fecal 
sludge management (82% of household toilets discharged to open drains) 
were poor. Significant household risk factors, associated with 44-56% 
increased risk of any enteric infection, included the presence of, and open 
defecation by, older siblings and adult caregivers. Reported household-
level water treatment (OR: 0.66, 95% CI: 0.50-0.88) and presence of a 
toilet (OR: 0.73, 95% CI: 0.55-0.97) were associated with reduced enteric 
infection risk. Residence in the spatial cluster of reported drain flooding, 
regardless of reported contact with drain or floodwater, was associated 
with significantly higher risk (OR: 2.39, 95% CI: 1.24-4.63) during the 
northeast monsoon. The risk factors associated with viral infections 
differed from those for any enteric infection, and included frequent 
use (>10 events/month) of public toilets as a unique risk factor for GII 
norovirus infection (OR: 2.05, 95% CI: 1.09 - 3.86). Overall, while some 
exposures, like the defecation practices of other household members, may 
be controllable within the household, conditions in the neighborhood 
environment may limit a household’s ability to control health risks. Thus, 
interventions to reduce fecal contamination in the public domain are also 
necessary.
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ASSESSING SEROCONVERSION AGAINST ENTERIC 
PATHOGENS RELATIVE TO REPORTED DIARRHEA AND THE 
RECEIPT OF A POINT-OF-USE WATER FILTER IN WESTERN 
PROVINCE, RWANDA
Laura D. Zambrano1, Miles Kirby2, Ghislaine Rosa2, Corey Nagel3, 
Thomas F. Clasen1
1Emory University, Atlanta, GA, United States, 2London School of Hygiene 
& Tropical Medicine, London, United Kingdom, 3Oregon Health and 
Science University, Portland, OR, United States
Diarrhea is a leading contributor to childhood morbidity and mortality 
in Sub-Saharan Africa. Given the infeasibility of blinding most water, 
sanitation and hygiene (WASH) interventions, diarrheal disease outcome 
measures in WASH intervention trials are fraught with potential bias 
and misclassification. We used the platform of a cluster-randomized 
controlled trial of a household-based drinking water filter in Western 
Province, Rwanda to examine the application of enteric seroconversion 
as an alternative and more objective outcome measure of current and 
recent infection. All children ≥ 6 and ≤12 months-old among 1582 study 
households were eligible for enrollment. All enrolled children had their 
blood drawn through capillary blood draw at baseline and 6 to 9 months 
after intervention distribution. Multiplex serologic assays for Giardia 
lamblia, Cryptosporidium parvum, Entamoeba histolytica, Salmonella spp., 
norovirus, Campylobacter spp., enterotoxigenic E. coli and V. cholerae 
were performed to compare seroconversion between the intervention 
and control groups on an intention-to-treat basis. The water filter was 
associated with a decrease in Cryptosporidium 17 kDa protein (Cp17) 
seroconversion (RR=0.72, 95%CI: 0.52-1.00) and serologic response 
against Cryptosporidium Cp17 was positively associated with reported 
diarrhea in the previous seven days (RR=1.78, 95%CI: 1.02-3.12). Children 
seroconverted against Cryptosporidium at relatively early ages (<6 months-
old) while Giardia seroconversion typically occurred after 12 months. 
Serological responses for other antigens increased steadily after 6 months 
of age, plateauing after 12 months. Seroconversion shows promise as an 
objective outcome measure for WASH trials among children in this age 
group in addition to being a potential indicator of recent diarrheal disease.
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ASSESSING USE, EXPOSURE AND HEALTH IMPACTS OF AN 
ADVANCED WATER FILTER AND ADVANCED COOKSTOVE 
DISTRIBUTION PROGRAM IN RURAL RWANDA
Miles A. Kirby1, Corey Nagel2, Ghislaine Abadie Rosa1, Evan A. 
Thomas3, Thomas F. Clasen4
1London School of Hygiene & Tropical Medicine, London, United Kingdom, 
2Oregon Health & Science University, Portland, OR, United States, 3Portland 
State University, Portland, OR, United States, 4Emory Rollins School of 
Public Health, Atlanta, GA, United States
Unsafe water and air pollution are two major environmental health risks 
and contribute to child diarrhea and pneumonia. Household water filters 
and advanced cookstoves could reduce exposure risks, but there is little 
evidence of medium-term uptake and impact when combined. In 2012, 
a public-private program provided a free rocket stove and water filter 
to houses in 15 rural villages. We matched 9 intervention to 9 control 
villages using propensity score matching. Houses with a child under 5 
(n=269) were enrolled and visited in 2 rounds over 12 months starting 
Nov 2013. At each visit, self-reported use, observed use, and reported 
health symptoms were recorded; a drinking water sample was also 
assessed for thermotolerant coliforms (TTC). Personal exposure to fine 
particulate matter (PM2.5) was assessed gravimetrically in cooks (n=211) 
and children under 5 (n=172) for 48 hours. Use of the advanced filter and 
stove was assessed using sensors for 8 days each round. Overall, 92.7% 
of intervention houses had the filter, 90% reported currently using it, and 
74.9% had water in it. Sensors indicated a daily average of 1.7L of water 
filtered/day (SD 2.5L). The control arm had a mean of 0.86 log TTC/100mL, 
compared to 0.37 log TTC/100mL in the intervention arm (p<.001). 95% 
of intervention houses had the stove, and 87% reported currently using it. 
Sensors indicated a daily average of 2.6 uses/day (SD 1.4 uses). Geometric 
mean (GM) PM2.5 for intervention cooks was 156.1 µg/m
3 (95% CI 139.2-
175.0) compared to 215.4 µg/m3 for controls (95% CI 191.1-242.8); 
GM for intervention children was 171.2 µg/m3 (95% CI 150.5-194.7) 
compared to 218.5 µg/m3 for controls (95% CI 189.2-252.4). Among 
children in the intervention arm relative to control, mixed effects models 
showed a significant reduction in the odds of both caretaker-reported 
diarrhea (OR=.52, p=.04) and cough with difficulty breathing (OR=.11, 
p<0.001). We found high uptake and sustained use of a home water filter 
and advanced cookstove 12-24 months after intervention delivery, with 
evidence of reductions in drinking water contamination, household air 
pollution and improvements in reported child health symptoms.
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ENVIRONMENTAL EXPOSURE OF RURAL BANGLADESHI 
CHILDREN 3-18 MONTHS OLD FROM HAND- AND OBJECT-
MOUTHING
Laura H. Kwong1, Ayse Ercumen2, Amy J. Pickering1, Leanne 
Unicomb3, Jennifer Davis1, Stephen P. Luby1
1Stanford University, Stanford, CA, United States, 2University of California 
Berkeley, Berkeley, CA, United States, 3International Centre for Diarrhoeal 
Disease Research, Bangladesh, Dhaka, Bangladesh
Children are exposed to environmental contaminants by placing 
contaminated hands or objects in their mouths. Exposure models based 
on mouthing data of children from high-income countries may be 
inappropriate to model exposure of children from different cultural and 
domestic settings due to differing mouthing frequencies. We sought to 
quantify hand and object mouthing frequencies of Bangladeshi children 
and determine if they differ from those of U.S. children, potentially 
indicating differences in types and levels of exposures. Trained observers 
used tablet computers to capture hand and object mouthing behaviors 
of 148 rural Bangladeshi children aged 3-18 months over five hours. For 
quality control, 11% of children were watched by more than one observer 
and inter-observer reliability was calculated. We analyzed the effect of 
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household and child characteristics on mouthing behavior and modeled 
mouthing frequencies using 2-parameter Weibull distributions to compare 
the modeled medians with those of U.S. children. Hand- and object- 
mouthing frequencies decreased with increasing age, and at all ages were 
higher than those of U.S. children. For hand mouthing, the median hourly 
frequency for Bangladeshi children 3-6 months old was 37.3 contacts vs. 
23.0 contacts for U.S. children; for Bangladeshi children 6-12 months old, 
34.4 contacts vs. U.S. 14.0 contacts; and for Bangladeshi children 12-18 
months old, 29.7 contacts vs. U.S. 14.0 contacts. For object mouthing, 
the median hourly frequency for Bangladeshi children 3-6 months old was 
23.1 contacts vs. 9.3 contacts for U.S. children; for Bangladeshi children 
6-12 months old, 29.6 contacts vs. U.S. 19.0 contacts; and for Bangladeshi 
children 12-18 months old, 15.2 contacts vs. U.S. 12.3 contacts. Mouthing 
frequencies were not associated with child location (indoor/outdoor). 
Using hand- and object-mouthing exposure models from U.S. and other 
high-income countries might not accurately estimate children’s exposure 
to environmental contaminants via mouthing in low- and middle-income 
countries.
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INCIDENCE OF ADULT DEATHS ASSOCIATED WITH HEPATITIS 
E VIRUS IN BANGLADESH
Repon C. Paul1, Arifa Nazneen2, Kajal Chandra Banik2, Shariful 
Amin Sumon2, Kishor Kumar Paul2, Hossain M S. Sazzad2, Manjur 
Hossain Khan Jony3, M. Salim Uzzaman3, Mahmudur Rahman3, 
Stephen P. Luby4, Heather Gidding1, Andrew Hayen1, Emily S. 
Gurley2
1UNSW, Sydney, Australia, 2International Centre for Diarrhoeal Disease 
Research, Bangladesh, Dhaka, Bangladesh, 3IEDCR, Dhaka, Bangladesh, 
4Stanford University, Stanford, CA, United States
Hepatitis E virus (HEV) causes acute infection of the liver. In addition to 
sporadic cases, HEV causes epidemic outbreaks in many countries in Asia 
and Africa, where fecal contamination of drinking water is common. 
A modelling study estimated 70,000 annual deaths globally from HEV. 
China has produced and licensed the first effective HEV vaccine but there 
are limited population-based data on burden of hepatitis E to take a 
rational decision of introducing HEV vaccine. In this study, we estimated 
the population-based incidence of adult deaths from HEV infection in 
Bangladesh. During Jan-Dec 2015, we conducted HEV surveillance in 
six tertiary hospitals in Bangladesh where we recruited all patients aged 
≥15 years admitted with acute jaundice, defined as new onset of either 
yellow eyes or skin during the past 3 months. We collected blood from all 
cases to test for anti-HEV IgM using enzyme-linked immunosorbent assay. 
We conducted a mortality survey in the hospital catchment communites 
where we asked the caregivers of all deaths aged ≥15 years occurring 
in the community in the 3 years prior to the survey if the decedent had 
jaundice, defined as new onset of either yellow eyes or skin during the 3 
months prior to death. We administered a verbal autopsy questionnaire 
for all identified jaundice associated deaths. We used a poisson model 
to estimate the incidence of jaundice associated mortality in the hospital 
catchment areas and then applied the proportion of laboratory confirmed 
HEV cases among patients admitted with jaundice to estimate the 
population-based incidence of adult deaths from HEV. We identified 519 
patients admitted with acute jaundice; 441 of them were tested and 
114 (26%) had laboratory confirmed HEV. In the hospital catchment 
communities with an adult population of 1,219,268, we identified 462 
deaths associated with acute jaundice. The incidence of adult deaths 
associated with HEV was 3.6 (95% CI: 2.9-4.4) per 100,000 adult 
population per year. The study provides the first population-based estimate 
of adult mortality associated with HEV in Bangladesh, which can be used 
in economic evaluations of interventions, including HEV vaccine.
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WOMEN’S SANITATION EXPERIENCES ARE ASSOCIATED 
WITH MENTAL HEALTH IN RURAL, ODISHA INDIA
Bethany A. Caruso, Hannah L. Cooper, Regine Haardoerfer, 
Craig Hadley, Kathryn Yount, Thomas Clasen
Emory University, Atlanta, GA, United States
Research on the impact of access to water and sanitation on health has 
focused on infectious agents and diseases, leaving other facets of health—
like mental health (MH)—underexplored. No research has quantified 
how prevalent women’s negative sanitation experiences are, how often 
they occur, and if their frequency and intensity influence MH. Qualitative 
studies suggest that women suffer assaults to MH due to poor sanitation 
conditions and negative experiences managing their needs, such as 
worrying about infection at urination and defecation sites, experiencing 
fear of potential harm, and limiting food and water to control urges. 
This study aimed to determine if a woman’s negative experiences of 
sanitation—collectively designated here as sanitation insecurity— and her 
access to a facility were associated with anxiety, depression, distress, and 
well-being in rural Odisha India. We used an exploratory, sequential, mixed 
methods design to create a culturally-grounded measure of sanitation 
insecurity and test its association with MH. Our measure assessed seven 
domains of women’s sanitation experience: Potential harms; Social 
expectations and repercussions; Physical exertion or strain; Night concerns; 
Dependent support; Physical agility; and Defecation location. From a 
survey with 1347 women, we found access to a latrine to be associated 
with higher well being scores, but not associated with anxiety, depression 
or distress. Women’s sanitation insecurity domains were associated with all 
four MH outcomes, with most negatively associated with well being scores 
and positively associated with anxiety, depression, and distress scores. 
These relationships existed independent of latrine access. These findings 
imply that women suffer assaults to MH when urinating and defecating 
even if they own a facility. They suggest that sanitation interventions 
should accommodate women’s experiences beyond management of 
excreta to more comprehensively impact health.
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THE IMPACT OF SANITATION INTERVENTIONS ON LATRINE 
COVERAGE AND USE: A SYSTEMATIC REVIEW AND META-
ANALYSIS
Joshua V. Garn, Matthew C. Freeman, Gloria D. Sclar, Patrick 
Brooks, Thomas Clasen
Emory University, Atlanta, GA, United States
It is estimated that 2.4 billion people lack access to improved sanitation 
and 946 million practice open defecation. A further understanding of 
how different sanitation interventions impact latrine coverage and latrine 
use is essential in order to more effectively attain sanitation access for 
all. We systematically reviewed the literature and used meta-analysis 
to quantitatively characterize how different sanitation interventions 
impact latrine coverage and latrine use. We also used both qualitative 
and quantitative studies to assess how different structural and design 
characteristics of sanitation impact individual latrine use. A total of 59 
studies met our eligibility criteria. We found 36 sanitation trials that, 
on average, found an increase in latrine coverage of 14% (95% CI: 
10%-18%). The interventions with the largest increases in coverage 
included the Indian government’s “Total Sanitation Campaign” (27%; 
95% CI: 14%-39%), education interventions (17%; 95% CI 5%-30%), 
sewerage interventions (14%; 95% CI: 1%-28%), Community-Led Total 
Sanitation interventions (10%; 95% CI: 0%-20%), and other latrine 
subsidy/provision interventions that incorporated education components 
(17%; 95% CI: -5%-38%). Only 11 of these trials also assessed latrine 
use and in these the interventions had an average increase in latrine use 
of 13% (95% CI: 5%-21%). Individual study success was often context 
specific. Although many studies showed improvements in coverage and 
use compared to controls, these studies usually did not reach sufficient 
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coverage and use thresholds to translate into health impacts. We found 
17 studies that examined how structural and design characteristics of 
sanitation were associated with latrine use. Better latrine maintenance, 
accessibility, privacy, facility type, cleanliness, newer latrine age, and better 
hygiene access were all frequently associated with higher latrine use, 
whereas poorer sanitation conditions were associated with lower use. A 
deeper understanding of how to effectively increase sanitation coverage 
and use could accelerate progress in eliminating open defecation and 
ultimately improve health.
1863
DISCOVERING AND OPTIMIZING BROAD-BASED 
ANTHELMINTICS USING PAN-PHYLUM ANALYSIS OF 
METABOLIC CHOKEPOINTS
Rahul Tyagi1, Ryan Chugani2, Mostafa Elfawal3, Chelsea Bidlow4, 
Bruce A. Rosa1, Scott Wildman5, Raffi Aroian3, Paul Brindley6, Judy 
Sakanari4, James W. Janetka2, Makedonka Mitreva1
1McDonnell Genome Institute, Washington University in St. Louis, St. 
Louis, MO, United States, 2Department of Biochemistry and Molecular 
Biophysics, Washington University in St. Louis, St. Louis, MO, United 
States, 3University of Massachusetts Medical School, Worcester, MA, 
United States, 4Deptartment of Pharmaceutical Chemistry, University of 
California San Francisco, San Francisco, CA, United States, 5University 
of Wisconsin Carbone Cancer Center, Madison, WI, United States, 
6School of Medicine and Health Sciences, George Washington University, 
Washington, DC, United States
Parasitic nematodes infect more than two billion people, resulting in 
significant morbidity and mortality. The development of new therapeutics 
is indispensable due to the limited number of currently available drugs, 
their limited efficacy against some species (or life-cycle stages) and 
increasing anti-drug resistance. We undertook a systems biology approach 
to reconstruct metabolic pathways and to identify, characterize and 
prioritize chokepoint reactions and enzymes (that produce a unique 
product or consume a unique substrate) that we could target with test 
compounds to evaluate their potential for developing selective inhibitors 
against them. This is facilitated by recent extensive sequencing and 
annotation of genomes and transcriptomes of parasites spanning the 
phylum Nematoda, along with the availability of binding, structure, 
pharmacology and toxicology data for a large set of small molecules in 
publicly available databases. Preliminary work on a broadly conserved 
chokepoint enzyme CPT (Carnitine palmitoyl transferase) resulted in 
compiling of a small library of 12 CPT inhibitors (from DrugBank and 
ChEMBL databases or synthesized by us) that we screened against 
five parasitic nematode species spanning the phylum Nematoda. A 
worm motility assay identified 8 effective compounds, including 3 with 
potential for broad applicability across clades. An extension of this 
work to identify more such chokepoints is currently underway using 
enzyme annotation and metabolic reconstruction of 17 species spanning 
the phylum. A comparison of these resulted in identification of 202 
chokepoints conserved across all taxonomic clades, including 87 that are 
conserved across all 17 species. These are currently being analyzed in 
order to prioritize a small number using multiple factors including level of 
conservation in nematodes and host, orthology in drug target databases, 
RNAi phenotype, expression profile across tissue and developmental 
stages, function in multiple pathways of interest, gene copy number etc. 
The chokepoints will be linked to inhibitors, and the predictions will be 
validated in multiple intestinal and filarial species.
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TRANSGENESIS IN STRONGYLOIDES: FREE-LIVING 
MALE WORMS AS TARGETS FOR GENE TRANSFER AND 
TRANSGENE PROPAGATION
James B. Lok, Hongguang Shao, Xinshe Li
University of Pennsylvania, Philadelphia, PA, United States
The capacity of parasitic nematodes in the genus Strongyloides to under 
go a generation of free-living development has enabled transgenesis in 
these worms by DNA transfer into oocyte nuclei. Anatomical similarity 
of free-living Strongyloides females to hermaphrodites of the free-
living nematode Caenorhabditis elegans has made it easy to adapt 
DNA transformation techniques developed for this model organism to 
S. stercoralis and S. ratti. The technique involves microinjecting DNA 
constructs into the ovarian syncytium of free-living female Strongyloides 
and mating these with wild type male worms. This process yields only 
small numbers of F1 transgenic progeny (<100), a large proportion of 
which are somatic transformants only. In light of this, we examined 
free-living male Strongyloides as targets of gene transfer, reasoning 
that transgenic males could propagate transgenes to multiple progeny 
by mating and that the majority of transformed progeny would carry 
transgenes in their germlines. To this end we microinjected testes of 10 
free-living male S. stercoralis with a solution containing 100 ng/µl of a 
proven reporter construct linking the coding sequence of green fluorescent 
protein (gfp) to the promoter of the ubiquitously expressed gene Ss-eft-3 
and the Ss-era-1 3’UTR. Microinjected males were plated along with 20 
wild type free-living females on NGM agar with a lawn of E. coli OP50 and 
incubated at 22° C for mating. F1 larvae were screened for GFP expression 
at 24 and 48 hours in culture. Of 150 progeny screened, 3 (2%) were 
transgenic as indicated by GFP fluorescence in the anatomical patterns 
typical of the Ss-eft-3 promoter. This indicates that the male germline of S. 
stercoralis may be transformed by microinjection of plasmid DNA and that 
transgenes may then be propagated to F1 progeny by mating with one or 
more wild type free-living females.
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MODULATION OF HUMAN DENDRITIC CELL ACTIVITY BY 
THE HELMINTH PARASITE ASCARIS SUUM
Andrew R. Williams, Helene L. Midttun, Sara Almeida, Peter 
Nejsum
University of Copenhagen, Frederiksberg C, Denmark
Ascariasis currently affects more than 1 billion people worldwide. Like 
many other helminths, Ascaris is thought to actively modulate and/or 
down-regulate host immune responses and inflammation. The mechanisms 
behind this immune-regulation have not been fully elucidated, although 
modulation of dendritic cell (DC) and macrophage function is likely to 
be involved. Here, we investigated in vitro modulatory effects of Ascaris 
suum (a swine parasite closely related to the human A. lumbricoides) on 
human DC function. Monocyte-derived DCs were matured with the TLR-
agonist lipopolysaccharide (LPS) in either the presence or absence of A. 
suum body fluid (ABF). DC function was assessed by analysis of cytokine 
secretion combined with transcriptomic and gene-set enrichment analysis 
(GSEA). ABF profoundly impacted on the response of DC to LPS. Secretion 
of the inflammatory cytokines IL-6, IL-12p70, IL-23 and TNF-α was strongly 
suppressed in ABF-treated DCs. Microarray analysis of ABF-treated DCs 
indicated a down-regulation of numerous genes encoding cytokines and 
chemokines, as well as molecules involved in intracellular inflammatory 
pathways and DC adhesion and migration. Selected genes were verified 
by qPCR and/or Western blotting. GSEA indicated significant disruption by 
ABF of numerous pathways involved in inflammation and DC maturation. 
Thus, we have demonstrated that Ascaris parasites strongly supress human 
DC function, suggesting that the parasite likely exerts a strong modulatory 
effect on the development of host immunity. These results increase our 
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understanding the host-parasite relationship in Ascaris infections and may 
contribute to the design of effective vaccines and other interventions for 
control of Ascariasis.
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GUT MICROBIOME CHANGES INDUCED BY EXPERIMENTAL 
TRICHURIS MURIS INFECTION ARE ASSOCIATED WITH 
DECREASED COGNITIVE FUNCTION IN MICE
Ricardo J. Soares Magalhães1, Paul Giacomin2, Zoltan Sarnyay3, 
Ann Kraeuter3, Tim Urich4, Mia Bengtsson4, Shuting Jin5, Eduardo 
A. Albornoz6, Richard Gordon6, Trent Woodruff6
1UQ Child Health Research Centre, The University of Queensland, South 
Brisbane, Australia, 2Australian Institute of Tropical Health and Medicine, 
James Cook University, Cairns Campus, Smithfield, Australia, 3Laboratory 
of Psychiatric Neuroscience, Australian Institute of Tropical Health and 
Medicine, James Cook University, Townsville Campus, Townsville, Australia, 
4Institute of Microbiology, University of Greifswald, Greifswald, Germany, 
5UQ School of Veterinary Science, The University of Queensland, Gatton, 
Australia, 6School of Biomedical Sciences, The University of Queensland, 
St. Lucia, Australia
The effect of helminth infections on cognitive function of children has 
recently been under increased scrutiny. The gastrointestinal microbiome 
can modulate the functional development of the central nervous system. 
Recently we have demonstrated that helminth infections are able to 
induce important changes in the gastrointestinal microbiome of children. 
However, to date no studies have sought to evaluate the effect that 
microbial shifts associated with helminth infections may have on the 
host’s cognition. This study aimed to investigate whether gastrointestinal 
helminthic infections are associated with decreased cognitive function as 
a result of changes to the gut microbiome. A chronic infection model was 
set-up using three groups of mice: two groups of 12 animals infected with 
Trichuris muris (a low and a high infection group) and 12 non-infected 
animals (control group). Mice were followed for 9 months and faecal 
samples were collected and stored in dichromate. Total DNA was extracted 
from the collected samples and changes in the structure and diversity 
of the gastrointestinal microbiome of mice in each group were done by 
evaluation of next-generation 16S rDNA sequencing. Cognitive function 
of mice was tested using the forced swim test (to identify depression-like 
endophenotype), working memory test (to measure general activity), a 
social interaction test and the reference Y-maze test (working memory). 
Our results indicate significant differences in diversity and abundance in 
the gut microbiome of mice in the control group compared to the low 
and high infection groups. Our results also indicated that mice in the high 
infection group show a deficit in reference memory compared to control 
and low infection groups associated with those alterations. This study 
demonstrates an alternative mechanism through which helminth infections 
can result in deficits in cognitive function. The functional profile of the 
groups of bacteria found altered and the clinical repercussions on cognitive 
delays of these alterations deserve further empirical studies in populations 
where both helminth infections and cognitive delays are highly prevalent.
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ASSESSING THE IMPACT OF MASS DEWORMING ON CO-
INFECTIONS WITH OTHER PARASITES AND COMMENSALS 
USING MOLECULAR TECHNIQUES
Alice V. Easton1, Conrad Shyu1, Charles S. Mwandawiro2, 
Sammy M. Njenga2, Jimmy H. Kihara2, Cassian Mwatele2, Mariam 
Quinones1, Jacquice Davis1, Yasmine Belkaid1, Rita G. Oliveira3, 
Poppy H. Lamberton3, Roy M. Anderson3, Thomas B. Nutman1
1National Institutes of Health, Bethesda, MD, United States, 2Eastern and 
Southern Africa Centre of International Parasite Control, KEMRI, Nairobi, 
Kenya, 3Imperial College London, London, United Kingdom
Studies in mice suggest that the presence of soil-transmitted helminths 
(STH) is associated with alterations in microbial community diversity. Some 
of these effects extend to anatomic locations within the gastrointestinal 
tract remote from where these helminths reside, and may persist after 
helminth clearance. Studies in humans have mostly failed to corroborate 
these findings. To demonstrate how molecular approaches to the human 
gut pathobiome and bacterial microbiome can provide insights into the 
complex interplay among disparate organisms, DNA was extracted from 
cryopreserved stools from subjects in 5 rural Kenyan villages and examined 
by qPCR for 9 intestinal parasites and by MiSeq 16S rRNA sequencing 
for bacterial communities before and 3 months following albendazole 
(ALB) therapy. Among 796 people surveyed by qPCR, 23% (186) had 
2 or more gastrointestinal parasites concurrently. There were no strong 
inter-species relationships between the presence of one infection and the 
presence of any other parasite, except for an association between Ascaris 
lumbricoides and Giardia lamblia (Pearson chi-square, p <0.001). Based on 
16S rRNA sequence from 192 pre-ALB samples, there was no significant 
association between STH infection and microbial community composition. 
However, when a measure of microbial species diversity (Shannon index) 
was applied to 39 pairs of samples from individuals pre- and post-ALB, 
there was a significantly higher microbial diversity post ALB (p=0.04) in 
individuals who had Necator americanus infection pre-ALB, whereas there 
were no significant differences in microbial diversity pre and post-ALB in 
those with A. lumbricoides or those without any STH infection. We are 
currently sequencing additional samples, so that our final dataset will 
include pre- and post-ALB pathobiome and microbiome data from a much 
larger sample size (at least 60 pairs of samples for each of the important 
STHs and appropriate controls). This increased sample size will sharpen our 
understanding of the broader impact of mass deworming programs on 
microbial communities and ultimately on human health.
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CONTROLLED HUMAN HOOKWORM INFECTION MODEL FOR 
TESTING THE EFFICACY OF EXPERIMENTAL HOOKWORM 
VACCINES
David Diemert1, Maria Zumer1, Doreen Campbell1, Caitlyn 
Leasure1, Landria Sheffey1, Melissa Keany1, Jill Brelsford1, Anna 
Yakovleva1, Rojelio Mejia2, David Pritchard3, John Hawdon1, Jeffrey 
Bethony1
1George Washington University, Washington, DC, United States, 
2Baylor College of Medicine, Houston, TX, United States, 3University of 
Nottingham, Nottingham, United Kingdom
A controlled human hookworm infection model is being developed to 
provide early proof-of-concept that experimental hookworm vaccine 
candidates are feasible and efficacious. The proposed model consists of 
vaccinating healthy, hookworm-naïve adults with a candidate hookworm 
vaccine, followed by challenging them with infectious Necator americanus 
larvae (L3). We are conducting a feasibility study in Washington, DC, in 
which different doses of L3 are administered to healthy adult hookworm-
naïve volunteers to determine the optimal dose that is safe, well-tolerated 
and results in consistent levels of infection. 3 cohorts of 10 healthy, 
hookworm-naive adult volunteers are receiving 25, 50, or 75 L3 in a 
dose-escalating design. L3 are obtained from the feces of an infected 
donor who is regularly screened for blood borne pathogens. Batches of 
L3 are tested for identity, motility/viability, and bacterial/fungal growth 
prior to release for use. Doses are prepared by counting motile L3 by 
microscopy; these are then applied to a gauze pad that is placed on the 
subject’s forearm for 1 hour. Subjects are seen weekly until 12-18 weeks 
post-infection, when they are treated with albendazole. Results from 
the 25 and 50 L3 cohorts indicate that these doses are well tolerated 
by volunteers. Early manifestations of infection included mild-to-severe 
pruritus, erythema, pain, and papulovesicular rash (duration: 4-76 days) at 
the skin application site. Gastrointestinal complaints (abdominal bloating, 
flatulence, nausea and abdominal pain) were frequent starting between 
weeks 4-5 post-infection although these were mostly mild or moderate in 
intensity. Eosinophilia developed in 9/10 and 10/10 in the first and second 
cohorts, respectively (range: 0.5-4.9 x 103/mm3). Hookworm eggs were 
detectable by microscopy in 3/10 (range by McMaster method: 0-33.3 
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eggs per gram [epg] feces) and 9/10 (range: 0-166.66 epg) in the first 
and second cohorts, respectively. Controlled hookworm infection with at 
least 50 L3 appears necessary to induce consistent infection in controls for 
future vaccination-challenge clinical trials.
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PHASE 1 TESTING OF THE NA-APR-1/ALHYDROGEL 
HOOKWORM VACCINE IN HEALTHY, HOOKWORM-NAIVE 
ADULTS
David Diemert1, Maria Zumer1, Aimee Desrosiers1, Doreen 
Campbell1, Shannon Grahek1, Jill Brelsford1, Anna Yakovleva1, 
Maria Elena Bottazzi2, Peter Hotez2, Jeffrey Bethony1
1George Washington University, Washington, DC, United States, 2Baylor 
College of Medicine, Houston, TX, United States
Necator americanus Aspartic Protease-1 (Na-APR-1) is a 42.2-kDa 
protein produced by adult hookworms that is the first enzyme in the 
ordered cascade of hemoglobinases that the worms use to digest 
host hemoglobin. Vaccination of laboratory dogs and hamsters with 
recombinant APR-1 resulted in reduced hookworm fecal egg counts and 
reduced adult worm burden following challenge with infective larvae. 
Recombinant Na-APR-1 was derived from Agrobacterium tumefaciens 
genetically engineered to express the antigen in Nicotiana benthamiana 
tobacco plants and formulated on Alhydrogel. A Phase 1 trial was 
conducted in Washington, DC. 40 healthy, hookworm-naïve adults were 
vaccinated with 1 of 2 different dose concentrations of Na-APR-1 (30 or 
100 µg) either with or without the point-of-injection addition of 2.5 or 
5 µg of an aqueous formulation of glucopyranosyl lipid A [GLA-AF], a 
synthetic Toll-like receptor-4 agonist. Subjects received 3 intramuscular 
injections at 2-month intervals. In this study, the vaccine was well 
tolerated: common adverse events included mild to moderate injection site 
pain and tenderness, headache, and nausea. No differences were observed 
in adverse events between dose groups or GLA formulations. Mean anti-
Na-APR-1 IgG antibody levels as measured by qualified indirect ELISA were 
modest after the 2nd vaccination, but increased significantly from baseline 
after the 3rd vaccination in those who received 100 µg Na-APR-1 (with or 
without GLA-AF). The highest peak IgG levels were observed in the cohort 
that received 100 µg Na-APR-1 in combination with 5 µg GLA-AF. In the 
30 µg Na-APR-1 groups, mean IgG levels did not increase above baseline 
in those who received the Alhydrogel-only formulation whereas significant 
increases were observed after the 2nd and 3rd vaccinations in those who 
received Na-ARP-1/Alhydrogel plus GLA-AF. IgG responses were sustained 
until the end of the trial, 6 months post-final vaccination. This first-in-
humans trial of the Na-APR-1 hookworm vaccine demonstrates that it is 
well-tolerated and immunogenic in unexposed healthy adults and justifies 
further clinical testing of this vaccine in endemic areas.
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IMPAIRED NEUTROPHIL RECRUITMENT TO INVADING 
LITOMOSOIDES SIGMODONTIS L3 LARVAE LEADS TO AN 
INCREASED WORM BURDEN IN NOD2 RECEPTOR AND IL-6 
DEFICIENT MICE
Jesuthas Ajendra, Sabine Specht, Sebastian Ziewer, Muhsin 
Muhsin, Kenneth Pfarr, Andrea Schiefer, Katrin Gentil, Achim 
Hoerauf, Marc P. Hübner
University Hospital of Bonn, Bonn, Germany
The NOD2 receptor is a widely spread intracellular pattern recognition 
receptor that is activated by muramyl-dipeptide (MDP), a bacterial cell 
wall component, triggering NFκB-induced pro-inflammatory responses. 
Since most human pathogenic filariae as well as the rodent filariae 
Litomosoides sigmodontis (L.s.) harbor endosymbiotic Wolbachia bacteria 
that synthesize the cell wall precursor lipid II, which contains MDP, we 
investigated the role of the NOD2 receptor during L.s. infection. Crude 
L.s. adult worm extract induced both NOD1 and NOD2 activation in NFkB 
reporter cell lines in a Wolbachia dependent manner. Upon infection 
with L.s., NOD2-/- mice harbored significantly more worms compared to 
wild-type (WT) controls. Lack of the NOD2 receptor did not change the 
cellular composition and analyzed cytokine/chemokine levels within the 
thoracic cavity, the site of worm residency. However, the skin stage of 
infection was essentially modulated in NOD2-/- mice, and bypassing the 
skin barrier by subcutaneous L3 injection resulted in a comparable worm 
burden in NOD2-/- and WT animals. Flow cytometric analyses and PCR 
arrays showed a significantly reduced neutrophil recruitment in the skin 
of NOD2-/- mice following intradermal injection of crude worm extract 
or L3 larvae, respectively. Further support that an impaired neutrophil 
recruitment mediates the increased worm burden in NOD2-/- mice was 
obtained by neutrophil depletion before natural L.s. infection, which 
significantly increased the worm recovery in WT, but did not alter the 
already elevated worm counts in NOD2-/- mice. That neutrophils are in 
general an essential part of the initial protective immune response against 
invading L3 larvae was further shown in IL-6-/- mice, which also had a 
delayed neutrophil recruitment within the skin resulting in an increased 
worm burden, which was not observed after subcutaneous infections. 
This study demonstrates that the NOD2 receptor is involved in protective 
immune responses against filarial nematodes by triggering the neutrophil-
driven initial protective immune response against invading L3 larvae within 
the skin.
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MICROFILARIAE OF BRUGIA MALAYI INDUCES 
AUTOPHAGY THROUGH THE INDUCTION OF INDOLEAMINE 
2,3-DIOXYGENASE (IDO) AND INTERFERON-γ (IFN-γ)
Prakash Babu Narasimhan, Leor Akabas, Thomas B Nutman, 
Roshanak Tolouei Semnani
National Institute of Allergy and Infectious Diseases, Bethesda, MD, United 
States
Monocyte dysfunction in filarial infection is one of the mechanisms 
proposed to explain the diminished parasite antigen-specific T cell 
responses seen with patent filarial infection. In fact, monocytes from 
filariae-infected individuals demonstrate internalized filarial antigens 
and, as a consequence, express inhibitory surface molecules and have 
diminished cytokine production. To investigate the mechanisms underlying 
these phenotypic and functional changes induced by filarial antigens in 
monocytes we exposed purified human monocytes to live microfilariae 
(mf) of Brugia malayi and compared the mRNA and protein expression 
of important inhibitory immune checkpoint molecules to mf-unexposed 
monocytes. Our results indicate that mf significantly induced the mRNA 
expression of indolamine 2,3-dioxygenase (IDO) - a tryptophan catabolic 
enzyme with immune-inhibitory properties- in human monocytes and 
also significantly enhanced tryptophan degradation (an indicator of IDO 
activity; p<0.005) in these cells. As IDO induces autophagy through the 
upregulation and activation of GCN2 (a serine/threonine protein kinase), 
we next examined the expression of this kinase and autophagy related 
genes BCN1, LC3B, ATG5, and ATG7. Interestingly, mf significantly 
induced the mRNA expression of GCN2 and each of these autophagy 
related genes (p<0.05) in human monocytes. This upregulation was shown 
to be dependent on interferon-γ (IFN-γ) as mf significantly induced the 
production of this cytokine in monocytes (p=0.03) and a neutralizing anti-
IFN-γ antibody reversed the expression of autophagy-related genes almost 
to the basal levels. Our data suggest that mf of B. malayi alter the function 
of monocytes by inducing IDO and IFN-γ, molecules that lead to monocyte 
autophagy that may in turn alter the host immune response.
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IMPACT OF MATERNAL PRAZIQUANTEL TREATMENT DURING 
PREGNANCY ON OFFSPRING IMMUNE RESPONSES TO 
SCHISTOSOME ANTIGENS AT SIX YEARS OF AGE IN LEYTE, 
PHILIPPINES: RESULTS FROM A RANDOMIZED CONTROLLED 
TRIAL
Mario A. Jiz1, Luz P. Acosta1, Palmera Baltazar1, Blanca Jarilla1, 
Veronica Tallo1, Marianne Sagliba1, Amabelle Moreno1, Maripaz 
Urbina1, Archie Pablo1, Remigio Olveda1, Hannah Wu2, Jonathan 
Kurtis2, Jennifer Friedman2
1Research Institute for Tropical Medicine, Muntinlupa City, Philippines, 
2Center for International Health Research, Rhode Island Hospital, 
Providence, RI, United States
Previous studies have suggested that schistosome antigens cross the 
placenta during pregnancy and influence newborn immune responses. 
We conducted a placebo-controlled trial of Praziquantel (PZQ) to 
schistosomiasis infected pregnant women in Leyte, Philippines. Here, we 
assess the impact of treatment on in utero sensitization to schistosome 
specific immune responses for N=107 six year old offspring of these 
mothers (55 PZQ, 52 placebo). We found no difference in schistosomiasis 
prevalence at age 6 (8.9% vs 13.5% in PZQ versus placebo, P=0.45). We 
purified PBMC from these children and stimulated them with schistosome 
worm (SWAP) and egg (SEA) antigens, and paramyosin. Cytokines 
(Interleukin-1, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, IL-12, IL-13, Interferon γ, 
TNF α) were measured in tissue culture supernatants using a multiplexed 
platform (Luminex). We evaluated differences in immune responses based 
on maternal treatment allocation using multivariate models adjusting for 
sex, schistosomiasis infection intensity and constitutive cytokine expression. 
Strikingly, children born to PZQ-treated mothers consistently demonstrated 
decreased levels (17% - 69%) of both Th1 and Th2 cytokines to SWAP (IL-
12 1.33 vs 1.10 pg/ml (placebo vs PZQ), P=0.02; IL-13 53.7 vs 16.6 pg/ml, 
P=0.04, marginal for IL-4, IL-5, IL-13, IFNγ & TNF-α). We also detected a 
trend toward decreased levels of Th2 cytokines in response to SEA among 
children born to PZQ-treated mothers (IL-5 63.2 vs 23.9 pg/ml & IL-13 75.9 
vs 29.4 pg/ml, both P=0.1). Interestingly, children born to PZQ-treated 
mothers had increased Th2 cytokine responses to paramyosin (IL-4 2.0 vs 
2.3 pg/ml P=0.02; IL-5 3.2 vs 4.4 pg/ml, P=0.05), an immune response 
we have previously reported is associated with significant protection from 
infection. In utero sensitization was not associated with differences in 
IL-10 levels. Our data indicate that treatment modifies in utero immune 
sensitization to schistosome antigens, having potentially profound effects 
on parasite-specific cytokine profiles even at age six. We will present data 
from an additional 87 children by the time of the meeting.
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EFFECT OF PRENATAL EXPOSURE TO SCHISTOSOMIASIS 
AND CO-INFECTIONS WITH SCHISTOSOMIASIS ON FETAL 
IMMUNE RESPONSES
Ruth K. Nyakundi1, Ronald K. Ottichilo2, Francis Mutuku2, 
Desiree LaBeaud3, Charles H. King4, Indu Malhotra4
1Institute of Primate Research, Nairobi, Kenya, 2Division of Vector Borne 
and Neglected Tropical Diseases, Ministry of Public Health and Sanitation, 
Nairobi, Kenya, 3Stanford School of Medicine, Stanford, CA, United States, 
4Case Western Reserve University, Centre for Global Health and Diseases, 
Cleveland, OH, United States
Prenatal maternal infections are known to influence fetal immune 
responses. This fetal priming can enhance or suppress responses to 
parasitic antigens, which may influence the child’s response to infection. 
Helminth infections are known to induce T-cell hyporesponsiveness and 
immunoregulatory mechanism. However, little is known on how helminth 
co-infections during pregnancy may impact on fetal immunity. We 
investigated immune responses from infants born to mothers with single 
or multiple infections. 79 Kenyan women were tested for the presence 
of Schistosoma haematobium (SH) and schistosome co-infection with 
filariasis and malaria (SH co-infected). Neonates’ cord blood lymphocyte 
responses to SH worm (SWAP) and egg antigens (SEA) were analyzed for 
proliferation and production of IL-2, IL-5, IL-6 IL-10, IL-12, IL-13, IFN-y, 
TNF-α and GM-CSF. Proliferation stimulation index (SI) and cytokine levels 
were compared between mothers with single (n=36), multiple (n=16) 
and no infection (n=27). Mothers with single infection at delivery were 
further classified based on treatment during pregnancy. Analysis was done 
using unpaired t test with welch’s correction. Results showed a higher 
SI to SWAP, SEA and PHA (p=0.047) in the SH co-infected group (3.22, 
2.77, 14.85) compared to the non-infected (1.26, 1.27, 4.96). Reduced 
IL-2, IL-5, IL-10, IL-12 and IFN- y responses were recorded in SH and 
SH co-infected groups but levels did not differ significantly. In contrast, 
significantly lower levels of SEA stimulated GM-CSF (p=0.021) was 
recorded in the SH compared to the SH co-infected group. Mothers in the 
SH group who received anti-malarial drugs had higher levels of immune 
responses compared to the group not exposed to malaria. We noted 
spontaneous production of IL-6 in all groups. Conversely, significantly 
higher levels of spontaneous production of GM-CSF (p=0.041) and TNF-α 
was recorded in the SH co-infected group compared to the SH group. 
These preliminary results indicate that while schistosomiasis infection 
results in immunosuppression, fetal immune priming is enhanced with 
multiple infections and is sustained post treatment.
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LYMPHATIC FILARIASIS: HOST AND PARASITE FACTORS 
AND THE PATHOGENESIS OF SYSTEMIC ADVERSE EVENTS 
FOLLOWING TREATMENT
Britt Andersen1, Jessica Kumar2, Christopher L. King2, Peter Uwe 
Fischer1, Gary J. Weil1
1Washington University School of Medicine, St. Louis, MO, United States, 
2Case Western Reserve University, Cleveland, OH, United States
Lymphatic filariasis (LF, aka “elephantiasis”) is a neglected tropical disease 
(NTD) that is caused by the nematode parasite Wuchereria bancrofti. 
Some 800 million people in 73 countries are at risk for infection and 
disability caused by these parasites. Mild to moderate systemic adverse 
events (AEs) such as fever, myalgia, and headache are common after 
treatment of LF, and these AEs pose a major challenge for the global LF 
elimination program that is using mass drug administration (MDA) to 
interrupt transmission of the disease. We are studying the pathogenesis of 
AEs with blood samples collected before and after treatment in infected 
volunteers in clinical trials in Côte d’Ivoire and Papua New Guinea. We 
have used a Bio-Plex cytokine panel to measure 27 cytokines in 24 LF-
infected individuals at seven time-points, from pre-treatment up until 
72 hours post-treatment. Results show that 19 out of the 27 cytokines 
were significantly increased in post-treatment plasma in individuals with 
moderate AEs compared to individuals with no/or mild AEs. This included 
the three main pro-inflammatory cytokines (IL-6, TNF-α and IL-1β) that 
were all increased in people with moderate AEs between 8-36 hours 
post-treatment. Another interesting, and unexpected result was observed 
for Eotaxin-1. This eosinophil-specific chemokine was significantly up-
regulated at baseline in individuals that would go on to develop moderate 
AEs after treatment. Eotaxin-1 could therefore be a potential biomarker for 
AEs risk. Preliminary results from global gene expression studies (RNAseq) 
suggest that several immune pathways are up-regulated in host leukocytes 
following treatment, and we hope to identify specific transcriptional 
signatures that are associated with AEs. Additionally, we have developed 
a qPCR assay for the detection of Wolbachia DNA in human plasma, 
and we have found that post-treatment plasma samples are more likely 
to test positive for Wolbachia. Improved understanding of the causes of 
post-treatment AEs may lead to improved methods for their prevention 
or management and increase compliance in mass drug administration 
programs that aim to eliminate LF.
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ONCHOCERCA VOLVULUS ANTIGEN PEPTIDE 
IMMUNOREACTIVITY DISTINGUISHES PARASITE 
POPULATIONS IN THE AMERICAS, WEST AFRICA, CENTRAL 
AFRICA AND EAST AFRICA
Carmelle T. Norice-Tra1, Jose‘ Ribeiro1, Sasi Bennuru1, Rahul 
Tyagi2, Makedonka Mitreva2, Thomas B. Nutman1
1National Institutes of Health, Bethesda, MD, United States, 2Washington 
University School of Medicine, St. Louis, MO, United States
Studies of Onchocerca volvulus (Ov) population biology may help elucidate 
its transmission, spread, emergence of drug resistance, and persistence 
despite control measures. Such studies are currently limited because 
they rely on the extraction of parasite material from their human hosts, 
material that is often limited in availability. Thus, we have developed a 
novel, serologically-based immunotyping approach to the study of Ov 
population diversity and spatial distribution. Using genomic sequence 
data and PCR-based genotyping, we identified non-synonymous single 
nucleotide polymorphisms (SNPs) in the coding sequences of many of 
the major known immunogenic Ov proteins: Ov 7, Ov 16, Ov ASP1, Ov 
CHI1, M3, Ov ALT1, Ov TMY1, Ov B8, Ov FAR1, Ov SOD1, Ov CPI1, Ov 
B20, Ov RAL1 and Ov RAL2. Using immunoassays to assess the antibody 
reactivity against synthetic SNP-containing peptides derived from these 
immunogenic proteins and well-characterized sera from a large cohort of 
patients (n=114) from multiple regions across Africa and the Americas, we 
have found statistically different geolocation-specific immunophenotypes 
(by Chi-Square analyses) against variant peptides derived from M3, Ov 
RAL1, Ov RAL 2, Ov SOD1, Ov CPI1, Ov B20, Ov RAL2, Ov TMY1, Ov16 
and OvCAL1. Hierarchical clustering analysis also identified immunotype 
differences by region. Specific patterns of immunoreactivity against 
variant peptides from Ov B20, Ov TMY1, Ov16 and OvCAL1 clearly 
distinguished East African samples from those originating from Central 
Africa, West Africa and the Americas. Our data show that differences in 
immunoreactivity to variant antigenic peptides may be used to characterize 
populations of Ov, thereby shedding light on features of Ov population 
biology that may have been inaccessible because of the reliance on 
archived parasite material of limited availability.
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HAPLOTYPES WITHIN NFKBIA PROMOTER ARE ASSOCIATED 
WITH SEVERE MALARIAL ANEMIA AND CIRCULATING IL-
10 AND IP-10 LEVELS IN CHILDREN WITH PLASMODIUM 
FALCIPARUM MALARIA
Elly O. Munde1, Angela O. Achieng1, Lily E. Kisia1, Zachery 
S. Karim1, Evans O. Raballah2, Prakasha Kempaiah1, John M. 
Ong’echa1, Collins Ouma3, Douglas J. Perkins1
1University of New Mexico School of Medicine, Albuquerque, NM, United 
States, 2Department of Medical Laboratory Sciences, Kakamega, Kenya, 
3Department of Biomedical Sciences and Technology, Maseno, Kenya
Pathogenesis of severe malarial anemia (SMA, Hb<5.0g/dL and any 
density parasitemia) in children has been described as a multifactorial 
process. Genetic susceptibility factors have been proposed as elements 
of this pathogenesis. Transcription factors are important in regulating 
cellular processes including immunity. The inhibitor of nuclear factor of 
kappa light enhancer in B-cells (IκBs) plays important roles in infectious 
and autoimmune diseases through their ability to regulate the production 
of soluble immune modulators such as cytokines whose imbalance have 
been shown to characterize SMA. Due to the important roles of NFκB in 
immunity, we hypothesized that genetic variations within the promoter 
region of its inhibitor, IκBs (NFKBIA) gene affect its production thereby the 
downstream modulators of immunity and hence influence Plasmodium 
falciparum malaria outcome. The association between NFKBIA (-826 G/A, 
rs2233406 and -310 G/A; rs2233409 and SMA in children (n=1,026, aged 
6-36mos.) with P. falciparum malaria from Siaya County, western Kenya, 
a P. falciparum holoendemic transmission area was determined. NFKBIA 
genotypes were determined using Taqman® genotyping assay. Bivariate 
regression analysis controlling for confounders revealed that existence 
of AA haplotype (NFKBIA-826A/-310A) was associated with risk of SMA 
(OR 1.60, 95%CI 1.01-2.55, P=0.047) while the AG haplotype (NFKBIA-
826A/-310G) was associated with protection from SMA (OR; 0.58, 95% 
CI; 0.34-0.98). To identify the downstream target mediators modulated 
by NFKBIA, we used 25 mediators from Hu Cytokine 25-plex Ab Bead Kit. 
Additional analysis revealed that the AG haplotype (NFKBIA-826A/-310G) 
was associated with elevated levels of IL-10 and IP-10 (P=0.0050 and 
P=0.008, respectively). Moreover, SMA was associated with low levels of 
IL-10 and IP-10 (P=0.048 and P=0.025). These results demonstrate that 
genetic variation in the regulatory region of NFKBIA are associated with 
susceptibility to SMA and influence changes in the levels of circulating IL-
10 and IP-10 during P. falciparum infection.
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PLASMODIUM MTRAP IS ESSENTIAL FOR GAMETE EGRESS 
AND PARASITE TRANSMISSION TO MOSQUITOES
Daniel Y. Bargieri1, Sabine Thiberge2, Chwen Tay3, Alison F. 
Carey2, Ursula Straschil3, Alice Rantz2, Audrey Lorthois4, Florian 
Hischen5, Takafumi Tsuboi6, Tony Triglia7, Pietro Alano8, Alan 
Cowman7, Jake Baum3, Gabriele Pradel5, Catherine Lavazec4, 
Robert Ménard2
1University of Sao Paulo, Sao Paulo, Brazil, 2Institut Pasteur, Paris, France, 
3Imperial College, London, United Kingdom, 4Institut Cochin, Paris, France, 
5Aachen University, Aachen, Germany, 6Ehime University, Ehime, Japan, 
7Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia, 
8Istituto Superiore di Sanità, Rome, Italy
Apicomplexan parasites use an actin-myosin motor to glide on substrates 
and actively invade host cells. The TRAP (thrombospondin-related 
anonymous protein) family of transmembrane proteins, which is conserved 
in the apicomplexan phylum, is involved in parasite motility and cell 
invasion by integrating actin in the parasite and ligands in the matrix/cell 
surfaces. In Plasmodium, the family member expressed in the merozoite 
stage, called merozoite-TRAP (MTRAP), is thought to act during merozoite 
invasion into erythrocytes in the mammalian host. We show here that 
MTRAP is dispensable for this step but essential in the mosquito vector for 
gamete egress from erythrocytes, an actin and myosin-dependent process, 
by allowing the disruption of the membrane of the gamete-containing 
vacuole. This indicates that the apicomplexan TRAP protein family 
mediates more than parasite motility and cell invasion, and that vacuolar 
membrane disruption may result, at least in part, of a motor- and TRAP-
dependent process.
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PROFILING GENE EXPRESSION IN A PHASE II PLASMODIUM 
VIVAX IRRADIATED SPOROZOITE VACCINE TRIAL
Monica L. Rojas-Peña1, Dalia Arafat1, Myriam Arévalo-Herrera2, 
Sócrates Herrera3, Juan M. Vásquez3, Greg Gibson1
1Center for Integrative Genomics, School of Biology, Georgia Institute of 
Technology, Atlanta, GA, United States, 2School of Health, Universidad del 
Valle, Cali, Colombia, 3Caucaseco Scientific Research Center (CSRC), Cali, 
Colombia
Malaria remains an important public health problem worldwide, with 
13.8 million cases caused by Plasmodium vivax, a parasite species that 
predominates in South-East Asia and the American continent. Despite 
the epidemiological importance of this species, studies of the immune 
response and their potential for vaccine development are limited. The 
vaccine that is in the most advanced stage of development is the anti-P. 
falciparum RTS,S vaccine, which has been reported to provide partial 
immunity when tested on a population of newborns and young children 
in West Africa. Development of more protective vaccines requires a 
better understanding of the human immune response. Here we report 
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initial results of gene expression profiling of peripheral blood before and 
after seven rounds of immunization with radiation attenuated P, vivax 
sporozoites (RAS) in 20 volunteers, as well as after controlled challenge 
with live P, vivax. RNASeq was used to generate whole transcriptome 
profiles for three non-immunized controls, five protected Duffy Fy-, five 
protected volunteers immunized with RAS, and seven not protected 
volunteers. The most remarkable changes in gene expression were 
observed between baseline and post- challenge, with distinct signatures 
differentiating protected and susceptible individuals. Analysis of 
transcriptional modules shows that B-cell signaling is reduced while cell 
cycle regulation and interferon response are highly elevated in individuals 
not protected by RAS, whereas T-cell signaling and an inflammatory 
response are elevated in protected individuals. Furthermore, some 
differences in the profiles associated with protection as a result of Duffy 
negative status and RAS immunization were observed, while vaccination 
itself also modified aspects of B and T cell gene expression. Combined 
with immune cell profiling we expect the systems biology approach may 
suggest novel approaches to improving the efficacy of malaria vaccines.
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HIGH-THROUGHPUT GENOMIC SURVEILLANCE OF 
PLASMODIUM INFECTIONS IN INDIA
Pavitra N. Rao1, Swapna Uplekar1, Prashant K. Mallick2, Nabamita 
Bandyopadhyay2, Sonal Kale2, Nicholas J. Hathaway3, Alex Eapen4, 
Ranvir Singh5, Khageswar Pradhan6, Jeffrey A. Bailey3, Om P. 
Singh7, Jane M. Carlton1
1New York University, New York, NY, United States, 2National Institute 
of Malaria Research, New Delhi, India, 3University of Massachusetts, 
Worcester, MA, United States, 4National Institute of Malaria Research, 
Chennai, India, 5National Institute of Malaria Research, Nadiad, India, 
6National Institute of Malaria Research, Raurkela, India, 7National Institute 
of Malaria Research, Delhi, India
High-throughput genomic sequencing technologies provide the resolution, 
quality and rapid turnover required for routine large-scale surveillance 
of Plasmodium - for example for the spread of drug resistance genes 
or determining the complexity of infection. Here, we describe the 
development of a high-throughput amplicon sequencing protocol for 
multiplexed sequencing of multiple Plasmodium genes for routine 
surveillance purposes. We are using this in our Genomics Core Facility at 
the National Institute Malaria Research in New Delhi, India as part of an 
NIH-funded International Center of Excellence for Malaria Research, for 
surveillance of Plasmodium samples collected during our epidemiology 
studies. The amplicon sequencing protocol has been designed for the 
bench-top Ion Torrent PGM platform and can be operated with minimal 
bioinformatics infrastructure making it ideal for use in endemic country 
settings. In one assay, deep sequencing of a panel of six P. falciparum 
genes including k13, crt, dhfr, dhps, mdr1 and mrp1, in ~150 clinical 
isolates from three epidemiologically diverse sites in India revealed a 
number of known and novel single nucleotide polymorphisms (e.g., in 
Pfk13), which could be associated with antimalarial drug resistance. In a 
second assay, we have shortlisted a panel of five Plasmodium vivax genes, 
including msp1, msp3, sera5, msp7 and clag identified as being highly 
polymorphic across 200 P. vivax genomes, to estimate the number of 
clones in ~150 P. vivax infections. Our studies are revealing the within-
host diversity of these isolates by using SeekDeep haplotype frequency 
estimation to infer the number of parasite clones and their change 
in frequencies after drug treatment. Our next-generation amplicon 
sequencing method facilitates surveillance of antimalarial drug resistance 
and helps elucidate the role of complexity of infection in disease outcome.
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REVERSIBLE HOST CELL REMODELING UNDERPINS 
DEFORMABILITY CHANGES IN MALARIA PARASITE SEXUAL 
BLOOD STAGES
Megan Dearnley1, Chu Trang2, Yao Zhang3, Oliver Looker1, 
Changjin Huang3, Nectarios Klonis1, Jeff Yeoman4, Mohit Arora2, 
James Osborne5, Rajesh Chandramohanadas2, Sulin Zhang3, Leann 
Tilley1, Matthew Dixon1
1Department of Biochemistry and Molecular Biology, Bio21 Institute, The 
University of Melbourne, Melbourne, Australia, 2Pillar of Engineering 
Product Development, Singapore University of Technology & Design, 
Singapore, Singapore, 3Department of Engineering Science and 
Mechanics, The Pennsylvania State University, University Park, PA, United 
States, 4Department of Biochemistry, La Trobe University, Melbourne, 
Australia, 5School of Mathematics and Statistics, The University of 
Melbourne, Melbourne, Australia
Survival of the human malaria parasite Plasmodium falciparum in the 
circulation of the host relies on its ability to drastically alter its red blood 
cell (RBC) host cell. The sexual blood stage (gametocyte) of the human 
malaria parasite P. falciparum undergoes remarkable biophysical changes 
as it prepares for transmission to mosquitoes. Developing mid-stage 
gametocytes show low deformability and sequester in the bone marrow, 
avoiding clearance during passage through splenic sinuses. Mature 
gametocytes exhibit increased deformability and reappear in the peripheral 
circulation, allowing uptake by mosquitoes. Here we define the reversible 
changes in RBC membrane organization that underpin this biomechanical 
transformation. Using a combination of biophysical techniques such as 
ektocytometry, spleen mimic filtration assays along with super resolution 
microscopy and atomic force microscopy techniques we functionally 
assess the role that RBC membrane skeleton remodelling plays in this 
reversible shift in deformability. We show that the length of the spectrin 
cross-members and the membrane skeleton mesh size increases in the 
non-deformable early gametocyte. These changes are accompanied by 
relocation of actin from the RBC membrane to the Maurer’s clefts. These 
changes are reversed in the late stage gametocyte allowing parasite 
survival within the host and disease transmission.
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SPATIAL HETEROGENEITY CAN UNDERMINE THE 
EFFECTIVENESS OF COUNTRY-LEVEL TEST AND TREAT 
POLICY FOR MALARIA: A CASE STUDY FROM BURKINA FASO 
USING RDT AND HEMOGLOBIN
Denis Valle, Justin Millar, Punam Amratia
University of Florida, Gainesville, FL, United States
Considerable debate has arisen regarding the appropriateness of the test 
and treat malaria policy recommended by the World Health Organization 
(WHO). While presumptive treatment has important drawbacks, 
the usefulness of test and treat can vary considerably across space, 
depending on several factors such as baseline malaria prevalence and 
RDT performance characteristics. Using 2010 Demographic and Health 
Survey (DHS) data, we fitted generalized linear mixed effects models to 
hemoglobin measurements, rapid diagnostic test (RDT), and microscopy 
results on 6,510 children under 5 years of age from Burkina Faso. Our 
statistical models revealed substantial variation in RDT performance, 
baseline prevalence, and hemoglobin measurements, both in space and as 
a function of covariates. As a result, an individual with a positive RDT result 
in one region can surprisingly have the same malaria infection probability 
as another individual with a negative RDT result in another region. These 
findings reveal that a test and treat policy might be reasonable in some 
settings but might be unacceptable in others given the high proportion of 
false negatives. Our results also suggest that in some regions RDT negative 
children that are severely anemic should be treated anyway for malaria. 
To aid the formulation of region-specific guidelines for malaria diagnosis 
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and treatment, we created proof-of-concept web-based tools for decision 
makers that enables them to interact with our modeling results. Our 
methods and results are likely to help improve current malaria policies in 
Burkina Faso and other malaria endemic countries.
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IMPROVING THE QUALITY OF MALARIA CASE 
MANAGEMENT IN PUBLIC HEALTH FACILITIES - THE 
MALARIACARE EXPERIENCE IN WESTERN KENYA
Beatrice Onyando1, Samwell Onditi1, Rodgers Mwinga1, Tiffany 
Clark2, Illah Evance1, Sarah Burnett2, Troy Martin2
1PATH, Kisumu, Kenya, 2PATH, Washington, DC, United States
Quality malaria case management remains a challenge in Kenya. To 
date, most health workers only receive occasional updates and irregular 
supervision visits which focus on infrastructural needs, not on skills 
assessment and improvement. In 2015, to address the deficits, MalariaCare 
is implementing a case management quality assurance (QA) program in 
eight counties around Lake Victoria. The QA strategy focuses on training 
QA teams of clinicians and laboratory technicians in the principles of 
quality malaria case management and mentoring and then supporting 
them in quarterly outreach training and support supervision (OTSS) visits 
using a structured checklist mentoring tool. After each OTSS round, county 
supervisors and health management teams will review data collected and 
design short-term approaches to address gaps at the county-level. To 
complete the QA cycle, following the first few rounds of OTSS, supervisors 
from multiple intervention counties will meet, along with national-level 
representatives, in lessons learned workshops, to exchange lessons 
learned across counties and develop action plans to address identified 
weaknesses. In addition, the project is working with hospitals to establish 
Medicines and Therapeutics Committees (MTCs) to assure that each case 
is managed according to quality assured protocols. The majority of public 
health facilities within the eight counties - including 71 hospitals, 185 
health centers and 584 dispensaries - are being enrolled in three phases 
over 18 months. Using specific selection criteria, 75 laboratory technicians 
are receiving microscopy refresher training, 75 clinicians are receiving case 
management refresher training, and all are receiving OTSS supervision 
training. This report will describe the outcomes of these trainings and 
three rounds of on-site OTSS. The key indicators for microscopy, RDT, and 
clinical care performance will be discussed. The lessons learned from large-
scale roll-out implementation of an electronic tablet-based and DHIS2-
linked data collection system will be discussed, and the initial findings for 
implementation of the MTC system will be shared.
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FINDINGS FROM THE FIRST MALARIA MOLECULAR EQA 
SCHEME LAUNCHED BY UK NEQAS (UNITED KINGDOM 
NATIONAL EXTERNAL QUALITY ASSESSMENT SERVICE) 
PARASITOLOGY
Jaya Shrivastava1, Agatha C. Saez1, Monika Manser1, Debbie 
Nolder2, Spencer Polley3, Peter L. Chiodini3
1Public Health England, London, United Kingdom, 2London School of 
Hygiene & Tropical Medicine, London, United Kingdom, 3Hospital for 
Topical Diseases, London, United Kingdom
The WHO policy brief on malaria diagnostics in low-transmission settings 
recommends use of Nucleic Acid Amplification (NAA), and an international 
External Quality Assurance (EQA) system to ensure that data obtained are 
reliable and comparable. UKNEQAS Parasitology has developed such an 
EQA and the outcome of the pre-pilot and pilot surveys plus development 
of the EQA will be presented in this talk. A pre-pilot followed by a pilot 
survey for malaria molecular diagnosis using freeze dried blood samples 
was run. For the surveys, two distributions each containing lyophilised 
blood specimens were dispatched to an overall of 60 participants in 24 
countries. The pre-pilot blood specimens contained parasite densities 
ranging from 20parasites/µL to 1parasite/µL. The pilot blood specimens 
contained parasite densities ranging from 40parasites/µL to 1parasite/µL. 
Both the surveys contained samples from single infections of Plasmodium 
falciparum, P, vivax, P. malariae and P. ovale. Negatives were also sent. 
Participants were requested to report on the presence or absence of 
malarial nucleic acid in reconstituted lyophilised blood using either 
qualitative or quantitative methods. The results showed reporting of 
higher false negatives at lower parasite densities whilst using both real 
time and nested PCR. Although a range of CT values and parasitaemia 
were reported by participants for each specimen, in general within a given 
assay the CT values increased with a decrease in the parasitaemia of the 
intended results, suggesting their ability to produce semi-quantitative 
results. In conclusion, the pre-pilot and pilot surveys demonstrate that NAA 
EQA schemes can successfully be run using lyophilised blood. Secondly, the 
majority of participants’ results were in good agreement with the intended 
results. Thirdly, it fulfilled the EQA criteria in that the specimens might 
help participants take individual action to investigate and remedy any 
discrepant results. Fourthly, lyophilised blood usage obviates the need for a 
cold chain distribution, significantly reducing associated costs and opening 
up the distribution of such samples to a global audience.
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BUILDING A SYSTEM OF QUALITY ASSURED MALARIA CASE 
MANAGEMENT IN THE DEMOCRATIC REPUBLIC OF THE 
CONGO
Jean-Yves Mukamba1, André Bope Bope2, Annie Ndaya B3, Eric 
Swedberg4, Troy Martin5
1PATH, Kinshasa/Gombe, Democratic Republic of the Congo, 2PSI, 
Kinshasa/Gombe, Democratic Republic of the Congo, 3National Program 
on Diarrhea Prevention, Kinshasa/Gombe, Democratic Republic of the 
Congo, 4Save the Children, Fairfield, CT, United States, 5PATH, Seattle, WA, 
United States
In the Democratic Republic of the Congo (DRC), assuring that microscopy 
and malaria rapid diagnostic tests (RDTs) are done properly and that test 
results are used appropriately remains a difficult challenge. To address this, 
the MalariaCare partnership has supported the National Malaria Control 
Program (NMCP) to implement a system of quality assured (QA) malaria 
case management. This system is designed on continuous improvement 
principles and includes updated training, certification of trainers, and on-
site supportive supervision linked with regular review and feedback by 
supervisors. Over the past four years, 97 diagnostics experts have been 
trained in microscopy skills and RDT performance, and 17 clinical experts 
have been trained in malaria treatment. Best performers are then trained 
as onsite laboratory and clinical outreach training and support supervision 
(OTSS) supervisors and perform joint supervision and mentoring for local 
laboratory and clinical staff in 13 of the DRC’s 26 provinces, including 
Kinshasa. The OTSS visits focus on skills observation and on-the-spot 
problem-solving, with primary goals of improving preparation and 
accuracy of malaria slide reading, assuring appropriate RDT results, and 
improving adherence by clinicians to test results. Between OTSS rounds 
6 (June 2015) and 7 (February 2016), microscopy performance improved 
by 18 points—from 67% to 85% overall—and RDT performance 
improved by 50 percentage points—from 42% to 92% compliance 
with the performance checklist. Supervisors also observed an increase in 
clinicians correctly ordering a malaria test, from 64% to 90%, and correct 
prescription per diagnosis, from 8% to 52%. To assure steady quality 
improvement in the program, the supervisors meet to review outcomes 
and share best practices during annual lessons learned workshops. Based 
on these program improvements, the NMCP recently adopted this QA 
system as one of the key components in its new national strategic plan 
and will expand use of the system outside PMI supported health zones.
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SHIFTING THE PARADIGM: WHAT CAN BE DONE TO PROTECT 
COMMUNITIES AGAINST THE THREAT OF SUBSTANDARD 
AND FALSIFIED MALARIA MEDICINES?
Nan Lewicky, Corinne M. Fordham, Cheryl Lettenmaier
Johns Hopkins University, Baltimore, MD, United States
Substandard, spurious, falsified, falsely-labeled and counterfeit (SSFFC) 
malaria medicines pose an incredible threat to malaria endemic countries, 
as they not only put the individual at risk of treatment failure and death, 
but also increase artemisinin resistance, waste national healthcare system’s 
limited financial resources and create distrust in the healthcare system. 
Unfortunately, these harmful medicines are quite common in low-income, 
malaria endemic countries, with recent quality assurance research 
finding that approximately one in ten doses of artemisinin-combination 
therapy (ACT) in sub-Sarahan Africa is poor quality. Most interventions 
designed to combat SSFFC malaria medicines work to improve quality 
assurance, address regulation policy reform, or operate within the criminal 
justice system, but few provide strategies to influence the demand for 
and purchasing practices regarding quality medicines. To this end, the 
Health Communication Capacity Collaborative (HC3) has developed a 
global initiative to unite stakeholders from regulatory agencies, criminal 
investigation units, clinical and pharmaceutical industries, national 
policymakers and program managers around promoting positive behaviors 
around malaria medicine purchasing, use, and reporting. HC3 will present 
findings from their pilot project in Akwa Ibom Nigeria, as well as introduce 
a step-by-step toolkit (Implementation Kit, or I-Kit) that can be used by 
any national or local entity to design and launch an effective program to 
combat substandard and falsified malaria medicines in their country or 
community.
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ANALYSIS OF ULTRA LOW COST NEAR-INFRARED 
SPECTROMETERS FOR DRUG AND BED NET QUALITY 
MONITORING
Benjamin K. Wilson1, Anthony Lozama1, Celina Schocken2, 
Elizabeth L. Allen3, David Bell2, Harparkash Kaur3
1Intellectual Ventures Laboratory, Bellevue, WA, United States, 2Global 
Good, Bellevue, WA, United States, 3London School of Hygiene & Tropical 
Medicine, London, United Kingdom
The prevalence of falsified and substandard drugs is a barrier to effective 
management of malaria and other disease in resource constrained 
settings. Beyond drugs, other important healthcare interventions, such 
as long-lasting insecticide-treated bed nets. A simple low-cost tool to 
identify falsified and degraded commodities would secure supply chains, 
inform planning for product replacement, greatly reducing avoidable 
mortality. Handheld near-infrared spectroscopy (NIRS) systems have 
recently been developed for consumer use capable of distinguishing 
chemical composition of various materials, with hardware costs of $250 - 
500. Spectroscopy is an attractive solution to drug and net quality testing 
due to low cost-per-test and the non-destructive nature of testing. The 
portability of these systems offer utility throughout supply chains. We 
investigated the capabilities of two portable NIRS devices, the Consumer 
Physics SCiO and the Texas Instrument NIRscan Nano, to perform quality 
assurance testing on a variety of drugs and nets. Spectral libraries were 
built for several classes of drugs including contraceptives, artemesinin 
combination therapies (ACTs), antibiotics, and others. The performance 
of these libraries was then tested in the laboratory and in field conditions 
with target users. Results were compared to reference testing with 
established reference standards, and with a laboratory-grade NIRS. Results 
include analysis of performance in falsified drug identification, active 
ingredient quantification (for finding substandard drugs), and active 
ingredient determination (for identifying unmarked pills). A bed net 
spectral library was compiled to quantify the presence of insecticide on 
the net. Both NIRS systems performed with high accuracy in identifying 
falsified drugs. In certain applications, active ingredients could be 
quantified sufficiently to assess degradation. Hand-held NIRS systems offer 
potential to revolutionize quality assurance of pharmaceuticals and other 
commodities in resource constrained settings.
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MALARIA INTERVENTION ASSESSMENT IN FOUR STATES 
OF NIGERIA: AN INNOVATIVE, COMPREHENSIVE, MIXED-
METHODS EVALUATION
Ana Claudia Franca-Koh1, Uwem Inyang2, Festus Okoh3, Taiwo 
Orimogunje3, Lanre Adesoye1, Balarabe Ibrahim1, Abimbola 
Olayemi1, Mariam Wahab1, Tajrina Hai1, Nnenna Ezeigwe3, 
Perpetua Uhomoibhi3, Timothy Obot3, Olufemi Ajumobi3, Jessica 
Margaret Kafuko2, Richard W. Niska2, Abidemi Okechukwu2, 
Yazoume Ye1
1MEASURE Evaluation/ICF International, Rockville, MD, United States, 2U.S. 
President’s Malaria Initiative/Nigeria, Abuja, Nigeria, 3National Malaria 
Elimination Programme, Abuja, Nigeria
The significant expansion of malaria control interventions in recent years 
has reduced the malaria disease burden in many countries, leading the 
global malaria community to set goals for elimination. In this context, 
there is need for appropriate tools and methods to document efforts and 
measure achievements. The Malaria Intervention Assessment (MIA), an 
innovative comprehensive evaluation methodology, funded by PMI, led by 
MEASURE Evaluation in partnership with the NMEP, is being implemented 
in four states of Nigeria supported by PMI: Cross River, Ebonyi, Nasarawa 
and Sokoto. The objective of MIA is to document progress in malaria 
control interventions from 2008-2016 in the four states. Specifically, MIA 
will describe the state-level malaria interventions; document trends in key 
malaria prevention and case management indicators and assess quality of 
care among PMI-supported and non-PMI-supported primary healthcare 
facilities (PHCs); document trends in malaria morbidity and mortality at 
the hospital level; assess the quality of monthly malaria data at PHCs; 
and document changes in contextual factors likely to affect malaria 
interventions and outcomes. MIA uses a quasi-experimental design and 
a comprehensive mixed-methods approach consisting of: (1) secondary 
data collation of malaria indicators from the routine health information 
system (RHIS) at 560 PHCs and their referral hospitals; (2) primary data 
collection, including: 2800 exit client interviews (5 at each PHC visited), 38 
qualitative key informant interviews, and observations of the availability 
of malaria commodities at the PHCs; (3) secondary data analysis of state-
level representative household surveys, and (4) document review. Using 
a stratified random sample with probability proportional to size, 140 
facilities were selected in each state, 70 PMI-supported and 70 non-PMI-
supported. Fieldwork will be completed in May 2016 so MIA results will 
be available to present at the ASTMH conference. The presentation will 
include key findings, strengths and challenges of MIA, and lessons learned 
for improving malaria control interventions and the RHIS.
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RAPID ACTIVE SEROPREVALENCE SURVEYS AS A TOOL TO 
MEASURE NOROVIRUS DISEASE BURDEN IN RESOURCE-
LIMITED SETTINGS
Daniel Olson1, Molly M. Lamb2, Alma Zacarias3, Maria Renee 
Lopez4, Maria Alejandra Paniagua5, Gabriela Samayoa-Reyes6, 
Ricardo Zambrano7, Sergio Rodriguez7, Celia Cordon-Rosales4, 
Edwin Asturias1
1University of Colorado School of Medicine and Public Health, Aurora, CO, 
United States, 2University of Colorado School of Public Health, Aurora, CO, 
United States, 3Fundacion para la Salud Integral de los Guatemaltecos, 
La Blanca, Guatemala, 4Universidad del Valle de Guatemala, Guatemala 
City, Guatemala, 5University of Pennsylvania Perelman School of Medicine, 
Philadelphia, PA, United States, 6University of Colorado School of 
Medicine, Aurora, CO, United States, 7Integra IT, Bogota, Colombia
Cost-effective surveillance systems capable of accurately detecting acute 
gastroenteritis (AGE) are necessary to estimate the burden of pathogens 
such as norovirus (NoV) and the potential effectiveness of vaccines. 
Cross-sectional seroprevalence surveys are commonly used for outbreak 
investigations, but they have not been validated as a timely, community-
based alternative to active surveillance. We used a 2-stage cluster design 
(30 clusters of 7 households) to enroll children age 0-17 years in a rural, 
resource-limited region of Guatemala into two parallel surveillance 
systems to estimate the burden of NoV-associated AGE. In the prospective 
Participatory Syndromic Surveillance (PSS) arm, 207 households with 483 
children (enrolled Apr-Sep 2015) were provided an internet-connected 
smartphone with a symptom diary application and asked to submit weekly 
reports of AGE symptoms. Subjects meeting case criteria of 3+ days of 
vomiting/diarrhea or 1+ day of both were visited and offered NoV PCR 
testing via rectal or fresh stool swabs. In the Rapid Active cross-sectional 
Surveys (RAS), 377 children from 209 households (cycle 1), and 369 
children from 210 households (cycle 2) from the same community were 
surveyed for AGE within the past 7 days and tested for NoV via PCR, 
regardless of symptoms. In the PSS arm, 50 children met AGE criteria 
during 362 person-years of observation (13.8 cases/100 person-years), 
and 9 of 34 (26%) tested were NoV+. In RAS cycles 1 (Oct-Nov 2015) 
and 2 (Jan-Feb 2016), 53 (14%) and 29 (8%) children had AGE in the 
preceding week and 6/39 (15%) and 5/24 (21%) tested were NoV-
positive, respectively; the asymptomatic:symptomatic NoV ratio was 3.2:1; 
79 (89%) of NoV isolates were genogroup I (GI) and 10 (11%) were GII. In 
logistic regression models adjusted for sex, younger age was a significant 
predictor of AGE but not NoV+ AGE. Our data demonstrate a large 
burden of NoV+ AGE and asymptomatic NoV shedding in this Guatemalan 
community. The more cost-effective RAS cross-sectional surveys provided 
comparable AGE incidence and NoV infection rates to the smartphone-
based PSS active surveillance cohort, and further surveillance is planned.
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HIGH HEPATITIS E SEROPREVALENCE AMONG DISPLACED 
PERSONS IN SOUTH SUDAN: EVIDENCE OF UNDETECTED 
TRANSMISSION AND IMPLICATIONS FOR VACCINATION
Andrew S. Azman1, Malika Bouhenia2, Anita S. Iyer3, John 
Rumunu4, Lul L. Deng4, Joseph F. Wamala5, Etienne Gignoux6, 
Francisco J. Luquero7, Daniel T. Leung3, Emily S. Gurley8, Iza 
Ciglenecki9
1Johns Hopkins School of Public Health, Baltimore, MD, United States, 
2World Health Organization, Geneva, Switzerland, 3Department of 
Internal Medicine, Division of Infectious Diseases, University of Utah 
School of Medicine, Salt Lake City, UT, United States, 4South Sudan 
Ministry of Health, Juba, South Sudan, 5World Health Organization, Juba, 
South Sudan, 6Epicentre, Geneva, Switzerland, 7Epicentre, Paris, France, 
8International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, 
Bangladesh, 9Médecins Sans Frontières, Geneva, Switzerland
Hepatitis E (HEV) is responsible for significant morbidity and mortality 
worldwide, especially among pregnant women. Large protracted 
outbreaks have been documented in East African IDP and refugee camps 
over the past decade though little data on burden and transmission exist 
outside these exceptional settings. Characterizing the population-level 
exposure to the pathogen through age-stratified serological studies has 
the potential to improve our understanding of this disease and provide 
new insights for improving surveillance and control. We conducted an 
age-stratified serological survey among 206 residents in a camp for 
internally displaced persons in Juba, South Sudan where no clinical 
cases of HEV had been reported. We tested serum for HEV IgM and IgG 
using standard ELISAs and estimated the population-level prevalence of 
seroprevalence to each. Using data on individuals’ sero-status, date of 
arrival in the camp and state of origin, we were able to construct a series 
of statistical models to estimate the rate of infection in the camp and that 
in the participants’ previous residence. The age-adjusted seroprevalence 
was 61% (95% CI 54-69%) and we found evidence of recent exposure 
in 3 participants (1.5%). We found increasing IgG seroprevalence with 
age and higher seroprevalence in women compared to men. We estimate 
that the rate of HEV exposure was nearly 5-fold (95% CrI 1.2-10.2) higher 
in the PoC camp than our estimates in the participants’ home states. 
The high seroprevalence estimated within this population suggests that 
HEV transmission may be much more common than previously thought, 
even in the absence of a detected outbreaks. The results suggest that 
the population is immunologically primed, which may have implications 
for control strategies, including vaccination, where a reduced-dose 
schedule may provide high levels of protection in immunologically primed 
individuals. Improved HEV surveillance is needed to understand the true 
burden of disease and to minimize the impact of epidemics.
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POSSIBLE HIGH EXPOSURE TO EBOLA AMONG NON-
FORMAL HEALTH CARE PROVIDERS IN A PREVIOUS 
OUTBREAK SITE, BOENDE, DEMOCRATIC REPUBLIC OF 
CONGO
Nicole A. Hoff1, Alexis Mwanza2, Reena H. Doshi1, Patrick 
Mukadi3, Daniel Mukadi4, Joseph Wasiswa5, Vivian Alfonso1, Jose 
Ngamboli3, Nathalie Kavira3, Rachel Mutombe3, Benoît Kebela 
Ilunga6, Emile Okitolonda7, Jean-Jacques Muyembe3, Anne W. 
Rimoin1
1University of California Los Angeles Fielding School of Public Health, 
Los Angeles, CA, United States, 2University of California Los Angeles-
DRC Research Program, Kinshasa, Democratic Republic of the Congo, 
3INRB, Kinshasa, Democratic Republic of the Congo, 4Faculty of Medicine, 
University of Kinshasa, Kinshasa, Democratic Republic of the Congo, 
5University of Kinshasa School of Public Health, Kinshasa, Democratic 
Republic of the Congo, 6Ministry of Health, Kinshasa, Democratic Republic 
of the Congo, 7Kinshasa School of Public Health, Kinshasa, Democratic 
Republic of the Congo
During an Ebola virus disease (EVD) outbreak, health care workers (HCWs) 
are on the frontline of the response, and their occupational health and 
safety is critical to control and elimination of the outbreak. Thus they may 
be at increased risk of disease acquisition given the presence of virus in 
bodily fluids and lack of compliance with precautions to prevent exposure. 
Therefore, we conducted a serosurvey among formal and informal HCWs 
in the Boende health zone in Tshuapa District, DRC, the site of the 2014 
Ebola outbreak. Field collection occurred in November 2015. Interviews 
and blood specimens were collected from all consenting individuals. 
Serum samples from 441 formal (doctors, nurses, midwives, and room 
attendants) and informal (religious leaders/pastors and traditional healers) 
HCW’s were screened for ZEBOV GP Ig detection using Human Anti-Zaire 
Ebola Virus Glycoprotein (GP) IgG ELISA Assay kits (Alpha diagnostic 
International, Inc.) in Kinshasa, DRC. Among the HCWs, 21% (93) were 
seropositive for ZEBOV GP IgG, of those, 25% of pastors (n=27) were 
seropositive, 37% of traditional healers (n=27) were seropositive compared 
to 19.6% of formal HCWs. 27.6% of pastors reported that they had come 
in contact with suspected cases of Ebola, and of those, 87.5% reported 
that they did not use PPE compared to the 28.6% of formal HCWs 
reporting contact with suspected Ebola cases. Both formal and informal 
HCWs in Boende appear to be highly exposed to Ebola virus. While there 
appears to be no significant difference between formal and informal 
HCWs, the number of informal HCWs participating in the last outbreak 
was high. It is important that informal HCWs, especially in areas that have 
experienced EVD outbreaks, be included in surveillance and biosafety 
training in order to help prevent disease circulation in future outbreaks.
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SIERRA LEONE TRIAL TO INTRODUCE A VACCINE AGAINST 
EBOLA (STRIVE): IMPLEMENTATION CHALLENGES, 
SUCCESSES AND LESSONS LEARNED
Ayesha Idriss1, Rosalind Carter Wertheim2, Brima Kargbo3, The 
STRIVE Study Team
1College of Medicine and Alllied Health Sciences, Freetown, Sierra Leone, 
2Centers for Disease Control and Prevention, Atlanta, GA, United States, 
3Ministry of Health and Sanitation, Freetown, Sierra Leone
STRIVE, a phase 2/3 trial of investigational rVSV-ZEBOV vaccine was 
conducted during an unprecedented Ebola epidemic. Eligible health 
care workers and front line Ebola response workers were individually 
randomized to immediate (within 7 days) or deferred (within 18-24 
weeks) vaccination and followed for 6 months for serious adverse events 
and Ebola. We describe lessons learned during trial implementation. 
Substantial infrastructure investments, including renovation of government 
cold chain facilities and importation of equipment to store and transport 
vaccine at -80oC, were needed. Generators and solar battery systems were 
used for backup. Staffing challenges centered on lack of experience with 
Investigational New Drug (IND) trials and their regulatory requirements. 
STRIVE built capacity by training >350 staff on IND research, including 
medical, pharmacy and nursing students whose classes had been cancelled 
during the outbreak. Didactic and practical training was reinforced with 
daily review and feedback meetings. CDC staff were paired long-term 
with local counterparts for role-specific skills transfer. The operational 
challenges of safety follow-up were addressed by issuing mobile phones 
to participants, establishing a nurse triage hotline, and providing access 
to free medical care. The effectiveness of these solutions was limited by 
frequent loss, breakage, or selling of study phones and frequent medical 
visits for minor ailments. Lessons learned include the need for back-up 
electrical and cold chain equipment, the importance of daily ongoing 
training supported by train-the-trainer approaches, the value of multiple 
participant locator information sources—including home visits—for 
participant follow-up, and the need for adequate staffing, systems, and 
guidance for free medical care. STRIVE enrolled ~8650 participants and 
vaccinated ~8,000 with excellent follow-up. Before the Ebola outbreak, 
Sierra Leone had limited infrastructure and staff to conduct clinical trials. 
Without interfering with the outbreak response, STRIVE responded to an 
urgent need and helped build this capacity.
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ASSESSING THE HETEROGENEITIES IN VIRAL HEMORRHAGIC 
FEVER OUTBREAK POTENTIAL ACROSS AFRICA
David M. Pigott
Institute for Health Metrics and Evaluation, Seattle, WA, United States
As the Ebola virus disease outbreak in West Africa comes to an end, 
considering where to prioritise reinforcing response capacities to viral 
hemorrhagic fevers (VHFs) such as Ebola, Marburg, Lassa fever and 
Crimean-Congo hemorrhagic fever will be a key focus. By characterizing 
three key transition points in a potential VHF outbreak, this output 
provides the first quantitative assessment for districts in Africa which 
identifies those that are more likely to see index cases of VHFs, and should 
insufficient timely intervention measures be put in place, districts more 
likely to see localized outbreaks as well as those which are more likely 
to seed infection in other districts leading to a widespread outbreak. 
Information derived from zoonotic niche maps defining the geographic 
extent of the virus, coupled with measures of in-district healthcare 
infrastructural capacity and population vulnerabilities (inspired by a pre-
existing index for risk management INFORM) as well as travel time surfaces 
are incorporated to provide this assessment across the African continent. 
The methodological framework is shown to be flexible to allow for 
improved, more disease specific covariates to be added as-and-when they 
become available. By understanding the inherent differences that exist 
across Africa, this method provides an alternative approach for identifying 
which districts to be targeted for broad scale healthcare improvement 
(focusing on VHF measures), as well as those to be prioritized for 
surveillance prior to outbreaks or the focus of rapid intervention should 
undiagnosed hemorrhagic fevers be reported.
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SPATIAL DETERMINANTS OF EBOLA VIRUS DISEASE RISK 
FOR THE WEST AFRICAN EPIDEMIC
Kate Zinszer1, Kathryn Zinszer2, Aman Verma2, John Brownstein1
1Boston Children’s Hospital, Boston, MA, United States, 2McGill University, 
Montreal, QC, Canada
Although many studies have investigated the probability of Ebola virus 
disease (EVD) outbreaks while other studies have simulated the size and 
speed of EVD outbreaks, few have investigated the environmental and 
population-level predictors of Ebola transmission once an outbreak is 
underway. Identifying strong predictors of transmission could help guide 
and target limited public health resources during an EVD outbreak. A 
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Bayesian hierarchical Poisson model was used to estimate EVD risk and 
to evaluate the spatial variability explained by the selected predictors. We 
categorized our predictors into terciles, and found that districts had greater 
risk of EVD with increasing proportion of households not possessing a 
radio (RRRadio2 2.79, 0.90-8.78; RRRadio3 4.23, 1.16-15.93), increasing 
rainfall (RRRainfall2 2.18; 95% credible interval 0.66-7.20; RRRainfall3 
5.34, 1.20-23.90), urban land cover (RRUrban2 4.87, 1.56-15.40; 
RRUrban3 5.74, 1.68-19.67), and years of education (RREducation3 
1.58, 0.40-6.25). We found that districts with higher proportion of radio 
ownership had reduced EVD transmission risk, suggesting that that the 
use of radio messaging for control and prevention purposes may have 
been crucial in reducing the EVD transmission risk in certain districts, a 
potential modifiable risk factor for future outbreaks. Additionally, in areas 
with low proportion of radio ownership, public health authorities may 
need to develop and introduce different communication strategies. Future 
research should examine the etiologic relationships between the identified 
risk factors and human-to-human transmission of EVD with a focus on 
factors related to population mobility and healthcare accessibility, which 
are critical features of epidemic propagation and control.
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RE-CURRENT EPIZOOTICS OF HIGHLY PATHOGENIC AVIAN 
INFLUENZA IN NIGERIA AND STATUS OF VACCINATION AS 
ALTERNATE CONTROL
Jeremiah O. Ijomanta, C. Chinyere, K. Olawuyi, O. Bankole, C. 
Meseko
National Veterinary Research Institute, Vom, Plateau State, Nigeria, Jos, 
Nigeria
Episodes of HPAI H5N1 in Nigeria are evidence of the risk of re-
introduction of the virus through annual migration of infected waterfowls 
from Asia and Europe. Concerns are rife on the possibility of the virus 
becoming endemic in domestic poultry. This is moreso that the current 
wave of outbreak was not sufficiently contained leading to more cases 
of infection within six months than was ever experienced between 2006-
2008. Current Federal Government status remains depopulation and 
decontamination without the use of vaccines. We however investigate 
evidence of vaccination by some poultry farmers desperate to prevention 
infection. In a limited prospective study in seven commercial poultry 
farms in South West Nigeria, 161 sera were randomly collected and 
tested by Agar Gel Immuno-diffusion (AGID) test to detect group specific 
nucleoprotein antigen of influenza A. Thereafter, Haemagglutinin 
Inhibition (HI) test was carried out using antigen directed against 
monospecific H5 subtype in a V-bottom microtitre plate with 1% solution 
of pooled chicken red blood cell as indicator. Eight (5%) sera had evidence 
of influenza A antibody shown by distinct precipitation line between 
antigen and antiserum in agar gel. Further analysis by HI showed three 
(2%) sera were positive for influenza antibody at low titer HI of 3log 
2. This study for the first time, showed evidence of antibody to avian 
influenza in domestic flock in Nigeria that is most likely due to vaccination. 
Previous serological tests in farms infected with HPAI H5N1 were negative. 
There are unconfirmed reports of vaccination in southwestern region, 
the hub of poultry production in Nigeria. Unregulated and inappropriate 
application of vaccine may results in poor antibody responses as 
demonstrated in this study. In view of these possibilities, it is in the best 
interest of avian influenza disease control to monitor the use of vaccines in 
commercial poultry and immune responses thereof.
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USE OF A QUANTIFIABLE STOOL RT-PCR ASSAY INCREASES 
DIAGNOSTIC YIELD IN CHILDHOOD TB
Andrew R. DiNardo1, Nadine Harris1, Thobile Simelane2, Celia 
Fung2, Godwin Mtetwa2, Gugu Maphalala3, Edward Graviss4, 
Anna M. Mandalakas1, Rojelio A. Mejia1
1Baylor College of Medicine, Houston, TX, United States, 2Baylor-Swaziland 
Children’s Foundation, Mbabane, Swaziland, 3Ministry of Health, 
Mbabane, Swaziland, 4Houston Methodist Hospital Research Institute, 
Houston, TX, United States
Quantification of Mycobacterium tuberculosis (Mtb) has potential to 
improve TB diagnostics and treatment monitoring, with particular 
relevance in childhood TB as its paucibacillary nature presents a diagnostic 
challenge. We evaluated the diagnostic yield of quantitative real-time 
PCR for the detection of Mtb in stool. Stool was collected from a cohort 
of adults and children with confirmed or clinically diagnosed TB (n=67). 
DNA was isolated from 50mg of stool using the MP Fast DNA soil kit. 
Tuberculosis-specific primers were designed from the IS6110 insertion 
element found exclusively within the Mtb complex. To determine a limit 
of detection (LOD), 10 to 106 CFU of H37Rv Mtb was spiked into 50mg 
of healthy stool and the DNA was isolated. All samples were analyzed 
using quantitative real-time PCR. The LOD of Mtb was < 10 CFU of Mtb 
per 50mg of stool. The CFU of Mtb spiked into stool and DNA quantified 
by PCR was well correlated (Figure 1A: Spearman r = 0.998, p< 0.0001). 
The quantity of Mtb DNA detected inversely correlated with time on ATT 
(Figure 1B; Spearman r = -0.4219; p = 0.04). The quantified Mtb DNA 
in stool at 2 months was lower than baseline levels (Figure 1C, Wilcox 
signed rank test; p< 0.0001). Stool qPCR had similar diagnostic accuracy 
as sputum GeneXpert Mtb/RIF (Xpert) amongst individuals who had stool 
collected within 72 hours of ATT initiation (Fisher´s exact p-value 0.32). 
Stool PCR identified 15% (4 of 26) children who were clinically diagnosed 
with TB despite having negative Xpert and culture results. In conclusion, 
detection of Mtb DNA from stool provides a quantifiable measure of an 
individual’s Mtb burden. PCR detection of Mtb in stool of children with 
clinically diagnosed TB (Xpert and culture negative) highlights the potential 
for this assay to increase bacteriologic confirmation of childhood TB.
1896
IS IT TINDZHAKA OR TUBERCULOSIS? A STUDY OF 
TRADITIONAL DIAGNOSIS AND TREATMENT AMONG 
HEALERS IN BUSHBUCKRIDGE, SOUTH AFRICA
Carolyn M. Audet1, Sizzy Ngobeni2, Ryan G. Wagner2
1Vanderbilt University, Nashville, TN, United States, 2University of the 
Witwatersrand, Johannesburg, South Africa
The prevalence of Tuberculosis (TB) in South Africa (SA) has increased 
significantly over the last 30 years, with an annual incidence rate of 1% 
(roughly 450,000 new cases per annum). In Bushbuckridge, SA, Tindzhaka 
is a common condition for which people seek the services of a traditional 
healer. Tindzhaka is an ailment that affects the lungs and can eventually 
lead to death. There is concern among clinicians that Tindzhaka and TB 
are the same illness; increased understanding about the causes, symptoms, 
treatment, and expected outcomes associated with Tindzhaka can be 
used to engage healers to support testing of suspected TB patients. In 
2015, we completed 27 in-depth interviews and 133 surveys with a simple 
random sample of traditional healers in rural Bushbuckridge, SA. Healers 
were mostly female (77%), older (median = 58 [IQR: 50-67 years]), with 
low levels of education (median = 3.7 [IQR: 3.2-4.2]) years). Seventy-
three percent of healers claimed to treat Tindzhaka (while less than 10% 
claimed to treat TB). Our research has revealed the overlapping symptoms 
of Tindzhaka and TB, including coughing, difficulty breathing, loss of body 
weight, fevers and, ultimately - if there is no treatment - death. Healers 
argue these to be two distinct illnesses. Color of the sputum (white 
indicates Tindzhaka, while yellow indicates TB) was identified as one 
means of distinguishing the two illnesses. Several social transgressions are 
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believed to cause Tindzhaka infection: (1) having sex with one’s partner 
before the family member’s death ceremonies are completed; (2) having 
sex with one’s partner too quickly after a funeral; or (3) bringing home 
any items (including food from the funeral) from the deceased member’s 
house. On average, healers charged patients with Tindzhaka 1376 SA 
Rand (IQR: 600-1500; 82 United States Dollars (USD)) and patients with 
TB 700 SA Rand (IQR: 400-1000; 47 USD) for treatment. With 11% 
mortality among those who contract TB in SA, widespread acceptability 
of traditional treatments for an illness with similar presentation may 
contribute to poor patient outcomes. Further engagement with traditional 
healers is required.
1897
FOLLOW-UP EVALUATION IN THE UNITED STATES OF NEWLY 
ARRIVED IMMIGRANTS AND REFUGEES AT HIGH RISK FOR 
TUBERCULOSIS, 2009-2015
Yecai Liu, Drew L. Posey, Susan A. Maloney, Kevin P. Cain, 
Michelle S. Weinberg, Nina Marano, Martin S. Cetron, Christina R. 
Phares
Centers for Disease Control and Prevention, Atlanta, GA, United States
Required culture-based overseas tuberculosis (TB) screening in U.S.-bound 
immigrants and refugees reduces importation of TB to the United States. It 
also identifies persons at high risk for TB, for whom post-arrival follow-up 
evaluation is recommended. We analyzed data collected by state and local 
health departments to determine TB rates among at-risk newly arrived 
immigrants and refugees. During 2009-2015, overseas screening identified 
92,248 U.S.-bound immigrants and refugees with Class B1 Pulmonary 
TB (chest radiograph, medical history, or examination suggestive of TB 
but smear- and culture-negative) and 57,475 with Class B2 Latent TB 
Infection (LTBI). Of 62,131 persons with Class B1 Pulmonary TB who 
completed follow-up evaluation, 1,028 were diagnosed with active TB 
within 1 year after arrival; of 403 culture-confirmed cases, 3.0% (12) had 
multi-drug resistant TB, 0.7% (3) were resistant to isoniazid, 6.2% (25) 
resistant to rifampin, and 3.7% (15) resistant to other first-line drugs. Of 
36,068 persons with Class B2 LTBI who completed follow-up evaluation, 
121 were diagnosed with active TB; of 13 culture-confirmed cases, 7.7% 
(1) were resistant to first-line drugs other than isoniazid or rifampin. TB 
rates were 1,655 and 336 cases per 100,000 persons for those with 
Class B1 Pulmonary TB and Class B2 LTBI within 1 year after their arrival, 
respectively. For persons with Class B2 LTBI, TB rates were 3,268, 308, and 
531 cases per 100,000 persons for those aged <2, 2-14, and ≥15 years, 
respectively. Of 98,199 persons with a Class B1 Pulmonary TB or Class B2 
LTBI, 40,718 persons were diagnosed with LTBI by follow-up evaluation, 
25,054 (61.5%) initiated preventive therapy but only 11,118 (27.3%) 
completed their treatment. Newly arrived immigrants and refugees have 
high rates of active TB, despite overseas screening. High TB rates among 
persons with Class B2 LTBI in all ages suggest that expanding overseas LTBI 
screening beyond the currently required 2-14 years should be considered. 
To further prevent TB in the United States, strategies are needed to 
improve the completion of follow-up evaluations for all persons, and 
preventive therapy for LTBI.
1898
USING POINT-OF-CARE C-REACTIVE PROTEIN TEST RESULTS 
TO TARGET ANTIBIOTIC PRESCRIPTION FOR RESPIRATORY 
ILLNESSES IN UNDER-FIVES: EXPERIENCE FROM A CLINICAL 
TRIAL IN DAR ES SALAAM, TANZANIA
Kristina Keitel1, Frank Kagoro2, John Masimba2, Zamzam Said2, 
Josephine Samaka2, Hosiana Temba2, Willy Sangu2, Alain Gervaix3, 
Blaise Genton4, Valérie D’Acremont5
1Swiss Tropical and Public Health Institute/Boston Children’s Hospital, 
Basel, Switzerland, 2Ifakara Health Institute, Dar es Salaam, United 
Republic of Tanzania, 3University Children’s Hospital Geneva, Geneva, 
Switzerland, 4Swiss Tropical and Public Health Institute/University Hospital 
Lausanne, Basel, Switzerland, 5Swiss Tropical and Public Health Institute/
Policlinique Universitaire Médicale Lausanne, Basel, Switzerland
We sought to determine the usefulness and safety of using C-reactive 
protein (CRP) test results in deciding on antibiotic prescription for 
respiratory illnesses among febrile children presenting to outpatient 
care. A sub-cohort of all patients with cough and no signs of severe 
illness from a larger trial that investigates a novel electronic algorithm for 
management of fever among under-fives in Dar es Salaam, Tanzania, was 
included. A two-step diagnostic approach was used to decide on antibiotic 
prescription: amoxicillin was given if a patient presented with i) respiratory 
rate (RR) between the 75th and <97th %ile for age and temperature 
based on a European derivation study as well as ii) CRP ≥80mg/L using a 
point-of-care assay (Bionexia™, Biomerieux). All children were followed 
until clinical cure or death. Out of the 922 patients with cough, 428 
patients met the 75th %ile cutoff for RR, of which 277 (64.7%), 115 
(26.9%), 26 (6.1%), and 10 (1.1%) patients had CRP levels of 0-9, 10-
39, 40-79, and ≥80mg/L, respectively. Antibiotics were thus prescribed 
in 10 (1.1%) of patients. Out of the 428 patients, 9 patients met clinical 
failure criteria per the main study at day (D)3 or D7 (7 had CRP values 
of 0-9, 2 of 10-39mg/L) : 2 developed severe respiratory symptoms, 3 
had persistent fever at D7, 4 still had clinical pneumonia with low CRP 
values at D3 but recovered before D7 without antibiotic treatment, and 1 
patient had clinical pneumonia at D7. There were no deaths. Using current 
IMCI cut-offs, 226 (53%) out of these 428 patients would have been 
prescribed an antibiotic at presentation. A two-step diagnostic approach 
using respiratory rate and a CRP ≥80mg/L is safe for deciding on antibiotic 
prescription among febrile children with respiratory symptoms and has the 
potential to significantly reduce antibiotic prescriptions. Further research 
should be conducted in children at higher risk for bacterial pneumonia, i.e. 
in areas with high rates of malnutrition and low immunization coverage. 
In addition, newer host biomarkers with better performance should be 
evaluated in clinical studies.
1899
WHAT DROVE THE DECLINE IN PNEUMONIA-SPECIFIC 
UNDER-FIVE DEATH IN MALAWI FROM 2000-2014?
Norman Lufesi1, Karen Finnegan2, Mercy Chimbalanga1, Patrick 
Naphini1, Ernest Kaludzu1, Lewis Gombwa3, Bethred Matipwiri4, 
Amos Misomali5, Neff Walker2, Melissa Marx2
1Malawi Ministry of Health, Lilongwe, Malawi, 2Bloomberg School of 
Public Health, Johns Hopkins University, Baltimore, MD, United States, 
3National Statistical Office of Malawi, Zomba, Malawi, 4Malawi Ministry 
of Health, Salima, Malawi, 5Bloomberg School of Public Health, Johns 
Hopkins University, Lilongwe, Malawi
Globally, pneumonia is the leading cause of mortality in post-neonatal 
children under 5 years of age. More than 95% of the estimated 0.9 million 
under-five children who died from pneumonia in 2013 lived in low and 
middle income countries. Overall mortality in children under five years of 
age has declined dramatically in the past ten years in Malawi, partly due 
to decreases in childhood pneumonia. We explore how scale-up of specific 
interventions contributed to this decline. Our objective is to determine 
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which interventions contributed the most to reducing pneumonia-specific 
mortality in Malawi from 2000 to 2014. We used the Lives Saved Tool 
(LiST; Spectrum v5.41 Beta 6) to conduct a retrospective analysis to 
estimate change in pneumonia-specific under-five mortality over the study 
period. Estimates of intervention coverage were drawn from Malawi 
Demographic Health Surveys (MDHSs) from 2000, 2004, and 2010, 
and the Multiple Indicator Cluster Survey (MICS) from 2006 and 2014. 
Data were interpolated from existing data for years without coverage 
estimates. Key outcomes included reduction in under-five mortality due 
to pneumonia and lives saved by pneumonia-specific interventions. 
Preliminary results show that among children under five, pneumonia-
specific mortality declined by 59% among children aged 1-59 months 
from 2000 to 2014. Although the number of neonatal deaths due to 
pneumonia has been decreasing since 2006, neonatal pneumonia deaths 
was slightly higher (8%) in 2014 relative to 2000. Nearly all (98%) of the 
lives saved were attributable to vaccination (37%), including H. influenzae 
b and pneumococcal conjugate vaccine, antibiotics for treatment of 
pneumonia (34%), and various interventions to reduce stunting and 
wasting (27%). Overall pneumonia-specific mortality in children under-five 
has declined sharply in Malawi since 2000. Treatment and prevention both 
played key roles in saving lives. Ongoing implementation of interventions is 
essential to maintain this trend.
1900
EPIDEMIOLOGY OF HUMAN METAPNEUMOVIRUS IN 
CHILDREN UNDER AGE FIVE — DAMANHOUR DISTRICT, 
EGYPT, 2009-2015
Adel Mansour1, Hoda Mansour1, Sahar El Alkamy2, Mostafa 
Maarouf2, Sahar El Shorbagy2, Mohammed Genidy2, Erik J. 
Reaves3, Mark Wooster3, Samir Refaey2, Amr Kandeel2
1U.S. Naval Medical Research Unit - 3, Cairo, Egypt, 2Ministry of Health 
and Population, Cairo, Egypt, 3Centers for Disease Control and Prevention, 
Cairo, Egypt
In 2013,Acute Respiratory Infection (ARI)was the 5thleading cause of 
under-five mortality in Egypt.Human metapneumovirus (hMPV) was 
the second most common cause of ARI. However, data is only available 
through sentinel surveillance. We sought to estimate the incidence and 
describe the characteristics of hMPV among ARI cases from population-
based surveillance in Damanhour, Egypt. During June 2009-December 
2015, hospitalized ARI patients were enrolled from three government 
referral and two private hospitals. An ARI patient was defined as having 
a temperature ≥38°C or <35.5°C, abnormal white blood cell count 
or differential, at least one respiratory symptom, and age<5 years. 
Nasopharyngeal and oropharyngeal specimens were tested by real-time 
reverse transcriptase polymerase chain reaction (rt-PCR) for hMPV. Data 
from a 2012 healthcare utilization survey were used to determine the 
proportion of individuals who sought care for ARI. Frequencies and 
chi-square test were used for data analysis. Among 4,400ARI cases, 
4181(95.0 %) had rt-PCR testing for hMPV; of these, 322 (7.7%) were 
positive. hMPV was the only pathogen in 276 (85.7%) cases. Overall, 
255 (79.2%) were rural residents and 185 (57.5%) were male. The 
highest proportion of hMPV infections among ARI cases occurred during 
December-February (214/1503, 14.2 %) compared to other months 
(108/2897, 3.7%), (p<0.01).Overall incidence of hMPV infection was 
2.3 per 1,000 child-years. hMPV infection increased over time (p<0.01) 
with the highest proportion occurring in 2010(12.5%).hMPV patients 
presented with sudden onset of fever (99.4%), cough (99.4%), abnormal 
breathing (82.9%),and tachypnea (55%).Among 197 patients with chest 
radiography, 43(21.8%) had consolidation. Mean duration of symptoms 
was 4.9+3.1days and hospitalization was 4.0+2.6 days. Thirteen (4.0%) 
patients were admitted to intensive care for a mean duration of 4.8 
(+2.5) days. Two patients died, both under age two years. hMPV infection 
peaked during winter and is a significant cause of ARI in children under 
age five years in Damanhour District, Egypt.
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ETIOLOGY OF ACUTE LOWER RESPIRATORY INFECTIONS IN 
INPATIENT CHILDREN IN GHANA - A CASE-CONTROL STUDY
Benno Kreuels1, Benedikt Hogan2, Kolja Nolte2, Isabella Eckerle3, 
Charity Wiafe4, Kennedy Gyau-Boahen4, Tabea Binger3, Daniel 
Eibach2, Ralf Krumkamp2, Nimako Sarpong4, Yaw Adu-Sarkodie5, 
Christian Drosten3, Ellis Owusu-Dabo4, Jürgen May2
1University Medical Center Hamburg-Eppendorf, Hamburg, Germany, 
2Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany, 
3University of Bonn, Bonn, Germany, 4Kumasi Centre for Collaborative 
Research in Tropical Medicine, Kumasi, Ghana, 5Kwame Nkrumah 
University for Science and Technology, Kumasi, Ghana
Background: An estimated 14.5 million pediatric hospital admissions 
are caused by acute lower respiratory tract infections (ALRI) each year. 
Molecular diagnostic tools have led to the detection of a large number 
of organisms claimed to be causal in ALRI. However, current data are 
insufficient to determine whether these viruses are truly pathogenic. The 
aim of this study was to assess the prevalence, pathogenicity and clinical 
relevance of organisms in respiratory infections of Ghanaian children using 
a case-control design. Methods: From September 2014 to August 2015 
all children admitted to a Hospital in Ghana with symptoms of ALRI were 
recruited. Healthy controls were recruited from the community. Pharyngeal 
swabs were analysed by PCR for Pneumococci, Mycoplasma, Influenza (A, 
B), Parainfluenza (1-4), hMPV, RSV, Entero-. Rhino-, Adeno-, Parechovirus 
and Human Corona Viruses (NL63, 229E, OC43, HKU-1). The frequency of 
organisms in both groups was determined and age-adjusted odds ratios 
(OR) for association with ALRI calculated using logistic regression models. 
The attributable risk fraction of ALRI for each organism was estimated. 
Results: 337 children were recruited as cases and 573 as healthy controls. 
Of these, 235 (69.7%) and 271 (47.3%) tested positive for at least one 
organism in the case and control group, respectively. The most common 
organisms in cases were pneumococci (163, 48.4%), Adenoviruses (60, 
17.8%) and Rhinoviruses (59, 17.5%). In the control group, pneumococci 
(176, 30.7%), Rhinoviruses (145, 25.3%) and Enteroviruses (113, 19.7%) 
were the most frequent organisms. The strongest association with ALRI 
symptoms was seen for influenza viruses (OR=32.3; 95% CI 7.7-136.0; 
p<0.001) and RSV (OR=12.3; 95% CI 3.6-42.0; p<0.001). The highest 
attributable fractions were 28.4% for pneumococcal infection and 9.6% 
for influenza virus infection. Discussion: Strong associations of influenza, 
RSV and hMPV with disease, indicate that these are most likely causative if 
detected in a child with ALRI. Despite the introduction of a vaccine 2 years 
prior to the study, pneumococcal infection was still the most important 
cause of ALRI.
1902
COMPARISON OF THE HUMORAL RESPONSE INDUCED 
BY DIFFERENT LINEAGES OF TRYPANOSOMA CRUZI IN A 
MURINE MODEL
Miryam Romano1, Julio Rubén Nasser1, Patricio Diosque2, Rubén 
Oscar Cimino1, Marcela Portelli3, Alejandro Javier Krolewiecki1, 
Paula Gabriela Ragone4
1Instituto de Investigaciones en Enfermedades Tropicales, Universidad 
Nacional de Salta, Oran, Salta, Argentina, 2Unidad de Instituto de 
Patología Experimental, Universidad Nacional de Salta, Salta, Argentina, 
3Cuerpo de Investigaciones Fiscales, Salta, Argentina, 4Unidad de 
Epidemiología Molecular, Instituto de Patología Experimental, Salta, 
Argentina
Trypanosoma cruzi is classified based on genetic variability into six discrete 
typing units (DTU TcI to TcVI). This genetic diversity may be related with 
the clinical features and humoral immunity observed in Chagas´s disease. 
The aim of this work was to evaluate the humoral responses induced 
by two different strains of T. cruzi (DTUs TcI and TcV), from an endemic 
area of Argentina. We used female BALB/c mice 45 days old infected 
intraperitoneally with 10.000 metacyclic trypomastigote forms. For the 
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measurement of antibody titers induced by the parasites we used an in-
house ELISA. Serum samples were taken at different time points, measured 
in days post-infection (dpi), since 8 to 120 dpi. As capture antigens we 
used protein homogenates (HP) of two different strains of T. cruzi (TcI, 
TcV). The homogenates were characterized by SDS-PAGE. We carried out 
two tests: ELISA-HPTcI and ELISA-HPTcV for each experimental group. 
Each serum set reacted with the antigens, demonstrating the presence 
of antibody anti-T. cruzi in the experimental groups. We observed a high 
sensitivity and specificity of the reaction between serum and antigen 
of the same DTU. The values of optical density (OD) in serums of mice 
infected with TcI were significantly higher (p <0.05) than serum of animals 
infected with TcV, when HPTcI was used. However, when HPTcV was used, 
we observed the highest OD in mice infected with TcV. On the other 
hand, we observed difference in the kinetics of antibodies. Serum of TcI-
mice presented an exponential increase in the antibody titers along time 
of the infection. While serum of TcV-mice showed the highest antibody 
titers at 90 dpi and then decreases. By SDS-PAGE technique we observed 
differences in the protein profile of each homogenate. In conclusion 
the results suggest that strains TcI and TcV induce different serological 
responses according to the antigen used. On the other hand the different 
proteins of each antigen could participate in the specificity and sensitivity 
of the technique used. These findings are potentially useful in the search 
for new antigens to be applied in serological tests or as molecular markers.
1903
PHENOTYPIC AND FUNCTIONAL CHARACTERISTICS OF 
HLA-DR+ NEUTROPHILS IDENTIFIED IN CIRCULATION OF 
BRAZILIAN CUTANEOUS LEISHMANIASIS PATIENTS
Richard E. Davis1, Smriti Sharma2, Jacilara Conceicao3, Pedro P. 
Carneiro3, Shyam Sundar2, Olivia Bacellar3, Edgar M. Carvalho3, 
Mary E. Wilson1
1University of Iowa, Iowa City, IA, United States, 2Banaras Hindu University, 
Varanasi, India, 3Universidade Federal da Bahia, Salvador, Brazil
The vector-borne protozoan Leishmania braziliensis causes the chronic 
ulcerative skin disease cutaneous leishmaniasis (CL) in individuals living 
in endemic regions. In murine models, neutrophils (PMNs) are recruited 
to the site of infection minutes after parasite inoculation, but their role 
during chronic infection, and the role of PMNs in human disease, remain 
undefined. We hypothesized that PMNs from patients with active CL 
would exhibit different functional properties compared to healthy subjects. 
Despite the fact that CL is a localized disease, a subset of CL patients 
had circulating neutrophils expressing HLA-DR, a molecule thought to 
be restricted to professional antigen presenting cells. We also examined 
lesion-recruited PMNs for these same surface markers. Circulating HLA-
DR+ PMNs also expressed the co-stimulatory molecules CD80, CD86 and 
CD40. Recently described low-density PMNs contain a high percentage 
of HLA-DR+ PMNs. Sorted HLA-DR+ PMNs morphologically resembled 
conventional PMNs, and they were capable of phagocytosis and 
reactive oxidant generation. Nonetheless, PMNs from subjects with high 
proportions of HLA-DR+ PMNs promoted significant in vitro proliferation 
of T cells. Compared to conventional HLA-DR- PMNs, HLA-DR+ PMNs 
showed increased activation, degranulation, oxidant generation and 
phagocytosis of parasites and zymosan particles. Incubation of whole 
blood with inflammatory cytokines resulted in increased HLA-DR+ PMNs, 
suggesting a connection between neutrophil “priming” and upregulation 
of HLA-DR. These data suggest that CL causes expansion of a subset of 
HLA-DR+ PMNs that are primed for activation.
1904
HLA DR EXPRESSING LOW DENSITY NEUTROPHIL SUBSETS 
EXPAND DURING HUMAN VISCERAL LEISHMANIASIS AND 
CAN CONTRIBUTE TO T CELL PROLIFERATION
Smriti Sharma1, Richard Davis2, Susanne Nylen3, David L. Sacks4, 
Shyam Sundar1, Mary E. Wilson2
1Institute of Medical Sciences, Banaras Hindu University, Varanasi, India, 
2University of Iowa, Iowa City, IA, United States, 3Karolinska Institutet, 
Stockholm, Sweden, 4National Institutes of Health, Bethesda, MD, United 
States
Visceral leishmaniasis (VL) is a chronic infectious parasitic disease, which 
if left untreated is almost always fatal.The role of neutrophils and how 
they affect or are affected during active VL is still unknown. Abebe et al 
reported that depletion of arginine was associated with suppressed T cell 
activity. We know that T cells from our subjects with visceral leishmaniasis 
respond differently to antigen when studied in isolated PBMCs or in 
whole blood, so we examined the hypothesis that there might be distinct 
subsets of circulating neutrophils in subjects with this infection. Indeed 
our studies revealed an enhanced population of low density neutrophils, 
similar to Abebe et al (2013 reference above).We fractionated whole 
blood over Ficoll to obtain both low density and normal density neutrophil 
populations. The neutrophils were identified and gated on Forward Side 
scatter and stained cells were CD66b+ CD14-, CD3-. The neutrophils 
were stained with HLA DR, CD80, CD86, CD63, CD11b, CD62L in our 
studies. For Neutrophil T cell cocultures we MACS purified CD66b cells 
and CD3 T cells from PBMCs and CD15 cells from NDG.In whole blood 
and fractions of whole blood i.e NDG and LDG we found that LDG were 
much more abundant during active disease and stained strongly for HLA 
DR. These cells were of different density and also expressed co-stimulatory 
molecules like CD80 and CD86. We performed Neutrophil-T cell co-culture 
experiments that lead us to this interesting finding that neutrophils can 
contribute to antigen presentation and proliferation in T cells. The CD66b+ 
neutrophils in VL subjects were CD62L low, CD11b high and are CD63 
high which indicates that they are activated and de-granulating. This study 
was performed on 83 Active VL subjects (29 female and 54 male). Our 
data indicate there are indeed unusual neutrophil subsets that expand 
during visceral leishmaniasis, and underscore the need to further our 
understanding of neutrophil populations in infectious and inflammatory 
diseases.
1905
ACTIVATION OF HUMAN KERATINOCYTES BY LEISHMANIA 
SPP.: DIVERGENT EFFECTS OF LEISHMANIA INFANTUM 
VERSUS LEISHMANIA MAJOR
Breanna Scorza, Mark Wacker, Kelly Messingham, Janet Fairley, 
Mary Wilson
University of Iowa, Iowa City, IA, United States
All Leishmania infections are initiated in skin, but clinical manifestations 
vary greatly with infecting species. Leishmania major (Lm) causes localized 
cutaneous lesions, whereas L. infantum (Li) causes potentially fatal 
disseminated disease without skin pathology. Early responses at the skin 
infection site influence adaptive responses to Leishmania, yet little is 
known of the role of keratinocytes. We hypothesized that Leishmania 
induce keratinocytes to produce factors influencing the immune response. 
Incubation of Li with primary or immortalized human keratinocytes caused 
a significant increase in pro-inflammatory cytokine transcripts il6, il8, tnfa, 
and il1b measured by RT-qPCR. However, keratinocytes exposed to five 
distinct Lm isolates did not induce these transcripts, highlighting a species-
specific difference in inflammatory response. Similar to live parasites, Li-
derived exosomes induced more il8 mRNA compared to control (p<0.01) 
or Lm-derived exosomes (p<0.05). Western blotting confirmed NFkB-p65 
phosphorylation in keratinocytes exposed to Li but not Lm. To examine 
whether soluble keratinocyte factors influence nearby immune cells, Li-
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infected human monocytes were co-cultured with keratinocytes across 
a trans well membrane. Soluble products of Li-exposed keratinocytes 
improved monocyte control of parasite replication compared with 
unexposed controls (p<0.01). However, culture with Lm-exposed 
keratinocytes across the trans well did not affect monocyte Lm infection. 
These data suggest that (1) activated keratinocytes may increase monocyte 
leishmanicidal activity and (2) keratinocytes support an early inflammatory 
environment, uniquely tailored to each Leishmania species, at the infection 
site.
1906
HEMOPHAGOCYTOSIS IN EXPERIMENTAL VISCERAL 
LEISHMANIASIS BY LEISHMANIA DONOVANI
Ayako Morimoto, Satoko Omachi, James K. Chambers, Kazuyuki 
Uchida, Chizu Sanjoba, Yoshitsugu Matsumoto, Yasuyuki Goto
Tokyo University, Tokyo, Japan
Visceral leishmaniasis (VL), also known as kala-azar, is caused by 
parasitic protozoa of the genus Leishmania. VL is characterized by 
clinical manifestations such as fever, weight loss, hepatosplenomegaly 
and anemia. Hemophagocytosis is a phenomenon of macrophages or 
histiocytes phagocytosing blood cells. There are reports on up-regulated 
hemophagocytosis in patients with infectious diseases including 
typhoid fever, tuberculosis, influenza and VL. However, mechanisms of 
infection-associated hemophagocytosis remained elusive due to lack of 
appropriate animal models. Here, we have established a mouse model 
of VL representing hemophagocytosis in order to elucidate mechanisms 
behind this phenomenon in VL. At 24 weeks after infection with 1 x 
107 promastigotes of Leishmania donovani, BALB/cA mice exhibited 
splenomegaly with an average tissue weight of 10 times as those of naïve 
mice and anemia with lower hematocrit, hemoglobin and red blood 
cell counts than the naïve mice. In the spleen, 28.6% of macrophages 
contained erythrocytes. All of hemophagocytosing macrophages were 
parasitized by L. donovani. When hemophagocytes were categorized 
based on the number of parasites per macrophage, higher levels of 
hemophagocytosis were observed in heavily infected cells (more than 
20 amastigotes). Besides, more than half of these hemophagocytes had 
two or more nuclei per cell whereas only 15.0% of splenic macrophages 
were multi-nucleated. Such multi-nucleated cells were not observed 
in spleens of uninfected mice. From these histological observations, 
hemophagocytes were presumed to be macrophages which acquired 
abnormal character by L. donovani infection. Through in vitro experiment 
with RAW264.7 cells, enhanced hemophagocytosis by macrophages was 
reproduced by infection with L. donovani in the presence of IFN-γ. These 
results suggested that L. donovani causes hyper-activation of macrophages 
to hemophagocytose. To our knowledge, this is the first report on 
hemophagocytosis in experimental Leishmania infections and may be 
useful to further understanding of the pathogenesis.
1907
INVOLVEMENT OF NUCLEOTIDE-BINDING DOMAIN 
LEUCINE-RICH REPEAT PROTEIN 12 (NLRP12) IN VISCERAL 
LEISHMANIASIS (VL)
Diogo Valadares, Gwendolyn Clay, Richard E. Davis, Bayan 
Sudan, Yani Chen, Breanna Scorza, Fayyaz Sutterwala, Mary E. 
Wilson
University of Iowa, Iowa City, IA, United States
Leishmania infantum chagasi (Lic) causes VL, with suppression of type 
1 immune responses. The NLR proteins include >20 cytosolic proteins 
that regulate inflammation and immunity. Activation of three NLRs or 
AIM2 can cause assembly of an inflammasome leading to IL-1β and IL-18 
release. Functions of non-inflammasome forming NLRs are not as well 
understood. We hypothesized that NLR proteins influence the course of 
VL by modifying the localized inflammatory response to Lic. We screened 
for NLR effects by infecting NLR pathway gene knockout or wild type (WT) 
mice with Lic coexpressing luciferase and mCherry. Progressive parasite 
expansion was monitored by in vivo imaging (IVIS), qPCR and, Luciferase 
assay. The screens suggested involvement of the non-inflammasome 
forming Nlrp12 in progression of VL. Lic parasite loads expanded early 
(day 28) but were controlled in WT mice, whereas Lic continued to 
expand and were 2-fold higher than WT on day 56 of Nlrp12-/- infection. 
Consistently, liver-derived infiltrating cells from Nlrp12-/- mice released less 
antigen-induced IFNgamma than WT cells on infection day 56 (24 vs. 41 
pg/mL). Flow Cytometry showed inflammatory monocytes expanded on 
day 28 in WT but not Nlrp12-/- mice, preceding parasite clearance from 
WT. Instead, resident macrophages expanded in Nlrp12-/- mice in parallel 
with the late expanding parasite load (day 56). The kinetics of monocyte 
derived dendritic cell (MNDC) recruitment paralleled parasite load, with 
recruitment at 28 days in WT but recruitment at 56 days in Nlrp12-/- mice. 
These data suggest that Nlrp12 plays a protective role in VL, associated 
with recruitment of both inflammatory monocytes and MNDCs at the 
time of peak parasite growth, followed by parasite clearance. Infiltration 
of inflammatory monocytes is impaired in the absence of Nlrp12, leading 
to delayed MNDC influx, impaired IFN-gamma, and expansion of resident 
macrophages, which permit parasite growth.
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EVALUATION OF THE USE OF LEISHMANIA DONOVANI 
DOUBLE KNOCK-OUT PARASITES (LDCEN-/-MIF-/-) AS 
PROTECTIVE VACCINE AGAINST VISCERAL LEISHMANIASIS
Jacqueline Araújo Fiuza1, Sreenivas Gannaravaram2, Soraya 
Torres Gaze Jangola1, Érica Alessandra Rocha Alves1, Andrea 
Teixeira de Carvalho3, Hira Nakhasi2, Rodrigo Correa-Oliveira1
1Laboratory of Cellular and Molecular Immunology-René Rachou Institute/
FIOCRUZ, Belo Horizonte, Brazil, 2Laboratory of Emerging Pathogens, 
Division of Emerging and Transfusion Transmitted Diseases, Office of Blood 
Research and Review, Center for Biologics Research and Review, Food 
and Drug Administration, Silver Spring, MD, United States, 3Laboratory of 
Biomarkers for Diagnosis and Monitoring, René Rachou Research Center/
FIOCRUZ, Belo Horizonte, Brazil
Visceral leishmaniasis (VL) is a neglected tropical disease, and fatal if 
untreated. There is no vaccine available against VL. Parasite persistence 
is thought to be important for an effective protective response. Such 
protection may also be achieved by immunization with gene-deleted 
live attenuated parasites that do not cause disease. We have previously 
reported on a genetically modified live attenuated parasite, with a 
cell division specific centrin1 gene deletion, producing strong immune 
protection in mice, hamsters and dogs. Leishmania parasites are shown 
to secrete an inflammatory cytokine, macrophage migration inhibitory 
factor (MIF) that causes poor T cell responses in the infected host due 
to excessive inflammation. In this study we have tested the L. donovani 
double gene deletion mutant strains deficient for centrin and MIF genes 
(LdCen-/-MIF-/-) for their safety and efficacy as a candidate vaccine. Our 
hypothesis is the double-attenuated strain induces more effective immune 
response through production of long-term memory T cells, being able to 
promptly respond to infection inducing protective response. Balb/c mice 
were immunized with LdCen-/-, LdMIF-/- or LdCen-/-MIF-/- parasites, and 
the immune responses were compared to a control group (PBS). After 4 
weeks of immunization (4wpi), some mutant parasites were detected in 
spleen and liver by serial dilution. Our preliminary results showed that, 
at 4wpi, LdCen-/-MIF-/- immunized group presented higher percentage 
of CD4 and CD8 central memory T cells, higher percentage of CD8 late 
effector memory T cells, and increased CD8 T cells proliferation after 
specific stimulation compared to PBS and LdMIF-/-. Protective immunity 
induced by LdCen-/-MIF-/- parasites is currently being evaluated in mice by 
parasitological and immunological assays following 4 wpi, and 4, 8 and 
12 weeks of challenge with wild type strain of L. infantum. These results 
demonstrate the role of parasite products involved in manipulating the 
host immunity and manipulating these mechanisms might enhance the 
vaccine induced protective immunity and help further development of 
vaccines against VL.
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TEST AND NOT TREAT (TNT): A SAFE STRATEGY TO PROVIDE 
COMMUNITY-BASED TREATMENT WITH IVERMECTIN IN LOA 
LOA ENDEMIC AREAS
Joseph Kamgno1, Sébastien Pion2, Matthew Bakalar3, Cédric 
Chesnais2, Mike D’Ambrosio3, Raceline Gonoue Kamkumo1, 
Charles D. Mackenzie4, Muriel Sonia Mehly Ngninzeko1, Narcisse 
Ngandjui5, Guy Roger Njitchouang1, Philippe Nwane1, Jules 
Tchatchueng Mbouga1, Armel Fabrice Tchinde Toussi1, Samuel 
Wanji5, Daniel Fletcher3, Thomas B. Nutman6, Amy Klion6, Michel 
Boussinesq2
1Centre for Research on Filariasis and other Tropical Diseases, Yaounde, 
Cameroon, 2Institut de Recherche pour le Développement, Montpellier, 
France, 3University of California, Berkeley, CA, United States, 4Liverpool 
School of Tropical Medicine, Liverpool, United Kingdom, 5Research 
Foundation for Tropical Diseases and the Environment, Buea, Cameroon, 
6National Institute of Allergy and Infectious Diseases, National Institutes of 
Health, Bethesda, MD, United States
Implementation of ivermectin (IVM)-based community treatment for 
onchocerciasis or lymphatic filariasis (LF) control/elimination has been 
delayed in Central Africa because IVM can induce serious adverse effects 
(SAE) in people with Loa loa microfilaremia exceeding 30,000 microfilariae 
(mf)/mL blood. The recent development of CellScope-Loa, a rapid field-
friendly diagnostic tool to quantify L. loa mf in peripheral blood, permits 
point-of-care (POC) identification of the few “at risk” individuals for 
exclusion from IVM treatment (to prevent SAEs) while the rest of the 
population can be safely treated. This “Test and not Treat” (TNT) strategy 
was evaluated in Okola district (Central Cameroon) where onchocerciasis 
and loiasis are co-endemic and where IVM distribution was halted in 
1999, after the occurrence of SAEs including fatalities. Between August 
and October 2015, 16,205 individuals from a target population (>5 
years) of 22,800 (participation: 71.1%) were tested at the point of care 
(POC) using the CellScope-Loa; those with fewer than a pre-determined 
threshold (20,000 mf/mL) were given IVM (n=15,469), whereas those 
above this threshold (n=343, 2.1%) were excluded from IVM treatment, 
in addition to 167 pregnant women and 226 people in a poor state 
of health). Adverse events were closely monitored by local volunteers 
and mobile medical teams visiting each village 1, 2, 3 and 6 days after 
treatment. No SAE was observed. A total of 970 individuals (6.3% of the 
IVM-treated population) experienced mild adverse effects (itching, rash, 
headache, arthralgia, myalgia, fever) that resolved within one week. About 
half of adverse events occurred in individuals who had no Loa mf before 
treatment. The TNT strategy based on the CellScope-Loa is an extremely 
promising and practical approach to the safe implementation of large-scale 
IVM-based treatment for LF and onchocerciasis elimination in Loa endemic 
areas.
1910
THE MACROFILARICIDAL ACTIVITY OF A SINGLE DOSE OF 
IVERMECTIN, ALBENDAZOLE AND DIETHYLCARBAMAZINE 
AGAINST WUCHERERIA BANCROFTI IN CÔTE D’IVOIRE
Catherine M. Bjerum1, Allassane Ouattara2, Benjamin G. 
Koudou3, Abdoulaye Meite4, James W. Kazura5, Gary Weil6, 
Christopher L. King5
1Case Western Reserve University, Cleveland, OH, United States, 
2Centre Suisse de Recherche en Cote d’Ivoire, Abidjan, Côte D’Ivoire, 
3Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, United 
Kingdom, 4Programme National de Lutte Contre la Schistosomiase, les 
Geohelminthiases et la Filariose Lymphatique, Abidjan, Côte D’Ivoire, 
5Center for Global Health and Diseases, Case Western Reserve University, 
Cleveland, OH, United States, 6Infectious Diseases Division, Department 
of Internal Medicine, Washington University School of Medicine, St. Louis, 
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Current single dose treatments for lymphatic Filariasis (LF) have limited 
ability to kill adult worms. In a recent pilot study in Papua New Guinea 
we showed a single dose of co-administered ivermectin (IVM, 200ug/kg), 
diethylcarbamazine (DEC, 6mg/kg), and albendazole (ALB, 400mg, IDA) 
completely cleared microfilaria (mg) 1 year after treatment compared to 
8% clearance with DEC/ALB. However, the effect of IDA on macrofilaria 
is not known. We used ultrasounds of the spermatic cord and inguinal 
lymphatic vessels immediately prior to treatment and 6 months later 
to compare the effects of two drug regimens on adult filarial worms in 
infected men in Côte d’Ivoire. The first group included 46 men treated 
with a single dose of IVM+ALB (IA, mean number of worms nests=3.2±1.4 
[range 1-13]) and the other group included 28 men who received IDA. 
Number of worm nests was the same at baseline (IA=3.2±1.4 range [1-
13], IDA=3.0±1.4 [1-8]). Thirty-six men treated with IA and 21 men treated 
with IDA underwent repeat ultrasound after 6 months. Worm nests were 
cleared more often after IDA (15 of 21, 71%) than after IA (9 of 36, 25%, 
P=0.0009). IDA also showed a reduction in nest size of 83%, compared to 
9% in the IA group, as well as 95.3% clearance of mf compared to 28.6% 
clearance of mf in IA (P<0.0001). These results suggest that a single dose 
of IDA killed most adult W. bancrofti and that IDA is more effective against 
adult filarial worms than IA.
1911
NEXT GENERATION IMMUNOASSAYS PROVIDE ONE-STEP 
SPECIES-SPECIFICITY FOR THE DIAGNOSIS OF FILARIAL 
INFECTIONS AND STRONGYLOIDES STERCORALIS IN 
TRAVELERS AND IMMIGRANTS
Joseph Kubofcik, Thomas B. Nutman
National Institutes of Health, Bethesda, MD, United States
Antifilarial antibody testing in the evaluation of returned travelers and 
immigrants to North America has relied on IgG- and IgG4-specific 
responses to crude filarial extracts (BmA). The anti-BmA IgG response 
is highly sensitive (~100%), but suffers from relatively poor (50%) 
specificity. It also suffers from significant cross-reactivity with Strongyloides 
stercoralis (Ss) and cannot distinguish among the infecting filarial species. 
Conversely, the IgG4 anti-BmA antibody test is close to 100% specific 
but has sensitivities that range between 50%-70%. Of the 10173 CLIA-
certified antifilarial antibody tests performed, 1809 (18%) filarial infections 
were diagnosed based on a positive IgG4 anti-BmA antibody response, 
and 4908 (48%) were excluded using an IgG anti-BmA test below the 
defined cutoff. Over the same period, filarial- (Ov16, Wb123, LL-SXP1) 
and Ss (SsIR, Ss-NIE)-species-specific recombinants have been identified 
and characterized. Each of these, when configured in a variety of single 
antigen IgG4-based immunoassay formats have demonstrated close to 
100% specificity for the species of interest but with variable sensitivities 
depending on the antigen. Thus, to create an all-in-one assay for screening 
of returned travelers and immigrants where infections with filariae or Ss 
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is being considered, we configured a multiplex suspension array assay 
to measure the IgG or IgG4 responses to BmA, LlSXP1, Ov16, Wb123, 
SsNIE and SsIR. When these multiplexed assays were assessed using serum 
samples from parasite-uninfected (n=70) subjects compare to definitively 
diagnosed (parasite-positive) infected patients with Loa loa (N=37), 
Onchocerca volvulus (n=185), Wuchereria bancrofti (N=24), and Ss (N=41) 
we were able to get IgG4 based assays that achieved 100% specificity for 
all infections and sensitivities that ranged from 67% for LL-SXP1 to 92% 
for Wb123. Using this novel multiplexed immunoassay, we have been 
able to de-convolute the anti-BMA reactivity and identify the species of 
infecting parasite responsible for the antibody positivity for better accuracy 
in the diagnosis of individual filarial and Ss infections.
1912
HIGH EFFICACY OF SINGLE DOSE OF CO-ADMINISTERED 
IVERMECTIN, DIETHYLCARBAMAZINE AND ALBENDAZOLE IN 
TREATMENT OF LYMPHATIC FILARIASIS IN CÔTE D’IVOIRE
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Abidjan, OH, United States, 6Infectious Diseases Division, Department of 
Internal Medicine, Washington University School of Medicine, St. Louis, 
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Available treatments for lymphatic filariasis (LF) are limited in their 
long-term clearance of microfilaria (mf) from the blood. Recently we 
reported that a single dose of co-administered Ivermectin (IVM, 200ug/
kg), Diethylcarbamazine (DEC, 6mg/kg), and Albendazole (ALB, 400mg) 
completely cleared mf 1 year following treatment, compared to 8% 
clearance with DEC/ALB alone in a small pilot study in Papua New Guinea. 
In order to confirm and expand these results in a different population 
we performed an open-labeled, single-blinded clinical trial where 
microfilaremic infected individuals were randomized into those treated 
with IVM/DEC/ALB (IDA, N=42) or IVM/ALB (IA, N=55) and mf levels 
measured immediately prior to and 6 months following treatment. Of 
those enrolled 83% are men, with median age of 37 years and overall 
geometric mean mf of 191.4 mf/ml (range 51-2,250). In the IDA group 
22 of 25 (88%) completely cleared their microfilaria. The remaining 
3 each had a single mf per 2 ml of blood. By contrast only 32.4% of 
individuals treated with IA completely cleared their mf, with the remaining 
participants averaged 92.8% (range 58.2-98.6%) reduction in mf levels. 
Adverse events (AEs) particularly fevers, myalgias, and pruritus were 
common, occurring in 54.8% vs 40.4% of those receiving triple-drug 
compared to 2-drug treatment respectively (P=0.18); all symptoms resolved 
within 7 days after treatment. IDA had more level 2 (scale 1-3) reactions 
[9 (21%) vs 1 (2%) in IA], however no serious AEs were observed in either 
group. This confirms that triple-drug therapy is safe and more effective 
than IVM/ALB for Bancroftian filariasis and has the potential to accelerate 
elimination of lymphatic filariasis.
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EFFECTIVENESS AND SAFETY OF ALBENDAZOLE FOR THE 
TREATMENT OF HYPERMICROFILAREMIC LOIASIS IN GABON
Marielle K. Bouyou-Akotet, Noe P. Mbondoukwe, Christian 
Nziengui, Eric Kendjo, Marie Noelle Mossavou Boussougou, 
Mathieu Owono Medang, Denise P. Mawili Mboumba, Maryvonne 
Kombila
Université des Sciences de la Santé, Libreville, Gabon
Loiasis is endemic in Gabon with prevalences ranging from 10 and 35 
%. Ivermectin, the drug known to be associated with serious adverse 
reactions in case of Loa loa hypermicrofilaremia, is used for the prevention 
of lymphatic filariasis and onchocerchiasis in areas where they coexist with 
loiasis. Albendazole is an alternative to ivermectin. Its efficacy and safety 
for the treatment of loiasis microfilaraemia was assessed in 128 individuals 
with more than 8000mf/mL. Parasitological data and clinical symptoms 
were monitored at days 7, 14, 21 and 63 after administration of increasing 
doses of albendazole (50 or 100mg to 400mg and 800mg/day) during 
six to eight weeks. Asthenia was the predominent drug-related adverse 
event recorded. The percentage of participants with ≥ 50% decrease of 
microfilaraemia from pre-treatment to 1 month was 69%. At 3 months 
post-treatment, 82% of patients had no microfilaraemia detected after 
leuconcentration of 4mL blood. Objective symptoms were not noticed 
after 3 months and pruritus was the most frequently reported post-
treatment clinical symptom. Data analysis is still ongoing. In conclusion, 
treatment of hypermicrofilaraemic loiasis with albendazole was safe and 
efficacious in continuously exposed patients.
1914
DEVELOPMENT OF MURINE MODELS OF LOIASIS TO ASSESS 
MICROFILARICIDAL ACTIVITY OF PRE-CLINICAL CANDIDATE 
ANTI-FILARIAL DRUGS
Hanna Sjoberg1, Nicolas Pionnier1, Haelly Metugene2, Abdel 
Njouendou2, Fanny Fombad2, Patrick Ndongmo2, Dizzle Tayong2, 
Bertrand Ndzeshang2, Andrew Steven1, Darren Cook1, Ghaith 
Alyaoussi1, Steve Ward1, Mark Taylor1, Samuel Wanji2, Joseph 
Turner1
1Liverpool School of Tropical Medicine, Liverpool, United Kingdom, 
2University of Buea, Buea, Cameroon
Development of new macrofilaricides to eliminate onchocerciasis in Africa 
requires assessments of safety for potential indications in loiasis co-
endemic regions. This is because rapid killing of Loa loa microfilariae (mf) 
following ivermectin (IVM) treatment in patients with high parasitaemias 
has been linked to the development of severe neurological adverse 
reactions. Via human pharmacokinetic profiling of IVM and the related 
macrocyclic lactone moxidectin (MOX) we define a mis-match between 
in vitro and in vivo drug sensitivities to the bloodborne human filariae 
Brugia malayi and L. loa. This indicates that safety evaluation of potential 
macrofilaricides requires screening in vivo against blood-stage L. loa mf. 
Here we describe the development of mouse models of loiasis with the 
goal of evaluating them as in vivo microfilaricide drug screens. BALB/c WT 
or SCID (+/- splenectomy) were perfused with Loa or Brugia mf. CB.17 
SCID, NOD.SCID or NOD.SCID IL-2gc-/- (NSG) strains were infected with 
Loa L3 and evaluated at 3-5 months post-inoculation. Recovered worms 
were then surgically re-implanted in NSG mice and evaluated 1 month 
post-implantation. To evaluate drug responsiveness, microfilariaemic mice 
were treated with bio-equivalent IVM. The vast majority of perfused mf 
(~10% of initial inoculates) were sequestered in the cardiopulmonary 
circulation. Splenectomy increased both the incidence of peripheral Loa 
mf in WT mice and the overall yield of cardiopulmonary mf six days post 
infusion. IVM induced a rapid decline (>80%) in circulating mf in WT 
and SCID mice. For patent Loa infections, NSG mice yielded an average 
recovery of adult worms of 33% of the initial inoculate at +5 months. No 
circulating mf were observed although embryograms of female worms 
identified occurrence of embryogenesis and inter-uterine mf. For the adult 
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Loa implanted NSG mice, circulating mf were observed both centrally 
and peripherally. IVM treatment reduced microfilaraemia in these mice. 
In conclusion, preliminary validation demonstrates both models could be 
implemented as pre-clinical macrofilaricide counter-screens and are thus in 
further development.
1915
PET/CT LYMPHOSCINTIGRAPHY DEMONSTRATES EARLY 
CHANGES IN LYMPHATIC FUNCTION IN THE BRUGIA 
MALAYI/FERRET MODEL OF LYMPHATIC FILARIASIS
Belinda M. Jackson, So Young Kim, Shalini Jaiswal, Jessica Scott, 
Colin M. Wilson, Scott Jones, Bernard J. Dardzinski, Edward Mitre
Uniformed Services University, Burtonsville, MD, United States
The goal of this study was to evaluate changes in lymphatic function in 
the Brugia malayi/ferret model of lymphatic filariasis. Injection of L3 larvae 
into the ferret footpad results in intralymphatic infection of the femoral 
and inguinal lymphatics. Development of microfilaremia and eosinophilia 
begin at 12-14 weeks post-infection. Ferrets were imaged at baseline, and 
again at 2 and 16 weeks post-infection. Imaging was performed using 
a Simeons Inveon Multimodality PET/CT scanner. Anesthetized animals 
were subcutaneously injected (between the toes of their right hind limb) 
with 18F-FDG (100-150 uCi), and monitored for tracer uptake for 90 
minutes. A CT scan for anatomical localization followed PET analysis. This 
approach enabled assessment of lymphatic function by quantification 
of tracer uptake into the inguinal lymph nodes over time. While single 
infectious challenges with L3s did not result in clinical disease as monitored 
by measurements of ankle and limb circumferences, they clearly caused 
marked changes in lymphatic anatomy and function as early as 2 weeks 
post infection. Compared to baseline imaging, expanded networks of 
tortuous and dilated lymphatic vessels were observed at all infected 
timepoints, along with the generation of collateral lymphatic vasculature. 
Whereas peak tracer uptake into the inguinal lymph nodes was observed 
by 20 minutes post-tracer injection in uninfected animals, peak uptake did 
not occur until 25-30 minutes after two weeks of infection and until 30-35 
minutes after 16 weeks of infection. Additionally, maximal intensities of 
tracer signal in the inguinal lymph nodes was reduced by 50% in infected 
animals at all timepoints evaluated. These results demonstrate that Brugia 
malayi cause marked alterations in lymphatic vessel anatomy and function 
early in the course of LF infection; occuring prior to microfilaria production 
and in the absence of frank clinical disease. In current studies we are 
evaluating whether this imaging protocol can be used to assess alterations 
in lymphatic function induced by treatment with antifilarial agents.
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MICROBIOLOGY AND OUTCOMES IN HOSPITALIZED 
NEONATES WITH SEPSIS: A ZAMBIAN COHORT STUDY
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Sepsis is a major cause of mortality in neonates in sub-Saharan Africa, 
yet is not well-studied. We are conducting an ongoing cohort study of 
infants hospitalized in a large neonatal intensive care unit in a public 
hospital in Zambia. Clinical and demographic data were captured by 
maternal interview and chart review. Blood cultures were obtained on 
all neonates with suspected sepsis. We examined the microbiology and 
outcomes of neonates with all-cause bacteremia and those with Klebsiella 
infection. From September 1, 2015 to March 31, 2016, we enrolled 711 
neonates, of whom 376 (53%) were male, and 543 (76%) were born 
at the study hospital. The median birth weight was 2690g (IQR 1600-
3135g) and 539 (77%) were born vaginally without instrumentation. 
Most enrolled infants had suspected sepsis (n=520; 73%), of whom half 
(n=265; 51%) had a culture-confirmed bacteremia. The most common 
isolates were K. pneumoniae (n=187; 70%), common skin commensal 
organisms (n=55; 21%), and Enterococcus spp. (n=22; 8%). There was 
one isolate each of Staphylococcus aureus and streptococcus agalactiae. 
Overall mortality was 31% and was greater among bacteremic infants 
than septic, non-bacteremic infants (36% vs. 27%, p= 0.04). Among 
bacteremic neonates, low birth weight (aOR=1.02) and Kleb. infection 
(aOR=1.80) were independent risk factors for death. Most Kleb. isolates 
were resistant to fluoroquinolones (n=177, 95%) and half were resistant 
to β-lactam antibiotics, (n=93, 50%), with 29 (15%) ESBL. Mortality 
among neonates with Kleb. infections was 42%. The risk of death was 
similar among infants with β-lactam-resistant as compared to susceptible 
strains of Kleb. (44% vs. 41%, p= 0.77). Age at sepsis onset, maternal 
HIV status, and birth location were not associated with death in either the 
all-cause bacteremia or the Kleb.-infected cohorts. Neonatal sepsis was 
common, often caused by multi-drug resistant organisms, and associated 
with a high case-fatality rate in this large NICU in Zambia. Kleb. infection 
was associated with an increased risk of death; however, infection with 
β-lactam-resistant Kleb. was not associated with an increased risk of 
death.
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HIGH SERUM ZINC LEVELS PROTECT AGAINST ROTAVIRUS 
INFECTION BUT NOT OTHER DIARRHEA-ASSOCIATED 
PATHOGENS IN A BIRTH COHORT IN BANGLADESH
E. Ross Colgate1, Dorothy M. Dickson1, Rashidul Haque2, Mami 
Taniuchi3, James A. Platts-Mills3, Josyf C. Mychaleckyj3, Uma 
Nayak3, Marya P. Carmolli1, William A. Petri3, Beth D. Kirkpatrick1
1University of Vermont College of Medicine, Burlington, VT, United States, 
2International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, 
Bangladesh, 3University of Virginia, Charlottesville, VA, United States
Diarrhea remains the world’s second leading cause of death in children. 
In combatting this challenge, zinc supplementation has been shown to 
reduce diarrheal morbidity and mortality, though the mechanisms are 
unclear. In most zinc efficacy trials, diarrhea has been treated as pathogen-
agnostic; however rotavirus causes an estimated 40% of acute diarrhea 
in developing countries where rotavirus vaccines perform poorly and 
alternative methods for diarrheal management are critical. In the PROVIDE 
study, a randomized controlled trial of oral rotavirus vaccine in a birth 
cohort in Dhaka, Bangladesh, we found a significant protective effect 
of serum zinc concentration at age 18 weeks on the risk of rotavirus 
diarrhea through one year based on rotavirus antigen detection by 
ELISA in diarrheal stools. Using advanced molecular techniques, here we 
interrogate whether the protective effect of zinc is specific to rotavirus 
or extends to other diarrheal pathogens. We performed multiplex 
PCR on 1,448 diarrheal specimens collected between weeks 18-52 
with the following targets: rotavirus, norovirus, sapovirus, astrovirus, 
Giardia, Cryptosporidium, and Entamoeba histolytica. Among these 
pathogens, only rotavirus correlated with zinc status (P=0.016, Kruskal-
Wallis test). This relationship was further tested by logistic regression 
to include variables that may modify the effect of zinc: courses of zinc 
supplementation, sex, urinary mannitol at week 40, household food 
deficit, exclusive breast feeding and stunting. In the final model of risk 
of rotavirus diarrhea, children with zinc levels in the highest quartile 
compared to children at risk of zinc deficiency were nearly four times more 
likely to have diarrhea without any rotavirus detected versus rotavirus 
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infections (OR 3.93, 95% CI 1.28 - 12.05, P=0.017). Other factors in 
the model were not associated with rotavirus infection and did not 
significantly modify the effect of zinc. These results suggest a particular 
utility of zinc interventions in reducing the burden of rotavirus diarrhea 
compared to other etiologies. Future research will examine mechanisms of 
zinc protection in rotavirus.
1918
DECLINING CHILD MORTALITY DUE TO INFECTIOUS 
DISEASES IN AN URBAN SLUM IN NAIROBI KENYA
Jennifer R. Verani1, Leonard Cosmas1, Shadrack Muema2, Alice 
Ouma2, Geofrey Masyongo2, Marc-Alain Widdowson1, Godfrey 
Bigogo2
1Division of Global Health Protection, Centers for Disease Control and 
Prevention, Nairobi, Kenya, 2Center for Global Health Research, Kenya 
Medical Research Institute, Nairobi, Kenya
Examining trends in causes of child mortality over time can help measure 
progress towards achieving Millennium Development Goal #4. Little 
is known about trends in child mortality in urban slums, where living 
conditions are precarious. We assessed child mortality rates and cause 
of death (COD) from 2009-2014 in a population of ~25,000 residents 
of Kibera slum in Nairobi, Kenya, under demographic surveillance. 
Participants were visited biweekly in their homes and queried about any 
deaths. Trained verbal autopsy (VA) interviewers used standardized World 
Health Organization VA questionnaires to gather data from a credible 
respondent on the circumstances leading up to death. InterVA-4 was 
used to code the most likely COD. We calculated rates of death per 1000 
person-years-observation (pyo); for cause-specific rates, we extrapolated 
the observed proportion of COD by year to those with missing VA data. 
From 2009-2014, 336 deaths were reported among children aged <5 
years. The child mortality rate declined from a high of 18.3/1000 pyo 
in 2009 to a low of 9.8/1000 pyo in 2013, then increased slightly to 
11.4/1000 pyo in 2014. VA was completed on 255 (76%); 18 (7%) 
were classified as ‘indeterminate’ and 5 (2%) as ‘other and unspecified 
neonatal’. Among the remaining 232 with a likely COD identified, the 
leading cause was acute respiratory infection/pneumonia, including 13/35 
(37%) neonatal deaths and 102/197 (52%) in children aged 29 days to 
<5 years. Other common causes included malaria (n=29, 12%), diarrhea 
(n=12, 5%), and HIV/AIDS-related (n=12, 5%). Rates of pneumonia deaths 
peaked in 2010 at 9.8/1000 pyo, then fell to a low of 4.5/1000 pyo in 
2014. Rates of all other infectious causes combined (excluding pneumonia) 
decreased from 9.8/1000 pyo in 2009 to 2.9/1000 pyo in 2013 and 
2014. We observed a reduction in child mortality of more than 35% in 
recent years in Kibera. The decline was driven by falling mortality due to 
pneumonia and other infectious diseases. Possible factors contributing to 
improved survival include introduction of the pneumococcal conjugate 
vaccine in 2011 and scaled up malaria control and HIV prevention efforts.
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A SYSTEMATIC REVIEW ON THE EFFECTIVENESS OF 
STRATEGIES TO IMPROVE HEALTH WORKER PERFORMANCE 
IN LOW- AND MIDDLE-INCOME COUNTRIES: PRELIMINARY 
RESULTS ON UTILIZATION OF HEALTH SERVICES
Alexander K. Rowe1, Samantha Y. Rowe1, David H. Peters2, 
Kathleen A. Holloway3, John Chalker4, Dennis Ross-Degnan5
1Centers for Disease Control and Prevention, Atlanta, GA, United States, 
2Johns Hopkins University, Baltimore, MD, United States, 3World Health 
Organization, New Delhi, India, 4Management Sciences for Health, 
Arlington, VA, United States, 5Harvard Medical School, Boston, MA, 
United States
Improving health worker (HW) performance is a global health priority. 
Strategies that improve performance might also increase utilization of 
health services. To characterize the effectiveness of such strategies in low- 
and middle-income countries (LMICs), we conducted a systematic review 
of 15 electronic databases, 30 document inventories of international 
organizations, and bibliographies of 510 articles. We included studies 
meeting accepted criteria for methodological adequacy (e.g., trials 
with comparison groups) of any strategy to improve HW performance 
on any health topic in any language, published or not. This analysis 
focuses on studies that measured continuous outcomes on the utilization 
of health services (e.g., number of patients seen per month). Effect 
sizes were calculated as percent change over time in the intervention 
group minus percent change over time among controls. We screened 
>105,000 citations, and 822 reports met inclusion criteria. Fifty-seven 
studies measured continuous utilization outcomes and were included 
in the analysis. Many strategies have been tested, usually with multiple 
intervention components. However, most strategies were tested by 
only one study. The median effect size (MES) across all studies was an 
improvement of 15 percentage-points (%-points) (interquartile range 
[IQR]: -14, 57). Among studies of facility-based HWs, three strategies 
tended to increase utilization: strategies that included financial incentives 
for HWs or health facilities (MES = 67 %-points, IQR: 2, 119), insurance 
schemes (MES = 16 %-points, IQR: -44, 47), and reducing or removing 
user fees (MES = 15 %-points, IQR: -12, 42). Introducing or increasing 
user fees tended to decrease utilization (MES = -53 %-points, IQR: -82, 
-17). Among studies of lay HWs, no clear patterns were identified. For 
example, strategies that included the combination of HW training + 
supervision + patient or community education had effect sizes of -29, 5, 
79, and 306 %-points. Contextual and methodological heterogeneity 
made comparisons difficult. These results should inform decision-making 
on increasing utilization of health services in LMICs.
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THE IMPACT OF ANEMIA DURING PREGNANCY AND ITS RISK 
FACTORS ON THE COGNITIVE DEVELOPMENT OF ONE-YEAR-
OLD CHILDREN
Michael O. Mireku1, Michel Cot2, Florence Bodeau-Livinec3
1Imperial College London, London, United Kingdom, 2Institut de recherche 
pour le développement (IRD), Paris, France, 3INSERM U1153, Paris, France
The aim was to investigate the impact of anemia during pregnancy and 
its risk factors on the cognitive development of one-year-old children. 
Our prospective cohort study included 636 mother-singleton child pairs 
from 828 eligible pregnant women who were enrolled during their 
first antenatal care visit (ANV) in Allada, Benin, into the MiPPAD clinical 
trial. Venous blood samples of women were assessed for ferritin and 
hemoglobin (Hb) concentrations at the first and second ANV of at least 
one-month interval and at delivery. Stool samples of pregnant women 
were also collected during these follow-up periods to test for helminths 
using the Kato-Katz technique. All pregnant women were administered a 
total of 600 mg of mebendazole (100 mg two times daily for 3 days) to be 
taken after the first ANV. Women were also given daily iron and folic acid 
supplements throughout pregnancy. The intake was not directly observed. 
At age one year, cognitive and motor functions of children were assessed 
using the Mullen Scales of Early Learning. The prevalence of iron deficiency 
(ID) among pregnant women at first and second ANC visits, and at delivery 
was 30.5%, 34.0% and 28.4%, respectively. Prevalence of helminth 
infection was 11.5%, 7.5% and 3.0% at first, second ANV and at delivery, 
respectively. Prevalence of anemia decreased from 67.1% at first ANV 
[mean gestational age (Standard deviation), 22.1(4.0) weeks] to 40.1% at 
delivery. Children of mothers who were infected with hookworms at first 
ANV had 4.9 (95% confidence interval, CI: 1.3 - 8.6) lower mean gross 
motor scores compared to those whose mothers were not infected with 
hookworms at the first ANV. We observed a significant negative quadratic 
relationship between infant gross motor function and Hb concentration at 
first and second ANVs. Prenatal helminth infection is associated with poor 
with infant cognitive and motor development. However, in the presence 
of iron supplementation, ID is not associated with infant neurocognitive 
development. Further, there appears to be an Hb concentration range (90-
110 g/L) that may be optimal for better gross motor function of one-year-
old children.
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MATERNAL AND INFANT FACTORS MEDIATING COGNITIVE 
DEVELOPMENT AT 12 MONTHS AMONG FILIPINO INFANTS
Sangshin Park1, David Bellinger2, Meredith Adamo1, Brady 
Bennett3, Namkyong Choi2, Palmera Baltazar4, Edna B. Ayaso4, 
Donna Bella S. Monterde4, Veronica Tallo5, Remigio M. Olveda5, 
Luz P. Acosta5, Jennifer F. Friedman1
1Alpert Medical School of Brown University, Providence, RI, United States, 
2Harvard Medical School, Boston, MA, United States, 3Health Council of 
South Florida, Miami, FL, United States, 4Remedios Trinidad Romualdez 
Hospital, Tacloban City, Philippines, 5Research Institute for Tropical 
Medicine, Manila, Philippines
The objective of this study was to identify pre- and post-natal 
predictors that directly or indirectly affect infant cognitive, language, 
and motor development at 12 months of age among Filipino infants 
and the pathways through which they act. The Bayley Scales of Infant 
Development, 3rd edition, was used to assess the development of 
314 infants who were enrolled in a trial to examine the effects of 
Praziquantel for the treatment of schistosomiasis given at 12-16 weeks 
gestation on pregnancy outcomes. Covariates evaluated from the trial 
included maternal iron, socio-economic, and nutritional status, as well 
as birthweight and newborn iron status. Infant nutritional status, iron 
and hemoglobin were captured at 1, 6, and 12 months of age and 
the Philippines Nonverbal Intelligence Test (PNIT) was administered 
to mothers. Multivariable linear regression and structural equation 
modeling were used to identify significant factors associated with infant 
development. In multivariable regression models, maternal treatment 
with Praziquantel, education, PNIT score, and iron status as well as infant 
WAZ, WLZ, and WAZ gains were significantly associated with specific 
domains of infant development at 12 months of age. Structural equation 
models demonstrated that maternal PNIT scores [standardized β (sβ) 
for cognitive=0.073, sβ for language=0.061, sβ for motor=0.20, all P 
<0.05] directly influenced most subscales of infant development and 
indirectly impacted development through birthweight and/or infant weight 
gain. Maternal iron status during gestation was a stronger predictor of 
development than infant iron status. Infant change in nutritional status 
was related to language and motor development (eg, sβs of WAZ gain/
mo for language=0.15 and motor=0.079, all P <0.05), suggesting catch 
up growth may ameliorate some cognitive deficits among LBW infants. 
Finally, exclusive breast feeding had a direct effect on infant expressive 
language, rather than through improved iron or nutritional status. This 
study identifies modifiable risk factors for impaired infant development 
beginning in utero and the key pathways through which they act.
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MOTHERS SCREENING FOR MALNUTRITION BY MUAC 
IS NON-INFERIOR TO COMMUNITY HEALTH WORKERS: 
RESULTS FROM A LARGE-SCALE PRAGMATIC TRIAL IN RURAL 
NIGER
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Blackwell1
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Community health workers (CHWs) commonly screen for acute 
malnutrition in the community by assessing mid-upper arm circumference 
(MUAC) on children aged 6-59 months. MUAC is a simple screening 
tool that has been shown to be a better predictor of mortality in acutely 
malnourished children than other practicable anthropometric indicators. 
This study compared, under program conditions, mothers and CHWs in 
screening for severe acute malnutrition (SAM) with color-banded MUAC 
tapes and checking for edema. It took place from May 2013 to April 2014 
in two health zones of Niger’s Mirriah District. Mothers in Dogo (Mothers 
zone) were trained to screen children for malnutrition in their household 
and CHWs in Takieta (CHWs zone) were trained to screen children in the 
community. Exhaustive coverage surveys were conducted quarterly, and 
relevant data collected routinely in the health and nutrition program. 
An efficacy and cost analysis of each screening strategy was performed. 
12,893 mothers were trained in the mothers zone and 36 CHWs in the 
CHWs zone, and point coverage was similar in both zones at the end 
of the study (35% [26/74] Mothers Zone vs 32% [11/34] CHWs zone; 
p=0.7772).The rate of MUAC agreement (compared with health center 
agent) was higher in the Mothers zone (75.4% [721/956] vs 40.1% 
[221/551]; p<0.0001) and cases were detected earlier, with median MUAC 
at admission for those enrolled by MUAC <115 mm estimated to be 1.56 
mm (95%CI 0.65-1.87) higher using a smoothed bootstrap procedure. 
Children in the mothers zone were less likely to need inpatient care, both 
at admission and during treatment, with the most pronounced difference 
at admission for those enrolled by MUAC <115 mm (0.7% [4/569] vs 
7.8% [32/413]; risk ratio 0.09 [95%CI 0.03-0.25]; p<0.0001). Training 
mothers required higher up-front costs, but overall costs were much lower 
($8,600 USD vs $21,980 USD). Mothers were not inferior to CHWs in 
screening for malnutrition at a substantially lower cost, and children in 
the Mothers zone were admitted at an earlier stage of SAM with fewer 
hospitalizations. Empowering mothers to screen for malnutrition should be 
a part of treatment programs globally.
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INTERMITTENT PREVENTIVE TREATMENT OF 
MALARIA IN HIV-INFECTED PREGNANT WOMEN WITH 
DIHYDROARTEMISININ-PIPERAQUINE: A DOUBLE BLINDED 
RANDOMIZED CONTROLLED TRIAL
Paul B. Natureeba
Infectious Diseases Research Collaboration, Kampala, Uganda
Intermittent preventive therapy with sulfadoxine-pyrimethamine (IPT-SP)
is recommended for the prevention of malaria among HIV-uninfected 
pregnant women in sub-Saharan Africa. The WHO recommends that HIV-
infected pregnant women receiving daily trimethoprim-sulfamethoxazole 
(TS) prophylaxis should not be given SP due to drug toxicity concerns. 
Although daily TS has been shown to be more effective than IPT-SP, 
resistance to this class of antimalarials is widespread, especially in East 
Africa. We recently showed that IPT with dihydroartemisinin-piperaquine 
(DP) was more effective than SP for the prevention of malaria in 
pregnancy in HIV-uninfected women. To extend this approach to HIV-
infected women, we are conducting a double blind randomized placebo 
controlled trial comparing daily TS alone with daily TS plus monthly DP 
in Tororo District, Uganda. 200 HIV-infected pregnant women between 
12-28 weeks gestational age were enrolled between December 2014 
and October 2015. At enrollment, all women received a long lasting 
insecticide treated bed net and ensured to be taking combination 
antiretroviral therapy. Participants are being followed in a dedicated study 
clinic for all their medical care and encouraged to deliver at an adjacent 
hospital.The primary outcome is the risk of placental malaria defined by 
histopathology. Secondary outcomes include placental malaria defined 
by placental blood smear, birth outcomes, and the incidence of adverse 
events. As of 29th February 2016, 188 women had delivered and 12 were 
still being followed during pregnancy. The risk of placental malaria was 
6.4% by histopathology and 0.6% by placental blood smear. Adverse birth 
outcomes include 3 spontaneous abortions (1.6%),1 stillbirth (0.5%), 5 
congenital anomalies (2.7%),16preterm deliveries (8.7%), and 23 with low 
birth weight (12.4%). It is anticipated that all women will have delivered 
by April 2016 and that the final un-blinded results of the trial will be 
presented at the meeting.
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IMPACT OF EFAVIRENZ AND PREGNANCY ON PIPERAQUINE 
EXPOSURE IN UGANDAN PREGNANT WOMEN
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In malaria endemic areas HIV+ pregnant women receiving EFV-based 
combination antiretroviral therapy (EFV-cART) may receive artemisinin-
based combination therapies (ACTs) for the treatment or prevention 
of malaria. One ACT, dihydroartemisinin-piperaquine (DHA-PQ), has 
shown excellent efficacy for the treatment of falciparum malaria and 
for intermittent preventive therapy (IPT) in pregnancy. We evaluated PQ 
pharmacokinetics in the setting of DHA-PQ and EFV-cART in pregnant 
(28 wks gestation) and postpartum Ugandan women using an intensive 
design. These studies were included as part of our trials (PROMOTE) in 
Tororo, Uganda to inform IPT dosing guidelines. PQ levels after standard 
dosing of DHA-PQ (qD x 3d) were compared between a) HIV- (no cART, 
n=30) and HIV+ (EFV-cART, n=26) pregnant women to determine the 
impact of EFV and b) HIV - antepartum (n=30) and postpartum (n=23) 
women to determine the impact of pregnancy. The area under the 
concentration-time curve (AUC) was measured over 21 d. PQ levels were 
measured by LC tandem MS. We found highly significant decreases 
in PQ exposure for HIV+ women on EFV compared to HIV- women, as 
measured by AUC (6.60 vs 10.6 hr.ug/mL; GMR:0.62, p<0.005) and Day 
7,14, and 21 PQ levels (5.46, 1.62, 0.668 ng/mL vs 15.5, 5.37, 3.78 
ng/mL; GMR:0.35, 0.30, and 0.18, respectively, all p values <0.0001). 
Pregnancy was also associated with decreased PQ AUC when comparing 
ante-partum and post-partum women (10.6 vs 17.2 hr.ug/mL; GMR:0.63, 
p<0.0001), and day 7, 14, and 21 PQ concentrations (15.5, 5.37, 3.78 ng/
mL vs 32.8, 17.4, 11.4 ng/mL; GMR: 0.47, 0.31, 0.33, respectively, all p 
values ≤0.0001). EFV and pregnancy resulted in significant reductions in 
PQ exposure. For both HIV+ and HIV- pregnant women, mean PQ terminal 
concentrations were consistently <10 ng/mL, lower than the concentration 
previously estimated to be required for effective chemoprevention (30 
ng/mL). Clinical correlates of these findings are underway. DHA-PQ dose 
escalation for pregnant women and those receiving EFV-cART may merit 
study.
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MALARIA IN HIV-INFECTED CHILDREN RECEIVING 
HIV PROTEASE-INHIBITOR-COMPARED WITH NON-
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ANTIRETROVIRAL THERAPY
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HIV and malaria geographically overlap. HIV protease inhibitors kill 
malaria parasites in vitro and in vivo, but further evaluation in clinical 
studies is needed. Children from Malawi, Uganda, and Zambia were 
enrolled in P1068s, a substudy within a larger randomized HIV treatment 
study. Children aged 4-36 months were followed every 3 months and 
at intercurrent illness visits for up to 47 months between September 
2009 and December 2011. We compared malaria parasite carriage by 
blood smear microscopy (BS) and confirmed clinical malaria incidence 
(CCM, or positive BS with malaria symptoms) in children initiated on 
HIV antiretroviral therapy (ART) with zidovudine, lamivudine, and either 
nevirapine (NVP), a non-nucleoside reverse transcriptase inhibitor, or 
lopinavir-ritonavir (LPV-rtv), a protease inhibitor. Because of low rates of BS 
positivity at Ugandan and Zambian sites, we analyzed results from Malawi 
only, an area of low to moderate malaria transmission intensity. We found 
an association between increased time to recurrent positive BS, but not 
CCM, when anti-malarial treatment and LPV-rtv based ART were used 
concurrently and when accounting for a LPV-rtv and antimalarial treatment 
interaction (adjusted HR 0·39; 95% CI (0·17,0·89); p=0·03). In our study, 
LPV-rtv in combination with malaria treatment is associated with lower 
risk of recurrent positive BS, but not CCM, in HIV-infected children. Larger, 
randomized studies are needed to confirm these findings which may 
permit ART optimization for malaria-endemic settings.
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EFFECT OF DAILY TRIMETHOPRIM SULFAMETHOXAZOLE 
PROPHYLAXIS ON THE LONG-TERM CLINICAL IMPACT OF 
MALARIA INFECTION AMONG HIV INFECTED ADULTS ON 
SUCCESSFUL ART IN BLANTYRE, MALAWI
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1Blantyre Malaria Project, University of Malawi College of Medicine, 
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Sub-Saharan Africa has 90% and 70% of all new cases of malaria and HIV 
respectively. The risk of malaria infection is higher in HIV infected adults. 
Malaria infection in HIV positive individuals is associated with increased 
HIV plasma viral load (VL) and decreased CD4+ T cells. Daily trimethoprim 
sulfamethoxazole (TS) reduces the risk of malaria infection in HIV positive 
individuals but its long term benefit after successful ART has not been 
well documented. To determine the impact of TS on malaria infection 
and disease, we analyzed data from clinically stable, non-pregnant HIV 
infected adults on non protease inhibitor ART enrolled in an ongoing 
randomized controlled trial in Blantyre, an area with low to moderate 
malaria transmission. Participants with CD4 count >250 cells/mm3 and 
HIV VL of <400 copies/ml were enrolled and randomized to continue 
daily TS, discontinue TS, or discontinue TS and begin chloroquine. During 
the rainy season, we measured asymptomatic infection by quantitative 
PCR of dried blood spots. Clinical malaria was diagnosed in participants 
with symptoms suggestive of malaria and positive malaria smear by 
microscopy. We included only a subset of participants who continued 
on TS prophylaxis (n=34) or stopped prophylaxis (n=27). The two groups 
were similar in age, gender distribution, CD4 count, hemoglobin level and 
bed net use. Four participants in the TS discontinuation group developed 
clinical malaria compared to only one from the daily TS group. No episodes 
of asymptomatic malaria infection were detected by qPCR. Even in this 
lower transmission setting, TS prophylaxis was associated with protection 
against clinical malaria disease. The absence of asymptomatic malaria 
infection is in contrast with the common finding of high rates of low-level 
asymptomatic parasitemia in Malawi. HIV infected adults may be more 
likely to develop symptomatic disease; another possible interpretation is 
that ART or malaria prophylaxis confer some protection. We are currently 
undertaking immunological evaluation to determine mechanism of this 
observed phenomenon.
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PERSISTENCE OF LOWER ANTIBODY LEVELS TO VAR2CSA IN 
HIV-POSITIVE KENYAN PREGNANT WOMEN DESPITE HAART
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Malaria and HIV epidemics intersect in sub-Saharan Africa, 
disproportionally affecting young women, including those of childbearing 
age. Pregnancy provides Plasmodium falciparum parasite an additional 
niche for evading the immune system. Parasite-infected erythrocytes 
sequester in the placenta using the VAR2CSA adhesion molecule, 
causing placental malaria. Antibodies (Ab) against VAR2CSA improve 
pregnancy outcomes and a vaccine based on VAR2CSA is under clinical 
evaluation. Ab levels to VAR2CSA are lower in HIV-positive women 
compared to healthy controls. It is not clear whether widespread HAART 
implementation and immune reconstitution in HIV-positive pregnant 
women will improve their Ab responses to VAR2CSA. In a longitudinal 
case-control study we compared Ab levels to the full—length VAR2CSA 
(FV2) and its individual DBL domains (DBL1-DBL6), antibody avidity and 
cytokine levels between HIV-positive pregnant women receiving HAART 
and HIV-negative Kenyan pregnant women. At delivery no significant 
differences were observed in peripheral plasma levels of IL1β, IL2, IL4, IL6, 
IL7, IL8, IL10, IL12, IL21, IFNγ, TNFα, MIP1α, MIP1β between HIV-positive 
and HIV-negative women (all p>0.05) after adjusting for malaria status 
(PCR) and gravidity. In a multiple regression model adjusted for malaria 
status and gravidity, HIV was associated with significantly lower Ab levels 
at delivery to FV2, DBL1+2, DBL3 and DBL5 (all FCR3 strain); no significant 
differences were observed for DBL2, DBL4 and DBL6. In addition, HIV was 
associated with 5% decrease of Ab avidity to FV2 (p=0.03). Ab data from 
earlier visits during pregnancy are currently being analyzed. Lower Ab 
levels at delivery in HIV-positive women could contribute to less protection 
from placental malaria during the next pregnancy. Data on Ab responses 
to VAR2CSA in HIV-positive women on HAART are important in order to 
guide VAR2CSA-based vaccine regiments for HIV-positive women in sub-
Saharan Africa.
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ASSESSING IMPACT OF COMMUNITY-BASED 
ANTIRETROVIRAL THERAPY AND ITS SCALE UP: 
PERSPECTIVES FROM FOUR PRIORITY LOCAL GOVERNMENT 
AREAS IN LAGOS, NIGERIA
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Community-based antiretroviral therapy (cART) delivery is effective 
in improving the early identification of HIV-positive clients, access to 
treatment and quality of health outcomes of people living with HIV. The 
cART project scale-up (cART Plus) aimed to further improve on those 
gains in achieving more individual testing in the community, improve 
ART coverage, strengthen linkage and retention in care and subsequently 
achieve viral suppression over the long-term; in line with the UNAIDS 
90-90-90 targets. The cART project is being supported by USAID through 
SIDHAS. 4 LGAs in Lagos Nigeria were selected based on epidemiological 
and mapping indices. Community volunteers were recruited and trained 
in areas subsequently working with the CBOs to carry out community 
mobilization, household testing and counselling, identify positives and 
enrol to care, track and follow up on defaulters, documentation and 
reporting of service output data using approved tools. Data analysis 
spanning October to December 2015 in these 4 LGAs showed that the 
indices assessed significantly improved upon cART scale-up (cART Plus). 
Number of individuals counselled, tested and received results for HIV in the 
community {cART (Oct: 24 307); cART Plus (Nov: 61 532; Dec: 50 049)}. 
Number of individuals tested HIV-positive {cART (Oct: 65); cART Plus (Nov: 
364; Dec: 268)}. The positivity rate in the general population being {cART 
(Oct: 0.27%); cART Plus (Nov: 0.59%; Dec: 0.54%)}. Number of persons 
newly enrolled into the ART programme for PreART care in the community 
{cART (Oct: 34); cART Plus (Nov: 283; Dec: 214)}. Percentage enrolment 
{cART (Oct: 52.3%; cART Plus (Nov: 77.7%; Dec: 79.9%)}. Number of 
persons newly started on ART in the community {cART (Oct: 13; cART Plus 
(Nov: 106; Dec: 123)}. In conclusion, the cART delivery scale-up has shown 
to improve uptake and accessibility of treatment. This concept could 
be adopted in more resource-limited settings to improve ART coverage. 
However, efforts need to be channeled into advocacy for community 
ownership as community programs need to be driven, owned by and 
embedded in the communities.
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DEVELOPMENT OF A MUCOSAL VACCINE AGAINST HIV 
BASED ON GENETICALLY-ENGINEERED SACCHAROMYCES 
CEREVISIAE PROBIOTIC STRAINS
Mariana L. Palma1, Flaviano S. Martins2, Ernesto T. Marques Jr3, 
Bruno Douradinha4
1Department of Infectious Diseases and Microbiology, University of 
Pittsburgh, Pittsburgh, PA, United States, 2Instituto de Ciências Biológicas, 
Universidade Federal de Minas Gerais, Belo Horizonte, Brazil, 3University 
of Pittsburgh Center for Vaccine Research, Pittsburgh, PA, United States, 
4Fondazione Ri.MED, Palermo, Italy
Human immunodeficiency virus (HIV) is a major public health problem. 
It is estimated that 37 million people worldwide are infected with HIV 
and 2 million new infections are reported each year. A vaccine against 
HIV is urgently required to stop this epidemic. An efficient prophylactic 
vaccine strategy must induce a mucosal immune response, since most 
infections occur during sexual intercourse through vaginal and rectal 
mucosae. Probiotic Saccharomyces cerevisiae strains are known to provide 
health benefits in the gut when administered in correct doses, including 
stimulation of secretion in the colon. We engineered several probiotic S. 
cerevisiae strains to express the HIV GAG antigen on their surface, and 
are assessing the GAG expression levels and the genetically-engineered 
strains ability to resist gastrointestinal stresses. We are also quantifying 
the in vitro phagocytosis rates of GAG-expressing yeasts by macrophages 
and quantifying the levels of tumor necrosis factor-alpha (TNF-α), 
interferon-gamma, (IFN-γ), interleukin (IL)-1β, IL-5, IL-6, IL-8, IL-10, and 
IL-12 secreted by these antigen presenting cells following contact with 
the fungal engineered vectors. We are currently developing a humanized 
mouse model to evaluate the efficacy of genetically-modified S. cerevisiae 
probiotic strains as a potential prophylactic vaccine against HIV.
1930
DIALOGUE BETWEEN NEUTROPHILS AND HOOKWORMS 
DETERMINES PARASITE DEVELOPMENT
Tiffany Bouchery1, Beatrice Volpe1, Graham LeGros LeGros2, 
Nicola Harris1
1UPHARRIS, Global Health Institute, EPFL, Lausanne, Switzerland, 
2Malaghan Institute of Medical Research, Wellington, New Zealand
Hookworms are skin-penetrating parasites infecting about 700 million 
people, principally within improvised communities. The skin has recently 
been shown to be an important bulwark against parasite establishment 
in immune hosts. However, the initial interaction between the host and 
parasite within the skin following the first encounter with the parasite 
is still poorly characterized. Here, we investigate the fate of the larvae 
from their skin penetration to their migration to the lungs using intravital 
microscopy. We observe that neutrophils are rapidly recruited to the site of 
infection and adhere to the larvae. Surprisingly however, neutrophils are 
not sufficient to cause parasite killing. We further show that the parasite 
adjusts its development to the presence of the neutrophils by an evasion 
demarche: on one hand, the parasite delays its exsheathment to benefit 
from an additional layer of cuticle protection; on the other, in response to 
bleach induced by the neutrophils, the parasite secretes specific Excretory-
Secretory (ES) products with anti-neutrophil activity. Building on these 
observations, we show that vaccination with parasitic ES products renders 
the parasite susceptible to killing by neutrophils, presumably by allowing 
the host to neutralization parasitic products capable of interfering with 
neutrophil activity. Altogether, this study highlights that targeting both the 
nematode’s sensing mechanism and its secretory products with neutrophil 
inhibitory potential could enable parasite killing early during its migration 
and thus block its transmission.
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GENOMIC ABLATION OF CYST-WALL-PROTEIN-1 PREVENTS 
STAGE-SPECIFIC FORMATION OF GOLGI-LIKE ORGANELLES 
AND REGULATED SECRETION OF A CYST WALL IN G. 
LAMBLIA
Jacqueline Ebneter1, Sally D. Heusser1, Elisabeth M. Schraner2, 
Carmen Faso1, Adrian B. Hehl1
1Institute of Parasitology, University of Zurich, Zurich, Switzerland, 
2Institute of Veterinary Anatomy, University of Zurich, Zurich, Switzerland
The genome of the ubiquitous protozoan parasite G. lamblia is organized 
in two diploid nuclei, which has so far precluded complete analysis of 
gene function. Here we used a previously developed Cre‐loxPbased 
knock‐out and selection marker salvage strategy in the human‐derived 
isolate WB‐C6 to eliminate all four copies of the Cyst Wall Protein 1 locus 
(cwp1). Because the cwp1 loci are silenced in proliferating trophozoites 
and expressed only in encysting cells, complete CWP1 ablation allowed 
functional characterization of a conditional phenotype in differentiating 
cells. Induced ‐cwp1 cells show morphological hallmarks of cyst 
development as well as karyokinesis, but are unable to establish the 
stage‐regulated trafficking machinery with Golgi‐like encystation‐specific 
vesicles required for cyst wall formation. The wall‐less “pseudocyst” 
phenotype could be rescued by transfection with an episomallymaintained 
CWP1 expression vector. This is the first example of genome editing and 
functional analysis or a locus essential for transmission between hosts in a 
diplomonad parasitic species.
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ADIPOSE TISSUE IS A MAJOR RESERVOIR OF FUNCTIONALLY 
DISTINCT TRYPANOSOMA BRUCEI PARASITES
Sandra Trindade1, Filipa Rijo-Ferreira1, Tânia Carvalho1, Daniel 
Pinto-Neves1, Fabien Guegan1, Francisco Aresta-Branco1, Fabio 
Bento1, Simon A. Young2, Andreia Pinto1, Jan Van Den Abbeele3, 
Ruy M. Ribeiro4, Sérgio Dias1, Terry K. Smith2, Luisa M. Figueiredo1
1Instituto de Medicina Molecular, Lisboa, Portugal, 2University of St. 
Andrews, St. Andrews, United Kingdom, 3Institute of Tropical Medicine 
Antwerp, Antwerp, Belgium, 4Los Alamos National Laboratory, Los 
Alamos, NM, United States
In the mammalian host, Trypanosoma brucei parasites are thought to 
reside mainly in the blood. Although these parasites are also present 
in the interstitial spaces of organs, such as brain, the extent of these 
extravascular sites has never been assessed. Using a mouse model, in this 
study, we identified the adipose tissue as a previously unknown major 
reservoir of T. brucei parasites. Histology and quantitative studies revealed 
that, in chronic stages of disease, there are 100-fold more parasites in 
adipose tissue than blood and 800-fold more than brain. Morphometric 
analysis of a GFP::PAD1UTR reporter cell-line showed that adipose tissue 
parasites (ATFs) can be found as slender, intermediate and stumpy forms. 
We also showed that ATFs are capable of infecting naïve mice, suggesting 
they are viable and can reestablish a blood infection. To test if parasites 
from adipose tissue and blood are functionally different, we performed 
RNA-seq of these parasites. ATFs are remarkably distinct from their blood 
counterparts in several key regulatory processes, including putative fatty 
acid ‐-oxidation enzymes. Pulse-chase biochemical assays confirmed 
that ATFs are indeed able to catabolize exogenous myristate and form 
‐-oxidation intermediates, suggesting that ATF parasites can use fatty acids 
as an external carbon source, a behavior never previously reported for any 
life cycle stage of this parasite. All together, these findings identify the 
adipose tissue as a niche for T. brucei during its mammalian life cycle. In 
the future, it will be interesting to test if this is the cause of the weight 
loss associated with sleeping sickness and to investigate how such a large 
parasite reservoir impacts population dynamics and transmission to other 
hosts.
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ANALYZING THE CRYPTIC STATOR OF THE ATP SYNTHASE 
COMPLEX IN TOXOPLASMA GONDII
Diego Huet, Saima M. Sidik, Sebastian Lourido
Whitehead Institute, Cambridge, MA, United States
The mitochondrial Fo-F1 ATP synthase is a macromolecular complex present 
in almost every organism that couples the proton-motive force generated 
by respiration to synthesis of ATP. The complex can be divided in two main 
portions: F1, which has the catalytic sites for ATP synthesis; and Fo, which 
forms a channel allowing protons to move down their electrochemical 
gradient. The Fo portion of the ATP synthase also contains a stator, which 
is needed to resist the rotational torque of F1. In apicomplexans, little is 
known about the organization and function of the ATP synthase. While 
all the F1 constituents have been identified, the information about the 
Fo subunits is fragmentary, and sequence-based searches have failed to 
identify any stator subunits. By performing a genome-wide CRISPR-based 
screen in Toxoplasma gondii, we identified several mitochondrially-
localized proteins, unique to apicomplexans, and essential for survival 
in human fibroblasts. One such subunit had structural similarity to the 
ATP synthase b subunit, a central stator component. Tagging the protein 
endogenously showed that it is localized to the parasite mitochondria 
and that it co-immunoprecipitates with all the ATP synthase F1 subunits, 
consistent with its putative role as the b subunit. Visualized by negative 
stain electron microscopy, the complex assumes the typical organization, as 
well as unusual higher-order arrangements. We are currently studying the 
function of the putative stator through a series of genetic and biochemical 
approaches. The study of the cryptic apicomplexan stator will yield new 
knowledge about the function of the ATP synthase in these parasites, and 
uncover potential therapeutic susceptibilities.
1934
TOXOPLASMA GONDII INTERACTIONS WITH THE HOST LIPID 
DROPLETS: RECRUITMENT, NEUTRAL LIPID SCAVENGING 
AND CONSEQUENCES
Sabrina Nolan, Julia D. Romano, Isabelle Coppens
Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United 
States
Toxoplasma gondii has evolved to recruit host mammalian organelles 
to its parasitophorous vacuole (PV) in part to divert essential nutrients 
present in host organelles. We explored the role of host lipid droplets (LD) 
as sources of neutral lipids for the parasite. We demonstrate that host 
LD cluster around the PV and LD numbers increase and then decrease 
with infection, suggesting that Toxoplasma manipulates these structures. 
Indeed, Toxoplasma scavenges lipids from host LD, in part through the 
interception of Rab7-associated LD, and through the translocation of intact 
host LD into its PV. In mammalian cells, the exogenous addition of oleic 
acid (OA) up to 1mM is non-toxic and stimulates LD biogenesis. When 
exposed to 0.2mM OA, intravacuolar Toxoplasma profusely scavenges 
OA, channels this fatty acid to newly formed LD, with a concurrent 
increase in transcriptional activities of neutral lipid-generating enzymes 
However, this condition slows down both parasite replication and egress. 
By comparison, 0.2mM palmitic acid added in the medium does not affect 
parasite development whereas 1mM jasmonic acid boosts parasite growth. 
Our ultrastructural analyses of OA-loaded Toxoplasma reveal, for the first 
time, the presence of coated pits at the parasite’s plasma membrane and 
additional structures potentially involved in endocytosis. More dramatically, 
exogenous addition of 0.4 mM OA results in the massive accumulation 
of lipid deposits in the PV and within parasite organelles, leading to 
replication defects and death. This highlights the high sensitivity of 
Toxoplasma towards deleterious effects of accumulating OA. Deciphering 
the lipotoxic response of the parasite may reveal new vulnerabilities 
amenable to controlling Toxoplasma infections.<!--EndFragment-->
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IDENTIFICATION OF BROADLY CONSERVED CROSS-SPECIES 
PROTECTIVE LEISHMANIA ANTIGEN AND ITS RESPONDING 
CD4+ T CELLS
Zhirong Mou1, Jintao Li2, Dong Liu2, Forough Khadem2, Ifeoma 
Okwor2, Jude E. Uzonna2
1Department of Immunology, College of Medicine, University of Manitoba, 
Winnipeg, MB, United States, 2Department of Immunology, College of 
Medicine, University of Manitoba, Winnipeg, MB, Canada
Despite a plethora of publication on immunology of leishmaniasis, there is 
still no vaccine against the disease. Recovery from natural or experimental 
infection with Leishmania major induces long-term protection to 
reinfection collectively known as infection-induced resistance. However, 
it is not known what antigens induce and maintain this resistance and 
whether these antigens preferentially favor the development of memory T 
cells. To identify protective Leishmania antigens, we eluted and identified 
naturally processed L. major peptides from I-Ab MHC II molecules on 
infected BMDCs by immunoproteomics approach. One of the peptides 
activated Leishmania-reactive T cells from mice that have healed their 
primary L. major infection in vitro. Interestingly, the source protein of 
this peptide, glycosomal phosphoenolpyruvate carboxykinase (PEPCK), 
was expressed in both the promastigote and amastigote stages of the 
parasite. Also, cellular immune responses against PEPCK were detected 
in L. major-infected patients, while antibody responses were detected 
in infected mice, dogs and human. I-Ab-PEPCK335-351 tetramer identified 
for the first time protective Leishmania-specific CD4+ T cells at clonal 
level, which comprised ~ 20% of all Leishmania-reactive CD4+ T cells at 
the peak of infection. PEPCK335-351-specific CD4
+ T cells are oligoclonal 
in their TCR usage, produce polyfunctional cytokines (IL-2, IFN-‐ and 
TNF) and undergo expansion, effector activities, contraction and stable 
maintenance following lesion resolution. Vaccination with PEPCK peptide, 
DNA expressing full length PEPCK or rPEPCK induced strong durable 
cross-species protection in both resistant and susceptible mice. Given 
the remarkable effectiveness and durability of protection in vaccinated 
mice, our study suggests a real possibility for development of a broadly 
cross-species protective vaccine against different forms leishmaniasis by 
targeting PEPCK.
1936
A NOVEL POPULATION OF NATURAL KILLER CELLS PLAYS A 
CRITICAL ROLE IN THE DEPLETION OF SPLENIC B2 B CELLS 
DURING EXPERIMENTAL AFRICAN TRYPANOSOMIASIS
Deborah Frenkel1, Samuel J. Black2
1University of Massachusetts, Department of Veterinary and Animal 
Sciences, Amherst, MA, United States, 2University of Massachusetts, 
Amherst, MA, United States
Mice infected with Trypanosoma brucei, the causative agent of human 
sleeping sickness and a contributor to nagana in cattle, rapidly lose 
the capacity to mount VSG-specific antibody responses, and die with 
uncontrolled parasitemia. We have shown (Bockstal et al., 2011, PLOS 
Pathogens) that the loss of humoral immune competence in the infected 
mice results from depletion of developing and mature splenic B cells. We 
now report that T. brucei-induced splenic B cell depletion is dependent 
upon the presence of the pore forming molecule perforin which is present 
in the cytotoxic granules of cytotoxic T lymphocytes, natural killer T 
cells and natural killer cells, occurs in the absence of T cells (and natural 
killer T cells), i.e., in T cell receptor (αβγδ)-/- mice, but does not occur 
in intact mice that are depleted of natural killer (NK) cells by treatment 
with monoclonal antibody specific for the NK1.1 differentiation antigen. 
In the intact mice, B cells are deleted after remission of the first T. brucei 
parasitemic wave. At this time natural killer cells are expressing the 
cytotoxic granule marker CD107a, indicating that they have degranulated, 
executing their effector function. Moreover, in vitro assays show that 
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B cells from T. brucei infected mice are killed by natural killer cells from 
uninfected C57BL/6 mice but not efficiently killed by CD107a positive 
natural killer cells isolated from infected mice, which may be functionally 
exhausted.
1937
ENDOGENOUS PHOSPHOLIPASE A2 GROUP 1B (PLA2G1B) 
HAS DIRECT ANTI-HELMINTH PROPERTIES AND IS ESSENTIAL 
FOR IMMUNITY TO HELIGMOSOMOIDES POLYGYRUS
Lewis Entwistle1, Victoria S. Pelly1, Stephanie M. Coomes1, 
Yashaswini Kannan1, Jimena Perez-Lloret1, Nikolay Nikolov1, 
Helena Helmby2, David Hui3, Mark S. Wilson1
1The Francis Crick Institute, Mill Hill Laboratory, London, United Kingdom, 
2Immunology and Infection Department, London School of Hygiene and 
Tropical Health, London, United Kingdom, 3Department of Pathology, 
Metabolic Diseases Institute, University of Cincinnati College of Medicine, 
Cincinnati, OH, United States
With emerging evidence of drug-resistant helminths, it is important to 
identify mechanisms of anti-helminth immunity to provide new avenues 
of therapeutic intervention. To identify novel mechanisms of immunity 
we compared the small intestinal transcriptome of mice that were 
susceptible (primary infected, H. p. 1o) or resistant (secondary challenge 
infected, H. p. 2o) to the evolutionally adapted murine intestinal helminth 
Heligmosomoides polygyrus. We identified distinct clusters of genes in 
resistant mice, some of which have previously been described, and many 
that have not. In particular, we identified elevated expression of lipid 
metabolism pathways and the lipid catabolising enzyme, Phospholipase 
A2 Group 1B (Pla2g1b), in resistant, but not susceptible mice. Elevated 
expression of Pla2g1b was dependent upon drug-mediated killing of 
H. polygyrus and was restricted to epithelial cells of the small intestine. 
Importantly, elevated expression of Pla2g1b was critical for immunity to H. 
polygyrus, as Pla2g1b—/— mice failed to expel a challenge infection with 
H. polygyrus. Proficient immunity to Nippostrongylus brasiliensis, but not 
Trichuris muris, also required Pla2g1b suggesting preferential requirement 
for Pla2g1b in the small intestine, but not large intestine. The failure to 
expel H. polygyrus in Pla2g1b—/— mice was not due to an ineffectual or 
aberrant immune response. Instead we show that Phospholipase A2 Group 
1B had a direct effect on H. polygyrus larvae, with in vitro treatment of L3 
larvae compromising their ability to establish in vivo and treatment of H. 
polygyrus larvae restoring immunity in Pla2g1b—/— mice. Together, these 
data indicate that endogenous epithelial cell-associated Pla2g1b is required 
for direct killing of invading larvae; revealing a previously unrecognised 
Pla2g1b-dependent mechanism of anti-helminth immunity.
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A SERUM FACTOR REGULATES SEXUAL COMMITMENT IN P. 
FALCIPARUM
Nicolas M. B. Brancucci1, Joseph P. Gerdt2, Charley Wang3, 
Mariana De Niz1, Nisha Philip1, Swamy R. Adapa3, Min Zhang3, 
Martha Clark4, Christoph Gruering4, Alison Demas4, Selma Bopp4, 
Dyann Wirth4, Manoj Duraisingh4, John Adams3, Andrew P. 
Waters1, Rays H. Y. Jiang3, Jon C. Clardy2, Matthias Marti1
1Wellcome Trust Centre for Molecular Parasitology, Institute of Infection, 
Immunity and Inflammation, College of Medical, Veterinary and Life 
Sciences, University of Glasgow, Glasgow, United Kingdom, 2Harvard 
Medical School, Department of Biological Chemistry and Molecular 
Pharmacology, Boston, MA, United States, 3Center for Global Health 
and Infectious Diseases Research, Department of Global Health, College 
of Public Health, University of South Florida, Tampa, FL, United States, 
4Harvard T.H. Chan School of Public Health, Department of Immunology 
and Infectious Diseases, Boston, MA, United States
Sexual commitment initiates production of the transmission-competent 
gametocyte stage in malaria parasites. Chromatin remodeling events at 
the ap2-g locus and activation of the encoded transcription factor are the 
earliest steps known in this differentiation process. Interestingly, the rate of 
gametocyte formation is not fixed and variation is thought to depend on 
environmental cues.
Using an assay to probe gametocyte formation in vitro, we found 
that parasites induce sexual commitment in response to depletion 
of human serum components. Fractionation experiments identified 
lysophosphatidylcholine (LysoPC) - a major phospholipid component of 
serum - as the active host factor. Low micromolar concentrations of LysoPC 
are sufficient to prevent sexual differentiation in P. falciparum cultured 
under otherwise commitment-inducing conditions. Metabolic labeling 
experiments revealed that parasites readily use LysoPC as a substrate for 
the synthesis of other lipids, including phosphatidylcholine (PC). In the 
absence of LysoPC, parasites induce a switch in lipid metabolism that is 
accompanied by the transcriptional up-regulation of enzymes used for 
de novo synthesis of PC (Kennedy pathway). RNAseq data revealed that 
LysoPC-depletion further induces the expression of both known (i.e. ap2-g) 
and new markers that define the transcriptional signature of commitment. 
A subset of those markers, including several kinases and cell cycle 
regulators, are currently under investigation. Altogether, our results provide 
unprecedented insights on how malaria parasites integrate external stimuli 
into the decision-making process of sexual differentiation.
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MOLECULAR DISSECTION OF CRYPTOSPORIDIUM LIFECYCLE
Jayesh V. Tandel, Adam Sateriale, Brittain Pinkston, Carrie 
Brooks, Boris Striepen
Center for Tropical and Emerging Global Diseases, University of Georgia, 
Athens, GA, United States
Cryptosporidium is a leading cause of diarrhea and an important 
contributor to infant mortality. Neither efficacious drugs nor vaccines are 
available and our knowledge of the Cryptosporidium biology to drive 
their development is scant. Cryptosporidium has a single-host lifecycle, 
and completes its asexual and sexual phases in the same host. While one 
model suggests that Cryptosporidium sustains continued infection of a 
single host through an asexual cycle, we believe progression from asexual 
to sexual stages to be obligatory, and favor a developmental model of 
continued autoinfection with sporozoites. Sex is thus a requirement of 
chronicity and an important target of therapy. To unravel this process 
at the molecular level we have developed a series of transgenic C. 
parvum strains that mark different stages of the lifecycle with fluorescent 
reporters. Using these tools we demonstrate and define asexual and 
sexual stages in tissue culture and infected animals and we observe 
mating. These strains also allow us to enrich specific stages by flow 
cytometry to discover sets of genes uniquely expressed at different points 
of the parasite’s lifecycle. ApiAP2 transcription factors are key regulators 
of apicomplexan development making them ideal targets to disrupt 
lifecycle progression. We have identified and tagged ApiAP2 factors 
that are expressed exclusively in early trophozoites, schizonts and female 
gamonts of Cryptosporidium parvum, respectively. Our current work uses 
conditional ablation of key AP2 genes to dissect the cellular mechanisms 
and transcriptional regulation of sex in Cryptosporidium.
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